PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Cuenca, A; Insinna, C; Zhao, HJ; John, P; Weiss, MA; Lu, QL; Walia, V; Specht, S; Manivannan, S; Stauffer, J; Peden, AA; Westlake, CJ				Cuenca, Adrian; Insinna, Christine; Zhao, Huijie; John, Peter; Weiss, Matthew A.; Lu, Quanlong; Walia, Vijay; Specht, Suzanne; Manivannan, Selvambigai; Stauffer, Jimmy; Peden, Andrew A.; Westlake, Christopher J.			The C7orf43/TRAPPC14 component links the TRAPPII complex to Rabin8 for preciliary vesicle tethering at the mother centriole during ciliogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cilia; Rab; intracellular trafficking; membrane trafficking; centrosome; ciliogenesis; mother centriole; Rabin8; TRAPPII complex; RAB3A-interacting protein (RAB3IP)	GUANINE-NUCLEOTIDE EXCHANGE; GTPASE RAB8; EARLY STEPS; PROTEIN; CILIA; GOLGI; SPECIFICITY; PATHWAYS; DOCKING; BINDING	The primary cilium is a cellular sensor that detects light, chemicals, and movement and is important for morphogen and growth factor signaling. The small GTPase Rab11?Rab8 cascade is required for ciliogenesis. Rab11 traffics the guanine nucleotide exchange factor (GEF) Rabin8 to the centrosome to activate Rab8, needed for ciliary growth. Rabin8 also requires the transport particle protein complex (TRAPPC) proteins for centrosome recruitment during ciliogenesis. Here, using an MS-based approach for identifying Rabin8-interacting proteins, we identified C7orf43 (also known as microtubule-associated protein 11 (MAP11)) as being required for ciliation both in human cells and zebrafish embryos. We find that C7orf43 directly binds to Rabin8 and that C7orf43 knockdown diminishes Rabin8 preciliary centrosome accumulation. Interestingly, we found that C7orf43 co-sediments with TRAPPII complex subunits and directly interacts with TRAPPC proteins. Our findings establish that C7orf43 is a TRAPPII-specific complex component, referred to here as TRAPPC14. Additionally, we show that TRAPPC14 is dispensable for TRAPPII complex integrity but mediates Rabin8 association with the TRAPPII complex. Finally, we demonstrate that TRAPPC14 interacts with the distal appendage proteins Fas-binding factor 1 (FBF1) and centrosomal protein 83 (CEP83), which we show here are required for GFP-Rabin8 centrosomal accumulation, supporting a role for the TRAPPII complex in tethering preciliary vesicles to the mother centriole during ciliogenesis. In summary, our findings have revealed an uncharacterized TRAPPII-specific component, C7orf43/TRAPPC14, that regulates preciliary trafficking of Rabin8 and ciliogenesis and support previous findings that the TRAPPII complex functions as a membrane tether.	[Cuenca, Adrian; Insinna, Christine; Zhao, Huijie; John, Peter; Weiss, Matthew A.; Lu, Quanlong; Walia, Vijay; Specht, Suzanne; Stauffer, Jimmy; Westlake, Christopher J.] NCI, Ctr Canc Res, NIH, Lab Cellular & Dev Signaling, Frederick, MD 21702 USA; [Manivannan, Selvambigai; Peden, Andrew A.] Univ Sheffield, Dept Biomed Sci, Sheffield S10 2TN, S Yorkshire, England	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Sheffield	Westlake, CJ (corresponding author), NCI, Ctr Canc Res, NIH, Lab Cellular & Dev Signaling, Frederick, MD 21702 USA.	chris.westlake@nih.gov	Lu, Quanlong/M-4436-2015; Westlake, Christopher/AAG-1150-2019; Zhao, Huijie/GNH-4458-2022	Lu, Quanlong/0000-0002-4261-5121; Westlake, Christopher/0000-0001-7476-2014; Zhao, Huijie/0000-0002-8595-8159; Manivannan, Selvambigai/0000-0003-0415-2928	Intramural Research Program of NCI, National Institutes of Health; Biotechnology and Biological Sciences Research Council UK [BB/L002841/1]; BBSRC [BB/L002841/1] Funding Source: UKRI	Intramural Research Program of NCI, National Institutes of Health; Biotechnology and Biological Sciences Research Council UK(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This research was supported by the Intramural Research Program of NCI, National Institutes of Health. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by Biotechnology and Biological Sciences Research Council UK Grant BB/L002841/1.	Bassik MC, 2013, CELL, V152, P909, DOI 10.1016/j.cell.2013.01.030; Bryant DM, 2010, NAT CELL BIOL, V12, P1035, DOI 10.1038/ncb2106; Cai HQ, 2005, J CELL BIOL, V171, P823, DOI 10.1083/jcb.200505145; Cai HQ, 2007, NATURE, V445, P941, DOI 10.1038/nature05527; Chen SL, 2011, MOL BIOL CELL, V22, P3634, DOI 10.1091/mbc.E11-03-0197; Chiba S, 2013, EMBO J, V32, P874, DOI 10.1038/emboj.2013.32; Choi C, 2011, TRAFFIC, V12, P715, DOI 10.1111/j.1600-0854.2011.01181.x; Daly OM, 2016, J CELL SCI, V129, P1769, DOI 10.1242/jcs.186221; Das S, 2010, J PROTEOME RES, V9, P6696, DOI 10.1021/pr100843x; Duerinckx S, 2018, MOL GENET GENOM MED, V6, P660, DOI 10.1002/mgg3.400; Feng SS, 2012, J BIOL CHEM, V287, P15602, DOI 10.1074/jbc.M111.333245; Finetti F, 2015, J CELL SCI, V128, P2541, DOI 10.1242/jcs.171652; Insinna C, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-08192-9; Jayaraman D, 2018, ANNU REV GENOM HUM G, V19, P177, DOI 10.1146/annurev-genom-083117-021441; Knodler A, 2010, P NATL ACAD SCI USA, V107, P6346, DOI 10.1073/pnas.1002401107; Li CM, 2017, EMBO J, V36, P441, DOI 10.15252/embj.201694866; Liang Y, 2007, MOL BIOL CELL, V18, P2533, DOI 10.1091/mbc.e07-03-0221; Lipatova Z, 2016, GENETICS, V204, P1117, DOI 10.1534/genetics.116.194910; Lobo GP, 2017, J BIOL CHEM, V292, P14814, DOI 10.1074/jbc.M117.795674; Lu Q, 2015, NAT CELL BIOL, V17, P228, DOI 10.1038/ncb3109; Lynch-Day MA, 2010, P NATL ACAD SCI USA, V107, P7811, DOI 10.1073/pnas.1000063107; Malicki J, 2011, METHOD CELL BIOL, V101, P39, DOI 10.1016/B978-0-12-387036-0.00003-7; Miyamoto T, 2011, HUM MOL GENET, V20, P2058, DOI 10.1093/hmg/ddr090; Mojallal M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5557; Molla-Herman A, 2010, J CELL SCI, V123, P1785, DOI 10.1242/jcs.059519; Morozova N, 2006, NAT CELL BIOL, V8, P1263, DOI 10.1038/ncb1489; Nachury MV, 2007, CELL, V129, P1201, DOI 10.1016/j.cell.2007.03.053; Ortiz D, 2002, J CELL BIOL, V157, P1005, DOI 10.1083/jcb.200201003; Patwardhan D, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-017-0101-9; Perez Y, 2019, BRAIN, V142, P574, DOI 10.1093/brain/awz004; Ramirez-Peinado S, 2017, J CELL SCI, V130, P2251, DOI 10.1242/jcs.199521; Reilly ML, 2019, HUM MOL GENET, V28, P778, DOI 10.1093/hmg/ddy381; Reiter JF, 2017, NAT REV MOL CELL BIO, V18, P533, DOI 10.1038/nrm.2017.60; Riedel F, 2018, J CELL BIOL, V217, P601, DOI 10.1083/jcb.201705068; ROSSI G, 1995, MOL BIOL CELL, V6, P1769, DOI 10.1091/mbc.6.12.1769; Sacher M, 1998, EMBO J, V17, P2494, DOI 10.1093/emboj/17.9.2494; Sacher M, 2001, MOL CELL, V7, P433, DOI 10.1016/S1097-2765(01)00190-3; Sacher M, 2019, TRAFFIC, V20, P5, DOI 10.1111/tra.12615; Santos-Cortez RLP, 2018, HUM GENET, V137, P735, DOI 10.1007/s00439-018-1928-6; Sato T, 2014, J CELL SCI, V127, P422, DOI 10.1242/jcs.136903; Schmidt KN, 2012, J CELL BIOL, V199, P1083, DOI 10.1083/jcb.201202126; Schou Kenneth B, 2014, Cilia, V3, P6, DOI 10.1186/2046-2530-3-6; Scrivens PJ, 2011, MOL BIOL CELL, V22, P2083, DOI 10.1091/mbc.E10-11-0873; SOROKIN S, 1962, J CELL BIOL, V15, P363, DOI 10.1083/jcb.15.2.363; Tanos BE, 2013, GENE DEV, V27, P163, DOI 10.1101/gad.207043.112; Thomas LL, 2016, J CELL BIOL, V215, P499, DOI 10.1083/jcb.201608123; Tokarev AA, 2009, TRAFFIC, V10, P1831, DOI 10.1111/j.1600-0854.2009.00988.x; Torres JZ, 2009, PROTEOMICS, V9, P2888, DOI 10.1002/pmic.200800873; Walia V, 2019, DEV CELL, V50, P229, DOI 10.1016/j.devcel.2019.05.022; Wang L, 2018, DEVELOPMENT, V145, DOI 10.1242/dev.151407; Wang N, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002437; Wang W, 2000, J CELL BIOL, V151, P289, DOI 10.1083/jcb.151.2.289; Waters AM, 2015, J MED GENET, V52, P147, DOI 10.1136/jmedgenet-2014-102691; Waters AM, 2011, PEDIATR NEPHROL, V26, P1039, DOI 10.1007/s00467-010-1731-7; Westlake CJ, 2007, P NATL ACAD SCI USA, V104, P1236, DOI 10.1073/pnas.0610500104; Westlake CJ, 2011, P NATL ACAD SCI USA, V108, P2759, DOI 10.1073/pnas.1018823108; Wu CT, 2018, NAT CELL BIOL, V20, P175, DOI 10.1038/s41556-017-0018-7; Xu SY, 2018, J CELL SCI, V131, DOI 10.1242/jcs.213710; Yamamoto K, 2002, CURR GENET, V42, P85, DOI 10.1007/s00294-002-0336-5; Yamasaki A, 2009, MOL BIOL CELL, V20, P4205, DOI 10.1091/mbc.E09-05-0387; Yang TT, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04469-1; Yip CK, 2010, NAT STRUCT MOL BIOL, V17, P1298, DOI 10.1038/nsmb.1914; Yoshimura S, 2007, J CELL BIOL, V178, P363, DOI 10.1083/jcb.200703047	63	10	10	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 18	2019	294	42					15418	15434		10.1074/jbc.RA119.008615	http://dx.doi.org/10.1074/jbc.RA119.008615			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JQ9HM	31467083	Green Published, hybrid			2022-12-26	WOS:000499248700019
J	Bekkering, I; Leeuwerke, M; Tanis, JC; Schoots, MH; Verkaik-Schakel, RN; Plosch, T; Bilardo, CM; Eijsink, JJH; Bos, AF; Scherjon, SA				Bekkering, Iris; Leeuwerke, Mariette; Tanis, Jozien C.; Schoots, Mirthe H.; Verkaik-Schakel, Rikst Nynke; Plosch, Torsten; Bilardo, Caterina M.; Eijsink, Jasper J. H.; Bos, Arend F.; Scherjon, Sicco A.			Differential placental DNA methylation of VEGFA and LEP in small-for-gestational age fetuses with an abnormal cerebroplacental ratio	PLOS ONE			English	Article							FETAL-GROWTH RESTRICTION; INDUCIBLE FACTOR-I; GENE-EXPRESSION; IMPRINTED GENES; PATTERNS; TISSUE; ERYTHROPOIETIN; DEMETHYLATION; PROMOTER; PROTEIN	Background In Fetal Growth Restriction 'fetal programming' may take place via DNA methylation, which has implications for short-term and long-term health outcomes. Small-for-gestational age fetuses are considered fetal growth restricted, characterized by brain-sparing when fetal Doppler hemodynamics are abnormal, expressed as a cerebroplacental ratio (CPR) < 1. We aimed to determine whether brain-sparing is associated with altered DNA methylation of selected genes. Methods We compared DNA methylation of six genes in 41 small-for-gestational age placentas with a normal or abnormal CPR. We selected EPO, HIF1A, VEGFA, LEP, PHLDA2, and DHCR24 for their role in angiogenesis, immunomodulation, and placental and fetal growth. DNA methylation was analyzed by pyrosequencing. Results Growth restricted fetuses with an abnormal CPR showed hypermethylation of the VEGFA gene at one CpG (VEGFA-309, p =.001) and an overall hypomethylation of the LEP gene, being significant at two CpGs (LEP-123, p =.049; LEP-51, p =.020). No differences in methylation were observed for the other genes. Conclusions VEGFA and LEP genes are differentially methylated in placentas of small-for-gestational age fetuses with brain-sparing. Hypermethylation of VEGFA-309 in abnormal CPR-placentas could indicate successful compensatory mechanisms. Methylation of LEP-51 is known to suppress LEP expression. Hypomethylation in small-for-gestational age placentas with abnormal CPR may result in hyperleptinemia and predispose to leptin-resistance later in life.	[Bekkering, Iris; Leeuwerke, Mariette; Tanis, Jozien C.; Verkaik-Schakel, Rikst Nynke; Plosch, Torsten; Bilardo, Caterina M.; Eijsink, Jasper J. H.; Scherjon, Sicco A.] Univ Groningen, Univ Med Ctr Groningen, Dept Obstet & Gynecol, Groningen, Netherlands; [Bekkering, Iris; Tanis, Jozien C.; Bos, Arend F.] Univ Groningen, Univ Med Ctr Groningen, Beatrix Childrens Hosp, Dept Neonatol, Groningen, Netherlands; [Schoots, Mirthe H.] Univ Groningen, Univ Med Ctr Groningen, Dept Pathol, Groningen, Netherlands	University of Groningen; University of Groningen; University of Groningen	Bekkering, I (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Obstet & Gynecol, Groningen, Netherlands.; Bekkering, I (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Beatrix Childrens Hosp, Dept Neonatol, Groningen, Netherlands.	i.bekkering@umcg.nl		Schoots, Mirthe/0000-0003-2168-2517; Bekkering, Iris/0000-0002-4480-9448				Ashworth CJ, 2000, REV REPROD, V5, P18, DOI 10.1530/ror.0.0050018; Beukers F, 2017, J PEDIATR-US, V188, P103, DOI 10.1016/j.jpeds.2017.06.003; Bouchard L, 2010, DIABETES CARE, V33, P2436, DOI 10.2337/dc10-1024; Ciesielski TH, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0627-8; Conrad KP, 1996, FASEB J, V10, P760, DOI 10.1096/fasebj.10.7.8635693; Diplas AI, 2009, EPIGENETICS-US, V4, P235, DOI 10.4161/epi.9019; Drzewinska J, 2011, MOL BIOL REP, V38, P1091, DOI 10.1007/s11033-010-0206-z; Green BB, 2015, BIOL REPROD, V92, DOI 10.1095/biolreprod.115.128066; Henson MC, 2000, BIOL REPROD, V63, P1219, DOI 10.1095/biolreprod63.5.1219; Henson MC, 2006, BIOL REPROD, V74, P218, DOI 10.1095/biolreprod.105.045120; Hillman SL, 2015, EPIGENETICS-US, V10, P50, DOI 10.4161/15592294.2014.989741; Iriyama T, 2015, HYPERTENSION, V65, P1307, DOI 10.1161/HYPERTENSIONAHA.115.05314; Janssen AB, 2016, BMC MED GENET, V17, DOI 10.1186/s12881-016-0279-1; Jensen AB, 2014, PLACENTA, V35, P528, DOI 10.1016/j.placenta.2014.04.018; Jones PA, 2012, NAT REV GENET, V13, P484, DOI 10.1038/nrg3230; Koslowski M, 2011, ONCOGENE, V30, P876, DOI 10.1038/onc.2010.481; Koukoura O, 2012, MOL MED REP, V5, P883, DOI 10.3892/mmr.2012.763; Krempler F, 2000, ARTERIOSCL THROM VAS, V20, P443, DOI 10.1161/01.ATV.20.2.443; Krishnan T, 2017, SEMIN FETAL NEONAT M, V22, P415, DOI 10.1016/j.siny.2017.04.005; Lazo-de-la-Vega-Monroy ML, 2017, HORM METAB RES, V49, P350, DOI 10.1055/s-0043-103345; Lea RG, 2000, MOL HUM REPROD, V6, P763, DOI 10.1093/molehr/6.8.763; Lesseur C, 2014, PSYCHONEUROENDOCRINO, V40, P1, DOI 10.1016/j.psyneuen.2013.10.012; Lesseur C, 2013, MOL CELL ENDOCRINOL, V381, P160, DOI 10.1016/j.mce.2013.07.024; Li Y, 2014, BIOMED PHARMACOTHER, V68, P45, DOI 10.1016/j.biopha.2013.10.006; Madan A, 1997, BLOOD CELL MOL DIS, V23, P169, DOI 10.1006/bcmd.1997.0134; Marchi M, 2011, EPIGENETICS-US, V6, P1198, DOI 10.4161/epi.6.10.16600; Marinoni E, 2008, AM J OBSTET GYNECOL, V199, DOI 10.1016/j.ajog.2008.02.047; McMinn J, 2006, PLACENTA, V27, P540, DOI 10.1016/j.placenta.2005.07.004; Melzner I, 2002, J BIOL CHEM, V277, P45420, DOI 10.1074/jbc.M208511200; Miller SL, 2016, J PHYSIOL-LONDON, V594, P807, DOI 10.1113/JP271402; Minihane AM, 2015, BRIT J NUTR, V114, P999, DOI 10.1017/S0007114515002093; Naylor C, 2016, TRENDS MOL MED, V22, P88, DOI 10.1016/j.molmed.2015.12.001; Pierre CC, 2015, BBA-GENE REGUL MECH, V1849, P1432, DOI 10.1016/j.bbagrm.2015.10.018; Siddique A, 2013, J MOL BIOL, V425, P479, DOI 10.1016/j.jmb.2012.11.038; Steinmann Katrin, 2011, Genes Cancer, V2, P65, DOI 10.1177/1947601911405043; Stoger R, 2006, EPIGENETICS-US, V1, P155; Sundrani DP, 2013, CLIN EPIGENETICS, V5, DOI 10.1186/1868-7083-5-6; Szentpeteri I, 2013, J MATERN-FETAL NEO M, V26, P984, DOI 10.3109/14767058.2013.766702; Tanis JC, 2016, ULTRASOUND OBST GYN, V48, P210, DOI 10.1002/uog.15744; Udagawa J, 2006, ENDOCRINOLOGY, V147, P647, DOI 10.1210/en.2005-0791; van den Broek AJM, 2010, EARLY HUM DEV, V86, P379, DOI 10.1016/j.earlhumdev.2010.04.007; Voron T, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00070; WLADIMIROFF JW, 1986, EUR J OBSTET GYN R B, V22, P23, DOI 10.1016/0028-2243(86)90086-9; Woollett LA, 2001, CURR OPIN LIPIDOL, V12, P305, DOI 10.1097/00041433-200106000-00010; Zimna A, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/549412	45	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2019	14	8							e0221972	10.1371/journal.pone.0221972	http://dx.doi.org/10.1371/journal.pone.0221972			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW6BO	31469872	Green Submitted, Green Published, gold			2022-12-26	WOS:000485062200044
J	Chen, R; Sugiyama, A; Seno, H; Sugimoto, M				Chen, Ru; Sugiyama, Aiko; Seno, Hiroshi; Sugimoto, Masahiro			Identification of modules and functional analysis in CRC subtypes by integrated bioinformatics analysis	PLOS ONE			English	Article							GENE ONTOLOGY; CANCER CELLS; HETEROGENEITY; EXPRESSION; RECEPTOR; CLASSIFICATION; GPR109A; LEVEL; CXCL1; TOOL	Colorectal cancer is one of the top three causes of cancer-related mortality globally, but no predictive molecular biomarkers are currently available for identifying the disease stage of colorectal cancer patients. Common molecular patterns in the disease, beyond superficial manifestations, can be significant in determining treatment choices. In this study, we used microarray data from colorectal cancer and adjacent normal tissue from the GEO database. These data were categorized into four consensus molecular subtypes based on distinct gene expression signatures. Weighted gene-based protein-protein interaction network analysis was performed for each subtype. NUSAP1, CD44, and COL4A1 modules were found to be statistically significant and present among all the subtypes and displayed though similar but not identical functional enrichment results. Reference of the characteristics of the subtypes to functional modules is necessary since the latter can stay resistant to platform changes and technique noise when compared with other analyses. The CMS4-mesenchymal group, which currently has a poor prognosis, was examined in the study. It is composed mainly of genes involved in immune and stromal expression, with modules focused on ECM dysregulation and chemokine biological processes. Hub genes detection and its' mapping into the protein-protein interaction network can be indicative of possible targets against specific modules. This approach identified subtypes using enrichment-oriented analysis in functional modules. Proper annotation of functional analysis of modules from different subtypes of CRC might be directive for finding extra options for treatment targets and guiding clinical routines.	[Chen, Ru; Seno, Hiroshi] Kyoto Univ, Grad Sch Med, Dept Gastroenterol & Hepatol, Kyoto, Japan; [Sugiyama, Aiko] Kyoto Univ, Med Innovat Ctr, Grad Sch Med, DSK Project, Kyoto, Japan; [Sugimoto, Masahiro] Tokyo Med Univ, Res & Dev Ctr Minimally Invas Therapies Hlth Prom, Tokyo, Japan	Kyoto University; Kyoto University; Tokyo Medical University	Sugimoto, M (corresponding author), Tokyo Med Univ, Res & Dev Ctr Minimally Invas Therapies Hlth Prom, Tokyo, Japan.	mshrsgmt@gmail.com		CHEN, RU/0000-0002-2732-3091; Sugimoto, Masahiro/0000-0003-3316-2543				Aguirre-Gamboa R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074250; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Assadian S, 2012, TUMOR STEM CELL 0117; Blanco-Calvo M, 2015, INT J MOL SCI, V16, P13610, DOI 10.3390/ijms160613610; Budinska E, 2013, J PATHOL, V231, P63, DOI 10.1002/path.4212; Cao Q, 2012, AM J PHYSIOL-CELL PH, V302, pC1731, DOI 10.1152/ajpcell.00213.2011; Carbon S, 2019, NUCLEIC ACIDS RES, V47, pD330, DOI 10.1093/nar/gky1055; Chen C, 2018, J HEMATOL ONCOL, V11, DOI 10.1186/s13045-018-0605-5; Chen WA, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/3537079; Dawson H, 2015, FRONT MED-LAUSANNE, V2, DOI 10.3389/fmed.2015.00011; Dennis G, 2003, GENOME BIOL, V4; Divella R, 2017, ANTICANCER RES, V37, P4867, DOI 10.21873/anticanres.11895; Downing A, 2017, GUT, V66, P89, DOI 10.1136/gutjnl-2015-311308; Eide PW, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16747-x; Elangovan S, 2014, CANCER RES, V74, P1166, DOI 10.1158/0008-5472.CAN-13-1451; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Fukumoto M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120616; Godone RLN, 2018, BIOMED PHARMACOTHER, V106, P14, DOI 10.1016/j.biopha.2018.06.066; Gonzalez-Pons M, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/149014; Guinney J, 2015, NAT MED, V21, P1350, DOI 10.1038/nm.3967; Han Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep37240; Hopkins AL, 2008, NAT CHEM BIOL, V4, P682, DOI 10.1038/nchembio.118; Inamura K, 2018, CANCERS, V10, DOI 10.3390/cancers10010026; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Kim JH, 2014, WORLD J GASTROENTERO, V20, P4230, DOI 10.3748/wjg.v20.i15.4230; Komor MA, 2018, J PATHOL, V246, P266, DOI 10.1002/path.5129; Kotian S, 2014, CANCER BIOL THER, V15, P533, DOI 10.4161/cbt.28019; Liu ZX, 2018, PATHOL RES PRACT, V214, P968, DOI 10.1016/j.prp.2018.05.017; Ma JC, 2017, WORLD J GASTROENTERO, V23, P5167, DOI 10.3748/wjg.v23.i28.5167; Mi HY, 2017, NUCLEIC ACIDS RES, V45, pD183, DOI 10.1093/nar/gkw1138; Overington JP, 2006, NAT REV DRUG DISCOV, V5, P993, DOI 10.1038/nrd2199; Pal Jagriti, 2016, Genes Cancer, V7, P136, DOI 10.18632/genesandcancer.105; Punt CJA, 2017, NAT REV CLIN ONCOL, V14, P235, DOI 10.1038/nrclinonc.2016.171; Qu XL, 2014, GENOMICS, V104, P242, DOI 10.1016/j.ygeno.2013.11.002; Schlicker A, 2012, BMC MED GENOMICS, V5, DOI 10.1186/1755-8794-5-66; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shenoi RA, 2001, J STRAIN ANAL ENG, V36, P1, DOI 10.1243/0309324011512559; Shida D, 2016, WORLD J GASTROENTERO, V22, P2503, DOI 10.3748/wjg.v22.i8.2503; Staubert C, 2015, ONCOTARGET, V6, P19706; Supek F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021800; Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003; Thangaraju M, 2009, CANCER RES, V69, P2826, DOI 10.1158/0008-5472.CAN-08-4466; Wang DW, 2017, EXP BIOL MED, V242, P429, DOI 10.1177/1535370216675068; Wang DZ, 2006, J EXP MED, V203, P941, DOI 10.1084/jem.20052124; Wang LP, 2003, CANCER LETT, V200, P57, DOI 10.1016/S0304-3835(03)00350-1; Worthley Daniel L, 2010, Clin Biochem Rev, V31, P31; Wu ZQ, 2016, BIOMED PHARMACOTHER, V78, P8, DOI 10.1016/j.biopha.2015.12.021; Zhai XF, 2017, MOL MED REP, V16, P6499, DOI 10.3892/mmr.2017.7412; Zhao SW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011764	49	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2019	14	8							e0221772	10.1371/journal.pone.0221772	http://dx.doi.org/10.1371/journal.pone.0221772			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW6BO	31469863	Green Published, Green Submitted, gold			2022-12-26	WOS:000485062200027
J	Jensen, KR; Hvidman, L; Kierkegaard, O; Gliese, H; Manser, T; Uldbjerg, N; Brogaard, L				Jensen, Kristiane Roed; Hvidman, Lone; Kierkegaard, Ole; Gliese, Henrik; Manser, Tanja; Uldbjerg, Niels; Brogaard, Lise			Noise as a risk factor in the delivery room: A clinical study	PLOS ONE			English	Article							LOCALLY WEIGHTED REGRESSION; COGNITIVE PERFORMANCE; IMPACT; DISTRACTIONS; STRESS; NUMBER; POWER	Introduction We aimed to investigate whether noise in delivery rooms is associated with impaired performance of obstetric teams managing major (>= 1000 mL) postpartum hemorrhage. Material and methods We included video recordings of 96 obstetric teams managing real-life major postpartum hemorrhage. Exposure was noise defined as the occurrence of sound level pressures (SPL) above 90 dB. The outcome was high clinical performance assessed through expert ratings using the TeamOBS-PPH tool. Results The 23 teams unexposed to noise had a significantly higher chance of high clinical performance than the 73 teams exposed to noise: 91.3% (95% CI; 72.0-98.9) versus 58.9% (95% CI; 46.8-70.3) (p < 0.001). The results remained significant when adjusting for the following possible confounders: team size, non-technical performance, bleeding velocity, hospital type, etiology of bleeding, event duration and time of day. Typical sources of noise above 90 dB SPL were mother or baby crying, dropping of instruments, and slamming of cupboard doors. Conclusion Noise in delivery rooms may be an independent source of impaired clinical performance.	[Jensen, Kristiane Roed; Kierkegaard, Ole; Brogaard, Lise] HEH Horsens Reg Hosp, Dept Obstet & Gynecol, Horsens, Denmark; [Hvidman, Lone; Uldbjerg, Niels] Aarhus Univ Hosp, Dept Obstet & Gynecol, Aarhus, Denmark; [Gliese, Henrik] ArbejdsmiljoEksperten AS, Occupat & Environm Consultants, Esbjerg, Denmark; [Manser, Tanja] Univ Appl Sci & Arts Northwestern Switzerland, Sch Appl Psychol FHNW, Olten, Switzerland	Aarhus University; FHNW University of Applied Sciences & Arts Northwestern Switzerland	Jensen, KR (corresponding author), HEH Horsens Reg Hosp, Dept Obstet & Gynecol, Horsens, Denmark.	kristiane@roedjensen.com	; Uldbjerg, Niels/O-2038-2016	Brogaard, Lise/0000-0001-5136-9682; Uldbjerg, Niels/0000-0002-6449-6426; Hjorth-Hansen, Kristiane Roed/0000-0002-0806-5744	Tryg Foundation (Trygfonden) [109507]; Regional Postgraduate Medical Education Administration Office North; Regional Hospital in Horsens; Department of Obstetrics and Gynecology	Tryg Foundation (Trygfonden); Regional Postgraduate Medical Education Administration Office North; Regional Hospital in Horsens; Department of Obstetrics and Gynecology	The study was funded by Tryg Foundation (Trygfonden) (grant ID no. 109507), https://www.trygfonden.dk; the Regional Hospital in Horsens, Department of Obstetrics and Gynecology and the Regional Postgraduate Medical Education Administration Office North. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JM, 2007, AM FAM PHYSICIAN, V75, P875; Basner M, 2014, LANCET, V383, P1325, DOI 10.1016/S0140-6736(13)61613-X; Boersma P, 2003, PRAAT MANUAL; Boersma P., 2018, PRAAT DOING PHONETIC; Brogaard L, 2018, ACTA OBSTET GYN SCAN, V97, P677, DOI 10.1111/aogs.13336; Busch-Vishniac IJ, 2005, J ACOUST SOC AM, V118, P3629, DOI 10.1121/1.2118327; CLEVELAND WS, 1979, J AM STAT ASSOC, V74, P829, DOI 10.2307/2286407; CLEVELAND WS, 1988, J AM STAT ASSOC, V83, P596, DOI 10.2307/2289282; DORNIC S, 1989, PERCEPT MOTOR SKILL, V68, P11, DOI 10.2466/pms.1989.68.1.11; Engelmann CR, 2014, ANN SURG, V259, P1025, DOI 10.1097/SLA.0000000000000253; Everest F.A., 2009, MASTER HDB ACOUSTICS; Folscher LL, 2015, EMERG MED J, V32, P468, DOI 10.1136/emermed-2014-203735; Fredriksson S, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-005793; Hancock M, 2016, J PHYSIOTHER, V62, P172, DOI [10.1016/j.jphys.2016.08.008, 10.1016/j.jphys.2016.02.016]; Hansen CH, 1996, ENG NOISE CONTROL, P245; Harrell FE, 2015, SPRINGER SER STAT, P63, DOI 10.1007/978-3-319-19425-7_4; Healey AN, 2006, ERGONOMICS, V49, P589, DOI 10.1080/00140130600568899; HODGE B, 1990, LANCET, V335, P891, DOI 10.1016/0140-6736(90)90486-O; Hoenig JM, 2001, AM STAT, V55, P19, DOI 10.1198/000313001300339897; Hygge S, 2002, PSYCHOL SCI, V13, P469, DOI 10.1111/1467-9280.00483; Irgens-Hansen K, 2015, NOISE HEALTH, V17, P320, DOI 10.4103/1463-1741.165057; JONES DM, 1979, J APPL PSYCHOL, V64, P627, DOI 10.1037/0021-9010.64.6.627; Keller S, 2016, ERGONOMICS, V59, P1541, DOI 10.1080/00140139.2016.1159736; Khajenasiri Farahnaz, 2016, Electron Physician, V8, P2088, DOI 10.19082/2088; KJELLBERG A, 1990, SCAND J WORK ENV HEA, V16, P29, DOI 10.5271/sjweh.1825; Mentis HM, 2016, SURG ENDOSC, V30, P1713, DOI 10.1007/s00464-015-4443-z; Moorthy K, 2003, SURG ENDOSC, V17, P1481, DOI 10.1007/s00464-002-9224-9; Morgan PJ, 2012, BMJ QUAL SAF, V21, P78, DOI 10.1136/bmjqs-2011-000296; Mousa HA, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003249.pub2; MURTHY VSSN, 1995, CAN J ANAESTH, V42, P608, DOI 10.1007/BF03011878; Peduzzi P, 1996, J CLIN EPIDEMIOL, V49, P1373, DOI 10.1016/S0895-4356(96)00236-3; Savoldelli GL, 2010, EUR J ANAESTH, V27, P683, DOI 10.1097/EJA.0b013e328333de09; Schlittmeier SJ, 2015, NOISE HEALTH, V17, P148, DOI 10.4103/1463-1741.155845; Senn SJ, 2002, BMJ-BRIT MED J, V325, P1304, DOI 10.1136/bmj.325.7375.1304; St  Pierre Jr RL, NOISE CON 2004; Swanepoel D, 2015, HEARING LOSS DUE REC; Szalma JL, 2011, PSYCHOL BULL, V137, P682, DOI 10.1037/a0023987; Van Pelt M, 2017, ANESTH ANALG, V125, P347, DOI 10.1213/ANE.0000000000002139; Wheelock A, 2015, ANN SURG, V261, P1079, DOI 10.1097/SLA.0000000000001051	39	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2019	14	8							e0221860	10.1371/journal.pone.0221860	http://dx.doi.org/10.1371/journal.pone.0221860			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW6BO	31469866	Green Submitted, gold, Green Published			2022-12-26	WOS:000485062200035
J	Ahmed, R; Tariq, M; Hussain, M; Andleeb, A; Masoud, MS; Ali, I; Mraiche, F; Hasan, A				Ahmed, Rashid; Tariq, Muhammad; Hussain, Maria; Andleeb, Anisa; Masoud, Muhammad Shareef; Ali, Imran; Mraiche, Fatima; Hasan, Anwarul			Phenolic contents-based assessment of therapeutic potential of Syzygium cumini leaves extract	PLOS ONE			English	Article							ANTIOXIDANT ACTIVITY; BARK; CONSTITUENTS; PLANTS	Syzygium cumini (S. cumini) is an evergreen tropical plant that is well recognized for its therapeutic potential of common diseases. In this study, the therapeutic potential and biomedical application of S. cumini are assessed in vitro and in vivo to find its effectiveness for different complications. The methanolic crude extract of S. cumini leaves were screened for total phenolic and flavonoid content. In vitro, the DPPH scavenging assay, XTT assay, prothrombin and activated partial thromboplastin time were used to assess antioxidant, cytoprotective and thrombolytic activity of the S. cumini extract, respectively. The anti-inflammatory potential and the analgesic activity of the S. cumini extract were analyzed in rabbits by the Carrageenan induced paw edema method and the writhing method, respectively. Phytochemical analysis showed the presence of considerable amounts of total phenolic (369.75 +/- 17.9 mg GAE/g) and flavonoid (75.8 +/- 5.3 mgRE/g) content in the S. cumini extract. The DPPH assay demonstrated a higher antioxidant potential (IC-50 value of 133 mu g/ml), which was comparable to the IC-50 of ascorbic acid (122.4 mu g/ml). Moreover, the S. cumini extract showed a dose dependent cytoprotective effect against H2O2 treated bone marrow mesenchymal stem cells (BM-MSCs). S. cumini also possesses significant anticoagulant activity with a prothrombin time of 28.3 +/- 1.8 seconds vs 15.8 +/- 0.2 seconds of control, p<0.05. The leaf extract also demonstrated an analgesic effect in rabbits as indicated by the decrease in writhing (12.2 +/- 1.7 control vs. 3.7 +/- 0.6 treated) and anti-inflammatory activity in rabbits paw with a protection against inflammation of 64.1 +/- 2.4%. Our findings suggest that the methanolic extract of S. cumini leaves has antioxidant, cytoprotective, anticoagulant, analgesic and anti-inflammatory properties, and therefore, can be applied for treating cardiovascular diseases and cancers.	[Ahmed, Rashid; Tariq, Muhammad; Hussain, Maria; Andleeb, Anisa; Ali, Imran] Mirpur Univ Sci & Technol, Dept Biotechnol, Mirpur, Ajk, Pakistan; [Ahmed, Rashid; Hasan, Anwarul] Qatar Univ, Coll Engn, Dept Mech & Ind Engn, Doha, Qatar; [Ahmed, Rashid; Hasan, Anwarul] Qatar Univ, Biomed Res Ctr, Doha, Qatar; [Masoud, Muhammad Shareef] Govt Coll Univ, Dept Bioinformat & Biotechnol, Faisalabad, Pakistan; [Mraiche, Fatima] Qatar Univ, Coll Pharm, Doha, Qatar	Qatar University; Qatar University; Government College University Faisalabad; Qatar University	Tariq, M (corresponding author), Mirpur Univ Sci & Technol, Dept Biotechnol, Mirpur, Ajk, Pakistan.; Hasan, A (corresponding author), Qatar Univ, Coll Engn, Dept Mech & Ind Engn, Doha, Qatar.; Hasan, A (corresponding author), Qatar Univ, Biomed Res Ctr, Doha, Qatar.	tariq.awan@must.edu.pk; hassan.anwarul.mit@gmail.com	Tariq, Muhammad/ABC-2204-2020; Hasan, Anwarul/AAX-7440-2020; Masoud, Muhammad Shareef/F-7156-2010	Tariq, Muhammad/0000-0002-8239-9339; Hasan, Anwarul/0000-0001-8380-2233; Masoud, Muhammad Shareef/0000-0003-2395-7721; Ahmed, Rashid/0000-0002-6512-769X	Qatar National Research Foundation [NPRP10-0120-170211]; Qatar National Research Fund (Qatar Foundation) [NPRP10-0120-170211]; Qatar National Library	Qatar National Research Foundation(National Research Foundation of Korea); Qatar National Research Fund (Qatar Foundation)(Qatar Foundation (QF)Qatar National Research Fund (QNRF)); Qatar National Library(Qatar National Research Fund (QNRF))	Funded by Dr. Anwarul Hasan Grant Number: NPRP10-0120-170211. Qatar National Research Foundation. http://www.qnrf.org/en-us/Funding/Research-Programs/National-Priorities-Research-Program-NPRP.; This article was made possible by the NPRP10-0120-170211 grant funded by Qatar National Research Fund (a part of Qatar Foundation). The statements made here are solely responsibility of authors. The authors also thankfully acknowledge the Qatar National Library for providing the funding for the publication of this study, and Mirpur University of Science and Technology (MUST), Mirpur, AJK, Pakistan for providing their facilities needed for completion of the current study.	Aasim M, 2018, GLOBAL PERSPECTIVES, P165; Acosta-Estrada BA, 2014, FOOD CHEM, V152, P46, DOI 10.1016/j.foodchem.2013.11.093; Ahmed R, 2019, POLY LACTIC CO GLYCO, P2019; Ahmed R, 2018, INT J BIOL MACROMOL, V120, P385, DOI 10.1016/j.ijbiomac.2018.08.057; Ramirez-Cisneros MA, 2012, MOLECULES, V17, P861, DOI 10.3390/molecules17010861; Anhe GF, 2012, EUR J PHARMACOL, V689, P285, DOI 10.1016/j.ejphar.2012.06.007; Aqil F, 2012, NUTR CANCER, V64, P428, DOI 10.1080/01635581.2012.657766; Ayyanar Muniappan, 2012, Asian Pacific Journal of Tropical Biomedicine, V2, P240, DOI 10.1016/S2221-1691(12)60050-1; Baliga MS, 2011, FOOD RES INT, V44, P1776, DOI 10.1016/j.foodres.2011.02.007; BHATIA IS, 1975, PLANTA MED, V28, P346, DOI 10.1055/s-0028-1097868; Cai YZ, 2003, J AGR FOOD CHEM, V51, P2288, DOI 10.1021/jf030045u; Chagas VT, 2015, FRONT PHARMACOL, V6, DOI 10.3389/fphar.2015.00259; Djipa CD, 2000, J ETHNOPHARMACOL, V71, P307, DOI 10.1016/S0378-8741(99)00186-5; Hossain MS, 2018, J BASIC CLIN PHYSL P; Kaneria M, 2009, INDIAN J PHARM SCI, V71, P406, DOI 10.4103/0250-474X.57289; Mao WJ, 2009, INT J BIOL MACROMOL, V44, P70, DOI 10.1016/j.ijbiomac.2008.10.003; Masood N, 2019, INT J PHARMACEUT, V559, P23, DOI 10.1016/j.ijpharm.2019.01.019; Modi D. C., 2010, Journal of Pharmaceutical Education and Research, V1, P68; Mollika S., 2014, GLOBAL J PHARM, V8, P39, DOI DOI 10.5829/ID0SI.GJP.2014.8; Muruganandan S, 2001, FITOTERAPIA, V72, P369, DOI 10.1016/S0367-326X(00)00325-7; Newman DJ, 2007, J NAT PROD, V70, P461, DOI 10.1021/np068054v; Parmar J, 2010, ASIAN PAC J CANCER P, V11, P261; Patel P. R., 2012, INT J CURR PHARM RES, V4, P36; Pugazhenthi G, 2008, INT J FOOD ENG, V4, DOI 10.2202/1556-3758.1385; Quettier-Deleu C, 2000, J ETHNOPHARMACOL, V72, P35, DOI 10.1016/S0378-8741(00)00196-3; Quintans JSS, 2014, PHARM BIOL, V52, P762, DOI 10.3109/13880209.2013.870582; Rastogi RP, 1990, DRUG RES PERSPECTIVE, V1, P10; Ruan ZP, 2008, MOLECULES, V13, P2545, DOI 10.3390/molecules13102545; Schmid-Schonbein GW, 2006, ANNU REV BIOMED ENG, V8, P93, DOI 10.1146/annurev.bioeng.8.061505.095708; Schulz M, 2016, FOOD RES INT, V89, P14, DOI 10.1016/j.foodres.2016.07.027; Shah M, 2017, BMC COMPLEM ALTERN M, V17, DOI 10.1186/s12906-017-2042-3; Sharma R, 2013, BMC COMPLEM ALTERN M, V13, DOI 10.1186/1472-6882-13-292; Singleton VL, 1999, METHOD ENZYMOL, V299, P152; Srivastava S, 2013, J SCI FOOD AGR, V93, P2084, DOI 10.1002/jsfa.6111; Swami SB, 2012, FOOD NUTR SCI, V3, P1100, DOI DOI 10.4236/FNS.2012.38146; Tariq M, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-115; Ugbabe GE, 2010, AFR J BIOTECHNOL, V9, P6943; Xie PY, 2017, FOOD FUNCT, V8, P2000, DOI 10.1039/c6fo01717g; Xie W, 2011, DIABETES OBES METAB, V13, P289, DOI 10.1111/j.1463-1326.2010.01336.x; You YL, 2007, MOLECULES, V12, P842, DOI 10.3390/12040842	40	10	10	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2019	14	8							e0221318	10.1371/journal.pone.0221318	http://dx.doi.org/10.1371/journal.pone.0221318			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW6AB	31465475	gold, Green Published, Green Submitted			2022-12-26	WOS:000485058200014
J	Li, L; Liu, CF				Li, Le; Liu, Changfu			A new approach for estimating living vegetation volume based on terrestrial point cloud data	PLOS ONE			English	Article							LEAF-AREA DISTRIBUTION; FOREST INVENTORY; INDIVIDUAL TREES; LIDAR DATA; LASER; WOOD; RECONSTRUCTION; SEPARATION; BRANCHES; CROWNS	Living vegetation volume (LVV), one of the most difficult tree parameters to calculate, is among the most important factors that indicates the biological characteristics and ecological functions of the crown. Obtaining precise LVV estimates is, however, challenging task because the irregularities of many crown shapes are difficult to capture using standard forestry field equipment. Terrestrial light detection and ranging (T-LiDAR) can be used to record the three-dimensional structures of trees. The primary branches of Larix olgensis and Quercus mongolica in the Qingyuan Experimental Station of Forest Ecology at the Chinese Academy of Sciences (CAS) were taken as the research objects. A new rapid LVV estimation method called the filling method was proposed in this paper based on a T-LiDAR point cloud. In the proposed method, the branch point clouds are divided into leaf points and wood points. We used RiSCAN PRO 1.64 to manually separate the leaf points and wood points under careful visual inspection, and calculated that leaf points and wood points accounted for 91% and 9% of the number of the point clouds of branches. Then, the equation LVV = V1N (where N is the number of leaf points, and V-1 is cube size) is used to calculate LVV. When the laser transmission frequency is 300,000 points/second and the point cloud is diluted to 30% using the octree method, the point cloud can be replaced by a cube (V-1) of 6.11 cm(3) to fill the branch space. The results showed that good performance for this approach, the measuring accuracy for L. olgensis and Q. mongolica at the levels of alpha = 0.05 and alpha = 0.01, respectively (94.35%, 90.01% and 91.99%, 85.63%, respectively). The results suggest that the proposed method can be conveniently used to calculate the LVV of coniferous and broad-leaf species under specific scanning settings. This work is explorative because hypotheses or a theoretical framework have not been previously defined. Rather, we would like to contribute to the formation of hypotheses as a background for further studies.	[Li, Le; Liu, Changfu] Chinese Acad Forestry, Res Inst Forest Ecol Environm & Protect, Beijing, Peoples R China; [Li, Le; Liu, Changfu] State Forestry & Grassland Adm, Key Lab Forest Ecol & Environm, Beijing, Peoples R China	Chinese Academy of Forestry; Research Institute of Forest Ecology, Environment and Protection, CAF	Liu, CF (corresponding author), Chinese Acad Forestry, Res Inst Forest Ecol Environm & Protect, Beijing, Peoples R China.; Liu, CF (corresponding author), State Forestry & Grassland Adm, Key Lab Forest Ecol & Environm, Beijing, Peoples R China.	liucf898@163.com		Liu, Changfu/0000-0001-6751-1620; Li, Le/0000-0002-0183-4432	National Natural Science Foundation of China [31570449, 31270490]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study is supported by the National Natural Science Foundation of China (project number: 31570449, 31270490).	Antonarakis AS, 2009, WATER RESOUR RES, V45, P2815; Beland M, 2014, AGR FOREST METEOROL, V184, P82, DOI 10.1016/j.agrformet.2013.09.005; Beland M, 2011, AGR FOREST METEOROL, V151, P1252, DOI 10.1016/j.agrformet.2011.05.004; Bienert A., 2007, INT ARCH PHOTOGRAM 3, V36, P50; Bienert A., 2006, P WORKSH 3D REM SENS, V14, P1; Brandeis T, 2009, J GEOPHYS RES, V118, P4729; Bucksch A, 2011, PHOTOGRAMM ENG REM S, V77, P229, DOI 10.14358/PERS.77.3.229; Chen YW, 2010, SENSORS-BASEL, V10, P7057, DOI 10.3390/s100707057; Dassot M, 2012, COMPUT ELECTRON AGR, V89, P86, DOI 10.1016/j.compag.2012.08.005; Dassot M, 2011, ANN FOREST SCI, V68, P959, DOI 10.1007/s13595-011-0102-2; Ferrara R, 2018, AGR FOREST METEOROL, V262, P434, DOI 10.1016/j.agrformet.2018.04.008; Gorte B, 2012, REMOTE SENSING SPATI, V36, pW2; Hecht R, 2008, IEEE T GEOSCI REMOTE, V46, P3832, DOI 10.1109/TGRS.2008.2001771; Hopkinson C, 2004, CAN J FOREST RES, V34, P573, DOI [10.1139/x03-225, 10.1139/X03-225]; Hosoi F, 2007, J EXP BOT, V58, P3463, DOI 10.1093/jxb/erm203; Hosoi F, 2006, IEEE T GEOSCI REMOTE, V44, P3610, DOI 10.1109/TGRS.2006.881743; Jaime-Gonzalez C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182451; Jim CY, 2009, CITIES, V26, P187, DOI 10.1016/j.cities.2009.03.003; Jupp DLB, 2009, TREE PHYSIOL, V29, P171, DOI 10.1093/treephys/tpn022; Kato A, 2009, REMOTE SENS ENVIRON, V113, P1148, DOI 10.1016/j.rse.2009.02.010; Ku NW, 2012, PHOTOGRAMM ENG REM S, V78, P349, DOI 10.14358/PERS.78.4.349; Laubhann D, 2010, FOREST ECOL MANAG, V260, P1498, DOI 10.1016/j.foreco.2010.07.048; Lee H, 2010, INT J REMOTE SENS, V31, P117, DOI 10.1080/01431160902882561; Lefsky MA, 2002, BIOSCIENCE, V52, P19, DOI 10.1641/0006-3568(2002)052[0019:LRSFES]2.0.CO;2; Lefsky MA, 2001, CAN J FOREST RES, V31, P78, DOI 10.1139/cjfr-31-1-78; Li SH, 2017, REMOTE SENS-BASEL, V9, DOI 10.3390/rs9111202; Li W, 2015, PHOTOGRAMMETRIC ENG, V78, P75; Li Z, 2013, INT GEOSCI REMOTE SE, P3383, DOI 10.1109/IGARSS.2013.6723554; Liu ChangFu, 2006, Journal of Beijing Forestry University, V28, P32; Liu X, 2009, VISUAL COMPUT, V25, P381, DOI 10.1007/s00371-009-0329-1; Ma LX, 2016, AGR FOREST METEOROL, V228, P217, DOI 10.1016/j.agrformet.2016.06.021; Maas HG, 2008, INT J REMOTE SENS, V29, P1579, DOI 10.1080/01431160701736406; Marselis SM, 2016, ENVIRON MODELL SOFTW, V82, P142, DOI 10.1016/j.envsoft.2016.04.025; Palace MW, 2015, REMOTE SENS ENVIRON, V161, P1, DOI 10.1016/j.rse.2015.01.020; Popescu SC, 2003, CAN J REMOTE SENS, V29, P564, DOI 10.5589/m03-027; Chen Q, 2006, PHOTOGRAMM ENG REM S, V72, P923, DOI 10.14358/PERS.72.8.923; Qin HM, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197510; Tao SL, 2015, ISPRS J PHOTOGRAMM, V110, P66, DOI 10.1016/j.isprsjprs.2015.10.007; Tao SL, 2015, PHOTOGRAMM ENG REM S, V81, P767, DOI 10.14358/PERS.81.10.767; Thies M, 2004, SCAND J FOREST RES, V19, P571, DOI 10.1080/02827580410019562; van Leeuwen M, 2010, EUR J FOREST RES, V129, P749, DOI 10.1007/s10342-010-0381-4; Wallace L, 2014, INT J APPL EARTH OBS, V30, P76, DOI 10.1016/j.jag.2014.01.010; Wehr A, 1999, ISPRS J PHOTOGRAMM, V54, P68, DOI 10.1016/S0924-2716(99)00011-8; Wei XueHua, 2013, Nongye Jixie Xuebao = Transactions of the Chinese Society for Agricultural Machinery, V44, P235; Wu JY, 2013, PHOTOGRAMM ENG REM S, V79, P1147, DOI 10.14358/PERS.79.12.1147; Zeide B, 1998, CAN J FOREST RES, V28, P106, DOI 10.1139/cjfr-28-1-106; [赵军 ZHAO Jun], 2007, [地理与地理信息科学, Geography and Geo-information Science], V23, P37; Zheng G, 2016, IEEE T GEOSCI REMOTE, V54, P1475, DOI 10.1109/TGRS.2015.2481492; Zhou J.H., 1995, J REMOTE SENS, V3, P162; [周廷刚 Zhou Tinggang], 2005, [生态学报, Acta Ecologica Sinica], V25, P415; [周一凡 ZHOU YiFan], 2006, [生态学报, Acta Ecologica Sinica], V26, P4204	51	5	5	3	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2019	14	8							e0221734	10.1371/journal.pone.0221734	http://dx.doi.org/10.1371/journal.pone.0221734			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW6AB	31465486	gold, Green Published, Green Submitted			2022-12-26	WOS:000485058200040
J	Meir, A; Weike, G; Schwerdtteger, F; Airapetov, LG; Ruthstein, S				Meir, Aviv; Weike, Gulshan; Schwerdtteger, Fabian; Airapetov, Lada Gevorkyan; Ruthstein, Sharon			Exploring the role of the various methionine residues in the Escherichia coli CusB adapter protein	PLOS ONE			English	Article							N-TERMINAL DOMAIN; EPR SPECTROSCOPY; COPPER HOMEOSTASIS; CRYSTAL-STRUCTURE; METAL-BINDING; CU(I) BINDING; SITE; ALZHEIMERS; STOICHIOMETRY; DYNAMICS	The dissemination of resistant pathogenic microbes has become one of the most challenging problems that modern medicine has faced. Developing novel drugs based on new molecular targets that previously were not targeted, is therefore the highest priority in antibiotics research. One approach that has been recently suggested is to inhibit copper transporters in prokaryotic systems. Copper is required for many biological pathways, but sometimes it can harm the cell. Pathogenic systems have a highly sophisticated copper-regulation network; therefore, a better understanding of how this network operates at the molecular level should assist in developing the next generation of antibiotics. The CusB protein is part of the CusCBA periplasmic Cu(I) efflux system in Gram-negative bacteria, and was recently reported to play a key role in the functioning of the whole CusCBA system, in which conformational changes as well as the assembly/disassembly process control the opening of the transporter. More knowledge of the underlying mechanism is needed to attain a full understanding of CusB functioning, which is associated with targeting specific and crucial residues in CusB. Here, we combine in-vitro structural measurements, which use EPR spectroscopy and UV-Vis measurements, with cell experiments to explore the role of the various methionine residues in CusB. We targeted two methionine residues (M227 and M241) that are essential for the proper functioning of CusB.	[Meir, Aviv; Weike, Gulshan; Schwerdtteger, Fabian; Airapetov, Lada Gevorkyan; Ruthstein, Sharon] Bar Ilan Univ, Dept Chem, Ramat Gan, Israel; [Schwerdtteger, Fabian] Albert Ludwigs Univ, Dept Chem & Pharm, Freiburg, Germany	Bar Ilan University; University of Freiburg	Ruthstein, S (corresponding author), Bar Ilan Univ, Dept Chem, Ramat Gan, Israel.	Sharon.ruthstein@biu.ac.il		Walke, Gulshan/0000-0002-2191-195X; Ruthstein, Sharon/0000-0002-1741-6892	ISF [176/16]	ISF(Israel Science Foundation)	SR acknowledges the support of ISF grant no. 176/16.	Aitha M, 2015, J BIOL INORG CHEM, V20, P585, DOI 10.1007/s00775-015-1244-8; Bagai I, 2007, J BIOL CHEM, V282, P35695, DOI 10.1074/jbc.M703937200; Bhatnagar J, 2012, BIOPHYS J, V102, P2192, DOI 10.1016/j.bpj.2012.03.038; Burkhead JL, 2009, NEW PHYTOL, V182, P799, DOI 10.1111/j.1469-8137.2009.02846.x; Cafiso DS, 2014, ACCOUNTS CHEM RES, V47, P3102, DOI 10.1021/ar500228s; Chacon KN, 2014, P NATL ACAD SCI USA, V111, P15373, DOI 10.1073/pnas.1411475111; Changela A, 2003, SCIENCE, V301, P1383, DOI 10.1126/science.1085950; DOLLWET HHA, 1985, TRACE ELEM MED, V2, P80; Donnelly PS, 2007, CURR OPIN CHEM BIOL, V11, P128, DOI 10.1016/j.cbpa.2007.01.678; Franke S, 2003, J BACTERIOL, V185, P3804, DOI 10.1128/JB.185.13.3804-3812.2003; Freed DM, 2013, BIOCHEMISTRY-US, V52, P2638, DOI 10.1021/bi3016108; Fu Y, 2014, ACCOUNTS CHEM RES, V47, P3605, DOI 10.1021/ar500300n; Gaggelli E, 2006, CHEM REV, V106, P1995, DOI 10.1021/cr040410w; Grass G, 2001, BIOCHEM BIOPH RES CO, V286, P902, DOI 10.1006/bbrc.2001.5474; Hubbell WL, 2013, CURR OPIN STRUC BIOL, V23, P725, DOI 10.1016/j.sbi.2013.06.008; Hubbell WL, 1998, CURR OPIN STRUC BIOL, V8, P649, DOI 10.1016/S0959-440X(98)80158-9; Janganan TK, 2011, J BIOL CHEM, V286, P26900, DOI 10.1074/jbc.M111.246595; Jeschke G, 2018, PROTEIN SCI, V27, P76, DOI 10.1002/pro.3269; Jeschke G, 2012, ANNU REV PHYS CHEM, V63, P419, DOI 10.1146/annurev-physchem-032511-143716; Joseph B, 2014, J BIOL CHEM, V289, P3176, DOI 10.1074/jbc.M113.512178; Kahra D, 2016, BIOPHYS J, V110, P95, DOI 10.1016/j.bpj.2015.11.016; Klare JP, 2013, BIOL CHEM, V394, P1281, DOI 10.1515/hsz-2013-0155; Lei HT, 2014, J MOL BIOL, V426, P403, DOI 10.1016/j.jmb.2013.09.042; Lutsenko S, 2010, CURR OPIN CHEM BIOL, V14, P211, DOI 10.1016/j.cbpa.2010.01.003; Mealman TD, 2012, BIOCHEMISTRY-US, V51, P6767, DOI 10.1021/bi300596a; Mealman TD, 2011, BIOCHEMISTRY-US, V50, P2559, DOI 10.1021/bi102012j; Meir A, 2017, BIOPHYS J, V112, P2494, DOI 10.1016/j.bpj.2017.05.013; Meir A, 2015, METALLOMICS, V7, P1163, DOI 10.1039/c5mt00053j; Outten FW, 2000, J BIOL CHEM, V275, P31024, DOI 10.1074/jbc.M006508200; Padilla-Benavides T, 2014, J BIOL CHEM, V289, P20492, DOI 10.1074/jbc.M114.577668; Pertersen C, 2000, GENE, V261, P289, DOI DOI 10.1016/S0378-; Rensing C, 2003, FEMS MICROBIOL REV, V27, P197, DOI 10.1016/S0168-6445(03)00049-4; Rensing C, 2000, P NATL ACAD SCI USA, V97, P652, DOI 10.1073/pnas.97.2.652; Sahu ID, 2013, BIOCHEMISTRY-US, V52, P6627, DOI 10.1021/bi4009984; Santiago AG, 2017, P NATL ACAD SCI USA, V114, P6694, DOI 10.1073/pnas.1704729114; Su CC, 2011, NATURE, V470, P558, DOI 10.1038/nature09743; Su CC, 2009, J MOL BIOL, V393, P342, DOI 10.1016/j.jmb.2009.08.029; Syme CD, 2004, J BIOL CHEM, V279, P18169, DOI 10.1074/jbc.M313572200; Tokuda E, 2014, HUM MOL GENET, V23, P1271, DOI 10.1093/hmg/ddt517; Ucisik MN, 2015, BIOCHEMISTRY-US, V54, P4226, DOI 10.1021/acs.biochem.5b00195; Ucisik MN, 2013, BIOCHEMISTRY-US, V52, P6911, DOI 10.1021/bi400606b; Xiao ZG, 2011, J BIOL CHEM, V286, P11047, DOI 10.1074/jbc.M110.213074; Xiao ZG, 2010, NAT PROD REP, V27, P768, DOI 10.1039/b906690j; Young TR, 2018, METALLOMICS, V10, P108, DOI 10.1039/c7mt00291b	44	6	6	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2019	14	8							e0219337	10.1371/journal.pone.0219337	http://dx.doi.org/10.1371/journal.pone.0219337			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW6AB	31465444	Green Published, gold, Green Submitted			2022-12-26	WOS:000485058200003
J	Zhu, T; Zheng, J; Lai, Y; Liu, Y				Zhu, Tingge; Zheng, Jiangbin; Lai, Yi; Liu, Ying			Image blind detection based on LBP residue classes and color regions	PLOS ONE			English	Article							MOVE FORGERY DETECTION; EFFICIENT; MOMENTS	Forgery detection is essential to verify the integrity and authenticity of images. Existing block-based detection techniques detect forgery in the same image, most of which use similar frameworks while differ in the feature extraction schemes. These methods have high accuracy in detecting the forged regions, but the computational load is heavy when facing exhaustive search problems. This paper describes a forgery detection method based on local binary pattern residue classes and color regions. An image is divided into overlapped blocks. Local binary pattern residue classes are computed for each block. The plane formed by a dimensional and b dimensional from Lab color space is divided into 16 regions. Similar blocks are searched in the overlapped blocks with the same local binary pattern residue class and color region, then they are grouped into several suspicious regions. Finally, we analyze the multi-region relation of these suspicious regions and their areas to locate the tampered regions. The small hole is filled through the morphologic operation. The results of experiments demonstrated that our method has good performance in that it improved detection accuracy and reduced execution time under various challenging conditions. As the proposed method reduces the search range for similar blocks, it has a higher speed than exhaustive search and has comparable detection results at the same time.	[Zhu, Tingge; Zheng, Jiangbin] Northwestern Polytech Univ, Sch Comp, Dept Comp Sci & Engn, Xian, Shaanxi, Peoples R China; [Zhu, Tingge; Lai, Yi; Liu, Ying] Xian Univ Posts & Telecommun, Sch Telecommun & Informat Engn, Xian, Shaanxi, Peoples R China; [Zhu, Tingge; Lai, Yi; Liu, Ying] Minist Publ Secur, Key Lab Elect Informat Proc Technol Crime Scene I, Xian, Shaanxi, Peoples R China	Northwestern Polytechnical University; Xi'an University of Posts & Telecommunications; Ministry of Public Security (China)	Zhu, T (corresponding author), Northwestern Polytech Univ, Sch Comp, Dept Comp Sci & Engn, Xian, Shaanxi, Peoples R China.; Zhu, T (corresponding author), Xian Univ Posts & Telecommun, Sch Telecommun & Informat Engn, Xian, Shaanxi, Peoples R China.; Zhu, T (corresponding author), Minist Publ Secur, Key Lab Elect Informat Proc Technol Crime Scene I, Xian, Shaanxi, Peoples R China.	tgzhu114@163.com						Al-Qershi OM, 2013, FORENSIC SCI INT, V231, P284, DOI 10.1016/j.forsciint.2013.05.027; Amerini I, 2011, IEEE T INF FOREN SEC, V6, P1099, DOI 10.1109/TIFS.2011.2129512; Bacchuwar KS, 2013, 2013 IEEE INTERNATIONAL MULTI CONFERENCE ON AUTOMATION, COMPUTING, COMMUNICATION, CONTROL AND COMPRESSED SENSING (IMAC4S), P723, DOI 10.1109/iMac4s.2013.6526502; Bayram S, 2009, INT CONF ACOUST SPEE, P1053, DOI 10.1109/ICASSP.2009.4959768; Boz A, 2016, IEEE SIGN PROC COMM, P1; Cancellaro M, 2011, SIGNAL PROCESS-IMAGE, V26, P1, DOI 10.1016/j.image.2010.11.001; Chihaoui T, 2014, 2014 1ST INTERNATIONAL CONFERENCE ON ADVANCED TECHNOLOGIES FOR SIGNAL AND IMAGE PROCESSING (ATSIP 2014), P125, DOI 10.1109/ATSIP.2014.6834590; Christlein V, 2012, IEEE T INF FOREN SEC, V7, P1841, DOI 10.1109/TIFS.2012.2218597; Dixit R, 2017, IET IMAGE PROCESS, V11, P746, DOI 10.1049/iet-ipr.2016.0322; Fridrich J, 2003, P DIG FOR RES WORKSH, P19, DOI DOI 10.1109/PACIIA.2008.240; Hu HT, 2014, PATTERN RECOGN, V47, P2596, DOI 10.1016/j.patcog.2014.02.014; Hwei-Jen Lin, 2009, WSEAS Transactions on Signal Processing, V5, P188; Liu L, 2014, 2014 TENTH INTERNATIONAL CONFERENCE ON INTELLIGENT INFORMATION HIDING AND MULTIMEDIA SIGNAL PROCESSING (IIH-MSP 2014), P626, DOI 10.1109/IIH-MSP.2014.162; Mahdian B, 2007, FORENSIC SCI INT, V171, P180, DOI 10.1016/j.forsciint.2006.11.002; Mahmood T, 2016, IEEE T SUSTAIN ENERG, P1; Muhammad G, 2012, DIGIT INVEST, V9, P49, DOI 10.1016/j.diin.2012.04.004; Neamtu C., 2013, 2013 INT C EL COMP A, P1; Ojala T, 2002, IEEE T PATTERN ANAL, V24, P971, DOI 10.1109/TPAMI.2002.1017623; Popescu A., 2004, EXPOSING DIGITAL FOR; Pun CM, 2015, IEEE T INF FOREN SEC, V10, P1705, DOI 10.1109/TIFS.2015.2423261; Ryu SJ, 2013, IEEE T INF FOREN SEC, V8, P1355, DOI 10.1109/TIFS.2013.2272377; Sekeh MA, 2013, DIGIT INVEST, V10, P73, DOI 10.1016/j.diin.2013.02.007; Silva E, 2015, J VIS COMMUN IMAGE R, V29, P16, DOI 10.1016/j.jvcir.2015.01.016; Soni B, 2018, IET IMAGE PROCESS, V12, P167, DOI 10.1049/iet-ipr.2017.0441; Tralic Dijana, 2013, Proceedings of the 2013 55th International Symposium. ELMAR-2013, P49; Ulutas G, 2013, SIG PROCESS COMMUN; Ustubioglu B., 2015, P 30 INT S COMP INF, P127; Wang YY, 2018, IEEE T FUZZY SYST, V26, P1164, DOI 10.1109/TFUZZ.2017.2710952; Wang ZY, 2019, IEEE T IMAGE PROCESS, V28, P2530, DOI 10.1109/TIP.2018.2887017; Warbhe AD, 2016, PROCEDIA COMPUT SCI, V78, P61, DOI 10.1016/j.procs.2016.02.011; Yang B, 2017, MULTIMED TOOLS APPL, V77, P1; Yang B, 2013, RADIOENGINEERING, V22, P1098; Yu LY, 2016, MULTIMED TOOLS APPL, V75, P1159, DOI 10.1007/s11042-014-2362-y; Zhang DY, 2015, J VISUAL COMMUNICATI, V30, P75; Zhao J, 2013, FORENSIC SCI INT, V233, P158, DOI 10.1016/j.forsciint.2013.09.013; Zhao Y, 2013, IEEE T INF FOREN SEC, V8, P55, DOI 10.1109/TIFS.2012.2223680; Zheng JB, 2016, MULTIDIM SYST SIGN P, V27, P989, DOI 10.1007/s11045-016-0416-1; Zhong JL, 2017, MULTIMED TOOLS APPL, V76, P14887, DOI 10.1007/s11042-016-4201-9; Zhou LG, 2019, IEEE T NEUR NET LEAR, V30, P3275, DOI 10.1109/TNNLS.2018.2890550; Zhou P, 2018, PROC CVPR IEEE, P1053, DOI 10.1109/CVPR.2018.00116; [朱叶 Zhu Ye], 2017, [自动化学报, Acta Automatica Sinica], V43, P390	42	0	0	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2019	14	8							e0221627	10.1371/journal.pone.0221627	http://dx.doi.org/10.1371/journal.pone.0221627			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW6AB	31465479	Green Published, Green Submitted, gold			2022-12-26	WOS:000485058200032
J	Basava, RK; Hash, CT; Mahendrakar, MD; Kishor, PBK; Satyavathi, CT; Kumar, S; Singh, RB; Yadav, RS; Gupta, R; Srivastava, RK				Basava, Ramana Kumari; Hash, Charles Thomas; Mahendrakar, Mahesh D.; Kishor, Kavi P. B.; Satyavathi, C. Tara; Kumar, Sushil; Singh, R. B.; Yadav, Rattan S.; Gupta, Rajeev; Srivastava, Rakesh K.			Discerning combining ability loci for divergent environments using chromosome segment substitution lines (CSSLs) in pearl millet	PLOS ONE			English	Article							MARKER-ASSISTED SELECTION; TRAITS DETERMINING GRAIN; SEQUENCE REPEAT MARKERS; DROUGHT TOLERANCE; GENETIC-BASIS; STOVER YIELD; HETEROSIS; RICE; SET; INTROGRESSION	Pearl millet is an important crop for arid and semi-arid regions of the world. Genomic regions associated with combining ability for yield-related traits under irrigated and drought conditions are useful in heterosis breeding programs. Chromosome segment substitution lines (CSSLs) are excellent genetic resources for precise QTL mapping and identifying naturally occurring favorable alleles. In the present study, testcross hybrid populations of 85 CSSLs were evaluated for 15 grain and stover yield-related traits for summer and wet seasons under irrigated control (CN) and moisture stress (MS) conditions. General combining ability (GCA) and specific combining ability (SCA) effects of all these traits were estimated and significant marker loci linked to GCA and SCA of the traits were identified. Heritability of the traits ranged from 53-94% in CN and 63-94% in MS. A total of 40 significant GCA loci and 36 significant SCA loci were identified for 14 different traits. Five QTLs (flowering time, panicle number and panicle yield linked to Xpsmp716 on LG4, flowering time and grain number per panicle with Xpsmp2076 on LG4) simultaneously controlled both GCA and SCA, demonstrating their unique genetic basis and usefulness for hybrid breeding programs. This study for the first time demonstrated the potential of a set of CSSLs for trait mapping in pearl millet. The novel combining ability loci linked with GCA and SCA values of the traits identified in this study may be useful in pearl millet hybrid and population improvement programs using marker-assisted selection (MAS).	[Basava, Ramana Kumari; Hash, Charles Thomas; Mahendrakar, Mahesh D.; Kumar, Sushil; Singh, R. B.; Gupta, Rajeev; Srivastava, Rakesh K.] Int Crops Res Inst Semi Arid Trop, Hyderabad, Telangana, India; [Kishor, Kavi P. B.] Osmania Univ, Hyderabad, Telangana, India; [Satyavathi, C. Tara] ICAR Res Complex, AICRP PM, Jodhpur, Rajasthan, India; [Kumar, Sushil] Anand Agr Univ, Anand, Gujarat, India; [Yadav, Rattan S.] Aberystwyth Univ, IBERS, Gogerddan, Wales	CGIAR; International Crops Research Institute for the Semi-Arid-Tropics (ICRISAT); Osmania University; Anand Agricultural University; Aberystwyth University; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Institute of Biological, Environmental, Rural & Sciences (IBERS)	Srivastava, RK (corresponding author), Int Crops Res Inst Semi Arid Trop, Hyderabad, Telangana, India.	r.k.srivastava@cgiar.org	Singh, Ram Baran/AAE-6848-2020; Mahendrakar, Mahesh D/I-5929-2018; Chellapilla, Tara Satyavathi/AAH-8545-2019; Kumar, Sushil/AAC-9502-2020	Singh, Ram Baran/0000-0002-2277-2576; Mahendrakar, Mahesh D/0000-0003-1052-0109; Kumar, Sushil/0000-0003-3767-8846; Yadav, Professor Rattan/0000-0001-6132-4541; Srivastava, Rakesh K/0000-0001-6715-0386; Gupta, Rajeev/0000-0002-1451-215X	Department of Biotechnology (DBT), Government of India; Biotechnology and Biological Sciences Research Council (BBSRC), Ministry of Science and Technology, Government of India; Department for International Development (DFID) [BB/F004133/1]	Department of Biotechnology (DBT), Government of India(Department of Biotechnology (DBT) India); Biotechnology and Biological Sciences Research Council (BBSRC), Ministry of Science and Technology, Government of India; Department for International Development (DFID)	The work in part was supported by the Department of Biotechnology (DBT), Government of India, Biotechnology and Biological Sciences Research Council (BBSRC), Ministry of Science and Technology, Government of India to CTH and the Department for International Development (DFID) via grant number BB/F004133/1 and administered by CAZS Natural Resources for the benefit of developing countries. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali ML, 2010, RICE, V3, P218, DOI 10.1007/s12284-010-9058-3; Allouis S, 2001, THEOR APPL GENET, V102, P1200, DOI 10.1007/s001220100559; Belicuas PR, 2014, EUPHYTICA, V198, P163, DOI 10.1007/s10681-014-1106-4; Bhardwaj R., 2015, FORAGE RES, V41, P78; Bidinger FR, 2007, CROP SCI, V47, P969, DOI 10.2135/cropsci2006.07.0465; BIDINGER FR, 1987, AUST J AGR RES, V38, P37, DOI 10.1071/AR9870037; Bidinger FR, 2005, FIELD CROP RES, V94, P14, DOI 10.1016/j.fcr.2004.11.006; Budak H, 2003, CROP SCI, V43, P2284, DOI 10.2135/cropsci2003.2284; Chigeza G, 2014, EUPHYTICA, V195, P183, DOI [10.1007/s10681-013-0985-0, 10.1007/s1]; Dave HR, 1986, P INT PEARL MILL WOR, P7; Dey SS, 2014, EUPHYTICA, V195, P169, DOI 10.1007/s10681-013-0981-4; Fasahat P, 2016, BBIJ, V4, P85; GRIFFING B., 1956, AUSTRALIAN JOUR BIOL SCI, V9, P463; HALLAUER AR, 1990, MAYDICA, V35, P1; Huang J, 2013, GENETICA, V141, P453, DOI 10.1007/s10709-013-9744-3; Jordan DR, 2003, THEOR APPL GENET, V106, P559, DOI 10.1007/s00122-002-1144-5; Joshi SK, 2004, HEREDITAS, V141, P115, DOI 10.1111/j.1601-5223.2004.01730.x; Kanatti A, 2014, SPRINGERPLUS, V3, DOI 10.1186/2193-1801-3-763; Kapoor R. L., 1989, HARYANA FARMING, V18, P17; Kumari BR, 2014, CROP SCI, V54, P2175, DOI 10.2135/cropsci2013.09.0589; Li LZ, 2013, J GENET, V92, P529, DOI 10.1007/s12041-013-0311-6; Lincoln SE, 1993, CONSTRUCTING GENETIC; Liu C, 2015, SCI REP-UK, V5, DOI 10.1038/srep12803; Lv AZ, 2012, J INTEGR AGR, V11, P43, DOI 10.1016/S1671-2927(12)60781-0; Mace ES, 2003, PLANT MOL BIOL REP, V21, p459a, DOI DOI 10.1007/BF02772596; MAHALAKSHMI V, 1986, J AGR SCI, V106, P113, DOI 10.1017/S0021859600061815; Makumbi D, 2011, EUPHYTICA, V180, P143, DOI 10.1007/s10681-010-0334-5; Mhike X, 2012, 3 RUF BIENN M ENT UG; Mohan M, 1997, MOL BREEDING, V3, P87, DOI 10.1023/A:1009651919792; Nepolean T, 2006, INT SORGHUM MILLETS, V47, P149; Nguyen H.T., 2004, PHYSL BIOTECHNOLOGY, P225; Owolade O. F., 2006, World Journal of Agricultural Sciences, V2, P109; Prioul JL, 1997, J EXP BOT, V48, P1151, DOI 10.1093/jxb/48.6.1151; Pucher A, 2016, FIELD CROP RES, V195, P9, DOI 10.1016/j.fcr.2016.04.035; Qi HH, 2013, THEOR APPL GENET, V126, P369, DOI 10.1007/s00122-012-1985-5; Qi X, 2004, THEOR APPL GENET, V109, P1485, DOI 10.1007/s00122-004-1765-y; Qi X, 2001, BIOTECHNIQUES, V31, P355, DOI 10.2144/01312st08; Qu Z, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028463; Rai KN, 1999, GENOME, V42, P617, DOI 10.1139/gen-42-4-617; Rajaram V, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-159; Ramya AR, 2018, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.01934; RATTUNDE HF, 1989, EUPHYTICA, V43, P233, DOI 10.1007/BF00023058; Schrag TA, 2010, THEOR APPL GENET, V120, P451, DOI 10.1007/s00122-009-1208-x; Senthilvel S, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-119; Serraj R, 2005, PLANT PROD SCI, V8, P334, DOI 10.1626/pps.8.334; Shukla SK, 2008, PLANT BREEDING, V127, P28, DOI 10.1111/j.1439-0523.2007.01432.x; Singh J, 2014, ADV CROP SCI TECH, V2, P147; Singh R.K., 1985, BIOMETRICAL METHODS; Sprague G. F., 1942, JOUR AMER SOC AGRON, V34, P923; TANKSLEY SD, 1993, ANNU REV GENET, V27, P205, DOI 10.1146/annurev.ge.27.120193.001225; Townsend T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061989; Tuberosa R, 2006, TRENDS PLANT SCI, V11, P15, DOI [10.1016/j.tplants.2005.11.002, DOI 10.1016/J.TPLANTS.2005.11.002]; Vadez V, 2015, J EXP BOT, V66, P5581, DOI 10.1093/jxb/erv251; Vadez V, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00386; Varshney Richa, 2017, Journal of Biological Control, V31, P69, DOI 10.18311/jbc/2017/15751; Voorrips RE, 2002, J HERED, V93, P77, DOI 10.1093/jhered/93.1.77; XIAO JH, 1995, GENETICS, V140, P745; Yadav OP, 2013, AGR RES, V2, P275, DOI 10.1007/s40003-013-0089-z; Yadav RS, 2011, J EXP BOT, V62, P397, DOI 10.1093/jxb/erq265; Yadav RS, 2004, EUPHYTICA, V136, P265, DOI 10.1023/B:EUPH.0000032711.34599.3a; Yadav RS, 2003, THEOR APPL GENET, V106, P512, DOI 10.1007/s00122-002-1081-3; Yadav RS, 2002, THEOR APPL GENET, V104, P67, DOI 10.1007/s001220200008; Zhao XW, 2016, SCI REP-UK, V6, DOI 10.1038/srep29553	63	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2019	14	8							e0218916	10.1371/journal.pone.0218916	http://dx.doi.org/10.1371/journal.pone.0218916			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5XV	31461465	Green Published, Green Accepted, Green Submitted, gold			2022-12-26	WOS:000485052300007
J	Currie, CJ; Berni, ER; Semi, TR; Jenkins-Jones, S; Sinsakul, M; Jermutus, L; Ambery, P; Jain, M				Currie, Craig J.; Berni, Ellen R.; Semi, Thomas R.; Jenkins-Jones, Sara; Sinsakul, Marvin; Jermutus, Lutz; Ambery, Philip; Jain, Meena			Major adverse cardiovascular events in people with chronic kidney disease in relation to disease severity and diabetes status	PLOS ONE			English	Article							PRACTICE RESEARCH DATABASE; ATHEROSCLEROSIS RISK; HEART-FAILURE; ALBUMINURIA; POPULATION; PREVALENCE; MORTALITY; SURVIVAL; OUTCOMES; GLUCOSE	Diabetes plays an important role in the complex relationship between chronic kidney disease (CKD) and cardiovascular disease. This retrospective observational study compared the influence of estimated glomerular filtration rate (eGFR) and proteinuria on the risk of major adverse cardiovascular event (MACE; myocardial infarction or stroke) in CKD patients with and without diabetes. Data were from a linked database of UK electronic health records. Individuals with CKD and no prior MACE were classified as type 1 diabetes (T1DM; n = 164), type 2 diabetes (T2DM; n = 9,711), and non-diabetes (non-DM; n = 75,789). Monthly updated time-dependent Cox proportional hazard models were constructed to calculate adjusted hazard ratios (aHRs) for progression to MACE from first record of abnormal eGFR or proteinuria (index date). In non-DM, aHRs (95% CIs) by baseline eGFR category (referent G2) were G1: 0.70 (0.55-0.90), G3a: 1.28 (1.20-1.35), G3b: 1.64 (1.52-1.76), G4: 2.19 (1.98-2.43), and G5: 3.12 (2.44-3.99), and by proteinuria category (referent A1) were A2: 1.13 (1.00-1.28), A2/3 (severity indeterminable): 1.58 (1.28-1.95), and A3: 1.64 (1.38-1.95). In T2DM, aHRs were G1: 0.98 (0.72-1.32), G3a: 1.18 (1.03-1.34), G3b: 1.31 (1.12-1.54), G4: 1.87 (1.53-2.29), G5: 2.87 (1.82-4.52), A2: 1.22 (1.04-1.42), A2/3: 1.45 (1.171.79), and A3: 1.82 (1.53-2.16). Low numbers in T1DM precluded analysis. Modelling T2DM and non-DM together, aHRs were, respectively, G1: 3.23 (2.38-4.40) and 0.70 (0.55-0.89); G2: 3.18 (2.73-3.70) and 1.00 (referent); G3a: 3.65 (3.13-4.25) and 1.28 (1.21-1.36); G3b: 4.01 (3.40-4.74) and 1.65 (1.54-1.77); G4: 5.78 (4.70-7.10) and 2.21 (2.00-2.45); G5: 9.00 (5.71-14.18) and 3.14 (2.46-4.00). In conclusion, reduced eGFR and proteinuria were independently associated with increased risk of MACE regardless of diabetes status. However, the risk of MACE in the same eGFR state was 4.6-2.4 times higher in T2DM than in non-DM.	[Currie, Craig J.; Berni, Ellen R.; Semi, Thomas R.; Jenkins-Jones, Sara] Pharmatelligence, Global Epidemiol, Cardiff, S Glam, Wales; [Currie, Craig J.] Cardiff Univ, Sch Med, Inst Populat Med, Cardiff, S Glam, Wales; [Sinsakul, Marvin] AstraZeneca, MedImmune, Global Med Affairs, Gaithersburg, MD USA; [Jermutus, Lutz; Ambery, Philip; Jain, Meena] AstraZeneca, MedImmune, Cardiovasc Renal & Metab, Cambridge, England; [Ambery, Philip] AstraZeneca AB, Gothenburg, Sweden	Cardiff University; AstraZeneca; Medimmune; AstraZeneca; Medimmune; AstraZeneca	Currie, CJ (corresponding author), Pharmatelligence, Global Epidemiol, Cardiff, S Glam, Wales.; Currie, CJ (corresponding author), Cardiff Univ, Sch Med, Inst Populat Med, Cardiff, S Glam, Wales.	currie@cardiff.ac.uk	Jermutus, Lutz/AAU-2047-2020		AstraZeneca PLC	AstraZeneca PLC(AstraZeneca)	CJC is a director of and EB, TRB, and SJJ are employees of Pharmatelligence, a research consultancy that received funding from MedImmune (now AstraZeneca PLC) for this work. MS, LJ, PA, and MJ on behalf of the funders played a role in the design of the study, the decision to publish, and the reviewing of the manuscript.	Abramson JL, 2003, KIDNEY INT, V64, P610, DOI 10.1046/j.1523-1755.2003.00109.x; Astor BC, 2006, AM HEART J, V151, P492, DOI 10.1016/j.ahj.2005.03.055; Benson Tim, 2011, Inform Prim Care, V19, P173; Bloomgarden Z, 2018, J DIABETES, V10, P88, DOI 10.1111/1753-0407.12616; Control CfD Prevention, 2014, NAT DIAB STAT REP ES; Currie CJ, 2010, LANCET, V375, P481, DOI 10.1016/S0140-6736(09)61969-3; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; Fox CS, 2012, LANCET, V380, P1662, DOI 10.1016/S0140-6736(12)61350-6; Gallagher AM, 2011, PHARMACOEPIDEM DR S, V20, pS230; Gerstein HC, 2001, JAMA-J AM MED ASSOC, V286, P421, DOI 10.1001/jama.286.4.421; Grundy SM, 1999, CIRCULATION, V100, P1134, DOI 10.1161/01.CIR.100.10.1134; Herrett E, 2015, INT J EPIDEMIOL, V44, P827, DOI 10.1093/ije/dyv098; Herrett E, 2010, BRIT J CLIN PHARMACO, V69, P4, DOI 10.1111/j.1365-2125.2009.03537.x; Hill NR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158765; Holden SE, 2017, DIABETIC MED, V34, P770, DOI 10.1111/dme.13332; Jha V, 2013, LANCET, V382, P260, DOI 10.1016/S0140-6736(13)60687-X; Johnson David W, 2007, Hemodial Int, V11, P1, DOI 10.1111/j.1542-4758.2007.00146.x; Keith DS, 2004, ARCH INTERN MED, V164, P659, DOI 10.1001/archinte.164.6.659; Kottgen A, 2007, J AM SOC NEPHROL, V18, P1307, DOI 10.1681/ASN.2006101159; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Levin A, 2013, KIDNEY INT SUPPL, V3, P5, DOI 10.1038/kisup.2012.77; Liang HF, 2015, BMJ OPEN DIAB RES CA, V3, DOI 10.1136/bmjdrc-2014-000071; Liu M, 2014, EUR REV MED PHARMACO, V18, P2918; Lo C, 2014, DIABETES RES CLIN PR, V104, P84, DOI 10.1016/j.diabres.2014.01.020; NHS Digital, OPCS CLASSIFICATION; PARVING HH, 1992, KIDNEY INT, V41, P758, DOI 10.1038/ki.1992.118; Schneider C, 2016, CLIN EPIDEMIOL, V8, P177, DOI 10.2147/CLEP.S107060; Segall L, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/937398; Shaw JE, 2010, DIABETES RES CLIN PR, V87, P4, DOI 10.1016/j.diabres.2009.10.007; World Health Organization, CLASSIFICATION OF DI	30	16	16	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2019	14	8							e0221044	10.1371/journal.pone.0221044	http://dx.doi.org/10.1371/journal.pone.0221044			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5XV	31461449	gold, Green Submitted, Green Accepted, Green Published			2022-12-26	WOS:000485052300022
J	Shin, D; Chang, SY; Bogere, P; Won, K; Choi, JY; Choi, YJ; Lee, HK; Hur, J; Park, BY; Kim, Y; Heo, J				Shin, Donghyun; Chang, Sung Yong; Bogere, Paul; Won, KyeongHye; Choi, Jae-Young; Choi, Yeon-Jae; Lee, Hak Kyo; Hur, Jin; Park, Byung-Yong; Kim, Younghoon; Heo, Jaeyoung			Beneficial roles of probiotics on the modulation of gut microbiota and immune response in pigs	PLOS ONE			English	Article							GROWTH-PERFORMANCE; GENE-EXPRESSION; INNATE IMMUNITY; LACTOBACILLUS-PLANTARUM; BACILLUS-SUBTILIS; WEANED PIGLETS; HEALTH; DIVERSITY; INTESTINE; BACTERIA	The importance of probiotics in swine production is widely acknowledged as crucial. However, gaps still remain in the exact roles played by probiotics in modulation of gut microbiota and immune response. This study determined the roles of probiotic Lactobacillus plantarum strain JDFM LP11 in gut microbiota modulation and immune response in weaned piglets. L. plantarum JDFM LP11 increased the population of lactic acid bacteria in feces and enhanced the development of villi in the small intestine. Metagenome analysis showed that microbial diversity and richness (Simpson, Shannon, ACE, Chao1) and the relative abundance of the Firmicutes were higher in weaned piglets fed probiotics. Five bacterial families were different in the relative abundance, especially; Prevotellaceae occupied the largest part of microbial community showed the most difference between two groups. Transcriptome analysis identified 25 differentially expressed genes using RNA-sequencing data of the ileum. Further gene ontology and immune DB analysis determined 8 genes associated with innate defense response and cytokine production. BPI, RSAD2, SLPI, LUM, OLFM4, DMBT1 and C6 genes were down-regulated by probiotic supplementation except PLA2G2A. PICRUSt analysis predicting functional profiling of microbial communities indicated branched amino acid biosynthesis and butyrate metabolism promoting gut development and health were increased by probiotics. Altogether, our data suggest that L. plantarum JDFM LP11 increases the diversity and richness in the microbial community, and attenuates the ileal immune gene expression towards gut inflammation, promoting intestinal development in weaned piglets.	[Shin, Donghyun; Won, KyeongHye; Lee, Hak Kyo] Chonbuk Natl Univ, Dept Anim Biotechnol, Jeonju, South Korea; [Chang, Sung Yong] Chonbuk Natl Univ, Dept Anim Sci, Jeonju, South Korea; [Chang, Sung Yong] Chonbuk Natl Univ, Inst Milk Genom, Jeonju, South Korea; [Bogere, Paul] Chonbuk Natl Univ, Dept Agr Convergence Technol, Jeonju, South Korea; [Choi, Jae-Young; Lee, Hak Kyo] Chonbuk Natl Univ, Anim Mol Genet & Breeding Ctr, Jeonju, South Korea; [Choi, Yeon-Jae; Heo, Jaeyoung] Chonbuk Natl Univ, Int Agr Dev & Cooperat Ctr, Jeonju, South Korea; [Hur, Jin; Park, Byung-Yong] Chonbuk Natl Univ, Coll Vet Med, Iksan, South Korea; [Kim, Younghoon] Seoul Natl Univ, Dept Agr Biotechnol, Seoul, South Korea; [Kim, Younghoon] Seoul Natl Univ, Res Inst Agr & Life Sci, Seoul, South Korea	Jeonbuk National University; Jeonbuk National University; Jeonbuk National University; Jeonbuk National University; Jeonbuk National University; Jeonbuk National University; Jeonbuk National University; Seoul National University (SNU); Seoul National University (SNU)	Heo, J (corresponding author), Chonbuk Natl Univ, Int Agr Dev & Cooperat Ctr, Jeonju, South Korea.	jyheobio@gmail.com		Bogere, Paul/0000-0002-3777-1226	Next-Generation BioGreen 21 Program, Rural Development Administration, Republic of Korea [PJ01322302]; Strategic Initiative for Microbiomes in Agriculture and Food, Ministry of Agriculture, Food and Rural Affairs, Republic of Korea [918002-04]	Next-Generation BioGreen 21 Program, Rural Development Administration, Republic of Korea; Strategic Initiative for Microbiomes in Agriculture and Food, Ministry of Agriculture, Food and Rural Affairs, Republic of Korea	This research was supported by a grant from the Next-Generation BioGreen 21 Program (PJ01322302), Rural Development Administration, Republic of Korea and the Strategic Initiative for Microbiomes in Agriculture and Food, Ministry of Agriculture, Food and Rural Affairs, Republic of Korea (Project No. 918002-04). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aliakbarpour HR, 2012, ASIAN AUSTRAL J ANIM, V25, P1285, DOI 10.5713/ajas.2012.12110; Angelakis E, 2017, MICROB PATHOGENESIS, V106, P162, DOI 10.1016/j.micpath.2016.11.002; [Anonymous], 2016, PROBIOTICS ANIMAL NU; Azad MB, 2015, CLIN EXP ALLERGY, V45, P632, DOI 10.1111/cea.12487; Bajaj BK, 2015, J MICROB BIOTEC FOOD, V4, P321, DOI 10.15414/jmbfs.2015.4.4.321-327; Barrios VE, 2003, BIOCHEM PHARMACOL, V66, P519, DOI 10.1016/S0006-2952(03)00292-2; Bearson SMD, 2013, INFECT GENET EVOL, V16, P330, DOI 10.1016/j.meegid.2013.03.022; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Breuer K, 2013, NUCLEIC ACIDS RES, V41, pD1228, DOI 10.1093/nar/gks1147; Brown M, 2011, J ANIM VET ADV, V10, P1895, DOI 10.3923/javaa.2011.1895.1900; Buzoianu SG, 2012, APPL ENVIRON MICROB, V78, P4217, DOI 10.1128/AEM.00307-12; Callaway T. R., 2008, Animal Health Research Reviews, V9, P217, DOI 10.1017/S1466252308001540; Cannon JG, 1998, MOL CELL BIOCHEM, V179, P159, DOI 10.1023/A:1006828425418; Canny GO, 2008, INFECT IMMUN, V76, P3360, DOI 10.1128/IAI.00187-08; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Castillo EF, 2016, EUR J IMMUNOL, V46, P2852, DOI 10.1002/eji.201646507; Chang SY, 2018, KOREAN J FOOD SCI AN, V38, P403, DOI 10.5851/kosfa.2018.38.2.403; Cho J.Z., 2011, J ANIM VET ADV, V10, P2; Corcionivoschi N., 2010, Lucrari Stiintifice - Zootehnie si Biotehnologii, Universitatea de Stiinte Agricole si Medicina Veterinara a Banatului Timisoara, V43, P35; Cromwell GL, 2002, ANIM BIOTECHNOL, V13, P7, DOI 10.1081/ABIO-120005767; Cui C, 2013, GENET MOL RES, V12, P1766, DOI 10.4238/2013.May.23.1; Daudelin JF, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-69; Debski B, 2016, POL J VET SCI, V19, P917, DOI 10.1515/pjvs-2016-0113; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Ding PP, 2016, IMMUNOBIOLOGY, V221, P1293, DOI 10.1016/j.imbio.2016.05.014; Dowarah R, 2017, ANIM NUTR, V3, P1, DOI 10.1016/j.aninu.2016.11.002; Drancourt M, 2000, J CLIN MICROBIOL, V38, P3623, DOI 10.1128/JCM.38.10.3623-3630.2000; Fairbrother John M., 2005, Animal Health Research Reviews, V6, P17, DOI 10.1079/AHR2005105; Frese SA, 2015, MICROBIOME, V3, DOI 10.1186/s40168-015-0091-8; Gareau MG, 2010, NAT REV GASTRO HEPAT, V7, P503, DOI 10.1038/nrgastro.2010.117; Giang HH, 2010, LIVEST SCI, V129, P95, DOI 10.1016/j.livsci.2010.01.010; Guerra-Ordaz AA, 2013, ANIM FEED SCI TECH, V185, P160, DOI 10.1016/j.anifeedsci.2013.07.009; Guo X, 2008, LETT APPL MICROBIOL, V47, P367, DOI 10.1111/j.1472-765X.2008.02408.x; Haiko Johanna, 2013, Biology (Basel), V2, P1242, DOI 10.3390/biology2041242; Hamer HM, 2008, ALIMENT PHARM THER, V27, P104, DOI 10.1111/j.1365-2036.2007.03562.x; Heo J, 2018, KOREAN J FOOD SCI AN, V38, P878, DOI 10.5851/kosfa.2018.e21; Hughes JB, 2001, APPL ENVIRON MICROB, V67, P4399, DOI 10.1128/AEM.67.10.4399-4406.2001; Iji PA, 2001, BRIT POULTRY SCI, V42, P523, DOI 10.1080/00071660120073160; Isaacson Richard, 2012, Animal Health Research Reviews, V13, P100, DOI 10.1017/S1466252312000084; Janczyk P, 2007, FEMS MICROBIOL ECOL, V61, P132, DOI 10.1111/j.1574-6941.2007.00317.x; Jang JS, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0889-y; Kabir SML, 2009, INT J MOL SCI, V10, P3531, DOI 10.3390/ijms10083531; Kelly D, 2005, TRENDS IMMUNOL, V26, P326, DOI 10.1016/j.it.2005.04.008; Kim D, 2015, NAT METHODS, V12, P357, DOI [10.1038/NMETH.3317, 10.1038/nmeth.3317]; Kim HB, 2012, P NATL ACAD SCI USA, V109, P15485, DOI 10.1073/pnas.1205147109; Kim HB, 2011, VET MICROBIOL, V153, P124, DOI 10.1016/j.vetmic.2011.05.021; Konstantinov SR, 2006, ENVIRON MICROBIOL, V8, P1191, DOI 10.1111/j.1462-2920.2006.01009.x; Kreuzer-Redmer S, 2016, APPL ENVIRON MICROB, V82, P2263, DOI 10.1128/AEM.04044-15; Kuczynski J, 2012, NAT REV GENET, V13, P47, DOI 10.1038/nrg3129; Lalles JP, 2007, P NUTR SOC, V66, P260, DOI 10.1017/S0029665107005484; Lamendella R, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-103; Le Bon M, 2010, LIVEST SCI, V133, P179, DOI 10.1016/j.livsci.2010.06.058; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Lindgreen S, 2016, SCI REP-UK, V6, DOI 10.1038/srep19233; Liu H, 2015, LIVEST SCI, V178, P251, DOI 10.1016/j.livsci.2015.06.002; Liu WL, 2016, CANCER METAST REV, V35, P201, DOI 10.1007/s10555-016-9624-2; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Madsen J, 2010, INNATE IMMUN-LONDON, V16, P160, DOI 10.1177/1753425910368447; Mappley LJ, 2013, J MED MICROBIOL, V62, P287, DOI 10.1099/jmm.0.051862-0; Mccoy S, 2007, J FOOD SCI, V72, pM94, DOI 10.1111/j.1750-3841.2007.00310.x; Moeser AJ, 2017, ANIM NUTR, V3, P313, DOI 10.1016/j.aninu.2017.06.003; Navas-Molina JA, 2013, METHOD ENZYMOL, V531, P371, DOI 10.1016/B978-0-12-407863-5.00019-8; Neveling DP, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12866-7; Okita Y, 2016, INFECT IMMUN, V84, P573, DOI 10.1128/IAI.01000-15; Okpe C. G., 2016, J BASIC APPL ZOOL, V75, P54; Pajarillo EAB, 2015, ANIM FEED SCI TECH, V201, P80, DOI 10.1016/j.anifeedsci.2015.01.011; Pajarillo EAB, 2015, ASIAN AUSTRAL J ANIM, V28, P584, DOI 10.5713/ajas.14.0651; Panpan Tong, 2017, Agri Gene, V5, P1, DOI 10.1016/j.aggene.2017.06.001; Pickard JM, 2017, IMMUNOL REV, V279, P70, DOI 10.1111/imr.12567; Pieper R, 2009, INT J FOOD MICROBIOL, V130, P227, DOI 10.1016/j.ijfoodmicro.2009.01.026; Pieper R, 2009, APPL ENVIRON MICROB, V75, P7006, DOI 10.1128/AEM.01343-09; Plaza-Diaz J, 2017, NUTRIENTS, V9, DOI 10.3390/nu9060555; Plaza-Diaz J, 2014, WORLD J GASTROENTERO, V20, P15632, DOI 10.3748/wjg.v20.i42.15632; Reid G, 2002, ANIM BIOTECHNOL, V13, P97, DOI 10.1081/ABIO-120005773; Riboulet-Bisson E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031113; Rognes T, 2016, PEERJ, V4, DOI 10.7717/peerj.2584; Sanders ME, 2011, J CLIN GASTROENTEROL, V45, pS115, DOI 10.1097/MCG.0b013e318227414a; Sneath P.H.A., 1973, NUMERICAL TAXONOMY; SOKAL ROBERT R., 1963, TAXON, V12, P190, DOI 10.2307/1217562; Steiner T., 2006, MANAGING GUT HLTH NA; Suo C, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-89; Thomsen LE, 2006, VET PARASITOL, V142, P112, DOI 10.1016/j.vetpar.2006.05.032; Unno T, 2015, J MICROBIOL BIOTECHN, V25, P431, DOI 10.4014/jmb.1408.08063; Vondruskova H, 2010, VET MED-CZECH, V55, P199, DOI 10.17221/2998-VETMED; Wang J, 2014, INT J MOL SCI, V15, P10989, DOI 10.3390/ijms150610989; Wang J, 2013, NUCLEIC ACIDS RES, V41, pW77, DOI 10.1093/nar/gkt439; Wang TW, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.00090; Williams SE, 2006, CLIN SCI, V110, P21, DOI 10.1042/CS20050115; Zahoor MA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106418; Zhang L, 2010, VET MICROBIOL, V141, P142, DOI 10.1016/j.vetmic.2009.09.003; Zhang SH, 2017, J ANIM SCI BIOTECHNO, V8, DOI 10.1186/s40104-016-0139-z; Zhang W, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.00977; Zhang ZW, 2016, BMC MICROBIOL, V16, DOI 10.1186/s12866-016-0783-7; Zhao PY, 2015, ANIM FEED SCI TECH, V200, P86, DOI 10.1016/j.anifeedsci.2014.12.010	96	51	55	3	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2019	14	8							e0220843	10.1371/journal.pone.0220843	http://dx.doi.org/10.1371/journal.pone.0220843			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5XV	31461453	Green Submitted, Green Published, gold			2022-12-26	WOS:000485052300017
J	Campos-Medina, VA; Cotrozzi, L; Stuart, JJ; Couture, JJ				Campos-Medina, Veronica A.; Cotrozzi, Lorenzo; Stuart, Jeffrey J.; Couture, John J.			Spectral characterization of wheat functional trait responses to Hessian fly: Mechanisms for trait-based resistance	PLOS ONE			English	Article							NEAR-INFRARED REFLECTANCE; DIPTERA-CECIDOMYIIDAE; LINEAR-REGRESSION; WINTER-WHEAT; PLANT; INSECT; LEAF; NITROGEN; LARVAE; GENES	Insect herbivores can manipulate host plants to inhibit defenses. Insects that induce plant galls are excellent examples of these interactions. The Hessian fly (HF, Mayetiola destructor) is a destructive pest of wheat (Triticum spp.) that occurs in nearly all wheat producing globally. Under compatible interactions (i.e., successful HF establishment), HF larvae alter host tissue physiology and morphology for their benefit, manifesting as the development of plant nutritive tissue that feeds the larva and ceases plant cell division and elongation. Under incompatible interactions (i.e., unsuccessful HF establishment), plants respond to larval feeding by killing the larva, permitting normal plant development. We used reflectance spectroscopy to characterize whole-plant functional trait responses during both compatible and incompatible interactions and related these findings with morphological and gene expression observations from earlier studies. Spectral models successfully characterized wheat foliar traits, with mean goodness of fit statistics of 0.84, 0.85, 0.94, and 0.69 and percent root mean square errors of 22, 10, 6, and 20%, respectively, for nitrogen and carbon concentrations, leaf mass per area, and total phenolic content. We found that larvae capable of generating compatible interactions successfully manipulated host plant chemical and morphological composition to create a more hospitable environment. Incompatible interactions resulted in lower host plant nutritional quality, thicker leaves, and higher phenolic levels. Spectral measurements successfully characterized wheat responses to compatible and incompatible interactions, providing an excellent example of the utility of Spectral phenotyping in quantifying responses of specific plant functional traits associated with insect resistance.	[Campos-Medina, Veronica A.; Cotrozzi, Lorenzo; Stuart, Jeffrey J.; Couture, John J.] Purdue Univ, Dept Entomol, W Lafayette, IN 47907 USA; [Cotrozzi, Lorenzo; Couture, John J.] Purdue Univ, Dept Forestry & Nat Resources, W Lafayette, IN 47907 USA; [Couture, John J.] Purdue Univ, Ctr Plant Biol, W Lafayette, IN 47907 USA; [Cotrozzi, Lorenzo] Univ Pisa, Dept Agr Food & Environm, Pisa, Italy	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; University of Pisa	Couture, JJ (corresponding author), Purdue Univ, Dept Entomol, W Lafayette, IN 47907 USA.; Couture, JJ (corresponding author), Purdue Univ, Dept Forestry & Nat Resources, W Lafayette, IN 47907 USA.; Couture, JJ (corresponding author), Purdue Univ, Ctr Plant Biol, W Lafayette, IN 47907 USA.	couture@purdue.edu		Cotrozzi, Lorenzo/0000-0002-4401-3896	USDA NIFA Hatch awards [IND011490, IND011462]; Becas Chile Scholarship	USDA NIFA Hatch awards; Becas Chile Scholarship	This work was supported by USDA NIFA Hatch awards IND011490 to JJC and IND011462 to JJS. VACM was supported by a Becas Chile Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank Dr. Anjali Iyer-Pascuzzi for access to WhinRHIZO program and scanner to measure leaf area, Daniel Edwards for laboratory and collection assistance, and Sue Cambron for insect material and plants. This work was supported by USDA NIFA Hatch awards IND011490 to JJC and IND011462 to JJS. VACM was supported by a Becas Chile Scholarship.	Aggarwal R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100958; Ainsworth EA, 2007, NAT PROTOC, V2, P875, DOI 10.1038/nprot.2007.102; Anderson KG, 2006, J ECON ENTOMOL, V99, P1842, DOI 10.1603/0022-0493-99.5.1842; Arens N, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01377; Asner GP, 2008, REMOTE SENS ENVIRON, V112, P3958, DOI 10.1016/j.rse.2008.07.003; Asner GP, 2011, ECOL APPL, V21, P85, DOI 10.1890/09-1999.1; Atzberger C, 2010, COMPUT ELECTRON AGR, V73, P165, DOI 10.1016/j.compag.2010.05.006; Basu S, 2018, MOL PLANT MICROBE IN, V31, P13, DOI 10.1094/MPMI-07-17-0183-FI; Berzonsky WA, 2002, PL BRED RE, V22, P221; Bolster KL, 1996, CAN J FOREST RES, V26, P590, DOI 10.1139/x26-068; Bronner R., 1992, P118; BYERS RA, 1972, J ECON ENTOMOL, V65, P955, DOI 10.1093/jee/65.4.955; Cambron SE, 2010, J ECON ENTOMOL, V103, P2229, DOI 10.1603/EC10219; Chen MS, 2008, INSECT SCI, V15, P101, DOI 10.1111/j.1744-7917.2008.00190.x; Chen MS, 2009, J ECON ENTOMOL, V102, P1663, DOI 10.1603/029.102.0434; Chen S, 2004, IEEE T SYST MAN CY B, V34, P898, DOI 10.1109/TSMCB.2003.817107; Chong IG, 2005, CHEMOMETR INTELL LAB, V78, P103, DOI 10.1016/j.chemolab.2004.12.011; Cotrozzi L, 2018, ENVIRON SCI POLLUT R, V25, P8249, DOI 10.1007/s11356-017-9568-2; Cotrozzi L, 2017, TREE PHYSIOL, V37, P1582, DOI 10.1093/treephys/tpx106; Couture JJ, 2018, PLANT DIS, V102, P2233, DOI 10.1094/PDIS-01-18-0054-RE; Couture JJ, 2016, METHODS ECOL EVOL, V7, P1402, DOI 10.1111/2041-210X.12596; Couture JJ, 2013, NEW PHYTOL, V198, P311, DOI 10.1111/nph.12159; CURRAN PJ, 1989, REMOTE SENS ENVIRON, V30, P271, DOI 10.1016/0034-4257(89)90069-2; Fagan WF, 2002, AM NAT, V160, P784, DOI 10.1086/343879; FERNANDES GW, 1990, ENVIRON ENTOMOL, V19, P1173, DOI 10.1093/ee/19.5.1173; Foley WJ, 1998, OECOLOGIA, V116, P293, DOI 10.1007/s004420050591; Giron D, 2016, J INSECT PHYSIOL, V84, P70, DOI 10.1016/j.jinsphys.2015.12.009; Grossman YL, 1996, REMOTE SENS ENVIRON, V56, P182, DOI 10.1016/0034-4257(95)00235-9; GROVER P, 1995, ENTOMOL EXP APPL, V74, P283, DOI 10.1007/BF02381793; Harris MO, 2010, PHYTOPATHOLOGY, V100, P279, DOI 10.1094/PHYTO-100-3-0279; Harris MO, 2006, ANN ENTOMOL SOC AM, V99, P305, DOI 10.1603/0013-8746(2006)099[0305:VHFDCL]2.0.CO;2; Hartley SE, 1998, OECOLOGIA, V113, P492, DOI 10.1007/s004420050401; Hoglund S, 2014, ECOL ENTOMOL, V39, P159, DOI 10.1111/een.12078; LESZCZYNSKI B, 1995, ENTOMOL EXP APPL, V76, P157, DOI 10.1007/BF02383213; Liu XM, 2005, THEOR APPL GENET, V111, P243, DOI 10.1007/s00122-005-2009-5; Liu X, 2007, J CHEM ECOL, V33, P2171, DOI 10.1007/s10886-007-9382-2; MATTSON WJ, 1980, ANNU REV ECOL SYST, V11, P119, DOI 10.1146/annurev.es.11.110180.001003; Mevik BH, 2007, J STAT SOFTW, V18, P1, DOI 10.18637/jss.v018.i02; Nation J. L., 2008, INSECT PHYSL BIOCH; Navarro L.F, 2016, THESIS; Oates CN, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17111891; PATTERSON FL, 1994, CROP SCI, V34, P315, DOI 10.2135/cropsci1994.0011183X003400010084x; Penuelas J, 1998, TRENDS PLANT SCI, V3, P151, DOI 10.1016/S1360-1385(98)01213-8; PRICE PW, 1987, ENVIRON ENTOMOL, V16, P15, DOI 10.1093/ee/16.1.15; Sankaran S, 2010, COMPUT ELECTRON AGR, V72, P1, DOI 10.1016/j.compag.2010.02.007; Santos JC, 2017, ARTHROPOD-PLANT INTE, V11, P163, DOI 10.1007/s11829-016-9472-6; Serbin SP, 2014, ECOL APPL, V24, P1651, DOI 10.1890/13-2110.1; Serbin SP, 2012, J EXP BOT, V63, P489, DOI 10.1093/jxb/err294; SHUKLE RH, 1992, ENVIRON ENTOMOL, V21, P845, DOI 10.1093/ee/21.4.845; Shukle RH, 2010, J INSECT PHYSIOL, V56, P754, DOI 10.1016/j.jinsphys.2010.01.005; Silva-Perez V, 2018, J EXP BOT, V69, P483, DOI 10.1093/jxb/erx421; Simmonds MSJ, 2003, PHYTOCHEMISTRY, V64, P21, DOI 10.1016/S0031-9422(03)00293-0; Stone GN, 2003, TRENDS ECOL EVOL, V18, P512, DOI 10.1016/S0169-5347(03)00247-7; Stuart J, 2015, CURR OPIN INSECT SCI, V9, P56, DOI 10.1016/j.cois.2015.02.010; Stuart JJ, 2012, ANNU REV PHYTOPATHOL, V50, P339, DOI 10.1146/annurev-phyto-072910-095255; Tooker JF, 2008, NEW PHYTOL, V178, P657, DOI 10.1111/j.1469-8137.2008.02392.x; Tooker JF, 2007, ECOL ENTOMOL, V32, P153, DOI 10.1111/j.1365-2311.2007.00852.x; Williams CE, 2011, J EXP BOT, V62, P4521, DOI 10.1093/jxb/err160; Wold S, 2001, CHEMOMETR INTELL LAB, V58, P109, DOI 10.1016/S0169-7439(01)00155-1; WOLD S, 1984, SIAM J SCI STAT COMP, V5, P735, DOI 10.1137/0905052; Zhao CY, 2016, J INSECT PHYSIOL, V84, P22, DOI 10.1016/j.jinsphys.2015.10.001; Zhao CY, 2015, CURR BIOL, V25, P613, DOI 10.1016/j.cub.2014.12.057; Zhu L, 2008, MOL PLANT MICROBE IN, V21, P70, DOI 10.1094/MPMI-21-1-0070	63	6	6	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2019	14	8							e0219431	10.1371/journal.pone.0219431	http://dx.doi.org/10.1371/journal.pone.0219431			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5RZ	31437174	Green Submitted, Green Published, gold			2022-12-26	WOS:000485036900007
J	Dagne, AH; Ayele, AD; Assefa, EM				Dagne, Asrat Hailu; Ayele, Alemu Degu; Assefa, Ephrem Mengesha			Assessment of breast self- examination practice and associated factors among female workers in Debre Tabor Town public health facilities, North West Ethiopia, 2018: Cross-sectional study	PLOS ONE			English	Article							MAMMOGRAPHY; ULTRASOUND; WOMEN; AGE	Background Although breast Self-Examination is no longer tenable as a standard method to detect early breast cancer, world health organization recommends breast self-examination for raising awareness of women about breast cancer. Secondary prevention through monthly breast self-examination is the best option to tackle the rising incidence of breast cancer. Therefore, the aim of this study was to assess breast self -examination practice and associated factors. Methods This cross-sectional study was conducted from April 23 to May 23, 2018. A total of 421 female workers in Debre Tabor Town public health facilities were included. The study participants were selected using simple random sampling technique from the study population. The collected data were checked for completeness. The data were entered and cleaned using EpiData version 3.1 then exported to SPSS version 20 for analysis. Crude odd ratio and probability value were identified for each independent variable and all independent variables with probability value of less than 0.2 were entered into multivariables logistic regression. Statistically significant associated factors were identified based on probability value (p-value) less than 0.05 and adjusted odd ratio with 95% confidence interval. Result The mean age of participants was 25.2 (S.D = 4.12) and 137 (32.5%) of the participants had practiced breast self-examination and 64 (15.2%) of them performed it monthly. Family history of breast cancer (adjusted OR = 6.5, CI = 1.54-21.4), Knowledge about breast -self examination (adjusted OR = 5.74, CI = 2.3-14.4) and self- efficacy in practicing breast self -examination (adjusted OR = 4.7, CI = 1.84-12.11) were significantly associated with breast self-examination practice. Conclusions The study showed that the prevalence of breast self-examination was low. Family history of breast cancer, knowledge about breast self-examination and self- efficacy in practicing breast self-examination did have statistically significant association with breast self examination practice.	[Dagne, Asrat Hailu; Ayele, Alemu Degu] Debre Tabor Univ, Dept Midwifery, Debre Tabor, Amhara Region, Ethiopia; [Assefa, Ephrem Mengesha] Debre Tabor Hlth Sci Coll, Dept Midwifery, Debre Tabor, Amhara Region, Ethiopia		Dagne, AH (corresponding author), Debre Tabor Univ, Dept Midwifery, Debre Tabor, Amhara Region, Ethiopia.	1221Asrat@gmail.com	Tebit, Kwenti/P-8688-2018	Tebit, Kwenti/0000-0001-5526-9179	Debre Tabor University	Debre Tabor University	The funder was Debre Tabor University, and we would like to thank Debre Tabor University for financial support during data collection and the support of stationary materials, printing and copy. But all the other activities of our research work were accomplished through the effort of investigators as part of free community service of the university. We would also like to inform you that we did not have grant number.	Abate S., 2016, INT J CANC RES MOL M, V2, P1, DOI [10.16966/2381-3318.121, DOI 10.16966/2381-3318.121]; Adeloye D, 2018, J GLOB HEALTH, V8, DOI 10.7189/jogh.08.021101; Akhigbe AO, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-203; Al-Azmy SF, 2013, ALEX J MED, V49, P281, DOI 10.1016/j.ajme.2012.08.009; Al-Naggar RA, 2011, ASIAN PAC J CANCER P, V12, P1173; Alkhasawneh IM, 2008, JORNAL ADV NURSING, V65, P412; Azage M, 2013, INT J BREAST CANC, V2013, P1; Beydag KD, 2010, ASIAN PAC J CANCER P, V11, P1761; Birhane K, 2017, INT J BREAST CANCER, V2017, DOI 10.1155/2017/8026297; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; DeSantis C, 2013, BREAST CANC FACTS FI, P1, DOI [DOI 10.3322/CAAC.21203, 10.3322/caac.21203]; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Ginsberg GM, 2012, BMJ-BRIT MED J, V344, P614, DOI DOI 10.1136/BMJ.E614; Ilanye B Hope, 2008, NIGERIAN HLTH J, V12, P16; Minasie A, 2017, REPROD SYST SEX DISO, V6, P219; Negeri EL., 2017, INT J MED MED SCI, V9, P148, DOI [10.5897/IJMMS2016.1269, DOI 10.5897/IJMMS2016.1269]; Nelson H, 2009, SCREENING BREAST CAN; Phi XA, 2016, BRIT J CANCER, V114, P631, DOI 10.1038/bjc.2016.32; Provencher L, 2016, CURR ONCOL, V23, pE332, DOI 10.3747/co.23.2881; Riedl CC, 2015, J CLIN ONCOL, V33, P1128, DOI 10.1200/JCO.2014.56.8626; Roshanaei, 2018, RANDOMIZED CONTROL T, V19, P3443, DOI [10.31557/APJCP.2018.19.12.3443, DOI 10.31557/APJCP.2018.19.12.3443]; Sama CB, 2017, PAN AFR MED J, V28, DOI 10.11604/pamj.2017.28.91.10986; Sani A. M., 2018, OBSTETRIC GYNECOLOGY, V9, P157; Sani AM, 2016, J BASIC CLINICALREPR, V5, P100; Sanvido VM, 2017, J CLIN DIAGN RES, V11, pXC01, DOI 10.7860/JCDR/2017/25504.9987; Sathian B, 2014, ASIAN PAC J CANCER P, V15, P4723, DOI 10.7314/APJCP.2014.15.11.4723; Segni M. T., 2016, GYNECOLOBSTET SUNNY, V6, P2161; Suh Mary Atanga Bi, 2012, BMC Res Notes, V5, P627, DOI 10.1186/1756-0500-5-627; Tastan S, 2011, ASIAN NURS RES, V5, P151, DOI 10.1016/j.anr.2011.09.001; Tavafian Sedigheh Sadat, 2009, BMC Womens Health, V9, P37, DOI 10.1186/1472-6874-9-37; Wilczek B, 2016, EUR J RADIOL, V85, P1554, DOI 10.1016/j.ejrad.2016.06.004	32	15	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2019	14	8							e0221356	10.1371/journal.pone.0221356	http://dx.doi.org/10.1371/journal.pone.0221356			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5RZ	31437209	Green Submitted, Green Published, gold			2022-12-26	WOS:000485036900058
J	Glazko, G; Zybailov, B; Emmert-Streib, F; Baranova, A; Rahmatallah, Y				Glazko, Galina; Zybailov, Boris; Emmert-Streib, Frank; Baranova, Ancha; Rahmatallah, Yasir			Proteome-transcriptome alignment of molecular portraits achieved by self-contained gene set analysis: Consensus colon cancer subtypes case study	PLOS ONE			English	Article							ENRICHMENT ANALYSIS; FUNCTIONAL-ANALYSIS; CLASSIFICATION; LISTS; MICROENVIRONMENT; HETEROGENEITY; ANNOTATION; METABOLISM; PREDICTION; MUTATIONS	Gene set analysis (GSA) has become the common methodology for analyzing transcriptomics data. However, self-contained GSA techniques are rarely, if ever, used for proteomics data analysis. Here we present a self-contained proteome level GSA of four consensus molecular subtypes (CMSs) previously established by transcriptome dissection of colon carcinoma specimens. Despite notable difference in structure of proteomics and transcriptomics data, many pathway-wide characteristic features of CMSs found at the mRNA level were reproduced at the protein level. In particular, CMS1 features show heavy involvement of immune system as well as the pathways related to mismatch repair, DNA replication and functioning of proteasome, while CMS4 tumors upregulate complement pathway and proteins participating in epithelial-to-mesenchymal transition (EMT). In addition, protein level GSA yielded a set of novel observations visible at the proteome, but not at the transcriptome level, including possible involvement of major histocompatibility complex II (MHCII) antigens in the known immunogenicity of CMS1 and a connection between cholesterol trafficking and the regulation of Integrin-linked kinase (ILK) in CMS3. Overall, this study proves utility of self-contained GSA approaches as a critical tool for analyzing proteomics data in general and dissecting protein-level molecular portraits of human tumors in particular.	[Glazko, Galina; Rahmatallah, Yasir] Univ Arkansas Med Sci, Dept Biomed Informat, Little Rock, AR 72205 USA; [Zybailov, Boris] Univ Arkansas Med Sci, Dept Biochem & Mol Biol, Little Rock, AR 72205 USA; [Emmert-Streib, Frank] Tampere Univ Technol, Computat Med & Stat Learning Lab, Tampere, Finland; [Baranova, Ancha] George Mason Univ, Sch Syst Biol, Manassas, VA USA; [Baranova, Ancha] Res Ctr Med Genet, Moscow, Russia	University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences; Tampere University; George Mason University; Research Centre for Medical Genetics	Glazko, G (corresponding author), Univ Arkansas Med Sci, Dept Biomed Informat, Little Rock, AR 72205 USA.	gvglazko@uams.edu	Emmert-Streib, Frank/AAF-2878-2020	Emmert-Streib, Frank/0000-0003-0745-5641; Zybailov, Boris/0000-0003-2432-9145; Rahmatallah, Yasir/0000-0002-8176-6328	NIH IDeA Networks of Biomedical Research Excellence (INBRE) [P20 GM103429]; Center for Translational Pediatric Research (CTPR) NIH Center of Biomedical Research Excellence award [P20 GM121293]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103429, P20GM121293] Funding Source: NIH RePORTER	NIH IDeA Networks of Biomedical Research Excellence (INBRE)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center for Translational Pediatric Research (CTPR) NIH Center of Biomedical Research Excellence award; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Support was provided in part by the NIH IDeA Networks of Biomedical Research Excellence (INBRE) grant (P20 GM103429) and by Center for Translational Pediatric Research (CTPR) NIH Center of Biomedical Research Excellence award (P20 GM121293). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Support was provided in part by the NIH IDeA Networks of Biomedical Research Excellence (INBRE) grant (P20 GM103429) and by Center for Translational Pediatric Research (CTPR) NIH Center of Biomedical Research Excellence award (P20 GM121293).	Ackermann M, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-47; Ahrens M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079380; Ananieva EA, 2018, CURR OPIN CLIN NUTR, V21, P64, DOI 10.1097/MCO.0000000000000430; Barbie DA, 2009, NATURE, V462, P108, DOI 10.1038/nature08460; Barker Thomas H, 2014, Res Rep Health Eff Inst, P3; Branson OE, 2016, J PROTEOME RES, V15, P4742, DOI 10.1021/acs.jproteome.6b00554; Budinska E, 2013, J PATHOL, V231, P63, DOI 10.1002/path.4212; Carnielli CM, 2015, BBA-PROTEINS PROTEOM, V1854, P46, DOI 10.1016/j.bbapap.2014.10.019; Casanova MR, 2018, FRONT NUTR, V5, DOI 10.3389/fnut.2018.00044; Cha SW, 2010, MOL CELL PROTEOMICS, V9, P2529, DOI 10.1074/mcp.M110.000398; Colle R, 2017, B CANCER, V104, P42, DOI 10.1016/j.bulcan.2016.11.006; De Sousa E Melo F, 2013, NAT MED, V19, P614, DOI 10.1038/nm.3174; Dienstmann R, 2017, ANN ONCOL, V28, P1023, DOI 10.1093/annonc/mdx052; Dienstmann R, 2017, NAT REV CANCER, V17, P79, DOI 10.1038/nrc.2016.126; Dinu I, 2009, BRIEF BIOINFORM, V10, P24, DOI 10.1093/bib/bbn042; Efron B, 2007, ANN APPL STAT, V1, P107, DOI 10.1214/07-AOAS101; Emmert-Streib F, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002053; FRIEDMAN JH, 1979, ANN STAT, V7, P697, DOI 10.1214/aos/1176344722; Gagne D, 2010, J CELL PHYSIOL, V222, P387, DOI 10.1002/jcp.21963; Goeman JJ, 2007, BIOINFORMATICS, V23, P980, DOI 10.1093/bioinformatics/btm051; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Guinney J, 2015, NAT MED, V21, P1350, DOI 10.1038/nm.3967; Haabeth OAW, 2018, CANCER RES, V78, P4573, DOI 10.1158/0008-5472.CAN-17-2426; Heusel M, 2019, MOL SYST BIOL, V15, DOI 10.15252/msb.20188438; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; IONOV Y, 1993, NATURE, V363, P558, DOI 10.1038/363558a0; Johnson DB, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10582; Jung HY, 2015, CLIN CANCER RES, V21, P962, DOI 10.1158/1078-0432.CCR-13-3173; Khatri P, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002375; Kruppa J, 2016, METHODS MOL BIOL, V1362, P143, DOI 10.1007/978-1-4939-3106-4_9; Laukens K, 2015, PROTEOMICS, V15, P981, DOI 10.1002/pmic.201400296; Lavallee-Adam M, 2014, J PROTEOME RES, V13, P5496, DOI 10.1021/pr500473n; Llosa NJ, 2015, CANCER DISCOV, V5, P43, DOI 10.1158/2159-8290.CD-14-0863; Lu PF, 2012, J CELL BIOL, V196, P395, DOI 10.1083/jcb.201102147; Lund-Johansen F, 2016, NAT METHODS, V13, P837, DOI 10.1038/nmeth.3967; Maby P, 2015, CANCER RES, V75, P3446, DOI 10.1158/0008-5472.CAN-14-3051; Maciejewski H, 2014, BRIEF BIOINFORM, V15, P504, DOI 10.1093/bib/bbt002; Marisa L, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001453; Maxfield FR, 2002, J CLIN INVEST, V110, P891, DOI 10.1172/JCI200216500; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Nam D, 2008, BRIEF BIOINFORM, V9, P189, DOI 10.1093/bib/bbn001; O'Connell JB, 2004, JNCI-J NATL CANCER I, V96, P1420, DOI 10.1093/jnci/djh275; Okugawa Y, 2015, GASTROENTEROLOGY, V149, P1204, DOI 10.1053/j.gastro.2015.07.011; Pino MS, 2010, GASTROENTEROLOGY, V138, P2059, DOI 10.1053/j.gastro.2009.12.065; Poliakov E, 2014, GENET RES INT, V2014, DOI 10.1155/2014/646193; Rafael D, 2015, CURR GENE THER, V15, P300, DOI 10.2174/1566523215666150126123642; Rahmatallah Y, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-017-1482-6; Rahmatallah Y, 2016, BRIEF BIOINFORM, V17, P393, DOI 10.1093/bib/bbv069; Rahmatallah Y, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/s12859-014-0397-8; Rahmatallah Y, 2014, BIOINFORMATICS, V30, P360, DOI 10.1093/bioinformatics/btt687; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Roche PA, 2015, NAT REV IMMUNOL, V15, P203, DOI 10.1038/nri3818; Roepman P, 2014, INT J CANCER, V134, P552, DOI 10.1002/ijc.28387; Sadanandam A, 2013, NAT MED, V19, P619, DOI 10.1038/nm.3175; Schlicker A, 2012, BMC MED GENOMICS, V5, DOI 10.1186/1755-8794-5-66; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Swiatly A, 2018, J OVARIAN RES, V11, DOI 10.1186/s13048-018-0460-6; Tamayo P, 2012, STAT METHODS MED RES; Tarca AL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079217; Tian L, 2005, P NATL ACAD SCI USA, V102, P13544, DOI 10.1073/pnas.0506577102; Tripathi S, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt054; Tyanova S, 2016, NAT METHODS, V13, P731, DOI [10.1038/nmeth.3901, 10.1038/NMETH.3901]; Vazquez A, 2016, J CELL SCI, V129, P3367, DOI 10.1242/jcs.181016; Vergara Daniele, 2016, EuPA Open Proteom, V10, P31, DOI 10.1016/j.euprot.2016.01.003; Vogel C, 2012, NAT REV GENET, V13, P227, DOI 10.1038/nrg3185; Wang W., 2018, SEMIN CANC BIOL; Wang X, 2013, INT J BIOCHEM CELL B, V45, P2574, DOI 10.1016/j.biocel.2013.08.014; Wu D, 2010, BIOINFORMATICS, V26, P2176, DOI 10.1093/bioinformatics/btq401; Wu XG, 2014, J THEOR BIOL, V362, P44, DOI 10.1016/j.jtbi.2014.05.031; Yang T, 2013, TRENDS MOL MED, V19, P714, DOI 10.1016/j.molmed.2013.08.005; Yu SM, 2018, BRIT J PHARMACOL, V175, P3111, DOI 10.1111/bph.14352; Zhang B, 2014, NATURE, V513, P382, DOI 10.1038/nature13438; Zhao L, 2018, BRIEF BIOINFORM	76	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2019	14	8							e0221444	10.1371/journal.pone.0221444	http://dx.doi.org/10.1371/journal.pone.0221444			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5RZ	31437237	gold, Green Published, Green Submitted			2022-12-26	WOS:000485036900073
J	Hunt, KJ; Grunder, R; Zahnd, A				Hunt, Kenneth J.; Grunder, Reto; Zahnd, Andreas			Identification and comparison of heart-rate dynamics during cycle ergometer and treadmill exercise	PLOS ONE			English	Article							FITNESS; ADULTS	Aim and methods The aim of this study was to compare the dynamics of heart rate (HR) response to exercise using a cycle ergometer (CE) and a treadmill (TM). Using a sample of 25 healthy male participants, the time constant of HR dynamics was estimated for both modalities in response to square-wave excitation. Results The principal finding was that the time constant of heart-rate dynamics around somewhat-hard exercise intensity (Borg rating of perceived exertion = 13) does not differ significantly between the CE and TM (68.7 s +/- 21.5 s vs. 62.5 s +/- 18.5 s [mean +/- standard deviation]; CE vs. TM; p = 0.20). An observed moderate level of evidence that root-mean-square model error was higher for the CE than for the TM (2.5 bpm +/- 0.5 bpm vs. 2.2 bpm +/- 0.5 bpm, p = 0.059) may reflect a decrease in heart rate variability with increasing HR intensity because, in order to achieve similar levels of perceived intensity, mean heart rate for the CE was similar to 25 bpm lower than for the TM. Conclusion and significance These results have important implications for model-based design of automatic HR controllers, because, in principle, the same dynamic controller, merely scaled according to the differing steady-state gains, should be able to be applied to the CE and TM exercise modalities.	[Hunt, Kenneth J.; Grunder, Reto; Zahnd, Andreas] Bern Univ Appl Sci, Dept Engn & Informat Technol, Div Mech Engn, Inst Rehabil & Performance Technol, Burgdorf, Switzerland		Hunt, KJ (corresponding author), Bern Univ Appl Sci, Dept Engn & Informat Technol, Div Mech Engn, Inst Rehabil & Performance Technol, Burgdorf, Switzerland.	kenneth.hunt@bfh.ch		Hunt, Kenneth/0000-0002-6521-9455				Argha A, 2017, MED BIOL ENG COMPUT, V55, P483, DOI 10.1007/s11517-016-1530-9; Bearden SE, 2001, J APPL PHYSIOL, V90, P2081, DOI 10.1152/jappl.2001.90.6.2081; BORG G, 1970, Scandinavian Journal of Rehabilitation Medicine, V2, P92; BORG G, 1990, SCAND J WORK ENV HEA, V16, P55, DOI 10.5271/sjweh.1815; BORG GAV, 1982, MED SCI SPORT EXER, V14, P377, DOI 10.1249/00005768-198205000-00012; Camm AJ, 1996, EUR HEART J, V17, P354; Garber CE, 2011, MED SCI SPORT EXER, V43, P1334, DOI 10.1249/MSS.0b013e318213fefb; Hunt KJ, 2019, BIOMED SIGNAL PROCES, V54, DOI 10.1016/j.bspc.2019.101601; Hunt KJ, 2018, BIOMED ENG ONLINE, V17, DOI 10.1186/s12938-018-0561-x; Hunt KJ, 2016, BIOMED SIGNAL PROCES, V30, P31, DOI 10.1016/j.bspc.2016.06.005; Hunt KJ, 2015, BIOMED ENG ONLINE, V14, DOI 10.1186/s12938-015-0112-7; Ljung L, 1998, APPL NUM HARM ANAL, P163; Ludwig M, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00778; Mazzoleni MJ, 2016, SPORTS ENG, V19, P117, DOI 10.1007/s12283-015-0193-3; Michael S, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00301; Millet GP, 2009, SPORTS MED, V39, P179, DOI 10.2165/00007256-200939030-00002; Ramos JS, 2015, SPORTS MED, V45, P679, DOI 10.1007/s40279-015-0321-z; Riebe D, 2018, ACSMS GUIDELINES EXE, P111; Roecker K, 2003, INT J SPORTS MED, V24, P173, DOI 10.1055/s-2003-39087; Shaffer F, 2017, FRONT PUBLIC HEALTH, V5, DOI 10.3389/fpubh.2017.00258; Shargal E, 2015, J SPORT MED PHYS FIT, V55, P1207; Wasserman K., 2012, PRINCIPLES EXERCISE, V1, P8; Weston M, 2014, SPORTS MED, V44, P1005, DOI 10.1007/s40279-014-0180-z; Zakynthinaki MS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118263	24	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2019	14	8							e0220826	10.1371/journal.pone.0220826	http://dx.doi.org/10.1371/journal.pone.0220826			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5RZ	31437177	Green Published, Green Submitted, gold			2022-12-26	WOS:000485036900020
J	Klein, N; Guenther, E; Botea, F; Pautov, M; Dima, S; Tomescu, D; Popescu, M; Ivorra, A; Stehling, M; Popescu, I				Klein, Nina; Guenther, Enric; Botea, Florin; Pautov, Mihail; Dima, Simona; Tomescu, Dana; Popescu, Mihai; Ivorra, Antoni; Stehling, Michael; Popescu, Irinel			The combination of electroporation and electrolysis (E2) employing different electrode arrays for ablation of large tissue volumes	PLOS ONE			English	Article							IRREVERSIBLE ELECTROPORATION; THERAPY	Background The combination of electroporation with electrolysis (E2) has previously been introduced as a novel tissue ablation technique. E2 allows the utilization of a wide parameter range and may therefore be a suitable technology for development of tissue-specific application protocols. Previous studies have implied that it is possible to achieve big lesions in liver in a very short time. The goal of this study was to test a variety of electrode configurations for the E2 application to ablate large tissue volumes. Materials and methods 27 lesions were performed in healthy porcine liver of five female pigs. Four, two and bipolar electrode-arrays were used to deliver various E2 treatment protocols. Liver was harvested approx. 20h after treatment and examined with H&E and Masson's trichrome staining, and via TUNEL staining for selective specimen. Results All animals survived the treatments without complications. With four electrodes, a lesion of up to 35x35x35mm volume can be achieved in less than 30s. The prototype bipolar electrode created lesions of 50x18x18mm volume in less than 10s. Parameters for two-electrode ablations with large exposures encompassing large veins were found to be good in terms of vessel preservation, but not optimal to reliably close the gap between the electrodes. Conclusion This study demonstrates the ability to produce large lesions in liver within seconds at lower limits of the E2 parameter space at different electrode configurations. The applicability of E2 for single electrode ablations was demonstrated with bipolar electrodes. Parameters for large 4-electrode ablation volumes were found suitable, while parameters for two electrodes still need optimization. However, since the parameter space of E2 is large, it is possible that for all electrode geometries optimal waveforms and application protocols for specific tissues will emerge with continuing research.	[Klein, Nina; Guenther, Enric; Stehling, Michael] Inter Sci GmbH, Luzern, Switzerland; [Klein, Nina; Guenther, Enric; Stehling, Michael] Inst Bildgebende Diagnost, Offenbach, Germany; [Klein, Nina; Ivorra, Antoni] Univ Pompeu Fabra, Dept Informat & Commun Technol, Barcelona, Spain; [Botea, Florin; Pautov, Mihail; Dima, Simona; Popescu, Irinel] Fundeni Clin Inst, Ctr Gen Surg & Liver Transplantat, Bucharest, Romania; [Botea, Florin; Pautov, Mihail; Dima, Simona; Tomescu, Dana; Popescu, Mihai; Popescu, Irinel] Fundeni Clin Inst, Ctr Translat Med, Bucharest, Romania; [Tomescu, Dana; Popescu, Mihai] Fundeni Clin Inst, Dept Anesthesiol & Intens Care 3, Bucharest, Romania	Pompeu Fabra University; Institutul Clinic Fundeni; Institutul Clinic Fundeni; Institutul Clinic Fundeni	Klein, N (corresponding author), Inter Sci GmbH, Luzern, Switzerland.; Klein, N (corresponding author), Inst Bildgebende Diagnost, Offenbach, Germany.; Klein, N (corresponding author), Univ Pompeu Fabra, Dept Informat & Commun Technol, Barcelona, Spain.	n.klein@biophysik.org	Dima, Simona/P-5582-2019; Botea, Florin/H-9990-2017; Tomescu, Dana/J-9941-2013; Popescu, Irinel/S-9228-2019; Ivorra, Antoni/A-3155-2008; Popescu, Mihai/K-2577-2016	Dima, Simona/0000-0001-5275-8938; Botea, Florin/0000-0001-7104-747X; Tomescu, Dana/0000-0001-9673-5754; Ivorra, Antoni/0000-0001-7718-8767; Popescu, Mihai/0000-0002-2947-335X				[Anonymous], JTMR; Dong SL, 2018, TECHNOL CANCER RES T, V17, DOI 10.1177/1533033818789692; Fosh BG, 2001, BMC GASTROENTEROL, V1, P111; Frandsen SK, 2018, TECHNOL CANCER RES T, V17, DOI 10.1177/1533033818788077; Guenther E, 2015, BIOCHEM BIOPH RES CO, V467, P736, DOI 10.1016/j.bbrc.2015.10.072; Horwitz EM, 2005, J UROLOGY, V173, P797, DOI 10.1097/01.ju.0000152556.53602.64; Klein N, 2017, PEERJ, V5, DOI 10.7717/peerj.3190; Martin Robert Cg, 2015, Anesth Pain Med, V5, pe22786, DOI 10.5812/aapm.22786; Miklavcic D, 2015, BIOMED ENG ONLINE, V14, DOI 10.1186/1475-925X-14-S3-I1; Mir LM, 2000, METH MOLEC MED, V37, P99, DOI 10.1385/1-59259-080-2:99; NEUMANN E, 1982, EMBO J, V1, P841, DOI 10.1002/j.1460-2075.1982.tb01257.x; Neumann E., 1989, ELECTROPORATION ELEC; Ni Y, 2005, ABDOM IMAGING, V30, P381, DOI 10.1007/s00261-004-0253-9; Nilsson E, 1998, BIOELECTROCH BIOENER, V47, P11, DOI 10.1016/S0302-4598(98)00157-3; Onik G, 2010, SER BIOMED ENG, P235, DOI 10.1007/978-3-642-05420-4_10; Phillips M, 2016, ANN BIOMED ENG, V44, P3144, DOI 10.1007/s10439-016-1624-4; Phillips M, 2015, TECHNOLOGY, V3, P45, DOI 10.1142/S233954781550003X; Phillips M, 2015, TECHNOL CANCER RES T, V14, P395, DOI 10.1177/1533034614560102; Rubinsky B, 2007, TECHNOL CANCER RES T, V6, P37, DOI 10.1177/153303460700600106; Rubinsky L, 2016, TECHNOL CANCER RES T, V15, pNP95, DOI 10.1177/1533034615601549; Ruiter SJS, 2019, EUR RADIOL, V29, P4026, DOI 10.1007/s00330-018-5842-z; Satkauskas S., 2016, HDB ELECTROPORATION, P1, DOI [10.1007/978-3-319-26779-1_140-1, DOI 10.1007/978-3-319-26779-1_140-1]; Scheffer HJ, 2015, TECH VASC INTERV RAD, V18, P159, DOI 10.1053/j.tvir.2015.06.007; Stehling MK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148317; Vogel JA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166987; Weaver JC, 1996, BIOELECTROCH BIOENER, V41, P135, DOI 10.1016/S0302-4598(96)05062-3; Yarmush ML, 2014, ANNU REV BIOMED ENG, V16, P295, DOI 10.1146/annurev-bioeng-071813-104622	27	8	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2019	14	8							e0221393	10.1371/journal.pone.0221393	http://dx.doi.org/10.1371/journal.pone.0221393			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5RZ	31437212	gold, Green Published, Green Submitted			2022-12-26	WOS:000485036900064
J	Munia, TTK; Aviyente, S				Munia, Tamanna Tabassum Khan; Aviyente, Selin			Graph-to-signal transformation based classification of functional connectivity brain networks	PLOS ONE			English	Article							SMALL-WORLD; PHASE SYNCHRONY; TIME-SERIES; RESISTANCE; DYNAMICS	Complex network theory has been successful at unveiling the topology of the brain and showing alterations to the network structure due to brain disease, cognitive function and behavior. Functional connectivity networks (FCNs) represent different brain regions as the nodes and the connectivity between them as the edges of a graph. Graph theoretic measures provide a way to extract features from these networks enabling subsequent characterization and discrimination of networks across conditions. However, these measures are constrained mostly to binary networks and highly dependent on the network size. In this paper, we propose a novel graph-to-signal transform that overcomes these shortcomings to extract features from functional connectivity networks. The proposed transformation is based on classical multidimensional scaling (CMDS) theory and transforms a graph into signals such that the Euclidean distance between the nodes of the network is preserved. In this paper, we propose to use the resistance distance matrix for transforming weighted functional connectivity networks into signals. Our results illustrate how well-known network structures transform into distinct signals using the proposed graph-to-signal transformation. We then compute well-known signal features on the extracted graph signals to discriminate between FCNs constructed across different experimental conditions. Based on our results, the signals obtained from the graph-to-signal transformation allow for the characterization of functional connectivity networks, and the corresponding features are more discriminative compared to graph theoretic measures.	[Munia, Tamanna Tabassum Khan; Aviyente, Selin] Michigan State Univ, Dept Elect & Comp Engn, E Lansing, MI 48824 USA	Michigan State University	Aviyente, S (corresponding author), Michigan State Univ, Dept Elect & Comp Engn, E Lansing, MI 48824 USA.	aviyente@egr.msu.edu		Aviyente, Selin/0000-0001-9023-107X	National Science Foundation [CCF-1218377]	National Science Foundation(National Science Foundation (NSF))	This work was supported by the National Science Foundation under Grants No. CCF-1218377 (S.A.). There was no additional external funding received for this study. The funders had no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript.	Aicher C, 2015, J COMPLEX NETW, V3, P221, DOI 10.1093/comnet/cnu026; Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; Anderson JS, 2011, BRAIN, V134, P3739, DOI 10.1093/brain/awr263; [Anonymous], 2010, GRAPHS MATRICES; Aviyente S, 2011, IEEE T SIGNAL PROCES, V59, P3086, DOI 10.1109/TSP.2011.2144589; Bapat RB, 2004, MATCH-COMMUN MATH CO, P73; Bassett DS, 2017, NEUROSCIENTIST, V23, P499, DOI 10.1177/1073858416667720; Bassett DS, 2011, P NATL ACAD SCI USA, V108, P7641, DOI 10.1073/pnas.1018985108; Bassett DS, 2006, NEUROSCIENTIST, V12, P512, DOI 10.1177/1073858406293182; Bolanos M, 2013, J NEUROSCI METH, V212, P133, DOI 10.1016/j.jneumeth.2012.10.004; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Cavanagh JF, 2009, J NEUROSCI, V29, P98, DOI 10.1523/JNEUROSCI.4137-08.2009; Centeno M, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00093; Cohen MX, 2011, NEUROIMAGE, V55, P1373, DOI 10.1016/j.neuroimage.2010.12.072; Delgado M., 2016, SIGNAL PROCESS, V64; Delgado M, 2016, AC SPEECH SIGN PROC; Dimitriadis SI, 2017, BRAIN CONNECT, V7, P661, DOI 10.1089/brain.2017.0512; Du YH, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00525; Ellens W, 2011, LINEAR ALGEBRA APPL, V435, P2491, DOI 10.1016/j.laa.2011.02.024; ERIKSEN BA, 1974, PERCEPT PSYCHOPHYS, V16, P143, DOI 10.3758/BF03203267; Estrada E, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.036111; Fallani FD, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0521; Fawcett T., 2004, MACH LEARN, V31, P1, DOI DOI 10.1016/J.PATREC.2005.10.010; Hall JR, 2007, PSYCHOL SCI, V18, P326, DOI 10.1111/j.1467-9280.2007.01899.x; Hamon R., 2015, ARXIV150204697; Hamon R., 2015, ARXIV150503044; Hamon R, 2014, INT CONF ACOUST SPEE; Haraguchi Y, 2009, LECT NOTES COMPUT SC, V5769, P325, DOI 10.1007/978-3-642-04277-5_33; Horvath S, 2011, WEIGHTED NETWORK ANALYSIS: APPLICATIONS IN GENOMICS AND SYSTEMS BIOLOGY, P1, DOI 10.1007/978-1-4419-8819-5; Humphries MD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002051; Kaiser RH, 2016, NEUROPSYCHOPHARMACOL, V41, P1822, DOI 10.1038/npp.2015.352; Kandel ER, 2013, NAT REV NEUROSCI, V14, P659, DOI 10.1038/nrn3578; Kayser J, 2006, CLIN NEUROPHYSIOL, V117, P348, DOI 10.1016/j.clinph.2005.08.034; KLEIN DJ, 1993, J MATH CHEM, V12, P81, DOI 10.1007/BF01164627; Kotsiantis SB, 2006, ARTIF INTELL REV, V26, P159, DOI 10.1007/S10462-007-9052-3; Lachaux JP, 1999, HUM BRAIN MAPP, V8, P194, DOI 10.1002/(SICI)1097-0193(1999)8:4<194::AID-HBM4>3.0.CO;2-C; Langer N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053199; Latora V, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.198701; Lee H, 2012, IEEE T MED IMAGING, V31, P2267, DOI 10.1109/TMI.2012.2219590; Leon Cohen, 1995, TIME FREQUENCY ANAL; Li X, 2013, IEEE INT SYMP CIRC S, P2505, DOI 10.1109/ISCAS.2013.6572388; Moran TP, 2015, SOC COGN AFFECT NEUR, V10, P1548, DOI 10.1093/scan/nsv046; Muldoon SF, 2016, SCI REP-UK, V6, DOI 10.1038/srep22057; Onnela JP, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.065103; Ozdemir A, 2015, IEEE T BIO-MED ENG, V62, P2158, DOI 10.1109/TBME.2015.2415733; Papo D, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0520; Pearson K, 1905, BIOMETRIKA, V4, P169, DOI 10.1093/biomet/4.1-2.169; Pearson K, 1894, PHILOS T R SOC A, V186, P343, DOI DOI 10.1098/RSTA.1895.0010; Rajpoot K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134944; RIHACZEK AW, 1968, IEEE T INFORM THEORY, V14, P369, DOI 10.1109/TIT.1968.1054157; Rossi Fabrice, 2006, P INT WORKSH WEB INF, P356; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Rubinov M, 2011, NEUROIMAGE, V56, P2068, DOI 10.1016/j.neuroimage.2011.03.069; Sang LQ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141815; Shannon C.E., 1951, MATH THEORY COMMUNIC; Sheline YI, 2013, BIOL PSYCHIAT, V74, P340, DOI 10.1016/j.biopsych.2012.11.028; Shimada Y, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.158701; Sohn H, 2010, CLIN NEUROPHYSIOL, V121, P1863, DOI 10.1016/j.clinph.2010.04.007; Sporns O, 2004, NEUROINFORMATICS, V2, P145, DOI 10.1385/NI:2:2:145; Stam Cornelius J., 2007, NONLINEAR BIOMEDICAL, V1, P1, DOI DOI 10.1186/1753-4631-1-3; Telesford QK, 2011, BRAIN CONNECT, V1, P367, DOI [10.1089/brain.2011.0038, 10.1089/brain.2011.0055]; Van Essen DC, 2012, NEUROIMAGE, V62, P2222, DOI 10.1016/j.neuroimage.2012.02.018; Villafane-Delgado M, 2016, IEEE GLOB CONF SIG, P1137, DOI 10.1109/GlobalSIP.2016.7906019; Wang K, 2007, HUM BRAIN MAPP, V28, P967, DOI 10.1002/hbm.20324; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Weng TF, 2014, PHYS REV E, V90, DOI 10.1103/PhysRevE.90.022804; Zeng LL, 2012, BRAIN, V135, P1498, DOI 10.1093/brain/aws059	68	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2019	14	8							e0212470	10.1371/journal.pone.0212470	http://dx.doi.org/10.1371/journal.pone.0212470			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5RZ	31437168	Green Submitted, gold, Green Published			2022-12-26	WOS:000485036900002
J	Reis, VM; Vianna, JM; Barbosa, TM; Garrido, N; Alves, JV; Carneiro, AL; Aidar, FJ; Novaes, J				Reis, Victor M.; Vianna, Jeferson M.; Barbosa, Tiago M.; Garrido, Nuno; Vilaca Alves, Jose; Carneiro, Andre L.; Aidar, Felipe J.; Novaes, Jefferson			Are wearable heart rate measurements accurate to estimate aerobic energy cost during low-intensity resistance exercise?	PLOS ONE			English	Article							OXYGEN-UPTAKE; VALIDITY; FITNESS; ARM	The aim of the present study was to assess the accuracy of heart rate to estimate energy cost during eight resistance exercises performed at low intensities: half squat, 45 inclined leg press, leg extension, horizontal bench press, 45 degrees inclined bench press, lat pull down, triceps extension and biceps curl. 56 males (27.5 +/- 4.9 years, 1.78 +/- 0.06 m height, 78.67 +/- 10.7 kg body mass and 11.4 +/- 4.1% estimated body fat) were randomly divided into four groups of 14 subjects each. Two exercises were randomly assigned to each group and subjects performed four bouts of 4-min constant-intensity at each assigned exercise: 12%, 16%, 20% and 24% 1-RM. Exercise and intensity order were random. Each subject performed no more than 2 bouts in the same testing session. A minimum recovery of 24h was kept between sessions. During testing VO2 was measured with Cosmed K4b2 and heart rate was measured with Polar V800 monitor. Energy cost was calculated from mean VO2 during the last 30-s of each bout by using the energy equivalent 1 ml O-2 = 5 calorie. Linear regressions with heart rate as predictor and energy cost as dependent variable were build using mean data from all subjects. Robustness of the regression lines was given by the scatter around the regression line (Sy.x) and Bland-Altman plots confirmed the agreement between measured and estimated energy costs. Significance level was set at p <= 0.05. The regressions between heart rate and energy cost in the eight exercises were significant (p<0.01) and robustness was: half squat (Sy.x = 0,48 kcal.min(-1)), 45 degrees inclined leg press (Sy.x = 0,54 kcal.min(-1)), leg extension (Sy.x = 0,59 kcal.min(-1)), horizontal bench press (Sy.x= 0,47 kcal.min(-1)), 45 inclined bench press (Sy.x = 0,54 kcal.min(-1)), lat pull down (Sy.x = 0,28 kcal.min(-1)), triceps extension (Sy.x = 0,08 kcal.min(-1)) and biceps curl (Sy.x = 0,13 kcal.min(-1)). We conclude that during low-intensity resistance exercises it is possible to estimate aerobic energy cost by wearable heart rate monitors with errors below 10% in healthy young trained males.	[Reis, Victor M.; Barbosa, Tiago M.; Garrido, Nuno; Vilaca Alves, Jose] CIDESD, Res Ctr Sports Sci Hlth Sci & Human Dev, Vila Real, Portugal; [Reis, Victor M.; Garrido, Nuno; Vilaca Alves, Jose] Univ Tras Os Montes & Alto Douro, Vila Real, Portugal; [Vianna, Jeferson M.; Novaes, Jefferson] Univ Fed Juiz de Fora, Juiz De Fora, MG, Brazil; [Barbosa, Tiago M.] Nanyang Technol Univ, Singapore, Singapore; [Barbosa, Tiago M.] Polytech Inst Braganca, Braganca, Portugal; [Carneiro, Andre L.] Univ Estadual Montes Claros, Montes Claros, MG, Brazil; [Aidar, Felipe J.] Univ Fed Sergipe, Aracaju, Brazil	University of Tras-os-Montes & Alto Douro; Universidade Federal de Juiz de Fora; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Instituto Politecnico de Braganca; Universidade Estadual de Montes Claros; Universidade Federal de Sergipe	Reis, VM (corresponding author), CIDESD, Res Ctr Sports Sci Hlth Sci & Human Dev, Vila Real, Portugal.; Reis, VM (corresponding author), Univ Tras Os Montes & Alto Douro, Vila Real, Portugal.	vmreis@utad.pt	Aidar, Felipe J./AAO-2744-2020; Vianna, Jeferson Macedo/GON-5641-2022; Garrido, Nuno Domingos/K-6842-2014; Vianna, Jeferson/AAP-6548-2020; Barbosa, Tiago M./ABE-6789-2020; REIS, VICTOR/M-3531-2013; Vilaca-Alves, Jose/I-3965-2012	Aidar, Felipe J./0000-0001-7378-4529; Vianna, Jeferson Macedo/0000-0003-1594-4429; Garrido, Nuno Domingos/0000-0002-8105-7580; Barbosa, Tiago M./0000-0001-7071-2116; REIS, VICTOR/0000-0002-4996-1414; Vilaca-Alves, Jose/0000-0001-5399-7797	Norte Portugal Regional Operational Programme (NORTE 2020), through Portugal 2020; European Regional Development Fund, NanoSTIMA [NORTE-01-0145-FEDER-000016]	Norte Portugal Regional Operational Programme (NORTE 2020), through Portugal 2020; European Regional Development Fund, NanoSTIMA	This research was supported by Norte Portugal Regional Operational Programme (NORTE 2020), through Portugal 2020 and the European Regional Development Fund, NanoSTIMA, NORTE-01-0145-FEDER-000016 to VMR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript..	Bernasconi S, 2006, APPL PHYSIOL NUTR ME, V31, P414, DOI 10.1139/H06-021; Bot SDM, 2000, ERGONOMICS, V43, P1578, DOI 10.1080/001401300750004005; Boudreaux BD, 2018, MED SCI SPORT EXER, V50, P624, DOI 10.1249/MSS.0000000000001471; Buitrago S, 2013, J STRENGTH COND RES, V27, P1091, DOI 10.1519/JSC.0b013e318260ec77; COLLINS MA, 1991, MED SCI SPORT EXER, V23, P636; Crouter SE, 2004, MED SCI SPORT EXER, V36, P1433, DOI 10.1249/01.MSS.0000135794.01507.48; Garber CE, 2011, MED SCI SPORT EXER, V43, P1334, DOI 10.1249/MSS.0b013e318213fefb; JACKSON AS, 1978, BRIT J NUTR, V40, P497, DOI 10.1079/BJN19780152; Koppo K, 2002, RESP PHYSIOL NEUROBI, V133, P241, DOI 10.1016/S1569-9048(02)00184-2; Kraemer W, 1995, PHYSL ASSESSMENT HUM, P115; McLaughlin JE, 2001, INT J SPORTS MED, V22, P280, DOI 10.1055/s-2001-13816; Oliveira João Carlos de, 2006, Rev Bras Med Esporte, V12, P333, DOI 10.1590/S1517-86922006000600007; RAYSON MP, 1995, EUR J APPL PHYSIOL O, V71, P405, DOI 10.1007/BF00635873; Reis VM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181311; Rocha RM, 2010, REV BRAS MED ESPORTE, V16, P282, DOI 10.1590/S1517-86922010000400010; Tian Y, 2015, INT J SPORTS MED, V36, P357, DOI 10.1055/s-0034-1395520; Welch WA, 2015, INT J SPORTS MED, V36, P414, DOI 10.1055/s-0034-1398575	17	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2019	14	8							e0221284	10.1371/journal.pone.0221284	http://dx.doi.org/10.1371/journal.pone.0221284			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5RZ	31437191	Green Submitted, Green Published, gold			2022-12-26	WOS:000485036900047
J	Wada, E; Kato, M; Yamashita, K; Kokuba, H; Liang, WC; Bonne, G; Hayashi, YK				Wada, Eiji; Kato, Megumi; Yamashita, Kaori; Kokuba, Hiroko; Liang, Wen-Chen; Bonne, Gisele; Hayashi, Yukiko K.			Deficiency of emerin contributes differently to the pathogenesis of skeletal and cardiac muscles in Lmna(H222P/H222P) mutant mice	PLOS ONE			English	Article							DREIFUSS MUSCULAR-DYSTROPHY; DILATED CARDIOMYOPATHY; NUCLEAR-ENVELOPE; MEMBRANE-PROTEINS; MUTATION; LMNA; LAMINOPATHIES; INHIBITION; MOUSE; ACTIVATION	Laminopathies are tissue-selective diseases that affect differently in organ systems. Mutations in nuclear envelopes, emerin (Emd) and lamin A/C (Lmna) genes, cause clinically indistinguishable myopathy called Emery-Dreifuss muscular dystrophy (EDMD) and limb-girdle muscular dystrophy. Several murine models for EDMD have been generated; however, emerin-null (Emd) mice do not show obvious skeletal and cardiac muscle phenotypes, and Lmna(H222P/H222P) mutant (H222P) mice show only a mild phenotype in skeletal muscle when they already have severe cardiomyopathy. Thus, the underlying molecular mechanism of muscle involvement due to nuclear abnormalities is still unclarified. We generated double mutant (Emd(-/-)/Lmna(H222P/H222P); EH) mice to characterize dystrophic changes and to elucidate interactions between emerin and lamin A/C in skeletal and cardiac muscles. As H222P mice, EH mice grow normally and have breeding productivity. EH mice showed severer muscle involvement compared with that of H222P mice which was an independent of cardiac abnormality at 12 weeks of age. Nuclear abnormalities, reduced muscle fiber size and increased fibrosis were prominent in EH mice. Roles of emerin and lamin A/C in satellite cells function and regeneration of muscle fiber were also evaluated by cardiotoxin-induced muscle injury. Delayed increases in myog and myh3 expression were seen in both H222P and EH mice; however, the expression levels of those genes were similar with control and regenerated muscle fiber size was not different at day 7 after injury. These results indicate that EH mouse is a suitable model for studying skeletal muscle involvement, independent of cardiac function, in laminopathies and an interaction between emerin and lamin A/C in different tissues.	[Wada, Eiji; Kato, Megumi; Yamashita, Kaori; Hayashi, Yukiko K.] Tokyo Med Univ, Dept Pathophysiol, Tokyo, Japan; [Kokuba, Hiroko] Tokyo Med Univ, Inst Med Sci, Tokyo, Japan; [Liang, Wen-Chen] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Pediat, Kaohsiung, Taiwan; [Liang, Wen-Chen] Kaohsiung Med Univ, Sch Med, Dept Pediat, Coll Med, Kaohsiung, Taiwan; [Bonne, Gisele] Sorbonne Univ, Inserm, UMRS 974, Ctr Res Myol, Paris, France	Tokyo Medical University; Tokyo Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite	Hayashi, YK (corresponding author), Tokyo Med Univ, Dept Pathophysiol, Tokyo, Japan.	yhayashi@tokyo-med.ac.jp	Bonne, Gisèle/G-3121-2013	Bonne, Gisèle/0000-0002-2516-3258	MEXT-Supported Program for the Strategic Research Foundation at Private Universities from the Ministry of Education, Culture, Sports, Science, and Technology [5020-03]; Japan Agency for Medical Research and Development (AMED); Ministry of Health Labour and Welfare; JSPS KAKENHI [JP18K15052]; Intramural Research Grant for Neurological and Psychiatric Disorders of NCNP [29-4]	MEXT-Supported Program for the Strategic Research Foundation at Private Universities from the Ministry of Education, Culture, Sports, Science, and Technology; Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); Ministry of Health Labour and Welfare(Ministry of Health, Labour and Welfare, Japan); JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Intramural Research Grant for Neurological and Psychiatric Disorders of NCNP(National Center for Neurology & Psychiatry - Japan)	MEXT-Supported Program for the Strategic Research Foundation at Private Universities (5020-03) from the Ministry of Education, Culture, Sports, Science, and Technology (YH), Acceleration Program for Intractable Diseases Research utilizing Diseasespecific iPS cells from the Japan Agency for Medical Research and Development (AMED) (YH), Research on Measures for Intractable Diseases from the Ministry of Health Labour and Welfare (YH) Intramural Research Grant (29-4) for Neurological and Psychiatric Disorders of NCNP (YH), JSPS KAKENHI Grant Number JP18K15052 (EW).	Andres V, 2009, J CELL BIOL, V187, P945, DOI 10.1083/jcb.200904124; Arimura T, 2005, HUM MOL GENET, V14, P155, DOI 10.1093/hmg/ddi017; Arimura T, 2013, CARDIOVASC RES, V99, P382, DOI 10.1093/cvr/cvt106; Arimura T, 2010, J AM COLL CARDIOL, V55, P1503, DOI 10.1016/j.jacc.2009.10.065; Astejada M N, 2007, Acta Myol, V26, P159; Ben Yaou R, 2007, NEUROLOGY, V68, P1883; BIONE S, 1994, NAT GENET, V8, P323, DOI 10.1038/ng1294-323; Bonne G, 2000, ANN NEUROL, V48, P170, DOI 10.1002/1531-8249(200008)48:2<170::AID-ANA6>3.0.CO;2-J; Bonne G, 1999, NAT GENET, V21, P285, DOI 10.1038/6799; Bonne G, 2013, HAND CLINIC, V113, P1367, DOI 10.1016/B978-0-444-59565-2.00007-1; Brunelli S, 2007, P NATL ACAD SCI USA, V104, P264, DOI 10.1073/pnas.0608277104; Burke B, 2006, ANNU REV GENOM HUM G, V7, P369, DOI 10.1146/annurev.genom.7.080505.115732; Chatzifrangkeskou M, 2016, HUM MOL GENET, V25, P2220, DOI 10.1093/hmg/ddw090; Choi JC, 2018, HUM MOL GENET, V27, P2290, DOI 10.1093/hmg/ddy134; Choi JC, 2012, J BIOL CHEM, V287, P40513, DOI 10.1074/jbc.M112.404541; Clements L, 2000, BIOCHEM BIOPH RES CO, V267, P709, DOI 10.1006/bbrc.1999.2023; Dorboz I, 2014, ORPHANET J RARE DIS, V9, DOI 10.1186/s13023-014-0174-9; Emery AEH, 2000, NEUROMUSCULAR DISORD, V10, P228, DOI 10.1016/S0960-8966(00)00105-X; Hayashi Y K, 2005, Acta Myol, V24, P98; Hetzer MW, 2005, ANNU REV CELL DEV BI, V21, P347, DOI 10.1146/annurev.cellbio.21.090704.151152; Ho CY, 2013, RARE DIS, V1, DOI 10.4161/rdis.27002; Holaska JM, 2007, BIOCHEMISTRY-US, V46, P8897, DOI 10.1021/bi602636m; Janin A, 2017, ORPHANET J RARE DIS, V12, DOI 10.1186/s13023-017-0698-x; Kayman-Kurekci G, 2014, NEUROMUSCULAR DISORD, V24, P624, DOI 10.1016/j.nmd.2014.04.007; Korfali N, 2010, MOL CELL PROTEOMICS, V9, P2571, DOI 10.1074/mcp.M110.002915; Le Dour C, 2017, HUM MOL GENET, V26, P333, DOI 10.1093/hmg/ddw389; Maggi L, 2016, CELLS-BASEL, V5, DOI 10.3390/cells5030033; MATSUDA R, 1995, J BIOCHEM-TOKYO, V118, P959, DOI 10.1093/jb/118.5.959; Melcon G, 2006, HUM MOL GENET, V15, P637, DOI 10.1093/hmg/ddi479; Muchir A, 2007, J CLIN INVEST, V117, P1282, DOI 10.1172/JCI29042; Muchir A, 2014, BIOCHEM BIOPH RES CO, V452, P958, DOI 10.1016/j.bbrc.2014.09.020; Muchir A, 2013, SKELET MUSCLE, V3, DOI 10.1186/2044-5040-3-17; Muchir A, 2012, HUM MOL GENET, V21, P4325, DOI 10.1093/hmg/dds265; Muchir A, 2012, CARDIOVASC RES, V93, P311, DOI 10.1093/cvr/cvr301; Muchir A, 2009, HUM MOL GENET, V18, P241, DOI 10.1093/hmg/ddn343; Nagano A, 1996, NAT GENET, V12, P254, DOI 10.1038/ng0396-254; Nikolova V, 2004, J CLIN INVEST, V113, P357, DOI 10.1172/JCI200419448; Ozawa R, 2006, AM J PATHOL, V168, P907, DOI 10.2353/ajpath.2006.050564; Park YE, 2009, AUTOPHAGY, V5, P795, DOI 10.4161/auto.8901; Park YE, 2009, NEUROMUSCULAR DISORD, V19, P29, DOI 10.1016/j.nmd.2008.09.018; Sakaki M, 2001, J BIOCHEM-TOKYO, V129, P321, DOI 10.1093/oxfordjournals.jbchem.a002860; Schirmer EC, 2003, SCIENCE, V301, P1380, DOI 10.1126/science.1088176; SENIOR A, 1988, J CELL BIOL, V107, P2029, DOI 10.1083/jcb.107.6.2029; Steele-Stallard HB, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.01332; Sullivan T, 1999, J CELL BIOL, V147, P913, DOI 10.1083/jcb.147.5.913; Thomasson R, 2019, HUM MOL GENET, V28, P2237, DOI 10.1093/hmg/ddz056; Ura S, 2007, ARCH NEUROL-CHICAGO, V64, P1038, DOI 10.1001/archneur.64.7.1038; Wada E, 2017, SKELET MUSCLE, V7, DOI 10.1186/s13395-017-0140-z; Wilkie GS, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.003129; Wilson KL, 2010, J CELL SCI, V123, P1973, DOI 10.1242/jcs.019042; Worman HJ, 2007, EXP CELL RES, V313, P2121, DOI 10.1016/j.yexcr.2007.03.028; Wu W, 2011, CIRCULATION, V123, P53, DOI 10.1161/CIRCULATIONAHA.110.970673; Wu W, 2010, BBA-MOL BASIS DIS, V1802, P632, DOI 10.1016/j.bbadis.2010.04.001	53	4	4	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2019	14	8							e0221512	10.1371/journal.pone.0221512	http://dx.doi.org/10.1371/journal.pone.0221512			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5OC	31430335	Green Published, gold, Green Submitted			2022-12-26	WOS:000485026800064
J	Botta, J; Bibic, L; Killoran, P; McCormick, PJ; Howell, LA				Botta, Joaquin; Bibic, Lucka; Killoran, Patrick; McCormick, Peter J.; Howell, Lesley A.			Design and development of stapled transmembrane peptides that disrupt the activity of G-protein?coupled receptor oligomers	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						G protein-coupled receptor (GPCR); cannabinoid receptor type 1 (CB1); dimerization; cell-penetrating peptide (CPP); peptide chemical synthesis; protein-protein interaction; serotonin receptor type 2A (5HT2A); NanoLuc binary technology (NanoBiT); hydrocarbon stapling; transmembrane peptide; bimolecular fluorescence complementation	ALPHA-HELICAL PEPTIDES; CRYSTAL-STRUCTURE; COUPLED RECEPTORS; DIMERIZATION; PHARMACOLOGY; ANTAGONIST; STABILITY; CXCR4; GPCR	Membrane proteins can associate into larger complexes. Examples include receptor tyrosine complexes, ion channels, transporters, and G protein?coupled receptors (GPCRs). For the latter, there is abundant evidence indicating that GPCRs assemble into complexes, through both homo- and heterodimerization. However, the tools for studying and disrupting these complexes, GPCR or otherwise, are limited. Here, we have developed stabilized interference peptides for this purpose. We have previously reported that tetrahydrocannabinol-mediated cognitive impairment arises from homo- or heterooligomerization between the GPCRs cannabinoid receptor type 1 (CB1R) and 5-hydroxytryptamine 2A (5-HT2AR) receptors. Here, to disrupt this interaction through targeting CB1?5-HT2A receptor heteromers in HEK293 cells and using an array of biochemical techniques, including calcium and cAMP measurements, bimolecular fluorescence complementation assays, and CD-based helicity assessments, we developed a NanoLuc binary technology (NanoBiT)-based reporter assay to screen a small library of aryl-carbon?stapled transmembrane-mimicking peptides produced by solid-phase peptide synthesis. We found that these stapling peptides have increased ?-helicity and improved proteolytic resistance without any loss of disrupting activity in vitro, suggesting that this approach may also have utility in vivo. In summary, our results provide proof of concept for using NanoBiT to study membrane protein complexes and for stabilizing disrupting peptides to target such membrane complexes through hydrocarbon-mediated stapling. We propose that these peptides could be developed to target previously undruggable GPCR heteromers.	[Botta, Joaquin; McCormick, Peter J.] Queen Mary Univ London, Ctr Endocrinol, Barts & London Sch Med & Dent, William Harvey Res Inst, Charterhouse Sq, London EC1M 6BQ, England; [Botta, Joaquin; Bibic, Lucka] Univ East Anglia, Sch Pharm, Norwich Res Pk, Norwich NR4 7TJ, Norfolk, England; [Killoran, Patrick] Liverpool John Moores Univ, Sch Pharm & Biomol Sci, James Parsons Bldg,Byrom St, Liverpool L3 3AF, Merseyside, England; [Howell, Lesley A.] Queen Mary Univ London, Sch Biol & Chem Sci, Mile End Rd, London E1 4NS, England	University of London; Queen Mary University London; University of East Anglia; Liverpool John Moores University; University of London; Queen Mary University London	McCormick, PJ (corresponding author), Queen Mary Univ London, Ctr Endocrinol, Barts & London Sch Med & Dent, William Harvey Res Inst, Charterhouse Sq, London EC1M 6BQ, England.; Howell, LA (corresponding author), Queen Mary Univ London, Sch Biol & Chem Sci, Mile End Rd, London E1 4NS, England.	p.mccormick@qmul.ac.uk; l.howell@qmul.ac.uk		Bibic, Lucka/0000-0002-0355-0740; Botta, Joaquin/0000-0001-6450-1267	University of East Anglia; Biotechnology and Biological Sciences Research Council; Queen Mary University of London; BBSRC [1794654] Funding Source: UKRI	University of East Anglia; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Queen Mary University of London; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the University of East Anglia through studentships (to J. B.) and a Biotechnology and Biological Sciences Research Council Doctoral Training Partnership (to P. J. M. and L. A. H. for L. B.) as well as start-up funds from Queen Mary University of London. The authors declare that they have no conflicts of interest with the contents of this article.	Aillard B, 2014, ORG BIOMOL CHEM, V12, P8775, DOI 10.1039/c4ob01832j; Alexander SPH, 2017, BRIT J PHARMACOL, V174, pS17, DOI 10.1111/bph.13878; Ali AM, 2019, COMPUT STRUCT BIOTEC, V17, P263, DOI 10.1016/j.csbj.2019.01.012; Bird GH, 2010, P NATL ACAD SCI USA, V107, P14093, DOI 10.1073/pnas.1002713107; Borroto-Escuela DO, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00037; Borroto-Escuela DO, 2011, BIOCHEM BIOPH RES CO, V404, P928, DOI 10.1016/j.bbrc.2010.12.083; Brea J, 2009, MOL PHARMACOL, V75, P1380, DOI 10.1124/mol.108.054395; Busnelli M, 2016, J MED CHEM, V59, P7152, DOI 10.1021/acs.jmedchem.6b00564; Cai X, 2017, SCI REP-UK, V7, DOI 10.1038/srep40335; Choe HW, 2011, NATURE, V471, P651, DOI 10.1038/nature09789; Ciruela F, 2010, TRENDS BIOTECHNOL, V28, P407, DOI 10.1016/j.tibtech.2010.05.002; Cottet M, 2011, PHARMACEUTICALS-BASE, V4, P202, DOI 10.3390/ph4010202; Dixon AS, 2016, ACS CHEM BIOL, V11, P400, DOI 10.1021/acschembio.5b00753; FOROOD B, 1993, P NATL ACAD SCI USA, V90, P838, DOI 10.1073/pnas.90.3.838; Gonzalez-Vera JA, 2017, SCI REP-UK, V7, DOI 10.1038/srep41293; Greenfield NJ, 2006, NAT PROTOC, V1, P2876, DOI 10.1038/nprot.2006.202; Hebert TE, 1996, J BIOL CHEM, V271, P16384, DOI 10.1074/jbc.271.27.16384; Huang JY, 2013, NAT STRUCT MOL BIOL, V20, P419, DOI 10.1038/nsmb.2504; Kawamoto SA, 2012, J MED CHEM, V55, P1137, DOI 10.1021/jm201125d; Kilpatrick LE, 2015, MOL PHARMACOL, V87, P718, DOI 10.1124/mol.114.095356; Kim MW, 2017, ELIFE, V6, DOI 10.7554/eLife.30233; Kim YW, 2011, NAT PROTOC, V6, P761, DOI 10.1038/nprot.2011.324; Kroeze WK, 2015, NAT STRUCT MOL BIOL, V22, P362, DOI 10.1038/nsmb.3014; Lee LTO, 2014, FASEB J, V28, P2632, DOI 10.1096/fj.13-246868; Manglik A, 2012, NATURE, V485, P321, DOI 10.1038/nature10954; Moreno E, 2018, NEUROPSYCHOPHARMACOL, V43, P964, DOI 10.1038/npp.2017.12; Murakami M, 2008, NATURE, V453, P363, DOI 10.1038/nature06925; Pelay-Gimeno M, 2015, ANGEW CHEM INT EDIT, V54, P8896, DOI 10.1002/anie.201412070; Qin JY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010611; Saghyan AS, 2010, TETRAHEDRON-ASYMMETR, V21, P2956, DOI 10.1016/j.tetasy.2010.11.024; Salom D, 2006, P NATL ACAD SCI USA, V103, P16123, DOI 10.1073/pnas.0608022103; Schafmeister CE, 2000, J AM CHEM SOC, V122, P5891, DOI 10.1021/ja000563a; Scheerer P, 2008, NATURE, V455, P497, DOI 10.1038/nature07330; Shepherd NE, 2005, J AM CHEM SOC, V127, P2974, DOI 10.1021/ja0456003; Szidonya L, 2008, J ENDOCRINOL, V196, P435, DOI 10.1677/JOE-07-0573; Vidi PA, 2008, MOL PHARMACOL, V74, P544, DOI 10.1124/mol.108.047472; Vinals X, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002194; Wager-Miller J, 2002, CHEM PHYS LIPIDS, V121, P83, DOI 10.1016/S0009-3084(02)00151-2; Walensky LD, 2014, J MED CHEM, V57, P6275, DOI 10.1021/jm4011675; Wang D, 2006, J AM CHEM SOC, V128, P9248, DOI 10.1021/ja062710w; Wang JH, 2006, MOL CANCER THER, V5, P2474, DOI 10.1158/1535-7163.MCT-05-0261; Wu BL, 2010, SCIENCE, V330, P1066, DOI 10.1126/science.1194396; Yano H, 2018, BIOTECHNIQUES, V65, P9, DOI 10.2144/btn-2018-0039; Zhang C, 2012, NATURE, V492, P387, DOI 10.1038/nature11701; Ziegler A, 2005, BIOCHEMISTRY-US, V44, P138, DOI 10.1021/bi0491604	45	13	13	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 8	2019	294	45					16587	16603		10.1074/jbc.RA119.009160	http://dx.doi.org/10.1074/jbc.RA119.009160			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JU6RP	31467080	Green Published, Green Submitted, hybrid, Green Accepted			2022-12-26	WOS:000501801900011
J	Lee, HS; Hua, HS; Wang, CH; Yu, MC; Chen, BC; Lin, CH				Lee, Hong-Sheng; Hua, Hung-Sheng; Wang, Cheng-Hui; Yu, Ming-Chih; Chen, Bing-Chang; Lin, Chien-Huang			Mycobacterium tuberculosis induces connective tissue growth factor expression through the TLR2-JNK-AP-1 pathway in human lung fibroblasts	FASEB JOURNAL			English	Article						M.tb; CTGF; HLFs	NF-KAPPA-B; INNATE IMMUNITY; P38 MAPK; COLLAGEN; CTGF; ACTIVATION; SECRETION; REQUIRES; AP-1; CCN2	Mycobacterium tuberculosis (M.tb) infection in lung causes pulmonary fibrosis, which leads to the irreversible reduction of pulmonary function. Fibrotic protein connective tissue growth factor (CTGF) expression has been confirmed to play a crucial role in lung fibrosis. However, the underlying signal pathway and effect of M.tb on CTGF expression in human lung fibroblasts are unclear. Our results revaled that M.tb caused time- and concentration-dependent increases in CTGF expression in human lung fibroblasts. A mechanistic investigation revealed that M.tb induced CTGF expression through TLR2 but not TLR4. The promoter activity assay indicated that M.tb-induced CTGF activity was mainly controlled by the promoter region at -747 to -184 bp, which contained signal transducer and activator of transcription 3 and activator protein 1 (AP-1) binding sites. Moreover, curcumin (AP-1 inhibitor) restrained M.tb-induced CTGF expression. M.tb also induced increases in AP-1 luciferase activity and DNA binding activity of c-Jun and c-Fos on the CTGF promoter. Furthermore, the knockdown of c-Jun by small interfering RNA attenuated M.tb-induced CTGF expression and AP-1 luciferase activity. A JNK inhibitor (SP600125) and a JNK dominant-negative mutant suppressed M.tb-induced CTGF expression. We also discovered that M.tb could induce the phosphorylation of JNK and c-Jun. Furthermore, SP600125 inhibited M.tb-induced c-Jun phosphorylation and AP-1-luciferase activity. M.tb-induced fibronectin expression was inhibited by anti-CTGF antibody. These results demonstrate that M.tb is activated through TLR2 to induce JNK activation, further increasing the DNA binding activity of c-Jun and c-Fos and finally inducing CTGF expression and extracellular matrix production.	[Lee, Hong-Sheng; Hua, Hung-Sheng; Lin, Chien-Huang] Taipei Med Univ, Wanfang Hosp, Grad Inst Med Sci, Taipei, Taiwan; [Yu, Ming-Chih; Chen, Bing-Chang] Taipei Med Univ, Wanfang Hosp, Sch Resp Therapy, Taipei, Taiwan; [Chen, Bing-Chang] Taipei Med Univ, Wanfang Hosp, Dept Internal Med, Sch Med,Coll Med, Taipei, Taiwan; [Wang, Cheng-Hui] Taipei Med Univ, Wanfang Hosp, Dept Lab Med, Taipei, Taiwan; [Wang, Cheng-Hui; Yu, Ming-Chih] Taipei Med Univ, Wanfang Hosp, Pulm Res Ctr, Taipei, Taiwan; [Yu, Ming-Chih] Taipei Med Univ, Wanfang Hosp, Div Pulm Med, Dept Internal Med, Taipei, Taiwan	Taipei Medical University; Taipei Municipal WanFang Hospital; Taipei Medical University; Taipei Municipal WanFang Hospital; Taipei Medical University; Taipei Municipal WanFang Hospital; Taipei Medical University; Taipei Municipal WanFang Hospital; Taipei Medical University; Taipei Municipal WanFang Hospital; Taipei Medical University; Taipei Municipal WanFang Hospital	Chen, BC (corresponding author), Taipei Med Univ, Sch Resp Therapy, Coll Med, 250 Wu Hsing St, Taipei 11031, Taiwan.; Lin, CH (corresponding author), Taipei Med Univ, Grad Inst Med Sci, Coll Med, 250 Wu Hsing St, Taipei 110, Taiwan.	bcchen@tmu.edu.tw; chlin@tmu.edu.tw		Lin, Chien-Huang/0000-0002-0916-8737	Taiwan Ministry of Science and Technology [MOST-101-2320-B-038-024-MY3]	Taiwan Ministry of Science and Technology	' This study was supported by the Taiwan Ministry of Science and Technology (MOST-101-2320-B-038-024-MY3). The authors declare no conflicts of interest.	Bai KJ, 2013, J LEUKOCYTE BIOL, V93, P101, DOI 10.1189/jlb.0911449; Bauer AK, 2005, J NATL CANCER I, V97, P1778, DOI 10.1093/jnci/dji403; Black SA, 2007, J BIOL CHEM, V282, P15416, DOI 10.1074/jbc.M610432200; Blom IE, 2001, J CLIN PATHOL-MOL PA, V54, P192, DOI 10.1136/mp.54.3.192; Bozinovski S, 2002, J BIOL CHEM, V277, P42808, DOI 10.1074/jbc.M207840200; Chang Y, 2010, MOL CELL BIOCHEM, V335, P83, DOI 10.1007/s11010-009-0245-8; Chen BC, 2004, J BIOL CHEM, V279, P20889, DOI 10.1074/jbc.M311279200; Chen WL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137979; Chiou MJ, 2006, BIOCHEM BIOPH RES CO, V349, P750, DOI 10.1016/j.bbrc.2006.08.095; Chu Arthur J., 2014, Inflammation & Allergy Drug Targets, V13, P34; Dheda K, 2005, J INFECT DIS, V192, P1201, DOI 10.1086/444545; Driessche KV, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/781320; Dye C, 2010, SCIENCE, V328, P856, DOI 10.1126/science.1185449; Ferrer Sancho J, 1996, Curr Opin Pulm Med, V2, P327; Fu Jian-Hua, 2011, Zhongguo Dang Dai Er Ke Za Zhi, V13, P36; Gu J, 2012, EXP CELL RES, V318, P2105, DOI 10.1016/j.yexcr.2012.06.015; Harris JE, 2007, J LEUKOCYTE BIOL, V81, P548, DOI 10.1189/jlb.0806512; Huang Min, 2010, Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi, V28, P729; Kawasaki H, 1997, Tanpakushitsu Kakusan Koso, V42, P424; Kendall RT, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00123; Khalil N, 2005, J BIOL CHEM, V280, P43000, DOI 10.1074/jbc.M510441200; Ko WC, 2012, ACTA PHARMACOL SIN, V33, P49, DOI 10.1038/aps.2011.178; Lin CH, 2013, BBA-MOL CELL RES, V1833, P2823, DOI 10.1016/j.bbamcr.2013.07.016; Lin CN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085354; Lipson KE, 2012, FIBROGENESIS TISSUE, V5, DOI 10.1186/1755-1536-5-S1-S24; Liu SX, 2011, ARTHRITIS RHEUM-US, V63, P239, DOI 10.1002/art.30074; Marshall BG, 1996, THORAX, V51, P1253, DOI 10.1136/thx.51.12.1253; Matsui F, 2013, AM J PHYSIOL-RENAL, V305, pF1014, DOI 10.1152/ajprenal.00620.2012; Moussad EEDA, 2000, MOL GENET METAB, V71, P276, DOI 10.1006/mgme.2000.3059; Mun JH, 2014, WOUND REPAIR REGEN, V22, P125, DOI 10.1111/wrr.12136; O'Kane CM, 2007, J IMMUNOL, V178, P3767, DOI 10.4049/jimmunol.178.6.3767; O'Kane CM, 2010, AM J RESP CELL MOL, V43, P465, DOI 10.1165/rcmb.2009-0211OC; Perbal B, 2004, LANCET, V363, P62, DOI 10.1016/S0140-6736(03)15172-0; Ryffel B, 2005, TUBERCULOSIS, V85, P395, DOI 10.1016/j.tube.2005.08.021; Simmons DP, 2010, J IMMUNOL, V185, P2405, DOI 10.4049/jimmunol.0904005; Sullivan DE, 2009, J CELL MOL MED, V13, P1866, DOI 10.1111/j.1582-4934.2009.00647.x; Tall EG, 2010, INVEST OPHTH VIS SCI, V51, P5002, DOI 10.1167/iovs.09-5110; Tao L, 2010, MOL MED REP, V3, P941, DOI 10.3892/mmr.2010.349; van Almen GC, 2011, AGING CELL, V10, P769, DOI 10.1111/j.1474-9726.2011.00714.x; Van Beek JP, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1890; Wang CY, 2014, J FORMOS MED ASSOC, V113, P50, DOI 10.1016/j.jfma.2012.04.004; Wang QJ, 2011, FIBROGENESIS TISSUE, V4, DOI 10.1186/1755-1536-4-4; Weng CM, 2014, BIOCHEM PHARMACOL, V88, P402, DOI 10.1016/j.bcp.2014.01.030; Wickremasinghe MI, 2004, J BIOL CHEM, V279, P27199, DOI 10.1074/jbc.M403107200; Worrall JAR, 2011, FEBS J, V278, P663, DOI 10.1111/j.1742-4658.2010.07988.x; Xia W, 2007, ANN SURG, V246, P886, DOI 10.1097/SLA.0b013e318070d54f; Yu CC, 2009, J IMMUNOL, V182, P7916, DOI 10.4049/jimmunol.0801582; Yu XW, 2014, BIOCHIMIE, V102, P1, DOI 10.1016/j.biochi.2014.02.012	48	9	10	1	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2019	33	11					12554	12564		10.1096/fj.201900487R	http://dx.doi.org/10.1096/fj.201900487R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC8ZX	31451010	Green Published			2022-12-26	WOS:000507461600074
J	Tampah-Naah, AM; Osman, A; Kumi-Kyereme, A				Tampah-Naah, Anthony Mwinilanaa; Osman, Adams; Kumi-Kyereme, Akwasi			Geospatial analysis of childhood morbidity in Ghana	PLOS ONE			English	Article							IRON-DEFICIENCY; GLOBAL BURDEN; MALARIA; CHILDREN; FEVER	Introduction Childhood morbidities are common in Ghana. The present study sought to geospatially analyze morbidities among children (0-23 months of age) using five different survey datasets (1993-2014) from the Ghana Demographic and Health Survey. Methods Logistic regression was used to examine childhood morbidity within a place of residence. Then three spatial statistical tools were applied to analyze morbidities among children (0-23 months of age). These tools were: spatial autocorrelation (Global Moran's I)-used to examine clustering or dispersion patterns; cluster and outlier analysis (Anselin's local Moran's I)-to ascertain geographic composition of childhood morbidity clusters and outliers; and hot spot analysis (Getis-Ord G)-to identify clusters of high values (hot spots) and low values (cold spots). Results Children in rural areas were much burdened with the occurrence of childhood morbidity. The study revealed positive spatial autocorrelation for childhood morbidity in Ghana. Childhood morbidity (diarrhoea, ARI, anaemia, and fever) clusters were identified within districts in the country. Children in rural areas were more likely to be morbid with diarrhoea, anaemia, and fever compared to those in urban areas. Hot spot districts for diarrhoea, anaemia and fever were mainly situated in semi-arid areas and those with ARI were located both at the semiarid areas and coastal portions of Ghana. Conclusion Rural children are much exposed to have higher burden of a childhood morbidity compared to their urban counterparts. Most semi-arid districts in Ghana are burdened with diarrhoea, ARI, anaemia, and fever. To minimize the occurrence of childhood morbidity in Ghana, designing of more context-based interventions to target hot spots districts of these morbidities are required in order to use scarce resources judiciously.	[Tampah-Naah, Anthony Mwinilanaa] Univ Dev Studies, Fac Integrated Dev Studies, Dept Environm & Resource Studies, Wa Campus, Tamale, Ghana; [Osman, Adams] Univ Cape Coast, Coll Humanities & Legal Studies, Dept Geog & Reg Planning, Cape Coast, Ghana; [Kumi-Kyereme, Akwasi] Univ Cape Coast, Coll Humanities & Legal Studies, Dept Populat & Hlth, Cape Coast, Ghana	University for Development Studies; University of Cape Coast; University of Cape Coast	Tampah-Naah, AM (corresponding author), Univ Dev Studies, Fac Integrated Dev Studies, Dept Environm & Resource Studies, Wa Campus, Tamale, Ghana.	atampah@uds.edu.gh	Osman, Adams/S-5965-2019; Tampah-Naah, Anthony Mwinilanaa/HCI-5529-2022	Osman, Adams/0000-0002-9027-7067; 				Aimone AM, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1388-1; [Anonymous], 2015, COMM LED TOT SAN; [Anonymous], 2008, WORLDWIDE PREVALENCE; Azage M, 2016, J HEALTH POPUL NUTR, V35, DOI 10.1186/s41043-016-0052-2; Bonsi E. A., 2014, African Journal of Food, Agriculture, Nutrition and Development, V14, P2036; Boots BN, 1998, POINT PATTERN ANAL; Cheng K., 2013, EVALUATING ACCESS DR; Currie J, 2012, LASTING EFFECTS CHIL; D'Acremont V, 2014, NEW ENGL J MED, V370, P809, DOI 10.1056/NEJMoa1214482; ESRI, 2017, SPAT AUT GLOB MOR WO; Ewusie JE, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-626; Ghana Statistical Service, 2014, GHANA DEMOGRAPHIC HL; Ghana Statistical Service, 2011, GHANA MULTIPLE INDIC; Guerrant RL, 2004, POTENTIAL LONG TERM; Kandala NB, 2004, A0414 SOUTH STAT SCI; Kotloff KL, 2017, VACCINE, V35, P6783, DOI 10.1016/j.vaccine.2017.07.036; Krefis AC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017905; Krishnan A, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1188-1; Liu WK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096674; Mitchell A., 2005, ESRI GUIDE GIS ANAL, V2; Nnedu ON, 2010, AM J TROP MED HYG, V82, P525, DOI 10.4269/ajtmh.2010.09-0188; Nyadanu SD, 2016, J HLTH MED NURSING, V28, P87; Osei FB, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4541-z; Prasad N, 2015, AM J TROP MED HYG, V93, P178, DOI 10.4269/ajtmh.14-0646; Quarmye N., 2017, UN GHANA NUTR; Scott LM, 2009, SPATIAL STAT ARCGIS, P27; Tsai SF, 2014, PEDIATR NEONATOL, V55, P466, DOI 10.1016/j.pedneo.2014.02.005; Walker CLF, 2013, LANCET, V381, P1405, DOI 10.1016/S0140-6736(13)60222-6; Zimmermann MB, 2005, AM J CLIN NUTR, V81, P115	29	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2019	14	8							e0221324	10.1371/journal.pone.0221324	http://dx.doi.org/10.1371/journal.pone.0221324			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW6BO	31469841	Green Submitted, Green Published, gold			2022-12-26	WOS:000485062200017
J	Deniz, B; Ambavane, A; Yang, S; Altincatal, A; Doan, J; Rao, S; Michaelson, MD				Deniz, Baris; Ambavane, Apoorva; Yang, Shuo; Altincatal, Arman; Doan, Justin; Rao, Sumati; Michaelson, M. Dror			Treatment sequences for advanced renal cell carcinoma: A health economic assessment	PLOS ONE			English	Article							COST-EFFECTIVENESS; 1ST-LINE TREATMENT; OPEN-LABEL; EVEROLIMUS; SUNITINIB; NIVOLUMAB; AXITINIB; THERAPY; CABOZANTINIB; GUIDELINES	Objective Advanced renal cell carcinoma (RCC) is commonly treated with vascular endothelial growth factor or mammalian target of rapamycin inhibitors. As new therapies emerge, interest grows in gaining a deeper understanding of treatment sequences. Recently, we developed a patient-level, discretely integrated condition event (DICE) simulation to estimate survival and lifetime costs for various cancer therapies, using a US payer perspective. Using this model, we explored the impact of treatments such as nivolumab and cabozantinib, and compared the clinical outcomes and cost consequences of commonly used treatment algorithms for patients with advanced RCC. Methods Included treatment sequences were pazopanib or sunitinib as first-line treatment, followed by nivolumab, cabozantinib, axitinib, pazopanib or everolimus. Efficacy inputs were derived from the CheckMate 025 trial and a network meta-analysis based on available literature. Safety and cost data were obtained from publicly available sources or literature. Results Based on our analysis, the average cost per life-year (LY) was lowest for sequences including nivolumab (sunitinib -> nivolumab, $75,268/LY; pazopanib -> nivolumab, $84,459/LY) versus axitinib, pazopanib, everolimus and cabozantinib as second-line treatments. Incremental costs per LY gained were $49,592, $73,927 and $30,534 for nivolumab versus axitinib, pazopanib and everolimus-containing sequences, respectively. The model suggests that nivolumab offers marginally higher life expectancy at a lower cost versus cabozantinib-including sequences. Conclusion Treatment sequences using nivolumab in the second-line setting are less costly compared with sequential use of targeted agents. In addition to efficacy and safety data, cost considerations may be taken into account when considering treatment algorithms for patients with advanced RCC.	[Deniz, Baris; Altincatal, Arman] Evidera Inc, Bethesda, MD 20814 USA; [Ambavane, Apoorva] Evidera Inc, London, England; [Yang, Shuo; Doan, Justin; Rao, Sumati] Bristol Myers Squibb, Princeton, NJ USA; [Michaelson, M. Dror] Massachusetts Gen Hosp, Ctr Canc, Hematol Oncol, Boston, MA USA	Evidera; Evidera; Bristol-Myers Squibb; Harvard University; Massachusetts General Hospital	Deniz, B (corresponding author), Evidera Inc, Bethesda, MD 20814 USA.	baris.deniz@evidera.com	Ambavane, Apoorva/AAW-4834-2020	Michaelson, Dror/0000-0001-9249-6338; Deniz, Baris/0000-0002-8423-5629	Bristol-Myers Squibb	Bristol-Myers Squibb(Bristol-Myers Squibb)	Bristol-Myers Squibb provided financial support to Evidera in relation to the conduct of the reported research study. The funder (Bristol-Myers Squibb) provided support in the form of salaries for those authors employed by the funder (S. Yang, J. Doan, and S. Rao) and had no additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Professional editorial assistance was provided by Richard Daniel, PhD, and Lawrence Hargett of PAREXEL, and was funded by Bristol-Myers Squibb.	Agency for Healthcare Research and Quality (AHRQ), AG HEALTHC RES QUAL; [Anonymous], 2014, INLVT AX TABL PRESCR; [Anonymous], REDBOOK; [Anonymous], 2016, AF EV TABL PRESCR IN; [Anonymous], 2017, VOTR PAZ TABL PI; [Anonymous], 2018, OPD NIV INJ PRESCR I; [Anonymous], 2016, CAB CAB TABL PRESCR; Benedict A, 2011, BJU INT, V108, P665, DOI 10.1111/j.1464-410X.2010.09957.x; Caro JJ, 2016, PHARMACOECONOMICS, V34, P665, DOI 10.1007/s40273-016-0394-z; Centers for Medicare and Medicaid Services, NAT PAYM AM HCPCS CO; Centers for Medicare and Medicaid Services, PAYM RAT HCPCS COD C; Chabot I, 2010, VALUE HEALTH, V13, P837, DOI 10.1111/j.1524-4733.2010.00738.x; Choueiri TK, 2015, NEW ENGL J MED, V373, P1814, DOI 10.1056/NEJMoa1510016; Chow WH, 2010, NAT REV UROL, V7, P245, DOI 10.1038/nrurol.2010.46; Coppin C, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001425.pub2; Escudier B, 2016, ANN ONCOL, V27, pv58, DOI 10.1093/annonc/mdw328; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Hodi FS, 2016, J CLIN ONCOL, V34, P1510, DOI 10.1200/JCO.2015.64.0391; Howlander N, 1975, SEER CANC STAT REV; Huang XL, 2016, STAT MED, V35, P2167, DOI 10.1002/sim.6860; Jonasch E, 2018, J NATL COMPR CANC NE, V16, P639, DOI 10.6004/jnccn.2018.0039; Latimer N., 14 NICE DSU, V2011; McCrea C, 2018, EXP HEMATOL ONCOL, V7, DOI 10.1186/s40164-018-0095-8; Meng J, 2018, CLINICOECONOMIC OUTC, V10, P243, DOI 10.2147/CEOR.S159833; Motzer RJ, 2015, NEW ENGL J MED, V373, P1803, DOI 10.1056/NEJMoa1510665; Motzer RJ, 2015, LANCET ONCOL, V16, P1473, DOI 10.1016/S1470-2045(15)00290-9; Motzer Robert J, 2015, J Natl Compr Canc Netw, V13, P151; Motzer RJ, 2014, LANCET ONCOL, V15, P286, DOI 10.1016/S1470-2045(14)70030-0; Motzer RJ, 2013, NEW ENGL J MED, V369, P722, DOI 10.1056/NEJMoa1303989; Neri B, 2013, INT J UROL, V20, P478, DOI 10.1111/j.1442-2042.2012.03204.x; NICE, 2018, TECHN APPR GUID TA49; NICE, 2017, TECHN APPR GUID TA41; Perrin A, 2015, J MED ECON, V18, P200, DOI 10.3111/13696998.2014.985789; Rasmussen F, 2013, CANCER IMAGING, V13, P374, DOI 10.1102/1470-7330.2013.9035; Remak E, 2009, VALUE HLTH ABSTRACTS, V12; Remak E, 2008, J CLIN ONCOL, V26, P3995, DOI 10.1200/JCO.2007.13.2662; Rini BI, 2013, CLIN GENITOURIN CANC, V11, P107, DOI 10.1016/j.clgc.2012.12.004; Rini BI, 2011, LANCET, V378, P1931, DOI 10.1016/S0140-6736(11)61613-9; Sarfaty M, 2018, EUR UROL, V73, P628, DOI 10.1016/j.eururo.2017.07.041; Shih YCT, 2011, PHARMACOECONOMICS, V29, P315, DOI 10.2165/11586100-000000000-00000; US Centers for Disease Control and Prevention, 2013, US LIF TABL; Weinstein MC, 1996, JAMA-J AM MED ASSOC, V276, P1253, DOI 10.1001/jama.276.15.1253; Wolchok JD, 2009, CLIN CANCER RES, V15, P7412, DOI 10.1158/1078-0432.CCR-09-1624	43	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2019	14	8							e0215761	10.1371/journal.pone.0215761	http://dx.doi.org/10.1371/journal.pone.0215761			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW6AB	31465470	Green Submitted, gold, Green Published			2022-12-26	WOS:000485058200001
J	Jeong, SY; Jin, H; Chang, JH				Jeong, Soo Yeon; Jin, Hyeonseok; Chang, Jeong Ho			Crystal structure of L-aspartate aminotransferase from Schizosaccharomyces pombe	PLOS ONE			English	Article							EVOLUTIONARY RELATIONSHIPS; 3-DIMENSIONAL STRUCTURE; STRUCTURE REFINEMENT; ESCHERICHIA-COLI; MECHANISM; ENZYME; PHENIX	L-aspartate aminotransferase is a pyridoxal 5'-phosphate-dependent transaminase that catalyzes reversible transfer of an alpha-amino group from aspartate to alpha-ketoglutarate or from glutamate to oxaloacetate. L-aspartate aminotransferase not only mediates amino acid and carbohydrate metabolism but also regulates the cellular level of amino acids by catalyzing amino acid degradation and biosynthesis. To expand our structural information, we determined the crystal structure of L-aspartate aminotransferase from Schizosaccharomyces pombe at 2.1 angstrom resolution. A structural comparison between two yeast L-aspartate aminotransferases revealed conserved enzymatic mechanism mediated by the open-closed conformational change. Compared with higher eukaryotic species, L-aspartate aminotransferases showed distinguishable inter-subunit interaction between the N-terminal arm and a large domain of the opposite subunit. Interestingly, structural homology search showed varied conformation of the N-terminal arm among 71 structures of the family. Therefore, we classified pyridoxal 5'-phosphate-dependent enzymes into eight subclasses based on the structural feature of N-terminal arms. In addition, structure and sequence comparisons showed strong relationships among the eight subclasses. Our results may provide insights into structure-based evolutionary aspects of pyridoxal 5'-phosphate-dependent enzymes.	[Jeong, Soo Yeon; Chang, Jeong Ho] Kyungpook Natl Univ, Dept Biol Educ, Daegu, South Korea; [Jin, Hyeonseok; Chang, Jeong Ho] Kyungpook Natl Univ, Res Inst Phylogen & Evolut, Daegu, South Korea	Kyungpook National University; Kyungpook National University	Chang, JH (corresponding author), Kyungpook Natl Univ, Dept Biol Educ, Daegu, South Korea.; Jin, H; Chang, JH (corresponding author), Kyungpook Natl Univ, Res Inst Phylogen & Evolut, Daegu, South Korea.	seika0608@gmail.com; jhcbio@knu.ac.kr		Chang, Jeong Ho/0000-0002-2126-0317	Basic Science Research Program through the National Research Foundation of Korea - Ministry of Science and ICT [NRF-2019R1A2C4069796]	Basic Science Research Program through the National Research Foundation of Korea - Ministry of Science and ICT	This research was supported by Basic Science Research Program through the National Research Foundation of Korea funded by the Ministry of Science and ICT (grand No. NRF-2019R1A2C4069796 to JHC).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; ALEXANDER FW, 1994, EUR J BIOCHEM, V219, P953, DOI 10.1111/j.1432-1033.1994.tb18577.x; Astner I, 2005, EMBO J, V24, P3166, DOI 10.1038/sj.emboj.7600792; Christen P, 1985, TANSAMINASES; Edayathumangalam R, 2013, P NATL ACAD SCI USA, V110, P17820, DOI 10.1073/pnas.1315887110; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FORD GC, 1980, P NATL ACAD SCI-BIOL, V77, P2559, DOI 10.1073/pnas.77.5.2559; GRISHIN NV, 1995, PROTEIN SCI, V4, P1291, DOI 10.1002/pro.5560040705; HARUTYUNYAN EG, 1982, FEBS LETT, V138, P113, DOI 10.1016/0014-5793(82)80407-9; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; IZARD T, 1990, J MOL BIOL, V215, P341, DOI 10.1016/S0022-2836(05)80355-9; JAGER J, 1994, J MOL BIOL, V239, P285, DOI 10.1006/jmbi.1994.1368; Jansonius JN, 1987, BIOL MACROMOL, P3; Jeffery CJ, 1998, ACTA CRYSTALLOGR D, V54, P659, DOI 10.1107/S0907444997016235; Kack H, 1999, J MOL BIOL, V291, P857, DOI 10.1006/jmbi.1999.2997; KIRSCH JF, 1984, J MOL BIOL, V174, P497, DOI 10.1016/0022-2836(84)90333-4; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Krupka HI, 2000, EMBO J, V19, P3168, DOI 10.1093/emboj/19.13.3168; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; MALASHKEVICH VN, 1995, J MOL BIOL, V247, P111, DOI 10.1006/jmbi.1994.0126; MALASHKEVICH VN, 1993, BIOCHEMISTRY-US, V32, P13451, DOI 10.1021/bi00212a010; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MCPHALEN CA, 1992, J MOL BIOL, V227, P197, DOI 10.1016/0022-2836(92)90691-C; MCPHALEN CA, 1992, J MOL BIOL, V225, P495, DOI 10.1016/0022-2836(92)90935-D; OKAMOTO A, 1994, J BIOCHEM, V116, P95, DOI 10.1093/oxfordjournals.jbchem.a124509; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Park Suk-Youl, 2017, Biodesign, V5, P30; Schneider G, 2000, STRUCT FOLD DES, V8, pR1, DOI 10.1016/S0969-2126(00)00085-X; SMITH DL, 1989, BIOCHEMISTRY-US, V28, P8161, DOI 10.1021/bi00446a030; Terwilliger TC, 2008, ACTA CRYSTALLOGR D, V64, P61, DOI 10.1107/S090744490705024X; Tomita T, 2009, PROTEINS, V75, P348, DOI 10.1002/prot.22245; Williams BB, 2014, CELL HOST MICROBE, V16, P495, DOI 10.1016/j.chom.2014.09.001; WINEFIELD CS, 1995, J MOL EVOL, V40, P455, DOI 10.1007/BF00164031	34	2	2	4	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2019	14	8							e0221975	10.1371/journal.pone.0221975	http://dx.doi.org/10.1371/journal.pone.0221975			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW6AB	31465495	Green Published, gold, Green Submitted			2022-12-26	WOS:000485058200076
J	Marukutira, T; Block, L; Alwano, MG; Behel, S; Jarvis, JN; Chakalisa, U; Powis, K; Novitsky, V; Bapati, W; Wang, HS; Ussery, F; Lebelonyane, R; Mills, LA; Moore, J; Bachanas, P				Marukutira, Tafireyi; Block, Lisa; Alwano, Mary Grace; Behel, Stephanie; Jarvis, Joseph N.; Chakalisa, Unoda; Powis, Kate; Novitsky, Vladimir; Bapati, William; Wang, Huisheng; Ussery, Faith; Lebelonyane, Refeletswe; Mills, Lisa A.; Moore, Janet; Bachanas, Pamela			Comparison of knowledge of HIV status and treatment coverage between non-citizens and citizens: Botswana Combination Prevention Project (BCPP)	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY	Introduction Non-citizens often face barriers to HIV care and treatment. Quantifying knowledge of positive HIV status and antiretroviral therapy (ART) coverage among non-citizens in a high HIV-prevalence country like Botswana that is close to achieving UNAIDS "90-90-90" targets may expose important gaps in achieving universal HIV testing and treatment. Methods The Botswana Combination Prevention Project (BCPP) is a pair-matched cluster-randomized trial evaluating the impact of prevention interventions on HIV incidence in 30 rural or peri-urban communities. Community case finding and HIV testing were conducted in home and mobile venues in 15 intervention communities from October 2013-September 2017. In this secondary analysis, we compared HIV positivity, knowledge of positive HIV-status, and ART status among all citizens and non-citizens assessed at intake in the intervention communities. Results HIV status was assessed in 57,556 residents in the intervention communities; 4% (n = 2,463) were non-citizens. Five communities accounted for 81% of the total non-citizens assessed. A lower proportion of non-citizens were HIV-positive (15%; n = 369) compared to citizens (21%; n = 11,416) [p = 0.026]; however, a larger proportion of non-citizens did not know their HIV-positive status prior to BCPP testing (75%) as compared to citizens (15%) [p = 0.003]. Among residents with knowledge of their HIV-positive status before BCPP, 79% of the non-citizens (72/91) were on ART compared to 86% (8,267/9,652) of citizens (p = 0.137). Conclusions Although non-citizens were less likely to know their HIV-positive status compared to citizens, there were no differences in treatment uptake among non-citizens and citizens who knew their status. Designing interventions for non-citizens that provide HIV testing and treatment services commensurate to that of citizens as well as targeting communities with the largest number of non-citizens may help close a meaningful gap in the HIV care cascade and ensure ethical treatment for all HIV-positive persons.	[Marukutira, Tafireyi; Alwano, Mary Grace; Jarvis, Joseph N.; Mills, Lisa A.] Ctr Dis Control & Prevent, Gaborone, Botswana; [Marukutira, Tafireyi] Burnet Inst, Publ Hlth, Melbourne, Vic, Australia; [Marukutira, Tafireyi] Monash Univ, Sch Publ Hlth & Prevent Med, Melbourne, Vic, Australia; [Block, Lisa; Wang, Huisheng] Northrop Grumman Corp, Atlanta, GA USA; [Behel, Stephanie; Ussery, Faith; Moore, Janet; Bachanas, Pamela] Ctr Dis Control & Prevent, Div Global HIV AIDS & TB, Atlanta, GA USA; [Jarvis, Joseph N.] Botswana UPenn Partnership, Gaborone, Botswana; [Jarvis, Joseph N.] London Sch Hyg & Trop Med, Fac Infect & Trop Dis, Dept Clin Res, London, England; [Chakalisa, Unoda; Powis, Kate] Botswana Harvard Partnership, Gaborone, Botswana; [Powis, Kate; Novitsky, Vladimir] Harvard TH Chan Sch Publ Hlth, Boston, MA USA; [Bapati, William] Tebelopele HIV Testing & Counselling Ctr, Gaborone, Botswana; [Lebelonyane, Refeletswe] Botswana Minist Hlth, Dept HIV AIDS Prevent & Care, Gaborone, Botswana	Burnet Institute; Monash University; Northrop Grumman Corporation; Centers for Disease Control & Prevention - USA; University of London; London School of Hygiene & Tropical Medicine; Harvard University; Harvard T.H. Chan School of Public Health	Marukutira, T (corresponding author), Ctr Dis Control & Prevent, Gaborone, Botswana.; Marukutira, T (corresponding author), Burnet Inst, Publ Hlth, Melbourne, Vic, Australia.; Marukutira, T (corresponding author), Monash Univ, Sch Publ Hlth & Prevent Med, Melbourne, Vic, Australia.	tafireyi.marukutira@burnet.edu.au		Marukutira, Tafireyi/0000-0003-1142-6114; Jarvis, Joseph/0000-0003-1459-5554	President's Emergency Plan for AIDS Relief (PEPFAR) through the Centers for Disease Control and Prevention (CDC) [U2G GH000073, U2G GH000419]	President's Emergency Plan for AIDS Relief (PEPFAR) through the Centers for Disease Control and Prevention (CDC)(United States Agency for International Development (USAID)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This project was supported by the President's Emergency Plan for AIDS Relief (PEPFAR) through the Centers for Disease Control and Prevention (CDC) under the terms of Cooperative Agreements U2G GH000073 and U2G GH000419.; This project has been supported by the President's Emergency Plan for AIDS Relief (PEPFAR) through the Centers for Disease Control and Prevention (CDC) under the terms of Cooperative Agreements U2G GH000073 and U2G GH000419. The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the funding agencies. Preliminary results were presented at the Conference on Retroviruses and Opportunistic Infections (CROI), Seattle, USA, 13-16 February 2017.	AIDS, 2017, GLOB AIDS UPD; Andrews JR, 2012, J INFECT DIS, V206, P543, DOI 10.1093/infdis/jis401; Gaolathe T, 2016, LANCET HIV, V3, pE221, DOI 10.1016/S2352-3018(16)00037-0; IOM (International Organization for Migration), 2018, WORLD MIGRATION REPO; Joint United Nations Programme on HIV/AIDS (UNAIDS), 2017, END AIDS PROGR 90 90; Makhema MJ, 2018, 22 INT AIDS C AMST N; Ministry of Health Botswana, 2012, NAT GUID HIV TEST CO; Ministry of Health Botswana., 2016, HDB BOTSW 2016 INT H; Moyo S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0204840; Tanser F, 2015, CURR OPIN HIV AIDS, V10, P430, DOI 10.1097/COH.0000000000000192; UNAIDS, 2014, 90 90 90 AMB TREATM; UNAIDS (Joint United Nations Programme on HIV and AIDS), 2016, FAST TRACK COMM END; Vearey J, 2018, J INT AIDS SOC, V21, DOI 10.1002/jia2.25137	13	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2019	14	8							e0221629	10.1371/journal.pone.0221629	http://dx.doi.org/10.1371/journal.pone.0221629			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW6AB	31465494	Green Published, Green Accepted, Green Submitted, gold			2022-12-26	WOS:000485058200033
J	Kull, JA; Proudfoot, KL; Pighetti, GM; Bewley, JM; O'Hara, BF; Donohue, KD; Krawczel, PD				Kull, Jessie A.; Proudfoot, Katy L.; Pighetti, Gina M.; Bewley, Jeffery M.; O'Hara, Bruce F.; Donohue, Kevin D.; Krawczel, Peter D.			Effects of acute lying and sleep deprivation on the behavior of lactating dairy cows	PLOS ONE			English	Article							ADRENAL-AXIS RESPONSES; SOMATIC-CELL COUNTS; GROWTH-HORMONE; HEAT-STRESS; TIME BUDGETS; MILK-FAT; CATTLE; PREFERENCES; METABOLISM; INCREASES	The objective was to determine the effects of sleep or lying deprivation on the behavior of dairy cows. Data were collected from 8 multi-and 4 primiparous cows (DIM = 199 +/- 44 (mean +/- SD); days pregnant = 77 +/- 30). Using a crossover design, each cow experienced: 1) sleep deprivation implemented by noise or physical contact when their posture suggested sleep, and 2) lying deprivation imposed by a grid placed on the pen floor. One day before treatment (baseline), and treatment day (treatment) were followed by a 12-d washout period (with the first 7 d used to evaluate recovery). Study days were organized from 2100 to 2059. During habituation (d -3 and -2 before treatment), baseline (d -1), and trt (d 0), housing was individual boxstalls (mattress with no bedding). After treatment, cows returned to sand-bedded freestalls for a 7-d recovery period (d 1 to 7) where data on lying behaviors were collected. Following the recovery period, an additional 5-d period was provided to allow the cows a 12-d period between exposures to treatments. Daily lying time, number lying bouts, bout duration, and number of steps were recorded by dataloggers attached to the hind leg of cows throughout the study period. Data were analyzed using a mixed model including fixed effects of treatment (sleep deprivation vs. sleep and lying deprivation), day, and their interaction with significant main effects separated using a PDIFF statement (P <= 0.05). Interactions between treatment and day were detected for daily lying time and the number of bouts. Lying time was lower for both treatments during the treatment period compared to baseline. Lying time increased during the recovery period for both lying and sleep deprived cows. However, it took 4 d for the lying deprived cows to fully recover their lying time after treatment, whereas it took the sleep deprived cows 2 d for their lying time to return to baseline levels. Results suggest that both sleep and lying deprivation can have impact cow behavior. Management factors that limit freestall access likely reduce lying time and sleep, causing negative welfare implications for dairy cows.	[Kull, Jessie A.; Pighetti, Gina M.; Krawczel, Peter D.] Univ Tennessee, Dept Anim Sci, Knoxville, TN 37901 USA; [Proudfoot, Katy L.] Ohio State Univ, Dept Prevent Vet Med, Columbus, OH 43210 USA; [Bewley, Jeffery M.] Alltech Inc, Nicholasville, KY USA; [O'Hara, Bruce F.] Univ Kentucky, Dept Biol, Lexington, KY USA; [Donohue, Kevin D.] Univ Kentucky, Dept Elect & Comp Engn, Lexington, KY USA	University of Tennessee System; University of Tennessee Knoxville; UT Institute of Agriculture; University System of Ohio; Ohio State University; University of Kentucky; University of Kentucky	Krawczel, PD (corresponding author), Univ Tennessee, Dept Anim Sci, Knoxville, TN 37901 USA.	krawczel@utk.edu		Krawczel, Peter/0000-0002-9867-2280	Agricultural Research Service [2015-67030-24295]	Agricultural Research Service(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	This work was supported by Agricultural Research Service #2015-67030-24295 to KP, PK, GP, JB, BO, and KD.	Akerlind M, 1999, LIVEST PROD SCI, V59, P1, DOI 10.1016/S0301-6226(99)00034-2; Bach A, 2008, J DAIRY SCI, V91, P3259, DOI 10.3168/jds.2008-1030; Bouraoui R, 2002, ANIM RES, V51, P479, DOI 10.1051/animres:2002036; Bradley A, 2005, IN PRACTICE, V27, P310, DOI 10.1136/inpract.27.6.310; Brandenberger G, 2000, LANCET, V356, P1408, DOI 10.1016/S0140-6736(00)02847-6; Cook NB, 2007, J DAIRY SCI, V90, P1674, DOI 10.3168/jds.2006-634; Cook NB, 2008, P PENN STAT DAIR CAT; Cooper MD, 2007, J DAIRY SCI, V90, P1149, DOI 10.3168/jds.S0022-0302(07)71601-6; DADO RG, 1994, J DAIRY SCI, V77, P132, DOI 10.3168/jds.S0022-0302(94)76936-8; Dash S, 2016, VET WORLD, V9, P235, DOI 10.14202/vetworld.2016.235-244; DAVIDSON JR, 1991, J PSYCHIATR NEUROSCI, V16, P96; Everson CA, 2004, AM J PHYSIOL-ENDOC M, V286, pE1060, DOI 10.1152/ajpendo.00553.2003; Fregonesi JA, 2007, J DAIRY SCI, V90, P5468, DOI 10.3168/jds.2007-0494; Fregonesi JA, 2009, J DAIRY SCI, V92, P1979, DOI 10.3168/jds.2008-1604; Gomez A, 2010, J DAIRY SCI, V93, P5772, DOI 10.3168/jds.2010-3436; Graves LA, 2003, LEARN MEMORY, V10, P168, DOI 10.1101/lm.48803; HART IC, 1978, J ENDOCRINOL, V77, P333, DOI 10.1677/joe.0.0770333; Herbut P, 2017, IT J ANIM SCI, V1, P1; Irwin MR, 2015, ANNU REV PSYCHOL, V66, P143, DOI 10.1146/annurev-psych-010213-115205; Ito K, 2009, J DAIRY SCI, V92, P4412, DOI 10.3168/jds.2009-2235; Jacobs JA, 2012, J DAIRY SCI, V95, P1575, DOI 10.3168/jds.2011-4710; Jenness R., 1985, Lactation, P164; Jensen MB, 2005, APPL ANIM BEHAV SCI, V90, P207, DOI 10.1016/j.applanim.2004.08.006; KAY SJ, 1977, J DAIRY RES, V44, P589, DOI 10.1017/S0022029900020549; Kelsey JA, 2003, J DAIRY SCI, V86, P2588, DOI 10.3168/jds.S0022-0302(03)73854-5; Kim MH, 2011, J VET SCI, V12, P151, DOI 10.4142/jvs.2011.12.2.151; Kok A, 2015, J DAIRY SCI, V98, P7911, DOI 10.3168/jds.2015-9554; Krawczel PD, 2012, J DAIRY SCI, V95, P4298, DOI 10.3168/jds.2011-4687; Kull JA, 2017, J DAIRY SCI, V100, P7379, DOI 10.3168/jds.2016-12307; Laugero KD, 2000, AM J PHYSIOL-ENDOC M, V279, pE44, DOI 10.1152/ajpendo.2000.279.1.E44; Ledoux L, 1996, BRAIN RES, V735, P108; Lensink BJ, 2003, APPL ANIM BEHAV SCI, V83, P325, DOI 10.1016/S0168-1591(03)00138-2; Linn J.G., 1988, DESIGNING FOODS ANIM, P224; MacKay JRD, 2012, APPL ANIM BEHAV SCI, V139, P35, DOI 10.1016/j.applanim.2012.03.008; Macmillan K, 2017, J DAIRY SCI, V100, P1045, DOI 10.3168/jds.2016-11337; Manninen E, 2002, APPL ANIM BEHAV SCI, V75, P281, DOI 10.1016/S0168-1591(01)00206-4; McGowan J. E., 2007, Proceedings of the New Zealand Society of Animal Production, V67, P136; METZ JHM, 1985, APPL ANIM BEHAV SCI, V13, P301, DOI 10.1016/0168-1591(85)90010-3; Moberg GP, 2000, BIOLOGY OF ANIMAL STRESS, P1, DOI 10.1079/9780851993591.0001; MUNKSGAARD L, 1993, CAN J ANIM SCI, V73, P847, DOI 10.4141/cjas93-087; Munksgaard L, 1999, ACTA AGR SCAND A-AN, V49, P172, DOI 10.1080/090647099424088; Munksgaard L, 1996, J ANIM SCI, V74, P769; Munksgaard L, 2005, APPL ANIM BEHAV SCI, V92, P3, DOI 10.1016/j.applanim.2004.11.005; Poroyko VA, 2016, SCI REP-UK, V6, DOI 10.1038/srep35405; Ravagnolo O, 2000, J DAIRY SCI, V83, P2120, DOI 10.3168/jds.S0022-0302(00)75094-6; Rhoads ML, 2009, J DAIRY SCI, V92, P1986, DOI 10.3168/jds.2008-1641; RUCKEBUS.Y, 1974, BRAIN RES, V78, P495, DOI 10.1016/0006-8993(74)90932-9; RUCKEBUSCH Y, 1972, ANIM BEHAV, V20, P637, DOI 10.1016/S0003-3472(72)80136-2; Schalm O. W, 1961, VET HEMATOLOGY, P155; Schepers AJ, 1997, J DAIRY SCI, V80, P1833, DOI 10.3168/jds.S0022-0302(97)76118-6; Schutz KE, 2008, APPL ANIM BEHAV SCI, V114, P307, DOI 10.1016/j.applanim.2008.04.001; Ternman E, 2019, J DAIRY SCI, V102, P5458, DOI 10.3168/jds.2018-15950; Ternman E, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195593; Ternman E, 2014, APPL ANIM BEHAV SCI, V160, P12, DOI 10.1016/j.applanim.2014.08.014; Ternman E, 2012, APPL ANIM BEHAV SCI, V140, P25, DOI 10.1016/j.applanim.2012.05.005; Tucker CB, 2004, J DAIRY SCI, V87, P2889, DOI 10.3168/jds.S0022-0302(04)73419-0; Tucker CB, 2003, J DAIRY SCI, V86, P521, DOI 10.3168/jds.S0022-0302(03)73630-3; van Gastelen S, 2011, J DAIRY SCI, V94, P4878, DOI 10.3168/jds.2010-4019; Venancio DP, BRAIN BEHAV IMMUNITY, V47, P109; von Keyserlingk MAG, 2008, J DAIRY SCI, V91, P1011, DOI 10.3168/jds.2007-0532; Wheelock J. V., 1980, Bulletin, International Dairy Federation, P83; WOODFORD JA, 1986, J DAIRY SCI, V69, P1035, DOI 10.3168/jds.S0022-0302(86)80499-4; Yagi Y, 2004, J VET MED SCI, V66, P381, DOI 10.1292/jvms.66.381	63	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2019	14	8							e0212823	10.1371/journal.pone.0212823	http://dx.doi.org/10.1371/journal.pone.0212823			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5XV	31461439	Green Submitted, Green Published, gold			2022-12-26	WOS:000485052300002
J	Potter, AS; Drake, K; Brunskill, EW; Potter, SS				Potter, Andrew S.; Drake, Keri; Brunskill, Eric W.; Potter, S. Steven			A bigenic mouse model of FSGS reveals perturbed pathways in podocytes, mesangial cells and endothelial cells	PLOS ONE			English	Article							FOCAL SEGMENTAL GLOMERULOSCLEROSIS; RETINOIC ACID; SLIT DIAPHRAGM; TENASCIN-C; NEPHROTIC SYNDROME; NESTIN EXPRESSION; STEROID-RESISTANT; SIGNALING PATHWAY; MYO1E MUTATIONS; CD2AP	Focal segmental glomerulosclerosis is a major cause of end stage renal disease. Many patients prove unresponsive to available therapies. An improved understanding of the molecular basis of the disease process could provide insights leading to novel therapeutic approaches. In this study we carried out an RNA-seq analysis of the altered gene expression patterns of podocytes, mesangial cells and glomerular endothelial cells of the bigenic Cd2ap+/-, Fyn-/- mutant mouse model of FSGS. In the podocytes we observed upregulation of many genes related to the Tgf beta family/pathway, including Gdnf, Tgf beta 1, Tgf beta 2, Snai2, Vegfb, Bmp4, and Tnc. The mutant podocytes also showed upregulation of Acta2, a marker of smooth muscle and associated with myofibroblasts, which are implicated in driving fibrosis. GO analysis of the podocyte upregulated genes identified elevated protein kinase activity, increased expression of growth factors, and negative regulation of cell adhesion, perhaps related to the observed podocyte loss. Both podocytes and mesangial cells showed strong upregulation of aldehyde dehydrogenase genes involved in the synthesis of retinoic acid. Similarly, the Cd2ap+/-, Fyn-/- mesangial cells, as well as podocytes in other genetic models, and the glomeruli of human FSGS patients, all show upregulation of the serine protease Prss23, with the common thread suggesting important functionality. Another gene with strong upregulation in the Cd2ap+/-, Fyn-/- mutant mesangial cells as well as multiple other mutant mouse models of FSGS was thrombospondin, which activates the secreted inactive form of Tgf beta. The Cd2ap+/-, Fyn-/- mutant endothelial cells showed elevated expression of genes involved in cell proliferation, angioblast migration, angiogenesis, and neovasculature, all consistent with the formation of new blood vessels in the diseased glomerulus. The resulting global definition of the perturbed molecular pathways in the three major cell types of the mutant glomerulus provide deeper understanding of the molecular pathogenic pathways.	[Potter, Andrew S.; Brunskill, Eric W.; Potter, S. Steven] Cincinnati Childrens Med Ctr, Dept Pediat, Div Dev Biol, Cincinnati, OH 45229 USA; [Drake, Keri] Univ Texas Southwestern Med Ctr Dallas, Dept Pediat, Div Nephrol, Dallas, TX USA	Cincinnati Children's Hospital Medical Center; University of Texas System; University of Texas Southwestern Medical Center Dallas	Potter, SS (corresponding author), Cincinnati Childrens Med Ctr, Dept Pediat, Div Dev Biol, Cincinnati, OH 45229 USA.	steve.potter@cchmc.org			National Institutes of Health [P50 DK096418]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P50DK096418] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the National Institutes of Health grant P50 DK096418 to SSP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhmetshina A, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1734; ANDREWS PM, 1983, FED PROC, V42, P3046; Asinobi AO, 2015, BMC NEPHROL, V16, DOI 10.1186/s12882-015-0208-0; Ballim RD, 2012, MOL BIOL CELL, V23, P2362, DOI 10.1091/mbc.E11-09-0790; Bennett MR, 2007, NEPHRON EXP NEPHROL, V107, pE30, DOI 10.1159/000106775; Bergmann C, 2016, LAB INVEST, V96, P151, DOI 10.1038/labinvest.2015.154; Bhattacharyya S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11703; Biernacka A, 2011, GROWTH FACTORS, V29, P196, DOI 10.3109/08977194.2011.595714; Boerries M, 2013, KIDNEY INT, V83, P1052, DOI 10.1038/ki.2012.487; Bowles J, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10845; Branton MH, 1999, MICROBES INFECT, V1, P1349, DOI 10.1016/S1286-4579(99)00250-6; Brunskill EW, 2015, BMC NEPHROL, V16, DOI 10.1186/s12882-015-0063-z; Brunskill EW, 2012, BMC NEPHROL, V13, DOI 10.1186/1471-2369-13-70; Brunskill EW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024640; Chen IH, 2013, CARDIOVASC RES, V97, P443, DOI 10.1093/cvr/cvs355; Crawford SE, 1998, CELL, V93, P1159, DOI 10.1016/S0092-8674(00)81460-9; D'Agati VD, 2004, AM J KIDNEY DIS, V43, P368, DOI 10.1053/j.ajkd.2003.10.024; Dhasarathy A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026514; Fan JG, 2006, J CELL PHYSIOL, V207, P499, DOI 10.1002/jcp.20593; Galkina E, 2006, J AM SOC NEPHROL, V17, P368, DOI 10.1681/ASN.2005080859; Gigante M, 2009, NEPHROL DIAL TRANSPL, V24, P1858, DOI 10.1093/ndt/gfn712; Grgic I, 2014, KIDNEY INT, V86, P1116, DOI 10.1038/ki.2014.204; Han SY, 2004, IMMUNOL CELL BIOL, V82, P568, DOI 10.1111/j.1440-1711.2004.01287.x; Hao HX, 2012, NATURE, V485, P195, DOI 10.1038/nature11019; He WC, 2009, J AM SOC NEPHROL, V20, P765, DOI 10.1681/ASN.2008060566; Hodgin JB, 2010, AM J PATHOL, V177, P1674, DOI 10.2353/ajpath.2010.090746; Huber TB, 2006, J CLIN INVEST, V116, P1337, DOI 10.1172/JCI27400; Janesick A, 2012, DEVELOPMENT, V139, P1213, DOI 10.1242/dev.071456; Jefferson JA, 2014, ADV CHRONIC KIDNEY D, V21, P408, DOI 10.1053/j.ackd.2014.05.009; Jia W, 2005, BLOOD, V106, P3854, DOI 10.1182/blood-2005-04-1658; Kim JH, 2003, KIDNEY INT, V64, P1715, DOI 10.1046/j.1523-1755.2003.00288.x; Kim JM, 2003, SCIENCE, V300, P1298, DOI 10.1126/science.1081068; Kitiyakara C, 2004, AM J KIDNEY DIS, V44, P815, DOI 10.1016/S0272-6386(04)01081-9; Kitiyakara C, 2003, SEMIN NEPHROL, V23, P172, DOI 10.1053/snep.2003.50025; Klein T, 2003, J HISTOCHEM CYTOCHEM, V51, P697, DOI 10.1177/002215540305100601; Konigshoff M, 2009, J CLIN INVEST, V119, P772, DOI 10.1172/JCI33950; Kopp JB, 2011, J AM SOC NEPHROL, V22, P2129, DOI 10.1681/ASN.2011040388; Kornberg RD, 2007, P NATL ACAD SCI USA, V104, P12955, DOI 10.1073/pnas.0704138104; Lennon R, 2015, PEDIATR NEPHROL, V30, P1459, DOI 10.1007/s00467-015-3067-9; Li H, 2006, EMBO J, V25, P4097, DOI 10.1038/sj.emboj.7601289; Li ZW, 2009, J LEUKOCYTE BIOL, V85, P124, DOI 10.1189/jlb.0208135; Lim BJ, 2016, J PATHOL TRANSL MED, V50, P405, DOI 10.4132/jptm.2016.09.21; Lowik MM, 2007, KIDNEY INT, V72, P1198, DOI 10.1038/sj.ki.5002469; Magella B, 2018, DEV BIOL, V434, P36, DOI 10.1016/j.ydbio.2017.11.006; Mallipattu SK, 2015, FRONT MED, V2, DOI 10.3389/fmed.2015.00016; Meehan SM, 2013, VIRCHOWS ARCH, V462, P229, DOI 10.1007/s00428-012-1355-3; Mele C, 2011, NEW ENGL J MED, V365, P295, DOI 10.1056/NEJMoa1101273; Midwood KS, 2016, J CELL SCI, V129, P4321, DOI 10.1242/jcs.190546; Midwood KS, 2009, J CELL COMMUN SIGNAL, V3, P287, DOI 10.1007/s12079-009-0075-1; Mokry J, 2004, STEM CELLS DEV, V13, P658, DOI 10.1089/scd.2004.13.658; Moreno-Manzano V, 2003, BRIT J PHARMACOL, V139, P823, DOI 10.1038/sj.bjp.0705311; Nakayama Y, 2004, AM J PATHOL, V164, P1773, DOI 10.1016/S0002-9440(10)63735-2; ORFANOS CE, 1987, DRUGS, V34, P459, DOI 10.2165/00003495-198734040-00003; Peinado H, 2003, J BIOL CHEM, V278, P21113, DOI 10.1074/jbc.M211304200; Peired A, 2013, J AM SOC NEPHROL, V24, P1756, DOI 10.1681/ASN.2012090950; Reiser J., 2016, F1000RESEARCH, V5, P5, DOI [10.12688/f1000research.7255.1, DOI 10.12688/F1000RESEARCH.7255.1]; Rosenberg AZ, 2017, CLIN J AM SOC NEPHRO, V12, P502, DOI 10.2215/CJN.05960616; Sadowski CE, 2015, J AM SOC NEPHROL, V26, P1279, DOI 10.1681/ASN.2014050489; Schwarz K, 2001, J CLIN INVEST, V108, P1621, DOI 10.1172/JCI12849; Shankland SJ, 2006, KIDNEY INT, V69, P2131, DOI 10.1038/sj.ki.5000410; Shen H, 2003, AM J PHYSIOL-GASTR L, V285, pG539, DOI 10.1152/ajpgi.00436.2002; Shih NY, 2001, AM J PATHOL, V159, P2303, DOI 10.1016/S0002-9440(10)63080-5; Shimizu T, 2006, NEUROL MED-CHIR, V46, P111, DOI 10.2176/nmc.46.111; Sprangers B, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/4632768; Suzuki A, 2003, J AM SOC NEPHROL, V14, P981, DOI 10.1097/01.ASN.0000057857.66268.8F; Swindle CS, 2001, J CELL BIOL, V154, P459, DOI 10.1083/jcb.200103103; Teranishi N, 2007, INT J ONCOL, V30, P593; Trautmann A, 2015, CLIN J AM SOC NEPHRO, V10, P592, DOI 10.2215/CJN.06260614; Tsui CC, 2006, J AM SOC NEPHROL, V17, P1543, DOI 10.1681/ASN.2005080835; Udalova IA, 2011, CRIT REV IMMUNOL, V31, P115, DOI 10.1615/CritRevImmunol.v31.i2.30; Verma R, 2003, J BIOL CHEM, V278, P20716, DOI 10.1074/jbc.M301689200; Wang YJ, 2017, CELL PHYSIOL BIOCHEM, V41, P1147, DOI 10.1159/000464121; Watanabe M, 2002, CIRC RES, V91, P382, DOI 10.1161/01.RES.0000033593.05545.7B; Zent R, 2007, SEMIN NEPHROL, V27, P161, DOI 10.1016/j.semnephrol.2007.01.007; Zhang J, 2012, NEPHRON EXP NEPHROL, V121, pE23, DOI 10.1159/000342808	75	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2019	14	8							e0216261	10.1371/journal.pone.0216261	http://dx.doi.org/10.1371/journal.pone.0216261			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5XV	31461442	Green Published, Green Submitted, gold			2022-12-26	WOS:000485052300005
J	Miksch, F; Jahn, B; Espinosa, KJ; Chhatwal, J; Siebert, U; Popper, N				Miksch, Florian; Jahn, Beate; Espinosa, Kurt Junshean; Chhatwal, Jagpreet; Siebert, Uwe; Popper, Nikolas			Why should we apply ABM for decision analysis for infectious diseases?-An example for dengue interventions	PLOS ONE			English	Article							VACCINATION PROGRAMS; ECONOMIC-EVALUATION; HEMORRHAGIC-FEVER; MODELING METHODS; VIRUS-INFECTION; AEGYPTI; EPIDEMIOLOGY; TRANSMISSION; IMPACT	For the evaluation of infectious-diseases interventions, the transmissible nature of such diseases plays a central role. Agent-based models (ABM) allow for dynamic transmission modeling but publications are limited. We aim to provide an overview of important characteristics of ABM for decision-analytic modeling of infectious diseases. A case study of dengue epidemics illustrates model characteristics, conceptualization, calibration and model analysis. First, major characteristics of ABM are outlined and discussed based on ISPOR and ISPOR-SMDM Good Practice guidelines. Second, in our case study, we modeled a dengue outbreak in Cebu City (Philippines) to assess the impact interventions to control the relative growth of the mosquito population. Model outcomes include prevalence and incidence of infected persons. The modular ABM simulates persons and mosquitoes over an annual time horizon considering daily time steps. The model was calibrated and validated. ABM is a dynamic, individual-level modeling approach that is capable to reproduce direct and indirect effects of interventions for infectious diseases. The ability to replicate emerging behavior and to include human behavior or the behavior of other agents is a distinguishing modeling characteristic (e.g., compared to Markov models). Modeling behavior may, however, require extensive calibration and validation. The analyzed hypothetical effectiveness of dengue interventions showed that a reduced human-mosquito ratio of 1:2.5 during rainy seasons leads already to a substantial decrease of infected persons. ABM can support decision-analyses for infectious diseases including disease dynamics, emerging behavior, and providing a high level of reusability due to modularity.	[Miksch, Florian; Popper, Nikolas] Dwh Gmbh, Vienna, Austria; [Miksch, Florian; Espinosa, Kurt Junshean] Univ Philippines Cebu, Dept Comp Sci, Cebu, Philippines; [Jahn, Beate; Siebert, Uwe] UMIT Univ Hlth Sci Med Informat & Technol, Inst Publ Hlth Med Decis Making & Hlth Technol As, Dept Publ Hlth Hlth Serv Res & Hlth Technol Asses, Hall In Tirol, Austria; [Chhatwal, Jagpreet; Siebert, Uwe] Harvard Med Sch, Massachusetts Gen Hosp, Inst Technol Assessment, Boston, MA 02115 USA; [Chhatwal, Jagpreet; Siebert, Uwe] Harvard Med Sch, Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02115 USA; [Siebert, Uwe] ONCOTYROL Ctr Personalized Canc Med, Div Hlth Technol Assessment & Bioinformat, Innsbruck, Austria; [Siebert, Uwe] Harvard TH Chan Sch Publ Hlth, Dept Hlth Policy & Management, Ctr Hlth Decis Sci, Boston, MA USA	University of the Philippines System; University of the Philippines Cebu; UMIT - Private University for Health Sciences, Medical Informatics & Technology GmbH; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard T.H. Chan School of Public Health	Jahn, B (corresponding author), UMIT Univ Hlth Sci Med Informat & Technol, Inst Publ Hlth Med Decis Making & Hlth Technol As, Dept Publ Hlth Hlth Serv Res & Hlth Technol Asses, Hall In Tirol, Austria.	beate.jahn@umit.at	Popper, Niki/AAL-6464-2021	Popper, Niki/0000-0003-4615-2774; Jahn, Beate/0000-0002-6764-6362; Siebert, Uwe/0000-0001-6425-7671	DEXHELPP (Decision Support for Health Policy and Planning: Methods, Models and Technologies based on Existing Health Care Data); BMVIT; BMWFW; OVPAA (Office of the Vice President for Academic Affairs, University of the Philippines)	DEXHELPP (Decision Support for Health Policy and Planning: Methods, Models and Technologies based on Existing Health Care Data); BMVIT; BMWFW; OVPAA (Office of the Vice President for Academic Affairs, University of the Philippines)	This project was supported in part by DEXHELPP (Decision Support for Health Policy and Planning: Methods, Models and Technologies based on Existing Health Care Data). DEXHELPP is in the frame of COMET-Competence Centers for Excellent Technologies. DEXHELPP is supported by BMVIT, BMWFW and the state Vienna. The COMET program is transacted by the FFG. In parts, this work has also been financially supported by a CREATIVE WORK AND RESEARCH GRANT by the OVPAA (Office of the Vice President for Academic Affairs, University of the Philippines). dwh GmbH provided support in the form of salaries for authors FM, NP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achee NL, 2015, PLOS NEGLECT TROP D, V9, DOI DOI 10.1371/JOURNAL.PNTD.0003655; Authority PS, STAT TABL SAMPL VAR; Bartley LM, 2002, T ROY SOC TROP MED H, V96, P387, DOI 10.1016/S0035-9203(02)90371-8; Bauer A, 2012, P INT WORKSH INN SIM, P115; Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060; Bonabeau E, 2002, P NATL ACAD SCI USA, V99, P7280, DOI 10.1073/pnas.082080899; Briggs AH, 2012, MED DECIS MAKING, V32, P722, DOI 10.1177/0272989X12458348; Brisson M, 2003, MED DECIS MAKING, V23, P76, DOI 10.1177/0272989X02239651; Bruch E, 2015, SOCIOL METHOD RES, V44, P186, DOI 10.1177/0049124113506405; Caro JJ, 2012, MED DECIS MAKING, V32, P667, DOI 10.1177/0272989X12454577; Chan M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050972; Chastel C, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00070; Chhatwal J, 2015, PHARMACOECONOMICS, V33, P423, DOI 10.1007/s40273-015-0254-2; Chikaki E, 2009, J INFECT DEV COUNTR, V3, P711, DOI 10.3855/jidc.616; Coudeville L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051244; Crooks A, 2013, DIS MODELING REFUGEE; de Soarez PC, 2019, VACCINE, V37, P2298, DOI 10.1016/j.vaccine.2019.03.026; Del Valle S, 2006, EPISIMS EPIDEMIC SIM, P06; DIETZ K, 1979, J MATH BIOL, V8, P291, DOI 10.1007/BF00276314; Eddy DM, 2012, MED DECIS MAKING, V32, P733, DOI 10.1177/0272989X12454579; Einzinger P, 2014, THESIS; Endy TP, 2002, AM J EPIDEMIOL, V156, P40, DOI 10.1093/aje/kwf005; Espinosa M, 2014, REV INST MED TROP SP, V56, P165, DOI 10.1590/S0036-46652014000200013; Eubank S, 2006, DIMACS SER DISCRET M, V70, P181; Flasche S, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002181; Gubler DJ, 1998, CLIN MICROBIOL REV, V11, P480, DOI 10.1128/CMR.11.3.480; Halstead SB, 2007, LANCET, V370, P1644, DOI 10.1016/S0140-6736(07)61687-0; HENCHAL EA, 1990, CLIN MICROBIOL REV, V3, P376, DOI 10.1128/CMR.3.4.376-396.1990; Hladish TJ, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006570; Hladish TJ, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004661; Hunink MGM, 2014, DECISION MAKING IN HEALTH AND MEDICINE: INTEGRATING EVIDENCE AND VALUES, 2ND EDITION, P1, DOI 10.1017/CBO9781139506779; Hunter E, 2017, JASSS-J ARTIF SOC S, V20, DOI 10.18564/jasss.3414; Jit M, 2011, PHARMACOECONOMICS, V29, P371, DOI 10.2165/11539960-000000000-00000; John TJ, 2000, EUR J EPIDEMIOL, V16, P601, DOI 10.1023/A:1007626510002; Kermack WO, 1927, P R SOC LOND A-CONTA, V115, P700, DOI 10.1098/rspa.1927.0118; Kim SY, 2008, PHARMACOECONOMICS, V26, P191, DOI 10.2165/00019053-200826030-00004; Klugl F, 2008, APPLIED COMPUTING 2008, VOLS 1-3, P39; Liccardo A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063935; Lipsitch M, 2002, CA ST AD DY, V2, P362; Louloudi A, 2012, FED C COMP SCI INF S; Macal CM, 2005, PROCEEDINGS OF THE 2005 WINTER SIMULATION CONFERENCE, VOLS 1-4, P2, DOI 10.1109/WSC.2005.1574234; Macal CM, 2007 WINT SIM C 2007; del Angel RM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003551; Marshall DA, 2015, VALUE HEALTH, V18, P147, DOI 10.1016/j.jval.2015.01.006; Marshall DA, 2015, VALUE HEALTH, V18, P5, DOI 10.1016/j.jval.2014.12.001; Martinez-Cerdeno V, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0030178, 10.1371/journal.pone.0041386]; McBride WJH, 2000, MICROBES INFECT, V2, P1041, DOI 10.1016/S1286-4579(00)01258-2; Miksch F, 2014, LECT NOTES COMPUT SC, V8407, P36, DOI 10.1007/978-3-642-55032-4_4; Nisalak A, 2003, AM J TROP MED HYG, V68, P191, DOI 10.4269/ajtmh.2003.68.191; Normile D, 2013, SCIENCE, V342, P415, DOI 10.1126/science.342.6157.415; North MJ, 2006, ACM T MODEL COMPUT S, V16, P1, DOI 10.1145/1122012.1122013; Oo TT, 2011, TROP BIOMED, V28, P302; Pitman R, 2012, MED DECIS MAKING, V32, P712, DOI 10.1177/0272989X12454578; Platt KB, 1997, AM J TROP MED HYG, V57, P119, DOI 10.4269/ajtmh.1997.57.119; Roberts M, 2012, MED DECIS MAKING, V32, P678, DOI [10.1177/0272989X12454941, 10.1016/j.jval.2012.06.016]; Siebert U., 2012, PUBLIC HLTH, P517; Siebert U, 2003, J HLTH EC, V4, P143, DOI DOI 10.1007/S10198-003-0205-2]; Siebert U, 2012, MED DECIS MAKING, V32, P690, DOI 10.1177/0272989X12455463; Sitepu MS, 2013, SE ASIAN J TROP MED, V44, P206; SOUTHWOOD T R E, 1972, Bulletin of the World Health Organization, V46, P211; Stahl JE, 2008, PHARMACOECONOMICS, V26, P131, DOI 10.2165/00019053-200826020-00004; Stanaway JD, 2016, LANCET INFECT DIS, V16, P712, DOI 10.1016/S1473-3099(16)00026-8; Ultsch B, 2016, PHARMACOECONOMICS, V34, P227, DOI 10.1007/s40273-015-0335-2; Wilder-Smith A, 2016, J INFECT DIS, V214, P1796, DOI 10.1093/infdis/jiw341; Wong J, 2011, J MED ENTOMOL, V48, P45, DOI 10.1603/ME10149	65	9	9	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2019	14	8							e0221564	10.1371/journal.pone.0221564	http://dx.doi.org/10.1371/journal.pone.0221564			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5WO	31454373	Green Submitted, gold, Green Published			2022-12-26	WOS:000485049000026
J	de Lamache, DD; Moges, R; Siddiq, A; Allain, T; Feener, TD; Muench, GP; McKenna, N; Yates, RM; Buret, AG				de Lamache, D. Desmonts; Moges, R.; Siddiq, A.; Allain, T.; Feener, T. D.; Muench, G. P.; McKenna, N.; Yates, R. M.; Buret, A. G.			Immuno-modulating properties of Tulathromycin in porcine monocyte-derived macrophages infected with porcine reproductive and respiratory syndrome virus	PLOS ONE			English	Article							ACTINOBACILLUS-PLEUROPNEUMONIAE; ANTIINFLAMMATORY BENEFITS; MOLECULAR-BIOLOGY; DUAL INFECTIONS; APOPTOSIS; SUSCEPTIBILITY; MECHANISMS; CD163; CELLS; PRRSV	Porcine reproductive and respiratory syndrome virus (PRRSV) is a positive-stranded RNA virus that grows in macrophages and causes acute pneumonia in pigs. PRRSV causes devastating losses to the porcine industry. However, due to its high antigenic variability and poorly understood immunopathogenesis, there is currently no effective vaccine or treatment to control PRRSV infection. The common occurrence of PRRSV infection with bacterial infections as well as its inflammatory-driven pathobiology raises the question of the value of antibiotics with immunomodulating properties for the treatment of the disease it causes. The macrolide antibiotic Tulathromycin (TUL) has been found to exhibit potent anti-inflammatory and immunomodulating properties in cattle and pigs. The aim of this study was to characterize the anti-viral and immunomodulating properties of TUL in PRRSV-infected porcine macrophages. Our findings indicate that blood monocyte-derived macrophages are readily infected by PRRSV and can be used as an effective cellular model to study PRRSV pathogenesis. TUL did not change intracellular or extracellular viral titers, not did it alter viral receptors (CD163 and CD169) expression on porcine macrophages. In contrast, TUL exhibited potent immunomodulating properties, which therefore occurred in the absence of any direct antiviral effects against PRRSV. TUL had an additive effect with PRRSV on the induction of macrophage apoptosis, and inhibited virus-induced necrosis. TUL significantly attenuated PRRSV-induced macrophage pro-inflammatory signaling (CXCL-8 and mitochondrial ROS production) and prevented PRRSV inhibition of non-opsonized and opsonized phagocytic function. Together, these data demonstrate that TUL inhibits PRRSV-induced inflammatory responses in porcine macrophages and protects against the phagocytic impairment caused by the virus. Research in live pigs is warranted to assess the potential clinical benefits of this antibiotic in the context of virally induced inflammation and tissue injury.	[de Lamache, D. Desmonts; Moges, R.; Siddiq, A.; Allain, T.; Feener, T. D.; Buret, A. G.] Univ Calgary, Dept Biol Sci, Calgary, AB, Canada; [Muench, G. P.; Yates, R. M.] Univ Calgary, Fac Vet Med, Calgary, AB, Canada; [McKenna, N.; Yates, R. M.] Univ Calgary, Dept Biochem & Mol Biol, Calgary, AB, Canada; [McKenna, N.; Yates, R. M.] Univ Calgary, Dept Comparat Biol & Expt Med, Calgary, AB, Canada	University of Calgary; University of Calgary; University of Calgary; University of Calgary	Buret, AG (corresponding author), Univ Calgary, Dept Biol Sci, Calgary, AB, Canada.	aburet@ucalgary.ca		Desmonts de Lamache, Dimitri/0000-0002-0777-6958	Margaret Gunn Endowment For Animal Health Research	Margaret Gunn Endowment For Animal Health Research	This work was supported by the Margaret Gunn Endowment For Animal Health Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MJ, 2017, ARCH VIROL, V162, P1441, DOI 10.1007/s00705-016-3215-y; Aderem A, 1999, ANNU REV IMMUNOL, V17, P593, DOI 10.1146/annurev.immunol.17.1.593; Akiyama H, 2017, J VIROL, V91, DOI 10.1128/JVI.00972-17; Albina E, 1998, VET IMMUNOL IMMUNOP, V61, P49, DOI 10.1016/S0165-2427(97)00134-7; Auray G, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156019; Beyer J, 2000, J VET MED B, V47, P9, DOI 10.1046/j.1439-0450.2000.00305.x; Brockmeier SL, 2001, AM J VET RES, V62, P521, DOI 10.2460/ajvr.2001.62.521; Buret AG, 2010, CAN J VET RES, V74, P1; Cafruny WA, 2008, VIROLOGY RES TREATME, V1, P17; Calvert JG, 2007, J VIROL, V81, P7371, DOI 10.1128/JVI.00513-07; Chaudhuri S, 2016, J GEN VIROL, V97, P669, DOI 10.1099/jgv.0.000384; Chiers K, 2010, VET RES, V41, DOI 10.1051/vetres/2010037; Chin AC, 1998, AM J VET RES, V59, P765; Chiou MT, 2000, VET MICROBIOL, V71, P9, DOI 10.1016/S0378-1135(99)00159-5; Cho JG, 2006, THERIOGENOLOGY, V66, P655, DOI 10.1016/j.theriogenology.2006.04.024; Cox SR, 2010, INT J APPL RES VET M, V8, P129; Crowley Lisa C, 2016, Cold Spring Harb Protoc, V2016, DOI 10.1101/pdb.prot087288; De Baere MI, 2012, VET RES, V43, DOI 10.1186/1297-9716-43-47; Drew TW, 2000, VET RES, V31, P27, DOI 10.1051/vetres:2000055; du Manoir JM, 2002, VET IMMUNOL IMMUNOP, V89, P175, DOI 10.1016/S0165-2427(02)00207-6; Du Y., 2011, J ANTIVIR ANTIRETROV, V3, P28, DOI DOI 10.4172/JAA.1000031; Duan X, 1997, ARCH VIROL, V142, P2483, DOI 10.1007/s007050050256; Duan X, 1997, VET MICROBIOL, V56, P9, DOI 10.1016/S0378-1135(96)01347-8; Duquette SC, 2015, AM J VET RES, V76, P507, DOI 10.2460/ajvr.76.6.507; ENGLEN MD, 1995, J IMMUNOL METHODS, V184, P281, DOI 10.1016/0022-1759(95)00136-X; Fadok VA, 1998, J CLIN INVEST, V101, P890, DOI 10.1172/JCI1112; Fadok VA, 2001, J IMMUNOL, V166, P6847, DOI 10.4049/jimmunol.166.11.6847; Fischer CD, 2013, ANTIMICROB AGENTS CH, V57, P1385, DOI 10.1128/AAC.01598-12; Fischer M, 2016, TRANSITION JUSTIC, P3; Flannagan RS, 2012, ANNU REV PATHOL-MECH, V7, P61, DOI 10.1146/annurev-pathol-011811-132445; Freeman SA, 2014, IMMUNOL REV, V262, P193, DOI 10.1111/imr.12212; Fullerton JN, 2016, NAT REV DRUG DISCOV, V15, P551, DOI 10.1038/nrd.2016.39; Gagnon CA, 2003, ARCH VIROL, V148, P951, DOI 10.1007/s00705-002-0943-y; Gomez-Laguna J, 2013, VET J, V195, P148, DOI 10.1016/j.tvjl.2012.11.012; Guo R, 2016, J VIROL, V90, P5163, DOI 10.1128/JVI.00036-16; Holtkamp DJ, 2013, J SWINE HEALTH PROD, V21, P72; Hunter CA, 2015, NAT IMMUNOL, V16, P448, DOI 10.1038/ni.3153; Jaffe A, 2001, PEDIATR PULM, V31, P464, DOI 10.1002/ppul.1076; Kanoh S, 2010, CLIN MICROBIOL REV, V23, P590, DOI 10.1128/CMR.00078-09; Keffaber K., 1989, AM ASS SWINE PRACT N, V1, P1; KIM HS, 1993, ARCH VIROL, V133, P477, DOI 10.1007/BF01313785; Lee SM, 2007, VIROLOGY, V365, P419, DOI 10.1016/j.virol.2007.04.001; Lee SM, 2005, VIROLOGY, V342, P47, DOI 10.1016/j.virol.2005.07.034; Lelkes E, 2014, TRENDS IMMUNOL, V35, P379, DOI 10.1016/j.it.2014.05.005; McWhorter FY, 2013, P NATL ACAD SCI USA, V110, P17253, DOI 10.1073/pnas.1308887110; Miller LC, 2004, VET IMMUNOL IMMUNOP, V102, P131, DOI 10.1016/j.vetimm.2004.09.004; Moges R, 2018, FRONT VET SCI, V5, DOI 10.3389/fvets.2018.00057; Nan YC, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01635; Oleksiewicz MB, 1999, VET MICROBIOL, V66, P15, DOI 10.1016/S0378-1135(98)00309-5; Opriessnig T., 2011, Animal Health Research Reviews, V12, P133, DOI 10.1017/S1466252311000120; Patton JB, 2009, VIRUS RES, V140, P161, DOI 10.1016/j.virusres.2008.12.002; Pilling D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007475; Pol JMA, 1997, VET MICROBIOL, V55, P259, DOI 10.1016/S0378-1135(96)01323-5; Prather RS, 2013, J VIROL, V87, P9538, DOI 10.1128/JVI.00177-13; Riber U, 2004, VET IMMUNOL IMMUNOP, V99, P169, DOI 10.1016/j.vetimm.2004.02.008; Rosenfeld P, 2009, CAN J VET RES, V73, P313; Sabat R, 2010, CYTOKINE GROWTH F R, V21, P331, DOI 10.1016/j.cytogfr.2010.09.002; Sassu EL, 2017, BMC VET RES, V13, DOI 10.1186/s12917-017-0979-6; Savill J, 2000, NATURE, V407, P784, DOI 10.1038/35037722; Singleton H, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00832; Snijder EJ, 1998, J GEN VIROL, V79, P961, DOI 10.1099/0022-1317-79-5-961; Snijder EJ, 2013, J GEN VIROL, V94, P2141, DOI 10.1099/vir.0.056341-0; Sulahian TH, 2000, CYTOKINE, V12, P1312, DOI 10.1006/cyto.2000.0720; Thacker EL, 1999, J CLIN MICROBIOL, V37, P620, DOI 10.1128/JCM.37.3.620-627.1999; Thanawongnuwech R, 2000, VET PATHOL, V37, P143, DOI 10.1354/vp.37-2-143; Thanawongnuwech Roongroje, 2000, Animal Health Research Reviews, V1, P95, DOI 10.1017/S1466252300000086; Van Gorp H, 2008, J GEN VIROL, V89, P2943, DOI 10.1099/vir.0.2008/005009-0; VanReeth K, 1996, VET MICROBIOL, V48, P325, DOI 10.1016/0378-1135(95)00145-X; Wang X, 2007, ARCH VIROL, V152, P289, DOI 10.1007/s00705-006-0857-1; Yu J, 2012, VET MICROBIOL, V158, P316, DOI 10.1016/j.vetmic.2012.03.001; Zhao ZZ, 2014, BIOCHEM PHARMACOL, V90, P73, DOI 10.1016/j.bcp.2014.04.015	71	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2019	14	8							e0221560	10.1371/journal.pone.0221560	http://dx.doi.org/10.1371/journal.pone.0221560			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5TR	31442273	Green Published, gold, Green Submitted			2022-12-26	WOS:000485041400049
J	O'Neill, J; Bounford, K; Anstey, A; D'Silva, J; Clark, L; Plein, S; Tayebjee, MH				O'Neill, James; Bounford, Katrina; Anstey, Alice; D'Silva, Jesvita; Clark, Lisa; Plein, Sven; Tayebjee, Muzahir H.			P wave indices, heart rate variability and anthropometry in a healthy South Asian population	PLOS ONE			English	Article							INCIDENT ATRIAL-FIBRILLATION; BODY-MASS; RISK; VOLUME; ETHNICITY; FAT; MECHANISMS; PREDICTION; DURATION; DISEASE	Background South Asians have a low prevalence of atrial fibrillation (AF) in comparison with White Europeans despite a higher burden of hypertension, diabetes mellitus and coronary artery disease. The reason for this disparity is unclear but may relate to electrophysiological or structural differences within the atria or variations in autonomic function. We aimed to assess these areas using a range of non-invasive cardiac investigations. Methods A prospective cohort study was performed on 200 South Asian and 200 Caucasian healthy volunteers aged 18-40 years. All subjects underwent electrocardiography (ECG), echocardiography and anthropometric measurements. Eighty subjects in each cohort underwent 24 hour ambulatory ECG and fifty subjects in each cohort underwent exercise testing. Results Compared with White Europeans, South Asians were of a smaller height with lower lean body mass and smaller left atrial size. They had reduced P wave dispersion and P wave terminal force in lead V-1. South Asians had a lower burden of supraventricular ectopy. They had a higher mean heart rate and South Asian males had lower heart rate variability, suggestive of sympathetic predominance. Exercise capacity was lower in South Asians. Conclusions South Asians have differences in left atrial size, P wave indices, burden of supraventricular ectopy, heart rate, heart rate variability and anthropometric measurements. These differences may relate to variations in atrial morphology, atrial electrophysiology and autonomic function and might help to explain why South Asians are less susceptible to developing AF.	[O'Neill, James; Bounford, Katrina; Anstey, Alice; D'Silva, Jesvita; Clark, Lisa; Tayebjee, Muzahir H.] Leeds Teaching Hosp NHS Trust, Leeds Gen Infirm, Dept Cardiol, Leeds, W Yorkshire, England; [Plein, Sven] Univ Leeds, MCRC, Leeds, W Yorkshire, England; [Plein, Sven] Univ Leeds, Leeds Inst Cardiovasc & Metab Med, Leeds, W Yorkshire, England	Leeds General Infirmary; University of Leeds; University of Leeds; University of Leeds	O'Neill, J (corresponding author), Leeds Teaching Hosp NHS Trust, Leeds Gen Infirm, Dept Cardiol, Leeds, W Yorkshire, England.	james.o'neill1@nhs.net			National Institute for Health Research (NIHR); Abbott; Biosense Webster; Medtronic; Boehringer Ingelheim	National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); Abbott(Abbott Laboratories); Biosense Webster; Medtronic(Medtronic); Boehringer Ingelheim(Boehringer Ingelheim)	This work was supported by the National Institute for Health Research (NIHR) Leeds Cardiovascular Clinical Research Facility. JO'N has received a fellowship from Abbott. MHT has received research/travel grants from Abbott, Biosense Webster, Medtronic and Boehringer Ingelheim. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal SK, 2017, J AM COLL CARDIOL, V69, P291, DOI 10.1016/j.jacc.2016.10.059; Bajaj HS, 2014, J OBES, V2014, DOI 10.1155/2014/461956; Bella JN, 1998, CIRCULATION, V98, P2538, DOI 10.1161/01.CIR.98.23.2538; BRUCE RA, 1973, AM HEART J, V85, P546, DOI 10.1016/0002-8703(73)90502-4; Camm AJ, 1996, CIRCULATION, V93, P1043; Chen PS, 2007, HEART RHYTHM, V4, pS61, DOI 10.1016/j.hrthm.2006.12.006; Cole CR, 1999, NEW ENGL J MED, V341, P1351, DOI 10.1056/NEJM199910283411804; Collis T, 2001, CIRCULATION, V103, P820, DOI 10.1161/01.CIR.103.6.820; Conway DSG, 2003, AM J CARDIOL, V92, P1476, DOI 10.1016/j.amjcard.2003.08.065; Dilaveris PE, 1998, AM HEART J, V135, P733, DOI 10.1016/S0002-8703(98)70030-4; DURNIN JVG, 1967, BRIT J NUTR, V21, P681, DOI 10.1079/BJN19670070; DURNIN JVGA, 1974, BRIT J NUTR, V32, P77, DOI 10.1079/BJN19740060; Eranti A, 2014, CIRC-ARRHYTHMIA ELEC, V7, P1116, DOI 10.1161/CIRCEP.114.001557; Eyre ELJ, 2013, ARCH DIS CHILD, V98, P292, DOI 10.1136/archdischild-2012-302266; Fenger-Gron M, 2017, J AM COLL CARDIOL, V69, P2488, DOI 10.1016/j.jacc.2017.03.558; Gillott RG, 2017, EUROPACE, V19, P356, DOI 10.1093/europace/euw010; Grundvold I, 2013, CIRC-ARRHYTHMIA ELEC, V6, P726, DOI 10.1161/CIRCEP.113.000267; Hoeffel EM., 2012, ASIAN POPULATION 201; Johnson LSB, 2015, HEART RHYTHM, V12, P1898, DOI 10.1016/j.hrthm.2015.04.042; KANNEL WB, 1998, AM J CARDIOL, V0082; Kirchhof P, 2016, EUR J CARDIO-THORAC, V50, pE1, DOI 10.1093/ejcts/ezw313; Larsson SC, 2014, J AM COLL CARDIOL, V64, P282, DOI 10.1016/j.jacc.2014.03.048; Lean MEJ, 2001, INT J OBESITY, V25, P1800, DOI 10.1038/sj.ijo.0801823; Lombardi F, 2004, EUR HEART J, V25, P1242, DOI 10.1016/j.ehj.2004.05.016; MOSTELLER RD, 1987, NEW ENGL J MED, V317, P1098, DOI 10.1056/nejm198710223171717; National Institute for Health and Care Excellence (Nice), 2014, ATR FIBR MAN ATR FIB; Nattel S, 2008, CIRC-ARRHYTHMIA ELEC, V1, P62, DOI 10.1161/CIRCEP.107.754564; Newton JD, 2005, HEART, V91, P1545, DOI 10.1136/hrt.2004.057935; Nielsen JB, 2015, HEART RHYTHM, V12, P1887, DOI 10.1016/j.hrthm.2015.04.026; Nistri S, 2011, EUR J ECHOCARDIOGR, V12, P826, DOI 10.1093/ejechocard/jer137; Perzanowski C, 2005, J ELECTROCARDIOL, V38, P43, DOI 10.1016/j.jelectrocard.2004.09.008; Pritchett AM, 2003, J AM COLL CARDIOL, V41, P1036, DOI 10.1016/S0735-1097(02)02981-9; Salles GF, 2014, J HYPERTENS, V32, P644, DOI 10.1097/HJH.0000000000000068; Schotten U, 2011, PHYSIOL REV, V91, P265, DOI 10.1152/physrev.00031.2009; Soliman EZ, 2013, J ELECTROCARDIOL, V46, P702, DOI 10.1016/j.jelectrocard.2013.05.006; Tsang TSM, 2001, MAYO CLIN PROC, V76, P467, DOI 10.4065/76.5.467; World Health Organization, 2017, WHO STEPS SURV MAN W; Yoshizawa T, 2014, INT HEART J, V55, P422, DOI 10.1536/ihj.14-052	38	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2019	14	8							e0220662	10.1371/journal.pone.0220662	http://dx.doi.org/10.1371/journal.pone.0220662			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5TR	31442233	Green Submitted, Green Published, gold			2022-12-26	WOS:000485041400012
J	Zhu, SS; Tian, Z; Torigoe, D; Zhao, JB; Xie, PY; Sugizaki, T; Sato, M; Horiguchi, H; Terada, K; Kadomatsu, T; Miyata, K; Oike, Y				Zhu, Shunshun; Tian, Zhe; Torigoe, Daisuke; Zhao, Jiabin; Xie, Peiyu; Sugizaki, Taichi; Sato, Michio; Horiguchi, Haruki; Terada, Kazutoyo; Kadomatsu, Tsuyoshi; Miyata, Keishi; Oike, Yuichi			Aging- and obesity-related peri-muscular adipose tissue accelerates muscle atrophy	PLOS ONE			English	Article							FOXO TRANSCRIPTION FACTORS; PLASMINOGEN-ACTIVATOR INHIBITOR-1; SARCOPENIC OBESITY; INSULIN-RESISTANCE; INFLAMMATION; HOMEOSTASIS; MECHANISM; FAT; ATROGIN-1; CELL	Sarcopenia due to loss of skeletal muscle mass and strength leads to physical inactivity and decreased quality of life. The number of individuals with sarcopenia is rapidly increasing as the number of older people increases worldwide, making this condition a medical and social problem. Some patients with sarcopenia exhibit accumulation of peri-muscular adipose tissue (PMAT) as ectopic fat deposition surrounding atrophied muscle. However, an association of PMAT with muscle atrophy has not been demonstrated. Here, we show that PMAT is associated with muscle atrophy in aged mice and that atrophy severity increases in parallel with cumulative doses of PMAT. We observed severe muscle atrophy in two different obese model mice harboring significant PMAT relative to respective control non-obese mice. We also report that denervation-induced muscle atrophy was accelerated in non-obese young mice transplanted around skeletal muscle with obese adipose tissue relative to controls transplanted with non-obese adipose tissue. Notably, transplantation of obese adipose tissue into peri-muscular regions increased nuclear translocation of FoxO transcription factors and upregulated expression FoxO targets associated with proteolysis (Atrogin1 and MuRF1) and cellular senescence (p19 and p21) in muscle. Conversely, in obese mice, PMAT removal attenuated denervation-induced muscle atrophy and suppressed upregulation of genes related to proteolysis and cellular senescence in muscle. We conclude that PMAT accumulation accelerates age- and obesity-induced muscle atrophy by increasing proteolysis and cellular senescence in muscle.	[Zhu, Shunshun; Tian, Zhe; Xie, Peiyu; Sugizaki, Taichi; Sato, Michio; Horiguchi, Haruki; Terada, Kazutoyo; Kadomatsu, Tsuyoshi; Miyata, Keishi; Oike, Yuichi] Kumamoto Univ, Grad Sch Med Sci, Dept Mol Genet, Kumamoto, Japan; [Torigoe, Daisuke] Kumamoto Univ, Div Lab Anim Sci, Kumamoto, Japan; [Zhao, Jiabin] Harbin Med Univ, Affiliated Hosp 1, Dept Emergency Surg, Harbin, Heilongjiang, Peoples R China; [Sugizaki, Taichi; Miyata, Keishi] Kumamoto Univ, Grad Sch Med Sci, Dept Immunol Allergy & Vasc Biol, Kumamoto, Japan; [Sato, Michio; Terada, Kazutoyo; Kadomatsu, Tsuyoshi; Miyata, Keishi; Oike, Yuichi] Kumamoto Univ, Ctr Metab Regulat Hlth Aging CMHA, Kumamoto, Japan; [Horiguchi, Haruki] Kumamoto Univ, IRDA, Div Kumamoto Mouse Clin, Kumamoto, Japan	Kumamoto University; Kumamoto University; Harbin Medical University; Kumamoto University; Kumamoto University; Kumamoto University	Tian, Z; Oike, Y (corresponding author), Kumamoto Univ, Grad Sch Med Sci, Dept Mol Genet, Kumamoto, Japan.; Oike, Y (corresponding author), Kumamoto Univ, Ctr Metab Regulat Hlth Aging CMHA, Kumamoto, Japan.	zhetian0118@gmail.com; oike@gpo.kumamoto-u.ac.jp	Miyata, Keishi/HGF-1876-2022	Miyata, Keishi/0000-0003-0336-1859; SATO, MICHIO/0000-0001-9339-1642	Japan Society for the Promotion of Science [17H05652]; Core Research for Evolutional Science and Technology (CREST) Program of the Japan Science and Technology Agency (JST) [13417915]; CREST Program of the Japan Agency for Medical Research and Development (AMED) [18gm0610007]; Project for Elucidating and Controlling Mechanisms of Aging and Longevity from AMED [17gm5010002]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Core Research for Evolutional Science and Technology (CREST) Program of the Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); CREST Program of the Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); Project for Elucidating and Controlling Mechanisms of Aging and Longevity from AMED	This work was supported by the Japan Society for the Promotion of Science, Grant 17H05652 (to Y.O.), the Core Research for Evolutional Science and Technology (CREST) Program of the Japan Science and Technology Agency (JST) Grant 13417915 (to Y.O.), the CREST Program of the Japan Agency for Medical Research and Development (AMED) Grant 18gm0610007 (to Y.O.), and by the Project for Elucidating and Controlling Mechanisms of Aging and Longevity from AMED Grant 17gm5010002 (to Y.O.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akima H, 2017, ARCH GERONTOL GERIAT, V70, P105, DOI 10.1016/j.archger.2017.01.014; Batsis JA, 2018, NAT REV ENDOCRINOL, V14, P513, DOI 10.1038/s41574-018-0062-9; Baumgartner RN, 2000, ANN NY ACAD SCI, V904, P437; Bouchard C, 2007, GENE DEV, V21, P2775, DOI 10.1101/gad.453107; Buford TW, 2010, AGEING RES REV, V9, P369, DOI 10.1016/j.arr.2010.04.004; Cesari M, 2005, AM J CLIN NUTR, V82, P428, DOI 10.1093/ajcn/82.2.428; Choi KM, 2016, KOREAN J INTERN MED, V31, P1054, DOI 10.3904/kjim.2016.193; Clavel S, 2006, MECH AGEING DEV, V127, P794, DOI 10.1016/j.mad.2006.07.005; Curcio F, 2016, EXP GERONTOL, V85, P1, DOI 10.1016/j.exger.2016.09.007; Doherty TJ, 2003, J APPL PHYSIOL, V95, P1717, DOI 10.1152/japplphysiol.00347.2003; DULLOO AG, 1988, AM J CLIN NUTR, V48, P1367, DOI 10.1093/ajcn/48.6.1367; Eijkelenboom A, 2013, NAT REV MOL CELL BIO, V14, P83, DOI 10.1038/nrm3507; Fabbrini E, 2010, GASTROENTEROLOGY, V139, P448, DOI 10.1053/j.gastro.2010.04.056; Fasshauer M, 2015, TRENDS PHARMACOL SCI, V36, P461, DOI 10.1016/j.tips.2015.04.014; Foletta VC, 2011, PFLUG ARCH EUR J PHY, V461, P325, DOI 10.1007/s00424-010-0919-9; Ghosh AK, 2016, ONCOTARGET, V7, P72443, DOI 10.18632/oncotarget.12494; Gumucio JP, 2013, ENDOCRINE, V43, P12, DOI 10.1007/s12020-012-9751-7; Hauck L, 2007, CIRC RES, V100, P50, DOI 10.1161/01.RES.0000254704.92532.b9; Kalinkovich A, 2017, AGEING RES REV, V35, P200, DOI 10.1016/j.arr.2016.09.008; Katayama K, 2008, ONCOGENE, V27, P1677, DOI 10.1038/sj.onc.1210813; Khan IM, 2015, INT J OBESITY, V39, P1607, DOI 10.1038/ijo.2015.104; Kumashiro N, 2011, P NATL ACAD SCI USA, V108, P16381, DOI 10.1073/pnas.1113359108; Lee JJ, 2018, AM J MED, V131, P684, DOI 10.1016/j.amjmed.2018.02.002; Mertens I, 2005, THROMB HAEMOSTASIS, V94, P1190, DOI 10.1160/TH05-01-0024; Naderi J, 2009, AM J PATHOL, V175, P763, DOI 10.2353/ajpath.2009.081009; Otowa K, 2008, CIRC J, V72, P458, DOI 10.1253/circj.72.458; Sakuma K, 2017, PFLUG ARCH EUR J PHY, V469, P573, DOI 10.1007/s00424-016-1933-3; Sandri M, 2004, CELL, V117, P399, DOI 10.1016/S0092-8674(04)00400-3; Stenholm S, 2008, CURR OPIN CLIN NUTR, V11, P693, DOI 10.1097/MCO.0b013e328312c37d; Sugizaki T, 2017, NPJ AGING MECH DIS, V3, DOI 10.1038/s41514-017-0012-0; Tamura Y, 2018, J BONE MINER METAB, V36, P148, DOI 10.1007/s00774-017-0825-8; Tang HB, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2004809; Tezze C, 2017, CELL METAB, V25, P1374, DOI 10.1016/j.cmet.2017.04.021; Tian Z, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13016; Tothova Z, 2007, CELL STEM CELL, V1, P140, DOI 10.1016/j.stem.2007.07.017; Trudel G, 2010, RADIOLOGY, V255, P434, DOI 10.1148/radiol.10091377; Tuttle LJ, 2012, INTERMUSCULAR ADIPOS, V2012, DOI [10.1155/2012/172957, DOI 10.1155/2012/172957]; Yamamoto K, 2002, P NATL ACAD SCI USA, V99, P890, DOI 10.1073/pnas.022608799; Zhao JB, 2018, J BIOL CHEM, V293, P1596, DOI 10.1074/jbc.M117.814996	39	50	51	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2019	14	8							e0221366	10.1371/journal.pone.0221366	http://dx.doi.org/10.1371/journal.pone.0221366			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5TR	31442231	Green Published, gold, Green Submitted			2022-12-26	WOS:000485041400029
J	Marchand, C; Lemay, G; Archambault, D				Marchand, Claude; Lemay, Guy; Archambault, Denis			The Jembrana disease virus Rev protein: Identification of nuclear and novel lentiviral nucleolar localization and nuclear export signals	PLOS ONE			English	Article							BOVINE IMMUNODEFICIENCY VIRUS; TARGETING SEQUENCES; TYPE-1 REV; I REX; BINDING; INFECTION; DOMAINS; SPECIFICITY; TRAFFICKING; INHIBITION	The lentiviral Rev protein, which is a regulatory protein essential for virus replication, has been first studied in the human immunodeficiency virus type 1 (HIV-1). The main function of Rev is to mediate the nuclear exportation of viral RNAs. To fulfill its function, Rev shuttles between the cytoplasm and the nucleus. The Jembrana disease virus (JDV), a lentivirus, is the etiologic agent of the Jembrana disease which was first described in Bali cattle in Indonesia in 1964. Despite the high mortality rate associated with JDV, this virus remains poorly studied. Herein the subcellular distribution of JDV Rev, the nuclear and nucleolar localization signals (NLS and NoLS, respectively) and the nuclear export signal (NES) of the protein were examined. JDV Rev fused to the enhanced green fluorescent protein (EGFP) predominantly localized to the cytoplasm and nucleolus of transfected cells, as determined by fluorescence microscopy analyses. Through transfection of a series of deletion mutants of JDV Rev, it was possible to localize the NLS/NoLS region between amino acids (aa) 74 to 105. By substituting basic residues with alanine within this sequence, we demonstrated that the JDV Rev NLS encompasses aa 76 to 86, and is exclusively composed of arginine residues, whereas a bipartite NoLS was observed for the first time in any retroviral Rev/Rev-like proteins. Finally, a NES was identified downstream of the NLS/NoLS and encompasses aa 116 to 128 of the JDV Rev protein. The JDV Rev NES was found to be of the protein kinase A inhibitor (PKI) class instead of the HIV-1 Rev class. It also corresponds to the most optimal consensus sequence of PKI NES and, as such, is novel among lentiviral Rev NES.	[Marchand, Claude; Archambault, Denis] Univ Quebec Montreal, Dept Sci Biol, Montreal, PQ, Canada; [Marchand, Claude; Lemay, Guy] Univ Montreal, Dept Microbiol Infectiol & Immunol, Montreal, PQ, Canada; [Archambault, Denis] Univ Quebec Montreal, CERMO FC, Montreal, PQ, Canada	University of Quebec; University of Quebec Montreal; Universite de Montreal; University of Quebec; University of Quebec Montreal	Archambault, D (corresponding author), Univ Quebec Montreal, Dept Sci Biol, Montreal, PQ, Canada.; Archambault, D (corresponding author), Univ Quebec Montreal, CERMO FC, Montreal, PQ, Canada.	archambault.denis@uqam.ca			National Sciences and Engineeering Research Council of Canada [RGPN-2016-06532]; Fonds de Recherche du Quebec, Nature et Technologie; Faculte des Etudes Superieures of Universite de Montreal; National Sciences and Engineering Research Council of Canada [RGPN-2016-06532]	National Sciences and Engineeering Research Council of Canada; Fonds de Recherche du Quebec, Nature et Technologie; Faculte des Etudes Superieures of Universite de Montreal; National Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was funded by an operating "Discovery" research grant from the National Sciences and Engineeering Research Council of Canada (RGPN-2016-06532) to D. Archambault.; C. Marchand was supported by a graduate studentship from the "Fonds de Recherche du Quebec, Nature et Technologie " and partial support from the "Faculte des Etudes Superieures of Universite de Montreal". This work was supported by an operating "Discovery" research grant from the National Sciences and Engineering Research Council of Canada (RGPN-2016-06532) to D. Archambault. The authors wish to thank Dr Yves Prairie, Universite du Quebec a Montreal, for his advice on statistics.	ALI SA, 1995, BIOTECHNIQUES, V18, P746; Askjaer P, 1998, J BIOL CHEM, V273, P33414, DOI 10.1074/jbc.273.50.33414; Bogerd HP, 1998, J VIROL, V72, P8627, DOI 10.1128/JVI.72.11.8627-8635.1998; CARPENTER S, 1992, J VIROL, V66, P1074, DOI 10.1128/JVI.66.2.1074-1083.1992; COCHRANE AW, 1990, J VIROL, V64, P881, DOI 10.1128/JVI.64.2.881-885.1990; Corredor AG, 2010, CURR HIV RES, V8, P2, DOI 10.2174/157016210790416343; Corredor AG, 2012, J VIROL, V86, P4892, DOI 10.1128/JVI.05132-11; Corredor AG, 2009, J VIROL, V83, P12842, DOI 10.1128/JVI.01613-09; DANG CV, 1989, J BIOL CHEM, V264, P18019; Desport M, 2010, CURR HIV RES, V8, P53, DOI 10.2174/157016210790416370; Desport M, 2009, VIROLOGY, V386, P310, DOI 10.1016/j.virol.2009.01.014; DINGWALL C, 1991, TRENDS BIOCHEM SCI, V16, P478, DOI 10.1016/0968-0004(91)90184-W; Emmott E, 2008, VIROLOGY, V380, P191, DOI 10.1016/j.virol.2008.05.032; Emmott E, 2009, EMBO REP, V10, P231, DOI 10.1038/embor.2009.14; FANKHAUSER C, 1991, MOL CELL BIOL, V11, P2567, DOI 10.1128/MCB.11.5.2567; FISCHER U, 1995, CELL, V82, P475, DOI 10.1016/0092-8674(95)90436-0; Fung HYJ, 2017, ELIFE, P6; Guttler T, 2010, NAT STRUCT MOL BIOL, V17, P1367, DOI 10.1038/nsmb.1931; Hahn MA, 2007, FEBS LETT, V581, P5070, DOI 10.1016/j.febslet.2007.09.050; Hakata Y, 2003, MOL CELL BIOL, V23, P8751, DOI 10.1128/MCB.23.23.8751-8761.2003; Harris ME, 1998, MOL CELL BIOL, V18, P3889, DOI 10.1128/MCB.18.7.3889; Henderson BR, 2000, EXP CELL RES, V256, P213, DOI 10.1006/excr.2000.4825; Henderson BR, 1997, J MOL BIOL, V274, P693, DOI 10.1006/jmbi.1997.1420; Hoffmann D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038305; HOPE TJ, 1991, J VIROL, V65, P6001, DOI 10.1128/JVI.65.11.6001-6007.1991; Horke S, 2004, J BIOL CHEM, V279, P26563, DOI 10.1074/jbc.M401017200; HUANG XJ, 1991, J VIROL, V65, P2131, DOI 10.1128/JVI.65.4.2131-2134.1991; Indik S, 2005, VIROLOGY, V337, P1, DOI 10.1016/j.virol.2005.03.040; Kempster S, 2002, ARCH VIROL, V147, P643, DOI 10.1007/s007050200014; KERTAYADNYA G, 1993, J GEN VIROL, V74, P1765, DOI 10.1099/0022-1317-74-9-1765; Kosugi S, 2009, J BIOL CHEM, V284, P478, DOI 10.1074/jbc.M807017200; KUBOTA S, 1989, BIOCHEM BIOPH RES CO, V162, P963, DOI 10.1016/0006-291X(89)90767-5; Kudo N, 1998, EXP CELL RES, V242, P540, DOI 10.1006/excr.1998.4136; la Cour T, 2004, PROTEIN ENG DES SEL, V17, P527, DOI 10.1093/protein/gzh062; LACASSE EC, 1995, NUCLEIC ACIDS RES, V23, P1647, DOI 10.1093/nar/23.10.1647; Lange A, 2007, J BIOL CHEM, V282, P5101, DOI 10.1074/jbc.R600026200; Lange A, 2010, TRAFFIC, V11, P311, DOI 10.1111/j.1600-0854.2009.01028.x; Lee JH, 2006, J VIROL, V80, P3844, DOI 10.1128/JVI.80.8.3844-3852.2006; Li RH, 2004, J BIOL CHEM, V279, P26666, DOI 10.1074/jbc.M314168200; Magin C, 2000, VIROLOGY, V274, P11, DOI 10.1006/viro.2000.0438; Mayer J, 2004, VIROLOGY, V322, P190, DOI 10.1016/j.virol.2004.01.023; McLinton EC, 2017, J GEN VIROL, V98, P563, DOI 10.1099/jgv.0.000703; Molina RP, 2002, VIROLOGY, V304, P10, DOI 10.1006/viro.2002.1688; NARAYAN O, 1989, J GEN VIROL, V70, P1617, DOI 10.1099/0022-1317-70-7-1617; Otero GC, 1998, J VIROL, V72, P7593, DOI 10.1128/JVI.72.9.7593-7597.1998; Passos-Castilho AM, 2018, VIROLOGY, V515, P158, DOI 10.1016/j.virol.2017.12.021; Pollard VW, 1998, ANNU REV MICROBIOL, V52, P491, DOI 10.1146/annurev.micro.52.1.491; Rawlinson SM, 2015, CELL MICROBIOL, V17, P1108, DOI 10.1111/cmi.12465; Romanelli MG, 2002, EUR J BIOCHEM, V269, P2727, DOI 10.1046/j.1432-1033.2002.02942.x; Salvetti A, 2014, BBA-MOL BASIS DIS, V1842, P840, DOI 10.1016/j.bbadis.2013.12.010; Snider TG, 2003, COMP IMMUNOL MICROB, V26, P1, DOI 10.1016/S0147-9571(02)00022-X; STABEL JR, 1995, VET IMMUNOL IMMUNOP, V45, P211, DOI 10.1016/0165-2427(94)05348-V; Stewart ME, 2008, VIRUS RES, V135, P336, DOI 10.1016/j.virusres.2008.03.017; Tenaya IWM, 2012, VET IMMUNOL IMMUNOP, V149, P167, DOI 10.1016/j.vetimm.2012.06.013; WILCOX GE, 1992, VET MICROBIOL, V33, P367, DOI 10.1016/0378-1135(92)90064-Z; Yang J, 1999, P NATL ACAD SCI USA, V96, P13404, DOI 10.1073/pnas.96.23.13404	56	3	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2019	14	8							e0221505	10.1371/journal.pone.0221505	http://dx.doi.org/10.1371/journal.pone.0221505			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5RZ	31437223	Green Submitted, Green Published, gold			2022-12-26	WOS:000485036900080
J	Timmermann, T; Poupin, MJ; Vega, A; Urrutia, C; Ruz, GA; Gonzalez, B				Timmermann, Tania; Josefina Poupin, Maria; Vega, Andrea; Urrutia, Cristobal; Ruz, Gonzalo A.; Gonzalez, Bernardo			Gene networks underlying the early regulation of Paraburkholderia phytofirmans PsJN induced systemic resistance in Arabidopsis	PLOS ONE			English	Article							GROWTH-PROMOTING RHIZOBACTERIA; SYRINGAE PV. TOMATO; TRANSCRIPTION FACTORS; PSEUDOMONAS-SYRINGAE; PLANT-RESPONSES; OXIDATIVE STRESS; LEAF SENESCENCE; INNATE IMMUNITY; SALICYLIC-ACID; JASMONIC ACID	Plant defense responses to biotic stresses are complex biological processes, all governed by sophisticated molecular regulations. Induced systemic resistance (ISR) is one of these defense mechanisms where beneficial bacteria or fungi prime plants to resist pathogens or pest attacks. In ISR, the defense arsenal in plants remains dormant and it is only triggered by an infection, allowing a better allocation of plant resources. Our group recently described that the well-known beneficial bacterium Paraburkholderia phytofirmans PsJN is able to induce Arabidopsis thaliana resistance to Pseudomonas syringae pv. tomato (Pst) DC3000 through ISR, and that ethylene, jasmonate and salicylic acid are involved in this protection. Nevertheless, the molecular networks governing this beneficial interaction remain unknown. To tackle this issue, we analyzed the temporal changes in the transcriptome of PsJN-inoculated plants before and after being infected with Pst DC3000. These data were used to perform a gene network analysis to identify highly connected transcription factors. Before the pathogen challenge, the strain PsJN regulated 405 genes (corresponding to 1.8% of the analyzed genome). PsJN-inoculated plants presented a faster and stronger transcriptional response at 1-hour post infection (hpi) compared with the non-inoculated plants, which presented the highest transcriptional changes at 24 hpi. A principal component analysis showed that PsJN-induced plant responses to the pathogen could be differentiated from those induced by the pathogen itself. Forty-eight transcription factors were regulated by PsJN at 1 hpi, and a system biology analysis revealed a network with four clusters. Within these clusters LHY, WRKY28, MYB31 and RRTF1 are highly connected transcription factors, which could act as hub regulators in this interaction. Concordantly with our previous results, these clusters are related to jasmonate, ethylene, salicylic, acid and ROS pathways. These results indicate that a rapid and specific response of PsJN-inoculated plants to the virulent DC3000 strain could be the pivotal element in the protection mechanism.	[Timmermann, Tania; Josefina Poupin, Maria; Urrutia, Cristobal; Ruz, Gonzalo A.; Gonzalez, Bernardo] Univ Adolfo Ibanez, Lab Bioingn, Fac Ingn & Ciencias, Santiago, Chile; [Timmermann, Tania; Josefina Poupin, Maria; Urrutia, Cristobal; Ruz, Gonzalo A.; Gonzalez, Bernardo] Ctr Appl Ecol & Sustainabil CAPES, Santiago, Chile; [Vega, Andrea] Millennium Inst Integrat Biol iBio, Santiago, Chile; [Vega, Andrea] Pontificia Univ Catolica Chile, Dept Genet Mol & Microbiol, Santiago, Chile	Universidad Adolfo Ibanez; Pontificia Universidad Catolica de Chile	Gonzalez, B (corresponding author), Univ Adolfo Ibanez, Lab Bioingn, Fac Ingn & Ciencias, Santiago, Chile.; Gonzalez, B (corresponding author), Ctr Appl Ecol & Sustainabil CAPES, Santiago, Chile.	bernardo.gonzalez@uai.cl	González, Bernardo/AAW-9578-2021; Vega, Andrea/J-2961-2016; Ruz, Gonzalo A./AAD-1799-2021; Vega, Andrea/Y-1874-2019	Vega, Andrea/0000-0003-0841-5713; Vega, Andrea/0000-0003-0841-5713; Gonzalez, Bernardo/0000-0003-1711-1471; Ruz, Gonzalo/0000-0001-7740-9865; Poupin, Maria Josefina/0000-0002-7355-7120	FONDECYT [1151130, 1190634]; CONICYT [PIA/BASAL FB0002]; National Commission for Science and Technology, CONICYT, Chile	FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); CONICYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)); National Commission for Science and Technology, CONICYT, Chile	FONDECYT grants 1151130 (B.G) and 1190634 (M.J.P.) and CONICYT PIA/BASAL FB0002 (B.G. and M.J.P.) funded this research. T. Timmermann was supported by a Ph.D. fellowship from the National Commission for Science and Technology, CONICYT, Chile. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allu AD, 2016, EMBO REP, V17, P1578, DOI 10.15252/embr.201642197; Aoki Y, 2016, PLANT CELL PHYSIOL, V57, DOI 10.1093/pcp/pcv165; Apel K, 2004, ANNU REV PLANT BIOL, V55, P373, DOI 10.1146/annurev.arplant.55.031903.141701; Atkinson NJ, 2013, PLANT PHYSIOL, V162, P2028, DOI 10.1104/pp.113.222372; Babalola OO, 2010, BIOTECHNOL LETT, V32, P1559, DOI 10.1007/s10529-010-0347-0; Babitha KC, 2013, TRANSGENIC RES, V22, P327, DOI 10.1007/s11248-012-9645-8; Bakker PAHM, 2018, CELL, V172, P1178, DOI 10.1016/j.cell.2018.02.024; Bakshi M, 2014, PLANT SIGNAL BEHAV, V9, DOI 10.4161/psb.27700; Balmer A, 2015, TRENDS PLANT SCI, V20, P443, DOI 10.1016/j.tplants.2015.04.002; Barka EA, 2006, APPL ENVIRON MICROB, V72, P7246, DOI 10.1128/AEM.01047-06; Beneduzi A, 2012, GENET MOL BIOL, V35, P1044, DOI 10.1590/S1415-47572012000600020; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berri S, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-120; Bhattacharyya PN, 2012, WORLD J MICROB BIOT, V28, P1327, DOI 10.1007/s11274-011-0979-9; Bindea G, 2009, BIOINFORMATICS, V25, P1091, DOI 10.1093/bioinformatics/btp101; Bouain N, 2018, PLOS GENET, V14, DOI 10.1371/journal.pgen.1007304; Boyes DC, 2001, PLANT CELL, V13, P1499, DOI 10.1105/tpc.13.7.1499; Breitling R, 2004, FEBS LETT, V573, P83, DOI 10.1016/j.febslet.2004.07.055; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Caarls L, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00170; Cartieaux F, 2008, MOL PLANT MICROBE IN, V21, P244, DOI 10.1094/MPMI-21-2-0244; Cecchini NM, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8658; Chen X, 2013, ADV EDUC RES, V33, P75; Chen YC, 2018, P NATL ACAD SCI USA, V115, pE4920, DOI 10.1073/pnas.1805291115; Cheng X, 2017, ENVIRON MICROBIOL, V19, P4638, DOI 10.1111/1462-2920.13927; Czechowski T, 2005, PLANT PHYSIOL, V139, P5, DOI 10.1104/pp.105.063743; DORN E, 1974, ARCH MICROBIOL, V99, P61, DOI 10.1007/BF00696222; Duke KA, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3848-6; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Esker P. D., 2012, CAB Reviews, V7, P1, DOI 10.1079/PAVSNNR20127052; Farmer EE, 2003, CURR OPIN PLANT BIOL, V6, P372, DOI 10.1016/S1369-5266(03)00045-1; Fernandez O, 2012, PLANTA, V236, P355, DOI 10.1007/s00425-012-1611-4; FROMMEL MI, 1991, PLANT PHYSIOL, V96, P928, DOI 10.1104/pp.96.3.928; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Glazebrook J, 2005, ANNU REV PHYTOPATHOL, V43, P205, DOI 10.1146/annurev.phyto.43.040204.135923; Goda H, 2004, PLANT PHYSIOL, V134, P1555, DOI 10.1104/pp.103.034736; Golldack D, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00151; Gust AA, 2007, J BIOL CHEM, V282, P32338, DOI 10.1074/jbc.M704886200; Hao DY, 1998, J BIOL CHEM, V273, P26857, DOI 10.1074/jbc.273.41.26857; Hartmann M, 2018, CELL, V173, P456, DOI 10.1016/j.cell.2018.02.049; Huang W, 2012, SCIENCE, V336, P75, DOI 10.1126/science.1219075; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Ismail A, 2014, J EXP BOT, V65, P2963, DOI 10.1093/jxb/eru159; Issa A, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.01397; Janiak A, 2018, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.02212; Jiang CH, 2016, J EXP BOT, V67, P157, DOI 10.1093/jxb/erv445; Jin JP, 2017, NUCLEIC ACIDS RES, V45, pD1040, DOI 10.1093/nar/gkw982; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Poupin MJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069435; Julkowska MM, 2015, TRENDS PLANT SCI, V20, P586, DOI 10.1016/j.tplants.2015.06.008; Katari MS, 2010, PLANT PHYSIOL, V152, P500, DOI 10.1104/pp.109.147025; Kim HJ, 2014, J EXP BOT, V65, P4023, DOI 10.1093/jxb/eru112; Kurepin LV, 2015, PLANT GROWTH REGUL, V75, P199, DOI 10.1007/s10725-014-9944-6; Ledger T, 2016, FRONT MICROBIOL, V7, P1, DOI [10.3389/fmicb.2016.00001, DOI 10.3389/FMICB.2016.00001]; Li Z, 2018, CURR BIOL, V28, P630, DOI 10.1016/j.cub.2018.01.001; Li ZH, 2013, PLANT CELL, V25, P3311, DOI 10.1105/tpc.113.113340; Llorca CM, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00169; Lyou SH, 2009, MOL CELLS, V27, P75, DOI 10.1007/s10059-009-0007-1; Mathys J, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00108; Matsuo M, 2015, MOL PLANT, V8, P1253, DOI 10.1016/j.molp.2015.03.011; Miotto-Vilanova L, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01236; Mishina TE, 2006, PLANT PHYSIOL, V141, P1666, DOI 10.1104/pp.106.081257; Morris JH, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-436; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Naveed M, 2014, ENVIRON EXP BOT, V97, P30, DOI 10.1016/j.envexpbot.2013.09.014; Naznin HA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086882; Nie PP, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00238; Niu DD, 2011, MOL PLANT MICROBE IN, V24, P533, DOI 10.1094/MPMI-09-10-0213; Niu DD, 2016, BIOCHEM BIOPH RES CO, V469, P120, DOI 10.1016/j.bbrc.2015.11.081; O'Malley RC, 2016, CELL, V165, P1280, DOI 10.1016/j.cell.2016.04.038; Obayashi T, 2014, PLANT CELL PHYSIOL, V55, DOI 10.1093/pcp/pct178; Oerke EC, 2006, J AGR SCI, V144, P31, DOI 10.1017/S0021859605005708; Pangesti N, 2016, J CHEM ECOL, V42, P1212, DOI 10.1007/s10886-016-0787-7; Perez-Rodriguez P, 2010, NUCLEIC ACIDS RES, V38, pD822, DOI 10.1093/nar/gkp805; Phukan UJ, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00760; Pieterse CMJ, 2009, NAT CHEM BIOL, V5, P308, DOI 10.1038/nchembio.164; Pinedo I, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00466; Poupin MJ, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00492; Poupin MJ, 2007, GENE, V404, P10, DOI 10.1016/j.gene.2007.08.005; Pruneda-Paz JL, 2010, TRENDS PLANT SCI, V15, P259, DOI 10.1016/j.tplants.2010.03.003; Raychaudhuri S, 2000, Pac Symp Biocomput, P455; Richards KD, 1998, PLANT PHYSIOL, V116, P409, DOI 10.1104/pp.116.1.409; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Sasaki-Sekimoto Y, 2013, PLANT PHYSIOL, V163, P291, DOI 10.1104/pp.113.220129; Sawana A, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00429; Schlaich NL, 2007, TRENDS PLANT SCI, V12, P412, DOI 10.1016/j.tplants.2007.08.009; Sessitsch A, 2005, INT J SYST EVOL MICR, V55, P1187, DOI 10.1099/ijs.0.63149-0; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Singh KB, 2002, CURR OPIN PLANT BIOL, V5, P430, DOI 10.1016/S1369-5266(02)00289-3; Sparks TC, 2017, PEST MANAG SCI, V73, P672, DOI 10.1002/ps.4457; Stringlis IA, 2018, P NATL ACAD SCI USA, V115, pE5213, DOI 10.1073/pnas.1722335115; Stringlis IA, 2018, PLANT J, V93, P166, DOI 10.1111/tpj.13741; Su F, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00810; Su G, 2010, BIOINFORMATICS, V26, P3135, DOI 10.1093/bioinformatics/btq596; Supek F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021800; Theocharis A, 2012, MOL PLANT MICROBE IN, V25, P241, DOI 10.1094/MPMI-05-11-0124; Thimm O, 2004, PLANT J, V37, P914, DOI 10.1111/j.1365-313X.2004.02016.x; Thomma BPHJ, 2001, CURR OPIN IMMUNOL, V13, P63, DOI 10.1016/S0952-7915(00)00183-7; Timmermann T, 2017, MOL PLANT MICROBE IN, V30, P215, DOI 10.1094/MPMI-09-16-0192-R; van de Mortel JE, 2012, PLANT PHYSIOL, V160, P2173, DOI 10.1104/pp.112.207324; Van der Does D, 2013, PLANT CELL, V25, P744, DOI 10.1105/tpc.112.108548; Van der Ent S, 2008, PLANT PHYSIOL, V146, P1293, DOI 10.1104/pp.107.113829; Van der Ent S, 2009, NEW PHYTOL, V183, P419, DOI 10.1111/j.1469-8137.2009.02851.x; van Hulten M, 2006, P NATL ACAD SCI USA, V103, P5602, DOI 10.1073/pnas.0510213103; van Loon LC, 2007, EUR J PLANT PATHOL, V119, P243, DOI 10.1007/s10658-007-9165-1; van Loon LC, 1998, ANNU REV PHYTOPATHOL, V36, P453, DOI 10.1146/annurev.phyto.36.1.453; Verhagen BWM, 2004, MOL PLANT MICROBE IN, V17, P895, DOI 10.1094/MPMI.2004.17.8.895; Verma V, 2016, BMC PLANT BIOL, V16, DOI 10.1186/s12870-016-0771-y; Vlot AC, 2009, ANNU REV PHYTOPATHOL, V47, P177, DOI 10.1146/annurev.phyto.050908.135202; Wang BX, 2015, PLANT PHYSIOL BIOCH, V86, P16, DOI 10.1016/j.plaphy.2014.11.008; Wang SN, 2018, MOL PLANT MICROBE IN, V31, P311, DOI 10.1094/MPMI-10-17-0240-R; Wang YQ, 2005, MOL PLANT MICROBE IN, V18, P385, DOI 10.1094/MPMI-18-0385; Weston DJ, 2012, MOL PLANT MICROBE IN, V25, P765, DOI 10.1094/MPMI-09-11-0253; Windram O, 2014, ANNU REV PHYTOPATHOL, V52, P93, DOI 10.1146/annurev-phyto-102313-050103; Wu GW, 2018, MOL PLANT MICROBE IN, V31, P560, DOI [10.1094/MPMI-11-17-0273-R, 10.1094/mpmi-11-17-0273-r]; Zamioudis C, 2014, NEW PHYTOL, V204, P368, DOI 10.1111/nph.12980; Zarei A, 2011, PLANT MOL BIOL, V75, P321, DOI 10.1007/s11103-010-9728-y; Zhang XH, 2017, PLANT PHYSIOL, V173, P1824, DOI 10.1104/pp.16.01494	118	11	11	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2019	14	8							e0221358	10.1371/journal.pone.0221358	http://dx.doi.org/10.1371/journal.pone.0221358			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5RZ	31437216	Green Submitted, gold, Green Published			2022-12-26	WOS:000485036900060
J	Ortega-Morales, AI; Zavortink, TJ; Garza-Hernandez, JA; Siller-Rodriguez, QK; Fernandez-Salas, I				Ortega-Morales, Aldo, I; Zavortink, Thomas J.; Alfonso Garza-Hernandez, Javier; Siller-Rodriguez, Quetzaly K.; Fernandez-Salas, Ildefonso			The mosquitoes (Diptera: Culicidae) of Nuevo Leon, Mexico, with descriptions of two new species	PLOS ONE			English	Article							WEST-NILE-VIRUS	To document the diversity and distribution of mosquitoes inhabiting the Mexican state of Nuevo Leon, collection trips were conducted to all physiographic regions (Grand Northamerican Plains, Coastal Plain of North Gulf, and Sierra Madre Oriental) and subregions across the state. A total of 3,176 specimens were collected. Additionally, we re-examined mosquito specimens in two Mexican entomological collections: The Collection of Insects and Mites of Medical Importance and the Collection of Arthropods of Medical Importance. These represent the two culicid subfamilies Anophelinae and Culicinae, 8 tribes, 12 genera, 25 subgenera, and 64 named species. Of these, 1 tribe, 2 genera, 5 subgenera, and 14 species are new records for the mosquito fauna of Nuevo Leon. Three undescribed species were collected. Two are described in this study: Aedes (Ochlerotatus) amateuri Ortega & Zavortink n. sp., and Aedes (Protomacleaya) lewnielseni Ortega & Zavortink n. sp. The third belongs to the genus Wyeomyia. Twelve species previously recorded from Nuevo Leon were not collected during this study. Taxonomic notes, new distribution limits, and comments about the medical importance of some species are reported.	[Ortega-Morales, Aldo, I] Univ Autonoma Agr Antonio Narro, Unidad Laguna, Dept Parasitol, Torreon, Coahuila, Mexico; [Zavortink, Thomas J.] Univ Calif Davis, Bohart Museum Entomol, Davis, CA 95616 USA; [Alfonso Garza-Hernandez, Javier] Univ Autonoma Ciudad Juarez, Inst Ciencias Biomed, Ciudad Juarez, Chihuahua, Mexico; [Siller-Rodriguez, Quetzaly K.] Univ Juarez Estado Durango, Fac Ciencias Biol, Gomez Palacio, Durango, Mexico; [Fernandez-Salas, Ildefonso] Inst Nacl Salud Publ, Ctr Invest Salud Publ, Tapachula, Chiapas, Mexico	University of California System; University of California Davis; Universidad Autonoma de Ciudad Juarez; Universidad Juarez del Estado de Durango; Instituto Nacional de Salud Publica	Garza-Hernandez, JA (corresponding author), Univ Autonoma Ciudad Juarez, Inst Ciencias Biomed, Ciudad Juarez, Chihuahua, Mexico.	biolgarza@gmail.com	Garza-Hernandez, Javier A./AAQ-6167-2021	Garza-Hernandez, Javier A./0000-0001-9580-2126; Siller, Quetzaly Karmy/0000-0003-2305-4856	Comision Nacional para el Conocimiento y Uso de la Biodiversidad (CONABIO) [GT018]	Comision Nacional para el Conocimiento y Uso de la Biodiversidad (CONABIO)	We thank Comision Nacional para el Conocimiento y Uso de la Biodiversidad (CONABIO), for financial supporting to performed some collectiion trips (Project's name: Catalogo Digital y Clave Ilustrada de los mosquitos (Diptera: Culicidae) de las zonas aridas de los estados de Nuevo Leon y Tamaulipas); Grant No. GT018. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARNELL J H, 1976, Contributions of the American Entomological Institute, V13, P1; Blitvich BJ, 2004, EMERG INFECT DIS, V10, P1314; Carpenter S. J., 1955, MOSQUITOES N AM N ME; Contreras-Balderas S, 1995, LISTADO PRELIMINAR F; COQUILLETT DW, 1904, P ENTOMOLOGICAL SOC, V6, P166; Darsie RFJ, 2005, IDENTIFICATION GEOGR; Diaz-Najera A., 1973, Revista invest Salud Publ, V33, P111; Direccion General de Epidemiologia, 2017, CAS CONF INF VIR ZIK; Dyar H. G., 1920, Insecutor Inscitiae Menstruus, V8; DYAR H. G., 1922, Proceedings of the United States National Museum, VIxii, P1; Dyar H. G., 1922, Insecutor Inscitiae Menstruus Washington DC, V10, P51; DYAR H. G., 1928, The Mosquitoes of the Americas.; EADS R. B., 1957, MOSQUITO NEWS, V17, P86; Elizondo-Quiroga A., 2002, THESIS; Elizondo-Quiroga D, 2005, EMERG INFECT DIS, V11, P1449, DOI 10.3201/eid1109.050121; Harbach R.E., 1980, TAXONOMISTS GLOSSARY; HEINEMANN S J, 1977, Mosquito Systematics, V9, P483; Ibanez-Bernal Sergio, 1995, Folia Entomologica Mexicana, V92, P43; MARTINI E., 1935, DEPT SALUBRIDAD PUBLICA BOL TECN SER A ENT MED Y PARASITOL, V1, P1; Orta Pensina Hector, 2001, Journal of the American Mosquito Control Association, V17, P260; Ortega-Morales AI, 2015, J MED ENTOMOL, V52, P171, DOI 10.1093/jme/tju008; Pan American Health Organization (PAHO), 2017, EP UPD YELL FEV 2 AU; Perez-Narvaez OA, 2005, THESIS; Quiroz-Martinez H, 1975, LISTA PREELIMINAR IN; Sanchez-Torres, 1984, THESIS; Sanchez-Trinidad A, 2014, J VECTOR ECOL, V39, P134, DOI 10.1111/j.1948-7134.2014.12079.x; Belkin J. N, 1970, Contr Am ent Inst, V6, P1; Secretaria de Gobernacion, 2002, NOM032SSA22002 SECR; Secretaria de Gobernacion, 2010, NOM032SSA22010 SECR; Solis-Santamarina IA., 1999, THESIS; TRAPIDO H, 1956, SCIENCE, V123, P634, DOI 10.1126/science.123.3198.634; Vargas L., 1956, Revista del Instituto de Salubridad y Enfermedades Tropicales Mexico, V16, P19; Vargas L., 1956, ANOFELINOS MEXICANOS; Walter Reed Biosystematics Unit, 2015, SYSTEMATIC CATALOG C; WOOD DM, 1979, MOSQUITOES CANADA DI; Zarate-Nahon E, 2008, THESIS; Zavortink T.J., 1972, CONTRIB AM ENTOMOLI, V8, P1; Zavortink TJ, 2009, P ENTOMOL SOC WASH, V111, P890, DOI 10.4289/0013-8797-111.4.890	38	9	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2019	14	8							e0217694	10.1371/journal.pone.0217694	http://dx.doi.org/10.1371/journal.pone.0217694			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5QN	31433813	Green Submitted, Green Published, gold			2022-12-26	WOS:000485033100003
J	Francksen, RM; Aebischer, NJ; Ludwig, SC; Baines, D; Whittingham, MJ				Francksen, Richard M.; Aebischer, Nicholas J.; Ludwig, Sonja C.; Baines, David; Whittingham, Mark J.			Measures of predator diet alone may underestimate the collective impact on prey: Common buzzard Buteo buteo consumption of economically important red grouse Lagopus lagopus scotica	PLOS ONE			English	Article							HARRIER CIRCUS-CYANEUS; ASSESSING RAPTOR DIET; HEN-HARRIERS; FUNCTIONAL-RESPONSES; BIRDS; POPULATIONS; MANAGEMENT; CONFLICT; CONSERVATION; PHEASANTS	Human-wildlife conflicts often centre on economic loss caused by wildlife. Yet despite being a major issue for land-managers, estimating total prey losses to predation can be difficult. Estimating impacts of protected wildlife on economically important prey can also help management decisions to be evidence-led. The recovery in population and range of common buzzards Buteo buteo in Britain has brought them into conflict with some gamebird interests. However, the magnitude of any impact is poorly understood. We used bioenergetics models that combine measures of buzzard abundance from field surveys with diets assessed by using cameras at nests, prey remains and pellet analysis, to estimate their impact on red grouse Lagopus lagopus scotica on a large (115 km(2)) moor managed for red grouse shooting in Scotland. Whilst grouse consumption by individual buzzards was lower than previous estimates for other raptor species present on our study site, total consumption could be greater given an estimated 55-73 buzzards were present on the study site year-round. Averaging across diet assessment methods, consumption models estimated that during each of three breeding seasons (April-July 2011-2013), the buzzards foraging on our study site consumed 73-141 adult grouse and 77-185 chicks (depending on year). This represented 5-11% of adult grouse present in April (22-67% of estimated adult mortality) and 2-5% of chicks that hatched (3-9% of estimated chick mortality). During two non-breeding seasons (August-March), consumption models using pellet analysis estimated that buzzards ate a total of 242-400 grouse, equivalent to 7-11% of those present at the start of August and 14-33% of estimated grouse mortality during the non-breeding season. Buzzard consumption of grouse has the potential to lead to non-trivial economic loss to grouse managers, but only if buzzards predated the grouse they ate, and if grouse mortality is additive to other causes.	[Francksen, Richard M.; Whittingham, Mark J.] Newcastle Univ, Sch Nat & Environm Sci, Newcastle Upon Tyne, Tyne & Wear, England; [Aebischer, Nicholas J.] Game & Wildlife Conservat Trust, Fordingbridge, Hants, England; [Ludwig, Sonja C.; Baines, David] Game & Wildlife Conservat Trust, Barnard Castle, Co Durham, England	Newcastle University - UK	Francksen, RM (corresponding author), Newcastle Univ, Sch Nat & Environm Sci, Newcastle Upon Tyne, Tyne & Wear, England.	richard.francksen@ncl.ac.uk	Francksen, Richard/AAO-4526-2021; Aebischer, Nicholas J/AAU-9285-2021	Francksen, Richard/0000-0002-1180-726X; Ludwig, Sonja/0000-0003-3209-0568	Game & Wildlife Conservation Trust; Scottish Natural Heritage; Royal Society for the Protection of Birds; Natural England; Buccleuch Estates	Game & Wildlife Conservation Trust; Scottish Natural Heritage; Royal Society for the Protection of Birds; Natural England; Buccleuch Estates	This study was conducted as part of the Langholm Moor Demonstration Project (http://www.langholmproject.com/), which was funded by the Game & Wildlife Conservation Trust (https://www.gwct.org.uk/), Scottish Natural Heritage (https://www.nature.scot/), Buccleuch Estates https://www.buccleuch.com/), Royal Society for the Protection of Birds (https://www.rspb.org.uk/), and Natural England (https://www.gov.uk/naturalengland).RF was supported by a Ph.D. studentship funded by the Game & Wildlife Conservation Trust, Scottish Natural Heritage, Buccleuch Estates and Natural England. Other than from individual authors named on the manuscript and those in the Acknowledgments, the funders had no role in study design, data collection, analysis, or preparation of the manuscript.	Allen BL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036426; [Anonymous], 1982, ESTIMATION ANIMAL AB; [Anonymous], 2015, EUR J WILDLIFE RES, V61, P181, DOI [10.1007/s10344-014-0893-1, DOI 10.1007/S10344-014-0893-1]; Aulagnier S., 2009, MAMMALS EUROPE N AFR; Austin G, 1997, BIRD STUDY, V44, P146, DOI 10.1080/00063659709461050; Baines D, 2008, IBIS, V150, P27, DOI 10.1111/j.1474-919X.2008.00848.x; Bairlein F, 1999, P 22 INT ORN C S AFR; Balmer D., 2014, BIRD ATLAS 2007 1 I; BARTON NWH, 1993, IBIS, V135, P363, DOI 10.1111/j.1474-919X.1993.tb02107.x; CORNELL H, 1976, AM NAT, V110, P317, DOI 10.1086/283068; Crocker RE, 2002, PN0908; Dare P., 1961, THESIS; Dare P., 2015, LIFE BUZZARDS; Douglas DJT, 2015, BIOL CONSERV, V191, P243, DOI 10.1016/j.biocon.2015.06.014; Elston DA, 2014, J APPL ECOL, V51, P1236, DOI 10.1111/1365-2664.12315; Francksen RM, 2017, IBIS, V159, P541, DOI 10.1111/ibi.12471; Francksen RM, 2016, BIRD STUDY, V63, P525, DOI 10.1080/00063657.2016.1238868; Francksen RM, 2016, BIRD STUDY, V63, P303, DOI 10.1080/00063657.2016.1183111; Francksen RM., 2016, THESIS; GRAHAM IM, 1995, BIRD STUDY, V42, P165, DOI 10.1080/00063659509477162; Gremillet D, 2003, J APPL ECOL, V40, P266, DOI 10.1046/j.1365-2664.2003.00806.x; Hardey J., 2013, RAPTORS FIELD GUIDE; Hodgson ID, 2018, LAND USE POLICY, V77, P332, DOI 10.1016/j.landusepol.2018.05.042; KENWARD RE, 1981, J WILDLIFE MANAGE, V45, P397, DOI 10.2307/3807921; Kenward RE, 2001, J APPL ECOL, V38, P813, DOI 10.1046/j.1365-2664.2001.00636.x; Kenward RE, 2000, OIKOS, V91, P271, DOI 10.1034/j.1600-0706.2000.910207.x; KORPIMAKI E, 1991, ECOLOGY, V72, P814, DOI 10.2307/1940584; Lees AC, 2013, CONSERV LETT, V6, P141, DOI 10.1111/j.1755-263X.2012.00301.x; Lewis SB, 2004, WILDLIFE SOC B, V32, P373, DOI 10.2193/0091-7648(2004)32[373:ACOMFA]2.0.CO;2; Ludwig SC, 2018, BIRD STUDY, V65, P431, DOI 10.1080/00063657.2018.1519524; Ludwig SC, 2018, WILDLIFE BIOL, DOI 10.2981/wlb.00430; Ludwig SC, 2017, WILDLIFE BIOL, DOI 10.2981/wlb.00246; McKinnon L, 2013, OIKOS, V122, P1042, DOI 10.1111/j.1600-0706.2012.20708.x; Musgrove Andy, 2013, British Birds, V106, P64; Nagy KA, 1999, ANNU REV NUTR, V19, P247, DOI 10.1146/annurev.nutr.19.1.247; Newton I., 1998, POPULATION LIMITATIO; Newton I., 1979, POPULATION ECOLOGY R; Ormerod SJ, 2002, J APPL ECOL, V39, P181, DOI 10.1046/j.1365-2664.2002.00722.x; Park KJ, 2008, IBIS, V150, P9, DOI 10.1111/j.1474-919X.2008.00847.x; Penteriani V, 2011, ANIM CONSERV, V14, P233, DOI 10.1111/j.1469-1795.2010.00433.x; Phillips RA, 1999, J APPL ECOL, V36, P218, DOI 10.1046/j.1365-2664.1999.00391.x; PICOZZI N, 1978, IBIS, V120, P498, DOI 10.1111/j.1474-919X.1978.tb06814.x; Redpath S, 1997, BIRDS PREY RED GROUS; Redpath S. M., 2014, ORYX, P1; Redpath SM, 1999, J ANIM ECOL, V68, P879, DOI 10.1046/j.1365-2656.1999.00340.x; Redpath SM, 2001, CONDOR, V103, P184, DOI 10.1650/0010-5422(2001)103[0184:ARDCPP]2.0.CO;2; Redpath Steve, 2003, P499; Robertson GS, 2017, WILDLIFE BIOL, DOI 10.2981/wlb.00276; Robertson PA, 2001, WILDLIFE BIOL, V7, P11, DOI 10.2981/wlb.2001.004; Roby DD, 2003, CAN J ZOOL, V81, P250, DOI 10.1139/Z02-242; Rooney E, 2015, IBIS, V157, P181, DOI 10.1111/ibi.12218; Rooney E, 2013, BIRD STUDY, V60, P147, DOI 10.1080/00063657.2013.772085; Salamolard M, 2000, ECOLOGY, V81, P2428, DOI 10.1890/0012-9658(2000)081[2428:ROAAPT]2.0.CO;2; Selas V, 2001, CAN J ZOOL, V79, P2086, DOI 10.1139/cjz-79-11-2086; SIMMONS R E, 1991, Journal of Raptor Research, V25, P63; Slagsvold T, 2010, J AVIAN BIOL, V41, P488, DOI 10.1111/j.1600-048X.2010.05081.x; Snow D.W., 1998, BIRDS W PALAEARCTIC, V1 and 2; Sotherton N, 2009, J APPL ECOL, V46, P955, DOI 10.1111/j.1365-2664.2009.01688.x; SWANN RL, 1995, BIRD STUDY, V42, P37, DOI 10.1080/00063659509477146; TATNER P, 1993, J ZOOL, V231, P215, DOI 10.1111/j.1469-7998.1993.tb01913.x; Thirgood S, 2000, CONSERV BIOL, V14, P95, DOI 10.1046/j.1523-1739.2000.99013.x; Thirgood SJ, 2000, P ROY SOC B-BIOL SCI, V267, P651, DOI 10.1098/rspb.2000.1051; Thirgood SJ, 2000, J ANIM ECOL, V69, P504, DOI 10.1046/j.1365-2656.2000.00413.x; Thomas L, 2010, J APPL ECOL, V47, P5, DOI 10.1111/j.1365-2664.2009.01737.x; Thompson PS, 2009, J APPL ECOL, V46, P950, DOI 10.1111/j.1365-2664.2009.01687.x; Tornberg Risto, 2012, International Journal of Ecology, P1; Tubbs C.R., 1974, THE BUZZARD; Valkama J, 2005, BIOL REV, V80, P171, DOI 10.1017/S146479310400658X; VICKERY PD, 1992, OIKOS, V63, P281, DOI 10.2307/3545389; Walls SS, 1998, IBIS, V140, P561, DOI 10.1111/j.1474-919X.1998.tb04700.x; Weisstein EW., CIRCULAR SECTOR MATH; Wheeler P, 2008, AGR ECOSYST ENVIRON, V123, P49, DOI 10.1016/j.agee.2007.04.003; Zarybnicka M, 2015, IBIS, V157, P459, DOI 10.1111/ibi.12265	73	4	4	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2019	14	8							e0221404	10.1371/journal.pone.0221404	http://dx.doi.org/10.1371/journal.pone.0221404			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5OC	31430344	Green Published, Green Submitted, gold			2022-12-26	WOS:000485026800047
J	Park, SH; Jeong, S; Kim, BR; Jeong, YA; Kim, JL; Na, YJ; Jo, MJ; Yun, HK; Kim, DY; Kim, BG; Lee, DH; Oh, SC				Park, Seong Hye; Jeong, Soyeon; Kim, Bo Ram; Jeong, Yoon A.; Kim, Jung Lim; Na, Yoo Jin; Jo, Min Jee; Yun, Hye Kyeong; Kim, Dae Yeong; Kim, Bu Gyeom; Lee, Dae-Hee; Oh, Sang Cheul			Activating CCT2 triggers Gli-1 activation during hypoxic condition in colorectal cancer	ONCOGENE			English	Article							ER STRESS; CHAPERONIN; CELLS; INHIBITOR; PROTEINS; TRIC/CCT; SURVIVAL; COMPLEX; GROWTH; HSP90	Hypoxia, or the deficiency of oxygen, in solid tumors is majorly responsible for the progression of cancer and remains unaffected by chemotherapy, but still requires definitive definition of the hypoxia signaling. Hypoxia disrupts the complete folding of mitochondrial proteins, leading to several diseases. The present study confirms that hypoxia activates the Hedgehog pathway in colorectal cancer (CRC), considering its role in cancer epithelial to mesenchymal transition, migration, and invasion. The activity of hypoxia-mediated Gli-1, a Hedgehog signaling factor in hypoxia, was confirmed by in vitro western blotting, immunofluorescence staining, wound-healing assay, and matrigel invasion assay, as well as by in vivo xenograft models (n = 5 per group). The Gli-1 mechanism in hypoxia was analyzed via mass spectrometry. Hypoxia enhanced the interaction of Gli-1 and T-complex protein 1 subunit beta (CCT2), as observed in the mass spectrometric analysis. We observed that reduction in CCT2 inhibits tumor induction by Gli-1. Ubiquitination-mediated Gli-1 degradation by beta-TrCP occurs during incomplete folding of Gli-1 in hypoxia. The human CRC tissues revealed greater CCT2 expression than did the normal colon tissues, indicating that higher CCT2 expression in tumor tissues from CRC patients reduced their survival rate. Moreover, we suggest that CCT2 correlates with Gli-1 expression and is an important determinant of survival in the CRC patients. The results reveal that CCT2 can regulate the folding of Gli-1 in relation to hypoxia in CRC.	[Park, Seong Hye; Jeong, Yoon A.; Na, Yoo Jin; Jo, Min Jee; Yun, Hye Kyeong; Kim, Dae Yeong; Kim, Bu Gyeom; Lee, Dae-Hee; Oh, Sang Cheul] Korea Univ, Coll Med, Grad Sch Med, Seoul, South Korea; [Jeong, Soyeon; Kim, Bo Ram; Kim, Jung Lim; Lee, Dae-Hee; Oh, Sang Cheul] Korea Univ, Guro Hosp, Dept Oncol, Seoul 152703, South Korea	Korea University; Korea University Medicine (KU Medicine); Korea University; Korea University Medicine (KU Medicine)	Lee, DH; Oh, SC (corresponding author), Korea Univ, Coll Med, Grad Sch Med, Seoul, South Korea.; Lee, DH; Oh, SC (corresponding author), Korea Univ, Guro Hosp, Dept Oncol, Seoul 152703, South Korea.	neogene@korea.ac.kr; sachoh@korea.ac.kr			National Research Foundation (NRF) of Korea - Korean government (MSIP) [NRF-2017R1A2B2011684, NRF-2018M3A9G1075561]	National Research Foundation (NRF) of Korea - Korean government (MSIP)	This work was supported by grant from the National Research Foundation (NRF) of Korea and funded by the Korean government (MSIP) (NRF-2017R1A2B2011684, NRF-2018M3A9G1075561).	Altaba ARI, 1999, TRENDS GENET, V15, P418, DOI 10.1016/S0168-9525(99)01840-5; Boudiaf-Benmammar C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060895; Briscoe J, 2013, NAT REV MOL CELL BIO, V14, P416, DOI 10.1038/nrm3598; Calderwood SK, 2006, TRENDS BIOCHEM SCI, V31, P164, DOI 10.1016/j.tibs.2006.01.006; Carr AC, 2017, ONCOTARGET, V8, P110273, DOI 10.18632/oncotarget.22681; Feldman DE, 2005, MOL CANCER RES, V3, P597, DOI 10.1158/1541-7786.MCR-05-0221; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Flamment M, 2012, TRENDS ENDOCRIN MET, V23, P381, DOI 10.1016/j.tem.2012.06.003; Gao Q, 2015, ONCOL LETT, V9, P2381, DOI 10.3892/ol.2015.2988; Guest ST, 2015, EXP CELL RES, V332, P223, DOI 10.1016/j.yexcr.2015.02.005; Hartl FU, 1996, NATURE, V381, P571, DOI 10.1038/381571a0; Huntzicker EG, 2006, GENE DEV, V20, P276, DOI 10.1101/gad.1380906; Kalisman N, 2012, P NATL ACAD SCI USA, V109, P2884, DOI 10.1073/pnas.1119472109; Kasembeli M, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001844; Kim BR, 2017, ONCOTARGET, V8, P101952, DOI 10.18632/oncotarget.21882; Koumenis C, 2006, CURR MOL MED, V6, P55, DOI 10.2174/156652406775574604; Koumenis C, 2002, MOL CELL BIOL, V22, P7405, DOI 10.1128/MCB.22.21.7405-7416.2002; KUBOTA H, 1994, CURR BIOL, V4, P89, DOI 10.1016/S0960-9822(94)00024-2; Lei JJ, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-66; Leitner A, 2012, STRUCTURE, V20, P814, DOI 10.1016/j.str.2012.03.007; Leu JIJ, 2009, MOL CELL, V36, P15, DOI 10.1016/j.molcel.2009.09.023; Melki R, 1997, BIOCHEMISTRY-US, V36, P5817, DOI 10.1021/bi962830o; Michieli P, 2009, CELL CYCLE, V8, P3291, DOI 10.4161/cc.8.20.9741; Morimoto RI, 2008, GENE DEV, V22, P1427, DOI 10.1101/gad.1657108; Pandolfi S, 2015, EXPERT REV MOL MED, V17, DOI 10.1017/erm.2015.3; Pennacchietti S, 2003, CANCER CELL, V3, P347, DOI 10.1016/S1535-6108(03)00085-0; Qualtrough D, 2015, CANCERS, V7, P1885, DOI 10.3390/cancers7030867; Roh SH, 2015, INT J MOL SCI, V16, P26706, DOI 10.3390/ijms161125975; Sergeeva OA, 2013, J BIOL CHEM M, VM112, P443929; SHUIN T, 1994, CANCER RES, V54, P2852; Teglund S, 2010, BBA-REV CANCER, V1805, P181, DOI 10.1016/j.bbcan.2010.01.003; Trinidad AG, 2013, MOL CELL, V50, P805, DOI 10.1016/j.molcel.2013.05.002; Tu BP, 2004, J CELL BIOL, V164, P341, DOI 10.1083/jcb.200311055; Varnat F, 2009, EMBO MOL MED, V1, P338, DOI 10.1002/emmm.200900039; Whitesell L, 2005, NAT REV CANCER, V5, P761, DOI 10.1038/nrc1716; Won KA, 1998, MOL CELL BIOL, V18, P7584, DOI 10.1128/MCB.18.12.7584; Workman P, 2007, NAT CHEM BIOL, V3, P455, DOI 10.1038/nchembio0807-455; Zhang K, 2015, MED ONCOL, V32, DOI 10.1007/s12032-014-0368-y	38	16	16	2	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN	2020	39	1					136	150		10.1038/s41388-019-0972-6	http://dx.doi.org/10.1038/s41388-019-0972-6			15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	KG3NM	31462707				2022-12-26	WOS:000509849200009
J	Liu, ZG; Li, N; Fang, H; Chen, XJ; Guo, YX; Gong, SH; Niu, MW; Zhou, HW; Jiang, Y; Chang, P; Chen, P				Liu, Zhanguo; Li, Na; Fang, Heng; Chen, Xiaojiao; Guo, Yuexun; Gong, Shenhai; Niu, Mengwei; Zhou, Hongwei; Jiang, Yong; Chang, Ping; Chen, Peng			Enteric dysbiosis is associated with sepsis in patients	FASEB JOURNAL			English	Article						gut microbiota; metabolomics; metaproteomics	GUT MICROBIOTA; WIDE ASSOCIATION; CRITICAL ILLNESS; INTENSIVE-CARE; LIVER-INJURY; DEFINITIONS; DYSFUNCTION; INHIBITION; METABOLISM; CIRRHOSIS	Sepsis is defined as a life-threatening organ dysfunction caused by a dysregulated host response to microbial infection. For decades, the potential role of gut microbiota in sepsis pathogenesis has been revealed. However, the systemic and functional link between gut microbiota and sepsis has remained unexplored. To address this gap in knowledge, we carried out systematic analyses on clinical stool samples from patients with sepsis, including 16S rDNA sequencing, metabolomics, and metaproteomics analyses. In addition, we performed fecal microbiota transplantation from human to mice to validate the roles of gut microbiota on sepsis progression. We found that the composition of gut microbiota was significantly disrupted in patients with sepsis compared with healthy individuals. Besides, the microbial functions were significantly altered in septic feces as identified by metabolomics and metaproteomics analyses. Interestingly, mice that received septic feces exhibited more severe hepatic inflammation and injury than mice that received healthy feces after cecal ligation and puncture. Finally, several strains of intestinal microbiota and microbial metabolites were corelated with serum total bilirubin levels in patients with sepsis. Taken together, our data indicated that sepsis development is associated with the disruption of gut microbiota at both compositional and functional levels, and such enteric dysbiosis could promote organ inflammation and injury during sepsis.	[Liu, Zhanguo; Fang, Heng; Guo, Yuexun; Chang, Ping; Chen, Peng] Southern Med Univ, Dept Intens Care Unit, Guangzhou, Peoples R China; [Chen, Xiaojiao; Zhou, Hongwei; Chen, Peng] Southern Med Univ, Microbiome Med Ctr, Guangzhou, Peoples R China; [Chen, Xiaojiao; Zhou, Hongwei] Southern Med Univ, Zhujiang Hosp, Div Lab Med, Guangzhou, Peoples R China; [Li, Na; Gong, Shenhai; Niu, Mengwei; Jiang, Yong; Chen, Peng] Southern Med Univ, Dept Pathophysiol, Guangdong Prov Key Lab Prote, Guangzhou, Peoples R China; [Li, Na; Gong, Shenhai; Niu, Mengwei; Jiang, Yong; Chen, Peng] Southern Med Univ, State Key Lab Organ Failure Res, Guangzhou, Peoples R China	Southern Medical University - China; Southern Medical University - China; Southern Medical University - China; Southern Medical University - China; Southern Medical University - China	Chang, P (corresponding author), Southern Med Univ, Zhujiang Hosp, Dept Intens Care Unit, Guangzhou 510515, Peoples R China.; Chen, P (corresponding author), Southern Med Univ, Dept Pathophysiol, Guangzhou 510515, Peoples R China.	changp963@163.com; perchen@smu.edu.cn	Zhou, Hongwei/B-4193-2008		National Science Funds for Distinguished Young Scholars of the Guangdong Province [2016A030306043]; Young Pearl Scholar of the Guangdong Province Award [81873926]; National Natural Science Foundation of China (NSFC) [81873926]; NSFCGuangdong Joint Fund of China [U1601225]; Key Science and Technology Projects Program of Guangzhou City [201607020016]; Clinical Research Startup Program of Southern Medical University by High-Level University Construction Funding of the Guangdong Provincial Department of Education [LC2019ZD014]	National Science Funds for Distinguished Young Scholars of the Guangdong Province(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); Young Pearl Scholar of the Guangdong Province Award; National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); NSFCGuangdong Joint Fund of China; Key Science and Technology Projects Program of Guangzhou City; Clinical Research Startup Program of Southern Medical University by High-Level University Construction Funding of the Guangdong Provincial Department of Education	This study was supported, in part, by the National Science Funds for Distinguished Young Scholars of the Guangdong Province (2016A030306043), the Young Pearl Scholar of the Guangdong Province Award and National Natural Science Foundation of China (NSFC) (81873926 to P.C.), the NSFCGuangdong Joint Fund of China (Grant U1601225) and Key Science and Technology Projects Program of Guangzhou City (201607020016 to Y.J.), and the Clinical Research Startup Program of Southern Medical University by High-Level University Construction Funding of the Guangdong Provincial Department of Education (LC2019ZD014 to Z.L.). Z.L., N.L., H.F., and X.C. share co-first authorship. The authors declare no conflicts of interest.	Bajaj JS, 2017, ALCOHOL CLIN EXP RES, V41, P1857, DOI 10.1111/acer.13498; Beyaert R, 2018, CELL HOST MICROBE, V23, P283, DOI 10.1016/j.chom.2018.02.007; Blasi A, 2018, HEPATOLOGY, V68, P2325, DOI 10.1002/hep.30103; Bloemen JG, 2009, CLIN NUTR, V28, P657, DOI 10.1016/j.clnu.2009.05.011; CARRICO CJ, 1986, ARCH SURG-CHICAGO, V121, P196; Chu HK, 2019, GUT, V68, P359, DOI 10.1136/gutjnl-2018-316307; DOI F, 1993, HEPATOLOGY, V17, P1086, DOI 10.1016/0270-9139(93)90127-9; Gando S, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.37; Gilbert JA, 2018, NAT MED, V24, P392, DOI 10.1038/nm.4517; Gilbert JA, 2016, NATURE, V535, P94, DOI 10.1038/nature18850; Gong SH, 2019, HEPATOLOGY, V69, P1751, DOI 10.1002/hep.30361; Gong SH, 2018, J HEPATOL, V69, P51, DOI 10.1016/j.jhep.2018.02.024; Gotts JE, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1585; Haak BW, 2017, LANCET GASTROENTEROL, V2, P135, DOI 10.1016/S2468-1253(16)30119-4; Hotchkiss RS, 2013, NAT REV IMMUNOL, V13, P862, DOI 10.1038/nri3552; Kaakoush NO, 2015, FRONT CELL INFECT MI, V5, DOI [10.3309/fcimb.2015.00004, 10.3389/fcimb.2015.00084]; Karlsson FH, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2266; Klingensmith NJ, 2016, CRIT CARE CLIN, V32, P203, DOI 10.1016/j.ccc.2015.11.004; Koeth RA, 2013, NAT MED, V19, P576, DOI 10.1038/nm.3145; Lin GL, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02147; Lynch SV, 2016, NEW ENGL J MED, V375, P2369, DOI 10.1056/NEJMra1600266; Lyons JD, 2017, PEDIATR CRIT CARE ME, V18, pS46, DOI 10.1097/PCC.0000000000001046; Mao JW, 2015, INT J CLIN EXP PATHO, V8, P3648; Meng M, 2017, CURR OPIN CRIT CARE, V23, P143, DOI 10.1097/MCC.0000000000000386; Ojima M, 2016, DIGEST DIS SCI, V61, P1628, DOI 10.1007/s10620-015-4011-3; Qin JJ, 2012, NATURE, V490, P55, DOI 10.1038/nature11450; Qin N, 2014, NATURE, V513, P59, DOI 10.1038/nature13568; Rainer F, 2018, ALIMENT PHARM THER, V47, P657, DOI 10.1111/apt.14474; Schafer C, 2002, ALCOHOL ALCOHOLISM, V37, P81, DOI 10.1093/alcalc/37.1.81; Scher JU, 2013, ELIFE, V2, DOI 10.7554/eLife.01202; Singer M, 2016, JAMA-J AM MED ASSOC, V315, P801, DOI 10.1001/jama.2016.0287; Surewaard BGJ, 2018, CELL HOST MICROBE, V24, P271, DOI 10.1016/j.chom.2018.06.017; Tripodi A, 2011, NEW ENGL J MED, V365, P147, DOI 10.1056/NEJMra1011170; Vincent JL, 2014, LANCET RESP MED, V2, P380, DOI 10.1016/S2213-2600(14)70061-X; Vincent JL, 2013, LANCET, V381, P774, DOI 10.1016/S0140-6736(12)61815-7; Wang LR, 2015, J IMMUNOL METHODS, V421, P44, DOI 10.1016/j.jim.2014.12.015; Wang ZN, 2015, CELL, V163, P1585, DOI 10.1016/j.cell.2015.11.055; Wang ZN, 2011, NATURE, V472, P57, DOI 10.1038/nature09922; Wiersinga WJ, 2014, VIRULENCE, V5, P36, DOI 10.4161/viru.25436; Wu GY, 2018, BIOCHEM BIOPH RES CO, V501, P16, DOI 10.1016/j.bbrc.2018.04.095; Wu KC, 2017, MOLECULES, V22, DOI 10.3390/molecules22040573; Yang J, 2019, NEPHROL DIAL TRANSPL, V34, P419, DOI 10.1093/ndt/gfy172; Zaborin A, 2014, MBIO, V5, DOI 10.1128/mBio.01361-14; Zeller G, 2014, MOL SYST BIOL, V10, DOI 10.15252/msb.20145645; Zhang F, 2010, AMINO ACIDS, V38, P237, DOI 10.1007/s00726-009-0233-z; Zhang X, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05357-4; Zhao KL, 2014, MOL MED REP, V10, P3185, DOI 10.3892/mmr.2014.2650; Zhou X, 2018, MICROBIOME, V6, DOI 10.1186/s40168-018-0441-4; Zhu LL, 2018, INFECT DRUG RESIST, V11, P1105, DOI 10.2147/IDR.S167616	49	37	40	3	41	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2019	33	11					12299	12310		10.1096/fj.201900398RR	http://dx.doi.org/10.1096/fj.201900398RR			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC8ZX	31465241	Green Published			2022-12-26	WOS:000507461600055
J	Xu, Y; Andrade, J; Ueberheide, B; Neel, BG				Xu, Yang; Andrade, Joshua; Ueberheide, Beatrix; Neel, Benjamin G.			Activated Thiol Sepharose-based proteomic approach to quantify reversible protein oxidation	FASEB JOURNAL			English	Article						redox regulation; PKM2; HLRCC; ATSP	TYROSINE-PHOSPHATASE 1B; TUMOR-SUPPRESSOR PTEN; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE; INACTIVATION; FUMARATE; PATHWAY; IDENTIFICATION; STABILIZATION; SUCCINATION; GENERATION	Reactive oxygen species (ROS) can act as second messengers in various signaling pathways, and abnormal oxidation contributes to multiple diseases, including cancer. Detecting and quantifying protein oxidation is crucial for a detailed understanding of reduction-oxidation reaction (redox) signaling. We developed an Activated Thiol Sepharose-based proteomic (ATSP) approach to quantify reversible protein oxidation. ATSP can enrich H2O2-sensitive thiol peptides, which are more likely to contain reactive cysteines involved in redox signaling. We applied our approach to analyze hereditary leiomyomatosis and renal cell carcinoma (HLRCC), a type of kidney cancer that harbors fumarate hydratase (FH)-inactivating mutations and has elevated ROS levels. Multiple proteins were oxidized in FH-deficient cells, including many metabolic proteins such as the pyruvate kinase M2 isoform (PKM2). Treatment of HLRCC cells with dimethyl fumarate or PKM2 activators altered PKM2 oxidation levels. Finally, we found that ATSP could detect Src homology region 2 domain-containing phosphatase-2 and PKM2 oxidation in cells stimulated with platelet-derived growth factor. This newly developed redox proteomics workflow can detect reversible oxidation of reactive cysteines and can be employed to analyze multiple physiologic and pathologic conditions.	[Xu, Yang; Neel, Benjamin G.] Univ Toronto, Univ Hlth Network, Dept Med Biophys, Toronto, ON, Canada; [Xu, Yang; Neel, Benjamin G.] Univ Toronto, Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON, Canada; [Xu, Yang; Neel, Benjamin G.] NYU, Langone Med Ctr, Laura & Isaac Perlmutter Canc Ctr, 522 First Ave,Smilow Bldg,Room 1201A, New York, NY 10016 USA; [Andrade, Joshua; Ueberheide, Beatrix] New York Univ NYU Langone Hlth, Div Adv Res Technol, Prote Lab, New York, NY USA; [Ueberheide, Beatrix] New York Univ NYU Langone Hlth, Dept Biochem & Mol Pharmacol, New York, NY USA; [Xu, Yang] Geneseeq Technol Inc, Translat Med Res Inst, Toronto, ON M5G 1L7, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; New York University; NYU Langone Medical Center; Geneseeq Technology Inc.	Neel, BG (corresponding author), NYU, Langone Med Ctr, Laura & Isaac Perlmutter Canc Ctr, 522 First Ave,Smilow Bldg,Room 1201A, New York, NY 10016 USA.	benjamin.neel@nyulangone.org	Xu, Yang/CAG-8877-2022	Xu, Yang/0000-0003-1670-6131; Ueberheide, Beatrix/0000-0003-2512-0204	NIH/NCI [R01CA49152]; Princess Margaret Cancer Foundation; Laura and Isaac Perlmutter Cancer Center Support Grant from the NCI [P30CA016087]; NIH Office of the Director [1S10OD010582-01A1]; NATIONAL CANCER INSTITUTE [P30CA016087, R01CA049152] Funding Source: NIH RePORTER	NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Princess Margaret Cancer Foundation(University of Toronto); Laura and Isaac Perlmutter Cancer Center Support Grant from the NCI; NIH Office of the Director(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors thank Dr. Nicholas Tonks (Cold Spring Harbor Laboratory, Cold Spring Harbor, NY, USA) for providing Rat1 cells, and Dr. W. Marston Linehan [U.S. National Institutes of Health (NIH) National Cancer Institute (NCI)] for providing HLRCC cells. This work was supported by NIH/NCI Grant R01CA49152 (to B.G.N.) and the Princess Margaret Cancer Foundation. The mass spectrometric analysis is, in part, supported by the Laura and Isaac Perlmutter Cancer Center Support Grant P30CA016087 from the NCI, and a shared instrumentation grant from the NIH Office of the Director (1S10OD010582-01A1) for the purchase of an Orbitrap Fusion Lumos Mass Spectrometer. B.G.N. is a cofounder of, receives consulting fees from, and holds equity in Northern Biologics (Toronto, ON, Canada) and Navire Pharma (San Francisco, CA, USA). He also is an expert witness for Johnson and Johnson (New Brunswick, NJ, USA). His spouse holds equity in Mirati Therapeutics (San Diego, CA, USA) and Array BioPharma (Boulder, CO, USA). Y.X. is an employee of Geneseeq. The remaining authors declare no conflicts of interest.	Adam J, 2011, CANCER CELL, V20, P524, DOI 10.1016/j.ccr.2011.09.006; Anastasiou D, 2011, SCIENCE, V334, P1278, DOI 10.1126/science.1211485; Biatnik M, 2008, ANN NY ACAD SCI, V1126, P272, DOI 10.1196/annals.1433.047; Blatnik M, 2008, DIABETES, V57, P41, DOI 10.2337/db07-0838; Boivin B, 2008, P NATL ACAD SCI USA, V105, P9959, DOI 10.1073/pnas.0804336105; Boivin B, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3137pl2; Caldas TD, 1998, PROTEIN EXPRES PURIF, V14, P65, DOI 10.1006/prep.1998.0922; CLAIBORNE A, 1993, FASEB J, V7, P1483, DOI 10.1096/fasebj.7.15.8262333; Dalla Rizza J, 2019, PROTEIN SCI, V28, P191, DOI 10.1002/pro.3520; Dayton TL, 2016, EMBO REP, V17, P1721, DOI 10.15252/embr.201643300; Dinkova-Kostova AT, 2002, P NATL ACAD SCI USA, V99, P11908, DOI 10.1073/pnas.172398899; EHRING R, 1969, J BIOL CHEM, V244, P4589; Forrester MT, 2011, J LIPID RES, V52, P393, DOI 10.1194/jlr.D011106; Frijhoff J, 2014, ANTIOXID REDOX SIGN, V20, P1994, DOI 10.1089/ars.2013.5643; Garcia FJ, 2016, MOL BIOSYST, V12, P1790, DOI 10.1039/c5mb00847f; Guo J, 2014, NAT PROTOC, V9, P64, DOI 10.1038/nprot.2013.161; Guo Z, 2010, SCIENCE, V330, P517, DOI 10.1126/science.1192912; Hitosugi T, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000431; Hu WT, 2010, ANAL BIOCHEM, V398, P245, DOI 10.1016/j.ab.2009.11.002; Hurd TR, 2008, J BIOL CHEM, V283, P24801, DOI 10.1074/jbc.M803432200; Ishii T, 1999, BIOCHEM PHARMACOL, V58, P133, DOI 10.1016/S0006-2952(99)00060-X; Kansanen E, 2013, REDOX BIOL, V1, P45, DOI 10.1016/j.redox.2012.10.001; Karisch R, 2013, FEBS J, V280, P459, DOI 10.1111/j.1742-4658.2012.08626.x; Karisch R, 2011, CELL, V146, P826, DOI 10.1016/j.cell.2011.07.020; KNOWLES JR, 1976, CRC CR REV BIOCH MOL, V4, P165, DOI 10.3109/10409237609105457; Kwon J, 2004, P NATL ACAD SCI USA, V101, P16419, DOI 10.1073/pnas.0407396101; Lee JG, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2532; Lee K, 2004, ELECTROPHORESIS, V25, P532, DOI 10.1002/elps.200305677; Lee SR, 2002, J BIOL CHEM, V277, P20336, DOI 10.1074/jbc.M111899200; Lee SR, 1998, J BIOL CHEM, V273, P15366, DOI 10.1074/jbc.273.25.15366; LEWIS CT, 1989, J BIOL CHEM, V264, P27; Liu H, 2000, MOL CELL BIOL, V20, P2198, DOI 10.1128/MCB.20.6.2198-2208.2000; Liu MA, 2010, ANAL CHEM, V82, P7160, DOI 10.1021/ac100569d; Maller C, 2011, ANTIOXID REDOX SIGN, V14, P49, DOI 10.1089/ars.2010.3149; Meng TC, 2004, J BIOL CHEM, V279, P37716, DOI 10.1074/jbc.M404606200; Meng TC, 2002, MOL CELL, V9, P387, DOI 10.1016/S1097-2765(02)00445-8; Ostman A, 2011, J BIOCHEM, V150, P345, DOI 10.1093/jb/mvr104; Paulsen CE, 2012, NAT CHEM BIOL, V8, P57, DOI 10.1038/nchembio.736; Raju K, 2012, BBA-GEN SUBJECTS, V1820, P684, DOI 10.1016/j.bbagen.2011.05.009; Salmeen A, 2003, NATURE, V423, P769, DOI 10.1038/nature01680; Sethuraman M, 2004, J PROTEOME RES, V3, P1228, DOI 10.1021/pr049887e; Sudarshan S, 2009, MOL CELL BIOL, V29, P4080, DOI 10.1128/MCB.00483-09; Sun JH, 2001, P NATL ACAD SCI USA, V98, P11158, DOI 10.1073/pnas.201289098; SUNDARESAN M, 1995, SCIENCE, V270, P296, DOI 10.1126/science.270.5234.296; Templeton DJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015012; Tomlinson IPM, 2002, NAT GENET, V30, P406, DOI 10.1038/ng849; Tsutsumi R, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00503-w; Victor KG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032527; Voss AA, 2004, J BIOL CHEM, V279, P34514, DOI 10.1074/jbc.M404290200; Wani R, 2011, P NATL ACAD SCI USA, V108, P10550, DOI 10.1073/pnas.1011665108; Weerapana E, 2010, NATURE, V468, P790, DOI 10.1038/nature09472; Winterbourn CC, 2013, METHOD ENZYMOL, V528, P3, DOI 10.1016/B978-0-12-405881-1.00001-X; Xu Y, 2018, CANCER RES, V78, P6539, DOI 10.1158/0008-5472.CAN-18-0901; Yang Y, 2010, CANCER GENET CYTOGEN, V196, P45, DOI 10.1016/j.cancergencyto.2009.08.018	54	2	2	1	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2019	33	11					12336	12347		10.1096/fj.201900693R	http://dx.doi.org/10.1096/fj.201900693R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC8ZX	31451050	Green Submitted, Green Published			2022-12-26	WOS:000507461600058
J	Fanni, AM; Vander Zanden, CM; Majewska, PV; Majewski, J; Chi, EY				Fanni, Adeline M.; Vander Zanden, Crystal M.; Majewska, Paulina, V; Majewski, Jaroslaw; Chi, Eva Y.			Membrane-mediated fibrillation and toxicity of the tau hexapeptide PHF6	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Alzheimer disease; Tau protein (Tau); membrane structure; toxicity; amyloid; neurodegeneration; membrane-mediated fibrillation; paired helical filament; PHF6; tauopathy	PAIRED HELICAL FILAMENTS; ALPHA-SYNUCLEIN; ALZHEIMERS-DISEASE; CONFORMATIONAL-CHANGES; LIPID-BILAYER; AMYLOID-BETA; PROTEIN; BINDING; AGGREGATION; CURVATURE	The aggregation of the tau protein into neurofibrillary tangles is believed to correlate with cognitive decline in several neurodegenerative disorders, including Alzheimer's disease. Recent studies suggest that tau's interactions with the cell membrane could serve as a toxicity pathway and also enhance fibrillation into paired helical filaments (PHFs). Conformational changes associated with tau-membrane interactions are poorly understood, and their characterization could improve our understanding of tau pathogenicity. In this study, we investigated the molecular level structural changes associated with the interaction of the tau hexapeptide PHF6 with model lipid membranes and characterized the effects of these interactions on membrane stability and peptide fibrillation. We used two PHF6 forms, the aggregation-prone PHF6 with N-terminal acetylation (Ac-PHF6) and the non-aggregation prone PHF6 with a standard N terminus (NH3+-PHF6). We found that both PHF6 peptides are neurotoxic and exhibit similar membrane-mediated changes, consisting of: 1) favorable interactions with anionic membranes, 2) membrane destabilization through lipid extraction, and 3) membrane-mediated fibrillation. The rate at which these changes occurred was the main difference between the two peptides. NH3+-PHF6 displayed slow membrane-mediated fibrillation after 6 days of incubation, whereas Ac-PHF6 adopted a ?-sheet conformation at the surface of the membrane within hours. Ac-PHF6 interactions with the membrane were also accompanied by membrane invagination and rapid membrane destabilization. Overall, our results reveal that membrane interactions could play a critical role in tau toxicity and fibrillation, and highlight that unraveling these interactions is important for significantly advancing the development of therapeutic strategies to manage tau-associated neurodegenerative diseases.	[Fanni, Adeline M.; Vander Zanden, Crystal M.; Majewska, Paulina, V; Chi, Eva Y.] Univ New Mexico, Ctr Biomed Engn, Albuquerque, NM 87131 USA; [Fanni, Adeline M.] Univ New Mexico, Biomed Engn Grad Program, Albuquerque, NM 87131 USA; [Vander Zanden, Crystal M.; Majewski, Jaroslaw; Chi, Eva Y.] Univ New Mexico, Dept Chem & Biol Engn, Albuquerque, NM 87131 USA; [Majewski, Jaroslaw] Los Alamos Natl Lab, Dept Theoret Biol & Biophys, Los Alamos, NM 87545 USA; [Majewski, Jaroslaw] Natl Sci Fdn, Div Mol & Cellular Biosci, Alexandria, VA 22314 USA	University of New Mexico; University of New Mexico; University of New Mexico; United States Department of Energy (DOE); Los Alamos National Laboratory; National Science Foundation (NSF); NSF - Directorate for Biological Sciences (BIO); NSF - Division of Molecular & Cellular Biosciences (MCB)	Chi, EY (corresponding author), Univ New Mexico, Dept Chem & Biol Engn, Albuquerque, NM 87131 USA.	evachi@unm.edu		Vander Zanden, Crystal/0000-0003-3248-6028	National Science Foundation [1150855, 1605225]; National Institutes of Health [NIGMS 5K12GM088021-09]; Independent Research and Development program grant from the National Science Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K12GM088021] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Independent Research and Development program grant from the National Science Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Science Foundation Grants 1150855 and 1605225 (to E. Y. C.), National Institutes of Health Grant NIGMS 5K12GM088021-09 (to C. M. V. Z.), and Independent Research and Development program grant from the National Science Foundation (to J. M.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ait-Bouziad N, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01575-4; Amos LA, 2004, ORG BIOMOL CHEM, V2, P2153, DOI 10.1039/b403634d; Ballatore C, 2007, NAT REV NEUROSCI, V8, P663, DOI 10.1038/nrn2194; Barre P, 2006, J MOL BIOL, V362, P312, DOI 10.1016/j.jmb.2006.07.018; Bhaskar K., 2012, NONFIBRILLAR AMYLOID, P135; Braun AR, 2012, J AM CHEM SOC, V134, P2613, DOI 10.1021/ja208316h; Buee L, 2000, BRAIN RES REV, V33, P95, DOI 10.1016/S0165-0173(00)00019-9; Chi EY, 2008, PROTEINS, V72, P1, DOI 10.1002/prot.21887; CROWTHER RA, 1991, P NATL ACAD SCI USA, V88, P2288, DOI 10.1073/pnas.88.6.2288; Elbaum-Garfinkle S, 2010, BIOPHYS J, V98, P2722, DOI 10.1016/j.bpj.2010.03.013; Ferreira ST, 2007, IUBMB LIFE, V59, P332, DOI 10.1080/15216540701283882; Fitzpatrick AWP, 2017, NATURE, V547, P185, DOI 10.1038/nature23002; Flach K, 2012, J BIOL CHEM, V287, P43223, DOI 10.1074/jbc.M112.396176; Georgieva ER, 2014, BIOPHYS J, V107, P1441, DOI 10.1016/j.bpj.2014.07.046; Ghoshal N, 2002, EXP NEUROL, V177, P475, DOI 10.1006/exnr.2002.8014; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Gorbenko GP, 2006, CHEM PHYS LIPIDS, V141, P72, DOI 10.1016/j.chemphyslip.2006.02.006; Goux WJ, 2004, J BIOL CHEM, V279, P26868, DOI 10.1074/jbc.M402379200; GUSTKE N, 1994, BIOCHEMISTRY-US, V33, P9511, DOI 10.1021/bi00198a017; Ingelsson M, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00408; Inouye H, 2006, BIOPHYS J, V90, P1774, DOI 10.1529/biophysj.105.070136; Jones EM, 2012, BIOCHEMISTRY-US, V51, P2539, DOI 10.1021/bi201857v; Kelly SM, 2005, BBA-PROTEINS PROTEOM, V1751, P119, DOI 10.1016/j.bbapap.2005.06.005; Kfoury N, 2012, J BIOL CHEM, V287, P19440, DOI 10.1074/jbc.M112.346072; Kolarova M., 2012, INT J ALZHEIMERS DIS, V2012, P13; LEE G, 1989, NEURON, V2, P1615, DOI 10.1016/0896-6273(89)90050-0; Lee KYC, 2008, ANNU REV PHYS CHEM, V59, P771, DOI 10.1146/annurev.physchem.58.032806.104619; Mazanetz MP, 2007, NAT REV DRUG DISCOV, V6, P464, DOI 10.1038/nrd2111; Middleton ER, 2010, BIOPHYS J, V99, P2279, DOI 10.1016/j.bpj.2010.07.056; Necula M, 2003, J BIOL CHEM, V278, P46674, DOI 10.1074/jbc.M308231200; Nelson D.L., 2017, LEHNINGER PRINCIPLES; Ouberai MM, 2013, J BIOL CHEM, V288, P20883, DOI 10.1074/jbc.M113.478297; Pfefferkorn CM, 2012, BIOPHYS J, V102, P613, DOI 10.1016/j.bpj.2011.12.051; Plumley JA, 2011, J PHYS CHEM B, V115, P10560, DOI 10.1021/jp205388q; Prangkio P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047261; Quist A, 2005, P NATL ACAD SCI USA, V102, P10427, DOI 10.1073/pnas.0502066102; Serpell LC, 2000, BBA-MOL BASIS DIS, V1502, P16, DOI 10.1016/S0925-4439(00)00029-6; Sogawa K, 2014, BIOPOLYMERS, V102, P288, DOI 10.1002/bip.22489; Standards ISO, 2009, 109935 ISO; Stefani M, 2003, J MOL MED, V81, P678, DOI 10.1007/s00109-003-0464-5; Sugiura Y, 2015, LANGMUIR, V31, P11549, DOI 10.1021/acs.langmuir.5b03332; Tolnay M, 1999, NEUROPATH APPL NEURO, V25, P171; von Bergen M, 2001, J BIOL CHEM, V276, P48165, DOI 10.1074/jbc.M105196200; von Bergen M, 2000, P NATL ACAD SCI USA, V97, P5129, DOI 10.1073/pnas.97.10.5129; Williams TL, 2011, FEBS J, V278, P3905, DOI 10.1111/j.1742-4658.2011.08228.x; ZACHOWSKI A, 1993, BIOCHEM J, V294, P1; Zhu M, 2003, J BIOL CHEM, V278, P40186, DOI 10.1074/jbc.M305326200	47	25	25	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 18	2019	294	42					15304	15317		10.1074/jbc.RA119.010003	http://dx.doi.org/10.1074/jbc.RA119.010003			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JQ9HM	31439664	Green Submitted, Green Published, hybrid			2022-12-26	WOS:000499248700010
J	Garnaes, E; Mortensen, C; Hobolth, L; Andersen, O; Nehlin, J; Moller, S				Garnaes, Emilie; Mortensen, Christian; Hobolth, Lise; Andersen, Ove; Nehlin, Jan; Moller, Soren			Kinetics of the soluble urokinase plasminogen activator receptor (suPAR) in cirrhosis	PLOS ONE			English	Article							FIBROSIS; DISEASE	Background The soluble urokinase plasminogen activator receptor (suPAR) is related to hepatic inflammation and fibrosis and has been suggested to participate in the development of liver cirrhosis. Therefore, the aim of the current study was to measure the concentration of suPAR in the hepatic vein of cirrhotic patients during a liver vein catheterization to identify a possible hepatic suPAR generation. Furthermore, we explored if suPAR levels were associated with the degree of cirrhosis and liver dysfunction. Methods and patients We included 105 cirrhotic patients and 19 liver-healthy controls. Blood was sampled from the hepatic vein and the femoral artery and suPAR was measured by enzyme-linked immunosorbent assay. Results We identified significantly higher median suPAR concentrations among the cirrhotic patients (7.2 ng/ml in the hepatic vein; 6.8 ng/ml in the femoral artery) compared to the controls (2.6 ng/ml, respectively, p-values <0.001). However, the median hepatic suPAR formation was 0.0 ng/ml in both groups. We observed significantly increasing suPAR levels according to higher Child classes (4.5 ng/ml, 6.9 ng/ml and 9.0 ng/ml, Child A, B, C respectively; p-value<0.001), and significantly higher median suPAR concentrations in patients with ascites versus patients without ascites (8.1 ng/ml versus 5.3 ng/ml, respectively, p-value<0.001). suPAR levels were significantly related to bilirubin (r = 0.48, p<0.001), the hepatic venous pressure gradient (r = 0.39, p<0.001), the cardiac index (r = 0.24, p = 0.02) and the plasma volume (r = 0.33, p = 0.001), whereas suPAR levels were significantly inversely related to albumin (r = -0.59, p<0.001), plasma coagulation factors (r-0.39, p<0.001), the mean arterial pressure (r = -0.28, p = 0.004), the systemic vascular resistance (r = 0.26, p = 0.007), the indocyanine green clearance (r = -0.51, p<0,001) and the galactose elimination capacity (r = -0.39, p<0.001). Conclusion We identified elevated suPAR concentration in cirrhotic patients, which correlated significantly with the degree of cirrhosis and liver failure, but we were not able to demonstrate hepatic suPAR generation per se. This suggests that further investigations of the source of suPAR in cirrhotic patients need to be undertaken.	[Garnaes, Emilie; Moller, Soren] Copenhagen Univ Hosp Hvidovre, Dept Clin & Nucl Med, Ctr Funct & Diagnost Imaging & Res, Hvidovre, Denmark; [Mortensen, Christian; Hobolth, Lise] Copenhagen Univ Hosp Hvidovre, Med Div, Gastro Unit, Hvidovre, Denmark; [Andersen, Ove; Nehlin, Jan] Copenhagen Univ Hosp Hvidovre, Clin Res Ctr, Hvidovre, Denmark	University of Copenhagen; University of Copenhagen; University of Copenhagen	Moller, S (corresponding author), Copenhagen Univ Hosp Hvidovre, Dept Clin & Nucl Med, Ctr Funct & Diagnost Imaging & Res, Hvidovre, Denmark.	soren.moller@regionh.dk	Nehlin, Jan O./AAR-8721-2020; Andersen, Ove/D-3091-2019	Nehlin, Jan O./0000-0001-6038-5027; Andersen, Ove/0000-0002-2274-548X; Hobolth, Lise/0000-0002-7607-3551; Mortensen, Christian/0000-0003-3738-168X; Moller, Soren/0000-0001-9684-7764				Andersen ES, 2011, EUR J CLIN MICROBIOL, V30, P761, DOI 10.1007/s10096-010-1149-y; [Anonymous], 2004, HEPATOLOGY, V39, P286, DOI [10.1002/hep.20061, DOI 10.1002/HEP.20061]; Berres ML, 2012, J CLIN GASTROENTEROL, V46, P334, DOI 10.1097/MCG.0b013e31822da19d; Connolly BM, 2010, BLOOD, V116, P1593, DOI 10.1182/blood-2010-03-276642; Desmedt S, 2017, CRIT REV CL LAB SCI, V54, P117, DOI 10.1080/10408363.2016.1269310; Eugen-Olsen J, 2010, J INTERN MED, V268, P296, DOI 10.1111/j.1365-2796.2010.02252.x; Groszmann RJ, 2004, HEPATOLOGY, V39, P280, DOI 10.1002/hep.20062; Hahm E, 2017, NAT MED, V23, P100, DOI 10.1038/nm.4242; Haupt TH, 2012, CRIT CARE, V16, DOI 10.1186/cc11434; Higazi AA, 2008, CLIN EXP IMMUNOL, V152, P163, DOI 10.1111/j.1365-2249.2008.03606.x; Hobolth L, 2012, SCAND J GASTROENTERO, V47, P887, DOI 10.3109/00365521.2012.706827; Kimer N, 2014, EUR J CLIN INVEST, V44, P441, DOI 10.1111/eci.12249; Moller S, 2015, DIGEST DIS SCI, V60, P3209, DOI 10.1007/s10620-015-3752-3; Moller S, 2011, GUT, V60, P1254, DOI 10.1136/gut.2010.235473; Mortensen C, 2013, LIVER INT, V33, P1309, DOI 10.1111/liv.12205; Pliyev BK, 2009, MOL CELL BIOCHEM, V321, P111, DOI 10.1007/s11010-008-9925-z; Sevgi DY, 2016, WIEN KLIN WOCHENSCHR, V128, P28, DOI 10.1007/s00508-015-0886-4; Shanmukhappa K, 2006, BMC GASTROENTEROL, V6, DOI 10.1186/1471-230X-6-40; Sjowall C, 2015, TRANSL RES, V165, P658, DOI 10.1016/j.trsl.2014.09.007; Sloand EA, 2008, EXP HEMATOL, V36, P1616, DOI 10.1016/j.exphem.2008.06.016; Thuno M, 2009, DIS MARKERS, V27, P157, DOI [10.1155/2009/504294, 10.3233/DMA-2009-0657]; Wei C, 2014, NAT MED, V6, P952; Wiese S, 2014, LIVER INT, V34, pE19, DOI 10.1111/liv.12428; Zimmermann HW, 2013, J INTERN MED, V274, P86, DOI 10.1111/joim.12054; Zimmermann HW, 2012, LIVER INT, V32, P500, DOI 10.1111/j.1478-3231.2011.02665.x	25	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2019	14	8							e0220697	10.1371/journal.pone.0220697	http://dx.doi.org/10.1371/journal.pone.0220697			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW6AB	31465463	Green Published, Green Submitted, gold			2022-12-26	WOS:000485058200006
J	Hamad, AF; Alessi-Severini, S; Mahmud, SM; Brownell, M; Kuo, IF				Hamad, Amani F.; Alessi-Severini, Silvia; Mahmud, Salaheddin M.; Brownell, Marni; Kuo, I. Fan			Prenatal antibiotics exposure and the risk of autism spectrum disorders: A population-based cohort study	PLOS ONE			English	Article							GUT-MICROBIOTA; PRIMARY-CARE; PREGNANCY; INFECTION; CHILDHOOD	Background Prenatal antibiotic exposure induces changes in infants' gut microbiota composition and is suggested as a possible contributor in the development of autism spectrum disorders (ASD). In this study, we examined the association between prenatal antibiotic exposure and the risk of ASD. Methods This was a population-based cohort study utilizing the Manitoba Population Research Data Repository. The cohort included 214 834 children born in Manitoba, Canada between April 1, 1998 and March 31, 2016. Exposure was defined as having filled one or more antibiotic prescription during pregnancy. The outcome was autism spectrum disorder diagnosis. Multivariable Cox proportional hazards regression was used to estimate the risk of developing ASD in the overall cohort and in a sibling cohort. Results Of all subjects, 80 750 (37.6%) were exposed to antibiotics prenatally. During follow-up, 2965 children received an ASD diagnosis. Compared to children who were not exposed to antibiotics prenatally, those who were exposed had a higher risk of ASD: (adjusted HR 1.10 [95% CI 1.01, 1.19]). The association was observed in those exposed to antibiotics in the second or third trimester (HR 1.11 [95% CI 1.01, 1.23] and 1.17 [95% CI 1.06, 1.30], respectively). In the siblings' cohort, ASD risk estimate remained unchanged (adjusted HR 1.08 [95% CI 0.90, 1.30], although it was not statistically significant. Conclusions Prenatal antibiotic exposure is associated with a small increase in the risk of ASD. Given the potential of residual confounding beyond what it was controlled through our study design and because of possible confounding by indication, such a small risk increase in the population is not expected to be clinically significant.	[Hamad, Amani F.; Alessi-Severini, Silvia; Mahmud, Salaheddin M.; Kuo, I. Fan] Univ Manitoba, Rady Fac Hlth Sci, Coll Pharm, Winnipeg, MB, Canada; [Alessi-Severini, Silvia; Brownell, Marni] Univ Manitoba, Rady Fac Hlth Sci, Max Ray Coll Med, Manitoba Ctr Hlth Policy, Winnipeg, MB, Canada; [Mahmud, Salaheddin M.; Brownell, Marni] Univ Manitoba, Rady Fac Hlth Sci, Dept Community Hlth Sci, Max Ray Coll Med, Winnipeg, MB, Canada; [Mahmud, Salaheddin M.] Univ Manitoba, Vaccine & Drug Evaluat Ctr, Winnipeg, MB, Canada	University of Manitoba; University of Manitoba; University of Manitoba; University of Manitoba	Kuo, IF (corresponding author), Univ Manitoba, Rady Fac Hlth Sci, Coll Pharm, Winnipeg, MB, Canada.	I.Kuo@umanitoba.ca		Brownell, Marni/0000-0001-7673-4404; Alessi-Severini, Silvia/0000-0002-6543-7719; Kuo, I fan/0000-0002-2660-2777	University of Manitoba Evelyn Shapiro Award for Health Services Research	University of Manitoba Evelyn Shapiro Award for Health Services Research	AFH was supported by the University of Manitoba Evelyn Shapiro Award for Health Services Research. The sponsor had no role in study design, data collection, analysis or interpretation of the data, or writing of the manuscript or in the decision to submit the paper for publication.	Aagaard K, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008599; Amann U, 2006, PHARMACOEPIDEM DR S, V15, P327, DOI 10.1002/pds.1225; American psychiatric association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; Atladottir HO, 2012, PEDIATRICS, V130, pE1447, DOI 10.1542/peds.2012-1107; Borre YE, 2014, TRENDS MOL MED, V20, P509, DOI 10.1016/j.molmed.2014.05.002; Boukhris T, 2016, JAMA PEDIATR, V170, P117, DOI 10.1001/jamapediatrics.2015.3356; Broe A, 2014, BJOG-INT J OBSTET GY, V121, P988, DOI 10.1111/1471-0528.12806; Brownell M, 2008, MANITOBA CHILD HLTH; Christensen DL, 2016, MMWR SURVEILL SUMM, V65, P1; Coo H, 2017, CAN J PUBLIC HEALTH, V108, pE530, DOI [10.17269/cjph.108.5963, 10.17269/CJPH.108.5963]; Dodds L, 2009, CHRONIC DIS CAN, V29, P102; Duan GQ, 2014, PSYCHIAT RES, V220, P410, DOI 10.1016/j.psychres.2014.05.057; Fang SY, 2015, PAEDIATR PERINAT EP, V29, P307, DOI 10.1111/ppe.12194; Gardener H, 2011, PEDIATRICS, V128, P344, DOI 10.1542/peds.2010-1036; Gardener H, 2009, BRIT J PSYCHIAT, V195, P7, DOI 10.1192/bjp.bp.108.051672; Geschwind DH, 2011, TRENDS COGN SCI, V15, P409, DOI 10.1016/j.tics.2011.07.003; Hallmayer J, 2011, ARCH GEN PSYCHIAT, V68, P1095, DOI 10.1001/archgenpsychiatry.2011.76; Hay SI, 2017, LANCET, V390, P1260, DOI 10.1016/S0140-6736(17)32130-X; Jimenez E, 2005, CURR MICROBIOL, V51, P270, DOI 10.1007/s00284-005-0020-3; Mezzelani A, 2015, NUTR NEUROSCI, V18, P145, DOI 10.1179/1476830513Y.0000000108; Parracho HMRT, 2005, J MED MICROBIOL, V54, P987, DOI 10.1099/jmm.0.46101-0; Petersen I, 2010, J ANTIMICROB CHEMOTH, V65, P2238, DOI 10.1093/jac/dkq307; Petra AI, 2015, CLIN THER, V37, P984, DOI 10.1016/j.clinthera.2015.04.002; Schulfer AF, 2018, NAT MICROBIOL, V3, P234, DOI 10.1038/s41564-017-0075-5; Song YL, 2004, APPL ENVIRON MICROB, V70, P6459, DOI 10.1128/AEM.70.11.6459-6465.2004; Taylor B, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003219; Tormo-Badia N, 2014, SCAND J IMMUNOL, V80, P250, DOI 10.1111/sji.12205; Valent F, 2015, J MATERN-FETAL NEO M, V28, P210, DOI 10.3109/14767058.2014.906572; Vehling L, 2016, HLTH PROMOT CHRONIC, V36, P270; Zerbo O, 2015, J AUTISM DEV DISORD, V45, P4002, DOI 10.1007/s10803-015-2579-2; Zwaigenbaum L, 2015, PEDIATRICS, V136, pS41, DOI 10.1542/peds.2014-3667D	31	20	21	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2019	14	8							e0221921	10.1371/journal.pone.0221921	http://dx.doi.org/10.1371/journal.pone.0221921			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW6AB	31465485	Green Published, Green Submitted, gold			2022-12-26	WOS:000485058200069
J	Harel, Y; Kalron, A; Menascu, S; Magalashvili, D; Dolev, M; Doniger, G; Simon, E; Achiron, A				Harel, Yermi; Kalron, Alon; Menascu, Shay; Magalashvili, David; Dolev, Mark; Doniger, Glen; Simon, Ely; Achiron, Anat			Cognitive function in multiple sclerosis: A long-term look on the bright side	PLOS ONE			English	Article							IMPAIRMENT; PERFORMANCE; PATTERNS	Background Multiple sclerosis (MS) may lead to cognitive decline over-time. Objectives Characterize cognitive performance in MS patients with long disease duration treated with disease modifying drugs (DMD) in relation to disability and determine the prevalence of cognitive resilience. Methods Cognitive and functional outcomes were assessed in 1010 DMD-treated MS patients at least 10 years from onset. Cognitive performance was categorized as high, moderate or low, and neurological disability was classified according to the Expanded Disability Status Scale (EDSS) as mild, moderate or severe. Relationship between cognitive performance and disability was examined. Results After a mean disease duration of 19.6 (SD = 7.7) years, low cognitive performance was observed in 23.7% (N = 239), moderate performance in 42.7% (N = 431), and 33.7% (N = 340) had high cognitive performance, meeting the definition of cognitively resilient patients. Within the group of patients with low cognitive performance, severe disability was observed in 50.6% (121/239), while in the group of patients with high cognitive performance, mild disability was observed in 64.4% (219/340). Differences between the group of patients with high cognitive performance and severe disability (4.5%) and the group of patients with low cognitive performance and mild disability (5.0%) were not accounted for by DMD treatment duration. Conclusions The majority of DMD treated MS patients did not have cognitive decline that could impair their quality of life after disease of extended duration.	[Harel, Yermi; Menascu, Shay; Magalashvili, David; Dolev, Mark; Achiron, Anat] Sheba Med Ctr, Multiple Sclerosis Ctr, Tel Hashomer, Israel; [Harel, Yermi] Loewenstein Hosp & Rehabil Ctr, Raanana, Israel; [Harel, Yermi; Achiron, Anat] Tel Aviv Univ, Sackler Fac Med, Tel Aviv, Israel; [Kalron, Alon] Tel Aviv Univ, Sch Hlth Profess, Dept Phys Therapy, Sackler Fac Med, Tel Aviv, Israel; [Kalron, Alon; Doniger, Glen; Achiron, Anat] Tel Aviv Univ, Sagol Neurosci Ctr, Tel Aviv, Israel; [Doniger, Glen; Simon, Ely] NeuroTrax Corp, Dept Clin Res, Medina, NY USA; [Doniger, Glen] Sheba Med Ctr, Ctr Adv Technol Rehabil, Tel Hashomer, Israel	Chaim Sheba Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv University; Chaim Sheba Medical Center	Achiron, A (corresponding author), Sheba Med Ctr, Multiple Sclerosis Ctr, Tel Hashomer, Israel.; Achiron, A (corresponding author), Tel Aviv Univ, Sackler Fac Med, Tel Aviv, Israel.; Achiron, A (corresponding author), Tel Aviv Univ, Sagol Neurosci Ctr, Tel Aviv, Israel.	Anat.Achiron@sheba.health.gov.il	Kalron, Alon/AAT-2960-2021; Kalron, Alon/AAB-3396-2019	Kalron, Alon/0000-0001-7999-0868; Achiron, Anat/0000-0002-2020-3126	Sheba MS research grant [AA-1171]	Sheba MS research grant	This research was supported by Sheba MS research grant (AA-1171). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. I confirm that Glen Doniger and Ely Simon are affiliated with NeuroTrax Corporation and that NeuroTrax Corporation provided support in the form of salaries for these authors (GD and ES), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are presented in the author contributions' section.	Achiron A, 2007, EUR J NEUROL, V14, P1102, DOI 10.1111/j.1468-1331.2007.01909.x; Achiron A, 2006, J NEUROL SCI, V245, P47, DOI 10.1016/j.jns.2005.05.019; Achiron A, 2005, J NEUROL NEUROSUR PS, V76, P744, DOI 10.1136/jnnp.2004.045518; Achiron A, MULT SCLER; Achiron A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071058; Baughman BC, 2015, J CLIN EXP NEUROPSYC, V37, P630, DOI 10.1080/13803395.2015.1039963; Bobholz JA, 2003, CURR OPIN NEUROL, V16, P283, DOI 10.1097/00019052-200306000-00006; Branger P, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149685; Chiaravalloti ND, 2008, LANCET NEUROL, V7, P1139, DOI 10.1016/S1474-4422(08)70259-X; Christensen H, 2001, PSYCHOL MED, V31, P15, DOI 10.1017/S0033291799002834; Cohen AB, 2012, J NEUROIMAGING, V22, P122, DOI 10.1111/j.1552-6569.2011.00589.x; de Frias CM, 2003, J GERONTOL B-PSYCHOL, V58, pP12, DOI 10.1093/geronb/58.1.P12; Dwolatzky Tzvi, 2003, BMC Geriatr, V3, P4, DOI 10.1186/1471-2318-3-4; Gholamzad M, 2019, INFLAMM RES, V68, P25, DOI 10.1007/s00011-018-1185-0; Guarnera C, 2017, DRUG DES DEV THER, V11, P2193, DOI 10.2147/DDDT.S137572; Gudesblatt M, 2018, CNS DRUGS, V32, P1173, DOI 10.1007/s40263-018-0553-1; Hawkins SA, 1999, J NEUROL NEUROSUR PS, V67, P148, DOI 10.1136/jnnp.67.2.148; Hofer SM, 2002, PSYCHOL AGING, V17, P194, DOI 10.1037//0882-7974.17.2.194; Kirk-Sanchez NJ, 2014, CLIN INTERV AGING, V9, DOI 10.2147/CIA.S39506; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; McEwen BS, 2016, ANN NY ACAD SCI, V1373, P56, DOI 10.1111/nyas.13020; Muckschel M, 2016, ACTA NEUROL SCAND, V134, P55, DOI 10.1111/ane.12656; Ouellette R, 2018, MULT SCLER RELAT DIS, V21, P110, DOI 10.1016/j.msard.2018.03.002; Polman CH, 2011, ANN NEUROL, V69, P292, DOI 10.1002/ana.22366; Ramsaransing GSM, 2007, EUR J NEUROL, V14, P885, DOI 10.1111/j.1468-1331.2007.01810.x; Rocca MA, 2010, NEUROLOGY, V74, P142, DOI 10.1212/WNL.0b013e3181c91a00; Rommer PS, 2018, EXPERT OPIN PHARMACO, V19, P483, DOI 10.1080/14656566.2018.1446944; Seeman TE, 2001, HEALTH PSYCHOL, V20, P243, DOI 10.1037//0278-6133.20.4.243; Stern Y, 2002, J INT NEUROPSYCH SOC, V8, P448, DOI 10.1017/S1355617702813248; Sumowski JF, 2010, BRAIN, V133, P362, DOI 10.1093/brain/awp307; Tsivgoulis G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116511; Wilson RS, 2002, JAMA-J AM MED ASSOC, V287, P742, DOI 10.1001/jama.287.6.742; Zivadinov R, 2001, NEURORADIOLOGY, V43, P272, DOI 10.1007/s002340000500	33	7	7	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2019	14	8							e0221784	10.1371/journal.pone.0221784	http://dx.doi.org/10.1371/journal.pone.0221784			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW6AB	31465498	gold, Green Submitted, Green Published			2022-12-26	WOS:000485058200054
J	Cui, JT; Yan, WJ; Xie, HJ; Xu, SX; Wang, QF; Zhang, WH; Ni, AP				Cui, Jingtao; Yan, Wenjuan; Xie, Hongjie; Xu, Shaoxia; Wang, Qiaofeng; Zhang, Weihong; Ni, Anping			Cytomegalovirus antigenemia in patients with autoimmune and non-autoimmune diseases in Beijing: A 10-year single hospital experience	PLOS ONE			English	Article							CLINICAL CHARACTERISTICS; INFECTION; REACTIVATION; LATENCY; VIRUS; RISK	Background Primary cytomegalovirus (CMV) infection is prevalent worldwide and usually results in latency in immunocompetent populations. Reactivation of latent CMV can cause life-threatening complications in immunocompromised hosts. Methods We used the CMV Brite assay to test CMV antigenemia (pp65) in whole blood samples from 22,192 patients with or without autoimmune diseases in Beijing during 2008-2018. Results The overall prevalence of CMV antigenemia was 19.5% (9.7%, males; 26.0%, females). The prevalence of CMV antigenemia was 35.1%, 58.6% and 11.4% in whole patients with autoimmune diseases, in patients with systemic lupus erythematosus (SLE) and in patients with non-SLE autoimmune diseases, respectively. All patients with non-autoimmune diseases, patients with HIV/AIDS or transplantation were found to have 5.0%, 27% or 14.8%, respectively. Patients <= 20 years with SLE had a significantly higher prevalence of CMV antigenemia than did all SLE patients, on average. Patients>51 years with non-SLE autoimmune diseases had a significantly higher prevalence than did all patients with non-SLE autoimmune diseases, on average. The prevalence of CMV antigenemia in patients admitted to intensive-care units (ICUs) were 9.2%, which was significantly higher than that among all patients with non-autoimmune diseases. Patients with SLE had 23.8% of negative conversion of CMV antigenemia, significantly lower than the percentage of patients with non-SLE autoimmune (64.3%) and non-autoimmune (61.0%) diseases. The mean number of days to negative conversion of CMV antigenemia in patients with SLE was 35.3 +/- 35.8 days, which was significantly longer than that in patients with non-SLE autoimmune diseases (15.4 +/- 11.9 days) and non-autoimmune diseases (13.6 +/- 7.7 days). Conclusions CMV antigenemia is found more likely in women than in men, more prevalently in patients with SLE than those with HIV/AIDS or transplant recipients, more frequently in patients admitted to ICUs. Patients with SLE had prolonged CMV antigenemia. The role of CMV appears important in SLE.	[Ni, Anping] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Clin Labs, Beijing, Peoples R China; Peking Union Med Coll, Beijing, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Ni, AP (corresponding author), Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Clin Labs, Beijing, Peoples R China.	niap@pumch.cn						Antona D, 2017, EPIDEMIOL INFECT, V145, P1471, DOI 10.1017/S0950268817000103; Brunner HI, 2008, ARTHRITIS RHEUM-US, V58, P556, DOI 10.1002/art.23204; Chan C, 2017, BMJ CASE REP, V2017; Choo HMC, 2019, ADV RHEUMATOL, V59, DOI 10.1186/s42358-019-0055-y; Chougule D, 2018, J MED VIROL, V90, P559, DOI 10.1002/jmv.24904; Cohen JI, 2009, CRIT CARE MED, V37, P2095, DOI 10.1097/CCM.0b013e3181a5e725; Cuchacovich R, 2009, RHEUM DIS CLIN N AM, V35, P75, DOI 10.1016/j.rdc.2009.03.003; Cui JT, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193171; Doaty S, 2016, CURR RHEUMATOL REP, V18, DOI 10.1007/s11926-016-0561-4; Fujimoto D, 2013, MOD RHEUMATOL, V23, P345, DOI 10.1007/s10165-012-0651-8; Griffiths PD, 2012, LANCET INFECT DIS, V12, P790, DOI 10.1016/S1473-3099(12)70197-4; Halenius A, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/472978; Ho SKN, 2000, J CLIN MICROBIOL, V38, P3743, DOI 10.1128/JCM.38.10.3743-3745.2000; Hung ML, 2019, J MICROBIOL IMMUNOL, V52, P114, DOI 10.1016/j.jmii.2018.12.002; Janahi EMA, 2018, MICROB PATHOGENESIS, V120, P132, DOI 10.1016/j.micpath.2018.04.041; Kamei Hideya, 2016, Ann Transplant, V21, P131; Kivity S, 2014, J AUTOIMMUN, V51, P17, DOI 10.1016/j.jaut.2014.02.008; Kudaeva FM, 2019, SEMIN ARTHRITIS RHEU, V48, P587, DOI 10.1016/j.semarthrit.2018.03.011; Lachmann R, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0200267; Landry ML, 1996, J CLIN MICROBIOL, V34, P1337, DOI 10.1128/JCM.34.5.1337-1339.1996; Li TD, 2017, EUR J CLIN MICROBIOL, V36, P863, DOI 10.1007/s10096-016-2873-8; Li X, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-3195-5; Li ZX, 2019, CLIN EXP MED, V19, P23, DOI 10.1007/s10238-018-0535-0; Limaye AP, 2008, JAMA-J AM MED ASSOC, V300, P413, DOI 10.1001/jama.300.4.413; Lino Katia, 2018, Braz. J. Nephrol., V40, P44, DOI [10.1590/2175-8239-JBN-3838, 10.1590/2175-8239-jbn-3838]; Lu Shih-Chien, 1999, Kaohsiung Journal of Medical Sciences, V15, P603; Pande A, 2019, INFECT DIS CLIN N AM, V33, P485, DOI 10.1016/j.idc.2019.02.008; Papazian L, 2016, INTENS CARE MED, V42, P28, DOI 10.1007/s00134-015-4066-9; Rozenblyum Evelyn V, 2013, Int J Clin Rheumtol, V8, P137; Sinclair J, 2008, J CLIN VIROL, V41, P180, DOI 10.1016/j.jcv.2007.11.014; Sinclair J, 2006, J GEN VIROL, V87, P1763, DOI 10.1099/vir.0.81891-0; Soderberg-Naucler C, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3525; Souquette A, 2017, GEROSCIENCE, V39, P293, DOI 10.1007/s11357-017-9982-x; Sternbaek L, 2019, SCAND J CLIN LAB INV, V79, P7, DOI 10.1080/00365513.2018.1550807; Strenger V, 2018, ANN HEMATOL, V97, P989, DOI 10.1007/s00277-018-3254-4; Su BYJ, 2007, MED MICROBIOL IMMUN, V196, P165, DOI 10.1007/s00430-007-0040-7; Takizawa Y, 2008, RHEUMATOLOGY, V47, P1373, DOI 10.1093/rheumatology/ken231; Tincani A, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-93; Tu WJ, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.02111; VANDERBIJ W, 1988, J CLIN MICROBIOL, V26, P2531, DOI 10.1128/JCM.26.12.2531-2535.1988; Vanheusden M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00645-3; Wang SW, 2017, MEDICINE, V96, DOI [10.1097/MD.0000000000006007, 10.1097/md.0000000000006007]; Whiting CC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133627; Zhang J, 2014, LUPUS, V23, P889, DOI 10.1177/0961203314532560; Zuhair M, 2019, REV MED VIROL, V29, DOI 10.1002/rmv.2034	45	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2019	14	8							e0221793	10.1371/journal.pone.0221793	http://dx.doi.org/10.1371/journal.pone.0221793			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5XV	31461496	gold, Green Published, Green Submitted			2022-12-26	WOS:000485052300055
J	de Souza, CR; Betelli, MT; Takazono, PS; de Oliveira, JA; Coelho, DB; Duysens, J; Teixeira, LA				de Souza, Caroline Ribeiro; Betelli, Marina Torres; Takazono, Patricia Sayuri; de Oliveira, Julia Avila; Coelho, Daniel Boari; Duysens, Jacques; Teixeira, Luis Augusto			Evaluation of balance recovery stability from unpredictable perturbations through the compensatory arm and leg movements (CALM) scale	PLOS ONE			English	Article							1ST TRIAL; DIRECTIONAL SENSITIVITY; EARLY ACTIVATION; LIMB MOVEMENTS; RESPONSES; FALLS; RISK; SINGLE; WAIST	Following unpredictable large-magnitude stance perturbations diverse patterns of arm and leg movements are performed to recover balance stability. Stability of these compensatory movements could be properly estimated through qualitative evaluation. In the present study, we present a scale for evaluation of compensatory arm and leg movements (CALM) in response to unpredictable displacements of the support base in the mediolateral direction. We tested the CALM scale for intra- and inter-rater reliability, correlation with kinematics of arm and leg movement amplitudes, and sensitivity to mode (rotation, translation and combined) and magnitude (velocity) of support base displacements, and also to perturbation-based balance training. Results showed significant intra- and inter-rater coefficients of agreement, ranging from moderate (0.46-0.53) for inter-rater reliability in the arm and global scores, to very high (0.87-0.99) for inter-rater leg scores and all intra-rater scores. Analysis showed significant correlation values between scale scores and the respective movement amplitudes both for arm and leg movements. Assessment of sensitivity revealed that the scale discriminated the responses between perturbation modes, platform velocities, in addition to higher balance recovery stability as a result of perturbation-based balance training. As a conclusion, the CALM scale was shown to provide adequate integrative evaluation of compensatory arm and leg movements for balance recovery stability after challenging stance perturbations, with potential application in fall risk prediction.	[de Souza, Caroline Ribeiro; Betelli, Marina Torres; Takazono, Patricia Sayuri; de Oliveira, Julia Avila; Teixeira, Luis Augusto] Univ Sao Paulo, Sch Phys Educ & Sport, Human Motor Syst Lab, Sao Paulo, Brazil; [de Souza, Caroline Ribeiro; Betelli, Marina Torres; Takazono, Patricia Sayuri; de Oliveira, Julia Avila; Teixeira, Luis Augusto] Fed Univ ABC, Brazil Ctr Engn Modeling & Appl Social Sci CECS, Sao Paulo, Brazil; [Coelho, Daniel Boari] Fed Univ ABC, Ctr Engn Modeling & Appl Social Sci CECS, Sao Paulo, Brazil; [Duysens, Jacques] Katholieke Univ Leuven, Fac Kinesiol & Rehabil Sci, Dept Movement Sci, Leuven, Belgium	Universidade de Sao Paulo; Universidade Federal do ABC (UFABC); Universidade Federal do ABC (UFABC); KU Leuven	de Souza, CR (corresponding author), Univ Sao Paulo, Sch Phys Educ & Sport, Human Motor Syst Lab, Sao Paulo, Brazil.; de Souza, CR (corresponding author), Fed Univ ABC, Brazil Ctr Engn Modeling & Appl Social Sci CECS, Sao Paulo, Brazil.	carolinecrs@usp.br	Teixeira, Luis/ABE-6305-2021; Coelho, Daniel/GSN-7128-2022; Coelho, Daniel Boari/I-9369-2012	Teixeira, Luis/0000-0003-4132-0484; Coelho, Daniel Boari/0000-0001-8758-6507; Ribeiro de Souza, Caroline/0000-0001-5595-4395; Avila de Oliveira, Julia/0000-0003-3396-4706; Torres Betelli, Marina/0000-0002-3883-8904	Brazilian Council of Science and Technology (CNPq) [302628/2013-4, 37844/2017-4]; Sao Paulo Research Foundation (FAPESP) [2011/20265-3, 2018/079425]; Coordination for the Improvement of Higher Level Personnel (CAPES, Brazil)	Brazilian Council of Science and Technology (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Coordination for the Improvement of Higher Level Personnel (CAPES, Brazil)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by the Brazilian Council of Science and Technology (CNPq, grant numbers 302628/2013-4 [LAT], 37844/2017-4 [PST]), Sao Paulo Research Foundation (FAPESP, grant numbers 2011/20265-3 [LAT], 2018/079425 [CRS]), and Coordination for the Improvement of Higher Level Personnel (CAPES, Brazil [JD, MTB]).	Allum JHJ, 2002, J PHYSIOL-LONDON, V542, P643, DOI 10.1113/jphysiol.2001.015644; Azzi NM, 2017, GAIT POSTURE, V57, P172, DOI 10.1016/j.gaitpost.2017.06.003; Bateni H, 2004, EXP BRAIN RES, V157, P49, DOI 10.1007/s00221-003-1815-8; BERG K, 1995, SCAND J REHABIL MED, V27, P27; Campbell AD, 2013, J NEUROPHYSIOL, V110, P2236, DOI 10.1152/jn.00766.2012; Cheng KB, 2015, J BIOMECH, V48, P3155, DOI 10.1016/j.jbiomech.2015.07.008; Cheng KB, 2014, HUM MOVEMENT SCI, V38, P173, DOI 10.1016/j.humov.2014.08.011; Coelho DB, 2017, EXP BRAIN RES, V235, P2375, DOI 10.1007/s00221-017-4980-x; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; Corbeil P, 2013, GAIT POSTURE, V37, P300, DOI 10.1016/j.gaitpost.2012.07.017; CORDO PJ, 1982, J NEUROPHYSIOL, V47, P287, DOI 10.1152/jn.1982.47.2.287; Feldman F, 2007, J BIOMECH, V40, P2612, DOI 10.1016/j.jbiomech.2007.01.019; Freyler K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167557; Fujimoto M, 2017, J BIOMECH, V55, P41, DOI 10.1016/j.jbiomech.2017.02.014; Gage WH, 2007, EXP BRAIN RES, V181, P627, DOI 10.1007/s00221-007-0959-3; Horak FB, 2009, PHYS THER, V89, P484, DOI 10.2522/ptj.20080071; Hurt CP, 2011, EXP BRAIN RES, V214, P557, DOI 10.1007/s00221-011-2854-1; Lord SR, 1999, J AM GERIATR SOC, V47, P1077, DOI 10.1111/j.1532-5415.1999.tb05230.x; MAKI BE, 1994, J GERONTOL, V49, pM72, DOI 10.1093/geronj/49.2.M72; Maki BE, 1997, PHYS THER, V77, P488, DOI 10.1093/ptj/77.5.488; Maki BE, 1996, J BIOMECH, V29, P343, DOI 10.1016/0021-9290(95)00053-4; Maki BE, 1996, J VESTIBUL RES-EQUIL, V6, P53, DOI 10.1016/0957-4271(95)00014-3; Maki BE, 2006, AGE AGEING, V35, P12, DOI 10.1093/ageing/afl078; Marigold DS, 2009, NEUROSCIENTIST, V15, P36, DOI 10.1177/1073858408322674; Marigold DS, 2003, J NEUROPHYSIOL, V89, P1727, DOI 10.1152/jn.00683.2002; MARSDEN CD, 1981, BRAIN, V104, P513, DOI 10.1093/brain/104.3.513; MCILROY WE, 1995, NEUROSCI LETT, V184, P177, DOI 10.1016/0304-3940(94)11200-3; Mcllroy W, 1995, GAIT POSTURE, V3, P43, DOI DOI 10.1016/0966-6362(95)90808-6; Mille ML, 2005, CLIN BIOMECH, V20, P607, DOI 10.1016/j.clinbiomech.2005.03.004; Misiaszek JE, 2003, EXP BRAIN RES, V151, P318, DOI 10.1007/s00221-003-1501-x; Nijhuis LBO, 2010, J NEUROPHYSIOL, V104, P2704, DOI 10.1152/jn.01080.2009; Nijhuis LBO, 2009, J NEUROPHYSIOL, V101, P2802, DOI 10.1152/jn.90945.2008; Park SH, 2018, AGING CLIN EXP RES, V30, P1, DOI 10.1007/s40520-017-0749-0; Pijnappels M, 2010, EXP BRAIN RES, V201, P689, DOI 10.1007/s00221-009-2088-7; Robinovitch SN, 2013, LANCET, V381, P47, DOI 10.1016/S0140-6736(12)61263-X; TINETTI ME, 1986, J AM GERIATR SOC, V34, P119, DOI 10.1111/j.1532-5415.1986.tb05480.x	36	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2019	14	8							e0221398	10.1371/journal.pone.0221398	http://dx.doi.org/10.1371/journal.pone.0221398			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW5XV	31461500	Green Accepted, Green Submitted, Green Published, gold			2022-12-26	WOS:000485052300029
J	Ribelayga, C; Mangel, SC				Ribelayga, Christophe; Mangel, Stuart C.			Circadian clock regulation of cone to horizontal cell synaptic transfer in the goldfish retina	PLOS ONE			English	Article							PHOTORECEPTOR CELLS; DOPAMINE RELEASE; GAP-JUNCTIONS; ROD; SENSITIVITY; ADAPTATION; MODULATION; INPUT; ACTIVATION; MELATONIN	Although it is well established that the vertebrate retina contains endogenous circadian clocks that regulate retinal physiology and function during day and night, the processes that the clocks affect and the means by which the clocks control these processes remain unresolved. We previously demonstrated that a circadian clock in the goldfish retina regulates rod-cone electrical coupling so that coupling is weak during the day and robust at night. The increase in rod-cone coupling at night introduces rod signals into cones so that the light responses of both cones and cone horizontal cells, which are post-synaptic to cones, become dominated by rod input. By comparing the light responses of cones, cone horizontal cells and rod horizontal cells, which are post-synaptic to rods, under dark-adapted conditions during day and night, we determined whether the daily changes in the strength of rodcone coupling could account entirely for rhythmic changes in the light response properties of cones and cone horizontal cells. We report that although some aspects of the day/night changes in cone and cone horizontal cell light responses, such as response threshold and spectral tuning, are consistent with modulation of rod-cone coupling, other properties cannot be solely explained by this phenomenon. Specifically, we found that at night compared to the day the time course of spectrally-isolated cone photoresponses was slower, cone-tocone horizontal cell synaptic transfer was highly non-linear and of lower gain, and the delay in cone-to-cone horizontal cell synaptic transmission was longer. However, under bright light-adapted conditions in both day and night, cone-to-cone horizontal cell synaptic transfer was linear and of high gain, and no additional delay was observed at the cone-to-cone horizontal cell synapse. These findings suggest that in addition to controlling rod-cone coupling, retinal clocks shape the light responses of cone horizontal cells by modulating cone-to-cone horizontal cell synaptic transmission.	[Ribelayga, Christophe; Mangel, Stuart C.] Ohio State Univ, Coll Med, Dept Neurosci, Columbus, OH 43210 USA; [Ribelayga, Christophe] Univ Texas Hlth Sci Ctr Houston, McGovern Med Sch, Dept Ophthalmol & Visual Sci, Houston, TX 77030 USA; [Ribelayga, Christophe] Univ Texas Hlth Sci Ctr Houston, MD Anderson UTHlth Grad Sch Biomed Sci, Houston, TX 77030 USA	University System of Ohio; Ohio State University; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston; UTMD Anderson Cancer Center	Mangel, SC (corresponding author), Ohio State Univ, Coll Med, Dept Neurosci, Columbus, OH 43210 USA.	Stuart.Mangel@osumc.edu		Mangel, Stuart/0000-0001-5729-1660	NIH [R01-EY029777]; Plum Foundation, Studio City, CA; NATIONAL EYE INSTITUTE [R01EY029777] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Plum Foundation, Studio City, CA; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported in part by grants from the NIH (R01-EY029777) and the Plum Foundation, Studio City, CA, to S.C.M. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barlow R, 2001, Prog Brain Res, V131, P487; Besharse JC, 2016, J BIOL RHYTHM, V31, P223, DOI 10.1177/0748730416642657; Bloomfield SA, 2009, NAT REV NEUROSCI, V10, P495, DOI 10.1038/nrn2636; Dmitriev AV, 2000, J PHYSIOL-LONDON, V522, P77, DOI 10.1111/j.1469-7793.2000.0077m.x; Dmitriev AV, 2001, J NEUROSCI, V21, P2897, DOI 10.1523/JNEUROSCI.21-08-02897.2001; Dowling J. E., 2012, RETINA APPROACHABLE; Dunlap J.C., 2004, CHRONOBIOLOGY BIOL T; Emran F, 2010, P NATL ACAD SCI USA, V107, P6034, DOI 10.1073/pnas.0914718107; Felder-Schmittbuhl MP, 2018, INVEST OPHTH VIS SCI, V59, P4856, DOI 10.1167/iovs.18-24957; Govardovskii VI, 2000, VISUAL NEUROSCI, V17, P509, DOI 10.1017/S0952523800174036; Hornstein EP, 2005, J NEUROSCI, V25, P11201, DOI 10.1523/JNEUROSCI.3416-05.2005; Iuvone PM, 2005, PROG RETIN EYE RES, V24, P433, DOI 10.1016/j.preteyeres.2005.01.003; KNAPP AG, 1987, NATURE, V325, P437, DOI 10.1038/325437a0; Ko GY, 2018, EUR J NEUROSCI; Ko GYP, 2001, NEURON, V29, P255, DOI 10.1016/S0896-6273(01)00195-7; Ko ML, 2007, J NEUROCHEM, V103, P784, DOI 10.1111/j.1471-4159.2007.04816.x; Krizaj D, 1998, J COMP NEUROL, V398, P529; Levy H, 2004, EUR J NEUROSCI, V20, P2963, DOI 10.1111/j.1460-9568.2004.03758.x; Mangel S C, 2001, Prog Brain Res, V131, P505; MANGEL SC, 1994, BRAIN RES, V659, P55, DOI 10.1016/0006-8993(94)90862-1; MARC RE, 1976, SCIENCE, V191, P487, DOI 10.1126/science.1246634; NAKA KI, 1968, J PHYSIOL-LONDON, V194, P259, DOI 10.1113/jphysiol.1968.sp008406; NORMANN RA, 1990, J PHYSIOL-LONDON, V421, P321, DOI 10.1113/jphysiol.1990.sp017947; Palacios AG, 1998, VISION RES, V38, P2135, DOI 10.1016/S0042-6989(97)00411-2; Park D, 2003, NAT NEUROSCI, V6, P337, DOI 10.1038/nn1033; Pozdeyev N, 2008, EUR J NEUROSCI, V27, P2691, DOI 10.1111/j.1460-9568.2008.06224.x; RAVIOLA E, 1973, P NATL ACAD SCI USA, V70, P1677, DOI 10.1073/pnas.70.6.1677; Ribelayga C, 2004, J PHYSIOL-LONDON, V554, P467, DOI 10.1113/jphysiol.2003.053710; Ribelayga C, 2003, J COMP NEUROL, V467, P243, DOI 10.1002/cne.10927; Ribelayga C, 2002, J PHYSIOL-LONDON, V544, P801, DOI 10.1113/jphysiol.2002.023671; Ribelayga C, 2008, NEURON, V59, P790, DOI 10.1016/j.neuron.2008.07.017; Ribelayga C, 2007, VISUAL NEUROSCI, V24, P333, DOI 10.1017/S0952523807070319; Ribelayga C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011020; Ribelayga CP, 2019, NETWORK FUNCTIONS PL; Rodieck RW, 1998, 1 STEP SEEING; Schneeweis DM, 1999, J NEUROSCI, V19, P1203; SCHWANZARA SA, 1967, VISION RES, V7, P121, DOI 10.1016/0042-6989(67)90079-X; Spiwoks-Becker I, 2004, EUR J NEUROSCI, V19, P1559, DOI 10.1111/j.1460-9568.2004.03198.x; STELL WK, 1975, J COMP NEUROL, V159, P473, DOI 10.1002/cne.901590404; STELL WK, 1976, VISION RES, V16, P647, DOI 10.1016/0042-6989(76)90013-4; Tsukamoto Y, 2001, J NEUROSCI, V21, P8616, DOI 10.1523/JNEUROSCI.21-21-08616.2001; Vollrath L, 1996, MICROSC RES TECHNIQ, V35, P472, DOI 10.1002/(SICI)1097-0029(19961215)35:6<472::AID-JEMT6>3.0.CO;2-K; Wang Y, 1996, P NATL ACAD SCI USA, V93, P4655, DOI 10.1073/pnas.93.10.4655; Wang Y, 1997, J NEUROPHYSIOL, V78, P439, DOI 10.1152/jn.1997.78.1.439; WITKOVSKY P, 1974, INVEST OPHTH VISUAL, V13, P996; Wu, 2010, ENCY EYE, V1, P283; WU SM, 1991, J NEUROPHYSIOL, V65, P1197, DOI 10.1152/jn.1991.65.5.1197; YANG XL, 1989, SCIENCE, V244, P352, DOI 10.1126/science.2711185; Zrang AJ, 2006, J COMP NEUROL, V499, P422, DOI 10.1002/cne.21117	49	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2019	14	8							e0218818	10.1371/journal.pone.0218818	http://dx.doi.org/10.1371/journal.pone.0218818			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5XV	31461464	gold, Green Published, Green Submitted			2022-12-26	WOS:000485052300006
J	Street, SM; Eytcheson, SA; LeBlanc, GA				Street, Stephanie M.; Eytcheson, Stephanie A.; LeBlanc, Gerald A.			The role of nuclear receptor E75 in regulating the molt cycle of Daphnia magna and consequences of its disruption	PLOS ONE			English	Article							DROSOPHILA-MELANOGASTER; MANDUCA-SEXTA; NITRIC-OXIDE; ECDYSONE; GROWTH; METAMORPHOSIS; BETA-FTZ-F1; INSIGHTS; NITROGEN; PATHWAY	Biological rhythms regulate innumerable physiological processes, yet little is known of factors that regulate many of these rhythms. Disruption in the timing of these rhythms can have devastating impacts on population sustainability. We hypothesized that the timing of the molt infradian rhythm in the crustacean Daphnia magna is regulated by the joint action of the protein E75 and nitric oxide. Further, we hypothesized that disruption of the function of E75 would adversely impact several physiological processes related to growth and reproduction. Analysis of mRNA levels of several genes, involved in regulating the molt cycle in insects, revealed the sequential accumulation of E75, its dimer partner HR3, FTZ-F1, and CYP18a1 during the molt cycle. Exposure to the nitric oxide donor sodium nitroprusside early in the molt cycle had no effect on E75 or HR3 mRNA levels, but delayed the peak accumulation of FTZ-F1 and CYP18a1 mRNA. The subsequent exuviation was also delayed consistent with the delay in peak accumulation of FTZ-F1 and CYP18a1. These results supported our assertion that nitric oxide binds E75 rendering it incapable of binding HR3. Excess HR3 protein then enhanced the accumulation of the downstream products FTZ-F1 and CYP18a1. Similarly, suppression of E75 mRNA levels, using siRNA, had no effect on mRNA levels of HR3 but elevated mRNA levels of FTZ-F1. Consistent with these molecular responses, the suppression of E75 using siRNA increased the duration of the molt cycle and reduced the number of offspring produced. We conclude that the molt cycle of daphnids is regulated in a manner similar to insects and disruption of E75 results in a lengthening of the molt cycle and a reduction the release of viable offspring.	[Street, Stephanie M.; Eytcheson, Stephanie A.; LeBlanc, Gerald A.] North Carolina State Univ, Dept Biol Sci, Raleigh, NC 27695 USA	University of North Carolina; North Carolina State University	LeBlanc, GA (corresponding author), North Carolina State Univ, Dept Biol Sci, Raleigh, NC 27695 USA.	gerald_leblanc@ncsu.edu	Eytcheson, Stephanie A/E-4192-2019	Eytcheson, Stephanie A/0000-0002-0007-2421; Street, Stephanie/0000-0003-0001-8537	National Science Foundation [IOS-1350998]	National Science Foundation(National Science Foundation (NSF))	This work was supported by the National Science Foundation grant IOS-1350998 to GAL. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIKEN DE, 1969, SCIENCE, V164, P149, DOI 10.1126/science.164.3876.149; BUIKEMA AJ, 1973, HYDROBIOLOGIA, V41, P391, DOI 10.1007/BF00016626; Caceres L, 2011, GENE DEV, V25, P1476, DOI 10.1101/gad.2064111; Cayre M, 2005, EUR J NEUROSCI, V21, P2893, DOI 10.1111/j.1460-9568.2005.04153.x; Cho KH, 2014, DEV BIOL, V385, P253, DOI 10.1016/j.ydbio.2013.11.003; Colbourne JK, 2011, SCIENCE, V331, P555, DOI 10.1126/science.1197761; de Rosny E, 2006, BIOCHEMISTRY-US, V45, P9727, DOI 10.1021/bi060537a; Diez MJ, 2013, HELGOLAND MAR RES, V67, P555, DOI 10.1007/s10152-012-0343-y; Dingle H, 2007, BIOSCIENCE, V57, P113, DOI 10.1641/B570206; ESKIN A, 1979, FED PROC, V38, P2570; Eytcheson SA, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-24087-7; FORMAN BM, 1994, MOL ENDOCRINOL, V8, P1253, DOI 10.1210/me.8.9.1253; Franke HD, 2014, HYDROBIOLOGIA, V732, P197, DOI 10.1007/s10750-014-1846-0; Galloway JN, 2002, AMBIO, V31, P64, DOI 10.1639/0044-7447(2002)031[0064:RNATWY]2.0.CO;2; Grant D, 2010, ACS CHEM BIOL, V5, P925, DOI 10.1021/cb100141y; Hannas BR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012453; Hannas BR, 2010, GEN COMP ENDOCR, V167, P268, DOI 10.1016/j.ygcen.2010.03.025; Hannas BR, 2010, MOL CELL ENDOCRINOL, V315, P208, DOI 10.1016/j.mce.2009.07.013; HUET F, 1995, DEVELOPMENT, V121, P1195; Klein JD, 2006, PEDIATRICS, V118, P2245, DOI 10.1542/peds.2006-2481; Lennon JT, 2001, J PLANKTON RES, V23, P425, DOI 10.1093/plankt/23.4.425; LLOYD M, 1966, EVOLUTION, V20, P133, DOI 10.1111/j.1558-5646.1966.tb03350.x; Lozinsky OV, 2012, ARCH INSECT BIOCHEM, V80, P166, DOI 10.1002/arch.21033; Martin-Creuzburg D, 2007, GEN COMP ENDOCR, V151, P66, DOI 10.1016/j.ygcen.2006.11.015; Mu XY, 2004, ENVIRON TOXICOL CHEM, V23, P1085, DOI 10.1897/03-273; Pardee KI, 2009, PLOS BIOL, V7, P384, DOI 10.1371/journal.pbio.1000043; Parks LG, 1996, AQUAT TOXICOL, V34, P291, DOI 10.1016/0166-445X(95)00045-6; Parvy JP, 2005, DEV BIOL, V282, P84, DOI 10.1016/j.ydbio.2005.02.028; Paul MJ, 2008, PHILOS T R SOC B, V363, P341, DOI 10.1098/rstb.2007.2143; Reinberg Alain, 2003, Dialogues Clin Neurosci, V5, P327; Reinking J, 2005, CELL, V122, P195, DOI 10.1016/j.cell.2005.07.005; Rewitz KF, 2010, DEV CELL, V19, P895, DOI 10.1016/j.devcel.2010.10.021; Riddiford LM, 2003, INSECT BIOCHEM MOLEC, V33, P1327, DOI 10.1016/j.ibmb.2003.06.001; Rider CV, 2005, J EXP BIOL, V208, P15, DOI 10.1242/jeb.01343; Song Y, 2017, ENVIRON SCI TECHNOL, V51, P4142, DOI 10.1021/acs.est.7b00480; Sumiya E, 2016, J APPL TOXICOL, V36, P1476, DOI 10.1002/jat.3306; Sumiya E, 2014, FRONT ZOOL, V11, DOI 10.1186/s12983-014-0060-2; Supriya NT, 2017, CHIN J OCEANOL LIMN, V35, P645, DOI 10.1007/s00343-017-5337-9; Suzuki Y, 2013, P NATL ACAD SCI USA, V110, P12518, DOI 10.1073/pnas.1311405110; TAKAHASHI JS, 1984, NATURE, V308, P186, DOI 10.1038/308186a0; Thomson SA, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-500; THUMMEL CS, 1990, BIOESSAYS, V12, P561, DOI 10.1002/bies.950121202; THUMMEL CS, 1995, CELL, V83, P871, DOI 10.1016/0092-8674(95)90203-1; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vitousek PM, 1997, ECOL APPL, V7, P737, DOI 10.2307/2269431; Williams DR, 2000, ARCH BIOCHEM BIOPHYS, V376, P389, DOI 10.1006/abbi.2000.1731	46	4	5	5	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2019	14	8							e0221642	10.1371/journal.pone.0221642	http://dx.doi.org/10.1371/journal.pone.0221642			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5WO	31454379	Green Published, gold, Green Submitted			2022-12-26	WOS:000485049000036
J	Iqbal, NT; Syed, S; Kabir, F; Jamil, Z; Akhund, T; Qureshi, S; Liu, J; Ma, JZ; Guleria, S; Gewirtz, A; Duggan, CP; Hughes, MA; Sadiq, K; Ali, A				Iqbal, Najeeha T.; Syed, Sana; Kabir, Furqan; Jamil, Zehra; Akhund, Tauseef; Qureshi, Shahida; Liu, Jie; Ma, Jennie Z.; Guleria, Shan; Gewirtz, Andrew; Duggan, Christopher P.; Hughes, Molly A.; Sadiq, Kamran; Ali, Asad			Pathobiome driven gut inflammation in Pakistani children with Environmental Enteric Dysfunction	PLOS ONE			English	Article							INTESTINAL INFLAMMATION; DIARRHEAL DISEASE; GROWTH DEFICITS; INFANTS; ENTEROPATHY; INFECTION; CHILDHOOD; INTERVENTIONS; ACQUISITION; FLAGELLIN	Environmental Enteric Dysfunction (EED) is an acquired small intestinal inflammatory condition underlying high rates of stunting in children <5 years of age in low- and middle-income countries. Children with EED are known to have repeated exposures to enteropathogens and environmental toxins that leads to malabsorptive syndrome. We aimed to characterize association of linear growth faltering with enteropathogen burden and subsequent changes in EED biomarkers. In a longitudinal birth cohort (n = 272), monthly anthropometric measurements (Length for Age Z score-LAZ) of asymptomatic children were obtained up to 18 months. Biological samples were collected at 6 and 9 months for the assessment of biomarkers. A customized TaqMan array card was used to target 40 enteropathogens in fecal samples. Linear regression was applied to study the effect of specific enteropathogen infection on change in linear growth (Delta LAZ). Presence of any pathogen in fecal sample correlated with serum flagellin IgA (6 mo, r = 0.19, p = 0.002), fecal Reg 1b (6 mo, r = 0.16, p = 0.01; 9mo, r = 0.16, p = 0.008) and serum Reg 1b (6 mo, r = 0.26, p<0.0001; 9 mo, r = 0.15, p = 0.008). At 6 months, presence of Campylobacter [beta (SE) 7751.2 (2608.5), p = 0.003] and ETEC LT [beta (SE) 7089.2 (3015.04), p = 0.019] was associated with increase in MPO. Giardia was associated with increase in Reg1b [beta (SE) 72.189 (26.394), p = 0.006] and antiflic IgA[beta (SE) 0.054 (0.021), p = 0.0091]. Multiple enteropathogen infections in early life negatively correlated with Delta LAZ, and simultaneous changes in gut inflammatory and permeability markers. A combination vaccine targeting enteropathogens in early life could help in the prevention of future stunting.	[Iqbal, Najeeha T.; Syed, Sana; Kabir, Furqan; Akhund, Tauseef; Qureshi, Shahida; Sadiq, Kamran; Ali, Asad] Aga Khan Univ, Dept Pediat & Child Hlth, Karachi, Pakistan; [Iqbal, Najeeha T.; Jamil, Zehra] Aga Khan Univ, Dept Biol & Biomed Sci, Karachi, Pakistan; [Syed, Sana; Guleria, Shan] Univ Virginia, Dept Pediat, Charlottesville, VA USA; [Liu, Jie; Ma, Jennie Z.; Sadiq, Kamran] Univ Virginia, Dept Med, Charlottesville, VA USA; [Gewirtz, Andrew] Georgia State Univ, Ctr Inflammat Immun & Infect, Atlanta, GA 30303 USA; [Duggan, Christopher P.] Boston Childrens Hosp, Div Gastroenterol Hepatol & Nutr, Boston, MA USA; [Duggan, Christopher P.] Harvard TH Chan Sch Publ Hlth, Dept Global Hlth & Populat, Boston, MA USA; [Duggan, Christopher P.] Harvard TH Chan Sch Publ Hlth, Dept Nutr, Boston, MA USA	Aga Khan University; Aga Khan University; University of Virginia; University of Virginia; University System of Georgia; Georgia State University; Harvard University; Boston Children's Hospital; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health	Ali, A (corresponding author), Aga Khan Univ, Dept Pediat & Child Hlth, Karachi, Pakistan.	asad.ali@aku.edu	Furqan Kabir/AAY-7400-2020	Ali, Syed Asad/0000-0001-5274-7665; Iqbal, Najeeha/0000-0003-4026-5655	Bill and Melinda Gates Foundation [OPP1066200, OPP1066203];  [NIH-K24DK104676];  [2P30 DK040561]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK040561, K24DK104676] Funding Source: NIH RePORTER	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); ; ; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the Bill and Melinda Gates Foundation grant OPP1066200 & Bill and Melinda Gates Foundation grant OPP1066203 was awarded to AA and CD. CD was also supported in part by NIH-K24DK104676 and 2P30 DK040561. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta AM, 2014, CLIN INFECT DIS, V59, pS193, DOI 10.1093/cid/ciu653; Al-Asy Hassan M, 2017, Int J Pediatr Adolesc Med, V4, P75, DOI 10.1016/j.ijpam.2016.12.004; Berkman DS, 2002, LANCET, V359, P564, DOI 10.1016/S0140-6736(02)07744-9; Bhutta ZA, 2008, LANCET, V371, P417, DOI 10.1016/S0140-6736(07)61693-6; BLACK RE, 1988, J INFECT DIS, V157, P472, DOI 10.1093/infdis/157.3.472; Campbell DI, 2004, J PEDIATR GASTR NUTR, V39, P153, DOI 10.1097/00005176-200408000-00005; Campbell DI, 2003, J NUTR, V133, P1332; de Onis M, 2007, B WORLD HEALTH ORGAN, V85, P660, DOI 10.2471/BLT.07.043497; Dewey KG, 2008, MATERN CHILD NUTR, V4, P24, DOI 10.1111/j.1740-8709.2007.00124.x; Donowitz JR, 2016, CLIN INFECT DIS, V63, P792, DOI 10.1093/cid/ciw391; Estivariz CF, 2008, JPEN-PARENTER ENTER, V32, P389, DOI 10.1177/0148607108317880; Gewirtz AT, 2001, J IMMUNOL, V167, P1882, DOI 10.4049/jimmunol.167.4.1882; Gewirtz AT, 2001, J CLIN INVEST, V107, P99, DOI 10.1172/JCI10501; Gilmartin AA, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0143; Guerrant RL, 2013, NAT REV GASTRO HEPAT, V10, P220, DOI 10.1038/nrgastro.2012.239; Herbinger KH, 2016, AM J TROP MED HYG, V95, P938, DOI 10.4269/ajtmh.16-0387; Iqbal NT, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21319-8; Kelly P, 2004, AM J TROP MED HYG, V70, P412; Keusch GT, 2014, CLIN INFECT DIS, V59, pS207, DOI 10.1093/cid/ciu485; Korpe PS, 2018, CLIN INFECT DIS, V67, P1660, DOI 10.1093/cid/ciy355; Korpe PS, 2012, TRENDS MOL MED, V18, P328, DOI 10.1016/j.molmed.2012.04.007; Kosek M, 2013, AM J TROP MED HYG, V88, P390, DOI 10.4269/ajtmh.2012.12-0549; Kosek MN, 2016, AM J TROP MED HYG, V95, P928, DOI 10.4269/ajtmh.16-0037; Kotloff KL, 2013, LANCET, V382, P209, DOI 10.1016/S0140-6736(13)60844-2; Lee G, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002036; Liu J, 2016, LANCET, V388, P1291, DOI 10.1016/S0140-6736(16)31529-X; Liu J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158199; Liu J, 2014, LANCET INFECT DIS, V14, P716, DOI 10.1016/S1473-3099(14)70808-4; Liu J, 2013, J CLIN MICROBIOL, V51, P472, DOI 10.1128/JCM.02658-12; Naylor C, 2015, EBIOMEDICINE, V2, P1759, DOI 10.1016/j.ebiom.2015.09.036; Peterson KM, 2013, AM J CLIN NUTR, V97, P1129, DOI 10.3945/ajcn.112.048306; Praharaj I, 2018, AM J TROP MED HYG, V98, P576, DOI 10.4269/ajtmh.17-0324; Prendergast AJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086928; Ramakrishna BS, 2006, POSTGRAD MED J, V82, P779, DOI 10.1136/pgmj.2006.048579; Rogawski ET, 2018, LANCET GLOB HEALTH, V6, pE1319, DOI [10.1016/s2214-109x(18)30351-6, 10.1016/S2214-109X(18)30351-6]; Rogawski ET, 2017, J PEDIATR INFECT DIS, V6, P153, DOI 10.1093/jpids/piw082; Rouhani S, 2016, CLIN INFECT DIS, V62, P1210, DOI 10.1093/cid/ciw072; Shinozaki S, 2001, GUT, V48, P623, DOI 10.1136/gut.48.5.623; Sow SO, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004729; Syed S, 2018, AM J TROP MED HYG, V98, P1577, DOI 10.4269/ajtmh.17-0306; Syed S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193768; Syed S, 2016, J PEDIATR GASTR NUTR, V63, P6, DOI 10.1097/MPG.0000000000001147; Thorpe CM, 1999, INFECT IMMUN, V67, P5985, DOI 10.1128/IAI.67.11.5985-5993.1999; Troeger H, 2009, GUT, V58, P1070, DOI 10.1136/gut.2008.160150; Wenneras C, 2004, J HEALTH POPUL NUTR, V22, P370; WHO, WHO CHILD GROWTH STA	46	5	5	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2019	14	8							e0221095	10.1371/journal.pone.0221095	http://dx.doi.org/10.1371/journal.pone.0221095			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5TR	31442248	gold, Green Published, Green Submitted			2022-12-26	WOS:000485041400020
J	Jhee, JH; Lee, S; Park, Y; Lee, SE; Kim, YA; Kang, SW; Kwon, JY; Park, JT				Jhee, Jong Hyun; Lee, SungHee; Park, Yejin; Lee, Sang Eun; Kim, Young Ah; Kang, Shin-Wook; Kwon, Ja-Young; Park, Jung Tak			Prediction model development of late-onset preeclampsia using machine learning-based methods	PLOS ONE			English	Article							ARTIFICIAL NEURAL-NETWORKS; PATTERN-RECOGNITION; HEART-FAILURE; PREGNANCY; ASSOCIATION; VARIABILITY; PATHOGENESIS; OUTCOMES; KIDNEY; LEVEL	Preeclampsia is one of the leading causes of maternal and fetal morbidity and mortality. Due to the lack of effective preventive measures, its prediction is essential to its prompt management. This study aimed to develop models using machine learning to predict late-onset preeclampsia using hospital electronic medical record data. The performance of the machine learning based models and models using conventional statistical methods were also compared. A total of 11,006 pregnant women who received antenatal care at Yonsei University Hospital were included. Maternal data were retrieved from electronic medical records during the early second trimester to 34 weeks. The prediction outcome was late-onset preeclampsia occurrence after 34 weeks' gestation. Pattern recognition and cluster analysis were used to select the parameters included in the prediction models. Logistic regression, decision tree model, naive Bayes classification, support vector machine, random forest algorithm, and stochastic gradient boosting method were used to construct the prediction models. C-statistics was used to assess the performance of each model. The overall preeclampsia development rate was 4.7% (474 patients). Systolic blood pressure, serum blood urea nitrogen and creatinine levels, platelet counts, serum potassium level, white blood cell count, serum calcium level, and urinary protein were the most influential variables included in the prediction models. C-statistics for the decision tree model, naive Bayes classification, support vector machine, random forest algorithm, stochastic gradient boosting method, and logistic regression models were 0.857, 0.776, 0.573, 0.894, 0.924, and 0.806, respectively. The stochastic gradient boosting model had the best prediction performance with an accuracy and false positive rate of 0.973 and 0.009, respectively. The combined use of maternal factors and common antenatal laboratory data of the early second trimester through early third trimester could effectively predict late-onset preeclampsia using machine learning algorithms. Future prospective studies are needed to verify the clinical applicability algorithms.	[Jhee, Jong Hyun] Yonsei Univ, Gangnam Severance Hosp, Coll Med, Div Nephrol,Dept Internal Med, Seoul, South Korea; [Jhee, Jong Hyun; Kang, Shin-Wook; Park, Jung Tak] Yonsei Univ, Inst Kidney Dis Res, Coll Med, Dept Internal Med, Seoul, South Korea; [Lee, SungHee; Lee, Sang Eun] Yonsei Univ, Coll Med, Dept Prevent Med, Seoul, South Korea; [Lee, SungHee; Lee, Sang Eun] Yonsei Univ, Coll Med, Biostat Collaborat Unit, Seoul, South Korea; [Park, Yejin; Kwon, Ja-Young] Yonsei Univ, Coll Med, Inst Womens Med Life Sci, Div Maternal Fetal Med,Dept Obstet & Gynecol, Seoul, South Korea; [Kim, Young Ah] Yonsei Univ Hlth Syst, Dept Med Informat, Seoul, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Park, JT (corresponding author), Yonsei Univ, Inst Kidney Dis Res, Coll Med, Dept Internal Med, Seoul, South Korea.; Kwon, JY (corresponding author), Yonsei Univ, Coll Med, Inst Womens Med Life Sci, Div Maternal Fetal Med,Dept Obstet & Gynecol, Seoul, South Korea.	JAYKWON@yuhs.ac; JTPARK@yuhs.ac		Park, Yejin/0000-0002-0545-7267; Kang, Shin-Wook/0000-0002-5677-4756; Park, Jung Tak/0000-0002-2325-8982; Kwon, Ja-Young/0000-0003-3009-6325	Ministry of Trade, Industry and Energy Grant - Korean government (Medical Device R&D Platform Project) [10060085]	Ministry of Trade, Industry and Energy Grant - Korean government (Medical Device R&D Platform Project)	This work was supported by the Ministry of Trade, Industry and Energy Grant funded by the Korean government (Medical Device R&D Platform Project, Project#: 10060085).	Akopov A S, 2013, Patol Fiziol Eksp Ter, P84; Ananth Cande V, 2013, BMJ, V347, pf6564, DOI 10.1136/bmj.f6564; Bangalore S, 2017, NEW ENGL J MED, V376, P1332, DOI 10.1056/NEJMoa1606148; Bottaci L, 1997, LANCET, V350, P469, DOI 10.1016/S0140-6736(96)11196-X; Bramham K, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2301; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Brown MA, 1997, CLIN EXP HYPERTENS, V19, P713, DOI 10.3109/10641969709083181; Chappell LC, 2013, CIRCULATION, V128, P2121, DOI 10.1161/CIRCULATIONAHA.113.003215; Corinna C, 1995, MACH LEARN, V20, P1, DOI DOI 10.1007/BF00994018; Cornelis T, 2011, SEMIN NEPHROL, V31, P4, DOI 10.1016/j.semnephrol.2010.10.002; Correa M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0206410; COX DR, 1958, J R STAT SOC B, V20, P215; Darcy AM, 2016, JAMA-J AM MED ASSOC, V315, P551, DOI 10.1001/jama.2015.18421; de Ridder D, 2013, BRIEF BIOINFORM, V14, P633, DOI 10.1093/bib/bbt020; Friedman JH, 2002, COMPUT STAT DATA AN, V38, P367, DOI 10.1016/S0167-9473(01)00065-2; Frizzell JD, 2017, JAMA CARDIOL, V2, P204, DOI 10.1001/jamacardio.2016.3956; Gabbay A, 2014, HYPERTENS PREGNANCY, V33, P311, DOI 10.3109/10641955.2013.877925; Gormley M, 2017, AM J OBSTET GYNECOL, V217, DOI 10.1016/j.ajog.2017.03.017; Habli M, 2009, AM J OBSTET GYNECOL, V201, pS32, DOI 10.1016/j.ajog.2009.10.073; Ilekis JV, 2016, AM J OBSTET GYNECOL, V215, pS1, DOI 10.1016/j.ajog.2016.03.001; Kim W, 2012, J BREAST CANCER, V15, P230, DOI 10.4048/jbc.2012.15.2.230; Leslie K, 2011, BEST PRACT RES CL OB, V25, P343, DOI 10.1016/j.bpobgyn.2011.01.002; Mahajan R, 2017, INT J MED INFORM, V108, P55, DOI 10.1016/j.ijmedinf.2017.09.006; Naljayan MV, 2013, ADV CHRONIC KIDNEY D, V20, P265, DOI 10.1053/j.ackd.2013.02.003; Nasrabadi NM, 2007, PATTERN RECOGNITION; Nelson DB, 2014, AM J OBSTET GYNECOL, V210, DOI 10.1016/j.ajog.2013.09.010; North RA, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d1875; Obermeyer Z, 2016, NEW ENGL J MED, V375, P1216, DOI 10.1056/NEJMp1606181; Payne BA, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001589; Rennie J.D., 2003, P 20 INT C MACH LEAR, DOI 10.5555/3041838.3041916; Roberts JM, 2013, OBSTET GYNECOL, V122, P1122, DOI 10.1097/01.AOG.0000437382.03963.88; Rocha VD, 2015, CLIN NUTR, V34, P1166, DOI 10.1016/j.clnu.2014.12.001; Saleem S, 2014, B WORLD HEALTH ORGAN, V92, P605, DOI 10.2471/BLT.13.127464; Sansone M, 2013, J HEALTHC ENG, V4, P465, DOI 10.1260/2040-2295.4.4.465; Sartore G, 2013, ACTA DIABETOL, V50, P437, DOI 10.1007/s00592-013-0459-9; Sharma S, 2013, AM J NEPHROL, V37, P526, DOI 10.1159/000351178; Sircar M, 2015, CURR OPIN NEPHROL HY, V24, P131, DOI 10.1097/MNH.0000000000000105; Sonek J, 2018, AM J OBSTET GYNECOL, V218, DOI 10.1016/j.ajog.2017.10.024; Steegers EAP, 2010, LANCET, V376, P631, DOI 10.1016/S0140-6736(10)60279-6; Thangaratinam S, 2017, HEALTH TECHNOL ASSES, V21, P1, DOI 10.3310/hta21180; Udenze I C, 2014, West Afr J Med, V33, P178; Ullman Jeffrey D., 1983, DATA STRUCTURES ALGO; van der Graaf AM, 2012, NEPHROL DIAL TRANSPL, V27, P51, DOI 10.1093/ndt/gfs278; von Dadelszen P, 2011, LANCET, V377, P219, DOI 10.1016/S0140-6736(10)61351-7; Wei FF, 2014, HYPERTENSION, V63, P790, DOI 10.1161/HYPERTENSIONAHA.113.02681; Wolak T, 2010, J MATERN-FETAL NEO M, V23, P994, DOI 10.3109/14767050903544736; Zeisler H, 2016, NEW ENGL J MED, V374, P13, DOI 10.1056/NEJMoa1414838	47	37	38	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2019	14	8							e0221202	10.1371/journal.pone.0221202	http://dx.doi.org/10.1371/journal.pone.0221202			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5TR	31442238	Green Published, Green Submitted, gold			2022-12-26	WOS:000485041400026
J	Song, OK; Chung, YE; Seo, N; Baek, SE; Choi, JY; Park, MS; Kim, MJ				Song, Ok Kyu; Chung, Yong Eun; Seo, Nieun; Baek, Song-Ee; Choi, Jin-Young; Park, Mi-Suk; Kim, Myeong-Jin			Metal implants influence CT scan parameters leading to increased local radiation exposure: A proposal for correction techniques	PLOS ONE			English	Article							TUBE-CURRENT MODULATION; DUAL-ENERGY CT; ARTIFACT REDUCTION; COMPUTED-TOMOGRAPHY; HIP PROSTHESES; IMAGE QUALITY; FEATURES	Metal implants not only deteriorate image quality, but also increase radiation exposure. The purpose of this study was to evaluate the effect of metal hip prosthesis on absorbed radiation dose and assess the efficacy of organ dose modulation (ODM) and metal artifact reduction (MAR) protocols on dose reduction. An anthropomorphic phantom was scanned with and without bilateral metal hip prostheses, and surface and deep level radiation doses were measured at the abdomen and pelvis. Finally, the absorbed radiation doses at pelvic and abdominal cavities in the reference, ODM, and two MAR scans (Gemstone spectral imaging, GE) were compared. The Mann Whitney-U test and Kruskal-Wallis test were performed to compare the volume CT dose index (CTDIvol) and mean absorbed radiation doses. Unilateral and bilateral metal hip prostheses increased CTDIVOL by 14.4% and 30.5%, respectively. MAR protocols decreased absorbed radiation doses in the pelvis. MAR showed the most significant dose reduction in the deep pelvic cavity followed by ODM. However, MAR protocols increased absorbed radiation doses in the upper abdomen. ODM significantly reduced absorbed radiation in the pelvis and abdomen. In conclusion, metal hip implants increased radiation doses in abdominopelvic CT scans. MAR and ODM techniques reduced absorbed radiation dose in abdominopelvic CT scans with metal hip prostheses.	[Song, Ok Kyu; Chung, Yong Eun; Seo, Nieun; Baek, Song-Ee; Choi, Jin-Young; Park, Mi-Suk; Kim, Myeong-Jin] Yonsei Univ, Coll Med, Dept Radiol, Yonsei Ro, South Korea	Yonsei University; Yonsei University Health System	Chung, YE (corresponding author), Yonsei Univ, Coll Med, Dept Radiol, Yonsei Ro, South Korea.	yelv@yuhs.ac	Kim, Myeong-Jin/E-1623-2011	Kim, Myeong-Jin/0000-0001-7949-5402; Seo, Nieun/0000-0001-8745-6454; Chung, Yong Eun/0000-0003-0811-9578; Choi, Jin-Young/0000-0002-9025-6274; Park, Mi-Suk/0000-0001-5817-2444				Angel E, 2009, PHYS MED BIOL, V54, P497, DOI 10.1088/0031-9155/54/3/003; Frellesen C, 2014, EUR RADIOL, V24, P1725, DOI 10.1007/s00330-014-3197-7; Gu KW, 2017, ABDOM RADIOL, V42, P1424, DOI 10.1007/s00261-016-1038-7; Han SC, 2014, AM J ROENTGENOL, V203, P788, DOI 10.2214/AJR.13.10980; HARAMATI N, 1994, COMPUT MED IMAG GRAP, V18, P429, DOI 10.1016/0895-6111(94)90080-9; Kato Sayuri, 2016, Nihon Shokakibyo Gakkai Zasshi, V113, P2050; Lee S, 2011, ACTA RADIOL, V52, P1101, DOI 10.1258/ar.2011.100295; Magistri P, 2017, DIGEST LIVER DIS, V49, P467, DOI 10.1016/j.dld.2017.01.166; Meinel FG, 2012, INVEST RADIOL, V47, P406, DOI 10.1097/RLI.0b013e31824c86a3; Morsbach F, 2013, RADIOLOGY, V268, P237, DOI 10.1148/radiol.13122089; Nawaz S, 2014, BIO-MED MATER ENG, V24, P3287, DOI 10.3233/BME-141151; Nukui M., 2012, GE HEALTHCARE; Park SH, 2017, J MAGN RESON IMAGING, V46, P267, DOI 10.1002/jmri.25568; Pessis E, 2015, SEMIN MUSCULOSKEL R, V19, P446, DOI 10.1055/s-0035-1569256; Rizzo SMR, 2005, AM J ROENTGENOL, V184, P491, DOI 10.2214/ajr.184.2.01840491; Suntharalingam S, 2016, EUR RADIOL, V26, P4072, DOI 10.1007/s00330-016-4285-7; Wolford Monica L, 2015, NCHS Data Brief, P1	17	3	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2019	14	8							e0221692	10.1371/journal.pone.0221692	http://dx.doi.org/10.1371/journal.pone.0221692			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5TR	31442288	Green Published, gold, Green Submitted			2022-12-26	WOS:000485041400069
J	Suzuki, Y; Matsubayashi, J; Ji, X; Yamada, S; Yoneyama, A; Imai, H; Matsuda, T; Aoyama, T; Takakuwa, T				Suzuki, Yuko; Matsubayashi, Jun; Ji, Xiang; Yamada, Shigehito; Yoneyama, Akio; Imai, Hirohiko; Matsuda, Tetsuya; Aoyama, Tomoki; Takakuwa, Tetsuya			Morphogenesis of the femur at different stages of normal human development	PLOS ONE			English	Article							FEMORAL-NECK ANTEVERSION; LIMBS	The present study aimed to better characterize the morphogenesis of the femur from the embryonic to the early fetal periods. Sixty-two human fetal specimens (crown-rump length [CRL] range: 11.4-185 mm) from the Kyoto Collection were used for this study. The morphogenesis and internal differentiation process of the femur were analyzed in 3D using phase-contrast X-ray computed tomography and magnetic resonance imaging. The cartilaginous femur was first observed at Carnegie stage 18. Major anatomical landmarks were formed prior to the initiation of ossification at the center of the diaphysis (CRL, 40 mm), as described by Bardeen. The region with very high signal intensity (phase 5 according to Streeter's classification; i.e., area described as cartilage disintegration) emerged at the center of the diaphysis, which split the region with slightly low signal intensity (phase 4; i.e., cartilage cells of maximum size) in fetuses with a CRL of 40.0 mm. The phase 4 and phase 5 regions became confined to the metaphysis, which might become the epiphyseal cartilage plate. Femur length and ossified shaft length (OSL) showed a strong positive correlation with CRL. The OSL-to-femur length ratio rapidly increased in fetuses with CRL between 40 and 75 mm, which became moderately increased in fetuses with a CRL of. 75 mm. Cartilage canal invasion occurred earlier at the proximal epiphysis (CRL, 62 mm) than at the distal epiphysis (CRL, 75 mm). Morphometry and Procrustes analysis indicated that changes in the femur shape after ossification were limited, which were mainly detected at the time of initial ossification and shortly after that. In contrast, femoral neck anteversion and torsion of the femoral head continuously changed during the fetal period. Our data could aid in understanding the morphogenesis of the femur and in differentiating normal and abnormal development during the early fetal period.	[Suzuki, Yuko; Matsubayashi, Jun; Ji, Xiang; Yamada, Shigehito; Aoyama, Tomoki; Takakuwa, Tetsuya] Kyoto Univ, Grad Sch Med, Human Hlth Sci, Kyoto, Japan; [Yamada, Shigehito] Kyoto Univ, Grad Sch Med, Congenital Anomaly Res Ctr, Kyoto, Japan; [Yoneyama, Akio] SAGA Light Source, Saga, Japan; [Imai, Hirohiko; Matsuda, Tetsuya] Kyoto Univ, Grad Sch Informat, Dept Syst Sci, Kyoto, Japan	Kyoto University; Kyoto University; Kyoto University	Takakuwa, T (corresponding author), Kyoto Univ, Grad Sch Med, Human Hlth Sci, Kyoto, Japan.	tez@hs.med.kyoto-u.ac.jp	Yoneyama, Akio/ABH-5357-2020; Yamada, Shigehito/G-2061-2010	Yamada, Shigehito/0000-0002-8194-6927; Matsubayashi, Jun/0000-0003-4104-6833; Matsuda, Tetsuya/0000-0002-2339-1521; Takakuwa, Tetsuya/0000-0002-9660-9384; Yoneyama, Akio/0000-0001-6925-6723	Japan Society for the Promotion of Science (KAKENHI) [JP26220004, JP16K15535, JP17H05294, JP18K07876]	Japan Society for the Promotion of Science (KAKENHI)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Financial support for the study was provided by Japan Society for the Promotion of Science (KAKENHI) Grant Numbers JP26220004, JP16K15535, JP17H05294, JP18K07876. (https://www.jsps.go.jp/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aghajanian P, 2018, BONE RES, V6, DOI 10.1038/s41413-018-0021-z; Bardeen CR, 1901, AM J ANAT, V1, P1, DOI 10.1002/aja.1000010102; Bardeen CR, 1905, AM J ANAT, V4, P265, DOI 10.1002/aja.1000040302; Blumer MJF, 2008, ANN ANAT, V190, P305, DOI 10.1016/j.aanat.2008.02.004; BROWNE D, 1955, ARCH DIS CHILD, V30, P37, DOI 10.1136/adc.30.149.37; Dhawan V, 2014, EUR J ANAT, V18, P273; FELTS WJL, 1954, AM J ANAT, V94, P1, DOI 10.1002/aja.1000940102; GARDNER E, 1970, AM J ANAT, V129, P121, DOI 10.1002/aja.1001290202; GUIDERA KJ, 1994, CLIN ORTHOP RELAT R, P17; Gulan G, 2000, COLLEGIUM ANTROPOL, V24, P521; Momose A, 2001, NUCL INSTRUM METH A, V467, P917, DOI 10.1016/S0168-9002(01)00523-X; NISHIMURA H, 1968, TERATOLOGY, V1, P281, DOI 10.1002/tera.1420010306; O'Rahilly R, 2001, HUMAN EMBRYOLOGY TER; O'Rahilly R., 1987, DEV STAGES HUMAN EMB; ORAHILLY R, 1975, ANAT EMBRYOL, V148, P1, DOI 10.1007/BF00315559; Pick JW., 1941, Q B NW U MED SCHOOL, V15, P281; Rosati P, 1997, EARLY HUM DEV, V49, P91, DOI 10.1016/S0378-3782(97)01881-1; ROTTEM S, 1989, LANCET, V1, P444; SHIOTA K, 1991, Congenital Anomalies, V31, P67, DOI 10.1111/j.1741-4520.1991.tb00360.x; Souza AD, 2015, MALAYS ORTHOP J, V9, P33, DOI 10.5704/MOJ.1507.009; STREETER GL, 1949, CONTRIB EMBRYOL, V33, P151; Toyoda S, 2015, ANAT REC, V298, P2081, DOI 10.1002/ar.23268; Uhthoff HK, 1990, EMBRYOLOGY HUMAN LOC, P15; Yamaguchi Y, 2018, CELLS TISSUES ORGANS, V205, P314, DOI 10.1159/000490672; Yoneyama A, 2004, NUCL INSTRUM METH A, V523, P217, DOI 10.1016/j.nima.2003.12.008; Yoneyama A, 2011, ADVANCED BIOMEDICAL ENGINEERING-BOOK, P107; Zhou X, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004820; ZORZOLI A, 1994, ULTRASOUND OBST GYN, V4, P29, DOI 10.1046/j.1469-0705.1994.04010029.x	28	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2019	14	8							e0221569	10.1371/journal.pone.0221569	http://dx.doi.org/10.1371/journal.pone.0221569			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5TR	31442281	gold, Green Published, Green Submitted			2022-12-26	WOS:000485041400052
J	Wronska-Pilarek, D; Wiatrowska, B; Bocianowski, J				Wronska-Pilarek, Dorota; Wiatrowska, Blanka; Bocianowski, Jan			Pollen morphology and variability of invasive Spiraea tomentosa L. (Rosaceae) from populations in Poland	PLOS ONE			English	Article							FEATURES	The aim of this study was to investigate the pollen morphology and the ranges of intraspecific and interindividual variability of the North American steeplebush-Spiraea tomentosa L., an invasive species in Poland. Steeplebush inflorescences were collected randomly from 30 localities of S. tomentosa in Poland. In total, 900 pollen grains were analysed with both a light and a scanning electron microscope. Nine quantitative and three qualitative pollen features were studied. The diagnostic features were: exine ornamentation (size and direction of the muri), operculum and perforation size. For the first time, the intraspecific and interindividual variability of the pollen grains of the highly invasive S. tomentosa were investigated. Pollen grain features were so similar, that they did not allow to differentiate individual samples of S. tomentosa and only groups of samples were recognized.	[Wronska-Pilarek, Dorota; Wiatrowska, Blanka] Poznan Univ Life Sci, Dept Forest Bot, Poznan, Poland; [Bocianowski, Jan] Poznan Univ Life Sci, Dept Math & Stat Methods, Poznan, Poland	Poznan University of Life Sciences; Poznan University of Life Sciences	Wronska-Pilarek, D (corresponding author), Poznan Univ Life Sci, Dept Forest Bot, Poznan, Poland.	dorota.wronska-pilarek@up.poznan.pl		Bocianowski, Jan/0000-0002-0102-0084; Wiatrowska, Blanka/0000-0003-2542-4953; Wronska-Pilarek, Dorota/0000-0003-2431-6192				[Anonymous], 2012, ROSLINY OBCEGO POCHO; [Anonymous], 2018, MAGNOLIOPHYTA PICRAM, VIX; [Anonymous], ILLUSTRATED POLLEN T; CAMUSSI A, 1985, GENETICS, V111, P945; Dajdok Z, 2011, INVASIVE ALIEN SPECI; EIDE F, 1981, Grana, V20, P101, DOI 10.1080/00173138109427651; ERDTMAN G., 1960, SVENSK BOT TIDSKR, V54, P561; Erdtman G., 1952, POLLEN MORPHOLOGY PL, P1; HEBDA RJ, 1990, REV PALAEOBOT PALYNO, V64, P103, DOI 10.1016/0034-6667(90)90123-Z; HEBDA RJ, 1994, ACTA BOT GALLICA, V141, P183, DOI 10.1080/12538078.1994.10515150; Kott S., 2009, Berichte der Naturforschenden Gesellschaft der Oberlausitz, V17, P21; Liu H, 2010, SCI TECHNOL WELD JOI, V15, P428, DOI 10.1179/136217110X12731414740031; Mahalanobis P.C., 1936, P NATL I SCI INDIA, V2, P49, DOI DOI 10.1145/1390156.1390302; Polyakova TA, 2008, CONTEMP PROBL ECOL, V1, P420, DOI 10.1134/S199542550804005X; Potter D, 2007, PLANT SYST EVOL, V266, P105, DOI 10.1007/s00606-007-0544-z; Potter D, 2007, PLANT SYST EVOL, V266, P5, DOI 10.1007/s00606-007-0539-9; Poyarkova AI, 1939, FLORA USSR, V9; Punt W, 2007, REV PALAEOBOT PALYNO, V143, P1, DOI 10.1016/j.revpalbo.2006.06.008; RENCHER AC, 1992, AM STAT, V46, P217, DOI 10.2307/2685219; Seidler-Lozykowska K, 2012, IND CROP PROD, V35, P140, DOI 10.1016/j.indcrop.2011.06.026; SHAPIRO SS, 1965, BIOMETRIKA, V52, P591, DOI 10.2307/2333709; Song JH, 2017, GRANA, V56, P351, DOI 10.1080/00173134.2016.1274334; Symes M., 1983, GARD HIST, V11, P112, DOI [10.2307/1586839, DOI 10.2307/1586839]; Tyler T, 2015, NORD J BOT, V33, P300, DOI 10.1111/njb.00773; Wiatrowska B, 2016, SYLWAN, V160, P696; Wronska-Pilarek D, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0204557; Wronska-Pilarek Dorota, 2016, PLoS One, V11, pe0161762, DOI 10.1371/journal.pone.0161762; Wronska-Pilarek D, 2013, BOT J LINN SOC, V172, P555, DOI 10.1111/boj.12033; Wronska-Pilarek D, 2012, DENDROBIOLOGY, V67, P25; Wronska-Pilarek D, 2012, BIOLOGIA, V67, P87, DOI 10.2478/s11756-011-0141-z; Wronska-Pilarek D, 2009, DENDROBIOLOGY, V62, P71; Zhou Li-Hua, 1999, Acta Botanica Yunnanica, V21, P303	32	3	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2019	14	8							e0218276	10.1371/journal.pone.0218276	http://dx.doi.org/10.1371/journal.pone.0218276			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5TR	31442232	Green Published, Green Submitted, gold			2022-12-26	WOS:000485041400004
J	Beetz, O; Kolb, J; Buck, B; Trautewig, B; Timrott, K; Vondran, FWR; Meder, I; Lobbert, C; Hundrieser, J; Klempnauer, J; Bektas, H; Lieke, T				Beetz, Oliver; Kolb, Joline; Buck, Benjamin; Trautewig, Britta; Timrott, Kai; Vondran, Florian W. R.; Meder, Ingrid; Loebbert, Corinna; Hundrieser, Joachim; Klempnauer, Juergen; Bektas, Hueseyin; Lieke, Thorsten			Recipient natural killer cells alter the course of rejection of allogeneic heart grafts in rats	PLOS ONE			English	Article							DONOR DENDRITIC CELLS; CD4(+) T-CELLS; NK CELLS; ALLOGRAFT-REJECTION; TRANSPLANTATION; TOLERANCE; ACTIVATION; INDUCTION; INNATE; MACROPHAGE	Rejection of solid organ grafts is regarded to be dependent on T cell responses. Nonetheless, numerous studies have focused on the contribution of NK cells in this process, resulting in contradictory theories. While some conclude that there is no participation of NK cells, others found an inflammatory or regulative role of NK cells. However, the experimental settings are rarely comparable with regard to challenged species, strain combinations or the nature of the graft. Thus, clear definition of NK cell contribution might be impeded by these circumstances. In this study we performed heterotopic heart transplantation (HTx) in rats, choosing one donor-recipient-combination leading to a fast and a second leading to a prolonged course of graft rejection. We intervened in the rejection process, by depletion of recipient NK cells on the one hand and by injection of activated NK cells syngeneic to the recipients on the other. The fast course of rejection could not be influenced by any of the NK cell manipulative treatments. However, the more prolonged course of rejection was highly susceptible to depletion of NK cells, resulting in significant acceleration of rejection, while injection of NK cells induced acceptance of the grafts. We suggest that, depending on the specific setting, NK cells can attenuate the first trigger of immune response, which allows establishing the regulatory activity leading to tolerance of the graft.	[Beetz, Oliver; Kolb, Joline; Buck, Benjamin; Trautewig, Britta; Timrott, Kai; Vondran, Florian W. R.; Meder, Ingrid; Loebbert, Corinna; Bektas, Hueseyin; Lieke, Thorsten] Hannover Med Sch, Dept Gen Visceral & Transplantat Surg, Regenerat Med & Expt Surg, Hannover, Germany; [Trautewig, Britta; Hundrieser, Joachim; Klempnauer, Juergen] Hannover Med Sch, Dept Gen Visceral & Transplantat Surg, Transplant Lab, Hannover, Germany; [Bektas, Hueseyin] Hosp Grp Gesundheit Nord, Dept Gen Visceral & Oncol Surg, Bremen, Germany	Hannover Medical School; Hannover Medical School	Lieke, T (corresponding author), Hannover Med Sch, Dept Gen Visceral & Transplantat Surg, Regenerat Med & Expt Surg, Hannover, Germany.	Lieke.Thorsten@mh-hannover.de						Andrews DM, 2010, J EXP MED, V207, P1333, DOI 10.1084/jem.20091193; Bektas H, 2005, J HEART LUNG TRANSPL, V24, P614, DOI 10.1016/j.healun.2004.01.016; Bose A, 2003, J IMMUNOL, V170, P1611, DOI 10.4049/jimmunol.170.4.1611; BUSHELL A, 1995, EUR J IMMUNOL, V25, P2643, DOI 10.1002/eji.1830250936; Coudert RD, 2002, J IMMUNOL, V169, P2979, DOI 10.4049/jimmunol.169.6.2979; Dahlke MH, 2002, BLOOD, V99, P3566, DOI 10.1182/blood.V99.10.3566; Deniz G, 2008, J IMMUNOL, V180, P850, DOI 10.4049/jimmunol.180.2.850; Fort MM, 1998, J IMMUNOL, V161, P3256; Gagne K, 2001, EUR J IMMUNOL, V31, P3111, DOI 10.1002/1521-4141(2001010)31:10<3111::AID-IMMU3111>3.0.CO;2-6; Grau V, 1998, CELL TISSUE RES, V291, P117; Grau V, 2001, TRANSPLANTATION, V71, P37, DOI 10.1097/00007890-200101150-00007; HEIDECKE CD, 1985, TRANSPLANTATION, V40, P441; Ito A, 2008, INT IMMUNOL, V20, P1343, DOI 10.1093/intimm/dxn092; KARRE K, 1986, NATURE, V319, P675, DOI 10.1038/319675a0; Kataoka M, 2002, SURGERY, V132, P167, DOI 10.1067/msy.2002.125303; KLEMPNAUER J, 1989, IMMUNOGENETICS, V30, P81, DOI 10.1007/BF02421535; Kou XX, 2015, J IMMUNOL, V194, P2810, DOI 10.4049/jimmunol.1303188; Kraus L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047074; Laffont S, 2008, BLOOD, V112, P661, DOI 10.1182/blood-2007-10-120089; Lair D, 2007, AM J TRANSPLANT, V7, P538, DOI 10.1111/j.1600-6143.2006.01660.x; Lee SH, 2009, J EXP MED, V206, P2235, DOI 10.1084/jem.20082387; Lu Y, 2012, PHYTOMEDICINE, V19, P882, DOI 10.1016/j.phymed.2012.04.010; Maier S, 2001, NAT MED, V7, P557, DOI 10.1038/87880; Maroof A, 2008, IMMUNITY, V29, P295, DOI 10.1016/j.immuni.2008.06.012; McNerney ME, 2006, AM J TRANSPLANT, V6, P505, DOI 10.1111/j.1600-6143.2005.01226.x; MINAMI Y, 1987, J BIOL CHEM, V262, P13342; NEMLANDER A, 1983, EUR J IMMUNOL, V13, P348, DOI 10.1002/eji.1830130415; Nessi V, 2010, J IMMUNOL, V185, P5656, DOI 10.4049/jimmunol.0903183; Obara H, 2005, AM J TRANSPLANT, V5, P2094, DOI 10.1111/j.1600-6143.2005.00995.x; ONO K, 1969, J THORAC CARDIOV SUR, V57, P225, DOI 10.1016/S0022-5223(19)42744-X; Petersson E, 1997, CELL IMMUNOL, V175, P25, DOI 10.1006/cimm.1996.1031; Raymond M, 2009, J ALLERGY CLIN IMMUN, V124, P1333, DOI 10.1016/j.jaci.2009.07.021; Ruggeri L, 2006, IMMUNOL REV, V214, P202, DOI 10.1111/j.1600-065X.2006.00455.x; SHELTON MW, 1992, TRANSPLANTATION, V54, P278, DOI 10.1097/00007890-199208000-00017; Shen KZ, 2008, AM J PHYSIOL-GASTR L, V294, pG1070, DOI 10.1152/ajpgi.00554.2007; Sun Y, 2016, J HEART LUNG TRANSPL, V35, P378, DOI 10.1016/j.healun.2015.10.041; Tao Y, 2011, TRANSPL P, V43, P1985, DOI 10.1016/j.transproceed.2011.01.160; van Leest Y, 2011, TRANSPL IMMUNOL, V24, P138, DOI 10.1016/j.trim.2010.11.001; Waggoner SN, 2012, NATURE, V481, P394, DOI 10.1038/nature10624; WALLGREN AC, 1995, TRANSPLANTATION, V60, P594, DOI 10.1097/00007890-199509270-00013; Yu G, 2006, J EXP MED, V203, P1851, DOI 10.1084/jem.20060603; Zenhaeusern G, 2009, AM J TRANSPLANT, V9, P2624, DOI 10.1111/j.1600-6143.2009.02808.x; Zhuo M, 2010, EUR J IMMUNOL, V40, P1748, DOI 10.1002/eji.200939779	43	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2019	14	8							e0220546	10.1371/journal.pone.0220546	http://dx.doi.org/10.1371/journal.pone.0220546			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5RZ	31437165	Green Published, gold, Green Submitted			2022-12-26	WOS:000485036900013
J	Faletti, ME; Chacin, DH; Peake, JA; MacDonald, TC; Stallings, CD				Faletti, Meaghan E.; Chacin, Dinorah H.; Peake, Jonathan A.; MacDonald, Timothy C.; Stallings, Christopher D.			Population dynamics of Pinfish in the eastern Gulf of Mexico (1998-2016)	PLOS ONE			English	Article							LAGODON-RHOMBOIDES; JUVENILE PINFISH; FISH ASSEMBLAGES; PREDATORY FISH; ENERGY DENSITY; NORTHERN GULF; GROWTH-RATES; SEAGRASS; ABUNDANCE; FORAGE	Forage fishes play an important role in marine ecosystems by transferring energy and nutrients through the food web. The population dynamics of forage species can therefore have cascading effects across multiple trophic levels. Here, we analyzed a 19-year dataset on Pinfish (Lagodon rhomboides) across four eastern Gulf of Mexico estuaries to investigate population dynamics, inter- and intra-annual synchrony, metapopulation portfolio effects, growth, and habitat effects. Young-of-year growth rates did not differ among estuaries. The population dynamics of these four systems were stable in the long-term, but highly dynamic inter-annually. Intra-annual dynamics were stable and predictable despite variation in long-term means. Some estuaries exhibited positive inter-annual synchrony, and all four estuaries were synchronous intra-annually. There was evidence for stronger portfolio effects for the entire four-estuary metapopulation, as well as for the two northern estuaries while the southern estuaries appeared to act as a single population. Submerged aquatic vegetation was by far the most important predictor for both presence and abundance of Pinfish. It is important to understand the factors driving forage fish population fluctuations to better predict ecosystem effects, including those to species of economic and ecological importance. These predictors can be useful for the implementation of ecosystem-based management decisions.	[Faletti, Meaghan E.; Chacin, Dinorah H.; Peake, Jonathan A.; Stallings, Christopher D.] Univ S Florida, Coll Marine Sci, St Petersburg, FL 33701 USA; [MacDonald, Timothy C.] Florida Fish & Wildlife Conservat Commiss, Fish & Wildlife Res Inst, St Petersburg, FL USA	State University System of Florida; University of South Florida; Florida Fish & Wildlife Conservation Commission	Faletti, ME (corresponding author), Univ S Florida, Coll Marine Sci, St Petersburg, FL 33701 USA.	mefaletti@mail.usf.edu	MacDonald, Tim/W-7133-2019	MacDonald, Tim/0000-0002-4784-5591; Stallings, Christopher/0000-0002-3410-4540	Florida Forage Fish Coalition; Florida Fish and Wildlife Research Institute; Pew Charitable Trusts; International Game Fish Association; FFRP	Florida Forage Fish Coalition; Florida Fish and Wildlife Research Institute; Pew Charitable Trusts; International Game Fish Association; FFRP	Funding for this research was provided by a fellowship from the Forage Fish Research Program (FFRP), which is a collaboration between the Florida Forage Fish Coalition, the Florida Fish and Wildlife Research Institute, the Pew Charitable Trusts, the International Game Fish Association, and Florida academics. The views expressed are those of the author(s) and do not necessarily reflect the views of the Forage Fish Research Program. The first author (M.E.F.) was awarded a fellowship from the FFRP to conduct this research. The FFRP supported us in our decision to publish. https://floridaforagefish.org/.	Anderson SC, 2013, METHODS ECOL EVOL, V4, P971, DOI 10.1111/2041-210X.12093; Anthony JA, 2000, J EXP MAR BIOL ECOL, V248, P53, DOI 10.1016/S0022-0981(00)00159-3; Attrill MJ, 2000, ECOGRAPHY, V23, P114, DOI 10.1034/j.1600-0587.2000.230112.x; BEVERTON RJH, 1990, J FISH BIOL, V37, P5, DOI 10.1111/j.1095-8649.1990.tb05015.x; Binns H., 2017, COMPASS POINTS; Bourque AS, 2015, MAR ECOL PROG SER, V540, P27, DOI 10.3354/meps11505; Caldwell DK, 1957, THESIS; CARR WES, 1973, T AM FISH SOC, V102, P511, DOI 10.1577/1548-8659(1973)102<511:FHOJMF>2.0.CO;2; Chacin DH, 2016, ESTUAR COAST SHELF S, V183, P52, DOI 10.1016/j.ecss.2016.10.015; Chacin DH, 2016, J EXP MAR BIOL ECOL, V483, P10, DOI 10.1016/j.jembe.2016.05.008; Collier CJ, 2014, MAR POLLUT BULL, V83, P483, DOI 10.1016/j.marpolbul.2014.03.050; Crowder LB, 1979, AQUATIC PLANTS LAKE, P251; Cury P, 2000, ICES J MAR SCI, V57, P603, DOI 10.1006/jmsc.2000.0712; Cury PM, 2011, SCIENCE, V334, P1703, DOI 10.1126/science.1212928; Dahlgren CP, 2006, MAR ECOL PROG SER, V312, P291, DOI 10.3354/meps312291; Darcy GH, 1985, NOAA TECHNICAL REPOR; Essington TE, 2015, P NATL ACAD SCI USA, V112, P6648, DOI 10.1073/pnas.1422020112; Essington TE, 2014, ECOL APPL, V24, P1543, DOI 10.1890/13-1403.1; Figge F, 2004, BIODIVERS CONSERV, V13, P827, DOI 10.1023/B:BIOC.0000011729.93889.34; Flaherty KE, 2011, ESTUAR COAST, V34, P417, DOI 10.1007/s12237-010-9350-x; Fox J, 2012, FUNCTIONS ACCOMPANY; Gallagher ML, 2001, J FISH BIOL, V58, P1704, DOI [10.1006/jfbi.2001.1581, 10.1111/j.1095-8649.2001.tb02324.x]; Gillanders BM, 2006, SEAGRASSES: BIOLOGY, ECOLOGY AND CONSERVATION, P503; Grenouillet G, 2002, ECOGRAPHY, V25, P641, DOI 10.1034/j.1600-0587.2002.250601.x; Hall-Scharf BJ, 2016, T AM FISH SOC, V145, P502, DOI 10.1080/00028487.2016.1143396; Hall-Scharf BJ, 2014, J EXP MAR BIOL ECOL, V460, P193, DOI 10.1016/j.jembe.2014.07.006; Hansen D., 1963, FISHERY B, P68; Harter SL, 2006, ESTUAR COAST, V29, P318, DOI 10.1007/BF02782000; Hays CG, 2005, J EXP MAR BIOL ECOL, V314, P53, DOI 10.1016/j.jembe.2004.08.017; Heck K.L. Jr, 1991, P281; Heck KL, 2003, MAR ECOL PROG SER, V253, P123, DOI 10.3354/meps253123; HECK KL, 1981, J EXP MAR BIOL ECOL, V53, P125, DOI 10.1016/0022-0981(81)90014-9; Hemminga M.A., 2000, SEAGRASS ECOLOGY, DOI [10.1017/CBO9780511525551, DOI 10.1017/CBO9780511525551]; Hildebrand SF, 1972, B US BUR FISH, V43, P388; Hildebrand SF, 1938, US BUREAU FISHERIES, V48, P505; Hill JM, 2015, OIKOS, V124, P750, DOI 10.1111/oik.01774; Houle JE, 2013, J FISH BIOL, V83, P890, DOI 10.1111/jfb.12163; IVERSON RL, 1986, ESTUAR COAST SHELF S, V22, P577, DOI 10.1016/0272-7714(86)90015-6; Jenkins TM, 1999, ECOLOGY, V80, P941, DOI 10.1890/0012-9658(1999)080[0941:EOPDOI]2.0.CO;2; Kovach RP, 2018, CAN J FISH AQUAT SCI, V75, P1960, DOI 10.1139/cjfas-2017-0466; Leibold MA, 1996, AM NAT, V147, P784, DOI 10.1086/285879; Levin PS, 1996, LIMNOL OCEANOGR, V41, P672, DOI 10.4319/lo.1996.41.4.0672; LEVIN SA, 1992, ECOLOGY, V73, P1943, DOI 10.2307/1941447; LIVINGSTON RJ, 1982, MAR ECOL PROG SER, V7, P1, DOI 10.3354/meps007001; Lorenzen K, 2002, P ROY SOC B-BIOL SCI, V269, P49, DOI 10.1098/rspb.2001.1853; Markowitz H, 1952, J FINANC, V7, P77, DOI 10.1111/j.1540-6261.1952.tb01525.x; Masi MD, 2014, ECOL MODEL, V284, P60, DOI 10.1016/j.ecolmodel.2014.04.005; McMichael R.H., 2009, FISHERIES INDEPENDEN; Menge BA, 2000, J EXP MAR BIOL ECOL, V250, P257, DOI 10.1016/S0022-0981(00)00200-8; MONTGOMERY JLM, 1992, J EXP MAR BIOL ECOL, V158, P37, DOI 10.1016/0022-0981(92)90307-V; Moody WD, 1949, Q J FLORIDA ACAD SCI, V12, P147; MORAN PAP, 1953, AUST J ZOOL, V1, P291, DOI 10.1071/ZO9530291; Morris W. F., 2002, QUANTITATIVE CONSERV; Mullaney TJ, 2013, LIMNOL OCEANOGR, V58, P1546, DOI 10.4319/lo.2013.58.5.1546; Mulligan T.J., 1983, Florida Scientist, V46, P250; Muncy R, 1984, OBS821126 US FISH WI; Murphy HM, 2013, MAR ECOL PROG SER, V487, P151, DOI 10.3354/meps10388; Nelson GA, 2002, FISH B-NOAA, V100, P582; Nelson GA, 1998, FISH B-NOAA, V96, P315; Nelson J, 2011, ENVIRON BIOL FISH, V90, P243, DOI 10.1007/s10641-010-9736-4; Nelson JA, 2013, ECOSYSTEMS, V16, P1130, DOI 10.1007/s10021-013-9672-1; Ohs CL, 2018, AQUACULT ECON MANAG, V22, P264, DOI 10.1080/13657305.2017.1298007; Orth RJ, 2006, BIOSCIENCE, V56, P987, DOI 10.1641/0006-3568(2006)56[987:AGCFSE]2.0.CO;2; PAINE RT, 1966, AM NAT, V100, P65, DOI 10.1086/282400; Peterson CH, 1983, BIOL SERVICES PROGRA; Pfister R, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00700; Pikitch EK, 2014, FISH FISH, V15, P43, DOI 10.1111/faf.12004; R Core Team, 2021, R LANGUAGE ENV STAT; Ripley B, 2018, FUNCTIONS DATA SETS; Robinson KL, 2015, ICES J MAR SCI, V72, P2301, DOI 10.1093/icesjms/fsv088; Scattergood L., 1950, PHALACROCORAX AURITU, V67, P506; Seaman Jr W, 1983, SPECIES PROFILES LIF; Smith ADM, 2011, SCIENCE, V333, P1147, DOI 10.1126/science.1209395; Spitzer PM, 2000, J EXP MAR BIOL ECOL, V244, P67, DOI 10.1016/S0022-0981(99)00130-6; SPRINGER S, 1957, ECOLOGY, V38, P166, DOI 10.2307/1932154; Stallings C.D., 2015, ECOLOGY, V96, P304; Stallings CD, 2008, ECOLOGY, V89, P2090, DOI 10.1890/07-1671.1; Stallings CD, 2010, ENVIRON BIOL FISH, V88, P389, DOI 10.1007/s10641-010-9655-4; Stallings CD, 2010, J EXP MAR BIOL ECOL, V389, P1, DOI 10.1016/j.jembe.2010.04.006; Stevens PW, 2016, ECOSPHERE, V7, DOI 10.1002/ecs2.1400; STONER AW, 1982, J EXP MAR BIOL ECOL, V58, P271, DOI 10.1016/0022-0981(82)90134-4; Tuckey TD, 2006, FISH B-NOAA, V104, P102; Van Pelt TI, 1997, COMP BIOCHEM PHYS A, V118, P1393, DOI 10.1016/S0300-9629(97)00240-5; VICTOR BC, 1986, ECOL MONOGR, V56, P145, DOI 10.2307/1942506; WEINSTEIN MP, 1982, B MAR SCI, V32, P791; Weisberg RH, 2016, J GEOPHYS RES-OCEANS, V121, P5672, DOI 10.1002/2015JC011384; Weisberg RH, 2014, CONT SHELF RES, V88, P11, DOI 10.1016/j.csr.2014.06.003; Wexler JB, 2007, FISH B-NOAA, V105, P1; [No title captured]	89	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2019	14	8							e0221131	10.1371/journal.pone.0221131	http://dx.doi.org/10.1371/journal.pone.0221131			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5RZ	31437179	Green Submitted, gold, Green Published			2022-12-26	WOS:000485036900033
J	Hoang, TT; Johnson, DA; Raines, RT; Johnson, JA				Hoang, Trish T.; Johnson, Delinda A.; Raines, Ronald T.; Johnson, Jeffrey A.			Angiogenin activates the astrocytic Nrf2/antioxidant-response element pathway and thereby protects murine neurons from oxidative stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						amyotrophic lateral sclerosis (ALS) (Lou Gehrig disease); astrocyte; neuroprotection; ribonuclease; angiogenin (ANG); motor neuron; neurodegeneration; oxidative stress	ANTIOXIDANT RESPONSE ELEMENT; NRF2-ARE PATHWAY; TRANSFER-RNA; THERAPEUTIC TARGET; CELL-PROLIFERATION; ENDOTHELIAL-CELLS; KINASE-C; TRANSCRIPTION; MECHANISMS; MUTATIONS	The angiogenin (ANG) gene is mutated frequently in individuals with amyotrophic lateral sclerosis (ALS), a fatal neurodegenerative disease characterized by the progressive loss of motor neurons. Delivering human ANG to mice that display ALS-like symptoms extends their lifespan and improves motor function. ANG is a secretory vertebrate RNase that enters neuronal cells and cleaves a subset of tRNAs, leading to the inhibition of translation initiation and the assembly of stress granules. Here, using murine neuronal and astrocytic cell lines, we find that ANG triggers the activation of the Nrf2 (nuclear factor erythroid 2-related factor 2) pathway, which provides a critical cellular defense against oxidative stress. This activation, which occurred in astrocytes but not in neurons, promoted the survival of proximal neurons that had oxidative injury. These findings extend the role of ANG as a neuroprotective agent and underscore its potential utility in ALS management.	[Hoang, Trish T.; Raines, Ronald T.] Univ Wisconsin, Dept Biochem, Madison, WI 53705 USA; [Raines, Ronald T.] Univ Wisconsin, Dept Chem, Madison, WI 53705 USA; [Johnson, Delinda A.; Johnson, Jeffrey A.] Univ Wisconsin, Sch Pharm, 77 Highland Ave, Madison, WI 53705 USA; [Raines, Ronald T.] MIT, Dept Chem, 77 Massachusetts Ave,18-498, Cambridge, MA 02139 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Massachusetts Institute of Technology (MIT)	Johnson, JA (corresponding author), Univ Wisconsin, Sch Pharm, 77 Highland Ave, Madison, WI 53705 USA.; Raines, RT (corresponding author), MIT, Dept Chem, 77 Massachusetts Ave,18-498, Cambridge, MA 02139 USA.	rtraines@mit.edu; jajohnson@pharmacy.wisc.edu			National Institutes of Health [R01 CA073808, P50 AG033514, T32 GM007215]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health Grants R01 CA073808 (to R. T. R.), P50 AG033514 (to J. A. J.), and T32 GM007215 (to T. T. H.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aparicio-Erriu IM, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00167; Bedlack R, 2016, AMYOTROPH LAT SCL FR, V17, P154, DOI 10.3109/21678421.2015.1088707; Benedusi V, 2012, J BIOL CHEM, V287, P35899, DOI 10.1074/jbc.M112.366419; Bloom DA, 2003, J BIOL CHEM, V278, P44675, DOI 10.1074/jbc.M307633200; BRAVO J, 1994, ANAL BIOCHEM, V219, P82, DOI 10.1006/abio.1994.1234; Calkins MJ, 2009, ANTIOXID REDOX SIGN, V11, P497, DOI [10.1089/ars.2008.2242, 10.1089/ARS.2008.2242]; Chan KM, 1996, P NATL ACAD SCI USA, V93, P13943, DOI 10.1073/pnas.93.24.13943; Cho GW, 2010, MOL CELL BIOCHEM, V340, P133, DOI 10.1007/s11010-010-0410-0; CORY AH, 1991, CANCER COMMUN, V3, P207, DOI 10.3727/095535491820873191; Couchman JR, 2003, NAT REV MOL CELL BIO, V4, P926, DOI 10.1038/nrm1257; Crabtree B, 2007, BIOCHEMISTRY-US, V46, P11810, DOI 10.1021/bi701333h; CURRAN TP, 1993, BIOCHEMISTRY-US, V32, P2307, DOI 10.1021/bi00060a023; D'Amico E, 2013, FREE RADICAL BIO MED, V65, P509, DOI 10.1016/j.freeradbiomed.2013.06.029; Ferguson R, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193302; Gellera C, 2008, NEUROGENETICS, V9, P33, DOI 10.1007/s10048-007-0111-3; Greenway MJ, 2006, NAT GENET, V38, P411, DOI 10.1038/ng1742; Guo YS, 2013, LAB INVEST, V93, P825, DOI 10.1038/labinvest.2013.73; Hoang TT, 2017, ANGEW CHEM INT EDIT, V56, P2619, DOI 10.1002/anie.201611446; Hoang TT, 2017, NUCLEIC ACIDS RES, V45, P818, DOI 10.1093/nar/gkw1192; Huang HC, 2002, J BIOL CHEM, V277, P42769, DOI 10.1074/jbc.M206911200; Ivanov P, 2014, P NATL ACAD SCI USA, V111, P18201, DOI 10.1073/pnas.1407361111; Ivanov P, 2011, MOL CELL, V43, P613, DOI 10.1016/j.molcel.2011.06.022; Johnson DA, 2002, J NEUROCHEM, V81, P1233, DOI 10.1046/j.1471-4159.2002.00913.x; Johnson DA, 2015, FREE RADICAL BIO MED, V88, P253, DOI 10.1016/j.freeradbiomed.2015.07.147; Johnson JA, 2008, ANN NY ACAD SCI, V1147, P61, DOI 10.1196/annals.1427.036; Kanninen KM, 2015, FREE RADICAL BIO MED, V88, P350, DOI 10.1016/j.freeradbiomed.2015.06.037; Kanno T, 2012, FREE RADICAL BIO MED, V53, P2028, DOI 10.1016/j.freeradbiomed.2012.09.010; Kaur SJ, 2016, GENE, V577, P109, DOI 10.1016/j.gene.2015.11.049; Kieran D, 2008, J NEUROSCI, V28, P14056, DOI 10.1523/JNEUROSCI.3399-08.2008; Kim GH, 2015, EXP NEUROBIOL, V24, P325, DOI 10.5607/en.2015.24.4.325; Kishimoto K, 2005, ONCOGENE, V24, P445, DOI 10.1038/sj.onc.1208223; Kraft AD, 2004, J NEUROSCI, V24, P1101, DOI 10.1523/JNEUROSCI.3817-03.2004; Kraft AD, 2007, EXP NEUROL, V207, P107, DOI 10.1016/j.expneurol.2007.05.026; Lei XG, 2016, PHYSIOL REV, V96, P307, DOI 10.1152/physrev.00010.2014; Leland PA, 2002, BIOCHEMISTRY-US, V41, P1343, DOI 10.1021/bi0117899; Li Jiang, 2007, V399, P67, DOI 10.1007/978-1-59745-504-6_6; Lyons SM, 2017, RNA BIOL, V14, P171, DOI 10.1080/15476286.2016.1272746; MOROIANU J, 1994, P NATL ACAD SCI USA, V91, P1677, DOI 10.1073/pnas.91.5.1677; Padhi AK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111963; Padhi AK, 2013, SCI REP-UK, V3, DOI 10.1038/srep01225; Peters OM, 2015, J CLIN INVEST, V125, P1767, DOI 10.1172/JCI71601; Pizzo E, 2013, J CELL SCI, V126, P4308, DOI 10.1242/jcs.134551; Raines RT, 1998, CHEM REV, V98, P1045, DOI 10.1021/cr960427h; Rueden CT, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-017-1934-z; Sebastia J, 2009, CELL DEATH DIFFER, V16, P1238, DOI 10.1038/cdd.2009.52; SHAPIRO R, 1989, BIOCHEMISTRY-US, V28, P7401, DOI 10.1021/bi00444a038; Sheng JH, 2014, J CELL PHYSIOL, V229, P521, DOI 10.1002/jcp.24477; Skorupa A, 2013, J PROTEOMICS, V91, P274, DOI 10.1016/j.jprot.2013.07.028; Skorupa A, 2012, J NEUROSCI, V32, P5024, DOI 10.1523/JNEUROSCI.6366-11.2012; STRYDOM DJ, 1985, BIOCHEMISTRY-US, V24, P5486, DOI 10.1021/bi00341a031; Suneetha A, 2016, J CHROMATOGR B, V1019, P15, DOI 10.1016/j.jchromb.2016.02.010; Taylor JP, 2016, NATURE, V539, P197, DOI 10.1038/nature20413; Thiyagarajan N, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2126; Thomas SP, 2018, RNA, V24, P1018, DOI 10.1261/rna.065516.117; Valko M, 2007, INT J BIOCHEM CELL B, V39, P44, DOI 10.1016/j.biocel.2006.07.001; Vargas MR, 2010, NEUROTHERAPEUTICS, V7, P471, DOI 10.1016/j.nurt.2010.05.012; Vargas MR, 2008, J NEUROSCI, V28, P13574, DOI 10.1523/JNEUROSCI.4099-08.2008; Wu D, 2007, ANN NEUROL, V62, P609, DOI 10.1002/ana.21221; Yamasaki S, 2009, J CELL BIOL, V185, P35, DOI 10.1083/jcb.200811106; Yeo KJ, 2014, CHEM COMMUN, V50, P12966, DOI 10.1039/c4cc05175k; Zhang K, 2015, NATURE, V525, P56, DOI 10.1038/nature14973	61	18	18	2	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 11	2019	294	41					15095	15103		10.1074/jbc.RA119.008491	http://dx.doi.org/10.1074/jbc.RA119.008491			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JQ9JH	31431502	Green Published, hybrid			2022-12-26	WOS:000499253400021
J	Collins, KS; Edie, SM; Gao, T; Bieler, R; Jablonski, D				Collins, K. S.; Edie, S. M.; Gao, T.; Bieler, R.; Jablonski, D.			Spatial filters of function and phylogeny determine morphological disparity with latitude	PLOS ONE			English	Article							FLORIDA-KEYS; MARINE BIVALVES; BODY-SIZE; DIVERSITY; EVOLUTION; GRADIENTS; OCEAN; CALCIFICATION; PREDICTORS; PREDATION	The drivers of latitudinal differences in the phylogenetic and ecological composition of communities are increasingly studied and understood, but still little is known about the factors underlying morphological differences. High-resolution, three-dimensional morphological data collected using computerized micro-tomography (micro-CT) allows comprehensive comparisons of morphological diversity across latitude. Using marine bivalves as a model system, this study combines 3D shape analysis (based on a new semi-automated procedure for placing landmarks and semilandmarks on shell surfaces) with non-shape traits: centroid size, proportion of shell to soft-tissue volume, and magnitude of shell ornamentation. Analyses conducted on the morphology of 95% of all marine bivalve species from two faunas along the Atlantic coast of North America, the tropical Florida Keys and the boreal Gulf of Maine, show that morphological shifts between these two faunas, and in phylogenetic and ecological subgroups shared between them, occur as changes in total variance with a bounded minimum rather than directional shifts. The dispersion of species in shell-shape morphospace is greater in the Gulf of Maine, which also shows a lower variance in ornamentation and size than the Florida Keys, but the faunas do not differ significantly in the ratio of shell to internal volume. Thus, regional differences conform to hypothesized effects of resource seasonality and predation intensity, but not to carbonate saturation or calcification costs. The overall morphological differences between the regional faunas is largely driven by the loss of ecological functional groups and family-level clades at high latitudes, rather than directional shifts in morphology within the shared groups with latitude. Latitudinal differences in morphology thus represent a complex integration of phylogenetic and ecological factors that are best captured in multivariate analyses across several hierarchical levels.	[Collins, K. S.; Edie, S. M.; Jablonski, D.] Univ Chicago, Dept Geophys Sci, 5734 S Ellis Ave, Chicago, IL 60637 USA; [Gao, T.] Univ Chicago, Dept Stat, Comm Computat & Appl Math, Chicago, IL 60637 USA; [Bieler, R.] Field Museum Nat Hist, Integrat Res Ctr, Chicago, IL 60605 USA	University of Chicago; University of Chicago; Field Museum of Natural History (Chicago)	Collins, KS (corresponding author), Univ Chicago, Dept Geophys Sci, 5734 S Ellis Ave, Chicago, IL 60637 USA.	kscollins@uchicago.edu	Bieler, Rudiger/F-3280-2010	Bieler, Rudiger/0000-0002-9554-1947; Gao, Tingran/0000-0002-0436-689X; Collins, Katie/0000-0002-3379-4201				Bambach RK, 2007, PALAEONTOLOGY, V50, P1, DOI 10.1111/j.1475-4983.2006.00611.x; Behrenfeld MJ, 1997, LIMNOL OCEANOGR, V42, P1, DOI 10.4319/lo.1997.42.1.0001; Belanger CL, 2012, P NATL ACAD SCI USA, V109, P14046, DOI 10.1073/pnas.1212381109; Berke SK, 2013, GLOBAL ECOL BIOGEOGR, V22, P173, DOI 10.1111/j.1466-8238.2012.00775.x; Bieler R, 2004, MALACOLOGIA, V46, P503; Bieler R, 2014, INVERTEBR SYST, V28, P32, DOI 10.1071/IS13010; Bookstein F L, 1997, Med Image Anal, V1, P225; Ciampaglio CN, 2001, PALEOBIOLOGY, V27, P695, DOI 10.1666/0094-8373(2001)027<0695:DCIMOP>2.0.CO;2; Combosch DJ, 2017, MOL PHYLOGENET EVOL, V107, P191, DOI 10.1016/j.ympev.2016.11.003; Crame JA, 2000, PALEOBIOLOGY, V26, P188; Edie SM, 2018, P NATL ACAD SCI USA, V115, P732, DOI 10.1073/pnas.1717636115; Field R, 2009, J BIOGEOGR, V36, P132, DOI 10.1111/j.1365-2699.2008.01963.x; Fine PVA, 2015, ANNU REV ECOL EVOL S, V46, P369, DOI 10.1146/annurev-ecolsys-112414-054102; FOOTE M, 1991, Contributions from the Museum of Paleontology University of Michigan, V28, P101; FOOTE M, 1993, PALEOBIOLOGY, V19, P403, DOI 10.1017/S0094837300014056; Freestone AL, 2011, ECOLOGY, V92, P983, DOI 10.1890/09-2379.1; Frieder CA, 2017, ICES J MAR SCI, V74, P941, DOI 10.1093/icesjms/fsw213; Gledhill DK, 2015, OCEANOGRAPHY, V28, P182, DOI 10.5670/oceanog.2015.41; Gledhill DK, 2008, J GEOPHYS RES-OCEANS, V113, DOI 10.1029/2007JC004629; Green MA, 2004, LIMNOL OCEANOGR, V49, P727, DOI 10.4319/lo.2004.49.3.0727; Guillen J, 2019, AMBIO, V48, P111, DOI 10.1007/s13280-018-1060-9; Halpern BS, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8615; Harper E.M., 1993, Scripta Geologica Special Issue, V2, P127; Hillebrand H, 2004, AM NAT, V163, P192, DOI 10.1086/381004; Jablonski D, 1997, NATURE, V385, P250, DOI 10.1038/385250a0; Jablonski D, 2017, EVOL BIOL, V44, P451, DOI 10.1007/s11692-017-9434-7; Kissling WD, 2012, GLOBAL ECOL BIOGEOGR, V21, P328, DOI 10.1111/j.1466-8238.2011.00679.x; Kosnik MA, 2006, PALAIOS, V21, P588, DOI 10.2110/palo.2006.p06-012r; Lemer S, 2019, P ROY SOC B-BIOL SCI, V286, DOI 10.1098/rspb.2018.2684; MacLeod N, 1999, PALEOBIOLOGY, V25, P107; Martinelli JC, 2016, PALAIOS, V31, P607, DOI 10.2110/palo.2016.018; Mikkelsen P.M., 2007, SEASHELLS SO FLORIDA; Mikkelsen PM, 2004, MALACOLOGIA, V46, P545; Mikkelsen PM, 2000, GEOL SOC SPEC PUBL, V177, P367, DOI 10.1144/GSL.SP.2000.177.01.25; Mittelbach GG, 2007, ECOL LETT, V10, P315, DOI 10.1111/j.1461-0248.2007.01020.x; Oksanen J, 2018, R PACKAG, V2, P5; PALMER AR, 1983, MAR BIOL, V75, P287, DOI 10.1007/BF00406014; Pigot AL, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.1929; POLLY PD, 2008, PALAEONTOL ELECTRON, V11, P1; Reid JM, 2005, US GEOL SURV DATA SE, V118, P1; Sbrocco E.J., 2013, ECOLOGY, V94, P979, DOI DOI 10.1890/12-1358.1; Schlager S., 2017, STAT SHAPE DEFORMATI, P217; Schluter D, 2016, AM NAT, V187, P1, DOI 10.1086/684193; Schumm M, 2019, P ROY SOC B-BIOL SCI, V286, DOI 10.1098/rspb.2019.0745; Seilacher A., 2014, MORPHODYNAMICS; Stanley S.M, 1970, RELATION SHELL FORM, VVolume 125; STANLEY SM, 1981, PALEOBIOLOGY, V7, P384, DOI 10.1017/S009483730000467X; Valentich-Scott P, 2004, MALACOLOGIA, V46, P339; Valentine J. W., 1973, EVOLUTIONARY PALEOEC; Valentine JW, 2015, J BIOGEOGR, V42, P997, DOI 10.1111/jbi.12515; VALENTINE JW, 1971, LETHAIA, V4, P51, DOI 10.1111/j.1502-3931.1971.tb01278.x; Vermeij G.J., 1978, BIOGEOGRAPHY ADAPTAT; Vermeij G.J, 1987, EVOLUTION ESCALATION; Watson SA, 2012, GLOBAL CHANGE BIOL, V18, P3026, DOI 10.1111/j.1365-2486.2012.02755.x; Webster NB, 2017, ZOOL J LINN SOC-LOND, V180, P732, DOI 10.1093/zoolinnean/zlw015; Zhang C, 2001, 2001 INTERNATIONAL CONFERENCE ON IMAGE PROCESSING, VOL III, PROCEEDINGS, P935, DOI 10.1109/ICIP.2001.958278	56	8	8	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2019	14	8							e0221490	10.1371/journal.pone.0221490	http://dx.doi.org/10.1371/journal.pone.0221490			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW6AB	31465483	Green Submitted, gold, Green Published			2022-12-26	WOS:000485058200019
J	Haraux, F; Lombes, A				Haraux, Francis; Lombes, Anne			Kinetic analysis of ATP hydrolysis by complex V in four murine tissues: Towards an assay suitable for clinical diagnosis	PLOS ONE			English	Article							SYNTHASE DEFICIENCY; INHIBITOR PROTEIN; MITOCHONDRIAL-DNA; MUTATIONS; IF1; IDENTIFICATION; SPECIFICITY; GENE	Background ATP synthase, the mitochondrial complex V, plays a major role in bioenergetics and its defects lead to severe diseases. Lack of a consensual protocol for the assay of complex V activity probably explains the under-representation of complex V defect among mitochondrial diseases. The aim of this work was to elaborate a fast, simple and reliable method to check the maximal complex V capacity in samples relevant to clinical diagnosis. Methods Using homogenates from four different murine organs, we tested the use of dodecylmaltoside, stability of the activity, linearity with protein amount, sensitivity to oligomycin and to exogenous inhibitory factor 1 (IF1), influence of freezing, and impact of mitochondrial purification. Results We obtained organ-dependent, reproducible and stable complex V specific activities, similar with fresh and frozen organs. Similar inhibition by oligomycin and exogenous IF1 demonstrated tight coupling between F-1 and F-0 domains. The Michaelis constant for MgATP had close values for all organs, in the 150-220 mu M range. Complex V catalytic turnover rate, as measured in preparations solubilized in detergent using immunotitration and activity measurements, was more than three times higher in extracts from brain or muscle than in extracts from heart or liver. This tissue specificity suggested post-translational modifications. Concomitant measurement of respiratory activities showed only slightly different complex II/complex V ratio in the four organs. In contrast, complex I/complex V ratio differed in brain as compared to the three other organs because of a high complex I activity in brain. Mitochondria purification preserved these ratios, except for brain where selective degradation of complex I occurred. Therefore, mitochondrial purification could introduce a biased enzymatic evaluation. Conclusion Altogether, this work demonstrates that a reliable assay of complex V activity is perfectly possible with very small samples from frozen biopsies, which was confirmed using control and deficient human muscles.	[Haraux, Francis] CEA, I2BC, Gif Sur Yvette, France; [Haraux, Francis] CNRS, UMR 9198, Gif Sur Yvette, France; [Haraux, Francis] Univ Paris Saclay, Univ Paris Sud, Gif Sur Yvette, France; [Lombes, Anne] INSERM, Unite U1016, Inst Cochin, Paris, France; [Lombes, Anne] CNRS, UMR 8104, Paris, France; [Lombes, Anne] Univ Paris 05, Paris, France	CEA; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Lombes, A (corresponding author), INSERM, Unite U1016, Inst Cochin, Paris, France.; Lombes, A (corresponding author), CNRS, UMR 8104, Paris, France.; Lombes, A (corresponding author), Univ Paris 05, Paris, France.	anne.lombes@inserm.fr	Lombes, Anne/G-4684-2014	Lombes, Anne/0000-0002-9064-0399	Fondation pour la Recherche Medicale (FRM) [DPM20121125550]; AFM Telethon [16416]; French Infrastructure for Integrated Structural Biology (FRISBI)	Fondation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale); AFM Telethon(Association Francaise contre les Myopathies); French Infrastructure for Integrated Structural Biology (FRISBI)	The authors are grateful for the support of the Fondation pour la Recherche Medicale (FRM) (grant DPM20121125550 to AL and FH), the AFM Telethon (grant 16416 to AL), and the French Infrastructure for Integrated Structural Biology (FRISBI, http://frisbi.eu) (to FH).	Andrianaivomananjaona T, 2011, BBA-BIOENERGETICS, V1807, P197, DOI 10.1016/j.bbabio.2010.10.002; Antonicka H, 2006, HUM MOL GENET, V15, P1835, DOI 10.1093/hmg/ddl106; Augereau O, 2005, CELL MOL LIFE SCI, V62, P1478, DOI 10.1007/s00018-005-5005-7; Aure K, 2013, NEUROLOGY, V81, P1810, DOI 10.1212/01.wnl.0000436067.43384.0b; Barca E, 2018, HUM MOL GENET, V27, P3305, DOI 10.1093/hmg/ddy231; Benit P, 2006, CLIN CHIM ACTA, V374, P81, DOI 10.1016/j.cca.2006.05.034; Cabezon E, 2002, J BIOL CHEM, V277, P41334, DOI 10.1074/jbc.M207169200; Cizkova A, 2008, NAT GENET, V40, P1288, DOI 10.1038/ng.246; Dautant A, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00329; De Meirleir L, 2004, J MED GENET, V41, P120, DOI 10.1136/jmg.2003.012047; Vazquez-Memije ME, 2009, J CELL BIOCHEM, V106, P878, DOI 10.1002/jcb.22055; Franko A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082392; Giorgio V, 2010, J BIOENERG BIOMEMBR, V42, P117, DOI 10.1007/s10863-010-9270-2; Gorman GS, 2016, NAT REV DIS PRIMERS, V2, P1, DOI 10.1038/nrdp.2016.80; Green DW, 2000, BBA-BIOENERGETICS, V1458, P343, DOI 10.1016/S0005-2728(00)00085-2; Hatefi Y, 1967, METHOD ENZYMOL, V10, P235; JAULT JM, 1993, J BIOL CHEM, V268, P1558; Jonckheere AI, 2013, BRAIN, V136, P1544, DOI 10.1093/brain/awt086; Kucharczyk R, 2010, BBA-BIOENERGETICS, V1797, P1105, DOI 10.1016/j.bbabio.2009.12.022; Lombes A, 2014, BIOCHIMIE, V100, P171, DOI 10.1016/j.biochi.2013.08.012; MATSUNOYAGI A, 1988, BIOCHEMISTRY-US, V27, P335, DOI 10.1021/bi00401a050; Mayr JA, 2004, PEDIATR RES, V55, P988, DOI 10.1203/01.pdr.0000127016.67809.6b; Mayr JA, 2010, HUM MOL GENET, V19, P3430, DOI 10.1093/hmg/ddq254; Medja F, 2009, MITOCHONDRION, V9, P331, DOI 10.1016/j.mito.2009.05.001; Olahova M, 2018, AM J HUM GENET, V102, P494, DOI 10.1016/j.ajhg.2018.01.020; Pecinova A, 2011, MITOCHONDRION, V11, P722, DOI 10.1016/j.mito.2011.05.006; Pfeffer G, 2012, J NEUROL NEUROSUR PS, V83, P883, DOI 10.1136/jnnp-2012-302568; PULLMAN ME, 1963, J BIOL CHEM, V238, P3762; Rossignol R, 1999, J BIOL CHEM, V274, P33426, DOI 10.1074/jbc.274.47.33426; RUSTIN P, 1994, CLIN CHIM ACTA, V228, P35, DOI 10.1016/0009-8981(94)90055-8; Schmitt S, 2013, ANAL BIOCHEM, V443, P66, DOI 10.1016/j.ab.2013.08.007; Shibata T, 2015, BIOCHEM BIOPH RES CO, V463, P563, DOI 10.1016/j.bbrc.2015.05.095; Sikorska M, 2009, MUSCLE NERVE, V40, P381, DOI 10.1002/mus.21355; Song JY, 2018, P NATL ACAD SCI USA, V115, P2850, DOI 10.1073/pnas.1801697115; Thompson K, 2018, EMBO MOL MED, V10, DOI 10.15252/emmm.201809060; vanRaaij MJ, 1996, BIOCHEMISTRY-US, V35, P15618, DOI 10.1021/bi960628f; Vantourout P, 2010, WORLD J GASTROENTERO, V16, P5925, DOI 10.3748/wjg.v16.i47.5925; Venard R, 2003, BIOCHEMISTRY-US, V42, P7626, DOI 10.1021/bi034394t; Wittig I, 2006, NAT PROTOC, V1, P418, DOI 10.1038/nprot.2006.62; ZIEGLER D, 1967, METHOD ENZYMOL, V10, P231	40	8	8	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2019	14	8							e0221886	10.1371/journal.pone.0221886	http://dx.doi.org/10.1371/journal.pone.0221886			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5XV	31461494	gold, Green Published, Green Submitted			2022-12-26	WOS:000485052300062
J	Chen, YD; Agnello, M; Dinis, M; Chien, KC; Wang, J; Hu, W; Shi, WY; He, XS; Zou, J				Chen, Yandi; Agnello, Melissa; Dinis, Marcia; Chien, Kenneth C.; Wang, Jing; Hu, Wei; Shi, Wenyuan; He, Xuesong; Zou, Jing			Lollipop containing Glycyrrhiza uralensis extract reduces Streptococcus mutans colonization and maintains oral microbial diversity in Chinese preschool children	PLOS ONE			English	Article							DENTAL-CARIES; PREVENTION; CHILDHOOD; LICORICE; RISK	The anticariogenic activity of the extract of Glycyrrhiza uralensis (licorice) has been well documented. We recently developed an herbal lollipop containing licorice extracts with Glycyrrhizol A, the compound displaying strong antimicrobial activity against Streptococcus mutans. Preliminary testing showed that the herbal lollipop reduced salivary S. mutans counts in vivo. In this study, we aimed to further test the efficacy of this herbal lollipop for reducing salivary S. mutans levels, and investigate its impact on salivary microbiome. Using a well-established in vitro oral microbiome model, we showed that licorice extract displays targeted killing against S. mutans without affecting the biodiversity of the community. In vivo study corroborated in vitro findings, showing for high caries-risk children aged 3-6 with salivary S. mutans levels >5x10(5) cells/ml, daily use of 2 licorice-containing lollipops for 3 weeks significantly reduced salivary S. mutans levels compared to the control group. Salivary microbiome analysis showed either no change or even increase in phylogenetic diversity of the oral community following herbal lollipop usage. Although further study with longer term observation is needed, these results suggest that use of licorice extract-containing lollipops can be as a simple and effective way to reduce the risk of dental caries in children.	[Chen, Yandi; Zou, Jing] Sichuan Univ, Natl Clin Res Ctr Oral Dis, West China Hosp Stomatol, State Key Lab Oral Dis, Chengdu, Sichuan, Peoples R China; [Agnello, Melissa; Dinis, Marcia] Univ Calif Los Angeles, Sch Dent, Los Angeles, CA 90024 USA; [Chien, Kenneth C.] Univ Calif San Francisco, Sch Dent, San Francisco, CA USA; [Wang, Jing] Shandong Univ Tradit Chinese Med, Coll Pharmaceut Sci, Jinan, Shandong, Peoples R China; [Hu, Wei] Shandong Univ, Microbial Technol Inst, State Key Lab Microbial Technol, Qingdao, Shandong, Peoples R China; [Shi, Wenyuan; He, Xuesong] Forsyth Inst, Cambridge, MA 02142 USA	Sichuan University; University of California System; University of California Los Angeles; University of California System; University of California San Francisco; Shandong University of Traditional Chinese Medicine; Shandong University; Harvard University; Forsyth Institute	Zou, J (corresponding author), Sichuan Univ, Natl Clin Res Ctr Oral Dis, West China Hosp Stomatol, State Key Lab Oral Dis, Chengdu, Sichuan, Peoples R China.; He, XS (corresponding author), Forsyth Inst, Cambridge, MA 02142 USA.	xhe@forsyth.org; zoujing1970@126.com	He, Xuesong/GXN-2297-2022; SHI, wen/GPW-9531-2022; Chen, Yandi/AAF-9040-2019	Dinis, Marcia/0000-0001-8734-4276; He, Xuesong/0000-0002-3333-9188; Chang Chien, Kenneth/0000-0001-8774-4229; Zou, Jing/0000-0002-3618-9672	National Institute of Dental and Craniofacial Research of the National Institutes of Health (NIH) [1R01DE023810, 1R01DE020102, 1R01DE026186]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE023810, R01DE026186, R01DE020102] Funding Source: NIH RePORTER	National Institute of Dental and Craniofacial Research of the National Institutes of Health (NIH); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This research was partly supported by the National Institute of Dental and Craniofacial Research of the National Institutes of Health (NIH) under awards 1R01DE020102, 1R01DE026186, and 1R01DE023810 to XH and WS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Research reported in this publication was partly supported by The National Institute of Dental and Craniofacial Research of the National Institutes of Health (NIH) under Awards 1R01DE023810, 1R01DE020102, 1R01DE026186 (to X.H. and W.S.).	Agnello M, 2017, J DENT RES, V96, P1378, DOI 10.1177/0022034517718819; ALALUUSUA S, 1989, CARIES RES, V23, P190, DOI 10.1159/000261176; Berkowitz Robert J, 2003, J Can Dent Assoc, V69, P304; Bowen WH, 2016, MOL ORAL MICROBIOL, V31, P228, DOI 10.1111/omi.12132; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chen T, 2010, DATABASE-OXFORD, DOI 10.1093/database/baq013; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Edlund A, 2013, MICROBIOME, V1, DOI 10.1186/2049-2618-1-25; FAITH DP, 1992, BIOL CONSERV, V61, P1, DOI 10.1016/0006-3207(92)91201-3; Filstrup Sara L, 2003, Pediatr Dent, V25, P431; Gu F, 2002, HYBRIDOMA HYBRIDOM, V21, P225, DOI 10.1089/153685902760213822; Guo LH, 2015, SCI REP-UK, V5, DOI 10.1038/srep18015; Guo LH, 2015, P NATL ACAD SCI USA, V112, P7569, DOI 10.1073/pnas.1506207112; Harris Rebecca, 2004, Community Dent Health, V21, P71; He J, 2006, J NAT PROD, V69, P121, DOI 10.1021/np058069d; Hou J, 2017, JOURNAL OF INVESTIGA, V8; Hu CH, 2011, INT J ORAL SCI, V3, P13, DOI 10.4248/IJOS11005; KRISTOFFERSSON K, 1985, J DENT RES, V64, P58, DOI 10.1177/00220345850640011101; Li LN, 2010, INT J ORAL SCI, V2, P66, DOI 10.4248/IJOS10024; LOESCHE WJ, 1986, MICROBIOL REV, V50, P353, DOI 10.1128/MMBR.50.4.353-380.1986; Messier C, 2012, ORAL DIS, V18, P32, DOI 10.1111/j.1601-0825.2011.01842.x; Nase L, 2001, CARIES RES, V35, P412, DOI 10.1159/000047484; Peters MC, 2010, EUR ARCH PAEDIATR DE, V11, P274, DOI 10.1007/BF03262762; Petersen PE, 2004, COMMUNITY DENT ORAL, V32, P319, DOI 10.1111/j.1600-0528.2004.00175.x; Qin M, 2008, PEDIATR DENT, V30, P122; Sedighinia F, 2012, AVICENNA J PHYTOMEDI, V2, P118; Tanzer J M, 2001, J Dent Educ, V65, P1028; Tian Y, 2010, MOL ORAL MICROBIOL, V25, P357, DOI 10.1111/j.2041-1014.2010.00585.x; Wayne P, 2007, M100S117 CLIN LAB ST; Yost J, 2008, MCN-AM J MATERN-CHIL, V33, P17, DOI 10.1097/01.NMC.0000305652.01743.8d; Zhang XN, 2016, SCI REP-UK, V6, DOI 10.1038/srep18897	31	7	7	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2019	14	8							e0221756	10.1371/journal.pone.0221756	http://dx.doi.org/10.1371/journal.pone.0221756			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5TR	31442287	Green Published, gold, Green Submitted			2022-12-26	WOS:000485041400073
J	Puga, MAM; Bandeira, LM; Pompilio, MA; de Rezende, GR; Soares, LS; de Castro, VDL; Tanaka, TSO; Cesar, GA; de Oliveira, SMDL; Teles, SA; Yassuda, RTS; Weis-Torres, SMD; Basilio, SF; Croda, J; Motta-Castro, ARC				Moreira Puga, Marco Antonio; Bandeira, Larissa Melo; Pompilio, Mauricio Antonio; de Rezende, Grazielli Rocha; Soares, Luana Silva; Langraf de Castro, Vivianne de Oliveira; Ortiz Tanaka, Tayana Serpa; Cesar, Gabriela Alves; do Valle Leone de Oliveira, Sandra Maria; Teles, Sheila Araujo; Shiguematsu Yassuda, Renata Terumi; dos Santos Weis-Torres, Sabrina Moreira; Basilio, Sarlete Ferreira; Croda, Julio; Coimbra Motta-Castro, Ana Rita			Screening for HBV, HCV, HIV and syphilis infections among bacteriologically confirmed tuberculosis prisoners: An urgent action required	PLOS ONE			English	Article							HEPATITIS-C VIRUS; VIRAL-HEPATITIS; HIGH PREVALENCE; RISK-FACTORS; B-VIRUS; EPIDEMIOLOGY; TRANSMISSION; POPULATION; PREVENTION; STATE	Viral hepatitis, syphilis, HIV, and tuberculosis infections in prisons have been identified globally as a public health problem. Tuberculosis (TB) and viral hepatitis co-infection may increase the risk of anti-tuberculosis treatment-induced hepatotoxicity, leading to the frequent cause of discontinuation of the first-line anti-tuberculosis drugs. Therefore, the aim of this cross-sectional study was to investigate the epidemiological features of HCV, HBV, syphilis and HIV infections among bacteriologically confirmed tuberculosis prisoners in Campo Grande (MS), Central Brazil. The participants who agreed to participate (n = 279) were interviewed and tested for the presence of active or current HCV, HBV, syphilis and HIV infections. The prevalence of HCV exposure was 4.7% (13/279; 95% CI 2.2-7.1). HCV RNA was detected in 84.6% (11/13) of anti-HCV positive samples. Out of 279 participants, 19 (6.8%; 95% CI 4.4-10.4) were HIV co-infected, 1.4% (4/279, 95% CI 0.5-3.8) had chronic hepatitis B virus (HBsAg positive) and 9.3% (26/279, 95% CI 6.4-13.4) had serological marker of exposure to hepatitis B virus (total anti-HBc positive). The prevalence of lifetime syphilis infection (anti-T. pallidum positive) was 10% (28/279, 95% CI 7.0-14.2) and active syphilis (VDRL >= 1/8 titre) was 5% (14/279, 95% CI 2.9-8.3). The prevalence of TB/HCV co-infection among prisoners with HIV (15.8%) was higher than among HIV-non-infected prisoners (3.8%; P<0.05). These results highlight the importance of hepatitis testing among prisoners with bacteriologically confirmed case of TB who can be more effectively and safely treated in order to reduce the side effects of hepatotoxic anti-TB drugs.	[Moreira Puga, Marco Antonio; Bandeira, Larissa Melo; Pompilio, Mauricio Antonio; de Rezende, Grazielli Rocha; Soares, Luana Silva; Langraf de Castro, Vivianne de Oliveira; Ortiz Tanaka, Tayana Serpa; Cesar, Gabriela Alves; dos Santos Weis-Torres, Sabrina Moreira; Croda, Julio; Coimbra Motta-Castro, Ana Rita] Univ Fed Mato Grosso do Sul, Campo Grande, MS, Brazil; [do Valle Leone de Oliveira, Sandra Maria; Croda, Julio; Coimbra Motta-Castro, Ana Rita] Fundacao Oswaldo Cruz, Campo Grande, MS, Brazil; [Teles, Sheila Araujo] Univ Fed Goias, Sch Nursing, Goiania, Go, Brazil; [Shiguematsu Yassuda, Renata Terumi; Basilio, Sarlete Ferreira] State Agcy Adm Prisons, Div Hlth, Campo Grande, MS, Brazil	Universidade Federal de Mato Grosso do Sul; Fundacao Oswaldo Cruz; Universidade Federal de Goias	Bandeira, LM (corresponding author), Univ Fed Mato Grosso do Sul, Campo Grande, MS, Brazil.	larissa_m_bandeira@hotmail.com	Teles, Sheila Araujo/D-8837-2015; Croda, Julio/I-5172-2013; Soares, Luana/AAL-1909-2020	Teles, Sheila Araujo/0000-0003-4030-6947; Croda, Julio/0000-0002-6665-6825; Soares, Luana/0000-0001-5924-1691; Bandeira, Larissa/0000-0003-1015-0187; Motta-Castro, Ana Rita/0000-0003-3070-1337; Moreira dos Santos Weis Torres, Sabrina/0000-0002-3457-1675; OLIVEIRA, SANDRA/0000-0002-8960-6716	Fundacao de Apoio ao Desenvolvimento do Ensino, Ciencia e Tecnologia do Estado de Mato Grosso do Sul-FUNDECT-MS [23/200, TO 0067/12, 0056/13]	Fundacao de Apoio ao Desenvolvimento do Ensino, Ciencia e Tecnologia do Estado de Mato Grosso do Sul-FUNDECT-MS(Fundacao de Apoio ao Desenvolvimento do Ensino Ciencia e Tecnologia do Estado de Mato Grosso do Sul (FUNDECT MS))	This work was supported by Fundacao de Apoio ao Desenvolvimento do Ensino, Ciencia e Tecnologia do Estado de Mato Grosso do Sul-FUNDECT-MS (n. 23/200, TO 0067/12 and 0056/13).	Abbara A, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2330-z; Agha MA, 2015, EGYPT J CHEST DIS TU, V64, P91, DOI 10.1016/j.ejcdt.2014.09.009; Almasio PL, 2011, DIGEST LIVER DIS, V43, P589, DOI 10.1016/j.dld.2010.12.004; Alter MJ, 2006, J HEPATOL, V44, pS6, DOI 10.1016/j.jhep.2005.11.004; Araujo-Mariz C, 2016, J MED VIROL, V88, P996, DOI 10.1002/jmv.24432; Babudieri S, 2012, EMERG INFECT DIS, V18, P689, DOI 10.3201/eid1804.111016; Bourdillon PM, 2017, EMERG INFECT DIS, V23, P496, DOI 10.3201/eid2303.161006; BRASIL. Ministerio da Saude, 2018, PROTOCOLO CLI PRIME; BRASIL. Ministerio da Saude, 2017, PROTOCOLO CLI NICO E; Chang TE, 2018, J CHIN MED ASSOC, V81, P111, DOI 10.1016/j.jcma.2017.10.002; Correa ME, 2017, AM J TROP MED HYG, V97, P1078, DOI 10.4269/ajtmh.17-0098; Costi C, 2017, MEM I OSWALDO CRUZ, V112, P255, DOI 10.1590/0074-02760160352; DEPEN. Departamento Penitencia rio Nacional, 2015, LEV NAC INF INFOPEN, P7; Dolan K, 2016, LANCET, V388, P1089, DOI 10.1016/S0140-6736(16)30466-4; Fernandes RM, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4210-2; Gheorghe L, 2013, EUR J GASTROEN HEPAT, V25, P56, DOI 10.1097/MEG.0b013e328358b0bb; Ginn S, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e5921; Heijnen M, 2016, J INT AIDS SOC, V19, DOI 10.7448/IAS.19.1.20873; ICPS. International Centre for Prison Studies, 2019, WORLD PRISION BRIEF; Kamarulzaman A, 2016, LANCET, V388, P1115, DOI 10.1016/S0140-6736(16)30769-3; Kim WS, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1344-2; Kuniholm MH, 2008, INT J INFECT DIS, V12, P51, DOI 10.1016/j.ijid.2007.04.015; Larney S, 2013, HEPATOLOGY, V58, P1215, DOI 10.1002/hep.26387; Lederer DJ, 2019, ANN AM THORAC SOC, V16, P22, DOI 10.1513/AnnalsATS.201808-564PS; Livramento A., 2014, SCI WORLD J NEW YORK, V2014, P1; Lomtadze N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083892; Lorent N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019566; Ministerio da Saude, 2015, 1092015 BRASIL MIN S; Puga MAM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169195; Mutagoma M, 2016, J SEXUALLY TRANSMITT, V2016; Pompilio MA, 2011, J VENOM ANIM TOXINS, V17, P216, DOI 10.1590/S1678-91992011000200013; Reis NRS, 2011, INT J TUBERC LUNG D, V15, P1397, DOI 10.5588/ijtld.10.0636; Richards DC, 2006, INT J TUBERC LUNG D, V10, P396; Sacchi FPC, 2015, EMERG INFECT DIS, V21, P452, DOI 10.3201/eid2103.140896; Barros LAS, 2013, REV SOC BRAS MED TRO, V46, P24, DOI 10.1590/0037-868216972013; Carbone ADS, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0764-8; Sirinak C, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-245; Torres MS, 2006, PREVALENCE OF INFECT; Ungo JR, 1998, AM J RESP CRIT CARE, V157, P1871, DOI 10.1164/ajrccm.157.6.9711039; Vescio MF, 2008, J EPIDEMIOL COMMUN H, V62, P305, DOI 10.1136/jech.2006.051599; WHO, 2017, GLOBAL TUBERCULOSIS; Wu PH, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001328	42	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2019	14	8							e0221265	10.1371/journal.pone.0221265	http://dx.doi.org/10.1371/journal.pone.0221265			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5RZ	31437184	Green Published, gold, Green Submitted			2022-12-26	WOS:000485036900044
J	Nomura, T; Arakawa, N; Yamamoto, T; Ueda, T; Adachi, S; Yonemaru, J; Abe, A; Takagi, H; Yokoyama, T; Ookawa, T				Nomura, Tomohiro; Arakawa, Naoya; Yamamoto, Toshio; Ueda, Tadamasa; Adachi, Shunsuke; Yonemaru, Jun-ichi; Abe, Akira; Takagi, Hiroki; Yokoyama, Tadashi; Ookawa, Taiichiro			Next generation long-culm rice with superior lodging resistance and high grain yield, Monster Rice 1	PLOS ONE			English	Article							DRY-MATTER PRODUCTION; FUNCTIONAL-ANALYSIS; BIOMASS PRODUCTION; INCREASES YIELD; QTL GENE; PANICLE; IMPROVEMENT; DIFFERENCE; LOCUS; INTENSIFICATION	During late 1960s Green Revolution, researchers utilized semidwarf 1 (sd1)to improve the yield and lodging resistance in rice (Oryza sativa L.). However, sd1 has a negative effect to culm strength and biomass production. To increase yield dramatically in 21th century, development of next generation long-culm rice for non-lodging and high grain yield independent of sd1 has been needed. The present study developed Monster Rice 1, a long-culm and heavy-panicle type of rice line and compared it with Takanari, a high-yielding semidwarf rice variety about yield and lodging resistance associated traits. Brown rice yield and bending moment at breaking of the basal elongated internode were higher in Monster Rice 1 than those in Takanari due to a large number of spikelets per panicle and thicker culm. Furthermore, to identify QTLs with superior alleles for these traits, QTL and haplotype analyses were performed using F-2 population and recombinant inbred lines derived from a cross between Monster Rice 1 and Takanari. The results from this study suggest that long-culm and heavy-panicle type of rice with a superior lodging resistance by culm strength can perform its high yield potential by using these identified QTLs contributing yield and lodging resistance.	[Nomura, Tomohiro; Arakawa, Naoya; Adachi, Shunsuke; Yokoyama, Tadashi; Ookawa, Taiichiro] Tokyo Univ Agr & Technol, Grad Sch Agr, Fuchu, Tokyo, Japan; [Yamamoto, Toshio] Okayama Univ, Inst Plant Sci & Resources, Kurashiki, Okayama, Japan; [Ueda, Tadamasa; Yonemaru, Jun-ichi] NARO, Inst Crop Sci, Tsukuba, Ibaraki, Japan; [Abe, Akira] Iwate Biotechnol Res Ctr, Dept Genom & Breeding, Kitakami, Iwate, Japan; [Takagi, Hiroki] Ishikawa Prefectural Univ, Fac Bioresources & Environm Sci, Nonoichi, Ishikawa, Japan	Tokyo University of Agriculture & Technology; Okayama University; National Agriculture & Food Research Organization - Japan; Iwate Biotechnology Research Center; Ishikawa Prefecture University	Ookawa, T (corresponding author), Tokyo Univ Agr & Technol, Grad Sch Agr, Fuchu, Tokyo, Japan.	ookawa@cc.tuat.ac.jp	Adachi, Shunsuke/G-7952-2016; Yamamoto, Toshio/AAX-7146-2020; Ookawa, Taiichiro/C-9323-2013	Adachi, Shunsuke/0000-0003-0471-3369; Yamamoto, Toshio/0000-0002-5209-7735; Ookawa, Taiichiro/0000-0002-6326-173X	Japan Society for the Promotion of Science [15H04442]; Ministry of Agriculture, Forestry and Fisheries of Japan [RBS2003]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Agriculture, Forestry and Fisheries of Japan(Ministry of Agriculture Forestry & Fisheries - Japan)	This work was supported in part by a Grant -in -Aid for Scientific Research (B) by the Japan Society for the Promotion of Science (Grant No. 15H04442) and by a grant from the Ministry of Agriculture, Forestry and Fisheries of Japan (Genomics-based Technology for Agricultural Improvement, RBS2003), https/Alm/wisps gap/english/, http://www maff go joie/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ando I., 1990, NIHON SAKUMOTSU GAKK, V5, P63; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Fitzgerald MA, 2009, TRENDS PLANT SCI, V14, P133, DOI 10.1016/j.tplants.2008.12.004; Fujita D, 2013, P NATL ACAD SCI USA, V110, P20431, DOI 10.1073/pnas.1310790110; Hirano K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096009; Huang XZ, 2009, NAT GENET, V41, P494, DOI 10.1038/ng.352; Ikeda-Kawakatsu K, 2012, PLANT J, V69, P168, DOI 10.1111/j.1365-313X.2011.04781.x; Ikeda-Kawakatsu K, 2009, PLANT PHYSIOL, V150, P736, DOI 10.1104/pp.109.136739; Imbe T., 2004, Bulletin of the National Institute of Crop Science, P35; Ishimaru K, 2008, PLANTA, V227, P601, DOI 10.1007/s00425-007-0642-8; KANEDA C, 1986, JARQ-JPN AGR RES Q, V19, P235; Kashiwagi T, 2004, PLANT PHYSIOL, V134, P676, DOI 10.1104/pp.103.029355; Kashiwagi T, 2008, THEOR APPL GENET, V117, P749, DOI 10.1007/s00122-008-0816-1; Kashiwagi T, 2016, EUPHYTICA, V210, P233, DOI 10.1007/s10681-016-1707-1; Kashiwagi T, 2014, EUPHYTICA, V198, P353, DOI 10.1007/s10681-014-1111-7; Khush GS, 1999, GENOME, V42, P646, DOI 10.1139/gen-42-4-646; Komatsu M, 2001, DEV BIOL, V231, P364, DOI 10.1006/dbio.2000.9988; KURODA E, 1989, JPN J CROP SCI, V58, P374, DOI 10.1626/jcs.58.374; LANDER E S, 1987, Genomics, V1, P174, DOI 10.1016/0888-7543(87)90010-3; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Ma Jun, 2004, Acta Agronomica Sinica, V30, P143; Matsubara K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151830; Mei W, 2016, NAT GEOSCI, V9, P753, DOI [10.1038/ngeo2792, 10.1038/NGEO2792]; Minakuchi K, 2010, PLANT CELL PHYSIOL, V51, P1127, DOI 10.1093/pcp/pcq083; MURRAY MG, 1980, NUCLEIC ACIDS RES, V8, P4321, DOI 10.1093/nar/8.19.4321; Niklas KJ, 2001, P NATL ACAD SCI USA, V98, P2922, DOI 10.1073/pnas.041590298; Okuno A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086870; OOKAWA T, 1992, JPN J CROP SCI, V61, P419, DOI 10.1626/jcs.61.419; Ookawa T, 2016, SCI REP-UK, V6, DOI 10.1038/srep30572; Ookawa T, 2014, SCI REP-UK, V4, DOI 10.1038/srep06567; Ookawa T, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1132; Ookawa T, 2010, PLANT PROD SCI, V13, P58, DOI 10.1626/pps.13.58; Sasaki K, 2017, J EXP BOT, V68, P2693, DOI 10.1093/jxb/erx128; TAKEDA T, 1983, JPN J CROP SCI, V52, P299, DOI 10.1626/jcs.52.299; Takeda T, 2003, PLANT J, V33, P513, DOI 10.1046/j.1365-313X.2003.01648.x; Tilman D, 2011, P NATL ACAD SCI USA, V108, P20260, DOI 10.1073/pnas.1116437108; Wang S, 2012, WINDOWS QTL CARTOGRA; Yabe S, 2018, FIELD CROP RES, V223, P155, DOI 10.1016/j.fcr.2018.04.013; Yano K, 2015, MOL PLANT, V8, P303, DOI 10.1016/j.molp.2014.10.009; Yoshinaga S, 2013, FIELD CROP RES, V150, P74, DOI 10.1016/j.fcr.2013.06.004; Zeng DL, 2017, NAT PLANTS, V3, DOI 10.1038/nplants.2017.31; Zhang GH, 2014, MOL PLANT, V7, P1350, DOI 10.1093/mp/ssu055	43	18	18	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2019	14	8							e0221424	10.1371/journal.pone.0221424	http://dx.doi.org/10.1371/journal.pone.0221424			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5RZ	31437205	Green Published, gold, Green Submitted			2022-12-26	WOS:000485036900070
J	Washburn, A; Kallen, RW; Lamb, M; Stepp, N; Shockley, K; Richardson, MJ				Washburn, Auriel; Kallen, Rachel W.; Lamb, Maurice; Stepp, Nigel; Shockley, Kevin; Richardson, Michael J.			Feedback delays can enhance anticipatory synchronization in human-machine interaction	PLOS ONE			English	Article							CHAOTIC SEMICONDUCTOR-LASERS; PHASE-TRANSITIONS; COORDINATION; MODEL; PERCEPTION; DYNAMICS	Research investigating the dynamics of coupled physical systems has demonstrated that small feedback delays can allow a dynamic response system to anticipate chaotic behavior. This counterintuitive phenomenon, termed anticipatory synchronization, has been observed in coupled electrical circuits, laser semi-conductors, and artificial neurons. Recent research indicates that the same process might also support the ability of humans to anticipate the occurrence of chaotic behavior in other individuals. Motivated by this latter work, the current study examined whether the process of feedback delay induced anticipatory synchronization could be employed to develop an interactive artificial agent capable of anticipating chaotic human movement. Results revealed that incorporating such delays within the movement-control dynamics of an artificial agent not only enhances an artificial agent's ability to anticipate chaotic human behavior, but to synchronize with such behavior in a manner similar to natural human-human anticipatory synchronization. The implication of these findings for the development of human-machine interaction systems is discussed.	[Washburn, Auriel] Stanford Univ, Dept Mus, Ctr Comp Res Mus & Acoust, Stanford, CA 94305 USA; [Kallen, Rachel W.; Richardson, Michael J.] Macquarie Univ, Dept Psychol, Ctr Elite Performance Expertise & Training, Sydney, NSW, Australia; [Kallen, Rachel W.; Richardson, Michael J.] Macquarie Univ, Percept Act Res Ctr, Sydney, NSW, Australia; [Lamb, Maurice; Shockley, Kevin] Univ Cincinnati, Dept Psychol, Ctr Cognit Act & Percept, Cincinnati, OH 45221 USA; [Stepp, Nigel] HRL Labs LLC, Malibu, CA USA	Stanford University; Macquarie University; Macquarie University; University System of Ohio; University of Cincinnati; HRL Laboratories	Washburn, A (corresponding author), Stanford Univ, Dept Mus, Ctr Comp Res Mus & Acoust, Stanford, CA 94305 USA.; Richardson, MJ (corresponding author), Macquarie Univ, Dept Psychol, Ctr Elite Performance Expertise & Training, Sydney, NSW, Australia.; Richardson, MJ (corresponding author), Macquarie Univ, Percept Act Res Ctr, Sydney, NSW, Australia.	alwashburn@eng.ucsd.edu; michael.j.richardson@mq.edu.au		Kallen, Rachel/0000-0002-0031-737X; Richardson, Michael/0000-0001-9159-2774; Washburn, Auriel/0000-0002-1163-9454	National Institutes of Health [R01GM105045]; National Science Foundation [1606904]; ARC Future Fellowship [FT180100447]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM105045] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); ARC Future Fellowship(Australian Research Council); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by the National Institutes of Health under award number R01GM105045 (MJR) and the National Science Foundation under award number 1606904 (AW). HRL Laboratories provided support in the form of author salary (NS). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of the authors are articulated in the 'author contributions' section. Research partly supported by ARC Future Fellowship (FT180100447) awarded to Michael Richardson.	Blakemore SJ, 2001, NAT REV NEUROSCI, V2, P561, DOI 10.1038/35086023; CANAVIER CC, 1990, BIOPHYS J, V57, P1245, DOI 10.1016/S0006-3495(90)82643-6; CHAY TR, 1985, BIOPHYS J, V47, P357, DOI 10.1016/S0006-3495(85)83926-6; Decety J, 1999, TRENDS COGN SCI, V3, P172, DOI 10.1016/S1364-6613(99)01312-1; Dumas G, 2014, P NATL ACAD SCI USA, V111, pE3726, DOI 10.1073/pnas.1407486111; Eckmann J-P., THEORY CHAOTIC ATTRA, P273; HAKEN H, 1985, BIOL CYBERN, V51, P347, DOI 10.1007/BF00336922; Hove MJ, 2009, SOC COGNITION, V27, P949, DOI 10.1521/soco.2009.27.6.949; Ijspeert AJ, 2013, NEURAL COMPUT, V25, P328, DOI 10.1162/NECO_a_00393; Iqbal T, 2016, IEEE T ROBOT, V32, P909, DOI 10.1109/TRO.2016.2570240; Kelso JAS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005749; KELSO JAS, 1993, VARIABILITY AND MOTOR CONTROL, P291; Kelso S., 1995, DYNAMIC PATTERNS SEL; Kostrubiec V, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142029; Lorenz T, 2016, INT J SOC ROBOT, V8, P125, DOI 10.1007/s12369-015-0325-8; Masoller C, 2001, PHYS REV LETT, V86, P2782, DOI 10.1103/PhysRevLett.86.2782; Medina JR, 2015, IEEE T ROBOT, V31, P180, DOI 10.1109/TRO.2014.2387571; Miles LK, 2011, EXP BRAIN RES, V211, P495, DOI 10.1007/s00221-011-2641-z; Mitra S, 1997, J MOTOR BEHAV, V29, P195, DOI 10.1080/00222899709600834; Nalepka P, 2017, PSYCHOL SCI, V28, P630, DOI 10.1177/0956797617692107; Pikovsky A., 2003, SYNCHRONIZATION UNIV; Richardson MJ, 2016, PROCEEDINGS OF THE 1ST INTERNATIONAL CONFERENCE ON COMPLEX INFORMATION SYSTEMS (COMPLEXIS), P155, DOI 10.5220/0005878101550164; Richman MB, 2016, PROCEDIA COMPUT SCI, V95, P229, DOI 10.1016/j.procs.2016.09.319; ROSENSTEIN MT, 1993, PHYSICA D, V65, P117, DOI 10.1016/0167-2789(93)90009-P; SALTZMAN E, 1987, PSYCHOL REV, V94, P84, DOI 10.1037/0033-295X.94.1.84; SCHMIDT RC, 1990, J EXP PSYCHOL HUMAN, V16, P227, DOI 10.1037/0096-1523.16.2.227; Schmidt RC, 1997, ECOL PSYCHOL, V9, P189, DOI 10.1207/s15326969eco0903_2; Sebanz N, 2006, TRENDS COGN SCI, V10, P70, DOI 10.1016/j.tics.2005.12.009; SHADMEHR R, 1994, J NEUROSCI, V14, P3208; Stepp N, 2010, COGN SYST RES, V11, P148, DOI 10.1016/j.cogsys.2009.03.003; Stepp N, 2008, BEHAV BRAIN SCI, V31, P216, DOI 10.1017/S0140525X08004007; Stepp N, 2015, ECOL PSYCHOL, V27, P103, DOI 10.1080/10407413.2015.1027123; Stepp N, 2009, EXP BRAIN RES, V198, P521, DOI 10.1007/s00221-009-1940-0; Tang S, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.194101; Toral R, 2003, PHYSICA A, V325, P192, DOI 10.1016/S0378-4371(03)00198-5; Varlet M, 2015, J EXP PSYCHOL HUMAN, V41, P36, DOI 10.1037/a0038640; Voss HU, 2016, J COMPUT NEUROSCI, V41, P295, DOI 10.1007/s10827-016-0618-4; Voss HU, 2002, INT J BIFURCAT CHAOS, V12, P1619, DOI 10.1142/S0218127402005340; Voss HU, 2001, PHYS LETT A, V279, P207, DOI 10.1016/S0375-9601(00)00840-9; Voss HU, 2000, PHYS REV E, V61, P5115, DOI 10.1103/PhysRevE.61.5115; Warren WH, 2006, PSYCHOL REV, V113, P358, DOI 10.1037/0033-295X.113.2.358; Washburn A, 2015, J EXP PSYCHOL HUMAN, V41, P1166, DOI 10.1037/xhp0000080; Wolpert DM, 2003, PHILOS T R SOC B, V358, P593, DOI 10.1098/rstb.2002.1238	43	7	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2019	14	8							e0221275	10.1371/journal.pone.0221275	http://dx.doi.org/10.1371/journal.pone.0221275			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW5RZ	31437192	Green Submitted, Green Published, gold			2022-12-26	WOS:000485036900045
J	Yang, TD; Park, K; Park, JS; Lee, JH; Choi, E; Lee, J; Choi, W; Choi, Y; Lee, KJ				Yang, Taeseok Daniel; Park, Kwanjun; Park, Jin-Sung; Lee, Jang-Hoon; Choi, Eunpyo; Lee, Jonghwan; Choi, Wonshik; Choi, Youngwoon; Lee, Kyoung J.			Two distinct actin waves correlated with turns-and-runs of crawling microglia	PLOS ONE			English	Article							SYNTHETIC-APERTURE MICROSCOPY; CELL-MIGRATION; MEMBRANE PROTRUSIONS; DYNAMICS; MOTILITY; NETWORKS	Freely crawling cells are often viewed as randomly moving Brownian particles but they generally exhibit some directional persistence. This property is often related to their zigzag motile behaviors that can be described as a noisy but temporally structured sequence of "runs" and "turns." However, its underlying biophysical mechanism is largely unexplored. Here, we carefully investigate the collective actin wave dynamics associated with the zigzag-crawling movements of microglia (as primary brain immune cells) employing a number of different quantitative imaging modalities including synthetic aperture microscopy and optical diffraction tomography, as well as conventional fluorescence imaging and scanning electron microscopy. Interestingly, we find that microglia exhibit two distinct types of actin waves working at two quite different time scales and locations, and they seem to serve different purposes. One type of actin waves is fast "peripheral ruffles" arising spontaneously with an oscillating period of about 6 seconds at some portion of the leading edge of crawling microglia, where the vigorously biased peripheral ruffles seem to set the direction of a new turn (in 2-D free space). When the cell turning events are inhibited with a physical confinement (in 1-D track), the peripheral ruffles still exist at the leading edge with no bias but showing phase coherence in the cell crawling direction. The other type is "dorsal actin waves" which also exhibits an oscillatory behavior but with a much longer period of around 2 minutes compared to the fast "peripheral ruffles". Dorsal actin waves (whether the cell turning events are inhibited or not) initiate in the lamellipodium just behind the leading edge, travelling down toward the core region of the cell and disappear. Such dorsal wave propagations seem to be correlated with migration of the cell. Thus, we may view the dorsal actin waves are connected with the "run" stage of cell body, whereas the fast ruffles at the leading front are involved in the "turn" stage.	[Yang, Taeseok Daniel; Choi, Youngwoon] Korea Univ, Sch Biomed Engn, Seoul, South Korea; [Yang, Taeseok Daniel; Lee, Jang-Hoon; Lee, Jonghwan] Brown Univ, Sch Engn, Providence, RI 02912 USA; [Park, Kwanjun; Choi, Youngwoon] Korea Univ, Dept Bioconvergence Engn, Seoul, South Korea; [Park, Jin-Sung; Choi, Wonshik] Inst for Basic Sci Korea, Ctr Mol Spect & Dynam, Seoul, South Korea; [Choi, Eunpyo] Chonnam Natl Univ, Sch Mech Engn, Gwangju, South Korea; [Choi, Wonshik; Lee, Kyoung J.] Korea Univ, Dept Phys, Seoul, South Korea	Korea University; Brown University; Korea University; Institute for Basic Science - Korea (IBS); Chonnam National University; Korea University	Choi, Y (corresponding author), Korea Univ, Sch Biomed Engn, Seoul, South Korea.; Choi, Y (corresponding author), Korea Univ, Dept Bioconvergence Engn, Seoul, South Korea.; Lee, KJ (corresponding author), Korea Univ, Dept Phys, Seoul, South Korea.	youngwoon@korea.ac.kr; kyoung@korea.ac.kr		Choi, Eunpyo/0000-0002-9689-6520; YANG, TAESEOK DANIEL/0000-0001-6452-7504	Korea University; National Research Foundation of Korea [2016R1D1A1B03930591, 2017R1A6A3A11031083, 2017R1C1B2010262]; Korea Health Industry Development Institute [H114C3477]; Institute for Basic Science [IBS-R023 D1]; MSIT [2019R1A2C4004804]; National Institute of Biomedical Imaging and Bioengineering [ROOEB014879]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R00EB014879] Funding Source: NIH RePORTER	Korea University; National Research Foundation of Korea(National Research Foundation of Korea); Korea Health Industry Development Institute(Korea Health Industry Development Institute (KHIDI)); Institute for Basic Science; MSIT(Ministry of Science & ICT (MSIT), Republic of Korea); National Institute of Biomedical Imaging and Bioengineering(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This research was supported by Korea University Grant to TDY, the National Research Foundation of Korea (2016R1D1A1B03930591 to KJL, 2017R1A6A3A11031083 to TDY, and 2017R1C1B2010262 to YC), the Korea Health Industry Development Institute (H114C3477 to KP and YC), the Institute for Basic Science (IBS-R023 D1 to WC and J -SP), MSIT (2019R1A2C4004804 to YC), and National Institute of Biomedical Imaging and Bioengineering (ROOEB014879 to JL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aknoun S, 2015, J BIOMED OPT, V20, DOI 10.1117/1.JBO.20.12.126009; Barnhart EL, 2010, BIOPHYS J, V98, P933, DOI 10.1016/j.bpj.2009.10.058; Bernitt E, 2017, PHYS REV LETT, V118, DOI 10.1103/PhysRevLett.118.048102; Bernitt E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115857; Bosgraaf L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005253; Choi W, 2007, NAT METHODS, V4, P717, DOI 10.1038/NMETH1078; Choi Y, 2011, OPT LETT, V36, P4263, DOI 10.1364/OL.36.004263; DeMali KA, 2003, J CELL SCI, V116, P2389, DOI 10.1242/jcs.00605; Dobereiner HG, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.038102; Dreher A, 2014, NEW J PHYS, V16, DOI 10.1088/1367-2630/16/5/055007; Ghosh M, 2004, SCIENCE, V304, P743, DOI 10.1126/science.1094561; Giannone G, 2004, CELL, V116, P431, DOI 10.1016/S0092-8674(04)00058-3; Heinisch JJ, 2012, J CELL SCI, V125, P4189, DOI 10.1242/jcs.106005; Hoon J-L, 2012, MOL CELL BIOL; Jourdain P, 2011, J NEUROSCI, V31, P11846, DOI 10.1523/JNEUROSCI.0286-11.2011; Kim G, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25886-8; Kim M, 2011, OPT LETT, V36, P148, DOI 10.1364/OL.36.000148; Krause M, 2014, NAT REV MOL CELL BIO, V15, P577, DOI 10.1038/nrm3861; Ladwein M, 2008, FEBS LETT, V582, P2066, DOI 10.1016/j.febslet.2008.04.033; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; Lee J, COMPOSITION DYNAMICS, V12; Lee S, 2017, SCI REPORTS, V7, DOI [10.1038/s41598-017-00035-9, DOI 10.1038/S41598-017-00035-9]; Li L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002093; Machacek M, 2006, BIOPHYS J, V90, P1439, DOI 10.1529/biophysj.105.070383; Mir M, 2011, P NATL ACAD SCI USA, V108, P13124, DOI 10.1073/pnas.1100506108; Mullins RD, 1998, P NATL ACAD SCI USA, V95, P6181, DOI 10.1073/pnas.95.11.6181; Park YK, 2010, P NATL ACAD SCI USA, V107, P1289, DOI 10.1073/pnas.0910785107; Petrie RJ, 2009, NAT REV MOL CELL BIO, V10, P538, DOI 10.1038/nrm2729; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Ponti A, 2004, SCIENCE, V305, P1782, DOI 10.1126/science.1100533; Rilla Kirsi, 2015, Int J Cell Biol, V2015, P769163, DOI 10.1155/2015/769163; Sastry SK, 2000, EXP CELL RES, V261, P25, DOI 10.1006/excr.2000.5043; Selmeczi D, 2005, BIOPHYS J, V89, P912, DOI 10.1529/biophysj.105.061150; Shutova M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040814; Sung Y, 2009, OPTICAL DIFFRACTION, P12; THERIOT JA, 1991, NATURE, V352, P126, DOI 10.1038/352126a0; Totsukawa G, 2004, J CELL BIOL, V164, P427, DOI 10.1083/jcb.200306172; Wang Z, 2011, SPATIAL LIGHT INTERF, P11; Wang Z, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3656732; Weiner OD, 2007, PLOS BIOL, V5, P2053, DOI 10.1371/journal.pbio.0050221; Yang TD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020255	41	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2019	14	8							e0220810	10.1371/journal.pone.0220810	http://dx.doi.org/10.1371/journal.pone.0220810			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5RZ	31437196	gold, Green Submitted, Green Published			2022-12-26	WOS:000485036900019
J	Cebria-Costa, JP; Pascual-Reguant, L; Gonzalez-Perez, A; Serra-Bardenys, G; Querol, J; Cosin, M; Verde, G; Cigliano, RA; Sanseverino, W; Segura-Bayona, S; Iturbide, A; Andreu, D; Nuciforo, P; Bernado-Morales, C; Rodilla, V; Arribas, J; Yelamos, J; de Herreros, AG; Stracker, TH; Peiro, S				Cebria-Costa, J. P.; Pascual-Reguant, L.; Gonzalez-Perez, A.; Serra-Bardenys, G.; Querol, J.; Cosin, M.; Verde, G.; Cigliano, R. A.; Sanseverino, W.; Segura-Bayona, S.; Iturbide, A.; Andreu, D.; Nuciforo, P.; Bernado-Morales, C.; Rodilla, V.; Arribas, J.; Yelamos, J.; Garcia de Herreros, A.; Stracker, T. H.; Peiro, S.			LOXL2-mediated H3K4 oxidation reduces chromatin accessibility in triple-negative breast cancer cells	ONCOGENE			English	Article							OXIDASE-LIKE 2; DOUBLE-STRAND BREAKS; TO-MESENCHYMAL TRANSITION; DNA-DAMAGE RESPONSE; LYSYL OXIDASE; GENOMIC INSTABILITY; E-CADHERIN; LOXL2; EXPRESSION; TRANSCRIPTION	Oxidation of H3 at lysine 4 (H3K4ox) by lysyl oxidase-like 2 (LOXL2) generates an H3 modification with an unknown physiological function. We find that LOXL2 and H3K4ox are higher in triple-negative breast cancer (TNBC) cell lines and patient-derived xenografts (PDXs) than those from other breast cancer subtypes. ChIP-seq revealed that H3K4ox is located primarily in heterochromatin, where it is involved in chromatin compaction. Knocking down LOXL2 reduces H3K4ox levels and causes chromatin decompaction, resulting in a sustained activation of the DNA damage response (DDR) and increased susceptibility to anticancer agents. This critical role that LOXL2 and oxidized H3 play in chromatin compaction and DDR suggests that functionally targeting LOXL2 could be a way to sensitize TNBC cells to conventional therapy.	[Cebria-Costa, J. P.; Pascual-Reguant, L.; Serra-Bardenys, G.; Querol, J.; Cosin, M.; Verde, G.; Nuciforo, P.; Bernado-Morales, C.; Rodilla, V.; Arribas, J.; Peiro, S.] Vall dHebron Inst Oncol VHIO, Barcelona 08035, Spain; [Gonzalez-Perez, A.; Segura-Bayona, S.; Stracker, T. H.] Barcelona Inst Sci & Technol, Inst Res Biomed IRB Barcelona, Barcelona 08028, Spain; [Verde, G.] Univ Int Catalunya, Fac Med & Hlth Sci, Barcelona, Spain; [Cigliano, R. A.; Sanseverino, W.] Sequentia Biotech SL, Comte Urgell 240, Barcelona, Spain; [Iturbide, A.] Helmoholtz Zentrum Munchen, Inst Epigenet & Stem Cells, D-81377 Munich, Germany; [Andreu, D.; Garcia de Herreros, A.] Univ Pompeu Fabra, Dept Ciencies Expt & Salut, Barcelona, Spain; [Bernado-Morales, C.; Arribas, J.] Ctr Invest Biomed Red Oncol CIBERONC, Barcelona 08035, Spain; [Arribas, J.] ICREA, Barcelona, Spain; [Arribas, J.] Univ Autonoma Barcelona, Dept Bioquim & Biol Mol, Bellaterra, Spain; [Yelamos, J.; Garcia de Herreros, A.] Inst Hosp del Mar Invest Med IMIM, Programa Recerca Canc, Barcelona, Spain	Vall d'Hebron Institut d'Oncologia (VHIO); Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; Universitat Internacional de Catalunya (UIC); Pompeu Fabra University; CIBER - Centro de Investigacion Biomedica en Red; CIBERONC; ICREA; Autonomous University of Barcelona; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar	Peiro, S (corresponding author), Vall dHebron Inst Oncol VHIO, Barcelona 08035, Spain.	speiro@vhio.net	Benito, Verónica Rodilla/A-5171-2018; Yelamos, Jose/N-2842-2016; Sanseverino, Walter/AAX-5254-2021; Reguant, Laura Pascual/AAB-6274-2019; Segura-Bayona, Sandra/W-8156-2019; Arribas, Joaquin/M-4482-2014; Verde, Gaetano/U-2749-2017	Benito, Verónica Rodilla/0000-0003-0512-4179; Sanseverino, Walter/0000-0003-3324-5912; Reguant, Laura Pascual/0000-0003-2361-1392; Segura-Bayona, Sandra/0000-0001-7788-9889; Bernado Morales, Cristina/0000-0003-1376-0407; Arribas, Joaquin/0000-0002-0504-0664; Peiro, Sandra/0000-0001-9519-3877; Yelamos, Jose/0000-0003-1195-1496; Verde, Gaetano/0000-0003-4768-0165; Cebria Costa, Joan Pau/0000-0002-3628-2973; Gonzalez-Perez, Abel/0000-0002-8582-4660	Instituto de Salud Carlos III (ISCIII) FIS/FEDER [PI12/01250, CP08/00223, PI16/00253, CB16/12/00449]; MINECO [SAF201348849-C2-1-R]; Breast Cancer Research Foundation [BCRF-17-008]; Worldwide Cancer Research; Red Tematica de Investigacion Cooperativa en Cancer [RD012/0036/005]; Fundacion Cientifica de la Asociacion Espanola contra el Cancer; Fundacio La Marato TV3; institutional funding (MINECO) through the Centres of Excellence Severo Ochoa award; CERCA Programme of the Catalan Government; Fundacio La Caixa fellowship; MINECO ("Juan de la Cierva Incorporation" fellowship) [IJCI-2014-20723]; Miguel Servet contract (ISCIII/FIS); Fundacio FERO; FI Fellowship from the Generalitat de Catalunya;  [BFU2015-68354];  [AGL2014-52395-C2-2-R]	Instituto de Salud Carlos III (ISCIII) FIS/FEDER; MINECO(Spanish Government); Breast Cancer Research Foundation; Worldwide Cancer Research; Red Tematica de Investigacion Cooperativa en Cancer; Fundacion Cientifica de la Asociacion Espanola contra el Cancer; Fundacio La Marato TV3; institutional funding (MINECO) through the Centres of Excellence Severo Ochoa award; CERCA Programme of the Catalan Government; Fundacio La Caixa fellowship; MINECO ("Juan de la Cierva Incorporation" fellowship); Miguel Servet contract (ISCIII/FIS); Fundacio FERO; FI Fellowship from the Generalitat de Catalunya(Generalitat de Catalunya); ; 	We would like to thank R. Pena and J. Valle for technical assistance, V.A. Raker for manuscript editing, G. Gil for manuscript reading and advice, A. Jordan for H1-GFP constructs, T. Jenuwein for SUV-39 constructs, and H. Galvez-Garcia for ATAC protocol implementation. This work was supported by grants from Instituto de Salud Carlos III (ISCIII) FIS/FEDER (PI12/01250; CP08/00223; PI16/00253; and CB16/12/00449), MINECO (SAF201348849-C2-1-R) to SP, BFU2015-68354 to THS, Breast Cancer Research Foundation (BCRF-17-008) to JA, AGL2014-52395-C2-2-R to DA, Worldwide Cancer Research, Red Tematica de Investigacion Cooperativa en Cancer (RD012/0036/005), Fundacion Cientifica de la Asociacion Espanola contra el Cancer, and Fundacio La Marato TV3. THS was supported by institutional funding (MINECO) through the Centres of Excellence Severo Ochoa award and the CERCA Programme of the Catalan Government, and SS-B, by a Fundacio La Caixa fellowship. We thank La Caixa Foundation and Cellex Foundation for provide research facilities and equipment. GV has received funding from the MINECO (a "Juan de la Cierva Incorporation" fellowship; IJCI-2014-20723). SP was a recipient of a Miguel Servet contract (ISCIII/FIS), and AI, JPC-C, LP-G, and GS-B are supported by contracts from Worldwide Cancer Research, Fundacio La Marato TV3, Fundacio FERO, and a FI Fellowship from the Generalitat de Catalunya, respectively.	Ahn SG, 2013, BREAST CANCER RES TR, V141, P89, DOI 10.1007/s10549-013-2662-3; Almendro V, 2014, CELL REP, V6, P514, DOI 10.1016/j.celrep.2013.12.041; Ayrapetov MK, 2014, P NATL ACAD SCI USA, V111, P9169, DOI 10.1073/pnas.1403565111; Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Baldeyron C, 2011, J CELL BIOL, V193, P81, DOI 10.1083/jcb.201101030; Bannister AJ, 2011, CELL RES, V21, P381, DOI 10.1038/cr.2011.22; Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Barker HE, 2012, NAT REV CANCER, V12, P540, DOI 10.1038/nrc3319; Bayona-Feliu A, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00338-5; Bekker-Jensen S, 2006, J CELL BIOL, V173, P195, DOI 10.1083/jcb.200510130; Bonilla CY, 2008, MOL CELL, V30, P267, DOI 10.1016/j.molcel.2008.03.023; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; Burgess RC, 2015, CELL, V162, P944, DOI 10.1016/j.cell.2015.08.006; Burgess RC, 2014, CELL REP, V9, P1703, DOI 10.1016/j.celrep.2014.10.060; Cano A, 2012, FUTURE ONCOL, V8, P1095, DOI [10.2217/FON.12.105, 10.2217/fon.12.105]; De Craene B, 2013, NAT REV CANCER, V13, P97, DOI 10.1038/nrc3447; Ernst J, 2012, NAT METHODS, V9, P215, DOI 10.1038/nmeth.1906; Escriva M, 2008, MOL CELL BIOL, V28, P1528, DOI 10.1128/MCB.02061-07; Fischer KR, 2015, NATURE, V527, P472, DOI 10.1038/nature15748; Fong SFT, 2007, GENE CHROMOSOME CANC, V46, P644, DOI 10.1002/gcc.20444; Gan WJ, 2011, GENE DEV, V25, P2041, DOI 10.1101/gad.17010011; Garcia-Rubio ML, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005674; Goodarzi AA, 2008, MOL CELL, V31, P167, DOI 10.1016/j.molcel.2008.05.017; Guelen L, 2008, NATURE, V453, P948, DOI 10.1038/nature06947; Gursoy-Yuzugullu O, 2016, J MOL BIOL, V428, P1846, DOI 10.1016/j.jmb.2015.11.021; Herranz N, 2008, MOL CELL BIOL, V28, P4772, DOI 10.1128/MCB.00323-08; Herranz N, 2016, FEBS J, V283, P4263, DOI 10.1111/febs.13922; Holliday DL, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2889; Iturbide A, 2015, MOL CELL, V58, P755, DOI 10.1016/j.molcel.2015.04.012; Iturbide A, 2015, FEBS J, V282, P1768, DOI 10.1111/febs.12961; Kaidi A, 2013, NATURE, V498, DOI 10.1038/nature12201; Khurana S, 2014, CELL REP, V8, P1049, DOI 10.1016/j.celrep.2014.07.024; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lerat E, 2017, NUCLEIC ACIDS RES, V45, DOI 10.1093/nar/gkw953; Martin A, 2015, EMBO J, V34, P1090, DOI 10.15252/embj.201489975; McDonald OG, 2011, NAT STRUCT MOL BIOL, V18, P867, DOI 10.1038/nsmb.2084; Millanes-Romero A, 2013, MOL CELL, V52, P746, DOI 10.1016/j.molcel.2013.10.015; Moreno-Bueno G, 2011, EMBO MOL MED, V3, P528, DOI 10.1002/emmm.201100156; Murga M, 2007, J CELL BIOL, V178, P1101, DOI 10.1083/jcb.200704140; Peinado H, 2005, EMBO J, V24, P3446, DOI 10.1038/sj.emboj.7600781; Peinado H, 2008, CANCER RES, V68, P4541, DOI 10.1158/0008-5472.CAN-07-6345; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Schietke R, 2010, J BIOL CHEM, V285, P6658, DOI 10.1074/jbc.M109.042424; Soria G, 2012, MOL CELL, V46, P722, DOI 10.1016/j.molcel.2012.06.002; Soutoglou E, 2008, SCIENCE, V320, P1507, DOI [10.1126/science.1159051, 10.1126/science.ll59051]; Tarazona S, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv711; Torres S, 2015, CLIN CANCER RES, V21, P4892, DOI 10.1158/1078-0432.CCR-14-3096; Toth KF, 2004, J CELL SCI, V117, P4277, DOI 10.1242/jcs.01293; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Tsompana M, 2014, EPIGENET CHROMATIN, V7, DOI 10.1186/1756-8935-7-33; Tuduri S, 2009, NAT CELL BIOL, V11, P1315, DOI 10.1038/ncb1984; Vega S, 2004, GENE DEV, V18, P1131, DOI 10.1101/gad.294104; Voloshenyuk TG, 2011, CYTOKINE, V55, P90, DOI 10.1016/j.cyto.2011.03.024; WILLIAMSON PR, 1986, J BIOL CHEM, V261, P9477; Wong CCL, 2014, HEPATOLOGY, V60, P1645, DOI 10.1002/hep.27320; Wu M, 2008, MOL CELL BIOL, V28, P7337, DOI 10.1128/MCB.00976-08; YOSHIDA M, 1990, J BIOL CHEM, V265, P17174; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zheng XF, 2015, NATURE, V527, P525, DOI 10.1038/nature16064; Ziv Y, 2006, NAT CELL BIOL, V8, P870, DOI 10.1038/ncb1446	61	16	16	0	4	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN	2020	39	1					79	121		10.1038/s41388-019-0969-1	http://dx.doi.org/10.1038/s41388-019-0969-1			43	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	KG3NM	31462706	hybrid, Green Published			2022-12-26	WOS:000509849200007
J	Rabinovich, S; Silberman, A; Adler, L; Agron, S; Levin-Zaidman, S; Bahat, A; Porat, Z; Ben-Zeev, E; Geva, I; Itkin, M; Malitsky, S; Buchaklian, A; Helbling, D; Dimmock, D; Erez, A				Rabinovich, Shiran; Silberman, Alon; Adler, Lital; Agron, Shani; Levin-Zaidman, Smadar; Bahat, Amir; Porat, Ziv; Ben-Zeev, Efrat; Geva, Inbal; Itkin, Maxim; Malitsky, Sergey; Buchaklian, Adam; Helbling, Daniel; Dimmock, David; Erez, Ayelet			The mitochondrial carrier Citrin plays a role in regulating cellular energy during carcinogenesis	ONCOGENE			English	Article							DEFICIENCY; CANCER; EXPERIENCE; ASPARTATE	Citrin, encoded by SLC25A13 gene, is an inner mitochondrial transporter that is part of the malate-aspartate shuttle, which regulates the NAD+/NADH ratio between the cytosol and mitochondria. Citrullinemia type II (CTLN-II) is an inherited disorder caused by germline mutations in SLC25A13, manifesting clinically in growth failure that can be alleviated by dietary restriction of carbohydrates. The association of citrin with glycolysis and NAD+/NADH ratio led us to hypothesize that it may play a role in carcinogenesis. Indeed, we find that citrin is upregulated in multiple cancer types and is essential for supplementing NAD+ for glycolysis and NADH for oxidative phosphorylation. Consequently, citrin deficiency associates with autophagy, whereas its overexpression in cancer cells increases energy production and cancer invasion. Furthermore, based on the human deleterious mutations in citrin, we found a potential inhibitor of citrin that restricts cancerous phenotypes in cells. Collectively, our findings suggest that targeting citrin may be of benefit for cancer therapy.	[Rabinovich, Shiran; Silberman, Alon; Adler, Lital; Agron, Shani; Bahat, Amir; Erez, Ayelet] Weizmann Inst Sci, Dept Biol Regulat, Rehovot, Israel; [Levin-Zaidman, Smadar] Weizmann Inst Sci, Dept Chem Res Support, Rehovot, Israel; [Porat, Ziv] Weizmann Inst Sci, Dept Cell Sorting, Rehovot, Israel; [Ben-Zeev, Efrat; Geva, Inbal] Weizmann Inst Sci, Grand Israel Natl Ctr Personalized Med, Rehovot, Israel; [Itkin, Maxim; Malitsky, Sergey] Weizmann Inst Sci, Dept Life Sci Core Facil, Rehovot, Israel; [Buchaklian, Adam; Helbling, Daniel; Dimmock, David] Med Coll Wisconsin, Human & Mol Genet & Biochem Ctr, Milwaukee, WI 53226 USA; [Dimmock, David] Rady Childrens Inst Genom Med, San Diego, CA USA	Weizmann Institute of Science; Weizmann Institute of Science; Weizmann Institute of Science; Weizmann Institute of Science; Weizmann Institute of Science; Medical College of Wisconsin	Erez, A (corresponding author), Weizmann Inst Sci, Dept Biol Regulat, Rehovot, Israel.	ayelet.erez@weizmann.ac.il	Itkin, Maxim/AFU-5181-2022; Malitsky, Sergey/ABC-2545-2020; Itkin, Maxim/ABB-9183-2020; Porat, Ziv/K-1672-2012	Itkin, Maxim/0000-0003-1348-2814; Malitsky, Sergey/0000-0003-4619-7219; Porat, Ziv/0000-0003-3059-181X	European research program [CIG618113, ERC614204]; Israel Science Foundation [1343/13, 1952/13]; Minerva grant [711730]; Adelis Foundation; Henry S. and Anne S. Reich Research Fund; Dukler Fund for Cancer Research; Paul Sparr Foundation; Saul and Theresa Esman Foundation; estate of Fannie Sherr; Weizmann Institute	European research program(European Commission); Israel Science Foundation(Israel Science Foundation); Minerva grant; Adelis Foundation; Henry S. and Anne S. Reich Research Fund; Dukler Fund for Cancer Research; Paul Sparr Foundation; Saul and Theresa Esman Foundation; estate of Fannie Sherr; Weizmann Institute	We acknowledge and thank the Weizmann Institute for providing financial and infrastructural support. We thank Tomer Shlomi and his student Won Dong-Lee, Gad Asher, Zvulun Elazar and his student Adi Abada, Yoav Shaul, Irit Sagi, Ron Rotkopf, and Sivan Galai for the intellectual and technical assistance. AE is incumbent of the Leah Omenn Career Development Chair and is supported by research grants from the European research program (CIG618113, ERC614204), the Israel Science Foundation (1343/13; 1952/13), and from the Minerva grant award (711730). AE received additional support from the Adelis Foundation, the Henry S. and Anne S. Reich Research Fund, the Dukler Fund for Cancer Research, the Paul Sparr Foundation, the Saul and Theresa Esman Foundation, from Joseph Piko Baruch, and from the estate of Fannie Sherr. The authors declare applying for a patent for citrin inhibition as cancer therapy.	Amoedo ND, 2016, BBA-MOL CELL RES, V1863, P2394, DOI 10.1016/j.bbamcr.2016.04.011; Bartolome Fernando, 2015, Methods Mol Biol, V1264, P263, DOI 10.1007/978-1-4939-2257-4_23; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Chang KW, 2011, MOL GENET METAB, V103, P293, DOI 10.1016/j.ymgme.2011.03.013; Chung HY, 2017, J CANCER PREV, V22, P127, DOI 10.15430/JCP.2017.22.3.127; Corbet C, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03525-0; Dimmock D, 2009, MOL GENET METAB, V96, P44, DOI 10.1016/j.ymgme.2008.10.007; Dimmock D, 2007, PEDIATRICS, V119, pE773, DOI 10.1542/peds.2006-1950; Dimmock D, 2010, CLIN CHEM, V56, P1119, DOI 10.1373/clinchem.2009.141549; Erez A, 2015, NAT REV CANCER, V15, P440, DOI 10.1038/nrc3949; Fass E, 2006, J BIOL CHEM, V281, P36303, DOI 10.1074/jbc.M607031200; Fiermonte G, 2011, MOL GENET METAB, V104, P501, DOI 10.1016/j.ymgme.2011.08.022; Garcia-Bermudez J, 2018, NAT CELL BIOL, V20, P775, DOI 10.1038/s41556-018-0118-z; Gaude E, 2018, MOL CELL, V69, P581, DOI 10.1016/j.molcel.2018.01.034; Hollinshead KER, 2016, WIRES SYST BIOL MED, V8, P272, DOI 10.1002/wsbm.1334; Kimura N, 2013, TRANSPL P, V45, P3432, DOI 10.1016/j.transproceed.2013.06.016; Kluza J, 2012, CANCER RES, V72, P5035, DOI 10.1158/0008-5472.CAN-12-0979; Komatsu M, 2010, FEBS LETT, V584, P1374, DOI 10.1016/j.febslet.2010.02.017; Malitsky S, 2016, NEW PHYTOL, V210, P88, DOI 10.1111/nph.13852; Porporato PE, 2014, CELL REP, V8, P754, DOI 10.1016/j.celrep.2014.06.043; Rabinovich S, 2015, NATURE, V527, P379, DOI 10.1038/nature15529; Revollo JR, 2007, CURR OPIN GASTROEN, V23, P164, DOI 10.1097/MOG.0b013e32801b3c8f; ROBINSON BH, 1985, AM J HUM GENET, V37, P938; Saheki T, 2010, MOL GENET METAB, V100, pS59, DOI 10.1016/j.ymgme.2010.02.014; Salem M, 2017, JOVE-J VIS EXP, V1, P124; Satrustegui J, 2007, PHYSIOL REV, V87, P29, DOI 10.1152/physrev.00005.2006; Shaul YD, 2016, NUCLEIC ACIDS RES, V44, pD560, DOI 10.1093/nar/gkv1337; Shinohara M, 2010, J BIOL CHEM, V285, P4481, DOI 10.1074/jbc.M109.071779; Song YZ, 2011, INT J MOL MED, V28, P33, DOI 10.3892/ijmm.2011.653; Sullivan LB, 2018, NAT CELL BIOL, V20, P782, DOI 10.1038/s41556-018-0125-0; Takeuchi S, 2015, PEDIATRICS, V136, pE530, DOI 10.1542/peds.2014-4172; Torrano V, 2016, NAT CELL BIOL, V18, P645, DOI 10.1038/ncb3357; van Niekerk G, 2018, CELL ONCOL, V41, P343, DOI 10.1007/s13402-018-0383-7; Xian ZY, 2015, TUMOR BIOL, V36, P8093, DOI 10.1007/s13277-015-3540-x; Hung YP, 2011, CELL METAB, V14, P545, DOI 10.1016/j.cmet.2011.08.012; Zheng L, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7001	36	11	11	2	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN	2020	39	1					164	175		10.1038/s41388-019-0976-2	http://dx.doi.org/10.1038/s41388-019-0976-2			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	KG3NM	31462712				2022-12-26	WOS:000509849200011
J	Lee, JY; Lee, YJ; Jeon, HY; Han, ET; Park, WS; Hong, SH; Kim, YM; Ha, KS				Lee, Jee-Yeon; Lee, Yeon-Ju; Jeon, Hye-Yoon; Han, Eun-Taek; Park, Won Sun; Hong, Seok-Ho; Kim, Young-Myeong; Ha, Kwon-Soo			The vicious cycle between transglutaminase 2 and reactive oxygen species in hyperglycemic memory-induced endothelial dysfunction	FASEB JOURNAL			English	Article						diabetes mellitus; ROS; TGase2; inflammation; apoptosis	C-PEPTIDE; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE; TISSUE TRANSGLUTAMINASE; VASCULAR LEAKAGE; FOLLOW-UP; INHIBITION; APOPTOSIS; PATHWAYS; P66(SHC); STRESS	Clinical trials suggested that the vascular system can remember episodes of poor glycemic control through a phenomenon known as hyperglycemic memory (HGM). HGM is associated with long-term diabetic vascular complications in type 1 and type 2 diabetes, although the molecular mechanism of that association is not clearly understood. We hypothesized that transglutaminase 2 (TGase2) and intracellular reactive oxygen species (ROS) play a key role in HGM-induced vascular dysfunction. We found that hyperglycemia induced persistent oxidative stress, expression of inflammatory adhesion molecules, and apoptosis in the aortic endothelium of HGM mice whose blood glucose levels had been normalized by insulin supplementation. TGase2 activation and ROS generation were in a vicious cycle in the aortic endothelium of HGM mice and also in human aortic endothelial cells after glucose normalization, which played a key role in the sustained expression of inflammatory adhesion molecules and apoptosis. Our findings suggest that the TGase2-ROS vicious cycle plays an important role in HGM-induced endothelial dysfunction.	[Lee, Jee-Yeon; Lee, Yeon-Ju; Jeon, Hye-Yoon; Kim, Young-Myeong; Ha, Kwon-Soo] Kangwon Natl Univ, Sch Med, Dept Mol & Cellular Biochem, Kangwondaehak Gil 1, Chunchon 24341, Kangwon Do, South Korea; [Han, Eun-Taek] Kangwon Natl Univ, Sch Med, Dept Med Environm Biol & Trop Med, Chunchon, South Korea; [Park, Won Sun] Kangwon Natl Univ, Sch Med, Dept Physiol, Chunchon, South Korea; [Hong, Seok-Ho] Kangwon Natl Univ, Sch Med, Dept Internal Med, Chunchon, South Korea	Kangwon National University; Kangwon National University; Kangwon National University; Kangwon National University	Ha, KS (corresponding author), Kangwon Natl Univ, Sch Med, Dept Mol & Cellular Biochem, Kangwondaehak Gil 1, Chunchon 24341, Kangwon Do, South Korea.	ksha@kangwon.ac.kr	Ha, Kwon-Soo/AAU-4417-2020	Ha, Kwon-Soo/0000-0002-4219-1787	National Research Foundation of Korea [2015R1A4A1038666, 2016R1A2A1A05004975]	National Research Foundation of Korea(National Research Foundation of Korea)	This work was supported by the National Research Foundation of Korea (2015R1A4A1038666 and 2016R1A2A1A05004975). K.-S.H. is the guarantor of this work, had full access to all of the data in the study, and takes responsibility for the integrity of the data and the accuracy of the data analysis. The authors declare no conflicts of interest.	Albers JW, 2010, DIABETES CARE, V33, P1090, DOI 10.2337/dc09-1941; Bhatt MP, 2016, J ENDOCRINOL, V231, P97, DOI 10.1530/JOE-16-0349; Bhatt MP, 2014, CARDIOVASC RES, V104, P234, DOI 10.1093/cvr/cvu211; Bhatt MP, 2013, DIABETES, V62, P3851, DOI 10.2337/db13-0039; Bhatt MP, 2013, DIABETES, V62, P243, DOI 10.2337/db12-0293; Brasacchio D, 2009, DIABETES, V58, P1229, DOI 10.2337/db08-1666; Brownlee M, 2001, NATURE, V414, P813, DOI 10.1038/414813a; Cooper AJL, 1997, P NATL ACAD SCI USA, V94, P12604, DOI 10.1073/pnas.94.23.12604; Di Sabatino A, 2012, AUTOIMMUN REV, V11, P746, DOI 10.1016/j.autrev.2012.01.007; Du XL, 2003, J CLIN INVEST, V112, P1049, DOI 10.1172/JCI200318127; El-Osta A, 2008, J EXP MED, V205, P2409, DOI 10.1084/jem.20081188; ENGERMAN RL, 1987, DIABETES, V36, P808, DOI 10.2337/diabetes.36.7.808; Forbes JM, 2013, PHYSIOL REV, V93, P137, DOI 10.1152/physrev.00045.2011; Giacco F, 2010, CIRC RES, V107, P1058, DOI 10.1161/CIRCRESAHA.110.223545; Holman RR, 2008, NEW ENGL J MED, V359, P1577, DOI 10.1056/NEJMoa0806470; Holman RR, 2008, NEW ENGL J MED, V359, P1565, DOI 10.1056/NEJMoa0806359; Ihnat MA, 2007, DIABETOLOGIA, V50, P1523, DOI 10.1007/s00125-007-0684-2; Jeon HY, 2019, FASEB J, V33, P750, DOI 10.1096/fj.201800723R; Kim DS, 2010, BIOCHEM BIOPH RES CO, V403, P479, DOI 10.1016/j.bbrc.2010.11.063; King P, 1999, BRIT J CLIN PHARMACO, V48, P643, DOI 10.1046/j.1365-2125.1999.00092.x; Kirkland RA, 2003, ANTIOXID REDOX SIGN, V5, P589, DOI 10.1089/152308603770310257; Lee YJ, 2018, FASEB J, V32; Lee YJ, 2017, J ENDOCRINOL, V235, P39, DOI 10.1530/JOE-17-0109; Lee YJ, 2016, DIABETES, V65, P2414, DOI 10.2337/db15-1594; Lim YC, 2014, CARDIOVASC RES, V101, P155, DOI 10.1093/cvr/cvt238; Nathan DM, 2005, NEW ENGL J MED, V353, P2643, DOI 10.1056/nejmoa052187; Nishikawa T, 2000, NATURE, V404, P787, DOI 10.1038/35008121; Okabe J, 2012, CIRC RES, V110, P1067, DOI 10.1161/CIRCRESAHA.112.266171; Paneni F, 2013, DIABETES, V62, P1800, DOI 10.2337/db12-1648; Paneni F, 2012, CIRC RES, V111, P278, DOI 10.1161/CIRCRESAHA.112.266593; Park D, 2010, AMINO ACIDS, V39, P619, DOI 10.1007/s00726-010-0500-z; Pirola L, 2010, NAT REV ENDOCRINOL, V6, P665, DOI 10.1038/nrendo.2010.188; Rodolfo C, 2004, J BIOL CHEM, V279, P54783, DOI 10.1074/jbc.M410938200; Ruan QM, 2007, FRONT BIOSCI-LANDMRK, V12, P891, DOI 10.2741/2111; Ruoppolo M, 2003, PROTEIN SCI, V12, P170, DOI 10.1110/ps.0216103; Sane DC, 2007, FRONT BIOSCI-LANDMRK, V12, P2530, DOI 10.2741/2253; Schisano B, 2011, DIABETOLOGIA, V54, P1219, DOI 10.1007/s00125-011-2049-0	37	18	19	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2019	33	11					12655	12667		10.1096/fj.201901358RR	http://dx.doi.org/10.1096/fj.201901358RR			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC8ZX	31462079	Green Published			2022-12-26	WOS:000507461600082
J	Kolev, NG; Rajan, KS; Tycowski, KT; Toh, JY; Shi, HF; Lei, YL; Michaeli, S; Tschudi, C				Kolev, Nikolay G.; Rajan, K. Shanmugha; Tycowski, Kazimierz T.; Toh, Justin Y.; Shi, Huafang; Lei, Yuling; Michaeli, Shulamit; Tschudi, Christian			The vault RNA of Trypanosoma brucei plays a role in the production of trans-spliced mRNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						RNA metabolism; RNA processing; RNA splicing; RNA; RNA-binding protein; Ro protein; spliced leader (SL); telomerase-associated protein 1 (TEP1); Trypanosoma brucei; vault RNA	SMALL CYTOPLASMIC RIBONUCLEOPROTEINS; NONCODING Y RNAS; TELOMERASE RNA; WIDE ANALYSIS; PROTEINS P80; EXPRESSION; TRANSCRIPTION; AUTOANTIGEN; GENE; REVEALS	The vault ribonucleoprotein (RNP), comprising vault RNA (vtRNA) and telomerase-associated protein 1 (TEP1), is found in many eukaryotes. However, previous studies of vtRNAs, for example in mammalian cells, have failed to reach a definitive conclusion about their function. vtRNAs are related to Y RNAs, which are complexed with Ro protein and influence Ro's function in noncoding RNA (ncRNA) quality control and processing. In Trypanosoma brucei, the small noncoding TBsRNA-10 was first described in a survey of the ncRNA repertoire in this organism. Here, we report that TBsRNA-10 in T. brucei is a vtRNA, based on its association with TEP1 and sequence similarity to those of other known and predicted vtRNAs. We observed that like vtRNAs in other species, TBsRNA-10 is transcribed by RNA polymerase III, which in trypanosomes also generates the spliceosomal U-rich small nuclear RNAs. In T. brucei, spliced leader (SL)-mediated trans-splicing of pre-mRNAs is an obligatory step in gene expression, and we found here that T. brucei's vtRNA is highly enriched in a non-nucleolar locus in the cell nucleus implicated in SL RNP biogenesis. Using a newly developed permeabilized cell system for the bloodstream form of T. brucei, we show that down-regulated vtRNA levels impair trans-spliced mRNA production, consistent with a role of vtRNA in trypanosome mRNA metabolism. Our results suggest a common theme for the functions of vtRNAs and Y RNAs. We conclude that by complexing with their protein-binding partners TEP1 and Ro, respectively, these two RNA species modulate the metabolism of various RNA classes.	[Kolev, Nikolay G.; Toh, Justin Y.; Shi, Huafang; Lei, Yuling; Tschudi, Christian] Yale Sch Publ Hlth, Dept Epidemiol Microbial Dis, 295 Congress Ave, New Haven, CT 06536 USA; [Rajan, K. Shanmugha; Michaeli, Shulamit] Bar Ilan Univ, Mina & Everard Goodman Fac Life Sci, IL-52900 Ramat Gan, Israel; [Rajan, K. Shanmugha; Michaeli, Shulamit] Bar Ilan Univ, Adv Mat & Nanotechnol Inst, IL-52900 Ramat Gan, Israel; [Tycowski, Kazimierz T.] Yale Univ, Howard Hughes Med Inst, Dept Mol Biophys & Biochem, Sch Med, New Haven, CT 06536 USA	Yale University; Bar Ilan University; Bar Ilan University; Howard Hughes Medical Institute; Yale University	Kolev, NG (corresponding author), Yale Sch Publ Hlth, Dept Epidemiol Microbial Dis, 295 Congress Ave, New Haven, CT 06536 USA.	nikolay.kolev@yale.edu	Michaeli, Shulamit/AAC-8255-2022	RAJAN, K. SHANMUGHA/0000-0003-4826-9802; Tschudi, Christian/0000-0002-9365-5254	National Institutes of Health [AI028798, AI110325]; Israel-United States Binational Science Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI110325, R01AI028798] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Israel-United States Binational Science Foundation(US-Israel Binational Science Foundation); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health Grants AI028798 and AI110325 (to C. T.) and by a grant from the Israel-United States Binational Science Foundation (to S. M. and C. T.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Amort M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8030; Anderson DH, 2007, PLOS BIOL, V5, P2661, DOI 10.1371/journal.pbio.0050318; Arimbasseri AG, 2013, MOL CELL BIOL, V33, P1571, DOI 10.1128/MCB.01733-12; Babatunde KA, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19149-9; Bastin P, 1996, MOL BIOCHEM PARASIT, V77, P235, DOI 10.1016/0166-6851(96)02598-4; Bateman A, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-49; Ben-Shlomo H, 1999, J BIOL CHEM, V274, P25642, DOI 10.1074/jbc.274.36.25642; Berriman M, 2005, SCIENCE, V309, P416, DOI 10.1126/science.1112642; Burroughs AM, 2016, NUCLEIC ACIDS RES, V44, P8525, DOI 10.1093/nar/gkw722; Buscher P, 2017, LANCET, V390, P2397, DOI 10.1016/S0140-6736(17)31510-6; Chen JJ, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191325; Chen XG, 2003, CURR BIOL, V13, P2206, DOI 10.1016/j.cub.2003.11.028; Chen XG, 2007, GENE DEV, V21, P1328, DOI 10.1101/gad.1548207; Chen XG, 2014, RNA, V20, P1715, DOI 10.1261/rna.047241.114; Chen XG, 2013, CELL, V153, P166, DOI 10.1016/j.cell.2013.02.037; Chikne V, 2016, SCI REP-UK, V6, DOI 10.1038/srep25296; Christiano R, 2017, MOL MICROBIOL, V106, P74, DOI 10.1111/mmi.13754; Fadda A, 2014, MOL MICROBIOL, V94, P307, DOI 10.1111/mmi.12764; FANTONI A, 1994, MOL CELL BIOL, V14, P2021, DOI 10.1128/MCB.14.3.2021; Fuchs G, 2006, NAT STRUCT MOL BIOL, V13, P1002, DOI 10.1038/nsmb1156; Gandhi L, 1998, GENE DEV, V12, P721, DOI 10.1101/gad.12.5.721; Gopinath SCB, 2010, MOL CANCER RES, V8, P1536, DOI 10.1158/1541-7786.MCR-10-0242; Green CD, 1998, RNA, V4, P750, DOI 10.1017/S1355838298971667; Gunzl A, 2010, EUKARYOT CELL, V9, P1159, DOI 10.1128/EC.00113-10; Gupta SK, 2013, FEBS LETT, V587, P1399, DOI 10.1016/j.febslet.2013.03.017; Harrington L, 1997, SCIENCE, V275, P973, DOI 10.1126/science.275.5302.973; HENDRICK JP, 1981, MOL CELL BIOL, V1, P1138, DOI 10.1128/MCB.1.12.1138; Hogg JR, 2007, GENE DEV, V21, P3067, DOI 10.1101/gad.1603907; Horos R, 2019, CELL, V176, P1054, DOI 10.1016/j.cell.2019.01.030; Hury A, 2009, EUKARYOT CELL, V8, P56, DOI 10.1128/EC.00322-08; Hussain S, 2013, CELL REP, V4, P255, DOI 10.1016/j.celrep.2013.06.029; Jeon SH, 2012, FEBS LETT, V586, P3477, DOI 10.1016/j.febslet.2012.07.076; KEDERSHA NL, 1986, J CELL BIOL, V103, P699, DOI 10.1083/jcb.103.3.699; KICKHOEFER VA, 1993, J BIOL CHEM, V268, P7868; Kickhoefer VA, 2003, GENE, V309, P65, DOI 10.1016/S0378-1119(03)00507-9; Kickhoefer VA, 1999, J BIOL CHEM, V274, P32712, DOI 10.1074/jbc.274.46.32712; Kickhoefer VA, 1998, J BIOL CHEM, V273, P8971, DOI 10.1074/jbc.273.15.8971; Kickhoefer VA, 1999, J CELL BIOL, V146, P917, DOI 10.1083/jcb.146.5.917; Kickhoefer VA, 2001, J CELL BIOL, V152, P157, DOI 10.1083/jcb.152.1.157; Kolev NG, 2017, MOL BIOCHEM PARASIT, V216, P52, DOI 10.1016/j.molbiopara.2017.07.002; Kolev NG, 2012, SCIENCE, V338, P1352, DOI 10.1126/science.1229641; Kolev NG, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001090; Kong L, 2015, ONCOTARGET, V6, P28371, DOI 10.18632/oncotarget.4948; Kramer S, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006456; LAIRD PW, 1987, NUCLEIC ACIDS RES, V15, P10087, DOI 10.1093/nar/15.24.10087; LAIRD PW, 1987, EMBO J, V6, P1055, DOI 10.1002/j.1460-2075.1987.tb04858.x; Lamontagne J, 1999, J BIOL CHEM, V274, P6602, DOI 10.1074/jbc.274.10.6602; Lasser C, 2017, RNA BIOL, V14, P58, DOI 10.1080/15476286.2016.1249092; Lee K, 2011, RNA, V17, P1076, DOI 10.1261/rna.2701111; Lee TI, 2006, NAT PROTOC, V1, P729, DOI 10.1038/nprot.2006.98; Li CCY, 2013, RNA BIOL, V10, P1333, DOI 10.4161/rna.25281; Li F, 2015, NUCLEIC ACIDS RES, V43, P10321, DOI 10.1093/nar/gkv1078; Liang XH, 2005, RNA, V11, P619, DOI 10.1261/rna.7174805; Liang XH, 2002, RNA, V8, P237, DOI 10.1017/S1355838202018290; Liu Y, 2000, MOL CELL BIOL, V20, P8178, DOI 10.1128/MCB.20.21.8178-8184.2000; Mahmoudi S, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000521; Marchetti MA, 2000, J CELL SCI, V113, P899; Mason DX, 2001, P NATL ACAD SCI USA, V98, P12368, DOI 10.1073/pnas.221456398; Michaeli S, 2012, NUCLEIC ACIDS RES, V40, P1282, DOI 10.1093/nar/gkr786; Michaeli S, 2011, FUTURE MICROBIOL, V6, P459, DOI [10.2217/fmb.11.20, 10.2217/FMB.11.20]; Nandy C, 2009, J MOL BIOL, V388, P776, DOI 10.1016/j.jmb.2009.03.031; Nawrocki EP, 2013, BIOINFORMATICS, V29, P2933, DOI 10.1093/bioinformatics/btt509; Nielsen S, 2013, SCIENCE, V340, P1577, DOI 10.1126/science.1237934; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; OBRIEN CA, 1994, GENE DEV, V8, P2891, DOI 10.1101/gad.8.23.2891; PELLE R, 1993, MOL BIOCHEM PARASIT, V59, P277, DOI 10.1016/0166-6851(93)90225-M; Persson H, 2009, NAT CELL BIOL, V11, P1268, DOI 10.1038/ncb1972; Poderycki MJ, 2005, NUCLEIC ACIDS RES, V33, P893, DOI 10.1093/nar/gki234; Preusser C, 2012, INT J MED MICROBIOL, V302, P221, DOI 10.1016/j.ijmm.2012.07.004; Shaked H, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq065; Shurtleff MJ, 2017, P NATL ACAD SCI USA, V114, pE8987, DOI 10.1073/pnas.1712108114; Siegel TN, 2009, GENE DEV, V23, P1063, DOI 10.1101/gad.1790409; Sim S, 2018, MICROBIOL SPECTR, V6, DOI 10.1128/microbiolspec.RWR-0023-2018; Stadler PF, 2009, MOL BIOL EVOL, V26, P1975, DOI 10.1093/molbev/msp112; Stein AJ, 2005, CELL, V121, P529, DOI 10.1016/j.cell.2005.03.009; Tanaka H, 2009, SCIENCE, V323, P384, DOI 10.1126/science.1164975; Tkacz ID, 2010, J BIOL CHEM, V285, P27982, DOI 10.1074/jbc.M109.095349; TSCHUDI C, 1990, CELL, V61, P459, DOI 10.1016/0092-8674(90)90527-L; Tschudi C, 2002, GENE EXPRESSION, V10, P3; Tycowski KT, 2009, MOL CELL, V34, P47, DOI 10.1016/j.molcel.2009.02.020; ULLU E, 1990, NUCLEIC ACIDS RES, V18, P3319, DOI 10.1093/nar/18.11.3319; Urbaniak MD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036619; van Zon A, 2001, J BIOL CHEM, V276, P37715, DOI 10.1074/jbc.M106055200; Venteicher AS, 2009, SCIENCE, V323, P644, DOI 10.1126/science.1165357; VILALTA A, 1994, J BIOL CHEM, V269, P29752; Wang W, 2018, STRUCTURE, V26, P1635, DOI 10.1016/j.str.2018.09.001; Waterhouse A, 2018, NUCLEIC ACIDS RES, V46, pW296, DOI 10.1093/nar/gky427; Wirtz E, 1999, MOL BIOCHEM PARASIT, V99, P89, DOI 10.1016/S0166-6851(99)00002-X; Wolin SL, 2013, RNA BIOL, V10, P1602, DOI 10.4161/rna.26166; WOLIN SL, 1984, P NATL ACAD SCI-BIOL, V81, P1996, DOI 10.1073/pnas.81.7.1996; Wurtmann EJ, 2010, P NATL ACAD SCI USA, V107, P4022, DOI 10.1073/pnas.1000307107; Yong JS, 2004, TRENDS CELL BIOL, V14, P226, DOI 10.1016/j.tcb.2004.03.010; Zamudio JR, 2009, MOL CELL BIOL, V29, P1202, DOI 10.1128/MCB.01496-08	93	10	10	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 25	2019	294	43					15559	15574		10.1074/jbc.RA119.008580	http://dx.doi.org/10.1074/jbc.RA119.008580			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JQ9JD	31439669	Green Published, hybrid			2022-12-26	WOS:000499253000001
J	Moore, ES; Daugherity, EK; Karambizi, DI; Cummings, BP; Behling-Kelly, E; Schaefer, DMW; Southard, TL; McFadden, JW; Weiss, RS				Moore, Elizabeth S.; Daugherity, Erin K.; Karambizi, David, I; Cummings, Bethany P.; Behling-Kelly, Erica; Schaefer, Deanna M. W.; Southard, Teresa L.; McFadden, Joseph W.; Weiss, Robert S.			Sex-specific hepatic lipid and bile acid metabolism alterations in Fancd2-deficient mice following dietary challenge	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cholesterol metabolism; metabolic syndrome; DNA damage response; fatty acid metabolism; lipid metabolism; liver metabolism; cholestasis; Fanconi anemia complementation group D2 (FANCD2); Fanconi anemia; nonalcoholic fatty liver disease	FANCONI-ANEMIA; INSULIN-RESISTANCE; MITOCHONDRIAL DYSFUNCTION; PHOSPHOLIPID-COMPOSITION; OXIDATIVE STRESS; CHOLESTEROL; LIVER; CELLS; PATHWAY; PROTEIN	Defects in the Fanconi anemia (FA) DNA damage?response pathway result in genomic instability, developmental defects, hematopoietic failure, cancer predisposition, and metabolic disorders. The endogenous sources of damage contributing to FA phenotypes and the links between FA and metabolic disease remain poorly understood. Here, using mice lacking the Fancd2 gene, encoding a central FA pathway component, we investigated whether the FA pathway protects against metabolic challenges. Fancd2(?/?) and wildtype (WT) mice were fed a standard diet (SD), a diet enriched in fat, cholesterol, and cholic acid (Paigen diet), or a diet enriched in lipid alone (high-fat diet (HFD)). Fancd2(?/?) mice developed hepatobiliary disease and exhibited decreased survival when fed a Paigen diet but not a HFD. Male Paigen diet?fed mice lacking Fancd2 had significant biliary hyperplasia, increased serum bile acid concentration, and increased hepatic pathology. In contrast, female mice were similarly impacted by Paigen diet feeding regardless of Fancd2 status. Upon Paigen diet challenge, male Fancd2(?/?) mice had altered expression of genes encoding hepatic bile acid transporters and cholesterol and fatty acid metabolism proteins, including Scp2/x, Abcg5/8, Abca1, Ldlr, Srebf1, and Scd-1. Untargeted lipidomic profiling in liver tissue revealed 132 lipid species, including sphingolipids, glycerophospholipids, and glycerolipids, that differed significantly in abundance depending on Fancd2 status in male mice. We conclude that the FA pathway has sex-specific impacts on hepatic lipid and bile acid metabolism, findings that expand the known functions of the FA pathway and may provide mechanistic insight into the metabolic disease predisposition in individuals with FA.	[Moore, Elizabeth S.; Daugherity, Erin K.; Karambizi, David, I; Cummings, Bethany P.; Southard, Teresa L.; Weiss, Robert S.] Cornell Univ, Dept Biomed Sci, T2-006C Vet Res Tower, Ithaca, NY 14853 USA; [Behling-Kelly, Erica] Cornell Univ, Dept Populat Med & Diagnost Sci, Ithaca, NY 14853 USA; [McFadden, Joseph W.] Cornell Univ, Dept Anim Sci, Ithaca, NY 14853 USA; [Daugherity, Erin K.] Cornell Univ, Ctr Anim Resources & Educ, Ithaca, NY 14853 USA; [Schaefer, Deanna M. W.] Univ Tennessee, Dept Biomed & Diagnost Sci, Knoxville, TN 37996 USA	Cornell University; Cornell University; Cornell University; Cornell University; University of Tennessee System; University of Tennessee Knoxville; UT Institute of Agriculture	Weiss, RS (corresponding author), Cornell Univ, Dept Biomed Sci, T2-006C Vet Res Tower, Ithaca, NY 14853 USA.	rsw26@cornell.edu		Moore, Elizabeth/0000-0003-2502-6429; Weiss, Robert/0000-0003-3327-1379; Schaefer, Deanna M. W./0000-0002-5260-2180	Cornell University College of Veterinary Medicine; National Institutes of Health Training [T32 ODO011000]; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [T32OD011000] Funding Source: NIH RePORTER	Cornell University College of Veterinary Medicine; National Institutes of Health Training(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported in part by a Cornell University College of Veterinary Medicine resident research grant and National Institutes of Health Training Grant Award T32 ODO011000 (to E. S. M.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Amarachintha S, 2015, STEM CELLS, V33, P3382, DOI 10.1002/stem.2100; Begriche K, 2006, MITOCHONDRION, V6, P1, DOI 10.1016/j.mito.2005.10.004; Behling-Kelly E, 2014, VET CLIN PATH, V43, P405, DOI 10.1111/vcp.12155; Cappelli E, 2017, BBA-MOL BASIS DIS, V1863, P1214, DOI 10.1016/j.bbadis.2017.03.008; Ceccaldi R, 2016, NAT REV MOL CELL BIO, V17, P337, DOI 10.1038/nrm.2016.48; Ceccaldi R, 2015, NATURE, V518, P258, DOI 10.1038/nature14184; Chaurasia B, 2015, TRENDS ENDOCRIN MET, V26, P538, DOI 10.1016/j.tem.2015.07.006; Chong J, 2018, BIOINFORMATICS, V34, P4313, DOI 10.1093/bioinformatics/bty528; Chong J, 2018, NUCLEIC ACIDS RES, V46, pW486, DOI 10.1093/nar/gky310; D'Angelo G, 2013, FEBS J, V280, P6338, DOI 10.1111/febs.12559; Daugherity EK, 2012, CELL CYCLE, V11, P1918, DOI 10.4161/cc.20259; Degan P, 2019, TRENDS MOL MED, V25, P167, DOI 10.1016/j.molmed.2019.01.003; Degan P, 2019, METAB SYNDR RELAT D, V17, P53, DOI 10.1089/met.2018.0085; DeLong CJ, 1999, J BIOL CHEM, V274, P29683, DOI 10.1074/jbc.274.42.29683; Du W, 2012, BLOOD, V119, P4142, DOI 10.1182/blood-2011-09-381970; Elder DA, 2008, PEDIATR BLOOD CANCER, V51, P256, DOI 10.1002/pbc.21589; Fan J, 2016, MOL CELL, V64, P859, DOI 10.1016/j.molcel.2016.10.014; FAST DG, 1995, BBA-LIPID LIPID MET, V1258, P159, DOI 10.1016/0005-2760(95)00116-T; FOLCH J, 1957, J BIOL CHEM, V226, P497; Fukao T, 2014, J INHERIT METAB DIS, V37, P541, DOI 10.1007/s10545-014-9704-9; Garcia-Bermudez J, 2016, MOL CELL, V64, P856, DOI 10.1016/j.molcel.2016.11.023; Giri N, 2007, J CLIN ENDOCR METAB, V92, P2624, DOI 10.1210/jc.2007-0135; Goldstein JL, 2006, CELL, V124, P35, DOI 10.1016/j.cell.2005.12.022; Grillari J, 2007, NUCLEIC ACIDS RES, V35, P7566, DOI 10.1093/nar/gkm1065; Guyot C, 2011, J HEPATOL, V55, P1368, DOI 10.1016/j.jhep.2011.04.014; HAKOMORI S, 1995, J BIOCHEM, V118, P1091, DOI 10.1093/oxfordjournals.jbchem.a124992; Han XL, 2016, NAT REV ENDOCRINOL, V12, P668, DOI 10.1038/nrendo.2016.98; He HL, 2018, J BIOL CHEM, V293, P9223, DOI 10.1074/jbc.RA118.002290; Hla T, 2014, CELL METAB, V20, P703, DOI 10.1016/j.cmet.2014.10.017; Houghtaling S, 2003, GENE DEV, V17, P2021, DOI 10.1101/gad.1103403; Jayabal P, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05150-1; Jornayvaz FR, 2012, CELL METAB, V15, P574, DOI 10.1016/j.cmet.2012.03.005; Kabarowski JHS, 2002, BIOCHEM PHARMACOL, V64, P161, DOI 10.1016/S0006-2952(02)01179-6; Kais Z, 2016, CELL REP, V15, P2488, DOI 10.1016/j.celrep.2016.05.031; Kim DH, 2011, P NATL ACAD SCI USA, V108, P12266, DOI 10.1073/pnas.1019678108; Kim SH, 2016, NUCLEIC ACIDS RES, V44, P9667, DOI 10.1093/nar/gkw643; Laffitte BA, 2001, MOL CELL BIOL, V21, P7558, DOI 10.1128/MCB.21.22.7558-7568.2001; Langevin F, 2011, NATURE, V475, P53, DOI 10.1038/nature10192; Li J, 2012, ANTIOXID REDOX SIGN, V17, P1083, DOI 10.1089/ars.2011.4417; Lorbek G, 2013, MOLECULES, V18, P11067, DOI 10.3390/molecules180911067; Maqdasy S, 2016, MOL ASPECTS MED, V49, P31, DOI 10.1016/j.mam.2016.04.001; Maxwell KN, 2003, J LIPID RES, V44, P2109, DOI 10.1194/jlr.M300203-JLR200; McMahon HT, 2015, J CELL SCI, V128, P1065, DOI 10.1242/jcs.114454; Mehta P., 2002, GENEREVIEWS, V19, p1; Morita S, 2011, FEBS J, V278, P4768, DOI 10.1111/j.1742-4658.2011.08377.x; Nepal M, 2018, AGING-US, V10, P1506, DOI 10.18632/aging.101487; Ntambi JM, 1999, J LIPID RES, V40, P1549; Oberbeck N, 2014, MOL CELL, V55, P807, DOI 10.1016/j.molcel.2014.07.010; Overmyer KA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117232; Pagano G, 2004, CARCINOGENESIS, V25, P1899, DOI 10.1093/carcin/bgh194; Pagano G, 2013, FREE RADICAL BIO MED, V58, P118, DOI 10.1016/j.freeradbiomed.2013.01.015; PAIGEN B, 1985, ATHEROSCLEROSIS, V57, P65, DOI 10.1016/0021-9150(85)90138-8; Panneerselvam J, 2016, J PROTEOME RES, V15, P1333, DOI 10.1021/acs.jproteome.6b00076; Petryk A, 2015, J CLIN ENDOCR METAB, V100, P803, DOI 10.1210/jc.2014-4357; Puzio-Kuter Anna M, 2011, Genes Cancer, V2, P385, DOI 10.1177/1947601911409738; Quazi F, 2011, ESSAYS BIOCHEM, V50, P265, DOI [10.1042/BSE0500265, 10.1042/bse0500265]; Ravera S, 2019, BRIT J HAEMATOL, V184, P693, DOI 10.1111/bjh.15171; Reccia I, 2017, METABOLISM, V72, P94, DOI 10.1016/j.metabol.2017.04.011; Ridpath JR, 2007, CANCER RES, V67, P11117, DOI 10.1158/0008-5472.CAN-07-3028; Rog T, 2014, CHEM PHYS LIPIDS, V184, P82, DOI 10.1016/j.chemphyslip.2014.10.004; Rose SR, 2012, PEDIATR BLOOD CANCER, V59, P690, DOI 10.1002/pbc.24095; Samuel VT, 2010, LANCET, V375, P2267, DOI 10.1016/S0140-6736(10)60408-4; Schulman IG, 2017, FEBS LETT, V591, P2978, DOI 10.1002/1873-3468.12702; Smid V, 2016, FOLIA BIOL-PRAGUE, V62, P148; SPECTOR A A, 1979, Progress in Lipid Research, V18, P31, DOI 10.1016/0163-7827(79)90003-1; Summers SA, 2006, PROG LIPID RES, V45, P42, DOI 10.1016/j.plipres.2005.11.002; Terasaka N, 2010, HDL HANDBOOK: BIOLOGICAL FUNCTIONS AND CLINICAL IMPLICATIONS, P199, DOI 10.1016/B978-0-12-382171-3.10010-5; Turley SD, 1998, HEPATOLOGY, V28, P1088, DOI 10.1002/hep.510280425; Unger RH, 2010, TRENDS ENDOCRIN MET, V21, P345, DOI 10.1016/j.tem.2010.01.009; Wajnrajch MP, 2001, PEDIATRICS, V107, P744, DOI 10.1542/peds.107.4.744; Wang DQH, 1997, J LIPID RES, V38, P1395; Wang N, 2004, P NATL ACAD SCI USA, V101, P9774, DOI 10.1073/pnas.0403506101; Zhang YC, 2010, J LIPID RES, V51, P3230, DOI 10.1194/jlr.M007641; Zhao XH, 2018, CLIN CANCER RES, V24, P2700, DOI 10.1158/1078-0432.CCR-17-3686	74	3	4	2	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 25	2019	294	43					15623	15637		10.1074/jbc.RA118.005729	http://dx.doi.org/10.1074/jbc.RA118.005729			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JQ9JD	31434739	Green Published, hybrid			2022-12-26	WOS:000499253000007
J	Cha, KC; Kim, HI; Kim, YW; Ahn, GJ; Kim, YS; Kim, SJ; Lee, JH; Hwang, SO				Cha, Kyoung-Chul; Kim, Hyung Il; Kim, Yong Won; Ahn, Gyo Jin; Kim, Yoon Seob; Kim, Sun Ju; Lee, Jun Hyuk; Hwang, Sung Oh			Comparison of hemodynamic effects and resuscitation outcomes between automatic simultaneous sterno-thoracic cardiopulmonary resuscitation device and LUCAS in a swine model of cardiac arrest	PLOS ONE			English	Article							MECHANICAL CHEST COMPRESSION; ASSOCIATION GUIDELINES UPDATE; SHORT-TERM SURVIVAL; LIFE-SUPPORT; BLOOD-FLOW; QUALITY	Introduction Mechanical cardiopulmonary resuscitation (CPR) devices are widely used to rescue patients from cardiac arrest. This study aimed to compare hemodynamic effects and resuscitation outcomes between a motor-driven, automatic simultaneous sterno-thoracic cardiopulmonary resuscitation device and the Lund University cardiac arrest system (LUCAS). Material and methods After 2 minutes of electrically induced ventricular fibrillation (VF), Yorkshire pigs (weight 35-60 kg) received CPR with an automatic simultaneous sterno-thoracic CPR device (X-CPR group, n = 13) or the Lund University cardiac arrest system (LUCAS group, n = 12). Basic life support for 6 minutes and advanced cardiovascular life support for 12 minutes, including defibrillation and epinephrine administration, were provided. Hemodynamic parameters and resuscitation outcomes, including return of spontaneous circulation (ROSC), 24-hour survival, and cerebral performance category (CPC) at 24 hours, were evaluated. Results Hemodynamic parameters, including aortic pressures, coronary perfusion pressure, carotid blood flow, and end-tidal carbon dioxide pressure were not significantly different between the two groups. Resuscitation outcomes were also not significantly different between the groups (X-CPR vs. LUCAS; rate of ROSC: 31% vs 25%, p = 1.000; 24-hour survival rate: 31% vs 17%, p = 0.645; neurological outcome with CPC. 2: 31% vs 17%, p = 0.645). Also no significant difference in incidence complications associated with resuscitation was found between the groups. Conclusions CPR with a motor-driven X-CPR and CPR with the LUCAS produced similar hemodynamic effects and resuscitation outcomes in a swine model of cardiac arrest.	[Cha, Kyoung-Chul; Ahn, Gyo Jin; Kim, Yoon Seob; Kim, Sun Ju; Hwang, Sung Oh] Yonsei Univ, Wonju Coll Med, Dept Emergency Med, Wonju, South Korea; [Kim, Hyung Il] Dankook Univ, Coll Med, Dept Emergency Med, Cheonan, South Korea; [Kim, Yong Won] Univ Ulsan, Ulsan Univ Hosp, Coll Med, Dept Emergency Med, Ulsan, South Korea; [Lee, Jun Hyuk] Yonsei Univ, Wonju Coll Med, Dept Biostat, Wonju, South Korea	Yonsei University; Dankook University; University of Ulsan; Ulsan University Hospital; Yonsei University	Hwang, SO (corresponding author), Yonsei Univ, Wonju Coll Med, Dept Emergency Med, Wonju, South Korea.	shwang@yonsei.ac.kr	Kim, Yong Won/AAA-2134-2022; Hwang, Sung Oh/AAO-5838-2021	Kim, Yong Won/0000-0003-0108-8932; Kim, Hyung-il/0000-0002-2843-5597; Kim, Yoon-Seop/0000-0001-5929-4291; Hwang, Sung Oh/0000-0003-4585-3181; KIM, SUN JU/0000-0002-8169-5750; Lee, Jun Hyeok/0000-0002-7745-3599	Korea Evaluation Institute of Industrial Technology, South Korea government [10045801]	Korea Evaluation Institute of Industrial Technology, South Korea government	This research was supported by the Korea Evaluation Institute of Industrial Technology, South Korea government, 10045801 to Dr. Sung Oh Hwang. The sponsor had no play any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Axelsson C, 2009, RESUSCITATION, V80, P1099, DOI 10.1016/j.resuscitation.2009.08.006; Benjamin EJ, 2018, CIRCULATION, V137, pE67, DOI 10.1161/CIR.0000000000000558; BERG RA, 1994, CRIT CARE MED, V22, P282, DOI 10.1097/00003246-199402000-00020; Bonnes JL, 2016, ANN EMERG MED, V67, P349, DOI 10.1016/j.annemergmed.2015.09.023; Brooks SC, 2015, CIRCULATION, V132, pS436, DOI 10.1161/CIR.0000000000000260; Christenson J, 2009, CIRCULATION, V120, P1241, DOI 10.1161/CIRCULATIONAHA.109.852202; Duchateau FX, 2010, INTENS CARE MED, V36, P1256, DOI 10.1007/s00134-010-1784-x; Friess SH, 2013, CRIT CARE MED, V41, P2698, DOI 10.1097/CCM.0b013e318298ad6b; HIGHTOWER D, 1995, ANN EMERG MED, V26, P300, DOI 10.1016/S0196-0644(95)70076-5; Hwang SO, 2002, RESUSCITATION, V53, P209, DOI 10.1016/S0300-9572(02)00011-4; Hwang SO, 2001, RESUSCITATION, V48, P293, DOI 10.1016/S0300-9572(00)00250-1; Idris AH, 2012, CIRCULATION, V125, P3004, DOI 10.1161/CIRCULATIONAHA.111.059535; Kashiura M, 2017, BMC ANESTHESIOL, V17, DOI 10.1186/s12871-017-0351-1; Kleinman ME, 2015, CIRCULATION, V132, pS414, DOI 10.1161/CIR.0000000000000259; Koster RW, 2017, EUR HEART J, V38, P3006, DOI 10.1093/eurheartj/ehx318; Larsen AI, 2010, RESUSCITATION, V81, P493, DOI 10.1016/j.resuscitation.2010.02.002; Lautz AJ, 2019, CRIT CARE MED, V47, pE241, DOI 10.1097/CCM.0000000000003620; Lee DK, 2018, J EMERG MED, V55, P226, DOI 10.1016/j.jemermed.2018.04.060; Lee MJ, 2016, CLIN EXP EMERG MED, V3, pS17, DOI 10.15441/ceem.16.134; Nolan JP, 2014, CURR OPIN CRIT CARE, V20, P227, DOI 10.1097/MCC.0000000000000083; Perkins GD, 2015, LANCET, V385, P947, DOI 10.1016/S0140-6736(14)61886-9; Perkins GD, 2005, RESUSCITATION, V64, P103, DOI 10.1016/j.resuscitation.2004.08.011; Rehatscatschek G, 2016, MINERVA ANESTESIOL, V82, P429; Rubertsson S, 2005, RESUSCITATION, V65, P357, DOI 10.1016/j.resuscitation.2004.12.006; Rubertsson S, 2014, JAMA-J AM MED ASSOC, V311, P53, DOI 10.1001/jama.2013.282538; Russi CS, 2016, WEST J EMERG MED, V17, P634, DOI 10.5811/westjem.2016.6.29949; Soar J, 2015, RESUSCITATION, V95, P100, DOI 10.1016/j.resuscitation.2015.07.016; Steen S, 2002, RESUSCITATION, V55, P285, DOI 10.1016/S0300-9572(02)00271-X; Wagner H, 2016, SCAND J TRAUMA RESUS, V24, DOI 10.1186/s13049-016-0198-3; Wang PL, 2018, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007260.pub4; Wik L, 2005, JAMA-J AM MED ASSOC, V293, P299, DOI 10.1001/jama.293.3.299; William P, 2016, CIRC J, V80, P1292, DOI 10.1253/circj.CJ-16-0330	32	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2019	14	8							e0221965	10.1371/journal.pone.0221965	http://dx.doi.org/10.1371/journal.pone.0221965			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW6BO	31469891	Green Submitted, gold, Green Published			2022-12-26	WOS:000485062200043
J	Leigh, C; Kandanaarachchi, S; McGree, JM; Hyndman, RJ; Alsibai, O; Mengersen, K; Peterson, EE				Leigh, Catherine; Kandanaarachchi, Sevvandi; McGree, James M.; Hyndman, Rob J.; Alsibai, Omar; Mengersen, Kerrie; Peterson, Erin E.			Predicting sediment and nutrient concentrations from high-frequency water-quality data	PLOS ONE			English	Article							GREAT-BARRIER-REEF; TOTAL SUSPENDED-SOLIDS; PHOSPHORUS CONCENTRATIONS; SURROGATE MEASURES; POLLUTANT-RUNOFF; MODEL; TURBIDITY; CATCHMENT; RIVER; MANAGEMENT	Water-quality monitoring in rivers often focuses on the concentrations of sediments and nutrients, constituents that can smother biota and cause eutrophication. However, the physical and economic constraints of manual sampling prohibit data collection at the frequency required to adequately capture the variation in concentrations through time. Here, we developed models to predict total suspended solids (TSS) and oxidized nitrogen (NOx) concentrations based on high-frequency time series of turbidity, conductivity and river level data from in situ sensors in rivers flowing into the Great Barrier Reef lagoon. We fit generalizedlinear mixed-effects models with continuous first-order autoregressive correlation structures to water-quality data collected by manual sampling at two freshwater sites and one estuarine site and used the fitted models to predict TSS and NOx from the in situ sensor data. These models described the temporal autocorrelation in the data and handled observations collected at irregular frequencies, characteristics typical of water-quality monitoring data. Turbidity proved a useful and generalizable surrogate of TSS, with high predictive ability in the estuarine and fresh water sites. Turbidity, conductivity and river level served as combined surrogates of NOx. However, the relationship between NOx and the covariates was more complex than that between TSS and turbidity, and consequently the ability to predict NOx was lower and less generalizable across sites than for TSS. Furthermore, prediction intervals tended to increase during events, for both TSS and NOx models, highlighting the need to include measures of uncertainty routinely in water-quality reporting. Our study also highlights that surrogate-based models used to predict sediments and nutrients need to better incorporate temporal components if variance estimates are to be unbiased and model inference meaningful. The transferability of models across sites, and potentially regions, will become increasingly important as organizations move to automated sensing for water-quality monitoring throughout catchments.	[Leigh, Catherine; Kandanaarachchi, Sevvandi; McGree, James M.; Hyndman, Rob J.; Alsibai, Omar; Mengersen, Kerrie; Peterson, Erin E.] Arc Ctr Excellence Math & Stat Frontiers ACEMS, Melbourne, Vic 3010, Australia; [Leigh, Catherine; Alsibai, Omar; Peterson, Erin E.] Queensland Univ Technol, Inst Future Environm, Brisbane, Qld, Australia; [Leigh, Catherine; McGree, James M.; Alsibai, Omar; Mengersen, Kerrie; Peterson, Erin E.] Queensland Univ Technol, Sci & Engn Fac, Sch Math Sci, Brisbane, Qld, Australia; [Kandanaarachchi, Sevvandi; Hyndman, Rob J.] Monash Univ, Dept Econometr & Business Stat, Clayton, Vic, Australia	Queensland University of Technology (QUT); Queensland University of Technology (QUT); Monash University	Leigh, C (corresponding author), Arc Ctr Excellence Math & Stat Frontiers ACEMS, Melbourne, Vic 3010, Australia.; Leigh, C (corresponding author), Queensland Univ Technol, Inst Future Environm, Brisbane, Qld, Australia.; Leigh, C (corresponding author), Queensland Univ Technol, Sci & Engn Fac, Sch Math Sci, Brisbane, Qld, Australia.	catherine.leigh@qut.edu.au	Mengersen, Kerrie/AHC-4096-2022	Kandanaarachchi, Sevvandi/0000-0002-0337-0395; Leigh, Catherine/0000-0003-4186-1678	Queensland Department of Environment and Science (DES); Australian Research Council Centre of Excellence for Mathematical and Statistical Frontiers (ACEMS) [CE140100049]	Queensland Department of Environment and Science (DES); Australian Research Council Centre of Excellence for Mathematical and Statistical Frontiers (ACEMS)(Australian Research Council)	Funding for this project was provided by the Queensland Department of Environment and Science (DES; https://www.des.qld.gov.au/) and the Australian Research Council Centre of Excellence for Mathematical and Statistical Frontiers (ACEMS; https://acems.org.au/home; Grant CE140100049).	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; ANZECC/ARMCANZ, 2000, AUSTR NZ GUID FRESH; Apha, 2012, AM PUBLIC HLTH ASS, V22nd; Bainbridge ZT, 2009, MAR FRESHWATER RES, V60, P1081, DOI 10.1071/MF08333; Boulton A.J., 2014, AUSTR FRESHWATER ECO; Brodie J., 2004, 0203 ACTFR J COOK U; Brodie JE, 2012, MAR POLLUT BULL, V65, P81, DOI 10.1016/j.marpolbul.2011.12.012; Carroll C, 2012, MAR POLLUT BULL, V65, P136, DOI 10.1016/j.marpolbul.2011.11.022; Cheang WK, 2000, J AM STAT ASSOC, V95, P1173, DOI 10.2307/2669758; Cressie N. A. C., 2011, STAT SPATIO TEMPORAL; DES, 2018, MON SAMPL MAN ENV PR; Diamantopoulou M.J., 2005, OPER RES, V5, P115, DOI [10.1007/BF02944165, DOI 10.1007/BF02944165, 10.1007/bf02944165]; Duncan JM, 2017, WATER RESOUR RES, V53, P7349, DOI 10.1002/2017WR020500; FERGUSON RI, 1986, WATER RESOUR RES, V22, P74, DOI 10.1029/WR022i001p00074; Franklin HM, 2018, SCI TOTAL ENVIRON, V636, P1470, DOI 10.1016/j.scitotenv.2018.04.195; Gladish DW, 2016, ANN APPL STAT, V10, P1590, DOI 10.1214/16-AOAS950; Godsey SE, 2009, HYDROL PROCESS, V23, P1844, DOI 10.1002/hyp.7315; Horsburgh JS, 2010, ENVIRON MODELL SOFTW, V25, P1031, DOI 10.1016/j.envsoft.2009.10.012; Huggins R., 2017, TOTAL SUSPENDED SOLI; Humanes A, SCI REPORTS, V7, P44101; Hunter HM, 2008, J HYDROL, V356, P131, DOI 10.1016/j.jhydrol.2008.04.003; Hyndman R. J., 2018, FORECASTING PRINCIPL; Isaak DJ, 2017, WATER RESOUR RES, V53, P9181, DOI 10.1002/2017WR020969; Jones AS, 2011, J AM WATER RESOUR AS, V47, P239, DOI 10.1111/j.1752-1688.2010.00505.x; Kim J, 2013, WATER ENVIRON J, V27, P79, DOI 10.1111/j.1747-6593.2012.00328.x; Kuhnert PM, 2018, MAR FRESHWATER RES, V69, P1187, DOI 10.1071/MF17237; Leigh C, 2019, SCI TOTAL ENVIRON, V664, P885, DOI 10.1016/j.scitotenv.2019.02.085; Leigh C, 2013, WATER-SUI, V5, P780, DOI 10.3390/w5020780; Lessels JS, 2013, J HYDROL, V498, P13, DOI 10.1016/j.jhydrol.2013.06.006; McInnes K, 2015, WET TROPICS CLUSTER; O'Brien KR, 2016, HYDROL EARTH SYST SC, V20, P4881, DOI 10.5194/hess-20-4881-2016; Pellerin BA, 2016, J AM WATER RESOUR AS, V52, P993, DOI 10.1111/1752-1688.12386; Peterson EE, 2006, ENVIRON MONIT ASSESS, V121, P615, DOI 10.1007/s10661-005-9163-8; Peterson EE, 2013, ECOL LETT, V16, P707, DOI 10.1111/ele.12084; Peterson EE, 2011, FRESHWATER BIOL, V56, P590, DOI 10.1111/j.1365-2427.2010.02507.x; Peterson EE, 2010, ECOLOGY, V91, P644, DOI 10.1890/08-1668.1; Pinheiro J., 2017, NLME LINEAR NONLINEA; Pinheiro J, 2001, MIXED EFFECTS MODELS; R Core Team, 2018, R LANG ENV STAT COMP; Rayner TS, 2008, MAR FRESHWATER RES, V59, P97, DOI 10.1071/MF07129; Roberts DR, 2017, ECOGRAPHY, V40, P913, DOI 10.1111/ecog.02881; Ruzycki EM, 2014, J AM WATER RESOUR AS, V50, P1138, DOI 10.1111/jawr.12175; Skarbovik E, 2015, ACTA AGR SCAND B-S P, V65, P63, DOI 10.1080/09064710.2014.966751; Slaets JIF, 2014, J HYDROL, V513, P45, DOI 10.1016/j.jhydrol.2014.03.034; Standards Australia, 1998, 5667101998 ASNZS; Standards Australia, 1998, 566711998 ASNZS; Steffy LY, 2018, RIVER RES APPL, V34, P1304, DOI 10.1002/rra.3373; Stutter M, 2017, SCI TOTAL ENVIRON, V607, P391, DOI 10.1016/j.scitotenv.2017.07.013; Viviano G, 2014, WATER RES, V64, P265, DOI 10.1016/j.watres.2014.07.009; Wallace R., 2016, TOTAL SUSPENDED SOLI; Wang YG, 2011, J HYDROL, V396, P148, DOI 10.1016/j.jhydrol.2010.11.003; West AO, 2016, LIMNOL OCEANOGR-METH, V14, P658, DOI 10.1002/lom3.10120; Wetzel R.G., 2001, LIMNOLOGY LAKE RIVER, DOI DOI 10.1046/J.1529-8817.2001.37602.X; Yoccoz NG, 2001, TRENDS ECOL EVOL, V16, P446, DOI 10.1016/S0169-5347(01)02205-4	54	12	12	3	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2019	14	8							e0215503	10.1371/journal.pone.0215503	http://dx.doi.org/10.1371/journal.pone.0215503			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW6BO	31469846	gold, Green Published, Green Submitted			2022-12-26	WOS:000485062200004
J	van Heuckelum, M; Linn, AJ; Vandeberg, L; Hebing, RCF; van Dijk, L; Vervloet, M; Flendrie, M; Nurmohamed, MT; van Dulmen, S; van den Bemt, BJF; van den Ende, CHM				van Heuckelum, M.; Linn, A. J.; Vandeberg, L.; Hebing, R. C. F.; van Dijk, L.; Vervloet, M.; Flendrie, M.; Nurmohamed, M. T.; van Dulmen, S.; van den Bemt, B. J. F.; van den Ende, C. H. M.			Implicit and explicit attitudes towards disease-modifying antirheumatic drugs as possible target for improving medication adherence	PLOS ONE			English	Article							RHEUMATOID-ARTHRITIS; ASSOCIATION TEST; SOCIAL COGNITION; QUESTIONNAIRE; CONSEQUENCES; METAANALYSIS	Objective This study aims to explore the contribution of implicit attitudes and associations towards conventional disease-modifying antirheumatic drugs (cDMARDs), alongside explicit measures, on medication-taking behaviour and clinical outcomes in adult patients with rheumatoid arthritis (RA). Methods In this observational study, implicit attitudes (positive-negative) and health-related associations (health-sickness) were measured with Single Category Implicit Association Tests, whereas explicit outcomes were measured with a bipolar evaluative adjective scale and the Beliefs about Medicines Questionnaire Specific. The primary outcome of this study was medication-taking behaviour subjectively measured by self-report (i.e. validated Compliance Questionnaire on Rheumatology) and objectively measured with electronic drug monitors over a 3 month period. Spearman rank correlations were used to describe correlations between implicit and explicit outcomes. Nested linear regression models were used to assess the additional value of implicit measures over explicit measures and patient-, clinical-, and treatment-related characteristics. Results Of the 1659 initially-invited patients, 254 patients with RA agreed to participate in this study. Implicit attitudes correlated significantly with necessity-concerns differential (NCD) scores (rho = 0.13, P = 0.05) and disease activity scores (rho = -0.17, P = 0.04), whereas implicit health-related associations correlated significantly with mean scores for explicitly reported health-related associations (rho = 0.18, P = 0.004). Significant differences in age, number of DMARDs, biologic DMARD use, NCD-scores, and self-reported correct dosing were found between the four attitudinal profiles. Nested linear regression models revealed no additional value of implicit measures in explaining self-reported medication-taking behaviour and clinical outcomes, over and above all other variables. Conclusion Implicit attitudes and associations had no additional value in explaining medication-taking behaviour and clinical outcomes over and above often used explicitly measured characteristics, attitudes and outcomes in the studied population. Only age and NCD scores contributed significantly when the dependent variable was correct dosing measured with self-report.	[van Heuckelum, M.; Flendrie, M.; van den Ende, C. H. M.] Sint Maartenskliniek, Dept Rheumatol, Nijmegen, Netherlands; [van Heuckelum, M.; van den Bemt, B. J. F.] Sint Maartenskliniek, Dept Pharm, Nijmegen, Netherlands; [Linn, A. J.; Vandeberg, L.] Univ Amsterdam, Amsterdam Sch Commun Res, Amsterdam, Netherlands; [Vandeberg, L.] Radboud Univ Nijmegen, Ctr Language Studies, Nijmegen, Netherlands; [Hebing, R. C. F.; Nurmohamed, M. T.] Amsterdam Rheumatol & Immunol Ctr, Dept Rheumatol, Amsterdam, Netherlands; [van Dijk, L.; Vervloet, M.; van Dulmen, S.] Nivel Netherlands Inst Hlth Serv Res, Utrecht, Netherlands; [van Dijk, L.] Univ Groningen, Fac Math & Nat Sci, Groningen Res Inst Pharm, Dept PharmacoTherapy Epidemiol & Econ PTEE, Groningen, Netherlands; [Nurmohamed, M. T.] Vrije Univ Amsterdam Med Ctr, Amsterdam Rheumatol & Immunol Ctr, Dept Rheumatol, Amsterdam, Netherlands; [van Dulmen, S.] Radboud Univ Nijmegen, Med Ctr, Radboud Inst Hlth Sci, Dept Primary & Community Care, Nijmegen, Netherlands; [van Dulmen, S.] Univ South Eastern Norway, Fac Hlth & Social Sci, Drammen, Norway; [van den Bemt, B. J. F.] Radboud Univ Nijmegen, Med Ctr, Dept Pharm, Nijmegen, Netherlands; [van den Bemt, B. J. F.] Maastricht Univ, Med Ctr, Dept Clin Pharm & Toxicol, Maastricht, Netherlands; [van den Ende, C. H. M.] Radboud Univ Nijmegen, Med Ctr, Dept Rheumatol, Nijmegen, Netherlands	Sint Maartens Clinic; Sint Maartens Clinic; University of Amsterdam; Radboud University Nijmegen; Vrije Universiteit Amsterdam; Netherlands Institute for Health Services Research; University of Groningen; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Radboud University Nijmegen; University College of Southeast Norway; Radboud University Nijmegen; Maastricht University; Radboud University Nijmegen	van Heuckelum, M (corresponding author), Sint Maartenskliniek, Dept Rheumatol, Nijmegen, Netherlands.; van Heuckelum, M (corresponding author), Sint Maartenskliniek, Dept Pharm, Nijmegen, Netherlands.	m.vanheuckelum@maartenskliniek.nl	Van den Bemt, Bart/Q-2740-2015; Hebing, Renske/ABI-2350-2020; van den Ende, Cornelia/ABG-7626-2020; van Dulmen, A.M./L-4287-2015	Van den Bemt, Bart/0000-0002-8560-9514; van Dulmen, A.M./0000-0002-1651-7544; Nurmohamed, Michael/0000-0002-6274-1934; Vandeberg, Lisa/0000-0002-7229-2378; Vervloet, Marcia/0000-0002-0325-9814; van Heuckelum, Milou/0000-0001-7179-4475	Dutch Arthritis Foundation [2015-1-011]	Dutch Arthritis Foundation	This research was supported financially by a grant from the Dutch Arthritis Foundation, 2015-1-011 to BJFvdB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackermann CL, 2015, RECH APPL MARKET-ENG, V30, P55, DOI 10.1177/2051570715579144; Ajzen I, 2001, ANNU REV PSYCHOL, V52, P27, DOI 10.1146/annurev.psych.52.1.27; AJZEN I, 1991, ORGAN BEHAV HUM DEC, V50, P179, DOI 10.1016/0749-5978(91)90020-T; [Anonymous], 1974, Health Education Monograph, V2, P324; Bender B, 2003, J ALLERGY CLIN IMMUN, V112, P489, DOI 10.1067/mai.2003.1680; Blanton H., 2007, PREDICTION CHANGE HL, P69; Blaschke TF, 2012, ANNU REV PHARMACOL, V52, P275, DOI 10.1146/annurev-pharmtox-011711-113247; Bohner G, 2011, ANNU REV PSYCHOL, V62, P391, DOI 10.1146/annurev.psych.121208.131609; Brownstein M, 2019, WIRES COGN SCI, V10, DOI 10.1002/wcs.1501; De Cuyper E, 2016, CLIN RHEUMATOL, V35, P1335, DOI 10.1007/s10067-016-3182-4; De Geest S, 2018, ANN INTERN MED, V169, P30, DOI 10.7326/M18-0543; De Houwer J, 2009, PSYCHOL BULL, V135, P347, DOI 10.1037/a0014211; de Klerk E, 1999, J RHEUMATOL, V26, P2635; de Klerk E, 2003, J RHEUMATOL, V30, P2469; Demonceau J, 2013, DRUGS, V73, P545, DOI 10.1007/s40265-013-0041-3; El Alili M, 2016, BRIT J CLIN PHARMACO, V82, P268, DOI 10.1111/bcp.12942; Fazio RH, 2003, ANNU REV PSYCHOL, V54, P297, DOI 10.1146/annurev.psych.54.101601.145225; Fleischmann B, 2014, PROD LOGIST, P1; Friese M, 2007, EXP PSYCHOL, V54, P247, DOI 10.1027/1618-3169.54.4.247; Galo JS, 2016, ANN RHEUM DIS, V75, P667, DOI 10.1136/annrheumdis-2014-206593; Green JA, 2016, J HEALTH PSYCHOL, V21, P927, DOI 10.1177/1359105314542818; GREENWALD AG, 1995, PSYCHOL REV, V102, P4, DOI 10.1037/0033-295X.102.1.4; Greenwald AG, 1998, J PERS SOC PSYCHOL, V74, P1464, DOI 10.1037/0022-3514.74.6.1464; Greenwald AG, 2003, J PERS SOC PSYCHOL, V85, P197, DOI 10.1037/0022-3514.85.2.197; Greenwald AG, 2009, J PERS SOC PSYCHOL, V97, P17, DOI 10.1037/a0015575; Guyer J.J., 2015, INT ENCY SOCIAL BEHA, V2, P183, DOI DOI 10.1016/B978-0-08-097086-8.24007-5; Harrold LR, 2013, J RHEUMATOL, V40, P137, DOI 10.3899/jrheum.120441; Horne R, 1999, PSYCHOL HEALTH, V14, P1, DOI 10.1080/08870449908407311; Karpinski A, 2001, J PERS SOC PSYCHOL, V81, P774, DOI 10.1037/0022-3514.81.5.774; Karpinski A, 2006, J PERS SOC PSYCHOL, V91, P16, DOI 10.1037/0022-3514.91.1.16; Lavielle M, 2018, RMD OPEN, V4, DOI 10.1136/rmdopen-2018-000684; Lindqvist E, 2003, ANN RHEUM DIS, V62, P611, DOI 10.1136/ard.62.7.611; Maison D, 2004, J CONSUM PSYCHOL, V14, P405, DOI 10.1207/s15327663jcp1404_9; Nosek BA, 2007, CURR DIR PSYCHOL SCI, V16, P65, DOI 10.1111/j.1467-8721.2007.00477.x; Osterberg L, 2005, NEW ENGL J MED, V353, P487, DOI 10.1056/NEJMra050100; Oswald FL, 2013, J PERS SOC PSYCHOL, V105, P171, DOI 10.1037/a0032734; Pasma A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171070; Pasma A, 2016, RHEUMATOLOGY, V55, P1812, DOI 10.1093/rheumatology/kew247; Payne B.K., 2010, HDB IMPLICIT SOCIAL, P1; ROSENSTOCK IM, 1974, HEALTH EDUC QUART, V2, P328, DOI 10.1177/109019817400200403; Rusch N, 2009, SCHIZOPHR RES, V112, P119, DOI 10.1016/j.schres.2009.04.011; Salt E, 2010, ORTHOP NURS, V29, P260, DOI 10.1097/NOR.0b013e3181e5c2c9; Scott DL, 2005, BEST PRACT RES CL RH, V19, P117, DOI 10.1016/j.berh.2004.08.007; Sheeran P, 2013, HEALTH PSYCHOL, V32, P460, DOI 10.1037/a0029203; Smolen JS, 2017, ANN RHEUM DIS, V76, P960, DOI 10.1136/annrheumdis-2016-210715; St Quinton T, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.00346; van den Bemt BJ, 2016, FRONT PHARMACOL, V7, P1; von Elm E, 2008, J CLIN EPIDEMIOL, V61, P344, DOI 10.2471/BLT.07.045120; Vrijens B, 2012, BRIT J CLIN PHARMACO, V73, P691, DOI 10.1111/j.1365-2125.2012.04167.x; Waimann CA, 2013, ARTHRITIS RHEUM-US, V65, P1421, DOI 10.1002/art.37917; Wilson TD, 2000, PSYCHOL REV, V107, P101, DOI 10.1037/0033-295X.107.1.101; Zwikker HE, 2014, PATIENT PREFER ADHER, V8, P1635, DOI 10.2147/PPA.S66849	52	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2019	14	8							e0221290	10.1371/journal.pone.0221290	http://dx.doi.org/10.1371/journal.pone.0221290			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW6BO	31469852	Green Submitted, Green Published, gold			2022-12-26	WOS:000485062200016
J	Majumdar, T; Bazin, T; Ribeiro, EMC; Frith, JE; Birbilis, N				Majumdar, Trina; Bazin, Tiphaine; Carvalho Ribeiro, Emily Massahud; Frith, Jessica Ellen; Birbilis, Nick			Understanding the effects of PBF process parameter interplay on Ti-6Al-4V surface properties	PLOS ONE			English	Article							MECHANICAL-PROPERTIES; CORROSION BEHAVIOR; BIOMEDICAL APPLICATIONS; ORTHOPEDIC IMPLANTS; TOPOLOGICAL DESIGN; TITANIUM-ALLOY; HEAT-TREATMENT; TI6AL4V ALLOY; LASER; MICROSTRUCTURE	Ti-6Al-4V is commonly used in orthopaedic implants, and fabrication techniques such as Powder Bed Fusion (PBF) are becoming increasingly popular for the net-shape production of such implants, as PBF allows for complex customisation and minimal material wastage. Present research into PBF fabricated Ti-6Al-4V focuses on new design strategies (e.g. designing pores, struts or lattices) or mechanical property optimisation through process parameter control-however, it is pertinent to examine the effects of altering PBF process parameters on properties relating to bioactivity. Herein, changes in Ti-6Al-4V microstructure, mechanical properties and surface characteristics were examined as a result of varying PBF process parameters, with a view to understanding how to tune Ti-6Al-4V bio-activity during the fabrication stage itself. The interplay between various PBF laser scan speeds and laser powers influenced Ti-6Al-4V hardness, porosity, roughness and corrosion resistance, in a manner not clearly described by the commonly used volumetric energy density (VED) design variable. Key findings indicate that the relationships between PBF process parameters and ultimate Ti-6Al-4V properties are not straightforward as expected, and that wide ranges of porosity (0.03 +/- 0.01% to 32.59 +/- 2.72%) and corrosion resistance can be achieved through relatively minor changes in process parameters used-indicating volumetric energy density is a poor predictor of PBF Ti-6Al-4V properties. While variations in electrochemical behaviour with respect to the process parameters used in the PBF fabrication of Ti-6Al-4V have previously been reported, this study presents data regarding important surface characteristics over a large process window, reflecting the full capabilities of current PBF machinery.	[Majumdar, Trina; Bazin, Tiphaine; Carvalho Ribeiro, Emily Massahud; Frith, Jessica Ellen; Birbilis, Nick] Monash Univ, Dept Mat Sci & Engn, Clayton, Vic, Australia; [Majumdar, Trina; Frith, Jessica Ellen; Birbilis, Nick] Monash Univ, MIME, Clayton, Vic, Australia; [Bazin, Tiphaine] Ecole Natl Super Chim Rennes, Rennes, France; [Carvalho Ribeiro, Emily Massahud] Ctr Fed Educ Tecnol Minas Gerais, Belo Horizonte, MG, Brazil	Monash University; Monash University; Ecole Nationale Superieure de Chimie de Rennes (ENSCR)	Majumdar, T (corresponding author), Monash Univ, Dept Mat Sci & Engn, Clayton, Vic, Australia.; Majumdar, T (corresponding author), Monash Univ, MIME, Clayton, Vic, Australia.	trina.majumdar@monash.edu	Frith, Jessica/J-6873-2017	Frith, Jessica/0000-0002-6558-5412; Majumdar, Trina/0000-0002-1427-1990				Ahsan MN, 2011, MAT SCI ENG A-STRUCT, V528, P7648, DOI 10.1016/j.msea.2011.06.074; Ali H, 2018, MAT SCI ENG A-STRUCT, V712, P175, DOI 10.1016/j.msea.2017.11.103; Arcam AB, 2014, TI 6AL 4V POWDER TEC, P4; Atapour M, 2010, CORROSION-US, V66, DOI 10.5006/1.3452400; BRANEMARK PI, 1983, J PROSTHET DENT, V50, P399, DOI 10.1016/S0022-3913(83)80101-2; Butscher A, 2011, ACTA BIOMATER, V7, P907, DOI 10.1016/j.actbio.2010.09.039; Cabanettes F, 2018, PRECIS ENG, V52, P249, DOI 10.1016/j.precisioneng.2018.01.002; Campanelli SL, 2014, MATERIALS, V7, P4803, DOI 10.3390/ma7064803; Chen LY, 2017, MAT SCI ENG A-STRUCT, V682, P389, DOI 10.1016/j.msea.2016.11.061; Chen ZE, 2018, ADDIT MANUF, V21, P91, DOI 10.1016/j.addma.2018.02.009; Chiu TM, 2018, ELECTROCHIM ACTA, V279, P143, DOI 10.1016/j.electacta.2018.04.189; Cox SC, 2017, ACS BIOMATER SCI ENG, V3, P1616, DOI 10.1021/acsbiomaterials.7b00336; Dai NAW, 2016, CORROS SCI, V111, P703, DOI 10.1016/j.corsci.2016.06.009; Dai NW, 2016, CORROS SCI, V102, P484, DOI 10.1016/j.corsci.2015.10.041; Edwards P, 2014, MAT SCI ENG A-STRUCT, V598, P327, DOI 10.1016/j.msea.2014.01.041; El-Sayed M., 2018, RAPID PROTOTYP J; Geetha M, 2004, CORROS SCI, V46, P877, DOI 10.1016/S0010-938X(03)00186-0; Gharbi M, 2013, J MATER PROCESS TECH, V213, P791, DOI 10.1016/j.jmatprotec.2012.11.015; GILBERT JL, 1993, METALL TRANS A, V24, P669, DOI 10.1007/BF02656635; Gong H., 2014, ADDIT MANUF, V1, P87, DOI [10.1016/j.addma.2014.08.002, DOI 10.1016/J.ADDMA.2014.08.002]; Gong HJ, 2015, MATER DESIGN, V86, P545, DOI 10.1016/j.matdes.2015.07.147; Hanzl P, 2015, PROCEDIA ENGINEER, V100, P1405, DOI 10.1016/j.proeng.2015.01.510; Hrabe N, 2013, MAT SCI ENG A-STRUCT, V573, P264, DOI 10.1016/j.msea.2013.02.064; Kao WH, 2018, SURF COAT TECH, V350, P172, DOI 10.1016/j.surfcoat.2018.07.011; Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002; Karazisis D, 2017, ACTA BIOMATER, V53, P559, DOI 10.1016/j.actbio.2017.02.026; Khorasani AM, 2016, MATER DESIGN, V103, P348, DOI 10.1016/j.matdes.2016.04.074; Koptyug Andrey, 2014, Materials Science Forum, V783-786, P1292, DOI 10.4028/www.scientific.net/MSF.783-786.1292; Kruth JP, 2007, CIRP ANN-MANUF TECHN, V56, P730, DOI 10.1016/j.cirp.2007.10.004; Kurzynowski T, 2012, PROC SPIE, V8239, DOI 10.1117/12.907292; Le Guehennec L, 2008, ACTA BIOMATER, V4, P535, DOI 10.1016/j.actbio.2007.12.002; Leuders S, 2013, INT J FATIGUE, V48, P300, DOI DOI 10.1016/J.IJFATIGUE.2012.11.011; Li Y, 2015, ACS APPL MATER INTER, V7, P5715, DOI 10.1021/acsami.5b00331; Li ZH, 2018, RAPID PROTOTYPING J, V24, P150, DOI 10.1108/RPJ-03-2016-0045; Lincks J, 1998, BIOMATERIALS, V19, P2219, DOI 10.1016/S0142-9612(98)00144-6; Liu QC, 2014, ADV MATER RES-SWITZ, V891-892, P1519, DOI [10.4028/www.scientific.net/AMR.891-892.1519, 10.4028/www.scientific.net/AMR.891-892.1524]; Liverani E, 2017, J MATER PROCESS TECH, V249, P255, DOI 10.1016/j.jmatprotec.2017.05.042; Longhitano GA, 2018, J ALLOY COMPD, V765, P961, DOI 10.1016/j.jallcom.2018.06.319; Markhoff J, 2017, MATERIALS, V10, DOI 10.3390/ma10010052; Masmoudi A, 2015, J MATER PROCESS TECH, V225, P122, DOI 10.1016/j.jmatprotec.2015.05.008; Metikos-Hukovic M, 2003, BIOMATERIALS, V24, P3765, DOI 10.1016/S0142-9612(03)00252-7; Milosev I, 2000, BIOMATERIALS, V21, P2103, DOI 10.1016/S0142-9612(00)00145-9; Mower TM, 2016, MAT SCI ENG A-STRUCT, V651, P198, DOI 10.1016/j.msea.2015.10.068; Murr LE, 2010, PHILOS T R SOC A, V368, P1999, DOI 10.1098/rsta.2010.0010; Murr LE, 2009, J MECH BEHAV BIOMED, V2, P20, DOI 10.1016/j.jmbbm.2008.05.004; Murr L.E., 2012, J MAT TECHNOL, V1, P42, DOI [10.1016/S2238-7854(12)70009-1, DOI 10.1016/S2238-7854(12)70009-1]; Murr LE, 2012, J MATER SCI TECHNOL, V28, P1, DOI 10.1016/S1005-0302(12)60016-4; Niemeyer TC, 2009, J ALLOY COMPD, V476, P172, DOI 10.1016/j.jallcom.2008.09.026; Palanivel S, 2016, MAT SCI ENG A-STRUCT, V654, P39, DOI 10.1016/j.msea.2015.12.021; Pattanayak DK, 2011, ACTA BIOMATER, V7, P1398, DOI 10.1016/j.actbio.2010.09.034; Pucci JU, 2017, BIOTECHNOL ADV, V35, P521, DOI 10.1016/j.biotechadv.2017.05.007; Qiu CL, 2013, MAT SCI ENG A-STRUCT, V578, P230, DOI 10.1016/j.msea.2013.04.099; Ran QC, 2018, J MECH BEHAV BIOMED, V84, P1, DOI 10.1016/j.jmbbm.2018.04.010; Sallica-Leva E, 2016, J MECH BEHAV BIOMED, V54, P149, DOI 10.1016/j.jmbbm.2015.09.020; Sallica-Leva E, 2013, J MECH BEHAV BIOMED, V26, P98, DOI 10.1016/j.jmbbm.2013.05.011; Shah FA, 2016, ACTA BIOMATER, V30, P357, DOI 10.1016/j.actbio.2015.11.013; Shang YT, 2017, MATEC WEB CONF, V95, DOI 10.1051/matecconf/20179501009; Shaoki A, 2016, BIOFABRICATION, V8, DOI 10.1088/1758-5090/8/4/045014; Shipley H, 2018, INT J MACH TOOL MANU, V128, P1, DOI 10.1016/j.ijmachtools.2018.01.003; Shunmugavel M, 2015, PROC TECH, V20, P231, DOI 10.1016/j.protcy.2015.07.037; Simonelli M, 2012, J PHYS CONF SER, V371, DOI 10.1088/1742-6596/371/1/012084; Simonelli M, 2014, J MATER RES, V29, P2028, DOI 10.1557/jmr.2014.166; Song B, 2012, INT J ADV MANUF TECH, V61, P967, DOI 10.1007/s00170-011-3776-6; Song B, 2012, MATER DESIGN, V35, P120, DOI 10.1016/j.matdes.2011.09.051; Suarez A, 2011, PHYSCS PROC, V12, P666, DOI 10.1016/j.phpro.2011.03.083; Tan XP, 2017, MAT SCI ENG C-MATER, V76, P1328, DOI 10.1016/j.msec.2017.02.094; Thijs L, 2010, ACTA MATER, V58, P3303, DOI 10.1016/j.actamat.2010.02.004; Vaithilingam J, 2016, MAT SCI ENG C-MATER, V67, P294, DOI 10.1016/j.msec.2016.05.054; Vandenbroucke B, 2007, RAPID PROTOTYPING J, V13, P196, DOI 10.1108/13552540710776142; Vrancken B, 2014, ACTA MATER, V68, P150, DOI 10.1016/j.actamat.2014.01.018; Vrancken B., 2016, STUDY RESIDUAL STRES; Vrancken B, 2012, J ALLOY COMPD, V541, P177, DOI 10.1016/j.jallcom.2012.07.022; Wang XJ, 2016, BIOMATERIALS, V83, P127, DOI 10.1016/j.biomaterials.2016.01.012; Wang ZH, 2017, J ALLOY COMPD, V717, P271, DOI 10.1016/j.jallcom.2017.05.079; Wu XH, 2004, MATER DESIGN, V25, P137, DOI 10.1016/j.matdes.2003.09.009; Xu W, 2015, ACTA MATER, V85, P74, DOI 10.1016/j.actamat.2014.11.028; Yadroitsev I, 2014, J ALLOY COMPD, V583, P404, DOI 10.1016/j.jallcom.2013.08.183; Yang JJ, 2017, METALL MATER TRANS A, V48A, P3583, DOI 10.1007/s11661-017-4087-9; Yang JJ, 2016, MATER DESIGN, V108, P308, DOI 10.1016/j.matdes.2016.06.117; Zhang LC, 2016, ADV ENG MATER, V18, P463, DOI 10.1002/adem.201500419; Zhang XY, 2018, J ALLOY COMPD, V735, P1562, DOI 10.1016/j.jallcom.2017.11.263; Zhu XL, 2004, BIOMATERIALS, V25, P4087, DOI 10.1016/j.biomaterials.2003.11.011	83	21	21	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2019	14	8							e0221198	10.1371/journal.pone.0221198	http://dx.doi.org/10.1371/journal.pone.0221198			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW6AB	31465449	Green Published, Green Submitted, gold			2022-12-26	WOS:000485058200012
J	Samuelsson, L; Tyden, J; Herwald, H; Hultin, M; Wallden, J; Steinvall, I; Sjoberg, F; Johansson, J				Samuelsson, Line; Tyden, Jonas; Herwald, Heiko; Hultin, Magnus; Wallden, Jakob; Steinvall, Ingrid; Sjoberg, Folke; Johansson, Joakim			Renal clearance of heparin-binding protein and elimination during renal replacement therapy: Studies in ICU patients and healthy volunteers	PLOS ONE			English	Article							SERUM CYSTATIN C; ORGAN DYSFUNCTION; EARLY MARKER; INFECTION; BIOMARKER; FAILURE; HBP	Background Heparin-binding protein (HBP) is released by neutrophils upon activation, and elevated plasma levels are seen in inflammatory states like sepsis, shock, cardiac arrest, and burns. However, little is known about the elimination of HBP. We wanted to study renal clearance of HBP in healthy individuals and in burn patients in intensive care units (ICUs). We also wished to examine the levels of HBP in the effluent of renal replacement circuits in ICU patients undergoing continuous renal replacement therapy (CRRT). Methods We measured plasma and urine levels of HBP and urine flow rate in 8 healthy individuals and 20 patients in a burn ICU. In 32 patients on CRRT, we measured levels of HBP in plasma and in the effluent of the CRRT circuit. Results Renal clearance of HBP (median (IQR) ml/min) was 0.19 (0.08-0.33) in healthy individuals and 0.30 (0.01-1.04) in burn ICU patients. In ICU patients with cystatin C levels exceeding 1.44 mg/l, clearance was 0.45 (0.15-2.81), and in patients with cystatin C below 1.44 mg/l clearance was lower 0.28 (0.14-0.55) (p = 0.04). Starting CRRT did not significantly alter plasma levels of HBP (p = 0.14), and the median HBP level in the effluent on CRRT was 9.1 ng/ml (IQR 7.8-14.4 ng/ml). Conclusion In healthy individuals and critically ill burn patients, renal clearance of HBP is low. It is increased when renal function is impaired. Starting CRRT in critically ill patients does not alter plasma levels of HBP significantly, but HBP can be found in the effluent. It seems unlikely that impaired kidney function needs to be considered when interpreting concentrations of HBP in previous studies. Starting CRRT does not appear to be an effective way of reducing HBP concentrations.	[Samuelsson, Line; Tyden, Jonas; Johansson, Joakim] Umea Univ, Dept Surg & Perioperat Sci, Anesthesiol & Intens Care Med Ostersund, Umea, Sweden; [Herwald, Heiko] Lund Univ, Dept Clin Sci, Lund, Sweden; [Hultin, Magnus] Umea Univ, Dept Surg & Perioperat Sci, Anesthesiol & Intens Care Med, Umea, Sweden; [Wallden, Jakob] Umea Univ, Anesthesiol & Intens Care Med Sundsvall, Dept Surg & Perioperat Sci, Umea, Sweden; [Steinvall, Ingrid; Sjoberg, Folke] Linkoping Univ, Dept Hand Surg Plast Surg & Burns, Linkoping, Sweden; [Steinvall, Ingrid; Sjoberg, Folke] Linkoping Univ, Dept Clin & Expt Med, Linkoping, Sweden; [Johansson, Joakim] Linkoping Univ, Dept Anesthesiol & Intens Care, Linkoping, Sweden	Umea University; Lund University; Umea University; Umea University; Linkoping University; Linkoping University; Linkoping University	Tyden, J (corresponding author), Umea Univ, Dept Surg & Perioperat Sci, Anesthesiol & Intens Care Med Ostersund, Umea, Sweden.	jonas.tyden@regionjh.se	Herwald, Heiko/AAN-3708-2021; Steinvall, Ingrid/I-5954-2019; Wallden, Jakob/AAY-4793-2020; Hultin, Magnus/A-1321-2010	Herwald, Heiko/0000-0002-8111-2842; Wallden, Jakob/0000-0002-8171-5184; Hultin, Magnus/0000-0003-2935-7161; Steinvall, Ingrid/0000-0002-8027-9632				Bentzer Peter, 2016, Intensive Care Med Exp, V4, P33; Cai XY, 2012, CLIN CHEM LAB MED, V50, P667, DOI 10.1515/cclm-2011-0838; Chew MS, 2012, INFLAMM RES, V61, P375, DOI 10.1007/s00011-011-0422-6; De Vriese AS, 1999, J AM SOC NEPHROL, V10, P846; Fisher J, 2017, J INTERN MED, V281, P562, DOI 10.1111/joim.12604; Fisher J, 2017, SHOCK, V48, P313, DOI 10.1097/SHK.0000000000000862; Gautam N, 2001, NAT MED, V7, P1123, DOI 10.1038/nm1001-1123; Gritters M, 2006, NEPHROL DIAL TRANSPL, V21, P153, DOI 10.1093/ndt/gfi069; Johansson J, 2013, ACTA ANAESTH SCAND, V57, P580, DOI 10.1111/aas.12070; Johansson J, 2015, J BURN CARE RES, V36, P484, DOI 10.1097/BCR.0000000000000211; Johansson J, 2009, BURNS, V35, P1185, DOI 10.1016/j.burns.2009.02.021; Kahn F, 2019, HEPARIN BINDING PRO, DOI [10.1097/SHK.0000000000001332, DOI 10.1097/SHK.0000000000001332]; Kjolvmark C, 2016, DIAGN MICR INFEC DIS, V85, P243, DOI 10.1016/j.diagmicrobio.2016.03.005; Kjolvmark C, 2014, OPEN FORUM INFECT DI, V1, DOI 10.1093/ofid/ofu004; Lin QH, 2013, CRIT CARE, V17, DOI 10.1186/cc12834; Linder A, 2015, CRIT CARE MED, V43, P2378, DOI 10.1097/CCM.0000000000001265; Linder A, 2012, CRIT CARE, V16, DOI 10.1186/cc11353; Linder A, 2009, CLIN INFECT DIS, V49, P1044, DOI 10.1086/605563; MAACK T, 1979, KIDNEY INT, V16, P251, DOI 10.1038/ki.1979.128; SHAFER WM, 1984, INFECT IMMUN, V45, P29, DOI 10.1128/IAI.45.1.29-35.1984; Sjoberg F, 2000, BURNS, V26, P553, DOI 10.1016/S0305-4179(00)00004-8; Tapper H, 2002, BLOOD, V99, P1785, DOI 10.1182/blood.V99.5.1785; Tverring J, 2017, ANN INTENSIVE CARE, V7, DOI 10.1186/s13613-017-0330-1; Tyden J, 2017, ACTA ANAESTH SCAND, V61, P797, DOI 10.1111/aas.12913; Tyden J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152035; Yim H, 2015, EUR J CLIN INVEST, V45, P594, DOI 10.1111/eci.12452	26	7	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2019	14	8							e0221813	10.1371/journal.pone.0221813	http://dx.doi.org/10.1371/journal.pone.0221813			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW6AB	31465432	Green Published, gold, Green Submitted			2022-12-26	WOS:000485058200055
J	Ferreira, D; Martins, B; Soares, M; Correia, J; Adega, F; Ferreira, F; Chaves, R				Ferreira, Daniela; Martins, Barbara; Soares, Maria; Correia, Jorge; Adega, Filomena; Ferreira, Fernando; Chaves, Raquel			Gene expression association study in feline mammary carcinomas	PLOS ONE			English	Article							PYRUVATE-KINASE M2; BREAST-CANCER; C-MYC; CYCLIN D1; PROGNOSTIC-FACTOR; CELL-GROWTH; PROTEIN; YB-1; P53; TUMORS	Works on cancer-related genes expression using feline mammary carcinomas (FMCs) are scarce but crucial, not only to validate these tumours as models for human breast cancer studies but also to improve small animal practice. Here, the expression of the cancer-related genes TP53, CCND1, FUS, YBX1, PTBP1, c-MYC and PKM2 was evaluated by real-time RT-qPCR, in a population of FMCs clinically characterized and compared with the disease-free tissue of the same individual. In most of the FMCs analysed, RNA quantification revealed normal expression levels for TP53, c-MYC, YBX1 and FUS, but overexpression in the genes CCND1, PTBP1 and PKM2. The expression levels of these cancer-related genes are strongly correlated with each other, with exception of c-MYC and PKM2 genes. The integration of clinicopathological data with the transcriptional levels revealed several associations. The oral contraceptive administration showed to be positively related with the TP53, YBX1, CCND1, FUS and PTBP1 RNA levels. Positive associations were found between tumour size and YBX1 RNA, and lymph node metastasis with c-MYC RNA levels. This work allowed to verify that many of these cancer-related genes are associated but may also, indirectly, influence other genes, creating a complex molecular cancer network that in the future can provide new cancer biomarkers.	[Ferreira, Daniela; Martins, Barbara; Adega, Filomena; Chaves, Raquel] Univ Tras Os Montes & Alto Douro, Dept Genet & Biotechnol, CAG Lab Cytogen & Anim Genom, Vila Real, Portugal; [Ferreira, Daniela; Adega, Filomena; Chaves, Raquel] Univ Lisbon, Fac Sci, BioISI Biosyst & Integrat Sci Inst, Lisbon, Portugal; [Soares, Maria] Univ Lusofona Humanidades & Tecnol, Fac Med Vet, CBiOS Res Ctr Biosci & Hlth Technol, Lisbon, Portugal; [Correia, Jorge; Ferreira, Fernando] Univ Lisbon, Fac Med Vet, CIISA, Ave Univ Tecn, Lisbon, Portugal	University of Tras-os-Montes & Alto Douro; BIOISI; Universidade de Lisboa; Lusofona University; Universidade de Lisboa; Universidade de Lisboa	Chaves, R (corresponding author), Univ Tras Os Montes & Alto Douro, Dept Genet & Biotechnol, CAG Lab Cytogen & Anim Genom, Vila Real, Portugal.; Chaves, R (corresponding author), Univ Lisbon, Fac Sci, BioISI Biosyst & Integrat Sci Inst, Lisbon, Portugal.	rchaves@utad.pt	Chaves, Raquel/K-3044-2013; Chaves, Raquel/S-2882-2019; Soares, Maria/AAF-4496-2021; Correia, Jorge/P-8411-2014; Ferreira, Daniela/U-5802-2017; Ferreira, Fernando Costa/D-8096-2018; Adega, Filomena/J-2875-2013	Chaves, Raquel/0000-0002-5970-7428; Chaves, Raquel/0000-0002-5970-7428; Correia, Jorge/0000-0002-1909-4540; Ferreira, Daniela/0000-0002-7094-4969; Ferreira, Fernando Costa/0000-0001-5765-576X; Soares, Maria/0000-0002-7461-2603; Adega, Filomena/0000-0001-5646-5534	Fundacao para a Ciencia e Tecnologia (Portugal) [PTDC/CVT-EPI/3638/2014, CIISA-UID/CVT/00276/2019, SFRH/BD/70720/2010, UID/MULTI/04046/2019]; Fundação para a Ciência e a Tecnologia [UID/CVT/00276/2019, UID/Multi/04046/2019, PTDC/CVT-EPI/3638/2014] Funding Source: FCT	Fundacao para a Ciencia e Tecnologia (Portugal)(Portuguese Foundation for Science and Technology); Fundação para a Ciência e a Tecnologia	This research was funded by Fundacao para a Ciencia e Tecnologia (Portugal) through the projects PTDC/CVT-EPI/3638/2014 (MS, JC, FA, FF and RC), CIISA-UID/CVT/00276/2019 (FF), the PhD grant SFRH/BD/70720/2010 (MS) and the UID/MULTI/04046/2019 Research Unit grant (FA and RC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acar A, 2016, STEM CELLS INT, V2016, DOI 10.1155/2016/2498764; Adega Filomena, 2016, Vet Sci, V3, DOI 10.3390/vetsci3030017; Arena V, 2016, EJSO-EUR J SURG ONC, V42, P433, DOI 10.1016/j.ejso.2015.11.005; Arnold HK, 2006, MOL CELL BIOL, V26, P2832, DOI 10.1128/MCB.26.7.2832-2844.2006; Bieche I, 1999, CANCER RES, V59, P2759; Cardellino U, 2007, MUTAGENESIS, V22, P417, DOI 10.1093/mutage/gem038; Castellana B, 2015, ONCOTARGET, V6, P38239, DOI 10.18632/oncotarget.5664; Chaves R, 2017, GENOME BIOL EVOL, V9, P3073, DOI 10.1093/gbe/evx212; Chrzan P, 2001, CLIN BIOCHEM, V34, P557, DOI 10.1016/S0009-9120(01)00260-0; Dagher E, 2019, VET PATHOL, V56, P660, DOI 10.1177/0300985819846870; Dai XF, 2016, J CANCER, V7, P1281, DOI 10.7150/jca.13141; David CJ, 2010, NATURE, V463, P364, DOI 10.1038/nature08697; De Maria R, 2005, CANCER RES, V65, P907; Dong GC, 2016, ONCOL LETT, V11, P1980, DOI 10.3892/ol.2016.4168; Duffy MJ, 2018, BREAST CANCER RES TR, V170, P213, DOI 10.1007/s10549-018-4753-7; Eliseeva IA, 2011, BIOCHEMISTRY-MOSCOW+, V76, P1402, DOI 10.1134/S0006297911130049; Elston C W, 2002, Histopathology, V41, P154; Fabregat A, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-017-1559-2; Farrell AS, 2014, CSH PERSPECT MED, V4, DOI 10.1101/cshperspect.a014365; Ferreira D, 2019, AGING-US, V11, P4688, DOI 10.18632/aging.102079; Ferreira D, 2019, FRONT GENET, V10, DOI 10.3389/fgene.2019.00101; Goldhirsch A, 2013, ANN ONCOL, V24, P2206, DOI 10.1093/annonc/mdt303; Green AR, 2016, BRIT J CANCER, V114, P917, DOI 10.1038/bjc.2016.46; Guo LY, 2015, INT J CLIN EXP MED, V8, P18656; He X, 2007, ONCOGENE, V26, P4961, DOI 10.1038/sj.onc.1210307; He X, 2014, ONCOGENESIS, V3, DOI 10.1038/oncsis.2013.47; Hsu MC, 2016, AM J CANCER RES, V6, P628; Huang WS, 2016, ONCOTARGETS THER, V9, P4377, DOI 10.2147/OTT.S94703; Huberts DHEW, 2010, BBA-MOL CELL RES, V1803, P520, DOI 10.1016/j.bbamcr.2010.01.022; Jung M, 2017, CANCER RES, V77, P971, DOI 10.1158/0008-5472.CAN-15-2906; Ke H, 2016, GENE REGUL SYST BIO, V10, P10, DOI 10.4137/GRSB.S29414; Kim HS, 2010, BREAST CANCER RES TR, V121, P777, DOI 10.1007/s10549-009-0560-5; Kim S, 2015, CANCER MANAG RES, V7, P225, DOI 10.2147/CMAR.S47797; Kontomanolis Emmanuel N, 2018, ScientificWorldJournal, V2018, P2415489, DOI 10.1155/2018/2415489; Lanson NA, 2012, BRAIN RES, V1462, P44, DOI 10.1016/j.brainres.2012.01.039; Lee AHY, 2015, BACTERIA-PLANT INTERACTIONS: ADVANCED RESEARCH AND FUTURE TRENDS, P1, DOI 10.1007/s12282-015-0625-8; Li ZS, 2016, AM J TRANSL RES, V8, P142; Lin Y, 2015, INT J CLIN EXP PATHO, V8, P8028; Lundberg A, 2019, BREAST CANCER RES, V21, DOI 10.1186/s13058-019-1121-4; Ma JW, 2016, ONCOTARGET, V7, P58915, DOI 10.18632/oncotarget.10410; Manzoor S, 2017, PAK J ZOOL, V49, P2147, DOI 10.17582/journal.pjz/2017.49.6.2147.2152; Millan Y, 2013, INSIGHTS FROM VETERI; Murakami Y, 2000, J VET MED SCI, V62, P743, DOI 10.1292/jvms.62.743; Mylona E, 2014, EJSO-EUR J SURG ONC, V40, P289, DOI 10.1016/j.ejso.2013.09.008; Nasir L, 2000, CANCER LETT, V155, P1, DOI 10.1016/S0304-3835(00)00337-2; Ortiz AB, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188068; Peurala E, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3376; Porter JR, 2017, MOL CELL, V67, P1013, DOI 10.1016/j.molcel.2017.07.028; Prakasam G, 2018, FRONT ONCOL, V8, DOI 10.3389/fonc.2018.00022; Rivlin Noa, 2011, Genes Cancer, V2, P466, DOI 10.1177/1947601911408889; Romagnoli S, 2015, J FELINE MED SURG, V17, P743, DOI 10.1177/1098612X15594987; Seixas F, 2011, VET J, V187, P65, DOI 10.1016/j.tvjl.2009.10.030; Shrestha M, 2016, KOREAN J PHYSIOL PHA, V20, P487, DOI 10.4196/kjpp.2016.20.5.487; Soares M, 2016, VET PATHOL, V53, P37, DOI 10.1177/0300985815588606; Soares M, 2016, BREAST, V27, P44, DOI 10.1016/j.breast.2016.02.016; Sorenmo KU., 2013, SMALL ANIMAL CLIN ON, DOI [10.1016/B978-1-4377-2362-5.00027-X, DOI 10.1016/B978-1-4377-2362-5.00027-X]; Stojadinovic O, 2005, AM J PATHOL, V167, P59, DOI 10.1016/S0002-9440(10)62953-7; Takahashi H, 2015, MOL CANCER THER, V14, P1705, DOI 10.1158/1535-7163.MCT-14-0142; Tan AY, 2012, CELL CYCLE, V11, P3349, DOI 10.4161/cc.21875; Wang X, 2018, J CELL PHYSIOL, V233, P8930, DOI 10.1002/jcp.26823; Wang X, 2015, INT J CLIN EXP MED, V8, P1780; Ward CL, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.508; Yang WW, 2015, J CELL SCI, V128, P1655, DOI 10.1242/jcs.166629; Yang WW, 2012, NAT CELL BIOL, V14, P1295, DOI 10.1038/ncb2629; Yu YN, 2010, INT J ONCOL, V37, P483, DOI 10.3892/ijo_00000697; Zhu H, 2016, ONCOTARGET, V8, P1628, DOI 10.18632/oncotarget.13703	66	9	10	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2019	14	8							e0221776	10.1371/journal.pone.0221776	http://dx.doi.org/10.1371/journal.pone.0221776			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5XV	31461477	Green Submitted, Green Published, gold			2022-12-26	WOS:000485052300051
J	Runnarong, N; Tretriluxana, J; Waiyasil, W; Sittisupapong, P; Tretriluxana, S				Runnarong, Nuttakarn; Tretriluxana, Jarugool; Waiyasil, Watinee; Sittisupapong, Preeyanuch; Tretriluxana, Suradej			Age-related changes in reach-to-grasp movements with partial visual occlusion	PLOS ONE			English	Article							FEEDBACK-CONTROL; ONLINE CONTROL; OLDER-ADULTS; PRECISION; INDIVIDUALS; OBJECT	This study investigated the influence of age and visual occlusion on fast reach-to-grasp movements. The effect of visual occlusion on reach-to-grasp movement was examined using a task that heavily relies on feed-forward control. Three groups of healthy adults aged 22, 49 and 65 on average performed fast reach-to-grasp movements with full visual and partial visual occlusion conditions of the hand during the initial part of movement. Regarding the effect of age, the all parameters of reach-to-grasp movement were deteriorated with age, except relative time to maximum velocity and spatial coordination. Regarding the effect of visual condition, participants reached with prolonged movement time, lower peak velocity, and later occurrences of peak velocity and peak aperture, as well as decrease in spatial coordination. Regarding the effect of age on visual condition, visual occlusion resulted in a longer movement time and delayed time to maximum velocity in middle-aged and older groups compared to full vision, but the difference was not observed in the younger groups. Conclusion: Reach-to-grasp performance deteriorated with age and the performance was affected when vision of the hand at initial movement was occluded. Overall, movement performance in middle-aged and older adults was affected by visual occlusion, whereas it was unaffected in younger adults. The results indicate that visual feedback of the hand at initial movement is important to control reach-to-grasp movement of middle-aged and older adults during real tasks.	[Runnarong, Nuttakarn; Waiyasil, Watinee; Sittisupapong, Preeyanuch] Srinakharinwirot Univ, Fac Phys Therapy, Nakhon Nayok, Thailand; [Tretriluxana, Jarugool] Mahidol Univ, Fac Phys Therapy, Motor Control & Neural Plastic Lab, Tambon Salaya, Nakhon Pathom, Thailand; [Tretriluxana, Suradej] King Mongkuts Inst Technol Ladkrabang, Fac Engn, Bangkok, Thailand	Srinakharinwirot University; Mahidol University; King Mongkuts Institute of Technology Ladkrabang	Tretriluxana, J (corresponding author), Mahidol Univ, Fac Phys Therapy, Motor Control & Neural Plastic Lab, Tambon Salaya, Nakhon Pathom, Thailand.	jarugool.tre@mahidol.ac.th		Runnarong, Nuttakarn/0000-0002-9129-9196	Faculty of Physical Therapy, Srinakharinwirot University, Thailand [299/2559]	Faculty of Physical Therapy, Srinakharinwirot University, Thailand	This work was supported by research grant from Faculty of Physical Therapy, Srinakharinwirot University, Thailand (grant number 299/2559) (to NR).	BENNETT KMB, 1994, J GERONTOL, V49, pP1, DOI 10.1093/geronj/49.1.P1; BENNETT KMB, 1995, PSYCHOL AGING, V10, P204, DOI 10.1037/0882-7974.10.2.204; Chun J, 2015, INT C CONTR AUTOMAT, P1801, DOI 10.1109/ICCAS.2015.7364651; Coats RO, 2011, EXP BRAIN RES, V214, P139, DOI 10.1007/s00221-011-2813-x; Cole KJ, 1999, J NEUROSCI, V19, P3238; Connolly JD, 1999, EXP BRAIN RES, V125, P281, DOI 10.1007/s002210050684; Dayanidhi S, 2014, J GERONTOL A-BIOL, V69, P1139, DOI 10.1093/gerona/glu025; Fukui T, 2006, HUM MOVEMENT SCI, V25, P349, DOI 10.1016/j.humov.2006.02.002; Grabowski P, 2012, VIRTUAL REALITY ENV; Grabowski P, 2011, P IADIS INT MULT COM; Grabowski PJ, 2014, INT J HUM-COMPUT ST, V72, P383, DOI 10.1016/j.ijhcs.2013.12.009; Hoellinger T, 2017, NEUROSCIENCE, V357, P384, DOI 10.1016/j.neuroscience.2017.04.010; Holt RJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069040; JAKOBSON LS, 1991, EXP BRAIN RES, V86, P199; Khacharoen Suweena, 2015, Journal of the Medical Association of Thailand, V98, P889; Lange BS, 2010, PHYS MED REH CLIN N, V21, P339, DOI 10.1016/j.pmr.2009.12.007; Lindberg P, 2009, EXP BRAIN RES, V193, P213, DOI 10.1007/s00221-008-1613-4; Masood A, 2019, 2019 IEEE 89 VEHICUL, P1; Perani D, 2001, NEUROIMAGE, V14, P749, DOI 10.1006/nimg.2001.0872; Raw RK, 2012, EXP BRAIN RES, V217, P35, DOI 10.1007/s00221-011-2971-x; Runnarong N, 2019, THAI J PHYS THERAPY, V41, P30; Runnarong Nuttakarn, 2014, Journal of the Medical Association of Thailand, V97, pS84; Saling M, 1998, EXP BRAIN RES, V118, P251, DOI 10.1007/s002210050279; Sarlegna FR, 2006, NEUROSCI LETT, V403, P309, DOI 10.1016/j.neulet.2006.05.003; Scharoun SM, 2016, DEV PSYCHOBIOL, V58, P439, DOI 10.1002/dev.21386; SEIDLER RD, 1995, QUEST, V47, P386, DOI 10.1080/00336297.1995.10484165; Seidler-Dobrin RD, 1998, EXP BRAIN RES, V119, P467, DOI 10.1007/s002210050362; Shumway-Cook A., 2001, MOTOR CONTROL THEORY, V2nd; Skoura X, 2005, BEHAV BRAIN RES, V165, P229, DOI 10.1016/j.bbr.2005.07.023; Tretriluxana J, 2008, EXP BRAIN RES, V188, P305, DOI 10.1007/s00221-008-1364-2; Winter D, 2005, BIOMECHANICS MOTOR C; Yan JH, 1998, EXP AGING RES, V24, P155	32	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2019	14	8							e0221320	10.1371/journal.pone.0221320	http://dx.doi.org/10.1371/journal.pone.0221320			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW5XV	31461484	Green Published, gold, Green Submitted			2022-12-26	WOS:000485052300028
J	Betsch, M; Michalik, R; Graber, M; Wild, M; Krauspe, R; Zilkens, C				Betsch, Marcel; Michalik, Roman; Graber, Maximilian; Wild, Michael; Krauspe, Ruediger; Zilkens, Christoph			Influence of leg length inequalities on pelvis and spine in patients with total hip arthroplasty	PLOS ONE			English	Article							LOW-BACK-PAIN; ANATOMICAL LANDMARKS; LUMBAR SPINE; DISCREPANCY; SHAPE; SURFACE; OSTEOARTHRITIS; ASYMMETRY; SURGERY; IMPACT	Background Leg length inequalities (LLIs) are a common finding in patients with a total hip arthroplasty (THA). Therefore, we compared the effects of simulated LLIs in patients with total hip arthroplasty (THA) with a matched control group. Research question Do LLIs lead to different effects on the musculoskeletal apparatus of patients with a THA then in a control group? Methods In 99 patients with a THA the effects of simulated LLIs were compared to a matched control group of 101 subjects without a hip arthroplasty. First, we compared methods for LLI quantification (tape measurements, pelvic x-ray and rasterstereography). Second, the effects of simulated LLIs on the spine and pelvis were evaluated in both groups using surface topography. LLIs of 5, 10, 15, 20 and 30 mm were simulated on both sides with a simulation platform. The changes of pelvic position (pelvic obliquity & pelvic torsion) and the effects on spinal posture (surface rotation & lateral deviation) were measured and analysed using a surface topography system. Results Mean LLI measured with a tape was 0.9 mm (SD +/-14.8). Mean pelvic obliquity measured on x-rays was 1.2 mm (SD +/- 11.6) and with surface topography 0.9 mm (SD +/- 7.9). Simulated LLIs resulted in significant changes of pelvic position and spinal posture in the patient and control group. Interestingly, our study showed that simulated LLIs lead to greater changes in pelvic position (p< 0.05) in patients with a THA. Significance This is the first study to demonstrate that LLIs might have a greater impact on the pelvic position of THA patients than in native hips, which could indicate that LLIs do need to be compensated differently in patients with THA than in patients without a THA.	[Betsch, Marcel; Michalik, Roman] Univ Hosp RWTH Aachen, Dept Orthopaed, Aachen, Germany; [Graber, Maximilian; Krauspe, Ruediger; Zilkens, Christoph] Univ Hosp Duesseldorf, Dept Orthopaed, Dusseldorf, Germany; [Wild, Michael] Klinikum Darmstadt, Dept Orthopaed Traumatol & Hand Surg, Darmstadt, Germany	RWTH Aachen University; RWTH Aachen University Hospital; Klinikum Darmstadt	Michalik, R (corresponding author), Univ Hosp RWTH Aachen, Dept Orthopaed, Aachen, Germany.	rmichalik@ukaachen.de	Michalik, Roman/ABE-3421-2020	Michalik, Roman/0000-0002-9431-0637; Wild, Michael/0000-0002-6306-4867				Ahmad R, 2009, HIP INT, V19, P264, DOI 10.1177/112070000901900313; Amstutz HC, 2004, CLIN ORTHOP RELAT R, P2; Beeck A, 2019, GAIT POSTURE, V67, P71, DOI 10.1016/j.gaitpost.2018.09.022; Ben-Galim P, 2007, SPINE, V32, P2099, DOI 10.1097/BRS.0b013e318145a3c5; Betsch M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070581; Betsch M, 2013, EUR SPINE J, V22, P1354, DOI 10.1007/s00586-013-2720-x; Crawford RJ, 2009, CLIN BIOMECH, V24, P467, DOI 10.1016/j.clinbiomech.2009.04.003; DRERUP B, 1992, J BIOMECH, V25, P1357, DOI 10.1016/0021-9290(92)90291-8; Drerup B, 1996, CLIN BIOMECH, V11, P376, DOI 10.1016/0268-0033(96)00025-3; DRERUP B, 1987, J BIOMECH, V20, P961, DOI 10.1016/0021-9290(87)90325-3; DRERUP B, 1987, J BIOMECH, V20, P971, DOI 10.1016/0021-9290(87)90326-5; DRERUP B, 1994, CLIN BIOMECH, V9, P28, DOI 10.1016/0268-0033(94)90055-8; Edeen J, 1995, Am J Orthop (Belle Mead NJ), V24, P347; Ellenrieder M, 2015, J ORTHOP SCI, V20, P1046, DOI 10.1007/s00776-015-0764-y; Friberg O, 1988, Int Disabil Stud, V10, P49; FRIBERG O, 1983, SPINE, V8, P643, DOI 10.1097/00007632-198309000-00010; GILES LGF, 1981, SPINE, V6, P510, DOI 10.1097/00007632-198109000-00014; GOFTON JP, 1971, CAN MED ASSOC J, V104, P791; Hackenberg Lars, 2002, Stud Health Technol Inform, V91, P241; Hofmann AA, 2000, ORTHOPEDICS, V23, P943; Kaufman KR, 1996, J PEDIATR ORTHOPED, V16, P144, DOI 10.1097/01241398-199603000-00002; Konyves A, 2005, J BONE JOINT SURG BR, V87B, P155, DOI 10.1302/0301-620X.87B2.14878; Lampe HIH, 1996, ACTA ORTHOP SCAND, V67, P242, DOI 10.3109/17453679608994680; Maloney WJ, 2004, J ARTHROPLASTY, V19, P108, DOI 10.1016/j.arth.2004.02.018; MEADOWS DM, 1970, APPL OPTICS, V9, P942, DOI 10.1364/AO.9.000942; Melvin M, 2010, SPINE, V35, P1353, DOI 10.1097/BRS.0b013e3181cbc157; Ranawat CS, 1997, J ARTHROPLASTY, V12, P359, DOI 10.1016/S0883-5403(97)90190-X; Sathappan SS, 2008, J ARTHROPLASTY, V23, P203, DOI 10.1016/j.arth.2007.01.022; Sayed-Noor AS, 2006, HIP INT, V16, P202, DOI 10.5301/HIP.2008.4186; ten Brinke A, 1999, SPINE, V24, P684, DOI 10.1097/00007632-199904010-00013; Terry MA, 2005, J PEDIATR ORTHOPED, V25, P197, DOI 10.1097/01.bpo.0000148496.97556.9f; Walker PS, 2000, CLIN ORTHOP RELAT R, P9; Walsh M, 2000, GAIT POSTURE, V12, P156, DOI 10.1016/S0966-6362(00)00067-9; Wen DY, 1997, MED SCI SPORT EXER, V29, P1291, DOI 10.1097/00005768-199710000-00003; WILLIAMSON JA, 1978, CLIN ORTHOP RELAT R, P135; Woerman A L, 1984, J Orthop Sports Phys Ther, V5, P230; Wylde V, 2009, INT ORTHOP, V33, P905, DOI 10.1007/s00264-008-0563-6	37	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2019	14	8							e0221695	10.1371/journal.pone.0221695	http://dx.doi.org/10.1371/journal.pone.0221695			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5WO	31454389	Green Published, Green Submitted, gold			2022-12-26	WOS:000485049000042
J	Garre, A; Penalver-Soto, JL; Esnoz, A; Iguaz, A; Fernandez, PS; Egea, JA				Garre, Alberto; Lucas Penalver-Soto, Jose; Esnoz, Arturo; Iguaz, Asuncion; Fernandez, Pablo S.; Egea, Jose A.			On the use of in-silico simulations to support experimental design: A case study in microbial inactivation of foods	PLOS ONE			English	Article							PARAMETER-ESTIMATION; LISTERIA-MONOCYTOGENES; KINETIC-PARAMETERS; SHELF-LIFE; GROWTH; MODEL; VARIABILITY; RESISTANCE; TEMPERATURE; QUALITY	The mathematical models used in predictive microbiology contain parameters that must be estimated based on experimental data. Due to experimental uncertainty and variability, they cannot be known exactly and must be reported with a measure of uncertainty (usually a standard deviation). In order to increase precision (i.e. reduce the standard deviation), it is usual to add extra sampling points. However, recent studies have shown that precision can also be increased without adding extra sampling points by using Optimal Experiment Design, which applies optimization and information theory to identify the most informative experiment under a set of constraints. Nevertheless, to date, there has been scarce contributions to know a priori whether an experimental design is likely to provide the desired precision in the parameter estimates. In this article, two complementary methodologies to predict the parameter precision for a given experimental design are proposed. Both approaches are based on in silico simulations, so they can be performed before any experimental work. The first one applies Monte Carlo simulations to estimate the standard deviation of the model parameters, whereas the second one applies the properties of the Fisher Information Matrix to estimate the volume of the confidence ellipsoids. The application of these methods to a case study of dynamic microbial inactivation, showing how they can be used to compare experimental designs and assess their precision, is illustrated. The results show that, as expected, the optimal experimental design is more accurate than the uniform design with the same number of data points. Furthermore, it is demonstrated that, for some heating profiles, the uniform design does not ensure that a higher number of sampling points increases precision. Therefore, optimal experimental designs are highly recommended in predictive microbiology.	[Garre, Alberto; Lucas Penalver-Soto, Jose; Esnoz, Arturo; Iguaz, Asuncion; Fernandez, Pablo S.] Univ Politecn Cartagena ETSIA, Inst Biotecnol Vegetal, Dept Ingn Alimentos & Equipamiento Agr, Paseo Alfonso 13, Cartagena, Spain; [Egea, Jose A.] Ctr Edafol & Biol Aplicada Segura, Campus Univ Espinardo, Murcia, Spain; [Garre, Alberto] Wageningen Univ & Res, Food Microbiol, Wageningen, Netherlands	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Edafologia y Biologia Aplicada del Segura (CEBAS); University of Murcia; Wageningen University & Research	Egea, JA (corresponding author), Ctr Edafol & Biol Aplicada Segura, Campus Univ Espinardo, Murcia, Spain.	jaegea@cebas.csic.es	Garre, Alberto/Y-4940-2019; Egea, Jose A./K-3433-2013; Fernandez, Pablo S./K-5694-2017	Garre, Alberto/0000-0002-4404-3550; Egea, Jose A./0000-0002-7821-1604; Fernandez, Pablo S./0000-0002-4273-7268; /0000-0001-8825-0706	Ministry of Science, Innovation and Universities of the Spanish Government; European Regional Development Fund (ERDF) [AGL2017-86840-C-21-R]; Seneca Foundation [20900/PD/18]; MINECO [BES-2014-070946]	Ministry of Science, Innovation and Universities of the Spanish Government(Spanish Government); European Regional Development Fund (ERDF)(European Commission); Seneca Foundation(Fundacion Seneca); MINECO(Spanish Government)	The financial support of this research work was provided by the Ministry of Science, Innovation and Universities of the Spanish Government and European Regional Development Fund (ERDF) through project AGL2017-86840-C-21-R, as well as the Seneca Foundation through project (20900/PD/18). AG is grateful to the MINECO for awarding him a pre-doctoral grant (Ref: BES-2014-070946). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akkermans S, 2018, FOOD MICROBIOL, V76, P504, DOI 10.1016/j.fm.2018.05.010; Akkermans S, 2018, FOOD RES INT, V106, P1105, DOI 10.1016/j.foodres.2017.11.083; [Anonymous], 2021, LANG ENV STAT COMP; Aryani DC, 2015, INT J FOOD MICROBIOL, V208, P19, DOI 10.1016/j.ijfoodmicro.2015.05.006; Aryani DC, 2015, INT J FOOD MICROBIOL, V193, P130, DOI 10.1016/j.ijfoodmicro.2014.10.021; Balsa-Canto E, 2008, IET SYST BIOL, V2, P163, DOI 10.1049/iet-syb:20070069; Balsa-Canto E, 2007, J FOOD ENG, V82, P178, DOI 10.1016/j.jfoodeng.2007.02.006; Balsa-Canto E, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-11; Banga JR, 2008, ESSAYS BIOCHEM, V45, P195, DOI 10.1042/BSE0450195; Bates D., 2007, NONLINEAR REGRESSION; Bigelow WD, 1920, J INFECT DIS, V27, P602, DOI 10.1093/infdis/27.6.602; Bigelow WD, 1921, J INFECT DIS, V29, P528, DOI 10.1093/infdis/29.5.528; BOX G.E.P., 2005, STAT EXPT DESIGN INN; Cattani F, 2016, FOOD RES INT, V89, P614, DOI 10.1016/j.foodres.2016.08.027; DATTA AK, 1993, J FOOD ENG, V18, P181, DOI 10.1016/0260-8774(93)90035-I; deAguiar PF, 1995, CHEMOMETR INTELL LAB, V30, P199, DOI 10.1016/0169-7439(94)00076-X; Dolan KD, 2013, ANNU REV FOOD SCI T, V4, P401, DOI 10.1146/annurev-food-022811-101247; Franceschini G, 2008, CHEM ENG SCI, V63, P4846, DOI 10.1016/j.ces.2007.11.034; Garcia MR, 2015, INT J FOOD MICROBIOL, V208, P65, DOI 10.1016/j.ijfoodmicro.2015.05.012; Garre A, 2018, FOOD RES INT, V112, P353, DOI 10.1016/j.foodres.2018.06.057; Garre A, 2018, FOOD RES INT, V107, P267, DOI 10.1016/j.foodres.2018.02.040; Garre A, 2018, INT J FOOD MICROBIOL, V266, P133, DOI 10.1016/j.ijfoodmicro.2017.11.023; Garre A, 2017, FOOD RES INT, V93, P66, DOI 10.1016/j.foodres.2017.01.012; Gonzalez-Tejedor GA, 2018, FOOD MICROBIOL, V72, P98, DOI 10.1016/j.fm.2017.11.005; Grijspeerdt K, 1999, FOOD MICROBIOL, V16, P593, DOI 10.1006/fmic.1999.0285; Janssen M, 2008, INT J FOOD MICROBIOL, V128, P136, DOI 10.1016/j.ijfoodmicro.2008.06.009; Koutsoumanis K, 2001, APPL ENVIRON MICROB, V67, P1821, DOI 10.1128/AEM.67.4.1821-1829.2001; Krausch N, 2019, FRONT BIOENG BIOTECH, V7, DOI 10.3389/fbioe.2019.00122; Lehmann E. L., 1998, THEORY POINT ESTIMAT; Ljung L., 1999, WILEY ENCY ELECT ELE, DOI [10.1002/047134608X.W1046, DOI 10.1002/047134608X.W1046]; Longhi DA, 2018, J FOOD ENG, V216, P20, DOI 10.1016/j.jfoodeng.2017.07.031; Longhi DA, 2017, INT J FOOD MICROBIOL, V240, P57, DOI 10.1016/j.ijfoodmicro.2016.06.042; Mate J, 2016, FOOD CONTROL, V59, P824, DOI 10.1016/j.foodcont.2015.07.020; Nauta MJ, 2000, INT J FOOD MICROBIOL, V57, P9, DOI 10.1016/S0168-1605(00)00225-7; NISHII R, 1993, DISCRETE MATH, V116, P209, DOI 10.1016/0012-365X(93)90402-F; Perez-Rodriguez F., 2012, PREDICTIVE MICROBIOL; Periago PM, 2004, INT J FOOD MICROBIOL, V95, P205, DOI 10.1016/j.ijfoodmicro.2004.02.015; Poschet F, 2004, MATH COMPUT SIMULAT, V65, P231, DOI 10.1016/j.matcom.2003.12.002; Ros-Chumillas M, 2017, NANOMATERIALS-BASEL, V7, DOI 10.3390/nano7030065; Schenkendorf R, 2018, PROCESSES, V6, DOI 10.3390/pr6040027; Schwaab M, 2007, CHEM ENG SCI, V62, P2750, DOI 10.1016/j.ces.2007.02.020; Stamati I, 2016, FOOD RES INT, V89, P689, DOI 10.1016/j.foodres.2016.08.001; van Derlinden E., 2010, PROGR QUANTITATIVE A, P67; Versyck KJ, 1999, INT J FOOD MICROBIOL, V51, P39, DOI 10.1016/S0168-1605(99)00093-8; Versyck KJ, 1997, BIOTECHNOL PROGR, V13, P524, DOI 10.1021/bp970080j	45	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2019	14	8							e0220683	10.1371/journal.pone.0220683	http://dx.doi.org/10.1371/journal.pone.0220683			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5WO	31454353	gold, Green Published, Green Submitted			2022-12-26	WOS:000485049000007
J	Ito, H; Tamura, K; Wada, T; Yamamoto, T; Morita, S				Ito, Hiromu; Tamura, Kazuhiro; Wada, Takayuki; Yamamoto, Taro; Morita, Satoru			Is the network of heterosexual contact in Japan scale free?	PLOS ONE			English	Article							SEXUAL CONTACTS; WEB; DISTRIBUTIONS; ISSUES; HIV	Elucidation of the structure of human sexual networks is not only an interesting topic in the area of social networks but also an important clue for understanding the spreading risk of sexually transmitted infections (STIs). Some previous studies have indicated that sexual networks are scale free, while others have suggested that they are not. We conducted a Web-based survey on sexual contact in Japan to collect data on cumulative (total) heterosexual partners and the number of recent (in the last three or previous three months) heterosexual partners. To determine whether the number of heterosexual contacts in Japan has a power-law tail, we used maximum likelihood fitting methods and Kolmogorov-Smirnov tests. For confirmation, we also used the Akaike information criterion (AIC) and the Bayesian information criterion (BIC). Our results indicate that the distributions of the number of sexual partners in Japan have power-law tails.	[Ito, Hiromu; Wada, Takayuki; Yamamoto, Taro] Nagasaki Univ, Inst Trop Med, Dept Int Hlth, Nagasaki, Japan; [Ito, Hiromu] Univ Basel, Dept Environm Sci, Zool, Basel, Switzerland; [Tamura, Kazuhiro; Morita, Satoru] Shizuoka Univ, Grad Sch Sci & Technol, Dept Environm & Energy Syst, Hamamatsu, Shizuoka, Japan; [Wada, Takayuki] Nagasaki Univ, Sch Trop Med & Global Hlth, Nagasaki, Japan; [Morita, Satoru] Shizuoka Univ, Grad Sch Integrated Sci & Technol, Dept Math & Syst Engn, Hamamatsu, Shizuoka, Japan	Nagasaki University; University of Basel; Shizuoka University; Nagasaki University; Shizuoka University	Morita, S (corresponding author), Shizuoka Univ, Grad Sch Sci & Technol, Dept Environm & Energy Syst, Hamamatsu, Shizuoka, Japan.; Morita, S (corresponding author), Shizuoka Univ, Grad Sch Integrated Sci & Technol, Dept Math & Syst Engn, Hamamatsu, Shizuoka, Japan.	morita.satoru@shizuoka.ac.jp		Ito, Hiromu/0000-0001-9350-0546	Japan Society for the Promotion of Science (JP); Foundation for Promotion of Material Science and Technology of Japan (JP); Japan Prize Foundation; Pfizer Health Research Foundation (JP) Core Research for Evolutional Science and Technology	Japan Society for the Promotion of Science (JP); Foundation for Promotion of Material Science and Technology of Japan (JP); Japan Prize Foundation(Japan Prize Foundation); Pfizer Health Research Foundation (JP) Core Research for Evolutional Science and Technology	Japan Society for the Promotion of Science (JP), Foundation for Promotion of Material Science and Technology of Japan (JP), Japan Prize Foundation, Pfizer Health Research Foundation (JP) Core Research for Evolutional Science and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alstott J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085777; ANDERSON R M, 1991; Aral SO, 2002, SEX TRANSM INFECT, V78, pI3, DOI 10.1136/sti.78.suppl_1.i3; Buchanan EA, 2009, J EMPIR RES HUM RES, V4, P37, DOI 10.1525/jer.2009.4.2.37; Clauset A, 2007, J CONFLICT RESOLUT, V51, P58, DOI 10.1177/0022002706296157; Clauset A, 2009, SIAM REV, V51, P661, DOI 10.1137/070710111; Cook C, 2000, EDUC PSYCHOL MEAS, V60, P821, DOI 10.1177/00131640021970934; Couper MP, 2007, AM J PREV MED, V32, pS83, DOI 10.1016/j.amepre.2007.01.017; Couper MP, 2008, PUBLIC OPIN QUART, V72, P831, DOI 10.1093/poq/nfn066; Couper MP, 2000, PUBLIC OPIN QUART, V64, P464, DOI 10.1086/318641; Eysenbach G, 2002, J MED INTERNET RES, V4, DOI 10.2196/jmir.4.2.e13; Ezoe S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031184; Hamilton DT, 2008, SEX TRANSM DIS, V35, P30, DOI 10.1097/OLQ.0b013e3181453a84; Handcock MS, 2004, THEOR POPUL BIOL, V65, P413, DOI 10.1016/j.tpb.2003.09.006; Hidaka Y, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-239; Ichikawa S, 2014, RES REPORT HLTH LABO; Ichikawa S, 2011, SEX HEALTH, V8, P123, DOI 10.1071/SH10073; Ito H, 2019, APPL MATH COMPUT, V348, P363, DOI 10.1016/j.amc.2018.12.002; Latora V, 2006, J MED VIROL, V78, P724, DOI 10.1002/jmv.20614; Liljeros F, 2001, NATURE, V411, P907, DOI 10.1038/35082140; Lou J, 2010, J MATH ANAL APPL, V365, P210, DOI 10.1016/j.jmaa.2009.10.044; Ministry of Internal Affairs and Communications, 2018, INF COMM STAT DIS; Mitchell KR, 2019, J SEX RES, V56, P1, DOI 10.1080/00224499.2018.1481193; Pastor-Satorras R, 2001, PHYS REV E, V63, DOI 10.1103/PhysRevE.63.066117; Pastor-Satorras R, 2015, REV MOD PHYS, V87, P925, DOI 10.1103/RevModPhys.87.925; Rhodes SD, 2003, J EPIDEMIOL COMMUN H, V57, P68, DOI 10.1136/jech.57.1.68; Roff DA, 2006, INTRODUCTION TO COMPUTER-INTENSIVE METHODS OF DATA ANALYSIS IN BIOLOGY, P1, DOI 10.2277/ 0521608651; Schneeberger A, 2004, SEX TRANSM DIS, V31, P380, DOI 10.1097/00007435-200406000-00012; Wiederman MW, 1997, J SEX RES, V34, P375, DOI 10.1080/00224499709551905; Zuidgeest M, 2011, J MED INTERNET RES, V13, DOI 10.2196/jmir.1241	30	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2019	14	8							e0221520	10.1371/journal.pone.0221520	http://dx.doi.org/10.1371/journal.pone.0221520			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW5WO	31454371	Green Published, gold			2022-12-26	WOS:000485049000024
J	Zhang, DY; Xu, HP; Qiao, L; Chen, L				Zhang, Dongyin; Xu, Hanping; Qiao, Li; Chen, Lei			LVRT capability enhancement of DFIG based wind turbine with coordination control of dynamic voltage restorer and inductive fault current limiter	PLOS ONE			English	Article							RIDE-THROUGH CAPABILITY; SMOOTHING OUTPUT POWER; PERFORMANCE; GENERATOR; OPERATION; TRACKING; STORAGE; SYSTEM	According to the coordination control of a dynamic voltage restorer (DVR) and an inductive fault current limiter (FCL), this paper proposes an efficient low-voltage ride-through (LVRT) scheme for a doubly fed induction generator (DFIG) based wind turbine. The DVR is located to the DFIG's stator circuit for stabilizing the terminal voltage and decreasing the generator current. The inductive FCL is connected to the DFIG's rotor circuit for suppressing the rotor overcurrent and protecting the converter. Theoretical discussions on structure, principle and scale criterion of the combined DVR-FCL are conducted, and simulation analyses of the proposed approach to handle symmetrical and asymmetrical faults are done in MATLAB/Simulink. In this study, the dynamic characteristics of the DFIG during the faults are analyzed from multiple aspects, and a detailed comparison of the proposed approach and the single action of DVR or FCL is carried out. From the simulation results, the effectiveness and superiority of the proposed approach are well demonstrated.	[Zhang, Dongyin; Xu, Hanping; Qiao, Li] State Grid Hubei Elect Power Co Ltd, Econ Res Inst, Wuhan, Hubei, Peoples R China; [Chen, Lei] Wuhan Univ, Sch Elect Engn & Automat, Wuhan, Hubei, Peoples R China	State Grid Corporation of China; Wuhan University	Chen, L (corresponding author), Wuhan Univ, Sch Elect Engn & Automat, Wuhan, Hubei, Peoples R China.	chen_lei@whu.edu.cn			National Natural Science Foundation of China [51507117]; Fundamental Research Funds for the Central Universities [2042018kf0214]; State Grid Hubei Electric Power Company Limited Economic Research Institute	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); State Grid Hubei Electric Power Company Limited Economic Research Institute	This work was supported by the National Natural Science Foundation of China (51507117), and the Fundamental Research Funds for the Central Universities (2042018kf0214). State Grid Hubei Electric Power Company Limited Economic Research Institute, provided support in the form of salaries for authors DZ, HX, and LQ, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Abad G., 2011, DOUBLY FED INDUCTION; Ajaei FB, 2011, IEEE T POWER DELIVER, V26, P2398, DOI 10.1109/TPWRD.2011.2132808; Amalorpavaraj RAJ, 2017, IEEE ACCESS, V5, P20494, DOI 10.1109/ACCESS.2017.2750738; Chen L, 2019, IEEE T APPL SUPERCON, V29, DOI 10.1109/TASC.2018.2881988; Chen L, 2018, IEEE T APPL SUPERCON, V28, DOI 10.1109/TASC.2017.2775566; Chen L, 2017, IEEE T APPL SUPERCON, V27, DOI 10.1109/TASC.2017.2656624; Chen L, 2015, CAN J ELECT COMPUT E, V38, P132, DOI 10.1109/CJECE.2015.2406665; Chen L, 2015, CAN J ELECT COMPUT E, V38, P10, DOI 10.1109/CJECE.2014.2335195; Chen L, 2015, INT J ELEC POWER, V69, P160, DOI 10.1016/j.ijepes.2015.01.007; Chen L, 2015, IEEE T APPL SUPERCON, V25, DOI 10.1109/TASC.2014.2373511; Chen X, 2018, IEEE T SUSTAIN ENERG, V9, P1265, DOI 10.1109/TSTE.2017.2781287; da Silveira SE, 2018, IET RENEW POWER GEN, V12, P1234, DOI 10.1049/iet-rpg.2017.0804; Du KJ, 2019, IEEE T APPL SUPERCON, V29, DOI 10.1109/TASC.2018.2883797; El-Naggar A, 2017, IET RENEW POWER GEN, V11, P1033, DOI 10.1049/iet-rpg.2016.0372; Firouzi M, 2018, IEEE T SUSTAIN ENERG, V9, P1118, DOI 10.1109/TSTE.2017.2771321; Gayen PK, 2016, ISA T, V62, P333, DOI 10.1016/j.isatra.2016.01.023; Ghafouri M, 2017, IEEE T POWER SYST, V32, P4934, DOI 10.1109/TPWRS.2017.2669260; Guo WY, 2015, IEEE T POWER ELECTR, V30, P3623, DOI 10.1109/TPEL.2014.2340852; Guo WY, 2012, IEEE T ENERGY CONVER, V27, P277, DOI 10.1109/TEC.2012.2187654; Hazari MR, 2018, APPL SCI-BASEL, V8, DOI 10.3390/app8010020; Hossain MM, 2016, IET RENEW POWER GEN, V10, P150, DOI 10.1049/iet-rpg.2015.0150; Huang PH, 2015, IEEE T POWER SYST, V30, P1442, DOI 10.1109/TPWRS.2014.2348175; Huang QJ, 2016, IEEE T POWER ELECTR, V31, P2150, DOI 10.1109/TPEL.2015.2429153; Huchel L, 2015, IEEE T SUSTAIN ENERG, V6, P303, DOI 10.1109/TSTE.2014.2371925; Jerin ARA, 2018, IET RENEW POWER GEN, V12, P1786, DOI 10.1049/iet-rpg.2018.5249; Jin P, 2017, APPL ENERG, V194, P343, DOI 10.1016/j.apenergy.2016.06.075; Li Y, 2019, IEEE T IND ELECTRON, V66, P1565, DOI 10.1109/TIE.2018.2840498; Liao SW, 2017, APPL ENERG, V203, P816, DOI 10.1016/j.apenergy.2017.06.086; Ling Y, 2013, ENERG CONVERS MANAGE, V76, P910, DOI 10.1016/j.enconman.2013.08.050; Liu J, 2020, IEEE T SUSTAIN ENERG, V11, P545, DOI 10.1109/TSTE.2019.2897596; Morren J, 2007, IEEE T ENERGY CONVER, V22, P174, DOI 10.1109/TEC.2006.889615; Naderi SB, 2019, IEEE T IND APPL, V55, P2021, DOI 10.1109/TIA.2018.2877400; Naderi SB, 2017, INT J ELEC POWER, V86, P104, DOI 10.1016/j.ijepes.2016.10.001; Ngamroo Issarachai, 2014, IEEE Transactions on Applied Superconductivity, V24, DOI 10.1109/TASC.2014.2340445; Ngamroo I, 2016, IEEE T APPL SUPERCON, V26, DOI 10.1109/TASC.2016.2592945; Oliveira F, 2016, ENERGIES, V9, DOI 10.3390/en9010016; Ou R, 2016, IEEE T APPL SUPERCON, V26, DOI 10.1109/TASC.2016.2574344; Ouyang Jinxin, 2010, Automation of Electric Power Systems, V34, P106; Pannell G, 2013, IEEE T ENERGY CONVER, V28, P535, DOI 10.1109/TEC.2013.2261301; Rahimi M, 2010, IEEE T ENERGY CONVER, V25, P514, DOI 10.1109/TEC.2009.2032169; Rahmann C, 2011, IEEE T POWER SYST, V26, P1555, DOI 10.1109/TPWRS.2010.2093546; Rashid G, 2017, IEEE T ENERGY CONVER, V32, P284, DOI 10.1109/TEC.2016.2603967; Rashid G, 2015, IEEE T ENERGY CONVER, V30, P939, DOI 10.1109/TEC.2015.2400220; Rauf AM, 2015, IEEE T IND ELECTRON, V62, P2683, DOI 10.1109/TIE.2014.2362096; Shi J, 2010, IEEE T APPL SUPERCON, V20, P1360, DOI 10.1109/TASC.2010.2041499; Taher SA, 2018, ENERGY SYST, V9, P899, DOI 10.1007/s12667-017-0252-x; Tohidi S, 2014, ELECTR POW SYST RES, V110, P64, DOI 10.1016/j.epsr.2013.12.018; Wessels C, 2011, IEEE T POWER ELECTR, V26, P807, DOI 10.1109/TPEL.2010.2099133; Xiang DW, 2006, IEEE T ENERGY CONVER, V21, P652, DOI 10.1109/TEC.2006.875783; Xiao XY, 2018, IEEE T APPL SUPERCON, V28, DOI 10.1109/TASC.2018.2802782; Xu Sixuan, 2014, Automation of Electric Power Systems, V38, P68, DOI 10.7500/AEPS201212187; Yang B, 2018, APPL ENERG, V210, P711, DOI 10.1016/j.apenergy.2017.08.027; Yang B, 2017, ENERG CONVERS MANAGE, V133, P427, DOI 10.1016/j.enconman.2016.10.062; Yang LH, 2012, IEEE T POWER SYST, V27, P713, DOI 10.1109/TPWRS.2011.2174387; Zou XD, 2018, IEEE T POWER ELECTR, V33, P7300, DOI 10.1109/TPEL.2018.2799218; Zou Z., 2016, IEEE T APPL SUPERCON, V26; Zou ZC, 2016, IEEE T APPL SUPERCON, V26, DOI 10.1109/TASC.2015.2507129	57	8	8	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2019	14	8							e0221410	10.1371/journal.pone.0221410	http://dx.doi.org/10.1371/journal.pone.0221410			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5WO	31454380	Green Submitted, Green Published, gold			2022-12-26	WOS:000485049000022
J	Nirengi, S; Wakabayashi, H; Matsushita, M; Domichi, M; Suzuki, S; Sukino, S; Suganuma, A; Kawaguchi, Y; Hashimoto, T; Saito, M; Sakane, N				Nirengi, Shinsuke; Wakabayashi, Hitoshi; Matsushita, Mami; Domichi, Masayuki; Suzuki, Shinichi; Sukino, Shin; Suganuma, Akiko; Kawaguchi, Yaeko; Hashimoto, Takeshi; Saito, Masayuki; Sakane, Naoki			An optimal condition for the evaluation of human brown adipose tissue by infrared thermography	PLOS ONE			English	Article							TEMPERATURE; SENSATIONS; PET/CT	Brown adipose tissue (BAT) is responsible for non-shivering thermogenesis and is an attractive therapeutic target for combating obesity and related diseases. Human BAT activity has been evaluated by 18 F-fluorodeoxyglucose-positron emission tomography/computed tomography (18 FDG-PET/CT) under acute cold exposure, but the method has some serious limitations, including radiation exposure. Infrared thermography (IRT) may be a simple and less-invasive alternative to evaluate BAT activity. In the present study, to establish an optimal condition for IRT, using a thermal imaging camera, skin temperature was measured in the supraclavicular region close to BAT depots (T-scv) and the control chest region (T-c) in 24 young healthy volunteers. Their BAT activity was assessed as the maximal standardized uptake value (SUVmax) by (18)FDG-PET/CT. Under a warm condition at 24-27 degrees C, no significant correlation was found between the IRT parameters (T-scv, T-c,T-, and the difference between T-scv and T-c,T-, Delta temp) and SUVmax, but 30-120 min after cold exposure at 19 degrees C, T-scv and Delta temp were significantly correlated with SUVmax (r = 0.40-0.48 and r = 0.68-0.76) Delta temp after cold exposure was not affected by mean body temperature, body fatness, and skin blood flow. A lower correlation (r = 0.43) of Delta temp with SUVmax was also obtained when the participant's hands were immersed in water at 18 degrees C for 5 min. Receiver operating characteristic analysis revealed that Delta temp after 30-60 min cold exposure can be used as an index for BAT evaluation with 74% sensitivity, 92% specificity, and 79% diagnostic accuracy. Thus, IRT may be useful as a simple and less-invasive method for evaluating BAT, particularly for large-scale screening and longitudinal repeat studies.	[Nirengi, Shinsuke; Domichi, Masayuki; Sukino, Shin; Suganuma, Akiko; Kawaguchi, Yaeko; Sakane, Naoki] Kyoto Med Ctr, Natl Hosp Org, Clin Res Inst, Div Prevent Med, Kyoto, Japan; [Wakabayashi, Hitoshi; Suzuki, Shinichi] Hokkaido Univ, Lab Environm Ergon, Fac Engn, Sapporo, Hokkaido, Japan; [Matsushita, Mami] Tenshi Coll, Dept Nutr, Sapporo, Hokkaido, Japan; [Hashimoto, Takeshi] D Eyes Inc, Osaka, Japan; [Saito, Masayuki] Hokkaido Univ, Sapporo, Hokkaido, Japan	Hokkaido University; Hokkaido University	Sakane, N (corresponding author), Kyoto Med Ctr, Natl Hosp Org, Clin Res Inst, Div Prevent Med, Kyoto, Japan.	sakane.naoki.zn@mail.hosp.go.jp		Nirengi, Shinsuke/0000-0003-1881-067X	Ministry of Education, Culture, Sports, Science, and Technology of Japan [17J11622, 26291099, 18K11013]; Kao Research Council	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Kao Research Council	This study was supported by Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (17J11622, 26291099, 18K11013) and Kao Research Council for the study of Healthcare Science. D-eyes provided support in the form of salaries for authors TH, but did not have any additional role in the study design, data curation and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Boon MR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098822; Chen KY, 2016, CELL METAB, V24, P210, DOI 10.1016/j.cmet.2016.07.014; Chondronikola M, 2018, J PHYSIOL-LONDON, V596, P363, DOI 10.1113/JP274255; Flynn A, 2015, J AM SOC ECHOCARDIOG, V28, P1247, DOI 10.1016/j.echo.2015.06.014; GAGGE AP, 1967, ENVIRON RES, V1, P1, DOI 10.1016/0013-9351(67)90002-3; Gatidis S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151152; Hardy JD, 1938, J NUTR, V15, P461, DOI 10.1093/jn/15.5.461; Hu HCH, 2014, MAGN RESON IMAGING, V32, P107, DOI 10.1016/j.mri.2013.10.003; Jang C, 2014, PHYSIOL REP, V2, DOI 10.14814/phy2.12167; Kajimura S, 2014, ANNU REV PHYSIOL, V76, P225, DOI 10.1146/annurev-physiol-021113-170252; Kanda Y, 2013, BONE MARROW TRANSPL, V48, P452, DOI 10.1038/bmt.2012.244; Law J, 2018, J NUCL MED, V59, P516, DOI 10.2967/jnumed.117.190546; NIELSEN R, 1990, ERGONOMICS, V33, P221, DOI 10.1080/00140139008927112; Nirengi S, 2016, J BIOMED OPT, V21, DOI 10.1117/1.JBO.21.9.091305; Ang QY, 2017, J PHYSIOL SCI, V67, P395, DOI 10.1007/s12576-016-0472-1; Saito M, 2009, DIABETES, V58, P1526, DOI 10.2337/db09-0530; Sarasniemi JT, 2018, ACTA PHYSIOL, V224, DOI 10.1111/apha.13095; Symonds ME, 2012, J PEDIATR-US, V161, P892, DOI 10.1016/j.jpeds.2012.04.056; van der Lans AAJJ, 2016, J PHYSIOL SCI, V66, P77, DOI 10.1007/s12576-015-0398-z; Wakabayashi H, 2012, INT J BIOMETEOROL, V56, P631, DOI 10.1007/s00484-011-0462-1; Wu ZB, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14101092	21	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2019	14	8							e0220574	10.1371/journal.pone.0220574	http://dx.doi.org/10.1371/journal.pone.0220574			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5UR	31449537	Green Published, gold, Green Submitted			2022-12-26	WOS:000485044000006
J	Pankowski, R; Roclawski, M; Ceynowa, M; Mazurek, T; Ciupik, L; Kierzkowska, A				Pankowski, Rafal; Roclawski, Marek; Ceynowa, Marcin; Mazurek, Tomasz; Ciupik, Lechoslaw; Kierzkowska, Agnieszka			Cadaveric biomechanical testing of torque - to - failure magnitude of Bilateral Apical Vertebral Derotation maneuver in the thoracic spine	PLOS ONE			English	Article							PEDICLE SCREW FIXATION; POSTERIOR TREATMENT; SCOLIOSIS; ROTATION; INSTRUMENTATION	It remains unclear what is the real safe limit of torque magnitude during Bilateral Apical Vertebral Derotation (BAVD) in thoracic curve correction. Up to author's knowledge there is no study except this one, to reproduce in-vivo real measurements and intraoperative conditions during BAVD maneuver. The objective of this study was to evaluate the torsional strength of the instrumented thoracic spine under axial rotation moment as well as to define safety limits under BAVD corrective maneuver in scoliosis surgery. 10 fresh, full-length, young and intact human cadavers were tested. After proper assembly of the apparatus, the torque was applied through its apical part, simulating thoracic curve derotation. During each experiment the torque magnitude and angular range of derotation were evaluated. For more accurate analysis after every experiment the examined section of the spine was resected from the cadaver and evaluated morphologically and with a CT scan. The average torque to failure during BAVD simulation was 73,3 +/- 5,49Nm. The average angle of BAVD to failure was 44,5 +/- 8,16 degrees. The majority of failures were in apical area. There was no significant difference between the fracture occurrence of left or right side of lateral wall of the pedicle. There was no spinal canal breach and/or medial wall failure in any specimen. The safety limits of thoracic spine and efficacy of BAVD for axial plane correction in the treatment of Adolescent Idiopathic Scoliosis (AIS) were established. It provided qualitative and quantitative information essential for the spinal derotation under safe loading limits.	[Pankowski, Rafal; Roclawski, Marek; Ceynowa, Marcin; Mazurek, Tomasz] Med Univ Gdansk, Dept Orthopaed, Gdansk, Poland; [Ciupik, Lechoslaw; Kierzkowska, Agnieszka] LfC IBeMT LfC Med IBeMT Inst Bioengn & Med Techno, Zielona Gora, Poland	Fahrenheit Universities; Medical University Gdansk	Roclawski, M (corresponding author), Med Univ Gdansk, Dept Orthopaed, Gdansk, Poland.	marrocla80@gmail.com						ANDRIACCHI T, 1974, J BIOMECH, V7, P497, DOI 10.1016/0021-9290(74)90084-0; Borkowski SL., 2016, SPINE DEFORM, V4, P85, DOI [10.1016/J.JSPD.2015.09.044, DOI 10.1016/J.JSPD.2015.09.044]; Chang MS, 2009, OPER TECH ORTHOP, V19, P19, DOI 10.1053/j.oto.2009.04.001; Cheng I, 2010, SPINE, V35, P1039, DOI 10.1097/BRS.0b013e3181d85ec8; Cobb J. R., 1948, OUTLINE STUDY SCOLIO, P261; Deviren V, 2005, SPINE, V30, P2530, DOI 10.1097/01.brs.0000186590.45675.ce; Di Silvestre M, 2013, EUR SPINE J, V22, P313, DOI 10.1007/s00586-012-2372-2; Hoernschemeyer Daniel G, 2012, Am J Orthop (Belle Mead NJ), V41, P41; Lee SM, 2004, SPINE, V29, P343, DOI 10.1097/01.BRS.0000109991.88149.19; NASH CL, 1969, J BONE JOINT SURG AM, VA 51, P223, DOI 10.2106/00004623-196951020-00002; Pankowski R, 2015, CHIR NARZADOW RUCHU, V80, P207; Pankowski R, 2016, SPINE, V41, P864, DOI 10.1097/BRS.0000000000001363; Pankowski R, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/460340; Parent S, 2008, SPINE, V33, P1966, DOI 10.1097/BRS.0b013e31817f12a9; PERDRIOLLE R, 1985, SPINE, V10, P785, DOI 10.1097/00007632-198511000-00001; Petit Y, 2004, J BIOMECH, V37, P173, DOI 10.1016/S0021-9290(03)00310-5; Vallespir GP, 2008, SPINE, V33, P1588, DOI 10.1097/BRS.0b013e3181788704; Salmingo R, 2012, CLIN BIOMECH, V27, P545, DOI 10.1016/j.clinbiomech.2012.01.004; Sandhu HK, 2013, J VASC SURG, V57, P1668, DOI 10.1016/j.jvs.2012.10.087; Sangiorgio Sophia N, 2013, Spine Deform, V1, P171, DOI 10.1016/j.jspd.2013.01.006; SCHULTZ AB, 1991, SPINE, V16, P1211, DOI 10.1097/00007632-199110000-00014; Sucato DJ, 2003, J BONE JOINT SURG AM, V85A, P1461, DOI 10.2106/00004623-200308000-00006; Sun L, 2013, BMC MUSCULOSKEL DIS, V14, DOI 10.1186/1471-2474-14-175; Theruvath A.S., 2012, KERALA J ORTHOP, V25, P73; Wagner MR, 2011, SPINE, V36, P243, DOI 10.1097/BRS.0b013e31820107d0; White AA, 1990, CLIN BIOMECHANICS SP, P105; Yilmaz G, 2012, J PEDIATR ORTHOPED, V32, P490, DOI 10.1097/BPO.0b013e318250c629; ZINDRICK MR, 1986, CLIN ORTHOP RELAT R, P99	28	2	2	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2019	14	8							e0221494	10.1371/journal.pone.0221494	http://dx.doi.org/10.1371/journal.pone.0221494			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5UR	31449561	gold, Green Published, Green Submitted			2022-12-26	WOS:000485044000021
J	Abdulmalek, SA; Balbaa, M				Abdulmalek, Shaymaa A.; Balbaa, Mahmoud			Synergistic effect of nano-selenium and metformin on type 2 diabetic rat model: Diabetic complications alleviation through insulin sensitivity, oxidative mediators and inflammatory markers	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; IN-VITRO ANTIOXIDANT; PLASMA SELENIUM; PROTECTIVE ROLE; ORAL DELIVERY; NANOPARTICLES; PROTEIN; OBESE; RESISTANCE; GLUTATHIONE	Background and objectives In the present article, we explore a novel strategy of selenium nanoparticles (Se-NPs) for the treatment of type 2 diabetes mellitus (T2DM) by investigating the effect of Se-NPs alone and in combination with standard anti-diabetic drug metformin (MET) in high-fat diet/streptozotocin (HFD/STZ)-induced T2DM. Methods HFD was supplemented daily to experimental rats for 8 weeks, followed by a single low dose injection of 35 mg/kg of STZ to induce T2DM. The synergistic effect of the different therapeutic strategies on diabetic complications was evaluated after the Se-NPs and MET administration for 8 weeks. Molecular and biochemical analyses were conducted to figure out the effectiveness of our treatment on insulin sensitivity, oxidative mediators and inflammatory markers. Results Our observations demonstrated that HFD/STZ-induced rats have a toxic effect on serum and hepatic tissues resulted in inducing remarkable oxidative damage and hyper-inflammation with a significant disturbance in the insulin signaling pathway. Experimental animals either treated with mono-therapeutic-two doses Se-NPs (0.1 and 0.4 mg/kg) and/or MET (100 mg/kg) alone as well as the combined therapy resulted in a remarkable protective antidiabetic effect illustrated by significant decreases in fasting blood glucose and insulin levels after 8 weeks treatment. At the same time, the levels of active insulin signaling proteins pIRS1/pAKT/pGSK-3 beta/pAMPK were significantly improved. Moreover, Se-NPs exhibited an anti-inflammatory effect by the mitigation of cytokine expression and a balance between oxidative stress and antioxidant status was restored. Furthermore, the anti-diabetic drug MET administration also exhibited a significant improvement in diabetic complications after the treatment period. Conclusion This study provides mightily the mechanism of action of combined Se-NPs and MET as a promising therapeutic alternative that synergistically alleviates most of diabetic complications and insulin resistance.	[Abdulmalek, Shaymaa A.; Balbaa, Mahmoud] Alexandria Univ, Fac Sci, Dept Biochem, Alexandria, Egypt	Egyptian Knowledge Bank (EKB); Alexandria University	Balbaa, M (corresponding author), Alexandria Univ, Fac Sci, Dept Biochem, Alexandria, Egypt.	mahmoud.balbaa@alexu.edu.eg	Abdulmalek, Shaymaa/AAY-7600-2021; Balbaa, Mahmoud/H-3572-2019	Balbaa, Mahmoud/0000-0002-0876-6604				AEBI H, 1984, METHOD ENZYMOL, V105, P121; Ahmed HH, 2017, BIOL TRACE ELEM RES, V177, P267, DOI 10.1007/s12011-016-0876-z; Akbaraly TN, 2010, NUTR METAB, V7, DOI 10.1186/1743-7075-7-21; Al-Quraishy S, 2015, INT J NANOMED, V10, P6741, DOI 10.2147/IJN.S91377; Andrews M, 2012, REV MED CHILE, V140, P1377, DOI 10.4067/S0034-98872012001100001; Bai Y, 2008, MATER LETT, V62, P2311, DOI 10.1016/j.matlet.2007.11.098; Balbaa M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172429; Balbaa M, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/2492107; Beisswenger P., 2003, Diabetes & Metabolism, V29, p6S95; Bryant NJ, 2002, NAT REV MOL CELL BIO, V3, P267, DOI 10.1038/nrm782; BURNETTE WN, 1981, ANAL BIOCHEM, V112, P195, DOI 10.1016/0003-2697(81)90281-5; Chung E, 2019, J NUTR BIOCHEM, V67, P36, DOI 10.1016/j.jnutbio.2019.01.021; Cruz KJC, 2014, BIOL TRACE ELEM RES, V160, P305, DOI 10.1007/s12011-014-0044-2; Coughlan Kimberly A, 2013, J Endocrinol Diabetes Obes, V1, P1008; Dasgupta A, 2014, ANTIOXIDANTS IN FOOD, VITAMINS AND SUPPLEMENTS: PREVENTION AND TREATMENT OF DISEASE, P277, DOI 10.1016/B978-0-12-405872-9.00015-X; DEFRONZO RA, 1991, J CLIN ENDOCR METAB, V73, P1294, DOI 10.1210/jcem-73-6-1294; Deng WJ, 2019, ACTA PHARM SIN B, V9, P74, DOI 10.1016/j.apsb.2018.09.009; Deng WJ, 2017, NANOMED-NANOTECHNOL, V13, P1965, DOI 10.1016/j.nano.2017.05.002; Dkhil MA, 2014, FOOD CHEM TOXICOL, V74, P98, DOI 10.1016/j.fct.2014.09.013; Emanuelli B, 2001, J BIOL CHEM, V276, P47944, DOI 10.1074/jbc.M104602200; Eskander EF, 2000, ARAB J LAB MED, V26, P185; Festa A, 2002, DIABETES, V51, P1131, DOI 10.2337/diabetes.51.4.1131; Feve B, 2009, NAT REV ENDOCRINOL, V5, P305, DOI 10.1038/nrendo.2009.62; Galan-Chilet I, 2017, REDOX BIOL, V12, P798, DOI 10.1016/j.redox.2017.04.022; Gao XY, 2002, ADV MATER, V14, P290, DOI 10.1002/1521-4095(20020219)14:4<290::AID-ADMA290>3.3.CO;2-L; Garabadu D, 2017, PHARM BIOL, V55, P72; Garabadu D, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/693074; Guan BZ, 2018, INT J NANOMED, V13, P7473, DOI 10.2147/IJN.S181343; Gulcin I, 2003, J PINEAL RES, V34, P278; HABIG WH, 1974, J BIOL CHEM, V249, P7130; Hirosumi J, 2002, NATURE, V420, P333, DOI 10.1038/nature01137; Horike N, 2008, J BIOL CHEM, V283, P33902, DOI 10.1074/jbc.M802537200; Ilahi Ikram, 2012, ISRN Pharmacol, V2012, P478023, DOI 10.5402/2012/478023; Jiang CH, 2015, J ETHNOPHARMACOL, V176, P17, DOI 10.1016/j.jep.2015.10.006; JOLLOW DJ, 1974, PHARMACOLOGY, V11, P151, DOI 10.1159/000136485; Jozanov-Stankov Olga, 1998, Journal of Environmental Pathology Toxicology and Oncology, V17, P251; Kim J, 2014, J BIOL CHEM, V289, P23246, DOI 10.1074/jbc.M114.577908; Koning E.J., 2008, TRENDS PHARMACOL SCI, V29, P218, DOI DOI 10.1016/J.TIPS.2008.02.001; Li Q, 2010, MATER LETT, V64, P614, DOI 10.1016/j.matlet.2009.12.019; Liao CD, 2010, FOOD CHEM, V119, P896, DOI 10.1016/j.foodchem.2009.07.056; Lin PP, 2013, INT J MOL MED, V32, P1319, DOI 10.3892/ijmm.2013.1524; Lin Y, 2018, ROY SOC OPEN SCI, V5, DOI 10.1098/rsos.181156; LITWACK G, 1953, J BIOL CHEM, V200, P303; Liu YT, 2018, INT J BIOL MACROMOL, V114, P632, DOI 10.1016/j.ijbiomac.2018.03.161; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loeschner K, 2014, METALLOMICS, V6, P330, DOI 10.1039/c3mt00309d; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Lund S, 2006, J NEUROIMMUNOL, V180, P71, DOI 10.1016/j.jneuroim.2006.07.007; Maiti Soumyajit, 2013, J Nat Sci Biol Med, V4, P68, DOI 10.4103/0976-9668.107263; Mannervik B, 2001, Curr Protoc Toxicol, VChapter 7, DOI 10.1002/0471140856.tx0702s00; Maritim AC, 2003, J BIOCHEM MOL TOXIC, V17, P24, DOI 10.1002/jbt.10058; MARKLUND S, 1974, EUR J BIOCHEM, V47, P469; Matough Fatmah A, 2012, Sultan Qaboos Univ Med J, V12, P5; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Mercuri F, 2000, Diabetes Technol Ther, V2, P589, DOI 10.1089/15209150050502014; Miroliaee AE, 2011, TOXICOL MECH METHOD, V21, P200, DOI 10.3109/15376516.2010.547887; Mohapatra P, 2014, INT J PHARMACOL, V10, P160, DOI 10.3923/ijp.2014.160.167; MONTGOMERY H, 1961, ANALYST, V86, P414; Nabi SA, 2013, BMC COMPLEM ALTERN M, V13, DOI 10.1186/1472-6882-13-37; PAGLIA DE, 1967, J LAB CLIN MED, V70, P158; Park K, 2012, DIABETES CARE, V35, P1544, DOI 10.2337/dc11-2136; Patel R.M., 2011, J ADV PHARM ED RES, V1, P52; Rahman AH, 2011, INT J PHARM SCI RES, V2, P1830, DOI 10.13040/IJPSR.0975-8232.2(7).1829-35; REESE JA, 1981, IN VITRO CELL DEV B, V17, P935; Ruan H, 2002, DIABETES, V51, P1319, DOI 10.2337/diabetes.51.5.1319; Salminen A, 2011, J MOL MED, V89, P667, DOI 10.1007/s00109-011-0748-0; Shen Ling, 2012, J Vis Exp, DOI 10.3791/3917; Sreejayan, 1997, J PHARM PHARMACOL, V49, P105, DOI 10.1111/j.2042-7158.1997.tb06761.x; STAMLER JS, 1992, SCIENCE, V258, P1898, DOI 10.1126/science.1281928; Steinbrenner H, 2013, FREE RADICAL BIO MED, V65, P1538, DOI 10.1016/j.freeradbiomed.2013.07.016; Sunil C, 2012, FOOD CHEM TOXICOL, V50, P1547, DOI 10.1016/j.fct.2012.01.029; TAPPEL A. L., 1959, ARCH BIOCHEM AND BIOPHYS, V80, P326, DOI 10.1016/0003-9861(59)90258-9; Tzatsos A, 2007, J BIOL CHEM, V282, P18069, DOI 10.1074/jbc.M610101200; Umamaheswari M, 2008, AFR J TRADIT COMPLEM, V5, P61; Wang JG, 2014, FOOD CHEM TOXICOL, V68, P183, DOI 10.1016/j.fct.2014.03.003; Wang L, 2019, FOOD FUNCT, V10, P539, DOI [10.1039/C8FO01958D, 10.1039/c8fo01958d]; Yildirim A, 2001, J AGR FOOD CHEM, V49, P4083, DOI 10.1021/jf0103572; Zeng SQ, 2018, COLLOID SURFACE B, V170, P115, DOI 10.1016/j.colsurfb.2018.06.003; Zhang JS, 2001, BIOFACTORS, V15, P27, DOI 10.1002/biof.5520150103; Zhu CH, 2017, J NANOBIOTECHNOL, V15, DOI 10.1186/s12951-017-0252-y	80	30	30	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2019	14	8							e0220779	10.1371/journal.pone.0220779	http://dx.doi.org/10.1371/journal.pone.0220779			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5TR	31442295	Green Submitted, Green Published, gold			2022-12-26	WOS:000485041400015
J	Ramanathan, M; Vijayan, B				Ramanathan, Mala; Vijayan, Bevin			Covariates of diarrhoea among under-five children in India: Are they level dependent?	PLOS ONE			English	Article							GLOBAL BURDEN; PREVENTION; DISEASE; HEALTH	Program interventions like access to improved water supply, sanitation and hygiene do not have a systematic response to the aggregate health outcomes. Therefore, this is an attempt at recognising the concept of level sensitivity while verifying the association between prevalence of diarrhoea in under-five children in a district and its corresponding coverage of improved water supply and sanitation and hygiene. Information obtained in the DLHS-4 including 275 districts from 19 states and 2 union territories of India forms the database for this analysis. Universal access to safe drinking water, improving coverage of sanitation in a district beyond 71 percent across the country and beyond 78 percent among the non-south DLHS districts, has the potential to realise reductions in the prevalence of diarrhoea in under-five children in a district. The effect of improved sanitation seems to work synergistically with these indicators only at better levels of prevalence of diarrhoea in under-five children in a district. This offers lessons for the Clean India Mission in terms of universalising access to safe water and coverage up to three-fourths of households with sanitation in a district for the positive externalities to manifest in reduced prevalence of diarrhoea in under-five children.	[Ramanathan, Mala; Vijayan, Bevin] Sree Chitra Tirunal Inst Med Sci & Technol, Achutha Menon Ctr Hlth Sci Studies, Trivandrum, Kerala, India	Department of Science & Technology (India); Sree Chitra Tirunal Institute for Medical Sciences Technology (SCTIMST)	Ramanathan, M (corresponding author), Sree Chitra Tirunal Inst Med Sci & Technol, Achutha Menon Ctr Hlth Sci Studies, Trivandrum, Kerala, India.	mala@sctimst.ac.in	Ramanathan, Mala/AAI-7031-2020; Vijayan, Bevin/AAT-7953-2021	Vijayan, Bevin/0000-0001-5674-6563; Ramanathan, Mala/0000-0003-0625-109X				[Anonymous], R LANG ENV STAT COMP, DOI DOI 10.1080/02705060.2017.1422558; Bartram J, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000367; Fewtrell L, 2005, LANCET INFECT DIS, V5, P42, DOI 10.1016/S1473-3099(04)01253-8; Government of India, 2014, DISTR LEV HOUS FAC S; Kahn G, 2012, INDIAN PEDIATR, V49, P467, DOI 10.1007/s13312-012-0076-7; Keusch GT, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P371; Lodha R, 2012, INDIAN PEDIATR, V49, P441; Lumley T, 2002, ANNU REV PUBL HEALTH, V23, P151, DOI 10.1146/annurev.publhealth.23.100901.140546; Ministry of Drinking Water and Sanitation Guidelines for Swachh Bharat Mission (Gramin), 2017, GUID SWACHH BHAR MIS; Mishra US, 2006, APPL ECON LETT, V13, P519, DOI 10.1080/13504850500400413; Mishra US, 2016, EVAL PROGRAM PLANN, V58, P70, DOI 10.1016/j.evalprogplan.2016.04.002; Nathan HSK, 2017, J INT DEV, V29, P520, DOI 10.1002/jid.2898; National Sample Survey Organisation, 2012, KEY IND DRINK WAT SA; Nilima,, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-6213-z; Paul S, 1996, APPL ECON LETT, V3, P677, DOI 10.1080/135048596355925; Progress of the Seasons, 2017, HAWTH VALL FARMSC EC; Schmidt AF, 2018, J CLIN EPIDEMIOL, V98, P146, DOI 10.1016/j.jclinepi.2017.12.006; SPSS Inc, 2008, IBM SPSS STAT WIND V; Troeger C, 2017, LANCET INFECT DIS, V17, P909, DOI 10.1016/S1473-3099(17)30276-1; Unicef, 2010, DIARRH WHY CHILDR AR; United Nations Children's Fund (UNICEF), 2012, PNEUM DIARRH TACKL D; Walker CLF, 2013, LANCET, V381, P1405, DOI 10.1016/S0140-6736(13)60222-6; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1	23	3	3	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2019	14	8							e0221200	10.1371/journal.pone.0221200	http://dx.doi.org/10.1371/journal.pone.0221200			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW5QN	31433822	Green Submitted, gold, Green Published			2022-12-26	WOS:000485033100020
J	Timaner, M; Kotsofruk, R; Raviv, Z; Magidey, K; Shechter, D; Kan, T; Nevelsky, A; Daniel, S; de Vries, EGE; Zhang, TW; Kaidar-Person, O; Kerbel, RS; Shaked, Y				Timaner, Michael; Kotsofruk, Ruslana; Raviv, Ziv; Magidey, Ksenia; Shechter, Dvir; Kan, Tal; Nevelsky, Alexander; Daniel, Shahar; de Vries, Elisabeth G. E.; Zhang, Tongwu; Kaidar-Person, Orit; Kerbel, Robert S.; Shaked, Yuval			Microparticles from tumors exposed to radiation promote immune evasion in part by PD-L1	ONCOGENE			English	Article							CANCER-THERAPY; RADIOTHERAPY; CELLS; MECHANISMS; EXPRESSION; MEDIATORS; RESPONSES; ASSAY; MICROENVIRONMENT; MICROVESICLES	Radiotherapy induces immune-related responses in cancer patients by various mechanisms. Here, we investigate the immunomodulatory role of tumor-derived microparticles (TMPs)-extracellular vesicles shed from tumor cells-following radiotherapy. We demonstrate that breast carcinoma cells exposed to radiation shed TMPs containing elevated levels of immune-modulating proteins, one of which is programmed death-ligand 1 (PD-L1). These TMPs inhibit cytotoxic T lymphocyte (CTL) activity both in vitro and in vivo, and thus promote tumor growth. Evidently, adoptive transfer of CTLs pre-cultured with TMPs from irradiated breast carcinoma cells increases tumor growth rates in mice recipients in comparison with control mice receiving CTLs pre-cultured with TMPs from untreated tumor cells. In addition, blocking the PD-1-PD-L1 axis, either genetically or pharmacologically, partially alleviates TMP-mediated inhibition of CTL activity, suggesting that the immunomodulatory effects of TMPs in response to radiotherapy is mediated, in part, by PD-L1. Overall, our findings provide mechanistic insights into the tumor immune surveillance state in response to radiotherapy and suggest a therapeutic synergy between radiotherapy and immune checkpoint inhibitors.	[Timaner, Michael; Kotsofruk, Ruslana; Raviv, Ziv; Magidey, Ksenia; Shechter, Dvir; Kan, Tal; Shaked, Yuval] Technion, Cell Biol & Canc Sci, Rappaport Fac Med, Haifa, Israel; [Nevelsky, Alexander; Daniel, Shahar; Kaidar-Person, Orit] Rambam Hlth Care Campus, Radiat Oncol Unit, Oncol Inst, Haifa, Israel; [de Vries, Elisabeth G. E.] Univ Groningen, Univ Med Ctr Groningen, Dept Med Oncol, Groningen, Netherlands; [Zhang, Tongwu] NCI, Div Canc Epidemiol & Genet, Integrat Tumor Epidemiol Branch, NIH, Bethesda, MD USA; [Kerbel, Robert S.] Sunnybrook Hlth Sci Ctr, Toronto, ON, Canada	Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Rambam Health Care Campus; University of Groningen; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center	Shaked, Y (corresponding author), Technion, Cell Biol & Canc Sci, Rappaport Fac Med, Haifa, Israel.	yshaked@tx.technion.ac.il		Zhang, Tongwu/0000-0003-2124-2706; Kaidar-Person, Orit/0000-0003-4023-1869; de Vries, Elisabeth/0000-0002-8949-7425	Israel Cancer Research Fund; European Research Council [771112]; Rappaport funds	Israel Cancer Research Fund; European Research Council(European Research Council (ERC)European Commission); Rappaport funds	This study was supported by grants from the Israel Cancer Research Fund supported the Buckstein Family to YS and RSK, the European Research Council (no. 771112) and Rappaport funds to YS.	Ahn GO, 2008, CANCER CELL, V13, P193, DOI 10.1016/j.ccr.2007.11.032; Al-Nedawi K, 2009, CELL CYCLE, V8, P2014, DOI 10.4161/cc.8.13.8988; Barcellos-Hoff MH, 2005, NAT REV CANCER, V5, P867, DOI 10.1038/nrc1735; Barcellos-Hoff MH, 2005, SEMIN CANCER BIOL, V15, P138, DOI 10.1016/j.semcancer.2004.08.010; Barker HE, 2015, NAT REV CANCER, V15, P409, DOI 10.1038/nrc3958; Chen G, 2018, NATURE, V560, P382, DOI 10.1038/s41586-018-0392-8; Cox J, 2014, MOL CELL PROTEOMICS, V13, P2513, DOI 10.1074/mcp.M113.031591; De Palma M, 2013, CANCER CELL, V23, P277, DOI 10.1016/j.ccr.2013.02.013; Deng LF, 2014, J CLIN INVEST, V124, P687, DOI 10.1172/JCI67313; Dovedi SJ, 2014, CANCER RES, V74, P5458, DOI 10.1158/0008-5472.CAN-14-1258; EHLERS G, 1973, BRIT J RADIOL, V46, P220, DOI 10.1259/0007-1285-46-543-220; Formenti SC, 2009, LANCET ONCOL, V10, P718, DOI 10.1016/S1470-2045(09)70082-8; Fremder E, 2014, INT J CANCER, V135, P270, DOI 10.1002/ijc.28678; FU YX, 1990, CANCER RES, V50, P227; GENOVESI EV, 1984, CANCER RES, V44, P1489; Hutchinson Lisa, 2011, Nat Rev Clin Oncol, V8, P508, DOI 10.1038/nrclinonc.2011.112; Issman L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083680; Jaiswal R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061515; Kang J, 2016, J IMMUNOTHER CANCER, V4, DOI 10.1186/s40425-016-0156-7; Keklikoglou I, 2019, NAT CELL BIOL, V21, P190, DOI 10.1038/s41556-018-0256-3; Koller KM, 2017, CANCER BIOL THER, V18, P36, DOI 10.1080/15384047.2016.1264543; Lee TH, 2011, SEMIN IMMUNOPATHOL, V33, P455, DOI 10.1007/s00281-011-0250-3; Ma RH, 2016, ONCOIMMUNOLOGY, V5, DOI 10.1080/2162402X.2015.1118599; Makinde AY, 2016, SEMIN RADIAT ONCOL, V26, P254, DOI 10.1016/j.semradonc.2016.07.001; Matsumura S, 2008, J IMMUNOL, V181, P3099, DOI 10.4049/jimmunol.181.5.3099; Mege D, 2018, METHODS MOL BIOL, V1765, P271, DOI 10.1007/978-1-4939-7765-9_17; Mell LK, 2017, INT J RADIAT ONCOL, V97, P536, DOI 10.1016/j.ijrobp.2016.11.027; Meng YR, 2010, MOL THER, V18, P912, DOI 10.1038/mt.2010.18; Palayoor ST, 2014, MOL CANCER RES, V12, P1002, DOI 10.1158/1541-7786.MCR-13-0623; Pardoll DM, 2012, NAT REV CANCER, V12, P252, DOI 10.1038/nrc3239; Peinado H, 2017, NAT REV CANCER, V17, P302, DOI 10.1038/nrc.2017.6; Peinado H, 2012, NAT MED, V18, P883, DOI 10.1038/nm.2753; Postow MA, 2015, J CLIN ONCOL, V33, P1974, DOI 10.1200/JCO.2014.59.4358; Rak J, 2010, SEMIN THROMB HEMOST, V36, P888, DOI 10.1055/s-0030-1267043; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Reynders K, 2015, PROG TUMOR RES, V42, P67, DOI 10.1159/000437185; Ricklefs FL, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aar2766; Rose B, 2017, PRACT RADIAT ONCOL, V7, pE291, DOI 10.1016/j.prro.2017.03.008; Russell JS, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00157; Shaked Y, 2016, NAT REV CLIN ONCOL, V13, P611, DOI 10.1038/nrclinonc.2016.57; Sharabi AB, 2015, LANCET ONCOL, V16, pE498, DOI 10.1016/S1470-2045(15)00007-8; Sharma P, 2015, CELL, V161, P205, DOI 10.1016/j.cell.2015.03.030; STONE HB, 1979, JNCI-J NATL CANCER I, V63, P1229; Tang K, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2282; Timaner Michael, 2016, Curr Protoc Cell Biol, V70, DOI 10.1002/0471143030.cb1918s70; Timaner M, 2015, ONCOTARGET, V6, P27537, DOI 10.18632/oncotarget.4826; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Tyanova S, 2018, METHODS MOL BIOL, V1711, P133, DOI 10.1007/978-1-4939-7493-1_7; VERMES I, 1995, J IMMUNOL METHODS, V184, P39, DOI 10.1016/0022-1759(95)00072-I; Voloshin T, 2014, CANCER MICROENVIRON, V7, P11, DOI 10.1007/s12307-014-0144-8; Wargo JA, 2015, SEMIN ONCOL, V42, P601, DOI 10.1053/j.seminoncol.2015.05.007; Wersall PJ, 2006, ACTA ONCOL, V45, P493, DOI 10.1080/02841860600604611; WINN HJ, 1961, J IMMUNOL, V86, P228; Wolford CC, 2013, J CLIN INVEST, V123, P2893, DOI 10.1172/JCI64410; Zhao LL, 2016, J EXP CLIN CANC RES, V35, DOI 10.1186/s13046-016-0328-9	55	23	25	2	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN	2020	39	1					187	203		10.1038/s41388-019-0971-7	http://dx.doi.org/10.1038/s41388-019-0971-7			17	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	KG3NM	31467431	Green Published, hybrid, Green Accepted			2022-12-26	WOS:000509849200013
J	Rajabi, H; Hata, T; Li, W; Long, MD; Hu, Q; Liu, S; Raina, D; Kui, L; Yasumizu, Y; Hong, DL; Samur, M; Kufe, D				Rajabi, Hasan; Hata, Tsuyoshi; Li, Wei; Long, Mark D.; Hu, Qiang; Liu, Song; Raina, Deepak; Kui, Ling; Yasumizu, Yota; Hong, Deli; Samur, Mehmet; Kufe, Donald			MUC1-C represses the RASSF1A tumor suppressor in human carcinoma cells	ONCOGENE			English	Article							DNA METHYLATION; IMMUNE EVASION; MST2 PATHWAY; ONCOPROTEIN; RAS; ASSOCIATION; DOMAIN; GENE; TRANSCRIPTION; ACTIVATION	RASSF1A encodes a tumor suppressor that inhibits the RAS -> RAF -> MEK -> ERK pathway and is one of the most frequently inactivated genes in human cancers. MUC1-C is an oncogenic effector of the cancer cell epigenome that is overexpressed in diverse carcinomas. We show here that MUC1-C represses RASSF1A expression in KRAS wild-type and mutant cancer cells. Mechanistically, MUC1-C occupies the RASSF1A promoter in a complex with the ZEB1 transcriptional repressor. In turn, MUC1-C/ZEB1 complexes recruit DNA methyltransferase 3b (DNMT3b) to the CpG island in the RASSF1A promoter. Targeting MUC1-C, ZEB1, and DNMT3b thereby decreases methylation of the CpG island and derepresses RASSF1A transcription. We also show that targeting MUC1-C regulates KRAS signaling, as evidenced by RNA-seq analysis, and decreases MEK/ERK activation, which is of importance for RAS-mediated tumorigenicity. These findings define a previously unrecognized role for MUC1-C in suppression of RASSF1A and support targeting MUC1-C as an approach for inhibiting MEK -> ERK signaling.	[Rajabi, Hasan; Hata, Tsuyoshi; Li, Wei; Raina, Deepak; Kui, Ling; Yasumizu, Yota; Hong, Deli; Samur, Mehmet; Kufe, Donald] Harvard Med Sch, Dana Farber Canc Inst, Boston, MA 02115 USA; [Long, Mark D.; Hu, Qiang; Liu, Song] Roswell Pk Comprehens Canc Ctr, Dept Biostat & Bioinformat, Buffalo, NY USA; [Raina, Deepak] Genus Oncol, Boston, MA USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School	Kufe, D (corresponding author), Harvard Med Sch, Dana Farber Canc Inst, Boston, MA 02115 USA.	donald_kufe@dfci.harvard.edu	wei, li/GSD-3630-2022; Hong, Deli/AAG-2565-2021; Wei, Li/AAE-9938-2020	Li, Wei/0000-0001-6728-1300; Hu, Qiang/0000-0002-4090-5539; Samur, Mehmet/0000-0002-9978-5682; Long, Mark/0000-0003-1120-8176	National Cancer Institute of the National Institutes of Health [CA97098, CA166480, CA216553, CA233084, U24CA232979]; NATIONAL CANCER INSTITUTE [R01CA166480, U01CA233084, R21CA216553, R01CA097098, U24CA232979] Funding Source: NIH RePORTER	National Cancer Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by Grants from the National Cancer Institute of the National Institutes of Health under award numbers CA97098, CA166480, CA216553, CA233084, and U24CA232979.	Agathanggelou A, 2005, CANCER RES, V65, P3497, DOI 10.1158/0008-5472.CAN-04-4088; Ahmad R, 2012, J BIOL CHEM, V287, P20866, DOI 10.1074/jbc.M112.357293; Ahmad R, 2009, CANCER RES, V69, P7013, DOI 10.1158/0008-5472.CAN-09-0523; Alam M, 2016, MOL CANCER RES, V14, P1266, DOI 10.1158/1541-7786.MCR-16-0233; Baksh S, 2005, MOL CELL, V18, P637, DOI 10.1016/j.molcel.2005.05.010; Bouillez A, 2016, CANCER RES, V76, P1538, DOI 10.1158/0008-5472.CAN-15-1804; Cox AD, 2014, NAT REV DRUG DISCOV, V13, P828, DOI 10.1038/nrd4389; Cox Adrienne D, 2010, Small GTPases, V1, P2; Dammann R, 2001, CANCER RES, V61, P3105; Dammann R, 2000, NAT GENET, V25, P315, DOI 10.1038/77083; Dammann RH, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18102160; Donninger H, 2007, J CELL SCI, V120, P3163, DOI 10.1242/jcs.010389; Donninger H, 2016, SEMIN CELL DEV BIOL, V58, P86, DOI 10.1016/j.semcdb.2016.06.007; Dubois F, 2016, CANCER RES, V76, P1627, DOI 10.1158/0008-5472.CAN-15-1008; Guo C, 2011, J BIOL CHEM, V286, P6253, DOI 10.1074/jbc.M110.178210; Harvey KF, 2013, NAT REV CANCER, V13, P246, DOI 10.1038/nrc3458; Hiraki M, 2017, ONCOGENE, V36, P2791, DOI 10.1038/onc.2016.439; Huang L, 2005, CANCER RES, V65, P10413, DOI 10.1158/0008-5472.CAN-05-2474; Kazanets A, 2016, BBA-REV CANCER, V1865, P275, DOI 10.1016/j.bbcan.2016.04.001; Kidger AM, 2018, PHARMACOL THERAPEUT, V187, P45, DOI 10.1016/j.pharmthera.2018.02.007; Kok K, 1997, ADV CANCER RES, V71, P27, DOI 10.1016/S0065-230X(08)60096-2; Kufe DW, 2013, ONCOGENE, V32, P1073, DOI 10.1038/onc.2012.158; Kufe DW, 2009, NAT REV CANCER, V9, P874, DOI 10.1038/nrc2761; Li YQ, 2003, ONCOGENE, V22, P6107, DOI 10.1038/sj.onc.1206732; Liberzon A, 2015, CELL SYST, V1, P417, DOI 10.1016/j.cels.2015.12.004; Maeda T, 2018, CANCER RES, V78, P205, DOI 10.1158/0008-5472.CAN-17-1636; Martin-Belmonte F, 2012, NAT REV CANCER, V12, P23, DOI 10.1038/nrc3169; Matallanas D, 2007, MOL CELL, V27, P962, DOI 10.1016/j.molcel.2007.08.008; Matallanas D, 2011, MOL CELL, V44, P893, DOI 10.1016/j.molcel.2011.10.016; O'Neill E, 2004, SCIENCE, V306, P2267, DOI 10.1126/science.1103233; Oh HJ, 2006, CANCER RES, V66, P2562, DOI 10.1158/0008-5472.CAN-05-2951; Palakurthy RK, 2009, MOL CELL, V36, P219, DOI 10.1016/j.molcel.2009.10.009; Panchamoorthy G, 2011, HYBRIDOMA, V30, P531, DOI 10.1089/hyb.2011.0070; PANDEY P, 1995, CANCER RES, V55, P4000; Papaspyropoulos A, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02786-5; Raina D, 2004, J BIOL CHEM, V279, P20607, DOI 10.1074/jbc.M310538200; Rajabi H, 2016, ONCOGENE, V35, P6439, DOI 10.1038/onc.2016.180; Rajabi H, 2014, ONCOGENE, V33, P1680, DOI 10.1038/onc.2013.114; Rajabi H, 2018, ONCOGENE, V37, P2079, DOI 10.1038/s41388-017-0096-9; Rajabi H, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07850-0; Rajabi H, 2017, BBA-REV CANCER, V1868, P117, DOI 10.1016/j.bbcan.2017.03.003; Rajabi H, 2012, J BIOL CHEM, V287, P10703, DOI 10.1074/jbc.M111.323311; Ram RR, 2014, MOL CELL BIOL, V34, P2350, DOI 10.1128/MCB.01506-13; Richter AM, 2009, BBA-REV CANCER, V1796, P114, DOI 10.1016/j.bbcan.2009.03.004; Romano D, 2014, NAT CELL BIOL, V16, P673, DOI 10.1038/ncb2986; Schmidt ML, 2018, CANCER RES, V78, P2614, DOI 10.1158/0008-5472.CAN-17-2466; Sekido Y, 1998, ONCOGENE, V16, P3151, DOI 10.1038/sj.onc.1201858; Strunnikova M, 2005, MOL CELL BIOL, V25, P3923, DOI 10.1128/MCB.25.10.3923-3933.2005; Tagde A, 2016, ONCOTARGET, V7, P38974, DOI 10.18632/oncotarget.9777; Takahashi H, 2015, ONCOGENE, V34, P5187, DOI 10.1038/onc.2014.442; Teng IW, 2011, CANCER RES, V71, P4653, DOI 10.1158/0008-5472.CAN-10-3418; Thaler S, 2009, CANCER RES, V69, P1748, DOI 10.1158/0008-5472.CAN-08-1377; Tolcher AW, 2018, MOL CANCER THER, V17, P3, DOI 10.1158/1535-7163.MCT-17-0349; van der Weyden L, 2007, BBA-REV CANCER, V1776, P58, DOI 10.1016/j.bbcan.2007.06.003; Vaseva AV, 2018, CANCER CELL, V34, P807, DOI 10.1016/j.ccell.2018.10.001; Vlahov N, 2015, CURR BIOL, V25, P3019, DOI 10.1016/j.cub.2015.09.072; Vos MD, 2006, J BIOL CHEM, V281, P4557, DOI 10.1074/jbc.M512128200; Vos MD, 2000, J BIOL CHEM, V275, P35669, DOI 10.1074/jbc.C000463200; Wei XL, 2005, CANCER CELL, V7, P167, DOI 10.1016/j.ccr.2005.01.008; Yamamoto M, 1997, J BIOL CHEM, V272, P12492, DOI 10.1074/jbc.272.19.12492; Zhou C, 2017, ONCOTARGET, V8, P54388, DOI 10.18632/oncotarget.17077; Zhou CX, 2017, ONCOTARGET, V8, P49534, DOI 10.18632/oncotarget.17743	62	12	12	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV 21	2019	38	47					7266	7277		10.1038/s41388-019-0940-1	http://dx.doi.org/10.1038/s41388-019-0940-1			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	JP0UL	31435022	hybrid, Green Accepted			2022-12-26	WOS:000497989400006
J	Zhang, P; Li, T; Liu, YQ; Zhang, H; Xue, SM; Li, G; Cheng, HYM; Cao, JM				Zhang, Peng; Li, Tao; Liu, Ya-Qin; Zhang, Hao; Xue, Si-Meng; Li, Guang; Cheng, Hai-Ying Mary; Cao, Ji-Min			Contribution of DNA methylation in chronic stress-induced cardiac remodeling and arrhythmias in mice	FASEB JOURNAL			English	Article						chronic restraint stress; cardiovascular diseases; reduced representation bisulfite sequencing	CHRONIC RESTRAINT STRESS; PARAVENTRICULAR NUCLEUS; DEPRESSIVE SYMPTOMS; HEART-FAILURE; ANXIETY; EXPRESSION; BEHAVIORS; DISEASE; METAANALYSIS; DYSFUNCTION	It is recognized that stress can induce cardiac dysfunction, but the underlying mechanisms are not well understood. The present study aimed to test the hypothesis that chronic negative stress leads to alterations in DNA methylation of certain cardiac genes, which in turn contribute to pathologic remodeling of the heart. We found that mice that were exposed to chronic restraint stress (CRS) for 4 wk exhibited cardiac remodeling toward heart failure, as characterized by ventricular chamber dilatation, wall thinning, and decreased contractility. CRS also induced cardiac arrhythmias, including intermittent sinus tachycardia and bradycardia, frequent premature ventricular contraction, and sporadic atrioventricular conduction block. Circulating levels of stress hormones were elevated, and the cardiac expression of tyrosine hydroxylase, a marker of sympathetic innervation, was increased in CRS mice. Using reduced representation bisulfite sequencing, we found that although CRS did not lead to global changes in DNA methylation in the murine heart, it nevertheless altered methylation at specific genes that are associated with the dilated cardiomyopathy (DCM) (e.g., desmin) and adrenergic signaling of cardiomyocytes (ASPC) (e.g., adrenergic receptor-al) pathways. We conclude that CRS induces cardiac remodeling and arrhythmias, potentially through altered methylation of myocardial genes associated with the DCM and ASPC pathways.	[Zhang, Peng; Li, Tao; Liu, Ya-Qin; Zhang, Hao; Xue, Si-Meng; Li, Guang; Cao, Ji-Min] Southwest Med Univ, Med Electrophysiol Key Lab Sichuan Prov, Minist Educ, Inst Cardiovasc Res,Key Lab Med Electrophysiol, Luzhou, Peoples R China; [Zhang, Peng; Li, Tao; Liu, Ya-Qin; Xue, Si-Meng; Cao, Ji-Min] Southwest Med Univ, Collaborat Innovat Ctr Prevent & Treatment Cardio, Luzhou, Peoples R China; [Cheng, Hai-Ying Mary] Univ Toronto Mississauga, Dept Biol, Mississauga, ON, Canada; [Cao, Ji-Min] Shanxi Med Univ, Dept Physiol, Key Lab Cellular Physiol, Minist Educ, Taiyuan, Peoples R China	Southwest Medical University; Southwest Medical University; University of Toronto; University Toronto Mississauga; Shanxi Medical University	Zhang, P (corresponding author), Southwest Med Univ, Minist Educ, Key Lab Med Electrophysiol, Inst Cardiovasc Res, Zhongshanlu San Duan 319, Luzhou 646000, Peoples R China.; Zhang, P (corresponding author), Southwest Med Univ, Med Electrophysiol Key Lab Sichuan Prov, Zhongshanlu San Duan 319, Luzhou 646000, Peoples R China.; Cao, JM (corresponding author), Shanxi Med Univ, Minist Educ, Key Lab Cellular Physiol, Taiyuan 030001, Shanxi, Peoples R China.; Cao, JM (corresponding author), Shanxi Med Univ, Dept Physiol, Taiyuan 030001, Shanxi, Peoples R China.	zhangpeng@swmu.edu.cn; caojimin@126.com		Zhang, Peng/0000-0001-9053-7327	Sichuan Science and Technology Program [2019YJ0472, 2019YJ0409]; Luzhou Science and Technology Program [2018LZXNYD-ZK44]; Collaborative Innovation Center for Prevention and Treatment of Cardiovascular Disease of Sichuan Province, Southwest Medical University [xtcx-2016-11]; fund for Shanxi "1331 Project" Key Subjects Construction [1331KSC]; National Natural Science Foundation of China (NSFC) [81670313]; Canadian Institutes of Health Research (CIHR); Natural Sciences and Engineering Research Councils of Canada (NSERC)	Sichuan Science and Technology Program; Luzhou Science and Technology Program; Collaborative Innovation Center for Prevention and Treatment of Cardiovascular Disease of Sichuan Province, Southwest Medical University; fund for Shanxi "1331 Project" Key Subjects Construction; National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Councils of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by the Sichuan Science and Technology Program (2019YJ0472 to P.Z. and 2019YJ0409 to T.L.), the Luzhou Science and Technology Program (2018LZXNYD-ZK44 to P.Z.), the Collaborative Innovation Center for Prevention and Treatment of Cardiovascular Disease of Sichuan Province, Southwest Medical University xtcx-2016-11 to P.Z.), a fund for Shanxi "1331 Project" Key Subjects Construction (1331KSC), and a National Natural Science Foundation of China (NSFC) grant (81670313 to J.-M.C.). H.-Y.M.C. was supported by operating grants from the Canadian Institutes of Health Research (CIHR) and the Natural Sciences and Engineering Research Councils of Canada (NSERC). The authors declare no conflicts of interest.	Akalin A, 2012, GENOME BIOL, V13, DOI [10.1186/gb-2012-13-10-r87, 10.1186/gb-2012-13-10-R87]; BRUHN JG, 1970, AM J PUBLIC HEALTH N, V60, P1477, DOI 10.2105/AJPH.60.8.1477; BRUHN JG, 1969, PSYCHOSOM MED, V31, P8, DOI 10.1097/00006842-196901000-00002; Burgi K, 2011, AM J PHYSIOL-REG I, V300, pR264, DOI 10.1152/ajpregu.00687.2009; Cao JM, 2000, CIRC RES, V86, P816, DOI 10.1161/01.RES.86.7.816; Chatterjee N, 2017, BIOMATERIALS, V115, P167, DOI 10.1016/j.biomaterials.2016.11.005; Chiba S, 2012, PROG NEURO-PSYCHOPH, V39, P112, DOI 10.1016/j.pnpbp.2012.05.018; Christiansen SH, 2011, BEHAV BRAIN RES, V216, P585, DOI 10.1016/j.bbr.2010.08.044; Cotecchia S, 2015, CELL SIGNAL, V27, P1984, DOI 10.1016/j.cellsig.2015.06.009; Flak JN, 2014, EUR J NEUROSCI, V39, P1903, DOI 10.1111/ejn.12587; Frasure-Smith N, 2005, PSYCHOSOM MED, V67, pS19, DOI 10.1097/01.psy.0000162253.07959.db; Gardner RT, 2016, CIRC-ARRHYTHMIA ELEC, V9, DOI 10.1161/CIRCEP.115.001359; Gervin K, 2016, CLIN EPIGENETICS, V8, DOI 10.1186/s13148-016-0277-3; Gottlieb SS, 2009, AM J CARDIOL, V103, P1285, DOI 10.1016/j.amjcard.2009.01.025; Groenen MAM, 2012, NATURE, V491, P393, DOI 10.1038/nature11622; Gu H, 2010, NAT METHODS, V7, P133, DOI 10.1038/nmeth.1414; Guichard JL, 2017, AM J PHYSIOL-HEART C, V313, pH32, DOI 10.1152/ajpheart.00027.2017; Haider S, 2012, GENOME BIOL, V13, DOI [10.1186/gb-2012-13-10-R90, 10.1186/gb-2012-13-10-r90]; Hein S, 2000, CARDIOVASC RES, V45, P273, DOI 10.1016/S0008-6363(99)00268-0; Januzzi JL, 2000, ARCH INTERN MED, V160, P1913, DOI 10.1001/archinte.160.13.1913; Khalid A, 2016, BMC NEUROSCI, V17, DOI 10.1186/s12868-016-0239-x; Kim SY, 2016, CURR OPIN CARDIOL, V31, P255, DOI 10.1097/HCO.0000000000000276; Koczor CA, 2015, TOXICOL SCI, V148, P183, DOI 10.1093/toxsci/kfv170; Kokoz YM, 2016, J MOL CELL CARDIOL, V100, P9, DOI 10.1016/j.yjmcc.2016.09.006; Krueger F, 2011, BIOINFORMATICS, V27, P1571, DOI 10.1093/bioinformatics/btr167; Lapmanee S, 2013, BEHAV BRAIN RES, V250, P316, DOI 10.1016/j.bbr.2013.05.018; Li-Tempel T, 2016, CLIN EPIGENETICS, V8, DOI 10.1186/s13148-016-0180-y; Lin QXX, 2019, NUCLEIC ACIDS RES, V47, pD145, DOI 10.1093/nar/gky1005; Maloyan A, 2009, CIRC RES, V104, P1021, DOI 10.1161/CIRCRESAHA.108.193516; del Campo CMZM, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19041224; Mendonca MM, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00670; Moraska AR, 2013, CIRC-HEART FAIL, V6, P387, DOI 10.1161/CIRCHEARTFAILURE.112.000118; Movassagh M, 2011, CIRCULATION, V124, P2411, DOI 10.1161/CIRCULATIONAHA.111.040071; Movassagh M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008564; Musselman DL, 1998, ARCH GEN PSYCHIAT, V55, P580, DOI 10.1001/archpsyc.55.7.580; Naert G, 2011, MOL CELL NEUROSCI, V46, P55, DOI 10.1016/j.mcn.2010.08.006; Nakatochi M, 2017, CLIN EPIGENETICS, V9, DOI 10.1186/s13148-017-0353-3; Nemeroff CB, 2012, NAT REV CARDIOL, V9, P526, DOI 10.1038/nrcardio.2012.91; Nicholson A, 2006, EUR HEART J, V27, P2763, DOI 10.1093/eurheartj/ehl338; Norman M, 2005, CIRCULATION, V112, P636, DOI 10.1161/CIRCULATIONAHA.104.532234; Osler W, 1910, LANCET, V1, P973; Pan A, 2011, JAMA-J AM MED ASSOC, V306, P1241, DOI 10.1001/jama.2011.1282; Perrino C, 2017, CARDIOVASC RES, V113, P725, DOI 10.1093/cvr/cvx070; PORSOLT RD, 1977, NATURE, V266, P730, DOI 10.1038/266730a0; Powell R C, 1977, Psychiatr Q, V49, P133, DOI 10.1007/BF01071661; Powell R C, 1978, Psychiatr Q, V50, P144, DOI 10.1007/BF01064814; Pyner S, 2014, EXP PHYSIOL, V99, P332, DOI 10.1113/expphysiol.2013.072678; Rosenkranz S, 2004, CARDIOVASC RES, V63, P423, DOI 10.1016/j.cardiores.2004.04.030; Ruo B, 2003, JAMA-J AM MED ASSOC, V290, P215, DOI 10.1001/jama.290.2.215; Salter EW, 2018, J PHYSIOL-LONDON, V596, P4157, DOI 10.1113/JP275669; Sanchez-Gonzalez MA, 2013, AM J HYPERTENS, V26, P1389, DOI 10.1093/ajh/hpt131; Sato M, 2018, BIOCHEM PHARMACOL, V148, P27, DOI 10.1016/j.bcp.2017.11.016; Slavich GM, 2014, PSYCHOL BULL, V140, P774, DOI 10.1037/a0035302; Tsikitis Mary, 2018, Biophys Rev, V10, P1007, DOI 10.1007/s12551-018-0443-2; Vujic A, 2015, J MOL CELL CARDIOL, V82, P174, DOI 10.1016/j.yjmcc.2015.03.007; WEISS E, 1957, ARCH INTERN MED, V99, P628, DOI 10.1001/archinte.1957.00260040128013; Xiao JJ, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00074; Xie YF, 2005, J APPL PHYSIOL, V99, P2416, DOI 10.1152/japplphysiol.00267.2005; Zhang P, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01046-2; Zhao X, 2013, NEUROSCIENCE, V246, P82, DOI 10.1016/j.neuroscience.2013.04.046; Zhu SH, 2014, NEUROREPORT, V25, P1151, DOI 10.1097/WNR.0000000000000243	61	6	7	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2019	33	11					12240	12252		10.1096/fj.201900100R	http://dx.doi.org/10.1096/fj.201900100R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC8ZX	31431066	Green Published			2022-12-26	WOS:000507461600050
J	Zhou, D; Fu, HY; Liu, SJ; Zhang, L; Xiao, LX; Bastacky, SI; Liu, YH				Zhou, Dong; Fu, Haiyan; Liu, Shijia; Zhang, Lu; Xiao, Liangxiang; Bastacky, Sheldon I.; Liu, Youhua			Early activation of fibroblasts is required for kidney repair and regeneration after injury	FASEB JOURNAL			English	Article						acute kidney injury; sonic hedgehog; Wnt-beta-catenin; injury repair	ACUTE-RENAL-FAILURE; GROWTH-FACTOR RECEPTOR; SONIC HEDGEHOG; AKI; PATHOPHYSIOLOGY; FIBROSIS; RECOVERY; CKD; EPIDEMIOLOGY; MECHANISMS	Acute kidney injury (AKI) is a devastating condition with high morbidity and mortality. AKI is characterized by tubular injury, inflammation, and vascular impairment. However, the role of interstitial fibroblasts in the pathogenesis of AKI is largely unknown. Here, we show that fibroblasts were activated, as defined by vimentin expression, at 1 h after AKI triggered by ischemia-reperfusion injury (IRI). They rapidly entered the cell cycle with Ki-67-positive staining, which started at 1 h and peaked at 12 h after IRI, whereas tubular cell proliferation peaked at 3 d. The trigger for such an early activation of fibroblasts was identified as sonic hedgehog (Shh), which was rapidly induced in renal tubules and could target interstitial fibroblasts. Tubule-specific knockout of Shh in mice inhibited fibroblast activation and aggravated kidney injury and functional decline after IRI. Likewise, pharmacologic inhibition of Shh signaling with cyclopamine also hindered fibroblast activation and exacerbated kidney damage. These studies uncover that tubule-derived Shh triggers the early activation of fibroblasts, which is required for kidney repair and regeneration. Our findings for the first time illustrate a previously unrecognized importance of interstitial fibroblasts in conferring renal protection in AKI.	[Zhou, Dong; Bastacky, Sheldon I.; Liu, Youhua] Univ Pittsburgh, Sch Med, Dept Pathol, Pittsburgh, PA USA; [Fu, Haiyan; Xiao, Liangxiang; Liu, Youhua] Southern Med Univ, Nanfang Hosp, Natl Clin Res Ctr Kidney Dis, State Key Lab Organ Failure Res, Guangzhou, Peoples R China; [Liu, Shijia] Nanjing Univ Chinese Med, Dept Clin Pharmacol, Affiliated Hosp, Nanjing, Peoples R China; [Zhang, Lu] Nanjing Univ Chinese Med, Dept Nephrol, Affiliated Hosp, Nanjing, Peoples R China	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Southern Medical University - China; Nanjing University of Chinese Medicine; Nanjing University of Chinese Medicine	Zhou, D (corresponding author), Univ Pittsburgh, Dept Pathol, 200 Lothrop St, Pittsburgh, PA 15261 USA.; Liu, YH (corresponding author), Univ Pittsburgh, Dept Pathol, BST, S-405,200 Lothrop St, Pittsburgh, PA 15261 USA.	zhoudong@pitt.edu; yhliu@pitt.edu	liu, shijia/AAH-3838-2021	Liu, Youhua/0000-0002-4740-805X	U.S. National Institutes of Health (NIH)/National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [DK064005, DK106049]; NIH/NIDDK [1K01DK116816]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK116816, R01DK106049, R01DK064005] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH)/National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIH/NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors are grateful to the Center for Biologic Imaging at the University of Pittsburgh for the use of core facilities. This work was supported by the U.S. National Institutes of Health (NIH)/National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Grants DK064005 and DK106049. D.Z. was supported by NIH/NIDDK Grant 1K01DK116816. The authors declare no conflicts of interest.	Bai CB, 2002, DEVELOPMENT, V129, P4753; Bonventre Joseph V, 2014, Trans Am Clin Climatol Assoc, V125, P293; Bonventre JV, 2011, J CLIN INVEST, V121, P4210, DOI 10.1172/JCI45161; Chen JC, 2013, J AM SOC NEPHROL, V24, P2023, DOI 10.1681/ASN.2013010076; Chen JC, 2012, KIDNEY INT, V82, P45, DOI 10.1038/ki.2012.43; Chen JL, 2011, KIDNEY INT, V79, P288, DOI 10.1038/ki.2010.381; Chiba Takuto, 2015, Curr Pathobiol Rep, V3, P67; Cosentino CC, 2013, J AM SOC NEPHROL, V24, P943, DOI 10.1681/ASN.2012111055; Dai CS, 2002, J AM SOC NEPHROL, V13, P411, DOI 10.1681/ASN.V132411; Dhaun N, 2013, KIDNEY INT, V84, P637, DOI 10.1038/ki.2013.158; Fu HY, 2017, J AM SOC NEPHROL, V28, P785, DOI 10.1681/ASN.2016020165; Fujigaki Y, 2005, VIRCHOWS ARCH, V446, P164, DOI 10.1007/s00428-004-1155-5; Gao GF, 2013, AM J PHYSIOL-RENAL, V304, pF515, DOI 10.1152/ajprenal.00533.2012; Grande MT, 2009, NAT REV NEPHROL, V5, P319, DOI 10.1038/nrneph.2009.74; Humphreys BD, 2016, J AM SOC NEPHROL, V27, P990, DOI 10.1681/ASN.2015030286; Kaddourah A, 2017, NEW ENGL J MED, V376, P11, DOI 10.1056/NEJMoa1611391; Kaissling B, 2008, HISTOCHEM CELL BIOL, V130, P247, DOI 10.1007/s00418-008-0452-5; Kinsey GR, 2014, J AM SOC NEPHROL, V25, P209, DOI 10.1681/ASN.2013101110; Kramann R, 2015, J CLIN INVEST, V125, P2935, DOI 10.1172/JCI74929; Kramann R, 2014, J AM SOC NEPHROL, V25, P1924, DOI 10.1681/ASN.2013101121; Kuzet SE, 2016, CELL TISSUE RES, V365, P607, DOI 10.1007/s00441-016-2467-x; LeBleu VS, 2013, NAT MED, V19, P1047, DOI 10.1038/nm.3218; Lech M, 2014, J AM SOC NEPHROL, V25, P292, DOI 10.1681/ASN.2013020152; Little MH, 2017, J AM SOC NEPHROL, V28, P34, DOI 10.1681/ASN.2016070748; Liu YH, 2011, NAT REV NEPHROL, V7, P684, DOI 10.1038/nrneph.2011.149; Ma ZW, 2014, BBA-MOL BASIS DIS, V1842, P1088, DOI 10.1016/j.bbadis.2014.04.002; Maisel AS, 2016, J AM COLL CARDIOL, V68, P1420, DOI 10.1016/j.jacc.2016.06.055; Rewa O, 2014, NAT REV NEPHROL, V10, P193, DOI 10.1038/nrneph.2013.282; Schiessl IM, 2018, J AM SOC NEPHROL, V29, P1383, DOI 10.1681/ASN.2017101069; Sharfuddin AA, 2011, NAT REV NEPHROL, V7, P189, DOI 10.1038/nrneph.2011.16; Singbartl K, 2012, KIDNEY INT, V81, P819, DOI 10.1038/ki.2011.339; Sun DF, 2002, AM J PATHOL, V161, P217, DOI 10.1016/S0002-9440(10)64173-9; Tan RJ, 2014, KIDNEY INT SUPPL, V4, P84, DOI 10.1038/kisup.2014.16; Xiao LX, 2019, BBA-MOL BASIS DIS, V1865, P1313, DOI 10.1016/j.bbadis.2019.01.027; Xiao LX, 2016, J AM SOC NEPHROL, V27, P1727, DOI 10.1681/ASN.2015040449; Xiao X, 2014, AM J PHYSIOL-RENAL, V306, pF1318, DOI 10.1152/ajprenal.00036.2014; Yang L, 2011, CONTRIB NEPHROL, V174, P149, DOI 10.1159/000329385; Yang L, 2010, NAT MED, V16, P535, DOI 10.1038/nm.2144; Zhou D, 2018, J AM SOC NEPHROL, V29, P1257, DOI 10.1681/ASN.2017080903; Zhou D, 2017, J AM SOC NEPHROL, V28, P2322, DOI 10.1681/ASN.2016080902; Zhou D, 2016, SCI CHINA LIFE SCI, V59, P920, DOI 10.1007/s11427-016-0020-y; Zhou D, 2016, NAT REV NEPHROL, V12, P68, DOI 10.1038/nrneph.2015.215; Zhou D, 2014, J AM SOC NEPHROL, V25, P2187, DOI 10.1681/ASN.2013080893; Zhou D, 2013, KIDNEY INT, V84, P509, DOI 10.1038/ki.2013.102; Zhou D, 2012, KIDNEY INT, V82, P537, DOI 10.1038/ki.2012.173	45	14	14	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2019	33	11					12576	12587		10.1096/fj.201900651RR	http://dx.doi.org/10.1096/fj.201900651RR			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC8ZX	31461626	Green Published			2022-12-26	WOS:000507461600076
J	Valente, JDS; Fiedler, RA; Heidemann, MS; Molento, CFM				Soares Valente, Julia de Paula; Fiedler, Rodrigo Alonso; Heidemann, Marina Sucha; Maiolino Molento, Carla Forte			First glimpse on attitudes of highly educated consumers towards cell-based meat and related issues in Brazil	PLOS ONE			English	Article							CULTURED MEAT; ANIMAL-WELFARE; STEM-CELLS; CHALLENGES; CONSUMPTION; ACCEPTANCE	Our aim was to study Brazilian consumer attitudes towards cell-based meat and related issues. From 408 respondents from Curitiba and 218 from Joinville, the majority was women with higher level of education; 65.2% and 70.2% frequently consumed meat and 50.7% and 50.9% would not stop eating meat; 81.6% and 82.6% had little or no knowledge about cell-based meat. After watching an explanatory video, 41.9% and 34.4% stated they would eat cell-based meat without restrictions; 24.5% and 23.9% stated they would try depending on conditionals. Overall, 63.6% declared they would eat cell-based meat; among vegetarians and vegans, 24% and 8% stated they would eat cell-based meat, with additional 25.0% and 27.0% stating "it depends"; thus, the major public for cell-based meat seems to be meat eaters. Animal welfare was the principal reason for considering not eating meat and a major benefit of cell-based meat. In conclusion, the majority of respondents would not stop eating meat; additionally, they would eat cell-based meat.	[Soares Valente, Julia de Paula; Fiedler, Rodrigo Alonso; Heidemann, Marina Sucha; Maiolino Molento, Carla Forte] Univ Fed Parana, Anim Welf Lab, Curitiba, Parana, Brazil	Universidade Federal do Parana	Molento, CFM (corresponding author), Univ Fed Parana, Anim Welf Lab, Curitiba, Parana, Brazil.	carlamolento@ufpr.br	VALENTE, JÚLIA/AAH-7114-2020; de Paula Soares Valente, Julia/AAO-7098-2021	Molento, Carla Forte Maiolino/0000-0003-1408-7891	CAPES (Coordination for the Improvement of Higher Education Personnel) [025/2014]	CAPES (Coordination for the Improvement of Higher Education Personnel)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	Grant number 025/2014, CAPES (Coordination for the Improvement of Higher Education Personnel), awarded to C. F. M. M. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors gladly acknowledge all anonymous respondents involved in this study and the assistance provided by Juliana da Costa Cidral in inviting respondents in Joinville. Also, we are thankful for the financial support granted by CAPES (Coordination for the Improvement of Higher Education Personnel), grant number 025/2014, awarded to CFMM.	[Anonymous], 2018, BRAZ LIV PROD ANN AN; Bar-On YM, 2018, P NATL ACAD SCI USA, V115, P6506, DOI 10.1073/pnas.1711842115; Bekker GA, 2017, APPETITE, V108, P245, DOI 10.1016/j.appet.2016.10.002; Bryant C, 2019, FRONT NUTR, V6, DOI 10.3389/fnut.2019.00103; Datar I, 2010, INNOV FOOD SCI EMERG, V11, P13, DOI 10.1016/j.ifset.2009.10.007; Day L, 2013, TRENDS FOOD SCI TECH, V32, P25, DOI 10.1016/j.tifs.2013.05.005; De Backer CJS, 2015, MEAT SCI, V99, P68, DOI 10.1016/j.meatsci.2014.08.011; Gasteratos K. S., 2018, CONSUMER INTEREST CL; GOODMAN LA, 1961, ANN MATH STAT, V32, P148, DOI 10.1214/aoms/1177705148; Graca J, 2015, APPETITE, V90, P80, DOI 10.1016/j.appet.2015.02.037; Grandin T, 2014, MEAT SCI, V98, P461, DOI 10.1016/j.meatsci.2014.05.011; Hartmann C, 2017, TRENDS FOOD SCI TECH, V61, P11, DOI 10.1016/j.tifs.2016.12.006; Hoek AC, 2011, APPETITE, V56, P662, DOI 10.1016/j.appet.2011.02.001; Hoek AC, 2011, FOOD QUAL PREFER, V22, P371, DOI 10.1016/j.foodqual.2011.01.008; Ingvar Ekesbo, 2018, FARM ANIMAL BEHAV CH; Instituto Brasileiro de Geografia e Estatistica, 2017, PROD AGR MUN; Instituto Brasileiro de Geografia e Estatistica-IBGE, 2010, CENS DEM; Instituto Brasileiro de Opiniao Publica e Estatistica, 2018, 14 POP SE DECL VEG; Instituto Brasileiro de Publica e Estatistica, 2012, DIA MUND VEG 8 POP B; Kadim IT, 2015, J INTEGR AGR, V14, P222, DOI 10.1016/S2095-3119(14)60881-9; Laestadius LI, 2015, PUBLIC HEALTH NUTR, V18, P2457, DOI 10.1017/S1368980015000622; Lynch J, 2019, FRONTIERS SUSTAINABL, V3; Malhotra Naresh K, 2008, PESQUISA MARKETING O; Mancini MC, 2019, MEAT SCI, V150, P101, DOI 10.1016/j.meatsci.2018.12.014; Maria Schlindwein Madalena, 2006, REV ECON SOCIOL RURA, V44, P549, DOI [10.1590/S0103-20032006000300009, DOI 10.1590/S0103-20032006000300009]; Mattick CS, 2015, ENVIRON SCI TECHNOL, V49, P11941, DOI 10.1021/acs.est.5b01614; Parker HW, 2019, NUTR REV, V77, P144, DOI 10.1093/nutrit/nuy067; Paul Shapiro, 2018, CLEAN MEAT; Post MJ, 2012, MEAT SCI, V92, P297, DOI 10.1016/j.meatsci.2012.04.008; Robinson TP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096084; Ruby MB, 2011, APPETITE, V56, P447, DOI 10.1016/j.appet.2011.01.018; Santos G., 2017, TRANSFORMING PATRIAR; Schosler H, 2015, APPETITE, V89, P152, DOI 10.1016/j.appet.2015.02.013; Siegrist M, 2017, APPETITE, V113, P320, DOI 10.1016/j.appet.2017.03.019; Stephens N, 2018, TRENDS FOOD SCI TECH, V78, P155, DOI 10.1016/j.tifs.2018.04.010; Tuomisto HL, 2011, ENVIRON SCI TECHNOL, V45, P6117, DOI 10.1021/es200130u; Verbeke W, 2015, J INTEGR AGR, V14, P285, DOI 10.1016/S2095-3119(14)60884-4; Verbeke W, 2015, MEAT SCI, V102, P49, DOI 10.1016/j.meatsci.2014.11.013; Wilks M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171904	39	29	29	3	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2019	14	8							e0221129	10.1371/journal.pone.0221129	http://dx.doi.org/10.1371/journal.pone.0221129			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW6BO	31469862	Green Submitted, Green Published, gold			2022-12-26	WOS:000485062200011
J	Wang, CC; Tsai, YC; Jeng, YM				Wang, Chung-Chieh; Tsai, Yu-Chieh; Jeng, Yung-Ming			Biological significance of GATA3, cytokeratin 20, cytokeratin 5/6 and p53 expression in muscle-invasive bladder cancer	PLOS ONE			English	Article							UROTHELIAL CARCINOMA; MOLECULAR TAXONOMY; BREAST; SUBTYPES; MARKER; IMMUNOHISTOCHEMISTRY; MUTATIONS; GRADE; GENE; IDENTIFICATION	Genetic profiling studies on muscle-invasive bladder cancers (MIBCs) have discovered molecular subtypes with different biological characteristics. Immunohistochemical (IHC) markers such as GATA3, cytokeratin (CK) 20, CK5/6, and p53 are associated with these subtypes. In this study, we investigated the biological and prognostic significance of these IHC markers in MIBCs from 91 patients who underwent radical cystectomy. High Ki-67 indices were associated with negative CK20 (p = 0.002) and diffuse CK5/6 (p = 0.001) staining. By contrast, tumors with diffuse GATA3 expression had low Ki-67 index (p = 0.006). Regarding p53, three staining patterns were associated with a high Ki-67 index: (1) complete absence, (2) diffusely strong nuclear reactivity, and (3) diffusely strong cytoplasmic staining (p < 0.001 compared with other patterns). CK5/6 and CK20 expression was typically present in a reciprocal fashion; however, diffuse GATA3 and CK5/6 coexpression was observed in 13 (14.29%) cases. Among 78 chemotherapy-naive patients, low GATA3 staining was associated with worse recurrence-free survival in both univariate (p = 0.008) and multivariate analyses (p = 0.002). CK20, CK5/6, or p53 expression was not associated with clinical outcome. Based on our results, IHC staining for GATA3 may help risk stratification in patients with MIBC receiving radical cystectomy. In addition, the differences in Ki-67 indices suggested that aberrant p53 expression was better defined by the three aforementioned patterns, rather than percentage of nuclear staining alone.	[Wang, Chung-Chieh; Jeng, Yung-Ming] Natl Taiwan Univ Hosp, Dept Pathol, Taipei, Taiwan; [Wang, Chung-Chieh; Jeng, Yung-Ming] Natl Taiwan Univ, Grad Inst Pathol, Taipei, Taiwan; [Tsai, Yu-Chieh] Natl Taiwan Univ Hosp, Dept Oncol, Taipei, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University; National Taiwan University Hospital	Jeng, YM (corresponding author), Natl Taiwan Univ Hosp, Dept Pathol, Taipei, Taiwan.; Jeng, YM (corresponding author), Natl Taiwan Univ, Grad Inst Pathol, Taipei, Taiwan.	mrna0912@yahoo.com.tw		Wang, Chung-Chieh/0000-0003-0108-240X	National Taiwan University Hospital [107-M3980]	National Taiwan University Hospital(National Taiwan University)	This work received a funding grant from National Taiwan University Hospital, grant number: 107-M3980 (https://www.ntuh.gov.tw/en/default_P.aspx) to CCW. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allred C, 2012, WHO CLASSIFICATION T, P22; Choi W, 2014, CANCER CELL, V25, P152, DOI 10.1016/j.ccr.2014.01.009; Dadhania V, 2016, EBIOMEDICINE, V12, P105, DOI 10.1016/j.ebiom.2016.08.036; Damrauer JS, 2014, P NATL ACAD SCI USA, V111, P3110, DOI 10.1073/pnas.1318376111; Dowsett M, 2011, JNCI-J NATL CANCER I, V103, P1; ESRIG D, 1993, AM J PATHOL, V143, P1389; Fedchenko N, 2014, DIAGN PATHOL, V9, DOI 10.1186/s13000-014-0221-9; FINLAY CA, 1988, MOL CELL BIOL, V8, P531, DOI 10.1128/MCB.8.2.531; Garg K, 2010, MODERN PATHOL, V23, P80, DOI 10.1038/modpathol.2009.153; Hodgson A, 2018, HISTOPATHOLOGY, V73, P748, DOI 10.1111/his.13696; Hodgson A, 2017, HISTOPATHOLOGY, V71, P296, DOI 10.1111/his.13225; Inoue S, 2017, HUM PATHOL, V64, P83, DOI 10.1016/j.humpath.2017.04.003; Kamoun A, 2018, CONSENSUS MOL CLASSI, DOI [10.1101/488460, DOI 10.1101/488460]; Kobel M, 2016, J PATHOL CLIN RES, V2, P247, DOI 10.1002/cjp2.53; Kollberg P, 2019, UROL ONCOL-SEMIN ORI, V37, P791, DOI 10.1016/j.urolonc.2019.04.010; KRAISS S, 1991, EXP CELL RES, V192, P157, DOI 10.1016/0014-4827(91)90170-Y; Lerner SP, 2016, BLADDER CANCER, V2, P37, DOI 10.3233/BLC-150037; Liu HY, 2012, AM J CLIN PATHOL, V138, P57, DOI 10.1309/AJCP5UAFMSA9ZQBZ; Malats W, 2005, LANCET ONCOL, V6, P678; Miettinen M, 2014, AM J SURG PATHOL, V38, P13, DOI 10.1097/PAS.0b013e3182a0218f; Miyamoto H, 2012, HUM PATHOL, V43, P2033, DOI 10.1016/j.humpath.2012.02.011; Mohammed KH, 2016, UROL ONCOL-SEMIN ORI, V34, DOI 10.1016/j.urolonc.2016.04.016; National Comprehensive Cancer Network, NCCN CLIN PRACT GUID; Netto GJ, 2012, NAT REV UROL, V9, P41, DOI 10.1038/nrurol.2011.193; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; REMMELE W, 1987, PATHOLOGE, V8, P138; Robertson AG, 2017, CELL, V171, P540, DOI 10.1016/j.cell.2017.09.007; Sikic D, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179602; Sjodahl G, 2017, J PATHOL, V242, P113, DOI 10.1002/path.4886; Sjodahl G, 2012, CLIN CANCER RES, V18, P3377, DOI 10.1158/1078-0432.CCR-12-0077-T; Sorlie T, 2003, P NATL ACAD SCI USA, V100, P8418, DOI 10.1073/pnas.0932692100; Weinstein JN, 2014, NATURE, V507, P315, DOI 10.1038/nature12965; Yemelyanova A, 2011, MODERN PATHOL, V24, P1248, DOI 10.1038/modpathol.2011.85	33	22	22	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2019	14	8							e0221785	10.1371/journal.pone.0221785	http://dx.doi.org/10.1371/journal.pone.0221785			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW6BO	31469885	Green Submitted, Green Published, gold			2022-12-26	WOS:000485062200029
J	Zhu, ZH; Cui, YF; Gong, Q; Huang, C; Guo, F; Li, W; Zhang, WB; Chen, YB; Cheng, X; Wang, YX				Zhu, Zhihong; Cui, Yufei; Gong, Qiang; Huang, Cong; Guo, Feng; Li, Wang; Zhang, Wenbo; Chen, Yanbo; Cheng, Xin; Wang, Yongxiang			Frequency of breakfast consumption is inversely associated with the risk of depressive symptoms among Chinese university students: A cross-sectional study	PLOS ONE			English	Article							LIFE-STYLE FACTORS; PREVALENCE; HEALTH; ADOLESCENTS; NUTRITION; PATTERNS; IMPACT; ADULTS	Introduction Eating breakfast has been proved to positively influence human health. However, evidence for the association between breakfast consumption and depressive symptoms is lacking, especially among young adults. The aim of this study was to determine whether breakfast consumption is associated with depressive symptoms among Chinese university students. Methods A cross-sectional study involving 10,174 undergraduate students (6,287 males and 3,887 females) was conducted in 2015. Breakfast consumption was assessed using a selfreported questionnaire. Depressive symptoms were assessed using the Zung self-rating depression scale (SDS) score. Three cut-off values of the SDS score (40, 45, and 50) were used to assess the severity of the depressive symptoms. Logistic regression models were used to analyze the association between the frequency of breakfast consumption and depressive symptoms. Results The mean SDS score was 37.1 +/- 8.0 in present study. In crude model, a higher frequency of breakfast consumption was primarily associated with a lower prevalence of depressive symptoms in all three SDS groups (p = 0.001, < 0.001, = 0.009 for SDS cut-off value 40, 45, and 50 points, respectively). These associations remained significant after adjustment for confounding factors. Conclusions A higher frequency of breakfast consumption was strongly associated with a lower prevalence of depressive symptoms among Chinese university students. These results corroborate the evidence that the habit of eating breakfast may be beneficial to mental health.	[Zhu, Zhihong; Cui, Yufei; Gong, Qiang; Guo, Feng; Li, Wang; Cheng, Xin; Wang, Yongxiang] Huaiyin Inst Technol, Inst Exercise Epidemiol, Huaian, Peoples R China; [Zhu, Zhihong; Cui, Yufei; Gong, Qiang; Guo, Feng; Li, Wang; Cheng, Xin; Wang, Yongxiang] Huaiyin Inst Technol, Dept Phys Educ, Huaian, Peoples R China; [Huang, Cong] Zhejiang Univ, Dept Phys Educ, Hangzhou, Zhejiang, Peoples R China; [Zhang, Wenbo] Changchun Inst Educ, Dept Phys Educ, Changchun, Jilin, Peoples R China; [Chen, Yanbo] Dalian Inst Sci & Technol, Dept Phys Educ, Dalian, Peoples R China	Huaiyin Institute of Technology; Huaiyin Institute of Technology; Zhejiang University; Dalian University of Technology	Zhu, ZH; Cui, YF (corresponding author), Huaiyin Inst Technol, Inst Exercise Epidemiol, Huaian, Peoples R China.; Zhu, ZH; Cui, YF (corresponding author), Huaiyin Inst Technol, Dept Phys Educ, Huaian, Peoples R China.	zhuzhihong@outlook.jp; yufei_big@hotmail.com	Eng, Amanda/AAC-6075-2019; Huang, Cong/N-4401-2019	Huang, Cong/0000-0002-2307-864X				Andrade L, 2003, INT J METH PSYCH RES, V12, P3, DOI 10.1002/mpr.138; Anzman-Frasca S, 2016, MATERN CHILD HLTH J, V20, P1578, DOI 10.1007/s10995-016-1957-5; Bayram N, 2008, SOC PSYCH PSYCH EPID, V43, P667, DOI 10.1007/s00127-008-0345-x; BLAZER D, 1991, J GERONTOL, V46, pM210, DOI 10.1093/geronj/46.6.M210; Bodnar LM, 2005, BIOL PSYCHIAT, V58, P679, DOI 10.1016/j.biopsych.2005.05.009; Bruce ML, 2001, AM J GERIAT PSYCHIAT, V9, P102, DOI 10.1176/appi.ajgp.9.2.102; Chen L, 2015, ADV EDUC SCI, V10, P3; Compton WM, 2006, AM J PSYCHIAT, V163, P2141, DOI 10.1176/appi.ajp.163.12.2141; Cui YF, 2018, AM J HEALTH BEHAV, V42, P156, DOI [10.5993/ajhb.42.1.15, 10.5993/AJHB.42.1.15]; Dubois L, 2009, PUBLIC HEALTH NUTR, V12, P19, DOI 10.1017/S1368980008001894; Feng Q, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0100914, 10.1371/journal.pone.0104348]; FRASURESMITH N, 1993, JAMA-J AM MED ASSOC, V270, P1819, DOI 10.1001/jama.270.15.1819; Garlow SJ, 2008, DEPRESS ANXIETY, V25, P482, DOI 10.1002/da.20321; Giovannini M, 2008, J INT MED RES, V36, P613, DOI 10.1177/147323000803600401; Gollub EA, 2004, J AM DIET ASSOC, V104, P1227, DOI 10.1016/j.jada.2004.05.204; Hu Hongxing, 2016, Shanghai Arch Psychiatry, V28, P335, DOI 10.11919/j.issn.1002-0829.216067; Hysenbegasi A, 2005, J MENT HEALTH POLICY, V8, P145; Jaycox LH, 2009, PEDIATRICS, V124, pE596, DOI 10.1542/peds.2008-3348; Lee SA, 2017, APPETITE, V114, P313, DOI 10.1016/j.appet.2017.04.007; Lee YS, 2019, PSYCHIAT RES, V271, P83, DOI 10.1016/j.psychres.2018.11.031; Lewinsohn PM, 2003, J ABNORM PSYCHOL, V112, P244, DOI 10.1037/0021-843X.112.2.244; Liu XC, 1999, SOC PSYCH PSYCH EPID, V34, P44, DOI 10.1007/s001270050110; Lowe GA, 2009, W INDIAN MED J, V58, P21; Miki T, 2019, PSYCHIAT RES, V273, P551, DOI 10.1016/j.psychres.2019.01.069; Miki T, 2016, NUTRITION, V32, P584, DOI 10.1016/j.nut.2015.11.014; Miyake Y, 2015, BJOG-INT J OBSTET GY, V122, P336, DOI 10.1111/1471-0528.12972; Nakao M, 2006, PSYCHIAT CLIN NEUROS, V60, P219, DOI 10.1111/j.1440-1819.2006.01489.x; Niemeier HM, 2006, J ADOLESCENT HEALTH, V39, P842, DOI 10.1016/j.jadohealth.2006.07.001; Pollitt E, 1998, AM J CLIN NUTR, V67, p804S, DOI 10.1093/ajcn/67.4.804S; Schulz R, 2002, BIOL PSYCHIAT, V52, P205, DOI 10.1016/S0006-3223(02)01423-3; Sjoberg A, 2003, EUR J CLIN NUTR, V57, P1569, DOI 10.1038/sj.ejcn.1601726; SKINNER JD, 1985, J AM DIET ASSOC, V85, P1093; Smith AP, 2003, NUTR NEUROSCI, V6, P59, DOI 10.1080/1028415021000042820; Sternberg RM, 2013, INT J WOMENS HEALTH, V5, P301, DOI 10.2147/IJWH.S43132; Wang X., 1999, MENTAL HLTH ASSESSME, V13, P194; Watanabe Yoko, 2014, J Rural Med, V9, P51, DOI 10.2185/jrm.2887; Wuenstel Justyna Weronika, 2015, Dev Period Med, V19, P193; Xu Y, 2016, PSYCHIAT RES, V245, P243, DOI 10.1016/j.psychres.2016.03.009; Yu B, 2015, J AFFECT DISORDERS, V172, P422, DOI 10.1016/j.jad.2014.10.026; ZUNG WWK, 1965, ARCH GEN PSYCHIAT, V12, P63, DOI 10.1001/archpsyc.1965.01720310065008	40	13	14	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2019	14	8							e0222014	10.1371/journal.pone.0222014	http://dx.doi.org/10.1371/journal.pone.0222014			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW6BO	31469883	gold, Green Submitted, Green Published			2022-12-26	WOS:000485062200048
J	Tian, W; Yao, YH; Fan, GC; Zhou, YX; Wu, MW; Xu, D; Deng, YC				Tian, Wei; Yao, Yihan; Fan, Guocai; Zhou, Yunxiang; Wu, Miaowei; Xu, Dong; Deng, Yongchuan			Changes in lipid profiles during and after (neo) adjuvant chemotherapy in women with early-stage breast cancer: A retrospective study	PLOS ONE			English	Article							OXIDATIVE STRESS; RISK-FACTOR; CARDIOTOXICITY; MORTALITY; PLASMA; HOMOCYSTEINE; STATISTICS; PREVENTION; OBESITY	Many different treatments may affect the serum lipid profiles of breast cancer patients. This study analyzed serum lipid levels at different periods during treatment to observe the changes in lipid profiles during and after chemotherapy and to compare the different effects of different chemotherapy regimens on serum lipid profiles. A total of 805 patients were included in this study. We measured the lipid profiles of patients who received surgery without chemotherapy prior to the operation and at 3, 6 and 12 months after operation. In addition, in patients who underwent chemotherapy, the lipid profiles were measured prior to chemotherapy, prior to the last cycle of chemotherapy and 6 months after chemotherapy. Lipid profile measurements included total cholesterol (TC), triglycerides (TG), low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C), homocysteine (HCY), and uric acid (UA). (Neo) Adjuvant chemotherapy exerted an adverse temporary effect on lipid levels (manifested as increased TG and LDL-C levels, and decreased HDL-C levels, particularly in the adjuvant chemotherapy group) during the chemotherapy periods. However, this influence was not sustained, as the lipid profiles levels were generally restored to baseline levels 6 months after chemotherapy completion. Different age groups showed different changes in lipid levels that were influenced by chemotherapy. The younger group (20-40 years old) showed a greater increase in TC and LDL-C levels during chemotherapy than the 41-65-year-old group. Chemotherapy exerts an adverse temporary effect, and the effects of different regimens on lipid levels are similar. Furthermore, lipid profiles in younger women may be more sensitive to chemotherapy.	[Tian, Wei; Yao, Yihan; Zhou, Yunxiang; Wu, Miaowei; Xu, Dong; Deng, Yongchuan] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Surg Oncol, Hangzhou, Zhejiang, Peoples R China; [Fan, Guocai] Peoples Hosp Suichang Cty, Dept Breast Surg, Lishui, Zhejiang, Peoples R China	Zhejiang University	Deng, YC (corresponding author), Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Surg Oncol, Hangzhou, Zhejiang, Peoples R China.	dyc001@zju.edu.cn	Zhou, Yunxiang/AAK-7758-2020	Zhou, Yunxiang/0000-0003-1000-0330; Deng, Yongchuan/0000-0002-7101-3250	National Natural Science Foundation of China [81773181]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	WT was supported by grants from the National Natural Science Foundation of China (grant no. 81502598). DX was supported by grants from the National Natural Science Foundation of China (grant nos. 81773181). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Qadir H, 2017, JAMA CARDIOL, V2, P88, DOI 10.1001/jamacardio.2016.3841; Ades F, 2014, BREAST, V23, P317, DOI 10.1016/j.breast.2014.04.002; ALEXOPOULOS CG, 1992, CANCER CHEMOTH PHARM, V30, P412, DOI 10.1007/BF00689971; Amin KA, 2012, J BREAST CANCER, V15, P306, DOI 10.4048/jbc.2012.15.3.306; Arpino G, 2015, BREAST CANCER RES TR, V154, P127, DOI 10.1007/s10549-015-3586-x; Bardia A, 2012, BREAST CANCER RES TR, V131, P907, DOI 10.1007/s10549-011-1843-1; Basso F, 2003, J LIPID RES, V44, P296, DOI 10.1194/jlr.M200414-JLR200; Chen WQ, 2017, CHINESE J CANCER RES, V29, P1, DOI 10.21147/j.issn.1000-9604.2017.01.01; Delgobo M, 2019, J NUTR BIOCHEM, V67, P190, DOI 10.1016/j.jnutbio.2019.02.012; DeSantis CE, 2017, CA-CANCER J CLIN, V67, P439, DOI 10.3322/caac.21412; Dieckmann KP, 2011, ANTICANCER RES, V31, P4501; dos Santos CR, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-132; Doyle JJ, 2005, J CLIN ONCOL, V23, P8597, DOI 10.1200/JCO.2005.02.5841; Guenancia C, 2016, J CLIN ONCOL, V34, P3157, DOI 10.1200/JCO.2016.67.4846; Huxley Rachel, 2002, Semin Vasc Med, V2, P315, DOI 10.1055/s-2002-35402; Jellinger PS, 2017, ENDOCR PRACT, V23, P479, DOI 10.4158/EP171764.GL; Li X, 2018, LIPIDS HEALTH DIS, V17, DOI 10.1186/s12944-018-0745-1; Matyszewski A, 2017, FUTURE ONCOL, V13, P593, DOI 10.2217/fon-2016-0425; Panis C, 2017, CANCER CHEMOTH PHARM, V80, P469, DOI 10.1007/s00280-017-3384-8; Patel A, 2004, CIRCULATION, V110, P2678, DOI 10.1161/01.CIR.0000145615.33955.83; REFSUM H, 1986, CANCER RES, V46, P5385; REFSUM H, 1991, CANCER RES, V51, P828; Rzymowska J, 1999, PATHOBIOLOGY, V67, P129, DOI 10.1159/000028062; Shaikh S, 2017, LIPIDS HEALTH DIS, V16, DOI 10.1186/s12944-017-0481-y; Sharma M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148049; Siegel RL, 2017, CA-CANCER J CLIN, V67, P7, DOI 10.3322/caac.21387; Smith DG, 2007, AM J MANAG CARE, V13, pS68; Smith LA, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-337; Tian W, 2018, CLIN PHARM DRUG DEV, V7, P837, DOI 10.1002/cpdd.420; Truong J, 2014, CAN J CARDIOL, V30, P869, DOI 10.1016/j.cjca.2014.04.029; van Boxtel JJA, 2011, J VISION, V11, DOI 10.1167/11.7.19; Vehmanen L, 2004, BRIT J CANCER, V91, P476, DOI 10.1038/sj.bjc.6601979; Wang YC, 2013, MED DECIS MAKING, V33, P176, DOI 10.1177/0272989X12458725; Willemse PPM, 2014, ACTA ONCOL, V53, P351, DOI 10.3109/0284186X.2013.819116; Yeo W, 2017, BMC WOMENS HEALTH, V17, DOI 10.1186/s12905-017-0409-8; Zecchina G, 2007, CLIN LUNG CANCER, V8, P264, DOI 10.3816/CLC.2007.n.004	36	25	25	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2019	14	8							e0221866	10.1371/journal.pone.0221866	http://dx.doi.org/10.1371/journal.pone.0221866			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW6AB	31465521	Green Published, Green Submitted, gold			2022-12-26	WOS:000485058200061
J	Dushianthan, A; Cusack, R; Koster, G; Grocott, MPW; Postle, AD				Dushianthan, Ahilanandan; Cusack, Rebecca; Koster, Grielof; Grocott, Michael P. W.; Postle, Anthony D.			Insight into erythrocyte phospholipid molecular flux in healthy humans and in patients with acute respiratory distress syndrome	PLOS ONE			English	Article							LIPID-COMPOSITION; FATTY-ACIDS; CELL; ASYMMETRY; PHOSPHATIDYLCHOLINE; INFLAMMATION; METABOLISM; MEMBRANES	Although the distribution of cellular membrane phospholipid composition is well characterised in human erythrocytes, in-vivo turnover and dynamic flux of phospholipids between plasma and erythrocytes in physiological and in particular during disease states are mostly unknown. Erythrocyte mass primarily consisted of lipids and phosphatidylcholine (PC) contributes to the significant proportion of phospholipid membrane composition. Esterified membrane PC can be utilised during pathological processes to generate pro and anti-inflammatory lipid mediators, which can contribute to the pathogenesis of acute respiratory distress syndrome (ARDS). In this study, utilising isotope labelling of choline and analytical methods with electrospray mass spectrometry (ESI-MS/MS), we characterised individual molecular composition and dynamic exchange of PC, sphingomyelins (SM) and lysophosphatidylcholines (LPC) between plasma and erythrocytes. In ARDS patients, there were significant alterations in PC molecular composition, coupled with a continuous loss of arachidonoyl-PC species over time. Infusion of methyl-D-9-choline chloride resulted in enrichment of labelled choline into plasma PC and LPC via CDP-choline pathway with subsequent incorporation into erythrocyte PC. As expected, erythrocyte methyl-D-9 PC enrichment is much slower than plasma. Patients had much faster and higher fractional enrichment of all PC and LPC molecules suggesting increased flux between plasma and erythrocytes. There was a particular pattern of incorporation, where the arachidonoyl-PC species achieved equilibrium with plasma rapidly and retained highest concentrations of enrichment compared to the other PC species. Increased enrichment of arachidonoyl-PC coupled with virtually no increase or depletion of its concentrations suggests the possibility of substrate donation for other cell types for the participation of eicosanoid biosynthesis during inflammatory conditions like ARDS. In summary, this study revealed an alerted pattern erythrocyte molecular phospholipid composition and flux in patients with acute respiratory distress syndrome and the pathological consequences of these changes needs further exploration.	[Dushianthan, Ahilanandan; Cusack, Rebecca; Koster, Grielof; Grocott, Michael P. W.; Postle, Anthony D.] Univ Hosp Southampton NHS Fdn Trust, NIHR Southampton Biomed Res Ctr, Southampton, Hants, England; [Dushianthan, Ahilanandan; Cusack, Rebecca; Koster, Grielof; Grocott, Michael P. W.; Postle, Anthony D.] Univ Southampton, Fac Med, Sir Henry Wellcome Labs, Clin & Expt Sci,Integrat Physiol & Crit Illness G, Southampton, Hants, England; [Dushianthan, Ahilanandan; Cusack, Rebecca; Grocott, Michael P. W.] Univ Hosp Southampton NHS Fdn Trust, Crit Care Anaesthesia & Perioperat Med Res Unit, Southampton, Hants, England	University of Southampton; University Hospital Southampton NHS Foundation Trust; University of Southampton; University of Southampton; University Hospital Southampton NHS Foundation Trust	Dushianthan, A (corresponding author), Univ Hosp Southampton NHS Fdn Trust, NIHR Southampton Biomed Res Ctr, Southampton, Hants, England.; Dushianthan, A (corresponding author), Univ Southampton, Fac Med, Sir Henry Wellcome Labs, Clin & Expt Sci,Integrat Physiol & Crit Illness G, Southampton, Hants, England.; Dushianthan, A (corresponding author), Univ Hosp Southampton NHS Fdn Trust, Crit Care Anaesthesia & Perioperat Med Res Unit, Southampton, Hants, England.	adushianthan@gmail.com	Dushianthan, Ahilanandan/T-8390-2019; Grocott, Michael/C-4394-2008	Dushianthan, Ahilanandan/0000-0002-0165-3359; Grocott, Michael/0000-0002-9484-7581	National Institute of Academic Anaesthesia (UK) [BJA/RCoA-AAGBI/AnaesthesiaWKR0-2010-0056]	National Institute of Academic Anaesthesia (UK)	This study was conducted by the NIHR Biomedical Research Centre and Critical Care/Anaesthesia and Perioperative Medicine Research Unit, University Hospital Southampton NHS Foundation Trust. This study was part supported by a grant from the National Institute of Academic Anaesthesia (UK) (BJA/RCoA-AAGBI/AnaesthesiaWKR0-2010-0056 to AD). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	BERNARD GR, 1994, AM J RESP CRIT CARE, V149, P818, DOI 10.1164/ajrccm.149.3.7509706; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Chung SM, 2007, ARTERIOSCL THROM VAS, V27, P414, DOI 10.1161/01.ATV.0000252898.48084.6a; Daleke DL, 2008, CURR OPIN HEMATOL, V15, P191, DOI 10.1097/MOH.0b013e3282f97af7; DEVAUX PF, 1991, BIOCHEMISTRY-US, V30, P1163, DOI 10.1021/bi00219a001; Dinkla S, 2016, BBA CLIN, V5, P186, DOI 10.1016/j.bbacli.2016.03.007; Dushianthan A, 2011, POSTGRAD MED J, V87, P612, DOI 10.1136/pgmj.2011.118398; Dushianthan A, 2018, J LIPID RES, V59, P1034, DOI 10.1194/jlr.P085050; Dushianthan A, 2014, RESP RES, V15, DOI 10.1186/s12931-014-0128-8; Frantzeskaki F, 2017, RESPIRATION, V93, P212, DOI 10.1159/000453002; Hermansson M, 2011, PROG LIPID RES, V50, P240, DOI 10.1016/j.plipres.2011.02.004; Hunt AN, 2002, FEBS LETT, V530, P89, DOI 10.1016/S0014-5793(02)03429-4; JAFFE ER, 1968, J CLIN INVEST, V47, P1375, DOI 10.1172/JCI105829; Kempe DS, 2007, J MOL MED-JMM, V85, P269, DOI 10.1007/s00109-006-0123-8; KIM DK, 1995, AM J PHYSIOL-LUNG C, V269, pL109, DOI 10.1152/ajplung.1995.269.1.L109; Labrouche S, 1996, METABOLISM, V45, P57, DOI 10.1016/S0026-0495(96)90200-0; Liebisch G, 2013, J LIPID RES, V54, P1523, DOI 10.1194/jlr.M033506; Reddy RD, 2004, SCHIZOPHRENIA BULL, V30, P901, DOI 10.1093/oxfordjournals.schbul.a007140; REED CF, 1968, J CLIN INVEST, V47, P749, DOI 10.1172/JCI105770; RENOOIJ W, 1979, BIOCHIM BIOPHYS ACTA, V558, P314, DOI 10.1016/0005-2736(79)90266-9; RENOOIJ W, 1974, BIOCHIM BIOPHYS ACTA, V363, P287, DOI 10.1016/0005-2736(74)90069-8; RENOOIJ W, 1976, EUR J BIOCHEM, V61, P53, DOI 10.1111/j.1432-1033.1976.tb09996.x; Scharte M, 2003, CRIT CARE MED, V31, pS651, DOI 10.1097/01.CCM.0000098036.90796.ED; SPECTOR AA, 1985, J LIPID RES, V26, P1015; van der Veen JN, 2017, BBA-BIOMEMBRANES, V1859, P1558, DOI 10.1016/j.bbamem.2017.04.006; Vance JE, 2015, TRAFFIC, V16, P1, DOI 10.1111/tra.12230; VANDEENEN LLM, 1981, FEBS LETT, V123, P3, DOI 10.1016/0014-5793(81)80007-5; Ware LB, 2000, NEW ENGL J MED, V342, P1334, DOI 10.1056/NEJM200005043421806; WAYS P, 1964, J LIPID RES, V5, P318; Woon LA, 1999, CELL CALCIUM, V25, P313, DOI 10.1054/ceca.1999.0029	30	7	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2019	14	8							e0221595	10.1371/journal.pone.0221595	http://dx.doi.org/10.1371/journal.pone.0221595			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5WO	31454387	Green Accepted, Green Published, gold			2022-12-26	WOS:000485049000031
J	Koizumi, Y; Hirooka, M; Tamaki, N; Yada, N; Nakashima, O; Izumi, N; Kudo, M; Hiasa, Y				Koizumi, Yohei; Hirooka, Masashi; Tamaki, Nobuharu; Yada, Norihisa; Nakashima, Osamu; Izumi, Namiki; Kudo, Masatoshi; Hiasa, Yoichi			New diagnostic technique to evaluate hepatic steatosis using the attenuation coefficient on ultrasound B mode	PLOS ONE			English	Article							FATTY LIVER-DISEASE; TIME TISSUE ELASTOGRAPHY; NONINVASIVE DIAGNOSIS; PARAMETER CAP; FIBROSIS; SEVERITY; ACCURACY	Purpose We have developed a diagnostic technique to evaluate hepatic steatosis using the attenuation coefficient (ATT) in ultrasound B mode imaging. A controlled attenuation parameter (CAP) by vibration-controlled transient elastography (VCTE) has also been used to evaluate hepatic steatosis. As that method uses ultrasound A mode, visualizing the liver in real time is difficult. We designed this clinical study to evaluate the diagnostic advantage of our technique using ATT compared to CAP. Materials and methods The study group included 94 patients with chronic liver disease who had undergone both ATT and CAP assessment at the time of liver biopsy. The M-probe and XL-probe were used for CAP measurement. Data for ATT and CAP were compared as a function of the steatosis grade. Results The area under the receiver operating characteristic curve (AUC-ROCs) for ATT and PAC as a function of the steatosis grade were as follows: grade 1, 0.74 and 0.81; grade 2, 0.80 and 0.85; and grade 3, 0.96 and 0.98, respectively. Conclusion The accuracy of steatosis grade diagnosis using ATT was the same as that using CAP, with no significant differences and with the added advantage of B mode ultrasound being more convenient and rapid, compared to A mode ultrasound, particularly for patients with subcutaneous fat thickness >= 2 cm.	[Koizumi, Yohei; Hirooka, Masashi; Hiasa, Yoichi] Ehime Univ, Dept Gastroenterol, Grad Sch Med, Toon, Ehime, Japan; [Koizumi, Yohei; Hirooka, Masashi; Hiasa, Yoichi] Ehime Univ, Dept Metabol, Grad Sch Med, Toon, Ehime, Japan; [Tamaki, Nobuharu; Izumi, Namiki] Musashino Red Cross Hosp, Dept Gastroenterol & Hepatol, Tokyo, Japan; [Yada, Norihisa; Kudo, Masatoshi] Kindai Univ, Fac Med, Dept Gastroenterol & Hepatol, Osaka, Japan; [Nakashima, Osamu] Kurume Univ Hosp, Pathol Div, Fukuoka, Fukuoka, Japan	Ehime University; Ehime University; Kindai University (Kinki University); Kurume University	Hiasa, Y (corresponding author), Ehime Univ, Dept Gastroenterol, Grad Sch Med, Toon, Ehime, Japan.; Hiasa, Y (corresponding author), Ehime Univ, Dept Metabol, Grad Sch Med, Toon, Ehime, Japan.	hiasa@m.ehime-u.ac.jp	Hiasa, Yoichi/ABD-2759-2021; Kudo, Masatoshi/AAA-9744-2019	Hiasa, Yoichi/0000-0003-4117-339X; Kudo, Masatoshi/0000-0002-4102-3474; Tamaki, Nobuharu/0000-0003-4634-6616				Andrade Patrícia, 2017, GE Port J Gastroenterol, V24, P161, DOI 10.1159/000453364; Cardoso AC, 2015, ANN HEPATOL, V14, P826, DOI 10.5604/16652681.1171762; Chan WK, 2018, J GASTROEN HEPATOL, V33, P1787, DOI 10.1111/jgh.14150; Chan WK, 2014, J GASTROEN HEPATOL, V29, P1470, DOI 10.1111/jgh.12557; de Ledinghen V, 2014, J HEPATOL, V60, P1026, DOI 10.1016/j.jhep.2013.12.018; Farrell GC, 2006, HEPATOLOGY, V43, pS99, DOI 10.1002/hep.20973; Ferraioli G, 2015, ULTRASOUND MED BIOL, V41, P1161, DOI 10.1016/j.ultrasmedbio.2015.03.007; Hamaguchi M, 2007, AM J GASTROENTEROL, V102, P2708, DOI 10.1111/j.1572-0241.2007.01526.x; Jung KS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098689; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Koizumi Y, 2017, HEPATOL RES, V47, P1252, DOI 10.1111/hepr.12861; Koizumi Y, 2011, RADIOLOGY, V258, P610, DOI 10.1148/radiol.10100319; Kwok R, 2016, GUT, V65, P1359, DOI 10.1136/gutjnl-2015-309265; Lazo M, 2008, SEMIN LIVER DIS, V28, P339, DOI 10.1055/s-0028-1091978; Lupsor-Platon M, 2015, J GASTROINTEST LIVER, V24, P35, DOI 10.15403/jgld.2014.1121.mlp; Millonig G, 2008, HEPATOLOGY, V48, P1718, DOI 10.1002/hep.22577; Ochi H, 2012, HEPATOLOGY, V56, P1271, DOI 10.1002/hep.25756; Petta S, 2017, HEPATOLOGY, V65, P1145, DOI 10.1002/hep.28843; Powell EE, 2005, HEPATOLOGY, V42, P5, DOI 10.1002/hep.20750; Regev A, 2002, AM J GASTROENTEROL, V97, P2614, DOI 10.1111/j.1572-0241.2002.06038.x; Runge JH, 2018, RADIOLOGY, V286, P547, DOI 10.1148/radiol.2017162931; Sasso M, 2012, CLIN RES HEPATOL GAS, V36, P13, DOI 10.1016/j.clinre.2011.08.001; Sasso M, 2010, ULTRASOUND MED BIOL, V36, P1825, DOI 10.1016/j.ultrasmedbio.2010.07.005; Shi KQ, 2014, J GASTROEN HEPATOL, V29, P1149, DOI 10.1111/jgh.12519; Starley BQ, 2010, HEPATOLOGY, V51, P1820, DOI 10.1002/hep.23594; Stern C, 2017, HEPATOL INT, V11, P70, DOI 10.1007/s12072-016-9772-z; Tamaki N, 2018, HEPATOL RES, V48, P821, DOI 10.1111/hepr.13179; Thiele M, 2018, J HEPATOL, V68, P1025, DOI 10.1016/j.jhep.2017.12.029; Williams CD, 2011, GASTROENTEROLOGY, V140, P124, DOI 10.1053/j.gastro.2010.09.038; Wong RJ, 2015, GASTROENTEROLOGY, V148, P547, DOI 10.1053/j.gastro.2014.11.039; YAJIMA Y, 1983, TOHOKU J EXP MED, V139, P43, DOI 10.1620/tjem.139.43	31	21	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2019	14	8							e0221548	10.1371/journal.pone.0221548	http://dx.doi.org/10.1371/journal.pone.0221548			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5WO	31454369	gold, Green Submitted, Green Published			2022-12-26	WOS:000485049000025
J	Carr, AL; Salgado, VL				Carr, Ann L.; Salgado, Vincent L.			Ticks home in on body heat: A new understanding of Haller's organ and repellent action	PLOS ONE			English	Article							RHODNIUS-PROLIXUS HEMIPTERA; DERMACENTOR-VARIABILIS; AMBLYOMMA-AMERICANUM; MOSQUITO	Ticks are second only to mosquitoes as vectors of disease to humans and animals. Tick host detection is mainly ascribed to Haller's organ, a complex sensory structure on the tick foreleg that detects odors, carbon dioxide and heat, but these host detection mechanisms are not well understood. There is anecdotal evidence that ticks and other ectoparasites are attracted to heat, but it has never been demonstrated that they use radiant heat to detect hosts at a distance. In fact, previous attempts to do this have concluded that radiant heat was not used by ticks. Here we use a novel thermotaxis assay to investigate the detection range, temperature dependence and repellent sensitivity of heat perception in ticks and to identify the sensory organ responsible for this sense. We show that Amblyomma americanum and Dermacentor variabilis ticks can locate a human from several meters away by radiant heat sensed by the part of Haller's organ known as the capsule, a covered spherical pit organ. An aperture in the capsule cover confers directionality and highly reflective interior surfaces of the capsule concentrate radiation on the sensilla to sharpen directionality and increase sensitivity. Commercial insect repellents provide an effective means of personal protection against potentially infectious tick bites by hindering host-seeking behavior. Low concentrations of the insect repellents DEET, picaridin, 2-undecanone, citronellal and nootkatone eliminate thermotaxis without affecting olfaction-stimulated host-seeking behavior. Our results demonstrate that the tick Haller's organ capsule is a radiant heat sensor used in host-finding and that repellents disrupt this sense at concentrations that do not disrupt olfaction. We anticipate that this discovery will significantly aid insect repellent research and provide novel targets for the development of innovative integrated pest management programs and personal protection strategies for ectoparasites and vector-borne disease.	[Carr, Ann L.; Salgado, Vincent L.] BASF Corp, Res Triangle Pk, NC 27709 USA; [Carr, Ann L.] Vanderbilt Univ, Dept Biol Sci, 221 Kirkland Hall, Nashville, TN 37235 USA	BASF; Vanderbilt University	Salgado, VL (corresponding author), BASF Corp, Res Triangle Pk, NC 27709 USA.	vincent.salgado@basf.com		Salgado, Vincent/0000-0002-2797-3932	BASF Corp.	BASF Corp.(BASF)	BASF Corp. provided support in the form of research materials and salaries for VLS and ALC, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adenubi OT, 2018, VET PARASITOL, V254, P160, DOI 10.1016/j.vetpar.2018.03.008; Apanaskevich Dmitry A., 2014, P59; Bissinger BW, 2010, PESTIC BIOCHEM PHYS, V96, P63, DOI 10.1016/j.pestbp.2009.09.010; BRUCE W A, 1971, Florida Entomologist, V54, P65, DOI 10.2307/3493790; Carr AL, 2013, MED VET ENTOMOL, V27, P86, DOI 10.1111/j.1365-2915.2012.01024.x; Carr AL, 2016, PESTIC BIOCHEM PHYS, V131, P60, DOI 10.1016/j.pestbp.2015.12.009; Carter MC, 2018, ALLERGY, V73, P1131, DOI 10.1111/all.13366; Costanzo KS, 2015, J VECTOR ECOL, V40, P164, DOI 10.1111/jvec.12146; Dickens JC, 2013, PESTIC BIOCHEM PHYS, V106, P149, DOI 10.1016/j.pestbp.2013.02.006; Du EJ, 2015, MOL CELLS, V38, P911, DOI 10.14348/molcells.2015.0215; FOELIX RF, 1972, Z ZELLFORSCH MIK ANA, V124, P275, DOI 10.1007/BF00355031; GRUNDFEST H, 1950, REV SCI INSTRUM, V21, P360, DOI 10.1063/1.1745583; Hardy JD, 1939, AM J PHYSIOL, V127, P454, DOI 10.1152/ajplegacy.1939.127.3.454; Knee Wayne, 2006, Canadian Journal of Arthropod Identification, V2, P1; Kwon Y, 2010, CURR BIOL, V20, P1672, DOI 10.1016/j.cub.2010.08.016; LAZZARI CR, 1989, J INSECT PHYSIOL, V35, P525, DOI 10.1016/0022-1910(89)90060-7; LEES AD, 1948, J EXP BIOL, V25, P145; LEONOVICH SA, 1986, PARAZITOLOGIYA+, V20, P431; McCullagh P, 1989, GEN LINEAR MODELS, Vxix; Mitchell RD, 2017, TICKS TICK-BORNE DIS, V8, P764, DOI 10.1016/j.ttbdis.2017.06.001; Sanford JL, 2013, NATURWISSENSCHAFTEN, V100, P269, DOI 10.1007/s00114-013-1021-x; Schmitz H, 2000, J INSECT PHYSIOL, V46, P745, DOI 10.1016/S0022-1910(99)00163-8; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sokabe T, 2016, CELL REP, V17, P336, DOI 10.1016/j.celrep.2016.09.028; Sonenshine Daniel E., 2002, P517, DOI 10.1016/B978-012510451-7/50026-8; Sonenshine DE, 2014, BIOL TICKS; STEULLET P, 1992, J COMP PHYSIOL A, V170, P665, DOI 10.1007/BF00198976; Wang GR, 2009, EUR J NEUROSCI, V30, P967, DOI 10.1111/j.1460-9568.2009.06901.x; WIGGLESWORTH V. B., 1941, PARASITOLOGY, V33, P67, DOI 10.1017/S0031182000024288; Wigglesworth VB, 1934, J EXP BIOL, V11, P120; Wikel SK, 2018, VET SCI, V5, DOI 10.3390/vetsci5020060	31	11	11	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2019	14	8							e0221659	10.1371/journal.pone.0221659	http://dx.doi.org/10.1371/journal.pone.0221659			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5TR	31442282	Green Published, gold, Green Submitted			2022-12-26	WOS:000485041400064
J	Ito, T; Akamatsu, K; Fujita, S; Kanzaki, Y; Ukimura, A; Hoshiga, M				Ito, Takahide; Akamatsu, Kanako; Fujita, Shu-ichi; Kanzaki, Yumiko; Ukimura, Akira; Hoshiga, Masaaki			Transient depression of myocardial function after influenza virus infection: A study of echocardiographic tissue imaging	PLOS ONE			English	Article							LEFT-VENTRICULAR RELAXATION; PERFORMANCE INDEX; ATRIAL STRAIN; TROPONIN-T; DOPPLER; MANIFESTATIONS; ABNORMALITIES; ASSOCIATION; PREVALENCE; INJURY	Background Influenza virus infection (IVI) was reported to be associated with minor cardiac changes, mostly those detected on electrocardiogram with and without elevated blood markers of myocardial injury; however, the characteristics of myocardial involvement in association with IVI are poorly understood. This study used echocardiographic tissue imaging (tissue Doppler, strain, and strain rate) to evaluate changes in left atrial (LA) and left ventricular (LV) myocardial function after IVI. Methods and results We examined 20 adult individuals (mean age, 43 years) at 2 and 4 weeks after diagnosis of IVI. For myocardial functional variables, we obtained LV global longitudinal strain (GLS), LV early diastolic strain rate (e'sr), LA strain, and LA stiffness (E/e'/LA strain), in addition to data on tissue Doppler (s', e', and a') and myocardial performance index. Blood markers of myocardial injury were also examined. During follow-up, there were no significant changes in global chamber function such as LV ejection fraction, E/e', and LA volume. However, significant changes in myocardial function were observed, namely, in s' (8.0 +/- 1.6 cm/s to 9.3 +/- 1.5 cm/s; p = 0.01), e' (10.2 +/- 2.8 cm/s to 11.4 +/- 3.0 cm/s; p < 0.001), e'sr (1.43 +/- 0.44 1/s to 1.59 +/- 0.43 1/s; p = 0.005), and LA strain (35 +/- 8% to 40 +/- 12%; p = 0.025), and the myocardial performance index (0.52 +/- 0.20 to 0.38 +/- 0.09; p = 0.009), but not in a', LA stiffness, or GLS. Cardiac troponin T and creatinine kinase isoenzyme MB were not elevated significantly at any examination. Conclusions Myocardial dysfunction during IVI recovery appeared to be transient particularly in the absence of myocardial injury. Echocardiographic tissue imaging may be useful to detect subclinical cardiac changes in association with IVI.	[Ito, Takahide; Akamatsu, Kanako; Fujita, Shu-ichi; Kanzaki, Yumiko; Hoshiga, Masaaki] Osaka Med Coll, Dept Cardiol, Takatsuki, Osaka, Japan; [Ukimura, Akira] Osaka Med Coll, Dept Gen Internal Med, Takatsuki, Osaka, Japan	Osaka Medical College; Osaka Medical College	Ito, T (corresponding author), Osaka Med Coll, Dept Cardiol, Takatsuki, Osaka, Japan.	in3016@osaka-med.ac.jp		Ito, Talahide/0000-0003-4850-9132	Ministry of Education, Science, and Culture of Japan [15K09588]	Ministry of Education, Science, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by Grants in Aid for Scientific Research from the Ministry of Education, Science, and Culture of Japan (No. 15K09588). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aretz H T, 1987, Am J Cardiovasc Pathol, V1, P3; Erden I, 2010, J INFECTION, V61, P60, DOI 10.1016/j.jinf.2010.04.006; Gaibazzi N, 2005, J AM SOC ECHOCARDIOG, V18, P1270, DOI 10.1016/j.echo.2005.06.006; GIBSON TC, 1959, AM HEART J, V57, P661, DOI 10.1016/0002-8703(59)90175-9; Greaves K, 2003, ARCH INTERN MED, V163, P165, DOI 10.1001/archinte.163.2.165; Han J, 2015, EUR J CLIN INVEST, V45, P117, DOI 10.1111/eci.12386; Hochstadt A, 2011, J CARDIOTHOR VASC AN, V25, P526, DOI 10.1053/j.jvca.2010.11.026; Ison MG, 2005, CLIN INFECT DIS, V40, P415, DOI 10.1086/427282; Ito T, 2018, INTERNAL MED, V57, P1819, DOI 10.2169/internalmedicine.0316-17; Kaji M, 2001, INTERNAL MED, V40, P594, DOI 10.2169/internalmedicine.40.594; KARJALAINEN J, 1980, ACTA MED SCAND, V207, P27; Kaya MG, 2014, J THORAC DIS, V6, P429, DOI 10.3978/j.issn.2072-1439.2014.03.19; Kurt M, 2009, CIRC-CARDIOVASC IMAG, V2, P10, DOI 10.1161/CIRCIMAGING.108.813071; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; Lauer B, 1997, J AM COLL CARDIOL, V30, P1354, DOI 10.1016/S0735-1097(97)00317-3; Lee KW, 2005, AM HEART J, V150, P756, DOI 10.1016/j.ahj.2004.11.019; Li RJ, 2014, BMC CARDIOVASC DISOR, V14, DOI 10.1186/1471-2261-14-141; Mamas MA, 2008, INT J CARDIOL, V130, P304, DOI 10.1016/j.ijcard.2008.04.044; Martin L, 2019, CHEST, V155, P427, DOI 10.1016/j.chest.2018.08.1037; Morris DA, 2018, JACC-CARDIOVASC IMAG, V11, P1405, DOI 10.1016/j.jcmg.2017.07.029; Morris DA, 2014, J AM SOC ECHOCARDIOG, V27, P493, DOI 10.1016/j.echo.2014.01.017; Nagueh SF, 1997, J AM COLL CARDIOL, V30, P1527, DOI 10.1016/S0735-1097(97)00344-6; Nizamuddin J, 2017, J CARDIOTHOR VASC AN, V31, P957, DOI 10.1053/j.jvca.2016.11.007; Nogi S, 2016, ECHOCARDIOGR-J CARD, V33, P216, DOI 10.1111/echo.13022; Pathan F, 2018, JACC-CARDIOVASC IMAG, V11, P1557, DOI 10.1016/j.jcmg.2017.07.027; Reisner SA, 2004, J AM SOC ECHOCARDIOG, V17, P630, DOI 10.1016/j.echo.2004.02.011; Smiseth OA, 2016, EUR HEART J, V37, P1196, DOI 10.1093/eurheartj/ehv529; Tei C, 1995, J Cardiol, V26, P357; Tei CW, 1996, J AM COLL CARDIOL, V28, P658, DOI 10.1016/0735-1097(96)00202-1; Vallabhajosyula S, 2019, J INTENSIVE CARE MED, V34, P87, DOI 10.1177/0885066618761750; VEREL D, 1976, AM HEART J, V92, P290, DOI 10.1016/S0002-8703(76)80109-3; Wang JW, 2007, CIRCULATION, V115, P1376, DOI 10.1161/CIRCULATIONAHA.106.662882; Yoshimizu N, 2014, INTERNAL MED, V53, P109, DOI 10.2169/internalmedicine.53.1117	33	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2019	14	8							e0221628	10.1371/journal.pone.0221628	http://dx.doi.org/10.1371/journal.pone.0221628			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5TR	31442264	gold, Green Submitted, Green Published			2022-12-26	WOS:000485041400059
J	Krumm, B; Klump, GM; Koppl, C; Langemann, U				Krumm, Bianca; Klump, Georg M.; Koeppl, Christine; Langemann, Ulrike			The barn owls' Minimum Audible Angle	PLOS ONE			English	Article							SOUND-LOCALIZATION BEHAVIOR; INTERAURAL TIME DIFFERENCES; AUDITORY SPATIAL ACUITY; TYTO-ALBA; CAT; SPACE; FREQUENCIES; MECHANISMS; PRECISION; RESPONSES	Interaural time differences (ITD) and interaural level differences (ILD) are physical cues that enable the auditory system to pinpoint the position of a sound source in space. This ability is crucial for animal communication and predator-prey interactions. The barn owl has evolved an exceptional sense of hearing and shows abilities of sound localisation that outperform most other species. So far, behavioural studies in the barn owl often used reflexive responses to investigate aspects of sound localisation. Furthermore, they predominately probed the higher frequencies of the owl's hearing range (>3 kHz). In the present study we used a Go/NoGo paradigm to measure the barn owl's behavioural sound localisation acuity (expressed as the Minimum Audible Angle, MAA) as a function of stimulus type (narrow-band noise centred at 500, 1000, 2000, 4000 and 8000 Hz, and broad-band noise) and sound source position. We found significant effects of both stimulus type and sound source position on the barn owls' MAA. The MAA improved with increasing stimulus frequency, from 14 degrees at 500 Hz to 6 degrees at 8000 Hz. The smallest MAA of 4 degrees was found for broadband noise stimuli. Comparing different sound source positions revealed smaller MAAs for frontal compared to lateral stimulus presentation, irrespective of stimulus type. These results are consistent with both the known variations in physical ITDs and variation in the width of neural ITD tuning curves with azimuth and frequency. Physical and neural characteristics combine to result in better spatial acuity for frontal compared to lateral sounds and reduced localisation acuity at lower frequencies.	[Krumm, Bianca; Klump, Georg M.; Langemann, Ulrike] Carl von Ossietzky Univ Oldenburg, Cluster Excellence Hearing4all, Div Anim Physiol & Behav, Sch Med & Hlth Sci,Dept Neurosci, Oldenburg, Germany; [Krumm, Bianca; Koeppl, Christine] Carl von Ossietzky Univ Oldenburg, Cluster Excellence Hearing4all, Div Cochlea & Auditory Brainstem Physiol, Sch Med & Hlth Sci,Dept Neurosci, Oldenburg, Germany	Carl von Ossietzky Universitat Oldenburg; Carl von Ossietzky Universitat Oldenburg	Langemann, U (corresponding author), Carl von Ossietzky Univ Oldenburg, Cluster Excellence Hearing4all, Div Anim Physiol & Behav, Sch Med & Hlth Sci,Dept Neurosci, Oldenburg, Germany.	ulrike.langemann@uni-oldenburg.de			Deutsche Forschungsgemeinschaft [TRR 31, EXC 1077]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This study was funded by the Deutsche Forschungsgemeinschaft (TRR 31, EXC 1077) to GMK and CK. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bala ADS, 2003, NATURE, V424, P771, DOI 10.1038/nature01835; Bala ADS, 2000, J COMP PHYSIOL A, V186, P425, DOI 10.1007/s003590050442; Brown AD, 2018, HEARING RES, V370, P65, DOI 10.1016/j.heares.2018.10.002; CALFORD MB, 1988, J COMP PHYSIOL A, V162, P503, DOI 10.1007/BF00612515; Carlile S, 1997, HEARING RES, V114, P179, DOI 10.1016/S0378-5955(97)00161-5; CARR CE, 1993, ANNU REV NEUROSCI, V16, P223, DOI 10.1146/annurev.ne.16.030193.001255; Carr CE, 2004, J PHYSIOL-PARIS, V98, P99, DOI 10.1016/j.jphysparis.2004.03.003; CARR CE, 1990, J NEUROSCI, V10, P3227; Cazettes F, 2018, J NEUROSCI, V38, P7270, DOI 10.1523/JNEUROSCI.0947-18.2018; Cazettes F, 2016, J NEUROSCI, V36, P2101, DOI 10.1523/JNEUROSCI.3753-15.2016; Cazettes F, 2014, ELIFE, V3, DOI 10.7554/eLife.04854; Christensen-Dalsgaard J, 2011, HEARING RES, V273, P37, DOI 10.1016/j.heares.2010.08.007; Dooling R.J., 1995, METHODS COMP PSYCHOA, P161, DOI [10.1007/978-3-0348-7463-2_14, DOI 10.1007/978-3-0348-7463-2_14]; Dyson ML, 1998, J COMP PHYSIOL A, V182, P695, DOI 10.1007/s003590050214; Feinkohl A, 2016, HEARING RES, V332, P238, DOI 10.1016/j.heares.2015.04.001; Feinkohl A, 2013, J COMP PHYSIOL A, V199, P127, DOI 10.1007/s00359-012-0774-6; Fischer BJ, 2011, NAT NEUROSCI, V14, P1061, DOI 10.1038/nn.2872; Green DM, 1966, SIGNAL DETECTION THE; Grothe B, 2010, PHYSIOL REV, V90, P983, DOI 10.1152/physrev.00026.2009; Hausmann L, 2010, J COMP PHYSIOL A, V196, P601, DOI 10.1007/s00359-010-0546-0; Heffner HE, 2005, J NEUROPHYSIOL, V94, P3653, DOI 10.1152/jn.00720.2005; Heffner RS, 1997, ACTA OTO-LARYNGOL, P46; HEFFNER RS, 1988, HEARING RES, V36, P221, DOI 10.1016/0378-5955(88)90064-0; HEFFNER RS, 1985, HEARING RES, V19, P85, DOI 10.1016/0378-5955(85)90100-5; JOHNSON DH, 1980, J ACOUST SOC AM, V68, P1115, DOI 10.1121/1.384982; Keller CH, 1996, J NEUROSCI, V16, P4300; Keller CH, 1998, HEARING RES, V118, P13, DOI 10.1016/S0378-5955(98)00014-8; Kettler L, 2017, ENEURO, V4, DOI 10.1523/ENEURO.0238-17.2017; Kettler L, 2016, BIOL CYBERN, V110, P333, DOI 10.1007/s00422-016-0689-3; Kettler L, 2014, J COMP PHYSIOL A, V200, P1033, DOI 10.1007/s00359-014-0953-8; Klump GM, 2000, COMP HEARING BIRDS R, P247, DOI 10.1007/978-1-4612-1182-2_6; KNUDSEN EI, 1978, SCIENCE, V200, P795, DOI 10.1126/science.644324; KNUDSEN EI, 1977, SCIENCE, V198, P1278, DOI 10.1126/science.929202; KNUDSEN EI, 1979, J COMP PHYSIOL, V133, P13, DOI 10.1007/BF00663106; KNUDSEN EI, 1979, J COMP PHYSIOL, V133, P1, DOI 10.1007/BF00663105; Koppl C, 2015, STURKIE'S AVIAN PHYSIOLOGY, 6TH EDITION, P71; KONISHI M, 1973, AM SCI, V61, P414; Koppl C, 2005, DEV DYNAM, V233, P1248, DOI 10.1002/dvdy.20394; Koppl C, 1997, J NEUROSCI, V17, P3312; KOPPL C, 1993, J COMP PHYSIOL A, V171, P695, DOI 10.1007/BF00213066; Koppl C, 1997, J COMP NEUROL, V378, P265; Krumm B, 2017, P ROY SOC B-BIOL SCI, V284, DOI 10.1098/rspb.2017.1584; Langemann U, 2015, PHYSL PSYCHOACOUSTIC, P219; Lawson J, 1950, RAD LAB SERIES; Macmillan NA, 2005, DETECTION THEORY USE; MARTIN RL, 1987, HEARING RES, V30, P239, DOI 10.1016/0378-5955(87)90140-7; McAlpine D, 2005, J PHYSIOL-LONDON, V566, P21, DOI 10.1113/jphysiol.2005.083113; MILLS AW, 1958, J ACOUST SOC AM, V30, P237, DOI 10.1121/1.1909553; MOISEFF A, 1981, J NEUROSCI, V1, P40, DOI 10.1523/JNEUROSCI.01-01-00040.1981; MOISEFF A, 1981, J COMP PHYSIOL, V144, P299, DOI 10.1007/BF00612561; MOISEFF A, 1989, J COMP PHYSIOL A, V164, P637, DOI 10.1007/BF00614506; MOISEFF A, 1989, J COMP PHYSIOL A, V164, P629, DOI 10.1007/BF00614505; Moore JM, 2008, HEARING RES, V238, P94, DOI 10.1016/j.heares.2007.11.006; Nodal FR, 2008, NEUROSCIENCE, V154, P397, DOI 10.1016/j.neuroscience.2007.12.022; Palanca-Castan N, 2015, BRAIN BEHAV EVOLUT, P1, DOI [10.1159/000375438, DOI 10.1159/000375438]; PAYNE RS, 1971, J EXP BIOL, V54, P535; Populin LC, 1998, J NEUROSCI, V18, P2147; Singheiser M, 2010, J COMP PHYSIOL A, V196, P227, DOI 10.1007/s00359-010-0508-6; Strutt J., 1907, PHILOS MAG, V13, P214, DOI [DOI 10.1080/14786440709463595, 10.1080/14786440709463595]; Tollin DJ, 2009, J ACOUST SOC AM, V126, P3125, DOI 10.1121/1.3257234; Tollin DJ, 2005, J NEUROPHYSIOL, V93, P1223, DOI 10.1152/jn.00747.2004; von Campenhausen M, 2006, J COMP PHYSIOL A, V192, P1073, DOI 10.1007/s00359-006-0139-0; WAGNER H, 1991, J COMP PHYSIOL A, V169, P281; Wagner H, 2013, J PHYSIOL-PARIS, V107, P51, DOI 10.1016/j.jphysparis.2012.03.004; Zwicker E., 2013, PSYCHOACOUSTICS FACT	65	4	4	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2019	14	8							e0220652	10.1371/journal.pone.0220652	http://dx.doi.org/10.1371/journal.pone.0220652			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5TR	31442234	Green Published, Green Submitted, Green Accepted, gold			2022-12-26	WOS:000485041400011
J	Karimi, SS; Pante, N				Karimi, Shaghayegh Sadr; Pante, Nelly			Carbon nanotubes as molecular transporters to study a new mechanism for molecular entry into the cell nucleus using actin polymerization force	PLOS ONE			English	Article							WASP FAMILY PROTEINS; PORE COMPLEX; IMPORT; LOCALIZATION; BARRIER	The transport of macromolecules into the cell nucleus occurs through nuclear pore complexes (NPCs) and is mediated by cellular receptors. Recently, a novel mechanism of nuclear entry, in which actin polymerization provides a propulsive force driving the transport through the NPC, has been proposed. This mechanism is used by the nucleocapsid from baculovirus, one of the largest viruses to replicate in the nucleus of their host cells, which crosses the NPC and enters the nucleus independently of cellular receptors. The baculovirus nucleocapsid contains a protein that hijacks the cellular actin polymerization machinery to assemble actin filaments that propel the nucleocapsid through the host cell cytoplasm. In this study, we functionalized carbon nanotubes by covalently attaching a protein domain responsible for inducing actin polymerization and investigated their nuclear entry. We found that the functionalized carbon nanotubes were able to enter the cell nucleus under permissive conditions for actin polymerization, but not when this process was inhibited. We conclude that the mechanical force generated by actin polymerization can drive cargo entry into the cell nucleus. Our results support a novel force-driven mechanism for molecular entry into the cell nucleus.	[Karimi, Shaghayegh Sadr; Pante, Nelly] Univ British Columbia, Dept Zool, Vancouver, BC, Canada	University of British Columbia	Pante, N (corresponding author), Univ British Columbia, Dept Zool, Vancouver, BC, Canada.	pante@zoology.ubc.ca	Pante, Nelly/GVR-8478-2022	Pante, Nelly/0000-0002-0926-9378	Natural Sciences and Engineering Research Council of Canada (NSERC) [RGPIN 2017-04600, EGP 485100-15]	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by grants from the Natural Sciences and Engineering Research Council of Canada (NSERC) RGPIN 2017-04600 and EGP 485100-15 to N.P.	ADAM SA, 1990, J CELL BIOL, V111, P807, DOI 10.1083/jcb.111.3.807; Adam SA, 2016, METHODS MOL BIOL, V1411, P479, DOI 10.1007/978-1-4939-3530-7_29; Alekhina O, 2017, J CELL SCI, V130, P2235, DOI 10.1242/jcs.199570; Alto NM, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a006114; Au S, 2016, J CELL SCI, V129, P2905, DOI 10.1242/jcs.191668; Au S, 2013, VIRUSES-BASEL, V5, P1885, DOI 10.3390/v5071885; Au S, 2012, J STRUCT BIOL, V177, P90, DOI 10.1016/j.jsb.2011.11.006; Beck M, 2017, NAT REV MOL CELL BIO, V18, P73, DOI 10.1038/nrm.2016.147; Blissard GW, 2018, ANNU REV VIROL, V5, P113, DOI 10.1146/annurev-virology-092917-043356; Cautain B, 2015, FEBS J, V282, P445, DOI 10.1111/febs.13163; Christie M, 2016, J MOL BIOL, V428, P2060, DOI 10.1016/j.jmb.2015.10.023; Chu FX, 2018, METHODS, V144, P53, DOI 10.1016/j.ymeth.2018.05.023; Cohen S, 2011, BBA-MOL CELL RES, V1813, P1634, DOI 10.1016/j.bbamcr.2010.12.009; Cossart P, 2014, COLD SPRING HARB PER, V6, P8, DOI DOI 10.1101/CSHPERSPECT.A016972; Das A, 2016, J BIOL CHEM, V291, P6096, DOI 10.1074/jbc.M115.708313; Durymanov M, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.00971; Elosegui-Artola A, 2017, CELL, V171, P1397, DOI 10.1016/j.cell.2017.10.008; Fay N, 2015, CURR OPIN VIROL, V12, P59, DOI 10.1016/j.coviro.2015.03.017; Fay N, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00467; Firat-Karalar EN, 2011, CURR OPIN CELL BIOL, V23, P4, DOI 10.1016/j.ceb.2010.10.007; Goley ED, 2006, SCIENCE, V314, P464, DOI 10.1126/science.1133348; Gorlich D, 1996, EMBO J, V15, P5584, DOI 10.1002/j.1460-2075.1996.tb00943.x; Herrero-Latorre C, 2015, ANAL CHIM ACTA, V853, P77, DOI 10.1016/j.aca.2014.10.008; Jiang KY, 2004, J MATER CHEM, V14, P37, DOI 10.1039/b310359e; Kabachinski G, 2015, J CELL SCI, V128, P423, DOI 10.1242/jcs.083246; Kost TA, 2016, ADV EXP MED BIOL, V896, P187, DOI 10.1007/978-3-319-27216-0_12; Lange A, 2007, J BIOL CHEM, V282, P5101, DOI 10.1074/jbc.R600026200; Lim CG, 2018, BMB REP, V51, P623, DOI 10.5483/BMBRep.2018.51.12.237; Lomakin A, 2017, DEV CELL, V43, P547, DOI 10.1016/j.devcel.2017.11.015; Machesky LM, 2001, TRENDS CELL BIOL, V11, P286, DOI 10.1016/S0962-8924(01)02009-8; Mohr D, 2009, EMBO J, V28, P2541, DOI 10.1038/emboj.2009.200; Mueller J, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001765; Nolen BJ, 2009, NATURE, V460, P1031, DOI 10.1038/nature08231; Ohkawa T, 2010, J CELL BIOL, V190, P187, DOI 10.1083/jcb.201001162; Pante N, 2002, MOL BIOL CELL, V13, P425, DOI 10.1091/mbc.01-06-0308; Riley MK, 2017, NANOMATERIALS-BASEL, V7, DOI 10.3390/nano7050094; Shiu JY, 2018, NAT CELL BIOL, V20, P262, DOI 10.1038/s41556-017-0030-y; Stanley GJ, 2017, SEMIN CELL DEV BIOL, V68, P42, DOI 10.1016/j.semcdb.2017.05.007; Veltman DM, 2010, MOL BIOL CELL, V21, P2880, DOI 10.1091/mbc.E10-04-0372; Walsh D, 2019, TRENDS MICROBIOL, V27, P39, DOI 10.1016/j.tim.2018.06.008	40	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2019	14	8							e0221562	10.1371/journal.pone.0221562	http://dx.doi.org/10.1371/journal.pone.0221562			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5RZ	31437229	Green Published, gold, Green Submitted			2022-12-26	WOS:000485036900090
J	Zhang, JB; Koussih, L; Shan, LY; Halayko, AJ; Tliba, O; Gounni, AS				Zhang, Jingbo; Koussih, Latifa; Shan, Lianyu; Halayko, Andrew J.; Tliba, Omar; Gounni, Abdelilah S.			Glucocorticoids regulate pentraxin-3 expression in human airway smooth muscle cells	PLOS ONE			English	Article							MESSENGER-RNA; IMMUNE-RESPONSES; EPITHELIAL-CELLS; GENE-EXPRESSION; PTX3; ASTHMA; EOTAXIN/CCL11; ORGANIZATION; INFLAMMATION; RECRUITMENT	Pentraxin-3 (PTX3) is a multifunctional protein involved in both innate and adaptive immunity. Glucocorticoid (GC) is the first-line therapy to mitigate airway inflammation in asthma. Previous pieces of evidence showed that GC has divergent effects on PTX3 production in various cell types. The molecular mechanisms controlling PTX3 expression in HASMC are, however, not yet characterized. In this study, we demonstrate that the synthetic GC, dexamethasone (DEX) increases the expression of PTX3 both at the protein and mRNA levels. We also found that such an effect of DEX was dependent on de novo protein synthesis and the GC receptor (GR). While DEX increases PTX3 mRNA stability, it did not affect its promoter activity. Interestingly, HASMC pre-treated with p42/p44 ERK inhibitor, but not with p38 or JNK-MAPK inhibitors, significantly interfered with DEX-induced PTX3 secretion. Taken together, our data suggest that GC regulates PTX3 expression in HASMC through transcriptional and post-transcriptional mechanisms in a GR and ERK-dependent manner.	[Zhang, Jingbo; Koussih, Latifa; Shan, Lianyu; Gounni, Abdelilah S.] Univ Manitoba, Rady Fac Hlth Sci, Dept Immunol, Max Rady Coll Med, Winnipeg, MB, Canada; [Koussih, Latifa] Univ St Boniface, Dept Expt Sci, Winnipeg, MB, Canada; [Halayko, Andrew J.] Univ Manitoba, Rady Fac Hlth Sci, Dept Physiol & Pathophysiol, Max Rady Coll Med, Winnipeg, MB, Canada; [Tliba, Omar] Long Isl Univ, Coll Vet Med, Dept Biomed Sci, Greenvale, NY 11548 USA; [Zhang, Jingbo] Third Mil Med Univ, Xinqiao Hosp, Chongqing, Peoples R China	University of Manitoba; University of Manitoba; Army Medical University	Gounni, AS (corresponding author), Univ Manitoba, Rady Fac Hlth Sci, Dept Immunol, Max Rady Coll Med, Winnipeg, MB, Canada.; Tliba, O (corresponding author), Long Isl Univ, Coll Vet Med, Dept Biomed Sci, Greenvale, NY 11548 USA.	omar.tliba@liu.edu; Abdel.gounni@umanitoba.ca	Gounni, Abdelilah Soussi/AAH-3456-2020	Soussi Gounni, Abdelilah/0000-0002-7282-0388; Gounni, Abdelilah/0000-0003-1265-6560	Canadian Institutes of Health Research (CIHR) [PJT-149062]; Manitoba Research Chair; National Institutes of Health (NIH) [RO1HL111541]; Research Manitoba; Children Hospital Research Institute of Manitoba (CHRIM); Canadian Institutes of Health Research [PJT-149062]; National Institute of Health (NIH) [RO1HL111541]; Children Hospital Research Institute of Manitoba (CHRIM) Fellowship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL111541] Funding Source: NIH RePORTER	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Manitoba Research Chair; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research Manitoba; Children Hospital Research Institute of Manitoba (CHRIM); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); National Institute of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Children Hospital Research Institute of Manitoba (CHRIM) Fellowship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the Canadian Institutes of Health Research (CIHR) grant (PJT-149062) and Manitoba Research Chair to ASG. OT was supported by the National Institutes of Health (NIH) grant RO1HL111541. JZ was supported by a postdoctoral fellowship from Research Manitoba and the Children Hospital Research Institute of Manitoba (CHRIM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The luciferase reporter construct containing the human PTX3 promoter was kindly provided by Dr. Andrea Doni (Istituto Clinico Humanitas, Italy). We would like to thank Dr. Yafei Li for helping statistical data analyses. This work was supported by grants from the Canadian Institutes of Health Research (PJT-149062) and Manitoba Research Chair to ASG; and the National Institute of Health (NIH) grant RO1HL111541 to OT. JZ was supported by a Children Hospital Research Institute of Manitoba (CHRIM) Fellowship.	Ammit AJ, 2002, AM J RESP CELL MOL, V26, P465, DOI 10.1165/ajrcmb.26.4.4681; An SS, 2007, EUR RESPIR J, V29, P834, DOI 10.1183/09031936.00112606; Balhara J, 2017, J ALLERGY CLIN IMMUN, V139, P950, DOI 10.1016/j.jaci.2016.04.063; Cheng SS, 2002, EXP MOL PATHOL, V73, P1, DOI 10.1006/exmp.2002.2439; Cheng SS, 2002, J IMMUNOL, V168, P2887, DOI 10.4049/jimmunol.168.6.2887; Damera G, 2009, PULM PHARMACOL THER, V22, P353, DOI 10.1016/j.pupt.2008.12.006; Deban L, 2010, NAT IMMUNOL, V11, P328, DOI 10.1038/ni.1854; Deban L, 2009, BIOFACTORS, V35, P138, DOI 10.1002/biof.21; DELANY AM, 1992, J CELL BIOCHEM, V50, P400, DOI 10.1002/jcb.240500409; Doni A, 2008, J BIOL CHEM, V283, P29983, DOI 10.1074/jbc.M805631200; Dragon S, 2007, AM J PHYSIOL-LUNG C, V292, pL1023, DOI 10.1152/ajplung.00306.2006; Elias JA, 1999, J CLIN INVEST, V104, P1001, DOI 10.1172/JCI8124; Fixman ED, 2007, EUR RESPIR J, V29, P379, DOI 10.1183/09031936.00053506; Garcia-Gras EA, 2000, J BIOL CHEM, V275, P22001, DOI 10.1074/jbc.M001048200; Goncharova EA, 2003, AM J RESP CELL MOL, V29, P19, DOI 10.1165/rcmb.2002-0254OC; Gounni AS, 2005, J IMMUNOL, V175, P2613, DOI 10.4049/jimmunol.175.4.2613; Han B, 2005, J IMMUNOL, V175, P8303, DOI 10.4049/jimmunol.175.12.8303; Hirst SJ, 1998, AM J RESP CRIT CARE, V158, pS201, DOI 10.1164/ajrccm.158.supplement_2.13tac190; Holgate Stephen T, 2008, Allergol Int, V57, P1, DOI 10.2332/allergolint.R-07-154; Holgate ST, 2012, NAT MED, V18, P673, DOI 10.1038/nm.2731; Inforzato A, 2008, J BIOL CHEM, V283, P10147, DOI 10.1074/jbc.M708535200; Ing NH, 2005, BIOL REPROD, V72, P1290, DOI 10.1095/biolreprod.105.040014; James AL, 2012, AM J RESP CRIT CARE, V185, P1058, DOI 10.1164/rccm.201110-1849OC; Koziol-White CJ, 2012, BBA-MOL BASIS DIS, V1822, P1638, DOI 10.1016/j.bbadis.2012.06.012; Koziol-White CJ, 2011, IMMUNOL REV, V242, P178, DOI 10.1111/j.1600-065X.2011.01022.x; Lazaar Aili L., 2001, Current Opinion in Pharmacology, V1, P259, DOI 10.1016/S1471-4892(01)00046-7; Lazaar AL, 2006, CLIN CHEST MED, V27, P53, DOI 10.1016/j.ccm.2005.10.003; Limbourg FP, 2003, J MOL MED-JMM, V81, P168, DOI 10.1007/s00109-003-0418-y; Lin SY, 2001, SCIENCE, V291, P445, DOI 10.1126/science.291.5503.445; Maina V, 2009, J LEUKOCYTE BIOL, V86, P123, DOI 10.1189/jlb.0608345; Moalli F, 2011, J BIOMED BIOTECHNOL, P1, DOI 10.1155/2011/830421; Naureckas ET, 1999, AM J RESP CRIT CARE, V160, P2062, DOI 10.1164/ajrccm.160.6.9903131; Nino G, 2010, J ALLERGY CLIN IMMUN, V125, P1020, DOI 10.1016/j.jaci.2010.02.007; Otulakowski G, 2009, PEDIATR RES, V65, P514, DOI 10.1203/PDR.0b013e3181998db6; Pang LH, 2001, FASEB J, V15, P261, DOI 10.1096/fj.00-0103com; Pascual RM, 2005, J ALLERGY CLIN IMMUN, V116, P477, DOI 10.1016/j.jaci.2005.07.011; Rahman MS, 2005, CLIN IMMUNOL, V115, P268, DOI 10.1016/j.clim.2005.01.014; Rubino M, 2017, ONCOIMMUNOLOGY, V6, DOI 10.1080/2162402X.2017.1333215; Salio M, 2008, CIRCULATION, V117, P1055, DOI 10.1161/CIRCULATIONAHA.107.749234; Salustri A, 2004, DEVELOPMENT, V131, P1577, DOI 10.1242/dev.01056; Scarchilli L, 2007, J BIOL CHEM, V282, P30161, DOI 10.1074/jbc.M703738200; Stellato Cristiana, 2004, Proc Am Thorac Soc, V1, P255, DOI 10.1513/pats.200402-015MS; Stevens PT, 2008, CLIN EXP ALLERGY, V38, P1901, DOI 10.1111/j.1365-2222.2008.03093.x; Vega CA, 2019, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.03048; Wenzel S, 2005, AM J RESP CRIT CARE, V172, P149, DOI 10.1164/rccm.200409-1181PP; Xu ZX, 1997, AM J PHYSIOL-LUNG C, V272, pL860, DOI 10.1152/ajplung.1997.272.5.L860; Zhang JB, 2015, ALLERGY ASTHMA CL IM, V11, DOI 10.1186/s13223-015-0104-y; Zhang JB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034965; Zhu Z, 2001, AM J RESP CRIT CARE, V164, pS67, DOI 10.1164/ajrccm.164.supplement_2.2106070	49	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2019	14	8							e0220772	10.1371/journal.pone.0220772	http://dx.doi.org/10.1371/journal.pone.0220772			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5RZ	31437159	Green Submitted, Green Published, gold			2022-12-26	WOS:000485036900016
J	Darshetkar, AM; Datar, MN; Tamhankar, S; Li, P; Choudhary, RK				Darshetkar, Ashwini M.; Datar, Mandar N.; Tamhankar, Shubhada; Li, Pan; Choudhary, Ritesh Kumar			Understanding evolution in Poales: Insights from Eriocaulaceae plastome	PLOS ONE			English	Article							ACETYL-COA CARBOXYLASE; CHLOROPLAST GENOME; FLORAL ANATOMY; SEQUENCE; PHYLOGENY; GENE; PAEPALANTHOIDEAE; MITOCHONDRIAL; SYNGONANTHUS; ANNOTATION	In this study, we report the plastome of Eriocaulon decemflorum (Eriocaulaceae) and make an effort to understand the genome evolution, structural rearrangements and gene content of the order Poales by comparing it with other available plastomes. The size of complete E. decemflorum plastome is 151,671 bp with an LSC (81,477bp), SSC (17,180bp) and a pair of IRs (26,507 bp). The plastome exhibits GC content of 35.8% and 134 protein-coding genes with 19 genes duplicated in the IR region. The Eriocaulaceae plastome is characterized by the presence of accD, ycf1 and ycf2 genes and presence of introns in clpP and rpoC1 genes which have been lost in the Graminid plastomes. Phylogenomic analysis based on 81 protein- coding genes placed Eriocaulaceae sister to Mayacaceae. The present study enhances our understanding of the evolution of Poales by analyzing the plastome data from the order.	[Darshetkar, Ashwini M.; Datar, Mandar N.; Tamhankar, Shubhada; Choudhary, Ritesh Kumar] Agharkar Res Inst, Pune, Maharashtra, India; [Darshetkar, Ashwini M.; Choudhary, Ritesh Kumar] Savitribai Phule Pune Univ, Pune, Maharashtra, India; [Li, Pan] Zhejiang Univ, Coll Life Sci, Hangzhou, Zhejiang, Peoples R China	Department of Science & Technology (India); Agharkar Research Institute (ARI); Savitribai Phule Pune University; Zhejiang University	Choudhary, RK (corresponding author), Agharkar Res Inst, Pune, Maharashtra, India.; Choudhary, RK (corresponding author), Savitribai Phule Pune Univ, Pune, Maharashtra, India.; Li, P (corresponding author), Zhejiang Univ, Coll Life Sci, Hangzhou, Zhejiang, Peoples R China.	panli_zju@126.com; rkchoudhary@aripune.org	Datar, Mandar N./F-4594-2010; Datar, Mandar N./I-1245-2019	Datar, Mandar N./0000-0002-4437-7796; Datar, Mandar N./0000-0002-4437-7796; Darshetkar, Ashwini/0000-0002-1839-8091	Agharkar Research Institute [BOT-22]; Zhejiang Provincial Natural Science Foundation [LY19C030007]; National Natural Science Foundation of China [31500184]; Council for Scientific and Industrial Research (CSIR), India	Agharkar Research Institute(Department of Science & Technology (India)); Zhejiang Provincial Natural Science Foundation(Natural Science Foundation of Zhejiang Province); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Council for Scientific and Industrial Research (CSIR), India(Council of Scientific & Industrial Research (CSIR) - India)	This research was supported by Agharkar Research Institute (Grant No. BOT-22), the Zhejiang Provincial Natural Science Foundation (Grant No. LY19C030007), and the National Natural Science Foundation of China (Grant No. 31500184). A memorandum of understanding between ARI and Zhejiang University facilitated this research. The first author (AMD) acknowledges Council for Scientific and Industrial Research CSIR), India for 'Senior Research Fellowship' support.	Andrews S., 2010, FASTQC QUALITY CONTR; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Bouchenak-Khelladi Y, 2014, BOT J LINN SOC, V175, P4, DOI 10.1111/boj.12160; Cai ZQ, 2008, J MOL EVOL, V67, P696, DOI 10.1007/s00239-008-9180-7; Chang CC, 2006, MOL BIOL EVOL, V23, P279, DOI 10.1093/molbev/msj029; Chang CS, 2014, KOREA, V534, P729; Watanabe MTC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141187; Cronan JE, 2002, PROG LIPID RES, V41, P407, DOI 10.1016/S0163-7827(02)00007-3; deAndrade MJ, 2016, THESIS; Dierckxsens N, 2017, NUCLEIC ACIDS RES, V45, DOI 10.1093/nar/gkw955; Dong WL, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19030716; Downie SR, 1996, SYST BOT, V21, P135, DOI 10.2307/2419744; DOYLE JJ, 1992, P NATL ACAD SCI USA, V89, P7722, DOI 10.1073/pnas.89.16.7722; Echternacht L, 2014, TAXON, V63, P47, DOI 10.12705/631.36; Fan YH, 2016, ENVIRON TOXICOL PHAR, V43, P13, DOI 10.1016/j.etap.2015.11.001; Fyson PF, 1919, J INDIAN BOT, V2, P259; Fyson PF., 1919, J INDIAN BOT, V2, P192; Fyson PF., 1919, J INDIAN BOT, V2, P133; Fyson PF, 1919, J INDIAN BOT, V3, P91; Fyson PF, 1919, J INDIAN BOT, V3, P12; Fyson PF, 1919, J INDIAN BOT, V1, P51; Fyson PF, 1919, J INDIAN BOT, V2, P307; Giulietti Ana M., 2012, Rodriguésia, V63, P001; Givnish TJ, 2010, ANN MO BOT GARD, V97, P584, DOI 10.3417/2010023; de Andrade MJG, 2010, TAXON, V59, P379, DOI 10.1002/tax.592004; Govaerts R., 2006, WORLD CHECKLIST ERIO; Graham Sean W., 2006, Aliso, V22, P3; Guisinger MM, 2010, J MOL EVOL, V70, P149, DOI 10.1007/s00239-009-9317-3; Han BQ, 2019, MITOCHONDRIAL DNA B, V4, P666, DOI 10.1080/23802359.2019.1572475; Harris ME, 2013, PLANT MOL BIOL REP, V31, P21, DOI 10.1007/s11105-012-0461-3; Hensold N., 1988, SYSTEMATIC BOT MONOG, V23, P1; Hochbach A, 2018, TAXON, V67, P521, DOI 10.12705/673.5; Hooker J.D., 1893, FLORA BRIT INDIA, V6; Iwatsuki K, 2016, FLORA JAPAN IVB ANGI; Katayama H, 1996, CURR GENET, V29, P572, DOI 10.1007/BF02426962; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Konishi T, 1996, PLANT CELL PHYSIOL, V37, P117, DOI 10.1093/oxfordjournals.pcp.a028920; Korean J. Pl., 2014, TAXON, V44, P222; Kurtz S, 2001, NUCLEIC ACIDS RES, V29, P4633, DOI 10.1093/nar/29.22.4633; Nguyen LT, 2015, MOL BIOL EVOL, V32, P268, DOI 10.1093/molbev/msu300; 류영현, 2015, [KOREAN JOURNAL OF MEDICINAL CROP SCIENCE, 한국약용작물학회지], V23, P57, DOI 10.7783/KJMCS.2015.23.1.57; Linder HP, 2005, ANNU REV ECOL EVOL S, V36, P107, DOI 10.1146/annurev.ecolsys.36.102403.135635; Lohse M, 2007, CURR GENET, V52, P267, DOI 10.1007/s00294-007-0161-y; Ma WL, 2000, FLORA CHINA, V24, P7; MAIER RM, 1995, J MOL BIOL, V251, P614, DOI 10.1006/jmbi.1995.0460; Martin M, 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, 10.10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; McKain MR, 2016, GENOME BIOL EVOL, V8, P1150, DOI 10.1093/gbe/evw060; Michelangeli FA, 2003, AM J BOT, V90, P93, DOI 10.3732/ajb.90.1.93; Miller M.A., 2010, P GAT COMP ENV WORKS; Morris LM, 2010, AM J BOT, V97, P620, DOI 10.3732/ajb.0900226; Nashima K, 2015, TREE GENET GENOMES, V11, DOI 10.1007/s11295-015-0892-8; Ogihara Y, 2002, MOL GENET GENOMICS, V266, P740, DOI 10.1007/s00438-001-0606-9; Poczai P, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187199; POWELL W, 1995, P NATL ACAD SCI USA, V92, P7759, DOI 10.1073/pnas.92.17.7759; Rosa MM, 2007, ANN BOT-LONDON, V99, P131, DOI 10.1093/aob/mcl231; Rosa MM, 2003, FLORA, V198, P188, DOI 10.1078/0367-2530-00090; Ruhland W., 1903, PFLANZENREICH 4, V30, P1, DOI DOI 10.11606/ISSN.2316-9052.V28I2P125-140; Sasaki Y, 2004, BIOSCI BIOTECH BIOCH, V68, P1175, DOI 10.1271/bbb.68.1175; Schulte W, 1997, P NATL ACAD SCI USA, V94, P3465, DOI 10.1073/pnas.94.7.3465; Schwartz S, 2003, NUCLEIC ACIDS RES, V31, P3518, DOI 10.1093/nar/gkg579; Stutzel T., 1998, FAMILIES GENERA VASC, P197; Thiel T., 2003, MISA MICROSATELLITE; Tillich M, 2017, NUCLEIC ACIDS RES, V45, pW6, DOI 10.1093/nar/gkx391; Trovo M, 2013, BOT J LINN SOC, V171, P225, DOI 10.1111/j.1095-8339.2012.01310.x; Unwin MM., THESIS; Wang MW, 2011, CHIN MED-UK, V6, DOI 10.1186/1749-8546-6-16; Wyman SK, 2004, BIOINFORMATICS, V20, P3252, DOI 10.1093/bioinformatics/bth352; Wysocki WP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163218; Xu QL, 2013, FOOD CHEM, V139, P149, DOI 10.1016/j.foodchem.2013.01.018; Zhang Z., 1999, THESIS	70	13	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2019	14	8							e0221423	10.1371/journal.pone.0221423	http://dx.doi.org/10.1371/journal.pone.0221423			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5OC	31430346	Green Published, gold, Green Submitted			2022-12-26	WOS:000485026800050
J	Nagasu, H; Sogawa, Y; Kidokoro, K; Itano, S; Yamamoto, T; Satoh, M; Sasaki, T; Suzuki, T; Yamamoto, M; Wigley, WC; Proksch, JW; Meyer, CJ; Kashihara, N				Nagasu, Hajime; Sogawa, Yuji; Kidokoro, Kengo; Itano, Seiji; Yamamoto, Toshiya; Satoh, Minoru; Sasaki, Tamaki; Suzuki, Takafumi; Yamamoto, Masayuki; Wigley, W. Christian; Proksch, Joel W.; Meyer, Colin J.; Kashihara, Naoki			Bardoxolone methyl analog attenuates proteinuria-induced tubular damage by modulating mitochondrial function	FASEB JOURNAL			English	Article						dh404; Nrf2; reactive oxidative species; inflammation	TRANSCRIPTION FACTOR NRF2; ISCHEMIA-REPERFUSION INJURY; OXIDATIVE STRESS; KIDNEY-DISEASE; DH404; INFLAMMATION; FILTRATION; MOUSE; RATS	Multiple clinical studies have shown that bardoxolone methyl, a potent activator of nuclear factor erythroid 2-related factor 2 (Nrf2), is effective in increasing glomerular filtration rate in patients with chronic kidney disease. However, whether an Nrf2 activator can protect tubules from proteinuria-induced tubular damage via anti-inflammatory and antioxidative stress mechanisms is unknown. Using an Institute of Cancer Research-derived glomerulonephritis (ICGN) mouse model of nephrosis, we examined the effects of dihydro-CDDO-trifluoroethyl amide (dh404), a rodent-tolerable bardoxolone methyl analog, in protecting the tubulointerstitium; dh404 markedly suppressed tubular epithelial cell damage in the renal interstitium of ICGN mice. The tubular epithelial cells of ICGN mice showed a decrease in the size and number of mitochondria, as well as the breakdown of the crista structure, whereas the number and ultrastructure of mitochondria were maintained by the dh404 treatment. To further determine the effect of dh404 on mitochondrial function, we used human proximal tubular cells in vitro. Stimulation with albumin and free fatty acid increased mitochondrial reactive oxygen species (ROS). However, dh404 administration diminished mitochondrial ROS. Our data show that dh404 significantly reduced proteinuria-induced tubular cell mitochondrial damage, suggesting that improved redox balance and mitochondrial function and suppression of inflammation underlie the cytoprotective mechanism of Nrf2 activators, induding bardoxolone methyl, in diabetic kidney disease.	[Nagasu, Hajime; Sogawa, Yuji; Kidokoro, Kengo; Itano, Seiji; Yamamoto, Toshiya; Satoh, Minoru; Sasaki, Tamaki; Kashihara, Naoki] Kawasaki Med Sch, Dept Nephrol & Hypertens, 577 Matsushima, Kurashiki, Okayama 7010192, Japan; [Suzuki, Takafumi; Yamamoto, Masayuki] Tohoku Univ, Grad Sch Med, Dept Med Biochem, Sendai, Miyagi, Japan; [Wigley, W. Christian; Proksch, Joel W.; Meyer, Colin J.] Reata Pharmaceut, Irving, TX USA	Kawasaki Medical School; Tohoku University	Nagasu, H (corresponding author), Kawasaki Med Sch, Dept Nephrol & Hypertens, 577 Matsushima, Kurashiki, Okayama 7010192, Japan.	hajimenagasu@med.kawasaki-m.ac.jp	Yamamoto, Masayuki/A-4873-2010; Suzuki, Takafumi/ABC-6582-2020	Yamamoto, Masayuki/0000-0002-9073-9436; Suzuki, Takafumi/0000-0002-3425-8208	Japan Society for the Promotion of Science (JSPS) Kakenhi [24591220, 18H02828]; Kawasaki Medical School [30B-75]	Japan Society for the Promotion of Science (JSPS) Kakenhi(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Kawasaki Medical School	The authors thank Etsuko Yorimasa, Yuriko Katayama, and Ayano Higashi (Kawasaki Medical School) for providing animal care, and Satomi Hanada, Keiko Shirakiya, and Keiko Satoh (Kawasaki Medical School) for assisting with the in vitro assays. The authors also thank Kyowa Hakko Kirin Co., Ltd. (Tokyo, Japan) for supporting the preparation of this manuscript. This work was supported, in part, by the Japan Society for the Promotion of Science (JSPS) Kakenhi Grants 24591220 and 18H02828 (to H.N. and N.K.), and Kawasaki Medical School Grant 30B-75 (to T.Y.). W. Christian Wigley, Joel W. Proksch, and Colin J. Meyer have ownership of Reata Pharmaceuticals stock. The remaining authors delcare no conflicts of interest.	Aminzadeh MA, 2014, XENOBIOTICA, V44, P570, DOI 10.3109/00498254.2013.852705; Astor BC, 2011, KIDNEY INT, V79, P1331, DOI 10.1038/ki.2010.550; Bellezza I, 2012, J NUTR BIOCHEM, V23, P1583, DOI 10.1016/j.jnutbio.2011.10.012; Benson DA, 2011, NUCLEIC ACIDS RES, V39, pD32, DOI [10.1093/nar/gkw1070, 10.1093/nar/gks1195, 10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkx1094, 10.1093/nar/gkn723, 10.1093/nar/gkp1024, 10.1093/nar/gkr1202]; Chin M, 2013, AM J PHYSIOL-RENAL, V304, pF1438, DOI 10.1152/ajprenal.00387.2012; Cho AR, 2006, MAMM GENOME, V17, P407, DOI 10.1007/s00335-005-0167-z; de Cavanagh EMV, 2006, AM J PHYSIOL-REG I, V290, pR1616, DOI 10.1152/ajpregu.00615.2005; de Zeeuw D, 2013, NEW ENGL J MED, V369, P2492, DOI 10.1056/NEJMoa1306033; Dinkova-Kostova AT, 2015, FREE RADICAL BIO MED, V88, P179, DOI 10.1016/j.freeradbiomed.2015.04.036; Erkan E, 2007, J AM SOC NEPHROL, V18, P1199, DOI 10.1681/ASN.2006040407; Gilbert RE, 2017, DIABETES, V66, P791, DOI 10.2337/db16-0796; Haruna Y, 2007, P NATL ACAD SCI USA, V104, P2331, DOI 10.1073/pnas.0611079104; Holmstrom KM, 2013, BIOL OPEN, V2, P761, DOI 10.1242/bio.20134853; Ishii Y, 2005, J IMMUNOL, V175, P6968, DOI 10.4049/jimmunol.175.10.6968; Itoh K, 2004, MOL CELL BIOL, V24, P36, DOI 10.1128/MCB.24.1.36-45.2004; Itoh K, 1997, BIOCHEM BIOPH RES CO, V236, P313, DOI 10.1006/bbrc.1997.6943; Kadoya H, 2015, FASEB J, V29, P3899, DOI 10.1096/fj.15-271734; Kobayashi EH, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11624; Kume S, 2010, J CLIN INVEST, V120, P1043, DOI 10.1172/JCI41376; Lee DF, 2009, MOL CELL, V36, P131, DOI 10.1016/j.molcel.2009.07.025; Liu MC, 2014, KIDNEY INT, V85, P134, DOI 10.1038/ki.2013.357; Mori KP, 2017, J AM SOC NEPHROL, V28, P278, DOI 10.1681/ASN.2015101168; Nezu M, 2017, KIDNEY INT, V91, P387, DOI 10.1016/j.kint.2016.08.023; Nishi Y, 2013, KIDNEY INT, V83, P662, DOI 10.1038/ki.2012.475; O'Neill LAJ, 2016, NAT REV IMMUNOL, V16, P553, DOI 10.1038/nri.2016.70; Pergola PE, 2011, NEW ENGL J MED, V365, P327, DOI 10.1056/NEJMoa1105351; Robles L, 2016, PANCREAS, V45, P720, DOI 10.1097/MPA.0000000000000518; Ruiz S, 2013, KIDNEY INT, V83, P1029, DOI 10.1038/ki.2012.439; Satoh M, 2011, LAB INVEST, V91, P190, DOI 10.1038/labinvest.2010.175; Seng S, 2010, J BIOL CHEM, V285, P26190, DOI 10.1074/jbc.M109.095786; Suzuki T, 2017, J BIOL CHEM, V292, P16817, DOI 10.1074/jbc.R117.800169; Taal MW, 2008, KIDNEY INT, V73, P1216, DOI 10.1038/ki.2008.36; Tan SM, 2014, DIABETES, V63, P3091, DOI 10.2337/db13-1743; Thomas B, 2017, J AM SOC NEPHROL, V28, P2167, DOI 10.1681/ASN.2016050562; Xiao L, 2017, REDOX BIOL, V11, P297, DOI 10.1016/j.redox.2016.12.022; Zhuang YB, 2015, AM J PHYSIOL-RENAL, V308, pF1012, DOI 10.1152/ajprenal.00509.2014	36	26	28	1	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2019	33	11					12253	12263		10.1096/fj.201900217R	http://dx.doi.org/10.1096/fj.201900217R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC8ZX	31431054	Green Published, hybrid			2022-12-26	WOS:000507461600051
J	Roberson, S; Dawit, R; Moore, J; Odoi, A				Roberson, Shamarial; Dawit, Rahel; Moore, Jaleesa; Odoi, Agricola			An exploratory investigation of geographic disparities of stroke prevalence in Florida using circular and flexible spatial scan statistics	PLOS ONE			English	Article							HEART-DISEASE; COUNTY-LEVEL; RISK-FACTORS; CLUSTERS; DISABILITY; AGREEMENT; MORTALITY; UPDATE; HEALTH	Background Stroke is a major public health concern due to the morbidity and mortality associated with it. Identifying geographic areas with high stroke prevalence is important for informing public health interventions. Therefore, the objective of this study was to investigate geographic disparities and identify geographic hotspots of stroke prevalence in Florida. Materials and methods County-level stroke prevalence data for 2013 were obtained from the Florida Department of Health's Behavioral Risk Factor Surveillance System (BRFSS). Geographic clusters of stroke prevalence were investigated using the Kulldorff's circular spatial scan statistics (CSSS) and Tango's flexible spatial scan statistics (FSSS) under Poisson model assumption. Exact McNemar's test was used to compare the proportion of cluster counties identified by each of the two methods. Both Cohen's Kappa and bias adjusted Kappa were computed to assess the level of agreement between CSSS and FSSS methods of cluster detection. Goodness-of-fit of the models were compared using Cluster Information Criterion. Identified clusters and selected stroke risk factors were mapped. Results Overall, 3.7% of adults in Florida reported that they had been told by a healthcare professional that they had suffered a stroke. Both CSSS and FSSS methods identified significant high prevalence stroke spatial clusters. However, clusters identified using CSSS tended to be larger than those identified using FSSS. The FSSS had a better fit than the CSSS. Most of the identified clusters are explainable by the prevalence distributions of the known risk factors assessed. Conclusions Geographic disparities of stroke risk exists in Florida with some counties having significant hotspots of high stroke prevalence. This information is important in guiding future research and control efforts to address the problem. Kulldorff's CSSS and Tango's FSSS are complementary to each other and should be used together to provide a more complete picture of the distributions of spatial clusters of health outcomes.	[Roberson, Shamarial; Dawit, Rahel; Moore, Jaleesa] Florida Dept Hlth, Div Community Hlth Promot, Bur Chron Dis Prevent, Tallahassee, FL USA; [Odoi, Agricola] Univ Tennessee, Coll Vet Med, Biomed & Diagnost Sci, Knoxville, TN 37996 USA	Florida Department of Health; University of Tennessee System; University of Tennessee Knoxville; UT Institute of Agriculture	Odoi, A (corresponding author), Univ Tennessee, Coll Vet Med, Biomed & Diagnost Sci, Knoxville, TN 37996 USA.	aodoi@utk.edu	Odoi, Agricola/I-9532-2019	Odoi, Agricola/0000-0001-5050-6737	NCI NIH HHS [T32 CA160056] Funding Source: Medline	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Ba HO, 2018, INT J HYPERTENS, V2018, DOI 10.1155/2018/6959165; Baernholdt M, 2012, J RURAL HEALTH, V28, P339, DOI 10.1111/j.1748-0361.2011.00403.x; Benjamin EJ, 2019, CIRCULATION, V139, pE56, DOI 10.1161/CIR.0000000000000659; BYRT T, 1993, J CLIN EPIDEMIOL, V46, P423, DOI 10.1016/0895-4356(93)90018-V; (CDC) C for DC and P, 2017, STATS OF THE STATE O; Duczmal L, 2004, COMPUT STAT DATA AN, V45, P269, DOI 10.1016/S0167-9473(02)00302-X; EASTON JD, 1995, CEREBROVASC DIS, V5, P375, DOI 10.1159/000107887; ESRI, 2016, ARCGIS 10 5; Feigin VL, 2018, NEW ENGL J MED, V379, P2429, DOI 10.1056/NEJMoa1804492; Go AS, 2014, CIRCULATION, V129, pE28, DOI 10.1161/01.cir.0000441139.02102.80; Goranson C, 2008, CLUSTER DETECTION CO; Hankey GJ, 2002, STROKE, V33, P1034, DOI 10.1161/01.STR.0000012515.66889.24; Harris T, 2013, TIBETAN TRADE GLOBAL; Karp DN, 2016, STROKE, V47, P1939, DOI 10.1161/STROKEAHA.116.012997; Kochanek Kenneth D, 2017, NCHS Data Brief, P1; Kulldorff M, 1997, COMMUN STAT-THEOR M, V26, P1481, DOI 10.1080/03610929708831995; KULLDORFF M, 1995, STAT MED, V14, P799, DOI 10.1002/sim.4780140809; Kulldorff M, 2016, SATSCAN V9 4 4 SOFTW; Labarthe DR, 2016, NEUROEPIDEMIOLOGY, V47, P96, DOI 10.1159/000449102; Lachkhem Y, 2018, STROKE RES TREAT, V2018, DOI 10.1155/2018/1897569; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Liao YL, 2009, STROKE, V40, P3336, DOI 10.1161/STROKEAHA.109.561688; Liu BT, 2019, INT J HYPERTENS, V2019, DOI 10.1155/2019/6413102; O'Donnell MJ, 2010, LANCET, V376, P112, DOI 10.1016/S0140-6736(10)60834-3; Office Prevention and Health Promotion, 2016, HEART DIS STROK HLTH; Petrea RE, 2009, STROKE, V40, P1032, DOI 10.1161/STROKEAHA.108.542894; R Core Team, 2021, R LANGUAGE ENV STAT; Rajsic S, 2019, EUR J HEALTH ECON, V20, P107, DOI 10.1007/s10198-018-0984-0; Rashid P, 2003, STROKE, V34, P2741, DOI 10.1161/01.STR.0000092488.40085.15; Roberson S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0145224; SAS Institute Inc, 2017, SAS 9 4 HELP DOC; Schieb LJ, 2013, STROKE, V44, P146, DOI 10.1161/STROKEAHA.112.669705; Sheeran M, 2019, CIRC-CARDIOVASC QUAL, V12, DOI [10.1161/hcq.12.suppl_1.180, DOI 10.1161/HCQ.12.SUPPL_1.180]; SIEGEL PZ, 1992, PUBLIC HEALTH REP, V107, P540; Tango T., 2008, JAPAN J BIOM, V29, P75, DOI [10.5691/jjb.29.75, DOI 10.5691/JJB.29.75]; Tango T, 2012, STAT MED, V31, P4207, DOI 10.1002/sim.5478; Tango Toshiro, 2005, Int J Health Geogr, V4, P11, DOI 10.1186/1476-072X-4-11; Thomsen PT, 2006, PREV VET MED, V75, P133, DOI 10.1016/j.prevetmed.2006.02.004; van Rheenen S, 2015, CAN J NEUROL SCI, V42, P299, DOI 10.1017/cjn.2015.241; WOLF PA, 1991, STROKE, V22, P983, DOI 10.1161/01.STR.22.8.983; Zhang FL, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-015758	41	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2019	14	8							e0218708	10.1371/journal.pone.0218708	http://dx.doi.org/10.1371/journal.pone.0218708			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW6BO	31469839	Green Published, gold, Green Submitted			2022-12-26	WOS:000485062200005
J	Das Gupta, R; Haider, SS; Sutradhar, I; Hashan, MR; Sajal, IH; Hasan, M; Haider, MR; Sarker, M				Das Gupta, Rajat; Haider, Shams Shabab; Sutradhar, Ipsita; Hashan, Mohammad Rashidul; Sajal, Ibrahim Hossain; Hasan, Mehedi; Haider, Mohammad Rifat; Sarker, Malabika			Association of frequency of television watching with overweight and obesity among women of reproductive age in India: Evidence from a nationally representative study	PLOS ONE			English	Article							GESTATIONAL DIABETES-MELLITUS; PHYSICAL-ACTIVITY; NONCOMMUNICABLE DISEASES; CHILDREN	Background For women of reproductive age, overweight and obesity are an established risk factor for several medical complications. To address the increasing rate of obesity in India through public health awareness programs, the association between common behaviors and overweight and obesity needs to be investigated. This study aims to determine whether there is any association between the frequency of television watching and overweight and obesity among women of reproductive age (15-49 years) in India. Methods This is a cross-sectional study that utilized data from the National Family Health Survey (NFHS-4), which utilized a nationally representative sample from all 29 states and 7 union territories of India. The survey itself followed a two-staged stratified random sampling technique. The primary outcome of interest was overweight (23.0 kg/m(2) to <27.5 kg/m(2)) and obesity (>= 27.5 kg/m(2)), measured by using the Asian body mass index cut-off. The major explanatory variable was the frequency of television watching, measured in days per week. Sample weight of NFHS-4 was adjusted during the analysis. Multilevel ordered logistic regression was conducted to identify the factors associated with overweight and obesity. To show the strength of association, both the unadjusted Crude Odds Ratio (COR) and the Adjusted Odds Ratio (AOR) were reported with a 95% confidence interval (CI). A p-value<0.05 was considered statistically significant. Results The analysis included weighted data from 644,006 Indian women of reproductive age (15-49 years). Among the respondents, 33.5% were overweight or obese (BMI >= 23.0 kg/m(2)). The prevalence of overweight and obesity increased with age (p-value <0.0001) and almost half of the women aged 35-49 years were either overweight or obese (48.6%). The prevalence was significantly higher among those living in an urban area compared to a rural area (urban 46.5% vs. rural 26.5%; p-value <0.001). The prevalence of overweight and obesity increased with the frequency of watching television and was the highest among the individuals who reported watching television almost every day (p-value <0.0001). Women watching television almost every day had 24% (AOR: 1.24, 95% CI: 1.21-1.26; p-value <0.001) increased odds of being overweight and obese compared to their counterparts who never watched television. Conclusions This study found that the likelihood of being overweight and obese significantly increased with the frequency of watching television; likely due to physical inactivity during leisure time. Further studies should examine the physical activity and food habits of this target group. Public health promotion programs in India should raise awareness regarding the harmful effects of the sedentary lifestyle associated with watching television.	[Das Gupta, Rajat; Sutradhar, Ipsita; Hasan, Mehedi; Sarker, Malabika] BRAC Univ, BRAC James P Grant Sch Publ Hlth, Ctr Noncommunicable Dis & Nutr, 68 Shaheed Tajuddin Ahmed Sarani, Dhaka, Bangladesh; [Das Gupta, Rajat; Haider, Shams Shabab; Sutradhar, Ipsita; Sajal, Ibrahim Hossain; Hasan, Mehedi; Sarker, Malabika] BRAC Univ, BRAC James P Grant Sch Publ Hlth, Ctr Sci Implementat & Scale Up, 68 Shaheed Tajuddin Ahmed Sarani, Dhaka, Bangladesh; [Das Gupta, Rajat] Univ South Carolina, Arnold Sch Publ Hlth, Dept Epidemiol & Biostat, Columbia, SC 29208 USA; [Hashan, Mohammad Rashidul] Dhaka Med Coll & Hosp, Dhaka, Bangladesh; [Sajal, Ibrahim Hossain] Univ Texas Dallas, Sch Nat Sci & Math, Dept Math Sci, Dallas, TX USA; [Haider, Mohammad Rifat] Ohio Univ, Coll Hlth Sci & Profess, Dept Social & Publ Hlth, Athens, OH 45701 USA; [Sarker, Malabika] Heidelberg Univ, Inst Publ Hlth, Heidelberg, Germany	Bangladesh Rural Advancement Committee BRAC; BRAC University; Bangladesh Rural Advancement Committee BRAC; BRAC University; University of South Carolina System; University of South Carolina Columbia; Dhaka Medical College; University of Texas System; University of Texas Dallas; University System of Ohio; Ohio University; Ruprecht Karls University Heidelberg	Das Gupta, R (corresponding author), BRAC Univ, BRAC James P Grant Sch Publ Hlth, Ctr Noncommunicable Dis & Nutr, 68 Shaheed Tajuddin Ahmed Sarani, Dhaka, Bangladesh.; Das Gupta, R (corresponding author), BRAC Univ, BRAC James P Grant Sch Publ Hlth, Ctr Sci Implementat & Scale Up, 68 Shaheed Tajuddin Ahmed Sarani, Dhaka, Bangladesh.; Das Gupta, R (corresponding author), Univ South Carolina, Arnold Sch Publ Hlth, Dept Epidemiol & Biostat, Columbia, SC 29208 USA.	rajat89.dasgupta@gmail.com	Gupta, Rajat Das/E-5545-2018; Haider, Mohammad Rifat/N-9987-2016; Sutradhar, Ipsita/AAW-6456-2021; Hasan, Mehedi/J-8056-2019; Hasan, Mehedi/HHC-4236-2022	Gupta, Rajat Das/0000-0002-7680-676X; Haider, Mohammad Rifat/0000-0002-0690-8242; Sutradhar, Ipsita/0000-0003-4747-7693; Hasan, Mehedi/0000-0003-2153-4979; 				Al-Ghamdi SH, 2013, J FAM COMMUNITY MED, V20, P83, DOI 10.4103/2230-8229.114767; Anjana RM, 2014, INT J BEHAV NUTR PHY, V11, DOI 10.1186/1479-5868-11-26; Basen-Engquist K, 2011, CURR ONCOL REP, V13, P71, DOI 10.1007/s11912-010-0139-7; Bennett GG, 2006, AM J PUBLIC HEALTH, V96, P1681, DOI 10.2105/AJPH.2005.080580; Biswas T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181080; Bonita R, 2013, LANCET, V381, P575, DOI 10.1016/S0140-6736(12)61993-X; Burke V, 2006, INT J PEDIATR OBES, V1, P248, DOI 10.1080/17477160600984975; Chen CY, 2015, SAGE OPEN, V5, DOI 10.1177/2158244015600480; Chopra SM, 2013, EUR J CLIN NUTR, V67, P688, DOI 10.1038/ejcn.2013.70; Das Gupta R, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-024680; Das Gupta R, 2018, EXPERT REV ENDOCRINO, V13, P149, DOI 10.1080/17446651.2018.1471354; Dinsa GD, 2012, OBES REV, V13, P1067, DOI 10.1111/j.1467-789X.2012.01017.x; Ezzati M, 2017, LANCET, V390, P2627, DOI 10.1016/S0140-6736(17)32129-3; Filmer D, 2001, DEMOGRAPHY, V38, P115, DOI 10.2307/3088292; Foucaut AM, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0210770; Garcia G, 2012, OBES SURG, V22, P810, DOI 10.1007/s11695-012-0601-8; Ghavamzadeh S, 2013, J HEALTH POPUL NUTR, V31, P334; Ghose B, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-020802; Ghose B, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-017142; Goldstein H., 2011, CLIN PHARMACOKINET, P1, DOI [DOI 10.2165/00003088-198207020-00001, DOI 10.1002/9780470973394]; Government of India International Institute for Population Sciences (IIPS) and ICF, 2022, NATL FAMILY HLTH SUR; Hox J.J, 2010, MULTILEVEL ANAL TECH, V2nd ed., DOI [10.4324/9780203852279, DOI 10.4324/9780203852279]; Hruby A, 2015, PHARMACOECONOMICS, V33, P673, DOI 10.1007/s40273-014-0243-x; Janjua NZ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122314; Jolliffe IT, 2016, PHILOS T R SOC A, V374, DOI 10.1098/rsta.2015.0202; Joseph N, 2015, J CLIN DIAGN RES, V9, pLC13, DOI 10.7860/JCDR/2015/13103.5969; Kanguru L, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188677; Kim SY, 2010, AM J PUBLIC HEALTH, V100, P1047, DOI 10.2105/AJPH.2009.172890; Kovesdy Csaba P, 2017, Afr J Prim Health Care Fam Med, V9, pe1, DOI 10.4102/phcfm.v9i1.1435; Kutner M. H., 2004, APPL LINEAR STAT MOD; Maher C, 2012, ACTA PAEDIATR, V101, P1170, DOI 10.1111/j.1651-2227.2012.02804.x; MALDONADO G, 1993, AM J EPIDEMIOL, V138, P923, DOI 10.1093/oxfordjournals.aje.a116813; Ministry of Health and Family Welfare. Government of India, NAT ACT PLAN MON FRA; Ministry of Health Nepal New ERA ICF, 2017, NEP HLTH FAC SURV 20; Nethan Suzanne, 2017, Asian Pac J Cancer Prev, V18, P2005, DOI 10.22034/APJCP.2017.18.7.2005; Nuttall Frank Q, 2015, Nutr Today, V50, P117; Piryani S, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010335; Rabe-Hesketh S., 2008, MULTILEVEL LONGITUDI; Resource Centre for Primary Health Care, 2014, RAP ASS MED COV JUNK; Rey-Lopez JP, 2008, NUTR METAB CARDIOVAS, V18, P242, DOI 10.1016/j.numecd.2007.07.008; Sharma R, 2013, REPROD BIOL ENDOCRIN, V11, DOI 10.1186/1477-7827-11-66; Stanaway JD, 2018, LANCET, V392, P1923, DOI 10.1016/s0140-6736(18)32225-6; Unnikrishnan, 2012, J MED NUTR NUTRACEUT, V1, P37, DOI DOI 10.4103/2278-019X.94634; Webber L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039589; WHO, 2004, LANCET, V363, P902; Wojtyla A, 2011, ANN AGR ENV MED, V18, P365; Zairian S, 2013, FOOD CULT SOC, V16, P551, DOI 10.2752/175174413X13758634982010	47	8	9	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2019	14	8							e0221758	10.1371/journal.pone.0221758	http://dx.doi.org/10.1371/journal.pone.0221758			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW6AB	31465465	Green Submitted, Green Published, gold			2022-12-26	WOS:000485058200045
J	Steele, JFC; Hughes, RK; Banfield, MJ				Steele, John F. C.; Hughes, Richard K.; Banfield, Mark J.			Structural and biochemical studies of an NB-ARC domain from a plant NLR immune receptor	PLOS ONE			English	Article							LEUCINE-RICH REPEAT; SECONDARY STRUCTURE ANALYSES; NUCLEOTIDE-BINDING DOMAIN; RUST RESISTANCE PROTEIN; PROGRAMMED CELL-DEATH; COILED-COIL DOMAINS; DISEASE RESISTANCE; CYTOCHROME-C; FLAX RUST; PROVIDES INSIGHTS	Plant NLRs are modular immune receptors that trigger rapid cell death in response to attempted infection by pathogens. A highly conserved nucleotide-binding domain shared with APAF-1, various R-proteins and CED-4 (NB-ARC domain) is proposed to act as a molecular switch, cycling between ADP (repressed) and ATP (active) bound forms. Studies of plant NLR NB-ARC domains have revealed functional similarities to mammalian homologues, and provided insight into potential mechanisms of regulation. However, further advances have been limited by difficulties in obtaining sufficient yields of protein suitable for structural and biochemical techniques. From protein expression screens in Escherichia coli and Sf9 insect cells, we defined suitable conditions to produce the NB-ARC domain from the tomato NLR NRC1. Biophysical analyses of this domain showed it is a folded, soluble protein. Structural studies revealed the NRC1 NB-ARC domain had co-purified with ADP, and confirmed predicted structural similarities between plant NLR NB-ARC domains and their mammalian homologues.	[Steele, John F. C.; Hughes, Richard K.; Banfield, Mark J.] Norwich Res Pk, Dept Biol Chem, John Innes Ctr, Norwich, Norfolk, England; [Steele, John F. C.] Lawrence Berkeley Natl Lab, Environm Genom & Syst Biol Div, Berkeley, CA USA	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory	Banfield, MJ (corresponding author), Norwich Res Pk, Dept Biol Chem, John Innes Ctr, Norwich, Norfolk, England.	mark.banfield@jic.ac.uk	Banfield, Mark/C-7453-2013; Hughes, Richard/E-9642-2015; Steele, John/E-7031-2017	Banfield, Mark/0000-0001-8921-3835; Hughes, Richard/0000-0001-9910-6566; Steele, John/0000-0002-4388-4956	Biotechnology and Biological Sciences Research Council (BBSRC, UK) [BB/P012574, BB/J004553]; John Innes Foundation; BBSRC [BBS/E/J/000PR9795] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council (BBSRC, UK)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); John Innes Foundation; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This research was funded by the Biotechnology and Biological Sciences Research Council (BBSRC, UK, www.bbsrc.ac.uk), including grant nos. BB/P012574, BB/J004553, both awarded to MJB, and the John Innes Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Axtell MJ, 2003, CELL, V112, P369, DOI 10.1016/S0092-8674(03)00036-9; Bai SW, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002752; BARBER MS, 1989, PHYSIOL MOL PLANT P, V34, P3, DOI 10.1016/0885-5765(89)90012-X; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; BAUREITHEL K, 1994, J BIOL CHEM, V269, P17931; Bej A, 2014, COMPUT BIOL MED, V53, P164, DOI 10.1016/j.compbiomed.2014.07.016; Bendahmane A, 2002, PLANT J, V32, P195, DOI 10.1046/j.1365-313X.2002.01413.x; Bentham A, 2017, ANN BOT-LONDON, V119, P689, DOI 10.1093/aob/mcw171; Bernoux M, 2011, CELL HOST MICROBE, V9, P200, DOI 10.1016/j.chom.2011.02.009; Berrow NS, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm047; Casey LW, 2016, P NATL ACAD SCI USA, V113, P12856, DOI 10.1073/pnas.1609922113; Cesari S, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00606; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chen XR, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-980; Delorenzi M, 2002, BIOINFORMATICS, V18, P617, DOI 10.1093/bioinformatics/18.4.617; Deslandes L, 2002, P NATL ACAD SCI USA, V99, P2404, DOI 10.1073/pnas.032485099; DeYoung BJ, 2006, NAT IMMUNOL, V7, P1243, DOI 10.1038/ni1410; Dodds PN, 2006, P NATL ACAD SCI USA, V103, P8888, DOI 10.1073/pnas.0602577103; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Fariselli P, 2007, LECT NOTES COMPUT SC, V4414, P292; Felix G, 1999, PLANT J, V18, P265, DOI 10.1046/j.1365-313X.1999.00265.x; Fenyk S, 2012, J BIOL CHEM, V287, P4023, DOI 10.1074/jbc.M111.314450; Finn RD, 2016, NUCLEIC ACIDS RES, V44, pD279, DOI 10.1093/nar/gkv1344; Flor HH, 1942, PHYTOPATHOLOGY, V32, P653; FLOR HH, 1955, PHYTOPATHOLOGY, V45, P680; Fujiwara S, 2004, MOL PLANT MICROBE IN, V17, P986, DOI 10.1094/MPMI.2004.17.9.986; Gabriels SHEJ, 2007, PLANT J, V50, P14, DOI 10.1111/j.1365-313X.2007.03027.x; Georgiou G, 1996, CURR OPIN BIOTECH, V7, P190, DOI 10.1016/S0958-1669(96)80012-7; Gomez-Gomez L, 2000, MOL CELL, V5, P1003, DOI 10.1016/S1097-2765(00)80265-8; Hanson PI, 2005, NAT REV MOL CELL BIO, V6, P519, DOI 10.1038/nrm1684; Hao W, 2013, J BIOL CHEM, V288, P35868, DOI 10.1074/jbc.M113.517417; Hematy K, 2009, CURR OPIN PLANT BIOL, V12, P406, DOI 10.1016/j.pbi.2009.06.007; Holm L, 2016, NUCLEIC ACIDS RES, V44, pW351, DOI 10.1093/nar/gkw357; Hu ZH, 2013, SCIENCE, V341, P172, DOI 10.1126/science.1236381; Jiang XJ, 2000, J BIOL CHEM, V275, P31199, DOI 10.1074/jbc.C000405200; Jones DA, 1997, ADV BOT RES, V24, P89; Jones JDG, 2016, SCIENCE, V354, DOI 10.1126/science.aaf6395; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Kim HE, 2005, P NATL ACAD SCI USA, V102, P17545, DOI 10.1073/pnas.0507900102; King SRF, 2014, PLANT CELL, V26, P1345, DOI 10.1105/tpc.113.120055; Kobe B, 2001, CURR OPIN STRUC BIOL, V11, P725, DOI 10.1016/S0959-440X(01)00266-4; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lamb C, 1997, ANNU REV PLANT PHYS, V48, P251, DOI 10.1146/annurev.arplant.48.1.251; Lelpe DD, 2004, J MOL BIOL, V343, P1, DOI 10.1016/j.jmb.2004.08.023; Li XY, 2005, P NATL ACAD SCI USA, V102, P12990, DOI 10.1073/pnas.0502425102; Maekawa T, 2011, NAT IMMUNOL, V12, P818, DOI 10.1038/ni.2083; Maekawa T, 2011, CELL HOST MICROBE, V9, P187, DOI 10.1016/j.chom.2011.02.008; Maqbool A, 2015, ELIFE, V4, DOI 10.7554/eLife.08709; Martino L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164662; McHale L, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-4-212; Meyers BC, 1999, PLANT J, V20, P317, DOI 10.1046/j.1365-313X.1999.t01-1-00606.x; Mogensen TH, 2009, CLIN MICROBIOL REV, V22, P240, DOI 10.1128/CMR.00046-08; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Nimchuk Z, 2003, ANNU REV GENET, V37, P579, DOI 10.1146/annurev.genet.37.110801.142628; Offord V, 2010, DEV COMP IMMUNOL, V34, P1035, DOI 10.1016/j.dci.2010.05.004; Ortiz D, 2017, PLANT CELL, V29, P156, DOI 10.1105/tpc.16.00435; Qi D, 2012, PLANT PHYSIOL, V158, P1819, DOI 10.1104/pp.112.194035; Riedl SJ, 2005, NATURE, V434, P926, DOI 10.1038/nature03465; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Shao F, 2003, SCIENCE, V301, P1230, DOI 10.1126/science.1085671; Stakman EC, 1915, J AGRIC RES, V4, P193; Sueldo DJ, 2015, NEW PHYTOL, V208, P210, DOI 10.1111/nph.13459; Takken FLW, 2012, CURR OPIN PLANT BIOL, V15, P375, DOI 10.1016/j.pbi.2012.05.001; Takken FLW, 2006, CURR OPIN PLANT BIOL, V9, P383, DOI 10.1016/j.pbi.2006.05.009; Tameling WIL, 2002, PLANT CELL, V14, P2929, DOI 10.1105/tpc.005793; Tameling WIL, 2006, PLANT PHYSIOL, V140, P1233, DOI 10.1104/pp.105.073510; Tatzelt J, 1996, EMBO J, V15, P6363, DOI 10.1002/j.1460-2075.1996.tb01027.x; Van Ooijen G, 2008, J EXP BOT, V59, P1383, DOI 10.1093/jxb/ern045; Walden M, 2014, PROTEINS, V82, P517, DOI 10.1002/prot.24420; Wang GF, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004674; Waterman D. G., 2013, CCP4 NEWSLETTER PROT, V49, P16; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371; Whitmore L, 2008, BIOPOLYMERS, V89, P392, DOI 10.1002/bip.20853; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Williams SJ, 2014, SCIENCE, V344, P299, DOI 10.1126/science.1247357; Williams SJ, 2011, MOL PLANT MICROBE IN, V24, P897, DOI 10.1094/MPMI-03-11-0052; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Winter G, 2013, ACTA CRYSTALLOGR D, V69, P1260, DOI 10.1107/S0907444913015308; Xiang TT, 2008, CURR BIOL, V18, P74, DOI 10.1016/j.cub.2007.12.020; Xu YW, 2000, NATURE, V408, P111, DOI 10.1038/35040600; Yan N, 2005, NATURE, V437, P831, DOI 10.1038/nature04002; Yang ZR, 2005, BIOINFORMATICS, V21, P3369, DOI 10.1093/bioinformatics/bti534; Yuan SJ, 2011, STRUCTURE, V19, P128, DOI 10.1016/j.str.2010.10.009; Zhang J, 2007, CELL HOST MICROBE, V1, P175, DOI 10.1016/j.chom.2007.03.006; Zhou MY, 2015, GENE DEV, V29, P2349, DOI 10.1101/gad.272278.115	88	27	28	4	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2019	14	8							e0221226	10.1371/journal.pone.0221226	http://dx.doi.org/10.1371/journal.pone.0221226			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5XV	31461469	Green Published, Green Submitted, gold			2022-12-26	WOS:000485052300027
J	Qneibi, M; Hamed, O; Natsheh, AR; Fares, O; Jaradat, N; Emwas, N; AbuHasan, Q; Al-Kerm, R; Al-Kerm, R				Qneibi, Mohammad; Hamed, Othman; Natsheh, Abdel-Razzak; Fares, Oswa; Jaradat, Nidal; Emwas, Nour; AbuHasan, Qais; Al-Kerm, Rana; Al-Kerm, Rola			Inhibition and assessment of the biophysical gating properties of GluA2 and GluA2/A3 AMPA receptors using curcumin derivatives	PLOS ONE			English	Article							GLUTAMATE RECEPTORS; MECHANISM; TALAMPANEL; EXCITOTOXICITY; PHARMACOLOGY; SAFETY; NMDA; DRUG	The development of efficacious and safe drugs for the treatment of neurological diseases related to glutamate toxicity has been a focus in neuropharmacological research. Specifically, discovering antagonists to modulate the activity and kinetics of AMPA receptors, which are the fastest ligand-gated ion channels involved in excitatory neurotransmission in response to glutamate. Thus, the current study investigated novel curcumin derivatives on the biophysical properties of AMPA receptors, specifically on the homomeric GluA2 and the heteromeric GluA2/A3 subunits and assessed for inhibitory actions. The biophysical parameter (i.e., desensitization, deactivation, and peak currents) were measured by using whole-cell patch clamp electrophysiology with and without the administration of the derivatives onto HEK293 cells. CR-NN, CR-NNPh, CR-MeNH, and CR-NO of the tested derivatives showed inhibition on all AMPA receptors up to 6 folds. Moreover, the inhibitory derivatives also increased desensitization and deactivation, which further intensifies the compounds' neuroprotective effects. However, CR-PhCl, CR-PhF, and CR-PhBr did not show any significant changes on the peak current, deactivation or desensitization rates. By comparison to other discovered and widely used antagonist, the prepared curcumin derivatives are not selective to a specific AMPA subunit, instead implement its effect in the same way between all types of AMPA receptors. Additionally, the obtained results provide derivatives that not only noncompetitively inhibit AMPARs but also decrease its biophysical kinetics, specifically desensitization and deactivation rates. Hence, to potentially serve as a new AMPAR inhibitor with therapeutic potential, the current study provides compounds that are non-selective and non-competitive antagonist, which also effect the desensitization and deactivation rates of the receptor.	[Qneibi, Mohammad; Emwas, Nour; AbuHasan, Qais] An Najah Natl Univ, Fac Med & Hlth Sci, Dept Biomed Sci, Nablus, Palestine; [Hamed, Othman; Fares, Oswa; Al-Kerm, Rana; Al-Kerm, Rola] An Najah Natl Univ, Fac Sci, Dept Chem, Nablus, Palestine; [Natsheh, Abdel-Razzak] An Najah Natl Univ, Fac Engn & Informat Technol, Dept Comp Informat Syst, Nablus, Palestine; [Jaradat, Nidal] An Najah Natl Univ, Fac Med & Hlth Sci, Dept Pharm, Nablus, Palestine	An Najah National University; An Najah National University; An Najah National University; An Najah National University	Qneibi, M (corresponding author), An Najah Natl Univ, Fac Med & Hlth Sci, Dept Biomed Sci, Nablus, Palestine.	mqneibi@najah.edu	Jaradat, Nidal/I-3136-2016; Qneibi, Mohammad/AAG-7374-2019	Jaradat, Nidal/0000-0003-2291-6821; Qneibi, Mohammad/0000-0002-0702-7834; AbuHasan, Qais/0000-0002-9055-8344	Palestinian Ministry of Education and Higher Education [ANNU-MoHE-1819-Sc009]	Palestinian Ministry of Education and Higher Education	This work was supported by a grant from the Palestinian Ministry of Education and Higher Education, Grant number: ANNU-MoHE-1819-Sc009 (http://www.mohe.pna.ps/) to MQ. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balannik V, 2005, NEURON, V48, P279, DOI 10.1016/j.neuron.2005.09.024; Bertoncello KT, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20897-x; Chang PKY, 2012, EUR J NEUROSCI, V35, P1908, DOI 10.1111/j.1460-9568.2012.08165.x; Chen CY, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0092271, 10.1371/journal.pone.0108021, 10.1371/journal.pone.0106248]; Cole GM, 2007, ADV EXP MED BIOL, V595, P197; Collingridge GL, 2009, NEUROPHARMACOLOGY, V56, P2, DOI 10.1016/j.neuropharm.2008.06.063; Cull-Candy S, 2006, CURR OPIN NEUROBIOL, V16, P288, DOI 10.1016/j.conb.2006.05.012; Dingledine R, 1999, PHARMACOL REV, V51, P7; Duan ML, 2019, J BIOTECHNOLOGY; Duprat F, 2003, PHILOS T ROY SOC B, V358, P715, DOI 10.1098/rstb.2002.1215; Iihara K, 2001, J NEUROSCI, V21, P2224, DOI 10.1523/JNEUROSCI.21-07-02224.2001; Isaac JTR, 2007, NEURON, V54, P859, DOI 10.1016/j.neuron.2007.06.001; Iwamoto FM, 2010, CANCER-AM CANCER SOC, V116, P1776, DOI 10.1002/cncr.24957; Jakaria M, 2018, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00307; Jayanarayanan S, 2013, CHEM-BIOL INTERACT, V201, P39, DOI 10.1016/j.cbi.2012.11.024; Kew JNC, 2005, PSYCHOPHARMACOLOGY, V179, P4, DOI 10.1007/s00213-005-2200-z; Langan YM, 2003, EPILEPSIA, V44, P46, DOI 10.1046/j.1528-1157.2003.128902.x; Lees GJ, 2000, DRUGS, V59, P33, DOI 10.2165/00003495-200059010-00004; Libbey JE, 2016, EXP NEUROL, V280, P89, DOI 10.1016/j.expneurol.2016.04.010; Ma H, 2014, J ALZHEIMERS DIS, V42, P915, DOI 10.3233/JAD-140579; Madsen U, 1996, J MED CHEM, V39, P1682, DOI 10.1021/jm950826p; Matteucci A, 2011, INVEST OPHTH VIS SCI, V52, P1070, DOI 10.1167/iovs.10-5966; Nikam SS, 2001, CURR MED CHEM, V8, P155, DOI 10.2174/0929867013373877; Pelletier JC, 1996, J MED CHEM, V39, P343, DOI 10.1021/jm950740w; Qneibi M, 2019, BIOMED RES INT, V2019; Qneibi M, 2019, EUR J PHARM SCI, V136, DOI 10.1016/j.ejps.2019.06.005; Qneibi MS, 2012, BIOCHEMISTRY-US, V51, P1787, DOI 10.1021/bi2017552; Rammes G, 1996, BRIT J PHARMACOL, V117, P1209, DOI 10.1111/j.1476-5381.1996.tb16718.x; Rugg-Gunn F, 2014, EPILEPSIA, V55, P13, DOI 10.1111/epi.12504; Schwenk J, 2014, NEURON, V84, P41, DOI 10.1016/j.neuron.2014.08.044; Shishodia S, 2005, ANN NY ACAD SCI, V1056, P206, DOI 10.1196/annals.1352.010; Simeone TA, 2004, J CHILD NEUROL, V19, P343, DOI 10.1177/088307380401900507; Singh SV, 1998, CARCINOGENESIS, V19, P1357, DOI 10.1093/carcin/19.8.1357; Sobolevsky AI, 2009, NATURE, V462, P745, DOI 10.1038/nature08624; Solyom S, 2002, CURR PHARM DESIGN, V8, P913, DOI 10.2174/1381612024607081; Song I, 2002, TRENDS NEUROSCI, V25, P578, DOI 10.1016/S0166-2236(02)02270-1; Sun Y, 2002, NATURE, V417, P245, DOI 10.1038/417245a; Traynelis SF, 2010, PHARMACOL REV, V62, P405, DOI 10.1124/pr.109.002451; Twomey EC, 2018, BIOCHEMISTRY-US, V57, P267, DOI 10.1021/acs.biochem.7b00891; Van Den Bosch L, 2000, J NEUROL SCI, V180, P29, DOI 10.1016/S0022-510X(00)00414-7; Varano F, 2002, J MED CHEM, V45, P1035, DOI 10.1021/jm010995b; Wang CZ, 2013, ACS CHEM NEUROSCI, V4, P635, DOI 10.1021/cn3002398	42	12	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2019	14	8							e0221132	10.1371/journal.pone.0221132	http://dx.doi.org/10.1371/journal.pone.0221132			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5WO	31454362	Green Submitted, gold, Green Published			2022-12-26	WOS:000485049000011
J	Maeda, Y; Ichikawa, R; Misawa, J; Shibuya, A; Hishiki, T; Maeda, T; Yoshino, A; Kondo, Y				Maeda, Yukihiro; Ichikawa, Rie; Misawa, Jimpei; Shibuya, Akiko; Hishiki, Teruyoshi; Maeda, Takeshi; Yoshino, Atsuo; Kondo, Yoshiaki			External validation of the TRISS, CRASH, and IMPACT prognostic models in severe traumatic brain injury in Japan	PLOS ONE			English	Article							MORTALITY PREDICTION MODEL; INTERNATIONAL MISSION; CLINICAL-TRIALS; HEAD-INJURY; SCORE; CLASSIFICATION; PROGESTERONE; MODERATE	In Japan, a range of patients with traumatic brain injury (TBI) has been recorded in a nationwide database (Japan Neurotrauma Data Bank; JNTDB). This study aimed to externally validate three international prediction models using JNTDB data: Trauma and Injury Severity Score (TRISS), Corticosteroid Randomization After Significant Head Injury (CRASH), and International Mission for Prognosis and Analysis of Clinical Trials in TBI (IMPACT). We also aimed to validate the applicability of these models in the Japanese population. Of 1,091 patients registered in the JNTDB from July 2009 to June 2011, we analyzed data for 635 patients. We examined factors associated with mortality in-hospital and unfavorable outcomes 6 months after TBI by applying the TRISS, CRASH, and IMPACT models. We also conducted an external validation of these models based on these data. The patients' mean age was 60.1 +/- 21.1 years, and 342 were alive at the time of discharge (53.9%). Univariate analysis revealed eight major risk factors for mortality in-hospital: age, Glasgow Coma Scale (GCS), Injury Severity Score (ISS), systolic blood pressure, heart rate, mydriasis, acute epidural hematoma (AEDH), and traumatic subarachnoid hemorrhage. A similar analysis identified five risk factors for unfavorable outcomes at 6 months: age, GCS, ISS, mydriasis, and AEDH. For mortality in-hospital, the TRISS had a satisfactory area under the curve value (0.75). For unfavorable outcomes at 6 months, the CRASH (basic and computed tomography) and IMPACT (core and core extended) models had satisfactory area under the curve values (0.86, 0.86, 0.81, and 0.85, respectively). The TRISS, CRASH, and IMPACT models were suitable for application to the JNTDB population, indicating these models had high value in Japanese patients with neurotrauma.	[Maeda, Yukihiro; Ichikawa, Rie; Misawa, Jimpei; Shibuya, Akiko; Kondo, Yoshiaki] Nihon Univ, Sch Med, Dept Hlth Care Serv Management, Tokyo, Japan; [Ichikawa, Rie] Nihon Univ, Sch Med, Dept Pediat & Child Hlth, Tokyo, Japan; [Shibuya, Akiko] Toyama Prefectural Univ, Sch Nursing, Dept Nursing, Toyama, Japan; [Hishiki, Teruyoshi] Toho Univ, Dept Informat Sci, Fac Sci, Chiba, Japan; [Maeda, Takeshi; Yoshino, Atsuo] Nihon Univ, Sch Med, Dept Neurol Surg, Tokyo, Japan	Nihon University; Nihon University; Toyama Prefectural University; Toho University; Nihon University	Ichikawa, R (corresponding author), Nihon Univ, Sch Med, Dept Hlth Care Serv Management, Tokyo, Japan.; Ichikawa, R (corresponding author), Nihon Univ, Sch Med, Dept Pediat & Child Hlth, Tokyo, Japan.	ichikawa.rie@nihon-u.ac.jp	Misawa, Jimpei/V-6855-2019	Misawa, Jimpei/0000-0003-3987-8251				Akay S, 2017, AM J EMERG MED, V35, P1056, DOI 10.1016/j.ajem.2017.02.035; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; BOYD CR, 1987, J TRAUMA, V27, P370, DOI 10.1097/00005373-198704000-00005; Brennan PM, 2018, J NEUROSURG, V128, P1612, DOI 10.3171/2017.12.JNS172780; CHAMPION HR, 1981, CRIT CARE MED, V9, P672, DOI 10.1097/00003246-198109000-00015; Han JLXG, 2017, WORLD NEUROSURG, V108, P885, DOI 10.1016/j.wneu.2017.08.147; Ichikawa R, 2018, PEDIATR EMERG CARE, V34, P825, DOI 10.1097/PEC.0000000000001321; Jinadasa Sayuri, 2016, Anesthesiol Clin, V34, P557, DOI 10.1016/j.anclin.2016.04.008; Kanda Y, 2013, BONE MARROW TRANSPL, V48, P452, DOI 10.1038/bmt.2012.244; Kunitz S. C., 1980, Proceedings of the Fourth Annual Symposium on Computer Applications in Medical Care, P1333; Lingsma H, 2013, J TRAUMA ACUTE CARE, V74, P639, DOI 10.1097/TA.0b013e31827d602e; Maegele M, 2017, EUR J TRAUMA EMERG S, V43, P439, DOI 10.1007/s00068-017-0771-0; Maejima S, 2001, WORLD J SURG, V25, P1205, DOI 10.1007/s00268-001-0083-7; Mataro M, 2001, J NEUROTRAUM, V18, P869, DOI 10.1089/089771501750451794; Mathis S, 2014, ANAESTHESIST, V63, P387, DOI 10.1007/s00101-014-2315-x; Menon DK, 2009, CURR OPIN CRIT CARE, V15, P437, DOI 10.1097/MCC.0b013e3283307a26; Osler T, 2008, ANN SURG, V247, P1041, DOI 10.1097/SLA.0b013e31816ffb3f; Panczykowski DM, 2012, J NEUROTRAUM, V29, P47, DOI 10.1089/neu.2010.1482; Roozenbeek B, 2012, CRIT CARE MED, V40, P1609, DOI 10.1097/CCM.0b013e31824519ce; Skolnick BE, 2014, NEW ENGL J MED, V371, P2467, DOI 10.1056/NEJMoa1411090; States JD, 1969, ABBREVIATED COMPREHE; Sun H, 2016, J NEUROTRAUM, V33, P1535, DOI 10.1089/neu.2015.4164; Vos PE, 2001, J NEUROTRAUM, V18, P649, DOI 10.1089/089771501750357591; Voskresensky IV, 2009, J SURG RES, V154, P105, DOI 10.1016/j.jss.2008.04.010; Wong GKC, 2013, J CLIN NEUROSCI, V20, P1693, DOI 10.1016/j.jocn.2012.12.032	25	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2019	14	8							e0221791	10.1371/journal.pone.0221791	http://dx.doi.org/10.1371/journal.pone.0221791			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5UR	31449548	Green Submitted, gold, Green Published			2022-12-26	WOS:000485044000034
J	Lee, YW; Lim, H; Seo, S; Cho, K; Kang, S				Lee, Young-woo; Lim, Hyunchan; Seo, Sungyoul; Cho, Keewon; Kang, Sungho			A low-cost concurrent TSV test architecture with lossless test output compression scheme	PLOS ONE			English	Article							ON-CHIP; TEST CHALLENGES; RESISTIVE OPEN; OPEN DEFECTS; 3-D ICS; DESIGN; PERFORMANCE; CIRCUITS; MODEL	As the traditional IC design migrates to three-dimensional integrated circuits (3D-ICs) design, new challenges need to be considered carefully to solve its reliability and yield issues. 3D-ICs using through-silicon-vias (TSVs) can have latent defects such as resistive open and bridge defects, which are caused by the thermal stress during the fabrication process. These latent defects lead to the deterioration of the electrical performance of TSVs caused by an undesired increase in the resistance-capacitance (RC) delay. For this reason, various post-bond test methodologies have been studied to improve the reliability of 3D-ICs. Cost reduction in these TSV test architectures is also currently being studied by decreasing various factors such as hardware overhead, test time, and the peak current consumption. Usually, a single test-clock-period is required to determine whether the test result contains the defective TSV. When the test result of any TSVs fails, we use another single test-clock-period to classify its defect type. In this paper, we propose a new TSV test architecture to transfer the combined test output of the test result and the specific defect type to the pad during the single test-clock-period. Our proposed test architecture also provides a reliable block-based concurrent testing to optimize the test time by dividing the die into concurrent blocks. The experimental results showed that our proposed test architecture could reduce the test time and the hardware overhead substantially by ensuring that the reasonable peak power consumption for mass production was reasonable without the test quality being adversely affected.	[Lee, Young-woo; Lim, Hyunchan; Seo, Sungyoul; Cho, Keewon; Kang, Sungho] Yonsei Univ, Dept Elect & Elect Engn, Seoul, South Korea	Yonsei University	Kang, S (corresponding author), Yonsei Univ, Dept Elect & Elect Engn, Seoul, South Korea.	shkang@yonsei.ac.kr	Lee, Young-woo/X-4678-2019	Kang, Sungho/0000-0002-7093-2095	National Research Foundation of Korea (NRF) - Korea government (MSIT) [2019R1A2C3011079]	National Research Foundation of Korea (NRF) - Korea government (MSIT)	This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIT) (no. 2019R1A2C3011079). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam SM, 2010, IEEE T VLSI SYST, V18, P450, DOI 10.1109/TVLSI.2008.2011910; [Anonymous], 2012, PREDICTIVE TECHNOLOG; Bottoms WR, 2011, IEEE CUST INTEGR CIR; Chen PY, 2009, ASIAN TEST SYMPOSIUM, P450, DOI 10.1109/ATS.2009.42; Chen YB, 2010, ICCAD-IEEE ACM INT, P471, DOI 10.1109/ICCAD.2010.5653753; Cho M, 2011, IEEE T COMP PACK MAN, V1, P1718, DOI 10.1109/TCPMT.2011.2166961; Gong Z, 2016, IEEE T COMPUT AID D, V35, P679, DOI 10.1109/TCAD.2015.2474411; Huang SY, 2012, DES AUT CON, P1031; Huang YJ, 2011, IEEE VLSI TEST SYMP, P20, DOI 10.1109/VTS.2011.5783749; Jang J, 2017, IEEE T VLSI SYST, V25, P1178, DOI 10.1109/TVLSI.2016.2623810; Jung M, 2017, IEEE T VLSI SYST, V25, P2109, DOI 10.1109/TVLSI.2017.2670508; Kang U, 2010, IEEE J SOLID-ST CIRC, V45, P111, DOI 10.1109/JSSC.2009.2034408; Katti G, 2010, IEEE T ELECTRON DEV, V57, P256, DOI 10.1109/TED.2009.2034508; Lee C., 2014, 2014 S VLSI CIRCUITS, P1; Lee HHS, 2009, IEEE DES TEST COMPUT, V26, P26, DOI 10.1109/MDT.2009.125; Lee YW, 2017, IEEE T COMPUT AID D, V36, P1759, DOI 10.1109/TCAD.2016.2611505; Lee YW, 2016, INT SOC DESIGN CONF, P129, DOI 10.1109/ISOCC.2016.7799724; Lu TT, 2017, IEEE T COMPUT AID D, V36, P1593, DOI 10.1109/TCAD.2017.2666604; Marinissen Erik Jan, 2009, Proceedings of the 2009 IEEE International Test Conference (ITC 2009), DOI 10.1109/TEST.2009.5355674; Marinissen EJ, 2010, PROCEEDINGS OF THE 2010 IEEE ASIA PACIFIC CONFERENCE ON CIRCUIT AND SYSTEM (APCCAS), P544, DOI 10.1109/APCCAS.2010.5775087; Park J, 2017, IEEE T RELIAB, V66, P458, DOI 10.1109/TR.2017.2681103; Penmetsa NL, 2015, INT SYMP ASYNCHRON C, P93, DOI 10.1109/ASYNC.2015.22; Qian LB, 2018, IEEE T COMP PACK MAN, V8, P1336, DOI 10.1109/TCPMT.2018.2854829; Salah K, 2011, IEEE INT SYMP CIRC S, P2321; Sung H, 2014, IEEE T VLSI SYST, V22, P2380, DOI 10.1109/TVLSI.2013.2289964; Tsai Menglin, 2009, P INT C 3D SYSTEM IN, P1; Vatajelu EI, 2019, IEEE T EMERG TOP COM, V7, P493, DOI 10.1109/TETC.2017.2691263; Wang C, 2015, IEEE T CIRCUITS-I, V62, P139, DOI 10.1109/TCSI.2014.2354752; Wang R, 2017, IEEE DES TEST, V34, P72, DOI 10.1109/MDAT.2017.2705077; Weerasekera R, 2007, IEEE IC CAD, P212; Xiang D, 2016, IEEE T COMPUT AID D, V35, P499, DOI 10.1109/TCAD.2015.2474365; Xu CA, 2010, IEEE T ELECTRON DEV, V57, P3405, DOI 10.1109/TED.2010.2076382; Ye FM, 2012, DES AUT CON, P1024; You JW, 2010, ASIAN TEST SYMPOSIUM, P389, DOI 10.1109/ATS.2010.73; Zhang B, 2015, I CONF VLSI DESIGN, P387, DOI 10.1109/VLSID.2015.71; Zhao Y, 2015, IEEE T VLSI SYST, V23, P1567, DOI 10.1109/TVLSI.2014.2343156	36	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2019	14	8							e0221043	10.1371/journal.pone.0221043	http://dx.doi.org/10.1371/journal.pone.0221043			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5TR	31442246	Green Published, gold, Green Submitted			2022-12-26	WOS:000485041400019
J	Mcdonald, LS; Salisbury, PA; Ford, R; Panozzo, JF				Mcdonald, Linda S.; Salisbury, Phillip A.; Ford, Rebecca; Panozzo, Joseph F.			Quantifying the colour loss of green field pea (Pisum sativum L.) due to bleaching	PLOS ONE			English	Article							RESISTANCE; VISION; SEEDS; RGB	Post-harvest change in the colour of green field pea (Pisum sativum L.) is undesirable as this impacts the visual quality and market value of the seed. To date, there is no standard, objective method to determine bleaching. Therefore, the aim of this study was to develop an objective method for scoring bleaching based on colour reflectance spectra, measured both by spectrophotometer and multispectral Image Analysis (IA). Green field pea seeds were sorted into samples of uniform colour and these were used to train the model. Spectra calculated from multispectral images (with colour bands at 405,470,530,590,660 and 850nm) were matched to the spectrophotometer output through multiple linear regression. All spectra were transformed to emphasize the wavelength regions most impacted during bleaching, following which two critical reflectance values were scaled to a single bleaching score. The bleaching assessment method was tested in a time-course experiment comprising seeds from five green-pea genotypes stored for six months. Each sample was divided into two so that half of the seeds were stored in the dark and the remainder were exposed to controlled light to exaggerate bleaching. Throughout this period, the samples were imaged at six-weekly intervals. Assessment of bleaching by the IA method agreed well with spectrophotometer measurements, achieving a Lin's concordance statistic of 0.99 and 0.96 for the calibration and time-course samples respectively. The IA method proved more versatile because assessments could be made on individual seeds enabling the computation of bleaching uniformity within each sample. This method captured differences between genotypes in the extent, rate and uniformity of bleaching. All genotypes exhibited susceptibility to bleaching when stored under the controlled light conditions. Excell was observed to be the most susceptible genotype with the greatest bleaching-rate and OZB1308 displayed the most colour-stability.	[Mcdonald, Linda S.; Panozzo, Joseph F.] Agr Victoria Res, Dept Jobs Precincts & Reg, Horsham, Vic, Australia; [Mcdonald, Linda S.; Salisbury, Phillip A.] Univ Melbourne, Fac Vet & Agr Sci, Parkville, Vic, Australia; [Ford, Rebecca] Griffith Univ, Sch Environm & Sci, Nathan, Qld, Australia	University of Melbourne; Griffith University	Mcdonald, LS (corresponding author), Agr Victoria Res, Dept Jobs Precincts & Reg, Horsham, Vic, Australia.; Mcdonald, LS (corresponding author), Univ Melbourne, Fac Vet & Agr Sci, Parkville, Vic, Australia.	linda.mcdonald@ecodev.vic.gov.au	Ford, Rebecca/AAQ-7535-2020	Ford, Rebecca/0000-0002-4192-0706; /0000-0003-3011-9953; McDonald, Linda/0000-0002-0501-559X	Department of Jobs, Precincts and Regions; Grains Research and Development Corporation [DAV00158]	Department of Jobs, Precincts and Regions; Grains Research and Development Corporation(Grains R&D Corp)	This research was jointly funded by the Department of Jobs, Precincts and Regions, (LSM and JFP) and the Grains Research and Development Corporation DAV00158, (LSM and JFP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atak M, 2008, PAK J BOT, V40, P2345; Brand J, 2015, PULSES MALLEE; CGC CGC, 2018, OFF GRAIN GRAD GUID; Cheng M, 2004, J FOOD SCI, V69, pC511, DOI 10.1111/j.1365-2621.2004.tb13644.x; Christiansen A.N., 2012, J SPECTR IMAGING, DOI DOI 10.1255/JSI.2012.A1; Ornelas-Paz JD, 2008, POSTHARVEST BIOL TEC, V50, P145, DOI 10.1016/j.postharvbio.2008.05.001; Dell'Aquila A, 2006, SEED SCI TECHNOL, V34, P609, DOI 10.15258/sst.2006.34.3.08; French RJ, 2016, REFERENCE MODULE FOO; Garrido-Novell C, 2012, J FOOD ENG, V113, P281, DOI 10.1016/j.jfoodeng.2012.05.038; GTA GTA, 2018, AUSTR PULS STAND 201; Gu SP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101000; GUBBELS GH, 1990, CAN J PLANT SCI, V70, P45, DOI 10.4141/cjps90-005; JATOI SA, 2001, PAK J BIOL SCI, V4, P1490, DOI DOI 10.3923/PJBS.2001.1490.1494; LeMasurier LS, 2014, J FOOD ENG, V128, P72, DOI 10.1016/j.jfoodeng.2013.12.018; Manninen H, 2015, LWT-FOOD SCI TECHNOL, V63, P1184, DOI 10.1016/j.lwt.2015.04.005; McCallum J, 1997, J AM SOC HORTIC SCI, V122, P218, DOI 10.21273/JASHS.122.2.218; McDonald LS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155523; Mendoza F, 2006, POSTHARVEST BIOL TEC, V41, P285, DOI 10.1016/j.postharvbio.2006.04.004; Nasar-Abbas SM, 2008, POSTHARVEST BIOL TEC, V47, P113, DOI 10.1016/j.postharvbio.2007.06.007; Nasar-Abbas SM, 2009, LWT-FOOD SCI TECHNOL, V42, P1703, DOI 10.1016/j.lwt.2009.05.013; NSDU, 2017, 2017 US PULS QUAL SU; Phelps S, 2015, BLEACHING GREEN PEA; Statistica, PROD VOL FIELD PEAS; Steet JA, 1996, J FOOD SCI, V61, P924, DOI 10.1111/j.1365-2621.1996.tb10903.x; Ubayasena L, 2013, EUPHYTICA, V193, P49, DOI 10.1007/s10681-013-0914-2; Ubayasena L, 2010, GENOME, V53, P346, DOI [10.1139/G10-013, 10.1139/g10-013]; Wiwart M, 2009, COMPUT ELECTRON AGR, V65, P125, DOI 10.1016/j.compag.2008.08.003; Wu D, 2013, WOODHEAD PUBL FOOD S, V253, P165, DOI 10.1533/9780857098856.2.165; Wu D, 2013, TRENDS FOOD SCI TECH, V29, P5, DOI 10.1016/j.tifs.2012.08.004; Yan X, 2010, PURITY IDENTIFICATIO	30	3	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2019	14	8							e0221523	10.1371/journal.pone.0221523	http://dx.doi.org/10.1371/journal.pone.0221523			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5TR	31442257	gold, Green Published			2022-12-26	WOS:000485041400041
J	Meskele, M; Khuzwayo, N; Taylor, M				Meskele, Mengistu; Khuzwayo, Nelisiwe; Taylor, Myra			Intimate partner violence against women living with and without HIV, and the associated factors in Wolaita Zone, Southern Ethiopia: A comparative cross-sectional study	PLOS ONE			English	Article							GENDER-BASED VIOLENCE; ALCOHOL-USE; RISK	Objectives This study aimed to measure the prevalence and associated factors of Intimate Partner Violence (IPV) among women living with and without HIV in Wolaita Zone, Southern Ethiopia. Methods A comparative cross-sectional study design was used to interview the 816 women between 18-49 years of age (408 = HIV positive, 408 = HIV negative). Using a multistage sampling technique, participants were recruited from nine health facilities based on probability proportional to the number of clients. After data entry (EpiData version 4.4.2.0) the data were exported to STATA/SE 15 software. Binary and multivariable logistic regression analysis were undertaken and the odds ratio (OR) and 95% confidence interval (CI) are presented. Results The lifetime prevalence of IPV among all women was 59.7%, [95% CI: 56.31%-63.05%]. IPV was slightly higher among women living with HIV, 250(61.3%), than those who were HIV negative, 238(58.1%). Lifetime prevalence of emotional violence 413(50.6%), physical violence 349(42.8%), sexual violence 219(26.8%), and controlling behaviours by husbands/partners 489(59.9%) were reported. Associations were found between IPV and controlling behaviour of husband/partner [AOR = 8.13; 95% CI: 4.93-13.42], income [AOR = 3.97; 95% CI: 1.81-8.72], bride price payment [AOR = 3.46; 95% CI: 1.74-6.87], women's decision to refuse sex [AOR = 2.99; 95% CI: 1.39-6.41], age group of women [AOR = 2.86; 95% CI: 1.67-4.90], partner's family choosing wife [AOR = 2.83; 95% CI: 1.70-4.69], alcohol consumption by partner [AOR = 2.36; 95% CI: 1.36-4.10], number of sexual partners [AOR = 2.35; 95% CI: 1.36-4.09], and if partner ever physically fought with another man [AOR = 1.83; 95% CI: 1.05-3.19]. Conclusions There is a high prevalence of IPV against women both living with and without HIV. Policy priorities should therefore involve males in programs of gender-based violence prevention in order to change their violent behaviour, and interventions are required to improve the economic status of women. Both sexes should be advised to have a single partner and marriage arrangements should be by mutual consent rather than being made by parents.	[Meskele, Mengistu] Wolaita Sodo Univ, Sch Publ Hlth, Wolaita Sodo, Ethiopia; [Khuzwayo, Nelisiwe] Univ KwaZulu Natal, Discipline Rural Hlth, Sch Nursing & Publ Hlth, Durban, South Africa; [Taylor, Myra] KwaZulu Natal, Discipline Publ Hlth, Sch Nursing & Publ Hlth, Durban, South Africa	University of Kwazulu Natal	Meskele, M (corresponding author), Wolaita Sodo Univ, Sch Publ Hlth, Wolaita Sodo, Ethiopia.	mengistu77@gmail.com	Khuzwayo, Nelisiwe/AAT-6202-2020	Meskele, Mengistu/0000-0001-6157-4591	University of KwaZulu-Natal, College of Health Science; Wolaita Sodo University, Ethiopia	University of KwaZulu-Natal, College of Health Science; Wolaita Sodo University, Ethiopia	The University of KwaZulu-Natal, College of Health Science has funded this research as part of a Ph.D. study. Wolaita Sodo University, Ethiopia has partially funded this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abate BA, 2016, BMC WOMENS HEALTH, V16, DOI 10.1186/s12905-016-0294-6; [Anonymous], 2019, ARRANGED MARRIAGE AD; Bernstein M, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-011999; Breiding Matthew J., 2015, INTIMATE PARTNER VIO; Central Intelligence Agency, 2019, ETH PEOPL 2019 SOURC; Central statistical agency (CSA)[Ethiopia] and ICF, 2016, ETH DEM HEAL SURV AD; Central Statistics Agency (CSA), 2016, ETH DEM HLTH SURV; Deribe K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036189; Dhairyawan R, 2013, HIV MED, V14, P303, DOI 10.1111/hiv.12009; Ellsberg M., 2005, RES VIOLENCE WOMEN P; Harling G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014257; Ho R., 2006, HDB UNIVARIATE MULTI; Interagency Federal Working Group Report, 2013, ADDR INT HIV AIDS VI; International Women Development Agency, 2018, ECONOMIC EMPOWERMENT; Jewkes R, 2002, LANCET, V359, P1423, DOI 10.1016/S0140-6736(02)08357-5; Krantz G, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-143; Pitpitan EV, 2013, J BEHAV MED, V36, P295, DOI 10.1007/s10865-012-9423-3; Pronyk PM, 2006, LANCET, V368, P1973, DOI 10.1016/S0140-6736(06)69744-4; Schulkind J, 2016, CULT HEALTH SEX, V18, P770, DOI 10.1080/13691058.2015.1124456; Semahegn A, 2015, REPROD HEALTH, V12, DOI 10.1186/s12978-015-0072-1; Semahegn A, 2013, REPROD HEALTH, V10, DOI 10.1186/1742-4755-10-63; Shamu S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109447; Shi CF, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-512; Silverman JG, 2008, JAMA-J AM MED ASSOC, V300, P703, DOI 10.1001/jama.300.6.703; Tegbar Yigzaw, 2004, Ethiopian Journal of Health Development, V18, P133; WHO, 2005, MULT STUD WOM HLTH D; WHO, 2005, SUMM REP WHO MULT ST; World Health Organization, 2021, GLOB REG EST VIOL WO	28	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2019	14	8							e0220919	10.1371/journal.pone.0220919	http://dx.doi.org/10.1371/journal.pone.0220919			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5TR	31442243	Green Submitted, gold, Green Published			2022-12-26	WOS:000485041400016
J	Pflugrad, H; Tryc, AB; Goldbecker, A; Barg-Hock, H; Strassburg, C; Klempnauer, J; Lanfermann, H; Weissenborn, K; Raab, P				Pflugrad, Henning; Tryc, Anita Blanka; Goldbecker, Annemarie; Barg-Hock, Hannelore; Strassburg, Christian; Klempnauer, Juergen; Lanfermann, Heinrich; Weissenborn, Karin; Raab, Peter			Cerebral metabolite alterations in patients with posttransplant encephalopathy after liver transplantation	PLOS ONE			English	Article							MAGNETIC-RESONANCE-SPECTROSCOPY; NERVOUS-SYSTEM COMPLICATIONS; HEPATIC-ENCEPHALOPATHY; NEUROLOGICAL COMPLICATIONS; MR SPECTROSCOPY; BRAIN; NEUROINFLAMMATION; NEUROTOXICITY; CIRRHOSIS; CREATINE	Background In the first weeks after liver transplantation about 30% of the patients develop a posttransplant encephalopathy. A posttransplant encephalopathy comprises metabolic-toxic caused symptoms such as disorientation, confusion, hallucinations, cognitive dysfunction and seizures. We hypothesize that alterations of cerebral metabolites before liver transplantation predispose posttransplant encephalopathy development after liver transplantation. Methods 31 patients with chronic liver disease underwent magnetic resonance spectroscopy (MRS) before liver transplantation to assess glutamine/glutamate (Glx), myo-Inositol (mI), choline (Cho), creatine/phosphocreatine- and N-acetyl-aspartate/N-acetyl-aspartate-glutamate concentrations in the thalamus, lentiform nucleus and white matter. Of these, 14 patients underwent MRS additionally after liver transplantation. Furthermore, 15 patients received MRS only after liver transplantation. Patients' data were compared to 20 healthy age adjusted controls. Results Patients showed significantly increased Glx and decreased mI and Cho concentrations compared to controls before liver transplantation (p <= 0.01). The MRS values before liver transplantation of patients with posttransplant encephalopathy showed no significant difference compared to patients without posttransplant encephalopathy. Patients after liver transplantation showed increased Glx concentrations (p <= 0.01) compared to controls, however, patients with and without posttransplant encephalopathy did not differ. Patients with posttransplant encephalopathy who underwent MRS before and after liver transplantation showed a significant mI increase in all three brain regions (p<0.04) and Glx decrease in the lentiform nucleus after liver transplantation (p = 0.04) while patients without posttransplant encephalopathy only showed a mI increase in the thalamus (p = 0.04). Conclusion Patients with and without posttransplant encephalopathy showed no significant difference in cerebral metabolites before liver transplantation. However, the paired sub-analysis indicates that the extent of cerebral metabolite alterations in patients with liver cirrhosis might be critical for the development of posttransplant encephalopathy after liver transplantation.	[Pflugrad, Henning; Tryc, Anita Blanka; Goldbecker, Annemarie; Weissenborn, Karin] Hannover Med Sch, Dept Neurol, Hannover, Germany; [Pflugrad, Henning; Tryc, Anita Blanka; Goldbecker, Annemarie; Klempnauer, Juergen; Weissenborn, Karin] Integrated Res & Treatment Ctr Transplantat, Hannover, Germany; [Barg-Hock, Hannelore; Klempnauer, Juergen] Hannover Med Sch, Clin Visceral & Transplant Surg, Hannover, Germany; [Strassburg, Christian] Hannover Med Sch, Dept Gastroenterol Hepatol & Endocrinol, Hannover, Germany; [Lanfermann, Heinrich; Raab, Peter] Hannover Med Sch, Inst Diagnost & Intervent Neuroradiol, Hannover, Germany; [Strassburg, Christian] Univ Hosp Bonn, Dept Med 1, Bonn, Germany	Hannover Medical School; Hannover Medical School; Hannover Medical School; Hannover Medical School; University of Bonn	Pflugrad, H (corresponding author), Hannover Med Sch, Dept Neurol, Hannover, Germany.; Pflugrad, H (corresponding author), Integrated Res & Treatment Ctr Transplantat, Hannover, Germany.	pflugrad.henning@mh-hannover.de	Lanfermann, Heinrich/AAR-4069-2021		German Federal Ministry of Education and Research [01EO0802]; German Research Foundation (DFG); Open Access Publication Fund of Hannover Medical School (MHH)	German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); German Research Foundation (DFG)(German Research Foundation (DFG)); Open Access Publication Fund of Hannover Medical School (MHH)	This study was supported by a grant from the German Federal Ministry of Education and Research (reference number: 01EO0802). We acknowledge support by the German Research Foundation (DFG) and the Open Access Publication Fund of Hannover Medical School (MHH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahluwalia V, 2016, LIVER TRANSPLANT, V22, P1379, DOI 10.1002/lt.24498; Ahluwalia V, 2015, LIVER TRANSPLANT, V21, P1123, DOI 10.1002/lt.24163; Alonso J, 2014, SEMIN ULTRASOUND CT, V35, P136, DOI 10.1053/j.sult.2013.09.008; Atluri DK, 2010, METAB BRAIN DIS, V25, P111, DOI 10.1007/s11011-010-9178-x; Balderramo D, 2011, TRANSPL INT, V24, P812, DOI 10.1111/j.1432-2277.2011.01280.x; Bernhardt M, 2015, LIVER TRANSPLANT, V21, P224, DOI 10.1002/lt.24035; Chamberlain KA, 2017, J NEUROSCI, V37, P1479, DOI 10.1523/JNEUROSCI.1941-16.2016; Chang L, 1996, LIFE SCI, V58, P2049, DOI 10.1016/0024-3205(96)00197-X; Chang LD, 2013, J NEUROIMMUNE PHARM, V8, P576, DOI 10.1007/s11481-013-9460-x; Chavarria L, 2014, METAB BRAIN DIS, V29, P937, DOI 10.1007/s11011-013-9452-9; Chavarria L, 2013, J CEREBR BLOOD F MET, V33, P272, DOI 10.1038/jcbfm.2012.173; Dhar R, 2008, NEUROCRIT CARE, V8, P253, DOI 10.1007/s12028-007-9020-4; Dhar R, 2011, NEUROL CLIN, V29, P943, DOI 10.1016/j.ncl.2011.07.002; Duarte-Silva S, 2018, MOVEMENT DISORD, V33, P815, DOI 10.1002/mds.27292; Hadjihambi A, 2018, HEPATOL INT, V12, pS135, DOI 10.1007/s12072-017-9812-3; Herzer K, 2016, CLIN TRANSPLANT, V30, P487, DOI 10.1111/ctr.12708; Illsinger S, 2011, CLIN TRANSPLANT, V25, P584, DOI 10.1111/j.1399-0012.2010.01301.x; Illsinger S, 2011, ANN TRANSPL, V16, P68; Jalan R, 2014, J HEPATOL, V61, P1038, DOI 10.1016/j.jhep.2014.06.012; Klawitter J, 2010, CHEM RES TOXICOL, V23, P608, DOI 10.1021/tx900351q; Lee JH, 1999, AM J GASTROENTEROL, V94, P2206; Long LL, 2009, EXP BIOL MED, V234, P1075, DOI 10.3181/0903-RM-118; Naegele T, 2000, RADIOLOGY, V216, P683, DOI 10.1148/radiology.216.3.r00se27683; Palacin M, 2013, CELL BIOL TOXICOL, V29, P407, DOI 10.1007/s10565-013-9263-0; Pflugrad H, 2018, LIVER TRANSPLANT, V24, P56, DOI 10.1002/lt.24984; Pflugrad H, 2017, WORLD J HEPATOL, V9, P519, DOI 10.4254/wjh.v9.i10.519; Provencher SW, 2001, NMR BIOMED, V14, P260, DOI 10.1002/nbm.698; Qi R, 2018, BIOCHEM BIOPH RES CO, V496, P941, DOI 10.1016/j.bbrc.2018.01.113; Quarantelli M, 2015, CLIN TRANSL IMAGING, V3, P475, DOI 10.1007/s40336-015-0142-y; Rompianesi G, 2015, TRANSPL INT, V28, P864, DOI 10.1111/tri.12564; Rovira A, 2001, AM J NEURORADIOL, V22, P1137; Saner FH, 2009, METAB BRAIN DIS, V24, P183, DOI 10.1007/s11011-008-9119-0; Saner FH, 2007, ARCH MED RES, V38, P75, DOI 10.1016/j.arcmed.2006.07.005; Schmitz B, 2018, J NEUROIMAGING, V28, P416, DOI 10.1111/jon.12514; Teperman LW, 2013, INT J HEPATOL, V2013, DOI 10.1155/2013/952828; Vizzini G, 2011, LIVER TRANSPLANT, V17, P1279, DOI 10.1002/lt.22383; Weissenborn K, 2007, GUT, V56, P1736, DOI 10.1136/gut.2006.110569; Wyss M, 2000, PHYSIOL REV, V80, P1107, DOI 10.1152/physrev.2000.80.3.1107; Zhu H, 2011, METHODS MOL BIOL, V711, P203, DOI 10.1007/978-1-61737-992-5_9	39	8	9	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2019	14	8							e0221626	10.1371/journal.pone.0221626	http://dx.doi.org/10.1371/journal.pone.0221626			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5TR	31442276	Green Published, Green Submitted, gold			2022-12-26	WOS:000485041400058
J	Nartowt, BJ; Hart, GR; Roffman, DA; Llor, X; Ali, I; Muhammad, W; Liang, Y; Deng, J				Nartowt, Bradley J.; Hart, Gregory R.; Roffman, David A.; Llor, Xavier; Ali, Issa; Muhammad, Wazir; Liang, Ying; Deng, Jun			Scoring colorectal cancer risk with an artificial neural network based on self-reportable personal health data	PLOS ONE			English	Article							VIRTUAL COLONOSCOPY; PREDICTION; HYPERTENSION; PROGNOSIS; MORTALITY; PATHOGENESIS; NEOPLASIA; TESTS; TOOL	Colorectal cancer (CRC) is third in prevalence and mortality among all cancers in the US. Currently, the United States Preventative Services Task Force (USPSTF) recommends anyone ages 50-75 and/or with a family history to be screened for CRC. To improve screening specificity and sensitivity, we have built an artificial neural network (ANN) trained on 12 to 14 categories of personal health data from the National Health Interview Survey (NHIS). Years 1997-2016 of the NHIS contain 583,770 respondents who had never received a diagnosis of any cancer and 1409 who had received a diagnosis of CRC within 4 years of taking the survey. The trained ANN has sensitivity of 0.57 +/- 0.03, specificity of 0.89 +/- 0.02, positive predictive value of 0.0075 +/- 0.0003, negative predictive value of 0.999 +/- 0.001, and concordance of 0.80 +/- 0.05 per the guidelines of Transparent Reporting of Multivariable Prediction Model for Individual Prognosis or Diagnosis (TRIPOD) level 2a, comparable to current risk-scoring methods. To demonstrate clinical applicability, both USPSTF guidelines and the trained ANN are used to stratify respondents to the 2017 NHIS into low-, medium- and high-risk categories (TRIPOD levels 4 and 2b, respectively). The number of CRC respondents misclassified as low risk is decreased from 35% by screening guidelines to 5% by ANN (in 60 cases). The number of non-CRC respondents misclassified as high risk is decreased from 53% by screening guidelines to 6% by ANN (in 25,457 cases). Our results demonstrate a robustly-tested method of stratifying CRC risk that is non-invasive, cost-effective, and easy to implement publicly.	[Nartowt, Bradley J.; Hart, Gregory R.; Ali, Issa; Muhammad, Wazir; Liang, Ying; Deng, Jun] Yale Univ, Sch Med, Dept Therapeut Radiol, New Haven, CT 06510 USA; [Roffman, David A.] Sun Nucl Corp, Melbourne, FL USA; [Llor, Xavier] Yale Univ, Sch Med, Dept Digest Dis, New Haven, CT USA	Yale University; Yale University	Deng, J (corresponding author), Yale Univ, Sch Med, Dept Therapeut Radiol, New Haven, CT 06510 USA.	jun.deng@yale.edu		Liang, Ying/0000-0002-4939-8705	National Institute of Biomedical Imaging and Bioengineering of the National Institutes of Health [R01EB022589]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB022589] Funding Source: NIH RePORTER	National Institute of Biomedical Imaging and Bioengineering of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	Research reported in this publication was solely supported by the National Institute of Biomedical Imaging and Bioengineering of the National Institutes of Health under Award Number R01EB022589. DAR was initially funded by R01EB022589 when writing the first working version of the ANN. BJN et al. took over and continued this study with the funding of R01EB022589 while DAR went on to be employed and supported with salary by Sun Nuclear Corporation. Sun Nuclear Corporation provided support in the form of salaries for authors DAR, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section. The specific role of DAR is articulated in the 'author contributions' section. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health or of Sun Nuclear Corporation.; Research reported in this publication was supported by the National Institute of Biomedical Imaging and Bioengineering of the National Institutes of Health under Award Number R01EB022589. DAR was funded by R01EB022589 while writing the first working version of the ANN, which BJN et al continued under R01EB022589 while DAR went on to be supported with salary by Sun Nuclear Corporation. Sun Nuclear Corporation did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of DAR is articulated in the 'author contributions' section. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health or of Sun Nuclear Corporation.	AALTONEN LA, 1993, SCIENCE, V260, P812, DOI 10.1126/science.8484121; AHMED FE, 2005, MOL CANCER, V4, DOI DOI 10.1186/1476-5498-4-29; Aleksandrova K, 2014, BMC MED, V12, DOI 10.1186/s12916-014-0168-4; Allison JE, 2007, JNCI-J NATL CANCER I, V99, P1462, DOI 10.1093/jnci/djm150; Andoni A, 2014, PROC 31ST INT CONF M; [Anonymous], 2018, NATIONAL HEALTH INTE; Benard F, 2018, WORLD J GASTROENTERO, V24, P124, DOI 10.3748/wjg.v24.i1.124; Bertsekas DP, 1998, INTRODUCTION TO PROB; Betes M, 2003, AM J GASTROENTEROL, V98, P2648, DOI 10.1016/j.amjgastroenterol.2203.09.041; Bujanda L, 2010, WORLD J GASTROENTERO, V16, P862, DOI 10.3748/wjg.v16.i7.862; Chen GC, 2014, CHINESE J CANCER RES, V26, P4, DOI 10.3978/j.issn.1000-9604.2014.02.03; Chiang PPC, 2015, BRIT J CANCER, V112, pS77, DOI 10.1038/bjc.2015.46; Choi Y, 2017, SEMIN ONCOL, V44, P34, DOI 10.1053/j.seminoncol.2017.02.002; Cohen MH, 2007, ONCOLOGIST, V12, P356, DOI 10.1634/theoncologist.12-3-356; Collins GS, 2015, CIRCULATION, V131, P211, DOI [10.1016/j.jclinepi.2014.11.010, 10.1161/CIRCULATIONAHA.114.014508, 10.1002/bjs.9736, 10.7326/M14-0697, 10.1016/j.eururo.2014.11.025, 10.1186/s12916-014-0241-z, 10.1136/bmj.g7594, 10.1038/bjc.2014.639, 10.7326/M14-0698]; Cruz JA, 2006, CANCER INFORM, V2, P59; Deng  J., 2014, KEY ENHANCE CORE COM, V1, P1; Doleman B, 2016, TECH COLOPROCTOL, V20, P517, DOI 10.1007/s10151-016-1498-3; Driver JA, 2007, AM J MED, V120, P257, DOI 10.1016/j.amjmed.2006.05.055; Hajian-Tilaki K, 2013, CASP J INTERN MED, V4, P627; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Hart GR, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0205264; Hippisley-Cox J, 2017, QCANCER; HOSMER DW, 2000, WILEY PS TX, P1; Hurwitz H, 2004, NEW ENGL J MED, V350, P2335, DOI 10.1056/NEJMoa032691; Imperiale TF, 2014, NEW ENGL J MED, V370, P1287, DOI 10.1056/NEJMoa1311194; IRVINE EJ, 1988, GUT, V29, P1188, DOI 10.1136/gut.29.9.1188; Kaminski MF, 2014, GUT, V63, P1112, DOI 10.1136/gutjnl-2013-304965; Lin CC, 2014, J CHIN MED ASSOC, V77, P508, DOI 10.1016/j.jcma.2014.03.007; Little RJA, 1988, STAT ANAL, V43; Lofton-Day C, 2008, CLIN CHEM, V54, P414, DOI 10.1373/clinchem.2007.095992; Ma GK, 2014, CLIN GASTROENTEROL H, V12, P1624, DOI 10.1016/j.cgh.2014.01.042; MANDEL JS, 1993, NEW ENGL J MED, V328, P1365, DOI 10.1056/NEJM199305133281901; Paterson WG, 2006, CAN J GASTROENTEROL, V20, P411, DOI 10.1155/2006/343686; Picard RR, 2012, J AM STAT ASSOC, V79, P575; Pineau BC, 2001, J GASTROINTEST CANC, V30, P133, DOI 10.1385/IJGC:30:3:133; Pineau BC, 2003, GASTROENTEROLOGY, V125, P304, DOI 10.1016/S0016-5085(03)00885-0; Quintero E, 2012, GASTROENTEROL ENDOSC, V54, P1510, DOI DOI 10.11280/GEE.54.1510; Roffman D, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19907-9; Rothwell PM, 2010, LANCET, V376, P1741, DOI 10.1016/S0140-6736(10)61543-7; Sargent DJ, 2001, CANCER-AM CANCER SOC, V91, P1636, DOI 10.1002/1097-0142(20010415)91:8+<1636::AID-CNCR1176>3.0.CO;2-D; Scartozzi M, 2009, ANN ONCOL, V20, P227, DOI 10.1093/annonc/mdn637; Sharara N, 2016, CAN J GASTROEN TEROL, V2016; Shaukat A, 2017, DIGEST DIS SCI, V62, P2511, DOI 10.1007/s10620-017-4682-z; Siegel RL, 2017, CA-CANCER J CLIN, V67, P7, DOI 10.3322/caac.21387; Song LL, 2016, WORLD J GASTRO ONCOL, V8, P793, DOI 10.4251/wjgo.v8.i11.793; Syrigos KN, 2011, BIODRUGS, V25, P159, DOI 10.2165/11590180-000000000-00000; Tu JV, 1996, J CLIN EPIDEMIOL, V49, P1225, DOI 10.1016/S0895-4356(96)00002-9; Usher-Smith JA, 2016, CANCER PREV RES, V9, P13, DOI 10.1158/1940-6207.CAPR-15-0274; van de Poll-Franse LV, 2012, DIABETOLOGIA, V55, P2163, DOI 10.1007/s00125-012-2555-8; Yeoh KG, 2011, GUT, V60, P1236, DOI 10.1136/gut.2010.221168	51	12	12	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2019	14	8							e0221421	10.1371/journal.pone.0221421	http://dx.doi.org/10.1371/journal.pone.0221421			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5RZ	31437221	Green Published, gold, Green Submitted			2022-12-26	WOS:000485036900069
J	de Medeiros, MAP; de Melo, APV; Bento, AD; de Souza, LBFC; Neto, FDB; Garcia, JBL; Zuza-Alves, DL; Francisco, EC; Melo, ASD; Chaves, GM				Paulo de Medeiros, Mariana Araujo; Vieira de Melo, Ana Patricia; Bento, Aurelio de Oliveira; Ferreira Canario de Souza, Luanda Barbara; Bezerra Neto, Francisco de Assis; Garcia, Jarmilla Bow-Ltaif; Zuza-Alves, Diana Luzia; Francisco, Elaine Cristina; de Azevedo Melo, Analy Salles; Chaves, Guilherme Maranhao			Epidemiology and prognostic factors of nosocomial candidemia in Northeast Brazil: A six-year retrospective study	PLOS ONE			English	Article							NATIONWIDE SENTINEL SURVEILLANCE; CRITICALLY-ILL PATIENTS; RISK-FACTORS; INFECTIONS; ALBICANS; COLONIZATION; CANDIDIASIS; MORTALITY	Candidemia has been considered a persistent public health problem with great impact on hospital costs and high mortality. We aimed to evaluate the epidemiology and prognostic factors of candidemia in a tertiary hospital in Northeast Brazil from January 2011 to December 2016. Demographic and clinical data of patients were retrospectively obtained from medical records and antifungal susceptibility profiling was performed using the broth micro dilution method. A total of 68 episodes of candidemia were evaluated. We found an average incidence of 2.23 episodes/1000 admissions and a 30-day mortality rate of 55.9%. The most prevalent species were Candida albicans (35.3%), Candida tropicalis (27.4%), Candida parapsilosis (21.6%) and Candida glabrata (11.8%). Higher mortality rates were observed in cases of candidemia due to C. albicans (61.1%) and C. glabrata (100%), especially when compared to C. parapsilosis (27.3%). Univariate analysis revealed some variables which significantly increased the probability of death: older age (P = 0.022; odds ratio [OR] = 1.041), severe sepsis (P < 0.001; OR = 8.571), septic shock (P = 0.035; OR = 3.792), hypotension (P = 0.003; OR = 9.120), neutrophilia (P = 0.046; OR = 3.080), thrombocytopenia (P = 0.002; OR = 6.800), mechanical ventilation (P = 0.009; OR = 8.167) and greater number of surgeries (P = 0.037; OR = 1.920). Multivariate analysis showed that older age (P = 0.040; OR = 1.055), severe sepsis (P = 0.009; OR = 9.872) and hypotension (P = 0.031; OR = 21.042) were independently associated with worse prognosis. There was no resistance to amphotericin B, micafungin or itraconazole and a low rate of resistance to fluconazole (5.1%). However, 20.5% of the Candida isolates were susceptible dose-dependent (SDD) to fluconazole and 7.7% to itraconazole. In conclusion, our results could assist in the adoption of strategies to stratify patients at higher risk for developing candidemia and worse prognosis, in addition to improve antifungal management.	[Paulo de Medeiros, Mariana Araujo; Vieira de Melo, Ana Patricia; Bento, Aurelio de Oliveira; Ferreira Canario de Souza, Luanda Barbara; Bezerra Neto, Francisco de Assis; Garcia, Jarmilla Bow-Ltaif; Zuza-Alves, Diana Luzia; Chaves, Guilherme Maranhao] Univ Fed Rio Grande do Norte, Dept Clin & Toxicol Anal, Lab Med & Mol Mycol, Natal, RN, Brazil; [Francisco, Elaine Cristina; de Azevedo Melo, Analy Salles] Univ Fed Sao Paulo, Dept Med, Special Mycol Lab, Sao Paulo, SP, Brazil	Universidade Federal do Rio Grande do Norte; Universidade Federal de Sao Paulo (UNIFESP)	Chaves, GM (corresponding author), Univ Fed Rio Grande do Norte, Dept Clin & Toxicol Anal, Lab Med & Mol Mycol, Natal, RN, Brazil.	guilherme.chaves@ufrnet.br	Francisco, Elaine Cristina/F-6836-2013; Chaves, Guilherme Maranhão/ABB-1199-2020; Chaves, Guilherme/AAS-4000-2021; Melo, Analy/AAY-7843-2020	Francisco, Elaine Cristina/0000-0002-5530-1332; 				Angus DC, 2013, NEW ENGL J MED, V369, P840, DOI [10.1056/NEJMc1312359, 10.1056/NEJMra1208623]; Arendrup MC, 2013, DAN MED J, V60; Barchiesi F, 2016, INFECTION, V44, P205, DOI 10.1007/s15010-015-0845-z; Bassetti M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127534; Berdal JE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103916; Braga PR, 2018, BRAZ J INFECT DIS, V22, P273, DOI 10.1016/j.bjid.2018.07.008; Caggiano G, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/256580; Chaves GM, 2012, MEM I OSWALDO CRUZ, V107, P198, DOI 10.1590/S0074-02762012000200008; Cisterna R, 2010, J CLIN MICROBIOL, V48, P4200, DOI 10.1128/JCM.00920-10; Clinical and Laboratory Standards Institute, 2012, M27S4 CLSI, VM27-S4; Clinical Laboratory Standards Institute, 2008, M27S3 CLSI; CLSI, 1908, M27A3 CLSI; Colombo AL, 2006, J CLIN MICROBIOL, V44, P2816, DOI 10.1128/JCM.00773-06; Colombo AL, 2013, MED MYCOL, V51, P38, DOI 10.3109/13693786.2012.698024; da Matta DA, 2017, J FUNGI, V3, DOI 10.3390/jof3020024; De Rosa FG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125149; Ding XR, 2015, MED MYCOL, V53, P684, DOI 10.1093/mmy/myv060; Doi AM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146909; Duggan S, 2015, VIRULENCE, V6, P316, DOI 10.4161/21505594.2014.988096; Edwards Jr JE, 2012, HARRISONS PRINCIPLES, P1651; Eggimann P, 2015, J HOSP INFECT, V89, P302, DOI 10.1016/j.jhin.2014.11.006; Gudlaugsson O, 2003, CLIN INFECT DIS, V37, P1172, DOI 10.1086/378745; Guinea J, 2014, CLIN MICROBIOL INFEC, V20, P5, DOI 10.1111/1469-0691.12539; Guyton A.C., 2006, TXB MED PHYSL; Hamill R, 2013, DRUGS, V73, P919, DOI 10.1007/s40265-013-0069-4; Hirano R, 2018, INFECT DRUG RESIST, V11, P821, DOI 10.2147/IDR.S156633; Kocmanova I, 2018, EPIDEMIOL MIKROBI IM, V67, P3; Leon C, 2006, CRIT CARE MED, V34, P730, DOI 10.1097/01.CCM.0000202208.37364.7D; Longo DL, 2012, HARRISONS PRINCIPLES; Magill SS, 2014, NEW ENGL J MED, V370, P1198, DOI 10.1056/NEJMoa1306801; Nucci M, 2013, PLOS ONE, V8, P3; Nucci M, 2010, CLIN INFECT DIS, V51, P561, DOI 10.1086/655683; Pappas PG, 2016, CLIN INFECT DIS, V62, pE1, DOI 10.1093/cid/civ933; Peman J, 2012, J ANTIMICROB CHEMOTH, V67, P1181, DOI 10.1093/jac/dks019; Pfaller MA, 2007, CLIN MICROBIOL REV, V20, P133, DOI 10.1128/CMR.00029-06; Pfaller MA, 2016, MED MYCOL, V54, P1, DOI 10.1093/mmy/myv076; PITTET D, 1994, ANN SURG, V220, P751, DOI 10.1097/00000658-199412000-00008; Poulat C, 2017, MED MALADIES INFECT, V47, P382, DOI 10.1016/j.medmal.2017.03.004; Rodriguez L, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175172; Sbrana F, 2018, INTERN EMERG MED, V13, P199, DOI 10.1007/s11739-017-1783-9; Trouve C, 2017, EUR J CLIN MICROBIOL, V36, P649, DOI 10.1007/s10096-016-2841-3; Yapar N, 2014, THER CLIN RISK MANAG, V10, P95, DOI 10.2147/TCRM.S40160; Yarrow D., 1998, P77, DOI 10.1016/B978-044481312-1/50014-9; Zuza-Alves DL, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01783	44	21	21	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2019	14	8							e0221033	10.1371/journal.pone.0221033	http://dx.doi.org/10.1371/journal.pone.0221033			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5RZ	31437188	Green Submitted, gold, Green Published			2022-12-26	WOS:000485036900028
J	Vera, L; Arias, DC; Muylle, S; Stergiopulos, N; Segers, P; van Loon, G				Vera, Lisse; Arias, Daime Campos; Muylle, Sofie; Stergiopulos, Nikos; Segers, Patrick; van Loon, Gunther			A 1D computer model of the arterial circulation in horses: An important resource for studying global interactions between heart and vessels under normal and pathological conditions	PLOS ONE			English	Article							SUDDEN-DEATH; BLOOD-FLOW; PRESSURE; HEMODYNAMICS; WAVES; VALIDATION	Arterial rupture in horses has been observed during exercise, after phenylephrine administration or during parturition (uterine artery). In human pathophysiological research, the use of computer models for studying arterial hemodynamics and understanding normal and abnormal characteristics of arterial pressure and flow waveforms is very common. The objective of this research was to develop a computer model of the equine arterial circulation, in order to study local intra-arterial pressures and flow dynamics in horses. Morphologically, large differences exist between human and equine aortic arch and arterial branching patterns. Development of the present model was based on post-mortem obtained anatomical data of the arterial tree (arterial lengths, diameters and branching angles); in vivo collected ultrasonographic flow profiles from the common carotid artery, external iliac artery, median artery and aorta; and invasively collected pressure curves from carotid artery and aorta. These data were used as input for a previously validated (in humans) 1D arterial network model. Data on terminal resistance and arterial compliance parameters were tuned to equine physiology. Given the large arterial diameters, Womersley theory was used to compute friction coefficients, and the input into the arterial system was provided via a scaled time-varying elastance model of the left heart. Outcomes showed plausible predictions of pressure and flow waveforms throughout the considered arterial tree. Simulated flow waveform morphology was in line with measured flow profiles. Consideration of gravity further improved model based predicted waveforms. Derived flow waveform patterns could be explained using wave power analysis. The model offers possibilities as a research tool to predict changes in flow profiles and local pressures as a result of strenuous exercise or altered arterial wall properties related to age, breed or gender.	[Vera, Lisse; van Loon, Gunther] Univ Ghent, Equine Cardioteam, Dept Large Anim Internal Med, Fac Vet Med, Ghent, Belgium; [Arias, Daime Campos; Segers, Patrick] Univ Ghent, IBiTech BioMMeda, Ghent, Belgium; [Arias, Daime Campos] CUJAE, Biomech & Biomat Res Grp, Havana, Cuba; [Muylle, Sofie] Univ Ghent, Fac Vet Med, Dept Morphol, Ghent, Belgium; [Stergiopulos, Nikos] Ecole Polytech Fed Lausanne, Lab Hemodynam & Cardiovasc Technol, Lausanne, Switzerland	Ghent University; Ghent University; Ghent University; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Vera, L (corresponding author), Univ Ghent, Equine Cardioteam, Dept Large Anim Internal Med, Fac Vet Med, Ghent, Belgium.	lisse.vera@ugent.be	van Loon, Gunther/B-8526-2009; Segers, Patrick/AAA-7844-2020	van Loon, Gunther/0000-0001-5191-5241; Segers, Patrick/0000-0003-3870-3409; Stergiopulos, Nikolaos/0000-0002-0519-0160; Vera, Lisse/0000-0003-3416-1745; Campos Arias, Daime/0000-0003-0930-0432	Special Research Fund of Ghent University; Research Foundation Flanders (FWO-Vlaanderen) (Lisse Vera)	Special Research Fund of Ghent University(Ghent University); Research Foundation Flanders (FWO-Vlaanderen) (Lisse Vera)(FWO)	This work was supported by the Special Research Fund of Ghent University (Daime Campos) and the Research Foundation Flanders (FWO-Vlaanderen) (Lisse Vera).	Arias DC, 2017, ARTIF ORGANS, V41, pE141, DOI 10.1111/aor.12922; Aslanidou L, 2016, ALTEX-ALTERN ANIM EX, V33, P13, DOI 10.14573/altex.1507071; AVOLIO AP, 1980, MED BIOL ENG COMPUT, V18, P709, DOI 10.1007/BF02441895; Barone R, ANATOMIE COMP MAMMIF, V5; BELZ GG, 1995, CARDIOVASC DRUG THER, V9, P73, DOI 10.1007/BF00877747; Bessems D, 2007, J FLUID MECH, V580, P145, DOI 10.1017/S0022112007005344; Boegli J, 2019, J VET INTERN MED, V33, P1446, DOI 10.1111/jvim.15494; BROWN CM, 1978, EQUINE VET J, V10, P216, DOI 10.1111/j.2042-3306.1978.tb02265.x; BROWN CM, 1978, EQUINE VET J, V10, P207, DOI 10.1111/j.2042-3306.1978.tb02263.x; Dobroserdova T, 2016, MATEC WEB CONF, V76, DOI 10.1051/matecconf/20167605001; Epstein S, 2015, AM J PHYSIOL-HEART C, V309, pH222, DOI 10.1152/ajpheart.00857.2014; Frederick J, 2010, JAVMA-J AM VET MED A, V237, P830, DOI 10.2460/javma.237.7.830; Gamilov T, 2014, MATH MODEL NAT PHENO, V9, P85, DOI 10.1051/mmnp/20149607; GELBERG HB, 1985, J AM VET MED ASSOC, V187, P1354; Lyle CH, 2012, EQUINE VET J, V44, P459, DOI 10.1111/j.2042-3306.2011.00496.x; Lyle CH, 2011, EQUINE VET J, V43, P324, DOI 10.1111/j.2042-3306.2010.00164.x; Mynard JP, 2016, AM J PHYSIOL-HEART C, V310, pH1026, DOI 10.1152/ajpheart.00954.2015; Mynard JP, 2015, ANN BIOMED ENG, V43, P1443, DOI 10.1007/s10439-015-1313-8; Obeid H, 2017, PHYSIOL MEAS, V38, P1953, DOI 10.1088/1361-6579/aa905a; OROURKE MF, 1967, J APPL PHYSIOL, V23, P139, DOI 10.1152/jappl.1967.23.2.139; PARKER KH, 1990, J BIOMECH ENG-T ASME, V112, P322, DOI 10.1115/1.2891191; PLATT H, 1982, BRIT VET J, V138, P417, DOI 10.1016/S0007-1935(17)30987-9; Ploeg M, 2017, EQUINE VET J, V49, P269, DOI 10.1111/evj.12641; Ploeg M, 2013, EQUINE VET J, V45, P101, DOI 10.1111/j.2042-3306.2012.00580.x; Poole DC, 2011, COMPR PHYSIOL, V1, P1, DOI 10.1002/cphy.c091001; Reed S.M., 2017, EQUINE INTERNAL MED; Reymond P, 2012, ANN BIOMED ENG, V40, P742, DOI 10.1007/s10439-011-0443-x; Reymond P, 2009, AM J PHYSIOL-HEART C, V297, pH208, DOI 10.1152/ajpheart.00037.2009; Sagawa K., 1988, CARDIAC CONTRACTION; Senzaki H, 1996, CIRCULATION, V94, P2497, DOI 10.1161/01.CIR.94.10.2497; Sherwin SJ, 2003, J ENG MATH, V47, P217, DOI 10.1023/B:ENGI.0000007979.32871.e2; STERGIOPULOS N, 1992, J BIOMECH, V25, P1477, DOI 10.1016/0021-9290(92)90060-E; Swillens A, 2008, IEEE T BIO-MED ENG, V55, P1602, DOI 10.1109/TBME.2007.913994; Ueno T, 2010, EQUINE VET J, V42, P529, DOI 10.1111/j.2042-3306.2010.00090.x; Vardoulis O, 2011, EUR J VASC ENDOVASC, V42, P704, DOI 10.1016/j.ejvs.2011.08.006; WEMPLE RR, 1972, J BIOMECH, V15, P629, DOI 10.1016/0021-9290(72)90035-8; Willemet M, 2013, MED ENG PHYS, V35, P1573, DOI 10.1016/j.medengphy.2013.04.012; Williams NM, 2012, J EQUINE VET SCI, V32, P281, DOI 10.1016/j.jevs.2011.11.002	38	1	1	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2019	14	8							e0221425	10.1371/journal.pone.0221425	http://dx.doi.org/10.1371/journal.pone.0221425			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5QN	31433827	gold, Green Published			2022-12-26	WOS:000485033100023
J	Zhu, S; Zhao, DY; Li, C; Li, QQ; Jiang, WH; Liu, QP; Wang, R; Fazli, L; Li, YA; Zhang, LL; Yi, Y; Meng, QS; Wang, WY; Wang, GY; Zhang, M; Zu, XB; Zhao, W; Deng, T; Yu, JD; Dong, XS; Chen, KF; Cao, Q				Zhu, Sen; Zhao, Dongyu; Li, Chao; Li, Qiaqia; Jiang, Weihua; Liu, Qipeng; Wang, Rui; Fazli, Ladan; Li, Yinan; Zhang, Lili; Yi, Yang; Meng, Qingshu; Wang, Wanyi; Wang, Guangyu; Zhang, Min; Zu, Xiongbing; Zhao, Wei; Deng, Tuo; Yu, Jindan; Dong, Xuesen; Chen, Kaifu; Cao, Qi			BMI1 is directly regulated by androgen receptor to promote castration-resistance in prostate cancer	ONCOGENE			English	Article							CELL; PROGRESSION; EZH2	B lymphoma Mo-MLV insertion region 1 (BMI1) has been reported to be an oncoprotein. BMI1 represses tumor suppressors to promote cell proliferation, epithelial-mesenchymal transition (EMT), and cancer progression. Although it is known that the expression of BMI1 is increased in many cancer types, the mechanism of BMI1 upregulation is not yet clear. We performed integrative analysis for 3 sets of prostate cancer (PCa) genomic data, and found that BMI1 and androgen receptor (AR) were positively correlated, suggesting that AR might regulate BMI1. Next, we showed that dihydrotestosterone (DHT) upregulated both mRNA and protein levels of BMI1 and that BMI1 was increased in castration-resistant prostate cancer (CRPC) from both human patients and a mouse xenograph model. We further identified an AR binding site in the promoter/enhancer region of BMI1, and confirmed BMI1 as the direct target of AR using gene-editing technology. We also demonstrated that high expression of BMI1 is critical for the development of castration-resistance. Our data also suggest that BMI1-specific inhibitors could be an effective treatment of CRPC.	[Zhu, Sen; Li, Chao; Li, Qiaqia; Jiang, Weihua; Liu, Qipeng; Wang, Rui; Zhang, Lili; Yi, Yang; Meng, Qingshu; Cao, Qi] Houston Methodist Res Inst, Ctr Inflammat & Epigenet, Houston, TX 77030 USA; [Zhao, Dongyu; Wang, Guangyu; Chen, Kaifu] Houston Methodist Res Inst, Ctr Bioinformat & Computat Biol, Houston, TX 77030 USA; [Zhao, Dongyu; Wang, Guangyu; Chen, Kaifu] Cornell Univ, Weill Cornell Med, Dept Cardiothorac Surg, New York, NY 10065 USA; [Li, Chao; Li, Qiaqia; Yi, Yang; Meng, Qingshu; Cao, Qi] Northwestern Univ, Feinberg Sch Med, Dept Urol, Chicago, IL 60611 USA; [Li, Chao; Zu, Xiongbing] Cent S Univ, Xiangya Hosp, Dept Urol, Changsha 410008, Peoples R China; [Li, Qiaqia; Liu, Qipeng] Cent S Univ, Xiangya Sch Med, Changsha 410008, Peoples R China; [Fazli, Ladan; Li, Yinan; Dong, Xuesen] Vancouver Gen Hosp, Vancouver Prostate Ctr, Vancouver, BC V6H 3Z6, Canada; [Fazli, Ladan; Li, Yinan; Dong, Xuesen] Univ British Columbia, Dept Urol Sci, Vancouver, BC V6H 3Z6, Canada; [Wang, Wanyi] Texas Womans Univ, Off Res & Sponsored Programs, Ctr Res Design & Anal, Houston, TX 77030 USA; [Zhang, Min] Houston Methodist Res Inst, Dept Cardiovasc Sci, Ctr Cardiovasc Regenerat, Houston, TX USA; [Zhao, Wei] Sun Yat Sen Univ, Zhongshan Sch Med, Guangzhou 510080, Peoples R China; [Deng, Tuo] Cent S Univ, Minist Educ, Xiangya Hosp 2, Dept Endocrinol & Metab, Changsha 410011, Peoples R China; [Deng, Tuo] Cent S Univ, Minist Educ, Key Lab Diabet Immunol, Changsha 410011, Peoples R China; [Yu, Jindan] Northwestern Univ, Feinberg Sch Med, Dept Med, Div Hematol Oncol, Chicago, IL 60611 USA; [Yu, Jindan; Cao, Qi] Northwestern Univ, Feinberg Sch Med, Robert H Lurie Comprehens Canc Ctr, Chicago, IL 60611 USA; [Cao, Qi] Houston Methodist Res Inst, Houston Methodist Canc Ctr, Houston, TX 77030 USA	The Methodist Hospital System; The Methodist Hospital - Houston; The Methodist Hospital System; The Methodist Hospital - Houston; Cornell University; Northwestern University; Feinberg School of Medicine; Central South University; Central South University; University of British Columbia; University of British Columbia; Texas Womans University; The Methodist Hospital System; The Methodist Hospital - Houston; Sun Yat Sen University; Central South University; Central South University; Northwestern University; Feinberg School of Medicine; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Feinberg School of Medicine; Robert H. Lurie Comprehensive Cancer Center; The Methodist Hospital System; The Methodist Hospital - Houston	Cao, Q (corresponding author), Houston Methodist Res Inst, Ctr Inflammat & Epigenet, Houston, TX 77030 USA.; Chen, KF (corresponding author), Houston Methodist Res Inst, Ctr Bioinformat & Computat Biol, Houston, TX 77030 USA.; Chen, KF (corresponding author), Cornell Univ, Weill Cornell Med, Dept Cardiothorac Surg, New York, NY 10065 USA.; Cao, Q (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Urol, Chicago, IL 60611 USA.; Cao, Q (corresponding author), Northwestern Univ, Feinberg Sch Med, Robert H Lurie Comprehens Canc Ctr, Chicago, IL 60611 USA.; Cao, Q (corresponding author), Houston Methodist Res Inst, Houston Methodist Canc Ctr, Houston, TX 77030 USA.	kchen2@houstonmethodist.org; qi.cao@northwestern.edu	Wang, Guangyu/AAM-5940-2021; Dong, Xuesen/AGF-9228-2022; Zhao, Dongyu/ABA-2574-2020; Cao, Qi/A-5517-2010	Wang, Guangyu/0000-0003-4803-7200; Cao, Qi/0000-0002-5140-3681; Wang, Wanyi/0000-0001-9482-9968	Houston Methodist Research Institute; Prostate Cancer Foundation [13YOUN007]; U.S. Department of Defense [W81XWH-15-1-0639, W81XWH-17-1-0357]; American Cancer Society [RSG-15-192-01-TBE]; NIH/NCI [R01CA208257, R01CA172384]; NIH/NIGMS [R01GM125632]; NIH/NHLBI [R01HL133254]; US Department of Defense [W81XWH-17-1-0405, W81XWH-17-1-0362, W81XWH-17-1-0578]; Canadian Institute of Health Research [MOP-137007]; TFRI New Frontier Grant [1062]; National Natural Science Foundation of China [81572766, 81972651, 31771630, 81770868, 91742103]; Guangdong Innovative and Entrepreneurial Research Team Program [2016ZT06S029]; Natural Science Foundation of Guangdong Province [2017A030312009]; China Scholarship Council [201706370147]; Innovation-driven Project of Central South University [2017CX011]; CPRIT [RP120348, RP170002]	Houston Methodist Research Institute; Prostate Cancer Foundation; U.S. Department of Defense(United States Department of Defense); American Cancer Society(American Cancer Society); NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH/NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH/NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); US Department of Defense(United States Department of Defense); Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); TFRI New Frontier Grant; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Innovative and Entrepreneurial Research Team Program; Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province); China Scholarship Council(China Scholarship Council); Innovation-driven Project of Central South University; CPRIT	This work is supported, in part, by grants from Houston Methodist Research Institute, Prostate Cancer Foundation (13YOUN007 to QC), U.S. Department of Defense (W81XWH-15-1-0639 and W81XWH-17-1-0357 to QC), American Cancer Society (Research Scholar Grant RSG-15-192-01-TBE to QC), and NIH/NCI (R01CA208257 to QC); KC is supported in part by grants from NIH/NIGMS (R01GM125632 to KC) and NIH/NHLBI (R01HL133254 to KC); JY is supported by NIH/NCI (R01CA172384), US Department of Defense (W81XWH-17-1-0405, W81XWH-17-1-0362, and W81XWH-17-1-0578). XD is supported by the Canadian Institute of Health Research (#MOP-137007) and TFRI New Frontier Grant #1062. WZ is supported by the National Natural Science Foundation of China (81572766,81972651 and 31771630), Guangdong Innovative and Entrepreneurial Research Team Program (2016ZT06S029), and Natural Science Foundation of Guangdong Province (2017A030312009); CL is supported by the China Scholarship Council (201706370147). TD is supported by National Natural Science Foundation of China (81770868 and 91742103), and Innovation-driven Project of Central South University (2017CX011). The University of Texas MD Anderson Cancer Center Science Park Next-Generation Sequencing (NGS) Facility is supported by CPRIT grants RP120348 and RP170002.	Bansal N, 2016, CLIN CANCER RES, V22, P6176, DOI 10.1158/1078-0432.CCR-15-3107; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chen KF, 2013, GENOME RES, V23, P341, DOI 10.1101/gr.142067.112; Clyne Melanie, 2011, Nat Rev Urol, V9, P4, DOI 10.1038/nrurol.2011.208; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Glinsky GV, 2005, J CLIN INVEST, V115, P1503, DOI 10.1172/JCI23412; Grant CE, 2011, BIOINFORMATICS, V27, P1017, DOI 10.1093/bioinformatics/btr064; Grasso CS, 2012, NATURE, V487, P239, DOI 10.1038/nature11125; Ji Q, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006816; Jin X, 2017, NAT MED, V23, P1352, DOI 10.1038/nm.4415; Kassi E, 2011, CANCER LETT, V302, P1, DOI 10.1016/j.canlet.2010.10.020; Kent WJ, 2010, BIOINFORMATICS, V26, P2204, DOI 10.1093/bioinformatics/btq351; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kreso A, 2014, NAT MED, V20, P29, DOI 10.1038/nm.3418; Kron KJ, 2017, NAT GENET, V49, P1336, DOI 10.1038/ng.3930; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li HL, 2016, CANCER RES, V76, P6701, DOI 10.1158/0008-5472.CAN-16-1518; Mounir Z, 2016, ELIFE, V5, DOI 10.7554/eLife.13964; Mourgues L, 2015, LEUKEMIA, V29, P1993, DOI 10.1038/leu.2015.112; Nishida Y, 2017, BLOOD CANCER J, V7, DOI 10.1038/bcj.2017.8; Ren H, 2016, J CANCER, V7, P1074, DOI 10.7150/jca.14031; Siddique HR, 2012, STEM CELLS, V30, P372, DOI 10.1002/stem.1035; Song LB, 2009, J CLIN INVEST, V119, P3626, DOI 10.1172/JCI39374; Takayama K, 2014, CANCER RES, V74, P6542, DOI 10.1158/0008-5472.CAN-14-1030; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; van Leenders GJLH, 2007, EUR UROL, V52, P455, DOI 10.1016/j.eururo.2006.11.020; Wang W, 2008, AM J SURG PATHOL, V32, P65, DOI 10.1097/PAS.0b013e318058a96b; Yong KJ, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad6066; Yoo YA, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12943; Yu Y, 2015, PROSTATE, V75, P1043, DOI 10.1002/pros.22988; Zhu S, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-02863-3	31	19	19	4	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN	2020	39	1					17	29		10.1038/s41388-019-0966-4	http://dx.doi.org/10.1038/s41388-019-0966-4			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	KG3NM	31462713	Green Accepted			2022-12-26	WOS:000509849200002
J	Majtan, T; Park, I; Cox, A; Branchford, BR; di Paola, J; Bublil, EM; Kraus, JP				Majtan, Tomas; Park, Insun; Cox, Allaura; Branchford, Brian R.; di Paola, Jorge; Bublil, Erez M.; Kraus, Jan P.			Behavior, body composition, and vascular phenotype of homocystinuric mice on methionine-restricted diet or enzyme replacement therapy	FASEB JOURNAL			English	Article						cystathionine beta-synthase; homocysteine; anxiety; endothelial dysfunction; thrombosis	CYSTATHIONINE BETA-SYNTHASE; MOUSE MODELS; DEFICIENCY; OSTEOPOROSIS; MASS	Classic homocystinuria (HCU) is an inherited disorder characterized by elevated homocysteine (Hcy) in plasma and tissues resulting from cystathionine beta-synthase (CBS) deficiency. There is no cure, and patients are predominantly managed by methionine-restricted diet (MRD) to limit the production of Hcy. In this study, we used the I278T mouse model of HCU to evaluate the long-term impact of a novel enzyme replacement therapy [truncated human CBS C155 mutant modified with linear 20-kDa N-hydroxysuccinimide ester polyethylene glycol OT-58)] on clinical end points relevant to human patients with HCU. In addition, we compared its efficacy on a background of either MRD or normal methionine intake [regular diet (REG)] to that of MRD alone. We found that, compared with untreated I278T mice, OT-58 treatment of I278T mice fed with the REG diet resulted in a 90% decrease in plasma Hcy concentrations and correction of learning/cognition, endothelial dysfunction, hemostasis, bone mineralization, and body composition. On background of the MRD, OT-58 performed equally well with plasma Hcy entirely normalized. The MRD alone decreased plasma Hcy by 67% and corrected the HCU phenotype in I278T mice. However, the MRD increased anxiety and reduced bone mineral content in both I278T mice and wild-type controls. This study shows that OT-58 is a highly efficacious novel treatment for HCU on the background of either normal or restricted methionine intake.	[Majtan, Tomas; Park, Insun; Kraus, Jan P.] Univ Colorado, Sect Genet, Aurora, CO USA; [Cox, Allaura; Branchford, Brian R.; di Paola, Jorge] Univ Colorado, Sch Med, Dept Pediat, Sect Hematol Oncol, Aurora, CO USA; [Cox, Allaura; Branchford, Brian R.; di Paola, Jorge] Univ Colorado, Hemophilia & Thrombosis Ctr, Aurora, CO USA; [Bublil, Erez M.] Orphan Technol Ltd, Rapperswil, Switzerland	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus	Majtan, T (corresponding author), Univ Colorado, Sch Med, 12800 E 19th Ave,Mail Stop 8313, Aurora, CO 80045 USA.	tomas.majtan@ucdenver.edu	Majtan, Tomas/AAE-8426-2021	Majtan, Tomas/0000-0002-2751-2124	American Heart Association Scientist Development Grant [16SDG30040000]; Orphan Technologies, Ltd., a private pharmaceutical company developing an enzyme replacement therapy for cystathionine b-synthase (CBS)-deficient homocystinuria; U.S. National Institutes of Health, Office of the Director [1S10OD018156-01]	American Heart Association Scientist Development Grant(American Heart Association); Orphan Technologies, Ltd., a private pharmaceutical company developing an enzyme replacement therapy for cystathionine b-synthase (CBS)-deficient homocystinuria; U.S. National Institutes of Health, Office of the Director(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The authors thank Teodoro Bottiglieri (Institute of Metabolic Disease, Baylor Scott and White Research Institute, Dallas, TX, USA) for plasma metabolites measurements; Nicolas Busquet and Stacey Zander (University of Colorado) for help with behavioral assessment; Korey Haefner, Sara Wennersten, and Maria Cavasin (University of Colorado) for assistance with flow-mediated vasodilation (FMD) measurements; and Kimberley Bruce (University of Colorado Anschutz Medical Campus, Aurora, CO, USA) for access to the dual-energy X-ray absorptiometry (DXA) scanner. T.M. is a recipient of American Heart Association Scientist Development Grant 16SDG30040000. This study was supported by research grants from Orphan Technologies, Ltd., a private pharmaceutical company developing an enzyme replacement therapy for cystathionine b-synthase (CBS)-deficient homocystinuria (to J.P.K. and T.M.). Shared resources funded by Grant 1S10OD018156-01 from the U.S. National Institutes of Health, Office of the Director were used. The authors declare the following conflicts of interest: T.M., E.M. B., and J. P.K. are inventors on patents related to the processes and products referred here (U.S. patents 9034318 and 9243239). T.M. provides consulting services to Orphan Technologies, Ltd. E.M.B. is an employee of Orphan Technologies, Ltd.	ABBOTT MH, 1987, AM J MED GENET, V26, P959, DOI 10.1002/ajmg.1320260427; Anthony TG, 2013, CURR OPIN CLIN NUTR, V16, P96, DOI 10.1097/MCO.0b013e32835b618b; Arning E, 2016, METHODS MOL BIOL, V1378, P255, DOI 10.1007/978-1-4939-3182-8_27; Ben Abdallah NMB, 2011, EXP NEUROL, V227, P42, DOI 10.1016/j.expneurol.2010.09.008; Bublil EM, 2016, J CLIN INVEST, V126, P2372, DOI 10.1172/JCI85396; Dayal S, 2006, BLOOD, V108, P2237, DOI 10.1182/blood-2006-02-005991; Dayal S, 2012, BLOOD, V119, P3176, DOI 10.1182/blood-2011-09-380568; El Bashir H, 2015, JIMD REP, V21, P89, DOI 10.1007/8904_2014_394; FINKELSTEIN JD, 1990, J NUTR BIOCHEM, V1, P228, DOI 10.1016/0955-2863(90)90070-2; Gupta S, 2014, FASEB J, V28, P781, DOI 10.1096/fj.13-240770; Gupta S, 2009, FASEB J, V23, P883, DOI 10.1096/fj.08-120584; Kluijtmans LAJ, 1999, AM J HUM GENET, V65, P59, DOI 10.1086/302439; Kruger WD, 2016, ANN NY ACAD SCI, V1363, P80, DOI 10.1111/nyas.12967; Maclean KN, 2010, MOL GENET METAB, V101, P153, DOI 10.1016/j.ymgme.2010.06.010; Maclean KN, 2010, MOL GENET METAB, V101, P163, DOI 10.1016/j.ymgme.2010.06.007; Majtan T, 2018, LIFE SCI, V200, P15, DOI 10.1016/j.lfs.2018.03.018; Majtan T, 2018, MOL THER, V26, P834, DOI 10.1016/j.ymthe.2017.12.014; Majtan T, 2018, HUM MUTAT, V39, P210, DOI 10.1002/humu.23360; Majtan T, 2017, FASEB J, V31, P5495, DOI 10.1096/fj.201700565R; Majtan T, 2017, BIOMACROMOLECULES, V18, P1747, DOI 10.1021/acs.biomac.7b00154; Majtan T, 2016, CURR DRUG TARGETS, V17, P1455, DOI 10.2174/1389450117666160302094910; Marchi R, 2012, THROMB HAEMOSTASIS, V108, P516, DOI 10.1160/TH12-05-0355; Morris AAM, 2017, J INHERIT METAB DIS, V40, P49, DOI 10.1007/s10545-016-9979-0; Mudd S., 2001, METABOLIC MOL BASES, P2007; MUDD SH, 1970, J CLIN INVEST, V49, P1762, DOI 10.1172/JCI106394; Parrot F, 2000, J INHERIT METAB DIS, V23, P338, DOI 10.1023/A:1005618927729; Prut L, 2003, EUR J PHARMACOL, V463, P3, DOI 10.1016/S0014-2999(03)01272-X; Schiff M, 2012, NEUROPEDIATRICS, V43, P295, DOI 10.1055/s-0032-1329883; Schuler D, 2014, ARTERIOSCL THROM VAS, V34, P2651, DOI 10.1161/ATVBAHA.114.304699; Walter JH, 1998, EUR J PEDIATR, V157, pS71, DOI 10.1007/PL00014308; Wang LQ, 2005, HUM MOL GENET, V14, P2201, DOI 10.1093/hmg/ddi224; WATANABE M, 1995, P NATL ACAD SCI USA, V92, P1585, DOI 10.1073/pnas.92.5.1585	32	12	13	0	1	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2019	33	11					12477	12486		10.1096/fj.201901203R	http://dx.doi.org/10.1096/fj.201901203R			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC8ZX	31450979	Green Published			2022-12-26	WOS:000507461600068
J	Zhang, J; Qu, C; Li, TT; Cui, W; Wang, XN; Du, J				Zhang, Jing; Qu, Chao; Li, Taotoa; Cui, Wei; Wang, Xiaonan; Du, Jie			Phagocytosis mediated by scavenger receptor class BI promotes macrophage transition during skeletal muscle regeneration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						muscle regeneration; scavenger receptor; macrophage; phagocytosis; inflammation; macrophage transition; scavenger receptor class BI	GROWTH-FACTOR-BETA; APOPTOTIC CELLS; SR-BI; DIFFERENTIATION; PROLIFERATION; INFLAMMATION; METABOLISM; ACTIVATION; EXPRESSION; PATHOLOGY	Macrophages play an essential role in skeletal muscle regeneration. The phagocytosis of muscle cell debris induces a switch of pro-inflammatory macrophages into an anti-inflammatory phenotype, but the cellular receptors mediating this phagocytosis are still unclear. In this paper, we report novel roles for SRB1 (scavenger receptor class BI) in regulating macrophage phagocytosis and macrophage phenotypic transitions for skeletal muscle regeneration. In a mouse model of cardiotoxin-induced muscle injury/regeneration, infiltrated macrophages expressed a high level of SRB1. Using SRB1 knockout mice, we observed the impairment of muscle regeneration along with decreased myogenin expression and increased matrix deposit. Bone marrow transplantation experiments indicated that SRB1 deficiency in bone marrow cells was responsible for impaired muscle regeneration. Compared with WT mice, SRB1 deficiency increased pro-inflammatory macrophage number and pro-inflammatory gene expression and decreased anti-inflammatory macrophage number and anti-inflammatory gene expression in injured muscle. In vitro, SRB1 deficiency led to a strong decrease in macrophage phagocytic activity on myoblast debris. SRB1-deficient macrophages easily acquired an M1 phenotype and failed to acquire an M2 phenotype in lipopolysaccharide/myoblast debris activation. Furthermore, SRB1 deficiency promoted activation of ERK1/2 MAPK signaling in macrophages stimulated with lipopolysaccharide/myoblast debris. Taken together, SRB1 in macrophages regulates phagocytosis and promotes M1 switch into M2 macrophages, contributing to muscle regeneration.	[Zhang, Jing; Qu, Chao; Li, Taotoa; Cui, Wei; Du, Jie] Capital Med Univ, Beijing Anzhen Hosp, Beijing Inst Heart Lung & Blood Vessel Dis, Beijing 100029, Peoples R China; [Zhang, Jing; Qu, Chao; Li, Taotoa; Cui, Wei; Du, Jie] Minist Educ, Key Lab Remodeling Related Cardiovasc Dis, Beijing 100029, Peoples R China; [Wang, Xiaonan] Emory Univ, Dept Med, Renal Div, Atlanta, GA 30322 USA	Capital Medical University; Emory University	Du, J (corresponding author), Capital Med Univ, Beijing Anzhen Hosp, Beijing Inst Heart Lung & Blood Vessel Dis, Beijing 100029, Peoples R China.; Du, J (corresponding author), Minist Educ, Key Lab Remodeling Related Cardiovasc Dis, Beijing 100029, Peoples R China.; Wang, XN (corresponding author), Emory Univ, Dept Med, Renal Div, Atlanta, GA 30322 USA.	xwang03@emory.edu; jiedu@ccmu.edu.cn		Jie, Du/0000-0003-0447-736X	National Natural Science Foundation of China [81430050, 81672151]; Ministry of Science and Technology of China (Key Projects of the Precision Medicine Program) [2016YFC0903000]; Beijing Municipal Science and Technology Commission [Z171100000417002]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China (Key Projects of the Precision Medicine Program); Beijing Municipal Science and Technology Commission(Beijing Municipal Science & Technology Commission)	This work was supported by National Natural Science Foundation of China Grants 81430050 and 81672151, Ministry of Science and Technology of China (Key Projects of the Precision Medicine Program) Grant 2016YFC0903000, and Beijing Municipal Science and Technology Commission Grant Z171100000417002. The authors declare that they have no conflicts of interest with the contents of this article.	Acton S, 1996, SCIENCE, V271, P518, DOI 10.1126/science.271.5248.518; Al-Shanti N, 2008, GROWTH FACTORS, V26, P61, DOI 10.1080/08977190802025024; Arnold L, 2007, J EXP MED, V204, P1057, DOI 10.1084/jem.20070075; Arya SB, 2018, J BIOL CHEM, V293, P9892, DOI 10.1074/jbc.RA117.000727; Bersini S, 2018, ADV DRUG DELIVER REV, V129, P64, DOI 10.1016/j.addr.2018.02.009; Biswas SK, 2010, NAT IMMUNOL, V11, P889, DOI 10.1038/ni.1937; Brouckaert G, 2004, MOL BIOL CELL, V15, P1089, DOI 10.1091/mbc.E03-09-0668; Canton J, 2013, NAT REV IMMUNOL, V13, P621, DOI 10.1038/nri3515; Chazaud B, 2009, EXERC SPORT SCI REV, V37, P18, DOI 10.1097/JES.0b013e318190ebdb; Chinetti G, 2000, CIRCULATION, V101, P2411, DOI 10.1161/01.CIR.101.20.2411; Chuang PC, 2009, J PATHOL, V219, P232, DOI 10.1002/path.2588; Darby IA, 2016, CELL MOL LIFE SCI, V73, P1145, DOI 10.1007/s00018-015-2110-0; Dargelos E, 2018, EXP CELL RES, V370, P623, DOI 10.1016/j.yexcr.2018.07.027; Deng B, 2012, J IMMUNOL, V189, P3669, DOI 10.4049/jimmunol.1103180; Fluiter K, 1998, J BIOL CHEM, V273, P8434, DOI 10.1074/jbc.273.14.8434; Freire-de-Lima CG, 2006, J BIOL CHEM, V281, P38376, DOI 10.1074/jbc.M605146200; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Greaves DR, 1998, CURR OPIN LIPIDOL, V9, P425, DOI 10.1097/00041433-199810000-00006; Greaves DR, 2005, J LIPID RES, V46, P11, DOI 10.1194/jlr.R400011-JLR200; Hao NB, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/948098; HUGHES DA, 1995, EUR J IMMUNOL, V25, P466, DOI 10.1002/eji.1830250224; Johann AM, 2006, CELL DEATH DIFFER, V13, P1533, DOI 10.1038/sj.cdd.4401832; Kharraz Y, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/491497; Kim J, 2017, J EXERC REHABIL, V13, P621, DOI 10.12965/jer.1735072.536; Kohno S, 2012, J APPL PHYSIOL, V112, P1773, DOI 10.1152/japplphysiol.00103.2012; Krieger M, 1998, P NATL ACAD SCI USA, V95, P4077, DOI 10.1073/pnas.95.8.4077; Langen RCJ, 2001, FASEB J, V15, P1169, DOI 10.1096/fj.00-0463; Ma Y, 2010, BLOOD, V116, P1932, DOI 10.1182/blood-2010-02-268508; Mahdy MAA, 2019, CELL TISSUE RES, V375, P575, DOI 10.1007/s00441-018-2955-2; Massimino ML, 1997, BIOCHEM BIOPH RES CO, V235, P754, DOI 10.1006/bbrc.1997.6823; Mounier R, 2013, CELL METAB, V18, P251, DOI 10.1016/j.cmet.2013.06.017; Mullan RH, 2010, AM J PATHOL, V176, P1999, DOI 10.2353/ajpath.2010.090014; Nakagawa A, 2005, MOL REPROD DEV, V71, P166, DOI 10.1002/mrd.20278; Noh KT, 2012, J BIOL CHEM, V287, P14226, DOI 10.1074/jbc.M111.308841; Peiser L, 2001, MICROBES INFECT, V3, P149, DOI 10.1016/S1286-4579(00)01362-9; Rigotti A, 2003, ENDOCR REV, V24, P357, DOI 10.1210/er.2001-0037; Schafer G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008448; Segawa M, 2008, EXP CELL RES, V314, P3232, DOI 10.1016/j.yexcr.2008.08.008; Summan M, 2006, AM J PHYSIOL-REG I, V290, pR1488, DOI 10.1152/ajpregu.00465.2005; Thomas CA, 2000, J EXP MED, V191, P147, DOI 10.1084/jem.191.1.147; Tidball JG, 2010, AM J PHYSIOL-REG I, V298, pR1173, DOI 10.1152/ajpregu.00735.2009; Valacchi G, 2011, ANN NY ACAD SCI, V1229, pE1, DOI 10.1111/j.1749-6632.2011.06205.x; Villalta SA, 2011, HUM MOL GENET, V20, P790, DOI 10.1093/hmg/ddq523; Villalta SA, 2009, HUM MOL GENET, V18, P482, DOI 10.1093/hmg/ddn376; Wang X, 2008, CELL MOL NEUROBIOL, V28, P113, DOI 10.1007/s10571-007-9247-9; Weisser Shelley B, 2013, Methods Mol Biol, V946, P225, DOI 10.1007/978-1-62703-128-8_14; Zhang J, 2014, J IMMUNOL, V193, P5149, DOI 10.4049/jimmunol.1303486; Zhang LP, 2010, J AM SOC NEPHROL, V21, P419, DOI 10.1681/ASN.2009060571	48	23	25	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 25	2019	294	43					15672	15685		10.1074/jbc.RA119.008795	http://dx.doi.org/10.1074/jbc.RA119.008795			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JQ9JD	31462534	Green Published, hybrid			2022-12-26	WOS:000499253000011
J	Yang, YL; Chung, MR; Zhou, SR; Gong, XY; Xu, HY; Hong, YY; Jin, AT; Huang, XR; Zou, WG; Dai, QG; Jiang, LY				Yang, Yiling; Chung, Mi Ri; Zhou, Siru; Gong, Xinyi; Xu, Hongyuan; Hong, Yueyang; Jin, Anting; Huang, Xiangru; Zou, Weiguo; Dai, Qinggang; Jiang, Lingyong			STAT3 controls osteoclast differentiation and bone homeostasis by regulating NFATc1 transcription	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						bone; osteoporosis; STAT3; osteoclast; NFAT transcription factor; transgenic mice	MEDIATED OSTEOCLASTOGENESIS; T-CELLS; ACTIVATION; PROTEIN; FAMILY; INACTIVATION; PRECURSORS; EXPRESSION; INDUCTION; ROLES	The transcription factor signal transducer and activator of transcription 3 (STAT3) plays a central role in cell survival and function. STAT3 has been demonstrated to participate in the maintenance of bone homeostasis in osteoblasts, but its role in osteoclasts in vivo remains poorly defined. Here, we generated a conditional knockout mouse model in which Stat3 was deleted in osteoclasts using a cathepsin K-Cre (Ctsk-Cre) driver. We observed that osteoclast-specific Stat3 deficiency caused increased bone mass in mice, which we attributed to impaired bone catabolism by osteoclasts. Stat3-deficient bone marrow macrophages (BMMs) showed decreased expression of nuclear factor of activated T cells, cytoplasm 1 (NFATc1), and reduced osteoclast differentiation determined by decreases in osteoclast number, tartrate-resistant acid phosphatase activity, and expression of osteoclast marker genes. Enforced expression of NFATc1 in Stat3-deficient BMMs rescued the impaired osteoclast differentiation. Mechanistically, we revealed that STAT3 could drive the transcription of NFATc1 by binding to its promoter. Furthermore, preventing STAT3 activation by using an inhibitor of upstream phosphorylases, AG490, also impaired osteoclast differentiation and formation in a similar way as gene deletion of Stat3. In summary, our data provide the first evidence that STAT3 is significant in osteoclast differentiation and bone homeostasis in vivo, and it may be identified as a potential pharmacological target for the treatment of bone metabolic diseases through regulation of osteoclast activity.	[Yang, Yiling; Chung, Mi Ri; Zhou, Siru; Gong, Xinyi; Xu, Hongyuan; Hong, Yueyang; Jin, Anting; Huang, Xiangru; Jiang, Lingyong] Shanghai Jiao Tong Univ, Peoples Hosp 9, Shanghai Key Lab Stomatol,Sch Med, Ctr Craniofacial Orthodont,Dept Oral & Craniomaxi, Shanghai 200011, Peoples R China; [Yang, Yiling; Chung, Mi Ri; Zhou, Siru; Gong, Xinyi; Xu, Hongyuan; Hong, Yueyang; Jin, Anting; Huang, Xiangru; Dai, Qinggang; Jiang, Lingyong] Natl Clin Res Ctr Stomatol, Shanghai Res Inst Stomatol, Shanghai 200011, Peoples R China; [Zou, Weiguo] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, State Key Lab Cell Biol,CAS Ctr Excellence Mol Ce, Shanghai 200031, Peoples R China; [Dai, Qinggang] Shanghai Jiao Tong Univ, Peoples Hosp 9, Dent Ctr 2, Shanghai Key Lab Stomatol,Sch Med, Shanghai 200011, Peoples R China	Shanghai Jiao Tong University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Shanghai Jiao Tong University	Dai, QG (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Peoples Hosp 9, Dent Ctr 2, 639 Zhi Zao Ju Rd, Shanghai 200011, Peoples R China.; Jiang, LY (corresponding author), Shanghai Jiao Tong Univ, Peoples Hosp 9, Dept Oral & Craniomaxillofacial Sci, Ctr Craniofacial Orthodont,Sch Med, 639 Zhi Zao Ju Rd, Shanghai 200011, Peoples R China.	daiqinggang@126.com; 247416218@qq.com		zou, weiguo/0000-0003-2516-0302; Dai, Qinggang/0000-0002-8177-2496; Yang, Yiling/0000-0001-9044-2897	National Natural Science Foundation of China (NSFC) [81570950, 81870740, 81800949]; Shanghai Summit & Plateau Disciplines; SHIPM-mu fund from Shanghai Institute of Precision Medicine, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine [JC201809]; Incentive Project of High-level Innovation Team for Shanghai Jiao Tong University School of Medicine; Scholar of the Outstanding Youth Medical Talents from Shanghai Jiaotong University; "Chen Xing" project from Shanghai Jiaotong University; Shanghai "Rising Stars of Medical Talent" Youth Development Program from Shanghai Jiaotong University	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Shanghai Summit & Plateau Disciplines; SHIPM-mu fund from Shanghai Institute of Precision Medicine, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine; Incentive Project of High-level Innovation Team for Shanghai Jiao Tong University School of Medicine; Scholar of the Outstanding Youth Medical Talents from Shanghai Jiaotong University; "Chen Xing" project from Shanghai Jiaotong University; Shanghai "Rising Stars of Medical Talent" Youth Development Program from Shanghai Jiaotong University	This work was supported in part by National Natural Science Foundation of China (NSFC) Grants 81570950, 81870740, and 81800949; Shanghai Summit & Plateau Disciplines; the SHIPM-mu fund from Shanghai Institute of Precision Medicine, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine Grant JC201809; and the Incentive Project of High-level Innovation Team for Shanghai Jiao Tong University School of Medicine. This work was also supported by Scholar of the Outstanding Youth Medical Talents, Shanghai "Rising Stars of Medical Talent" Youth Development Program and the "Chen Xing" project from Shanghai Jiaotong University. The authors declare that they have no conflicts of interest with the contents of this article.	Aliprantis AO, 2008, J CLIN INVEST, V118, P3775, DOI 10.1172/JCI35711; Black DM, 2016, NEW ENGL J MED, V374, P254, DOI 10.1056/NEJMcp1513724; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; Chen X, 2018, CONNECT TISSUE RES, V59, P99, DOI 10.1080/03008207.2017.1290085; Chuvpilo S, 2002, IMMUNITY, V16, P881, DOI 10.1016/S1074-7613(02)00329-1; Cummings SR, 2002, LANCET, V359, P1761, DOI 10.1016/S0140-6736(02)08657-9; Dai QG, 2017, CELL DEATH DIFFER, V24, P1886, DOI 10.1038/cdd.2017.110; Dai QG, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04422-0; Dai QG, 2017, J BIOL CHEM, V292, P196, DOI 10.1074/jbc.M116.764761; Debnath S, 2018, NATURE, V562, P133, DOI 10.1038/s41586-018-0554-8; Han YJ, 2019, J CLIN INVEST, V129, P1895, DOI 10.1172/JCI124590; Harmer D, 2019, FRONT ENDOCRINOL, V9, DOI 10.3389/fendo.2018.00788; Hikata T, 2009, BLOOD, V113, P2202, DOI 10.1182/blood-2008-06-162594; Hirano T, 2000, ONCOGENE, V19, P2548, DOI 10.1038/sj.onc.1203551; Ikeda F, 2004, J CLIN INVEST, V114, P475, DOI 10.1172/JCI200419657; Ikeda K, 2016, J BIOCHEM, V159, P1, DOI 10.1093/jb/mvv112; Itoh S, 2006, BONE, V39, P505, DOI 10.1016/j.bone.2006.02.074; Johnson RW, 2015, BONE, V81, P343, DOI 10.1016/j.bone.2015.08.005; Joung YH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159891; Kim K, 2007, J IMMUNOL, V178, P5588, DOI 10.4049/jimmunol.178.9.5588; Li CH, 2013, BIOCHEM BIOPH RES CO, V435, P533, DOI 10.1016/j.bbrc.2013.04.084; Li J., 2013, ECS ELECTROCHEMISTY, V2, pA25, DOI DOI 10.4161/JKST.23930; Liu Z, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11149; Matsuo K, 2004, J BIOL CHEM, V279, P26475, DOI 10.1074/jbc.M313973200; Mori T, 2011, INT IMMUNOL, V23, P701, DOI 10.1093/intimm/dxr077; Nakamura T, 2007, CELL, V130, P811, DOI 10.1016/j.cell.2007.07.025; Sitara D, 2010, IMMUNOL REV, V233, P286, DOI 10.1111/j.0105-2896.2009.00849.x; Sun J, 2018, BONE RES, V6, DOI 10.1038/s41413-018-0015-x; Takayanagi H, 2002, DEV CELL, V3, P889, DOI 10.1016/S1534-5807(02)00369-6; Takayanagi H, 2007, ANN NY ACAD SCI, V1116, P227, DOI 10.1196/annals.1402.071; Wang G, 2016, ONCOGENE, V35, P4388, DOI 10.1038/onc.2015.446; Wotton CJ, 2019, BONE, V124, P69, DOI 10.1016/j.bone.2019.04.003; Wu Q, 2017, CELL PHYSIOL BIOCHEM, V41, P1360, DOI 10.1159/000465455; Yang WL, 2018, J CELL PHYSIOL, V233, P4606, DOI 10.1002/jcp.26372; Yu H, 2014, NAT REV CANCER, V14, P736, DOI 10.1038/nrc3818; Zhou HK, 2011, BONE, V49, P404, DOI 10.1016/j.bone.2011.04.020; Zou WG, 2013, J EXP MED, V210, P1793, DOI 10.1084/jem.20111790	37	37	41	5	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 18	2019	294	42					15395	15407		10.1074/jbc.RA119.010139	http://dx.doi.org/10.1074/jbc.RA119.010139			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JQ9HM	31462535	Green Published, hybrid			2022-12-26	WOS:000499248700017
J	Yombo, DJK; Mentink-Kane, MM; Wilson, MS; Wynn, TA; Madala, SK				Yombo, Dan J. K.; Mentink-Kane, Margaret M.; Wilson, Mark S.; Wynn, Thomas A.; Madala, Satish K.			Heat shock protein 70 is a positive regulator of airway inflammation and goblet cell hyperplasia in a mouse model of allergic airway inflammation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						heat shock protein (HSP); allergy; inflammation; asthma; cytokine; Th2 immune responses	MOLECULAR CHAPERONES; TRANSCRIPTION FACTOR; EPITHELIAL-CELLS; SMOOTH-MUSCLE; IL-4 RECEPTOR; MURINE MODEL; ASTHMA; HSP70; EXPRESSION; SECRETION	Heat shock proteins (Hsps) are highly conserved molecular chaperones that are ubiquitously expressed in all species to aid the solubilization of misfolded proteins, protein degradation, and transport. Elevated levels of Hsp70 have been found in the sputum, serum, and bronchoalveolar lavage (BAL) fluid of asthma patients and are known to correlate with disease severity. However, the function of Hsp70 in allergic airway inflammation has remained largely unknown. This study aimed to determine the role of Hsp70 in airway inflammation and remodeling using a mouse model of allergic airway inflammation. WT and Hsp70 double-knockout (Hsp70.1/.3(?/?)) mice were sensitized and challenged intratracheally with Schistosoma mansoni soluble egg antigens (SEAs) to induce robust Th2 responses and airway inflammation in the lungs. The lack of Hsp70 resulted in a significant reduction in airway inflammation, goblet cell hyperplasia, and Th2 cytokine production, including IL-4, IL-5, and IL-13. An analysis of the BAL fluid suggested that Hsp70 is critically required for eosinophilic infiltration, collagen accumulation, and Th2 cytokine production in allergic airways. Furthermore, our bone marrow (BM) transfer studies show that SEA-induced airway inflammation, goblet cell hyperplasia, and Th2 cytokine production were attenuated in WT mice that were reconstituted with Hsp70-deficient BM, but these effects were not attenuated in Hsp70-deficient mice that were reconstituted with WT BM. Together, these studies identify a pathogenic role for Hsp70 in hematopoietic cells during allergic airway inflammation; this illustrates the potential utility of targeting Hsp70 to alleviate allergen-induced Th2 cytokines, goblet cell hyperplasia, and airway inflammation.	[Yombo, Dan J. K.; Madala, Satish K.] Cincinnati Childrens Hosp Med Ctr, Div Pulm Med, 3333 Burnet Ave,MLC 2021, Cincinnati, OH 45229 USA; [Yombo, Dan J. K.; Madala, Satish K.] Univ Cincinnati, Coll Med, Dept Pediat, Cincinnati, OH 45267 USA; [Mentink-Kane, Margaret M.] Biomed Res Inst, Rockville, MD 20850 USA; [Wilson, Mark S.] Francis Crick Inst, Mill Hill Lab, London NW1 1AT, England; [Wynn, Thomas A.] NIAID, Lab Parasit Dis, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA	Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Francis Crick Institute; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Madala, SK (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Pulm Med, 3333 Burnet Ave,MLC 2021, Cincinnati, OH 45229 USA.	satish.madala@cchmc.org	Wynn, Thomas A/AAO-3523-2021	Wynn, Thomas A/0000-0002-7244-8731; Yombo, Dan Justin Kalenda/0000-0002-1469-503X	United States Department of Defense [W81XWH-17-1-0666]; National Institutes of Health [1R01 HL134801, 1R21 AI137309]; NIAID, National Institutes of Health; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL134801] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R21AG059533] Funding Source: NIH RePORTER	United States Department of Defense(United States Department of Defense); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAID, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the United States Department of Defense Grant W81XWH-17-1-0666 (to S. K. M.), National Institutes of Health Grants 1R01 HL134801 and 1R21 AI137309 (to S. K. M.), and the intramural research program of the NIAID, National Institutes of Health. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	ABRAVAYA K, 1992, GENE DEV, V6, P1153, DOI 10.1101/gad.6.7.1153; Alford KA, 2007, J BIOL CHEM, V282, P6232, DOI 10.1074/jbc.M610987200; Alrifai M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085839; Anderson GP, 2008, LANCET, V372, P1107, DOI 10.1016/S0140-6736(08)61452-X; Baturcam E, 2017, J INNATE IMMUN, V9, P52, DOI 10.1159/000449101; Bertorelli G, 1998, CLIN EXP ALLERGY, V28, P551; Breed ER, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-30752-8; Bukau B, 2006, CELL, V125, P443, DOI 10.1016/j.cell.2006.04.014; Chen ZJ, 2013, IMMUNITY, V39, P272, DOI 10.1016/j.immuni.2013.08.006; Choy DF, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aab3142; Cooper PR, 2009, AM J PHYSIOL-LUNG C, V297, pL530, DOI 10.1152/ajplung.00133.2009; Croisant S, 2014, ADV EXP MED BIOL, V795, P17, DOI 10.1007/978-1-4614-8603-9_2; Danov O, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0207767; Edukulla R, 2015, J BIOL CHEM, V290, P13510, DOI 10.1074/jbc.M114.622126; Fang SJ, 2013, AM J PHYSIOL-LUNG C, V304, pL511, DOI 10.1152/ajplung.00337.2012; Ferat-Osorio E, 2014, J INFLAMM-LOND, V11, DOI 10.1186/1476-9255-11-19; Figueiredo C, 2009, BLOOD, V113, P3008, DOI 10.1182/blood-2008-06-162727; Flood-Page P, 2007, AM J RESP CRIT CARE, V176, P1062, DOI 10.1164/rccm.200701-085OC; Gieseck RL, 2018, NAT REV IMMUNOL, V18, P62, DOI 10.1038/nri.2017.90; Gonzalez-Ramos M, 2013, INT J BIOCHEM CELL B, V45, P232, DOI 10.1016/j.biocel.2012.10.001; Harkins MS, 2003, ANN ALLERG ASTHMA IM, V91, P567, DOI 10.1016/S1081-1206(10)61536-0; Hastie AT, 2018, CLIN EXP ALLERGY, V48, P787, DOI 10.1111/cea.13129; Hou CC, 2011, CELL STRESS CHAPERON, V16, P663, DOI 10.1007/s12192-011-0271-9; Hunt CR, 2004, MOL CELL BIOL, V24, P899, DOI 10.1128/MCB.24.2.899-911.2004; Ianaro A, 2001, FEBS LETT, V499, P239, DOI 10.1016/S0014-5793(01)02569-8; Kampinga HH, 2009, CELL STRESS CHAPERON, V14, P105, DOI 10.1007/s12192-008-0068-7; Kim YK, 2006, CIRCULATION, V113, P2589, DOI 10.1161/CIRCULATIONAHA.105.598409; Krakowiak J, 2018, ELIFE, V7, DOI 10.7554/eLife.31668; Kudo M, 2012, NAT MED, V18, P547, DOI 10.1038/nm.2684; Li X, 2018, ALLERGY, V73, P361, DOI 10.1111/all.13296; Li Y, 2013, ARCH MED SCI, V9, P906, DOI 10.5114/aoms.2013.33180; Loftus PA, 2016, CURR OPIN OTOLARYNGO, V24, P245, DOI 10.1097/MOO.0000000000000262; LUKACS NW, 1994, AM J RESP CELL MOL, V10, P526, DOI 10.1165/ajrcmb.10.5.8179915; Luzina IG, 2013, AM J RESP CELL MOL, V49, P999, DOI 10.1165/rcmb.2013-0093OC; Madala SK, 2014, AM J RESP CELL MOL, V50, P777, DOI 10.1165/rcmb.2013-0042OC; Madala SK, 2010, J IMMUNOL, V184, P3955, DOI 10.4049/jimmunol.0903008; Malyshev I., 2013, IMMUNITY TUMORS AGIN, P15; McDonough H, 2003, CELL STRESS CHAPERON, V8, P303, DOI 10.1379/1466-1268(2003)008<0303:CALBTC>2.0.CO;2; McGregor MC, 2019, AM J RESP CRIT CARE, V199, P433, DOI 10.1164/rccm.201810-1944CI; Min HJ, 2017, INT FORUM ALLERGY RH, V7, P530, DOI 10.1002/alr.21905; Miyata Y, 2013, ACS CHEM NEUROSCI, V4, P930, DOI 10.1021/cn300210g; Mortaz E, 2006, EXP HEMATOL, V34, P8, DOI 10.1016/j.exphem.2005.10.012; Munitz A, 2008, P NATL ACAD SCI USA, V105, P7240, DOI 10.1073/pnas.0802465105; Namba T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027296; Pezzulo AA, 2019, J CLIN INVEST, V129, P744, DOI 10.1172/JCI123524; Pirooznia M, 2007, BIOINFORMATION, V1, P420, DOI 10.6026/97320630001420; Qu BG, 2015, CELL STRESS CHAPERON, V20, P885, DOI 10.1007/s12192-015-0618-8; Ramalingam TR, 2008, NAT IMMUNOL, V9, P25, DOI 10.1038/ni1544; Rappa F, 2012, ANTICANCER RES, V32, P5139; Sellares J, 2019, AM J RESP CELL MOL, V60, P629, DOI 10.1165/rcmb.2017-0268OC; Shevchenko MA, 2016, BIOCHEMISTRY-MOSCOW+, V81, P1384, DOI 10.1134/S0006297916110158; Sontake V, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.121252; Sontake V, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.91454; Tanaka KI, 2010, BIOCHEM PHARMACOL, V80, P920, DOI 10.1016/j.bcp.2010.05.025; Tukaj S, 2014, J INFLAMM-LOND, V11, DOI 10.1186/1476-9255-11-10; van Eden W, 2012, CELL STRESS CHAPERON, V17, P281, DOI 10.1007/s12192-011-0311-5; Vannella KM, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf1938; VIGNOLA AM, 1995, AM J RESP CELL MOL, V13, P683, DOI 10.1165/ajrcmb.13.6.7576706; Webb LM, 2017, EMBO J, V36, P2404, DOI 10.15252/embj.201695345; Wei Q, 2014, AM J RESP CRIT CARE, V189, P16, DOI 10.1164/rccm.201305-0874OC; Wills-Karp M, 2004, IMMUNOL REV, V202, P175, DOI 10.1111/j.0105-2896.2004.00215.x; Wilson MS, 2008, J IMMUNOL, V181, P6942, DOI 10.4049/jimmunol.181.10.6942; Wilson MS, 2007, J CLIN INVEST, V117, P2941, DOI 10.1172/JCI31546; Wilson MS, 2010, J EXP MED, V207, P535, DOI 10.1084/jem.20092121; Wynn TA, 2015, NAT REV IMMUNOL, V15, P271, DOI 10.1038/nri3831; Yusuf N, 2009, J IMMUNOL, V182, P675, DOI 10.4049/jimmunol.182.1.675; Zininga T, 2018, MOLECULES, V23, DOI 10.3390/molecules23112846	67	9	11	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 11	2019	294	41					15082	15094		10.1074/jbc.RA119.009145	http://dx.doi.org/10.1074/jbc.RA119.009145			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JQ9JH	31431507	hybrid, Green Published			2022-12-26	WOS:000499253400020
J	Perez, AB; Chueca, N; Macias, J; Pineda, JA; Salmeron, J; Rivero-Juarez, A; Hidalgo-Tenorio, C; Espinosa, MD; Tellez, F; Von-Wichmann, MA; Omar, M; Santos, J; Hernandez-Quero, J; Anton, JJ; Collado, A; Lozano, AB; Garcia-Deltoro, M; Casado, M; Pascasio, JM; Selfa, A; Rosales, JM; De la Iglesia, A; Arenas, JI; Garcia-Bujalance, S; Rios, MJ; Bernal, E; Martinez, O; Garcia-Herola, A; Velez, M; Rincon, P; Garcia, F				Belen Perez, Ana; Chueca, Natalia; Macias, Juan; Antonio Pineda, Juan; Salmeron, Javier; Rivero-Juarez, Antonio; Hidalgo-Tenorio, Carmen; Dolores Espinosa, Maria; Tellez, Francisco; Angel Von-Wichmann, Miguel; Omar, Mohamed; Santos, Jesus; Hernandez-Quero, Jose; Joaquin Anton, Jose; Collado, Antonio; Belen Lozano, Ana; Garcia-Deltoro, Miguel; Casado, Marta; Manuel Pascasio, Juan; Selfa, Aida; Miguel Rosales, Jose; De la Iglesia, Alberto; Ignacio Arenas, Juan; Garcia-Bujalance, Silvia; Jose Rios, Maria; Bernal, Enrique; Martinez, Onofre; Garcia-Herola, Antonio; Velez, Monica; Rincon, Pilar; Garcia, Federico			Prevalence of resistance associated substitutions and efficacy of baseline resistance-guided chronic hepatitis C treatment in Spain from the GEHEP-004 cohort	PLOS ONE			English	Article							HCV GENOTYPE; ANTIVIRAL DRUGS; VIRUS-INFECTION; REAL-LIFE; SUBTYPES	Treatment guidelines differ in their recommendation to determine baseline resistance associated substitutions (RAS) before starting a first-line treatment with direct-acting antivirals (DAAs). Here we analyze the efficacy of DAA treatment with baseline RAS information. We conducted a prospective study involving 23 centers collaborating in the GEHEP-004 DAA resistance cohort. Baseline NS5A and NS3 RASs were studied by Sanger sequencing. After issuing a comprehensive resistance report, the treating physician decided the therapy, duration and ribavirin use. Sustained virological response (SVR12) data are available in 275 patients. Baseline NS5A RAS prevalence was between 4.3% and 26.8% according to genotype, and NS3 RASs prevalence (GT1a) was 6.3%. Overall, SVR12 was 97.8%. Amongst HCV-GT1a patients, 75.0% had >800,000 IU/ml and most of those that started grazoprevir/elbasvir were treated for 12 weeks. In genotype 3, NS5A Y93H was detected in 9 patients. 42.8% of the HCV-GT3 patients that started sofosbuvir/velpatasvir included ribavirin, although only 14.7% carried Y93H. The efficacy of baseline resistance-guided treatment in our cohort has been high across the most prevalent HCV genotypes in Spain. The duration of the grazoprevir/elbasvir treatment adhered mostly to AASLD/IDSA recommendations. In cirrhotic patients infected with GT-3 there has been a high use of ribavirin.	[Belen Perez, Ana] Univ Hosp Reina Sofia, Inst Maimonides Invest Biomed Cordoba IMIBIC, Clin Microbiol Unit, Cordoba, Spain; [Chueca, Natalia; Garcia, Federico] Univ Hosp San Cecilio, Inst Invest Ibs Granada, Clin Microbiol Unit, Granada, Spain; [Macias, Juan; Antonio Pineda, Juan; Rincon, Pilar] Univ Hosp Nuestra Senora de Valme, Infect Dis Unit, Seville, Spain; [Salmeron, Javier] Univ Hosp San Cecilio Granada, Inst Invest Ibs CIBERehd, Hepatol Unit, Granada, Spain; [Rivero-Juarez, Antonio] Univ Cordoba, Univ Hosp Reina Sofia, Inst Maimonides Invest Biomed Cordoba IMIBIC, Infect Dis Unit, Cordoba, Spain; [Hidalgo-Tenorio, Carmen] Univ Hosp Virgen Nieves, Infect Dis Unit, Granada, Spain; [Dolores Espinosa, Maria] Univ Hosp Virgen Nieves, Hepatol Unit, Granada, Spain; [Tellez, Francisco] Hosp Puerto Real, Infect Dis Unit, Cadiz, Spain; [Angel Von-Wichmann, Miguel] Univ Hosp Donostia, Infect Dis Unit, San Sebastian, Spain; [Omar, Mohamed] Complejo Hosp Jaen, Infect Dis Unit, Jaen, Spain; [Santos, Jesus] Univ Hosp Virgen Victoria, Infect Dis Unit, Malaga, Spain; [Hernandez-Quero, Jose] Univ Hosp San Cecilio, Infect Dis Unit, Granada, Spain; [Joaquin Anton, Jose] Albolote Penitenciary, Granada, Spain; [Collado, Antonio] Complejo Hosp Torrecardenas, Infect Dis Unit, Almeria, Spain; [Belen Lozano, Ana] Hosp Poniente, Infect Dis Unit, Almeria, Spain; [Garcia-Deltoro, Miguel] Hosp Gen Valencia, Infect Dis Unit, Valencia, Spain; [Casado, Marta] Complejo Hosp Torrecardenas, Hepatol Unit, Almeria, Spain; [Manuel Pascasio, Juan] Univ Hosp Virgen Rocio, Hepatol Unit, Seville, Spain; [Selfa, Aida] Hosp Comarcal Santa Ana, Hepatol Unit, Motril Granada, Spain; [Miguel Rosales, Jose] Hosp Costa del Sol, Hepatol Unit, Malaga, Spain; [De la Iglesia, Alberto] Univ Hosp Infanta Elena, Clin Microbiol Unit, Huelva, Spain; [Ignacio Arenas, Juan] Univ Hosp Donostia, Hepatol Unit, San Sebastian, Spain; [Garcia-Bujalance, Silvia] Univ Hosp La Paz, Clin Microbiol Unit, Madrid, Spain; [Jose Rios, Maria] Univ Hosp Virgen Macarena, Infect Dis Unit, Seville, Spain; [Bernal, Enrique] Hosp Gen Reina Sofia, Infect Dis Unit, Murcia, Spain; [Martinez, Onofre] Univ Hosp Santa Lucia, Infect Dis Unit, Cartagena, Spain; [Garcia-Herola, Antonio] Hosp Marina Baixa, Hepatol Unit, Alicante, Spain; [Velez, Monica] Hosp Gen La Palma, Infect Dis Unit, La Palma, Spain	Hospital Universitario San Cecilio; Universidad de Cordoba; Hospital Universitario Virgen de las Nieves; Hospital Universitario Virgen de las Nieves; Universidad de Cadiz; Hospital Universitario Puerto Real; University Hospital Donostia; Complejo Hospitalario de Jaen; Hospital Universitario San Cecilio; Hospital Torrecardenas; Hospital Torrecardenas; Virgen del Rocio University Hospital; University Hospital Donostia; Hospital Universitario La Paz; Hospital Universitario Virgen Macarena	Garcia, F (corresponding author), Univ Hosp San Cecilio, Inst Invest Ibs Granada, Clin Microbiol Unit, Granada, Spain.	fegarcia@ugr.es	Rosales-Zabal, Jose Miguel/Q-7170-2018; Pineda, Juan A./AAO-9312-2021; Garcia, Federico/AAA-3175-2020	Rosales-Zabal, Jose Miguel/0000-0001-6751-6720; Pineda, Juan A./0000-0002-3751-0296; Garcia, Federico/0000-0001-7611-781X; Perez, Ana Belen/0000-0001-9655-817X; Macias, Juan/0000-0002-4778-790X; Bernal, Enrique/0000-0002-4041-0579; GARCIA HEROLA, ANTONIO/0000-0002-6755-4994; Tellez, Francisco/0000-0002-9997-6761	Fondo de Investigacion Sanitaria [PI15/00713]; Plan Nacional de I+D+I; Fondo Europeo de Desarrollo Regional-FEDER [RD16/0025/0040]; Fundacion Progreso y salud, Junta de Andalucia [PI-0411-2014]; GEHEP-SEIMC [GEHEP-004]	Fondo de Investigacion Sanitaria(Instituto de Salud Carlos III); Plan Nacional de I+D+I; Fondo Europeo de Desarrollo Regional-FEDER(European Commission); Fundacion Progreso y salud, Junta de Andalucia(Junta de Andalucia); GEHEP-SEIMC	This work was supported in part by grants from Fondo de Investigacion Sanitaria (www.isciii.es) (PI15/00713), Plan Nacional de I+D+I and Fondo Europeo de Desarrollo Regional-FEDER (http://www.ciencia.gob.es/portal/site/MICINN/menuitem. dbc68b34d11ccbd5d52ffeb801 432ea0/? vgnextoid= e331aa27bfba7610VgnVC M1000001d04140aRCRD) (RD16/0025/0040), Fundacion Progreso y salud, Junta de Andalucia (https://www.sspa.juntadeandalucia.es/fundacion progresoysalud/gestionconvocatorias/ugc/login. sol. jsp? id=10) (PI-0411-2014), and GEHEP-SEIMC (GEHEP-004).	AASLD-IDSA, REC TEST MAN TREAT H; AEEH/SEIMC, 2018, GUIA AEEH DE TRATAMI; Aguilera A, 2017, J VIRAL HEPATITIS, V24, P725, DOI 10.1111/jvh.12700; Bartlett SR, 2017, HEPATOL COMMUN, V1, P379, DOI 10.1002/hep4.1050; Blach S, 2017, LANCET GASTROENTEROL, V2, P161, DOI 10.1016/S2468-1253(16)30181-9; Cento V, 2017, J ANTIMICROB CHEMOTH, V72, P3420, DOI 10.1093/jac/dkx302; European Assoc Study Liver, 2018, J HEPATOL, V69, P461, DOI 10.1016/j.jhep.2018.03.026; European Medicines Agency, TECHN DAT SOF VELP E; Ferret MB, 2018, J HEPATOL, V68, pS20, DOI 10.1016/S0168-8278(18)30260-5; Gane EJ, 2017, HEPATOLOGY, V66, P1083, DOI 10.1002/hep.29256; Grandal M, 2018, J MED VIROL, V90, P1094, DOI 10.1002/jmv.25048; Harrington PR, 2018, HEPATOLOGY, V67, P2430, DOI 10.1002/hep.29693; Hedskog C, 2017, HEPATOLOGY, V66, p121A; Hezode C, 2018, LIVER INT, V38, P21, DOI 10.1111/liv.13638; Jacobson IM, 2017, GASTROENTEROLOGY, V152, P1372, DOI 10.1053/j.gastro.2017.01.050; Kartashev V, 2016, J CLIN VIROL, V81, P82, DOI 10.1016/j.jcv.2016.05.010; Komatsu TE, 2017, GASTROENTEROLOGY, V152, P586, DOI 10.1053/j.gastro.2016.10.017; Lontok E, 2015, HEPATOLOGY, V62, P1623, DOI 10.1002/hep.27934; Messina JP, 2015, HEPATOLOGY, V61, P77, DOI 10.1002/hep.27259; OGATA N, 1991, P NATL ACAD SCI USA, V88, P3392, DOI 10.1073/pnas.88.8.3392; Pawlotsky JM, 2016, GASTROENTEROLOGY, V151, P70, DOI 10.1053/j.gastro.2016.04.003; Perez AB, 2017, HEPATOLOGY, V66, p575A; Sarrazin C, 2016, J HEPATOL, V64, P486, DOI 10.1016/j.jhep.2015.09.011; Smith DB, HCV CLASS; Smith DB, 2014, HEPATOLOGY, V59, P318, DOI 10.1002/hep.26744; Sorbo MC, 2018, DRUG RESIST UPDATE, V37, P17, DOI 10.1016/j.drup.2018.01.004; von Felden J, 2018, ALIMENT PHARM THER, V47, P1288, DOI 10.1111/apt.14592; Zeuzem S, 2018, NEW ENGL J MED, V378, P354, DOI 10.1056/NEJMoa1702417; Zeuzem S, 2017, J HEPATOL, V66, P910, DOI 10.1016/j.jhep.2017.01.007	29	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2019	14	8							e0221231	10.1371/journal.pone.0221231	http://dx.doi.org/10.1371/journal.pone.0221231			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW6BO	31469856	Green Published, gold, Green Submitted			2022-12-26	WOS:000485062200014
J	Li, BQ; Lu, XC; Moeini, M; Sakadzic, S; Thorin, E; Lesage, F				Li, Baoqiang; Lu, Xuecong; Moeini, Mohammad; Sakadzic, Sava; Thorin, Eric; Lesage, Frederic			Atherosclerosis is associated with a decrease in cerebral microvascular blood flow and tissue oxygenation	PLOS ONE			English	Article							TRANSIT-TIME HETEROGENEITY; VASCULAR RISK-FACTORS; ALZHEIMERS-DISEASE; ENDOTHELIAL DYSFUNCTION; BRAIN; STROKE; MICE; PATHOGENESIS; MICROSCOPY; DEMENTIA	Chronic atherosclerosis may cause cerebral hypoperfusion and inadequate brain oxygenation, contributing to the progression of cognitive decline. In this study, we exploited two-photon phosphorescence lifetime microscopy to measure the absolute partial pressure of oxygen (PO2) in cortical tissue in both young and old LDLR-/-, hApoB100(+/+) mice, spontaneously developing atherosclerosis with age. Capillary red-blood-cell (RBC) speed, flux, hematocrit and capillary diameter were also measured by two-photon imaging of FITC-labelled blood plasma. Our results show positive correlations between RBC speed, flux, diameter and capillary-adjacent tissue PO2. When compared to the young mice, we observed lower tissue PO2, lower RBC speed and flux, and smaller capillary diameter in the old atherosclerotic mice. The old mice also exhibited a higher spatial heterogeneity of tissue PO2, and RBC speed and flux, suggesting a less efficient oxygen extraction.	[Li, Baoqiang; Lu, Xuecong; Lesage, Frederic] Ecole Polytech Montreal, Inst Biomed Engn, Montreal, PQ, Canada; [Li, Baoqiang; Lu, Xuecong; Thorin, Eric; Lesage, Frederic] Montreal Heart Inst, Res Ctr, Montreal, PQ, Canada; [Moeini, Mohammad] Amirkabir Univ Technol, Dept Biomed Engn, Tehran Polytech, Tehran, Iran; [Sakadzic, Sava] Harvard Med Sch, Athinoula A Martinos Ctr Biomed Imaging, Massachusetts Gen Hosp, Charlestown, MA USA; [Thorin, Eric] Univ Montreal, Fac Med, Dept Surg, Montreal, PQ, Canada	Universite de Montreal; Polytechnique Montreal; Universite de Montreal; Amirkabir University of Technology; Harvard University; Massachusetts General Hospital; Universite de Montreal	Lesage, F (corresponding author), Ecole Polytech Montreal, Inst Biomed Engn, Montreal, PQ, Canada.; Lesage, F (corresponding author), Montreal Heart Inst, Res Ctr, Montreal, PQ, Canada.	frederic.lesage@polymtl.ca	Moeini, Mohammad/S-5631-2019	Moeini, Mohammad/0000-0001-7620-8404	Natural Sciences and Engineering Research Council of Canada; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R24NS092986, P01NS055104, R01NS091230] Funding Source: NIH RePORTER	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was supported with a discovery grant from the Natural Sciences and Engineering Research Council of Canada awarded to F. L. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amarenco P, 1996, NEW ENGL J MED, V334, P1216; Bolduc V, 2012, AM J PHYSIOL-HEART C, V302, pH1330, DOI 10.1152/ajpheart.01044.2011; Bolduc V, 2011, AM J PHYSIOL-HEART C, V301, pH2081, DOI 10.1152/ajpheart.00706.2011; CELERMAJER DS, 1992, LANCET, V340, P1111, DOI 10.1016/0140-6736(92)93147-F; Chambless LE, 2000, AM J EPIDEMIOL, V151, P478; Davignon J, 2004, CIRCULATION, V109, P27, DOI 10.1161/01.CIR.0000131515.03336.f8; de la Torre JC, 2010, AGEING RES REV, V9, P218, DOI 10.1016/j.arr.2010.04.002; Desjardins M, 2014, NEUROBIOL AGING, V35, P1947, DOI 10.1016/j.neurobiolaging.2014.01.136; Dickstein DL, 2010, MT SINAI J MED, V77, P82, DOI 10.1002/msj.20155; Drouin A, 2011, PFLUG ARCH EUR J PHY, V462, P371, DOI 10.1007/s00424-011-0973-y; Drouin A, 2011, AM J PHYSIOL-HEART C, V300, pH1032, DOI 10.1152/ajpheart.00410.2010; Eskildsen SF, 2017, NEUROBIOL AGING, V50, P107, DOI 10.1016/j.neurobiolaging.2016.11.004; Farhat N, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000201; Finikova OS, 2008, CHEMPHYSCHEM, V9, P1673, DOI 10.1002/cphc.200800296; Gendron ME, 2010, AM J PHYSIOL-HEART C, V298, pH2062, DOI 10.1152/ajpheart.00532.2009; Golub AS, 2005, AM J PHYSIOL-HEART C, V288, pH2735, DOI 10.1152/ajpheart.00711.2004; Hofman A, 1997, LANCET, V349, P151, DOI 10.1016/S0140-6736(96)09328-2; Iadecola C, 2010, ACTA NEUROPATHOL, V120, P287, DOI 10.1007/s00401-010-0718-6; Janssen BJA, 2004, AM J PHYSIOL-HEART C, V287, pH1618, DOI 10.1152/ajpheart.01192.2003; Jespersen SN, 2012, J CEREBR BLOOD F MET, V32, P264, DOI 10.1038/jcbfm.2011.153; Jurado MB, 2017, NEUROLOGY, V88; Kalback W, 2004, NEUROL RES, V26, P525, DOI 10.1179/016164104225017668; Kivipelto M, 2001, BMJ-BRIT MED J, V322, P1447, DOI 10.1136/bmj.322.7300.1447; Kleinfeld D, 1998, P NATL ACAD SCI USA, V95, P15741, DOI 10.1073/pnas.95.26.15741; Lecoq J, 2011, NAT MED, V17, P893, DOI 10.1038/nm.2394; LEENDERS KL, 1990, BRAIN, V113, P27, DOI 10.1093/brain/113.1.27; Li BQ, 2017, J BIOMED OPT, V22, DOI 10.1117/1.JBO.22.1.016014; Li BQ, 2014, BIOMED OPT EXPRESS, V5, P1664, DOI 10.1364/BOE.5.001664; Lu X, 2017, SIMULTANEOUS 2 PHOTO, DOI [10.1117/12.2251437, DOI 10.1117/12.2251437]; Lyons DG, 2016, ELIFE, V5, DOI 10.7554/eLife.12024; Mintun MA, 2001, P NATL ACAD SCI USA, V98, P6859, DOI 10.1073/pnas.111164398; Moeini M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-26543-w; Moskowitz MA, 2010, NEURON, V67, P181, DOI 10.1016/j.neuron.2010.07.002; Nguyen A, 2016, PLOS ONE, V11, P1, DOI DOI 10.1371/J0URNAL.P0NE.0151526; Ohira T, 2006, STROKE, V37, P2493, DOI 10.1161/01.STR.0000239694.19359.88; Ostergaard L, 2014, J CEREBR BLOOD F MET, V34, P1585, DOI 10.1038/jcbfm.2014.131; Pantoni L, 2010, LANCET NEUROL, V9, P689, DOI 10.1016/S1474-4422(10)70104-6; Parpaleix A, 2013, NAT MED, V19, P241, DOI 10.1038/nm.3059; Peers C, 2007, ESSAYS BIOCHEM, V43, P153, DOI 10.1042/bse0430153; Peers C, 2009, ANN NY ACAD SCI, V1177, P169, DOI 10.1111/j.1749-6632.2009.05026.x; Popa-Wagner A, 2015, J NEURAL TRANSM, V122, P47, DOI 10.1007/s00702-013-1129-3; Pries AR, 1996, CARDIOVASC RES, V32, P654, DOI 10.1016/S0008-6363(96)00065-X; Sakadzic S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6734; Sakadzic S, 2010, NAT METHODS, V7, P755, DOI 10.1038/nmeth.1490; Sanan DA, 1998, P NATL ACAD SCI USA, V95, P4544, DOI 10.1073/pnas.95.8.4544; Santisakultarm TP, 2012, AM J PHYSIOL-HEART C, V302, pH1367, DOI 10.1152/ajpheart.00417.2011; Tomita Y, 2002, J CEREBR BLOOD F MET, V22, P663, DOI 10.1097/00004647-200206000-00004; Van Teeffelen JWGE, 2008, J PHYSIOL-LONDON, V586, P3207, DOI 10.1113/jphysiol.2008.152975; Yaffe K, 2014, CIRCULATION, V129, P1560, DOI 10.1161/CIRCULATIONAHA.113.004798	49	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2019	14	8							e0221547	10.1371/journal.pone.0221547	http://dx.doi.org/10.1371/journal.pone.0221547			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW6BO	31469849	Green Submitted, gold, Green Published, Green Accepted			2022-12-26	WOS:000485062200022
J	Ramos, PL; Nascimento, DC; Ferreira, PH; Weber, KT; Santos, TEG; Louzada, F				Ramos, Pedro L.; Nascimento, Diego C.; Ferreira, Paulo H.; Weber, Karina T.; Santos, Taiza E. G.; Louzada, Francisco			Modeling traumatic brain injury lifetime data: Improved estimators for the Generalized Gamma distribution under small samples	PLOS ONE			English	Article							LIKELIHOOD; PARAMETER; MODERATE; FAMILY	In this paper, from the practical point of view, we focus on modeling traumatic brain injury data considering different stages of hospitalization, related to patients' survival rates following traumatic brain injury caused by traffic accidents. From the statistical point of view, the primary objective is related to overcoming the limited number of traumatic brain injury patients available for studying by considering different estimation methods to obtain improved estimators of the model parameters, which can be recommended to be used in the presence of small samples. To have a general methodology, at least in principle, we consider the very flexible Generalized Gamma distribution. We compare various estimation methods using extensive numerical simulations. The results reveal that the penalized maximum likelihood estimators have the smallest mean square errors and biases, proving to be the most efficient method among the investigated ones, mainly to be used in the presence of small samples. The Simulated Annealing technique is used to avoid numerical problems during the optimization process, as well as the need for good initial values. Overall, we considered an amount of three real data sets related to traumatic brain injury caused by traffic accidents to demonstrate that the Generalized Gamma distribution is a simple alternative to be used in this type of applications for different occurrence rates and risks, and in the presence of small samples.	[Ramos, Pedro L.; Nascimento, Diego C.; Louzada, Francisco] Univ Sao Paulo, Inst Math & Comp Sci, Sao Carlos, SP, Brazil; [Ferreira, Paulo H.] Univ Fed Bahia, Inst Math & Stat, Salvador, BA, Brazil; [Weber, Karina T.; Santos, Taiza E. G.] Univ Sao Paulo, Med Sch Ribeirao Preto, Ribeirao Preto, Brazil	Universidade de Sao Paulo; Universidade Federal da Bahia; Universidade de Sao Paulo	Ramos, PL (corresponding author), Univ Sao Paulo, Inst Math & Comp Sci, Sao Carlos, SP, Brazil.	pedrolramos@usp.br	Ramos, Pedro L/U-3270-2017; Edwards, Taiza GS/F-9214-2012; Nascimento, Diego/AAV-9709-2021; Nascimento, Diego/GZM-2912-2022	Ramos, Pedro L/0000-0002-5387-2457; Edwards, Taiza GS/0000-0003-3033-2981; Nascimento, Diego/0000-0002-3406-4518; Nascimento, Diego/0000-0002-3406-4518; Ferreira, Paulo Henrique/0000-0001-6312-6098	CNPq; FAPESP; CAPES	CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	The research was partially supported by the Brazilian organizations CNPq, FAPESP, and CAPES, and was carried out using the computational resources of the Center for Mathematical Sciences Applied to Industry (CeMEAI) funded by FAPESP.	Aarts E., 1989, SIMULATED ANNEALING; Akaike H., 1977, J R STAT SOC C-APPL, P27; Bagheri SF, 2014, J STAT COMPUT SIM, V84, P2345, DOI 10.1080/00949655.2013.793342; Bonow RH, 2018, WORLD NEUROSURG, V111, pE82, DOI 10.1016/j.wneu.2017.11.171; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Chen F, 2018, J SAFETY RES, V65, P153, DOI 10.1016/j.jsr.2018.02.010; Chen F, 2011, ACCIDENT ANAL PREV, V43, P1677, DOI 10.1016/j.aap.2011.03.026; Cheng R.C.H., 1979, MAXIMUM PRODUCT SPAC, p79; CHENG RCH, 1983, J ROY STAT SOC B MET, V45, P394; Cox C, 2007, STAT MED, V26, P4352, DOI 10.1002/sim.2836; DICICCIO TJ, 1987, TECHNOMETRICS, V29, P33, DOI 10.2307/1269881; DiCiccio TJ, 1996, STAT SCI, V11, P189; FIRTH D, 1993, BIOMETRIKA, V80, P27, DOI 10.2307/2336755; GLASER RE, 1980, J AM STAT ASSOC, V75, P667; HAARIO H, 1991, ADV APPL PROBAB, V23, P866, DOI 10.2307/1427681; Hager H., 1970, J AM STAT ASSOC, V65, P1601, DOI [10.1080/01621459.1970.10481190, DOI 10.2307/2284343, DOI 10.1080/01621459.1970.10481190]; Huang PH, 2006, TAIWAN J MATH, V10, P1083, DOI 10.11650/twjm/1500403894; HURVICH CM, 1989, BIOMETRIKA, V76, P297, DOI 10.2307/2336663; Izquierdo-Marquez I, 2018, INFORM SCIENCES, V460, P172, DOI 10.1016/j.ins.2018.05.047; Jeffreys H., 1998, THEORY PROBABILITY; Khodabin M., 2010, MATH SCI, V4, P9; Kim JK, 2013, ACCIDENT ANAL PREV, V50, P1073, DOI 10.1016/j.aap.2012.08.011; KIRKPATRICK S, 1983, SCIENCE, V220, P671, DOI 10.1126/science.220.4598.671; Louzada F, 2020, COMMUN STAT-SIMUL C, V49, P1024, DOI 10.1080/03610918.2018.1491988; Louzada F, 2018, J STAT COMPUT SIM, V88, P1134, DOI 10.1080/00949655.2017.1422503; Louzada F, 2016, COMPUT MATH METHOD M, V2016, DOI 10.1155/2016/8727951; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Marshall AW, 1997, BIOMETRIKA, V84, P641, DOI 10.1093/biomet/84.3.641; METROPOLIS N, 1953, J CHEM PHYS, V21, P1087, DOI 10.1063/1.1699114; Mock C., 2004, GUIDELINES ESSENTIAL; Mudholkar GS, 1996, J AM STAT ASSOC, V91, P1575, DOI 10.2307/2291583; MUDHOLKAR GS, 1995, TECHNOMETRICS, V37, P436, DOI 10.2307/1269735; Noufaily A, 2013, COMPUTATION STAT, V28, P505, DOI 10.1007/s00180-012-0314-4; Owens PW, 2018, BRAIN INJURY, V32, P900, DOI 10.1080/02699052.2018.1466366; PRENTICE RL, 1974, BIOMETRIKA, V61, P539, DOI 10.1093/biomet/61.3.539; R Core Team, 2018, R LANG ENV STAT COMP; Ramos PL, 2020, J APPL STAT, V47, P306, DOI 10.1080/02664763.2019.1644488; RANNEBY B, 1984, SCAND J STAT, V11, P93; Rodrigues GC, 2018, J APPL STAT, V45, P128, DOI 10.1080/02664763.2016.1268571; Salter LA, 2001, SYST BIOL, V50, P7, DOI 10.1080/106351501750107413; STACY EW, 1962, ANN MATH STAT, V33, P1187, DOI 10.1214/aoms/1177704481; STACY EW, 1965, TECHNOMETRICS, V7, P349, DOI 10.2307/1266594; SUGIURA N, 1978, COMMUN STAT A-THEOR, V7, P13, DOI 10.1080/03610927808827599; Teimouri M, 2013, STATISTICS-ABINGDON, V47, P93, DOI 10.1080/02331888.2011.559657; Torres-Jimenez J, 2015, INFORM SCIENCES, V303, P33, DOI 10.1016/j.ins.2014.12.041; Torres-Jimenez J, 2012, INFORM SCIENCES, V185, P137, DOI 10.1016/j.ins.2011.09.020; Weber KT, 2016, ARQ NEURO-PSIQUIAT, V74, P409, DOI 10.1590/0004-282X20160053; WINGO DR, 1987, IEEE T RELIAB, V36, P586, DOI 10.1109/TR.1987.5222478	49	10	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2019	14	8							e0221332	10.1371/journal.pone.0221332	http://dx.doi.org/10.1371/journal.pone.0221332			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW6BO	31469851	Green Submitted, Green Published, gold			2022-12-26	WOS:000485062200018
J	Lagunilla, AH; Carrancho, A; Villalain, JJ; Mallol, C; Hernandez, CM				Herrejon Lagunilla, Angela; Carrancho, Angel; Jose Villalain, Juan; Mallol, Carolina; Manuel Hernandez, Cristo			An experimental approach to the preservation potential of magnetic signatures in anthropogenic fires	PLOS ONE			English	Article							SITE-FORMATION PROCESSES; LES FRAUX DORDOGNE; MIDDLE STONE-AGE; ABRIC DEL PASTOR; ARCHAEOLOGICAL EVIDENCE; COMBUSTION FEATURES; FIRING TEMPERATURE; HABITUAL USE; QESEM CAVE; HEARTHS	Archaeomagnetic and rock-magnetic methods are of great value in the identification of archaeological fire, especially in Palaeolithic sites where evidence is usually scarce, ambiguous or poorly preserved. Although taphonomic processes can significantly modify Palaeolithic combustion structures, the extent to which such processes affect the magnetic record remains unknown. Here we report the results of an archaeomagnetic study involving five, two-to-five-year-old experimental combustion structures in open-air and cave settings. Some of these combustion structures involved post-combustion human actions such as trampling and relighting. Our results show pseudo-single domain (PSD) magnetite as the main magnetic carrier. Wood ash layers of combustion structures are the most magnetic facies followed by thermally altered sediments constituting the combustion substrates. A decreasing magnetic concentration pattern in depth was observed as a function of temperature. Positive correlation was found between good-quality directional data and macroscopically well-preserved combustion structures. Partial thermoremanent magnetization (pTRM) was the main magnetization mechanism identified in the combustion substrate facies. These data coupled with partial thermomagnetic curve experiments show the potential of these methods to estimate maximum temperatures of the last combustion event. Relightings show very good directional results, but they cannot be identified because the time between them is not enough to statistically distinguish directional variations of the local Earth's magnetic field. The substrate sediment of an intensively trampled combustion structure yielded reliable archaeomagnetic directions. The results are discussed in terms of magnetization preservation potential and the effects of taphonomic processes on the archaeomagnetic record.	[Herrejon Lagunilla, Angela; Jose Villalain, Juan] Univ Burgos, Dept Fis, Burgos, Spain; [Carrancho, Angel] Univ Burgos, Dept His Geograf & Comunicac, Area Prehist, Burgos, Spain; [Mallol, Carolina; Manuel Hernandez, Cristo] Univ La Laguna, Fac Humanidades, Area Prehist, Dept Geograf & Hist, Campus Guajara, Tenerife, Spain; [Mallol, Carolina] Inst Univ Bioorgan Antonio Gonzalez, Archaeol Micromorphol & Biomarkers AMBI Lab, Avda Astrofis Francisco Sanchez, Tenerife, Spain	Universidad de Burgos; Universidad de Burgos; Universidad de la Laguna; Universidad de la Laguna	Lagunilla, AH (corresponding author), Univ Burgos, Dept Fis, Burgos, Spain.	aherrejon@ubu.es	Carrancho, Ángel/R-5077-2018	Carrancho, Ángel/0000-0001-7119-6424; Hernandez Gomez, Cristo M./0000-0002-0777-5963; Herrejon Lagunilla, Angela/0000-0001-6574-5001	Junta de Castilla y Leon; European Social Funds (ESF; Operational Programme for Castilla y Leon); Junta de Castilla y Leon [BU235P18]; European Fund for Economic and Regional Development (EFRD); Spanish Ministry of Economy and Competitiveness (MINECO); EFRD [CGL2016-77560, HAR2015-68321-P]; The Leakey Foundation; ERC [PALEOCHAR - 648871]; MINECO	Junta de Castilla y Leon(Junta de Castilla y Leon); European Social Funds (ESF; Operational Programme for Castilla y Leon); Junta de Castilla y Leon(Junta de Castilla y Leon); European Fund for Economic and Regional Development (EFRD); Spanish Ministry of Economy and Competitiveness (MINECO)(Spanish Government); EFRD(European Commission); The Leakey Foundation; ERC(European Research Council (ERC)European Commission); MINECO(Spanish Government)	This work was supported by: -A.H.L.: predoctoral contract of Junta de Castilla y Leon with also European Social Funds (ESF; Operational Programme for Castilla y Leon); -A.C., J.J.V.: Junta de Castilla y Leon (Project BU235P18) with also European Fund for Economic and Regional Development (EFRD) funding; -A.H.L., J.J.V.: Spanish Ministry of Economy and Competitiveness (MINECO) with also EFRD funding (Project CGL2016-77560); -C.M., C.M.H., A.H.L., A.C.: The Leakey Foundation (Neandertal Fire Technology Project) -C.M.: ERC Consolidator Grant project PALEOCHAR - 648871 https://erc.europa.eu/funding/consolidator-grants; -C.M., C.M.H., A.H.L.: MINECO and EFRD funding (HAR2015-68321-P Project). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert R. M., 2007, Israel Journal of Earth Sciences, V56, P175, DOI 10.1560/IJES.56.2-4.175; Aldeias V, 2017, CURR ANTHROPOL, V58, pS191, DOI 10.1086/691210; Aldeias V, 2016, J ARCHAEOL SCI, V67, P64, DOI 10.1016/j.jas.2016.01.016; Alperson-Afil N., 2007, PALEOANTHROPOLOGY, V2007, P1; Alperson-Afil N, 2008, QUATERNARY SCI REV, V27, P1733, DOI 10.1016/j.quascirev.2008.06.009; Asmussen B, 2009, J ARCHAEOL SCI, V36, P528, DOI 10.1016/j.jas.2008.10.005; Backhouse PN, 2007, J ARCHAEOL SCI, V34, P1367, DOI 10.1016/j.jas.2006.10.027; Beatrice C, 2008, PHYS CHEM EARTH, V33, P458, DOI 10.1016/j.pce.2008.02.018; BELLOMO RV, 1993, J ARCHAEOL SCI, V20, P525, DOI 10.1006/jasc.1993.1033; Bentsen S.E., 2013, S AFRICAN ARCHAEOLOG, V68, P137; Bentsen SE, 2014, J ARCHAEOL RES, V22, P141, DOI 10.1007/s10814-013-9069-x; Bentsen SE, 2012, QUATERN INT, V270, P95, DOI 10.1016/j.quaint.2011.09.002; Berna F, 2007, J ARCHAEOL SCI, V34, P358, DOI 10.1016/j.jas.2006.05.011; Berna F, 2012, P NATL ACAD SCI USA, V109, pE1215, DOI 10.1073/pnas.1117620109; Berna Francesco, 2007, Israel Journal of Earth Sciences, V56, P107, DOI 10.1560/IJES.56.2-4.107; Braadbaart F, 2012, J ARCHAEOL SCI, V39, P836, DOI 10.1016/j.jas.2011.10.009; BRAIN CK, 1988, NATURE, V336, P464, DOI 10.1038/336464a0; Brodard A, 2016, ARCHAEOL ANTHROP SCI, V8, P673, DOI 10.1007/s12520-015-0250-7; Brodard A, 2012, QUAT GEOCHRONOL, V10, P353, DOI 10.1016/j.quageo.2012.04.013; Brown KS, 2009, SCIENCE, V325, P859, DOI 10.1126/science.1175028; Buonasera T, 2019, J ARCHAEOL METHOD TH; Calvo-Rathert M, 2012, QUATERNARY RES, V77, P326, DOI 10.1016/j.yqres.2011.11.001; Canti M., 2000, P PREHIST SOC, V66, P385, DOI DOI 10.1017/S0079497X00001869; Carrancho A, 2016, QUATERN INT, V417, P39, DOI 10.1016/j.quaint.2015.12.083; Carrancho A, 2016, QUATERN INT, V414, P244, DOI 10.1016/j.quaint.2015.10.010; Carrancho A, 2012, QUATERN INT, V275, P14, DOI 10.1016/j.quaint.2012.01.010; Carrancho A, 2011, EARTH PLANET SC LETT, V312, P176, DOI 10.1016/j.epsl.2011.10.006; Carrancho A, 2009, GEOPHYS J INT, V179, P79, DOI 10.1111/j.1365-246X.2009.04276.x; Chadima M., 2006, TRAVAUX GEOPHYS, VXXVII, P20; Clemente-Conte Ignacio., 1997, SILICEOUS ROCKS CULT, P525; DAY R, 1977, PHYS EARTH PLANET IN, V13, P260, DOI 10.1016/0031-9201(77)90108-X; Dunlop D. J., 2002, Journal of Geophysical Research, V107, pEPM5, DOI [10.1029/2001JB000486, 10.1029/2001JB000487]; Dunlop D. J., 1997, ROCK MAGNETISM FUNDA; Ellingham STD, 2015, SCI JUSTICE, V55, P181, DOI 10.1016/j.scijus.2014.12.002; Castillo RF, 2013, FORENSIC SCI INT, V226, P33, DOI 10.1016/j.forsciint.2012.11.012; Friesem DE, 2014, QUATERN INT, V331, P128, DOI 10.1016/j.quaint.2013.03.023; Goldberg P, 2017, CURR ANTHROPOL, V58, pS175, DOI 10.1086/692729; Goldberg P, 2012, QUATERN INT, V247, P325, DOI 10.1016/j.quaint.2010.11.015; Goldberg P, 2009, ARCHAEOL ANTHROP SCI, V1, P95, DOI 10.1007/s12520-009-0008-1; Gose WA, 2000, J ARCHAEOL SCI, V27, P409, DOI 10.1006/jasc.1999.0465; Gowlett JAJ, 2013, AZANIA, V48, P5, DOI 10.1080/0067270X.2012.756754; Gur-Arieh S, 2012, J FIELD ARCHAEOL, V37, P121, DOI 10.1179/0093469012Z.00000000011; Hathaway JH, 1990, ARCHAEOMAGNETIC DATI, P178; Hathaway JH, 1990, ARCHAEOMAGNETIC DATI, P158; Henry A, 2014, J ARCHAEOL SCI, V52, P321, DOI 10.1016/j.jas.2014.09.005; Hrouda F, 2003, PHYS CHEM EARTH, V28, P653, DOI 10.1016/S1474-7065(03)00119-0; Kapper KL, 2014, GEOPHYS J INT, V198, P1208, DOI 10.1093/gji/ggu184; Karkanas P, 2007, J HUM EVOL, V53, P197, DOI 10.1016/j.jhevol.2007.04.002; Kostadinova-Avramova M, 2013, GEOPHYS J INT, V195, P1534, DOI 10.1093/gji/ggt329; Lacanette D, 2017, INT J THERM SCI, V120, P1, DOI 10.1016/j.ijthermalsci.2017.05.021; Lebon M., 2010, PALETHNOLOGY, P145; Leierer L, INSIGHTS NEANDERTHAL; Leonhardt R, 2006, COMPUT GEOSCI-UK, V32, P1420, DOI 10.1016/j.cageo.2006.01.006; Liedgren L, 2017, J ARCHAEOL SCI, V79, P62, DOI 10.1016/j.jas.2017.01.012; Linford N, 2004, PHYS EARTH PLANET IN, V147, P197, DOI 10.1016/j.pepi.2004.06.007; Mallol C, 2017, CURR ANTHROPOL, V58, pS217, DOI 10.1086/691422; Mallol C, 2016, QUATERN INT, V417, P1, DOI 10.1016/j.quaint.2016.09.021; Mallol C, 2013, QUATERN INT, V315, P3, DOI 10.1016/j.quaint.2013.04.009; Mallol C, 2013, J ARCHAEOL SCI, V40, P2515, DOI 10.1016/j.jas.2012.09.017; Verges JM, 2016, QUATERN INT, V414, P304, DOI 10.1016/j.quaint.2016.01.032; MCCLEAN RG, 1993, EARTH PLANET SC LETT, V119, P387, DOI 10.1016/0012-821X(93)90146-Z; Meignen L, 2007, ISRAEL MIDDLE UPPER, P90; Mentzer SM, 2014, J ARCHAEOL METHOD TH, V21, P616, DOI 10.1007/s10816-012-9163-2; Miller CE, 2010, PALETHNOLOGIE, V2, P25; Miller CE, 2012, J ARCHAEOL SCI, V39, P3039, DOI 10.1016/j.jas.2012.02.007; Morley MW, 2017, J ARCHAEOL SCI, V77, P125, DOI 10.1016/j.jas.2016.06.004; Mulville A, 2002, ZOOARCHAEOLOGY MILK, P50; Nakazawa Y, 2009, J ARCHAEOL SCI, V36, P684, DOI 10.1016/j.jas.2008.10.015; Ozan IL, 2017, ARCHAEOMETRY, V59, P1135, DOI 10.1111/arcm.12291; Peters C., 2001, ARCHAEOL PROSPECT, V8, P227, DOI 10.1002/arp.171; Rodriguez-Cintas A, 2017, QUATERN INT, V431, P16, DOI 10.1016/j.quaint.2015.09.043; Roebroeks W, 2011, P NATL ACAD SCI USA, V108, P5209, DOI 10.1073/pnas.1018116108; Sandgathe DM, 2017, CURR ANTHROPOL, V58, pS165, DOI 10.1086/691424; Schiegl S, 1996, J ARCHAEOL SCI, V23, P763, DOI 10.1006/jasc.1996.0071; Shahack-Gross R, 2014, J ARCHAEOL SCI, V44, P12, DOI 10.1016/j.jas.2013.11.015; SHIPMAN P, 1984, J ARCHAEOL SCI, V11, P307, DOI 10.1016/0305-4403(84)90013-X; Sievers C, 2008, J ARCHAEOL SCI, V35, P2909, DOI 10.1016/j.jas.2008.06.008; Smith GP, 1990, ARCHAEOMAGNETIC DATI, P148; Spassov S, 2006, GEOPHYS J INT, V167, P592, DOI 10.1111/j.1365-246X.2006.03114.x; SPENCER JQ, 1994, RADIAT MEAS, V23, P465, DOI 10.1016/1350-4487(94)90080-9; STACEY FD, 1967, EARTH PLANET SC LETT, V2, P67, DOI 10.1016/0012-821X(67)90174-4; Tema E, 2019, J CULT HERIT, V35, P64, DOI 10.1016/j.culher.2018.05.008; Thebault E, 2015, EARTH PLANETS SPACE, V67, DOI 10.1186/s40623-015-0228-9; THERYPARISOT I, 2010, PALETHNOLOGIE, V2, P79; VALLADAS H, 1980, NUCL INSTRUM METHODS, V175, P230, DOI 10.1016/0029-554X(80)90315-8; Vidal- Matutano P, 2017, ENVIRON ARCHAEOL, P1; Vidal-Matutano P, 2017, J ARCHAEOL SCI, V80, P109, DOI 10.1016/j.jas.2017.03.001; Vidal-Matutano P, 2015, QUATERNARY SCI REV, V111, P81, DOI 10.1016/j.quascirev.2015.01.010; Wadley L, 2012, QUATERN INT, V247, P341, DOI 10.1016/j.quaint.2010.10.026; Werts SP, 2007, J ARCHAEOL SCI, V34, P850, DOI 10.1016/j.jas.2006.05.007; White R, 2017, CURR ANTHROPOL, V58, pS288, DOI 10.1086/692708; Wroth K, 2019, ARCHAEOL ANTHR SCI; Zhang Y, 2014, CHINESE SCI BULL, V59, P1013, DOI 10.1007/s11434-013-0111-7	93	8	9	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2019	14	8							e0221592	10.1371/journal.pone.0221592	http://dx.doi.org/10.1371/journal.pone.0221592			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW6AB	31465517	gold, Green Published, Green Submitted			2022-12-26	WOS:000485058200029
J	Lonnqvist, S; Junker, JPE; Sedell, M; Nyman, E; Kratz, G				Lonnqvist, Susanna; Junker, Johan P. E.; Sedell, Maria; Nyman, Erika; Kratz, Gunnar			Tracking keratinocytes and melanocytes using carboxyfluorescein hydroxysuccinimidyl ester staining	PLOS ONE			English	Article							MACROPOROUS GELATIN SPHERES; HUMAN EPIDERMAL-KERATINOCYTES; BIODEGRADABLE SCAFFOLD; IN-VIVO; TRANSPLANTATION; CELL; REGENERATION; CULTIVATION; MIGRATION; VITILIGO	Introduction The treatment of burn wounds and hypopigmentation conditions often require autologous transplantation of keratinocytes and melanocytes. Tracking transplanted cells to ascertain their contribution to tissue recapitulation presents a challenge. This study demonstrates a methodology based on passive staining with carboxyfluorescein hydroxysuccinimidyl ester ( CFSE) that enables localization of cells in tissue sections to investigate the fate of transplanted cells in wound re-epithelialisation. Methods Viability and migration of CFSE-stained keratinocytes and melanocytes were investigated using viability staining and scratch assays, while proliferation of cells was measured using flow cytometry. In addition, CFSE-stained keratinocytes and melanocytes were transplanted to a human ex vivo wound model, either in suspension, or with the aid of macroporous gelatine microcarriers. Wounds were analysed seven, 14 and 21 days post transplantation using cryosectioning and fluorescence microscopy. Sections from wounds with transplanted co-cultured keratinocytes and melanocytes were stained for pancytokeratin to distinguish keratinocytes. Results CFSE-staining of keratinocytes and melanocytes did not affect the viability, migration or proliferation of the cells. Transplanted cells were tracked in ex vivo wounds for 21 days, illustrating that the staining had no effect on wound re-epithelialisation. In conclusion, this study presents a novel application of CFSE-staining for tacking transplanted primary human keratinocytes and melanocytes.	[Lonnqvist, Susanna; Junker, Johan P. E.; Sedell, Maria; Nyman, Erika; Kratz, Gunnar] Linkoping Univ, Div Expt Plast Surg, Dept Clin & Expt Med, Linkoping, Sweden; [Junker, Johan P. E.] Linkoping Univ Hosp, Dept Clin & Expt Med, Ctr Disaster Med & Traumatol, Linkoping, Sweden; [Nyman, Erika; Kratz, Gunnar] Linkoping Univ Hosp, Dept Hand Surg Plast Surg & Burns, Linkoping, Sweden	Linkoping University; Linkoping University; Linkoping University	Junker, JPE (corresponding author), Linkoping Univ, Div Expt Plast Surg, Dept Clin & Expt Med, Linkoping, Sweden.; Junker, JPE (corresponding author), Linkoping Univ Hosp, Dept Clin & Expt Med, Ctr Disaster Med & Traumatol, Linkoping, Sweden.	johan.junker@liu.se		Kratz, Gunnar/0000-0002-0476-2155; Junker, Johan/0000-0003-3708-1978	Region Ostergotland [LIO-695901]	Region Ostergotland	This study was funded by the Region Ostergotland (grant number LIO-695901 awarded to Professor Gunnar Kratz). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bocharov G, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00264; BRONNERFRASER M, 1985, J CELL BIOL, V101, P610, DOI 10.1083/jcb.101.2.610; Brusselaers N, 2010, J TRAUMA, V68, P490, DOI 10.1097/TA.0b013e3181c9c074; Callard R, 2007, IMMUNOL REV, V216, P119; Chadli Loubna, 2013, Methods Mol Biol, V989, P83, DOI 10.1007/978-1-62703-330-5_8; Compton CC, 1998, J BURN CARE REHABIL, V19, P330, DOI 10.1097/00004630-199807000-00011; Cong LD, 2008, INVEST OPHTH VIS SCI, V49, P4115, DOI 10.1167/iovs.08-1976; Fredriksson C, 2008, BURNS, V34, P212, DOI 10.1016/j.burns.2007.03.008; Green H, 1977, Prog Clin Biol Res, V17, P493; Gustafson CJ, 2007, BURNS, V33, P726, DOI 10.1016/j.burns.2006.10.382; Hackl F, 2012, PLAST RECONSTR SURG, V129, p443E, DOI 10.1097/PRS.0b013e318241289c; Hu F, 2015, J DERMATOL SCI, V78, P181, DOI 10.1016/j.jdermsci.2015.03.009; Huss FRM, 2007, J PLAST RECONSTR AES, V60, P543, DOI 10.1016/j.bjps.2005.10.031; Huss FRM, 2010, J PLAST RECONSTR AES, V63, P848, DOI 10.1016/j.bjps.2009.01.068; Kormos B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017197; Kratz G, 1998, MICROSC RES TECHNIQ, V42, P345, DOI 10.1002/(SICI)1097-0029(19980901)42:5<345::AID-JEMT5>3.0.CO;2-O; LONTZ W, 1994, J AM ACAD DERMATOL, V30, P591; Madonna S, 2008, FASEB J, V22, P3287, DOI 10.1096/fj.08-106831; Mcheik JN, 2014, PRS-GLOB OPEN, V2, DOI 10.1097/GOX.0000000000000176; MEEK CP, 1958, AM J SURG, V96, P557, DOI 10.1016/0002-9610(58)90975-9; Mitra AD, 2013, J INVEST DERMATOL, V133, P1556, DOI 10.1038/jid.2013.3; Parish CR, 1999, IMMUNOL CELL BIOL, V77, P499, DOI 10.1046/j.1440-1711.1999.00877.x; RHEINWALD JG, 1975, CELL, V6, P331, DOI 10.1016/S0092-8674(75)80001-8; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Seland H, 2011, BURNS, V37, P99, DOI 10.1016/j.burns.2010.03.014; Singh M, 2017, BURNS, V43, P1149, DOI 10.1016/j.burns.2017.01.015; SMIT NPM, 1989, J INVEST DERMATOL, V92, P18, DOI 10.1111/1523-1747.ep13070406; Sommar P, 2013, J PLAST SURG HAND SU, V47, P8, DOI 10.3109/2000656X.2012.731411; Tang LY, 2012, DERMATOLOGY, V224, P145, DOI 10.1159/000336777; TANNER J C Jr, 1964, Plast Reconstr Surg, V34, P287; van Geel N, 2001, DERMATOLOGY, V202, P162, DOI 10.1159/000051626	31	2	3	3	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2019	14	8							e0221878	10.1371/journal.pone.0221878	http://dx.doi.org/10.1371/journal.pone.0221878			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW6AB	31465496	gold, Green Published, Green Submitted			2022-12-26	WOS:000485058200063
J	Nensen, O; Hansell, P; Palm, F				Nensen, Oskar; Hansell, Peter; Palm, Fredrik			Role of carbonic anhydrase in acute recovery following renal ischemia reperfusion injury	PLOS ONE			English	Article							ACUTE KIDNEY INJURY; GLOMERULAR-FILTRATION; OXYGEN-CONSUMPTION; MOLECULE-1 KIM-1; REABSORPTION; MECHANISMS	Ischemia reperfusion (IR) injury can cause acute kidney injury. It has previously been reported that kidney oxygen consumption (QO(2)) in relation to glomerular filtration rate (GFR), and thus tubular sodium load, is markedly increased following IR injury, indicating reduced electrolyte transport efficiency. Since proximal tubular sodium reabsorption (TNa) is a major contributor to overall kidney QO(2), we investigated whether inhibition of proximal tubular sodium transport through carbonic anhydrase (CA) inhibition would improve renal oxygenation following ischemia reperfusion. Anesthetized adult male Sprague Dawley rats were administered the CA inhibitor acetazolamide (50 mg/kg bolus iv), or volume-matched vehicle, and kidney function, hemodynamics and QO(2) were estimated before and after 45 minutes of unilateral complete warm renal ischemia. CA inhibition per se reduced GFR (-20%) and TNa (-22%), while it increased urine flow and urinary sodium excretion (36-fold). Renal blood flow was reduced (-31%) due to increased renal vascular resistance (+37%) without affecting QO(2). IR per se resulted in similar decrease in GFR and TNa, independently of CA activity. However, the QO(2)/TNa ratio following ischemia-reperfusion was profoundly increased in the group receiving CA inhibition, indicating a significant contribution of basal oxygen metabolism to the total kidney QO(2) following inhibition of proximal tubular function after IR injury. Ischemia increased urinary excretion of kidney injury molecule-1, an effect that was unaffected by CA. In conclusion, this study demonstrates that CA inhibition further impairs renal oxygenation and does not protect tubular function in the acute phase following IR injury. Furthermore, these results indicate a major role of the proximal tubule in the acute recovery from an ischemic insult.	[Nensen, Oskar; Hansell, Peter; Palm, Fredrik] Uppsala Univ, Dept Med Cell Biol, Uppsala, Sweden; [Nensen, Oskar] Uppsala Univ Hosp, Uppsala, Sweden	Uppsala University; Uppsala University; Uppsala University Hospital	Palm, F (corresponding author), Uppsala Univ, Dept Med Cell Biol, Uppsala, Sweden.	Fredrik.Palm@mcb.uu.se	Hansell, Peter/AAM-6488-2020	Hansell, Peter/0000-0002-0315-8554	Swedish Research Council [2014-02728]	Swedish Research Council(Swedish Research CouncilEuropean Commission)	This study was funded by the Swedish Research Council grant 2014-02728 awarded to FP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blantz Roland C, 2007, Trans Am Clin Climatol Assoc, V118, P23; BREZIS M, 1994, AM J PHYSIOL-RENAL, V267, pF1059, DOI 10.1152/ajprenal.1994.267.6.F1059; Cruz DN, 2007, CRIT CARE, V11, DOI 10.1186/cc5965; De Rosa S, 2017, NEPHROL DIAL TRANSPL, V32, P241, DOI 10.1093/ndt/gfw038; Devarajan P, 2006, J AM SOC NEPHROL, V17, P1503, DOI 10.1681/ASN.2006010017; Edwards A, 2000, FRONT BIOSCI-LANDMRK, V5, pE36, DOI 10.2741/edwards; Etezadi F, 2012, DARU, V20, DOI 10.1186/2008-2231-20-36; GELMAN S, 1995, ANESTHESIOLOGY, V82, P1026, DOI 10.1097/00000542-199504000-00027; Han WK, 2002, KIDNEY INT, V62, P237, DOI 10.1046/j.1523-1755.2002.00433.x; Ichimura T, 1998, J BIOL CHEM, V273, P4135, DOI 10.1074/jbc.273.7.4135; Le Clef N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152153; Moe OW, 1997, CURR OPIN NEPHROL HY, V6, P440, DOI 10.1097/00041552-199709000-00006; MOLITORIS BA, 1989, J CLIN INVEST, V84, P1334, DOI 10.1172/JCI114302; Papazova DA, 2015, AM J PHYSIOL-RENAL, V308, pF22, DOI 10.1152/ajprenal.00278.2014; PERSSON AEG, 1982, ACTA PHYSIOL SCAND, V114, P1, DOI 10.1111/j.1748-1716.1982.tb06945.x; Persson P, 2010, ACTA PHYSIOL, V200, P3, DOI 10.1111/j.1748-1716.2010.02147.x; Piccinni P, 2011, MINERVA ANESTESIOL, V77, P1072; Redfors B, 2010, CRIT CARE MED, V38, P1695, DOI 10.1097/CCM.0b013e3181e61911; Redfors B, 2009, INTENS CARE MED, V35, P115, DOI 10.1007/s00134-008-1206-5; Robert AM, 2010, ANN THORAC SURG, V90, P1939, DOI 10.1016/j.athoracsur.2010.08.018; Wei QQ, 2012, AM J PHYSIOL-RENAL, V303, pF1487, DOI 10.1152/ajprenal.00352.2012; WEINSTEIN SW, 1984, AM J PHYSIOL, V247, pF151, DOI 10.1152/ajprenal.1984.247.1.F151; Wilcox CS, 2005, AM J PHYSIOL-REG I, V289, pR913, DOI 10.1152/ajpregu.00250.2005; Yeung KK, 2016, BEST PRACT RES-CLIN, V30, P305, DOI 10.1016/j.bpa.2016.07.005	24	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2019	14	8							e0220185	10.1371/journal.pone.0220185	http://dx.doi.org/10.1371/journal.pone.0220185			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW6AB	31465457	Green Published, gold			2022-12-26	WOS:000485058200004
J	Balog, BM; Tangada, A; Sheth, P; Song, QX; Couri, BM; Porras, LL; Deng, GG; Damaser, MS				Balog, Brian M.; Tangada, Abhilasha; Sheth, Pooja; Song, Qi-Xiang; Couri, Bruna M.; Porras, Leah L.; Deng, Gary G.; Damaser, Margot S.			Combination phosphodiesterase type 4 inhibitor and phosphodiesterase type 5 inhibitor treatment reduces non-voiding contraction in a rat model of overactive bladder	PLOS ONE			English	Article							OUTLET OBSTRUCTION; DETRUSOR OVERACTIVITY; DOUBLE-BLIND; MULTICENTER; RELAXATION; ROLIPRAM; MEN	Introduction Current treatments for overactive bladder (OAB) are often discontinued due to side effects or lack of efficacy. The goal of this study was to determine if combining a phosphodiesterase type 4 inhibitor (PDE4i); with a type 5 inhibitor (PDE5i); would have a beneficial effect on OAB symptoms and if a reduced dose of PDE4i in combination with PDE5i could also provide a beneficial effect in OAB. We hypothesized that PDE5i and PDE4i combination treatment could be utilized to reduce non-voiding contractions and smooth muscle disruption in a rat model of OAB. Methods Fifty-eight age-matched Sprague-Dawley rats underwent PBOO and daily gavage with PDE4i alone (roflumilast; 1mg/kg), PDE5i alone (tadalafil; 10mg/kg), high dose combination (PDE4i 1mg/kg, PDE5i 10mg/kg), low dose combination (PDE4i 0.2mg/kg, PDE5i 10mg/kg), or vehicle for 28 days. Fourteen animals underwent sham PBOO with vehicle. Rats underwent conscious and anesthetized cystometry 28 days after PBOO and were euthanized for qualitative bladder histology. One-way ANOVA on ranks with a Dunn's post hoc test was used to indicate statistically significant differences between groups (p<0.05). Results Bladder & urethral weight was significantly increased after PBOO with vehicle, PDE4i alone, and PDE5i alone, but not with either combination treatment. Frequency of non-voiding contractions during both conscious and anesthetized cystometry increased significantly after PBOO with vehicle, but not after PDE4i or high dose combination treatments compared to sham PBOO. Threshold pressure for voiding was significantly decreased with high dose combination compared to vehicle. PBOO treated with PDE4i alone or high dose combination showed less bladder smooth muscle fibrosis than vehicle, PDE5i alone, or low dose combination treatments. Conclusion A PDE4i and PDE5i combination treatment has potential benefit in reducing OAB symptoms, but future research is needed.	[Balog, Brian M.; Tangada, Abhilasha; Sheth, Pooja; Song, Qi-Xiang; Couri, Bruna M.; Damaser, Margot S.] Cleveland Clin, Dept Biomed Engn, Lerner Res Inst, Cleveland, OH 44106 USA; [Balog, Brian M.; Tangada, Abhilasha; Song, Qi-Xiang; Damaser, Margot S.] Louis Stokes Cleveland Vet Affairs Med Ctr, Adv Platform Technol Ctr, Cleveland, OH 44106 USA; [Balog, Brian M.] Univ Akron, Dept Biol, Akron, OH 44325 USA; [Song, Qi-Xiang] Naval Med Univ, Changhai Hosp, Dept Urol, Shanghai, Peoples R China; [Couri, Bruna M.] Cleveland Clin, Dept Obstet & Gynecol, Cleveland, OH 44106 USA; [Porras, Leah L.; Deng, Gary G.] Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN 46285 USA; [Damaser, Margot S.] Cleveland Clin, Glickman Urol & Kidney Inst, Cleveland, OH 44106 USA	Cleveland Clinic Foundation; US Department of Veterans Affairs; Veterans Health Administration (VHA); Case Western Reserve University; Louis Stokes Cleveland Veterans Affairs Medical Center; University System of Ohio; University of Akron; Naval Medical University; Cleveland Clinic Foundation; Eli Lilly; Cleveland Clinic Foundation	Damaser, MS (corresponding author), Cleveland Clin, Dept Biomed Engn, Lerner Res Inst, Cleveland, OH 44106 USA.; Damaser, MS (corresponding author), Louis Stokes Cleveland Vet Affairs Med Ctr, Adv Platform Technol Ctr, Cleveland, OH 44106 USA.; Damaser, MS (corresponding author), Cleveland Clin, Glickman Urol & Kidney Inst, Cleveland, OH 44106 USA.	damasem@ccf.org		Balog, Brian/0000-0002-3548-9315; Damaser, Margot/0000-0003-4743-9283	Eli Lilly; Cleveland Clinic; U.S. Department of Veterans Affairs	Eli Lilly(Eli Lilly); Cleveland Clinic; U.S. Department of Veterans Affairs(US Department of Veterans Affairs)	This work was done with a sponsored research agreement to the Cleveland Clinic from Eli Lilly (P.I. MSD). The funder provided support in the form of salaries for authors LLP and GGD, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. Eli Lilly employees participated in study design and preparation of manuscript, but final decisions were made by Dr. Damaser and her group at the Cleveland Clinic. Data collection and analysis was done solely by Dr. Damaser and her group. Additional support from the Cleveland Clinic and the U.S. Department of Veterans Affairs was provided.	Abraham N, 2015, EXPERT OPIN PHARMACO, V16, P79, DOI 10.1517/14656566.2015.977253; Abrams P, 2003, UROLOGY, V61, P37, DOI 10.1016/S0090-4295(02)02243-4; Beamon CR, 2009, BJU INT, V104, P252, DOI 10.1111/j.1464-410X.2008.08324.x; Benli E, 2017, INT BRAZ J UROL, V43, P345, DOI [10.1590/S1677-5538.IBJU.2016.0075, 10.1590/s1677-5538.ibju.2016.0075]; Buyuknacar HS, 2008, EUR J PHARMACOL, V586, P293, DOI 10.1016/j.ejphar.2008.02.022; Cannon TW, 2001, LIFE SCI, V69, P1193; Cho ST, 2012, UROLOGY, V80, DOI 10.1016/j.urology.2012.05.002; Chung JM, 2012, UROLOGY, V80, DOI 10.1016/j.urology.2012.07.019; Cumming G, 2007, J CELL BIOL, V177, P7, DOI 10.1083/jcb.200611141; Damaser MS, 1999, NEUROUROL URODYNAM, V18, P659, DOI 10.1002/(SICI)1520-6777(1999)18:6<659::AID-NAU17>3.0.CO;2-C; Filippi S, 2007, ENDOCRINOLOGY, V148, P1019, DOI 10.1210/en.2006-1079; Gasbarro G, 2010, AM J PHYSIOL-RENAL, V298, pF72, DOI 10.1152/ajprenal.00309.2009; Kaiho Y, 2008, BJU INT, V101, P615, DOI 10.1111/j.1464-410X.2007.07307.x; Kanai A, 2012, NEUROUROL URODYNAM, V31, P300, DOI 10.1002/nau.21246; Kang JY, 2013, KOREAN J UROL, V54, P339, DOI 10.4111/kju.2013.54.5.339; Kawai Y, 2016, NEUROUROL URODYNAM, V35, P444, DOI 10.1002/nau.22732; Kobayashi M, 2011, INT IMMUNOPHARMACOL, V11, P732, DOI 10.1016/j.intimp.2011.01.023; Medeiros VDLP, 2017, ACTA CIR BRAS, V32, P90, DOI 10.1590/s0102-865020170201; LLUEL P, 2003, J UROLOGY, P2253, DOI [10.1097/00005392-199812010-00095, DOI 10.1097/00005392-199812010-00095]; Matsumoto S, 2014, UROLOGY, V83, DOI 10.1016/j.urology.2013.11.030; Matsumoto S, 2009, BJU INT, V103, P987, DOI 10.1111/j.1464-410X.2008.08185.x; Morgado M, 2012, CELL MOL LIFE SCI, V69, P247, DOI 10.1007/s00018-011-0815-2; Nishiguchi J, 2007, BJU INT, V99, P680, DOI 10.1111/j.1464-410X.2006.06643.x; OConnor LT, 1997, J UROLOGY, V158, P631, DOI 10.1016/S0022-5347(01)64573-7; Oger S, 2007, EUR UROL, V51, P772, DOI 10.1016/j.eururo.2006.10.023; Parsons Brian A, 2011, Handb Exp Pharmacol, P15, DOI 10.1007/978-3-642-16499-6_2; Phelan MW, 2001, J UROLOGY, V165, P1107, DOI 10.1016/S0022-5347(05)66438-5; Pinggera GM, 2014, UROLOGY, V84, P412, DOI 10.1016/j.urology.2014.02.063; Porst H, 2006, EUR UROL, V50, P351, DOI 10.1016/j.eururo.2006.02.052; Rahnama'i MS, 2013, NAT REV UROL, V10, P414, DOI 10.1038/nrurol.2013.101; Ribeiro ASF, 2014, J SEX MED, V11, P930, DOI 10.1111/jsm.12456; Richter W, 2013, EXPERT OPIN THER TAR, V17, P1011, DOI 10.1517/14728222.2013.818656; Stewart WF, 2002, WORLD J UROL, V20, P327, DOI 10.1007/s00345-002-0301-4; Wrobel A, 2015, J PHARMACOL TOX MET, V74, P7, DOI 10.1016/j.vascn.2015.04.006; Zeng JW, 2012, NEUROUROL URODYNAM, V31, P178, DOI 10.1002/nau.21219; Zhai K, 2014, CELL SIGNAL, V26, P1001, DOI 10.1016/j.cellsig.2014.01.020	36	2	2	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2019	14	8							e0220788	10.1371/journal.pone.0220788	http://dx.doi.org/10.1371/journal.pone.0220788			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5XV	31461445	Green Published, Green Submitted, gold			2022-12-26	WOS:000485052300015
J	Ebrahimi, H; Pishgar, F; Yoosefi, M; Moradi, S; Rezaei, N; Djalalinia, S; Modirian, M; Peykari, N; Naderimagham, S; Haghshenas, R; Rahimi, S; Jamshidi, H; Esteghamati, A; Larijani, B; Farzadfar, F				Ebrahimi, Hedyeh; Pishgar, Farhad; Yoosefi, Moein; Moradi, Sedighe; Rezaei, Nazila; Djalalinia, Shirin; Modirian, Mitra; Peykari, Niloofar; Naderimagham, Shohreh; Haghshenas, Rosa; Rahimi, Saral; Jamshidi, Hamidreza; Esteghamati, Alireza; Larijani, Bagher; Farzadfar, Farshad			Insulin pen use and diabetes treatment goals: A study from Iran STEPS 2016 survey	PLOS ONE			English	Article							CONVENTIONAL VIAL/SYRINGE; GLYCEMIC CONTROL; ECONOMIC-IMPACT; THERAPY; VIALS; ADHERENCE; BARRIERS; MELLITUS; OUTCOMES; CHARGES	Background Frequency of insulin pen use, despite its higher costs, is increasing to substitute the traditional use of insulin vials. This study aims to report insulin pen use frequency and its associated factors among participants of the STEPS survey 2016 in Iran, which was conducted based on the World Health Organization (WHO) STEPS methodology. Methods In this cross-sectional study, 19,503 (mean age of 46.03 +/- 0.13) out of 30,541 participants of the Iran STEPS survey were included (Inclusion criteria: aged >25 years old and availability of their demographic, clinical, and laboratory results for serum glucose, HbA1c, and lipid profile). Clinical and demographic characteristics, a frequency of use of each diabetes mellitus treatment type, and the association of insulin pen use with health outcomes are reported using descriptive analysis and propensity score modeling. Results There were 1,999(10.85%) individuals diagnosed with diabetes in the population, while 1,160(56.87%) cases were taking antihyperglycemic treatments. In this subset, 240 (21.14%) individuals administered insulin with or without using oral agents at the same time. 52.28% of participants who were under insulin therapy used insulin pens. None of the socioeconomic determinants, including gender (p-value = 0.11), type of residential areas (p-value = 0.52), years of schooling (p-value = 0.27), wealth index (p-value = 0.19), marital status (p-value = 0.37), and insurance types (p-value = 0.72) were significantly different among groups using insulin pens and insulin vials. Moreover, in the propensity score modeling, pen usage was not associated with a lower heart attack and ischemic stroke histories, systolic blood pressure, serum lipid profile, blood glucose, or HbA1c levels. Conclusion Results showed that the use of the higher-costing insulin pens compared to traditional vials and syringes is not associated with improved glycemic control and better lipid profile in our sample. Future studies are needed to confirm these findings and to compare other aspects of insulin pen use, including adherence to treatment and cost-effectiveness.	[Ebrahimi, Hedyeh; Pishgar, Farhad; Yoosefi, Moein; Rezaei, Nazila; Djalalinia, Shirin; Modirian, Mitra; Peykari, Niloofar; Naderimagham, Shohreh; Haghshenas, Rosa; Farzadfar, Farshad] Univ Tehran Med Sci, Noncommunicable Dis Res Ctr, Endocrinol & Metab Populat Sci Inst, Tehran, Iran; [Yoosefi, Moein] Shahid Beheshti Univ Med Sci, Fac Paramed Sci, Dept Biostat, Tehran, Iran; [Moradi, Sedighe] Iran Univ Med Sci, Endocrine Res Ctr, Inst Endocrinol & Metab, Tehran, Iran; [Djalalinia, Shirin] Minist Hlth & Med Educ, Deputy Res & Technol, Tehran, Iran; [Peykari, Niloofar] Minist Hlth & Med Educ, Tehran, Iran; [Rahimi, Saral] Islamic Azad Univ, Pharmaceut Sci Branch, Tehran, Iran; [Jamshidi, Hamidreza] Shahid Beheshti Univ Med Sci, Sch Med, Dept Pharmacol, Tehran, Iran; [Esteghamati, Alireza] Univ Tehran Med Sci, Vali Asr Hosp, Endocrinol & Metab Res Ctr, Sch Med, Tehran, Iran; [Larijani, Bagher] Univ Tehran Med Sci, Endocrinol & Metab Res Ctr, Endocrinol & Metab Clin Sci Inst, Tehran, Iran	Tehran University of Medical Sciences; Shahid Beheshti University Medical Sciences; Iran University of Medical Sciences; Ministry of Health & Medical Education (MOHME); Ministry of Health & Medical Education (MOHME); Islamic Azad University; Shahid Beheshti University Medical Sciences; Tehran University of Medical Sciences; Tehran University of Medical Sciences	Farzadfar, F (corresponding author), Univ Tehran Med Sci, Noncommunicable Dis Res Ctr, Endocrinol & Metab Populat Sci Inst, Tehran, Iran.	F-Farzadfar@tums.ac.ir	Ebrahimi, Hedyeh/AAR-2899-2021; larijani, Bagher/ABE-3315-2020; Moradi, Sedighe/AAE-8262-2020	larijani, Bagher/0000-0001-5386-7597; Esteghamati, Alireza/0000-0001-5114-3982; Haghshenas, Rosa/0000-0001-8453-8446; Moradi, Sedighe/0000-0002-1840-6186; Peykari, Niloofar/0000-0003-3219-3751; Farzadfar, Farshad/0000-0001-8288-4046; Ebrahimi, Hedyeh/0000-0003-3647-7356	Ministry of Health and Medical Education of Islamic Republic of Iran [241/M/93259]	Ministry of Health and Medical Education of Islamic Republic of Iran	This study was funded by Ministry of Health and Medical Education of Islamic Republic of Iran (Grant Number: 241/M/93259). There are no external founding resources affecting the data collection, analysis, interpretation. The authors have not been paid by any pharmaceutical companies or other related agencies and the corresponding author of the manuscript had full access to all the data in the study and had final responsibility for the decision to submit for publication.	Asche CV, 2013, CURR MED RES OPIN, V29, P1287, DOI 10.1185/03007995.2013.825590; Bonita R., 2001, SURVEILLANCE OF RISK; Chawla A, 2018, MATER TODAY COMMUN, V14, P47, DOI 10.1016/j.mtcomm.2017.12.010; Cheen HHM, 2014, CLIN THER, V36, P1043, DOI 10.1016/j.clinthera.2014.05.009; Cobden D, 2007, PHARMACOTHERAPY, V27, P948, DOI 10.1592/phco.27.7.948; Djalalinia S, 2017, ARCH IRAN MED, V20, P608, DOI 0172009/AIM.009; Eby Elizabeth L, 2013, J Med Econ, V16, P1231, DOI 10.3111/13696998.2013.823091; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Hay SI, 2017, LANCET, V390, P1260, DOI 10.1016/S0140-6736(17)32130-X; Ho DE, 2007, POLIT ANAL, V15, P199, DOI 10.1093/pan/mpl013; Ho DE, 2011, J STAT SOFTW, V42; Horne Juliann, 2015, Hosp Pharm, V50, P514, DOI 10.1310/hpj5006-514; Hua XY, 2016, JAMA-J AM MED ASSOC, V315, P1400, DOI 10.1001/jama.2016.0126; Javanbakht M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026864; Korytkowski M, 2003, CLIN THER, V25, P2836, DOI 10.1016/S0149-2918(03)80337-5; Lasalvia Pieralessandro, 2016, J Diabetes Sci Technol, V10, P959, DOI 10.1177/1932296816633721; Lee Lauren J, 2011, J Diabetes Sci Technol, V5, P1116; Lee WC, 2006, CLIN THER, V28, P1712, DOI 10.1016/j.clinthera.2006.10.004; Nathan DM, 2014, DIABETES CARE, V37, P9, DOI 10.2337/dc13-2112; Ng CJ, 2015, INT J CLIN PRACT, V69, P1050, DOI 10.1111/ijcp.12691; Olyaeemanesh Alireza, 2018, Med J Islam Repub Iran, V32, P39, DOI 10.14196/mjiri.32.39; Owens DR, 2013, DIABETES TECHNOL THE, V15, P776, DOI 10.1089/dia.2013.0081; Perez-Nieves M, 2015, CURR MED RES OPIN, V31, P891, DOI 10.1185/03007995.2015.1020366; Rahmany Keivan, 2018, Med J Islam Repub Iran, V32, P102, DOI 10.14196/mjiri.32.102; Ramadan WH, 2015, PATIENT PREFER ADHER, V9, P517, DOI 10.2147/PPA.S78225; Shahraz S, 2017, JAMA-J AM MED ASSOC, V318, P1825, DOI 10.1001/jama.2017.11927; Sharma A, 2018, INT HEALTH, V10, P182, DOI 10.1093/inthealth/ihy012; Sharma A, 2016, BMJ GLOB HEALTH, V1, DOI 10.1136/bmjgh-2016-000112; Slabaugh SL, 2015, ADV THER, V32, P1206, DOI 10.1007/s12325-015-0266-5; Thethi Tina K, 2013, J Med Econ, V16, P1228, DOI 10.3111/13696998.2013.832259; Tziomalos K, 2017, EXPERT OPIN PHARMACO, V18, P233, DOI 10.1080/14656566.2017.1280462; World Health Organization, GLOB PHYS ACT QUEST; Zoungas S, 2017, LANCET DIABETES ENDO, V5, P431, DOI 10.1016/S2213-8587(17)30104-3	33	6	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2019	14	8							e0221462	10.1371/journal.pone.0221462	http://dx.doi.org/10.1371/journal.pone.0221462			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5XV	31461470	gold, Green Published, Green Submitted			2022-12-26	WOS:000485052300034
J	Lorenzoni, V; Staley, J; Marchant, T; Onderdijk, KE; Maes, PJ; Leman, M				Lorenzoni, Valerio; Staley, Jacob; Marchant, Thierry; Onderdijk, Kelsey E.; Maes, Pieter-Jan; Leman, Marc			The sonic instructor: A music-based biofeedback system for improving weightlifting technique	PLOS ONE			English	Article							PERFORMANCE; EXERCISE; FEEDBACK	In this study, we assumed that correct functional movements for weightlifting can be learned with the help of a music-based biofeedback system. We compared musical feedback with verbal feedback from experienced trainers using two independent groups. The focus was on one specific movement called deadlift. Physical parameters under considerations were the spine (i.e. loss of midline stability resulting in flexion) and the forward displacement of the barbell during the repetitions relative to the mid-foot. We recruited 31 recreational weight lifters (21-42 years of age). Results revealed that both feedback types are effective in improving the movements for deadlift. No significant differences were found across the two feedback types, neither in terms of movement, nor in terms of clarity and motivation. The results suggest that the proposed feedback system is a valid tool for technology-aided training and self-training practices.	[Lorenzoni, Valerio; Onderdijk, Kelsey E.; Maes, Pieter-Jan; Leman, Marc] Univ Ghent, IPEM, Dept Musicol, Ghent, Belgium; [Staley, Jacob] Univ Ghent, Internet Technol & Data Sci Lab IDLAB, Ghent, Belgium; [Marchant, Thierry] Univ Ghent, Data Anal Dept, Ghent, Belgium	Ghent University; Ghent University; Ghent University	Lorenzoni, V (corresponding author), Univ Ghent, IPEM, Dept Musicol, Ghent, Belgium.	valerio.lorenzoni@ugent.be		Leman, Marc/0000-0002-9780-2194; Maes, Pieter-Jan/0000-0002-9237-3298; Lorenzoni, Valerio/0000-0001-6666-0659; Onderdijk, Kelsey E./0000-0001-9992-7620	Ghent University (Methusalem-BOF council)	Ghent University (Methusalem-BOF council)	This research was conducted in the framework of the EmcoMetecca II project, granted by Ghent University (Methusalem-BOF council) to Prof. Dr. Marc Leman. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alahakone AU, 2009, IEEE ASME INT C ADV, P1141; Bird S, 2010, STRENGTH COND J, V32, P46, DOI 10.1519/SSC.0b013e3181d59582; Borg G., 1998, BORGS PERCEIVED EXER; CHOLEWICKI J, 1991, Medicine and Science in Sports and Exercise, V23, P1179; Edworthy J, 2006, ERGONOMICS, V49, P1597, DOI 10.1080/00140130600899104; Escamilla RF, 2000, MED SCI SPORT EXER, V32, P1265, DOI 10.1097/00005768-200007000-00013; Fritz TH, 2013, P NATL ACAD SCI USA, V110, P17784, DOI 10.1073/pnas.1217252110; Giggins OM, 2013, J NEUROENG REHABIL, V10, DOI 10.1186/1743-0003-10-60; GRANHED H, 1987, SPINE, V12, P146, DOI 10.1097/00007632-198703000-00010; Huang H, 2006, J NEUROENG REHABIL, V3, DOI 10.1186/1743-0003-3-11; Isakov E, 2007, Eura Medicophys, V43, P21; Karageorghis CI, 2010, PSYCHOL SPORT EXERC, V11, P551, DOI 10.1016/j.psychsport.2010.06.004; Karageorghis CI, 2006, J SPORT SCI, V24, P899, DOI 10.1080/02640410500298107; Leman M, 2016, THE EXPRESSIVE MOMEN; Lim H. B., 2014, PSYCHOPHYSIOLOGICAL; Lorenzoni V, 2018, J MULTIMODAL USER IN, P1; Maes PJ, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00548; McGuigan MR., 1996, J STRENGTH COND RES, V10, P250; Murgia M., 2012, REV PSYCHOL, V19, P13; Onate JA, 2001, J ORTHOP SPORT PHYS, V31, P511, DOI 10.2519/jospt.2001.31.9.511; PETRUZZELLO SJ, 1991, BEHAV THER, V22, P379, DOI 10.1016/S0005-7894(05)80372-7; Rendi M, 2008, SPORT PSYCHOL, V22, P175, DOI 10.1123/tsp.22.2.175; Shaulov N, 2009, PERCEPT MOTOR SKILL, V108, P597, DOI 10.2466/PMS.108.2.597-607; Sigrist R, 2015, EXP BRAIN RES, V233, P909, DOI 10.1007/s00221-014-4167-7; Smith MM, 2013, J STRENGTH COND RES, V27, P3159, DOI 10.1519/JSC.0b013e318289e59f; Tate JJ, 2010, PHYS THER, V90, P1123, DOI 10.2522/ptj.20080281	26	6	6	3	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2019	14	8							e0220915	10.1371/journal.pone.0220915	http://dx.doi.org/10.1371/journal.pone.0220915			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW5XV	31461448	Green Published, gold, Green Submitted			2022-12-26	WOS:000485052300020
J	Blair, RW; Dunne, NJ; Lennon, AB; Menary, GH				Blair, Ross W.; Dunne, Nicholas J.; Lennon, Alex B.; Menary, Gary H.			Multi-objective optimisation of material properties and strut geometry for poly(L-lactic acid) coronary stents using response surface methodology	PLOS ONE			English	Article							DRUG-ELUTING STENTS; BIORESORBABLE SCAFFOLDS; DESIGN OPTIMIZATION; MECHANICAL PERFORMANCE; COMPUTATIONAL ANALYSIS; RESTENOSIS; PARAMETERS; PLATFORM; METAANALYSIS; THROMBOSIS	Coronary stents for treating atherosclerosis are traditionally manufactured from metallic alloys. However, metal stents permanently reside in the body and may trigger undesirable immunological responses. Bioresorbable polymer stents can provide a temporary scaffold that resorbs once the artery heals but are mechanically inferior, requiring thicker struts for equivalent radial support, which may increase thrombosis risk. This study addresses the challenge of designing mechanically effective but sufficiently thin poly(L-lactic acid) stents through a computational approach that optimises material properties and stent geometry. Forty parametric stent designs were generated: cross-sectional area (post-dilation), foreshortening, stent-to-artery ratio and radial collapse pressure were evaluated computationally using finite element analysis. Response surface methodology was used to identify performance trade-offs by formulating relationships between design parameters and response variables. Multi-objective optimisation was used to identify suitable stent designs from approximated Pareto fronts and an optimal design is proposed that offers comparable performance to designs in clinical practice. In summary, a computational framework has been developed that has potential application in the design of high stiffness, thin strut polymeric stents.	[Blair, Ross W.; Lennon, Alex B.; Menary, Gary H.] Queens Univ, Sch Mech & Aerosp Engn, Belfast, Antrim, North Ireland; [Dunne, Nicholas J.] Dublin City Univ, Sch Mech & Mfg Engn, Dublin, Ireland; [Dunne, Nicholas J.] Dublin City Univ, Ctr Med Engn Res, Sch Mech & Mfg Engn, Dublin, Ireland; [Dunne, Nicholas J.] Queens Univ, Sch Pharm, Belfast, Antrim, North Ireland; [Dunne, Nicholas J.] Trinity Coll Dublin, Trinity Ctr Bioengn, Dublin, Ireland; [Dunne, Nicholas J.] Royal Coll Surgeons Ireland, Adv Mat & Bioengn Res Ctr AMBER, Dublin, Ireland; [Dunne, Nicholas J.] Trinity Coll Dublin, Dublin, Ireland	Queens University Belfast; Dublin City University; Dublin City University; Queens University Belfast; Trinity College Dublin; Royal College of Surgeons - Ireland; Trinity College Dublin	Blair, RW (corresponding author), Queens Univ, Sch Mech & Aerosp Engn, Belfast, Antrim, North Ireland.	rblair522@qub.ac.uk		Lennon, Alex/0000-0003-2722-8227; Dunne, Nicholas/0000-0003-4649-2410	Engineering and Physical Sciences Research Council (EPSRC) [S3804ASA]; Marie Sklodowska-Curie Research and Innovation Staff Exchange (RISE) [691238]	Engineering and Physical Sciences Research Council (EPSRC)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Marie Sklodowska-Curie Research and Innovation Staff Exchange (RISE)	The authors wish to acknowledge funding from the Engineering and Physical Sciences Research Council (EPSRC) (S3804ASA) and the Marie Sklodowska-Curie Research and Innovation Staff Exchange (RISE), grant agreement 691238. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott, 2012, ABS BIOR VASC SCAFF; AGRAWAL CM, 1992, BIOMATERIALS, V13, P176, DOI 10.1016/0142-9612(92)90068-Y; Ako J, 2007, AM J CARDIOL, V100, p3M, DOI 10.1016/j.amjcard.2007.08.016; Alexy RD, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/137985; Ang HY, 2017, INT J CARDIOL, V228, P931, DOI 10.1016/j.ijcard.2016.11.258; [Anonymous], R LANG ENV STAT COMP, DOI DOI 10.1080/02705060.2017.1422558; Barragan P, 2000, CATHETER CARDIO INTE, V50, P112, DOI 10.1002/(SICI)1522-726X(200005)50:1<112::AID-CCD25>3.0.CO;2-X; Bavry AA, 2006, AM J MED, V119, P1056, DOI 10.1016/j.amjmed.2006.01.023; Bedoya J, 2006, J BIOMECH ENG-T ASME, V128, P757, DOI 10.1115/1.2246236; Bergstrom JS, 2016, ANN BIOMED ENG, V44, P330, DOI 10.1007/s10439-015-1455-8; Blair RW, 2019, J MECH BEHAV BIOMED, V97, P346, DOI 10.1016/j.jmbbm.2019.05.039; Blair RW, 2018, J MECH BEHAV BIOMED, V86, P113, DOI 10.1016/j.jmbbm.2018.06.017; Bobel AC, 2015, CARDIOVASC ENG TECHN, V6, P519, DOI 10.1007/s13239-015-0235-9; Bobel AC, 2018, CARDIOVASC ENG TECHN, V9, P60, DOI 10.1007/s13239-017-0333-y; Bobel AC, 2016, POLYM TEST, V54, P150, DOI 10.1016/j.polymertesting.2016.07.011; Bressloff NW, 2016, ANN BIOMED ENG, V44, P357, DOI 10.1007/s10439-015-1373-9; Brugaletta S, 2011, EUR HEART J, V32, P400; Garcia A, 2012, J MECH BEHAV BIOMED, V10, P166, DOI 10.1016/j.jmbbm.2012.02.006; Gomez-Lara J, 2010, JACC-CARDIOVASC INTE, V3, P1190, DOI 10.1016/j.jcin.2010.07.016; Grogan JA, 2012, J MECH BEHAV BIOMED, V12, P129, DOI 10.1016/j.jmbbm.2012.02.013; Grogan JA, 2013, BIOMATERIALS, V34, P8049, DOI 10.1016/j.biomaterials.2013.07.010; GRUNTZIG A, 1978, LANCET, V1, P263, DOI 10.1016/s0140-6736(78)90500-7; Hunter JD, 2007, COMPUT SCI ENG, V9, P90, DOI 10.1109/MCSE.2007.55; Iqbal J, 2014, EUR HEART J, V35, P765, DOI 10.1093/eurheartj/eht542; Jones E., 2001, SCIPY OPEN SOURCE SC; Kang SH, 2016, JACC-CARDIOVASC INTE, V9, P1203, DOI 10.1016/j.jcin.2016.03.038; Kastrati A, 2001, CIRCULATION, V103, P2816; Kawamoto H, 2016, JACC-CARDIOVASC INTE, V9, P299, DOI 10.1016/j.jcin.2015.11.019; Kolandaivelu K, 2011, CIRCULATION, V123, P1400, DOI 10.1161/CIRCULATIONAHA.110.003210; Lally C, 2005, J BIOMECH, V38, P1574, DOI 10.1016/j.jbiomech.2004.07.022; Li HX, 2017, POLYMERS-BASEL, V9, DOI 10.3390/polym9010020; Lim DY, 2008, ANN BIOMED ENG, V36, P1118, DOI 10.1007/s10439-008-9504-1; McMahon S, 2018, PROG POLYM SCI, V83, P79, DOI 10.1016/j.progpolymsci.2018.05.002; Menown IBA, 2010, ADV THER, V27, P129, DOI 10.1007/s12325-010-0022-9; Migliavacca F, 2002, J BIOMECH, V35, P803, DOI 10.1016/S0021-9290(02)00033-7; Morice M, 2002, NEW ENGL J MED, V346, P1773, DOI 10.1056/NEJMoa012843; MORRIS MD, 1995, J STAT PLAN INFER, V43, P381, DOI 10.1016/0378-3758(94)00035-T; Oliphant T.E., 2006, A GUIDE TO NUMPY, V1; Ota T, 2014, J CARDIOL, V64, P347, DOI 10.1016/j.jjcc.2014.02.013; Pant S, 2011, BIOMATERIALS, V32, P7755, DOI 10.1016/j.biomaterials.2011.07.059; Pant S, 2012, BIOMECH MODEL MECHAN, V11, P61, DOI 10.1007/s10237-011-0293-3; Pauck RG, 2015, MED ENG PHYS, V37, P7, DOI 10.1016/j.medengphy.2014.09.014; Schmidt W, 2009, IFMBE PROC, V25, P136, DOI 10.1007/978-3-642-03906-5_37; Schmidt W, 2016, CARDIOVASC REVASCULA, V17, P375, DOI 10.1016/j.carrev.2016.05.001; Serruys PW, 2016, LANCET, V388, P2479, DOI 10.1016/S0140-6736(16)32050-5; SIGWART U, 1987, NEW ENGL J MED, V316, P701, DOI 10.1056/NEJM198703193161201; Stettler C, 2007, LANCET, V370, P937, DOI 10.1016/S0140-6736(07)61444-5; Timmins LH, 2007, MED BIOL ENG COMPUT, V45, P505, DOI 10.1007/s11517-007-0180-3; van Beusekom HMM, 2007, EUR HEART J, V28, P974, DOI 10.1093/eurheartj/ehm064; Wang WQ, 2006, J BIOMECH, V39, P21, DOI 10.1016/j.jbiomech.2004.11.003; Windecker S, 2001, CIRCULATION, V104, P928, DOI 10.1161/hc3401.093146; Wu JH, 2013, J POLYM ENVIRON, V21, P303, DOI 10.1007/s10924-012-0523-5	52	15	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2019	14	8							e0218768	10.1371/journal.pone.0218768	http://dx.doi.org/10.1371/journal.pone.0218768			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5UR	31449528	Green Published, Green Submitted, gold			2022-12-26	WOS:000485044000005
J	Lee, SM; Kim, BJ; Koo, JN; Norwitz, ER; Oh, IH; Kim, SM; Kim, SY; Kim, GM; Kwak, SH; Kim, W; Joo, SK; Shin, S; Vixa, C; Park, CW; Jun, JK; Park, JS				Lee, Seung Mi; Kim, Byoung Jae; Koo, Ja Nam; Norwitz, Errol R.; Oh, Ig Hwan; Kim, Sun Min; Kim, Sang Youn; Kim, Gyoung Min; Kwak, Soo Heon; Kim, Won; Joo, Sae Kyung; Shin, Sue; Vixa, Chanthalakeo; Park, Chan-Wook; Jun, Jong Kwan; Park, Joong Shin			Nonalcoholic fatty liver disease is a risk factor for large-for-gestational-age birthweight	PLOS ONE			English	Article							MATERNAL SERUM TRIGLYCERIDE; CORONARY-HEART-DISEASE; INSULIN-RESISTANCE; PREGNANCY; GROWTH; ADIPONECTIN; ADIPOSITY; LEPTIN; LIPIDS; WOMEN	Objective Nonalcoholic fatty liver disease (NAFLD) is a well-recognized hepatic manifestation of metabolic disease in adults and has been associated with the development of gestational diabetes (GDM). Hepatic insulin resistance can result in increased release of glucose (from gluconeogenesis) and free fatty acids (due to enhanced lipolysis), which can lead in turn to fetal overgrowth. However, the relationship between maternal metabolic factors (such as circulating levels of triglycerides, free fatty acids [FFA], or adipokines) and excessive fetal birthweight in NAFLD has not been carefully examined. In this study, we evaluated the relationship between NAFLD and the subsequent risk of large-for-gestational-age (LGA) birthweight. Method Singleton nondiabetic pregnant women were evaluated for the presence of fatty liver at 10-14 weeks of gestation by abdominal ultrasound. The degree of fatty liver was classified as Grade 0-3 steatosis. At the time of liver ultrasound, maternal blood was taken after fasting and measured for adiponectin and FFA. LGA was defined as birthweight >90th percentile for gestational age. Results A total of 623 women were included in the analysis. The frequency of LGA was 10.9% (68/623), and the frequency of NAFLD was 18.9%. The risk of LGA increased significantly in patients with Grade 2-3 steatosis in the first trimester. The relationship between Grade 2-3 steatosis and LGA remained significant after adjustment for maternal age, pre-pregnancy BMI, GDM, and maternal serum triglyceride levels. The concentration of maternal blood adiponectin at 10-14 weeks was significantly lower in cases with LGA than non-LGA, but the maternal blood FFA concentrations were not different between the groups. Conclusion The presence of Grade 2-3 steatosis on ultrasound in early pregnancy was associated with the increased risk of delivering an LGA infant, even after adjustment for multiple confounding factors including GDM. Adiponectin may be the linking biomarker between NAFLD and LGA.	[Lee, Seung Mi; Kim, Byoung Jae; Kim, Sun Min; Park, Chan-Wook; Jun, Jong Kwan; Park, Joong Shin] Seoul Natl Univ, Coll Med, Dept Obstet & Gynecol, Seoul, South Korea; [Kim, Byoung Jae; Kim, Sun Min] Seoul Natl Univ, Boramae Med Ctr, Seoul Metropolitan Govt, Dept Obstet & Gynecol, Seoul, South Korea; [Koo, Ja Nam; Oh, Ig Hwan] Seoul Womens Hosp, Incheon, South Korea; [Norwitz, Errol R.] Tufts Univ, Sch Med, Dept Obstet & Gynecol, Boston, MA 02111 USA; [Kim, Sang Youn] Seoul Natl Univ, Coll Med, Dept Radiol, Seoul, South Korea; [Kim, Gyoung Min] Yeonsei Univ, Coll Med, Dept Radiol, Seoul, South Korea; [Kwak, Soo Heon; Kim, Won; Joo, Sae Kyung] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul, South Korea; [Kim, Won; Joo, Sae Kyung] Seoul Natl Univ, Boramae Med Ctr, Seoul Metropolitan Govt, Dept Internal Med, Seoul, South Korea; [Shin, Sue] Seoul Natl Univ, Coll Med, Dept Lab Med, Seoul, South Korea; [Shin, Sue] Seoul Natl Univ, Boramae Med Ctr, Seoul Metropolitan Govt, Dept Lab Med, Seoul, South Korea; [Vixa, Chanthalakeo] Univ Hlth Sci, Dept Obstet & Gynecol, Viangchan, Laos	Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital; Tufts University; Seoul National University (SNU); Yonsei University; Yonsei University Health System; Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital	Park, JS (corresponding author), Seoul Natl Univ, Coll Med, Dept Obstet & Gynecol, Seoul, South Korea.	jsparkmd@snu.ac.kr	Kim, Won/H-6940-2019	Kim, Won/0000-0002-2926-1007; Kim, Sang Youn/0000-0003-4038-7345	Bio & Medical Technology Development Program of the National Research Foundation (NRF) - Ministry of Science and ICT of Korea [2016M3A9B6902061]; Seoul Metropolitan Government Seoul National University (SMG-SNU) Boramae Medical Center [03-2014-4]	Bio & Medical Technology Development Program of the National Research Foundation (NRF) - Ministry of Science and ICT of Korea; Seoul Metropolitan Government Seoul National University (SMG-SNU) Boramae Medical Center	Park JS received funding from Bio & Medical Technology Development Program of the National Research Foundation (NRF) funded by the Ministry of Science and ICT of Korea (2016M3A9B6902061). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Kim BJ received funding from the Seoul Metropolitan Government Seoul National University (SMG-SNU) Boramae Medical Center (03-2014-4). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aye ILMH, 2013, PLACENTA, V34, pS40, DOI 10.1016/j.placenta.2012.11.024; Barker DJP, 2006, CLIN OBSTET GYNECOL, V49, P270, DOI 10.1097/00003081-200606000-00009; Bedogni G, 2006, BMC GASTROENTEROL, V6, DOI 10.1186/1471-230X-6-33; Birkenfeld AL, 2014, HEPATOLOGY, V59, P713, DOI 10.1002/hep.26672; Catalano PM, 2003, AM J OBSTET GYNECOL, V189, P1698, DOI 10.1016/S0002-9378(03)00828-7; Cho HC, 2015, GUT LIVER; Choi SY, 2009, AM J GASTROENTEROL, V104, P1953, DOI 10.1038/ajg.2009.238; Daniel S, 1999, AM J GASTROENTEROL, V94, P3010, DOI 10.1111/j.1572-0241.1999.01451.x; De Souza LR, 2016, AM J GASTROENTEROL, V111, P665, DOI 10.1038/ajg.2016.43; Gastaldelli A, 2009, HEPATOLOGY, V49, P1537, DOI 10.1002/hep.22845; Hagstrom H, 2016, LIVER INT, V36, P268, DOI 10.1111/liv.12902; Harder T, 2007, AM J EPIDEMIOL, V165, P849, DOI 10.1093/aje/kwk071; Jovanovic L, 2001, JAMA-J AM MED ASSOC, V286, P2516, DOI 10.1001/jama.286.20.2516; Kitajima M, 2001, OBSTET GYNECOL, V97, P776, DOI 10.1016/S0029-7844(01)01328-X; KNOPP RH, 1992, DIABETES CARE, V15, P1605, DOI 10.2337/diacare.15.11.1605; Lee SM, 2019, DIABETOLOGIA, V62, P238, DOI 10.1007/s00125-018-4779-8; Lee SM, 2018, DIABETOLOGIA; Loomba R, 2013, NAT REV GASTRO HEPAT, V10, P686, DOI 10.1038/nrgastro.2013.171; Metzger BE, 2008, NEW ENGL J MED, V358, P1991, DOI 10.1056/NEJMoa0707943; NOLAN CJ, 1995, DIABETES CARE, V18, P1550, DOI 10.2337/diacare.18.12.1550; Pardo IMCG, 2004, OBES RES, V12, P521, DOI 10.1038/oby.2004.59; Park NH, 1991, KOREAN J OBSTET GYNE, V34, P9; Saadeh S, 2002, GASTROENTEROLOGY, V123, P745, DOI 10.1053/gast.2002.35354; Schaefer-Graf UM, 2011, DIABETIC MED, V28, P1053, DOI 10.1111/j.1464-5491.2011.03346.x; Schaefer-Graf UM, 2005, DIABETES CARE, V28, P1745, DOI 10.2337/diacare.28.7.1745; Schaefer-Graf UM, 2008, DIABETES CARE, V31, P1858, DOI 10.2337/dc08-0039; Tsai PJ, 2004, CLIN ENDOCRINOL, V61, P88, DOI 10.1111/j.1365-2265.2004.02057.x; Vernon G, 2011, ALIMENT PHARM THER, V34, P274, DOI 10.1111/j.1365-2036.2011.04724.x; Yarrington CD, 2016, AM J OBSTET GYNECOL, V215, DOI 10.1016/j.ajog.2016.04.051	29	17	17	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2019	14	8							e0221400	10.1371/journal.pone.0221400	http://dx.doi.org/10.1371/journal.pone.0221400			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5UR	31449538	Green Published, Green Submitted, gold			2022-12-26	WOS:000485044000014
J	Heo, YJ; Lee, YA; Lee, B; Lee, YJ; Lim, YH; Chung, HR; Shin, SH; Shin, CH; Yang, SW				Heo, You Jung; Lee, Young Ah; Lee, Bora; Lee, Yun Jeong; Lim, Youn Hee; Chung, Hye Rim; Shin, Seung Han; Shin, Choong Ho; Yang, Sei Won			How can the occurrence of delayed elevation of thyroid stimulating hormone in preterm infants born between 35 and 36 weeks gestation be predicted?	PLOS ONE			English	Article							CONGENITAL HEART-DISEASE; HYPOTHYROIDISM; CHILDREN; HYPERTHYROTROPINEMIA; THYROTROPIN; DYSFUNCTION; RISK	Objective We evaluated frequency and risk factors of delayed TSH elevation (dTSH) and investigated follow-up outcomes in the dTSH group with venous TSH (v-TSH) levels of 6-20 mU/L according to whether late preterm infants born at gestational age (GA) 35-36 weeks had risk factors. Methods The medical records of 810 neonates (414 boys) born at Seoul National University Hospital who had a normal neonatal screening test (NST) and underwent the first repeat venous blood test at 10-21 days post birth were reviewed. Results Seventy-three (9.0%) neonates showed dTSH, defined as a v-TSH level. 6.0 mU/L, 12 of whom (1.5%) were started on levothyroxine medication. A multivariate-adjusted model indicated that a low birth weight (LBW <2,000 g), a congenital anomaly, and exposure to iodine contrast media (ICM) were significant predictors for dTSH (all p < 0.05). Among these 73 dTSH infants, all 5 infants with TSH levels >= 20 mU/L began levothyroxine medication, and 6 of 16 infants with v-TSH levels of 10-20 mU/L were indicated for levothyroxine, regardless of coexisting risk factors. However, only 1 of 52 infants with v-TSH levels of 6-10 mU/L who had a congenital anomaly was indicated for levothyroxine. All healthy late preterm infants, including LBW and multiple births, with v-TSH levels of 6-10 mU/L exhibited normal thyroid function. Conclusions dTSH was detected in 9.0% and levothyroxine was indicated in 1.5% of infants born at GA 35-36 weeks, particularly those with a LBW, a congenital anomaly, or history of ICM exposure. Either levothyroxine or retesting is indicated for late preterm neonates with TSH levels. 10 mU/L regardless of risk factors. If healthy preterm neonates show v-TSH levels of 6-10 mU/L, a second repeat test may not be necessary; however, further studies are required to set a threshold for retesting.	[Heo, You Jung; Lee, Young Ah; Lee, Bora; Lee, Yun Jeong; Shin, Seung Han; Shin, Choong Ho; Yang, Sei Won] Seoul Natl Univ, Coll Med, Dept Pediat, Childrens Hosp, Seoul, South Korea; [Lim, Youn Hee] Seoul Natl Univ, Med Res Ctr, Inst Environm Med, Seoul, South Korea; [Chung, Hye Rim] Seoul Natl Univ, Bundang Hosp, Dept Pediat, Seongnam, South Korea	Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University (SNU)	Lee, YA (corresponding author), Seoul Natl Univ, Coll Med, Dept Pediat, Childrens Hosp, Seoul, South Korea.	nina337@snu.ac.kr		Shin, Choong Ho/0000-0002-9813-1134				Ahmet A, 2009, ACTA PAEDIATR, V98, P1568, DOI 10.1111/j.1651-2227.2009.01412.x; Bijarnia S, 2011, J INHERIT METAB DIS, V34, P827, DOI 10.1007/s10545-011-9286-8; CALACIURA F, 1995, CLIN ENDOCRINOL, V43, P473, DOI 10.1111/j.1365-2265.1995.tb02620.x; Chung HR, 2009, J CLIN ENDOCR METAB, V94, P4444, DOI 10.1210/jc.2009-0632; Delange F, 1997, HORM RES, V48, P51, DOI 10.1159/000185485; Filippi L, 2007, ARCH DIS CHILD-FETAL, V92, P367, DOI 10.1136/adc.2006.098566; Fisher DA., 2002, DISORDERS THYROID NE, P164; Fisher Delbert A, 2007, Pediatr Endocrinol Rev, V4, P317; Fisher DA, 2008, SEMIN PERINATOL, V32, P387, DOI 10.1053/j.semperi.2008.09.003; Hollanders JJ, 2015, J CLIN ENDOCR METAB, V100, P4648, DOI 10.1210/jc.2015-3078; Kumar J, 2009, J PEDIATR-US, V154, P263, DOI 10.1016/j.jpeds.2008.08.023; Larson C, 2003, J PEDIATR-US, V143, P587, DOI 10.1067/S0022-3476(03)00332-9; Lee HJ, 2017, ANN PEDIATR ENDOCRIN, V22, P253, DOI 10.6065/apem.2017.22.4.253; Leger J, 2014, J CLIN ENDOCR METAB, V99, P363, DOI 10.1210/jc.2013-1891; Leonardi D, 2008, J CLIN ENDOCR METAB, V93, P2679, DOI 10.1210/jc.2007-2612; Mandel SJ, 2000, THYROID, V10, P693, DOI 10.1089/10507250050137770; Mass Screening Committee, 2015, Clin Pediatr Endocrinol, V24, P107, DOI 10.1297/cpe.24.107; Olivieri A, 2002, J CLIN ENDOCR METAB, V87, P557, DOI 10.1210/jc.87.2.557; Olivieri A, 2007, J CLIN ENDOCR METAB, V92, P3141, DOI 10.1210/jc.2007-0238; Perry R, 2002, J CLIN ENDOCR METAB, V87, P4072, DOI 10.1210/jc.2001-011995; RE RN, 1976, J CLIN ENDOCR METAB, V43, P338, DOI 10.1210/jcem-43-2-338; Rose SR, 2006, PEDIATRICS, V117, P2290; Sakka SD, 2009, J CLIN ENDOCR METAB, V94, P1338, DOI 10.1210/jc.2008-1624; Sauerbrei W, 2015, BIOMETRICAL J, V57, P531, DOI 10.1002/bimj.201300222; Selva KA, 2005, J PEDIATR-US, V147, P775, DOI 10.1016/j.jpeds.2005.07.024; Tarr G, 2018, J STAT SOFTW, V83, P1, DOI 10.18637/jss.v083.i09; Thaker VV, 2017, J ENDOCR SOC, V1, P1067, DOI 10.1210/js.2017-00174; van Wassenaer Aleid G, 2004, Semin Neonatol, V9, P3, DOI 10.1016/S1084-2756(03)00114-3; Williams FLR, 2017, J PERINAT MED, V45, P135, DOI 10.1515/jpm-2016-0141; WOLFF J, 1949, ENDOCRINOLOGY, V45, P504, DOI 10.1210/endo-45-5-504; Zung AN, 2017, J CLIN ENDOCR METAB, V102, P3050, DOI 10.1210/jc.2017-00701; Zung A, 2016, J PEDIATR-US, V178, P135, DOI 10.1016/j.jpeds.2016.07.022	32	3	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2019	14	8							e0220240	10.1371/journal.pone.0220240	http://dx.doi.org/10.1371/journal.pone.0220240			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5TR	31442229	Green Submitted, gold, Green Published			2022-12-26	WOS:000485041400008
J	Li, XH; Fan, YC; Assanangkornchai, S; McNeil, EB				Li, Xinhua; Fan, Yancun; Assanangkornchai, Sawitri; McNeil, Edward B.			Application of the Theory of Planned Behavior to couples' fertility decision-making in Inner Mongolia, China	PLOS ONE			English	Article							SEX-RATIO; IMPACT; EDUCATION; QUALITY; COUNTRIES; HEALTH; POLICY; CHILD	China relaxed its family planning policy and adopted a universal two-child policy on January 1, 2016 to actively address the country's aging trend. However, the policy has failed to have any significant effect on the fertility rate of many provinces. In light of the country having the highest sex ratio at birth in the world and the huge burden of the aging population, improving the fertility rate is an urgent priority in China. This facility-based cross-sectional survey aimed to study determinants of fertility decision-making among couples based on the Theory of Planned Behavior. The study was conducted in Inner Mongolia Autonomous Region of China. A structured self-administered questionnaire was completed by 1,399 couples, consisting of wives aged 20-49 years and their husbands. Based on the structural equation modeling method of analysis, determinants of fertility decision-making were perceived behavior control (perceived importance of having a stable income and cost of raising a child), subjective norms (perceived social pressure about "sex preference of the newborn by themselves and their partner") and attitudes (only healthy parents can have a child). Other significant factors influencing fertility decision were ethnicity and education level, with ethnic minority couples having less perception of social norm towards fertility and those with higher education having higher perceived control toward having a (further) child. The study reveals the importance of the China's infrastructure and public facilities to support child-rearing to increase the fertility rate among couples of child-bearing age, which in turn will reduce the burden associated with an aging society.	[Li, Xinhua; Fan, Yancun] Inner Mongolia Med Univ, Fac Hlth Management, Hohhot, Inner Mongolia, Peoples R China; [Li, Xinhua; Assanangkornchai, Sawitri; McNeil, Edward B.] Prince Songkla Univ, Fac Med, Epidemiol Unit, Hat Yai, Songkhla, Thailand	Inner Mongolia Medical University; Prince of Songkla University	Assanangkornchai, S (corresponding author), Prince Songkla Univ, Fac Med, Epidemiol Unit, Hat Yai, Songkhla, Thailand.	savitree.a@psu.ac.th		Assanangkornchai, Sawitri/0000-0003-2174-3287; Li, Xinhua/0000-0002-8174-3978; McNeil, Edward Braddon/0000-0002-9492-1040	Key Research Base of Humanities and Social Science of Inner Mongolia Autonomous Region of China; China Medical Board; Prince of Songkla University	Key Research Base of Humanities and Social Science of Inner Mongolia Autonomous Region of China; China Medical Board; Prince of Songkla University	This work received the research fund from the Key Research Base of Humanities and Social Science of Inner Mongolia Autonomous Region of China, China Medical Board, and Prince of Songkla University to XL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adsera A, 2004, J POPUL ECON, V17, P17, DOI 10.1007/s00148-003-0166-x; AJZEN I, 1991, ORGAN BEHAV HUM DEC, V50, P179, DOI 10.1016/0749-5978(91)90020-T; Ajzen I., 1985, BEHAV INTERVENT, DOI [10.1016/0749-5978(91)90020-T, DOI 10.1016/0749-5978(91)90020-T]; Ajzen I, 2013, DEMOGR RES, V29, P203; ANDERSON JC, 1988, PSYCHOL BULL, V103, P411, DOI 10.1037/0033-2909.103.3.411; Angrist J, 1996, CHILDREN THEIR PAREN; Bjorklund A, 2006, J POPUL ECON, V19, P3, DOI 10.1007/s00148-005-0024-0; Bollen KA, 2001, ANNU REV SOCIOL, V27, P153, DOI 10.1146/annurev.soc.27.1.153; Bongaarts J, 2008, STUD FAMILY PLANN, V39, P105, DOI 10.1111/j.1728-4465.2008.00157.x; Burch TK., 2018, MODEL BASED DEMOGRAP, P97; Cai Y, 2010, POPUL DEV REV, V36, P419, DOI 10.1111/j.1728-4457.2010.00341.x; Croll EJ, 2006, OXF DEV STUD, V34, P473, DOI 10.1080/13600810601045833; Dana DD, 2018, SCI J APPL MATH STAT, V6, P65, DOI [10.11648/j.sjams.20180603.11, DOI 10.11648/J.SJAMS.20180603.11]; Das Gupta M, 2003, J DEV STUD, V40, P153, DOI 10.1080/00220380412331293807; Dommermuth L, 2011, ADV LIFE COURSE RES, V16, P42, DOI 10.1016/j.alcr.2011.01.002; Eklund L., 2016, INTERSECTIONS-GENDER, V39; Francis J., 2004, CONSTRUCTING QUESTIO, V5th ed.; Grech V, 2018, EARLY HUM DEV, V118, P22, DOI 10.1016/j.earlhumdev.2018.02.002; GREENHAUS JH, 1985, ACAD MANAGE REV, V10, P76, DOI 10.5465/AMR.1985.4277352; Henriksen E., 2002, DEMOGRAPHIC EX UNPUB, P1; Hesketh T, 2006, P NATL ACAD SCI USA, V103, P13271, DOI 10.1073/pnas.0602203103; Hu BY, 2014, J RES CHILD EDUC, V28, P461, DOI 10.1080/02568543.2014.944720; Jackson DN, 2000, HUM PERFORM, V13, P371, DOI 10.1207/S15327043HUP1304_3; Jin SY, 1998, CHINESE POPULATION S, V65, P11; Kim J, 2016, FEMALE ED ITS IMPACT, DOI [10.15185/izawol.228, DOI 10.15185/IZAWOL.228]; Kline R. B., 2015, PRINCIPLES AND PRACT; Kravdal O, 2008, AM SOCIOL REV, V73, P854, DOI 10.1177/000312240807300508; Liu FS, 2016, COMP EDUC REV, V60, P105; Liu P, 2013, J HUM LACT, V29, P253, DOI 10.1177/0890334413477240; Liu T-X, 2017, 2 CHILD POLICY GENDE, DOI [10.13140/RG.2.2.31435.69924, DOI 10.13140/RG.2.2.31435.69924]; Mencarini L, 2015, ADV LIFE COURSE RES, V23, P14, DOI 10.1016/j.alcr.2014.12.004; Monga M, 2004, UROLOGY, V63, P126, DOI 10.1016/j.urology.2003.09.015; Monstad K, 2008, SCAND J ECON, V110, P827, DOI 10.1111/j.1467-9442.2008.00563.x; Nozaki Y, 2017, INT J SOC ECON, V44, P653, DOI 10.1108/IJSE-12-2014-0246; Philipov D, 2009, EUR J POPUL, V25, P355, DOI 10.1007/s10680-009-9202-1; Rijken AJ, 2009, EUR J POPUL, V25, P27, DOI 10.1007/s10680-008-9156-8; Tavakol M, 2011, INT J MED EDUC, V2, P1, DOI 10.5116/ijme.4d27.32ff; Wei JQ, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0202968; Wu XG, 2014, CHINESE SOCIOL REV, V46, P3, DOI 10.2753/CSA2162-0555460301; Xue JL, 2015, POPULATION J, V37, P11, DOI [10.16405/j.cnki.1004-129X.2015.04.003, DOI 10.16405/J.CNKI.1004-129X.2015.04.003]; Zeng Y, 2016, LANCET, V388, P1930, DOI 10.1016/S0140-6736(16)31405-2; Zhang LP, 2013, HEILONGJIANG SOCIAL, V140, P7; Zhang Y., 2018, QUALITATIVE STUDY CH; Zhang Z., 1995, HIST POPULATION INNE, V59, P10; Zhao ZW, 2018, DEMOGRAPHY, V55, P733, DOI 10.1007/s13524-018-0662-y; Zheng G, 2005, VALUE OF CHILDREN IN CROSS-CULTURAL PERSPECTIVE, P239; Zhou XD, 2011, SOC SCI MED, V73, P1422, DOI 10.1016/j.socscimed.2011.07.033; Zhu J., 2009, INT J CHILD CARE EDU, V3, P51, DOI DOI 10.1007/2288-6729-3-1-51	48	3	3	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2019	14	8							e0221526	10.1371/journal.pone.0221526	http://dx.doi.org/10.1371/journal.pone.0221526			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW5TR	31442271	Green Published, Green Submitted, gold			2022-12-26	WOS:000485041400042
J	Morcillo, L; Camacho-Garzon, A; Calderon, JS; Bautista, S				Morcillo, Luna; Camacho-Garzon, Azucena; Sebastian Calderon, Juan; Bautista, Susana			Functional similarity and competitive symmetry control productivity in mixtures of Mediterranean perennial grasses	PLOS ONE			English	Article							STRESS-GRADIENT HYPOTHESIS; GRASSLAND COMMUNITIES; POSITIVE INTERACTIONS; PLANT DIVERSITY; LYGEUM-SPARTUM; BIODIVERSITY; MECHANISMS; EMERGENCE; ABILITY; TRAITS	Competition is a major factor structuring plant communities and controlling their productivity. The functional similarity between the interacting species and the context resource availability are assumed to be most critical factors that modulate the strength, sign, and outcome of plant competition, yet their roles and interactions are subjected to debate. In a glasshouse experiment, we constructed monocultures and bi-specific cultures of three common perennial grasses of Mediterranean drylands, the short grass Brachypodium retusum and the tussock grasses Stipa tenacissima and Lygeum spartum, and investigated how the functional similarity between these species modulate their interactions and culture productivity under contrasting levels of water availability. Regardless the degree of functional similarity between the interacting species, B. retusum consistently exhibited a greater competitive ability than the other two species, followed by L. spartum, and with S. tenacissima behaving as the weakest competitor. Bi-specific cultures of B. retusum and either L. spartum or S. tenacissima produced higher biomass than the average biomass of the respective monocultures (i.e. overyielding), whereas the combination of the most similar species, L. spartum-S. tenacissima, which exhibited the highest competition symmetry (i.e., the more similar mutual impact), did not show any significant overyielding. Higher water availability increased productivity and promoted transgressive overyielding for the most dissimilar species, B. retusum and L. spartum, which however exhibited intermediate competition asymmetry. This study calls attention to the thin line between differences in functional traits and competition asymmetry that could eventually lead to either competitive exclusion or resource partitioning and coexistence.	[Morcillo, Luna; Camacho-Garzon, Azucena; Sebastian Calderon, Juan; Bautista, Susana] Univ Alicante, Dept Ecol, Alicante, Spain; [Morcillo, Luna; Camacho-Garzon, Azucena; Sebastian Calderon, Juan; Bautista, Susana] Univ Alicante, IMEM, Alicante, Spain; [Morcillo, Luna] Univ Alicante, Joint Res Unit Univ Alicante CEAM, Mediterranean Ctr Environm Studies, CEAM Fdn, Alicante, Spain	Universitat d'Alacant; Universitat d'Alacant; Universitat d'Alacant	Morcillo, L (corresponding author), Univ Alicante, Dept Ecol, Alicante, Spain.; Morcillo, L (corresponding author), Univ Alicante, IMEM, Alicante, Spain.; Morcillo, L (corresponding author), Univ Alicante, Joint Res Unit Univ Alicante CEAM, Mediterranean Ctr Environm Studies, CEAM Fdn, Alicante, Spain.	luna_morcillo@hotmail.com	Bautista, Susana/AAD-1123-2020	Bautista, Susana/0000-0001-7175-7076; Morcillo, Luna/0000-0002-8589-4300	Spanish Ministry of Science, Innovation and Universities through the project DRYEX [CGL2014-59074-R]; Spanish Ministry of Science, Innovation and Universities through the project DRYEX2 [CGL2017-89804-R]; Generalitat Valenciana; Spanish Ministry of Science, Innovation and Universities [CGL2014-59074-R, CGL2017-89804-R]	Spanish Ministry of Science, Innovation and Universities through the project DRYEX; Spanish Ministry of Science, Innovation and Universities through the project DRYEX2; Generalitat Valenciana(Center for Forestry Research & Experimentation (CIEF)European Commission); Spanish Ministry of Science, Innovation and Universities(Spanish Government)	This study was financially supported by the Spanish Ministry of Science, Innovation and Universities (http://www.ciencia.gob.es/) through the projects DRYEX (CGL2014-59074-R) and DRYEX2 (CGL2017-89804-R). The CEAM foundation is supported by Generalitat Valenciana. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Diana Turrion and Manuel Ruiz for their help with the experiment, Paco Rodriguez for statistical advice, and the Spanish Ministry of Science, Innovation and Universities (projects CGL2014-59074-R and CGL2017-89804-R) for financial support. The CEAM Foundation is supported by Generalitat Valenciana.	Aarssen LW, 1997, OIKOS, V80, P183, DOI 10.2307/3546531; ABRAMS PA, 1995, ECOLOGY, V76, P2019, DOI 10.2307/1941677; [Anonymous], 2001, PLANT STRATEGIES VEG; Armas C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027791; Armas C, 2011, J VEG SCI, V22, P818, DOI 10.1111/j.1654-1103.2011.01301.x; Aschehoug ET, 2016, ANNU REV ECOL EVOL S, V47, P263, DOI 10.1146/annurev-ecolsys-121415-032123; Bazzaz F.A., 1990, PERSPECTIVES PLANT C, P240; Bennett JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043703; Benot ML, 2013, J ECOL, V101, P626, DOI 10.1111/1365-2745.12066; BERTNESS MD, 1994, TRENDS ECOL EVOL, V9, P191, DOI 10.1016/0169-5347(94)90088-4; Cardinale BJ, 2011, AM J BOT, V98, P572, DOI 10.3732/ajb.1000364; CataluYn P., 2016, GENETICS GENOMICS BR, P9, DOI DOI 10.1007/7397_2015_17; Cheplick GP, 2000, CAN J BOT, V78, P537, DOI 10.1139/cjb-78-4-537; Chesson P, 2000, ANNU REV ECOL SYST, V31, P343, DOI 10.1146/annurev.ecolsys.31.1.343; Coates KD, 2013, J ECOL, V101, P806, DOI 10.1111/1365-2745.12072; Conesa HM, 2007, ENVIRON POLLUT, V145, P700, DOI 10.1016/j.envpol.2006.06.002; CONNELL JH, 1977, AM NAT, V111, P1119, DOI 10.1086/283241; Contu S., 2013, IUCN RED LIST THREAT; Craine JM, 2005, J ECOL, V93, P1041, DOI 10.1111/j.1365-2745.2005.01043.x; De Baets S, 2007, PLANT SOIL, V294, P169, DOI 10.1007/s11104-007-9244-2; Dickson TL, 2011, ECOL LETT, V14, P380, DOI 10.1111/j.1461-0248.2011.01599.x; DOUST LL, 1981, J ECOL, V69, P743, DOI 10.2307/2259633; Dyer AR, 2000, ECOL LETT, V3, P523, DOI 10.1046/j.1461-0248.2000.00187.x; Foster BL, 2000, PLANT ECOL, V151, P171, DOI 10.1023/A:1026569432257; GAUDET CL, 1989, NATURE, V337, P123, DOI 10.1038/337123a0; Goldberg DE, 1996, PHILOS T R SOC B, V351, P1377, DOI 10.1098/rstb.1996.0121; GOLDBERG DE, 1991, J ECOL, V79, P1013, DOI 10.2307/2261095; GOLDBERG DE, 1987, J ECOL, V75, P1131, DOI 10.2307/2260318; Hector A, 1999, SCIENCE, V286, P1123, DOI 10.1126/science.286.5442.1123; Hector A, 2002, ECOL LETT, V5, P502, DOI 10.1046/j.1461-0248.2002.00337.x; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; Huston MA, 1997, OECOLOGIA, V110, P449, DOI 10.1007/s004420050180; JOHANSSON ME, 1991, OIKOS, V60, P27, DOI 10.2307/3544988; KADMON R, 1995, J ECOL, V83, P253, DOI 10.2307/2261564; Kunstler G, 2016, NATURE, V529, P204, DOI 10.1038/nature16476; Kunstler G, 2012, ECOL LETT, V15, P831, DOI 10.1111/j.1461-0248.2012.01803.x; Loreau M, 2004, OIKOS, V104, P606, DOI 10.1111/j.0030-1299.2004.12685.x; Loreau M, 2001, NATURE, V412, P72, DOI 10.1038/35083573; Lortie CJ, 2006, J ECOL, V94, P7, DOI 10.1111/j.1365-2745.2005.01066.x; MACARTHUR R, 1967, AM NAT, V101, P377, DOI 10.1086/282505; Maestre FT, 2009, J ECOL, V97, P199, DOI 10.1111/j.1365-2745.2008.01476.x; Maestre FT, 2004, P ROY SOC B-BIOL SCI, V271, pS331, DOI 10.1098/rsbl.2004.0181; Mayfield MM, 2010, ECOL LETT, V13, P1085, DOI 10.1111/j.1461-0248.2010.01509.x; Michalet R, 2007, NEW PHYTOL, V173, P3, DOI 10.1111/j.1469-8137.2006.01949.x; MILLER TE, 1994, AM J BOT, V81, P1, DOI 10.2307/2445555; Mueller KE, 2013, ECOLOGY, V94, P787, DOI 10.1890/12-1399.1; Nedjimi B, 2016, RANGELAND J, V38, P493, DOI 10.1071/RJ16046; Pugnaire FI, 1996, ANN BOT-LONDON, V77, P81, DOI 10.1006/anbo.1996.0010; ROSS MA, 1972, J ECOL, V60, P77, DOI 10.2307/2258041; Schob C, 2015, NEW PHYTOL, V205, P720, DOI 10.1111/nph.13043; Semchenko M, 2018, PLANT SOIL, V424, P157, DOI 10.1007/s11104-017-3282-1; Soreng RJ, 2015, J SYST EVOL, V53, P117, DOI 10.1111/jse.12150; Spehn EM, 2000, FUNCT ECOL, V14, P326, DOI 10.1046/j.1365-2435.2000.00437.x; Tielborger K, 2000, PLANT ECOL, V150, P53, DOI 10.1023/A:1026541428547; Tilman D, 1997, P NATL ACAD SCI USA, V94, P1857, DOI 10.1073/pnas.94.5.1857; Tilman D, 2001, SCIENCE, V294, P843, DOI 10.1126/science.1060391; Tilman D, 2014, ANNU REV ECOL EVOL S, V45, P471, DOI 10.1146/annurev-ecolsys-120213-091917; Trinder CJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029413; Verdu M, 2005, ECOLOGY, V86, P1385, DOI 10.1890/04-1647; Wang P, 2010, FUNCT ECOL, V24, P196, DOI 10.1111/j.1365-2435.2009.01612.x; Williams LJ, 2017, NAT ECOL EVOL, V1, DOI 10.1038/s41559-016-0063; Wilson MV, 2007, J ECOL, V95, P301, DOI 10.1111/j.1365-2745.2007.01215.x; WILSON SD, 1993, J ECOL, V81, P445, DOI 10.2307/2261523	63	3	3	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2019	14	8							e0221667	10.1371/journal.pone.0221667	http://dx.doi.org/10.1371/journal.pone.0221667			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5TR	31442283	Green Published, gold, Green Submitted			2022-12-26	WOS:000485041400068
J	Carbone, F; Bruno, L; Perrotta, G; Bitonti, MB; Muzzalupo, I; Chiappetta, A				Carbone, Fabrizio; Bruno, Leonardo; Perrotta, Gaetano; Bitonti, Maria B.; Muzzalupo, Innocenzo; Chiappetta, Adriana			Identification of miRNAs involved in fruit ripening by deep sequencing of Olea europaea L. transcriptome	PLOS ONE			English	Article							GENE-EXPRESSION; TOMATO FRUIT; TRANSLATIONAL INHIBITION; HUMAN HEALTH; SMALL RNAS; ARABIDOPSIS; BIOSYNTHESIS; MICRORNAS; PROANTHOCYANIDINS; BIOCHEMISTRY	Background The ripening process of olive fruits is associated with chemical and/or enzymatic specific transformations, making them particularly attractive to animals and humans. In olive drupes, including 'Cassanese' ones, ripening is usually accompanied by progressive chromatic change, resulting in a final red-brown colourization of both epidermis and mesocarp. This event has an exception in the Leucocarpa', in which we observed the destabilization in the equilibrium between the chlorophyll metabolism and that of the other pigments, particularly the anthocyanins, whose switch-off during maturation promotes the white colouration of the fruits. Recently, transcription profiling of Leucocarpa' and 'Cassanese' olives along ripening, performed through an Illumina RNA-seq approach, has provided useful insights on genes functions involved in fruit maturation such as those related to the biosynthesis of flavonoids and anthocyanins. Methodology To assess expression alterations of genes involved in flavonoids and anthocyanins biosynthetic pathways during ripening, possibly caused by small nuclear RNA (snRNA) in olive drupes, snRNA libraries from Leucocarpa' and 'Cassanese' were constructed with RNAs extracted at 100 and 130 Days After Flowering (DAF) and sequenced by an Illumina approach. 130 conserved microRNAs (miRNA) in the Viridiplantae belonging to 14 miRNA families were identified. Regarding the 130 conserved miRNAs, approximately the 48% were identified in all libraries, 5 and 18 miRNAs were shared between the "Cassanese" (C100, C130) and "Leucocarpa" (L100, L130) libraries, respectively. Conclusion For the remaining reads not-matching with known miRNAs in the Viridiplantae, we combined secondary structure and minimum free energy to discover novel olive miRNAs. Based on these analyses, 492 sequences were considered as putative novel miRNAs. The putative target genes of identified miRNA were computationally predicted by alignment with the olive drupe transcripts obtained from the same samples. A total of 218 transcripts were predicted as targets of 130 known and 492 putative novel miRNAs. Interestingly, some identified target genes are involved in negative regulation of anthocyanin metabolic process. Quantification of the expression pattern of three miRNA and their target transcripts by qRT-PCR assay confirmed the results of Illumina sequencing.	[Carbone, Fabrizio; Muzzalupo, Innocenzo] Univ Calabria, Dept Biol Ecol & Earth Sci, Arcavacata Di Rende, CS, Italy; [Bruno, Leonardo; Bitonti, Maria B.; Chiappetta, Adriana] Council Agr Res & Econ, Res Ctr Olive Citrus & Tree Fruit, Arcavacata Di Rende, CS, Italy; [Perrotta, Gaetano] ENEA, TRISAIA Res Ctr, Rotondella, MT, Italy	University of Calabria; Consiglio per la Ricerca in Agricoltura e L'analisi Dell'economia Agraria (CREA); Italian National Agency New Technical Energy & Sustainable Economics Development	Muzzalupo, I (corresponding author), Univ Calabria, Dept Biol Ecol & Earth Sci, Arcavacata Di Rende, CS, Italy.; Chiappetta, A (corresponding author), Council Agr Res & Econ, Res Ctr Olive Citrus & Tree Fruit, Arcavacata Di Rende, CS, Italy.	innocenzo.muzzalupo@crea.gov.it; adriana.chiappetta@unical.it	Carbone, Fabrizio/O-2443-2017; Carbone, Fabrizio/AAE-1065-2019; Bitonti, Maria/AAO-7345-2020	Carbone, Fabrizio/0000-0002-0393-7099; Carbone, Fabrizio/0000-0002-0393-7099; Muzzalupo, Innocenzo/0000-0002-0264-1392	Regione Calabria	Regione Calabria(Regione Calabria)	Funded by Regione Calabria Award Number: POR Calabria FESR-FSE 2014-2020, Action 1.2.2, S3 strategies: "Extra virgin olive oil digital ID management - ODIN".vertical bar Recipient: Prof. Adriana Chiappetta. Regione Calabria Award Number: POR Calabria FESR-FSE 2014-2020, Action 1.2.2, S3 strategies: "Extra virgin olive oil digital ID management - ODIN". vertical bar Recipient: Dr. lnnocenzo Muzzalupo, PhD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed NU, 2014, GENE, V550, P46, DOI 10.1016/j.gene.2014.08.013; Alagna F, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-399; Allen RS, 2007, P NATL ACAD SCI USA, V104, P16371, DOI 10.1073/pnas.0707653104; Barik S, 2014, GENOMICS, V103, P114, DOI 10.1016/j.ygeno.2013.11.004; Bassolino L, 2013, NEW PHYTOL, V200, P650, DOI 10.1111/nph.12524; Baumberger N, 2005, P NATL ACAD SCI USA, V102, P11928, DOI 10.1073/pnas.0505461102; Brodersen P, 2008, SCIENCE, V320, P1185, DOI 10.1126/science.1159151; Buer CS, 2010, J INTEGR PLANT BIOL, V52, P98, DOI 10.1111/j.1744-7909.2010.00905.x; Bulgakov VP, 2015, BIOTECHNOL LETT, V37, P1719, DOI 10.1007/s10529-015-1863-8; Cartolano M, 2007, NAT GENET, V39, P901, DOI 10.1038/ng2056; Chen WW, 2015, SCI REP-UK, V5, DOI 10.1038/srep07852; Chuck G, 2007, NAT GENET, V39, P544, DOI 10.1038/ng2001; Conde C, 2008, J PLANT PHYSIOL, V165, P1545, DOI 10.1016/j.jplph.2008.04.018; Cruz F, 2016, GIGASCIENCE, V5, DOI 10.1186/s13742-016-0134-5; Cui LG, 2014, PLANT J, V80, P1108, DOI 10.1111/tpj.12712; de Pascual-Teresa S, 2010, INT J MOL SCI, V11, P1679, DOI 10.3390/ijms11041679; Delgado-Vargas F., 2003, NATURAL COLORANTS FO, P167; Dixon RA, 2005, NEW PHYTOL, V165, P9, DOI 10.1111/j.1469-8137.2004.01217.x; Donaire L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027916; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Eldem V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050298; Eriksson EM, 2004, PLANT PHYSIOL, V136, P4184, DOI 10.1104/pp.104.045765; Fagard M, 2000, P NATL ACAD SCI USA, V97, P11650, DOI 10.1073/pnas.200217597; Silva GFFE, 2014, PLANT J, V78, P604, DOI 10.1111/tpj.12493; Fraser PD, 2001, PHYTOCHEMISTRY, V58, P75, DOI 10.1016/S0031-9422(01)00175-3; Galla G, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-128; Gandikota M, 2007, PLANT J, V49, P683, DOI 10.1111/j.1365-313X.2006.02983.x; Gao F, 2016, RNA BIOL, V13, P343, DOI 10.1080/15476286.2015.1125075; Giacomelli JI, 2012, NEW PHYTOL, V195, P766, DOI 10.1111/j.1469-8137.2012.04259.x; Gou JY, 2011, PLANT CELL, V23, P1512, DOI 10.1105/tpc.111.084525; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Gupta OP, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00374; Hamilton AJ, 1999, SCIENCE, V286, P950, DOI 10.1126/science.286.5441.950; He F, 2008, MOLECULES, V13, P2674, DOI 10.3390/molecules13102674; Iaria DL, 2016, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.01246; Itaya A, 2008, BBA-GENE REGUL MECH, V1779, P99, DOI 10.1016/j.bbagrm.2007.09.003; JIAO Z, 2012, AFR J BIOTECHNOL, P11, DOI DOI 10.5897/AJB11.3859; Jones-Rhoades MW, 2006, ANNU REV PLANT BIOL, V57, P19, DOI 10.1146/annurev.arplant.57.032905.105218; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lepiniec L, 2006, ANNU REV PLANT BIOL, V57, P405, DOI 10.1146/annurev.arplant.57.032905.105252; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Li ST, 2014, PLANT SIGNAL BEHAV, V9, DOI 10.4161/psb.27522; Li XY, 2017, BMC PLANT BIOL, V17, DOI 10.1186/s12870-017-0983-9; Liu YL, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-695; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Llave C, 2002, SCIENCE, V297, P2053, DOI 10.1126/science.1076311; Loumou A, 2003, AGRIC HUMAN VALUES, V20, P87, DOI 10.1023/A:1022444005336; Mao XZ, 2005, BIOINFORMATICS, V21, P3787, DOI 10.1093/bioinformatics/bti430; Martin RC, 2006, CAN J BOT, V84, P189, DOI 10.1139/B05-141; Matzke M, 2001, SCIENCE, V293, P1080, DOI 10.1126/science.1063051; Minutolo A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-30718-w; Mohorianu I, 2011, PLANT J, V67, P232, DOI 10.1111/j.1365-313X.2011.04586.x; Palatnik JF, 2003, NATURE, V425, P257, DOI 10.1038/nature01958; Pang MX, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r122; Pojer E, 2013, COMPR REV FOOD SCI F, V12, P483, DOI 10.1111/1541-4337.12024; Quattrocchio F, 2006, PLANT CELL, V18, P1274, DOI 10.1105/tpc.105.034041; Ramsay NA, 2005, TRENDS PLANT SCI, V10, P63, DOI 10.1016/j.tplants.2004.12.011; Ravaglia D, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-68; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Reyes JL, 2007, PLANT J, V49, P592, DOI 10.1111/j.1365-313X.2006.02980.x; SERVILI M, 2012, THE OLIVE CULTIVATIO, P151, DOI DOI 10.5772/3314; Singh A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03632-w; Spencer JPE, 2010, BRIT J NUTR, V104, pS40, DOI 10.1017/S0007114510003934; Stracke R, 2007, PLANT J, V50, P660, DOI 10.1111/j.1365-313X.2007.03078.x; Surbanovski N, 2016, PLANT J, V85, P70, DOI 10.1111/tpj.13090; Taylor LP, 2005, CURR OPIN PLANT BIOL, V8, P317, DOI 10.1016/j.pbi.2005.03.005; Tian Li, 2008, Phytochemistry Reviews, V7, P445, DOI 10.1007/s11101-007-9076-y; Vance V, 2001, SCIENCE, V292, P2277, DOI 10.1126/science.1061334; Vauzour D, 2010, NUTRIENTS, V2, P1106, DOI 10.3390/nu2111106; Wang JW, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002012; Wang WC, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-328; Winkel-Shirley B, 2001, PLANT PHYSIOL, V126, P485, DOI 10.1104/pp.126.2.485; Wu J, 2013, GENOME RES, V23, P396, DOI 10.1101/gr.144311.112; Yanik H, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-10; Yue JY, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.01155; Zeng SH, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00778; Zhang H, 2013, MOL BIOL REP, V40, P6245, DOI 10.1007/s11033-013-2736-7; Zhang JH, 2011, CORONARY ARTERY DIS, V22, P145, DOI 10.1097/MCA.0b013e328343fbbb; Zhang L, 2012, CELL RES, V22, P107, DOI 10.1038/cr.2011.158; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	82	6	6	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2019	14	8							e0221460	10.1371/journal.pone.0221460	http://dx.doi.org/10.1371/journal.pone.0221460			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5RZ	31437230	Green Submitted, gold, Green Published			2022-12-26	WOS:000485036900075
J	Nouri, K; Azad, T; Lightbody, E; Khanal, P; Nicol, CJ; Yang, XL				Nouri, Kazem; Azad, Taha; Lightbody, Elizabeth; Khanal, Prem; Nicol, Christopher J.; Yang, Xiaolong			A kinome-wide screen using a NanoLuc LATS luminescent biosensor identifies ALK as a novel regulator of the Hippo pathway in tumorigenesis and immune evasion	FASEB JOURNAL			English	Article						PD-L1; kinases; lung cancer; immunotherapy; breast cancer	SIGNALING PATHWAYS; KINASES; CANCER; REPORTER	The Hippo pathway is an emerging signaling pathway that plays important roles in organ size control, tissue homeostasis, tumorigenesis, metastasis, drug resistance, and immune response. Although many regulators of the Hippo pathway have been reported, the extracellular stimuli and kinase regulators of the Hippo pathway remain largely unknown. To identify novel regulars of the Hippo pathway, in this study we created the first ultra-bright NanoLuc biosensor (BS) to monitor the activity of large tumor suppressor (LATS) kinase 1, a central player of the Hippo pathway. We show that this NanoLuc BS achieves significantly advanced sensitivity and stability both in vitro using purified proteins and in vivo in living cells and mice. Using this BS, we perform the first kinome-wide screen and identify many kinases regulating LATS and its effectors yes-associated protein (YAP) and transcriptional co-activator with PDZ- binding motif (TAZ). We also show for the first time that activation of receptor tyrosine kinase anaplastic lymphoma kinase (ALK) by its extracellular ligand family with sequence similarity (FAM)150 activates Hippo effector YAP/TAZ by increasing their nuclear translocation. Significantly, we show that constitutively active ALK induces tumorigenic phenotypes, such as increased cancer cell proliferation/colony formation via YAP/TAZ and elevated immune evasion via YAP/TAZ-programmed death-ligand 1 in breast and lung cancer cells. In summary, we have developed a new LATS BS for cancer biology and therapeutics research and uncovered a novel ALK-LATS-YAP/TAZ signaling axis that may play important roles in cancer and possibly other biologic processes.	[Nouri, Kazem; Azad, Taha; Lightbody, Elizabeth; Khanal, Prem; Nicol, Christopher J.; Yang, Xiaolong] Queens Univ, Dept Pathol & Mol Med, 88 Stuart St,Richardson Lab Room 306A, Kingston, ON K7L 3N6, Canada	McMaster University; Queens University - Canada	Yang, XL (corresponding author), Queens Univ, Dept Pathol & Mol Med, 88 Stuart St,Richardson Lab Room 306A, Kingston, ON K7L 3N6, Canada.	yangx@queensu.ca	Azad, Taha/AAO-7975-2020; Azad, Taha/AAF-5600-2020	Nouri, Kazem/0000-0001-7787-1304; Azad, Taha/0000-0002-9498-0657	Queen's University Terry Fox Research Institute Transdisciplinary Training Program in Cancer Research Fellowship; Dr. Robert John Wilson Graduate Fellowship; Canadian Institute of Health Research (CIHR) [119325, 148629]; Canadian Breast Cancer Foundation/Canadian Cancer Society (CBCF/CRS); Breast Cancer Action Kingston and Kingston General Hospital Foundation; Vanier Canada Graduate Scholarship; Ontario International Graduate Scholarship	Queen's University Terry Fox Research Institute Transdisciplinary Training Program in Cancer Research Fellowship; Dr. Robert John Wilson Graduate Fellowship; Canadian Institute of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Canadian Breast Cancer Foundation/Canadian Cancer Society (CBCF/CRS); Breast Cancer Action Kingston and Kingston General Hospital Foundation; Vanier Canada Graduate Scholarship; Ontario International Graduate Scholarship	The authors thank Yawei Hao (Queen's University) for performing the quantitative RT-PCR and technical support. The authors also thank Dr. Ruth Palmer (Gothenburg University, Gothenburg, Sweden) and Dr. Jikui Guan (Gothenburg University) for providing the FAM150 plasmid, and Dr. Alessandro Datti (S.M.A.R.T. Laboratory for the High-Throughput Screening Programs of the Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, ON, Canada) for high-throughput screen for kinases regulating large tumor suppressor kinase 1. E.L. was supported by the Queen's University Terry Fox Research Institute Transdisciplinary Training Program in Cancer Research Fellowship and the Dr. Robert John Wilson Graduate Fellowship. This work was supported by grants from Canadian Institute of Health Research (CIHR; 119325 and 148629 to X.Y.), the Canadian Breast Cancer Foundation/Canadian Cancer Society (CBCF/CRS; to X. Y. and C.J.N.), and the Breast Cancer Action Kingston and Kingston General Hospital Foundation (to C.J.N.). T.A. was supported by the Vanier Canada Graduate Scholarship and Ontario International Graduate Scholarship. The authors declare no conflicts of interest.	Azad T, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03278-w; Azad T., 2018, JOVE-J VIS EXP, V139; Baltussen LL, 2018, PROG NEURO-PSYCHOPH, V84, P343, DOI 10.1016/j.pnpbp.2017.12.006; Beauchamp RL, 2015, ONCOTARGET, V6, P16981, DOI 10.18632/oncotarget.4858; Burke JE, 2018, MOL CELL, V71, P653, DOI 10.1016/j.molcel.2018.08.005; Cao ZF, 2019, ONCOL LETT, V17, P2020, DOI 10.3892/ol.2018.9856; Clark CA, 2017, AUTOPHAGY, V13, P987, DOI 10.1080/15548627.2017.1280223; Clark CA, 2016, CANCER RES, V76, P6964, DOI 10.1158/0008-5472.CAN-16-0258; Della Corte CM, 2018, MOL CANCER, V17, DOI 10.1186/s12943-018-0776-2; Dixon AS, 2016, ACS CHEM BIOL, V11, P400, DOI 10.1021/acschembio.5b00753; England CG, 2016, BIOCONJUGATE CHEM, V27, P1175, DOI 10.1021/acs.bioconjchem.6b00112; Fu V, 2017, CURR OPIN CELL BIOL, V49, P99, DOI 10.1016/j.ceb.2017.12.012; Furth N, 2017, CELL DEATH DIFFER, V24, P1488, DOI 10.1038/cdd.2017.99; Golding B, 2018, MOL CANCER, V17, DOI 10.1186/s12943-018-0810-4; Guan JK, 2015, ELIFE, V4, DOI 10.7554/eLife.09811; Hall MP, 2012, ACS CHEM BIOL, V7, P1848, DOI 10.1021/cb3002478; Hallberg B, 2016, ANN ONCOL, V27, P4, DOI 10.1093/annonc/mdw301; Hansen CG, 2015, TRENDS CELL BIOL, V25, P499, DOI 10.1016/j.tcb.2015.05.002; Hao YW, 2008, J BIOL CHEM, V283, P5496, DOI 10.1074/jbc.M709037200; Ho KC, 2011, P NATL ACAD SCI USA, V108, P4870, DOI 10.1073/pnas.1101273108; Jaiswal M, 2012, METHODS MOL BIOL, V827, P37, DOI 10.1007/978-1-61779-442-1_3; Kim JM, 2016, ANN ONCOL, V27, P1492, DOI 10.1093/annonc/mdw217; Koh J, 2016, ONCOIMMUNOLOGY, V5, DOI 10.1080/2162402X.2015.1108514; Loirand G, 2015, PHARMACOL REV, V67, P1074, DOI 10.1124/pr.115.010595; Nandipati KC, 2017, MOL CELL BIOCHEM, V426, P27, DOI 10.1007/s11010-016-2878-8; Nouri K, 2016, J BIOL CHEM, V291, P26364, DOI 10.1074/jbc.M116.752121; Ota K, 2015, CLIN CANCER RES, V21, P4014, DOI 10.1158/1078-0432.CCR-15-0016; Pavan S, 2018, ONCOGENE, V37, P4197, DOI 10.1038/s41388-018-0270-8; Regad T, 2015, CANCERS, V7, P1758, DOI 10.3390/cancers7030860; Reuven N, 2019, METHODS MOL BIOL, V1893, P215, DOI 10.1007/978-1-4939-8910-2_17; Salmaninejad A, 2019, J CELL PHYSIOL, V234, P16824, DOI 10.1002/jcp.28358; Shen J, 2018, CELL DEATH DIFFER, V25, P2053, DOI 10.1038/s41418-018-0080-0; Shin CH, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8020178; Siraj AK, 2015, BREAST CANCER RES, V17, DOI 10.1186/s13058-015-0610-3; Taha Z, 2018, CANCERS, V10, DOI 10.3390/cancers10040094; Thompson BJ, 2015, J CELL BIOL, V210, P871, DOI 10.1083/jcb.201507005; Tzeng YDT, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.01285; van Rensburg HJJ, 2018, CANCER RES, V78, P1457, DOI 10.1158/0008-5472.CAN-17-3139; van Rensburg HJJ, 2016, CELL SIGNAL, V28, P1761, DOI 10.1016/j.cellsig.2016.08.004; Wang L, 2020, MOL PSYCHIATR, V25, P2504, DOI 10.1038/s41380-018-0325-9; Yang XL, 2011, CELL RES, V21, P715, DOI 10.1038/cr.2011.63; Yokota T, 2016, GENE, V575, P369, DOI 10.1016/j.gene.2015.09.030; Zanconato F, 2016, CANCER CELL, V29, P783, DOI 10.1016/j.ccell.2016.05.005; Zhao YR, 2018, 2018 3RD IEEE INTERNATIONAL CONFERENCE ON ADVANCED ROBOTICS AND MECHATRONICS (IEEE ICARM), P165, DOI 10.1109/ICARM.2018.8610786; Zhao YL, 2018, MOL CANCER RES, V16, P1046, DOI 10.1158/1541-7786.MCR-17-0593; Zhao YL, 2015, INT J CANCER, V137, P2767, DOI 10.1002/ijc.29293	46	24	24	1	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2019	33	11					12487	12499		10.1096/fj.201901343R	http://dx.doi.org/10.1096/fj.201901343R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC8ZX	31431076	Green Published			2022-12-26	WOS:000507461600069
J	Wu, W; Liu, LY; Zhu, HR; Sun, YT; Wu, Y; Liao, HZ; Gui, YH; Li, L; Liu, L; Sun, F; Lin, HW				Wu, Wei; Liu, Liyun; Zhu, Hongrui; Sun, Yating; Wu, Ying; Liao, Hongze; Gui, Yuhan; Li, Lei; Liu, Lei; Sun, Fan; Lin, Houwen			Butyrolactone-I, an efficient alpha-glucosidase inhibitor, improves type 2 diabetes with potent TNF-alpha-lowering properties through modulating gut microbiota in db/db mice	FASEB JOURNAL			English	Article						inflammatory cytokines; antidiabetic; anti-inflammation	CHAIN FATTY-ACIDS; INDUCED INFLAMMATION; ASPERGILLUS-TERREUS; INNATE IMMUNITY; BETA-CELLS; FUNGUS; OBESITY; DERIVATIVES; IMPACT; DYSFUNCTION	The aim of this study was to evaluate the effects of butyrolactone-I (A6) on type 2 diabetes (T2D) in db/db mice because A6 was found to inhibit alpha-glucosidase activities and TNF-alpha release, which were associated with improving T2D. Male db/db mice were divided into 6 groups and given an equivalent volume of olive oil, acarbose, or different doses of A6 for 4 wk (n = 8/group). In this study, 11 butenolide derivatives were screened for their alpha-glucosidase and TNF-alpha suppressive activity in vitro. A6, an efficient alpha-glucosidase inhibitor, exerts hypoglycemic and multiple activities in reducing weight, improving glucose tolerance and insulin resistance, increasing short-chain fatty acid (SCFA) levels, activating SCFA-induced increases in glucagon-like peptide 1 and peroxisome proliferator-activated receptor-gamma expression, enhancing intestinal mucosal barrier function and mitigating endoxemia in db/db mice. These effects may result from mediation of gut microbiota by A6. Meanwhile, A6, with potent TNF-alpha-lowering properties, was demonstrated to have multiple salutary effects with excellent structural stability and long-term safety in vivo. A6, an effective alpha-glucosidase inhibitor with high security and stability, exerted potent antidiabetic effects in vivo. Furthermore, the modulation of gut microbiota of A6 was demonstrated to be one of the mechanisms contributing to anti-inflammation properties and improving endoxemia. Our work confirms that the compound A6 is a prospective drug candidate for T2D.	[Wu, Wei; Liu, Liyun; Sun, Yating; Wu, Ying; Liao, Hongze; Gui, Yuhan; Li, Lei; Liu, Lei; Sun, Fan; Lin, Houwen] Shanghai Jiao Tong Univ, State Key Lab Oncogenes & Related Genes, Res Ctr Marine Drugs, Dept Pharm,Sch Med,Ren Ji Hosp, Pujian Rd 160, Shanghai 200127, Peoples R China; [Zhu, Hongrui] Shenyang Pharmaceut Univ, Sch Life Sci & Biopharmaceut Sci, Shenyang, Liaoning, Peoples R China	Shanghai Jiao Tong University; Shenyang Pharmaceutical University	Sun, F; Lin, HW (corresponding author), Shanghai Jiao Tong Univ, State Key Lab Oncogenes & Related Genes, Res Ctr Marine Drugs, Dept Pharm,Sch Med,Ren Ji Hosp, Pujian Rd 160, Shanghai 200127, Peoples R China.	sunfan2017@163.com; franklin67@126.com		Lin, Hou-Wen/0000-0002-7097-0876	National Key Research and Development Program of China [2018YFC0310900]; National Natural Science Foundation of China [U1605221, 81502936, 21502113]	National Key Research and Development Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Key Research and Development Program of China (2018YFC0310900) and National Natural Science Foundation of China Grants/Awards: U1605221, 81502936, and 21502113. The authors declare no conflicts of interest.	An X, 2017, XENOBIOTICA, V47, P236, DOI 10.3109/00498254.2016.1172280; Andoh A, 2016, J CLIN BIOCHEM NUTR, V59, P65, DOI 10.3164/jcbn.15-152; Anuradha R, 2014, DNA CELL BIOL, V33, P743, DOI 10.1089/dna.2014.2352; Byndloss MX, 2017, SCIENCE, V357, P570, DOI 10.1126/science.aam9949; Cani PD, 2008, DIABETES, V57, P1470, DOI 10.2337/db07-1403; Chassaing B, 2015, NATURE, V519, P92, DOI 10.1038/nature14232; Chassaing B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044328; Christiansen CB, 2018, AM J PHYSIOL-GASTR L, V315, pG53, DOI 10.1152/ajpgi.00346.2017; da Silva IP, 2017, WORLD J MICROB BIOT, V33, DOI 10.1007/s11274-017-2228-3; DiNicolantonio JJ, 2015, OPEN HEART, V2, DOI [10.1136/openhrt-2014-000230, 10.1136/openhrt-2015-000326]; Frydrych L, 2018, J LEUKOCYTE BIOL, V104, P525, DOI 10.1002/JLB.5VMR0118-021RR; Furusawa Y, 2013, NATURE, V504, P446, DOI 10.1038/nature12721; Goutam J, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01334; Gu YY, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01682-2; Han LP, 2016, J DIABETES RES, V2016, DOI 10.1155/2016/2641248; Ibrahim M, 2018, DIABETES-METAB RES, V34, DOI 10.1002/dmrr.3021; Jiang CY, 2016, APPL ENVIRON MICROB, V82, P2210, DOI 10.1128/AEM.03588-15; KIRIYAMA N, 1977, CHEM PHARM BULL, V25, P2593; Lepoittevin JP, 2009, CHEM REC, V9, P258, DOI 10.1002/tcr.200900013; Li Z, 2018, GUT, V67, P1269, DOI 10.1136/gutjnl-2017-314050; Lin X., 2016, MOLECULES, V22, pE3; Ling ZX, 2014, SCI REP-UK, V4, DOI 10.1038/srep07485; Liu GM, 2018, MOL NUTR FOOD RES, V62, DOI 10.1002/mnfr.201700954; Luo C, 2015, INT IMMUNOPHARMACOL, V28, P744, DOI 10.1016/j.intimp.2015.07.018; Manco M, 2010, ENDOCR REV, V31, P817, DOI 10.1210/er.2009-0030; MAURY J, 1993, DIABETOLOGIA, V36, P503, DOI 10.1007/BF02743265; Meehan CJ, 2014, GENOME BIOL EVOL, V6, P703, DOI 10.1093/gbe/evu050; Miller DN, 1999, APPL ENVIRON MICROB, V65, P4715; Mohammad MK, 2006, INT IMMUNOL, V18, P1101, DOI 10.1093/intimm/dxl045; Morrison DJ, 2016, GUT MICROBES, V7, P189, DOI 10.1080/19490976.2015.1134082; Naguib G, 2004, J INVEST DERMATOL, V123, P87, DOI 10.1111/j.0022-202X.2004.22711.x; Nishio K, 1996, ANTICANCER RES, V16, P3387; Niu XM, 2008, J NAT PROD, V71, P689, DOI 10.1021/np070341r; Palonen Elina K, 2014, Microorganisms, V2, P111, DOI 10.3390/microorganisms2020111; Priyadarshini M, 2016, TRENDS ENDOCRIN MET, V27, P653, DOI 10.1016/j.tem.2016.03.011; Qin JJ, 2012, NATURE, V490, P55, DOI 10.1038/nature11450; Raina S, 2012, PROCESS BIOCHEM, V47, P843, DOI 10.1016/j.procbio.2012.02.021; Rossi AG, 2006, NAT MED, V12, P1056, DOI 10.1038/nm1468; Rutledge PJ, 2015, NAT REV MICROBIOL, V13, P509, DOI 10.1038/nrmicro3496; Schimmel TG, 1998, APPL ENVIRON MICROB, V64, P3707; Shang QS, 2017, TOXICOL LETT, V279, P87, DOI 10.1016/j.toxlet.2017.07.904; Shaw JE, 2010, DIABETES RES CLIN PR, V87, P4, DOI 10.1016/j.diabres.2009.10.007; Shen F, 2017, HEPATOB PANCREAT DIS, V16, P375, DOI 10.1016/S1499-3872(17)60019-5; Shi H, 2006, J CLIN INVEST, V116, P3015, DOI 10.1172/JCI28898; Su BL, 2015, J DIABETES, V7, P729, DOI 10.1111/1753-0407.12232; Sun YT, 2018, BIOORG MED CHEM LETT, V28, P315, DOI 10.1016/j.bmcl.2017.12.049; Tsou YC, 2016, NEUROSCI LETT, V628, P186, DOI 10.1016/j.neulet.2016.06.040; Ubeda M, 2016, J HEPATOL, V64, P1049, DOI 10.1016/j.jhep.2015.12.010; Wang B, 2018, MEDICINE, V97, DOI 10.1097/MD.0000000000012633; Wang C, 2016, J NAT PROD, V79, P2977, DOI 10.1021/acs.jnatprod.6b00766; Wang K, 2018, J MED CHEM, V61, P3609, DOI 10.1021/acs.jmedchem.8b00107; Wu W, 2016, INT IMMUNOPHARMACOL, V39, P218, DOI 10.1016/j.intimp.2016.07.031; Zhang LH, 2016, BIOORG MED CHEM LETT, V26, P346, DOI 10.1016/j.bmcl.2015.12.009; Zhang YY, 2018, MAR DRUGS, V16, DOI 10.3390/md16060202; Ziegler TR, 2008, AM J PHYSIOL-REG I, V294, pR402, DOI 10.1152/ajpregu.00650.2007; Zuo Yi-Nan, 2017, Sichuan Da Xue Xue Bao Yi Xue Ban, V48, P368	56	13	13	4	23	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2019	33	11					12616	12629		10.1096/fj.201901061R	http://dx.doi.org/10.1096/fj.201901061R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC8ZX	31450982	Green Published			2022-12-26	WOS:000507461600079
J	Kusano, S; Ikeda, M				Kusano, Shuichi; Ikeda, Masanori			Interaction of phospholipid scramblase 1 with the Epstein-Barr virus protein BZLF1 represses BZLF1-mediated lytic gene transcription	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						protein-protein interaction; transcription regulation; herpesvirus; transcription factor; viral transcription; BZLF1; Epstein-Barr virus; phospholipid scramblase 1	REGULATES C-MYC; SPECIFICALLY INTERACT; DOMAIN PROTEINS; INTERFERON-ALPHA; EXPRESSION; INFECTION; APOPTOSIS; TRANSACTIVATION; IDENTIFICATION; PATHOGENESIS	Human phospholipid scramblase 1 (PLSCR1) is strongly expressed in response to interferon (IFN) treatment and viral infection, and PLSCR1 has been suggested to play an important role in IFN-dependent antiviral responses. In this study, we showed that the basal expression of PLSCR1 was significantly elevated in Epstein-Barr virus (EBV)?infected nasopharyngeal carcinoma (NPC). PLSCR1 was observed to directly interact with the EBV immediate-early transactivator BZLF1 in vitro and in vivo, and this interaction repressed the BZLF1-mediated transactivation of an EBV lytic BMRF1 promoter construct. In addition, PLSCR1 expression decreased the BZLF1-mediated up-regulation of lytic BMRF1 mRNA and protein expression in WT and PLSCR1-knockout EBV-infected NPC cells. Furthermore, we showed that PLSCR1 represses the interaction between BZLF1 and CREB-binding protein (CBP), which enhances the BZLF1-mediated transactivation of EBV lytic promoters. These results reveal for the first time that PLSCR1 specifically interacts with BZLF1 and negatively regulates its transcriptional regulatory activity by preventing the formation of the BZLF1-CBP complex. This interaction may contribute to the establishment of latent EBV infection in EBV-infected NPC cells.	[Kusano, Shuichi; Ikeda, Masanori] Kagoshima Univ, Joint Res Ctr Human Retrovirus Infect, Div Biol Informat Technol, 8-35-1 Sakuragaoka, Kagoshima, Kagoshima 8908544, Japan	Kagoshima University	Kusano, S (corresponding author), Kagoshima Univ, Joint Res Ctr Human Retrovirus Infect, Div Biol Informat Technol, 8-35-1 Sakuragaoka, Kagoshima, Kagoshima 8908544, Japan.	k2873052@kadai.jp	Kusano, Shuichi/I-5225-2019	Kusano, Shuichi/0000-0001-6293-486X	Japan Society for the Promotion of Science (JSPS) [JP19K07644]; Kodama Memorial Fund for Medical Research	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Kodama Memorial Fund for Medical Research	This work was supported by Japan Society for the Promotion of Science (JSPS) Grant JP19K07644 (to S. K.) and by A Grant from Kodama Memorial Fund for Medical Research (to S. K.). The authors declare that they have no conflicts of interest with the contents of this article.	AB RICKINSON, 2001, FIELDS VIROLOGY, P2575; Adamson AL, 1999, J VIROL, V73, P6551, DOI 10.1128/JVI.73.8.6551-6558.1999; Bevers EM, 2010, FEBS LETT, V584, P2724, DOI 10.1016/j.febslet.2010.03.020; Bristol JA, 2010, J VIROL, V84, P12362, DOI 10.1128/JVI.00712-10; Chen CG, 2009, CANCER BIOL THER, V8, P987, DOI 10.4161/cbt.8.11.8369; Cooper A, 2003, J VIROL, V77, P999, DOI 10.1128/JVI.77.2.999-1010.2003; Der SD, 1998, P NATL ACAD SCI USA, V95, P15623, DOI 10.1073/pnas.95.26.15623; Dong BH, 2004, J VIROL, V78, P8983, DOI 10.1128/JVI.78.17.8983-8993.2004; DOTTO GP, 1986, EMBO J, V5, P2853, DOI 10.1002/j.1460-2075.1986.tb04579.x; FLEMINGTON EK, 1992, J VIROL, V66, P922, DOI 10.1128/JVI.66.2.922-929.1992; Frasch SC, 2004, J BIOL CHEM, V279, P17625, DOI 10.1074/jbc.M313414200; GUTSCH DE, 1994, MOL CELL BIOL, V14, P1939, DOI 10.1128/MCB.14.3.1939; Hicks MR, 2001, J VIROL, V75, P5381, DOI 10.1128/JVI.75.11.5381-5384.2001; KIEFF E, 2001, FIELDS VIROLOGY, P2511; Kusano S, 2015, VIROLOGY, V486, P219, DOI 10.1016/j.virol.2015.09.020; Kusano S, 2013, BIOCHEM BIOPH RES CO, V433, P438, DOI 10.1016/j.bbrc.2013.02.098; Kusano S, 2012, VIROLOGY, V432, P343, DOI 10.1016/j.virol.2012.06.019; Kusano S, 2011, BIOCHIMIE, V93, P1555, DOI 10.1016/j.biochi.2011.05.016; Kusano S, 2010, BIOCHEM BIOPH RES CO, V396, P608, DOI 10.1016/j.bbrc.2010.04.111; Li YJ, 2006, MOL CELL BIOL, V26, P3401, DOI 10.1128/MCB.26.9.3401-3413.2006; LIEBERMAN PM, 1990, J VIROL, V64, P1143, DOI 10.1128/JVI.64.3.1143-1155.1990; Lo AKF, 2006, NEOPLASIA, V8, P173, DOI 10.1593/neo.05625; Luo WY, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006851; Morrison JA, 2004, CANCER RES, V64, P5251, DOI 10.1158/0008-5472.CAN-04-0538; Ohashi M, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004822; Peng K, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-208; Raab-Traub N, 2002, SEMIN CANCER BIOL, V12, P431, DOI 10.1016/S1044579X0200086X; RaabTraub N, 1996, SEMIN VIROL, V7, P315, DOI 10.1006/smvy.1996.0039; Radivojac P, 2007, BIOPHYS J, V92, P1439, DOI 10.1529/biophysj.106.094045; Raver RM, 2013, J VIROL, V87, P8053, DOI 10.1128/JVI.00546-13; Robinson AR, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002516; Ruf IK, 1999, MOL CELL BIOL, V19, P1651; Shair KHY, 2008, CANCER RES, V68, P6997, DOI 10.1158/0008-5472.CAN-08-1178; SHARP NA, 1989, J GEN VIROL, V70, P2521, DOI 10.1099/0022-1317-70-9-2521; Sinclair AJ, 2003, J GEN VIROL, V84, P1941, DOI 10.1099/vir.0.19112-0; Smits JPH, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12041-y; Suzuki J, 2010, NATURE, V468, P834, DOI 10.1038/nature09583; Talukder AH, 2012, CELL RES, V22, P1129, DOI 10.1038/cr.2012.45; Thornburg NJ, 2004, J VIROL, V78, P12848, DOI 10.1128/JVI.78.23.12848-12856.2004; Tsao SW, 2012, SEMIN CANCER BIOL, V22, P137, DOI 10.1016/j.semcancer.2012.02.004; Tsurumi T, 2005, REV MED VIROL, V15, P3, DOI 10.1002/rmv.441; Vinnakota JM, 2016, BIOCHEM BIOPH RES CO, V469, P412, DOI 10.1016/j.bbrc.2015.11.131; Watt FM, 2008, NAT REV CANCER, V8, P234, DOI 10.1038/nrc2328; Wen WR, 2007, J VIROL, V81, P1037, DOI 10.1128/JVI.01416-06; Wiedmer T, 2003, BIOCHEMISTRY-US, V42, P1227, DOI 10.1021/bi026679w; Yu A, 2003, J BIOL CHEM, V278, P9706, DOI 10.1074/jbc.M204614200; Yuan YZ, 2015, J PROTEOME RES, V14, P154, DOI 10.1021/pr500943x; ZHANG Q, 1994, MOL CELL BIOL, V14, P1929, DOI 10.1128/MCB.14.3.1929; Zhao KW, 2005, J BIOL CHEM, V280, P42707, DOI 10.1074/jbc.M506178200; Zhou QS, 1997, J BIOL CHEM, V272, P18240, DOI 10.1074/jbc.272.29.18240	50	3	3	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 11	2019	294	41					15104	15116		10.1074/jbc.RA119.008193	http://dx.doi.org/10.1074/jbc.RA119.008193			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JQ9JH	31434743	hybrid, Green Published			2022-12-26	WOS:000499253400022
J	Park, E; Kim, H; Han, HM; Choi, IH; Jung, HH; Im, GJ				Park, Euyhyun; Kim, Hyunjung; Han, Hye Min; Choi, In Hak; Jung, Hak Hyun; Im, Gi Jung			The optimal and safe intensity for facial nerve stimulation during intraoperative neuromonitoring in middle ear surgery	PLOS ONE			English	Article							RECURRENT LARYNGEAL NERVE; THYROIDECTOMY	Objective This study aimed to investigate the optimal and safe intensity for facial nerve stimulation during middle ear surgery. Methods Thirty-seven patients who had their facial nerve exposed prior to surgery were prospectively enrolled in this study, and electromyography (EMG) recordings were obtained from the orbicularis oculi and orbicularis oris muscles. Four pigs were also enrolled in an animal study, and continuous stimulation was performed on the facial nerves of the pigs for 10 minutes. The EMG responses were measured and the pathologic outcomes of the facial nerve after stimulation were determined. Results In the human study, the mean intensity of the minimal electrical stimulation threshold was 0.21 mA (range: 0.1-0.3 mA). A linear correlation was observed between stimulus intensity and response amplitude for intensities below 0.4 mA. Response amplitudes reached a plateau between 0.4 mA and 1.0 mA. The minimal stimulus intensity that could generate a maximal response was 0.4 mA in the orbicularis oculi (244 mu V) and orbicularis oris (545 mu V). In the animal study, there were no observed changes in EMG or nerve damage incidence after the continuous stimulation of 3.0 mA. Conclusions 0.4 mA is considered to be the optimal intensity of facial nerve stimulation during middle ear surgery, and it was estimated through the animal study that a stimulation of 3.0 mA is safe from facial nerve damage.	[Park, Euyhyun; Kim, Hyunjung; Han, Hye Min; Choi, In Hak; Jung, Hak Hyun; Im, Gi Jung] Korea Univ, Coll Med, Dept Otolaryngol Head & Neck Surg, Seoul, South Korea	Korea University; Korea University Medicine (KU Medicine)	Im, GJ (corresponding author), Korea Univ, Coll Med, Dept Otolaryngol Head & Neck Surg, Seoul, South Korea.	logopas@korea.ac.kr	IM, GI JUNG/AAI-9755-2020	IM, GI JUNG/0000-0002-9457-4253; Park, Euyhyun/0000-0003-4373-6942	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Korea Evaluation Institute of Industrial Technology [R1621961]; Korea Health Industry Development Institute [R1606511]; Korea University research grant [K1609821, Q1620561]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Korea Evaluation Institute of Industrial Technology; Korea Health Industry Development Institute(Korea Health Industry Development Institute (KHIDI)); Korea University research grant	This research was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Korea Evaluation Institute of Industrial Technology (R1621961), the Korea Health Industry Development Institute (R1606511), and a Korea University research grant (K1609821, Q1620561). These funding sources only provided financial support and played no specific scientific role in this study.	Chen SC, 2015, AURIS NASUS LARYNX, V42, P113, DOI 10.1016/j.anl.2014.08.008; Choung YH, 2006, OTOLARYNG HEAD NECK, V135, P872, DOI 10.1016/j.otohns.2006.04.008; Dillon Francis X, 2010, Anesthesiol Clin, V28, P423, DOI 10.1016/j.anclin.2010.07.011; Heman-Ackah SE, 2013, LARYNGOSCOPE, V123, P2, DOI 10.1002/lary.23363; HOUSE JW, 1985, OTOLARYNG HEAD NECK, V93, P146, DOI 10.1177/019459988509300202; Liu SW, 2015, CLIN NEUROL NEUROSUR, V133, P83, DOI 10.1016/j.clineuro.2015.03.016; Misra BK, 2013, WORLD NEUROSURG, V80, pE195, DOI 10.1016/j.wneu.2011.12.066; Nilssen ELK, 1997, J LARYNGOL OTOL, V111, P113, DOI 10.1017/S0022215100136618; Noss RS, 2001, LARYNGOSCOPE, V111, P831, DOI 10.1097/00005537-200105000-00014; Ozemir IA, 2016, INT J SURG, V35, P172, DOI 10.1016/j.ijsu.2016.10.001; Pellant A, 1973, Cesk Otolaryngol, V22, P353; Schneider R, 2013, HEAD NECK-J SCI SPEC, V35, P1591, DOI 10.1002/hed.23187; Suh I, 2016, JAMA SURG, V151, P290, DOI 10.1001/jamasurg.2015.3249; Sung ES, 2018, WORLD J SURG, V42, P137, DOI 10.1007/s00268-017-4159-4; Wu CW, 2010, HEAD NECK-J SCI SPEC, V32, P1295, DOI 10.1002/hed.21324	15	0	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2019	14	8							e0221748	10.1371/journal.pone.0221748	http://dx.doi.org/10.1371/journal.pone.0221748			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW6AB	31465477	gold, Green Submitted, Green Published			2022-12-26	WOS:000485058200042
J	Cooper, SK; Hoover, CE; Henderson, DM; Haley, NJ; Mathiason, CK; Hoover, EA				Cooper, Sarah K.; Hoover, Clare E.; Henderson, Davin M.; Haley, Nicholas J.; Mathiason, Candace K.; Hoover, Edward A.			Detection of CWD in cervids by RT-QuIC assay of third eyelids	PLOS ONE			English	Article							CHRONIC WASTING DISEASE; CERVUS-ELAPHUS NELSONI; WHITE-TAILED DEER; PRION PROTEIN; MULE DEER; ELK; TRANSMISSION; SCRAPIE; TISSUES; BIOPSY	The diagnosis of chronic wasting disease (CWD) relies on demonstration of the disease-associated misfolded CWD prion protein (PrPCWD) in brain or retropharyngeal lymph node tissue by immunodetection methods, e.g. ELISA and immunohistochemistry (IHC). The success of these methods relies on a quality sample of tissues, which requires both anatomical knowledge and considerable dissection to collect. As the prevalence of CWD continues to increase globally, the development of fast and cost-effective methods to detect the disease is vital to facilitate CWD detection and surveillance. To address these issues, we have evaluated third eyelids from CWD-infected deer and elk using real-time quaking induced conversion (RT-QuIC). We identified prion seeding activity in third eyelids in 24 of 25 (96%) CWD-infected white-tailed deer (Odocoileus virginianus). We detected RT-QuIC positivity in the third eyelid as early as 1 month after experimental CWD exposure. In addition, we identified prion seeding activity in third eyelids of 18 of 25 (72%) naturally exposed asymptomatic CWD-positive rocky mountain elk (Cervus canadensis nelson). We compared CWD detection by RT-QuIC and IHC in third eyelid, retropharyngeal lymph node, and brain in 10 deer in early symptomatic stage of disease. IHC detected PrPCWD deposition in third eyelid lymphoid follicles in 5 of 10 deer (50%) whereas third eyelids of all 10 animals were positive by RT-QuIC. This difference reflected in part a lower requirement for lymphoid follicle presence for seeding activity detection by RT-QuIC. In conclusion, RT-QuIC analysis of the third eyelid, an easily accessed tissue, has potential to advance CWD detection and testing compliance.	[Cooper, Sarah K.; Hoover, Clare E.; Henderson, Davin M.; Mathiason, Candace K.; Hoover, Edward A.] Colorado State Univ, Coll Vet Med & Biomed Sci, Dept Microbiol Immunol & Pathol, Prion Res Ctr, Ft Collins, CO 80523 USA; [Haley, Nicholas J.] Midwestern Univ, Dept Microbiol & Immunol, Glendale, AZ USA; [Hoover, Clare E.] AstraZeneca, Waltham, MA USA	Colorado State University; Midwestern University; AstraZeneca	Hoover, EA (corresponding author), Colorado State Univ, Coll Vet Med & Biomed Sci, Dept Microbiol Immunol & Pathol, Prion Res Ctr, Ft Collins, CO 80523 USA.	edward.hoover@colostate.edu		Cooper, Sarah/0000-0002-3469-1060; Cooper, Sarah/0000-0001-9656-2283	Foundation for the National Institutes of Health [R01-NS061902, P01-AI-077774, R01-AI112956]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI112956, P01AI077774] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS061902] Funding Source: NIH RePORTER	Foundation for the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work received support from the Foundation for the National Institutes of Health, R01-NS061902, to Dr. Edward A. Hoover; the Foundation for the National Institutes of Health, P01-AI-077774, to Dr. Edward A. Hoover; and the Foundation for the National Institutes of Health, R01-AI112956, to Dr. Candace K. Mathiason. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atarashi R, 2011, PRION, V5, P150, DOI 10.4161/pri.5.3.16893; Davenport KA, 2018, J CLIN MICROBIOL, V56; Denkers N. D., 2012, J VIROLOGY; Denkers ND, 2013, J VIROL, V87, P1890, DOI 10.1128/JVI.02852-12; Gabizon R, 1996, NAT MED, V2, P59, DOI 10.1038/nm0196-59; Goni F, 2015, VACCINE, V33, P726, DOI 10.1016/j.vaccine.2014.11.035; Haley NJ, 2018, PRION, V12, P93, DOI 10.1080/19336896.2018.1436925; Haley NJ, 2017, PATHOGENS, V6, DOI 10.3390/pathogens6030035; Haley NJ, 2015, ANNU REV ANIM BIOSCI, V3, P305, DOI 10.1146/annurev-animal-022114-111001; Haley NJ, 2011, J VIROL, V85, P6309, DOI 10.1128/JVI.00425-11; Henderson DM, 2015, J VIROL, V89, P9338, DOI 10.1128/JVI.01118-15; Henderson DM, 2015, J GEN VIROL, V96, P210, DOI 10.1099/vir.0.069906-0; Henderson DM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074377; Hoover CE, 2017, J VIROL; Hoover CE, 2016, SCI REP-UK, V6, DOI 10.1038/srep25098; Johnson C, 2003, J WILDLIFE DIS, V39, P576, DOI 10.7589/0090-3558-39.3.576; Kurt TD, 2011, J VIROL, V85, P8528, DOI 10.1128/JVI.00809-11; Maggs D. J, 2013, SLATTERS FUNDAMENTAL; Mathiason CK, 2006, SCIENCE, V314, P133, DOI 10.1126/science.1132661; Miller MW, 2004, EMERG INFECT DIS, V10, P1003, DOI 10.3201/eid1006.040010; Nalls AV, 2017, J VIROL, V91, DOI 10.1128/JVI.00501-17; O'Rourke KI, 2007, NEUROREPORT, V18, P1935, DOI 10.1097/WNR.0b013e3282f1ca2f; O'Rourke KI, 2002, CLIN DIAGN LAB IMMUN, V9, P966, DOI 10.1128/CDLI.9.5.966-971.2002; O'Rourke KI, 2000, J CLIN MICROBIOL, V38, P3254, DOI 10.1128/JCM.38.9.3254-3259.2000; Perrott M. R., 2012, J GEN VIROLOGY; PRUSINER SB, 1984, CELL, V38, P127, DOI 10.1016/0092-8674(84)90533-6; Robinson SJ, 2012, PRION, V6, P153, DOI 10.4161/pri.19640; Sigurdson CJ, 1999, J GEN VIROL, V80, P2757, DOI 10.1099/0022-1317-80-10-2757; Sigurdson CJ, 2002, J GEN VIROL, V83, P2617, DOI 10.1099/0022-1317-83-10-2617; Spraker TR, 2009, J VET DIAGN INVEST, V21, P15, DOI 10.1177/104063870902100103; Spraker TR, 2004, VET REC, V155, P295, DOI 10.1136/vr.155.10.295; Telling GC, 1996, SCIENCE, V274, P2079, DOI 10.1126/science.274.5295.2079; Wilham JM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001217; WILLIAMS ES, 1982, J WILDLIFE DIS, V18, P465, DOI 10.7589/0090-3558-18.4.465; Williams ES, 2002, REV SCI TECH OIE, V21, P305, DOI 10.20506/rst.21.2.1340; WILLIAMS ES, 1980, J WILDLIFE DIS, V16, P89, DOI 10.7589/0090-3558-16.1.89	36	17	18	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2019	14	8							e0221654	10.1371/journal.pone.0221654	http://dx.doi.org/10.1371/journal.pone.0221654			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5XV	31461493	Green Published, gold, Green Submitted			2022-12-26	WOS:000485052300040
J	Sethi, V; Dinachandra, K; Murira, Z; Gausman, J; Bhanot, A; de Wagt, A; Unisa, S; Bhatia, S; Baswal, D; Subramanian, SV				Sethi, Vani; Dinachandra, Konsam; Murira, Zivai; Gausman, Jewel; Bhanot, Arti; de Wagt, Arjan; Unisa, Sayeed; Bhatia, Salima; Baswal, Dinesh; Subramanian, S., V			Nutrition status of nulliparous married Indian women 15-24 years: Decadal trends, predictors and program implications	PLOS ONE			English	Article							REPRODUCTIVE HEALTH OUTCOMES; FOR-GESTATIONAL-AGE; MATERNAL NUTRITION; ADOLESCENT GIRLS; BIRTH-WEIGHT; PREGNANCY; SUPPLEMENTATION; INCOME; RISK	In India, 66% of 8 million married adolescents (similar to 5.3 million) are nulliparous and likely to conceive soon. Among married young women aged 20-24 years about 9.1 million are nulliparous. This group remains relatively less reached in maternal nutrition programs. Current estimates of their nutritional status and predictors of body mass index (BMI) are unavailable. Thinness (BMI <18.5 kg/m(2)), severe thinness (BMI < 16 kg/m(2)), overweight or obesity (BMI >= 23kg/m(2)) prevalence estimates are presented based on a sample of 11,265 married nulliparous adolescents (15-19 years, married, no parity) and 15,358 young women (20-24 years, married, no parity) drawn from the National Family Health Surveys 2005-06 and 2015-16. Trends by age, time and state were analysed. Predictors of BMI were investigated using linear regression. Using BMI for age z score (BAZ) as standard reference, BMI cut-off was calculated for thinness (-2SD) and overweight or obesity (+ 1SD) among married nulliparous adolescents as recommended for population under 19 years. 35% sampled adolescents and 26% young women were thin; 4%-5% severely thin. Overweight or obesity was higher among married nulliparous young women than married nulliparous adolescents (21% versus 11%). Eight in 1000 were short, thin and young and six in 1000 were short, thin, anemic and young. At 15 years of age, prevalence of thinness based on BMI was 46.5% while based on BAZ, 7.6%. At 24 years of age thinness was 22.5%. Decadal reduction in thinness was half among married nulliparous adolescents (4% points) compared with married nulliparous young women (8% points). Decadal increase in overweight/obesity ranged from 4% to 5% in both age groups. Western states had high prevalence of thinness; Tamil Nadu had highest prevalence of overweight or obesity. Incremental increase in age and wealth increased BMI among young women more than adolescents. BMI was lower among adolescents and young women wanting a child later than soon [beta -0.28 (CI -0.49- 0.07), beta-0.33(CI -0.56- -0.093), respectively]. BMI cut-off 16.49 kg/m(2) and 24.12 kg/m(2) had a high sensitivity (100%, 99.7%) and specificity (98.9%, 98.5%) to screen thin and overweight or obese adolescents, respectively. Owing to the high prevalence of both thinness and over-weight/obesity among nulliparous married adolescents and women, nutritional anthropometry based screening should be initiated for this target group, along with a treatment package in states with high and persistent malnutrition. Family planning services should be integrated in nutrition programs for this target group to achieve normal nutritional status before conception.	[Sethi, Vani; de Wagt, Arjan] UNICEF India, Nutr Sect, Country Off, New Delhi, India; [Dinachandra, Konsam; Unisa, Sayeed] Int Inst Populat Sci, Mumbai, Maharashtra, India; [Murira, Zivai] UNICEF, Reg Off South Asia, Kathmandu, Nepal; [Gausman, Jewel] Harvard TH Chan Sch Publ Hlth, Dept Global Hlth & Populat, Women & Hlth Initiat, Boston, MA USA; [Bhatia, Salima; Baswal, Dinesh] Govt India, Minist Hlth & Family Welf, Gauhati, Assam, India; [Subramanian, S., V] Harvard TH Chan Sch Publ Hlth, Boston, MA USA	International Institute for Population Sciences; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health	Sethi, V (corresponding author), UNICEF India, Nutr Sect, Country Off, New Delhi, India.	vsethi@unicef.org	Unisa, Sayeed/AAS-9588-2020	Sethi, Vani/0000-0001-9408-2956; Dinachandra Singh, Konsam/0000-0001-9071-0601	UNICEF	UNICEF	This research was funded by UNICEF. The text has not been edited to UNICEF official publication standards and UNICEF accepts no responsibility for errors. The views expressed are those of authors and not necessarily those of UNICEF. The designations in this publication do not imply an opinion or legal status of any country or territory, or of its authorities, or the delimitation of frontiers.	Aguayo VM, 2017, BMJ-BRIT MED J, V357, DOI 10.1136/bmj.j1309; Aguayo VM, 2016, MATERN CHILD NUTR, V12, P3, DOI 10.1111/mcn.12283; [Anonymous], 2016, IND FACT SHEET NAT F; [Anonymous], 2010, NAT GUID ANT CAR SKI, VMinistry of Health and Family Welfare, Government of India; [Anonymous], 1989, PREV CONTR IR DEF AN; Bhanot A., 2019, ECON POLIT WEEKLY, V54, P43; Black RE, 2003, LANCET, V361, P2226, DOI 10.1016/S0140-6736(03)13779-8; Bold M. V., 2013, 01294 IFPRI; Burmeister E, 2012, AUST CRIT CARE, V25, P271, DOI 10.1016/j.aucc.2012.07.002; CAAN B, 1987, AM J CLIN NUTR, V45, P29, DOI 10.1093/ajcn/45.1.29; Central TB. Division Ministry of Health and Family Welfare, 2017, GUID DOC NUTR CAR SU; Coffey D, 2014, P NATL ACAD SCI; Collins S, 2000, ASSESSMENT NUTR STAT; De-Regil LM, 2016, J NUTR, V146, p1461S, DOI 10.3945/jn.115.223487; Dean SV, 2014, REPROD HEALTH, V11, DOI [10.1186/1742-4755-11-S3-S1, 10.1186/1742-4755-11-S3-S3]; Egata G, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-864; Fluss R, 2005, BIOMETRICAL J, V47, P458, DOI 10.1002/bimj.200410135; Godha D, 2013, J ADOLESCENT HEALTH, V52, P552, DOI 10.1016/j.jadohealth.2013.01.021; Goli S, 2015, MATERN CHILD HLTH J, V19, P1864, DOI 10.1007/s10995-015-1700-7; Government of Karnataka, 2017, ETHN STUD MATHR YOJ; Hodgetts VA, 2015, BJOG-INT J OBSTET GY, V122, P478, DOI 10.1111/1471-0528.13202; IIPS. National Family Health Survey, 2007, NAT FAM HLTH SURV NF; King JC, 2016, J NUTR, V146, p1437S, DOI 10.3945/jn.115.223479; Kozuki N, 2015, J NUTR, V145, P2542, DOI 10.3945/jn.115.216374; Lassi ZS, 2014, REPROD HEALTH, V11, DOI 10.1186/1742-4755-11-S3-S6; MCDONALD EC, 1981, AM J CLIN NUTR, V34, P2133, DOI 10.1093/ajcn/34.10.2133; Ministry of Health and Family Welfare, 2015, HLTH FAM WELF STAT I; Ministry of Health and Family Welfare, 2014, NAT GUID DEW PREGN; Ministry of Health and Family Welfare, 2018, AN MUKT BHAR INT NAT; Ministry of Health and Family Welfare (MoHFW) Government of India, 2014, NAT GUID CALC SUPPL; Ministry of Home Affairs. Office of the Registrar General and Census Commissioner India, 2011, POP EN DAT 2011; Misra A, 2009, J Assoc Physicians India, V57, P163; NITI Aayog, 2018, TRANSF ASP DISTR BAS; Onis M. de, 2006, Acta Paediatrica, V95, P76; Pimple Y., 2016, INT J COMMUNITY MED, V3, P3291, DOI 10.18203/2394-6040.ijcmph20164250; Popkin BM, 2001, ASIA PAC J CLIN NUTR, V10, pS13, DOI 10.1046/j.1440-6047.2001.00211.x; Potdar RD, 2014, AM J CLIN NUTR, V100, P1257, DOI 10.3945/ajcn.114.084921; Rah JH, 2008, J NUTR, V138, P1505, DOI 10.1093/jn/138.8.1505; Ramakrishnan U, 2012, PAEDIATR PERINAT EP, V26, P285, DOI 10.1111/j.1365-3016.2012.01281.x; Rana MJ., 2017, INDIAN J HUMAN DEV, V11, P56, DOI [10.1177/0973703017712392, DOI 10.1177/0973703017712392]; Reshmi RS, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0210836; Rohatgi VK, 2001, WILEY SERIES PROBABI; Santhya KG, 2010, INT PERSPECT SEX R H, V36, P132, DOI 10.1363/ipsrh.36.132.10; Sethi V., 2019, FIELD EXCH, V59, P24; Shankar H, 2010, INDIAN J PREVENTIVE, V41, P192; Singla S., 2016, INT J RES MED SCI, V4, P5310; Stephenson J, 2018, LANCET, V391, P1830, DOI [10.1016/S0140-6736(18)30311-8, 10.1016/s0140-6736(18)30311-8]; UNICEF, 2018, STOP STUNT POW MAT N; World Health Organization (WHO), 2014, PREC CAR REG EXP GRO; World Health Organization (WHO), 1995, TECHNICAL REPORT SER, V854, P3; Young MF, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0203201	51	3	3	3	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2019	14	8							e0221125	10.1371/journal.pone.0221125	http://dx.doi.org/10.1371/journal.pone.0221125			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5WO	31454363	Green Published, gold, Green Submitted			2022-12-26	WOS:000485049000010
J	Kim, JG; Gwak, JH; Jung, MY; An, SU; Hyun, JH; Kang, S; Rhee, SK				Kim, Jong-Geol; Gwak, Joo-Han; Jung, Man-Young; An, Sung-Uk; Hyun, Jung-Ho; Kang, Sanghoon; Rhee, Sung-Keun			Distinct temporal dynamics of planktonic archaeal and bacterial assemblages in the bays of the Yellow Sea	PLOS ONE			English	Article							16S RIBOSOMAL-RNA; MICROBIAL COMMUNITY STRUCTURE; AMMONIA-OXIDIZING ARCHAEA; SPRING PHYTOPLANKTON BLOOM; GROUP-II; MARINE; OCEAN; SUCCESSION; STRATIFICATION; NITRIFICATION	The Yellow Sea features unique characteristics due to strong tides and nutrient-enriched freshwater outflows from China and Korea. The coupling of archaeal and bacterial assemblages associated with environmental factors at two bay areas in the Yellow Sea was investigated. Temporal variations of the archaeal and bacterial assemblages were shown to be greater than the spatial variations based on an analysis of the 16S rRNA gene sequences. Distinct temporal dynamics of both planktonic archaeal and bacterial assemblages was associated with temperature, NO2-, and chlorophyll a ([chl-a]) concentrations in the bays of the Yellow Sea. The [chl-a] was the prime predictor of bacterial abundance, and some taxa were clearly correlated with [chl-a]. Bacteroidetes and Alpha-proteobacteria dominated at high [chl-a] stations while Gamma-proteobacteria (esp. SAR86 clade) and Actinobacteria (Candidatus Actinomarina clade) were abundant at low [chl-a] stations. The archaeal abundance was comparable with the bacterial abundance in most of the October samples. Co-dominance of Marine Group II (MGII) and Candidatus Nitrosopumilus suggests that the assimilation of organic nitrogen by MGII could be coupled with nitrification by ammonia-oxidizing archaea. The distinct temporal dynamics of the archaeal and bacterial assemblages might be attributable to the strong tides and the inflow of nutrient-rich freshwater.	[Kim, Jong-Geol; Gwak, Joo-Han; Rhee, Sung-Keun] Chungbuk Natl Univ, Dept Microbiol, Cheongju, South Korea; [Jung, Man-Young] Univ Vienna, Div Microbial Ecol, Dept Microbiol & Ecosyst Sci, Althanstr, Vienna, Austria; [An, Sung-Uk; Hyun, Jung-Ho] Hanyang Univ, Dept Marine Sci & Convergent Technol, Hanyangdaehak Ro Ansan, Gyeonggi Do, South Korea; [Kang, Sanghoon] Eastern Illinois Univ, Dept Biol Sci, Charleston, IL 61920 USA	Chungbuk National University; University of Vienna; Hanyang University; Eastern Illinois University	Rhee, SK (corresponding author), Chungbuk Natl Univ, Dept Microbiol, Cheongju, South Korea.; Kang, S (corresponding author), Eastern Illinois Univ, Dept Biol Sci, Charleston, IL 61920 USA.	Sanghoon_Kang@baylor.edu; rhees@chungbuk.ac.kr	/GLN-3052-2022	/0000-0002-0464-4722; Kang, Sanghoon/0000-0002-3504-7955	Chungbuk National University; C1 Gas Refinery Program [NRF-2015M3D3A1A01064881]; National Research Foundation of Korea [2018K2A9A2A06021751N]; Ministry of Oceans and Fisheries; Young Researcher Supporting Program [NRF-2017R1C1B1011324]	Chungbuk National University; C1 Gas Refinery Program; National Research Foundation of Korea(National Research Foundation of Korea); Ministry of Oceans and Fisheries; Young Researcher Supporting Program	This work was supported by the Research Year of Chungbuk National University in 2019, C1 Gas Refinery Program (NRF-2015M3D3A1A01064881) and the framework of international cooperation program (2018K2A9A2A06021751N) managed by the National Research Foundation of Korea, and the project titled "Long-term change of structure and function in marine ecosystems of Korea," funded by the Ministry of Oceans and Fisheries. J.-G. K. was supported by the Young Researcher Supporting Program (NRF-2017R1C1B1011324). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allers E, 2007, ENVIRON MICROBIOL, V9, P2417, DOI 10.1111/j.1462-2920.2007.01360.x; Alonso-Saez L, 2008, ENVIRON MICROBIOL, V10, P2444, DOI 10.1111/j.1462-2920.2008.01674.x; Aronesty E., 2011, EA UTILS COMMAND LIN; Aronesty E., 2013, OPEN BIOINFORM J, V7, P1, DOI 10.2174/1875036201307010001; Bowman JS, 2012, ISME J, V6, P11, DOI 10.1038/ismej.2011.76; Brown MV, 2009, ISME J, V3, P1374, DOI 10.1038/ismej.2009.86; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chow CET, 2013, ISME J, V7, P2259, DOI 10.1038/ismej.2013.122; Collos Y, 1998, MAR ECOL PROG SER, V171, P293, DOI 10.3354/meps171293; Coyte KZ, 2015, SCIENCE, V350, P663, DOI 10.1126/science.aad2602; DELONG EF, 1992, P NATL ACAD SCI USA, V89, P5685, DOI 10.1073/pnas.89.12.5685; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Elliott JA, 2008, FRESHWATER BIOL, V53, P32, DOI 10.1111/j.1365-2427.2007.01865.x; Fenchel T., 1983, THE ECOLOGICAL ROLE, P257; Francis CA, 2005, P NATL ACAD SCI USA, V102, P14683, DOI 10.1073/pnas.0506625102; Fuhrman JA, 2009, NATURE, V459, P193, DOI 10.1038/nature08058; Galand PE, 2006, AQUAT MICROB ECOL, V44, P115, DOI 10.3354/ame044115; Galand PE, 2008, J MARINE SYST, V74, P774, DOI 10.1016/j.jmarsys.2007.12.001; Grossart HP, 2005, ENVIRON MICROBIOL, V7, P860, DOI 10.1111/j.1462-2920.2005.00759.x; Herndl GJ, 2005, APPL ENVIRON MICROB, V71, P2303, DOI 10.1128/AEM.71.5.2303-2309.2005; Hur H.B., 1999, J OCEANOGR, V55, P171, DOI [10.1023/A:1007885828278, DOI 10.1023/A:1007885828278]; Ingalls AE, 2006, P NATL ACAD SCI USA, V103, P6442, DOI 10.1073/pnas.0510157103; Iverson V, 2012, SCIENCE, V335, P587, DOI 10.1126/science.1212665; Kang I, 2013, P NATL ACAD SCI USA, V110, P12343, DOI 10.1073/pnas.1219930110; Karner MB, 2001, NATURE, V409, P507, DOI 10.1038/35054051; Kiang P, 2009, ASIAN AMER HIST CULT, P77; Kirchman DL, 2007, LIMNOL OCEANOGR, V52, P495, DOI 10.4319/lo.2007.52.2.0495; Kirchman DL, 2010, ENVIRON MICROBIOL, V12, P1132, DOI 10.1111/j.1462-2920.2010.02154.x; Klawonn I, 2015, ISME J, V9, P1456, DOI 10.1038/ismej.2014.232; Konneke M, 2005, NATURE, V437, P543, DOI 10.1038/nature03911; LANE DJ, 1985, P NATL ACAD SCI USA, V82, P6955, DOI 10.1073/pnas.82.20.6955; Larsen A, 2004, LIMNOL OCEANOGR, V49, P180, DOI 10.4319/lo.2004.49.1.0180; Lin C, 2005, J MARINE SYST, V55, P223, DOI 10.1016/j.jmarsys.2004.08.001; Liu HD, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01098; Liu M, 2013, DEEP-SEA RES PT II, V97, P85, DOI 10.1016/j.dsr2.2013.05.016; Liu Q, 2018, ISME J, V12, P1473, DOI 10.1038/s41396-018-0066-4; Marra G, 2011, COMPUT STAT DATA AN, V55, P2372, DOI 10.1016/j.csda.2011.02.004; Martens-Habbena W, 2009, NATURE, V461, P976, DOI 10.1038/nature08465; Martin-Cuadrado AB, 2015, ISME J, V9, P1619, DOI 10.1038/ismej.2014.249; Massana R, 2000, APPL ENVIRON MICROB, V66, P1777, DOI 10.1128/AEM.66.5.1777-1787.2000; Merbt SN, 2012, FEMS MICROBIOL LETT, V327, P41, DOI 10.1111/j.1574-6968.2011.02457.x; Milici M, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00649; Murray AE, 1999, AQUAT MICROB ECOL, V20, P129, DOI 10.3354/ame020129; Needham DM, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.5, 10.1038/nmicrobiol.2016.5]; Nelson JD, 2008, FEMS MICROBIOL ECOL, V65, P484, DOI 10.1111/j.1574-6941.2008.00553.x; O'Dwyer JP, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002832; Orsi WD, 2016, ISME J, V10, P2158, DOI 10.1038/ismej.2016.20; Park BJ, 2010, APPL ENVIRON MICROB, V76, P7575, DOI 10.1128/AEM.01478-10; Park SJ, 2008, EXTREMOPHILES, V12, P605, DOI 10.1007/s00792-008-0165-7; Parsons TR, 1984, 4 3 FLUOROMETRIC DET, P107; Pernthaler A, 2002, APPL ENVIRON MICROB, V68, P661, DOI 10.1128/AEM.68.2.661-667.2002; Qian PY, 2011, ISME J, V5, P507, DOI 10.1038/ismej.2010.112; Roesch LF, 2007, ISME J, V1, P283, DOI 10.1038/ismej.2007.53; Sapp M, 2007, MICROB ECOL, V53, P683, DOI 10.1007/s00248-006-9162-5; Sapp M, 2007, APPL ENVIRON MICROB, V73, P3117, DOI 10.1128/AEM.02274-06; Sison-Mangus MP, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01433; Strom SL, 2008, DEEP-SEA RES PT II, V55, P1761, DOI 10.1016/j.dsr2.2008.04.008; Sun DL, 2013, APPL ENVIRON MICROB, V79, P5962, DOI 10.1128/AEM.01282-13; SUZUKI Y, 1992, DEEP-SEA RES, V39, P185, DOI 10.1016/0198-0149(92)90104-2; Team RC, 2016, R LANG ENV STAT COMP; Teeling H, 2012, SCIENCE, V336, P608, DOI 10.1126/science.1218344; Treusch AH, 2009, ISME J, V3, P1148, DOI 10.1038/ismej.2009.60; Tsementzi D, 2016, NATURE, V536, P179, DOI 10.1038/nature19068; Turner BL, 2002, ANN ASSOC AM GEOGR, V92, P52, DOI 10.1111/1467-8306.00279; Walker CB, 2010, P NATL ACAD SCI USA, V107, P8818, DOI 10.1073/pnas.0913533107; Wuchter C, 2006, P NATL ACAD SCI USA, V103, P12317, DOI 10.1073/pnas.0600756103; Xie W, 2018, ENVIRON MICROBIOL, V20, P734, DOI 10.1111/1462-2920.14004; Yin Q, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055148	69	9	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2019	14	8							e0221408	10.1371/journal.pone.0221408	http://dx.doi.org/10.1371/journal.pone.0221408			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5UR	31449563	Green Published, Green Submitted, gold			2022-12-26	WOS:000485044000016
J	Soroko, M; Zaborski, D; Dudek, K; Yarnell, K; Gorniak, W; Vardasca, R				Soroko, Maria; Zaborski, Daniel; Dudek, Krzysztof; Yarnell, Kelly; Gorniak, Wanda; Vardasca, Ricardo			Evaluation of thermal pattern distributions in racehorse saddles using infrared thermography	PLOS ONE			English	Article							SENSING ARRAY TECHNOLOGY; PRESSURE DISTRIBUTION; HINDLIMB LAMENESS; HORSE; RIDER; BACK; SYMMETRY; VALIDITY; FIT	The impact of a rider's and saddle's mass on saddle thermal pattern distribution was evaluated using infrared thermography (IRT). Eighteen racehorses were ridden by four riders with their own saddle. Images of the saddle panels were captured at each of six thermographic examinations. On each image, six regions of interest (ROIs) were marked on the saddle panels. The mean temperature for each ROI was extracted. To evaluate the influence of load on saddle fit, 4 indicators were used: Delta T-max (difference between the mean temperature of the warmest and coolest ROI); standard deviation of the mean temperature of the six ROIs; right/left; bridging/rocking and front/back thermal pattern indicator. Incorrect saddle fit was found in 25 measurements (23.1%) with Delta T-max greater than 2 degrees C. The relationships between rider and saddle fit as well as saddle fit and horse were significant (p<0.001). An average Delta T-max in rider A was significantly higher than in other riders (p<0.001). The right/left thermal pattern differed significantly from the optimal value for riders A and B; while the bridging/rocking thermal pattern differed significantly from this value for riders A, C and D (p<0.05). Front saddle thermal pattern was most frequent for rider A (41.5%), whereas back saddle thermal pattern was most frequent for rider C (85.7%). Measurement of the mean temperature in 6 ROIs on saddle panels after training was helpful in assessing the influence of rider and saddle mass on saddle fit. IRT offered a non-invasive, rapid and simple method for assessing load on thermal pattern distribution in race saddles.	[Soroko, Maria] Wroclaw Univ Environm & Life Sci, Inst Anim Breeding, Dept Horse Breeding & Equestrian Studies, Wroclaw, Poland; [Zaborski, Daniel] West Pomeranian Univ Technol, Dept Ruminants Sci, Szczecin, Poland; [Dudek, Krzysztof] Wroclaw Univ Technol, Fac Mech Engn, Wroclaw, Poland; [Yarnell, Kelly] Nottingham Trent Univ, Sch Anim Rural & Environm Sci, Southwell, Notts, England; [Gorniak, Wanda] Wroclaw Univ Environm & Life Sci, Dept Environm Hyg & Anim Welf, Wroclaw, Poland; [Vardasca, Ricardo] Univ Porto, Fac Engn, INEGI LAETA, Porto, Portugal	Wroclaw University of Environmental & Life Sciences; West Pomeranian University of Technology; Wroclaw University of Science & Technology; Nottingham Trent University; Wroclaw University of Environmental & Life Sciences; Universidade do Porto	Soroko, M (corresponding author), Wroclaw Univ Environm & Life Sci, Inst Anim Breeding, Dept Horse Breeding & Equestrian Studies, Wroclaw, Poland.	kontakt@eqma.pl	Vardasca, Ricardo/J-4948-2013; Górniak, Wanda/ABB-8904-2021; Soroko-Dubrovina, Maria/AEA-3348-2022	Vardasca, Ricardo/0000-0003-4217-2882; Górniak, Wanda/0000-0003-0151-6642; Soroko-Dubrovina, Maria/0000-0002-8585-8000; Zaborski, Daniel/0000-0003-3590-3229; Yarnell, Kelly/0000-0001-7464-8764				Arruda TZ, 2011, J EQUINE VET SCI, V31, P625, DOI 10.1016/j.jevs.2011.05.011; Belock B, 2012, VET J, V193, P87, DOI 10.1016/j.tvjl.2011.11.017; Bowers J R, 1999, Equine Vet J Suppl, P52; de Cocq P, 2006, VET J, V172, P265, DOI 10.1016/j.tvjl.2005.05.009; De Cocq P, 2004, EQUINE VET J, V36, P758, DOI 10.2746/0425164044848000; de Cocq P, 2009, VET J, V181, P266, DOI 10.1016/j.tvjl.2008.03.002; De La Corte FD, 2003, P 8 C WORLD EQ VET A, P230; Dyson S., 2012, P AM ASS EQ PRACT FO, P2; Fruehwirth B, 2004, EQUINE VET J, V36, P754, DOI 10.2746/0425164044848235; Greve L, 2015, EQUINE VET J, V47, P415, DOI 10.1111/evj.12304; Greve L, 2014, EQUINE VET J, V46, P687, DOI 10.1111/evj.12222; Greve L, 2013, EQUINE VET J, V45, P570, DOI 10.1111/evj.12029; Harman J, 1999, VET CLIN N AM-EQUINE, V15, P247; HARMAN JC, 1994, J EQUINE VET SCI, V14, P606, DOI 10.1016/S0737-0806(06)81667-9; Harman JC, 1997, PFERDEHEILKUNDE, V13, P129; Jeffcoat LB, 1999, VET J, V158, P113, DOI 10.1053/tvjl.1998.0334; JetTcott LB, 2005, EQUINE MED SURG, P433; Kotschwar AB, 2010, VET J, V184, P322, DOI 10.1016/j.tvjl.2009.02.018; Lagarde J, 2005, J MOTOR BEHAV, V37, P418, DOI 10.3200/JMBR.37.6.418-424; Martin BB, 1999, VET CLIN N AM-EQUINE, V15, P61; Meschan EM, 2007, VET J, V173, P578, DOI 10.1016/j.tvjl.2006.02.005; MEYNERS E, 2004, EFFECTIVE TEACHING R; Monkemoller S, 2005, PFERDEHEILKUNDE, V21, P102; Nyikos S, 2005, PFERDEHEILKUNDE, V21, P187, DOI 10.21836/PEM20050301; Peham C, 2004, HUM MOVEMENT SCI, V23, P663, DOI 10.1016/j.humov.2004.10.006; Peham C, 2010, VET J, V184, P56, DOI 10.1016/j.tvjl.2009.04.007; Peham C, 2001, VET REC, V148, P750, DOI 10.1136/vr.148.24.750; Pullin JG, 1996, J EQUINE VET SCI, V16, P207, DOI 10.1016/S0737-0806(96)80114-6; Robartes H, 2013, VET J, V198, pE52, DOI 10.1016/j.tvjl.2013.09.033; Roepstorff L, 2009, EQUINE VET J, V41, P292, DOI 10.2746/042516409X397127; Shimazaki Y, 2015, APPL ERGON, V49, P55, DOI 10.1016/j.apergo.2015.01.007; Sloet M.M., 1995, EQUINE VET J, P413; Soroko M, 2018, J EQUINE VET SCI, V63, P30, DOI 10.1016/j.jevs.2018.01.006; Soroko M, 2013, J EQUINE VET SCI, V33, P760, DOI 10.1016/j.jevs.2012.11.009; Stashak TS, 2002, ADAMSLAMENESS HORSES, P113; Symes D, 2009, VET J, V181, P34, DOI 10.1016/j.tvjl.2009.03.016; Turner T. A., 2004, Proceedings of the 50th Annual Convention of the American Association of Equine Practitioners, Denver, Colorado, USA, 4-8 December, 2004, P196; TURNER TA, 1991, VET CLIN N AM-EQUINE, V7, P311, DOI 10.1016/S0749-0739(17)30502-3; Yavuz M, 2014, J BIOMECH, V47, P3767, DOI 10.1016/j.jbiomech.2014.09.028; Zimmerman M, 2012, EQUINE VET J, V44, P178, DOI 10.1111/j.2042-3306.2011.00373.x	40	6	6	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2019	14	8							e0221622	10.1371/journal.pone.0221622	http://dx.doi.org/10.1371/journal.pone.0221622			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5UR	31449556	Green Published, Green Submitted, Green Accepted, gold			2022-12-26	WOS:000485044000028
J	Mell, B; Cheng, X; Joe, B				Mell, Blair; Cheng, Xi; Joe, Bina			QTL mapping of rat blood pressure loci on RNO1 within a homologous region linked to human hypertension on HSA15	PLOS ONE			English	Article							SALT-SENSITIVE HYPERTENSION; QUANTITATIVE TRAIT LOCUS; CHROMATIN; MUTATION; GENE	Fine-mapping of regions linked to the inheritance of hypertension is accomplished by genetic dissection of blood pressure quantitative trait loci (BP QTLs) in rats. The goal of the current study was to further fine-map two genomic regions on rat chromosome 1 with opposing blood pressure effects (BP QTL1b1 and BP QTL1b1a), the homologous region of which on human chromosome 15 harbors BP QTLs. Two new substrains were constructed and studied from the previously reported BP QTL1b1, one having significantly lower systolic BP by 17 mmHg than that of the salt-sensitive (S) rat (P = 0.007). The new limits of BP QTL1b1 were between 134.09 Mb and 135.40 Mb with a 43% improvement from the previous 2.31 Mb to the current 1.31 Mb interval containing 4 protein-coding genes (Rgma, Chd2, Fam174b, and St8sia2), 2 predicted miRNAs, and 4 lncRNAs. One new substrain was constructed and studied from the previously reported BPQTL1b1a having a significantly higher systolic BP by 22 mmHg (P = 0.006) than that of the S rat. The new limits of BPQTL1b1a were between 133.53 Mb and 134.52 Mb with a 32% improvement from the previous1.45 Mb to the current 990.21 Kb interval containing 1 protein-coding gene, Mctp2, and a lncRNA. The congenic segments of these two BP QTLs overlapped between 134.09 Mb and 134.52 Mb. No exonic variants were detected in any of the genes. These findings reiterate complexity of genetic regulation of BP within QTL regions, where elements beyond protein-coding sequences could be factors in controlling BP.	[Mell, Blair; Cheng, Xi; Joe, Bina] Univ Toledo, Dept Physiol & Pharmacol, Coll Med & Life Sci, Program Physiol Genom,Ctr Hypertens & Precis Med, 2801 W Bancroft St, Toledo, OH 43606 USA	University System of Ohio; University of Toledo	Joe, B (corresponding author), Univ Toledo, Dept Physiol & Pharmacol, Coll Med & Life Sci, Program Physiol Genom,Ctr Hypertens & Precis Med, 2801 W Bancroft St, Toledo, OH 43606 USA.	bina.joe@utoledo.edu	Cheng, Xi/AAV-6176-2020	Cheng, Xi/0000-0002-0838-5094	University of Toledo; National Heart Lung and Blood Institute of the National Institutes of Health [HL020176]	University of Toledo; National Heart Lung and Blood Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported from the University of Toledo and funding from the National Heart Lung and Blood Institute of the National Institutes of Health (HL020176) to BJ. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brandt MM, 2018, J AM SOC NEPHROL, V29, P462, DOI 10.1681/ASN.2016080875; Chang YC, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000005174; Chen H, 2018, NAT GENET; Cheng X, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006961; Cowley AW, 2016, PHYSIOL GENOMICS, V48, P62, DOI 10.1152/physiolgenomics.00097.2015; Cowley AW, 2014, PHYSIOL GENOMICS, V46, P398, DOI 10.1152/physiolgenomics.00179.2013; Deng AY, 2018, HYPERTENSION, V72, P755, DOI 10.1161/HYPERTENSIONAHA.118.11385; Deng AY, 2015, J HYPERTENS, V33, P669, DOI 10.1097/HJH.0000000000000479; Endres BT, 2014, P NATL ACAD SCI USA, V111, P12817, DOI 10.1073/pnas.1410745111; Garrett MR, 1998, GENOME RES, V8, P711, DOI 10.1101/gr.8.7.711; Gopalakrishnan Kathirvel, 2012, Frontiers in Genetics, V3, P138, DOI 10.3389/fgene.2012.00138; Gopalakrishnan K, 2011, HYPERTENSION, V57, P764, DOI 10.1161/HYPERTENSIONAHA.110.165803; Haitjema S, 2017, CIRC CARDIOVASC GENE, V10; Joe B, 2005, PHYSIOL GENOMICS, V23, P318, DOI 10.1152/physiolgenomics.00164.2004; Joe B, 2003, J HYPERTENS, V21, P2077, DOI 10.1097/00004872-200311000-00017; Johnson AC, 2013, MAMM GENOME, V24, P95, DOI 10.1007/s00335-013-9447-1; Kotchen TA, 2016, JAMA-J AM MED ASSOC, V315, P343, DOI 10.1001/jama.2015.18359; Kraja AT, 2005, OBES RES, V13, P1885, DOI 10.1038/oby.2005.231; Levine M, 2010, CURR BIOL, V20, pR754, DOI 10.1016/j.cub.2010.06.070; Mell B, 2015, HYPERTENS RES, V38, P61, DOI 10.1038/hr.2014.134; Montasser ME, 2009, J HYPERTENS, V27, P491, DOI 10.1097/HJH.0b013e32831ef54f; Padmanabhan S, 2017, PHYSIOL REV, V97, P1469, DOI 10.1152/physrev.00035.2016; Saad Y, 2001, PHYSIOL GENOMICS, V4, P201, DOI 10.1152/physiolgenomics.2001.4.3.201; Saad Y, 2007, HYPERTENSION, V50, P891, DOI 10.1161/HYPERTENSIONAHA.107.097105; Semba Y, 2017, NUCLEIC ACIDS RES, V45, P8758, DOI 10.1093/nar/gkx475; Shimoyama Mary, 2011, Human Genomics, V5, P124; Stoll M, 2000, GENOME RES, V10, P473, DOI 10.1101/gr.10.4.473; Stoll M, 2001, Curr Hypertens Rep, V3, P157, DOI 10.1007/s11906-001-0031-9; Toland EJ, 2008, MAMM GENOME, V19, P209, DOI 10.1007/s00335-008-9093-1; Weder AB, 2003, HYPERTENSION, V41, P842, DOI 10.1161/01.HYP.0000048703.16933.6D	30	4	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2019	14	8							e0221658	10.1371/journal.pone.0221658	http://dx.doi.org/10.1371/journal.pone.0221658			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5TR	31442284	gold, Green Published, Green Submitted			2022-12-26	WOS:000485041400063
J	Sakashita, T; Sato, T; Hamada, N				Sakashita, Tetsuya; Sato, Tatsuhiko; Hamada, Nobuyuki			A biologically based mathematical model for spontaneous and ionizing radiation cataractogenesis	PLOS ONE			English	Article							PARTIALLY SHIELDED LENS; AGE-RELATED CATARACT; AMINO-ACID; EXPOSURE; LIGHT; RISK; OPACITIES; OXIDATION; GROWTH; CELLS	Cataracts have long been known, but a biomathematical model is still unavailable for cataratogenesis. There has been a renewed interest in ionizing radiation cataracts because the recent international recommendation of the reduced lens dose limit stimulated the discussion toward its regulatory implementation in various countries. Nevertheless, a relationship between radiation (dose and dose rate) and response (e.g., incidence, onset and progression) remains incompletely understood, raising the need for a risk-predictive mathematical model. We here report for the first time an in silico model for cataractogenesis. First, a simplified cell proliferation model was developed for human lens growth based on stem and progenitor cell proliferation as well as epithelial-fiber cell differentiation. Then, a model for spontaneous cataractogenesis was developed to reproduce the human data on a relationship between age and cataract incidence. Finally, a model for radiation cataractogenesis was developed that can reproduce the human data on a relationship between dose and cataract onset at various ages, which was further applied to estimate cataract incidence following chronic lifetime exposure. The model can serve as the foundation for further development of the risk-predictive model for cataractogenesis along with additional considerations of various biological mechanisms and epidemiological datasets.	[Sakashita, Tetsuya] Natl Inst Quantum & Radiol Sci & Technol QST, Quantum Beam Sci Res Directorate, Dept Radiat Appl Biol Res, Takasaki, Gunma, Japan; [Sato, Tatsuhiko] JAEA, Nucl Sci & Engn Ctr, Res Grp Radiat Transport Anal, Tokai, Ibaraki, Japan; [Hamada, Nobuyuki] CRIEPI, Nucl Technol Res Lab, Radiat Safety Res Ctr, Tokyo, Japan	National Institutes for Quantum Science & Technology; Japan Atomic Energy Agency; Central Research Institute of Electric Power Industry - Japan	Hamada, N (corresponding author), CRIEPI, Nucl Technol Res Lab, Radiat Safety Res Ctr, Tokyo, Japan.	hamada-n@criepi.denken.or.jp		Sato, Tatsuhiko/0000-0001-9902-7083; Hamada, Nobuyuki/0000-0003-2518-6131				ABELSON PH, 1949, SCIENCE, V110, P655, DOI 10.1126/science.110.2868.655; Ainsbury EA, 2009, RADIAT RES, V172, P1, DOI 10.1667/RR1688.1; Ainsbury EA, 2016, MUTAT RES-REV MUTAT, V770, P238, DOI 10.1016/j.mrrev.2016.07.010; ALTER AJ, 1953, AMA ARCH OPHTHALMOL, V49, P257, DOI 10.1001/archopht.1953.00920020264002; [Anonymous], 1955, J Radiol Electrol Arch Electr Medicale, V36, P1; Augusteyn RC, 2007, MOL VIS, V13, P252; Augusteyn RC, 2010, EXP EYE RES, V90, P643, DOI 10.1016/j.exer.2010.01.013; Azizova TV, 2019, RADIAT ENVIRON BIOPH, V58, P139, DOI 10.1007/s00411-019-00787-0; Azizova TV, 2018, EUR J EPIDEMIOL, V33, P1193, DOI 10.1007/s10654-018-0450-4; Azizova TV, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164357; Bahia S, 2018, INT J RADIAT BIOL, V94, P366, DOI 10.1080/09553002.2018.1439194; Chalupecky H, 1897, ZENTRALBL PRAKT AUGE, V21, P234; Chen Y, 2009, OCUL SURF, V7, P176, DOI 10.1016/S1542-0124(12)70185-4; Clayton E, 2007, NATURE, V446, P185, DOI 10.1038/nature05574; COGAN DG, 1949, SCIENCE, V110, P654, DOI 10.1126/science.110.2868.654; COX DR, 1972, J R STAT SOC B, V34, P187; CRUICKSHANKS KJ, 1992, AM J PUBLIC HEALTH, V82, P1658, DOI 10.2105/AJPH.82.12.1658; Dauer LT, 2018, EUR J EPIDEMIOL, V33, P1135, DOI 10.1007/s10654-018-0458-9; Finley EL, 1998, PHOTOCHEM PHOTOBIOL, V68, P9, DOI 10.1562/0031-8655(1998)068<0009:RIOOBC>2.3.CO;2; FRANCOIS J, 1959, Bull Mem Soc Fr Ophtalmol, V72, P297; Frank SA, 2003, GENETICS, V163, P1527; FUJII N, 1986, J RADIAT RES, V27, P183, DOI 10.1269/jrr.27.183; Fujimichi Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098154; Goldmann H, 1938, A VONGRAEFES ARCH OP, V138, P722; Hamada N, 2017, INT J RADIAT BIOL, V93, P1024, DOI 10.1080/09553002.2016.1266407; Hamada N, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181530; Hamada N, 2016, MUTAT RES-REV MUTAT, V770, P262, DOI 10.1016/j.mrrev.2016.08.005; Hamada N, 2015, CANCER LETT, V368, P262, DOI 10.1016/j.canlet.2015.02.017; Hamada N, 2014, J RADIAT RES, V55, P831, DOI 10.1093/jrr/rru036; Hamada N, 2014, J RADIAT RES, V55, P629, DOI 10.1093/jrr/rru019; Harocopos GJ, 1998, INVEST OPHTH VIS SCI, V39, P2696; Hodge WG, 1995, EPIDEMIOL REV, V17, P336, DOI 10.1093/oxfordjournals.epirev.a036197; ICRP, 2015, ICRP PUBL, V44; ICRP, 2007, ICRP PUBL, V103, DOI 10.1016/j.icrp.2007.10.003; ICRP, 2017, ICRP INT COMM RAD PR, V118; ICRP (International Commission on Radiological Protection), 2007, ANN ICRP, V37; International Commission on Radiological Protection, 2015, ICRP PUBL, V131; Kim I, 2015, BIOCHEM BIOPH RES CO, V466, P622, DOI 10.1016/j.bbrc.2015.09.075; KLEIN BEK, 1993, AM J PREV MED, V9, P27, DOI 10.1016/S0749-3797(18)30763-3; Klein BEK, 1998, ARCH OPHTHALMOL-CHIC, V116, P219, DOI 10.1001/archopht.116.2.219; KUSZAK JR, 1994, PRINCIPLES PRACTICE, P82; LEINFELDER PJ, 1956, ARCH OPHTHALMOL-CHIC, V55, P84; Linetsky M, 2014, J BIOL CHEM, V289, P17111, DOI 10.1074/jbc.M114.554410; Little MP, 2013, RADIAT ENVIRON BIOPH, V52, P435, DOI 10.1007/s00411-013-0484-7; Markiewicz E, 2015, OPEN BIOL, V5, DOI 10.1098/rsob.150011; MERRIAM GR, 1957, AMER J ROENTGENOL RA, V77, P759; Nakashima E, 2006, HEALTH PHYS, V90, P154, DOI 10.1097/01.HP.0000175442.03596.63; Nakashima E, 2013, HEALTH PHYS, V105, P253, DOI 10.1097/HP.0b013e3182932e4c; NCRP, 2016, NCRP COMM, V26; NCRP, 2018, NCRP COMM, V27; Neriishi K, 2012, RADIOLOGY, V265, P167, DOI 10.1148/radiol.12111947; Oduntan OA., 2011, S AFR OPTOM, V70, P191, DOI 10.4102/aveh.v70i4.116; Oka M, 2010, MOL VIS, V16, P945; Pascolini D, 2012, BRIT J OPHTHALMOL, V96, P614, DOI 10.1136/bjophthalmol-2011-300539; PIRIE A, 1957, ARCH OPHTHALMOL-CHIC, V57, P849; Rollins W, 1903, BOSTON MED SURG J, V148, P0364, DOI 10.1056/NEJM190304021481404; Ruhm W, 2017, INT J RADIAT BIOL, V93, P1093, DOI 10.1080/09553002.2017.1310405; Shore RE, 2016, MUTAT RES-REV MUTAT, V770, P231, DOI 10.1016/j.mrrev.2016.06.006; Sklar E, 2007, ARTIF LIFE, V13, P303, DOI 10.1162/artl.2007.13.3.303; SLINEY DH, 1987, J CATARACT REFR SURG, V13, P296, DOI 10.1016/S0886-3350(87)80074-3; Stewart F. A., 2012, Annals of the ICRP, V41, P37, DOI 10.1016/j.icrp.2012.02.001; Taylor VL, 1996, INVEST OPHTH VIS SCI, V37, P1396; Uwineza A, 2019, MUTAT RES-REV MUTAT, V779, P68, DOI 10.1016/j.mrrev.2019.02.004; Woraul BV, 2007, RADIAT RES, V167, P233, DOI 10.1667/RR0298.1; Wu JJ, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2015.0391	65	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2019	14	8							e0221579	10.1371/journal.pone.0221579	http://dx.doi.org/10.1371/journal.pone.0221579			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5TR	31442279	Green Published, Green Submitted, gold			2022-12-26	WOS:000485041400055
J	Yemshanov, D; Haight, RG; Chen, CC; Liu, N; MacQuarrie, CJK; Koch, FH; Venette, R; Ryall, K				Yemshanov, Denys; Haight, Robert G.; Chen, Cuicui; Liu, Ning; MacQuarrie, Christian J. K.; Koch, Frank H.; Venette, Robert; Ryall, Krista			Managing biological invasions in urban environments with the acceptance sampling approach	PLOS ONE			English	Article							EMERALD ASH BORER; COLEOPTERA BUPRESTIDAE; RISK ANALYSIS; HOST TREES; SURVEILLANCE; STRATEGIES; FOREST; COST; PREVENTION; INSPECTION	Detections of invasive species outbreaks are often followed by the removal of susceptible host organisms in order to slow the spread of the invading pest population. We propose the acceptance sampling approach for detection and optional removal of susceptible host trees to manage an outbreak of the emerald ash borer (EAB), a highly destructive forest pest, in Winnipeg, Canada. We compare the strategy with two common delimiting survey techniques that do not consider follow-up management actions such as host removal. Our results show that the management objective influences the survey strategy. The survey-only strategies maximized the capacity to detect new infestations and prioritized sites with high likelihood of being invaded. Comparatively, the surveys with subsequent host removal actions allocated most of the budget to sites where complete host removal would minimize the pest's ability to spread to uninvaded locations. Uncertainty about the pest's spread causes the host removal measures to cover a larger area in a uniform spatial pattern and extend to farther distances from already infested sites. If a decision maker is ambiguity-averse and strives to avoid the worst-case damages from the invasion, the optimal strategy is to survey more sites with high host densities and remove trees from sites at farther distances, where EAB arrivals may be uncertain, but could cause significant damage if not detected quickly. Accounting for the uncertainty about spread helps develop a more robust pest management strategy. The approach is generalizable and can support management programs for new pest incursions.	[Yemshanov, Denys; Liu, Ning; MacQuarrie, Christian J. K.; Ryall, Krista] Canadian Forest Serv, Nat Resources Canada, Great Lakes Forestry Ctr, Sault Ste Marie, ON, Canada; [Haight, Robert G.] US Forest Serv, USDA, Northern Res Stn, St Paul, MN USA; [Chen, Cuicui] SUNY Albany, Albany, NY 12222 USA; [Koch, Frank H.] US Forest Serv, USDA, Southern Res Stn, Eastern Forest Environm Threat Assessment Ctr, Res Triangle Pk, NC USA; [Venette, Robert] US Forest Serv, USDA, Northern Res Stn, St Paul, MN USA	Natural Resources Canada; Canadian Forest Service; Great Lakes Forestry Centre; United States Department of Agriculture (USDA); United States Forest Service; State University of New York (SUNY) System; State University of New York (SUNY) Albany; United States Department of Agriculture (USDA); United States Forest Service; United States Department of Agriculture (USDA); United States Forest Service	Yemshanov, D (corresponding author), Canadian Forest Serv, Nat Resources Canada, Great Lakes Forestry Ctr, Sault Ste Marie, ON, Canada.	Denys.Yemshanov@canada.ca	MacQuarrie, Chris/A-3640-2009	MacQuarrie, Chris/0000-0001-8760-746X; Yemshanov, Denys/0000-0002-6992-9614; Koch, Frank/0000-0002-3750-4507	Interdepartmental Canadian Forest Service Canadian Food Inspection Agency Forest Invasive Alien Species Initiative	Interdepartmental Canadian Forest Service Canadian Food Inspection Agency Forest Invasive Alien Species Initiative	This work has been funded by Interdepartmental Canadian Forest Service Canadian Food Inspection Agency Forest Invasive Alien Species Initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acerbi C., 2002, EC NOTES BANCA MONTE, V31, P379, DOI DOI 10.1111/1468-0300.00091; Baker R. H. A., 2009, Bulletin OEPP, V39, P87, DOI 10.1111/j.1365-2338.2009.02246.x; Buyuktahtakin IE, 2018, ANN OPER RES, V271, P357, DOI 10.1007/s10479-017-2670-5; Chen CC, 2018, RISK ANAL, V38, P603, DOI 10.1111/risa.12880; Christensen J, 2000, PREV VET MED, V45, P83, DOI 10.1016/S0167-5877(00)00118-5; Epanchin-Niell RS, 2015, ECOL ECON, V116, P146, DOI 10.1016/j.ecolecon.2015.04.014; Epanchin-Niell RS, 2014, ECOL APPL, V24, P1258, DOI 10.1890/13-1331.1; Epanchin-Niell RS, 2012, ECOL LETT, V15, P803, DOI 10.1111/j.1461-0248.2012.01800.x; Fahrner SJ, 2017, URBAN FOR URBAN GREE, V24, P184, DOI 10.1016/j.ufug.2017.03.017; Finnoff D, 2007, ECOL ECON, V62, P216, DOI 10.1016/j.ecolecon.2006.03.025; GAMS, 2018, GEN ALG MOD SYST GAM; GILBOA I, 1989, J MATH ECON, V18, P141, DOI 10.1016/0304-4068(89)90018-9; Haack R.A., 2002, NEWSLETTER MICHIGAN, V47, P1; Hauser CE, 2009, ECOL LETT, V12, P683, DOI 10.1111/j.1461-0248.2009.01323.x; Herms DA, 2014, ANNU REV ENTOMOL, V59, P13, DOI 10.1146/annurev-ento-011613-162051; Hester S, 2012, HUM ECOL RISK ASSESS, V18, P181, DOI 10.1080/10807039.2012.632307; Homans F, 2011, ECOL ECON, V70, P1129, DOI 10.1016/j.ecolecon.2011.01.004; Hopkin A., 2004, FOREST HLTH BIODIVER; Horie T, 2013, ECOL ECON, V86, P78, DOI 10.1016/j.ecolecon.2012.09.017; Inui K, 2005, J BANK FINANC, V29, P853, DOI 10.1016/j.jbankfin.2004.08.005; Jorion P, 2006, VALUE RISK NEW BENCH; Kobilinsky A, 2005, CHEMOMETR INTELL LAB, V75, P189, DOI 10.1016/j.chemolab.2004.07.005; Koch FH, 2018, FOREST ECOL MANAG, V417, P222, DOI 10.1016/j.foreco.2018.03.004; Kovacs KF, 2014, RESOUR ENERGY ECON, V36, P270, DOI 10.1016/j.reseneeco.2013.04.008; Kovacs KF, 2010, ECOL ECON, V69, P569, DOI 10.1016/j.ecolecon.2009.09.004; Leung B, 2002, P ROY SOC B-BIOL SCI, V269, P2407, DOI 10.1098/rspb.2002.2179; Lodge DM, 2006, ECOL APPL, V16, P2035, DOI 10.1890/1051-0761(2006)016[2035:BIRFUP]2.0.CO;2; McCullough DG, 2012, INT J PEST MANAGE, V58, P9, DOI 10.1080/09670874.2011.637138; McKenney Daniel W., 2012, Arboriculture & Urban Forestry, V38, P81; Mehta SV, 2007, ECOL ECON, V61, P237, DOI 10.1016/j.ecolecon.2006.10.024; Minnesota Department of Agriculture (MDA), 2018, GUID SLOW GROWTH SPR; Moore AL, 2016, METHODS ECOL EVOL, V7, P891, DOI 10.1111/2041-210X.12564; Orlova-Bienkowskaja MJ, 2018, ECOL EVOL, V8, P9295, DOI 10.1002/ece3.4437; Osthus J., 2017, TRACKING EAB INFESTA; Poland TM, 2006, J FOREST, V104, P118; Powell MR, 2014, RISK ANAL, V34, P93, DOI 10.1111/risa.12054; Rockafellar R. T., 2000, J RISK, V2, P21, DOI 10.21314/JOR.2000.038; Rockafellar RT, 2002, J BANK FINANC, V26, P1443, DOI 10.1016/S0378-4266(02)00271-6; Rout TM, 2014, J APPL ECOL, V51, P804, DOI 10.1111/1365-2664.12234; Ryall K, 2015, CAN ENTOMOL, V147, P290, DOI 10.4039/tce.2015.7; Ryall KL, 2013, ENTOMOL EXP APPL, V147, P126, DOI 10.1111/eea.12052; Ryall KL, 2011, ENVIRON ENTOMOL, V40, P679, DOI 10.1603/EN10310; Schilling EG., 2009, ACCEPTANCE SAMPLING, V2nd ed, DOI DOI 10.1201/9781584889533; Sims C, 2013, RESOUR ENERGY ECON, V35, P235, DOI 10.1016/j.reseneeco.2013.02.001; Springborn MR, 2014, J ENVIRON ECON MANAG, V68, P226, DOI 10.1016/j.jeem.2014.05.004; Starbird SA, 2005, AM J AGR ECON, V87, P15, DOI 10.1111/j.0002-9092.2005.00698.x; Studer G., 1997, THESIS; TreeKeeper software, 2018, MUN TREE INV DAT MUN; Turgeon JJ, 2015, CAN ENTOMOL, V148, P361; Venette RC, 2002, ANNU REV ENTOMOL, V47, P143, DOI 10.1146/annurev.ento.47.091201.145147; WETHERILL GB, 1975, INT STAT REV, V43, P191, DOI 10.2307/1402898; Whiting RC, 2006, INT J FOOD MICROBIOL, V110, P263, DOI 10.1016/j.ijfoodmicro.2006.04.038; Yamamura K, 2016, POPUL ECOL, V58, P63, DOI 10.1007/s10144-015-0521-2; Yemshanov D, 2020, FORESTRY, V93, P280, DOI 10.1093/forestry/cpz028; Yemshanov D, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181482; Yemshanov D, 2017, ECOL ECON, V133, P86, DOI 10.1016/j.ecolecon.2016.11.018; Yemshanov D, 2015, DIVERS DISTRIB, V21, P1349, DOI 10.1111/ddi.12358	57	4	4	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2019	14	8							e0220687	10.1371/journal.pone.0220687	http://dx.doi.org/10.1371/journal.pone.0220687			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW5TR	31442239	Green Published, Green Submitted, gold			2022-12-26	WOS:000485041400013
J	Zhuang, ZM; Li, N; Raj, ANJ; Mahesh, VGV; Qiu, SM				Zhuang, Zhemin; Li, Nan; Raj, Alex Noel Joseph; Mahesh, Vijayalakshmi G. V.; Qiu, Shunmin			An RDAU-NET model for lesion segmentation in breast ultrasound images	PLOS ONE			English	Article							CANCER STATISTICS; PULMONARY NODULES; U-NET; NETWORKS	Breast cancer is a common gynecological disease that poses a great threat to women health due to its high malignant rate. Breast cancer screening tests are used to find any warning signs or symptoms for early detection and currently, Ultrasound screening is the preferred method for breast cancer diagnosis. The localization and segmentation of the lesions in breast ultrasound (BUS) images are helpful for clinical diagnosis of the disease. In this paper, an RDAU-NET (Residual-Dilated-Attention-Gate-UNet) model is proposed and employed to segment the tumors in BUS images. The model is based on the conventional U-Net, but the plain neural units are replaced with residual units to enhance the edge information and overcome the network performance degradation problem associated with deep networks. To increase the receptive field and acquire more characteristic information, dilated convolutions were used to process the feature maps obtained from the encoder stages. The traditional cropping and copying between the encoder-decoder pipelines were replaced by the Attention Gate modules which enhanced the learning capabilities through suppression of background information. The model, when tested with BUS images with benign and malignant tumor presented excellent segmentation results as compared to other Deep Networks. A variety of quantitative indicators including Accuracy, Dice coefficient, AUC(Area-Under-Curve), Precision, Sensitivity, Specificity, Recall, F1score and M-IOU (Mean-Intersection-Over-Union) provided performances above 80%. The experimental results illustrate that the proposed RDAU-NET model can accurately segment breast lesions when compared to other deep learning models and thus has a good prospect for clinical diagnosis.	[Zhuang, Zhemin; Li, Nan; Raj, Alex Noel Joseph] Shantou Univ, Dept Elect Engn, Key Lab Digital Signal & Image Proc Guangdong Pro, Shantou, Guangdong, Peoples R China; [Mahesh, Vijayalakshmi G. V.] BMS Inst Technol & Management, Dept Elect & Commun Engn, Bengaluru, Karnataka, India; [Qiu, Shunmin] Shantou Univ, Hosp 1, Imaging Dept, Med Coll, Shantou, Guangdong, Peoples R China	Shantou University; Shantou University	Raj, ANJ (corresponding author), Shantou Univ, Dept Elect Engn, Key Lab Digital Signal & Image Proc Guangdong Pro, Shantou, Guangdong, Peoples R China.	jalexnoel@stu.edu.cn	noel, alex/V-6663-2019; Mahesh, Vijayalakshmi G V/AAB-5967-2020	noel, alex/0000-0003-1505-3159; Mahesh, Vijayalakshmi G V/0000-0002-1917-7506; zhuang, zhemin/0000-0002-7236-6859	Key Project of Guangdong Province Science & Technology Plan [2015B020233018]; National Natural Science Foundation of China [61471228]; Research Start up Fund Subsidized Project of Shantou University, China [NTF17016]	Key Project of Guangdong Province Science & Technology Plan; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Start up Fund Subsidized Project of Shantou University, China	This work was supported by Key Project of Guangdong Province Science & Technology Plan (No. 2015B020233018, Zhenmin Zhuang); The National Natural Science Foundation of China (No. 61471228, Zhenmin Zhuang); and The Research Start up Fund Subsidized Project of Shantou University, China: NTF17016 (Alex Noel Joseph Raj).	Abraham N, 2018, ARXIV PREPRINT ARXIV; Badrinarayanan V, 2017, IEEE T PATTERN ANAL, V39, P2481, DOI 10.1109/TPAMI.2016.2644615; Chan TF, 2001, IEEE T IMAGE PROCESS, V10, P266, DOI 10.1109/83.902291; Chen Y, 2019, APPL ACOUST, V148, P123, DOI 10.1016/j.apacoust.2018.12.019; Daoud MI, 2019, EXPERT SYST APPL, V121, P78, DOI 10.1016/j.eswa.2018.11.024; Daoud MI, 2012, 8TH INTERNATIONAL CONFERENCE ON SIGNAL IMAGE TECHNOLOGY & INTERNET BASED SYSTEMS (SITIS 2012), P137, DOI 10.1109/SITIS.2012.30; DeSantis CE, 2016, CA-CANCER J CLIN, V66, P290, DOI 10.3322/caac.21340; DICE LR, 1945, ECOLOGY, V26, P297, DOI 10.2307/1932409; Gomez W, 2010, MED PHYS, V37, P82, DOI 10.1118/1.3265959; Hariharan B, 2014, LECT NOTES COMPUT SC, V8695, P297, DOI 10.1007/978-3-319-10584-0_20; Horsch K, 2001, MED PHYS, V28, P1652, DOI 10.1118/1.1386426; Iandola FN, 2016, ARXIV; Kaiming He, 2016, 2016 IEEE Conference on Computer Vision and Pattern Recognition (CVPR), P770, DOI 10.1109/CVPR.2016.90; Khened M, 2019, MED IMAGE ANAL, V51, P21, DOI 10.1016/j.media.2018.10.004; Kriti, 2019, BIOCYBERN BIOMED ENG, V39, P100, DOI 10.1016/j.bbe.2018.10.002; Krizhevsky A., 2012, ADV NEURAL INF PROCE; Li GJ, 2009, ACM T ALGORITHMS, V5, DOI 10.1145/1497290.1497296; Lian S, 2018, J VIS COMMUN IMAGE R, V56, P296, DOI 10.1016/j.jvcir.2018.10.001; Long J, 2015, PROC CVPR IEEE, P3431, DOI 10.1109/CVPR.2015.7298965; Oktay O., 2018, ARXIV180403999; Panigrahi L, 2019, EXPERT SYST APPL, V115, P486, DOI 10.1016/j.eswa.2018.08.013; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; PERONA P, 1990, IEEE T PATTERN ANAL, V12, P629, DOI 10.1109/34.56205; Rad RM, 2018, IEEE INT WORKSH MULT; Ronneberger O, 2015, LECT NOTES COMPUT SC, V9351, P234, DOI 10.1007/978-3-319-24574-4_28; Roth H. R, 2017, ARXIV PREPRINT ARXIV; Roth HR, 2018, MED IMAGE ANAL, V45, P94, DOI 10.1016/j.media.2018.01.006; Schildkraut JS, 2010, MED PHYS, V37, P5703, DOI 10.1118/1.3495538; Schlemper J, 2019, MED IMAGE ANAL, V53, P197, DOI 10.1016/j.media.2019.01.012; Sidike P., 2018, HIST BEGAN ALEXNET C; Tong GF, 2018, OPTIK, V174, P460, DOI 10.1016/j.ijleo.2018.08.086; Xia Xide, 2017, ARXIV171108506; Xu Y, 2019, ULTRASONICS, V91, P1, DOI 10.1016/j.ultras.2018.07.006; Yap MH, 2018, IEEE J BIOMED HEALTH, V22, P1218, DOI 10.1109/JBHI.2017.2731873; Ye X, 2009, WORKSHOP ON PULMONAR; Yu F., 2015, ARXIV PREPRINT ARXIV; Zhang ZX, 2018, IEEE GEOSCI REMOTE S, V15, P749, DOI 10.1109/LGRS.2018.2802944; Zhuang ZM, 2019, MED BIOL ENG COMPUT, V57, P623, DOI 10.1007/s11517-018-1907-z	38	44	44	5	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2019	14	8							e0221535	10.1371/journal.pone.0221535	http://dx.doi.org/10.1371/journal.pone.0221535			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5TR	31442268	gold, Green Submitted, Green Published			2022-12-26	WOS:000485041400047
J	Javed, S; Mitchell, K; Sidsworth, D; Sellers, SL; Reutens-Hernandez, J; Massicotte, HB; Egger, KN; Lee, CH; Payne, GW				Javed, Sumreen; Mitchell, Kevin; Sidsworth, Danielle; Sellers, Stephanie L.; Reutens-Hernandez, Jennifer; Massicotte, Hugues B.; Egger, Keith N.; Lee, Chow H.; Payne, Geoffrey W.			Inonotus obliquus attenuates histamine-induced microvascular inflammation	PLOS ONE			English	Article							MAST-CELLS; CONDUCTED VASODILATION; ENDOTHELIUM; ATHEROSCLEROSIS; EXTRACTS	Cell-to-cell communication is a key element of microvascular blood flow control, including rapidly carrying signals through the vascular endothelium in response to local stimuli. This cell-to-cell communication is negatively impacted during inflammation through the disruption of junctional integrity. Such disruption is associated with promoting the onset of cardiovascular diseases as a result of altered microvascular blood flow regulation. Therefore, understanding the mechanisms how inflammation drives microvascular dysfunction and compounds that mitigate such inflammation and dysfunction are of great interest for development. As such we aimed to investigate extracts of mushrooms as potential novel compounds. Using intravital microscopy, the medicinal mushroom, inonotus obliquus was observed, to attenuate histamine-induced inflammation conducted vasodilation in second-order arterioles in the gluteus maximus muscle of C57BL/6 mice. Mast cell activation by C48/80 similarly disrupted endothelial junctions and conducted vasodilation but only histamine was blocked by the histamine antagonist, pyrilamine not C48/80 suggesting the importance of mast cell activation. Data presented here supports that histamine induced inflammation is a major disruptor of junctional integrity, and highlights the important anti-inflammatory properties of Inonotus obliquus focusing future assessment of mast cells as putative target for Inonotus obliquus.	[Javed, Sumreen; Reutens-Hernandez, Jennifer; Lee, Chow H.] Univ Northern British Columbia, Biochem & Mol Biol Program, Prince George, BC, Canada; [Mitchell, Kevin; Sidsworth, Danielle; Payne, Geoffrey W.] Univ Northern British Columbia, Northern Med Program, Prince George, BC, Canada; [Sellers, Stephanie L.] Univ British Columbia, Ctr Heart Lung Innovat, Vancouver, BC, Canada; [Sellers, Stephanie L.] Univ British Columbia, Dept Radiol, Vancouver, BC, Canada; [Sellers, Stephanie L.] St Pauls Hosp, Vancouver, BC, Canada; [Massicotte, Hugues B.; Egger, Keith N.] Univ Northern British Columbia, Ecosyst Sci & Management Program, Prince George, BC, Canada	University of Northern British Columbia; University of Northern British Columbia; University of British Columbia; University of British Columbia; St. Paul's Hospital; University of Saskatchewan; University of Northern British Columbia	Payne, GW (corresponding author), Univ Northern British Columbia, Northern Med Program, Prince George, BC, Canada.	geoff.payne@unbc.ca	Payne, Geoffrey/AAG-8282-2019	Sidsworth, Danielle/0000-0003-0845-8844; Sellers, Stephanie/0000-0002-3539-5730; Reutens Hernandez, Jennifer/0000-0002-5684-0370	UNBC	UNBC	This work was funded by UNBC internal grants to GWP, CHL and SJ. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham SN, 2010, NAT REV IMMUNOL, V10, P440, DOI 10.1038/nri2782; Balkwill F, 2001, LANCET, V357, P539, DOI 10.1016/S0140-6736(00)04046-0; Barnes PJ, 2001, PULM PHARMACOL THER, V14, P329, DOI 10.1006/pupt.2000.0318; Bearden SE, 2004, J PHYSIOL-LONDON, V561, P535, DOI 10.1113/jphysiol.2004.068262; Bruunsgaard H, 2005, J LEUKOCYTE BIOL, V78, P819, DOI 10.1189/jlb.0505247; Choi HW, 2015, MOL IMMUNOL, V63, P74, DOI 10.1016/j.molimm.2014.02.006; Choi SY, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/943516; Coussens LM, 1999, GENE DEV, V13, P1382, DOI 10.1101/gad.13.11.1382; Cragg GM, 2013, BBA-GEN SUBJECTS, V1830, P3670, DOI 10.1016/j.bbagen.2013.02.008; Debnath T, 2012, FOOD SCI BIOTECHNOL, V21, P1235, DOI 10.1007/s10068-012-0162-6; Lee DM, 2002, SCIENCE, V297, P1689, DOI 10.1126/science.1073176; Libby P, 2009, J AM COLL CARDIOL, V54, P2129, DOI 10.1016/j.jacc.2009.09.009; Liu J, 2009, NAT MED, V15, P940, DOI 10.1038/nm.1994; Looft-Wilson RC, 2004, J APPL PHYSIOL, V97, P1152, DOI 10.1152/japplphysiol.00133.2004; Ma LS, 2013, FOOD CHEM, V139, P503, DOI 10.1016/j.foodchem.2013.01.030; Newman DJ, 2012, J NAT PROD, V75, P311, DOI 10.1021/np200906s; Park YM, 2005, J ETHNOPHARMACOL, V101, P120, DOI 10.1016/j.jep.2005.04.003; Payne GW, 2004, FASEB J, V18, P280, DOI 10.1096/fj.03-0752com; Payne GW, 2003, AM J PHYSIOL-HEART C, V285, pH493, DOI 10.1152/ajpheart.00071.2003; SCHWARTZ LB, 1984, PROG ALLERGY, V34, P271; Secor VH, 2000, J EXP MED, V191, P813, DOI 10.1084/jem.191.5.813; Smith A, 2017, INT J MED MUSHROOMS, V19, P485, DOI 10.1615/IntJMedMushrooms.v19.i6.10; Stone KD, 2010, J ALLERGY CLIN IMMUN, V125, pS73, DOI 10.1016/j.jaci.2009.11.017; Sun JS, 2007, NAT MED, V13, P719, DOI 10.1038/nm1601; Taofiq O, 2016, TRENDS FOOD SCI TECH, V50, P193, DOI 10.1016/j.tifs.2016.02.005; Nguyet TMN, 2018, INT IMMUNOPHARMACOL, V54, P286, DOI 10.1016/j.intimp.2017.11.025; Triggiani M, 2001, J IMMUNOL, V166, P4083, DOI 10.4049/jimmunol.166.6.4083; Tyml K, 2011, CAN J PHYSIOL PHARM, V89, P1, DOI 10.1139/y10-099; Van Q, 2009, J ETHNOPHARMACOL, V125, P487, DOI 10.1016/j.jep.2009.06.026; Viaro F, 2008, NITRIC OXIDE-BIOL CH, V18, P87, DOI 10.1016/j.niox.2007.11.004	30	8	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2019	14	8							e0220776	10.1371/journal.pone.0220776	http://dx.doi.org/10.1371/journal.pone.0220776			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5RZ	31437163	Green Published, gold, Green Submitted			2022-12-26	WOS:000485036900017
J	Waldenberg, C; Hebelka, H; Brisby, H; Lagerstrand, KM				Waldenberg, Christian; Hebelka, Hanna; Brisby, Helena; Lagerstrand, Kerstin Magdalena			Differences in IVD characteristics between low back pain patients and controls associated with HIZ as revealed with quantitative MRI	PLOS ONE			English	Article							HIGH-INTENSITY ZONE; LUMBAR INTERVERTEBRAL DISC; CLINICAL-SIGNIFICANCE; ANNULUS FIBROSUS; DEGENERATION; DISCOGRAPHY; PREVALENCE; IMAGES; TEARS	Background Magnetic resonance imaging (MRI) can provide objective continuous intervertebral disc (IVD) measures in low back pain (LBP) patients. However, there are limited studies comparing quantitative IVD measures of symptomatic and asymptomatic individuals. Purpose This study aimed to investigate possible differences in IVD tissue composition in patients with chronic LBP and controls using quantitative MRI and correlate IVD measures with the phenotype High-Intensity Zone (HIZ). Methods The lumbar spine of 25 LBP-patients (25-69y, mean 38y, 11 males) and 12 controls (25-59y, mean 38y, 7 males) was examined with T2-mapping on a 1.5T MRI scanner. The mean T2-map value and standard deviation were determined in three midsagittal IVD slices and five sub-regions dividing each IVD in the sagittal plane. The distribution of T2-map values over the IVD was also determined with histogram analysis (Delta mu = distribution width). Results When compared to controls, patient IVDs displayed lower values for all metrics, with significant differences for the T2-map value, standard deviation (p = 0.026) and Delta mu (p = 0.048). Significantly different T2-map values were found between cohorts in the region representing nucleus pulposus and the border zone between nucleus pulposus and posterior annulus fibrosus (p = 0.047-0.050). Excluding all IVDs with HIZs resulted in no significant difference between the cohorts for any of the analyzed metrics (p = 0.053-0.995). Additionally, the T2-map values were lower in patients with HIZ in comparison without HIZ. Conclusions Differences in IVD characteristics, measured with quantitative MRI, between LBP patients and controls were found. The T2-differences may reflect altered IVD function associated with HIZ. Future studies are recommended to explore IVD functionality in relation to HIZ and LBP.	[Waldenberg, Christian; Lagerstrand, Kerstin Magdalena] Sahlgrens Univ Hosp, Dept Med Phys & Tech, Gothenburg, Sweden; [Waldenberg, Christian; Hebelka, Hanna; Brisby, Helena; Lagerstrand, Kerstin Magdalena] Univ Gothenburg, Sahlgrenska Acad, Inst Clin Sci, Gothenburg, Sweden; [Hebelka, Hanna] Sahlgrens Univ Hosp, Dept Radiol, Gothenburg, Sweden; [Brisby, Helena] Sahlgrens Univ Hosp, Dept Orthopaed, Gothenburg, Sweden	Sahlgrenska University Hospital; University of Gothenburg; Sahlgrenska University Hospital; Sahlgrenska University Hospital	Waldenberg, C (corresponding author), Sahlgrens Univ Hosp, Dept Med Phys & Tech, Gothenburg, Sweden.; Waldenberg, C (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Inst Clin Sci, Gothenburg, Sweden.	christian.waldenberg@vgregion.se			ALF agreement [ALFGBG-792231, ALFGBG-813301]; swedish government [ALFGBG-792231, ALFGBG-813301]	ALF agreement; swedish government	The study was financed by grants from the swedish state under agreement between the swedish government and the county councils, the ALF agreement ALFGBG-792231 (HH), ALFGBG-813301 (KL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MA, 2006, SPINE, V31, P2151, DOI 10.1097/01.brs.0000231761.73859.2c; APRILL C, 1992, BRIT J RADIOL, V65, P361, DOI 10.1259/0007-1285-65-773-361; Carragee EJ, 2000, SPINE, V25, P2987, DOI 10.1097/00007632-200012010-00005; Cicchetti D.V., 1994, PSYCHOL ASSESS, V6, P284, DOI [10.1037/1040-3590.6.4.284, DOI 10.1037/1040-3590.6.4.284]; Deoni SCL, 2003, MAGNET RESON MED, V49, P515, DOI 10.1002/mrm.10407; Glaser C, 2005, RADIOL CLIN N AM, V43, P641, DOI 10.1016/j.rcl.2005.02.007; Hanna H, 2013, EUR SPINE J, V22, P734, DOI 10.1007/s00586-012-2501-y; Hoy D, 2014, ANN RHEUM DIS, V73, P968, DOI 10.1136/annrheumdis-2013-204428; Jha SC, 2016, J MED INVESTIG, V63, P1, DOI 10.2152/jmi.63.1; Lam KS, 2000, EUR SPINE J, V9, P36, DOI 10.1007/s005860050006; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lebel RM, 2010, MAGN RESON MED, V64, P1005, DOI 10.1002/mrm.22487; Lukzen NN, 2009, J MAGN RESON, V196, P164, DOI 10.1016/j.jmr.2008.11.008; Luoma K, 2000, SPINE, V25, P487, DOI 10.1097/00007632-200002150-00016; Maquer G, 2014, MED ENG PHYS, V36, P219, DOI 10.1016/j.medengphy.2013.11.008; Matsumoto M, 2010, SPINE, V35, P1359, DOI 10.1097/BRS.0b013e3181c17067; Modic MT, 2007, RADIOLOGY, V245, P43, DOI 10.1148/radiol.2451051706; Mok FPS, 2016, SPINE J, V16, P32, DOI 10.1016/j.spinee.2015.09.060; Mok GSP, 2016, J ORTHOP TRANSL, V6, P34, DOI 10.1016/j.jot.2016.02.003; Nilsson M, 2016, EUR SPINE J, V25, P2856, DOI 10.1007/s00586-016-4670-6; Ogon I, 2015, J ORTHOP SCI, V20, P295, DOI 10.1007/s00776-014-0686-0; Panagopoulos J, 2017, AM J NEURORADIOLOGY; Peng BG, 2006, EUR SPINE J, V15, P583, DOI 10.1007/s00586-005-0892-8; Pfirrmann CWA, 2001, SPINE, V26, P1873, DOI 10.1097/00007632-200109010-00011; Prasloski T, 2012, MAGN RESON MED, V67, P1803, DOI 10.1002/mrm.23157; ROSS JS, 1989, AM J NEURORADIOL, V10, P1251; Sharma A, 2011, SPINE, V36, P1794, DOI 10.1097/BRS.0b013e31821590ad; Stadnik TW, 1998, RADIOLOGY, V206, P49, DOI 10.1148/radiology.206.1.9423651; Stelzeneder D, 2012, EUR J RADIOL, V81, P324, DOI 10.1016/j.ejrad.2010.12.093; Trattnig S, 2010, EUR RADIOL, V20, P2715, DOI 10.1007/s00330-010-1843-2; Vahid A, 2017, THE EFFECTS OF AXIAL; Waldenberg C, 2017, EUR SPINE J	32	13	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2019	14	8							e0220952	10.1371/journal.pone.0220952	http://dx.doi.org/10.1371/journal.pone.0220952			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5RZ	31437172	Green Submitted, Green Published, gold			2022-12-26	WOS:000485036900023
J	Son, B; Lee, S; Kim, H; Kang, H; Jeon, J; Jo, S; Seong, KM; Lee, SJ; Youn, H; Youn, B				Son, Beomseok; Lee, Sungmin; Kim, Hyunwoo; Kang, Hyunkoo; Jeon, Jaewan; Jo, Sunmi; Seong, Ki Moon; Lee, Su-Jae; Youn, HyeSook; Youn, BuHyun			Decreased FBP1 expression rewires metabolic processes affecting aggressiveness of glioblastoma	ONCOGENE			English	Article							IN-VIVO; CANCER; GLIOMA; THERAPY; RADIORESISTANCE; GLYCOLYSIS; STRESS; EMODIN; BRAIN; CELLS	Radiotherapy is a standard treatment option for patients with glioblastoma (GBM). Although it has high therapeutic efficacy, some proportion of the tumor cells that survive after radiotherapy may cause side effects. In this study, we found that fructose 1,6-bisphosphatase 1 (FBP1), a rate-limiting enzyme in gluconeogenesis, was downregulated upon treatment with ionizing radiation (IR). Ets1, which was found to be overexpressed in IR-induced infiltrating GBM, was suggested to be a transcriptional repressor of FBP1. Furthermore, glucose uptake and extracellular acidification rates were increased upon FBP1 downregulation, which indicated an elevated glycolysis level. We found that emodin, an inhibitor of phosphoglycerate mutase 1 derived from natural substances, significantly suppressed the glycolysis rate and IR-induced GBM migration in in vivo orthotopic xenograft mouse models. We propose that the reduced FBP1 level reprogrammed the metabolic state of GBM cells, and thus, FBP1 is a potential therapeutic target regulating GBM metabolism following radiotherapy.	[Son, Beomseok; Lee, Sungmin; Kim, Hyunwoo; Kang, Hyunkoo; Jeon, Jaewan; Youn, BuHyun] Pusan Natl Univ, Dept Integrated Biol Sci, Busan 46241, South Korea; [Jo, Sunmi] Inje Univ, Sch Med, Haeundae Paik Hosp, Dept Radiat Oncol, Busan 48108, South Korea; [Seong, Ki Moon] Korea Inst Radiol & Med Sci, Natl Radiat Emergency Med Ctr, Lab Low Dose Risk Assessment, Seoul 01812, South Korea; [Lee, Su-Jae] Hanyang Univ, Res Inst Nat Sci, Dept Life Sci, Seoul 04763, South Korea; [Youn, HyeSook] Sejong Univ, Dept Integrat Biosci & Biotechnol, Seoul 05006, South Korea; [Youn, BuHyun] Pusan Natl Univ, Dept Biol Sci, Busan 46241, South Korea	Pusan National University; Inje University; Korea Institute of Radiological & Medical Sciences; Hanyang University; Sejong University; Pusan National University	Youn, B (corresponding author), Pusan Natl Univ, Dept Integrated Biol Sci, Busan 46241, South Korea.; Youn, B (corresponding author), Pusan Natl Univ, Dept Biol Sci, Busan 46241, South Korea.	bhyoun72@pusan.ac.kr		Jo, Sunmi/0000-0002-1761-8953	Nuclear Safety Research Program through the Korea Foundation Of Nuclear Safety (KoFONS); Nuclear Safety and Security Commission (NSSC) of the Republic of Korea [1805019]	Nuclear Safety Research Program through the Korea Foundation Of Nuclear Safety (KoFONS); Nuclear Safety and Security Commission (NSSC) of the Republic of Korea	This work was supported by the Nuclear Safety Research Program through the Korea Foundation Of Nuclear Safety (KoFONS) using the financial resource granted by the Nuclear Safety and Security Commission (NSSC) of the Republic of Korea (No. 1805019). We thank Dr. Akio Soeda (Gifu University) for providing patient-derived X01 GBM cells.	Abbadi S, 2014, MOL CANCER RES, V12, P1547, DOI 10.1158/1541-7786.MCR-14-0106-T; Bhat KPL, 2013, CANCER CELL, V24, P331, DOI 10.1016/j.ccr.2013.08.001; Brady ST, 2012, BASIC NEUROCHEMISTRY: PRINCIPLES OF MOLECULAR, CELLULAR, AND MEDICAL NEUROBIOLOGY, 8THEDITION, P1; Chang L, 2004, MOL MED, V10, P65, DOI 10.2119/2005-00029.Saltiel; Chen J, 2011, ONCOGENE, V30, P4297, DOI 10.1038/onc.2011.137; Cong Jingjing, 2018, CELL METAB, V28, P243; Cooper LAD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012548; Desvergne B, 2006, PHYSIOL REV, V86, P465, DOI 10.1152/physrev.00025.2005; Ferrer VP, 2018, GLIA, V66, P1542, DOI 10.1002/glia.23309; Graziose Rocky, 2010, Curr Drug Discov Technol, V7, P2; Halliday J, 2014, P NATL ACAD SCI USA, V111, P5248, DOI 10.1073/pnas.1321014111; Han TY, 2013, CELL ADHES MIGR, V7, P395, DOI 10.4161/cam.26345; Han XT, 2017, ONCOTARGET, V8, P100931, DOI 10.18632/oncotarget.21753; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Haris K, 2014, ASIAN PAC J CANCER P, V15, P4499, DOI 10.7314/APJCP.2014.15.11.4499; Hitosugi T, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2759; Hitosugi T, 2012, CANCER CELL, V22, P585, DOI 10.1016/j.ccr.2012.09.020; Husain SR, 2015, CANCER GENE THER, V22, P554, DOI 10.1038/cgt.2015.58; Huse JT, 2011, GLIA, V59, P1190, DOI 10.1002/glia.21165; Jiang XL, 2014, INT J CANCER, V135, P1991, DOI 10.1002/ijc.28637; Kanehisa M, 2014, NUCLEIC ACIDS RES, V42, pD199, DOI 10.1093/nar/gkt1076; Kang J, 2017, ONCOGENE, V36, P1585, DOI 10.1038/onc.2016.328; Ke C, 2014, ONCOTARGET, V5, P1657, DOI 10.18632/oncotarget.1823; Kim MS, 2005, INT J ONCOL, V27, P839; Kim W, 2011, RADIAT RES, V176, P539, DOI 10.1667/RR2609.1; Le A, 2010, P NATL ACAD SCI USA, V107, P2037, DOI 10.1073/pnas.0914433107; Lee E, 2018, SEMIN CANCER BIOL, V53, P201, DOI 10.1016/j.semcancer.2018.07.006; Lee S, 2018, CELL PHYSIOL BIOCHEM, V47, P2233, DOI 10.1159/000491535; Lee S, 2017, CELL PHYSIOL BIOCHEM, V42, P1684, DOI 10.1159/000479418; Li B, 2014, NATURE, V513, P251, DOI 10.1038/nature13557; Li J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167857; Li SN, 2016, SCI REP-UK, V6, DOI 10.1038/srep28479; Li XG, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00325; Li YH, 2015, NAT CELL BIOL, V17, P1327, DOI 10.1038/ncb3240; Liu H, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189353; Lu CL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121046; Martinez-Outschoorn UE, 2017, NAT REV CLIN ONCOL, V14, P11, DOI 10.1038/nrclinonc.2016.60; Messeguer X, 2002, BIOINFORMATICS, V18, P333, DOI 10.1093/bioinformatics/18.2.333; Noushmehr H, 2010, CANCER CELL, V17, P510, DOI 10.1016/j.ccr.2010.03.017; Ostrom QT, 2013, NEURO-ONCOLOGY, V15, P1, DOI 10.1093/neuonc/not151; Parekh HS, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-21; Peterson CW, 2010, MOL CELL BIOL, V30, P2887, DOI 10.1128/MCB.01613-09; Rahman SA, 2009, J CHEMINFORMATICS, V1, DOI 10.1186/1758-2946-1-12; Robinson DR, 2017, NATURE, V548, P297, DOI 10.1038/nature23306; Seyfried TN, 2015, CANCER LETT, V356, P289, DOI 10.1016/j.canlet.2014.07.015; Shi WK, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0435-y; Soeda A, 2009, ONCOGENE, V28, P3949, DOI 10.1038/onc.2009.252; Son B, 2017, AM J PHYSIOL-LUNG C, V313, pL916, DOI 10.1152/ajplung.00144.2017; Thakkar JP, 2014, CANCER EPIDEM BIOMAR, V23, P1985, DOI 10.1158/1055-9965.EPI-14-0275; Tran B, 2010, J CLIN NEUROSCI, V17, P417, DOI 10.1016/j.jocn.2009.09.004; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Verschoor ML, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013565; Wang CY, 2007, EUR J PHARMACOL, V577, P58, DOI 10.1016/j.ejphar.2007.08.033; Wang YL, 2005, BIOCHEM BIOPH RES CO, V331, P1207, DOI 10.1016/j.bbrc.2005.03.243; Weller M, 2015, NAT REV DIS PRIMERS, V1, DOI 10.1038/nrdp.2015.17; Winter SF, 2017, CRIT REV ONCOL HEMAT, V112, P41, DOI 10.1016/j.critrevonc.2017.02.016; Wolf A, 2010, ONCOTARGET, V1, P552, DOI 10.18632/oncotarget.190; Xie Q, 2014, NEURO-ONCOLOGY, V16, P1575, DOI 10.1093/neuonc/nou147; Yoon JC, 2001, NATURE, V413, P131, DOI 10.1038/35093050; Zhang WW, 2006, J BIOL CHEM, V281, P10105, DOI 10.1074/jbc.M600272200; Zuccoli G, 2010, NUTR METAB, V7, DOI 10.1186/1743-7075-7-33	61	19	19	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN	2020	39	1					36	49		10.1038/s41388-019-0974-4	http://dx.doi.org/10.1038/s41388-019-0974-4			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	KG3NM	31444412				2022-12-26	WOS:000509849200004
J	An, YA; Zhang, HF; Wang, C; Jiao, FT; Xu, HY; Wang, XF; Luan, WJ; Ma, FX; Ni, LH; Tang, XD; Liu, MY; Guo, WY; Yu, L				An, Yanan; Zhang, Haifeng; Wang, Chao; Jiao, Fangtai; Xu, Hongyue; Wang, Xuefei; Luan, Wenjing; Ma, Fangxue; Ni, Lihui; Tang, Xudong; Liu, Mingyuan; Guo, Weiying; Yu, Lu			Activation of ROS/MAPKs/NF-kappa B/NLRP3 and inhibition of efferocytosis in osteoclast-mediated diabetic osteoporosis	FASEB JOURNAL			English	Article						diabetes mellitus osteoporosis; reactive oxygen species; osteoclasts; infalmmasome	NF-KAPPA-B; BONE LOSS; OXIDATIVE STRESS; LIPOPOLYSACCHARIDE; INFLAMMASOME; MACROPHAGES; RESOLUTION; CLEARANCE; RECEPTOR; DIFFERENTIATION	Diabetes mellitus (DM) affects bone metabolism and leads to osteoporosis; however, its pathogenetic mechanisms remain unknown. We found that high glucose (HG) conditions induced the production of reactive oxygen species (ROS) and the expression of proteins related to MAPKs [phosphorylated (p)-ERK, p-JNK, and p-p38], NF-kappa B (NF-kappa B, p-I kappa B, and IKK), and NACHT-LRR-PYD domains-containing protein 3 (NALP3) (NLRP3) [apoptosis-associated speck-like protein containing a caspase activation and recruitment domain (ASC), caspase-1, IL-18, IL-1 beta, and NLRP3] in osteoclasts (OCs) in vitro. Further analysis showed that in HG-induced OCs, ROS is an upstream signal for MAPKs, NF-kappa B, and the NLRP3 inflammasome. Moreover, MAPKs mediated the activation of NF-kappa B and NLRP3, whereas NF-kappa B up-regulated the NLRP3 inflammasome response. Interestingly, HG inducement enhanced the bone resorption of OCs but inhibited their efferocytosis, whereas insulin and lipoxin A4 (4) treatment reversed this phenomenon. In streptozotocin-induced diabetic rats in vivo, the numbers and the bone-resorption capacity of OCs as well as the serum levels of TRACP-5b were significantly increased, and the expression of MAPK-, NF-kappa B-, and NLRP3 inflammasome- related proteins in the proximal tibia were also significantly elevated; however, treatment with insulin and LXA4 reversed this elevation. Together, these results demonstrated that the activation of ROS/MAPKs/NF-kappa B/NLRP3 and the inhibition of efferocytosis in OCs are the main causes of osteoporosis in DM.	[An, Yanan; Zhang, Haifeng; Wang, Chao; Jiao, Fangtai; Xu, Hongyue; Wang, Xuefei; Luan, Wenjing; Ma, Fangxue; Ni, Lihui; Liu, Mingyuan; Guo, Weiying; Yu, Lu] Jilin Univ, Key Lab Zoonosis Res, Dept Intervent Therapy, Dept Endocrinol,Minist Educ,Hosp 1, Changchun, Peoples R China; [An, Yanan; Zhang, Haifeng; Wang, Chao; Jiao, Fangtai; Xu, Hongyue; Wang, Xuefei; Luan, Wenjing; Ma, Fangxue; Ni, Lihui; Liu, Mingyuan; Guo, Weiying; Yu, Lu] Jilin Univ, Coll Vet Med, Inst Zoonosis, Changchun, Peoples R China; [Tang, Xudong] Tsinghua Univ Shenzhen, Res Inst, Key Lab New Drugs Res Tradit Chinese Med TCM, Shenzhen, Peoples R China; [Liu, Mingyuan] Jiangsu Coinnovat Ctr Prevent & Control Important, Yangzhou, Jiangsu, Peoples R China	Jilin University; Jilin University; Tsinghua University	Guo, WY (corresponding author), Jilin Univ, Hosp 1, Dept Endocrine & Metab, Xinmin St 71, Changchun 130021, Peoples R China.; Yu, L (corresponding author), Jilin Univ, Coll Vet Med, Inst Zoonosis, Key Lab Zoonosis Res,Minist Educ, Xian Rd 5333, Changchun 130000, Peoples R China.	guowy@jlu.edu.cn; yu_lu@jlu.edu.cn			Project of Science and Technology Department of Jilin Province [20180414036GH]; Education Department of Jilin Province [2016444]; State Key Project of Research and Development Plan [2017YFD0502200, 2016YFD0501302]; National Nature Science Foundation of China [31172364, 81801972]; Fund for Science and Technology Development of Jilin Province [20150101108JC]; Important National Science and Technology Specific Projects [2012ZX10003002]; Program for New Century Excellent Talents in University [NCET-09-0434]; Science, Technology and Innovation Commission of Shenzhen Municipality [JCYJ2016031100720906, JSGG20160301100442775]	Project of Science and Technology Department of Jilin Province; Education Department of Jilin Province; State Key Project of Research and Development Plan; National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fund for Science and Technology Development of Jilin Province; Important National Science and Technology Specific Projects; Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Science, Technology and Innovation Commission of Shenzhen Municipality	The authors thank Dr. Yang Wang (Jilin University) for her help in manuscript revision. This work was supported by the Project of Science and Technology Department of Jilin Province (20180414036GH); the Education Department of Jilin Province (2016444); the State Key Project of Research and Development Plan (2017YFD0502200 and 2016YFD0501302); the National Nature Science Foundation of China (31172364 and 81801972); the Fund for Science and Technology Development of Jilin Province (20150101108JC); the Important National Science and Technology Specific Projects (2012ZX10003002); the Program for New Century Excellent Talents in University (NCET-09-0434); and the Science, Technology and Innovation Commission of Shenzhen Municipality (JCYJ2016031100720906 and JSGG20160301100442775). The authors declare no conflicts of interest.	Ajizian SJ, 1999, J INFECT DIS, V179, P939, DOI 10.1086/314659; Alippe Y, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07014-0; Asagiri M, 2007, BONE, V40, P251, DOI 10.1016/j.bone.2006.09.023; Aziz Monowar, 2013, Curr Protoc Immunol, VChapter 14, DOI 10.1002/0471142735.im1431s100; Baichwal VR, 1997, CURR BIOL, V7, pR94, DOI 10.1016/S0960-9822(06)00046-7; Bain S, 1997, BONE, V21, P147, DOI 10.1016/S8756-3282(97)00104-X; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; Brancaleone V, 2013, BLOOD, V122, P608, DOI 10.1182/blood-2013-04-496661; Dickinson RJ, 2006, J CELL SCI, V119, P4607, DOI 10.1242/jcs.03266; Douda DN, 2015, P NATL ACAD SCI USA, V112, P2817, DOI 10.1073/pnas.1414055112; Evans JL, 2002, ENDOCR REV, V23, P599, DOI 10.1210/er.2001-0039; Franchi L, 2009, NAT IMMUNOL, V10, P241, DOI 10.1038/ni.1703; Fredman G, 2015, SCI TRANSL MED, V7; Fredman G, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa1065; Fredman G, 2012, SCI REP-UK, V2, DOI 10.1038/srep00639; Garbin U, 2013, CARDIOVASC RES, V97, P125, DOI 10.1093/cvr/cvs301; Ghonime MG, 2014, J IMMUNOL, V192, P3881, DOI 10.4049/jimmunol.1301974; Green DR, 2016, CELL DEATH DIFFER, V23, P915, DOI 10.1038/cdd.2015.172; Harada S, 2003, NATURE, V423, P349, DOI 10.1038/nature01660; HERSKIND AM, 1992, DIABETES METAB, V18, P63; Hie M, 2009, EUR J PHARMACOL, V621, P1, DOI 10.1016/j.ejphar.2009.08.025; Irwin R, 2006, ENDOCRINOLOGY, V147, P5760, DOI 10.1210/en.2006-0700; Jaghsi Sawsan, 2018, Open Rheumatol J, V12, P1, DOI 10.2174/1874312901812010001; Jeong DW, 2019, EVID-BASED COMPL ALT, V2019, DOI 10.1155/2019/3231784; Lacey DL, 1998, CELL, V93, P165, DOI 10.1016/S0092-8674(00)81569-X; Lawrence T, 2005, NATURE, V434, P1138, DOI 10.1038/nature03491; Li NX, 1999, FASEB J, V13, P1137, DOI 10.1096/fasebj.13.10.1137; Liang W, 2011, EUR J PHARMACOL, V670, P317, DOI 10.1016/j.ejphar.2011.08.014; Lu HF, 2003, ENDOCRINOLOGY, V144, P346, DOI 10.1210/en.2002-220072; Lukens JR, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00315; Manolagas SC, 2000, ENDOCR REV, V21, P115, DOI 10.1210/er.21.2.115; Martinez R.M., 2018, J DERMATOL SCI; Masters SL, 2009, ANNU REV IMMUNOL, V27, P621, DOI 10.1146/annurev.immunol.25.022106.141627; Mendis E, 2008, BIOORGAN MED CHEM, V16, P8390, DOI 10.1016/j.bmc.2008.08.037; Moore KJ, 2011, CELL, V145, P341, DOI 10.1016/j.cell.2011.04.005; Morimoto K, 2006, J IMMUNOL, V176, P7657, DOI 10.4049/jimmunol.176.12.7657; Nassar H, 2007, PERIODONTOL 2000, V43, P233, DOI 10.1111/j.1600-0757.2006.00168.x; Pisoschi AM, 2015, EUR J MED CHEM, V97, P55, DOI 10.1016/j.ejmech.2015.04.040; Poon IKH, 2014, NAT REV IMMUNOL, V14, P166, DOI 10.1038/nri3607; Rains JL, 2011, FREE RADICAL BIO MED, V50, P567, DOI 10.1016/j.freeradbiomed.2010.12.006; Saito M, 2010, OSTEOPOROSIS INT, V21, P195, DOI 10.1007/s00198-009-1066-z; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Schwartz AV, 2003, CALCIFIED TISSUE INT, V73, P515, DOI 10.1007/s00223-003-0023-7; Soehnlein O, 2010, NAT REV IMMUNOL, V10, P427, DOI 10.1038/nri2779; Suzuki K, 2002, J BONE MINER RES, V17, P1486, DOI 10.1359/jbmr.2002.17.8.1486; Tabas I, 2016, CIRC RES, V118, P653, DOI 10.1161/CIRCRESAHA.115.306256; Tak PP, 2001, J CLIN INVEST, V107, P7, DOI 10.1172/JCI11830; Thorp E, 2011, J BIOL CHEM, V286, P33335, DOI 10.1074/jbc.M111.263020; Toker H, 2012, J PERIODONTAL RES, V47, P793, DOI 10.1111/j.1600-0765.2012.01497.x; Vestergaard P, 2009, CURR OPIN ENDOCRINOL, V16, P125, DOI 10.1097/MED.0b013e328325d155; Viola JR, 2016, CIRC RES, V119, P1030, DOI 10.1161/CIRCRESAHA.116.309492; Wang TL, 2002, INT IMMUNOPHARMACOL, V2, P1509, DOI 10.1016/S1567-5769(02)00058-9; Wei F, 2016, FRONT MICROBIOL, V7, DOI [10.3389/fmicb.2016.00334, 10.3389/fmicb.2016.00502]; Youm YH, 2013, CELL METAB, V18, P519, DOI 10.1016/j.cmet.2013.09.010	54	111	120	9	48	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2019	33	11					12515	12527		10.1096/fj.201802805RR	http://dx.doi.org/10.1096/fj.201802805RR			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC8ZX	31461386	Bronze, Green Published			2022-12-26	WOS:000507461600071
J	Hou, X; Wu, QT; Rajagopalan, C; Zhang, C; Bouhamdan, M; Wei, HG; Chen, XQ; Zaman, K; Li, CY; Sun, XN; Chen, S; Frizzell, RA; Sun, F				Hou, Xia; Wu, Qingtian; Rajagopalan, Carthic; Zhang, Chunbing; Bouhamdan, Mohamad; Wei, Hongguang; Chen, Xuequn; Zaman, Khalequz; Li, Chunying; Sun, Xiaonan; Chen, Song; Frizzell, Raymond A.; Sun, Fei			CK19 stabilizes CFTR at the cell surface by limiting its endocytic pathway degradation	FASEB JOURNAL			English	Article						K19; lysosomal degradation; membrane stability; Rab7	TRANSMEMBRANE CONDUCTANCE REGULATOR; CYSTIC-FIBROSIS; QUALITY-CONTROL; RAB7 EFFECTOR; KERATIN 19; HALF-LIFE; IN-VITRO; TRAFFICKING; PROTEIN; MEMBRANE	Protein interactions that stabilize the cystic fibrosis (CF) transmembrane conductance regulator (CFTR) at the apical membranes of epithelial cells have not yet been fully elucidated. We identified keratin 19 (CK19 or K19) as a novel CFTR-interacting protein. CK19 overexpression stabilized both wild-type (WT)-CFTR and Lumacaftor (VX-809)-rescued F508del-CFTR (where F508del is the deletion of the phenylalanine residue at position 508) at the plasma membrane (PM), promoting Cl- secretion across human bronchial epithelial (HBE) cells. CK19 prevention of Rab7A-mediated lysosomal degradation was a key mechanism in apical CFTR stabilization. Unexpectedly, CK19 expression was decreased by similar to 40% in primary HBE cells from homogenous F508del patients with CF relative to non-CF controls. CK19 also positively regulated multidrug resistance-associated protein 4 expression at the PM, suggesting that this keratin may regulate the apical expression of other ATP-binding cassette proteins as well as CFTR.	[Hou, Xia; Wu, Qingtian; Rajagopalan, Carthic; Bouhamdan, Mohamad; Wei, Hongguang; Chen, Xuequn; Sun, Fei] Wayne State Univ, Sch Med, Dept Physiol, Scott Hall,Room 5229,540 E Canfield St, Detroit, MI 48201 USA; [Hou, Xia; Zhang, Chunbing] Jiamusi Univ, Sch Basic Med, Dept Biochem & Mol Biol, Jiamusi, Peoples R China; [Zaman, Khalequz] Univ Virginia, Sch Med, Dept Pediat Resp Med, Charlottesville, VA 22908 USA; [Li, Chunying; Sun, Xiaonan] Georgia State Univ, Ctr Mol & Translat Med, Atlanta, GA 30303 USA; [Chen, Song] Jiangsu Coll Nursing, Inst Med Biotechnol, Huaian, Peoples R China; [Frizzell, Raymond A.] Univ Pittsburgh, Sch Med, Dept Pediat, Pittsburgh, PA 15261 USA; [Frizzell, Raymond A.] Univ Pittsburgh, Sch Med, Dept Cell Biol, Pittsburgh, PA USA	Wayne State University; Jiamusi University; University of Virginia; University System of Georgia; Georgia State University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Hou, X; Sun, F (corresponding author), Wayne State Univ, Sch Med, Dept Physiol, Scott Hall,Room 5229,540 E Canfield St, Detroit, MI 48201 USA.	xhou@med.wayne.edu; fsun@med.wayne.edu	Hou, Xia/AAD-2235-2020	Hou, Xia/0000-0002-6733-086X	U.S. National Institutes of Health (NIH) National Heart, Lung, and Blood Institute [HL133162]; NIH National Institute of Diabetes and Digestive and Kidney Diseases [DK068196]; Cystic Fibrosis Foundation [SUN15XX0, FRIZZE13XX0]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK068196] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIH National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors thank all the people mentioned in this study and their laboratory members. The authors specifically thank the Cystic Fibrosis (CF) Research Center, University of Pittsburgh, for primary human bronchial epithelial (HBE) cells, helpful comments, and laboratory support. The authors also thank Carol A. Bertrand (Department of Cell Biology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA) for whole-cell current recordings, and Dr. Yongming Xie (Karmanos Cancer Institute and Department of Oncology, Wayne State University School of Medicine, Detroit, MI, USA) for comments on the manuscript. Additionally, the authors thank the Lipidomics Core Facility and the Imaging and Histopathology Core of Wayne State University School of Medicine. This work was supported by U.S. National Institutes of Health (NIH) National Heart, Lung, and Blood Institute Grant HL133162 (to F.S.) and NIH National Institute of Diabetes and Digestive and Kidney Diseases Grant DK068196 (to R.A.F.), and Cystic Fibrosis Foundation Grants SUN15XX0 (to F.S.) and FRIZZE13XX0 (to R.A.F.). The authors declare no conflicts of interest.	Aloisi AL, 2013, HISTOL HISTOPATHOL, V28, P839, DOI 10.14670/HH-28.839; Amaral MD, 2004, J MOL NEUROSCI, V23, P41, DOI 10.1385/JMN:23:1-2:041; Ameen N, 2007, J CYST FIBROS, V6, P1, DOI 10.1016/j.jcf.2006.09.002; Arin MJ, 2009, HUM GENET, V125, P355, DOI 10.1007/s00439-009-0646-5; Asai K, 2005, SCAND J GASTROENTERO, V40, P326, DOI 10.1080/00365520510011605; Begicevic RR, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18112362; Bertrand CA, 2017, AM J PHYSIOL-LUNG C, V312, pL912, DOI 10.1152/ajplung.00178.2016; Boswell-Casteel RC, 2018, AAPS J, V20, DOI 10.1208/s12248-017-0165-6; Bucci C, 2000, MOL BIOL CELL, V11, P467, DOI 10.1091/mbc.11.2.467; Chandel DS, 2011, PEDIATR RES, V70, P153, DOI 10.1203/PDR.0b013e3182225ac9; Cholon DM, 2010, AM J PHYSIOL-LUNG C, V298, pL304, DOI 10.1152/ajplung.00016.2009; Colombat M, 2003, J PATHOL, V201, P260, DOI 10.1002/path.1451; Duan YY, 2012, J BIOL CHEM, V287, P40547, DOI 10.1074/jbc.M112.403584; Dupre DJ, 2003, J BIOL CHEM, V278, P48228, DOI 10.1074/jbc.M304082200; Favia M, 2010, MOL BIOL CELL, V21, P73, DOI 10.1091/mbc.E09-03-0185; FENG Y, 1995, J CELL BIOL, V131, P1435, DOI 10.1083/jcb.131.6.1435; Fischer H, 2004, P NATL ACAD SCI USA, V101, P3691, DOI 10.1073/pnas.0308393100; Fradette J, 1998, J BIOL CHEM, V273, P35176, DOI 10.1074/jbc.273.52.35176; Ganeshan R, 2007, BBA-MOL CELL RES, V1773, P192, DOI 10.1016/j.bbamcr.2006.09.031; Ganley IG, 2004, MOL BIOL CELL, V15, P5420, DOI 10.1091/mbc.E04-08-0747; Gentzsch M, 2004, MOL BIOL CELL, V15, P2684, DOI 10.1091/mbc.E04-03-0176; Gong XY, 2019, MOL BIOL CELL, V30, P4, DOI 10.1091/mbc.E18-04-0252; Greene NP, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00950; Guggino WB, 2004, AM J RESP CRIT CARE, V170, P815, DOI 10.1164/rccm.200403-381WS; Guggino WB, 2006, NAT REV MOL CELL BIO, V7, P426, DOI 10.1038/nrm1949; Haggie PM, 2006, MOL BIOL CELL, V17, P4937, DOI 10.1091/mbc.E06-08-0670; Hampton TH, 2012, AM J PHYSIOL-LUNG C, V303, pL509, DOI 10.1152/ajplung.00226.2011; Heda GD, 2001, AM J PHYSIOL-CELL PH, V280, pC166, DOI 10.1152/ajpcell.2001.280.1.C166; Holleran JP, 2013, J CELL SCI, V126, P2692, DOI 10.1242/jcs.120196; Hou X, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23284-8; Hou YN, 2015, STEM CELL RES, V14, P133, DOI 10.1016/j.scr.2014.12.001; Howard M, 2000, AM J PHYSIOL-CELL PH, V279, pC375, DOI 10.1152/ajpcell.2000.279.2.C375; JENSEN TJ, 1995, CELL, V83, P129, DOI 10.1016/0092-8674(95)90241-4; Jones PM, 2004, CELL MOL LIFE SCI, V61, P682, DOI 10.1007/s00018-003-3336-9; Jurkuvenaite A, 2010, AM J RESP CELL MOL, V42, P363, DOI 10.1165/rcmb.2008-0434OC; Ku NO, 2016, HEPATOLOGY, V64, P966, DOI 10.1002/hep.28493; Kumari V, 2017, J CYST FIBROS, V16, P327, DOI 10.1016/j.jcf.2017.03.012; Lee JS, 2012, J PROTEOMICS, V75, P3952, DOI 10.1016/j.jprot.2012.05.017; Lee S, 2014, MOL CELL BIOL, V34, P2554, DOI 10.1128/MCB.01042-13; Li CY, 2007, CELL, V131, P940, DOI 10.1016/j.cell.2007.09.037; Lobo MJ, 2016, J CELL SCI, V129, P2599, DOI 10.1242/jcs.185629; Luz S, 2014, J BIOL CHEM, V289, P15080, DOI 10.1074/jbc.M114.563742; Marozkina NV, 2010, P NATL ACAD SCI USA, V107, P11393, DOI 10.1073/pnas.0909128107; Marwaha R, 2017, J CELL BIOL, V216, P1051, DOI 10.1083/jcb.201607085; McNamara J, 2019, LANCET RESP MED, V7, P325, DOI 10.1016/S2213-2600(18)30460-0; Michel M, 1996, J CELL SCI, V109, P1017; Okiyoneda T, 2007, BBA-MOL CELL RES, V1773, P476, DOI 10.1016/j.bbamcr.2007.01.004; Okiyoneda T, 2010, SCIENCE, V329, P805, DOI 10.1126/science.1191542; Onishi Y, 2018, DRUG DISCOV TODAY, V23, P1556, DOI 10.1016/j.drudis.2018.05.037; Pankiv S, 2010, J CELL BIOL, V188, P253, DOI 10.1083/jcb.200907015; Pilewski Joseph M., 1999, Physiological Reviews, V79, pS215; Premchandar A, 2017, PROTEIN SCI, V26, P343, DOI 10.1002/pro.3086; Ramachandran S, 2016, J BIOL CHEM, V291, P25489, DOI 10.1074/jbc.M116.754283; Rasgado-Flores H, 2013, AM J PHYSIOL-CELL PH, V305, pC1114, DOI 10.1152/ajpcell.00166.2013; Romani L, 2018, NAT MED, V24, P1481, DOI 10.1038/s41591-018-0100-0; Romani L, 2017, NAT MED, V23, P590, DOI 10.1038/nm.4305; Sapmaz A, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09437-x; Sharma M, 2004, J CELL BIOL, V164, P923, DOI 10.1083/jcb.200312018; Shen KY, 2014, J IMMUNOL, V192, P4233, DOI 10.4049/jimmunol.1302850; Shinde SR, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10689; Silverman Ed, 2015, Manag Care, V24, P16; Snider NT, 2016, KIDNEY INT, V89, P738, DOI 10.1016/j.kint.2015.12.040; Sun F, 2008, FASEB J, V22, P3255, DOI 10.1096/fj.07-105338; Sun F, 2006, J BIOL CHEM, V281, P36856, DOI 10.1074/jbc.M607085200; Swiatecka-Urban A, 2005, J BIOL CHEM, V280, P36762, DOI 10.1074/jbc.M508944200; Swiatecka-Urban A, 2007, J BIOL CHEM, V282, P23725, DOI 10.1074/jbc.M608531200; Tang DD, 2008, AM J PHYSIOL-CELL PH, V294, pC869, DOI 10.1152/ajpcell.00154.2007; Tazi MF, 2016, AUTOPHAGY, V12, P2026, DOI 10.1080/15548627.2016.1217370; Toivola DM, 2005, TRENDS CELL BIOL, V15, P608, DOI 10.1016/j.tcb.2005.09.004; Traub LM, 2003, J CELL BIOL, V163, P203, DOI 10.1083/jcb.200309175; Van Goor F, 2011, P NATL ACAD SCI USA, V108, P18843, DOI 10.1073/pnas.1105787108; Vasiliou Vasilis, 2009, Human Genomics, V3, P281; Wang TL, 2011, CELL SIGNAL, V23, P516, DOI 10.1016/j.cellsig.2010.09.012; Wang W, 2017, P NATL ACAD SCI USA, V114, P8366, DOI 10.1073/pnas.1701289114; Wang YZ, 2007, BLOOD, V110, P962, DOI 10.1182/blood-2007-01-066027; WELSH MJ, 1995, SCI AM, V273, P52, DOI 10.1038/scientificamerican1295-52; Willett R, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01871-z; Wilson JD, 2016, TRAFFIC, V17, P1027, DOI 10.1111/tra.12418; Yap CC, 2018, J CELL BIOL, V217, P3141, DOI 10.1083/jcb.201711039; Ye YH, 2004, NATURE, V429, P841, DOI 10.1038/nature02656; Younger JM, 2006, CELL, V126, P571, DOI 10.1016/j.cell.2006.06.041; Zhang L.J., 2009, ETHYLENE IND, V25, P7, DOI DOI 10.1371/J0URNAL.PBI0.1000155; Zhang YN, 2018, J VIROL, V92, DOI [10.1128/jvi.00797-18, 10.1128/JVI.00797-18]	83	7	7	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2019	33	11					12602	12615		10.1096/fj.201901050R	http://dx.doi.org/10.1096/fj.201901050R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC8ZX	31450978	Green Published			2022-12-26	WOS:000507461600078
J	Kesireddy, VS; Chillappagari, S; Ahuja, S; Knudsen, L; Henneke, I; Graumann, J; Meiners, S; Ochs, M; Ruppert, C; Korfei, M; Seeger, W; Mahavadi, P				Kesireddy, Vidya Sagar; Chillappagari, Shashi; Ahuja, Saket; Knudsen, Lars; Henneke, Ingrid; Graumann, Johannes; Meiners, Silke; Ochs, Matthias; Ruppert, Clemens; Korfei, Martina; Seeger, Werner; Mahavadi, Poornima			Susceptibility of microtubule-associated protein 1 light chain 3 beta (MAP1LC3B/LC3B) knockout mice to lung injury and fibrosis	FASEB JOURNAL			English	Article						alveolar epithelial cells; lamellar bodies; autophagy; aging; lysosome	IDIOPATHIC PULMONARY-FIBROSIS; LAMELLAR BODIES; CATHEPSIN-A; AUTOPHAGY; CELL; STRESS; HOMEOSTASIS; INHIBITION; SECRETION; APOPTOSIS	Insufficient autophagy has been reported in idiopathic pulmonary fibrosis (IPF) lungs. Specific roles of autophagy-related proteins in lung fibrosis development remain largely unknown. Here, we investigated the role of autophagy marker protein microtubule-associated protein 1 light chain 3 beta (LC3B) in the development of lung fibrosis. LC3B(-/-) mice upon aging show smaller lamellar body profiles, increased cellularity, alveolar epithelial cell type II (AECII) apoptosis, surfactant alterations, and lysosomal and endoplasmic reticulum stress. Autophagosomal soluble N-ethylmaleimide-sensitive factor attachment protein receptor syntaxin 17 is increased in the AECII of aged LC3B(-/-) mice and patients with IPF. Proteasomal activity, however, remained unaltered in LC3B(-/- )mice. In vitro knockdown of LC3B sensitized mouse lung epithelial cells to bleomycin-induced apoptosis, but its overexpression was protective. In vivo, LC3B(-/-) mice displayed increased susceptibility to bleomycin-induced lung injury and fibrosis. We identified cathepsin A as a novel LC3B binding partner and its overexpression in vitro drives MLE12 cells to apoptosis. Additionally, cathepsin A is increased in the AECII of aged LC3B(-/-) mice and in the lungs of patients with IPF. Our study reveals that LC3B mediated autophagy plays essential roles in AECII by modulating the functions of proteins like cathepsin A and protects alveolar epithelial cells from apoptosis and subsequent lung injury and fibrosis.	[Kesireddy, Vidya Sagar; Ahuja, Saket; Henneke, Ingrid; Ruppert, Clemens; Korfei, Martina; Seeger, Werner; Mahavadi, Poornima] JLU, Dept Internal Med, Giessen, Germany; [Chillappagari, Shashi] JLU, Fac Med, Dept Biochem, Giessen, Germany; [Seeger, Werner] JLU, Cardiopulm Inst, Giessen, Germany; [Kesireddy, Vidya Sagar; Ahuja, Saket; Henneke, Ingrid; Ruppert, Clemens; Korfei, Martina; Seeger, Werner; Mahavadi, Poornima] UGMLC, German Ctr Lung Res DZL, Giessen, Germany; [Knudsen, Lars; Ochs, Matthias] Hannover Med Sch, Inst Funct & Appl Anat, Hannover, Germany; [Knudsen, Lars; Ochs, Matthias] DZL, Biomed Res Endstage & Obstruct Lung Dis Hannover, Hannover, Germany; [Knudsen, Lars; Ochs, Matthias] Regenerat Biol & Reconstruct Therapies REBIRTH Cl, Hannover, Germany; [Graumann, Johannes] Max Planck Inst Heart & Lung Res, Biomol Mass Spectrometry, Bad Nauheim, Germany; [Graumann, Johannes] German Ctr Cardiovasc Res DZHK, Partner Site Rhine Main, Frankfurt, Germany; [Meiners, Silke] LMU, Helmholtz Zentrum M unchen, Univ Hosp, CPC,DZL, Munich, Germany; [Ochs, Matthias] Charite Univ Med Berlin, Inst Vegetat Anat, Berlin, Germany	Justus Liebig University Giessen; Justus Liebig University Giessen; Justus Liebig University Giessen; Hannover Medical School; Max Planck Society; German Centre for Cardiovascular Research; University of Munich; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Mahavadi, P (corresponding author), Univ Giessen, Marburg Lung Ctr, Justus Liebig Univ Giessen, Dept Internal Med, Seltersberg House C EG,Gaffkystr 11, D-35392 Giessen, Germany.	poornima.mahavadi@innere.med.uni-giessen.de	Graumann, Johannes/C-5241-2008; Mahavadi, Poornima/AAC-2500-2020; Meiners, S/M-9822-2014; Knudsen, Lars/G-3146-2013	Graumann, Johannes/0000-0002-3015-5850; Mahavadi, Poornima/0000-0002-7580-4738; Meiners, S/0000-0003-3678-7995; Knudsen, Lars/0000-0002-7926-3879; Seeger, Werner/0000-0003-1946-0894	German Research Foundation	German Research Foundation(German Research Foundation (DFG))	The authors thank the German Research Foundation for supporting this study through an independent research grant to P.M. The authors also thank Silke Haendel, Stefanie Hezel [Department of Internal Medicine, Justus-Liebig University (JLU) Giessen], and Susanne Fassbender (Institute of Functional and Applied Anatomy, Hannover Medical School) for their excellent technical support. The authors also thank Prof. Dr. Saverio Bellusci (Department of Internal Medicine, JLU Giessen) and laboratory members for help with fluorescence miscroscopy. The authors declare no conflicts of interest.	Ahuja S, 2016, AM J PHYSIOL-LUNG C, V310, pL519, DOI 10.1152/ajplung.00213.2015; Alers S, 2012, CELL COMMUN SIGNAL, V10, DOI 10.1186/1478-811X-10-7; Alers S, 2012, MOL CELL BIOL, V32, P2, DOI 10.1128/MCB.06159-11; Bueno M, 2015, J CLIN INVEST, V125, P521, DOI 10.1172/JCI74942; Cabrera S, 2015, AUTOPHAGY, V11, P670, DOI 10.1080/15548627.2015.1034409; Cann GM, 2008, DEV DYNAM, V237, P187, DOI 10.1002/dvdy.21392; Cheong H, 2014, AUTOPHAGY, V10, P45, DOI 10.4161/auto.26505; Codogno P, 2005, CELL DEATH DIFFER, V12, P1509, DOI 10.1038/sj.cdd.4401751; Cuervo AM, 2003, EMBO J, V22, P47, DOI 10.1093/emboj/cdg002; Fehrenbach H, 2001, RESP RES, V2, P33, DOI 10.1186/rr36; GUNDERSEN HJG, 1988, APMIS, V96, P857, DOI 10.1111/j.1699-0463.1988.tb00954.x; Hamasaki M, 2013, NATURE, V495, P389, DOI 10.1038/nature11910; Hiraiwa M, 1999, CELL MOL LIFE SCI, V56, P894, DOI 10.1007/s000180050482; Janen SB, 2010, GLIA, V58, P1766, DOI 10.1002/glia.21047; King TE, 2011, LANCET, V378, P1949, DOI 10.1016/S0140-6736(11)60052-4; Lahm T, 2012, AUTOPHAGY, V8, P1146, DOI 10.4161/auto.20520; Lee SJ, 2011, AM J RESP CRIT CARE, V183, P649, DOI 10.1164/rccm.201005-0746OC; Lee VY, 2005, AM J PHYSIOL-LUNG C, V289, pL521, DOI 10.1152/ajplung.00340.2004; Lutz D, 2015, AM J RESP CELL MOL, V52, P232, DOI 10.1165/rcmb.2014-0078OC; Mahavadi P, 2015, J PATHOL CLIN RES, V1, P252, DOI 10.1002/cjp2.20; Mahavadi P, 2014, TOXICOL SCI, V142, P285, DOI 10.1093/toxsci/kfu177; Mahavadi P, 2010, AM J RESP CRIT CARE, V182, P207, DOI 10.1164/rccm.200909-1414OC; Martens S, 2016, J CELL BIOL, V215, P761, DOI 10.1083/jcb.201611116; MILLER BE, 1990, ENVIRON HEALTH PERSP, V85, P15, DOI 10.2307/3430661; Mizushima N, 2007, GENE DEV, V21, P2861, DOI 10.1101/gad.1599207; MYERS JL, 1988, CHEST, V94, P1309, DOI 10.1378/chest.94.6.1309; Nedelsky NB, 2008, BBA-MOL BASIS DIS, V1782, P691, DOI 10.1016/j.bbadis.2008.10.002; Patel AS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041394; Petrera A, 2016, J PROTEOME RES, V15, P3188, DOI 10.1021/acs.jproteome.6b00413; Raghu G, 2011, AM J RESP CRIT CARE, V183, P788, DOI 10.1164/rccm.2009-040GL; Rasmussen MS, 2017, AUTOPHAGY, V13, P834, DOI 10.1080/15548627.2017.1287651; SCHMITZ G, 1991, J LIPID RES, V32, P1539; Selman Moises, 2006, Proc Am Thorac Soc, V3, P364, DOI 10.1513/pats.200601-003TK; Tang BZ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091482; Thomas AQ, 2002, AM J RESP CRIT CARE, V165, P1322, DOI 10.1164/rccm.200112-123OC; Travis W.D., 2002, AM J RESP CRIT CARE, V165, P277, DOI [DOI 10.1164/AJRCCM.165.2.ATS01, 10.1164/ajrccm.165.2.ats01]; Tschanz S, 2014, ANN ANAT, V196, P3, DOI 10.1016/j.aanat.2013.04.011; Tsuboyama K, 2016, SCIENCE, V354, P1036, DOI 10.1126/science.aaf6136; Wang RQ, 2000, AM J PHYSIOL-LUNG C, V279, pL143, DOI 10.1152/ajplung.2000.279.1.L143; Weaver TE, 2002, SEMIN CELL DEV BIOL, V13, P263, DOI 10.1016/S1084952102000551; Welk V, 2016, J BIOL CHEM, V291, P13147, DOI 10.1074/jbc.M116.717652; Zhu K, 2010, ONCOGENE, V29, P451, DOI 10.1038/onc.2009.343	42	7	9	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2019	33	11					12392	12408		10.1096/fj.201900854R	http://dx.doi.org/10.1096/fj.201900854R			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC8ZX	31431059	Green Published			2022-12-26	WOS:000507461600062
J	Xu, XY; Yan, Q; Liu, XY; Li, P; Li, XS; Chen, YW; Simoncini, T; Liu, JX; Zhu, DX; Fu, XD				Xu, Xingyan; Yan, Qing; Liu, Xiaoyun; Li, Ping; Li, Xiaosa; Chen, Yiwen; Simoncini, Tommaso; Liu, Junxiu; Zhu, Dongxing; Fu, Xiaodong			17?-Estradiol nongenomically induces vascular endothelial H2S release by promoting phosphorylation of cystathionine ?-lyase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cyclic GMP (cGMP); protein kinase G (PKG); estrogen; hydrogen sulfide; endothelial cell; 17?-estradiol; vascular endothelial cells; cystathionine ?-lyase; vasodilation; vasorelaxation; cell signaling; gene regulation; nongenomic regulation; sulfur metabolism	PROTEIN-KINASE G; G-ALPHA-I; ESTROGEN-RECEPTOR; SMOOTH-MUSCLE; HYDROGEN-SULFIDE; CELL-MIGRATION; CARDIOVASCULAR-DISEASE; KNOCKOUT MICE; ER-ALPHA; CGMP	Estrogen exerts its cardiovascular protective role at least in part by regulating endothelial hydrogen sulfide (H2S) release, but the underlying mechanisms remain to be fully elucidated. Estrogen exerts genomic effects, i.e. those involving direct binding of the estrogen receptor (ER) to gene promoters in the nucleus, and nongenomic effects, mediated by interactions of the ER with other proteins. Here, using human umbilical vein endothelial cells (HUVECs), immunological detection, MS-based analyses, and cGMP and H2S assays, we show that 17?-estradiol (E2) rapidly enhances endothelial H2S release in a nongenomic manner. We found that E2 induces phosphorylation of cystathionine ?-lyase (CSE), the key enzyme in vascular endothelial H2S generation. Mechanistically, E2 enhanced the interaction of membrane ER? with the G? subunit G?i-2/3, which then transactivated particulate guanylate cyclase-A (pGC-A) to produce cGMP, thereby activating protein kinase G type I (PKG-I). We also found that PKG-I?, but not PKG-I?, interacts with CSE, leading to its phosphorylation, and rapidly induces endothelial H2S release. Furthermore, we report that silencing of either CSE or pGC-A in mice attenuates E2-induced aorta vasodilation. These results provide detailed mechanistic insights into estrogen's nongenomic effects on vascular endothelial H2S release and advance our current understanding of the protective activities of estrogen in the cardiovascular system.	[Xu, Xingyan; Yan, Qing; Liu, Xiaoyun; Li, Ping; Li, Xiaosa; Chen, Yiwen; Zhu, Dongxing; Fu, Xiaodong] Guangzhou Med Univ, Affiliated Hosp 6, Dept Gynecol & Obstet, Guangzhou 510260, Guangdong, Peoples R China; [Xu, Xingyan; Yan, Qing; Liu, Xiaoyun; Li, Ping; Li, Xiaosa; Chen, Yiwen; Zhu, Dongxing; Fu, Xiaodong] Guangzhou Med Univ, Sch Basic Med Sci, State Key Lab Resp Dis, Guangzhou 511436, Guangdong, Peoples R China; [Simoncini, Tommaso] Univ Pisa, Dept Reprod Med & Child Dev, Mol & Cellular Gynecol Endocrinol Lab, I-56100 Pisa, Italy; [Liu, Junxiu] Sun Yat Sen Univ, Dept Gynecol & Obstet, Affiliated Hosp 1, Guangzhou 510080, Guangdong, Peoples R China	Guangzhou Medical University; Guangzhou Medical University; State Key Laboratory of Respiratory Disease; University of Pisa; Sun Yat Sen University	Zhu, DX; Fu, XD (corresponding author), Guangzhou Med Univ, Affiliated Hosp 6, Dept Gynecol & Obstet, Guangzhou 510260, Guangdong, Peoples R China.; Zhu, DX; Fu, XD (corresponding author), Guangzhou Med Univ, Sch Basic Med Sci, State Key Lab Resp Dis, Guangzhou 511436, Guangdong, Peoples R China.; Liu, JX (corresponding author), Sun Yat Sen Univ, Dept Gynecol & Obstet, Affiliated Hosp 1, Guangzhou 510080, Guangdong, Peoples R China.	liujunxiu99@163.com; dongxing.hu@gzhmu.edu.cn; fuxiaod@mail.gzhmu.edu.cn	Simoncini, Tommaso/AAC-1879-2019; zhu, dongxing/AAM-4330-2020	Simoncini, Tommaso/0000-0002-2971-0079; zhu, dongxing/0000-0001-5419-438X	National Natural Science Foundation [81871137, 81471426, 81701411, 81872128, 81800428]; Project of Principal Scientists-Guang-zhou Municipal Universities 'Yangcheng Scholars' Grant [1201541587]; Project of Department of Education of Guangdong Province [2015KTSCX109]; National Funds of Developing Local Colleges and Universities [B16056001]; Science and Technology Program of Guangzhou [201804010376, 201904010289]; Guangzhou 121 Talent Program; Guangdong Natural Science Foundation [2017A030310158, 2018A030310178]; Innovation Project of Department of Education of Guangdong Province [2017KTSCX158]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Project of Principal Scientists-Guang-zhou Municipal Universities 'Yangcheng Scholars' Grant; Project of Department of Education of Guangdong Province; National Funds of Developing Local Colleges and Universities; Science and Technology Program of Guangzhou; Guangzhou 121 Talent Program; Guangdong Natural Science Foundation(National Natural Science Foundation of Guangdong Province); Innovation Project of Department of Education of Guangdong Province	This work was supported by National Natural Science Foundation Grants 81871137, 81471426 (to X. F.), The Project of Principal Scientists-Guang-zhou Municipal Universities 'Yangcheng Scholars' Grant 1201541587 (to X. F.), The Project of Department of Education of Guangdong Province Grant 2015KTSCX109 (to X. F.), National Funds of Developing Local Colleges and Universities Grant B16056001 (to X. F.), Science and Technology Program of Guangzhou Grant 201804010376 (to X. F.), Guangzhou 121 Talent Program (to X. F.), National Natural Science Foundation for Young Scientists of China Grant 81701411 (to X. Liu), Guangdong Natural Science Foundation Grant 2017A030310158 (to X. Liu), National Natural Science Foundation Grant 81872128 (to J. L.), National Natural Science Foundation for Young Scientists of China Grant 81800428 (to D. Z.), The Innovation Project of Department of Education of Guangdong Province Grant 2017KTSCX158 (to D. Z.), Guangdong Natural Science Foundation Grant 2018A030310178 (to D. Z.), and Science and Technology Program of Guangzhou Grant 201904010289 (to D. Z.). The authors declare that they have no conflicts of interest with the contents of this article.	Arnal JF, 2009, CLIMACTERIC, V12, P12, DOI 10.1080/13697130902820006; Arnal JF, 2010, ARTERIOSCL THROM VAS, V30, P1506, DOI 10.1161/ATVBAHA.109.191221; Bartell SM, 2013, MOL ENDOCRINOL, V27, P649, DOI 10.1210/me.2012-1368; Belo NO, 2008, ENDOCRINOLOGY, V149, P1399, DOI 10.1210/en.2007-0572; Bibli SI, 2019, CIRCULATION, V139, P101, DOI 10.1161/CIRCULATIONAHA.118.034757; Bourassa PAK, 1996, P NATL ACAD SCI USA, V93, P10022, DOI 10.1073/pnas.93.19.10022; Chambliss KL, 2010, J CLIN INVEST, V120, P2319, DOI 10.1172/JCI38291; Chen HJ, 2008, J BIOL CHEM, V283, P4439, DOI 10.1074/jbc.M709439200; Dennis MK, 2011, J STEROID BIOCHEM, V127, P358, DOI 10.1016/j.jsbmb.2011.07.002; Ellerbroek SM, 2003, J BIOL CHEM, V278, P19023, DOI 10.1074/jbc.M213066200; Fallahian F, 2011, FEBS J, V278, P3360, DOI 10.1111/j.1742-4658.2011.08260.x; Fu XD, 2013, INT J CARDIOL, V167, P1061, DOI 10.1016/j.ijcard.2012.10.071; Genazzani AR, 2013, NAT REV ENDOCRINOL, V9, P5, DOI 10.1038/nrendo.2012.228; Goglia L, 2010, MOL HUM REPROD, V16, P761, DOI 10.1093/molehr/gaq049; Harman SM, 2014, FERTIL STERIL, V101, P887, DOI 10.1016/j.fertnstert.2014.02.042; Hodis HN, 2016, NEW ENGL J MED, V374, P1221, DOI 10.1056/NEJMoa1505241; Hofmann F, 2006, PHYSIOL REV, V86, P1, DOI 10.1152/physrev.00015.2005; Holt AW, 2016, CELL SIGNAL, V28, P1364, DOI 10.1016/j.cellsig.2016.06.012; Iwakura A, 2003, CIRCULATION, V108, P3115, DOI 10.1161/01.CIR.0000106906.56972.83; Jackson-Weaver O, 2013, AM J PHYSIOL-HEART C, V304, pH1446, DOI 10.1152/ajpheart.00506.2012; Jiang P, 2010, J MOL ENDOCRINOL, V45, P87, DOI 10.1677/JME-09-0166; KENNELLY PJ, 1991, J BIOL CHEM, V266, P15555; Keung W, 2011, PHARMACOL RES, V64, P509, DOI 10.1016/j.phrs.2011.05.010; Kim HY, 2017, J PHYSIOL PHARMACOL, V68, P215; Kim KH, 2014, MOL CELL ENDOCRINOL, V389, P65, DOI 10.1016/j.mce.2014.02.001; Koika V, 2010, VASC PHARMACOL, V53, P215, DOI 10.1016/j.vph.2010.08.004; Kumar P, 2007, MOL ENDOCRINOL, V21, P1370, DOI 10.1210/me.2006-0360; Levin ER, 2009, TRENDS ENDOCRIN MET, V20, P477, DOI 10.1016/j.tem.2009.06.009; Li P, 2017, J CLIN ENDOCR METAB, V102, P594, DOI 10.1210/jc.2016-2974; Liu J, 2010, NAT NEUROSCI, V13, P715, DOI 10.1038/nn.2540; Madhani M, 2006, BRIT J PHARMACOL, V149, P797, DOI 10.1038/sj.bjp.0706920; Mani S, 2013, CIRCULATION, V127, P2523, DOI 10.1161/CIRCULATIONAHA.113.002208; Marathe N, 2012, J BIOL CHEM, V287, P978, DOI 10.1074/jbc.M111.294959; Mendelsohn ME, 1999, NEW ENGL J MED, V340, P1801, DOI 10.1056/NEJM199906103402306; Meyer MR, 2009, CARDIOVASC RES, V83, P605, DOI 10.1093/cvr/cvp187; Moens SJB, 2012, CIRCULATION, V126, P1993, DOI 10.1161/CIRCULATIONAHA.112.124529; Mombouli JV, 1999, J MOL CELL CARDIOL, V31, P61, DOI 10.1006/jmcc.1998.0844; Mozaffarian D, 2016, CIRCULATION, V133, pE38, DOI 10.1161/CIR.0000000000000350; Mustafa AK, 2011, CIRC RES, V109, P1259, DOI 10.1161/CIRCRESAHA.111.240242; Pan LL, 2012, ANTIOXID REDOX SIGN, V17, P106, DOI 10.1089/ars.2011.4349; Pfeifer A, 1998, EMBO J, V17, P3045, DOI 10.1093/emboj/17.11.3045; Predmore BL, 2011, FRONT PHYSIOL, V2, DOI 10.3389/fphys.2011.00104; Renga B, 2015, AM J PHYSIOL-HEART C, V309, pH114, DOI 10.1152/ajpheart.00087.2015; Sabrane K, 2005, J CLIN INVEST, V115, P1666, DOI 10.1172/JCI23360; Schierbeck LL, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e6409; Schlossmann J, 2000, NATURE, V404, P197, DOI 10.1038/35004606; Shah RC, 2018, NITRIC OXIDE-BIOL CH, V76, P97, DOI 10.1016/j.niox.2018.03.013; Simoncini T, 2000, NATURE, V407, P538, DOI 10.1038/35035131; Simoncini T, 2006, MOL ENDOCRINOL, V20, P1756, DOI 10.1210/me.2005-0259; Stratton RC, 2010, J BIOL CHEM, V285, P27201, DOI 10.1074/jbc.M110.103630; Surks HK, 1999, SCIENCE, V286, P1583, DOI 10.1126/science.286.5444.1583; Tokudome T, 2005, CIRCULATION, V111, P3095, DOI 10.1161/CIRCULATIONAHA.104.510594; Wang YF, 2009, ARTERIOSCL THROM VAS, V29, P173, DOI 10.1161/ATVBAHA.108.179333; Weber S, 2007, CIRC RES, V101, P1096, DOI 10.1161/CIRCRESAHA.107.154351; Wooldridge AA, 2004, J BIOL CHEM, V279, P34496, DOI 10.1074/jbc.M405957200; Wu D, 2018, OXID MED CELL LONGEV, V2018, DOI 10.1155/2018/4579140; Wu Q, 2013, MOL ENDOCRINOL, V27, P2, DOI 10.1210/me.2011-1378; Yang GD, 2008, SCIENCE, V322, P587, DOI 10.1126/science.1162667; Yuan GX, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.2005846; Zhao WM, 2001, EMBO J, V20, P6008, DOI 10.1093/emboj/20.21.6008; Zheng SH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022439; Zhou KW, 2013, MOL HUM REPROD, V19, P169, DOI 10.1093/molehr/gas044	62	19	19	3	10	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 25	2019	294	43					15577	15592		10.1074/jbc.RA119.008597	http://dx.doi.org/10.1074/jbc.RA119.008597			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JQ9JD	31439665	Green Published, hybrid			2022-12-26	WOS:000499253000003
J	Sakhtemani, R; Senevirathne, V; Stewart, J; Perera, MLW; Pique-Regi, R; Lawrence, MS; Bhagwat, AS				Sakhtemani, Ramin; Senevirathne, Vimukthi; Stewart, Jessica; Perera, Madusha L. W.; Pique-Regi, Roger; Lawrence, Michael S.; Bhagwat, Ashok S.			Genome-wide mapping of regions preferentially targeted by the human DNA-cytosine deaminase APOBEC3A using uracil-DNA pulldown and sequencing	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA repair; base excision repair (BER); ChIP-sequencing (ChIP-seq); mutagenesis; DNA sequencing; AID; APOBEC; cytosine deaminase; UPD-Seq; uracilome	CYTIDINE DEAMINASE; ESCHERICHIA-COLI; ANTIBODY DIVERSIFICATION; NONTRANSCRIBED STRAND; MUTATIONAL PROCESSES; TRANSCRIPTION; MUTAGENESIS; POLYMERASE; REPAIR; GENES	Activation-induced deaminase (AID) and apolipoprotein B mRNA-editing enzyme catalytic subunit (APOBEC) enzymes convert cytosines to uracils, creating signature mutations that have been used to predict sites targeted by these enzymes. Mutation-based targeting maps are distorted by the error-prone or error-free repair of these uracils and by selection pressures. To directly map uracils created by AID/APOBEC enzymes, here we used uracil-DNA glycosylase and an alkoxyamine to covalently tag and sequence uracil-containing DNA fragments (UPD-Seq). We applied this technique to the genome of repair-defective, APOBEC3A-expressing bacterial cells and created a uracilation genome map, i.e. uracilome. The peak uracilated regions were in the 5?-ends of genes and operons mainly containing tRNA genes and a few protein-coding genes. We validated these findings through deep sequencing of pulldown regions and whole-genome sequencing of independent clones. The peaks were not correlated with high transcription rates or stable RNA:DNA hybrid formation. We defined the uracilation index (UI) as the frequency of occurrence of TT in UPD-Seq reads at different original TC dinucleotides. Genome-wide UI calculation confirmed that APOBEC3A modifies cytosines in the lagging-strand template during replication and in short hairpin loops. APOBEC3A's preference for tRNA genes was observed previously in yeast, and an analysis of human tumor sequences revealed that in tumors with a high percentage of APOBEC3 signature mutations, the frequency of tRNA gene mutations was much higher than in the rest of the genome. These results identify multiple causes underlying selection of cytosines by APOBEC3A for deamination, and demonstrate the utility of UPD-Seq.	[Sakhtemani, Ramin; Senevirathne, Vimukthi; Stewart, Jessica; Perera, Madusha L. W.; Bhagwat, Ashok S.] Wayne State Univ, Dept Chem, Detroit, MI 48202 USA; [Pique-Regi, Roger] Wayne State Univ, Ctr Mol Med & Genet, Sch Med, Detroit, MI 48201 USA; [Bhagwat, Ashok S.] Wayne State Univ, Dept Biochem Microbiol & Immunol, Sch Med, Detroit, MI 48201 USA; [Lawrence, Michael S.] Massachusetts Gen Hosp, Dept Pathol & Canc Ctr, Boston, MA 02114 USA	Wayne State University; Wayne State University; Wayne State University; Harvard University; Massachusetts General Hospital	Bhagwat, AS (corresponding author), Wayne State Univ, 443 Chem Bldg, Detroit, MI 48202 USA.	axb@chem.wayne.edu	Bhagwat, Ashok/ABA-3861-2020; Bhagwat, Ashok/AAU-4186-2021; Lawrence, Michael/AAC-8202-2020	Bhagwat, Ashok/0000-0003-1188-0579; Sakhtemani, Ramin/0000-0001-5342-9415	National Institutes of Health [R01GM57200]; Wayne State University	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wayne State University	This work was supported by National Institutes of Health Grant R01GM57200 and Wayne State University. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adolph MB, 2017, NUCLEIC ACIDS RES, V45, P11925, DOI 10.1093/nar/gkx832; Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Beletskii A, 1996, P NATL ACAD SCI USA, V93, P13919, DOI 10.1073/pnas.93.24.13919; Beletskii A, 2001, J BACTERIOL, V183, P6491, DOI 10.1128/JB.183.21.6491-6493.2001; Bhagwat AS, 2016, P NATL ACAD SCI USA, V113, P2176, DOI 10.1073/pnas.1522325113; Blatter N, 2014, CHEMBIOCHEM, V15, P1735, DOI 10.1002/cbic.201400051; BOGUSLAWSKI SJ, 1986, J IMMUNOL METHODS, V89, P123, DOI 10.1016/0022-1759(86)90040-2; Boudsocq F, 2001, NUCLEIC ACIDS RES, V29, P4607, DOI 10.1093/nar/29.22.4607; Bryan DS, 2014, GENOME RES, V24, P1534, DOI 10.1101/gr.174052.114; Buisson R, 2019, SCIENCE, V364, P1251, DOI 10.1126/science.aaw2872; Burns MB, 2015, BIOMED J, V38, P102, DOI 10.4103/2319-4170.148904; Burns MB, 2013, NAT GENET, V45, P977, DOI 10.1038/ng.2701; Burns MB, 2013, NATURE, V494, P366, DOI 10.1038/nature11881; Chan K, 2015, NAT GENET, V47, P1067, DOI 10.1038/ng.3378; Chiarle R, 2011, CELL, V147, P107, DOI 10.1016/j.cell.2011.07.049; Choi JY, 2010, J MOL BIOL, V404, P34, DOI 10.1016/j.jmb.2010.09.015; Conticello Silvestro G, 2007, Adv Immunol, V94, P37, DOI 10.1016/S0065-2776(06)94002-4; COOPER S, 1968, J MOL BIOL, V31, P519, DOI 10.1016/0022-2836(68)90425-7; El Hage A, 2010, GENE DEV, V24, P1546, DOI 10.1101/gad.573310; Favorov A, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002529; Flaherty P, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr861; Gazumyan A, 2012, ADV CANCER RES, V113, P167, DOI 10.1016/B978-0-12-394280-7.00005-1; Ginno PA, 2012, MOL CELL, V45, P814, DOI 10.1016/j.molcel.2012.01.017; GOULIAN M, 1980, P NATL ACAD SCI-BIOL, V77, P1956, DOI 10.1073/pnas.77.4.1956; Hansen EC, 2016, ELIFE, V5, DOI 10.7554/eLife.18447; Haradhvala NJ, 2016, CELL, V164, P538, DOI 10.1016/j.cell.2015.12.050; Henderson S, 2014, CELL REP, V7, P1833, DOI 10.1016/j.celrep.2014.05.012; Hoopes JI, 2016, CELL REP, V14, P1273, DOI 10.1016/j.celrep.2016.01.021; Jinks-Robertson S, 2014, ANNU REV GENET, V48, P341, DOI 10.1146/annurev-genet-120213-092015; Kennedy EM, 2011, J BIOL CHEM, V286, P25047, DOI 10.1074/jbc.M111.234047; Keseler IM, 2017, NUCLEIC ACIDS RES, V45, pD543, DOI 10.1093/nar/gkw1003; Klein IA, 2011, CELL, V147, P95, DOI 10.1016/j.cell.2011.07.048; KONRAD EB, 1975, P NATL ACAD SCI USA, V72, P2150, DOI 10.1073/pnas.72.6.2150; Krokan HE, 2014, DNA REPAIR, V19, P38, DOI 10.1016/j.dnarep.2014.03.028; Lada AG, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005217; Lada AG, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003736; Lari SU, 2006, DNA REPAIR, V5, P1407, DOI 10.1016/j.dnarep.2006.06.009; Lawrence MS, 2014, NATURE, V505, P495, DOI 10.1038/nature12912; Leonard B, 2013, CANCER RES, V73, P7222, DOI 10.1158/0008-5472.CAN-13-1753; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Li N, 2010, METHODS, V52, P203, DOI 10.1016/j.ymeth.2010.04.009; LINDAHL T, 1974, BIOCHEMISTRY-US, V13, P3405, DOI 10.1021/bi00713a035; Mundade R, 2014, CELL CYCLE, V13, P2847, DOI 10.4161/15384101.2014.949201; Nair DT, 2011, J MOL BIOL, V406, P18, DOI 10.1016/j.jmb.2010.12.016; Nik-Zainal S, 2016, NATURE, V534, P47, DOI 10.1038/nature17676; Nik-Zainal S, 2012, CELL, V149, P979, DOI 10.1016/j.cell.2012.04.024; Pettersen HS, 2015, DNA REPAIR, V25, P60, DOI 10.1016/j.dnarep.2014.11.006; R Core Team, 2021, R LANGUAGE ENV STAT; Ransom M, 2018, METHODS MOL BIOL, V1672, P63, DOI 10.1007/978-1-4939-7306-4_6; Roberts SA, 2013, NAT GENET, V45, P970, DOI 10.1038/ng.2702; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Saini N, 2017, DNA REPAIR, V53, P4, DOI 10.1016/j.dnarep.2017.03.003; Salter JD, 2018, TRENDS BIOCHEM SCI, V43, P606, DOI 10.1016/j.tibs.2018.04.013; Seplyarskiy VB, 2016, GENOME RES, V26, P174, DOI 10.1101/gr.197046.115; Shu XT, 2018, NAT CHEM BIOL, V14, P680, DOI 10.1038/s41589-018-0065-9; Sikorsky JA, 2007, BIOCHEM BIOPH RES CO, V355, P431, DOI 10.1016/j.bbrc.2007.01.169; Siriwardena SU, 2019, MOL CELL BIOL, V39, DOI 10.1128/MCB.00238-18; Siriwardena SU, 2016, CHEM REV, V116, P12688, DOI 10.1021/acs.chemrev.6b00296; Song CX, 2012, NAT METHODS, V9, P75, DOI [10.1038/NMETH.1779, 10.1038/nmeth.1779]; Sousa MML, 2007, MOL ASPECTS MED, V28, P276, DOI 10.1016/j.mam.2007.04.006; Swanton C, 2015, CANCER DISCOV, V5, P704, DOI 10.1158/2159-8290.CD-15-0344; Taylor BJM, 2014, ELIFE, V3, DOI 10.7554/eLife.03553; Taylor BJM, 2013, ELIFE, V2, DOI 10.7554/eLife.00534; TYE BK, 1977, P NATL ACAD SCI USA, V74, P154, DOI 10.1073/pnas.74.1.154; Visnes T, 2009, PHILOS T R SOC B, V364, P563, DOI 10.1098/rstb.2008.0186; Wahba L, 2016, GENE DEV, V30, P1327, DOI 10.1101/gad.280834.116; Weerasooriya S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107915; Wei SQ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185010; Weil AF, 2013, P NATL ACAD SCI USA, V110, pE448, DOI 10.1073/pnas.1219702110; Weinstein JN, 2013, NAT GENET, V45, P1113, DOI 10.1038/ng.2764; Wijesinghe P, 2012, NUCLEIC ACIDS RES, V40, P9206, DOI 10.1093/nar/gks685; Wright ES, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-3217-x; Yan N, 2011, P NATL ACAD SCI USA, V108, P9244, DOI 10.1073/pnas.1102943108; Yu KF, 2005, MOL CELL BIOL, V25, P1730, DOI 10.1128/MCB.25.5.1730-1736.2005; Yu KF, 2003, NAT IMMUNOL, V4, P442, DOI 10.1038/ni919; Zanotti KJ, 2016, DNA REPAIR, V38, P110, DOI 10.1016/j.dnarep.2015.11.011; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhang Zheng Z, 2015, BMC Res Notes, V8, P127, DOI 10.1186/s13104-015-1092-1; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	79	11	11	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 11	2019	294	41					15037	15051		10.1074/jbc.RA119.008053	http://dx.doi.org/10.1074/jbc.RA119.008053			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JQ9JH	31431505	hybrid, Green Published			2022-12-26	WOS:000499253400017
J	Nakamura, T; Ichii, O; Sunden, Y; Elewa, YHA; Yoshiyasu, T; Hattori, H; Tatsumi, O; Kon, Y; Nagasaki, K				Nakamura, Teppei; Ichii, Osamu; Sunden, Yuji; Elewa, Yaser Hosny Ali; Yoshiyasu, Tomoji; Hattori, Hideki; Tatsumi, Osamu; Kon, Yasuhiro; Nagasaki, Ken-ichi			Slc:Wistar/ST rats develop unilateral thyroid dysgenesis: A novel animal model of thyroid hemiagenesis	PLOS ONE			English	Article							SOLID CELL NESTS; STIMULATING HORMONE; PREVALENCE; DELETION	Developmental anomalies of the thyroid gland lead to congenital malformations such as thyroglossal duct cysts and thyroid dysgenesis. However, the pathogenesis of thyroid dysgenesis remains unclear due to the lack of suitable animal models. This study demonstrated that Slc:Wistar/ST rats frequently developed unilateral thyroid dysgenesis, including hemiagenesis, characterized by the absence of one lobe. In Wistar/ST rats, each thyroid lobe was frequently different in size, and approximately 27% and 20% of the rats presented with hemihypoplasia and hemiagenesis of the thyroid gland, respectively. Dysgenesis was predominant on the left side in both sexes, without sex differences. At a young age, thyroid hemiagenesis did not alter body weight. In rats of both sexes with thyroid hemiagenesis, plasma total triiodothyronine and total triiodothyronine levels remained unchanged while plasma thyroid-stimulating hormone levels were significantly elevated in young rats. The remaining thyroid lobes increased in weight, but the follicular epithelial cells appeared normal in terms of their height and proliferating activities. On the side of thyroid dysgenesis, the parathyroid glands were normally localized and were situated at the same location as the contralateral glands. The ultimobranchial body remnants were localized at the level of the thyroid gland along with the cranial thyroid artery and vein, forming cell clusters or cystic structures and containing calcitonin-positive C-cells. In conclusion, Wistar/ST rats developed unilateral thyroid dysgenesis and may be novel and useful animal models for thyroid hemiagenesis in humans and for morphogenesis of pharyngeal pouch-derived organs.	[Nakamura, Teppei; Tatsumi, Osamu] Japan Food Res Labs, Chitose Lab, Sect Biomed Sci, Chitose, Hokkaido, Japan; [Nakamura, Teppei; Ichii, Osamu; Elewa, Yaser Hosny Ali; Kon, Yasuhiro] Hokkaido Univ, Div Vet Med, Dept Basic Vet Sci, Lab Anat,Fac Vet Med, Sapporo, Hokkaido, Japan; [Sunden, Yuji] Tottori Univ, Lab Vet Pathol, Fac Agr, Tottori, Japan; [Elewa, Yaser Hosny Ali] Zagazig Univ, Dept Histol & Cytol, Fac Vet Med, Zagazig, Egypt; [Yoshiyasu, Tomoji; Hattori, Hideki] Japan Food Res Labs, Chitose Lab, Sect Biol Safety Res, Chitose, Hokkaido, Japan; [Nagasaki, Ken-ichi] Japan Food Res Labs, Sect Biol Safety Res, Tama Lab, Tama Ku, Tokyo, Japan	Hokkaido University; Tottori University; Egyptian Knowledge Bank (EKB); Zagazig University	Nakamura, T (corresponding author), Japan Food Res Labs, Chitose Lab, Sect Biomed Sci, Chitose, Hokkaido, Japan.; Nakamura, T (corresponding author), Hokkaido Univ, Div Vet Med, Dept Basic Vet Sci, Lab Anat,Fac Vet Med, Sapporo, Hokkaido, Japan.	nakamurate@jfrl.or.jp	Elewa, Yaser/T-7550-2019; Elewa, Yaser/ABD-8332-2020	Elewa, Yaser/0000-0002-7347-4587; NAKAMURA, Teppei/0000-0003-3204-0245	JSPS KAKENHI [JP18K0703708]; Japan Food Research Laboratories	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Japan Food Research Laboratories	This study was funded by JSPS KAKENHI, Grant Number: JP18K0703708. There was no additional external funding received for this study. TN, TY, HH, OT, and KN are employed by Japan Food Research Laboratories. Japan Food Research Laboratories provided support in the form of salaries for authors TN, TY, HH, OT, and KN, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "author contributions" section.	Amendola E, 2005, ENDOCRINOLOGY, V146, P5038, DOI 10.1210/en.2005-0882; Budny B, 2017, ENDOCRINE, V56, P279, DOI 10.1007/s12020-017-1287-4; CLARK OH, 1976, ENDOCRINOLOGY, V99, P988, DOI 10.1210/endo-99-4-988; Fagman H, 2007, HUM MOL GENET, V16, P276, DOI 10.1093/hmg/ddl455; Fagman H, 2004, AM J PATHOL, V164, P1865, DOI 10.1016/S0002-9440(10)63745-5; Fagman H, 2011, J MOL ENDOCRINOL, V46, pR33, DOI 10.1677/JME-10-0084; Fagman H, 2010, MOL CELL ENDOCRINOL, V323, P35, DOI 10.1016/j.mce.2009.12.008; Grevellec A, 2010, SEMIN CELL DEV BIOL, V21, P325, DOI 10.1016/j.semcdb.2010.01.022; Kameda Y, 2016, DEV DYNAM, V245, P323, DOI 10.1002/dvdy.24377; Kimura S, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00055; Korpal-Szczyrska M, 2008, THYROID, V18, P637, DOI 10.1089/thy.2007.0408; Kurt A, 2007, SAUDI MED J, V28, P593; Maiorana R, 2003, J CLIN ENDOCR METAB, V88, P1534, DOI 10.1210/jc.2002-021574; MELNICK JC, 1981, J CLIN ENDOCR METAB, V52, P247, DOI 10.1210/jcem-52-2-247; Mikosch P, 1999, THYROID, V9, P1075, DOI 10.1089/thy.1999.9.1075; Nakamura T, 2018, J VET MED SCI, V80, P1368, DOI 10.1292/jvms.18-0298; Nakamura T, 2018, HISTOL HISTOPATHOL, V33, P555, DOI 10.14670/HH-11-946; Nakanishi S, 2015, EXP ANIM TOKYO, V64, P25, DOI 10.1538/expanim.14-0051; Nilsson M, 2017, DEVELOPMENT, V144, P2123, DOI 10.1242/dev.145615; Polak M, 2004, HORM RES, V62, P14, DOI 10.1159/000080494; Postiglione MP, 2002, P NATL ACAD SCI USA, V99, P15462, DOI 10.1073/pnas.242328999; RAPP JP, 1974, P SOC EXP BIOL MED, V146, P1021; Rastogi MV, 2010, ORPHANET J RARE DIS, V5, DOI 10.1186/1750-1172-5-17; Reis JS, 2003, MODERN PATHOL, V16, P43, DOI 10.1097/01.MP.0000047306.72278.39; Moreno MJR, 2011, ENDOCR PATHOL, V22, P35, DOI 10.1007/s12022-010-9145-4; Ruchala M, 2010, EUR J ENDOCRINOL, V162, P153, DOI 10.1530/EJE-09-0590; Shabana W, 2000, EUR J PEDIATR, V159, P456, DOI 10.1007/s004310051307; Srbecka K, 2017, VIRCHOWS ARCH, V471, P393, DOI 10.1007/s00428-017-2201-4; Suzuki S, 2017, THYROID, V27, P1011, DOI 10.1089/thy.2016.0662; Szczepanek-Parulska E, 2017, J CLIN ENDOCR METAB, V102, P3124, DOI 10.1210/jc.2017-00784; Verma A, 2016, INT J SURG CASE REP, V27, P59, DOI 10.1016/j.ijscr.2016.07.055; Villacorte M, 2016, DEVELOPMENT, V143, P1958, DOI 10.1242/dev.134171; WILLIAMS ED, 1989, J PATHOL, V159, P135, DOI 10.1002/path.1711590208	33	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2019	14	8							e0221939	10.1371/journal.pone.0221939	http://dx.doi.org/10.1371/journal.pone.0221939			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW6AB	31465501	Green Published, Green Submitted, gold			2022-12-26	WOS:000485058200074
J	Bergeau, D; Mazurier, S; Barbey, C; Merieau, A; Chane, A; Goux, D; Bernard, S; Driouich, A; Lemanceau, P; Vicre, M; Latour, X				Bergeau, Dorian; Mazurier, Sylvie; Barbey, Corinne; Merieau, Annabelle; Chane, Andrea; Goux, Didier; Bernard, Sophie; Driouich, Azeddine; Lemanceau, Philippe; Vicre, Meite; Latour, Xavier			Unusual extracellular appendages deployed by the model strain Pseudomonas fluorescens C7R12	PLOS ONE			English	Article							III SECRETION SYSTEM; SYRINGAE PV. TOMATO; HRP PILUS; NONSPECIFIC ADHERENCE; BIOLOGICAL-CONTROL; ACTINOBACILLUS-ACTINOMYCETEMCOMITANS; POPULATION-DYNAMICS; IRON ACQUISITION; GENE-EXPRESSION; FE-PYOVERDINE	Pseudomonas fluorescens is considered to be a typical plant-associated saprophytic bacterium with no pathogenic potential. Indeed, some P. fluorescens strains are well-known rhizobacteria that promote plant growth by direct stimulation, by preventing the deleterious effects of pathogens, or both. Pseudomonas fluorescens C7R12 is a rhizosphere-competent strain that is effective as a biocontrol agent and promotes plant growth and arbuscular mycorrhization. This strain has been studied in detail, but no visual evidence has ever been obtained for extracellular structures potentially involved in its remarkable fitness and biocontrol performances. On transmission electron microscopy of negatively stained C7R12 cells, we observed the following appendages: multiple polar flagella, an inducible putative type three secretion system typical of phytopathogenic Pseudomonas syringae strains and densely bundled fimbria-like appendages forming a broad fractal-like dendritic network around single cells and microcolonies. The deployment of one or other of these elements on the bacterial surface depends on the composition and affinity for the water of the microenvironment. The existence, within this single strain, of machineries known to be involved in motility, chemotaxis, hypersensitive response, cellular adhesion and biofilm formation, may partly explain the strong interactions of strain C7R12 with plants and associated microflora in addition to the type three secretion system previously shown to be implied in mycorrhizae promotion.	[Bergeau, Dorian; Barbey, Corinne; Merieau, Annabelle; Chane, Andrea; Latour, Xavier] Normandie Univ, LMSM EA 4312, Evreux, France; [Mazurier, Sylvie; Lemanceau, Philippe] Univ Bourgogne Franche Comte, Univ Bourgogne, INRA, Agroecol,AgroSup Dijon, Dijon, France; [Barbey, Corinne; Merieau, Annabelle; Bernard, Sophie; Driouich, Azeddine; Vicre, Meite; Latour, Xavier] Struct Federat Rech Normandie Vegetale 4277 NORVE, Normandie, France; [Goux, Didier] Univ Caen Normandie, CMAbio3, SFR ICORE 4206, Ctr Microscopie Appl Biol, Caen, France; [Bernard, Sophie; Driouich, Azeddine; Vicre, Meite] Univ Rouen, EA 4358, Normandie Univ, Lab Glycobiol & Matrice Extracellulaire Vegetale, Mont St Aignan, France	INRAE; Institut Agro; AgroSup Dijon; Universite de Bourgogne; Universite de Caen Normandie; Universite de Rouen Normandie	Latour, X (corresponding author), Normandie Univ, LMSM EA 4312, Evreux, France.; Latour, X (corresponding author), Struct Federat Rech Normandie Vegetale 4277 NORVE, Normandie, France.	xavier.latour@univ-rouen.fr			French institution (Ministere de l'Enseignement Superieur, de la Recherche et de l'innovation, Region Normandie); French institution (Evreux Portes de Normandie agglomeration); VASI (Vegetal-Agronomie-Sols-Innovation) network; FEDER (European Union)	French institution (Ministere de l'Enseignement Superieur, de la Recherche et de l'innovation, Region Normandie); French institution (Evreux Portes de Normandie agglomeration); VASI (Vegetal-Agronomie-Sols-Innovation) network; FEDER (European Union)(European Commission)	This research was supported by grants from French institutions (Ministere de l'Enseignement Superieur, de la Recherche et de l'innovation, Region Normandie & the Evreux Portes de Normandie agglomeration), the VASI (Vegetal-Agronomie-Sols-Innovation) network & FEDER (European Union). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Backer R, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.01473; Barahona E, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2010.01471; Barahona E, 2011, APPL ENVIRON MICROB, V77, P5412, DOI 10.1128/AEM.00320-11; Barret M, 2013, ENV MICROBIOL REP, V5, P377, DOI 10.1111/1758-2229.12039; Belas R, 2014, TRENDS MICROBIOL, V22, P517, DOI 10.1016/j.tim.2014.05.002; Berg HC, 2003, ANNU REV BIOCHEM, V72, P19, DOI 10.1146/annurev.biochem.72.121801.161737; Bergsma-Vlami M, 2005, FEMS MICROBIOL ECOL, V52, P59, DOI 10.1016/j.femsec.2004.10.007; Bernard CS, 2009, J BACTERIOL, V191, P1961, DOI 10.1128/JB.01330-08; Berry JL, 2015, FEMS MICROBIOL REV, V39, P134, DOI 10.1093/femsre/fuu001; Bhattacharjee MK, 2001, J BACTERIOL, V183, P5927, DOI 10.1128/JB.183.20.5927-5936.2001; Bossis E, 2000, AGRONOMIE, V20, P51, DOI 10.1051/agro:2000112; Bouffartigues E, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00630; BOWEN GD, 1976, ANNU REV PHYTOPATHOL, V14, P121, DOI 10.1146/annurev.py.14.090176.001005; Boyd JM, 2008, INFECT IMMUN, V76, P1445, DOI 10.1128/IAI.01019-07; Brown IR, 2001, MOL PLANT MICROBE IN, V14, P394, DOI 10.1094/MPMI.2001.14.3.394; Burrows LL, 2012, ANNU REV MICROBIOL, V66, P493, DOI 10.1146/annurev-micro-092611-150055; Cole BJ, 2017, PLOS BIOL, V15, DOI 10.1371/journal.pbio.2002860; Collmer A, 2000, P NATL ACAD SCI USA, V97, P8770, DOI 10.1073/pnas.97.16.8770; Collmer A, 2002, TRENDS MICROBIOL, V10, P462, DOI 10.1016/S0966-842X(02)02451-4; Conrad JC, 2011, BIOPHYS J, V100, P1608, DOI 10.1016/j.bpj.2011.02.020; Cornelis GR, 2006, NAT REV MICROBIOL, V4, P811, DOI 10.1038/nrmicro1526; Cornelis GR, 2010, BIOL CHEM, V391, P745, DOI 10.1515/BC.2010.079; Crabill E, 2010, PLANT PHYSIOL, V154, P233, DOI 10.1104/pp.110.159723; Cusano AM, 2011, ENV MICROBIOL REP, V3, P203, DOI 10.1111/j.1758-2229.2010.00209.x; Dasgupta N, 2006, INFECT IMMUN, V74, P3334, DOI 10.1128/IAI.00090-06; De Weert S, 2006, PLANT-ASSOCIATED BACTERIA, P317; Dean P, 2011, FEMS MICROBIOL REV, V35, P1100, DOI 10.1111/j.1574-6976.2011.00271.x; DEWEGER LA, 1987, J BACTERIOL, V169, P2769, DOI 10.1128/jb.169.6.2769-2773.1987; Deziel E, 2001, J BACTERIOL, V183, P1195, DOI 10.1128/JB.183.4.1195-1204.2001; Diallo S, 2011, FEMS MICROBIOL ECOL, V75, P351, DOI 10.1111/j.1574-6941.2010.01023.x; DOWLING DN, 1994, TRENDS BIOTECHNOL, V12, P133, DOI 10.1016/0167-7799(94)90091-4; Engel J, 2009, CURR OPIN MICROBIOL, V12, P61, DOI 10.1016/j.mib.2008.12.007; EPARVIER A, 1991, FEMS MICROBIOL ECOL, V86, P177, DOI 10.1111/j.1574-6968.1991.tb04807.x; Fravel DR, 2005, ANNU REV PHYTOPATHOL, V43, P337, DOI 10.1146/annurev.phyto.43.032904.092924; Frey P, 1997, APPL ENVIRON MICROB, V63, P1852, DOI 10.1128/AEM.63.5.1852-1860.1997; Fu ZQ, 2006, J BACTERIOL, V188, P6060, DOI 10.1128/JB.00718-06; Geilfus CM, 2017, MOL PLANT, V10, P1371, DOI 10.1016/j.molp.2017.09.018; Ghirardi S, 2012, MICROB ECOL, V64, P725, DOI 10.1007/s00248-012-0065-3; Greenberg JT, 2003, CURR OPIN MICROBIOL, V6, P20, DOI 10.1016/S1369-5274(02)00004-8; Guo M, 2009, MOL PLANT MICROBE IN, V22, P1069, DOI 10.1094/MPMI-22-9-1069; Haapalainen M, 2009, MOL PLANT MICROBE IN, V22, P282, DOI 10.1094/MPMI-22-3-0282; Haas D, 2005, NAT REV MICROBIOL, V3, P307, DOI 10.1038/nrmicro1129; Haiko Johanna, 2013, Biology (Basel), V2, P1242, DOI 10.3390/biology2041242; Hazelbauer GL, 2008, TRENDS BIOCHEM SCI, V33, P9, DOI 10.1016/j.tibs.2007.09.014; Hintsche M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16428-9; HUYNH TV, 1989, SCIENCE, V245, P1374, DOI 10.1126/science.2781284; Jin QL, 2001, SCIENCE, V294, P2556, DOI 10.1126/science.1066397; Kachlany SC, 2000, J BACTERIOL, V182, P6169, DOI 10.1128/JB.182.21.6169-6176.2000; Kachlany SC, 2001, TRENDS MICROBIOL, V9, P429, DOI 10.1016/S0966-842X(01)02161-8; Kachlany SC, 2001, MOL MICROBIOL, V40, P542, DOI 10.1046/j.1365-2958.2001.02422.x; Kearns DB, 2010, NAT REV MICROBIOL, V8, P634, DOI 10.1038/nrmicro2405; KING EO, 1954, J LAB CLIN MED, V44, P301; Kohler T, 2000, J BACTERIOL, V182, P5990, DOI 10.1128/JB.182.21.5990-5996.2000; Latour X, 2003, AGRONOMIE, V23, P397, DOI 10.1051/agro:2003015; Latour X, 1996, APPL ENVIRON MICROB, V62, P2449, DOI 10.1128/AEM.62.7.2449-2456.1996; Latour X, 1997, AGRONOMIE, V17, P427, DOI 10.1051/agro:19970901; LEMANCEAU P, 1991, CROP PROT, V10, P279, DOI 10.1016/0261-2194(91)90006-D; LEMANCEAU P, 1995, APPL ENVIRON MICROB, V61, P1004, DOI 10.1128/AEM.61.3.1004-1012.1995; Li CM, 2002, EMBO J, V21, P1909, DOI 10.1093/emboj/21.8.1909; Liu P, 2016, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.01190; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loper JE, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002784; Lugtenberg BJJ, 2001, ANNU REV PHYTOPATHOL, V39, P461, DOI 10.1146/annurev.phyto.39.1.461; Marchi M, 2013, ENV MICROBIOL REP, V5, P393, DOI 10.1111/1758-2229.12048; Mavrodi DV, 2011, J BACTERIOL, V193, P177, DOI 10.1128/JB.00895-10; Mazurier S, 2004, FEMS MICROBIOL ECOL, V49, P455, DOI 10.1016/j.femsec.2004.04.019; Mazurier S, 2015, APPL ENVIRON MICROB, V81, P2579, DOI 10.1128/AEM.04160-14; Meyer JM, 2002, APPL ENVIRON MICROB, V68, P2745, DOI 10.1128/AEM.68.6.2745-2753.2002; Mirleau P, 2001, APPL ENVIRON MICROB, V67, P2627, DOI 10.1128/AEM.67.6.2627-2635.2001; Mirleau P, 2000, FEMS MICROBIOL ECOL, V34, P35, DOI 10.1111/j.1574-6941.2000.tb00752.x; Nazir R, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00038; Nykyri J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073718; Oh HS, 2010, MOL PLANT MICROBE IN, V23, P727, DOI 10.1094/MPMI-23-6-0727; Ortiz-Martin I, 2010, MOL PLANT MICROBE IN, V23, P665, DOI 10.1094/MPMI-23-5-0665; Palleroni NJ, 1992, PROKARYOTES, P3071; Paul MJ, 2008, ANNU REV PLANT BIOL, V59, P417, DOI 10.1146/annurev.arplant.59.032607.092945; Ping LY, 2013, FEMS MICROBIOL ECOL, V86, P36, DOI 10.1111/1574-6941.12076; Pivato B, 2009, MYCORRHIZA, V19, P81, DOI 10.1007/s00572-008-0205-2; Ponnu J, 2011, FRONT PLANT SCI, V2, DOI 10.3389/fpls.2011.00070; Poueymiro M, 2014, MBIO, V5, DOI 10.1128/mBio.02065-14; Preston GM, 2001, MOL MICROBIOL, V41, P999, DOI 10.1046/j.1365-2958.2001.02560.x; Quinaud M, 2005, J BIOL CHEM, V280, P36293, DOI 10.1074/jbc.M508089200; Raatz M, 2015, EUR PHYS J-SPEC TOP, V224, P1185, DOI 10.1140/epjst/e2015-02454-3; Ramos JL., 2004, PSEUDOMONAS VIRULENC, V2; Rashid MH, 2000, P NATL ACAD SCI USA, V97, P4885, DOI 10.1073/pnas.060030097; Rezzonico F, 2005, MOL PLANT MICROBE IN, V18, P991, DOI 10.1094/MPMI-18-0991; Roine E, 1997, P NATL ACAD SCI USA, V94, P3459, DOI 10.1073/pnas.94.7.3459; Rossignol G, 2009, RES MICROBIOL, V160, P337, DOI 10.1016/j.resmic.2009.04.004; Rossignol G, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-189; Ryan PR, 2009, PLANT SOIL, V321, P363, DOI 10.1007/s11104-009-0001-6; Sanchez L, 2005, PLANT PHYSIOL, V139, P1065, DOI 10.1104/pp.105.067603; Shirley M, 2011, BOTANY, V89, P731, DOI [10.1139/B11-054, 10.1139/b11-054]; Silby MW, 2011, FEMS MICROBIOL REV, V35, P652, DOI 10.1111/j.1574-6976.2011.00269.x; Silby MW, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-5-r51; Spiers AJ, 2000, MICROBIOL-SGM, V146, P2345, DOI 10.1099/00221287-146-10-2345; Tampakaki AP, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00114; TAUSCHEL HD, 1987, ARCH MICROBIOL, V148, P159, DOI 10.1007/BF00425366; Tomich M, 2007, NAT REV MICROBIOL, V5, P363, DOI 10.1038/nrmicro1636; Trapet P, 2016, PLANT PHYSIOL, V171, P675, DOI 10.1104/pp.15.01537; Treseder KK, 2015, MICROBIOL MOL BIOL R, V79, P243, DOI 10.1128/MMBR.00001-15; Troisfontaines P, 2005, PHYSIOLOGY, V20, P326, DOI 10.1152/physiol.00011.2005; Tseng TT, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-S1-S2; Turnbull L, 2014, METHODS MOL BIOL, V1149, P73, DOI 10.1007/978-1-4939-0473-0_9; Van Gijsegem F, 2000, MOL MICROBIOL, V36, P249, DOI 10.1046/j.1365-2958.2000.01851.x; VANLAERE A, 1989, FEMS MICROBIOL LETT, V63, P201, DOI 10.1016/0378-1097(89)90130-4; Vansuyt G, 2007, MOL PLANT MICROBE IN, V20, P441, DOI 10.1094/MPMI-20-4-0441; Viollet A, 2017, MYCORRHIZA, V27, P23, DOI 10.1007/s00572-016-0730-3; Viollet A, 2011, FEMS MICROBIOL ECOL, V75, P457, DOI 10.1111/j.1574-6941.2010.01021.x; Wairuri CK, 2012, MOL PLANT MICROBE IN, V25, P546, DOI 10.1094/MPMI-06-11-0166; Weller DM, 2007, PHYTOPATHOLOGY, V97, P250, DOI 10.1094/PHYTO-97-2-0250; Weston DJ, 2012, MOL PLANT MICROBE IN, V25, P765, DOI 10.1094/MPMI-09-11-0253; Wiemken V, 2007, NEW PHYTOL, V174, P228, DOI 10.1111/j.1469-8137.2007.02049.x; Yang A, 2017, BIOPHYS J, V112, P1462, DOI 10.1016/j.bpj.2017.02.019	113	5	5	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2019	14	8							e0221025	10.1371/journal.pone.0221025	http://dx.doi.org/10.1371/journal.pone.0221025			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5XV	31461454	gold, Green Submitted, Green Published			2022-12-26	WOS:000485052300021
J	Kim, B; Choi, W; Lee, H				Kim, Baeksoo; Choi, Wonjun; Lee, Hyunju			A corpus of plant-disease relations in the biomedical domain	PLOS ONE			English	Article							DISCOVERY; AGREEMENT	Background Many new medicines have been derived from natural sources such as plants, which have a long history of being used for disease treatment. Thus, their benefits and side effects have been studied, and plant-related information including plant and disease relations have been accumulated in Medline articles. Because numerous articles are available in Medline and are written in natural language, text-mining is important. However, a corpus of plant and disease relations is not available yet. Thus, we aimed to construct such a corpus. Methods and results In this study, we designed and annotated a plant-disease relations corpus, and proposed a computational model to predict plant-disease relations using the corpus. We categorized plant and disease relations into four types: treatments of diseases, causes of diseases, associations, and negative relations. To construct a corpus of plant-disease relations, we first created its annotation guidelines and randomly selected 200 Medline abstracts. From these abstracts, we identified 1,405 and 1,755 plant and disease mentions, annotated to 105 and 237 unique plant and disease identifiers, respectively. When we selected sentences containing at least one plant and one disease mention, we extracted 878 plant and 1,077 disease entities, which finally generated a corpus of plant-disease relations including 1,309 relations from 199 abstracts. To verify the effectiveness of the corpus, we proposed a convolutional neural network model with the shortest dependency path (SDP-CNN) and applied it to the constructed corpus. The micro F-score with ten-fold cross-validation was found to be 0.764. We also applied the proposed SDP-CNN model to all Medline abstracts. When we measured its performance for 483 randomly selected plant-disease co-occurring sentences, the model showed a precision of 0.707. Conclusion The plant-disease relations corpus is unique and represents an important resource for biomedical text-mining. The corpus of plant and disease relations is available at http://gcancer.org/pdr/.	[Kim, Baeksoo; Choi, Wonjun; Lee, Hyunju] Gwangju Inst Sci & Technol, Sch Elect Engn & Comp Sci, Gwangju, South Korea	Gwangju Institute of Science & Technology (GIST)	Lee, H (corresponding author), Gwangju Inst Sci & Technol, Sch Elect Engn & Comp Sci, Gwangju, South Korea.	hyunjulee@gist.ac.kr	Choi, Wonjun/AAW-4388-2020	Lee, Hyunju/0000-0003-2389-7183	Bio-Synergy Research Project of the Ministry of Science, ICT and Future Planning through the National Research Foundation (NRF) [NRF-2016M3A9C4939665]; NRF of Korea grant - Korea government (MSIT) [NRF-2018M3A9A7053266]	Bio-Synergy Research Project of the Ministry of Science, ICT and Future Planning through the National Research Foundation (NRF); NRF of Korea grant - Korea government (MSIT)	This work was supported by Bio-Synergy Research Project (NRF-2016M3A9C4939665) of the Ministry of Science, ICT and Future Planning through the National Research Foundation (NRF) (HL); and NRF of Korea grant funded by the Korea government (MSIT) NRF-2018M3A9A7053266 (HL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was supported by the Bio-Synergy Research Project (NRF-2016M3A9C4939665) of the Ministry of Science, ICT and Future Planning through the National Research Foundation (NRF) and by NRF of Korea grant funded by the Korea government(MSIT) NRF-2018M3A9A7053266.	Barnes L., 2013, J AUSTR TRADITIONAL, V19, P179; Bjorne J, 2013, P BIONLP SHAR TASK 2, P16; Carpenter Bob, 2007, P 2 BIOCR CHALL EV W, V23, P307; Chin YW, 2006, AAPS J, V8, pE239, DOI 10.1007/BF02854894; Cohen AM, 2005, BRIEF BIOINFORM, V6, P57, DOI 10.1093/bib/6.1.57; Coletti MH, 2001, J AM MED INFORM ASSN, V8, P317, DOI 10.1136/jamia.2001.0080317; Davis AP, 2013, DATABASE-OXFORD, DOI 10.1093/database/bat080; Davis AP, 2012, DATABASE-OXFORD, DOI 10.1093/database/bar065; Dogan RI, 2014, J BIOMED INFORM, V47, P1, DOI 10.1016/j.jbi.2013.12.006; Fang YC, 2008, BMC COMPLEM ALTERN M, V8, DOI 10.1186/1472-6882-8-58; Federhen S, 2012, NUCLEIC ACIDS RES, V40, pD136, DOI 10.1093/nar/gkr1178; FEINSTEIN AR, 1990, J CLIN EPIDEMIOL, V43, P543, DOI 10.1016/0895-4356(90)90158-L; Hamosh A, 2005, NUCLEIC ACIDS RES, V33, pD514; Haruechaiyasak C., 2011, P 2011 WORKSH BIOM N, P186; Hendrickx I., 2009, P WORKSH SEM EV REC, P94, DOI DOI 10.3115/1621969.1621986; Holley JW, 1964, ED PSYCHOL MEASUREME; Huang CC, 2016, BRIEF BIOINFORM, V17, P132, DOI 10.1093/bib/bbv024; Kim HU, 2015, NAT BIOTECHNOL, V33, P264, DOI 10.1038/nbt.3167; Kim J, 2009, IEEE MICRO, V29, P33, DOI 10.1109/MM.2009.5; Kim Y., 2014, ARXIV14085882, DOI DOI 10.3115/V1/D14-1181; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Leaman R, 2013, BIOINFORMATICS, V29, P2909, DOI 10.1093/bioinformatics/btt474; Mikolov T., 2013, P ICLR WORKSH POST S; Moen S., 2013, P LBM, P39; Stenetorp Pontus, 2012, P DEM 13 C EUR CHAPT, P102; Tu YY, 2011, NAT MED, V17, P1217, DOI 10.1038/nm.2471; Wan HY, 2016, J AM MED INFORM ASSN, V23, P356, DOI 10.1093/jamia/ocv092; Wei CH, 2013, NUCLEIC ACIDS RES, V41, pW518, DOI 10.1093/nar/gkt441; Wei CH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038460; Wu ZH, 2004, LECT NOTES ARTIF INT, V3202, P459; Xu Y, 2015, CLASSIFYING RELATION, P1785, DOI DOI 10.18653/V1/D15-1206; Zeng D., 2014, COLING	32	3	4	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2019	14	8							e0221582	10.1371/journal.pone.0221582	http://dx.doi.org/10.1371/journal.pone.0221582			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5XV	31461491	Green Published, Green Submitted			2022-12-26	WOS:000485052300036
J	Kwon, E; Devkota, SR; Pathak, D; Dahal, P; Kim, DY				Kwon, Eunju; Devkota, Shankar Raj; Pathak, Deepak; Dahal, Pawan; Kim, Dong Young			Structural analysis of the recognition of the-35 promoter element by SigW from Bacillus subtilis	PLOS ONE			English	Article							BACTERIAL RNA-POLYMERASE; INTRAMEMBRANE PROTEOLYSIS; ANTIMICROBIAL PEPTIDES; STRESS-RESPONSE; SIGMA(W); SEQUENCE; IDENTIFICATION	Sigma factors are key proteins that mediate the recruitment of RNA polymerase to the promoter regions of genes, for the initiation of bacterial transcription. Multiple sigma factors in a bacterium selectively recognize their cognate promoter sequences, thereby inducing the expression of their own regulons. In this paper, we report the crystal structure of the sigma 4 domain of Bacillus subtilis SigW bound to the -35 promoter element. Purine-specific hydrogen bonds of the -35 promoter element with the recognition helix alpha 9 of the sigma 4 domain occurs at three nucleotides of the consensus sequence (G(-35), A(-34), and G'(-31) in G(-35)A(-34)A(-33)A(-32) C-31C-30T-29). The hydrogen bonds of the backbone with the alpha 7 and alpha 8 of the sigma 4 domain occurs at G'(-30). These results elucidate the structural basis of the selective recognition of the promoter by SigW. In addition, comparison of SigW structures complexed with the -35 promoter element or with anti-sigma RsiW reveals that DNA recognition and anti-sigma factor binding of SigW are mutually exclusive.	[Kwon, Eunju; Devkota, Shankar Raj; Pathak, Deepak; Dahal, Pawan; Kim, Dong Young] Yeungnam Univ, Coll Pharm, Gyongsan, Gyeongbuk, South Korea	Yeungnam University	Kim, DY (corresponding author), Yeungnam Univ, Coll Pharm, Gyongsan, Gyeongbuk, South Korea.	dyokim@ynu.ac.kr		Devkota, Shankar Raj/0000-0002-3154-7928; Kim, Dong Young/0000-0001-7594-9083	Yeungnam University Research Grant	Yeungnam University Research Grant	DYK was supported by the Yeungnam University Research Grant. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Asai K, 2017, GENES GENET SYST, V92, P223, DOI 10.1266/ggs.17-00046; BARTON GJ, 1993, PROTEIN ENG, V6, P37, DOI 10.1093/protein/6.1.37; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; BURGESS RR, 1969, NATURE, V221, P43, DOI 10.1038/221043a0; Campagne S, 2014, NAT STRUCT MOL BIOL, V21, P269, DOI 10.1038/nsmb.2777; Campbell EA, 2002, MOL CELL, V9, P527, DOI 10.1016/S1097-2765(02)00470-7; Cao M, 2002, MOL MICROBIOL, V45, P1267, DOI 10.1046/j.1365-2958.2002.03050.x; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Devkota SR, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174284; Ellermeier CD, 2006, GENE DEV, V20, P1911, DOI 10.1101/gad.1440606; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; ERICKSON JW, 1989, GENE DEV, V3, P1462, DOI 10.1101/gad.3.9.1462; Feklistov A, 2014, ANNU REV MICROBIOL, V68, P357, DOI 10.1146/annurev-micro-092412-155737; Feklistov A, 2011, CELL, V147, P1257, DOI 10.1016/j.cell.2011.10.041; Hahne H, 2010, J BACTERIOL, V192, P870, DOI 10.1128/JB.01106-09; Haran TE, 2009, Q REV BIOPHYS, V42, P41, DOI 10.1017/S0033583509004752; Haugen SP, 2008, P NATL ACAD SCI USA, V105, P3292, DOI [10.1073/pnas.0709513105, 10.1073/pnas.07095l3105]; Haugen SP, 2006, CELL, V125, P1069, DOI 10.1016/j.cell.2006.04.034; Heinrich J, 2009, MOL MICROBIOL, V74, P1412, DOI 10.1111/j.1365-2958.2009.06940.x; Helmann JD, 2002, ADV MICROB PHYSIOL, V46, P47; Holm L, 2016, NUCLEIC ACIDS RES, V44, pW351, DOI 10.1093/nar/gkw357; Huang XJ, 1998, J BACTERIOL, V180, P3765, DOI 10.1128/JB.180.15.3765-3770.1998; Hubin EA, 2017, ELIFE, V6, DOI 10.7554/eLife.22520; Jurrus E, 2018, PROTEIN SCI, V27, P112, DOI 10.1002/pro.3280; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kunst F, 1997, NATURE, V390, P249, DOI 10.1038/36786; Lane WJ, 2006, PLOS BIOL, V4, P1491, DOI 10.1371/journal.pbio.0040269; Laskowski RA, 2011, J CHEM INF MODEL, V51, P2778, DOI 10.1021/ci200227u; Li LT, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09096-y; LONETTO M, 1992, J BACTERIOL, V174, P3843, DOI 10.1128/jb.174.12.3843-3849.1992; Lu XJ, 2008, NAT PROTOC, V3, P1213, DOI 10.1038/nprot.2008.104; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Miticka H, 2004, FEMS MICROBIOL LETT, V238, P227, DOI 10.1016/j.femsle.2004.07.039; Osterberg S, 2011, ANNU REV MICROBIOL, V65, P37, DOI 10.1146/annurev.micro.112408.134219; Paget MS, 2015, BIOMOLECULES, V5, P1245, DOI 10.3390/biom5031245; Park Suk-Youl, 2017, Biodesign, V5, P30; Pietiainen M, 2005, MICROBIOL-SGM, V151, P1577, DOI 10.1099/mic.0.27761-0; Rhodius VA, 2006, PLOS BIOL, V4, P43, DOI 10.1371/journal.pbio.0040002; Saecker RM, 2011, J MOL BIOL, V412, P754, DOI 10.1016/j.jmb.2011.01.018; Schobel S, 2004, MOL MICROBIOL, V52, P1091, DOI 10.1111/j.1365-2958.2004.04031.x; Schrodinger L.L.C.,, 2015, PYMOL MOL GRAPHICS S; Staron A, 2009, MOL MICROBIOL, V74, P557, DOI 10.1111/j.1365-2958.2009.06870.x; Steil L, 2003, J BACTERIOL, V185, P6358, DOI 10.1128/JB.185.21.6358-6370.2003; Wiegert T, 2001, MOL MICROBIOL, V41, P59, DOI 10.1046/j.1365-2958.2001.02489.x; Wigneshweraraj S, 2008, MOL MICROBIOL, V68, P538, DOI 10.1111/j.1365-2958.2008.06181.x; Yoshimura M, 2004, MICROBIOL-SGM, V150, P591, DOI 10.1099/mic.0.26712-0; Zellmeier S, 2006, MOL MICROBIOL, V61, P1569, DOI 10.1111/j.1365-2958.2006.05323.x	48	2	2	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2019	14	8							e0221666	10.1371/journal.pone.0221666	http://dx.doi.org/10.1371/journal.pone.0221666			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5XV	31461489	Green Submitted, Green Published, gold			2022-12-26	WOS:000485052300041
J	Patrick, R; Jain, J; Harvey-Vera, A; Semple, SJ; Rangel, G; Patterson, TL; Pines, HA				Patrick, Rudy; Jain, Jennifer; Harvey-Vera, Alicia; Semple, Shirley J.; Rangel, Gudelia; Patterson, Thomas L.; Pines, Heather A.			Perceived barriers to pre-exposure prophylaxis use among HIV-negative men who have sex with men in Tijuana, Mexico: A latent class analysis	PLOS ONE			English	Article							YOUNG MEN; SOCIAL SUPPORT; ANTIRETROVIRAL PROPHYLAXIS; TRANSGENDER PERSONS; BISEXUAL MEN; PREVENTION; RISK; PREP; ACCEPTABILITY; GAY	Background Given the slow uptake of PrEP among cisgender men who have sex with men (MSM) in high-income countries, efforts to roll-out PrEP in low- and middle-income countries (LMIC) should address barriers to PrEP use to facilitate its more rapid uptake. To inform PrEP programs in LMIC, we examined patterns of perceived barriers to PrEP use among HIV-negative MSM in Tijuana, Mexico. Methods From 03/2016-09/2017, 364 MSM completed interviewer-administered surveys assessing perceived barriers to PrEP use across 4 domains: PrEP attribute, individual, interpersonal, and structural. Latent class analysis was performed to identify distinct classes with respect to perceived barriers to PrEP use. Multinomial logistic regression was used to identify factors associated with class membership. Results We identified three classes characterized by (1) high levels of perceived barriers across domains (12%), (2) low levels of perceived barriers across domains (43%), and (3) perceived PrEP attribute barriers (i.e., side-effects and cost) (45%). Membership in the high level of perceived barriers class (vs. the low level of perceived barriers class) was positively associated with having a history of incarceration (AOR: 2.44; 95% CI: 1.04, 5.73) and negatively associated with more social support (AOR: 0.99; 95% CI: 0.98, 1.00). Membership in the perceived PrEP attribute barriers class was positively associated with having seen a healthcare provider in the past year (AOR: 2.78; 95% CI: 1.41, 5.45) and negatively associated with having any HIV-positive or status unknown partners (AOR: 0.56; 95% CI: 0.31, 1.01). Conclusions Since most participants were in either the low level of perceived barriers class or the perceived PrEP attribute barriers class, future PrEP uptake may be high among MSM in Tijuana. However, these findings suggest that achieving sufficient PrEP uptake and adherence among MSM in Tijuana may require a range of comprehensive HIV prevention interventions.	[Patrick, Rudy; Jain, Jennifer; Harvey-Vera, Alicia; Pines, Heather A.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Semple, Shirley J.; Patterson, Thomas L.] Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92093 USA; [Rangel, Gudelia] US Mexico Border Hlth Commiss, Tijuana, Mexico; [Rangel, Gudelia] El Colegio Frontera Norte, Tijuana, Mexico	University of California System; University of California San Diego; University of California System; University of California San Diego; Colegio Frontera Norte	Pines, HA (corresponding author), Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA.	hpines@ucsd.edu		Pines, Heather/0000-0002-7173-1981; HARVEY-VERA, ALICIA/0000-0002-8708-8169	National Institute on Drug Abuse [KO1DA040543, RO1DA037811, T32DA023356]; NATIONAL INSTITUTE ON DRUG ABUSE [K01DA040543, R01DA037811, T32DA023356] Funding Source: NIH RePORTER	National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by grants from the National Institute on Drug Abuse: KO1DA040543 (HAP), RO1DA037811 (TLP), and T32DA023356. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams LM, 2016, AIDS CARE, V28, P1154, DOI 10.1080/09540121.2016.1153595; Albertie A, 2017, GLOB PUBLIC HEALTH, V12, P170, DOI 10.1080/17441692.2015.1091023; Baeten JM, 2012, NEW ENGL J MED, V367, P399, DOI 10.1056/NEJMoa1108524; Bakk Z, 2014, POLIT ANAL, V22, P520, DOI 10.1093/pan/mpu003; Bandoli G, 2018, PAEDIATR PERINAT EP, V32, P390, DOI 10.1111/ppe.12474; Baral S, 2007, PLOS MED, V4, P1901, DOI 10.1371/journal.pmed.0040339; Bauermeister JA, 2014, CURR HIV RES, V11, P520, DOI 10.2174/1570162X12666140129100411; Bautista-Arredondo S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072616; Beyrer C, 2012, LANCET, V380, P367, DOI 10.1016/S0140-6736(12)60821-6; Bourey C, 2018, AIDS BEHAV, V22, P4019, DOI 10.1007/s10461-018-2216-0; Brooks RA, 2011, AIDS CARE, V23, P1136, DOI 10.1080/09540121.2011.554528; Caceres CF, 2016, J INT AIDS SOC, V19, DOI 10.7448/IAS.19.7.21108; Calabrese SK, 2018, J INT AIDS SOC, V21, DOI 10.1002/jia2.25147; Calabrese SK, 2018, AIDS BEHAV, V22, P1122, DOI 10.1007/s10461-017-1979-z; Castel AD, 2015, JAIDS-J ACQ IMM DEF, V70, P520, DOI 10.1097/QAI.0000000000000780; Centers for Disease Control and Prevention (CDC), 2003, MMWR Morb Mortal Wkly Rep, V52, P81; Chakrapani V, 2015, AIDS PATIENT CARE ST, V29, P569, DOI 10.1089/apc.2015.0143; Chan PA, 2015, AIDS PATIENT CARE ST, V29, P597, DOI 10.1089/apc.2015.0113; Choopanya K, 2013, LANCET, V381, P2083, DOI 10.1016/S0140-6736(13)61127-7; Cohen SE, 2014, J ACQ IMMUN DEF SYND, V68, P439, DOI DOI 10.1097/QAI.0000000000000479; Collins LindaM., 2010, LATENT CLASS LATENT, DOI DOI 10.1002/9780470567333; Cunningham WE, 2018, JAMA INTERN MED, V178, P542, DOI 10.1001/jamainternmed.2018.0150; Draper BL, 2017, J INT AIDS SOC, V20, DOI 10.7448/IAS.20.1.22284; Dûíaz RM., 1998, LATINO GAY MEN HIV C; Galea JT, 2011, INT J STD AIDS, V22, P256, DOI 10.1258/ijsa.2009.009255; Glidden DV, 2016, CLIN INFECT DIS, V62, P1172, DOI 10.1093/cid/ciw022; Golub SA, 2013, AIDS PATIENT CARE ST, V27, P248, DOI 10.1089/apc.2012.0419; Gomez GB, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001323; GOODMAN LA, 1974, BIOMETRIKA, V61, P215, DOI 10.2307/2334349; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; Greenland S, 1999, EPIDEMIOLOGY, V10, P37, DOI 10.1097/00001648-199901000-00008; HAGENAARS JA, 1988, SOCIOL METHOD RES, V16, P379, DOI 10.1177/0049124188016003002; Heckathorn DD, 1997, SOC PROBL, V44, P174, DOI 10.1525/sp.1997.44.2.03x0221m; Hoornenborg E, 2017, AIDS, V31, P2179, DOI 10.1097/QAD.0000000000001627; Irwin M, 1999, ARCH INTERN MED, V159, P1701, DOI 10.1001/archinte.159.15.1701; Jenness SM, 2016, J INFECT DIS, V214, P1800, DOI 10.1093/infdis/jiw223; Salas-Espinoza KJ, 2017, AIDS BEHAV, V21, P3271, DOI 10.1007/s10461-017-1931-2; Khan MR, 2019, AIDS CARE, V31, P349, DOI 10.1080/09540121.2018.1499861; King HL, 2014, AIDS BEHAV, V18, P1722, DOI 10.1007/s10461-014-0845-5; Kojima N, 2016, OPEN FORUM INFECT DI, V3, DOI 10.1093/ofid/ofv221; Kubicek K, 2015, ARCH SEX BEHAV, V44, P487, DOI 10.1007/s10508-014-0398-8; Lazarsfeld P.F., 1968, LATENT STRUCTURE ANA; LeVasseur MT, 2018, JAIDS-J ACQ IMM DEF, V77, P31, DOI 10.1097/QAI.0000000000001555; Verduzco IL, 2016, AM J MENS HEALTH, V10, P270, DOI 10.1177/1557988314561490; MacKellar DA, 2007, PUBLIC HEALTH REP, V122, P39, DOI 10.1177/00333549071220S107; McCarty-Caplan D, 2014, AIDS BEHAV, V18, P1339, DOI 10.1007/s10461-013-0622-x; Moser A, 2012, J CLIN EPIDEMIOL, V65, P1107, DOI 10.1016/j.jclinepi.2012.04.007; Mugwanya KK, 2016, EXPERT OPIN DRUG SAF, V15, P265, DOI 10.1517/14740338.2016.1128412; Oldenburg CE, 2016, AIDS BEHAV, V20, P1451, DOI 10.1007/s10461-015-1226-4; Otis J, 2016, AIDS BEHAV, V20, P2812, DOI 10.1007/s10461-016-1344-7; Peng P, 2018, AIDS BEHAV, V22, P1063, DOI 10.1007/s10461-017-1675-z; Perez-Figueroa RE, 2015, AIDS EDUC PREV, V27, P112, DOI 10.1521/aeap.2015.27.2.112; Petroll AE, 2011, SEX TRANSM DIS, V38, P63, DOI 10.1097/OLQ.0b013e3181ebd50f; Pines HA, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010388; Pinto RM, 2018, AIDS BEHAV, V22, P3681, DOI 10.1007/s10461-018-2184-4; Pitpitan EV, 2015, J INT AIDS SOC, V18, DOI 10.7448/IAS.18.1.19304; Punyacharoensin N, 2016, LANCET HIV, V3, pE94, DOI 10.1016/S2352-3018(15)00056-9; Rendina HJ, 2017, SOC SCI MED, V172, P115, DOI 10.1016/j.socscimed.2016.10.030; Saleh LD, 2016, PSYCHOL HEALTH, V31, P549, DOI 10.1080/08870446.2015.1120301; Santos GM, 2013, JAIDS-J ACQ IMM DEF, V63, pE167, DOI 10.1097/QAI.0b013e318294de80; SAS Institute, SAS STAT 9; SAUNDERS JB, 1993, ADDICTION, V88, P791, DOI 10.1111/j.1360-0443.1993.tb02093.x; Strathdee SA, 2012, ANN EPIDEMIOL, V22, P426, DOI 10.1016/j.annepidem.2012.04.002; Strauss BB, 2017, AIDS BEHAV, V21, P1288, DOI 10.1007/s10461-016-1480-0; Thigpen MC, 2012, NEW ENGL J MED, V367, P423, DOI 10.1056/NEJMoa1110711; UNAIDS, 2015, OR PREEXP PROPH PUTT; Vermunt J, 2016, TECHNICAL GUIDE LATE; Vermunt JK, 2010, POLIT ANAL, V18, P450, DOI 10.1093/pan/mpq025; Westreich D, 2013, AM J EPIDEMIOL, V177, P292, DOI 10.1093/aje/kws412; Wheelock A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054288; Wohl AR, 2010, AIDS BEHAV, V14, P1149, DOI 10.1007/s10461-010-9666-3; World Health Organization, 2014, POL BRIEF CONS GUID; Xu WJ, 2018, AIDS PATIENT CARE ST, V32, P408, DOI 10.1089/apc.2018.0061; Yi S, 2017, J INT AIDS SOC, V20, DOI 10.7448/IAS.20.1.21580	75	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2019	14	8							e0221558	10.1371/journal.pone.0221558	http://dx.doi.org/10.1371/journal.pone.0221558			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW5RZ	31437243	Green Submitted, gold, Green Published			2022-12-26	WOS:000485036900089
J	Hwang, BJ; Zhang, Y; Brozowski, JM; Liu, Z; Burette, S; Lough, K; Smith, CC; Shan, Y; Chen, JB; Li, N; Williams, S; Su, M; Googe, P; Thomas, NE; Liu, Z				Hwang, Bin-Jin; Zhang, Yang; Brozowski, Jaime M.; Liu, Zhen; Burette, Susan; Lough, Kendall; Smith, Christof C.; Shan, Yue; Chen, Jinbo; Li, Ning; Williams, Scott; Su, Maureen; Googe, Paul; Thomas, Nancy E.; Liu, Zhi			The dysfunction of BP180/collagen XVII in keratinocytes promotes melanoma progression	ONCOGENE			English	Article							SQUAMOUS-CELL CARCINOMA; SUPPRESSOR-CELLS; EPIDERMOLYSIS-BULLOSA; COLLAGEN-XVII; MYELOID CELLS; BP180; INFLAMMATION; EXPRESSION; METASTASIS; CHEMOKINE	BP180, also termed collagen XVII, is a hemidesmosomal transmembrane glycoprotein expressed in basal keratinocytes, and functions as a cell-matrix adhesion molecule in the dermal-epidermal junction of the skin. Its function, other than cell-matrix adhesion, remains unclear. We generated a mouse strain with BP180 dysfunction (termed Delta NC16A), which develops spontaneous skin inflammation accompanied by an influx of myeloid derived suppressor cells (MDSCs). We used the B16 mouse melanoma model to demonstrate that BP180 dysfunction in either skin or basal keratinocytes promotes MDSC influx into skin and tumor progression. MDSC depletion reduced tumor progression in Delta NC16A mice, demonstrating a critical role for BP180 dysfunction-driven MDSCs in melanoma progression. This study provides the first direct evidence that BP180, a cell-cell matrix adhesion molecule, possesses antitumor function through modulating infiltration of MDSCs. Basal keratinocytes actively participate in skin microenvironment changes caused by BP180 dysfunction. Delta NC16A mice could be a new animal model to study the melanoma microenvironment.	[Hwang, Bin-Jin; Brozowski, Jaime M.; Smith, Christof C.; Liu, Zhi] Univ N Carolina, Dept Microbiol & Immunol, Sch Med, Chapel Hill, NC 27515 USA; [Zhang, Yang; Liu, Zhen; Burette, Susan; Li, Ning; Googe, Paul; Thomas, Nancy E.; Liu, Zhi] Univ N Carolina, Dept Dermatol, Sch Med, Chapel Hill, NC 27515 USA; [Zhang, Yang] Xi An Jiao Tong Univ, Hosp 2, Sch Med, Dept Dermatol, Xian, Shaanxi, Peoples R China; [Brozowski, Jaime M.] Duke Univ, Sch Med, Dept Med Rheumatol & Immunol, Durham, NC USA; [Liu, Zhen] Guangdong Ctr Adverse Drug React Monitoring, Guangzhou, Guangdong, Peoples R China; [Lough, Kendall; Williams, Scott] Univ N Carolina, Dept Pathol & Lab Med, Sch Med, Chapel Hill, NC 27515 USA; [Shan, Yue] Univ N Carolina, Dept Biostat, Sch Publ Hlth, Chapel Hill, NC 27515 USA; [Chen, Jinbo] Huazhong Univ Sci & Technol, Wuhan 1 Hosp, Tongji Med Coll, Dept Dermatol, Wuhan, Hubei, Peoples R China; [Su, Maureen] Univ N Carolina, Dept Pediat, Sch Med, Chapel Hill, NC 27515 USA; [Su, Maureen; Thomas, Nancy E.; Liu, Zhi] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27515 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Xi'an Jiaotong University; Duke University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; Huazhong University of Science & Technology; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill	Liu, Z (corresponding author), Univ N Carolina, Dept Microbiol & Immunol, Sch Med, Chapel Hill, NC 27515 USA.; Liu, Z (corresponding author), Univ N Carolina, Dept Dermatol, Sch Med, Chapel Hill, NC 27515 USA.; Liu, Z (corresponding author), Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27515 USA.	zhi_liu@med.unc.edu	, UNC Flow Cytometry Core/AGU-9839-2022	Su, Maureen/0000-0002-3680-9982; Chen, Jinbo/0000-0002-9665-8506; Williams, Scott/0000-0001-9975-7334	Cancer Center Core Support Grant [P30 CA016086]; NIH [R01 AI40768, R01 AR072694]; 15 UNC Cancer Center Research Award; UNC Graduate School Dissertation 16 Completion Fellowship;  [P01CA206980]; NATIONAL CANCER INSTITUTE [P01CA206980, P30CA016086] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR072694] Funding Source: NIH RePORTER	Cancer Center Core Support Grant; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); 15 UNC Cancer Center Research Award; UNC Graduate School Dissertation 16 Completion Fellowship; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank Dr. Dennis Loop for providing the Krt-14 promoter driven Cre mice. We thank Dr. Donna Culton and Susan McCray for assistance in Flow Cytometry. We thank Dr. Yisong Wan and Dr. Jenny PY Ting for their assistance. We thank the UNC Flow Cytometry Core Facility, which is supported in part by P30 CA016086 Cancer Center Core Support Grant to the UNC Lineberger Comprehensive Cancer Center, for their assistance in flow cytometry analyses. This work was supported by the NIH (R01 AI40768 and R01 AR072694 to ZL), the 15 UNC Cancer Center Research Award (to ZL) and UNC Graduate School Dissertation 16 Completion Fellowship (to BJH) and P01CA206980 (to NT).	Aho S, 1999, 180 KD BULLOUS PEMPH, V367, P356; Bangert C, 2011, CLIN DERMATOL, V29, P360, DOI 10.1016/j.clindermatol.2011.01.006; Bleehen S., 1998, TXB DERMATOLOGY, P1765; Bobek V, 2010, ANTICANCER RES, V30, P4799; Bronte V, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12150; Bruce DW, 2017, J CLIN INVEST, V127, P1813, DOI 10.1172/JCI91816; Bubier JA, 2010, J INVEST DERMATOL, V130, P1819, DOI 10.1038/jid.2010.46; Chen RY, 2002, J IMMUNOL, V169, P3987, DOI 10.4049/jimmunol.169.7.3987; Chen RY, 2001, J CLIN INVEST, V108, P1151, DOI 10.1172/jci11494; Colotta F, 2009, CARCINOGENESIS, V30, P1073, DOI 10.1093/carcin/bgp127; Condamine T, 2015, ANNU REV MED, V66, P97, DOI 10.1146/annurev-med-051013-052304; Di Meglio P, 2011, IMMUNITY, V35, P857, DOI 10.1016/j.immuni.2011.12.003; Fine JD, 2012, J AM ACAD DERMATOL, V66, P856, DOI 10.1016/j.jaad.2012.01.045; Fine JD, 2010, ORPHANET J RARE DIS, V5, DOI 10.1186/1750-1172-5-12; Fine JD, 2010, ANN NY ACAD SCI, V1194, P213, DOI 10.1111/j.1749-6632.2010.05463.x; Fine JD, 2009, J AM ACAD DERMATOL, V60, P203, DOI 10.1016/j.jaad.2008.09.035; GIUDICE GJ, 1992, J INVEST DERMATOL, V99, P243, DOI 10.1111/1523-1747.ep12616580; Golan T, 2015, MOL CELL, V59, P664, DOI 10.1016/j.molcel.2015.06.028; Hammers CM, 2016, ANNU REV PATHOL-MECH, V11, P175, DOI 10.1146/annurev-pathol-012615-044313; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hopkinson SB, 2000, MOL BIOL CELL, V11, P277, DOI 10.1091/mbc.11.1.277; Hurskainen T, 2014, J INVEST DERMATOL, P1; Hurskainen T, 2012, CELL TISSUE RES, V348, P579, DOI 10.1007/s00441-012-1368-x; Jonkman MF, 1982, 180 KD BULLOUS PEMPH, P1345; Kiritsi D, 2011, J MED GENET, V48, P450, DOI 10.1136/jmg.2010.086751; Koster J, 2003, J CELL SCI, V116, P387, DOI 10.1242/jcs.00241; Krenacs T, 2012, HISTOCHEM CELL BIOL, V138, P653, DOI 10.1007/s00418-012-0981-9; Kumar V, 2016, TRENDS IMMUNOL, V37, P208, DOI 10.1016/j.it.2016.01.004; Leighty L, 2007, ARCH DERMATOL RES, V299, P417, DOI 10.1007/s00403-007-0790-5; Liu Z, 2008, J AUTOIMMUN, V31, P331, DOI 10.1016/j.jaut.2008.08.009; Lund AW, 2016, CANCER DISCOV, V6, P22, DOI 10.1158/2159-8290.CD-15-0023; Mabuchi E, 2007, BRIT J DERMATOL, V157, P596, DOI 10.1111/j.1365-2133.2007.08046.x; Mallipeddi R, 2002, CLIN EXP DERMATOL, V27, P616, DOI 10.1046/j.1365-2230.2002.01130.x; Margadant C, 2008, CURR OPIN CELL BIOL, V20, P589, DOI 10.1016/j.ceb.2008.05.001; Matsumura H, 2016, SCIENCE, V351, DOI 10.1126/science.aad4395; MCGRATH JA, 1995, NAT GENET, V11, P83, DOI 10.1038/ng0995-83; Murdoch C, 2008, NAT REV CANCER, V8, P618, DOI 10.1038/nrc2444; Nishie W, 2007, NAT MED, V13, P378, DOI 10.1038/nm1496; Ortiz ML, 2015, J EXP MED, V212, P351, DOI 10.1084/jem.20140835; Ostrand-Rosenberg S, 2009, J IMMUNOL, V182, P4499, DOI 10.4049/jimmunol.0802740; Parikka M, 2006, EXP CELL RES, V312, P1431, DOI 10.1016/j.yexcr.2006.01.015; Parikka M, 2003, J HISTOCHEM CYTOCHEM, V51, P921, DOI 10.1177/002215540305100707; Parikka M, 2001, J ORAL PATHOL MED, V30, P589, DOI 10.1034/j.1600-0714.2001.301003.x; Rozenberg GI, 2010, MELANOMA RES, V20, P361, DOI 10.1097/CMR.0b013e328336ee17; Sawanobori Y, 2008, BLOOD, V111, P5457, DOI 10.1182/blood-2008-01-136895; Silvers WK, 1979, INBRED GENETICALLY 1, P1979; Stelkovics E, 2008, APPL IMMUNOHISTO M M, V16, P433, DOI 10.1097/PAI.0b013e318162f8aa; Talmadge JE, 2013, NAT REV CANCER, V13, P739, DOI 10.1038/nrc3581; Tang L., 2016, J MOL SIGNAL, V11, P1; Tanimura S, 2011, CELL STEM CELL, V8, P177, DOI 10.1016/j.stem.2010.11.029; Van den Bergh F, 2012, EXP DERMATOL, V21, P605, DOI 10.1111/j.1600-0625.2012.01529.x; van Deventer HW, 2010, CANCER RES, V70, P10161, DOI 10.1158/0008-5472.CAN-10-1921; Van Kilsdonk JWJ, 2010, MELANOMA RES, V20, P372, DOI 10.1097/CMR.0b013e32833d8d70; Williams SE, 2011, NATURE, V470, P353, DOI 10.1038/nature09793; Youn JI, 2008, J IMMUNOL, V181, P5791, DOI 10.4049/jimmunol.181.8.5791; Youn JI, 2010, EUR J IMMUNOL, V40, P2969, DOI 10.1002/eji.201040895; Zhang Y, 2018, P NATL ACAD SCI USA, V115, P6434, DOI 10.1073/pnas.1721805115	57	8	8	1	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	DEC 12	2019	38	50					7491	7503		10.1038/s41388-019-0961-9	http://dx.doi.org/10.1038/s41388-019-0961-9			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	JV7GY	31435021	Green Accepted			2022-12-26	WOS:000502530500004
J	Nasyrov, E; Nolan, KA; Wenger, RH; Marti, HH; Kunze, R				Nasyrov, Emil; Nolan, Karen A.; Wenger, Roland H.; Marti, Hugo H.; Kunze, Reiner			The neuronal oxygen-sensing pathway controls postnatal vascularization of the murine brain	FASEB JOURNAL			English	Article						PHD; HIF; VEGF; adrenomedullin; cerebral angiogenesis	CENTRAL-NERVOUS-SYSTEM; ADRENOMEDULLIN-RAMP2 SYSTEM; ENDOTHELIAL-CELLS; HYPOXIC RESPONSE; SURVIVAL; ANGIOGENESIS; HIF-1-ALPHA; DEFICIENCY; MECHANISMS; EXPRESSION	The contribution of neurons to growth and refinement of the microvasculature during postnatal brain development is only partially understood. Tissue hypoxia is the physiologic stimulus for angiogenesis by enhancing angiogenic mediators partly through activation of hypoxia-inducible factors (HIFs). Hence, we investigated the HIF oxygen-sensing pathway in postmitotic neurons for physiologic angiogenesis in the murine forebrain during postnatal development by using mice lacking the HIF suppressing enzyme prolyl-4-hydroxylase domain (PHD)2 and/or HIF-1/2 alpha in postmitotic neurons. Perinatal activation or inactivation of the HIF pathway in neurons inversely modulated brain vascularization, including endothelial cell number and proliferation, density of total and perfused microvessels, and vascular branching. Accordingly, several angiogenesis-related genes were up-regulated in vivo and in primary neurons derived from PHD2-deficient mice. Among them, only VEGF and adrenomedullin (Adm) promoted angiogenic sprouting of brain endothelial cells. VEGF and Adm additively enhanced endothelial sprouting through activation of multiple pathways. PHD2 deficiency in neurons caused HIF-alpha stabilization and increased VEGF mRNA levels not only in neurons but unexpectedly also in astrocytes, suggesting a new mechanism of neuron-to-astrocyte signaling. Collectively, our results identify the PHD-HIF pathway in neurons as an important determinant for vascularization of the brain during postnatal development.	[Nasyrov, Emil; Marti, Hugo H.; Kunze, Reiner] Heidelberg Univ, Inst Physiol & Pathophysiol, Dept Cardiovasc Physiol, Neuenheimer Feld 326, D-69120 Heidelberg, Germany; [Nolan, Karen A.; Wenger, Roland H.] Univ Zurich, Inst Physiol, Zurich, Switzerland; [Nolan, Karen A.; Wenger, Roland H.] Natl Ctr Competence Res Kidney CH, Zurich, Switzerland	Ruprecht Karls University Heidelberg; University of Zurich	Kunze, R (corresponding author), Heidelberg Univ, Inst Physiol & Pathophysiol, Dept Cardiovasc Physiol, Neuenheimer Feld 326, D-69120 Heidelberg, Germany.	reiner.kunze@physiologie.uni-heidelberg.de	Kunze, Reiner/K-8048-2019; Wenger, Roland/B-7953-2009	Kunze, Reiner/0000-0002-8428-1027; Marti, Hugo/0000-0002-8456-334X; Nolan, Karen A./0000-0003-1999-1417; Wenger, Roland/0000-0001-7592-4839	Boehringer Ingelheim Fonds; National Centre of Competence in Research (NCCR) Kidney; European Union's Seventh Framework Programme for Research, Technological Development, and Demonstration [608847]	Boehringer Ingelheim Fonds(Boehringer Ingelheim); National Centre of Competence in Research (NCCR) Kidney; European Union's Seventh Framework Programme for Research, Technological Development, and Demonstration	The authors thank Dr. Caroline Arnold (Heidelberg University) for help with the angiogenic sprouting assay. The expert technical assistance of Nadine Heselmaier, Maria Harlacher, and Inge Keller (all from Heidelberg University) is gratefully acknowledged. E.N. was supported by a travel grant of the Boehringer Ingelheim Fonds. R.H.W. was supported by the National Centre of Competence in Research (NCCR) Kidney.CH. K.A.N. was supported by the European Union's Seventh Framework Programme for Research, Technological Development, and Demonstration (Grant 608847). The authors declare no conflicts of interest.	Andreone BJ, 2015, ANNU REV NEUROSCI, V38, P25, DOI 10.1146/annurev-neuro-071714-033835; Araque A, 2014, NEURON, V81, P728, DOI 10.1016/j.neuron.2014.02.007; Bai YY, 2009, J PATHOL, V219, P446, DOI 10.1002/path.2611; Barteczek P, 2017, J CEREBR BLOOD F MET, V37, P291, DOI 10.1177/0271678X15624933; Berra E, 2003, EMBO J, V22, P4082, DOI 10.1093/emboj/cdg392; Bickler PE, 2002, J EXP BIOL, V205, P3579; Burnstock G, 2007, PHYSIOL REV, V87, P659, DOI 10.1152/physrev.00043.2006; Casanova E, 2001, GENESIS, V31, P37, DOI 10.1002/gene.1078; Ding K, 2005, INVEST OPHTH VIS SCI, V46, P1010, DOI 10.1167/iovs.04-0788; Durkee CA, 2019, NEUROSCIENCE, V396, P73, DOI 10.1016/j.neuroscience.2018.11.010; Ernst AS, 2019, ACTA NEUROPATHOL COM, V7, DOI 10.1186/s40478-019-0669-7; Fernandez AP, 2008, P NATL ACAD SCI USA, V105, P12581, DOI 10.1073/pnas.0803174105; Fernandez AP, 2010, ENDOCRINOLOGY, V151, P4908, DOI 10.1210/en.2010-0121; Fields RD, 2000, TRENDS NEUROSCI, V23, P625, DOI 10.1016/S0166-2236(00)01674-X; Gerhardt H, 2003, J CELL BIOL, V161, P1163, DOI 10.1083/jcb.200302047; Gruneberg D, 2016, EXP NEUROL, V286, P93, DOI 10.1016/j.expneurol.2016.10.001; Haigh JJ, 2003, DEV BIOL, V262, P225, DOI 10.1016/S0012-1606(03)00356-7; Heiss M, 2015, FASEB J, V29, P3076, DOI 10.1096/fj.14-267633; Himmels P, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14583; Hirayama Y, 2017, GLIA, V65, P523, DOI 10.1002/glia.23109; Hirayama Y, 2015, J NEUROSCI, V35, P3794, DOI 10.1523/JNEUROSCI.4218-14.2015; Igarashi K, 2014, PEPTIDES, V62, P21, DOI 10.1016/j.peptides.2014.08.013; Kaelin WG, 2008, MOL CELL, V30, P393, DOI 10.1016/j.molcel.2008.04.009; Kis B, 2002, J NEUROENDOCRINOL, V14, P283, DOI 10.1046/j.1365-2826.2002.00778.x; Koyama T, 2015, J ATHEROSCLER THROMB, V22, P647, DOI 10.5551/jat.29967; Kunze R, 2012, STROKE, V43, P2748, DOI 10.1161/STROKEAHA.112.669598; Li LX, 2016, NEUROBIOL DIS, V91, P221, DOI 10.1016/j.nbd.2016.03.018; Lin-Holderer J, 2016, NEUROPHARMACOLOGY, V105, P228, DOI 10.1016/j.neuropharm.2016.01.023; Maurice T, 2013, J PSYCHOPHARMACOL, V27, P1044, DOI 10.1177/0269881113494939; MONTESANO R, 1990, CELL, V62, P435, DOI 10.1016/0092-8674(90)90009-4; Nakamura-Ishizu A, 2012, DEV BIOL, V363, P106, DOI 10.1016/j.ydbio.2011.12.027; Paredes I, 2018, DEV CELL, V45, P10, DOI 10.1016/j.devcel.2018.01.023; Peeters C, 2003, BRAIN RES, V963, P72, DOI 10.1016/S0006-8993(02)03843-X; Raab S, 2004, THROMB HAEMOSTASIS, V91, P595, DOI 10.1160/TH03-09-0582; Rabie T, 2011, INT J DEV NEUROSCI, V29, P655, DOI 10.1016/j.ijdevneu.2011.06.003; Regen T, 2011, BRAIN BEHAV IMMUN, V25, P957, DOI 10.1016/j.bbi.2010.10.009; Religa P, 2013, SCI REP-UK, V3, DOI 10.1038/srep02053; Rey S, 2010, CARDIOVASC RES, V86, P236, DOI 10.1093/cvr/cvq045; Sapieha P, 2008, NAT MED, V14, P1067, DOI 10.1038/nm.1873; Schoch HJ, 2002, BRAIN, V125, P2549, DOI 10.1093/brain/awf257; Scott A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011863; Segura I, 2016, CELL REP, V14, P2653, DOI 10.1016/j.celrep.2016.02.047; Semenza GL, 2019, ANNU REV PHARMACOL, V59, P379, DOI 10.1146/annurev-pharmtox-010818-021637; Serrano J, 2000, BRAIN RES, V853, P245, DOI 10.1016/S0006-8993(99)02273-8; Shindo T, 2019, PEPTIDES, V111, P55, DOI 10.1016/j.peptides.2018.04.004; Simons M, 2016, NAT REV MOL CELL BIO, V17, P611, DOI 10.1038/nrm.2016.87; STONE J, 1995, J NEUROSCI, V15, P4738, DOI 10.1523/jneurosci.15-07-04738.1995; Takeda K, 2007, CIRCULATION, V116, P774, DOI 10.1161/CIRCULATIONAHA.107.701516; Tata M, 2015, MECH DEVELOP, V138, P26, DOI 10.1016/j.mod.2015.07.001; Usui V, 2015, J CLIN INVEST, V125, P2335, DOI 10.1172/JCI80297; Walchli T, 2015, NEURON, V87, P271, DOI 10.1016/j.neuron.2015.06.038; Weidemann A, 2010, GLIA, V58, P1177, DOI 10.1002/glia.20997; Zhang SJ, 2007, NEURON, V53, P549, DOI 10.1016/j.neuron.2007.01.025	53	5	5	0	2	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2019	33	11					12812	12824		10.1096/fj.201901385RR	http://dx.doi.org/10.1096/fj.201901385RR			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC8ZX	31469589	Green Published			2022-12-26	WOS:000507461600094
J	Sato, M; Aoki-Saito, H; Fukuda, H; Ikeda, H; Koga, Y; Yatomi, M; Tsurumaki, H; Maeno, T; Saito, T; Nakakura, T; Mori, T; Yanagawa, M; Abe, M; Sako, Y; Dobashi, K; Ishizuka, T; Yamada, M; Shuto, S; Hisada, T				Sato, Makiko; Aoki-Saito, Haruka; Fukuda, Hayato; Ikeda, Hiroyuki; Koga, Yasuhiko; Yatomi, Masakiyo; Tsurumaki, Hiroaki; Maeno, Toshitaka; Saito, Tsugumichi; Nakakura, Takashi; Mori, Tetsuya; Yanagawa, Masataka; Abe, Mitsuhiro; Sako, Yasushi; Dobashi, Kunio; Ishizuka, Tamotsu; Yamada, Masanobu; Shuto, Satoshi; Hisada, Takeshi			Resolvin E3 attenuates allergic airway inflammation via the interleukin-23-interleukin-17A pathway	FASEB JOURNAL			English	Article						house dust mite; omega-3 fatty acid; IL-17A	LEUKOTRIENE B-4 RECEPTOR; RESOLUTION; IL-23; CELLS; E1; ASTHMA; PSORIASIS; MODEL; FISH	We investigated the effects of resolvin E (RvE) 1, RvE2, and RvE3 on IL-4- and IL-33-stimulated bone marrow-derived dendritic cells (BMDCs) from house dust mite (HDM)-sensitized mice. We also investigated the role of RvE3 in a murine model of HDM-induced airway inflammation. In vitro, BMDCs from HDM-sensitized mice were stimulated with IL-4 and IL-33 and then treated with RvE1, RvE2, RvE3, or vehicle. RvE1, RvE2, and RvE3 suppressed IL-23 release from BMDCs. In vivo, RvE3 administrated to HDM-sensitized and challenged mice in the resolution phase promoted a decline in total numbers of inflammatory cells and eosinophils, reduced levels of IL-23 and IL-17 in lavage fluid, and suppressed IL-23 and IL-17A mRNA expression in lung and peribronchial lymph nodes. RvE3 also reduced resistance in the lungs of HDM-sensitized mice. A NanoBiT beta-arrestin recruitment assay using human embryonic kidney 293 cells revealed that pretreatment with RvE3 suppressed the leukotriene B4 (LTB4)-induced beta-arrestin 2 binding to LTB4 receptor 1 (BLT1R), indicating that RvE3 antagonistically interacts with BLT1R. Collectively, these findings indicate that RvE3 facilitates the resolution of allergic airway inflammation, partly by regulating BLT1R activity and selective cytokine release by dendritic cells. Our results accordingly identify RvE3 as a potential therapeutic target for the management of asthma.	[Sato, Makiko; Aoki-Saito, Haruka; Koga, Yasuhiko; Yatomi, Masakiyo; Tsurumaki, Hiroaki; Maeno, Toshitaka; Dobashi, Kunio; Hisada, Takeshi] Gunma Univ, Grad Sch Med, Dept Resp Med, 3-39-22 Showa Machi, Maebashi, Gunma 3718514, Japan; [Sato, Makiko; Saito, Tsugumichi; Yamada, Masanobu] Gunma Univ, Grad Sch Med, Dept Med & Mol Sci, Gunma, Japan; [Fukuda, Hayato] Nagasaki Univ, Grad Sch Biomed Sci, Nagasaki, Japan; [Ikeda, Hiroyuki; Shuto, Satoshi] Hokkaido Univ, Fac Pharmaceut Sci, Sapporo, Hokkaido, Japan; [Ikeda, Hiroyuki; Shuto, Satoshi] Hokkaido Univ, Ctr Res & Educ Drug Discovery, Sapporo, Hokkaido, Japan; [Nakakura, Takashi] Teikyo Univ, Dept Anat, Tokyo, Japan; [Mori, Tetsuya] Takasaki Univ Hlth & Welf, Fac Pharm, Lab Allergy & Immunol, Gunma, Japan; [Yanagawa, Masataka; Abe, Mitsuhiro; Sako, Yasushi] RIKEN, Cluster Pioneering Res, Cellular Informat Lab, Saitama, Japan; [Ishizuka, Tamotsu] Univ Fukui, Fac Med Sci, Dept Internal Med 3, Fukui, Japan; [Hisada, Takeshi] Gunma Univ, Grad Sch Hlth Sci, Gunma, Japan	Gunma University; Gunma University; Nagasaki University; Hokkaido University; Hokkaido University; Teikyo University; RIKEN; University of Fukui; Gunma University	Aoki-Saito, H (corresponding author), Gunma Univ, Grad Sch Med, Dept Resp Med, 3-39-22 Showa Machi, Maebashi, Gunma 3718514, Japan.	a-haruka@gunma-u.ac.jp	KOGA, YASUHIKO/GQG-9830-2022; Yanagawa, Masataka/C-3789-2017; Abe, Mitsuhiro/C-3602-2017; Tsurumaki, Hiroaki/HDL-6889-2022; Shuto, Satoshi/AAH-4998-2020; Abe, Mitsuhiro/AAN-1275-2020	KOGA, YASUHIKO/0000-0002-4974-9026; Yanagawa, Masataka/0000-0001-7832-0918; Shuto, Satoshi/0000-0001-7850-8064; Abe, Mitsuhiro/0000-0002-6244-1771; Nakakura, Takashi/0000-0003-1898-563X; Tsurumaki, Hiroaki/0000-0003-0837-9329	Japan Society for the Promotion of Science (JSPS) Kakenhi [15K19412, 18K08382, 18K08404]; Novartis Foundation (Tokyo, Japan) for the Promotion of Science	Japan Society for the Promotion of Science (JSPS) Kakenhi(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Novartis Foundation (Tokyo, Japan) for the Promotion of Science	The authors thank Y. Ebara, Y. Yamashita, and A. Sato (Gunma University) for technical assistance. The authors also thank Y. Shichida (Ritsumeikan University, Kusatsu, Japan) for providing the HEK293S cell line, R. J. Lefkowitz (Duke University Medical Center, Durham, NC, USA) for providing b-arrestin 2 cDNA, and B. L. Roth (University of North Carolina, Chapel Hill, NC, USA) for providing BLT1R cDNA. This study was supported by the Japan Society for the Promotion of Science (JSPS) Kakenhi (15K19412, 18K08382, and 18K08404) and the Novartis Foundation (Tokyo, Japan) for the Promotion of Science. The authors declare no conflicts of interest.	Aoki H, 2008, BIOCHEM BIOPH RES CO, V367, P509, DOI 10.1016/j.bbrc.2008.01.012; Aoki H, 2010, BIOCHEM BIOPH RES CO, V400, P128, DOI 10.1016/j.bbrc.2010.08.025; Arita M, 2007, J IMMUNOL, V178, P3912, DOI 10.4049/jimmunol.178.6.3912; Barros R, 2011, BRIT J NUTR, V106, P441, DOI 10.1017/S0007114511000328; Busse WW, 2001, NEW ENGL J MED, V344, P350, DOI 10.1056/NEJM200102013440507; Chan JR, 2006, J EXP MED, V203, P2577, DOI 10.1084/jem.20060244; Dixon AS, 2016, ACS CHEM BIOL, V11, P400, DOI 10.1021/acschembio.5b00753; Gilroy DW, 2004, NAT REV DRUG DISCOV, V3, P401, DOI 10.1038/nrd1383; Gold MJ, 2014, J ALLERGY CLIN IMMUN, V133, P1142, DOI 10.1016/j.jaci.2014.02.033; Grunig G, 1998, SCIENCE, V282, P2261, DOI 10.1126/science.282.5397.2261; Haworth O, 2008, NAT IMMUNOL, V9, P873, DOI 10.1038/ni.1627; Haworth O, 2011, J IMMUNOL, V186, P6129, DOI 10.4049/jimmunol.1004007; Hiroshima M, 2018, J MOL BIOL, V430, P1386, DOI 10.1016/j.jmb.2018.02.018; HORROBIN DF, 1987, MED HYPOTHESES, V22, P421, DOI 10.1016/0306-9877(87)90037-5; Isobe Y, 2012, J BIOL CHEM, V287, P10525, DOI 10.1074/jbc.M112.340612; Kim JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018556; Kroeze WK, 2015, NAT STRUCT MOL BIOL, V22, P362, DOI 10.1038/nsmb.3014; Kuhn H, 2006, PROG LIPID RES, V45, P334, DOI 10.1016/j.plipres.2006.02.003; Langowski JL, 2006, NATURE, V442, P461, DOI 10.1038/nature04808; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; Lewkowich IP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003879; Li JJ, 2013, AM J CLIN NUTR, V97, P173, DOI 10.3945/ajcn.112.041145; Martinez GJ, 2008, ANN NY ACAD SCI, V1143, P188, DOI 10.1196/annals.1443.021; Mickleborough TD, 2006, CHEST, V129, P39, DOI 10.1378/chest.129.1.39; Mogi C, 2009, J IMMUNOL, V182, P3243, DOI 10.4049/jimmunol.0803466; Molet S, 2001, J ALLERGY CLIN IMMUN, V108, P430, DOI 10.1067/mai.2001.117929; Nakajima Hiroshi, 2010, Immune Netw, V10, P1, DOI 10.4110/in.2010.10.1.1; Nakamura M, 2011, CHEM REV, V111, P6231, DOI 10.1021/cr100392s; Nakanishi Y, 2018, SCI SIGNAL, V11, DOI 10.1126/scisignal.aao5390; Oh SF, 2012, J IMMUNOL, V188, P4527, DOI 10.4049/jimmunol.1103652; Okuno T, 2003, J BIOL CHEM, V278, P41500, DOI 10.1074/jbc.M307335200; Peng J, 2010, CELL RES, V20, P62, DOI 10.1038/cr.2009.128; Pichavant M, 2008, J EXP MED, V205, P385, DOI 10.1084/jem.20071507; Schwab JM, 2007, NATURE, V447, P869, DOI 10.1038/nature05877; Serhan CN, 2002, J EXP MED, V196, P1025, DOI 10.1084/jem.20020760; Serhan CN, 2000, J EXP MED, V192, P1197, DOI 10.1084/jem.192.8.1197; Shenoy SK, 2005, J BIOL CHEM, V280, P15315, DOI 10.1074/jbc.M412418200; Vroman H, 2015, IMMUNOBIOLOGY, V220, P254, DOI 10.1016/j.imbio.2014.09.016; Wakashin H, 2008, AM J RESP CRIT CARE, V178, P1023, DOI 10.1164/rccm.200801-086OC; Yago T, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2297; Yanagawa M, 2018, SCI SIGNAL, V11, DOI 10.1126/scisignal.aao1917	41	22	24	1	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2019	33	11					12750	12759		10.1096/fj.201900283R	http://dx.doi.org/10.1096/fj.201900283R			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC8ZX	31469599	Green Published, Bronze			2022-12-26	WOS:000507461600089
J	Seib, KL; Haag, AF; Oriente, F; Fantappie, L; Borghi, S; Semchenko, EA; Schulz, BL; Ferlicca, F; Taddei, AR; Giuliani, MM; Pizza, M; Delany, I				Seib, Kate L.; Haag, Andreas F.; Oriente, Francesca; Fantappie, Laura; Borghi, Sara; Semchenko, Evgeny A.; Schulz, Benjamin L.; Ferlicca, Francesca; Taddei, Anna Rita; Giuliani, Marzia M.; Pizza, Mariagrazia; Delany, Isabel			The meningococcal vaccine antigen GNA2091 is an analogue of YraP and plays key roles in outer membrane stability and virulence	FASEB JOURNAL			English	Article						Bexsero; 4CMenB; outer membrane; phospholipid; zinc	HEPARIN-BINDING PROTEIN; NEISSERIA-MENINGITIDIS; PHOSPHOLIPID-SYNTHESIS; ESCHERICHIA-COLI; CELL-SEPARATION; GENES; PHOSPHATIDYLETHANOLAMINE; VESICLES; IDENTIFICATION; INVOLVEMENT	GNA2091 is one of the components of the 4-component meningococcal serogroup B vaccine (4CMenB) vaccine and is highly conserved in all meningococcal strains. However, its functional role has not been fully characterized. Here we show that nmb2091 is part of an operon and is cotranscribed with the nmb2089, nmb2090, and nmb2092 adjacent genes, and a similar but reduced operon arrangement is conserved in many other gram-negative bacteria. Deletion of the nmb2091 gene causes an aggregative phenotype with a mild defect in cell separation; differences in the outer membrane composition and phospholipid profile, in particular in the phosphoethanolamine levels; an increased level of outer membrane vesicles; and deregulation of the zinc-responsive genes such as znuD. Finally, the A2091 strain is attenuated with respect to the wild-type strain in competitive index experiments in the infant rat model of meningococcal infection. Altogether these data suggest that GNA2091 plays important roles in outer membrane architecture, biogenesis, homeostasis, and in meningococcal survival in vivo, and a model for its role is discussed. These findings highlight the importance of GNA2091 as a vaccine component.	[Seib, Kate L.; Semchenko, Evgeny A.] Griffith Univ, Inst Glyc, Gold Coast, Qld, Australia; [Haag, Andreas F.; Oriente, Francesca; Fantappie, Laura; Borghi, Sara; Ferlicca, Francesca; Giuliani, Marzia M.; Pizza, Mariagrazia; Delany, Isabel] GlaxoSmithKline GSK Vaccines, Siena, Italy; [Schulz, Benjamin L.] Univ Queensland, Sch Chem & Mol Biosci, Brisbane, Qld, Australia; [Taddei, Anna Rita] Univ Tuscia, Interdept Ctr Electron Microscopy CIME, Tuscia, Italy; [Oriente, Francesca] Univ Glasgow, Coll Med Vet & Life Sci, Inst Infect Immun & Inflammat, Glasgow, Lanark, Scotland; [Fantappie, Laura] Toscana Life Sci, Siena, Italy; [Borghi, Sara] Rockefeller Univ, Leonard Wagner Lab Mol Genet & Immunol, 1230 York Ave, New York, NY 10021 USA	Griffith University; University of Queensland; Tuscia University; University of Glasgow; Rockefeller University	Delany, I (corresponding author), GSK Vaccines, Via Fiorentina 1, I-53100 Siena, Italy.	isabel.x.delany@gsk.com	Haag, Andreas F/R-8775-2019; Seib, Kate L/B-4670-2015	Haag, Andreas F/0000-0002-6783-0231; Seib, Kate L/0000-0002-7094-3528; Semchenko, Evgeny/0000-0002-5188-7946	Australian National Health and Medical Research Council (NHMRC); Marie Curie Fellowship [PIEF-GA-2012328377]; Novartis fellowship from University of Siena (Siena, Italy); Novartis fellowship from University of Bologna (Bologna, Italy); Novartis Vaccines	Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Marie Curie Fellowship(European Commission); Novartis fellowship from University of Siena (Siena, Italy); Novartis fellowship from University of Bologna (Bologna, Italy); Novartis Vaccines	K.L.S. was supported by the Australian National Health and Medical Research Council (NHMRC) C. J. Martin Fellowship and Career Development Fellowship. A.F.H. was supported by a Marie Curie Fellowship (PIEF-GA-2012328377). F.O., L.F., and S.B. were recipients of Novartis fellowships from the Ph.D. program of the University of Siena (Siena, Italy) and University of Bologna (Bologna, Italy), respectively. The authors thank Dr. Amanda Nouwens (The University of Queensland, School of Chemistry and Molecular Biosciences Mass Spectrometry Facility) for assistance and expertise. This study was sponsored by Novartis Vaccines, now acquired by the GlaxoSmithKline (GSK) group of companies. F.O., F.F., M.G., M.P., and I.D. are employees of the GSK group of companies. Bexsero is a trademark of the GSK group of companies. This study was sponsored by Novartis Vaccines now acquired by GSK group of companies. Authors have declared the following interests: F.O., F.F., M. M.G., M.P., and I. D. are employees of the GSK group of companies. M.M. G., M.P., and I.D. report ownership of GSK stocks. M.M. G., and M.P. are listed as inventors on patents on vaccine candidates owned by the GSK group of companies. The remaining authors declare no conflicts of interest.	Adu-Bobie J, 2004, INFECT IMMUN, V72, P1914, DOI 10.1128/IAI.72.4.1914-1919.2004; Arenas J, 2013, MOL MICROBIOL, V87, P254, DOI 10.1111/mmi.12097; BARFIELD KD, 1985, BIOCHEM BIOPH RES CO, V128, P389, DOI 10.1016/0006-291X(85)91691-2; Binder H, 2001, BIOPHYS CHEM, V90, P57, DOI 10.1016/S0301-4622(01)00130-2; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bogdanov M, 1998, EMBO J, V17, P5255, DOI 10.1093/emboj/17.18.5255; Bogdanov M, 1999, J BIOL CHEM, V274, P12339, DOI 10.1074/jbc.274.18.12339; BOGDANOV M, 1995, J BIOL CHEM, V270, P732, DOI 10.1074/jbc.270.2.732; Bos MP, 2007, ANNU REV MICROBIOL, V61, P191, DOI 10.1146/annurev.micro.61.080706.093245; Bos MP, 2014, J BIOL CHEM, V289, P15602, DOI 10.1074/jbc.M113.539510; Brooke JS, 1996, J BACTERIOL, V178, P3339, DOI 10.1128/jb.178.11.3339-3341.1996; Carman GM, 2007, BBA-MOL CELL BIOL L, V1771, P322, DOI 10.1016/j.bbalip.2006.05.006; Delany I, 2006, J BACTERIOL, V188, P2483, DOI 10.1128/JB.188.7.2483-2492.2006; Delany I, 2004, MOL MICROBIOL, V52, P1081, DOI 10.1111/j.1365-2958.2004.04030.x; Donnarumma D, 2015, FASEB J, V29, P2260, DOI 10.1096/fj.14-263954; Dowhan W, 2013, BBA-MOL CELL BIOL L, V1831, P471, DOI 10.1016/j.bbalip.2012.08.007; Echenique-Rivera H, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002027; Ekiert DC, 2017, CELL, V169, P273, DOI 10.1016/j.cell.2017.03.019; Ercoli G, 2015, MBIO, V6, DOI 10.1128/mBio.02575-14; Fagnocchi L, 2013, INFECT IMMUN, V81, P560, DOI 10.1128/IAI.01085-12; Fantappie L, 2011, MICROBIOL-SGM, V157, P2235, DOI 10.1099/mic.0.048033-0; Giuliani MM, 2006, P NATL ACAD SCI USA, V103, P10834, DOI 10.1073/pnas.0603940103; Hadad R, 2012, APMIS, V120, P750, DOI 10.1111/j.1600-0463.2012.02903.x; Hooda Y, 2017, PATHOG DIS, V75, DOI 10.1093/femspd/ftx010; Jacobsson S, 2009, VACCINE, V27, P1579, DOI 10.1016/j.vaccine.2008.12.052; Konovalova A, 2017, ANNU REV MICROBIOL, V71, P539, DOI 10.1146/annurev-micro-090816-093754; Lappann M, 2016, INFECT IMMUN, V84, P3484, DOI 10.1128/IAI.00584-16; Lenz JD, 2016, J BIOL CHEM, V291, P10916, DOI 10.1074/jbc.M116.715573; Malinverni JC, 2009, P NATL ACAD SCI USA, V106, P8009, DOI 10.1073/pnas.0903229106; Metruccio MME, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000710; Morris FC, 2018, INFECT IMMUN, V86, DOI 10.1128/IAI.00829-17; Muzzi A, 2013, MBIO, V4, DOI 10.1128/mBio.00163-13; O'Ryan M, 2014, DRUGS, V74, P15, DOI 10.1007/s40265-013-0155-7; Onufryk C, 2005, J BACTERIOL, V187, P4552, DOI 10.1128/JB.187.13.4552-4561.2005; Patel GJ, 2013, BIOCHEMISTRY-US, V52, P3974, DOI 10.1021/bi400103t; Pawlik MC, 2012, J BACTERIOL, V194, P6594, DOI 10.1128/JB.01091-12; Pizza M, 2000, SCIENCE, V287, P1816, DOI 10.1126/science.287.5459.1816; Rahman MM, 2000, MICROBIOL-UK, V146, P1901, DOI 10.1099/00221287-146-8-1901; Roier S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10515; Seib KL, 2015, EXPERT REV VACCINES, V14, P841, DOI 10.1586/14760584.2015.1016915; Seib KL, 2011, INFECT IMMUN, V79, P970, DOI 10.1128/IAI.00891-10; Seib KL, 2010, VACCINE, V28, P2416, DOI 10.1016/j.vaccine.2009.12.082; Serruto D, 2010, P NATL ACAD SCI USA, V107, P3770, DOI 10.1073/pnas.0915162107; Stephens DS, 2007, FEMS MICROBIOL REV, V31, P3, DOI 10.1111/j.1574-6976.2006.00051.x; Stork M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000969; Tettelin H, 2000, SCIENCE, V287, P1809, DOI 10.1126/science.287.5459.1809; Toneatto D, 2017, EXPERT REV VACCINES, V16, P433, DOI 10.1080/14760584.2017.1308828; Tsang MJ, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006888; Vacca I, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162878; Vitrac H, 2015, P NATL ACAD SCI USA, V112, P13874, DOI 10.1073/pnas.1512994112; Volokhina EB, 2011, J BACTERIOL, V193, P1612, DOI 10.1128/JB.00532-10; WAI SN, 1995, MICROBIOL IMMUNOL, V39, P451, DOI 10.1111/j.1348-0421.1995.tb02228.x; White T, 1998, ANAL BIOCHEM, V258, P109, DOI 10.1006/abio.1997.2545; Wu HJ, 2006, MOL MICROBIOL, V60, P401, DOI 10.1111/j.1365-2958.2006.05079.x; Yeats C, 2003, TRENDS BIOCHEM SCI, V28, P352, DOI 10.1016/S0968-0004(03)00115-4; YIM HH, 1992, J BACTERIOL, V174, P3637, DOI 10.1128/JB.174.11.3637-3644.1992	56	3	3	1	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2019	33	11					12324	12335		10.1096/fj.201900669R	http://dx.doi.org/10.1096/fj.201900669R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC8ZX	31442078	Green Published, Green Accepted			2022-12-26	WOS:000507461600057
J	Charlton, PE; Schatz, KC; Burke, K; Paul, MJ; Dent, ML				Charlton, Payton E.; Schatz, Kelcie C.; Burke, Kali; Paul, Matthew J.; Dent, Micheal L.			Sex differences in auditory brainstem response audiograms from vasopressin-deficient Brattleboro and wild-type Long-Evans rats	PLOS ONE			English	Article							50-KHZ ULTRASONIC VOCALIZATIONS; SENSORINEURAL HEARING-LOSS; OTOACOUSTIC EMISSIONS; ARGININE VASOTOCIN; COCHLEAR FUNCTION; GRAY TREEFROG; ANXIETY-LIKE; SOCIAL PLAY; ADULT RATS; INNER-EAR	Rats are highly social creatures that produce ultrasonic vocalizations (USVs) during social interactions. Brattleboro rats, a Long-Evans derived rat that lacks vasopressin (AVP) due to a mutation in the Avp gene, exhibit atypical social behavior, including fewer USVs with altered spectrotemporal characteristics during social interactions. It is unclear why Brattle-boro rats produce atypical USVs, but one factor could be differences in auditory acuity between them and wild-type Long Evans rats with functional vasopressin. Previous studies have suggested a link between increased levels of AVP and auditory processing. Additionally, few studies have investigated sex differences in auditory perception by Long-Evans rats. Sex differences in auditory acuity have been found throughout the animal kingdom, but have not yet been demonstrated in rat audiograms. This study aimed to measure auditory brainstem response (ABR) derived audiograms for frequencies ranging from 1 to 64 kHz in male and female homozygous Brattleboro (Hom), heterozygous Brattleboro (Het), and wild-type (WT) Long-Evans rats to better understand the role of AVP and sex differences in auditory processing by these rats. We failed to detect significant differences between the ABR audiograms of Hom, Het, and WT Long-Evans rats, suggesting that varying levels of AVP do not affect auditory processing. Interestingly, males and females of all genotypes did differ in their ABR thresholds, with males exhibiting higher thresholds than females. The sex differences in auditory acuity were significant at the lowest and highest frequencies, possibly affecting the perception of USVs. These are the first known sex differences in rat audiograms.	[Charlton, Payton E.; Schatz, Kelcie C.; Burke, Kali; Paul, Matthew J.; Dent, Micheal L.] Univ Buffalo State Univ New York, Dept Psychol, Buffalo, NY 14260 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Dent, ML (corresponding author), Univ Buffalo State Univ New York, Dept Psychol, Buffalo, NY 14260 USA.	mdent@buffalo.edu		Burke, Kali/0000-0002-1736-480X; Dent, Micheal/0000-0001-7462-501X	National Institutes of Health R01s [DC012302, DC016641]; National Science Foundation [IOS-1754878]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC012302, R01DC016641] Funding Source: NIH RePORTER	National Institutes of Health R01s(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by the National Institutes of Health R01s DC012302 and DC016641 (https://www.nih.gov/) to MLD and National Science Foundation IOS-1754878 (https://www.nsf.gov/) to MJP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold AP, 2017, J NEUROSCI RES, V95, P291, DOI 10.1002/jnr.23884; Bester-Meredith JK, 2015, FRONT ENDOCRINOL, V6, DOI 10.3389/fendo.2015.00005; Bleickardt C, 2009, PSYCHOPHARMACOLOGY, V202, P711, DOI 10.1007/s00213-008-1354-x; Bohn KM, 2006, BIOL LETT-UK, V2, P561, DOI 10.1098/rsbl.2006.0501; Borszcz GS, 2006, PAIN, V123, P155, DOI 10.1016/j.pain.2006.02.026; Bosch OJ, 2012, HORM BEHAV, V61, P293, DOI 10.1016/j.yhbeh.2011.11.002; Bowers JM, 2013, J NEUROSCI, V33, P3276, DOI 10.1523/JNEUROSCI.0425-12.2013; BOYD SK, 1992, BRAIN RES, V588, P304, DOI 10.1016/0006-8993(92)91590-B; Bredewold R, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00216; BRUDZYNSKI SM, 1992, PHYSIOL BEHAV, V52, P655, DOI 10.1016/0031-9384(92)90393-G; Brudzynski SM, 2013, CURR OPIN NEUROBIOL, V23, P310, DOI 10.1016/j.conb.2013.01.014; Brudzynski SM, 2009, ILAR J, V50, P43, DOI 10.1093/ilar.50.1.43; Burgdorf J, 2008, J COMP PSYCHOL, V122, P357, DOI 10.1037/a0012889; Burke CJ, 2018, ANIM BEHAV, V140, P81, DOI 10.1016/j.anbehav.2018.03.019; Burke CJ, 2017, BEHAV PROCESS, V144, P72, DOI 10.1016/j.beproc.2017.09.014; Burke K, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197774; Caldwell HK, 2016, CURR TOP BEHAV NEURO, V27, P51, DOI 10.1007/7854_2015_390; Campbell P, 2009, J COMP NEUROL, V516, P321, DOI 10.1002/cne.22116; Caruana DA, 2012, LEARN MEMORY, V19, P391, DOI 10.1101/lm.025304.111; Charitidi K, 2009, HEARING RES, V252, P71, DOI 10.1016/j.heares.2008.12.009; COLEMAN JR, 1994, HEARING RES, V80, P209, DOI 10.1016/0378-5955(94)90112-0; Cooper WA, 1999, AUDIOLOGY, V38, P7; CROWLEY DE, 1966, J COMP PHYSIOL PSYCH, V62, P427, DOI 10.1037/h0023953; de Vries GJ, 2014, CURR TOP BEHAV NEURO, V16, P79, DOI 10.1007/7854_2014_286; de Vries GJ, 1998, PROG BRAIN RES, V119, P3; Dent ML, 2018, SPRINGER HANDB AUDIT, V67, P71, DOI 10.1007/978-3-319-92495-3_4; Eckhard A, 2012, MOL ASPECTS MED, V33, P612, DOI 10.1016/j.mam.2012.06.004; ENDLER JA, 1992, AM NAT, V139, pS125, DOI 10.1086/285308; Furuta H, 1998, HEARING RES, V117, P140, DOI 10.1016/S0378-5955(98)00009-4; Gall MD, 2010, J COMP PHYSIOL A, V196, P559, DOI 10.1007/s00359-010-0543-3; Goodson JL, 2003, J COMP NEUROL, V462, P1, DOI 10.1002/cne.10679; Goodson JL, 2000, J COMP NEUROL, V422, P363, DOI 10.1002/1096-9861(20000703)422:3<363::AID-CNE4>3.0.CO;2-8; Graham Lauren K., 2009, Psychol. Neurosci., V2, P219, DOI 10.3922/j.psns.2009.2.015; Gu FM, 2006, HEARING RES, V222, P70, DOI 10.1016/j.heares.2006.08.016; Guimaraes P, 2004, HEARING RES, V192, P83, DOI 10.1016/j.heares.2004.01.013; Hammerschmidt K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041133; Heffner RS, 2001, HEARING RES, V157, P138, DOI 10.1016/S0378-5955(01)00298-2; Himmler BT, 2014, BEHAV PROCESS, V106, P60, DOI 10.1016/j.beproc.2014.04.014; Hodgson RA, 2014, EUR J PHARMACOL, V730, P157, DOI 10.1016/j.ejphar.2014.02.027; Hultcrantz M, 2006, ACTA OTO-LARYNGOL, V126, P10, DOI 10.1080/00016480510038617; JERGER J, 1988, EAR HEARING, V9, P168, DOI 10.1097/00003446-198808000-00002; Kelly AM, 2014, FRONT NEUROENDOCRIN, V35, P512, DOI 10.1016/j.yfrne.2014.04.005; Kilicdag EB, 2004, AM J OBSTET GYNECOL, V190, P77, DOI 10.1016/j.ajog.2003.06.001; Kime NM, 2007, BRAIN BEHAV EVOLUT, V69, P254, DOI 10.1159/000099613; Kime NM, 2010, GEN COMP ENDOCR, V165, P221, DOI 10.1016/j.ygcen.2009.06.023; Kitano H, 1999, NEUROREPORT, V10, P1205, DOI 10.1097/00001756-199904260-00009; Kumagami H, 1998, PFLUG ARCH EUR J PHY, V436, P970, DOI 10.1007/s004240050731; Ladich F, 1998, J COMP PHYSIOL A, V182, P737, DOI 10.1007/s003590050218; Lin RE, 2013, PHYSIOL REP, V1, DOI 10.1002/phy2.100; Litvin Y, 2007, BEHAV BRAIN RES, V182, P166, DOI 10.1016/j.bbr.2006.11.038; Lukas M, 2015, PSYCHONEUROENDOCRINO, V56, P35, DOI 10.1016/j.psyneuen.2015.03.005; Manley GA, 2010, J EXP BIOL, V213, P1876, DOI 10.1242/jeb.040196; McCarthy MM, 2018, PHYSIOL BEHAV, V187, P13, DOI 10.1016/j.physbeh.2017.10.030; MCFADDEN D, 1993, P NATL ACAD SCI USA, V90, P11900, DOI 10.1073/pnas.90.24.11900; McFadden D, 1998, DEV NEUROPSYCHOL, V14, P261, DOI 10.1080/87565649809540712; McFadden D, 2000, HEARING RES, V142, P23, DOI 10.1016/S0378-5955(00)00002-2; Fernandez-Carrobles MM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141556; Naganuma H, 2014, AURIS NASUS LARYNX, V41, P249, DOI 10.1016/j.anl.2013.12.004; Paul MJ, 2016, ENEURO, V3, DOI 10.1523/ENEURO.0150-15.2016; Popelar J, 2006, NEUROBIOL AGING, V27, P490, DOI 10.1016/j.neurobiolaging.2005.03.001; Popelar J, 2003, HEARING RES, V186, P75, DOI 10.1016/S0378-5955(03)00329-0; Pultorak JD, 2017, ANIM BEHAV, V125, P13, DOI 10.1016/j.anbehav.2016.12.023; Rendall D, 2009, ANIM BEHAV, V78, P233, DOI 10.1016/j.anbehav.2009.06.007; Ryan MJ, 1998, SCIENCE, V281, P1999, DOI 10.1126/science.281.5385.1999; Scattoni ML, 2008, BEHAV BRAIN RES, V187, P371, DOI 10.1016/j.bbr.2007.09.034; Schatz KC, 2019, PHYSIOL BEHAV, V206, P125, DOI 10.1016/j.physbeh.2019.04.004; Schatz KC, 2018, HORM BEHAV, V106, P1, DOI 10.1016/j.yhbeh.2018.08.015; SCHMALE H, 1984, NATURE, V308, P705, DOI 10.1038/308705a0; Sewall KB, 2010, HORM BEHAV, V58, P544, DOI 10.1016/j.yhbeh.2010.04.002; Snihur AWK, 2012, NEUROSCIENCE, V210, P258, DOI 10.1016/j.neuroscience.2012.02.006; Snihur AWK, 2011, BRAIN COGNITION, V77, P40, DOI 10.1016/j.bandc.2011.06.004; Takumida M, 2012, ACTA OTO-LARYNGOL, V132, P807, DOI 10.3109/00016489.2012.662718; Tito MB, 1999, HORM BEHAV, V36, P166, DOI 10.1006/hbeh.1999.1540; Trainor BC, 2003, BRAIN BEHAV EVOLUT, V61, P165, DOI 10.1159/000070700; Varga J, 2015, AMINO ACIDS, V47, P2409, DOI 10.1007/s00726-015-2034-x; Vasconcelos RO, 2008, J EXP BIOL, V211, P502, DOI 10.1242/jeb.008474; Veenema AH, 2012, HORM BEHAV, V61, P50, DOI 10.1016/j.yhbeh.2011.10.002; Veenema AH, 2013, PSYCHONEUROENDOCRINO, V38, P2554, DOI 10.1016/j.psyneuen.2013.06.002; WHARTON JA, 1990, AUDIOLOGY, V29, P196; Wilczynski W, 2017, FRONT ENDOCRINOL, V8, P1; Willey AR, 2009, BEHAV BRAIN RES, V202, P122, DOI 10.1016/j.bbr.2009.03.025; Willott JF, 2009, HEARING RES, V252, P89, DOI 10.1016/j.heares.2008.12.002; WINSLOW JT, 1993, EUR J PHARMACOL, V233, P101, DOI 10.1016/0014-2999(93)90354-K; Wohr M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001365; Wright JM, 2010, PSYCHOPHARMACOLOGY, V211, P1, DOI 10.1007/s00213-010-1859-y; Wright TF, 2004, P ROY SOC B-BIOL SCI, V271, pS409, DOI 10.1098/rsbl.2004.0204; Wright TF, 2003, J COMP PSYCHOL, V117, P87, DOI 10.1037/0735-7036.117.1.87; Xu N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152463; Yamaguchi A, 2006, ACOUSTIC COMMUNICATI, P275; Zala SM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188647	90	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2019	14	8							e0222096	10.1371/journal.pone.0222096	http://dx.doi.org/10.1371/journal.pone.0222096			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW6BO	31469871	Green Submitted, gold, Green Published			2022-12-26	WOS:000485062200049
J	Huang, YJ; Yang, SS; Yeh, HZ; Chang, CS; Peng, YC				Huang, Yi-Jie; Yang, Sheng-Shun; Yeh, Hong-Zen; Chang, Chi-Sen; Peng, Yen-Chun			Association of virological breakthrough and clinical outcomes in entecavir-treated HBeAg-positive chronic hepatitis B	PLOS ONE			English	Article							HBV-DNA LEVEL; HEPATOCELLULAR-CARCINOMA; LONG-TERM; VIRUS-DNA; NATURAL-HISTORY; NAIVE PATIENTS; LAMIVUDINE; CIRRHOSIS; RISK; RESISTANCE	Background & aims To evaluate virological breakthrough (VBT) and the risk of hepatocellular carcinoma (HCC) in HBeAg-positive chronic hepatitis B (CHB) patients receiving entecavir (ETV) treatment. Methods A retrospective cohort study was conducted in a tertiary referral hospital and a total of 228 HBeAg-positive CHB patients treated with ETV for more than 48 weeks were enrolled. Clinical outcome measures included HBeAg seroclearance, maintained virological response and the development of HCC. Results During a median follow-up period of 197 weeks, VBT developed in 26 (11.4%) patients (VBT group), and the other 202 patients without VBT (non-VBT group). The overall cumulative rate of HBeAg seroclearance in the VBT group and non-VBT group were 23.1% and 23.8%, 27.1% and 37.9%, 27.1% and 55.1%, 27.1% and 74.1%, 27.1% and 76.7% from week 48 to 240, respectively(p = 0.013). The cumulative probability of maintained virological responses from week 48 to 240 were 7.69% and 21.78%, 7.69% in the VBT groups and 36.85%, 7.69% and 51.68%, 7.69% and 64.97%, 7.69% and 72.1% in the non-VBT groups, respectively (p< 0.001). In the multivariate analysis, age (p< 0.001) and virological response at week 24 (p = 0.005) were independently associated with VBT. Cox regression analysis showed that cirrhosis had carried the highest risk for HCC (HR = 4.99, CI = 1.14-21.81, p = 0.033). Subgroup survival analysis by Kaplan-Meier method showed that patients with VBT had higher incidence of developing HCC than without VBT in cirrhotic patients (50% (95% CI = 1-99%) vs 9% (95% CI = 1-9%); p = 0.048). Conclusions VBT was associated with adverse clinical outcomes, including a low probability of HBeAg seroclearance, failure to achieve maintained virological responses, and a risk of developing HCC. Patients, particularly with cirrhosis, who had experienced VBT during ETV treatment, more likely developed HCC.	[Huang, Yi-Jie; Yang, Sheng-Shun; Yeh, Hong-Zen; Chang, Chi-Sen; Peng, Yen-Chun] Taichung Vet Gen Hosp, Dept Internal Med, Div Gastroenterol, Taichung, Taiwan; [Yang, Sheng-Shun; Chang, Chi-Sen] Chung Shan Med Univ, Sch Med, Taichung, Taiwan; [Yeh, Hong-Zen; Peng, Yen-Chun] Natl Yang Ming Univ, Sch Med, Taipei, Taiwan; [Peng, Yen-Chun] Taichung Vet Gen Hosp, Dept Internal Med, Chiayi Branch, Chiayi, Taiwan	Taichung Veterans General Hospital; Chung Shan Medical University; National Yang Ming Chiao Tung University; Taichung Veterans General Hospital	Peng, YC (corresponding author), Taichung Vet Gen Hosp, Dept Internal Med, Div Gastroenterol, Taichung, Taiwan.; Peng, YC (corresponding author), Natl Yang Ming Univ, Sch Med, Taipei, Taiwan.; Peng, YC (corresponding author), Taichung Vet Gen Hosp, Dept Internal Med, Chiayi Branch, Chiayi, Taiwan.	pychunppp@gmail.com		Peng, Yen-Chun/0000-0002-8993-3039; Yang, Sheng-Shun/0000-0001-5800-1901				Bruix J, 2011, HEPATOLOGY, V53, P1020, DOI 10.1002/hep.24199; Chen CJ, 2006, JAMA-J AM MED ASSOC, V295, P65, DOI 10.1001/jama.295.1.65; Chen JD, 2010, GASTROENTEROLOGY, V138, P1747, DOI 10.1053/j.gastro.2010.01.042; Chevaliez S, 2013, J HEPATOL, V58, P676, DOI 10.1016/j.jhep.2012.11.039; Chu CM, 2006, SEMIN LIVER DIS, V26, P142, DOI 10.1055/s-2006-939752; El-Serag HB, 2007, GASTROENTEROLOGY, V132, P2557, DOI 10.1053/j.gastro.2007.04.061; Eun JR, 2010, J HEPATOL, V53, P118, DOI 10.1016/j.jhep.2010.02.026; European Assoc Study Liver, 2017, J HEPATOL, V67, P370, DOI 10.1016/j.jhep.2017.03.021; Franco E, 2012, WORLD J HEPATOL, V4, P74, DOI 10.4254/wjh.v4.i3.74; Fung J, 2011, J ANTIMICROB CHEMOTH, V66, P2715, DOI 10.1093/jac/dkr388; Gish RG, 2010, J VIRAL HEPATITIS, V17, P16, DOI 10.1111/j.1365-2893.2009.01146.x; Hashimoto Y, 2010, J MED VIROL, V82, P684, DOI 10.1002/jmv.21681; Hongthanakorn C, 2011, HEPATOLOGY, V53, P1854, DOI 10.1002/hep.24318; Huang YJ, 2017, J CHIN MED ASSOC, V80, P341, DOI 10.1016/j.jcma.2016.12.005; Iloeje UH, 2006, GASTROENTEROLOGY, V130, P678, DOI 10.1053/j.gastro.2005.11.016; Kim JH, 2016, LOW LEVEL VIREMIA IN, DOI [10.1002/hep.28916, DOI 10.1002/HEP.28916]; Kim MC, 2011, DIGEST DIS SCI, V56, P1215, DOI 10.1007/s10620-010-1537-2; Kim SS, 2014, AM J GASTROENTEROL, V109, P1223, DOI 10.1038/ajg.2014.145; Kobashi H, 2011, HEPATOL RES, V41, P405, DOI 10.1111/j.1872-034X.2011.00785.x; Liaw YF, 2009, HEPATOL INT, V3, P425, DOI 10.1007/s12072-009-9140-3; Liaw YF, 2009, GASTROENTEROLOGY, V136, P486, DOI 10.1053/j.gastro.2008.10.026; Mendy ME, 2010, J VIRAL HEPATITIS, V17, P115, DOI 10.1111/j.1365-2893.2009.01168.x; Miyauchi T, 2013, INT J MED SCI, V10, P647, DOI 10.7150/ijms.5904; Peng CY, 2015, J FORMOS MED ASSOC, V114, P308, DOI 10.1016/j.jfma.2013.10.023; Sarin SK, 2016, HEPATOL INT, V10, P1, DOI 10.1007/s12072-015-9675-4; Schweitzer A, 2015, LANCET, V386, P1546, DOI 10.1016/S0140-6736(15)61412-X; Su CW, 2013, J GASTROEN HEPATOL, V28, P1849, DOI 10.1111/jgh.12283; Szpakowski JL, 2013, HEPATOLOGY, V58, P21, DOI 10.1002/hep.26110; Tenney DJ, 2009, HEPATOLOGY, V49, P1503, DOI 10.1002/hep.22841; Terrault NA, 2016, HEPATOLOGY, V63, P261, DOI 10.1002/hep.28156; Xu C, 2014, CANCER LETT, V345, P216, DOI 10.1016/j.canlet.2013.08.035; Yegin EG, 2014, HEPATOB PANCREAT DIS, V13, P602, DOI 10.1016/S1499-3872(14)60303-9; Yuen MF, 2011, AM J GASTROENTEROL, V106, P1264, DOI 10.1038/ajg.2011.45; Yuen MF, 2001, HEPATOLOGY, V34, P785, DOI 10.1053/jhep.2001.27563; Zeuzem S, 2009, J HEPATOL, V51, P11, DOI 10.1016/j.jhep.2008.12.019	35	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2019	14	8							e0221958	10.1371/journal.pone.0221958	http://dx.doi.org/10.1371/journal.pone.0221958			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW6BO	31469875	Green Submitted, Green Published, gold			2022-12-26	WOS:000485062200042
J	Nam, O; Park, JM; Lee, H; Jin, E				Nam, Onyou; Park, Jong-Moon; Lee, Hookeun; Jin, EonSeon			De novo transcriptome profile of coccolithophorid alga Emiliania huxleyi CCMP371 at different calcium concentrations with proteome analysis	PLOS ONE			English	Article							HYDROGEN ISOTOPE FRACTIONATION; CALCIFICATION; BIOMINERALIZATION; PHOTOSYNTHESIS; ANNOTATION; EXPRESSION; MECHANISM; PATHWAYS; IDENTIFICATION; SALINITY	The haptophyte alga Emiliania huxleyi is the most abundant coccolithophore in the modern ocean and produces elaborate calcite crystals, called coccolith, in a separate intracellular compartment known as the coccolith vesicle. Despite the importance of biomineralization in coccolithophores, the molecular mechanism underlying it remains unclear. Understanding this precise machinery at the molecular level will provide the knowledge needed to enable further manipulation of biomineralization. In our previous study, altering the calcium concentration modified the calcifying ability of E. huxleyi CCMP371. Therefore in this study, we tested E. huxleyi cells acclimated to three different calcium concentrations (0, 0.1, and 10 mM). To understand the whole transcript profile at different calcium concentrations, RNA-sequencing was performed and used for de novo assembly and annotation. The differentially expressed genes (DEGs) among the three different calcium concentrations were analyzed. The functional classification by gene ontology (GO) revealed that 'intrinsic component of membrane' was the most enriched of the GO terms at the ambient calcium concentration (10 mM) compared with the limited calcium concentrations (0 and 0.1 mM). Moreover, the DEGs in those comparisons were enriched mainly in 'secondary metabolites biosynthesis, transport and catabolism' and 'signal transduction mechanisms' in the KOG clusters and 'processing in endoplasmic reticulum', and 'ABC transporters' in the KEGG pathways. Furthermore, metabolic pathways involved in protein synthesis were enriched among the differentially expressed proteins. The results of this study provide a molecular profile for understanding the expression of transcripts and proteins in E. huxleyi at different calcium concentrations, which will help to identify the detailed mechanism of its calcification.	[Nam, Onyou; Jin, EonSeon] Hanyang Univ, Dept Life Sci, Seoul, South Korea; [Park, Jong-Moon; Lee, Hookeun] Gachon Univ, Gachon Inst Pharmaceut Sci, Gachon Coll Pharm, Incheon, South Korea	Hanyang University; Gachon University	Jin, E (corresponding author), Hanyang Univ, Dept Life Sci, Seoul, South Korea.	esjin@hanyang.ac.kr	Jin, EonSeon/AAW-6839-2020	Jin, EonSeon/0000-0001-5691-0124; Lee, Hookeun/0000-0002-0696-8421; Park, Jong-Moon/0000-0002-4407-1383	Basic Core Technology Development Program for the Oceans and the Polar Regions of the National Research Foundation of Korea (NRF) - Ministry of Science, ICT [2015M1A5A1037053]	Basic Core Technology Development Program for the Oceans and the Polar Regions of the National Research Foundation of Korea (NRF) - Ministry of Science, ICT	This study was supported by the Basic Core Technology Development Program for the Oceans and the Polar Regions of the National Research Foundation of Korea (NRF, https://www.nrf.re.kr) funded by the Ministry of Science, ICT (2015M1A5A1037053) (E. Jin). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu RD, 2009, MOL BIOSYST, V5, P1512, DOI 10.1039/b908315d; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Araie H, 2011, PLANT CELL PHYSIOL, V52, P1204, DOI 10.1093/pcp/pcr070; Bach LT, 2013, NEW PHYTOL, V199, P121, DOI 10.1111/nph.12225; Benner I, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2013.0049; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Buchfink B, 2015, NAT METHODS, V12, P59, DOI 10.1038/nmeth.3176; Clapham DE, 2007, CELL, V131, P1047, DOI 10.1016/j.cell.2007.11.028; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Conesa A, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0881-8; Corstjens PLAM, 1998, J PHYCOL, V34, P622, DOI 10.1046/j.1529-8817.1998.340622.x; Endo H, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-29482-8; Endo H, 2016, SCI REP-UK, V6, DOI 10.1038/srep22252; Frand AR, 2000, TRENDS CELL BIOL, V10, P203, DOI 10.1016/S0962-8924(00)01745-1; Fu LM, 2012, BIOINFORMATICS, V28, P3150, DOI 10.1093/bioinformatics/bts565; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Guan BJ, 2014, J BIOL CHEM, V289, P12593, DOI 10.1074/jbc.M113.543215; Guillard R.R.L., 1975, CULTURE MARINE INVER, P29, DOI [10.1007/978-1-4615-8714-9_3, DOI 10.1007/978-1-4615-8714-9_3]; Gulshan K, 2011, TRAFFIC, V12, P1257, DOI 10.1111/j.1600-0854.2011.01228.x; Gussone N, 2006, GEOLOGY, V34, P625, DOI 10.1130/G22733.1; Herfort L, 2004, J STRUCT BIOL, V148, P307, DOI 10.1016/j.jsb.2004.07.005; Herfort L, 2002, NEW PHYTOL, V156, P427, DOI 10.1046/j.1469-8137.2002.00523.x; Hiong KC, 2017, PHYSL REPORTS, V5; Hu MY, 2018, ELIFE, V7, DOI 10.7554/eLife.36600; Jakob I, 2017, ENG LIFE SCI, V17, P605, DOI 10.1002/elsc.201600183; Jones PM, 2004, CELL MOL LIFE SCI, V61, P682, DOI 10.1007/s00018-003-3336-9; Kim SH, 2018, BIOSENSORS BIOELECTR; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Leek JT, 2012, BIOINFORMATICS, V28, P882, DOI 10.1093/bioinformatics/bts034; Leonardos N, 2009, J PHYCOL, V45, P1046, DOI 10.1111/j.1529-8817.2009.00726.x; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; M'boule D, 2014, GEOCHIM COSMOCHIM AC, V130, P126, DOI 10.1016/j.gca.2014.01.029; Mackinder L, 2011, ENVIRON MICROBIOL, V13, P3250, DOI 10.1111/j.1462-2920.2011.02561.x; Marsh ME, 2003, COMP BIOCHEM PHYS B, V136, P743, DOI 10.1016/S1096-4959(03)00180-5; Martin JA, 2011, NAT REV GENET, V12, P671, DOI 10.1038/nrg3068; Masuda M, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000238; MELDRUM E, 1991, BIOCHIM BIOPHYS ACTA, V1092, P49, DOI 10.1016/0167-4889(91)90177-Y; Muller MN, 2015, BIOGEOSCIENCES, V12, P6493, DOI 10.5194/bg-12-6493-2015; Nam O, 2018, ALGAE-SEOUL, V33, P181, DOI 10.4490/algae.2018.33.4.21; Nguyen B, 2005, APPL ENVIRON MICROB, V71, P2564, DOI 10.1128/AEM.71.5.2564-2575.2005; Oliveros J.C., 2007, INTERACTIVE TOOL COM; Paasche E, 2001, PHYCOLOGIA, V40, P503, DOI 10.2216/i0031-8884-40-6-503.1; Powers ET, 2013, NAT REV MOL CELL BIO, V14, P237, DOI 10.1038/nrm3542; Pulli I, 2018, BBA-MOL CELL RES, V1865, P1668, DOI 10.1016/j.bbamcr.2018.04.012; Putney James W, 2012, Adv Biol Regul, V52, P152; Quinn P, 2006, APPL ENVIRON MICROB, V72, P5512, DOI 10.1128/AEM.00343-06; Read BA, 2013, NATURE, V499, P209, DOI 10.1038/nature12221; Richier S, 2011, MAR BIOL, V158, P551, DOI 10.1007/s00227-010-1580-8; Rokitta SD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052212; Sasser TL, 2012, BIOCHEM J, V448, P365, DOI 10.1042/BJ20120847; Simao FA, 2015, BIOINFORMATICS, V31, P3210, DOI 10.1093/bioinformatics/btv351; Skeffington AW, 2018, CURR OPIN BIOTECH, V49, P57, DOI 10.1016/j.copbio.2017.07.013; Sotoj AR, 2006, APPL ENVIRON MICROB, V72, P5500, DOI 10.1128/AEM.00237-06; Sriram M, 1997, STRUCTURE, V5, P403, DOI 10.1016/S0969-2126(97)00197-4; Sviben S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11228; Taylor AR, 2017, ANNU REV MAR SCI, V9, P283, DOI 10.1146/annurev-marine-122414-034032; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Trimborn S, 2007, LIMNOL OCEANOGR, V52, P2285, DOI 10.4319/lo.2007.52.5.2285; Vogel C, 2012, NAT REV GENET, V13, P227, DOI 10.1038/nrg3185; von Dassow P, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-10-r114; Wahlund TM, 2004, MICROPALEONTOLOGY, V50, P145, DOI 10.2113/50.Suppl_1.145; Wahlund TM, 2004, MAR BIOTECHNOL, V6, P278, DOI 10.1007/s10126-003-0035-3; Walker CE, 2018, NEW PHYTOLOGIST; Weiss GM, 2017, BIOGEOSCIENCES, V14, P5693, DOI 10.5194/bg-14-5693-2017; WESTBROEK P, 1989, J PROTOZOOL, V36, P368, DOI 10.1111/j.1550-7408.1989.tb05528.x; Wu JM, 2006, NUCLEIC ACIDS RES, V34, pW720, DOI 10.1093/nar/gkl167; Wu ST, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-444; Young JC, 2004, NAT REV MOL CELL BIO, V5, P781, DOI 10.1038/nrm1492	69	8	8	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2019	14	8							e0221938	10.1371/journal.pone.0221938	http://dx.doi.org/10.1371/journal.pone.0221938			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW6AB	31465514	Green Published, gold, Green Submitted			2022-12-26	WOS:000485058200073
J	Stock, M; Reisch, F; Elmeros, M; Gabriel, D; Kloas, W; Kreuz, E; Lassen, P; Esther, A				Stoeck, Matthias; Reisch, Florian; Elmeros, Morten; Gabriel, Doreen; Kloas, Werner; Kreuz, Eva; Lassen, Pia; Esther, Alexandra			The potential of VKORC1 polymorphisms in Mustelidae for evolving anticoagulant resistance through selection along the food chain	PLOS ONE			English	Article							VITAMIN-K REQUIREMENT; WARFARIN RESISTANCE; POPULATION-GENETICS; RATTUS-NORVEGICUS; SOFT SWEEPS; RODENTICIDES; EXPOSURE; ADAPTATION; ERMINEA; RISK	In response to strong selection, new mutations can arise quickly and sweep through populations, particularly, if survival and reproduction depend on certain allele copies for adaptation to rapidly changing environments, like resistance against deadly diseases or strong toxins. Since the 1950s, resistance to anticoagulant rodenticides in several rodents has emerged through single nucleotide mutations in the vitamin-K-epoxid-reductase-complex-subunit-1 (VKORC1) gene, often located in its exon 3. Detection of high prevalence and concentrations of anticoagulant rodenticides in non-target vertebrates, including carnivorous Mustelidae, let us assume that secondary exposure by feeding on poisoned prey may also cause selection along the food chain and we hypothesized that VKORC1-based resistance might also have evolved in rodents' predators. Using newly-developed mustelid-specific primers for direct sequencing of genomic DNA, we studied VKORC1-DNA-polymorphisms in 115 mustelids of five species (Martes martes, M. foina, Mustela nivalis, M. erminea, M. putorius), obtained from northern Denmark, yielding six sites with nonsynonymous and several synonymous amino acid polymorphisms in exon 3. Comparison of these VKORC1-genotypes with hepatic rodenticide residues (obtained by HPLC combined with fluorescence or mass spectrometry) in 83 individuals (except M. martes), using generalized linear models, suggested that anticoagulant levels depended on species and specific polymorphisms. Although most VKORC-1 polymorphisms may present standing genetic variation, some are situated in resistance-mediating membrane parts of the VKORC1-encoded protein, and might be a result of selection due to exposure to anticoagulant poisons. Our new molecular markers might allow detecting indirect effects of anticoagulant rodenticides on rodent predator populations in the future.	[Stoeck, Matthias; Reisch, Florian; Kloas, Werner; Kreuz, Eva] Leibniz Inst Freshwater Ecol & Inland Fisheries, Dept Ecophysiol & Aquaculture, Berlin, Germany; [Reisch, Florian] Univ Med Berlin Charite, Inst Biochem, Berlin, Germany; [Elmeros, Morten] Aarhus Univ, Dept Biosci, Ronde, Denmark; [Gabriel, Doreen] Fed Res Ctr Cultivated Plants, Julius Kuhn Inst, Inst Crop & Soil Sci, Braunschweig, Germany; [Lassen, Pia] Aarhus Univ, Dept Environm Sci, Aarhus, Denmark; [Esther, Alexandra] Fed Res Ctr Cultivated Plants, Julius Kuhn Inst, Inst Plant Protect Hort & Forests, Munster, Germany	Leibniz Institut fur Gewasserokologie und Binnenfischerei (IGB); Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Aarhus University; Julius Kuhn-Institut; Aarhus University; Julius Kuhn-Institut	Stock, M (corresponding author), Leibniz Inst Freshwater Ecol & Inland Fisheries, Dept Ecophysiol & Aquaculture, Berlin, Germany.; Esther, A (corresponding author), Fed Res Ctr Cultivated Plants, Julius Kuhn Inst, Inst Plant Protect Hort & Forests, Munster, Germany.	matthias.stoeck@igb-berlin.de; alexandra.esther@julius-kuehn.de	Stöck, Matthias/E-7245-2014	Stöck, Matthias/0000-0003-4888-8371	Leibniz-Institute of Freshwater Ecology and Inland Fisheries; Julius Kuhn Institute	Leibniz-Institute of Freshwater Ecology and Inland Fisheries; Julius Kuhn Institute	This work was supported by Leibniz-Institute of Freshwater Ecology and Inland Fisheries to MS, and Julius Kuhn Institute to AE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert CA, 2010, ARCH ENVIRON CON TOX, V58, P451, DOI 10.1007/s00244-009-9402-z; Alterio N, 1996, NEW ZEAL J ZOOL, V23, P331, DOI 10.1080/03014223.1996.9518092; [Anonymous], 2010, BY OG LANDSK PLAN FO; [Anonymous], 2018, EMMEANS ESTIMATED MA, DOI [10.1080/19315260.2017.1354242, DOI 10.1080/19315260.2017.1354242]; Barrett RDH, 2008, TRENDS ECOL EVOL, V23, P38, DOI 10.1016/j.tree.2007.09.008; Barton K, 2018, MUMIN MULTIMODEL INF; Berny P, 2014, P VERT PEST C, P342; Berny P, 2014, RISK MITIGATION MEAS; BOYLE CM, 1960, NATURE, V188, P517, DOI 10.1038/188517a0; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Christensen TK, 2012, ARCH ENVIRON CON TOX, V63, P437, DOI 10.1007/s00244-012-9771-6; Czogalla KJ, 2013, BLOOD, V122, P2743, DOI 10.1182/blood-2013-05-501692; Dennis J, 2011, INT J EPIDEMIOL, V40, P1329, DOI 10.1093/ije/dyr088; Desvars-Larrive A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184015; Elmeros M, 2018, SCI TOTAL ENVIRON, V612, P1358, DOI 10.1016/j.scitotenv.2017.09.034; Elmeros M, 2011, SCI TOTAL ENVIRON, V409, P2373, DOI 10.1016/j.scitotenv.2011.03.006; Fernandez-de-Simon J, 2019, PEST MANAG SCI, V75, P900, DOI 10.1002/ps.5194; Fournier-Chambillon C., 2014, J WILDLIFE DIS, V40, P688; Fraser D, 2018, MOL ECOL, V27, P1170, DOI 10.1111/mec.14531; Gabriel MW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040163; Geduhn A, 2016, SCI TOTAL ENVIRON, V544, P150, DOI 10.1016/j.scitotenv.2015.11.117; Geduhn A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139191; Greaves J.H., 1985, Acta Zoologica Fennica, P159; Grolleau G, 1989, EPPO B, V19, P633; Gryseels S, 2015, J HERED, V106, P637, DOI 10.1093/jhered/esv054; Hedrick PW, 2012, TRENDS ECOL EVOL, V27, P698, DOI 10.1016/j.tree.2012.08.012; Heiberg AC, 2006, PEST MANAG SCI, V62, P862, DOI 10.1002/ps.1249; Hermisson J, 2005, GENETICS, V169, P2335, DOI 10.1534/genetics.104.036947; Huang AC, 2016, ECOTOXICOLOGY, V25, P1061, DOI 10.1007/s10646-016-1662-6; Huang BH, 2011, J PEST SCI, V84, P87, DOI 10.1007/s10340-010-0330-5; Iacucci A, 2018, HYSTRIX, V29, P95, DOI 10.4404/hystrix-00055-2018; Jacob J, 2012, PEST MANAG SCI, V68, P378, DOI 10.1002/ps.2273; Jones A, 1996, B ENVIRON CONTAM TOX, V56, P8, DOI 10.1007/s001289900002; Karlsson EK, 2014, NAT REV GENET, V15, P379, DOI 10.1038/nrg3734; Li T, 2004, NATURE, V427, P541, DOI 10.1038/nature02254; LINK KP, 1959, CIRCULATION, V19, P97, DOI 10.1161/01.CIR.19.1.97; Link KP, 1942, HARVEY LECT, V39, P162; Litwack G, 2008, VITAM HORM, V78, P1; Lodal J., 2010, RESISTENS HOS BRUNE; Markussen MDK, 2003, PEST MANAG SCI, V59, P913, DOI 10.1002/ps.703; McClain MR, 2008, GENET MED, V10, P89, DOI 10.1097/GIM.0b013e31815bf924; McDonald RA, 1998, ENVIRON POLLUT, V103, P17, DOI 10.1016/S0269-7491(98)00141-9; Messer PW, 2016, TRENDS GENET, V32, P408, DOI 10.1016/j.tig.2016.04.005; MYSZKA DG, 1991, J BIOL CHEM, V266, P4789; O'Connor J. A., 1948, Research London, V1, P334; Pelz HJ, 2012, PEST MANAG SCI, V68, P254, DOI 10.1002/ps.2254; Pelz HJ, 2005, GENETICS, V170, P1839, DOI 10.1534/genetics.104.040360; Prescott CV, 2007, INT J PEST MANAGE, V53, P265, DOI 10.1080/09670870701245249; Pritchard JK, 2010, CURR BIOL, V20, pR208, DOI 10.1016/j.cub.2009.11.055; R Core Team, 2018, R LANG ENV STAT COMP; Reid NM, 2016, SCIENCE, V354, P1305, DOI 10.1126/science.aah4993; Rost S, 2005, THROMB HAEMOSTASIS, V94, P780, DOI 10.1160/TH05-02-0082; Rost S, 2004, NATURE, V427, P537, DOI 10.1038/nature02214; ROWE FP, 1965, J HYG-CAMB, V63, P417, DOI 10.1017/S0022172400045307; RRAC, 2016, RRAC GUID ANT ROD RE; RRAC [Rodenticide Resistance Action Committee of CropLife International], 2003, TECHNICAL MONOGRAPH; Sainsbury KA, 2018, ENVIRON POLLUT, V236, P689, DOI 10.1016/j.envpol.2018.02.004; Scepovic T, 2016, PEST MANAG SCI, V72, P574, DOI 10.1002/ps.4027; SEIDMAN M, 1950, J AM CHEM SOC, V72, P5193, DOI 10.1021/ja01167a113; Stahmann A, BIOL CHEM, V194, P513; Stephan W, 2016, MOL ECOL, V25, P79, DOI 10.1111/mec.13288; Tanaka KD, 2012, PESTIC BIOCHEM PHYS, V103, P144, DOI 10.1016/j.pestbp.2012.04.011; Tang Y, 2016, R J, V8, P474, DOI 10.32614/rj-2016-060; Tie JK, 2005, J BIOL CHEM, V280, P16410, DOI 10.1074/jbc.M500765200; TOWNSEND MG, 1984, J WILDLIFE MANAGE, V48, P628, DOI 10.2307/3801205; Vandenbroucke V, 2008, J VET PHARMACOL THER, V31, P437, DOI 10.1111/j.1365-2885.2008.00979.x; Wang HS, 2008, PESTIC BIOCHEM PHYS, V91, P90, DOI 10.1016/j.pestbp.2008.01.007; Watanabe KP, 2010, COMP BIOCHEM PHYS C, V152, P114, DOI 10.1016/j.cbpc.2010.03.006; WRIGHT IS, 1948, AM HEART J, V36, P801, DOI 10.1016/0002-8703(48)90278-6	69	2	2	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2019	14	8							e0221706	10.1371/journal.pone.0221706	http://dx.doi.org/10.1371/journal.pone.0221706			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW6AB	31465484	Green Submitted, Green Published, gold			2022-12-26	WOS:000485058200039
J	Verma, A; Ghosh, T; Bhushan, B; Packirisamy, G; Navani, NK; Sarangi, PP; Ambatipudi, K				Verma, Aparna; Ghosh, Tamoghna; Bhushan, Bharat; Packirisamy, Gopinath; Navani, Naveen K.; Sarangi, Pranita P.; Ambatipudi, Kiran			Characterization of difference in structure and function of fresh and mastitic bovine milk fat globules	PLOS ONE			English	Article							LACTOBACILLUS-ACIDOPHILUS; BACTERIAL ADHESION; GENE-EXPRESSION; POLAR LIPIDS; WHOLE MILK; MEMBRANE; MICROSCOPY; CHEESE; SIZE; SPHINGOMYELIN	Characterization of milk fat globule (MFG) was performed to investigate the difference in MFG membrane (MFGM) between fresh and mastitis Holstein Friesian cow milk. Lipid distribution investigated by exogenous phospholipids using microscopy showed higher phospholipid content in fresh compared to mastitic MFGM. Xanthine oxidase assay indicative of membrane impairment revealed lower activity in mastitic samples compared to fresh globules. Of note, significantly higher roughness of globule surface and zeta potential was observed in mastitis compared to fresh globules. Influence of globule membrane on the interaction with L. fermentum demonstrated preferential adhesion of bacteria to fresh compared to mastitic globules including enhanced extent of binding. Results of the present study provides an insight of the interfacial changes occurring at the globule surface as well as highlighting the importance of selective bacterial interaction with milk components for the potential development of functional food with relevance to human health.	[Verma, Aparna; Ghosh, Tamoghna; Packirisamy, Gopinath; Navani, Naveen K.; Sarangi, Pranita P.; Ambatipudi, Kiran] Indian Inst Technol, Dept Biotechnol, Roorkee, Uttar Pradesh, India; [Bhushan, Bharat; Packirisamy, Gopinath] Indian Inst Technol, Ctr Nanotechnol, Roorkee, Uttar Pradesh, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Roorkee; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Roorkee	Ambatipudi, K (corresponding author), Indian Inst Technol, Dept Biotechnol, Roorkee, Uttar Pradesh, India.	kiranfbt@iitr.ac.in	Gopinath/O-8237-2017	Gopinath/0000-0003-1379-1203	Department of Biotechnology (DBT), Government of India [BT/PR12721/AAQ/1/618/2015]; DBT, Government of India fellowship [DBT/2014/IITR-R/110]	Department of Biotechnology (DBT), Government of India(Department of Biotechnology (DBT) India); DBT, Government of India fellowship	This work is supported by Department of Biotechnology (DBT), Government of India; Grant No. BT/PR12721/AAQ/1/618/2015 (KA). AV is supported by DBT, Government of India fellowship (DBT/2014/IITR-R/110). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An YH, 1998, J BIOMED MATER RES, V43, P338, DOI 10.1002/(SICI)1097-4636(199823)43:3<338::AID-JBM16>3.0.CO;2-B; ANDERSON M, 1975, J DAIRY RES, V42, P459, DOI 10.1017/S0022029900015508; Argov N, 2008, TRENDS FOOD SCI TECH, V19, P617, DOI 10.1016/j.tifs.2008.07.006; Azcarate-Peril MA, 2009, J DAIRY SCI, V92, P870, DOI 10.3168/jds.2008-1457; Bergmeyer HU, 1974, METHODS ENZYMATIC AN; Brisson G, 2010, J AGR FOOD CHEM, V58, P5612, DOI 10.1021/jf904381s; Buck BL, 2005, APPL ENVIRON MICROB, V71, P8344, DOI 10.1128/AEM.71.12.8344-8351.2005; BUSSCHER HJ, 1987, FEMS MICROBIOL LETT, V46, P165, DOI 10.1111/j.1574-6968.1987.tb02457.x; Dague E, 2010, LANGMUIR, V26, P11010, DOI 10.1021/la101862n; Dewettinck K, 2008, INT DAIRY J, V18, P436, DOI 10.1016/j.idairyj.2007.10.014; ERWIN RE, 1975, J DAIRY SCI, V58, P9, DOI 10.3168/jds.S0022-0302(75)84509-7; Evers JM, 2008, INT DAIRY J, V18, P1081, DOI 10.1016/j.idairyj.2008.06.001; FOLCH J, 1957, J BIOL CHEM, V226, P497; Gallier S, 2010, J AGR FOOD CHEM, V58, P4250, DOI 10.1021/jf9032409; Guerin J, 2018, COLLOID SURFACE B, V167, P44, DOI 10.1016/j.colsurfb.2018.03.044; Hamosh M, 1999, SEMIN PERINATOL, V23, P242, DOI 10.1016/S0146-0005(99)80069-X; Haug A., 2007, Lipids in Health and Disease, V6; Hettinga K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019433; Keenan T. W., 1995, STRUCTURE MILK IMPLI, P5; Laloy E, 1996, INT DAIRY J, V6, P729, DOI 10.1016/0958-6946(95)00068-2; Le TT, 2012, J DAIRY SCI, V95, P2307, DOI 10.3168/jds.2011-4947; Lee H, 2018, FRONT PEDIATR, V6, DOI 10.3389/fped.2018.00313; Lima SF, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193671; Lopez C, 2006, J AGR FOOD CHEM, V54, P5855, DOI 10.1021/jf060214l; Lopez C, 2014, FOOD RES INT, V58, P59, DOI 10.1016/j.foodres.2014.01.049; Lopez C, 2011, FOOD CHEM, V125, P355, DOI 10.1016/j.foodchem.2010.09.005; Lopez C, 2010, FOOD CHEM, V120, P22, DOI 10.1016/j.foodchem.2009.09.065; Ly MH, 2006, COLLOID SURFACE B, V52, P149, DOI 10.1016/j.colsurfb.2006.04.015; Menard O, 2010, FOOD CHEM, V120, P544, DOI 10.1016/j.foodchem.2009.10.053; Michalski MC, 2002, COLLOID SURFACE B, V23, P23, DOI 10.1016/S0927-7765(01)00203-X; Mizuno K, 2012, J HUM LACT, V28, P529, DOI 10.1177/0890334412455946; MURPHY SC, 1989, J DAIRY SCI, V72, P620, DOI 10.3168/jds.S0022-0302(89)79152-9; Murrieta-Pazos I, 2011, COLLOID SURFACE B, V87, P1, DOI 10.1016/j.colsurfb.2011.05.001; Nguyen HTH, 2015, FOOD RES INT, V67, P35, DOI 10.1016/j.foodres.2014.10.022; OBERG CJ, 1993, FOOD STRUCT, V12, P251; Parker P, 2010, GLYCOCONJUGATE J, V27, P89, DOI 10.1007/s10719-009-9269-2; Preethirani PL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142717; Quinn P.J., 2011, VET MICROBIOLOGY MIC, V2nd; RANDOLPH HE, 1974, J DAIRY SCI, V57, P865, DOI 10.3168/jds.S0022-0302(74)84978-7; Salminen S, 1996, ANTON LEEUW INT J G, V70, P347, DOI 10.1007/BF00395941; SCHALM O. W., 1957, JOUR AMER VET MED ASSOC, V130, P199; Sharma P, 2015, FOOD HYDROCOLLOID, V47, P99, DOI 10.1016/j.foodhyd.2015.01.023; Sharma R, 2018, BIORESOURCE TECHNOL, V249, P1000, DOI 10.1016/j.biortech.2017.10.106; Spitsberg VL, 2005, J DAIRY SCI, V88, P2289, DOI 10.3168/jds.S0022-0302(05)72906-4; STEWART JCM, 1980, ANAL BIOCHEM, V104, P10, DOI 10.1016/0003-2697(80)90269-9; Vanderghem C, 2011, INT DAIRY J, V21, P312, DOI 10.1016/j.idairyj.2010.12.006; Wang JC, 2012, RES MICROBIOL, V163, P357, DOI 10.1016/j.resmic.2012.04.002; Wurth R, 2015, J FUNCT FOODS, V15, P116, DOI 10.1016/j.jff.2015.02.046	48	6	6	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2019	14	8							e0221830	10.1371/journal.pone.0221830	http://dx.doi.org/10.1371/journal.pone.0221830			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW6AB	31465429	Green Published, Green Submitted, gold			2022-12-26	WOS:000485058200057
J	Vidyanti, AN; Chan, L; Lin, CL; Muo, CH; Hsu, CY; Chen, YC; Wu, DA; Hu, CJ				Vidyanti, Amelia Nur; Chan, Lung; Lin, Cheng-Li; Muo, Chih-Hsin; Hsu, Chung Y.; Chen, You-Chia; Wu, Dean; Hu, Chaur-Jong			Aspirin better than clopidogrel on major adverse cardiovascular events reduction after ischemic stroke: A retrospective nationwide cohort study	PLOS ONE			English	Article							LONG-TERM RISK; SECONDARY PREVENTION; RECURRENT STROKE; CLINICAL-TRIALS; POLYMORPHISMS; CONSEQUENCES; RESISTANCE; EFFICACY; ATTACK	Background Several clinical trials reported that clopidogrel was superior to aspirin in secondary stroke prevention by reducing the risk of major adverse cardiovascular events (MACE). We aimed to compare the efficacy of clopidogrel with aspirin in reducing one-year risk of MACE based on real-world evidence from Taiwan Health Insurance Database. Methods We identified ischemic stroke patients between 2000 and 2012 who took aspirin or clopidogrel within 7 days of stroke onset for 1-year follow-up. The primary outcome was one-year MACE including recurrent stroke, acute myocardial infarction, and death. Propensity score matching and conditional Cox proportional hazards regression were conducted to control the confounding factors. Results From 9,089 ischemic stroke patients, we found 654 patients on aspirin and 465 patients on clopidogrel who met the selective inclusion criteria. After propensity score matching, 379 patients were selected from each group. The clopidogrel group had a 1.78-fold MACE risk compared with the aspirin group at one-year follow-up (95% CI = 1.41-2.26, p<0.01). The MACE-free rate in the aspirin group was 15.74% higher than in the clopidogrel group at one-year follow-up. Sub-analysis of the three components of MACE showed that clopidogrel conferred higher risk of recurrent stroke (OR 1.43, 95% CI = 1.06-1.92, p 0.02) and acute myocardial infarction (OR 3.72, 95% CI = 1.04-13.3, p 0.04), but no different risk of death than that of aspirin. Conclusions Among first-ever ischemic stroke patients, secondary stroke prevention using clopidogrel was associated with higher rates of MACE than aspirin. Aspirin might have better efficacy in secondary stroke prevention and was associated with lower risk of MACE. The real-world evidence raises the need to re-assess the current therapeutic options in secondary stroke prevention applying aspirin vs. clopidogrel.	[Vidyanti, Amelia Nur] Taipei Med Univ, Coll Med, Int Master PhD Program Med, Taipei, Taiwan; [Vidyanti, Amelia Nur] Univ Gadjah Mada, Fac Med Publ Hlth & Nursing, Dept Neurol, Yogyakarta, Indonesia; [Chan, Lung; Hu, Chaur-Jong] Taipei Med Univ, Coll Med, Dept Neurol, Taipei, Taiwan; [Chan, Lung; Chen, You-Chia; Wu, Dean; Hu, Chaur-Jong] Taipei Med Univ, Shuang Ho Hosp, Dept Neurol, New Taipei, Taiwan; [Chan, Lung; Chen, You-Chia; Wu, Dean; Hu, Chaur-Jong] Taipei Med Univ, Shuang Ho Hosp, Stroke Ctr, New Taipei, Taiwan; [Lin, Cheng-Li; Muo, Chih-Hsin] China Med Univ Hosp, Clin Trial Res Ctr, Management Off Hlth Data, Taichung, Taiwan; [Hsu, Chung Y.] China Med Univ Hosp, Dept Neurol, Taichung, Taiwan; [Hsu, Chung Y.] China Med Univ, Grad Inst Clin Med Sci, Taichung, Taiwan; [Chen, You-Chia; Hu, Chaur-Jong] Taipei Neurosci Inst, Taipei, Taiwan; [Wu, Dean] TMU Neurosci Res Ctr Sleep Med, Taipei, Taiwan; [Hu, Chaur-Jong] Taipei Med Univ, Coll Med Sci & Technol, PhD Program Neural Regenerat Med, Taipei, Taiwan	Taipei Medical University; Gadjah Mada University; Taipei Medical University; Taipei Medical University; Shuang Ho Hospital; Taipei Medical University; Shuang Ho Hospital; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; Taipei Medical University	Hu, CJ (corresponding author), Taipei Med Univ, Coll Med, Dept Neurol, Taipei, Taiwan.; Hu, CJ (corresponding author), Taipei Med Univ, Shuang Ho Hosp, Dept Neurol, New Taipei, Taiwan.; Hu, CJ (corresponding author), Taipei Med Univ, Shuang Ho Hosp, Stroke Ctr, New Taipei, Taiwan.; Hu, CJ (corresponding author), Taipei Neurosci Inst, Taipei, Taiwan.; Hu, CJ (corresponding author), Taipei Med Univ, Coll Med Sci & Technol, PhD Program Neural Regenerat Med, Taipei, Taiwan.	chaurjongh@tmu.edu.tw	Chan, Lung/AAI-6349-2020; Vidyanti, Amelia Nur/ABD-2242-2020; Chan, Lung/AAM-3231-2021	Chan, Lung/0000-0001-5795-4460; Vidyanti, Amelia Nur/0000-0002-2741-2983; 	Taiwan Ministry of Health and Welfare Clinical Trial Center [MOHW108-TDU-B-212-133004]; China Medical University Hospital, Academia Sinica Stroke Biosignature Project [BM10701010021]; MOST Clinical Trial Consortium for Stroke [MOST 108-2321-B-039-003]; Tseng-Lien Lin Foundation, Taichung, Taiwan; Katsuzo and Kiyo Aoshima Memorial Funds, Japan	Taiwan Ministry of Health and Welfare Clinical Trial Center; China Medical University Hospital, Academia Sinica Stroke Biosignature Project; MOST Clinical Trial Consortium for Stroke; Tseng-Lien Lin Foundation, Taichung, Taiwan; Katsuzo and Kiyo Aoshima Memorial Funds, Japan	This study was supported in part by Taiwan Ministry of Health and Welfare Clinical Trial Center (MOHW108-TDU-B-212-133004), China Medical University Hospital, Academia Sinica Stroke Biosignature Project (BM10701010021), MOST Clinical Trial Consortium for Stroke (MOST 108-2321-B-039-003), Tseng-Lien Lin Foundation, Taichung, Taiwan, and Katsuzo and Kiyo Aoshima Memorial Funds, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amer Diabet Assoc, 2018, DIABETES CARE, V41, pS86, DOI 10.2337/dc18-S009; BURN J, 1994, STROKE, V25, P333, DOI 10.1161/01.STR.25.2.333; Caro JJ, 1999, AM J MED, V107, P568, DOI 10.1016/S0002-9343(99)00295-8; Chi NF, 2018, J AM HEART ASSOC, V7, DOI 10.1161/JAHA.118.009856; Criqui MH, 2015, CIRC RES, V116, P1509, DOI 10.1161/CIRCRESAHA.116.303849; Desta Z, 2002, CLIN PHARMACOKINET, V41, P913, DOI 10.2165/00003088-200241120-00002; Durand-Zaleski I, 2004, PHARMACOECONOMICS, V22, P19, DOI 10.2165/00019053-200422004-00005; Fiolaki A, 2017, J NEUROL SCI, V376, P112, DOI 10.1016/j.jns.2017.03.010; Gent M, 1996, LANCET, V348, P1329, DOI 10.1016/s0140-6736(96)09457-3; Greving JP, 2019, STROKE, V50, P1812, DOI 10.1161/STROKEAHA.118.024497; Hankey GJ, 1998, STROKE, V29, P2491, DOI 10.1161/01.STR.29.12.2491; Huang K- C, 2014, EVIDENCE BASED COMPL, V2014; Inzitari D, 2010, INT J STROKE, V5, P306, DOI 10.1111/j.1747-4949.2010.00443.x; Kernan WN, 2014, STROKE, V45, P2160, DOI 10.1161/STR.0000000000000024; Lee M, 2017, STROKE, V48, P2610, DOI 10.1161/STROKEAHA.117.017895; Lee M, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-006672; Logman JFS, 2010, APPL HEALTH ECON HEA, V8, P251, DOI 10.2165/11535520-000000000-00000; Maasland L, 2009, STROKE, V40, P2662, DOI 10.1161/STROKEAHA.109.551812; McQuaid KR, 2006, AM J MED, V119, P624, DOI 10.1016/j.amjmed.2005.10.039; Mega JL, 2009, NEW ENGL J MED, V360, P354, DOI 10.1056/NEJMoa0809171; Mijajlovic MD, 2013, ACTA NEUROL SCAND, V128, P213, DOI 10.1111/ane.12111; Pan YS, 2017, CIRCULATION, V135, P21, DOI 10.1161/CIRCULATIONAHA.116.024913; Sherman RE, 2016, NEW ENGL J MED, V375, P2293, DOI 10.1056/NEJMsb1609216; Shi XL, 1999, MOL CELL BIOCHEM, V199, P93, DOI 10.1023/A:1006934612368; Sudlow CLM, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001246.pub2; Topcuoglu MA, 2011, EXPERT REV NEUROTHER, V11, P251, DOI 10.1586/ERN.10.203; Wang YL, 2016, JAMA-J AM MED ASSOC, V316, P70, DOI 10.1001/jama.2016.8662	27	3	4	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2019	14	8							e0221750	10.1371/journal.pone.0221750	http://dx.doi.org/10.1371/journal.pone.0221750			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW6AB	31465467	Green Published, Green Submitted, gold			2022-12-26	WOS:000485058200043
J	Lagundzin, D; Hu, WF; Law, HCH; Krieger, KL; Chao, FF; Clement, EJ; Drincic, AT; Nedic, O; Naldrett, MJ; Alvarez, S; Woods, NT				Lagundzin, Dragana; Hu, Wen-Feng; Law, Henry C. H.; Krieger, Kimiko L.; Chao, Fangfang; Clement, Emalie J.; Drincic, Andjela T.; Nedic, Olgica; Naldrett, Michael J.; Alvarez, Sophie; Woods, Nicholas T.			Delineating the role of FANCA in glucose-stimulated insulin secretion in beta cells through its protein interactome	PLOS ONE			English	Article							BONE-MARROW FAILURE; CHRONIC OXIDATIVE STRESS; DIABETES-MELLITUS; DNA-REPAIR; TRANSFERRIN RECEPTOR; ANEMIA; TRANSPLANTATION; RESISTANCE; TOLERANCE; TOXICITY	Hyperinsulinemia affects 72% of Fanconi anemia (FA) patients and an additional 25% experience lowered glucose tolerance or frank diabetes. The underlying molecular mechanisms contributing to the dysfunction of FA pancreas beta cells is unknown. Therefore, we sought to evaluate the functional role of FANCA, the most commonly mutated gene in FA, in glucose-stimulated insulin secretion (GSIS). This study reveals that FANCA or FANCB knockdown impairs GSIS in human pancreas beta cell line EndoC-beta H3. To identify potential pathways by which FANCA might regulate GSIS, we employed a proteomics approach to identify FANCA protein interactions in EndoC-beta H3 differentially regulated in response to elevated glucose levels. Glucose-dependent changes in the FANCA interaction network were observed, including increased association with other FA family proteins, suggesting an activation of the DNA damage response in response to elevated glucose levels. Reactive oxygen species increase in response to glucose stimulation and are necessary for GSIS in EndoC-beta H3 cells. Glucose-induced activation of the DNA damage response was also observed as an increase in the DNA damage foci marker gamma-H2AX and dependent upon the presence of reactive oxygen species. These results illuminate the role of FANCA in GSIS and its protein interactions regulated by glucose stimulation that may explain the prevalence of beta cell-specific endocrinopathies in FA patients.	[Lagundzin, Dragana; Hu, Wen-Feng; Law, Henry C. H.; Krieger, Kimiko L.; Chao, Fangfang; Clement, Emalie J.; Woods, Nicholas T.] Univ Nebraska Med Ctr, Eppley Inst Res Canc & Allied Dis, Fred & Pamela Buffett Canc Ctr, Omaha, NE 68198 USA; [Lagundzin, Dragana] Univ Nebraska Med Ctr, Mass Spectrometry & Prote Core Facil, Omaha, NE USA; [Drincic, Andjela T.] Univ Nebraska Med Ctr, Dept Internal Med Diabet Endocrinol & Metab, Omaha, NE USA; [Nedic, Olgica] Univ Belgrade, Inst Applicat Nucl Energy, Belgrade, Serbia; [Naldrett, Michael J.; Alvarez, Sophie] Univ Nebraska, Nebraska Ctr Biotechnol, Prote & Metabol Facil, Lincoln, NE USA	University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Belgrade; University of Nebraska System; University of Nebraska Lincoln	Woods, NT (corresponding author), Univ Nebraska Med Ctr, Eppley Inst Res Canc & Allied Dis, Fred & Pamela Buffett Canc Ctr, Omaha, NE 68198 USA.	nicholas.woods@unmc.edu	Law, Henry/AAS-3328-2020; Lagundzin, Dragana/AAY-3565-2020; Lagundzin, Dragana/AAH-1317-2020	Lagundzin, Dragana/0000-0003-0001-8449; Law, Henry Chun Hin/0000-0003-4532-9750; Woods, Nicholas/0000-0002-4962-9083; Krieger, Kimiko/0000-0002-7432-2729	Fanconi Anemia Research Fund; NIH Centers for Biomedical Research Excellence (COBRE) award [P20GM121316]; Fred & Pamela Buffett Cancer Center Support Grant [P30CA036727]; UNMC Pancreatic SPORE through a Career Enhancement Program award [1P50CA127297]; Cancer Biology Training Program [T32CA009476]; NATIONAL CANCER INSTITUTE [P30CA036727, P50CA127297, T32CA009476] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM121316] Funding Source: NIH RePORTER	Fanconi Anemia Research Fund; NIH Centers for Biomedical Research Excellence (COBRE) award; Fred & Pamela Buffett Cancer Center Support Grant; UNMC Pancreatic SPORE through a Career Enhancement Program award; Cancer Biology Training Program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by the Fanconi Anemia Research Fund to N.T.W., the NIH Centers for Biomedical Research Excellence (COBRE) award (P20GM121316) to N.T.W., the Fred & Pamela Buffett Cancer Center Support Grant (P30CA036727), the UNMC Pancreatic SPORE (1P50CA127297) through a Career Enhancement Program award to N.T.W., and the Cancer Biology Training Program (T32CA009476) to K.L.K. and E.J.C. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Bagby GC, 2003, CURR OPIN HEMATOL, V10, P68, DOI 10.1097/00062752-200301000-00011; Baker KS, 2007, BLOOD, V109, P1765, DOI 10.1182/blood-2006-05-022335; Benazra M, 2015, MOL METAB, V4, P916, DOI 10.1016/j.molmet.2015.09.008; Benitez A, 2014, NUCLEIC ACIDS RES, V42, P1671, DOI 10.1093/nar/gkt975; Berquist BR, 2012, CANCER LETT, V327, P61, DOI 10.1016/j.canlet.2012.02.001; Bhattacharya D, 2018, EXCLI J, V17, P709, DOI 10.17179/excli2018-1353; Bonanomi S, 2006, PEDIATR TRANSPLANT, V10, P461, DOI 10.1111/j.1399-3046.2006.00498.x; Chatr-aryamontri A, 2017, NUCLEIC ACIDS RES, V45, pD369, DOI 10.1093/nar/gkw1102; Cheung RS, 2017, INT J HEMATOL, V106, P335, DOI 10.1007/s12185-017-2283-4; Chirnomas SD, 2013, PEDIATR CLIN N AM, V60, P1291, DOI 10.1016/j.pcl.2013.09.007; Choi H, 2011, NAT METHODS, V8, P70, DOI 10.1038/NMETH.1541; Domin J, 2000, J BIOL CHEM, V275, P11943, DOI 10.1074/jbc.275.16.11943; Dominguez V, 2011, J BIOL CHEM, V286, P4216, DOI 10.1074/jbc.M110.200295; Elder DA, 2008, PEDIATR BLOOD CANCER, V51, P256, DOI 10.1002/pbc.21589; Erduran E, 2016, PEDIATR HEMAT ONCOL, V33, P13, DOI 10.3109/08880018.2015.1106626; Giri N, 2007, J CLIN ENDOCR METAB, V92, P2624, DOI 10.1210/jc.2007-0135; Gluckman E, 2008, BONE MARROW TRANSPL, V41, P127, DOI 10.1038/sj.bmt.1705960; Hoffmeister PA, 2004, J PEDIAT HEMATOL ONC, V26, P81, DOI 10.1097/00043426-200402000-00003; Hu WF, 2019, CELL DEATH DISCOV, V5, DOI 10.1038/s41420-019-0185-3; John PR, 2002, LIVER TRANSPLANT, V8, P708, DOI 10.1053/jlts.2002.34638; Knight JDR, 2017, NAT METHODS, V14, P645, DOI 10.1038/nmeth.4330; Komatsu M, 2013, J DIABETES INVEST, V4, P511, DOI 10.1111/jdi.12094; Kulanuwat S, 2018, MOL MED REP, V18, P2485, DOI 10.3892/mmr.2018.9163; Kutler DI, 2003, BLOOD, V101, P1249, DOI 10.1182/blood-2002-07-2170; Lamb CA, 2013, NAT REV MOL CELL BIO, V14, P759, DOI 10.1038/nrm3696; Levy JE, 1999, NAT GENET, V21, P396, DOI 10.1038/7727; Li J, 2012, ANTIOXID REDOX SIGN, V17, P1083, DOI 10.1089/ars.2011.4417; Li J, 2007, J CLIN INVEST, V117, P3283, DOI 10.1172/JCI31772; Longerich S, 2014, BLOOD, V124, P2812, DOI 10.1182/blood-2014-04-526293; Martin A, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-91; McCluskey JT, 2011, J BIOL CHEM, V286, P21982, DOI 10.1074/jbc.M111.226795; Mellacheruvu D, 2013, NAT METHODS, V10, P730, DOI 10.1038/nmeth.2557; MORRELL D, 1986, DIABETES, V35, P143, DOI 10.2337/diabetes.35.2.143; MUNHOZ AC, 2016, PLOS ONE, V11, DOI DOI 10.1371/JOURNAL.PONE.0158166; Nepusz T, 2012, NAT METHODS, V9, P471, DOI [10.1038/nmeth.1938, 10.1038/NMETH.1938]; Nouspikel T, 2000, MOL CELL BIOL, V20, P1562, DOI 10.1128/MCB.20.5.1562-1570.2000; ORCI L, 1987, CELL, V49, P865, DOI 10.1016/0092-8674(87)90624-6; Pagano G, 2003, BIOESSAYS, V25, P589, DOI 10.1002/bies.10283; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Petryk A, 2015, J CLIN ENDOCR METAB, V100, P803, DOI 10.1210/jc.2014-4357; PHILLIPS DIW, 1994, DIABETIC MED, V11, P286, DOI 10.1111/j.1464-5491.1994.tb00273.x; Pi JB, 2007, DIABETES, V56, P1783, DOI 10.2337/db06-1601; Polgreen LE, 2009, PEDIATR BLOOD CANCER, V53, P191, DOI 10.1002/pbc.22043; Robertson RP, 2003, DIABETES, V52, P581, DOI 10.2337/diabetes.52.3.581; Robertson RP, 2004, DIABETES, V53, pS119, DOI 10.2337/diabetes.53.2007.S119; Robertson RP, 2004, J BIOL CHEM, V279, P42351, DOI 10.1074/jbc.R400019200; Rose SR, 2012, PEDIATR BLOOD CANCER, V59, P690, DOI 10.1002/pbc.24095; ROTH D, 1989, TRANSPLANTATION, V47, P278, DOI 10.1097/00007890-198902000-00016; ROTHENBERGER S, 1987, CELL, V49, P423, DOI 10.1016/0092-8674(87)90295-9; Schneider L, 2012, CELL DEATH DIFFER, V19, P582, DOI 10.1038/cdd.2011.129; Shalitin S, 2006, BONE MARROW TRANSPL, V37, P1109, DOI 10.1038/sj.bmt.1705374; Sumpter R, 2016, CELL, V165, P867, DOI 10.1016/j.cell.2016.04.006; Teo GC, 2014, J PROTEOMICS, V100, P37, DOI 10.1016/j.jprot.2013.10.023; Tooze SA, 1998, BBA-MOL CELL RES, V1404, P231, DOI 10.1016/S0167-4889(98)00059-7; Vizcaino JA, 2014, NAT BIOTECHNOL, V32, P223, DOI 10.1038/nbt.2839; Wajnrajch MP, 2001, PEDIATRICS, V107, P744, DOI 10.1542/peds.107.4.744; Woods NT, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002255	57	3	3	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2019	14	8							e0220568	10.1371/journal.pone.0220568	http://dx.doi.org/10.1371/journal.pone.0220568			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5XV	31461451	Green Submitted, gold, Green Published			2022-12-26	WOS:000485052300012
J	Zeh, N; Schneider, H; Mathias, S; Raab, N; Kleemann, M; Schmidt-Hertel, S; Weis, B; Wissing, S; Strempel, N; Handrick, R; Otte, K				Zeh, Nikolas; Schneider, Helga; Mathias, Sven; Raab, Nadja; Kleemann, Michael; Schmidt-Hertel, Sabine; Weis, Benjamin; Wissing, Silke; Strempel, Nikola; Handrick, Rene; Otte, Kerstin			Human CAP cells represent a novel source for functional, miRNA-loaded exosome production	PLOS ONE			English	Article							EXTRACELLULAR VESICLES; STEM-CELLS; DELIVERY PLATFORMS; CANCER CELLS; APOPTOSIS; MICRORNA; MECHANISMS; RESISTANT; PLAYERS; LINE	Exosomes represent a promising delivery tool for nucleic acid-based pharmaceuticals. They are highly suitable for transporting therapeutic miRNAs to tumor cells, due to their natural membrane components. Further, exosomes are capable of effectively protecting nucleic acids against ribonucleases and enable the delivery of their content through cell membranes. However, no suitable production host for miRNA containing exosomes of non-tumorigenic origin has yet been identified. In this study we engineered an immortalised human amniocyte cell line (CAP (R) cells), whose exosomes were enriched and characterised. The cell line modifications not only enabled the production of GFP-labelled but also pro-apoptotic miRNA containing exosomes without negative influence on host cell growth. Furthermore, we demonstrated that pro-apoptotic miRNA containing CAP exosomes are taken up by ovarian cancer cells. Strikingly, delivery of functional exosomal miRNA led to downregulation of several reported target genes in the treated tumor cells. In summary, we revealed CAP cells of non-tumorigenic origin as a novel and efficient exosome production host with the potential to produce functional miRNA-loaded exosomes.	[Zeh, Nikolas; Schneider, Helga; Mathias, Sven; Raab, Nadja; Kleemann, Michael; Weis, Benjamin; Handrick, Rene; Otte, Kerstin] Univ Appl Sci Biberach, Inst Appl Biotechnol, Biberach, Germany; [Schmidt-Hertel, Sabine; Wissing, Silke; Strempel, Nikola] CEVEC Pharmaceut GmbH, Cologne, Germany		Zeh, N (corresponding author), Univ Appl Sci Biberach, Inst Appl Biotechnol, Biberach, Germany.	nikolas.zeh@gmx.net	Zeh, Nikolas/AAS-6297-2021	Zeh, Nikolas/0000-0003-4889-7761; Mathias, Sven/0000-0002-2842-8549	CEVEC Pharmaceuticals GmbH; University of Applied Sciences Biberach; CEVEC Pharmaceuticals	CEVEC Pharmaceuticals GmbH; University of Applied Sciences Biberach; CEVEC Pharmaceuticals	This study was funded by CEVEC Pharmaceuticals GmbH in a cooperation-project with the University of Applied Sciences Biberach. CEVEC Pharmaceuticals funded the material for this study. CEVEC Pharmaceuticals GmbH also provided support for this study in the form of salaries for SS, SW, and NS. The funders had no additional role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmadzada Tamkin, 2018, Biophys Rev, V10, P69, DOI 10.1007/s12551-017-0392-1; Alvarez-Erviti L, 2011, NAT BIOTECHNOL, V29, P341, DOI 10.1038/nbt.1807; Bang C, 2012, INT J BIOCHEM CELL B, V44, P2060, DOI 10.1016/j.biocel.2012.08.007; Baumann V, 2014, FUTURE MED CHEM, V6, P1967, DOI 10.4155/fmc.14.116; Catalanotto C, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17101712; Chang CH, 2015, STEM CELL REP, V5, P378, DOI 10.1016/j.stemcr.2015.07.009; Chen XF, 2016, BIOMED PHARMACOTHER, V81, P379, DOI [10.1016/j.biopha.2016.04.023, 10.1016/j.biopha.2016.09.038]; Colombo M, 2014, ANNU REV CELL DEV BI, V30, P255, DOI 10.1146/annurev-cellbio-101512-122326; Dang XT, 2016, GENE, V575, P377, DOI 10.1016/j.gene.2015.08.067; Deb B, 2018, J CELL PHYSIOL, V233, P3846, DOI 10.1002/jcp.26095; Denzer K, 2000, J CELL SCI, V113, P3365; Endo-Takahashi Y, 2014, SCI REP-UK, V4, DOI 10.1038/srep03883; Fischer S, 2012, BIOTECHNOL BIOENG, V109, P2250, DOI 10.1002/bit.24514; Fujita Y, 2018, J CLIN MED, V7, DOI 10.3390/jcm7100355; Ge QY, 2014, MOLECULES, V19, P1568, DOI 10.3390/molecules19021568; Guan H, 2017, ONCOTARGET, V8, P14693, DOI 10.18632/oncotarget.14711; Guo W, 2017, ONCOL REP, V38, P665, DOI 10.3892/or.2017.5714; Gyorgy B, 2015, ANNU REV PHARMACOL, V55, P439, DOI 10.1146/annurev-pharmtox-010814-124630; Janas T, 2015, FEBS LETT, V589, P1391, DOI 10.1016/j.febslet.2015.04.036; Johnsen KB, 2016, CYTOTECHNOLOGY, V68, P2125, DOI 10.1007/s10616-016-9952-7; Karlsen TA, 2013, MOL THER, V21, P1169, DOI 10.1038/mt.2013.55; Kleemann M, 2019, CELL MOL LIFE SCI, V76, P539, DOI 10.1007/s00018-018-2958-x; Kleemann M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-27438-6; Kojima R, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03733-8; Krause M, 2015, FRONT CELL DEV BIOL, V3, P1; Lamichhane TN, 2015, MOL PHARMACEUT, V12, P3650, DOI 10.1021/acs.molpharmaceut.5b00364; Lan HY, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/125094; Lee JH, 2019, TRANSFUSION, V59, P876, DOI 10.1111/trf.14838; Lee Y, 2012, HUM MOL GENET, V21, pR125, DOI 10.1093/hmg/dds317; Lin YC, 2014, INT J MOL SCI, V15, P5011, DOI 10.3390/ijms15035011; Liu DM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5182; Lotvall J, 2014, J EXTRACELL VESICLES, V3, DOI 10.3402/jev.v3.26913; Maguire CT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053372; Maybruck BT, 2017, J IMMUNOTHER CANCER, V5, DOI 10.1186/s40425-017-0269-7; Mittelbrunn M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1285; Momen-Heravi F, 2014, NANOMED-NANOTECHNOL, V10, P1517, DOI 10.1016/j.nano.2014.03.014; Orang AV, 2014, INT J GENOMICS, V2014, DOI 10.1155/2014/970607; Pal MK, 2015, CANCER BIOL MED, V12, P328, DOI 10.7497/j.issn.2095-3941.2015.0024; Palmero EI, 2011, GENET MOL BIOL, V34, P363, DOI 10.1590/S1415-47572011000300001; Phan J, 2018, J EXTRACELL VESICLES, V7, DOI 10.1080/20013078.2018.1522236; Pileczki Valentina, 2016, Clujul Med, V89, P50, DOI 10.15386/cjmed-512; Pitt JM, 2016, J CLIN INVEST, V126, P1224, DOI 10.1172/JCI81137; Pollock K, 2006, EXP NEUROL, V199, P143, DOI 10.1016/j.expneurol.2005.12.011; Rajagopal C, 2018, FRONT ONCOL, V8, DOI 10.3389/fonc.2018.00066; Sanz-Rubio D, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-28748-5; Schiedner G, 2000, HUM GENE THER, V11, P2105, DOI 10.1089/104303400750001417; Schiedner G, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-13; Seo Y, 2019, STEM CELLS INT, V2019, DOI 10.1155/2019/5126156; Shurtleff MJ, 2016, ELIFE, V5, DOI 10.7554/eLife.19276; Simons M, 2009, CURR OPIN CELL BIOL, V21, P575, DOI 10.1016/j.ceb.2009.03.007; Tan A, 2013, ADV DRUG DELIVER REV, V65, P357, DOI 10.1016/j.addr.2012.06.014; Tian T, 2014, J BIOL CHEM, V289, P22258, DOI 10.1074/jbc.M114.588046; Turturici G, 2014, AM J PHYSIOL-CELL PH, V306, pC621, DOI 10.1152/ajpcell.00228.2013; Ueno K, 2012, MOL CANCER THER, V11, P244, DOI 10.1158/1535-7163.MCT-11-0592; Ventimiglia LN, 2016, FRONT CELL DEV BIOL, V4, DOI 10.3389/fcell.2016.00084; Villarroya-Beltri C, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3980; Walker J M, 1994, Methods Mol Biol, V32, P5; Walther P, 2002, J MICROSC-OXFORD, V208, P3, DOI 10.1046/j.1365-2818.2002.01064.x; Wang GN, 2018, INT J MOL MED, V41, P1740, DOI 10.3892/ijmm.2018.3358; Wang Y, 2009, J CELL MOL MED, V13, P12, DOI 10.1111/j.1582-4934.2008.00510.x; Weidle UH, 2017, CANCER GENOM PROTEOM, V14, P1, DOI 10.21873/cgp.20015; Weis BL, 2018, BIOTECHNOL BIOENG, V115, P2027, DOI 10.1002/bit.26715; Wissing S., 2015, BMC P, V9, pP12, DOI DOI 10.1186/1753-6561-9-S9-P12; Xu YQ, 2017, BIOMED PHARMACOTHER, V93, P334, DOI 10.1016/j.biopha.2017.06.047; Zhang D, 2017, AM J PHYSIOL-LUNG C, V312, pL110, DOI 10.1152/ajplung.00423.2016; Zhang Y, 2013, J CONTROL RELEASE, V172, P962, DOI 10.1016/j.jconrel.2013.09.015; Zheng YZ, 2014, BREAST CANCER RES TR, V145, P349, DOI 10.1007/s10549-014-2967-x; Zhu XH, 2017, J EXTRACELL VESICLES, V6, DOI 10.1080/20013078.2017.1324730	68	12	13	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2019	14	8							e0221679	10.1371/journal.pone.0221679	http://dx.doi.org/10.1371/journal.pone.0221679			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5XV	31461486	Green Published, gold, Green Submitted			2022-12-26	WOS:000485052300043
J	Bradshaw, CD; Hemming, D; Baker, R; Everatt, M; Eyre, D; Korycinska, A				Bradshaw, Catherine D.; Hemming, Deborah; Baker, Richard; Everatt, Matthew; Eyre, Dominic; Korycinska, Anastasia			A novel approach for exploring climatic factors limiting current pest distributions: A case study of Bemisia tabaci in north-west Europe and assessment of potential future establishment in the United Kingdom under climate change	PLOS ONE			English	Article							ALEYRODIDAE; HOMOPTERA; BIONOMICS; DATASET	Bemisia tabaci (the tobacco whitefly) is an important agricultural pest of global significance primarily because of its ability to transmit multiple damaging plant viruses. To date, UK outbreaks of the whitefly have been restricted to glasshouses and there are no records of the whitefly establishing outdoors during the summer. This is despite the fact that annual degree-day models (that estimate accumulated warmth over the year above the development threshold), indicate that B. tabaci has the thermal potential for multiple summer generations in the UK. A set of 49 climate indices calculated using the present day climate (1986-2015) were therefore compared between the UK and the south of France, where B. tabaci is able to establish outdoors, to identify the factors limiting its establishment. The number of cold days and nights in summer, as well as the time spent within the whitefly's optimum temperature range, were most significantly different between the two areas. These indices may impact the development of B. tabaci and offer an explanation for the absence of the whitefly outdoors in the UK during the summer. Further analyses undertaken with climate projections suggest that in a 2-4 degrees C warmer world this pest could pose a risk to outdoor UK crops in July and August. A clear south-north gradient can be demonstrated for these indices. Linking any possible northwards spread of B. tabaci populations outdoors in France with changes in these indices could therefore provide an important indicator of any change in the risks of outdoor populations of this species developing in the UK. The effectiveness of climate indices in pest risk analysis is compellingly demonstrated, and it is recommended that in-depth comparisons of climatic indices between areas of pest presence and absence are conducted in other situations where forecasting the risks of pest establishment are complex and challenging.	[Bradshaw, Catherine D.; Hemming, Deborah] Met Off, Hadley Ctr, Exeter, Devon, England; [Hemming, Deborah] Birmingham Inst Forest Res, Sch Geog, Birmingham, W Midlands, England; [Baker, Richard; Everatt, Matthew; Eyre, Dominic; Korycinska, Anastasia] Defra, Plant Hlth Risk & Horizon Scanning Team, York, N Yorkshire, England	Met Office - UK; Hadley Centre	Bradshaw, CD (corresponding author), Met Off, Hadley Ctr, Exeter, Devon, England.	catherine.bradshaw@metoffice.gov.uk		Bradshaw, Catherine/0000-0003-4305-380X	Joint UK BEIS/Defra Met Office Hadley Centre Climate Programme [GA01101]	Joint UK BEIS/Defra Met Office Hadley Centre Climate Programme	CDB and DH were funded by the Joint UK BEIS/Defra Met Office Hadley Centre Climate Programme [GA01101]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agri4castWiki, 2015, INT OBS WEATH; [Anonymous], 2016, ASC UK CLIMATE CHANG; [Anonymous], 2000, B SANIDAD VEGETAL PL, V26, P605; BAKER C R B, 1980, Bulletin OEPP, V10, P83; Baker RHA, 2002, INVASIVE ARTHROPODS IN AGRICULTURE: PROBLEMS AND SOLUTIONS, P207; Baker R, 2013, EFSA J, V11, DOI 10.2903/j.efsa.2013.3162; BELLOWS TS, 1988, ENVIRON ENTOMOL, V17, P225, DOI 10.1093/ee/17.2.225; Betts RA, 2018, PHILOS T R SOC A, V376, DOI 10.1098/rsta.2016.0452; Bonato O, 2007, PHYSIOL ENTOMOL, V32, P50, DOI 10.1111/j.1365-3032.2006.00540.x; Bosco D, 1998, EUR J ENTOMOL, V95, P519; Cuthbertson AGS, 2015, INSECTS, V6, P432, DOI 10.3390/insects6020432; Cuthbertson Andrew G.S., 2013, Insects, V4, P198, DOI 10.3390/insects4020198; CZAJKA MC, 1990, J EXP BIOL, V148, P245; Deschamps C, 2011, ANN SOC ENTOMOL FR, V47, P340, DOI 10.1080/00379271.2011.10697725; Eade R., 2012, J GEOPHYS RES ATMOSP, V117; ENKEGAARD A, 1993, B ENTOMOL RES, V83, P535, DOI 10.1017/S0007485300039961; European Climate Assessment & Dataset, 2013, EPJ029135 KNMI; Eyre D., 2017, TOBACCO SWEET POTATO; Gilioli G, 2014, PEST MANAG SCI, V70, P1611, DOI 10.1002/ps.3734; Hadjistylli M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165105; Haylock M. R., 2008, J GEOPHYS RES-ATMOS, V113, DOI [10.1029/2007jd009286, DOI 10.1029/2007JD009286]; Hempel S, 2013, EARTH SYST DYNAM, V4, P219, DOI 10.5194/esd-4-219-2013; Henri H, 2013, INT J PEST MANAGE, V59, P329, DOI 10.1080/09670874.2013.869374; Hu J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016061; Isaacs R, 1998, J ANIM ECOL, V67, P741, DOI 10.1046/j.1365-2656.1998.00236.x; Izumi Y, 2009, ENTOMOL SCI, V12, P376, DOI 10.1111/j.1479-8298.2009.00336.x; Korycinska A., 2017, Bulletin OEPP, V47, P246, DOI 10.1111/epp.12378; Lee Richard E. Jr, 2010, P35, DOI 10.1017/CBO9780511675997.003; Ma FZ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103279; Morice CP, 2012, J GEOPHYS RES-ATMOS, V117, DOI 10.1029/2011JD017187; Muniz M, 2001, ENVIRON ENTOMOL, V30, P720, DOI 10.1603/0046-225X-30.4.720; Oude Voshaar J, 1994, 533 DLO WIN STAR CTR, P105; Robinet C, 2007, GLOBAL ECOL BIOGEOGR, V16, P460, DOI 10.1111/j.1466-8238.2006.00302.x; Roditakis E, 2005, PEST MANAG SCI, V61, P577, DOI 10.1002/ps.1029; Senior CA, 2016, J ADV MODEL EARTH SY, V8, P813, DOI 10.1002/2015MS000614; Shah MMR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077368; Sheffield J, 2006, J CLIMATE, V19, P3088, DOI 10.1175/JCLI3790.1; Speight M.R., 2008, ECOLOGY INSECTS CONC, P33; STRANGE RE, 1962, J GEN MICROBIOL, V29, P719, DOI 10.1099/00221287-29-4-719; Tank AMGK, 2009, GUIDELINES ANAL EXTR; Taylor KE, 2012, B AM METEOROL SOC, V93, P485, DOI 10.1175/BAMS-D-11-00094.1; Williams KD, 2015, GEOSCI MODEL DEV, V8, P1509, DOI 10.5194/gmd-8-1509-2015; Xiao N, 2016, SCI REP-UK, V6, DOI 10.1038/srep24306	43	6	6	6	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2019	14	8							e0221057	10.1371/journal.pone.0221057	http://dx.doi.org/10.1371/journal.pone.0221057			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5WO	31454397	Green Submitted, Green Published, gold			2022-12-26	WOS:000485049000009
J	Suresh, S; Paxton, A; Pun, BK; Gyawali, MR; Kshetri, ID; Rana, PP; Cunningham, K				Suresh, Shalini; Paxton, Anne; Pun, Bhim Kumari; Gyawali, Min Raj; Kshetri, Indra Dhoj; Rana, Pooja Pandey; Cunningham, Kenda			Degree of exposure to interventions influences maternal and child dietary practices: Evidence from a large-scale multisectoral nutrition program	PLOS ONE			English	Article							MASS-MEDIA; WOMEN; DIVERSITY; IMPACT	The prevalence of maternal and child malnutrition in Nepal is among the highest in the world, despite substantial reductions in the last few decades. One effort to combat this problem is Suaahara II (SII), a multi-sectoral program implemented in 42 of Nepal's 77 districts to improve dietary diversity (DD) and reduce maternal and child undernutrition. Using cross-sectional data from SII's 2017 annual monitoring survey, this study explores associations between exposure to SII and maternal and child DD. The study sample included 3635 mothers with at least one child under the age of five. We focused on three primary SII intervention platforms: interpersonal communication (IPC) by frontline workers, community mobilization (CM) via events, and mass media through a weekly radio program (Bhanchhin Aama); and also created an exposure scale to assess the dose-response relationship. DD was measured both as a continuous score and as a binary measure of meeting the recommended minimum dietary diversity of consuming foods from at least 5 of 10 food groups for mothers and at least 4 of 7 food groups for children. We used linear and logistic regression models, controlling for potentially confounding factors at the individual and household level. We found a positive association between any exposure to SII platforms and maternal DD scores (b = 0.09; p = 0.05), child (aged 2-5 years) DD scores (b = 0.11; p = 0.03), and mothers meeting minimum dietary diversity (OR = 1.16; p = 0.05). There were significant, positive associations between both IPC and CM events and meeting minimum DD (IPC: OR = 1.31, p = 0.05; CM: OR = 1.37; p<0.001) and also between CM events and DD scores (b = 0.14; p = 0.03) among mothers. We found significant, positive associations between mass media and meeting minimum DD (OR: 1.38; p = 0.04) among children aged 6-24 months and between mass media and DD scores (b = 0.15; p = 0.01) among children aged 2-5 years. We also found that exposure to all three platforms, versus fewer platforms, had the strongest association with maternal DD scores (b = 0.45; p = 0.01), child (aged 2-5 years) DD scores (b = 0.41; p<0.001) and mothers meeting MDD (OR = 2.33; p<0.001). These findings suggest that a multi-pronged intervention package is necessary to address poor maternal and child dietary practices and that the barriers to behavior change for maternal diets may differ from those for child diets. They also highlight the importance of IPC and CM for behavior change and as a pre-requisite to mass media programs being effective, particularly for maternal diets.	[Suresh, Shalini; Paxton, Anne] Columbia Univ, Mailman Sch Publ Hlth, Dept Epidemiol, New York, NY USA; [Suresh, Shalini; Pun, Bhim Kumari; Rana, Pooja Pandey; Cunningham, Kenda] Helen Keller Int, Kathmandu, Nepal; [Gyawali, Min Raj] CARE, Kathmandu, Nepal; [Kshetri, Indra Dhoj] Digital Broadcast Initiat Equal Access, Kathmandu, Nepal	Columbia University	Cunningham, K (corresponding author), Helen Keller Int, Kathmandu, Nepal.	kcunningham@hki.org			USAID	USAID(United States Agency for International Development (USAID))	The data used in this research was obtained from a USAID-funded program in Nepal. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank all the respondents of the annual survey for providing valuable data and the New ERA team for collecting the data used in this analysis. We also thank the Monitoring, Evaluation and Research team at Suaahara II for cleaning and preparing the data for analysis. We would like to acknowledge Gary Mundy, Rolf Klemm and Ame Stormer for their valuable insight and feedback on preliminary and final drafts of this manuscript. All authors deeply acknowledge USAID for their support. The contents of this manuscript are the sole responsibility of authors and do not necessarily reflect the views of USAID or the United States Government.	Aasland A., 2011, J ASIAN AFR STUD, V46, P184; Acharya Dilaram, 2015, BMC Res Notes, V8, P345, DOI 10.1186/s13104-015-1312-8; Campbell RK, 2014, J HEALTH POPUL NUTR, V32, P198; Cunningham K, 2017, MATERN CHILD NUTR, V13, DOI 10.1111/mcn.12415; Cunningham K, 2017, GLOB FOOD SECUR-AGR, V13, P30, DOI 10.1016/j.gfs.2017.02.001; Department for International Development (DfID) and the World Bank, 2006, UN CIT GEND CAST ETH; Dulal B, 2017, FOOD NUTR BULL, V38, P338, DOI 10.1177/0379572117703264; FHI 360/LINKAGES, 2016, MINIMUM DIETARY DIVE; Harris-Fry HA, 2018, EUR J CLIN NUTR; Henjum S, 2015, PUBLIC HEALTH NUTR, V18, P3201, DOI 10.1017/S1368980015000671; Management Mf, 2015, EQUITYTOOL NEP; Mehata S, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/5079234; Menon P, 2014, ANN NY ACAD SCI, V1332, P39, DOI 10.1111/nyas.12447; Ministry of Health and Population (MOHP) [Nepal] New ERA & ICF International Inc, 2012, NEP DEM HLTH SURV 20; Nepal Ministry of Health New ERA ICF, 2017, NEP DEM HLTH SURV 20; Nguyen PH, 2016, MATERN CHILD NUTR, V12, P713, DOI 10.1111/mcn.12330; Sanghvi T, 2016, MATERN CHILD NUTR, V12, P141, DOI 10.1111/mcn.12277; Smith LC, 2013, WORLD DEV, V41, P196, DOI 10.1016/j.worlddev.2012.06.018; World Health Organization, 2010, NUTR LANDSC INF SYST, DOI 10.1159/000362780.Interpretation; World Health Organization, 2010, IND ASS INF YOUNG CH	20	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2019	14	8							e0221260	10.1371/journal.pone.0221260	http://dx.doi.org/10.1371/journal.pone.0221260			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5UR	31449529	Green Submitted, Green Published, gold			2022-12-26	WOS:000485044000010
J	Miniter, BM; Arruda, AG; Zuckerman, J; Caceres, AV; Ben-Amotz, R				Miniter, Brianna M.; Arruda, Andrela Goncalves; Zuckerman, Joshua; Caceres, Ana V.; Ben-Amotz, Ron			Use of computed tomography (CT) for the diagnosis of mechanical gastrointestinal obstruction in canines and felines	PLOS ONE			English	Article							SMALL-BOWEL OBSTRUCTION; ABDOMINAL RADIOGRAPHY; ULTRASONOGRAPHY; DOGS; ULTRASOUND	The objective of this study was to describe the use of computed tomography (CT) for diagnosis of mechanical gastrointestinal (GIT) obstruction in canines and felines. Medical records of 130 canines and felines that underwent an abdominal CT scan between 2013 and 2015 at a specialty referral hospital for suspected gastrointestinal tract (GIT) obstruction were reviewed. Images were evaluated by a single board-certified radiologist for the presence of foreign material, evidence of obstruction, and location of foreign material present. Confirmation of CT findings was based on surgical exploration or medical management if surgery was not indicated. Of the 97 patients that met the inclusion criteria, 48 (49.48%) had evidence of foreign material present within the GIT and 49 (50.52%) did not. Forty-one patients had evidence of mechanical gastrointestinal obstruction. Thirty-nine of these patients had an obstruction due to foreign material; one had an intussusception with no foreign material, and another had obstruction secondary to mucosal thickening. Forty-five patients underwent exploratory laparotomy, and CT findings were confirmed in all patients. The presence of a GIT obstruction was confirmed intra-operatively in 37 patients and lack of obstruction was confirmed in the remaining eight. Non-surgical medical management was pursued for the remaining patients. Based on follow-up client interviews, clinical signs resolved in all of these patients. In conclusion, computed tomography appears to be useful for the diagnosis of GIT obstruction in canines and felines and is a helpful tool for guiding the recommendation for surgical intervention.	[Miniter, Brianna M.] Vet Specialty & Emergency Ctr, Small Anim Surg Dept, Levittown, PA USA; [Arruda, Andrela Goncalves] Ohio State Univ, Coll Vet Med, Dept Vet Prevent Med, Columbus, OH 43210 USA; [Zuckerman, Joshua] Cape Cod Vet Specialists, Surg Dept, Buzzards Bay, MA USA; [Caceres, Ana V.] Vet Specialty & Emergency Ctr, Diagnost Imaging Dept, Levittown, PA USA; [Ben-Amotz, Ron] Vet Specialty & Emergency Ctr, Small Anim Surg Dept, Philadelphia, PA 19147 USA	University System of Ohio; Ohio State University	Ben-Amotz, R (corresponding author), Vet Specialty & Emergency Ctr, Small Anim Surg Dept, Philadelphia, PA 19147 USA.	Ronba1@gmail.com						Boag AK, 2005, J VET INTERN MED, V19, P816, DOI 10.1892/0891-6640(2005)19[816:AAEAID]2.0.CO;2; Ciasca TC, 2013, VET RADIOL ULTRASOUN, V54, P207, DOI 10.1111/vru.12032; Drost WT, 2016, VET RADIOL ULTRASOUN, V57, P366, DOI 10.1111/vru.12353; Fields EL, 2012, VET RADIOL ULTRASOUN, V53, P513, DOI 10.1111/j.1740-8261.2012.01949.x; Finck C, 2014, VET RADIOL ULTRASOUN, V55, P472, DOI 10.1111/vru.12153; FRAGER D, 1994, AM J ROENTGENOL, V162, P37, DOI 10.2214/ajr.162.1.8273686; Hayes G, 2009, J SMALL ANIM PRACT, V50, P576, DOI 10.1111/j.1748-5827.2009.00783.x; Lappas JC, 2001, AM J ROENTGENOL, V176, P167, DOI 10.2214/ajr.176.1.1760167; Maglinte DDT, 1996, AM J ROENTGENOL, V167, P1451, DOI 10.2214/ajr.167.6.8956576; Manczur F, 2000, ACTA VET HUNG, V48, P9, DOI 10.1556/AVet.48.2000.1.2; Nicolaou S, 2005, AM J ROENTGENOL, V185, P1036, DOI 10.2214/AJR.04.0815; Pastore GE, 2007, J AM ANIM HOSP ASSOC, V43, P264, DOI 10.5326/0430264; Riedesel EA, 2013, TXB VET DIAGNOSTIC R, P789; Shanaman Miriam M, 2013, Vet Radiol Ultrasound, V54, P591, DOI 10.1111/vru.12079; Shanaman MM, 2012, VET RADIOL ULTRASOUN, V53, P605, DOI 10.1111/j.1740-8261.2012.01973.x; Sharma A, 2011, VET RADIOL ULTRASOUN, V52, P248, DOI 10.1111/j.1740-8261.2010.01791.x; Suri S, 1999, ACTA RADIOL, V40, P422, DOI 10.3109/02841859909177758; Tyrrell D, 2006, VET RADIOL ULTRASOUN, V47, P404, DOI 10.1111/j.1740-8261.2006.00160.x; Winter MD, 2017, JAVMA-J AM VET MED A, V251, P315, DOI 10.2460/javma.251.3.315	19	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2019	14	8							e0219748	10.1371/journal.pone.0219748	http://dx.doi.org/10.1371/journal.pone.0219748			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5TR	31442244	Green Published, gold, Green Submitted			2022-12-26	WOS:000485041400007
J	Miettinen, T; Kautiainen, H; Mantyselka, P; Linton, SJ; Kalso, E				Miettinen, Teemu; Kautiainen, Hannu; Mantyselka, Pekka; Linton, Steven J.; Kalso, Eija			Pain interference type and level guide the assessment process in chronic pain: Categorizing pain patients entering tertiary pain treatment with the Brief Pain Inventory	PLOS ONE			English	Article							DISORDERS IDENTIFICATION TEST; CONFIRMATORY FACTOR-ANALYSIS; QUALITY-OF-LIFE; PHYSICAL-ACTIVITY; CANCER PAIN; PSYCHOMETRIC PROPERTIES; BACK-PAIN; ACCEPTANCE; ALCOHOL; DEPRESSION	Chronic pain patients enter treatment with different problem profiles making careful assessment a necessity for more individualized treatment plans. In this cross-sectional study we assigned 320 patients entering tertiary multidisciplinary pain treatment into four categories based on whether they scored low or high on the activity and the affective pain interference dimensions of the Brief Pain Inventory (BPI). To determine whether this categorization system delineates issues that should be assessed further, the categories were compared with ANOVA and MANOVA analyses on three domains: variables affecting physical well-being (body mass index, exercise, substance use), psychological resources (mood), and painspecific psychological factors (pain anxiety, pain acceptance). The results indicated that subjects who scored low on both interference dimensions compared similarly in weight: mean Body Mass Index (BMI) 27.0 (SD 6.0) kg/m(2), and exercise: mean of 2.4 (SD 1.7) exercising sessions over 20 minutes per week, to the general population, had no depressive symptoms on average: mean Beck Depression Index II (BDI-II) score 11.7 (SD 7.5), and had the most favorable psychological reactions to pain relative to the other categories: mean total Pain Anxiety Symptoms Scale-20 (PASS-20) score 36.4 (SD 17.9). In contrast, when interference was high on activity, more physical well-being problems were evident e.g. weight: mean BMI 31.0 (SD 7.3) kg/m(2), diminished exercise: mean of 1.5 (SD 1.6) exercising sessions per week, and avoidance behavior: mean PASS-20 Escape/Avoidance subscale 3.7 (95% CI: 1.7 to 5.8) scores higher in comparison to activity interference remaining low. With high affective interference, more depressive symptoms: mean BDI-II score 17.7 (SD 7.3), and more cognitive pain anxiety: mean PASS-20 Cognitive Anxiety subscale 2.8 (95% CI 0.7 to 4.8) scores higher in comparison to affective interference remaining low, emerged. Having high interference on both dimensions indicated accumulated risks for reduced physical well-being: mean BMI 29.9 (SD 6.1) kg/m(2), mean of 1.2 (SD 1.7) exercising sessions per week, mood problems: mean BDI-II 20.3 (SD 10.6), and negative psychological reactions to pain: mean total PASS-20 score 53.2 (18.4). The results suggest that low interference on both dimensions may allow assessment with only physician consultations, while high interference on either dimension may call attention to distinct issues to be addressed with the help of a physiotherapist or a psychologist, whereas high interference on both dimensions highlights the need for a full multidisciplinary assessment.	[Miettinen, Teemu; Kalso, Eija] Univ Helsinki, Dept Anesthesiol Intens Care & Pain Med, Div Pain Med, Helsinki, Finland; [Miettinen, Teemu; Kalso, Eija] Helsinki Univ Hosp, Helsinki, Finland; [Kautiainen, Hannu] Folkhalsan Res Ctr, Helsinki, Finland; [Mantyselka, Pekka] Univ Eastern Finland, Inst Publ Hlth & Clin Nutr, Kuopio, Finland; [Mantyselka, Pekka] Kuopio Univ Hosp, Primary Hlth Care Unit, Kuopio, Finland; [Linton, Steven J.] Orebro Univ, Ctr Hlth & Med Psychol, Dept Law Psychol & Social Work, Orebro, Sweden	University of Helsinki; University of Helsinki; Helsinki University Central Hospital; Folkhalsan Research Center; University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland; Orebro University	Miettinen, T (corresponding author), Univ Helsinki, Dept Anesthesiol Intens Care & Pain Med, Div Pain Med, Helsinki, Finland.; Miettinen, T (corresponding author), Helsinki Univ Hosp, Helsinki, Finland.	teemu.miettinen@helsinki.fi		Mantyselka, Pekka/0000-0002-5236-1815; Miettinen, Teemu/0000-0003-3504-4663	Finnish Association for the Study of Pain; State Funding for University-level Health Research [TYH2014214]; Signe and Ane Gyllenberg Foundation	Finnish Association for the Study of Pain; State Funding for University-level Health Research; Signe and Ane Gyllenberg Foundation	The study was funded by the Finnish Association for the Study of Pain (www.skty.org), State Funding for University-level Health Research (TYH2014214), and the Signe and Ane Gyllenberg Foundation (gyllenbergs. fi/en). The funders had no role on the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams MP, 2007, J PAIN, V8, P879, DOI 10.1016/j.jpain.2007.06.004; Adams MH, 2018, J PAIN, V19, P1074, DOI 10.1016/j.jpain.2018.04.005; Allen JP, 1997, ALCOHOL CLIN EXP RES, V21, P613, DOI 10.1111/j.1530-0277.1997.tb03811.x; Arola HM, 2010, EUR J PAIN, V14, P966, DOI 10.1016/j.ejpain.2010.02.012; Atkinson TM, 2011, J PAIN SYMPTOM MANAG, V41, P558, DOI 10.1016/j.jpainsymman.2010.05.008; Barry DT, 2013, J PSYCHIATR RES, V47, P1658, DOI 10.1016/j.jpsychires.2013.08.004; Beck AT, 1996, J PERS ASSESS, V67, P588, DOI 10.1207/s15327752jpa6703_13; Borodulin K, 2012, NATL FINRISK 2012 2; Brede E, 2011, PAIN PRACT, V11, P430, DOI 10.1111/j.1533-2500.2011.00448.x; Bushnell MC, 2013, NAT REV NEUROSCI, V14, P502, DOI 10.1038/nrn3516; Cherkin D, 2016, BMC MUSCULOSKEL DIS, V17, DOI 10.1186/s12891-016-1219-0; Cleeland C. S., 1994, Annals Academy of Medicine Singapore, V23, P129; Cleeland CS, 1996, PAIN, V67, P267, DOI 10.1016/0304-3959(96)03131-4; Ditre JW, 2011, PSYCHOL BULL, V137, P1065, DOI 10.1037/a0025544; Egli M, 2012, NEUROSCI BIOBEHAV R, V36, P2179, DOI 10.1016/j.neubiorev.2012.07.010; Eslami V, 2017, GERONTOLOGY, V63, P3, DOI 10.1159/000446651; Flor H., 2011, CHRONIC PAIN INTEGRA; Gagliese L, 1997, PAIN, V70, P3, DOI 10.1016/0304-3959(77)90032-X; Gatchel RJ, 2014, AM PSYCHOL, V69, P119, DOI 10.1037/a0035514; Harris CA, 2008, PAIN, V137, P609, DOI 10.1016/j.pain.2007.10.022; Hassmen P, 2000, PREV MED, V30, P17, DOI 10.1006/pmed.1999.0597; Hill JC, 2008, ARTHRIT RHEUM-ARTHR, V59, P632, DOI 10.1002/art.23563; Hirsh AT, 2011, AM J PHYS MED REHAB, V90, P713, DOI 10.1097/PHM.0b013e31822409b2; Holen JC, 2008, CLIN J PAIN, V24, P219, DOI 10.1097/AJP.0b013e31815ec22a; Janke EA, 2007, J REHABIL RES DEV, V44, P245, DOI 10.1682/JRRD.2006.06.0060; Karoly P, 2007, PAIN MED, V8, P563, DOI 10.1111/j.1526-4637.2006.00230.x; Keller S, 2004, CLIN J PAIN, V20, P309, DOI 10.1097/00002508-200409000-00005; Klepstad P, 2002, J PAIN SYMPTOM MANAG, V24, P517, DOI 10.1016/S0885-3924(02)00526-2; Koponen P, 2018, HLTH FUNCTIONAL CAPA, P4; Kratz AL, 2017, J PAIN, V18, P319, DOI 10.1016/j.jpain.2016.11.006; Kurtze N, 2008, SCAND J PUBLIC HEALT, V36, P52, DOI 10.1177/1403494807085373; Lapane KL, 2014, J PAIN SYMPTOM MANAG, V47, P325, DOI 10.1016/j.jpainsymman.2013.03.023; Lillis J, 2017, HEADACHE, V57, P709, DOI 10.1111/head.13058; Linton SJ, 2011, SCAND J PAIN, V2, P47, DOI 10.1016/j.sjpain.2011.01.005; Marcus DA, 2004, CLIN J PAIN, V20, P186, DOI 10.1097/00002508-200405000-00009; McCracken Lance M, 2002, Pain Res Manag, V7, P45; McCracken LM, 2004, PAIN, V109, P4, DOI 10.1016/j.pain.2004.02.006; McCracken LM, 2004, PAIN, V107, P159, DOI 10.1016/j.pain.2003.10.012; McCracken LM, SPINE PHILA PA 1976; McDermott KA, 2018, DRUG ALCOHOL DEPEN, V186, P53, DOI 10.1016/j.drugalcdep.2018.01.011; Means-Christensen AJ, 2008, DEPRESS ANXIETY, V25, P593, DOI 10.1002/da.20342; Moffett JAK, 2004, SPINE, V29, P1167, DOI 10.1097/00007632-200406010-00002; Osborne TL, 2007, PAIN, V127, P52, DOI 10.1016/j.pain.2006.07.017; Peltonen M., 2008, NATL FINRISKI 2007 S, pB34; Reinert DF, 2007, ALCOHOL CLIN EXP RES, V31, P185, DOI 10.1111/j.1530-0277.2006.00295.x; Roelofs J, 2004, J BEHAV MED, V27, P167, DOI 10.1023/B:JOBM.0000019850.51400.a6; SAUNDERS JB, 1993, ADDICTION, V88, P791, DOI 10.1111/j.1360-0443.1993.tb02093.x; Smith MY, 2002, PAIN, V98, P9, DOI 10.1016/S0304-3959(01)00431-6; Tan G, 2004, J PAIN, V5, P133, DOI 10.1016/j.jpain.2003.12.005; TURK DC, 1988, J CONSULT CLIN PSYCH, V56, P233, DOI 10.1037/0022-006X.56.2.233; Vartiainen P, 2017, PAIN, V158, P1577, DOI 10.1097/j.pain.0000000000000954; Vartiainen P, 2016, PAIN, V157, P2269, DOI 10.1097/j.pain.0000000000000641; Verbunt JA, 2003, EUR J PAIN, V7, P9, DOI 10.1016/S1090-3801(02)00071-X; Von Korff M, 2005, PAIN, V117, P304, DOI 10.1016/j.pain.2005.06.017; VONKORFF M, 1992, PAIN, V50, P133, DOI 10.1016/0304-3959(92)90154-4; Vowles KE, 2008, PAIN, V140, P284, DOI 10.1016/j.pain.2008.08.012; Walton DM, 2016, SCAND J PAIN, V12, P110, DOI 10.1016/j.sjpain.2016.05.002; Wicksell RK, 2009, EUR J PAIN, V13, P760, DOI 10.1016/j.ejpain.2008.09.003	58	17	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2019	14	8							e0221437	10.1371/journal.pone.0221437	http://dx.doi.org/10.1371/journal.pone.0221437			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW5OC	31430355	Green Submitted, Green Published, gold			2022-12-26	WOS:000485026800054
J	Liu, X; Huang, QL; Chen, LH; Zhang, HL; Schonbrunn, E; Chen, JD				Liu, Xia; Huang, Qingling; Chen, Lihong; Zhang, Huilai; Schonbrunn, Ernst; Chen, Jiandong			Tumor-derived CK1 alpha mutations enhance MDMX inhibition of p53	ONCOGENE			English	Article							CASEIN KINASE 1-ALPHA; MYELODYSPLASTIC SYNDROME; BETA-CATENIN; DEGRADATION; UBIQUITINATION; IDENTIFICATION; DESTRUCTION; DELETION; COMPLEX; SWITCH	Somatic missense mutations of the CSNK1A1 gene encoding casein kinase 1 alpha (CK1 alpha) occur in a subset of myelodysplastic syndrome (MDS) with del(5q) karyotype. The chromosomal deletion causes CSNK1A1 haplo-insufficiency. CK1 alpha mutations have also been observed in a variety of solid and hematopoietic tumors at low frequency. The functional consequence of CK1 alpha mutation remains unknown. Here we show that tumor-associated CK1 alpha mutations exclusively localize to the substrate-binding cleft. Functional analysis of recurrent mutants E98K and D140A revealed enhanced binding to the p53 inhibitor MDMX, increased ability to stimulate MDMX-p53 binding, and increased suppression of p21 expression. Furthermore, E98K and D140A mutants have reduced ability to promote phosphorylation of beta-catenin, resulting in enhanced Wnt signaling. The results suggest that the CK1 alpha mutations observed in tumors cause gain-of-function in cooperating with MDMX and inhibiting p53, and partial loss-of-function in suppressing Wnt signaling. These functional changes may promote expansion of abnormal myeloid progenitors in del(5q) MDS, and in rare cases drive the progression of other tumors.	[Liu, Xia; Huang, Qingling; Chen, Lihong; Chen, Jiandong] H Lee Moffitt Canc Ctr & Res Inst, Mol Oncol Dept, 12902 Magnolia Dr, Tampa, FL 33612 USA; [Liu, Xia; Zhang, Huilai] Tianjin Med Univ Canc Inst & Hosp, Tianjin Clin Res Ctr Canc, Sino US Ctr Lymphoma & Leukemia Res,Dept Lymphoma, Natl Clin Res Ctr Canc,Key Lab Canc Prevent & The, Tianjin 300060, Peoples R China; [Schonbrunn, Ernst] H Lee Moffitt Canc Ctr & Res Inst, Drug Discovery Dept, 12902 Magnolia Dr, Tampa, FL 33612 USA	H Lee Moffitt Cancer Center & Research Institute; Tianjin Medical University; H Lee Moffitt Cancer Center & Research Institute	Chen, JD (corresponding author), H Lee Moffitt Canc Ctr & Res Inst, Mol Oncol Dept, 12902 Magnolia Dr, Tampa, FL 33612 USA.	Jiandong.chen@moffitt.org	Huang, Qingling/AAO-1728-2021	Zhang, Huilai/0000-0002-8558-3131; Schonbrunn, Ernst/0000-0002-3589-3510; Huang, Qingling/0000-0002-0538-8249	National Institutes of Health [CA141244, CA186917]; NCI Cancer Center Support Grant [P30-CA076292]; Tianjin Medical University Cancer Institute and Hospital	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI Cancer Center Support Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Tianjin Medical University Cancer Institute and Hospital	We would like to thank the Moffitt Flow Cytometry Core. This work was supported in part by grants from the National Institutes of Health (CA141244, CA186917) (JC), and by the NCI Cancer Center Support Grant P30-CA076292. XL was partly supported by Tianjin Medical University Cancer Institute and Hospital.	Bello E, 2015, BRIT J HAEMATOL, V171, P210, DOI 10.1111/bjh.13563; Chen LH, 2005, MOL CELL BIOL, V25, P6509, DOI 10.1128/MCB.25.15.6509-6520.2005; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; Drexler HG, 2009, LEUKEMIA RES, V33, P1011, DOI 10.1016/j.leukres.2009.03.005; Ebert BL, 2008, NATURE, V451, P335, DOI 10.1038/nature06494; Elyada E, 2011, NATURE, V470, P409, DOI 10.1038/nature09673; Forbes SA, 2017, NUCLEIC ACIDS RES, V45, pD777, DOI 10.1093/nar/gkw1121; Heuser M, 2015, LEUKEMIA, V29, P1942, DOI 10.1038/leu.2015.49; Huart AS, 2009, J BIOL CHEM, V284, P32384, DOI 10.1074/jbc.M109.052647; Jaras M, 2014, J EXP MED, V211, P605, DOI 10.1084/jem.20131033; Knippschild U, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00096; Komrokji RS, 2013, BEST PRACT RES CL HA, V26, P365, DOI 10.1016/j.beha.2013.10.013; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Kronke J, 2015, NATURE, V523, P183, DOI 10.1038/nature14610; Kronke J, 2014, SCIENCE, V343, P301, DOI 10.1126/science.1244851; Kulasekararaj AG, 2013, BRIT J HAEMATOL, V160, P660, DOI 10.1111/bjh.12203; Lu G, 2014, SCIENCE, V343, P305, DOI 10.1126/science.1244917; Petzold G, 2016, NATURE, V532, P127, DOI 10.1038/nature16979; Pribluda A, 2013, CANCER CELL, V24, P242, DOI 10.1016/j.ccr.2013.06.005; Schneider RK, 2016, NAT MED, V22, P288, DOI 10.1038/nm.4047; Schneider RK, 2014, CANCER CELL, V26, P509, DOI 10.1016/j.ccr.2014.08.001; Sinnberg T, 2010, CANCER RES, V70, P6999, DOI 10.1158/0008-5472.CAN-10-0645; Smith AE, 2015, LANCET HAEMATOL, V2, pE212, DOI 10.1016/S2352-3026(15)00050-2; Sobrado P, 2005, J CELL BIOCHEM, V94, P217, DOI 10.1002/jcb.20350; Starczynowski DT, 2010, NAT MED, V16, P49, DOI 10.1038/nm.2054; Tsujioka T, 2013, EXP HEMATOL, V41, P189, DOI 10.1016/j.exphem.2012.10.006; Wang L, 2008, HAEMATOL-HEMATOL J, V93, P994, DOI 10.3324/haematol.12603; Wei X, 2016, P NATL ACAD SCI USA, V113, pE2558, DOI 10.1073/pnas.1603838113; Winston JT, 1999, GENE DEV, V13, P270, DOI 10.1101/gad.13.3.270; Wu SF, 2012, MOL CELL BIOL, V32, P4821, DOI 10.1128/MCB.00851-12	30	3	4	2	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN	2020	39	1					176	186		10.1038/s41388-019-0979-z	http://dx.doi.org/10.1038/s41388-019-0979-z			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	KG3NM	31462704	Green Accepted			2022-12-26	WOS:000509849200012
J	Wei, LY; Zhang, XM; Wang, J; Ye, QR; Zheng, X; Peng, Q; Zheng, Y; Liu, PS; Zhang, XY; Li, ZS; Liu, C; Yan, Q; Li, GY; Ma, J				Wei, Lingyu; Zhang, Xuemei; Wang, Jia; Ye, Qiurong; Zheng, Xiang; Peng, Qiu; Zheng, Ying; Liu, Peishan; Zhang, Xiaoyue; Li, Zhengshuo; Liu, Can; Yan, Qun; Li, Guiyuan; Ma, Jian			Lactoferrin deficiency induces a pro-metastatic tumor microenvironment through recruiting myeloid-derived suppressor cells in mice	ONCOGENE			English	Article							TOLL-LIKE RECEPTOR; IMMUNOSUPPRESSIVE ACTIVITY; NASOPHARYNGEAL CARCINOMA; PANCREATIC-CANCER; IMMUNE; LACTOTRANSFERRIN; DIFFERENTIATION; EXPRESSION; PROMOTES; MONOCYTES	Lactoferrin, an innate immunity molecule, is involved in anti-inflammatory, anti-microbial, and anti-tumor activities. We previously reported that lactoferrin is downregulated in specimens of nasopharyngeal carcinoma and negatively associated with tumor progression and metastasis of patients with nasopharyngeal carcinoma. However, the relationship between lactoferrin and the pro-metastatic microenvironment has not been reported yet. Here, by using the lactoferrin knockout mouse, we found that lactoferrin deficiency facilitated melanoma cells metastasizing to lungs, through recruiting myeloid-derived suppressor cells (MDSCs) in the lungs. Mechanistic studies showed that in the lung microenvironment of the lactoferrin knockout mice, the TLR9 signaling was the most repressed signaling. Lactoferrin can induce MDSCs differentiation and apoptosis, as well as upregulate TLR9 expression. TLR9 agonist or lactoferrin treatment can rescue this phenotype in the tumor metastasis mouse model. Our results suggest a protective role of lactoferrin in cancer metastasis, along with a deficiency in certain components of the innate immune system, may lead to a pro-metastatic tumor microenvironment.	[Wei, Lingyu; Zhang, Xuemei; Li, Guiyuan; Ma, Jian] Cent S Univ, Hunan Key Lab Nonresolving Inflammat & Canc, Xiangya Hosp 3, Changsha, Peoples R China; [Wei, Lingyu; Zhang, Xuemei; Wang, Jia; Ye, Qiurong; Zheng, Xiang; Peng, Qiu; Liu, Peishan; Zhang, Xiaoyue; Li, Zhengshuo; Liu, Can; Li, Guiyuan; Ma, Jian] Cent S Univ, Sch Basic Med, Canc Res Inst, Changsha, Peoples R China; [Wei, Lingyu; Li, Guiyuan; Ma, Jian] Minist Hlth, Key Lab Carcinogenesis, Changsha, Peoples R China; [Wei, Lingyu; Li, Guiyuan; Ma, Jian] Minist Hlth, Key Lab Carcinogenesis & Canc Invas, Changsha, Peoples R China; [Wei, Lingyu; Zhang, Xuemei; Ma, Jian] Cent S Univ, Hunan Key Lab Translat Radiat Oncol, Hunan Canc Hosp, Changsha, Peoples R China; [Wei, Lingyu; Zhang, Xuemei; Ma, Jian] Cent S Univ, Xiangya Sch Med, Affiliated Canc Hosp, Changsha, Peoples R China; [Zheng, Ying] Cent S Univ, Xiangya Hosp 2, Ctr Med Res, Changsha, Peoples R China; [Yan, Qun] Cent S Univ, Xiangya Hosp, Dept Clin Lab, Changsha, Peoples R China	Central South University; Central South University; Central South University; Central South University; Central South University; Central South University	Ma, J (corresponding author), Cent S Univ, Hunan Key Lab Nonresolving Inflammat & Canc, Xiangya Hosp 3, Changsha, Peoples R China.; Ma, J (corresponding author), Cent S Univ, Sch Basic Med, Canc Res Inst, Changsha, Peoples R China.; Ma, J (corresponding author), Minist Hlth, Key Lab Carcinogenesis, Changsha, Peoples R China.; Ma, J (corresponding author), Minist Hlth, Key Lab Carcinogenesis & Canc Invas, Changsha, Peoples R China.; Ma, J (corresponding author), Cent S Univ, Hunan Key Lab Translat Radiat Oncol, Hunan Canc Hosp, Changsha, Peoples R China.; Ma, J (corresponding author), Cent S Univ, Xiangya Sch Med, Affiliated Canc Hosp, Changsha, Peoples R China.	majian@csu.edu.cn		Ma, Jian/0000-0001-9395-0416	National Natural Science Foundation of China [81672889, 81874170, 81472694]; China 111 Project [111-2-12]; Hunan Province Science and Technology Project [2016JC2035]; Open Research Fund Program of Key Laboratory of Translational Radiation Oncology, Hunan Province [2015TP1009]; Independent Exploration and Innovation Project of Central South University [178301003]; National College Students' Innovation and Entrepreneurship Training Program of China [201810533376, GS201910533237]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China 111 Project(Ministry of Education, China - 111 Project); Hunan Province Science and Technology Project; Open Research Fund Program of Key Laboratory of Translational Radiation Oncology, Hunan Province; Independent Exploration and Innovation Project of Central South University; National College Students' Innovation and Entrepreneurship Training Program of China	This work was funded by National Natural Science Foundation of China (81672889, 81874170, and 81472694), China 111 Project (111-2-12), Hunan Province Science and Technology Project (2016JC2035), Open Research Fund Program of Key Laboratory of Translational Radiation Oncology, Hunan Province (2015TP1009), Independent Exploration and Innovation Project of Central South University (178301003), and National College Students' Innovation and Entrepreneurship Training Program of China (201810533376, GS201910533237). We thank Professors Wen Zhou and Ya Cao for providing reagents; Professor Penghui Zhou providing key suggestions.	Acharya KR, 2014, J BIOL CHEM, V289, P17406, DOI 10.1074/jbc.R113.546218; Acharyya S, 2012, CELL, V150, P165, DOI 10.1016/j.cell.2012.04.042; Aghaeepour N, 2017, J IMMUNOL, V199, P2171, DOI 10.4049/jimmunol.1700421; Aguirre-Gamboa R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074250; Amit I, 2009, SCIENCE, V326, P257, DOI 10.1126/science.1179050; Balkwill FR, 2012, J CELL SCI, V125, P5591, DOI 10.1242/jcs.116392; Ballas ZK, 2001, J IMMUNOL, V167, P4878, DOI 10.4049/jimmunol.167.9.4878; Binnewies M, 2018, NAT MED, V24, P541, DOI 10.1038/s41591-018-0014-x; Blais A, 2014, BIOMETALS, V27, P857, DOI 10.1007/s10534-014-9779-7; Casey T, 2009, BREAST CANCER RES TR, V114, P47, DOI 10.1007/s10549-008-9982-8; Castano Z, 2018, NAT CELL BIOL, V20, P1084, DOI 10.1038/s41556-018-0173-5; Cen XH, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.00878; Chen HM, 2018, J CLIN INVEST, V128, P5647, DOI 10.1172/JCI97570; Clark CE, 2007, CANCER RES, V67, P9518, DOI 10.1158/0008-5472.CAN-07-0175; Clavijo PE, 2019, CANCER IMMUNOL RES, V7, P282, DOI 10.1158/2326-6066.CIR-18-0156; Condamine T, 2015, J LEUKOCYTE BIOL, V98, P913, DOI 10.1189/jlb.4RI0515-204R; Deng M, 2013, ONCOGENE, V32, P4273, DOI 10.1038/onc.2012.434; Fang LS, 2019, ONCOGENE, V38, P896, DOI 10.1038/s41388-018-0484-9; Fehri E, 2016, CURR RES TRANSL MED, V64, P155, DOI 10.1016/j.retram.2016.01.010; Gabrilovich DI, 2017, CANCER IMMUNOL RES, V5, P3, DOI 10.1158/2326-6066.CIR-16-0297; Gallina G, 2006, J CLIN INVEST, V116, P2777, DOI 10.1172/JCI28828; Gonzalez-Chavez SA, 2009, INT J ANTIMICROB AG, V33, DOI 10.1016/j.ijantimicag.2008.07.020; He YM, 2018, NAT MED, V24, P224, DOI 10.1038/nm.4467; Hiratsuka S, 2008, NAT CELL BIOL, V10, P1349, DOI 10.1038/ncb1794; Hiratsuka S, 2006, NAT CELL BIOL, V8, P1369, DOI 10.1038/ncb1507; Hossain DMS, 2015, CLIN CANCER RES, V21, P3771, DOI 10.1158/1078-0432.CCR-14-3145; Huh SJ, 2010, CANCER RES, V70, P6071, DOI 10.1158/0008-5472.CAN-09-4442; Ichikawa M, 2011, MOL CANCER RES, V9, P133, DOI 10.1158/1541-7786.MCR-10-0394; Jiang J, 2018, EXP CELL RES, V367, P81, DOI 10.1016/j.yexcr.2018.03.025; Joyce JA, 2009, NAT REV CANCER, V9, P239, DOI 10.1038/nrc2618; Kerkar SP, 2012, CANCER RES, V72, P3125, DOI 10.1158/0008-5472.CAN-11-4094; Kitakaze T, 2018, MOL MED REP, V17, P5912, DOI 10.3892/mmr.2018.8603; Kolonin MG, 2017, CANCER RES, V77, P3144, DOI 10.1158/0008-5472.CAN-16-0708; Kumar V, 2016, TRENDS IMMUNOL, V37, P208, DOI 10.1016/j.it.2016.01.004; Kusmartsev S, 2008, CLIN CANCER RES, V14, P8270, DOI 10.1158/1078-0432.CCR-08-0165; Lee Jae-Hye, 2016, Oncotarget, V7, P79774, DOI 10.18632/oncotarget.12967; Legrand D, 2012, BIOCHEM CELL BIOL, V90, P252, DOI [10.1139/O11-056, 10.1139/o11-056]; Li HY, 2017, J AGR FOOD CHEM, V65, P10464, DOI 10.1021/acs.jafc.7b03390; Lim KH, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a011247; Maglione PJ, 2015, ANN NY ACAD SCI, V1356, P1, DOI 10.1111/nyas.12763; Mantovani A, 2018, IMMUNOL REV, V281, P57, DOI 10.1111/imr.12614; Marigo I, 2008, IMMUNOL REV, V222, P162, DOI 10.1111/j.1600-065X.2008.00602.x; Martinez-Campos C, 2017, VIRAL IMMUNOL, V30, P98, DOI 10.1089/vim.2016.0103; Mei SY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135867; Moreno-Exposito L, 2018, LIFE SCI, V195, P61, DOI 10.1016/j.lfs.2018.01.002; Oh K, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3473; Ortiz ML, 2014, CANCER IMMUNOL RES, V2, P50, DOI 10.1158/2326-6066.CIR-13-0129; Perdijk O, 2018, NUTRIENTS, V10, DOI 10.3390/nu10070848; Raber P, 2012, IMMUNOL INVEST, V41, P614, DOI 10.3109/08820139.2012.680634; Ribechini E, 2017, BLOOD ADV, V1, P947, DOI 10.1182/bloodadvances.2017006858; Rodrigues L, 2009, CRIT REV FOOD SCI, V49, P203, DOI 10.1080/10408390701856157; Ruffell B, 2013, GENE DEV, V27, P2086, DOI 10.1101/gad.224899.113; Sathyanesan A, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05656-w; Silvestrini MT, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.90521; Simpson KD, 2012, J IMMUNOL, V189, P5533, DOI 10.4049/jimmunol.1201161; Siqueiros-Cendon T, 2014, ACTA PHARMACOL SIN, V35, P557, DOI 10.1038/aps.2013.200; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Takahashi K, 2018, ONCOGENE, V37, P2757, DOI 10.1038/s41388-018-0144-0; Tasli PN, 2014, APPL BIOCHEM BIOTECH, V174, P2257, DOI 10.1007/s12010-014-1204-8; Telang S, 2018, NUTRIENTS, V10, DOI 10.3390/nu10091228; Teng CT, 2010, BIOMETALS, V23, P359, DOI 10.1007/s10534-010-9310-8; Totiger TM, 2019, MOL CANCER THER, V18, P301, DOI 10.1158/1535-7163.MCT-18-0464; Uchida R, 2017, BIOCHEM CELL BIOL, V95, P64, DOI 10.1139/bcb-2016-0147; Valenti P, 2014, BIOMETALS, V27, P803, DOI 10.1007/s10534-014-9787-7; Vandrovcova M, 2015, J BIOMED MATER RES A, V103, P525, DOI 10.1002/jbm.a.35199; Velusamy SK, 2014, ANTIMICROB AGENTS CH, V58, P397, DOI 10.1128/AAC.00020-13; Velusamy SK, 2013, J PERIODONTOL, V84, P1690, DOI 10.1902/jop.2013.120587; Wakabayashi H, 2014, J INFECT CHEMOTHER, V20, P666, DOI 10.1016/j.jiac.2014.08.003; Wang B, 2019, CRIT REV FOOD SCI, V59, P580, DOI 10.1080/10408398.2017.1381583; Wang C, 2014, ASIAN PAC J CANCER P, V15, P4187, DOI 10.7314/APJCP.2014.15.10.4187; Won H, 2017, J LEUKOCYTE BIOL, V102, P423, DOI 10.1189/jlb.3MA1016-451RR; Xie F, 2018, ACTA BIOCH BIOPH SIN, V50, P121, DOI 10.1093/abbs/gmx123; Yang L, 2008, CANCER CELL, V13, P23, DOI 10.1016/j.ccr.2007.12.004; Yang Q, 2017, ONCOGENE, V36, P2969, DOI 10.1038/onc.2016.448; Ye QR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103298; Zambirinis CP, 2015, J EXP MED, V212, P2077, DOI 10.1084/jem.20142162; Zhang CX, 2019, CELL DEATH DIFFER, V26, P2314, DOI 10.1038/s41418-019-0302-0; Zhang H, 2017, ONCOGENE, V36, P2095, DOI 10.1038/onc.2016.367; Zhang WL, 2015, TUMOR BIOL, V36, P675, DOI 10.1007/s13277-014-2650-1; Zhou YH, 2008, INT J CANCER, V123, P2065, DOI 10.1002/ijc.23727; Zoglmeier C, 2011, CLIN CANCER RES, V17, P1765, DOI 10.1158/1078-0432.CCR-10-2672	81	12	18	6	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN	2020	39	1					122	135		10.1038/s41388-019-0970-8	http://dx.doi.org/10.1038/s41388-019-0970-8			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	KG3NM	31462711				2022-12-26	WOS:000509849200008
J	Yu, XF; Wang, RK; Zhang, YN; Zhou, L; Wang, W; Liu, HD; Li, W				Yu, Xinfang; Wang, Ruike; Zhang, Yangnan; Zhou, Li; Wang, Wei; Liu, Haidan; Li, Wei			Skp2-mediated ubiquitination and mitochondrial localization of Akt drive tumor growth and chemoresistance to cisplatin	ONCOGENE			English	Article							SENSITIZES NASOPHARYNGEAL CARCINOMA; POOR-PROGNOSIS; CANCER CELLS; SKP2; ACTIVATION; GLYCOLYSIS; LUNG; DEGRADATION; CONTRIBUTES; RESISTANCE	The E3 ligase S-phase kinase-associated protein 2(Skp2) is overexpressed in human cancers and correlated with poor prognosis, but its contributions to tumorigenesis and chemoresistance in nasopharyngeal carcinoma (NPC) are not evident. Herein we show that Skp2 is highly expressed in NPC tumor tissues and cell lines. Knockdown of Skp2 suppresses tumor cell growth, colony formation, glycolysis, and in vivo tumor growth. Skp2 promotes Akt K63-mediated ubiquitination and activation, which is required for EGF-induced Akt mitochondrial localization. Importantly, K63-linked ubiquitination enhances the interaction between Akt and HK2 and eventually increases HK2 phosphorylation on Thr473 and mitochondrial localization. Overexpression of Skp2 impaired the intrinsic apoptotic pathway and confers cisplatin resistance. Moreover, ectopic expression of Myr-Akt1 or phosphomimetic HK2-T473D rescued cisplatin-induced tumor suppression in Skp2 knockdown stable cells. Also, depletion of Akt ubiquitination enhances the antitumor efficacy of cisplatin in vitro and in vivo. Finally, we demonstrated that Skp2 is positively correlated with p-Akt and HK2 in NPC tumor tissues. This study highlights the clinical value of Skp2 targeting in NPC treatment.	[Yu, Xinfang; Liu, Haidan] Cent S Univ, Dept Cardiovasc Surg, Xiangya Hosp 2, Changsha 410011, Hunan, Peoples R China; [Yu, Xinfang; Liu, Haidan] Cent S Univ, Clin Ctr Gene Diag & Therapy, Xiangya Hosp 2, Changsha 410011, Hunan, Peoples R China; [Yu, Xinfang] Cleveland Clin, Dept Canc Biol, Lerner Res Inst, 9500 Euclid Ave, Cleveland, OH 44195 USA; [Wang, Ruike; Zhang, Yangnan] Cent S Univ, Xiangya Sch Med, Changsha 410000, Hunan, Peoples R China; [Zhou, Li] Cent S Univ, Dept Pathol, Xiangya Hosp, Changsha 410008, Hunan, Peoples R China; [Wang, Wei; Li, Wei] Cent S Univ, Dept Radiol, Xiangya Hosp 3, Changsha 410000, Hunan, Peoples R China	Central South University; Central South University; Cleveland Clinic Foundation; Central South University; Central South University; Central South University	Liu, HD (corresponding author), Cent S Univ, Dept Cardiovasc Surg, Xiangya Hosp 2, Changsha 410011, Hunan, Peoples R China.; Liu, HD (corresponding author), Cent S Univ, Clin Ctr Gene Diag & Therapy, Xiangya Hosp 2, Changsha 410011, Hunan, Peoples R China.; Wang, W; Li, W (corresponding author), Cent S Univ, Dept Radiol, Xiangya Hosp 3, Changsha 410000, Hunan, Peoples R China.	cjr.wangwei@vip.163.com; haidanliu@csu.edu.cn; weililx@csu.edu.cn			National Natural Science Foundation of China [81572280, 81502121, 81401548]; Natural Science Foundation of Hunan Province [2018JJ3787, 2019JJ40420]; New Xiangya Talent Project of the Third Xiangya Hospital of Central South University [JY2015011]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Hunan Province(Natural Science Foundation of Hunan Province); New Xiangya Talent Project of the Third Xiangya Hospital of Central South University	This work was supported by the National Natural Science Foundation of China (Nos. 81572280, 81502121, and 81401548), the Natural Science Foundation of Hunan Province (2018JJ3787 and 2019JJ40420), and the New Xiangya Talent Project of the Third Xiangya Hospital of Central South University (No. JY2015011).	Bhattacharyya T, 2018, J ONCOL, V2018, DOI 10.1155/2018/3725837; Bijur GN, 2003, J NEUROCHEM, V87, P1427, DOI 10.1046/j.1471-4159.2003.02113.x; Bissey PA, 2018, ONCOGENESIS, V7, DOI 10.1038/s41389-018-0050-x; Byun WS, 2018, BIOCHEM PHARMACOL, V158, P84, DOI 10.1016/j.bcp.2018.10.002; Chae YC, 2016, CANCER CELL, V30, P257, DOI 10.1016/j.ccell.2016.07.004; Chan CH, 2013, CELL, V154, P556, DOI 10.1016/j.cell.2013.06.048; Chan CH, 2012, CELL, V149, P1098, DOI 10.1016/j.cell.2012.02.065; Chen D, 2011, CURR CANCER DRUG TAR, V11, P239, DOI 10.2174/156800911794519752; Cheng CY, 2018, BIOMED PHARMACOTHER, V108, P194, DOI 10.1016/j.biopha.2018.09.031; Fan L, 2018, INT J MOL MED, V42, P2247, DOI 10.3892/ijmm.2018.3778; Feng SY, 2017, CELL CYCLE, V16, P869, DOI 10.1080/15384101.2017.1308617; Frescas D, 2008, NAT REV CANCER, V8, P438, DOI 10.1038/nrc2396; Fu HC, 2016, ONCOTARGET, V7, P44047, DOI 10.18632/oncotarget.10057; Gallo LH, 2017, CELL CYCLE, V16, P634, DOI 10.1080/15384101.2017.1288326; Gao W, 2017, CANCER MED-US, V6, P439, DOI 10.1002/cam4.982; Ghosh JC, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/dju502; Katano A, 2018, MEDICINE, V97, DOI 10.1097/MD.0000000000010502; Kuang CM, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.271; Lam W K Jacky, 2018, F1000Res, V7, DOI 10.12688/f1000research.15066.1; Lee AWM, 2015, J CLIN ONCOL, V33, P3356, DOI 10.1200/JCO.2015.60.9347; Lee AWM, 2005, J CLIN ONCOL, V23, P6966, DOI 10.1200/JCO.2004.00.7542; Lee SW, 2015, MOL CELL, V57, P1022, DOI 10.1016/j.molcel.2015.01.015; Lee VH, 2018, J ONCOL PRACT, V14, P594, DOI 10.1200/JOP.18.00219; Li SN, 2017, BRIT J CANCER, V117, P1518, DOI 10.1038/bjc.2017.323; Li S, 2017, CELL CYCLE, V16, P1601, DOI 10.1080/15384101.2017.1356508; Li W, 2018, J CELL MOL MED, V22, P6213, DOI 10.1111/jcmm.13908; Li W, 2018, CELL SIGNAL, V50, P131, DOI 10.1016/j.cellsig.2018.07.001; Li W, 2017, ONCOTARGET, V8, P32586, DOI 10.18632/oncotarget.15937; Li W, 2013, CANCER RES, V73, P6938, DOI 10.1158/0008-5472.CAN-13-0913; Liu F, 2018, CANCER BIOL THER, V19, P534, DOI 10.1080/15384047.2018.1450119; Liu HD, 2016, ONCOTARGET, V7, P56338, DOI 10.18632/oncotarget.10841; Mair R, 2018, CANCER RES, V78, P5408, DOI 10.1158/0008-5472.CAN-18-0759; Majewski N, 2004, MOL CELL, V16, P819, DOI 10.1016/j.molcel.2004.11.014; Manning BD, 2017, CELL, V169, P381, DOI 10.1016/j.cell.2017.04.001; Pastorino JG, 2002, J BIOL CHEM, V277, P7610, DOI 10.1074/jbc.M109950200; Roberts DJ, 2013, J BIOL CHEM, V288, P23798, DOI 10.1074/jbc.M113.482026; Ruan D, 2017, ONCOGENE, V36, P4299, DOI 10.1038/onc.2017.64; Shi C, 2018, ONCOGENE, V37, P3260, DOI 10.1038/s41388-018-0217-0; Shuang H, 2019, CLIN TRANSL ONCOL, V21, P213, DOI 10.1007/s12094-018-1911-7; Su CC, 2012, AM J PHYSIOL-HEART C, V302, pH716, DOI 10.1152/ajpheart.00455.2011; Swatek KN, 2016, CELL RES, V26, P399, DOI 10.1038/cr.2016.39; Tian YF, 2013, TUMOR BIOL, V34, P1107, DOI 10.1007/s13277-013-0652-z; Timmerbeul I, 2006, P NATL ACAD SCI USA, V103, P14009, DOI 10.1073/pnas.0606316103; Tsvetkov LM, 1999, CURR BIOL, V9, P661, DOI 10.1016/S0960-9822(99)80290-5; Wang J, 2014, ONCOTARGET, V5, P5591, DOI 10.18632/oncotarget.2149; Wang ZW, 2012, FRONT ONCOL, V1, DOI [10.3389/fonc.2011.00057, 10.3389/fonc.2012.00201]; Wu J, 2012, MOL CELL, V46, P351, DOI 10.1016/j.molcel.2012.02.018; Xiao L, 2014, ONCOGENE, V33, P4568, DOI 10.1038/onc.2014.32; Xie P, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.195; Yang TT, 2018, ONCOGENE, V37, P5997, DOI 10.1038/s41388-018-0386-x; Yang WL, 2009, SCIENCE, V325, P1134, DOI 10.1126/science.1175065; Yao F, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04620-y; Yu XF, 2017, MOL CARCINOGEN, V56, P1414, DOI 10.1002/mc.22602; Yu ZK, 1998, P NATL ACAD SCI USA, V95, P11324, DOI 10.1073/pnas.95.19.11324; Zhang XY, 2018, INT J BIOCHEM CELL B, V95, P9, DOI 10.1016/j.biocel.2017.12.010; Zhao HL, 2013, CANCER CELL, V24, P645, DOI 10.1016/j.ccr.2013.09.021; Zhen Y, 2017, ONCOGENE, V36, P275, DOI 10.1038/onc.2016.201	57	36	39	4	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	DEC 12	2019	38	50					7457	7472		10.1038/s41388-019-0955-7	http://dx.doi.org/10.1038/s41388-019-0955-7			16	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	JV7GY	31435020				2022-12-26	WOS:000502530500002
J	Li, XZ; Ballantyne, LL; Yu, Y; Funk, CD				Li, Xinzhi; Ballantyne, Laurel L.; Yu, Ying; Funk, Colin D.			Perivascular adipose tissue-derived extracellular vesicle miR-221-3p mediates vascular remodeling	FASEB JOURNAL			English	Article						exosome; microRNAs; smooth muscle cell; inflammation; obesity	MUSCLE-CELL-PROLIFERATION; OBESE MICE; EXPRESSION; FAT; COACTIVATOR; PGC-1-ALPHA; PHENOTYPE; MICRORNA-221; DYSFUNCTION; MODULATION	Adipose tissue-secreted extracellular vesicles (EVs) containing microRNAs (miRNAs) convey intercellular message signaling. The biogenesis of EV-miRNAs from perivascular adipose tissue (PVAT) and their roles in intercellular communication in response to obesity-associated inflammation have not yet been fully explored. By feeding mice a high-fat diet for 16 wk, we established obesity-associated, chronic low-grade inflammation in PVAT, characterized as hypertrophy of perivascular adipocytes, decreased adipogenesis, and proinflammatory macrophage infiltration. We show that PVAT-derived EVs and their encapsulated miRNAs can be taken up into vascular smooth muscle cells (VSMCs) in vivo and in vitro. miR-221-3p is one of the highly enriched miRNAs in obese PVAT and PVAT-derived EVs. Transfer and direct overexpression of miR-221-3p dramatically enhances VSMC proliferation and migration. Peroxisome proliferator-activated receptor gamma coactivator 1 alpha is identified as a miR-221-3p target in VSMC phenotypic modulation. Obese mice secrete abundant miRNA-containing EVs, evoking inflammatory responses in PVAT and vascular phenotypic switching in abdominal aorta of lean mice. Local delivery of miR-221-3p mimic in femoral artery causes vascular dysfunction by suppressing the contractile genes in the arterial wall. Our findings provide an EV-miR-221-3p-mediated mechanism by which PVAT triggers an early-stage vascular remodeling in the context of obesity-associated inflammation.	[Li, Xinzhi; Ballantyne, Laurel L.; Funk, Colin D.] Queens Univ, Dept Biomed & Mol Sci, 433 Botterell Hall,18 Stuart St, Kingston, ON K7L 3N6, Canada; [Yu, Ying] Tianjin Med Univ, Sch Basic Med Sci, Dept Pharmacol, Tianjin, Peoples R China	Queens University - Canada; Tianjin Medical University	Funk, CD (corresponding author), Queens Univ, Dept Biomed & Mol Sci, 433 Botterell Hall,18 Stuart St, Kingston, ON K7L 3N6, Canada.	funkc@queensu.ca			Canadian Institutes of Health Research (CIHR) [MOP142476]; Tier 1 Canada Research Chair in Molecular, Cellular, and Physiological Medicine	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Tier 1 Canada Research Chair in Molecular, Cellular, and Physiological Medicine	The authors thank Brooke Ring-Snetsinger for the technical assistance in NanoString analysis, and Xiaohu Yan for help with electron microscopy (both from Queen's University). This work was supported by Canadian Institutes of Health Research (CIHR) Grant MOP142476. C.D.F. was supported by a Tier 1 Canada Research Chair in Molecular, Cellular, and Physiological Medicine. The authors declare no conflicts of interest.	Arany Z, 2005, CELL METAB, V1, P259, DOI 10.1016/j.cmet.2005.03.002; Bang C, 2014, J CLIN INVEST, V124, P2136, DOI 10.1172/JCI70577; Bidarimath M, 2017, SCI REP-UK, V7, DOI 10.1038/srep40476; Britton KA, 2011, CLIN LIPIDOL, V6, P79, DOI 10.2217/CLP.10.89; Brown NK, 2014, ARTERIOSCL THROM VAS, V34, P1621, DOI 10.1161/ATVBAHA.114.303029; Chatterjee TK, 2009, CIRC RES, V104, P541, DOI 10.1161/CIRCRESAHA.108.182998; Cheng YH, 2009, CIRC RES, V105, P158, DOI 10.1161/CIRCRESAHA.109.197517; Cinti S, 2005, J LIPID RES, V46, P2347, DOI 10.1194/jlr.M500294-JLR200; Coleman CB, 2013, MOL CELL ENDOCRINOL, V374, P125, DOI 10.1016/j.mce.2013.04.019; Connolly KD, 2018, ENDOCRINOLOGY, V159, P3259, DOI 10.1210/en.2018-00266; Cordes KR, 2009, NATURE, V460, P705, DOI 10.1038/nature08195; Crewe C, 2018, CELL, V175, P695, DOI 10.1016/j.cell.2018.09.005; Davis BN, 2009, J BIOL CHEM, V284, P3728, DOI 10.1074/jbc.M808788200; Deng ZB, 2009, DIABETES, V58, P2498, DOI 10.2337/db09-0216; Eguchi A, 2016, J MOL MED, V94, P1241, DOI 10.1007/s00109-016-1446-8; Finck BN, 2007, CIRCULATION, V115, P2540, DOI 10.1161/CIRCULATIONAHA.107.670588; Fitzgibbons TP, 2011, AM J PHYSIOL-HEART C, V301, pH1425, DOI 10.1152/ajpheart.00376.2011; Flaherty SE, 2019, SCIENCE, V363, P989, DOI 10.1126/science.aaw2586; Fornari F, 2008, ONCOGENE, V27, P5651, DOI 10.1038/onc.2008.178; Galardi S, 2007, J BIOL CHEM, V282, P23716, DOI 10.1074/jbc.M701805200; Haemmerle G, 2011, NAT MED, V17, P1076, DOI 10.1038/nm.2439; Handschin C, 2008, NATURE, V454, P463, DOI 10.1038/nature07206; Hill DA, 2018, P NATL ACAD SCI USA, V115, pE5096, DOI 10.1073/pnas.1802611115; Hou NN, 2016, J MOL CELL CARDIOL, V99, P188, DOI 10.1016/j.yjmcc.2016.09.005; Ji RR, 2007, CIRC RES, V100, P1579, DOI 10.1161/CIRCRESAHA.106.141986; Jia LY, 2018, FASEB J, V32, P4534, DOI 10.1096/fj.201701337RR; Jordan SD, 2011, NAT CELL BIOL, V13, P434, DOI 10.1038/ncb2211; Kapustin AN, 2015, CIRC RES, V116, P1312, DOI 10.1161/CIRCRESAHA.116.305012; Kingsley K, 2002, BIOCHEM BIOPH RES CO, V293, P1000, DOI 10.1016/S0006-291X(02)00331-5; Kranendonk MEG, 2014, OBESITY, V22, P1296, DOI 10.1002/oby.20679; le Sage C, 2007, EMBO J, V26, P3699, DOI 10.1038/sj.emboj.7601790; Lehman JJ, 2000, J CLIN INVEST, V106, P847, DOI 10.1172/JCI10268; Li XL, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.114.001412; Li XZ, 2018, J LIPID RES, V59, P89, DOI 10.1194/jlr.M079996; Lightell DJ, 2018, ATHEROSCLEROSIS, V269, P71, DOI 10.1016/j.atherosclerosis.2017.12.016; Liu GZ, 2018, FASEB J, V32, P5413, DOI 10.1096/fj.201800173R; Liu XJ, 2012, J MOL CELL CARDIOL, V52, P245, DOI 10.1016/j.yjmcc.2011.11.008; Liu XJ, 2009, CIRC RES, V104, P476, DOI 10.1161/CIRCRESAHA.108.185363; Meerson A, 2013, DIABETOLOGIA, V56, P1971, DOI 10.1007/s00125-013-2950-9; Morales-Kastresana A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01731-2; Mysore R, 2017, J CLIN ENDOCR METAB, V102, P4001, DOI 10.1210/jc.2017-00453; Nie XW, 2019, VASC PHARMACOL, V116, P24, DOI 10.1016/j.vph.2017.07.002; Ogawa R, 2010, BIOCHEM BIOPH RES CO, V398, P723, DOI 10.1016/j.bbrc.2010.07.008; Padilla J, 2013, AM J PHYSIOL-REG I, V304, pR543, DOI 10.1152/ajpregu.00567.2012; Pardo R, 2019, FASEB J, V33, P2343, DOI 10.1096/fj.201800310R; Peng J, 2018, J CELL BIOCHEM, V119, P6418, DOI 10.1002/jcb.26589; Perez S, 2019, J PATHOL, V247, P48, DOI 10.1002/path.5166; Police SB, 2010, AM J PHYSIOL-HEART C, V298, pH1932, DOI 10.1152/ajpheart.00961.2009; Prats-Puig A, 2013, J CLIN ENDOCR METAB, V98, pE1655, DOI 10.1210/jc.2013-1496; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; Qu AJ, 2009, AM J PHYSIOL-CELL PH, V297, pC645, DOI 10.1152/ajpcell.00469.2008; Rajsheker S, 2010, CURR OPIN PHARMACOL, V10, P191, DOI 10.1016/j.coph.2009.11.005; Seeley JJ, 2018, NATURE, V559, P114, DOI 10.1038/s41586-018-0253-5; Seta F, 2009, AM J PHYSIOL-REG I, V296, pR1751, DOI 10.1152/ajpregu.90985.2008; Sharma H, 2018, FASEB J, V32, P5174, DOI 10.1096/fj.201701558R; Sun XH, 2016, CIRC RES, V118, P810, DOI 10.1161/CIRCRESAHA.115.308166; Tang YF, 2017, AM J PHYSIOL-HEART C, V313, pH641, DOI 10.1152/ajpheart.00660.2016; Thomou T, 2017, NATURE, V542, P450, DOI 10.1038/nature21365; Togliatto G, 2018, DIABETES, V67, P704, DOI 10.2337/db17-0371; Trajkovic K, 2008, SCIENCE, V319, P1244, DOI 10.1126/science.1153124; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; de Voorde J, 2013, METABOLISM, V62, P1513, DOI 10.1016/j.metabol.2013.06.004; van Niel G, 2018, NAT REV MOL CELL BIO, V19, P213, DOI 10.1038/nrm.2017.125; Wang YC, 2013, DIABETOLOGIA, V56, P2275, DOI 10.1007/s00125-013-2996-8; Wei YY, 2013, AM J PHYSIOL-HEART C, V304, pH1050, DOI 10.1152/ajpheart.00267.2012; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; Xie ZL, 2018, J AM HEART ASSOC, V7, DOI 10.1161/JAHA.117.007442; Xue YX, 2015, ATHEROSCLEROSIS, V241, P671, DOI 10.1016/j.atherosclerosis.2015.06.031; Yang F, 2018, CIRCULATION, V137, P1824, DOI 10.1161/CIRCULATIONAHA.117.027799; Ying W, 2017, CELL, V171, P372, DOI 10.1016/j.cell.2017.08.035; Zhang YQ, 2016, J MOL CELL BIOL, V8, P505, DOI 10.1093/jmcb/mjw040; Zhang ZB, 2018, DIABETES, V67, P1549, DOI 10.2337/db18-0098; Zhu LY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004182	73	48	51	0	13	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2019	33	11					12704	12722		10.1096/fj.201901548R	http://dx.doi.org/10.1096/fj.201901548R			19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC8ZX	31469602	Green Published			2022-12-26	WOS:000507461600086
J	Woo, JA; Castano, M; Goss, A; Kim, D; Lewandowski, EM; Chen, Y; Liggett, SB				Woo, Jung A.; Castano, Maria; Goss, Ashley; Kim, Donghwa; Lewandowski, Eric M.; Chen, Yu; Liggett, Stephen B.			Differential long-term regulation of TAS2R14 by structurally distinct agonists	FASEB JOURNAL			English	Article						desensitization; internalization; down-regulation; beta-arrestin; [Ca2+](i)	AIRWAY SMOOTH-MUSCLE; BITTER TASTE RECEPTORS; BETA(2)-ADRENERGIC RECEPTORS; SWISS-MODEL; DESENSITIZATION; ASTHMA; BRONCHODILATORS; EXPRESSION; DOCKING	Bitter taste receptor-14 (TAS2R14) is a GPCR also expressed on human airway smooth muscle cells, which signals to intracellular [Ca2+], resulting in relaxation of the airway, and is a novel target for bronchodilators. Here, we examine long-term, agonist-promoted down-regulation of TAS2R14 expression because tachyphylaxis would be an undesirable therapeutic characteristic. Five TAS2R structurally distinct full agonists were studied to ascertain biasing away from down-regulation. Agonist exposure for 18 h caused minimal desensitization by diphenhydramine (DPD) compared with similar to 50% desensitization with all other agonists. Agonists evoked beta-arrestin recruitment to TAS2R14, which was not seen with a phosphoacceptor-deficient mutant, TAS2R14-10A. All agonists except for DPD also caused subsequent TAS2R14 internalization and trafficking via early and late endosomes to down-regulation. TAS2R14-10A failed to undergo these events with any agonist. Molecular docking showed that DPD has specific interactions deep within a binding pocket that are not observed with the other agonists, which may lock the receptor in a conformation that does not internalize and therefore does not undergo down-regulation. Thus, TAS2R14 is subject to beta-arrestin-mediated internalization and subsequent down-regulation with chronic exposure to most agonists. However, by manipulating the agonist structure, biasing toward G-protein coupling but away from long-term down-regulation can be achieved.	[Woo, Jung A.; Liggett, Stephen B.] Univ S Florida, Dept Mol Pharmacol & Physiol, Morsani Coll Med, Tampa, FL 33620 USA; [Castano, Maria; Goss, Ashley; Kim, Donghwa; Liggett, Stephen B.] Univ S Florida, Dept Med, Morsani Coll Med, Tampa, FL 33620 USA; [Lewandowski, Eric M.; Chen, Yu] Univ S Florida, Dept Mol Med, Morsani Coll Med, Tampa, FL 33620 USA	State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida	Liggett, SB (corresponding author), Univ S Florida, Morsani Coll Med, 12901 Bruce B Downs Blvd,MDC 2, Tampa, FL 33635 USA.	sliggett@health.usf.edu	Kim, Donghwa/AAJ-8148-2021	Kim, Donghwa/0000-0002-8994-8513; Woo, Jung A/0000-0002-9194-1361; Liggett, Stephen B./0000-0002-0128-3669	U.S. National Institutes of Health, National Heart, Lung, and Blood Institute [HL114471, HL045967]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL045967, P01HL114471] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The authors thank Melissa Steward (University of South Florida Morsani College of Medicine) for manuscript preparations. This work was funded by U.S. National Institutes of Health, National Heart, Lung, and Blood Institute Grants HL114471 and HL045967. The authors declare no conflicts of interest.	Adler E, 2000, CELL, V100, P693, DOI 10.1016/S0092-8674(00)80705-9; An SS, 2017, CELL SIGNAL, V41, P82, DOI 10.1016/j.cellsig.2017.02.002; Belvisi MG, 2011, NAT MED, V17, P776, DOI [10.1038/nm0711-776a, 10.1038/nm0711-776b]; Bengtsson T, 1996, J BIOL CHEM, V271, P33366, DOI 10.1074/jbc.271.52.33366; Benkert P, 2011, BIOINFORMATICS, V27, P343, DOI 10.1093/bioinformatics/btq662; Bertoni M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09654-8; Bienert S, 2017, NUCLEIC ACIDS RES, V45, pD313, DOI 10.1093/nar/gkw1132; Chandrashekar J, 2000, CELL, V100, P703, DOI 10.1016/S0092-8674(00)80706-0; Clark AA, 2012, FASEB J, V26, P4827, DOI 10.1096/fj.12-215087; Deshpande DA, 2010, NAT MED, V16, P1299, DOI 10.1038/nm.2237; Drazen JM, 2000, BRIT MED BULL, V56, P1054, DOI 10.1258/0007142001903535; EASON MG, 1994, MOL PHARMACOL, V45, P696; EASON MG, 1992, J BIOL CHEM, V267, P25473; Gainetdinov RR, 2004, ANNU REV NEUROSCI, V27, P107, DOI 10.1146/annurev.neuro.27.070203.144206; GREEN SA, 1995, AM J RESP CELL MOL, V13, P25, DOI 10.1165/ajrcmb.13.1.7598936; Guex N, 2009, ELECTROPHORESIS, V30, pS162, DOI 10.1002/elps.200900140; Huang N, 2006, J MED CHEM, V49, P6789, DOI 10.1021/jm0608356; Irannejad R, 2015, CURR OPIN CELL BIOL, V35, P137, DOI 10.1016/j.ceb.2015.05.005; Jewell-Motz EA, 2000, J BIOL CHEM, V275, P28989, DOI 10.1074/jbc.M005381200; Kim D, 2019, AM J RESP CELL MOL, V60, P532, DOI 10.1165/rcmb.2018-0189OC; Kim DW, 2017, AM J RESP CELL MOL, V56, P762, DOI 10.1165/rcmb.2016-0373OC; Kim D, 2016, J BIOL CHEM, V291, P17616, DOI 10.1074/jbc.M116.722736; Liggett Stephen B, 2014, Trans Am Clin Climatol Assoc, V125, P64; Liggett SB, 2013, EXPERT OPIN THER TAR, V17, P721, DOI 10.1517/14728222.2013.782395; Lim VJY, 2018, PROTEINS, V86, P978, DOI 10.1002/prot.25533; Lorber DM, 2005, CURR TOP MED CHEM, V5, P739, DOI 10.2174/1568026054637683; Lorber DM, 1998, PROTEIN SCI, V7, P938; Malmstrom K, 1999, ANN INTERN MED, V130, P487, DOI 10.7326/0003-4819-130-6-199903160-00005; Matera MG, 2011, TRENDS PHARMACOL SCI, V32, P495, DOI 10.1016/j.tips.2011.04.003; MENG EC, 1993, PROTEINS, V17, P266, DOI 10.1002/prot.340170305; Meyerhof W, 2010, CHEM SENSES, V35, P157, DOI 10.1093/chemse/bjp092; Rajagopal S, 2017, CELL SIGNAL, V41, P9, DOI 10.1016/j.cellsig.2017.01.024; Robinett KS, 2011, AM J RESP CELL MOL, V45, P1069, DOI 10.1165/rcmb.2011-0061OC; Rockman HA, 2002, NATURE, V415, P206, DOI 10.1038/415206a; Salazar NC, 2007, BBA-BIOMEMBRANES, V1768, P1006, DOI 10.1016/j.bbamem.2007.02.010; Sharma S, 2008, J ALLERGY CLIN IMMUN, V122, P921, DOI 10.1016/j.jaci.2008.09.004; Shoichet BK, 1999, PROTEINS, V34, P4, DOI 10.1002/(SICI)1097-0134(19990101)34:1<4::AID-PROT2>3.0.CO;2-6; Shrewsbury S, 2000, BMJ-BRIT MED J, V320, P1368, DOI 10.1136/bmj.320.7246.1368; Swift SM, 2007, AM J RESP CELL MOL, V36, P236, DOI 10.1165/rcmb.2006-0257OC; TURKI J, 1995, AM J PHYSIOL-LUNG C, V269, pL709, DOI 10.1152/ajplung.1995.269.5.L709; Wang WCH, 2011, P NATL ACAD SCI USA, V108, P6246, DOI 10.1073/pnas.1101439108; Wang WCH, 2009, P NATL ACAD SCI USA, V106, P15007, DOI 10.1073/pnas.0906034106; Waterhouse A, 2018, NUCLEIC ACIDS RES, V46, pW296, DOI 10.1093/nar/gky427; Wettschureck N, 2005, PHYSIOL REV, V85, P1159, DOI 10.1152/physrev.00003.2005; Wisler JW, 2014, CURR OPIN CELL BIOL, V27, P18, DOI 10.1016/j.ceb.2013.10.008	45	6	6	5	13	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2019	33	11					12213	12225		10.1096/fj.201802627RR	http://dx.doi.org/10.1096/fj.201802627RR			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC8ZX	31430434	Green Published			2022-12-26	WOS:000507461600048
J	Wu, JY; Huang, QY; Li, PL; Wang, YX; Zheng, CH; Lei, XH; Li, ST; Gong, WQ; Yin, BH; Luo, CW; Xiao, J; Zhou, WD; Xu, ZZ; Chen, YH; Peng, FF; Long, HB				Wu, Jiayu; Huang, Qianyin; Li, Peilin; Wang, Yuxian; Zheng, Chenghao; Lei, Xianghong; Li, Shuting; Gong, Wangqiu; Yin, Bohui; Luo, Congwei; Xiao, Jing; Zhou, Weidong; Xu, Zhaozhong; Chen, Yihua; Peng, Fenfen; Long, Haibo			MicroRNA-145 promotes the epithelial-mesenchymal transition in peritoneal dialysis-associated fibrosis by suppressing fibroblast growth factor 10	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						fibrosis; microRNA (miRNA); mRNA; translation regulation; epithelial-mesenchymal transition (EMT); fibroblast growth factor 10 (FGF10); peritoneal dialysis (PD); kidney disease; renal replacement therapy	MESOTHELIAL CELLS; RENAL FIBROSIS; PROGRESSION; ACTIVATION; TGF-BETA-1; DIFFERENTIATION; EXPRESSION; MEMBRANE; EXPOSURE; STRESS	Peritoneal fibrosis is a common complication of long-term peritoneal dialysis (PD) and the principal cause of ultrafiltration failure during PD. The initial and reversible step in PD-associated peritoneal fibrosis is the epithelial-mesenchymal transition (EMT). Although the mechanisms in the EMT have been the focus of many studies, only limited information is currently available concerning microRNA (miRNA) regulation in peritoneal fibrosis. In this study, we aimed to characterize the roles of microRNA-145 (miR-145) and fibroblast growth factor 10 (FGF10) in peritoneal fibrosis. After inducing EMT with transforming growth factor-?1 (TGF-?1) in vitro, we found that miR-145 is significantly up-regulated, whereas FGF10 is markedly down-regulated, suggesting a close link between miR-145 and FGF10 in peritoneal fibrosis, further confirmed in luciferase reporter experiments. Furthermore, in human peritoneal mesothelial cells (i.e. HMrSV5 cells), miR-145 mimics induced EMT, whereas miR-145 inhibition suppressed EMT, and we also observed that miR-145 suppressed FGF10 expression. In vivo, we found that the exogenous delivery of an miR-145 expression plasmid both blocked FGF10 and intensified the EMT, whereas miR-145 inhibition promoted the expression of FGF10 and reversed the EMT. In conclusion, miR-145 promotes the EMT during the development of peritoneal fibrosis by suppressing FGF10 activity, suggesting that miR-145 represents a potential therapeutic target for managing peritoneal fibrosis.	[Wu, Jiayu; Huang, Qianyin; Li, Peilin; Lei, Xianghong; Li, Shuting; Gong, Wangqiu; Yin, Bohui; Luo, Congwei; Xiao, Jing; Zhou, Weidong; Chen, Yihua; Peng, Fenfen; Long, Haibo] Southern Med Univ, Zhujiang Hosp, Dept Nephrol, Guangzhou 510280, Guangdong, Peoples R China; [Wang, Yuxian] Southern Med Univ, Zhujiang Hosp, Dept Gerontol, Guangzhou 510280, Guangdong, Peoples R China; [Xu, Zhaozhong] Southern Med Univ, Zhujiang Hosp, Dept Emergency, Guangzhou 510280, Guangdong, Peoples R China; [Zheng, Chenghao] Southern Med Univ, Clin Med Sch 2, Guangzhou 510280, Guangdong, Peoples R China	Southern Medical University - China; Southern Medical University - China; Southern Medical University - China; Southern Medical University - China	Chen, YH; Peng, FF; Long, HB (corresponding author), Southern Med Univ, Zhujiang Hosp, Dept Nephrol, Guangzhou 510280, Guangdong, Peoples R China.	13724005373@163.com; doctorpff@163.com; longhb1966@163.com			National Natural Science Foundation of China (NSFC) [81673792, 81600624, 81704134, 81873346, U1801288]; Natural Science Foundation of Guangdong Province, China [2017A030313708, 2014A030310065]; Science and Technology Planning Project of Guangdong Province, China [2014A020210011, 2015A020211012, 2017A020215158]; Science and Technology Planning Project of Guangzhou, China [201510010137, 201707010286]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangdong Province, China(National Natural Science Foundation of Guangdong Province); Science and Technology Planning Project of Guangdong Province, China; Science and Technology Planning Project of Guangzhou, China	This work was supported by the National Natural Science Foundation of China (NSFC) Grants 81673792, 81600624, 81704134, 81873346, and U1801288; Natural Science Foundation of Guangdong Province, China, Grants 2017A030313708 and 2014A030310065; Science and Technology Planning Project of Guangdong Province, China, Grants 2014A020210011, 2015A020211012, and 2017A020215158; and Science and Technology Planning Project of Guangzhou, China, Grants 201510010137 and 201707010286. The authors declare that they have no conflicts of interest with the contents of this article.	Nieto MA, 2016, CELL, V166, P21, DOI 10.1016/j.cell.2016.06.028; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Chang HY, 2002, P NATL ACAD SCI USA, V99, P12877, DOI 10.1073/pnas.162488599; Che MW, 2017, J AM SOC NEPHROL, V28, P2459, DOI 10.1681/ASN.2016060663; Correll KA, 2018, PHYSIOL REP, V6, DOI 10.14814/phy2.13794; del Peso G, 2008, KIDNEY INT, V73, pS26, DOI 10.1038/sj.ki.5002598; Dhanakijcharoen Prateep, 2011, J Med Assoc Thai, V94 Suppl 4, pS153; Emoto H, 1997, J BIOL CHEM, V272, P23191, DOI 10.1074/jbc.272.37.23191; Gupte VV, 2009, AM J RESP CRIT CARE, V180, P424, DOI 10.1164/rccm.200811-1794OC; Itoh N, 2016, CYTOKINE GROWTH F R, V28, P63, DOI 10.1016/j.cytogfr.2015.10.001; Kabir FL, 2018, AM J RESP CRIT CARE, V197, P632, DOI 10.1164/rccm.201704-0732OC; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kokoroishi K, 2016, CLIN EXP NEPHROL, V20, P30, DOI 10.1007/s10157-015-1128-9; Li D, 2018, J CELL MOL MED, V22, P3452, DOI 10.1111/jcmm.13622; Liu H, 2014, CELL MOL BIOL LETT, V19, P315, DOI 10.2478/s11658-014-0199-z; Liu Y, 2015, PERITON DIALYSIS INT, V35, P14, DOI 10.3747/pdi.2014.00188; Lopez-Cabrera M, 2014, ADV MED, V2014; Ma YL, 2018, INT J MOL MED, V41, P1030, DOI 10.3892/ijmm.2017.3268; Margetts PJ, 2003, PERITON DIALYSIS INT, V23, P530; Men RT, 2017, SCI REP-UK, V7, DOI 10.1038/srep40468; Mutsaers SE, 2015, FRONT PHARMACOL, V6, DOI 10.3389/fphar.2015.00113; Ornitz DM, 2015, WIRES DEV BIOL, V4, P215, DOI 10.1002/wdev.176; Patel P, 2010, KIDNEY INT, V77, P319, DOI 10.1038/ki.2009.436; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Rivara MB, 2014, CURR OPIN NEPHROL HY, V23, P586, DOI 10.1097/MNH.0000000000000066; Rougier JP, 1997, KIDNEY INT, V51, P337, DOI 10.1038/ki.1997.42; Selgas R, 2006, NEPHROL DIAL TRANSPL, V21, DOI 10.1093/ndt/gfl183; Shang J, 2019, J CELL PHYSIOL, V234, P9746, DOI 10.1002/jcp.27660; Shin HS, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05836-6; Shin HS, 2015, LAB INVEST, V95, P1157, DOI 10.1038/labinvest.2015.91; Shirakihara T, 2011, EMBO J, V30, P783, DOI 10.1038/emboj.2010.351; Skrypek N, 2018, EPIGENET CHROMATIN, V11, DOI 10.1186/s13072-018-0239-4; Stein JA, 2003, NEW ENGL J MED, V348, P2037; Strippoli R, 2015, EMBO MOL MED, V7, P102, DOI 10.15252/emmm.201404127; Sun WL, 2018, TOXICOL LETT, V282, P37, DOI 10.1016/j.toxlet.2017.09.009; Tulchinsky E, 2019, BBA-REV CANCER, V1871, P29, DOI 10.1016/j.bbcan.2018.10.003; Vargha R, 2008, NEPHROL DIAL TRANSPL, V23, P3494, DOI 10.1093/ndt/gfn353; Wang L, 2016, J AM SOC NEPHROL, V27, P2631, DOI 10.1681/ASN.2015030299; Watson J, 2018, FRONT GENET, V9, DOI 10.3389/fgene.2018.00500; Williams JD, 2002, J AM SOC NEPHROL, V13, P470, DOI 10.1681/ASN.V132470; Xiao L, 2015, LAB INVEST, V95, P817, DOI 10.1038/labinvest.2015.57; Yanez-Mo M, 2003, NEW ENGL J MED, V348, P403, DOI 10.1056/NEJMoa020809; Yang SZ, 2013, FASEB J, V27, P2382, DOI 10.1096/fj.12-219493; Yao LP, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1053-4; Yu JW, 2014, LAB INVEST, V94, P978, DOI 10.1038/labinvest.2014.91; Zeisberg M, 2009, J CLIN INVEST, V119, P1429, DOI 10.1172/JCI36183; Zhao S, 2019, ECOTOX ENVIRON SAFE, V169, P266, DOI 10.1016/j.ecoenv.2018.10.073; Zhou DD, 2016, MOL IMMUNOL, V75, P151, DOI 10.1016/j.molimm.2016.05.018; Zhou Q, 2013, AM J PATHOL, V183, P808, DOI 10.1016/j.ajpath.2013.05.019	49	12	14	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 11	2019	294	41					15052	15067		10.1074/jbc.RA119.007404	http://dx.doi.org/10.1074/jbc.RA119.007404			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JQ9JH	31431501	Green Published, hybrid			2022-12-26	WOS:000499253400018
J	Corkins, ME; Krneta-Stankic, V; Kloc, M; McCrea, PD; Gladden, AB; Miller, RK				Corkins, Mark E.; Krneta-Stankic, Vanja; Kloc, Malgorzata; McCrea, Pierre D.; Gladden, Andrew B.; Miller, Rachel K.			Divergent roles of the Wnt/PCP Formin Daam1 in renal ciliogenesis	PLOS ONE			English	Article							PLANAR CELL POLARITY; CONVERGENT EXTENSION; CHIBBY FUNCTIONS; PRIMARY CILIA; XENOPUS; GENE; PROTEINS; ACTIN; KIDNEY; DOMAIN	Kidneys are composed of numerous ciliated epithelial tubules called nephrons. Each nephron functions to reabsorb nutrients and concentrate waste products into urine. Defects in primary cilia are associated with abnormal formation of nephrons and cyst formation in a wide range of kidney disorders. Previous work in Xenopus laevis and zebrafish embryos established that loss of components that make up the Wnt/PCP pathway, Daam1 and ArhGEF19 (wGEF) perturb kidney tubulogenesis. Dishevelled, which activates both the canonical and non-canonical Wnt/PCP pathway, affect cilia formation in multiciliated cells. In this study, we investigated the role of the noncanoncial Wnt/PCP components Daam1 and ArhGEF19 (wGEF) in renal ciliogenesis utilizing polarized mammalian kidney epithelia cells (MDCKII and IMCD3) and Xenopus laevis embryonic kidney. We demonstrate that knockdown of Daam1 and ArhGEF19 in MDCKII and IMCD3 cells leads to loss of cilia, and Daam1's effect on ciliogenesis is mediated by the formin-activity of Daam1. Moreover, Daam1 co-localizes with the ciliary transport protein Ift88 and is present in cilia. Interestingly, knocking down Daam1 in Xenopus kidney does not lead to loss of cilia. These data suggests a new role for Daam1 in the formation of primary cilia.	[Corkins, Mark E.; Krneta-Stankic, Vanja; Miller, Rachel K.] UTHlth McGovern Med Sch, Pediat Res Ctr, Dept Pediat, Houston, TX 77030 USA; [Krneta-Stankic, Vanja] UTHlth Grad Sch Biomed Sci, Program Genes & Dev, MD Anderson Canc Ctr, Houston, TX USA; [Krneta-Stankic, Vanja; McCrea, Pierre D.; Gladden, Andrew B.; Miller, Rachel K.] UTHlth Grad Sch Biomed Sci, Program Genet & Epigenet, MD Anderson Canc Ctr, Houston, TX 77030 USA; [Kloc, Malgorzata] Houston Methodist, Res Inst, Houston, TX USA; [Kloc, Malgorzata; McCrea, Pierre D.; Gladden, Andrew B.; Miller, Rachel K.] Univ Texas MD Anderson Canc Ctr, Dept Genet, Houston, TX 77030 USA; [Miller, Rachel K.] UTHlth Grad Sch Biomed Sci, Program Biochem & Cell Biol, MD Anderson Canc Ctr, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; The Methodist Hospital System; The Methodist Hospital - Houston; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Miller, RK (corresponding author), UTHlth McGovern Med Sch, Pediat Res Ctr, Dept Pediat, Houston, TX 77030 USA.; Miller, RK (corresponding author), UTHlth Grad Sch Biomed Sci, Program Genet & Epigenet, MD Anderson Canc Ctr, Houston, TX 77030 USA.; Miller, RK (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Genet, Houston, TX 77030 USA.; Miller, RK (corresponding author), UTHlth Grad Sch Biomed Sci, Program Biochem & Cell Biol, MD Anderson Canc Ctr, Houston, TX 77030 USA.	Rachel.K.Miller@uth.tmc.edu	Kloc, Malgorzata/AAF-6982-2020	Miller, Rachel/0000-0001-6381-7198; krneta-stankic, vanja/0000-0003-4163-1346	National Institute of Diabetes and Digestive and Kidney Diseases [K01DK092320, R03DK118771, R01DK115655]; National Kidney Foundation [FLB1628]; UTHealth McGovern Medical School Department of Pediatrics Startup Funds; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK092320, R03DK118771, R01DK115655] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Kidney Foundation; UTHealth McGovern Medical School Department of Pediatrics Startup Funds; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by: National Institute of Diabetes and Digestive and Kidney Diseases K01DK092320 to Rachel K. Miller; National Institute of Diabetes and Digestive and Kidney Diseases R03DK118771 to Rachel K. Miller; National Institute of Diabetes and Digestive and Kidney Diseases R01DK115655 to Rachel K. Miller; UTHealth McGovern Medical School Department of Pediatrics Startup Funds to Rachel K. Miller; National Kidney Foundation FLB1628 to Rachel K. Miller. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberts AS, 2001, J BIOL CHEM, V276, P2824, DOI 10.1074/jbc.M006205200; Arts HH, 2013, PEDIATR NEPHROL, V28, P863, DOI 10.1007/s00467-012-2259-9; Baek JI, 2016, J BIOL CHEM, V291, P8632, DOI 10.1074/jbc.M115.688663; Bryant DM, 2010, NAT CELL BIOL, V12, P1035, DOI 10.1038/ncb2106; Chen W, 1998, MOL BIOL CELL; Copeland SJ, 2018, MOL BIOL CELL, V29, P1611, DOI 10.1091/mbc.E18-02-0088; Corbit KC, 2008, NAT CELL BIOL, V10, P70, DOI 10.1038/ncb1670; Corkins ME, 2018, GENES-BASEL, V9, DOI 10.3390/genes9040197; DeLay BD, 2019, FRONT PHYSIOL, V10, DOI 10.3389/fphys.2019.00143; DeLay BD, 2018, GENETICS, V208, P673, DOI 10.1534/genetics.117.300468; DeLay BD, 2016, JOVE-J VIS EXP, DOI 10.3791/53799; Ding J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05680-8; Drummond ML, 2018, J CELL BIOL, V217, P3255, DOI 10.1083/jcb.201703196; Elia Natalie, 2009, Curr Protoc Cell Biol, VChapter 4, DOI 10.1002/0471143030.cb0422s43; Faber J., 1994, NORMAL TABLE XENOPUS, P2; Fogelgren B, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001361; Habas R, 2001, CELL, V107, P843, DOI 10.1016/S0092-8674(01)00614-6; Hebert AM, 2012, GENE DEV, V26, P2709, DOI 10.1101/gad.194027.112; HEMMATIBRIVANLOU A, 1994, CELL, V77, P273, DOI 10.1016/0092-8674(94)90319-0; Hoffmann AK, 2014, FASEB J, V28, P3075, DOI 10.1096/fj.13-247049; Ishikawa H, 2012, CURR BIOL, V22, P414, DOI 10.1016/j.cub.2012.01.031; Jin H, 2009, CURR BIOL, V19, pR472, DOI 10.1016/j.cub.2009.04.015; Jones C, 2008, NAT GENET, V40, P69, DOI 10.1038/ng.2007.54; Kida YS, 2007, P NATL ACAD SCI USA, V104, P6708, DOI 10.1073/pnas.0608946104; Lee JE, 2011, GENOME MED, V3, DOI 10.1186/gm275; Lee M, 2019, J CELL BIOL, V218, P2659, DOI 10.1083/jcb.201811147; Lee YL, 2014, MOL BIOL CELL, V25, P2919, DOI 10.1091/mbc.E14-02-0735; Liu Q, 2007, MOL CELL PROTEOMICS, V6, P1299, DOI 10.1074/mcp.M700054-MCP200; Liu W, 2008, P NATL ACAD SCI USA, V105, P210, DOI 10.1073/pnas.0707277105; Longo PA, 2013, METHOD ENZYMOL, V529, P227, DOI 10.1016/B978-0-12-418687-3.00018-5; Lu J, 2007, J MOL BIOL, V369, P1258, DOI 10.1016/j.jmb.2007.04.002; Luo WW, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163915; Mahuzier A, 2012, J CELL BIOL, V198, P927, DOI 10.1083/jcb.201111009; MANDERS EMM, 1993, J MICROSC-OXFORD, V169, P375, DOI 10.1111/j.1365-2818.1993.tb03313.x; MCCREA PD, 1993, J CELL BIOL, V123, P477, DOI 10.1083/jcb.123.2.477; McMurray RJ, 2013, SCI REP-UK, V3, DOI 10.1038/srep03545; Mick DU, 2015, DEV CELL, V35, P497, DOI 10.1016/j.devcel.2015.10.015; Miller RK, 2011, J AM SOC NEPHROL, V22, P1654, DOI 10.1681/ASN.2010101086; Mirvis M, 2018, BIOCHEM J, V475, P2329, DOI 10.1042/BCJ20170453; Mitchell KAP, 2009, METHOD CELL BIOL, V94, P87, DOI 10.1016/S0091-679X(08)94004-8; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; MOODY SA, 1987, DEV BIOL, V122, P300, DOI 10.1016/0012-1606(87)90296-X; Moseley JB, 2006, METHOD ENZYMOL, V406, P215, DOI 10.1016/S0076-6879(06)06016-2; MOYER JH, 1994, SCIENCE, V264, P1329, DOI 10.1126/science.8191288; Nagai T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183030; O'Brien LE, 2001, NAT CELL BIOL, V3, P831, DOI 10.1038/ncb0901-831; ONUCHIC LF, 1995, MAMM GENOME, V6, P805, DOI 10.1007/BF00539009; Park TJ, 2008, NAT GENET, V40, P871, DOI 10.1038/ng.104; Polgar N, 2015, AM J PHYSIOL-CELL PH, V309, pC190, DOI 10.1152/ajpcell.00011.2015; Richter KN, 2018, EMBO J, V37, P139, DOI 10.15252/embj.201695709; Ross AJ, 2005, NAT GENET, V37, P1135, DOI 10.1038/ng1644; Satir P, 2010, J CELL SCI, V123, P499, DOI 10.1242/jcs.050377; Shah AS, 2008, P NATL ACAD SCI USA, V105, P3380, DOI 10.1073/pnas.0712327105; Shi JL, 2014, DEV BIOL, V395, P287, DOI 10.1016/j.ydbio.2014.09.008; Siller SS, 2015, CELL CYCLE, V14, P3163, DOI 10.1080/15384101.2015.1080396; Sive HL, 2000, EARLY DEV XENOPUS LA, DOI [10.1101/pdb.prot5536, DOI 10.1101/PDB.PROT5536]; Steere N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041077; TAIRA M, 1992, GENE DEV, V6, P356, DOI 10.1101/gad.6.3.356; Tanegashima K, 2008, EMBO J, V27, P606, DOI 10.1038/emboj.2008.9; Tisdale EJ, 2001, J BIOL CHEM, V276, P2480, DOI 10.1074/jbc.M007567200; Wang YH, 2004, BIOCHEM BIOPH RES CO, V324, P1053, DOI 10.1016/j.bbrc.2004.09.153; Werner ME, 2011, J CELL BIOL, V195, P19, DOI 10.1083/jcb.201106110; Williams E, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189081; Yasunaga T, 2015, J CELL BIOL, V211, P963, DOI 10.1083/jcb.201502043; Yoder BK, 2002, AM J PHYSIOL-RENAL, V282, pF541, DOI 10.1152/ajprenal.00273.2001; Zhu B, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006627; Zhu P, 2015, BIOL OPEN, V4, P1376, DOI 10.1242/bio.012088; Zuo XF, 2019, J BIOL CHEM, V294, P6710, DOI 10.1074/jbc.RA118.006527	68	7	8	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2019	14	8							e0221698	10.1371/journal.pone.0221698	http://dx.doi.org/10.1371/journal.pone.0221698			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW6BO	31469868	gold, Green Submitted, Green Published			2022-12-26	WOS:000485062200025
J	Varga, C; Guerin, MT; Brash, ML; Slavic, D; Boerlin, P; Susta, L				Varga, Csaba; Guerin, Michele T.; Brash, Marina L.; Slavic, Durda; Boerlin, Patrick; Susta, Leonardo			Antimicrobial resistance in Campylobacter jejuni and Campylobacter coli isolated from small poultry flocks in Ontario, Canada: A two-year surveillance study	PLOS ONE			English	Article							ANTIBIOTIC-RESISTANCE; MACROLIDE RESISTANCE; UNITED-STATES; SALMONELLA; PATHOGENS; ALBERTA; SPP.; EPIDEMIOLOGY; INFECTIONS; CHICKEN	Antimicrobial resistance in Campylobacter, common in poultry, is a global public health issue. The emergence and spread of antimicrobial resistant Campylobacter has been linked to the use of antimicrobials in food animals. Small poultry flocks are becoming increasingly popular not only as a source of food but also as pets, yet not all small flock owners are aware of proper antimicrobial use practices and safe food handling protocols. This trend could contribute to antimicrobial resistance. In order to determine the prevalence of antimicrobial resistance in Campylobacter in small poultry flocks, we analyzed data from birds that had been submitted to a diagnostic laboratory in Ontario between October 2015 and September 2017. A pooled cecal sample was obtained from each submission and cultured for Campylobacter jejuni and Campylobacter coli. Three isolates were recovered from each positive sample and tested for susceptibility to nine antimicrobials using a broth microdilution method. Overall, 176 isolates were recovered (141 chicken, 21 turkey, 6 duck, and 8 game bird). A high frequency of resistance to tetracycline was observed in the C. jejuni isolates from chickens (77%) and turkeys (100%), and in the C. coli isolates from turkeys (50%) and game birds (40%). Campylobacter jejuni isolates had higher odds of resistance to tetracycline (OR = 3.54, P <= 0.01) compared to C. coli isolates. Overall, there was a low frequency of resistance to quinolones and a very low frequency of resistance to macrolides. Multidrug resistance was uncommon. The high prevalence of tetracycline resistance emphasizes the importance of prudent antimicrobial use in small flocks. Although low, the presence of resistance to macrolides and quinolones, which are used to treat campylobacteriosis in humans, highlights the need for proper food safety and infection control practices by small flock owners to prevent exposure to antimicrobial resistant Campylobacter.	[Varga, Csaba] Ontario Minist Agr Food & Rural Affairs, Guelph, ON 1, Canada; [Guerin, Michele T.] Univ Guelph, Ontario Vet Coll, Dept Populat Med, Guelph, ON, Canada; [Brash, Marina L.; Slavic, Durda] Univ Guelph, Anim Hlth Lab, Guelph, ON, Canada; [Boerlin, Patrick; Susta, Leonardo] Univ Guelph, Ontario Vet Coll, Dept Pathobiol, Guelph, ON, Canada	University of Guelph; University of Guelph; University of Guelph	Varga, C (corresponding author), Ontario Minist Agr Food & Rural Affairs, Guelph, ON 1, Canada.	cvarga@uoguelph.ca	Susta, Leonardo/I-2968-2019; Varga, Csaba/Y-1006-2018	Susta, Leonardo/0000-0002-4578-6145; Varga, Csaba/0000-0003-2751-3677	OMAFRA-University of Guelph Strategic Partnership, under the Disease Surveillance Plan [UofG 2015-2282]; Ontario Agri-Food Innovation Alliance, under the Disease Surveillance Plan [009098]	OMAFRA-University of Guelph Strategic Partnership, under the Disease Surveillance Plan; Ontario Agri-Food Innovation Alliance, under the Disease Surveillance Plan	The surveillance project led by Dr. L. Susta, was funded by the OMAFRA-University of Guelph Strategic Partnership (grant UofG 2015-2282), under the Disease Surveillance Plan, which was a joint federal-provincial Growing Forward 2 project. The antimicrobial susceptibility testing project led by Dr. C. Varga, was funded by the Ontario Agri-Food Innovation Alliance, under the Disease Surveillance Plan (Project #: 009098).	Agunos A, 2018, CAN J VET RES, V82, P163; Agunos A, 2013, EMERG INFECT DIS, V19, P1121, DOI 10.3201/eid1907.111417; Angulo FJ, 2004, J VET MED B, V51, P374, DOI 10.1111/j.1439-0450.2004.00789.x; Basler C, 2016, EMERG INFECT DIS, V22, P1705, DOI 10.3201/eid2210.150765; Bolinger H, 2017, APPL ENVIRON MICROB, V83, DOI [10.1128/AEM.00416-17, 10.1128/aem.00416-17]; Brochu NM, 2019, J VET DIAGN INVEST, V31, P327, DOI 10.1177/1040638719843577; Centers for Disease Control and Prevention, NAT ANT RES MON SYST; Conover WJ., 1999, PRACTICAL NONPARAMET, V3rd; de Vries SPW, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194481; Dohoo I., 2009, VET EPIDEMIOLOGY RES; Doyle ME, 2015, FOODBORNE PATHOG DIS, V12, P261, DOI 10.1089/fpd.2014.1865; El-Tras WF, 2015, EPIDEMIOL INFECT, V143, P308, DOI 10.1017/S095026881400096X; Elhadidy M, 2019, TRANSBOUND EMERG DIS, V66, P463, DOI 10.1111/tbed.13046; Giacomelli M, 2014, MICROB DRUG RESIST, V20, P181, DOI 10.1089/mdr.2013.0110; Gibreel A, 2004, ANTIMICROB AGENTS CH, V48, P3442, DOI 10.1128/AAC.48.9.3442-3450.2004; Gibreel A, 2006, J ANTIMICROB CHEMOTH, V58, P243, DOI 10.1093/jac/dkl210; Government of Canada, 2018, CAN INT PROGR ANT RE; Government of Canada, 2009, CAT ANT DRUGS BAS IM; Greenacre Michael J, 1994, CORRES ANAL SOCIAL S; Hoelzer K, 2017, BMC VET RES, V13, DOI 10.1186/s12917-017-1131-3; Kaufman L., 1990, FINDING GROUPS DATA, DOI 10.1002/9780470316801; Kim JM, 2010, J FOOD PROTECT, V73, P1430, DOI 10.4315/0362-028X-73.8.1430; Kirk MD, 2015, PLOS MED, V12, DOI [10.1371/journal.pmed.1001921, 10.1371/journal.pmed.1001940]; Lebert L, 2018, ZOONOSES PUBLIC HLTH, V65, P134, DOI 10.1111/zph.12381; Leclercq R, 2002, CLIN INFECT DIS, V34, P482, DOI 10.1086/324626; Li BB, 2017, FOODBORNE PATHOG DIS, V14, P96, DOI 10.1089/fpd.2016.2186; Luo ND, 2005, P NATL ACAD SCI USA, V102, P541, DOI 10.1073/pnas.0408966102; Magiorakos AP, 2012, CLIN MICROBIOL INFEC, V18, P268, DOI 10.1111/j.1469-0691.2011.03570.x; Mainali C, 2017, AVIAN DIS, V61, P46, DOI [10.1637/11460-062716-Reg, 10.1637/AVIANDISEASESJOURNAL-00000-000000.s1]; Mamelli L, 2005, J ANTIMICROB CHEMOTH, V56, P491, DOI 10.1093/jac/dki253; McEwen SA, 2002, CLIN INFECT DIS, V34, pS93, DOI 10.1086/340246; Moore JE, 2006, MICROBES INFECT, V8, P1955, DOI 10.1016/j.micinf.2005.12.030; Narvaez-Bravo C, 2017, INT J FOOD MICROBIOL, V253, P43, DOI 10.1016/j.ijfoodmicro.2017.04.019; Pohjola L, 2016, ZOONOSES PUBLIC HLTH, V63, P420, DOI 10.1111/zph.12247; Reddy S, 2017, ONDERSTEPOORT J VET, V84, DOI 10.4102/ojvr.v84i1.1411; Sahin O, 2015, AVIAN DIS, V59, P185, DOI 10.1637/11072-032315-Review; Scallan E, 2015, EPIDEMIOL INFECT, V143, P2795, DOI 10.1017/S0950268814003185; Thakur S, 2010, FOODBORNE PATHOG DIS, V7, P835, DOI 10.1089/fpd.2009.0487; Thomas MK, 2015, FOODBORNE PATHOG DIS, V12, P820, DOI 10.1089/fpd.2015.1966; Nguyen TNM, 2016, GUT PATHOG, V8, DOI 10.1186/s13099-016-0121-5; Varga C, BMC VET RES; Varga C, 2009, FOODBORNE PATHOG DIS, V6, P23, DOI 10.1089/fpd.2008.0118; Wozniak-Biel A, 2018, MICROB DRUG RESIST, V24, P314, DOI 10.1089/mdr.2016.0249	43	22	22	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2019	14	8							e0221429	10.1371/journal.pone.0221429	http://dx.doi.org/10.1371/journal.pone.0221429			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW6AB	31465474	Green Published, Green Submitted, gold			2022-12-26	WOS:000485058200017
J	Cho, YJ; Han, MS; Kim, WS; Choim, EH; Choi, YH; Yun, KW; Lee, S; Cheon, JE; Kim, IO; Lee, HJ				Cho, Yeon Jin; Han, Mi Seon; Kim, Woo Sun; Choim, Eun Hwa; Choi, Young Hun; Yun, Ki Wook; Lee, SeungHyun; Cheon, Jung-Eun; Kim, In-One; Lee, Hoan Jong			Correlation between chest radiographic findings and clinical features in hospitalized children with Mycoplasma pneumoniae pneumonia	PLOS ONE			English	Article							PEDIATRIC-PATIENTS; PULMONARY-DISEASE; INFECTION; CHILDHOOD; DIAGNOSIS	Background Radiologic evaluation of children with Mycoplasma pneumoniae is important for diagnosis and management. Objective To investigate the correlation between chest radiographic findings and the clinical features in children with Mycoplasma pneumoniae pneumonia. Materials and methods This study included 393 hospitalized children diagnosed with M. pneumoniae pneumonia between January 2000 and August 2016. Their clinical features and chest radiographs were reviewed. Radiographic findings were categorized and grouped as consolidation group (lobar or segmental consolidation) and non-consolidation group (patchy infiltration, localized reticulonodular infiltration, or parahilar peribronchial infiltration). Results Lobar or segmental consolidation (37%) was the most common finding, followed by parahilar or peribronchial infiltration (27%), localized reticulonodular infiltration (21%) and patchy infiltration (15%). The consolidation group was more frequently accompanied by pleural effusions (63%), compared to the non-consolidation group (16%). Compared with patients in the non-consolidation group, those in the consolidation group were associated with a significantly higher rate of hypoxia, tachypnea, tachycardia, extrapulmonary manifestations, prolonged fever, and longer periods of anti-mycoplasma therapy and hospitalization. Lobar or segmental consolidation was significantly more frequent in children >= 5 years old (44%) compared with children 2-5 years old (34%) and < 2 years old (13%). Parahilar peribronchial infiltration was significantly more frequent in children < 2 years old (56%) compared with children 2-5 years old (32%) and >= 5 years old (18%). Conclusion The chest radiographic findings of children with M. pneumoniae pneumonia correlate well with the clinical features. Consolidative lesions were frequently observed in older children and were associated with more severe clinical features.	[Cho, Yeon Jin; Kim, Woo Sun; Choi, Young Hun; Lee, SeungHyun; Cheon, Jung-Eun; Kim, In-One] Seoul Natl Univ, Dept Radiol, Coll Med, Seoul, South Korea; [Cho, Yeon Jin; Kim, Woo Sun; Choi, Young Hun; Lee, SeungHyun; Cheon, Jung-Eun; Kim, In-One] Seoul Natl Univ Hosp, Dept Radiol, Seoul, South Korea; [Han, Mi Seon; Choim, Eun Hwa; Yun, Ki Wook; Lee, Hoan Jong] Seoul Natl Univ, Coll Med, Dept Pediat, Seoul, South Korea; [Han, Mi Seon; Choim, Eun Hwa; Yun, Ki Wook; Lee, Hoan Jong] Seoul Natl Univ Hosp, Dept Pediat, Seoul, South Korea; [Kim, Woo Sun; Cheon, Jung-Eun; Kim, In-One] Seoul Natl Univ, Med Res Ctr, Inst Radiat Med, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU)	Kim, WS (corresponding author), Seoul Natl Univ, Dept Radiol, Coll Med, Seoul, South Korea.; Kim, WS (corresponding author), Seoul Natl Univ Hosp, Dept Radiol, Seoul, South Korea.; Choim, EH (corresponding author), Seoul Natl Univ, Coll Med, Dept Pediat, Seoul, South Korea.; Choim, EH (corresponding author), Seoul Natl Univ Hosp, Dept Pediat, Seoul, South Korea.	kimws@snu.ac.kr; eunchoi@snu.ac.kr		Cho, Yeon Jin/0000-0001-9820-3030; Lee, Seunghyun/0000-0003-1858-0640	Basic Science Research Program through the National Research Foundation of Korea - Ministry of Education, Science and Technology [NRF-2018R1D1A1A09082098]	Basic Science Research Program through the National Research Foundation of Korea - Ministry of Education, Science and Technology	One author (E.W.C) received a grant from the Basic Science Research Program through the National Research Foundation of Korea, which is funded by the Ministry of Education, Science and Technology (NRF-2018R1D1A1A09082098), URL: https://nrf.re.kr/index. The funding source had no involvement in concept, design, data acquisition, analysis, interpretation or submission of this study.	Association AH Pediatrics AAo, 2017, PEDIATRIC EMERGENCY; Bradley JS, 2011, CLIN INFECT DIS, V53, pE25, DOI [10.1093/cid/cir531, 10.1093/cid/cir625]; CAMERON DC, 1977, CLIN RADIOL, V28, P173, DOI 10.1016/S0009-9260(77)80097-4; Cherry JD., 2014, FEIGIN CHERRYS TXB P; Defilippi A, 2008, RESP MED, V102, P1762, DOI 10.1016/j.rmed.2008.06.022; Ding S, 2016, MULTIMED TOOLS APPL, V2016, P1; Fancourt N, 2017, CLIN INFECT DIS, V64, pS262, DOI 10.1093/cid/cix089; Grigg J, 1999, EUR RESPIR J, V14, P1198, DOI 10.1183/09031936.99.14511989; GUCKEL C, 1989, PEDIATR RADIOL, V19, P499, DOI 10.1007/BF02389556; Hsieh SC, 2007, PEDIATR INT, V49, P363, DOI 10.1111/j.1442-200X.2007.02363.x; Jain S, 2015, NEW ENGL J MED, V372, P835, DOI 10.1056/NEJMoa1405870; John SD, 2001, RADIOGRAPHICS, V21, P121, DOI 10.1148/radiographics.21.1.g01ja10121; Kassisse E, 2018, ARCH ARGENT PEDIATR, V116, P179, DOI [10.5546/aap.2018.179, 10.5546/aap.2018.eng.179]; Kelly MS, 2016, PEDIATR INFECT DIS J, V35, P257, DOI 10.1097/INF.0000000000000990; Kim NH, 2007, PEDIATR INFECT DIS J, V26, P897, DOI 10.1097/INF.0b013e31812e4b81; Lee I, 2006, EUR RADIOL, V16, P719, DOI 10.1007/s00330-005-0026-z; Ma YJ, 2015, J MICROBIOL IMMUNOL, V48, P632, DOI 10.1016/j.jmii.2014.08.003; Maffey AF, 2010, PEDIATR PULM, V45, P619, DOI 10.1002/ppul.21236; Miyashita N, 2007, J MED MICROBIOL, V56, P1625, DOI 10.1099/jmm.0.47119-0; Narita M, 2000, CLIN DIAGN LAB IMMUN, V7, P909, DOI 10.1128/CDLI.7.6.909-914.2000; Narita M, 2001, CLIN DIAGN LAB IMMUN, V8, P1028, DOI 10.1128/CDLI.8.5.1028-1030.2001; Narita M, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00023; Principi N, 2001, Lancet Infect Dis, V1, P334, DOI 10.1016/S1473-3099(01)00147-5; Principi Nicola, 2001, Clinical Infectious Diseases, V32, P1281, DOI 10.1086/319981; PUTMAN CE, 1975, AM J ROENTGENOL, V124, P417, DOI 10.2214/ajr.124.3.417; Reynolds JH, 2010, BRIT J RADIOL, V83, P998, DOI 10.1259/bjr/31200593; Scott JAG, 2012, CLIN INFECT DIS, V54, pS109, DOI 10.1093/cid/cir1065; Tanaka H, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00695; Waites KB, 2004, CLIN MICROBIOL REV, V17, P697, DOI 10.1128/CMR.17.4.697-728.2004; Wang RS, 2004, PEDIATR INFECT DIS J, V23, P564, DOI 10.1097/01.inf.0000130074.56368.4b; Yoon IA, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2500-z; Youn YS, 2010, BMC PEDIATR, V10, DOI 10.1186/1471-2431-10-48	32	13	14	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2019	14	8							e0219463	10.1371/journal.pone.0219463	http://dx.doi.org/10.1371/journal.pone.0219463			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5XV	31461462	Green Published, gold, Green Submitted			2022-12-26	WOS:000485052300008
J	Arneill, GE; Perrins, CM; Wood, MJ; Murphy, D; Pisani, L; Jessopp, MJ; Quinn, JL				Arneill, Gavin E.; Perrins, Christopher M.; Wood, Matt J.; Murphy, David; Pisani, Luca; Jessopp, Mark J.; Quinn, John L.			Sampling strategies for species with high breeding-site fidelity: A case study in burrow-nesting seabirds	PLOS ONE			English	Article							GUILLEMOTS URIA-AALGE; NORTH-SEA; POPULATION DECLINE; STATISTICAL POWER; PUFFINUS-PUFFINUS; IMPACT ASSESSMENT; SKOMER ISLAND; LOW-COST; CENSUS; HABITAT	Sampling approaches used to census and monitor populations of flora and fauna are diverse, ranging from simple random sampling to complex hierarchal stratified designs. Usually the approach taken is determined by the spatial and temporal distribution of the study population, along with other characteristics of the focal species. Long-term monitoring programs used to assess seabird population trends are facilitated by their high site fidelity, but are often hampered by large and difficult to access colonies, with highly variable densities that require intensive survey. We aimed to determine the sampling effort required to (a) estimate population size with a high degree of confidence, and (b) detect different scenarios of population change in a regionally important species in the Atlantic, the Manx shearwater (Puffinus puffinus). Analyses were carried out using data collected from tape-playback surveys on four islands in the North Atlantic. To explore how sampling effort influenced confidence around abundance estimates, we used the heuristic approach of imagining the areas sampled represented the total population, and bootstrapped varying proportions of subsamples. This revealed that abundance estimates vary dramatically when less than half of all plots (n dependent on the size of the site) is randomly subsampled, leading to an unacceptable lack of confidence in population estimates. Confidence is substantially improved using a multi-stage stratified approach based on previous information on distribution in the colonies. In reality, this could lead to reducing the number of plots required by up to 80%. Furthermore, power analyses suggested that random selection of monitoring plots using a matched pairs approach generates little power to detect overall population changes of 10%, and density-dependent changes as large as 50%, because variation in density between plots is so high. Current monitoring programs have a high probability of failing to detect population-level changes due to inappropriate sampling efforts. Focusing sampling in areas of high density with low plot to plot variance dramatically increases the power to detect year to year population change, albeit at the risk of not detecting increases in low density areas, which may be an unavoidable strategy when resources are limited. We discuss how challenging populations with similar features to seabirds might be censused and monitored most effectively.	[Arneill, Gavin E.; Murphy, David; Pisani, Luca; Jessopp, Mark J.; Quinn, John L.] Univ Coll Cork, Sch Biol Earth & Environm Sci, Cork, Ireland; [Arneill, Gavin E.; Jessopp, Mark J.] Univ Coll Cork, MaREI Ctr, Environm Res Inst, Ringaskiddy, Ireland; [Perrins, Christopher M.] Univ Oxford, Edward Grey Inst Field Ornithol, Dept Zool, Oxford, England; [Wood, Matt J.] Univ Gloucestershire, Sch Nat & Social Sci, Cheltenham, Glos, England	University College Cork; University College Cork; University of Oxford; University of Gloucestershire	Arneill, GE (corresponding author), Univ Coll Cork, Sch Biol Earth & Environm Sci, Cork, Ireland.; Arneill, GE (corresponding author), Univ Coll Cork, MaREI Ctr, Environm Res Inst, Ringaskiddy, Ireland.	gavin.arneill@ucc.ie	Wood, Matthew J/B-6124-2011; Wood, Matthew/HDN-1469-2022; Jessopp, Mark/AAI-4786-2020	Wood, Matthew J/0000-0003-0920-8396; Jessopp, Mark/0000-0002-2692-3730; Arneill, Gavin/0000-0002-9630-8530	National Parks and Wildlife Service (NPWS) under the Department of Arts, Heritage and Gaeltacht, Ireland [R16331]; Countryside Council for Wales	National Parks and Wildlife Service (NPWS) under the Department of Arts, Heritage and Gaeltacht, Ireland; Countryside Council for Wales	The funding to carry out the surveys of Irish colonies was provided by the National Parks and Wildlife Service (NPWS) under the Department of Arts, Heritage and Gaeltacht, Ireland (grant no. R16331). The census on Skomer was funded by the Countryside Council for Wales.	Amano T, 2010, BIOL CONSERV, V143, P2238, DOI 10.1016/j.biocon.2010.06.010; ANKERNILSSEN T, 1993, ORNIS SCAND, V24, P1, DOI 10.2307/3676402; Arneill GE, 2020, IBIS, V162, P416, DOI 10.1111/ibi.12740; Arneill GE., 2018, THESIS; Bender DJ, 1998, ECOLOGY, V79, P517, DOI 10.2307/176950; Blums P, 2002, J ANIM ECOL, V71, P438, DOI 10.1046/j.1365-2656.2002.00613.x; Borker AL, 2014, CONSERV BIOL, V28, P1100, DOI 10.1111/cobi.12264; BROOKE MDL, 1978, ANIM BEHAV, V26, P622; Caravaggi A, 2019, IBIS, V161, P648, DOI 10.1111/ibi.12664; Carrara E, 2015, BIOL CONSERV, V184, P117, DOI 10.1016/j.biocon.2015.01.014; Chardine JW, 2013, J FIELD ORNITHOL, V84, P187, DOI 10.1111/jofo.12017; Cohen J.E., 1988, STAT POWER ANAL BEHA; Collas M, 2011, KNOWL MANAG AQUAT EC, DOI 10.1051/kmae/2011061; Condit R, 2000, SCIENCE, V288, P1414, DOI 10.1126/science.288.5470.1414; Cordes LS, 2015, POPUL ECOL, V57, P467, DOI 10.1007/s10144-015-0496-z; Corona P, 2010, PLANT BIOSYST, V144, P171, DOI 10.1080/11263500903560710; Cotter R, 2007, CAN FIELD NAT, V121, P274, DOI 10.22621/cfn.v121i3.475; Croxall JP, 2012, BIRD CONSERV INT, V22, P1, DOI 10.1017/S0959270912000020; Delord K, 2015, J FIELD ORNITHOL, V86, P173, DOI 10.1111/jofo.12100; Descamps S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029659; Diamond AW, 2003, ENVIRON MONIT ASSESS, V88, P153, DOI 10.1023/A:1025560805788; Dolrenry S, 2016, CONSERV BIOL, V30, P467, DOI 10.1111/cobi.12703; Freckleton RP, 2002, J ECOL, V90, P419, DOI 10.1046/j.1365-2745.2002.00692.x; Frederiksen M, 2004, J APPL ECOL, V41, P1129, DOI 10.1111/j.0021-8901.2004.00966.x; Frey A, 2014, ENDANGER SPECIES RES, V23, P63, DOI 10.3354/esr00565; Gremillet D, 2018, CURR BIOL, V28, P4009, DOI 10.1016/j.cub.2018.10.051; Gremillet D, 2010, ECOL APPL, V20, P1498, DOI 10.1890/09-1586.1; Harris MP, 2016, BIRD STUDY, V63, P311, DOI 10.1080/00063657.2016.1202889; Hartill BW, 2016, FISH RES, V183, P488, DOI 10.1016/j.fishres.2016.06.002; Hatch SA, 2003, BIOL CONSERV, V111, P317, DOI 10.1016/S0006-3207(02)00301-4; Hodgson JC, 2016, SCI REP-UK, V6, DOI 10.1038/srep22574; Jackson AL, 2008, BIOL CONSERV, V141, P2932, DOI 10.1016/j.biocon.2008.09.002; JAMES PC, 1985, AUK, V102, P878; Kroodsma DE, 2001, ANIM BEHAV, V61, P1029, DOI 10.1006/anbe.2000.1676; Kruger L, 2018, BIRD CONSERV INT, V28, P197, DOI 10.1017/S0959270916000289; Mac Nally R, 1997, BIOL CONSERV, V82, P355, DOI 10.1016/S0006-3207(97)00050-5; Madders M, 2003, BIRD STUDY, V50, P55, DOI 10.1080/00063650309461290; Mavor RA, 2008, 31 JOINT NAT CONS CO; Meade J, 2013, J AVIAN BIOL, V44, P55, DOI 10.1111/j.1600-048X.2012.05742.x; Metzger MJ, 2013, ECOL INDIC, V33, P26, DOI 10.1016/j.ecolind.2012.11.009; Meyer CFJ, 2010, BIOL CONSERV, V143, P2797, DOI 10.1016/j.biocon.2010.07.029; Mitchell PI, 2004, SEABIRD POPULATIONS; Nalwanga D, 2012, BIRD STUDY, V59, P83, DOI 10.1080/00063657.2011.648164; Oaks JL, 2004, NATURE, V427, P630, DOI 10.1038/nature02317; Perkins AJ, 2017, BIRD STUDY, V64, P146, DOI 10.1080/00063657.2017.1307940; Perrins Chris M., 2012, Seabird, V25, P1; Phillips RA, 2010, EMU, V110, pI, DOI 10.1071/MUv110n4_ED; Plotkin JB, 2002, ECOLOGY, V83, P3344, DOI 10.1890/0012-9658(2002)083[3344:STSCOA]2.0.CO;2; Ratcliffe N, 1998, BIRD STUDY, V45, P302, DOI 10.1080/00063659809461101; Rayner MJ, 2007, EMU, V107, P59, DOI 10.1071/MU06038; Rodway Michael S., 2011, Marine Ornithology, V39, P243; Rodway MS, 1996, BIOL CONSERV, V76, P311, DOI 10.1016/0006-3207(94)00118-9; Rosenberg DK, 2016, ECOSPHERE, V7, DOI 10.1002/ecs2.1630; RYAN PG, 1993, S AFR J SCI, V89, P309; Scott D, 2009, NEW ZEAL J ZOOL, V36, P291, DOI 10.1080/03014220909510156; Sims M, 2006, J APPL ECOL, V43, P537, DOI 10.1111/j.1365-2664.2006.01163.x; Smith S, 2001, BIRD STUDY, V48, P330, DOI 10.1080/00063650109461232; Stubbings S, 2015, SEABIRD MONITORING S; Svancara LK, 2005, BIOSCIENCE, V55, P989, DOI 10.1641/0006-3568(2005)055[0989:PVECAR]2.0.CO;2; Tchoubi S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143215; Thomas SL, 2001, RES HIGH EDUC, V42, P517, DOI 10.1023/A:1011098109834; Thompson, 1987, ECOLOGY MANX SHEARWA; Walsh P.M., 1995, SEABIRD MONITORING H; Wanless S, 2007, PROG OCEANOGR, V72, P30, DOI 10.1016/j.pocean.2006.07.007; Wimmer J, 2013, ECOL APPL, V23, P1419, DOI 10.1890/12-2088.1; Woinarski JCZ, 2010, WILDLIFE RES, V37, P116, DOI 10.1071/WR09125	66	4	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2019	14	8							e0221625	10.1371/journal.pone.0221625	http://dx.doi.org/10.1371/journal.pone.0221625			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5WO	31454375	Green Submitted, Green Published, gold, Green Accepted			2022-12-26	WOS:000485049000033
J	Arroyo-Morales, M; Martin-Alguacil, J; Lozano-Lozano, M; Cuesta-Vargas, AI; Fernandez-Fernandez, AJ; Gonzalez, JA; Tegner, Y; Cantarero-Villanueva, I				Arroyo-Morales, Manuel; Martin-Alguacil, Jose; Lozano-Lozano, Mario; Cuesta-Vargas, Antonio, I; Fernandez-Fernandez, Andres J.; Gonzalez, Jose A.; Tegner, Yelverton; Cantarero-Villanueva, Irene			The Lysholm score: Cross cultural validation and evaluation of psychometric properties of the Spanish version	PLOS ONE			English	Article							CRUCIATE LIGAMENT INJURIES; TEGNER ACTIVITY SCALE; KNEE; VALIDITY; RELIABILITY; ADAPTATION; RESPONSIVENESS; TRANSLATION; GUIDELINES; CRITERIA	Background This study aims at assessing the validity and reliability of the Spanish version of the Lysholm score, a widely used instrument for assessing knee function and activity level after ligament injuries. Methods Ninety-five participants (67.4% male, 22 +/- 5 years) completed the questionnaire twice within 7 days and a subsample of 42 participants completed a test-retest reliability. Reliability, validity and feasibility psychometric properties were studied. The validity of the questionnaire was analysed using ceiling and floor effects. Factor structure and construct validity were analysed with the SF-36, the Hip and Knee Questionnaire (HKQ) and one leg jump test (OLJT). Results Criterion validity with the SF-36 Physical State was moderate (r = 0.50 and p<0.01), poor and inverse relationship (r = -0.31, p<0.01) with HKQ and positive moderate (r = 0.59, p<0.01) with OLJT. Measurement error from MDC90 was 3.9%. Exploratory factor analysis demonstrated a one-factor solution explaining 51.5% of total variance. The x2 test for the one-factor model was significant (x2 = 29.58, df = 20, p < 0.08). Test-retest reliability level was high (ICC2.1 = 0.92, p<0.01) and also the internal consistency (alpha = 0.77). Conclusion The Spanish Lysholm score demonstrated that it is a reliable and valid instrument that can be used to assess knee function after ligament injuries.	[Arroyo-Morales, Manuel; Lozano-Lozano, Mario; Fernandez-Fernandez, Andres J.; Cantarero-Villanueva, Irene] Univ Granada, Dept Phys Therapy, Granada, Spain; [Arroyo-Morales, Manuel; Cantarero-Villanueva, Irene] Biohlth Res Inst Granada Ibs GRANADA, Granada, Spain; [Arroyo-Morales, Manuel; Lozano-Lozano, Mario; Cantarero-Villanueva, Irene] Sport & Hlth Univ Res Inst iMUDS, Granada, Spain; [Martin-Alguacil, Jose] Hosp Nuestra Senora Salud, Orthoped Surg Serv, Granada, Spain; [Cuesta-Vargas, Antonio, I] Univ Malaga, Fac Hlth Sci, Dept Phys Therapy, Andalucia Tech,Inst Invest Biomed Malaga IBIMA,Gr, Malaga, Spain; [Cuesta-Vargas, Antonio, I] Queensland Univ Technol, Sch Clin Sci, Brisbane, Qld, Australia; [Gonzalez, Jose A.] Univ Sheffield, Dept Comp Sci, Sheffield, S Yorkshire, England; [Tegner, Yelverton] Lulea Univ Technol, Dept Hlth Sci, Div Med Sci, Lulea, Sweden	University of Granada; Instituto de Investigacion Biosanitaria IBS Granada; Universidad de Malaga; Queensland University of Technology (QUT); University of Sheffield; Lulea University of Technology	Cantarero-Villanueva, I (corresponding author), Univ Granada, Dept Phys Therapy, Granada, Spain.; Cantarero-Villanueva, I (corresponding author), Biohlth Res Inst Granada Ibs GRANADA, Granada, Spain.; Cantarero-Villanueva, I (corresponding author), Sport & Hlth Univ Res Inst iMUDS, Granada, Spain.	irenecantarero@ugr.es	Gonzalez, Jose A./AAA-8130-2019; Lozano-Lozano, Mario/G-2564-2016; Cantarero-Villanueva, Irene/L-8405-2014	Gonzalez, Jose A./0000-0002-5531-8994; Lozano-Lozano, Mario/0000-0001-5854-3567; Cantarero-Villanueva, Irene/0000-0002-3834-1711; Cuesta-Vargas, Antonio I/0000-0002-8880-4315; Tegner, Yelverton/0000-0003-3628-0705; Fernandez-Fernandez, Andres Jesus/0000-0003-3682-2260	University of Granada, Plan Propio de Investigacion; Unit of Excellence on Exercise and Health (UCEES)	University of Granada, Plan Propio de Investigacion; Unit of Excellence on Exercise and Health (UCEES)	This study takes place thanks to the additional funding from the University of Granada, Plan Propio de Investigacion 2016, Excellence actions: Units of Excellence; Unit of Excellence on Exercise and Health (UCEES). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALONSO J, 1995, MED CLIN-BARCELONA, V104, P771; Beaton DE, 2000, SPINE, V25, P3186, DOI 10.1097/00007632-200012150-00014; Beynnon BD, 2005, AM J SPORT MED, V33, P1579, DOI 10.1177/0363546505279913; BOSCO C, 1983, EUR J APPL PHYSIOL O, V51, P357, DOI 10.1007/BF00429072; Briggs KK, 2009, AM J SPORT MED, V37, P890, DOI 10.1177/0363546508330143; Briggs KK, 2009, AM J SPORT MED, V37, P898, DOI 10.1177/0363546508330149; Briggs KK, 2006, J BONE JOINT SURG AM, V88A, P698, DOI 10.2106/JBJS.E.00339; Caplan N, 2014, CLASSIC PAPERS ORTHO, P201; Castellet E, 2014, HEALTH QUAL LIFE OUT, V12, DOI 10.1186/1477-7525-12-76; Celik D, 2013, CLIN ORTHOP RELAT R, V471, P2602, DOI 10.1007/s11999-013-3046-z; Cerciello S, 2018, J ORTHOP TRAUMATOL, V19, DOI 10.1186/s10195-018-0508-9; Cronbach LJ, 1951, PSYCHOMETRIKA, V16, P297; Del Coso J, 2018, J SPORT HEALTH SCI, V7, P183, DOI 10.1016/j.jshs.2016.09.002; Eshuis R, 2016, J ORTHOP SPORT PHYS, V46, P976, DOI 10.2519/jospt.2016.6566; Field A., 2013, DISCOVERING STAT USI; Flores G, 2006, NEW ENGL J MED, V355, P229, DOI 10.1056/NEJMp058316; Herrero H, 2014, AM J SPORT MED, V42, P78, DOI 10.1177/0363546513507767; Hewett TE, 2006, AM J SPORT MED, V34, P490, DOI 10.1177/0363546505282619; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Johnson DS, 2001, KNEE, V8, P51, DOI 10.1016/S0968-0160(01)00068-0; Kocher MS, 2004, J BONE JOINT SURG AM, V86A, P1139, DOI 10.2106/00004623-200406000-00004; Levy AS, 1997, AM J SPORT MED, V25, P360, DOI 10.1177/036354659702500315; Logerstedt DS, 2010, J ORTHOP SPORT PHYS, V40, pA1, DOI [10.2519/jospt.2010.0303, 10.2519/jospt.2010.0304]; Martinez-Gonzalez M., 2014, BIOESTADISTICA AMIGA, V3rd ed.; Mokkink LB, 2010, J CLIN EPIDEMIOL, V63, P737, DOI 10.1016/j.jclinepi.2010.02.006; Mundfrom DJ, 2005, INT J TEST, V5, P159, DOI 10.1207/s15327574ijt0502_4; Muniz J, 2013, PSICOTHEMA, V25, P151, DOI 10.7334/psicothema2013.24; Nunnally J., 1978, PSYCHOMETRIC THEORY; Paxton EW, 2003, AM J SPORT MED, V31, P487, DOI 10.1177/03635465030310040201; Piontek Tomasz, 2012, Pol Orthop Traumatol, V77, P115; Ratner B., 2009, J TARGET MEAS ANAL M, V17, P139, DOI [10.1057/jt.2009.5, DOI 10.1057/JT.2009.5]; Risberg MA, 2004, PHYS THER SPORT, V5, P125, DOI 10.1016/j.ptsp.2004.02.003; Stratford P. W., 2004, PHYSIOTHER CAN, V56, P27, DOI [10.2310/6640.2004.15377, DOI 10.2310/6640.2004.15377]; Swanenburg J, 2014, SWISS MED WKLY, V144, DOI 10.4414/smw.2014.13976; TEGNER Y, 1985, CLIN ORTHOP RELAT R, P43; Terwee CB, 2007, J CLIN EPIDEMIOL, V60, P34, DOI 10.1016/j.jclinepi.2006.03.012; Wang W, 2016, BMC MUSCULOSKEL DIS, V17, DOI 10.1186/s12891-016-1283-5	38	7	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2019	14	8							e0221376	10.1371/journal.pone.0221376	http://dx.doi.org/10.1371/journal.pone.0221376			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW5WO	31454386	Green Published, Green Submitted, gold			2022-12-26	WOS:000485049000018
J	Chen, R; Kou, ZQ; Xu, LC; Cao, J; Liu, ZW; Wen, XJ; Wang, ZY; Wen, HL				Chen, Rui; Kou, Zengqiang; Xu, Liuchen; Cao, Jie; Liu, Ziwei; Wen, Xiaojing; Wang, Zhiyu; Wen, Hongling			Analysis of epidemiological characteristics of four natural-focal diseases in Shandong Province, China in 2009-2017: A descriptive analysis	PLOS ONE			English	Article							HUMAN GRANULOCYTIC ANAPLASMOSIS; SCRUB TYPHUS; SEVERE FEVER; TRANSMISSION; DIAGNOSIS; RODENTS	Background Natural-focal diseases are serious diseases that endanger human health. They threaten about 100 million people in Shandong Province, and cause illness in thousands of people each year. However, information on the epidemiological characteristics of natural-focal diseases in Shandong Province has been limited. The purpose of the study was to describe and analyze the epidemiological characteristics of natural-focal diseases in Shandong Province, 2009-2017. Methods We describe the incidence and distribution of four natural-focal diseases in Shandong Province using surveillance data from 2009-2017. Results From 2009-2017, 11123 cases of four natural-focal diseases including 257 deaths were reported in Shandong Province, China. The four natural-focal diseases were severe fever with thrombocytopenia syndrome (SFTS), human granulocytic anaplasmosis (HGA), typhus, and scrub typhus. The high-risk groups of the four diseases were farmers and the elderly. The incidence rate of scrub typhus was significantly higher in females. However, this difference was not seen in the other three diseases. The four diseases were mainly clustered in the middle-southern part of Shandong Province and the Shandong Peninsula. The annual incidence of SFTS and scrub typhus increased, typhus was relatively stable, and HGA declined. However, the range of SFTS expanded, while HGA shrunk, and typhus and scrub typhus were unchanged. The epidemic period of SFTS and HGA was from May to October, typhus was from October to November, and scrub typhus was from September to November. The fatality rates of SFTS, typhus, scrub typhus, and HGA were 9.19%, 0%, 0.01%, and 2.24%, respectively. Conclusions Our study described and analyzed the prevalence of natural-focal diseases in Shandong Province, and confirmed that age was closely related to the SFTS fatality rate. This study may help to improve the understanding of the prevalence of natural-focal diseases in Shandong Province in recent years and to better develop accurate prevention and control strategies for natural-focal diseases.	[Chen, Rui; Liu, Ziwei; Wen, Xiaojing; Wang, Zhiyu; Wen, Hongling] Shandong Univ, Dept Microbiol Lab Technol, Sch Publ Hlth, Key Lab Prevent & Control Infect Dis,Key Lab Chin, Jinan, Shandong, Peoples R China; [Kou, Zengqiang; Xu, Liuchen; Cao, Jie] Shandong Ctr Dis Control & Prevent, Shandong Prov Key Lab Infect Dis Prevent & Contro, Jinan, Shandong, Peoples R China	Shandong University	Wen, HL (corresponding author), Shandong Univ, Dept Microbiol Lab Technol, Sch Publ Hlth, Key Lab Prevent & Control Infect Dis,Key Lab Chin, Jinan, Shandong, Peoples R China.	wenhongling@sdu.edu.cn			Shandong Provincial Key Laboratory of Infectious Disease Prevention and Control [2017KEYLAB02]	Shandong Provincial Key Laboratory of Infectious Disease Prevention and Control	This study was supported by Shandong Provincial Key Laboratory of Infectious Disease Prevention and Control (2017KEYLAB02) to HW. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakken JS, 2006, ANN NY ACAD SCI, V1078, P236, DOI 10.1196/annals.1374.042; Dahlgren FS, 2015, AM J TROP MED HYG, V93, P66, DOI 10.4269/ajtmh.15-0122; Ding Lei, 2012, Zhonghua Yu Fang Yi Xue Za Zhi, V46, P338; Ding SJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111736; Fu Y.L., 2016, J ENERGY INST, V06, P1, DOI DOI 10.1038/SREP19563; Han L, 2012, J SHANDONG U, V03, P43; Huang XD, 2017, KOREAN J PARASITOL, V55, P555, DOI 10.3347/kjp.2017.55.5.555; Jensenius M, 2004, CLIN INFECT DIS, V39, P1493, DOI 10.1086/425365; Jensenius M, 2009, EMERG INFECT DIS, V15, P1791, DOI 10.3201/eid1511.090677; Jia N, 2013, NEW ENGL J MED, V369, P1178, DOI 10.1056/NEJMc1303004; Jia N, 2013, NEW ENGL J MED, V369, P1176, DOI 10.1056/NEJMc1303625; Kapogiannis BG, 2011, CLIN INFECT DIS, V53, P1024, DOI 10.1093/cid/cir641; KURITZ SJ, 1988, ANNU REV PUBL HEALTH, V9, P123, DOI 10.1146/annurev.pu.09.050188.001011; Lee IY, 2009, KOREAN J PARASITOL, V47, P381, DOI 10.3347/kjp.2009.47.4.381; Li HY, 2011, INT J INFECT DIS, V15, pE859, DOI 10.1016/j.ijid.2011.09.008; Li T, 2014, BMC INFECT DIS, V14, P139, DOI DOI 10.1186/1471-2334-14-139; Li Yu, 2015, Zhonghua Liu Xing Bing Xue Za Zhi, V36, P598; Li Z, 2009, INFECT DIS INF, V22, P165; Li ZF, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06853-1; Li ZF, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004574; Liu K, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002820; Liu Y., 2012, CHIN J PREMED, V46, P500; Liu Y, 2012, VECTOR-BORNE ZOONOT, V12, P156, DOI 10.1089/vbz.2011.0758; Luo LM, 2015, EMERG INFECT DIS, V21, P1770, DOI 10.3201/eid2110.150126; Lyu YN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063668; Naimi WA, 2018, TROP MED INFECT DIS, V3, DOI 10.3390/tropicalmed3030078; Ning Z, 2008, J CHINA U MIN TECHNO, V2008, P44; Qin XR, 2018, TICKS TICK-BORNE DIS, V9, P840, DOI 10.1016/j.ttbdis.2018.03.014; Sun JianWei, 2016, Modern Preventive Medicine, V43, P4233; Sun JM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08042-6; Sun JM, 2016, SCI REP-UK, V6, DOI 10.1038/srep33175; Wang YP, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0057085, 10.1371/journal.pone.0065634]; Wormser GP, 2016, EMERG INFECT DIS, V22, P1728, DOI 10.3201/eid2210.160161; Wu YC, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004875; Wu YC, 2016, AM J TROP MED HYG, V94, P532, DOI 10.4269/ajtmh.15-0663; Xiong ChenHao, 2015, Chinese Journal of Zoonoses, V31, P169; [许华茹 Xu Huaru], 2016, [中国病原生物学杂志, Journal of Pathogen Biology], V11, P60; Ya HongXiang, 2017, Zhongguo Meijie Shengwuxue ji Kongzhi Zazhi = Chinese Journal of Vector Biology and Control, V28, P359; Yang L, 2008, CHIN J PUBLIC HLTH, V24, P877; Yang LP, 2014, EPIDEMIOL INFECT, V142, P2217, DOI 10.1017/S0950268813003208; Yu XJ, 2011, NEW ENGL J MED, V364, P1523, DOI 10.1056/NEJMoa1010095; Zhang L, 2005, CHIN PREV MED, V6, P415; Zhang L, 2014, BIOMED RES INT, V2014, P1, DOI DOI 10.1016/J.MICPATH.2014.06.006; Zhang L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111127; Zhang LJ, 2008, JAMA-J AM MED ASSOC, V300, P2263, DOI 10.1001/jama.2008.626; Zhang Rong, 2016, Zhongguo Meijie Shengwuxue ji Kongzhi Zazhi = Chinese Journal of Vector Biology and Control, V27, P133; Zhao G, 2018, SPATITAL DISTRIBUTIO; Zheng L, 2015, EPIDEMIOL INFECT, V143, P2451, DOI 10.1017/S0950268814003598; Zheng L, 2015, INFECT GENET EVOL, V36, P126, DOI 10.1016/j.meegid.2015.09.008	49	4	6	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2019	14	8							e0221677	10.1371/journal.pone.0221677	http://dx.doi.org/10.1371/journal.pone.0221677			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5WO	31454372	Green Submitted, gold, Green Published			2022-12-26	WOS:000485049000038
J	Assis, JCA; Lopez-Hernandez, D; Pulido-Murillo, EA; Melo, AL; Pinto, HA				Assis, Jordana C. A.; Lopez-Hernandez, Danimar; Pulido-Murillo, Eduardo A.; Melo, Alan L.; Pinto, Hudson A.			A morphological, molecular and life cycle study of the capybara parasite Hippocrepis hippocrepis (Trematoda: Notocotylidae)	PLOS ONE			English	Article							MYOCASTOR-COYPUS RODENTIA; N. SP DIGENEA; HYDROCHOERUS-HYDROCHAERIS; INTESTINAL HELMINTHS; SYSTEMATICS; GASTROPODA; DIVERSITY; PATAGONIA; LINNAEUS	Hippocrepis hippocrepis is a notocotylid that has been widely reported in capybaras; however, the molluscs that act as intermediate hosts of this parasite remain unknown. Furthermore, there are currently no molecular data available for H. hippocrepis regarding its phylogenetic relationship with other members of the family Notocotylidae. In the present study, we collected monostome cercariae and adult parasites from the planorbid Biomphalaria straminea and in the large intestine of capybaras, respectively, from Belo Horizonte, Minas Gerais, Brazil. We subjected them to morphological and molecular (amplification and sequencing of partial regions of 28S and cox-1 genes) studies. Adult parasites collected from the capybaras were identified as H. hippocrepis and the sequences obtained for both molecular markers showed 100% similarity with monostome cercariae found in B. straminea. The sequences obtained for H. hippocrepis were compared with data available in public databases; analysis revealed this species differs from other notocotylids with available sequences (1.5-3.8% with respect to 28S and 11.4%-13.8% with respect to cox-1). On the phylogenetic analyses, H. hippocrepis appeared to be a distinct lineage in relation to other notocotylids. Some ecological aspects related to the infection of capybaras with H. hippocrepis are briefly discussed.	[Assis, Jordana C. A.; Lopez-Hernandez, Danimar; Pulido-Murillo, Eduardo A.; Melo, Alan L.; Pinto, Hudson A.] Univ Fed Minas Gerais, Inst Biol Sci, Dept Parasitol, Lab Biol Trematoda, Belo Horizonte, MG, Brazil	Universidade Federal de Minas Gerais	Pinto, HA (corresponding author), Univ Fed Minas Gerais, Inst Biol Sci, Dept Parasitol, Lab Biol Trematoda, Belo Horizonte, MG, Brazil.	hudsonalves13@icb.ufmg.br	Pinto, Hudson/AAE-7958-2021	Pinto, Hudson/0000-0002-5519-1348; Pulido Murillo, Eduardo Alberto/0000-0002-9039-3068	National Council for the Improvement of Higher Education (CAPES, Brazil); National Council for Scientific and Technological and Technological Development (CNPq, Brazil); Pro-Reitoria de Pesquisa, Universidade Federal de Minas Gerais (PRPqUFMG) [Edital 02/2019]	National Council for the Improvement of Higher Education (CAPES, Brazil)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); National Council for Scientific and Technological and Technological Development (CNPq, Brazil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)Fundacao de Apoio a Pesquisa do Distrito Federal (FAPDF)); Pro-Reitoria de Pesquisa, Universidade Federal de Minas Gerais (PRPqUFMG)	This work was supported by a student scholarships from National Council for the Improvement of Higher Education (CAPES, Brazil) to JCAA and DLH; a student scholarships from National Council for Scientific and Technological and Technological Development (CNPq, Brazil) to HAP and ALM and a Pro-Reitoria de Pesquisa, Universidade Federal de Minas Gerais (PRPqUFMG) (Edital 02/2019) to HAP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALHO C J R, 1987, Revista Brasileira de Biologia, V47, P87; Azcarate TD., 1980, ACTA VERTEBRATA, V7, P13; Barreto G.R., 2013, CAPYBARA BIOL USE CO, P83, DOI [10.1007/978-1-4614-4000-0_4, DOI 10.1007/978-1-4614-4000-0_4]; Barton DP, 2005, KEYS TREMATODA, V2; Besprozvannykh VV, 2013, HELMINTHOLOGIA, V50, P190, DOI 10.2478/s11687-013-0131-5; Blasco-Costa I, 2017, ADV PARASIT, V98, P167, DOI 10.1016/bs.apar.2017.05.001; Blasco-Costa I, 2016, SYST PARASITOL, V93, P295, DOI 10.1007/s11230-016-9631-2; Boero JJ, 1967, REV FACULTAD CIENCIA, V21, P161; Bonuti MR., 2002, SEMIN-CIENC AGRAR, V23, P57, DOI [10.5433/1679-0359.2002v23n1p57, DOI 10.5433/1679-0359.2002V23N1P57]; Boyce K, 2012, PARASITOLOGY, V139, P1630, DOI 10.1017/S0031182012000911; CASAS MC, 1995, J HELMINTHOL SOC W, V62, P87; Costa CA., 1994, REV BRAS BIOL, V54, P39; DAWES B., 1968, TREMATODA SPECIAL RE; Enabulele EE, 2018, PARASITOLOGY, V145, P307, DOI 10.1017/S0031182017001640; Fernandes BMM., 2015, S AM TREMATODES PARA; Flores V, 2005, SYST PARASITOL, V61, P207, DOI 10.1007/s11230-005-3166-2; Flores VR, 2007, COMP PARASITOL, V74, P233, DOI 10.1654/4254.1; Gilardoni C, 2019, J HELMINTHOL, V93, P342, DOI 10.1017/S0022149X18000329; Gonchar A, 2019, PARASITOL RES, V118, P1445, DOI 10.1007/s00436-019-06297-8; Gonchar A, 2017, PARASITOL RES, V116, P45, DOI 10.1007/s00436-016-5260-6; Hamman MI, 1993, AMB SUBTROP, V3, P19; HERRERA EA, 1989, J ANIM ECOL, V58, P667, DOI 10.2307/4855; Izrailskaia AV, 2019, PARASITOL RES, V118, P469, DOI 10.1007/s00436-018-6182-2; Justo M. C. N., 2017, Neotropical Helminthology, V11, P187; KOHN A, 1970, MEM I OSWALDO CRUZ, V68, P1, DOI 10.1590/S0074-02761970000100001; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Labruna MB, 2018, J PARASITOL, V104, P173, DOI 10.1645/17-114; Labruna Marcelo B, 2017, Vet Parasitol Reg Stud Reports, V8, P82, DOI 10.1016/j.vprsr.2017.02.007; Laidemitt MR, 2017, PARASITOLOGY, V144, P131, DOI 10.1017/S0031182016001827; Lopez-Hernandez D, 2018, INFECT GENET EVOL, V63, P95, DOI 10.1016/j.meegid.2018.05.010; Miura O, 2005, INT J PARASITOL, V35, P793, DOI 10.1016/j.ijpara.2005.02.014; MONES A, 1982, Revista de la Facultad de Humanidades y Ciencias Serie Ciencias Biologicas, V1, P297; Nogueira MF, 2007, DOENCAS CAPIVARA; O'Dwyer K, 2014, SYST PARASITOL, V89, P133, DOI 10.1007/s11230-014-9515-2; Ostrowski de Nunez M, 1976, PHYSIS B, V91, P125; PAITHANKAR KR, 1991, NUCLEIC ACIDS RES, V19, P1346, DOI 10.1093/nar/19.6.1346; Paraense WL, 2002, INTRO GEOGRAFIA MED; Pinto H. A., 2013, Revista de Patologia Tropical, V42, P369; Pinto HA., 2013, THESIS; Rocha Ana Gabriela da S., 2012, Neotropical Helminthology, V6, P185; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Rothschild M., 1938, Novitates Zoologicae Tring, V41, P75; Salas V, 2004, MEM I OSWALDO CRUZ, V99, P563, DOI 10.1590/S0074-02762004000600004; Schell CS, 1970, KNOW TREMATODES; Sinkoc AL, 2009, BRAZ ARCH BIOL TECHN, V52, P327, DOI 10.1590/S1516-89132009000200009; Soldanova M, 2017, INT J PARASITOL, V47, P327, DOI 10.1016/j.ijpara.2016.12.008; Souza GTR, 2015, AQUAT MAMM, V41, P213, DOI 10.1578/AM.41.2.2015.213; Sutton Carola Ana, 1997, Gayana Zoologia, V61, P23; Tkach VV, 2003, SYST PARASITOL, V56, P1, DOI 10.1023/A:1025546001611; Travassos L., 1922, Folha Medica Rio de Janeiro, V3, P187; Travassos L., 1930, Memorias do Instituto Oswaldo Cruz, V23, P169; Valadas S, 2010, J PARASITOL, V96, P521, DOI 10.1645/GE-2368.1; Veitenheimer-Mendes I. L., 1995, BIOCIENCIAS, V3, P73; Verdade L. M., 2006, Braz. J. Biol., V66, P371; Vicente Joaquim Julio, 1997, Revista Brasileira de Zoologia, V14, P1; Wittrock DD, 1992, PARASITOL RES, V67, P37	56	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2019	14	8							e0221662	10.1371/journal.pone.0221662	http://dx.doi.org/10.1371/journal.pone.0221662			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5TR	31442291	Green Published, gold, Green Submitted			2022-12-26	WOS:000485041400066
J	Mkandawire, E; Hendriks, SL				Mkandawire, Elizabeth; Hendriks, Sheryl L.			"The role of the man is to look for food": Lessons from men's involvement in maternal and child health programmes in rural Central Malawi	PLOS ONE			English	Article							DECISION-MAKING; TIME POVERTY; GENDER; WOMEN	Many studies purport that in low-income countries, women are often responsible for producing, preparing and purchasing food. Consequently, policies related to food and nutrition overemphasise the role of women, underestimating the potential for cooperation and complementarity between men and women. This focus on women does not account for socially constructed expectations of women that undermine their decision-making in resource allocation. Using desk reviews, in-depth interviews and focus group discussions, our case study in Malawi sought to understand the complementary role of men in maternal and child nutrition. International agreements and Malawi's policies were reviewed to understand how men's involvement emerged on the nutrition policy agenda. Policymakers, stakeholders and men and women from rural Central Malawi were interviewed, sharing their experiences of men's role in maternal and child health. The study found that men's involvement in maternal and child health has been on the development agenda since as early as 1995. Malawi has made efforts to involve men in these areas through several policy actions and programmes. Contrary to literature suggesting that women are the main producers, procurers and preparers of food, this study found that men in rural Central Malawi are increasingly becoming responsible for providing and purchasing food. Men also play a supportive role in food preparation, helping women access diverse diets during and after pregnancy. They also take up a supportive role in household activities, providing women with assistance in housework and looking after children. The positive change in men's roles presents an opportunity for exploring how men can contribute to food security and nutrition. Opportunities exist for designing inclusive food and agriculture policies that promote cooperation between men and women in food and nutrition. These policies can challenge misinterpretations of women's role in food security and the underlying systems that reinforce gender inequalities.	[Mkandawire, Elizabeth; Hendriks, Sheryl L.] Univ Pretoria, Inst Food Nutr & Wellbeing, Pretoria, South Africa; [Hendriks, Sheryl L.] Univ Pretoria, Dept Agr Econ Extens & Rural Dev, Pretoria, South Africa	University of Pretoria; University of Pretoria	Mkandawire, E (corresponding author), Univ Pretoria, Inst Food Nutr & Wellbeing, Pretoria, South Africa.	elizabeth.mkandawire@up.ac.za	Mkandawire, Elizabeth/AAC-1660-2020; Mkandawire, Elizabeth/AAP-6580-2021; Hendriks, Sheryl L/E-6537-2010	Mkandawire, Elizabeth/0000-0001-6648-6435; Hendriks, Sheryl L/0000-0002-1487-4302	American people through the United States Agency for International Development (USAID) under the Feed the Future initiative [EDH-A-00-07-00005-00]	American people through the United States Agency for International Development (USAID) under the Feed the Future initiative(United States Agency for International Development (USAID))	This study was made possible by the Feed the Future Innovation Lab for Food Security Policy award EDH-A-00-07-00005-00 through the generous support of the American people through the United States Agency for International Development (USAID) under the Feed the Future initiative. The contents are the responsibility of the study authors and do not necessarily reflect the views of USAID or the United States Government.	Afandi MD., 2018, LENSA KAJIAN KEBAHAS, V8, P1; African Union Commission (AUC), 2003, COMPR AFR AGR DEV PR; Arora D, 2017, FEM ECON, V23, P93, DOI 10.1080/13545701.2016.1220676; AUC, 2014, MAL DECL ACC AGR GRO; Catholic Relief Services (CRS), 2016, FATH ENG NUTR QUAL A; Catholic Relief Services (CRS), 2012, GETT ZER DIV METH MA; Concern Worldwide, 2014, ENG MEN GEND EQ LEAR; Delaplace D, TRADITIONAL CHIEFDOM; Development Initiatives, 2018, GLOB NUTR REP; Dimova R, 2010, P GERM DEV EC C HANN; Djurfeldt AA, 2018, LAND USE POLICY, V70, P601, DOI 10.1016/j.landusepol.2017.10.048; DNHA, 2018, NAT MULT NUTR POL; Doss C., 2011, 1104 ESA FAO AGR DEV; Doss C, 2018, GLOB FOOD SECUR-AGR, V16, P69, DOI 10.1016/j.gfs.2017.10.001; Doss CR, 2018, DEV POLICY REV, V36, P35, DOI 10.1111/dpr.12243; FAO, 2011, STAT FOOD SEC NUTR W; FAO, 2015, SOC CONT ROL AGR COU; FAO, 1997, FAO FOC WOM FOOD SEC; Ferrant G., 2014, UNPAID CARE WORK MIS; Green C., 1994, 23 I DEV STUD; Haruna M, 2017, ACAD RES INT, V7, P246; IMF, 2017, MAL EC DEV DOC; Kerr RB, 2005, J S AFR STUD, V31, P53, DOI 10.1080/03057070500035679; Kululanga LI, 2012, J RES NURS MIDWIFERY, V1, P1; Kululanga LI, 2011, REPROD HEALTH, V8, DOI 10.1186/1742-4755-8-36; Lewis S, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0599-8; Lyon S, 2017, AGR HUM VALUES, V34, P317, DOI 10.1007/s10460-016-9716-1; Manda-Taylor L., BMC PREGNANCY CHILDB, V17, P1; Mbweza E, 2008, J NURS SCHOLARSHIP, V40, P12, DOI 10.1111/j.1547-5069.2007.00200.x; Ministry of Finance Economic Planning and Development (MoFEPD)., 2018, MAL GROWTH DEV STRAT; Ministry of Gender and Community Services, PROGR BEIJ 10 REP; Ministry of Health (MoH), 2006, NAT REPR HLTH STRAT; Mkandawire E, 2018, BMC PREGNANCY CHILDB, V18, DOI 10.1186/s12884-018-1669-5; MoH, 2009, SEX REPR HLTH RIGHTS; Morgan M, 2017, REV AQUACULT, V9, P317, DOI 10.1111/raq.12137; Moser C., 1993, GENDER PLANNING DEV; Mudege NN, 2017, GENDER PLACE CULT, V24, P1689, DOI [10.1080/0966369X.2017.1383363, 10.1080/0966369x.2017.1383363]; Muula A. S., 2014, BMC INT HEALTH HUM R, V14, P1; National Statistical Office (NSO), 2017, MAL DEM HLTH SURV; National Statistics Office, 2013, MAL LAB FORC PART SU; National Statistics Office (NSO), 2019, MAL 4 INT HOUS SURV; NSO and ICF Macro, 2010, MAL DEM HLTH SURV; Olah S., 2018, ROLES MEN WOMEN IMPL; Philipose A., HIV AIDS GENDER FOOD; Razavi S, 1995, WOMEN DEV GENDER DEV; Singh K, 2018, BMC PREGNANCY CHILDB, V18, DOI 10.1186/s12884-018-2084-7; Taulo Frank, 2010, Malawi Med J, V22, P2; Tokhi M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191620; UN, 1995, 4 WORLD C WOM BEIJ 4; UN Women World Bank Group UNDP., 2015, COST GEND GAP AGR PR; UNFPA, 1994, CAIR DECL POP DEV; Walsh A, 2018, HEALTH POLICY PLANN, V33, P879, DOI 10.1093/heapol/czy059; Whiteside M., 2000, 99 ODI AGR RES EXT N; WHO, 2015, REC HLTH PROM INT MA; WHO FAO, 1992, INT C NUTR ICN	55	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2019	14	8							e0221623	10.1371/journal.pone.0221623	http://dx.doi.org/10.1371/journal.pone.0221623			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW5TR	31442269	gold, Green Published, Green Submitted			2022-12-26	WOS:000485041400057
J	Soto-Heras, S; Menendez-Blanco, I; Catala, MG; Izquierdo, D; Thompson, JG; Paramio, MT				Soto-Heras, Sandra; Menendez-Blanco, Irene; Catala, Maria-Gracia; Izquierdo, Dolors; Thompson, Jeremy G.; Paramio, Maria-Teresa			Biphasic in vitro maturation with C-type natriuretic peptide enhances the developmental competence of juvenile-goat oocytes	PLOS ONE			English	Article							RECEPTOR 2 NPR2; BOVINE OOCYTES; CUMULUS CELL; EMBRYO PRODUCTION; OXIDATIVE STRESS; GENE-EXPRESSION; CAMP MODULATORS; MEIOTIC ARREST; CYCLIC-AMP; ACQUISITION	In vitro embryo production success in juvenile animals is compromised due to their intrinsic lower oocyte quality. Conventional in vitro maturation (IVM) impairs oocyte competence by inducing spontaneous meiotic resumption. A series of experiments were performed to determine if maintaining meiotic arrest during a pre-maturation culture phase (pre-IVM) prior to conventional IVM improves oocyte competence of juvenile-goat (2 months old) cumulus-oocyte complexes (COCs). In experiment 1, COCs were cultured with C-type natriuretic peptide (CNP; 0, 50, 100, 200 nM) for 6 and 8 h. Nuclear stage was assessed, revealing no differences in the incidence of germinal vesicle (GV) breakdown. In experiment 2, the same CNP concentrations were assessed plus 10 nM estradiol, the known upstream agonist activating expression of NPR2, the exclusive receptor of CNP. CNP (200 nM) plus estradiol increased the rate of oocytes at GV stage at 6 h compared to control group (74.7% vs 28.3%; P<0.05) with predominantly condensed chromatin configuration. In experiment 3, relative mRNA quantification revealed NPR2 expression was down-regulated after pre-IVM (6 h). In experiment 4, analysis of transzonal projections indicated that pre-IVM maintained cumulus-oocyte communication after oocyte recovery. For experiments 5 and 6, biphasic IVM (6 h pre-IVM with CNP and estradiol, plus 24 h IVM) and control IVM (24 h) were compared. Biphasic IVM increased intra-oocyte glutathione and decreased ROS, up-regulated DNA-methyltransferase 1 and pentraxin 3 expression and led to an increase in rate of blastocyst development compared to control group (30.2% vs 17.2%; P<0.05). In conclusion, a biphasic IVM, including a pre-IVM with CNP, maintains oocyte meiotic arrest for 6 h and enhances the embryo developmental competence of oocytes from juvenile goats.	[Soto-Heras, Sandra; Menendez-Blanco, Irene; Catala, Maria-Gracia; Izquierdo, Dolors; Paramio, Maria-Teresa] Univ Autonoma Barcelona, Fac Vet, Dept Ciencia Anim & Dels Aliments, Barcelona, Spain; [Thompson, Jeremy G.] Univ Adelaide, Sch Paedriat & Reprod Hlth, Robinson Res Inst, Adelaide, SA, Australia; [Thompson, Jeremy G.] Univ Adelaide, Adelaide Med Sch, Adelaide, SA, Australia; [Thompson, Jeremy G.] Univ Adelaide, Ctr Excellence Nanoscale BioPhoton, Australian Res Council, Adelaide, SA, Australia; [Thompson, Jeremy G.] Univ Adelaide, Davies Res Ctr, Inst Photon & Adv Sensing, Adelaide, SA, Australia	Autonomous University of Barcelona; Robinson Research Institute; University of Adelaide; University of Adelaide; University of Adelaide; University of Adelaide	Paramio, MT (corresponding author), Univ Autonoma Barcelona, Fac Vet, Dept Ciencia Anim & Dels Aliments, Barcelona, Spain.	teresa.paramio@uab.cat	Izquierdo, Maria Dolors/K-3844-2014; Soto-Heras, Sandra/ABF-1467-2020; Paramio, Maria-Teresa/A-9608-2008; Thompson, Jeremy/G-1371-2012	Izquierdo, Maria Dolors/0000-0002-1954-2868; Soto-Heras, Sandra/0000-0002-6867-8569; Paramio, Maria-Teresa/0000-0002-3653-654X; Thompson, Jeremy/0000-0003-4941-7731; Menendez Blanco, Irene/0000-0003-1170-5092	Spanish Ministry of Science, Innovation and Universities [AGL2017-85837-R]; Spanish Ministry of Education [FPU14/00423]	Spanish Ministry of Science, Innovation and Universities; Spanish Ministry of Education(Spanish Government)	This work was supported by the Spanish Ministry of Science, Innovation and Universities (AGL2017-85837-R) granted to MTP and a predoctoral grant awarded to SSH by the Spanish Ministry of Education (FPU14/00423). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albertini DF, 2001, REPRODUCTION, V121, P647, DOI 10.1530/rep.0.1210647; Albuz FK, 2010, HUM REPROD, V25, P2999, DOI 10.1093/humrep/deq246; Bermejo-Alvarez P, 2008, PHYSIOL GENOMICS, V32, P264, DOI 10.1152/physiolgenomics.00234.2007; Brown HM, 2013, FAILURE LAUNCH ABERR; CHO WK, 1974, J EXP ZOOL, V187, P383, DOI 10.1002/jez.1401870307; Cotterill M, 2013, MOL HUM REPROD, V19, P444, DOI 10.1093/molehr/gat013; DEMATOS DG, 1995, MOL REPROD DEV, V42, P432, DOI 10.1002/mrd.1080420409; EDWARDS RG, 1965, NATURE, V208, P349, DOI 10.1038/208349a0; El-Hayek S, 2014, P NATL ACAD SCI USA, V111, P16778, DOI 10.1073/pnas.1414648111; Ferreira EM, 2009, THERIOGENOLOGY, V71, P836, DOI 10.1016/j.theriogenology.2008.10.023; Fragouli E, 2015, SEMIN REPROD MED, V33, P401, DOI 10.1055/s-0035-1567821; Franciosi F, 2014, BIOL REPROD, V91, DOI 10.1095/biolreprod.114.118869; Gilchrist RB, 2016, REPRODUCTION, V152, pR143, DOI 10.1530/REP-15-0606; Gilchrist RB, 2008, HUM REPROD UPDATE, V14, P159, DOI 10.1093/humupd/dmm040; Gilchrist RB, 2007, THERIOGENOLOGY, V67, P6, DOI 10.1016/j.theriogenology.2006.09.027; Catala MG, 2011, REPRODUCTION, V142, P517, DOI 10.1530/REP-10-0528; Guerin P, 2001, HUM REPROD UPDATE, V7, P175, DOI 10.1093/humupd/7.2.175; Heinzmann J, 2011, MOL REPROD DEV, V78, P188, DOI 10.1002/mrd.21281; Huang WP, 2016, REPROD FERT DEVELOP, V28, P349, DOI 10.1071/RD14023; Jiao GZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058018; Keelan J, 2001, J NEUROSCI RES, V66, P873, DOI 10.1002/jnr.10085; Khan DR, 2015, PHYSIOL GENOMICS, V47, P432, DOI 10.1152/physiolgenomics.00043.2015; Koeman J, 2003, THERIOGENOLOGY, V60, P879, DOI 10.1016/S0093-691X(03)00090-6; Lamas-Toranzo I, 2018, THERIOGENOLOGY, V119, P156, DOI 10.1016/j.theriogenology.2018.07.007; Li HJ, 2016, HUM REPROD, V31, P810, DOI 10.1093/humrep/dew020; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lodde V, 2007, MOL REPROD DEV, V74, P740, DOI 10.1002/mrd.20639; Luciano AM, 2011, BIOL REPROD, V85, P1252, DOI 10.1095/biolreprod.111.092858; Luciano AM, 2004, BIOL REPROD, V70, P465, DOI 10.1095/biolreprod.103.020644; Macaulay AD, 2014, BIOL REPROD, V91, DOI 10.1095/biolreprod.114.119867; Macaulay AD, 2016, BIOL REPROD, V94, DOI 10.1095/biolreprod.114.127571; Morton KM, 2008, REPROD DOMEST ANIM, V43, P137, DOI 10.1111/j.1439-0531.2008.01153.x; Norris RP, 2009, DEVELOPMENT, V136, P1869, DOI 10.1242/dev.035238; Paramio MT, 2014, REPROD DOMEST ANIM, V49, P37, DOI 10.1111/rda.12334; Park SH, 2014, REPROD DOMEST ANIM, V49, P370, DOI 10.1111/rda.12281; PERREAULT SD, 1988, DEV BIOL, V125, P181, DOI 10.1016/0012-1606(88)90070-X; Prentice-Biensch JR, 2012, THERIOGENOLOGY, V78, P1633, DOI 10.1016/j.theriogenology.2012.07.013; Rodriguez-Gonzalez E, 2003, MOL REPROD DEV, V65, P446, DOI 10.1002/mrd.10316; Romero S, 2016, BIOL REPROD, V95, DOI 10.1095/biolreprod.116.139808; Russell DL, 2016, THERIOGENOLOGY, V86, P62, DOI 10.1016/j.theriogenology.2016.04.019; Sanchez F, 2017, HUM REPROD, V32, P2056, DOI 10.1093/humrep/dex262; Santiquet NW, 2017, J ASSIST REPROD GEN, V34, P1079, DOI 10.1007/s10815-017-0958-7; Sasseville M, 2009, BIOL REPROD, V81, P415, DOI 10.1095/biolreprod.108.074450; Sirard MA, 2006, THERIOGENOLOGY, V65, P126, DOI 10.1016/j.theriogenology.2005.09.020; Soto-Heras S, 2019, ANIM REPROD SCI, V202, P49, DOI 10.1016/j.anireprosci.2019.01.007; Sugimura S, 2018, J REPROD DEVELOP, V64, P233, DOI 10.1262/jrd.2018-009; Sui HS, 2005, MOL REPROD DEV, V71, P227, DOI 10.1002/mrd.20251; Tamura H, 2008, J PINEAL RES, V44, P280, DOI 10.1111/j.1600-079X.2007.00524.X; Thouas G. A., 2001, Reprod Biomed Online, V3, P25; Uysal F, 2017, RESULTS PROBL CELL D, V63, P211, DOI 10.1007/978-3-319-60855-6_10; Van Blerkom J, 2009, SEMIN CELL DEV BIOL, V20, P354, DOI 10.1016/j.semcdb.2008.12.005; Xi GY, 2018, THERIOGENOLOGY, V106, P198, DOI 10.1016/j.theriogenology.2017.09.003; Yang L, 2016, J OVARIAN RES, V9, DOI 10.1186/s13048-016-0218-y; Zeng HT, 2014, BIOL REPROD, V91, DOI 10.1095/biolreprod.114.118471; Zhang JH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132318; Zhang MJ, 2011, ENDOCRINOLOGY, V152, P4377, DOI 10.1210/en.2011-1118; Zhang MJ, 2010, SCIENCE, V330, P366, DOI 10.1126/science.1193573; Zhang T, 2018, BIOCHEM BIOPH RES CO, V497, P200, DOI 10.1016/j.bbrc.2018.02.054; Zhang T, 2017, IN VITRO CELL DEV-AN, V53, P199, DOI 10.1007/s11626-016-0101-6; Zhang WQ, 2015, J CELL PHYSIOL, V230, P71, DOI 10.1002/jcp.24682; Zhang YH, 2017, REPROD BIOL ENDOCRIN, V15, P1, DOI 10.1186/s12958-017-0258-1	61	14	14	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2019	14	8							e0221663	10.1371/journal.pone.0221663	http://dx.doi.org/10.1371/journal.pone.0221663			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5TR	31442286	gold, Green Published			2022-12-26	WOS:000485041400067
J	Vergani, L; Mapelli, F; Suman, J; Cajthaml, T; Uhlik, O; Borin, S				Vergani, Lorenzo; Mapelli, Francesca; Suman, Jachym; Cajthaml, Tomas; Uhlik, Ondrej; Borin, Sara			Novel PCB-degrading Rhodococcus strains able to promote plant growth for assisted rhizoremediation of historically polluted soils	PLOS ONE			English	Article							POLYCHLORINATED-BIPHENYLS PCBS; CONTAMINATED SOILS; BACTERIA; DEGRADATION; BIOREMEDIATION; DESORPTION; GENES; FATE; SITE; AREA	Extended soil contamination by polychlorinated biphenyls (PCBs) represents a global environmental issue that can hardly be addressed with the conventional remediation treatments. Rhizoremediation is a sustainable alternative, exploiting plants to stimulate in situ the degradative bacterial communities naturally occurring in historically polluted areas. This approach can be enhanced by the use of bacterial strains that combine PCB degradation potential with the ability to promote plant and root development. With this aim, we established a collection of aerobic bacteria isolated from the soil of the highly PCB-polluted site "SIN Brescia-Caffaro" (Italy) biostimulated by the plant Phalaris arundinacea. The strains, selected on biphenyl and plant secondary metabolites provided as unique carbon source, were largely dominated by Actinobacteria and a significant number showed traits of interest for remediation, harbouring genes homologous to bphA, involved in the PCB oxidation pathway, and displaying 2,3-catechol dioxygenase activity and emulsification properties. Several strains also showed the potential to alleviate plant stress through 1-aminocyclopropane-1-carboxylate deaminase activity. In particular, we identified three Rhodococcus strains able to degrade in vitro several PCB congeners and to promote lateral root emergence in the model plant Arabidopsis thaliana in vivo. In addition, these strains showed the capacity to colonize the root system and to increase the plant biomass in PCB contaminated soil, making them ideal candidates to sustain microbial-assisted PCB rhizoremediation through a bioaugmentation approach.	[Vergani, Lorenzo; Mapelli, Francesca; Borin, Sara] Univ Milan, Dept Food Environm & Nutr Sci, Milan, Italy; [Suman, Jachym; Uhlik, Ondrej] Univ Chem & Technol Prague, Dept Biochem & Microbiol, Prague, Czech Republic; [Cajthaml, Tomas] Czech Acad Sci, Inst Microbiol, Prague, Czech Republic	University of Milan; University of Chemistry & Technology, Prague; Czech Academy of Sciences; Institute of Microbiology of the Czech Academy of Sciences	Borin, S (corresponding author), Univ Milan, Dept Food Environm & Nutr Sci, Milan, Italy.	sara.borin@unimi.it	Šuman, Jáchym/AAB-5244-2020; Uhlik, Ondrej/D-3672-2010; Šuman, Jáchym/S-6942-2019; VERGANI, LORENZO/N-4852-2019; Šuman, Jáchym/CAC-0010-2022	Šuman, Jáchym/0000-0003-1828-8391; Uhlik, Ondrej/0000-0002-0506-202X; Šuman, Jáchym/0000-0003-1828-8391; VERGANI, LORENZO/0000-0001-6072-4906; Šuman, Jáchym/0000-0003-1828-8391	Ente Regionale per i Servizi all'Agricoltura e alle Foreste (ERSAF), Decreto ERSAF [III/5426]; Czech Science Foundation [17-00227S]	Ente Regionale per i Servizi all'Agricoltura e alle Foreste (ERSAF), Decreto ERSAF; Czech Science Foundation(Grant Agency of the Czech Republic)	LV, FM and SB acknowledge the funding agency Ente Regionale per i Servizi all'Agricoltura e alle Foreste (ERSAF), Decreto ERSAF n. III/5426 del 09.12.2013. FM and LV acknowledge personal support from the project "Unveiling plant bacterium interaction for agriculture and bioremediation (NURTURE)" (Piano di Sostegno alla Ricerca 2018: Linea 2 Azione A). OU, JS and TC acknowledge the Czech Science Foundation (project no.17-00227S).	Abhilash PC, 2016, TRENDS BIOTECHNOL, V34, P847, DOI 10.1016/j.tibtech.2016.05.005; Ancona V, 2017, NEW BIOTECHNOL, V38, P65, DOI 10.1016/j.nbt.2016.09.006; Arenskotter M, 2004, APPL ENVIRON MICROB, V70, P3195, DOI 10.1128/AEM.70.6.3195-3204.2004; Barbato M, 2016, MAR POLLUT BULL, V104, P211, DOI 10.1016/j.marpolbul.2016.01.029; Belimov AA, 2005, SOIL BIOL BIOCHEM, V37, P241, DOI 10.1016/j.soilbio.2004.07.033; Beyer A, 2009, REV ENVIRON CONTAM T, V201, P137, DOI 10.1007/978-1-4419-0032-6_5; Cesco S, 2012, BIOL FERT SOILS, V48, P123, DOI 10.1007/s00374-011-0653-2; Chouaia B, 2010, APPL ENVIRON MICROB, V76, P7444, DOI 10.1128/AEM.01747-10; Cvancarova M, 2012, CHEMOSPHERE, V88, P1317, DOI 10.1016/j.chemosphere.2012.03.107; Di Guardo A, 2017, ENVIRON POLLUT, V223, P367, DOI 10.1016/j.envpol.2017.01.033; DONNELLY PK, 1994, CHEMOSPHERE, V28, P981, DOI 10.1016/0045-6535(94)90014-0; Dvorska A, 2008, ENVIRON POLLUT, V156, P403, DOI 10.1016/j.envpol.2008.01.034; El Fantroussi S, 2005, CURR OPIN MICROBIOL, V8, P268, DOI 10.1016/j.mib.2005.04.011; Fu H., 2014, ADV MICROBIOL-IRVINE, V4, P747, DOI [10.4236/aim.2014.412081, DOI 10.4236/AIM.2014.412081, DOI 10.4236/aim.2014.412081]; Fuchs G, 2011, NAT REV MICROBIOL, V9, P803, DOI 10.1038/nrmicro2652; Furukawa K, 2008, J BIOSCI BIOENG, V105, P433, DOI 10.1263/jbb.105.433; Garrido-Sanz D, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00232; Gioia R, 2014, ENVIRON SCI POLLUT R, V21, P6278, DOI 10.1007/s11356-013-1739-1; Gomes HI, 2013, SCI TOTAL ENVIRON, V445, P237, DOI 10.1016/j.scitotenv.2012.11.098; Hermanson MH, 2007, CHEMOSPHERE, V68, P191, DOI 10.1016/j.chemosphere.2006.11.068; Iwai S, 2010, ISME J, V4, P279, DOI 10.1038/ismej.2009.104; Jepson PD, 2016, SCI REP-UK, V6, DOI 10.1038/srep18573; Kugler J K, 2015, FRONTIERS MICROBIOLO, V6, P12, DOI [10.3389/fmicb.2015.00012, DOI 10.3389/FMICB.2015.00012]; Kuiper I, 2004, MOL PLANT MICROBE IN, V17, P6, DOI 10.1094/MPMI.2004.17.1.6; Leewis MC, 2016, SCI REP-UK, V6, DOI 10.1038/srep22145; LeFevre GH, 2013, ENVIRON SCI TECHNOL, V47, P11545, DOI 10.1021/es402446v; Leigh MB, 2006, APPL ENVIRON MICROB, V72, P2331, DOI 10.1128/AEM.72.4.2331-2342.2006; Mapelli F, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/248078; Marasco R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048479; Margesin R, 2003, EXTREMOPHILES, V7, P451, DOI 10.1007/s00792-003-0347-2; MASAI E, 1995, APPL ENVIRON MICROB, V61, P2079, DOI 10.1128/AEM.61.6.2079-2085.1995; Master ER, 1998, APPL ENVIRON MICROB, V64, P4823; Meggo RE, 2013, ECOL ENG, V57, P285, DOI 10.1016/j.ecoleng.2013.04.052; Musilova L, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17081205; Passatore L, 2014, J HAZARD MATER, V278, P189, DOI 10.1016/j.jhazmat.2014.05.051; Pham TTM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126033; Ridl J, 2018, STAND GENOMIC SCI, V13, DOI 10.1186/s40793-017-0306-7; Segura A, 2009, MICROB BIOTECHNOL, V2, P452, DOI 10.1111/j.1751-7915.2009.00113.x; Taniyasu S, 2003, ENVIRON POLLUT, V126, P169, DOI 10.1016/S0269-7491(03)00207-0; Terzaghi E, 2019, SCI TOTAL ENVIRON, V686, P484, DOI 10.1016/j.scitotenv.2019.05.458; Terzaghi E, 2018, SCI TOTAL ENVIRON, V612, P544, DOI 10.1016/j.scitotenv.2017.08.189; Thijs S, 2014, PLANT SOIL, V385, P15, DOI 10.1007/s11104-014-2260-0; Toussaint JP, 2012, APPL MICROBIOL BIOT, V95, P1589, DOI 10.1007/s00253-011-3824-z; Turrio-Baldassarri L, 2007, CHEMOSPHERE, V67, P1822, DOI 10.1016/j.chemosphere.2006.05.124; Uhlik O, 2011, APPL ENVIRON MICROB, V77, P6858, DOI 10.1128/AEM.05465-11; Vergani L, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01385; Vergani L, 2017, SCI TOTAL ENVIRON, V575, P1395, DOI 10.1016/j.scitotenv.2016.09.218; Xing Y, 2005, CHEMOSPHERE, V60, P731, DOI 10.1016/j.chemosphere.2005.05.001; Xu L, 2010, SCI TOTAL ENVIRON, V408, P1007, DOI 10.1016/j.scitotenv.2009.11.031; Yoon SH, 2017, INT J SYST EVOL MICR, V67, P1613, DOI 10.1099/ijsem.0.001755	50	16	17	5	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2019	14	8							e0221253	10.1371/journal.pone.0221253	http://dx.doi.org/10.1371/journal.pone.0221253			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5RZ	31437185	gold, Green Published, Green Submitted			2022-12-26	WOS:000485036900042
J	Prasannan, CB; Mishra, V; Jaiswal, D; Wangikar, PP				Prasannan, Charulata B.; Mishra, Vivek; Jaiswal, Damini; Wangikar, Pramod P.			Mass Isotopologue Distribution of dimer ion adducts of intracellular metabolites for potential applications in C-13 Metabolic Flux Analysis	PLOS ONE			English	Article							SPECTROMETRY; IDENTIFICATION; COMPLEX; MS	C-13 Metabolic Flux Analysis (C-13-MFA) is a powerful tool for quantification of carbon flux distribution in metabolic pathways. However, the requirement to obtain accurate labeling patterns, especially for compounds with low abundance, poses a challenge. Chromatographic separation and high sensitivity of the modern mass spectrometers (MS) alleviate this problem to a certain extent. However, the presence of derivatives such as in-source fragments, multimer ion adducts, and multiply charged ions result in reduced intensity of the molecular ion. While multimer ion adducts have been reported in the field of metabolomics, their presence is considered undesirable in quantitative studies. Here, we demonstrate a novel application of dimer ion adducts in calculating the mass isotopologue distribution (MIDs) of the corresponding monomer ions for public domain and in-house generated datasets comprising of C-13-labeling time-course experiments. Out of the 100 standard compounds analyzed, we could detect multimer ion adducts in 24 of the intermediate metabolites. Further, a subset of these multimer ions were detected in all the biological samples analyzed. Majority of these ion adducts were either not detected in the original study or labeled as a putative features. Regression analysis was performed to estimate the monomer MIDs from those of the dimer. This resulted in accurate estimation regardless of the biological system, chromatographic method, the MS hardware, or the relative abundance of the dimer ion. We argue that this analysis may be useful in cases where satisfactory data cannot be extracted from the chromatographic peaks of the monomer ions.	[Prasannan, Charulata B.; Mishra, Vivek; Jaiswal, Damini; Wangikar, Pramod P.] Indian Inst Technol, Dept Chem Engn, Mumbai, Maharashtra, India; [Prasannan, Charulata B.; Wangikar, Pramod P.] Indian Inst Technol, DBT Pan IIT Ctr Bioenergy, Mumbai, Maharashtra, India; [Wangikar, Pramod P.] Indian Inst Technol, Wadhwani Res Ctr Bioengn, Mumbai, Maharashtra, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Bombay; DBT-Pan IIT Centre for Bioenergy; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Bombay; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Bombay	Wangikar, PP (corresponding author), Indian Inst Technol, Dept Chem Engn, Mumbai, Maharashtra, India.; Wangikar, PP (corresponding author), Indian Inst Technol, DBT Pan IIT Ctr Bioenergy, Mumbai, Maharashtra, India.; Wangikar, PP (corresponding author), Indian Inst Technol, Wadhwani Res Ctr Bioengn, Mumbai, Maharashtra, India.	wangikar@iitb.ac.in		Wangikar, Pramod/0000-0003-0108-7585; Jaiswal, Damini/0000-0002-5822-2541	Department of Biotechnology, Ministry of Science and Technology, Government of India towards the DBT Pan-IIT Centre for Bioenergy [BT/EB/PAN IIT/2012]	Department of Biotechnology, Ministry of Science and Technology, Government of India towards the DBT Pan-IIT Centre for Bioenergy	We gratefully acknowledge the financial support received from the Department of Biotechnology, Ministry of Science and Technology, Government of India towards the DBT Pan-IIT Centre for Bioenergy (Grant No: BT/EB/PAN IIT/2012). The grant was awarded to Dr. Pramod P. Wangikar.	Abernathy MH, 2017, BIOTECHNOL BIOFUELS, V10, P1, DOI [10.1186/s13068-016-0693-9, DOI 10.1186/S13068-016-0693-9]; Alagesan S, 2013, PHOTOSYNTH RES, V118, P191, DOI 10.1007/s11120-013-9911-5; ANDERSSEN RS, 1969, J GEOPHYS RES, V74, P1045, DOI 10.1029/JB074i004p01045; Antoniewicz MR, 2007, ANAL CHEM, V79, P7554, DOI 10.1021/ac0708893; Benton HP, 2015, ANAL CHEM, V87, P884, DOI 10.1021/ac5025649; BUSMAN M, 1994, RAPID COMMUN MASS SP, V8, P211, DOI 10.1002/rcm.1290080217; Capellades J, 2016, ANAL CHEM, V88, P621, DOI 10.1021/acs.analchem.5b03628; Cassier-Chauvat C, 2017, APPL MICROBIOL BIOT, V101, P1359, DOI 10.1007/s00253-017-8105-z; Hendry JI, 2017, BIOTECHNOL BIOENG, V114, P2298, DOI 10.1002/bit.26350; Jaiswal D, 2018, SCI REP, P1, DOI [10.1038/s41598-017-17765-5, DOI 10.1038/S41598-017-17765-5]; Jaiswal D, 2018, ANAL CHEM, V90, P6486, DOI 10.1021/acs.analchem.7b05329; Jazmin Lara J, 2013, Methods Mol Biol, V985, P367, DOI 10.1007/978-1-62703-299-5_18; Jazmin LJ, 2014, METHOD MOL BIOL, P182, DOI [10.1007/978-1-62703-688-7, DOI 10.1007/978-1-62703-688-7]; Kiefer P, 2015, ANAL CHEM, V87, P9679, DOI 10.1021/acs.analchem.5b01660; Kim DH, 2015, METABOLOMICS, V11, P1721, DOI 10.1007/s11306-015-0827-2; Knoot CJ, 2018, J BIOL CHEM, V293, P5044, DOI 10.1074/jbc.R117.815886; Li SZ, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003123; Lynn KS, 2015, ANAL CHEM, V87, P2143, DOI 10.1021/ac503325c; Ma FF, 2014, P NATL ACAD SCI USA, V111, P16967, DOI 10.1073/pnas.1319485111; Narainsamy K, 2013, METABOLOMICS, V9, P21, DOI 10.1007/s11306-011-0382-4; Novotny NR, 2014, J MASS SPECTROM, V49, P316, DOI 10.1002/jms.3345; Prasannan CB, 2018, IMPROVED METHOD EXTR, P1, DOI [10.21228/M8WT20, DOI 10.21228/M8WT20]; Srivastava A, 2017, J PROTEOME RES, V16, P1492, DOI 10.1021/acs.jproteome.6b00902; Stefansson M, 1996, ANAL CHEM, V68, P1792, DOI 10.1021/ac950980j; Tautenhahn R, 2012, NAT BIOTECHNOL, V30, P826, DOI 10.1038/nbt.2348; Tautenhahn R, 2012, ANAL CHEM, V84, P5035, DOI 10.1021/ac300698c; Wang J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01435-7; Wiechert W, 2001, METAB ENG, V3, P195, DOI 10.1006/mben.2001.0187; Wiechert W, 2013, CURR OPIN BIOTECH, V24, P979, DOI 10.1016/j.copbio.2013.03.024; Wu C, 2015, PLANT PHYSIOL, V167, P586, DOI 10.1104/pp.114.250688; Xiong W, 2015, NAT PLANTS, V1, DOI 10.1038/NPLANTS.2015.53; Young JD, 2014, BIOINFORMATICS, V30, P1333, DOI 10.1093/bioinformatics/btu015; Young JD, 2011, METAB ENG, V13, P656, DOI 10.1016/j.ymben.2011.08.002; Zhu ZJ, 2013, NAT PROTOC, V8, P451, DOI 10.1038/nprot.2013.004	34	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2019	14	8							e0220412	10.1371/journal.pone.0220412	http://dx.doi.org/10.1371/journal.pone.0220412			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5QN	31433815	Green Submitted, Green Published, gold			2022-12-26	WOS:000485033100011
J	Nakamura, Y; Kato, K; Tsuchida, N; Matsumoto, N; Takahashi, Y; Saitoh, S				Nakamura, Yuji; Kato, Kohji; Tsuchida, Naomi; Matsumoto, Naomichi; Takahashi, Yoshiyuki; Saitoh, Shinji			Constitutive activation of mTORC1 signaling induced by biallelic loss-of-function mutations in SZT2 underlies a discernible neurodevelopmental disease	PLOS ONE			English	Article							DEVELOPMENTAL DELAY; ENCEPHALOPATHY; METABOLISM; EPILEPSY; GROWTH; GENE	There have been increasing number of reports of SZT2-related neurological diseases, the main symptoms of which are epilepsy, developmental delay, macrocephaly and a dysmorphic corpus callosum. SZT2 functions as a regulator of mechanistic target of rapamycin complex 1 (mTORC1) signaling in cultured human cell lines and mouse tissues. However, it remains to be determined whether mutations in SZT2 in human patients alter mTORC1 signaling. In this study, we aimed to investigate the functional consequence of biallelic SZT2 variants in Epstein-Barr virus-induced lymphoblastoid cell lines (LCLs) established from two patients with a typical SZT2-related neurodevelopmental disease. Increased phosphorylation of S6 kinase and S6 was identified in patient-derived cell lines under amino acid-starved condition, suggestive of constitutive hyperactivation of mTORC1 signaling. This result was validated by constitutive lysosomal localization of mTOR in patients' LCLs. Furthermore, patients' LCLs display an excessive response to slight amino acid stimulation. Our data suggest the loss-of-function nature of SZT2 mutations in the patients, and consequent hyperactivation of mTORC1 signaling in response to both amino acid starvation and stimulation in their LCLs. By these functional analyses, the pathogenicity of newly identified SZT2 variants can be determined, allowing for more detailed characterization of genotype-phenotype correlations.	[Nakamura, Yuji; Kato, Kohji; Saitoh, Shinji] Nagoya City Univ, Grad Sch Med Sci, Dept Pediat & Neonatol, Nagoya, Aichi, Japan; [Kato, Kohji; Takahashi, Yoshiyuki] Nagoya Univ, Dept Pediat, Grad Sch Med, Nagoya, Aichi, Japan; [Tsuchida, Naomi; Matsumoto, Naomichi] Yokohama City Univ, Grad Sch Med, Dept Human Genet, Yokohama, Kanagawa, Japan	Nagoya City University; Nagoya University; Yokohama City University	Saitoh, S (corresponding author), Nagoya City Univ, Grad Sch Med Sci, Dept Pediat & Neonatol, Nagoya, Aichi, Japan.	ss11@med.nagoya-cu.ac.jp		Tsuchida, Naomi/0000-0001-7203-884X; Nakamura, Yuji/0000-0002-6531-9018; Saitoh, Shinji/0000-0001-6911-3351	Initiative on Rare and Undiagnosed Diseases from the Japanese Agency for Medical Research and Development (AMED) [JP18ek0109301, JP18ek0109280]	Initiative on Rare and Undiagnosed Diseases from the Japanese Agency for Medical Research and Development (AMED)	This study was supported by the Initiative on Rare and Undiagnosed Diseases from the Japanese Agency for Medical Research and Development (AMED) under the grant numbers JP18ek0109301 (YT, SS) and JP18ek0109280 (NM). There was no additional external funding received for this study.; This study was supported by the Initiative on Rare and Undiagnosed Diseases from the Japanese Agency for Medical Research and Development (AMED) under the grant numbers JP18ek0109301 (YT, SS) and JP18ek0109280 (NM). There was no additional external funding received for this study.	Basel-Vanagaite L, 2013, AM J HUM GENET, V93, P524, DOI 10.1016/j.ajhg.2013.07.005; Chantranupong L, 2016, CELL, V165, P153, DOI 10.1016/j.cell.2016.02.035; Falcone M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082810; Frankel WN, 2009, GENES BRAIN BEHAV, V8, P568, DOI 10.1111/j.1601-183X.2009.00509.x; Gordo G, 2018, CLIN GENET, V93, P762, DOI 10.1111/cge.13135; Kariminejad A, 2019, EUR J MED GENET, V62, DOI 10.1016/j.ejmg.2018.10.008; Kato K, 2018, BRAIN DEV-JPN, V40, P678, DOI 10.1016/j.braindev.2018.04.008; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Nakamura Y, 2018, BRAIN DEV-JPN, V40, P134, DOI 10.1016/j.braindev.2017.08.003; Naseer MI, 2018, GENES GENOM, V40, P1149, DOI 10.1007/s13258-018-0673-5; Negishi Y, 2017, BMC MED GENET, V18, DOI 10.1186/s12881-016-0363-6; NEITZEL H, 1986, HUM GENET, V73, P320, DOI 10.1007/BF00279094; Peng M, 2017, NATURE, V543, P433, DOI 10.1038/nature21378; Peron A, 2018, AM J MED GENET C, V178, P281, DOI 10.1002/ajmg.c.31651; Pizzino A, 2018, AM J MED GENET A, V176, P1443, DOI 10.1002/ajmg.a.38717; Riviere JB, 2012, NAT GENET, V44, P934, DOI 10.1038/ng.2331; Sancak Y, 2010, CELL, V141, P290, DOI 10.1016/j.cell.2010.02.024; Saxton RA, 2017, CELL, V168, P960, DOI [10.1016/j.cell.2017.03.035, 10.1016/j.cell.2017.02.004]; Tsuchida N, 2018, CLIN GENET, V93, P266, DOI 10.1111/cge.13061; Vanderver A, 2016, ANN NEUROL, V79, P1031, DOI 10.1002/ana.24650; Venkatesan C, 2016, EPILEPTIC DISORD, V18, P195, DOI 10.1684/epd.2016.0828; Wolfson RL, 2017, NATURE, V543, P438, DOI 10.1038/nature21423; Wolfson RL, 2016, SCIENCE, V351, P43, DOI 10.1126/science.aab2674	23	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2019	14	8							e0221482	10.1371/journal.pone.0221482	http://dx.doi.org/10.1371/journal.pone.0221482			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5OC	31430354	Green Published, Green Submitted, gold			2022-12-26	WOS:000485026800060
J	Bianchi, F; Veggi, D; Santini, L; Buricchi, F; Bartolini, E; Lo Surdo, P; Martinelli, M; Finco, O; Masignani, V; Bottomley, MJ; Maione, D; Cozzi, R				Bianchi, Federica; Veggi, Daniele; Santini, Laura; Buricchi, Francesca; Bartolini, Erika; Lo Surdo, Paola; Martinelli, Manuele; Finco, Oretta; Masignani, Vega; Bottomley, Matthew J.; Maione, Domenico; Cozzi, Roberta			Cocrystal structure of meningococcal factor H binding protein variant 3 reveals a new crossprotective epitope recognized by human mAb 1E6	FASEB JOURNAL			English	Article						Neisseria meningitidis; fHbp; human antibodies; vaccine	COMPLEMENT FACTOR-H; NEISSERIA-MENINGITIDIS; MONOCLONAL-ANTIBODIES; BACTERICIDAL ACTIVITY; CONJUGATE VACCINE; OPEN-LABEL; HUMAN-IGG; IMMUNOGENICITY; DISEASE; ANTIGEN	The 4 component meningococcus B vaccine (4CMenB) vaccine is the first vaccine containing recombinant proteins licensed for the prevention of invasive meningococcal disease caused by meningococcal serogroup B strains. 4CMenB contains 3 main recombinant proteins, including the Neisseria meningitidis factor H binding protein (fHbp), a lipoprotein able to bind the human factor H. To date, over 1000 as sequences of fHbp have been identified, and they can be divided into variant groups 1, 2, and 3, which are usually not crossprotective. Nevertheless, previous characterizations of a small set (n = 10) of mAbs generated in humans after 4CMenB immunization revealed 2 human Fabs (huFabs) (1A12, 1G3) with some crossreactivity for variants 1, 2, and 3. This unexpected result prompted us to examine a much larger set of human mAbs (n = 110), with the aim of better understanding the extent and nature of crossreactive anti-fHbp antibodies. In this study, we report an analysis of the human antibody response to fHbp, by the characterization of 110 huFabs collected from 3 adult vaccinees during a 6-mo study. Although the 4CMenB vaccine contains fHbp variant 1,13 huFabs were also found to be crossreactive with variants 2 and 3. The crystal structure of the crossreactive huFab 1E6 in complex with fHbp variant 3 was determined, revealing a novel, highly conserved epitope distinct from the epitopes recognized by 1A12 or 1G3. Further, functional characterization shows that human mAb 1E6 is able to elicit rabbit, but not human, complement-mediated bactericidal activity against meningococci displaying fHbp from any of the 3 different variant groups. This functional and structural information about the human antibody response upon 4CMenB immunization contributes to further unraveling the immunogenic properties of fHbp. Knowledge gained about the epitope profile recognized by the human antibody repertoire could guide future vaccine design.	[Bianchi, Federica; Veggi, Daniele; Santini, Laura; Buricchi, Francesca; Bartolini, Erika; Martinelli, Manuele; Finco, Oretta; Masignani, Vega; Maione, Domenico; Cozzi, Roberta] GlaxoSmithKline, Siena, Italy; [Bianchi, Federica] Univ Florence, Florence, Italy; [Lo Surdo, Paola; Bottomley, Matthew J.] GlaxoSmithKline, Rockville, MD USA	GlaxoSmithKline; University of Florence; GlaxoSmithKline	Maione, D; Cozzi, R (corresponding author), GSK Vaccines, Via Fiorentina 1, I-53100 Siena, Italy.	domenico.x.maione@gsk.com; roberta.x.cozzi@gsk.com			Novartis Vaccines; Diagnostics Srl; GlaxoSmithKline	Novartis Vaccines; Diagnostics Srl; GlaxoSmithKline(GlaxoSmithKline)	N. meningitidis strains used in this work were kindly provided by the following people and institutions: MC58 by E. Richard Moxon (University of Oxford, Oxford, United Kingdom); M08-240104 and M01-0240320 by Ray Borrow (Health Protection Agency, Manchester, United Kingdom); M11295 by the Centers for Disease Control and Prevention (Atlanta, GA, USA). The authors thank Alexander H. Lucas and Donald C. Reason (Children's Hospital Oakland Research Institute, Oakland, CA, USA) for single-cell variable region of the IgG heavylight chain pairs amplification, cloning, and sequencing. The authors are grateful to Dr. Enrico Malito (GlaxoSmithKline) for useful discussions regarding structure refinement. The authors thank the clinical studies participants. This study was sponsored by Novartis Vaccines and Diagnostics Srl (the Novartis noninfluenza vaccines business was acquired by the GlaxoSmithKline group of companies in March 2015). F.B. participated in a postgraduate studentship program at GlaxoSmithKline. All authors were permanent employees of Novartis Vaccines at the time of the study, and are now permanent employees of the GlaxoSmithKline group of companies. All authors are listed as inventors on patents owned by the GlaxoSmithKline group of companies. Bexsero is a trademark owned by or licensed to the GlaxoSmithKline group of companies.	AlLazikani B, 1997, J MOL BIOL, V273, P927, DOI 10.1006/jmbi.1997.1354; Anderson AS, 2011, EXPERT REV VACCINES, V10, P617, DOI [10.1586/ERV.11.50, 10.1586/erv.11.50]; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Beernink PT, 2008, INFECT IMMUN, V76, P4232, DOI 10.1128/IAI.00367-08; Beernink PT, 2015, MBIO, V6, DOI 10.1128/mBio.00842-15; Biagini M, 2016, P NATL ACAD SCI USA, V113, P2714, DOI 10.1073/pnas.1521142113; Cantini F, 2009, J BIOL CHEM, V284, P9022, DOI 10.1074/jbc.C800214200; Cendron L, 2011, ACTA CRYSTALLOGR F, V67, P531, DOI 10.1107/S1744309111006154; Chang Qiuzhi, 2012, Clin Epidemiol, V4, P237, DOI 10.2147/CLEP.S28410; Cooper B, 2011, EXPERT REV VACCINES, V10, P21, DOI 10.1586/ERV.10.147; Costa I, 2014, MBIO, V5, DOI 10.1128/mBio.01625-14; Csermely P, 2010, TRENDS BIOCHEM SCI, V35, P539, DOI 10.1016/j.tibs.2010.04.009; Domina M, 2016, SCI REP-UK, V6, DOI 10.1038/srep31458; Faleri A, 2014, FASEB J, V28, P1644, DOI 10.1096/fj.13-239012; Findlow J, 2010, CLIN INFECT DIS, V51, P1127, DOI 10.1086/656741; FINNE J, 1987, J IMMUNOL, V138, P4402; Giuliani M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22057-7; Giuliani MM, 2005, INFECT IMMUN, V73, P1151, DOI 10.1128/IAI.73.2.1151-1160.2005; Giuntini S, 2015, INFECT IMMUN, V83, P1536, DOI 10.1128/IAI.02984-14; Giuntini S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034272; Giuntini S, 2012, INFECT IMMUN, V80, P187, DOI 10.1128/IAI.05956-11; Giuntini S, 2011, INFECT IMMUN, V79, P3751, DOI 10.1128/IAI.05182-11; Hall DA, 2007, MECH AGEING DEV, V128, P161, DOI 10.1016/j.mad.2006.11.021; Jodar Luis, 2000, Biologicals, V28, P193, DOI 10.1006/biol.2000.0253; Johnson S, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002981; Jolley KA, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-595; Keyserling H, 2005, ARCH PEDIAT ADOL MED, V159, P907, DOI 10.1001/archpedi.159.10.907; Koeberling O, 2011, VACCINE, V29, P4728, DOI 10.1016/j.vaccine.2011.04.095; Konar M, 2015, P NATL ACAD SCI USA, V112, P14823, DOI 10.1073/pnas.1507829112; Konar M, 2013, J INFECT DIS, V208, P627, DOI 10.1093/infdis/jit239; Lopez-Sagaseta J, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-02827-7; Lucidarme J, 2010, CLIN VACCINE IMMUNOL, V17, P919, DOI 10.1128/CVI.00027-10; MacRaild CA, 2016, STRUCTURE, V24, P148, DOI 10.1016/j.str.2015.10.028; Madico G, 2006, J IMMUNOL, V177, P501, DOI 10.4049/jimmunol.177.1.501; Malito E, 2016, BIOCHEM J, V473, P4699, DOI 10.1042/BCJ20160806; Malito E, 2014, P NATL ACAD SCI USA, V111, P17128, DOI 10.1073/pnas.1419686111; Malito E, 2013, P NATL ACAD SCI USA, V110, P3304, DOI 10.1073/pnas.1222845110; Marshall HS, 2013, VACCINE, V31, P1569, DOI 10.1016/j.vaccine.2013.01.021; Mascioni A, 2010, BBA-BIOMEMBRANES, V1798, P87, DOI 10.1016/j.bbamem.2009.09.021; Masignani V, 2003, VACCINE, V21, pS110, DOI 10.1016/S0264-410X(03)00209-3; Masignani V, 2003, J EXP MED, V197, P789, DOI 10.1084/jem.20021911; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McNeil LK, 2009, VACCINE, V27, P3417, DOI 10.1016/j.vaccine.2009.01.075; Parikh SR, 2016, LANCET, V388, P2775, DOI 10.1016/S0140-6736(16)31921-3; Pizza M, 2015, CURR OPIN MICROBIOL, V23, P68, DOI 10.1016/j.mib.2014.11.006; Poolman JT, 2015, EXPERT REV VACCINES, V14, P1277, DOI 10.1586/14760584.2015.1071670; Rosenstein N, 2001, INT J EPIDEMIOL, V30, P1447, DOI 10.1093/ije/30.6.1447; Rosenstein NE, 2001, METH MOLEC MED, V67, P333, DOI 10.1385/1-59259-149-3:333; Rouphael NG, 2012, METHODS MOL BIOL, V799, P1, DOI 10.1007/978-1-61779-346-2_1; Rubinstein ND, 2008, MOL IMMUNOL, V45, P3477, DOI 10.1016/j.molimm.2007.10.016; Sadarangani M, 2016, CLIN MICROBIOL INFEC, V22, pS103, DOI 10.1016/j.cmi.2016.03.006; Saphire EO, 2001, SCIENCE, V293, P1155, DOI 10.1126/science.1061692; Scarselli M, 2009, J MOL BIOL, V386, P97, DOI 10.1016/j.jmb.2008.12.005; Schneider MC, 2006, J IMMUNOL, V176, P7566, DOI 10.4049/jimmunol.176.12.7566; Schneider MC, 2009, NATURE, V458, P890, DOI 10.1038/nature07769; Seib KL, 2011, INFECT IMMUN, V79, P970, DOI 10.1128/IAI.00891-10; Stanfield RL, 2006, J MOL BIOL, V357, P1566, DOI 10.1016/j.jmb.2006.01.023; Stephens DS, 2007, LANCET, V369, P2196, DOI 10.1016/S0140-6736(07)61016-2; Vidarsson G, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00520; Vu DM, 2012, SCI REP-UK, V2, DOI 10.1038/srep00341; Zimmer SM, 2004, EXPERT OPIN PHARMACO, V5, P855, DOI 10.1517/14656566.5.4.855	61	3	3	1	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2019	33	11					12099	12111		10.1096/fj.201900374R	http://dx.doi.org/10.1096/fj.201900374R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC8ZX	31442074	Green Published, hybrid			2022-12-26	WOS:000507461600039
J	Li, ZL; Lv, LL; Wang, B; Tang, TT; Feng, Y; Cao, JY; Jiang, LQ; Sun, YB; Liu, H; Zhang, XL; Ma, KL; Tang, RN; Liu, BC				Li, Zuo-Lin; Lv, Lin-Li; Wang, Bin; Tang, Tao-Tao; Feng, Ye; Cao, Jing-Yuan; Jiang, Li-Qiong; Sun, Yan-Bei; Liu, Hong; Zhang, Xiao-Liang; Ma, Kun-Ling; Tang, Ri-Ning; Liu, Bi-Cheng			The profibrotic effects of MK-8617 on tubulointerstitial fibrosis mediated by the KLF5 regulating pathway	FASEB JOURNAL			English	Article						HIF-PHI; tubulointerstitial fibrosis; HIF-1; Kruppel-like factor 5; TGF-beta 1	HYDROXYLASE INHIBITOR GSK1278863; ROXADUSTAT FG-4592; KIDNEY INJURY; TGF-BETA; HYPOXIA; CELLS; ANEMIA; EXPRESSION; ERYTHROPOIETIN; HIF-1-ALPHA	The discovery of hypoxia-inducible factor (HIF)-prolyl hydroxylase inhibitor (PHI) has revolutionized the treatment strategy for renal anemia. However, the presence of multiple transcription targets of HIF raises safety concerns regarding HIF-PHI. Here, we explored the dose-dependent effect of MK-8617 (MK), a kind of HIF-PHI, on renal fibrosis. MK was administered by oral gavage to mice for 12 wk at doses of 1.5, 5, and 12.5 mg/kg. In vitro, the human proximal tubule epithelial cell line HK-2 was treated with increasing doses of MK administration. Transcriptome profiling was performed, and fibrogenesis was evaluated. The dose-dependent biphasic effects of MK on tubulointerstitial fibrosis (TIF) were observed in chronic kidney disease mice. Accordingly, high-dose MK treatment could significantly enhance TIF. Using RNA-sequencing, combined with in vivo and in vitro experiments, we found that Kriippel-like factor 5 (KLF5) expression level was significantly increased in the proximal tubular cells, which could be transcriptionally regulated by HIF-la with high-dose MK treatment but not low-dose MK. Furthermore, our study clarified that HIF-1 alpha-KLF5-TGF-beta 1 signaling activation is the potential mechanism of high-dose MK-induced TIF, as knockdown of KLF5 reduced TIF in vivo. Collectively, our study demonstrates that high-dose MK treatment initiates TIF by activating HIF-1 alpha-KLF5-TGF-beta 1 signaling. These findings provide novel insights into TIF induction by high-dose MK (HIF-PHI), suggesting that the safety dosage window needs to be emphasized in future clinical applications.	[Li, Zuo-Lin; Lv, Lin-Li; Wang, Bin; Tang, Tao-Tao; Feng, Ye; Cao, Jing-Yuan; Jiang, Li-Qiong; Sun, Yan-Bei; Liu, Hong; Zhang, Xiao-Liang; Ma, Kun-Ling; Tang, Ri-Ning; Liu, Bi-Cheng] Southeast Univ, Inst Nephrol, Zhong Da Hosp, Sch Med, 87 Dingjiaqiao Rd, Nanjing 210000, Peoples R China	Southeast University - China	Lv, LL; Liu, BC (corresponding author), Southeast Univ, Inst Nephrol, Zhong Da Hosp, Sch Med, 87 Dingjiaqiao Rd, Nanjing 210000, Peoples R China.	linlilv2000@hotmail.com; Liubc64@163.com		Liu, Bi-cheng/0000-0002-4584-1853; Li, Zuo-lin/0000-0002-6694-8406	National Natural Scientific Foundation of China [81720108007, 81470922, 31671194, 81470997, 81670696]; National Key Research and Development Program of China [2018YFC1314002]	National Natural Scientific Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Research and Development Program of China	The authors thank Fang-Yuan Qian (Southeast University School of Medicine) for the valuable comments and suggestions in histological analysis. The authors also thank Chen-Chen Zhang (Southeast University School of Medicine) for confocal image acquisition and valuable technical support. This study is supported by the National Natural Scientific Foundation of China (Grants 81720108007, 81470922, 31671194, 81470997, and 81670696) and National Key Research and Development Program of China (2018YFC1314002). The authors declare no conflicts of interest.	Baek JH, 2015, J CLIN INVEST, V125, P3198, DOI 10.1172/JCI81166; Baumann B, 2016, KIDNEY INT, V90, P797, DOI 10.1016/j.kint.2016.05.026; Besarab A, 2016, J AM SOC NEPHROL, V27, P1225, DOI 10.1681/ASN.2015030241; Brigandi RA, 2016, AM J KIDNEY DIS, V67, P861, DOI 10.1053/j.ajkd.2015.11.021; Chen N, 2017, NEPHROL DIAL TRANSPL, V32, P1373, DOI 10.1093/ndt/gfx011; Chen WC, 2015, AM J PATHOL, V185, P2468, DOI 10.1016/j.ajpath.2015.05.019; Debenham JS, 2016, J MED CHEM, V59, P11039, DOI 10.1021/acs.jmedchem.6b01242; Fujiu K, 2011, J CLIN INVEST, V121, P3425, DOI 10.1172/JCI57582; Ganz T, 2016, SEMIN NEPHROL, V36, P87, DOI 10.1016/j.semnephrol.2016.02.001; Gerl K, 2015, KIDNEY INT, V88, P1345, DOI 10.1038/ki.2015.274; Haase VH, 2017, EXP CELL RES, V356, P160, DOI 10.1016/j.yexcr.2017.05.004; Haase VH, 2013, BLOOD REV, V27, P41, DOI 10.1016/j.blre.2012.12.003; Hanna C, 2013, AM J PHYSIOL-RENAL, V305, pF1323, DOI 10.1152/ajprenal.00155.2013; Higashi AY, 2019, J AM SOC NEPHROL, V30, P80, DOI 10.1681/ASN.2018060644; Higgins DF, 2007, J CLIN INVEST, V117, P3810, DOI 10.1172/JCI30487; Holdstock L, 2016, J AM SOC NEPHROL, V27, P1234, DOI 10.1681/ASN.2014111139; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Kalucka J, 2015, J MOL MED, V93, P891, DOI 10.1007/s00109-015-1264-4; Kim DH, 2015, CELL STEM CELL, V16, P88, DOI 10.1016/j.stem.2014.11.005; Kimura K, 2008, AM J PHYSIOL-RENAL, V295, pF1023, DOI 10.1152/ajprenal.90209.2008; Kobayashi H, 2016, J CLIN INVEST, V126, P1926, DOI 10.1172/JCI83551; Koury MJ, 2015, NAT REV NEPHROL, V11, P394, DOI 10.1038/nrneph.2015.82; Li ZL, 2019, KIDNEY INT, V95, P388, DOI 10.1016/j.kint.2018.09.013; Liu BC, 2018, KIDNEY INT, V93, P568, DOI 10.1016/j.kint.2017.09.033; Liu D, 2015, J BIOL CHEM, V290, P18018, DOI 10.1074/jbc.M115.662064; Luo RN, 2015, HYPERTENSION, V66, P75, DOI 10.1161/HYPERTENSIONAHA.115.05578; Maxwell PH, 2016, NAT REV NEPHROL, V12, P157, DOI 10.1038/nrneph.2015.193; Meng XM, 2016, NAT REV NEPHROL, V12, P325, DOI 10.1038/nrneph.2016.48; Paliege A, 2010, KIDNEY INT, V77, P312, DOI 10.1038/ki.2009.460; Pergola PE, 2016, KIDNEY INT, V90, P1115, DOI 10.1016/j.kint.2016.07.019; Provenzano R, 2016, CLIN J AM SOC NEPHRO, V11, P982, DOI 10.2215/CJN.06890615; Schodel J, 2011, BLOOD, V117, pE207, DOI 10.1182/blood-2010-10-314427; Semenza GL, 2019, ANNU REV PHARMACOL, V59, P379, DOI 10.1146/annurev-pharmtox-010818-021637; Shindo T, 2002, NAT MED, V8, P856, DOI 10.1038/nm738; Souma T, 2013, J AM SOC NEPHROL, V24, P1599, DOI 10.1681/ASN.2013010030; Sugahara M, 2017, KIDNEY INT, V92, DOI 10.1016/j.kint.2017.02.035; Sun SR, 2009, KIDNEY INT, V75, P1278, DOI 10.1038/ki.2009.62; Szeto SG, 2016, J AM SOC NEPHROL, V27, P3117, DOI 10.1681/ASN.2015050499; Takeda N, 2010, J CLIN INVEST, V120, P254, DOI 10.1172/JCI40295; Grande MT, 2015, NAT MED, V21, P989, DOI 10.1038/nm.3901; Wang LY, 2015, INT J BIOCHEM CELL B, V58, P17, DOI 10.1016/j.biocel.2014.10.030; Yokoro M, 2017, J AM SOC NEPHROL, V28, P2671, DOI 10.1681/ASN.2016111184	42	15	17	3	22	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2019	33	11					12630	12643		10.1096/fj.201901087RR	http://dx.doi.org/10.1096/fj.201901087RR			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC8ZX	31451021	Green Published			2022-12-26	WOS:000507461600080
J	Dave, P; George, B; Raheja, H; Rani, P; Behera, P; Das, S				Dave, Pratik; George, Biju; Raheja, Harsha; Rani, Priya; Behera, Padmanava; Das, Saumitra			The mammalian host protein DAP5 facilitates the initial round of translation of Coxsackievirus B3 RNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						translation; RNA virus; eukaryotic translation initiation factor 4G (eIF4G); eukaryotic translation initiation; viral protease; Coxsackievirus B3; DAP5; internal initiation of translation; IRES mediated translation	RIBOSOME ENTRY SITE; CAP-BINDING-PROTEIN; MEDIATED TRANSLATION; SPLICING FACTOR; CLEAVAGE; IRES; REPLICATION; PROTEOLYSIS; MECHANISM; INFECTION	During enteroviral infections, the canonical translation factor eukaryotic translation initiation factor 4 ? I (eIF4GI) is cleaved by viral protease 2A. The resulting C-terminal fragment is recruited by the viral internal ribosome entry site (IRES) for efficient translation of the viral RNA. However, the 2A protease is not present in the viral capsid and is synthesized only after the initial round of translation. This presents the conundrum of how the initial round of translation occurs in the absence of the C-terminal eIF4GI fragment. Interestingly, the host protein DAP5 (also known as p97, eIF4GIII, and eIF4G2), an isoform of eIF4GI, closely resembles the eIF4GI C-terminal fragment produced after 2A protease?mediated cleavage. Using the Coxsackievirus B3 (CVB3) IRES as a model system, here we demonstrate that DAP5, but not the full-length eIF4GI, is required for CVB3 IRES activity for translation of input viral RNA. Additionally, we show that DAP5 is specifically required by type I IRES but not by type II or type III IRES, in which cleavage of eIF4GI has not been observed. We observed that both DAP5 and C-terminal eIF4GI interact with CVB3 IRES in the same region, but DAP5 exhibits a lower affinity for CVB3 IRES compared with the C-terminal eIF4GI fragment. It appears that DAP5 is required for the initial round of viral RNA translation by sustaining a basal level of CVB3 IRES activity. This activity leads to expression of 2A protease and consequent robust CVB3 IRES-mediated translation by the C-terminal eIF4GI fragment.	[Dave, Pratik; George, Biju; Raheja, Harsha; Rani, Priya; Behera, Padmanava; Das, Saumitra] Indian Inst Sci, Dept Microbiol & Cell Biol, Bangalore 560012, Karnataka, India; [Das, Saumitra] Indian Inst Sci, Ctr Infect Dis Res, Bangalore 560012, Karnataka, India; [Das, Saumitra] Natl Inst Biomed Genom, Kalyani 741251, W Bengal, India	Indian Institute of Science (IISC) - Bangalore; Indian Institute of Science (IISC) - Bangalore; Department of Biotechnology (DBT) India; National Institute of Biomedical Genomics (NIBMG)	Das, S (corresponding author), Indian Inst Sci, Dept Microbiol & Cell Biol, Bangalore 560012, Karnataka, India.; Das, S (corresponding author), Indian Inst Sci, Ctr Infect Dis Res, Bangalore 560012, Karnataka, India.; Das, S (corresponding author), Natl Inst Biomed Genom, Kalyani 741251, W Bengal, India.	sdas@iisc.ac.in		Behera, Padmanava/0000-0002-6360-4704	Fund for Improvement of Science and Technology Infrastructure level II infrastructure; University Grants Commission Centre of Advanced Studies; Department of Biotechnology, Ministry of Science and Technology, Government of India DBT-IISc (Department of Biotechnology -Indian Institute of Science) Partnership Program; Council of Scientific and Industrial Research; University Grants Commission, Government of India; MHRD (Ministry of Human Resource Development); J. C. Bose fellowship from the Department of Science and Technology, Government of India	Fund for Improvement of Science and Technology Infrastructure level II infrastructure; University Grants Commission Centre of Advanced Studies; Department of Biotechnology, Ministry of Science and Technology, Government of India DBT-IISc (Department of Biotechnology -Indian Institute of Science) Partnership Program; Council of Scientific and Industrial Research(Council of Scientific & Industrial Research (CSIR) - India); University Grants Commission, Government of India(University Grants Commission, India); MHRD (Ministry of Human Resource Development); J. C. Bose fellowship from the Department of Science and Technology, Government of India	This work was supported by the Fund for Improvement of Science and Technology Infrastructure level II infrastructure and the University Grants Commission Centre of Advanced Studies. This work was also supported by the Department of Biotechnology, Ministry of Science and Technology, Government of India DBT-IISc (Department of Biotechnology -Indian Institute of Science) Partnership Program. The authors declare that they have no conflicts of interest with the contents of this article.; Supported by a research fellowship from the Council of Scientific and Industrial Research.; Supported by a D. S. Kothari fellowship from the University Grants Commission, Government of India.; Supported by MHRD (Ministry of Human Resource Development).; Supported by a J. C. Bose fellowship from the Department of Science and Technology, Government of India. To whom correspondence should be addressed: Tel.: 91-80-2293-2886; E-mail: sdas@iisc.ac.in.	Avanzino BC, 2018, J BIOL CHEM, V293, P15471, DOI 10.1074/jbc.RA118.004913; Avanzino BC, 2017, P NATL ACAD SCI USA, V114, P9611, DOI 10.1073/pnas.1704390114; Blyn LB, 1997, J VIROL, V71, P6243, DOI 10.1128/JVI.71.8.6243-6246.1997; Chamond N, 2014, NUCLEIC ACIDS RES, V42, P10373, DOI 10.1093/nar/gku720; Ciofani G, 2010, BIOCHEM BIOPH RES CO, V394, P405, DOI 10.1016/j.bbrc.2010.03.035; Dave P, 2017, NUCLEIC ACIDS RES, V45, P9068, DOI 10.1093/nar/gkx519; de Breyne S, 2009, P NATL ACAD SCI USA, V106, P9197, DOI 10.1073/pnas.0900153106; ETCHISON D, 1982, J BIOL CHEM, V257, P4806; Fitzgerald KD, 2013, J VIROL, V87, P2390, DOI 10.1128/JVI.02396-12; Fitzgerald KD, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002127; Gradi A, 1998, P NATL ACAD SCI USA, V95, P11089, DOI 10.1073/pnas.95.19.11089; Hanson PJ, 2016, CELL DEATH DIFFER, V23, P828, DOI 10.1038/cdd.2015.145; Henis-Korenblit S, 2002, P NATL ACAD SCI USA, V99, P5400, DOI 10.1073/pnas.082102499; Henis-Korenblit S, 2000, MOL CELL BIOL, V20, P496, DOI 10.1128/MCB.20.2.496-506.2000; Huang PN, 2011, NUCLEIC ACIDS RES, V39, P9633, DOI 10.1093/nar/gkr682; Jackson RJ, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a011569; Jackson RJ, 2010, NAT REV MOL CELL BIO, V11, P113, DOI 10.1038/nrm2838; Kafasla P, 2010, EMBO J, V29, P3710, DOI 10.1038/emboj.2010.231; Kempf BJ, 2008, J VIROL, V82, P5835, DOI 10.1128/JVI.01513-07; Kolupaeva VG, 1998, J BIOL CHEM, V273, P18599, DOI 10.1074/jbc.273.29.18599; Kolupaeva VG, 2003, MOL CELL BIOL, V23, P687, DOI 10.1128/MCB.23.2.687-698.2003; KRAUSSLICH HG, 1987, J VIROL, V61, P2711; Lanke KHW, 2009, J VIROL, V83, P11940, DOI 10.1128/JVI.01244-09; Liberman N, 2015, NUCLEIC ACIDS RES, V43, P3764, DOI 10.1093/nar/gkv205; Marcotrigiano J, 2001, MOL CELL, V7, P193, DOI 10.1016/S1097-2765(01)00167-8; Nousch M, 2007, RNA, V13, P374, DOI 10.1261/rna.372307; Ray PS, 2002, NUCLEIC ACIDS RES, V30, P4500, DOI 10.1093/nar/gkf583; Song QQ, 2015, VIRUS RES, V208, P22, DOI 10.1016/j.virusres.2015.05.020; Sweeney TR, 2014, EMBO J, V33, P76, DOI 10.1002/embj.201386124; Verma B, 2010, J GEN VIROL, V91, P1245, DOI 10.1099/vir.0.018507-0; Virgili G, 2013, STRUCTURE, V21, P517, DOI 10.1016/j.str.2013.01.015; Weingarten-Gabbay S, 2014, ONCOGENE, V33, P611, DOI 10.1038/onc.2012.626; Wu S, 2014, VIROL J, V11, DOI 10.1186/s12985-014-0192-1; Yoffe Y, 2016, GENE DEV, V30, P1991, DOI 10.1101/gad.285239.116; YU SF, 1995, J VIROL, V69, P247, DOI 10.1128/JVI.69.1.247-252.1995	35	3	3	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 18	2019	294	42					15386	15394		10.1074/jbc.RA119.009000	http://dx.doi.org/10.1074/jbc.RA119.009000			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JQ9HM	31455634	Green Published, Green Accepted, hybrid			2022-12-26	WOS:000499248700016
J	Oddo, VM; Maehara, M; Lzwardy, D; Sugihantono, A; Ali, PB; Rah, JH				Oddo, Vanessa M.; Maehara, Masumi; Lzwardy, Doddy; Sugihantono, Anung; Ali, Pungkas B.; Rah, Jee Hyun			Risk factors for nutrition-related chronic disease among adults in Indonesia	PLOS ONE			English	Article							C-REACTIVE PROTEIN; SWEETENED BEVERAGE CONSUMPTION; CORONARY-HEART-DISEASE; HIGH BLOOD-PRESSURE; PHYSICAL-ACTIVITY; CARDIOVASCULAR-DISEASE; DIABETES-MELLITUS; LARGE POPULATION; CENTRAL OBESITY; HYPERTENSION	Objective To conduct a secondary data analysis detailing the associations between sociodemographic and behavioral factors and nutrition-related chronic disease. Methods These analyses utilized 2014 data from the Indonesian Family Life Survey, a home-based survey that collected socioeconomic, dietary intake, physical activity, and biological data among adults. We explored four outcomes in relation to sociodemographic and behavioral determinants: 1) hypertension, 2) elevated high-sensitivity c-reactive protein (hs-CRP), and 3) central obesity, as these are critical metabolic determinants in the progression to cardiovascular disease, and 4) type 2 diabetes. Hypertension was defined as systolic blood pressure >= 140 mm or diastolic blood pressure >= 90mm or current use of antihypertensive medication. Elevated hs-CRP was defined as hs-CRP > 3 mg/dL. Central obesity was defined as waist circumference >= 90 cm if male and waist circumference >= 80 cm if female, which are specific to South Asia. Type 2 diabetes was defined as glycated hemoglobin >= 6.5%. We employed separate gender-stratified multivariate logistic regression models to test the associations between sociodemographic and behavioral determinants and each nutrition-related chronic disease outcome. All analyses employed sampling weights, which account for the survey design. Results In 2014, about 30% of adults were hypertensive and one-fifth had elevated hs-CRP. Approximately 70% of women had central obesity and 11.6% of women and 8.9% of men had diabetes. Older-age was consistently associated with nutrition-related chronic disease and being overweight was associated with hypertension, elevated hs-CRP, and type 2 diabetes. Regularly consuming instant noodles (women) and soda (men) were associated with elevated hs-CRP and soda consumption was associated with central obesity among men. Conclusions Large segments of the adult population in Indonesia now have or are at risk for non-communicable disease. Our analyses provide preliminary empirical evidence that interventions that target healthful food intake (e.g. reduce the intake of ultra-processed foods) should be considered and that the reduction of overweight is critical for preventing chronic diseases in Indonesia.	[Oddo, Vanessa M.] Univ Washington, Sch Publ Hlth, Dept Hlth Serv, Seattle, WA 98195 USA; [Maehara, Masumi; Rah, Jee Hyun] United Nations Childrens Fund, Child Survival & Dev, Jakarta, Indonesia; [Lzwardy, Doddy] Minist Hlth, Natl Inst Hlth Res & Dev, Jakarta, Indonesia; [Sugihantono, Anung] Minist Hlth, Dis Prevent & Control, Jakarta, Indonesia; [Ali, Pungkas B.] Minist Natl Dev Planning, Publ Hlth & Nutr, Jakarta, Indonesia	University of Washington; University of Washington Seattle; Ministry of Health - Indonesia; National Institute of Health Research & Development - Indonesia; Ministry of Health - Indonesia	Oddo, VM (corresponding author), Univ Washington, Sch Publ Hlth, Dept Hlth Serv, Seattle, WA 98195 USA.	voddo@uw.edu		Oddo, Vanessa/0000-0002-8893-0637				Aburto NJ, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1326; Adriono G, 2011, ARCH OPHTHALMOL-CHIC, V129, P930, DOI 10.1001/archophthalmol.2011.147; Aekplakorn W, 2006, DIABETES CARE, V29, P1872, DOI 10.2337/dc05-2141; Afshin A, 2019, LANCET, V393, P1958, DOI 10.1016/S0140-6736(19)30041-8; Anna V, 2008, DIABETES CARE, V31, P2288, DOI 10.2337/dc08-1038; [Anonymous], 556 ADBI; [Anonymous], **DATA OBJECT**, DOI DOI 10.0.HTTPS://CRAN.R-PR0JECT.0RG/PACKAGE=TABLE0NE; Asia Pacific Cohort Studies Collaboration, 2006, CENTR OB RISK CARD D; Barba C, 2004, LANCET, V363, P157, DOI 10.1016/S0140-6736(03)15268-3; Batcagan-Abueg APM, 2013, ASIA PAC J CLIN NUTR, V22, P490, DOI 10.6133/apjcn.2013.22.4.04; Bennett Nadia R, 2014, Front Cardiovasc Med, V1, P12, DOI 10.3389/fcvm.2014.00012; Bloom E, 2015, RESISTING REFORM: RECLAIMING PUBLIC EDUCATION THROUGH GRASSROOTS ACTIVISM, P1; Center for Disease Control Research and Development; NIHRD Ministry of Health Republic of Indonesia World Health Organization., 2006, MON EV INT COMM BAS; Chobanian AV., 2003, HYPERTENSION, V42, P1206, DOI [10.1161/01.HYP.0000107251, DOI 10.1161/01.HYP.9.2_PT_2.II36, DOI 10.1161/01.HYP.0000107251.49515.C2]; Christiani Y, 2015, J HUM HYPERTENS, V29, P683, DOI 10.1038/jhh.2015.8; Cook NR, 2009, ARCH INTERN MED, V169, P32, DOI 10.1001/archinternmed.2008.523; Crimmins E, 2014, BIODEMOGR SOC BIOL, V60, P38, DOI 10.1080/19485565.2014.901885; Danesh J, 2000, BMJ-BRIT MED J, V321, P199, DOI 10.1136/bmj.321.7255.199; Danesh J, 2004, NEW ENGL J MED, V350, P1387, DOI 10.1056/NEJMoa032804; Mendonca RD, 2016, AM J CLIN NUTR, V104, P1433, DOI 10.3945/ajcn.116.135004; de Koning L, 2012, CIRCULATION, V125, P1735, DOI 10.1161/CIRCULATIONAHA.111.067017; de Souza RJ, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h3978; Dhaliwal SS, 2009, AM J CARDIOL, V103, P1403, DOI 10.1016/j.amjcard.2008.12.048; FIOLET T, 2018, BMJ-BRIT MED J, V360, DOI DOI 10.1136/BMJ.K322; Geldsetzer P, 2018, JAMA INTERN MED, V178, P363, DOI 10.1001/jamainternmed.2017.8094; Gillett Melissa J, 2009, Clin Biochem Rev, V30, P197; Hall KD, 2019, CELL METAB; Harbuwono DS, 2018, MED J INDONES, V27, P53, DOI 10.13181/mji.v27i2.1512; HELMRICH SP, 1991, NEW ENGL J MED, V325, P147, DOI 10.1056/NEJM199107183250302; Herningtyas EH, 2018, IFLS WAVE 5 DRIED BL; Hu LH, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170238; Hu PF, 2015, AM J HUM BIOL, V27, P579, DOI 10.1002/ajhb.22664; Huai PC, 2013, HYPERTENSION, V62, P1021, DOI 10.1161/HYPERTENSIONAHA.113.01965; Idris H, 2017, ACTA MED INDONES, V49, P291; International Diabetes Federation (IDF), 2006, IDF CONS WORLDW DEF; Jaacks LM, 2015, J NUTR, V145, P352, DOI 10.3945/jn.114.203562; Johnson RJ, 2007, AM J CLIN NUTR, V86, P899; Lepkowska, 2017, SECED; Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8; Li GW, 2008, LANCET, V371, P1783, DOI 10.1016/S0140-6736(08)60766-7; Ma JT, 2016, CIRCULATION, V133, P370, DOI 10.1161/CIRCULATIONAHA.115.018704; Malik VS, 2006, AM J CLIN NUTR, V84, P274; MANSON JE, 1992, JAMA-J AM MED ASSOC, V268, P63, DOI 10.1001/jama.268.1.63; Mayer-Davis EJ, 1998, JAMA-J AM MED ASSOC, V279, P669, DOI 10.1001/jama.279.9.669; Mazidi M, 2018, ANN MED, V50, P1, DOI 10.1080/07853890.2017.1325967; Mboi N, 2018, LANCET, V392, P581, DOI 10.1016/S0140-6736(18)30595-6; McDade TW, 2008, J NUTR, V138, P2442, DOI 10.3945/jn.108.092700; Mendez MA, 2005, AM J CLIN NUTR, V81, P714; Mendis S, 2005, B WORLD HEALTH ORGAN, V83, P820; Meneilly GS, 1999, DIABETES CARE, V22, P112, DOI 10.2337/diacare.22.1.112; Mihardja Laurentia, 2009, Acta Med Indones, V41, P169; Monteiro CA, 2013, OBES REV, V14, P21, DOI 10.1111/obr.12107; Monteiro CA, 2011, PUBLIC HEALTH NUTR, V14, P5, DOI 10.1017/S1368980010003241; Ng N, 2006, B WORLD HEALTH ORGAN, V84, P305, DOI 10.2471/BLT.05.023721; Oddo VM, 2017, INT J BEHAV NUTR PHY, V14, DOI 10.1186/s12966-017-0522-y; Organization WH, 2018, NONCOMMUNICABLE DIS; Pan XR, 1997, DIABETES CARE, V20, P1664, DOI 10.2337/diacare.20.11.1664; Peltzer K, 2018, INT J HYPERTENS, V2018, DOI 10.1155/2018/5610725; Pengpid S, 2017, PLOS ONE, V11, P1; Popkin BM, 1999, WORLD DEV, V27, P1905, DOI 10.1016/S0305-750X(99)00094-7; Pradhan AD, 2001, JAMA-J AM MED ASSOC, V286, P327, DOI 10.1001/jama.286.3.327; Pramono L.A., 2010, AGE, V46, P100; Pujilestari CU, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16010116; Rachmi CN, 2017, PUBLIC HEALTH, V147, P20, DOI 10.1016/j.puhe.2017.02.002; Rahman Abdul Rashid Abdul, 2015, Asia Pac Fam Med, V14, P2, DOI 10.1186/s12930-015-0018-3; Roberts WL, 2004, CIRCULATION, V110, pE572, DOI 10.1161/01.CIR.0000148986.52696.07; Sacks FM, 2001, NEW ENGL J MED, V344, P3, DOI 10.1056/NEJM200101043440101; Sahakyan KR, 2015, ANN INTERN MED, V163, P827, DOI 10.7326/M14-2525; Schroders J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179186; Schulze MB, 2005, AM J CLIN NUTR, V82, P675, DOI 10.1093/ajcn/82.3.675; Shrimpton R., 2013, DOUBLE BURDEN MALNUT; Soegondo Sidartawan, 2011, Acta Med Indones, V43, P99; Soewondo P, 2013, GLOBALIZATION HEALTH, V9, DOI 10.1186/1744-8603-9-63; Strauss J, 2016, THE FIFTH WAVE OF TH; The National Institute of Health Research and Development HI, 2014, NAT REP BAS HLTH RES; The World Bank Group, 2015, IND CURR EXP HLTH; The World Bank Group, 2018, IND SUPP PRIM HEALTH; Trieu K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130247; Venn BJ, 2010, DIABETIC MED, V27, P1205, DOI 10.1111/j.1464-5491.2010.03069.x; Visser M, 1999, JAMA-J AM MED ASSOC, V282, P2131, DOI 10.1001/jama.282.22.2131; Whelton PK, 2018, J AM COLL CARDIOL, V71, P2275, DOI 10.1016/j.jacc.2018.03.016; Widjaja FF, 2013, MED J INDONES, V22, P39, DOI 10.13181/mji.v22i1.519; Widjojo S, 2014, UNICEF HLTH SECTOR R; World Health Organisation, 2013, EXP M POP SOD RED ST; World Health Organization, 2017, PRIM HLTH CAR SYST P; World Health Organization, 2018, TOP 10 CAUS DEATH; Yang QH, 2014, JAMA INTERN MED, V174, P516, DOI 10.1001/jamainternmed.2013.13563; Yoon KH, 2006, LANCET, V368, P1681, DOI 10.1016/S0140-6736(06)69703-1; Zhou B, 2016, LANCET, V387, P1513, DOI 10.1016/S0140-6736(16)00618-8	89	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2019	14	8							e0221927	10.1371/journal.pone.0221927	http://dx.doi.org/10.1371/journal.pone.0221927			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW6BO	31469876	Green Submitted, gold, Green Published			2022-12-26	WOS:000485062200038
J	Brown, DM; Poucher, ZA; Myers, M; Graham, JD; Cairney, J				Brown, Denver M.; Poucher, Zoe A.; Myers, Matt; Graham, Jeffrey D.; Cairney, John			Sinister right-handedness provides Canadian-born Major League Baseball players with an offensive advantage: A further test of the hockey influence on batting hypothesis	PLOS ONE			English	Article							PERFORMANCE	Recent research has shown Major League Baseball (MLB) players that bat left-handed and throw right-handed, otherwise known as sinister right-handers, are more likely to have a career batting average (BA) of .299 or higher compared to players with other combinations of batting and throwing handedness. Moreover, possibly owing to early exposure to hockey, Canadian-born MLB players have an increased propensity to be sinister right-handers, however, it has yet to be determined whether this provides a relative offensive performance advantage compared to players born in other countries. Using the largest archival dataset of MLB statistics available, the present study examined the independent influence of batting (i.e., left, right, switch) and throwing (i.e., left, right) handedness combinations and country/region of origin (i.e., Canada, USA, Latin America, Asia, Other) on several indices of offensive performance including BA, slugging percentage (SLG), on-base plus slugging (OPS), on-base plus slugging plus (OPS+), home runs (HR), runs batted in (RBI), strikeouts (SO) and wins above replacement (WAR). Mediation models were also computed to examine whether birthplace influences offensive performance through handedness. Examination of all recorded MLB batters revealed that batting left, regardless of throwing handedness, confers an offensive performance advantage. Since the inception of the MLB, the relative proportion of Canadian-born sinister right-handers is at least two times greater than players from other regions, although being Canadian-born does not provide a direct offensive advantage. Rather, results showed evidence of a significant indirect effect in that being Canadian-born increases the odds of being a sinister right-hander and in turn leads to greater performance across each offensive performance statistic. Collectively, findings provide further support for the hockey influence on batting hypothesis and suggest this effect extends to offensive performance.	[Brown, Denver M.; Poucher, Zoe A.; Cairney, John] Univ Toronto, Fac Kinesiol & Phys Educ, Toronto, ON, Canada; [Myers, Matt] Univ Toronto, Inst Biomat & Biomed Engn, Toronto, ON, Canada; [Graham, Jeffrey D.; Cairney, John] McMaster Univ, Dept Family Med, Hamilton, ON, Canada	University of Toronto; University of Toronto; McMaster University	Brown, DM (corresponding author), Univ Toronto, Fac Kinesiol & Phys Educ, Toronto, ON, Canada.	denver.brown@utoronto.ca	Cairney, John/AAQ-9703-2020; Brown, Denver/AAG-2413-2020	Cairney, John/0000-0003-2856-3967; Brown, Denver/0000-0003-4078-8253; Poucher, Zoe/0000-0002-5278-0219; Graham, Jeffrey/0000-0002-6728-2597				BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Cairney J, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195252; Chu CYC, 2016, JING JI LUN WEN, V44, P171; Clotfelter ED, 2008, J COMP PSYCHOL, V122, P68, DOI 10.1037/0735-7036.122.1.68; Grondin S, 1999, J EXP PSYCHOL HUMAN, V25, P747, DOI 10.1037/0096-1523.25.3.747; Grondin S, 1994, STAPS, V35, P65; Guiard Yves, 1996, P175; Hagemann N, 2009, ATTEN PERCEPT PSYCHO, V71, P1641, DOI 10.3758/APP.71.7.1641; Iacobucci D, 2012, J CONSUM PSYCHOL, V22, P582, DOI 10.1016/j.jcps.2012.03.006; Loffing F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105800; Mann DL, 2017, NEW ENGL J MED, V377, P1688, DOI 10.1056/NEJMc1711659; MCLEAN JM, 1982, NEW ENGL J MED, V307, P1278; Parsons Talcott, 1951, GEN THEORY ACTION TH; Streiner DL, 2011, CHEST, V140, P16, DOI 10.1378/chest.11-0523; Walsh J., 2007, THE HARDBALL TIMES	15	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2019	14	8							e0221501	10.1371/journal.pone.0221501	http://dx.doi.org/10.1371/journal.pone.0221501			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW6AB	31465478	Green Published, Green Submitted, gold			2022-12-26	WOS:000485058200020
J	Kinnaird, E; Norton, C; Pimblett, C; Stewart, C; Tchanturia, K				Kinnaird, Emma; Norton, Caroline; Pimblett, Caroline; Stewart, Catherine; Tchanturia, Kate			Eating as an autistic adult: An exploratory qualitative study	PLOS ONE			English	Article							SPECTRUM DISORDER; FOOD SELECTIVITY; NUTRIENT INTAKE; CHILDREN; DISTURBANCES; DISABILITIES; IMPAIRMENT; BEHAVIORS; STUDENTS; OUTCOMES	Background Although eating difficulties are known to be common in children on the autism spectrum, there is a lack of research on whether these behaviours persist or change into adulthood. Emerging evidence suggests that autistic adults may experience higher levels of disordered eating than the general population, indicating the impact of autism on eating in this adult population warrants further exploration. Method This study interviewed 12 autistic adults about their eating habits, with a focus on the continuing or changing presence of behaviours often seen in autistic children such as sensory sensitivity or a preference for routines. Interviews were transcribed and analysed using thematic analysis. Results Overall, participants suggested that autism did continue to impact their eating into adulthood, particularly in the areas of sensory sensitivity, medical difficulties, executive functioning difficulties, and rigidity, but that they had learned to adapt so that these issues no longer represented a problem. However, a minority of participants did feel that their autism had a negative effect on their eating, particularly those diagnosed with eating disorders. Additionally, eating behaviours associated with autism were identified as potentially contributing to having an unhealthy body weight. Conclusions Certain traits associated with autism, such as cognitive rigidity and sensory sensitivity, could potentially continue to influence the eating behaviours of autistic adults. These traits are typically experienced as differences which can be adapted around and managed, rather than specific problems. However, these traits can potentially contribute to difficulties such as disordered eating and weight gain, and the implications of these should be explored by future research.	[Kinnaird, Emma; Tchanturia, Kate] Kings Coll London, Inst Psychiat Psychol & Neurosci, London, England; [Norton, Caroline; Pimblett, Caroline; Stewart, Catherine; Tchanturia, Kate] S London & Maudsley NHS Fdn Trust, London, England; [Tchanturia, Kate] Illia State Univ, Tbilisi, Georgia	University of London; King's College London; South London & Maudsley NHS Trust	Tchanturia, K (corresponding author), Kings Coll London, Inst Psychiat Psychol & Neurosci, London, England.; Tchanturia, K (corresponding author), S London & Maudsley NHS Fdn Trust, London, England.; Tchanturia, K (corresponding author), Illia State Univ, Tbilisi, Georgia.	Kate.tchanturia@kcl.ac.uk	Tchanturia, Kate/H-1474-2011	Tchanturia, Kate/0000-0001-8988-3265; Kinnaird, Emma/0000-0002-6821-8386	Medical Research Council Doctoral Training Partnership (MRC DTP) scheme [MR/N013700/1]; MRC; MRF Child and Young Adult Mental Health [MR/R004595/1]; the Health Foundation; MRC [MR/R004595/1, 1847521, MR/S020381/1] Funding Source: UKRI	Medical Research Council Doctoral Training Partnership (MRC DTP) scheme; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRF Child and Young Adult Mental Health; the Health Foundation; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	EK received PhD funding for this project through the Medical Research Council Doctoral Training Partnership (MRC DTP) scheme (MR/N013700/1). KT would like to acknowledge support from MRC and MRF Child and Young Adult Mental Health (MR/R004595/1) and support by the Health Foundation, an independent charity committed to bringing better health care for people in the UK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bandini LG, 2010, J PEDIATR-US, V157, P259, DOI 10.1016/j.jpeds.2010.02.013; Barnhill K, 2018, RES AUTISM SPECT DIS, V50, P51, DOI 10.1016/j.rasd.2018.03.002; Beighley JS, 2013, RES DEV DISABIL, V34, P3497, DOI 10.1016/j.ridd.2013.07.026; Ben-Sasson A, 2009, J AUTISM DEV DISORD, V39, P1, DOI 10.1007/s10803-008-0593-3; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Call NA, 2015, J AUTISM DEV DISORD, V45, P2105, DOI 10.1007/s10803-015-2375-z; Cermak SA, 2010, J AM DIET ASSOC, V110, P238, DOI 10.1016/j.jada.2009.10.032; Crane L, 2009, AUTISM, V13, P215, DOI 10.1177/1362361309103794; Croen LA, 2015, AUTISM, V19, P814, DOI 10.1177/1362361315577517; Curtin C, 2010, PREVALENCE OBESITY C; Dias EC, 2018, REV CUID, V9, P2059, DOI [10.15649/cuidarte.v9i1.485, 10.15649/cuidarie.v9i1.485]; Fodstad JC, 2008, J DEV PHYS DISABIL, V20, P541, DOI 10.1007/s10882-008-9116-6; Garfinkel SN, 2016, BIOL PSYCHOL, V114, P117, DOI 10.1016/j.biopsycho.2015.12.003; Graf-Myles J, 2013, J DEV BEHAV PEDIATR, V34, P449, DOI 10.1097/DBP.0b013e3182a00d17; Granich J, 2016, AUTISM, V20, P916, DOI 10.1177/1362361315616345; Green D, 2009, DEV MED CHILD NEUROL, V51, P311, DOI 10.1111/j.1469-8749.2008.03242.x; Healy S, 2018, INT J OBESITY; Hyman SL, 2012, PEDIATRICS, V130, pS145, DOI 10.1542/peds.2012-0900L; Karjalainen L, 2016, COMPR PSYCHIAT, V66, P79, DOI 10.1016/j.comppsych.2015.12.009; Karlsson L, 2013, RES DEV DISABIL, V34, P2224, DOI 10.1016/j.ridd.2013.03.035; Kenny L, 2016, AUTISM, V20, P442, DOI 10.1177/1362361315588200; Kinnaird E, 2019, INT REV PSYCHIATR, V31, P308, DOI 10.1080/09540261.2018.1531831; Klein U, 1999, Spec Care Dentist, V19, P200, DOI 10.1111/j.1754-4505.1999.tb01386.x; Kollndorfer K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167520; Kuschner ES, 2015, RES AUTISM SPECT DIS, V15-16, P53, DOI 10.1016/j.rasd.2015.04.005; Loomes R, 2017, J AM ACAD CHILD PSY, V56, P466, DOI 10.1016/j.jaac.2017.03.013; Magiati I, 2014, CLIN PSYCHOL REV, V34, P73, DOI 10.1016/j.cpr.2013.11.002; Mari-Bauset S, 2017, AUTISM, V21, P310, DOI 10.1177/1362361316636976; Marshall J, 2014, INT J SPEECH-LANG PA, V16, P151, DOI 10.3109/17549507.2013.808700; Matheson BE, 2017, REV J AUTISM DEV DIS, V4, P142, DOI 10.1007/s40489-017-0103-7; McElhanon BO, 2014, PEDIATRICS, V133, P872, DOI 10.1542/peds.2013-3995; Mechling LC, 2013, REM SPEC EDUC, V34, P371, DOI 10.1177/0741932513494856; Mechling LC, 2009, EXCEPTIONALITY, V17, P103, DOI 10.1080/09362830902805889; Organization WH, 2018, OBESITY OVERWEIGHT D; Pan CY, 2008, J AUTISM DEV DISORD, V38, P1292, DOI 10.1007/s10803-007-0518-6; Rastam M, 2008, CLIN NEUROPSYCHIATR, V5, P31; Schiffman Susan S, 2018, World J Otorhinolaryngol Head Neck Surg, V4, P84, DOI 10.1016/j.wjorl.2018.02.005; Schmitt L., 2008, Topics in Clinical Nutrition, V23, P23; Schreck KA, 2004, J AUTISM DEV DISORD, V34, P433, DOI 10.1023/B:JADD.0000037419.78531.86; Sharp WG, 2018, J ACAD NUTR DIET, V118, P1943, DOI 10.1016/j.jand.2018.05.005; Smith AA, 2005, NUTRITION, V21, P14, DOI 10.1016/j.nut.2004.09.004; Tavassoli T, 2012, J AUTISM DEV DISORD, V42, P1419, DOI 10.1007/s10803-011-1377-8; Tavassoli T, 2014, AUTISM, V18, P428, DOI 10.1177/1362361313477246; Tchanturia K, 2019, AUTISM, V23, P123, DOI 10.1177/1362361317722431; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; Vissoker RE, 2015, RES AUTISM SPECT DIS, V12, P10, DOI 10.1016/j.rasd.2014.12.010; Wallace GL, 2016, J AUTISM DEV DISORD, V46, P1071, DOI 10.1007/s10803-015-2655-7; Westwood H, 2017, CURR PSYCHIAT REP, V19, DOI 10.1007/s11920-017-0791-9; Williams P G, 2000, Pediatr Nurs, V26, P259	49	21	21	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2019	14	8							e0221937	10.1371/journal.pone.0221937	http://dx.doi.org/10.1371/journal.pone.0221937			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW6AB	31465510	Green Submitted, Green Published, gold			2022-12-26	WOS:000485058200072
J	Wargny, M; Smati, S; Pichelin, M; Bigot-Corbel, E; Authier, C; Dierry, V; Zair, Y; Jacquin, V; Hadjadj, S; Boursier, J; Cariou, B				Wargny, Matthieu; Smati, Sarra; Pichelin, Matthieu; Bigot-Corbel, Edith; Authier, Charlotte; Dierry, Violette; Zair, Yassine; Jacquin, Vincent; Hadjadj, Samy; Boursier, Jerome; Cariou, Bertrand			Fatty liver index is a strong predictor of changes in glycemic status in people with prediabetes: The IT-DIAB study	PLOS ONE			English	Article							GAMMA-GLUTAMYL-TRANSFERASE; INSULIN-RESISTANCE; DISEASE; RISK; AMINOTRANSFERASE; MELLITUS	Background & aims In patients at metabolic risk, nonalcoholic fatty liver disease is a strong and highly prevalent predictor for type 2 diabetes. Its assessment in clinical practice is not easy but the fatty liver index (FLI) could be used as a surrogate. Here, we studied the association between the FLI and the conversion to new-onset diabetes (NOD) or prediabetes reversion in patients with prediabetes. Methods The IT-DIAB observational study included 389 individuals with prediabetes, defined as fasting plasma glucose (FPG) between 110 and 125 mg/dL. NOD conversion was defined as a first FPG value >= 126 mg/dL and prediabetes reversion as a first FPG value < 110 mg/dL. The associations of both events with baseline FLI were studied separately using multivariate Cox models. Results After a median follow-up of 3.9 years (range 0.1-6.1), 138 individuals (35.5%) converted to NOD. FLI was associated with a higher risk of NOD conversion (unadjusted HR per SD = 1.54, 95%CI 1.27-1.86, p<0.0001), even after multiple adjustment on FPG, HbA(1c) and diabetes risk score (adjusted HR per SD 1.31, 95%CI 1.07-1.61, p = 0.008). FLI was also associated with prediabetes reversion: adjusted HR per SD = 0.85, 95%CI 0.75-0.96, p = 0.0077. Changes in FLI were significantly associated with changes in FPG during follow-up (p<0.0001). When compared to a full model including the diabetes risk score, FPG, HbA(1C) and FLI, only HbA(1C) added a significant prediction information (AUROC: 72.8% for full model vs 69.4% for the model without HbA(1C); p = 0.028), while the removal of FLI to the fullmodel did not alter its predictive value (AUROC 72.2%). The predictive value for NOD conversion was not significantly better for HOMA-IR compared to FLI (AUROC: 69.3 vs 63.7%, p = 0.067). Conclusions FLI is a simple, practical score to further stratify the risk of conversion to NOD or the possibility of prediabetes reversion in clinical practice, independently of classical glucose parameters.	[Wargny, Matthieu; Smati, Sarra; Pichelin, Matthieu; Dierry, Violette; Zair, Yassine; Jacquin, Vincent; Hadjadj, Samy; Cariou, Bertrand] CHU Nantes, CIC INSERM 1413, Dept Endocrinol, Inst Thorax, Nantes, France; [Wargny, Matthieu; Pichelin, Matthieu; Hadjadj, Samy; Cariou, Bertrand] UNIV NANTES, CHU Nantes, INSERM, Inst Thorax,CNRS, Nantes, France; [Wargny, Matthieu] CHU Nantes, Clin Donnees, Nantes, France; [Bigot-Corbel, Edith] CHU Nantes, Dept Biochem, Nantes, France; [Authier, Charlotte] Ctr Examens Caisse Primaire Assurance Malad Loire, St Nazaire, France; [Boursier, Jerome] Angers Univ Hosp, Hepatol Dept, Angers, France; [Boursier, Jerome] Angers Univ, UPRES 3859, SFR 4208, HIFIH Lab, Angers, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; CHU de Nantes; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; CHU de Nantes; Nantes Universite; CHU de Nantes; Nantes Universite; CHU de Nantes; Universite d'Angers; Centre Hospitalier Universitaire d'Angers; Universite d'Angers	Cariou, B (corresponding author), CHU Nantes, CIC INSERM 1413, Dept Endocrinol, Inst Thorax, Nantes, France.; Cariou, B (corresponding author), UNIV NANTES, CHU Nantes, INSERM, Inst Thorax,CNRS, Nantes, France.	bertand.cariou@univ-nantes.fr	PICHELIN, Matthieu/D-3562-2015; Wargny, Matthieu/Y-1071-2018; Smati, Sarra/ABH-3217-2020	PICHELIN, Matthieu/0000-0002-6822-6132; Wargny, Matthieu/0000-0001-6027-9486; Smati, Sarra/0000-0002-5749-983X; Cariou, Bertrand/0000-0002-1580-8040	ISI grant from OSEO-BPI (OSEO-Banque Publique pour l'Innovation)., France; CHU de Nantes, France	ISI grant from OSEO-BPI (OSEO-Banque Publique pour l'Innovation)., France; CHU de Nantes, France	IT-DIAB was funded by an ISI grant from OSEO-BPI (OSEO-Banque Publique pour l'Innovation)., France to Genfit (coordinator of IT-Diab consortium) and CHU de Nantes, France.	Alberti KGMM, 2005, LANCET, V366, P1059, DOI 10.1016/S0140-6736(05)67402-8; Amer Diabet Assoc, 2018, DIABETES CARE, V41, pS13, DOI 10.2337/dc18-S002; Anstee QM, 2013, NAT REV GASTRO HEPAT, V10, P330, DOI 10.1038/nrgastro.2013.41; Bae JC, 2011, DIABETES CARE, V34, P727, DOI 10.2337/dc10-1991; Balkau B, 2010, BMC GASTROENTEROL, V10, DOI 10.1186/1471-230X-10-56; Ballestri S, 2016, J GASTROEN HEPATOL, V31, P936, DOI 10.1111/jgh.13264; Bedogni G, 2006, BMC GASTROENTEROL, V6, DOI 10.1186/1471-230X-6-33; Cefalu WT, 2019, DIABETES CARE, V42, pS29, DOI 10.2337/dc19-S003; Donnelly KL, 2005, J CLIN INVEST, V115, P1343, DOI 10.1172/JCI200523621; Franch-Nadal J, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0198327; Fraser A, 2009, DIABETES CARE, V32, P741, DOI 10.2337/dc08-1870; Gastaldelli A, 2009, HEPATOLOGY, V49, P1537, DOI 10.1002/hep.22845; Goessling W, 2008, GASTROENTEROLOGY, V135, P1935, DOI 10.1053/j.gastro.2008.09.018; Jager S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124749; Kim CH, 2008, DIABETIC MED, V25, P476, DOI 10.1111/j.1464-5491.2008.02410.x; Koehler EM, 2013, CLIN GASTROENTEROL H, V11, P1201, DOI 10.1016/j.cgh.2012.12.031; Kotronen A, 2007, J CLIN ENDOCR METAB, V92, P3490, DOI 10.1210/jc.2007-0482; Lee DH, 2003, DIABETOLOGIA, V46, P359, DOI 10.1007/s00125-003-1036-5; Lindstrom J, 2003, DIABETES CARE, V26, P725, DOI 10.2337/diacare.26.3.725; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Nishi T, 2015, J DIABETES INVEST, V6, P309, DOI 10.1111/jdi.12290; Park SK, 2013, HEPATOLOGY, V57, P1378, DOI 10.1002/hep.26183; Sung KC, 2013, J CLIN ENDOCR METAB, V98, P3637, DOI 10.1210/jc.2013-1519; Tilg H, 2017, NAT REV GASTRO HEPAT, V14, P32, DOI 10.1038/nrgastro.2016.147; Yang BL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120443; Yki-Jarvinen H, 2014, LANCET DIABETES ENDO, V2, P901, DOI 10.1016/S2213-8587(14)70032-4; Younossi Z, 2018, NAT REV GASTRO HEPAT, V15, P11, DOI 10.1038/nrgastro.2017.109; Younossi ZM, 2016, HEPATOLOGY, V64, P73, DOI 10.1002/hep.28431	28	18	18	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2019	14	8							e0221524	10.1371/journal.pone.0221524	http://dx.doi.org/10.1371/journal.pone.0221524			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW6AB	31465427	Green Published, Green Submitted, gold			2022-12-26	WOS:000485058200023
J	Brecheisen, ZS; Cook, CW; Heine, PR; Ryang, J; Richter, DD				Brecheisen, Zachary S.; Cook, Charles W.; Heine, Paul R.; Ryang, Junmo; Richter, Daniel deB			Development and deployment of a field-portable soil O-2 and CO2 gas analyzer and sampler	PLOS ONE			English	Article							CARBON-DIOXIDE	Here we present novel method development and instruction in the construction and use of Field Portable Gas Analyzers study of belowground aerobic respiration dynamics of deep soil systems. Our Field-Portable Gas Analysis (FPGA) platform has been developed at the Calhoun Critical Zone Observatory (CCZO) for the measurement and monitoring of soil O-2 and CO2 in a variety of ecosystems around the world. The FPGA platform presented here is cost-effective, lightweight, compact, and reliable for monitoring dynamic soil gasses in-situ in the field. The FPGA platform integrates off-the-shelf components for non-dispersive infrared (NDIR) CO2 measurement and electro-chemical O-2 measurement via flow-through soil gas analyses. More than 2000 soil gas measurements have been made to date using these devices over 4 years of observations. Measurement accuracy of FPGAs is consistently high as validated via conventional bench-top gas chromatography. Further, time series representations of paired CO2 and O-2 measurement under hardwood forests at the CCZO demonstrate the ability to observe and track seasonal and climatic patterns belowground with this FPGA platform. Lastly, the ability to analyze the apparent respiratory quotient, the ratio of apparent CO2 accumulation divided by apparent O-2 consumption relative to the above-ground atmosphere, indicates a high degree of nuanced analyses are made possible with tools like FPGAs. In sum, the accuracy and reliability of the FPGA platform for soil gas monitoring allows for low-cost temporally extensive and spatially expansive field studies of deep soil respiration.	[Brecheisen, Zachary S.; Cook, Charles W.; Heine, Paul R.; Ryang, Junmo; Richter, Daniel deB] Duke Univ, Nicholas Sch Environm, Soils Lab, Durham, NC 27708 USA	Duke University	Brecheisen, ZS (corresponding author), Duke Univ, Nicholas Sch Environm, Soils Lab, Durham, NC 27708 USA.	zbrecheisen@gmail.com	Richter, D.D./AAN-4583-2021	Brecheisen, Zachary/0000-0002-3712-1725	National Science Foundation Geosciences Directorate Division of Earth Sciences Critical Zone Observatory program [EAR-1331846]; Duke University's National Science Foundation Integrative Graduate Education and Research Traineeship "Wireless Intelligent Sensor Network" program [DGE-1068871]; Forest History Society's Weyerhaeuser Fellowship program	National Science Foundation Geosciences Directorate Division of Earth Sciences Critical Zone Observatory program; Duke University's National Science Foundation Integrative Graduate Education and Research Traineeship "Wireless Intelligent Sensor Network" program; Forest History Society's Weyerhaeuser Fellowship program	This work was supported by the National Science Foundation Geosciences Directorate Division of Earth Sciences Critical Zone Observatory program (EAR-1331846) to ZSB, CWC, PRH, DDR; Duke University's National Science Foundation Integrative Graduate Education and Research Traineeship "Wireless Intelligent Sensor Network" program (DGE-1068871) to ZB and the Forest History Society's Weyerhaeuser Fellowship program to ZB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angert A, 2015, BIOGEOSCIENCES, V12, P2089, DOI 10.5194/bg-12-2089-2015; [Anonymous], 2021, LANG ENV STAT COMP; Billings S., 2018, ELEMENTA WASH C, V6, P1; Brantley S, 2014, RELATING WEATHERING; Brantley SL, 2016, EARTH SURF DYNAM, V4, P211, DOI 10.5194/esurf-4-211-2016; Brecheisen ZS, 2019, REMOTE SENS ENVIRON, V222, P78, DOI 10.1016/j.rse.2018.12.025; Cherkinsky A, 2018, RADIOCARBON, V60, P1357, DOI 10.1017/RDC.2018.99; Davidson E, 1995, TELLUS B, p47B; ESRI, 2016, ARCGIS DESKT VERS 10; Gorelick N, 2017, REMOTE SENS ENVIRON, V202, P18, DOI 10.1016/j.rse.2017.06.031; Hall SJ, 2013, ECOSYSTEMS, V16, P576, DOI 10.1007/s10021-012-9631-2; Hasenmueller EA, 2015, APPL GEOCHEM, V63, P58, DOI 10.1016/j.apgeochem.2015.07.005; Hijmans RJ., 2015, PACKAGE RASTER R PAC; Huete A, 2002, REMOTE SENS ENVIRON, V83, P195, DOI 10.1016/S0034-4257(02)00096-2; Jenkins ME, 2011, SOIL BIOL BIOCHEM, V43, P1266, DOI 10.1016/j.soilbio.2011.02.017; Johnson MS, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL034619; Kim H, 2017, EARTH PLANET SC LETT, V460, P29, DOI 10.1016/j.epsl.2016.12.003; Liptzin D, 2011, ECOSYSTEMS, V14, P171, DOI 10.1007/s10021-010-9402-x; Liu M, 2015, ATMOS ENVIRON, V114, P75, DOI 10.1016/j.atmosenv.2015.05.026; Masiello CA, 2008, J GEOPHYS RES-BIOGEO, V113, DOI 10.1029/2007JG000534; Mayorga E, 2005, NATURE, V436, P538, DOI 10.1038/nature03880; Nychka D., 2016, FIELDS TOOLS SPATIAL; Richter DD, 2015, NEW PHYTOL, V206, P900, DOI 10.1111/nph.13338; Schmutz M, 2016, J GEOPHYS RES-ATMOS, V121, P8649, DOI 10.1002/2016JD025063; Silver W, 1999, BIOGEOCHEMISTRY, P44; Wohlfahrt G, 2017, AGR FOREST METEOROL, V237, P135, DOI 10.1016/j.agrformet.2017.02.012	26	4	4	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2019	14	8							e0220176	10.1371/journal.pone.0220176	http://dx.doi.org/10.1371/journal.pone.0220176			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5XV	31461460	gold, Green Published, Green Submitted			2022-12-26	WOS:000485052300010
J	Choi, JH; Kim, HJ; Lee, JY; Yoo, D; Im, JH; Paek, SH; Jeon, B				Choi, Ji-Hyun; Kim, Han-Joon; Lee, Jee-Young; Yoo, Dallah; Im, Jin Hee; Paek, Sun Ha; Jeon, Beomseok			Long-term effects of bilateral subthalamic nucleus stimulation on sleep in patients with Parkinson's disease	PLOS ONE			English	Article							DEEP BRAIN-STIMULATION; DAYTIME SLEEPINESS; ARCHITECTURE; SYMPTOMS; SCALE	Objectives Deep brain stimulation (DBS) of the subthalamic nucleus (STN) has been reported to have a positive effect on sleep-wake disturbance in Parkinson's disease (PD). We aimed to investigate the long-term effects of STN DBS on sleep in patients with PD. Methods Sixty-one patients with PD who had undergone bilateral STN DBS were followed for 3 years with assessments including the Parkinson's disease sleep scale (PDSS), Epworth sleepiness scale (ESS), total sleep hours per day, Unified PD Rating Scale part I-III, Hoehn & Yahr stage, levodopa equivalent dose, quality of life measure, and depression scale measured preoperatively and at 6 months after postoperatively, and annually thereafter. Results Among the 61 patients at baseline, 46 patients completed the last follow-up assessment. The total PDSS score significantly improved after STN DBS from baseline up to 3 years after STN DBS (79.0 +/- 30, 100.0 +/- 23.3, 98.8 +/- 23.0, 97.1 +/- 29.6, and 93.3 +/- 28.0 at baseline, 6, 12, 24, and 36 months, respectively, p = 0.006 for the change over time). Among the eight PDSS domains, the domains for overall quality of a night's sleep, sleep onset and maintenance insomnia, and nocturnal motor symptoms showed significant improvement after STN DBS (p = 0.036, 0.029, and < 0.001, respectively, for the change over time). The total sleep hours per day were increased, but the total ESS score did not show significant change after STN DBS (p = 0.001 and 0.055, respectively, for the change over time). Changes in the total PDSS were associated with changes in the depression and motivation items in the Unified PD Rating Scale part I, depression scale, and quality of life measure, but those variables at baseline were not predictive of changes in the total PDSS after STN DBS. Conclusion In the largest systematic long-term follow-up study, the improvement in subjective sleep quality after bilateral STN DBS was sustained in PD patients. Improved nocturnal sleep and nocturnal motor symptoms were correlated with an improved mood and quality of life. However, STN DBS did not reduce excessive daytime sleepiness despite reductions in antiparkinsonian medications.	[Choi, Ji-Hyun; Kim, Han-Joon; Yoo, Dallah; Im, Jin Hee; Jeon, Beomseok] Seoul Natl Univ, Seoul Natl Univ Hosp, Coll Med, Dept Neurol, Seoul, South Korea; [Choi, Ji-Hyun; Kim, Han-Joon; Yoo, Dallah; Im, Jin Hee; Paek, Sun Ha; Jeon, Beomseok] Seoul Natl Univ, Seoul Natl Univ Hosp, Coll Med, Movement Disorder Ctr, Seoul, South Korea; [Choi, Ji-Hyun; Lee, Jee-Young; Yoo, Dallah; Im, Jin Hee] Seoul Natl Univ, Boramae Med Ctr, Coll Med, Dept Neurol,Seoul Metropolitan Govt, Seoul, South Korea; [Paek, Sun Ha] Seoul Natl Univ, Seoul Natl Univ Hosp, Coll Med, Dept Neurosurg, Seoul, South Korea	Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University Hospital	Jeon, B (corresponding author), Seoul Natl Univ, Seoul Natl Univ Hosp, Coll Med, Dept Neurol, Seoul, South Korea.; Paek, SH; Jeon, B (corresponding author), Seoul Natl Univ, Seoul Natl Univ Hosp, Coll Med, Movement Disorder Ctr, Seoul, South Korea.; Paek, SH (corresponding author), Seoul Natl Univ, Seoul Natl Univ Hosp, Coll Med, Dept Neurosurg, Seoul, South Korea.	paeksh@snu.ac.kr; brain@snu.ac.kr	Yoo, Dallah/ABB-6365-2021	Yoo, Dallah/0000-0002-9736-6118; Lee, Jee-Young/0000-0002-9120-2075	Korea Research-Based Pharmaceutical Industry Association; Korean Pharmaceutical Manufacturers Association; Seoul National University Hospital; Seoul National University College of Medicine; Sinyang Cultural Foundation; Peptron; Abbvie Korea	Korea Research-Based Pharmaceutical Industry Association; Korean Pharmaceutical Manufacturers Association; Seoul National University Hospital; Seoul National University College of Medicine; Sinyang Cultural Foundation; Peptron; Abbvie Korea(AbbVie)	This research was funded by a travel grant by the Korea Research-Based Pharmaceutical Industry Association, Korean Pharmaceutical Manufacturers Association, Seoul National University Hospital, to BJ, and a research grant by the Seoul National University College of Medicine, Seoul National University Hospital, Sinyang Cultural Foundation, Peptron, Abbvie Korea, to BJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baumann-Vogel H, 2017, SLEEP, V40, DOI 10.1093/sleep/zsx033; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Benarroch EE, 2008, NEUROLOGY, V71, P944, DOI 10.1212/01.wnl.0000326066.57313.13; Breen David P, 2015, Open Neurol J, V9, P70, DOI 10.2174/1874205X01509010070; Chahine LM, 2011, PARKINSONISM RELAT D, V17, P208, DOI 10.1016/j.parkreldis.2010.11.017; Chaudhuri KR, 2002, J NEUROL NEUROSUR PS, V73, P629, DOI 10.1136/jnnp.73.6.629; Chou KL, 2012, PARKINSONISM RELAT D, V18, P510, DOI 10.1016/j.parkreldis.2012.01.018; Cicolin A, 2004, SLEEP MED, V5, P207, DOI 10.1016/j.sleep.2003.10.010; Defer GL, 1999, MOVEMENT DISORD, V14, P572, DOI 10.1002/1531-8257(199907)14:4<572::AID-MDS1005>3.0.CO;2-C; Goetz CG, 2003, MOVEMENT DISORD, V18, P738, DOI 10.1002/mds.10473; Hjort N, 2004, MOVEMENT DISORD, V19, P196, DOI 10.1002/mds.10639; HOEHN MM, 1967, NEUROLOGY, V17, P427, DOI 10.1212/WNL.17.5.427; Iranzo A, 2002, J NEUROL NEUROSUR PS, V72, P661, DOI 10.1136/jnnp.72.5.661; Jiang LL, 2015, CHINESE MED J-PEKING, V128, P2433, DOI 10.4103/0366-6999.164925; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Khoo TK, 2013, NEUROLOGY, V80, P276, DOI 10.1212/WNL.0b013e31827deb74; Kim HJ, 2010, NEUROSURGERY, V67, P626, DOI 10.1227/01.NEU.0000374850.98949.D4; Lilleeng B, 2015, ACTA NEUROL SCAND, V132, P251, DOI 10.1111/ane.12391; Lyons KE, 2006, J NEUROSURG, V104, P502, DOI 10.3171/jns.2006.104.4.502; Merlino G, 2014, SLEEP MED, V15, P637, DOI 10.1016/j.sleep.2013.12.016; Monaca C, 2004, J NEUROL, V251, P214, DOI 10.1007/s00415-004-0305-7; Nishida N, 2011, MOVEMENT DISORD, V26, P2418, DOI 10.1002/mds.23862; Odekerken VJJ, 2013, LANCET NEUROL, V12, P37, DOI 10.1016/S1474-4422(12)70264-8; Peppe A, 2012, SLEEP, V35, P1637, DOI 10.5665/sleep.2234; Rye DB, 1997, SLEEP, V20, P757, DOI 10.1093/sleep/20.9.757; Schwab R.S., 1969, 3 S PARK DIS, P152; Simuni T, 2008, ANN NEUROL, V64, pS65, DOI 10.1002/ana.21472; Suzuki K, 2011, PARKINSONS DIS-US, V2011, DOI 10.4061/2011/219056; Tomlinson CL, 2010, MOVEMENT DISORD, V25, P2649, DOI 10.1002/mds.23429; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002	30	15	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2019	14	8							e0221219	10.1371/journal.pone.0221219	http://dx.doi.org/10.1371/journal.pone.0221219			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5WO	31454366	Green Submitted, Green Published, gold			2022-12-26	WOS:000485049000014
J	Uyei, J; Taddei, TH; Kaplan, DE; Chapko, M; Stevens, ER; Braithwaite, RS				Uyei, Jennifer; Taddei, Tamar H.; Kaplan, David E.; Chapko, Michael; Stevens, Elizabeth R.; Braithwaite, R. Scott			Setting ambitious targets for surveillance and treatment rates among patients with hepatitis C related cirrhosis impacts the cost-effectiveness of hepatocellular cancer surveillance and substantially increases life expectancy: A modeling study	PLOS ONE			English	Article							VIRUS-RELATED CIRRHOSIS; LONG-TERM OUTCOMES; LIVER-TRANSPLANTATION; NATURAL-HISTORY; RADIOFREQUENCY ABLATION; CARCINOMA SURVEILLANCE; COMPENSATED CIRRHOSIS; PROGNOSTIC INDICATORS; RESECTION; SURVIVAL	Background Hepatocelluar cancer (HCC) is the leading cause of death among people with hepatitis C virus (HCV)-related cirrhosis. Our aim was to determine the optimal surveillance frequency for patients with HCV-related compensated cirrhosis. Methods We developed a decision analytic Markov model and validated it against data from the Veterans Outcomes and Costs Associated with Liver Disease (VOCAL) study group and published epidemiologic studies. Four strategies of different surveillance intervals were compared: no surveillance and ultrasound surveillance every 12, 6, and 3 months. We estimated lifetime survival, life expectancy, quality adjusted life years (QALY), total costs associated with each strategy, and incremental cost effectiveness ratios. We applied a willingness to pay threshold of $100,000. Analysis was conducted for two scenarios: a scenario reflecting current HCV and HCC surveillance compliance rates and treatment use and an aspirational scenario. Results In the current scenario the preferred strategy was 3-month surveillance with an incremental cost-effectiveness ratio (ICER) of $7,159/QALY. In the aspirational scenario, 6-month surveillance was preferred with an ICER of $82,807/QALY because treating more people with HCV led to a lower incidence of HCC. Sensitivity analyses suggested that surveillance every 12 months would suffice in the particular circumstance when patients are very likely to return regularly for testing and when appropriate HCV and HCC treatment is readily available. Compared with the current scenario, the aspirational scenario resulted in a 1.87 year gain in life expectancy for the cohort because of large reductions in decompensated cirrhosis and HCC incidence. Conclusions HCC surveillance has good value for money for patients with HCV-related compensated cirrhosis. Investments to improve adherence to surveillance should be made when rates are suboptimal. Surveillance every 12 months will suffice when patients are very likely to return regularly for testing and when appropriate HCV and HCC treatment is readily available.	[Uyei, Jennifer; Stevens, Elizabeth R.; Braithwaite, R. Scott] NYU, Sch Med, Dept Populat Hlth, Div Comparat Effectiveness & Decis Sci, New York, NY 10003 USA; [Taddei, Tamar H.] VA Connecticut Healthcare Syst, West Haven, CT USA; [Kaplan, David E.] Corporal Michael J Crescenz VA Med Ctr, Philadelphia, PA USA; [Chapko, Michael] VA Puget Sound, Ctr Innovat Vet Ctr & Value Driven Care, Hlth Serv Res & Dev, Seattle, WA USA	New York University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Connecticut Healthcare System; US Department of Veterans Affairs; Veterans Health Administration (VHA); Vet Affairs Puget Sound Health Care System	Uyei, J (corresponding author), NYU, Sch Med, Dept Populat Hlth, Div Comparat Effectiveness & Decis Sci, New York, NY 10003 USA.	jennyuyei@gmail.com		Braithwaite, Ronald Scott/0000-0001-7067-3655	Veterans Administration HIV, Hepatitis and Related Conditions Program	Veterans Administration HIV, Hepatitis and Related Conditions Program	This study was funded by a grant from the Veterans Administration HIV, Hepatitis and Related Conditions Program received by RSB, and salary support from the VA for THT, DEK, and MC. Salary support and computing resources for JU and RSB were partially provided by the NYU School of Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AASLD, 2019, PRACTICE GUIDELINES; Abu-Hilal M, 2008, J GASTROINTEST SURG, V12, P1521, DOI 10.1007/s11605-008-0553-4; Arguedas MR, 2003, AM J GASTROENTEROL, V98, P679, DOI [10.1016/S0002-9270(02)06049-5, 10.1111/j.1572-0241.2003.07327.x]; Arias Elizabeth, 2014, Natl Vital Stat Rep, V63, P1; Asselah T, 2018, LIVER INT, V38, P7, DOI 10.1111/liv.13673; Backus LI, 2016, HEPATOLOGY, V64, p1000A; BARBARA L, 1992, HEPATOLOGY, V16, P132, DOI 10.1002/hep.1840160122; Beste LA, 2015, GASTROENTEROLOGY, V149, P1471, DOI 10.1053/j.gastro.2015.07.056; Beste LA, 2015, CLIN GASTROENTEROL H, V13, P172, DOI 10.1016/j.cgh.2014.04.033; Braithwaite RS, 2008, MED CARE, V46, P349, DOI 10.1097/MLR.0b013e31815c31a7; Bruix J, 2011, HEPATOLOGY, V53, P1020, DOI 10.1002/hep.24199; Buchanan-Hughes AM, 2019, QUAL LIFE RES, V28, P297, DOI 10.1007/s11136-018-1992-3; Bureau of Labor Statistics, 2017, CONS PRIC IND ONL; Carlson MDA, 2010, J CLIN ONCOL, V28, P4371, DOI 10.1200/JCO.2009.26.1818; Centers for Medicare and Medicaid Services, 2014, HOSP OUTP PROSP PAYM; Centers for Medicare and Medicaid Services, 2016, CHEST; Chhatwal J, 2017, CLIN GASTROENTEROL H, V15, P827, DOI 10.1016/j.cgh.2016.09.015; Coon JT, 2007, HEALTH TECHNOL ASSES, V11, P1; D'Amico G, 2006, J HEPATOL, V44, P217, DOI 10.1016/j.jhep.2005.10.013; DAMICO G, 1986, DIGEST DIS SCI, V31, P468, DOI 10.1007/BF01320309; Dan AA, 2008, LIVER TRANSPLANT, V14, P321, DOI 10.1002/lt.21376; Davila JA, 2013, HEPATOLOGY, V57, P1858, DOI 10.1002/hep.26287; Degos F, 2000, GUT, V47, P131, DOI 10.1136/gut.47.1.131; Delis SG, 2008, WORLD J GASTROENTERO, V14, P3452, DOI 10.3748/wjg.14.3452; Department of Veterans Affairs, 2009, MAN HEP CARC HCC; EBARA M, 1986, GASTROENTEROLOGY, V90, P289, DOI 10.1016/0016-5085(86)90923-6; El-Serag HB, 2011, NEW ENGL J MED, V365, P1118, DOI 10.1056/NEJMra1001683; Fattovich G, 2004, GASTROENTEROLOGY, V127, pS35, DOI 10.1053/j.gastro.2004.09.014; Fattovich G, 2002, AM J GASTROENTEROL, V97, P2886, DOI 10.1111/j.1572-0241.2002.07057.x; Fattovich G, 1997, GASTROENTEROLOGY, V112, P463, DOI 10.1053/gast.1997.v112.pm9024300; Forner A, 2010, SEMIN LIVER DIS, V30, P61, DOI 10.1055/s-0030-1247133; GINES P, 1987, HEPATOLOGY, V7, P122, DOI 10.1002/hep.1840070124; Goldberg DS, 2017, HEPATOLOGY, V65, P864, DOI 10.1002/hep.28765; Hemming AW, 2001, ANN SURG, V233, P652, DOI 10.1097/00000658-200105000-00009; Hsu PC, 2012, J GASTROEN HEPATOL, V27, P149, DOI 10.1111/j.1440-1746.2011.06813.x; Hu KQ, 1999, HEPATOLOGY, V29, P1311, DOI 10.1002/hep.510290424; Hui JM, 2003, HEPATOLOGY, V38, P420, DOI 10.1053/jhep.2003.50320; Jain A, 2000, ANN SURG, V232, P490, DOI 10.1097/00000658-200010000-00004; Khandelwal N, 2014, CHEST, V146, P1594, DOI 10.1378/chest.14-0182; Kim WR, 2012, OPTN SRTR 2012 ANN D; Lawitz E, 2013, NEW ENGL J MED, V368, P1878, DOI 10.1056/NEJMoa1214853; Li L, 2014, WORLD J GASTROENTERO, V20, P17235, DOI 10.3748/wjg.v20.i45.17235; Lin OS, 2004, ALIMENT PHARM THER, V19, P1159, DOI 10.1111/j.1365-2036.2004.01963.x; Livraghi T, 2003, RADIOLOGY, V226, P441, DOI 10.1148/radiol.2262012198; Llovet JM, 2002, LANCET, V359, P1734, DOI 10.1016/S0140-6736(02)08649-X; Llovet JM, 1999, HEPATOLOGY, V30, P1434, DOI 10.1002/hep.510300629; Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857; Lupo L, 2007, HPB (Oxford), V9, P429, DOI 10.1080/13651820701713758; Montorsi M, 2005, J GASTROINTEST SURG, V9, P62, DOI 10.1016/j.gassur.2004.10.003; Morgan RL, 2013, ANN INTERN MED, V158, P329, DOI 10.7326/0003-4819-158-5-201303050-00005; Nathan H, 2012, CANCER-AM CANCER SOC, V118, P1838, DOI 10.1002/cncr.26501; Partitt JR, 2007, LIVER TRANSPLANT, V13, P543, DOI 10.1002/lt.21078; Patel D, 2005, CLIN GASTROENTEROL H, V3, P75, DOI 10.1016/S1542-3565(04)00443-4; Pelletier SJ, 2009, LIVER TRANSPLANT, V15, P859, DOI 10.1002/lt.21778; Roayaie S, 2009, GASTROENTEROLOGY, V137, P850, DOI 10.1053/j.gastro.2009.06.003; Schlitt HJ, 1999, J CLIN ONCOL, V17, P324, DOI 10.1200/JCO.1999.17.1.324; Serfaty L, 1998, HEPATOLOGY, V27, P1435, DOI 10.1002/hep.510270535; Shimoda M, 2004, LIVER TRANSPLANT, V10, P1478, DOI 10.1002/lt.20303; Signal A, 2012, CANCER EPIDEM BIOMAR, V21, DOI [10.1186/1471-230X-10-78, DOI 10.1186/1471-230X-10-78]; Singal A, 2009, ALIMENT PHARM THER, V30, P37, DOI 10.1111/j.1365-2036.2009.04014.x; Singal AG, 2013, AM J GASTROENTEROL, V108, P425, DOI 10.1038/ajg.2012.449; Singal AG, 2012, J GEN INTERN MED, V27, P861, DOI 10.1007/s11606-011-1952-x; Tohme S, 2013, HPB, V15, P210, DOI 10.1111/j.1477-2574.2012.00541.x; TreeAge Pro Inc, 2017, TREEAGE SOFTW; Trinchet JC, 2011, HEPATOLOGY, V54, P1987, DOI 10.1002/hep.24545; Tsai JF, 1997, BRIT J CANCER, V76, P968, DOI 10.1038/bjc.1997.493; Vermehren J, 2018, J HEPATOL, DOI [10.1016/j, DOI 10.1016/J]; Wells CD, 2004, DIGEST DIS SCI, V49, P453, DOI 10.1023/B:DDAS.0000020502.46886.c1; Yao FY, 2001, HEPATOLOGY, V33, P1394, DOI 10.1053/jhep.2001.24563; Zhou YM, 2010, BMC GASTROENTEROL, V10, DOI 10.1186/1471-230X-10-78	70	3	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2019	14	8							e0221614	10.1371/journal.pone.0221614	http://dx.doi.org/10.1371/journal.pone.0221614			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5UR	31449554	gold, Green Submitted, Green Published			2022-12-26	WOS:000485044000027
J	Gustafson, JA; Park, SS; Cunningham, ML				Gustafson, Jonas A.; Park, Sarah S.; Cunningham, Michael L.			Calvarial osteoblast gene expression in patients with craniosynostosis leads to novel polygenic mouse model	PLOS ONE			English	Article							PROMOTES OSTEOGENIC DIFFERENTIATION; SINGLE-SUTURE CRANIOSYNOSTOSIS; CORONAL SYNOSTOSIS; RARE VARIANTS; TWIST; GROWTH; PATHWAY; RUNX2; IDENTIFICATION; MUTATIONS	Craniosynostosis is the premature fusion of the sutures of the calvaria and is principally designated as being either syndromic (demonstrating characteristic extracranial malformations) or non-syndromic. While many forms of syndromic craniosynostosis are known to be caused by specific mutations, the genetic etiology of non-syndromic, single-suture craniosynostosis (SSC) is poorly understood. Based on the low recurrence rate (4-7%) and the fact that recurrent mutations have not been identified for most cases of SSC, we propose that some cases of isolated, single suture craniosynostosis may be polygenic. Previous work in our lab identified a disproportionately high number of rare and novel gain-of-function IGF1R variants in patients with SSC as compared to controls. Building upon this result, we used expression array data from calvarial osteoblasts isolated from infants with and without SSC to ascertain correlations between high IGF1 expression and expression of other osteogenic genes of interest. We identified a positive correlation between increased expression of IGF1 and RUNX2, a gene known to cause SSC with increased gene dosage. Subsequent phosphorylation assays revealed that osteoblast cell lines from cases with high IGF1 expression demonstrated inhibition of GSK3 beta, a serine/threonine kinase known to inhibit RUNX2, thus activating osteogenesis through the IRS1-mediated Akt pathway. With these findings, we have utilized established mouse strains to examine a novel model of polygenic inheritance (a phenotype influenced by more than one gene) of SSC. Compound heterozygous mice with selective disinhibition of RUNX2 and either overexpression of IGF1 or loss of function of GSK3 beta demonstrated an increase in the frequency and severity of synostosis as compared to mice with the RUNX2 disinhibition alone. These polygenic mouse models reinforce, in-vivo, that the combination of activation of the IGF1 pathway and disinhibition of the RUNX2 pathway leads to an increased risk of developing craniosynostosis and serves as a model of human SSC.	[Gustafson, Jonas A.; Park, Sarah S.; Cunningham, Michael L.] Seattle Childrens Res Inst, Ctr Dev Biol & Regenerat Med, Seattle, WA 98101 USA; [Cunningham, Michael L.] Seattle Childrens Hosp, Craniofacial Ctr, Seattle, WA 98105 USA; [Cunningham, Michael L.] Univ Washington, Dept Pediat, Seattle, WA 98195 USA	Seattle Children's Hospital; Seattle Children's Hospital; University of Washington; University of Washington Seattle	Cunningham, ML (corresponding author), Seattle Childrens Res Inst, Ctr Dev Biol & Regenerat Med, Seattle, WA 98101 USA.; Cunningham, ML (corresponding author), Seattle Childrens Hosp, Craniofacial Ctr, Seattle, WA 98105 USA.; Cunningham, ML (corresponding author), Univ Washington, Dept Pediat, Seattle, WA 98195 USA.	michael.cunningham@seattlechildrens.org			NIH/NIDCR [R01DE018227]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE018227] Funding Source: NIH RePORTER	NIH/NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by a grant to MLC, R01DE018227, NIH/NIDCR, https://www.nidcr.nih.gov. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Rekabi Z, 2016, J CELL SCI, V129, P483, DOI 10.1242/jcs.175976; Baker N, 2015, STEM CELL RES THER, V6, DOI 10.1186/s13287-015-0225-8; Barrett T, 2013, NUCLEIC ACIDS RES, V41, pD991, DOI 10.1093/nar/gks1193; Bialek P, 2004, DEV CELL, V6, P423, DOI 10.1016/S1534-5807(04)00058-9; Browning VL, 2001, GENOMICS, V73, P291, DOI 10.1006/geno.2001.6523; Bult CJ, 2018, NUCL ACIDS RES; Chen L, 2016, BMB REP, V49, P122, DOI 10.5483/BMBRep.2016.49.2.228; Clarke CM, 2018, AM J MED GENET A, V176, P290, DOI 10.1002/ajmg.a.38540; Cunningham ML, 2011, AM J MED GENET A, V155A, P91, DOI 10.1002/ajmg.a.33781; Desbois-Mouthon C, 2001, ONCOGENE, V20, P252, DOI 10.1038/sj.onc.1204064; di Rocco F, 2014, EUR J HUM GENET, V22, P1413, DOI 10.1038/ejhg.2014.57; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; ElGhouzzi V, 1997, NAT GENET, V15, P42; Gao XJ, 2013, CELL BIOL INT, V37, P768, DOI 10.1002/cbin.10095; Gaur T, 2005, J BIOL CHEM, V280, P33132, DOI 10.1074/jbc.M500608200; Georgy SR, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/djv152; Greenwood J, 2014, GENET MED, V16, P302, DOI 10.1038/gim.2013.134; Gripp KW, 1998, J PEDIATR-US, V132, P714, DOI 10.1016/S0022-3476(98)70366-X; Guo Y, 2017, DEV GROWTH DIFFER, V59, P94, DOI 10.1111/dgd.12342; Howard TD, 1997, NAT GENET, V15, P36, DOI 10.1038/ng0197-36; Kita K, 2008, GENES CELLS, V13, P839, DOI 10.1111/j.1365-2443.2008.01209.x; Komaki M, 2007, J CELL BIOCHEM, V100, P303, DOI 10.1002/jcb.21038; Komori T, 2003, J BONE MINER METAB, V21, P193, DOI 10.1007/s00774-002-0408-0; Komori T, 2018, HISTOCHEM CELL BIOL, V149, P313, DOI 10.1007/s00418-018-1640-6; Kronenberg HM, 2004, DEV CELL, V6, P317, DOI 10.1016/S1534-5807(04)00069-3; Kugimiya F, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000837; Lajeunie E, 1996, AM J MED GENET, V62, P282, DOI 10.1002/(SICI)1096-8628(19960329)62:3<282::AID-AJMG15>3.0.CO;2-G; Lee E, 2018, GENET MED, V20, P1061, DOI 10.1038/gim.2017.214; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; McGonnell Imelda M, 2012, Front Endocrinol (Lausanne), V3, P88, DOI 10.3389/fendo.2012.00088; Mefford HC, 2010, AM J MED GENET A, V152A, P2203, DOI 10.1002/ajmg.a.33557; Mulliken JB, 2004, PLAST RECONSTR SURG, V113, P1899, DOI 10.1097/01.PRS.0000122202.26792.bf; Park SS, 2015, BONE, V76, P169, DOI 10.1016/j.bone.2015.03.001; Seto ML, 2007, AM J MED GENET A, V143A, P678, DOI 10.1002/ajmg.a.31630; Stamper BD, 2012, PHYSIOL GENOMICS, V44, P1154, DOI 10.1152/physiolgenomics.00085.2012; Stamper BD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026557; Varvagiannis K, 2013, AM J MED GENET A, V161A, P343, DOI 10.1002/ajmg.a.35727; Wang L, 2010, J BONE MINER RES, V25, P1138, DOI 10.1002/jbmr.5; Wang T, 2015, J BONE MINER RES, V30, P1572, DOI 10.1002/jbmr.2510; Wu YJ, 2009, ENDOCRINOLOGY, V150, P4395, DOI 10.1210/en.2009-0272; Xi JC, 2015, J RECEPT SIG TRANSD, V35, P640, DOI 10.3109/10799893.2015.1041647; Xian LL, 2012, NAT MED, V18, P1095, DOI 10.1038/nm.2793; Xue P, 2013, BIOCHEM BIOPH RES CO, V433, P226, DOI 10.1016/j.bbrc.2013.02.088; Yakar S, 2002, J CLIN INVEST, V110, P771, DOI 10.1172/JCI200215463; Zimmerman H, 2019, FRONT GENET, V10, DOI 10.3389/fgene.2019.00291	45	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2019	14	8							e0221402	10.1371/journal.pone.0221402	http://dx.doi.org/10.1371/journal.pone.0221402			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5TR	31442251	gold, Green Submitted, Green Published			2022-12-26	WOS:000485041400031
J	Sicard, A; Merfa, MV; Voeltz, M; Zeilinger, AR; De La Fuente, L; Almeida, RPP				Sicard, Anne; Merfa, Marcus V.; Voeltz, Michael; Zeilinger, Adam R.; De La Fuente, Leonardo; Almeida, Rodrigo P. P.			Discriminating between viable and membrane-damaged cells of the plant pathogen Xylella fastidiosa	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; REAL-TIME PCR; PROPIDIUM MONOAZIDE; PIERCES-DISEASE; LISTERIA-MONOCYTOGENES; QUANTITATIVE PCR; VIABILITY; GRAPEVINE; MOVEMENT; MULTIPLICATION	Xylella fastidiosa is a plant pathogenic bacterium with devastating consequences to several crops of economic importance across the world. While this pathogen has been studied for over a century in the United States, several aspects of its biology remain to be investigated. Determining the physiological state of bacteria is essential to understand the effects of its interactions with different biotic and abiotic factors on cell viability. Although X. fastidiosa is culturable, its slow growing nature makes this technique cumbersome to assess the physiological state of cells present in a given environment. PMA-qPCR, i.e. the use of quantitative PCR combined with the pre-treatment of cells with the dye propidium monoazide, has been successfully used in a number of studies on human pathogens to calculate the proportion of viable cells, but has less frequently been tested on plant pathogens. We found that the use of a version of PMA, PMAxx, facilitated distinguishing between viable and non-viable cells based on cell membrane integrity in vitro and in planta. Additional experiments comparing the number of culturable, viable, and total cells in planta would help further confirm our initial results. Enhancers, intended to improve the efficacy of PMAxx, were not effective and appeared to be slightly toxic to X. fastidiosa.	[Sicard, Anne; Voeltz, Michael; Zeilinger, Adam R.; Almeida, Rodrigo P. P.] Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA; [Merfa, Marcus V.; De La Fuente, Leonardo] Auburn Univ, Dept Entomol & Plant Pathol, Auburn, AL 36849 USA	University of California System; University of California Berkeley; Auburn University System; Auburn University	Almeida, RPP (corresponding author), Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA.	rodrigoalmeida@berkeley.edu	Almeida, Rodrigo/GZH-0682-2022	Sicard, Anne/0000-0002-0575-195X; Voeltz, Michael/0000-0002-1839-3813	California Department of Food and Agriculture Pierce's Disease Research Program; HATCH AAES (Alabama Agricultural Experiment Station) program; European Union [707013]	California Department of Food and Agriculture Pierce's Disease Research Program; HATCH AAES (Alabama Agricultural Experiment Station) program; European Union(European Commission)	This work was funded by the California Department of Food and Agriculture Pierce's Disease Research Program; and partially from the HATCH AAES (Alabama Agricultural Experiment Station) program provided to LD. AS is currently supported by a Marie Sklodowska-Curie Fellowship (European Union's Horizon 2020 Research and Innovation Program, grant agreement 707013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida RPP, 2015, PLANT DIS, V99, P1457, DOI 10.1094/PDIS-02-15-0159-FE; Almeida RPP, 2001, PLANT DIS, V85, P382, DOI 10.1094/PDIS.2001.85.4.382; Baccari C, 2011, PHYTOPATHOLOGY, V101, P77, DOI 10.1094/PHYTO-04-10-0104; Barbau-Piednoir E, 2014, J MICROBIOL METH, V103, P131, DOI 10.1016/j.mimet.2014.06.003; Bengoechea JA, 1998, MICROBIOL-UK, V144, P1517, DOI 10.1099/00221287-144-6-1517; Chatterjee S, 2008, ANNU REV PHYTOPATHOL, V46, P243, DOI 10.1146/annurev.phyto.45.062806.094342; Cornara D, 2017, J APPL ENTOMOL, V141, P80, DOI 10.1111/jen.12365; Cornara D, 2016, PHYTOPATHOLOGY, V106, P1285, DOI 10.1094/PHYTO-05-16-0202-R; Danilevich VN, 2006, RUSS J BIOORG CHEM+, V32, P521, DOI 10.1134/S1068162006060045; DAVIS MJ, 1981, CURR MICROBIOL, V6, P309, DOI 10.1007/BF01566883; DAVIS MJ, 1980, PHYTOPATHOLOGY, V70, P425, DOI 10.1094/Phyto-70-425; Doyle J. J., 1987, PHYTOCHEM B, P11; Feil H, 2001, PLANT DIS, V85, P1230, DOI 10.1094/PDIS.2001.85.12.1230; Fittipaldi M, 2011, MICROB ECOL, V61, P7, DOI 10.1007/s00248-010-9719-1; Francis M, 2006, EUR J PLANT PATHOL, V115, P203, DOI 10.1007/s10658-006-9009-4; HILL BL, 1995, PHYTOPATHOLOGY, V85, P1368, DOI 10.1094/Phyto-85-1368; HILL BL, 1995, PHYTOPATHOLOGY, V85, P209, DOI 10.1094/Phyto-85-209; HOPKINS DL, 1984, PHYTOPATHOLOGY, V74, P1395, DOI 10.1094/Phyto-74-1395; Kralik P, 2010, INT J FOOD MICROBIOL, V141, pS80, DOI 10.1016/j.ijfoodmicro.2010.03.018; Kung SH, 2014, MICROBIOL-SGM, V160, P37, DOI 10.1099/mic.0.070581-0; Labroussaa F, 2017, MICROBIOL-SGM, V163, P502, DOI 10.1099/mic.0.000438; Li WB, 2013, J MICROBIOL METH, V92, P79, DOI 10.1016/j.mimet.2012.10.008; Lovdal T, 2011, J MICROBIOL METH, V85, P164, DOI 10.1016/j.mimet.2011.01.027; Martins PMM, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.01099; Merfa MV, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00904; Muranaka LS, 2012, J BACTERIOL, V194, P4561, DOI 10.1128/JB.00436-12; Navarrete F, 2014, APPL ENVIRON MICROB, V80, P1097, DOI 10.1128/AEM.02998-13; Newman KL, 2003, APPL ENVIRON MICROB, V69, P7319, DOI 10.1128/AEM.69.12.7319-7327.2003; Nocker A, 2007, J MICROBIOL METH, V70, P252, DOI 10.1016/j.mimet.2007.04.014; Nocker A, 2006, J MICROBIOL METH, V67, P310, DOI 10.1016/j.mimet.2006.04.015; Oliveira AC, 2002, PHYTOPATHOLOGY, V92, P1048, DOI 10.1094/PHYTO.2002.92.10.1048; Pan Y, 2007, APPL ENVIRON MICROB, V73, P8028, DOI 10.1128/AEM.01198-07; Parker JK, 2016, ENVIRON MICROBIOL, V18, P1620, DOI 10.1111/1462-2920.13242; Purcell AH, 1999, PHYTOPATHOLOGY, V89, P53, DOI 10.1094/PHYTO.1999.89.1.53; RAJU BC, 1983, PHYTOPATHOLOGY, V73, P1309, DOI 10.1094/Phyto-73-1309; Raju BC, 1980, AM J ENOL VITICULT, V31, P5; Rudi K, 2005, LETT APPL MICROBIOL, V40, P301, DOI 10.1111/j.1472-765X.2005.01672.x; Ruijter JM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp045; Scarpari LM, 2003, FEMS MICROBIOL LETT, V222, P83, DOI 10.1016/S0378-1097(03)00251-9; Schaad NW, 2002, PHYTOPATHOLOGY, V92, P721, DOI 10.1094/PHYTO.2002.92.7.721; Vesper S, 2008, J MICROBIOL METH, V72, P180, DOI 10.1016/j.mimet.2007.11.017; Yasunaga A, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-157	42	13	13	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2019	14	8							e0221119	10.1371/journal.pone.0221119	http://dx.doi.org/10.1371/journal.pone.0221119			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5TR	31442247	Green Published, gold, Green Submitted			2022-12-26	WOS:000485041400021
J	Marozik, P; Alekna, V; Rudenko, E; Tamulaitiene, M; Rudenka, A; Mastaviciute, A; Samokhovec, V; Cernovas, A; Kobets, K; Mosse, I				Marozik, Pavel; Alekna, Vidmantas; Rudenko, Ema; Tamulaitiene, Marija; Rudenka, Alena; Mastaviciute, Asta; Samokhovec, Volha; Cernovas, Andrejus; Kobets, Katsiaryna; Mosse, Irma			Bone metabolism genes variation and response to bisphosphonate treatment in women with postmenopausal osteoporosis	PLOS ONE			English	Article							ALENDRONATE TREATMENT; OFFICIAL POSITIONS; DENSITY RESPONSE; MINERAL DENSITY; CHINESE WOMEN; POLYMORPHISMS; ASSOCIATION; FRACTURE; THERAPY; EFFICACY	Introduction Long-term treatment is used in patients with osteoporosis, and bisphosphonates (BPs) are the most commonly prescribed medications. However, in some patients this therapy is not effective, cause different side effects and complications. Unfortunately, at least one year is needed to identify and confirm an ineffectiveness of BPs therapy on bone mineral density (BMD). Among other factors, a response to BPs therapy may also be explained by genetic factors. The aim of this study was to analyze the influence of SOST, PTH, FGF2, FDPS, GGPS1, and LRP5 gene variants on the response to treatment with aminobisphosphonates. Materials and methods Women with postmenopausal osteoporosis were included to this study if they used aminobisphosphonates for at least 12 months. Exclusion criteria were: persistence on BPs therapy less than 80%, bone metabolic diseases, diseases deemed to affect bone metabolism, malignant tumours, using of any medications influencing BMD. The study protocol was approved by the local ethics committee. The BMD at the lumbar spine and femoral neck were measured using dual x-ray absorptiometry (GE Lunar) before and at least 12 months after treatment with BPs. According to BMD change, patients were divided in two groups-responders and non-responders to BPs terapy. Polymorphic variants in SOST, PTH, FGF2, FDPS, GGPS1, and LRP5 genes were determined using PCR analysis with TaqMan probes (Thermo Scientific). Results In total, 201 women with BPs therapy were included in the study. No statistically significant differences were observed in age, age at menopause, weight, height, BMI and baseline BMD levels between responders (122 subjects) and non-responders (79 subjects). As single markers, the SOST rs1234612 T/T (OR = 2.3; P = 0.02), PTH rs7125774 T/T (OR = 2.8, P = 0.0009), FDPS rs2297480 G/G (OR = 29.3, P = 2.2x10(-7)), and GGPS1 rs10925503 C/C+C/T (OR = 2.9; P = 0.003) gene variants were over-represented in non-responders group. No significant association between FGF2 rs6854081 and LRP5 rs3736228 gene variants and response to BPs treatment was observed. The carriers of T-T-G-C allelic combination (constructed from rs1234612, rs7125774, rs2297480, and rs10925503) were predisposed to negative response to BPs treatment (OR = 4.9, 95% CI 1.7-14.6, P = 0.005). The C-C-T-C combination was significantly over-represented in responders (OR = 0.1, 95% CI 0.1-0.5, P = 0.006). Conclusions Our findings highlight the importance of identified single gene variants and their allelic combinations for pharmacogenetics of BPs therapy of osteoporosis. Complex screening of these genetic markers could be used as a new strategy for personalized antiresorptive therapy.	[Marozik, Pavel; Kobets, Katsiaryna; Mosse, Irma] Natl Acad Sci Belarus, Inst Genet & Cytol, Lab Human Genet, Minsk, BELARUS; [Marozik, Pavel; Mosse, Irma] Belarusian State Univ, Int Sakharov Environm Inst, Dept Gen Ecol Biol & Environm Genet, Minsk, BELARUS; [Alekna, Vidmantas; Tamulaitiene, Marija; Mastaviciute, Asta; Cernovas, Andrejus] Vilnius Univ, Fac Med, Vilnius, Lithuania; [Rudenko, Ema] Belarusian State Med Univ, Dept Cardiol & Internal Dis, Minsk, BELARUS; [Rudenka, Alena; Samokhovec, Volha] Belarusian Med Acad Postgrad Educ, Dept Cardiol & Rheumatol, Minsk, BELARUS	National Academy of Sciences of Belarus (NASB); Institute of Genetics & Cytology of the National Academy of Sciences of Belarus; Belarusian State University; Vilnius University; Belarusian State Medical University	Marozik, P (corresponding author), Natl Acad Sci Belarus, Inst Genet & Cytol, Lab Human Genet, Minsk, BELARUS.; Marozik, P (corresponding author), Belarusian State Univ, Int Sakharov Environm Inst, Dept Gen Ecol Biol & Environm Genet, Minsk, BELARUS.	P.Marozik@igc.by	Kobets, Kate/AAQ-3824-2021; Rudenka, Alena/ABI-4658-2020; Tamulaitiene, Marija/Y-1054-2019; Marozik, Pavel M/B-5235-2016	Kobets, Kate/0000-0001-5819-6745; Tamulaitiene, Marija/0000-0003-0712-0884; Marozik, Pavel M/0000-0002-5973-7870	Research Council of Lithuania [S -LB -17-3]; Foundation for Basic Research of Belarusian Republic [B17LITG-008]; grant 6.3 of the Union State Program "DNA Identification"	Research Council of Lithuania(Research Council of Lithuania (LMTLT)); Foundation for Basic Research of Belarusian Republic; grant 6.3 of the Union State Program "DNA Identification"	This study was performed within joint Belarusian-Lithuanian cooperation program in science and technology and supported by a grant (No. S -LB -17-3) from the Research Council of Lithuania, by a grant (project B17LITG-008) from the Foundation for Basic Research of Belarusian Republic, and partially funded by a grant 6.3 of the Union State Program "DNA Identification". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baim S, 2008, J CLIN DENSITOM, V11, P75, DOI 10.1016/j.jocd.2007.12.007; Black DM, 2012, J BONE MINER RES, V27, P243, DOI 10.1002/jbmr.1494; Choi HJ, 2010, YONSEI MED J, V51, P231, DOI 10.3349/ymj.2010.51.2.231; Chubachi S, 2015, RESPIROLOGY, V20, P286, DOI 10.1111/resp.12429; Clark EM, 2016, OSTEOPOROSIS INT, V27, P579, DOI 10.1007/s00198-015-3271-2; Coffin JD, 2018, J ENDOCR SOC, V2, P657, DOI 10.1210/js.2018-00105; Cosman F, 2014, OSTEOPOROSIS INT, V25, P2359, DOI 10.1007/s00198-014-2794-2; Diez-Perez A, 2012, OSTEOPOROSIS INT, V23, P2769, DOI 10.1007/s00198-012-2093-8; Eisman JA, 2012, J BONE MINER RES, V27, P2039, DOI 10.1002/jbmr.1698; Gonzalez JR, 2007, BIOINFORMATICS, V23, P644, DOI 10.1093/bioinformatics/btm025; Guo Y, 2010, J BONE MINER RES, V25, P1042, DOI 10.1359/jbmr.091040; Han Lan-wen, 2016, Chinese Medical Sciences Journal, V31, P8; Kanis JA, 2007, ASSESSMENT OSTEOPORO; Kennel KA, 2009, MAYO CLIN PROC, V84, P632, DOI 10.1016/S0025-6196(11)60752-0; Kruk M, 2009, CALCIFIED TISSUE INT, V84, P171, DOI 10.1007/s00223-008-9207-5; Lei SF, 2011, J BONE MINER RES, V26, P72, DOI 10.1002/jbmr.186; Lima CAD, 2017, INFLAMMOPHARMACOLOGY, V25, P191, DOI 10.1007/s10787-017-0322-7; Liu Y, 2014, CHINESE MED J-PEKING, V127, P662, DOI 10.3760/cma.j.issn.0366-6999.20132382; Marini F, 2008, CURR MED RES OPIN, V24, P2609, DOI 10.1185/03007990802352894 ; Mellstrom DD, 2004, CALCIFIED TISSUE INT, V75, P462, DOI 10.1007/s00223-004-0286-7; Moayyeri A, 2014, HUM MOL GENET, V23, P3054, DOI 10.1093/hmg/ddt675; Olmos JM, 2012, PHARMACOGENOMICS J, V12, P227, DOI 10.1038/tpj.2010.88; Peng J, 2016, GENET MOL RES, V15, DOI 10.4238/gmr.15017552; Pisani P, 2016, WORLD J ORTHOP, V7, P171, DOI 10.5312/wjo.v7.i3.171; Qureshi AM, 2002, CALCIFIED TISSUE INT, V70, P158, DOI 10.1007/s00223-001-1035-9; Reginster JY, 2011, DRUGS, V71, P65, DOI 10.2165/11587570-000000000-00000; Schwartz AV, 2010, J BONE MINER RES, V25, P976, DOI 10.1002/jbmr.11; Vieira Helena Parente, 2013, Int Arch Med, V6, P24, DOI 10.1186/1755-7682-6-24; Wang C, 2015, PHARMACOGENOMICS J, V15, P158, DOI 10.1038/tpj.2014.52; Wang WJ, 2019, PHARMACOGENOMICS J, V19, P490, DOI 10.1038/s41397-018-0059-8; Zheng H, 2016, PHARMACOGENET GENOM, V26, P12, DOI 10.1097/FPC.0000000000000181; Zhou PR, 2015, PHARMACOGENOMICS, V16, P1077, DOI [10.2217/PGS.15.76, 10.2217/pgs.15.76]; Zysset P, 2015, J CLIN DENSITOM, V18, P359, DOI 10.1016/j.jocd.2015.06.011	33	10	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2019	14	8							e0221511	10.1371/journal.pone.0221511	http://dx.doi.org/10.1371/journal.pone.0221511			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5RZ	31437227	gold, Green Submitted, Green Published			2022-12-26	WOS:000485036900084
J	Rosario, EVN; Gomes, MC; Brito, M; Costa, D				Nova Rosario, Edite Vila; Gomes, Manuel Carmo; Brito, Miguel; Costa, Diogo			Determinants of maternal health care and birth outcome in the Dande Health and Demographic Surveillance System area, Angola	PLOS ONE			English	Article							ANTENATAL CARE; DEVELOPING-COUNTRIES; COVERAGE; TRENDS; STILLBIRTHS; MORTALITY; FACILITY; AFRICA; WOMEN	Objectives Maternal health care improvement and reduction of maternal and child mortality are priorities of the global health agenda. In Angola, maternal mortality remains high and the risk of pregnancy-related death was 1 in 32 during 2015. This study aims to identify demographic and social factors influencing antenatal care and health facility delivery among women in Dande and to understand their impact on birth outcomes. Methods This study is based on community based longitudinal data collected by the Dande Health and Demographic Surveillance System between 2009 and 2015. Data on pregnancy outcomes (10,289 outcomes of 8,066 women) were collected for all reported pregnancies, including sociodemographic information, health services utilisation and women's reproductive history. Logistic regression was used to investigate the determinants of birth outcomes, antenatal care attendance and institutionalised delivery. Findings Of the 10,289 pregnancy outcomes, 98.5% resulted in live births, 96.8% attended antenatal care, and 82.5% had four or more visits. Yet, 50.7% of the women delivered outside a health facility. Antenatal care attendance was a determinant of birth outcomes (stillbirth: unadjusted OR = 0.34 95% CI = 0.16-0.70; abortion: OR = 0.07 95% CI = 0.04-0.12). Older women, with lower education, living at a greater distance of a health facility and in rural areas, were less likely to use maternal health care. Having had previous pregnancies, namely resulting in live births, also decreased the likelihood of health care utilization by pregnant women. Conclusions The study identifies relevant social determinants for the utilisation of antenatal care, place of delivery and their impact on birth outcome, thereby providing insight on how best to address inequities in health care utilization.	[Nova Rosario, Edite Vila; Brito, Miguel] CISA, Bengo, Angola; [Nova Rosario, Edite Vila; Costa, Diogo] ISPUP, Porto, Portugal; [Gomes, Manuel Carmo] Univ Lisbon, Fac Ciencias, Lisbon, Portugal; [Brito, Miguel] Inst Politecnico Lisboa, H&TRC, Escola Super Tecnol Saude Lisboa, Lisbon, Portugal	Universidade do Porto; Universidade de Lisboa; Universidade de Lisboa	Rosario, EVN (corresponding author), CISA, Bengo, Angola.; Rosario, EVN (corresponding author), ISPUP, Porto, Portugal.	edite.rosario@cisacaxito.org	Brito, Miguel/A-7970-2016; Gomes, Manuel/AFI-6075-2022; Costa, Diogo/AAN-5827-2021; Gomes, Manuel C/F-9633-2011	Brito, Miguel/0000-0001-6394-658X; Gomes, Manuel/0000-0002-2679-0974; Costa, Diogo/0000-0001-9696-7088; Gomes, Manuel C/0000-0002-2679-0974	Camoes - Portuguese Institute for Cooperation and Language; Calouste Gulbenkian Foundation; Angolan Ministry of Health; Bengo Province Government	Camoes - Portuguese Institute for Cooperation and Language; Calouste Gulbenkian Foundation; Angolan Ministry of Health; Bengo Province Government	The core funding of all CISA activities has been provided by Camoes - Portuguese Institute for Cooperation and Language, by the Calouste Gulbenkian Foundation, by the Angolan Ministry of Health and by the Bengo Province Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adewuyi EO, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197324; Adjiwanou V, 2013, SOC SCI MED, V86, P26, DOI 10.1016/j.socscimed.2013.02.047; Akowuah JA, 2018, J TROP MED-US, V2018, DOI 10.1155/2018/1673517; [Anonymous], 2014, ROAD DIGN 2030 END P; Arthur E, 2012, HEALTH ECON REV, V2, DOI 10.1186/2191-1991-2-14; Asseffa NA, 2016, BMC PREGNANCY CHILDB, V16, DOI 10.1186/s12884-016-1151-1; Asundep NN, 2013, J EPIDEMIOL GLOB HEA, V3, P279, DOI 10.1016/j.jegh.2013.09.004; Babalola S, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-43; Bayou YT, 2016, BMC PREGNANCY CHILDB, V16, DOI 10.1186/s12884-016-0930-z; BENOVA L, 2018, BMJ GLOB HEALTH, V3, DOI DOI 10.1136/BMJGH-2018-000779; Best RR, 2019, THE BRITISH STUDENT, V3, DOI [10.18573/bsdj.76, DOI 10.18573/BSDJ.76]; Blanc AK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059864; Boah M, 2018, BMC PREGNANCY CHILDB, V18, DOI 10.1186/s12884-018-1749-6; Burgess C, 2008, SECRETS STOLEN, FORTUNES LOST: PREVENTING INTELLECTUAL PROPERTY THEFT AND ECONOMIC ESPIONAGE IN THE 21ST CENTURY, P3, DOI 10.1016/B978-1-59749-255-3.00001-0; Caliskan Z, 2015, INT J PUBLIC HEALTH, V60, P815, DOI 10.1007/s00038-015-0711-x; Campbell OMR, 2016, LANCET, V388, P2193, DOI 10.1016/S0140-6736(16)31528-8; Choulagai BP, 2015, GLOBAL HEALTH ACTION, V8, P1, DOI 10.3402/gha.v8.29396; de Camargo KR, 2011, GLOB PUBLIC HEALTH, V6, P102, DOI 10.1080/17441692.2010.514617; Dimbuene ZT, 2018, J BIOSOC SCI, V50, P725, DOI 10.1017/S0021932017000505; Doctor HV, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5695-z; Emelumadu OF, 2014, ANN MED HEALTH SCI R, V4, P374, DOI 10.4103/2141-9248.133463; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Gabriel SA, 2009, BE J ECON ANAL POLI, V9, DOI 10.1186/1471-2393-9-34; Graham W, 2016, LANCET, V388, P2164, DOI 10.1016/S0140-6736(16)31533-1; Heaman Maureen I, 2008, BMC Pregnancy Childbirth, V8, P15, DOI 10.1186/1471-2393-8-15; Heredia-Pi I, 2016, B WORLD HEALTH ORGAN, V94, P452, DOI 10.2471/BLT.15.168302; Hijazi HH, 2018, REPROD HEALTH, V15, DOI 10.1186/s12978-018-0542-3; INE, 2008, POP WELL BEING INT S; Instituto Nacional de Estatistica (INE) Ministerio da Saude (MINSA) Ministerio do Planeamento e do Desenvolvimento Territorial (MINPLAN) e ICF, 2017, 2015 16 MULT IND HLT; Kadobera D, 2012, GLOBAL HEALTH ACTION, V5, P1, DOI 10.3402/gha.v5i0.19099; Kuhnt J, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-017122; Kujala S, 2017, TROP MED INT HEALTH, V22, P63, DOI 10.1111/tmi.12807; Lawn JE, 2011, LANCET, V377, P1448, DOI 10.1016/S0140-6736(10)62187-3; LUMBIGANON P, 1990, INT J EPIDEMIOL, V19, P997, DOI 10.1093/ije/19.4.997; Moller AB, 2017, LANCET GLOB HEALTH, V5, pE977, DOI 10.1016/S2214-109X(17)30325-X; Moses P., 2017, INT J INNOVATIVE RES, V6, P7; Moyer CA, 2013, REPROD HEALTH, V10, DOI 10.1186/1742-4755-10-40; Mwase T, 2018, INT J EQUITY HEALTH, V17, DOI 10.1186/s12939-018-0770-8; Nimi T, 2016, INT J GYNECOL OBSTET, V135, pS72, DOI 10.1016/j.ijgo.2016.08.013; Rosario EVN, 2017, INT J EPIDEMIOL, V46, P1094, DOI 10.1093/ije/dyx072; Nyongesa C, 2018, BMC PREGNANCY CHILDB, V18, DOI 10.1186/s12884-018-1727-z; Odwe G, 2015, INT J POPUL RES, V2015, P1, DOI DOI 10.1155/2015/296437; Osamor PE, 2016, INT J WOMENS HEALTH, V8, P191, DOI 10.2147/IJWH.S105483; Pervin J, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-111; Raynes-Greenow C, 2017, LANCET GLOB HEALTH, V5, pE949, DOI 10.1016/S2214-109X(17)30346-7; Ronsmans C, 2006, LANCET, V368, P1189, DOI 10.1016/S0140-6736(06)69380-X; Rossier C, 2014, GLOBAL HEALTH ACTION, V7, P1, DOI 10.3402/gha.v7.24351; Rurangirwa AA, 2017, BMC PREGNANCY CHILDB, V17, DOI 10.1186/s12884-017-1328-2; Simkhada B, 2008, J ADV NURS, V61, P244, DOI 10.1111/j.1365-2648.2007.04532.x; Tran TK, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-40; Udo IE, 2016, AFR J REPROD HEALTH, V20, P108, DOI 10.29063/ajrh2016/v20i3.15; Umar Abubakar Sadiq, 2016, Int J MCH AIDS, V5, P61; USAID, 2020, MAT NEON CHILD HLTH; Wang WJ, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0497-0; WHO, 2022, WHO RECOMMENDATIONS; WHO, 2015, THE MILLENNIUM DEVEL; Wilunda C, 2015, REPROD HEALTH, V12, DOI 10.1186/s12978-015-0067-y; Woldegiorgis MA, 2018, INT J PUBLIC HEALTH, V63, P525, DOI 10.1007/s00038-018-1086-6; Yaya S, 2018, BMC PREGNANCY CHILDB, V18, DOI 10.1186/s12884-018-1846-6	59	26	26	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2019	14	8							e0221280	10.1371/journal.pone.0221280	http://dx.doi.org/10.1371/journal.pone.0221280			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW5RZ	31437180	Green Published, Green Submitted, gold			2022-12-26	WOS:000485036900046
J	Lancker, K; Deppenmeier, AL; Demissie, T; Schmidt, JO				Lancker, Kira; Deppenmeier, Anna-Lena; Demissie, Teferi; Schmidt, Joern O.			Climate change adaptation and the role of fuel subsidies: An empirical bio-economic modeling study for an artisanal open-access fishery	PLOS ONE			English	Article							SMALL PELAGIC FISH; NORTH-WEST AFRICA; SARDINELLA SARDINELLA-AURITA; CHANGE IMPACTS; POPULATION; FOOD; EXTINCTION; ECOSYSTEMS; ABUNDANCE; RESPONSES	Climate change can severely impact artisanal fisheries and affect the role they play in food security. We study climate change effects on the triple bottom line of ecological productivity, fishers' incomes, and fish consumption for an artisanal open-access fishery. We develop and apply an empirical, stochastic bio-economic model for the Senegalese artisanal purse seine fishery on small pelagic fish and compare the simulated fishery's development using four climate projections and two policy scenarios. We find that economic processes of adaptation may amplify the effects of climate variations. The regions' catch potential increases with climate change, induced by stock distribution changes. However, this outcome escalates over-fishing, whose effects outpace the incipiently favorable climate change effects under three of the four climate projections. Without policy action, the fishery is estimated to collapse in 2030-2035 on average over 1000 runs. We propose an easily implementable and overall welfare-increasing intervention: reduction of fuel subsidies. If fuel subsidies were abolished, ecological sustainability as well as the fishery's welfare contribution would increase regardless of the climate projection.	[Lancker, Kira] German Ctr Integrat Biodivers Halle Jena Leipzig, Biodivers Econ, Leipzig, Germany; [Deppenmeier, Anna-Lena] Wageningen Univ, Meteorol & Air Qual Dept, Wageningen, Netherlands; [Deppenmeier, Anna-Lena] Royal Netherlands Meteorol Inst KNMI, R&D Weather & Climate Modeling, De Bilt, Netherlands; [Demissie, Teferi] NORCE Norwegian Res Ctr AS, NORCE Climate, Bergen, Norway; [Demissie, Teferi] Agr & Food Secur CCAFS East Africa, CGIAR Res Program Climate Change, Addis Ababa, Ethiopia; [Schmidt, Joern O.] Christian Albrechts Univ Kiel, Dept Econ, Kiel, Germany	Wageningen University & Research; Royal Netherlands Meteorological Institute; Norwegian Research Centre (NORCE); CGIAR; University of Kiel	Lancker, K (corresponding author), German Ctr Integrat Biodivers Halle Jena Leipzig, Biodivers Econ, Leipzig, Germany.	kira.lancker@idiv.de	Schmidt, Jörn Oliver/A-7714-2008	Schmidt, Jörn Oliver/0000-0002-4420-6532; Lancker, Kira/0000-0001-8787-1148	EU; Cluster of Excellence Future Ocean; German Centre for Integrative Biodiversity Research (iDiv) Halle-Jena-Leipzig - German Research Foundation [FZT 118]; German Research Foundation (DFG); Leipzig University within the program of Open Access Publishing	EU(European Commission); Cluster of Excellence Future Ocean; German Centre for Integrative Biodiversity Research (iDiv) Halle-Jena-Leipzig - German Research Foundation; German Research Foundation (DFG)(German Research Foundation (DFG)); Leipzig University within the program of Open Access Publishing	We gratefully acknowledge data provision by the Centre of Oceanographic Research of DakarThiaroye (CRODT), the Direction des peches maritimes (DPM), the National Agency of Statistics and Demography (ANSD), the European Centre for Medium-Range Weather Forecasts (ECMWF). We thank M. Quaas and R. Voss for valuable comments. All four authors were supported by the EU FP7/2007-2013 PREFACE Project, for which we are grateful. J. O. Schmidt acknowledges support from the Cluster of Excellence Future Ocean. Kira Lancker gratefully acknowledges the support of the German Centre for Integrative Biodiversity Research (iDiv) Halle-Jena-Leipzig funded by the German Research Foundation (FZT 118). We acknowledge support from the German Research Foundation (DFG) and Leipzig University within the program of Open Access Publishing.	Abraham T, 2018, FINANC INNOV, V4, DOI 10.1186/s40854-018-0094-0; Andrews T, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL051607; Arnason R, 2004, AM J AGR ECON, V86, P531, DOI 10.1111/j.0092-5853.2004.00597.x; Arnason R., 2008, NAT RESOUR MODEL, V20, P163, DOI [10.1111/j.1939-7445.2007.tb00205.x, DOI 10.1111/J.1939-7445.2007.TB00205.X]; Ba A, 2017, MAR POLICY, V76, P152, DOI 10.1016/j.marpol.2016.11.008; Bacha M, 2016, J FISH BIOL, V89, P2153, DOI 10.1111/jfb.13117; Bacha M, 2017, FISH OCEANOGR, V26, P282, DOI 10.1111/fog.12192; Bakun A, 1996, PATTERNS OCEAN OCEAN, V61; Barton ED, 2013, PROG OCEANOGR, V116, P167, DOI 10.1016/j.pocean.2013.07.007; Belhabib D, 2016, MAR POLICY, V71, P15, DOI 10.1016/j.marpol.2016.05.009; Belhabib D, 2016, ENVIRON DEV, V17, P157, DOI 10.1016/j.envdev.2015.08.004; Belhabib D, 2015, OCEAN COAST MANAGE, V111, P72, DOI 10.1016/j.ocecoaman.2015.04.010; Belhabib D, 2014, FISH RES, V151, P1, DOI 10.1016/j.fishres.2013.12.006; Bene C, 2010, DEV POLICY REV, V28, P325, DOI 10.1111/j.1467-7679.2010.00486.x; Binet D, 1997, OCEANOL ACTA, V20, P177; BJORNDAL T, 1989, LAND ECON, V65, P49, DOI 10.2307/3146263; Braham CB, 2014, FISH RES, V154, P195, DOI 10.1016/j.fishres.2014.02.020; Brehmer P, 2007, MAR ECOL PROG SER, V334, P263, DOI 10.3354/meps334263; Brochier T, 2009, PROG OCEANOGR, V83, P261, DOI 10.1016/j.pocean.2009.07.044; Brochier T, 2018, PROG OCEANOGR, V164, P12, DOI 10.1016/j.pocean.2018.03.011; CAMPBELL HF, 1991, J ENVIRON ECON MANAG, V20, P262, DOI 10.1016/0095-0696(91)90012-8; Cheung WWL, 2013, NATURE, V497, P365, DOI 10.1038/nature12156; Cheung WWL, 2010, GLOBAL CHANGE BIOL, V16, P24, DOI 10.1111/j.1365-2486.2009.01995.x; COMITINI S, 1967, J POLIT ECON, V75, P366, DOI 10.1086/259292; Corten A, 2013, SARDINELLE AFRIQUE N; Cropper TE, 2014, DEEP-SEA RES PT I, V86, P94, DOI 10.1016/j.dsr.2014.01.007; CURY P, 1989, CAN J FISH AQUAT SCI, V46, P670, DOI 10.1139/f89-086; Da-Rocha JM, 2017, MAR POLICY, V81, P185, DOI 10.1016/j.marpol.2017.03.029; Daures F, 2013, FISH RES, V146, P74, DOI 10.1016/j.fishres.2013.03.022; Del Valle I, 2003, APPL ECON, V35, P63, DOI 10.1080/00036840210158949; Deme M., 2012, RAPPORT TECHNIQUE CO; Deme M., 2011, FISHERIES SUBSIDIES, P67; Diankha O, 2018, FISH OCEANOGR, P1; Diankha O, 2017, AQUAT LIVING RESOUR, V30, DOI 10.1051/alr/2017027; Diankha O, 2015, THALASSAS, V31, P9; Ding Q, 2017, MAR POLICY, V83, P55, DOI 10.1016/j.marpol.2017.05.011; Direction des maritimes, 2001, RES GEN PECH MAR; Direction des peches maritimes, 2006, RES GEN PECH MAR; Direction des peches maritimes, 2008, RES GEN PECH MAR; Direction des peches maritimes, 2004, RES GEN PECH MAR; Direction des peches maritimes, 2003, RES GEN PECH MAR; Direction des peches maritimes, 2007, RES GEN PECH MAR; Direction des peches maritimes, 2009, RES GEN PECH MAR; Direction des peches maritimes, 2002, RES GEN PECH MAR; Direction des peches maritimes, 2005, RES GEN PECH MAR; Direction des peches maritimes, 2011, RES GEN PECH MAR; Durand JD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077483; ECMWF, 2012, MONTHL MEANS; EIA, 2018, EIA OP DAT API EUR B; Eigaard OR, 2014, REV FISH SCI AQUAC, V22, P156, DOI 10.1080/23308249.2014.899557; FAILLER P., 2014, J FISHERIES LIVESTOC, V2, P1; FAO, 2008, REP FAO WORK GROUP A; FAO, 2011, REP FAO WORK GROUP A; FAO, 2013, REP FAO WORK GROUP A; Food and Agriculture Organization of the United Nations, 2018, STAT WORLD FISH AQ M, DOI 10.18356/8d6ea4b6-en; FRAEDRICH K, 1987, MON WEATHER REV, V115, P1640, DOI 10.1175/1520-0493(1987)115<1640:CPSIST>2.0.CO;2; Fritsch JM, 2000, WEATHER FORECAST, V15, P571, DOI 10.1175/1520-0434(2000)015<0571:MC>2.0.CO;2; Harper S, 2012, FISH RES, V113, P143, DOI 10.1016/j.fishres.2011.10.007; Hawkins E, 2013, AGR FOREST METEOROL, V170, P19, DOI 10.1016/j.agrformet.2012.04.007; Hazeleger W, 2012, CLIM DYNAM, V39, P2611, DOI 10.1007/s00382-011-1228-5; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; Huntingford C, 2005, PHILOS T R SOC B, V360, P1999, DOI 10.1098/rstb.2005.1748; Krakstad J., 2004, SURVEY PELAGIC FISH; Krakstad J., 2005, SURVEY PELAGIC FISH; Krakstad JO, 2006, SURVEY PELAGIC FISH; Krakstad JO, 2003, SURVEY PELAGIC FISH; Lam VWY, 2012, AFR J MAR SCI, V34, P103, DOI 10.2989/1814232X.2012.673294; LANDE R, 1993, AM NAT, V142, P911, DOI 10.1086/285580; Lathuiliere C, 2008, J GEOPHYS RES-OCEANS, V113, DOI 10.1029/2007JC004433; LEIGH EG, 1981, J THEOR BIOL, V90, P213; Marcello J, 2011, INT J REMOTE SENS, V32, P1843, DOI 10.1080/01431161003631576; Ndoye S, 2014, J GEOPHYS RES-OCEANS, V119, P8315, DOI 10.1002/2014JC010242; NORDHAUS WD, 1993, RESOUR ENERGY ECON, V15, P27, DOI 10.1016/0928-7655(93)90017-O; Osborne T, 2013, AGR FOREST METEOROL, V170, P183, DOI 10.1016/j.agrformet.2012.07.006; Palamara GM, 2013, J THEOR BIOL, V334, P61, DOI 10.1016/j.jtbi.2013.06.007; Prellezo R, 2009, FISH RES, V97, P24, DOI 10.1016/j.fishres.2008.12.015; Quaas MF, 2017, ENV RESOURCE EC; Seck PD, 2008, ETUDE RELATIVE LANAL; SQUIRES D, 1987, J ENVIRON ECON MANAG, V14, P268, DOI 10.1016/0095-0696(87)90020-9; Sumaila UR, 2016, MAR POLICY, V69, P189, DOI 10.1016/j.marpol.2015.12.026; Sumaila UR, 2008, ICES J MAR SCI, V65, P832, DOI 10.1093/icesjms/fsn070; Suuronen P, 2012, FISH RES, V119, P135, DOI 10.1016/j.fishres.2011.12.009; Sydeman WJ, 2014, SCIENCE, V345, P77, DOI [10.1126/science.1251635, 10.1126/science.1250830]; The World Bank, 2017, CONS PRIC IND; Thiao D., 2009, THESIS; Thiaw M, 2017, FISH OCEANOGR, V26, P583, DOI 10.1111/fog.12218; Tiedemann M, 2017, FISH OCEANOGR, V26, P655, DOI 10.1111/fog.12224; Tjiputra JF, 2013, GEOSCI MODEL DEV, V6, P301, DOI 10.5194/gmd-6-301-2013; TORESEN R, 2002, SURVEY PELAGIC FISH; Toresen R, 2001, SURVEY PELAGIC FISH; Willmann R, 2009, SUNKEN BILLIONS EC J; World Bank, 2007, CHANG FAC WAT PROM C; York R, 2004, ECOL ECON, V48, P293, DOI 10.1016/j.ecolecon.2003.10.009; Yu VPB, 2005, REFLECTING SUSTAINAB; Zeeberg J, 2008, FISH RES, V89, P65, DOI 10.1016/j.fishres.2007.08.020	96	5	5	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2019	14	8							e0220433	10.1371/journal.pone.0220433	http://dx.doi.org/10.1371/journal.pone.0220433			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW5QN	31433801	gold, Green Published, Green Submitted			2022-12-26	WOS:000485033100012
J	Sepuru, KM; Rajarathnam, K				Sepuru, Krishna Mohan; Rajarathnam, Krishna			Structural basis of chemokine interactions with heparan sulfate, chondroitin sulfate, and dermatan sulfate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						nuclear magnetic resonance (NMR); heparan sulfate; chondroitin sulfate; dermatan sulfate; chemokine; glycosaminoglycan	PULMONARY HOST-DEFENSE; GLYCOSAMINOGLYCAN INTERACTIONS; NEUTROPHIL TRAFFICKING; SPINAL-CORD; CXCR2; BINDING; CXCL5; MIGRATION; DIMER; OLIGOMERIZATION	Chemokines play diverse roles in human pathophysiology, ranging from trafficking leukocytes and immunosurveillance to the regulation of metabolism and neural function. Chemokine function is intimately coupled to binding tissue glycosaminoglycans (GAGs), heparan sulfate (HS), chondroitin sulfate (CS), and dermatan sulfate (DS). Currently, very little is known about how the structural features and sequences of a given chemokine, the structure and sulfation pattern of a given GAG, and structural differences among GAGs and among chemokines impact binding interactions. In this study, we used solution NMR spectroscopy to characterize the binding interactions of two related neutrophil-activating chemokines, CXCL1 and CXCL5, with HS, CS, and DS. For both chemokines, the dimer bound all three GAGs with higher affinity than did the monomer, and affinities of the chemokines for CS and DS were lower than for HS. NMR-based structural models reveal diverse binding geometries and show that the binding surfaces for each of the three GAGs were different between the two chemokines. However, a given chemokine had similar binding interactions with CS and DS that were different from HS. Considering the fact that CXCL1 and CXCL5 activate the same CXCR2 receptor, we conclude that GAG interactions play a role in determining the nature of chemokine gradients, levels of free chemokine available for receptor activation, how chemokines bind their receptors, and that differences in these interactions determine chemokine-specific function.	[Sepuru, Krishna Mohan; Rajarathnam, Krishna] Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA; [Rajarathnam, Krishna] Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX 77555 USA; [Sepuru, Krishna Mohan; Rajarathnam, Krishna] Univ Texas Med Branch, Sealy Ctr Struct Biol & Mol Biophys, Galveston, TX 77555 USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston	Rajarathnam, K (corresponding author), Dept Biochem & Mol Biol, 5-142 Med Res Bldg, Galveston, TX 77555 USA.	krrajara@utmb.edu	Sepuru, Krishna Mohan/K-5321-2014	Sepuru, Krishna Mohan/0000-0002-3675-6294	National Institutes of Health [P01HL107152, R21AI124681]; Sealy and Smith Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL107152] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI124681] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sealy and Smith Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by National Institutes of Health Grants P01HL107152 and R21AI124681 and a Sealy and Smith Foundation grant to the Sealy Center for Structural Biology and Molecular Biophysics. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Brown AJ, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01248; Cai SS, 2010, J IMMUNOL, V185, P6214, DOI 10.4049/jimmunol.0903843; Cardona AE, 2008, J LEUKOCYTE BIOL, V84, P587, DOI 10.1189/jlb.1107763; Celie JWAM, 2009, FRONT BIOSCI-LANDMRK, V14, P4932, DOI 10.2741/3578; Couchman JR, 2010, ANNU REV CELL DEV BI, V26, P89, DOI 10.1146/annurev-cellbio-100109-104126; De Vries SJ, 2007, PROTEINS, V69, P726, DOI 10.1002/prot.21723; Derler R, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18122605; Deshauer C, 2015, STRUCTURE, V23, P1066, DOI 10.1016/j.str.2015.03.024; Disteldorf EM, 2015, J AM SOC NEPHROL, V26, P55, DOI 10.1681/ASN.2013101061; Djerbal L, 2017, GLYCOCONJUGATE J, V34, P363, DOI 10.1007/s10719-017-9761-z; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; FAIRBROTHER WJ, 1994, J MOL BIOL, V242, P252, DOI 10.1006/jmbi.1994.1577; Frevert CW, 2003, AM J RESP CELL MOL, V28, P464, DOI 10.1165/rcmb.2002-0084OC; Gandhi NS, 2008, CHEM BIOL DRUG DES, V72, P455, DOI 10.1111/j.1747-0285.2008.00741.x; Gangavarapu P, 2012, J LEUKOCYTE BIOL, V91, P259, DOI 10.1189/jlb.0511239; Gill SE, 2016, AM J RESP CELL MOL, V55, P243, DOI 10.1165/rcmb.2015-0193OC; Ishiguro K, 2001, J BIOL CHEM, V276, P47483, DOI 10.1074/jbc.M106268200; Jansma AL, 2010, J BIOL CHEM, V285, P14424, DOI 10.1074/jbc.M109.091108; Joseph PRB, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-30697-y; Joseph PRB, 2017, OPEN BIOL, V7, DOI 10.1098/rsob.170168; Joseph PRB, 2015, BIOCHEM J, V472, P121, DOI 10.1042/BJ20150059; Kobayashi Y, 2008, FRONT BIOSCI-LANDMRK, V13, P2400, DOI 10.2741/2853; Lin M, 2007, J LEUKOCYTE BIOL, V81, P786, DOI 10.1189/jlb.0806502; Massena S, 2010, BLOOD, V116, P1924, DOI 10.1182/blood-2010-01-266072; Mei JJ, 2012, J CLIN INVEST, V122, P974, DOI 10.1172/JCI60588; Mei JJ, 2010, IMMUNITY, V33, P106, DOI 10.1016/j.immuni.2010.07.009; Meneghetti MCZ, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2015.0589; Monneau Y, 2016, J LEUKOCYTE BIOL, V99, P935, DOI 10.1189/jlb.3MR0915-440R; Monneau YR, 2017, OPEN BIOL, V7, DOI 10.1098/rsob.170133; Nouailles G, 2014, J CLIN INVEST, V124, P1268, DOI 10.1172/JCI72030; Pichert A, 2012, GLYCOBIOLOGY, V22, P134, DOI 10.1093/glycob/cwr120; Pomin VH, 2015, CURR OPIN STRUC BIOL, V34, P17, DOI 10.1016/j.sbi.2015.05.007; Rajarathnam K, 2019, CELL SIGNAL, V54, P69, DOI 10.1016/j.cellsig.2018.11.004; Rajarathnam K, 2018, J HISTOCHEM CYTOCHEM, V66, P229, DOI 10.1369/0022155417739864; Ravindran A, 2013, J BIOL CHEM, V288, P12244, DOI 10.1074/jbc.M112.443762; Ravindran A, 2009, BIOCHEMISTRY-US, V48, P8795, DOI 10.1021/bi901194p; Salanga CL, 2011, EXP CELL RES, V317, P590, DOI 10.1016/j.yexcr.2011.01.004; Sarris M, 2012, CURR BIOL, V22, P2375, DOI 10.1016/j.cub.2012.11.018; Sawant KV, 2016, SCI REP-UK, V6, DOI 10.1038/srep33123; Sawant KV, 2015, J INNATE IMMUN, V7, P647, DOI 10.1159/000430914; Schaefer L, 2010, CELL TISSUE RES, V339, P237, DOI 10.1007/s00441-009-0821-y; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Sepuru KM, 2018, J BIOL CHEM, V293, P17817, DOI 10.1074/jbc.RA118.004866; Sepuru KM, 2018, BIOCHEMISTRY-US, V57, P5969, DOI 10.1021/acs.biochem.8b00756; Sepuru KM, 2018, ANALYST, V143, P635, DOI 10.1039/c7an01406f; Sepuru KM, 2016, J BIOL CHEM, V291, P20539, DOI 10.1074/jbc.M116.745265; Sepuru KM, 2016, J BIOL CHEM, V291, P4247, DOI 10.1074/jbc.M115.697888; Sepuru KM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093228; Stone MJ, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18020342; Tanino Y, 2010, J IMMUNOL, V184, P2677, DOI 10.4049/jimmunol.0903274; Tanino Y, 2012, AM J RESP CELL MOL, V47, P196, DOI 10.1165/rcmb.2011-0294OC; Tsai HH, 2002, CELL, V110, P373, DOI 10.1016/S0092-8674(02)00838-3; Wang LC, 2005, NAT IMMUNOL, V6, P902, DOI 10.1038/ni1233; Xu D, 2014, ANNU REV BIOCHEM, V83, P129, DOI 10.1146/annurev-biochem-060713-035314; ZGraggen K, 1997, GASTROENTEROLOGY, V113, P808, DOI 10.1016/S0016-5085(97)70175-6; Zhang ZJ, 2013, PAIN, V154, P2185, DOI 10.1016/j.pain.2013.07.002; Ziarek JJ, 2013, J BIOL CHEM, V288, P737, DOI 10.1074/jbc.M112.394064	57	20	21	2	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 25	2019	294	43					15650	15661		10.1074/jbc.RA119.009879	http://dx.doi.org/10.1074/jbc.RA119.009879			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JQ9JD	31455633	hybrid, Green Published			2022-12-26	WOS:000499253000009
J	Sasahara, K; Yamaguchi, K; So, M; Goto, Y				Sasahara, Kenji; Yamaguchi, Keiichi; So, Masatomo; Goto, Yuji			Polyphosphates diminish solubility of a globular protein and thereby promote amyloid aggregation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						amyloid; thermodynamics; protein aggregation; isothermal titration calorimetry (ITC); conformational change	SUPERSATURATION; LYSOZYME; BETA(2)-MICROGLOBULIN; FIBRILS; STABILIZATION; STABILITY; MECHANISM; OLIGOMERS; BINDING; PHASE	Structural changes of globular proteins and their resultant amyloid aggregation have been associated with various human diseases, such as lysozyme amyloidosis and light-chain amyloidosis. Because many globular proteins can convert into amyloid fibrils in vitro, the mechanisms of amyloid fibril formation have been studied in various experimental systems, but several questions remain unresolved. Here, using several approaches, such as turbidimetry, fluorescence and CD spectroscopy, EM, and isothermal titration calorimetry, we examined the binding of polyphosphates to hen egg-white lysozyme under acidic conditions and observed polyphosphate-induced structural changes of the protein promoting its aggregation. Our data indicate that negatively charged polyphosphates bind to protein molecules with a net positive charge. The polyphosphate-bound, structurally destabilized protein molecules then start assembling into insoluble amorphous aggregates once they pass the solubility limit. We further show that the polyphosphates decrease the solubility limit of the protein and near this limit, the protein molecules are in a labile state and highly prone to converting into amyloid fibrils. Our results explain how polyphosphates affect amorphous aggregation of proteins, how amyloid formation is induced in the presence of polyphosphates, and how polyphosphate chain length is an important factor in amyloid formation.	[Sasahara, Kenji; Yamaguchi, Keiichi; So, Masatomo; Goto, Yuji] Osaka Univ, Inst Prot Res, 3-2 Yamadaoka, Suita, Osaka 5650871, Japan	Osaka University	Goto, Y (corresponding author), Osaka Univ, Inst Prot Res, 3-2 Yamadaoka, Suita, Osaka 5650871, Japan.	gtyj8126@protein.osaka-u.ac.jp		So, Masatomo/0000-0002-4815-4995; Goto, Yuji/0000-0003-1221-1270	Cooperative Research Program for the Institute for Protein, Osaka University [CR-15-02, ICR-16-02]; JSPS KAKENHI [15H04362, 17K07363, 17K15074]; MEXT KAKENHI [16H00836, 17H06352]; JSPS Core-to-Core Program A (Advanced Research Networks); SENTAN from the Japan Agency for Medical Research and Development (AMED)	Cooperative Research Program for the Institute for Protein, Osaka University; JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); MEXT KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); JSPS Core-to-Core Program A (Advanced Research Networks)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); SENTAN from the Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED))	This work was supported by Cooperative Research Program for the Institute for Protein, Osaka University, Grants CR-15-02 and ICR-16-02, and JSPS KAKENHI Grants 15H04362, 17K07363, and 17K15074, and MEXT KAKENHI Grants 16H00836 and 17H06352, JSPS Core-to-Core Program A (Advanced Research Networks), and the SENTAN from the Japan Agency for Medical Research and Development (AMED). The authors declare that they have no conflicts of interest with the contents of this article.	Adachi M, 2018, J BIOL CHEM, V293, P14775, DOI 10.1074/jbc.RA118.004683; Adachi M, 2015, J BIOL CHEM, V290, P18134, DOI 10.1074/jbc.M115.648139; Albi T, 2016, WORLD J MICROB BIOT, V32, DOI 10.1007/s11274-015-1983-2; Annunziata O, 2008, J AM CHEM SOC, V130, P13347, DOI 10.1021/ja804304e; ARAKAWA T, 1982, BIOCHEMISTRY-US, V21, P6545, DOI 10.1021/bi00268a034; Arosio P, 2015, PHYS CHEM CHEM PHYS, V17, P7606, DOI 10.1039/c4cp05563b; Auer S, 2017, J PHYS CHEM B, V121, P8893, DOI 10.1021/acs.jpcb.7b05400; Bagchi B, 2005, CHEM REV, V105, P3197, DOI 10.1021/cr020661+; Baldwin RL, 1996, BIOPHYS J, V71, P2056, DOI 10.1016/S0006-3495(96)79404-3; Bellotti V, 2008, CURR OPIN STRUC BIOL, V18, P771, DOI 10.1016/j.sbi.2008.10.001; Bemporad F, 2012, CHEM BIOL, V19, P315, DOI 10.1016/j.chembiol.2012.02.003; Boatz JC, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15137; Bye JW, 2013, PROTEIN SCI, V22, P1563, DOI 10.1002/pro.2355; Calamai M, 2006, BIOCHEMISTRY-US, V45, P12806, DOI 10.1021/bi0610653; Chiti F, 2017, ANNU REV BIOCHEM, V86, P27, DOI 10.1146/annurev-biochem-061516-045115; Chiti F, 2009, NAT CHEM BIOL, V5, P15, DOI 10.1038/nchembio.131; Ciryam P, 2015, TRENDS PHARMACOL SCI, V36, P72, DOI 10.1016/j.tips.2014.12.004; Ciryam P, 2013, CELL REP, V5, P781, DOI 10.1016/j.celrep.2013.09.043; Cremers CM, 2016, MOL CELL, V63, P768, DOI 10.1016/j.molcel.2016.07.016; Dumoulin M, 2003, NATURE, V424, P783, DOI 10.1038/nature01870; Dusa A, 2006, BIOCHEMISTRY-US, V45, P2752, DOI 10.1021/bi051426z; Eichner T, 2011, MOL CELL, V43, P8, DOI 10.1016/j.molcel.2011.05.012; Gosal WS, 2005, J MOL BIOL, V351, P850, DOI 10.1016/j.jmb.2005.06.040; Gray MJ, 2014, MOL CELL, V53, P689, DOI 10.1016/j.molcel.2014.01.012; Ikenoue T, 2014, P NATL ACAD SCI USA, V111, P6654, DOI 10.1073/pnas.1322602111; Ke PC, 2017, CHEM SOC REV, V46, P6492, DOI 10.1039/c7cs00372b; KUMBLE KD, 1995, J BIOL CHEM, V270, P5818, DOI 10.1074/jbc.270.11.5818; Kuroda Yutaka, 2018, Biophys Rev, V10, P473, DOI 10.1007/s12551-017-0342-y; Lebendiker M, 2014, FEBS LETT, V588, P236, DOI 10.1016/j.febslet.2013.10.044; Liu CL, 2011, ADV PROTEIN CHEM STR, V84, P1, DOI 10.1016/B978-0-12-386483-3.00005-7; Miti T, 2015, BIOMACROMOLECULES, V16, P326, DOI 10.1021/bm501521r; Motamedi-Shad N, 2012, NAT STRUCT MOL BIOL, V19, P547, DOI 10.1038/nsmb.2286; Motamedi-Shad N, 2009, J BIOCHEM, V146, P805, DOI 10.1093/jb/mvp128; Nitani A, 2017, J BIOL CHEM, V292, P21219, DOI 10.1074/jbc.M117.813097; Pace CN, 2009, J BIOL CHEM, V284, P13285, DOI 10.1074/jbc.R800080200; Raman B, 2005, BIOCHEMISTRY-US, V44, P1288, DOI 10.1021/bi048029t; Ray SS, 2005, P NATL ACAD SCI USA, V102, P3639, DOI 10.1073/pnas.0408277102; Riek R, 2016, NATURE, V539, P227, DOI 10.1038/nature20416; Sasahara K, 2007, J MOL BIOL, V372, P981, DOI 10.1016/j.jmb.2007.06.088; So M, 2016, CURR OPIN STRUC BIOL, V36, P32, DOI 10.1016/j.sbi.2015.11.009; Soldi G, 2006, J MED CHEM, V49, P6057, DOI 10.1021/jm0606488; Souillac PO, 2002, J BIOL CHEM, V277, P12666, DOI 10.1074/jbc.M109229200; Swaminathan R, 2011, ADV PROTEIN CHEM STR, V84, P63, DOI 10.1016/B978-0-12-386483-3.00003-3; Yoshimura Y, 2012, P NATL ACAD SCI USA, V109, P14446, DOI 10.1073/pnas.1208228109; Zhang CM, 2019, P NATL ACAD SCI USA, V116, P12833, DOI 10.1073/pnas.1819813116; Zhang YJ, 2010, ANNU REV PHYS CHEM, V61, P63, DOI 10.1146/annurev.physchem.59.032607.093635; Zhou HX, 2018, CHEM REV, V118, P1691, DOI 10.1021/acs.chemrev.7b00305	47	5	5	2	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 18	2019	294	42					15318	15329		10.1074/jbc.RA119.008662	http://dx.doi.org/10.1074/jbc.RA119.008662			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JQ9HM	31439662	hybrid, Green Published			2022-12-26	WOS:000499248700011
J	Andreadis, C; Hulme, L; Wensley, K; Liu, JL				Andreadis, Christos; Hulme, Lydia; Wensley, Katherine; Liu, Ji-Long			The TOR pathway modulates cytoophidium formation in Schizosaccharomyces pombe	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Schizosaccharomyces pombe; target of rapamycin (TOR); nucleotide; pyrimidine; yeast; yeast genetics; TOR complex (TORC); subcellular organelle; signal transduction; metabolic regulation; CTP synthase; cytoophidium; fission yeast; kinase signaling; protein filamentation	CTP SYNTHETASE-ACTIVITY; PROTEIN-KINASE-A; FISSION YEAST; SACCHAROMYCES-CEREVISIAE; CYCLOPENTENYL CYTOSINE; PHOSPHATIDYLCHOLINE SYNTHESIS; NUCLEOTIDE SYNTHESIS; NITROGEN STARVATION; GENE-EXPRESSION; CELL-GROWTH	CTP synthase (CTPS) has been demonstrated to form evolutionarily-conserved filamentous structures termed cytoophidia whose exact cellular functions remain unclear, but they may play a role in intracellular compartmentalization. We have previously shown that the mammalian target of rapamycin complex 1 (mTORC1)-S6K1 pathway mediates cytoophidium assembly in mammalian cells. Here, using the fission yeast Schizosaccharomyces pombe as a model of a unicellular eukaryote, we demonstrate that the target of rapamycin (TOR)-signaling pathway regulates cytoophidium formation (from the S. pombe CTPS ortholog Cts1) also in S. pombe. Conducting a systematic analysis of all viable single TOR subunit-knockout mutants and of several major downstream effector proteins, we found that Cts1 cytoophidia are significantly shortened and often dissociate when TOR is defective. We also found that the activities of the downstream effector kinases of the TORC1 pathway, Sck1, Sck2, and Psk1 S6, as well as of the S6K/AGC kinase Gad8, the major downstream effector kinase of the TORC2 pathway, are necessary for proper cytoophidium filament formation. Interestingly, we observed that the Crf1 transcriptional corepressor for ribosomal genes is a strong effector of Cts1 filamentation. Our findings connect TOR signaling, a major pathway required for cell growth, with the compartmentalization of the essential nucleotide synthesis enzyme CTPS, and we uncover differences in the regulation of its filamentation among higher multicellular and unicellular eukaryotic systems.	[Andreadis, Christos; Liu, Ji-Long] ShanghaiTech Univ, Sch Life Sci & Technol, Shanghai 201210, Peoples R China; [Hulme, Lydia; Wensley, Katherine; Liu, Ji-Long] Univ Oxford, Dept Physiol Anat & Genet, MRC Funct Genom Unit, Oxford OX1 3PT, England	ShanghaiTech University; University of Oxford	Liu, JL (corresponding author), ShanghaiTech Univ, Sch Life Sci & Technol, Shanghai 201210, Peoples R China.; Liu, JL (corresponding author), Univ Oxford, Dept Physiol Anat & Genet, Oxford OX1 3PT, England.	liujl3@shanghaitech.edu.cn			ShanghaiTech University; UK Medical Research Council [MC_UU_12021/3, MC_U137788471]; MRC [MC_U137788471, MC_UU_12021/3] Funding Source: UKRI	ShanghaiTech University; UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by ShanghaiTech University and UK Medical Research Council Grants MC_UU_12021/3 and MC_U137788471 (to J. L. L.). The authors declare that they have no conflicts of interest with the contents of this article.	Alvarez B, 2006, J CELL SCI, V119, P4475, DOI 10.1242/jcs.03241; Aughey GN, 2016, CRIT REV BIOCHEM MOL, V51, P282, DOI 10.3109/10409238.2016.1172555; Aughey GN, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005867; Aughey GN, 2014, BIOL OPEN, V3, P1045, DOI 10.1242/bio.201410165; Azzam G, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003256; Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; Barry RM, 2014, ELIFE, V3, DOI 10.7554/eLife.03638; Beltrao P, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000134; Ben-Sahra I, 2013, SCIENCE, V339, P1323, DOI 10.1126/science.1228792; Carcamo WC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029690; Chang YF, 2007, J BIOL CHEM, V282, P17613, DOI 10.1074/jbc.M702799200; Chen KN, 2011, J GENET GENOMICS, V38, P391, DOI 10.1016/j.jgg.2011.08.004; Choi MG, 2003, J BIOL CHEM, V278, P23610, DOI 10.1074/jbc.M303337200; Chong ZZ, 2012, FUTUR NEUROL, V7, P733, DOI 10.2217/FNL.12.72; Cohen A, 2016, J BIOL CHEM, V291, P9371, DOI 10.1074/jbc.M115.705251; Davie E, 2015, CURR BIOL, V25, P445, DOI 10.1016/j.cub.2014.12.034; Dazert E, 2011, CURR OPIN CELL BIOL, V23, P744, DOI 10.1016/j.ceb.2011.09.003; Du W, 2012, BIOL OPEN, V1, P884, DOI 10.1242/bio.20122022; Fingar DC, 2004, ONCOGENE, V23, P3151, DOI 10.1038/sj.onc.1207542; FRICKE J, 1995, J BACTERIOL, V177, P517, DOI 10.1128/jb.177.3.517-523.1995; Furuta E, 2010, BBA-REV CANCER, V1805, P141, DOI 10.1016/j.bbcan.2010.01.005; GIBSON DM, 1956, BIOCHIM BIOPHYS ACTA, V21, P86, DOI 10.1016/0006-3002(56)90096-8; Gou KM, 2014, EXP CELL RES, V323, P242, DOI 10.1016/j.yexcr.2014.01.029; GROBLEWSKI GE, 1995, J BIOL CHEM, V270, P1437, DOI 10.1074/jbc.270.3.1437; Halova L, 2013, J CELL BIOL, V203, P595, DOI 10.1083/jcb.201305103; Han GS, 2005, J BIOL CHEM, V280, P38328, DOI 10.1074/jbc.M509622200; Hatse S, 1999, BIOCHEM PHARMACOL, V58, P539, DOI 10.1016/S0006-2952(99)00035-0; Hayashi T, 2007, GENES CELLS, V12, P1357, DOI 10.1111/j.1365-2443.2007.01141.x; Huang Y, 2017, EXP CELL RES, V354, P122, DOI 10.1016/j.yexcr.2017.03.042; Ikai N, 2011, OPEN BIOL, V1, DOI 10.1098/rsob.110007; Ingerson-Mahar M, 2010, NAT CELL BIOL, V12, P739, DOI 10.1038/ncb2087; Kabeche R, 2011, MOL BIOL CELL, V22, P4059, DOI 10.1091/mbc.E11-07-0605; Knutsen JHJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017175; Laplante M, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a011593; Li H, 2018, FASEB J, V32, P5891, DOI 10.1096/fj.201800045RR; Li XZ, 2018, HISTOCHEM CELL BIOL, V149, P61, DOI 10.1007/s00418-017-1612-2; Liu JL, 2016, ANNU REV CELL DEV BI, V32, P349, DOI 10.1146/annurev-cellbio-111315-124907; Liu JL, 2011, BIOESSAYS, V33, P159, DOI 10.1002/bies.201000129; Liu JL, 2010, J GENET GENOMICS, V37, P281, DOI 10.1016/S1673-8527(09)60046-1; Lynch EM, 2017, NAT STRUCT MOL BIOL, V24, P507, DOI 10.1038/nsmb.3407; Martin DE, 2004, CELL, V119, P969, DOI 10.1016/j.cell.2004.11.047; Matsuo T, 2003, EMBO J, V22, P3073, DOI 10.1093/emboj/cdg298; Matsuo T, 2007, MOL CELL BIOL, V27, P3154, DOI 10.1128/MCB.01039-06; MEUTH M, 1984, MUTAT RES, V126, P107, DOI 10.1016/0027-5107(84)90051-4; Moss J, 2010, GENE DEV, V24, P2705, DOI 10.1101/gad.1970810; Nakashima A, 2012, J CELL SCI, V125, P5840, DOI 10.1242/jcs.111146; Nakashima A, 2010, J CELL SCI, V123, P777, DOI 10.1242/jcs.060319; Narayanaswamy R, 2009, P NATL ACAD SCI USA, V106, P10147, DOI 10.1073/pnas.0812771106; Nilsson R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4128; Noree C, 2014, MOL BIOL CELL, V25, P2282, DOI 10.1091/mbc.E14-04-0912; Noree C, 2010, J CELL BIOL, V190, P541, DOI 10.1083/jcb.201003001; Otsubo Y, 2017, BIOMOLECULES, V7, DOI 10.3390/biom7030050; OZIERKALOGEROPOULOS O, 1991, MOL GEN GENET, V231, P7, DOI 10.1007/BF00293815; OZIERKALOGEROPOULOS O, 1994, MOL GEN GENET, V242, P431, DOI 10.1007/BF00281793; Park TS, 2003, J BIOL CHEM, V278, P20785, DOI 10.1074/jbc.M301394200; Park TS, 1999, BIOCHEMISTRY-US, V38, P8839, DOI 10.1021/bi990784x; Pearce LR, 2010, NAT REV MOL CELL BIO, V11, P9, DOI 10.1038/nrm2822; Perez-Hidalgo L, 2017, BIOMOLECULES, V7, DOI 10.3390/biom7030059; PHEAR G, 1987, P NATL ACAD SCI USA, V84, P4450, DOI 10.1073/pnas.84.13.4450; Raimondo L, 2016, ONCOTARGET, V7, P40073, DOI 10.18632/oncotarget.9484; Rallis C, 2013, AGING CELL, V12, P563, DOI 10.1111/acel.12080; Ralph E, 2006, EMBO REP, V7, P1134, DOI 10.1038/sj.embor.7400827; Robitaille AM, 2013, SCIENCE, V339, P1320, DOI 10.1126/science.1228771; Roguev A, 2008, SCIENCE, V322, P405, DOI 10.1126/science.1162609; Rosner M, 2008, MUTAT RES-REV MUTAT, V659, P284, DOI 10.1016/j.mrrev.2008.06.001; Saxton RA, 2017, CELL, V168, P960, DOI [10.1016/j.cell.2017.03.035, 10.1016/j.cell.2017.02.004]; Schonbrun M, 2013, J BIOL CHEM, V288, P19649, DOI 10.1074/jbc.M113.464974; Schonbrun M, 2009, MOL CELL BIOL, V29, P4584, DOI 10.1128/MCB.01879-08; Sparks CA, 2010, ONCOGENE, V29, P3733, DOI 10.1038/onc.2010.139; Strochlic TI, 2014, EMBO REP, V15, P1184, DOI 10.15252/embr.201438688; Sun Z, 2019, J GENET GENOMICS, V46, P65, DOI 10.1016/j.jgg.2018.11.006; Takahara T, 2012, GENES CELLS, V17, P698, DOI 10.1111/j.1365-2443.2012.01618.x; Tastan OY, 2015, J GENET GENOMICS, V42, P261, DOI 10.1016/j.jgg.2015.04.006; Valentin-Hansen P, 1978, Methods Enzymol, V51, P308; VANDENBERG AA, 1995, EUR J CANCER, V31A, P108, DOI 10.1016/0959-8049(94)00442-8; VANDENBERG AA, 1993, EUR J BIOCHEM, V216, P161; Verschuur AC, 2001, LEUKEMIA RES, V25, P891, DOI 10.1016/S0145-2126(01)00047-9; Verschuur AC, 2000, BRIT J HAEMATOL, V110, P161, DOI 10.1046/j.1365-2141.2000.02136.x; Vershuur AC, 2002, INT J CANCER, V98, P616, DOI 10.1002/ijc.10211; Weisman R, 2005, GENETICS, V169, P539, DOI 10.1534/genetics.104.034983; Weisman R, 2007, GENETICS, V175, P1153, DOI 10.1534/genetics.106.064170; WHELAN J, 1993, NAT GENET, V3, P317, DOI 10.1038/ng0493-317; Wilkinson MG, 1999, EMBO J, V18, P4210, DOI 10.1093/emboj/18.15.4210; WILLIAMS JC, 1978, NATURE, V271, P71, DOI 10.1038/271071a0; Wise DR, 2010, TRENDS BIOCHEM SCI, V35, P427, DOI 10.1016/j.tibs.2010.05.003; Wullschleger S, 2006, CELL, V127, P5, DOI 10.1016/j.cell.2006.01.016; Zhang J, 2014, BIOL OPEN, V3, P1092, DOI 10.1242/bio.20149613; Zhang SS, 2018, PLOS GENET, V14, DOI 10.1371/journal.pgen.1007737; Zhao Y, 2006, MOL CELL BIOL, V26, P4853, DOI 10.1128/MCB.02367-05	89	16	17	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 4	2019	294	40					14686	14703		10.1074/jbc.RA119.009913	http://dx.doi.org/10.1074/jbc.RA119.009913			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JP0II	31431504	Green Published, hybrid			2022-12-26	WOS:000497955000015
J	Rolfsjord, LB; Skjerven, HO; Bakkeheim, E; Berents, TL; Carlsen, KH; Carlsen, KCL				Rolfsjord, Leif Bjarte; Skjerven, Havard Ove; Bakkeheim, Egil; Berents, Teresa Lovold; Carlsen, Kai-Hakon; Carlsen, Karin C. Lodrup			Quality of life, salivary cortisol and atopic diseases in young children	PLOS ONE			English	Article							ACUTE BRONCHIOLITIS; 1ST YEAR; REFERENCE VALUES; ASTHMA; STRESS; SEVERITY; ALLERGY; SEX; AGE	Background Children with atopic disease may have reduced health-related quality of life (QoL) and morning cortisol. Possible links between QoL, morning cortisol and atopic disease are unclear. We aimed to determine if QoL was associated with morning salivary cortisol at two years of age, and if asthma, atopic dermatitis and/or allergic sensitisation influenced this association. Secondarily, we aimed to determine if QoL at one year of age was associated with salivary cortisol one year later. Methods and findings The Bronchiolitis All SE-Norway study included infants during hospitalisation for acute bronchiolitis in infancy (bronchiolitis group) and population-based control infants (controls). The present study included all 358 subjects with available Infant Toddler Quality of Life Questionnaire (ITQOL) from parents, consisting of 13 domains and morning salivary cortisol at two years of age. Answers from the same 0-100 score questionnaire, with optimal score 100 nine months after enrolment, was also available for 289 of these children at about one year of age. Recurrent bronchial obstruction was used as an asthma proxy. Atopic dermatitis was defined by Hanifin and Rajka criteria and allergic sensitisation by a positive skin prick test. Due to different inclusion criteria, we tested possible interactions with affiliation groups. Associations between QoL and cortisol were analysed by multivariate analyses, stratified by bronchiolitis and control groups due to interaction from affiliation grouping on results. At two years of age, QoL decreased significantly with decreasing cortisol in 8/13 QoL domains in the bronchiolitis group, but only with General health in the controls. The associations in the bronchiolitis group showed 0.06-0.19 percentage points changes per nmol/L cortisol for each of the eight domains (p-values 0.0001-0.034). The associations remained significant but diminished by independently including recurrent bronchial obstruction and atopic dermatitis, but remained unchanged by allergic sensitisation. In the bronchiolitis group only, 7/13 age and gender adjusted QoL domains in one-year old children were lower with lower cortisol levels at two years of age (p = 0.0005-0.04). Conclusions At two years, most QoL domains decreased with lower salivary cortisol among children who had been hospitalised for acute bronchiolitis in infancy, but for one domain only among controls. Recurrent bronchial obstruction and to a lesser extent atopic dermatitis, weakened these associations that nevertheless remained significant. After bronchiolitis, lower QoL in one-year old children was associated with lower salivary cortisol at two years.	[Rolfsjord, Leif Bjarte] Innlandet Hosp Trust, Dept Paediat, Elverum, Norway; [Rolfsjord, Leif Bjarte; Skjerven, Havard Ove; Bakkeheim, Egil; Carlsen, Kai-Hakon; Carlsen, Karin C. Lodrup] Oslo Univ Hosp, Div Paediat & Adolescent Med, Oslo, Norway; [Rolfsjord, Leif Bjarte; Skjerven, Havard Ove; Carlsen, Kai-Hakon; Carlsen, Karin C. Lodrup] Univ Oslo, Inst Clin Med, Oslo, Norway; [Berents, Teresa Lovold] Oslo Univ Hosp, Dept Dermatol, Oslo, Norway	Innlandet Hospital Trust; University of Oslo; University of Oslo; University of Oslo	Rolfsjord, LB (corresponding author), Innlandet Hosp Trust, Dept Paediat, Elverum, Norway.; Rolfsjord, LB (corresponding author), Oslo Univ Hosp, Div Paediat & Adolescent Med, Oslo, Norway.; Rolfsjord, LB (corresponding author), Univ Oslo, Inst Clin Med, Oslo, Norway.	rolfl@sykehuset-innlandet.no			Innlandet Hospital Trust from a research fund foundation, Klosterstiftelsen [150189]	Innlandet Hospital Trust from a research fund foundation, Klosterstiftelsen	The project was supported by a grant to the first author's employer, Innlandet Hospital Trust, (Project no. 150189 to LBR) from a research fund foundation, Klosterstiftelsen. Klosterstiftelsen does not have any specific URL, but further information can be reached at https://www.purehelp.no/m/company/details/klosterstiftelsen/982953146. No commercial companies funded the study or authors. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The other authors did not receive any specific funding for this work.	Bakkeheim E, 2010, ACTA PAEDIATR, V99, P1705, DOI 10.1111/j.1651-2227.2009.01598.x; Bakkeheim E, 2016, MORNING SALIVARY COR; Bhandari P, 2012, HEALTH QUAL LIFE OUT, V10, DOI 10.1186/1477-7525-10-26; Bont L, 2004, PEDIATR INFECT DIS J, V23, P414, DOI 10.1097/01.inf.0000122604.32137.29; CARLSEN KH, 1987, EUR J RESPIR DIS, V70, P86; Chamlin SL, 2010, IMMUNOL ALLERGY CLIN, V30, P281, DOI 10.1016/j.iac.2010.05.004; Chen E, 2003, PSYCHOSOM MED, V65, P984, DOI 10.1097/01.PSY.0000097340.54195.3C; Clow A, 2004, STRESS, V7, P29, DOI 10.1080/10253890410001667205; DREGER LC, 2010, THE JOURNAL OF ALLER, V125, P116, DOI DOI 10.1016/J.JACI.2009.09.051; Everhart RS, 2009, PATIENT EDUC COUNS, V75, P162, DOI 10.1016/j.pec.2008.10.001; Hamilton. L.C., 1992, REGRESSION GRAPHICS; HANIFIN JM, 1980, ACTA DERM-VENEREOL, P44; HOSMER DW, 2000, WILEY PS TX, P1; Ivars K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129502; Kantar A, 2017, J THORAC DIS, V9, P907, DOI 10.21037/jtd.2017.03.53; Kojima R, 2013, PEDIATR DERMATOL, V30, P17, DOI 10.1111/j.1525-1470.2012.01770.x; Lang A, 2010, PEDIAT ALLERG IMM-UK, V21, P945, DOI 10.1111/j.1399-3038.2010.01072.x; Lee A, 2016, J ALLERGY CLIN IMMUN, V138, P740, DOI 10.1016/j.jaci.2016.01.014; Mohangoo AD, 2012, QUAL LIFE RES, V21, P545, DOI 10.1007/s11136-011-9957-9; Nagakura T, 2012, ALLERGY ASTHMA PROC, V33, P362, DOI 10.2500/aap.2012.33.3578; Oostenbrink R, 2006, PEDIATR PULM, V41, P993, DOI 10.1002/ppul.20486; Priftis KN, 2009, ALLERGY, V64, P18, DOI 10.1111/j.1398-9995.2008.01948.x; Raat H, 2007, QUAL LIFE RES, V16, P445, DOI 10.1007/s11136-006-9134-8; Rolfsjord LB, 2019, QUALITY LIFE SALIVAR; Rolfsjord LB, 2017, J PEDIATR-US, V184, P193, DOI 10.1016/j.jpeds.2017.01.064; Rolfsjord LB, 2016, ACTA PAEDIATR, V105, P834, DOI 10.1111/apa.13396; Rolfsjord LB, 2015, ACTA PAEDIATR, V104, P53, DOI 10.1111/apa.12792; Sigurs N, 2010, THORAX, V65, P1045, DOI 10.1136/thx.2009.121582; Skjerven HO, 2016, J INFECT DIS, V213, P915, DOI 10.1093/infdis/jiv513; Skjerven HO, 2015, LANCET RESP MED, V3, P702, DOI 10.1016/S2213-2600(15)00319-7; Skjerven HO, 2013, NEW ENGL J MED, V368, P2286, DOI 10.1056/NEJMoa1301839; Smidesang I, 2010, PEDIAT ALLERG IMM-UK, V21, P315, DOI 10.1111/j.1399-3038.2009.00954.x; Spuijbroek AT, 2011, QUAL LIFE RES, V20, P779, DOI 10.1007/s11136-010-9806-2; Sredniawa A, 2019, TRENDS PSYCHIATR PSY, V41, P60, DOI 10.1590/2237-6089-2017-0154; Stenius F, 2011, J ALLERGY CLIN IMMUN, V128, P1335, DOI 10.1016/j.jaci.2011.07.038; Wolf JM, 2008, BIOL PSYCHOL, V78, P20, DOI 10.1016/j.biopsycho.2007.12.004; Yoshida S, 2017, TOHOKU J EXP MED, V243, P275, DOI 10.1620/tjem.243.275	38	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2019	14	8							e0214040	10.1371/journal.pone.0214040	http://dx.doi.org/10.1371/journal.pone.0214040			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW6BO	31469854	Green Published, gold, Green Submitted			2022-12-26	WOS:000485062200001
J	Gendron, N; Chahabi, SZ; Poenou, G; Rivet, N; Belleville-Rolland, T; Lemaire, P; Escuret, A; Ciaudo, M; Curis, E; Gaussem, P; Siguret, V; Darnige, L				Gendron, Nicolas; Chahabi, Sara Zia; Poenou, Geraldine; Rivet, Nadia; Belleville-Rolland, Tiphaine; Lemaire, Pierre; Escuret, Antoine; Ciaudo, Michele; Curis, Emmanuel; Gaussem, Pascale; Siguret, Virginie; Darnige, Luc			Pain assessment and factors influencing pain during bone marrow aspiration: A prospective study	PLOS ONE			English	Article							LIDOCAINE; ANXIETY	Although bone marrow aspiration (BMA) is still considered a painful procedure, pain level remains poorly documented. We therefore conducted a prospective study intended to evaluate pain level in adult patients undergoing BMA at the sternal or iliac crest site to identify factors associated with pain. We enrolled a total of 448 patients who underwent 461 BMA and asked those patients to score their pain intensity after BMA using numerical pain rating scale (NPRS). The following factors: level of anxiety, quality of the information given to the patient, operator's experience, and bone texture were recorded using a standardized questionnaire. The median NPRS score was 3.5 (IQR [2.0; 5.0]) the sternal site (n = 405) was associated with an increased median NPRS score (3.5 [2.0; 5.0]) compared to the iliac crest (n = 56, 2.5 [1.0; 4.0]; p<0.0001). For those patients who underwent sternal BMA, the median NPRS score was significantly lower when using lidocaine infiltration (p = 0.0159) as compared with no anesthetic use. Additionally there was no significant effect of anesthetic cream found. After multivariate analysis, the model of NPRS score at the sternal site included patient anxiety (p<0.0001) and the use of lidocaine infiltration (0.0378). This study underlines the usefulness of a comprehensive management including pain relief and efforts to reduce anxiety including appropriate information given to the patient during BMA.	[Gendron, Nicolas; Chahabi, Sara Zia; Poenou, Geraldine; Rivet, Nadia; Belleville-Rolland, Tiphaine; Lemaire, Pierre; Escuret, Antoine; Ciaudo, Michele; Gaussem, Pascale; Siguret, Virginie; Darnige, Luc] Hop Europeen Georges Pompidou, AP HP, Serv Hematol Biol, Paris, France; [Gendron, Nicolas; Chahabi, Sara Zia; Poenou, Geraldine; Rivet, Nadia; Belleville-Rolland, Tiphaine; Escuret, Antoine; Curis, Emmanuel; Gaussem, Pascale; Siguret, Virginie; Darnige, Luc] Univ Paris, Paris, France; [Gendron, Nicolas; Rivet, Nadia; Belleville-Rolland, Tiphaine; Gaussem, Pascale; Siguret, Virginie; Darnige, Luc] INSERM UMR S1140, Paris, France; [Chahabi, Sara Zia; Siguret, Virginie] Hop Lariboisiere, AP HP, Paris, France; [Curis, Emmanuel] Univ Paris 05, Fac Pharm Paris, Lab Biomath, Plateau B2, Paris, France; [Curis, Emmanuel] Hop St Louis, AP HP, Serv Biostat & Informat Med, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite	Darnige, L (corresponding author), Hop Europeen Georges Pompidou, AP HP, Serv Hematol Biol, Paris, France.; Darnige, L (corresponding author), Univ Paris, Paris, France.; Darnige, L (corresponding author), INSERM UMR S1140, Paris, France.	luc.darnige@aphp.fr	Gaussem, Pascale/ABA-2228-2020; Gaussem, P./ABA-1222-2020; Curis, Emmanuel/A-4185-2012; Gaussem, Pascale/AGY-9723-2022; Darnige, Luc/AAO-6452-2021; Gendron, Nicolas/AAB-8014-2022; SIGURET, Virginie/GPC-5530-2022; darnige, luc/J-2538-2019	Gaussem, P./0000-0002-9139-2147; Curis, Emmanuel/0000-0001-8382-1493; Darnige, Luc/0000-0003-3210-2821; Gendron, Nicolas/0000-0003-4852-4738; 	AP-HP (Assistance Publique - Hopitaux de Paris)	AP-HP (Assistance Publique - Hopitaux de Paris)	This work was supported by a grant from AP-HP (Assistance Publique - Hopitaux de Paris) to NG. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bain BJ, 2006, HAEMATOLOGICA, V91, P1293; Bain BJ, 2001, J CLIN PATHOL, V54, P657, DOI 10.1136/jcp.54.9.657; Brunetti GA, 2011, ANN HEMATOL, V90, P1233, DOI 10.1007/s00277-011-1166-7; Degen C, 2010, ANN HEMATOL, V89, P619, DOI 10.1007/s00277-010-0934-0; Kuball J., 2004, ACUTE PAIN, V6, P9, DOI [DOI 10.1016/J.ACPAIN.2004.02.003, 10.1016/j.acpain.2004.02.003]; Kuivalainen AM, 2014, SCAND J PAIN, V5, P43, DOI 10.1016/j.sjpain.2013.10.003; Kuivalainen AM, 2012, SCAND J PAIN, V3, P92, DOI 10.1016/j.sjpain.2011.11.002; Kuivalainen AM, 2010, EUR J PAIN, V14, P160, DOI 10.1016/j.ejpain.2009.04.012; Mainwaring CJ, 1996, CLIN LAB HAEMATOL, V18, P285; Malempati Suman, 2009, N Engl J Med, V361, pe28, DOI 10.1056/NEJMvcm0804634; Odejide OO, 2013, CANCER-AM CANCER SOC, V119, P3472, DOI 10.1002/cncr.28249; Ozdemir U, 2019, PAIN MANAG NURS, V20, P82, DOI 10.1016/j.pmn.2018.04.009; Portnow Jana, 2003, J Natl Compr Canc Netw, V1, P435; Puntillo KA, 2002, AM J CRIT CARE, V11, P415, DOI 10.4037/ajcc2002.11.5.415; Santavy P, 2013, HEMATOL REP, V5, P43, DOI 10.4081/hr.2013.e13; Societe Francaise d'Hematologie, 2003, GUID BONN PAR PONCT; Talamo Giampaolo, 2012, J Support Oncol, V10, P166, DOI 10.1016/j.suponc.2012.04.002; Vanhelleputte PA, 2003, J PAIN SYMPTOM MANAG, V26, P860, DOI 10.1016/S0885-3924(03)00312-9; Yuvali Karacan Y, 2017, AGRI, V29, P167, DOI 10.5505/agri.2017.90582	19	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2019	14	8							e0221534	10.1371/journal.pone.0221534	http://dx.doi.org/10.1371/journal.pone.0221534			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW6AB	31465426	Green Published, gold, Green Submitted			2022-12-26	WOS:000485058200024
J	Kimbara, R; Isaka, N; Matsuzaki, R; Kawai-Toyooka, H; Kawachi, M; Nozaki, H				Kimbara, Ryosuke; Isaka, Nanako; Matsuzaki, Ryo; Kawai-Toyooka, Hiroko; Kawachi, Masanobu; Nozaki, Hisayoshi			Morphological and molecular identification of the dioecious "African species Volvox rousseletii (Chlorophyceae) in the water column of a Japanese lake based on field-collected and cultured materials	PLOS ONE			English	Article								Volvox rousseletii is a dioecious species belonging to Volvox sect. Volvox that has previously only been found in Africa. During field surveys in a large dam lake (Lake Sagami) in Kanagawa Prefecture, central Japan, we encountered a Volvox sect. Volvox species that produces dioecious sexual spheroids in the water column. Although sexual induction of this species in culture did not produce adequately well-developed sexual spheroids for species identification, molecular data directly obtained from field-collected sexual spheroids verified the identity of field-collected male and female sexual spheroids as well as cultured materials. Based on molecular and morphological data, the species was identified as V. rousseletii. This is the first record of a dioecious species of Volvox sect. Volvox in Japan.	[Kimbara, Ryosuke; Isaka, Nanako; Kawai-Toyooka, Hiroko; Nozaki, Hisayoshi] Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Bunkyo Ku, Tokyo, Japan; [Matsuzaki, Ryo; Kawachi, Masanobu] Natl Inst Environm Studies, Ctr Environm Biol & Ecosyst Studies, Tsukuba, Ibaraki, Japan; [Matsuzaki, Ryo] Univ Tsukuba, Fac Life & Environm Sci, Tsukuba, Ibaraki, Japan	University of Tokyo; National Institute for Environmental Studies - Japan; University of Tsukuba	Nozaki, H (corresponding author), Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Bunkyo Ku, Tokyo, Japan.	nozaki@bs.s.u-tokyo.ac.jp	Kimbara, Ryosuke/AHD-9667-2022	Kimbara, Ryosuke/0000-0003-3328-0638; Nozaki, Hisayoshi/0000-0002-9308-4498; Matsuzaki, Ryo/0000-0002-8989-5933; Kawachi, Masanobu/0000-0001-9911-0688	Ministry of Education, Culture, Sports, Science and Technology (MEXT)/Japan Society for the Promotion of Science (JSPS) KAKENHI [16H02518]	Ministry of Education, Culture, Sports, Science and Technology (MEXT)/Japan Society for the Promotion of Science (JSPS) KAKENHI	HN was supported by a Grant-in-Aid for Scientific Research (grant number 16H02518) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT)/Japan Society for the Promotion of Science (JSPS) KAKENHI (https://www.jsps.go.jp/english/e-grants/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayres DL, 2012, SYST BIOL, V61, P170, DOI [10.1093/sysbio/syr100, 10.1093/sysbio/sys029]; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Hanschen ER, 2018, EVOL ECOL RES, V19, P299; Isaka N, 2012, J PHYCOL, V48, P759, DOI 10.1111/j.1529-8817.2012.01142.x; IYENGAR M.O.P., 1933, J LINN SOC BOT, V49, P323; KATO S, 1982, Japanese Journal of Phycology, V30, P63; Kawachi M, 2013, LIST STRAINS; McCracken M. D, 1970, Arch. Protistenk., V112, P262; NOZAKI H, 1988, PHYCOLOGIA, V27, P209, DOI 10.2216/i0031-8884-27-2-209.1; Nozaki H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167148; Nozaki H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142632; Nozaki H, 2015, PHYCOLOGIA, V54, P316, DOI 10.2216/15-14.1; Pringsheim E.G., 1946, PURE CULTURES ALGAE; RICH FLORENCE, 1933, ANN S AFRICAN MUS, V16, P427; Smith Gilbert M., 1944, TRANS AMER MICROSC SOC, V63, P265, DOI 10.2307/3223302; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]	16	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2019	14	8							e0221632	10.1371/journal.pone.0221632	http://dx.doi.org/10.1371/journal.pone.0221632			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW6AB	31465476	Green Published, gold, Green Submitted			2022-12-26	WOS:000485058200034
J	Aron, M; Herzog, S; Parlitz, U; Luther, S; Lilienkamp, T				Aron, Marcel; Herzog, Sebastian; Parlitz, Ulrich; Luther, Stefan; Lilienkamp, Thomas			Spontaneous termination of chaotic spiral wave dynamics in human cardiac ion channel models	PLOS ONE			English	Article							VENTRICULAR-FIBRILLATION; TRANSIENT CHAOS; ARRHYTHMIAS	Chaotic spiral or scroll wave dynamics can be found in diverse systems. In cardiac dynamics, spiral or scroll waves of electrical excitation determine the dynamics during life-threatening arrhythmias like ventricular fibrillation. In numerical studies it was found that chaotic episodes of spiral and scroll waves can be transient, thus they terminate spontaneously. We show in this study that this behavior can also be observed using models which describe the ion channel dynamics of human cardiomyocytes (Bueno-Orovio-Cherry-Fenton model and the Ten Tusscher-Noble-Noble-Panfilov model). For both models we find that the average lifetime of the chaotic transients grows exponentially with the system size. With this behavior, we classify the systems into the group of type-II supertransients. We observe a significant difference of the breakup behavior between the models, which results in a distinct dynamics during the final phase just before the termination. The observation of a (temporally) stable single-spiral state affects the prevailing description of the dynamics of type-II supertransients as being "quasi-stationary" and also the feasibility of predicting the spontaneous termination of the spiral wave dynamics. In the long term, the relation between the breakup behavior of spiral waves and properties of chaotic transients like predictability or average transient lifetime may contribute to an improved understanding and classification of cardiac arrhythmias.	[Aron, Marcel; Herzog, Sebastian; Parlitz, Ulrich; Luther, Stefan; Lilienkamp, Thomas] Max Planck Inst Dynam & Self Org, Gottingen, Germany; [Aron, Marcel; Herzog, Sebastian; Parlitz, Ulrich; Luther, Stefan] Georg August Univ Gottingen, Inst Dynam Komplexer Syst, Gottingen, Germany; [Herzog, Sebastian] Univ Gottingen, Inst Phys 3, Friedrich Hund Pl 1, Gottingen, Germany; [Herzog, Sebastian] Bernstein Ctr Computat Neurosci, Friedrich Hund Pl 1, Gottingen, Germany; [Parlitz, Ulrich; Luther, Stefan; Lilienkamp, Thomas] DZHK German Ctr Cardiovasc Res, Partner Site Gottingen, Gottingen, Germany; [Luther, Stefan] Univ Med Ctr Gottingen, Dept Pharmacol & Toxicol, Gottingen, Germany; [Lilienkamp, Thomas] Univ Med Ctr Gottingen, Dept Cardiol & Pneumol, Gottingen, Germany	Max Planck Society; University of Gottingen; University of Gottingen; German Centre for Cardiovascular Research; University of Gottingen; University of Gottingen	Lilienkamp, T (corresponding author), Max Planck Inst Dynam & Self Org, Gottingen, Germany.; Lilienkamp, T (corresponding author), DZHK German Ctr Cardiovasc Res, Partner Site Gottingen, Gottingen, Germany.; Lilienkamp, T (corresponding author), Univ Med Ctr Gottingen, Dept Cardiol & Pneumol, Gottingen, Germany.	thomas.lilienkamp@ds.mpg.de	Luther, Stefan/C-7226-2009	Lilienkamp, Thomas/0000-0003-1117-6733	German Centre for Cardiovascular Research (DZHK e.V.); Max Planck Research School (IMPRS) for Physics of Biological and Complex Systems (PBCS); Federal Ministry of Education and Research (BMBF) [FKZ031A147]	German Centre for Cardiovascular Research (DZHK e.V.); Max Planck Research School (IMPRS) for Physics of Biological and Complex Systems (PBCS); Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF))	T.L. was funded by German Centre for Cardiovascular Research (DZHK e.V., Project GOE MD 1 UMG "Herzinsuffizienz -Transition", and "Arrhythmia Modelling"). S.H. was funded by Max Planck Research School (IMPRS) for Physics of Biological and Complex Systems (PBCS). S.L. was funded by the Federal Ministry of Education and Research (BMBF, FKZ031A147, GO-Bio) and U.P. was funded by the Federal Ministry of Education and Research (BMBF, FKZ031A147, GO-Bio). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aras Kedar K, 2018, CIRC-ARRHYTHMIA ELEC, V11; Aslanidi OV, 2002, CHAOS, V12, P843, DOI 10.1063/1.1500496; Bueno-Orovio A, 2008, J THEOR BIOL, V253, P544, DOI 10.1016/j.jtbi.2008.03.029; Buran P, 2017, CHAOS, V27, DOI 10.1063/1.5010787; Cherry EM, 2008, NEW J PHYS, V10, DOI 10.1088/1367-2630/10/12/125016; CLAYTON RH, 1993, LANCET, V341, P93, DOI 10.1016/0140-6736(93)92567-D; CRUTCHFIELD JP, 1988, PHYS REV LETT, V60, P2715, DOI 10.1103/PhysRevLett.60.2715; DAVIDENKO JM, 1992, NATURE, V355, P349, DOI 10.1038/355349a0; Ellner SP, 2005, OIKOS, V111, P620, DOI 10.1111/j.1600-0706.2005.14129.x; Faisst Holger, 2003, Phys Rev Lett, V91, P224502; Gray RA, 1998, NATURE, V392, P75, DOI 10.1038/32164; HTTPS, 2010, NEW ENGL J MED, V10, P25; HTTPS, NEJM; HTTPS, NEW ENGL J MED, DOI DOI 10.1136/HRT.2004.042473; JA P, 1994, PHYSREVLETT, V73, P529; Kahan T, 2005, HEART, V91, P250, DOI 10.1136/hrt.2004.042473; Konishi Shozo, 2014, J Cardiol Cases, V10, P136, DOI 10.1016/j.jccase.2014.06.005; Konstantino Y, 2011, AM J CARDIOL, V107, P638, DOI 10.1016/j.amjcard.2010.10.025; LAI YCTE, 2011, SPRINGER; Lilienkamp T, 2018, PHYS REV E, V98, DOI 10.1103/PhysRevE.98.022215; Lilienkamp T, 2018, PHYS REV LETT, V120, DOI 10.1103/PhysRevLett.120.094101; Lilienkamp T, 2017, PHYS REV LETT, V119, DOI 10.1103/PhysRevLett.119.054101; Lloyd CM, 2008, BIOINFORMATICS, V24, P2122, DOI 10.1093/bioinformatics/btn390; Luther S, 2011, NATURE, V475, P235, DOI 10.1038/nature10216; Maclachlan Mary C., 2007, Computer Methods in Biomechanics and Biomedical Engineering, V10, P317, DOI 10.1080/10255840701259301; Marcotte CD, 2017, CHAOS, V27, DOI 10.1063/1.5003259; MCLENACHAN JM, 1987, NEW ENGL J MED, V317, P787, DOI 10.1056/NEJM198709243171302; Panfilov AV, 2006, HEART RHYTHM, V3, P862, DOI 10.1016/j.hrthm.2005.12.022; Poole B, 2016, ARXIV 160605340; QU Z, 2005, AM J PHYSIOL-HEART C, V290, pH25, DOI DOI 10.1038/NATURE10216; REZNIK D, 1993, Z PHYS B CON MAT, V91, P309, DOI 10.1007/BF01344059; Sugimura K, 2015, PHYS REV E, V92, DOI 10.1103/PhysRevE.92.062915; ten Tusscher KHWJ, 2006, AM J PHYSIOL-HEART C, V291, pH1088, DOI 10.1152/ajpheart.00109.2006; ten Tusscher KHWJ, 2004, AM J PHYSIOL-HEART C, V286, pH1573, DOI 10.1152/ajpheart.00794.2003; Verma A, 2008, JACC-CARDIOVASC IMAG, V1, P582, DOI 10.1016/j.jcmg.2008.05.012; Witkowski FX, 1998, NATURE, V392, P78, DOI 10.1038/32170; Wu X, 1994, NETWORK COMPUTATION, V5, P47, DOI 10.1088/0954-898X_5_1_003; Yamazaki M, 2006, AM J PHYSIOL, V292, pH539; Yang XS, 2005, NEUROCOMPUTING, V69, P232, DOI 10.1016/j.neucom.2005.06.005	39	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2019	14	8							e0221401	10.1371/journal.pone.0221401	http://dx.doi.org/10.1371/journal.pone.0221401			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5XV	31461472	Green Published, gold, Green Submitted			2022-12-26	WOS:000485052300030
J	Nakahashi, M; Esumi, M; Tokuhashi, Y				Nakahashi, Masahiro; Esumi, Mariko; Tokuhashi, Yasuaki			Detection of apoptosis and matrical degeneration within the intervertebral discs of rats due to passive cigarette smoking	PLOS ONE			English	Article							LOW-BACK-PAIN; NUCLEUS PULPOSUS; GENE-EXPRESSION; RISK-FACTORS; FOLLOW-UP; NICOTINE; HOSPITALIZATION; ASSOCIATION; INHIBITION; PREDICTORS	Although low-back pain is considered to be associated with cigarette smoking, the influence of cigarette smoking on the intervertebral discs (IVD) has not been confirmed. We established a rat model of passive cigarette smoking-induced IVD degeneration, and investigated the cytohistological changes in the IVD and the accompanying changes in gene expression. IVD from rats exposed to 8 weeks of passive cigarette smoking were stained with Elastica van Gieson, and exhibited marked destruction of the supportive structure of the reticular matrix in the nucleus pulposus (NP). Positive signals on safranin O, alcian blue, type II collagen and aggrecan staining were decreased in the destroyed structure. Safranin O and type II collagen signals were also decreased in the cartilage end-plate (CEP) after 4- and 8-weeks of cigarette smoking. In the CEP, the potential for apoptosis was increased significantly, as demonstrated by staining for single-strand DNA. However, there were no signs of apoptosis in the NP or annulus fibrosus cells. Based on these findings, we hypothesized that passive cigarette smoking-induced stress stimuli first affect the CEP through blood flow due to the histological proximity, thereby stimulating chondrocyte apoptosis and reduction of the extracellular matrix (ECM). This leads to reduction of the ECM in the NP, destroying the NP matrix, which can then progress to IVD degeneration.	[Nakahashi, Masahiro; Tokuhashi, Yasuaki] Nihon Univ, Dept Orthopaed Surg, Sch Med, Itabashi Ku, Tokyo, Japan; [Nakahashi, Masahiro; Esumi, Mariko; Tokuhashi, Yasuaki] Nihon Univ, Dept Therapeut Aging Locomot Disorders, Sch Med, Itabashi Ku, Tokyo, Japan; [Esumi, Mariko] Nihon Univ, Dept Biomed Sci, Sch Med, Itabashi Ku, Tokyo, Japan	Nihon University; Nihon University; Nihon University	Esumi, M (corresponding author), Nihon Univ, Dept Therapeut Aging Locomot Disorders, Sch Med, Itabashi Ku, Tokyo, Japan.; Esumi, M (corresponding author), Nihon Univ, Dept Biomed Sci, Sch Med, Itabashi Ku, Tokyo, Japan.	esumi.mariko@nihon-u.ac.jp	TOKUHASHI, YASUAKI/AAC-4812-2020					Akmal M, 2004, SPINE, V29, P568, DOI 10.1097/01.BRS.0000101422.36419.D8; Arana CJ, 2010, ARTHRITIS RHEUM-US, V62, P3395, DOI 10.1002/art.27651; Ariga K, 2001, SPINE, V26, P2414, DOI 10.1097/00007632-200111150-00004; Behrend C, 2012, J BONE JOINT SURG AM, V94A, P2161, DOI 10.2106/JBJS.K.01598; Daffner SD, 2015, SPINE J, V15, P1402, DOI 10.1016/j.spinee.2015.02.041; Elmasry S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136137; ERNST E, 1993, BRIT J RHEUMATOL, V32, P239; Frymoyer J W, 1992, Instr Course Lect, V41, P217; FRYMOYER JW, 1983, J BONE JOINT SURG AM, V65, P213, DOI 10.2106/00004623-198365020-00010; FRYMOYER JW, 1980, SPINE, V5, P419, DOI 10.1097/00007632-198009000-00005; Glassman SD, 2000, SPINE, V25, P2608, DOI 10.1097/00007632-200010150-00011; Goldberg MS, 2000, SPINE, V25, P995, DOI 10.1097/00007632-200004150-00016; Goldenberg-Cohen N, 2012, APOPTOSIS, V17, P278, DOI 10.1007/s10495-011-0678-x; Ha KY, 2006, SPINE, V31, P1309, DOI 10.1097/01.brs.0000219493.76081.d6; HELIOVAARA M, 1991, SPINE, V16, P608, DOI 10.1097/00007632-199106000-00002; HOLM S, 1988, UPSALA J MED SCI, V93, P91, DOI 10.1517/03009734000000042; Huang LE, 1999, J BIOL CHEM, V274, P9038, DOI 10.1074/jbc.274.13.9038; Hunter CJ, 2003, TISSUE ENG, V9, P667, DOI 10.1089/107632703768247368; Ishibashi M, 2010, BIOCHEM BIOPH RES CO, V392, P397, DOI 10.1016/j.bbrc.2010.01.034; Iwahashi M, 2002, SPINE, V27, P1396, DOI 10.1097/00007632-200207010-00005; Kaila-Kangas L, 2003, SPINE, V28, P1860, DOI 10.1097/01.BRS.0000083284.47176.80; KELSEY JL, 1984, SPINE, V9, P608, DOI 10.1097/00007632-198409000-00012; Kepler CK, 2013, SPINE J, V13, P318, DOI 10.1016/j.spinee.2012.12.003; Mattila VM, 2008, PAIN, V139, P209, DOI 10.1016/j.pain.2008.03.028; Mattila VM, 2008, EUR SPINE J, V17, P1317, DOI 10.1007/s00586-008-0738-2; Michaud SE, 2003, FASEB J, V17, P1150, DOI 10.1096/fj.02-0172fje; Mikkonen P, 2008, SPINE, V33, P527, DOI 10.1097/BRS.0b013e3181657d3c; Miller VM, 2000, AM J PHYSIOL-HEART C, V279, pH1913, DOI 10.1152/ajpheart.2000.279.4.H1913; Nakajima A, 2003, J NIHON U MED ASS, V62, P650; Vo N, 2011, J ORTHOP RES, V29, P1585, DOI 10.1002/jor.21417; Nasto LA, 2014, SPINE J, V14, P416, DOI 10.1016/j.spinee.2013.08.034; Ngo K, 2017, SPINE, V42, P1521, DOI 10.1097/BRS.0000000000002258; Numaguchi S, 2016, J ORTHOP RES, V34, P39, DOI 10.1002/jor.22941; Oda H, 2004, J ORTHOP SCI, V9, P135, DOI 10.1007/s00776-003-0759-y; Ogawa T, 2005, PATHOBIOLOGY, V72, P146, DOI 10.1159/000084118; Pye SR, 2007, ANN RHEUM DIS, V66, P426, DOI 10.1136/ard.2006.057166; Rupprecht LE, 2016, NICOTINE TOB RES, V18, P1869, DOI 10.1093/ntr/ntw113; Ryu JH, 2012, CELL DEATH DIFFER, V19, P440, DOI 10.1038/cdd.2011.111; Scott SC, 1999, SPINE, V24, P1090, DOI 10.1097/00007632-199906010-00008; Shiri Rahman, 2010, Am J Med, V123, DOI 10.1016/j.amjmed.2009.05.028; Uei H, 2006, SPINE, V31, P510, DOI 10.1097/01.brs.0000201304.81875.cc; Wang D, 2012, OSTEOARTHR CARTILAGE, V20, P896, DOI 10.1016/j.joca.2012.04.010; Wang F, 2011, INJURY, V42, P790, DOI 10.1016/j.injury.2011.01.034	43	5	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2019	14	8							e0218298	10.1371/journal.pone.0218298	http://dx.doi.org/10.1371/journal.pone.0218298			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5WO	31454348	Green Submitted, gold, Green Published			2022-12-26	WOS:000485049000003
J	Neradilova, S; Connell, L; Hulva, P; Bolfikova, BC				Neradilova, Silvie; Connell, Laurie; Hulva, Pavel; Bolfikova, Barbora Cerna			Tracing genetic resurrection of pointing dog breeds: Cesky Fousek as both survivor and rescuer	PLOS ONE			English	Article							POPULATION-STRUCTURE; SOFTWARE; CLUSTERS; MULTIPLE; NUMBER	Cesky Fousek is considered to be one of the oldest pointing dog breeds in Europe and has been appreciated for its versatile working skills. Because it faced extinction in the past, the Cesky Fousek was restored from German Wirehaired and Shorthaired Pointers. Additionally, the breed was recently used in the USA with the initial intent of improvement of the Wirehaired Pointing Griffon (synonymous with Korthals Griffon) by the Bohemian Wirehaired Pointing Griffon Club of America. This study evaluates genetic diversity parameters of Cesky Fousek and compares them to the other continental pointing dogs that played a role in the formation of its gene pool. DNA from buccal swab and blood samples (n = 405) were analyzed using 18 microsatellite markers. Parameters of genetic polymorphism show that the Cesky Fousek breed has a comparable rate of variation as other hunting breeds despite the low population size and severe historical bottlenecks. Clustering analyses reveal a unique genetic status as a distinct pointing dog breed and the relatedness of the breeds is in good concordance with historical data. The present study demonstrates that despite historical admixture among lineages, separate pointing breeds constitute genetically differentiated units, mirroring unique breeding stocks and pedigree isolation among specific breed clubs, reflecting differences in breeding programs under each association.	[Neradilova, Silvie; Bolfikova, Barbora Cerna] Czech Univ Life Sci, Fac Trop AgriSci, Dept Anim Sci & Food Proc, Prague, Czech Republic; [Connell, Laurie] Univ Maine, Mol & Biomed Sci, Orono, ME USA; [Hulva, Pavel] Charles Univ Prague, Fac Sci, Dept Zool, Prague, Czech Republic; [Hulva, Pavel] Univ Ostrava, Dept Biol & Ecol, Ostrava, Czech Republic	Czech University of Life Sciences Prague; University of Maine System; University of Maine Orono; Charles University Prague; University of Ostrava	Bolfikova, BC (corresponding author), Czech Univ Life Sci, Fac Trop AgriSci, Dept Anim Sci & Food Proc, Prague, Czech Republic.	bolfikova@ftz.czu.cz	Bolfikova, Barbora Cerna/I-6620-2019	Bolfikova, Barbora Cerna/0000-0001-8059-4889; Neradilova, Silvie/0000-0001-8633-9213	Czech University of Life Sciences Prague [IGA 20195012, CIGA 20185006]	Czech University of Life Sciences Prague	The project was funded by IGA 20195012 (BCB, SN) and CIGA 20185006 (BCB, SN) of Czech University of Life Sciences Prague (https://www.czu.cz/en/).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerman L., 2011, GENETIC CONNECTION G; Asher L, 2009, VET J, V182, P402, DOI 10.1016/j.tvjl.2009.08.033; Bailey J., 1996, GRIFFON GUN DOG SUPR; Belkhir K, 2004, 5171 CNRS UMR LAB GE; Carty D., 2010, GUN DOG MAGAZIN 0923; Castaing J., 1960, CHIENS ARRET; Clutton-Brock J, 1999, NATURAL HIST DOMESTI; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Germonpre M, 2012, J ARCHAEOL SCI, V39, P184, DOI 10.1016/j.jas.2011.09.022; GUO SW, 1992, AM J HUM GENET, V51, P1111; Ionascu I., 2013, Scientific Works. Series C. Veterinary Medicine, V59, P109; Koshyk C., 2011, POINTING DOGS, V1; Langella O, 1999, POPULATIONS 1 2 30; Leroy G, 2009, ANIM GENET, V40, P323, DOI 10.1111/j.1365-2052.2008.01842.x; Li YL, 2018, MOL ECOL RESOUR, V18, P176, DOI 10.1111/1755-0998.12719; Lindblad-Toh K, 2005, NATURE, V438, P803, DOI 10.1038/nature04338; Mortlock SA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147941; Napierala H, 2012, INT J OSTEOARCHAEOL, V22, P127, DOI 10.1002/oa.1182; NEI M, 1972, AM NAT, V106, P283, DOI 10.1086/282771; Nelson MJ, 2011, GUN DOG MAGAZIN 0207; O'Farrell V., 1995, THE DOMESTIC DOG; Parker HG, 2004, SCIENCE, V304, P1160, DOI 10.1126/science.1097406; Parra D, 2008, ANIM GENET, V39, P1, DOI 10.1111/j.1365-2052.2007.01658.x; Pritchard JK, 2000, GENETICS, V155, P945; Puechmaille SJ, 2016, MOL ECOL RESOUR, V16, P608, DOI 10.1111/1755-0998.12512; Rambaut A, 2006, FIGTREE V1 4 2; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Savolainen P, 2002, SCIENCE, V298, P1610, DOI 10.1126/science.1073906; Schmutz SM, 2007, ANIM GENET, V38, P539, DOI 10.1111/j.1365-2052.2007.01664.x; Shaffer JP, 2016, FRONT ECOL EVOL, V4, DOI 10.3389/fevo.2016.00116; Shariflou MR, 2011, VET J, V189, P203, DOI 10.1016/j.tvjl.2011.06.020; Smetanova M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143807; Streitberger K, 2012, ANIM GENET, V43, P577, DOI 10.1111/j.1365-2052.2011.02300.x; Urfer SR, 2009, ACTA VET SCAND, V51, DOI 10.1186/1751-0147-51-21; Vila C, 1997, SCIENCE, V276, P1687, DOI 10.1126/science.276.5319.1687; vonKadich H., 1888, MONOGRAPHISCHER BEIT	38	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2019	14	8							e0221418	10.1371/journal.pone.0221418	http://dx.doi.org/10.1371/journal.pone.0221418			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5UR	31449543	Green Published, Green Submitted, gold			2022-12-26	WOS:000485044000017
J	Liu, KS; Zhang, C; Dong, HL; Li, KK; Han, QB; Wan, Y; Chen, R; Yang, F; Li, HL; Ko, CH; Han, XQ				Liu, Kai-Sheng; Zhang, Cheng; Dong, Hong-Liang; Li, Kai-Kai; Han, Quan-Bin; Wan, Yong; Chen, Rui; Yang, Fang; Li, Hai-Li; Ko, Chun-Hay; Han, Xiao-Qiang			GSP-2, a polysaccharide extracted from Ganoderma sinense, is a novel toll-like receptor 4 agonist	PLOS ONE			English	Article							NF-KAPPA-B; LINKING INNATE; MECHANISMS; EXPRESSION; ANTITUMOR; LUCIDUM	Ganoderma sinense is a Chinese unique medicinal fungus that has been used in folk medicine for thousands of years. Polysaccharides are considered to be biologically active ingredients due to their immune-modulating functions. Previously we found that GSP-2, a new polysaccharide isolated from Ganoderma sinense, exerts an immunomodulatory effect in human peripheral blood mononuclear cells but the underlying mechanism is unclear. The present study aimed to investigate how GSP-2 triggers immunologic responses and the implicated signaling pathways. GSP-2 effects were investigated both in a macrophagic cell line, RAW264.7, and in primary macrophages. Moreover, the molecular basis of GSP-2 recognition by immune cells, and the consequent activation of signaling cascades, were explored by employing recombinant human HEK293-TLR-Blue clones, individually over-expressing various Toll-like receptors. GSP-2 dose-dependently induced the overexpression of Toll-like receptor 4 (TLR4) but did not affect the expression of other TLRs. Moreover, GSP-2 induced TNF alpha secretion in primary macrophages from wild-type, but not TLR4-knockout mice. In addition, GSP-2 upregulated TLR4 protein expression and activated the MAPK pathway in RAW246.7 macrophages. Finally, GSP-2 induced the production of the cytokines TNF alpha, IL1 beta, and IL6. Our data demonstrated that GSP-2 was specifically recognized by TLR4, promoting cytokine secretion and immune modulation in macrophages.	[Liu, Kai-Sheng; Wan, Yong; Yang, Fang; Li, Hai-Li] Jinan Univ, Southern Univ Sci & Technol, Clin Med Coll 2, Shenzhen Peoples Hosp,Affiliated Hosp 1, Shenzhen, Guangdong, Peoples R China; [Zhang, Cheng; Ko, Chun-Hay] Chinese Univ Hong Kong, Inst Chinese Med, Shatin, Hong Kong, Peoples R China; [Dong, Hong-Liang] Soochow Univ, Inst Biol & Med Sci, Suzhou, Jiangsu, Peoples R China; [Li, Kai-Kai] Huazhong Agr Univ, Coll Food Sci & Technol, Wuhan, Hubei, Peoples R China; [Han, Quan-Bin] Hong Kong Baptist Univ, Sch Chinese Med, Kowloon, Hong Kong, Peoples R China; [Chen, Rui; Han, Xiao-Qiang] Chinese Univ Hong Kong, Shenzhen Res Inst, Shenzhen, Guangdong, Peoples R China	Jinan University; Southern University of Science & Technology; Chinese University of Hong Kong; Soochow University - China; Huazhong Agricultural University; Hong Kong Baptist University; Chinese University of Hong Kong, Shenzhen	Ko, CH (corresponding author), Chinese Univ Hong Kong, Inst Chinese Med, Shatin, Hong Kong, Peoples R China.; Han, XQ (corresponding author), Chinese Univ Hong Kong, Shenzhen Res Inst, Shenzhen, Guangdong, Peoples R China.	gohey@live.hk; tonyhxq@gmail.com	Li, Kai/HCI-8860-2022; dong, hongliang/GWZ-6956-2022	Liu, Kaisheng/0000-0002-4755-0523	National Natural Science Foundation of China [81802749, 81303210]; Cultivating Fund Project of Shenzhen People's Hospital [SYKYPY201928]; Science and Technology Foundation of Shenzhen [JCYJ20180301170047864]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Cultivating Fund Project of Shenzhen People's Hospital; Science and Technology Foundation of Shenzhen	This work was funded by the National Natural Science Foundation of China (NO. 81802749, NO. 81303210), the Cultivating Fund Project of Shenzhen People's Hospital (SYKYPY201928), and the Science and Technology Foundation of Shenzhen (JCYJ20180301170047864). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ando I, 2002, INT IMMUNOPHARMACOL, V2, P1155, DOI 10.1016/S1567-5769(02)00076-0; Carneiro AB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076233; Chen HS, 2004, BIOORGAN MED CHEM, V12, P5595, DOI 10.1016/j.bmc.2004.08.003; Cheng CH, 2010, NUTR CANCER, V62, P648, DOI 10.1080/01635581003605516; Da J, 2012, J CHROMATOGR A, V1222, P59, DOI 10.1016/j.chroma.2011.12.017; Fischer M, 2008, ANN NY ACAD SCI, V1143, P21, DOI 10.1196/annals.1443.012; Gregersen R, 2000, J CEREBR BLOOD F MET, V20, P53, DOI 10.1097/00004647-200001000-00009; Guven-Maiorov E, 2015, SCI REP-UK, V5, DOI 10.1038/srep13128; Han XQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100380; Han XQ, 2012, J AGR FOOD CHEM, V60, P4276, DOI 10.1021/jf205056u; Huang SQ, 2010, INT J BIOL MACROMOL, V47, P336, DOI 10.1016/j.ijbiomac.2010.03.019; Hug H, 2018, NUTRIENTS, V10, DOI 10.3390/nu10020203; Hurst J, 2008, AUTOIMMUN REV, V7, P204, DOI 10.1016/j.autrev.2007.11.006; Kadowaki N, 2001, J EXP MED, V194, P863, DOI 10.1084/jem.194.6.863; Le Blanc K, 2012, NAT REV IMMUNOL, V12, P383, DOI 10.1038/nri3209; Liu JQ, 2012, PLANTA MED, V78, P368, DOI 10.1055/s-0031-1280441; Novak M, 2008, J IMMUNOTOXICOL, V5, P47, DOI 10.1080/15476910802019045; Pasare C, 2004, MICROBES INFECT, V6, P1382, DOI 10.1016/j.micinf.2004.08.018; Pasare C, 2005, ADV EXP MED BIOL, V560, P11; Roeder A, 2004, MED MYCOL, V42, P485, DOI 10.1080/13693780400011112; Shao BM, 2004, BIOCHEM BIOPH RES CO, V320, P1103, DOI 10.1016/j.bbrc.2004.06.065; Shoham S, 2001, J IMMUNOL, V166, P4620, DOI 10.4049/jimmunol.166.7.4620; Szatmary Z, 2012, GEN PHYSIOL BIOPHYS, V31, P357, DOI 10.4149/gpb_2012_048; Wei W, 2016, J ETHNOPHARMACOL, V179, P243, DOI 10.1016/j.jep.2015.12.060; Yue GGL, 2006, J ALTERN COMPLEM MED, V12, P777, DOI 10.1089/acm.2006.12.777; Yue GGL, 2013, NUTR CANCER, V65, P765, DOI 10.1080/01635581.2013.788725; Zhang GL, 2001, J CLIN INVEST, V107, P13, DOI 10.1172/JCI11837; Zhong J, 2007, J BIOL CHEM, V282, P24246, DOI 10.1074/jbc.M703422200; Zhu YJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep11087	29	5	7	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2019	14	8							e0221636	10.1371/journal.pone.0221636	http://dx.doi.org/10.1371/journal.pone.0221636			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5TR	31442262	Green Published, Green Submitted, gold			2022-12-26	WOS:000485041400060
J	Alptekin, A; Ye, BW; Yu, YJ; Poole, CJ; van Riggelen, J; Zha, YH; Ding, HF				Alptekin, Ahmet; Ye, Bingwei; Yu, Yajie; Poole, Candace J.; van Riggelen, Jan; Zha, Yunhong; Ding, Han-Fei			Glycine decarboxylase is a transcriptional target of MYCN required for neuroblastoma cell proliferation and tumorigenicity	ONCOGENE			English	Article							ONE-CARBON METABOLISM; N-MYC; GLUTAMINE-METABOLISM; PROGNOSTIC MARKER; SYNTHESIS PATHWAY; C-MYC; SERINE; CANCER; FOLATE; FLUX	Genomic amplification of the oncogene MYCN is a major driver in the development of high-risk neuroblastoma, a pediatric cancer with poor prognosis. Given the challenge in targeting MYCN directly for therapy, we sought to identify MYCN-dependent metabolic vulnerabilities that can be targeted therapeutically. Here, we report that the gene encoding glycine decarboxylase (GLDC), which catalyzes the first and rate-limiting step in glycine breakdown with the production of the one-carbon unit 5,10-methylene-tetrahydrofolate, is a direct transcriptional target of MYCN. As a result, GLDC expression is markedly elevated in MYCN-amplified neuroblastoma tumors and cell lines. This transcriptional upregulation of GLDC expression is of functional significance, as GLDC depletion by RNA interference inhibits the proliferation and tumorigenicity of MYCN-amplified neuroblastoma cell lines by inducing G1 arrest. Metabolomic profiling reveals that GLDC knockdown disrupts purine and central carbon metabolism and reduces citrate production, leading to a decrease in the steady-state levels of cholesterol and fatty acids. Moreover, blocking purine or cholesterol synthesis recapitulates the growth-inhibitory effect of GLDC knockdown. These findings reveal a critical role of GLDC in sustaining the proliferation of neuroblastoma cells with high-level GLDC expression and suggest that MYCN amplification is a biomarker for GLDC-based therapeutic strategies against high-risk neuroblastoma.	[Alptekin, Ahmet; Poole, Candace J.; van Riggelen, Jan; Ding, Han-Fei] Augusta Univ, Med Coll Georgia, Dept Biochem & Mol Biol, Augusta, GA 30912 USA; [Alptekin, Ahmet; Ye, Bingwei; Poole, Candace J.; van Riggelen, Jan; Ding, Han-Fei] Augusta Univ, Med Coll Georgia, Georgia Canc Ctr, Augusta, GA 30912 USA; [Yu, Yajie; Zha, Yunhong] Three Gorges Univ, Hosp Yichang 1, Inst Neural Regenerat & Repair, Coll Med, Yichang 443000, Peoples R China; [Yu, Yajie; Zha, Yunhong] Three Gorges Univ, Hosp Yichang 1, Dept Neurol, Coll Med, Yichang 443000, Peoples R China; [Ding, Han-Fei] Augusta Univ, Med Coll Georgia, Dept Pathol, Augusta, GA 30912 USA	University System of Georgia; Augusta University; University System of Georgia; Augusta University; China Three Gorges University; China Three Gorges University; University System of Georgia; Augusta University	Ding, HF (corresponding author), Augusta Univ, Med Coll Georgia, Dept Biochem & Mol Biol, Augusta, GA 30912 USA.; Ding, HF (corresponding author), Augusta Univ, Med Coll Georgia, Georgia Canc Ctr, Augusta, GA 30912 USA.; Ding, HF (corresponding author), Augusta Univ, Med Coll Georgia, Dept Pathol, Augusta, GA 30912 USA.	hding@augusta.edu	Ye, Bingwei/AAH-1139-2021	Alptekin, Ahmet/0000-0002-7039-1911; Ding, Han-Fei/0000-0001-5702-3439; Langan, Candace Jean/0000-0003-1811-587X; yu, yajie/0000-0002-8645-9976	NIH [R01 CA190429]; NATIONAL CANCER INSTITUTE [R01CA190429] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by an NIH grant (R01 CA190429) to HFD.	Alam G, 2009, AM J PATHOL, V175, P856, DOI 10.2353/ajpath.2009.090019; Altman BJ, 2016, NAT REV CANCER, V16, P619, DOI 10.1038/nrc.2016.71; BRODEUR GM, 1984, SCIENCE, V224, P1121, DOI 10.1126/science.6719137; Brodeur GM, 2003, NAT REV CANCER, V3, P203, DOI 10.1038/nrc1014; Brooks EE, 1997, J BIOL CHEM, V272, P29207, DOI 10.1074/jbc.272.46.29207; Campbell K, 2017, CANCER-AM CANCER SOC, V123, P4224, DOI 10.1002/cncr.30873; Cheung NKV, 2013, NAT REV CANCER, V13, P397, DOI 10.1038/nrc3526; Cohn SL, 2009, J CLIN ONCOL, V27, P289, DOI 10.1200/JCO.2008.16.6785; Comte B, 2002, AM J PHYSIOL-HEART C, V283, pH1505, DOI 10.1152/ajpheart.00287.2002; Conter C, 2006, J INHERIT METAB DIS, V29, P135, DOI 10.1007/s10545-006-0202-6; Cui HJ, 2005, J BIOL CHEM, V280, P9474, DOI 10.1074/jbc.M410450200; DADAMO AF, 1965, J BIOL CHEM, V240, P613; Dang CV, 2017, NAT REV CANCER, V17, P502, DOI 10.1038/nrc.2017.36; Dang CV, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a014217; Dang CV, 2012, CELL, V149, P22, DOI 10.1016/j.cell.2012.03.003; DeBerardinis RJ, 2008, CELL METAB, V7, P11, DOI 10.1016/j.cmet.2007.10.002; Dejure FR, 2017, EMBO J, V36, P3409, DOI 10.15252/embj.201796438; Ding J, 2013, CELL METAB, V18, P896, DOI 10.1016/j.cmet.2013.11.004; Ducker GS, 2017, CELL METAB, V25, P27, DOI 10.1016/j.cmet.2016.08.009; Ducker GS, 2016, CELL METAB, V23, P1140, DOI 10.1016/j.cmet.2016.04.016; Fiehn O, 2008, PLANT J, V53, P691, DOI 10.1111/j.1365-313X.2007.03387.x; Herbig K, 2002, J BIOL CHEM, V277, P38381, DOI 10.1074/jbc.M205000200; Holleran AL, 1995, MOL CELL BIOCHEM, V152, P95, DOI 10.1007/BF01076071; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang M, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a014415; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kim D, 2015, NATURE, V520, P363, DOI 10.1038/nature14363; Kocak H, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.84; Labuschagne CF, 2014, CELL REP, V7, P1248, DOI 10.1016/j.celrep.2014.04.045; Lamers Y, 2009, J NUTR, V139, P666, DOI 10.3945/jn.108.103580; Leung KY, 2017, CELL REP, V21, P1795, DOI 10.1016/j.celrep.2017.10.072; Liu ML, 2016, CELL REP, V17, P609, DOI 10.1016/j.celrep.2016.09.021; Locasale JW, 2013, NAT REV CANCER, V13, P572, DOI 10.1038/nrc3557; Locasale JW, 2011, NAT GENET, V43, P869, DOI 10.1038/ng.890; Malumbres M, 2009, NAT REV CANCER, V9, P153, DOI 10.1038/nrc2602; MANFREDI JP, 1985, ANNU REV PHYSIOL, V47, P691, DOI 10.1146/annurev.ph.47.030185.003355; Mao L, 2012, ONCOGENE, V31, P3785, DOI 10.1038/onc.2011.536; Maris JM, 2007, LANCET, V369, P2106, DOI 10.1016/S0140-6736(07)60983-0; Marshall GM, 2014, NAT REV CANCER, V14, P277, DOI 10.1038/nrc3679; Metallo CM, 2012, NATURE, V481, P380, DOI 10.1038/nature10602; Molenaar JJ, 2012, NATURE, V483, P589, DOI 10.1038/nature10910; Narisawa A, 2012, HUM MOL GENET, V21, P1496, DOI 10.1093/hmg/ddr585; Narkewicz MR, 1996, BIOCHEM J, V313, P991, DOI 10.1042/bj3130991; NEWSHOLME EA, 1985, BIOSCIENCE REP, V5, P393, DOI 10.1007/BF01116556; Nilsson R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4128; Pai YJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7388; Pajic A, 2000, INT J CANCER, V87, P787, DOI 10.1002/1097-0215(20000915)87:6<787::AID-IJC4>3.0.CO;2-6; Park JR, 2013, PEDIATR BLOOD CANCER, V60, P985, DOI 10.1002/pbc.24433; PFENDNER W, 1980, ARCH BIOCHEM BIOPHYS, V200, P503, DOI 10.1016/0003-9861(80)90382-3; Pinto NR, 2015, J CLIN ONCOL, V33, P3008, DOI 10.1200/JCO.2014.59.4648; Possemato R, 2011, NATURE, V476, P346, DOI 10.1038/nature10350; Puissant A, 2013, CANCER DISCOV, V3, P308, DOI 10.1158/2159-8290.CD-12-0418; Reid MA, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07868-6; ROSIERS CD, 1995, J BIOL CHEM, V270, P10027, DOI 10.1074/jbc.270.17.10027; Schuhmacher M, 1999, CURR BIOL, V9, P1255, DOI 10.1016/S0960-9822(99)80507-7; SCHWAB M, 1993, SEMIN CANCER BIOL, V4, P13; SEEGER RC, 1985, NEW ENGL J MED, V313, P1111, DOI 10.1056/NEJM198510313131802; Stewart E, 2017, NATURE, V549, P96, DOI 10.1038/nature23647; Stover PJ, 1997, J BIOL CHEM, V272, P1842, DOI 10.1074/jbc.272.3.1842; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tadesse S, 2019, J MED CHEM, V62, P4233, DOI 10.1021/acs.jmedchem.8b01469; Teitz T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019133; Tibbetts AS, 2010, ANNU REV NUTR, V30, P57, DOI 10.1146/annurev.nutr.012809.104810; Valentijn LJ, 2012, P NATL ACAD SCI USA, V109, P19190, DOI 10.1073/pnas.1208215109; Wang WW, 2013, AMINO ACIDS, V45, P463, DOI 10.1007/s00726-013-1493-1; Weiss WA, 1997, EMBO J, V16, P2985, DOI 10.1093/emboj/16.11.2985; Wiederschain D, 2009, CELL CYCLE, V8, P498, DOI 10.4161/cc.8.3.7701; Xia JG, 2011, NAT PROTOC, V6, P743, DOI 10.1038/nprot.2011.319; Xia YF, 2019, CANCER RES, V79, P3837, DOI 10.1158/0008-5472.CAN-18-3541; Yang M, 2016, NAT REV CANCER, V16, P650, DOI 10.1038/nrc.2016.81; Yoo H, 2008, J BIOL CHEM, V283, P20621, DOI 10.1074/jbc.M706494200; YOSHIDA T, 1970, ARCH BIOCHEM BIOPHYS, V139, P380, DOI 10.1016/0003-9861(70)90490-X; Zhang J, 2017, EMBO J, V36, P1302, DOI 10.15252/embj.201696151; Zhang WC, 2012, CELL, V148, P259, DOI 10.1016/j.cell.2011.11.050; Zhang WQ, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0694-1; Zhao EH, 2016, CELL REP, V14, P506, DOI 10.1016/j.celrep.2015.12.053	76	12	12	0	9	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	DEC 12	2019	38	50					7504	7520		10.1038/s41388-019-0967-3	http://dx.doi.org/10.1038/s41388-019-0967-3			17	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	JV7GY	31444411	Green Accepted			2022-12-26	WOS:000502530500005
J	Subedi, P; Paxman, JJ; Wang, GQ; Ukuwela, AA; Xiao, ZG; Heras, B				Subedi, Pramod; Paxman, Jason J.; Wang, Geqing; Ukuwela, Ashwinie A.; Xiao, Zhiguang; Heras, Begona			The Scs disulfide reductase system cooperates with the metallochaperone CueP in Salmonella copper resistance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						disulfide; electron transfer; copper; Salmonella enterica; oxidation-reduction (redox); bacterial copper resistance; copper homeostasis; disulfide catalysis; Dsb proteins; Scs proteins	ENTERICA SEROVAR TYPHIMURIUM; FUNCTIONAL-CHARACTERIZATION; STRUCTURAL BASIS; TERMINAL DOMAIN; ISOMERASE DSBC; BOND FORMATION; APO FORMS; PROTEIN; CU(I); OXIDOREDUCTASE	The human pathogen Salmonella enterica serovar Typhimurium (S. Typhimurium) contains a complex disulfide bond (Dsb) catalytic machinery. This machinery encompasses multiple Dsb thiol-disulfide oxidoreductases that mediate oxidative protein folding and a less-characterized suppressor of copper sensitivity (scs) gene cluster, associated with increased tolerance to copper. To better understand the function of the Salmonella Scs system, here we characterized two of its key components, the membrane protein ScsB and the periplasmic protein ScsC. Our results revealed that these two proteins form a redox pair in which the electron transfer from the periplasmic domain of ScsB (n-ScsB) to ScsC is thermodynamically driven. We also demonstrate that the Scs reducing pathway remains separate from the Dsb oxidizing pathways and thereby avoids futile redox cycles. Additionally, we provide new insight into the molecular mechanism underlying Scs-mediated copper tolerance in Salmonella. We show that both ScsB and ScsC can bind toxic copper(I) with femtomolar affinities and transfer it to the periplasmic copper metallochaperone CueP. Our results indicate that the Salmonella Scs machinery has evolved a dual mode of action, capable of transferring reducing power to the oxidizing periplasm and protecting against copper stress by cooperating with the cue regulon, a major copper resistance mechanism in Salmonella. Overall, these findings expand our understanding of the functional diversity of Dsb-like systems, ranging from those mediating oxidative folding of proteins required for infection to those contributing to defense mechanisms against oxidative stress and copper toxicity, critical traits for niche adaptation and survival.	[Subedi, Pramod; Paxman, Jason J.; Wang, Geqing; Heras, Begona] La Trobe Univ, La Trobe Inst Mol Sci, Dept Biochem & Genet, Kingsbury Dr, Bundoora, Vic 3083, Australia; [Ukuwela, Ashwinie A.; Xiao, Zhiguang] Univ Melbourne, Sch Chem, Parkville, Vic 3010, Australia; [Ukuwela, Ashwinie A.; Xiao, Zhiguang] Univ Melbourne, Bio21 Mol Sci & Biotechnol Inst, Parkville, Vic 3010, Australia; [Xiao, Zhiguang] Univ Melbourne, Florey Inst Neurosci & Mental Hlth, Melbourne Dementia Res Ctr, Parkville, Vic 3052, Australia	La Trobe University; University of Melbourne; University of Melbourne; Florey Institute of Neuroscience & Mental Health; University of Melbourne	Heras, B (corresponding author), La Trobe Univ, La Trobe Inst Mol Sci, Dept Biochem & Genet, Kingsbury Dr, Bundoora, Vic 3083, Australia.	b.heras@latrobe.edu.au	Subedi, Pramod/AAV-6214-2021	Heras, Begona/0000-0003-3469-7988; Wang, Geqing/0000-0002-9419-8657; Paxman, Jason/0000-0002-1418-5910; Xiao, Zhiguang/0000-0001-6908-8897; Subedi, Pramod/0000-0002-3390-9830	Australian Research Council (ARC) [DP190101613, DP180102987, DP150102287, DP190102573, DP130100728]; ARC Future Fellowship [FT130100580]; National Health and Medical Research Council (NHMRC) [APP1144046]	Australian Research Council (ARC)(Australian Research Council); ARC Future Fellowship(Australian Research Council); National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by Australian Research Council (ARC) Project Grants DP190101613, DP180102987, DP150102287, DP190102573, and DP130100728; ARC Future Fellowship FT130100580; and National Health and Medical Research Council (NHMRC) Project Grant APP1144046. The authors declare that they have no conflicts of interest with the contents of this article.	Achard MES, 2012, BIOCHEM J, V444, P51, DOI 10.1042/BJ20112180; Achard MES, 2010, INFECT IMMUN, V78, P2312, DOI 10.1128/IAI.01208-09; Allen S, 2013, DALTON T, V42, P3233, DOI 10.1039/c2dt32166a; Anwar N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064948; Arnesano F, 2001, BIOCHEMISTRY-US, V40, P1528, DOI 10.1021/bi0014711; Asmar BI, 2016, INFECT DIS-NOR, V48, P147, DOI 10.3109/23744235.2015.1094823; Banci L, 2004, BIOCHEMISTRY-US, V43, P3396, DOI 10.1021/bi036042s; Banci L, 2010, NATURE, V465, P645, DOI 10.1038/nature09018; BARDWELL JCA, 1993, P NATL ACAD SCI USA, V90, P1038, DOI 10.1073/pnas.90.3.1038; Bouwman CW, 2003, J BACTERIOL, V185, P991, DOI 10.1128/JB.185.3.991-1000.2003; Brose J, 2014, METALLOMICS, V6, P793, DOI 10.1039/c4mt00020j; Cho SH, 2012, MBIO, V3, DOI 10.1128/mBio.00291-11; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; Espariz M, 2007, MICROBIOL-SGM, V153, P2989, DOI 10.1099/mic.0.2007/006536-0; Furlong EJ, 2018, J BIOL CHEM, V293, P5793, DOI 10.1074/jbc.RA118.001860; Furlong EJ, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms16065; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Giner-Lamia J, 2015, MICROBIOLOGYOPEN, V4, P167, DOI 10.1002/mbo3.231; Gordon MA, 2008, J INFECTION, V56, P413, DOI 10.1016/j.jinf.2008.03.012; Gupta SD, 1997, J BACTERIOL, V179, P4977, DOI 10.1128/jb.179.16.4977-4984.1997; Heras B, 2010, J BIOL CHEM, V285, P18423, DOI 10.1074/jbc.M110.101360; Heras B, 2009, NAT REV MICROBIOL, V7, P215, DOI 10.1038/nrmicro2087; Inaba K, 2005, J BIOL CHEM, V280, P33035, DOI 10.1074/jbc.M506189200; Jarrott R, 2010, ACTA CRYSTALLOGR F, V66, P601, DOI 10.1107/S1744309110011942; Jiao L, 2013, J STRUCT BIOL, V183, P1, DOI 10.1016/j.jsb.2013.05.013; Kim JS, 2002, FEMS MICROBIOL LETT, V210, P99, DOI 10.1111/j.1574-6968.2002.tb11166.x; Ladomersky E, 2015, METALLOMICS, V7, P957, DOI 10.1039/c4mt00327f; Landeta C, 2018, NAT MICROBIOL, V3, P270, DOI 10.1038/s41564-017-0106-2; Lin D, 2008, J BACTERIOL, V190, P87, DOI 10.1128/JB.01323-07; Lin DX, 2009, MICROBIOL-SGM, V155, P4014, DOI 10.1099/mic.0.032904-0; Lopez C, 2018, J BACTERIOL, V200, DOI 10.1128/JB.00126-18; Lutsenko S, 1997, J BIOL CHEM, V272, P18939, DOI 10.1074/jbc.272.30.18939; Mavridou DAI, 2011, J BIOL CHEM, V286, P24943, DOI 10.1074/jbc.M111.236141; Miki T, 2004, J BIOL CHEM, V279, P34631, DOI 10.1074/jbc.M402760200; Osman D, 2013, MOL MICROBIOL, V87, P466, DOI 10.1111/mmi.12107; Osman D, 2010, J BIOL CHEM, V285, P25259, DOI 10.1074/jbc.M110.145953; Pezza A, 2016, P NATL ACAD SCI USA, V113, P11573, DOI 10.1073/pnas.1603192113; Pontel LB, 2009, MOL MICROBIOL, V73, P212, DOI 10.1111/j.1365-2958.2009.06763.x; Rozhkova A, 2004, EMBO J, V23, P1709, DOI 10.1038/sj.emboj.7600178; Scallan E, 2011, EMERG INFECT DIS, V17, P16, DOI [10.3201/eid1701.P21101, 10.3201/eid1701.091101p2]; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Shepherd M, 2013, ANTIOXID REDOX SIGN, V19, P1494, DOI 10.1089/ars.2012.4939; Smith RP, 2018, J BIOL CHEM, V293, P16559, DOI 10.1074/jbc.RA118.004847; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Szklarczyk D, 2017, NUCLEIC ACIDS RES, V45, pD362, DOI 10.1093/nar/gkw937; Tsivkovskii R, 2001, J BIOL CHEM, V276, P2234, DOI 10.1074/jbc.M003238200; Turcot I, 2001, CAN J MICROBIOL, V47, P711, DOI 10.1139/cjm-47-8-711; Vincent M, 2018, J APPL MICROBIOL, V124, P1032, DOI 10.1111/jam.13681; Vivian JP, 2009, J MOL BIOL, V394, P931, DOI 10.1016/j.jmb.2009.09.065; Walden PM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081440; Wernimont AK, 2000, NAT STRUCT BIOL, V7, P766; Xiao ZG, 2004, J AM CHEM SOC, V126, P3081, DOI 10.1021/ja0390350; Xiao ZG, 2013, METALLOMICS, V5, P501, DOI 10.1039/c3mt00032j; Xiao ZG, 2011, J BIOL CHEM, V286, P11047, DOI 10.1074/jbc.M110.213074; Xiao ZG, 2010, NAT PROD REP, V27, P768, DOI 10.1039/b906690j; Yoon BY, 2014, MOL CELLS, V37, P100, DOI 10.14348/molcells.2014.2238; Yoon BY, 2014, BIOCHEM BIOPH RES CO, V446, P971, DOI 10.1016/j.bbrc.2014.03.043; Young TR, 2015, METALLOMICS, V7, P567, DOI 10.1039/c4mt00301b; Yun BY, 2011, ACTA CRYSTALLOGR F, V67, P675, DOI [10.1107/S1744309111010645, 10.1107/S1744309111010645675]	59	13	13	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 1	2019	294	44					15876	15888		10.1074/jbc.RA119.010164	http://dx.doi.org/10.1074/jbc.RA119.010164			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JR2RL	31444272	Green Published, hybrid			2022-12-26	WOS:000499478600001
J	He, K; Hemmila, MR; Cain-Nielsen, AH; Machado-Aranda, DA; Frydrych, LM; Delano, MJ				He, Katherine; Hemmila, Mark R.; Cain-Nielsen, Anne H.; Machado-Aranda, David A.; Frydrych, Lynn M.; Delano, Matthew J.			Complications and resource utilization in trauma patients with diabetes	PLOS ONE			English	Article							VENTILATOR-ASSOCIATED PNEUMONIA; INTENSIVE INSULIN THERAPY; HYPERGLYCEMIA; PERFORMANCE; IMPROVEMENT; MORBIDITY; MORTALITY; DISEASES	Diabetes is associated with poor outcomes in critically ill populations. The goal of this study was to determine if diabetic patients suffer poorer outcomes following trauma. Collaborative trauma patient data from 2012-2018 was analyzed. Patients with no signs-of-life, Injury Severity Score (ISS) <5, age <16 years, and hospitalization <1 day were excluded. Multivariable logistic and linear regression were used to compare patients with and without diabetes for selected outcomes. Risk-adjustment variables included demographics, physiology, comorbidities, and injury scoring. Of 106,141 trauma patients, 14,150 (13%) had diabetes. On admission, diabetes was associated with significantly increased risk of any, serious, infectious, urinary tract, sepsis, pneumonia, and cardiac complications. Diabetes was also associated with increased ventilator days (7.5 vs. 6.6 days, p = 0.003), intensive care unit days (5.8 vs. 5.3 days, p<0.001), and hospital length of stay (5.7 vs. 5.3 days, p<0.001). Subgroup analysis revealed the least injured diabetic category (ISS 5-15) suffered higher odds of hospital mortality and any, serious, infectious and cardiac complications. The association between diabetes, hospital mortality and complication rates in mild traumatic injury is independent of age. Trauma patients with diabetes experience higher rates of complications and resource utilization. The largest cohort of diabetics experience the least severe injuries and suffer the greatest in hospital mortality and complication rates. A better understanding of the physiologic derangements associated with diabetes is necessary to develop novel approaches to reduce excess trauma morbidity, mortality and resource consumption.	[He, Katherine] Brigham & Womens Hosp, Dept Surg, 75 Francis St, Boston, MA 02115 USA; [Hemmila, Mark R.; Cain-Nielsen, Anne H.; Machado-Aranda, David A.; Frydrych, Lynn M.; Delano, Matthew J.] Univ Michigan, Dept Surg, Div Acute Care Surg, Ann Arbor, MI 48109 USA; [Hemmila, Mark R.; Cain-Nielsen, Anne H.] Michigan Trauma Qual Improvement Program, Ann Arbor, MI USA	Harvard University; Brigham & Women's Hospital; University of Michigan System; University of Michigan	He, K (corresponding author), Brigham & Womens Hosp, Dept Surg, 75 Francis St, Boston, MA 02115 USA.	Katherine_He@bwh.havard.edu	Machado-Aranda, David/AAF-4447-2020	He, Katherine/0000-0001-6402-8537; Delano, Matthew/0000-0001-7540-5166; Machado-Aranda, David/0000-0003-3716-962X	2017 American Surgical Association Foundation Fellowship Research Award; 2016 Shock Society Faculty Research Award; 2015 American Association for the Surgery of Trauma Research and Education Foundation Scholarship; Michigan Trauma Quality Improvement Program (MTQIP) - Blue Cross Blue Shield of Michigan/Blue Care Network;  [T32 HL007517]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007517] Funding Source: NIH RePORTER	2017 American Surgical Association Foundation Fellowship Research Award; 2016 Shock Society Faculty Research Award; 2015 American Association for the Surgery of Trauma Research and Education Foundation Scholarship; Michigan Trauma Quality Improvement Program (MTQIP) - Blue Cross Blue Shield of Michigan/Blue Care Network; ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	MJD would like to acknowledge the 2017 American Surgical Association Foundation Fellowship Research Award, the 2016 Shock Society Faculty Research Award, and the 2015 American Association for the Surgery of Trauma Research and Education Foundation Scholarship that supported this work. LMF would like to acknowledge T32 HL007517, which supported this work. MRH and AHCN were supported by the Michigan Trauma Quality Improvement Program (MTQIP) supported by Blue Cross Blue Shield of Michigan/Blue Care Network, a non-profit mutual corporation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; MJD would like to acknowledge the 2017 American Surgical Association Foundation Fellowship Research Award, the 2016 Shock Society Faculty Research Award, and the 2015 American Association for the Surgery of Trauma Research and Education Foundation Scholarship that supported this work.; LMF would like to acknowledge T32 HL007517, which supported this work.; MRH and AHCN were supported by the Michigan Trauma Quality Improvement Program (MTQIP) supported by Blue Cross Blue Shield of Michigan/Blue Care Network, a non-profit mutual corporation.	Ahmad R, 2007, ARCH SURG-CHICAGO, V142, P613, DOI 10.1001/archsurg.142.7.613; Allshouse MJ, 2008, J TRAUMA, V65, P47; Amer Diabet Assoc, 2013, DIABETES CARE, V36, P1033, DOI 10.2337/dc12-2625; [Anonymous], 2017, NAT DIAB STAT REP; Arthur LE, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004267.pub4; Bochicchio GV, 2005, J TRAUMA, V58, P921, DOI 10.1097/01.TA.0000162141.26392.07; Boyanova L, 2013, EXPERT REV ANTI-INFE, V11, P411, DOI [10.1586/ERI.13.19, 10.1586/eri.13.19]; Calland JF, 2012, J TRAUMA ACUTE CARE, V73, P1086, DOI 10.1097/TA.0b013e31826fc7a0; Centers for Disease Control, 2020, NATL DIABETES STAT R; Chin TL, 2012, SURGERY, V152, P315, DOI 10.1016/j.surg.2012.06.015; Cook DJ, 1998, JAMA-J AM MED ASSOC, V279, P1605, DOI 10.1001/jama.279.20.1605; Delano MJ, 2016, IMMUNOL REV, V274, P330, DOI 10.1111/imr.12499; Delano MJ, 2016, J CLIN INVEST, V126, P23, DOI 10.1172/JCI82224; Deng HP, 2009, INT IMMUNOPHARMACOL, V9, P1251, DOI 10.1016/j.intimp.2009.07.009; Hemmila MR, 2008, SURGERY, V144, P629, DOI 10.1016/j.surg.2008.07.001; Hemmila MR, 2008, SURGERY, V144, P307, DOI 10.1016/j.surg.2008.05.003; Heyland DK, 1999, AM J RESP CRIT CARE, V159, P1249, DOI 10.1164/ajrccm.159.4.9807050; Kalil AC, 2016, CLIN INFECT DIS, V63, P575, DOI 10.1093/cid/ciw504; Kao LS, 2006, AM J SURG, V192, P710, DOI 10.1016/j.amjsurg.2006.08.031; Laird AM, 2004, J TRAUMA, V56, P1058, DOI 10.1097/01.TA.0000123267.39011.9F; Machado-Aranda DA, 2015, J AM COLL SURGEONS, V221, P661, DOI 10.1016/j.jamcollsurg.2015.05.006; National Hospital Ambulatory Medical Care Survey, 2015, 2015 EM DEP SUMM TAB, P34; Read JL, 2007, AACN ADV CRIT CARE, V18, P200, DOI 10.1097/01.AACN.0000269264.22041.1c; Stokes A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170219; Trevelin SC, 2017, SHOCK, V47, P276, DOI 10.1097/SHK.0000000000000778; Van den Berghe G, 2001, NEW ENGL J MED, V345, P1359, DOI 10.1056/NEJMoa011300; Vos T, 2012, LANCET, V380, P2163, DOI 10.1016/S0140-6736(12)61729-2; Wahl WL, 2008, J TRAUMA, V65, P42, DOI 10.1097/TA.0b013e318176c54e; Warren DK, 2003, CRIT CARE MED, V31, P1312, DOI 10.1097/01.CCM.0000063087.93157.06; Yendamuri S, 2003, J TRAUMA, V55, P33, DOI 10.1097/01.TA.0000074434.39928.72; Zhou B, 2016, LANCET, V387, P1513, DOI 10.1016/S0140-6736(16)00618-8	31	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2019	14	8							e0221414	10.1371/journal.pone.0221414	http://dx.doi.org/10.1371/journal.pone.0221414			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5XV	31461502	gold, Green Published, Green Submitted			2022-12-26	WOS:000485052300032
J	Benov, L				Benov, Ludmil			Effect of growth media on the MTT colorimetric assay in bacteria	PLOS ONE			English	Article							ESCHERICHIA-COLI; STAPHYLOCOCCUS-AUREUS; TETRAZOLIUM SALTS; CELL VIABILITY; BIOLOGY	Reduction of tetrazolium salts to colored formazan products by metabolically active cells is widely used for assessment of cell viability. Among the tetrazolium compounds most commonly used is MTT [3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide]. Numerous studies about sites and mechanisms of cellular reduction of MTT, performed in mammalian cell cultures, have identified various parameters that affect formazan production and can lead to overestimation/underestimation of viable cells or effects of treatment. Irrespective of lack of such data for prokaryotic cells, the MTT assay is commonly used for microbiological studies, which often leads to contradictory results or misinterpretation of data. The aim of this study was to investigate how components of growth media and conditions of growth, affect formazan formation by microbial cells. Results showed that MTT reduction depended on the amino acid composition of the medium. Several amino acids potentiated formazan production by Gram-positive and Gram-negative bacteria, with histidine having the strongest effect. Results of this study demonstrate that data obtained with the MTT test should be interpreted with caution, particularly when different growth media are used or treatments affect metabolic pathways, and that evaluation of the reliability of the MTT assay under specific conditions should be performed, to avoid erroneous results. Performing the assay with cells suspend in glucose-supplemented buffer would eliminate the effects of metabolites and will limit cell division during incubation with MTT. Another critical element to be considered is the choice of a proper solvent for dissolution of formazan crystals.	[Benov, Ludmil] Kuwait Univ, Fac Med, Dept Biochem, Kuwait, Kuwait	Kuwait University	Benov, L (corresponding author), Kuwait Univ, Fac Med, Dept Biochem, Kuwait, Kuwait.	lbenov@hsc.edu.kw	Benov, Ludmil/AAD-3714-2020	Benov, Ludmil/0000-0002-0205-0146	Kuwait University [MB01/18]	Kuwait University	LB was supported by Kuwait University grant MB01/18 (http://www.ovpr.kuniv.edu/research/). The funder did not play any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asakura H, 2007, MICROBIOL IMMUNOL, V51, P875, DOI 10.1111/j.1348-0421.2007.tb03969.x; Barer MR, 1999, ADV MICROB PHYSIOL, V41, P93, DOI 10.1016/S0065-2911(08)60166-6; Bender RA, 2012, MICROBIOL MOL BIOL R, V76, P565, DOI 10.1128/MMBR.00014-12; Bernas T, 2000, ARCH BIOCHEM BIOPHYS, V380, P108, DOI 10.1006/abbi.2000.1907; Berridge MV, 2005, BIOTECHNOL ANN REV, V11, P127, DOI 10.1016/S1387-2656(05)11004-7; Grela E, 2018, ACTA HISTOCHEM, V120, P303, DOI 10.1016/j.acthis.2018.03.007; IMLAY JA, 1991, J BIOL CHEM, V266, P6957; Liochev SI, 1999, J BIOL CHEM, V274, P9479, DOI 10.1074/jbc.274.14.9479; Liu YB, 1997, J NEUROCHEM, V69, P581, DOI 10.1046/j.1471-4159.1997.69020581.x; Nystrom T, 2001, ARCH MICROBIOL, V176, P159, DOI 10.1007/s002030100314; Pasquaroli S, 2013, J ANTIMICROB CHEMOTH, V68, P1812, DOI 10.1093/jac/dkt086; PLUMB JA, 1989, CANCER RES, V49, P4435; Stockert JC, 2018, ACTA HISTOCHEM, V120, P159, DOI 10.1016/j.acthis.2018.02.005; Stockert JC, 2012, ACTA HISTOCHEM, V114, P785, DOI 10.1016/j.acthis.2012.01.006; Sylvester PW, 2011, METHODS MOL BIOL, V716, P157, DOI 10.1007/978-1-61779-012-6_9; Udo EE, 2000, FEMS MICROBIOL LETT, V189, P79, DOI 10.1111/j.1574-6968.2000.tb09209.x; Wang HW, 2012, ANAL BIOCHEM, V421, P324, DOI 10.1016/j.ab.2011.10.043; Wang HW, 2010, J MICROBIOL METH, V82, P330, DOI 10.1016/j.mimet.2010.06.014; Wang SG, 2011, TOXICOL IN VITRO, V25, P2147, DOI 10.1016/j.tiv.2011.07.007; White Catharine E., 2006, P39, DOI 10.1017/CBO9780511541506.004; Young FM, 2005, TOXICOL IN VITRO, V19, P1051, DOI 10.1016/j.tiv.2005.05.001	21	35	35	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2019	14	8							e0219713	10.1371/journal.pone.0219713	http://dx.doi.org/10.1371/journal.pone.0219713			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5WO	31454355	Green Published, Green Submitted, gold			2022-12-26	WOS:000485049000004
J	Kappert, KDR; van Alphen, MJA; Smeele, LE; Balm, AJM; van der Heijden, F				Kappert, K. D. R.; van Alphen, M. J. A.; Smeele, L. E.; Balm, A. J. M.; van der Heijden, F.			Quantification of tongue mobility impairment using optical tracking in patients after receiving primary surgery or chemoradiation	PLOS ONE			English	Article							ORAL-CANCER; ELECTROMAGNETIC ARTICULOGRAPHY; ARTICULATORY FUNCTION; POST-GLOSSECTOMY; SPEECH; MOTION; RANGE	Purpose Tongue mobility has shown to be a clinically interesting parameter on functional results after tongue cancer treatment which can be objectified by measuring the Range Of Motion (ROM). Reliable measurements of ROM would enable us to quantify the severity of functional impairments and use these for shared decision making in treatment choices, rehabilitation of speech and swallowing disturbances after treatment. Method Nineteen healthy participants, eighteen post-chemotherapy patients and seventeen post-surgery patients were asked to perform standardized tongue maneuvers in front of a 3D camera system, which were subsequently tracked and corrected for head and jaw motion. Indicators, such as the left-right tongue range and the deflection angle with the horizontal axis were extracted from the tongue trajectory to serve as a quantitative measure for the impaired tongue mobility. Results The range and deflection angle showed an excellent intra- and interrater reliability (ICC 0.9) The repeatability experiment showed an average standard deviation of 2.5 mm to 3.5 mm for every movement, except the upward movement. The post-surgery patient group showed a smaller tongue range and higher deflection angle overall than the healthy participants. Post-chemoradiation patients showed less difference in tongue ROM compared with healthy participants. Only a few patients showed asymmetrical movement after treatment, which could not always be explained by T-stage or the side of treatment alone. Conclusion We introduced a reliable and reproducible method for measuring the ROM and to quantify for motion impairments, that was able to show differences in tongue ROM between healthy subjects and patients after chemoradiation or surgery. Future research should focus on measuring patients with oral cancer pre- and post-treatment in combination with the collection of detailed information about the individual tongue anatomy, so that the full ROM trajectory can be used to identify changes over time and to quantify functional impairment.	[Kappert, K. D. R.; van Alphen, M. J. A.; Smeele, L. E.; Balm, A. J. M.; van der Heijden, F.] Netherlands Canc Inst, Head & Neck Oncol & Surg, Amsterdam, Netherlands; [Kappert, K. D. R.; Balm, A. J. M.; van der Heijden, F.] Univ Twente, Robot & Mechatron, Enschede, Netherlands; [Smeele, L. E.; Balm, A. J. M.] Univ Amsterdam, Amsterdam UMC, Oral & Maxillofacial Surg, Amsterdam, Netherlands	Netherlands Cancer Institute; University of Twente; University of Amsterdam	Kappert, KDR (corresponding author), Netherlands Canc Inst, Head & Neck Oncol & Surg, Amsterdam, Netherlands.; Kappert, KDR (corresponding author), Univ Twente, Robot & Mechatron, Enschede, Netherlands.	k.kappert@nki.nl		van der Heijden, Ferdinand/0000-0001-8065-8053; Kappert, Kilian/0000-0002-1278-205X	Virtutis Opis foundation; Atos Medical AB (Malmo, Sweden)	Virtutis Opis foundation; Atos Medical AB (Malmo, Sweden)	This study was financially supported by private funding from the Virtutis Opis foundation (www.anbiportal.nl/web/svo), Mr B. Verwelius and, Mr W. de Graaf. The Department of Head and Neck Oncology and Surgery of the Netherlands Cancer Institute received a research grant from Atos Medical AB (Malmo, Sweden, www.atosmedical.nl). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blyth KM, 2016, J COMMUN DISORD, V61, P1, DOI 10.1016/j.jcomdis.2016.02.004; Borggreven PA, 2005, HEAD NECK-J SCI SPEC, V27, P785, DOI 10.1002/hed.20236; Bressmann T, 2004, J ORAL MAXIL SURG, V62, P298, DOI 10.1016/j.joms.2003.04.017; Bressmann T, 2007, OTOLARYNG HEAD NECK, V136, P799, DOI 10.1016/j.otohns.2006.11.022; Buchaillard S, 2007, INT J MED ROBOT COMP, V3, P252, DOI 10.1002/rcs.142; Fuentes R, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/7134389; Garnaes E, 2015, BRIT J CANCER, V113, P131, DOI 10.1038/bjc.2015.198; Ha J, 2016, J APPL ORAL SCI, V24, P472, DOI 10.1590/1678-775720150421; Haworth B, 2019, COMP M BIO BIO E-IV, V7, P406, DOI 10.1080/21681163.2018.1434423; Husaini H, 2014, DYSPHAGIA, V29, P376, DOI 10.1007/s00455-014-9520-2; Kaburagi T, 2002, J ACOUST SOC AM, V111, P1414, DOI 10.1121/1.1445785; Kappert KDR, 2019, COMPUT METHOD BIOMEC, V22, P827, DOI 10.1080/10255842.2019.1599362; Katz WF, 2017, J ACOUST SOC AM, V141, pEL57, DOI 10.1121/1.4973907; Konstantinovic VS, 1998, BRIT J PLAST SURG, V51, P589, DOI 10.1016/S0007-1226(98)90202-8; Kreeft AM, 2009, EUR ARCH OTO-RHINO-L, V266, P1687, DOI 10.1007/s00405-009-1089-2; Kuruvilla M, 2007, BRAIN INJURY, V21, P601, DOI 10.1080/02699050701427525; Lander-Portnoy M., 2017, J ACOUST SOC AM, V142, P2641, DOI [10.1121/1.5014684, DOI 10.1121/1.5014684]; Lazarus CL, 2014, DYSPHAGIA, V29, P489, DOI 10.1007/s00455-014-9534-9; Lee DY, 2014, J ORAL REHABIL, V41, P754, DOI 10.1111/joor.12193; Masterson JA, 2019, J ACOUST SOC AM, V145, P1794, DOI [10.1121/1.5101563, DOI 10.1121/1.5101563]; Matsui Y, 2007, INT J ORAL MAX SURG, V36, P601, DOI 10.1016/j.ijom.2007.01.014; PERKELL JS, 1992, J ACOUST SOC AM, V92, P3078, DOI 10.1121/1.404204; Ramanarayanan V, 2018, COMPUT SPEECH LANG, V52, P1, DOI 10.1016/j.csl.2018.04.002; Rosebush Molly S, 2011, J Tenn Dent Assoc, V91, P24; Sessions DG, 2002, LARYNGOSCOPE, V112, P616, DOI 10.1097/00005537-200204000-00005; Stone M, 2014, J SPEECH LANG HEAR R, V57, P707, DOI 10.1044/1092-4388(2013/13-0085); Suarez-Cunqueiro MM, 2008, ARCH OTOLARYNGOL, V134, P1299, DOI 10.1001/archotol.134.12.1299; UK Cancer Research, 2019, HEAD NECK CANC INC S; van Alphen MJA, 2013, BRIT J ORAL MAX SURG, V51, P747, DOI 10.1016/j.bjoms.2013.06.012; van der Molen L, 2012, J VOICE, V26, DOI 10.1016/j.jvoice.2011.08.016; van Dijk S, 2016, DYSPHAGIA, V31, P97, DOI 10.1007/s00455-015-9665-7; Xing F, 2016, J SPEECH LANG HEAR R, V59, P468, DOI 10.1044/2016_JSLHR-S-14-0155; Xu KT, 2016, 2016 10TH INTERNATIONAL SYMPOSIUM ON CHINESE SPOKEN LANGUAGE PROCESSING (ISCSLP), DOI 10.3109/02699206.2015.1110714; Zuydam AC, 2005, CLIN OTOLARYNGOL, V30, P428, DOI 10.1111/j.1365-2273.2005.01061.x	34	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2019	14	8							e0221593	10.1371/journal.pone.0221593	http://dx.doi.org/10.1371/journal.pone.0221593			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW5WO	31454385	gold, Green Published			2022-12-26	WOS:000485049000030
J	Oz, E				Oz, Emel			Inhibitory effects of black cumin on the formation of heterocyclic aromatic amines in meatball	PLOS ONE			English	Article							GROUND-BEEF PATTIES; LIPID OXIDATION; DIRECT ADDITION; MODEL SYSTEMS; COOKED FOODS; COOKING; HYDROCARBONS; ANTIOXIDANTS; PRODUCTS; PROTEIN	The impact of black cumin usage on some qualitative properties and formation of heterocyclic aromatic amines (HAAs) in meatball production was investigated. It was found that black cumin usage rate, cooking process and temperature had a significant effect (p< 0,01) on the water content, pH, and thiobarbituric acid reactive substances (TBARS) values of meatballs. On the other hand, black cumin usage significantly (p< 0,01) reduced the water content and cooking loss. The water content and cooking loss of the meatballs decreased with increases in the usage rate. While IQx, IQ, MeIQ, 7,8-DiMeIQx, 4,8-DiMeIQx, AaC, and MeAaC could not be detected in meatballs, varying amounts of MeIQx (up to 1,53 ng/g) and PhIP (up to 1,22 ng/g) were determined. The total amounts of HAAs ranged between non-detected (nd) to 2,75 ng/g. Both the usage rate and cooking temperature had a very significant effect (p< 0,01) on the total contents of HAAs. The total amounts of HAAs were decreased in correlation with the increases in the usage rate; the proportion which is increased when the cooking temperature increased as well. Results of the present study suggested that addition of black cumin may have a substantial role in decreasing the TBARS value, cooking loss, and HAA contents during meatball production. Therefore, using of black cumin in meatball production has been suggested.	[Oz, Emel] Ataturk Univ, Fac Agr, Dept Food Engn, Erzurum, Turkey	Ataturk University	Oz, E (corresponding author), Ataturk Univ, Fac Agr, Dept Food Engn, Erzurum, Turkey.	emel.oz@atauni.edu.tr	Oz, Emel/AAL-9187-2020	Oz, Emel/0000-0003-3766-2713				Abdulkarim BG, 1998, J AGR FOOD CHEM, V46, P4680, DOI 10.1021/jf980175g; Apple JK, 2014, MEAT SCI, V96, P56, DOI 10.1016/j.meatsci.2013.06.015; Balogh Z, 2000, FOOD CHEM TOXICOL, V38, P395, DOI 10.1016/S0278-6915(00)00010-7; Britt C, 1998, J AGR FOOD CHEM, V46, P4891, DOI 10.1021/jf980233y; Cichoski AJ, 2011, CIENCIA TECNOL ALIME, V31, P436, DOI 10.1590/S0101-20612011000200024; Ekiz E, 2019, J SCI FOOD AGR, V99, P1509, DOI 10.1002/jsfa.9325; Fay LB, 1997, MUTAT RES-FUND MOL M, V376, P29, DOI 10.1016/S0027-5107(97)00022-5; FELTON JS, 1984, CARCINOGENESIS, V5, P95, DOI 10.1093/carcin/5.1.95; Felton JS, 1999, CANCER LETT, V143, P127, DOI 10.1016/S0304-3835(99)00141-X; Forouzanfar F, 2014, IRAN J BASIC MED SCI, V17, P929; Gerber N, 2009, MEAT SCI, V81, P148, DOI 10.1016/j.meatsci.2008.07.012; Girard P.J., 1992, TECHNOLOGY MEAT MEAT, P32; Gokalp HY, 1999, 69 FAC AGR, V69; Gokalp HY, 1999, ATATURK U PUBL, V786; GROSS GA, 1990, CARCINOGENESIS, V11, P1597, DOI 10.1093/carcin/11.9.1597; IARC, 1993, MONOGRAPHS EVALUATIO, P163; Jagerstad M, 1998, Z LEBENSM UNTERS F A, V207, P419, DOI 10.1007/s002170050355; Johansson MAE, 1996, FOOD CHEM, V56, P69, DOI 10.1016/0308-8146(95)00160-3; Juntachote T, 2006, MEAT SCI, V72, P446, DOI 10.1016/j.meatsci.2005.08.009; Kilic B, 2003, J FOOD SCI, V68, P686, DOI 10.1111/j.1365-2621.2003.tb05732.x; Klassen RD, 2002, FOOD RES INT, V35, P837, DOI 10.1016/S0963-9969(02)00087-X; KNIZE MG, 1994, FOOD CHEM TOXICOL, V32, P595, DOI 10.1016/0278-6915(94)90002-7; Laycock L, 2003, MEAT SCI, V65, P959, DOI 10.1016/S0309-1740(02)00311-X; Lu F, 2018, FOOD CONTROL, V92, P399, DOI 10.1016/j.foodcont.2018.05.018; Messner C, 2004, J CHROMATOGR B, V802, P19, DOI 10.1016/j.jchromb.2003.11.015; Murkovic M, 1998, Z LEBENSM UNTERS F A, V207, P477, DOI 10.1007/s002170050364; Murkovic M, 2004, EUR J LIPID SCI TECH, V106, P777, DOI 10.1002/ejlt.200400993; NAGAO M, 1977, CANCER LETT, V2, P221, DOI 10.1016/S0304-3835(77)80025-6; Nuray M, 2019, J SCI FOOD AGR, V99, P3538, DOI 10.1002/jsfa.9574; Oz F, 2015, J FOOD PROCESS PRES, V39, P2820, DOI 10.1111/jfpp.12533; Oz F, 2010, J ANIM VET ADV, V9, P1436; Oz F, 2016, J AGR FOOD CHEM, V64, P3070, DOI 10.1021/acs.jafc.5b05716; Oz F, 2016, FOOD CHEM, V203, P59, DOI 10.1016/j.foodchem.2016.02.041; Oz F, 2016, LWT-FOOD SCI TECHNOL, V65, P861, DOI 10.1016/j.lwt.2015.09.023; Oz F, 2015, LWT-FOOD SCI TECHNOL, V64, P120, DOI 10.1016/j.lwt.2015.05.050; Oz F, 2013, FOOD ANAL METHOD, V6, P1370, DOI 10.1007/s12161-012-9553-9; Oz F, 2011, J FOOD PROCESS PRES, V35, P739, DOI 10.1111/j.1745-4549.2011.00524.x; Oz F, 2011, J FOOD PROCESS PRES, V35, P806, DOI 10.1111/j.1745-4549.2011.00532.x; Oz F, 2011, FOOD CONTROL, V22, P596, DOI 10.1016/j.foodcont.2010.10.010; Pais P, 2000, J CHROMATOGR B, V747, P139, DOI 10.1016/S0378-4347(00)00118-3; Pais P, 1999, J AGR FOOD CHEM, V47, P1098, DOI 10.1021/jf980644e; PEARSON AM, 1992, FREE RADICAL BIO MED, V13, P161, DOI 10.1016/0891-5849(92)90078-U; Puangsombat K, 2010, J FOOD SCI, V75, pT40, DOI 10.1111/j.1750-3841.2009.01491.x; Rivera L, 1996, J CHROMATOGR A, V731, P85, DOI 10.1016/0021-9673(95)01224-9; RobbanaBarnat S, 1996, ENVIRON HEALTH PERSP, V104, P280, DOI 10.2307/3432886; RodriguezEstrada MT, 1997, MEAT SCI, V45, P365, DOI 10.1016/S0309-1740(96)00123-4; Rojas MC, 2007, J FOOD SCI, V72, pS282, DOI 10.1111/j.1750-3841.2007.00335.x; Sabally K, 2016, MEAT SCI, V117, P57, DOI 10.1016/j.meatsci.2016.02.040; del Pulgar JS, 2012, MEAT SCI, V90, P828, DOI 10.1016/j.meatsci.2011.11.024; Shin HS, 2002, J FOOD SCI, V67, P3304, DOI 10.1111/j.1365-2621.2002.tb09583.x; Shin HS, 2002, J FOOD PROTECT, V65, P1766, DOI 10.4315/0362-028X-65.11.1766; Singh S, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/918209; Sinha R, 1998, FOOD CHEM TOXICOL, V36, P279, DOI 10.1016/S0278-6915(97)00162-2; Skog K, 2002, FOOD CHEM TOXICOL, V40, P1197, DOI 10.1016/S0278-6915(02)00052-2; Skog K, 1997, FOOD CHEM TOXICOL, V35, P555, DOI 10.1016/S0278-6915(97)00021-5; Szterk A, 2015, J FOOD COMPOS ANAL, V40, P39, DOI 10.1016/j.jfca.2014.12.011; Szterk A, 2014, MEAT SCI, V96, P1177, DOI 10.1016/j.meatsci.2013.11.019; Tang S, 2001, FOOD RES INT, V34, P651, DOI 10.1016/S0963-9969(00)00190-3; Tengilimoglu-Metin MM, 2017, MEAT SCI, V134, P68, DOI 10.1016/j.meatsci.2017.07.018; Tengilimoglu-Metin MM, 2017, FOOD RES INT, V99, P586, DOI 10.1016/j.foodres.2017.06.044; THIEBAUD HP, 1994, J AGR FOOD CHEM, V42, P1502, DOI 10.1021/jf00043a021; Trigui I, 2018, INT J BIOL MACROMOL, V117, P937, DOI 10.1016/j.ijbiomac.2018.05.202; Turesky RJ, 2005, J AGR FOOD CHEM, V53, P3248, DOI 10.1021/jf048290g; Usta C, 2016, ANKARA AKUPUNKTUR, V4, P15; Viegas O, 2012, FOOD CHEM TOXICOL, V50, P2128, DOI 10.1016/j.fct.2012.03.051; Vitaglione P, 2004, J CHROMATOGR B, V802, P189, DOI 10.1016/j.jchromb.2003.09.029; WAKABAYASHI K, 1993, ENVIRON HEALTH PERSP, V99, P129, DOI 10.2307/3431468; Wanasundara UN, 1998, FOOD CHEM, V63, P335, DOI 10.1016/S0308-8146(98)00025-9; YAMAIZUMI Z, 1986, MUTAT RES, V173, P1, DOI 10.1016/0165-7992(86)90002-3; Zeng MM, 2016, MEAT SCI, V116, P50, DOI 10.1016/j.meatsci.2016.02.002	70	21	22	4	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2019	14	8							e0221680	10.1371/journal.pone.0221680	http://dx.doi.org/10.1371/journal.pone.0221680			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5WO	31454384	Green Submitted, Green Published, gold			2022-12-26	WOS:000485049000040
J	Radtke, JP; Giganti, F; Wiesenfarth, M; Stabile, A; Marenco, J; Orczyk, C; Kasivisvanathan, V; Nyarangi-Dix, JN; Schutz, V; Dieffenbacher, S; Gortz, M; Stenzinger, A; Roth, W; Freeman, A; Punwani, S; Bonekamp, D; Schlemmer, HP; Hohenfellner, M; Emberton, M; Moore, CM				Radtke, Jan Philipp; Giganti, Francesco; Wiesenfarth, Manuel; Stabile, Armando; Marenco, Jose; Orczyk, Clement; Kasivisvanathan, Veeru; Nyarangi-Dix, Joanne Nyaboe; Schuetz, Viktoria; Dieffenbacher, Svenja; Goertz, Magdalena; Stenzinger, Albrecht; Roth, Wilfried; Freeman, Alex; Punwani, Shonit; Bonekamp, David; Schlemmer, Heinz-Peter; Hohenfellner, Markus; Emberton, Mark; Moore, Caroline M.			Prediction of significant prostate cancer in biopsy-naive men: Validation of a novel risk model combining MRI and clinical parameters and comparison to an ERSPC risk calculator and PI-RADS	PLOS ONE			English	Article							TRANSRECTAL ULTRASOUND FUSION; RESONANCE-IMAGING MRI; DIAGNOSTIC-ACCURACY; TARGETED BIOPSY; TRANSPERINEAL	Background Risk models (RM) need external validation to assess their value beyond the setting in which they were developed. We validated a RM combining mpMRI and clinical parameters for the probability of harboring significant prostate cancer (sPC, Gleason Score >= 3+4) for biopsy-naive men. Material and methods The original RM was based on data of 670 biopsy-naive men from Heidelberg University Hospital who underwent mpMRI with PI-RADS scoring prior to MRI/TRUS-fusion biopsy 2012-2015. Validity was tested by a consecutive cohort of biopsy-naive men from Heidelberg (n = 160) and externally by a cohort of 133 men from University College London Hospital (UCLH). Assessment of validity was performed at fusion-biopsy by calibration plots, receiver operating characteristics curve and decision curve analyses. The RM's performance was compared to ERSPC-RC3, ERSPC-RC3+PI-RADSv1.0 and PI-RADSv1.0 alone. Results SPC was detected in 76 men (48%) at Heidelberg and 38 men (29%) at UCLH. The areas under the curve (AUC) were 0.86 for the RM in both cohorts. For ERSPC-RC3+PI-RADSv1.0 the AUC was 0.84 in Heidelberg and 0.82 at UCLH, for ERSPC-RC3 0.76 at Heidelberg and 0.77 at UCLH and for PI-RADSv1.0 0.79 in Heidelberg and 0.82 at UCLH. Calibration curves suggest that prevalence of sPC needs to be adjusted to local circumstances, as the RM overestimated the risk of harboring sPC in the UCLH cohort. After prevalence-adjustment with respect to the prevalence underlying ERSPC-RC3 to ensure a generalizable comparison, not only between the Heidelberg and die UCLH subgroup, the RM's Net benefit was superior over the ERSPC's and the mpMRI's for threshold probabilities above 0.1 in both cohorts. Conclusions The RM discriminated well between men with and without sPC at initial MRI-targeted biopsy but overestimated the sPC-risk at UCLH. Taking prevalence into account, the model demonstrated benefit compared with clinical risk calculators and PI-RADSv1.0 in making the decision to biopsy men at suspicion of PC. However, prevalence differences must be taken into account when using or validating the presented risk model.	[Radtke, Jan Philipp; Nyarangi-Dix, Joanne Nyaboe; Schuetz, Viktoria; Dieffenbacher, Svenja; Goertz, Magdalena; Hohenfellner, Markus] Univ Hosp Heidelberg, Dept Urol, Heidelberg, Germany; [Radtke, Jan Philipp; Dieffenbacher, Svenja; Bonekamp, David; Schlemmer, Heinz-Peter] German Canc Res Ctr, Dept Radiol, Heidelberg, Germany; [Giganti, Francesco; Punwani, Shonit] Univ Coll London Hosp NHS Fdn Trust, Dept Radiol, London, England; [Giganti, Francesco; Stabile, Armando; Orczyk, Clement; Kasivisvanathan, Veeru; Emberton, Mark; Moore, Caroline M.] UCL, Div Surg & Intervent Sci, London, England; [Wiesenfarth, Manuel] German Canc Res Ctr, Div Biostat, Heidelberg, Germany; [Stabile, Armando; Marenco, Jose; Orczyk, Clement; Kasivisvanathan, Veeru; Emberton, Mark; Moore, Caroline M.] Univ Coll London Hosp NHS Fdn Trust, Dept Urol, London, England; [Stabile, Armando] Osped San Raffaele, IRCCS, URI, Div Oncol,Unit Urol, Milan, Italy; [Stabile, Armando] Univ Vita Salute San Raffaele, Milan, Italy; [Stenzinger, Albrecht; Roth, Wilfried] Heidelberg Univ, Inst Pathol, Heidelberg, Germany; [Roth, Wilfried] Univ Med Mainz, Inst Pathol, Mainz, Germany; [Freeman, Alex] Univ Coll Hosp, Dept Pathol, London, England; [Punwani, Shonit] UCL, Univ Coll London Hosp NHS Fdn Trust, Ctr Med Imaging, London, England; [Radtke, Jan Philipp] Univ Hosp Essen, Dept Urol, Essen, Germany	Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); University College London Hospitals NHS Foundation Trust; University of London; University College London; University of London; University College London; Helmholtz Association; German Cancer Research Center (DKFZ); University College London Hospitals NHS Foundation Trust; University of London; University College London; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; Ruprecht Karls University Heidelberg; Johannes Gutenberg University of Mainz; University of London; University College London; University College London Hospitals NHS Foundation Trust; University of London; University College London; University of Duisburg Essen	Radtke, JP (corresponding author), Univ Hosp Heidelberg, Dept Urol, Heidelberg, Germany.; Radtke, JP (corresponding author), German Canc Res Ctr, Dept Radiol, Heidelberg, Germany.; Radtke, JP (corresponding author), Univ Hosp Essen, Dept Urol, Essen, Germany.	j.radtke@dkfz-heidelberg.de	Stabile, Armando/AAB-7639-2022; Moore, Caroline/T-2391-2017	Stabile, Armando/0000-0002-3700-0069; PD Dr. med. Radtke, Jan Philipp/0000-0003-1009-6563; Orczyk, Clement/0000-0003-3067-2409; Moore, Caroline/0000-0003-0202-7912; Kasivisvanathan, Veeru/0000-0002-0832-382X	UCL Graduate Research Scholarship; United Kingdom National Institute of Health Research (NIHR); UCL Hospitals; Profound Medical; Invivo Uronav; Bender Group; Beckelmann and Partners; Saegeling Medizintechnik; Brahm PhD scholarship in memory of Chris Adams	UCL Graduate Research Scholarship; United Kingdom National Institute of Health Research (NIHR)(National Institute for Health Research (NIHR)); UCL Hospitals; Profound Medical; Invivo Uronav; Bender Group; Beckelmann and Partners; Saegeling Medizintechnik; Brahm PhD scholarship in memory of Chris Adams	The study group was funded by the UCL Graduate Research Scholarship (awarded to Dr Francesco Giganti), Brahm PhD scholarship in memory of Chris Adams (awarded to Dr Francesco Giganti), United Kingdom National Institute of Health Research (NIHR) Senior Investigator awarded to Prof Mark Emberton), UCL Hospitals (awarded to Prof Mark Emberton), Profound Medical (awarded to Prof David Bonekamp), Invivo Uronav (awarded to Dr Jan Radtke), Bender Group (awarded to Dr Jan Radtke), Beckelmann and Partners (awarded to Dr Jan Radtke), and Saegeling Medizintechnik (awarded to Dr Jan Radtke). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed HU, 2017, LANCET, V389, P815, DOI 10.1016/S0140-6736(16)32401-1; Alberts AR, 2019, EUR UROL, V75, P310, DOI 10.1016/j.eururo.2018.07.031; Auer T, 2016, WORLD J UROL; Barentsz JO, 2012, EUR RADIOL, V22, P746, DOI 10.1007/s00330-011-2377-y; Bjurlin MA, 2018, UROLOGY, V112, P112, DOI 10.1016/j.urology.2017.09.035; Bossuyt PM, 2003, RADIOLOGY, V226, P24, DOI 10.1148/radiol.2261021292; Drost FJ, 2019, EUR UROL SUPPL, V18, pe728; Dwivedi DK, 2018, J MAGN RESON IMAGING, V47, P1227, DOI 10.1002/jmri.25850; Faria R, 2018, EUR UROL, V73, P23, DOI 10.1016/j.eururo.2017.08.018; Futterer JJ, 2015, EUR UROL, V68, P1045, DOI 10.1016/j.eururo.2015.01.013; Humid S, 2019, EUR UROL, V75, P733, DOI 10.1016/j.eururo.2018.08.007; Iasonos A, 2008, J CLIN ONCOL, V26, P1364, DOI 10.1200/JCO.2007.12.9791; Janssen KJM, 2009, CAN J ANAESTH, V56, P194, DOI 10.1007/s12630-009-9041-x; Kasivisvanathan V, 2018, NEW ENGL J MED, V378, P1767, DOI 10.1056/NEJMoa1801993; Kasivisvanathan V, 2013, J UROLOGY, V189, P860, DOI 10.1016/j.juro.2012.10.009; Kim EH, 2017, UROLOGY, V102, P183, DOI 10.1016/j.urology.2016.08.074; Mehralivand S, 2018, JAMA ONCOL, V4, P678, DOI 10.1001/jamaoncol.2017.5667; Moore CM, 2013, EUR UROL, V64, P544, DOI 10.1016/j.eururo.2013.03.030; Moore CM, 2013, EUR UROL, V63, P125, DOI 10.1016/j.eururo.2012.06.004; Pavlou M, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h3868; Poyet C, 2016, BJU INT, V117, P401, DOI 10.1111/bju.13314; PRENTICE RL, 1979, BIOMETRIKA, V66, P403, DOI 10.1093/biomet/66.3.403; Puech P, 2013, RADIOLOGY, V268, P461, DOI 10.1148/radiol.13121501; Radtke JP, 2016, EUR UROL, V70, P846, DOI 10.1016/j.eururo.2015.12.052; Radtke JP, 2017, EUR UROL, V72, P888, DOI 10.1016/j.eururo.2017.03.039; Roobol MJ, 2012, EUR UROL, V61, P577, DOI 10.1016/j.eururo.2011.11.012; Schoots IG, 2015, EUR UROL, V68, P438, DOI 10.1016/j.eururo.2014.11.037; Schroder FH, 2014, LANCET, V384, P2027, DOI 10.1016/S0140-6736(14)60525-0; Simmons LAM, 2017, BRIT J CANCER, V116, P1159, DOI 10.1038/bjc.2017.57; Siriwardana A, 2017, BJU INT, V120, P673, DOI [10.1111/bju.13814, 10.1111/bju.13919]; Valerio M, 2015, EUR UROL, V68, P8, DOI 10.1016/j.eururo.2014.10.026; van der Leest M, 2019, EUR UROL, V75, P570, DOI 10.1016/j.eururo.2018.11.023; Vickers AJ, 2008, BMC MED INFORM DECIS, V8, DOI 10.1186/1472-6947-8-53; Wegelin O, 2019, EUR UROL, V75, P582, DOI 10.1016/j.eururo.2018.11.040; Wegelin O, 2017, EUR UROL, V71, P517, DOI 10.1016/j.eururo.2016.07.041; Woo S, 2017, EUR UROL, V72, P177, DOI 10.1016/j.eururo.2017.01.042; Wysock JS, 2014, EUR UROL, V66, P343, DOI 10.1016/j.eururo.2013.10.048; Yaxley AJ, 2017, BJU INT, V120, P43, DOI 10.1111/bju.13971	38	9	10	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2019	14	8							e0221350	10.1371/journal.pone.0221350	http://dx.doi.org/10.1371/journal.pone.0221350			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5UR	31450235	Green Published, gold, Green Submitted			2022-12-26	WOS:000485044000011
J	Severijns, P; Overbergh, T; Scheys, L; Moke, L; Desloovere, K				Severijns, Pieter; Overbergh, Thomas; Scheys, Lennart; Moke, Lieven; Desloovere, Kaat			Reliability of the balance evaluation systems test and trunk control measurement scale in adult spinal deformity	PLOS ONE			English	Article							AGREEMENT; ALIGNMENT; CHILDREN; IMPACT	Objective To test the reliability of the Balance Evaluation Systems Test (BESTest) and Trunk Control Measurement Scale (TCMS) between sessions and raters in the adult spinal deformity (ASD) population. Summary of background data Up to now evaluation in ASD was mainly based on static radiographic parameters. Recently literature showed that dynamic balance was a better predictor of health-related quality of life than radiographic parameters, stressing the importance of balance assessment. However, to the best of our knowledge, reliability of balance assessment tools has not yet been investigated in the ASD population. Methods Twenty ASD patients participated in this study. Ten patients were included in the test-retest study, including repeated measurements. Ten patients were measured once, simultaneously but independently by three raters. Each participant performed two balance scales, namely the BESTest and the TCMS. Statistical analysis consisted of intra class correlations (ICC) on scale- and subscale level, and kappa scores on item-level. Cronbach's alpha on total scores, standard errors of measurement (SEM), smallest detectable differences and percentages of agreement were also calculated. Bland-altman plots were created to investigate systematic bias. Results ICC scores between sessions and raters for TCMS (0.76 and 0.88) and BESTest (0.90 and 0.94) total scores were good to excellent. SEM's between sessions and raters were also low for total scores on TCMS (1.66 and 2.35) and BESTest (2.99 and 2.32). However, on subscale- and item-level reliability decreased and ceiling effects were observed. No systematic bias was observed between sessions and raters. Conclusion BESTest and TCMS showed to be reliable tools to measure balance in ASD on scale-level. However, on subscale- and item-level reliability decreased and ceiling effects were observed. Therefore, the question arises if there is need for an ASD-specific balance scale.	[Severijns, Pieter; Overbergh, Thomas; Scheys, Lennart; Moke, Lieven] Katholieke Univ Leuven, Fac Med, Dept Dev & Regenerat, IORT, Leuven, Belgium; [Severijns, Pieter; Desloovere, Kaat] Katholieke Univ Leuven, Dept Rehabil Sci, Leuven, Belgium; [Severijns, Pieter; Desloovere, Kaat] Univ Hosp Leuven, CMAL, Leuven, Belgium; [Scheys, Lennart; Moke, Lieven] Univ Hosp Leuven, Div Orthopaed, Leuven, Belgium	KU Leuven; KU Leuven; KU Leuven; University Hospital Leuven; KU Leuven; University Hospital Leuven	Severijns, P (corresponding author), Katholieke Univ Leuven, Fac Med, Dept Dev & Regenerat, IORT, Leuven, Belgium.; Severijns, P (corresponding author), Katholieke Univ Leuven, Dept Rehabil Sci, Leuven, Belgium.; Severijns, P (corresponding author), Univ Hosp Leuven, CMAL, Leuven, Belgium.	pieter.severijns@kuleuven.be	Severijns, Pieter/AFQ-8711-2022; Scheys, Lennart/A-3584-2019; Moke, Lieven/B-2254-2019	Scheys, Lennart/0000-0002-1727-533X; Severijns, Pieter/0000-0003-1552-7844; Moke, Lieven/0000-0003-0500-2710	Research Foundation -Flanders (FWO) [1S56019N]; KU Leuven Grant for Advanced Spinal Evaluation and Surgical Planning Platform (ASESPP); Klinische Onderzoeks-en Opleidingsraad (KOOR) from University Hospitals Leuven; Medtronic Educational Chair for spinal deformity research	Research Foundation -Flanders (FWO)(FWO); KU Leuven Grant for Advanced Spinal Evaluation and Surgical Planning Platform (ASESPP); Klinische Onderzoeks-en Opleidingsraad (KOOR) from University Hospitals Leuven; Medtronic Educational Chair for spinal deformity research	This work received a PhD Fellowship 'strategic basic research' of the Research Foundation -Flanders (FWO), 1S56019N to PS. This study was also funded by following grants/chairs: KU Leuven Grant for Advanced Spinal Evaluation and Surgical Planning Platform (ASESPP), Grant of Klinische Onderzoeks-en Opleidingsraad (KOOR) from University Hospitals Leuven, Medtronic Educational Chair for spinal deformity research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ailon T, 2015, NEUROSURGERY, V77, pS75, DOI 10.1227/NEU.0000000000000938; Bae J, 2017, SPINE, V42, P733, DOI 10.1097/BRS.0000000000001898; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Boissiere L, 2017, SPINE J, V17, P480, DOI 10.1016/j.spinee.2016.10.013; Chapman TM, 2016, SPINE, V41, P1701, DOI 10.1097/BRS.0000000000001613; Diebo BG, 2015, SPINE, V40, P642, DOI 10.1097/BRS.0000000000000844; Ferrero E, 2016, J NEUROSURG-SPINE, V24, P436, DOI 10.3171/2015.5.SPINE14989; GELB DE, 1995, SPINE, V20, P1351, DOI 10.1097/00007632-199506000-00005; HAAS M, 1991, J MANIP PHYSIOL THER, V14, P119; Hawker GA, 2011, ARTHRIT CARE RES, V63, pS240, DOI 10.1002/acr.20543; Heyrman L, 2011, RES DEV DISABIL, V32, P2624, DOI 10.1016/j.ridd.2011.06.012; Horak FB, 2009, PHYS THER, V89, P484, DOI 10.2522/ptj.20080071; Husson J-L, 2010, ORTHOP TRAUMATOL-SUR, V96, P1, DOI [10.1016/j.otsr.2010.03.006, DOI 10.1016/J.OTSR.2010.03.006]; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Marsico P, 2017, DEV MED CHILD NEUROL, V59, P706, DOI 10.1111/dmcn.13425; Moke L., 2016, GAIT POSTURE, V49, P153, DOI [10.1016/j.gaitpost.2016.07.212, DOI 10.1016/J.GAITPOST.2016.07.212]; Moke L, 2018, SPINE, V43, P637, DOI 10.1097/BRS.0000000000002390; Obeid Ibrahim, 2011, Eur Spine J, V20 Suppl 5, P681, DOI 10.1007/s00586-011-1936-x; Pollock AS, 2000, CLIN REHABIL, V14, P402, DOI 10.1191/0269215500cr342oa; Portney LG, 2009, FDN CLIN RES APPL PR, V3rd, DOI DOI 10.1016/S0039-6257(02)00362-4; Potter K, 2018, PHYSIOTHERAPY, V104, P142, DOI 10.1016/j.physio.2017.06.001; Randolph JJ, 2008, ONLINE KAPPA CALCULA; Schwab F, 2012, SPINE, V37, P1077, DOI 10.1097/BRS.0b013e31823e15e2; Severijns P, 2017, GAIT POSTURE, V57, P188, DOI [10.1016/j.gaitpost.2017.06.016, DOI 10.1016/J.GAITPOST.2017.06.016]; SHUMWAYCOOK A, 1988, ARCH PHYS MED REHAB, V69, P395; Smith JS, 2013, SPINE, V38, P1663, DOI 10.1097/BRS.0b013e31829ec563; Sparrey CJ, 2014, NEUROSURG FOCUS, V36, DOI 10.3171/2014.1.FOCUS13551; Vedantam R, 1998, SPINE, V23, P211, DOI 10.1097/00007632-199801150-00012; Wang-Hsu E, 2018, J GERIATR PHYS THER, V41, P173, DOI 10.1519/JPT.0000000000000117	29	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2019	14	8							e0221489	10.1371/journal.pone.0221489	http://dx.doi.org/10.1371/journal.pone.0221489			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5UR	31449540	gold, Green Published, Green Submitted			2022-12-26	WOS:000485044000020
J	Tastad, KJ; Schleiss, MR; Lammert, SM; Basta, NE				Tastad, Katie J.; Schleiss, Mark R.; Lammert, Sara M.; Basta, Nicole E.			Awareness of congenital cytomegalovirus and acceptance of maternal and newborn screening	PLOS ONE			English	Article							TO-MOTHER TRANSMISSION; PREVENTION	Objectives To assess awareness of cytomegalovirus (CMV); attitudes towards screening; and frequency of behaviors that could increase the risk of prenatal infection. Methods We conducted a survey among 726 women at the 2017 Minnesota State Fair. Minnesota residents aged 18-44 were eligible if they had never been pregnant or had been pregnant within the past 10 years. We compared responses between never-pregnant and recently-pregnant women. Results Only 20% of study participants had previously heard of CMV. Remarkably, recently-pregnant women were no more likely to be aware of CMV than never-pregnant women after adjusting for potential confounders. After receiving information about CMV, nearly all participants indicated they believed prenatal (96%) or newborn (96%) screening should be offered. Conclusions Although baseline awareness of CMV was low (even among recently-pregnant women), after learning more about the risks, women supported screening. Several states have passed or proposed legislation promoting CMV education and/or screening programs. We identified important gaps in knowledge about CMV among women who may benefit from education about how to reduce their risk of exposure and who may need to decide whether they would be willing to screen for CMV in the future.	[Tastad, Katie J.; Lammert, Sara M.; Basta, Nicole E.] Univ Minnesota, Sch Publ Hlth, Div Epidemiol & Community Hlth, Minneapolis, MN 55455 USA; [Schleiss, Mark R.] Univ Minnesota, Sch Med, Div Pediat Infect Dis & Immunol, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Basta, NE (corresponding author), Univ Minnesota, Sch Publ Hlth, Div Epidemiol & Community Hlth, Minneapolis, MN 55455 USA.	nebasta@umn.edu	Schleiss, Mark/ABI-8450-2020	Schleiss, Mark/0000-0002-2108-9433	Community Health Impact in Pediatrics grant - Minnesota Vikings Children's Fund Award, "If You Don't Pass, Screen"; University of Minnesota Medical School Department of Pediatrics	Community Health Impact in Pediatrics grant - Minnesota Vikings Children's Fund Award, "If You Don't Pass, Screen"; University of Minnesota Medical School Department of Pediatrics	This work was supported by a Community Health Impact in Pediatrics grant (awarded to MS) funded by the Minnesota Vikings Children's Fund Award, "If You Don't Pass, Screen" and the University of Minnesota Medical School Department of Pediatrics. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler SP, 2004, J PEDIATR-US, V145, P485, DOI 10.1016/j.jpeds.2004.05.041; Binda S, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1861-z; Cannon MJ, 2012, PREV MED, V54, P351, DOI 10.1016/j.ypmed.2012.03.009; Cannon MJ, 2009, J CLIN VIROL, V46, pS6, DOI 10.1016/j.jcv.2009.09.002; Din ES, 2011, PEDIATRICS, V128, pE1434, DOI 10.1542/peds.2011-1444; Dollard SC, 2007, REV MED VIROL, V17, P355, DOI 10.1002/rmv.544; Doutre SM, 2016, J EARLY HEAR DETECT, V1, P39, DOI DOI 10.15142/T32G62; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Jeon J, 2006, INFECT DIS OBSTET GY, V2006, DOI [10.1155/IDOG/2006/80383, DOI 10.1155/IDOG/2006/80383]; Kenneson A, 2007, REV MED VIROL, V17, P253, DOI 10.1002/rmv.535; Minnesota Office of Higher Education, ED ATT DAT; National CMV Foundation, CMV LEG; National CMV Foundation, 2019, NOM CMV RUSP; Revello MG, 2015, EBIOMEDICINE, V2, P1205, DOI 10.1016/j.ebiom.2015.08.003; Ross DS, 2008, J WOMENS HEALTH, V17, P849, DOI 10.1089/jwh.2007.0523; Schleiss MR, 2018, J INFECT DIS, V217, P1861, DOI 10.1093/infdis/jiy104; Thackeray R, 2017, BMC WOMENS HEALTH, V17, DOI 10.1186/s12905-017-0492-x; Thackeray Rosemary, 2016, Prev Med Rep, V4, P517; Tu WW, 2004, J IMMUNOL, V172, P3260, DOI 10.4049/jimmunol.172.5.3260; Vauloup-Fellous C, 2009, J CLIN VIROL, V46, pS49, DOI 10.1016/j.jcv.2009.09.003	20	15	15	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2019	14	8							e0221725	10.1371/journal.pone.0221725	http://dx.doi.org/10.1371/journal.pone.0221725			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5UR	31449545	Green Submitted, Green Published, gold			2022-12-26	WOS:000485044000033
J	Ang, WJ; Zunaina, E; Norfadzillah, AJ; Raja-Norliza, RO; Julieana, M; Ab-Hamid, SA; Mahaneem, M				Ang, Wen Jeat; Zunaina, Embong; Norfadzillah, Abdul Jalil; Raja-Norliza, Raja Omar; Julieana, Muhammed; Ab-Hamid, Siti Azrin; Mahaneem, Mohamed			Evaluation of vascular endothelial growth factor levels in tears and serum among diabetic patients	PLOS ONE			English	Article							EPITHELIAL BASEMENT-MEMBRANE; VITREOUS LEVELS; MICROVASCULAR PERMEABILITY; AQUEOUS-HUMOR; MACULAR EDEMA; RETINOPATHY; FLUID; VEGF; BEVACIZUMAB; EXPRESSION	Objective Detection of vascular endothelial growth factor (VEGF) levels in ocular tissue may perhaps provide insight into the role of VEGF in the pathogenesis and progression of diabetic retinopathy (DR). The aim of this study was to evaluate the levels of VEGF in tears and serum amongst type 2 diabetes mellitus (DM) patients. Methods A comparative cross-sectional study was conducted between August 2016 and May 2018 involving type 2 DM patients with no DR, non-proliferative DR (NPDR), and proliferative DR (PDR). Tear samples were collected using no.41 Whatman filter paper (Schirmer strips) and 5 mL blood samples were drawn by venous puncture. VEGF levels in tears and serum were measured by enzyme-linked immunosorbent assay. Results A total of 88 type 2 DM patients (no DR: 30 patients, NPDR: 28 patients, PDR: 30 patients) were included in the study. Mean tear VEGF levels were significantly higher in the NPDR and PDR groups (114.4 SD 52.5 pg/mL and 150.8 SD 49.7 pg/mL, respectively) compared to the no DR group (40.4 SD 26.5 pg/mL, p<0.001). There was no significant difference in the mean serum VEGF levels between the three groups. There was a fair correlation between serum and tear VEGF levels (p = 0.015, r = 0.263). Conclusion VEGF levels in tears were significantly higher amongst diabetic patients with DR compared to those without DR and were significantly associated with the severity of DR. There was a fair correlation between serum and tear VEGF levels. Detection of VEGF in tears is a good non-invasive predictor test for the severity of DR. A large cohort study is needed for further evaluation.	[Ang, Wen Jeat; Zunaina, Embong; Julieana, Muhammed] Univ Sains Malaysia, Sch Med Sci, Dept Ophthalmol, Hlth Campus, Kubang Kerian, Kelantan, Malaysia; [Ang, Wen Jeat; Norfadzillah, Abdul Jalil; Raja-Norliza, Raja Omar] Melaka Gen Hosp, Dept Ophthalmol, Jalan Mufti Haji Khalil, Melaka, Malaysia; [Ab-Hamid, Siti Azrin] Univ Sains Malaysia, Unit Biostat & Res Methodol, Sch Med Sci, Hlth Campus, Kubang Kerian, Kelantan, Malaysia; [Mahaneem, Mohamed] Univ Sains Malaysia, Dept Physiol, Sch Med Sci, Hlth Campus, Kubang Kerian, Kelantan, Malaysia	Universiti Sains Malaysia; Universiti Sains Malaysia; Universiti Sains Malaysia	Zunaina, E (corresponding author), Univ Sains Malaysia, Sch Med Sci, Dept Ophthalmol, Hlth Campus, Kubang Kerian, Kelantan, Malaysia.	zunaina@usm.my	Embong, Zunaina/C-7386-2018; Mohamed, Mahaneem/F-1159-2011; Ab Hamid, Siti Azrin/N-4028-2015	Mohamed, Mahaneem/0000-0001-9333-1957; Zunaina, Embong/0000-0001-5394-6105; Ab Hamid, Siti Azrin/0000-0002-8212-9849	University Bridging Grant Universiti Sains Malaysia [304]	University Bridging Grant Universiti Sains Malaysia(Universiti Sains Malaysia)	This work is supported by University Bridging Grant Universiti Sains Malaysia (Account No: 304.PPSP.6316167). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu El-Asrar AM, 2006, EUR CYTOKINE NETW, V17, P155, DOI 10.1684/ecn.2006.0033; Adamis AP, 2008, SEMIN IMMUNOPATHOL, V30, P65, DOI 10.1007/s00281-008-0111-x; AIELLO LP, 1994, NEW ENGL J MED, V331, P1480, DOI 10.1056/NEJM199412013312203; AZAR DT, 1992, ARCH OPHTHALMOL-CHIC, V110, P537, DOI 10.1001/archopht.1992.01080160115045; Baharivand N, 2012, CLIN OPHTHALMOL, V6, P185, DOI 10.2147/OPTH.S27423; Bates DO, 2002, J ANAT, V200, P581, DOI 10.1046/j.1469-7580.2002.00066.x; Bates DO, 1997, AM J PHYSIOL-HEART C, V273, pH687, DOI 10.1152/ajpheart.1997.273.2.H687; BEDNARZ J, 1995, CORNEA, V14, P372, DOI 10.1097/00003226-199507000-00005; Boursiquot BC, 2017, HYPERTENSION, V70, P552, DOI 10.1161/HYPERTENSIONAHA.117.09275; Burgos R, 1997, DIABETOLOGIA, V40, P1107, DOI 10.1007/s001250050794; Demircan N, 2006, EYE, P20; Doganay S, 2002, EYE, V16, P163, DOI 10.1038/sj.eye.6700095; Duh EJ, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.93751; Ermakova N A, 2008, Vestn Oftalmol, V124, P25; Farias E, 2013, PESQUI VET BRASIL, V33, P261, DOI 10.1590/S0100-736X2013000200021; Feisul M. I., 2013, NATL DIABETES REGIST; Ford KM, 2012, INVEST OPHTH VIS SCI, V53, P7520, DOI 10.1167/iovs.12-10098; Funatsu H, 2005, GRAEF ARCH CLIN EXP, V243, P3, DOI 10.1007/s00417-004-0950-7; Hernandez C, 2002, DIABETIC MED, V19, P655, DOI 10.1046/j.1464-5491.2002.00768.x; Hernandez C, 2001, DIABETES CARE, V24, P516, DOI 10.2337/diacare.24.3.516; Javitt JC, 1996, ANN INTERN MED, V124, P164, DOI 10.7326/0003-4819-124-1_Part_2-199601011-00017; Kasza M, 2015, GRAEF ARCH CLIN EXP, V253, P1581, DOI 10.1007/s00417-015-3030-2; King P, 1999, BRIT J CLIN PHARMACO, V48, P643, DOI 10.1046/j.1365-2125.1999.00092.x; KLEIN R, 1984, ARCH OPHTHALMOL-CHIC, V102, P527, DOI 10.1001/archopht.1984.01040030405011; Ljubimov AV, 1998, J HISTOCHEM CYTOCHEM, V46, P1033, DOI 10.1177/002215549804600907; Maier R, 2008, MOL VIS, V14, P637; Matsumoto T, 2017, GRAEF ARCH CLIN EXP, V255, P1981, DOI 10.1007/s00417-017-3756-0; Nath M, 2017, INDIAN J OPHTHALMOL, V65, P191, DOI 10.4103/ijo.IJO_866_16; Nathan DM, 2014, DIABETES CARE, V37, P9, DOI 10.2337/dc13-2112; Nguyen TT, 2009, DIABETES CARE, V32, P1704, DOI 10.2337/dc09-0102; PATZ A, 1980, INVEST OPHTH VIS SCI, V19, P1133; Posa A, 2013, ANN ANAT, V195, P137, DOI 10.1016/j.aanat.2012.10.001; Quah JHM, 2014, OPTOMETRY VISION SCI, V91, P452, DOI 10.1097/OPX.0000000000000188; Rentka A, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/573681; Rossi S, 2012, ARCH ITAL BIOL, V150, P15, DOI 10.4449/aib.v150i1.1382; Sawada O, 2007, ARCH OPHTHALMOL-CHIC, V125, P1363, DOI 10.1001/archopht.125.10.1363; Simo R, 2002, AM J OPHTHALMOL, V134, P376, DOI 10.1016/S0002-9394(02)01538-6; Ugur MG, 2018, CLIN RESPIR J, V12, P1912, DOI 10.1111/crj.12755; van Buggenum IMH, 2002, DIABETOLOGIA, V45, P203, DOI 10.1007/s00125-001-0747-8; van Setten GB, 1997, ACTA OPHTHALMOL SCAN, V75, P649; Watanabe D, 2005, AM J OPHTHALMOL, V139, P476, DOI 10.1016/j.ajo.2004.10.004; Wilkinson CP, 2003, OPHTHALMOLOGY, V110, P1677, DOI 10.1016/S0161-6420(03)00475-5; Williams R, 2004, EYE, V18, P963, DOI 10.1038/sj.eye.6701476; Wu HL, 2017, J OPHTHALMOL, V2017, DOI 10.1155/2017/9402198; Yuuki T, 2001, J DIABETES COMPLICAT, V15, P257, DOI 10.1016/S1056-8727(01)00155-6; Zechariah A, 2013, ARTERIOSCL THROM VAS, V33, P1561, DOI 10.1161/ATVBAHA.112.300749; Zhou L, 2009, J PROTEOME RES, V8, P4889, DOI 10.1021/pr900686s	47	21	21	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2019	14	8							e0221481	10.1371/journal.pone.0221481	http://dx.doi.org/10.1371/journal.pone.0221481			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5RZ	31437234	Green Published, gold, Green Submitted			2022-12-26	WOS:000485036900079
J	Santos, OR; Rocha, MOD; de Almeida, FR; da Cunha, PFS; Souza, SCS; Saad, GP; Santos, TADQ; Ferreira, AM; Tan, TC; Nunes, MCP				Santos Junior, Omar Ribeiro; da Costa Rocha, Manoel Otavio; de Almeida, Fernanda Rodrigues; Sales da Cunha, Pedro Ferrari; Silva Souza, Stella Cristina; Saad, Gabriel Prado; de Deus Queiroz Santos, Thiago Adriano; Ferreira, Ariela Mota; Tan, Timothy C.; Pereira Nunes, Maria Carmo			Speckle tracking echocardiographic deformation indices in Chagas and idiopathic dilated cardiomyopathy: Incremental prognostic value of longitudinal strain	PLOS ONE			English	Article							VENTRICULAR DIASTOLIC FUNCTION; MYOCARDIAL FIBROSIS; DELAYED ENHANCEMENT; EJECTION FRACTION; EUROPEAN-SOCIETY; DISEASE; RISK; RECOMMENDATIONS; ASSOCIATION; BRANCH	Background Chagas cardiomyopathy (CDC) is associated with a poor prognosis compared to other cardiomyopathies. Speckle tracking echocardiography (STE), which provides direct assessment of myocardial fiber deformation, may be useful in predicting prognosis. Objective This study assessed STE in CDC and compared with idiopathic cardiomyopathy (IDC), and also examined the incremental prognostic information of STE over left ventricular ejection fraction (LVEF) in these patients. Methods We enrolled 112 patients, age of 56.7 +/- 11.8 years, 81 with CDC and 31 with IDC. STE indices were obtained at baseline in all patients. The endpoint was a composite of death, hospitalization for heart failure, or need for heart transplantation. Results Patients with IDC had worse LV systolic function compared to CDC, with LVEF of 34.5% vs 41.3%, p = 0.004, respectively. After adjustment for LVEF, there were no differences in STE values between CDC and IDC. During a median follow-up of 18.2 months (range, 11 to 22), 26 patients met the composite end point (24%). LV longitudinal strain was a strong predictor of adverse events, incremental to LVEF and E/e' ratio (HR 1.463, 95% CI 1.130-1.894; p = 0.004). The risk of cardiac events increased significantly in patients with GLS > - 12% (log-rank p = 0.035). Conclusions STE indices were abnormal in patients with dilated cardiomyopathy, without differences between CDC and IDC. LV longitudinal strain was a powerful predictor of outcome, adding prognostic information beyond that provided by LVEF and E/e' ratio.	[Santos Junior, Omar Ribeiro; da Costa Rocha, Manoel Otavio; de Almeida, Fernanda Rodrigues; Saad, Gabriel Prado; de Deus Queiroz Santos, Thiago Adriano; Pereira Nunes, Maria Carmo] Univ Fed Minas Gerais, Sch Med, Postgrad Course Infect Dis & Trop Med, Belo Horizonte, MG, Brazil; [Sales da Cunha, Pedro Ferrari; Silva Souza, Stella Cristina] Univ Fed Minas Gerais, Sch Med, Belo Horizonte, MG, Brazil; [Ferreira, Ariela Mota] Univ Estadual Montes Claros, Postgrad Program Hlth Sci, State Univ Montes Claros, Montes Claros, MG, Brazil; [Tan, Timothy C.] Univ Western Sydney, Blacktown Hosp, Dept Cardiol, Sydney, NSW, Australia	Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; Universidade Estadual de Montes Claros; Blacktown & Mount Druitt Hospital; Western Sydney University	Nunes, MCP (corresponding author), Univ Fed Minas Gerais, Sch Med, Postgrad Course Infect Dis & Trop Med, Belo Horizonte, MG, Brazil.	mcarmo@waymail.com.br	Nunes, Maria Carmo/AAV-5185-2020	Tan, Timothy/0000-0003-4449-1457; Nunes, Maria Carmo/0000-0001-8801-1828	Brazilian Research agency Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) (MCTI/CNPq) [14/2014]; Brazilian Research agency Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)	Brazilian Research agency Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) (MCTI/CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Brazilian Research agency Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG))	This work was supported by grants from the Brazilian Research agencies Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) (MCTI/CNPq N 14/2014 to MCPN), and Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG). MOC Rocha and MCP Nunes are fellows of the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbosa MM, 2014, ECHOCARDIOGR-J CARD, V31, P623, DOI 10.1111/echo.12426; Cho GY, 2009, J AM COLL CARDIOL, V54, P618, DOI 10.1016/j.jacc.2009.04.061; Coura JR, 2010, NATURE, V465, pS6, DOI 10.1038/nature09221; de Mello RP, 2012, ARQ BRAS CARDIOL, V98, P421, DOI 10.1590/S0066-782X2012005000031; Elliott P, 2008, EUR HEART J, V29, P270, DOI 10.1093/eurheartj/ehm342; Freitas HFG, 2005, INT J CARDIOL, V102, P239, DOI 10.1016/j.ijcard.2004.05.025; Garcia-Alvarez A, 2011, J CARD FAIL, V17, P1028, DOI 10.1016/j.cardfail.2011.08.007; Garcia-Alvarez A, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000826; Geyer H, 2010, J AM SOC ECHOCARDIOG, V23, P351, DOI 10.1016/j.echo.2010.02.015; Gomes VA, 2016, J AM SOC ECHOCARDIOG; Horton KD, 2009, J AM SOC ECHOCARDIOG, V22, P776, DOI 10.1016/j.echo.2009.04.027; Hwang IC, 2018, J AM SOC ECHOCARDIOG, V31, P52, DOI 10.1016/j.echo.2017.08.016; Kalam K, 2014, HEART, V100, P1673, DOI 10.1136/heartjnl-2014-305538; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; Macedo CT, 2015, IJC HEART VASC, V8, P75, DOI 10.1016/j.ijcha.2015.05.007; MacIver DH, 2015, IJC HEART VASC, V7, P113, DOI 10.1016/j.ijcha.2015.03.007; MacIver DH, 2012, EXP CLIN CARDIOL, V17, P5; Marwick TH, 2006, J AM COLL CARDIOL, V47, P1313, DOI 10.1016/j.jacc.2005.11.063; Mewton N, 2011, J AM COLL CARDIOL, V57, P891, DOI 10.1016/j.jacc.2010.11.013; Nagueh SF, 2009, J AM SOC ECHOCARDIOG, V22, P107, DOI 10.1016/j.echo.2008.11.023; Nascimento CAS, 2013, J AM SOC ECHOCARDIOG, V26, P1424, DOI 10.1016/j.echo.2013.08.018; Nunes MCP, 2013, J AM COLL CARDIOL, V62, P767, DOI 10.1016/j.jacc.2013.05.046; Nunes MDP, 2010, REV ESP CARDIOL, V63, P788, DOI 10.1016/S0300-8932(10)70181-0; Regueiro A, 2011, INT J CARDIOLOGY; Requena-Mendez A, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003540; Ribeiro AL, 2012, NAT REV CARDIOL, V9, P576, DOI 10.1038/nrcardio.2012.109; Rochitte CE, 2005, J AM COLL CARDIOL, V46, P1553, DOI 10.1016/j.jacc.2005.06.067; Silva Carlos Eduardo Suaide, 2005, Arq. Bras. Cardiol., V84, P285, DOI 10.1590/S0066-782X2005000400003; Silva CP, 2008, ARQ BRAS CARDIOL, V91, P358; Steyerberg E., 2009, CLIN PREDICTION MODE; Braga JCV, 2008, INT J CARDIOL, V126, P276, DOI 10.1016/j.ijcard.2007.01.097; Voigt JU, 2015, EUR HEART J-CARD IMG, V16, P1, DOI 10.1093/ehjci/jeu184; Volpe GJ, 2018, J AM COLL CARDIOL, V72, P2567, DOI 10.1016/j.jacc.2018.09.035	33	8	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2019	14	8							e0221028	10.1371/journal.pone.0221028	http://dx.doi.org/10.1371/journal.pone.0221028			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5RZ	31437176	Green Published, Green Submitted, gold			2022-12-26	WOS:000485036900026
J	Machado, ACZ; Amaro, PM; da Silva, SA				Zamboni Machado, Andressa Cristina; Amaro, Priscila Moreira; da Silva, Santino Aleandro			Two novel potential pathogens for soybean	PLOS ONE			English	Article							SOIL NEMATODE COMMUNITIES; TYLENCHIDA HOPLOLAIMIDAE; HELICOTYLENCHUS; MELOIDOGYNE; STEINER	Nematode diseases have a worldwide importance for several economic agricultural crops, such as soybean. Frequently, new or secondary pathogens arise as emergent diseases due to the intensified use of agricultural lands, causing extensive yield losses. Helicotylenchus dihystera (Hd) and Scutellonema brachyurus (Sb) appear as potential pathogens for soybean in Brazil, since their spread and population densities have been increased on soybean growing areas. Aiming to evaluate the quantitative distribution of Hd and Sb in soybean fields in South Brazil, a survey was conducted during the growing seasons of 2014-2015 and 2015-2016 in which 1,088 soil samples and 1,043 root samples were analyzed. Besides, two greenhouse experiments were conducted to evaluate the pathogenicity of both nematodes to soybean plants, in comparison with P. brachyurus (Pb), a known pathogen of the crop. The survey demonstrated that Pb, Hd and Sb are widely distributed in the States of Parana, Santa Catarina and Mato Grosso do Sul. Besides, we proved that Hd and Sb multiply and cause root lesions in soybean cv. Potencia, since they were found inside roots, and can be considered as potential pathogens for soybean plants.	[Zamboni Machado, Andressa Cristina; Amaro, Priscila Moreira; da Silva, Santino Aleandro] Inst Agron Parana, Dept Plant Protect, Londrina, Parana, Brazil	Instituto Agronomico de Campinas (IAC)	Machado, ACZ (corresponding author), Inst Agron Parana, Dept Plant Protect, Londrina, Parana, Brazil.	andressaczmachado@hotmail.com	Machado, Andressa Cristina Zamboni/AAT-8800-2020	Machado, Andressa Cristina Zamboni/0000-0003-4383-2221				Antonio SF, 2012, PERDAS PRODUTIVIDADE; Arieira G. de O., 2013, Revista Brasileira de Ciencias Agrarias (Agraria), V8, P570, DOI 10.5039/agraria.v8i4a3027; Baermann G., 1917, NEDERLANDS TIJDSCRIF, V57, P131; Baia FC, 2015, INCIDENCIA SCUTELLON; Baida FC, 2015, OCORRENCIA HELICOTYL; Boneti JI, 1981, FITOPATOL BRAS, V6, P533; Boutsika K., 2002, THESIS; Byrd D.W., 1983, J NEMATOL, V15, P142; Cardoso MD, 2015, SOIL USE MANAGE, V31, P397, DOI 10.1111/sum.12190; Castillo P, 2007, NEMATOL MONOGR PERSP, V6, P1; De Abreu Mattos Jean Kleber, 2006, Nematologia Brasileira, V30, P267; Doucet ME, 2015, NEMATODOS FITOPARASI; Favoreto L, 2018, PLANT DIS, V102, P2662, DOI [10.1094/pdis-02-18-0334-pdn, 10.1094/PDIS-02-18-0334-PDN]; Fundacao Rio Verde, 2014, LEV POP ESP NEM CULT; Gomes G. S., 2003, Fitopatologia Brasileira, V28, P258, DOI 10.1590/S0100-41582003000300006; Kirsch VG, 2016, NEMATROPICA, V46, P197; Krall E. L., 1978, PARASITIC ROOT NEMAT; Lima FSO, 2009, TROPICAL PLANT PATHO, V34, P207; LOPES C. M., 2015, THESIS; Maceda A, 2009, 2 INT C TROP NEM MAC; Machado ACZ, 2007, NEMATROPICA, V37, P249; Machado A. C. Z., 2014, Current Agricultural Science and Technology, V20, P26; Machado ACZ, 2015, TROP PLANT PATHOL, V40, P102, DOI 10.1007/s40858-015-0013-0; Mattos Jean K. A., 2008, Nematologia Brasileira, V32, P142; Meyer MC, 2017, TROP PLANT PATHOL, V42, P403, DOI 10.1007/s40858-017-0167-z; Moens M, 2010, ROOT-KNOT NEMATODES, P1; Moens M, 2009, ANNU REV PHYTOPATHOL, V47, P313, DOI 10.1146/annurev-phyto-080508-081846; Mondino EA, 2009, ACTA SCI-AGRON, V31, P509, DOI 10.4025/actasciagron.v31i3.433; ORBIN DP, 1973, J NEMATOL, V5, P37; Pinto NFJA, 2006, CULTIVO MILHO EMBRAP, V1; R Core Team, 2013, R LANG ENV STAT COMP; Ribeiro NR, 2010, B PESQUISA SOJA; Rodrigues CVMA, 2011, NEMATROPICA, V41, P5; Santiago DC, 2012, NEMATOLOGY, V14, P209, DOI 10.1163/138855411X587103; Sharma RD, 2001, COMUNICADO TECNICO, V56, P1; SHER S. A., 1964, Nematologica, V9, P421; Silva FEP, 2007, THESIS; Silva JFV., 1999, NEMATOIDE CISTO EXPE, P15; Silva RA, 2002, OCORRENCIA NEMATOIDE; Sites JW, 2004, ANNU REV ECOL EVOL S, V35, P199, DOI 10.1146/annurev.ecolsys.35.112202.130128; Stanton JM, 1998, AUSTRALAS PLANT PATH, V27, P112, DOI 10.1071/AP98014; Starr J. L., 2002, P229, DOI 10.1079/9780851994666.0229; Subbotin SA, 2015, NEMATOLOGY, V17, P27, DOI 10.1163/15685411-00002850; Subbotin SA, 2011, NEMATOLOGY, V13, P333, DOI 10.1163/138855410X520936; van den Berg E, 2013, NEMATOLOGY, V15, P719, DOI 10.1163/15685411-00002714; Venables WN., 2002, MODERN APPL STAT S 4	46	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2019	14	8							e0221416	10.1371/journal.pone.0221416	http://dx.doi.org/10.1371/journal.pone.0221416			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5RZ	31437224	Green Published, Green Submitted, gold			2022-12-26	WOS:000485036900067
J	Xu, HL; Gajda, AM; Zhou, YX; Panetta, C; Sifnakis, Z; Fatima, A; Henderson, GC; Storch, J				Xu, Heli; Gajda, Angela M.; Zhou, Yin Xiu; Panetta, Cristina; Sifnakis, Zoe; Fatima, Anam; Henderson, Gregory C.; Storch, Judith			Muscle metabolic reprogramming underlies the resistance of liver fatty acid?binding protein (LFABP)-null mice to high-fat feeding?induced decline in exercise capacity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						fatty acid; fatty acid binding protein; muscle physiology; obesity; exercise	ACID-BINDING PROTEIN; PPAR-ALPHA; PHYSICAL INACTIVITY; LIPID-METABOLISM; HEALTHY OBESITY; OXYGEN-UPTAKE; NULL MICE; OXIDATION; PERFORMANCE; ABLATION	Liver fatty acid-binding protein (LFABP) binds long-chain fatty acids with high affinity and is abundantly expressed in the liver and small intestine. Although LFABP is thought to function in intracellular lipid trafficking, studies of LFABP-null (LFABP(?/?)) mice have also indicated a role in regulating systemic energy homeostasis. We and others have reported that LFABP(?/?) mice become more obese than wildtype (WT) mice upon high-fat feeding. Here, we show that despite increased body weight and fat mass, LFABP(?/?) mice are protected from a high-fat feeding?induced decline in exercise capacity, displaying an approximate doubling of running distance compared with WT mice. To understand this surprising exercise phenotype, we focused on metabolic alterations in the skeletal muscle due to LFABP ablation. Compared with WT mice, resting skeletal muscle of LFABP(?/?) mice had higher glycogen and intramuscular triglyceride levels as well as an increased fatty acid oxidation rate and greater mitochondrial enzyme activities, suggesting higher substrate availability and substrate utilization capacity. Dynamic changes in the respiratory exchange ratio during exercise indicated that LFABP(?/?) mice use more carbohydrate in the beginning of an exercise period and then switch to using lipids preferentially in the later stage. Consistently, LFABP(?/?) mice exhibited a greater decrease in muscle glycogen stores during exercise and elevated circulating free fatty acid levels postexercise. We conclude that, because LFABP is not expressed in muscle, its ablation appears to promote interorgan signaling that alters muscle substrate levels and metabolism, thereby contributing to the prevention of high-fat feeding?induced skeletal muscle impairment.	[Xu, Heli; Gajda, Angela M.; Zhou, Yin Xiu; Panetta, Cristina; Sifnakis, Zoe; Fatima, Anam; Storch, Judith] Rutgers State Univ, Dept Nutr Sci, New Brunswick, NJ 08901 USA; [Henderson, Gregory C.] Rutgers State Univ, Dept Exercise Sci, New Brunswick, NJ 08901 USA; [Xu, Heli; Gajda, Angela M.; Henderson, Gregory C.; Storch, Judith] Rutgers State Univ, Rutgers Ctr Lipid Res, New Brunswick, NJ 08901 USA; [Henderson, Gregory C.] Purdue Univ, Dept Nutr Sci, W Lafayette, IN 47907 USA	Rutgers State University New Brunswick; Rutgers State University New Brunswick; Rutgers State University New Brunswick; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Storch, J (corresponding author), Rutgers State Univ, Dept Nutr Sci, New Brunswick, NJ 08901 USA.	Storch@sebs.rutgers.edu	Zhou, yixin/HGE-2329-2022	Storch, Judith/0000-0001-5482-1777; Xu, Heli/0000-0002-9792-2727	NIDDK, National Institutes of Health [DK-38389]; New Jersey Agricultural Experiment Station; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK038389] Funding Source: NIH RePORTER	NIDDK, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); New Jersey Agricultural Experiment Station; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by NIDDK, National Institutes of Health Grant DK-38389 and funds from the New Jersey Agricultural Experiment Station (to J. S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Appleton SL, 2013, DIABETES CARE, V36, P2388, DOI 10.2337/dc12-1971; Atshaves BP, 2010, LIPIDS, V45, P97, DOI 10.1007/s11745-009-3379-2; Bassett DR, 2000, MED SCI SPORT EXER, V32, P70, DOI 10.1097/00005768-200001000-00012; Blair SN, 1999, MED SCI SPORT EXER, V31, pS646, DOI 10.1097/00005768-199911001-00025; Bluher M, 2014, EUR J ENDOCRINOL, V171, pR209, DOI 10.1530/EJE-14-0540; Borghouts LB, 2000, INT J SPORTS MED, V21, P1, DOI 10.1055/s-2000-8847; Boudonck KJ, 2009, TOXICOL PATHOL, V37, P280, DOI 10.1177/0192623309332992; Bouzakri K, 2008, DIABETES, V57, P1508, DOI 10.2337/db07-0583; BROOKS GA, 1994, J APPL PHYSIOL, V76, P2253, DOI 10.1152/jappl.1994.76.6.2253; Chmurzynska A, 2006, J APPL GENET, V47, P39, DOI 10.1007/BF03194597; Choi CS, 2008, P NATL ACAD SCI USA, V105, P19926, DOI 10.1073/pnas.0810339105; COSTILL DL, 1970, J APPL PHYSIOL, V28, P251, DOI 10.1152/jappl.1970.28.3.251; DeHaven CD, 2010, J CHEMINFORMATICS, V2, DOI 10.1186/1758-2946-2-9; Eaton S, 2002, PROG LIPID RES, V41, P197, DOI 10.1016/S0163-7827(01)00024-8; Ebeling P, 1998, FEBS LETT, V436, P301, DOI 10.1016/S0014-5793(98)01149-1; Erol E, 2003, FASEB J, V17, P347, DOI 10.1096/fj.03-0330fje; Evans AM, 2009, ANAL CHEM, V81, P6656, DOI 10.1021/ac901536h; Finck BN, 2005, CELL METAB, V1, P133, DOI 10.1016/j.cmet.2005.01.006; FOLCH J, 1957, J BIOL CHEM, V226, P497; Francis GA, 2003, ANNU REV PHYSIOL, V65, P261, DOI 10.1146/annurev.physiol.65.092101.142528; Gabriel BM, 2017, CELL METAB, V25, P1000, DOI 10.1016/j.cmet.2017.04.018; Gajda AM, 2013, J BIOL CHEM, V288, P30330, DOI 10.1074/jbc.M113.501676; Garcia-Cazarin ML, 2011, JOVE-J VIS EXP, DOI 10.3791/2452; Guerre-Millo M, 2001, DIABETES, V50, P2809, DOI 10.2337/diabetes.50.12.2809; Haunerland NH, 2004, PROG LIPID RES, V43, P328, DOI 10.1016/j.plipres.2004.05.001; Hawley JA, 2004, DIABETES-METAB RES, V20, P383, DOI 10.1002/dmrr.505; Herschey MDVE, 2010, PROTOCOL EXCHANGE, DOI [10.1038/nprot.2010.92, DOI 10.1038/NPROT.2010.92]; Hindi L, 2017, BIO-PROTOCOL, V7, DOI 10.21769/BioProtoc.2248; Hostetler HA, 2009, J LIPID RES, V50, P1663, DOI 10.1194/jlr.M900058-JLR200; Huynh FK, 2014, METHOD ENZYMOL, V542, P391, DOI 10.1016/B978-0-12-416618-9.00020-0; Jung CH, 2017, KOREAN J INTERN MED, V32, P611, DOI 10.3904/kjim.2016.259; Kersten S, 2000, NATURE, V405, P421, DOI 10.1038/35013000; Koopman R, 2001, HISTOCHEM CELL BIOL, V116, P63; Koves TR, 2008, CELL METAB, V7, P45, DOI 10.1016/j.cmet.2007.10.013; Kravitz L., 2002, IDEA RESOURCE SERIES, P21; Lagakos WS, 2013, J BIOL CHEM, V288, P19805, DOI 10.1074/jbc.M113.473579; Lagakos WS, 2011, AM J PHYSIOL-GASTR L, V300, pG803, DOI 10.1152/ajpgi.00229.2010; Lavasani Mitra, 2013, Methods Mol Biol, V976, P53, DOI 10.1007/978-1-62703-317-6_5; Lee-Young RS, 2011, INT J OBESITY, V35, P982, DOI 10.1038/ijo.2010.220; Leonardi R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011107; Lewis GD, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001006; Martin GG, 2005, BIOCHEM J, V391, P549, DOI 10.1042/BJ20050296; Martin GG, 2006, AM J PHYSIOL-GASTR L, V290, pG36, DOI 10.1152/ajpgi.00510.2004; Martin GG, 2003, BIOCHEMISTRY-US, V42, P11520, DOI 10.1021/bi0346749; Martin GG, 2003, J BIOL CHEM, V278, P21429, DOI 10.1074/jbc.M300287200; Martin GG, 2009, AM J PHYSIOL-GASTR L, V297, pG1053, DOI 10.1152/ajpgi.00116.2009; Martins AR, 2012, LIPIDS HEALTH DIS, V11, DOI 10.1186/1476-511X-11-30; McLean J., 1987, ANIMAL HUMAN CALORIM, P30; Montgomery MK, 2015, ENDOCR CONNECT, V4, DOI 10.1530/EC-14-0092; Murray AJ, 2009, FASEB J, V23, P4353, DOI 10.1096/fj.09-139691; Newberry EP, 2006, HEPATOLOGY, V44, P1191, DOI 10.1002/hep.21369; Newberry EP, 2009, MOL CELL BIOCHEM, V326, P79, DOI 10.1007/s11010-008-0002-4; Newberry EP, 2003, J BIOL CHEM, V278, P51664, DOI 10.1074/jbc.M309377200; Nishiumi S, 2007, BIOSCI BIOTECH BIOCH, V71, P2343, DOI 10.1271/bbb.70342; O'Neill HM, 2011, P NATL ACAD SCI USA, V108, P16092, DOI 10.1073/pnas.1105062108; PASSONNEAU JV, 1974, ANAL BIOCHEM, V60, P405, DOI 10.1016/0003-2697(74)90248-6; Petersen KF, 2007, P NATL ACAD SCI USA, V104, P12587, DOI 10.1073/pnas.0705408104; Phillips CM, 2013, REV ENDOCR METAB DIS, V14, P219, DOI 10.1007/s11154-013-9252-x; REGENSTEINER JG, 1995, MED SCI SPORT EXER, V27, P661; ROMIJN JA, 1993, AM J PHYSIOL, V265, pE380, DOI 10.1152/ajpendo.1993.265.3.E380; Salvadori A, 1999, RESPIRATION, V66, P25, DOI 10.1159/000029333; Savage DB, 2007, PHYSIOL REV, V87, P507, DOI 10.1152/physrev.00024.2006; Soriguer F, 2013, J CLIN ENDOCR METAB, V98, P2318, DOI 10.1210/jc.2012-4253; Spinazzi M, 2012, NAT PROTOC, V7, P1235, DOI 10.1038/nprot.2012.058; Stefan N, 2013, LANCET DIABETES ENDO, V1, P152, DOI 10.1016/S2213-8587(13)70062-7; Thompson J, 1997, J BIOL CHEM, V272, P7140, DOI 10.1074/jbc.272.11.7140; Unger RH, 2003, ENDOCRINOLOGY, V144, P5159, DOI 10.1210/en.2003-0870; WASSERMAN DH, 1992, AM J PHYSIOL, V263, pE345, DOI 10.1152/ajpendo.1992.263.2.E345; Wei M, 2000, ANN INTERN MED, V132, P605, DOI 10.7326/0003-4819-132-8-200004180-00002; Wolfrum C, 1999, BBA-MOL CELL BIOL L, V1437, P194, DOI 10.1016/S1388-1981(99)00008-6; Wolfrum C, 2001, P NATL ACAD SCI USA, V98, P2323, DOI 10.1073/pnas.051619898; Xiao Y, 2017, LIPIDS HEALTH DIS, V16, DOI 10.1186/s12944-017-0424-7; XU H, 2017, FASEB J S1, V31; Xu KY, 2008, CELL METAB, V8, P289, DOI 10.1016/j.cmet.2008.09.006; Yokota T, 2009, AM J PHYSIOL-HEART C, V297, pH1069, DOI 10.1152/ajpheart.00267.2009	75	3	3	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 18	2019	294	42					15358	15372		10.1074/jbc.RA118.006684	http://dx.doi.org/10.1074/jbc.RA118.006684			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JQ9HM	31451493	hybrid, Green Published			2022-12-26	WOS:000499248700014
J	Ki, DH; Oppel, F; Durbin, AD; Look, AT				Ki, Dong Hyuk; Oppel, Felix; Durbin, Adam D.; Look, A. Thomas			Mechanisms underlying synergy between DNA topoisomerase I-targeted drugs and mTOR kinase inhibitors in NF1-associated malignant peripheral nerve sheath tumors	ONCOGENE			English	Article							PHASE-II; NUCLEAR EXPORT; SOFT-TISSUE; CAMPTOTHECIN; INITIATION; ZEBRAFISH; PATHWAYS; MODELS; TRANSLATION; REPRESSION	Malignant peripheral nerve sheath tumors (MPNSTs) are soft-tissue sarcomas that frequently arise in patients with neurofibromatosis type 1 (NF1). Most of these tumors are unresectable at diagnosis and minimally responsive to conventional treatment, lending urgency to the identification of new pathway dependencies and drugs with potent antitumor activities. We therefore examined a series of candidate agents for their ability to induce apoptosis in MPNST cells arising in nf1/tp53-deficient zebrafish. In this study, we found that DNA topoisomerase I-targeted drugs and mTOR kinase inhibitors were the most effective single agents in eliminating MPNST cells without prohibitive toxicity. In addition, three members of these classes of drugs, either AZD2014 or INK128 in combination with irinotecan, acted synergistically to induce apoptosis both in vitro and in vivo. In mechanistic studies, irinotecan not only induces apoptosis by eliciting a DNA damage response, but also acts synergistically with AZD2014 to potentiate the hypophosphorylation of 4E-BP1, a downstream target of mTORC1. Profound hypophosphorylation of 4E-BP1 induced by this drug combination causes an arrest of protein synthesis, which potently induces tumor cell apoptosis. Our findings provide a compelling rationale for further in vivo evaluation of the combination of DNA topoisomerase I-targeted drugs and mTOR kinase inhibitors against these aggressive nerve sheath tumors.	[Ki, Dong Hyuk; Oppel, Felix; Durbin, Adam D.; Look, A. Thomas] Harvard Med Sch, Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; [Ki, Dong Hyuk; Oppel, Felix; Durbin, Adam D.; Look, A. Thomas] Boston Childrens Hosp, Div Pediat Hematol Oncol, Boston, MA 02115 USA; [Durbin, Adam D.] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Look, AT (corresponding author), Harvard Med Sch, Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA.	Thomas_Look@dfci.harvard.edu		Ki, Dong Hyuk/0000-0002-1571-7077; Look, A. Thomas/0000-0001-7851-8617; Durbin, Adam/0000-0002-5472-9847	Boston Children's Hospital Neurofibromatosis program; Department of Defense [W81XWH-12-1-0125]; Drug Discovery Initiative Award; NF1 Research Consortium Fund; Children's Tumor Foundation; NF Research Initiative at Boston Children's Hospital; German Cancer Aid; Mildred-Scheel-Postdoctoral program of the Mildred-Scheel Foundation; Alex's Lemonade Stand Young Investigator Award; American Society of Clinical Oncology Young Investigator Award; Rally Foundation for Childhood Cancer Research Young Investigator Award;  [DRSG-24-18]	Boston Children's Hospital Neurofibromatosis program; Department of Defense(United States Department of Defense); Drug Discovery Initiative Award; NF1 Research Consortium Fund; Children's Tumor Foundation; NF Research Initiative at Boston Children's Hospital; German Cancer Aid(Deutsche Krebshilfe); Mildred-Scheel-Postdoctoral program of the Mildred-Scheel Foundation; Alex's Lemonade Stand Young Investigator Award; American Society of Clinical Oncology Young Investigator Award; Rally Foundation for Childhood Cancer Research Young Investigator Award; 	We thank Dr. Donna Neuberg for biostatistical advice regarding the sample size, statistical power, and most appropriate statistical tests. We are grateful to Hillary Layden and Grace Thurston for their expert assistance with zebrafish husbandry and to Drs. Karen Cichowski and Nancy Ratner for providing human MPNST cell lines. This work was supported by the Latsis family fellowship from the Boston Children's Hospital Neurofibromatosis program, a grant from the Department of Defense (grant number W81XWH-12-1-0125), a Drug Discovery Initiative Award, the NF1 Research Consortium Fund, and Children's Tumor Foundation Young Investigator Award to DHK supported by the NF Research Initiative at Boston Children's Hospital made possible by an anonymous gift. FO acknowledges the German Cancer Aid for their generous funding within the Mildred-Scheel-Postdoctoral program of the Mildred-Scheel Foundation. ADD is a Damon-Runyon Sohn Pediatric Fellow (grant number DRSG-24-18), and acknowledges grant support from the Alex's Lemonade Stand Young Investigator Award, the American Society of Clinical Oncology Young Investigator Award and the Rally Foundation for Childhood Cancer Research Young Investigator Award.	Barbazuk WB, 2000, GENOME RES, V10, P1351, DOI 10.1101/gr.144700; Beauchamp RL, 2015, ONCOTARGET, V6, P16981, DOI 10.18632/oncotarget.4858; BLAIR SC, 1994, AM J CLIN ONCOL-CANC, V17, P480, DOI 10.1097/00000421-199412000-00005; Brohl AS, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15183-1; Cam H, 2010, MOL CELL, V40, P509, DOI 10.1016/j.molcel.2010.10.030; Cam M, 2014, J BIOL CHEM, V289, P4083, DOI 10.1074/jbc.M113.530303; Charest Mathieu, 2017, J Nucl Med Technol, DOI 10.2967/jnmt.117.199927; Choo AY, 2008, P NATL ACAD SCI USA, V105, P17414, DOI 10.1073/pnas.0809136105; Chugh R, 2009, J CLIN ONCOL, V27, P3148, DOI 10.1200/JCO.2008.20.5054; Cichowski K, 2001, CELL, V104, P593, DOI 10.1016/S0092-8674(01)00245-8; Cubitt Christopher L., 2013, Sarcoma, V2013, P365723, DOI 10.1155/2013/365723; De Raedt T, 2014, NATURE, V514, P247, DOI 10.1038/nature13561; Dickson MA, 2016, ANN ONCOL, V27, P1855, DOI 10.1093/annonc/mdw281; Durbin AD, 2016, ADV EXP MED BIOL, V916, P495, DOI 10.1007/978-3-319-30654-4_22; Endo M, 2013, CLIN CANCER RES, V19, P450, DOI 10.1158/1078-0432.CCR-12-1067; EricksonMiller CL, 1997, CANCER CHEMOTH PHARM, V39, P467, DOI 10.1007/s002800050600; Etchin J, 2013, BRIT J HAEMATOL, V161, P117, DOI 10.1111/bjh.12231; Evans DGR, 2011, EUR J HUM GENET, V19, P1187, DOI 10.1038/ejhg.2011.113; Ferner RE, 2007, LANCET NEUROL, V6, P340, DOI 10.1016/S1474-4422(07)70075-3; Ferrari Andrea, 2007, Paediatr Drugs, V9, P239, DOI 10.2165/00148581-200709040-00005; Gilbert DC, 2012, BRIT J CANCER, V106, P18, DOI 10.1038/bjc.2011.498; Goodsell DS, 1999, STEM CELLS, V17, P235, DOI 10.1002/stem.170235; Gupta G, 2008, NEUROSURG CLIN N AM, V19, P533, DOI 10.1016/j.nec.2008.07.004; Hagel C, 2007, J NEURO-ONCOL, V82, P187, DOI 10.1007/s11060-006-9266-2; HAGHIGHAT A, 1995, EMBO J, V14, P5701, DOI 10.1002/j.1460-2075.1995.tb00257.x; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Jessen WJ, 2013, J CLIN INVEST, V123, P340, DOI 10.1172/JCI60578; Kebudi R, 2013, PEDIATR HEMAT ONCOL, V30, P170, DOI 10.3109/08880018.2013.767868; Ki DH, 2017, ONCOGENE, V36, P1058, DOI 10.1038/onc.2016.269; Kim AeRang, 2017, Sarcoma, V2017, P7429697, DOI 10.1155/2017/7429697; Kim J, 2016, NATURE, V538, P114, DOI 10.1038/nature19771; Kroep JR, 2011, ANN ONCOL, V22, P207, DOI 10.1093/annonc/mdq338; Lansiaux A, 2007, MOL PHARMACOL, V72, P311, DOI 10.1124/mol.107.034637; Lee W, 2014, NAT GENET, V46, P1227, DOI 10.1038/ng.3095; Li TK, 2001, ANNU REV PHARMACOL, V41, P53, DOI 10.1146/annurev.pharmtox.41.1.53; MADER S, 1995, MOL CELL BIOL, V15, P4990; Maki RG, 2009, J CLIN ONCOL, V27, P3133, DOI 10.1200/JCO.2008.20.4495; Malone CF, 2014, CANCER DISCOV, V4, P1062, DOI 10.1158/2159-8290.CD-14-0159; MARTIN GA, 1990, CELL, V63, P843, DOI 10.1016/0092-8674(90)90150-D; Nair JS, 2017, CLIN CANCER RES, V23, P4301, DOI 10.1158/1078-0432.CCR-16-2632; Nkere UU, 1997, EUR J CARDIO-THORAC, V12, P144, DOI 10.1016/S1010-7940(97)00085-7; Schuetze SM, 2016, CANCER-AM CANCER SOC, V122, P868, DOI 10.1002/cncr.29858; Shin J, 2012, DIS MODEL MECH, V5, P881, DOI 10.1242/dmm.009779; Staker BL, 2002, P NATL ACAD SCI USA, V99, P15387, DOI 10.1073/pnas.242259599; Stucky CCH, 2012, ANN SURG ONCOL, V19, P878, DOI 10.1245/s10434-011-1978-7; Tee AR, 2000, ONCOGENE, V19, P3021, DOI 10.1038/sj.onc.1203622; Thompson J, 1998, BBA-GENE STRUCT EXPR, V1400, P301, DOI 10.1016/S0167-4781(98)00143-2; Duong TA, 2011, ORPHANET J RARE DIS, V6, DOI 10.1186/1750-1172-6-18; Valentin T, 2016, EUR J CANCER, V56, P77, DOI 10.1016/j.ejca.2015.12.015; Varin J, 2016, ONCOTARGET, V7, P35753, DOI 10.18632/oncotarget.7099; Wang JC, 1996, ANNU REV BIOCHEM, V65, P635, DOI 10.1146/annurev.bi.65.070196.003223; Wang Jun, 2014, Cancer Cell Microenviron, V1; Watson AL, 2014, ONCOTARGET, V5, P1502, DOI 10.18632/oncotarget.1609; Westerfield M, 2000, ZEBRAFISH BOOK GUIDE; White RM, 2008, CELL STEM CELL, V2, P183, DOI 10.1016/j.stem.2007.11.002; Zhao CJ, 2011, CARCINOGENESIS, V32, P1143, DOI 10.1093/carcin/bgr076	56	11	11	0	5	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 26	2019	38	39					6585	6598		10.1038/s41388-019-0965-5	http://dx.doi.org/10.1038/s41388-019-0965-5			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	JA5AQ	31444410	hybrid			2022-12-26	WOS:000487856000002
J	Ferreras, E; Matapo, B; Chizema-Kawesha, E; Chewe, O; Mzyece, H; Blake, A; Moonde, L; Zulu, G; Poncin, M; Sinyange, N; Kasese-Chanda, N; Phiri, C; Malama, K; Mukonka, V; Cohuet, S; Uzzeni, F; Ciglenecki, I; Danovaro-Holliday, MC; Luquero, FJ; Pezzoli, L				Ferreras, Eva; Matapo, Belem; Chizema-Kawesha, Elizabeth; Chewe, Orbrie; Mzyece, Hannah; Blake, Alexandre; Moonde, Loveness; Zulu, Gideon; Poncin, Marc; Sinyange, Nyambe; Kasese-Chanda, Nancy; Phiri, Caroline; Malama, Kennedy; Mukonka, Victor; Cohuet, Sandra; Uzzeni, Florent; Ciglenecki, Iza; Danovaro-Holliday, M. Carolina; Luquero, Francisco J.; Pezzoli, Lorenzo			Delayed second dose of oral cholera vaccine administered before high-risk period for cholera transmission: Cholera control strategy in Lusaka, 2016	PLOS ONE			English	Article							MASS VACCINATION; ADVERSE EVENTS; OUTBREAK; COVERAGE; ACCEPTABILITY; SURVEILLANCE; POPULATION; DHAKA	Background In April 2016, an emergency vaccination campaign using one dose of Oral Cholera Vaccine (OCV) was organized in response to a cholera outbreak that started in Lusaka in February 2016. In December 2016, a second round of vaccination was conducted, with the objective of increasing the duration of protection, before the high-risk period for cholera transmission. We assessed vaccination coverage for the first and second rounds of the OCV campaign. Methods Vaccination coverage was estimated after each round from a sample selected from targeted- areas for vaccination using a cross-sectional survey in to establish the vaccination status of the individuals recruited. The study population included all individuals older than 12 months residing in the areas targeted for vaccination. We interviewed 505 randomly selected individuals after the first round and 442 after the second round. Vaccination status was ascertained either by vaccination card or verbal reporting. Households were selected using spatial random sampling. Results The vaccination coverage with two doses was 58.1% (25/43; 95% CI: 42.1-72.9) in children 1-5 years old, 59.5% (69/116; 95% CI: 49.9-68.5) in children 5-15 years old and 19.9% (56/281; 95% CI: 15.4-25.1) in adults above 15 years old. The overall dropout rate was 10.9% (95% CI: 8.1-14.1). Overall, 69.9% (n = 309/442; 95% CI: 65.4-74.1) reported to have received at least one OCV dose. Conclusions The areas at highest risk of suffering cholera outbreaks were targeted for vaccination obtaining relatively high vaccine coverage after each round. However, the long delay between doses in areas subject to considerable population movement resulted in many individuals receiving only one OCV dose. Additional vaccination campaigns may be required to sustain protection over time in case of persistence of risk. Further evidence is needed to establish a maximum optimal interval time of a delayed second dose and variations in different settings.	[Ferreras, Eva; Matapo, Belem] WHO, Lusaka, Zambia; [Ferreras, Eva; Blake, Alexandre; Cohuet, Sandra; Luquero, Francisco J.] Epicentre, Paris, France; [Chizema-Kawesha, Elizabeth; Chewe, Orbrie; Mzyece, Hannah; Moonde, Loveness; Zulu, Gideon; Sinyange, Nyambe; Kasese-Chanda, Nancy; Phiri, Caroline; Malama, Kennedy] Minist Hlth, Lusaka, Zambia; [Chewe, Orbrie; Mzyece, Hannah; Sinyange, Nyambe; Mukonka, Victor] Zambia Natl Publ Hlth Inst, Lusaka, Zambia; [Poncin, Marc; Uzzeni, Florent; Ciglenecki, Iza] Medecins Sans Frontieres, Geneva, Switzerland; [Danovaro-Holliday, M. Carolina; Pezzoli, Lorenzo] WHO, Geneva, Switzerland; [Luquero, Francisco J.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD USA	World Health Organization; Doctors Without Borders; World Health Organization; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Ferreras, E (corresponding author), WHO, Lusaka, Zambia.; Ferreras, E (corresponding author), Epicentre, Paris, France.	ferreras_eva@yahoo.fr	Pezzoli, Lorenzo/AAA-9894-2019; Matapo, Belem/GLN-7335-2022	Blake, Alexandre/0000-0002-1627-4992; ferreras, eva/0000-0002-6488-6088	Medecins Sans Frontieres; World Health Organization	Medecins Sans Frontieres; World Health Organization(World Health Organization)	This study was funded by Medecins Sans Frontieres https://www.msf.org/and the World Health Organization https://www.who.int/, who played a role in all aspects of this study, including the design, data collection, analysis, decision to publish and in the preparation of the manuscript.	[Anonymous], 2017, Wkly Epidemiol Rec, V92, P521; Azman AS, 2016, LANCET GLOB HEALTH, V4, pE856, DOI [10.1016/S2214-109X(16)30211-X, 10.1016/s2214-109x(16)30211-x]; Azman AS, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001867; Bi QF, 2017, LANCET INFECT DIS, V17, P1080, DOI [10.1016/S1473-3099(17)30359-6, 10.1016/s1473-3099(17)30359-6]; British Broadcasting Corporation (BBC), 2016, ZAMB XEN RIOTS 2 BUR; Ferreras E, 2018, NEW ENGL J MED, V378, P577, DOI 10.1056/NEJMc1711583; Khan IA, 2013, VACCINE, V31, P6058, DOI 10.1016/j.vaccine.2013.10.021; Lam E, 2017, EMERG INFECT DIS, V23, P38, DOI 10.3201/eid2301.160881; Luquero FJ, 2014, NEW ENGL J MED, V370, P2111, DOI 10.1056/NEJMoa1312680; Luquero FJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002465; Ministry of Health, 2011, 2010 ZAMB CHOL CONTR; Olu O, 2013, East Afr Med J, V90, P324; Parker LA, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005652; Pearson AL, 2015, INT J HEALTH GEOGR, V14, DOI 10.1186/s12942-015-0026-4; Phares CR, 2016, VACCINE, V34, P128, DOI 10.1016/j.vaccine.2015.10.112; Poncin M, 2018, B WORLD HEALTH ORGAN, V96, P86, DOI 10.2471/BLT.16.189241; Qadri F, 2016, NEW ENGL J MED, V374, P1723, DOI 10.1056/NEJMoa1510330; Tohme RA, 2015, EMERG INFECT DIS, V21, P984, DOI 10.3201/eid2106.141797; Uddin MJ, 2014, VACCINE, V32, P5690, DOI 10.1016/j.vaccine.2014.08.021; World Health Organization, 2017, CHOL VACC WHO POS PA	20	5	5	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2019	14	8							e0219040	10.1371/journal.pone.0219040	http://dx.doi.org/10.1371/journal.pone.0219040			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW6BO	31469853	Green Published, Green Submitted, gold			2022-12-26	WOS:000485062200007
J	Rodriguez-Castro, L; Mendez, V; Duran, RE; Seeger, M				Rodriguez-Castro, Laura; Mendez, Valentina; Duran, Roberto E.; Seeger, Michael			Long-chain flavodoxin FldX1 improves Paraburkholderia xenovorans LB400 tolerance to oxidative stress caused by paraquat and H2O2	PLOS ONE			English	Article							ESCHERICHIA-COLI; OXIDIZED FLAVODOXIN; PSEUDOMONAS-PUTIDA; HYDROGEN-PEROXIDE; PROTEIN; BIODEGRADATION; DEGRADATION; RHIZOSPHERE; REDUCTASE; SEQUENCE	Flavodoxins are small electron transfer proteins containing flavin mononucleotide (FMN) as a prosthetic group, which play an important role during oxidative stress or iron limitation. The aims of this study were the identification and characterization of flavodoxins in the model aromatic-degrader Paraburkholderia xenovorans LB400 and the analyses of their protective effects during oxidative stress induced by paraquat and H2O2. Two genes (BxeA0278 and BxeB0391) encoding flavodoxins (hereafter referred to as fldX for flavodoxin from P. xenovorans), were identified at the LB400 major and minor chromosome. Genomic context of the flavodoxin-encoding genes showed genes encoding membrane proteins, transporters, and proteins involved in redox processes and biosynthesis of macromolecules. A secondary structure prediction of both LB400 flavodoxins showed the characteristic flavodoxin structure of five beta-sheets intercalated with five beta-helices. FldX1 contains a loop intercalated in the fifth beta-strand, which indicates that it belongs to the long-chain flavodoxins, whereas FldX2 is a shortchain flavodoxin. A phylogenetic analysis of 73 flavodoxins from 43 bacterial genera revealed eight clusters (I-VIII), while FldX1 and FldX2 grouped separately within a long-chain and a short-chain flavodoxin clades. FldX1 and FldX2 were overexpressed in P. xenovorans. Interestingly, the strain overexpressing the long-chain flavodoxin FldX1 (p2-fldX1) showed a faster growth in glucose than the control strain. The recombinant strain overexpressing the longchain flavodoxin FldX1 (p2-fldx1) exposed to paraquat (20 mM) possessed lower susceptibility to growth inhibition on plates and higher survival in liquid medium than the control strain. The strains overexpressing the flavodoxins FldX1 and FldX2 showed higher survival during exposure to 1 mM paraquat (> 95%) than the control strain (68%). Compared to the control strain, strains overexpressing FldX1 and FldX2 showed lower lipid peroxidation (> 20%) after exposure to 1 mM paraquat and a lower protein carbonylation (similar to 30%) after exposure to 1 mM H2O2 was observed. During exposure to paraquat, strain p2-fldx1 downregulated the katG4, hpf, trxB1 and ohr genes (> 2-fold), whereas strain p2-fldx2 upregulated the oxyR and ahpC1 genes (> 2-fold). In conclusion, the flavodoxins FldX1 and FldX2 of P. xenovorans LB400 conferred protection to cells exposed to the oxidizing agents paraquat and H2O2.	[Rodriguez-Castro, Laura; Mendez, Valentina; Duran, Roberto E.; Seeger, Michael] Univ Tecn Federico Santa Maria, Lab Microbiol Mol & Biotecnol Ambiental, Dept Quim, Valparaiso, Chile; [Rodriguez-Castro, Laura; Mendez, Valentina; Duran, Roberto E.] Univ Tecn Federico Santa Maria, Ctr Biotecnol, Valparaiso, Chile	Universidad Tecnica Federico Santa Maria; Universidad Tecnica Federico Santa Maria	Seeger, M (corresponding author), Univ Tecn Federico Santa Maria, Lab Microbiol Mol & Biotecnol Ambiental, Dept Quim, Valparaiso, Chile.	michael.seeger@gmail.com	Rodriguez-Castro, Laura/AAV-6108-2021; Duran, Roberto E./AAG-2416-2020; Seeger, Michael/AFK-3436-2022	Rodriguez-Castro, Laura/0000-0001-9974-4752; Duran, Roberto E./0000-0003-0077-9483; Seeger, Michael/0000-0003-1000-4278	CONICYT PhD fellowship [21170062]; CONICYT Gastos Operacionales scholarship [21170062]; Universidad Tecnica Federico Santa Maria Programa de Incentivos a la Iniciacion Cientifica fellowship; FONDECYT [1151174]; CONICYT Programa de Investigacion Asociativa (PIA) Anillo GAMBIO [ACT172128]; USM	CONICYT PhD fellowship; CONICYT Gastos Operacionales scholarship; Universidad Tecnica Federico Santa Maria Programa de Incentivos a la Iniciacion Cientifica fellowship; FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); CONICYT Programa de Investigacion Asociativa (PIA) Anillo GAMBIO; USM	This study was supported by CONICYT PhD fellowship (LR-C, 21170062), CONICYT Gastos Operacionales scholarship (LR-C, 21170062), Universidad Tecnica Federico Santa Maria Programa de Incentivos a la Iniciacion Cientifica (LR-C) fellowship, FONDECYT 1151174 (MS) (http://www.fondecyt.cl), CONICYT Programa de Investigacion Asociativa (PIA) Anillo GAMBIO ACT172128 (MS, VM, RED, LR-C) (http://www.conicyt.cl) and USM (2017) (http://www.usm.cl) grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agullo L, 2007, FEMS MICROBIOL LETT, V267, P167, DOI 10.1111/j.1574-6968.2006.00554.x; Agullo L, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169544; Allocati N, 2009, FEBS J, V276, P58, DOI 10.1111/j.1742-4658.2008.06743.x; Amineni U, 2010, J Chem Biol, V3, P165, DOI 10.1007/s12154-010-0039-1; Arenas Felipe A, 2011, PLoS One, V6, pe15979, DOI 10.1371/journal.pone.0015979; Ayres DL, 2012, SYST BIOL, V61, P170, DOI [10.1093/sysbio/syr100, 10.1093/sysbio/sys029]; Boratyn GM, 2012, BIOL DIRECT, V7, DOI 10.1186/1745-6150-7-12; Buckel W, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00401; Cabiscol Elisa, 2000, International Microbiology, V3, P3; Cardenas F., 2015, THESIS; Chain PSG, 2006, P NATL ACAD SCI USA, V103, P15280, DOI 10.1073/pnas.0606924103; de la Pena TC, 2013, J APPL MICROBIOL, V115, P236, DOI 10.1111/jam.12224; Consortium TU., 2014, NUCLEIC ACIDS RES, V43, P204; Cussiol JRR, 2010, J BIOL CHEM, V285, P21943, DOI 10.1074/jbc.M110.117283; Dutta SK, 2015, PROTEIN SCI, V24, P1600, DOI 10.1002/pro.2743; Dwyer DJ, 2014, P NATL ACAD SCI USA, V111, pE2100, DOI 10.1073/pnas.1401876111; Freigang J, 2002, PROTEIN SCI, V11, P253, DOI 10.1110/ps.28602; Fuentes S, 2014, APPL MICROBIOL BIOT, V98, P4781, DOI 10.1007/s00253-014-5684-9; Gaudu P, 2000, J BACTERIOL, V182, P1788, DOI 10.1128/JB.182.7.1788-1793.2000; Gil F, 2007, RES MICROBIOL, V158, P529, DOI 10.1016/j.resmic.2007.05.004; Gonzalez A, 2018, BIOCHEM MOL BIOL EDU, V46, P493, DOI 10.1002/bmb.21136; Gravina F, 2017, ECOTOX ENVIRON SAFE, V139, P89, DOI 10.1016/j.ecoenv.2017.01.027; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Hoover DM, 1997, PROTEIN SCI, V6, P2525; Imlay JA, 2015, ANNU REV MICROBIOL, V69, P93, DOI 10.1146/annurev-micro-091014-104322; Imlay JA, 2013, NAT REV MICROBIOL, V11, P443, DOI 10.1038/nrmicro3032; Isik K, 2007, PROCESS BIOCHEM, V42, P235, DOI 10.1016/j.procbio.2006.08.013; JACOBSON MR, 1989, J BACTERIOL, V171, P1017, DOI 10.1128/jb.171.2.1017-1027.1989; Romero-Silva MJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056038; Katoh Kazutaka, 2013, Mol Biol Evol, V30, P772, DOI 10.1093/molbev/mst010; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Kim J, 2014, APPL MICROBIOL BIOT, V98, P6933, DOI 10.1007/s00253-014-5883-4; KOVACH ME, 1995, GENE, V166, P175, DOI 10.1016/0378-1119(95)00584-1; Krapp AR, 2002, J BACTERIOL, V184, P1474, DOI 10.1128/JB.184.5.1474-1480.2002; Lamazares E, 2017, PHYS CHEM CHEM PHYS, V19, P19021, DOI 10.1039/c7cp02606d; Lanfear R, 2017, MOL BIOL EVOL, V34, P772, DOI 10.1093/molbev/msw260; Larsson A, 2014, BIOINFORMATICS, V30, P3276, DOI 10.1093/bioinformatics/btu531; Lascano Ramiro, 2011, P135; Martinez P, 2007, ARCH MICROBIOL, V188, P289, DOI 10.1007/s00203-007-0247-4; Mendez V, 2017, THESIS; Mendez V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017583; Mesquita CS, 2014, ANAL BIOCHEM, V458, P69, DOI 10.1016/j.ab.2014.04.034; MESSING J, 1983, METHOD ENZYMOL, V101, P20; Moyano AJ, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004163; Nikel PI, 2016, ENVIRON MICROBIOL, V18, P3565, DOI 10.1111/1462-2920.13434; Park W, 2006, BIOCHEM BIOPH RES CO, V341, P51, DOI 10.1016/j.bbrc.2005.12.142; Pei JM, 2008, NUCLEIC ACIDS RES, V36, P2295, DOI 10.1093/nar/gkn072; Perez-Dorado I, 2013, INT J MOL SCI, V14, P1152, DOI 10.3390/ijms14011152; Perez-Pantoja D, 2012, ENVIRON MICROBIOL, V14, P1091, DOI 10.1111/j.1462-2920.2011.02613.x; Karlusich JJP, 2014, J EXP BOT, V65, P5161, DOI 10.1093/jxb/eru273; Ponce BL, 2011, ENZYME MICROB TECH, V49, P509, DOI 10.1016/j.enzmictec.2011.04.021; Sancho J, 2006, CELL MOL LIFE SCI, V63, P855, DOI 10.1007/s00018-005-5514-4; Sandoval JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025573; Seaver LC, 2001, J BACTERIOL, V183, P7173, DOI 10.1128/JB.183.24.7173-7181.2001; Semchyshyn H, 2005, CELL BIOL INT, V29, P898, DOI 10.1016/j.cellbi.2005.08.002; Seo JS, 2009, INT J ENV RES PUB HE, V6, P278, DOI 10.3390/ijerph6010278; Sigrist CJA, 2013, NUCLEIC ACIDS RES, V41, pE344, DOI 10.1093/nar/gks1067; Tognetti VB, 2007, ENVIRON SCI TECHNOL, V41, P4071, DOI 10.1021/es070015y; Van Driessche G, 2003, J MOL EVOL, V57, P181, DOI 10.1007/s00239-003-2465-y; Yan YL, 2008, P NATL ACAD SCI USA, V105, P7564, DOI 10.1073/pnas.0801093105; Yeom J, 2012, FEMS MICROBIOL LETT, V335, P47, DOI 10.1111/j.1574-6968.2012.02643.x	61	3	3	3	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2019	14	8							e0221881	10.1371/journal.pone.0221881	http://dx.doi.org/10.1371/journal.pone.0221881			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW6BO	31469877	Green Published, gold, Green Submitted			2022-12-26	WOS:000485062200036
J	Tavares, MD; Joao, GAP; Bastos, MS; Gimaque, JBL; Almeida, ACG; Ngo, TT; Bahamon, C; Baia-da-Silva, DC; Monteiro, WM; Mourao, MPG; Lacerda, MVG				Tavares, Michel de Araujo; Pivoto Joao, Guilherme Augusto; Bastos, Michele Souza; Lima Gimaque, Joao Bosco; Gomes Almeida, Anne Cristina; Thanh Thu Ngo; Bahamon, Cecilia; Baia-da-Silva, Djane Clarys; Monteiro, Wuelton Marcelo; Gomes Mourao, Maria Paula; Guimaraes Lacerda, Marcus Vincius			Clinical relevance of gallbladder wall thickening for dengue severity: A cross-sectional study	PLOS ONE			English	Article							FEVER	Dengue fever is the most important arthropod-borne viral infection worldwide. Secondary prevention to reduce mortality through improved clinical case management has substantially lowered the mortality rate for severe dengue during the past two decades. Gallbladder wall thickening (GBWT) is a nonspecific finding often associated with more severe cases of dengue infection. This study had the aim to describe the ultrasonographic findings in hospitalized patients with dengue infection from Manaus (in the Western Brazilian Amazon) and to correlate the GBWT with dengue severity, symptoms and laboratorial analysis. Patients from 13-84 years admitted to the emergency department at the Fundacao de Medicina Tropical Dr. Heitor Vieira Dourado (FMT-HVD) were enrolled in this study. Patients' selection occurred during the most recent and huge dengue outbreak within the first semester of 2011. All enrolled subjects were systematically tested in order to rule out other possible etiologies for gallbladder inflammation. Abdominal ultrasound was performed by a single physician through bedside portable equipment and all other clinical and laboratorial information were retrieved from patients' electronic files. 54 subjects were considered for analysis, with confirmed dengue infection by NS1 and/or RT-PCR positivity. From all enrolled patients, 50 (42.4%) presented GBWT. GBWT was significantly and independently related to: age under 31 years, pregnancy, presence of bleeding, presence of any cavitary effusion, DHF classification and severe dengue classifications. During dengue outbreaks, the GBWT identification through a non-invasive and bedside procedure is a confident marker for prompt recognition of potential severe cases.	[Tavares, Michel de Araujo; Gomes Almeida, Anne Cristina; Baia-da-Silva, Djane Clarys; Monteiro, Wuelton Marcelo; Gomes Mourao, Maria Paula] Univ Estado Amazonas, Manaus, Amazonas, Brazil; [Pivoto Joao, Guilherme Augusto; Bastos, Michele Souza; Lima Gimaque, Joao Bosco; Baia-da-Silva, Djane Clarys; Monteiro, Wuelton Marcelo; Gomes Mourao, Maria Paula; Guimaraes Lacerda, Marcus Vincius] Fundacao Med Trop Dr Heitor Vieira Dourado, Manaus, Amazonas, Brazil; [Thanh Thu Ngo; Bahamon, Cecilia] Univ Massachusetts, Boston, MA 02125 USA; [Guimaraes Lacerda, Marcus Vincius] Fiocruz MS, Inst Leonidas & Maria Deane, Manaus, Amazonas, Brazil	Universidade do Estado do Amazonas; University of Massachusetts System; University of Massachusetts Boston; Fundacao Oswaldo Cruz	Lacerda, MVG (corresponding author), Fundacao Med Trop Dr Heitor Vieira Dourado, Manaus, Amazonas, Brazil.; Lacerda, MVG (corresponding author), Fiocruz MS, Inst Leonidas & Maria Deane, Manaus, Amazonas, Brazil.	marcuslacerda.br@gmail.com	Mourao, Maria/AAW-5989-2021; Bastos, Michele/AAS-7386-2020	Bastos, Michele/0000-0003-3450-666X; Mourao, Maria Paula/0000-0002-6458-0900				Barsky AJ, 2001, J GEN INTERN MED, V16, P266, DOI 10.1046/j.1525-1497.2001.016004266.x; Bastos MD, 2012, REV SOC BRAS MED TRO, V45, P393, DOI 10.1590/S0037-86822012000300022; Colbert JA, 2007, PEDIATR INFECT DIS J, V26, P850, DOI 10.1097/INF.0b013e3180619692; Cordeiro MT, 2007, AM J TROP MED HYG, V77, P1128, DOI 10.4269/ajtmh.2007.77.1128; Gubler DJ, 2012, AM J TROP MED HYG, V86, P743, DOI 10.4269/ajtmh.2012.12-0157; Huffman JL, 2010, CLIN GASTROENTEROL H, V8, P15, DOI 10.1016/j.cgh.2009.08.034; Khor BS, DENGUE HEMORRHAGIC F; KUNO G, 1987, AM J TROP MED HYG, V36, P153, DOI 10.4269/ajtmh.1987.36.153; LANCIOTTI RS, 1992, J CLIN MICROBIOL, V30, P545, DOI 10.1128/JCM.30.3.545-551.1992; Michels M, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002277; Mourao MPG, 2001, BRAZ J INFECT DIS, pS22; Oliveira GA, 2010, PEDIATR RADIOL, V40, P720, DOI 10.1007/s00247-009-1489-x; SETIAWAN MW, 1995, J CLIN ULTRASOUND, V23, P357, DOI 10.1002/jcu.1870230605; Sharma N, 2006, J GASTROEN HEPATOL, V21, P664, DOI 10.1111/j.1440-1746.2006.04295.x; SHLAER WJ, 1981, AM J ROENTGENOL, V136, P337, DOI 10.2214/ajr.136.2.337; Simmons CP, DENGUE; Tapia-Conyer R, 2012, PAEDIATR INT CHILD H, V32, P14, DOI 10.1179/2046904712Z.00000000046; Tomashek KM, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001614; who, GUIDELINES; World Health Organization, 2009, DENGUE GUIDELINES DI; Wu KL, 2004, J CLIN ULTRASOUND, V32, P386, DOI 10.1002/jcu.20060; Zulkarnain Iskandar, 2004, Acta Med Indones, V36, P84	22	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2019	14	8							e0218939	10.1371/journal.pone.0218939	http://dx.doi.org/10.1371/journal.pone.0218939			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW6BO	31469845	gold, Green Submitted, Green Published			2022-12-26	WOS:000485062200006
J	Abreu, LRS; Shirley, MK; Castro, NP; Euclydes, VV; Bergamaschi, DP; Luzia, LA; Cruz, AM; Rondo, PHC				Abreu, Laisa R. S.; Shirley, Meghan K.; Castro, Natalia P.; Euclydes, Veronica V.; Bergamaschi, Denise P.; Luzia, Liania A.; Cruz, Ana M.; Rondo, Patricia H. C.			Gestational diabetes mellitus, pre-pregnancy body mass index, and gestational weight gain as risk factors for increased fat mass in Brazilian newborns	PLOS ONE			English	Article							AIR-DISPLACEMENT PLETHYSMOGRAPHY; NEONATAL ADIPOSITY; CHAINED EQUATIONS; INFANTS; OBESITY; BIRTH; WOMEN; FETAL; OVERWEIGHT; PREGNANCY	Background Gestational diabetes mellitus (GDM) is a common complication of pregnancy. It may predispose offspring to increased fat mass (FM) and the development of obesity, however few data from Latin America exist. Objective To investigate the influence of GDM on newborn FM in mother-newborn pairs recruited from a public maternity care center in Sao Paulo, Brazil. Methods Data were collected cross-sectionally in 2013-2014 from 72 mothers diagnosed with GDM, and 211 mothers with normal glucose tolerance (NGT). Newborn FM was evaluated by air-displacement plethysmography (PEA POD), and relevant demographic and obstetric data were collected from hospital records. Associations between maternal GDM status and newborn FM were investigated by multiple linear regression analysis, with adjustment for maternal age, pre-pregnancy BMI, gestational weight gain, type of delivery, sex of the child, and gestational age. Results FM was greater in GDM versus NGT newborns in a bivariable model (Median (IQR), GDM: 0.35 (0.3) kg vs. NGT: 0.27 (0.2) kg, p = 0.02), however GDM status was not a significant predictor of FM with adjustment for other variables. Rather, pre-pregnancy BMI (coefficient (beta) 1.46; 95% confidence interval (CI) 0.66, 2.27), gestational weight gain (beta 1.32; 95% CI 0.49, 2.15), and male sex (beta - 17.8; 95% CI -27.2, -8.29) predicted newborn FM. Analyzing GDM and NGT groups separately, pre- pregnancy BMI (beta 6.75; 95% CI 2.36, 11.1) and gestational weight gain (beta 5.64; 95% CI 1.16, 10.1) predicted FM in the GDM group, while male sex alone predicted FM in the NGT group (beta -12.3; 95% CI -18.3, -6.34). Conclusions Combined model results suggest that in our cohort, pre- pregnancy BMI and gestational weight gain are more important risk factors for increased neonatal FM than GDM. However, group-specific model results suggest that GDM status may contribute to variation in the relationship between maternal/offspring factors and FM. Our use of a binary GDM variable in the combined model may have precluded clearer results on this point. Prospective cohort studies including data on maternal pre- pregnancy BMI, GWG, and glycemic profile are needed to better understand associations among these variables and their relative influence on offspring FM.	[Abreu, Laisa R. S.; Shirley, Meghan K.; Castro, Natalia P.; Euclydes, Veronica V.; Luzia, Liania A.; Rondo, Patricia H. C.] Univ Sao Paulo, Sch Publ Hlth, Nutr Dept, Sao Paulo, SP, Brazil; [Bergamaschi, Denise P.] Univ Sao Paulo, Sch Publ Hlth, Epidemiol Dept, Sao Paulo, SP, Brazil; [Cruz, Ana M.] Univ Sao Paulo, Sch Publ Hlth, Geraldo de Paula Souza Hlth Ctr, Sao Paulo, SP, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo	Shirley, MK (corresponding author), Univ Sao Paulo, Sch Publ Hlth, Nutr Dept, Sao Paulo, SP, Brazil.	m.shirley@usp.br	Abreu, Laísa/AAL-7055-2020; Bergamaschi, Denise Pimentel/I-7383-2017; Castro, Natalia/AAC-5934-2020; de carvalho rondo, Patricia Rondo;/E-1936-2015; Euclydes, Veronica/D-1403-2012	Bergamaschi, Denise Pimentel/0000-0002-6889-8588; de carvalho rondo, Patricia Rondo;/0000-0002-8308-6393; Pinheiro-Castro, Natalia/0000-0002-8123-4815; Euclydes, Veronica/0000-0003-0526-1456	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) Brazil [2011/10382-2]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) Brazil; FAPESP [2018/13468-4]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) Brazil(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) Brazil(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) Brazil, www.fapesp.br, grant number 2011/10382-2. LRSA, NPC, and VVE were supported by scholarships from Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) Brazil, www.capes.gov.br.MKS is supported by FAPESP, grant number 2018/13468-4. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Admassu B, 2018, NUTR DIABETES, V8, DOI 10.1038/s41387-018-0056-7; Andersen GS, 2013, AM J CLIN NUTR, V98, P885, DOI 10.3945/ajcn.113.063032; Aspray TJ, 2000, T ROY SOC TROP MED H, V94, P637, DOI 10.1016/S0035-9203(00)90216-5; Au CP, 2013, EARLY HUM DEV, V89, P839, DOI 10.1016/j.earlhumdev.2013.07.028; Au CP, 2013, DIABETES CARE, V36, P562, DOI 10.2337/dc12-1557; Azur MJ, 2011, INT J METH PSYCH RES, V20, P40, DOI 10.1002/mpr.329; Bayol SA, 2014, J DEV ORIG HLTH DIS, V5, P420, DOI 10.1017/S2040174414000452; Bellamy L, 2009, LANCET, V373, P1773, DOI 10.1016/S0140-6736(09)60731-5; Biro FM, 2010, AM J CLIN NUTR, V91, p1499S, DOI 10.3945/ajcn.2010.28701B; Blackwell SC, 2016, OBSTET GYNECOL, V128, P1325, DOI 10.1097/AOG.0000000000001773; Breij LM, 2017, PEDIATR OBES, V12, P286, DOI 10.1111/ijpo.12139; Breij LM, 2015, HORM RES PAEDIAT, V84, P388, DOI 10.1159/000441298; Brunner S, EXCESSIVE GESTATIONA; Buchanan TA, 2012, NAT REV ENDOCRINOL, V8, P639, DOI 10.1038/nrendo.2012.96; Butte NF, 2003, AM J OBSTET GYNECOL, V189, P1423, DOI 10.1067/S0002-9378(03)00596-9; Catalano PM, 2012, DIABETES CARE, V35, P780, DOI 10.2337/dc11-1790; Catalano PM, 2003, AM J OBSTET GYNECOL, V189, P1698, DOI 10.1016/S0002-9378(03)00828-7; Chen L., 2016, CURR EPIDEMIOL REP, V3, P1, DOI [10.1007/s40471-016-0063-y, DOI 10.1007/S40471-016-0063-Y]; Chiefari E, 2017, J ENDOCRINOL INVEST, V40, P899, DOI 10.1007/s40618-016-0607-5; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Dabelea D, 2011, DIABETES, V60, P1849, DOI 10.2337/db11-0400; de Santis MSN, 2010, ULTRASOUND OBST GYN, V36, P328, DOI 10.1002/uog.7575; Ellis KJ, 2007, AM J CLIN NUTR, V85, P90, DOI 10.1093/ajcn/85.1.90; Ensenauer R, 2013, INT J OBESITY, V37, P505, DOI 10.1038/ijo.2012.226; Ezzati M, 2017, LANCET, V390, P2627, DOI 10.1016/S0140-6736(17)32129-3; Ferrara A, 2007, DIABETES CARE, V30, pS141, DOI 10.2337/dc07-s206; FOMON SJ, 1982, AM J CLIN NUTR, V35, P1169, DOI 10.1093/ajcn/35.5.1169; Friis CM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057467; Gibson KS, 2012, OBSTET GYNECOL, V119, P560, DOI 10.1097/AOG.0b013e31824758e0; Goldenberg RL, 2016, AM J PERINAT, V33, P1227, DOI 10.1055/s-0036-1584152; Gromping U, 2006, J STAT SOFTW, V17, DOI 10.18637/jss.v017.i01; Holland E, 2013, MATERN CHILD HLTH J, V17, P1872, DOI 10.1007/s10995-012-1210-9; Hull HR, 2011, AM J OBSTET GYNECOL, V205, DOI 10.1016/j.ajog.2011.04.004; IDF International Diabetes Federation, 2017, DIABETES ATLAS, V8th; Institute of Medicine, 2009, WEIGHT GAIN PREGNANC; Ismail LC, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i555; Josefson JL, 2013, PEDIATR OBES, V8, pe33, DOI 10.1111/j.2047-6310.2012.00132.x; Jouret B, 2007, AM J CLIN NUTR, V85, P1643, DOI 10.1093/ajcn/85.6.1643; Kubo A, 2014, DIABETES CARE, V37, P2996, DOI 10.2337/dc14-1438; Langer O, 2005, AM J OBSTET GYNECOL, V192, P989, DOI 10.1016/j.ajog.2004.11.039; Lee MJ, 2019, CLIN ENDOCRINOL, V90, P102, DOI 10.1111/cen.13874; Lingwood BE, 2011, DIABETES CARE, V34, P2581, DOI 10.2337/dc11-0728; Logan KM, 2017, ARCH DIS CHILD-FETAL, V102, pF65, DOI 10.1136/archdischild-2015-309750; Logan KM, 2016, DIABETES CARE, V39, P1045, DOI 10.2337/dc16-0030; Lohman T. G., 1998, ANTROPOMETRIC STANDA; Longmore DK, 2019, PEDIATR OBES, V14, DOI 10.1111/ijpo.12490; Ma GS, 2004, AM J CLIN NUTR, V79, P653; Monasta L, 2010, OBES REV, V11, P695, DOI 10.1111/j.1467-789X.2010.00735.x; Organization WH, 2016, GLOB REP DIAB, DOI [10.2337/db15-0956, DOI 10.2337/DB15-0956]; Paley C, 2016, PEDIATR OBES, V11, P361, DOI 10.1111/ijpo.12072; Piper L. K., 2017, OBSTET GYNAECOL REPR, V27, P171; R Core Team, 2018, R LANG ENV STAT COMP; Rios-Castillo I, 2015, MATERN CHILD NUTR, V11, P595, DOI 10.1111/mcn.12024; Sentalin PBR, 2019, MEDICINE, V98, DOI 10.1097/MD.0000000000015666; Rodrigo N, 2018, J CLIN MED, V7, DOI 10.3390/jcm7060120; Shaw JE, 2010, DIABETES RES CLIN PR, V87, P4, DOI 10.1016/j.diabres.2009.10.007; Srikanthan P, 2011, J CLIN ENDOCR METAB, V96, P2898, DOI 10.1210/jc.2011-0435; Starling AP, 2015, AM J CLIN NUTR, V101, P302, DOI 10.3945/ajcn.114.094946; Stuebe AM, 2012, AM J OBSTET GYNECOL, V207, DOI 10.1016/j.ajog.2012.04.035; Sun GW, 1996, J CLIN EPIDEMIOL, V49, P907, DOI 10.1016/0895-4356(96)00025-X; Tam CHT, 2018, DIABETOLOGIA, V61, P2539, DOI 10.1007/s00125-018-4724-x; Toftemo I, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5952-1; Uebel K, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-138; van Buuren S, 2011, J STAT SOFTW, V45, P1; Villar J, 2017, PEDIATR RES, V82, P305, DOI 10.1038/pr.2017.52; Waters TP, 2012, J CLIN ENDOCR METAB, V97, P3648, DOI 10.1210/jc.2012-1781; Wells JCK, 2005, INT J OBESITY, V29, P483, DOI 10.1038/sj.ijo.0802899; Wells JCK, 2007, BEST PRACT RES CL EN, V21, P415, DOI 10.1016/j.beem.2007.04.007; Yajnik CS, 2003, INT J OBESITY, V27, P173, DOI 10.1038/sj.ijo.802219; Zhu YY, 2016, CURR DIABETES REP, V16, DOI 10.1007/s11892-015-0699-x	70	9	9	4	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2019	14	8							e0221971	10.1371/journal.pone.0221971	http://dx.doi.org/10.1371/journal.pone.0221971			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW6AB	31465493	Green Published, Green Submitted, gold			2022-12-26	WOS:000485058200075
J	Chen, PH; Chuang, LY; Wu, KC; Wang, YH; Shieh, TY; Sheu, JJC; Chang, HW; Yang, CH				Chen, Ping-Ho; Chuang, Li-Yeh; Wu, Kuo-Chuan; Wang, Yan-Hsiung; Shieh, Tien-Yu; Sheu, Jim Jinn-Chyuan; Chang, Hsueh-Wei; Yang, Cheng-Hong			Application of simulation-based CYP26 SNP-environment barcodes for evaluating the occurrence of oral malignant disorders by odds ratio-based binary particle swarm optimization: A case-control study in the Taiwanese population	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; GENE-GENE INTERACTIONS; ARECA NUT EXTRACT; BREAST-CANCER; COMBINATIONAL POLYMORPHISMS; ALCOHOL-CONSUMPTION; NEURAL-NETWORK; D-LOOP; RISK; SUSCEPTIBILITY	Introduction Genetic polymorphisms and social factors (alcohol consumption, betel quid (BQ) usage, and cigarette consumption), both separately or jointly, play a crucial role in the occurrence of oral malignant disorders such as oral and pharyngeal cancers and oral potentially malignant disorders (OPMD). Material and methods Simultaneous analyses of multiple single nucleotide polymorphisms (SNPs) and environmental effects on oral malignant disorders are essential to examine, albeit challenging. Thus, we conducted a case-control study (N = 576) to analyze the risk of occurrence of oral malignant disorders by using binary particle swarm optimization (BPSO) with an odds ratio (OR)-based method. Results We demonstrated that a combination of SNPs (CYP26B1 rs887844 and CYP26C1 rs12256889) and socio-demographic factors (age, ethnicity, and BQ chewing), referred to as the combined effects of SNP-environment, correlated with maximal risk diversity of occurrence observed between the oral malignant disorder group and the control group. The risks were more prominent in the oral and pharyngeal cancers group (OR = 10.30; 95% confidence interval (CI) = 4.58-23.15) than in the OPMD group (OR = 5.42; 95% CI = 1.94-15.12). Conclusions Simulation-based "SNP-environment barcodes" may be used to predict the risk of occurrence of oral malignant disorders. Applying simulation-based "SNP-environment barcodes" may provide insight into the importance of screening tests in preventing oral and pharyngeal cancers and OPMD.	[Chen, Ping-Ho; Wang, Yan-Hsiung] Kaohsiung Med Univ, Coll Dent Med, Sch Dent, Kaohsiung, Taiwan; [Chen, Ping-Ho] Kaohsiung Med Univ, Ctr Canc Res, Kaohsiung, Taiwan; [Chen, Ping-Ho; Sheu, Jim Jinn-Chyuan; Chang, Hsueh-Wei] Natl Sun Yat Sen Univ, Inst Biomed Sci, Kaohsiung, Taiwan; [Chuang, Li-Yeh] I Shou Univ, Dept Chem Engn, Kaohsiung, Taiwan; [Chuang, Li-Yeh] I Shou Univ, Inst Biotechnol & Chem Engn, Kaohsiung, Taiwan; [Wu, Kuo-Chuan; Yang, Cheng-Hong] Natl Kaohsiung Univ Sci & Technol, Dept Elect Engn, Kaohsiung, Taiwan; [Wu, Kuo-Chuan] Natl Kaohsiung Univ Sci & Technol, Dept Comp Sci & Informat Engn, Kaohsiung, Taiwan; [Wang, Yan-Hsiung] Kaohsiung Med Univ, Orthopaed Res Ctr, Kaohsiung, Taiwan; [Shieh, Tien-Yu] Global Ctr Excellence Oral Hlth Res & Dev, Kaohsiung, Taiwan; [Sheu, Jim Jinn-Chyuan] Natl Sun Yat Sen Univ, Inst Biopharmaceut Sci, Kaohsiung, Taiwan; [Sheu, Jim Jinn-Chyuan] China Med Univ, Sch Chinese Med, Taichung, Taiwan; [Sheu, Jim Jinn-Chyuan] Asia Univ, Dept Hlth & Nutr Biotechnol, Taichung, Taiwan; [Chang, Hsueh-Wei] Natl Sun Yat Sen Univ, Inst Med Sci & Technol, Kaohsiung, Taiwan; [Chang, Hsueh-Wei] Kaohsiung Med Univ Hosp, Dept Med Res, Kaohsiung, Taiwan; [Chang, Hsueh-Wei] Kaohsiung Med Univ, Dept Biomed Sci & Environm Biol, Kaohsiung, Taiwan; [Yang, Cheng-Hong] Kaohsiung Med Univ, PhD Program Biomed Engn, Kaohsiung, Taiwan	Kaohsiung Medical University; Kaohsiung Medical University; National Sun Yat Sen University; I Shou University; I Shou University; National Kaohsiung University of Science & Technology; National Kaohsiung University of Science & Technology; Kaohsiung Medical University; National Sun Yat Sen University; China Medical University Taiwan; Asia University Taiwan; National Sun Yat Sen University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University	Chang, HW (corresponding author), Natl Sun Yat Sen Univ, Inst Biomed Sci, Kaohsiung, Taiwan.; Yang, CH (corresponding author), Natl Kaohsiung Univ Sci & Technol, Dept Elect Engn, Kaohsiung, Taiwan.; Chang, HW (corresponding author), Natl Sun Yat Sen Univ, Inst Med Sci & Technol, Kaohsiung, Taiwan.; Chang, HW (corresponding author), Kaohsiung Med Univ Hosp, Dept Med Res, Kaohsiung, Taiwan.; Chang, HW (corresponding author), Kaohsiung Med Univ, Dept Biomed Sci & Environm Biol, Kaohsiung, Taiwan.; Yang, CH (corresponding author), Kaohsiung Med Univ, PhD Program Biomed Engn, Kaohsiung, Taiwan.	changhw@kmu.edu.tw; chyang@cc.kuas.edu.tw	Wang, Yan-Hsiung/ABD-4004-2020	Wang, Yan-Hsiung/0000-0001-8161-7472; Chen, Ping-Ho/0000-0002-0357-8081; Wu, Kuo-Chuan/0000-0003-3566-4379	Kaohsiung Medical University Research Foundation [KMU-M106020, KMU-M108022]; Ministry of Science and Technology [MOST 106-2314-B-037-014-, MOST 108-2320-B-037-015-MY3]; NSYSU-KMU JOINT RESEARCH PROJECT [NSYSUKMU 105-P021]; Chimei-KMU jointed project [108CM-KMU11]; ChangHua Christian Hospital-KMU Fund [108-CCH-KMU-008]; Ministry of Health and Welfare (MOHW) Health and welfare surcharge of tobacco products, Taiwan [MOHW108-TDU-B-212-124016]; Kaohsiung Medical University Research Center Grant [KMU-TC108A04]	Kaohsiung Medical University Research Foundation; Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); NSYSU-KMU JOINT RESEARCH PROJECT; Chimei-KMU jointed project; ChangHua Christian Hospital-KMU Fund; Ministry of Health and Welfare (MOHW) Health and welfare surcharge of tobacco products, Taiwan; Kaohsiung Medical University Research Center Grant	This study design, data collection, analysis, interpretation and manuscript writing were supported by the Kaohsiung Medical University Research Foundation (KMU-M106020, KMU-M108022), the Ministry of Science and Technology (MOST 106-2314-B-037-014- and MOST 108-2320-B-037-015-MY3), NSYSU-KMU JOINT RESEARCH PROJECT, (#NSYSUKMU 105-P021), Chimei-KMU jointed project (108CM-KMU11), ChangHua Christian Hospital-KMU Fund (108-CCH-KMU-008), and Ministry of Health and Welfare (MOHW) Health and welfare surcharge of tobacco products (MOHW108-TDU-B-212-124016), Taiwan. This study is supported partially by Kaohsiung Medical University Research Center Grant (KMU-TC108A04). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study design, data collection, analysis, interpretation and manuscript writing were supported by the Kaohsiung Medical University Research Foundation (KMU-M106020, KMU-M108022), the Ministry of Science and Technology (MOST 106-2314-B-037-014- and MOST 108-2320-B-037-015-MY3), NSYSU-KMU JOINT RESEARCH PROJECT, (# NSYSUKMU 105-P021), Chimei-KMU jointed project (108CM-KMU-11), ChangHua Christian Hospital-KMU Fund (108-CCH-KMU-008), and Ministry of Health and Welfare (MOHW) Health and welfare surcharge of tobacco products (MOHW108-TDU-B-212-124016), Taiwan. This study is supported partially by Kaohsiung Medical University Research Center Grant (KMU-TC108A04).	Biggerstaff BJ, 2000, STAT MED, V19, P649, DOI 10.1002/(SICI)1097-0258(20000315)19:5&lt;649::AID-SIM371&gt;3.0.CO;2-H; Bratton D, 2007, 2007 IEEE SWARM INTELLIGENCE SYMPOSIUM, P120, DOI 10.1109/SIS.2007.368035; Brookes AJ, 1999, GENE, V234, P177, DOI 10.1016/S0378-1119(99)00219-X; Chang HW, 2008, OMICS, V12, P71, DOI 10.1089/omi.2007.0036; Chang HW, 2012, CURR DRUG METAB, V13, P991, DOI 10.2174/138920012802138679; Chang HW, 2009, COMPUT BIOL CHEM, V33, P114, DOI 10.1016/j.compbiolchem.2008.07.029; Chang MC, 2001, CARCINOGENESIS, V22, P1527, DOI 10.1093/carcin/22.9.1527; Chen JB, 2013, MITOCHONDRION, V13, P698, DOI 10.1016/j.mito.2013.01.013; Chen PH, 2014, SCI WORLD J, DOI 10.1155/2014/810561; Chen PH, 2011, ORAL ONCOL, V47, P594, DOI 10.1016/j.oraloncology.2011.04.024; Chiang SL, 2008, CANCER RES, V68, P8489, DOI 10.1158/0008-5472.CAN-08-0823; Chiang SL, 2007, TOXICOL SCI, V100, P66, DOI 10.1093/toxsci/kfm201; Chuang LY, 2014, ANN GEN PSYCHIATR, V13, DOI 10.1186/1744-859X-13-15; Chuang Li-Yeh, 2013, J Clin Bioinforma, V3, P4, DOI 10.1186/2043-9113-3-4; Chuang LY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037018; Collins RL, 2013, BIODATA MIN, V6, DOI 10.1186/1756-0381-6-4; Dasgupta S, 2013, ANN HUM GENET, V77, P288, DOI 10.1111/ahg.12020; Evans TRJ, 1999, BRIT J CANCER, V80, P1, DOI 10.1038/sj.bjc.6690312; Fanale D, 2012, ONCOGENE, V31, P2121, DOI 10.1038/onc.2011.408; Fu OY, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/281263; Greliche N, 2013, BMC MED GENET, V14, DOI 10.1186/1471-2350-14-36; Hamon SC, 2006, HUM HERED, V61, P87, DOI 10.1159/000093384; Health Promotion Administration Ministry of Health and Welfare Taiwan (R. O. C.), 2016, CANC REG SYST ANN RE; Ho PS, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-260; Hsue SS, 2007, J ORAL PATHOL MED, V36, P25; Hung HC, 1997, CANCER EPIDEM BIOMAR, V6, P901; IARC, 2004, BET QUID AND AR NUT; Kanojia D, 2006, ORAL ONCOL, V42, P655, DOI 10.1016/j.oraloncology.2005.10.013; Kao SY, 2002, J ORAL PATHOL MED, V31, P505, DOI 10.1034/j.1600-0714.2002.00158.x; Kennedy J., 1997, SYST MAN CYB 1997 CO; Kennedy J., 1995, P ICNN 95 INT C NEUR, V194, P2; Kietthubthew S, 2001, ENVIRON MOL MUTAGEN, V37, P111, DOI 10.1002/em.1018; KO YC, 1995, J ORAL PATHOL MED, V24, P450, DOI 10.1111/j.1600-0714.1995.tb01132.x; Kraft P, 2010, NAT GENET, V42, P819, DOI 10.1038/ng1010-819; Lee CH, 2003, BRIT J CANCER, V88, P366, DOI 10.1038/sj.bjc.6600727; Lee CH, 2012, BRIT J PSYCHIAT, V201, P383, DOI 10.1192/bjp.bp.111.107961; Lee CH, 2011, INT J CANCER, V129, P1741, DOI 10.1002/ijc.25809; Li JM, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2772; Li P, 2015, BRIEF FUNCT GENOMICS, V14, P143, DOI 10.1093/bfgp/elu036; Lin GT, 2009, OMICS, V13, P165, DOI 10.1089/omi.2008.0050; McKinney Brett A, 2006, Appl Bioinformatics, V5, P77, DOI 10.2165/00822942-200605020-00002; Meindl A, 2009, BREAST CARE, V4, P93, DOI 10.1159/000211991; Moore JH, 2010, BIOINFORMATICS, V26, P445, DOI 10.1093/bioinformatics/btp713; Moore JH, 2003, HUM HERED, V56, P73, DOI 10.1159/000073735; Moore JH, 2002, ANN MED, V34, P88, DOI 10.1080/07853890252953473; Musani SK, 2007, HUM HERED, V63, P67, DOI 10.1159/000099179; Nelson MR, 2001, GENOME RES, V11, P458, DOI 10.1101/gr.172901; Oh DY, 2013, ASIAN AUSTRAL J ANIM, V26, P1218, DOI 10.5713/ajas.2013.13058; Ritchie MD, 2001, AM J HUM GENET, V69, P138, DOI 10.1086/321276; Ritchie MD, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-28; Ross AC, 2011, ANNU REV NUTR, V31, P65, DOI 10.1146/annurev-nutr-072610-145127; Shin MN, 2000, BRIT J CANCER, V82, P1871, DOI 10.1054/bjoc.2000.1208; Su WH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083034; Tang JY, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/359634; Thomas G, 2009, NAT GENET, V41, P579, DOI 10.1038/ng.353; Topcu Z, 2002, CARCINOGENESIS, V23, P595, DOI 10.1093/carcin/23.4.595; Wang YY, 2014, BMC ORAL HEALTH, V14, DOI 10.1186/1472-6831-14-99; Warnakulasuriya S, 2007, J ORAL PATHOL MED, V36, P575, DOI 10.1111/j.1600-0714.2007.00582.x; Warnakulasuriya S, 2009, ORAL ONCOL, V45, P309, DOI 10.1016/j.oraloncology.2008.06.002; Wu Shyh-Jong, 2015, ScientificWorldJournal, V2015, P160185, DOI 10.1155/2015/160185; Wu SJ, 2013, MOL BIOL REP, V40, P4227, DOI 10.1007/s11033-013-2504-8; Yang CH, 2016, J BIOMED INFORM, V63, P112, DOI 10.1016/j.jbi.2016.08.009; Yang CH, 2015, OMICS, V19, P238, DOI 10.1089/omi.2014.0121; Yang CH, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/172049; Yang CH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079387; Yang CH, 2013, IEEE ACM T COMPUT BI, V10, P361, DOI 10.1109/TCBB.2013.27; Yang CH, 2012, KAOHSIUNG J MED SCI, V28, P362, DOI 10.1016/j.kjms.2012.02.002; Yang CH, 2011, OMICS, V15, P399, DOI 10.1089/omi.2010.0028; Yang CH, 2009, CANCER EPIDEMIOL, V33, P147, DOI 10.1016/j.canep.2009.07.001; Yang PY, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S1-S10; Yen CY, 2008, J ORAL PATHOL MED, V37, P271, DOI 10.1111/j.1600-0714.2007.00608.x; YOUDEN W. J., 1950, CANCER, V3, P32, DOI 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3; Yu JC, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2821; Zhang YD, 2011, SENSORS-BASEL, V11, P4721, DOI 10.3390/s110504721	74	1	1	3	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2019	14	8							e0220719	10.1371/journal.pone.0220719	http://dx.doi.org/10.1371/journal.pone.0220719			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW6AB	31465460	gold, Green Published, Green Submitted			2022-12-26	WOS:000485058200007
J	Fearon, E; Spiering, MJ				Fearon, Eric; Spiering, Martin J.			Peptides come to the rescue of pancreatic beta cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material							GLUCAGON-LIKE PEPTIDE-1		[Fearon, Eric] Univ Michigan, Sch Med, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Fearon, E (corresponding author), Univ Michigan, Sch Med, Ann Arbor, MI 48109 USA.	mspiering@asbmb.org		Spiering, Martin/0000-0002-9160-5296				Drucker DJ, 2017, J CLIN INVEST, V127, P4217, DOI 10.1172/JCI97233; Fu Z, 2013, CURR DIABETES REV, V9, P25, DOI 10.2174/157339913804143225; Holst JJ, 2007, PHYSIOL REV, V87, P1409, DOI 10.1152/physrev.00034.2006; Li YZ, 2003, J BIOL CHEM, V278, P471, DOI 10.1074/jbc.M209423200; LORENZO A, 1994, NATURE, V368, P756, DOI 10.1038/368756a0; Prentki M, 2006, J CLIN INVEST, V116, P1802, DOI 10.1172/JCI29103; Swedberg JE, 2016, J BIOL CHEM, V291, P15778, DOI 10.1074/jbc.M116.724542	7	0	0	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 23	2019	294	34					12622	12623		10.1074/jbc.CL119.010307	http://dx.doi.org/10.1074/jbc.CL119.010307			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IV6YV	31444308	Green Published, hybrid			2022-12-26	WOS:000484414600006
J	Goncalves, B; Coutinho, D; Exel, J; Travassos, B; Lago, C; Sampaio, J				Goncalves, Bruno; Coutinho, Diogo; Exel, Juliana; Travassos, Bruno; Lago, Carlos; Sampaio, Jaime			Extracting spatial-temporal features that describe a team match demands when considering the effects of the quality of opposition in elite football	PLOS ONE			English	Article							GAME-RELATED STATISTICS; SMALL-SIDED GAMES; MOVEMENT BEHAVIOR; APPROXIMATE ENTROPY; PERFORMANCE; POSITION; SPORTS; VARIABLES; SPACE; PITCH	Spatiotemporal patterns of play can be extracted from competitive environments to design representative training tasks and underlying processes that sustain performance outcomes. To support this statement, the aims of this study were: (i) describe the collective behavioural patterns that relies upon the use of player positioning in interaction with teammates, opponents and ball positioning; (ii) and define the underlying structure among the variables through application of a factorial analysis. The sample comprised a total of 1,413 ball possession sequences, obtained from twelve elite football matches from one team (the team ended the season in the top-5 position). The dynamic position of the players (from both competing teams), as well as the ball, were captured and transformed to two-dimensional coordinates. Data included the ball possession sequences from six matches played against top opponents (TOP, the three teams classified in the first 3 places at the end of the season) and six matches against bottom opponents (BOTTOM, the three teams classified in the last 3 at the end of the season). The variables calculated for each ball possession were the following: ball position; team space in possession; game space (comprising the outfield players of both teams); position and space at the end of ball possession. Statistical comparisons were carried with magnitude-based decisions and null-hypothesis analysis and factor analysis to define the underlying structure among variables according to the considered contexts. Results showed that playing against TOP opponents, there was similar to 38 meters game length per similar to 43 meters game width with 12% of coefficient of variation (%). Ball possessions lasted for similar to 28 seconds and tended to end at similar to 83m of pitch length. Against BOTTOM opponents, a decrease in the game length with an increase in game width and in the deepest location was observed in comparison with playing against TOP opponents. The duration of ball possession increased considerable (similar to 37 seconds), and the ball speed entropy was higher, suggesting lower levels of regularity in comparison with TOP opponents. The BOTTOM teams revealed a small EPS. The Principal Component Analysis showed a strong association of the ball speed, entropy of the ball speed and the coefficient of variation (%) of the ball speed. The EPS of the team in possession was well correlated with the game space, especially the game width facing TOP opponents. Against BOTTOM opponents, there was a strong association of ball possession duration, game width, distance covered by the ball, and length/width ratio of the ball movement. The overall approach carried out in this study may serve as the starting point to elaborate normative models of positioning behaviours measures to support the coaches' operating decisions.	[Goncalves, Bruno; Coutinho, Diogo; Exel, Juliana; Travassos, Bruno; Sampaio, Jaime] Res Ctr Sports Sci Hlth Sci & Human Dev CIDESD, CreativeLab Res Community, Vila Real, Portugal; [Goncalves, Bruno; Coutinho, Diogo; Exel, Juliana; Sampaio, Jaime] Univ Tras Os Montes & Alto Douro, Vila Real, Portugal; [Travassos, Bruno] Univ Beira Interior, Covilha, Portugal; [Lago, Carlos] Univ Vigo, Fac Educ & Sport, Pontevedra, Spain	University of Tras-os-Montes & Alto Douro; Universidade da Beira Interior; Universidade de Vigo	Goncalves, B (corresponding author), Res Ctr Sports Sci Hlth Sci & Human Dev CIDESD, CreativeLab Res Community, Vila Real, Portugal.; Goncalves, B (corresponding author), Univ Tras Os Montes & Alto Douro, Vila Real, Portugal.	air.bruno.23@gmail.com	Sampaio, Jaime/B-7392-2008; Gonçalves, Bruno/M-5361-2013; Travassos, Bruno/G-4478-2013; Coutinho, D./H-7313-2016; LAGO-PENAS, CARLOS/E-3957-2016	Sampaio, Jaime/0000-0003-2335-9991; Gonçalves, Bruno/0000-0001-7874-4104; Travassos, Bruno/0000-0002-2165-2687; Coutinho, D./0000-0001-6605-9505; Exel, Juliana/0000-0003-4409-7329; LAGO-PENAS, CARLOS/0000-0002-1626-2035	Fundo Europeu de Desenvolvimento Regional (FEDER)-NORTE 2020; Project NanoSTIMA: Macro-to-Nano Human Sensing: Towards Integrated Multimodal Health Monitoring and Analytics [NORTE-01-0145-FEDER-000016]	Fundo Europeu de Desenvolvimento Regional (FEDER)-NORTE 2020; Project NanoSTIMA: Macro-to-Nano Human Sensing: Towards Integrated Multimodal Health Monitoring and Analytics	This work was supported by Project NanoSTIMA: Macro-to-Nano Human Sensing: Towards Integrated Multimodal Health Monitoring and Analytics, NORTE-01-0145-FEDER-000016, cofinanced by Fundo Europeu de Desenvolvimento Regional (FEDER)-NORTE 2020. There was no additional external funding received for this study.	Aguiar M, 2015, J SPORT SCI, V33, P1259, DOI 10.1080/02640414.2015.1022571; Baptista J, 2018, J STRENGTH COND RES; Batterham AM, 2006, INT J SPORT PHYSIOL, V1, P50, DOI 10.1123/ijspp.1.1.50; Bradley PS, 2018, INT J SPORT PHYSIOL, P1; Brunswik E., 1956, PERCEPTION AND THE R; Carling C, 2009, PERFORMANCE ASSESSME; Carling C, 2011, J SPORT SCI, V29, P63, DOI 10.1080/02640414.2010.521945; Castellano J, 2016, J HUM KINET, V51, P153, DOI 10.1515/hukin-2015-0178; Castellano J, 2015, INT J PERF ANAL SPOR, V15, P135, DOI 10.1080/24748668.2015.11868782; Castellano J, 2013, INT J PERF ANAL SPOR, V13, P822, DOI 10.1080/24748668.2013.11868691; Coutinho D, 2015, J SPORT SCI, V33, P1229, DOI 10.1080/02640414.2015.1022575; Di Salvo V, 2007, INT J SPORTS MED, V28, P222, DOI 10.1055/s-2006-924294; Dicks M, 2009, INT J SPORT PSYCHOL, V40, P506; Duarte R, 2013, J SYST SCI COMPLEX, V26, P62, DOI 10.1007/s11424-013-2290-3; Folgado H, 2018, RES SPORTS MED, V26, P51, DOI 10.1080/15438627.2017.1393754; Folgado H, 2014, EUR J SPORT SCI, V14, pS487, DOI 10.1080/17461391.2012.730060; Fonseca S, 2012, J MOTOR BEHAV, V44, P179, DOI 10.1080/00222895.2012.668233; Fradua L, 2013, J SPORT SCI, V31, P573, DOI 10.1080/02640414.2012.746722; Gomez MA, 2012, EUR J SPORT SCI, V12, P393, DOI 10.1080/17461391.2011.566373; Goncalves B, 2016, J SPORT SCI, V34, P1346, DOI 10.1080/02640414.2016.1143111; Goncalves B, 2018, J HUM KINET; Goncalves B, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0200019; Goncalves B, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171156; Goncalves BV, 2014, J SPORT SCI, V32, P191, DOI 10.1080/02640414.2013.816761; Grehaigne JF, 1997, J SPORT SCI, V15, P137, DOI 10.1080/026404197367416; GREHAIGNE JF, 1995, QUEST, V47, P490, DOI 10.1080/00336297.1995.10484171; Gudmundsson J, 2017, ACM COMPUT SURV, V50, DOI 10.1145/3054132; Hair R. L., 2010, MULTIVARIATE DATA AN, V7th; Harbourne RT, 2009, PHYS THER, V89, P284, DOI 10.2522/ptj.20080130.ar; Hill-Haas SV, 2011, SPORTS MED, V41, P199, DOI 10.2165/11539740-000000000-00000; Hopkins W., 2002, STAT VS CLIN PRACTIC, V6; Hopkins WG, 2000, A NEW VIEW OF STATIS; Hopkins WG, 2007, SPORTSCIENCE A SPREA; Hristovski R., 2013, COMPLEX SYSTEMS SPOR, P3; Hughes M, 2005, J SPORT SCI, V23, P509, DOI 10.1080/02640410410001716779; Hughes M, 2007, THE ESSENTIALS OF PE; Lago C, 2010, EUR J SPORT SCI, V10, P103, DOI 10.1080/17461390903273994; LINK D, 2016, PLOS ONE, V11; Link D, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179953; Liu HY, 2016, J SPORT SCI, V34, P509, DOI 10.1080/02640414.2015.1117121; Maliki ABHM, 2017, J FUNDAM APPL SCI, V9, P539, DOI 10.4314/jfas.v9i2s35; Martin-Garcia A, 2018, J STRENGTH COND RES, V32, P3511, DOI 10.1519/JSC.0000000000002816; McGarry T, 2002, J SPORT SCI, V20, P771, DOI 10.1080/026404102320675620; McGarry T., 2009, INT J PERF ANAL SPOR, V9, P128, DOI [10.1186/s12913-016-1423-5, DOI 10.1080/24748668.2009.11868469]; Memmert D, 2018, DATA ANALYTICS IN FO; Memmert D, 2017, SPORTS MED, V47, P1, DOI 10.1007/s40279-016-0562-5; Moura FA, 2014, J SPORT SCI, V32, P1881, DOI 10.1080/02640414.2013.853130; Olthof SBH, 2019, J STRENGTH COND RES, V33, P167, DOI 10.1519/JSC.0000000000002936; Olthof SBH, 2019, J STRENGTH COND RES, V33, P523, DOI 10.1519/JSC.0000000000002978; PINCUS SM, 1991, P NATL ACAD SCI USA, V88, P2297, DOI 10.1073/pnas.88.6.2297; Plotly Technologies Inc, 2015, COLLABORATIVE DATA S; R Development Core Team, 2018, R A LANGUAGE AND ENV; Rein R, 2016, SPRINGERPLUS, V5, DOI 10.1186/s40064-016-3108-2; Ric A, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyd.2016.01513; Sampaio J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132894; Sampaio JE, 2014, J SCI MED SPORT, V17, P229, DOI 10.1016/j.jsams.2013.04.005; Silva P, 2016, INT J PERF ANAL SPOR, V16, P753, DOI 10.1080/24748668.2016.11868921; Stergiou N., 2004, INNOVATIVE ANAL HUMA; Tenga A, 2015, INT J PERF ANAL SPOR, V15, P411, DOI 10.1080/24748668.2015.11868802; Torrents C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168866; Travassos B, 2013, PSYCHOL SPORT EXERC, V14, P211, DOI 10.1016/j.psychsport.2012.11.002; Travassos B, 2013, INT J PERF ANAL SPOR, V13, P83, DOI 10.1080/24748668.2013.11868633; Travassos B, 2012, J SPORT SCI, V30, P1447, DOI 10.1080/02640414.2012.712716; Williams A. M., 2004, INT J SPORT EXERC PS, V2, P301, DOI DOI 10.1080/1612197X.2004.9671747; Yentes JM, 2013, ANN BIOMED ENG, V41, P349, DOI 10.1007/s10439-012-0668-3; Zubillaga A, 2013, INT J SPORTS SCI COA, V8, P713, DOI 10.1260/1747-9541.8.4.713	66	20	20	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2019	14	8							e0221368	10.1371/journal.pone.0221368	http://dx.doi.org/10.1371/journal.pone.0221368			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW5RZ	31437220	Green Published, Green Submitted, gold			2022-12-26	WOS:000485036900062
J	Lammer, F; Delbridge, C; Wurstle, S; Neff, F; Meyer, B; Schlegel, J; Kessel, KA; Schmid, TE; Schilling, D; Combs, SE				Laemmer, Friederike; Delbridge, Claire; Wuerstle, Silvia; Neff, Frauke; Meyer, Bernhard; Schlegel, Juergen; Kessel, Kerstin A.; Schmid, Thomas E.; Schilling, Daniela; Combs, Stephanie E.			Cytosolic Hsp70 as a biomarker to predict clinical outcome in patients with glioblastoma	PLOS ONE			English	Article							HEAT-SHOCK-PROTEIN-70 HSP70; EXPRESSION; PROTEIN; TEMOZOLOMIDE; PROGNOSIS; MARKER; TUMORS	Introduction The major stress-inducible heat shock protein 70 (Hsp70) is induced after different stress stimuli. In tumors, elevated intracellular Hsp70 levels were associated on the one hand with radio- and chemotherapy resistance and on the other hand with a favorable outcome for patients. This study was undertaken to investigate cytosolic Hsp70 (cHsp70) as a potential biomarker for progression free (PFS) and overall survival (OS) in patients with primary glioblastomas (GBM). Methods The cHsp70 expression in tumor tissue of 60 patients diagnosed with primary GBM was analyzed by immunohistochemistry. The cHsp70 expression was correlated to the PFS and OS of the patients. Results A high cHsp70 expression was associated with a prolonged PFS (hazard ratio = 0.374, p = 0.001) and OS (hazard ratio = 0.416, p = 0.014) in GBM patients treated according to the standard Stupp protocol with surgery, radiotherapy and temozolomide. Conclusions These data suggest that the intracellular Hsp70 expression might serve as a prognostic marker in patients with primary GBM.	[Laemmer, Friederike; Kessel, Kerstin A.; Schmid, Thomas E.; Schilling, Daniela; Combs, Stephanie E.] Tech Univ Munich, Dept Radiat Oncol, Klinikum Rechts Isar, Munich, Germany; [Laemmer, Friederike; Delbridge, Claire; Wuerstle, Silvia; Schlegel, Juergen] Tech Univ Munich, Inst Pathol, Munich, Germany; [Neff, Frauke] Stadt Klinikum Munchen GmbH, Inst Pathol, Klinikum Bogenhausen, Munich, Germany; [Meyer, Bernhard] Tech Univ Munich, Dept Neurosurg, Klinikum Rechts Isar, Munich, Germany; [Kessel, Kerstin A.; Schmid, Thomas E.; Schilling, Daniela; Combs, Stephanie E.] Helmholtz Zentrum Munchen, IRM, DRS, Neuherberg, Germany; [Combs, Stephanie E.] Partner Site Munich, Deutsch Konsortium Translat Krebsforsch, Munich, Germany	Technical University of Munich; Technical University of Munich; Munchen Klinik; Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Combs, SE (corresponding author), Tech Univ Munich, Dept Radiat Oncol, Klinikum Rechts Isar, Munich, Germany.; Combs, SE (corresponding author), Helmholtz Zentrum Munchen, IRM, DRS, Neuherberg, Germany.; Combs, SE (corresponding author), Partner Site Munich, Deutsch Konsortium Translat Krebsforsch, Munich, Germany.	stephanie.combs@tum.de		Schlegel, Jurgen/0000-0002-5544-2717; Wurstle, Silvia/0000-0003-0787-3894; Combs, Stephanie Elisabeth/0000-0002-5233-1536; Schmid, Thomas/0000-0002-8894-8087	German Consortium for Translational Cancer Research; Medical Faculty of TUM	German Consortium for Translational Cancer Research; Medical Faculty of TUM	This project was funded in part by the German Consortium for Translational Cancer Research, Munich/TUM site as well as by the Medical Faculty of TUM.	Bauer K, 2012, CELL ONCOL, V35, P197, DOI 10.1007/s13402-012-0079-3; Beaman GM, 2014, MOL CELL BIOCHEM, V393, P301, DOI 10.1007/s11010-014-2074-7; Bettstetter M, 2008, LAB INVEST, V88, P1367, DOI 10.1038/labinvest.2008.100; Binabaj MM, 2018, J CELL PHYSIOL, V233, P378, DOI 10.1002/jcp.25896; Cai MB, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-96; Combs SE, 2016, CANCERS, V8, DOI 10.3390/cancers8010015; Davidson B, 2016, HUMAN PATHOLOGY; ELLEDGE RM, 1994, CANCER RES, V54, P3752; Gastpar R, 2005, CANCER RES, V65, P5238, DOI 10.1158/0008-5472.CAN-04-3804; Gunther S, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00556; Hau P, 2007, DIS MARKERS, V23, P97, DOI 10.1155/2007/159242; Hegi ME, 2005, NEW ENGL J MED, V352, P997, DOI 10.1056/NEJMoa043331; Hermisson M, 2000, NEUROLOGY, V54, P1357, DOI 10.1212/WNL.54.6.1357; Kampinga HH, 2009, CELL STRESS CHAPERON, V14, P105, DOI 10.1007/s12192-008-0068-7; Lee HW, 2013, VIRCHOWS ARCH, V463, P489, DOI 10.1007/s00428-013-1461-x; Lee SJ, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-2034-y; LINDQUIST S, 1988, ANNU REV GENET, V22, P631, DOI 10.1146/annurev.ge.22.120188.003215; Louis DN, 2016, ACTA NEUROPATHOL, V131, P803, DOI 10.1007/s00401-016-1545-1; Marnbula SS, 2007, METHODS, V43, P168, DOI 10.1016/j.ymeth.2007.06.009; Mostafa H, 2016, J HEMATOL ONCOL, V9, DOI 10.1186/s13045-016-0272-3; Multhoff G, 2001, CELL STRESS CHAPERON, V6, P337, DOI 10.1379/1466-1268(2001)006<0337:AMHPSN>2.0.CO;2; Multhoff G, 2007, METHODS, V43, P229, DOI 10.1016/j.ymeth.2007.06.006; Murphy ME, 2013, CARCINOGENESIS, V34, P1181, DOI 10.1093/carcin/bgt111; Muth C, 2016, STRAHLENTHER ONKOL, V192, P146, DOI 10.1007/s00066-015-0926-z; Nadin SB, 2014, CELL STRESS CHAPERON, V19, P493, DOI 10.1007/s12192-013-0475-2; Park TS, 2014, LUNG CANCER, V86, P262, DOI 10.1016/j.lungcan.2014.08.009; Quillien V, 2012, CANCER-AM CANCER SOC, V118, P4201, DOI 10.1002/cncr.27392; Ricaniadis N, 2001, EUR J SURG ONCOL, V27, P88, DOI 10.1053/ejso.1999.1018; Sagol O, 2002, PATHOL RES PRACT, V198, P77, DOI 10.1078/0344-0338-00190; Shin E, 2011, J HEPATO-BIL-PAN SCI, V18, P544, DOI 10.1007/s00534-010-0367-0; Specht HM, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00162; Strik HM, 2000, ANTICANCER RES, V20, P4457; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Tavassol F, 2011, HEAD NECK ONCOL, V3, DOI 10.1186/1758-3284-3-10; Thorsteinsdottir J, 2017, J NEURO-ONCOL, V135, P443, DOI 10.1007/s11060-017-2600-z	35	12	12	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2019	14	8							e0221502	10.1371/journal.pone.0221502	http://dx.doi.org/10.1371/journal.pone.0221502			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5OC	31430337	Green Published, gold, Green Submitted			2022-12-26	WOS:000485026800062
J	Wang, W; Wu, TC; Zhao, DG; Guo, CY; Luo, WZ; Pang, YJ				Wang, Wei; Wu, Tiecheng; Zhao, Dagang; Guo, Chunyu; Luo, Wanzhen; Pang, Yongjie			Experimental-numerical analysis of added resistance to container ships under presence of wind-wave loads	PLOS ONE			English	Article							LARGE-EDDY SIMULATION; MOTIONS	Experimental and numerical analyses performed on a scaled-down model of a 1900TEU container-ship are reported herein. Wind-tunnel and towing-tank experiments along with computational-fluid-dynamic simulations were performed to obtain (1) wind-load coefficients for superstructure of container ship at different wind angles under full-load operating conditions; (2) wave resistance of the model sans the superstructure under different wave conditions; and (3) combined wind-wave resistance of the model in the head waves coupled with a fluctuating wind. Wind-tunnel experiments were first performed to determine wind-load coefficients concerning of the superstructure at different wind angles. Subsequently, the obtained wind-load coefficients from the wind tunnel test were compared against numerical and empirically obtained results to validate the applicability of the applied numerical methods. Next, the wave-induced resistance to ship motion was investigated via a series of towing-tank experiments and numerical simulations to analyze the resistance and motion of ship under wavy conditions. Finally, characteristics of the added resistance to ship motion under conditions of combined wind-wave load were analyzed, and the coupling between ship motion and combined wind-wave load was used to investigate the changes in added resistance under different load scenarios. The results reveal that combined wind-wave load causes the resistance to ship motion to exceed the algebraic sum of the corresponding resistances under standalone wind-and wave-load conditions. The additional resistance was observed to be a combined manifestation of resistances induced by ship motion and wave-parameter alterations.	[Wang, Wei; Wu, Tiecheng; Zhao, Dagang; Guo, Chunyu; Luo, Wanzhen; Pang, Yongjie] Harbin Engn Univ, Coll Shipbldg Engn, Harbin, Heilongjiang, Peoples R China; [Wu, Tiecheng; Luo, Wanzhen] Sun Yat Sen Univ, Sch Marine Engn & Technol, Zhuhai, Peoples R China	Harbin Engineering University; Sun Yat Sen University	Zhao, DG; Guo, CY (corresponding author), Harbin Engn Univ, Coll Shipbldg Engn, Harbin, Heilongjiang, Peoples R China.	zhaodagang_heu@outlook.com; guochunyu_heu@outlook.com			National Natural Science Foundation of China [51379043, 51709060, 41176074]; Equipment pre research project of china [41407010501]; equipment preresearch project of China [41407010501]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Equipment pre research project of china; equipment preresearch project of China	This work was financially supported by the National Natural Science Foundation of China (Grant Nos. 51379043, 51709060, 41176074), the Equipment pre research project of china (Grant No. 41407010501).; This work was financially supported by the National Natural Science Foundation of China (Grant Nos. 51379043, 51709060 and 41176074) and the equipment preresearch project of China (Grant No. 41407010501). We would like to thank Editage [www.editage.cn] for English language editing.	Afshary M, 2014, 29 IWWWFB OS JAP JAN; Arribas FP, 2007, OCEAN ENG, V34, P946, DOI 10.1016/j.oceaneng.2006.06.002; Bai Y., 2016, MARINE STRUCTURAL DE, P95, DOI [10.1016/B978-0-08-099997-5.00006-X., DOI 10.1016/B978-0-08-099997-5.00006-X]; Barcarolo D, 2016, ASME 35 INT C OC OFF; Carrica PM, 2007, COMPUT FLUIDS, V36, P1415, DOI 10.1016/j.compfluid.2007.01.007; Carrica PM, 2010, J MAR SCI TECH-JAPAN, V15, P316, DOI 10.1007/s00773-010-0098-6; CD-Adapco, 2016, US GUID STAR CCM VER; Choi J, 2009, COAST ENG, V56, P1043, DOI 10.1016/j.coastaleng.2009.06.009; Deng GB, 2010, J HYDRODYN, V22, P459, DOI 10.1016/S1001-6058(09)60239-0; [Duan Wenyang 段文洋], 2013, [船舶力学, Journal of Ship Mechanics], V17, P226; Fan Jie-chuan, 2002, HDB WIND TUNNEL TEST, P639; Forrest JS, 2010, COMPUT FLUIDS, V39, P656, DOI 10.1016/j.compfluid.2009.11.002; Fossati F., 2014, 23 HISWA INT S YACHT; Fujiwara T, 2009, EXPT INVESTIGATION E, P9; HIRT CW, 1981, J COMPUT PHYS, V39, P201, DOI 10.1016/0021-9991(81)90145-5; Hong BG, 1991, J DALIAN MAR COLL, V02, P113; Isherwood R., 1972, R I NAV ARCHIT, V115, P327; Jiang Y, 2014, COMPUT FLUIDS, V104, P73, DOI 10.1016/j.compfluid.2014.08.003; Joosen W.P.A., 1966, P 6 S NAV HYDR; Kalvig SM, 2013, ENRGY PROCED, V35, P148, DOI 10.1016/j.egypro.2013.07.168; Kim DJ, 2019, OCEAN ENG, V175, P197, DOI 10.1016/j.oceaneng.2019.02.011; Kulkarni PR, 2007, COMPUT FLUIDS, V36, P794, DOI 10.1016/j.compfluid.2006.07.001; Liu SK, 2011, OCEAN ENG, V38, P641, DOI 10.1016/j.oceaneng.2010.12.007; Ma Y, 2014, J HYDRODYN, V26, P865, DOI 10.1016/S1001-6058(14)60095-0; Mehta D, 2014, J WIND ENG IND AEROD, V133, P1, DOI 10.1016/j.jweia.2014.07.002; MENTER FR, 1994, AIAA J, V32, P1598, DOI 10.2514/3.12149; Paskyabi MB, 2014, ENRGY PROCED, V53, P184, DOI 10.1016/j.egypro.2014.07.227; Paulsen BT, 2014, COAST ENG, V86, P57, DOI 10.1016/j.coastaleng.2014.01.006; Seo S, 2017, OCEAN ENG, V137, P309, DOI 10.1016/j.oceaneng.2017.04.009; Sigmund S, 2018, OCEAN ENG, V147, P51, DOI 10.1016/j.oceaneng.2017.10.010; SNYDER W H, 1972, Boundary-Layer Meteorology, V3, P113, DOI 10.1007/BF00769111; Som S K, 2011, INTRO FLUID MECH FLU, P11; Thornber B, 2010, AERONAUT J, V114, P715, DOI 10.1017/S0001924000004218; Wang F, 2014, LASER ENG, V29, P133; WEISS JM, 1995, AIAA J, V33, P2050, DOI 10.2514/3.12946; Wilcox D.C., 1994, TURBULENCE MODELING, P15; Wu CS, 2011, INT J NAV ARCH OCEAN, V3, P105, DOI 10.3744/JNAOE.2011.3.1.105; Zhang F., 2009, P 47 AIAA AER SCI M; Zou L., NUM SHIP HYDR ASS GO	39	8	8	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2019	14	8							e0221453	10.1371/journal.pone.0221453	http://dx.doi.org/10.1371/journal.pone.0221453			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5OC	31430338	gold, Green Published, Green Submitted			2022-12-26	WOS:000485026800057
J	Wei, HC; Sundararaman, A; Dickson, E; Rennie-Campbell, L; Cross, E; Heesom, KJ; Mellor, H				Wei, Haoche; Sundararaman, Ananthalakshmy; Dickson, Emily; Rennie-Campbell, Lewis; Cross, Eloise; Heesom, Kate J.; Mellor, Harry			Characterization of the polarized endothelial secretome	FASEB JOURNAL			English	Article						endothelial cell; secretion; extracellular matrix; polarization; intracellular traffic	EXTRACELLULAR VESICLES; CELLS; PROTEIN; MORPHOGENESIS; DYSTROGLYCAN; PHYSIOLOGY; PROTEOMICS; SITES	Endothelial cells (ECs) form an active barrier between the circulation and the body. In addition to controlling transport of molecules between these 2 compartments, the endothelium is a major secretory organ, releasing proteins both into the circulation and into the vascular matrix. Although it is clearly important that proteins are correctly sorted into these 2 spaces, we currently know little of the polarization of this secretion or how it is controlled. Here, we present an optimized system for the analysis of polarized secretion and show that it allows the derivation of deep, robust proteomes from small numbers of primary ECs. We present the first endothelial apically and basolaterally secreted proteomes, demonstrating that ECs polarize the secretion of extracellular vesicle cargoes to the apical surface. Conversely, we find that protein secretion at the basolateral surface is focused on components of the extracellular matrix (ECM). Finally, we examine the role of liprin-alpha 1 in secretion toward the basolateral compartment and identify a subset of ECM components that share this route with fibronectin.	[Wei, Haoche] Sichuan Univ, Coll Life Sci, Ctr Growth Metab & Aging, Minist Educ,Key Lab Bioresource & Ecoenvironm, Chengdu, Peoples R China; [Wei, Haoche; Sundararaman, Ananthalakshmy; Dickson, Emily; Rennie-Campbell, Lewis; Cross, Eloise; Heesom, Kate J.; Mellor, Harry] Univ Bristol, Fac Life Sci, Sch Biochem, Biomed Sci Bldg, Bristol, Avon, England	Sichuan University; University of Bristol	Mellor, H (corresponding author), Univ Bristol, Sch Biochem, Biomed Sci Bldg, Bristol BS8 1TD, Avon, England.	h.mellor@bristol.ac.uk		Cross, Eloise/0000-0002-9982-8056; Sundararaman, Ananthalakshmy/0000-0002-5661-4656	Chinese Scholarship Council [PG/16/62/32295]; British Heart Foundation	Chinese Scholarship Council(China Scholarship Council); British Heart Foundation(British Heart Foundation)	The authors thank Sarah George (University of Bristol, Bristol, United Kingdom) for help and advice with human coronary artery endothelial cells. H.W. was supported by a scholarship from the Chinese Scholarship Council. A.S. was supported by project grant PG/16/62/32295 from the British Heart Foundation. The authors declare no conflicts of interest.	Albers JJ, 2012, BBA-MOL CELL BIOL L, V1821, P345, DOI 10.1016/j.bbalip.2011.06.013; Augustin HG, 2017, SCIENCE, V357, DOI 10.1126/science.aal2379; Bal G, 2013, CELL TRANSPLANT, V22, P1185, DOI 10.3727/096368912X657288; Barresi R, 2006, J CELL SCI, V119, P199, DOI 10.1242/jcs.02814; Burghoff S, 2011, J PROTEOME RES, V10, P1160, DOI 10.1021/pr100937a; Chautard E, 2009, BIOINFORMATICS, V25, P690, DOI 10.1093/bioinformatics/btp025; Chen ZH, 2017, CARDIOVASC RES, V113, P620, DOI 10.1093/cvr/cvx001; Cines DB, 1998, BLOOD, V91, P3527; Cortazar AR, 2017, DATABASE-OXFORD, DOI 10.1093/database/baw171; D'Souza-Schorey C, 2018, ESSAYS BIOCHEM, V62, P125, DOI 10.1042/EBC20170078; da Silva ML, 2016, BLOOD, V128, P277, DOI 10.1182/blood-2015-10-677054; Fung KYY, 2018, TRAFFIC, V19, P5, DOI 10.1111/tra.12533; Galley HF, 2004, BRIT J ANAESTH, V93, P105, DOI 10.1093/bja/aeh163; Galvagni F, 2016, ONCOTARGET, V7, P10090, DOI 10.18632/oncotarget.7136; GHITESCU L, 1986, J CELL BIOL, V102, P1304, DOI 10.1083/jcb.102.4.1304; Glembotski CC, 2012, J BIOL CHEM, V287, P25893, DOI 10.1074/jbc.M112.356345; Hamidi H, 2017, CURR BIOL, V27, pR158, DOI 10.1016/j.cub.2016.12.036; Hawksworth J, 2018, EMBO MOL MED, V10, DOI 10.15252/emmm.201708454; Hromada C, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00275; Kim DK, 2015, BIOINFORMATICS, V31, P933, DOI 10.1093/bioinformatics/btu741; Korf-Klingebiel M, 2015, NAT MED, V21, P140, DOI 10.1038/nm.3778; KOWALCZYK AP, 1990, BLOOD, V75, P2335; Lugano R, 2018, J CLIN INVEST, V128, P3280, DOI 10.1172/JCI97459; Lynch M, 2016, J INTERN MED, V280, P325, DOI 10.1111/joim.12486; Mana G, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13546; Martinez-Martinez E, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12305-7; McCormack JJ, 2017, J CELL SCI, V130, P3611, DOI 10.1242/jcs.208033; Mohr T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179065; Muniyappa R, 2013, REV ENDOCR METAB DIS, V14, P5, DOI 10.1007/s11154-012-9229-1; Neumueller Josef, 2008, P520, DOI 10.1007/978-3-211-76310-0_31; Noda K, 2010, MOL BIOL CELL, V21, P584, DOI 10.1091/mbc.E09-07-0580; Richards M, 2015, CURR BIOL, V25, P2325, DOI 10.1016/j.cub.2015.07.045; Rodriguez C, 2008, CARDIOVASC RES, V79, P7, DOI 10.1093/cvr/cvn102; Sercu S, 2008, CANCER INVEST, V26, P375, DOI 10.1080/07357900701788148; Thurston G, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006650; Todorova D, 2017, CIRC RES, V120, P1658, DOI 10.1161/CIRCRESAHA.117.309681; Tunica DG, 2009, PROTEOMICS, V9, P4991, DOI 10.1002/pmic.200900065; UNEMORI EN, 1990, J BIOL CHEM, V265, P445; Verma S, 2006, BRAIN BEHAV IMMUN, V20, P449, DOI 10.1016/j.bbi.2005.10.005; WAGNER OF, 1992, J BIOL CHEM, V267, P16066; Yurchenco PD, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004911; Zanivan S, 2013, MOL CELL PROTEOMICS, V12, P3599, DOI 10.1074/mcp.M113.031344; ZERWES HG, 1987, J CELL BIOL, V105, P2037, DOI 10.1083/jcb.105.5.2037; Zhang LC, 2017, METHODS MOL BIOL, V1550, P185, DOI 10.1007/978-1-4939-6747-6_14; Zhang XF, 2007, MICROVASC RES, V74, P90, DOI 10.1016/j.mvr.2007.04.007	45	13	13	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2019	33	11					12277	12287		10.1096/fj.201900262R	http://dx.doi.org/10.1096/fj.201900262R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC8ZX	31431053	Green Submitted			2022-12-26	WOS:000507461600053
J	Wu, H; Jiang, X; Gao, YX; Liu, WH; Wang, F; Gong, ML; Chen, R; Yu, XQ; Zhang, WJ; Gao, B; Song, CY; Han, DS				Wu, Han; Jiang, Xing; Gao, Yunxiao; Liu, Weihua; Wang, Fei; Gong, Maolei; Chen, Ran; Yu, Xiaoqin; Zhang, Wenjing; Gao, Bo; Song, Chengyi; Han, Daishu			Mumps virus infection disrupts blood-testis barrier through the induction of TNF-alpha in Sertoli cells	FASEB JOURNAL			English	Article						male infertility; transepithelial electrical resistance; Occludin; ZO-1; spermatogenesis	NECROSIS-FACTOR-ALPHA; SYSTEMIC TREATMENT; ORCHITIS; INTERFERON-ALPHA-2B; MICROFILAMENTS; PERMEABILITY; INFERTILITY; RESPONSES; DYNAMICS; OCCLUDIN	Mumps virus (MuV) has high tropism to the testis and may lead to male infertility. Sertoli cells are the major targets of MuV infection. However, the mechanisms by which MuV infection impairs male fertility and Sertoli cell function remain unclear. The present study elucidated the effect of MuV infection on the blood-testis barrier (BTB). The transepithelial electrical resistance of MuV-infected mouse Sertoli cells was monitored, and the expression of major proteins of the BTB was examined. We demonstrated that MuV infection disrupted the BTB by reducing the levels of occludin and zonula occludens 1. Sertoli cells derived from Tlr2(-/-) and Tnfa(-/-) mice were analyzed for mediating MuV-induced impairment. TLR2-mediated TNF-alpha production by Sertoli cells in response to MuV infection impaired BTB integrity. MuV-impaired BTB was not observed in Tlr2(-/-) and Tnfa(-/-) Sertoli cells. Moreover, an inhibitor of TNF-alpha, pomalidomide, prevents the disruption of BTB in response to MuV infection. FITC-labeled biotin tracing assay confirmed that BTB permeability and spermatogenesis were transiently impaired by MuV infection in vivo. These findings suggest that the disruption of the BTB could be one of the mechanisms underlying MuV-impaired male fertility, in which TNF-alpha could play a critical role.	[Wu, Han; Gao, Bo; Song, Chengyi] Yangzhou Univ, Inst Mobilome & Genome, Coll Anim Sci & Technol, 88 Daxue South Rd, Yangzhou 225009, Jiangsu, Peoples R China; [Wu, Han; Jiang, Xing; Liu, Weihua; Wang, Fei; Gong, Maolei; Chen, Ran; Yu, Xiaoqin; Zhang, Wenjing; Han, Daishu] Chinese Acad Med Sci, Peking Union Med Coll, Inst Basic Med Sci, Beijing, Peoples R China; [Jiang, Xing] Shenzhen Univ, Sch Med, Guangdong Key Lab Genome Stabil & Dis Prevent, Shenzhen, Peoples R China; [Gao, Yunxiao] China Japan Friendship Hosp, Dept Androl, Beijing, Peoples R China	Yangzhou University; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Shenzhen University; China-Japan Friendship Hospital	Song, CY (corresponding author), Yangzhou Univ, Inst Mobilome & Genome, Coll Anim Sci & Technol, 88 Daxue South Rd, Yangzhou 225009, Jiangsu, Peoples R China.; Han, DS (corresponding author), Chinese Acad Med Sci, Peking Union Med Coll, Inst Basic Med Sci, Dept Cell Biol, 5 Dong Dan San Tiao, Beijing 100005, Peoples R China.	cysong@yzu.edu.cn; dshan@ibms.pumc.edu.cn	song, chengyi/AHA-9123-2022; Zhang, Wenjing/G-5932-2012	song, chengyi/0000-0002-0488-4718; Zhang, Wenjing/0000-0001-6931-900X	Chinese Academy of Medical Sciences (CAMS) Initiative for Innovative Medicine [2017-IZM-BR-06, 2017-IZM-3-007]; Major State Basic Research Project of China [2016YFA0101001, 2018YFC1003902]; National Natural Science Foundation of China [1701430]; China Postdoctoral Science Foundation [2017M611931]	Chinese Academy of Medical Sciences (CAMS) Initiative for Innovative Medicine; Major State Basic Research Project of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	The authors thank Prof. Qihan Li (Institute of Medical Biology, Chinese Academy of Medical Sciences, Kunming, China) for the gift of mumps virus strain. The authors also thank LetPub (Shanghai, China) for its linguistic assistance during the preparation of this manuscript. This work was supported by grants from the Chinese Academy of Medical Sciences (CAMS) Initiative for Innovative Medicine (Grants 2017-IZM-B&R-06 and 2017-IZM-3-007), the Major State Basic Research Project of China (Grants 2016YFA0101001 and 2018YFC1003902), the National Natural Science Foundation of China (Grant 1701430), and the China Postdoctoral Science Foundation (Grant 2017M611931). The authors declare no conflicts of interest.	ADAMOPOULOS DA, 1978, BMJ-BRIT MED J, V1, P1177, DOI 10.1136/bmj.1.6121.1177; AIMAN J, 1980, J CLIN ENDOCR METAB, V50, P380, DOI 10.1210/jcem-50-2-380; Brainard J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004475; Coffin KM, 2018, CELL HOST MICROBE, V24, P405, DOI 10.1016/j.chom.2018.08.003; Davis NF, 2010, BJU INT, V105, P1060, DOI 10.1111/j.1464-410X.2009.09148.x; ERPENBACH KHJ, 1991, J UROLOGY, V146, P54, DOI 10.1016/S0022-5347(17)37713-3; Govero J, 2016, NATURE, V540, P438, DOI 10.1038/nature20556; HEW KW, 1993, BIOL REPROD, V49, P840, DOI 10.1095/biolreprod49.4.840; HUME DA, 1984, ANAT REC, V210, P503, DOI 10.1002/ar.1092100311; Hviid A, 2008, LANCET, V371, P932, DOI 10.1016/S0140-6736(08)60419-5; Jacobo P, 2011, AUTOIMMUN REV, V10, P201, DOI 10.1016/j.autrev.2010.09.026; Jalal H, 2004, J MED VIROL, V73, P147, DOI 10.1002/jmv.10544; Jiang Q, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0834-0; Jiang Q, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.560; Ku JH, 1999, BJU INT, V84, P839; Lane TM, 2006, BJU INT, V97, P1, DOI 10.1111/j.1464-410X.2006.05869.x; Le Tortorec A, 2008, HUM REPROD, V23, P2095, DOI 10.1093/humrep/den207; Li MWM, 2006, J ENDOCRINOL, V190, P313, DOI 10.1677/joe.1.06781; Liang Y, 2014, HUM VACC IMMUNOTHER, V10, P1382, DOI 10.4161/hv.28334; Lie PPY, 2011, FASEB J, V25, P1244, DOI 10.1096/fj.10-169995; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lui WY, 2001, ENDOCRINOLOGY, V142, P1865, DOI 10.1210/en.142.5.1865; Ma WQ, 2016, CELL, V167, P1511, DOI 10.1016/j.cell.2016.11.016; Masarani M, 2006, J ROY SOC MED, V99, P573, DOI 10.1258/jrsm.99.11.573; Matheron S, 2016, CLIN INFECT DIS, V63, DOI 10.1093/cid/ciw509; Meng J, 2005, P NATL ACAD SCI USA, V102, P16696, DOI 10.1073/pnas.0506084102; Mruk DD, 2015, ENDOCR REV, V36, P681, DOI [10.1210/er.2015-1127, 10.1210/er.2014-1101]; Patel LN, 2017, CLIN INFECT DIS, V64, P408, DOI 10.1093/cid/ciw762; Philip J, 2006, BJU INT, V97, P138, DOI 10.1111/j.1464-410X.2006.05902.x; Rubin S, 2015, J PATHOL, V235, P242, DOI 10.1002/path.4445; RUTHER U, 1995, EUR UROL, V27, P174; Salam AP, 2017, EMERG INFECT DIS, V23, P1922, DOI 10.3201/eid2311.171049; Sharpe RM, 2003, REPRODUCTION, V125, P769, DOI 10.1530/rep.0.1250769; Sheng ZY, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00272; Siu MKY, 2003, ENDOCRINOLOGY, V144, P371, DOI 10.1210/en.2002-220786; Tsigos C, 1999, J INTERF CYTOK RES, V19, P1271, DOI 10.1089/107999099312948; Wiebe JP, 2000, J ANDROL, V21, P625; Willocks LJ, 2017, EPIDEMIOL INFECT, V145, P3219, DOI [10.1017/S0950268817002102, 10.1017/s0950268817002102]; Wu H, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00117; Wu H, 2016, SCI REP-UK, V6, DOI 10.1038/srep19507; Xia WL, 2009, DEV BIOL, V327, P48, DOI 10.1016/j.ydbio.2008.11.028; XIONG YT, 1993, ENDOCRINOLOGY, V132, P2438, DOI 10.1210/en.132.6.2438; YULE TD, 1988, J IMMUNOL, V141, P1161; Zeng XK, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2017.113; Zhao ST, 2014, CELL MOL IMMUNOL, V11, P428, DOI 10.1038/cmi.2014.38	45	26	29	0	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2019	33	11					12528	12540		10.1096/fj.201901089R	http://dx.doi.org/10.1096/fj.201901089R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC8ZX	31450968	Green Published			2022-12-26	WOS:000507461600072
J	Parvathaneni, S; Sharma, S				Parvathaneni, Swetha; Sharma, Sudha			The DNA repair helicase RECQ1 has a checkpoint-dependent role in mediating DNA damage responses induced by gemcitabine	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA helicase; DNA damage response; anticancer drug; breast cancer; checkpoint control; DNA repair; gemcitabine; genome stability; missense mutation; RecQ; replication stress	REPLICATION FORKS; UNWINDING ACTIVITY; STRAND-SEPARATION; CELL-DEATH; ACTIVATION; RESTART; BINDING; ATR; RECOMBINATION; POLYMERASE	The response of cancer cells to therapeutic drugs that cause DNA damage depends on genes playing a role in DNA repair. RecQ-like helicase 1 (RECQ1), a DNA repair helicase, is critical for genome stability, and loss-of-function mutations in the RECQ1 gene are associated with increased susceptibility to breast cancer. In this study, using a CRISPR/Cas9-edited cell-based model, we show that the genetic or functional loss of RECQ1 sensitizes MDA-MB-231 breast cancer cells to gemcitabine, a nucleoside analog used in chemotherapy for triple-negative breast cancer. RECQ1 loss led to defective ATR Ser/Thr kinase (ATR)/checkpoint kinase 1 (ChK1) activation and greater DNA damage accumulation in response to gemcitabine treatment. Dual deficiency of MUS81 structure-specific endonuclease subunit (MUS81) and RECQ1 increased gemcitabine-induced, replication-associated DNA double-stranded breaks. Consistent with defective checkpoint activation, a ChK1 inhibitor further sensitized RECQ1-deficient cells to gemcitabine and increased cell death. Our results reveal an important role for RECQ1 in controlling cell cycle checkpoint activation in response to gemcitabine-induced replication stress.	[Parvathaneni, Swetha; Sharma, Sudha] Howard Univ, Dept Biochem & Mol Biol, Coll Med, Washington, DC 20059 USA; [Sharma, Sudha] Howard Univ, Natl Human Genome Ctr, Coll Med, Washington, DC 20059 USA	Howard University; Howard University	Sharma, S (corresponding author), Howard Univ, Dept Biochem & Mol Biol, Coll Med, Washington, DC 20059 USA.	sudha.sharma@howard.edu	Sharma, Sudha/AAV-6152-2021	Sharma, Sudha/0000-0003-2765-2482	NIGMS, National Institutes of Health [SC1GM093999]; National Science Foundation [NSF1832163]; NIA, National Institutes of Health [1R25 AG047843]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [SC1GM093999] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R25AG047843] Funding Source: NIH RePORTER	NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Science Foundation(National Science Foundation (NSF)); NIA, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by NIGMS, National Institutes of Health Grant SC1GM093999 and National Science Foundation Grant NSF1832163. This work was also supported by NIA, National Institutes of Health Grant 1R25 AG047843. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Arora A, 2017, MOL CANCER THER, V16, P239, DOI 10.1158/1535-7163.MCT-16-0290; Awasthi P, 2016, J CELL SCI, V129, P1285, DOI 10.1242/jcs.188631; Banerjee T, 2015, CURR BIOL, V25, P2830, DOI 10.1016/j.cub.2015.09.026; Berti M, 2013, NAT STRUCT MOL BIOL, V20, P347, DOI 10.1038/nsmb.2501; Bowden AR, 2019, BREAST CANCER RES TR, V174, P553, DOI 10.1007/s10549-018-05096-6; Bugreev DV, 2008, J BIOL CHEM, V283, P20231, DOI 10.1074/jbc.M801582200; Cliby WA, 2002, J BIOL CHEM, V277, P1599, DOI 10.1074/jbc.M106287200; Cortez D, 2001, SCIENCE, V294, P1713, DOI 10.1126/science.1065521; Cortez D, 2005, GENE DEV, V19, P1007, DOI 10.1101/gad.1316905; Cortez D, 2019, MOL CELL, V74, P866, DOI 10.1016/j.molcel.2019.04.027; Croteau DL, 2014, ANNU REV BIOCHEM, V83, P519, DOI 10.1146/annurev-biochem-060713-035428; Cui S, 2003, J BIOL CHEM, V278, P1424, DOI 10.1074/jbc.M209407200; Cui S, 2004, NUCLEIC ACIDS RES, V32, P2158, DOI 10.1093/nar/gkh540; Cybulski C, 2015, NAT GENET, V47, P643, DOI 10.1038/ng.3284; Doherty KM, 2005, J BIOL CHEM, V280, P28085, DOI 10.1074/jbc.M500265200; Hanada K, 2007, NAT STRUCT MOL BIOL, V14, P1096, DOI 10.1038/nsmb1313; Hengel SR, 2017, CELL CHEM BIOL, V24, P1101, DOI 10.1016/j.chembiol.2017.08.027; Im MM, 2016, RADIAT RES, V186, P466, DOI 10.1667/RR14443.1; Imreh G, 2011, J CELL SCI, V124, P2951, DOI 10.1242/jcs.081612; Jones RM, 2014, MOL CANCER THER, V13, P2412, DOI 10.1158/1535-7163.MCT-13-0862; Karnitz LM, 2005, MOL PHARMACOL, V68, P1636, DOI 10.1124/mol.105.012716; KAUFMANN SH, 1993, CANCER RES, V53, P3976; Lambert S, 2007, DNA REPAIR, V6, P1042, DOI 10.1016/j.dnarep.2007.02.024; Lemacon D, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01180-5; Li DH, 2006, J CLIN ONCOL, V24, P1720, DOI 10.1200/JCO.2005.04.4206; Liu JL, 2004, J BIOL CHEM, V279, P42794, DOI 10.1074/jbc.M405008200; Lucic B, 2011, NUCLEIC ACIDS RES, V39, P1703, DOI 10.1093/nar/gkq1031; Mansilla S, 2006, CELL CYCLE, V5, P53, DOI 10.4161/cc.5.1.2267; Mirzaei H, 2012, P NATL ACAD SCI USA, V109, P19357, DOI 10.1073/pnas.1210304109; Montano R, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-604; Parsels LA, 2016, CELL CYCLE, V15, P730, DOI 10.1080/15384101.2016.1148841; Parvathaneni S, 2017, ONCOTARGET, V8, P75924, DOI 10.18632/oncotarget.18237; Parvathaneni S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062481; Pike ACW, 2009, P NATL ACAD SCI USA, V106, P1039, DOI 10.1073/pnas.0806908106; PLUNKETT W, 1995, SEMIN ONCOL, V22, P3; Pommier Y, 2010, CHEM BIOL, V17, P421, DOI 10.1016/j.chembiol.2010.04.012; Popuri V, 2012, CELL CYCLE, V11, P4252, DOI 10.4161/cc.22581; PURANAM KL, 1994, J BIOL CHEM, V269, P29838; Qiu ZJ, 2018, RADIOTHER ONCOL, V126, P450, DOI 10.1016/j.radonc.2017.09.043; Regairaz M, 2011, J CELL BIOL, V195, P739, DOI 10.1083/jcb.201104003; Sakurikar N, 2016, ONCOTARGET, V7, P1380, DOI 10.18632/oncotarget.6364; Salic A, 2008, P NATL ACAD SCI USA, V105, P2415, DOI 10.1073/pnas.0712168105; Sami F, 2016, MUTAT RES-FUND MOL M, V790, P8, DOI 10.1016/j.mrfmmm.2016.05.005; Sami F, 2015, BIOCHEM J, V468, P227, DOI 10.1042/BJ20141021; Shaltiel IA, 2015, J CELL SCI, V128, P607, DOI 10.1242/jcs.163766; Sharma S, 2005, J BIOL CHEM, V280, P28072, DOI 10.1074/jbc.M500264200; Sharma S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001297; Sharma S, 2007, MOL CELL BIOL, V27, P1784, DOI 10.1128/MCB.01620-06; Sharma S, 2012, DNA REPAIR, V11, P537, DOI 10.1016/j.dnarep.2012.04.003; Sun J, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005228; Symington LS, 2016, CRIT REV BIOCHEM MOL, V51, P195, DOI 10.3109/10409238.2016.1172552; Thangavel S, 2015, J CELL BIOL, V208, P545, DOI 10.1083/jcb.201406100; Viziteu E, 2017, LEUKEMIA, V31, P2104, DOI 10.1038/leu.2017.54; Warren NJH, 2019, J BIOL CHEM, V294, P1763, DOI 10.1074/jbc.RA118.005231; Woodrick J, 2017, EMBO J, V36, P1605, DOI 10.15252/embj.201694920; Zellweger R, 2015, J CELL BIOL, V208, P563, DOI 10.1083/jcb.201406099; Zhang J, 2015, INT J CANCER, V136, P204, DOI 10.1002/ijc.28966; Zhao H, 2001, MOL CELL BIOL, V21, P4129, DOI 10.1128/MCB.21.13.4129-4139.2001; Zhou BBS, 2000, NATURE, V408, P433, DOI 10.1038/35044005	59	11	11	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 18	2019	294	42					15330	15345		10.1074/jbc.RA119.008420	http://dx.doi.org/10.1074/jbc.RA119.008420			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JQ9HM	31444271	Green Published, hybrid			2022-12-26	WOS:000499248700012
J	Clement-Zhao, A; Tanguy, ML; Cottu, P; De La Lande, B; Bontemps, P; Lemanski, C; Baumann, P; Savignoni, A; Levy, C; Peignaux, K; Reynaud-Bougnoux, A; Gobillion, A; Kirova, Y				Clement-Zhao, Alice; Tanguy, Marie-Laure; Cottu, Paul; De La Lande, Brigitte; Bontemps, Patrick; Lemanski, Claire; Baumann, Pierre; Savignoni, Alexia; Levy, Christelle; Peignaux, Karine; Reynaud-Bougnoux, Agnes; Gobillion, Aline; Kirova, Youlia			Toxicity of locoregional radiotherapy in combination with bevacizumab in patients with non-metastatic breast cancer (TOLERAB): Final long-term evaluation	PLOS ONE			English	Article							PHASE-II; RADIATION-THERAPY; CONCURRENT BEVACIZUMAB; SINGLE-ARM; CHEMOTHERAPY; CARCINOMA; TRIAL; CAPECITABINE; TRASTUZUMAB; GEMCITABINE	Background and purpose Few data are available concerning the safety of bevacizumab (B) in combination with locoregional radiation therapy (RT). The objective of this study was to evaluate the 5-year late toxicity of concurrent B and RT in non-metastatic breast cancer. Materials and methods This multicentre prospective study included non-metastatic breast cancer patients enrolled in phase 3 clinical trials evaluating B with concurrent RT versus RT alone. All patients received neoadjuvant or adjuvant chemotherapy and normofractionated breast or chest wall RT, with or without regional lymph node RT. B was administered at an equivalent dose of 5 mg/kg once a week for 1 year. The safety profile was evaluated 1, 3 and 5 years after completion of radiotherapy. Results A total of 64 patients were included between November 2007 and April 2010. Median followup was 60 months (12-73) and 5-year late toxicity data were available for 46 patients. The majority of tumours were triple-negative (68.8%), tumour size < 2cm (41.3%) with negative nodal status (50.8%). Median total dose of B was 15,000mg and median duration was 11.2 months. No grade >= 3 toxicity was observed. Only 8 patients experienced grade 1-2 toxicities: n = 3 (6.5%) grade 1 lymphedema, n = 2 (4.3%) grade 1 pain, n = 1 (2.2%) grade 2 lymphedema, n = 1 (2.2%) grade 1 fibrosis. Five-year overall survival was 93.8%, diseasefree survival was 89% and locoregional recurrence-free survival was 93.1%. Conclusion Concurrent B and locoregional RT are associated with acceptable 5-year toxicity in patients with non-metastatic breast cancer. No grade >= 3 toxicity was observed.	[Clement-Zhao, Alice; Kirova, Youlia] Inst Curie, Radiotherapy Dept, Paris, France; [Tanguy, Marie-Laure; Savignoni, Alexia; Gobillion, Aline] Inst Curie, Biostat Dept, Paris, France; [Cottu, Paul] Inst Curie, Oncol Dept, Paris, France; [De La Lande, Brigitte] Rene Huguenin Hosp, Inst Curie, Radiotherapy Dept, St Cloud, France; [Bontemps, Patrick] CHU Jean Minjoz, Radiotherapy Dept, Besancon, France; [Lemanski, Claire] Inst Reg Canc Montpellier, Radiotherapy Dept, Montpellier, France; [Baumann, Pierre] Ctr Oncol Gentilly, Radiotherapy Dept, Nancy, France; [Levy, Christelle] Ctr Francois Baclesse, Radiotherapy Dept, Caen, France; [Peignaux, Karine] Ctr Georges Francois Leclerc, Radiotherapy Dept, Dijon, France; [Reynaud-Bougnoux, Agnes] CHU Tours, Radiat Oncol Dept, Tours, France	UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Rene Huguenin Hospital; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Universite de Franche-Comte; CHU Besancon; UNICANCER; Universite de Montpellier; Institut Regional du Cancer Montpellier / Val d'Aurelle (ICM); UNICANCER; Centre Francois Baclesse; UNICANCER; Centre Georges-Francois Leclerc; CHU Tours	Clement-Zhao, A (corresponding author), Inst Curie, Radiotherapy Dept, Paris, France.	alice.clement313@gmail.com	Cottu, Paul/ABC-8595-2020					Bell R, 2017, ANN ONCOL, V28, P754, DOI 10.1093/annonc/mdw665; Bertucci F, 2016, LANCET ONCOL, V17, P600, DOI 10.1016/S1470-2045(16)00011-5; Cameron D, 2013, LANCET ONCOL, V14, P933, DOI 10.1016/S1470-2045(13)70335-8; Chinot OL, 2014, NEW ENGL J MED, V370, P709, DOI 10.1056/NEJMoa1308345; Crane CH, 2006, J CLIN ONCOL, V24, P1145, DOI 10.1200/JCO.2005.03.6780; Crane CH, 2009, J CLIN ONCOL, V27, P4096, DOI 10.1200/JCO.2009.21.8529; Dautruche A, 2018, CANCER RADIOTHER, V22, P222, DOI 10.1016/j.canrad.2017.10.004; Dings RPM, 2007, CLIN CANCER RES, V13, P3395, DOI 10.1158/1078-0432.CCR-06-2441; Goyal S, 2011, INT J RADIAT ONCOL, V79, P408, DOI 10.1016/j.ijrobp.2009.11.021; HARRIS JR, 1979, INT J RADIAT ONCOL, V5, P257, DOI 10.1016/0360-3016(79)90729-6; Jacob J, 2014, BREAST CANCER RES TR, V148, P345, DOI 10.1007/s10549-014-3166-5; Kumler I, 2014, CANCER TREAT REV, V40, P960, DOI 10.1016/j.ctrv.2014.05.006; Le Scodan R, 2009, J CLIN ONCOL, V27, P1375, DOI 10.1200/JCO.2008.19.5396; Lee NY, 2012, LANCET ONCOL, V13, P172, DOI 10.1016/S1470-2045(11)70303-5; Miles D, 2018, EUR J CANCER, V90, P153, DOI 10.1016/j.ejca.2017.10.018; Miles D, 2017, EUR J CANCER, V70, P146, DOI 10.1016/j.ejca.2016.09.024; Miller K, 2007, NEW ENGL J MED, V357, P2666, DOI 10.1056/NEJMoa072113; Pernin V, 2015, BRIT J RADIOL, V88, DOI 10.1259/bjr.20140800; Pernin V, 2014, BREAST, V23, P816, DOI 10.1016/j.breast.2014.08.015; Pierga JY, 2012, LANCET ONCOL, V13, P375, DOI 10.1016/S1470-2045(12)70049-9; Relf M, 1997, CANCER RES, V57, P963; Schefter TE, 2012, INT J RADIAT ONCOL, V83, P1179, DOI 10.1016/j.ijrobp.2011.10.060; Slamon DJ, 2013, CANCER RES, V73, DOI 10.1158/0008-5472.SABCS13-S1-03; Small W, 2011, INT J RADIAT ONCOL, V80, P476, DOI 10.1016/j.ijrobp.2010.02.030; Socinski MA, 2012, J CLIN ONCOL, V30, P3953, DOI 10.1200/JCO.2012.41.9820; Spigel DR, 2010, J CLIN ONCOL, V28, P43, DOI 10.1200/JCO.2009.24.7353; Vuky J, 2012, INT J RADIAT ONCOL, V82, pE609, DOI 10.1016/j.ijrobp.2011.09.002	27	4	4	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2019	14	8							e0221816	10.1371/journal.pone.0221816	http://dx.doi.org/10.1371/journal.pone.0221816			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW6BO	31469859	Green Published, Green Submitted, gold			2022-12-26	WOS:000485062200032
J	Dyskova, T; Kriegova, E; Slobodova, Z; Zehnalova, S; Kudelka, M; Schneiderova, P; Fillerova, R; Gallo, J				Dyskova, Tereza; Kriegova, Eva; Slobodova, Zuzana; Zehnalova, Sarka; Kudelka, Milos; Schneiderova, Petra; Fillerova, Regina; Gallo, Jiri			Inflammation time-axis in aseptic loosening of total knee arthroplasty: A preliminary study	PLOS ONE			English	Article							CEMENT-BONE INTERLOCK; NECROSIS-FACTOR-ALPHA; OSTEOCLAST DIFFERENTIATION; PERIPROSTHETIC OSTEOLYSIS; GENETIC SUSCEPTIBILITY; HIP-ARTHROPLASTY; JOINT FLUID; RESORPTION; MECHANISM; PATTERNS	Objective Aseptic loosening (AL) is the most frequent long-term reason for revision of total knee arthroplasty (TKA) affecting about 15-20% patients within 20 years after the surgery. Although there is a solid body of evidence about the crucial role of inflammation in the AL pathogenesis, scared information on inflammation signature and its time-axis in tissues around TKA exists. Design The inflammation protein signatures in pseudosynovial tissues collected at revision surgery from patients with AL (AL, n = 12) and those with no clinical/radiographic signs of AL (nonAL, n = 9) were investigated by Proximity Extension Assay (PEA)-Immunoassay and immunohistochemistry. Results AL tissues had elevated levels of TNF-family members sTNFR2, TNFSF14, sFasL, sBAFF, cytokines/chemokines IL8, CCL2, IL1RA/IL36, sIL6R, and growth factors sAREG, CSF1, comparing to non-AL. High interindividual variability in protein levels was evident particularly in non-AL. Levels of sTNFR2, sBAFF, IL8, sIL6R, and MPO discriminated between AL and non-AL and were associated with the time from index surgery, suggesting the cumulative character of inflammatory osteolytic response to prosthetic byproducts. The source of elevated inflammatory molecules was macrophages and multinucleated osteoclast-like cells in AL and histiocytes and osteoclast-like cells in non-AL tissues, respectively. All proteins were present in higher levels in osteoclast-like cells than in macrophages. Conclusions Our study revealed a differential inflammation signature between AL and non-AL stages of TKA. It also highlighted the unique patient's response to TKA in non-AL stages. Further confirmation of our preliminary results on a larger cohort is needed. Analysis of the time-axis of processes ongoing around TKA implantation may help to understand the mechanisms driving periprosthetic bone resorption needed for diagnostic/preventative strategies.	[Dyskova, Tereza; Kriegova, Eva; Schneiderova, Petra; Fillerova, Regina] Palacky Univ Olomouc, Fac Med & Dent, Dept Immunol, Olomouc, Czech Republic; [Dyskova, Tereza; Kriegova, Eva; Slobodova, Zuzana; Schneiderova, Petra; Fillerova, Regina; Gallo, Jiri] Univ Hosp Olomouc, Olomouc, Czech Republic; [Zehnalova, Sarka; Kudelka, Milos] VSB Tech Univ Ostrava, Dept Comp Sci, Fac Elect Engn & Comp Sci, Ostrava, Czech Republic; [Gallo, Jiri] Palacky Univ Olomouc, Dept Orthopaed, Fac Med & Dent, Olomouc, Czech Republic	Palacky University Olomouc; University Hospital Olomouc; Technical University of Ostrava; Palacky University Olomouc	Gallo, J (corresponding author), Palacky Univ Olomouc, Dept Orthopaed, Fac Med & Dent, Olomouc, Czech Republic.	jiri.gallo@volny.cz	Kudelka, Milos/D-8457-2014	Kudelka, Milos/0000-0002-7219-1008; Kriegova, Eva/0000-0002-8969-4197; Gallo, Jiri/0000-0002-7424-8653	Grant Agency of Ministry of Health of the Czech Republic (AZV MZ CR) [VES16-31852A]; MH CZ - DRO [00098892]	Grant Agency of Ministry of Health of the Czech Republic (AZV MZ CR); MH CZ - DRO	JG received the Grant Agency of Ministry of Health of the Czech Republic (AZV MZ CR VES16-31852A), in part by the MH CZ - DRO (FNOL, 00098892). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004; Assarsson E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095192; Athanasou NA, 2016, BONE JOINT RES, V5, P162, DOI 10.1302/2046-3758.55.BJR-2016-0086; Bendre MS, 2005, CANCER RES, V65, P11001, DOI 10.1158/0008-5472.CAN-05-2630; Bendre MS, 2003, BONE, V33, P28, DOI 10.1016/S8756-3282(03)00086-3; Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008; Brunetti G, 2014, ONCOTARGET, V5, P12950, DOI 10.18632/oncotarget.2633; Catelas Isabelle, 2010, Instr Course Lect, V59, P3; Chaganti RK, 2014, CLIN ORTHOP RELAT R, V472, P584, DOI 10.1007/s11999-013-3235-9; Cooper HJ, 2014, EXPERT REV PROTEOMIC, V11, P5, DOI 10.1586/14789450.2014.865522; Cyndari KI, 2017, J ARTHROPLASTY, V32, P2289, DOI 10.1016/j.arth.2017.01.047; Dasa V, 2012, CLIN ORTHOP RELAT R, V470, P1879, DOI 10.1007/s11999-011-2191-5; Del Buono A, 2012, BRIT MED BULL, V101, P39, DOI 10.1093/bmb/ldr011; Eastwood SE, 2015, HIP INT, V25, P355, DOI 10.5301/hipint.5000241; Evans JT, 2019, LANCET, V393, P655, DOI 10.1016/S0140-6736(18)32531-5; Fahlgren A, 2010, ACTA ORTHOP, V81, P508, DOI 10.3109/17453674.2010.504610; Feng W, 2017, SCI REP-UK, V7, DOI 10.1038/srep41411; Flecher X, 2009, J CLIN IMMUNOL, V29, P681, DOI 10.1007/s10875-009-9305-9; Gallo J, 2013, ACTA BIOMATER, V9, P8046, DOI 10.1016/j.actbio.2013.05.005; Gallo J, 2008, NEW MICROBIOL, V31, P97; Gallo J, 2014, ACTA BIOMATER, V10, P2354, DOI 10.1016/j.actbio.2014.02.003; Goodheart JR, 2017, J ORTHOP RES, V35, P2773, DOI 10.1002/jor.23586; Greenfield EM, 2014, CLIN ORTHOP RELAT R, V472, P3709, DOI 10.1007/s11999-014-3786-4; Hallab NJ, 2017, FRONT ENDOCRINOL, V8, DOI 10.3389/fendo.2017.00005; He T, 2013, INT ORTHOP, V37, P1025, DOI 10.1007/s00264-013-1837-1; Jiang XY, 2016, J ORTHOP RES, V34, P58, DOI 10.1002/jor.22977; Khan UA, 2016, J CELL BIOCHEM, V117, P382, DOI 10.1002/jcb.25282; Kitaura H, 2005, J CLIN INVEST, V115, P3418, DOI 10.1172/JCI26132; Kobayashi K, 2000, J EXP MED, V191, P275, DOI 10.1084/jem.191.2.275; Konttinen YT, 2005, CLIN ORTHOP RELAT R, P28, DOI 10.1097/01.blo.0000150451.50452.da; Kudelka M, 2017, LECT NOTES COMPUTER; Landgraeber S, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/185150; Lee YM, 2010, INT IMMUNOL, V22, P805, DOI 10.1093/intimm/dxq431; Lu X, 2009, GENE DEV, V23, P1882, DOI 10.1101/gad.1824809; Mbalaviele G, 2017, J CLIN INVEST, V127, P2030, DOI 10.1172/JCI93356; Mukka SS, 2017, J ARTHROPLASTY, V32, P3219, DOI 10.1016/j.arth.2017.05.030; Nabeshima A, 2017, BIOMATERIALS, V117, P1, DOI 10.1016/j.biomaterials.2016.11.039; Nason R, 2009, JARO-J ASSOC RES OTO, V10, P151, DOI 10.1007/s10162-008-0153-8; Novack DV, 2003, J EXP MED, V198, P771, DOI 10.1084/jem.20030116; Ogle ME, 2016, EXP BIOL MED, V241, P1084, DOI 10.1177/1535370216650293; Pajarinen J, 2017, TISSUE ENG PART C-ME, V23, P1003, DOI [10.1089/ten.TEC.2017.0166, 10.1089/ten.tec.2017.0166]; Panagopoulos V, 2017, MOL CELL ENDOCRINOL, V440, P8, DOI 10.1016/j.mce.2016.11.007; Park H, 2005, J IMMUNOL, V175, P7193, DOI 10.4049/jimmunol.175.11.7193; Pathak JL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131041; Petrackova A, 2017, CLIN PROTEOM, V14, DOI 10.1186/s12014-017-9167-8; Pinol I, 2014, KNEE, V21, P402, DOI 10.1016/j.knee.2013.10.013; Schneiderova P, 2017, ONCOTARGET, V8, P69408, DOI 10.18632/oncotarget.11242; Shanbhag AS, 2007, J BONE JOINT SURG AM, V89A, P1081, DOI 10.2106/JBJS.F.00330; Sharkey PF, 2014, J ARTHROPLASTY, V29, P1774, DOI 10.1016/j.arth.2013.07.024; Takacova S, 2012, CANCER CELL, V21, P517, DOI 10.1016/j.ccr.2012.01.021; Taverna S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03460-y; Tomankova T, 2014, OSTEOARTHR CARTILAGE, V22, P1851, DOI 10.1016/j.joca.2014.08.004; Turcsanyi P, 2019, LEUKEMIA RES, V79, P60, DOI 10.1016/j.leukres.2019.02.005; Vallabhapurapu S, 2009, ANNU REV IMMUNOL, V27, P693, DOI 10.1146/annurev.immunol.021908.132641; Wei S, 2005, J CLIN INVEST, V115, P282, DOI 10.1172/JCI200523394; Willert HG, 1996, CLIN ORTHOP RELAT R, P4	56	9	10	3	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2019	14	8							e0221056	10.1371/journal.pone.0221056	http://dx.doi.org/10.1371/journal.pone.0221056			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW6BO	31469844	gold, Green Published, Green Submitted			2022-12-26	WOS:000485062200010
J	Baltin, C; Kron, F; Urbanski, A; Zander, T; Kron, A; Berlth, F; Kleinert, R; Hallek, M; Hoelscher, AH; Chon, SH				Baltin, Christoph; Kron, Florian; Urbanski, Alexander; Zander, Thomas; Kron, Anna; Berlth, Felix; Kleinert, Robert; Hallek, Michael; Hoelscher, Arnulf Heinrich; Chon, Seung-Hun			The economic burden of endoscopic treatment for anastomotic leaks following oncological Ivor Lewis esophagectomy	PLOS ONE			English	Article							GASTROENTEROLOGY; DIAGNOSIS; STENT	Background Complications after surgery for esophageal cancer are associated with significant resource utilization. The aim of this study was to analyze the economic burden of two frequently used endoscopic treatments for anastomotic leak management after esophageal surgery: Treatment with a Self-expanding Metal Stent (SEMS) and Endoscopic Vacuum Therapy (EVT). Materials and methods Between January 2012 and December 2016, we identified 60 German-Diagnosis Related Group (G-DRG) cases of patients who received a SEMS and / or EVT for esophageal anastomotic leaks. Direct costs per case were analyzed according to the Institute for Remuneration System in Hospitals (InEK) cost-accounting approach by comparing DRG payments on the case level, including all extra fees per DRG catalogue. Results In total, 60 DRG cases were identified. Of these, 15 patients were excluded because they received a combination of SEMS and EVT. Another 6 cases could not be included due to incomplete DRG data. Finally, N = 39 DRG cases were analyzed from a profit-center perspective. A further analysis of the most frequent DRG code-G03-including InEK cost accounting, revealed almost twice the deficit for the EVT group (N = 13 cases, (sic) - 9.282 per average case) compared to that for the SEMS group (N = 9 cases, (sic) - 5.156 per average case). Conclusion Endoscopic treatments with SEMS and EVT for anastomotic leaks following oncological Ivor Lewis esophagectomies are not cost-efficient for German hospitals. Due to longer hospitalization and insufficient reimbursements, EVT is twice as costly as SEMS treatment. An adequate DRG cost compensation is needed for SEMS and EVT.	[Baltin, Christoph] Univ Hosp Cologne, Dept Orthoped & Trauma Surg, Cologne, Germany; [Kron, Florian; Zander, Thomas; Kron, Anna] FOM Univ Appl Sci, Essen, Germany; [Kron, Florian; Hallek, Michael] Univ Hosp Cologne, Dept Internal Med Med 1, Cologne, Germany; [Urbanski, Alexander; Kleinert, Robert; Chon, Seung-Hun] Univ Hosp Cologne, Dept Gen Visceral & Canc Surg, Cologne, Germany; [Berlth, Felix] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Gen Visceral & Transplant Surg, Mainz, Germany; [Hoelscher, Arnulf Heinrich] AGAPLES Markus Krankenhaus, Ctr Esophageal & Gastr Surg, Frankfurt, Germany	University of Cologne; University of Cologne; University of Cologne; Johannes Gutenberg University of Mainz	Chon, SH (corresponding author), Univ Hosp Cologne, Dept Gen Visceral & Canc Surg, Cologne, Germany.	Seung-Hun.Chon@uk-koeln.de	Hallek, Michael/Y-3191-2019	Hallek, Michael/0000-0002-7425-4455; Chon, Seung-Hun/0000-0002-8923-6428; Berlth, Felix/0000-0002-3780-0728				Alanezi Khaled, 2004, Ann Thorac Cardiovasc Surg, V10, P71; Baltin CT, 2018, CHIRURG, V89, P229, DOI 10.1007/s00104-018-0590-9; Berlth F, 2018, J GASTROINTEST SURG; Bootsma BT, 2018, INT J SURG, V54, P113, DOI 10.1016/j.ijsu.2018.04.045; Brangewitz M, 2013, ENDOSCOPY, V45, P433, DOI 10.1055/s-0032-1326435; Goense L, 2017, EJSO-EUR J SURG ONC, V43, P696, DOI 10.1016/j.ejso.2016.11.013; Griffin SM, 2001, BRIT J SURG, V88, P1346, DOI 10.1046/j.0007-1323.2001.01918.x; Guo L W, 2017, Zhonghua Liu Xing Bing Xue Za Zhi, V38, P102, DOI 10.3760/cma.j.issn.0254-6450.2017.01.020; Mennigen R, 2015, J GASTROINTEST SURG, V19, P1229, DOI 10.1007/s11605-015-2847-7; Rathmayer M, 2015, Z GASTROENTEROL, V53, P183, DOI 10.1055/s-0034-1399199; Rathmayer M, 2017, Z GASTROENTEROL, V55, P1038, DOI 10.1055/s-0043-118350; Schreyogg Jonas, 2006, Health Care Manag Sci, V9, P269, DOI 10.1007/s10729-006-9094-0; Tan SS, 2014, EUR J PUBLIC HEALTH, V24, P1023, DOI 10.1093/eurpub/cku025; Vogl M, 2012, HEALTH ECON REV, V2, DOI 10.1186/2191-1991-2-15; Wilke MH, 2016, VISC MED, V32, P29, DOI 10.1159/000443652	15	9	10	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2019	14	8							e0221406	10.1371/journal.pone.0221406	http://dx.doi.org/10.1371/journal.pone.0221406			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5XV	31461487	Green Published, Green Submitted, gold			2022-12-26	WOS:000485052300031
J	Hoffman, JD; Yanckello, LM; Chlipala, G; Hammond, TC; McCulloch, SD; Parikh, I; Sun, S; Morganti, JM; Green, SJ; Lin, AL				Hoffman, Jared D.; Yanckello, Lucille M.; Chlipala, George; Hammond, Tyler C.; McCulloch, Scott D.; Parikh, Ishita; Sun, Sydney; Morganti, Josh M.; Green, Stefan J.; Lin, Ai-Ling			Dietary inulin alters the gut microbiome, enhances systemic metabolism and reduces neuroinflammation in an APOE4 mouse model	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; SCYLLO-INOSITOL; AMYLOID-BETA; SUPPLEMENTATION; INFLAMMATION; PREBIOTICS; PHENOTYPE; MICROGLIA; GENOTYPE; BACTERIA	The apolipoprotein epsilon 4 allele (APOE4) is the strongest genetic risk factor for Alzheimer's disease (AD). APOE4 carriers develop systemic metabolic dysfunction decades before showing AD symptoms. Accumulating evidence shows that the metabolic dysfunction accelerates AD development, including exacerbated amyloid-beta (A beta) retention, neuroinflammation and cognitive decline. Therefore, preserving metabolic function early on may be critical to reducing the risk for AD. Here, we show that inulin increases beneficial microbiota and decreases harmful microbiota in the feces of young, asymptomatic APOE4 transgenic (E4FAD) mice and enhances metabolism in the cecum, periphery and brain, as demonstrated by increases in the levels of SCFAs, tryptophan-derived metabolites, bile acids, glycolytic metabolites and scyllo-inositol. We show that inulin also reduces inflammatory gene expression in the hippocampus. This knowledge can be utilized to design early precision nutrition intervention strategies that use a prebiotic diet to enhance systemic metabolism and may be useful for reducing AD risk in asymptomatic APOE4 carriers.	[Hoffman, Jared D.; Yanckello, Lucille M.; Hammond, Tyler C.; Parikh, Ishita; Sun, Sydney; Morganti, Josh M.; Lin, Ai-Ling] Univ Kentucky, Sanders Brown Ctr Aging, Lexington, KY 40536 USA; [Hoffman, Jared D.; Yanckello, Lucille M.; Lin, Ai-Ling] Univ Kentucky, Dept Pharmacol & Nutr Sci, Lexington, KY 40506 USA; [Chlipala, George; Green, Stefan J.] Univ Illinois, Res Resources Ctr, Chicago, IL USA; [Hammond, Tyler C.; Morganti, Josh M.; Lin, Ai-Ling] Univ Kentucky, Dept Neurosci, Lexington, KY 40506 USA; [McCulloch, Scott D.] Metabolon Inc, Durham, NC USA; [Parikh, Ishita] Oklahoma Med Res Fdn, 825 NE 13th St, Oklahoma City, OK 73104 USA; [Morganti, Josh M.] Univ Kentucky, Spinal Cord & Brain Injury Res Ctr, Lexington, KY USA; [Lin, Ai-Ling] Univ Kentucky, Joseph Halcomb III MD Dept Biomed Engn, Lexington, KY 40506 USA	University of Kentucky; University of Kentucky; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Kentucky; Metabolon; Oklahoma Medical Research Foundation; University of Kentucky; University of Kentucky	Lin, AL (corresponding author), Univ Kentucky, Sanders Brown Ctr Aging, Lexington, KY 40536 USA.; Lin, AL (corresponding author), Univ Kentucky, Dept Pharmacol & Nutr Sci, Lexington, KY 40506 USA.; Lin, AL (corresponding author), Univ Kentucky, Dept Neurosci, Lexington, KY 40506 USA.; Lin, AL (corresponding author), Univ Kentucky, Joseph Halcomb III MD Dept Biomed Engn, Lexington, KY 40506 USA.	ailing.lin@uky.edu	Morganti, Josh/AAL-9727-2020	Morganti, Josh/0000-0002-4183-0049; Green, Stefan/0000-0003-2781-359X; Chlipala, George/0000-0003-0203-3191	NIH (NIA) [R01AG054459, R01AG062480]; NIH (ODS) [R01AG054459, R01AG062480]; NIH/CTSA [UL1TR000117]; American Federation for Aging Research [A12474]; NIH/NIA [R21AG058006]; NIH/NIDDK [T32DK007778]; S10 NIH Shared Instrumentation Program Grant [1S10RR029541-01]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007778] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG054459, R21AG058006] Funding Source: NIH RePORTER	NIH (NIA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIH (ODS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH/CTSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); American Federation for Aging Research; NIH/NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIH/NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); S10 NIH Shared Instrumentation Program Grant; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported by NIH grants R01AG054459 (funded by NIA and ODS), R01AG062480, NIH/CTSA grant UL1TR000117, and American Federation for Aging Research Grant #A12474 to A-LL and NIH/NIA R21AG058006 to JMM, and NIH/NIDDK Training Grant T32DK007778 to JDH and LMY. The 7T ClinScan small animal MRI scanner of the UK was funded by the S10 NIH Shared Instrumentation Program Grant (1S10RR029541-01). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute on Aging or the National Institutes of Health. SDM is employed by Metabolon Inc.. Metabolon Inc. provided support in the form of salary for author SDM but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amato A, 2017, NUTRIENTS, V9, DOI 10.3390/nu9050492; Bitsch A, 1999, AM J NEURORADIOL, V20, P1619; Blacher E, 2017, J IMMUNOL, V198, P572, DOI 10.4049/jimmunol.1601247; Bloom GS, 2014, JAMA NEUROL, V71, P505, DOI 10.1001/jamaneurol.2013.5847; Boehme M, 2020, MOL PSYCHIATR, V25, P2567, DOI 10.1038/s41380-019-0425-1; Bonfili L, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02587-2; Bourassa MW, 2016, NEUROSCI LETT, V625, P56, DOI 10.1016/j.neulet.2016.02.009; Bredesen DE, 2016, AGING-US, V8, P1250, DOI 10.18632/aging.100981; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chen TT, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02995-4; Chyan YJ, 1999, J BIOL CHEM, V274, P21937, DOI 10.1074/jbc.274.31.21937; Correa RO, 2016, CLIN TRANSL IMMUNOL, V5, DOI 10.1038/cti.2016.17; Coudray C, 1997, EUR J CLIN NUTR, V51, P375, DOI 10.1038/sj.ejcn.1600417; Craft S, 2009, ARCH NEUROL-CHICAGO, V66, P300, DOI 10.1001/archneurol.2009.27; DeHaven CD, 2010, J CHEMINFORMATICS, V2, DOI 10.1186/1758-2946-2-9; Desai MS, 2016, CELL, V167, P1339, DOI 10.1016/j.cell.2016.10.043; Eagan Danielle E, 2012, Cardiovasc Psychiatry Neurol, V2012, P120540, DOI 10.1155/2012/120540; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Evans AM, 2009, ANAL CHEM, V81, P6656, DOI 10.1021/ac901536h; Evans M., 2014, METABOLOMICS, V4, P1, DOI DOI 10.4172/2153-0769.1000132; Fooks LJ, 2002, BRIT J NUTR, V88, pS39, DOI [10.1079/BJN2002628, 10.1079/BJNBJN2002591]; Fuller JP, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00235; Galimberti D, 2006, ARCH NEUROL-CHICAGO, V63, P538, DOI 10.1001/archneur.63.4.538; Gargari BP, 2013, DIABETES METAB J, V37, P140, DOI 10.4093/dmj.2013.37.2.140; Govindarajan K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167319; Green SJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128122; Guo J, 2015, FRONT AGING NEUROSCI, V7, DOI 10.3389/fnagi.2015.00213; Hadley W., 2016, GGPLOT2; Hamilton AL, 2018, CLIN MICROBIOL REV, V31, DOI 10.1128/CMR.00085-17; Hauptmann S, 2009, NEUROBIOL AGING, V30, P1574, DOI 10.1016/j.neurobiolaging.2007.12.005; Hoffman JD, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00298; Holmes E, 2012, CELL METAB, V16, P559, DOI 10.1016/j.cmet.2012.10.007; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Ishii M, 2015, CELL METAB, V22, P761, DOI 10.1016/j.cmet.2015.08.016; Johnson LA, 2017, SCI REP-UK, V7, DOI 10.1038/srep43701; Joyce SA, 2014, P NATL ACAD SCI USA, V111, P7421, DOI 10.1073/pnas.1323599111; Kang DM, 2017, BMC MICROBIOL, V17, DOI 10.1186/s12866-017-1065-8; Kelly G, 2008, ALTERN MED REV, V13, P315; Kovatcheva-Datchary P, 2015, CELL METAB, V22, P971, DOI 10.1016/j.cmet.2015.10.001; Krasemann S, 2017, IMMUNITY, V47, P566, DOI 10.1016/j.immuni.2017.08.008; Kuo SM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060270; Larsen OFA, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20141-6; Laukens D, 2016, FEMS MICROBIOL REV, V40, P117, DOI 10.1093/femsre/fuv036; Leszek J, 2017, CURR TOP MED CHEM, V17, P1331, DOI 10.2174/1568026617666170103163403; Ma D, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25190-5; McDonald D, 2012, ISME J, V6, P610, DOI 10.1038/ismej.2011.139; Minter MR, 2016, SCI REP-UK, V6, DOI 10.1038/srep30028; Modrego P, 2019, NEURODEGENER DIS MAN, V9, P119, DOI 10.2217/nmt-2019-0006; Nicholson JK, 2012, SCIENCE, V336, P1262, DOI 10.1126/science.1223813; Nicholson JK, 2003, NAT REV DRUG DISCOV, V2, P668, DOI 10.1038/nrd1157; Nishitsuji K, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16189-5; Nuzzo D, 2018, NUTRIENTS, V10, DOI 10.3390/nu10091130; O'Connor S, 2017, MATURITAS, V104, P11, DOI 10.1016/j.maturitas.2017.07.005; Oakley H, 2006, J NEUROSCI, V26, P10129, DOI 10.1523/JNEUROSCI.1202-06.2006; Oksanen J, 2022, R PACKAGE VERSION; Parbo P, 2018, NEUROBIOL DIS, V117, P211, DOI 10.1016/j.nbd.2018.06.004; Raber J, 2004, NEUROBIOL AGING, V25, P641, DOI 10.1016/j.neurobiolaging.2003.12.023; Rafii MS, 2017, J ALZHEIMERS DIS, V58, P401, DOI 10.3233/JAD-160965; Reiman EM, 2005, P NATL ACAD SCI USA, V102, P8299, DOI 10.1073/pnas.0500579102; Sharon G, 2014, CELL METAB, V20, P719, DOI 10.1016/j.cmet.2014.10.016; Sun YD, 2008, BIOORGAN MED CHEM, V16, P7177, DOI 10.1016/j.bmc.2008.06.045; Tai LM, 2017, J LIPID RES, V58, P1733, DOI 10.1194/jlr.R076315; Takahashi S, 2012, ASN NEURO, V4, P71, DOI 10.1042/AN20120002; Tao QS, 2018, JAMA NETW OPEN, V1, DOI 10.1001/jamanetworkopen.2018.3597; Torres-Perez E, 2016, ATHEROSCLEROSIS, V245, P35, DOI 10.1016/j.atherosclerosis.2015.11.029; Trauner M, 2005, J CLIN GASTROENTEROL, V39, pS111, DOI 10.1097/01.mcg.0000155551.37266.26; Trautwein EA, 1998, J NUTR, V128, P1937, DOI 10.1093/jn/128.11.1937; Tse JKY, 2017, ACS CHEM NEUROSCI, V8, P1438, DOI 10.1021/acschemneuro.7b00176; Uronis JM, 2011, INFLAMM BOWEL DIS, V17, P289, DOI 10.1002/ibd.21366; Voevodskaya O, 2016, NEUROLOGY, V86, P1754, DOI 10.1212/WNL.0000000000002672; Walter J, 2008, APPL ENVIRON MICROB, V74, P4985, DOI 10.1128/AEM.00753-08; Yasuda K, 2007, J NUTR, V137, P2399, DOI 10.1093/jn/137.11.2399; Youmans KL, 2012, J BIOL CHEM, V287, P41774, DOI 10.1074/jbc.M112.407957; Zdunczyk Z, 2004, ARCH ANIM NUTR, V58, P89, DOI 10.1080/00039420310001656703; Zhang JJ, 2014, BIOINFORMATICS, V30, P614, DOI 10.1093/bioinformatics/btt593; Zhao LP, 2018, SCIENCE, V359, P1151, DOI 10.1126/science.aao5774; Zhu M, 2014, J NEUROPATH EXP NEUR, V73, P362, DOI 10.1097/NEN.0000000000000060	77	44	44	3	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2019	14	8							e0221828	10.1371/journal.pone.0221828	http://dx.doi.org/10.1371/journal.pone.0221828			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5XV	31461505	Green Published, gold, Green Submitted			2022-12-26	WOS:000485052300058
J	Lee, HW; Lee, SJ; Lee, MY; Park, MW; Kim, SS; Shin, N; Lovett, DH; Bae, SS; Ahn, J; Park, JS; Oh, JH; Choi, JH; Lee, HC; Cha, KS; Hong, TJ; Song, SH				Lee, Hye Won; Lee, Sun Ju; Lee, Min Young; Park, Mi Wha; Kim, Sang Sik; Shin, Nari; Lovett, David H.; Bae, Sun Sik; Ahn, Jinhee; Park, Jin-Sup; Oh, Jun-Hyok; Choi, Jung Hyun; Lee, Han Cheol; Cha, Kwang Soo; Hong, Taek Jong; Song, Sang Heon			Enhanced cardiac expression of two isoforms of matrix metalloproteinase-2 in experimental diabetes mellitus	PLOS ONE			English	Article							MYOCARDIAL-INFARCTION; HEART-FAILURE; DYSFUNCTION; INHIBITION; MECHANISMS; MODEL; MMPS	Background Diabetic cardiomyopathy (DM CMP) is defined as cardiomyocyte damage and ventricular dysfunction directly associated with diabetes independent of concomitant coronary artery disease or hypertension. Matrix metalloproteinases (MMPs), especially MMP-2, have been reported to underlie the pathogenesis of DM CMP by increasing extracellular collagen content. Purpose We hypothesized that two discrete MMP-2 isoforms (full length MMP-2, FL-MMP-2; N-terminal truncated MMP-2, NTT-MMP-2) are induced by high glucose stimulation in vitro and in an experimental diabetic heart model. Methods Rat cardiomyoblasts (H9C2 cells) were examined to determine whether high glucose can induce the expression of the two isoforms of MMP-2. For the in vivo study, we used the streptozotocin-induced DM mouse heart model and age-matched controls. The changes of each MMP-2 isoform expression in the diabetic mice hearts were determined using quantitative real-time polymerase chain reaction (qRT-PCR). Immunohistochemical stains were conducted to identify the location and patterns of MMP-2 isoform expression. Echocardiography was performed to compare and analyze the changes in cardiac function induced by diabetes. Results Quantitative RT-PCR and immunofluorescence staining showed that the two MMP-2 isoforms were strongly induced by high glucose stimulation in H9C2 cells. Although no definite histologic features of diabetic cardiomyopathy were observed in diabetic mice hearts, left ventricular systolic dysfunction was determined by echocardiography. Quantitative RT-PCR and IHC staining showed this abnormal cardiac function was accompanied with the increases in the mRNA levels of the two isoforms of MMP-2 and related to intracellular localization. Conclusion Two isoforms of MMP-2 were induced by high glucose stimulation in vitro and in a Type 1 DM mouse heart model. Further study is required to examine the role of these isoforms in DM CMP.	[Lee, Hye Won; Lee, Sun Ju; Lee, Min Young; Park, Mi Wha; Kim, Sang Sik; Ahn, Jinhee; Park, Jin-Sup; Oh, Jun-Hyok; Choi, Jung Hyun; Lee, Han Cheol; Cha, Kwang Soo; Hong, Taek Jong; Song, Sang Heon] Pusan Natl Univ Hosp, Biomed Res Inst, Dept Internal Med, Busan, South Korea; [Shin, Nari] Hanmaeum Changwon Hosp, Dept Pathol, Chang Won, South Korea; [Lovett, David H.] Univ Calif San Francisco, Dept Med, San Francisco Vet Affairs Med Ctr, San Francisco, CA USA; [Bae, Sun Sik] Pusan Natl Univ, Sch Med, MRC Ischem Tissue Regenerat Med Res Inst, Yangsan, South Korea; [Bae, Sun Sik] Pusan Natl Univ, Sch Med, Dept Pharmacol, Yangsan, South Korea	Pusan National University; Pusan National University Hospital; University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA); San Francisco VA Medical Center; Pusan National University; Pusan National University Hospital; Pusan National University; Pusan National University Hospital	Song, SH (corresponding author), Pusan Natl Univ Hosp, Biomed Res Inst, Dept Internal Med, Busan, South Korea.	shsong0209@gmail.com	jin sup, park/GRJ-7388-2022	Shin, Nari/0000-0001-8743-3615	National Research Foundation of Korea (NRF) - Korea government (MSIP) [NRF-2017R1C1B1010962, 2016R1A2B4008243]; Department of Veterans Affairs Merit Review Award [I-1BX000593]; National Institute of Diabetes, Digestive and Kidney Disease grant [RO1DK39776]	National Research Foundation of Korea (NRF) - Korea government (MSIP); Department of Veterans Affairs Merit Review Award(US Department of Veterans Affairs); National Institute of Diabetes, Digestive and Kidney Disease grant	This work was supported by a National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIP) (NRF-2017R1C1B1010962). Sang Heon Song was supported by a National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIP) (2016R1A2B4008243). DHL was supported by Department of Veterans Affairs Merit Review Award I-1BX000593 and National Institute of Diabetes, Digestive and Kidney Disease grant RO1DK39776. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali MAM, 2012, J CELL PHYSIOL, V227, P3397, DOI 10.1002/jcp.24040; Ali MAM, 2010, CIRCULATION, V122, P2039, DOI 10.1161/CIRCULATIONAHA.109.930222; Aon MA, 2015, ANTIOXID REDOX SIGN, V22, P1563, DOI 10.1089/ars.2014.6123; Asbun J, 2006, J AM COLL CARDIOL, V47, P693, DOI 10.1016/j.jacc.2005.09.050; Bergman MR, 2006, AM J PHYSIOL-HEART C, V292, pH1847; Brauer PR, 2006, FRONT BIOSCI-LANDMRK, V11, P447, DOI 10.2741/1810; Creemers EEJM, 2001, CIRC RES, V89, P201, DOI 10.1161/hh1501.094396; Falcao-Pires I, DIABETIC CARDIOMYOPA; Falcao-Pires I, 2012, HEART FAIL REV, V17, P325, DOI 10.1007/s10741-011-9257-z; Galloway CA, MITOCHONDRIAL DYNAMI; Hughes BG, 2014, BASIC RES CARDIOL, V109, DOI 10.1007/s00395-014-0424-y; Janssens S, 2006, CARDIOVASC RES, V69, P585, DOI 10.1016/j.cardiores.2005.12.010; KANNEL WB, 1974, AM J CARDIOL, V34, P29, DOI 10.1016/0002-9149(74)90089-7; Kim SS, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171625; King MK, 2003, CIRC RES, V92, P177, DOI 10.1161/01.RES.0000052312.41419.55; Liu Q, 2014, J DIABETES INVEST, V5, P623, DOI 10.1111/jdi.12250; Lovett DH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068154; Lovett DH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034177; Lovett DH, 2014, FRONT PHYSIOL, V5, P1, DOI [10.3389/fphys.2014.00001, DOI 10.3389/FPHYS.2014.00001]; Mizushige K, 2000, CIRCULATION, V101, P899, DOI 10.1161/01.CIR.101.8.899; Nilsson L, 2012, HEART, V98, P31, DOI 10.1136/heartjnl-2011-300079; Ong SB, 2010, CARDIOVASC RES, V88, P16, DOI 10.1093/cvr/cvq237; Peterson JT, 2001, CIRCULATION, V103, P2303; Sariahmetoglu M, 2007, FASEB J, V21, P2486, DOI 10.1096/fj.06-7938com; Shen X, 2004, AM J PHYSIOL-ENDOC M, V287, pE896, DOI 10.1152/ajpendo.00047.2004; Shirakabe A, 2012, J CARDIOL, V59, P374, DOI 10.1016/j.jjcc.2012.01.009; Spinale FG, 2007, PHYSIOL REV, V87, P1285, DOI 10.1152/physrev.00012.2007; Strongin AY, 2006, CANCER METAST REV, V25, P87, DOI 10.1007/s10555-006-7892-y; Van Eyk JE, 1998, BREAKDOWN AND RELEAS; Viappiani S, 2009, BIOCHEM PHARMACOL, V77, P826, DOI 10.1016/j.bcp.2008.11.004; Voulgari C, VASC HLTH RISK MANAG; Wang GY, 2006, CARDIOVASC RES, V69, P688, DOI 10.1016/j.cardiores.2005.08.023; Wang WJ, 2002, CIRCULATION, V106, P1543, DOI 10.1161/01.CIR.0000028818.33488.7B; Wold LE, 2005, J MOL CELL CARDIOL, V39, P297, DOI 10.1016/j.yjmcc.2005.03.014; Yu XC, 2007, CARDIOVASC DIABETOL, V6, DOI 10.1186/1475-2840-6-6; Zhang SW, 2005, CIRCULATION, V111, P3457, DOI 10.1161/CIRCULATIONAHA.104.523563	36	13	15	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2019	14	8							e0221798	10.1371/journal.pone.0221798	http://dx.doi.org/10.1371/journal.pone.0221798			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5XV	31461499	Green Submitted, Green Published, gold			2022-12-26	WOS:000485052300056
J	Li, G; Kolomenskiy, D; Liu, H; Thiria, B; Godoy-Diana, R				Li, Gen; Kolomenskiy, Dmitry; Liu, Hao; Thiria, Benjamin; Godoy-Diana, Ramiro			On the energetics and stability of a minimal fish school	PLOS ONE			English	Article							TAIL BEAT FREQUENCY; COLLECTIVE MOTION; HYDRODYNAMICS; SIMULATIONS; KINEMATICS; SINGLE; BODY	The physical basis for fish schooling is examined using three-dimensional numerical simulations of a pair of swimming fish, with kinematics and geometry obtained from experimental data. Energy expenditure and efficiency are evaluated using a cost of transport function, while the effect of schooling on the stability of each swimmer is examined by probing the lateral force and the lateral and longitudinal force fluctuations. We construct full maps of the aforementioned quantities as functions of the spatial pattern of the swimming fish pair and show that both energy expenditure and stability can be invoked as possible reasons for the swimming patterns and tail-beat synchronization observed in real fish. Our results suggest that high cost of transport zones should be avoided by the fish. Wake capture may be energetically unfavorable in the absence of kinematic adjustment. We hereby hypothesize that fish may restrain from wake capturing and, instead, adopt side-to-side configuration as a conservative strategy, when the conditions of wake energy harvesting are not satisfied. To maintain a stable school configuration, compromise between propulsive efficiency and stability, as well as between school members, ought to be considered.	[Li, Gen; Kolomenskiy, Dmitry] Japan Agcy Marine Earth Sci & Technol JAMSTEC, Yokohama, Kanagawa, Japan; [Liu, Hao] Chiba Univ, Grad Sch Engn, Chiba, Japan; [Thiria, Benjamin; Godoy-Diana, Ramiro] Univ Paris Diderot, Sorbonne Univ, ESPCI Paris PSL Res Univ,CNRS, Lab Phys & Mecan Milieux Heterogenes,PMMH,UMR 763, Paris, France	Japan Agency for Marine-Earth Science & Technology (JAMSTEC); Chiba University; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Ecole Superieure de Physique et de Chimie Industrielles de la Ville de Paris (ESPCI); Sorbonne Universite; Universite Paris Cite	Li, G; Kolomenskiy, D (corresponding author), Japan Agcy Marine Earth Sci & Technol JAMSTEC, Yokohama, Kanagawa, Japan.	ligen@jamstec.go.jp; dkolomenskiy@jamstec.go.jp	Li/O-7610-2019; Kolomenskiy, Dmitry/H-3825-2019; Godoy-Diana, Ramiro/A-9284-2013	Li/0000-0002-4423-3266; Kolomenskiy, Dmitry/0000-0003-0107-6894; Godoy-Diana, Ramiro/0000-0001-9561-2699; Liu, Hao/0000-0002-8687-3237	Japan Society for the Promotion of Science [JP17K17641, JP18K13693, 24120007]; Sasakawa Scientific Research Grant from The Japan Science Society [2018-7022]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Sasakawa Scientific Research Grant from The Japan Science Society	G.L. is funded by the Japan Society for the Promotion of Science (JP17K17641), and the Sasakawa Scientific Research Grant 2018-7022 from The Japan Science Society. D. K. is supported by the Japan Society for the Promotion of Science (JP18K13693). H.L. is partly supported by the Grant-in-Aid for Scientific Research on Innovative Areas of No. 24120007, Japan Society for the Promotion of Science.	Ashraf I, 2016, J R SOC INTERFACE, V13, DOI 10.1098/rsif.2016.0734; Becker AD, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9514; Bergmann M, 2011, J COMPUT PHYS, V230, P329, DOI 10.1016/j.jcp.2010.09.017; BREDER C. M., 1965, ZOOLOGICA NEW YORK, V50, P97; Brumley DR, 2014, ELIFE, V3, DOI 10.7554/eLife.02750; Czirok A, 1999, PHYSICA A, V264, P299, DOI 10.1016/S0378-4371(98)00468-3; Daghooghi M, 2015, BIOINSPIR BIOMIM, V10, DOI 10.1088/1748-3190/10/5/056018; Dai LZ, 2018, J R SOC INTERFACE, V15, DOI 10.1098/rsif.2018.0490; FIELDS PA, 1990, AM ZOOL, V30, pA134; Filella A, 2018, PHYS REV LETT, V120, DOI 10.1103/PhysRevLett.120.198101; Gazzola M, 2014, SIAM J SCI COMPUT, V36, pB622, DOI 10.1137/130943078; Gazzola M, 2011, J COMPUT PHYS, V230, P7093, DOI 10.1016/j.jcp.2011.04.025; Halsey LG, 2018, COMP BIOCHEM PHYS A, V218, P63, DOI 10.1016/j.cbpa.2018.01.015; Hemelrijk CK, 2015, FISH FISH, V16, P511, DOI 10.1111/faf.12072; Herskin J, 1998, J FISH BIOL, V53, P366, DOI 10.1006/jfbi.1998.0708; Hunt J.C.R., 1988, STUDYING TURBULENCE, V2; Johansen JL, 2010, MAR ECOL PROG SER, V420, P221, DOI 10.3354/meps08885; Kawamura Y, 2018, PHYS REV E, V97, DOI 10.1103/PhysRevE.97.022212; Li G, 2019, HYDRODYNAMIC C UNPUB; Li G., 2019, J ABMECH, V8, P27, DOI [10.5226/jabmech.8.27, DOI 10.5226/JABMECH.8.27]; Li G, 2016, J R SOC INTERFACE, V13, DOI 10.1098/rsif.2016.0068; Li G, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0848; Li G, 2012, J EXP BIOL, V215, P4015, DOI 10.1242/jeb.071837; Liao JC, 2007, PHILOS T R SOC B, V362, P1973, DOI 10.1098/rstb.2007.2082; Liu H, 2009, J COMPUT PHYS, V228, P439, DOI 10.1016/j.jcp.2008.09.020; Lopez U, 2012, INTERFACE FOCUS, V2, P693, DOI 10.1098/rsfs.2012.0033; Marras S, 2015, BEHAV ECOL SOCIOBIOL, V69, P219, DOI 10.1007/s00265-014-1834-4; Novati G, 2017, BIOINSPIR BIOMIM, V12, DOI 10.1088/1748-3190/aa6311; Park SG, 2018, J FLUID MECH, V840, P154, DOI 10.1017/jfm.2018.64; PARTRIDGE BL, 1982, SCI AM, V246, P114, DOI 10.1038/scientificamerican0682-114; Peng ZR, 2018, J FLUID MECH, V849, P1068, DOI 10.1017/jfm.2018.447; Prewitt NC, 2000, PROG AEROSP SCI, V36, P117, DOI 10.1016/S0376-0421(99)00013-5; Ristroph L, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.194502; Shaker K, 2016, PHYS SCI REV, V1, DOI 10.1515/psr-2016-0024; SHAW E, 1978, AM SCI, V66, P166; Verma S, 2018, P NATL ACAD SCI USA, V115, P5849, DOI 10.1073/pnas.1800923115; Vicsek T, 2012, PHYS REP, V517, P71, DOI 10.1016/j.physrep.2012.03.004; WEIHS D, 1973, NATURE, V241, P290, DOI 10.1038/241290a0; Zhu XJ, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.238105	43	20	21	3	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2019	14	8							e0215265	10.1371/journal.pone.0215265	http://dx.doi.org/10.1371/journal.pone.0215265			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5XV	31461457	Green Submitted, Green Published, gold			2022-12-26	WOS:000485052300003
J	Nam, KW; Kim, TJ; Lee, JS; Park, SH; Jeong, HB; Yoon, BW; Ko, SB				Nam, Ki-Woong; Kim, Tae Jung; Lee, Ji Sung; Park, Soo-Hyun; Jeong, Hae-Bong; Yoon, Byung-Woo; Ko, Sang-Bae			Neutrophil-to-lymphocyte ratio predicts early worsening in stroke due to large vessel disease	PLOS ONE			English	Article							NEUROLOGICAL DETERIORATION; ISCHEMIC-STROKE; INFLAMMATION; SEVERITY; STENOSIS; OUTCOMES	Background Inflammation plays an important role in atherosclerosis and its complications. Since a dysregulated inflammatory response is associated with early neurological deterioration (END), serum neutrophil-to-lymphocyte ratio (NLR) could be a marker of END as well. Aim In this study, we evaluated the relationship between the serum NLR and END in patients with ischemic stroke due to large-artery atherosclerosis (LAA). Methods We evaluated consecutive patients with ischemic stroke due to LAA between January 2010 and December 2015. END was defined as an increase. >= 2 on the total NIHSS score or. >= 1 on the motor NIHSS score within the first 72 hours of admission. The NLR was calculated by dividing the absolute neutrophil count by the absolute lymphocyte count. Results Of the 349 included patients, 18.1% (n = 63) had END events. In multivariate analysis, serum NLR was independently associated with END (adjusted odds ratio, 1.08; 95% confidence interval [1.00-1.16], P = 0.043). Time to admission, and in-situ thrombosis and artery-to-artery embolization mechanisms were also significantly associated with END events. In an analysis of the relationship between serum NLR and vascular lesion burden, serum NLR was positively correlated with both the degree of stenotic lesions (P for trend = 0.006) and the number of vessel stenosis (P for trend = 0.038) in a dose-response manner. We also compared serum NLR by the stroke mechanisms: patients with hypoperfusion or in-situ thrombosis had the highest levels of NLR: however, only those with in-situ thrombosis had significantly higher NLR in the END group compared to the non-END group (P = 0.005). Conclusions Serum NLR levels were associated with END events in patients with ischemic stroke due to LAA. Since NLR was also closely correlated with the underlying vascular lesions, our results indicated clues for mechanisms of END events.	[Nam, Ki-Woong; Kim, Tae Jung; Yoon, Byung-Woo; Ko, Sang-Bae] Seoul Natl Univ, Coll Med, Dept Neurol, Seoul, South Korea; [Nam, Ki-Woong; Kim, Tae Jung; Park, Soo-Hyun; Jeong, Hae-Bong; Yoon, Byung-Woo; Ko, Sang-Bae] Seoul Natl Univ Hosp, Dept Neurol, Seoul, South Korea; [Lee, Ji Sung] Asan Med Ctr, Clin Res Ctr, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital; Samsung; University of Ulsan; Asan Medical Center	Ko, SB (corresponding author), Seoul Natl Univ, Coll Med, Dept Neurol, Seoul, South Korea.; Ko, SB (corresponding author), Seoul Natl Univ Hosp, Dept Neurol, Seoul, South Korea.	sangbai1378@gmail.com			National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning [NRF-2013M3A9B2076531]	National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning	This study was supported in part by National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT & Future Planning (NRF-2013M3A9B2076531 to S-BK). The funding organization had no role in the design, conduct, or analysis conducted during this study, or in the preparation of this report.	ADAMS HP, 1993, STROKE, V24, P35, DOI 10.1161/01.STR.24.1.35; Al Kasab S, 2018, JOURNAL OF STROKE AN; Balta S, 2016, CLIN APPL THROMB-HEM, V22, P405, DOI 10.1177/1076029615569568; Bang OY, 2014, J STROKE, V16, P27, DOI 10.5853/jos.2014.16.1.27; Barnett HJM, 1998, NEW ENGL J MED, V339, P1415, DOI 10.1056/NEJM199811123392002; Bhat T, 2013, EXPERT REV CARDIOVAS, V11, P55, DOI [10.1586/erc.12.159, 10.1586/ERC.12.159]; Brooks SD, 2014, J NEUROINTERV SURG, V6, P578, DOI 10.1136/neurintsurg-2013-010780; Buyukkaya E, 2014, CLIN APPL THROMB-HEM, V20, P159, DOI 10.1177/1076029612459675; Chimowitz M, 2004, WARFARIN ASPIRIN SYM; Corriere T, 2018, NUTR METAB CARDIOVAS, V28, P23, DOI 10.1016/j.numecd.2017.10.022; Duan ZH, 2018, CEREBROVASC DIS, V45, P221, DOI 10.1159/000489401; Guo ZL, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0680-x; Hyun S, 2015, J STROKE CEREBROVASC, V24, P2646, DOI 10.1016/j.jstrokecerebrovasdis.2015.07.024; Imtiaz Fauzia, 2012, Int Arch Med, V5, P2, DOI 10.1186/1755-7682-5-2; Jiang H, 2017, J STROKE CEREBROVASC, V26, P1182, DOI 10.1016/j.jstrokecerebrovasdis.2017.01.002; Kang DW, 2007, ARCH NEUROL-CHICAGO, V64, P50, DOI 10.1001/archneur.64.1.50; Kim Jong S, 2005, J Clin Neurol, V1, P1, DOI 10.3988/jcn.2005.1.1.1; Kim TJ, 2019, EUR J NEUROL, V26, P261, DOI 10.1111/ene.13801; Koklu E, 2016, J STROKE CEREBROVASC, V25, P578, DOI 10.1016/j.jstrokecerebrovasdis.2015.10.031; Lang T, 2007, CHEST, V131, P628, DOI 10.1378/chest.06-2088; Lee DK, 2005, STROKE, V36, P2583, DOI 10.1161/01.STR.0000189999.19948.14; Lee SJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185314; Li TW, 2018, ANGIOLOGY, V69, P256, DOI 10.1177/0003319717718330; Libby P, 2002, CIRCULATION, V105, P1135, DOI 10.1161/hc0902.104353; Libby P, 2012, ARTERIOSCL THROM VAS, V32, P2045, DOI 10.1161/ATVBAHA.108.179705; Lind L, 2003, ATHEROSCLEROSIS, V169, P203, DOI 10.1016/S0021-9150(03)00012-1; Min K, 2017, J CLIN LAB ANAL, V31, DOI 10.1002/jcla.22041; Nam KW, 2017, EUR J NEUROL, V24, P617, DOI 10.1111/ene.13259; Nam KW, 2017, EUR J NEUROL, V24, P205, DOI 10.1111/ene.13184; Nam KW, 2018, ATHEROSCLEROSIS, V269, P117, DOI 10.1016/j.atherosclerosis.2017.12.035; Petrone L, 2016, CEREBROVASC DIS, V41, P87, DOI 10.1159/000442577; Siegler JE, 2011, INT J STROKE, V6, P211, DOI 10.1111/j.1747-4949.2011.00596.x; Smith CJ, 2015, STROKE, V46, P2335, DOI 10.1161/STROKEAHA.115.009617; Stott DJ, 2009, QJM-INT J MED, V102, P243, DOI 10.1093/qjmed/hcp012; Tokgoz S, 2014, J STROKE CEREBROVASC, V23, P2163, DOI 10.1016/j.jstrokecerebrovasdis.2014.04.007; Wahlgren N, 2008, STROKE, V39, P3316, DOI 10.1161/STROKEAHA.107.510768; Weimar C, 2005, ARCH NEUROL-CHICAGO, V62, P393, DOI 10.1001/archneur.62.3.393; Xue J, 2017, J STROKE CEREBROVASC, V26, P650, DOI 10.1016/j.jstrokecerebrovasdis.2016.11.010; Yamamoto N, 2017, J STROKE CEREBROVASC, V26, P1801, DOI 10.1016/j.jstrokecerebrovasdis.2017.04.011; Yu S, 2018, J NEUROL SCI, V387, P115, DOI 10.1016/j.jns.2018.02.002	40	16	16	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2019	14	8							e0221597	10.1371/journal.pone.0221597	http://dx.doi.org/10.1371/journal.pone.0221597			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5UR	31449547	gold, Green Submitted, Green Published			2022-12-26	WOS:000485044000025
J	Yoon, CI; Ahn, SG; Bae, SJ; Shin, YJ; Cha, C; Park, SE; Lee, JH; Ooshima, A; Lee, HS; Yang, KM; Kim, SJ; Park, SH; Jeong, J				Yoon, Chang Ik; Ahn, Sung Gwe; Bae, Soong June; Shin, Yun Jin; Cha, Chihwan; Park, So Eun; Lee, Ji-Hyung; Ooshima, Akira; Lee, Hye Sun; Yang, Kyung-Min; Kim, Seong-Jin; Park, Seok Hee; Jeong, Joon			High A20 expression negatively impacts survival in patients with breast cancer	PLOS ONE			English	Article							NF-KAPPA-B; TNFAIP3 A20; APOPTOSIS; CELLS; A20/TNFAIP3; METASTASIS; RESISTANCE; MUTATIONS; REGULATOR; GENES	Background A20 protein has ubiquitin-editing activities and acts as a key regulator of inflammation and immunity. Previously, our group showed that A20 promotes tumor metastasis through multi-monoubiquitylation of SNAIL1 in basal-like breast cancer. Here, we investigated survival outcomes in patients with breast cancer according to A20 expression. Patients and methods We retrospectively collected tumor samples from patients with breast cancer. Immunohistochemistry (IHC) with an A20-specific antibody was performed, and survival outcomes were analyzed. Results A20 expression was evaluated in 442 patients. High A20 expression was associated with advanced anatomical stage and young age. High A20 expression showed significantly inferior recurrence-free-survival and overall-survival (P<0.001 and P<0.001, respectively). Multivariate analysis showed that A20 was an independent prognostic marker for RFS (HRs: 2.324, 95% CIs: 1.446-3.736) and OS (HRs: 2.629, 95% CIs: 1.585-4.361). In human epidermal growth factor receptor 2 (HER2)-positive and triple negative breast cancer (TNBC) subtypes, high A20 levels were associated with poor OS. Conclusion We found that A20 expression is a poor prognostic marker in breast cancer. The prognostic impact of A20 was pronounced in aggressive tumors, such as HER2-positive and TNBC subtypes. Our findings suggested that A20 may be a valuable target in patients with aggressive breast cancer.	[Yoon, Chang Ik] Catholic Univ, Coll Med, St Marys Hosp, Dept Surg, Seoul, South Korea; [Ahn, Sung Gwe; Bae, Soong June; Cha, Chihwan; Park, So Eun; Jeong, Joon] Yonsei Univ, Coll Med, Gangnam Severance Hosp, Dept Surg, Seoul, South Korea; [Shin, Yun Jin] Yonsei Univ, Coll Med, Gangnam Severance Hosp, Seoul, South Korea; [Lee, Ji-Hyung; Park, Seok Hee] Sungkyunkwan Univ, Dept Biol Sci, Suwon, Gyeonggi Do, South Korea; [Ooshima, Akira; Yang, Kyung-Min; Kim, Seong-Jin] Yonsei Univ, Coll Med, Adv Inst Convergence Technol, Precis Med Res Ctr, Seoul, South Korea; [Lee, Hye Sun] Yonsei Univ, Coll Med, Biostat Collaborat Unit, Seoul, South Korea; [Kim, Seong-Jin] Seoul Natl Univ, Grad Sch Convergence Sci & Technol, Dept Transdisciplinary Studies, Suwon, Kyunggi Do, South Korea	Catholic University of Korea; Catholic University Korea Hospital; Seoul St. Mary's Hospital; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Sungkyunkwan University (SKKU); Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Seoul National University (SNU)	Jeong, J (corresponding author), Yonsei Univ, Coll Med, Gangnam Severance Hosp, Dept Surg, Seoul, South Korea.	gsjjoon@yuhs.ac	Cha, Chihwan/AAS-4502-2021; Lee, Hye Sun/J-2154-2015	Jeong, Joon/0000-0003-0397-0005; Ahn, Sung Gwe/0000-0002-8778-9686; Lee, Hye Sun/0000-0001-6328-6948; Yoon, Chang Ik/0000-0002-7273-8886; Park, Soeun/0000-0001-6421-2107; Bae, Soong June/0000-0002-0012-9694	Basic Science Research Program through the NRF - Ministry of Science, ICT, & Future Planning [NRF-2016R1D1A1A09917675]; National R&D Program for Cancer Control, Ministry of Health & Welfare, Republic of Korea [1520120]	Basic Science Research Program through the NRF - Ministry of Science, ICT, & Future Planning; National R&D Program for Cancer Control, Ministry of Health & Welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea)	This research was supported by the Basic Science Research Program through the NRF, funded by the Ministry of Science, ICT, & Future Planning (NRF-2016R1D1A1A09917675 to SGA), and grant from the National R&D Program for Cancer Control, Ministry of Health & Welfare, Republic of Korea (1520120). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn SG, 2013, BREAST CANCER RES TR, V141, P89, DOI 10.1007/s10549-013-2662-3; Bailey ST, 2014, MOL CANCER RES, V12, P408, DOI 10.1158/1541-7786.MCR-13-0206-T; Biswas DK, 2003, CANCER RES, V63, P290; Boone DL, 2004, NAT IMMUNOL, V5, P1052, DOI 10.1038/ni1110; Bosanac I, 2010, MOL CELL, V40, P548, DOI 10.1016/j.molcel.2010.10.009; Catrysse L, 2014, TRENDS IMMUNOL, V35, P22, DOI 10.1016/j.it.2013.10.005; Compagno M, 2009, NATURE, V459, P717, DOI 10.1038/nature07968; DIXIT VM, 1990, J BIOL CHEM, V265, P2973; Dong BF, 2012, BIOCHEM BIOPH RES CO, V418, P433, DOI 10.1016/j.bbrc.2012.01.056; Fouad TM, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0204372; Foulkes WD, 2010, NEW ENGL J MED, V363, P1938, DOI 10.1056/NEJMra1001389; GUERIN M, 1989, INT J CANCER, V43, P201, DOI 10.1002/ijc.2910430205; Guo QD, 2009, EXPERT OPIN THER TAR, V13, P733, DOI 10.1517/14728220903045018; Gupta P, 2014, MOL ONCOL, V8, P1532, DOI 10.1016/j.molonc.2014.06.006; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; Hjelmeland AB, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000319; Jaattela M, 1996, J IMMUNOL, V156, P1166; Jemal A, 2007, CA-CANCER J CLIN, V57, P43, DOI 10.3322/canjclin.57.1.43; Kato M, 2011, THE JAPANESE JOURNAL, V52, P313; Komander D, 2008, BIOCHEM J, V409, P77, DOI 10.1042/BJ20071399; Lee EG, 2000, SCIENCE, V289, P2350, DOI 10.1126/science.289.5488.2350; Lee JH, 2017, NAT CELL BIOL, V19, P1260, DOI 10.1038/ncb3609; Lerebours F, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-41; Li J, 2017, ONCOTARGET, V8, P114259, DOI 10.18632/oncotarget.23216; Lin SC, 2008, J MOL BIOL, V376, P526, DOI 10.1016/j.jmb.2007.11.092; Ma A, 2012, NAT REV IMMUNOL, V12, P774, DOI 10.1038/nri3313; Musone SL, 2008, NAT GENET, V40, P1062, DOI 10.1038/ng.202; Novak U, 2009, BLOOD, V113, P4918, DOI 10.1182/blood-2008-08-174110; Perou CM, 2011, ONCOLOGIST, V16, P61, DOI 10.1634/theoncologist.2011-S1-61; Schmitz R, 2009, J EXP MED, V206, P981, DOI 10.1084/jem.20090528; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Ueda Y, 2004, J BIOL CHEM, V279, P24505, DOI 10.1074/jbc.M400081200; Uno H, 2013, STAT MED, V32, P2430, DOI 10.1002/sim.5647; Vendrell JA, 2007, ONCOGENE, V26, P4656, DOI 10.1038/sj.onc.1210269; Wang Shizhen Emily, 2011, J Signal Transduct, V2011, P804236, DOI 10.1155/2011/804236; Wertz IE, 2004, NATURE, V430, P694, DOI 10.1038/nature02794; Wolff AC, 2007, J CLIN ONCOL, V25, P118, DOI 10.1200/JCO.2006.09.2775; Yang CZ, 2018, CANCER RES, V78, P1069, DOI 10.1158/0008-5472.CAN-17-2143	38	16	16	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2019	14	8							e0221721	10.1371/journal.pone.0221721	http://dx.doi.org/10.1371/journal.pone.0221721			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5UR	31449546	Green Published, gold, Green Submitted			2022-12-26	WOS:000485044000032
J	Das, A; Huang, XQ				Das, Anindya; Huang, Xiaoqiu			HPC: Hierarchical phylogeny construction	PLOS ONE			English	Article							TREES; EVOLUTION	Rapid improvements in DNA sequencing technology have resulted in long genome sequences for a large number of similar isolates with a wide range of single nucleotide polymorphism (SNP) rates, where some isolates can have thousands of times lower SNP rates than others. Genome sequences of this kind are a challenge to existing methods for construction of phylogenetic trees. We address the issues by developing a hierarchical approach to phylogeny construction. In this method, the construction is performed at multiple levels, where at each level, groups of isolates with similar levels of similarity are identified and their phylogenetic trees are constructed. Time savings are achieved by using a sufficiently large number of columns from the input alignment, instead of all its columns. Our results show that the new approach is 20-60 times more efficient than existing programs and more accurate in situations where highly similar isolates have a wide range of SNP rates.	[Das, Anindya; Huang, Xiaoqiu] Iowa State Univ, Dept Comp Sci, Ames, IA 50011 USA	Iowa State University	Huang, XQ (corresponding author), Iowa State Univ, Dept Comp Sci, Ames, IA 50011 USA.	xqhuang@iastate.edu						FELSENSTEIN J, 1981, J MOL EVOL, V17, P368, DOI 10.1007/BF01734359; FITCH WM, 1971, SYST ZOOL, V20, P406, DOI 10.2307/2412116; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Huang XQ, 2008, J COMPUT BIOL, V15, P129, DOI 10.1089/cmb.2007.0155; Huang XQ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158183; Kang YY, 2019, GENES-BASEL, V10, DOI 10.3390/genes10020073; Nguyen LT, 2015, MOL BIOL EVOL, V32, P268, DOI 10.1093/molbev/msu300; Lee TH, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-162; LEEKITCHAROENPHON, 2012, BMC GENOMICS S7, V13, DOI DOI 10.1186/1471-2164-13-S7-S6; NEYMAN J, 1971, STAT DECISION THEORY, P1; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Rambaut A, 1997, COMPUT APPL BIOSCI, V13, P235; ROBINSON DF, 1981, MATH BIOSCI, V53, P131, DOI 10.1016/0025-5564(81)90043-2; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; SANKOFF D, 1975, SIAM J APPL MATH, V28, P35, DOI 10.1137/0128004; SOKAL ROBERT R., 1958, UNIV KANSAS SCI BULL, V38, P1409; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Tavare S., 1986, LECT MATH LIFE SCI, V17, P57; YANG ZH, 1994, SYST BIOL, V43, P329, DOI 10.2307/2413672; Zielezinski A, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1319-7	20	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2019	14	8							e0221357	10.1371/journal.pone.0221357	http://dx.doi.org/10.1371/journal.pone.0221357			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5RZ	31437210	Green Submitted, Green Published, gold			2022-12-26	WOS:000485036900059
J	Mate, I; Come, CE; Goncalves, MP; Cliff, J; Gudo, ES				Mate, Inocencio; Come, Charlotte Elizabeth; Goncalves, Maria Patricia; Cliff, Julie; Gudo, Eduardo Samo			Knowledge, attitudes and practices regarding antibiotic use in Maputo City, Mozambique	PLOS ONE			English	Article							SELF-MEDICATION PRACTICES; ANTIMICROBIAL RESISTANCE; COMMUNITY PHARMACIES; PRESCRIPTION; CHILDREN; MANAGEMENT; TRENDS; MISUSE; ENUGU; SALE	Background Irrational use of antibiotics is a major driver of antimicrobial resistance (AMR) worldwide. Sub-Saharan Africa, where the risk of spread of AMR is highest, lacks data on the knowledge, attitudes and practices regarding antibiotic prescription and use. This is the first study in Mozambique to address this gap. Methods A cross-sectional study was conducted in 2016 in 1091 adults (age >= 18 years) living in five districts in peri-urban areas of Maputo City. Three stage cluster sampling was used to select the households. A semi-structured questionnaire was used to collect information on the knowledge, attitudes and practices regarding antibiotics and their use and socio-demographic data. Results Of the 1091 participants, 20.9% (228/1091) had used non-prescribed antibiotics. Most of the non-prescribed antibiotics were purchased in pharmacies (199/228; 87.3%). The proportion of use of non-prescribed antibiotics was higher in those who purchased from informal markets (82.6%; 14/17) and home stores (66.7%; 12/18), compared to pharmacies (24.6%; 199/810) (p = 0.000). Variables significantly associated with use of non-prescribed antibiotics were male gender (p = 0.004), living in the Central A (p<0.001), Aeroporto B (p<0.001) or 25 de Junho (p<0.001) neighborhoods, purchase of antibiotics in informal markets (p<0.002) or obtaining from home stores (p = 0.026), not completing the course (p<0.001) and having poor knowledge on the use of antibiotics (p<0.001). Main reasons for use of non-prescribed antibiotics were a perception that there was no need to attend a health facility (26.8%), followed by someone else's advice (7.7%), symptoms similar to a previous episode (6.2%) and poor quality of care in health facilities (6.7%). Conclusions Our study shows for the first time that knowledge regarding antibiotics is poor in Maputo City. Purchase of non-prescribed antibiotics is a common practice and most are sold in pharmacies, indicating deficient inspection. Interventions to reinforce adherence by pharmacies to current legislation for dispensing antibiotics, combined with community education are urgently needed.	[Mate, Inocencio; Come, Charlotte Elizabeth; Goncalves, Maria Patricia; Gudo, Eduardo Samo] Minist Hlth, Natl Inst Hlth, Maputo, Mozambique; [Cliff, Julie] Eduardo Mondlane Univ, Community Hlth Dept, Fac Med, Maputo, Mozambique	Eduardo Mondlane University	Gudo, ES (corresponding author), Minist Hlth, Natl Inst Hlth, Maputo, Mozambique.	esamogudojr@gmail.com		Cliff, Julie/0000-0002-3080-0311	African Field Epidemiology Network	African Field Epidemiology Network	This work was funded by African Field Epidemiology Network, http://www.afenet.net.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Faham Z, 2011, J INFECT DEV COUNTR, V5, P396, DOI 10.3855/jidc.1248; Al-Tawfiq JA, 2017, ANN THORAC MED, V12, P51, DOI 10.4103/1817-1737.197779; Arnold SR, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003539.pub2; Awad AI, 2007, ANN PHARMACOTHER, V41, P1249, DOI 10.1345/aph.1K068; Babatunde OA, 2016, PAN AFR MED J, V24, DOI 10.11604/pamj.2016.24.312.8146; Baskaradoss JK, 2018, BMC ORAL HEALTH, V18, DOI 10.1186/s12903-018-0640-1; Chalker J, 2005, SOC SCI MED, V60, P131, DOI 10.1016/j.socscimed.2004.04.019; Cheaito L, 2014, INT J PUBLIC HEALTH, V59, P319, DOI 10.1007/s00038-013-0493-y; Ekwochi U, 2014, J TROP PEDIATRICS, V60, P249, DOI 10.1093/tropej/fmt111; Ekwochi U, 2013, J TROP PEDIATRICS, V59, P314, DOI 10.1093/tropej/fmt016; Esimone CO, 2007, PHARM WORLD SCI, V29, P655, DOI 10.1007/s11096-007-9124-0; Farmacia M-CTdTe, 2007, FORMULARIO NACL MEDI; Goossens H, 2005, LANCET, V365, P579, DOI 10.1016/S0140-6736(05)17907-0; Hadi MA, 2016, INT J INFECT DIS, V47, P95, DOI 10.1016/j.ijid.2016.06.003; Hart CA, 1998, BRIT MED J, V317, P647, DOI 10.1136/bmj.317.7159.647; Jamhour A, 2017, AM J INFECT CONTROL, V45, P384, DOI 10.1016/j.ajic.2016.11.026; Kalungia AC, 2016, EXPERT REV ANTI-INFE, V14, P1215, DOI 10.1080/14787210.2016.1227702; Leung E, 2011, B WORLD HEALTH ORGAN, V89, P390, DOI 10.2471/BLT.11.088435; Mandomando I, 2007, J ANTIMICROB CHEMOTH, V60, P662, DOI 10.1093/jac/dkm257; Mandomando I, 2010, AM J TROP MED HYG, V83, P152, DOI 10.4269/ajtmh.2010.09-0578; MISAU, 2017, 141 MISAU; Morgan DJ, 2011, LANCET INFECT DIS, V11, P692, DOI 10.1016/S1473-3099(11)70054-8; Mshana SE, 2013, ANN CLIN MICROB ANTI, V12, DOI 10.1186/1476-0711-12-28; Napolitano F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084177; Okeke IN, 2005, LANCET INFECT DIS, V5, P481, DOI 10.1016/S1473-3099(05)70189-4; ONeill J., 2014, REV ANTIMICROB RESIS; Pan H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041314; Roca I., 2015, New Microbes and New Infections, V6, P22, DOI 10.1016/j.nmni.2015.02.007; Sabry NA, 2014, RES SOC ADMIN PHARM, V10, P168, DOI 10.1016/j.sapharm.2013.03.004; Saha S, 2017, BMC HEALTH SERV RES, V17, DOI 10.1186/s12913-017-2072-z; Santa-Ana-Tellez Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075550; Shehadeh M, 2012, SAUDI PHARM J, V20, P125, DOI 10.1016/j.jsps.2011.11.005; Tenover FC, 2006, AM J INFECT CONTROL, V34, pS3, DOI 10.1016/j.ajic.2006.05.219; Van Boeckel TP, 2014, LANCET INFECT DIS, V14, P742, DOI 10.1016/S1473-3099(14)70780-7; van der Meeren BT, 2013, SAMJ S AFR MED J, V103, P382, DOI [10.7196/SAMJ.5941, 10.7196/samj.5941, 10.7196/sam]; World Health Organization, 2014, ANTIMICROBIAL RESIST, VVolume 61, P383, DOI 10.1007/s13312-014-0374-3; World Health Organization, 2015, GLOB ACT PLAN AMR; Zajacova A, 2018, ANNU REV PUBL HEALTH, V39, P273, DOI 10.1146/annurev-publhealth-031816-044628; Zajmi D, 2017, PHARM PRACT-GRANADA, V15, DOI [10.18549/PharmPract.2017.01.827, 10.18549/pharmpract.2017.01.827]	39	15	15	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2019	14	8							e0221452	10.1371/journal.pone.0221452	http://dx.doi.org/10.1371/journal.pone.0221452			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5RZ	31437215	Green Submitted, Green Published, gold			2022-12-26	WOS:000485036900074
J	Mathes, KA; Radelof, K; Engelke, E; Rohn, K; Pfarrer, C; Fehr, M				Mathes, Karina A.; Radelof, Katharina; Engelke, Elisabeth; Rohn, Karl; Pfarrer, Christiane; Fehr, Michael			Specific anatomy and radiographic illustration of the digestive tract and transit time of two orally administered contrast media in Inland bearded dragons (Pogona vitticeps)	PLOS ONE			English	Article							TRACHEMYS-SCRIPTA-ELEGANS; GASTROINTESTINAL-TRACT; BARIUM-SULFATE; GREEN IGUANA; CELOMIC CAVITY; DISORDERS; RADIOLOGY; REPTILES; PASSAGE; SYSTEM	The aim of this study was to describe the specific gross and radiographic anatomy of the digestive tract of inland bearded dragons (Pogona vitticeps). Eleven bearded dragon cadavers of both sexes (6 females, 5 males) were dissected to examine, measure, and document the specific gross anatomy of the alimentary canal. Measurements collected from the cadavers included snout-vent length, total length of the alimentary canal, and the lengths of the individual sections of the gastrointestinal tract, including the esophagus, stomach, small intestine, ampulla coli, isthmus coli, rectum, and the distance from the coprodeum to the vent opening. Twenty-two healthy adult bearded dragons (13 females, 9 males) maintained under standardized husbandry conditions underwent a physical examination, blood collection, and whole-body dorsoventral and lateral survey radiographs; these animals were used to provide the radiographic images of the complete digestive tract. For the subsequent contrast passage studies, two different contrast media, barium sulfate (BaSO4, Barilux suspension) and an iodinated ionic radiocontrast agent (Sodium meglumine amidotrizoate [SMAT], Gastrografin), were used. Water-diluted Barilux suspension (dose 9 ml/kg) was administered orally to 5 bearded dragons, while Gastrografin (dose 5ml/kg) was administered orally to 21 bearded dragons. Four animals were used for both contrast media studies, but received a break of four weeks in between. Dorsoventral and laterolateral radiographs were collected at 0 (baseline), 15, 30, and 45 minutes and 1, 2, 3, 4, 5, 6, 8, 10, 12, 24, 30, and 36 hours after each contrast medium was administered. Both contrast media were found to illustrate the alimentary tracts in the adult bearded dragons. Transit time was substantially faster with SMAT, and SMAT illustrated the entire gastrointestinal tract within 36 hours; BaSO4 did not fully illustrate the gastrointestinal tract in 36 hours. These results might serve as a guideline for the interpretation of subsequent contrast studies in this lizard species.	[Mathes, Karina A.; Radelof, Katharina; Fehr, Michael] Univ Vet Med, Dept Reptiles & Amphibians, Clin Small Mammals Reptiles & Birds, Hannover, Germany; [Engelke, Elisabeth; Pfarrer, Christiane] Univ Vet Med Hannover, Inst Anat, Hannover, Germany; [Rohn, Karl] Univ Vet Med, Inst Biometry Epidemiol & Informat Proc, Hannover, Germany	University of Veterinary Medicine Hannover, Foundation; University of Veterinary Medicine Hannover, Foundation; University of Veterinary Medicine Hannover, Foundation	Mathes, KA (corresponding author), Univ Vet Med, Dept Reptiles & Amphibians, Clin Small Mammals Reptiles & Birds, Hannover, Germany.	karina.mathes@tiho-hannover.de		Mathes, Karina/0000-0003-2320-4578				Ashley LM, 1962, LAB ANATOMY TURTLE; Banzato T, 2013, ANAT HISTOL EMBRYOL, V42, P453, DOI 10.1111/ahe.12037; Banzato T, 2013, VET REC, V173, P43, DOI 10.1136/vr.101450; Banzato T, 2012, AM J VET RES, V73, P996, DOI 10.2460/ajvr.73.7.996; Banzato T, 2011, AM J VET RES, V72, P1592, DOI 10.2460/ajvr.72.12.1592; BARBOZA PS, 1995, J COMP PHYSIOL B, V165, P193; Baur M., 2003, UNTERSUCHUNGEN VERGL; Bayer SM, 2002, RONTGENOLOGISCHE UNT; Beregi A, 1999, ACTA VET HUNG, V47, P395, DOI 10.1556/AVet.47.1999.4.1; Bogdassarow AA, 1933, SAMMLUNG VERGIFTUNGS, V4, pA99, DOI [10.1007/bf02462657, DOI 10.1007/BF02462657]; Bojanus LH, 1970, ANATOME TESTUDINIS E, P1819; Bucy DS, 2015, JAVMA-J AM VET MED A, V246, P868, DOI 10.2460/javma.246.8.868; Cojean O, 2018, VET RADIOL ULTRASOUN, V59, P333, DOI 10.1111/vru.12599; De Voe Ryan S., 2014, Veterinary Clinics of North America Exotic Animal Practice, V17, P249, DOI 10.1016/j.cvex.2014.01.009; Di Bello A, 2006, VET RADIOL ULTRASOUN, V47, P351, DOI 10.1111/j.1740-8261.2006.00152.x; Diaz-Figueroa O., 2006, REPTILE MED SURG, P145, DOI DOI 10.1016/B0-72-169327-X/50016-X; Dictionaries EotAHM, 2007, AM HERITAGE MED DICT; Divers SJ, 1999, SEMIN AVIAN EXOT PET, V8, P122, DOI 10.1016/S1055-937X(99)80047-4; Franz R, 2011, COMP BIOCHEM PHYS A, V158, P94, DOI 10.1016/j.cbpa.2010.09.007; Grosset C, 2014, VET RADIOL ULTRASOUN, V55, P241, DOI 10.1111/vru.12128; Gunther P, 2013, TIERAERZTL PRAX K H, V41, P191; Hernandez-Divers S, 2001, IN PRACTICE, V23, P370; Holland MF, 2008, JAVMA-J AM VET MED A, V233, P590, DOI 10.2460/javma.233.4.590; Ihle J., 1971, ERNAHRUNGSORGANE VER, P518; Jacobshagen E., 1937, HDB VERGLEICHENDEN A; Kardong KV., 2015, RESP SYSTEM VERTEBRA; Karlo H., 2009, THESIS; Kohler G., 2003, BARTAGAMEN BIOL PFLE; Kophamel S, 2018, WIEN TIERARZTL MONAT, V105, P73; Lauridsen H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017879; Lebens M, 2016, SCHWEIZ ARCH TIERH, V158, P759, DOI 10.17236/sat00093; Long CT, 2010, VET RADIOL ULTRASOUN, V51, P42, DOI 10.1111/j.1740-8261.2009.01619.x; Luppa H., 1977, P225; Mans C, 2013, J EXOT PET MED, V22, P141, DOI 10.1053/j.jepm.2013.05.006; Mathes K., 2015, ECHSEN SCHLANGEN HEI, P163; Mathes KA, 2009, TIERAERZTL PRAX K H, V37, P427; Mathes KA, 2004, TIERAERZTL PRAX AUSG, P101; Mathes KA, 2017, AM J VET RES, V78, P1387, DOI 10.2460/ajvr.78.12.1387; Meyer J, 1998, J ZOO WILDLIFE MED, V29, P183; Meyer J., 1996, RONTGENOLOGISCHE COM; Mitchell MA, 2010, J EXOT PET MED, V19, P56, DOI 10.1053/j.jepm.2010.01.015; Mitchell Mark A., 2005, Veterinary Clinics of North America Exotic Animal Practice, V8, P277, DOI 10.1016/j.cvex.2005.01.008; Muller PM, 2010, BARTAGAMEN GATTUNG P; Nickel R, 2004, LEHRBUCH ANATOMIE HA, VII; Olayinka-Adefemi F, 2017, WEST AFR J RADIOL, V24, P147; Parsons T.S., 1977, P159; Peters G., 1985, HDB ZOOTIERKRANKHEIT, V1, P139; Prutz M, 2015, TIERAERZTL PRAX K H, V43, P231, DOI 10.15654/TPK-140152; Prutz M, 2016, BERL MUNCH TIERARZTL, V129, P167, DOI 10.2376/0005-9366-129-167; Redrobe S, 2002, BSAVA MANUAL EXOTIC; RENDANO VT, 1981, CAN VET J, V22, P331; Ritter JM, 2009, VET PATHOL, V46, P1109, DOI 10.1354/vp.09-VP-0019-K-FL; Romao MF, 2011, INT J MORPHOL, V29, P94, DOI 10.4067/S0717-95022011000100016; Rubel A, 1991, BIOMEDICAL SURG ASPE, VI, P185; Santos ALQ, 2011, PUBVET, V5; SCHILDGER BJ, 1991, BERL MUNCH TIERARZTL, V104, P20; Schildger BJ, 1999, ENDOSKOPIE BEI REPTI; Schulze P, 2008, ANATOMISCHES WORTERB; Schumacher J, 2001, SEMIN AVIAN EXOT PET, V10, P162, DOI 10.1053/saep.2001.24671; Scoczylas R., 1978, BIOL REPTILIA, P589; Silverman S, 2016, J VET CARDIOL, V18, P168, DOI 10.1016/j.jvc.2015.10.011; SILVERMAN S, 1993, VET CLIN N AM-SMALL, V23, P1287, DOI 10.1016/S0195-5616(93)50156-0; Silverman S., 2006, REPTILE MED SURG, V2nd ed., P471; Smith D, 2001, VET RADIOL ULTRASOUN, V42, P515, DOI 10.1111/j.1740-8261.2001.tb00979.x; Starck D., 1982, VERGLEICHENDE ANATOM; STOSKOPF MK, 1989, J ZOO WILDLIFE MED, V20, P396; Summa Noemie M., 2012, Journal of Herpetological Medicine and Surgery, V22, P107, DOI 10.5818/1529-9651-22.3.107; Taylor SK, 1996, J ZOO WILDLIFE MED, V27, P180; TROYER K, 1984, PHYSIOL ZOOL, V57, P1; TSCHELIESSNIGG KH, 1978, ACTA CHIR AUSTRIACA, V10, P40; Valente AL, 2008, RES VET SCI, V84, P132, DOI 10.1016/j.rvsc.2007.03.013; Valente ALS, 2006, AM J VET RES, V67, P1347, DOI 10.2460/ajvr.67.8.1347; Wachsmann S, 2010, THESIS; Wright K, 2008, J EXOT PET MED, V17, P267, DOI 10.1053/j.jepm.2008.07.004; Wyneken J, 2001, EXOTIC DVM, V4, P35; Wyneken Jeanette, 2008, P213; Zentek J, 1997, TIERARZTL PRAX K H, V25, P684	77	3	3	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2019	14	8							e0221050	10.1371/journal.pone.0221050	http://dx.doi.org/10.1371/journal.pone.0221050			40	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5RZ	31437183	Green Published, gold, Green Submitted			2022-12-26	WOS:000485036900031
J	Gupta, R; Verma, R; Pradhan, D; Jain, AK; Umamaheswari, A; Rai, CS				Gupta, Reena; Verma, Rashi; Pradhan, Dibyabhaba; Jain, Arun Kumar; Umamaheswari, Amineni; Rai, Chandra Shekhar			An in silico approach towards identification of novel drug targets in pathogenic species of Leptospira	PLOS ONE			English	Article							LIPOPOLYSACCHARIDE BIOSYNTHESIS; PROTEIN; INTERROGANS; GENE; EPIDEMIOLOGY; PREDICTION; NETWORKS; FEATURES	Leptospirosis is one of the leading zoonotic infections worldwide. As with other infectious diseases, report of antimicrobial resistance to existing therapeutic arsenal poses challenges in the management of disease. Hence, identification of novel drug targets for the pathogen deems essential. Present study used combined approach of comparative and subtractive genomics to identify putative drug targets. Crucial genes of 16 pathogenic Leptospira strains were filtered and subjected to homology search via target identification tool "TiD". Thereafter, comparative analysis was performed for non-homologous, essential genes to accomplish the broad-spectrum drug target. Consequently, 37 essential genes were found to be conserved in at least 10 strains of Leptospira. Further, prioritization of resultant set of genes revealed 18 were hubs in protein-protein interaction network. Sixteen putative targets among the hub genes were conserved in all strains of Leptospira. Out of sixteen, fourteen were enzymes while 8 were novel and 4 were involved in virulence mechanism. In addition, genome scale metabolic network reconstruction and choke point analysis revealed cobA (porphyrin and chlorophyll metabolism) and thiL (thiamine metabolism) as chokepoints in their respective metabolic pathways. The proposed hub genes could act as putative broad-spectrum drug targets for Leptospira species, however, these putative targets should be validated to ensure them as real one prior to utilizing them for target based lead discovery.	[Gupta, Reena; Rai, Chandra Shekhar] Guru Gobind Singh Indraprastha Univ, Univ Sch Informat Commun & Technol, New Delhi, India; [Verma, Rashi; Jain, Arun Kumar] Indian Council Med Res, Natl Inst Pathol, Biomed Informat Ctr, New Delhi, India; [Pradhan, Dibyabhaba] Indian Council Med Res, Computat Genom Ctr, Campus All India Inst Med Sci, New Delhi, India; [Umamaheswari, Amineni] Sri Venkateswara Inst Med Sci, Dept Bioinformat, Tirupati, Andhra Pradesh, India	GGS Indraprastha University; Indian Council of Medical Research (ICMR); ICMR - National Institute of Pathology (IOP); Indian Council of Medical Research (ICMR)	Rai, CS (corresponding author), Guru Gobind Singh Indraprastha Univ, Univ Sch Informat Commun & Technol, New Delhi, India.; Pradhan, D (corresponding author), Indian Council Med Res, Computat Genom Ctr, Campus All India Inst Med Sci, New Delhi, India.	dbpinfo@gmail.com; csrai@ipu.ac.in	Pradhan, Dibyabhaba/AFO-4655-2022; Verma, Rashi/GQA-9121-2022; Umamaheswari, amineni/O-2944-2017	Pradhan, Dibyabhaba/0000-0002-2459-5032; Verma, Rashi/0000-0002-2989-4162; Umamaheswari, amineni/0000-0001-6092-1715				Amineni U, 2010, J Chem Biol, V3, P165, DOI 10.1007/s12154-010-0039-1; Anishetty S, 2005, COMPUT BIOL CHEM, V29, P368, DOI 10.1016/j.compbiolchem.2005.07.001; [Anonymous], 1999, Wkly Epidemiol Rec, V74, P237; Assenov Y, 2008, BIOINFORMATICS, V24, P282, DOI 10.1093/bioinformatics/btm554; Bader GD, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-2; Benkert P, 2011, BIOINFORMATICS, V27, P343, DOI 10.1093/bioinformatics/btq662; Bian J, 2011, J BACTERIOL, V193, P3912, DOI 10.1128/JB.00386-11; Bourhy P, 2014, INT J SYST EVOL MICR, V64, P4061, DOI 10.1099/ijs.0.066597-0; Bulach DM, 2000, J MOL MICROB BIOTECH, V2, P375; Caimi K, 2017, INFECT GENET EVOL, V54, P478, DOI 10.1016/j.meegid.2017.08.013; Chaemchuen S, 2011, VET MICROBIOL, V153, P178, DOI 10.1016/j.vetmic.2011.04.030; Charon NW, 2002, ANNU REV GENET, V36, P47, DOI 10.1146/annurev.genet.36.041602.134359; Cline MS, 2007, NAT PROTOC, V2, P2366, DOI 10.1038/nprot.2007.324; Costa F, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003898; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Fair RJ, 2014, PERSPECT MED CHEM, V6, P25, DOI 10.4137/PMC.S14459; Ferla MP, 2014, MICROBIOL-SGM, V160, P1571, DOI 10.1099/mic.0.077826-0; Fernandes LGV, 2012, INFECT IMMUN, V80, P3679, DOI 10.1128/IAI.00474-12; Fouts DE, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004403; Fu LM, 2012, BIOINFORMATICS, V28, P3150, DOI 10.1093/bioinformatics/bts565; Gamberini M, 2005, FEMS MICROBIOL LETT, V244, P305, DOI 10.1016/j.femsle.2005.02.004; Gupta R, 2017, GENOMICS, V109, P51, DOI 10.1016/j.ygeno.2016.11.005; Haake DA, 2015, CURR TOP MICROBIOL, V387, P65, DOI 10.1007/978-3-662-45059-8_5; Hema K, 2015, BIOCH ANAL BIOCH, V4; Himani D, 2013, J FOODBORNE ZOONOTIC, V1, P6; Izurieta Ricardo, 2008, J Emerg Trauma Shock, V1, P21, DOI 10.4103/0974-2700.40573; Kanehisa M, 2016, NUCLEIC ACIDS RES, V44, pD457, DOI 10.1093/nar/gkv1070; Karp PD, BRIEF BIOINFORM, DOI [10.1093/bib/bbx085/4084231, DOI 10.1093/BIB/BBX085/4084231]; Karp Peter D, 2002, Bioinformatics, V18 Suppl 1, pS225; Krieger E, 2009, PROTEINS, V77, P114, DOI 10.1002/prot.22570; La Scola B, 2006, FEMS MICROBIOL LETT, V263, P142, DOI 10.1111/j.1574-6968.2006.00377.x; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Levett PN, 2001, CLIN MICROBIOL REV, V14, P296, DOI 10.1128/CMR.14.2.296-326.2001; Liao SM, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-253; Moriya Y, 2007, NUCLEIC ACIDS RES, V35, pW182, DOI 10.1093/nar/gkm321; Nascimento ALTO, 2004, J BACTERIOL, V186, P2164, DOI 10.1128/JB.186.7.2164-2172.2004; Pal M., 2017, AIR WATER BORNE DIS, V6, P133, DOI 10.4172/2167-7719.1000133; Pandey M, 2015, INT J COMPUT APPL, V109, P29, DOI DOI 10.5120/19426-0455; Patra KP, 2015, BMC MICROBIOL, V15, DOI 10.1186/s12866-015-0581-7; Phimda K, 2007, ANTIMICROB AGENTS CH, V51, P3259, DOI 10.1128/AAC.00508-07; Plank R, 2000, MICROBES INFECT, V2, P1265, DOI 10.1016/S1286-4579(00)01280-6; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; Ren SX, 2003, NATURE, V422, P888, DOI 10.1038/nature01597; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Saint-Macary ME, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0111108; Rao R. Sambasiva, 2003, Braz J Infect Dis, V7, P178, DOI 10.1590/S1413-86702003000300003; Sethi S, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000579; Sivaprakasam Venkat, 2014, JMM Case Rep, V1, pe000003, DOI 10.1099/jmmcr.0.000003; TAYLOR J., 1931, INDIAN J MED RES, V20, P55, DOI 10.2307/3271745; Taylor PL, 2008, J BIOL CHEM, V283, P2835, DOI 10.1074/jbc.M706163200; Tian W, 2018, NUCLEIC ACIDS RES, V46, pW363, DOI 10.1093/nar/gky473; Victoriano AFB, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-147; Wang ZJ, 2007, MICROB CELL FACT, V6, DOI 10.1186/1475-2859-6-39; Webb B, 2014, METHODS MOL BIOL, V1137, P1, DOI 10.1007/978-1-4939-0366-5_1; Wiederstein M, 2007, NUCLEIC ACIDS RES, V35, pW407, DOI 10.1093/nar/gkm290; Ye YN, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-769; Yeh W, 2004, GENOME RES, V14, P917, DOI 10.1101/gr.2050304; Yu CS, 2006, PROTEINS, V64, P643, DOI 10.1002/prot.21018; Yu NY, 2010, BIOINFORMATICS, V26, P1608, DOI 10.1093/bioinformatics/btq249	59	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2019	14	8							e0221446	10.1371/journal.pone.0221446	http://dx.doi.org/10.1371/journal.pone.0221446			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5OC	31430340	gold, Green Submitted, Green Published			2022-12-26	WOS:000485026800056
J	Al Khazal, F; Holte, MN; Bolon, B; White, TA; LeBrasseur, N; Maher, LJ				Al Khazal, Fatimah; Holte, Molly Nelson; Bolon, Brad; White, Thomas A.; LeBrasseur, Nathan; Maher, L. James, III			A conditional mouse model of complex II deficiency manifesting as Leigh-like syndrome	FASEB JOURNAL			English	Article						mitochondrial disease; succinate dehydrogenase; familial paraganglioma; hypoxia	JOINT PUBLICATION; REVISED GUIDES; MICE; MUTATIONS; DISEASE; RATS; RITA; DYSFUNCTION; BRAIN; CYCLE	Leigh syndrome embodies degenerative disorders with a collection of symptoms secondary to inborn errors of metabolism. Combinations of hypomorphic and loss-of-function alleles in many genes have been shown to result in Leigh syndrome. Interestingly, deficiency for the tricarboxylic acid cycle enzyme succinate dehydrogenase (SDH) can lead to Leigh-like syndrome in some circumstances and to cancer (paraganglioma, renal cell carcinoma, gastrointestinal stromal tumor) in others. In our experiments originally intended to create an inducible whole-body SDH-loss mouse model of tumorigenesis, we generated a condition reminiscent of Leigh-like syndrome that is lethal to mice within 4 wk. Remarkably, as has been shown for other mitochondrial diseases, chronic hypoxia offers substantial protection to mice from this condition after systemic SDH loss, allowing survival in the context of profoundly impaired oxidative metabolism.	[Al Khazal, Fatimah; Holte, Molly Nelson; Maher, L. James, III] Mayo Clin, Coll Med & Sci, Dept Biochem & Mol Biol, 200 First St SW, Rochester, MN 55905 USA; [White, Thomas A.; LeBrasseur, Nathan] Mayo Clin, Robert & Arlene Kogod Ctr Aging, Rochester, MN USA; [Bolon, Brad] GEMpath, Longmont, CO USA	Mayo Clinic; Mayo Clinic	Maher, LJ (corresponding author), Mayo Clin, Coll Med & Sci, Dept Biochem & Mol Biol, 200 First St SW, Rochester, MN 55905 USA.	maher@mayo.edu			Paradifference Foundation; U.S. National Institutes of Health (NIH) National Cancer Institute [RO1 CA166025]; Robert and Arlene Kogod Center on Aging (Mayo Clinic); NIH National Institute of Diabetes and Digestive and Kidney Diseases [U24DK100469]; NIH Director's Common Fund; NATIONAL CANCER INSTITUTE [R01CA166025] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U24DK100469] Funding Source: NIH RePORTER	Paradifference Foundation; U.S. National Institutes of Health (NIH) National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Robert and Arlene Kogod Center on Aging (Mayo Clinic); NIH National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIH Director's Common Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors acknowledge the European Conditional Mouse Mutagenesis Program (Wellcome Sanger Institute, Hinxton, United Kingdom) for providing the SDHC gene trap mouse line. The technical assistance of Jenny Pattengill and the Mayo Clinic Metabolomics Core Facility and the Mayo Clinic Mouse Histology Core Facility is acknowledged. This work was supported by generous funding from the Paradifference Foundation, U.S. National Institutes of Health (NIH) National Cancer Institute Grant RO1 CA166025 (to L. J. M), and by the Robert and Arlene Kogod Center on Aging (Mayo Clinic). Funding of the Mayo Clinic Metabolomics Resource Core was by NIH National Institute of Diabetes and Digestive and Kidney Diseases Grant U24DK100469, and originated from the NIH Director's Common Fund. The authors declare no conflicts of interest.	Agostino A, 2003, HUM MOL GENET, V12, P399, DOI 10.1093/hmg/ddg038; Alston CL, 2012, J MED GENET, V49, P569, DOI 10.1136/jmedgenet-2012-101146; Astrom K, 2003, HUM GENET, V113, P228, DOI 10.1007/s00439-003-0969-6; Baertling F, 2014, J NEUROL NEUROSUR PS, V85, P257, DOI 10.1136/jnnp-2012-304426; Bailis W, 2019, NATURE, V571, P403, DOI 10.1038/s41586-019-1311-3; Baric I, 2013, EUR J HUM GENET, V21, P871, DOI 10.1038/ejhg.2012.272; Birch-Machin MA, 2000, ANN NEUROL, V48, P330, DOI 10.1002/1531-8249(200009)48:3<330::AID-ANA7>3.0.CO;2-A; Bolon B, 2013, TOXICOL PATHOL, V41, P1028, DOI 10.1177/0192623312474865; Cawthorne Christopher, 2007, J Biomol Tech, V18, P120; de Haas R, 2016, BEHAV BRAIN RES, V296, P191, DOI 10.1016/j.bbr.2015.09.006; Finsterer J, 2006, ACTA NEUROL SCAND, V114, P217, DOI 10.1111/j.1600-0404.2006.00671.x; Gill AJ, 2010, HUM PATHOL, V41, P805, DOI 10.1016/j.humpath.2009.12.005; Her YF, 2015, INT J ENDOCRINOL, V2015, DOI 10.1155/2015/296167; Her YF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127471; Hoekstra AS, 2013, BBA-BIOENERGETICS, V1827, P543, DOI 10.1016/j.bbabio.2012.11.005; Horvath R, 2006, J NEUROL NEUROSUR PS, V77, P74, DOI 10.1136/jnnp.2005.067041; Jabeen SA, 2016, ANN INDIAN ACAD NEUR, V19, P140, DOI 10.4103/0972-2327.175437; Jackson CB, 2014, J MED GENET, V51, P170, DOI 10.1136/jmedgenet-2013-101932; Jain IH, 2016, SCIENCE, V352, P54, DOI 10.1126/science.aad9642; Kittel B, 2004, EXP TOXICOL PATHOL, V55, P413, DOI 10.1078/0940-2993-00349; Kruse SE, 2008, CELL METAB, V7, P312, DOI 10.1016/j.cmet.2008.02.004; Maher L. J., 2011, PHEOCHROMOCYTOMA NEW, P25, DOI DOI 10.5772/25346; Melov S, 1998, NAT GENET, V18, P159, DOI 10.1038/ng0298-159; Mochel F, 2005, J CLIN ENDOCR METAB, V90, P3780, DOI 10.1210/jc.2005-0009; Morawietz G, 2004, EXP TOXICOL PATHOL, V55, P433, DOI 10.1078/0940-2993-00350; Moslemi AR, 2005, NEUROPEDIATRICS, V36, P314, DOI 10.1055/s-2005-872845; Oh EH, 2017, NEUROLOGY, V89, P1754, DOI 10.1212/WNL.0000000000004528; Pal G, 2013, NEUROLOGY, V80; Peters JP, 2015, BIOL OPEN, V4, P1281, DOI 10.1242/bio.013623; Phadke R, 2017, J CLIN MED, V6, DOI 10.3390/jcm6070064; Piruat JI, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00200; Quintana A, 2012, J CLIN INVEST, V122, P2359, DOI 10.1172/JCI62923; Quintana A, 2010, P NATL ACAD SCI USA, V107, P10996, DOI 10.1073/pnas.1006214107; Rahman S, 1996, ANN NEUROL, V39, P343, DOI 10.1002/ana.410390311; Ruehl-Fehlert C, 2003, EXP TOXICOL PATHOL, V55, P91, DOI 10.1016/S0940-2993(04)70148-7; Ruhoy LS, 2014, APPL CLIN GENET, V7, P221, DOI 10.2147/TACG.S46176; Rustin P, 1997, BBA-MOL BASIS DIS, V1361, P185, DOI 10.1016/S0925-4439(97)00035-5; Sakushima K, 2011, NEUROLOGIST, V17, P222, DOI 10.1097/NRL.0b013e318217357a; Selak MA, 2005, CANCER CELL, V7, P77, DOI 10.1016/j.ccr.2004.11.022; Spinazzi M, 2019, P NATL ACAD SCI USA, V116, P277, DOI 10.1073/pnas.1811938116; Wang YM, 2015, WORLD J GASTROENTERO, V21, P2303, DOI 10.3748/wjg.v21.i8.2303; Wesolowska Maria, 2015, J Neuromuscul Dis, V2, P409; Williamson SR, 2015, MODERN PATHOL, V28, P80, DOI 10.1038/modpathol.2014.86	43	4	4	1	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2019	33	12					13189	13201		10.1096/fj.201802655RR	http://dx.doi.org/10.1096/fj.201802655RR			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC9BO	31469588	Bronze, Green Published			2022-12-26	WOS:000507466100013
J	Dembitz, V; Tomic, B; Kodvanj, I; Simon, JA; Bedalov, A; Visnjic, D				Dembitz, Vilma; Tomic, Barbara; Kodvanj, Ivan; Simon, Julian A.; Bedalov, Antonio; Visnjic, Dora			The ribonucleoside AICAr induces differentiation of myeloid leukemia by activating the ATR/Chk1 via pyrimidine depletion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						leukemia; cell cycle; cell differentiation; nucleotide; pyrimidine; DNA damage response; AMP-activated kinase (AMPK); AICAr; AML; Chk1	STEM-CELLS; AMPK; INHIBITION; APOPTOSIS; AGONISTS; CYCLE; P53; MECHANISM; ACADESINE; KINASE	Metabolic pathways play important roles in proliferation and differentiation of malignant cells. 5-Aminoimidazole-4-carboxamide ribonucleoside (AICAr), a precursor in purine biosynthesis and a well-established activator of AMP-activated protein kinase (AMPK), induces widespread metabolic alterations and is commonly used for dissecting the role of metabolism in cancer. We have previously reported that AICAr promotes differentiation and inhibits proliferation of myeloid leukemia cells. Here, using metabolic assays, immunoblotting, flow cytometry analyses, and siRNA-mediated gene silencing in leukemia cell lines, we show that AICAr-mediated differentiation was independent of the known metabolic effects of AMPK, including glucose consumption, but instead depends on the activation of the DNA damage?associated enzyme checkpoint kinase 1 (Chk1) induced by pyrimidine depletion. LC/MS/MS metabolomics analysis revealed that AICAr increases orotate levels and decreases uridine monophosphate (UMP) levels, consistent with inhibition of UMP synthesis at a step downstream of dihydroorotate dehydrogenase (DHODH). AICAr and the DHODH inhibitor brequinar had similar effects on differentiation markers and S-phase arrest, and genetic or pharmacological Chk1 inactivation abrogated both of these effects. Our results delineate an AMPK-independent effect of AICAr on myeloid leukemia differentiation that involves perturbation of pyrimidine biosynthesis and activation of the DNA damage response network.	[Dembitz, Vilma; Tomic, Barbara; Kodvanj, Ivan; Visnjic, Dora] Univ Zagreb, Sch Med, Dept Physiol, Salata 3, Zagreb 10000, Croatia; [Dembitz, Vilma; Tomic, Barbara; Kodvanj, Ivan; Visnjic, Dora] Univ Zagreb, Sch Med, Croatian Inst Brain Res, Salata 3, Zagreb 10000, Croatia; [Simon, Julian A.; Bedalov, Antonio] Fred Hutchinson Canc Res Ctr, Clin Res Div, Seattle, WA 98109 USA	University of Zagreb; University of Zagreb; Fred Hutchinson Cancer Center	Visnjic, D (corresponding author), Univ Zagreb, Sch Med, Dept Physiol, Salata 3, Zagreb 10000, Croatia.; Visnjic, D (corresponding author), Univ Zagreb, Sch Med, Croatian Inst Brain Res, Salata 3, Zagreb 10000, Croatia.	visnjic@mef.hr	Kodvanj, Ivan/AAI-9407-2020; Dembitz, Vilma/AAN-3608-2021	Kodvanj, Ivan/0000-0002-1359-3701; Dembitz, Vilma/0000-0002-9463-253X	Croatian Science Foundation Hrvatska Zaklada za Znanost (HRZZ) - European Union through European Social Fund (ESF) Operational Programme Efficient Human Resources 2014-2020 Project [IP-2016-06-4581, DOK-01-20189599, DOK-2018-01-9599]; National Institute of Health [R01CA206462, R01GM117446]; Scientific Centre of Excellence for Basic, Clinical and Translational Neuroscience Project "Experimental and clinical research of hypoxic-ischemic damage in perinatal and adult brain" - European Union through the European Regional Development Fund [GA KK01.1.1.01.0007]; NATIONAL CANCER INSTITUTE [R01CA206462] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM117446] Funding Source: NIH RePORTER	Croatian Science Foundation Hrvatska Zaklada za Znanost (HRZZ) - European Union through European Social Fund (ESF) Operational Programme Efficient Human Resources 2014-2020 Project; National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Scientific Centre of Excellence for Basic, Clinical and Translational Neuroscience Project "Experimental and clinical research of hypoxic-ischemic damage in perinatal and adult brain" - European Union through the European Regional Development Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by Croatian Science Foundation Hrvatska Zaklada za Znanost (HRZZ) Projects IP-2016-06-4581 (to D. V.) and DOK-01-20189599 co-funded by the European Union through European Social Fund (ESF) Operational Programme Efficient Human Resources 2014-2020 Project DOK-2018-01-9599 (to D. V.); National Institute of Health Grants R01CA206462 (to A. B. and J. A. S.) and R01GM117446 (to A. B.); and Scientific Centre of Excellence for Basic, Clinical and Translational Neuroscience Project "Experimental and clinical research of hypoxic-ischemic damage in perinatal and adult brain" Grant GA KK01.1.1.01.0007 funded by the European Union through the European Regional Development Fund. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bardeleben C, 2013, MOL CANCER THER, V12, P1310, DOI 10.1158/1535-7163.MCT-12-1042; Bertoli S, 2015, ONCOTARGET, V6, P38061, DOI 10.18632/oncotarget.5706; Bode AM, 2007, CANCER LETT, V247, P26, DOI 10.1016/j.canlet.2006.03.032; Bost F, 2016, ONCOGENESIS, V5, DOI 10.1038/oncsis.2015.46; Campas C, 2005, LEUKEMIA, V19, P292, DOI 10.1038/sj.leu.2403593; Chae HD, 2012, STEM CELLS, V30, P140, DOI 10.1002/stem.778; de The H, 2018, NAT REV CANCER, V18, P117, DOI 10.1038/nrc.2017.103; Dembitz V, 2017, CELL DEATH DISCOV, V3, DOI 10.1038/cddiscovery.2017.66; Dembitz V, 2015, INT J HEMATOL, V102, P12, DOI 10.1007/s12185-015-1776-2; Du LJ, 2019, FASEB J, V33, P4525, DOI 10.1096/fj.201801559RR; Ducker GS, 2016, CELL METAB, V23, P1140, DOI 10.1016/j.cmet.2016.04.016; Fordham SE, 2018, BLOOD ADV, V2, P1157, DOI 10.1182/bloodadvances.2017015214; Inomata K, 2009, CELL, V137, P1088, DOI 10.1016/j.cell.2009.03.037; Kanazawa I, 2009, AM J PHYSIOL-ENDOC M, V296, pE139, DOI 10.1152/ajpendo.90677.2008; Kueh HY, 2013, SCIENCE, V341, P670, DOI 10.1126/science.1240831; Lalic H, 2014, LEUKEMIA LYMPHOMA, V55, P2375, DOI 10.3109/10428194.2013.876633; Lin TX, 2005, NAT CELL BIOL, V7, P165, DOI 10.1038/ncb1211; Liu QS, 2013, CANCER RES, V73, P2574, DOI 10.1158/0008-5472.CAN-12-1702; Liu XN, 2014, P NATL ACAD SCI USA, V111, pE435, DOI 10.1073/pnas.1311121111; Losman JA, 2013, SCIENCE, V339, P1621, DOI 10.1126/science.1231677; Maes T, 2018, CANCER CELL, V33, P495, DOI 10.1016/j.ccell.2018.02.002; Mangano DT, 1997, JAMA-J AM MED ASSOC, V277, P325, DOI 10.1001/jama.277.4.325; Mathur D, 2017, CANCER DISCOV, V7, P380, DOI 10.1158/2159-8290.CD-16-0612; Matkovic K, 2006, LEUKEMIA, V20, P941, DOI 10.1038/sj.leu.2404204; Narkar VA, 2008, CELL, V134, P405, DOI 10.1016/j.cell.2008.06.051; Paglia G, 2012, ANAL BIOANAL CHEM, V402, P1183, DOI 10.1007/s00216-011-5556-4; Pikman Y, 2016, J EXP MED, V213, P1285, DOI 10.1084/jem.20151574; Radomska HS, 2012, J CLIN INVEST, V122, P2955, DOI 10.1172/JCI43354; Robert G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007889; Rohle D, 2013, SCIENCE, V340, P626, DOI 10.1126/science.1236062; Santidrian AF, 2010, BLOOD, V116, P3023, DOI 10.1182/blood-2010-05-283960; Santos MA, 2014, NATURE, V514, P107, DOI 10.1038/nature13483; Scotland S, 2013, LEUKEMIA, V27, P2129, DOI 10.1038/leu.2013.107; Sykes DB, 2016, CELL, V167, P171, DOI 10.1016/j.cell.2016.08.057; THOMAS CB, 1981, J CELL PHYSIOL, V107, P335, DOI 10.1002/jcp.1041070305; Towler MC, 2007, CIRC RES, V100, P328, DOI 10.1161/01.RES.0000256090.42690.05; Vakana E, 2011, BLOOD, V118, P6399, DOI 10.1182/blood-2011-01-332783; Vincent EE, 2015, ONCOGENE, V34, P3627, DOI 10.1038/onc.2014.301; Visnjic D, 2019, CURR MED CHEM, V26, P2208, DOI 10.2174/0929867325666180117105522; Wang F, 2013, SCIENCE, V340, P622, DOI 10.1126/science.1234769; WU H, 1991, DIFFERENTIATION, V48, P51, DOI 10.1111/j.1432-0436.1991.tb00242.x; Zang Y, 2008, J BIOL CHEM, V283, P6201, DOI 10.1074/jbc.M708619200	42	12	12	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 18	2019	294	42					15257	15270		10.1074/jbc.RA119.009396	http://dx.doi.org/10.1074/jbc.RA119.009396			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JQ9HM	31431503	Green Published, hybrid			2022-12-26	WOS:000499248700006
J	Ghimire, S; Hill, CV; Sy, FS; Rodriguez, R				Ghimire, Saruna; Hill, Carl, V; Sy, Francisco S.; Rodriguez, Rachelle			Decline in telomere length by age and effect modification by gender, allostatic load and comorbidities in National Health and Nutrition Examination Survey (1999-2002)	PLOS ONE			English	Article							MARITAL-STATUS; BREAST-CANCER; HEART-DISEASE; DNA-DAMAGE; STRESS; RISK; ASSOCIATION; ESTROGEN; LIFE; SENESCENCE	Background This study aims to assess the decline in telomere length (TL) with age and evaluate effect modification by gender, chronic stress, and comorbidity in a representative sample of the US population. Methods Cross-sectional data on 7826 adults with a TL measurement, were included from the National Health and Nutrition Examination Survey, years 1999-2002. The population rate of decline in TL across 10-year age categories was estimated using crude and adjusted regression. Results In an adjusted model, the population rate of decline in TL with age was consistent and linear for only three age categories: 20-29 (beta = -0.0172, 95% CI: -0.0342, -0.0002), 50-59 (beta = -0.0182, 95% CI: -0.0311, -0.0054) and 70-79 (beta = -0.0170, 95% CI: -0.0329, -0.0011) years. The population rate of decline in TL with age was significantly greater for males and those with high allostatic load and a history of comorbidities. When the population rate of decline in TL was analyzed by gender in 10-year age bins, a fairly consistent yet statistically non-significant decline for males was observed; however, a trough in the rate was observed for females in the age categories 20-29 years (beta = -0.0284, 95% CI: -0.0464, -0.0103) and 50-59 years (beta = -0.0211, 95% CI: -0.0391, -0.0032). To further elucidate the gender difference observed in the primary analyses, secondary analyses were conducted with reproductive and hormonal status; a significant inverse association was found between TL and parity, menopause, and age at menopause. Conclusions TL was shorter with increasing age and this decline was modified by gender, chronic stress and comorbidities; individuals with chronic morbidity and/or chronic stress and females in their twenties and fifties experienced greater decline. Female reproductive factors, i.e., parity and menopause, were associated with TL.	[Ghimire, Saruna] Miami Univ, Dept Sociol & Gerontol, Oxford, OH 45056 USA; [Ghimire, Saruna; Sy, Francisco S.] Univ Nevada, Sch Publ Hlth, Las Vegas, NV 89154 USA; [Hill, Carl, V] NIA, Off Special Populat, Bethesda, MD 20892 USA; [Rodriguez, Rachelle] Purdue Pharma LP, Stamford, CT USA	University System of Ohio; Miami University; Nevada System of Higher Education (NSHE); University of Nevada Las Vegas; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Purdue Pharma L.P.	Ghimire, S (corresponding author), Miami Univ, Dept Sociol & Gerontol, Oxford, OH 45056 USA.; Ghimire, S (corresponding author), Univ Nevada, Sch Publ Hlth, Las Vegas, NV 89154 USA.	ghimirs@miamiOH.edu	Ghimire, Saruna/Y-7905-2019	Ghimire, Saruna/0000-0002-2662-2006	UNLV Open Article Fund	UNLV Open Article Fund	UNLV Open Article Fund supported the publication of this study. No additional funding was received for this study.	Ahrens KA, 2016, PAEDIATR PERINAT EP, V30, P325, DOI 10.1111/ppe.12277; Aviv A, 2002, J MOL MED, V80, P689, DOI 10.1007/s00109-002-0377-8; Bayne S, 2011, PROTEIN CELL, V2, P333, DOI 10.1007/s13238-011-1033-2; Blackburn EH, 2006, NAT MED, V12, P1133, DOI 10.1038/nm1006-1133; Broer L, 2014, TELOMERE TELOMERASE, V1, P3771, DOI [10.1128/mcb.20.11.3764-3771.2000, DOI 10.1128/MCB.20.11.3764-3771.2000]; Brouilette SW, 2007, LANCET, V369, P107, DOI 10.1016/S0140-6736(07)60071-3; Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47; Cha Y, 2008, MOL CELLS, V26, P454; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chen XL, 2014, ANN EPIDEMIOL, V24, P612, DOI 10.1016/j.annepidem.2014.05.014; Curtin LR, 1999, VITAL HLTH STAT SERI, V2, P1; Engstrom M, 2006, ARTERIOSCL THROM VAS, V26, P643, DOI 10.1161/01.ATV.0000200100.14612.bb; Epel ES, 2004, P NATL ACAD SCI USA, V101, P17312, DOI 10.1073/pnas.0407162101; Fuster JJ, 2006, CIRC RES, V99, P1167, DOI 10.1161/01.RES.0000251281.00845.18; Gardner M, 2014, EXP GERONTOL, V51, P15, DOI 10.1016/j.exger.2013.12.004; Gotlib IH, 2015, MOL PSYCHIATR, V20, P615, DOI 10.1038/mp.2014.119; Gray KE, 2014, EPIDEMIOLOGY, V25, P139, DOI 10.1097/EDE.0000000000000017; Haycock PC, 2017, JAMA ONCOL, V3, P636, DOI 10.1001/jamaoncol.2016.5945; Haycock PC, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g4227; Jasienska G, 2001, FOUND HUM B, P59; Lee DC, 2005, YONSEI MED J, V46, P471, DOI 10.3349/ymj.2005.46.4.471; Lin J, 2011, BRAIN RES, V1379, P224, DOI 10.1016/j.brainres.2010.10.033; Mainous AG, 2011, AGE AGEING, V40, P73, DOI 10.1093/ageing/afq118; McCreary ML, 2006, INT CUL PSY, P487; McEwen BS, 1999, ANN NY ACAD SCI, V896, P30, DOI 10.1111/j.1749-6632.1999.tb08103.x; MCKINLAY SM, 1994, EXP GERONTOL, V29, P479, DOI 10.1016/0531-5565(94)90029-9; Michael YL, 2002, J PSYCHOSOM RES, V52, P285, DOI 10.1016/S0022-3999(01)00270-7; Minamino T, 2002, CIRCULATION, V105, P1541, DOI 10.1161/01.CIR.0000013836.85741.17; Misiti S, 2000, MOL CELL BIOL, V20, P3764, DOI 10.1128/MCB.20.11.3764-3771.2000; Molloy GJ, 2009, SOC SCI MED, V69, P223, DOI 10.1016/j.socscimed.2009.05.010; National Center for Health Statistics, 2013, VITAL HLTH STAT, V2, P1; Needham BL, 2015, EPIDEMIOLOGY, V26, P528, DOI 10.1097/EDE.0000000000000299; Needham BL, 2013, SOC SCI MED, V85, P1, DOI 10.1016/j.socscimed.2013.02.023; O'Donovan A, 2009, BRAIN BEHAV IMMUN, V23, P446, DOI 10.1016/j.bbi.2008.11.006; O'Donovan A, 2011, BIOL PSYCHIAT, V70, P465, DOI 10.1016/j.biopsych.2011.01.035; Okereke OI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040516; Oliveira BS, 2016, AGEING RES REV, V26, P37, DOI 10.1016/j.arr.2015.12.006; Parente V, 2013, PSYCHO-ONCOLOGY, V22, P621, DOI 10.1002/pon.3044; Passos JF, 2007, NUCLEIC ACIDS RES, V35, P7505, DOI 10.1093/nar/gkm893; Rehkopf DH, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002188; Rewak M, 2014, BIOL PSYCHOL, V99, P92, DOI 10.1016/j.biopsycho.2014.03.007; Ridout KK, 2016, J AFFECT DISORDERS, V191, P237, DOI 10.1016/j.jad.2015.11.052; Rode L, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/djv074; Rufer N, 1999, J EXP MED, V190, P157, DOI 10.1084/jem.190.2.157; Sampson MJ, 2006, DIABETES CARE, V29, P283, DOI 10.2337/diacare.29.02.06.dc05-1715; Sbarra DA, 2009, PSYCHOSOM MED, V71, P828, DOI 10.1097/PSY.0b013e3181b4c4f2; Scafato E, 2008, SOC SCI MED, V67, P1456, DOI 10.1016/j.socscimed.2008.06.026; Seeman TE, 2001, P NATL ACAD SCI USA, V98, P4770, DOI 10.1073/pnas.081072698; Serra V, 2003, J BIOL CHEM, V278, P6824, DOI 10.1074/jbc.M207939200; Simon NM, 2006, BIOL PSYCHIAT, V60, P432, DOI 10.1016/j.biopsych.2006.02.004; SLAGBOOM PE, 1994, AM J HUM GENET, V55, P876; Stice JP, 2009, FUTUR CARDIOL, V5, P93, DOI 10.2217/14796678.5.1.93; Tomiyama AJ, 2012, PHYSIOL BEHAV, V106, P40, DOI 10.1016/j.physbeh.2011.11.016; Tyrka AR, 2010, BIOL PSYCHIAT, V67, P531, DOI 10.1016/j.biopsych.2009.08.014; van der Harst P, 2007, J AM COLL CARDIOL, V49, P1459, DOI 10.1016/j.jacc.2007.01.027; Vasa M, 2000, CIRC RES, V87, P540, DOI 10.1161/01.RES.87.7.540; Verhoeven JE, 2015, PSYCHOSOM MED, V77, P882, DOI 10.1097/PSY.0000000000000226; von Zglinicki T, 2000, LAB INVEST, V80, P1739, DOI 10.1038/labinvest.3780184; von Zglinicki T, 2005, CURR MOL MED, V5, P197; Weischer M, 2012, ARTERIOSCL THROM VAS, V32, P822, DOI 10.1161/ATVBAHA.111.237271; Xing DQ, 2009, ARTERIOSCL THROM VAS, V29, P289, DOI 10.1161/ATVBAHA.108.182279; Yang ZW, 2009, HYPERTENSION, V53, P639, DOI 10.1161/HYPERTENSIONAHA.108.123752; Yen YC, 2013, AGE AGEING, V42, P234, DOI 10.1093/ageing/afs122; Zhu X, 2016, SCI REP-UK, V6, DOI 10.1038/srep22243; Zhuravliova E, 2009, BEHAV BRAIN RES, V205, P377, DOI 10.1016/j.bbr.2009.07.009	65	20	22	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2019	14	8							e0221690	10.1371/journal.pone.0221690	http://dx.doi.org/10.1371/journal.pone.0221690			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW6BO	31469870	Green Published, gold			2022-12-26	WOS:000485062200024
J	Trung, NV; Hoi, LT; Cuong, D; Ha, DT; Hoa, TM; Lien, VN; Hoa, NT; Hoe, LNM; Huong, DT; Bich, VTN; van Doorn, HR; Nadjm, B; Richards, AL				Nguyen Vu Trung; Le Thi Hoi; Do Duy Cuong; Doan The Ha; Tran Mai Hoa; Vu Ngoc Lien; Nguyen Thi Hoa; Le Nguyen Minh Hoe; Dang Thi Huong; Vu Thi Ngoc Bich; van Doorn, H. Rogier; Nadjm, Behzad; Richards, Allen L.			Analysis of the 56-kDa type specific antigen gene of Orientia tsutsugamushi from northern Vietnam	PLOS ONE			English	Article							SCRUB TYPHUS; GENOTYPES; SEVERITY	Scrub typhus has been documented since 1932 in Vietnam, however, the disease burden of scrub typhus remains poorly understood in the country. We conducted this study to describe the phylogenetic analysis of the 56-kDa type-specific antigen (TSA) gene of Orientia tsutsugamushi associated with PCR positive cases of scrub typhus. Of 116 positive samples, 65 type-specific antigen gene sequences were obtained and classified into 3 genogroups: Karp, Kato and Gilliam. The Karp genogroup was the most frequently detected phylogenetic cluster in the study with 30 samples (46%), followed by Kato and Gilliam with 20 (31%) and 15 (23%), respectively. All sequences showed 94-100% nucleotide similarity to reference sequences collected in the central part of Vietnam in 2017. Patients infected with Karp genogroup were more likely to have significant thrombocytopenia than the other genogroups. These results suggest that any scrub typhus vaccine considered for use in Vietnam should provide protection against each of these 3 genogroups.	[Nguyen Vu Trung; Le Thi Hoi; Tran Mai Hoa; Vu Ngoc Lien; Nguyen Thi Hoa; Le Nguyen Minh Hoe; Dang Thi Huong] Natl Hosp Trop Dis, Hanoi, Vietnam; [Nguyen Vu Trung; Doan The Ha] Hanoi Med Univ, Hanoi, Vietnam; [Do Duy Cuong] Bach Mai Hosp, Hanoi, Vietnam; [Vu Thi Ngoc Bich; van Doorn, H. Rogier; Nadjm, Behzad] Univ Oxford, Wellcome Trust Asia Program, Clin Res Unit, Hanoi, Vietnam; [Richards, Allen L.] Naval Med Res Ctr, Silver Spring, MD 20910 USA; [Richards, Allen L.] Uniformed Serv Univ Hlth Sci, Bethesda, MD 20814 USA	National Hospital of Tropical Diseases; Hanoi Medical University; University of Oxford; Naval Medical Research Center (NMRC); Uniformed Services University of the Health Sciences - USA	Richards, AL (corresponding author), Naval Med Res Ctr, Silver Spring, MD 20910 USA.; Richards, AL (corresponding author), Uniformed Serv Univ Hlth Sci, Bethesda, MD 20814 USA.	Allen.Richards@comcast.net	van Doorn, H. Rogier/H-3080-2019	van Doorn, H. Rogier/0000-0002-9807-1821	National Foundation for Science and Technology Development of Vietnam (NAFOSTED) [106-YS.042014.10]; DTRA [A1266]; Wellcome Trust of Great Britain [106680/Z/14/Z]	National Foundation for Science and Technology Development of Vietnam (NAFOSTED)(National Foundation for Science & Technology Development (NAFOSTED)); DTRA(United States Department of DefenseDefense Threat Reduction Agency); Wellcome Trust of Great Britain(Wellcome Trust)	This work was supported by the National Foundation for Science and Technology Development of Vietnam (NAFOSTED) (https://nafosted.gov.vn/en/) [106-YS.042014.10] and was partially supported by the DTRA (http://www.dtra.mil/) work unit #A1266 (ALR) and the Wellcome Trust of Great Britain (https://wellcome.ac.uk/) #106680/Z/14/Z (SOL, BN, MC, JEB, HRvD). All sponsors/funders did not play any role in study design, data collection and analysis, decision to publish, nor preparation of the manuscript. The following authors received partial funding of their salaries from the appropriate funders: NVT, LTH, DDC and VNL received part of their salaries from NAFOSTED; ALR received partial funding of his salary from DTRA, and VTNB, BN, and HRvD received part of their salaries from the Wellcome Trust. The three funder agencies had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acestor N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044269; BEYTOUT D., 1964, BULL SOC PATHOL EXOTIQUE, V57, P257; Blacksell SD, 2008, FEMS IMMUNOL MED MIC, V52, P335, DOI 10.1111/j.1574-695X.2007.00375.x; Duong V, 2013, INFECT GENET EVOL, V15, P35, DOI 10.1016/j.meegid.2011.01.004; Fournier PE, 2008, CLIN MICROBIOL INFEC, V14, P168, DOI 10.1111/j.1469-0691.2007.01889.x; Hamaguchi S, 2015, AM J TROP MED HYG, V92, P972, DOI 10.4269/ajtmh.14-0806; Jiang J, 2004, AM J TROP MED HYG, V70, P351, DOI 10.4269/ajtmh.2004.70.351; Kelly DJ, 2009, CLIN INFECT DIS, V48, pS203, DOI 10.1086/596576; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Lim CC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122009; Lu HY, 2010, AM J TROP MED HYG, V83, P658, DOI 10.4269/ajtmh.2010.09-0608; Nagano I, 1996, MICROBIOL IMMUNOL, V40, P743, DOI 10.1111/j.1348-0421.1996.tb01135.x; Nguyen HLK, 2017, T ROY SOC TROP MED H, V111, P137, DOI 10.1093/trstmh/trx022; Trung NV, 2017, AM J TROP MED HYG, V96, P1084, DOI 10.4269/ajtmh.16-0399; Viet NL, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005397; OHASHI N, 1990, J CLIN MICROBIOL, V28, P2111, DOI 10.1128/JCM.28.9.2111-2113.1990; Park SW, 2011, AM J TROP MED HYG, V85, P924, DOI 10.4269/ajtmh.2011.11-0134; Su TH, 2013, J FORMOS MED ASSOC, V112, P201, DOI 10.1016/j.jfma.2012.02.002; Tamura A, 2001, MICROBIOL IMMUNOL, V45, P439, DOI 10.1111/j.1348-0421.2001.tb02643.x; Wei YH, 2017, VECTOR-BORNE ZOONOT, V17, P260, DOI 10.1089/vbz.2016.2045; Wi YM, 2016, EMERG INFECT DIS, V22, P1992, DOI 10.3201/eid2211.160597; Yang HY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046364	22	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2019	14	8							e0221588	10.1371/journal.pone.0221588	http://dx.doi.org/10.1371/journal.pone.0221588			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW6BO	31469878	Green Submitted, Green Published, gold			2022-12-26	WOS:000485062200023
J	Drew, JA; McKeon, M				Drew, Joshua A.; McKeon, Mallory			Shark-based tourism presents opportunities for facultative dietary shift in coral reef fish	PLOS ONE			English	Article							HERBIVOROUS FISHES; TEETH	Tourism represents an important opportunity to provide sustainable funding for many ecosystems, including marine systems. Tourism that is reliant on aggregating predator species in a specific area using food provisioning raises questions about the long-term ecological impacts to the ecosystem at large? Here, using opportunistically collected video footage, we document that 61 different species of fish across 16 families are consuming tuna flesh at two separate shark dive tourism operations in the Republic of Fiji. Of these fish, we have resolved 55 to species level. Notably, 35 (63%) of the identified species we observed consuming tuna flesh were from ostensibly non-piscivorous fishes, including four Acanthuridae species, a group primarily recognized as browsers or grazers of algae and epibenthic detritus. Our results indicate that shark diving is having a direct impact on species other than sharks and that many species are facultatively expanding their trophic niches to accommodate the hyperabundance of resources provided by ecotourism.	[Drew, Joshua A.; McKeon, Mallory] Columbia Univ, Dept Ecol Evolut & Environm Biol, New York, NY 10027 USA; [Drew, Joshua A.] SUNY Coll Environm Sci & Forestry, Dept Environm & Forest Biol, Syracuse, NY 13210 USA	Columbia University; State University of New York (SUNY) System; State University of New York (SUNY) College of Environmental Science & Forestry	Drew, JA (corresponding author), Columbia Univ, Dept Ecol Evolut & Environm Biol, New York, NY 10027 USA.; Drew, JA (corresponding author), SUNY Coll Environm Sci & Forestry, Dept Environm & Forest Biol, Syracuse, NY 13210 USA.	jadrew@esf.edu			Mindlin Foundation; Earth Institute, Columbia University	Mindlin Foundation; Earth Institute, Columbia University	This work was supported by Mindlin Foundation grants to Joshua Drew and Mallory McKeon, as well as a Earth Institute, Columbia University grant to Mallory McKeon. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrantes KG, 2018, BIOL CONSERV, V224, P300, DOI 10.1016/j.biocon.2018.05.021; Bergman JN, 2017, J FISH BIOL, V91, P460, DOI 10.1111/jfb.13351; Bolnick DI, 2007, P NATL ACAD SCI USA, V104, P10075, DOI 10.1073/pnas.0703743104; Bolnick DI, 2010, P ROY SOC B-BIOL SCI, V277, P1789, DOI 10.1098/rspb.2010.0018; Brunnschweiler JM, 2018, ANIM CONSERV, V21, P31, DOI 10.1111/acv.12370; Brunnschweiler JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086682; Bshary R, 2011, ETHOLOGY, V117, P246, DOI 10.1111/j.1439-0310.2010.01872.x; Bumann GB, 2002, WILDLIFE SOC B, V30, P853; Choat JH, 2002, MAR BIOL, V140, P613, DOI 10.1007/s00227-001-0715-3; Connell SD, 1998, MAR FRESHWATER RES, V49, P25, DOI 10.1071/MF97034; Craig MT, 2007, COPEIA, P459; Ferry-Graham LA, 2001, J EXP MAR BIOL ECOL, V256, P167, DOI 10.1016/S0022-0981(00)00312-9; Frederich B, 2009, ICHTHYOL RES, V56, P10, DOI 10.1007/s10228-008-0053-2; Gallagher AJ, 2015, BIOL CONSERV, V184, P365, DOI 10.1016/j.biocon.2015.02.007; Gleason JS, 2005, CAN FIELD NAT, V119, P591, DOI 10.22621/cfn.v119i4.215; Goatley CHR, 2010, MAR ECOL PROG SER, V415, P237, DOI 10.3354/meps08761; Haas AR, 2017, BIOL CONSERV, V207, P55, DOI 10.1016/j.biocon.2017.01.007; Harmelin-Vivien M.L., 1983, Coral Reefs, V2, P119, DOI 10.1007/BF02395282; Holmes TH, 2012, CORAL REEFS, V31, P1113, DOI 10.1007/s00338-012-0934-8; HORN MH, 1983, OECOLOGIA, V58, P345, DOI 10.1007/BF00385234; LANDRY MR, 1981, MAR BIOL, V65, P77, DOI 10.1007/BF00397070; Marshell A, 2012, CORAL REEFS, V31, P1093, DOI 10.1007/s00338-012-0931-y; McKeon MG, PACIFIC CONSERVATION; Mourier J, 2016, CURR BIOL, V26, P2011, DOI 10.1016/j.cub.2016.05.058; Murphy SE, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0198279; Oates J, 2010, ETHOLOGY, V116, P309, DOI 10.1111/j.1439-0310.2010.01742.x; Peers Michael J.L., 2018, Northwestern Naturalist, V99, P232; Pratchett MS, 2008, J FISH BIOL, V73, P1730, DOI 10.1111/j.1095-8649.2008.02062.x; Pratchett MS, 2001, CORAL REEFS, V20, P13, DOI 10.1007/s003380000113; STEWART MC, 1993, OCEAN COAST MANAGE, V20, P201, DOI 10.1016/0964-5691(93)90067-9; Vongraven D, 2014, J MAR BIOL ASSOC UK, V94, P1357, DOI 10.1017/S0025315413001707; WARNER RR, 1984, AM SCI, V72, P128; WESTNEAT MW, 1988, CORAL REEFS, V7, P89, DOI 10.1007/BF00301646; Whitenack LB, 2010, BIOL J LINN SOC, V100, P271, DOI 10.1111/j.1095-8312.2010.01421.x; Wong CWM, 2019, ENVIRON MANAGE, V63, P282, DOI 10.1007/s00267-018-1125-3; Wyatt ASJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013682	36	3	3	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2019	14	8							e0221781	10.1371/journal.pone.0221781	http://dx.doi.org/10.1371/journal.pone.0221781			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW6AB	31465491	gold, Green Published, Green Submitted			2022-12-26	WOS:000485058200053
J	Pacheco-Sandoval, A; Schramm, Y; Heckel, G; Brassea-Perez, E; Martinez-Porchas, M; Lago-Leston, A				Pacheco-Sandoval, Arlette; Schramm, Yolanda; Heckel, Gisela; Brassea-Perez, Elizabeth; Martinez-Porchas, Marcel; Lago-Leston, Asuncion			The Pacific harbor seal gut microbiota in Mexico: Its relationship with diet and functional inferences	PLOS ONE			English	Article							PHOCA-VITULINA-RICHARDII; BAJA-CALIFORNIA; COMMUNITIES; CAPTIVITY; WILD; MOVEMENTS; PHYLOGENY; EVOLUTION; ABUNDANCE; SEDIMENTS	Diet is a primary driver of the composition of gut microbiota and is considered one of the main routes of microbial colonization. Prey identification is fundamental for correlating the diet with the presence of particular microbial groups. The present study examined how diet influenced the composition and function of the gut microbiota of the Pacific harbor seal (Phoca vitulina richardii) in order to better understand the role of prey consumption in shaping its microbiota. This species is a good indicator of the quality of the local environment due to both its foraging and haul-out site fidelity. DNA was extracted from 20 fecal samples collected from five harbor seal colonies located in Baja California, Mexico. The V4 region of 16S rRNA gene was amplified and sequenced using the Illumina technology. Results showed that the gut microbiota of the harbor seals was dominated by the phyla Firmicutes (37%), Bacteroidetes (26%) and Fusobacteria (26%) and revealed significant differences in its composition among the colonies. Funtional analysis using the PICRUSt software suggests a high number of pathways involved in the basal metabolism, such as those for carbohydrates (22%) and amino acids (20%), and those related to the degradation of persistent environmental pollutants. In addition, a DNA metabarcoding analysis of the same samples, via the amplification and sequencing of the mtRNA 16S and rRNA 18S genes, was used to identify the prey consumed by harbor seals revealing the consumption of prey with mainly demersal habits. Functional redundancy in the seal gut microbiota was observed, irrespective of diet or location. Our results indicate that the frequency of occurrence of specific prey in the harbor seal diet plays an important role in shaping the composition of the gut microbiota of harbor seals by influencing the relative abundance of specific groups of gut microorganisms. A significant relationship was found among diet, gut microbiota composition and OTUs assigned to a particular metabolic pathway.	[Pacheco-Sandoval, Arlette; Heckel, Gisela; Brassea-Perez, Elizabeth; Lago-Leston, Asuncion] Ctr Invest Cient & Educ Super Ensenada, Ensenada, Baja California, Mexico; [Schramm, Yolanda] Univ Autonoma Baja California, Ensenada, Baja California, Mexico; [Martinez-Porchas, Marcel] Ctr Invest Alimentac & Desarrollo, Hermosillo, Sonora, Mexico	CICESE - Centro de Investigacion Cientifica y de Educacion Superior de Ensenada; Universidad Autonoma de Baja California; CIAD - Centro de Investigacion en Alimentacion y Desarrollo	Lago-Leston, A (corresponding author), Ctr Invest Cient & Educ Super Ensenada, Ensenada, Baja California, Mexico.	alago@cicese.mx	Lago-Lestón, Asunción/AFR-8125-2022; Lago, Asuncion/AFS-1438-2022; Heckel, Gisela/K-9170-2016	Lago-Lestón, Asunción/0000-0003-4361-7732; Brassea-Perez, Elizabeth/0000-0002-3334-610X; Martinez-Porchas, Marcel/0000-0003-4074-6731; Heckel, Gisela/0000-0002-6003-7898; Schramm, Yolanda/0000-0001-6951-4884; Pacheco-Sandoval, Arlette/0000-0003-0718-3391	National Council for Science and Technology (CONACyT) of Mexico [179451, 589142]	National Council for Science and Technology (CONACyT) of Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This study was partially funded by the National Council for Science and Technology (CONACyT) of Mexico, through project 179451 (Basic Science 2012) granted to YS and a scholarship number 589142 to APS.	Alaman R., 2014, THESIS; Alfano N, 2015, SCI REP-UK, V5, DOI 10.1038/srep10189; Allen SG, 2011, HARBOR SEAL FIELD GU, P431; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Amaral-Zettler LA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006372; Amato KR, 2015, MICROB ECOL, V69, P434, DOI 10.1007/s00248-014-0554-7; Amato KR, 2013, MICROBIOME SCI MED, V1, P10, DOI DOI 10.2478/MICSM-2013-0002; [Anonymous], 2019, R LANG ENV STAT COMP; Biesalski HK, 2016, ANN NY ACAD SCI, V1372, P53, DOI 10.1111/nyas.13145; Bik EM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10516; Blankenberg D, 2010, BIOINFORMATICS, V26, P1783, DOI 10.1093/bioinformatics/btq281; Borbon-Garcia A, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01316; Borrelli L, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16560-6; Brassea-Perez E, 2019, MAR BIOL, V166, DOI 10.1007/s00227-019-3555-8; BROWN RF, 1983, FISH B-NOAA, V81, P291; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Cunningham L, 2009, AQUAT CONSERV, V19, P398, DOI 10.1002/aqc.983; Deagle BE, 2013, MOL ECOL RESOUR, V13, P620, DOI 10.1111/1755-0998.12103; Deagle BE, 2009, MOL ECOL, V18, P2022, DOI 10.1111/j.1365-294X.2009.04158.x; Degnan PH, 2012, P NATL ACAD SCI USA, V109, P13034, DOI 10.1073/pnas.1110994109; Delport TC, 2016, APPL ENVIRON MICROB, V82, P3440, DOI 10.1128/AEM.00192-16; Durazo RP, 2015, THESIS; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Eguchi T, 2005, MAR MAMMAL SCI, V21, P283, DOI 10.1111/j.1748-7692.2005.tb01228.x; Eilam O, 2014, MBIO, V5, DOI 10.1128/mBio.01526-14; Elorriaga-Verplancken FR, 2013, AQUAT MAMM, V39, P415, DOI 10.1578/AM.39.4.2013.415; Flint S, 2012, J ENVIRON MANAGE, V104, P19, DOI 10.1016/j.jenvman.2012.03.021; Galindo EAG, 1996, MAR POLLUT BULL, V32, P378, DOI 10.1016/0025-326X(95)00187-R; Gehlenborg N, 2016, UPSETR MORE SCALABLE; Glad T, 2010, MICROB ECOL, V60, P320, DOI 10.1007/s00248-010-9690-x; Guerrero-Ferreira RC, 2007, CLADISTICS, V23, P497, DOI 10.1111/j.1096-0031.2007.00155.x; Hanning I, 2015, MICROBIOME, V3, DOI 10.1186/s40168-015-0113-6; Hasegawa M, 2014, INT IMMUNOL, V26, P481, DOI 10.1093/intimm/dxu049; Huerta-Diaz MA, 2008, MAR ENVIRON RES, V66, P345, DOI 10.1016/j.marenvres.2008.05.008; Hume F, 2004, MAR BIOL, V144, P407, DOI 10.1007/s00227-003-1219-0; June A, 2015, OCEANIC MICROCOSMS C; Klindworth A, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks808; La Reau AJ, 2016, MICROB GENOMICS, V2, DOI 10.1099/mgen.0.000099; Lahti L, 2013, PEERJ, V1, DOI 10.7717/peerj.32; Langille MGI, 2013, NAT BIOTECHNOL, V31, P814, DOI 10.1038/nbt.2676; Leser TD, 2009, ENVIRON MICROBIOL, V11, P2194, DOI 10.1111/j.1462-2920.2009.01941.x; Ley RE, 2008, NAT REV MICROBIOL, V6, P776, DOI 10.1038/nrmicro1978; Ley RE, 2008, SCIENCE, V320, P1647, DOI 10.1126/science.1155725; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Lubinsky-Jinich D, 2019, MAR MAMMAL SCI, V35, P1173, DOI 10.1111/mms.12579; Lubinsky-Jinich D, 2017, AQUAT MAMM, V43, P73, DOI 10.1578/AM.43.1.2017.73; Mallott EK, 2018, AM J PHYS ANTHROPOL, V165, P576, DOI 10.1002/ajpa.23395; McFall-Ngai M, 2013, P NATL ACAD SCI USA, V110, P3229, DOI 10.1073/pnas.1218525110; Meehan CJ, 2014, GENOME BIOL EVOL, V6, P703, DOI 10.1093/gbe/evu050; Merson SD, 2014, FEMS MICROBIOL ECOL, V87, P601, DOI 10.1111/1574-6941.12248; Moya A, 2016, TRENDS MICROBIOL, V24, P402, DOI 10.1016/j.tim.2016.02.002; Muegge BD, 2011, SCIENCE, V332, P970, DOI 10.1126/science.1198719; Nelson TM, 2015, MICROBIOL AUST, V36, P8, DOI 10.1071/MA15004; Nelson TM, 2013, ENVIRON MICROBIOL, V15, P1132, DOI 10.1111/1462-2920.12022; Nelson TC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071552; Numberger D, 2016, MICROBIOLOGYOPEN, V5, P782, DOI 10.1002/mbo3.369; Olsen MA, 2000, CAN J MICROBIOL, V46, P85, DOI 10.1139/cjm-46-1-85; Pompanon F, 2012, MOL ECOL, V21, P1931, DOI 10.1111/j.1365-294X.2011.05403.x; Reijnders P J. H., 2009, ENCY MARINE MAMMALS, DOI [10.1016/B978-0-12-373553-9.00205-4, DOI 10.1016/B978-0-12-373553-9.00205-4]; Reindl AR, 2015, WATER AIR SOIL POLL, V226, DOI 10.1007/s11270-015-2536-x; Sanders JG, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9285; Sanfilippo M., 2011, World Journal of Fish and Marine Sciences, V3, P44; Smith SC, 2013, FEMS MICROBIOL ECOL, V86, P246, DOI 10.1111/1574-6941.12157; Steingass Sheanna, 2017, Northwestern Naturalist, V98, P8; Sugita H, 1996, LETT APPL MICROBIOL, V23, P275, DOI 10.1111/j.1472-765X.1996.tb00188.x; Tapia-Harris C, 2017, MAR MAMMAL SCI, V33, P817, DOI 10.1111/mms.12400; Tollit DJ, 1998, J ZOOL, V244, P209, DOI 10.1111/j.1469-7998.1998.tb00026.x; Tsukinowa E, 2008, J GEN APPL MICROBIOL, V54, P25, DOI 10.2323/jgam.54.25; Vorkamp K, 2004, SCI TOTAL ENVIRON, V331, P157, DOI 10.1016/j.scitotenv.2004.03.027; Wichmann A, 2013, CELL HOST MICROBE, V14, P582, DOI 10.1016/j.chom.2013.09.012; Wu GD, 2011, SCIENCE, V334, P105, DOI 10.1126/science.1208344; Yildirim S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013963	74	14	15	3	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2019	14	8							e0221770	10.1371/journal.pone.0221770	http://dx.doi.org/10.1371/journal.pone.0221770			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW6AB	31465508	Green Published, Green Submitted, gold			2022-12-26	WOS:000485058200051
J	Ren, SX; Rutto, L; Katuuramu, D				Ren, Shuxin; Rutto, Laban; Katuuramu, Dennis			Melatonin acts synergistically with auxin to promote lateral root development through fine tuning auxin transport in Arabidopsis thaliana	PLOS ONE			English	Article							OF-FUNCTION MUTATION; ADVENTITIOUS-ROOT; EXOGENOUS MELATONIN; IN-VIVO; PROTEIN; STRESS; GROWTH; RICE; EXPRESSION; REGENERATION	Melatonin (N-acetyl-5-methoxytryptamine) plays important roles in plant developmental growth, especially in root architecture. The similarity in both chemical structure and biosynthetic pathway suggests a potential linkage between melatonin and auxin signaling. However the molecular mechanism regulating this melatonin-mediated root architecture changes is not yet elucidated. In the present study, we re-analyzed previously conducted transcriptome data and identified 16 auxin-related genes whose expression patterns were altered by treatment with melatonin. Several of these genes encoding important auxin transporters or strongly affecting auxin transport were significantly down regulated. In wild type Arabidopsis, Melatonin inhibited both primary root growth and hypocotyl elongation, but enhanced lateral root development in a dose dependent manner. However, the lateral-root-promoting role of melatonin was abolished when each individual null mutant affecting auxin transport including pin5, wag1, tt4 and tt5, was examined. Furthermore, melatonin acts synergistically with auxin to promote lateral root development in wild type Arabidopsis, but such synergistic effects were absent in knockout mutants of individual auxin transport related genes examined. These results strongly suggest that melatonin enhances lateral root development through regulation of auxin distribution via modulation of auxin transport. A working model is proposed to explain how melatonin and auxin act together to promote lateral root development. The present study deepens our understanding of the relationship between melatonin and auxin signaling in plant species.	[Ren, Shuxin; Rutto, Laban; Katuuramu, Dennis] Virginia State Univ, Agr Res Stn, Petersburg, VA 23806 USA	Virginia State University	Ren, SX (corresponding author), Virginia State Univ, Agr Res Stn, Petersburg, VA 23806 USA.	sren@vsu.edu		Katuuramu, Dennis N./0000-0002-6316-6601				Armengot L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157168; Arnao MB, 2018, ANN BOT-LONDON, V121, P195, DOI 10.1093/aob/mcx114; Arnao MB, 2017, ACTA PHYSIOL PLANT, V39, DOI 10.1007/s11738-017-2428-3; Arnao MB, 2007, J PINEAL RES, V42, P147, DOI 10.1111/j.1600-079X.2006.00396.x; Arnao MB, 2006, PLANT SIGNAL BEHAV, V1, P89, DOI 10.4161/psb.1.3.2640; Arnao MB, 2019, TRENDS PLANT SCI, V24, P38, DOI 10.1016/j.tplants.2018.10.010; Arnao MB, 2015, J PINEAL RES, V59, P133, DOI 10.1111/jpi.12253; Arnao MB, 2014, TRENDS PLANT SCI, V19, P789, DOI 10.1016/j.tplants.2014.07.006; Back K, 2016, J PINEAL RES, V61, P426, DOI 10.1111/jpi.12364; Bajwa VS, 2014, J PINEAL RES, V56, P238, DOI 10.1111/jpi.12115; Barbez E, 2012, NATURE, V485, P119, DOI 10.1038/nature11001; Brown DE, 2001, PLANT PHYSIOL, V126, P524, DOI 10.1104/pp.126.2.524; Buer CS, 2009, J EXP BOT, V60, P751, DOI 10.1093/jxb/ern323; Buer CS, 2004, PLANT CELL, V16, P1191, DOI 10.1105/tpc.020313; Byeon Y, 2014, J PINEAL RES, V56, P189, DOI 10.1111/jpi.12111; Byeon Y, 2012, J PINEAL RES, V53, P107, DOI 10.1111/j.1600-079X.2012.00976.x; Cain CC, 1997, PLANT MOL BIOL, V35, P377, DOI 10.1023/A:1005846620791; Carrillo-Vico A, 2013, INT J MOL SCI, V14, P8638, DOI 10.3390/ijms14048638; Chen Q, 2009, J PLANT PHYSIOL, V166, P324, DOI 10.1016/j.jplph.2008.06.002; Christensen SK, 2000, CELL, V100, P469, DOI 10.1016/S0092-8674(00)80682-0; DeLong A, 2002, PLANT MOL BIOL, V49, P285, DOI 10.1023/A:1015246828230; Dindas J, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03582-5; DUBBELS R, 1995, J PINEAL RES, V18, P28, DOI 10.1111/j.1600-079X.1995.tb00136.x; Fukaki H, 2002, PLANT J, V29, P153, DOI 10.1046/j.0960-7412.2001.01201.x; Gao SP, 2014, PLANT PHYSIOL, V165, P1035, DOI 10.1104/pp.114.238584; Han QH, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00785; Hardeland R, 2012, J PINEAL RES, V52, P139, DOI 10.1111/j.1600-079X.2011.00934.x; HATTORI A, 1995, BIOCHEM MOL BIOL INT, V35, P627; Hernandez-Ruiz J, 2005, J PINEAL RES, V39, P137, DOI 10.1111/j.1600-079X.2005.00226.x; Inukai Y, 2005, PLANT CELL, V17, P1387, DOI 10.1105/tpc.105.030981; Kim M, 2016, J PLANT PHYSIOL, V190, P67, DOI 10.1016/j.jplph.2015.11.009; Korkmaz A, 2017, J AGR SCI-TARIM BILI, V23, P167; Kostopoulou Z, 2015, PLANT PHYSIOL BIOCH, V86, P155, DOI 10.1016/j.plaphy.2014.11.021; Koyama FC, 2013, J EUKARYOT MICROBIOL, V60, P646, DOI 10.1111/jeu.12080; Krecek P, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-12-249; Lavenus J, 2013, TRENDS PLANT SCI, V18, P455, DOI 10.1016/j.tplants.2013.04.006; LERNER AB, 1958, J AM CHEM SOC, V80, P2587, DOI 10.1021/ja01543a060; Li C, 2016, J PINEAL RES, V61, P218, DOI 10.1111/jpi.12342; Liang CZ, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00134; Liu HJ, 2005, PLANT J, V43, P47, DOI 10.1111/j.1365-313X.2005.02434.x; Liu N, 2015, SCI HORTIC-AMSTERDAM, V181, P18, DOI 10.1016/j.scienta.2014.10.049; Liu SP, 2009, CELL RES, V19, P1110, DOI 10.1038/cr.2009.70; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maloney GS, 2014, PLANT PHYSIOL, V166, P614, DOI 10.1104/pp.114.240507; Michniewicz M, 2007, CELL, V130, P1044, DOI 10.1016/j.cell.2007.07.033; Middleton AM, 2018, CELL REP, V22, P3044, DOI 10.1016/j.celrep.2018.02.074; Mravec J, 2009, NATURE, V459, P1136, DOI 10.1038/nature08066; Mukherjee S, 2014, PHYSIOL PLANTARUM, V152, P714, DOI 10.1111/ppl.12218; Overvoorde P, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001537; Pandi-Perumal SR, 2008, NAT CLIN PRACT NEURO, V4, P436, DOI 10.1038/ncpneuro0847; Pape C, 2006, J PINEAL RES, V41, P157, DOI 10.1111/j.1600-079X.2006.00348.x; Park S, 2012, J PINEAL RES, V53, P385, DOI 10.1111/j.1600-079X.2012.01008.x; Park WJ, 2011, J PLANT BIOL, V54, P143, DOI 10.1007/s12374-011-9159-6; Peer WA, 2004, PLANT CELL, V16, P1898, DOI 10.1105/tpc.021501; Peer WA, 2007, TRENDS PLANT SCI, V12, P556, DOI 10.1016/j.tplants.2007.10.003; Pelagio-Flores R, 2012, J PINEAL RES, V53, P279, DOI 10.1111/j.1600-079X.2012.00996.x; Posmyk MM, 2009, J PINEAL RES, V46, P214, DOI 10.1111/j.1600-079X.2008.00652.x; Rashotte AM, 2001, PLANT CELL, V13, P1683, DOI 10.1105/tpc.13.7.1683; Ren SX, 2004, PLANT CELL, V16, P2910, DOI 10.1105/tpc.104.025072; Rogg LE, 2001, PLANT CELL, V13, P465, DOI 10.1105/tpc.13.3.465; Santner AA, 2006, PLANT J, V45, P752, DOI 10.1111/j.1365-313X.2005.02641.x; Sarropoulou V, 2012, PLANT PHYSIOL BIOCH, V61, P162, DOI 10.1016/j.plaphy.2012.10.001; Sarropoulou VN, 2012, J PINEAL RES, V52, P38, DOI 10.1111/j.1600-079X.2011.00914.x; Sarrou E, 2014, TURK J BOT, V38, P293, DOI 10.3906/bot-1302-55; Shi HT, 2015, J EXP BOT, V66, P681, DOI 10.1093/jxb/eru373; Shi HT, 2015, J PINEAL RES, V58, P26, DOI 10.1111/jpi.12188; SHIRLEY BW, 1992, PLANT CELL, V4, P333, DOI 10.1105/tpc.4.3.333; Tan DX, 2015, MOLECULES, V20, P18886, DOI 10.3390/molecules201018886; Tan DX, 2013, J PINEAL RES, V54, P127, DOI 10.1111/jpi.12026; Tan DX, 2019, MELATONIN RES, V2, P44, DOI DOI 10.32794/MR11250011; Tatematsu K, 2004, PLANT CELL, V16, P379, DOI 10.1105/tpc.018630; Tian Q, 1999, DEVELOPMENT, V126, P711; Tuomi T, 2016, CELL METAB, V23, P1067, DOI 10.1016/j.cmet.2016.04.009; Uehara T, 2008, PLANT CELL PHYSIOL, V49, P1025, DOI 10.1093/pcp/pcn079; Wang L, 2017, J PINEAL RES, V63, DOI 10.1111/jpi.12429; Wang L, 2014, J PINEAL RES, V56, P134, DOI 10.1111/jpi.12105; Wang QN, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01882; Wasson AP, 2006, PLANT CELL, V18, P1617, DOI 10.1105/tpc.105.038232; Weeda S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093462; Wei J, 2018, J PINEAL RES, V65, DOI 10.1111/jpi.12500; Wei X, 2001, BIOPHYS J, V84, P1317; Wen D, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00718; Yang XQ, 2004, PLANT J, V40, P772, DOI 10.1111/j.1365-313X.2004.02254.x; Zhang N, 2015, J EXP BOT, V66, P647, DOI 10.1093/jxb/eru336; Zhang N, 2014, J PINEAL RES, V56, P39, DOI 10.1111/jpi.12095; Zhang N, 2013, J PINEAL RES, V54, P15, DOI 10.1111/j.1600-079X.2012.01015.x; Zhang RM, 2017, J PINEAL RES, V62, DOI 10.1111/jpi.12403; Zhao YD, 2012, MOL PLANT, V5, P334, DOI 10.1093/mp/ssr104; Zourelidou M, 2014, ELIFE, V3, DOI 10.7554/eLife.02860; Zuo BX, 2014, J PINEAL RES, V57, P408, DOI 10.1111/jpi.12180	90	24	25	7	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2019	14	8							e0221687	10.1371/journal.pone.0221687	http://dx.doi.org/10.1371/journal.pone.0221687			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5XV	31461482	Green Submitted, Green Published, gold			2022-12-26	WOS:000485052300044
J	Marinho, PRD; Silva, RB; Bourguignon, M; Cordeiro, GM; Nadarajah, S				Marinho, Pedro Rafael D.; Silva, Rodrigo B.; Bourguignon, Marcelo; Cordeiro, Gauss M.; Nadarajah, Saralees			AdequacyModel: An R package for probability distributions and general purpose optimization	PLOS ONE			English	Article								Several lifetime distributions have played an important role to fit survival data. However, for some of these models, the computation of maximum likelihood estimators is quite difficult due to presence of flat regions in the search space, among other factors. Several well-known derivative-based optimization tools are unsuitable for obtaining such estimates. To circumvent this problem, we introduce the AdequacyModel computational library version 2.0.0 for the R statistical environment with two major contributions: a general optimization technique based on the Particle Swarm Optimization (PSO) method (with a minor modification of the original algorithm) and a set of statistical measures for assessment of the adequacy of the fitted model. This library is very useful for researchers in probability and statistics and has been cited in various papers in these areas. It serves as the basis for the Newdistns library (version 2.1) published in an impact journal in the area of computational statistics, see https://CRAN.R-project.org/package=Newdistns. It is also the basis of the Wrapped library (version 2.0), see https://CRAN.R-project.org/package=Wrapped. A third package making use of the AdequacyModel library can be found in https://CRAN.R-project.org/package=sglg. In addition, the proposed library has proved to be very useful for maximizing log-likelihood functions with complex search regions. The library provides a greater control of the optimization process by introducing a stop criterion based on a minimum number of iterations and the variance of a given proportion of optimal values. We emphasize that the new library can be used not only in statistics but in physics and mathematics as proved in several examples throughout the paper.	[Marinho, Pedro Rafael D.; Silva, Rodrigo B.] Univ Fed Paraiba, Dept Stat, Joao Pessoa, Paraiba, Brazil; [Bourguignon, Marcelo] Univ Fed Rio Grande do Norte, Dept Stat, Natal, RN, Brazil; [Cordeiro, Gauss M.] Univ Fed Pernambuco, Dept Stat, Recife, PE, Brazil; [Nadarajah, Saralees] Univ Manchester, Sch Math, Manchester, Lancs, England	Universidade Federal da Paraiba; Universidade Federal do Rio Grande do Norte; Universidade Federal de Pernambuco; University of Manchester	Marinho, PRD (corresponding author), Univ Fed Paraiba, Dept Stat, Joao Pessoa, Paraiba, Brazil.	pedro.rafael.marinho@gmail.com	Cordeiro, Moutinho/AAR-6126-2021	Marinho, Pedro Rafael/0000-0003-1591-8300				AARSET MV, 1987, IEEE T RELIAB, V36, P106, DOI 10.1109/TR.1987.5222310; Andras P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048710; Bratton Dan, 2008, Journal of Artificial Evolution & Applications, DOI 10.1155/2008/654184; Bratton D, 2007, 2007 IEEE SWARM INTELLIGENCE SYMPOSIUM, P120, DOI 10.1109/SIS.2007.368035; CHEN GM, 1995, J QUAL TECHNOL, V27, P154, DOI 10.1080/00224065.1995.11979578; Davison AC, 1997, BOOTSTRAP METHODS TH, V1; DUMONCEAUX R, 1973, TECHNOMETRICS, V15, P923, DOI 10.2307/1267401; Kennedy J, 1995, 1995 IEEE INTERNATIONAL CONFERENCE ON NEURAL NETWORKS PROCEEDINGS, VOLS 1-6, P1942, DOI 10.1109/icnn.1995.488968; Kennedy J., 1995, P ICNN 95 INT C NEUR, P1942; Khan A., 2010, IJCSE INT J COMPUT S, V2, P2223; Lins ID, 2012, QUAL RELIAB ENG INT, V28, P141, DOI 10.1002/qre.1221; Nichols MD, 2006, QUAL RELIAB ENG INT, V22, P141, DOI 10.1002/qre.691; Tahir MH, 2016, J STAT DISTRIBUTIONS, P3; Wang FK, 2014, J STAT COMPUT SIM, V84, P1975, DOI 10.1080/00949655.2013.778992; Ying L, 20 INT C PATT REC IC	16	19	19	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2019	14	8							e0221487	10.1371/journal.pone.0221487	http://dx.doi.org/10.1371/journal.pone.0221487			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5UR	31450236	Green Submitted, gold, Green Published			2022-12-26	WOS:000485044000019
J	Tipton, CD; Sanford, NE; Everett, JA; Gabrilska, RA; Wolcott, RD; Rumbaugh, KP; Phillips, CD				Tipton, Craig D.; Sanford, Nicholas E.; Everett, Jake A.; Gabrilska, Rebecca A.; Wolcott, Randall D.; Rumbaugh, Kendra P.; Phillips, Caleb D.			Chronic wound microbiome colonization on mouse model following cryogenic preservation	PLOS ONE			English	Article							BIOFILM-INFECTED WOUNDS; PSEUDOMONAS-AERUGINOSA; DIABETIC FOOT; PATHOGENESIS	Chronic wound infections are increasingly recognized to be dynamic and polymicrobial in nature, necessitating the development of wound models which reflect the complexities of infection in a non-healing wound. Wound slough isolated from human chronic wounds and transferred to mice was recently shown to create polymicrobial infection in mice, and there is potential this tool may be improved by cryogenic preservation. The purpose of this study was to investigate the application of cryogenic preservation to transferring polymicrobial communities, specifically by quantifying the effects of cryopreservation and wound microbiome transplantation. Slough from an established murine polymicrobial surgical excision model and five patients were subjected to three preservation strategies: refrigeration until infection, freezing in liquid nitrogen, or freezing in liquid nitrogen with glycerol solution prior to infection in individual mice. Four days following inoculation onto mice, wound microbiota were quantified using either culture isolation or by 16s rRNA gene community profiling and quantitative PCR. Cryogenic preservation did not significantly reduce bacterial viability. Reestablished microbial communities were significantly associated with patient of origin as well as host context (i.e., originally preserved from a patient versus mouse infection). Whereas preservation treatment did not significantly shape community composition, the transfers of microbiomes from human to mouse were characterized by reduced diversity and compositional changes. These findings indicated that changes should be expected to occur to community structure after colonization, and that compositional change is likely due to the rapid change in infection context as opposed to preservation strategy. Furthermore, species that were present in higher relative abundance in wound inoculate were more likely to colonize subsequent wounds, and wound inoculate with higher bacterial load established wound communities that were more compositionally similar. Results inform expectations for the complementation of chronic wound in vivo modeling with cryogenic preservation archives.	[Tipton, Craig D.; Phillips, Caleb D.] Texas Tech Univ, Dept Biol Sci, Lubbock, TX 79409 USA; [Tipton, Craig D.] RTL Genom, Res & Testing Labs, Lubbock, TX 79424 USA; [Sanford, Nicholas E.; Wolcott, Randall D.] Southwest Reg Wound Care Ctr, Lubbock, TX USA; [Everett, Jake A.; Gabrilska, Rebecca A.; Rumbaugh, Kendra P.] Texas Tech Univ, Hlth Sci Ctr, Dept Surg, Lubbock, TX 79430 USA; [Phillips, Caleb D.] Texas Tech Univ, Nat Sci Res Lab, Lubbock, TX 79409 USA	Texas Tech University System; Texas Tech University; Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center; Texas Tech University System; Texas Tech University	Tipton, CD (corresponding author), Texas Tech Univ, Dept Biol Sci, Lubbock, TX 79409 USA.; Tipton, CD (corresponding author), RTL Genom, Res & Testing Labs, Lubbock, TX 79424 USA.	craig.tipton@ttu.edu	Tipton, Craig/AAQ-9649-2020	Tipton, Craig/0000-0002-0405-9371	Natural Science Research Laboratory at TTU	Natural Science Research Laboratory at TTU	The authors thank the Southwest Regional Wound Care Center and the Natural Science Research Laboratory at TTU for their support and technical assistance, Dr. Jeremy Wilkinson for procedural insight and Oscar Sandate for statistical programming assistance.	Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Andreasson A, 2013, BIOPRESERV BIOBANK, V11, P366, DOI 10.1089/bio.2013.0038; Costalonga M, 2014, IMMUNOL LETT, V162, P22, DOI 10.1016/j.imlet.2014.08.017; Dai TH, 2011, VIRULENCE, V2, P296, DOI 10.4161/viru.2.4.16840; Dalton T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027317; De Paoli P, 2005, FEMS MICROBIOL REV, V29, P897, DOI 10.1016/j.femsre.2005.01.005; DeLeon S, 2014, INFECT IMMUN, V82, P4718, DOI 10.1128/IAI.02198-14; Driver VR, 2010, J VASC SURG, V52, p17S, DOI 10.1016/j.jvs.2010.06.003; Dumont F, 2004, APPL ENVIRON MICROB, V70, P268, DOI 10.1128/AEM.70.1.268-272.2004; FAITH DP, 1987, VEGETATIO, V69, P57, DOI 10.1007/BF00038687; Flemming HC, 2016, NAT REV MICROBIOL, V14, P563, DOI 10.1038/nrmicro.2016.94; Gabrilska RA, 2015, FUTURE MICROBIOL, V10, P1997, DOI 10.2217/fmb.15.109; Giannini C, 2011, ARCH PATHOL LAB MED, V135, P347, DOI 10.1043/2010-0044-SA.1; Guilbaud M, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01465; Gurjala AN, 2011, WOUND REPAIR REGEN, V19, P400, DOI 10.1111/j.1524-475X.2011.00690.x; Holmes CJ, 2015, ADV WOUND CARE, V4, P24, DOI 10.1089/wound.2014.0546; Kalan L., 2016, MBIO, V7, P5, DOI DOI 10.1128/MBI0.01058-16; Kolenbrander PE, 2010, NAT REV MICROBIOL, V8, P471, DOI 10.1038/nrmicro2381; Legendre P, 2001, OECOLOGIA, V129, P271, DOI 10.1007/s004420100716; Loesche M, 2017, J INVEST DERMATOL, V137, P237, DOI 10.1016/j.jid.2016.08.009; Makrantonaki E, 2017, J DTSCH DERMATOL GES, V15, P255, DOI 10.1111/ddg.13199; McLean BS, 2016, J MAMMAL, V97, P287, DOI 10.1093/jmammal/gyv178; Muhlebach MS, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006798; Nakagami G, 2017, WOUND REPAIR REGEN, V25, P131, DOI 10.1111/wrr.12505; Nocker A, 2007, APPL ENVIRON MICROB, V73, P5111, DOI 10.1128/AEM.02987-06; Phillips CD, 2017, INTEGR COMP BIOL, V57, P743, DOI 10.1093/icb/icx011; Pletzer D, 2017, MBIO, V8, DOI 10.1128/mBio.00140-17; Qian LW, 2016, WOUND REPAIR REGEN, V24, P26, DOI 10.1111/wrr.12381; R Core Team, 2016, R A LANGUAGE ENVIRON; Ramette A, 2007, FEMS MICROBIOL ECOL, V62, P142, DOI 10.1111/j.1574-6941.2007.00375.x; Reiber GE, 1998, AM J SURG, V176, p5S, DOI 10.1016/S0002-9610(98)00181-0; Schaudinn C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186946; Seaton M, 2015, ILAR J, V56, P127, DOI 10.1093/ilar/ilv016; Seth AK, 2012, J SURG RES, V178, P330, DOI 10.1016/j.jss.2012.06.048; Seth AK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042897; Seth AK, 2012, PLAST RECONSTR SURG, V129, p262E, DOI 10.1097/PRS.0b013e31823aeb3b; Sun Y, 2009, J Wound Care, V18, P426; Sun Y, 2008, WOUND REPAIR REGEN, V16, P805, DOI 10.1111/j.1524-475X.2008.00434.x; Tipton CD, 2017, WOUND REPAIR REGEN, V25, P673, DOI 10.1111/wrr.12555; Trivedi U, 2017, CRIT REV MICROBIOL, V43, P453, DOI 10.1080/1040841X.2016.1252312; Wolcott R, 2016, J WOUND CARE, V25, pS33, DOI 10.12968/jowc.2016.25.Sup10.S33; Wolcott RD, 2016, WOUND REPAIR REGEN, V24, P163, DOI 10.1111/wrr.12370; Wolcott RD, 2010, MICROBIOLOGY OF WOUNDS, P219, DOI 10.1201/9781420079944-c7; Zhao H, 2016, J BACTERIOL, V198, P2936, DOI 10.1128/JB.00448-16	44	7	7	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2019	14	8							e0221565	10.1371/journal.pone.0221565	http://dx.doi.org/10.1371/journal.pone.0221565			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5TR	31442275	Green Published, gold, Green Submitted			2022-12-26	WOS:000485041400051
J	Dominguez-Vicent, A; Brautaset, R; Venkataraman, AP				Dominguez-Vicent, Alberto; Brautaset, Rune; Venkataraman, Abinaya Priya			Repeatability of quantitative measurements of retinal layers with SD-OCT and agreement between vertical and horizontal scan protocols in healthy eyes	PLOS ONE			English	Article							NERVE-FIBER LAYER; OPTICAL COHERENCE TOMOGRAPHY; INNER PLEXIFORM LAYER; SPECTRAL-DOMAIN; THICKNESS MEASUREMENTS; MACULAR THICKNESS; TIME-DOMAIN; REPRODUCIBILITY; VARIABILITY; AGE	Purpose To evaluate the repeatability of the new spectral domain optical coherence tomography (HOCT-1F), and also to evaluate the agreement between vertical and horizontal scan protocols. In addition, we also evaluated the relation between the repeatability and age. Methods Three consecutive measurements of the inner limiting membrane retinal pigment epithelium (ILM-RPE), inner limiting membrane inner plexiform layer (ILM-IPL) from macular horizontal and vertical scans, and inner limiting membrane retinal nerve fiber layer (ILM-RNFL) from optic disc horizontal scan. 159 subjects were included in the analysis. The within subject standard deviation (Sw) and the repeatability limits (R-limit) are used to represent the repeatability of the parameters for the different sectors. Results The Sw for the ILM-RPE thickness was less than 3.5 mu m for each sector and scan direction. The Sw values varied within the sectors and scan modes, with horizontal scan modes resulting in better values for the horizontal sectors, and vice versa. The Sw for the GCL-IPL thickness was less than 2 mu m, and was similar between the vertical and horizontal scan modes for each sector map. For the optic disc scan, the Sw was not symmetric along the clock-hour map sectors, the largest Sw values were seen in the vertical sectors (8.6 mu m). The mean difference between the vertical and horizontal scans was less than 2 mu m for each retinal thickness sector map. Significant but weak correlation between the Sw and the subject's age was seen in both macular and optic disc scans. Conclusions The repeatability of the HOCT-1 F to measure the ILM-RPE-, ILM-IPL- and ILM-RNFL-thickness is good. The repeatability of the ILM-RPE thickness is dependent on the scan direction,which should be taken into account when calculating retinal thickness. There is a weak correlation between the repeatability and the subject's age.	[Dominguez-Vicent, Alberto; Brautaset, Rune; Venkataraman, Abinaya Priya] Karolinska Inst, Dept Clin Neurosci, Unit Optometry, Stockholm, Sweden	Karolinska Institutet	Dominguez-Vicent, A (corresponding author), Karolinska Inst, Dept Clin Neurosci, Unit Optometry, Stockholm, Sweden.	alberto.dominguez.vicent@ki.se	Dominguez-Vicent, Alberto/GPT-0905-2022; Brautaset, Rune/GQZ-1681-2022; Venkataraman, Abinaya/AAG-6996-2021					Alamouti B, 2003, BRIT J OPHTHALMOL, V87, P899, DOI 10.1136/bjo.87.7.899; [Anonymous], 1994, ACC TRUEN PREC MEA 1; Bland JM, 1999, STAT METHODS MED RES, V8, P135, DOI 10.1191/096228099673819272; Caldito NG, 2018, CURR EYE RES, V43, P415, DOI 10.1080/02713683.2017.1406526; Camacho P, 2017, OPHTHALMOLOGICA, V238, P31, DOI 10.1159/000468965; Cheung CYL, 2008, OPHTHALMOLOGY, V115, P1347, DOI 10.1016/j.ophtha.2007.11.027; Comyn O, 2012, INVEST OPHTH VIS SCI, V53, P7754, DOI 10.1167/iovs.12-10895; Ctori I, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129005; Denniss J, 2019, CLIN EXP OPTOM, V102, P291, DOI 10.1111/cxo.12844; Eriksson U, 2012, ACTA OPHTHALMOL, V90, P620, DOI 10.1111/j.1755-3768.2011.02112.x; Hood DC, 2008, J GLAUCOMA, V17, P519, DOI 10.1097/IJG.0b013e3181629a02; ISO, 2006, PROB GEN STAT TERMS; Krzystolik MG, 2007, OPHTHALMOLOGY, V114, P1520, DOI 10.1016/j.ophtha.2006.10.055; Lee SY, 2017, J GLAUCOMA, V26, pE46, DOI [10.1097/IJG.000000000000536, 10.1097/IJG.0000000000000536]; Leung CKS, 2009, OPHTHALMOLOGY, V116, P1257, DOI 10.1016/j.ophtha.2009.04.013; Liu XT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087996; Liu YN, 2015, AM J OPHTHALMOL, V159, P565, DOI 10.1016/j.ajo.2014.12.006; Matlach J, 2014, INVEST OPHTH VIS SCI, V55, P6536, DOI 10.1167/iovs.14-15072; McAlinden C, 2011, OPHTHAL PHYSL OPT, V31, P330, DOI 10.1111/j.1475-1313.2011.00851.x; Mwanza JC, 2018, EYE VISION, V5, DOI 10.1186/s40662-018-0101-6; Mwanza JC, 2018, CURR OPIN OPHTHALMOL, V29, P121, DOI 10.1097/ICU.0000000000000452; Nittala MG, 2019, OPHTHALMOL RETINA, V3, P112, DOI 10.1016/j.oret.2018.09.017; Patel NB, 2014, INVEST OPHTH VIS SCI, V55, P5134, DOI 10.1167/iovs.14-14303; Pierro L, 2012, INVEST OPHTH VIS SCI, V53, P5912, DOI 10.1167/iovs.11-8644; Seibold LK, 2010, AM J OPHTHALMOL, V150, P807, DOI 10.1016/j.ajo.2010.06.024; Shi C, 2019, INVEST OPHTH VIS SCI, V60, P1213, DOI 10.1167/iovs.18-25809; Toteberg-Harms M, 2012, GRAEF ARCH CLIN EXP, V250, P279, DOI 10.1007/s00417-011-1811-9; Wadhwani M, 2015, J GLAUCOMA, V24, pe109, DOI 10.1097/IJG.0000000000000203; Wintergerst MWM, 2017, TRANSL VIS SCI TECHN, V6, DOI 10.1167/tvst.6.4.10; Wolf-Schnurrbusch UEK, 2009, INVEST OPHTH VIS SCI, V50, P3432, DOI 10.1167/iovs.08-2970; Wu ZC, 2018, TRANSL VIS SCI TECHN, V7, DOI 10.1167/tvst.7.3.5; Wu ZQ, 2007, OPHTHALMOLOGY, V114, P1505, DOI 10.1016/j.ophtha.2006.10.061	32	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2019	14	8							e0221466	10.1371/journal.pone.0221466	http://dx.doi.org/10.1371/journal.pone.0221466			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5RZ	31437222	Green Published, Green Submitted, gold			2022-12-26	WOS:000485036900076
J	Li, YC				Li, Ying-Chun			Continuity of care for newly diagnosed diabetic patients: A population-based study	PLOS ONE			English	Article							PREVENTABLE HOSPITALIZATION; INTERPERSONAL CONTINUITY; AMBULATORY-CARE; OUTCOMES; IMPACT; MEDICATION; ASTHMA; COHORT; RISK; EXPENDITURES	This study explores whether continuity of care is associated with health care outcomes and medical care use among patients with newly diagnosed diabetes. A retrospective cohort analysis was performed using the Taiwanese National Health Insurance database, and cases were followed up from January 2010 to December 2012. Four thousand and seven patients with newly diagnosed diabetes were followed for 3 years. The continuity of care was measured using the continuity of care index (COCI) and the usual provider continuity score (UPCS) with high and low dichotomous categories. The probabilities of dementia, hospitalization, emergency room visits, and death were used as health care outcomes. Medical care use was defined as the number of hospital admissions, length of hospital stays, and number of emergency room visits. Adjusted odds ratios (ORs) were obtained using multivariate logistic regression; adjusted ORs for the probabilities of dementia, hospital admissions, and emergency room visits in the higher COCI patient group were 0.582 (p < 0.05), 0.623 (p < 0.001), and 0.650 (p < 0.001), respectively. Negative binomial regression models for medical resource use indicated that the group with higher COCI scores used fewer medical resources compared with the group with lower COCI scores. The findings of UPCS analysis showed that those in the high COCI group also fell into the high UPCS group. In this study, continuity of care was associated with favorable health care outcomes and less medical care uses among newly diagnosed diabetic patients. Long-term relationships between patients and health care providers should be enhanced to provide improved continuity of care.	[Li, Ying-Chun] Natl Sun Yat Sen Univ, Inst Hlth Care Management, Kaohsiung, Taiwan	National Sun Yat Sen University	Li, YC (corresponding author), Natl Sun Yat Sen Univ, Inst Hlth Care Management, Kaohsiung, Taiwan.	ycli@mail.nsysu.edu.tw		Li, Ying-Chun/0000-0001-8516-970X	Ministry of Science and Technology in Taiwan [MOST 103-2410-H-110-076]	Ministry of Science and Technology in Taiwan(Ministry of Science and Technology, Taiwan)	This study was supported by Ministry of Science and Technology (MOST 103-2410-H-110-076) in Taiwan to YCL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by the Ministry of Science and Technology (MOST 103-2410-H-110-076) of Taiwan. The funders had no role in study design, data collection, and analysis, the decision to publish, or preparation of the manuscript.	Aller MB, 2013, INT J QUAL HEALTH C, V25, P291, DOI 10.1093/intqhc/mzt010; Bentler SE, 2014, QUAL LIFE RES, V23, P185, DOI 10.1007/s11136-013-0472-z; BICE TW, 1977, MED CARE, V15, P347, DOI 10.1097/00005650-197704000-00010; BRESLAU N, 1975, J MED EDUC, V50, P965; Bynum JPW, 2004, J AM GERIATR SOC, V52, P187, DOI 10.1111/j.1532-5415.2004.52054.x; Charlson ME, 2008, J CLIN EPIDEMIOL, V61, P1234, DOI 10.1016/j.jclinepi.2008.01.006; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chen TJ, 2006, BMC HEALTH SERV RES, V6, DOI 10.1186/1472-6963-6-54; Cheng SH, 2014, MED CARE, V52, P149, DOI 10.1097/MLR.0000000000000042; Cho KH, 2016, INT J QUAL HEALTH C, V28, P478, DOI 10.1093/intqhc/mzw050; Cho KH, 2015, BMC HEALTH SERV RES, V15, DOI 10.1186/s12913-015-0745-z; Chu HY, 2012, MED CARE, V50, P1002, DOI 10.1097/MLR.0b013e31826c870f; Coleman EA, 2004, ANN INTERN MED, V141, P533, DOI 10.7326/0003-4819-141-7-200410050-00009; Comino EJ, 2015, DIABETES RES CLIN PR, V108, P296, DOI 10.1016/j.diabres.2015.02.003; Crane PK, 2013, NEW ENGL J MED, V369, P540, DOI [10.1056/NEJMoa1215740, 10.1056/NEJMc1311765]; Dearinger AT, 2008, J GEN INTERN MED, V23, P937, DOI 10.1007/s11606-008-0654-5; Gill James M, 2003, Ann Fam Med, V1, P162, DOI 10.1370/afm.22; Gill JM, 1998, ARCH FAM MED, V7, P352, DOI 10.1001/archfami.7.4.352; Gill JM, 2000, ARCH FAM MED, V9, P333, DOI 10.1001/archfami.9.4.333; Gulliford MC, 2007, FAM PRACT, V24, P245, DOI 10.1093/fampra/cmm014; Haggerty JL, 2003, BRIT MED J, V327, P1219, DOI 10.1136/bmj.327.7425.1219; Hong JS, 2010, J KOREAN MED SCI, V25, P1259, DOI 10.3346/jkms.2010.25.9.1259; Hong JS, 2013, HEALTH POLICY, V109, P158, DOI 10.1016/j.healthpol.2012.09.009; Huang CC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087095; HURLEY RE, 1991, INQUIRY-J HEALTH CAR, V28, P375; Jee SH, 2006, MED CARE RES REV, V63, P158, DOI 10.1177/1077558705285294; Kawamura T, 2012, J DIABETES INVEST, V3, P413, DOI 10.1111/j.2040-1124.2012.00234.x; Kristjansson E, 2013, BMC FAM PRACT, V14, DOI 10.1186/1471-2296-14-72; L'Heveder R, 2013, DIABETES RES CLIN PR, V101, P349, DOI 10.1016/j.diabres.2013.08.003; Lin W, 2010, INT J QUAL HEALTH C, V22, P3, DOI 10.1093/intqhc/mzp059; Lustman A, 2016, PRIM CARE DIABETES, V10, P165, DOI 10.1016/j.pcd.2015.10.001; Meurer JR, 1998, PEDIATRICS, V102, part. no., DOI 10.1542/peds.102.6.e70; Ministry of Health and Welfare, NAT HLTH INS STAT; Napolitano F, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154940; Nyweide DJ, 2013, JAMA INTERN MED, V173, P1879, DOI 10.1001/jamainternmed.2013.10059; Raddish M, 1999, AM J MANAG CARE, V5, P727; Saultz John W, 2003, Ann Fam Med, V1, P134, DOI 10.1370/afm.23; Shin DW, 2014, ANN FAM MED, V12, P534, DOI 10.1370/afm.1685; SHORTELL SM, 1976, MED CARE, V14, P377, DOI 10.1097/00005650-197605000-00001; SKOBELOFF EM, 1992, JAMA-J AM MED ASSOC, V268, P3437, DOI 10.1001/jama.268.24.3437; Smith SR, 1999, HEALTH SERV RES, V34, P123; Sokol MC, 2005, MED CARE, V43, P521, DOI 10.1097/01.mlr.0000163641.86870.af; van den Berg E, 2006, DRUG TODAY, V42, P741, DOI 10.1358/dot.2006.42.11.1003542; Williams BA., 2006, TECHNICAL REPORT SER, V79; Wolff JL, 2002, ARCH INTERN MED, V162, P2269, DOI 10.1001/archinte.162.20.2269; Wolinsky FD, 2007, J GERONTOL B-PSYCHOL, V62, pS160, DOI 10.1093/geronb/62.3.S160; Worrall G, 2011, CAN FAM PHYSICIAN, V57, pE16; Yang Hailin, 2011, Shengwu Jiagong Guocheng, V9, P1, DOI 10.3969/j.issn.1672-3678.2011.06.001	48	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2019	14	8							e0221327	10.1371/journal.pone.0221327	http://dx.doi.org/10.1371/journal.pone.0221327			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW5RZ	31437219	Green Published, Green Submitted, gold			2022-12-26	WOS:000485036900051
J	Fernandes, D; Sirak, K; Cheronet, O; Howcroft, R; Cavka, M; Los, D; Burmaz, J; Pinhasi, R; Novak, M				Fernandes, Daniel; Sirak, Kendra; Cheronet, Olivia; Howcroft, Rachel; Cavka, Mislav; Los, Dzeni; Burmaz, Josip; Pinhasi, Ron; Novak, Mario			Cranial deformation and genetic diversity in three adolescent male individuals from the Great Migration Period from Osijek, eastern Croatia	PLOS ONE			English	Article							ANCIENT DNA; ARTIFICIAL DEFORMATION; POROTIC HYPEROSTOSIS; ENAMEL HYPOPLASIA; AGE; POPULATIONS; STRESS; MORPHOLOGY; SEQUENCE; BASE	Three individuals dating to the Great Migration Period (5th century CE) were discovered in a pit at the Hermanov vinograd site in Osijek, Croatia. We were inspired to study these individuals based on their unusual burial context as well as the identification of two different types of artificial cranial deformation in two of the individuals. We combine bioarchaeological analysis with radiographic imaging, stable isotopes analysis, and ancient DNA to analyze their dietary patterns, molecular sex, and genetic affinities in the context of the archaeological data and their bioarchaeological attributes. While all three individuals were adolescent males with skeletal evidence of severe malnutrition and similar diets, the most striking observation is that they had major differences in their genetic ancestry. Results of the genetic analyses of the nuclear ancient DNA data for these individuals indicate that the individual without artificial cranial deformation shows broadly West Eurasian associated-ancestry, the individual with tabular oblique-type has East Asian ancestry and the third individual with circular erect-type has Near Eastern associated-ancestry. Based on these results, we speculate that artificial cranial deformation type may have been a visual indicator membership in a specific cultural group, and that these groups were interacting intimately on the Pannonian Plain during the Migration Period.	[Fernandes, Daniel; Cheronet, Olivia; Pinhasi, Ron] Univ Vienna, Dept Evolutionary Anthropol, Vienna, Austria; [Fernandes, Daniel; Cheronet, Olivia; Howcroft, Rachel; Pinhasi, Ron; Novak, Mario] Univ Coll Dublin, Sch Archaeol, Dublin, Ireland; [Fernandes, Daniel] Univ Coimbra, Dept Life Sci, CIAS, Coimbra, Portugal; [Sirak, Kendra] Harvard Med Sch, Dept Genet, Boston, MA 02115 USA; [Cavka, Mislav] Univ Hosp Ctr Zagreb, Dept Diagnost & Intervent Radiol, Zagreb, Croatia; [Los, Dzeni; Burmaz, Josip] Kaducej Ltd, Split, Croatia; [Novak, Mario] Inst Anthropol Res, Zagreb, Croatia	University of Vienna; University College Dublin; Universidade de Coimbra; Harvard University; Harvard Medical School; University of Zagreb; Institute for Anthropological Research Zagreb	Pinhasi, R (corresponding author), Univ Vienna, Dept Evolutionary Anthropol, Vienna, Austria.; Pinhasi, R; Novak, M (corresponding author), Univ Coll Dublin, Sch Archaeol, Dublin, Ireland.; Novak, M (corresponding author), Inst Anthropol Res, Zagreb, Croatia.	ron.pinhasi@univie.ac.at; mario.novak@inantro.hr	Novak, Mario/AAX-1795-2021; Pinhasi, Ron/AAT-1531-2020; Novak, Mario/AAW-6417-2021	Pinhasi, Ron/0000-0003-1629-8131; Cheronet, Olivia/0000-0001-6760-1204; M Fernandes, Daniel/0000-0002-7434-6552; Novak, Mario/0000-0002-4567-8742	Irish Research Council Post-Graduate grant [GOIPG/2013/36]; European Research Council [ERC-2010-StG 263441]; Irish Research Council [GOIPD/2013/1]; Croatian Science Fund [HRZZ IP-201606-1450]	Irish Research Council Post-Graduate grant(Irish Research Council for Science, Engineering and Technology); European Research Council(European Research Council (ERC)European Commission); Irish Research Council(Irish Research Council for Science, Engineering and Technology); Croatian Science Fund	DF was supported by an Irish Research Council Post-Graduate grant GOIPG/2013/36. RP was supported by the European Research Council Starting Grant ERC-2010-StG 263441. MN was supported by the Irish Research Council Postdoctoral Fellowship grant GOIPD/2013/1, and by the Croatian Science Fund grant HRZZ IP-201606-1450. http://research.ie/; https://erc.europa.eu/; http://www.hrzz.hr/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Two of the co-authors (Dz. eni Los and Josip Burmaz) are employed by a commercial company Kaducej Ltd. The funders provided support in the form of salaries for authors DF and MN, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander DH, 2009, GENOME RES, V19, P1655, DOI 10.1101/gr.094052.109; Allison M. J., 1981, CHUNGARA, V7, P238; Amorim CEG, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06024-4; Andric S., 2002, SCRINIA SLAVONICA, V2, P117; ANTON SC, 1989, AM J PHYS ANTHROPOL, V79, P253, DOI 10.1002/ajpa.1330790213; Aufderheide A. C., 1998, HUMAN PALEOPATHOLOGY; Bass W. M., 2005, HUMAN OSTEOLOGY LAB, V5th; Bereczki Z, 2006, ARTIFICIAL DEFORMATI, V5, P96; Blackwood B, 1955, J R ANTHROPOL INST G, V85, P173, DOI 10.2307/2844190; BLAKEY ML, 1994, AM J PHYS ANTHROPOL, V95, P371, DOI 10.1002/ajpa.1330950402; Brown P., 1981, ARCHAEOL OCEAN, V16, P156; Buikstra J. E., 1994, STANDARDS DATA COLLE; Champlot S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013042; Cooper A, 2000, SCIENCE, V289, P1139; Cottin M, 2017, CR PALEVOL, V16, P545, DOI 10.1016/j.crpv.2017.03.001; Crisan C, 2010, EPHEMERIS NAPOCENSIS, V20, P221; Dabney J, 2013, P NATL ACAD SCI USA, V110, P15758, DOI 10.1073/pnas.1314445110; Dembo A., 1938, DEFORMACIONES INTENC; Dingwall EJ, 1931, ARTIFICIAL CRANIAL D; Durband AC, 2008, HOMO, V59, P261, DOI 10.1016/j.jchb.2008.06.001; Gepidi Gracanin H., 2007, SCRINIA SLAVONICA, V7, P7; GOODMAN AH, 1980, HUM BIOL, V52, P515; Gracanin Hrvoje, 2011, JUZNA PANONIJA U KAS; GUSTAFSON G, 1974, ODONTOL REVY, V25, P297; Hakenbeck SE, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173079; Hanko KI, 1972, SZEKSZARDI BERI BALO, V2, P67; Hasluck M, 1947, MAN, V47, P130, DOI 10.2307/2791469; Hillson S, 2014, TOOTH DEVELOPMENT IN HUMAN EVOLUTION AND BIOARCHAEOLOGY, P1, DOI 10.1017/CBO9780511894916; Jonsson H, 2013, BIOINFORMATICS, V29, P1682, DOI 10.1093/bioinformatics/btt193; Kiszely I., 1978, BRIT ARCHAEOLOGICAL; Krogman WM., 1986, HUMAN SKELETON FOREN; Larsen C.S., 1997, BIOARCHAEOLOGY INTER; Lazaridis I, 2016, NATURE, V536, P419, DOI 10.1038/nature19310; Lazaridis I, 2014, NATURE, V513, P409, DOI 10.1038/nature13673; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Llamas B, 2017, SCI TECHNOL ARCHAEOL, V3, P1, DOI 10.1080/20548923.2016.1258824; Lukasik S, 2014, HOMO, V65, P296, DOI 10.1016/j.jchb.2013.11.005; Maresh M. M., 1970, HUMAN GROWTH DEV, P157; Martin M, 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, 10.10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; MCNEILL RW, 1965, AM J PHYS ANTHROPOL, V23, P241; Meikelejohn C., 1992, PAL ORIENT, V18, P83, DOI [10.3406/paleo.1992.4574, DOI 10.3406/PALEO.1992.4574]; MEINDL RS, 1985, AM J PHYS ANTHROPOL, V68, P57, DOI 10.1002/ajpa.1330680106; Meyer Matthias, 2010, Cold Spring Harb Protoc, V2010, DOI 10.1101/pdb.prot5448; Mikic Z, 2007, BALCANICA, V38, P45; Miladinovic-Radmilovic N, 2016, STARINAR, V66, P65; Miritoiu N., 2011, PEUCE SERIE NOUA STU, V9, P539; Molnar M, 2014, NEUROSURG FOCUS, V36, DOI 10.3171/2014.1.FOCUS13466; MOORREES COENRAAD F.A., 1963, JOUR DENT RES, V42, P1490, DOI 10.1177/00220345630420062701; MOSS ML, 1958, AM J PHYS ANTHROPOL, V16, P269, DOI 10.1002/ajpa.1330160302; Motuzaite-Matuzeviciute G, 2013, ANTIQUITY, V87, P1073, DOI 10.1017/S0003598X00049875; MUNIZAGA JR, 1976, AM J PHYS ANTHROPOL, V45, P687, DOI 10.1002/ajpa.1330450335; Nemeskeri J, 1976, NACHRICHTEN NIEDERSA, V45, P129; Neparaczki E, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0205920; Noche-Dowdy L., 2015, MULTIISOTOPE ANAL RE; Novak M, 2009, ARHEOL RAD RASPR, V16, P265; Ortner D. J., 2003, IDENTIFICATION PATHO, DOI DOI 10.1016/B978-012528628-2/50057-0; Papesa AR, 2015, PRIL INST ARHEOL ZAG, V32, P261; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Patterson N, 2012, GENETICS, V192, P1065, DOI 10.1534/genetics.112.145037; Pinhasi R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129102; Pomeroy E, 2010, INT J OSTEOARCHAEOL, V20, P317, DOI 10.1002/oa.1044; Rhode MP, 2006, AM J PHYS ANTHROPOL, V130, P462, DOI 10.1002/ajpa.20333; Roberts Charlotte, 2005, ARCHAEOLOGY DIS; Romero J., 1970, HDB MIDDLE AM INDIAN, V9, P55; Scheuer J. L., 2000, DEV JUVENILE OSTEOLO; Schijman E, 2005, CHILD NERV SYST, V21, P945, DOI 10.1007/s00381-004-1127-8; Schmolzer A., 2018, P INT GRAD DOCT STUD, P58; Simic J., 2008, HERMANOV VINOGRAD AR; Skoglund P, 2013, J ARCHAEOL SCI, V40, P4477, DOI 10.1016/j.jas.2013.07.004; Slaus M, 2004, HOMO, V54, P240, DOI 10.1078/0018-442X-00072; Slaus M., 2002, BIOARCHAEOLOGY CONTI; STUARTMACADAM P, 1985, AM J PHYS ANTHROPOL, V66, P391, DOI 10.1002/ajpa.1330660407; Tiesler V, 2014, INTERD CONTRIB ARCH, V7, P1, DOI 10.1007/978-1-4614-8760-9; Torres-Rouff C, 2005, HOMO, V56, P1, DOI 10.1016/j.jchb.2004.09.001; Torres-Rouff C, 2003, AM J PHYS ANTHROPOL, P210; Tubbs RS, 2006, CLIN ANAT, V19, P372, DOI 10.1002/ca.20177; Veeramah KR, 2018, P NATL ACAD SCI USA, V115, P3494, DOI 10.1073/pnas.1719880115; Verano J., 2001, PALEOPATHOLOGY HUMAN; Vidal-Ronchas R, 2019, ARCHAEOL ANTHROP SCI, V11, P1727, DOI 10.1007/s12520-018-0628-4; Walker PL, 2009, AM J PHYS ANTHROPOL, V139, P109, DOI 10.1002/ajpa.21031; Weidenreich F., 1939, Peking Natural History Bulletin, V13, P161; Wheeler SM, 2012, INT J OSTEOARCHAEOL, V22, P219, DOI 10.1002/oa.1201; Wiewegh Z, 2013, HRVATSKI ARHEOLOSKI, P27; Zhirov E.V, 1940, KSIIMK, VVIII, P81	85	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2019	14	8							e0216366	10.1371/journal.pone.0216366	http://dx.doi.org/10.1371/journal.pone.0216366			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW5QN	31433816	Green Published, Green Submitted, gold			2022-12-26	WOS:000485033100002
J	Harisseh, R; Abrial, M; Chiari, P; Al-Mawla, R; Villedieu, C; Tessier, N; Bidaux, G; Ovize, M; Gharib, A				Harisseh, Rania; Abrial, Maryline; Chiari, Pascal; Al-Mawla, Ribal; Villedieu, Camille; Tessier, Nolwenn; Bidaux, Gabriel; Ovize, Michel; Gharib, Abdallah			A modified calcium retention capacity assay clarifies the roles of extra- and intracellular calcium pools in mitochondrial permeability transition pore opening	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						calcium; cardiomyocyte; mitochondria; mitochondrial permeability transition (MPT); ryanodine receptor; sarcoplasmic reticulum (SR); anoxia?reoxygenation; caffeine; cardiac infarction; ryanodine	HYPOXIA-REOXYGENATION; CA2+; CARDIOMYOCYTES; ISCHEMIA; RELEASE; OXYGEN; HEART; PH; HOMEOSTASIS; INHIBITION	Calcium homeostasis is essential for cell survival and is precisely controlled by several cellular actors such as the sarco/endoplasmic reticulum and mitochondria. Upon stress induction, Ca2+ released from sarco/endoplasmic reticulum stores and from extracellular Ca2+ pools accumulates in the cytosol and in the mitochondria. This induces Ca2+ overload and ultimately the opening of the mitochondrial permeability transition pore (mPTP), promoting cell death. Currently, it is unclear whether intracellular Ca2+ stores are sufficient to promote the mPTP opening. Ca2+ retention capacity (CRC) corresponds to the maximal Ca2+ uptake by the mitochondria before mPTP opening. In this study, using permeabilized cardiomyocytes isolated from adult mice, we modified the standard CRC assay by specifically inducing reticular Ca2+ release to investigate the respective contributions of reticular Ca2+ and extracellular Ca2+ to mPTP opening in normoxic conditions or after anoxia?reoxygenation. Our experiments revealed that Ca2+ released from the sarco/endoplasmic reticulum is not sufficient to trigger mPTP opening and corresponds to ?50% of the total Ca2+ levels required to open the mPTP. We also studied mPTP opening after anoxia?reoxygenation in the presence or absence of extracellular Ca2+. In both conditions, Ca2+ leakage from internal stores could not trigger mPTP opening by itself but significantly decreased the CRC. Our findings highlight how a modified CRC assay enables the investigation of the role of reticular and extracellular Ca2+ pools in the regulation of the mPTP. We propose that this method may be useful for screening molecules of interest implicated in mPTP regulation.	[Harisseh, Rania; Abrial, Maryline; Chiari, Pascal; Al-Mawla, Ribal; Villedieu, Camille; Tessier, Nolwenn; Bidaux, Gabriel; Ovize, Michel; Gharib, Abdallah] Univ Lyon 1, IHU OPERA, CarMeN Lab, INSERM UMR 1060, F-69677 Lyon, France; [Chiari, Pascal] Hosp Civils Lyon, Hop Louis Pradel, Serv Anesthesie Reanimat, F-69677 Lyon, France; [Ovize, Michel] Hosp Civils Lyon, Hop Louis Pradel, Serv Explorat Fonct Cardiovasc, F-69677 Lyon, France; [Ovize, Michel] Hosp Civils Lyon, Hop Louis Pradel, Ctr Invest Clin Lyon, F-69677 Lyon, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; CHU Lyon; CHU Lyon; Institut National de la Sante et de la Recherche Medicale (Inserm)	Chiari, P (corresponding author), Hosp Civils Lyon, Hop Louis Pradel, Serv Anesthesie Reanimat, F-69677 Lyon, France.	pascal.chiari@chu-lyon.fr	Ovize, michel/AAL-9247-2020; Carmen, Team3/Y-7384-2019; Bidaux, Gabriel/F-1294-2016	Carmen, Team3/0000-0002-3614-0924; Lab, Carmen/0000-0002-5935-3236; Bidaux, Gabriel/0000-0002-6162-3223	Institut National de la Sante et de la Recherche Medicale (INSERM, U1060, Lyon, France)	Institut National de la Sante et de la Recherche Medicale (INSERM, U1060, Lyon, France)	This work was supported by the Institut National de la Sante et de la Recherche Medicale (INSERM, U1060, Lyon, France). The authors declare that they have no conflicts of interest with the contents of this article.	Argaud Laurent, 2005, J Mol Cell Cardiol, V38, P367, DOI 10.1016/j.yjmcc.2004.12.001; Baines CP, 2005, NATURE, V434, P658, DOI 10.1038/nature03434; BARRY WH, 1991, TRENDS CARDIOVAS MED, V1, P162, DOI 10.1016/1050-1738(91)90022-7; Becker LB, 1999, AM J PHYSIOL-HEART C, V277, pH2240, DOI 10.1152/ajpheart.1999.277.6.H2240; Bernardi P, 2015, J MOL CELL CARDIOL, V78, P100, DOI 10.1016/j.yjmcc.2014.09.023; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Bompotis GC, 2016, MED CHEM, V12, P114, DOI 10.2174/1573406411666150928112420; Brustovetsky N, 2003, J NEUROSCI, V23, P4858; COMTE J, 1976, BIOCHIM BIOPHYS ACTA, V419, P271, DOI 10.1016/0005-2736(76)90353-9; del Arco A, 2016, BBA-MOL CELL RES, V1863, P2413, DOI 10.1016/j.bbamcr.2016.03.024; Doczi J, 2011, J BIOL CHEM, V286, P6345, DOI 10.1074/jbc.M110.196600; Garcia-Ruiz C, 2000, FASEB J, V14, P847, DOI 10.1096/fasebj.14.7.847; Gharib A, 2012, J MOL CELL CARDIOL, V52, P1091, DOI 10.1016/j.yjmcc.2012.02.005; Giorgio V, 2018, CELL CALCIUM, V70, P56, DOI 10.1016/j.ceca.2017.05.004; Hall AE, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.91; Harisseh R, 2017, J CARDIOVASC PHARM, V69, P326, DOI 10.1097/FJC.0000000000000479; Harisseh R, 2017, BASIC RES CARDIOL, V112, DOI 10.1007/s00395-016-0595-9; Hong S, 2015, BIOCHEM BIOPH RES CO, V460, P931, DOI 10.1016/j.bbrc.2015.03.129; HUNTER DR, 1979, ARCH BIOCHEM BIOPHYS, V195, P453, DOI 10.1016/0003-9861(79)90371-0; Kim JS, 2006, AM J PHYSIOL-HEART C, V290, pH2024, DOI 10.1152/ajpheart.00683.2005; Kohlhaas M, 2013, CARDIOVASC RES, V98, P259, DOI 10.1093/cvr/cvt032; KORN ED, 1969, ANNU REV BIOCHEM, V38, P263, DOI 10.1146/annurev.bi.38.070169.001403; Kuznetsov AV, 2008, NAT PROTOC, V3, P965, DOI 10.1038/nprot.2008.61; LATTANZIO FA, 1987, J BIOL CHEM, V262, P2711; Lemasters JJ, 1999, CARDIOVASC RES, V44, P470, DOI 10.1016/S0008-6363(99)00368-5; LEQUOC K, 1985, J BIOL CHEM, V260, P7422; Li B, 2012, BBA-BIOENERGETICS, V1817, P1628, DOI 10.1016/j.bbabio.2012.05.011; MEISSNER G, 1986, J BIOL CHEM, V261, P6300; O'Connell Timothy D, 2007, Methods Mol Biol, V357, P271; Paillard M, 2013, CIRCULATION, V128, P1555, DOI 10.1161/CIRCULATIONAHA.113.001225; Panel M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04618-4; Rieusset J, 2018, BIOCHEM BIOPH RES CO, V500, P35, DOI 10.1016/j.bbrc.2017.06.097; Rodriguez-Sinovas A, 2012, BBA-BIOMEMBRANES, V1818, P1962, DOI 10.1016/j.bbamem.2011.07.041; Satoh H, 2000, CIRCULATION, V101, P1441, DOI 10.1161/01.CIR.101.12.1441; Seidlmayer LK, 2015, CARDIOVASC RES, V106, P237, DOI 10.1093/cvr/cvv097; Seidlmayer LK, 2012, J GEN PHYSIOL, V139, P321, DOI 10.1085/jgp.201210788; Szymanski J, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18071576; Talukder MAH, 2009, CARDIOVASC RES, V84, P345, DOI 10.1093/cvr/cvp264; Teixeira G, 2013, J MOL CELL CARDIOL, V56, P55, DOI 10.1016/j.yjmcc.2012.11.023; Tubbs E, 2018, DIABETES, V67, P636, DOI 10.2337/db17-0316; Vanden Abeele F, 2002, CANCER CELL, V1, P169; VERCESI AE, 1991, J BIOL CHEM, V266, P14431	42	12	13	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 18	2019	294	42					15282	15292		10.1074/jbc.RA119.009477	http://dx.doi.org/10.1074/jbc.RA119.009477			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JQ9HM	31434742	Green Published, hybrid			2022-12-26	WOS:000499248700008
J	Kaus, K; Biester, A; Chupp, E; Lu, JY; Visudharomn, C; Olson, R				Kaus, Katherine; Biester, Alison; Chupp, Ethan; Lu, Jianyi; Visudharomn, Charlie; Olson, Rich			The 1.9 angstrom crystal structure of the extracellular matrix protein Bap1 from Vibrio cholerae provides insights into bacterial biofilm adhesion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						microbial pathogenesis; biofilm; amyloid; lectin; glycobiology; Vibrio cholerae; X-ray crystallography; virulence factor; extracellular matrix protein; cholera	RUGOSE COLONY MORPHOLOGY; ACTIVE-SITE; IDENTIFICATION; DETERMINANTS; ARCHITECTURE; PREDICTION; FEATURES; AGGREGATION; ENVIRONMENT; RESISTANCE	Growth of the cholera bacterium Vibrio cholerae in a biofilm community contributes to both its pathogenicity and survival in aquatic environmental niches. The major components of V. cholerae biofilms include Vibriopolysaccharide (VPS) and the extracellular matrix proteins RbmA, RbmC, and Bap1. To further elucidate the previously observed overlapping roles of Bap1 and RbmC in biofilm architecture and surface attachment, here we investigated the structural and functional properties of Bap1. Soluble expression of Bap1 was possible only after the removal of an internal 57-amino-acid-long hydrophobic insertion sequence. The crystal structure of Bap1 at 1.9 angstrom resolution revealed a two-domain assembly made up of an eight-bladed beta-propeller interrupted by a beta-prism domain. The structure also revealed metal-binding sites within canonical calcium blade motifs, which appear to have structural rather than functional roles. Contrary to results previously observed with RbmC, the Bap1 beta-prism domain did not exhibit affinity for complex N-glycans, suggesting an altered role of this domain in biofilm-surface adhesion. Native polyacrylamide gel shift analysis did suggest that Bap1 exhibits lectin activity with a preference for anionic or linear polysaccharides. Our results suggest a model for V. cholerae biofilms in which Bap1 and RbmC play dominant but differing adhesive roles in biofilms, allowing bacterial attachment to diverse environmental or host surfaces.	[Kaus, Katherine; Biester, Alison; Chupp, Ethan; Lu, Jianyi; Visudharomn, Charlie; Olson, Rich] Wesleyan Univ, Dept Mol Biol & Biochem, Mol Biophys Program, Middletown, CT 06459 USA; [Kaus, Katherine] Univ Texas Med Branch, Dept Pharmacol & Toxicol, Galveston, TX 77555 USA	Wesleyan University; University of Texas System; University of Texas Medical Branch Galveston	Olson, R (corresponding author), Wesleyan Univ, Dept Mol Biol & Biochem, 52 Lawn Ave, Middletown, CT 06459 USA.	rolson@wesleyan.edu		Kaus, Katherine/0000-0001-9174-7588	DOE Office of Science [DE-SC0012704]; National Institutes of Health [R24 GM098791, P41 GM103694]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103694] Funding Source: NIH RePORTER	DOE Office of Science(United States Department of Energy (DOE)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Dr. Bing Hao at the University of Connecticut Health Center and Dr. Victoria Robinson at the University of Connecticut, Storrs, for allowing use of their home X-ray sources. Additional thanks to Prof. Dr. Markus Wahl and Dr. Ursula Neu for support during manuscript revisions. High-resolution X-ray data were collected at the 17-ID-1 (AMX) beamline of the National Synchrotron Light Source II, a United States Department of Energy Office (DOE) of Science User Facility operated for the DOE Office of Science by Brookhaven National Laboratory under Contract No. DE-SC0012704. We thank NSLS-II beamline staff personnel Dr. Jean Jakoncic and Dr. Alexei Soares for assistance in X-ray data collection and processing. V. cholerae N16961 DNA was provided by Dr. Erika Taylor. Glycan data were obtained from the Protein-Glycan Interaction Resource of the CFG (National Institutes of Health Supporting Grant R24 GM098791) and the National Center for Functional Glycomics (NCFG) at Beth Israel Deaconess Medical Center, Harvard Medical School (National Institutes of Health Supporting Grant P41 GM103694).	Absalon C, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002210; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Berk V, 2012, SCIENCE, V337, P236, DOI 10.1126/science.1222981; Bonnardel F, 2019, STRUCTURE, V27, P764, DOI 10.1016/j.str.2019.02.002; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Conchillo-Sole O, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-65; Conner Jenna G, 2016, Microbiol Spectr, V4, DOI 10.1128/microbiolspec.VMBF-0015-2015; De S, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006841; Drescher K, 2016, P NATL ACAD SCI USA, V113, pE2066, DOI 10.1073/pnas.1601702113; Drozdetskiy A, 2015, NUCLEIC ACIDS RES, V43, pW389, DOI 10.1093/nar/gkv332; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Fernandez-Escamilla AM, 2004, NAT BIOTECHNOL, V22, P1302, DOI 10.1038/nbt1012; Fong JCN, 2006, J BACTERIOL, V188, P1049, DOI 10.1128/JB.188.3.1049-1059.2006; Fong JCN, 2007, J BACTERIOL, V189, P2319, DOI 10.1128/JB.01569-06; Fong JCN, 2017, ELIFE, V6, DOI 10.7554/eLife.26163; Fong JCN, 2010, MICROBIOL-SGM, V156, P2757, DOI 10.1099/mic.0.040196-0; Garbuzynskiy SO, 2010, BIOINFORMATICS, V26, P326, DOI 10.1093/bioinformatics/btp691; Gasteiger E., 2005, PROTEOMICS PROTOC HD, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Giglio KM, 2013, J BACTERIOL, V195, P3277, DOI 10.1128/JB.00374-13; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hollenbeck EC, 2014, BIOPHYS J, V107, P2245, DOI 10.1016/j.bpj.2014.10.015; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; HUQ A, 1983, APPL ENVIRON MICROB, V45, P275, DOI 10.1128/AEM.45.1.275-283.1983; Huq A, 2011, INFECT DIS-SER, P311, DOI 10.1007/978-1-60327-265-0_18; Islam MS, 2007, MICROBIOL IMMUNOL, V51, P369, DOI 10.1111/j.1348-0421.2007.tb03924.x; Jurrus E, 2018, PROTEIN SCI, V27, P112, DOI 10.1002/pro.3280; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kawate T, 2006, STRUCTURE, V14, P673, DOI 10.1016/j.str.2006.01.013; Kuttel MM, 2016, J COMPUT CHEM, V37, P2098, DOI 10.1002/jcc.24428; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Laskowski RA, 2011, J CHEM INF MODEL, V51, P2778, DOI 10.1021/ci200227u; Levan S, 2013, J MOL BIOL, V425, P944, DOI 10.1016/j.jmb.2012.12.016; Liu ZY, 2015, INFECT IMMUN, V83, P1114, DOI 10.1128/IAI.02841-14; Maestre-Reyna M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082458; Maurer-Stroh S, 2010, NAT METHODS, V7, P237, DOI [10.1038/NMETH.1432, 10.1038/nmeth.1432]; MILLER CJ, 1984, J HYG-CAMBRIDGE, V93, P475, DOI 10.1017/S0022172400065074; Moorthy S, 2005, MOL MICROBIOL, V57, P1623, DOI 10.1111/j.1365-2958.2005.04797.x; Munoz-Munoz J, 2017, P NATL ACAD SCI USA, V114, P4936, DOI 10.1073/pnas.1701130114; Ochiai A, 2009, J BIOL CHEM, V284, P10181, DOI 10.1074/jbc.M807799200; Pons T, 2004, PROTEINS, V54, P424, DOI 10.1002/prot.10604; Quistgaard EM, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-46; Reichhardt C, 2015, BBA-BIOMEMBRANES, V1848, P378, DOI 10.1016/j.bbamem.2014.05.030; Rigden DJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021507; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Scheuermann TH, 2015, METHODS, V76, P87, DOI 10.1016/j.ymeth.2014.11.024; Taglialegna A, 2016, J BACTERIOL, V198, P2579, DOI 10.1128/JB.00122-16; Tamayo R, 2010, INFECT IMMUN, V78, P3560, DOI 10.1128/IAI.00048-10; TAMPLIN ML, 1990, APPL ENVIRON MICROB, V56, P1977, DOI 10.1128/AEM.56.6.1977-1980.1990; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Teschler JK, 2015, NAT REV MICROBIOL, V13, P255, DOI 10.1038/nrmicro3433; Tielen P, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-159; Tsolis AC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054175; Wai SN, 1998, APPL ENVIRON MICROB, V64, P3648; Walsh I, 2014, NUCLEIC ACIDS RES, V42, pW301, DOI 10.1093/nar/gku399; Yan J, 2016, P NATL ACAD SCI USA, V113, pE5337, DOI 10.1073/pnas.1611494113; Yildiz FH, 1999, P NATL ACAD SCI USA, V96, P4028, DOI 10.1073/pnas.96.7.4028; Yildiz F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086751; Yu ACY, 2012, STRUCTURE, V20, P707, DOI 10.1016/j.str.2012.02.015; Zechel DL, 2000, ACCOUNTS CHEM RES, V33, P11, DOI 10.1021/ar970172+; Zheng HP, 2014, NAT PROTOC, V9, P156, DOI 10.1038/nprot.2013.172	62	5	5	1	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 4	2019	294	40					14499	14511		10.1074/jbc.RA119.008335	http://dx.doi.org/10.1074/jbc.RA119.008335			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JP0II	31439670	hybrid, Green Published			2022-12-26	WOS:000497955000002
J	Meyer, MB; Lee, SM; Carlson, AH; Benkusky, NA; Kaufmann, M; Jones, G; Pike, JW				Meyer, Mark B.; Lee, Seong Min; Carlson, Alex H.; Benkusky, Nancy A.; Kaufmann, Martin; Jones, Glenville; Pike, J. Wesley			A chromatin-based mechanism controls differential regulation of the cytochrome P450 gene Cyp24a1 in renal and non-renal tissues	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cytochrome P450; CRISPR; Cas; ChIP-sequencing (ChIP-Seq); vitamin D; gene regulation; fibroblast growth factor (FGF); parathyroid hormone (PTH); 1; Cyp24a1; Cyp27b1; FGF23; Cyp27b1-KO	25-HYDROXYVITAMIN D-3 24-HYDROXYLASE; VITAMIN-D-RECEPTOR; 1,25-DIHYDROXYVITAMIN D-3; MESSENGER-RNA; PARATHYROID-HORMONE; IN-VIVO; EXPRESSION; MICE; D-3-24-HYDROXYLASE; CYP27B1	Cytochrome P450 family 27 subfamily B member 1 (CYP27B1) and CYP24A1 function to maintain physiological levels of 1,25-dihydroxyvitamin D-3 (1,25(OH)(2)D-3) in the kidney. Renal Cyp27b1 and Cyp24a1 expression levels are transcriptionally regulated in a highly reciprocal manner by parathyroid hormone (PTH), fibroblast growth factor 23 (FGF23), and 1,25(OH)(2)D-3. In contrast, Cyp24a1 regulation in nonrenal target cells (NRTCs) is limited to induction by 1,25(OH)(2)D-3. Herein, we used ChIP-Seq analyses of mouse tissues to identify regulatory regions within the Cyp24a1 gene locus. We found an extended region downstream of Cyp24a1 containing a cluster of sites, termed C24-DS1, binding PTH-sensitive cAMP-responsive element?binding protein (CREB) and a cluster termed C24-DS2 binding the vitamin D receptor (VDR). VDR-occupied sites were present in both the kidney and NRTCs, but pCREB sites were occupied only in the kidney. We deleted each segment in the mouse and observed that although the overt phenotypes of both cluster deletions were unremarkable, RNA analysis in the C24-DS1?deleted strain revealed a loss of basal renal Cyp24a1 expression, total resistance to FGF23 and PTH regulation, and secondary suppression of renal Cyp27b1; 1,25(OH)(2)D-3 induction remained unaffected in all tissues. In contrast, loss of the VDR cluster in the C24-DS2?deleted strain did not affect 1,25(OH)(2)D-3 induction of renal Cyp24a1 expression yet reduced but did not eliminate Cyp24a1 responses in NRTCs. We conclude that a chromatin-based mechanism differentially regulates Cyp24a1 in the kidney and NRTCs and is essential for the specific functions of Cyp24a1 in these two tissue types.	[Meyer, Mark B.; Lee, Seong Min; Carlson, Alex H.; Benkusky, Nancy A.; Pike, J. Wesley] Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA; [Kaufmann, Martin; Jones, Glenville] Queens Univ, Dept Biomed & Mol Sci, Kingston, ON K7L 3N6, Canada; [Kaufmann, Martin] Queens Univ, Dept Surg, Kingston, ON K7L 3N6, Canada	University of Wisconsin System; University of Wisconsin Madison; Queens University - Canada; Queens University - Canada	Pike, JW (corresponding author), Univ Wisconsin, Dept Biochem, Hector F DeLuca Biochem Labs, Rm 543D,433 Babcock Dr, Madison, WI 53706 USA.	jpike@wisc.edu		Meyer, Mark/0000-0001-6612-7491	NIDDK, National Institutes of Health [R01-DK072281, R01-DK117475]; University of Wisconsin Carbone Cancer Center Support Grant P30; Department of Biochemistry, University of Wisconsin (Madison, WI); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK117475] Funding Source: NIH RePORTER	NIDDK, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); University of Wisconsin Carbone Cancer Center Support Grant P30; Department of Biochemistry, University of Wisconsin (Madison, WI); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by NIDDK, National Institutes of Health, Grants R01-DK072281 and R01-DK117475 (to J. W. P.), University of Wisconsin Carbone Cancer Center Support Grant P30, and the Department of Biochemistry, University of Wisconsin (Madison, WI). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	ALLEGRETTO EA, 1995, J BIOL CHEM, V270, P23906, DOI 10.1074/jbc.270.41.23906; CHANDLER JS, 1984, J BIOL CHEM, V259, P2214; CHANDLER JS, 1982, J STEROID BIOCHEM, V16, P303, DOI 10.1016/0022-4731(82)90181-9; Dardenne O, 2001, ENDOCRINOLOGY, V142, P3135, DOI 10.1210/en.142.7.3135; Dhawan P, 2005, MOL CELL BIOL, V25, P472, DOI 10.1128/MCB.25.1.472-487.2005; Dhawan P, 2009, J BIOL CHEM, V284, P3086, DOI 10.1074/jbc.M803602200; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Ernst J, 2010, NAT BIOTECHNOL, V28, P817, DOI 10.1038/nbt.1662; Glorieux FH, 1998, RECENT PROG HORM RES, V53, P341; Glorieux Francis H, 2014, Bonekey Rep, V3, P524, DOI 10.1038/bonekey.2014.19; HAUSSLER MR, 1976, CLIN ENDOCRINOL, V5, pS151, DOI 10.1111/j.1365-2265.1976.tb03823.x; Heikkinen S, 2011, NUCLEIC ACIDS RES, V39, P9181, DOI 10.1093/nar/gkr654; HOLICK MF, 1973, J BIOL CHEM, V248, P6691; Jones G, 2002, J BONE MINER RES, V17, P179, DOI 10.1359/jbmr.2002.17.1.179; Jones G, 2014, J LIPID RES, V55, P13, DOI 10.1194/jlr.R031534; Jones G, 2012, ARCH BIOCHEM BIOPHYS, V523, P9, DOI 10.1016/j.abb.2011.11.003; Kaufmann M, 2019, J STEROID BIOCHEM, V188, P23, DOI 10.1016/j.jsbmb.2018.12.001; Kaufmann M, 2017, J BONE MINER RES, V32, P1589, DOI 10.1002/jbmr.3135; Kaufmann M, 2015, ENDOCRINOLOGY, V156, P4388, DOI 10.1210/en.2015-1664; Kaufmann M, 2014, J CLIN ENDOCR METAB, V99, P2567, DOI 10.1210/jc.2013-4388; Martineau C, 2018, J CLIN INVEST, V128, P3546, DOI 10.1172/JCI98093; Masuda S, 2005, ENDOCRINOLOGY, V146, P825, DOI 10.1210/en.2004-1116; Meyer MB, 2007, J BIOL CHEM, V282, P22344, DOI 10.1074/jbc.M703475200; Meyer MB, 2019, J BIOL CHEM, V294, P9518, DOI 10.1074/jbc.RA119.008760; Meyer MB, 2017, J BIOL CHEM, V292, P17541, DOI 10.1074/jbc.M117.806901; Meyer MB, 2015, J BIOL CHEM, V290, P11093, DOI 10.1074/jbc.M115.648394; Meyer MB, 2014, J BIOL CHEM, V289, P19539, DOI 10.1074/jbc.M114.578104; Meyer MB, 2014, J BIOL CHEM, V289, P16016, DOI 10.1074/jbc.M114.552216; Meyer MB, 2013, J STEROID BIOCHEM, V136, P120, DOI 10.1016/j.jsbmb.2012.08.006; Meyer MB, 2012, MOL ENDOCRINOL, V26, P37, DOI 10.1210/me.2011-1109; Meyer MB, 2010, J STEROID BIOCHEM, V121, P136, DOI 10.1016/j.jsbmb.2010.02.011; Meyer MB, 2010, J BIOL CHEM, V285, P15599, DOI 10.1074/jbc.M110.119958; Meyer M, 2010, P NATL ACAD SCI USA, V107, P15022, DOI 10.1073/pnas.1009424107; OHYAMA Y, 1993, BIOCHEMISTRY-US, V32, P76, DOI 10.1021/bi00052a011; Ohyama Y, 1996, J BIOL CHEM, V271, P30381, DOI 10.1074/jbc.271.48.30381; OHYAMA Y, 1994, J BIOL CHEM, V269, P10545; OHYAMA Y, 1991, FEBS LETT, V278, P195, DOI 10.1016/0014-5793(91)80115-J; Onal M, 2016, J BONE MINER RES, V31, P416, DOI 10.1002/jbmr.2698; Quarles LD, 2012, NAT REV ENDOCRINOL, V8, P276, DOI 10.1038/nrendo.2011.218; Raval-Pandya M, 2001, MOL ENDOCRINOL, V15, P1035, DOI 10.1210/me.15.6.1035; Schlingmann KP, 2011, NEW ENGL J MED, V365, P410, DOI 10.1056/NEJMoa1103864; Seth-Vollenweider T, 2014, J BIOL CHEM, V289, P33958, DOI 10.1074/jbc.M114.583302; St-Arnaud R, 2000, ENDOCRINOLOGY, V141, P2658, DOI 10.1210/en.141.7.2658; St-Arnaud R, 2010, J STEROID BIOCHEM, V121, P254, DOI 10.1016/j.jsbmb.2010.02.002; StArnaud R, 1997, J BONE MINER RES, V12, P1552, DOI 10.1359/jbmr.1997.12.10.1552; Veldurthy V, 2016, BONE RES, V4, DOI 10.1038/boneres.2016.41; Veldurthy V, 2016, VITAM HORM, V100, P137, DOI 10.1016/bs.vh.2015.10.005; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; WANG YZ, 1993, J BONE MINER RES, V8, P1483; Yang W, 1999, AM J PHYSIOL-ENDOC M, V276, pE793, DOI 10.1152/ajpendo.1999.276.4.E793; Zierold C, 2000, ARCH BIOCHEM BIOPHYS, V381, P323, DOI 10.1006/abbi.2000.1964; ZIEROLD C, 1995, J BIOL CHEM, V270, P1675, DOI 10.1074/jbc.270.4.1675; Zierold C, 2002, ARCH BIOCHEM BIOPHYS, V404, P18, DOI 10.1016/S0003-9861(02)00238-2; Zierold C, 2001, P NATL ACAD SCI USA, V98, P13572, DOI 10.1073/pnas.241516798	54	21	22	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 27	2019	294	39					14467	14481		10.1074/jbc.RA119.010173	http://dx.doi.org/10.1074/jbc.RA119.010173			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JQ9HH	31439663	Green Published, hybrid			2022-12-26	WOS:000499248200025
J	Keppler, AM; Nuritidinow, T; Mueller, A; Hoefling, H; Schieker, M; Clay, I; Bocker, W; Furmetz, J				Keppler, Alexander M.; Nuritidinow, Timur; Mueller, Arne; Hoefling, Holger; Schieker, Matthias; Clay, Ieuan; Boecker, Wolfgang; Fuermetz, Julian			Validity of accelerometry in step detection and gait speed measurement in orthogeriatric patients	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; TRIAXIAL ACCELEROMETERS; ACCURACY; WALKING; VALIDATION; LIFE	Background Mobile accelerometry is a powerful and promising option to capture long-term changes in gait in both clinical and real-world scenarios. Increasingly, gait parameters have demonstrated their value as clinical outcome parameters, but validation of these parameters in elderly patients is still limited. Objective The aim of this study was to implement a validation framework appropriate for elderly patients and representative of real-world settings, and to use this framework to test and improve algorithms for mobile accelerometry data in an orthogeriatric population. Methods Twenty elderly subjects wearing a 3D-accelerometer completed a parcours imitating a realworld scenario. High-definition video and mobile reference speed capture served to validate different algorithms. Results Particularly at slow gait speeds, relevant improvements in accuracy have been achieved. Compared to the reference the deviation was less than 1% in step detection and less than 0.05 m/s in gait speed measurements, even for slow walking subjects (< 0.8 m/s). Conclusion With the described setup, algorithms for step and gait speed detection have successfully been validated in an elderly population and demonstrated to have improved performance versus previously published algorithms. These results are promising that long-term and/or real-world measurements are possible with an acceptable accuracy even in elderly frail patients with slow gait speeds.	[Keppler, Alexander M.; Nuritidinow, Timur; Boecker, Wolfgang; Fuermetz, Julian] Ludwig Maximilians Univ Munchen, Univ Hosp, Dept Gen Trauma & Reconstruct Surg, Munich, Germany; [Mueller, Arne; Hoefling, Holger; Schieker, Matthias; Clay, Ieuan] Novartis Inst Biomed Res, Translat Med, Basel, Switzerland	University of Munich; Novartis	Keppler, AM (corresponding author), Ludwig Maximilians Univ Munchen, Univ Hosp, Dept Gen Trauma & Reconstruct Surg, Munich, Germany.	alexander.keppler@med.uni-muenchen.de	Keppler, Alexander M./ABD-4426-2020; Schieker, Matthias/AGZ-2030-2022; Schieker, Matthias/J-6511-2015	Keppler, Alexander M./0000-0002-1800-5278; Schieker, Matthias/0000-0002-1230-3653; Schieker, Matthias/0000-0002-1230-3653; Clay, Ieuan/0000-0001-9722-8834				Afilalo J, 2010, J AM COLL CARDIOL, V56, P1668, DOI 10.1016/j.jacc.2010.06.039; Aigner G, 2019, PEERJ PREPRINTS, V7; Aminian K, 1999, MED BIOL ENG COMPUT, V37, P304, DOI 10.1007/BF02513304; Bassett DR, 2017, SPORTS MED, V47, P1303, DOI 10.1007/s40279-016-0663-1; Clay I, 2017, CLIN PHARMACOL THER, V102, P912, DOI 10.1002/cpt.866; Crapo RO, 2002, AM J RESP CRIT CARE, V166, P111, DOI 10.1164/rccm.166/1/111; Cyarto EV, 2004, MED SCI SPORT EXER, V36, P205, DOI 10.1249/01.MSS.0000113476.62469.98; Feng YY, 2017, GAIT POSTURE, V53, P11, DOI 10.1016/j.gaitpost.2016.12.014; Fortune E, 2014, MED ENG PHYS, V36, P659, DOI 10.1016/j.medengphy.2014.02.006; Goldman Myla D, 2010, Ther Adv Neurol Disord, V3, P229, DOI 10.1177/1756285610374117; GREIG C, 1993, J AM GERIATR SOC, V41, P15, DOI 10.1111/j.1532-5415.1993.tb05941.x; Grimm B, 2016, EFORT OPEN REV, V1, P112, DOI 10.1302/2058-5241.1.160022; Jeong JN, 2019, MEDICINE, V98, DOI 10.1097/MD.0000000000016060; Khan AM, 2010, MED BIOL ENG COMPUT, V48, P1271, DOI 10.1007/s11517-010-0701-3; Koolhaas CM, 2018, CLIN EPIDEMIOL, V10, P1, DOI 10.2147/CLEP.S147613; Lauretani F, 2018, AGING CLIN EXPT RES; Lipperts M, 2017, J ORTHOP TRANSL, V11, P19, DOI 10.1016/j.jot.2017.02.003; McGinnis RS, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178366; Motl RW, 2012, GAIT POSTURE, V35, P192, DOI 10.1016/j.gaitpost.2011.09.005; Mueller Arne, 2018, Digit Biomark, V2, P79, DOI 10.1159/000490919; Paudel S, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-46154-3; Peri K, 2008, AGE AGEING, V37, P57, DOI 10.1093/ageing/afm135; Pitta F, 2006, EUR RESPIR J, V27, P1040, DOI 10.1183/09031936.06.00064105; Plasqui G, 2007, OBESITY, V15, P2371, DOI 10.1038/oby.2007.281; Raymond M, 2015, J PHYS ACT HEALTH, V12, P1298, DOI 10.1123/jpah.2014-0347; Sabatini AM, 2015, BIOMED ENG ONLINE, V14, DOI 10.1186/s12938-015-0103-8; Schimpl M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023299; Schimpl M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023080; Sievi NA, 2017, INT J CHRONIC OBSTR, V12, P1113, DOI 10.2147/COPD.S130195; Storti KL, 2008, MED SCI SPORT EXER, V40, P59, DOI 10.1249/mss.0b013e318158b504; Takayanagi N, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-39695-0; Thorup CB, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-011742	32	16	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2019	14	8							e0221732	10.1371/journal.pone.0221732	http://dx.doi.org/10.1371/journal.pone.0221732			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW6BO	31469864	Green Published, gold, Green Submitted			2022-12-26	WOS:000485062200026
J	Pearson, AL; Shortridge, A; Delamater, PL; Horton, TH; Dahlin, K; Rzotkiewicz, A; Marchiori, MJ				Pearson, Amber L.; Shortridge, Ashton; Delamater, Paul L.; Horton, Teresa H.; Dahlin, Kyla; Rzotkiewicz, Amanda; Marchiori, Michael J.			Effects of freshwater blue spaces may be beneficial for mental health: A first, ecological study in the North American Great Lakes region	PLOS ONE			English	Article							GREEN SPACE; EXPOSURE; ACCESS; PREFERENCE; STRESS; IMPACT	Research linking green space and mental health abounds. It also appears that oceanic blue spaces may be salutogenic, benefitting mental health through their expansive viewscapes, and possibly auditory and olfactory stimuli. Yet, it is unknown whether the same is true for freshwater bodies. In this ecological study, we explored associations between hospitalizations for anxiety/mood disorder in Michigan (> 30,000) and proximity to the North American Great Lakes. As a sensitivity analysis, we examined associations for 15 different inland lake sizes. Results showed small, protective effects for distance to Great Lake (beta = 0.06, p< 0.001) and percentage of inland lakes (beta = -0.04, p = 0.004). Unexpectedly, shorter distance to nearest inland lake was associated with higher anxiety/mood disorder hospitalizations. The protective effects of percentage area covered by inland lakes was observed for all lake sizes. These initial findings provide a foundation for future individual-level research with finer measurement of health outcomes and blue space exposure.	[Pearson, Amber L.; Shortridge, Ashton; Dahlin, Kyla; Rzotkiewicz, Amanda; Marchiori, Michael J.] Michigan State Univ, Dept Geog Environm & Spatial Sci, E Lansing, MI 48824 USA; [Pearson, Amber L.] Univ Otago, Dept Publ Hlth, Wellington, New Zealand; [Delamater, Paul L.] Univ N Carolina, Dept Geog, Chapel Hill, NC 27515 USA; [Delamater, Paul L.] Carolina Populat Ctr, Chapel Hill, NC 27515 USA; [Horton, Teresa H.] Northwestern Univ, Dept Anthropol, Evanston, IL 60208 USA	Michigan State University; University of Otago; University of North Carolina; University of North Carolina Chapel Hill; Northwestern University	Pearson, AL (corresponding author), Michigan State Univ, Dept Geog Environm & Spatial Sci, E Lansing, MI 48824 USA.; Pearson, AL (corresponding author), Univ Otago, Dept Publ Hlth, Wellington, New Zealand.	apearson@msu.edu		Horton, Teresa/0000-0002-3734-8065; Pearson, Amber L./0000-0002-8848-1798	Michigan State University's Provost Initative for Undergraduate Research; Michigan Department of Health and Human Services (MDHHS), Certificate of Need Section; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P2CHD050924] Funding Source: NIH RePORTER	Michigan State University's Provost Initative for Undergraduate Research; Michigan Department of Health and Human Services (MDHHS), Certificate of Need Section; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work received funding support for MM from Michigan State University's Provost Initative for Undergraduate Research. AP, AS and PD received support from the Michigan Department of Health and Human Services (MDHHS), Certificate of Need Section. MDHHS had no role in the research design, dissemination of the results, or decision to publish the manuscript.	Amoly E, 2014, ENVIRON HEALTH PERSP, V122, P1351, DOI 10.1289/ehp.1408215; Barton J, 2010, ENVIRON SCI TECHNOL, V44, P3947, DOI 10.1021/es903183r; Beyer KMM, 2014, INT J ENV RES PUB HE, V11, P3453, DOI 10.3390/ijerph110303453; de Bell S, 2017, LANDSCAPE URBAN PLAN, V167, P118, DOI 10.1016/j.landurbplan.2017.06.003; de Vries S, 2003, ENVIRON PLANN A, V35, P1717, DOI 10.1068/a35111; de Vries S, 2016, BJPSYCH OPEN, V2, P366, DOI 10.1192/bjpo.bp.115.002469; DNR, 2019, MICH RECR BOAT INF S; Finlay J, 2015, HEALTH PLACE, V34, P97, DOI 10.1016/j.healthplace.2015.05.001; Foley R, 2015, HEALTH PLACE, V35, P157, DOI 10.1016/j.healthplace.2015.07.003; Garrett JK, 2019, HEALTH PLACE, V55, P100, DOI 10.1016/j.healthplace.2018.11.003; Gascon M, 2015, INT J ENV RES PUB HE, V12, P4354, DOI 10.3390/ijerph120404354; Ibarra FF, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.00632; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; McCormick R, 2017, J PEDIATR NURS, V37, P3, DOI 10.1016/j.pedn.2017.08.027; Nutsford D, 2013, PUBLIC HEALTH, V127, P1005, DOI 10.1016/j.puhe.2013.08.016; Nutsford D, 2016, HEALTH PLACE, V39, P70, DOI 10.1016/j.healthplace.2016.03.002; Pogue P, 1999, COAST MANAGE, V27, P219; Quinn P, 2013, NAT HAZARDS, V65, P1227, DOI 10.1007/s11069-012-0379-y; Rautio N, 2018, INT J SOC PSYCHIATR, V64, P92, DOI 10.1177/0020764017744582; Roberts AL, 2015, JAMA PSYCHIAT, V72, P203, DOI 10.1001/jamapsychiatry.2014.2632; Thompson CW, 2012, LANDSCAPE URBAN PLAN, V105, P221, DOI 10.1016/j.landurbplan.2011.12.015; Volker S, 2011, INT J HYG ENVIR HEAL, V214, P449, DOI 10.1016/j.ijheh.2011.05.001; White M, 2010, J ENVIRON PSYCHOL, V30, P482, DOI 10.1016/j.jenvp.2010.04.004; White MP, 2016, GREEN EXERCISE: LINKING NATURE, HEALTH AND WELL-BEING, P69; White MP, 2013, HEALTH PLACE, V23, P97, DOI 10.1016/j.healthplace.2013.05.006	25	21	21	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2019	14	8							e0221977	10.1371/journal.pone.0221977	http://dx.doi.org/10.1371/journal.pone.0221977			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW6BO	31469889	Green Submitted, Green Published, gold			2022-12-26	WOS:000485062200045
J	Ye, YN; Zhang, LX; Yan, WH; Wang, AP; Wang, WQ; Gao, ZN; Tang, XL; Yan, L; Wan, Q; Luo, ZJ; Qin, GJ; Chen, LL; Wang, SQ; Wang, YX; Mu, MM				Ye, Yingnan; Zhang, Linxi; Yan, Wenhua; Wang, Anping; Wang, Weiqing; Gao, Zhengnan; Tang, Xulei; Yan, Li; Wan, Qin; Luo, Zuojie; Qin, Guijun; Chen, Lulu; Wang, Shiqing; Wang, Yuxia; Mu, Miming			Self-reported sleep duration and daytime napping are associated with renal hyperfiltration and microalbuminuria in an apparently healthy Chinese population	PLOS ONE			English	Article							GLOMERULAR-FILTRATION-RATE; CHRONIC KIDNEY-DISEASE; RESTLESS LEGS SYNDROME; CARDIOVASCULAR-DISEASE; RISK-FACTOR; HYPERTENSION; ADULTS; MECHANISMS; MORTALITY; DECLINE	Background Sleep duration affects health in various ways. The objective of the present study was to investigate the relationships among sleep duration, daytime napping and kidney function in a middle-aged apparently healthy Chinese population. Methods According to self-reported total sleep and daytime napping durations, 33,850 participants who were 38-90 years old and recruited from eight regional centers were divided into subgroups. Height, weight, waist circumference, hip circumference, blood pressure, biochemical indexes, fasting blood glucose (FBG), postprandial blood glucose (PBG), HbA1c, creatinine and urinary albumin-creatinine ratio (UACR) were measured and recorded for each subject. Microalbuminuria was defined as UACR >= 30 mg/g, chronic kidney disease (CKD) was defined as eGFR < 60 ml/min, and hyperfiltration was defined as eGFR >= 135 ml/min. Multiple logistic regression was applied to investigate the association between sleep and kidney function. Results Compared to sleeping for 7-8 h/day, the ORs for microalbuminuria for sleeping for > 9 h/day, 8-9 h/day 6-7 h/day and < 6 h/day were 1.343 (1.228-1.470, P< 0.001), 1.223 (1.134-1.320, P< 0.001), 1.130 (1.003-1.273, P = 0.045) and 1.140 (0.908-1.431, P = 0.259), respectively. The eGFR levels exhibited a U-shaped association with sleep duration among subjects with an eGFR >= 90 ml/min and an N-shaped association with sleep duration among subjects with an eGFR < 90 ml/min. The OR for hyperfiltration for > 9 h/day of sleep was 1.400 (1.123-1.745, P = 0.003) among participants with an eGFR >= 90 ml/min. Daytime napping had a negative effect on renal health. Compared to the absence of a napping habit, the ORs for microalbuminuria for 0-1 h/day, 1-1.5 h/day and > 1.5 h/day of daytime napping were 1.552 (1.444-1.668, P< 0.001), 1.301 (1.135-1.491, P< 0.001) and 1.567 (1.353-1.814, P< 0.001), respectively. Conclusion The association of total sleep duration with renal health outcomes is U-shaped. Daytime napping has a negative effect on renal health.	[Ye, Yingnan; Zhang, Linxi; Yan, Wenhua; Wang, Anping; Wang, Shiqing; Wang, Yuxia; Mu, Miming] Chinese Peoples Liberat Army Gen Hosp, Dept Endocrinol, Beijing, Peoples R China; [Ye, Yingnan; Wang, Shiqing; Wang, Yuxia; Mu, Miming] Nankai Univ, Dept Med, Tianjin, Peoples R China; [Wang, Weiqing] Shanghai Jiao Tong Univ, Affiliated Ruijin Hosp, Shanghai, Peoples R China; [Gao, Zhengnan] Ctr Hosp Dalian, Dalian, Liaoning, Peoples R China; [Tang, Xulei] Lanzhou Univ, Hosp 1, Lanzhou, Gansu, Peoples R China; [Yan, Li] Zhongshan Univ, Sun Yat Sen Mem Hosp, Guangzhou, Guangdong, Peoples R China; [Wan, Qin] Southwest Med Univ, Affiliated Hosp, Luzhou, Sichuan, Peoples R China; [Luo, Zuojie] Guangxi Med Univ, Affiliated Hosp 1, Nanning, Guangxi, Peoples R China; [Qin, Guijun] Zhengzhou Univ, Affiliated Hosp 1, Zhengzhou, Henan, Peoples R China; [Chen, Lulu] Wuhan Union Hosp, Wuhan, Hubei, Peoples R China	Chinese People's Liberation Army General Hospital; Nankai University; Shanghai Jiao Tong University; Lanzhou University; Sun Yat Sen University; Southwest Medical University; Guangxi Medical University; Zhengzhou University; Huazhong University of Science & Technology	Mu, MM (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Dept Endocrinol, Beijing, Peoples R China.; Mu, MM (corresponding author), Nankai Univ, Dept Med, Tianjin, Peoples R China.	muyiming@301hospital.com.cn			Key Laboratory for Endocrine and Metabolic Diseases of Ministry of Health [1994DP131044]; National Key New Drug Creation and Manufacturing Program of Ministry of Science and Technology [2012ZX09303006-001]; National High Technology Research and Development Program of China (863 Program) [2011AA020107]; National Science and Technology Major Project 288 [2011ZX09307-001-08]; Chinese Society of Endocrinologoy	Key Laboratory for Endocrine and Metabolic Diseases of Ministry of Health; National Key New Drug Creation and Manufacturing Program of Ministry of Science and Technology; National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); National Science and Technology Major Project 288; Chinese Society of Endocrinologoy	Present study was supported by award the author Yiming Mu received by Chinese Society of Endocrinologoy, the Key Laboratory for Endocrine and Metabolic Diseases of Ministry of Health (1994DP131044), the National Key New Drug Creation and Manufacturing Program of Ministry of Science and Technology (2012ZX09303006-001), the National High Technology Research and Development Program of China (863 Program, 2011AA020107), National Science and Technology Major Project 288 (2011ZX09307-001-08). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The present study was supported by the Chinese Society of Endocrinology, the Key Laboratory for Endocrine and Metabolic Diseases of Ministry of Health (1994DP131044), the National Key New Drug Creation and Manufacturing Program of Ministry of Science and Technology (2012ZX09303006-001), the National High Technology Research and Development Program of China (863 Program, 2011AA020107), and the National Science and Technology Major Project 288 (2011ZX09307- 001- 08).	Agarwal R, 2011, CLIN J AM SOC NEPHRO, V6, P1258, DOI 10.2215/CJN.10581110; Anujuo K, 2015, SLEEP MED, V16, P1482, DOI 10.1016/j.sleep.2015.08.014; Arima S, 2003, NEPHROL DIAL TRANSPL, V18, P1966, DOI 10.1093/ndt/gfg263; Ayas NT, 2003, DIABETES CARE, V26, P380, DOI 10.2337/diacare.26.2.380; Bash LD, 2009, AM J KIDNEY DIS, V53, P596, DOI 10.1053/j.ajkd.2008.10.044; Brown IJ, 2009, INT J EPIDEMIOL, V38, P791, DOI 10.1093/ije/dyp139; Buckley TM, 2005, J CLIN ENDOCR METAB, V90, P3106, DOI 10.1210/jc.2004-1056; Canales MT, 2011, SLEEP BREATH, V15, P137, DOI 10.1007/s11325-010-0339-2; Charloux A, 2001, J SLEEP RES, V10, P27, DOI 10.1046/j.1365-2869.2001.00235.x; Chen G, 2014, J CLIN ENDOCR METAB, V99, P2869, DOI 10.1210/jc.2013-3629; Choi H, 2017, KOREAN J INTERN MED, V32, P323, DOI 10.3904/kjim.2015.400; DINGES DF, 1994, J CLIN INVEST, V93, P1930, DOI 10.1172/JCI117184; Franke FJ, 2019, SLEEP MED, V54, P205, DOI 10.1016/j.sleep.2018.10.034; Fujibayashi K, 2012, J ATHEROSCLER THROMB, V19, P932, DOI 10.5551/jat.12781; Gangwisch JE, 2006, HYPERTENSION, V47, P833, DOI 10.1161/01.HYP.0000217362.34748.e0; Ge BH, 2015, INT J STROKE, V10, P177, DOI 10.1111/ijs.12398; Guo XF, 2015, J SLEEP RES, V24, P351, DOI 10.1111/jsr.12274; Hall JE, 1999, ANN NY ACAD SCI, V892, P91, DOI 10.1111/j.1749-6632.1999.tb07788.x; Ikehara S, 2009, SLEEP, V32, P295, DOI 10.1093/sleep/32.3.295; Innes KE, 2012, SLEEP MED REV, V16, P309, DOI 10.1016/j.smrv.2011.04.001; Kamperis K, 2010, AM J PHYSIOL-RENAL, V299, pF404, DOI 10.1152/ajprenal.00126.2010; Kim CW, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175298; Kim CW, 2015, ARTERIOSCL THROM VAS, V35, P2238, DOI 10.1161/ATVBAHA.115.306110; Knutson KL, 2018, J SLEEP RES, V27, P281, DOI 10.1111/jsr.12573; Leng Y, 2014, AM J EPIDEMIOL, V179, P1115, DOI 10.1093/aje/kwu036; Li JJ, 2017, CLIN J AM SOC NEPHRO, V12, P885, DOI 10.2215/CJN.09270816; Lin M, 2018, SLEEP BREATH, V22, P223, DOI 10.1007/s11325-017-1470-0; Martino TA, 2008, AM J PHYSIOL-REG I, V294, pR369; McMullan CJ, 2016, KIDNEY INT, V89, P1324, DOI 10.1016/j.kint.2015.12.048; Meerlo P, 2008, SLEEP MED REV, V12, P197, DOI 10.1016/j.smrv.2007.07.007; Meier-Ewert HK, 2004, J AM COLL CARDIOL, V43, P678, DOI 10.1016/j.jacc.2003.07.050; Merlino G, 2007, SLEEP, V30, P866, DOI 10.1093/sleep/30.7.866; Moriya T, 2012, KIDNEY INT, V81, P486, DOI 10.1038/ki.2011.404; Musselman DL, 1998, ARCH GEN PSYCHIAT, V55, P580, DOI 10.1001/archpsyc.55.7.580; Nagai M, 2015, AM J HYPERTENS, V28, P884, DOI 10.1093/ajh/hpu243; Ohkuma T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078968; Okada R, 2012, NEPHROL DIAL TRANSPL, V27, P1821, DOI 10.1093/ndt/gfr651; Palatini P, 2012, NEPHROL DIAL TRANSPL, V27, P1708, DOI 10.1093/ndt/gfs037; Patel SR, 2014, INT J OBESITY, V38, P1159, DOI 10.1038/ijo.2014.13; Patel SR, 2006, SLEEP, V29, P881, DOI 10.1093/sleep/29.7.881; Patel SR, 2009, SLEEP, V32, P200, DOI 10.1093/sleep/32.2.200; Perry JC, 2011, J RENIN-ANGIO-ALDO S, V12, P146, DOI 10.1177/1470320310391504; Petrov ME, 2016, SLEEP HEALTH, V2, P75, DOI 10.1016/j.sleh.2015.12.003; Petrov ME, 2014, SLEEP MED, V15, P1140, DOI 10.1016/j.sleep.2014.05.021; Ricardo AC, 2017, J AM SOC NEPHROL, V28, P3708, DOI 10.1681/ASN.2016121288; Rosinger AY, 2019, SLEEP, V42, DOI 10.1093/sleep/zsy210; RUDBERG S, 1992, KIDNEY INT, V41, P822, DOI 10.1038/ki.1992.126; Ruggenenti P, 2012, DIABETES CARE, V35, P2061, DOI 10.2337/dc11-2189; Salifu I, 2014, CARDIORENAL MED, V4, P210, DOI 10.1159/000368205; Sasaki S, 2014, J OCCUP ENVIRON MED, V56, P1243, DOI 10.1097/JOM.0000000000000322; Sedaghat S, 2015, CLIN J AM SOC NEPHRO, V10, P2190, DOI 10.2215/CJN.03000315; Stone KL, 2009, J AM GERIATR SOC, V57, P604, DOI 10.1111/j.1532-5415.2008.02171.x; Sung SA, 2018, CLIN J AM SOC NEPHRO, V13, P858, DOI 10.2215/CJN.11351017; Tomaszewski M, 2007, KIDNEY INT, V71, P816, DOI 10.1038/sj.ki.5002160; Tonneijck L, 2017, J AM SOC NEPHROL, V28, P1023, DOI 10.1681/ASN.2016060666; Vgontzas AN, 2004, J CLIN ENDOCR METAB, V89, P2119, DOI 10.1210/jc.2003-031562; Wang QJ, 2012, HYPERTENS RES, V35, P1012, DOI 10.1038/hr.2012.91; Wang Y, 2015, J CLIN SLEEP MED, V11, P1047, DOI 10.5664/jcsm.5024; Xi B, 2014, SLEEP MED REV, V18, P293, DOI 10.1016/j.smrv.2013.06.001; Xu Q, 2010, DIABETES CARE, V33, P78, DOI 10.2337/dc09-1143; Yamamoto R, 2018, CLIN J AM SOC NEPHRO, V13, P1825, DOI 10.2215/CJN.01340118; Yu JH, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192980	62	6	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2019	14	8							e0214776	10.1371/journal.pone.0214776	http://dx.doi.org/10.1371/journal.pone.0214776			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW6BO	31469836	gold, Green Submitted, Green Published			2022-12-26	WOS:000485062200002
J	Ijas, H; Koivunen, S; Raudaskoski, T; Kajantie, E; Gissler, M; Vaarasmaki, M				Ijas, Hilkka; Koivunen, Sanna; Raudaskoski, Tytti; Kajantie, Eero; Gissler, Mika; Vaarasmaki, Marja			Independent and concomitant associations of gestational diabetes and maternal obesity to perinatal outcome: A register-based study	PLOS ONE			English	Article							INSULIN-RESISTANCE; PREGNANCY; HYPERGLYCEMIA; OVERWEIGHT; QUALITY; IMPACT; RISK	Aims Gestational diabetes (GDM) is often accompanied by maternal overweight. Our aim was to evaluate the separate and concomitant effects of GDM and maternal overweight/obesity on perinatal outcomes. Methods We used the Finnish Medical Birth Register to identify all 24,577 women with a singleton pregnancy who delivered in 2009 in Finland and underwent an oral glucose tolerance test (OGTT). Women were divided into groups according to the result of OGTT (GDM/no GDM) and pre-pregnancy body mass index (BMI): normal weight (<= 24.9 kg/m(2)), overweight (25.0-29.9 kg/m(2)), and obese (>= 30.0 kg/m(2)). Primary outcomes included macrosomia, caesarean delivery, and treatment at neonatal ward. Normal weight women without GDM constituted the reference group. Results Compared to reference group, overweight or obese women without GDM had an increased risk of macrosomia [odds ratio adjusted for age, parity, smoking and socio-economic status (aOR) 1.18 (95% CI 1.09-1.28) and 1.50 (95% CI 1.19-1.88)], and caesarean delivery [aORs 1.17 (95% CI 1.07-1.28) and 1.52 (95% CI 1.37-1.69)], respectively. In normal weight GDM women the risk of macrosomia [aOR 1.17 (95% CI 0.85-1.62)] and caesarean delivery [aOR 1.10 (95% CI 0.96-1.27)] was not significantly increased as compared to normal weight women without GDM. GDM increased the risk of treatment at neonatal ward in all BMI categories and maternal obesity without GDM was also a risk factor for treatment at neonatal ward. Interaction p values between BMI and GDM on these outcomes were <0.001. Conclusions Maternal overweight and obesity without GDM increased the risk of macrosomia and caesarean delivery when compared to the reference group. These risks were amplified when overweight/obesity was accompanied by GDM. Obesity without GDM was a risk factor for treatment at neonatal ward; GDM increased this risk in all BMI categories. Our results suggest that especially maternal obesity should be considered as a risk factor for adverse pregnancy outcomes and GDM further amplifies this risk.	[Ijas, Hilkka; Koivunen, Sanna; Raudaskoski, Tytti; Kajantie, Eero; Vaarasmaki, Marja] Oulu Univ Hosp, PEDEGO Res Unit, Res Unit Pediat Dermatol Clin Genet Obstet & Gyne, MRC Oulu, Oulu, Finland; [Ijas, Hilkka; Koivunen, Sanna; Raudaskoski, Tytti; Kajantie, Eero; Vaarasmaki, Marja] Univ Oulu, Oulu, Finland; [Ijas, Hilkka; Koivunen, Sanna; Kajantie, Eero; Gissler, Mika; Vaarasmaki, Marja] THL Natl Inst Hlth & Welf, Dept Chron Dis Prevent, Helsinki, Finland; [Ijas, Hilkka; Koivunen, Sanna; Kajantie, Eero; Gissler, Mika; Vaarasmaki, Marja] THL Natl Inst Hlth & Welf, Dept Chron Dis Prevent, Oulu, Finland; [Kajantie, Eero] Univ Helsinki, Childrens Hosp, Helsinki, Finland; [Kajantie, Eero] Helsinki Univ Hosp, Helsinki, Finland; [Kajantie, Eero] Norwegian Univ Sci & Technol, Dept Clin & Mol Med, Trondheim, Norway; [Gissler, Mika] Karolinska Inst, Stockholm, Sweden	University of Oulu; University of Oulu; Finland National Institute for Health & Welfare; Finland National Institute for Health & Welfare; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; Norwegian University of Science & Technology (NTNU); Karolinska Institutet	Ijas, H (corresponding author), Oulu Univ Hosp, PEDEGO Res Unit, Res Unit Pediat Dermatol Clin Genet Obstet & Gyne, MRC Oulu, Oulu, Finland.; Ijas, H (corresponding author), Univ Oulu, Oulu, Finland.; Ijas, H (corresponding author), THL Natl Inst Hlth & Welf, Dept Chron Dis Prevent, Helsinki, Finland.; Ijas, H (corresponding author), THL Natl Inst Hlth & Welf, Dept Chron Dis Prevent, Oulu, Finland.	hilkka.iias@oulu.fi		Gissler, Mika/0000-0001-8254-7525; Nikkinen, Hilkka/0000-0001-5578-0006; Vaarasmaki, Marja/0000-0002-8234-4434	Academy of Finland [127437, 129306, 130326, 134791, 263924, 315690]; European Commission [733280]; Finnish Foundation for Pediatric Research; Juho Vainio Foundation; Novo Nordisk Foundation; Signe and Ane Gyllenberg Foundation; Sigrid Juselius Foundation; Yrjo Jahnsson Foundation	Academy of Finland(Academy of Finland); European Commission(European CommissionEuropean Commission Joint Research Centre); Finnish Foundation for Pediatric Research; Juho Vainio Foundation; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Signe and Ane Gyllenberg Foundation; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Yrjo Jahnsson Foundation	This study was funded by Academy of Finland (Grants 127437, 129306, 130326, 134791, 263924 and 315690 to EK); the European Commission (Horizon2020 award 733280 RECAP Research on Children and Adults Born Preterm to Eero Kajantie); the Finnish Foundation for Pediatric Research (to Eero Kajantie); the Juho Vainio Foundation (to Eero Kajantie and Marja Vaarasmaki); the Novo Nordisk Foundation (to Eero Kajantie and Marja Vaarasmaki); the Signe and Ane Gyllenberg Foundation (to Eero Kajantie); the Sigrid Juselius Foundation (to Eero Kajantie); and the Yrjo Jahnsson Foundation (to Eero Kajantie and Marja Vaarasmaki). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberico S, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-23; Blickstein I, 2018, J MATERN-FETAL NEO M, V31, P640, DOI 10.1080/14767058.2017.1293030; Catalano PM, 2006, BJOG-INT J OBSTET GY, V113, P1126, DOI 10.1111/j.1471-0528.2006.00989.x; Catalano PM, 2012, DIABETES CARE, V35, P780, DOI 10.2337/dc11-1790; Catalano PM, 2010, REPRODUCTION, V140, P365, DOI 10.1530/REP-10-0088; Catalano PM, 2009, DIABETES CARE, V32, P1076, DOI 10.2337/dc08-2077; Chu SY, 2007, OBES REV, V8, P385, DOI 10.1111/j.1467-789X.2007.00397.x; Crowther CA, 2005, NEW ENGL J MED, V352, P2477, DOI 10.1056/NEJMoa042973; European Perinatal Health Report, 2010, HLTH CAR PREGN WOM B; Gissler M, 2003, J EPIDEMIOL COMMUN H, V57, P433, DOI 10.1136/jech.57.6.433; Gissler M, 2002, MED INFORM INTERNET, V27, P33, DOI 10.1080/14639230110119234; GISSLER M, 1995, SCAND J SOC MED, V23, P75, DOI 10.1177/140349489502300113; Harmon KA, 2011, DIABETES CARE, V34, P2198, DOI 10.2337/dc11-0723; Hermann M, 2014, AM J OBSTET GYNECOL; Heslehurst N, 2007, BJOG-INT J OBSTET GY, V114, P334, DOI 10.1111/j.1471-0528.2006.01230.x; Hilden K, 2019, DIABETIC MED, V36, P151, DOI 10.1111/dme.13843; Kaaja R, 2013, GESTATIONAL DIABETES; Landon MB, 2009, NEW ENGL J MED, V361, P1339, DOI 10.1056/NEJMoa0902430; Li N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082310; Liu J, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003798; Metzger BE, 2008, NEW ENGL J MED, V358, P1991, DOI 10.1056/NEJMoa0707943; Morgan KL, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-003983; Owens LA, 2010, DIABETES CARE, V33, P577, DOI 10.2337/dc09-0911; Pihkala J, 1989, Duodecim, V105, P1540; Pirkola J, 2010, J CLIN ENDOCR METAB, V95, P772, DOI 10.1210/jc.2009-1075; Raatikainen K, 2006, OBESITY, V14, P165, DOI 10.1038/oby.2006.20; Wahabi HA, 2014, BMC ENDOCR DISORD, V14, DOI 10.1186/1472-6823-14-47	27	17	18	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2019	14	8							e0221549	10.1371/journal.pone.0221549	http://dx.doi.org/10.1371/journal.pone.0221549			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW6AB	31465425	Green Published, gold, Green Submitted			2022-12-26	WOS:000485058200025
J	Imai, A; Kuniga, T; Yoshioka, T; Nonaka, K; Mitani, N; Fukamachi, H; Hiehata, N; Yamamoto, M; Hayashi, T				Imai, Atsushi; Kuniga, Takeshi; Yoshioka, Terutaka; Nonaka, Keisuke; Mitani, Nobuhito; Fukamachi, Hiroshi; Hiehata, Naofumi; Yamamoto, Masashi; Hayashi, Takeshi			Single-step genomic prediction of fruit-quality traits using phenotypic records of non-genotyped relatives in citrus	PLOS ONE			English	Article							GENETIC EVALUATION; FULL PEDIGREE; DAIRY-CATTLE; SELECTION; INFORMATION; APPLE; BLUP	The potential of genomic selection (GS) is currently being evaluated for fruit breeding. GS models are usually constructed based on information from both the genotype and phenotype of population. However, information from phenotyped but non-genotyped relatives can also be used to construct GS models, and this additional information can improve their accuracy. In the present study, we evaluated the utility of single-step genomic best linear unbiased prediction (ssGBLUP) in citrus breeding, which is a genomic prediction method that combines the kinship information from genotyped and non-genotyped relatives into a single relationship matrix for a mixed model to apply GS. Fruit weight, sugar content, and acid content of 1,935 citrus individuals, of which 483 had genotype data of 2,354 genome-wide single nucleotide polymorphisms, were evaluated from 2009-2012. The prediction accuracy of ssGBLUP for genotyped individuals was similar to or higher than that of usual genomic best linear unbiased prediction method using only genotyped individuals, especially for sugar content. Therefore, ssGBLUP could yield higher accuracy in genotyped individuals by adding information from non-genotyped relatives. The prediction accuracy of ssGBLUP for non-genotyped individuals was also slightly higher than that of conventional best linear unbiased prediction method using pedigree information. This indicates that ssGBLUP can enhance prediction accuracy of breeding values for non-genotyped individuals using genomic information of genotyped relatives. These results demonstrate the potential of ssGBLUP for fruit breeding, including citrus.	[Imai, Atsushi; Mitani, Nobuhito] Natl Agr & Food Res Org, Inst Fruit Tree & Tea Sci, Tsukuba, Ibaraki, Japan; [Imai, Atsushi; Hayashi, Takeshi] Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki, Japan; [Kuniga, Takeshi; Yoshioka, Terutaka] Natl Agr & Food Res Org, Western Reg Agr Res Ctr, Zentsuji, Kagawa, Japan; [Nonaka, Keisuke; Fukamachi, Hiroshi] Natl Agr & Food Res Org, Inst Fruit Tree & Tea Sci, Shimizu, Shizuoka, Japan; [Hiehata, Naofumi] Nagasaki Prefectural Govt, Nagasaki Agr & Forestry Tech Dev Ctr, Nagasaki, Japan; [Yamamoto, Masashi] Kagoshima Univ, Fac Agr, Kagoshima, Kagoshima, Japan; [Hayashi, Takeshi] Natl Agr & Food Res Org, Inst Crop Sci, Tsukuba, Ibaraki, Japan	National Agriculture & Food Research Organization - Japan; University of Tsukuba; National Agriculture & Food Research Organization - Japan; National Agriculture & Food Research Organization - Japan; Kagoshima University; National Agriculture & Food Research Organization - Japan	Hayashi, T (corresponding author), Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki, Japan.; Hayashi, T (corresponding author), Natl Agr & Food Res Org, Inst Crop Sci, Tsukuba, Ibaraki, Japan.	hayatk@affrc.go.jp						Aguilar I, 2011, J ANIM BREED GENET, V128, P422, DOI 10.1111/j.1439-0388.2010.00912.x; Aguilar I, 2010, J DAIRY SCI, V93, P743, DOI 10.3168/jds.2009-2730; Ashraf B, 2016, CROP SCI, V56, P957, DOI 10.2135/cropsci2015.02.0111; Asins MJ, 2015, TREE GENET GENOMES, V11, DOI 10.1007/s11295-015-0949-8; Cappa EP, 2018, PLANT SCI, V271, P27, DOI 10.1016/j.plantsci.2018.03.014; Cappa EP, 2017, MOL BREEDING, V37, DOI 10.1007/s11032-017-0725-6; Chen CY, 2011, J ANIM SCI, V89, P23, DOI 10.2527/jas.2010-3071; Christensen OF, 2012, ANIMAL, V6, P1565, DOI 10.1017/S1751731112000742; Christensen OF, 2010, GENET SEL EVOL, V42, DOI 10.1186/1297-9686-42-2; Crow JF, 2010, PHILOS T R SOC B, V365, P1241, DOI 10.1098/rstb.2009.0275; Daetwyler HD, 2010, GENETICS, V185, P1021, DOI 10.1534/genetics.110.116855; Daetwyler HD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003395; Desta ZA, 2014, TRENDS PLANT SCI, V19, P592, DOI 10.1016/j.tplants.2014.05.006; Elshire RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019379; Evans K, 2012, ACTA HORTIC, V945, P233; Fernando RL, 2014, GENET SEL EVOL, V46, DOI 10.1186/1297-9686-46-50; Fisher R. A., 1919, Transactions of the Royal Society of Edinburgh, V52; Frett TJ, 2012, J AM POMOL SOC, V66, P214; Gao HD, 2012, GENET SEL EVOL, V44, DOI 10.1186/1297-9686-44-8; Goddard M, 2009, GENETICA, V136, P245, DOI 10.1007/s10709-008-9308-0; Habier D, 2010, GENET SEL EVOL, V42, DOI 10.1186/1297-9686-42-5; Hayes BJ, 2009, J DAIRY SCI, V92, P433, DOI 10.3168/jds.2008-1646; Heffner EL, 2009, CROP SCI, V49, P1, DOI 10.2135/cropsci2008.08.0512; Henderson C.R., 1973, J ANIM SCI, V1973, P10, DOI DOI 10.1093/ANSCI/1973.SYMPOSIUM.10; Hill WG, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000008; Imai A, 2018, TREE GENET GENOMES, V14, DOI 10.1007/s11295-018-1238-0; Imai A, 2017, TREE GENET GENOMES, V13, DOI 10.1007/s11295-017-1162-8; Imai A, 2016, TREE GENET GENOMES, V12, DOI 10.1007/s11295-016-1078-8; Iwata H, 2016, BREEDING SCI, V66, P100, DOI 10.1270/jsbbs.66.100; Iwata H, 2013, BREEDING SCI, V63, P125, DOI 10.1270/jsbbs.63.125; Jannink JL, 2010, BRIEF FUNCT GENOMICS, V9, P166, DOI 10.1093/bfgp/elq001; Klapste J, 2018, J HERED, V109, P802, DOI 10.1093/jhered/esy051; Koivula M, 2012, J DAIRY SCI, V95, P4065, DOI 10.3168/jds.2011-4874; Kouassi AB, 2009, TREE GENET GENOMES, V5, P659, DOI 10.1007/s11295-009-0217-x; Kumar S, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-393; Kumar S, 2010, EUPHYTICA, V173, P207, DOI 10.1007/s10681-009-0090-6; Legarra A, 2009, J DAIRY SCI, V92, P4656, DOI 10.3168/jds.2009-2061; Lourenco DAL, 2015, J ANIM SCI, V93, P2653, DOI 10.2527/jas.2014-8836; Mathey MM, 2013, J AM POMOL SOC, V67, P205; Meuwissen THE, 2001, GENETICS, V157, P1819; Minamikawa MF, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-30154-w; Minamikawa MF, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05100-x; Misztal I., 2002, BLUPF90 RELATED PROG; Misztal I, 2013, POULTRY SCI, V92, P2530, DOI 10.3382/ps.2012-02739; Mitani N, 2008, SCI HORTIC-AMSTERDAM, V116, P452, DOI 10.1016/j.scienta.2008.03.003; Morais OP, 2018, CROP SCI, V58, P2347, DOI 10.2135/cropsci2018.02.0087; Morais OP, 2018, CROP SCI, V58, P592, DOI 10.2135/cropsci2017.06.0366; Onogi A, 2014, J ANIM SCI, V92, P1931, DOI 10.2527/jas.2014-7168; Perez-Rodriguez P, 2017, PLANT GENOME-US, V10, DOI 10.3835/plantgenome2016.09.0089; Ratcliffe B, 2017, G3-GENES GENOM GENET, V7, P935, DOI 10.1534/g3.116.037895; Sargolzaei M, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-478; Solberg TR, 2008, J ANIM SCI, V86, P2447, DOI 10.2527/jas.2007-0010; VanRaden PM, 2008, J DAIRY SCI, V91, P4414, DOI 10.3168/jds.2007-0980; VanRaden PM, 2009, J DAIRY SCI, V92, P16, DOI 10.3168/jds.2008-1514; Vitezica ZG, 2011, GENET RES, V93, P357, DOI 10.1017/S001667231100022X; Westhues M, 2019, THEOR APPL GENET, P1, DOI [10.1007/s00122-018-3219-y, DOI 10.1007/S00122-018-3219-Y]; Wiggans GR, 2009, J DAIRY SCI, V92, P3431, DOI 10.3168/jds.2008-1758; Yamamoto T, 2016, BREEDING SCI, V66, P1, DOI 10.1270/jsbbs.66.1; Yu Y, 2016, TREE GENET GENOMES, V12, DOI 10.1007/s11295-016-1034-7	59	8	8	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2019	14	8							e0221880	10.1371/journal.pone.0221880	http://dx.doi.org/10.1371/journal.pone.0221880			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW6AB	31465502	Green Published, Green Submitted, gold			2022-12-26	WOS:000485058200064
J	Matsudaira, I; Oba, K; Takeuchi, H; Sekiguchi, A; Tomita, H; Taki, Y; Kawashima, R				Matsudaira, Izumi; Oba, Kentaro; Takeuchi, Hikaru; Sekiguchi, Atsushi; Tomita, Hiroaki; Taki, Yasuyuki; Kawashima, Ryuta			rs1360780 of the FKBP5 gene modulates the association between maternal acceptance and regional gray matter volume in the thalamus in children and adolescents	PLOS ONE			English	Article							ENVIRONMENT INTERACTION RESEARCH; CHILDHOOD MALTREATMENT; BRAIN STRUCTURE; EARLY STRESS; CORTISOL; AMYGDALA; MODERATION; PREDICTS; BASAL	Investigating the effects of gene-environment interactions (G x E) with regard to brain structure may help to elucidate the putative mechanisms associated with psychiatric risk. rs1360780 (C/T) is a functional single-nucleotide polymorphism (SNP) in the gene encoding FK506-binding protein 5 (FKBP5), which is involved in the regulation of the hypothalamic-pituitary-adrenal (HPA) axis stress responses. The minor (T) allele of FKBP5 is considered a risk allele for stress-related disorders, due to the overproduction of FKBP5, which results in impaired communication of stress signals with the HPA axis. Previous studies have reported that interactions between childhood maltreatment and the rs1360780 genotype affect structures in subcortical areas of the brain. However, it is unclear how this SNP modulates the association between non-adverse environments and brain structure. In this study, we examined the interactive effect of the rs1360780 genotype and maternal acceptance on the regional gray matter volume (rGMV) in 202 Japanese children. Maternal acceptance was assessed using a Japanese psychological questionnaire for mothers. Whole-brain multiple regression analysis using voxel-based morphometry showed a significant positive association between maternal acceptance and rGMV in the left thalamus of T-allele carriers, while a significant negative association was found in C/C homozygotes. Post-hoc analysis revealed that at or below the 70th percentiles of maternal acceptance, the T-allele carriers had a reduced thalamic rGMV compared with that of C/C homozygotes. Thus, our investigation indicated that the effect of the maternal acceptance level on brain development was different, depending on the rs1360780 genotype. Importantly, we found that the differences in brain structure between the T-allele carriers and C/C homozygotes at low to moderate levels of maternal acceptance, which is not equivalent to maltreatment. The present study contributes to the G x E research by highlighting the necessity to investigate the role of non-adverse environmental factors.	[Matsudaira, Izumi] Tohoku Univ, Inst Dev Aging & Canc, Dept Nucl Med & Radiol, Sendai, Miyagi, Japan; [Matsudaira, Izumi] Japan Soc Promot Sci, Tokyo, Japan; [Oba, Kentaro] Tohoku Univ, Inst Dev Aging & Canc, Dept Human Brain Sci, Sendai, Miyagi, Japan; [Takeuchi, Hikaru; Kawashima, Ryuta] Tohoku Univ, Inst Dev Aging & Canc, Div Dev Cognit Neurosci, Sendai, Miyagi, Japan; [Sekiguchi, Atsushi] Natl Ctr Neurol & Psychiat, Natl Inst Mental Hlth, Dept Behav Med, Tokyo, Japan; [Sekiguchi, Atsushi; Taki, Yasuyuki] Tohoku Univ, Tohoku Med Megabank Org, Dept Community Med Supports, Div Med Neuroimaging Anal, Sendai, Miyagi, Japan; [Tomita, Hiroaki] Tohoku Univ, Int Res Inst Disaster Sci, Dept Disaster Psychiat, Sendai, Miyagi, Japan; [Tomita, Hiroaki] Tohoku Univ Hosp, Dept Psychiat, Sendai, Miyagi, Japan; [Taki, Yasuyuki; Kawashima, Ryuta] Tohoku Univ, Inst Dev Aging & Canc, Smart Aging Res Ctr, Sendai, Miyagi, Japan; [Kawashima, Ryuta] Tohoku Univ, Inst Dev Aging & Canc, Dept Adv Brain Sci, Sendai, Miyagi, Japan; [Kawashima, Ryuta] Tohoku Univ, Inst Dev Aging & Canc, Smart Aging Int Res Ctr, Sendai, Miyagi, Japan	Tohoku University; Japan Society for the Promotion of Science; Tohoku University; Tohoku University; National Center for Neurology & Psychiatry - Japan; Tohoku University; Tohoku University; Tohoku University; Tohoku University; Tohoku University; Tohoku University	Matsudaira, I (corresponding author), Tohoku Univ, Inst Dev Aging & Canc, Dept Nucl Med & Radiol, Sendai, Miyagi, Japan.; Matsudaira, I (corresponding author), Japan Soc Promot Sci, Tokyo, Japan.	izumi.matsudaira.t8@dc.tohoku.ac.jp	Takeuchi, Hikaru/D-1057-2011	Takeuchi, Hikaru/0000-0002-8022-9694	Ministry of Education, Culture, Sports, Science and Technology [20790875, 16H06526]; Division for Interdsciplinary Advanced Research and Education, Tohoku University; Kumon Institute of Education Co., Ltd	Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Division for Interdsciplinary Advanced Research and Education, Tohoku University; Kumon Institute of Education Co., Ltd	This study was funded by a Grant-in-Aid for Young Scientists (B), 20790875, and a Grant-in-Aid for Scientific Research on Innovative Areas, 16H06526, from the Ministry of Education, Culture, Sports, Science and Technology to Yasuyuki Taki. This study was also supported by a research fund from the Division for Interdsciplinary Advanced Research and Education, Tohoku University to Izumi Matsudaira. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. This study was also funded by Kumon Institute of Education Co., Ltd to Ryuta Kawashima. This funder also had no role in the study design, data collection and analysis, decision to publish, preparation of the manuscript, employment, consultancy, patents, products in development, or marketed products.	Andersen SL, 2004, NEUROPSYCHOPHARMACOL, V29, P1988, DOI 10.1038/sj.npp.1300528; Azuma H, 2002, FAMILY DIAGNOSTIC TE; Belsky J, 2011, J CHILD PSYCHOL PSYC, V52, P409, DOI 10.1111/j.1469-7610.2010.02281.x; Binder EB, 2009, PSYCHONEUROENDOCRINO, V34, P99, DOI 10.1016/j.psyneuen.2009.05.021; Bogdan R, 2017, BIOL PSYCHIAT, V82, P165, DOI 10.1016/j.biopsych.2016.12.030; Bogdan R, 2016, NEUROPSYCHOPHARMACOL, V41, P275, DOI 10.1038/npp.2015.216; Chen H, 2017, MOL BRAIN, V10, DOI 10.1186/s13041-017-0295-x; Chen RQ, 2016, PSYCHONEUROENDOCRINO, V74, P101, DOI 10.1016/j.psyneuen.2016.08.023; Dahmen B, 2018, DEV NEUROSCI-BASEL, V40, P13, DOI 10.1159/000484238; Dick DM, 2015, PERSPECT PSYCHOL SCI, V10, P37, DOI 10.1177/1745691614556682; Duarte DGG, 2016, J AFFECT DISORDERS, V197, P74, DOI 10.1016/j.jad.2016.02.068; Duncan LE, 2011, AM J PSYCHIAT, V168, P1041, DOI 10.1176/appi.ajp.2011.11020191; Fani N, 2013, JAMA PSYCHIAT, V70, P392, DOI 10.1001/2013.jamapsychiatry.210; Franke B, 2016, NAT NEUROSCI, V19, P420, DOI 10.1038/nn.4228; Fujii T, 2014, J PSYCHIATR RES, V58, P96, DOI 10.1016/j.jpsychires.2014.07.009; Grabe HJ, 2016, HUM BRAIN MAPP, V37, P1602, DOI 10.1002/hbm.23123; Haber SN, 2009, BRAIN RES BULL, V78, P69, DOI 10.1016/j.brainresbull.2008.09.013; Holz NE, 2015, BRAIN STRUCT FUNCT, V220, P1355, DOI 10.1007/s00429-014-0729-5; Ising M, 2008, EUR J NEUROSCI, V28, P389, DOI 10.1111/j.1460-9568.2008.06332.x; Jaferi A, 2006, ENDOCRINOLOGY, V147, P4917, DOI 10.1210/en.2005-1393; Johnson P. O., 1936, STAT RES MEMOIRS; Keller MC, 2014, BIOL PSYCHIAT, V75, P18, DOI 10.1016/j.biopsych.2013.09.006; Klengel T, 2013, NAT NEUROSCI, V16, P33, DOI 10.1038/nn.3275; Lau WKW, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00163; Liao M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071898; Luby JL, 2012, P NATL ACAD SCI USA, V109, P2854, DOI 10.1073/pnas.1118003109; Luijk MPCM, 2010, PSYCHONEUROENDOCRINO, V35, P1454, DOI 10.1016/j.psyneuen.2010.04.012; Matsudaira I, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154220; Morey RA, 2016, NEUROPSYCHOPHARMACOL, V41, P791, DOI 10.1038/npp.2015.205; Morimoto M, 1996, NEUROSCI RES, V26, P235, DOI 10.1016/S0168-0102(96)01105-4; Numakawa T, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18112312; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Peters SK, 2016, FRONT SYST NEUROSCI, V10, DOI 10.3389/fnsys.2016.00104; Preacher KJ, 2006, J EDUC BEHAV STAT, V31, P437, DOI 10.3102/10769986031004437; Rabl U, 2014, J NEUROSCI, V34, P9917, DOI 10.1523/JNEUROSCI.3113-13.2014; Reus LM, 2017, SCI REP-UK, V7, DOI 10.1038/srep42140; Rohner R., 2009, THEY LOVE ME THEY LO; Scharf SH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016883; Seay A, 2014, NURS FORUM, V49, P200, DOI 10.1111/nuf.12093; Shaw P, 2008, J NEUROSCI, V28, P3586, DOI 10.1523/JNEUROSCI.5309-07.2008; Sheikh HI, 2014, NEUROIMAGE-CLIN, V6, P77, DOI 10.1016/j.nicl.2014.08.013; Sheu YS, 2010, NEUROIMAGE, V53, P412, DOI 10.1016/j.neuroimage.2010.06.043; Sowell ER, 2003, NAT NEUROSCI, V6, P309, DOI 10.1038/nn1008; Suarez MM, 1997, PHYSIOL BEHAV, V62, P373, DOI 10.1016/S0031-9384(97)00032-2; Takeuchi H, 2018, HUM BRAIN MAPP, V39, P4471, DOI 10.1002/hbm.24286; Takeuchi H, 2015, J NEUROSCI, V35, P2233, DOI 10.1523/JNEUROSCI.0598-14.2015; Taki Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015213; Teicher MH, 2006, ANN NY ACAD SCI, V1071, P313, DOI 10.1196/annals.1364.024; Teicher MH, 2016, NAT REV NEUROSCI, V17, P652, DOI 10.1038/nrn.2016.111; Tozzi L, 2016, NEUROPSYCHOPHARMACOL, V41, P487, DOI 10.1038/npp.2015.170; Tsujimoto S, 2011, TRENDS COGN SCI, V15, P169, DOI 10.1016/j.tics.2011.02.001; Vogt BA, 2016, J CHEM NEUROANAT, V74, P28, DOI 10.1016/j.jchemneu.2016.01.010; White MG, 2012, GENES BRAIN BEHAV, V11, P869, DOI 10.1111/j.1601-183X.2012.00837.x; Whittle S, 2014, DEV COGN NEUROS-NETH, V8, P7, DOI 10.1016/j.dcn.2013.10.006; Yang JY, 2018, NEUROPSYCHOLOGIA, V109, P165, DOI 10.1016/j.neuropsychologia.2017.12.017	55	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2019	14	8							e0221768	10.1371/journal.pone.0221768	http://dx.doi.org/10.1371/journal.pone.0221768			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW6AB	31465499	gold, Green Published, Green Submitted			2022-12-26	WOS:000485058200049
J	Mostafa, AA; 't Hart, BM; Henriques, DYP				Mostafa, Ahmed A.; 't Hart, Bernard Marius; Henriques, Denise Y. P.			Motor learning without moving: Proprioceptive and predictive hand localization after passive visuoproprioceptive discrepancy training	PLOS ONE			English	Article							VISUOMOTOR ADAPTATION; REACH ADAPTATION; FORCE-FIELD; RECALIBRATION; CEREBELLUM; TASK; CONSEQUENCES; INFORMATION; MEMORY; TARGET	An accurate estimate of limb position is necessary for movement planning, before and after motor learning. Where we localize our unseen hand after a reach depends on felt hand position, or proprioception, but in studies and theories on motor adaptation this is quite often neglected in favour of predicted sensory consequences based on efference copies of motor commands. Both sources of information should contribute, so here we set out to further investigate how much of hand localization depends on proprioception and how much on predicted sensory consequences. We use a training paradigm combining robot controlled hand movements with rotated visual feedback that eliminates the possibility to update predicted sensory consequences ('exposure training'), but still recalibrates proprioception, as well as a classic training paradigm with self-generated movements in another set of participants. After each kind of training we measure participants' hand location estimates based on both efference-based predictions and afferent proprioceptive signals with self-generated hand movements ('active localization') as well as based on proprioception only with robot-generated movements ('passive localization'). In the exposure training group, we find indistinguishable shifts in passive and active hand localization, but after classic training, active localization shifts more than passive, indicating a contribution from updated predicted sensory consequences. Both changes in open-loop reaches and hand localization are only slightly smaller after exposure training as compared to after classic training, confirming that proprioception plays a large role in estimating limb position and in planning movements, even after adaptation. (data: https://doi.org/10.17605/osf.io/zfdth,preprint:https://doi.org/10.1101/384941)	[Mostafa, Ahmed A.; 't Hart, Bernard Marius; Henriques, Denise Y. P.] York Univ, CVR Kinesiol & Hlth Sci, Toronto, ON, Canada; [Mostafa, Ahmed A.] Mansoura Univ, Fac Phys Educ, Mansoura, Egypt	York University - Canada; Egyptian Knowledge Bank (EKB); Mansoura University	't Hart, BM (corresponding author), York Univ, CVR Kinesiol & Hlth Sci, Toronto, ON, Canada.	thartbm@gmail.com	't Hart, Bernard/AHD-9519-2022; Mostafa, Ahmad/AAJ-9470-2020	't Hart, Bernard/0000-0002-0045-3769; 	Canadian Network for Research and Innovation in Machining Technology NSERC; German Research Foundation (DFG) [HA 6861/2-1]	Canadian Network for Research and Innovation in Machining Technology NSERC; German Research Foundation (DFG)(German Research Foundation (DFG))	This work was supported by a Canadian Network for Research and Innovation in Machining Technology NSERC Operating grant (DYPH) and the German Research Foundation (DFG) under grant no. HA 6861/2-1 (BMtH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], R LANG ENV STAT COMP, DOI DOI 10.1080/02705060.2017.1422558; Bao SC, 2017, NEUROSCI LETT, V638, P109, DOI 10.1016/j.neulet.2016.12.028; BARKLEY V, 2014, FRONT HUM NEUROSCI, V8, P1, DOI DOI 10.3389/FNHUM.2014.00001; Bastian AJ, 2006, CURR OPIN NEUROBIOL, V16, P645, DOI 10.1016/j.conb.2006.08.016; Byrne PA, 2013, NEUROPSYCHOLOGIA, V51, P26, DOI 10.1016/j.neuropsychologia.2012.10.008; Cameron BD, 2012, CONSCIOUS COGN, V21, P4, DOI 10.1016/j.concog.2010.11.006; Clayton HA, 2014, EXP BRAIN RES, V232, P2073, DOI 10.1007/s00221-014-3896-y; Clayton HA, 2013, EXP BRAIN RES, V230, P311, DOI 10.1007/s00221-013-3656-4; Cressman EK, 2010, EXP BRAIN RES, V205, P533, DOI 10.1007/s00221-010-2392-2; Cressman EK, 2010, J NEUROPHYSIOL, V103, P1888, DOI 10.1152/jn.01002.2009; Cressman EK, 2009, J NEUROPHYSIOL, V102, P3505, DOI 10.1152/jn.00514.2009; Criscimagna-Hemminger SE, 2010, J NEUROPHYSIOL, V103, P2275, DOI 10.1152/jn.00822.2009; Day KA, 2016, ENEURO, V3, DOI 10.1523/ENEURO.0005-16.2016; Donchin O, 2012, J NEUROPHYSIOL, V107, P134, DOI 10.1152/jn.00007.2011; DUHAMEL JR, 1992, SCIENCE, V255, P90, DOI 10.1126/science.1553535; Ernst MO, 2002, NATURE, V415, P429, DOI 10.1038/415429a; Fiehler K, 2010, EXP BRAIN RES, V203, P485, DOI 10.1007/s00221-010-2251-1; Henriques DYP, 2014, NEUROPSYCHOLOGIA, V64, P195, DOI 10.1016/j.neuropsychologia.2014.09.029; Henriques DYP, 2012, J MOTOR BEHAV, V44, P435, DOI 10.1080/00222895.2012.659232; Izawa J, 2012, J NEUROSCI, V32, P4230, DOI 10.1523/JNEUROSCI.6353-11.2012; Jones SAH, 2012, NEUROPSYCHOLOGIA, V50, P1462, DOI 10.1016/j.neuropsychologia.2012.02.031; Jones SAH, 2010, NEUROPSYCHOLOGIA, V48, P3782, DOI 10.1016/j.neuropsychologia.2010.10.001; Jones SAH, 2010, LECT NOTES COMPUT SC, V6192, P321, DOI 10.1007/978-3-642-14075-4_47; Krakauer JW, 2000, J NEUROSCI, V20, P8916, DOI 10.1523/jneurosci.20-23-08916.2000; Luke SG, 2017, BEHAV RES METHODS, V49, P1494, DOI 10.3758/s13428-016-0809-y; Maksimovic S, 2018, NEUROPSYCHOLOGIA, V114, P65, DOI 10.1016/j.neuropsychologia.2018.04.009; Martin TA, 1996, BRAIN, V119, P1199, DOI 10.1093/brain/119.4.1199; Maschke M, 2004, J NEUROPHYSIOL, V91, P230, DOI 10.1152/jn.00557.2003; Mikula L, 2018, J NEUROPHYSIOL, V119, P1981, DOI 10.1152/jn.00338.2017; Mostafa AA, 2017, MOTOR LEARNING MOVIN, DOI [10.17605/osf.io/zfdth, DOI 10.17605/OSF.IO/ZFDTH]; Mostafa AA, 2015, EXP BRAIN RES, V233, P817, DOI 10.1007/s00221-014-4157-9; Mostafa AA, 2014, EXP BRAIN RES, V232, P1639, DOI 10.1007/s00221-014-3833-0; Nourouzpour N, 2015, EXP BRAIN RES, V233, P1019, DOI 10.1007/s00221-014-4176-6; Ohashi H, 2019, EXP BRAIN RES, V237, P1303, DOI 10.1007/s00221-019-05509-y; Ostry DJ, 2016, TRENDS NEUROSCI, V39, P114, DOI 10.1016/j.tins.2015.12.006; Ruttle JE, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0200621; Sakamoto T, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00279; Salomonczyk D, 2013, EXP BRAIN RES, V228, P313, DOI 10.1007/s00221-013-3564-7; Salomonczyk D, 2011, NEUROPSYCHOLOGIA, V49, P3053, DOI 10.1016/j.neuropsychologia.2011.07.006; Shadmehr R, 2008, EXP BRAIN RES, V185, P359, DOI 10.1007/s00221-008-1280-5; Synofzik M, 2008, CURR BIOL, V18, P814, DOI 10.1016/j.cub.2008.04.071; 't Hart BM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163556; t Hart BM, 2018, OPEN SCI FRAMEWORK, DOI [10.17605/OSF.IO/WV3DB, DOI 10.17605/OSF.IO/WV3DB]; van Beers RJ, 2002, CURR BIOL, V12, P834, DOI 10.1016/S0960-9822(02)00836-9; WOLPERT DM, 1995, SCIENCE, V269, P1880, DOI 10.1126/science.7569931; Wolpert DM, 1998, TRENDS COGN SCI, V2, P338, DOI 10.1016/S1364-6613(98)01221-2; Wong AL, 2019, BRAIN, V142, P662, DOI 10.1093/brain/awy334; Yavari F, 2016, EXP BRAIN RES, V234, P997, DOI 10.1007/s00221-015-4523-2	48	10	10	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2019	14	8							e0221861	10.1371/journal.pone.0221861	http://dx.doi.org/10.1371/journal.pone.0221861			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW6AB	31465524	Green Submitted, Green Published, gold			2022-12-26	WOS:000485058200060
J	Soyman, E; Vicario, DS				Soyman, Efe; Vicario, David S.			Rapid and long-lasting improvements in neural discrimination of acoustic signals with passive familiarization	PLOS ONE			English	Article							CONTEXTUAL INTERFERENCE; COMMUNICATION SIGNALS; PERCEPTUAL ADAPTATION; NETWORK INTERACTIONS; SONG; MEMORY; PREEXPOSURE; NEOSTRIATUM; PLASTICITY; PRINCIPLES	Sensory representations in the adult brain must undergo dynamic changes to adapt to the complexity of the external world. This study investigated how passive exposure to novel sounds modifies neural representations to facilitate recognition and discrimination, using the zebra finch model organism. The neural responses in an auditory structure in the zebra finch brain, Caudal Medial Nidopallium (NCM), undergo a long-term form of adaptation with repeated stimulus presentation, providing an excellent substrate to probe the neural underpinnings of adaptive sensory representations. In Experiment 1, electrophysiological activity in NCM was recorded under passive listening conditions as novel natural vocalizations were familiarized through playback. Neural decoding of stimuli using the temporal profiles of both single-unit and multi-unit responses improved dramatically during the first few stimulus presentations. During subsequent encounters, these signals were recognized after hearing fewer initial acoustic features. Remarkably, the accuracy of neural decoding was higher when different stimuli were heard in separate blocks compared to when they were presented randomly in a shuffled sequence. NCM neurons with narrow spike waveforms generally yielded higher neural decoding accuracy than wide spike neurons, but the rate at which these accuracies improved with passive exposure was comparable between the two neuron types. Experiment 2 supported and extended these findings by showing that the rapid gains in neural decoding of novel vocalizations with passive familiarization were long-lasting, maintained for 20 hours after the initial encounter, in multi-unit responses. Taken together, these findings provide valuable insights into the mechanisms by which the nervous system dynamically modulates sensory representations to improve discrimination of novel complex signals over short and long timescales. Similar mechanisms may also be engaged during processing of human speech signals, and thus may have potential translational relevance for elucidating the neural basis of speech comprehension difficulties.	[Soyman, Efe; Vicario, David S.] Rutgers State Univ, Dept Psychol, New Brunswick, NJ 08901 USA; [Soyman, Efe] Netherlands Inst Neurosci, Amsterdam, Netherlands	Rutgers State University New Brunswick; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute for Neuroscience (NIN-KNAW)	Soyman, E (corresponding author), Rutgers State Univ, Dept Psychol, New Brunswick, NJ 08901 USA.; Soyman, E (corresponding author), Netherlands Inst Neurosci, Amsterdam, Netherlands.	e.soyman@nin.knaw.nl	Soyman, Efe/AAY-9923-2020	Soyman, Efe/0000-0003-0192-1541	National Institute on Deafness and Other Communication Disorders [R01 DC 008854, R21 DC 013174]	National Institute on Deafness and Other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was funded by the National Institute on Deafness and Other Communication Disorders (R01 DC 008854 and R21 DC 013174 to DSV). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adank P, 2010, NEUROIMAGE, V49, P1124, DOI 10.1016/j.neuroimage.2009.07.032; Adibi M, 2013, J NEUROSCI, V33, P2108, DOI 10.1523/JNEUROSCI.3449-12.2013; Bartho P, 2004, J NEUROPHYSIOL, V92, P600, DOI 10.1152/jn.01170.2003; Battig W., 1972, TOPICS LEARNING PERF, P131; Bradlow AR, 2008, COGNITION, V106, P707, DOI 10.1016/j.cognition.2007.04.005; Calabrese A, 2015, P NATL ACAD SCI USA, V112, P3517, DOI 10.1073/pnas.1408545112; CHEW SJ, 1995, P NATL ACAD SCI USA, V92, P3406, DOI 10.1073/pnas.92.8.3406; Chew SJ, 1996, P NATL ACAD SCI USA, V93, P1950, DOI 10.1073/pnas.93.5.1950; Chew SJ, 1996, SCIENCE, V274, P1909, DOI 10.1126/science.274.5294.1909; Clarke CM, 2004, J ACOUST SOC AM, V116, P3647, DOI 10.1121/1.1815131; CREELMAN CD, 1957, J ACOUST SOC AM, V29, P655, DOI 10.1121/1.1909003; Dagostin AA, 2015, FRONT CELL NEUROSCI, V9, DOI [10.3389/fneel.2015.00471, 10.3389/fncel.2015.00471]; Dahmen JC, 2007, CURR OPIN NEUROBIOL, V17, P456, DOI 10.1016/j.conb.2007.07.004; Dahmen JC, 2010, NEURON, V66, P937, DOI 10.1016/j.neuron.2010.05.018; de Zilva D, 2012, Q J EXP PSYCHOL, V65, P1123, DOI 10.1080/17470218.2011.644304; Dean I, 2005, NAT NEUROSCI, V8, P1684, DOI 10.1038/nn1541; Dong S, 2009, NEUROBIOL LEARN MEM, V92, P183, DOI 10.1016/j.nlm.2008.09.009; Dwyer DM, 2004, Q J EXP PSYCHOL-B, V57, P245, DOI 10.1080/02724990344000114; Erb J, 2013, J NEUROSCI, V33, P10688, DOI 10.1523/JNEUROSCI.4596-12.2013; Frey BJ, 2007, SCIENCE, V315, P972, DOI 10.1126/science.1136800; Guediche S, 2014, FRONT SYST NEUROSCI, V7, DOI 10.3389/fnsys.2013.00126; Kourtzi Z, 2006, CURR OPIN NEUROBIOL, V16, P152, DOI 10.1016/j.conb.2006.03.012; Krentzel AA, 2018, ENDOCRINOLOGY, V159, P1360, DOI 10.1210/en.2017-03102; Kvale MN, 2004, J NEUROPHYSIOL, V91, P604, DOI 10.1152/jn.00484.2003; Lavis Y, 2006, Q J EXP PSYCHOL, V59, P2083, DOI 10.1080/17470210600705198; Liss JM, 2002, J ACOUST SOC AM, V112, P3022, DOI 10.1121/1.1515793; Lu K, 2018, J NEUROSCI, V38, P9955, DOI 10.1523/JNEUROSCI.2118-18.2018; Meliza CD, 2012, J NEUROSCI, V32, P15158, DOI 10.1523/JNEUROSCI.0845-12.2012; MILLER DB, 1979, ANIM BEHAV, V27, P376, DOI 10.1016/0003-3472(79)90172-6; Mitchell C, 2008, J EXP PSYCHOL-ANIM B, V34, P475, DOI 10.1037/0097-7403.34.4.475; Mitchell C, 2008, J EXP PSYCHOL LEARN, V34, P237, DOI 10.1037/0278-7393.34.1.237; Mouterde SC, 2017, J NEUROSCI, V37, P3491, DOI 10.1523/JNEUROSCI.2220-16.2017; MULLENNIX JW, 1989, J ACOUST SOC AM, V85, P365, DOI 10.1121/1.397688; Natan RG, 2015, ELIFE, V4, DOI [10.7554/eLife.09868, 10.7554/eLife.09868.001]; Nelken I, 2014, BIOL CYBERN, V108, P655, DOI 10.1007/s00422-014-0585-7; Ono S, 2016, J COMP PHYSIOL A, V202, P163, DOI 10.1007/s00359-016-1070-7; Phan ML, 2017, FRONT SYST NEUROSCI, V11, DOI 10.3389/fnsys.2017.00065; Phan ML, 2006, P NATL ACAD SCI USA, V103, P1088, DOI 10.1073/pnas.0510136103; Pinaud R, 2008, J NEUROPHYSIOL, V100, P441, DOI 10.1152/jn.01239.2007; Pinaud R, 2007, J CHEM NEUROANAT, V34, P1, DOI 10.1016/j.jchemneu.2007.03.005; Quiroga RQ, 2004, NEURAL COMPUT, V16, P1661, DOI 10.1162/089976604774201631; Schneider DM, 2013, NEURON, V79, P141, DOI 10.1016/j.neuron.2013.04.038; SHEA JB, 1979, J EXP PSYCHOL-HUM L, V5, P179, DOI 10.1037/0278-7393.5.2.179; Soyman E, 2017, J NEUROPHYSIOL, V117, P1266, DOI 10.1152/jn.00462.2016; Stripling R, 1997, J NEUROSCI, V17, P3883; Stripling R, 2001, J NEUROBIOL, V48, P163, DOI 10.1002/neu.1049; Tchernichovski O, 2000, ANIM BEHAV, V59, P1167, DOI 10.1006/anbe.1999.1416; Ulanovsky N, 2003, NAT NEUROSCI, V6, P391, DOI 10.1038/nn1032; van Rossum MCW, 2001, NEURAL COMPUT, V13, P751, DOI 10.1162/089976601300014321; Vicario DS, 2001, ANIM BEHAV, V61, P805, DOI 10.1006/anbe.2000.1651; Weinberger NM, 2004, NAT REV NEUROSCI, V5, P279, DOI 10.1038/nrn1366; Wright D, 2016, PSYCHON B REV, V23, P1, DOI 10.3758/s13423-015-0887-3; Yanagihara S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11946	53	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2019	14	8							e0221819	10.1371/journal.pone.0221819	http://dx.doi.org/10.1371/journal.pone.0221819			34	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW6AB	31465431	Green Published, Green Submitted, gold			2022-12-26	WOS:000485058200056
J	Tekedar, HC; Kumru, S; Blom, J; Perkins, AD; Griffin, MJ; Abdelhamed, H; Karsi, A; Lawrence, ML				Tekedar, Hasan C.; Kumru, Salih; Blom, Jochen; Perkins, Andy D.; Griffin, Matt J.; Abdelhamed, Hossam; Karsi, Attila; Lawrence, Mark L.			Comparative genomics of Aeromonas veronii: Identification of a pathotype impacting aquaculture globally	PLOS ONE			English	Article							III SECRETION SYSTEM; PROTEIN SECRETION; CLINICAL ISOLATE; INSERTION SEQUENCES; HYDROPHILA; VIRULENCE; EXPRESSION; EFFECTOR; SALMONICIDA; DIVERSITY	Aeromonas veronii is a gram-negative species abundant in aquatic environments that causes disease in humans as well as terrestrial and aquatic animals. In the current study, 41 publicly available A. veronii genomes were compared to investigate distribution of putative virulence genes, global dissemination of pathotypes, and potential mechanisms of virulence. The complete genome of A. veronii strain ML09-123 from an outbreak of motile aeromonas septicemia in farm-raised catfish in the southeastern United States was included. Dissemination of A. veronii strain types was discovered in dispersed geographical locations. Isolate ML09-123 is highly similar to Chinese isolate TH0426, suggesting the two strains have a common origin and may represent a pathotype impacting aquaculture in both countries. Virulence of strain ML09-123 in catfish in a dose-dependent manner was confirmed experimentally. Subsystem category disposition showed the majority of genomes exhibit similar distribution of genomic elements. The type I secretion system (T1SS), type II secretion system (T2SS), type 4 pilus (T4P), and flagellum core elements are conserved in all A. veronii genomes, whereas the type III secretion system (T3SS), type V secretion system (T5SS), type VI secretion system (T6SS), and tight adherence (TAD) system demonstrate variable dispersal. Distribution of mobile elements is dependent on host and geographic origin, suggesting this species has undergone considerable genetic exchange. The data presented here lends insight into the genomic variation of A. veronii and identifies a pathotype impacting aquaculture globally.	[Tekedar, Hasan C.; Kumru, Salih; Griffin, Matt J.; Abdelhamed, Hossam; Karsi, Attila; Lawrence, Mark L.] Mississippi State Univ, Coll Vet Med, Mississippi State, MS 39762 USA; [Blom, Jochen] Justus Liebig Univ Giessen, Bioinformat & Syst Biol, Giessen, Hesse, Germany; [Perkins, Andy D.] Mississippi State Univ, Dept Comp Sci & Engn, Mississippi State, MS 39762 USA; [Griffin, Matt J.] Cochran Natl Warmwater Aquaculture Ctr, Stoneville, MS USA	Mississippi State University; Justus Liebig University Giessen; Mississippi State University	Lawrence, ML (corresponding author), Mississippi State Univ, Coll Vet Med, Mississippi State, MS 39762 USA.	lawrence@cvm.msstate.edu	Karsi, Attila/AAG-5046-2019; Kumru, Salih/AAM-4550-2020	Karsi, Attila/0000-0001-6845-3346; Griffin, Matt/0000-0002-7920-3446	MLL U.S. Department of Agriculture [2017-67015-26794]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103476] Funding Source: NIH RePORTER	MLL U.S. Department of Agriculture; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by MLL U.S. Department of Agriculture grant #2017-67015-26794, https://nifa.usda.gov/program/agricultureand-food-research-initiative-afri. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abby SS, 2016, SCI REP-UK, V6, DOI 10.1038/srep23080; Abby SS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110726; Aberer AJ, 2011, IEEE INT C BIOINFORM, P118, DOI 10.1109/BIBM.2011.70; Arndt D, 2016, NUCLEIC ACIDS RES, V44, pW16, DOI 10.1093/nar/gkw387; Ast VM, 2002, MOL MICROBIOL, V44, P217, DOI 10.1046/j.1365-2958.2002.02870.x; Austin B., 2012, BACTERIAL FISH PATHO; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Basler M, 2012, SCIENCE, V337, P815, DOI 10.1126/science.1222901; Blom J, 2016, NUCLEIC ACIDS RES, V44, pW22, DOI 10.1093/nar/gkw255; Bonemann G, 2009, EMBO J, V28, P315, DOI 10.1038/emboj.2008.269; Bomar L, 2013, GENOME ANNOUNCEMENTS, V1, DOI 10.1128/genomeA.00800-13; Bomar L, 2011, MBIO, V2, DOI 10.1128/mBio.00012-11; Boucher Y, 2007, TRENDS MICROBIOL, V15, P301, DOI 10.1016/j.tim.2007.05.004; Boyd E Fidelma, 2012, Bacteriophage, V2, P139; Cai SH, 2012, BRAZ J MICROBIOL, V43, P382, DOI [10.1590/S1517-838220120001000046, 10.1590/S1517-83822012000100046]; Chen JS, 2013, AQUACULTURE, V406, P62, DOI 10.1016/j.aquaculture.2013.05.006; Chen LH, 2005, NUCLEIC ACIDS RES, V33, pD325, DOI 10.1093/nar/gki008; Cianciotto NP, 2005, TRENDS MICROBIOL, V13, P581, DOI 10.1016/j.tim.2005.09.005; Cianfanelli FR, 2016, TRENDS MICROBIOL, V24, P51, DOI 10.1016/j.tim.2015.10.005; COLLIS CM, 1995, ANTIMICROB AGENTS CH, V39, P155, DOI 10.1128/AAC.39.1.155; Colston SM, 2014, MBIO, V5, DOI 10.1128/mBio.02136-14; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Cury J, 2016, NUCLEIC ACIDS RES, V44, P4539, DOI 10.1093/nar/gkw319; Darling ACE, 2004, GENOME RES, V14, P1394, DOI 10.1101/gr.2289704; Deng WY, 2017, NAT REV MICROBIOL, V15, P323, DOI 10.1038/nrmicro.2017.20; Dolores JS, 2015, MOL MICROBIOL, V95, P590, DOI 10.1111/mmi.12879; Dong HT, 2017, J FISH DIS, V40, P1395, DOI 10.1111/jfd.12617; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Ghatak S, 2016, ANTON LEEUW INT J G, V109, P945, DOI 10.1007/s10482-016-0693-6; Green ER, 2016, MICROBIOL SPECTR, V4, DOI 10.1128/microbiolspec.VMBF-0012-2015; Grissa I, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-172; Grissa I, 2007, NUCLEIC ACIDS RES, V35, pW52, DOI 10.1093/nar/gkm360; Hadi N, 2012, INFECT IMMUN, V80, P1351, DOI 10.1128/IAI.06304-11; Hassan Mohamed A., 2017, Egyptian Journal of Aquatic Research, V43, P161; Henderson IR, 2004, MICROBIOL MOL BIOL R, V68, P692, DOI 10.1128/MMBR.68.4.692-744.2004; Horvath P, 2010, SCIENCE, V327, P167, DOI 10.1126/science.1179555; Hossain MJ, 2014, MBIO, V5, DOI 10.1128/mBio.00848-14; Jagoda SSSD, 2017, GENOM DATA, V11, P46, DOI 10.1016/j.gdata.2016.11.011; Janda JM, 2010, CLIN MICROBIOL REV, V23, P35, DOI 10.1128/CMR.00039-09; Jia BF, 2017, NUCLEIC ACIDS RES, V45, pD566, DOI 10.1093/nar/gkw1004; Joss MJ, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-118; Kalyaanamoorthy S, 2017, NAT METHODS, V14, P587, DOI [10.1038/NMETH.4285, 10.1038/nmeth.4285]; Kang YH, 2016, J BIOTECHNOL, V227, P81, DOI 10.1016/j.jbiotec.2016.04.009; Kanonenberg K, 2013, RES MICROBIOL, V164, P596, DOI 10.1016/j.resmic.2013.03.011; Kenzaka T, 2014, GENOME ANNOUNCEMENTS, V2, DOI 10.1128/genomeA.01115-14; Khajanchi BK, 2010, APPL ENVIRON MICROB, V76, P2313, DOI 10.1128/AEM.02535-09; Khajanchi BK, 2009, MICROBIOL-SGM, V155, P3518, DOI 10.1099/mic.0.031575-0; Kim M, 2014, INT J SYST EVOL MICR, V64, P346, DOI 10.1099/ijs.0.059774-0; Korotkov KV, 2012, NAT REV MICROBIOL, V10, P336, DOI 10.1038/nrmicro2762; Letoffe S, 1996, EMBO J, V15, P5804, DOI 10.1002/j.1460-2075.1996.tb00967.x; Li YX, 2011, J BACTERIOL, V193, P3389, DOI 10.1128/JB.00347-11; Liu D, 2016, ISR J AQUACULT-BAMID, V68; Ma LS, 2012, J BIOL CHEM, V287, P15610, DOI 10.1074/jbc.M111.301630; Maltz M, 2011, APPL ENVIRON MICROB, V77, P597, DOI 10.1128/AEM.01621-10; MCGAREY DJ, 1991, EXPERIENTIA, V47, P441; Mellies JL, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-123; Mosser T, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01218; Natrah FMI, 2012, VET MICROBIOL, V159, P77, DOI 10.1016/j.vetmic.2012.03.014; Nelson MC, 2012, GUT MICROBES, V3, P322, DOI 10.4161/gmic.20227; Nivaskumar M, 2014, BBA-MOL CELL RES, V1843, P1568, DOI 10.1016/j.bbamcr.2013.12.020; Notti RQ, 2016, MICROBIOL SPECTR, V4, DOI 10.1128/microbiolspec.VMBF-0004-2015; Origgi FC, 2017, FISH SHELLFISH IMMUN, V60, P334, DOI 10.1016/j.fsi.2016.12.006; Zepeda-Velazquez AP, 2015, CAN J VET RES, V79, P250; Pang MB, 2015, SCI REP-UK, V5, DOI 10.1038/srep09833; Peabody CR, 2003, MICROBIOL-SGM, V149, P3051, DOI 10.1099/mic.0.26364-0; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Pridgeon JW, 2011, DIS AQUAT ORGAN, V94, P249, DOI 10.3354/dao02332; Rangrez AY, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000115; Roeselers G, 2011, ISME J, V5, P1595, DOI 10.1038/ismej.2011.38; Schreiner HC, 2003, P NATL ACAD SCI USA, V100, P7295, DOI 10.1073/pnas.1237223100; Sha J, 2007, MICROB PATHOGENESIS, V43, P127, DOI 10.1016/j.micpath.2007.05.002; Shimodaira H, 1999, MOL BIOL EVOL, V16, P1114, DOI 10.1093/oxfordjournals.molbev.a026201; Siguier P, 2014, FEMS MICROBIOL REV, V38, P865, DOI 10.1111/1574-6976.12067; Silver AC, 2007, P NATL ACAD SCI USA, V104, P9481, DOI 10.1073/pnas.0700286104; Sreedharan K, 2011, DIS AQUAT ORGAN, V94, P29, DOI 10.3354/dao02304; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Suarez G, 2008, MICROB PATHOGENESIS, V44, P344, DOI 10.1016/j.micpath.2007.10.005; Suarez G, 2010, MICROBIOL-SGM, V156, P3678, DOI 10.1099/mic.0.041277-0; Sun JJ, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17040496; Tekedar HC, 2019, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.03216; Tekedar HC, 2013, GENOME ANNOUNCEMENTS, V1, DOI 10.1128/genomeA.00755-13; Tomich M, 2007, NAT REV MICROBIOL, V5, P363, DOI 10.1038/nrmicro1636; Touchon M, 2007, MOL BIOL EVOL, V24, P969, DOI 10.1093/molbev/msm014; Tseng TT, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-S1-S2; Uzun E, 2015, AQUACULTURE, V437, P30, DOI 10.1016/j.aquaculture.2014.11.017; Varani AM, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-3-r30; Vilches S, 2009, APPL ENVIRON MICROB, V75, P6382, DOI 10.1128/AEM.00222-09; Webb HE, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147363; Zhang XJ, 2014, AQUACULTURE, V432, P1, DOI 10.1016/j.aquaculture.2014.04.017	90	32	33	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2019	14	8							e0221018	10.1371/journal.pone.0221018	http://dx.doi.org/10.1371/journal.pone.0221018			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW6AB	31465454	Green Submitted, gold, Green Published			2022-12-26	WOS:000485058200010
J	Useche, SA; Alonso, F; Sanmartin, J; Montoro, LV; Cendales, B				Useche, Sergio A.; Alonso, Francisco; Sanmartin, Jaime; Montoro, Luis, V; Cendales, Boris			Well-being, behavioral patterns and cycling crashes of different age groups in Latin America: Are aging adults the safest cyclists?	PLOS ONE			English	Article							RISK PERCEPTION; MENTAL-HEALTH; TRAFFIC OFFENDERS; BICYCLE ACCIDENTS; DISTRACTED BIKING; PHYSICAL-ACTIVITY; DRIVING BEHAVIOR; PUBLIC-HEALTH; HELMET USE; YOUNG	Objectives This study aimed at analyzing the cycling safety-related factors and the mental health indicators of elderly cyclists in comparison with other age groups. Methods For this cross-sectional study, we analyzed the data of 911 bicyclists from two Latin American countries that have been experiencing a substantial growth of urban cycling during the last few years: Colombia and Argentina. Participants responded to an e-questionnaire on bicycling behaviors, mental health and cycling safety. Results Aging adults reported lower rates of risky behaviors and traffic crashes (around .38 in five years), and, on the other hand, more cycling protective behaviors, a higher risk perception and a better knowledge of traffic norms than both other adults (26-50 years old) and young cyclists (<26). Cycling behaviors and crashes were found to be significantly related to mental health indicators, the latter being higher in aging cyclists. However, this population remains more prone to distractions experienced while cycling than other age groups. Conclusions Although the behavioral features of aging adults were comparatively "safer" than the ones displayed by other age groups, factors such as cycling distractions and this population's over-representation in traffic crashes suggest the need of enforcing policymaking for a better integration of this age segment in alternative transportation dynamics.	[Useche, Sergio A.; Alonso, Francisco; Sanmartin, Jaime; Montoro, Luis, V] Univ Valencia, Fac Psychol, INTRAS Res Inst Traff & Rd Safety, Valencia, Spain; [Cendales, Boris] El Bosque Univ, Fac Econ & Adm Sci, Bogota, Colombia	University of Valencia; Universidad El Bosque	Useche, SA (corresponding author), Univ Valencia, Fac Psychol, INTRAS Res Inst Traff & Rd Safety, Valencia, Spain.	Sergio.Useche@uv.es	Useche, Sergio A./O-7552-2014; Montoro, Luis/M-3965-2019; Alonso, Francisco/D-5659-2012; Sanmartin, Jaime/I-1767-2013	Useche, Sergio A./0000-0002-5099-4627; Montoro, Luis/0000-0003-0169-4705; Alonso, Francisco/0000-0002-9482-8874; Sanmartin, Jaime/0000-0002-2770-2577				Abdoli N, 2015, NEUROPSYCH DIS TREAT, V11, P2063, DOI 10.2147/NDT.S89916; Alonso F, 2017, CARRETERAS, V212, P40; Alveano-Aguerrebere I., 2017, INT J ENV RES PUB HE, V15, P1, DOI [10.3390/ijer, DOI 10.3390/IJER]; [Anonymous], 2019, HAVANA TIMES; [Anonymous], 2019, SBS NEWS; Attia NA, 2017, PAK J MED SCI, V33, P860, DOI 10.12669/pjms.334.12560; Avila-Palencia I, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-013542; Azami-Aghdash Saber, 2018, Bull Emerg Trauma, V6, P279, DOI 10.29252/beat-060403; Baumann C, 2013, CYCLING LATIN AM CAR; Biddle S, 2016, WORLD PSYCHIATRY, V15, P176, DOI 10.1002/wps.20331; Bil M, 2010, ACCIDENT ANAL PREV, V42, P1632, DOI 10.1016/j.aap.2010.04.001; Bosehans G, 2018, TRANSPORT RES F-TRAF, V58, P414, DOI 10.1016/j.trf.2018.06.029; Brand S, 2012, WORLD J ORTHOP, V3, P151, DOI 10.5312/wjo.v3.i9.151; Carse A, 2013, J TRANSP GEOGR, V28, P67, DOI 10.1016/j.jtrangeo.2012.10.013; Celis-Morales Carlos A, 2017, BMJ, V357, pj1456, DOI 10.1136/bmj.j1456; Cervero R, 2009, INT J SUSTAIN TRANSP, V3, P203, DOI 10.1080/15568310802178314; Copenhaguenize Index, 2019, THE MOST BICYCLE FRI; Cripton PA, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-006654; de Waard D, 2010, ERGONOMICS, V53, P30, DOI 10.1080/00140130903381180; DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13; Donaire-Gonzalez D, 2015, AM J PREV MED, V49, P842, DOI 10.1016/j.amepre.2015.03.036; Ethan D, 2016, J COMMUN HEALTH, V41, P138, DOI 10.1007/s10900-015-0079-0; Florindo AA, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15040562; Gaymard S, 2009, EUR J PSYCHOL APPL L, V1, P165; Gaymard S, 2011, EUR J PSYCHOL APPL L, V3, P11; Goldberg DP, 1997, PSYCHOL MED, V27, P191, DOI 10.1017/S0033291796004242; Gomez LF, 2015, SOC SCI MED, V131, P18, DOI 10.1016/j.socscimed.2015.02.042; Heesch KC, 2013, HEALTH PROMOT J AUST, V24, P227, DOI 10.1071/HE13062; Ikpeze TC, 2018, GERIATR ORTHOP SURG, V9, DOI 10.1177/2151458517748742; Ivers R, 2009, AM J PUBLIC HEALTH, V99, P1638, DOI 10.2105/AJPH.2008.150367; KIBURZ D, 1986, AM J SPORT MED, V14, P416, DOI 10.1177/036354658601400516; Kobau R, 2010, APPL PSYCHOL-HLTH WE, V2, P272, DOI 10.1111/j.1758-0854.2010.01035.x; Lang IA, 2007, INJURY PREV, V13, P355, DOI 10.1136/ip.2007.015941; Leyland LA, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0211779; Ma CX, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16132308; Maitland Murray E, 2012, Clin J Sport Med, V22, P292, DOI 10.1097/JSM.0b013e318256e797; Marti-Belda A, 2019, EUR J PSYCHOL APPL L, V11, P81, DOI 10.5093/ejpalc2019a3; Martinez-Ruiz V, 2014, ACCIDENT ANAL PREV, V62, P259, DOI 10.1016/j.aap.2013.10.011; Matsui Y, 2018, TRAFFIC INJ PREV, V19, P60, DOI 10.1080/15389588.2017.1336663; McDonald CC, 2014, INJURY PREV, V20, P365, DOI 10.1136/injuryprev-2014-041150; Meehan WP, 2013, J PEDIATR-US, V163, P726, DOI 10.1016/j.jpeds.2013.03.073; Mitra AK, 2010, INT J ENV RES PUB HE, V7, P2238, DOI 10.3390/ijerph7052238; Becerra JM, 2013, CAD SAUDE PUBLICA, V29, P654, DOI [10.1590/S0102-311X2013000800004, 10.1590/S0102-311X2013000400004]; Mosquera J, 2012, J PHYS ACT HEALTH, V9, P776, DOI 10.1123/jpah.9.6.776; Mwakalonge J.L., 2014, INT J TRAFFIC TRANSP, V2014, P42, DOI [DOI 10.5923/J.IJTTE.20140302.02, 10.5923/j.ijtte.20140302.02]; Oja P, 2011, SCAND J MED SCI SPOR, V21, P496, DOI 10.1111/j.1600-0838.2011.01299.x; Oviedo-Trespalacios O, 2018, ACCIDENT ANAL PREV, V110, P18, DOI 10.1016/j.aap.2017.09.008; Rasmussen MG, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002076; Raza W, 2018, GLOBAL HEALTH ACTION, V11, DOI 10.1080/16549716.2018.1429081; Reis RS, 2013, AM J PREV MED, V44, pE9, DOI 10.1016/j.amepre.2012.10.014; Scott-Parker B, 2011, TRAFFIC INJ PREV, V12, P559, DOI 10.1080/15389588.2011.621000; Scott-Parker B, 2017, ACCIDENT ANAL PREV, V99, P30, DOI 10.1016/j.aap.2016.11.001; Stavrinos D, 2018, CHILD DEV, V89, P118, DOI 10.1111/cdev.12827; Tajvar Abdolhamid, 2015, Electron Physician, V7, P1566, DOI 10.19082/1566; TRANKLE U, 1990, ACCIDENT ANAL PREV, V22, P119, DOI 10.1016/0001-4575(90)90063-Q; Tyrer S, 2016, BJPSYCH BULL, V40, P57, DOI 10.1192/pb.bp.114.050203; Useche SA, 2019, TRANSPORT RES F-TRAF, V62, P587, DOI 10.1016/j.trf.2019.02.014; Useche SA, 2019, SAFETY SCI, V113, P105, DOI 10.1016/j.ssci.2018.11.021; Useche SA, 2019, DATA BRIEF, V22, P627, DOI 10.1016/j.dib.2018.12.066; Useche SA, 2018, TRANSPORT RES F-TRAF, V58, P1021, DOI 10.1016/j.trf.2018.08.003; Useche SA, 2018, PEERJ, V6, DOI 10.7717/peerj.5616; Wang Y, 2017, EDUC PSYCHOL MEAS, V77, P305, DOI 10.1177/0013164416645162; Wolfe ES, 2016, J TRAUMA NURS, V23, P65, DOI 10.1097/JTN.0000000000000188; Zander A, 2013, J ENVIRON PUBLIC HEA, V2013, DOI 10.1155/2013/547453; Zeuwts LHRH, 2017, ACCIDENT ANAL PREV, V105, P64, DOI 10.1016/j.aap.2016.04.034	65	13	13	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2019	14	8							e0221864	10.1371/journal.pone.0221864	http://dx.doi.org/10.1371/journal.pone.0221864			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW5XV	31461508	Green Submitted, Green Published, gold			2022-12-26	WOS:000485052300061
J	Jao, T; Nayak, K				Jao, Terrence; Nayak, Krishna			Analysis of physiological noise in quantitative cardiac magnetic resonance	PLOS ONE			English	Article							DIFFUSE MYOCARDIAL FIBROSIS; BLOOD-FLOW; HEART; QUANTIFICATION; OXYGENATION; VALIDATION; EDEMA; T2	Purpose To determine the impact of imaging parameters on the temporal signal-to-noise ratio (TSNR) of quantitative cardiac magnetic resonance (MR) in humans, and to determine applicability of the physiological noise covariance (PNC) model for physiological noise (PN). Methods We conducted MRI experiments in four healthy volunteers, and obtained series of shortaxis cardiac images acquired with snapshot balanced steady-state free precession (bSSFP) and snapshot gradient echo (GRE) using a broad range of spatial resolutions and parallel imaging acceleration factors commonly used in quantitative cardiac MR. We measured regional SNR and TSNR in these datasets and fit the measurements to the PNC model for PN, which assumes that PN scales with signal strength. Results The relationship between SNR and TSNR in human cardiac MR without contrast preparation was well modeled by the PNC model. SNR consistently decreased as the spatial resolution (matrix size) and acceleration factor (R) increased for both GRE and bSSFP imaging. TSNR varied linearly with SNR using GRE imaging, when SNR was low (SNR < 20), and approached an asymptotic limit using bSSFP imaging, when SNR was high (SNR > 40). Conclusions The PNC model can be used to guide the choice of matrix size and acceleration factor to optimize TSNR in stable contrast cardiac MR, such as T2-prepared Blood-Oxygen-Level-Dependent (BOLD) and several variants of Arterial Spin Labeled (ASL) cardiac MR.	[Jao, Terrence] Univ Southern Calif, Viterbi Sch Engn, Dept Biomed Engn, Los Angeles, CA 90007 USA; [Nayak, Krishna] Univ Southern Calif, Viterbi Sch Engn, Ming Hsieh Dept Elect & Comp Engn, Los Angeles, CA 90007 USA	University of Southern California; University of Southern California	Jao, T (corresponding author), Univ Southern Calif, Viterbi Sch Engn, Dept Biomed Engn, Los Angeles, CA 90007 USA.	terrencejao@gmail.com		Nayak, Krishna/0000-0001-5735-3550	National Institutes of Health [R01-HL130494]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL130494] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This research was supported by the National Institutes of Health, R01-HL130494, to KN. The funder had no role in study design, data collection or analysis, decision to publish, or manuscript preparation.	Anderson LJ, 2001, EUR HEART J, V22, P2171, DOI 10.1053/euhj.2001.2822; Arnold JR, 2012, J AM COLL CARDIOL, V59, P1954, DOI 10.1016/j.jacc.2012.01.055; Avants BB, ADV NORMALIZATION TO; Capron T, 2015, MAGN RESON MED, V74, P990, DOI 10.1002/mrm.25479; Cerqueira MD, 2002, CIRCULATION, V105, P539, DOI 10.1161/hc0402.102975; Fieno DS, 2004, CIRCULATION, V110, P1284, DOI 10.1161/01.CIR.0000140673.13057.34; Flett AS, 2010, CIRCULATION, V122, P138, DOI 10.1161/CIRCULATIONAHA.109.930636; Griswold MA, 2002, MAGN RESON MED, V47, P1202, DOI 10.1002/mrm.10171; Hsu LY, 2012, JACC-CARDIOVASC IMAG, V5, P154, DOI 10.1016/j.jcmg.2011.07.013; Do HP, 2014, J CARDIOVASC MAGN R, V16, DOI 10.1186/1532-429X-16-15; Iles L, 2008, J AM COLL CARDIOL, V52, P1574, DOI 10.1016/j.jacc.2008.06.049; Jerosch-Herold M, 2008, AM J PHYSIOL-HEART C, V295, pH1234, DOI 10.1152/ajpheart.00429.2008; Kellman P, 2012, J CARDIOVASC MAGN R, V14, DOI 10.1186/1532-429X-14-64; Kruger G, 2001, MAGNET RESON MED, V46, P631, DOI 10.1002/mrm.1240; Northrup BE, 2008, J CARDIOVASC MAGN R, V10, DOI 10.1186/1532-429X-10-53; Robson PM, 2008, MAGN RESON MED, V60, P895, DOI 10.1002/mrm.21728; ROEMER PB, 1990, MAGNET RESON MED, V16, P192, DOI 10.1002/mrm.1910160203; Salerno M, 2013, JACC-CARDIOVASC IMAG, V6, P806, DOI 10.1016/j.jcmg.2013.05.005; Schelbert EB, 2011, J CARDIOVASC MAGN R, V13, DOI 10.1186/1532-429X-13-16; Sung K, 2008, J MAGN RESON IMAGING, V27, P643, DOI 10.1002/jmri.21253; Triantafyllou C, 2016, MAGN RESON MED, V76, P1708, DOI 10.1002/mrm.26041; Triantafyllou C, 2011, NEUROIMAGE, V55, P597, DOI 10.1016/j.neuroimage.2010.11.084; Verhaert D, 2011, JACC-CARDIOVASC IMAG, V4, P269, DOI 10.1016/j.jcmg.2010.09.023; Zia MI, 2012, CIRC-CARDIOVASC IMAG, V5, P566, DOI 10.1161/CIRCIMAGING.112.973222; Zun ZH, 2011, JACC-CARDIOVASC IMAG, V4, P1253, DOI 10.1016/j.jcmg.2011.06.023	25	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2019	14	8							e0214566	10.1371/journal.pone.0214566	http://dx.doi.org/10.1371/journal.pone.0214566			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5WO	31454354	gold, Green Published, Green Submitted			2022-12-26	WOS:000485049000002
J	Sutrave, S; Kikhney, J; Schmidt, J; Petrich, A; Wiessner, A; Kursawe, L; Gebhardt, M; Kertzscher, U; Gabel, G; Goubergrits, L; Affeld, K; Moter, A				Sutrave, S.; Kikhney, J.; Schmidt, J.; Petrich, A.; Wiessner, A.; Kursawe, Laura; Gebhardt, M.; Kertzscher, U.; Gabel, G.; Goubergrits, L.; Affeld, K.; Moter, A.			Effect of daptomycin and vancomycin on Staphylococcus epidermidis biofilms: An in vitro assessment using fluorescence in situ hybridization	PLOS ONE			English	Article							TARGETED OLIGONUCLEOTIDE PROBES; BLOOD-STREAM INFECTION; AUREUS; MODEL; IDENTIFICATION; RESISTANCE; DEVICE	Colonization of in-dwelling catheters by microbial biofilms is a major concern in patient health eventually leading to catheter-related blood stream infections. Biofilms are less susceptible to standard antibiotic therapies that are effective against planktonic bacteria. Standard procedure for the detection of microorganisms on the catheter tip is culture. However, viable but non-culturable cells (VBNCs) may be missed. The aim of this study was to evaluate the use of fluorescence in situ hybridization (FISH) as an indicator to visualize and quantify the effect of the antibiotics daptomycin and vancomycin on biofilms in situ. We established an in vitro catheter biofilm model of Staphylococcus epidermidis biofilms on polyurethane catheters. Biofilm activity was measured by FISH and correlated to colony forming units (CFU) data. Digital image analysis was used for quantification of total biofilm mass and the area of the FISH positive biofilm cells. FISH showed a pronounced effect of both antibiotics on the biofilms, with daptomycin having a significantly stronger effect in terms of both reduction of biofilm mass and number of FISH-positive cells. This supports the anti-biofilm capacity of daptomycin. Interestingly, neither antibiotic was able to eradicate all of the FISH-positive cells. In summary, FISH succeeded in visualization, quantification, and localization of antibiotic activity on biofilms. This technique adds a new tool to the arsenal of test systems for anti-biofilm compounds. FISH is a valuable complementary technique to CFU since it can be highly standardized and provides information on biofilm architecture and quantity and localization of survivor cells.	[Sutrave, S.; Kikhney, J.; Schmidt, J.; Petrich, A.; Wiessner, A.; Kursawe, Laura; Gebhardt, M.; Moter, A.] Charite Univ Med Berlin, Inst Microbiol Infect Dis & Immunol, Biofilmctr, Berlin, Germany; [Sutrave, S.; Kikhney, J.; Schmidt, J.; Petrich, A.; Wiessner, A.; Kursawe, Laura; Gebhardt, M.; Kertzscher, U.; Gabel, G.; Goubergrits, L.; Affeld, K.; Moter, A.] Free Univ Berlin, Berlin, Germany; [Sutrave, S.; Kikhney, J.; Schmidt, J.; Petrich, A.; Wiessner, A.; Kursawe, Laura; Gebhardt, M.; Kertzscher, U.; Gabel, G.; Goubergrits, L.; Affeld, K.; Moter, A.] Humboldt Univ, Berlin, Germany; [Sutrave, S.; Kikhney, J.; Schmidt, J.; Petrich, A.; Wiessner, A.; Kursawe, Laura; Gebhardt, M.; Kertzscher, U.; Gabel, G.; Goubergrits, L.; Affeld, K.; Moter, A.] Berlin Inst Hlth, Berlin, Germany; [Kertzscher, U.; Gabel, G.; Goubergrits, L.; Affeld, K.] Charite Univ Med Berlin, Biofluid Mech Lab, Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Berlin Institute of Health; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Kikhney, J (corresponding author), Charite Univ Med Berlin, Inst Microbiol Infect Dis & Immunol, Biofilmctr, Berlin, Germany.; Kikhney, J (corresponding author), Free Univ Berlin, Berlin, Germany.; Kikhney, J (corresponding author), Humboldt Univ, Berlin, Germany.; Kikhney, J (corresponding author), Berlin Inst Hlth, Berlin, Germany.	Judith.kikhney@charite.de	Goubergrits, Leonid/AAB-2332-2022; , 叶叶叶/ABE-1619-2020	Goubergrits, Leonid/0000-0002-1961-3179; Kertzscher, Ulrich/0000-0003-1594-1295; Moter, Annette/0000-0003-1318-5780; Kikhney, Judith/0000-0002-4849-7947; Kursawe, Laura/0000-0002-1532-3334; Petrich, Annett/0000-0002-2372-826X				AMANN RI, 1990, APPL ENVIRON MICROB, V56, P1919, DOI 10.1128/AEM.56.6.1919-1925.1990; Basas J, 2017, ANTIMICROB AGENTS CH; Benvenuto M, 2006, ANTIMICROB AGENTS CH, V50, P3245, DOI 10.1128/AAC.00247-06; BLASER J, 1995, ANTIMICROB AGENTS CH, V39, P1134, DOI 10.1128/AAC.39.5.1134; Blot SI, 2005, CLIN INFECT DIS, V41, P1591, DOI 10.1086/497833; Chaftari AM, 2010, INT J ANTIMICROB AG, V36, P182, DOI 10.1016/j.ijantimicag.2010.03.015; Daims H, 2006, ENVIRON MICROBIOL, V8, P200, DOI 10.1111/j.1462-2920.2005.00880.x; Dimick JB, 2001, ARCH SURG-CHICAGO, V136, P229, DOI 10.1001/archsurg.136.2.229; El Haj C, 2018, INT J ANTIMICROB AG, V51, P854, DOI 10.1016/j.ijantimicag.2018.01.014; Ferreira IS, 2015, INT J NANOMED, V10, P4351, DOI 10.2147/IJN.S84108; Fowler VG, 2006, NEW ENGL J MED, V355, P653, DOI 10.1056/NEJMoa053783; Garcia I, 2010, J MICROBIOL METH, V83, P307, DOI 10.1016/j.mimet.2010.09.017; Gescher DM, 2008, INT J ANTIMICROB AG, V32, pS51, DOI 10.1016/j.ijantimicag.2008.06.007; Hajdu S, 2009, J ORTHOP RES, V27, P1361, DOI 10.1002/jor.20902; LaPlante KL, 2007, NEPHROL DIAL TRANSPL, V22, P2239, DOI 10.1093/ndt/gfm141; Lewis K, 2007, NAT REV MICROBIOL, V5, P48, DOI 10.1038/nrmicro1557; Lubin AS, 2011, CLIN INFECT DIS, V52, P997, DOI 10.1093/cid/cir118; MACK D, 1992, INFECT IMMUN, V60, P2048, DOI 10.1128/IAI.60.5.2048-2057.1992; Maki DG, 2006, MAYO CLIN PROC, V81, P1159, DOI 10.4065/81.9.1159; Mascio CTM, 2007, ANTIMICROB AGENTS CH, V51, P4255, DOI 10.1128/AAC.00824-07; Mermel LA, 2009, CLIN INFECT DIS, V49, P1, DOI 10.1086/599376; Moter A, 1998, MICROBIOL-UK, V144, P2459, DOI 10.1099/00221287-144-9-2459; Olson ME, 2010, J ANTIMICROB CHEMOTH, V65, P2164, DOI 10.1093/jac/dkq314; Pai MP, 2017, ANTIMICROB AGENTS CH, V61, DOI [10.1128/AAC.01402-17, 10.1128/aac.01402-17]; Pankey GA, 2004, CLIN INFECT DIS, V38, P864, DOI 10.1086/381972; Raad I, 2007, ANTIMICROB AGENTS CH, V51, P1656, DOI 10.1128/AAC.00350-06; Schillinger C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037583; Stewart PS, 2009, ANTIMICROB AGENTS CH, V53, P3505, DOI 10.1128/AAC.01728-08; Stewart PS, 2001, LANCET, V358, P135, DOI 10.1016/S0140-6736(01)05321-1; Vaudaux P, 2001, J ANTIMICROB CHEMOTH, V47, P163, DOI 10.1093/jac/47.2.163; WALLNER G, 1993, CYTOMETRY, V14, P136, DOI 10.1002/cyto.990140205; Weiss EC, 2009, ANTIMICROB AGENTS CH, V53, P2475, DOI 10.1128/AAC.01432-08	32	8	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2019	14	8							e0221786	10.1371/journal.pone.0221786	http://dx.doi.org/10.1371/journal.pone.0221786			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5WO	31454398	Green Published, Green Submitted, gold			2022-12-26	WOS:000485049000046
J	Crawford, MS; Gumpricht, E; Sweazea, KL				Crawford, Meli'sa S.; Gumpricht, Eric; Sweazea, Karen L.			A novel organic mineral complex prevented high fat diet-induced hyperglycemia, endotoxemia, liver injury and endothelial dysfunction in young male Sprague-Dawley rats	PLOS ONE			English	Article							METABOLIC SYNDROME; FULVIC-ACID; OXIDATIVE STRESS; IN-VITRO; OBESITY	The prevalence of metabolic syndrome (MetSyn) has risen 35% since 2012 and over two-thirds of Americans exhibit features characterizing this condition (obesity, dyslipidemia, hyperglycemia, insulin resistance and/or endothelial dysfunction). The aim of this study was to evaluate the effects of a novel dietary supplemental organic mineral complex (OMC) on these risk factors in a rodent model of MetSyn. Six-week old male Sprague-Dawley rats were fed either standard chow or a high-fat diet (HFD) composed of 60% kcal from fat for 10 weeks. Rats were also treated with OMC in their drinking water at either 0 mg/mL (control), 0.6 mg/mL, or 3.0 mg/mL. The HFD-treated rats exhibited significantly increased body mass (p<0.05), epididymal fat pad mass (p<0.001), waist circumference (p = 0.010), in addition to elevations in plasma endotoxins (p<0.001), ALT activity (p<0.001), fasting serum glucose (p = 0.025) and insulin concentrations (p = 0.009). OMC did not affect body weight or adiposity induced by the HFD. At the higher dose OMC significantly blunted HFD-induced hyperglycemia (p = 0.021), whereas both low and high doses of OMC prevented HFD-induced endotoxemia (p = 0.002 and <0.001, respectively) and hepatocyte injury (ALT activity, p<0.01). Despite evidence of oxidative stress (elevated urinary H2O2 p = 0.032) in HFD-fed rats, OMC exhibited no demonstrable antioxidative effect. Consistent with prior studies, mesenteric arteries from HFD rats had more uncoupled eNOS (p = 0.006) and iNOS protein expression (p = 0.027) in addition to impaired endothelium-dependent vasodilation that was abrogated by the high dose of OMC (p<0.05). This effect of OMC may be attributed to the high nitrate content of the supplement. These findings suggest that the OMC supplement, particularly at the higher dose, ameliorated several risk factors associated with MetSyn via a non-antioxidant-dependent mechanism.	[Crawford, Meli'sa S.; Sweazea, Karen L.] Arizona State Univ, Sch Life Sci, Tempe, AZ 85281 USA; [Gumpricht, Eric] Isagenix Int LLC, Gilbert, AZ USA; [Sweazea, Karen L.] Arizona State Univ, Coll Hlth Solut, Phoenix, AZ 85004 USA	Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Downtown Phoenix	Sweazea, KL (corresponding author), Arizona State Univ, Sch Life Sci, Tempe, AZ 85281 USA.; Sweazea, KL (corresponding author), Arizona State Univ, Coll Hlth Solut, Phoenix, AZ 85004 USA.	Karen.Sweazea@asu.edu	Sweazea, Karen/AAT-4151-2020	Gumpricht, Eric/0000-0001-6034-3484; Sweazea, Karen/0000-0003-0345-4086	Isagenix International, LLC	Isagenix International, LLC	This study was funded by a grant from Isagenix International, LLC (to KLS). The funder provided support in the form of salaries for authors (MSC, EG) but did not have a role in the study design, data collection and analysis, decision to publish, or preparation of the first draft of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; Almeda-Valdes P, 2019, CURR MED CHEM, V26, P3613, DOI 10.2174/0929867324666170518095316; Aslam MN, 2012, BIOL TRACE ELEM RES, V147, P267, DOI 10.1007/s12011-011-9316-2; Aslam MN, 2010, INTEGR CANCER THER, V9, P93, DOI 10.1177/1534735409360360; Auberval N, 2014, DIABETOL METAB SYNDR, V6, DOI 10.1186/1758-5996-6-130; Azadbakht L, 2005, DIABETES CARE, V28, P2823, DOI 10.2337/diacare.28.12.2823; Bastard JP, 2000, J CLIN ENDOCR METAB, V85, P3338, DOI 10.1210/jc.85.9.3338; Beltran-Sanchez H, 2013, J AM COLL CARDIOL, V62, P697, DOI 10.1016/j.jacc.2013.05.064; BERNARDI.LL, 1970, EXPERIENTIA, V26, P789, DOI 10.1007/BF02232553; Bowe JE, 2014, J ENDOCRINOL, V222, pG13, DOI 10.1530/JOE-14-0182; Rodriguez NC, 2011, J FOOD AGRIC ENVIRON, V9, P123; Chang Q, 2014, J ANIM SCI, V92, P4921, DOI 10.2527/jas.2014-8137; Chen H, 2005, DIABETES, V54, P1914, DOI 10.2337/diabetes.54.7.1914; Chien SJ, 2015, BMC COMPLEM ALTERN M, V15, DOI 10.1186/s12906-015-0583-x; Crawford M, 2019, LIPIDS, V54, P119, DOI 10.1002/lipd.12131; Crinigan C, 2015, J NUTR METAB, V2015, DOI 10.1155/2015/157520; Deneau J, 2011, INT J VITAM NUTR RES, V81, P34, DOI 10.1024/0300-9831/a000048; Ghosal S, 1988, PHYTOTHER RES, V2, P187, DOI [10.1002/ptr.2650020408, DOI 10.1002/PTR.2650020408]; Gusdon AM, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/637027; Han CY, 2016, DIABETES METAB J, V40, P272, DOI 10.4093/dmj.2016.40.4.272; Hord NG, 2009, AM J CLIN NUTR, V90, P1, DOI 10.3945/ajcn.2008.27131; Hsu HY, 2002, J BIOL CHEM, V277, P22131, DOI 10.1074/jbc.M111883200; Kai M, 2017, J SURG RES, V212, P22, DOI 10.1016/j.jss.2016.11.048; Lamar RT, 2014, J AOAC INT, V97, P721, DOI 10.5740/jaoacint.13-393; Li S, 2015, INT J MOL SCI, V16, P26087, DOI 10.3390/ijms161125942; Lopez-Moreno J, 2017, J AGR FOOD CHEM, V65, P7756, DOI 10.1021/acs.jafc.7b01909; McMurray F, 2016, OBESITY, V24, P2301, DOI 10.1002/oby.21654; Moss JWE, 2018, BBA-MOL BASIS DIS, V1864, P1562, DOI 10.1016/j.bbadis.2018.02.006; Novelli ELB, 2007, LAB ANIM-UK, V41, P111, DOI 10.1258/002367707779399518; Ostman C, 2017, CARDIOVASC DIABETOL, V16, DOI 10.1186/s12933-017-0590-y; Panchal SK, 2011, J CARDIOVASC PHARM, V57, P611, DOI [10.1097/FJC.0b013e3181feb90a, 10.1097/FJC.0b013e31821b1379]; Rios-Hoyol A, 2014, INT J VITAM NUTR RES, V84, P113, DOI 10.1024/0300-9831/a000198; Robberecht H, 2017, J TRACE ELEM MED BIO, V43, P23, DOI 10.1016/j.jtemb.2016.10.005; Sweazea KL, 2011, HORM METAB RES, V43, P470, DOI 10.1055/s-0031-1273763; Sweazea KL, 2010, NUTR METAB, V7, DOI 10.1186/1743-7075-7-48; Tsigos C, 1999, METABOLISM, V48, P1332, DOI 10.1016/S0026-0495(99)90277-9; Van Guilder GP, 2006, J CARDIOVASC PHARM, V47, P310, DOI 10.1097/01.fjc.0000205097.29946.d3; van Rensburg CEJ, 2000, J ANTIMICROB CHEMOTH, V46, P853, DOI 10.1093/jac/46.5.853; Wang XY, 2010, SUBCELL BIOCHEM, V53, P3, DOI 10.1007/978-90-481-9078-2_1	39	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2019	14	8							e0221392	10.1371/journal.pone.0221392	http://dx.doi.org/10.1371/journal.pone.0221392			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5UR	31449541	Green Submitted, Green Published, gold			2022-12-26	WOS:000485044000013
J	Schroeder, N; Wuelling, M; Hoffmann, D; Brand-Saberi, B; Vortkamp, A				Schroeder, Nadine; Wuelling, Manuela; Hoffmann, Daniel; Brand-Saberi, Beate; Vortkamp, Andrea			Atoh8 acts as a regulator of chondrocyte proliferation and differentiation in endochondral bones	PLOS ONE			English	Article							TRANSCRIPTION FACTOR; INDIAN-HEDGEHOG; MICROMASS CULTURES; EXPRESSION; CARTILAGE; GENES; MATH6; BMP; IDENTIFICATION; CALCINEURIN	Atonal homolog 8 (Atoh8) is a transcription factor of the basic helix-loop-helix (bHLH) protein family, which is expressed in the cartilaginous elements of endochondral bones. To analyze its function during chondrogenesis we deleted Atoh8 in mice using a chondrocyte-(Atoh8(flox/flox); Col2a1-Cre) and a germline-(Atoh8(flox/flox); Prx1-Cre(female)) specific Cre allele. In both strains, Atoh8 deletion leads to a reduced skeletal size of the axial and appendicular bones, but the stages of phenotypic manifestations differ. While we observed obviously shortened bones in Atoh8(flox/flox); Col2a1-Cre mice only postnatally, the bones of Atoh8(flox/flox); Prx1-Cre(female) mice are characterized by a reduced bone length already at prenatal stages. Detailed histological and molecular investigations revealed reduced zones of proliferating and hypertrophic chondrocytes. In addition, Atoh8 deletion identified Atoh8 as a positive regulator of chondrocyte proliferation. As increased Atoh8 expression is found in the region of prehypertrophic chondrocytes where the expression of Ihh, a main regulator of chondrocyte proliferation and differentiation, is induced, we investigated a potential interaction of Atoh8 function and Ihh signaling. By activating Ihh signaling with Purmorphamine we demonstrate that Atoh8 regulates chondrocyte proliferation in parallel or downstream of Ihh signaling while it acts on the onset of hypertrophy upstream of Ihh likely by modulating Ihh expression levels.	[Schroeder, Nadine; Wuelling, Manuela; Vortkamp, Andrea] Univ Duisburg Essen, Dept Dev Biol, Ctr Med Biotechnol, Essen, Germany; [Hoffmann, Daniel] Univ Duisburg Essen, Ctr Med Biotechnol Bioinformat & Computat Biophys, Essen, Germany; [Brand-Saberi, Beate] Ruhr Univ Bochum, Dept Anat & Mol Embryol, Bochum, Germany	University of Duisburg Essen; University of Duisburg Essen; Ruhr University Bochum	Vortkamp, A (corresponding author), Univ Duisburg Essen, Dept Dev Biol, Ctr Med Biotechnol, Essen, Germany.	Andrea.Vortkamp@uni-due.de	Hoffmann, Daniel/P-5624-2019; Brand-Saberi, Beate/GVT-9451-2022	Hoffmann, Daniel/0000-0003-2973-7869; Wuelling, Manuela/0000-0003-4534-3528	Mercator Research Center Ruhr [Pr2012-0058]	Mercator Research Center Ruhr	This work was supported by the Mercator Research Center Ruhr (grant no. Pr2012-0058) to AV and BBs. The funder had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	ATSUMI T, 1990, CELL DIFFER DEV, V30, P109, DOI 10.1016/0922-3371(90)90079-C; Balakrishnan-Renuka A, 2014, HISTOCHEM CELL BIOL, V141, P289, DOI 10.1007/s00418-013-1155-0; BenArie N, 1997, NATURE, V390, P169, DOI 10.1038/36579; BITGOOD MJ, 1995, DEV BIOL, V172, P126, DOI 10.1006/dbio.1995.0010; Boing M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-33387-x; Brown NL, 1998, DEVELOPMENT, V125, P4821; Carpenter B, 2017, J STAT SOFTW, V76, P1, DOI 10.18637/jss.v076.i01; Chang CH, 2019, DEV CELL, V48, P184, DOI 10.1016/j.devcel.2018.12.017; Chen JC, 2016, HISTOCHEM CELL BIOL, V145, P5, DOI 10.1007/s00418-015-1368-5; Ejarque M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146273; Fang F, 2014, J CELL SCI, V127, P1428, DOI 10.1242/jcs.136358; Gray PA, 2004, SCIENCE, V306, P2255, DOI 10.1126/science.1104935; Gross S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043553; Guttsches AK, 2015, HISTOCHEM CELL BIOL, V143, P443, DOI 10.1007/s00418-014-1299-6; Gurdziel K, 2016, BMC DEV BIOL, V16, DOI 10.1186/s12861-016-0106-0; HORTON W, 1987, P NATL ACAD SCI USA, V84, P8864, DOI 10.1073/pnas.84.24.8864; Horvat-Gordon M, 2010, COMP BIOCHEM PHYS D, V5, P12, DOI 10.1016/j.cbd.2009.08.002; Huang C, 2014, CURR TOP DEV BIOL, V110, P75, DOI 10.1016/B978-0-12-405943-6.00002-6; Inoue C, 2001, GENES CELLS, V6, P977, DOI 10.1046/j.1365-2443.2001.00476.x; JACENKO O, 1993, NATURE, V365, P56, DOI 10.1038/365056a0; Karp SJ, 2000, DEVELOPMENT, V127, P543; Kautz L, 2008, BLOOD, V112, P1503, DOI 10.1182/blood-2008-03-143354; KOHNO K, 1984, J BIOL CHEM, V259, P3668; Lanske B, 1996, SCIENCE, V273, P663, DOI 10.1126/science.273.5275.663; LINSENMAYER TF, 1991, DEVELOPMENT, V111, P191; Logan M, 2002, GENESIS, V33, P77, DOI 10.1002/gene.10092; Long FX, 2001, DEVELOPMENT, V128, P5099; Lynn FC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002430; Matta C, 2014, CELL SIGNAL, V26, P2175, DOI 10.1016/j.cellsig.2014.06.013; Minina E, 2002, DEV CELL, V3, P439, DOI 10.1016/S1534-5807(02)00261-7; Minina E, 2001, DEVELOPMENT, V128, P4523; Ohba S, 2016, J DEV BIOL, V4, DOI 10.3390/jdb4020020; PHILLIPS SEV, 1994, STRUCTURE, V2, P1, DOI 10.1016/S0969-2126(00)00002-2; Ranger AM, 2000, J EXP MED, V191, P9, DOI 10.1084/jem.191.1.9; Ratzka A, 2008, DEV DYNAM, V237, P339, DOI 10.1002/dvdy.21423; Rawnsley DR, 2013, J BIOL CHEM, V288, P24429, DOI 10.1074/jbc.M113.463083; Reinhold MI, 2004, J BIOL CHEM, V279, P38209, DOI 10.1074/jbc.M404855200; RIDDLE RD, 1993, CELL, V75, P1401, DOI 10.1016/0092-8674(93)90626-2; Rigueur D, 2014, METHODS MOL BIOL, V1130, P113, DOI 10.1007/978-1-62703-989-5_9; Ross MD, 2006, DEV DYNAM, V235, P3102, DOI 10.1002/dvdy.20934; Shwartz Y, 2014, METHODS MOL BIOL, V1130, P203, DOI 10.1007/978-1-62703-989-5_15; St-Jacques B, 1999, GENE DEV, V13, P2072, DOI 10.1101/gad.13.16.2072; Terpstra L, 2003, J CELL BIOL, V162, P139, DOI 10.1083/jcb.200302066; Tomita M, 2002, J BIOL CHEM, V277, P42214, DOI 10.1074/jbc.C200504200; Underhill TM, 2014, METHODS MOL BIOL, V1130, P251, DOI 10.1007/978-1-62703-989-5_19; Vehtari A, 2017, STAT COMPUT, V27, P1413, DOI 10.1007/s11222-016-9696-4; Vortkamp A, 1996, SCIENCE, V273, P613, DOI 10.1126/science.273.5275.613; Wang BG, 2015, HISTOCHEM CELL BIOL, V143, P575, DOI 10.1007/s00418-014-1305-z; Wang JX, 2009, J PATHOL, V219, P163, DOI 10.1002/path.2578; Wuelling M, 2014, METHODS MOL BIOL, V1130, P89, DOI 10.1007/978-1-62703-989-5_7; Wuelling M, 2011, ENDOCR DEV, V21, P1, DOI 10.1159/000328081; Wuelling M, 2009, DEV BIOL, V328, P40, DOI 10.1016/j.ydbio.2009.01.012; Ye MS, 2017, ONCOL REP, V37, P2955, DOI 10.3892/or.2017.5554; Zakany R, 2005, EXP CELL RES, V305, P190, DOI 10.1016/j.yexcr.2004.12.016	54	4	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2019	14	8							e0218230	10.1371/journal.pone.0218230	http://dx.doi.org/10.1371/journal.pone.0218230			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5UR	31449527	Green Published, gold, Green Submitted			2022-12-26	WOS:000485044000004
J	Sahakyan, H; Abelyan, N; Arakelov, V; Arakelov, G; Nazaryan, K				Sahakyan, Harutyun; Abelyan, Narek; Arakelov, Vahram; Arakelov, Grigor; Nazaryan, Karen			In silico study of colchicine resistance molecular mechanisms caused by tubulin structural polymorphism	PLOS ONE			English	Article							FAMILIAL MEDITERRANEAN FEVER; BETA-TUBULIN; DYNAMICS; PROTEIN; AMBER; REDUCTION; GENE	Starting from 1972, colchicine is known as the most useful drug for prevention of familial Mediterranean fever attacks. However, some patients do not respond to colchicine treatment, even taken in high doses. Despite the fact, that different hypotheses have been proposed, the molecular mechanisms of colchicine resistance are not completely clear. It is generally known, that colchicine binds beta-tubulin and inhibits microtubules polymerization. The beta-tubulin gene has SNPs, which lead to amino acid substitutions, and some of them are located in colchicine binding site (CBS). We have assumed, that this SNPs can affect tubulin-colchicine interaction and might be the reason for colchicine resistance. With this in mind, we modeled 7 amino acid substitutions in CBS, performed molecular dynamics simulations of tubulin-colchicine complex and calculated binding energies for every amino acid substitution. Thus, our study shows, that two amino acid substitutions in the beta-tubulin, namely A248T and M257V, reduce binding energy for approximately 2-fold. Based on this, we assume, that these amino acid substitutions could be the reason for colchicine resistance. Thus, our study gives a new insight into colchicine resistance mechanism and provides information for designing colchicine alternatives, that could be effective for colchicine resistant patients.	[Sahakyan, Harutyun; Abelyan, Narek; Arakelov, Vahram; Arakelov, Grigor; Nazaryan, Karen] Russian Armenian Univ, Dept Bioengn Bioinformat & Mol Biol, Yerevan, Armenia; [Abelyan, Narek; Arakelov, Vahram; Arakelov, Grigor; Nazaryan, Karen] Inst Mol Biol, Lab Computat Modeling Biol Proc, Yerevan, Armenia	Russian Armenian Slavonic University; National Academy of Sciences of Armenia; Institute of Molecular Biology - NAS RA	Nazaryan, K (corresponding author), Russian Armenian Univ, Dept Bioengn Bioinformat & Mol Biol, Yerevan, Armenia.; Nazaryan, K (corresponding author), Inst Mol Biol, Lab Computat Modeling Biol Proc, Yerevan, Armenia.	karen.nazaryan@rau.am		Abelyan, Narek/0000-0002-2937-8985; Arakelov, Vahram/0000-0003-0841-9175; Nazaryan, Karen/0000-0002-5231-3928; Sahakyan, Harutyun/0000-0003-3750-8118	Ministry of Education and Science [18A-1f15]	Ministry of Education and Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was funded by Ministry of Education and Science "PhD students researches support program - 2018" (18A-1f15). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABAGYAN R, 1994, J COMPUT CHEM, V15, P488, DOI 10.1002/jcc.540150503; Abraham Mark James, 2015, SoftwareX, V1-2, P19, DOI 10.1016/j.softx.2015.06.001; Amargant F, 2018, BIOL REPROD; Ben-Chetrit E, 2009, CLIN EXP RHEUMATOL, V27, pS1; Bezalel Y, 2009, CLIN EXP RHEUMATOL, V27, pS103; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; Chae JJ, 2008, BLOOD, V112, P1794, DOI 10.1182/blood-2008-01-134932; Chaudhuri AR, 2000, J MOL BIOL, V303, P679, DOI 10.1006/jmbi.2000.4156; Cheung CHA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012564; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Dokholyan NV, 1998, FOLD DES, V3, P577, DOI 10.1016/S1359-0278(98)00072-8; Figueira Thais Rezende e Silva, 2012, BMC Res Notes, V5, P185, DOI 10.1186/1756-0500-5-185; FORDHAM JN, 1981, ANN RHEUM DIS, V40, P605, DOI 10.1136/ard.40.6.605; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hou TJ, 2011, J CHEM INF MODEL, V51, P69, DOI 10.1021/ci100275a; Huzil JT, 2007, CANC INFORM, V3; Jordan MA, 2004, NAT REV CANCER, V4, P253, DOI 10.1038/nrc1317; Kumari R, 2014, J CHEM INF MODEL, V54, P1951, DOI 10.1021/ci500020m; Kumbhar BV, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194934; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Leandro-Garcia LJ, 2010, CYTOSKELETON, V67, P214, DOI 10.1002/cm.20436; Leung YY, 2015, SEMIN ARTHRITIS RHEU, V45, P341, DOI 10.1016/j.semarthrit.2015.06.013; Lidar M, 2004, SEMIN ARTHRITIS RHEU, V33, P273, DOI 10.1053/S0049-0172(03)00137-9; Lindorff-Larsen K, 2010, PROTEINS, V78, P1950, DOI 10.1002/prot.22711; Lowe J, 2001, J MOL BIOL, V313, P1045, DOI 10.1006/jmbi.2001.5077; Majcher U, 2018, CELLS-BASEL, V7, DOI 10.3390/cells7110216; Manukyan G, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00456; Mark P, 2001, J PHYS CHEM A, V105, P9954, DOI 10.1021/jp003020w; Niel E, 2006, JOINT BONE SPINE, V73, P672, DOI 10.1016/j.jbspin.2006.03.006; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; PEARLMAN DA, 1995, COMPUT PHYS COMMUN, V91, P1, DOI 10.1016/0010-4655(95)00041-D; Prota AE, 2013, SCIENCE, V339, P587, DOI 10.1126/science.1230582; Salum LB, 2013, EUR J MED CHEM, V63, P501, DOI 10.1016/j.ejmech.2013.02.037; Spasevska I, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18081676; Terkeltaub RA, 2011, ARTHRITIS RHEUM-US, V63, P2226, DOI 10.1002/art.30389; Tufan A, 2007, J RHEUMATOL, V34, P1540; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40	38	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2019	14	8							e0221532	10.1371/journal.pone.0221532	http://dx.doi.org/10.1371/journal.pone.0221532			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5TR	31442266	Green Submitted, Green Published, gold			2022-12-26	WOS:000485041400045
J	Wagner, J; Fillebeen, C; Haliotis, T; Charlebois, E; Katsarou, A; Mui, J; Vali, H; Pantopoulos, K				Wagner, John; Fillebeen, Carine; Haliotis, Tina; Charlebois, Edouard; Katsarou, Angeliki; Mui, Jeannie; Vali, Hojatollah; Pantopoulos, Kostas			Mouse models of hereditary hemochromatosis do not develop early liver fibrosis in response to a high fat diet	PLOS ONE			English	Article							NONALCOHOLIC STEATOHEPATITIS; IRON-METABOLISM; HEPCIDIN; INJURY; HFE; ACTIVATION; OVERLOAD; STRESS; EXCESS	Hepatic iron overload, a hallmark of hereditary hemochromatosis, triggers progressive liver disease. There is also increasing evidence for a pathogenic role of iron in non-alcoholic fatty liver disease (NAFLD), which may progress to non-alcoholic steatohepatitis (NASH), fibrosis, cirrhosis and hepatocellular cancer. Mouse models of hereditary hemochromatosis and NAFLD can be used to explore potential interactions between iron and lipid metabolic pathways. Hfe-/- mice, a model of moderate iron overload, were reported to develop early liver fibrosis in response to a high fat diet. However, this was not the case with Hjv-/- mice, a model of severe iron overload. These data raised the possibility that the Hfe gene may protect against liver injury independently of its iron regulatory function. Herein, we addressed this hypothesis in a comparative study utilizing wild type, Hfe-/-, Hjv-/- and double Hfe-/- Hjv-/- mice. The animals, all in C57BL/6J background, were fed with high fat diets for 14 weeks and developed hepatic steatosis, associated with iron overload. Hfe co-ablation did not sensitize steatotic Hjv-deficient mice to liver injury. Moreover, we did not observe any signs of liver inflammation or fibrosis even in single steatotic Hfe-/- mice. Ultrastructural studies revealed a reduced lipid and glycogen content in Hjv-/- hepatocytes, indicative of a metabolic defect. Interestingly, glycogen levels were restored in double Hfe-/- Hjv-/- mice, which is consistent with a metabolic function of Hfe. We conclude that hepatocellular iron excess does not aggravate diet-induced steatosis to steatohepatitis or early liver fibrosis in mouse models of hereditary hemochromatosis, irrespectively of the presence or lack of Hfe.	[Wagner, John; Fillebeen, Carine; Haliotis, Tina; Charlebois, Edouard; Katsarou, Angeliki; Pantopoulos, Kostas] Jewish Gen Hosp, Lady Davis Inst Med Res, Montreal, PQ, Canada; [Wagner, John; Fillebeen, Carine; Haliotis, Tina; Charlebois, Edouard; Katsarou, Angeliki; Pantopoulos, Kostas] McGill Univ, Dept Med, Montreal, PQ, Canada; [Mui, Jeannie; Vali, Hojatollah] McGill Univ, Dept Anat & Cell Biol, Montreal, PQ, Canada	Lady Davis Institute; McGill University; McGill University; McGill University	Pantopoulos, K (corresponding author), Jewish Gen Hosp, Lady Davis Inst Med Res, Montreal, PQ, Canada.; Pantopoulos, K (corresponding author), McGill Univ, Dept Med, Montreal, PQ, Canada.	kostas.pantopoulos@mcgill.ca	Katsarou, Angeliki/AAY-1710-2020		Canadian Institutes for Health Research (CIHR) [PJT-159730]	Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	This work was supported by a grant from the Canadian Institutes for Health Research (CIHR; PJT-159730).; We thank Drs. Naciba Benlimame for assistance with histology. This work was supported by a grant from the Canadian Institutes for Health Research (CIHR; PJT-159730).	Bellentani S, 2017, LIVER INT, V37, P81, DOI 10.1111/liv.13299; Bloomer SA, 2016, CELL BIOCHEM FUNCT, V34, P628, DOI 10.1002/cbf.3238; Brissot P, 2018, NAT REV DIS PRIMERS, V4, DOI 10.1038/nrdp.2018.16; Britton LJ, 2016, WORLD J GASTROENTERO, V22, P8112, DOI 10.3748/wjg.v22.i36.8112; Brunt EM, 2015, NAT REV DIS PRIMERS, V1, DOI 10.1038/nrdp.2015.80; Daba A, 2013, J MOL MED, V91, P95, DOI 10.1007/s00109-012-0937-5; Das SK, 2016, LIVER INT, V36, P246, DOI 10.1111/liv.12893; Datz C, 2017, MINERVA ENDOCRINOL, V42, P173, DOI 10.23736/S0391-1977.16.02565-7; Dongiovanni P, 2011, J HEPATOL, V55, P920, DOI 10.1016/j.jhep.2011.05.008; Ganz T, 2013, PHYSIOL REV, V93, P1721, DOI 10.1152/physrev.00008.2013; George DK, 1998, GASTROENTEROLOGY, V114, P311, DOI 10.1016/S0016-5085(98)70482-2; Handa P, 2016, AM J PHYSIOL-GASTR L, V310, pG117, DOI 10.1152/ajpgi.00246.2015; Higashi T, 2017, ADV DRUG DELIVER REV, V121, P27, DOI 10.1016/j.addr.2017.05.007; Kent P, 2015, J MOL MED, V93, P489, DOI 10.1007/s00109-015-1253-7; Lunova M, 2014, J HEPATOL, V61, P633, DOI 10.1016/j.jhep.2014.04.034; Maliken BD, 2013, HEPATOLOGY, V57, P1806, DOI 10.1002/hep.26238; Nelson JE, 2011, HEPATOLOGY, V53, P448, DOI 10.1002/hep.24038; Padda RS, 2015, AM J PHYSIOL-GASTR L, V308, pG251, DOI 10.1152/ajpgi.00137.2014; Pantopoulos K, 2018, FRONT NUTR, V5, DOI 10.3389/fnut.2018.00103; Pantopoulos K, 2015, HEPATOLOGY, V62, P1922, DOI 10.1002/hep.27777; Parrow NL, 2014, ANNU REV NUTR, V34, P77, DOI 10.1146/annurev-nutr-071813-105646; Pietrangelo A, 2016, LIVER INT, V36, P116, DOI 10.1111/liv.13020; Powell EE, 2005, GASTROENTEROLOGY, V129, P1937, DOI 10.1053/j.gastro.2005.09.015; Sebastiani G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025138; Sonnweber T, 2012, J NUTR BIOCHEM, V23, P1600, DOI 10.1016/j.jnutbio.2011.10.013; Sorrentino P, 2009, J HEPATOL, V50, P351, DOI 10.1016/j.jhep.2008.09.011; Tan TCH, 2013, LAB INVEST, V93, P1295, DOI 10.1038/labinvest.2013.121; Tan TCH, 2011, AM J PHYSIOL-GASTR L, V301, pG865, DOI 10.1152/ajpgi.00150.2011; Valenti L, 2010, GASTROENTEROLOGY, V138, P905, DOI 10.1053/j.gastro.2009.11.013	29	9	9	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2019	14	8							e0221455	10.1371/journal.pone.0221455	http://dx.doi.org/10.1371/journal.pone.0221455			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5TR	31442254	Green Submitted, Green Published, gold			2022-12-26	WOS:000485041400035
J	Yang, WL; Bose, B; Zhang, L; Mcstea, M; Cho, Y; Fahim, M; Hawley, CM; Pascoe, EM; Johnson, DW				Yang, Wen-ling; Bose, Bhadran; Zhang, Lei; Mcstea, Megan; Cho, Yeoungjee; Fahim, Magid; Hawley, Carmel M.; Pascoe, Elaine M.; Johnson, David W.			Long-term outcomes of patients with end-stage kidney disease due to membranous nephropathy: A cohort study using the Australia and New Zealand Dialysis and Transplant Registry	PLOS ONE			English	Article							RENAL-TRANSPLANTATION; GLOMERULONEPHRITIS; RECURRENT; DIAGNOSIS; POSTTRANSPLANT; RECOVERY; SUBTYPES; RISK	Background Clinical outcomes of patients with end-stage kidney disease (ESKD) secondary to membranous nephropathy (MN) have not been well described. This study aimed to evaluate patient and/or allograft outcomes of dialysis or kidney transplantation in patients with ESKD secondary to MN. Material and methods All adult patients with ESKD commencing renal replacement therapy in Australia and New Zealand from January 1998 to December 2010 were extracted retrospectively from ANZDATA registry on 31 st December 2013. Outcomes of MN were compared to other causes of ESKD. In a secondary analysis, outcomes of MN were compared to all patients with ESKD due to other forms of glomerulonephritis. Results Of 32,788 included patients, 417 (1.3%) had MN. Compared to other causes of ESKD, MN experienced lower mortality on dialysis (adjusted hazard ratio [aHR] 0.79, 95% CI 0.68-0.92, p = 0.002) and following kidney transplantation (aHR 0.57, 95% CI 0.33-0.97, p = 0.04), had a higher risk of death-censored kidney allograft failure (aHR 1.55, 95% CI: 1.00-2.41, p = 0.05) but comparable risk of overall kidney allograft failure (aHR 1.35, 95% CI 0.91-2.01, p = 0.13). Similar results were obtained using competing-risk regression analyses. MN patients were significantly more likely to receive a kidney transplant (aHR 1.38, 95% CI 1.16-1.63, p<0.001) and to experience primary kidney disease recurrence in the allograft (aHR 4.92, 95% CI 3.02-8.01, p<0.001). Compared to other forms of glomerulonephritis, MN experienced comparable dialysis and transplant patient survival, but higher rates of kidney transplantation, primary renal disease recurrence and death-censored allograft failure. Conclusion MN was associated with superior survival on dialysis and following kidney transplantation compared to patients with other causes of ESKD, and comparable patient survival compared to patients with other forms of glomerulonephritis. However, patients with MN exhibited a higher rate of death-censored allograft loss as a result of primary kidney disease recurrence.	[Yang, Wen-ling] Peking Univ, Hosp 3, Dept Nephrol, Beijing, Peoples R China; [Yang, Wen-ling; Zhang, Lei; Cho, Yeoungjee; Fahim, Magid; Hawley, Carmel M.; Johnson, David W.] Princess Alexandra Hosp, Div Nephrol, Brisbane, Qld, Australia; [Yang, Wen-ling; Bose, Bhadran; Zhang, Lei; Mcstea, Megan; Cho, Yeoungjee; Fahim, Magid; Hawley, Carmel M.; Pascoe, Elaine M.; Johnson, David W.] Australia & New Zealand Dialysis & Transplant ANZ, Adelaide, SA, Australia; [Yang, Wen-ling; Bose, Bhadran; Mcstea, Megan; Cho, Yeoungjee; Fahim, Magid; Hawley, Carmel M.; Pascoe, Elaine M.; Johnson, David W.] Univ Queensland, Australasian Kidney Trials Network, Brisbane, Qld, Australia; [Bose, Bhadran] Nepean Hosp, Dept Nephrol, Kingswood, NSW, Australia; [Zhang, Lei] Guangdong Prov Hosp Chinese Med, Dept Nephrol, Guangzhou, Guangdong, Peoples R China; [Hawley, Carmel M.; Johnson, David W.] Translat Res Inst, Brisbane, Qld, Australia	Peking University; University of Queensland; Nepean Hospital; Guangzhou University of Chinese Medicine	Yang, WL (corresponding author), Peking Univ, Hosp 3, Dept Nephrol, Beijing, Peoples R China.; Yang, WL (corresponding author), Princess Alexandra Hosp, Div Nephrol, Brisbane, Qld, Australia.; Yang, WL (corresponding author), Australia & New Zealand Dialysis & Transplant ANZ, Adelaide, SA, Australia.; Yang, WL (corresponding author), Univ Queensland, Australasian Kidney Trials Network, Brisbane, Qld, Australia.	yanglw2003@hotmail.com	McStea, Megan/M-7721-2019; Johnson, David/F-2897-2011	McStea, Megan/0000-0002-1241-7845; yang, wen-ling/0000-0002-6348-7747; Johnson, David/0000-0001-5491-3460; Pascoe, Elaine/0000-0003-1653-5803	Australian Organ and Tissue Donation and Transplantation Authority; New Zealand Ministry of Health; Kidney Health Australia; Better Evidence and Translation in Chronic Kidney Disease (BEAT-CKD)	Australian Organ and Tissue Donation and Transplantation Authority; New Zealand Ministry of Health; Kidney Health Australia; Better Evidence and Translation in Chronic Kidney Disease (BEAT-CKD)	We acknowledge the substantial contributions of the entire Australian and New Zealand nephrology community (physicians, surgeons, database managers, nurses, renal operators, and patients) in providing information for and maintaining the ANZDATA Registry database. The ANZDATA Registry is funded by the Australian Organ and Tissue Donation and Transplantation Authority, the New Zealand Ministry of Health, Kidney Health Australia and Better Evidence and Translation in Chronic Kidney Disease (BEAT-CKD).	Aaltonen S, 2011, NEPHROL DIAL TRANSPL, V26, P2871, DOI 10.1093/ndt/gfq841; Abbas Fedaey, 2017, World J Transplant, V7, P285, DOI 10.5500/wjt.v7.i6.285; Alfaadhel T, 2015, KIDNEY DIS-BASEL, V1, P126, DOI 10.1159/000437287; Allen PJ, 2017, KIDNEY INT, V92, P461, DOI 10.1016/j.kint.2017.03.015; Briganti EM, 2002, NEW ENGL J MED, V347, P103, DOI 10.1056/NEJMoa013036; Canaud G, 2012, TRANSPL INT, V25, P812, DOI 10.1111/j.1432-2277.2012.01483.x; Cattran DC, 2017, KIDNEY INT, V91, P566, DOI 10.1016/j.kint.2016.09.048; Chembo CL, 2015, NEPHROLOGY, V20, P899, DOI 10.1111/nep.12538; Chen YZ, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004293.pub3; Chou YH, 2012, CLIN J AM SOC NEPHRO, V7, P1401, DOI 10.2215/CJN.04500511; Couser WG, 2017, CLIN J AM SOC NEPHRO, V12, P983, DOI 10.2215/CJN.11761116; Craven AMS, 2007, PERITON DIALYSIS INT, V27, P184; Eckardt KU, 2012, KIDNEY INT SUPPL, V2, P7, DOI 10.1038/kisup.2012.8; El-Zoghby ZM, 2009, AM J TRANSPLANT, V9, P2800, DOI 10.1111/j.1600-6143.2009.02851.x; Fervenza FC, 2008, CLIN J AM SOC NEPHRO, V3, P905, DOI 10.2215/CJN.04321007; Gupta S, 2018, NEPHROL DIAL TRANSPL, V33, P1493, DOI 10.1093/ndt/gfx296; Hariharan S, 1998, AM J KIDNEY DIS, V31, P928, DOI 10.1053/ajkd.1998.v31.pm9631835; Honda K, 2011, CLIN TRANSPLANT, V25, P191, DOI 10.1111/j.1399-0012.2010.01213.x; Huh H, 2017, BMC NEPHROL, V18, DOI 10.1186/s12882-017-0525-6; Jiang SH, 2018, BMC NEPHROL, V19, DOI 10.1186/s12882-018-1135-7; Macdonald JA, 2009, NEPHROL DIAL TRANSPL, V24, P2825, DOI 10.1093/ndt/gfp216; MONTAGNINO G, 1989, TRANSPLANTATION, V47, P725, DOI 10.1097/00007890-198904000-00032; Moroni G, 2010, NEPHROL DIAL TRANSPL, V25, P3408, DOI 10.1093/ndt/gfq223; O'Shaughnessy MM, 2017, TRANSPLANTATION, V101, P2636, DOI 10.1097/TP.0000000000001657; O'Shaughnessy MM, 2017, J AM SOC NEPHROL, V28, P632, DOI 10.1681/ASN.2016020126; O'Shaughnessy MM, 2015, CLIN J AM SOC NEPHRO, V10, P1170, DOI 10.2215/CJN.11261114; Pippias M, 2016, TRANSPLANTATION, V100, P1955, DOI 10.1097/TP.0000000000000962; Ponticelli C, 2014, CLIN J AM SOC NEPHRO, V9, P609, DOI 10.2215/CJN.04160413; Ponticelli C, 2010, CLIN J AM SOC NEPHRO, V5, P2363, DOI 10.2215/CJN.06720810; Pruthi R, 2016, KIDNEY INT, V89, P918, DOI 10.1016/j.kint.2015.11.022; Ronco P, 2015, LANCET, V385, P1983, DOI 10.1016/S0140-6736(15)60731-0; Seitz-Polski B, 2017, NEPHROL THER, V13, pS75, DOI 10.1016/j.nephro.2017.01.012; Spinner ML, 2015, AM J NEPHROL, V41, P37, DOI 10.1159/000371587; Sprangers B, 2013, TRANSPLANT REV-ORLAN, V27, P126, DOI 10.1016/j.trre.2013.07.004; Sprangers B, 2010, CLIN J AM SOC NEPHRO, V5, P790, DOI 10.2215/CJN.04120609; TRUONG L, 1989, AM J KIDNEY DIS, V14, P131, DOI 10.1016/S0272-6386(89)80189-1; Yu TM, 2012, WORLD J SURG, V36, P2923, DOI 10.1007/s00268-012-1759-x; Zhang L, 2016, KIDNEY INT, V89, P1337, DOI 10.1016/j.kint.2016.02.014	38	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2019	14	8							e0221531	10.1371/journal.pone.0221531	http://dx.doi.org/10.1371/journal.pone.0221531			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5TR	31442267	Green Submitted, Green Published, gold			2022-12-26	WOS:000485041400044
J	de Lange, MMA; Scheepmaker, A; van der Hoek, W; Leclercq, M; Schneeberger, PM				de Lange, Marit M. A.; Scheepmaker, Arko; van der Hoek, Wim; Leclercq, Monique; Schneeberger, Peter M.			Risk of chronic Q fever in patients with cardiac valvulopathy, seven years after a large epidemic in the Netherlands	PLOS ONE			English	Article							COXIELLA-BURNETII; PREVALENCE; INFECTION; HISTORY; DISEASE	Background From 2007 through 2010, a large epidemic of acute Q fever occurred in the Netherlands. Patients with cardiac valvulopathy are at high risk to develop chronic Q fever after an acute infection. This patient group was not routinely screened, so it is unknown whether all their chronic infections were diagnosed. This study aims to investigate how many chronic Q fever patients can be identified by routinely screening patients with valvulopathy and to establish whether the policy of not screening should be changed. Methods In a cross-sectional study (2016-2017) in a hospital at the epicentre of the Q fever epidemic, a blood sample was taken from patients 18 years and older who presented with cardiac valvulopathy. The sample was tested for IgG antibodies against phase I and II of Coxiella burnetii using an immunofluorescence assay. An IgG phase II titre of >= 1:64 was considered serological evidence of a previous Q fever infection. An IgG phase I titre of >= 1:512 was considered suspicious for a chronic infection, and these patients were referred for medical examination. Results Of the 904 included patients, 133 (15%) had evidence of a previous C. burnetii infection, of whom 6 (5%) had a chronic infection on medical examination. Conclusions In a group of high-risk patients with a heart valve defect, we diagnosed new chronic Q fever infections seven years after the epidemic, emphasizing the need for screening of this group to prevent complications in those not yet diagnosed in epidemic areas.	[de Lange, Marit M. A.; van der Hoek, Wim] Natl Inst Publ Hlth & Environm, Ctr Infect Dis Control Netherlands, Bilthoven, Netherlands; [Scheepmaker, Arko] Bernhoven Hosp, Dept Cardiol, Uden, Netherlands; [Leclercq, Monique] Bernhoven Hosp, Dept Internal Med, Uden, Netherlands; [Schneeberger, Peter M.] Jeroen Bosch Hosp, Dept Med Microbiol, Shertogenbosch, Netherlands	Netherlands National Institute for Public Health & the Environment; Jeroen Bosch Ziekenhuis	de Lange, MMA (corresponding author), Natl Inst Publ Hlth & Environm, Ctr Infect Dis Control Netherlands, Bilthoven, Netherlands.	marit.de.lange@rivm.nl			Q-support foundation [JBDZ150320-00]	Q-support foundation	This study was financially supported by Q-support foundation, project number JBDZ150320-00 to PMS. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Botelho-Nevers E, 2007, EUR J CLIN MICROBIOL, V26, P635, DOI 10.1007/s10096-007-0357-6; de Boer PT, 2017, RIVM REPORT 2017 012; de Lange MMA, 2018, CLIN INFECT DIS, V67, P360, DOI 10.1093/cid/ciy128; Dijkstra F, 2012, FEMS IMMUNOL MED MIC, V64, P3, DOI 10.1111/j.1574-695X.2011.00876.x; Fenollar F, 2006, CLIN INFECT DIS, V42, P818, DOI 10.1086/500402; Fenollar F, 2001, CLIN INFECT DIS, V33, P312, DOI 10.1086/321889; Hagenaars JCJP, 2014, J INFECTION, V69, P154, DOI 10.1016/j.jinf.2014.03.009; Kampschreur LM, 2014, J CLIN MICROBIOL, V52, P1637, DOI 10.1128/JCM.03221-13; Kampschreur LM, 2012, CLIN VACCINE IMMUNOL, V19, P1165, DOI 10.1128/CVI.00185-12; Maurin M, 1999, CLIN MICROBIOL REV, V12, P518, DOI 10.1128/CMR.12.4.518; Million M, 2017, EMERG INFECT DIS, V23, P856, DOI 10.3201/eid2305.151159; Million M, 2010, LANCET INFECT DIS, V10, P527, DOI 10.1016/S1473-3099(10)70135-3; Morroy G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131777; Raoult D, 2005, LANCET INFECT DIS, V5, P219, DOI 10.1016/S1473-3099(05)70052-9; RIVM, 20170127 RIVM; SAMUEL JE, 1985, INFECT IMMUN, V49, P775, DOI 10.1128/IAI.49.3.775-779.1985; Schneeberger Peter M, 2010, Clin Vaccine Immunol, V17, P286, DOI 10.1128/CVI.00454-09; Tissot-Dupont H, 2007, CLIN INFECT DIS, V44, P232, DOI 10.1086/510389; Vahanian A, 2007, EUR HEART J, V28, P230, DOI 10.1093/eurheartj/ehl428; van der Hoek W, 2012, EUROSURVEILLANCE, V17, P11; van der Hoek W, 2012, ADV EXP MED BIOL, V984, P329, DOI 10.1007/978-94-007-4315-1_17; Wegdam-Blans MCA, 2012, J INFECTION, V64, P247, DOI 10.1016/j.jinf.2011.12.014; Wegdam-Blans MCA, 2011, EUR J VASC ENDOVASC, V42, P384, DOI 10.1016/j.ejvs.2011.04.013; Wielders CCH, 2015, EPIDEMICS-NETH, V13, P37, DOI 10.1016/j.epidem.2015.07.001; Wielders CCH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131848; Wielders CCH, 2013, EUR J CLIN INVEST, V43, P616, DOI 10.1111/eci.12073	26	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2019	14	8							e0221247	10.1371/journal.pone.0221247	http://dx.doi.org/10.1371/journal.pone.0221247			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5RZ	31437175	gold, Green Published, Green Submitted			2022-12-26	WOS:000485036900040
J	Duan, WX; Zhang, HY; Xie, BT; Wang, BQ; Zhang, LM				Duan, Wenxue; Zhang, Haiyan; Xie, Beitao; Wang, Baoqing; Zhang, Liming			Impacts of nitrogen fertilization rate on the root yield, starch yield and starch physicochemical properties of the sweet potato cultivar Jishu 25	PLOS ONE			English	Article							MOLECULAR-STRUCTURE; AMYLOSE; AMYLOPECTIN	In recent years, the sweet potato cultivar Jishu 25 has exhibited good characteristics for starch processing in northern China. The storage root dry matter yields of this cultivar can exceed one ton per mu (1/15 of a hectare) at nitrogen (N) rates of 60-90 kg ha(-1) based on soil nutrient content. However, the effect of N fertilizer on the physicochemical properties of starches isolated from this cultivar has not been reported. In order to evaluate these effects, three different N rates, 0 (control, N0), 75 (N1), and 150 kg ha(-1) (N2), were selected for a field experiment in 2017. The results showed that N1 exhibited the highest storage root yield and starch yield. Compared to the control group, N fertilizer significantly increased the total starch content while no significant difference was found in these between the N1 and N2 groups. The amylose (AM) content was highest in the N2 group and lowest in the N0 group. In addition, N fertilizer exhibited no significant effects on the values of [D(v, 0.9)], D [4, 3] and D [3, 2]. Compared to the control group, N1 demonstrated significantly higher setback viscosity (SV), while N2 showed significantly higher peak viscosity (PV), cold paste viscosity (CPV) and SV. However, there were no significant differences in the hot paste viscosity (HPV), peak time and pasting temperature between the N1 and N2 groups. For the thermal properties of starch, there were no significant differences in peak temperature (T-p), conclusion temperature (T-c) or gelatinization enthalpy (Delta H) between the N1 and N2 groups. Overall, for the starch samples of cultivar Jishu 25, N fertilizer exerts significant effects on the starch content, AM content and viscosity properties but little effect on the particle size distribution and Delta H. 75 kg N ha(-1) can easily lead to substantial planting benefits from the high storage root yield, dry matter yield and total starch content of this cultivar.	[Duan, Wenxue; Zhang, Haiyan; Xie, Beitao; Wang, Baoqing] Shandong Acad Agr Sci, Crop Res Inst, Jinan, Shandong, Peoples R China; [Duan, Wenxue; Zhang, Haiyan; Xie, Beitao; Wang, Baoqing; Zhang, Liming] Minist Agr & Rural Affairs, Sci Observat & Expt Stn Tuber & Root Crops Huang, Jinan, Shandong, Peoples R China; [Zhang, Liming] Shandong Acad Agr Sci, Jinan, Shandong, Peoples R China; [Zhang, Liming] Shandong Normal Univ, Coll Life Sci, Jinan, Shandong, Peoples R China	Shandong Academy of Agricultural Sciences; Ministry of Agriculture & Rural Affairs; Shandong Academy of Agricultural Sciences; Shandong Normal University	Duan, WX (corresponding author), Shandong Acad Agr Sci, Crop Res Inst, Jinan, Shandong, Peoples R China.; Duan, WX; Zhang, LM (corresponding author), Minist Agr & Rural Affairs, Sci Observat & Expt Stn Tuber & Root Crops Huang, Jinan, Shandong, Peoples R China.; Zhang, LM (corresponding author), Shandong Acad Agr Sci, Jinan, Shandong, Peoples R China.; Zhang, LM (corresponding author), Shandong Normal Univ, Coll Life Sci, Jinan, Shandong, Peoples R China.	duanwenxue2010@163.com; zhanglm2016saas@163.com			China Agriculture Research System [CARS-10-608]; Modern Agricultural Technology System of Tubers and Root Crops in Shandong Province [SDAIT-1609]; Agricultural Variety Project in Shandong Province [2017LZGC011]	China Agriculture Research System; Modern Agricultural Technology System of Tubers and Root Crops in Shandong Province; Agricultural Variety Project in Shandong Province	This study was funded by the China Agriculture Research System (CARS-10-608), the Modern Agricultural Technology System of Tubers and Root Crops in Shandong Province (SDAIT-1609), the Agricultural Variety Project in Shandong Province (2017LZGC011).	Abegunde OK, 2013, FOOD HYDROCOLLOID, V33, P169, DOI 10.1016/j.foodhyd.2013.03.005; Antonio G.C., 2011, FRUIT VEG CEREAL SCI, V5, P1; BeMiller JN, 2009, FOOD SCI TECHNOL-INT, pXVII, DOI 10.1016/B978-0-12-746275-2.00023-9; [陈晓光 Chen Xiaoguang], 2015, [植物营养与肥料学报, Journal of Plant Nutrition and Fertitizer], V21, P979; Chen Z, 2003, J FOOD SCI, V68, P431, DOI 10.1111/j.1365-2621.2003.tb05690.x; Collado LS, 1997, CEREAL CHEM, V74, P182, DOI 10.1094/CCHEM.1997.74.2.182; Dai QW, 2015, AGR OUTLOOK, V10, P1; Duan W, 2018, S AFR J BOT, V115, P199, DOI 10.1016/j.sajb.2017.11.016; Food and agriculture organization of the united nations, 2017, STAT DAT FOOD AGR OR; Hoover R, 2001, CARBOHYD POLYM, V45, P253, DOI 10.1016/S0144-8617(00)00260-5; Hoover R., 2001, CURR PROTOC FOOD ANA, V00, P1, DOI 10.1002/0471142913.fae0203s00; Huang HuaHong, 2005, Agricultural Sciences in China, V4, P436; Kaupa P, 2014, FIELD CROP RES, V168, P48, DOI 10.1016/j.fcr.2014.08.011; Kitahara K., 1996, Journal of Applied Glycoscience, V43, P59; Lai YC, 2016, FOOD CHEM, V199, P556, DOI 10.1016/j.foodchem.2015.12.053; Li GT, 2017, CARBOHYD POLYM, V164, P396, DOI 10.1016/j.carbpol.2017.02.014; Lin L, 1996, P SIM MULT NEW ORL L, P216; Liu Q, 2006, FOOD CHEM, V99, P470, DOI 10.1016/j.foodchem.2005.08.008; Liu Y, 2010, INT J FOOD SCI TECH, V45, P1925, DOI 10.1111/j.1365-2621.2010.02356.x; Mahasukhonthachat K, 2010, J FOOD ENG, V96, P18, DOI 10.1016/j.jfoodeng.2009.06.051; Mussoline W.A., 2015, IND BIOTECHNOL, V11, P113; Noda T, 1996, STARCH-STARKE, V48, P395, DOI 10.1002/star.19960481103; Oliveira Ademar P. de, 2005, Hortic. Bras., V23, P925, DOI 10.1590/S0102-05362005000400012; Park IM, 2007, STARCH-STARKE, V59, P69, DOI 10.1002/star.200600568; Phillips SB, 2005, HORTSCIENCE, V40, P214, DOI 10.21273/HORTSCI.40.1.214; Schirmer M, 2013, FOOD HYDROCOLLOID, V32, P52, DOI 10.1016/j.foodhyd.2012.11.032; Su J, 2012, TRANSL PEDIATR, V1, P108, DOI 10.3978/j.issn.2224-4336.2012.04.06; TAKEDA Y, 1986, STARCH-STARKE, V38, P345, DOI 10.1002/star.19860381006; TESTER RF, 1990, CEREAL CHEM, V67, P551; Thao H., 2011, J FOOD PROCESSING TE, V2, P105, DOI [10.4172/2157-7110.1000105, DOI 10.4172/2157-7110.1000105]; Waramboi JG, 2011, FOOD CHEM, V126, P1759, DOI 10.1016/j.foodchem.2010.12.077; Zhou WZ, 2015, CARBOHYD POLYM, V122, P417, DOI 10.1016/j.carbpol.2014.11.003; Zhu F, 2018, FOOD HYDROCOLLOID, V83, P165, DOI 10.1016/j.foodhyd.2018.05.004; Zhu F, 2011, STARCH-STARKE, V63, P249, DOI 10.1002/star.201000134	34	10	10	3	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2019	14	8							e0221351	10.1371/journal.pone.0221351	http://dx.doi.org/10.1371/journal.pone.0221351			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5RZ	31437204	gold, Green Submitted, Green Published			2022-12-26	WOS:000485036900055
J	Machulin, AV; Deryusheva, EI; Selivanova, OM; Galzitskaya, OV				Machulin, Andrey V.; Deryusheva, Evgenia I.; Selivanova, Olga M.; Galzitskaya, Oxana V.			The number of domains in the ribosomal protein S1 as a hallmark of the phylogenetic grouping of bacteria	PLOS ONE			English	Article							ESCHERICHIA-COLI; OB-FOLD; BINDING DOMAIN; EVOLUTION; REPEATS; RECOGNITION; TRANSLATION; INITIATION; SEQUENCES; GENES	The family of ribosomal proteins S1 contains about 20% of all bacterial proteins including the S1 domain. An important feature of this family is multiple copies of structural domains in bacteria, the number of which changes in a strictly limited range from one to six. In this study, the automated exhaustive analysis of 1453 sequences of S1 allowed us to demonstrate that the number of domains in S1 is a distinctive characteristic for phylogenetic bacterial grouping in main phyla. 1453 sequences of S1 were identified in 25 out of 30 different phyla according to the List of Prokaryotic Names with Standing in Nomenclature. About 62% of all records are identified as six-domain S1 proteins, which belong to phylum Proteobacteria. Four-domain S1 are identified mainly in proteins from phylum Firmicutes and Actinobacteria. Records belonging to these phyla are 33% of all records. The least represented two-domain S1 are about 0.6% of all records. The third and fourth domains for the most representative four- and six-domain S1 have the highest percentage of identity with the S1 domain from polynucleotide phosphorylase and S1 domains from one-domain S1. In addition, for these groups, the central part of S1 (the third domain) is more conserved than the terminal domains.	[Machulin, Andrey V.] Russian Acad Sci, Pushchino Sci Ctr Biol Res, Fed Res Ctr, Skryabin Inst Biochem & Physiol Microorganisms, Pushchino, Moscow Region, Russia; [Deryusheva, Evgenia I.] Russian Acad Sci, Pushchino Sci Ctr Biol Res, Fed Res Ctr, Inst Biol Instrumentat, Pushchino, Moscow Region, Russia; [Selivanova, Olga M.; Galzitskaya, Oxana V.] Russian Acad Sci, Inst Prot Res, Pushchino, Moscow Region, Russia; [Galzitskaya, Oxana V.] Russian Acad Sci, Inst Theoret & Expt Biophys, Pushchino, Moscow Region, Russia	Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Russian Academy of Sciences; Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Theoretical & Experimental Biophysics	Galzitskaya, OV (corresponding author), Russian Acad Sci, Inst Prot Res, Pushchino, Moscow Region, Russia.; Galzitskaya, OV (corresponding author), Russian Acad Sci, Inst Theoret & Expt Biophys, Pushchino, Moscow Region, Russia.	ogalzit@vega.protres.ru	Machulin, Andrey/J-8563-2017; Selivanova, Olga/HDL-9515-2022; Deryusheva, Evgeniya/B-1848-2015	Machulin, Andrey/0000-0002-4859-7219; Deryusheva, Evgeniya/0000-0002-6213-2784	Russian Science Foundation [18-14-00321]	Russian Science Foundation(Russian Science Foundation (RSF))	Funded by Russian Science Foundation, grant number 18-14-00321 for all authors. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal V, 2003, CURR PROTEIN PEPT SC, V4, P195, DOI 10.2174/1389203033487207; Aliprandi P, 2008, J BIOL CHEM, V283, P13289, DOI 10.1074/jbc.M707111200; Amblar M, 2007, RNA, V13, P317, DOI 10.1261/rna.220407; Andrade MA, 2001, J STRUCT BIOL, V134, P117, DOI 10.1006/jsbi.2001.4392; Arcus V, 2002, CURR OPIN STRUC BIOL, V12, P794, DOI 10.1016/S0959-440X(02)00392-5; BHUGRA B, 1992, MOL MICROBIOL, V6, P1149, DOI 10.1111/j.1365-2958.1992.tb01553.x; BLANCHARD A, 1990, MOL MICROBIOL, V4, P669, DOI 10.1111/j.1365-2958.1990.tb00636.x; Boni IV, 2000, J BACTERIOL, V182, P5872, DOI 10.1128/JB.182.20.5872-5879.2000; Bycroft M, 1997, CELL, V88, P235, DOI 10.1016/S0092-8674(00)81844-9; Deryusheva EI, 2012, BIOCHEMISTRY-MOSCOW+, V77, P1487, DOI 10.1134/S000629791213007X; Deryusheva EI, 2010, MOL BIOL+, V44, P642, DOI 10.1134/S0026893310040205; Deryusheva EI, 2017, PROTEINS, V85, P602, DOI 10.1002/prot.25237; Duan HF, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/271728; GIRI L, 1977, FEBS LETT, V81, P199, DOI 10.1016/0014-5793(77)80958-7; GRIBSKOV M, 1992, GENE, V119, P107, DOI 10.1016/0378-1119(92)90073-X; Gupta RS, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00327; Gupta RS, 2004, CRIT REV MICROBIOL, V30, P123, DOI 10.1080/10408410490435133; Gytz H, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv1212; Hadley C, 1999, STRUCT FOLD DES, V7, P1099, DOI 10.1016/S0969-2126(99)80177-4; Kamneva OK, 2012, GENOME BIOL EVOL, V4, P1375, DOI 10.1093/gbe/evs113; Lecompte O, 2002, NUCLEIC ACIDS RES, V30, P5382, DOI 10.1093/nar/gkf693; Machulin A, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20102377; MURZIN AG, 1993, EMBO J, V12, P861, DOI 10.1002/j.1460-2075.1993.tb05726.x; Neimark H., 1979, MYCOPLASMAS, V1, P43, DOI 10.1099/00207713-42-2-226; Okada T, 2004, BIOSCI BIOTECH BIOCH, V68, P2319, DOI 10.1271/bbb.68.2319; Ponting CP, 2000, J MOL BIOL, V302, P1041, DOI 10.1006/jmbi.2000.4087; Razin S, 1998, MICROBIOL MOL BIOL R, V62, P1094, DOI 10.1128/MMBR.62.4.1094-1156.1998; Roberts E, 2008, P NATL ACAD SCI USA, V105, P13953, DOI 10.1073/pnas.0804861105; Salah P, 2009, NUCLEIC ACIDS RES, V37, P5578, DOI 10.1093/nar/gkp547; Sengupta J, 2001, P NATL ACAD SCI USA, V98, P11991, DOI 10.1073/pnas.211266898; Sirand-Pugnet P, 2007, PLOS GENET, V3, P744, DOI 10.1371/journal.pgen.0030075; SKOUV J, 1990, J BIOL CHEM, V265, P17044; Sorensen MA, 1998, J MOL BIOL, V280, P561, DOI 10.1006/jmbi.1998.1909; SURYANARAYANA T, 1984, BIOCHEMISTRY-US, V23, P1047, DOI 10.1021/bi00301a002; Vonskii, 2002, MYCOPLASMAS; Yutin N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036972	36	12	13	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2019	14	8							e0221370	10.1371/journal.pone.0221370	http://dx.doi.org/10.1371/journal.pone.0221370			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5RZ	31437214	Green Published, gold, Green Submitted			2022-12-26	WOS:000485036900063
J	Singh, J; Vijay, S; Mansuri, R; Rawal, R; Kadian, K; Sahoo, GC; Kumar, M; Sharma, A				Singh, Jagbir; Vijay, Sonam; Mansuri, Rani; Rawal, Ritu; Kadian, Kavita; Sahoo, Ganesh Chandra; Kumar, Mahesh; Sharma, Arun			Computational and experimental elucidation of Plasmodium falciparum phosphoethanolamine methyltransferase inhibitors: Pivotal drug target	PLOS ONE			English	Article							PHOSPHATIDYLCHOLINE BIOSYNTHESIS; N-METHYLTRANSFERASE; IN-VITRO; SURVIVAL; DOCKING; PATHWAY; GROWTH; GENE	Introduction Plasmodium falciparum synthesizes phosphatidylcholine for the membrane development through serine decarboxylase-phosphoethanolamine methyltransferase pathway for growth in human host. Phosphoethanolamine-methyltransferase (PfPMT) is a crucial enzyme for the synthesis of phosphocholine which is a precursor for phosphatidylcholine synthesis and is considered as a pivotal drug target as it is absent in the host. The inhibition of PfPMT may kill malaria parasite and hence is being considered as potential target for rational antimalarial drug designing. Methods In this study, we have used computer aided drug designing (CADD) approaches to establish potential PfPMT inhibitors from Asinex compound library virtually screened for ADMET and the docking affinity. The selected compounds were tested for in-vitro schizonticidal, gametocidal and cytotoxicity activity. Nontoxic compounds were further studied for PfPMT enzyme specificity and antimalarial efficacy for P. berghei in albino mice model. Results Our results have identified two nontoxic PfPMT competitive inhibitors ASN.1 and ASN.3 with better schizonticidal and gametocidal activity which were found to inhibit PfPMT at IC50 1.49 mu M and 2.31 mu M respectively. The promising reduction in parasitaemia was found both in orally (50 & 10 mg/kg) and intravenous (IV) (5& 1 mg/kg) however, the better growth inhibition was found in intravenous groups. Conclusion We report that the compounds containing Pyridinyl-Pyrimidine and Phenyl-Furan scaffolds as the potential inhibitors of PfPMT and thus may act as promising antimalarial inhibitor candidates which can be further optimized and used as leads for template based antimalarial drug development.	[Singh, Jagbir; Vijay, Sonam; Rawal, Ritu; Kadian, Kavita; Sharma, Arun] ICMR Natl Inst Malaria Res, Prot Biochem & Struct Biol, New Delhi, India; [Singh, Jagbir; Kumar, Mahesh] Maharshi Dayanand Univ, Dept Pharmaceut Sci, Rohtak, Haryana, India; [Mansuri, Rani] ApeejayStya Univ, Sch Pharmaceut Sci, Gurugram, India; [Sahoo, Ganesh Chandra] Rajendra Mem Res Inst, Dept Biomed Sci, Patna, Bihar, India	Indian Council of Medical Research (ICMR); ICMR - National Institute of Malaria Research (NIMR); Maharshi Dayanand University; Indian Council of Medical Research (ICMR); ICMR - Rajendra Memorial Research Institute of Medical Sciences (RMRI)	Sharma, A (corresponding author), ICMR Natl Inst Malaria Res, Prot Biochem & Struct Biol, New Delhi, India.	arushar@gmail.com	mansuri, rani/AAA-3018-2021; kumar, mahesh/AAQ-5194-2020	kumar, mahesh/0000-0002-5147-2249	NIMR [NIMR/PB/2015/310]; ICMR	NIMR; ICMR(Indian Council of Medical Research (ICMR))	Study was funded by NIMR through Intramural grant (Id: NIMR/PB/2015/310) from NIMR, Dwarka sector-8(ICMR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are thankful to ICMR-National Institute of Medical Research, for providing working environment and accesstothe resources. We are highly thankful to ICMR for providing Senior Research Fellowship to Mr. Jagbir Singh. We would also like to acknowledge Biomedical Informatics Centre at RMRIMS, Patna, India for providing scientific assistances and procurement of compounds. We are highly thankful to JALMA for providing ethical approval for carrying out animal experiments and result analysis. We thank Bhanu Arya, Poonam Gupta and Alakh Deo for their valuable assistance during the conduct of experiments.	Aktas M, 2010, EUR J CELL BIOL, V89, P888, DOI 10.1016/j.ejcb.2010.06.013; [Anonymous], 2018, WORLD REP MAL; Bobenchik AM, 2013, P NATL ACAD SCI USA, V110, P18262, DOI 10.1073/pnas.1313965110; Bobenchik AM, 2011, FEMS MICROBIOL REV, V35, P609, DOI 10.1111/j.1574-6976.2011.00267.x; Bobenchik AM, 2010, BMC BIOCHEM, V11, DOI 10.1186/1471-2091-11-4; Bolognese CP, 2000, PLANT PHYSIOL, V124, P1800, DOI 10.1104/pp.124.4.1800; Charron JBF, 2002, PLANT PHYSIOL, V129, P363, DOI 10.1104/pp.001776; Chatterjee A, 2014, BIOORGAN MED CHEM, V22, P6409, DOI 10.1016/j.bmc.2014.09.043; Cheng AL, 2003, J MED CHEM, V46, P3572, DOI 10.1021/jm020266b; Comerci DJ, 2006, J BACTERIOL, V188, P1929, DOI 10.1128/JB.188.5.1929-1934.2006; Conover GM, 2008, CELL MICROBIOL, V10, P514, DOI 10.1111/j.1462-5822.2007.01066.x; CORPET F, 1988, NUCLEIC ACIDS RES, V16, P10881, DOI 10.1093/nar/16.22.10881; Egan WJ, 2000, J MED CHEM, V43, P3867, DOI 10.1021/jm000292e; Friesner RA, 2006, J MED CHEM, V49, P6177, DOI 10.1021/jm051256o; Garg A, 2015, SCI REP-UK, V5, DOI 10.1038/srep09064; Gombar VK, 1996, J CHEM INF COMP SCI, V36, P1127, DOI 10.1021/ci960028n; Hall T., 2011, GERF B BIOSCI, V2, P60; India Committee for the Purpose of Control and Supervision on Experiments on Animals, 2003, Indian Journal of Pharmacology, V35, P257; Krause RGE, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193833; Lee SG, 2012, J BIOL CHEM, V287, P1426, DOI 10.1074/jbc.M111.315267; Lipinski Christopher A, 2004, Drug Discov Today Technol, V1, P337, DOI 10.1016/j.ddtec.2004.11.007; Liu JF, 2003, CURR OPIN CHEM BIOL, V7, P5, DOI 10.1016/S1367-5931(02)00003-0; Lykidis A, 2001, PROG NUCLEIC ACID RE, V65, P361; Melariri P., 2012, ADV STUD BIOL, V4, P333; Mitchell A, 2015, NUCLEIC ACIDS RES, V43, pD213, DOI 10.1093/nar/gku1243; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Nuccio ML, 2000, J BIOL CHEM, V275, P14095, DOI 10.1074/jbc.275.19.14095; Pascal R, 2009, ANT DRUG RES STRAT 1; Pessi G, 2005, J BIOL CHEM, V280, P12461, DOI 10.1074/jbc.M414626200; Pessi G, 2004, P NATL ACAD SCI USA, V101, P6206, DOI 10.1073/pnas.0307742101; Puntervoll P, 2003, NUCLEIC ACIDS RES, V31, P3625, DOI 10.1093/nar/gkg545; Reynolds JM, 2008, J BIOL CHEM, V283, P7894, DOI 10.1074/jbc.M709869200; RIECKMANN KH, 1978, LANCET, V1, P22; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Selvaraj V, 2014, INT J NANOMED, V12, P13; Selvaraj V, 2014, INT J NANOMED, V9, P1379, DOI 10.2147/IJN.S52625; Singh J, 2019, BMC CHEM, V13, DOI 10.1186/s13065-019-0551-5; Singh J, 2016, J PHARM BIOALLIED SC, V8, P188, DOI 10.4103/0975-7406.171682; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Wadi I, 2018, MALARIA J, V17, DOI 10.1186/s12936-017-2153-9; Witola WH, 2008, J BIOL CHEM, V283, P27636, DOI 10.1074/jbc.M804360200	41	3	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2019	14	8							e0221032	10.1371/journal.pone.0221032	http://dx.doi.org/10.1371/journal.pone.0221032			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5RZ	31437171	Green Published, gold, Green Submitted			2022-12-26	WOS:000485036900027
J	Moghadamrad, S; Hassan, M; McCoy, KD; Kirundi, J; Kellmann, P; De Gottardi, A				Moghadamrad, Sheida; Hassan, Mohsin; McCoy, Kathy D.; Kirundi, Jorum; Kellmann, Philipp; De Gottardi, Andrea			Attenuated fibrosis in specific pathogen-free microbiota in experimental cholestasis- and toxin-induced liver injury	FASEB JOURNAL			English	Article						altered Schaedler flora; portal hypertension; bile duct ligation; alpha-SMA; carbon tetrachloride	OBSTRUCTIVE CHOLESTASIS; BACTERIAL TRANSLOCATION; INTESTINAL MICROBIOME; GUT MICROBIOME; STELLATE CELLS; OSTEOPONTIN; DISEASE; MUCIN; NEUTROPHILS; EXPRESSION	In advanced chronic liver disease (CLD), the translocation of intestinal bacteria and the resultant increase of proinflammatory cytokines in the splanchnic and systemic circulation may contribute to the progression of fibrosis. We therefore speculated that fibrosis and portal hypertension (PHT) would be attenuated in a mouse model of limited intestinal colonization with altered Schaedler flora (ASF) compared to a more complex colonization with specific pathogen-free (SPF) flora. We induced liver fibrosis in ASF and SPF mice by common bile duct ligation (BDL) or by carbon tetrachloride (CCl4) treatment. We then measured portal pressure (PP), portosystemic shunts (PSSs), and harvested tissues for further analyses. There were no differences in PP between sham-treated ASF or SPF mice. After BDL or CCl4 treatment, PP, PSSs, and hepatic collagen deposition increased in both groups. However, the increase in PP and the degree of fibrosis was significantly higher in ASF than SPF mice. Expression of fibrotic markers alpha-smooth muscle actin, desmin, and platelet-derived growth factor receptor beta were significantly higher in ASF than SPF mice. This was associated with higher activation of hepatic immune cells (macrophages, neutrophils) and decreased expression of the intestinal epithelial tight junction proteins (claudin-1, occludin-1). In 2 models of advanced CLD, SPF mice presented significantly attenuated liver injury, fibrosis, and PHT compared to ASF mice. In contrast to our hypothesis, these findings suggest that a complex intestinal microbiota may play a "hepato-protective" role.	[Moghadamrad, Sheida; Hassan, Mohsin; Kellmann, Philipp; De Gottardi, Andrea] Univ Bern, Dept Biomed Res, Hepatol, Murtenstr 35, Bern, Switzerland; [McCoy, Kathy D.; Kirundi, Jorum] Univ Bern, Dept Biomed Res, Gastroenterol, Bern, Switzerland; [Moghadamrad, Sheida; De Gottardi, Andrea] Inselspital Bern, Clin Visceral Surg & Med, Bern, Switzerland; [McCoy, Kathy D.] Univ Calgary, Cumming Sch Med, Dept Physiol & Pharmacol, Calgary, AB, Canada	University of Bern; University of Bern; University of Bern; University Hospital of Bern; University of Calgary	Moghadamrad, S; De Gottardi, A (corresponding author), Univ Bern, Dept Biomed Res, Hepatol, Murtenstr 35, Bern, Switzerland.; Moghadamrad, S; De Gottardi, A (corresponding author), Univ Bern, Clin Visceral Surg & Med, Murtenstr 35, CH-3008 Bern, Switzerland.	sheida.moghadamrad@dbmr.unibe.ch; andrea.degottardi@insel.ch	McCoy, Kathy/ABD-5814-2021; Moghadamrad, Sheida/AAV-5199-2021	Moghadamrad, Sheida/0000-0001-7322-4759; Kirundi, Jorum/0000-0001-9617-0634	Novartis Foundation for Medical-Biological Research [10A19]; Swiss National Science Foundation [31003A_129842]	Novartis Foundation for Medical-Biological Research(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	The authors thank Dr. Deborah Stroka and Felix Baier (Department for Biomedical Research, University of Berne), for help in total bile acids measurement, and the staff from the Clean Mouse Facility of the University of Bern for help during experiments with ASF mice. This work was supported by a grant from the Novartis Foundation for Medical-Biological Research (Project 10A19) and from the Swiss National Science Foundation (Grant 31003A_129842 to A.D.G.). The authors declare no conflicts of interest.	Albillos A, 2014, J HEPATOL, V61, P1385, DOI 10.1016/j.jhep.2014.08.010; [Anonymous], 2018, GUT; Artis D, 2008, NAT REV IMMUNOL, V8, P411, DOI 10.1038/nri2316; Assimakopoulos SF, 2007, WORLD J GASTROENTERO, V13, P6458, DOI 10.3748/wjg.13.6458; Bosch J, 2015, J HEPATOL, V62, pS121, DOI 10.1016/j.jhep.2015.01.003; Cacopardo B, 2012, HEPAT MON, V12, DOI 10.5812/hepatmon.7611; Fickert P, 2010, LAB INVEST, V90, P844, DOI 10.1038/labinvest.2010.61; Fouts DE, 2012, J HEPATOL, V56, P1283, DOI 10.1016/j.jhep.2012.01.019; Friedman SL, 2008, GASTROENTEROLOGY, V134, P1655, DOI 10.1053/j.gastro.2008.03.003; Georgiev P, 2008, BRIT J SURG, V95, P646, DOI 10.1002/bjs.6050; GROSZMANN RJ, 1982, AM J PHYSIOL, V242, pG156, DOI 10.1152/ajpgi.1982.242.2.G156; Gujral JS, 2003, HEPATOLOGY, V38, P355, DOI 10.1053/jhep.2003.50341; Kawashima R, 1999, BIOCHEM BIOPH RES CO, V256, P527, DOI 10.1006/bbrc.1999.0372; Li H, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9292; LIN RS, 1995, J HEPATOL, V22, P165, DOI 10.1016/0168-8278(95)80424-2; Lorena D, 2006, J HEPATOL, V44, P383, DOI 10.1016/j.jhep.2005.07.024; Macpherson AJ, 2016, CELL HOST MICROBE, V20, P561, DOI 10.1016/j.chom.2016.10.016; Mazagova M, 2015, FASEB J, V29, P1043, DOI 10.1096/fj.14-259515; McAuley JL, 2007, J CLIN INVEST, V117, P2313, DOI 10.1172/JCI26705; Mcguckin MA, 2007, GASTROENTEROLOGY, V133, P1210, DOI 10.1053/j.gastro.2007.07.003; Nishida A, 2012, GASTROENTEROLOGY, V142, P865, DOI 10.1053/j.gastro.2011.12.036; Qin N, 2014, NATURE, V513, P59, DOI 10.1038/nature13568; Riva A, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00167; Rosshart SP, 2017, CELL, V171, P1015, DOI 10.1016/j.cell.2017.09.016; Sato A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114065; Sato A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092515; SCHAEDLER RW, 1965, J EXP MED, V122, P59, DOI 10.1084/jem.122.1.59; Schnabl B, 2014, GASTROENTEROLOGY, V146, P1513, DOI 10.1053/j.gastro.2014.01.020; Schon Hans-Theo, 2014, Hepatobiliary Surg Nutr, V3, P386, DOI 10.3978/j.issn.2304-3881.2014.11.06; Seki E, 2008, HEPATOLOGY, V48, P322, DOI 10.1002/hep.22306; Seki E, 2007, NAT MED, V13, P1324, DOI 10.1038/nm1663; Smith K, 2007, SEMIN IMMUNOL, V19, P59, DOI 10.1016/j.smim.2006.10.002; Tabibian JH, 2016, HEPATOLOGY, V63, P185, DOI 10.1002/hep.27927; Tacke F, 2014, J HEPATOL, V60, P1090, DOI 10.1016/j.jhep.2013.12.025; Tilg H, 2016, GUT, V65, P2035, DOI 10.1136/gutjnl-2016-312729; Wang B, 2009, J HEPATOL, V51, P1037, DOI 10.1016/j.jhep.2009.06.020; Wiest R, 2017, J HEPATOL, V67, P1084, DOI 10.1016/j.jhep.2017.05.007; Wiest R, 2014, J HEPATOL, V60, P197, DOI 10.1016/j.jhep.2013.07.044; Xu RN, 2014, CELL MOL IMMUNOL, V11, P224, DOI 10.1038/cmi.2014.2; Yang M, 2014, TOXICOL LETT, V224, P186, DOI 10.1016/j.toxlet.2013.10.030	40	11	11	1	13	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2019	33	11					12464	12476		10.1096/fj.201901113R	http://dx.doi.org/10.1096/fj.201901113R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC8ZX	31431085	Green Published			2022-12-26	WOS:000507461600067
J	Lei, X; Wong, GW				Lei, Xia; Wong, G. Willaim			C1q/TNF-related protein 2 (CTRP2) deletion promotes adipose tissue lipolysis and hepatic triglyceride secretion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						adipose tissue; adipokine; liver metabolism; dyslipidemia; lipid metabolism; adipocyte biology; C1q; TNF-related protein; endocrine metabolism; hepatic triglyceride secretion; secreted protein; C1q family; obesity; lipolysis; CTRP	INSULIN SENSITIVITY; GLUCOSE; OBESITY; INFLAMMATION; ACTIVATION; ADIPOCYTES; ADIPOKINE; LIPASE; FAMILY; MICE	The highly conserved C1q/TNF-related protein (CTRP) family of secreted hormones has emerged as important regulators of insulin action and of sugar and fat metabolisms. Among these, the specific biological function of CTRP2 remains elusive. Here, we show that the expression of human CTRP2 is positively correlated with body mass index (BMI) and is up-regulated in obesity. We used a knockout (KO) mouse model to determine CTRP2 function and found that Ctrp2-KO mice have significantly elevated metabolic rates and energy expenditure leading to lower body weights and lower adiposity. CTRP2 deficiency up-regulated the expression of lipolytic enzymes and protein kinase A signaling, resulting in enhanced adipose tissue lipolysis. In cultured adipocytes, CTRP2 treatment suppressed triglyceride (TG) hydrolysis, and its deficiency enhanced agonist-induced lipolysis in vivo. CTRP2-deficient mice also had altered hepatic and plasma lipid profiles. Liver size and hepatic TG content were significantly reduced, but plasma TG was elevated in KO mice. Both plasma and hepatic cholesterol levels, however, were reduced in KO mice. Loss of CTRP2 also enhanced hepatic TG secretion and contributed to impaired plasma lipid clearance following an oral lipid gavage. Liver metabolomic analysis revealed significant changes in diacylglycerols and phospholipids, suggesting that increased membrane remodeling may underlie the altered hepatic TG secretion we observed. Our results provide the first in vivo evidence that CTRP2 regulates lipid metabolism in adipose tissue and liver.	[Lei, Xia; Wong, G. Willaim] Johns Hopkins Univ, Dept Physiol, Sch Med, Baltimore, MD 21205 USA; [Lei, Xia; Wong, G. Willaim] Johns Hopkins Univ, Sch Med, Ctr Metab & Obes Res, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University	Lei, X; Wong, GW (corresponding author), Johns Hopkins Univ, Dept Physiol, Sch Med, Baltimore, MD 21205 USA.; Lei, X (corresponding author), Oklahoma State Univ, Dept Biochem & Mol Biol, Stillwater, OK 74078 USA.	xia.lei@okstate.edu; gwwong@jhmi.edu		Lei, Xia/0000-0003-4241-6576	National Institutes of Health [DK084171]; American Heart Association [POST17070119]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK084171] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grant DK084171 (to G. W. W.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.r Recipient of American Heart Association postdoctoral fellowship POST17070119. To whom correspondence may be addressed: Dept. of Biochemistry and Molecular Biology, Oklahoma State University, Stillwater, OK 74078. Tel: 410-502-4862; Fax: 410-614-8033; E-mail: xia.lei@ okstate.edu.	Ahima RS, 2008, MOL ENDOCRINOL, V22, P1023, DOI 10.1210/me.2007-0529; Attie AD, 2009, J LIPID RES, V50, pS395, DOI 10.1194/jlr.R800057-JLR200; Dietschy JM, 2002, J BIOL CHEM, V277, P3801, DOI 10.1074/jbc.R100057200; Duncan RE, 2007, ANNU REV NUTR, V27, P79, DOI 10.1146/annurev.nutr.27.061406.093734; Enomoto T, 2011, J BIOL CHEM, V286, P34552, DOI 10.1074/jbc.M111.277319; Gruffat D, 1996, REPROD NUTR DEV, V36, P375, DOI 10.1051/rnd:19960404; Han S, 2016, J NUTR BIOCHEM, V27, P43, DOI 10.1016/j.jnutbio.2015.08.018; HOLLENBERG C, 1961, ENDOCRINOLOGY, V68, P589, DOI 10.1210/endo-68-4-589; Kim JY, 2006, AM J PHYSIOL-ENDOC M, V291, pE115, DOI 10.1152/ajpendo.00317.2005; Kishore U, 2004, TRENDS IMMUNOL, V25, P551, DOI 10.1016/j.it.2004.08.006; Lei X, 2017, J BIOL CHEM, V292, P14836, DOI [10.1074/jbc.m116.766808, 10.1074/jbc.M116.766808]; Lei X, 2016, AM J PHYSIOL-ENDOC M, V310, pE1036, DOI 10.1152/ajpendo.00010.2016; LITOSCH I, 1982, MOL PHARMACOL, V22, P109; Little HC, 2019, FASEB J, V33, P8666, DOI 10.1096/fj.201900520R; Liu LF, 2009, DIABETES OBES METAB, V11, P131, DOI 10.1111/j.1463-1326.2008.00916.x; Millar JS, 2005, J LIPID RES, V46, P2023, DOI 10.1194/jlr.D500019-JLR200; Nakajima K, 2011, CLIN CHIM ACTA, V412, P1306, DOI 10.1016/j.cca.2011.04.018; Nielsen S, 2004, J CLIN INVEST, V113, P1582, DOI [10.1172/JCI200421047, 10.1172/JCI21047]; Nielsen TS, 2014, J MOL ENDOCRINOL, V52, pR199, DOI 10.1530/JME-13-0277; Nishimaki-Mogami T, 2002, J LIPID RES, V43, P1035, DOI 10.1194/jlr.M100354-JLR200; Ouchi N, 2011, NAT REV IMMUNOL, V11, P85, DOI 10.1038/nri2921; Petersen PS, 2017, AM J PHYSIOL-ENDOC M, V312, pE309, DOI 10.1152/ajpendo.00344.2016; Peterson JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088535; Peterson JM, 2013, AM J PHYSIOL-REG I, V305, pR522, DOI 10.1152/ajpregu.00110.2013; Peterson JM, 2013, AM J PHYSIOL-GASTR L, V305, pG214, DOI 10.1152/ajpgi.00102.2013; Peterson JM, 2012, J BIOL CHEM, V287, P1576, DOI 10.1074/jbc.M111.278333; Peterson JM, 2010, J BIOL CHEM, V285, P39691, DOI 10.1074/jbc.M110.180695; Qiao LP, 2011, DIABETES, V60, P1519, DOI 10.2337/db10-1017; Reitman ZJ, 2011, P NATL ACAD SCI USA, V108, P3270, DOI 10.1073/pnas.1019393108; RIZACK MA, 1964, J BIOL CHEM, V239, P392; Rodriguez S, 2016, AM J PHYSIOL-ENDOC M, V311, pE678, DOI 10.1152/ajpendo.00087.2016; Rohrbach S, 2007, MOL CELL ENDOCRINOL, V277, P26, DOI 10.1016/j.mce.2007.07.005; Rosen ED, 2006, NATURE, V444, P847, DOI 10.1038/nature05483; Rosen ED, 2014, CELL, V156, P20, DOI 10.1016/j.cell.2013.12.012; Scherer PE, 2006, DIABETES, V55, P1537, DOI 10.2337/db06-0263; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Seldin MM, 2014, REV ENDOCR METAB DIS, V15, P111, DOI 10.1007/s11154-013-9255-7; Seldin MM, 2012, J BIOL CHEM, V287, P11968, DOI 10.1074/jbc.M111.336834; Sundaram M, 2010, NUTR METAB, V7, DOI 10.1186/1743-7075-7-35; Tan SY, 2016, PHYSIOL GENOMICS, V48, P936, DOI 10.1152/physiolgenomics.00111.2016; Tsai MY, 2004, CLIN CHEM, V50, P1201, DOI 10.1373/clinchem.2004.032938; VAUGHAN M, 1964, J BIOL CHEM, V239, P401; Villena JA, 2004, J BIOL CHEM, V279, P47066, DOI 10.1074/jbc.M403855200; Wang H, 2009, AM J PHYSIOL-ENDOC M, V297, pE271, DOI 10.1152/ajpendo.90920.2008; Wedellova Z, 2011, PHYSIOL RES, V60, P139, DOI 10.33549/physiolres.931863; Wei ZK, 2014, AM J PHYSIOL-ENDOC M, V306, pE779, DOI 10.1152/ajpendo.00593.2013; Wei ZK, 2013, J BIOL CHEM, V288, P10214, DOI 10.1074/jbc.M113.458711; Wei ZK, 2012, J BIOL CHEM, V287, P10301, DOI 10.1074/jbc.M111.303651; Wei ZK, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.201087; Wolf RM, 2016, AM J PHYSIOL-ENDOC M, V310, pE332, DOI 10.1152/ajpendo.00248.2015; Wong GW, 2009, FASEB J, V23, P241, DOI 10.1096/fj.08-114991; Wong GW, 2008, BIOCHEM J, V416, P161, DOI 10.1042/BJ20081240; Wong GW, 2004, P NATL ACAD SCI USA, V101, P10302, DOI 10.1073/pnas.0403760101; YAO ZM, 1988, J BIOL CHEM, V263, P2998	54	11	12	0	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 25	2019	294	43					15638	15649		10.1074/jbc.RA119.009230	http://dx.doi.org/10.1074/jbc.RA119.009230			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JQ9JD	31439668	hybrid, Green Published			2022-12-26	WOS:000499253000008
J	Snowsill, TM; Ryan, NAJ; Crosbie, EJ; Frayling, IM; Evans, DG; Hyde, CJ				Snowsill, Tristan M.; Ryan, Neil A. J.; Crosbie, Emma J.; Frayling, Ian M.; Evans, D. Gareth; Hyde, Chris J.			Cost-effectiveness analysis of reflex testing for Lynch syndrome in women with endometrial cancer in the UK setting	PLOS ONE			English	Article							COLORECTAL-CANCER; SCREENING STRATEGIES; IMPLEMENTATION; SURVEILLANCE; PERFORMANCE; IDENTIFY; IMMUNOHISTOCHEMISTRY; PREVALENCE; MANAGEMENT; SURVIVAL	Background Lynch syndrome is a hereditary cancer syndrome caused by constitutional pathogenic variants in the DNA mismatch repair (MMR) system, leading to increased risk of colorectal, endometrial and other cancers. The study aimed to identify the incremental costs and consequences of strategies to identify Lynch syndrome in women with endometrial cancer. Methods A decision-analytic model was developed to evaluate the relative cost-effectiveness of reflex testing strategies for identifying Lynch syndrome in women with endometrial cancer taking the NHS perspective and a lifetime horizon. Model input parameters were sourced from various published sources. Consequences were measured using quality-adjusted life years (QALYs). A cost-effectiveness threshold of 20 pound 000/QALY was used. Results Reflex testing for Lynch syndrome using MMR immunohistochemistry and MLH1 methylation testing was cost-effective versus no testing, costing 14 pound 200 per QALY gained. There was uncertainty due to parameter imprecision, with an estimated 42% chance this strategy is not cost-effective compared with no testing. Age had a significant impact on cost-effectiveness, with testing not predicted to be cost-effective in patients aged 65 years and over. Conclusions Testing for Lynch syndrome in younger women with endometrial cancer using MMR immunohistochemistry and MLH1 methylation testing may be cost-effective. Age cut-offs may be controversial and adversely affect implementation.	[Snowsill, Tristan M.] Univ Exeter, Med Sch, Hlth Econ Grp, Exeter, Devon, England; [Ryan, Neil A. J.; Crosbie, Emma J.] Univ Manchester, Fac Biol & Hlth, Div Canc Sci, Manchester, Lancs, England; [Ryan, Neil A. J.; Evans, D. Gareth] Univ Manchester, Fac Biol & Hlth, Div Evolut & Genom Med, Manchester, Lancs, England; [Crosbie, Emma J.] Manchester Univ NHS Fdn Trust, St Marys Hosp, Directorate Gynaecol, Manchester, Lancs, England; [Frayling, Ian M.] Cardiff Univ, Inst Canc & Genet, Inherited Tumour Syndromes Res Grp, Cardiff, S Glam, Wales; [Evans, D. Gareth] Manchester Univ NHS Fdn Trust, Manchester Ctr Genom Med, Manchester, Lancs, England; [Hyde, Chris J.] Univ Exeter, Med Sch, Exeter Test Grp, Exeter, Devon, England	University of Exeter; University of Manchester; University of Manchester; University of Manchester; Cardiff University; University of Exeter	Snowsill, TM (corresponding author), Univ Exeter, Med Sch, Hlth Econ Grp, Exeter, Devon, England.	t.m.snowsill@exeter.ac.uk	Evans, D Gareth/AAB-4308-2022	Evans, D Gareth/0000-0002-8482-5784; Crosbie, Emma/0000-0003-0284-8630; Snowsill, Tristan/0000-0001-7406-2819; Christopher, Hyde/0000-0002-7349-0616; Ryan, Neil/0000-0003-3117-3257; Frayling, Ian/0000-0002-3420-0794	NIHR Biomedical research centre Manchester [IS-BRC-1215-20007]; National Institute for Health Research (NIHR) Collaboration for Leadership in Applied Health Research and Care South West Peninsula (NIHR CLAHRC South West Peninsula); MRC [MR/M018431/1] Funding Source: UKRI	NIHR Biomedical research centre Manchester(National Institute for Health Research (NIHR)); National Institute for Health Research (NIHR) Collaboration for Leadership in Applied Health Research and Care South West Peninsula (NIHR CLAHRC South West Peninsula); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	NAJR is an MRC Doctoral Research Fellow (MR/M018431/1) and DGE is an NIHR Senior Investigator (NF-SI-0513-10076). EJC and DGE are supported by the NIHR Biomedical research centre Manchester (IS-BRC-1215-20007). CJH is supported by the National Institute for Health Research (NIHR) Collaboration for Leadership in Applied Health Research and Care South West Peninsula (NIHR CLAHRC South West Peninsula). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The views expressed are those of the author(s) and not necessarily those of the MRC, NHS, the NIHR or the Department of Health and Social Care.	Anagnostopoulos A, 2017, INT J GYNECOL CANCER, V27, P931, DOI 10.1097/IGC.0000000000000962; Ara R, 2017, PHARMACOECONOMICS, V35, pS89, DOI 10.1007/s40273-017-0551-z; Ara R, 2010, VALUE HEALTH, V13, P509, DOI 10.1111/j.1524-4733.2010.00700.x; Arber M, 2017, INT J TECHNOL ASSESS, V33, P472, DOI 10.1017/S0266462317000897; Arrigoni A, 2005, EUR J GASTROEN HEPAT, V17, P213, DOI 10.1097/00042737-200502000-00013; Australian Institute of Health and Welfare, AUSTR CANC INC MORT; Batte BAL, 2014, GYNECOL ONCOL, V134, P319, DOI 10.1016/j.ygyno.2014.06.009; Berends MJW, 2003, J CLIN ONCOL, V21, P4364, DOI 10.1200/JCO.2003.04.094; Briggs A, 2006, DECISION MODELLING H; Buchanan DD, 2014, J CLIN ONCOL, V32, P90, DOI 10.1200/JCO.2013.51.2129; Burn J, 2011, LANCET, V378, P2081, DOI 10.1016/S0140-6736(11)61049-0; ClinGen, 2018, COL CANC POL GEN CUR; Curtis L, 2016, UNIT COSTS HLTH SOCI; Department of Health, 2016, REF COSTS 2015 2016; Djalalov S, 2014, MED DECIS MAKING, V34, P809, DOI 10.1177/0272989X14536779; Egoavil C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079737; Ferguson SE, 2014, CANCER-AM CANCER SOC, V120, P3932, DOI 10.1002/cncr.28933; Goverde A, 2016, GYNECOL ONCOL, V143, P453, DOI 10.1016/j.ygyno.2016.10.008; Grosse SD, 2008, GENET MED, V10, P648, DOI 10.1097GIM.0b013e3181837217; Hampel H, 2006, CANCER RES, V66, P7810, DOI 10.1158/0008-5472.CAN-06-1114; Hampel H, 2011, CANCER PREV RES, V4, P1, DOI 10.1158/1940-6207.CAPR-10-0345; Heald B, 2013, J CLIN ONCOL, V31, P1336, DOI 10.1200/JCO.2012.45.1674; Howlader NNA, 2020, SEER CANC STAT REV; Husereau D, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1049; Jablonska M, 1995, Sb Lek, V96, P275; Jarvinen HJ, 2000, GASTROENTEROLOGY, V118, P829, DOI 10.1016/S0016-5085(00)70168-5; Kurnit KC, 2019, CANCER-AM CANCER SOC, V125, P2154, DOI 10.1002/cncr.32058; Kwon JS, 2011, J CLIN ONCOL, V29, P2247, DOI 10.1200/JCO.2010.32.9979; Ladabaum U, 2015, GASTROENTEROLOGY, V149, P783, DOI 10.1053/j.gastro.2015.07.037; Ladabaum U, 2011, ANN INTERN MED, V155, P69, DOI 10.7326/0003-4819-155-2-201107190-00002; Lautrup CK, 2015, FAM CANCER, V14, P553, DOI 10.1007/s10689-015-9812-1; Leenen CHM, 2012, GYNECOL ONCOL, V125, P414, DOI 10.1016/j.ygyno.2012.01.049; Lu KH, 2007, J CLIN ONCOL, V25, P5158, DOI 10.1200/JCO.2007.10.8597; Mas-Moya J, 2015, HUM PATHOL, V46, P1616, DOI 10.1016/j.humpath.2015.06.022; Mcallister M, 2008, J HEALTH PSYCHOL, V13, P895, DOI 10.1177/1359105308095063; Mecklin JP, 2007, GASTROENTEROLOGY, V133, P1093, DOI 10.1053/j.gastro.2007.08.019; Mercado RC, 2012, GENET MED, V14, P670, DOI 10.1038/gim.2012.18; Mills AM, 2014, AM J SURG PATHOL, V38, P1501, DOI 10.1097/PAS.0000000000000321; Moline J, 2013, GYNECOL ONCOL, V130, P121, DOI 10.1016/j.ygyno.2013.04.022; Moller P, 2018, GUT, V67, P1306, DOI 10.1136/gutjnl-2017-314057; Moller P, 2017, GUT, V66, P1657, DOI 10.1136/gutjnl-2016-311403; Moller P, 2017, GUT, V66, P464, DOI 10.1136/gutjnl-2015-309675; Mvundura M, 2010, GENET MED, V12, P93, DOI 10.1097/GIM.0b013e3181cd666c; Naimark DMJ, 2013, MED DECIS MAKING, V33, P961, DOI 10.1177/0272989X13501558; Najdawi F, 2017, PATHOLOGY, V49, P457, DOI 10.1016/j.pathol.2017.05.004; National Cancer Intelligence Network, 2009, COL CANC SURV STAG 2; National Institute for Health and Care Excellence, GUID METH TECHN APPR; National Institute for Health and Care Excellence, 2017, DIAGN GUID DG27 MOL; Payne K, 2008, VALUE HEALTH, V11, P497, DOI 10.1111/j.1524-4733.2007.00259.x; Reitsma JB, 2005, J CLIN EPIDEMIOL, V58, P982, DOI 10.1016/j.jclinepi.2005.02.022; Resnick K, 2009, OBSTET GYNECOL, V114, P530, DOI 10.1097/AOG.0b013e3181b11ecc; Ring KL, 2016, MODERN PATHOL, V29, P1381, DOI 10.1038/modpathol.2016.135; Rubio I, 2016, ONCOLOGY-BASEL, V91, P171, DOI 10.1159/000447972; Schmeler KM, 2006, NEW ENGL J MED, V354, P261, DOI 10.1056/NEJMoa052627; Seppala T, 2017, HERED CANCER CLIN PR, V15, DOI 10.1186/s13053-017-0078-5; Slade I, 2016, J COMMUN GENET, V7, P185, DOI 10.1007/s12687-016-0266-4; Snowsill T, 2017, HEALTH TECHNOL ASSES, V21, P1, DOI 10.3310/hta21510; Snowsill T, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1254-5; Snowsill T, 2014, HEALTH TECHNOL ASSES, V18, P1, DOI [10.3310/hta19020, 10.3310/hta18580]; Steliarova-Foucher E, 2012, EUROPEAN CANC OBSERV; Stuckless S, 2012, CLIN GENET, V82, P439, DOI 10.1111/j.1399-0004.2011.01802.x; Stupart DA, 2009, COLORECTAL DIS, V11, P126, DOI 10.1111/j.1463-1318.2008.01702.x; Tappenden P., 2011, THESIS; UK Genetic Testing Network, 2018, COL CANC HER NONP LY; Vasen HFA, 2013, GUT, V62, P812, DOI 10.1136/gutjnl-2012-304356; Watkins JC, 2017, INT J GYNECOL PATHOL, V36, P115, DOI 10.1097/PGP.0000000000000312; Whyte S, 2012, EARLY AWARENESS INTE; Win AK, 2017, CANCER EPIDEM BIOMAR, V26, P404, DOI [10.1158/1055-9965.EPI-16-0693, 10.1158/1055-9965.epi-16-0693]	68	19	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2019	14	8							e0221419	10.1371/journal.pone.0221419	http://dx.doi.org/10.1371/journal.pone.0221419			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW6BO	31469860	Green Accepted, Green Published, gold, Green Submitted			2022-12-26	WOS:000485062200019
J	Berry, ASF; Salazar-Sanchez, R; Castillo-Neyra, R; Borrini-Mayori, K; Chipana-Ramos, C; Vargas-Maquera, M; Ancca-Juarez, J; Naquira-Velarde, C; Levy, MZ; Brisson, D				Berry, Alexander S. F.; Salazar-Sanchez, Renzo; Castillo-Neyra, Ricardo; Borrini-Mayori, Katty; Chipana-Ramos, Claudia; Vargas-Maquera, Melina; Ancca-Juarez, Jenny; Naquira-Velarde, Cesar; Levy, Michael Z.; Brisson, Dustin		Chagas Dis Working Grp Arequipa	Immigration and establishment of Trypanosoma cruzi in Arequipa, Peru	PLOS ONE			English	Article							TARGETED SCREENING STRATEGIES; CHAGAS-DISEASE; TRIATOMA-INFESTANS; POPULATION-STRUCTURE; URBANIZATION; BIODIVERSITY; TRANSMISSION; COMMUNITIES; DISPERSAL; INFECTION	Changing environmental conditions, including those caused by human activities, reshape biological communities through both loss of native species and establishment of non-native species in the altered habitats. Dynamic interactions with the abiotic environment impact both immigration and initial establishment of non-native species into these altered habitats. The repeated emergence of disease systems in urban areas worldwide highlights the importance of understanding how dynamic migratory processes affect the current and future distribution and abundance of pathogens in urban environments. In this study, we examine the pattern of invasion of Trypanosoma cruzi-the causative agent of human Chagas disease-in the city of Arequipa, Peru. Phylogenetic analyses of 136 T. cruzi isolates from Arequipa and other South American locations suggest that only one T. cruzi lineage established a population in Arequipa as all T. cruzi isolated from vectors in Arequipa form a recent monophyletic group within the broader South American phylogeny. We discuss several hypotheses that may explain the limited number of established T. cruzi lineages despite multiple introductions of the parasite.	[Berry, Alexander S. F.] Childrens Hosp Philadelphia, Div Gastroenterol Hepatol & Nutr, Philadelphia, PA 19104 USA; [Berry, Alexander S. F.; Brisson, Dustin] Univ Penn, Dept Biol, Philadelphia, PA 19104 USA; [Salazar-Sanchez, Renzo; Castillo-Neyra, Ricardo; Borrini-Mayori, Katty; Chipana-Ramos, Claudia; Vargas-Maquera, Melina; Ancca-Juarez, Jenny; Naquira-Velarde, Cesar; Levy, Michael Z.] Univ Peruana Cayetano Heredia, Univ Penn Zoonot Dis Res Lab, Arequipa, Peru; [Castillo-Neyra, Ricardo; Levy, Michael Z.] Univ Penn, Perelman Sch Med, Dept Biostat Epidemiol & Informat, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Universidad Peruana Cayetano Heredia; University of Pennsylvania; Pennsylvania Medicine	Brisson, D (corresponding author), Univ Penn, Dept Biol, Philadelphia, PA 19104 USA.	dbrisson@sas.upenn.edu	; Brisson, Dustin/B-2428-2008	Castillo-Neyra, Ricardo/0000-0001-6629-2139; Brisson, Dustin/0000-0002-9493-7579; ANCCA JUAREZ, JENNY MAGALY/0000-0001-6727-4450	National Institute of Health [T32HG000046, T32AI007532, R01AI142572, R01AI097137, NIAID 5R01AI101229]; National Science Foundation [DEB-1354184]; Burroughs Wellcome Fund [1012376]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [T32HG000046] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI097137, T32AI007532, R01AI142572, R01AI101229] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Burroughs Wellcome Fund(Burroughs Wellcome Fund); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by grants from the National Institute of Health (https://www.nih.gov/) (T32HG000046 (AB), T32AI007532 (AB), R01AI142572 (DB), R01AI097137 (DB), and NIAID 5R01AI101229 (MZL)), the National Science Foundation (https://nsf.gov/) (DEB-1354184 (DB)), and Burroughs Wellcome Fund (https://www.bwfund.org/) (1012376 (DB)). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adalja AA, 2012, EMERG INFECT DIS, V18, P608, DOI 10.3201/eid1804.110968; Alirol E, 2011, LANCET INFECT DIS, V11, P131, DOI 10.1016/S1473-3099(10)70223-1; Alroy KA, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003779; Aronson MFJ, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.3330; Ayres DL, 2012, SYST BIOL, V61, P170, DOI [10.1093/sysbio/syr100, 10.1093/sysbio/sys029]; Bayer AM, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000567; Beninde J, 2015, ECOL LETT, V18, P581, DOI 10.1111/ele.12427; Berry ASF, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0007392; Billig E., 2017, THESIS; Blair RB, 2001, BIOTIC HOMOGENIZATION, P33; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Bouckaert R, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003537; Bowman NM, 2008, CLIN INFECT DIS, V46, P1822, DOI 10.1086/588299; Bradley CA, 2007, TRENDS ECOL EVOL, V22, P95, DOI 10.1016/j.tree.2006.11.001; Caceres AG, 2002, REV PERU MED EXP SAL, V19, P17; Castillo-Neyra R, 2016, PARASITOL INT, V65, P50, DOI 10.1016/j.parint.2015.09.009; Castillo-Neyra R, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003433; Cohen JE, 2001, SCIENCE, V293, P694, DOI 10.1126/science.1060638; Crowl TA, 2008, FRONT ECOL ENVIRON, V6, P238, DOI 10.1890/070151; Curtis-Robles R, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005298; Deguines N, 2016, ECOL EVOL, V6, P1967, DOI 10.1002/ece3.2009; Denys C, 1998, OECOLOGIA, V113, P269, DOI 10.1007/s004420050378; Deplazes P, 2004, TRENDS PARASITOL, V20, P77, DOI 10.1016/j.pt.2003.11.011; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Dumonteil E, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22455-x; Foley EA, 2013, MOL ECOL, V22, P5162, DOI 10.1111/mec.12471; Foley JA, 2005, SCIENCE, V309, P570, DOI 10.1126/science.1111772; Gaunt MW, 2003, NATURE, V421, P936, DOI 10.1038/nature01438; Geer LY, 2010, NUCLEIC ACIDS RES, V38, pD492, DOI 10.1093/nar/gkp858; Gurtler RE, 2007, PARASITOLOGY, V134, P69, DOI 10.1017/S0031182006001259; Gurtler RE, 1998, AM J TROP MED HYG, V58, P748, DOI 10.4269/ajtmh.1998.58.748; Hahs AK, 2009, ECOL LETT, V12, P1165, DOI 10.1111/j.1461-0248.2009.01372.x; HARINGTON JS, 1960, PARASITOLOGY, V50, P273, DOI 10.1017/S0031182000025361; Harrington LC, 2005, AM J TROP MED HYG, V72, P209, DOI 10.4269/ajtmh.2005.72.209; Heled J, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-289; Higo H, 2004, PARASITOL INT, V53, P337, DOI 10.1016/j.parint.2004.06.001; Hodo CL, 2018, ECOHEALTH, P1; Hunter GC, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001468; Kerr B, 2002, NATURE, V418, P171, DOI 10.1038/nature00823; Koboldt DC, 2009, BIOINFORMATICS, V25, P2283, DOI 10.1093/bioinformatics/btp373; KOWARIK I, 1995, PLANT INVASIONS, P85; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Levy MZ, 2007, PLOS NEGLECT TROP D, V1, DOI 10.1371/journal.pntd.0000103; Levy MZ, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.2807; Levy MZ, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.1003; Levy MZ, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002146; Levy MZ, 2006, EMERG INFECT DIS, V12, P1345, DOI 10.3201/eid1209.051662; Lima L., 1997, CLIN TERAPEUTICA DOE, P85; Llewellyn MS, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000510; Llewellyn MS, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000410; Lockwood JL, 2005, TRENDS ECOL EVOL, V20, P223, DOI 10.1016/j.tree.2005.02.004; lvarez O, 2015, ACTA TROP, V151, P166, DOI [10.1016/j.actatropica.2015.07.015, DOI 10.1016/J.ACTATR0PICA.2015.07.015, DOI 10.1016/J.ACTATROPICA.2015.07.015]; MACKIN-ROGALSKA R, 1988, Polish Ecological Studies, V14, P293; McIntyre NE, 2000, ANN ENTOMOL SOC AM, V93, P825, DOI 10.1603/0013-8746(2000)093[0825:EOUAAR]2.0.CO;2; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; McKinney ML, 2002, BIOSCIENCE, V52, P883, DOI 10.1641/0006-3568(2002)052[0883:UBAC]2.0.CO;2; New TR, 2018, AUSTRAL ENTOMOLOGY; Nouvellet P, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002505; Oliveira RP, 1998, P NATL ACAD SCI USA, V95, P3776, DOI 10.1073/pnas.95.7.3776; Pedersen D, 2008, SOC SCI MED, V67, P205, DOI 10.1016/j.socscimed.2008.03.040; Pekin BK, 2012, DIVERS DISTRIB, V18, P909, DOI 10.1111/j.1472-4642.2012.00928.x; Perez CJ, 2014, TRENDS PARASITOL, V30, P176, DOI 10.1016/j.pt.2014.01.008; Pitelka LF, 1997, AM SCI, V85, P464; QGIS Development Team, QGIS GEOGR INF SYST; RABINOVICH JE, 1990, B WORLD HEALTH ORGAN, V68, P737; Rambaut A, 2018, SYST BIOL, V67, P901, DOI 10.1093/sysbio/syy032; Seto KC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023777; Seto KC, 2012, P NATL ACAD SCI USA, V109, P16083, DOI 10.1073/pnas.1211658109; Strohbach MW, 2009, ECOL SOC, V14; Suchard MA, 2009, BIOINFORMATICS, V25, P1370, DOI 10.1093/bioinformatics/btp244; Theoharides KA, 2007, NEW PHYTOL, V176, P256, DOI 10.1111/j.1469-8137.2007.02207.x; Thomas CD, 2011, TRENDS ECOL EVOL, V26, P216, DOI 10.1016/j.tree.2011.02.006; Vitousek PM, 1996, AM SCI, V84, P468	74	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2019	14	8							e0221678	10.1371/journal.pone.0221678	http://dx.doi.org/10.1371/journal.pone.0221678			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5WO	31454370	gold, Green Published, Green Submitted			2022-12-26	WOS:000485049000039
J	Takehana, A; Uehara, T; Sakaguchi, Y				Takehana, Akira; Uehara, Tsukasa; Sakaguchi, Yutaka			Audiovisual synchrony perception in observing human motion to music	PLOS ONE			English	Article							VESTIBULAR INFLUENCE; RHYTHMIC ENGAGEMENT; TIME PERCEPTION; MIRROR NEURONS; STREET DANCERS; MOVEMENT; BEAT; GESTURES; VELOCITY; SYSTEM	To examine how individuals perceive synchrony between music and body motion, we investigated the characteristics of synchrony perception during observation of a Japanese Radio Calisthenics routine. We used the constant stimuli method to present video clips of an individual performing an exercise routine. We generated stimuli with a range of temporal shifts between the visual and auditory streams, and asked participants to make synchrony judgments. We then examined which movement-feature points agreed with music beats when the participants perceived synchrony. We found that extremities (e.g., hands and feet) reached the movement endpoint or moved through the lowest position at music beats associated with synchrony. Movement onsets never agreed with music beats. To investigate whether visual information about the feature points was necessary for synchrony perception, we conducted a second experiment where only limited portions of video clips were presented to the participants. Participants consistently judged synchrony even when the video image did not contain the critical feature points, suggesting that a prediction mechanism contributes to synchrony perception. To discuss the meaning of these feature points with respect to synchrony perception, we examined the temporal relationship between the motion of body parts and the ground reaction force (GRF) of exercise performers, which reflected the total force acting on the performer. Interestingly, vertical GRF showed local peaks consistently synchronized with music beats for most exercises, with timing that was closely correlated with the timing of movement feature points. This result suggests that synchrony perception in humans is based on some global variable anticipated from visual information, instead of the feature points found in the motion of individual body parts. In summary, the present results indicate that synchrony perception during observation of human motion to music depends largely on spatiotemporal prediction of the performer's motion.	[Takehana, Akira; Uehara, Tsukasa; Sakaguchi, Yutaka] Univ Electrocommun, Grad Sch Informat & Engn, Dept Mech Engn & Intelligent Syst, Chofu, Tokyo, Japan; [Sakaguchi, Yutaka] Univ Electrocommun, Res Ctr Performance Art Sci, Chofu, Tokyo, Japan; [Takehana, Akira] Canon Inc, Image Commun Business Operat, Utsunomiya, Tochigi, Japan	University of Electro-Communications - Japan; University of Electro-Communications - Japan; Canon Incorporated	Sakaguchi, Y (corresponding author), Univ Electrocommun, Grad Sch Informat & Engn, Dept Mech Engn & Intelligent Syst, Chofu, Tokyo, Japan.; Sakaguchi, Y (corresponding author), Univ Electrocommun, Res Ctr Performance Art Sci, Chofu, Tokyo, Japan.	yutaka.sakaguchi@uec.ac.jp		Sakaguchi, Yutaka/0000-0002-5573-8462	JSPS (Japan Society for the Promotion of Science) KAKENHI Grant [18K19823]; fundamental fund for research and education of graduate students from the University of Electro-Communications	JSPS (Japan Society for the Promotion of Science) KAKENHI Grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); fundamental fund for research and education of graduate students from the University of Electro-Communications	This research was supported by JSPS (Japan Society for the Promotion of Science) KAKENHI Grant to YS (18K19823) and by the fundamental fund for research and education of graduate students to YS from the University of Electro-Communications. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Arrighi R, 2006, J VISION, V6, P260, DOI 10.1167/6.3.6; Bernstein N, 1967, COORDINATION REGULAT; Burger B, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00903; Burger B, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00183; Colley ID, 2018, ACTA PSYCHOL, V191, P190, DOI 10.1016/j.actpsy.2018.09.014; Cook P, 2013, J COMP PSYCHOL, V127, P412, DOI 10.1037/a0032345; Dalla Bella S, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00663; DIXON NF, 1980, PERCEPTION, V9, P719, DOI 10.1068/p090719; Donohue SE, 2010, ATTEN PERCEPT PSYCHO, V72, P1120, DOI 10.3758/APP.72.4.1120; Du Y, 2017, EXP BRAIN RES, V235, P1541, DOI 10.1007/s00221-017-4918-3; Eg R, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00736; Eijk R. L. J., 2008, PERCEPT PSYCHOPHYS, V70, P955; Fabbri-Destro M, 2008, PHYSIOLOGY, V23, P171, DOI 10.1152/physiol.00004.2008; Fitch WT, 2007, MUSIC PERCEPT, V25, P43, DOI 10.1525/mp.2007.25.1.43; Fujii S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097680; Fujisaki W, 2005, EXP BRAIN RES, V166, P455, DOI 10.1007/s00221-005-2385-8; Garcia-Perez MA, 2012, PSYCHON B REV, V19, P820, DOI 10.3758/s13423-012-0278-y; Grant K, 2003, P INT C AUD VIS SPEE; Hajnal A, 2009, EXP BRAIN RES, V199, P89, DOI 10.1007/s00221-009-1958-3; Hannon EE, 2017, J EXP CHILD PSYCHOL, V159, P159, DOI 10.1016/j.jecp.2017.01.006; Himberg T, 2011, DANCE RES, V29, P305, DOI 10.3366/drs.2011.0022; Hommel B, 2001, BEHAV BRAIN SCI, V24, P849, DOI 10.1017/S0140525X01000103; Hove MJ, 2014, P NATL ACAD SCI USA, V111, P10383, DOI 10.1073/pnas.1402039111; Ihaka R., 1996, J COMPUT GRAPH STAT, V5, P299, DOI [DOI 10.1080/10618600.1996.10474713, 10.2307/1390807]; Ilari B, 2015, J RES MUSIC EDUC, V62, P332, DOI 10.1177/0022429414555984; Japan Post Insurance, RAD CAL MOV; Keysers C, 2003, EXP BRAIN RES, V153, P628, DOI 10.1007/s00221-003-1603-5; Latash ML, 2008, SYNERGY; Lee H, 2011, P NATL ACAD SCI USA, V108, pE1441, DOI 10.1073/pnas.1115267108; Lenc T, 2018, P NATL ACAD SCI USA, V115, P8221, DOI 10.1073/pnas.1801421115; Levitin DJ, 2018, ANNU REV PSYCHOL, V69, P51, DOI 10.1146/annurev-psych-122216-011740; Lewkowicz DJ, 1996, J EXP PSYCHOL HUMAN, V22, P1094, DOI 10.1037/0096-1523.22.5.1094; Luck G, 2008, MUSIC PERCEPT, V25, P225, DOI 10.1525/MP.2008.25.3.225; Luck G, 2006, MUSIC PERCEPT, V24, P189, DOI 10.1525/mp.2006.24.2.189; Ludolph N, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187666; Miura Akito, 2015, J Dance Med Sci, V19, P11, DOI 10.12678/1089-313X.19.1.11; Miura A, 2013, NEUROSCI LETT, V544, P157, DOI 10.1016/j.neulet.2013.04.005; Miura A, 2011, HUM MOVEMENT SCI, V30, P1260, DOI 10.1016/j.humov.2010.08.006; Miyata K, 2018, NEUROSCI LETT, V682, P132, DOI 10.1016/j.neulet.2018.07.024; Miyata K, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16151-5; Miyata K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115495; Petrini K, 2009, EXP BRAIN RES, V198, P339, DOI 10.1007/s00221-009-1817-2; Petrini K, 2009, COGNITION, V110, P432, DOI 10.1016/j.cognition.2008.11.015; Phillips-Silver J, 2005, SCIENCE, V308, P1430, DOI 10.1126/science.1110922; Phillips-Silver J, 2008, BRAIN COGNITION, V67, P94, DOI 10.1016/j.bandc.2007.11.007; Phillips-Silver J, 2007, COGNITION, V105, P533, DOI 10.1016/j.cognition.2006.11.006; Prinz W, 1997, EUR J COGN PSYCHOL, V9, P129, DOI 10.1080/713752551; Prinz W., 1990, RELATIONSHIPS PERCEP, DOI DOI 10.1007/978-3-642-75348-0_7; Riggle M, 2009, EMPIR MUSICOL REV, V4, P19, DOI 10.18061/1811/36603; Rizzolatti G, 2004, ANNU REV NEUROSCI, V27, P169, DOI 10.1146/annurev.neuro.27.070203.144230; Rizzolatti G, 2008, CURR OPIN NEUROBIOL, V18, P179, DOI 10.1016/j.conb.2008.08.001; Rizzolatti G, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0420; Roerdink M, 2005, HUM MOVEMENT SCI, V24, P379, DOI 10.1016/j.humov.2005.06.007; Snyder J, 2001, MUSIC PERCEPT, V18, P455, DOI 10.1525/mp.2001.18.4.455; Spence C, 2003, CURR BIOL, V13, pR519, DOI 10.1016/S0960-9822(03)00445-7; Su YH, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00186; Su YH, 2016, SCI REP-UK, V6, DOI 10.1038/srep22774; Su YH, 2014, COGNITION, V131, P330, DOI 10.1016/j.cognition.2014.02.004; Todd NPM, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00444; Todd NPM, 2000, J ACOUST SOC AM, V107, P496, DOI 10.1121/1.428317; Todd NPM, 1999, J NEW MUSIC RES, V28, P5, DOI 10.1076/jnmr.28.1.5.3124; Toiviainen P, 2010, MUSIC PERCEPT, V28, P59, DOI 10.1525/MP.2010.28.1.59; Trainor LJ, 2009, CORTEX, V45, P35, DOI 10.1016/j.cortex.2007.10.014; Varlet M, 2014, J EXP PSYCHOL HUMAN, V40, P1849, DOI 10.1037/a0037417; Vatakis A, 2006, BRAIN RES, V1111, P134, DOI 10.1016/j.brainres.2006.05.078; Vroomen J, 2010, ATTEN PERCEPT PSYCHO, V72, P871, DOI 10.3758/APP.72.4.871; Zelic G, 2016, ACTA PSYCHOL, V169, P61, DOI 10.1016/j.actpsy.2016.05.008; Zentner M, 2010, P NATL ACAD SCI USA, V107, P5768, DOI 10.1073/pnas.1000121107	68	0	0	4	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2019	14	8							e0221584	10.1371/journal.pone.0221584	http://dx.doi.org/10.1371/journal.pone.0221584			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW5WO	31454393	Green Published, Green Submitted, gold			2022-12-26	WOS:000485049000029
J	Charyeva, Z; Curtis, S; Mullen, S; Senik, T; Zaliznyak, O				Charyeva, Zulfiya; Curtis, Sian; Mullen, Stephanie; Senik, Tatyana; Zaliznyak, Olga			What works best for ensuring treatment adherence. Lessons from a social support program for people treated for tuberculosis in Ukraine	PLOS ONE			English	Article								Background Worldwide, TB is one of the top 10 causes of death and the leading cause from a single infectious agent. Ukraine is one of 30 countries with the highest burden of multidrug-resistant tuberculosis. Global literature shows that social support (SS) is important in improving TB treatment adherence, reducing lost to follow up rates and improving treatment outcomes. There are several models of SS available, and the literature provides little information on what aspects of SS are most important to TB patients in improving their adherence. Methods We used qualitative data collected through in-depth interviews (IDI) with 21 TB patients and 15 SS providers and coordinators in Ukraine in August-September 2016 to understand how the SS program promoted treatment adherence among patients. We examined the aspects of outpatient TB treatment that made adherence particularly difficult for patients in at-risk groups and aspects of the SS programs that worked best for addressing those barriers. Interviews were transcribed and analysis was performed to derive emergent themes. Results Main barriers included side effects from medicine, the amount of time required daily for transportation and waiting in lines at the health facility, transportation expenses, risks of being identified when visiting a TB facility and lack of motivation to seek treatment. Features of the SS program most valued by patients were convenience of not having to visit facility and support provided by nurses. These two features directly addressed most of the barriers identified. The commitment and qualities of the nurses that provided the SS was an important element of the program. Conclusions This qualitative study suggests that the SS program in Ukraine was successful in reducing treatment default among patients at high risk of default because it directly addressed most of the major barriers they faced to treatment adherence.	[Charyeva, Zulfiya; Curtis, Sian; Mullen, Stephanie] Univ N Carolina, Carolina Populat Ctr, MEASURE Evaluat Project, Chapel Hill, NC 27515 USA; [Charyeva, Zulfiya] Palladium, Chapel Hill, NC 27514 USA; [Curtis, Sian] Univ N Carolina, Gillings Sch Global Publ Hlth, Dept Maternal & Child Hlth, Chapel Hill, NC 27515 USA; [Mullen, Stephanie] John Snow Inc, Rosslyn, VA USA; [Senik, Tatyana; Zaliznyak, Olga] IFAK Inst, Int Res Agcy, Kiev, Ukraine	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Charyeva, Z (corresponding author), Univ N Carolina, Carolina Populat Ctr, MEASURE Evaluat Project, Chapel Hill, NC 27515 USA.; Charyeva, Z (corresponding author), Palladium, Chapel Hill, NC 27514 USA.	Zulfiya.Charyeva@thepalladiumgroup.com			United States Agency for International Development (USAID) [AID-OAA-L-14-00004]	United States Agency for International Development (USAID)(United States Agency for International Development (USAID))	This publication was produced with the support of the United States Agency for International Development (USAID) under the terms of MEASURE Evaluation cooperative agreement AID-OAA-L-14-00004. MEASURE Evaluation is implemented by the Carolina Population Center, University of North Carolina at Chapel Hill in partnership with ICF International; John Snow, Inc.; Management Sciences for Health; Palladium; and Tulane University. Views expressed are not necessarily those of USAID or the United States government. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez Gordillo G. del C., 2003, Revista Panamericana de Salud Publica/Pan American Journal of Public Health, V14, P402, DOI 10.1590/S1020-49892003001100005; [Anonymous], 2018, GLOB TB REP 2018; Coker RJ, 2004, TROP MED INT HEALTH, V9, P25, DOI 10.1046/j.1365-3156.2003.01156.x; Deshmukh R D, 2018, Indian J Tuberc, V65, P41, DOI 10.1016/j.ijtb.2017.05.003; Kaliakbarova G., 2013, OPEN INFECT DIS J, V7, P60, DOI [10.2174/1874279301307010060, DOI 10.2174/1874279301307010060]; Law S, 2019, EUR RESPIR J, V53, DOI 10.1183/13993003.01030-2018; Skiles MP, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0199513; Tanimura T, 2014, EUR RESPIR J, V43, P1763, DOI 10.1183/09031936.00193413; van Hoorn R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154095	9	4	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2019	14	8							e0221688	10.1371/journal.pone.0221688	http://dx.doi.org/10.1371/journal.pone.0221688			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5UR	31449542	Green Published, gold, Green Submitted			2022-12-26	WOS:000485044000030
J	Peng, YL; Lee, CT; Tain, YL; Huang, YB; Chuang, HY; Wen, YH; Huang, SH; Tsai, CY; Hsu, CN				Peng, Yueh-Lung; Lee, Chien-Te; Tain, You-Lin; Huang, Yaw-Bin; Chuang, Hung-Yi; Wen, Yen-Hsia; Huang, Shiou-Huei; Tsai, Chun-Yu; Hsu, Chien-Ning			The impact of adoption of a new uratelowering agent on trends in utilization and cost in practice	PLOS ONE			English	Article							INTERRUPTED TIME-SERIES; BUDGET IMPACT; RISK-FACTOR; URIC-ACID; GOUT; MANAGEMENT; ALLOPURINOL; FEBUXOSTAT; EPIDEMIOLOGY; HYPERURICEMIA	Objectives Changes in treatment choice of therapy and size of treated population that can lead to under-or overestimate of payer's budget are less likely to be reassured after reimbursement adoption of a new drug. The aim of this study was to evaluate the effects of febuxostat introduction and the modifications in its insurance coverage on the utilization and expenditure of urate-lowering therapy (ULT). Methods Electronic medical records for adults patients prescribed any ULT during 2010-2015 was derived from the largest medical organization in Taiwan. Aggregated estimates of ULT use and costs were assessed per 3-month and per patient per month (PPPM). Factors associated with total ULT expenditure were assessed using a time series design with factored Autoregressive Integrated Moving Average (ARIMA) models. Results ULT prevalent users increased 34.1% from 2010 to 2015 and a 123% increase in total ULT expenditure. Numbers on allopurinol and sulfinpyrazone both declined 31%, and on benzbromarone and febuxostat gradually increased to 38.21% and 22.89% of all users in 2015. Insurance payments PPPM ($4.44 to $9.22) and total monthly ULT cost ($32,946 to $85,732) growth more than doubled in 6 years, trend changes generated mostly by individuals switching to febuxostat. Conclusions ULT use moved to favor benzbromarone and febuxostat; greater expensive uptake for febuxostat led to a rapid rise in ULT cost. Marginal values of increasing access to febuxostat for asymptomatic hyperuricemia should be focus on future studies to facilitate drug prices negotiation and ensure appropriate ULT use.	[Peng, Yueh-Lung; Huang, Yaw-Bin; Wen, Yen-Hsia; Hsu, Chien-Ning] Kaohsiung Med Univ, Sch Pharm, Kaohsiung, Taiwan; [Peng, Yueh-Lung] Ctr Drug Evaluat, Div Hlth Technol Assessment, Taipei, Taiwan; [Lee, Chien-Te] Chang Gung Univ, Coll Med, Kaohsiung Chang Gung Mem Hosp, Dept Internal Med,Div Nephrol, Kaohsiung, Taiwan; [Tain, You-Lin] Chang Gung Univ, Kaohsiung Chang Gung Mem Hosp, Coll Med, Dept Pediat,Div Pediat Nephrol, Kaohsiung, Taiwan; [Chuang, Hung-Yi] Dept Publ Hlth, Kaohsiung, Taiwan; [Chuang, Hung-Yi] Ctr Excellence Environm Med, Kaohsiung, Taiwan; [Huang, Shiou-Huei; Hsu, Chien-Ning] Kaohsiung Chang Gung Mem Hosp, Dept Pharm, Kaohsiung, Taiwan; [Tsai, Chun-Yu] Chang Gung Mem Fdn, Dept Pharmaceut Mat Management, Taoyuan, Taiwan	Kaohsiung Medical University; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital	Hsu, CN (corresponding author), Kaohsiung Med Univ, Sch Pharm, Kaohsiung, Taiwan.; Hsu, CN (corresponding author), Kaohsiung Chang Gung Mem Hosp, Dept Pharm, Kaohsiung, Taiwan.	chien_ning_hsu@hotmail.com	Tain, You-Lin/H-2827-2019; Chuang, H. Y./AAM-3118-2021; Hsu, Chien-Ning/GLS-4014-2022	Tain, You-Lin/0000-0002-7059-6407; Chuang, H. Y./0000-0002-8321-8720; Hsu, Chien-Ning/0000-0001-7470-528X; Huang, Yaw-Bin/0000-0002-6024-0108; Wen, yen-hsia/0000-0002-4168-5857				[Anonymous], ARIMA PROC SAS ONLIN; Becker MA, 2005, NEW ENGL J MED, V353, P2450, DOI 10.1056/NEJMoa050373; Center for Drug Evaluation, HLTH TECH ASS REP FE; Chen JH, 2009, ARTHRIT RHEUM-ARTHR, V61, P225, DOI 10.1002/art.24164; Cheng CL, 2014, PHARMACOEPIDEM DR S, V23, P309, DOI 10.1002/pds.3550; Chonchol M, 2007, AM J KIDNEY DIS, V50, P239, DOI 10.1053/j.ajkd.2007.05.013; Chou HY, 2015, J CLIN PHARM THER, V40, P689, DOI 10.1111/jcpt.12322; Claxton K, 2008, BMJ-BRIT MED J, V336, P251, DOI 10.1136/bmj.39434.500185.25; Cook T.C., 1979, QUASIEXPERIMENTATION; Inker LA, 2014, AM J KIDNEY DIS, V63, P713, DOI 10.1053/j.ajkd.2014.01.416; Iseki K, 2004, AM J KIDNEY DIS, V44, P642, DOI 10.1016/S0272-6386(04)00934-5; Jandoc R, 2015, J CLIN EPIDEMIOL, V68, P950, DOI 10.1016/j.jclinepi.2014.12.018; Jordan KM, 2007, RHEUMATOLOGY, V46, P1372, DOI 10.1093/rheumatology/kem056a; Karmacharya P, 2016, CLIN RHEUMATOL, V35, P523, DOI 10.1007/s10067-015-3042-7; Ke CH, 2017, J RHEUMATOL, V44, P835, DOI 10.3899/jrheum.151476; Khanna D, 2012, ARTHRIT CARE RES, V64, P1447, DOI 10.1002/acr.21773; Khanna PP, 2012, HEALTH QUAL LIFE OUT, V10, DOI 10.1186/1477-7525-10-117; Khanna PP, 2011, RHEUMATOLOGY, V50, P740, DOI 10.1093/rheumatology/keq346; Kim KY, 2003, CLIN THER, V25, P1593, DOI 10.1016/S0149-2918(03)80158-3; Kim SC, 2013, ARTHRIT CARE RES, V65, P2008, DOI 10.1002/acr.22067; Kuo CF, 2015, NAT REV RHEUMATOL, V11, P649, DOI 10.1038/nrrheum.2015.91; Kuo CF, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0522-8; Messori A, 2016, SCI PHARM, V84, P73, DOI 10.3797/scipharm.1506-03; Mills T. C., 1990, TIME SERIES TECHNIQU; Mitri G, 2016, J MANAG CARE SPEC PH, V22, P326, DOI 10.18553/jmcp.2016.22.4.326; National Health Insurance Administration Ministry of Welfare and Health, FEB REIMB COV; Nuijten MJC, 2011, EUR J HEALTH ECON, V12, P231, DOI 10.1007/s10198-010-0236-4; Pontremoli R, 2017, CURR MED RES OPIN, V33, P27, DOI 10.1080/03007995.2017.1378523; Rodriguez-Aguilar R, 2018, COST EFFECT RESOUR A, V16, DOI 10.1186/s12962-018-0094-y; Singh JA, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0624-3; Smolen LJ, 2016, CLIN THER, V38, P1710, DOI 10.1016/j.clinthera.2016.05.007; Wagner AK, 2002, J CLIN PHARM THER, V27, P299, DOI 10.1046/j.1365-2710.2002.00430.x; Wen CP, 2010, AM J KIDNEY DIS, V56, P273, DOI 10.1053/j.ajkd.2010.01.024; Zhang W, 2006, ANN RHEUM DIS, V65, P1312, DOI 10.1136/ard.2006.055269	34	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2019	14	8							e0221504	10.1371/journal.pone.0221504	http://dx.doi.org/10.1371/journal.pone.0221504			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5UR	31449565	Green Published, Green Submitted, gold			2022-12-26	WOS:000485044000023
J	Cantarero, A; Perez-Rodriguez, L; Romero-Haro, AA; Chastel, O; Alonso-Alvarez, C				Cantarero, Alejandro; Perez-Rodriguez, Lorenzo; Angela Romero-Haro, Ana; Chastel, Olivier; Alonso-Alvarez, Carlos			Carotenoid-based coloration predicts both longevity and lifetime fecundity in male birds, but testosterone disrupts signal reliability	PLOS ONE			English	Article							OXIDATION HANDICAP HYPOTHESIS; COMBINED AROMATASE INHIBITOR; PLUMAGE COLORATION; TRADE-OFFS; TERRITORIAL AGGRESSION; REPRODUCTIVE SUCCESS; SEXUAL ATTRACTIVENESS; ZEBRA FINCH; MATE CHOICE; STRESS	Sexual selection promotes the evolution of conspicuous animal ornaments. To evolve as signals, these traits must reliably express the "quality" of the bearer, an indicator of individual fitness. Direct estimates of individual fitness may include the contribution of longevity and fecundity. However, evidence of a correlation between the level of signal expression and these two fitness components are scarce, at least among vertebrates. Relative fitness is difficult to assess in the wild as age at death and extra-pair paternity rates are often unknown. Here, in captive male red-legged partridges, we show that carotenoid-based ornament expression, i.e., redness of the bill and eye rings, at the beginning of reproductive life predicts both longevity (1-7 years) and lifetime breeding output (offspring number and hatching success). The recently proposed link between the individual capacity to produce red (keto) carotenoid pigments and the efficiency of cell respiration could, ultimately, explain the correlation with lifespan and, indirectly, fecundity. Nonetheless, in males of avian species, carotenoid-based coloration in bare parts is also partially controlled by testosterone. We also manipulated androgen levels throughout life by treating males with testosterone or anti-androgen compounds. Treatments caused correlations between signal levels and both fitness components to disappear, thus making the signals unreliable. This suggests that the evolution of carotenoid-based sexual signals requires a tightly-controlled steroid metabolism.	[Cantarero, Alejandro] Univ Turku, Sect Ecol, Turku, Finland; [Perez-Rodriguez, Lorenzo] IREC CSIC UCLM JCCM, Inst Invest Recursos Cineget, Ciudad Real, Spain; [Angela Romero-Haro, Ana] Univ Exeter, Ctr Ecol & Conservat, Penryn, England; [Chastel, Olivier] Ctr Etud Biol Chize, CNRS UMR 7372, Villiers En Bois, France; [Chastel, Olivier] Univ La Rochelle, Villiers En Bois, France; [Alonso-Alvarez, Carlos] CSIC, Museo Nacl Ciencias Nat, Dept Ecol Evolut, Madrid, Spain	University of Turku; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigacion en Recursos Cinegeticos (IREC); Universidad de Castilla-La Mancha; University of Exeter; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); La Rochelle Universite; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Museo Nacional de Ciencias Naturales (MNCN)	Cantarero, A (corresponding author), Univ Turku, Sect Ecol, Turku, Finland.; Alonso-Alvarez, C (corresponding author), CSIC, Museo Nacl Ciencias Nat, Dept Ecol Evolut, Madrid, Spain.	alex.cantarero@hotmail.com; carlos.alonso@csic.es	Pérez-Rodríguez, Lorenzo/G-1811-2011; Alonso-Alvarez, Carlos/M-6804-2014; Cantarero, Alejandro/P-3962-2014	Pérez-Rodríguez, Lorenzo/0000-0002-5926-1438; Alonso-Alvarez, Carlos/0000-0002-4765-551X; Cantarero, Alejandro/0000-0002-5816-701X; Romero Haro, Ana Angela/0000-0002-7127-4733	JCCM [PII1I09-0271-5037, PII1C09-0128-4724, SBPLY/17/180501/000468]; European Regional Development Fund-ERDF; Ministerio de Ciencia e Innovacion (MICIN, Spain) [CGL2009-10883-C02-02]; Ministerio de Economia, Industria y Competitividad (MINECO) [CGL2015-69338-C2-2-P]; "Juan de la Cierva-formacion" postdoctoral grant (MINECO) [FJCI-2015-23536]; SECTI postdoctoral contract from the University of Castilla-La Mancha (UCLM); Fundacion Ramon Areces	JCCM; European Regional Development Fund-ERDF(European Commission); Ministerio de Ciencia e Innovacion (MICIN, Spain)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Ministerio de Economia, Industria y Competitividad (MINECO)(Spanish Government); "Juan de la Cierva-formacion" postdoctoral grant (MINECO); SECTI postdoctoral contract from the University of Castilla-La Mancha (UCLM); Fundacion Ramon Areces	Financial support was obtained from the projects PII1I09-0271-5037, PII1C09-0128-4724, SBPLY/17/180501/000468 from the JCCM (cofinanced with European Regional Development Fund -ERDF), CGL2009-10883-C02-02 from Ministerio de Ciencia e Innovacion (MICIN, Spain) and CGL2015-69338-C2-2-P from Ministerio de Economia, Industria y Competitividad (MINECO). AC and LP-R were supported by a "Juan de la Cierva-formacion" postdoctoral grant (MINECO, FJCI-2015-23536) and a SECTI postdoctoral contract from the University of Castilla-La Mancha (UCLM), respectively. AC is currently supported by a postdoctoral fellowship from Fundacion Ramon Areces.	Acosta MJ, 2016, BBA-BIOENERGETICS, V1857, P1079, DOI 10.1016/j.bbabio.2016.03.036; Alonso-Alvarez C, 2008, J EVOLUTION BIOL, V21, P1789, DOI 10.1111/j.1420-9101.2008.01591.x; Alonso-Alvarez C, 2004, ECOL LETT, V7, P363, DOI 10.1111/j.1461-0248.2004.00594.x; Alonso-Alvarez C, 2009, P ROY SOC B-BIOL SCI, V276, P2093, DOI 10.1098/rspb.2008.1891; Alonso-Alvarez C, 2007, P ROY SOC B-BIOL SCI, V274, P819, DOI 10.1098/rspb.2006.3764; Alonso-Alvarez C, 2017, BIOSCIENCE, V67, P258, DOI 10.1093/biosci/biw176; Alonso-Alvarez C, 2012, BEHAV ECOL SOCIOBIOL, V66, P731, DOI 10.1007/s00265-012-1321-8; Alonso-Alvarez C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019403; Andersson Malte, 1994, pi; Badeau M, 2005, J STEROID BIOCHEM, V96, P271, DOI 10.1016/j.jsbmb.2005.04.034; BELETSKY LD, 1992, HORM BEHAV, V26, P420, DOI 10.1016/0018-506X(92)90011-J; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Biernaskie JM, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0876; Blas J, 2006, P NATL ACAD SCI USA, V103, P18633, DOI 10.1073/pnas.0609189103; Blount JD, 2003, SCIENCE, V300, P125, DOI 10.1126/science.1082142; BOTTONI L, 1993, HORM BEHAV, V27, P308, DOI 10.1006/hbeh.1993.1023; Bradbury J. W., 2011, PRINCIPLES ANIMAL CO; Britton G, 2009, CAROTENOIDS NUTR HLT, V5, P431; Burley NT, 1996, BEHAV ECOL, V7, P218, DOI 10.1093/beheco/7.2.218; Cantarero A, 2018, SCI NAT-HEIDELBERG, V105, DOI 10.1007/s00114-018-1565-x; Cantarero A, 2017, BIOL LETTERS, V13, DOI 10.1098/rsbl.2017.0455; Cantarero A, 2015, ETHOLOGY, V121, P946, DOI 10.1111/eth.12407; Casas F, 2010, 13 C NAC 10 IB ET CI; Casas F, 2009, IBIS, V151, P743, DOI 10.1111/j.1474-919X.2009.00958.x; Chastel O, 2003, J AVIAN BIOL, V34, P298, DOI 10.1034/j.1600-048X.2003.02528.x; Cramp S., 1992, BIRDS W PALEARCTIC, VVI; Crary AL, 2012, J FIELD ORNITHOL, V83, P130, DOI 10.1111/j.1557-9263.2012.00363.x; Davies NB, 2012, INTRO BEHAV ECOLOGY; DUFTY AM, 1989, HORM BEHAV, V23, P185, DOI 10.1016/0018-506X(89)90059-7; Durieux J, 2011, CELL, V144, P79, DOI 10.1016/j.cell.2010.12.016; Edward DA, 2011, MECHANISMS OF LIFE HISTORY EVOLUTION: THE GENETICS AND PHYSIOLOGY OF LIFE HISTORY TRAITS AND TRADE-OFFS, P137; Emlen DJ, 2012, SCIENCE, V337, P860, DOI 10.1126/science.1224286; Figuerola J, 2007, OIKOS, V116, P636, DOI 10.1111/j.2007.0030-1299.14719.x; Foerster K, 2004, BEHAV ECOL SOCIOBIOL, V56, P482, DOI 10.1007/s00265-004-0809-2; Foley J. D., 1982, FUNDAMENTALS INTERAC, P2; FOLSTAD I, 1992, AM NAT, V139, P603, DOI 10.1086/285346; Forstmeier W, 2011, P NATL ACAD SCI USA, V108, P10608, DOI 10.1073/pnas.1103195108; Fusani L, 2008, GEN COMP ENDOCR, V157, P249, DOI 10.1016/j.ygcen.2008.04.016; Garcia-de Blas E, 2016, PEERJ, V4, DOI 10.7717/peerj.2237; Garcia-de Blas E, 2013, PHYSIOL BIOCHEM ZOOL, V86, P483, DOI 10.1086/671812; Getty T, 2006, TRENDS ECOL EVOL, V21, P83, DOI 10.1016/j.tree.2005.10.016; GRAFEN A, 1990, J THEOR BIOL, V144, P517, DOI 10.1016/S0022-5193(05)80088-8; Greenfield MD, 2004, ANIM BEHAV, V68, P1461, DOI 10.1016/j.anbehav.2004.01.014; Hartley RC, 2004, TRENDS ECOL EVOL, V19, P353, DOI 10.1016/j.tree.2004.04.002; Hartmann N, 2011, AGING CELL, V10, P824, DOI 10.1111/j.1474-9726.2011.00723.x; Helfenstein F, 2010, ECOL LETT, V13, P213, DOI 10.1111/j.1461-0248.2009.01419.x; HILL GE, 1991, NATURE, V350, P337, DOI 10.1038/350337a0; Hill GE, 2014, INTEGR COMP BIOL, V54, P645, DOI 10.1093/icb/icu029; Hill GE, 2011, ECOL LETT, V14, P625, DOI 10.1111/j.1461-0248.2011.01622.x; Hirschenhauser K, 2006, ANIM BEHAV, V71, P265, DOI 10.1016/j.anbehav.2005.04.014; Horak P, 2001, OECOLOGIA, V126, P166, DOI 10.1007/s004420000513; Ingleby FC, 2010, J EVOLUTION BIOL, V23, P2031, DOI 10.1111/j.1420-9101.2010.02080.x; Irschick DJ, 2015, ANIMAL SIGNALING AND FUNCTION: AN INTEGRATIVE APPROACH, P1; Johnson JD, 2013, BIOCHIMIE, V95, P436, DOI 10.1016/j.biochi.2012.10.021; Kellner KF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111436; Koch RE, 2019, J EXP BIOL, V222, DOI 10.1242/jeb.188102; Koch RE, 2018, FUNCT ECOL, V32, P1908, DOI 10.1111/1365-2435.13122; Kokko H, 2003, P ROY SOC B-BIOL SCI, V270, P653, DOI 10.1098/rspb.2002.2235; Laidre ME, 2013, CURR BIOL, V23, pR829, DOI 10.1016/j.cub.2013.07.070; Lee SJ, 2010, CURR BIOL, V20, P2131, DOI 10.1016/j.cub.2010.10.057; LESSELLS CM, 1987, AUK, V104, P116, DOI 10.2307/4087240; Lopes RJ, 2016, CURR BIOL, V26, P1427, DOI 10.1016/j.cub.2016.03.076; Martinez-Padilla J, 2014, HORM BEHAV, V65, P435, DOI 10.1016/j.yhbeh.2014.03.012; Martinez-Padilla J, 2014, ECOLOGY, V95, P1033, DOI 10.1890/12-1905.1; Maynard Smith J, 2003, ANIMAL SIGNALS, p[i, 1]; Mcglothlin JW, 2008, J EVOLUTION BIOL, V21, P39, DOI 10.1111/j.1420-9101.2007.01471.x; McGlothlin JW, 2008, PHILOS T R SOC B, V363, P1611, DOI 10.1098/rstb.2007.0002; McGlothlin JW, 2005, EVOLUTION, V59, P658; McGraw KJ, 2006, BEHAV ECOL SOCIOBIOL, V60, P117, DOI 10.1007/s00265-005-0135-3; McGraw KJ, 2003, AM NAT, V162, P704, DOI 10.1086/378904; Metcalfe NB, 2010, FUNCT ECOL, V24, P984, DOI 10.1111/j.1365-2435.2010.01750.x; Mills SC, 2009, AM NAT, V173, P475, DOI 10.1086/597222; Monaghan P, 2009, ECOL LETT, V12, P75, DOI 10.1111/j.1461-0248.2008.01258.x; Moore IT, 2004, GEN COMP ENDOCR, V135, P223, DOI 10.1016/j.ygcen.2003.09.012; Mougeot F, 2007, FUNCT ECOL, V21, P886, DOI 10.1111/j.1365-2435.2007.01302.x; Mougeot F, 2005, J ANIM ECOL, V74, P488, DOI 10.1111/j.1365-2656.2005.00947.x; Mougeot F, 2009, P ROY SOC B-BIOL SCI, V276, P1093, DOI 10.1098/rspb.2008.1570; Mundy NI, 2016, CURR BIOL, V26, P1435, DOI 10.1016/j.cub.2016.04.047; Ng LF, 2014, FREE RADICAL BIO MED, V71, P390, DOI 10.1016/j.freeradbiomed.2014.03.003; Nolan PM, 1998, P ROY SOC B-BIOL SCI, V265, P961, DOI 10.1098/rspb.1998.0384; NOLAN V, 1992, CONDOR, V94, P364, DOI 10.2307/1369209; Perez-Rodriguez L, 2008, NATURWISSENSCHAFTEN, V95, P821, DOI 10.1007/s00114-008-0389-5; Perez-Rodriguez L, 2008, BEHAV ECOL SOCIOBIOL, V62, P995, DOI 10.1007/s00265-007-0527-7; Perez-Rodriguez L, 2009, BIOESSAYS, V31, P1116, DOI 10.1002/bies.200900070; Peters A, 2007, BIOESSAYS, V29, P427, DOI 10.1002/bies.20563; Pike TW, 2007, P ROY SOC B-BIOL SCI, V274, P1591, DOI 10.1098/rspb.2007.0317; PRICE DK, 1994, AM NAT, V144, P908, DOI 10.1086/285718; Reed WL, 2006, AM NAT, V167, P667, DOI 10.1086/503054; Reid JM, 2005, AM NAT, V165, P299, DOI 10.1086/428299; Roberts ML, 2012, J AVIAN BIOL, V43, P264, DOI 10.1111/j.1600-048X.2012.05571.x; Rowe M, 2012, COMP BIOCHEM PHYS B, V163, P285, DOI 10.1016/j.cbpb.2012.06.005; Rowe M, 2008, CONDOR, V110, P694, DOI 10.1525/cond.2008.8604; Saino N, 1995, BEHAV ECOL, V6, P397, DOI 10.1093/beheco/6.4.397; Salmon AB, 2001, EVOLUTION, V55, P1600, DOI 10.1111/j.0014-3820.2001.tb00679.x; SCHWABL H, 1991, HORM BEHAV, V25, P180, DOI 10.1016/0018-506X(91)90049-N; SEARCY WA, 2005, MG BEH ECOL, P1; Silverin B, 1998, ANIM BEHAV, V56, P811, DOI 10.1006/anbe.1998.0823; Simons MJP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043088; Simons MJP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040721; Soma KK, 1999, GEN COMP ENDOCR, V115, P442, DOI 10.1006/gcen.1999.7334; Speakman JR, 2014, BIOESSAYS, V36, P93, DOI 10.1002/bies.201300108; Stearns S.C., 1992, pi; Taff CC, 2014, HORM BEHAV, V66, P276, DOI 10.1016/j.yhbeh.2014.05.006; Tomasek O, 2017, P ROY SOC B-BIOL SCI, V284, DOI 10.1098/rspb.2016.2444; TUREK FW, 1976, GEN COMP ENDOCR, V28, P395, DOI 10.1016/0016-6480(76)90147-7; Van Duyse E, 2005, HORM BEHAV, V48, P243, DOI 10.1016/j.yhbeh.2005.02.013; Van Oort H, 2005, FUNCT ECOL, V19, P822, DOI 10.1111/j.1365-2435.2005.01035.x; Velando A, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-38535-5; Vergara P, 2012, J EVOLUTION BIOL, V25, P20, DOI 10.1111/j.1420-9101.2011.02399.x; VLECK CM, 1993, HORM BEHAV, V27, P92, DOI 10.1006/hbeh.1993.1007; von Schantz T, 1999, P ROY SOC B-BIOL SCI, V266, P1, DOI 10.1098/rspb.1999.0597; Walsh N, 2012, P ROY SOC B-BIOL SCI, V279, P58, DOI 10.1098/rspb.2011.0765; Weaver RJ, 2017, PHILOS T R SOC B, V372, DOI 10.1098/rstb.2016.0343; WINGFIELD JC, 1994, ANIM BEHAV, V47, P77, DOI 10.1006/anbe.1994.1009; ZAHAVI A, 1977, J THEOR BIOL, V67, P603, DOI 10.1016/0022-5193(77)90061-3	115	12	12	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2019	14	8							e0221436	10.1371/journal.pone.0221436	http://dx.doi.org/10.1371/journal.pone.0221436			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5TR	31442265	gold, Green Published			2022-12-26	WOS:000485041400033
J	Xi, Y; Li, Q; Gao, N; He, SY; Tang, XY				Xi, Yang; Li, Qi; Gao, Ning; He, Siyuan; Tang, Xiaoyu			Cortical network underlying audiovisual semantic integration and modulation of attention: An fMRI and graph-based study	PLOS ONE			English	Article							SUPERIOR TEMPORAL SULCUS; SENSORY-SPECIFIC CORTICES; MULTISENSORY INTEGRATION; SELECTIVE ATTENTION; SPEECH; KNOWLEDGE; CORTEX; ASSOCIATION; INFORMATION; MECHANISMS	Many neuroimaging and electrophysiology studies have suggested that semantic integration as a high-level cognitive process involves various cortical regions and is modulated by attention. However, the cortical network specific to semantic integration and the modulatory mechanism of attention remain unclear. Here, we designed an fMRI experiment using "bimodal stimulus" to extract information regarding the cortical activation related to the effects of semantic integration with and without attention, and then analyzed the characteristics of the cortical network and the modulating effect of attention on semantic integration. To further investigate the related cortical regions, we constructed a functional brain network for processing attended AV stimuli to evaluate the nodal properties using a graph-based method. The results of the fMRI and graph-based analyses showed that the semantic integration with attention activated the anterior temporal lobe (ATL), temporoparietal junction (TPJ), and frontoparietal cortex, with the ATL showing the highest nodal degree and efficiency; in contrast, semantic integration without attention involved a relatively small cortical network, including the posterior superior temporal gyrus (STG), Heschl's gyrus (HG), and precentral gyrus. These results indicated that semantic integration is a complex cognitive process that occurs not only in the attended condition but also in the unattended condition, and that attention could modulate the distribution of cortical networks related to semantic integration. We suggest that semantic integration with attention is a conscious process and needs a wide cortical network working together, in which the ATL plays the role of a central hub; in contrast, semantic integration without attention is a pre-attentive process and involves a relatively smaller cortical network, in which the HG may play an important role. Our study will provide valuable insights into semantic integration and will be useful for investigations on multisensory integration and attention mechanism at multiple processing stages and levels within the cortical hierarchy.	[Xi, Yang; Li, Qi; Gao, Ning; He, Siyuan] Changchun Univ Sci & Technol, Sch Comp Sci & Technol, Changchun, Jilin, Peoples R China; [Xi, Yang] Northeast Elect Power Univ, Sch Comp Sci, Jilin, Jilin, Peoples R China; [Tang, Xiaoyu] Liaoning Normal Univ, Sch Psychol, Dalian, Liaoning, Peoples R China	Changchun University of Science & Technology; Northeast Electric Power University; Liaoning Normal University	Li, Q (corresponding author), Changchun Univ Sci & Technol, Sch Comp Sci & Technol, Changchun, Jilin, Peoples R China.	liqi@cust.edu.cn			National Natural Science Foundation of China [61773076, 61806025, 31600882]; Jilin Scientific and Technological Development Program [20190302072GX, 20180519012JH]; Scientific Research Project of Jilin Provincial Department of Education during the 13th Five-Year Plan Period [JJKH20190597KJ]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jilin Scientific and Technological Development Program; Scientific Research Project of Jilin Provincial Department of Education during the 13th Five-Year Plan Period	This work was financially supported by the National Natural Science Foundation of China (grant numbers 61773076, 61806025 and 31600882), Jilin Scientific and Technological Development Program (grant numbers 20190302072GX and 20180519012JH), and Scientific Research Project of Jilin Provincial Department of Education during the 13th Five-Year Plan Period (grant number JJKH20190597KJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beauchamp MS, 2004, NEURON, V41, P809, DOI 10.1016/S0896-6273(04)00070-4; Binder JR, 2011, TRENDS COGN SCI, V15, P527, DOI 10.1016/j.tics.2011.10.001; Binney RJ, 2012, J COGNITIVE NEUROSCI, V24, P1998, DOI 10.1162/jocn_a_00263; Burdette JH, 2010, FRONT AGING NEUROSCI, V2, DOI 10.3389/fnagi.2010.00023; Calvert GA, 2000, CURR BIOL, V10, P649, DOI 10.1016/S0960-9822(00)00513-3; Calvert GA, 1999, NEUROREPORT, V10, P2619, DOI 10.1097/00001756-199908200-00033; Chiou R, 2019, NEUROIMAGE, V199, P114, DOI 10.1016/j.neuroimage.2019.05.059; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Deco G, 2004, VISION RES, V44, P621, DOI 10.1016/j.visres.2003.09.037; Driver J, 2008, NEURON, V57, P11, DOI 10.1016/j.neuron.2007.12.013; Duncan J, 2013, NEURON, V80, P35, DOI 10.1016/j.neuron.2013.09.015; Garcia AM, 2019, NEUROIMAGE, V197, P439, DOI 10.1016/j.neuroimage.2019.05.002; Hernaandez M, 2019, BRAIN LANG, V194, P12, DOI 10.1016/j.bandl.2019.03.003; Horn A, 2014, NEUROIMAGE, V102, P142, DOI 10.1016/j.neuroimage.2013.09.069; Huang J, 2018, NEUROPSYCHOLOGY, V32, P329, DOI 10.1037/neu0000393; Jackson RL, 2015, CEREB CORTEX, V25, P4319, DOI 10.1093/cercor/bhv003; Kayser C, 2008, CEREB CORTEX, V18, P1560, DOI 10.1093/cercor/bhm187; Lakatos P, 2007, NEURON, V53, P279, DOI 10.1016/j.neuron.2006.12.011; Laurienti PJ, 2003, HUM BRAIN MAPP, V19, P213, DOI 10.1002/hbm.10112; Laurienti PJ, 2002, J COGNITIVE NEUROSCI, V14, P420, DOI 10.1162/089892902317361930; Li Q, 2017, NEUROREPORT, V28, P63, DOI 10.1097/WNR.0000000000000719; Li YQ, 2016, SCI REP-UK, V6, DOI 10.1038/srep18914; Liu Y, 2011, APPL MECH MATER, V69, P6, DOI 10.4028/www.scientific.net/AMM.69.6; Mahon BZ, 2008, J PHYSIOL-PARIS, V102, P59, DOI 10.1016/j.jphysparis.2008.03.004; Meredith MA, 1996, J NEUROPHYSIOL, V75, P1843, DOI 10.1152/jn.1996.75.5.1843; Meyer GF, 2011, J COGNITIVE NEUROSCI, V23, P2291, DOI 10.1162/jocn.2010.21593; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Mirman D, 2017, PSYCHOL BULL, V143, P499, DOI 10.1037/bul0000092; Naghavi HR, 2011, NEUROSCI LETT, V505, P191, DOI 10.1016/j.neulet.2011.10.022; Naumer MJ, 2009, CEREB CORTEX, V19, P1641, DOI 10.1093/cercor/bhn200; Noesselt T, 2010, J NEUROSCI, V30, P13609, DOI 10.1523/JNEUROSCI.4524-09.2010; Okada K, 2009, NEUROSCI LETT, V452, P219, DOI 10.1016/j.neulet.2009.01.060; Patterson K, 2007, NAT REV NEUROSCI, V8, P976, DOI 10.1038/nrn2277; Plank T, 2012, HUM BRAIN MAPP, V33, P797, DOI 10.1002/hbm.21254; Pobric G, 2010, CURR BIOL, V20, P964, DOI 10.1016/j.cub.2010.03.070; Pobric G, 2010, NEUROPSYCHOLOGIA, V48, P1336, DOI 10.1016/j.neuropsychologia.2009.12.036; Ralph MAL, 2017, NAT REV NEUROSCI, V18, P42, DOI 10.1038/nrn.2016.150; Ralph MAL, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2012.0392; Ralph MAL, 2010, P NATL ACAD SCI USA, V107, P2717, DOI 10.1073/pnas.0907307107; Rauschecker JP, 2009, NAT NEUROSCI, V12, P718, DOI 10.1038/nn.2331; Relander K, 2009, J COGNITIVE NEUROSCI, V21, P1511, DOI 10.1162/jocn.2009.21127; Rogers TT, 2007, NEUROPSYCHOLOGIA, V45, P3285, DOI 10.1016/j.neuropsychologia.2007.06.020; Sadaghiani S, 2009, J NEUROSCI, V29, P6490, DOI 10.1523/JNEUROSCI.5437-08.2009; Schroeder CE, 2003, INT J PSYCHOPHYSIOL, V50, P5, DOI 10.1016/S0167-8760(03)00120-X; Schwartz MF, 2011, P NATL ACAD SCI USA, V108, P8520, DOI 10.1073/pnas.1014935108; Stevenson RA, 2007, EXP BRAIN RES, V179, P85, DOI 10.1007/s00221-006-0770-6; Stevenson RA, 2009, NEUROIMAGE, V44, P1210, DOI 10.1016/j.neuroimage.2008.09.034; Talsma D, 2005, J COGNITIVE NEUROSCI, V17, P1098, DOI 10.1162/0898929054475172; Talsma D, 2007, CEREB CORTEX, V17, P679, DOI 10.1093/cercor/bhk016; Talsma D, 2010, TRENDS COGN SCI, V14, P400, DOI 10.1016/j.tics.2010.06.008; Van der Burg E, 2008, J EXP PSYCHOL HUMAN, V34, P1053, DOI 10.1037/0096-1523.34.5.1053; Van der Burg E, 2009, NEUROSCI LETT, V450, P60, DOI 10.1016/j.neulet.2008.11.002; Weibel S, 2013, CONSCIOUS COGN, V22, P517, DOI 10.1016/j.concog.2013.02.010; Werner S, 2010, CEREB CORTEX, V20, P1829, DOI 10.1093/cercor/bhp248; Werner S, 2010, J NEUROSCI, V30, P2662, DOI 10.1523/JNEUROSCI.5091-09.2010; Whitfield-Gabrieli S, 2012, BRAIN CONNECT, V2, P125, DOI 10.1089/brain.2012.0073; Wu K, 2019, INT J NEUROSCI, V129, P882, DOI 10.1080/00207454.2019.1581189; Ye Z, 2017, NEUROSCIENCE, V356, P1, DOI 10.1016/j.neuroscience.2017.05.017; Zhang Y, 2019, BRAIN LANG, V194, P23, DOI 10.1016/j.bandl.2019.04.001; Zhou FA, 2012, ATTEN PERCEPT PSYCHO, V74, P105, DOI 10.3758/s13414-011-0221-8; Zuo XN, 2012, CEREB CORTEX, V22, P1862, DOI 10.1093/cercor/bhr269	61	5	5	3	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2019	14	8							e0221185	10.1371/journal.pone.0221185	http://dx.doi.org/10.1371/journal.pone.0221185			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5TR	31442242	gold, Green Published, Green Submitted			2022-12-26	WOS:000485041400025
J	Zhang, Y; Huo, W; Wen, Y; Li, H				Zhang, Yun; Huo, Wei; Wen, Yan; Li, Hai			Silencing Nogo-B receptor inhibits penile corpus cavernosum vascular smooth muscle cell apoptosis of rats with diabetic erectile dysfunction by down-regulating ICAM-1	PLOS ONE			English	Article							ADHESION MOLECULE-1 ICAM-1; PROTEIN; CANCER; ACTIVATION; EXPRESSION; TADALAFIL; THERAPY; PYK2	Erectile dysfunction (ED) is a major sexual problem for men. Nogo-B receptor (NgBR) has been found to be involved in the regulation of vascular remodeling and angiogenesis. The present study explores the effects of NgBR in penile corpus cavernosum in rats with diabetic ED. Firstly, the ED model of Sprague Dawley rats was established. Hematoxylin-eosin staining and Masson staining were conducted to observe pathological morphology. Immunochemical assay was adopted to detect alpha-smooth muscle actin (alpha-SMA), NgBR and intercellular cell adhesion molecule-1 (ICAM-1) expression. Reverse transcription quantitative polymerase chain reaction assay and Western blot analysis were carried out for the assessment of NgBR, factors correlated to ICAM-1, including steroid receptor coactivator (SRC) and proline-rich tyrosine kinase2 (PYK2), and factors associated with apoptosis, including B-cell lymphoma-2 (Bcl-2), Bcl-2 associated protein X (Bax), caspase 3 and cleaved-caspase 3. The results found that capillaries and vascular smooth muscle cell content reduced, and NgBR and ICAM-1 were elevated in rats with diabetic ED. si-NgBR relieved ED by decreasing penile corpus cavernosum smooth muscle systolic percentage and increasing erectile time and rate, intracavernous pressure (ICP)/mean arterial pressure (MAP) and diastolic percentage, improving the pathological changes and inhibiting cavernosum cell apoptosis. si-NgBR also resulted in the down-regulation of ICAM-1 and downstream SRC and PYK2 and promoted alpha-SMA expression. In conclusion, si-NgBR can provide a potential therapy for diabetic ED in rats by down-regulating ICAM-1, SRC and PYK2, making it a potential therapeutic option for diabetic ED.	[Zhang, Yun; Huo, Wei; Li, Hai] Jilin Univ, China Japan Union Hosp, Dept Urol, Changchun, Jilin, Peoples R China; [Wen, Yan] Jilin Univ, China Japan Union Hosp, Dept Endocrine, Changchun, Jilin, Peoples R China	Jilin University; Jilin University	Li, H (corresponding author), Jilin Univ, China Japan Union Hosp, Dept Urol, Changchun, Jilin, Peoples R China.	muandkamu_2012@aliyun.com		Li, Hai/0000-0002-0485-4981	Department of Science and Technology of Jilin Province [20190201045JC]	Department of Science and Technology of Jilin Province	This study was supported by the Department of Science and Technology of Jilin Province (Grant No. 20190201045JC). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allingham MJ, 2007, J IMMUNOL, V179, P4053, DOI 10.4049/jimmunol.179.6.4053; Aversa A, 2007, INT J IMPOT RES, V19, P200, DOI 10.1038/sj.ijir.3901513; Burchardt M, 2005, UROLOGY, V66, P665, DOI 10.1016/j.urology.2005.03.058; Chen Y, 2012, ASIAN J ANDROL, V14, P616, DOI 10.1038/aja.2012.22; Compostella L, 2017, EUR J PREV CARDIOL, V24, P460, DOI 10.1177/2047487316686434; Di Lorenzo A, 2011, BLOOD, V117, P2284, DOI 10.1182/blood-2010-04-281956; Eckharter C, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00454; Francis SH, 2008, INT J IMPOT RES, V20, P333, DOI 10.1038/ijir.2008.4; Jin Y, 2018, CANCER LETT, V419, P233, DOI 10.1016/j.canlet.2018.01.054; Kim I, 2001, J BIOL CHEM, V276, P7614, DOI 10.1074/jbc.M009705200; Kouidrat Y, 2017, DIABETIC MED, V34, P1185, DOI 10.1111/dme.13403; Long SL, 2017, DNA CELL BIOL, V36, P1142, DOI 10.1089/dna.2017.3813; Magee TR, 2007, J SEX MED, V4, P633, DOI 10.1111/j.1743-6109.2007.00459.x; Maiorino MI, 2018, J ENDOCRINOL INVEST, V41, P1249, DOI 10.1007/s40618-018-0872-6; Miao RQ, 2006, P NATL ACAD SCI USA, V103, P10997, DOI 10.1073/pnas.0602427103; Patel JP, 2017, CURR CARDIOL REP, V19, DOI 10.1007/s11886-017-0889-z; Patel JP, 2016, REPROD HLTH, V13, P140, DOI [10.1007/s11886-017-0889-z, DOI 10.1007/S11886-017-0889-Z]; Roskoski R, 2015, PHARMACOL RES, V94, P9, DOI 10.1016/j.phrs.2015.01.003; Ryu JK, 2013, J UROLOGY, V190, P779, DOI 10.1016/j.juro.2013.02.100; Sahin TD, 2018, CAN J PHYSIOL PHARM, V96, P933, DOI 10.1139/cjpp-2017-0778; Sahin TD, 2018, CAN J PHYSIOL PHARM, V96, P200, DOI 10.1139/cjpp-2017-0113; Seid A, 2017, BMC ENDOCR DISORD, V17, DOI 10.1186/s12902-017-0167-5; Sun C, 2012, INT J ANDROL, V35, P601, DOI 10.1111/j.1365-2605.2012.01250.x; Suzuki C, 2017, CLIN IMMUNOL, V179, P17, DOI 10.1016/j.clim.2017.01.013; Teng R. J, 2014, RECEPTORS CLIN INVES, V1, pe144; Teng RJ, 2014, AM J RESP CELL MOL, V51, P169, DOI 10.1165/rcmb.2013-0298OC; Usami Y, 2013, INT J CANCER, V133, P568, DOI 10.1002/ijc.28066; Wang B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078083; Wang HZ, 2017, DEV BIOL, V428, P52, DOI 10.1016/j.ydbio.2017.05.016; Wespes E, 2002, INT J IMPOT RES, V14, pS17, DOI 10.1038/sj.ijir.3900792; Wu DH, 2018, CANCER LETT, V418, P135, DOI 10.1016/j.canlet.2018.01.030; Yang R, 2008, J ANDROL, V29, P586, DOI 10.2164/jandrol.107.004721; Zhang Y, 2018, CELL PHYSIOL BIOCHEM, V45, P419, DOI 10.1159/000486919; Zhang Z, 2019, ENDOCRINE, V63, P615, DOI 10.1007/s12020-018-1810-2; Zheng H, 2011, MED HYPOTHESES, V77, P278, DOI 10.1016/j.mehy.2011.04.035; Zhu Y, 2017, CELL PHYSIOL BIOCHEM, V41, P274, DOI 10.1159/000456094	36	3	4	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2019	14	8							e0220715	10.1371/journal.pone.0220715	http://dx.doi.org/10.1371/journal.pone.0220715			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5TR	31442237	Green Published, Green Submitted, gold			2022-12-26	WOS:000485041400014
J	Zhu, QL; King, GJ; Liu, XY; Shan, N; Borpatragohain, P; Baten, A; Wang, PT; Luo, S; Zhou, QH				Zhu, Qianglong; King, Graham J.; Liu, Xingyue; Shan, Nan; Borpatragohain, Priyakshee; Baten, Abdul; Wang, Putao; Luo, Sha; Zhou, Qinghong			Identification of SNP loci and candidate genes related to four important fatty acid composition in Brassica napus using genome wide association study	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; SEED OIL; OILSEED RAPE; QTL ANALYSIS; LINKAGE MAP; GLUCOSINOLATE; POPULATION; ARCHITECTURE; DIVERSITY; DISCOVERY	Rapeseed oil (canola, Brassica napus L.) is an important healthy vegetable oil throughout the world, the nutritional and economical value of which largely depends on its seed fatty acid composition. In this study, based on 201,187 SNP markers developed from the SLAF-seq (specific locus amplified fragment sequencing), a genome wide association study of four important fatty acid content traits (erucic acid, oleic acid, linoleic acid and linolenic acid) in a panel of 300 inbred lines of rapeseed in two environments (JXAU and JXRIS) was carried out. A total of 148 SNP loci significantly associated with these traits were detected by MLM model analysis respectively, and 30 SNP loci on A08 and C03 chromosomes were detected in three traits of erucic acid, oleic acid and linoleic acid contents simultaneously. Furthermore, 108 highly favorable alleles for increasing oleic acid and linoleic acid content, also for decreasing erucic acid content simultaneously were observed. By a basic local alignment search tool (BLAST) search with in a distance of 100 Kb around these significantly SNP-trait associations, we identified 20 orthologs of the functional candidate genes related to fatty acid biosynthesis, including the known vital fatty acid biosynthesis genes of BnaA. FAE1 and BnaC. FAE1 on the A08 and C03 chromosomes, and other potential candidate genes involving in the fatty acid biosynthesis pathway, such as the orthologs genes of FAD2, LACS09, KCS17, CER4, TT16 and ACBP5. This study lays a basis for uncovering the genetic variations and the improvement of fatty acid composition in B. napus.	[Zhu, Qianglong; Liu, Xingyue; Shan, Nan; Wang, Putao; Luo, Sha; Zhou, Qinghong] Jiangxi Agr Univ, Agron Coll, Minist Educ, Key Lab Crop Physiol Ecol & Genet Breeding, Nanchang, Jiangxi, Peoples R China; [King, Graham J.; Borpatragohain, Priyakshee; Baten, Abdul] Southern Cross Univ, Southern Cross Plant Sci, Lismore, NSW, Australia	Jiangxi Agricultural University; Southern Cross University	Zhou, QH (corresponding author), Jiangxi Agr Univ, Agron Coll, Minist Educ, Key Lab Crop Physiol Ecol & Genet Breeding, Nanchang, Jiangxi, Peoples R China.	qinghongzhou@126.com	BORPATRAGOHAIN, PRIYAKSHEE/AAM-2080-2020; King, Graham J/AAW-3368-2020	BORPATRAGOHAIN, PRIYAKSHEE/0000-0002-9598-5986; King, Graham J/0000-0002-5975-6051; Baten, Abdul/0000-0003-4673-0685; qianglong, zhu/0000-0001-5355-8815	National Science Foundation of China [31860392]	National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Science Foundation of China project "Exploration of SNP loci and vital candidate genes related to Aluminum tolerance of Brassica napus by combining genome-wide association study and RNA-sequencing analysis", project number 31860392. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander DH, 2009, GENOME RES, V19, P1655, DOI 10.1101/gr.094052.109; [Anonymous], 2018, J OPEN SOURCE SOFTW, DOI DOI 10.21105/JOSS.00731; Barker GC, 2007, PLANT PHYSIOL, V144, P1827, DOI 10.1104/pp.107.096172; Bates PD, 2013, CURR OPIN PLANT BIOL, V16, P358, DOI 10.1016/j.pbi.2013.02.015; Baud S, 2010, PROG LIPID RES, V49, P235, DOI 10.1016/j.plipres.2010.01.001; Bonaventure G, 2003, PLANT CELL, V15, P1020, DOI 10.1105/tpc.008946; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Burns MJ, 2003, HEREDITY, V90, P39, DOI 10.1038/sj.hdy.6800176; Carvalho IS, 2006, IND CROP PROD, V24, P75, DOI 10.1016/j.indcrop.2006.03.005; Chen G, 2010, EUPHYTICA, V175, P161, DOI 10.1007/s10681-010-0144-9; CHEN JL, 1990, THEOR APPL GENET, V80, P465, DOI 10.1007/BF00226746; Davey JW, 2011, NAT REV GENET, V12, P499, DOI 10.1038/nrg3012; DAVID E, 2013, THEORETICAL AND APPL, V126, P1, DOI DOI 10.1007/S11032-015-0340-3; Farmer EE, 1998, PLANTA, V206, P167, DOI 10.1007/s004250050388; Fourmann M, 1998, THEOR APPL GENET, V96, P852, DOI 10.1007/s001220050812; GAJARDO HA, 2015, MOL BREEDING, V35, DOI DOI 10.1007/S00122-016-2697-Z; HAIYAN L, 2011, PLOS ONE, V6, P3; Hardy OJ, 2002, MOL ECOL NOTES, V2, P618, DOI 10.1046/j.1471-8286.2002.00305.x; Hasan M, 2008, THEOR APPL GENET, V116, P1035, DOI 10.1007/s00122-008-0733-3; Hu XY, 2006, THEOR APPL GENET, V113, P497, DOI 10.1007/s00122-006-0315-1; Huang JX, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00987; Huang XH, 2014, ANNU REV PLANT BIOL, V65, P531, DOI 10.1146/annurev-arplant-050213-035715; JAMES DW, 1995, PLANT CELL, V7, P309, DOI 10.2307/3869853; JE P, 2008, PLANT MOLECULAR BIOL, V67, P547, DOI DOI 10.2134/AGRONJ2009.0252; Jiang CC, 2014, THEOR APPL GENET, V127, P957, DOI 10.1007/s00122-014-2271-5; JIANYI Z, 2006, THEORETICAL AND APPL, V113, P33, DOI DOI 10.1007/S00122-006-0376-1; Jianyi Z, 2006, CROP SCI, V113, P33, DOI 10.1007/s00122-006-0267-5; Khan F.A., 2015, AM-EURASIAN J AGRIC, V15, P1568, DOI [DOI 10.5829/idosi.aejaes.2015.15.8.12746, 10.5829/idosi.aejaes.2015.15.8.12746]; KOSPACING D, 2016, FRONTIERS IN PLANT S, V7, P7, DOI DOI 10.1111/PCE.12644; LATION, CROP SCI, DOI DOI 10.1146/ANNUREV-ARPLANT-050213-035715; LATION, CROP SCI, DOI DOI 10.1038/SJ.HDY.6800176; LATION, CROP SCI, DOI DOI 10.1093/BIOINFORMATICS/BTM308; Li F, 2014, DNA RES, V21, P355, DOI 10.1093/dnares/dsu002; LI LL, 2015, ENERGY CONSERVATION, V3, P20; Liu S, 2016, THEOR APPL GENET, V129, P1203, DOI 10.1007/s00122-016-2697-z; Lofton J, 2010, AGRON J, V102, P327, DOI 10.2134/agronj2009.0252; Mahmood T, 2006, THEOR APPL GENET, V113, P1211, DOI 10.1007/s00122-006-0376-1; Moreno-Perez AJ, 2012, PLANTA, V235, P629, DOI 10.1007/s00425-011-1534-5; MURRAY MG, 1980, NUCLEIC ACIDS RES, V8, P4321, DOI 10.1093/nar/8.19.4321; OKULEY J, 1994, PLANT CELL, V6, P147, DOI 10.1105/tpc.6.1.147; Qian W, 2006, THEOR APPL GENET, V113, P49, DOI 10.1007/s00122-006-0269-3; Qiu D, 2006, THEOR APPL GENET, V114, P67, DOI 10.1007/s00122-006-0411-2; QU CM, 2017, BMC GENOMICS, V18, DOI DOI 10.1371/JOURNAL.PONE.0119425; Raman H, 2016, PLANT CELL ENVIRON, V39, P1228, DOI 10.1111/pce.12644; RAMAN H, 2014, PUBMED CENTRAL, V7, P6804, DOI DOI 10.1038/NRG3012; Rowland O, 2006, PLANT PHYSIOL, V142, P866, DOI 10.1104/pp.106.086785; Salas JJ, 2002, ARCH BIOCHEM BIOPHYS, V403, P25, DOI 10.1016/S0003-9861(02)00017-6; Scheffler JA, 1997, THEOR APPL GENET, V94, P583, DOI 10.1007/s001220050454; Schierholt A, 2000, THEOR APPL GENET, V101, P897, DOI 10.1007/s001220051559; Shahidi F., 1990, CANOLA AND RAPESEED, P3; Smooker AM, 2011, THEOR APPL GENET, V122, P1075, DOI 10.1007/s00122-010-1512-5; Sun X., 2013, PLOS ONE, V8; Tang QY, 2013, INSECT SCI, V20, P254, DOI 10.1111/j.1744-7917.2012.01519.x; Thelen JJ, 2002, METAB ENG, V4, P12, DOI 10.1006/mben.2001.0204; UNTERGASSER A, 2012, NUCLEIC ACIDS RES, V40, DOI DOI 10.1007/S00122-006-0269-3; UZUNOVA M, 1995, THEOR APPL GENET, V90, P194, DOI 10.1007/BF00222202; Velasco L., 2002, Journal of Crop Production, V5, P309, DOI 10.1300/J144v05n01_13; WANG N, 2016, FRONTIERS IN PLANT S, V7, DOI DOI 10.1371/JOURNAL.PONE.0101673; Wang N, 2008, NEW PHYTOL, V180, P751, DOI 10.1111/j.1469-8137.2008.02619.x; Wen J, 2015, J AM OIL CHEM SOC, V92, P541, DOI 10.1007/s11746-015-2618-3; Wickham H., 2010, J STAT SOFTW, V35, P65, DOI [10.18637/jss.v077.b02, DOI 10.18637/JSS.V077.B02, DOI 10.1080/15366367.2019.1565254]; Wu G, 2008, THEOR APPL GENET, V116, P491, DOI 10.1007/s00122-007-0685-z; Xu JF, 2015, EUPHYTICA, V205, P647, DOI 10.1007/s10681-015-1379-2; Yang QY, 2012, THEOR APPL GENET, V125, P715, DOI 10.1007/s00122-012-1863-1; ZHAO J, OIL; Zhao JY, 2008, MOL BREEDING, V21, P115, DOI 10.1007/s11032-007-9113-y; ZHOU QH, 2017, FRONT PLANT SCI, V8, DOI DOI 10.1111/J.1744-7917.2012.01519.X; Zhou QH, 2018, DNA RES, V25, P229, DOI 10.1093/dnares/dsx052	68	12	13	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2019	14	8							e0221578	10.1371/journal.pone.0221578	http://dx.doi.org/10.1371/journal.pone.0221578			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5TR	31442274	gold, Green Published, Green Submitted			2022-12-26	WOS:000485041400054
J	Larkin, F; Oostenbroek, J; Lee, YJ; Hayward, E; Meins, E				Larkin, Fionnuala; Oostenbroek, Janine; Lee, Yujin; Hayward, Emily; Meins, Elizabeth			Proof of concept of a smartphone app to support delivery of an intervention to facilitate mothers' mind-mindedness	PLOS ONE			English	Article							INFANT ATTACHMENT SECURITY; MATERNAL SENSITIVITY; SOCIOECONOMIC-STATUS; ROLES; AGGRESSION; PREDICTORS; LANGUAGE; LINKS	The present study reports on the first evaluation of a parenting intervention utilizing a smartphone app, BabyMind. The intervention aimed to facilitate mothers' mind-mindedness-attunement to their infants' internal states. Mothers in the intervention group (n = 90) used the BabyMind app from their infants' births and were followed up at age 6 months (n = 66). Mothers in the control group (n = 151) were recruited when their infants were age 6 months and had never used the BabyMind app. Mind-mindedness when interacting with their infants was significantly higher in intervention group mothers than in control group mothers. The intervention was equally effective in facilitating mind-mindedness in young and older mothers. These findings are discussed in terms of the potential for interventions utilizing smartphone apps to improve parenting and children's developmental outcome in vulnerable and hard-to-reach groups.	[Larkin, Fionnuala; Lee, Yujin; Hayward, Emily; Meins, Elizabeth] Univ York, Dept Psychol, York, N Yorkshire, England; [Oostenbroek, Janine] Univ Virginia, Dept Psychol, Gilmer Hall, Charlottesville, VA 22903 USA	University of York - UK; University of Virginia	Meins, E (corresponding author), Univ York, Dept Psychol, York, N Yorkshire, England.	elizabeth.meins@york.ac.uk		Lee, Yujin/0000-0001-7019-9498; Hayward, Emily/0000-0002-2413-0104; Larkin, Fionnuala/0000-0003-3838-9165	Economic and Social Research Council [ES/K010719/1]; ESRC [ES/K010719/1] Funding Source: UKRI	Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	Funded by EM: ES/K010719/1, Economic and Social Research Council. baps://esrc.ukri.org. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful to the following for their help with recruitment: the Research Midwives and Community Midwives at York Teaching Hospitals NHS Foundation Trust, Harrogate and District NHS Foundation Trust, Leeds Teaching Hospital Foundation Trust, Northumbria Healthcare NHS Foundation Trust, and North Tyneside NHS CCG; Health Visitors and Children's Centres staff in the City of York Council, North Yorkshire County Council, and Leeds City Council; the Boulevard Centre in Hull; Gleanna Oland at Baby Sensory York; Acomb Library; Emily Pickard at York Mumbler; and Tiny Tots in Bishopthorpe. We thank Karin Fothergill, Sarah Fitsell, Corinne Lee, and Xuezhen Li for their invaluable contributions to the project, Charles Fernyhough for his helpful comments, and the mothers and infants for their generous participation.	Arnott B, 2007, B MENNINGER CLIN, V71, P132, DOI 10.1521/bumc.2007.71.2.132; Bakermans-Kranenburg MJ, 2003, PSYCHOL BULL, V129, P195, DOI 10.1037/0033-2909.129.2.195; Bernier A, 2017, DEV PSYCHOL, V53, P210, DOI 10.1037/dev0000225; Bigelow AE, 2015, INFANCY, V20, P263, DOI 10.1111/infa.12079; Camoirano A, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.00014; Centifanti LCM, 2016, J CHILD PSYCHOL PSYC, V57, P84, DOI 10.1111/jcpp.12445; Colonnesi C, 2013, RES SOCIAL WORK PRAC, V23, P179, DOI 10.1177/1049731512469301; Coyne CA, 2013, TWIN RES HUM GENET, V16, P679, DOI 10.1017/thg.2013.23; Demers I, 2010, INT J BEHAV DEV, V34, P529, DOI 10.1177/0165025410365802; Eyberg SM, 2008, J CLIN CHILD ADOLESC, V37, P215, DOI 10.1080/15374410701820117; Goldsmith H. H., 1996, TECHNICAL MANUAL; Gravenhorst F, 2015, PERS UBIQUIT COMPUT, V19, P335, DOI 10.1007/s00779-014-0829-5; Hall D., 2007, DCSFRW022; Hay DF, 2014, DEVELOPMENTAL SCI, V17, P471, DOI 10.1111/desc.12133; Hay DF, 2010, AGGRESSIVE BEHAV, V36, P351, DOI 10.1002/ab.20363; Kirk E, 2015, BRIT J DEV PSYCHOL, V33, P434, DOI 10.1111/bjdp.12104; Laranjo J, 2013, EARLY CHILD DEV CARE, V183, P951, DOI 10.1080/03004430.2012.699964; Laranjo J, 2014, J EXP CHILD PSYCHOL, V125, P48, DOI 10.1016/j.jecp.2014.02.005; Laranjo J, 2010, INFANCY, V15, P300, DOI 10.1111/j.1532-7078.2009.00014.x; Laranjo J, 2008, INFANT BEHAV DEV, V31, P688, DOI 10.1016/j.infbeh.2008.04.008; Lundy BL, 2003, INFANT BEHAV DEV, V26, P200, DOI 10.1016/S0163-6383(03)00017-1; McMahon C, 2016, INFANT MENT HEALTH J, V37, P17, DOI 10.1002/imhj.21548; McMahon CA, 2017, DEV REV, V46, P54, DOI 10.1016/j.dr.2017.07.001; Meins E, 2002, CHILD DEV, V73, P1715, DOI 10.1111/1467-8624.00501; Meins E, 2001, J CHILD PSYCHOL PSYC, V42, P637, DOI 10.1111/1469-7610.00759; Meins E., 2015, MIND MINDEDNESS CODI; Meins E., 1997, SECURITY ATTACHMENT; Meins E, 2019, CHILD DEV, V90, pE454, DOI 10.1111/cdev.13028; Meins E, 2018, CHILD DEV, V89, P1022, DOI 10.1111/cdev.12778; Meins E, 2013, CHILD DEV, V84, P1777, DOI 10.1111/cdev.12061; Meins E, 2013, J ABNORM CHILD PSYCH, V41, P543, DOI 10.1007/s10802-012-9699-3; Meins E, 2012, INFANCY, V17, P393, DOI 10.1111/j.1532-7078.2011.00087.x; Meins E, 2011, INFANCY, V16, P137, DOI 10.1111/j.1532-7078.2010.00039.x; Mollborn S, 2012, POPUL RES POLICY REV, V31, P31, DOI 10.1007/s11113-011-9218-1; National Institute for Health and Care Excellent (NICE), 2010, MOD SERV PROV PREGN; Rich-Edwards JW, 2006, J EPIDEMIOL COMMUN H, V60, P221, DOI 10.1136/jech.2005.039370; Schacht R, 2017, DEV PSYCHOPATHOL, V29, P555, DOI 10.1017/S0954579417000177; Sirin SR, 2005, REV EDUC RES, V75, P417, DOI 10.3102/00346543075003417; Slade A, 2006, PSYCHOANAL INQ, V26, P640, DOI 10.1080/07351690701310698; Tripp N, 2014, WOMEN BIRTH, V27, P64, DOI 10.1016/j.wombi.2013.11.001; van Oort FVA, 2011, SOC PSYCH PSYCH EPID, V46, P167, DOI 10.1007/s00127-010-0191-5; Waters CS, 2014, PERINATAL PSYCHIAT L, P175	42	19	19	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2019	14	8							e0220948	10.1371/journal.pone.0220948	http://dx.doi.org/10.1371/journal.pone.0220948			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW5RZ	31437173	Green Published, Green Accepted, gold, Green Submitted			2022-12-26	WOS:000485036900022
J	Lindgren, A; Anttila, M; Rautiainen, S; Arponen, O; Hamalainen, K; Kononen, M; Vanninen, R; Sallinen, H				Lindgren, Auni; Anttila, Maarit; Rautiainen, Suvi; Arponen, Otso; Hamalainen, Kirsi; Kononen, Mervi; Vanninen, Ritva; Sallinen, Hanna			Dynamic contrast-enhanced perfusion parameters in ovarian cancer: Good accuracy in identifying high HIF-1 alpha expression	PLOS ONE			English	Article							PROGNOSTIC VALUE; CERVICAL-CANCER; MICROVESSEL DENSITY; GENE-EXPRESSION; HYPOXIA; MRI; ANGIOGENESIS; HYPOXIA-INDUCIBLE-FACTOR-1-ALPHA; CARCINOMA; HIF-1	Background Hypoxia significantly influences treatment response and clinical outcome in solid tumors. A noninvasive marker for hypoxia will help physicians in treatment planning and encourage the efficient use of hypoxia targeted therapies. The purpose of this study was to investigate whether pharmacokinetic dynamic contrast-enhanced (DCE) perfusion parameters are associated with a specific marker of hypoxia, hypoxia-inducible factor 1 alpha (HIF-1 alpha) in ovarian cancer (OC). Materials and methods Thirty-eight patients with primary OC were enrolled in this prospective study approved by the local ethical committee. Patients underwent dynamic gadolinium-enhanced 3.0 T MRI as part of their staging investigations. Pharmacokinetic perfusion parameters, including a rate constant for transfer of contrast agent from plasma to extravascular extracellular space (EES) (K-trans) and a rate constant from EES to plasma (K-ep), were measured by drawing two types of regions of interest (ROIs): a large solid lesion (L-ROI) and a solid, most enhancing small area (S-ROI) (NordicICE platform). Tissue samples for immunohistochemical analysis were collected during surgery. Kruskal Wallis, Mann Whitney U and Chi-square tests were used in statistical analyses. Receiver Operating Characteristic curve analyzes were done for DCE parameters to discriminate high HIF-1 alpha expression. Results Pharmacokinetic perfusion parameters K-trans and K-ep were inversely associated with HIF-1 alpha expression (K-trans L-ROI P = 0.021; K-trans S-ROI P = 0.018 and K-ep L-ROI P = 0.032; K-ep S-ROI P = 0.033). K-trans and K-ep showed good accuracy in identifying high HIF-1 alpha expression (AUC = 0.832 K-trans L-ROI; 0.840 K-trans S-ROI; 0.808 K-ep L-ROI and 0.808 K-ep L-ROI). Conclusion This preliminary study demonstrated that pharmacokinetic DCE-MRI perfusion parameters are associated with the hypoxia specific marker, HIF-1 alpha in OC. DCE-MRI may be a useful supplementary tool in the characterization of OC tumors in a staging investigation.	[Lindgren, Auni; Anttila, Maarit] Univ Eastern Finland, Fac Hlth Sci, Sch Med, Inst Clin Med Obstet & Gynecol, Kuopio, Finland; [Anttila, Maarit; Sallinen, Hanna] Kuopio Univ Hosp, Dept Obstet & Gynecol, Kuopio, Finland; [Anttila, Maarit; Vanninen, Ritva] Univ Eastern Finland, Canc Ctr Eastern Finland, Kuopio, Finland; [Rautiainen, Suvi; Arponen, Otso; Kononen, Mervi; Vanninen, Ritva] Kuopio Univ Hosp, Dept Clin Radiol, Kuopio, Finland; [Hamalainen, Kirsi] Kuopio Univ Hosp, Dept Clin Pathol & Forens Med, Kuopio, Finland; [Hamalainen, Kirsi] Univ Eastern Finland, Fac Hlth Sci, Sch Med, Inst Clin Med Pathol & Forens Med, Kuopio, Finland; [Kononen, Mervi] Kuopio Univ Hosp, Dept Clin Neurophysiol, Kuopio, Finland; [Vanninen, Ritva] Univ Eastern Finland, Fac Hlth Sci, Sch Med, Inst Clin Med,Clin Radiol, Kuopio, Finland	University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland; University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland; University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland; University of Eastern Finland	Lindgren, A (corresponding author), Univ Eastern Finland, Fac Hlth Sci, Sch Med, Inst Clin Med Obstet & Gynecol, Kuopio, Finland.	auni.lehikoinen@gmail.com		Kononen, Mervi/0000-0002-9622-2796; Lindgren, Auni/0000-0002-3765-6738	Instrumentarium Science Foundation; Finnish Cultural Foundation; Kuopio University Hospital Research Foundation; Finnish Medical Foundation; Kuopio University Hospital (VTR grant)	Instrumentarium Science Foundation; Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science); Kuopio University Hospital Research Foundation; Finnish Medical Foundation; Kuopio University Hospital (VTR grant)	This work was supported by: AL: The Instrumentarium Science Foundation; AL: The Finnish Cultural Foundation; AL: The Kuopio University Hospital Research Foundation; AL: The Finnish Medical Foundation; HS: The Finnish Medical Foundation and Kuopio University Hospital (VTR grant). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Awasthi R, 2012, NEURORADIOLOGY, V54, P205, DOI 10.1007/s00234-011-0874-y; Berg A, 2016, ONCOTARGET, V7, P69844, DOI 10.18632/oncotarget.12004; Bhattarai D, 2018, MED RES REV, V38, P1404, DOI 10.1002/med.21477; Borren A, 2013, ONCOL REP, V29, P2249, DOI 10.3892/or.2013.2392; BRIX G, 1991, J COMPUT ASSIST TOMO, V15, P621, DOI 10.1097/00004728-199107000-00018; Chen J, 2016, MAGN RESON IMAGING, V34, P177, DOI 10.1016/j.mri.2015.10.013; Cuenod C A, 2013, Diagn Interv Imaging, V94, P1187, DOI 10.1016/j.diii.2013.10.010; Daponte A, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-335; Desir S, 2016, ONCOTARGET, V7, P43150, DOI 10.18632/oncotarget.9504; Dickie BR, 2017, BRIT J CANCER, V116, P1436, DOI 10.1038/bjc.2017.121; Engels K, 2007, J PATHOL, V211, P532, DOI 10.1002/path.2134; Escuin D, 2005, CANCER RES, V65, P9021, DOI 10.1158/0008-5472.CAN-04-4095; Falchook GS, 2014, ONCOTARGET, V5, P10280, DOI 10.18632/oncotarget.2163; FOX SB, 1995, J PATHOL, V177, P275, DOI 10.1002/path.1711770310; George ML, 2001, BRIT J SURG, V88, P1628, DOI 10.1046/j.0007-1323.2001.01947.x; Halle C, 2012, CANCER RES, V72, P5285, DOI 10.1158/0008-5472.CAN-12-1085; Jensen RL, 2014, NEURO-ONCOLOGY, V16, P280, DOI 10.1093/neuonc/not148; Jiang H, 2006, INT J GYNECOL CANCER, V16, P405, DOI 10.1111/j.1525-1438.2006.00310.x; Kawashima H, 2017, ACAD RADIOL, V24, P1575, DOI 10.1016/j.acra.2017.06.016; Keith B, 2012, NAT REV CANCER, V12, P9, DOI 10.1038/nrc3183; Kuhl CK, 1999, RADIOLOGY, V211, P101, DOI 10.1148/radiology.211.1.r99ap38101; Laughner E, 2001, MOL CELL BIOL, V21, P3995, DOI 10.1128/MCB.21.12.3995-4004.2001; Ledermann JA, 2013, ANN ONCOL, V24, P24, DOI 10.1093/annonc/mdt333; Lee K, 2009, P NATL ACAD SCI USA, V106, P2353, DOI 10.1073/pnas.0812801106; Lindgren A, 2019, EUR J RADIOL, V115, P66, DOI 10.1016/j.ejrad.2019.03.023; Liu YV, 2007, MOL CELL, V25, P207, DOI 10.1016/j.molcel.2007.01.001; Loncaster JA, 2002, INT J RADIAT ONCOL, V54, P759, DOI 10.1016/S0360-3016(02)02972-3; Masoud GN, 2015, ACTA PHARM SIN B, V5, P378, DOI 10.1016/j.apsb.2015.05.007; Mayr NA, 1996, INT J RADIAT ONCOL, V36, P623, DOI 10.1016/S0360-3016(97)85090-0; Moroney J, 2012, CLIN CANCER RES, V18, P5796, DOI 10.1158/1078-0432.CCR-12-1158; Nakayama K, 2002, CANCER LETT, V176, P215, DOI 10.1016/S0304-3835(01)00762-5; Osada R, 2007, HUM PATHOL, V38, P1310, DOI 10.1016/j.humpath.2007.02.010; OVERGAARD J, 1994, ONCOL RES, V6, P509; Semenza GL, 1999, ANNU REV CELL DEV BI, V15, P551, DOI 10.1146/annurev.cellbio.15.1.551; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Shin DH, 2008, BLOOD, V111, P3131, DOI 10.1182/blood-2007-11-120576; Thomassin-Naggara I, 2012, EUR RADIOL, V22, P738, DOI 10.1007/s00330-011-2329-6; TOFTS PS, 1995, MAGN RESON MED, V33, P564, DOI 10.1002/mrm.1910330416; Torre LA, 2018, CA-CANCER J CLIN, V68, P284, DOI 10.3322/caac.21456; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; Wegner CS, 2017, ACTA ONCOL, V56, P1754, DOI 10.1080/0284186X.2017.1343494; Wilson WR, 2011, NAT REV CANCER, V11, P393, DOI 10.1038/nrc3064; Xie Q, 2018, RADIOLOGY, DOI [10.1016/j.acra.2018.04.015, DOI 10.1016/J.ACRA.2018.04.015]; Zahra MA, 2007, LANCET ONCOL, V8, P63, DOI 10.1016/S1470-2045(06)71012-9; Zahra MA, 2009, INT J RADIAT ONCOL, V74, P766, DOI 10.1016/j.ijrobp.2008.08.023; Zhong H, 2001, EXP ONCOL, V23, P88	46	11	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2019	14	8							e0221340	10.1371/journal.pone.0221340	http://dx.doi.org/10.1371/journal.pone.0221340			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5RZ	31437208	Green Published, Green Submitted, gold			2022-12-26	WOS:000485036900052
J	Seki, M; Furukawa, N; Koitabashi, N; Obokata, M; Conway, SJ; Arakawa, H; Kurabayashi, M				Seki, Mitsuru; Furukawa, Nozomi; Koitabashi, Norimichi; Obokata, Masaru; Conway, Simon J.; Arakawa, Hirokazu; Kurabayashi, Masahiko			Periostin-expressing cell-specific transforming growth factor-beta inhibition in pulmonary artery prevents pulmonary arterial hypertension	PLOS ONE			English	Article							BONE MORPHOGENETIC PROTEIN; OSTEOBLAST-SPECIFIC FACTOR; SMOOTH-MUSCLE-CELLS; TGF-BETA; RECEPTOR; PROLIFERATION; PROGRESSION; MUTATIONS	Transforming growth factor beta (TGF-beta) has been shown to play a critical role in pathogenesis of pulmonary arterial hypertension (PAH) although the precise role of TGF-beta signaling remains uncertain. A recent report has shown that periostin (Pn) is one of the most upregulated proteins in human PAH lung compared with healthy lungs. We established type I TGF-beta receptor knockout mice specifically with Pn expressing cell (Pn-Cre/Tgfb1(fl/fl) mice). Increases in PA pressure and pulmonary artery muscularization were induced by hypoxia of 10% oxygen for 4 weeks. Lung Pn expression was markedly induced by 4 week-hypoxia. Pn-Cre/Tgfb1(fl/fl) mice showed lower right ventricular pressure elevation, inhibition of PA medial thickening. Fluorescent co-immunostaining showed that Smad3 activation in Pn expressing cell is attenuated. These results suggest that TGF-beta signaling in Pn expressing cell may have an important role in the pathogenesis of PAH by controlling medial thickening.	[Seki, Mitsuru; Arakawa, Hirokazu] Gunma Univ, Grad Sch Med, Dept Pediat, Maebashi, Gunma, Japan; [Seki, Mitsuru; Furukawa, Nozomi; Koitabashi, Norimichi; Obokata, Masaru; Kurabayashi, Masahiko] Gunma Univ, Grad Sch Med, Dept Cardiovasc Med, Maebashi, Gunma, Japan; [Seki, Mitsuru] Jichi Med Univ, Dept Pediat, Shimotsuke, Tochigi, Japan; [Conway, Simon J.] Indiana Univ Sch Med, Herman B Wells Ctr Pediat Res, Indianapolis, IN 46202 USA	Gunma University; Gunma University; Jichi Medical University; Indiana University System; Indiana University Bloomington	Koitabashi, N (corresponding author), Gunma Univ, Grad Sch Med, Dept Cardiovasc Med, Maebashi, Gunma, Japan.	norikoitabashi@gmail.com	Koitabashi, Norimichi/AAM-8788-2020	Obokata, Masaru/0000-0002-5473-0688	Japan Society for the Promotion of Science; NOVARTIS Foundation (Japan) for the Promotion of Science/Japan Heart Foundation; National Institutes of Health [HL135657]; Takeda Science Foundation	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NOVARTIS Foundation (Japan) for the Promotion of Science/Japan Heart Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Takeda Science Foundation(Takeda Science Foundation (TSF))	This work was supported in part by a Grant -in -Aid for Scientific Research from the Japan Society for the Promotion of Science (to M.K. and N.K.), a grant from the NOVARTIS Foundation (Japan) for the Promotion of Science/Japan Heart Foundation (to N.K.), National Institutes of Health grant HL135657 (S.J.C.) and a grant from Takeda Science Foundation (to N.K.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul-Salam VB, 2010, CIRCULATION, V122, P2058, DOI 10.1161/CIRCULATIONAHA.110.972745; Ashley SL, 2017, MUCOSAL IMMUNOL, V10, P341, DOI 10.1038/mi.2016.61; Bao SD, 2004, CANCER CELL, V5, P329, DOI 10.1016/S1535-6108(04)00081-9; Conway SJ, 2014, CELL MOL LIFE SCI, V71, P1279, DOI 10.1007/s00018-013-1494-y; Conway SJ, 2008, CURR GENOMICS, V9, P548, DOI 10.2174/138920208786847917; Davie NJ, 2004, AM J PHYSIOL-LUNG C, V286, pL668, DOI 10.1152/ajplung.00108.2003; Davies RJ, 2012, AM J PHYSIOL-LUNG C, V302, pL604, DOI 10.1152/ajplung.00309.2011; Deng ZM, 2000, AM J HUM GENET, V67, P737, DOI 10.1086/303059; Frid MG, 2002, CIRC RES, V90, P1189, DOI 10.1161/01.RES.0000021432.70309.28; Gaine SP, 1998, LANCET, V352, P719, DOI 10.1016/S0140-6736(98)02111-4; Gyorfi AH, 2018, MATRIX BIOL, V68-69, P8, DOI 10.1016/j.matbio.2017.12.016; Horiuchi K, 1999, J BONE MINER RES, V14, P1239, DOI 10.1359/jbmr.1999.14.7.1239; Humbert M, 2004, J AM COLL CARDIOL, V43, p13S, DOI 10.1016/j.jacc.2004.02.029; Jones PL, 1997, AM J PATHOL, V150, P1349; Koitabashi N, 2011, J CLIN INVEST, V121, P2301, DOI 10.1172/JCI44824; Kruzynska-Frejtag A, 2001, MECH DEVELOP, V103, P183, DOI 10.1016/S0925-4773(01)00356-2; Lane KB, 2000, NAT GENET, V26, P81, DOI 10.1038/79226; Larsson J, 2001, EMBO J, V20, P1663, DOI 10.1093/emboj/20.7.1663; Li GH, 2006, ATHEROSCLEROSIS, V188, P292, DOI 10.1016/j.atherosclerosis.2005.11.002; Li P, 2004, J APPL PHYSIOL, V97, P1550, DOI 10.1152/japplphysiol.01311.2003; Li P, 2007, J APPL PHYSIOL, V102, P390, DOI 10.1152/japplphysiol.00468.2006; Long L, 2009, CIRCULATION, V119, P566, DOI 10.1161/CIRCULATIONAHA.108.821504; Morrell NW, 2001, CIRCULATION, V104, P790, DOI 10.1161/hc3201.094152; Naik PK, 2012, AM J PHYSIOL-LUNG C, V303, pL1046, DOI 10.1152/ajplung.00139.2012; Norris RA, 2007, J CELL BIOCHEM, V101, P695, DOI 10.1002/jcb.21224; Oka T, 2007, CIRC RES, V101, P313, DOI 10.1161/CIRCRESAHA.107.149047; Omura J, 2016, CIRC RES, V119, P197, DOI 10.1161/CIRCRESAHA.115.308178; Passman JN, 2008, P NATL ACAD SCI USA, V105, P9349, DOI 10.1073/pnas.0711382105; Pegorier S, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-85; Rabinovitch M, 2012, J CLIN INVEST, V122, P4306, DOI 10.1172/JCI60658; Sakao S, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-95; Satoh K, 2014, CIRC RES, V115, P738, DOI 10.1161/CIRCRESAHA.115.304563; Snider P, 2009, CIRC RES, V105, P934, DOI 10.1161/CIRCRESAHA.109.201400; Takeda N, 2010, J CLIN INVEST, V120, P254, DOI 10.1172/JCI40295; TAKESHITA S, 1993, BIOCHEM J, V294, P271, DOI 10.1042/bj2940271; Taniyama Y, 2016, HYPERTENSION, V67, P356, DOI 10.1161/HYPERTENSIONAHA.115.06265; Walker JT, 2016, CELL TISSUE RES, V365, P453, DOI 10.1007/s00441-016-2426-6; Wang XD, 2016, BIOMED PHARMACOTHER, V83, P514, DOI 10.1016/j.biopha.2016.07.007; Yamaji-Kegan K, 2014, AM J PHYSIOL-LUNG C, V306, pL1090, DOI 10.1152/ajplung.00279.2013; Yokota K, 2017, AM J PATHOL, V187, P639, DOI 10.1016/j.ajpath.2016.11.010	40	5	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2019	14	8							e0220795	10.1371/journal.pone.0220795	http://dx.doi.org/10.1371/journal.pone.0220795			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5RZ	31437169	gold, Green Published, Green Submitted			2022-12-26	WOS:000485036900018
J	Bendezu, J; Ruiz, SM; Montesinos, R; Guevara, RC; Rojas-Neyra, A; Pauyac-Antezana, K; Fernandez-Diaz, M				Bendezu, Jorge; Morales Ruiz, Sandra; Montesinos, Ricardo; Choque Guevara, Ricardo; Rojas-Neyra, Aldo; Pauyac-Antezana, Katherine; Fernandez-Diaz, Manolo			Glycoprotein G (gG) production profile during infectious laryngotracheitis virus (ILTV) infection	PLOS ONE			English	Article							IDENTIFICATION; PATHOGENICITY; PROTEINS; STRAINS	Glycoprotein G (gG) is a conserved protein, and it has been described as a chemokine-binding protein in most members of the alphaherpesviruses. In case of the infectious laryngotracheitis virus (ILTV), an alphaherpesvirus that infects chickens, this protein is a virulence factor that plays an immunomodulatory role in the chicken immune response. Nevertheless, the gG production profile during ILTV infection has not yet been studied. In this study, we developed monoclonal antibodies in order to determine the gG production profile during ILTV infection in chicken hepatocellular carcinoma (LMH) cell cultures as well as embryonated specific-pathogen-free (SPF) chicken eggs and SPF chickens using a sandwich enzyme-linked immunosorbent assay (ELISA). Despite the fact that inoculated LMH cell cultures showed an increase in both gG production and viral genome copy number up to 96 h after inoculation, we observed that gG production started earlier than the increase in viral genome copy number in ILTV infected embryonated SPF chicken eggs. Likewise, a gG production peak and an increase of viral genome copy number was observed prior to the appearance of clinical signs in infected SPF chickens. According to the production profiles, gG was also produced quite early in eggs and chickens inoculated with ILTV. These findings contribute to the knowledge of the gG role during the ILTV infection as a virulence factor.	[Bendezu, Jorge; Morales Ruiz, Sandra; Montesinos, Ricardo; Choque Guevara, Ricardo; Rojas-Neyra, Aldo; Pauyac-Antezana, Katherine; Fernandez-Diaz, Manolo] FARVET, Lab Invest & Desarrollo, Chincha Alta, Ica, Peru		Bendezu, J; Ruiz, SM (corresponding author), FARVET, Lab Invest & Desarrollo, Chincha Alta, Ica, Peru.	eduar156@yahoo.es; smr_sandra@yahoo.es		Choque Guevara, Ricardo/0000-0002-5926-1526; Montesinos Millan, Ricardo/0000-0001-8747-7458; Morales Ruiz, Sandra/0000-0003-0986-0798; Rojas, Aldo/0000-0002-0053-9458; Bendezu, Jorge/0000-0001-7102-3144	Programa Nacional de Innovacion Agraria (PNIA) of the Peruvian Government; Laboratorios de Investigacion y Desarrollo FARVET [021-2015-INIA-PNIA/UPMSI/IE]; Programa Nacional de Innovacion Agraria (PNIA)	Programa Nacional de Innovacion Agraria (PNIA) of the Peruvian Government; Laboratorios de Investigacion y Desarrollo FARVET; Programa Nacional de Innovacion Agraria (PNIA)	This study was co-financially supported by Programa Nacional de Innovacion Agraria (PNIA) of the Peruvian Government and Laboratorios de Investigacion y Desarrollo FARVET under the contract 021-2015-INIA-PNIA/UPMSI/IE. JB, SMR and MFD were granted by the Programa Nacional de Innovacion Agraria (PNIA). These funders supported salaries for JB, SMR, RM, RCG and KPA and supplied materials for the study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Alcami A, 2000, CKEMOKINE BINDING PR; [Anonymous], 2015, BAC TO BAC BAC EXP S; Coppo MJC, 2018, J VIROL, V92, DOI [10.1128/JVI.01534-17, 10.1128/jvi.01534-17]; Coppo MJC, 2013, DEV COMP IMMUNOL, V41, P454, DOI 10.1016/j.dci.2013.03.022; Davison AJ, 2010, VET MICROBIOL, V143, P52, DOI 10.1016/j.vetmic.2010.02.014; Devlin JM, 2006, J GEN VIROL, V87, P2839, DOI 10.1099/vir.0.82194-0; Devlin JM, 2010, VACCINE, V28, P1325, DOI 10.1016/j.vaccine.2009.11.013; Euthanasia AP, 2013, AVMA GUIDELINES EUTH; Fuchs W, 2005, J VIROL, V79, P705, DOI 10.1128/JVI.79.2.705-716.2005; Fuchs W, 2007, VET RES, V38, P261, DOI 10.1051/vetres:200657; GARCIA OG, 2013, DIS POULTRY, P161; Gonzalez-Motos V, 2016, CYTOKINE GROWTH F R, V30, P71, DOI 10.1016/j.cytogfr.2016.02.007; Helferich D, 2007, J GEN VIROL, V88, P719, DOI 10.1099/vir.0.82532-0; KONGSUWAN K, 1993, VIRUS RES, V29, P125, DOI 10.1016/0168-1702(93)90054-Q; Koski DM, 2015, BIOLOGICALS, V43, P232, DOI 10.1016/j.biologicals.2015.05.005; Lee SW, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-197; Mahmoudian A, 2012, COMP IMMUNOL MICROB, V35, P103, DOI 10.1016/j.cimid.2011.11.001; Morales Ruiz S, 2018, GENOME ANNOUNC, V6; Morales Ruiz S, 2018, AVIAN DIS, V62, P9; Oldoni I, 2009, AVIAN PATHOL, V38, P47, DOI 10.1080/03079450802632031; Ruiz SM, 2018, BMC VET RES, V14, DOI 10.1186/s12917-018-1729-0; Sun ZG, 2005, SCI CHINA SER C, V48, P487, DOI 10.1360/062005-17; Tataje-Lavanda L, 2018, J VET SCI TECHNOLOGY, V9; Tataje-Lavanda L., 2016, VET REC CASE REP, V4, DOI DOI 10.1136/VETRECCR-2016-000292; Vagnozzi A, 2015, AVIAN DIS, V59, P394, DOI 10.1637/11075-033115-Reg.1; Walker JM, 2007, BACULOVIRUS INSECT C; WHITFORD M, 1989, J VIROL, V63, P1393, DOI 10.1128/JVI.63.3.1393-1399.1989	27	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2019	14	8							e0219475	10.1371/journal.pone.0219475	http://dx.doi.org/10.1371/journal.pone.0219475			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5QN	31433806	Green Submitted, Green Published, gold			2022-12-26	WOS:000485033100004
J	Cicaloni, V; Spiga, O; Dimitri, GM; Maiocchi, R; Millucci, L; Giustarini, D; Bernardini, G; Bernini, A; Marzocchi, B; Braconi, D; Santucci, A				Cicaloni, Vittoria; Spiga, Ottavia; Dimitri, Giovanna Maria; Maiocchi, Rebecca; Millucci, Lia; Giustarini, Daniela; Bernardini, Giulia; Bernini, Andrea; Marzocchi, Barbara; Braconi, Daniela; Santucci, Annalisa			Interactive alkaptonuria database: investigating clinical data to improve patient care in a rare disease	FASEB JOURNAL			English	Article						precision medicine; machine learning; biomarkers	THIOLATION INDEX PTI; SERUM AMYLOID-A; OXIDATIVE STRESS; ASCORBIC-ACID; CHITOTRIOSIDASE ACTIVITY; HOMOGENTISIC ACID; INFLAMMATION; BIOMARKER; HISTORY; PATHWAY	Alkaptonuria (AKU) is an ultrarare autosomal recessive disorder (MIM 203500) that is caused byby a complex set of mutations in homogentisate 1,2-dioxygenasegene and consequent accumulation of homogentisic acid (HGA), causing a significant protein oxidation. A secondary form of amyloidosis was identified in AKU and related to high circulating serum amyloid A (SAA) levels, which are linked with inflammation and oxidative stress and might contribute to disease progression and patients' poor quality of life. Recently, we reported that inflammatory markers (SAA and chitotriosidase) and oxidative stress markers (protein thiolation index) might be disease activity markers in AKU. Thanks to an international network, we collected genotypic, phenotypic, and clinical data from more than 200 patients with AKU. These data are currently stored in our AKU database, named ApreciseKUre. In this work, we developed an algorithm able to make predictions about the oxidative status trend of each patient with AKU based on 55 predictors, namely circulating HGA, body mass index, total cholesterol, SAA, and chitotriosidase. Our general aim is to integrate the data of apparently heterogeneous patients with AKUAKU by using specific bioinformatics tools, in order to identify pivotal mechanisms involved in AKU for a preventive, predictive, and personalized medicine approach to AKU.	[Cicaloni, Vittoria; Spiga, Ottavia; Maiocchi, Rebecca; Millucci, Lia; Giustarini, Daniela; Bernardini, Giulia; Bernini, Andrea; Marzocchi, Barbara; Braconi, Daniela; Santucci, Annalisa] Univ Siena, Dept Biotechnol Chem & Pharm, Via A Moro 2, I-53100 Siena, Italy; [Cicaloni, Vittoria; Maiocchi, Rebecca] Toscana Life Sci Fdn, Siena, Italy; [Dimitri, Giovanna Maria] Univ Cambridge, Dept Comp Sci, Cambridge, England; [Marzocchi, Barbara] Azienda Osped Senese, UOC, Patol Clin, Siena, Italy	University of Siena; University of Cambridge; University of Siena; University Hospital of Siena	Spiga, O (corresponding author), Univ Siena, Dept Biotechnol Chem & Pharm, Via A Moro 2, I-53100 Siena, Italy.	ottavia.spiga@unisi.it	Giustarini, Daniela/AAV-6629-2021; Bernardini, Giulia/ABG-2209-2020; Braconi, Daniela/J-9616-2018; Dimitri, Giovanna Maria/AGG-4991-2022; Bernini, Andrea/H-9412-2012; Santucci, Annalisa/K-1932-2018	Bernardini, Giulia/0000-0003-0016-0728; Braconi, Daniela/0000-0002-9657-4169; Dimitri, Giovanna Maria/0000-0002-2728-4272; Bernini, Andrea/0000-0002-7528-2749; Santucci, Annalisa/0000-0001-6976-9086; Cicaloni, Vittoria/0000-0002-8329-1565	Telethon Italy [GGP10058]; Toscana Life Sciences Orphan_1 Project; Associazione Italiana Malati di Alkaptonuria Alkaptonuria [ORPHA263402]; Tuscany Region Pegaso Ph.D. School in Biochemistry and Molecular Biology (Fondazione Vita Its Probits) [113195]	Telethon Italy(Fondazione Telethon); Toscana Life Sciences Orphan_1 Project; Associazione Italiana Malati di Alkaptonuria Alkaptonuria; Tuscany Region Pegaso Ph.D. School in Biochemistry and Molecular Biology (Fondazione Vita Its Probits)	The authors acknowledge support from Telethon Italy Grant GGP10058, the Toscana Life Sciences Orphan_1 Project, and Associazione Italiana Malati di Alkaptonuria Alkaptonuria (ORPHA263402). The authors thank the Toscana Life Sciences Foundation. V.C. was supported by a Ph.D. fellowship from the Tuscany Region Pegaso Ph.D. School in Biochemistry and Molecular Biology (Fondazione Vita Its Probits, 113195). The authors declare no conflicts of interest.	Albatayneh Eman M, 2019, J Clin Med Res, V11, P337, DOI 10.14740/jocmr3801; Ally MMTM, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/183653; Basok BI, 2014, J MED BIOCHEM, V33, P245, DOI 10.2478/jomb-2014-0010; Bernardini G, 2012, PROTEOMICS, V12, P708, DOI 10.1002/pmic.201100358; Braconi D, 2018, OSTEOARTHR CARTILAGE, V26, P1078, DOI 10.1016/j.joca.2018.05.017; Braconi D, 2016, INT J BIOCHEM CELL B, V81, P271, DOI 10.1016/j.biocel.2016.08.016; Braconi D, 2015, FREE RADICAL BIO MED, V88, P70, DOI 10.1016/j.freeradbiomed.2015.02.021; Braconi D, 2012, J CELL PHYSIOL, V227, P3333, DOI 10.1002/jcp.24033; Braconi D, 2011, J INHERIT METAB DIS, V34, P1163, DOI 10.1007/s10545-011-9377-6; Braconi D, 2010, J CELL BIOCHEM, V111, P922, DOI 10.1002/jcb.22780; Braconi D, 2010, RHEUMATOLOGY, V49, P1975, DOI 10.1093/rheumatology/keq175; Bruce B, 2003, J RHEUMATOL, V30, P167; Brunner JKH, 2008, RHEUMATOL INT, V28, P949, DOI 10.1007/s00296-008-0558-z; Calkins MJ, 2009, ANTIOXID REDOX SIGN, V11, P497, DOI [10.1089/ars.2008.2242, 10.1089/ARS.2008.2242]; Cantarini L, 2012, YONSEI MED J, V53, P1045, DOI 10.3349/ymj.2012.53.5.1045; Chambers J. M., 1992, STAT MMODELS S, V251; Cicaloni V., 2016, PEERJ PREPRINTS, V4, DOI DOI 10.7287/PEERJ.PREPRINTS.2174V1; Ciftci S, 2016, J CLIN LAB ANAL, V30, P1158, DOI 10.1002/jcla.21997; Cox TF, 2011, J INHERIT METAB DIS, V34, P1153, DOI 10.1007/s10545-011-9367-8; Davison AS, 2016, J INHERIT METAB DIS, V39, P203, DOI 10.1007/s10545-015-9902-0; de Seny D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066769; Duzova A, 2003, CLIN EXP RHEUMATOL, V21, P509; FernandezCanon JM, 1996, NAT GENET, V14, P19, DOI 10.1038/ng0996-19; Gillmore JD, 2001, LANCET, V358, P24, DOI 10.1016/S0140-6736(00)05252-1; Giustarini D, 2017, ANAL BIOCHEM, V538, P38, DOI 10.1016/j.ab.2017.09.010; Giustarini D, 2012, FREE RADICAL BIO MED, V53, P907, DOI 10.1016/j.freeradbiomed.2012.06.022; Guo YF, 1995, J INHERIT METAB DIS, V18, P717, DOI 10.1007/BF02436762; Hughes AT, 2015, ANN CLIN BIOCHEM, V52, P597, DOI 10.1177/0004563215571969; Jung SY, 2007, YONSEI MED J, V48, P218, DOI 10.3349/ymj.2007.48.2.218; Li JQ, 2009, EXPERT OPIN THER TAR, V13, P785, DOI 10.1517/14728220903025762; Manna P, 2015, METAB SYNDR RELAT D, V13, P423, DOI 10.1089/met.2015.0095; Maritim AC, 2003, J BIOCHEM MOL TOXIC, V17, P24, DOI 10.1002/jbt.10058; Marseglia L, 2015, INT J MOL SCI, V16, P378, DOI 10.3390/ijms16010378; Mayatepek E, 1998, EUR J PEDIATR, V157, P867, DOI 10.1007/s004310050956; Millucci L, 2015, J INHERIT METAB DIS, V38, P797, DOI 10.1007/s10545-015-9842-8; Millucci L, 2015, J CELL PHYSIOL, V230, P1148, DOI 10.1002/jcp.24850; Millucci L, 2014, DIAGN PATHOL, V9, DOI 10.1186/s13000-014-0185-9; Millucci L, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/258471; Millucci L, 2014, INT J CARDIOL, V172, pE121, DOI 10.1016/j.ijcard.2013.12.117; Millucci L, 2012, BBA-MOL BASIS DIS, V1822, P1682, DOI 10.1016/j.bbadis.2012.07.011; Mistry JB, 2013, RARE DIS, V1, DOI 10.4161/rdis.27475; Morava E, 2003, ANN CLIN BIOCHEM, V40, P108, DOI 10.1258/000456303321016268; Nemethova M, 2016, EUR J HUM GENET, V24, P66, DOI 10.1038/ejhg.2015.60; Phornphutkul C, 2002, NEW ENGL J MED, V347, P2111, DOI 10.1056/NEJMoa021736; R Core Team, 2018, R LANG ENV STAT COMP; Ramos LF, 2008, J AM SOC NEPHROL, V19, P593, DOI 10.1681/ASN.2007030355; Ranganath LR, 2016, ANN RHEUM DIS, V75, P362, DOI 10.1136/annrheumdis-2014-206033; Ranganath LR, 2013, J CLIN PATHOL, V66, P367, DOI 10.1136/jclinpath-2012-200877; Rencher A. C., 2008, LINEAR MMODELS SSTAT; Ruiz S, 2013, KIDNEY INT, V83, P1029, DOI 10.1038/ki.2012.439; Shimojima Y, 2005, INTERNAL MED, V44, P1009, DOI 10.2169/internalmedicine.44.1009; Spiga O, 2018, COMPUT BIOL MED, V103, P1, DOI 10.1016/j.compbiomed.2018.10.002; Spiga O, 2017, BMC MED INFORM DECIS, V17, DOI 10.1186/s12911-017-0438-0; Su XH, 2018, FREE RADICAL BIO MED, V115, P471, DOI 10.1016/j.freeradbiomed.2017.12.004; Tharini Gk, 2011, Indian J Dermatol, V56, P194, DOI 10.4103/0019-5154.80415; Tinti L, 2010, J CELL PHYSIOL, V225, P84, DOI 10.1002/jcp.22199; Vilboux T, 2009, HUM MUTAT, V30, P1611, DOI 10.1002/humu.21120; WILKINSON GN, 1973, ROY STAT SOC C-APP, V22, P392; WOLFF JA, 1989, PEDIATR RES, V26, P140, DOI 10.1203/00006450-198908000-00015; Wu K., 2018, EUR J RHEUMATOL, V6, P1; Yang RL, 2008, J CLIN BIOCHEM NUTR, V43, P154, DOI 10.3164/jcbn.2008044	61	9	9	0	0	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2019	33	11					12696	12703		10.1096/fj.201901529R	http://dx.doi.org/10.1096/fj.201901529R			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC8ZX	31462106	Green Published			2022-12-26	WOS:000507461600085
J	Yu, JH; Lim, SW; Luo, K; Cui, S; Quan, Y; Shin, YJ; Lee, KE; Kim, HL; Ko, EJ; Chung, BH; Kim, JH; Chung, SJ; Yang, CW				Yu, Ji Hyun; Lim, Sun Woo; Luo, Kang; Cui, Sheng; Quan, Yi; Shin, Yoo Jin; Lee, Kyung Eun; Kim, Hong Lim; Ko, Eun Jeong; Chung, Byung Ha; Kim, Ju Hwan; Chung, Sang J.; Yang, Chul Woo			Coenzyme Q(10) alleviates tacrolimus-induced mitochondrial dysfunction in kidney	FASEB JOURNAL			English	Article						3D reconstruction; nephrotoxicity; reactive oxygen species	CHRONIC CYCLOSPORINE NEPHROPATHY; ASCORBIC-ACID PALMITATE; OXIDATIVE STRESS; FK506 NEPHROTOXICITY; EXPERIMENTAL-MODEL; BETA-CAROTENE; REDUCED FORM; VITAMIN-E; TROLOX-C; ACETYLCYSTEINE	The major side effect of tacrolimus (Tac) is nephrotoxicity. We studied whether supplementation of coenzyme Q(10), (CoQ(10)) a potent antioxidant, can reduce Tac-induced nephrotoxicity via improving mitochondrial function. In an in vitro study, CoQ(10) reduced the production of Tac-induced mitochondrial reactive oxygen species and abolished the loss of mitochondrial membrane potential in proximal tubular cell line. Assessment of mitochondrial function revealed that CoQ(10) decreased oxygen consumption and mitochondrial respiration rate increased by Tac, suggesting improvement of mitochondrial function to synthesize ATP with CoQ(10) treatment. The effect of the CoQ(10) in vitro study was observed in an experimental model of chronic Tac-induced nephropathy. CoQ(10) attenuated Tac-induced oxidative stress and was accompanied by function and histologic improvement. On electron microscopy, addition of CoQ(10) increased not only the number but also the volume of mitochondria compared with Tac treatment only. Our data indicate that CoQ(10) improves Tac-induced mitochondrial dysfunction in kidney. Supplementary CoQ(10) treatment may be a promising approach to reduce Tac-induced nephrotoxicity.	[Yu, Ji Hyun; Ko, Eun Jeong; Chung, Byung Ha; Yang, Chul Woo] Catholic Univ Korea, Sch Med, Dept Internal Med, Seoul, South Korea; [Lim, Sun Woo; Luo, Kang; Cui, Sheng; Quan, Yi; Shin, Yoo Jin; Ko, Eun Jeong; Chung, Byung Ha; Yang, Chul Woo] Catholic Univ Korea, Sch Med, Seoul St Marys Hosp, Convergent Res Consortium Immunol Dis, Seoul, South Korea; [Lim, Sun Woo; Luo, Kang; Cui, Sheng; Quan, Yi; Shin, Yoo Jin; Ko, Eun Jeong; Chung, Byung Ha; Yang, Chul Woo] Catholic Univ Korea, Sch Med, Transplant Res Ctr, Seoul, South Korea; [Kim, Hong Lim] Catholic Univ Korea, Sch Med, Integrat Res Support Ctr, Seoul, South Korea; [Lee, Kyung Eun] Korea Inst Sci & Technol, Adv Anal Ctr, Seoul, South Korea; [Kim, Ju Hwan] Abtis, Suwon, South Korea; [Chung, Sang J.] Sungkyunkwan Univ, Sch Pharm, Suwon, South Korea	Catholic University of Korea; Catholic University of Korea; Seoul St. Mary's Hospital; Catholic University of Korea; Catholic University of Korea; Korea Institute of Science & Technology (KIST); Sungkyunkwan University (SKKU)	Yang, CW (corresponding author), Catholic Univ Korea, Seoul St Marys Hosp, Sch Med, Dept Internal Med, 222 Banpo Daero, Seoul 06591, South Korea.	yangch@catholic.ac.kr		Ko, Eun Jeong/0000-0002-5604-1296	Korean Health Technology Research and Development Project, Ministry for Health and Welfare [HI14C3417, HI16C1641]; Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, Information and Communications Technology (ICT) and Future Planning [NRF-2018R1D1A1A02043014]	Korean Health Technology Research and Development Project, Ministry for Health and Welfare; Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, Information and Communications Technology (ICT) and Future Planning	This work was supported by the Korean Health Technology Research and Development Project, Ministry for Health and Welfare (HI14C3417, HI16C1641), and the Basic Science Research Program through the National Research Foundation of Korea (NRF), funded by the Ministry of Science, Information and Communications Technology (ICT) and Future Planning (NRF-2018R1D1A1A02043014). The authors declare no conflicts of interest.	Acosta MJ, 2016, BBA-BIOENERGETICS, V1857, P1079, DOI 10.1016/j.bbabio.2016.03.036; ANDOH TF, 1994, TRANSPLANTATION, V57, P483; ANDOH TF, 1995, CLIN EXP PHARMACOL P, V22, P646, DOI 10.1111/j.1440-1681.1995.tb02082.x; Archer SL, 2013, NEW ENGL J MED, V369, P2236, DOI 10.1056/NEJMra1215233; Back JH, 2015, TRANSPL P, V47, P2032, DOI 10.1016/j.transproceed.2015.06.008; Bentinger M, 2003, FREE RADICAL BIO MED, V34, P563, DOI 10.1016/S0891-5849(02)01357-6; Bhagavan HN, 2007, MITOCHONDRION, V7, pS78, DOI 10.1016/j.mito.2007.03.003; Carrasco J, 2014, BJU INT, V113, P942, DOI 10.1111/bju.12485; CHEN H, 1995, FREE RADICAL RES, V22, P177, DOI 10.3109/10715769509147537; CHEN H, 1995, FREE RADICAL BIO MED, V18, P949, DOI 10.1016/0891-5849(94)00238-F; Chevalier RL, 2016, AM J PHYSIOL-RENAL, V311, pF145, DOI 10.1152/ajprenal.00164.2016; Crane FL, 2001, J AM COLL NUTR, V20, P591, DOI 10.1080/07315724.2001.10719063; Doh KC, 2013, AM J NEPHROL, V37, P421, DOI 10.1159/000349921; Dott W, 2014, REDOX BIOL, V2, P224, DOI 10.1016/j.redox.2013.12.028; Fouad AA, 2010, TOXICOLOGY, V274, P49, DOI 10.1016/j.tox.2010.05.007; Hernandez-Camacho JD, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00044; Huo J, 2018, OXID MED CELL LONGEV, V2018, DOI 10.1155/2018/3181759; Ishikawa A, 2012, INT BRAZ J UROL, V38, P230, DOI 10.1590/S1677-55382012000200011; Jin J, 2017, AM J TRANSPLANT, V17, P2601, DOI 10.1111/ajt.14316; Lim SW, 2015, LAB INVEST, V95, P1174, DOI 10.1038/labinvest.2015.93; Lim SW, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.365; Modi K, 2006, BIOL TRACE ELEM RES, V109, P25, DOI 10.1385/BTER:109:1:025; Montini G, 2008, NEW ENGL J MED, V358, P2849, DOI 10.1056/NEJMc0800582; Moreira PI, 2005, EXP NEUROL, V196, P112, DOI 10.1016/j.expneurol.2005.07.012; Olyaei A J, 2001, Curr Opin Crit Care, V7, P384, DOI 10.1097/00075198-200112000-00003; Piao SG, 2014, TRANSPLANTATION, V98, P22, DOI 10.1097/TP.0000000000000146; Piao SG, 2013, TRANSPLANTATION, V96, P146, DOI 10.1097/TP.0b013e318296c9a9; Piao SG, 2012, TRANSPLANTATION, V93, P383, DOI 10.1097/TP.0b013e3182421604; Sato T, 2013, EXP CLIN TRANSPLANT, V11, P17, DOI 10.6002/ect.2012.0126; Shihab FS, 1997, TRANSPLANTATION, V64, P1829, DOI 10.1097/00007890-199712270-00034; Sohet FM, 2009, BIOCHEM PHARMACOL, V78, P1391, DOI 10.1016/j.bcp.2009.07.008; Spindler M, 2009, NEUROPSYCH DIS TREAT, V5, P597; Stillman IE, 1995, LAB INVEST, V73, P794; Sun IO, 2019, KOREAN J INTERN MED, V34, P365, DOI 10.3904/kjim.2017.004; Upaganlawar Anian, 2006, Indian Journal of Experimental Biology, V44, P416; Venegoni W, 2017, J ADV NURS, V73, P1331, DOI 10.1111/jan.13259; Yoon Hye Eun, 2009, Korean Journal of Internal Medicine, V24, P81, DOI 10.3904/kjim.2009.24.2.81; Zorzano A, 2009, CURR OPIN DRUG DISC, V12, P597	38	17	18	0	2	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2019	33	11					12288	12298		10.1096/fj.201900386RR	http://dx.doi.org/10.1096/fj.201900386RR			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC8ZX	31431058	Green Published			2022-12-26	WOS:000507461600054
J	Wang, YJ; Zhang, HL; Na, L; Du, C; Zhang, ZY; Zheng, YH; Wang, XJ				Wang, Yujie; Zhang, Haili; Na, Lei; Du, Cheng; Zhang, Zhenyu; Zheng, Yong-Hui; Wang, Xiaojun			ANP32A and ANP32B are key factors in the Rev-dependent CRM1 pathway for nuclear export of HIV-1 unspliced mRNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						human immunodeficiency virus (HIV); nucleoside; nucleotide transport; protein-protein interaction; viral replication; viral protein	TRANS-ACTIVATOR; PROTEIN; HELICASE; REQUIREMENT; INHIBITION; EXPRESSION; I-1(PP2A); SUBUNIT; COMPLEX; BINDING	The nuclear export receptor CRM1 is an important regulator involved in the shuttling of various cellular and viral RNAs between the nucleus and the cytoplasm. HIV-1 Rev interacts with CRM1 in the late phase of HIV-1 replication to promote nuclear export of unspliced and single spliced HIV-1 transcripts. However, other cellular factors involved in the CRM1-dependent viral RNA nuclear export remain largely unknown. Here, we demonstrate that ANP32A and ANP32B mediate the export of unspliced or partially spliced viral mRNA via interactions with Rev and CRM1. We found that a double, but not single, knockout of ANP32A and ANP32B significantly decreased the expression of gag protein. Reconstitution of either ANP32A or ANP32B restored the viral production equally. Disruption of both ANP32A and ANP32B expression led to a dramatic accumulation of unspliced viral mRNA in the nucleus. We further identified that ANP32A and ANP32B interact with both Rev and CRM1 to promote RNA transport. Our data strongly suggest that ANP32A and ANP32B play an important role in the Rev?CRM1 pathway, which is essential for HIV-1 replication, and our findings provide a candidate therapeutic target for host defense against retroviral infection.	[Wang, Yujie; Zhang, Haili; Na, Lei; Du, Cheng; Zhang, Zhenyu; Zheng, Yong-Hui; Wang, Xiaojun] Chinese Acad Agr Sci, Harbin Vet Res Inst, State Key Lab Vet Biotechnol, Harbin 150001, Heilongjiang, Peoples R China; [Zheng, Yong-Hui] Michigan State Univ, Dept Microbiol & Mol Genet, E Lansing, MI 48824 USA	Chinese Academy of Agricultural Sciences; Harbin Veterinary Research Institute, CAAS; Michigan State University	Wang, XJ (corresponding author), Chinese Acad Agr Sci, Harbin Vet Res Inst, State Key Lab Vet Biotechnol, Harbin 150001, Heilongjiang, Peoples R China.	wangxiaojun@caas.cn	zhang, zhenyu/HCI-5576-2022; Zheng, Yong-Hui/AAP-4492-2021; Zhang, Haili/ABA-5438-2020; Wang, Xiaojun/AAF-5687-2020	zhang, zhenyu/0000-0003-4974-1400; Zheng, Yong-Hui/0000-0002-1098-7385; Wang, Xiaojun/0000-0003-4521-4099	National Natural Science Foundation of China [81561128010, 31222054]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China Grants 81561128010 and 31222054 (to X. W.). The authors declare that they have no conflicts of interest with the contents of this article.	Bauer A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097233; Bodem J, 2011, J VIROL, V85, P2333, DOI 10.1128/JVI.01518-10; Bogerd HP, 1998, J VIROL, V72, P8627, DOI 10.1128/JVI.72.11.8627-8635.1998; Brennan CM, 2000, J CELL BIOL, V151, P1, DOI 10.1083/jcb.151.1.1; Budhiraja S, 2015, J VIROL, V89, P3557, DOI 10.1128/JVI.03232-14; CHANG DD, 1989, CELL, V59, P789, DOI 10.1016/0092-8674(89)90602-8; Chen S, 2008, J BIOL CHEM, V283, P10513, DOI 10.1074/jbc.M709852200; Cullen BR, 2003, TRENDS BIOCHEM SCI, V28, P419, DOI 10.1016/S0968-0004(03)00142-7; Cullen BR, 1998, VIROLOGY, V249, P203, DOI 10.1006/viro.1998.9331; Dayton AI, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-62; de Chiara C, 2007, J BIOMOL NMR, V38, P177, DOI 10.1007/s10858-006-9101-2; Edgcomb SP, 2012, J MOL BIOL, V415, P61, DOI 10.1016/j.jmb.2011.10.032; EMERMAN M, 1989, CELL, V57, P1155, DOI 10.1016/0092-8674(89)90053-6; FELBER BK, 1989, P NATL ACAD SCI USA, V86, P1495, DOI 10.1073/pnas.86.5.1495; Fornerod M, 1997, CELL, V90, P1051, DOI 10.1016/S0092-8674(00)80371-2; Fries B, 2007, J BIOL CHEM, V282, P4504, DOI 10.1074/jbc.M608849200; Frohlich A, 2016, BBA-GENE REGUL MECH, V1859, P719, DOI 10.1016/j.bbagrm.2016.03.009; HAMMARSKJOLD ML, 1989, J VIROL, V63, P1959; Hammond JA, 2018, J MOL BIOL, V430, P537, DOI 10.1016/j.jmb.2017.06.023; Huang F, 2015, VIROLOGY, V486, P15, DOI 10.1016/j.virol.2015.08.026; Ji S, 2018, J VIROL, V92, DOI 10.1128/JVI.00499-18; Li M, 1996, BIOCHEMISTRY-US, V35, P6998, DOI 10.1021/bi960581y; Long JS, 2016, NATURE, V529, P101, DOI 10.1038/nature16474; MALIM MH, 1991, CELL, V65, P241, DOI 10.1016/0092-8674(91)90158-U; MALIM MH, 1989, NATURE, V338, P254, DOI 10.1038/338254a0; MALIM MH, 1989, CELL, V58, P205, DOI 10.1016/0092-8674(89)90416-9; Matilla A, 1997, NATURE, V389, P974, DOI 10.1038/40159; Modem S, 2005, NUCLEIC ACIDS RES, V33, P873, DOI 10.1093/nar/gki231; Neville M, 1997, CURR BIOL, V7, P767, DOI 10.1016/S0960-9822(06)00335-6; Pan W, 2009, J BIOL CHEM, V284, P6946, DOI 10.1074/jbc.M805801200; Pollard VW, 1998, ANNU REV MICROBIOL, V52, P491, DOI 10.1146/annurev.micro.52.1.491; Reilly PT, 2014, BIOESSAYS, V36, P1062, DOI 10.1002/bies.201400058; Ren XX, 2016, J BIOL CHEM, V291, P4580, DOI 10.1074/jbc.M115.706135; Schneider R, 2004, J BIOL CHEM, V279, P23859, DOI 10.1074/jbc.C400151200; Seo SB, 2002, J BIOL CHEM, V277, P14005, DOI 10.1074/jbc.M112455200; Staller E, 2019, J VIROL, V93, DOI 10.1128/JVI.00217-19; Sugiyama K, 2015, ELIFE, V4, DOI 10.7554/eLife.08939; Suhasini M, 2009, CURR HIV RES, V7, P91, DOI 10.2174/157016209787048474; Sun QX, 2013, P NATL ACAD SCI USA, V110, P1303, DOI 10.1073/pnas.1217203110; Sutherland BW, 2008, J MASS SPECTROM, V43, P699, DOI 10.1002/jms.1415; Tochio N, 2010, J MOL BIOL, V401, P97, DOI 10.1016/j.jmb.2010.06.005; Toro-Ascuy D, 2018, NUCLEIC ACIDS RES, V46, P11539, DOI 10.1093/nar/gky851; Wang XJ, 2010, J BIOL CHEM, V285, P14346, DOI 10.1074/jbc.M110.109314; Wiczer BM, 2009, J LIPID RES, V50, P2502, DOI 10.1194/jlr.M900218-JLR200; Yedavalli VSRK, 2004, CELL, V119, P381, DOI 10.1016/j.cell.2004.09.029; Zhang HL, 2019, J VIROL, V93, DOI 10.1128/JVI.00174-19; Zhou XX, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0065040, 10.1371/journal.pone.0062245]	47	10	11	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 18	2019	294	42					15346	15357		10.1074/jbc.RA119.008450	http://dx.doi.org/10.1074/jbc.RA119.008450			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JQ9HM	31444273	Green Submitted, hybrid, Green Published			2022-12-26	WOS:000499248700013
J	Berry, ASF; Kelly, BJ; Barnhart, D; Kelly, DJ; Beiting, DP; Baldassano, RN; Redding, LE				Berry, Alexander S. F.; Kelly, Brendan J.; Barnhart, Denise; Kelly, Donna J.; Beiting, Daniel P.; Baldassano, Robert N.; Redding, Laurel E.			Gut microbiota features associated with Clostridioides difficile colonization in puppies	PLOS ONE			English	Article							POTENTIAL RESERVOIR; INFECTION; CARRIAGE; COMMUNITY; STRAINS; PERFRINGENS; POPULATION; PREVALENCE; PATHOGEN; CHILDREN	In people, colonization with Clostridioides difficile, the leading cause of antibiotic-associated diarrhea, has been shown to be associated with distinct gut microbial features, including reduced bacterial community diversity and depletion of key taxa. In dogs, the gut microbiota features that define C. difficile colonization are less well understood. We sought to define the gut microbiota features associated with C. difficile colonization in puppies, a population where the prevalence of C. difficile has been shown to be elevated, and to define the effect of puppy age and litter upon these features and C. difficile risk. We collected fecal samples from weaned (n = 27) and unweaned (n = 74) puppies from 13 litters and analyzed the effects of colonization status, age and litter on microbial diversity using linear mixed effects models. Colonization with C. difficile was significantly associated with younger age, and colonized puppies had significantly decreased bacterial community diversity and differentially abundant taxa compared to non-colonized puppies, even when adjusting for age. C. difficile colonization remained associated with decreased bacterial community diversity, but the association did not reach statistical significance in a mixed effects model incorporating litter as a random effect. Even though litter explained a greater proportion (67%) of the variability in microbial diversity than colonization status, we nevertheless observed heterogeneity in gut microbial community diversity and colonization status within more than half of the litters, suggesting that the gut microbiota contributes to colonization resistance against C. difficile. The colonization of puppies with C. difficile has important implications for the potential zoonotic transfer of this organism to people. The identified associations point to mechanisms by which C. difficile colonization may be reduced.	[Berry, Alexander S. F.; Baldassano, Robert N.] Childrens Hosp Philadelphia, Div Gastroenterol Hepatol & Nutr, Philadelphia, PA 19104 USA; [Berry, Alexander S. F.; Barnhart, Denise; Kelly, Donna J.; Beiting, Daniel P.] Univ Penn, Sch Vet Med, Dept Pathobiol, Kennett Sq, Philadelphia, PA 19104 USA; [Kelly, Brendan J.] Univ Penn, Div Infect Dis, Perelman Sch Med, Philadelphia, PA 19104 USA; [Kelly, Brendan J.] Univ Penn, Div Epidemiol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Redding, Laurel E.] Univ Penn, Sch Vet Med, Dept Clin Sci, Kennett Sq, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania	Redding, LE (corresponding author), Univ Penn, Sch Vet Med, Dept Clin Sci, Kennett Sq, Philadelphia, PA 19104 USA.	lredding@vet.upenn.edu	Beiting, Daniel/AAG-6275-2019	Kelly, Brendan/0000-0003-2023-646X; Redding, Laurel/0000-0002-3414-1202	Penn Vet Center for Host Microbial Interaction; Penn-CHOP Microbiome Program; NIH [K23 AI121485]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K23AI121485] Funding Source: NIH RePORTER	Penn Vet Center for Host Microbial Interaction; Penn-CHOP Microbiome Program; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by funding from the Penn Vet Center for Host Microbial Interaction and the Penn-CHOP Microbiome Program. BJK is supported by NIH K23 AI121485. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adlerberth I, 2014, J CLIN MICROBIOL, V52, P173, DOI 10.1128/JCM.01701-13; Alvarez-Perez S, 2015, J SMALL ANIM PRACT, V56, P190, DOI 10.1111/jsap.12311; [Anonymous], 2016, Nat Rev Dis Primers, V2, P16021, DOI 10.1038/nrdp.2016.21; Arroyo LG, 2005, J CLIN MICROBIOL, V43, P5341, DOI 10.1128/JCM.43.10.5341-5343.2005; Bates D, 2013, J STAT SOFTW, V52, P1, DOI 10.18637/jss.v052.i05; Baverud V, 2003, EQUINE VET J, V35, P465, DOI 10.2746/042516403775600505; BORRIELLO SP, 1983, J CLIN PATHOL, V36, P84, DOI 10.1136/jcp.36.1.84; Britton RA, 2012, TRENDS MICROBIOL, V20, P313, DOI 10.1016/j.tim.2012.04.001; BUOGO C, 1995, SCHWEIZ ARCH TIERH, V137, P165; Burdet C, 2018, ANTIMICROB AGENTS CH, V62, DOI 10.1128/AAC.00925-18; Callahan BJ, 2016, NAT METHODS, V13, P581, DOI [10.1038/NMETH.3869, 10.1038/nmeth.3869]; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chang JY, 2008, J INFECT DIS, V197, P435, DOI 10.1086/525047; Chen LA, 2018, J PEDIAT GASTROENTER; Coelho LP, 2018, MICROBIOME, V6, DOI 10.1186/s40168-018-0450-3; COLLIGNON A, 1993, EUR J PEDIATR, V152, P319, DOI 10.1007/BF01956743; Deng P, 2015, BRIT J NUTR, V113, pS6, DOI 10.1017/S0007114514002943; Edwards AN, 2013, JOVE-J VIS EXP, DOI 10.3791/50787; Perez-Cobas AE, 2015, ANTIBIOTICS-BASEL, V4, P337, DOI 10.3390/antibiotics4030337; Fallani M, 2006, J MICROBIOL METH, V67, P150, DOI 10.1016/j.mimet.2006.03.010; Galdys AL, 2014, EXPERT REV ANTI-INFE, V12, P967, DOI 10.1586/14787210.2014.920252; Grzeskowiak T, 2018, METHOD PHARMACOL TOX, P1, DOI 10.1007/978-1-4939-7425-2_1; Guard BC, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175718; Hammitt MC, 2008, VET MICROBIOL, V127, P343, DOI 10.1016/j.vetmic.2007.09.002; Han SH, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0212626; Hopkins MJ, 2002, J MED MICROBIOL, V51, P448, DOI 10.1099/0022-1317-51-5-448; Hopman NEM, 2011, VET MICROBIOL, V149, P186, DOI 10.1016/j.vetmic.2010.10.013; Hoy YE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142825; Hussain I, 2015, ANAEROBE, V36, P9, DOI 10.1016/j.anaerobe.2015.09.006; Jasarevic E, 2018, NAT NEUROSCI, V21, P1061, DOI 10.1038/s41593-018-0182-5; JONES RL, 1988, J AM VET MED ASSOC, V193, P76; Karlstrom O, 1998, CLIN INFECT DIS, V26, P141, DOI 10.1086/516277; Katoh Kazutaka, 2013, Mol Biol Evol, V30, P772, DOI 10.1093/molbev/mst010; Keessen EC, 2011, VET MICROBIOL, V153, P205, DOI 10.1016/j.vetmic.2011.03.020; Khanna S, 2013, CLIN INFECT DIS, V56, P1401, DOI 10.1093/cid/cit075; Knight DR, 2013, APPL ENVIRON MICROB, V79, P2630, DOI 10.1128/AEM.03951-12; Kuijper EJ, 2006, CLIN MICROBIOL INFEC, V12, P2, DOI 10.1111/j.1469-0691.2006.01580.x; Kyne L, 2000, NEW ENGL J MED, V342, P390, DOI 10.1056/NEJM200002103420604; Lessa FC, 2015, NEW ENGL J MED, V372, P825, DOI [10.1056/NEJMoa1408913, 10.1056/NEJMc1505190]; Louie TJ, 2009, ANTIMICROB AGENTS CH, V53, P261, DOI 10.1128/AAC.01443-07; McCafferty J, 2013, ISME J, V7, P2116, DOI 10.1038/ismej.2013.106; McMurdie PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061217; Merrigan MM, 2009, INT J ANTIMICROB AG, V33, pS46, DOI 10.1016/S0924-8579(09)70017-2; Milani C, 2016, SCI REP-UK, V6, DOI 10.1038/srep25945; Montgomery M, 2018, MULTIDRUG RESISTANT; Moono P, 2016, FOODBORNE PATHOG DIS, V13, P647, DOI 10.1089/fpd.2016.2181; Moono P, 2016, ANAEROBE, V37, P62, DOI 10.1016/j.anaerobe.2015.11.012; Oksanen J., 2015, PACKAGE VEGAN; PERRIN J, 1993, J VET MED B, V40, P222, DOI 10.1111/j.1439-0450.1993.tb00131.x; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Rea MC, 2012, J CLIN MICROBIOL, V50, P867, DOI 10.1128/JCM.05176-11; Rodriguez C, 2015, BMC MICROBIOL, V15, DOI 10.1186/s12866-015-0514-5; Rousseau C, 2012, CLIN INFECT DIS, V55, P1209, DOI 10.1093/cid/cis637; Rousseau C, 2011, J CLIN MICROBIOL, V49, P858, DOI 10.1128/JCM.01507-10; Samarkos M, 2018, EUR J INTERN MED, V50, P28, DOI 10.1016/j.ejim.2018.02.006; Shim JK, 1998, LANCET, V351, P633, DOI 10.1016/S0140-6736(97)08062-8; Skraban J, 2013, VET MICROBIOL, V165, P416, DOI 10.1016/j.vetmic.2013.04.014; SMITH HW, 1965, J PATHOL BACTERIOL, V90, P495, DOI 10.1002/path.1700900218; Songer JG, 2006, ANAEROBE, V12, P1, DOI 10.1016/j.anaerobe.2005.09.001; Stecher B, 2013, NAT REV MICROBIOL, V11, P277, DOI 10.1038/nrmicro2989; Stone NE, 2019, ANAEROBE, DOI [10.1016/j.anaerobe.2019.03, DOI 10.1016/J.ANAEROBE.2019.03]; Tamma PD, 2012, J PEDIATR INFECT DIS, V1, P230, DOI [10.1093/jpids/pis071, 10.1093/JPIDS/PIS071]; Thornton CS, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-3337-9; Vazquez-Baeza Y, 2013, GIGASCIENCE, V2, DOI 10.1186/2047-217X-2-16; Vilson A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193507; Weese JS, 2010, ANAEROBE, V16, P501, DOI 10.1016/j.anaerobe.2010.08.001; Weese JS, 2003, J VET INTERN MED, V17, P813, DOI 10.1892/0891-6640(2003)017&lt;0813:OODDIA&gt;2.3.CO;2; Wickham H., 2016, GGPLOT2 ELEGANT GRAP, DOI 10.1007/978-3-319-24277-4; Zhang LH, 2015, ANAEROBE, V34, P1, DOI 10.1016/j.anaerobe.2015.03.008	69	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2019	14	8							e0215497	10.1371/journal.pone.0215497	http://dx.doi.org/10.1371/journal.pone.0215497			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW6BO	31469837	Green Published, gold, Green Submitted			2022-12-26	WOS:000485062200003
J	Tesfaye, BT; Gudina, EK; Bosho, DD; Mega, TA				Tesfaye, Behailu Terefe; Gudina, Esayas Kebede; Bosho, Dula Dessalegn; Mega, Teshale Ayele			Short-term clinical outcomes of patients admitted with chronic liver disease to selected teaching hospitals in Ethiopia	PLOS ONE			English	Article							HEPATIC-ENCEPHALOPATHY; DECOMPENSATED CIRRHOSIS; RISK-FACTORS; BURDEN; MORTALITY; COMPLICATIONS; FAILURE; ASCITES	Background Chronic liver disease (CLD) is a progressive destruction of liver tissue with subsequent necrosis that persists for at least 6 months. In Ethiopia, despite the high burden report, data on CLD is limited. The objective of this study was to assess short-term clinical outcomes in patients admitted with chronic liver disease to three tertiary teaching hospitals in Ethiopia and to identify predictors of mortality. Methods A cohort of 109 patients admitted with CLD to three tertiary teaching hospitals in Ethiopia, were prospectively followed from the time of admission to 30-days of hospital discharge. The study was conducted from April 1, 2018, to October 5, 2018. Kaplan-Maier curve was used to estimate survival and cox-regression analysis to identify predictors of mortality. Result A total of 109 patients (80% male) diagnosed with CLD were included. Median age of the participants was 38(IQR, 30-48). The overall median length of hospital stay was 7(IQR, 4-11) days. Of the total, 39(35.8%) patients were HBsAg positive, and 12(11%) patients were anti-HCV positive. The 30-day mortality was 38(34.9%), and most of the deaths, 31 (81.6%) occurred before hospital discharge. Hepatic encephalopathy at admission; being with unidentified risk factor/etiologies of CLD and total bilirubin level were independent predictors of in-hospital mortality. Patients with hepatic encephalopathy at admission had approximately 11 times increased risk of death as compared to patients without hepatic encephalopathy at admission. Similarly, the hazard of mortality was 5.8 times higher in those patients with unidentified risk factor/etiology as compared to others. The risk of dying had also increased with an increase in bilirubin (1.188[95% CI, 1.0719-1.316]) level. Conclusion Approximately one-quarter of patients with CLD died during their hospital stay, and the risk of death continued after hospital discharge. Hepatic encephalopathy at admission, unidentified risk factor/etiology and increased level of total bilirubin are poor prognostic factors. Given that more than one third the patients had HBV-infection, access to antiviral drugs could help improve the prognosis of patients with end-stage liver disease in Ethiopia, as well as prevent the progression of the disease if initiated earlier.	[Tesfaye, Behailu Terefe; Bosho, Dula Dessalegn; Mega, Teshale Ayele] Jimma Univ, Sch Pharm, Dept Clin Pharm, Jimma, Ethiopia; [Gudina, Esayas Kebede] Jimma Univ, Sch Med, Dept Internal Med, Jimma, Ethiopia	Jimma University; Jimma University	Tesfaye, BT (corresponding author), Jimma Univ, Sch Pharm, Dept Clin Pharm, Jimma, Ethiopia.	terefebh@gmail.com	Gudina, Esayas Kebede/AAX-2374-2020; MEGA, TESHALE AYELE/AAE-6330-2022; Tesfaye, Behailu Terefe/AAL-6003-2020	Gudina, Esayas Kebede/0000-0002-6264-9695; Tesfaye, Behailu Terefe/0000-0002-4512-2111				Adhanom M, 2017, ETHIOPIAN MED J, V55, P267; Ashenafi W, 2017, POPUL HEALTH METR, V15, P1; Bajaj JS, 2017, CLIN GASTROENTEROL H, V15, P565, DOI 10.1016/j.cgh.2016.09.157; Charif I., 2014, OPEN J GASTROENTEROL, V4, P141, DOI DOI 10.4236/OJGAS.2014.43021; Cordoba J, 2014, J HEPATOL, V60, P275, DOI 10.1016/j.jhep.2013.10.004; Ethiopian data portal, 2017, WORLD GDP CAP RANK 2; Fagan KJ, 2014, INTERN MED J, V44, P865, DOI 10.1111/imj.12491; Federal Democratic Republic of Ethiopia, 2009, HLTH DEV, P2; Garcia-Tsao G, 2010, HEPATOLOGY, V51, P1445, DOI 10.1002/hep.23478; Giannousis IP, 2010, EUR J GASTROEN HEPAT, V22, P172, DOI 10.1097/MEG.0b013e328331115b; Heidelbaugh JJ, 2006, AM FAM PHYSICIAN, V74, P767; Hsiang JC, 2014, INTERN MED J, P160; Institute for Health Metrics and Evaluation (IHME), 2018, GBD COMP DAT VIS; Jimma university HMIS, 2017, HOSP PROF; Kasper D, 2015, HARRISONS PRINCIPLES, P2031; Kim Bong Sik Matthew, 2014, World J Gastrointest Pathophysiol, V5, P467, DOI 10.4291/wjgp.v5.i4.467; Kooffreh-Ada M., 2015, IOSR J MED DENT SCI, V14, P6; Levesque E, 2012, J HEPATOL, V56, P95, DOI 10.1016/j.jhep.2011.06.024; Magnus S, 2018, BMC GASTROENTEROL BM, V18, P1; Moriwaki H, 2010, J GASTROEN HEPATOL, V25, P858, DOI 10.1111/j.1440-1746.2010.06242.x; Mukherjee PS, 2017, PLOS ONE, V10, P1; Murphy S, 2017, DEATHS FINAL DATA 20; NICE, 2017, LIV DIS QUAL STAND, P1; Nusrat S, 2014, WORLD J GASTROENTERO, V20, P5442, DOI 10.3748/wjg.v20.i18.5442; Review World Population, 2018, ETH POP 2018; Samonakis DN, 2014, WORLD J HEPATOL, V6, P504, DOI 10.4254/wjh.v6.i7.504; St Paul's Millennium Medical College, WHO WE AR; Tanaka A, 2015, HEPATOL RES, V45, P994, DOI [10.1111/hepr.12442, DOI 10.1111/HEPR.12442]; Topdagi O, 2014, EURASIAN J MED, V46, P110, DOI 10.5152/eajm.2014.25; TSEGA E, 1992, ETHIOPIAN MED J, V30, P1; Udompap P, 2015, CLIN GASTROENTEROL H, V13, P2031, DOI 10.1016/j.cgh.2015.08.015; UNDP, 2018, HUMAN DEV INDICES IN; Vicco MH, 2015, REV ASSOC MED BRAS, V61, P35, DOI 10.1590/1806-9282.61.01.035; Wang FS, 2014, HEPATOLOGY, V60, P2099, DOI 10.1002/hep.27406; Warren A, 2017, ANN INTENSIVE CARE, V7, DOI 10.1186/s13613-017-0257-6; Weldearegawi B, 2013, HEALTH POLICY PLANN, V28, P891, DOI 10.1093/heapol/czs135; World Health Organization, 2016, GLOB HLTH SECT STRAT; World Health Organization, 2017, GLOB ACT PLAN PUBL H, P1; Zubieta-Rodriguez R., 2017, INTEGR MED RES, V82, P203, DOI [10.1016/j.rgmxen.2016.10.005, DOI 10.1016/J.RGMXEN.2016.10.005]	39	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2019	14	8							e0221806	10.1371/journal.pone.0221806	http://dx.doi.org/10.1371/journal.pone.0221806			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW6BO	31469861	Green Submitted, gold, Green Published			2022-12-26	WOS:000485062200030
J	Vahed, M; Ishihara, J; Takahashi, H				Vahed, Mohammad; Ishihara, Jun-ichi; Takahashi, Hiroki			DIpartite: A tool for detecting bipartite motifs by considering base interdependencies	PLOS ONE			English	Article							BACILLUS-SUBTILIS; BINDING-SITES; TRANSCRIPTION; DNA; SEQUENCE; PROTEIN; DISCOVERY; IDENTIFICATION; PROFILES; DATABASE	It is extremely important to identify transcription factor binding sites (TFBSs). Some TFBSs are proposed to be bipartite motifs known as two-block motifs separated by gap sequences with variable lengths. While position weight matrix (PWM) is commonly used for the representation and prediction of TFBSs, dinucleotide weight matrix (DWM) enables expression of the interdependencies of neighboring bases. By incorporating DWM into the detection of bipartite motifs, we have developed a novel tool for ab initio motif detection, DIpartite (bipartite motif detection tool based on dinucleotide weight matrix) using a Gibbs sampling strategy and the minimization of Shannon's entropy. DIpartite predicts the bipartite motifs by considering the interdependencies of neighboring positions, that is, DWM. We compared DIpartite with other available alternatives by using test datasets, namely, of CRP in E. coli, sigma factors in B. subtilis, and promoter sequences in humans. We have developed DIpartite for the detection of TFBSs, particularly bipartite motifs. DIpartite enables ab initio prediction of conserved motifs based on not only PWM, but also DWM. We evaluated the performance of DIpartite by comparing it with freely available tools, such as MEME, Bio-Prospector, BiPad, and AMD. Taken the obtained findings together, DIpartite performs equivalently to or better than these other tools, especially for detecting bipartite motifs with variable gaps. DIpartite requires users to specify the motif lengths, gap length, and PWM or DWM. DIpartite is available for use at https://github.com/Mohammad-Vahed/DIpartite.	[Vahed, Mohammad; Ishihara, Jun-ichi; Takahashi, Hiroki] Chiba Univ, Med Mycol Res Ctr, Chiba, Japan; [Takahashi, Hiroki] Chiba Univ, Mol Chiral Res Ctr, Chiba, Japan	Chiba University; Chiba University	Takahashi, H (corresponding author), Chiba Univ, Med Mycol Res Ctr, Chiba, Japan.; Takahashi, H (corresponding author), Chiba Univ, Mol Chiral Res Ctr, Chiba, Japan.	hiroki.takahashi@chiba-u.jp			MEXT KAKENHI [16H06279, 16K18671]; AMED [JP19fm0208024]; Tenure Tracking System Program of MEXT; Institute for Global Prominent Research, Chiba University	MEXT KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); AMED(Japan Agency for Medical Research and Development (AMED)); Tenure Tracking System Program of MEXT; Institute for Global Prominent Research, Chiba University	This work was partly supported by MEXT KAKENHI (16K18671) to HT, AMED under Grant Number JP19fm0208024 to HT, the Tenure Tracking System Program of MEXT to HT, the Institute for Global Prominent Research, Chiba University, to HT, and MEXT KAKENHI (16H06279) to HT and JI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baichoo N, 2002, J BACTERIOL, V184, P5826, DOI 10.1128/JB.184.21.5826-5832.2002; Bailey T L, 1994, Proc Int Conf Intell Syst Mol Biol, V2, P28; Bi CP, 2008, MOL PHARMACEUT, V5, P3, DOI 10.1021/mp7001126; Bi CP, 2004, NUCLEIC ACIDS RES, V32, P4979, DOI 10.1093/nar/gkh825; Boeva V, 2016, FRONT GENET, V7, DOI 10.3389/fgene.2016.00024; Chen CY, 2008, P NATL ACAD SCI USA, V105, P2527, DOI 10.1073/pnas.0712188105; Chumsakul O, 2017, J BACTERIOL, V199, DOI 10.1128/JB.00086-17; Chumsakul O, 2011, NUCLEIC ACIDS RES, V39, P414, DOI 10.1093/nar/gkq780; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Gama-Castro S, 2016, NUCLEIC ACIDS RES, V44, pD133, DOI 10.1093/nar/gkv1156; GuhaThakurta D, 2001, BIOINFORMATICS, V17, P608, DOI 10.1093/bioinformatics/17.7.608; HALDENWANG WG, 1995, MICROBIOL REV, V59, P1; Handschin C, 2003, PHARMACOL REV, V55, P649, DOI 10.1124/pr.55.4.2; Hertz GZ, 1999, BIOINFORMATICS, V15, P563, DOI 10.1093/bioinformatics/15.7.563; Jensen ST, 2004, BIOINFORMATICS, V20, P1557, DOI 10.1093/bioinformatics/bth127; Johnson DS, 2007, SCIENCE, V316, P1497, DOI 10.1126/science.1141319; Khan A, 2018, NUCLEIC ACIDS RES, V46, pD260, DOI 10.1093/nar/gkx1126; LAWRENCE CE, 1993, SCIENCE, V262, P208, DOI 10.1126/science.8211139; Liu Y, 2001, IFAC WORK S, P127; Lu RP, 2017, NUCLEIC ACIDS RES, V45, DOI 10.1093/nar/gkw1036; Luscombe NM, 2001, NUCLEIC ACIDS RES, V29, P2860, DOI 10.1093/nar/29.13.2860; Makita Y, 2004, NUCLEIC ACIDS RES, V32, pD75, DOI 10.1093/nar/gkh074; Martinez-Antonio A, 2003, CURR OPIN MICROBIOL, V6, P482, DOI 10.1016/j.mib.2003.09.002; MORAN CP, 1982, MOL GEN GENET, V186, P339, DOI 10.1007/BF00729452; Salama RA, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq274; Shi JX, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001388; Shultzaberger RK, 2001, J MOL BIOL, V313, P215, DOI 10.1006/jmbi.2001.5040; Siddharthan R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009722; Stormo GD, 2000, BIOINFORMATICS, V16, P16, DOI 10.1093/bioinformatics/16.1.16; STRAUCH MA, 1995, J BACTERIOL, V177, P4532, DOI 10.1128/jb.177.15.4532-4536.1995; Tompa M, 2005, NAT BIOTECHNOL, V23, P137, DOI 10.1038/nbt1053; Weirauch MT, 2013, NAT BIOTECHNOL, V31, P126, DOI 10.1038/nbt.2486; Xie XH, 2005, NATURE, V434, P338, DOI 10.1038/nature03441; Xu K, 1996, J BACTERIOL, V178, P4319, DOI 10.1128/jb.178.14.4319-4322.1996; Zhao Y, 2012, GENETICS, V191, P781, DOI 10.1534/genetics.112.138685	35	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2019	14	8							e0220207	10.1371/journal.pone.0220207	http://dx.doi.org/10.1371/journal.pone.0220207			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW6BO	31469855	Green Submitted, gold, Green Published			2022-12-26	WOS:000485062200008
J	Luu, HN; Huang, JY; Wang, RW; Adams-Haduch, J; Jin, AZ; Koh, WP; Yuan, JM				Luu, Hung N.; Huang, Joyce Y.; Wang, Renwei; Adams-Haduch, Jennifer; Jin, Aizhen; Koh, Woon-Puay; Yuan, Jian-Min			Association between leukocyte telomere length and the risk of pancreatic cancer: Findings from a prospective study	PLOS ONE			English	Article							POPULATION-BASED SAMPLE; BODY-MASS INDEX; CIGARETTE-SMOKING; PHYSICAL-ACTIVITY; OLDER CHINESE; SINGAPORE; TISSUES; CELLS; FREQUENCY; BLOOD	Introduction Telomeres and telomerase play important role in maintaining chromosome integrity and genomic stability. Recent epidemiologic data showed inconsistent findings which suggested that both short and long leukocyte telomeres could be associated with increased risk of pancreatic cancer. We prospectively examined the association between telomere length and pancreatic cancer risk in a population-based cohort study. Methods The Singapore Chinese Health Study recruited 63,257 Chinese aged 45 to 74 years from 1993 to 1998 in Singapore. Relative telomere length in peripheral blood leukocytes was quantified using a validated monochrome multiplex quantitative polymerase chain reaction method in 26,540 participants, including 116 participants who later developed pancreatic cancer after an average of 13 years of follow-up. Cox proportional hazard regression method was used to calculate hazard ratio (HR) and its 95% confidence interval (CI) of pancreatic cancer risk associated with telomere length, with adjustment for confounding factors. Results Longer telomeres were significantly associated with higher risk of pancreatic cancer (P-trend = 0.02). Compared with lowest quartile, subjects with highest quartile of telomere length had an HR of 2.18 (95% CI: 1.25-3.80) for developing pancreatic cancer. In stratified analysis, this association remained among pancreatic adenocarcinoma patients but not among pancreatic non-adenocarcinoma patients. In continuous scale, the HRs and 95% CIs were 3.08 (1.17-8.11) for adenocarcinoma patients and 1.47 (0.43-5.06) for non-adenocarcinoma patients. The HRs and 95% CIs of the highest quartile of telomere length, compared with the lowest quartile, for adenocarcinoma and non-adenocarcinoma were 2.50 (1.22-5.13) and 1.63 (0.66-4.03), respectively. The length of follow-up from the collection of blood for the measurement of telomere length to the diagnosis of cancer (median = 8.0, range: from 5.0 months to 16.2 years) had no significant impact on the association between telomere length and pancreatic cancer risk. Conclusions The present study demonstrates that longer telomeres are associated with increased risk of overall pancreatic cancer.	[Luu, Hung N.; Huang, Joyce Y.; Wang, Renwei; Adams-Haduch, Jennifer; Yuan, Jian-Min] Univ Pittsburgh, UPMC Hillman Canc Ctr, Div Canc Control & Populat Sci, Pittsburgh, PA 15260 USA; [Luu, Hung N.; Yuan, Jian-Min] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Epidemiol, Pittsburgh, PA 15260 USA; [Jin, Aizhen; Koh, Woon-Puay] Duke NUS Med Sch Singapore, Hlth Serv & Syst Res, Singapore, Singapore; [Koh, Woon-Puay] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore, Singapore	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; National University of Singapore; National University of Singapore	Luu, HN (corresponding author), Univ Pittsburgh, UPMC Hillman Canc Ctr, Div Canc Control & Populat Sci, Pittsburgh, PA 15260 USA.; Luu, HN (corresponding author), Univ Pittsburgh, Grad Sch Publ Hlth, Dept Epidemiol, Pittsburgh, PA 15260 USA.	luuh@upmc.edu		Luu, Hung/0000-0002-2172-1849	United States National Institute of Cancer (NCI) [R01 CA144034, UM1 CA182876]; National Medical Research Council, Singapore [NMRC/CSA/0055/2013]; NIH/NCI [P20 CA210300-01]; University of Pittsburgh Medical Center Hillman Cancer Center start-up grant; NATIONAL CANCER INSTITUTE [UM1CA182876, P20CA210300] Funding Source: NIH RePORTER	United States National Institute of Cancer (NCI); National Medical Research Council, Singapore(National Medical Research Council, SingaporeUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); University of Pittsburgh Medical Center Hillman Cancer Center start-up grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	J-M Yuan is supported by the United States National Institute of Cancer (NCI) (Grants #R01 CA144034 and UM1 CA182876). W-P Koh is supported by the National Medical Research Council, Singapore (NMRC/CSA/0055/2013). HN Luu is supported by NIH/NCI Grant #P20 CA210300-01 and the University of Pittsburgh Medical Center Hillman Cancer Center start-up grant.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Aladdin H, 2003, SCAND J IMMUNOL, V57, P485, DOI 10.1046/j.1365-3083.2003.01258.x; Antwi SO, 2018, PANCREAS, V47, P265, DOI [10.1097/MPA.0000000000000995, 10.1097/MPA.000000000]; Antwi SO, 2017, CANCER EPIDEM BIOMAR, V26, P971, DOI 10.1158/1055-9965.EPI-17-0100; Antwi SO, 2016, CARCINOGENESIS, V37, P481, DOI 10.1093/carcin/bgw022; Astuti Y, 2017, ENVIRON RES, V158, P480, DOI 10.1016/j.envres.2017.06.038; Bao Y, 2017, GUT, V66, P1116, DOI 10.1136/gutjnl-2016-312510; Blackburn EH, 2010, ANGEW CHEM INT EDIT, V49, P7405, DOI 10.1002/anie.201002387; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Brune KA, 2010, JNCI-J NATL CANCER I, V102, P119, DOI 10.1093/jnci/djp466; Campa D, 2014, CANCER EPIDEM BIOMAR, V23, P2447, DOI 10.1158/1055-9965.EPI-14-0247; Cawthon RM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkn1027; Codd V, 2013, NAT GENET, V45, P422, DOI 10.1038/ng.2528; Daniali L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2602; di Fagagna FD, 2003, NATURE, V426, P194, DOI 10.1038/nature02118; Du MM, 2012, AM J EPIDEMIOL, V175, P414, DOI 10.1093/aje/kwr330; Friedrich U, 2000, MECH AGEING DEV, V119, P89, DOI 10.1016/S0047-6374(00)00173-1; Gadalla SM, 2010, AGING-US, V2, P867, DOI 10.18632/aging.100235; Gardner JP, 2007, J GERONTOL A-BIOL, V62, P367, DOI 10.1093/gerona/62.4.367; Granick Mark, 2011, Eplasty, V11, pe15; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hankin JH, 2001, NUTR CANCER, V39, P187, DOI 10.1207/S15327914nc392_5; Harley CB, 1998, CIBA F SYMP, V211, P129; Haycock PC, 2017, JAMA ONCOL, V3, P636, DOI 10.1001/jamaoncol.2016.5945; Huang JY, 2016, CANCER EPIDEM BIOMAR, V25, P417, DOI 10.1158/1055-9965.EPI-15-0594; Huzen J, 2014, J INTERN MED, V275, P155, DOI 10.1111/joim.12149; Kaszubowska L, 2008, J PHYSIOL PHARMACOL, V59, P169; Kipling D, 1998, CIBA F SYMP, V211, P139; Latifovic L, 2016, CANCER EPIDEM BIOMAR, V25, P374, DOI 10.1158/1055-9965.EPI-14-1364; Lynch SM, 2013, INT J CANCER, V133, P2672, DOI 10.1002/ijc.28272; Maciejowski J, 2017, NAT REV MOL CELL BIO, V18, P175, DOI 10.1038/nrm.2016.171; Maisonneuve P, 2015, INT J EPIDEMIOL, V44, P186, DOI 10.1093/ije/dyu240; Parkin DM, 2002, CANC INCIDENCE 5 CON, VVIII; Rode L, 2014, J CLIN ENDOCR METAB, V99, pE1671, DOI 10.1210/jc.2014-1161; Seow A, 1998, CANCER EPIDEM BIOMAR, V7, P135; Seow A, 1998, CANCER EPIDEM BIOMAR, V7, P775; Siegel RL, 2018, CA-CANCER J CLIN, V68, P7, DOI 10.3322/caac.21442; Skinner HG, 2012, CANCER EPIDEM BIOMAR, V21, P2095, DOI 10.1158/1055-9965.EPI-12-0671; SLAGBOOM PE, 1994, AM J HUM GENET, V55, P876; Stewart SA, 2006, ANNU REV CELL DEV BI, V22, P531, DOI 10.1146/annurev.cellbio.22.010305.104518; Stewart SA, 2010, CANCER RES, V70, P7365, DOI 10.1158/0008-5472.CAN-10-1373; Tomasetti C, 2015, SCIENCE, V347, P78, DOI 10.1126/science.1260825; Valdes AM, 2005, LANCET, V366, P662, DOI 10.1016/S0140-6736(05)66630-5; WHO, 2004, LANCET, V363, P902; Yuan JM, 2018, INT J CANCER, V142, P2234, DOI 10.1002/ijc.31251; Yuan JM, 2003, CANCER EPIDEM BIOMAR, V12, P890; Zamarron BF, 2011, INT J BIOL SCI, V7, P651, DOI 10.7150/ijbs.7.651; Zhang R, 2016, ONCOTARGET, V7, P38579, DOI 10.18632/oncotarget.9536	48	13	13	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2019	14	8							e0221697	10.1371/journal.pone.0221697	http://dx.doi.org/10.1371/journal.pone.0221697			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW6AB	31465482	gold, Green Submitted, Green Published			2022-12-26	WOS:000485058200036
J	Persmark, A; Wemrell, M; Zettermark, S; Leckie, G; Subramanian, SV; Merlo, J				Persmark, Anna; Wemrell, Maria; Zettermark, Sofia; Leckie, George; Subramanian, S., V; Merlo, Juan			Precision public health: Mapping socioeconomic disparities in opioid dispensations at Swedish pharmacies by Multilevel Analysis of Individual Heterogeneity and Discriminatory Accuracy (MAIHDA)	PLOS ONE			English	Article							BRIEF CONCEPTUAL TUTORIAL; SOCIAL EPIDEMIOLOGY; MENTAL-HEALTH; INTERSECTIONALITY THEORY; USE DISORDERS; RISK-FACTORS; POPULATION; DETERMINANTS; ASSOCIATION; MORTALITY	Background In light of the opioid epidemic in the United States, there is growing concern about the use of opioids in Sweden as it may lead to misuse and overuse and, in turn, severe public health problems. However, little is known about the distribution of opioid use across different demographic and socioeconomic dimensions in the Swedish general population. Therefore, we applied an intersectional Multilevel Analysis of Individual Heterogeneity and Discriminatory Accuracy (MAIHDA), to obtain an improved mapping of the risk heterogeneity of and socioeconomic inequalities in opioid prescription receipt. Methods and findings Using data from 6,846,106 residents in Sweden aged 18 and above, we constructed 72 intersectional strata from combinations of gender, age, income, cohabitation status, and presence or absence of psychological distress. We modelled the absolute risk (AR) of opioid prescription receipt in a series of multilevel logistic regression models distinguishing between additive and interaction effects. By means of the Variance Partitioning Coefficient (VPC) and the area under the receiver operating characteristic curve (AUC), we quantified the discriminatory accuracy (DA) of the intersectional strata for discerning those who received opioid prescriptions from those who did not. The AR of opioid prescription receipt ranged from 2.77% (95% CI 2.69-2.86) among low-income men aged 18-34, living alone, without psychological distress, to 28.25% (95% CI 27.95-28.56) among medium-income women aged 65 and older, living alone, with psychological distress. In a model that conflated both additive and interaction effects, the intersectional strata had a fair DA for discerning opioid users from non-users (VPC = 13.2%, AUC = 0.68). However, in the model that decomposed total effects into additive and interaction effects, the VPC was very low (0.42%) indicating the existence of small interaction effects for a number of the intersectional strata. Conclusions The intersectional MAIHDA approach aligns with the aims of precision public health, through improving the evidence base for health policy by increasing understanding of both health inequalities and individual heterogeneity. This approach is particularly relevant for socioeconomically conditioned outcomes such as opioid prescription receipt. We have identified intersections of social position within the Swedish population at greater risk for opioid prescription receipt.	[Persmark, Anna; Wemrell, Maria; Zettermark, Sofia; Leckie, George; Merlo, Juan] Lund Univ, Fac Med, Unit Social Epidemiol, Malmo, Sweden; [Wemrell, Maria] Lund Univ, Fac Social Sci, Dept Gender Studies, Lund, Sweden; [Leckie, George] Univ Bristol, Ctr Multilevel Modelling, Bristol, Avon, England; [Subramanian, S., V] Harvard TH Chan Sch Publ Hlth, Dept Social & Behav Sci, Boston, MA USA; [Merlo, Juan] Ctr Primary Hlth Care Res, Malmo, Sweden	Lund University; Lund University; University of Bristol; Harvard University; Harvard T.H. Chan School of Public Health	Persmark, A; Wemrell, M (corresponding author), Lund Univ, Fac Med, Unit Social Epidemiol, Malmo, Sweden.; Wemrell, M (corresponding author), Lund Univ, Fac Social Sci, Dept Gender Studies, Lund, Sweden.	apersmark@gmail.com; maria.wemrell@med.lu.se	Wemrell, Maria/AAO-4079-2021; Zettermark, Sofia/AAD-1920-2021; Merlo, Juan/E-2136-2011	Zettermark, Sofia/0000-0003-3181-8609; Wemrell, Maria/0000-0002-3186-9054; Merlo, Juan/0000-0001-8379-9708; Persmark, Anna/0000-0001-5446-1484	Swedish Research Council (Vetenskapsradet) [2017-01321]; Faculty of Medicine, Lund University; Region Skane County Council	Swedish Research Council (Vetenskapsradet)(Swedish Research Council); Faculty of Medicine, Lund University; Region Skane County Council	This work was supported by Swedish Research Council (Vetenskapsradet), https://www.vr.se/inenglish.4.12fff4451215cbd83e4800015152.html, Grant #: 2017-01321, JM; Faculty of Medicine, Lund University, https://www.med.lu.se/english, JM; Region Skane County Council, http://www.researchweb.org/is/ssvr, JM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2017, USERS GUIDE MLWIN V3; Backryd E., 2017, LAKARTIDNINGEN, V114; Bauer GR, 2014, SOC SCI MED, V110, P10, DOI 10.1016/j.socscimed.2014.03.022; Bayer R, 2015, NEW ENGL J MED, V373, P499, DOI 10.1056/NEJMp1506241; Bohnert ASB, 2011, JAMA-J AM MED ASSOC, V305, P1315, DOI 10.1001/jama.2011.370; Bonnie RJ, 2017, JAMA-J AM MED ASSOC, V318, P423, DOI 10.1001/jama.2017.10046; Browne W. J., 2017, MCMC ESTIMATION MLWI; Browne WJ, 2017, MLWIN VERSION 301; Choo HY, 2010, SOCIOL THEOR, V28, P129, DOI 10.1111/j.1467-9558.2010.01370.x; Crenshaw Kimberle, 1989, UNIV CHICAGO LEG FOR, P139, DOI DOI 10.4324/9780429500480-5; CRUTCHFIELD RD, 1984, SOC SCI MED, V18, P503, DOI 10.1016/0277-9536(84)90008-X; Degenhardt L, 2014, ADDICTION, V109, P1320, DOI 10.1111/add.12551; Edlund MJ, 2010, CLIN J PAIN, V26, P1, DOI 10.1097/AJP.0b013e3181b99f35; Evans C. R, 2015, INNOVATIVE APPROACHE; Evans CR, 2019, SOC SCI MED, V220, P1, DOI 10.1016/j.socscimed.2018.10.019; Evans CR, 2018, SOC SCI MED, V203, P64, DOI 10.1016/j.socscimed.2017.11.011; Fisk SA, 2018, SSM-POPUL HLTH, V4, P334, DOI 10.1016/j.ssmph.2018.03.005; Frenk S.M., 2015, PRESCRIPTION OPIOID; Fugelstad A, 2015, SOCIALMEDICINSK TIDS, V92; Galea S, 2004, EPIDEMIOL REV, V26, P36, DOI 10.1093/epirev/mxh007; Galobardes B, 2007, BRIT MED BULL, V81-82, P21, DOI 10.1093/bmb/ldm001; Ghith N, 2016, PLOS ONE, V11; Goldstein H., 2002, Understanding Statistics, V1, P223, DOI 10.1207/S15328031US0104_02; Green MA, 2017, SOC SCI MED, V178, P214, DOI 10.1016/j.socscimed.2017.02.029; Gustafsson A, 2011, BERAKNINGSDEFINITION; Han B, 2017, ANN INTERN MED, V167, pI24, DOI 10.7326/P17-9042; Hancock A.M., 2013, UC IRVINE LAW REV, V3, P259; Hernandez-Yumar A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0208624; Hudson TJ, 2008, J PAIN SYMPTOM MANAG, V36, P280, DOI 10.1016/j.jpainsymman.2007.10.003; Imtiaz S, 2014, SUBST ABUSE TREAT PR, V9, DOI 10.1186/1747-597X-9-43; Ivert AK, 2016, ETHNIC HEALTH, V21, P578, DOI 10.1080/13557858.2016.1143090; Jones K., 2016, METHODOL INNOV, V9, P1, DOI DOI 10.1177/2059799116672874; Juarez SP, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005388; Katz C, 2013, DRUG ALCOHOL DEPEN, V132, P107, DOI 10.1016/j.drugalcdep.2013.01.010; Khoury MJ, 2016, JAMA-J AM MED ASSOC, V316, P1357, DOI 10.1001/jama.2016.12260; Khoury MJ, 2016, AM J PREV MED, V50, P398, DOI 10.1016/j.amepre.2015.08.031; King NB, 2014, AM J PUBLIC HEALTH, V104, pE32, DOI 10.2105/AJPH.2014.301966; Kolodny A, 2015, ANNU REV PUBL HEALTH, V36, P559, DOI 10.1146/annurev-publhealth-031914-122957; Leckie G, 2013, J STAT SOFTW, V52, P1; Link BG, 2006, LANCET, V367, P528, DOI 10.1016/S0140-6736(06)68184-1; Ludvigsson JF, 2016, EUR J EPIDEMIOL, V31, P125, DOI 10.1007/s10654-016-0117-y; Lynch JW., 2000, SOCIAL EPIDEMIOLOGY, P13; MANCHIKANTI L, 2012, PAIN PHYS S, V15, pES; McCall L, 2005, SIGNS, V30, P1771, DOI 10.1086/426800; Merlo J, 2005, MED CARE, V43, P1092, DOI 10.1097/01.mlr.0000182484.14608.b9; Merlo J, 2005, J EPIDEMIOL COMMUN H, V59, P729, DOI 10.1136/jech.2004.023929; Merlo J, 2004, AM J EPIDEMIOL, V159, P1168, DOI 10.1093/aje/kwh160; Merlo J, 2009, J EPIDEMIOL COMMUN H, V63, P1043, DOI 10.1136/jech.2009.088310; Merlo J, 2003, J EPIDEMIOL COMMUN H, V57, P550, DOI 10.1136/jech.57.8.550; Merlo J, 2006, J EPIDEMIOL COMMUN H, V60, P290, DOI 10.1136/jech.2004.029454; Merlo J, 2013, EUR J EPIDEMIOL, V28, P135; Merlo J, 2015, EC SALUD BOLETI INFO, V84; Merlo J, 2013, EUR J EPIDEMIOL S, V28, P148; Merlo J, 2018, SOC SCI MED, V203, P74, DOI 10.1016/j.socscimed.2017.12.026; Merlo J, 2017, SSM-POPUL HLTH, V3, P684, DOI 10.1016/j.ssmph.2017.08.005; Merlo J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153778; Merlo J, 2015, EUR J PUBLIC HEALTH, V25, P910, DOI 10.1093/eurpub/ckv209; Merlo J, 2014, AM J EPIDEMIOL, V180, P208, DOI 10.1093/aje/kwu108; Mulinari S, 2018, CRIT PUBLIC HEALTH, V28, P177, DOI 10.1080/09581596.2017.1316831; Mulinari S, 2015, EUR J PUBLIC HEALTH, V25, P911, DOI 10.1093/eurpub/ckv099; Ohlsson H, 2011, MED CARE, V49, P327, DOI 10.1097/MLR.0b013e31820325c5; Pepe MS, 2004, AM J EPIDEMIOL, V159, P882, DOI 10.1093/aje/kwh101; Rhodin A, 2014, LAKARTIDNINGEN, V111, pCZW3; Scherbaum N, 2008, INT J METH PSYCH RES, V17, pS39, DOI 10.1002/mpr.244; Seal KH, 2012, JAMA-J AM MED ASSOC, V307, P940, DOI 10.1001/jama.2012.234; Seng JS, 2012, SOC SCI MED, V75, P2437, DOI 10.1016/j.socscimed.2012.09.023; Shah A, 2017, J PAIN, V18, P1374, DOI 10.1016/j.jpain.2017.06.010; Socialstyrelsen, STAT LAK 2017; Socialstyrelsen, 2017, STAT LAK 2016; Subramanian SV, 2004, SOC SCI MED, V58, P1961, DOI 10.1016/S0277-9536(03)00415-5; Subramanian SV, 2007, MACROSOCIAL DETERMIN, P301, DOI DOI 10.1007/978-0-387-70812-6_15; Svendsen K, 2014, ACTA ANAESTH SCAND, V58, P437, DOI 10.1111/aas.12281; Tjaderborn M, 2009, PHARMACOEPIDEM DR S, V18, P1192, DOI 10.1002/pds.1838; VanderWeele TJ, 2014, EPIDEMIOL METHODS, V3, P33, DOI [DOI 10.1515/EM-2013-0005, 10.1515/em-2013-0005]; Wagner P, 2015, INT J EPIDEMIOL, V44, P49; Wemrell M, 2017, SOC SCI MED, V178, P217, DOI 10.1016/j.socscimed.2017.02.040; Wemrell M, 2017, SOC SCI MED, V177, P213, DOI 10.1016/j.socscimed.2017.01.050; Wettermark B, 2007, PHARMACOEPIDEM DR S, V16, P726, DOI 10.1002/pds.1294	78	16	16	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2019	14	8							e0220322	10.1371/journal.pone.0220322	http://dx.doi.org/10.1371/journal.pone.0220322			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW5WO	31454361	Green Submitted, Green Published, gold			2022-12-26	WOS:000485049000005
J	Liu, Y; Li, LP; Huang, T; Wang, R; Liang, WW; Yang, Q; Lei, AY; Chen, M				Liu, Yu; Li, Liping; Huang, Ting; Wang, Rui; Liang, Wanwen; Yang, Qiong; Lei, Aiying; Chen, Ming			Comparative multi-omics systems analysis reveal the glycolysis/gluconeogenesis signal pathway play an important role in virulence attenuation in fish-derived GBS YM001	PLOS ONE			English	Article							TILAPIA OREOCHROMIS-NILOTICUS; GROUP-B STREPTOCOCCUS; MOLECULAR CHARACTERIZATION; SUBUNIT VACCINE; NILE TILAPIA; AGALACTIAE; EFFICACY; GENES; RESISTANCE; EXPRESSION	Streptococcus agalactiae(GBS) is a seriously threat to the farmed tilapia, and oral vaccination was considered to be the most desirable means which requires deep understanding of virulence mechanism of the fish-derived GBS. Our previous genome study of the fish-derived attenuated strain YM001 showed that there were two large deletions in YM001 compared to its parental virulent strain HN016. In this study, a combined transcriptomic and proteomic analysis was performed on YM001 and HN016 strains, and the important genes were verified by RT-qPCR in bacteria strains and infected-tilapia tissues. Overall, we have shown that a total of 958 genes and 331 proteins were significantly differential expressed between YM001 and HN016. By functional annotation of these DEGs and DEPs, genes that were enriched in pentose phosphate pathway(pgm, ptsG, pgi pfkA, fbaA and FBP3) and pyruvate metabolism pathway(pdhA, pdhB, pdhC and pdhD) were identifed as important candidate genes for leads low growth ability in attenuated strain, which may be an important reasons leading virulence attenuation in the end. The expression levels the candidate genes in pentose phosphate pathway and pyruvate metabolism pathway were significant differential expressed in tilapia' brain and spleen when infected with YM001 and HN016. Our study indicated that the pentose phosphate pathway and pyruvate metabolism pathway that affecting the growth of the strain may be one of the important reasons for the virulence attenuation in HN016.	[Liu, Yu; Li, Liping; Huang, Ting; Wang, Rui; Liang, Wanwen; Yang, Qiong; Lei, Aiying; Chen, Ming] Guangxi Acad Fishery Sci, Nanning, Peoples R China		Chen, M (corresponding author), Guangxi Acad Fishery Sci, Nanning, Peoples R China.	cmbegin990919@163.com			National Natural Science Foundation of China [31460695]; Guangxi innovationdriven development special funds [AA17204081-3]; Guangxi Key Laboratory for Aquatic Genetic Breeding and Healthy Aquaculture; Guangxi Natural Science Foundation [2016GXNSFDA380020]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangxi innovationdriven development special funds; Guangxi Key Laboratory for Aquatic Genetic Breeding and Healthy Aquaculture; Guangxi Natural Science Foundation(National Natural Science Foundation of Guangxi Province)	This work was supported by National Natural Science Foundation of China, M C (Grant no. 31460695); Guangxi innovationdriven development special funds, M C (Grant no. AA17204081-3); The funds of Guangxi Key Laboratory for Aquatic Genetic Breeding and Healthy Aquaculture, M C (2018); Guangxi Natural Science Foundation, LP L(Grant no. 2016GXNSFDA380020). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Andreu Domingo A, 1997, An Esp Pediatr, V46, P383; BAYA AM, 1990, J FISH DIS, V13, P251, DOI 10.1111/j.1365-2761.1990.tb00781.x; Bradley RK, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000343; Carmeliet P, 1998, NATURE, V394, P485, DOI 10.1038/28867; Chen M, 2012, VET MICROBIOL, V159, P526, DOI 10.1016/j.vetmic.2012.04.035; Chen M, 2012, VACCINE, V30, P6088, DOI 10.1016/j.vaccine.2012.07.044; Cheng S, 2010, VACCINE, V28, P2636, DOI 10.1016/j.vaccine.2010.01.016; DEPAOLA A, 1995, APPL ENVIRON MICROB, V61, P2335, DOI 10.1128/AEM.61.6.2335-2340.1995; Doran KS, 2005, J CLIN INVEST, V115, P2499, DOI 10.1172/JCI23829; Duremdez R, 2004, J FISH DIS, V27, P307, DOI 10.1111/j.1365-2761.2004.00538.x; Dutra VG, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-323; ELDAR A, 1995, VET MICROBIOL, V43, P33, DOI 10.1016/0378-1135(94)00052-X; Evans JJ, 2004, VACCINE, V22, P3769, DOI 10.1016/j.vaccine.2004.03.012; Florindo C, 2012, J MICROBIOL METH, V90, P220, DOI 10.1016/j.mimet.2012.05.011; Franceschini A, 2013, NUCLEIC ACIDS RES, V41, pD808, DOI 10.1093/nar/gks1094; Gudding R, 2013, FISH SHELLFISH IMMUN, V35, P1683, DOI 10.1016/j.fsi.2013.09.031; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Huang LY, 2014, FISH SHELLFISH IMMUN, V38, P34, DOI 10.1016/j.fsi.2014.02.017; Jantrakajorn S, 2014, J WORLD AQUACULT SOC, V45, P392, DOI 10.1111/jwas.12131; Jiang BH, 1997, CANCER RES, V57, P5328; Johri AK, 2003, INFECT IMMUN, V71, P6707, DOI 10.1128/IAI.71.12.6707-6711.2003; Johri AK, 2006, NAT REV MICROBIOL, V4, P932, DOI 10.1038/nrmicro1552; Jones P, 2014, BIOINFORMATICS, V30, P1236, DOI 10.1093/bioinformatics/btu031; Kainulainen V, 2012, J BACTERIOL, V194, P2509, DOI 10.1128/JB.06704-11; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Kayansamruaj P, 2014, J VET DIAGN INVEST, V26, P488, DOI 10.1177/1040638714534237; Kizaki Z, 2009, J BIOL CHEM, V277, P47965, DOI DOI 10.1074/JBC.X200007200; Koppang EO, 2005, J FISH DIS, V28, P13, DOI 10.1111/j.1365-2761.2004.00583.x; Li LP, 2015, FISH SHELLFISH IMMUN, V45, P955, DOI 10.1016/j.fsi.2015.06.014; Lin JHY, 2005, DEV BIOLOGICALS, V121, P175; Liu GJ, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-775; Markestad A, 1997, DEV BIOLOGICALS, V90, P365; Marohn ME, 2013, VACCINE, V31, P3485, DOI 10.1016/j.vaccine.2013.05.096; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Murarka A, 2010, J BIOL CHEM, V285, P31548, DOI 10.1074/jbc.M110.121095; Noraini O, 2013, J AQUAT ANIM HEALTH, V25, P142, DOI 10.1080/08997659.2013.781553; Nur-Nazifah M, 2014, FISH SHELLFISH IMMUN, V37, P193, DOI 10.1016/j.fsi.2014.01.011; Pasnik DJ, 2005, J FISH DIS, V28, P205, DOI 10.1111/j.1365-2761.2005.00619.x; PLUMB JA, 1974, T AM FISH SOC, V103, P358, DOI 10.1577/1548-8659(1974)103<358:SSFMFA>2.0.CO;2; Pridgeon JW, 2013, VACCINE, V31, P2705, DOI 10.1016/j.vaccine.2013.03.066; Ramsey MR, 2006, NAT CELL BIOL, V8, P1213, DOI 10.1038/ncb1106-1213; Reisch AS, 2007, METHOD CELL BIOL, V80, P199, DOI 10.1016/S0091-679X(06)80010-5; Sautin YY, 2007, AM J PHYSIOL-CELL PH, V293, pC584, DOI 10.1152/ajpcell.00600.2006; SCOTT AI, 1975, IRISH J MED SCI, P15; Wang LK, 2010, BIOINFORMATICS, V26, P136, DOI 10.1093/bioinformatics/btp612; Wang R, 2017, VET MICROBIOL, V207, P164, DOI 10.1016/j.vetmic.2017.06.007; Wang R, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2026-y; Ye X, 2011, FISHERIES SCI, V77, P623, DOI 10.1007/s12562-011-0365-4; Young MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r14; Zhang DF, 2013, AQUACULTURE, V412, P64, DOI 10.1016/j.aquaculture.2013.07.014	51	2	2	4	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2019	14	8							e0221634	10.1371/journal.pone.0221634	http://dx.doi.org/10.1371/journal.pone.0221634			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5UR	31449567	Green Published, gold, Green Submitted			2022-12-26	WOS:000485044000029
J	Laroche, M; Roussel, P; Cury, F; Boiche, J				Laroche, Manon; Roussel, Peggy; Cury, Francois; Boiche, Julie			Understanding the dynamics of physical activity practice in the health context through Regulatory Focus and Self-Determination theories	PLOS ONE			English	Article							ACTIVITY QUESTIONNAIRE; FIT; PREVENTION; PROMOTION; TESTS; IPAQ	This research aimed to associate for the first time in the literature Regulatory Focus and Self-Determination theories to understand the dynamics of physical activity practice in the health context. Two cross-sectional studies were conducted with 603 (Study 1) and 395 (Study 2) French volunteer participants aged from 18 to 69 and 19 to 71 respectively, who were healthy or concerned by a health condition. The main results of structural equation modeling analyses demonstrated that across the two studies, health promotion focus was positively associated with intrinsic motivation (.44 < beta < .74, p < .001), integrated regulation (.47 < beta < .72, p < .001), identified regulation (.40 < beta < .69, p < .001) and introjected regulation (.41 < beta < .53, p < .001), whereas health prevention focus was positively related with external regulation (.31 < beta < .45, p < .001) and amotivation (.32 < beta < .38, p < .001). Boot-strapping analyses main results in Study 2 showed that health promotion focus was indirectly associated with physical activity through intrinsic motivation (95% CI [.02 to .11]), integrated regulation (95% CI [.00 to .08]), identified regulation (95% CI [.00 to .09]) and introjected regulation (95% CI [.04 to .12]), whereas health prevention focus was indirectly associated with physical activity through external regulation (95% CI [.00 to .12]). These studies reveal meaningful associations between Regulatory Focus and Self-Determination theories' variables which support the relevance of associating these two models to understand the processes underlying the physical activity practice.	[Laroche, Manon; Roussel, Peggy; Cury, Francois] Aix Marseille Univ, CNRS, ISM, Marseille, France; [Boiche, Julie] Univ Montpellier, Univ Paul Valery Montpellier 3, EPSYLON EA, Montpellier, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Universite de Montpellier; Universite Paul-Valery	Laroche, M (corresponding author), Aix Marseille Univ, CNRS, ISM, Marseille, France.	manon.laroche@univ-amu.fr		Laroche, Manon/0000-0002-3833-2735				Assor A, 2009, J EDUC PSYCHOL, V101, P482, DOI 10.1037/a0014236; Boiche J, 2016, J HLTH PSYCHOL; Chalmers RP, 2012, J STAT SOFTW, V48, P1; Chen FF, 2008, J RES PERS, V42, P259, DOI 10.1016/j.jrp.2007.05.006; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; Criniere L, 2011, J PHYS ACT HEALTH, V8, P858, DOI 10.1123/jpah.8.6.858; Deci EL, 2000, PSYCHOL INQ, V11, P227, DOI 10.1207/S15327965PLI1104_01; Deci EL, 1985, INTRINSIC MOTIVATION; Ding D, 2016, LANCET, V388, P1311, DOI 10.1016/S0140-6736(16)30383-X; European Commission, 2018, SPORT PHYS ACT, P272; Ferrer RA, 2017, SOC SCI MED, V195, P50, DOI 10.1016/j.socscimed.2017.10.029; Fuglestad PT, 2008, HEALTH PSYCHOL, V27, pS260, DOI 10.1037/0278-6133.27.3(Suppl.).S260; Gauthier AP, 2009, J PHYS ACT HEALTH, V6, pS54, DOI 10.1123/jpah.6.s1.s54; Gomez P, 2013, J CONSUM PSYCHOL, V23, P451, DOI 10.1016/j.jcps.2013.02.001; Gourlan M, 2016, BEHAV MED, V42, P227, DOI 10.1080/08964289.2014.1001810; Hayes AF., PROCESS FOR SPSS VER; Higgins ET, 2000, AM PSYCHOL, V55, P1217, DOI 10.1037/0003-066X.55.11.1217; Higgins ET, 1998, ADV EXP SOC PSYCHOL, V30, P1, DOI 10.1016/S0065-2601(08)60381-0; Higgins ET, 1997, AM PSYCHOL, V52, P1280, DOI 10.1037/0003-066X.52.12.1280; Hui CM, 2013, J PERS SOC PSYCHOL, V105, P61, DOI 10.1037/a0032503; Lalot F, 2018, J EXP PSYCHOL APPL; Laroche M, 2019, SPAN J PSYCHOL, V22, DOI 10.1017/sjp.2019.22; Meade AW, 2008, J APPL PSYCHOL, V93, P568, DOI 10.1037/0021-9010.93.3.568; Ng JYY, 2012, PERSPECT PSYCHOL SCI, V7, P325, DOI 10.1177/1745691612447309; Pfeffer I, 2013, J SPORT EXERCISE PSY, V35, P119, DOI 10.1123/jsep.35.2.119; Rzewnicki R, 2003, PUBLIC HEALTH NUTR, V6, P299, DOI 10.1079/PHN2002427; Schmalbach B, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.02005; Stephan Y, 2010, PSYCHOL WOMEN QUART, V34, P339, DOI 10.1111/j.1471-6402.2010.01579.x; Teixeira PJ, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-78; Uskul AK, 2008, PSYCHOL HEALTH, V23, P327, DOI 10.1080/14768320701360385; Vaughn LA, 2017, PERS SOC PSYCHOL B, V43, P313, DOI 10.1177/0146167216684132; World Health Organization (WHO), 2018, MOR ACT PEOPL HEALTH	32	5	5	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2019	14	8							e0216760	10.1371/journal.pone.0216760	http://dx.doi.org/10.1371/journal.pone.0216760			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW5TR	31443106	Green Published, gold, Green Submitted			2022-12-26	WOS:000485041400003
J	Sung, SI; Chang, YS; Choi, JH; Ho, Y; Kim, J; Ahn, SY; Park, WS				Sung, Se In; Chang, Yun Sil; Choi, Jin Hwa; Ho, Yohan; Kim, Jisook; Ahn, So Yoon; Park, Won Soon			Increased risk of refeeding syndrome-like hypophosphatemia with high initial amino acid intake in small-for-gestational-age, extremely-low-birthweight infants	PLOS ONE			English	Article							PARENTERAL-NUTRITION; PRETERM INFANTS; GROWTH	Background Recent nutrition guidelines for extremely-low-birth-weight infants (ELBWIs) recommend implementation of high initial amino acid (AA) supplementation in parenteral nutrition. Objective We sought to evaluate the influence of AA intake on refeeding syndrome-like electrolyte disturbances including hypophosphatemia in ELBWIs. Study design Medical records of 142 ELBWIs were reviewed. Demographic, nutritional, outcome, and electrolyte data were compared between ELBWIs with initial low (1.5 g/kg/day) and high (3 g/kg/day) AA intake. Multivariate analysis was conducted to determine the odds ratio of hypophosphatemia with high AA intake and small-for-gestational-age (SGA) ELBWIs. Results The incidence of hypophosphatemia and severe hypophosphatemia increased from 51% and 8% in period I to 59% and 20% in period II, respectively (p = 0.36 and <0.01). Specifically, SGA ELBWIs showed higher incidence of hypophosphatemia than appropriate-forgestational age (AGA) ELBWIs in period II, whereas there was no difference in period I. For severe hypophosphatemia, SGA ELBWIs presented a 27% incidence versus a 2% incidence in AGA ELBWIs, even with low initial AA intake. Despite no difference in phosphate intake between infants with and without hypophosphatemia, serum phosphate level reached a nadir at the sixth postnatal day and gradually recovered over the second week in infants with hypophosphatemia. In multivariate analyses, the odds ratios for severe hypophosphatemia were 3.6 and 6.6 with high AA intake and SGA status, respectively, with the highest being 18.0 with combined high AA intake and SGA status. Conclusions In summary, high initial AA intake significantly increased the risk of refeeding syndrome-like electrolyte dysregulations including severe hypophosphatemia in ELBWIs. In SGA ELBWIs, the risk of electrolyte disturbance was significantly higher, even with low initial AA intake. Therefore, new tailored parenteral nutrition protocols starting with lower energy intake and a gradual increase over the first week may be warranted for application in high-risk SGA ELBWIs.	[Sung, Se In; Chang, Yun Sil; Choi, Jin Hwa; Ho, Yohan; Kim, Jisook; Ahn, So Yoon; Park, Won Soon] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Pediat, Seoul, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center	Park, WS (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Pediat, Seoul, South Korea.	wonspark@skku.edu		Kim, Ji Sook/0000-0002-0100-5845	20 by 20 Project (Best) from Samsung Medical Center [3, GFO1150091]	20 by 20 Project (Best) from Samsung Medical Center	This study was supported by grants from the 20 by 20 Project (Best#3, GFO1150091) from Samsung Medical Center (Yun Sil Chang received the fund) The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bonsante F, 2011, EUR J CLIN NUTR, V65, P1088, DOI 10.1038/ejcn.2011.79; Bonsante F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072880; Boubred F, 2015, ACTA PAEDIATR, V104, P1077, DOI 10.1111/apa.13093; Lozano GB, 2019, JPEN-PARENTER ENTER, V43, P419, DOI 10.1002/jpen.1426; Ehrenkranz RA, 2011, PEDIATR RES, V69, P522, DOI 10.1203/PDR.0b013e318217f4f1; Fuentebella J, 2009, PEDIATR CLIN N AM, V56, P1201, DOI 10.1016/j.pcl.2009.06.006; Hakan N, 2014, J PERINATOL, V34, P247, DOI 10.1038/jp.2013.181; Iacobelli S, 2010, NEONATOLOGY, V98, P84, DOI 10.1159/000276979; Ichikawa G, 2012, J PEDIATR ENDOCR MET, V25, P317, DOI 10.1515/jpem-2011-0485; Igarashi A, 2017, DIS MARKERS, V2017, DOI 10.1155/2017/9748031; Jamin A, 2010, NEONATOLOGY, V97, P321, DOI 10.1159/000260135; Koletzko Berthold, 2005, J Pediatr Gastroenterol Nutr, V41 Suppl 2, pS1, DOI 10.1097/01.mpg.0000181841.07090.f4; Kotsopoulos K, 2006, J PERINATOL, V26, P749, DOI 10.1038/sj.jp.7211611; Mizumoto H, 2012, PEDIATR INT, V54, P715, DOI 10.1111/j.1442-200X.2012.03590.x; Moltu SJ, 2013, CLIN NUTR, V32, P207, DOI 10.1016/j.clnu.2012.09.004; Mulla S, 2017, ARCH DIS CHILD-FETAL, V102, pF451, DOI 10.1136/archdischild-2016-311107; Olsen IE, 2010, PEDIATRICS, V125, pE214, DOI 10.1542/peds.2009-0913; Osborn DA, 2018, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005949.pub2; Poindexter BB, 2006, J PEDIATR-US, V148, P300, DOI 10.1016/j.jpeds.2005.10.038; Ross JR, 2013, J PERINATOL, V33, P717, DOI 10.1038/jp.2013.28; SOLOMON SM, 1990, JPEN-PARENTER ENTER, V14, P90, DOI 10.1177/014860719001400190; Thureen PJ, 2003, PEDIATR RES, V53, P24, DOI 10.1203/00006450-200301000-00008; van Goudoever JB, 2018, CLIN NUTR, V37, P2315, DOI [10.1016/j.clnu.2018.05.029, 10.1016/j.clnu.2018.06.945]; VANGOUDOEVER JB, 1995, J PEDIATR-US, V127, P458, DOI 10.1016/S0022-3476(95)70083-8	24	4	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2019	14	8							e0221042	10.1371/journal.pone.0221042	http://dx.doi.org/10.1371/journal.pone.0221042			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5TR	31442245	gold, Green Submitted, Green Published			2022-12-26	WOS:000485041400018
J	Cordova, D; Lua, FM; Munoz-Velazquez, J; Street, K; Bauermeister, JA; Fessler, K; Adelman, N; Stewart, I; Riano-Mojica, E; Warford, B; Machado, F; Hubbard, K; Abuelsamid, M; Rahman, S; Rahmna, Z; Chestang, Z; Messer, K; Neilands, TB; Boyer, CB				Cordova, David; Lua, Frania Mendoza; Munoz-Velazquez, Jaime; Street, Katie; Bauermeister, Jose A.; Fessler, Kathryn; Adelman, Nicole; Stewart, Ian; Riano-Mojica, Erika; Warford, Bishop; Machado, Franco; Hubbard, Kiristen; Abuelsamid, Max; Rahman, Sakinah; Rahmna, Zaki; Chestang, Ziara; Messer, Katheryne; Neilands, Torsten B.; Boyer, Cherrie B.		Youth Leadership Council	A multilevel mHealth drug abuse and STI/HIV preventive intervention for clinic settings in the United States: A feasibility and acceptability study	PLOS ONE			English	Article							PRELIMINARY EFFICACY; YOUNG MEN; ADOLESCENTS; SEX; EMPOWERMENT; VALIDITY; HIV/STI	Background Drug abuse and sexually transmitted infections (STIs), including the human immunodeficiency virus (HIV), remain significant public health concerns in the United States. Youth are at disproportionate risk of drug use and STIs/HIV, yet interventions aimed at improving STI and HIV testing and reducing STI/HIV risk behaviors through technology-based engagement in clinic settings are limited. The purpose of this study was to examine the feasibility and acceptability of Storytelling 4 Empowerment (S4E), a multilevel mobile-health drug abuse and STI/HIV preventive application (app) for clinic settings. We also explored uptake of STI/HIV testing among youth immediately post-intervention. Method Employing community-based participatory research principles and a multi-method research design, we developed a clinician-facing app, and examined the feasibility and acceptability of S4E among clinicians (n = 6) and youth (n = 20) in an urban youth-centered community health clinic. S4E aimed to improve clinician youth risk communication and youths' drug use and STI/HIV knowledge, self-efficacy, and refusal skills. We also explored youths' uptake of STI and HIV testing. Quantitative data were analyzed by computing mean scores and proportions, and qualitative analyses followed the tenets of content analysis. Results Among eligible participants, 86.9% of youth and 85.7% of clinicians enrolled in the study, suggesting the feasibility of recruiting participants from the targeted clinic. Most clinicians identified as non-Hispanic white (83%) and female (66.7%). Among the youth, 70% identified as non-Hispanic white, followed by 30% African American, and 50% identified as female with a mean age of 19.6 (SD = 1.5, Range = 16-21). The quantitative findings suggest that the acceptability of S4E is high, as indicated by the Client Satisfaction Questionnaire (mean score = 25.2, SD: 4.8). Immediately post-intervention, all youth who reported past 90-day condomless sex or having never been tested for STIs or HIV in their lifetime, were tested for both STIs and HIV. Qualitative themes revealed four overarching themes, including S4E: (1) faciliated timely, targeted, and tailored prevention and risk reduction strategies; (2) shaped clinician and youth communication and interaction during the clinic visit; (3) may have improved uptake of STI/HIV testing and increased STI/HIV knowledge and self-efficacy; and (4) had high feasibiliy and acceptability among youth and clninicans. Conclusions Findings suggest the feasibility and acceptability of S4E in an urban community-based health clinic setting. A next important step is to examine the efficacy of S4E in a randomized controlled trial design.	[Cordova, David; Munoz-Velazquez, Jaime; Street, Katie] Univ Michigan, Sch Social Work, Ann Arbor, MI 48109 USA; [Lua, Frania Mendoza] Univ Chicago, Sch Social Serv Adm, Chicago, IL 60637 USA; [Bauermeister, Jose A.] Univ Penn, Sch Nursing, Philadelphia, PA 19104 USA; [Fessler, Kathryn; Adelman, Nicole; Youth Leadership Council] Corner Hlth Ctr, Ypsilanti, MI USA; [Neilands, Torsten B.; Boyer, Cherrie B.] Univ Calif San Francisco, San Francisco, CA 94143 USA	University of Michigan System; University of Michigan; University of Chicago; University of Pennsylvania; University of California System; University of California San Francisco	Cordova, D (corresponding author), Univ Michigan, Sch Social Work, Ann Arbor, MI 48109 USA.	cordovad@umich.edu	Bauermeister, Jose/X-8960-2018	Bauermeister, Jose/0000-0002-9276-2306	National Institute of Mental Health [R25 M H067127]; National Institute on Drug Abuse [1 RO3DA041891 01A1]; National Institute on Minority Health and Health Disparities Loan Repayment Program [L60 MD006269]; NATIONAL INSTITUTE OF MENTAL HEALTH [R25MH067127] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R03DA041891] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); National Institute on Minority Health and Health Disparities Loan Repayment Program; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Funded by TN: National Institute of Mental Health (Grant No. R25 M H067127) https II ww.nimh nih.goviindex.shtml. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the the manuscript. DC: National Institute on Drug Abuse (Grant No. 1 RO3DA041891 01A1) https//www.drugabuse..gov/.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the the manuscript. https//wwv) mhdnih gov/programstextram u rali loan -repayment html National Institute on Minority Health and Health Disparities Loan Repayment Program (Grant No. L60 MD006269). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the the manuscript.	[Anonymous], 2015, NVIVO QUAL DAT AN SO; Attkisson C., CLIENT SATISFACTION; Bauermeister JA, 2015, AIDS BEHAV, V19, P1860, DOI 10.1007/s10461-015-1009-y; Beckman SL, 2007, CALIF MANAGE REV, V50, P25, DOI 10.2307/41166415; Brawner BM, 2013, ANN HUM BIOL, V40, P485, DOI 10.3109/03014460.2013.806590; Brown JL, 2015, PEDIATRICS, V136, pE551, DOI 10.1542/peds.2015-0239; Buzi RS, 2016, PUBLIC HEALTH REP, V131, P130, DOI 10.1177/00333549161310S115; Campbell C, 2007, MED EDUC, V41, P123, DOI 10.1111/j.1365-2929.2006.02657.x; CDC, 2017, STDS AND HIV CDC FAC, P2; Centers for Disease Control and Prevention (CDC), 2017, 2015 STD TREATMENT G; Centers for Disease Control and Prevention (CDC), 2018, SEXUALLY TRANSMITTED; Centers for Disease Control and Prevention (CDC), 2012, HIV AMONG YOUTH IN T; Centers for Disease Control and Prevention (CDC), 2017, SEXUALLY TRANSMITTED; Centers for Disease Control and Prevention (CDC), 2017, HIV PREVENTION WORKS; Centers for Disease Control and Prevention (CDC), 2018, TEEN SUBSTANCE USE R; Centers for Disease Control and Prevention (CDC), 2017, SEX TRANSM DIS SURV; Centers for Disease Control. Reported STDs in the United States, 2017, CDC FACT SHEET; Cordova D, 2015, JMIR MHEALTH UHEALTH, V3, P1; Cordova D, 2018, HEALTH COMMUN, V33, P1177, DOI 10.1080/10410236.2017.1339379; Cordova D, 2018, BEHAV MED, V44, P36, DOI 10.1080/08964289.2016.1189396; Cordova David, 2017, JMIR Public Health Surveill, V3, pe96, DOI 10.2196/publichealth.7129; Cordova D, 2014, J ETHN CULT DIVERSIT, V23, P148, DOI 10.1080/15313204.2013.809510; Dowshen N, 2016, J ADOLESCENT HEALTH, V58, pS81; Gassman RA, 2016, ADDICT RES THEORY, V24, P177, DOI 10.3109/16066359.2015.1094061; Harris KM, 2008, J SUBST ABUSE TREAT, V34, P347, DOI 10.1016/j.jsat.2007.05.004; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Hightow-Weidman L, 2018, JMIR PUBLIC HLTH SUR, V4, P209, DOI 10.2196/publichealth.8923; IBM Corp, 2017, IBM SPSS STATISTICS; Israel BA, 2005, METHODS COMMUNITY BA, P1; Jemmott JB, 1998, JAMA-J AM MED ASSOC, V279, P1529, DOI 10.1001/jama.279.19.1529; Johnson KE, 2019, J ADOLESCENT RES, V34, P597, DOI 10.1177/0743558418765397; Kann L, 2018, YOUTH RISK BEHAVIOR; Knight JR, 2002, ARCH PEDIAT ADOL MED, V156, P607, DOI 10.1001/archpedi.156.6.607; Lelutiu-Weinberger C, 2015, AIDS BEHAV, V19, P1214, DOI 10.1007/s10461-014-0911-z; Lenhart A., 2015, TEENS SOCIAL MEDIA A; Marsch LA, 2014, J SUBST ABUSE TREAT, V46, P1, DOI 10.1016/j.jsat.2013.08.010; Morrow SL, 2005, J COUNS PSYCHOL, V52, P250, DOI 10.1037/0022-0167.52.2.250; Mustanski B, 2013, AIDS BEHAV, V17, P2999, DOI 10.1007/s10461-013-0507-z; Napoles Anna Maria, 2016, BMC Med Inform Decis Mak, V16, P44, DOI 10.1186/s12911-016-0284-5; National Institute of Drug Abuse, 2003, PRINCIPLES OF DRUG U; Nelson A, 2016, J ADOLESCENT RES, V31, P202, DOI 10.1177/0743558415588350; Ocfemia MC, 2018, MORBIDITY AND MORTAL; Ortega Johis, 2012, Hisp Health Care Int, V10, P42; Schulenberg JE, 2018, MONITORING THE FUTUR, V2; Substance Abuse and Mental Health Services Administration, 2017, SUBSTANCE USE AND ME; Szapocznik J, 1999, DRUG ABUSE ORIGINS I, P31; Weinhardt LS, 1998, ARCH SEX BEHAV, V27, P155, DOI 10.1023/A:1018682530519; White House Office of National AIDS Policy, 2015, NAT HIV AIDS STRAT U; Young SD, 2015, CURR HIV-AIDS REP, V12, P462, DOI 10.1007/s11904-015-0295-3; ZIMMERMAN MA, 1992, AM J COMMUN PSYCHOL, V20, P707, DOI 10.1007/BF00942234	50	4	4	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2019	14	8							e0221508	10.1371/journal.pone.0221508	http://dx.doi.org/10.1371/journal.pone.0221508			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW5RZ	31437240	Green Published, Green Submitted, gold			2022-12-26	WOS:000485036900082
J	Gwak, WS; Lee, SN; Choi, JB; Kim, HS; Han, BK; Bae, SM; Je, YH; Woo, SD				Gwak, Won Seok; Lee, See Nae; Choi, Jae Bang; Kim, Hyun Soo; Han, Beom Ku; Bae, Sung Min; Je, Yeon Ho; Woo, Soo Dong			Baculovirus entire ORF1629 is not essential for viral replication	PLOS ONE			English	Article							OPEN READING FRAME; ESCHERICHIA-COLI; GENERATION; ENCODES; GENE	It is generally accepted that ORF1629 is essential for baculovirus replication, which has enabled isolation of recombinant viruses in a baculovirus expression system using linearized viral DNA. ORF1629-defective viruses cannot replicate in insect cells; only recombinant virus with complete ORF1629 restoration by recombination can propagate, allowing for pure isolation and the development of bacmids for easy selection of recombinant viruses. We inadvertently found proliferation in insect cells of a bacmid lacking a complete ORF1629. PCR indicated no other viruses but a lack of complete ORF1629 in the proliferated bacmid, suggesting that the baculovirus propagated without a complete ORF1629. Lack of ORF1629 decreased the virus growth rate and yield; it also increased the occlusion body (OB) size but decreased its yield. These results were confirmed for Autographa californica multicapsid nucleopolyhedrovirus (AcMNPV) and Bombyx mori NPV (BmNPV). Thus, entire ORF1629 is not essential for viral replication, though it does affect the virus growth rate, yield, and size and OB production.	[Gwak, Won Seok; Kim, Hyun Soo; Woo, Soo Dong] Chungbuk Natl Univ, Dept Agr Biol, Coll Agr Life & Environm Sci, Cheongju, South Korea; [Lee, See Nae; Choi, Jae Bang; Han, Beom Ku] Optipharm Inc, Osong, South Korea; [Bae, Sung Min] ImmuneMed Inc, Diagnost Dev Team 2, Chunchon, South Korea; [Je, Yeon Ho] Seoul Natl Univ, Dept Agr Biotechnol, Coll Agr & Life Sci, Seoul, South Korea	Chungbuk National University; Seoul National University (SNU)	Woo, SD (corresponding author), Chungbuk Natl Univ, Dept Agr Biol, Coll Agr Life & Environm Sci, Cheongju, South Korea.	sdwoo@cbnu.ac.kr		Woo, Soo-Dong/0000-0002-3739-4264	National Research Foundation of Korea (NRF) - Ministry of Education [NRF-2017R1D1A1B040 36274]	National Research Foundation of Korea (NRF) - Ministry of Education	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (NRF-2017R1D1A1B040 36274). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors declare no conflicts of interest. Optipharm Inc. and ImmuneMed Inc. provided support in the form of salary for authors SNL, JBC, BKH and SMB, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	BEAMES B, 1990, VIROLOGY, V174, P354, DOI 10.1016/0042-6822(90)90089-A; BLISSARD GW, 1990, ANNU REV ENTOMOL, V35, P127, DOI 10.1146/annurev.en.35.010190.001015; Chambers Adam C, 2018, Curr Protoc Protein Sci, V91, DOI 10.1002/cpps.47; Harrison RL, 1996, VIROLOGY, V226, P34, DOI 10.1006/viro.1996.0625; Irons Sarah L, 2018, Curr Protoc Protein Sci, V91, DOI 10.1002/cpps.45; Jarvis DL, 2009, METHOD ENZYMOL, V463, P191, DOI 10.1016/S0076-6879(09)63014-7; Je Y.H., 2001, INT J IND ENTOMOL, V2, P155; Je YH, 2001, BIOTECHNOL LETT, V23, P575; Je YH, 2001, BIOTECHNOL LETT, V23, P1809, DOI 10.1023/A:1012475004212; Kitts P A, 1995, Methods Mol Biol, V39, P129; KITTS PA, 1990, NUCLEIC ACIDS RES, V18, P5667, DOI 10.1093/nar/18.19.5667; OReilly D.R., 1992, BACULOVIRUS EXPRESSI; PHAM DQD, 1993, GENE, V137, P275, DOI 10.1016/0378-1119(93)90020-4; Possee RD., 1992, BACULOVIRUS EXPRESSI; Russell RLQ, 1997, VIROLOGY, V227, P142, DOI 10.1006/viro.1996.8304; van Oers MM, 2007, CURR DRUG TARGETS, V8, P1051, DOI 10.2174/138945007782151333; VIALARD JE, 1993, J VIROL, V67, P5859, DOI 10.1128/JVI.67.10.5859-5866.1993	17	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2019	14	8							e0221594	10.1371/journal.pone.0221594	http://dx.doi.org/10.1371/journal.pone.0221594			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5RZ	31437242	Green Published, gold, Green Submitted			2022-12-26	WOS:000485036900091
J	Jang, B; Kim, I; Kim, JW				Jang, Beakcheol; Kim, Inhwan; Kim, Jong Wook			Word2vec convolutional neural networks for classification of news articles and tweets	PLOS ONE			English	Article								Big web data from sources including online news and Twitter are good resources for investigating deep learning. However, collected news articles and tweets almost certainly contain data unnecessary for learning, and this disturbs accurate learning. This paper explores the performance of word2vec Convolutional Neural Networks (CNNs) to classify news articles and tweets into related and unrelated ones. Using two word embedding algorithms of word2vec, Continuous Bag-of-Word (CBOW) and Skip-gram, we constructed CNN with the CBOW model and CNN with the Skip-gram model. We measured the classification accuracy of CNN with CBOW, CNN with Skip-gram, and CNN without word2vec models for real news articles and tweets. The experimental results indicated that word2vec significantly improved the accuracy of the classification model. The accuracy of the CBOW model was higher and more stable when compared to that of the Skip-gram model. The CBOW model exhibited better performance on news articles, and the Skip-gram model exhibited better performance on tweets. Specifically, CNN with word2vec models was more effective on news articles when compared to that on tweets because news articles are typically more uniform when compared to tweets.	[Jang, Beakcheol; Kim, Inhwan; Kim, Jong Wook] Sangmyung Univ, Dept Comp Sci, Seoul, South Korea	Sang Myung University	Kim, JW (corresponding author), Sangmyung Univ, Dept Comp Sci, Seoul, South Korea.	jkim@smu.ac.kr						Abadi M., 2016, TENSORFLOW LARGE SCA; Bengio Y, 2001, ADV NEUR IN, V13, P932; Berardi G, 2015, WORD EMBEDDINGS GO I; Bergstra J., 2010, P 9 PYTH SCI C, P3, DOI DOI 10.25080/MAJORA-92BF1922-003; Burel G., 2017, WORKSH SEM DEEP LEAR; Chiu B, 2016, P 15 WORKSH BIOM NAT, P166; Cohen W., 2003, KDD WORKSH DAT CLEAN, V3, P73; Collobert R., 2008, P 25 ICML, V25, P160, DOI DOI 10.1145/1390156.1390177; Culotta A., 2010, P 1 WORKSHOP SOCIAL, P115, DOI [10.1145/1964858.1964874, DOI 10.1145/1964858.1964874]; Du Y, 2015, PROC CVPR IEEE, P1110, DOI 10.1109/CVPR.2015.7298714; Feng XC, 2018, SCI CHINA INFORM SCI, V61, DOI 10.1007/s11432-017-9359-x; Finkelstein L., 2001, P 10 INT C WORLD WID, P406, DOI DOI 10.1145/371920.372094; Jang B, 2018, IEEE ACCESS, V6, P18061, DOI 10.1109/ACCESS.2018.2818792; Jeon H, 2016, KONLP KOREAN NLP PAC; Jia YQ, 2014, PROCEEDINGS OF THE 2014 ACM CONFERENCE ON MULTIMEDIA (MM'14), P675, DOI 10.1145/2647868.2654889; Joulin Armand, 2016, ARXIV160701759; Junker M., 1999, Proceedings of the Fifth International Conference on Document Analysis and Recognition. ICDAR '99 (Cat. No.PR00318), P713, DOI 10.1109/ICDAR.1999.791887; Kalchbrenner N, 2014, PROCEEDINGS OF THE 52ND ANNUAL MEETING OF THE ASSOCIATION FOR COMPUTATIONAL LINGUISTICS, VOL 1, P655, DOI 10.3115/v1/p14-1062; Karpathy A, 2014, PROC CVPR IEEE, P1725, DOI 10.1109/CVPR.2014.223; Kim E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053419; Kim Yoon, 2014, P 2014 C EMPIRICAL M, P1746, DOI [DOI 10.3115/V1/D14-1181, 10.3115/v1/D14-1181]; Kirk D.B., 2007, P 6 INT S MEMORY MAN, P103, DOI [DOI 10.1145/1296907.1296909, 10.1145/1296907.1296909]; Krizhevsky A., 2012, ADV NEURAL INF PROCE; Lai SW, 2016, IEEE INTELL SYST, V31, P5, DOI 10.1109/MIS.2016.45; Landauer TK, 1997, PSYCHOL REV, V104, P211, DOI 10.1037/0033-295X.104.2.211; LeCun Y, 2015, NATURE, V521, P436, DOI 10.1038/nature14539; Levy O, 2014, PROCEEDINGS OF THE 52ND ANNUAL MEETING OF THE ASSOCIATION FOR COMPUTATIONAL LINGUISTICS, VOL 2, P302, DOI 10.3115/v1/p14-2050; Ling Wang, 2015, P 2015 C N AM CHAPT, P1299, DOI [DOI 10.3115/V1/N15-1142, 10.3115/v1/N15-1142]; Liu H., 2017, ARXIV170400177; Mikolov T., 2013, COMPUTING RES REPOSI, V1301, P3781; Mikolov Tomas, 2013, P ADV NEUR INF PROC, P3111, DOI DOI 10.1162/JMLR.2003.3.4-5.951; Mnih A., 2007, INT C MACHINE LEARNI, P641, DOI DOI 10.1145/1273496.1273577; Nalisnick E, 2016, PROCEEDINGS OF THE 25TH INTERNATIONAL CONFERENCE ON WORLD WIDE WEB (WWW'16 COMPANION), P83, DOI 10.1145/2872518.2889361; Nguyen T.H., 2016, NAACL; Nguyen TH, P 53 ANN M ASS COMP, V2; Oh KS, 2004, PATTERN RECOGN, V37, P1311, DOI 10.1016/j.patcog.2004.01.013; Pakhomov Serguei, 2010, AMIA Annu Symp Proc, V2010, P572; Pang Bo, 2005, CS0506075 ARXIV, P115, DOI DOI 10.3115/1219840.1219855; Parker R., 2011, ENGLISH GIGAWORD, V5th ed.; Paul MJ, 2014, PLOS ONE, V9, DOI [10.1371/currents.outbreaks.90b9ed0f59bae4ccaa683a39865d9117, 10.1371/journal.pone.0103408]; Peng Haoruo, 2016, P 2016 C EMP METH NA, P392, DOI DOI 10.18653/V1/D16-1038; Pennington J., 2014, P 2014 C EMPIRICAL M, P1532, DOI DOI 10.3115/V1/D14-1162; Powers D. M, 2011, ARXIV201016061; RONNQVIST S, 2015, COMPUTATIONAL INTELL, P890, DOI DOI 10.1109/SSCI.2015.131; Sahlgren M, 2008, ITAL J LINGUIST, V20, P33; Schuster M, 1997, IEEE T SIGNAL PROCES, V45, P2673, DOI 10.1109/78.650093; Seok MR, 2015, 4 INT C ART INT APPL, P754; Severyn A, 2015, SIGIR 2015: PROCEEDINGS OF THE 38TH INTERNATIONAL ACM SIGIR CONFERENCE ON RESEARCH AND DEVELOPMENT IN INFORMATION RETRIEVAL, P959, DOI 10.1145/2766462.2767830; Socher Richard, 2013, P 2013 C EMPIRICALME, P1631, DOI DOI 10.1371/JOURNAL.PONE.0073791; Tang DY, 2014, PROCEEDINGS OF THE 52ND ANNUAL MEETING OF THE ASSOCIATION FOR COMPUTATIONAL LINGUISTICS, VOL 1, P1555; Team D, 2016, DEEPLEARNING4J OPEN, V2; Verma Ishan, 2015, Pattern Recognition and Machine Intelligence. 6th International Conference, PReMI 2015. Proceedings: LNCS 9124, P575, DOI 10.1007/978-3-319-19941-2_55; Wang WY, 2017, PROCEEDINGS OF THE 55TH ANNUAL MEETING OF THE ASSOCIATION FOR COMPUTATIONAL LINGUISTICS (ACL 2017), VOL 2, P422, DOI 10.18653/v1/P17-2067; Wang YS, 2018, J BIOMED INFORM, V87, P12, DOI 10.1016/j.jbi.2018.09.008; Yang X, 2018, INFORM RETRIEVAL J, V21, P183, DOI 10.1007/s10791-017-9319-5; Yoon JC, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195628; Zhang DW, 2015, EXPERT SYST APPL, V42, P1857, DOI 10.1016/j.eswa.2014.09.011; Zhang X., 2015, P 28 INT C NEURAL IN; Zhang Y, 2016, MATH PROBL ENG, V2016, DOI 10.1155/2016/8951524	62	40	44	6	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2019	14	8							e0220976	10.1371/journal.pone.0220976	http://dx.doi.org/10.1371/journal.pone.0220976			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5RZ	31437181	Green Submitted, Green Published, gold			2022-12-26	WOS:000485036900025
J	King, HAD; Gonelli, CA; Tullett, KM; Lahoud, MH; Purcell, DFJ; Drummer, HE; Poumbourios, P; Center, RJ				King, Hannah A. D.; Gonelli, Christopher A.; Tullett, Kirsteen M.; Lahoud, Mireille H.; Purcell, Damian F. J.; Drummer, Heidi E.; Poumbourios, Pantelis; Center, Rob J.			Conjugation of an scFab domain to the oligomeric HIV envelope protein for use in immune targeting	PLOS ONE			English	Article							SINGLE-CHAIN FV; VIRUS TYPE-1 ENVELOPE; NEUTRALIZING ANTIBODY-RESPONSES; DENDRITIC CELLS; T-CELL; MONOCLONAL-ANTIBODIES; GLYCOPROTEIN TRIMERS; NONHUMAN-PRIMATES; FRAMEWORK REGIONS; RATIONAL DESIGN	A promising strategy for the enhancement of vaccine-mediated immune responses is by directly targeting protein antigens to immune cells. Targeting of antigens to the dendritic cell (DC) molecule Clec9A has been shown to enhance antibody affinity and titers for model antigens, and influenza and enterovirus antigens, and may be advantageous for immunogens that otherwise fail to elicit antibodies with sufficient titers and breadth for broad protection, such as the envelope protein (Env) of HIV. Previously employed targeting strategies often utilize receptor-specific antibodies, however it is impractical to conjugate a bivalent IgG antibody to oligomeric antigens, including HIV Env trimers. Here we designed single chain variable fragment (scFv) and single chain Fab (scFab) constructs of a Clec9A-targeting antibody, expressed as genetically fused conjugates with the soluble ectodomain of Env, gp140. This conjugation did not affect the presentation of Env neutralising antibody epitopes. The scFab moiety was shown to be more stable than scFv, and in the context of gp140 fusions, was able to mediate better binding to recombinant and cell surface-expressed Clec9A, although the level of binding to cell-surface Clec9A was lower than that of the anti-Clec9A IgG. However, binding to Clec9A on the surface of DCs was not detected. Mouse immunization experiments suggested that the Clec9A-binding activity of the scFab-gp140 conjugate was insufficient to enhance Env-specific antibody responses. This is an important first proof of principle study demonstrating the conjugation of a scFab to an oligomeric protein antigen, and that an scFab displays better antigen binding than the corresponding scFv. Future developments of this technique that increase the scFab affinity will provide a valuable means to target oligomeric proteins to cell surface antigens of interest, improving vaccine-generated immune responses.	[King, Hannah A. D.; Lahoud, Mireille H.; Drummer, Heidi E.; Poumbourios, Pantelis; Center, Rob J.] Burnet Inst, Dis Eliminat, Melbourne, Vic, Australia; [King, Hannah A. D.; Gonelli, Christopher A.; Purcell, Damian F. J.; Drummer, Heidi E.; Center, Rob J.] Univ Melbourne, Peter Doherty Inst Infect & Immun, Dept Microbiol & Immunol, Melbourne, Vic, Australia; [Tullett, Kirsteen M.; Lahoud, Mireille H.] Monash Univ, Monash Biomed Discovery Inst, Infect & Immun Program, Melbourne, Vic, Australia; [Tullett, Kirsteen M.; Lahoud, Mireille H.] Monash Univ, Dept Biochem & Mol Biol, Melbourne, Vic, Australia; [Drummer, Heidi E.; Poumbourios, Pantelis] Monash Univ, Dept Microbiol, Melbourne, Vic, Australia	Burnet Institute; University of Melbourne; Monash University; Monash University; Monash University	Center, RJ (corresponding author), Burnet Inst, Dis Eliminat, Melbourne, Vic, Australia.; Center, RJ (corresponding author), Univ Melbourne, Peter Doherty Inst Infect & Immun, Dept Microbiol & Immunol, Melbourne, Vic, Australia.	rob.center@burnet.edu.au	Purcell, Damian F/G-5068-2011; Lahoud, Mireille/F-1299-2013	Drummer, Heidi/0000-0002-0042-6277; Lahoud, Mireille/0000-0001-8472-6201; Tullett, Kirsteen/0000-0002-2389-9819; Gonelli, Christopher/0000-0002-7521-8528	Australian Centre for HIV and Hepatitis Virology (ACH2) Research Grant; Australian National Health and Medical Research Council (NHMRC) [1146082]; Australian Postgraduate Awards - Australian Federal Government; NHMRC [APP1082665, 1041897, GNT1125822]; University of Melbourne; Australian NHMRC [1146082, 1106581]; ACH2	Australian Centre for HIV and Hepatitis Virology (ACH2) Research Grant; Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Australian Postgraduate Awards - Australian Federal Government; NHMRC(National Health and Medical Research Council (NHMRC) of Australia); University of Melbourne(University of Melbourne); Australian NHMRC(National Health and Medical Research Council (NHMRC) of Australia); ACH2	The work was supported by an Australian Centre for HIV and Hepatitis Virology (ACH2) Research Grant, awarded to RJC, which was entitled: "Targeting HIV immunogens to immune cells to enhance vaccine efficacy". RJC was also supported by a Project Grant from the Australian National Health and Medical Research Council (NHMRC), grant number 1146082. HADK and CAG were supported by Australian Postgraduate Awards, funded by the Australian Federal Government. MHL and KMT were supported by an NHMRC Project Grant APP1082665. DFJP was supported by the University of Melbourne. HED was supported by Project Grants from the Australian NHMRC, grant numbers 1106581 and 1146082, and a Fellowship from the NHMRC, 1041897. PP was supported by an NHMRC project grant, GNT1125822, and a grant awarded by ACH2. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahrens S, 2012, IMMUNITY, V36, P635, DOI 10.1016/j.immuni.2012.03.008; BEREK C, 1991, CELL, V67, P1121, DOI 10.1016/0092-8674(91)90289-B; Binley JM, 1996, AIDS RES HUM RETROV, V12, P911, DOI 10.1089/aid.1996.12.911; Bower JF, 2004, J VIROL, V78, P4710, DOI 10.1128/JVI.78.9.4710-4719.2004; Bower JF, 2006, ADV EXP MED BIOL, V586, P249; Caminschi I, 2008, BLOOD, V112, P3264, DOI 10.1182/blood-2008-05-155176; Castoldi R, 2012, PROTEIN ENG DES SEL, V25, P551, DOI 10.1093/protein/gzs048; Castoldi R, 2016, PROTEIN ENG DES SEL, V29, P467, DOI 10.1093/protein/gzw037; Center RJ, 2004, J VIROL, V78, P2265, DOI 10.1128/JVI.78.5.2265-2276.2004; Center RJ, 2009, VACCINE, V27, P6605, DOI 10.1016/j.vaccine.2009.08.016; Chaplin JW, 2013, J EXP MED, V210, P2135, DOI 10.1084/jem.20130188; Chen XY, 2013, ADV DRUG DELIVER REV, V65, P1357, DOI 10.1016/j.addr.2012.09.039; Cheng WW, 2010, EXPERT OPIN DRUG DEL, V7, P461, DOI 10.1517/17425240903579963; Crozat K, 2010, J EXP MED, V207, P1283, DOI 10.1084/jem.20100223; de Taeye SW, 2015, CELL, V163, P1702, DOI 10.1016/j.cell.2015.11.056; Dorner BG, 2009, IMMUNITY, V31, P823, DOI 10.1016/j.immuni.2009.08.027; EARL PL, 1991, J VIROL, V65, P31, DOI 10.1128/JVI.65.1.31-41.1991; FREED EO, 1995, J BIOL CHEM, V270, P23883, DOI 10.1074/jbc.270.41.23883; Georgiev IS, 2014, J IMMUNOL, V192, P1100, DOI 10.4049/jimmunol.1302515; Gray ES, 2011, J VIROL, V85, P4828, DOI 10.1128/JVI.00198-11; Green TD, 2003, J VIROL, V77, P2046, DOI 10.1128/JVI.77.3.2046-2055.2003; Havenar-Daughton C, 2016, CELL REP, V17, P2195, DOI 10.1016/j.celrep.2016.10.085; Hu JK, 2015, J VIROL, V89, P10383, DOI 10.1128/JVI.01653-15; Huber M, 2010, J VIROL, V84, P10700, DOI 10.1128/JVI.01111-10; Hust M, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-14; Huysamen C, 2008, J BIOL CHEM, V283, P16693, DOI 10.1074/jbc.M709923200; Idoyaga J, 2011, P NATL ACAD SCI USA, V108, P2384, DOI 10.1073/pnas.1019547108; JACOB J, 1991, NATURE, V354, P389, DOI 10.1038/354389a0; Joffre OP, 2010, EUR J IMMUNOL, V40, P1255, DOI 10.1002/eji.201040419; Jordan E, 2007, MICROB CELL FACT, V6, DOI 10.1186/1475-2859-6-38; Kato Y, 2015, J IMMUNOL, V195, P1006, DOI 10.4049/jimmunol.1500767; Koch M, 2005, VIROLOGY, V340, P277, DOI 10.1016/j.virol.2005.06.034; Koerber JT, 2015, J MOL BIOL, V427, P576, DOI 10.1016/j.jmb.2014.11.017; Kramski M, 2012, ANTIMICROB AGENTS CH, V56, P4310, DOI 10.1128/AAC.00453-12; Lahoud MH, 2011, J IMMUNOL, V187, P842, DOI 10.4049/jimmunol.1101176; Lee HS, 1999, MOL IMMUNOL, V36, P61, DOI 10.1016/S0161-5890(98)00109-6; Leelawattanachai J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124440; Li J, 2015, EUR J IMMUNOL, V45, P854, DOI 10.1002/eji.201445127; Liao HX, 2011, J EXP MED, V208, P2237, DOI 10.1084/jem.20110363; Longo PA, 2013, METHOD ENZYMOL, V529, P227, DOI 10.1016/B978-0-12-418687-3.00018-5; Macri C, 2016, CLIN TRANSL IMMUNOL, V5, DOI 10.1038/cti.2016.6; MARKS JD, 1992, J BIOL CHEM, V267, P16007; Marraco SAF, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00331; Melchers M, 2012, J VIROL, V86, P2488, DOI 10.1128/JVI.06259-11; Mikell I, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001251; Moldt B, 2016, AIDS, V30, P1543, DOI 10.1097/QAD.0000000000001102; Moldt B, 2012, P NATL ACAD SCI USA, V109, P18921, DOI 10.1073/pnas.1214785109; Muller-Loennies S, 2000, GLYCOBIOLOGY, V10, P121, DOI 10.1093/glycob/10.2.121; MUSTER T, 1993, J VIROL, V67, P6642, DOI 10.1128/JVI.67.11.6642-6647.1993; Nwe K, 2009, CANCER BIOTHER RADIO, V24, P289, DOI 10.1089/cbr.2008.0626; Pancera M, 2010, J VIROL, V84, P8098, DOI 10.1128/JVI.00966-10; Park HY, 2017, NPJ VACCINES, V2, DOI 10.1038/s41541-017-0033-5; Park HY, 2013, J IMMUNOL, V191, P4919, DOI 10.4049/jimmunol.1301947; Pauthner M, 2017, IMMUNITY, V46, P1073, DOI 10.1016/j.immuni.2017.05.007; Pegu A, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008992; Poulin LF, 2012, BLOOD, V119, P6052, DOI 10.1182/blood-2012-01-406967; Poumbourios P, 2003, J BIOL CHEM, V278, P42149, DOI 10.1074/jbc.M305223200; Quintero-Hernandez V, 2007, MOL IMMUNOL, V44, P1307, DOI 10.1016/j.molimm.2006.05.009; Rao MF, 2016, ANAL METHODS-UK, V8, P3140, DOI [10.1039/C6AY00224B, 10.1039/c6ay00224b]; REITER Y, 1994, PROTEIN ENG, V7, P697, DOI 10.1093/protein/7.5.697; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Ross TM, 2001, AIDS RES HUM RETROV, V17, P829, DOI 10.1089/088922201750252025; Rothlisberger D, 2005, J MOL BIOL, V347, P773, DOI 10.1016/j.jmb.2005.01.053; Rudicell RS, 2014, J VIROL, V88, P12669, DOI 10.1128/JVI.02213-14; Sancho D, 2008, J CLIN INVEST, V118, P2098, DOI 10.1172/JCI34584; Sanders RW, 2002, J VIROL, V76, P8875, DOI 10.1128/JVI.76.17.8875-8889.2002; Sanders RW, 2002, J VIROL, V76, P7293, DOI 10.1128/JVI.76.14.7293-7305.2002; Saunders KO, 2015, J VIROL, V89, P5895, DOI 10.1128/JVI.00210-15; Schanzer JM, 2016, MABS-AUSTIN, V8, P811, DOI 10.1080/19420862.2016.1160989; Schanzer JM, 2014, J BIOL CHEM, V289, P18693, DOI 10.1074/jbc.M113.528109; Schirrmann T, 2010, MABS-AUSTIN, V2, P73, DOI 10.4161/mabs.2.1.10784; Schreibelt G, 2012, BLOOD, V119, P2284, DOI 10.1182/blood-2011-08-373944; Sepulveda-Toepfer JA, 2019, HUM VACC IMMUNOTHER, V15, P179, DOI 10.1080/21645515.2018.1514223; Shingai M, 2014, J EXP MED, V211, P2061, DOI 10.1084/jem.20132494; Simonich CA, 2016, CELL, V166, P77, DOI 10.1016/j.cell.2016.05.055; Sok D, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003754; SOSNICK TR, 1992, BIOCHEMISTRY-US, V31, P1779, DOI 10.1021/bi00121a028; Tu C, 2016, J BIOL CHEM, V291, P1267, DOI 10.1074/jbc.M115.688010; Unkauf T, 2016, ADV EXP MED BIOL, V917, P55, DOI 10.1007/978-3-319-32805-8_4; van Gils MJ, 2009, AIDS, V23, P2405, DOI 10.1097/QAD.0b013e32833243e7; van Rosmalen M, 2017, BIOCHEMISTRY-US, V56, P6565, DOI 10.1021/acs.biochem.7b00902; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Walker LM, 2009, J MOL BIOL, V389, P365, DOI 10.1016/j.jmb.2009.04.019; Weatherill EE, 2012, PROTEIN ENG DES SEL, V25, P321, DOI 10.1093/protein/gzs021; White AL, 2010, IMMUNOLOGY, V131, P141, DOI 10.1111/j.1365-2567.2010.03285.x; Wiehe K, 2018, CELL HOST MICROBE, V23, P759, DOI 10.1016/j.chom.2018.04.018; Willuda J, 1999, CANCER RES, V59, P5758; Wrammert J, 2011, J EXP MED, V208, P181, DOI 10.1084/jem.20101352; Wranik BJ, 2012, J BIOL CHEM, V287, P43331, DOI 10.1074/jbc.M112.397869; Wu XL, 2011, SCIENCE, V333, P1593, DOI 10.1126/science.1207532; Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659; Xiao XD, 2009, BIOCHEM BIOPH RES CO, V390, P404, DOI 10.1016/j.bbrc.2009.09.029; Yan ZY, 2016, ONCOTARGET, V7, P40437, DOI 10.18632/oncotarget.9624; Yang XZ, 2000, J VIROL, V74, P4746, DOI 10.1128/JVI.74.10.4746-4754.2000; Yu DB, 2015, IMMUNOL LETT, V168, P293, DOI 10.1016/j.imlet.2015.10.007; Yu L, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00250; Zeng B, 2018, J CLIN INVEST; Zhang JG, 2012, IMMUNITY, V36, P646, DOI 10.1016/j.immuni.2012.03.009; Zhao JX, 2011, INT J MOL SCI, V12, P1, DOI 10.3390/ijms12010001; Zhou JJ, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195657; Zhou Y, 2012, MOL CANCER THER, V11, P1467, DOI 10.1158/1535-7163.MCT-11-1038	101	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2019	14	8							e0220986	10.1371/journal.pone.0220986	http://dx.doi.org/10.1371/journal.pone.0220986			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5OC	31430333	Green Published, gold			2022-12-26	WOS:000485026800021
J	Sirkisoon, SR; Carpenter, RL; Rimkus, T; Doheny, D; Zhu, DQ; Aguayo, NR; Xing, F; Chan, M; Ruiz, J; Metheny-Barlow, LJ; Strowd, R; Lin, J; Regua, AT; Arrigo, A; Anguelov, M; Pasche, B; Debinski, W; Watabe, K; Lo, HW				Sirkisoon, Sherona R.; Carpenter, Richard L.; Rimkus, Tadas; Doheny, Daniel; Zhu, Dongqin; Aguayo, Noah R.; Xing, Fei; Chan, Michael; Ruiz, Jimmy; Metheny-Barlow, Linda J.; Strowd, Roy; Lin, Jiayuh; Regua, Angelina T.; Arrigo, Austin; Anguelov, Marlyn; Pasche, Boris; Debinski, Waldemar; Watabe, Kounosuke; Lo, Hui-Wen			TGLI1 transcription factor mediates breast cancer brain metastasis via activating metastasis-initiating cancer stem cells and astrocytes in the tumor microenvironment	ONCOGENE			English	Article							PROGNOSTIC-FACTORS; PREFERENTIAL SITE; SPLICE VARIANT; EXPRESSION; GLIOBLASTOMA; OCT4; GLI1; ANGIOGENESIS; RESISTANCE; SUBTYPES	Mechanisms for breast cancer metastasis remain unclear. Whether truncated glioma-associated oncogene homolog 1 (TGLI1), a transcription factor known to promote angiogenesis, migration and invasion, plays any role in metastasis of any tumor type has never been investigated. In this study, results of two mouse models of breast cancer metastasis showed that ectopic expression of TGLI1, but not GLI1, promoted preferential metastasis to the brain. Conversely, selective TGLI1 knockdown using antisense oligonucleotides led to decreased breast cancer brain metastasis (BCBM) in vivo. Immunohistochemical staining showed that TGLI1, but not GLI1, was increased in lymph node metastases compared to matched primary tumors, and that TGLI1 was expressed at higher levels in BCBM specimens compared to primary tumors. TGLI1 activation is associated with a shortened time to develop BCBM and enriched in HER2-enriched and triple-negative breast cancers. Radioresistant BCBM cell lines and specimens expressed higher levels of TGLI1, but not GLI1, than radiosensitive counterparts. Since cancer stem cells (CSCs) are radioresistant and metastasis-initiating cells, we examined TGLI1 for its involvement in breast CSCs and found TGLI1 to transcriptionally activate stemness genes CD44, Nanog, Sox2, and OCT4 leading to CSC renewal, and TGLI1 outcompetes with GLI1 for binding to target promoters. We next examined whether astrocyte-priming underlies TGLI1-mediated brain tropism and found that TGLI1-positive CSCs strongly activated and interacted with astrocytes in vitro and in vivo. These findings demonstrate, for the first time, that TGLI1 mediates breast cancer metastasis to the brain, in part, through promoting metastasis-initiating CSCs and activating astrocytes in BCBM microenvironment.	[Sirkisoon, Sherona R.; Carpenter, Richard L.; Rimkus, Tadas; Doheny, Daniel; Zhu, Dongqin; Aguayo, Noah R.; Regua, Angelina T.; Arrigo, Austin; Anguelov, Marlyn; Pasche, Boris; Debinski, Waldemar; Watabe, Kounosuke; Lo, Hui-Wen] Wake Forest Univ, Bowman Gray Sch Med, Dept Canc Biol, 300 S Hawthorne Rd, Winston Salem, NC 27103 USA; [Xing, Fei; Chan, Michael; Ruiz, Jimmy; Metheny-Barlow, Linda J.; Strowd, Roy; Pasche, Boris; Debinski, Waldemar; Watabe, Kounosuke; Lo, Hui-Wen] Wake Forest Univ, Bowman Gray Sch Med, Comprehens Canc Ctr, 300 S Hawthorne Rd, Winston Salem, NC 27103 USA; [Chan, Michael; Metheny-Barlow, Linda J.] Wake Forest Univ, Bowman Gray Sch Med, Dept Radiat Oncol, 300 S Hawthorne Rd, Winston Salem, NC 27103 USA; Wake Forest Univ, Bowman Gray Sch Med, Dept Hematol & Oncol, 300 S Hawthorne Rd, Winston Salem, NC 27103 USA; [Ruiz, Jimmy] Wake Forest Univ, Bowman Gray Sch Med, Dept Neurol, 300 S Hawthorne Rd, Winston Salem, NC 27103 USA; [Strowd, Roy] Univ Maryland, Sch Med, Dept Biochem & Mol Biol, Baltimore, MD 21201 USA; [Lin, Jiayuh] Indiana Univ Sch Med, Dept Biochem & Mol Biol, Bloomington, IN USA	Wake Forest University; Wake Forest Baptist Medical Center; Wake Forest University; Wake Forest Baptist Medical Center; Wake Forest University; Wake Forest Baptist Medical Center; Wake Forest University; Wake Forest Baptist Medical Center; Wake Forest University; Wake Forest Baptist Medical Center; University System of Maryland; University of Maryland Baltimore; Indiana University System; Indiana University Bloomington	Lo, HW (corresponding author), Wake Forest Univ, Bowman Gray Sch Med, Dept Canc Biol, 300 S Hawthorne Rd, Winston Salem, NC 27103 USA.; Lo, HW (corresponding author), Wake Forest Univ, Bowman Gray Sch Med, Comprehens Canc Ctr, 300 S Hawthorne Rd, Winston Salem, NC 27103 USA.	hlo@wakehealth.edu		Doheny, Daniel/0000-0002-1455-3090; Carpenter, Richard/0000-0001-9986-6493; Regua, Angelina/0000-0003-2595-8242; Strowd, Roy/0000-0001-6651-5267	NIH [R01NS087169, F31CA224805-01A1, T32CA079448, R01NS087169-3S1, P30CA012197]; DoD [W81XWH-17-1-0044, W81XWH-19-1-0072, BC181274]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DoD(United States Department of Defense)	We thank Dr. Shadi Qasem for providing pathology support. We acknowledge the funding support from NIH grants R01NS087169 (to H-WL), F31CA224805-01A1 (to SRS, HWL), T32CA079448 (to SK, RLC), R01NS087169-3S1 (to H-WL, SRS), P30CA012197 (to BP; core facility), and DoD grants W81XWH-17-1-0044 (to H-WL), W81XWH-19-1-0072 (to H-WL), and BC181274 (to H-WL).	Abraham BK, 2005, CLIN CANCER RES, V11, P1154; Ahmed MAH, 2012, BREAST CANCER RES TR, V133, P979, DOI 10.1007/s10549-011-1865-8; Akrap N, 2016, STEM CELL REP, V6, P121, DOI 10.1016/j.stemcr.2015.12.006; Almeida MI, 2011, MUTAT RES-FUND MOL M, V717, P1, DOI 10.1016/j.mrfmmm.2011.03.009; Bora-Singhal N, 2015, NEOPLASIA, V17, P538, DOI 10.1016/j.neo.2015.07.001; Bos PD, 2009, NATURE, V459, P1005, DOI 10.1038/nature08021; Cao X, 2012, ONCOGENE, V31, P104, DOI 10.1038/onc.2011.219; Carpenter RL, 2015, ONCOTARGET, V6, P22653, DOI 10.18632/oncotarget.4248; Dahmane N, 2001, DEVELOPMENT, V128, P5201; Deleidi M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019926; Di Mauro C, 2017, BRIT J CANCER, V116, P1425, DOI 10.1038/bjc.2017.116; Duex JE, 2017, CANCER RES, V77, P4858, DOI 10.1158/0008-5472.CAN-17-0367; Ekici K, 2016, J BUON, V21, P958; Fan YH, 2016, ONCOGENE, V35, P116, DOI 10.1038/onc.2015.67; Gril B, 2013, AM J PATHOL, V182, P2368, DOI 10.1016/j.ajpath.2013.02.043; Gwak JM, 2017, ONCOTARGET, V8, P36305, DOI 10.18632/oncotarget.16750; Han W, 2013, CANC HALLMARKS, V1, P28, DOI DOI 10.1166/CH.2013.1006; He DX, 2015, J PHARMACEUT BIOMED, V102, P500, DOI 10.1016/j.jpba.2014.10.018; Huang DL, 2018, J EXP CLIN CANC RES, V37, DOI 10.1186/s13046-018-0917-x; Komada M, 2008, BIOCHEM BIOPH RES CO, V369, P350, DOI 10.1016/j.bbrc.2008.02.015; Li Q, 2016, J BIOL CHEM, V291, P7171, DOI 10.1074/jbc.M116.714857; Liberzon A, 2015, CELL SYST, V1, P417, DOI 10.1016/j.cels.2015.12.004; Lo HW, 2009, CANCER RES, V69, P6790, DOI 10.1158/0008-5472.CAN-09-0886; Lorger M, 2010, AM J PATHOL, V176, P2958, DOI 10.2353/ajpath.2010.090838; Miyake A, 2005, DEV BIOL, V288, P259, DOI 10.1016/j.ydbio.2005.09.042; Niikura N, 2014, BREAST CANCER RES TR, V147, P103, DOI 10.1007/s10549-014-3090-8; Rimkus TK, 2018, CANCER RES, V78, P2589, DOI 10.1158/0008-5472.CAN-17-2933; Shen L, 2014, BBA-MOL BASIS DIS, V1842, P2087, DOI 10.1016/j.bbadis.2014.07.015; Sheridan C, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1610; Siegel RL, 2017, CA-CANCER J CLIN, V67, P7, DOI 10.3322/caac.21387; Sirkisoon SR, 2018, ONCOGENE, V37, P2502, DOI 10.1038/s41388-018-0132-4; Smid M, 2008, CANCER RES, V68, P3108, DOI 10.1158/0008-5472.CAN-07-5644; Wang JX, 2017, EUR REV MED PHARMACO, V21, P3857; Wang L, 2018, METHODS MOL BIOL, V1692, P31, DOI 10.1007/978-1-4939-7401-6_3; Wang T, 2015, ONCOTARGET, V6, P44191, DOI 10.18632/oncotarget.6176; Wang Z, 2012, CELL STEM CELL, V10, P440, DOI 10.1016/j.stem.2012.02.016; Wang Z, 2017, INT J BIOL MARKER, V32, pE75, DOI 10.5301/jbm.5000224; Wu Q, 2017, ONCOTARGET, V8, P27990, DOI 10.18632/oncotarget.15856; Zhang XM, 2013, CANCER RES, V73, P4885, DOI 10.1158/0008-5472.CAN-12-4081; Zhao XD, 2018, MOL CARCINOGEN, V57, P1616, DOI 10.1002/mc.22884; Zhu H, 2014, CANCER LETT, V343, P51, DOI 10.1016/j.canlet.2013.09.014; Zucchi I, 2004, P NATL ACAD SCI USA, V101, P18147, DOI 10.1073/pnas.0408260101	42	38	40	2	24	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN	2020	39	1					64	78		10.1038/s41388-019-0959-3	http://dx.doi.org/10.1038/s41388-019-0959-3			15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	KG3NM	31462709	Green Submitted, Green Accepted			2022-12-26	WOS:000509849200006
J	Yao, N; Fu, Y; Chen, L; Liu, Z; He, J; Zhu, YC; Xia, TS; Wang, S				Yao, Na; Fu, Yue; Chen, Lie; Liu, Zhao; He, Jing; Zhu, Yichao; Xia, Tiansong; Wang, Shui			Long non-coding RNA NONHSAT101069 promotes epirubicin resistance, migration, and invasion of breast cancer cells through NONHSAT101069/miR-129-5p/Twist1 axis	ONCOGENE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; HEPATOCELLULAR-CARCINOMA; POOR-PROGNOSIS; CHEMORESISTANCE; METASTASIS; ACTIVATION; MIR-129-5P; CERNA; TWIST; PROLIFERATION	Drug resistance, including epirubicin-based therapeutic resistance, is one of the major reasons responsible for the unfavorable prognosis of patients diagnosed with breast cancer (BC). Acquired chemoresistance and metastatic properties have been identified to be closely associated with the process of epithelial-mesenchymal transition (EMT). Recently, dysregulation of long non-coding RNAs (lncRNAs) have been increasingly reported to perform promotive or suppressive functions in chemoresistance and EMT process in multiple cancers. However, relevant novel lncRNA participating in epirubicin resistance and EMT and its underlying molecular mechanisms remain unknown in BC. Herein, we established the epirubicin-resistant breast cancer cell subline (MCF-7/ADR), which presented mesenchymal phenotype and increased metastatic potential. A panel of differentially expressed lncRNAs, including 268 upregulated and 49 downregulated lncRNAs, were identified by high-flux microarray investigation in MCF-7 and MCF-7/ADR cells. The novel lncRNA NONHSAT101069 was significantly overexpressed in BC specimens, BC cell lines, and epirubicin-resistant cell sublines. The knockdown of NONHSAT101069 significantly repressed, whereas overexpression of NONHSAT101069 promoted the epirubicin resistance, migration, invasion and EMT process of BC cells both in vitro and in vivo. Further mechanism-related researches uncovered that NONHSAT101069 functioned as a ceRNA (competing endogenous RNA) via sponging miR-1295p. Twist1 was a direct downstream protein of NONHSAT101069/miR-129-5p axis in BC cells. To conclude, NONHSAT101069 was upregulated in BC tissues and promoted epirubicin resistance, migration and invasion of BC cells via regulation of NONHSAT101069/miR-129-5p/Twist1 axis, highlighting its potential as an oncogene and a therapeutic biomarker for BC.	[Yao, Na; Chen, Lie; Xia, Tiansong; Wang, Shui] Nanjing Med Univ, Breast Dis Ctr, Affiliated Hosp 1, Nanjing 210029, Jiangsu, Peoples R China; [Yao, Na] Nanjing Univ TCM, Wuxi City Hosp TCM, Dept Thyroid & Breast Surg, Affiliated Hosp, Wuxi 214000, Jiangsu, Peoples R China; [Fu, Yue] Nanjing Med Univ, Dept Gen Surg, Affiliated Changzhou Peoples Hosp 2, Changzhou 213000, Jiangsu, Peoples R China; [Liu, Zhao] Xuzhou Med Univ, Dept Thyroid & Breast Surg, Affiliated Hosp, Xuzhou 222100, Jiangsu, Peoples R China; [He, Jing] Jiangnan Univ, Dept Surg Oncol, Affiliated Hosp, Wuxi 214000, Jiangsu, Peoples R China; [Zhu, Yichao] Nanjing Med Univ, Dept Physiol, Nanjing 211166, Jiangsu, Peoples R China; [Zhu, Yichao] Nanjing Med Univ, State Key Lab Reprod Med, Nanjing 211166, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing University of Chinese Medicine; Nanjing Medical University; Xuzhou Medical University; Jiangnan University; Nanjing Medical University; Nanjing Medical University	Xia, TS; Wang, S (corresponding author), Nanjing Med Univ, Breast Dis Ctr, Affiliated Hosp 1, Nanjing 210029, Jiangsu, Peoples R China.; Zhu, YC (corresponding author), Nanjing Med Univ, Dept Physiol, Nanjing 211166, Jiangsu, Peoples R China.; Zhu, YC (corresponding author), Nanjing Med Univ, State Key Lab Reprod Med, Nanjing 211166, Jiangsu, Peoples R China.	zhuyichao@njmu.edu.cn; xiats@njmu.edu.cn; ws0801@hotmail.com	yao, na/HDL-8772-2022		National Natural Science Foundation of China [81572607, 81472703]; Natural Science Foundation of Jiangsu Province [BK20181367]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province)	This work was supported by grants from the National Natural Science Foundation of China (81572607, 81472703) and the Natural Science Foundation of Jiangsu Province (BK20181367). The results shown here were partially based upon data obtained from public TCGA datasets. We thank Prof. Donglei Yang (Nanjing Agricultural University, Nanjing, China) and Dr. Macara (University of Virginia, VA) for providing the technical guidance to Northern blotting and the constructs of MS2-tagged RNA affinity purification assay, respectively.	Cheng GZ, 2008, CANCER RES, V68, P957, DOI 10.1158/0008-5472.CAN-07-5067; DeSantis C, 2014, CA-CANCER J CLIN, V64, P52, DOI 10.3322/caac.21203; Fang L, 2017, AM J PHYSIOL-GASTR L, V313, pG150, DOI 10.1152/ajpgi.00426.2016; Fatica A, 2014, NAT REV GENET, V15, P7, DOI 10.1038/nrg3606; Fischer KR, 2015, NATURE, V527, P472, DOI 10.1038/nature15748; Fu Y, 2018, J EXP CLIN CANC RES, V37, DOI 10.1186/s13046-018-0807-2; Gao YR, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.311; Gonzalez-Angulo AM, 2007, ADV EXP MED BIOL, V608, P1; Hiscox S, 2006, INT J CANCER, V118, P290, DOI 10.1002/ijc.21355; Hu GH, 2009, CANCER CELL, V15, P9, DOI 10.1016/j.ccr.2008.11.013; Huarte M, 2015, NAT MED, V21, P1253, DOI 10.1038/nm.3981; Karunarathna U, 2016, ONCOGENE, V35, P1433, DOI 10.1038/onc.2015.208; Khasraw M, 2012, BREAST, V21, P142, DOI 10.1016/j.breast.2011.12.012; Lee HJ, 2016, MOL CELL, V63, P1021, DOI 10.1016/j.molcel.2016.08.009; Lee JW, 2018, CANCER SCI, V109, P1404, DOI 10.1111/cas.13588; Li PL, 2017, MOL CANCER THER, V16, P739, DOI 10.1158/1535-7163.MCT-16-0591; Liang  Y., 2018, ADV MATER INTERFACES, V5, P1, DOI DOI 10.1017/S0266466617000317; Liang YR, 2018, CANCER BIOL THER, V19, P120, DOI 10.1080/15384047.2017.1394543; Liu K, 2017, CELL CYCLE, V16, P578, DOI 10.1080/15384101.2017.1288324; Lu W, 2017, MOL CANCER, V16, DOI 10.1186/s12943-017-0685-9; Luan QX, 2016, EUR REV MED PHARMACO, V20, P4257; Ma N, 2015, BIOCHEM BIOPH RES CO, V461, P618, DOI 10.1016/j.bbrc.2015.04.075; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Meng QC, 2018, ONCOGENE, V37, P5843, DOI 10.1038/s41388-018-0392-z; Qi XL, 2015, J MED GENET, V52, P710, DOI 10.1136/jmedgenet-2015-103334; Rho JK, 2009, LUNG CANCER, V63, P219, DOI 10.1016/j.lungcan.2008.05.017; Salmena L, 2011, CELL, V146, P353, DOI 10.1016/j.cell.2011.07.014; Santisteban M, 2009, CANCER RES, V69, P2887, DOI 10.1158/0008-5472.CAN-08-3343; Shen CJ, 2017, J DRUG TARGET, V25, P637, DOI 10.1080/1061186X.2017.1307379; Shi SJ, 2015, ONCOTARGET, V6, P11652, DOI 10.18632/oncotarget.3457; Shi Y, 2015, INT J INF TECH DECIS, V14, P1, DOI 10.1142/S0219622015020022; Tang J, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.518; Tay Y, 2014, NATURE, V505, P344, DOI 10.1038/nature12986; Thomson DW, 2016, NAT REV GENET, V17, P272, DOI 10.1038/nrg.2016.20; Tuck AC, 2013, CELL, V154, P996, DOI 10.1016/j.cell.2013.07.047; Ulitsky I, 2013, CELL, V154, P26, DOI 10.1016/j.cell.2013.06.020; van Staalduinen J, 2018, ONCOGENE, V37, P6195, DOI 10.1038/s41388-018-0378-x; Vesuna F, 2012, ONCOGENE, V31, P3223, DOI 10.1038/onc.2011.483; Wang YF, 2017, MOL CANCER, V16, DOI 10.1186/s12943-017-0702-z; Wang ZW, 2009, CANCER RES, V69, P2400, DOI 10.1158/0008-5472.CAN-08-4312; Wu YH, 2017, INT J CANCER, V141, P2305, DOI 10.1002/ijc.30932; Xu T, 2016, CANCER LETT, V377, P140, DOI 10.1016/j.canlet.2016.04.026; Xu Y, 2017, ONCOGENE, V36, P1157, DOI 10.1038/onc.2016.286; Yang MH, 2010, NAT CELL BIOL, V12, P982, DOI 10.1038/ncb2099; Yao N, 2019, MOL CARCINOGEN, V58, P1291, DOI 10.1002/mc.23011; Yu Y, 2015, ONCOTARGET, V6, P34423, DOI 10.18632/oncotarget.5406; Zhang DY, 2017, BIOMED PHARMACOTHER, V95, P1187, DOI 10.1016/j.biopha.2017.09.045; Zhang P, 2017, CELL PHYSIOL BIOCHEM, V42, P242, DOI 10.1159/000477323; Zhang YZ, 2016, ONCOL LETT, V12, P5163, DOI 10.3892/ol.2016.5372; Zheng XF, 2015, NATURE, V527, P525, DOI 10.1038/nature16064	50	61	63	2	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV 21	2019	38	47					7216	7233		10.1038/s41388-019-0904-5	http://dx.doi.org/10.1038/s41388-019-0904-5			18	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	JP0UL	31444414				2022-12-26	WOS:000497989400003
J	He, S; Liu, YJ; Ye, FY; Li, RP; Dai, RJ				He, Sheng; Liu, Yi-Jun; Ye, Fei-Yue; Li, Ren-Pu; Dai, Ren-Jun			A new grid- and modularity-based layout algorithm for complex biological networks	PLOS ONE			English	Article							CYTOSCAPE	The visualization of biological networks is critically important to aid researchers in understanding complex biological systems and arouses interest in designing efficient layout algorithms to draw biological networks according to their topology structures, especially for those networks with potential modules. The algorithms of grid layout series have an advantage in generating compact layouts with overlap-free nodes compared to force-directed; however, extant grid layout algorithms have difficulty in drawing modular networks and often generate layouts of high visual complexity when applied to networks with dense or clustered connectivity structure. To specifically assist the study of modular networks, we propose a grid-and modularity-based layout algorithm (GML) that consists of three stages: network preprocessing, module layout and grid optimization. The algorithm can draw complex biological networks with or without predefined modules based on the grid layout algorithm. It also outperforms other existing grid-based algorithms in the measurement of computation performance, ratio of edge-edge/node-edge crossings, relative edge lengths, and connectivity F-measures. GML helps users to gain insight into the network global characteristics through module layout, as well as to discern network details with grid optimization. GML has been developed as a VisANT plugin (https://hscz.github.io/Biological-Network-Visualization/) and is freely available to the research community.	[He, Sheng; Liu, Yi-Jun; Ye, Fei-Yue; Li, Ren-Pu; Dai, Ren-Jun] Jiangsu Univ Technol, Sch Comp Engn, Changzhou, Peoples R China	Jiangsu University of Technology	Ye, FY (corresponding author), Jiangsu Univ Technol, Sch Comp Engn, Changzhou, Peoples R China.	yfy@jsut.edu.cn			National Natural Science Foundation of China [61472166]; Youth Foundation Project of Humanities and Social Sciences Research of Ministry of Education in China [17YJC870011]; Natural Science Foundation of Jiangsu Province of China [BK20161199]; Jiangsu Overseas Research & Training Program for University Prominent Young & Middle-aged Teachers and Presidents [201613]; Planning Foundation Project of Humanities and Social Sciences Research of Ministry of Education in China [19YJA870005]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Youth Foundation Project of Humanities and Social Sciences Research of Ministry of Education in China; Natural Science Foundation of Jiangsu Province of China(Natural Science Foundation of Jiangsu Province); Jiangsu Overseas Research & Training Program for University Prominent Young & Middle-aged Teachers and Presidents; Planning Foundation Project of Humanities and Social Sciences Research of Ministry of Education in China	The work presented in this paper was carried out thanks to the support of the National Natural Science Foundation of China [grant number 61472166]; the Youth Foundation Project of Humanities and Social Sciences Research of Ministry of Education in China [grant number 17YJC870011]; the Natural Science Foundation of Jiangsu Province of China [grant number BK20161199]; the Jiangsu Overseas Research & Training Program for University Prominent Young & Middle-aged Teachers and Presidents [grant number 201613]; and the Planning Foundation Project of Humanities and Social Sciences Research of Ministry of Education in China [grant number 19YJA870005]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; Andersen MR, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.12; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Barsky A, 2007, BIOINFORMATICS, V23, P1040, DOI 10.1093/bioinformatics/btm057; Bu Zhan, 2019, IEEE Trans Cybern, V49, P328, DOI 10.1109/TCYB.2017.2772880; Czerwinska U, 2015, BMC SYST BIOL, V9, DOI 10.1186/s12918-015-0189-4; Forster J, 2003, GENOME RES, V13, P244, DOI 10.1101/gr.234503; FRUCHTERMAN TMJ, 1991, SOFTWARE PRACT EXPER, V21, P1129, DOI 10.1002/spe.4380211102; Funahashi A, 2008, P IEEE, V96, P1254, DOI 10.1109/JPROC.2008.925458; He S, 2018, J COMPLEX NETW, V6, P145, DOI 10.1093/comnet/cnx026; He S, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-31; Hu ZJ, 2007, NAT BIOTECHNOL, V25, P547, DOI 10.1038/nbt1304; Hu ZJ, 2013, NUCLEIC ACIDS RES, V41, pW225, DOI 10.1093/nar/gkt401; Hu ZJ, 2009, NUCLEIC ACIDS RES, V37, pW115, DOI 10.1093/nar/gkp406; Inoue K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037739; Ito T, 2001, P NATL ACAD SCI USA, V98, P4569, DOI 10.1073/pnas.061034498; Jacomy M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098679; Jin D, 2019, GRAPH CONVOLUTIONAL, P152; Jin D, 2018, 2018 16TH IEEE INT CONF ON DEPENDABLE, AUTONOM AND SECURE COMP, 16TH IEEE INT CONF ON PERVAS INTELLIGENCE AND COMP, 4TH IEEE INT CONF ON BIG DATA INTELLIGENCE AND COMP, 3RD IEEE CYBER SCI AND TECHNOL CONGRESS (DASC/PICOM/DATACOM/CYBERSCITECH), P318, DOI 10.1109/DASC/PiCom/DataCom/CyberSciTec.2018.00061; Kato Mitsuru, 2005, Genome Inform, V16, P22; Kojima K, 2008, BIOINFORMATICS, V24, P1433, DOI 10.1093/bioinformatics/btn196; Kojima K, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-76; Kojima K, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-335; Kurata H, 2003, NUCLEIC ACIDS RES, V31, P4071, DOI 10.1093/nar/gkg461; Li HJ, 2018, IEEE TETCI, V2, P214, DOI 10.1109/TETCI.2018.2829906; Li WJ, 2005, BIOINFORMATICS, V21, P2036, DOI 10.1093/bioinformatics/bti290; Merico D, 2009, NAT BIOTECHNOL, V27, P921, DOI 10.1038/nbt.1567; Noack A, 2008, MULTILEVEL ALGORITHM, DOI [10.1038/35001009, DOI 10.1038/35001009]; Noack Andreas, 2009, Phys Rev E Stat Nonlin Soft Matter Phys, V79, P026102, DOI 10.1103/PhysRevE.79.026102; Oberhardt MA, 2008, J BACTERIOL, V190, P2790, DOI 10.1128/JB.01583-07; Oliveira AP, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-39; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Suderman M, 2007, BIOINFORMATICS, V23, P2651, DOI 10.1093/bioinformatics/btm401; Tuikkala J, 2012, BIODATA MIN, V5, DOI 10.1186/1756-0381-5-2; Udrescu L, 2016, SCI REP-UK, V6, DOI 10.1038/srep32745; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; Vongsangnak W, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-245; Wang HC, 2018, 2018 11TH INTERNATIONAL SYMPOSIUM ON CHINESE SPOKEN LANGUAGE PROCESSING (ISCSLP), P300, DOI 10.1109/ISCSLP.2018.8706622; Wang JB, 2016, IEEE T CYBERNETICS, V46, P2782, DOI 10.1109/TCYB.2015.2489702; Wang L, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02344-z; Yamada T., 2003, P 20 INT C MACH LEAR, P832; Yu HY, 2008, SCIENCE, V322, P104, DOI 10.1126/science.1158684	42	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2019	14	8							e0221620	10.1371/journal.pone.0221620	http://dx.doi.org/10.1371/journal.pone.0221620			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW6AB	31465473	Green Submitted, gold, Green Published			2022-12-26	WOS:000485058200031
J	Goulev, Y; Matifas, A; Heyer, V; Reina-San-Martin, B; Charvin, G				Goulev, Youlian; Matifas, Audrey; Heyer, Vincent; Reina-San-Martin, Bernardo; Charvin, Gilles			COSPLAY: An expandable toolbox for combinatorial and swift generation of expression plasmids in yeast	PLOS ONE			English	Article							NEAREST-NEIGHBOR THERMODYNAMICS; CENTER-DOT-C; SACCHAROMYCES-CEREVISIAE; SHUTTLE VECTORS; DNA; MISMATCHES; CLONING; DELETION; NMR; PCR	A large number of genetic studies in yeast rely on the use of expression vectors. To facilitate the experimental approach of these studies, several collections of expression vectors have been generated (YXplac, pRS series, etc.). Subsequently, these collections have been expanded by adding more diversity to many of the plasmid features, including new selection markers and new promoter sequences. However, the ever growing number of plasmid features makes it unrealistic for research labs to maintain an up-to-date collection of plasmids. Here, we developed the COSPLAY toolbox: a Golden Gate approach based on the scheme of a simple modular plasmid that recapitulates and completes all the properties of the pRS plasmids. The COSPLAY toolbox contains a basal collection of individual functional modules. Moreover, we standardized a simple and rapid, software-assisted protocol which facilitates the addition of new personalized modules. Finally, our toolbox includes the possibility to select a genomic target location and to perform a single copy integration of the expression vector.	[Goulev, Youlian; Matifas, Audrey; Heyer, Vincent; Reina-San-Martin, Bernardo; Charvin, Gilles] Inst Genet & Biol Mol & Cellulaire, Dept Dev Biol & Stem Cells, Illkirch Graffenstaden, France; [Goulev, Youlian; Matifas, Audrey; Heyer, Vincent; Reina-San-Martin, Bernardo; Charvin, Gilles] CNRS, UMR7104, Illkirch Graffenstaden, France; [Goulev, Youlian; Matifas, Audrey; Heyer, Vincent; Reina-San-Martin, Bernardo; Charvin, Gilles] INSERM, U964, Illkirch Graffenstaden, France; [Goulev, Youlian; Matifas, Audrey; Heyer, Vincent; Reina-San-Martin, Bernardo; Charvin, Gilles] Univ Strasbourg, Illkirch Graffenstaden, France; [Goulev, Youlian] Harvard Med Sch, Dept Syst Biol, Boston, MA 02115 USA	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Harvard University; Harvard Medical School	Goulev, Y; Charvin, G (corresponding author), Inst Genet & Biol Mol & Cellulaire, Dept Dev Biol & Stem Cells, Illkirch Graffenstaden, France.; Goulev, Y; Charvin, G (corresponding author), CNRS, UMR7104, Illkirch Graffenstaden, France.; Goulev, Y; Charvin, G (corresponding author), INSERM, U964, Illkirch Graffenstaden, France.; Goulev, Y; Charvin, G (corresponding author), Univ Strasbourg, Illkirch Graffenstaden, France.; Goulev, Y (corresponding author), Harvard Med Sch, Dept Syst Biol, Boston, MA 02115 USA.	youlian_goulev@hms.harvard.edu; charvin@igbmc.fr	; REINA-SAN-MARTIN, Bernardo/I-9484-2016	Goulev, Youlian/0000-0003-0370-4567; REINA-SAN-MARTIN, Bernardo/0000-0003-2083-6166	ATIP-Avenir program; Agence Nationale de la Recherche [ANR-10-IDEX-0002-02]; Agence Nationale pour la Recherche [ANR-10-LABX-0030-INRT]; French State [ANR-10-LABX-0030-INRT, TANR-10-IDEX-0002-02]	ATIP-Avenir program; Agence Nationale de la Recherche(French National Research Agency (ANR)); Agence Nationale pour la Recherche(French National Research Agency (ANR)); French State	This work was supported by the ATIP-Avenir program (G.C.), and by the Agence Nationale de la Recherche under the frame program Investissements d'Avenir ANR-10-IDEX-0002-02. This work was also supported by the Agence Nationale pour la Recherche, ANR-10-LABX-0030-INRT (https://anr.fr) to GC and ANR-10-LABX-0030-INRT to BR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Maxime Diem and Vincent Hisler for contributions to this project during their stay in the lab as undergraduate interns. This work was supported by the ATIP-Avenir program (G.C.), and by the grant ANR-10-LABX-0030-INRT, a French State fund managed by the Agence Nationale de la Recherche under the frame program Investissements d'Avenir TANR-10-IDEX-0002-02.	Alberti S, 2007, YEAST, V24, P913, DOI 10.1002/yea.1502; Allawi HT, 1998, BIOCHEMISTRY-US, V37, P9435, DOI 10.1021/bi9803729; Allawi HT, 1998, BIOCHEMISTRY-US, V37, P2170, DOI 10.1021/bi9724873; Allawi HT, 1997, BIOCHEMISTRY-US, V36, P10581, DOI 10.1021/bi962590c; Allawi HT, 1998, NUCLEIC ACIDS RES, V26, P2694, DOI 10.1093/nar/26.11.2694; Allawi HT, 1998, NUCLEIC ACIDS RES, V26, P4925, DOI 10.1093/nar/26.21.4925; Blazeck J, 2012, BIOTECHNOL BIOENG, V109, P2884, DOI 10.1002/bit.24552; Brachmann CB, 1998, YEAST, V14, P115; Buchler NE, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.30; Chee MK, 2012, G3-GENES GENOM GENET, V2, P515, DOI 10.1534/g3.111.001917; Curran KA, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5002; Curran KA, 2013, METAB ENG, V19, P88, DOI 10.1016/j.ymben.2013.07.001; Engler C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003647; Engler C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005553; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Giaever G, 2014, GENETICS, V197, P451, DOI 10.1534/genetics.114.161620; Gibson DG, 2009, NUCLEIC ACIDS RES, V37, P6984, DOI 10.1093/nar/gkp687; Gietz RD, 2007, NAT PROTOC, V2, P31, DOI 10.1038/nprot.2007.13; Gietz RD, 2001, BIOTECHNIQUES, V30, P816, DOI 10.2144/01304rv02; GIETZ RD, 1988, GENE, V74, P527, DOI 10.1016/0378-1119(88)90185-0; Hartley JL, 2000, GENOME RES, V10, P1788, DOI 10.1101/gr.143000; Hillenmeyer ME, 2008, SCIENCE, V320, P362, DOI 10.1126/science.1150021; Howson R, 2005, COMP FUNCT GENOM, V6, P2, DOI 10.1002/cfg.449; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Leavitt JM, 2016, BIOTECHNOL J, V11, P866, DOI 10.1002/biot.201600029; Lee ME, 2015, ACS SYNTH BIOL, V4, P975, DOI 10.1021/sb500366v; Li MZ, 2007, PROTOCOL EXCHANGE, DOI [10.1038/nprot.2007.90, DOI 10.1038/NPROT.2007.90]; Lu Y, 2010, CELL, V141, P268, DOI 10.1016/j.cell.2010.03.021; Miyazaki K, 2011, METHOD ENZYMOL, V498, P399, DOI 10.1016/B978-0-12-385120-8.00017-6; MUMBERG D, 1994, NUCLEIC ACIDS RES, V22, P5767, DOI 10.1093/nar/22.25.5767; Owczarzy R, 2004, BIOCHEMISTRY-US, V43, P3537, DOI 10.1021/bi034621r; Peyret N, 1999, BIOCHEMISTRY-US, V38, P3468, DOI 10.1021/bi9825091; Pothoulakis G, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194588; Quan JY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006441; Redden H, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8810; Rozen S, 2000, Methods Mol Biol, V132, P365; SantaLucia J, 1998, P NATL ACAD SCI USA, V95, P1460, DOI 10.1073/pnas.95.4.1460; Sarrion-Perdigones A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021622; Shetty Reshma P, 2008, J Biol Eng, V2, P5, DOI 10.1186/1754-1611-2-5; WACH A, 1994, YEAST, V10, P1793, DOI 10.1002/yea.320101310; Weber E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019722; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Wosika V, 2016, MOL GENET GENOMICS, V291, P2231, DOI 10.1007/s00438-016-1249-1; Zhang YW, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr1288	44	4	4	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2019	14	8							e0220694	10.1371/journal.pone.0220694	http://dx.doi.org/10.1371/journal.pone.0220694			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5XV	31461461	Green Submitted, gold, Green Published			2022-12-26	WOS:000485052300014
J	Abe, M; Akaishi, T; Miki, T; Miki, M; Funamizu, Y; Araya, K; Ishizawa, K; Takayama, S; Takase, K; Abet, T; Ishii, T; Ito, S				Abe, Michiaki; Akaishi, Tetsuya; Miki, Takashi; Miki, Mika; Funamizu, Yasuharu; Araya, Kaori; Ishizawa, Kota; Takayama, Shin; Takase, Kei; Abet, Takaaki; Ishii, Tadashi; Ito, Sadayoshi			Influence of renal function and demographic data on intrarenal Doppler ultrasonography	PLOS ONE			English	Article							RESISTIVE INDEX; CREATININE CLEARANCE; ULTRASOUND; HYPERTENSION; SONOGRAPHY; VELOCITY	Intrarenal Doppler ultrasonography is a non-invasive method to evaluate the renal blood flow in patients with renal arterial stenosis as well as chronic kidney diseases (CKD). Until recently, the relationship between ultrasonography findings and CKD stage has not been fully understood. Overall, 162 patients with CKD without apparent renal arterial stenosis were included in this study, and the pulsed-wave Doppler ultrasonography findings were evaluated in terms of the following parameters: peak systolic velocity (PSV), end-diastolic velocity (EDV), and resistive index (RI) at the renal arterial trunk, hilum, segmental, and interlobar regions. Age showed a significant negative correlation with the estimated glomerular filtration rate (eGFR), kidney size, and aortic PSV. Additionally, age showed a significant positive correlation with RI in all 4 regions. The eGFR showed a positive correlation with the aortic PSV and kidney size, but a negative correlation with RI. Both age and eGFR were found to be independently associated with aortic blood flow. On the intrarenal ultrasound, EDV and RI showed stronger correlations with eGFR than PSV, suggesting that the former indices would be better markers of renal function. In particular, the interlobar EDV was found to be the best index that reflects renal function. Although the RI is also a good marker of renal function, it is confounded by age; thus, its utility would be weaker than that of the EDV. In conclusion, intrarenal pulsed-wave Doppler ultrasonography is a useful tool to estimate and evaluate the renal function; the interlobar EDV may be the best index to estimate the effective perfusion and filtration of the kidneys.	[Abe, Michiaki; Akaishi, Tetsuya; Ishizawa, Kota; Takayama, Shin; Ishii, Tadashi] Tohoku Univ Hosp, Dept Educ & Support Reg Med, Sendai, Miyagi, Japan; [Abe, Michiaki; Abet, Takaaki; Ito, Sadayoshi] Tohoku Univ Hosp, Dept Nephrol, Endocrinol & Vasc Med, Sendai, Miyagi, Japan; [Miki, Takashi; Miki, Mika; Funamizu, Yasuharu; Araya, Kaori] Tohoku Univ Hosp, Clin Physiol Ctr, Sendai, Miyagi, Japan; [Takase, Kei] Tohoku Univ Hosp, Diagnost Radiol, Sendai, Miyagi, Japan	Tohoku University; Tohoku University; Tohoku University; Tohoku University	Abe, M (corresponding author), Tohoku Univ Hosp, Dept Educ & Support Reg Med, Sendai, Miyagi, Japan.; Abe, M (corresponding author), Tohoku Univ Hosp, Dept Nephrol, Endocrinol & Vasc Med, Sendai, Miyagi, Japan.	michiabe@med.tohoku.ac.jp	Takayama, Shin/AAP-7007-2021; Takayama, Shin/GSN-7228-2022; Akaishi, Tetsuya/ABI-7460-2022	Takayama, Shin/0000-0002-6388-4566; 	JSPS, KAKENHI [JP 16K08487]	JSPS, KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	MA received JSPS Grant-in-Aid for Scientific Research (C), KAKENHI Grant Number JP 16K08487.	Anderson JL, 2011, CIRCULATION, V123, pE627, DOI 10.1161/CIR.0b013e3182231fc2; Battaglia S, 2010, J Ultrasound, V13, P107, DOI 10.1016/j.jus.2010.10.001; Bige N, 2012, BMC NEPHROL, V13, DOI 10.1186/1471-2369-13-139; Boddi M, 2017, ADV EXP MED BIOL, V956, P191, DOI 10.1007/5584_2016_170; Cauwenberghs N, 2015, PULSE, V3, P172, DOI 10.1159/000442445; Chen QK, 2014, EXP THER MED, V7, P439, DOI 10.3892/etm.2013.1442; Hirooka Y, 2016, J MED ULTRASON, V43, P145, DOI 10.1007/s10396-015-0651-3; Ikee R, 2005, AM J KIDNEY DIS, V46, P603, DOI 10.1053/j.ajkd.2005.06.006; Koda M, 2000, J GASTROEN HEPATOL, V15, P1424, DOI 10.1046/j.1440-1746.2000.02366.x; Koivistoinen T, 2007, CLIN PHYSIOL FUNCT I, V27, P191, DOI 10.1111/j.1475-097X.2007.00734.x; Lee J, 2013, PULSE, V1, P108, DOI 10.1159/000354110; LEW SQ, 1991, J AM SOC NEPHROL, V2, P856; Lippi G, 2006, CLIN CHEM LAB MED, V44, P311, DOI 10.1515/CCLM.2006.054; Lubas A, 2014, INT UROL NEPHROL, V46, P395, DOI 10.1007/s11255-013-0528-6; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; MOSTBECK GH, 1991, J ULTRAS MED, V10, P189, DOI 10.7863/jum.1991.10.4.189; PETERSEN LJ, 1995, NEPHROL DIAL TRANSPL, V10, P2060; PREECE MJ, 1972, NEPHRON, V9, P106, DOI 10.1159/000180140; Rundback JH, 2002, CIRCULATION, V106, P1572, DOI 10.1161/01.CIR.0000029805.87199.45; Samra Manpreet, 2012, Perm J, V16, P51; Schnell D, 2015, CRIT ULTRASOUND J, V7, DOI 10.1186/s13089-015-0024-6; STRANDNESS DE, 1994, AM J KIDNEY DIS, V24, P674, DOI 10.1016/S0272-6386(12)80230-7; Viazzi F, 2014, J HYPERTENS, V32, P149, DOI 10.1097/HJH.0b013e328365b29c; YURA T, 1993, J ULTRAS MED, V12, P215	24	8	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2019	14	8							e0221244	10.1371/journal.pone.0221244	http://dx.doi.org/10.1371/journal.pone.0221244			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5WO	31454365	gold, Green Published, Green Submitted			2022-12-26	WOS:000485049000015
J	Iqbal, J; Javed, A; Baig, MA				Iqbal, Jamshaid; Javed, Atif; Baig, Muhammad Anwar			Growth and nutrient removal efficiency of duckweed (lemna minor) from synthetic and dumpsite leachate under artificial and natural conditions	PLOS ONE			English	Article							WASTE-WATER TREATMENT; LANDFILL; PERFORMANCE; BIOMASS	Sustainable management of leachate produced from the dumpsite is one of the major concerns in developing countries Aquatic plants such as duckweed have the potential to remove pollutants from wastewater which can also be cost-effective and feasible options for leachate treatment. Therefore, the objective of our present study was to examine the growth and nutrient removal efficiency of duckweed (Lemna minor) on leachate. Three tests were performed each by growing lemna minor on synthetic leachate under controlled conditions and on dumpsite leachate under natural conditions. During each test, duckweed was grown in 300 ml plastic containers with a surface area of 25.8 cm(2). About 60 mg of fresh mass of duckweed was grown on 250 ml leachate at an internal depth of 9.5 cm. Results revealed that, in comparison to synthetic leachate, duckweed removed Chemical Oxygen Demand (COD), nitrogen (N), and phosphorous (P) more efficiently from dumpsite leachate under natural climatic conditions. However, the amounts of N and P absorbed into duckweed body mass were about 16% and 35% respectively more at synthetic leachate under controlled conditions. Maximum growth rate of duckweed (7.03 g m(-2) day(-1)) was also observed for synthetic leachate in comparison to the growth rate of 4.87 g m(-2) day(-1) at dumpsite leachate. Results of this study provide a useful interpretation of duckweed growth and nutrient removal dynamics from leachate under natural and laboratory conditions.	[Iqbal, Jamshaid] Inst Business Management IoBM, Coll Business Management, Dept Environm & Energy Management, Karachi, Sindh, Pakistan; [Javed, Atif] Univ Okara, Dept Environm Sci, Okara, Punjab, Pakistan; [Baig, Muhammad Anwar] Natl Univ Sci & Technol, Sch Civil & Environm Engn, Inst Environm Sci & Engn, Islamabad, Pakistan	National University of Sciences & Technology - Pakistan	Iqbal, J (corresponding author), Inst Business Management IoBM, Coll Business Management, Dept Environm & Energy Management, Karachi, Sindh, Pakistan.	jamshaidiqbal88@yahoo.com	Iqbal, Jamshaid/AAU-3185-2020; Javed, Atif/W-1473-2019	Iqbal, Jamshaid/0000-0001-8247-4127; Javed, Atif/0000-0002-5101-4715	Higher Education Commission of Pakistan	Higher Education Commission of Pakistan(Higher Education Commission of Pakistan)	Authors are grateful to Higher Education Commission of Pakistan for providing financial support during the execution of this research study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akinbile CO, 2012, WASTE MANAGE, V32, P1387, DOI 10.1016/j.wasman.2012.03.002; Al Nozaily F, 2000, PERFORMANCE PROCESS; Alaerts GJ, 1996, WATER RES, V30, P843, DOI 10.1016/0043-1354(95)00234-0; American Public Health Association (APHA), 2005, STANDARD METHODS EXA; [Anonymous], [No title captured]; Madera-Parra CA, 2017, ENV CHEM SUSTAIN WOR, V8, P121, DOI 10.1007/978-3-319-58622-9_5; Aziz S.Q., 2016, CIVIL ENV ENG CONCEP, P248; Bakhshoodeh R, 2017, ECOL ENG, V105, P7, DOI 10.1016/j.ecoleng.2017.04.058; Campbell N. A., 2002, BIOLOGY; Cedergreen N, 2002, NEW PHYTOL, V155, P285, DOI 10.1046/j.1469-8137.2002.00463.x; Cheng J, 2002, T ASAE, V45, P1003, DOI 10.13031/2013.9953; Cheng JJ, 2009, CLEAN-SOIL AIR WATER, V37, P17, DOI 10.1002/clen.200800210; Dalu JM, 2003, PHYS CHEM EARTH, V28, P1147, DOI 10.1016/j.pce.2003.08.036; Driever SM, 2005, AQUAT BOT, V81, P245, DOI 10.1016/j.aquabot.2004.12.002; DUONG TP, 1985, CAN J MICROBIOL, V31, P327, DOI 10.1139/m85-062; EDWARDS P, 1992, BIORESOURCE TECHNOL, V40, P109, DOI 10.1016/0960-8524(92)90195-4; Gao JL, 2015, REV ENVIRON SCI BIO, V14, P93, DOI 10.1007/s11157-014-9349-z; Ge XM, 2012, BIORESOURCE TECHNOL, V124, P485, DOI 10.1016/j.biortech.2012.08.050; Godwin A, 2016, INT LETT NATURAL SCI, V57; Iqbal JA, 2017, ENV PROTECTION ENG, V43; Kalcikova G, 2011, MANAG ENVIRON QUAL, V22, P612, DOI 10.1108/14777831111159734; Krishna KCB, 2008, ECOL ENG, V34, P243, DOI 10.1016/j.ecoleng.2008.08.013; Landesman L., 2002, WORLD AQUAC, V33, P39; Landolt E, 1987, FAMILY LEMNACEAE MON, V2; Landolt E., 1987, BIOSYSTEMATIC INVEST, V4; Lasfar S, 2007, WATER RES, V41, P2333, DOI 10.1016/j.watres.2007.01.059; Leng R., 1995, LIVESTOCK RES RURAL, V7, P36; Liu S., 2013, LANDFILL LEACHATE TR; Muller GT, 2015, WASTE MANAGE, V36, P177, DOI 10.1016/j.wasman.2014.10.024; Omar H, 2015, FRONT CHEM SCI ENG, V9, P15, DOI 10.1007/s11705-015-1501-y; Ozengin N, 2007, J ENVIRON BIOL, V28, P307; Pablos MV, 2011, WASTE MANAGE, V31, P1841, DOI 10.1016/j.wasman.2011.03.022; Sangodoyin A.Y., 2012, OPEN J CIVIL ENG, V2, P33, DOI DOI 10.4236/OJCE.2012.21006; Vermaat JE, 1998, WATER RES, V32, P2569, DOI 10.1016/S0043-1354(98)00037-2; Zhang K, 2014, ENVIRON TECHNOL, V35, P562, DOI 10.1080/09593330.2013.837937; Zhao Z, 2014, BIORESOURCE TECHNOL, V167, P383, DOI 10.1016/j.biortech.2014.06.031; Zimmo OR, 2004, WATER RES, V38, P913, DOI 10.1016/j.watres.2003.10.044	37	12	12	9	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2019	14	8							e0221755	10.1371/journal.pone.0221755	http://dx.doi.org/10.1371/journal.pone.0221755			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5WO	31454381	Green Published, gold, Green Submitted			2022-12-26	WOS:000485049000045
J	Girdwood, SJ; Nichols, BE; Moyo, C; Crompton, T; Chimhamhiwa, D; Rosen, S				Girdwood, Sarah J.; Nichols, Brooke E.; Moyo, Crispin; Crompton, Thomas; Chimhamhiwa, Dorman; Rosen, Sydney			Optimizing viral load testing access for the last mile: Geospatial cost model for point of care instrument placement	PLOS ONE			English	Article								Introduction Viral load (VL) monitoring programs have been scaled up rapidly, but are now facing the challenge of providing access to the most remote facilities (the "last mile"). For the hardestto- reach facilities in Zambia, we compared the cost of placing point of care (POC) viral load instruments at or near facilities to the cost of an expanded sample transportation network (STN) to deliver samples to centralized laboratories. Methods We extended a previously described geospatial model for Zambia that first optimized a STN for centralized laboratories for 90% of estimated viral load volumes. Amongst the remaining 10% of volumes, facilities were identified as candidates for POC placement, and then instrument placement was optimized such that access and instrument utilization is maximized. We evaluated the full cost per test under three scenarios: 1) POC placement at all facilities identified for POC; 2) an optimized combination of both on-site POC placement and placement at facilities acting as POC hubs; and 3) integration into the centralized STN to allow use of centralized laboratories. Results For the hardest-to-reach facilities, optimal POC placement covered a quarter of HIV-treating facilities. Scenario 2 resulted in a cost per test of $39.58, 6% less than the cost per test of scenario 1, $41.81. This is due to increased POC instrument utilization in scenario 2 where facilities can act as POC hubs. Scenario 3 was the most costly at $53.40 per test, due to high transport costs under the centralized model ($36 per test compared to $12 per test in scenario 2). Conclusions POC VL testing may reduce the costs of expanding access to the hardest-to-reach populations, despite the cost of equipment and low patient volumes. An optimal combination of both on-site placement and the use of POC hubs can reduce the cost per test by 6-35% by reducing transport costs and increasing instrument utilization.	[Girdwood, Sarah J.; Nichols, Brooke E.; Rosen, Sydney] Univ Witwatersrand, Fac Hlth Sci, Sch Clin Med, Hlth Econ & Epidemiol Res Off,Dept Internal Med, Johannesburg, South Africa; [Nichols, Brooke E.; Rosen, Sydney] Boston Univ, Sch Publ Hlth, Dept Global Hlth, Boston, MA USA; [Moyo, Crispin] EQUIP Zambia, Lusaka, Zambia; [Crompton, Thomas; Chimhamhiwa, Dorman] Right Care, GIS Mapping Dept, Johannesburg, South Africa	University of Witwatersrand; Boston University	Girdwood, SJ (corresponding author), Univ Witwatersrand, Fac Hlth Sci, Sch Clin Med, Hlth Econ & Epidemiol Res Off,Dept Internal Med, Johannesburg, South Africa.	sgirdwood@heroza.org	Nichols, Brooke E./V-5496-2019	Nichols, Brooke E./0000-0003-4682-4999; Crompton, Thomas/0000-0001-5525-3468	United States Agency for International Development (USAID) [AID-OAA-A-15-00070]	United States Agency for International Development (USAID)(United States Agency for International Development (USAID))	This work was funded by the United States Agency for International Development (USAID) through the following cooperative agreement: AID-OAA-A-15-00070 to BEN, SJG, TC, DC, and SR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. SJG had full access to all the date in the study and had final responsibility for the decision to submit for publication. The authors' views expressed in this publication do not necessarily reflect the views of the United States Agency for International Development or the United States Government.	Agutu CA, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0218369; Amukele TK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134020; [Anonymous], 2017, MSF ACCESS, P112; Barbasov V. K., 2016, ELECT POWER STATIONS, P1023; Bianchi F, 2017, INT AIDS SOC C PAR F; Cassim N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115420; Dorward J, 2018, LANCET HIV, V5, pE8, DOI 10.1016/S2352-3018(17)30211-4; Drain PK, 2019, CLIN MICROBIOL REV, V32, DOI 10.1128/CMR.00097-18; Drain PK, 2017, CURR OPIN HIV AIDS, V12, P175, DOI [10.1097/COH.0000000000000351, 10.1097/coh.0000000000000351]; Drain PK, 2019, C RETR OPP INF SEATT; Estill J, 2013, AIDS, V27, P1483, DOI 10.1097/QAD.0b013e328360a4e5; Frank SC, 2019, LANCET HIV, V6, pE182, DOI 10.1016/S2352-3018(18)30328-X; Girdwood SJ, 2019, LANCET HIV, V6, pE146, DOI 10.1016/S2352-3018(18)30335-7; Glencross DK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114727; Habiyambere V, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0201341; Heffernan A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158303; Hyle EP, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001725; Joint United Nations Programme on HIV/AIDS (UNAIDS), 2017, PROGR 90 90 90 TARG; Moyo S, 2016, J CLIN MICROBIOL, V54, P3050, DOI 10.1128/JCM.01594-16; Ndlovu Z, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193577; Nichols B, 2018, INT AIDS C; Nichols BE, 2020, CLIN INFECT DIS, V70, P1014, DOI 10.1093/cid/ciz338; Nichols BE, 2018, J INT AIDS SOC, V21, DOI 10.1002/jia2.25206; Pham MD, 2017, AIDS RES THER, V14, DOI 10.1186/s12981-017-0131-5; Phillips AN, 2016, OPEN FORUM INFECT DI, V3, DOI 10.1093/ofid/ofw161; Roberts T, 2016, CLIN INFECT DIS, V62, P1043, DOI 10.1093/cid/ciw001; Stover J, 2017, AIDS, V31, pS5, DOI 10.1097/QAD.0000000000001322; The Global Fund, 2017, HIV VIR LOAD EARL IN; UNAIDS, 2017, PAN PEOPL LIV HIV RE; World Health Organization, 2016, CONS GUID US ANT DRU, DOI [10.1016/j.jped.2014.04.007, DOI 10.1016/J.JPED.2014.04.007]; Zambian Ministry of Health, 2016, VIR LOAD EARL INF DI	31	13	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2019	14	8							e0221586	10.1371/journal.pone.0221586	http://dx.doi.org/10.1371/journal.pone.0221586			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5UR	31449559	gold, Green Submitted, Green Published			2022-12-26	WOS:000485044000024
J	Haider, S; Ponnusamy, K; Singh, RKB; Chakraborti, A; Bamezai, RNK				Haider, Shazia; Ponnusamy, Kalaiarasan; Singh, R. K. Brojen; Chakraborti, Anirban; Bamezai, Rameshwar N. K.			Hamiltonian energy as an efficient approach to identify the significant key regulators in biological networks	PLOS ONE			English	Article							DATABASE; EXPRESSION; STABILITY; COMPLEXES; RESOURCE; GENES	The topological characteristics of biological networks enable us to identify the key nodes in terms of modularity. However, due to a large size of the biological networks with many hubs and functional modules across intertwined layers within the network, it often becomes difficult to accomplish the task of identifying potential key regulators. We use for the first time a generalized formalism of Hamiltonian Energy (HE) with a recursive approach. The concept, when applied to the Apoptosis Regulatory Gene Network (ARGN), helped us identify 11 Motif hubs (MHs), which influenced the network up to motif levels. The approach adopted allowed to classify MHs into 5 significant motif hubs (S-MHs) and 6 non-significant motif hubs (NS-MHs). The significant motif hubs had a higher HE value and were considered as high-active key regulators; while the non-significant motif hubs had a relatively lower HE value and were considered as low-active key regulators, in network control mechanism. Further, we compared the results of the HE analyses with the topological characterization, after subjecting to the three conditions independently: (i) removing all MHs, (ii) removing only S-MHs, and (iii) removing only NS-MHs from the ARGN. This procedure allowed us to cross-validate the role of 5 S-MHs, NFk-B1, BRCA1, CEBPB, AR, and POU2F1 as the potential key regulators. The changes in HE calculations further showed that the removal of 5 S-MHs could cause perturbation at all levels of the network, a feature not discernible by topological analysis alone.	[Haider, Shazia] AIIMS, Dept Neurol, New Delhi, India; [Ponnusamy, Kalaiarasan] Jawaharlal Nehru Univ, Sch Biotechnol, New Delhi, India; [Singh, R. K. Brojen; Chakraborti, Anirban] Jawaharlal Nehru Univ, Sch Computat & Integrat Sci, New Delhi, India; [Bamezai, Rameshwar N. K.] Jawaharlal Nehru Univ, Natl Ctr Appl Human Genet, Sch Life Sci, New Delhi, India	All India Institute of Medical Sciences (AIIMS) New Delhi; Jawaharlal Nehru University, New Delhi; Jawaharlal Nehru University, New Delhi; Jawaharlal Nehru University, New Delhi	Singh, RKB; Chakraborti, A (corresponding author), Jawaharlal Nehru Univ, Sch Computat & Integrat Sci, New Delhi, India.; Bamezai, RNK (corresponding author), Jawaharlal Nehru Univ, Natl Ctr Appl Human Genet, Sch Life Sci, New Delhi, India.	bamezai@hotmail.com; anirban@jnu.ac.in; rk.brojen@gmail.com	Chakraborti, Anirban/AAD-2187-2020; Chakraborti, Anirban/A-4565-2010	Chakraborti, Anirban/0000-0002-6235-0204; Chakraborti, Anirban/0000-0002-6235-0204; Bamezai, R.N.K/0000-0002-5128-2859				Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; Ali S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0198525; Alm E, 2003, CURR OPIN STRUC BIOL, V13, P193, DOI 10.1016/S0959-440X(03)00031-9; Almaas E, 2007, J EXP BIOL, V210, P1548, DOI 10.1242/jeb.003731; Alon U, 2003, SCIENCE, V301, P1866, DOI 10.1126/science.1089072; Anders G, 2012, NUCLEIC ACIDS RES, V40, pD180, DOI 10.1093/nar/gkr1007; Assenov Y, 2008, BIOINFORMATICS, V24, P282, DOI 10.1093/bioinformatics/btm554; Bader GD, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-2; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Barzel B, 2013, NAT PHYS, V9, P673, DOI [10.1038/nphys2741, 10.1038/NPHYS2741]; Bassett D.S., 2013, J NONLINEAR SCI, V23, P13142, DOI DOI 10.1063/1.4790830; Betel D, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r90; Bryne JC, 2008, NUCLEIC ACIDS RES, V36, pD102, DOI 10.1093/nar/gkm955; Chatr-Aryamontri A, 2007, NUCLEIC ACIDS RES, V35, pD572, DOI 10.1093/nar/gkl950; Chen BL, 2014, BRIEF BIOINFORM, V15, P177, DOI 10.1093/bib/bbt039; Chirom K, 2017, IDENTIFICATION OF IN, P29; Chu LH, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-56; Cowen L, 2017, NAT REV GENET, V18, P551, DOI 10.1038/nrg.2017.38; Dorogovtsev SN, 2004, EUR PHYS J B, V38, P177, DOI 10.1140/epjb/e2004-00019-y; Farooqui A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-28375-0; Fortunato S, 2010, PHYS REP, V486, P75, DOI 10.1016/j.physrep.2009.11.002; Fox RF, 1993, BIOPHYS J, V65, P2698; Garcia DM, 2011, NAT STRUCT MOL BIOL, V18, P1139, DOI 10.1038/nsmb.2115; Ghiassian SD, 2016, SCI REP-UK, V6, DOI 10.1038/srep27414; Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799; Gochhait S, 2009, CANCER LETT, V273, P305, DOI 10.1016/j.canlet.2008.08.009; Haider S, 2014, LEUKEMIA LYMPHOMA, V55, P2241, DOI 10.3109/10428194.2013.876630; He XL, 2006, PLOS GENET, V2, P826, DOI 10.1371/journal.pgen.0020088; Hermjakob H, 2004, NUCLEIC ACIDS RES, V32, pD452, DOI 10.1093/nar/gkh052; Heylighen F., 2001, ENCY LIFE SUPPORT SY; Holleman A, 2006, BLOOD, V107, P769, DOI 10.1182/blood-2005-07-2930; Hsu SD, 2014, NUCLEIC ACIDS RES, V42, pD78, DOI 10.1093/nar/gkt1266; Hu JX, 2016, NAT REV GENET, V17, P615, DOI 10.1038/nrg.2016.87; Karolchik D, 2004, NUCLEIC ACIDS RES, V32, pD493, DOI 10.1093/nar/gkh103; Kertesz M, 2007, NAT GENET, V39, P1278, DOI 10.1038/ng2135; Kovacs IA, 2015, NATURE, V524, P38, DOI 10.1038/524038a; Li H, 2014, CELL DEATH DIFFER, V21, P1493, DOI 10.1038/cdd.2014.69; Maslov S, 2002, SCIENCE, V296, P910, DOI 10.1126/science.1065103; Matys V, 2006, NUCLEIC ACIDS RES, V34, pD108, DOI 10.1093/nar/gkj143; Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824; Nafis S, 2016, MOL BIOSYST, V12, P3357, DOI 10.1039/c6mb00526h; Nafis S, 2015, BRIEF BIOINFORM, V16, P675, DOI 10.1093/bib/bbu036; Pal R, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-303; Pal R, 2011, BREAST CANCER RES TR, V126, P333, DOI 10.1007/s10549-010-0900-5; Pastor-Satorras R, 2001, PHYS REV LETT, V86, P3200, DOI 10.1103/PhysRevLett.86.3200; Peri S, 2004, NUCLEIC ACIDS RES, V32, pD497, DOI 10.1093/nar/gkh070; Ravasz E, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.026112; Ravasz E, 2002, SCIENCE, V297, P1551, DOI 10.1126/science.1073374; Reichardt J, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.218701; Reichardt J, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.015102; Reichardt J, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.016110; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Song CM, 2005, NATURE, V433, P392, DOI 10.1038/nature03248; Stark C, 2006, NUCLEIC ACIDS RES, V34, pD535, DOI 10.1093/nar/gkj109; Szklarczyk D, 2017, NUCLEIC ACIDS RES, V45, pD362, DOI 10.1093/nar/gkw937; Tang ZF, 2016, J THEOR BIOL, V408, P274, DOI 10.1016/j.jtbi.2016.06.036; Traag VA, 2013, SCI REP-UK, V3, DOI 10.1038/srep02930; Traag VA, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.016114; Vandin F, 2011, J COMPUT BIOL, V18, P507, DOI 10.1089/cmb.2010.0265; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Wong RSY, 2011, J EXP CLIN CANC RES, V30, DOI 10.1186/1756-9966-30-87; WU FY, 1982, REV MOD PHYS, V54, P235, DOI 10.1103/RevModPhys.54.235; Xenarios I, 2000, NUCLEIC ACIDS RES, V28, P289, DOI 10.1093/nar/28.1.289; Xiao FF, 2009, NUCLEIC ACIDS RES, V37, pD105, DOI 10.1093/nar/gkn851; Yu YH, 2009, CURR CANCER DRUG TAR, V9, P566, DOI 10.2174/156800909788486759	66	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2019	14	8							e0221463	10.1371/journal.pone.0221463	http://dx.doi.org/10.1371/journal.pone.0221463			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5TR	31442253	Green Submitted, Green Published, gold			2022-12-26	WOS:000485041400036
J	Haller-Bull, V; Bode, M				Haller-Bull, Vanessa; Bode, Michael			Superadditive and subadditive dynamics are not inherent to the types of interacting threat	PLOS ONE			English	Article							MULTIPLE STRESSORS; CORAL-REEFS; ANTAGONISM; ECOSYSTEMS; MANAGEMENT; SYNERGISM; IMPACT; MAP	Species and ecosystems usually face more than one threat. The damage caused by these multiple threats can accumulate nonlinearly: either subadditively, when the joint damage of combined threats is less than the damages of both threats individually added together, or superadditively, when the joint damage is greater than the two individual damages added together. These additivity dynamics are commonly attributed to the nature of the threatening processes, but conflicting empirical observations challenge this assumption. Here, we use a theoretical model to demonstrate that the additivity of threats can change with different magnitudes of threat impacts (effect of a threat on the population parameter, like growth rate). We use a harvested single-species population model to integrate the effects of multiple threats on equilibrium abundance. Our results reveal that threats do not always display consistent additive behavior, even in simple systems. Instead, their additivity depends on the magnitudes of the impacts of two threats, and the population parameter that is impacted by each threat. In our model specifically, when multiple threats have a low impact on the growth rate of a population, they display superadditive dynamics. In contrast, threats that impact the species' carrying capacity are always additive or subadditive. These dynamics can be understood by reference to the curvature of the relationship between a given population parameter (e.g., growth) and equilibrium population size. Our results suggest that management actions can achieve amplified benefits if they target low-amplitude threats that affect the growth rate, since these will be in a superadditive phase. More generally, our results suggest that cumulative impact theory should focus more than previously on the magnitude of the impact on the population parameter, and should be cautious about attributing additive dynamics to particular threat combinations.	[Haller-Bull, Vanessa; Bode, Michael] James Cook Univ, ARC Ctr Excellence Coral Reef Studies, Townsville, Qld, Australia; [Haller-Bull, Vanessa] Australian Inst Marine Sci, AIMS JCU, Townsville, Qld, Australia; [Haller-Bull, Vanessa; Bode, Michael] Queensland Univ Technol, Sch Math Sci, Brisbane, Qld, Australia	James Cook University; Australian Institute of Marine Science; Queensland University of Technology (QUT)	Haller-Bull, V (corresponding author), James Cook Univ, ARC Ctr Excellence Coral Reef Studies, Townsville, Qld, Australia.; Haller-Bull, V (corresponding author), Australian Inst Marine Sci, AIMS JCU, Townsville, Qld, Australia.; Haller-Bull, V (corresponding author), Queensland Univ Technol, Sch Math Sci, Brisbane, Qld, Australia.	v.haller@hdr.qut.edu.au	; Bode, Michael/A-7116-2009	Haller-Bull, Vanessa/0000-0002-3919-7053; Bode, Michael/0000-0002-5886-4421				Brown CJ, 2014, DIVERS DISTRIB, V20, P538, DOI 10.1111/ddi.12159; Brown CJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065765; Carwardine J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002586; CASWELL H, 1978, AM NAT, V112, P127, DOI 10.1086/283257; CONNELL JH, 1978, SCIENCE, V199, P1302, DOI 10.1126/science.199.4335.1302; Coors A, 2008, J APPL ECOL, V45, P1820, DOI 10.1111/j.1365-2664.2008.01566.x; Crain CM, 2009, ANN NY ACAD SCI, V1162, P39, DOI 10.1111/j.1749-6632.2009.04496.x; Crain CM, 2008, ECOL LETT, V11, P1304, DOI 10.1111/j.1461-0248.2008.01253.x; Darling ES, 2008, ECOL LETT, V11, P1278, DOI 10.1111/j.1461-0248.2008.01243.x; DEANGELIS DL, 1987, ECOL MONOGR, V57, P1, DOI 10.2307/1942636; Folt CL, 1999, LIMNOL OCEANOGR, V44, P864, DOI 10.4319/lo.1999.44.3_part_2.0864; Fulton EA, 2011, FISH FISH, V12, P171, DOI 10.1111/j.1467-2979.2011.00412.x; Gurney GG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080137; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; HARRIS GP, 1980, CAN J FISH AQUAT SCI, V37, P877, DOI 10.1139/f80-117; Hughes TP, 1999, LIMNOL OCEANOGR, V44, P932, DOI 10.4319/lo.1999.44.3_part_2.0932; Judd AD, 2015, ENVIRON SCI POLICY, V54, P254, DOI 10.1016/j.envsci.2015.07.008; Kukkala AS, 2013, BIOL REV, V88, P443, DOI 10.1111/brv.12008; Melbourne-Thomas J, 2011, ECOL MODEL, V222, P1756, DOI 10.1016/j.ecolmodel.2011.03.008; Paine RT, 1998, ECOSYSTEMS, V1, P535, DOI 10.1007/s100219900049; Piggott JJ, 2015, ECOL EVOL, V5, P1538, DOI 10.1002/ece3.1465; Reddingius J, 1972, GAMBLING EXISTENCE D; Scheffer M, 2015, SCIENCE, V347, P1317, DOI 10.1126/science.aaa3769; Schloder C, 2004, J EXP MAR BIOL ECOL, V313, P255, DOI 10.1016/j.jembe.2004.08.012; Tulloch VJD, 2015, FRONT ECOL ENVIRON, V13, P91, DOI 10.1890/140022; Wiens J.A., 1984, P439	26	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2019	14	8							e0211444	10.1371/journal.pone.0211444	http://dx.doi.org/10.1371/journal.pone.0211444			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5TR	31442226	Green Published, gold, Green Submitted, Green Accepted			2022-12-26	WOS:000485041400001
J	Song, CH; Kim, N; Kim, DH; Lee, HN; Surh, YJ				Song, Chin-Hee; Kim, Nayoung; Kim, Do-Hee; Lee, Ha-Na; Surh, Young-Joon			17-beta estradiol exerts anti-inflammatory effects through activation of Nrf2 in mouse embryonic fibroblasts	PLOS ONE			English	Article							NF-KAPPA-B; OXIDATIVE STRESS; ESTROGEN-RECEPTORS; CHRONIC INFLAMMATION; IDENTIFICATION; GENES; ALPHA; ASTROCYTES; EXPRESSION; CONVERSION	Several reports indicate crosstalk between the transcription factor nuclear factor erythroid 2-related factor 2 (Nrf2) and estrogen, which has a protective effect in colorectal cancer (CRC). The aim of this study was to investigate the role of Nrf2 signaling in the anti-inflammatory effect of estrogen using Nrf2 knockout (Nrf2 KO) mouse embryonic fibroblasts (MEFs), a powerful system to test the function of target genes due to their easy accessibility, and rapid growth rates. After inducing inflammation by tumor necrosis factor alpha (TNF-alpha), the effects of 17 beta-estradiol (E2) on the expression of proinflammatory mediators [i.e., NF-kappa B and inducible nitric oxide synthase (iNOS)] and estrogen receptors were evaluated by Western blot. In wild type (WT) MEFs, E2 treatment ameliorated TNF-alpha-induced nuclear translocation of NF-kappa B and expression of its target protein iNOS. Estrogen receptor beta (ER beta) expression was decreased by TNF-alpha-induced inflammation and restored by E2 treatment. When treated to WT MEFs, E2 induced nuclear translocation of Nrf2. The inhibitory effect of E2 on TNF-alpha-induced enhancement of iNOS was markedly dampened in Nrf2 KO MEFs. Notably, ER beta expression was significantly diminished in Nrf2 KO MEFs compared to that in WT cells. Promoter Database (EPD) revealed two putative anti-oxidant response elements (AREs) within the mouse ER beta promoter. Furthermore, in WT MEFs, E2 treatment repressed TNF-alpha-induced expression of iNOS protein and recovered by 4-(2-phenyl-5,7-bis(trifluoromethyl) pyrazolo(1,5-a)pyrimidin-3-yl)phenol (PHTPP), a selective ER beta antagonist, treatment, but not in Nrf2 KO MEFs. In conclusion, Nrf2 plays a pivotal role in the anti-inflammatory of estrogen by direct regulating the expression of ER beta.	[Song, Chin-Hee; Kim, Nayoung] Seoul Natl Univ, Bundang Hosp, Dept Internal Med, Seongnam, Gyeonggi Do, South Korea; [Kim, Nayoung] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul, South Korea; [Kim, Nayoung] Seoul Natl Univ, Coll Med, Liver Res Inst, Seoul, South Korea; [Kim, Do-Hee; Lee, Ha-Na; Surh, Young-Joon] Seoul Natl Univ, Coll Pharm, Tumor Microenvironm Global Core Res Ctr, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU)	Kim, N (corresponding author), Seoul Natl Univ, Bundang Hosp, Dept Internal Med, Seongnam, Gyeonggi Do, South Korea.; Kim, N (corresponding author), Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul, South Korea.; Kim, N (corresponding author), Seoul Natl Univ, Coll Med, Liver Res Inst, Seoul, South Korea.	nayoungkim49@empas.com			National Research Foundation of Korea (NRF) - government of the Republic of Korea [2016R1A2B4013133]	National Research Foundation of Korea (NRF) - government of the Republic of Korea	This work was supported by a grant from the National Research Foundation of Korea (NRF) funded by the government of the Republic of Korea (2016R1A2B4013133 to NK). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amor S, 2010, IMMUNOLOGY, V129, P154, DOI 10.1111/j.1365-2567.2009.03225.x; Bellezza I, 2012, J NUTR BIOCHEM, V23, P1583, DOI 10.1016/j.jnutbio.2011.10.012; Blakytny Robert, 2004, J CELL PHYSIOL, V199, P67, DOI [10.1002/jcp.10454, DOI 10.1002/JCP.25284, 10.1002/jcp.25284, DOI 10.15430/JCP.2016.21.4.271]; Boyanapalli SSS, 2014, CHEM RES TOXICOL, V27, P2036, DOI 10.1021/tx500234h; Bradley JR, 2008, J PATHOL, V214, P149, DOI 10.1002/path.2287; Chan KM, 1996, P NATL ACAD SCI USA, V93, P13943, DOI 10.1073/pnas.93.24.13943; Cheung KL, 2014, MOL CARCINOGEN, V53, P77, DOI 10.1002/mc.21950; Chlebowski RT, 2004, NEW ENGL J MED, V350, P991, DOI 10.1056/NEJMoa032071; Dreos R, 2015, NUCLEIC ACIDS RES, V43, pD92, DOI 10.1093/nar/gku1111; Efe JA, 2011, NAT CELL BIOL, V13, P215, DOI 10.1038/ncb2164; Ferrero-Miliani L, 2007, CLIN EXP IMMUNOL, V147, P227, DOI 10.1111/j.1365-2249.2006.03261.x; GARZONCASTANO SC, 1937, NRF, V7, DOI DOI 10.12688/F1000RESEARCH.17165.2; GORRINI C, 2014, P NATL ACAD SCI USA, V111, P2; HTTPS, JCP, DOI DOI 10.15430/JCP.2016.21.4.271; HTTPS, JCP, DOI DOI 10.15430/JCP.2016.21.4.271; HTTPS, JCP, DOI DOI 10.15430/JCP.2016.21.4.271; HTTPS, JCP, DOI DOI 10.15430/JCP.2016.21.4.271; HTTPS, JCP, DOI DOI 10.15430/JCP.2016.21.4.271; Itoh K, 2004, MOL CELL BIOL, V24, P36, DOI 10.1128/MCB.24.1.36-45.2004; Khan A, 2018, NUCLEIC ACIDS RES, V46, pD260, DOI 10.1093/nar/gkx1126; Khansari N, 2009, RECENT PATENTS INFLA, V3, P73, DOI 10.2174/187221309787158371; Kim J, 2010, MUTAT RES-FUND MOL M, V690, P12, DOI 10.1016/j.mrfmmm.2009.09.007; Kobayashi EH, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11624; Kovats S, 2015, CELL IMMUNOL, V294, P63, DOI 10.1016/j.cellimm.2015.01.018; Kuiper GGJM, 1997, ENDOCRINOLOGY, V138, P863, DOI 10.1210/en.138.3.863; Kundu JK, 2010, PHARM RES-DORDR, V27, P999, DOI 10.1007/s11095-010-0096-8; Lawrence T, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001651; Lee HG, 2010, ANTIOXID REDOX SIGN, V13, P1639, DOI 10.1089/ars.2010.3226; Lee JM, 2003, J BIOL CHEM, V278, P12029, DOI 10.1074/jbc.M211558200; Lee Sun Min, 2016, J Cancer Prev, V21, P271, DOI 10.15430/JCP.2016.21.4.271; Levonen AL, 2007, ARTERIOSCL THROM VAS, V27, P741, DOI 10.1161/01.ATV.0000258868.80079.4d; Ma Q, 2006, AM J PATHOL, V168, P1960, DOI 10.2353/ajpath.2006.051113; Osburn WO, 2007, INT J CANCER, V121, P1883, DOI 10.1002/ijc.22943; Ospina JA, 2004, AM J PHYSIOL-HEART C, V286, pH2010, DOI 10.1152/ajpheart.00481.2003; PAREEK TK, 2011, SCI REP-UK, V1, DOI DOI 10.1016/J.JNUTBIO.2011.10.012; Piantadosi CA, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.207738; Principi M, 2014, WORLD J GASTROENTERO, V20, P11496, DOI 10.3748/wjg.v20.i33.11496; Rojo de la Vega Montserrat, 2016, Curr Pharmacol Rep, V2, P91; RUSHMORE TH, 1991, J BIOL CHEM, V266, P11632; Saleiro D, 2012, INT J CANCER, V131, P2553, DOI 10.1002/ijc.27578; SCHUTZE S, 1995, IMMUNOBIOLOGY, V193, P193, DOI 10.1016/S0171-2985(11)80543-7; Soares MP, 2004, J IMMUNOL, V172, P3553, DOI 10.4049/jimmunol.172.6.3553; Son HJ, 2020, KOREAN J INTERN MED, V35, P310, DOI 10.3904/kjim.2018.098; Son HJ, 2019, CANCER RES TREAT, V51, P632, DOI 10.4143/crt.2018.060; Song CH, 2018, GUT LIVER, V12, P682, DOI 10.5009/gnl18221; Spence RD, 2013, J NEUROSCI, V33, P10924, DOI 10.1523/JNEUROSCI.0886-13.2013; Straub RH, 2007, ENDOCR REV, V28, P521, DOI 10.1210/er.2007-0001; Straub RH, 2016, EVOL MED PUBLIC HLTH, P37, DOI 10.1093/emph/eow001; Stumpo Deborah J, 2016, BIO PROTOCOLS, V6, pe1859; Surh YJ, 2008, GENES NUTR, V2, P313, DOI 10.1007/s12263-007-0063-0; Tamm C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081156; Thimmulappa RK, 2002, CANCER RES, V62, P5196; Torihata Y, 2018, DIGEST DIS SCI, V63, P345, DOI 10.1007/s10620-017-4885-3; Vegeto E, 2008, FRONT NEUROENDOCRIN, V29, P507, DOI 10.1016/j.yfrne.2008.04.001; Vierbuchen T, 2010, NATURE, V463, P1035, DOI 10.1038/nature08797; Wu JJ, 2014, EXP CELL RES, V328, P351, DOI 10.1016/j.yexcr.2014.08.030; Wu TY, 2011, AAPS J, V13, P1, DOI 10.1208/s12248-010-9239-4; Xie Hui, 2018, J CELL PHYSIOL, V234, P11156, DOI [10.1002/jcp.27764, DOI 10.1002/JCP.27764]; Zhu XG, 2018, BLOOD, V131, P558, DOI 10.1182/blood-2017-10-810531	59	17	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2019	14	8							e0221650	10.1371/journal.pone.0221650	http://dx.doi.org/10.1371/journal.pone.0221650			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5TR	31442293	gold, Green Submitted, Green Published			2022-12-26	WOS:000485041400062
J	Chow, AHC; Cai, T; McPherson, B; Yang, F				Chow, Ann Hiu Ching; Cai, Ting; McPherson, Bradley; Yang, Feng			Otitis media with effusion in children: Cross-frequency correlation in pure tone audiometry	PLOS ONE			English	Article							CLINICAL-PRACTICE GUIDELINES; HEARING; MANAGEMENT; BURDEN	Different guidelines are adopted in clinics and countries to assess pure tone hearing sensitivity in children with otitis media with effusion (OME). Some guidelines specify a broad range of audiometric frequencies that must be tested and from which average thresholds determined, while others leave test frequencies unspecified. For guidelines that suggest specific frequencies there are various pure tone frequencies and frequency ranges given. The present study investigated whether (1) a full range of audiometric frequencies is required to evaluate hearing loss caused by OME in children, or if neighboring frequencies provide essentially the same threshold information, and (2) if different combinations of test frequency pure tone averaging calculations may affect decision criteria for surgical treatment. In a retrospective cohort study, right and left ear air conduction pure tone threshold data were obtained, from 125 Hz to 8 kHz, for 96 children with OME aged 4 to 12 years. Paired t-tests, correlation tests (Pearson's r, Cronbach's alpha, intraclass correlation) and absolute differences were used to examine the relationships among pure tone audiometric (PTA) frequencies for all ears with hearing loss. 168 ears were found to have OME-related hearing loss. Only the 125 Hz-250 Hz comparison showed no statistically significant difference between neighboring thresholds. However, only the 4 kHz and 8 kHz comparison showed a clinically significant mean difference of >= 10 dB. When viewing individual differences, comparison between 250 Hz and 500 Hz, 125 Hz and 500 Hz, and 4 kHz and 8 kHz, showed a large number of ears with clinically significant differences between test frequencies. Comparisons among low frequency 3 PTA average (500 Hz, 1 kHz, 2 kHz), high frequency 3 PTA average (1 kHz, 2 kHz, 4 kHz), and 4 frequency PTA average (500 Hz, 1 kHz, 2 kHz, 4 kHz) showed no statistically significant differences, with very strong correlations for all comparisons. In addition, for all the combinations of PTA averages, no clinically significant differences were found for the various comparisons or among individual results. Clinically, testing hearing sensitivity in the 125 Hz to 8 kHz range is worthwhile in evaluating hearing sensitivity in children with OME due to large individual variability across audiometric frequencies. However, frequencies tested for criterion averages for surgical treatments of children with OME may be restricted to 3 frequency PTA averages, either an average of 500 Hz, 1 kHz, 2 kHz or an average of 1 kHz, 2 kHz, 4 kHz, as no clinically significant differences were found using these or a 4 frequency averaging technique. For research purposes, 250 Hz can proxy for hearing thresholds at 125 Hz; and the low frequency 3 PTA average, high frequency 3 PTA average and 4 frequency PTA average may be used interchangeably, as no statistically significant differences were found among these measures.	[Chow, Ann Hiu Ching; Cai, Ting; McPherson, Bradley] Univ Hong Kong, Fac Educ, Div Speech & Hearing Sci, Hong Kong, Peoples R China; [Yang, Feng] Shenzhen Childrens Hosp, Dept Speech Therapy, Shenzhen, Peoples R China	University of Hong Kong	Yang, F (corresponding author), Shenzhen Childrens Hosp, Dept Speech Therapy, Shenzhen, Peoples R China.	hkufrank@163.com	; McPherson, Bradley/A-3140-2010	YANG, FENG/0000-0002-0106-2831; McPherson, Bradley/0000-0002-7982-1033	University of Hong Kong [201309176026]; Shenzhen Municipal Science and Technology Innovation Committee [JCYJ20140416141331555]	University of Hong Kong(University of Hong Kong); Shenzhen Municipal Science and Technology Innovation Committee	This research was supported in part by the Small Project Fund (No. 201309176026, recipient: BM) and Faculty of Education Research Fund (recipient: TC) from the University of Hong Kong. This study was also supported by funding from the Shenzhen Municipal Science and Technology Innovation Committee (No. JCYJ20140416141331555, recipient: FY). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American National Standard Institute, 2008, S3111999 ANSI; American National Standards Institute, 2007, S3391987 ANSI; American Speech-Language-Hearing Association (ASHA), 2005, GUID MAN PUR TON THR; Atkinson H, 2015, POSTGRAD MED, V127, P381, DOI 10.1080/00325481.2015.1028317; Bland JM, 1997, BRIT MED J, V314, P572, DOI 10.1136/bmj.314.7080.572; Bland JM, 1999, STAT METHODS MED RES, V8, P135, DOI 10.1191/096228099673819272; British Columbia Medical Association, 2010, OT MED AC OT MED AOM; British Society of Audiology, 2011, REC PROC PUR TON AIR; Brouwer CNM, 2005, INT J PEDIATR OTORHI, V69, P1031, DOI 10.1016/j.ijporl.2005.03.013; Bruton A, 2000, PHYSIOTHERAPY, V86, P94, DOI [10.1016/S0031-9406(05)61211-4, DOI 10.1016/S0031-9406(05)61211-4, 10.1016/s0031-9406(05)61211-4]; Cai T, 2018, DISABIL REHABIL, V40, P1166, DOI 10.1080/09638288.2017.1290698; Cai T, 2017, INT J AUDIOL, V56, P65, DOI 10.1080/14992027.2016.1250960; CHINN S, 1991, THORAX, V46, P454, DOI 10.1136/thx.46.6.454; Clark J G, 1981, ASHA, V23, P493; Cohen J.E., 1988, STAT POWER ANAL BEHA; Gravel JS, 2000, J SPEECH LANG HEAR R, V43, P631, DOI 10.1044/jslhr.4303.631; Gravel JS, 2003, EVIDENCE BASED OTITI, P359; Gstoettner W, 2004, ACTA OTO-LARYNGOL, V124, P348, DOI 10.1080/00016480410016432; Harlor Allen D Buz Jr, 2009, Pediatrics, V124, P1252, DOI 10.1542/peds.2009-1997; Heidemann CH, 2016, INT J PEDIATR OTORHI, V87, P154, DOI 10.1016/j.ijporl.2016.06.003; Herefordshire Clinical Commissioning Group, 2018, HER CCG TREATM POL; International Organization for Standardization, 2004, 38912004 ISO; Ito M, 2017, AURIS NASUS LARYNX, V44, P501, DOI 10.1016/j.anl.2017.03.018; JERGER J, 1970, ARCHIV OTOLARYNGOL, V92, P311; Kim J, 2015, J AUDIOL OTOL, V19, P1, DOI 10.7874/jao.2015.19.1.1; Kim YE, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/3596261; Klein JO, 2000, VACCINE, V19, pS2, DOI 10.1016/S0264-410X(00)00271-1; Koo TK, 2016, J CHIROPR MED, V15, P155, DOI 10.1016/j.jcm.2016.02.012; Lee HJ, 2012, J KOREAN MED SCI, V27, P835, DOI 10.3346/jkms.2012.27.8.835; Monasta L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036226; Morris~ P, 2010, RECOMMENDATIONS CLIN; National Collaborating Centre for Women's and Children's Health (UK), 2008, SURG MAN OT MED EFF; North West London Collaboration of Clinical Commissioning Groups, 2013, PLANN PROC THRESH VE; Paparella MM, 2002, ORL J OTO-RHINO-LARY, V64, P65, DOI 10.1159/000057783; Rosenfeld RM, 2016, OTOLARYNG HEAD NECK, V154, pS1, DOI 10.1177/0194599815623467; Rosenfeld RM, 2003, EVIDENCE BASED OTITI, P180; Schlauch R.S., 2014, HDB CLIN AUDIOLOGY E, P29; Scottish Intercollegiate Guidelines Network (SIGN), 2003, 66 SIGN; SHAH N, 1991, J ROY SOC MED, V84, P581; Speets A, 2011, J MULTIDISCIP HEALTH, V4, P53, DOI 10.2147/JMDH.S17529; Tavakol M, 2011, INT J MED EDUC, V2, P1, DOI 10.5116/ijme.4d27.32ff; Taylor Penelope S, 2009, Expert Rev Pharmacoecon Outcomes Res, V9, P133, DOI 10.1586/erp.09.6; TAYLOR R, 1990, J DIAGN MED SONOG, V6, P219, DOI 10.1177/875647939000600404; Tillery KL., 2015, HDB CLIN AUDIOLOGY, P137; Zulkiflee S, 2013, Malays Fam Physician, V8, P32	45	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2019	14	8							e0221405	10.1371/journal.pone.0221405	http://dx.doi.org/10.1371/journal.pone.0221405			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5RZ	31437206	Green Published, gold, Green Submitted			2022-12-26	WOS:000485036900065
J	Coker, G; Richard, M; Bayne, K; Smaill, S; Garrett, L; Matson, A; Wakelin, S				Coker, Graham; Richard, Mathis; Bayne, Karen; Smaill, Simeon; Garrett, Loretta; Matson, Amanda; Wakelin, Steven			Stakeholder valuation of soil ecosystem services from New Zealand's planted forests	PLOS ONE			English	Article							BIOLOGICAL INDICATORS; PROKARYOTIC DIVERSITY; STARTING POINT; QUALITY; BIODIVERSITY; PROVISION; VALUES	The goal of this study was to determine if there were differences among stakeholders in the values they attribute to soil ecosystem services from plantation forests in New Zealand. Groups of forest-associated stakeholders were identified (e.g. land owners, forest owners, wood processors, and recreational forest users) and surveyed to assess their cultural background (indigenous New Zealand Maori or not) and then the relative importance they placed on 10 forest soil ecosystem services. Across all survey respondents, very high importance was placed on the ability of soils to sustain forest growth across multiple plantings/rotations (sustainable production). Interestingly, this was more highly valued than maximising short-term production. Maori placed greater importance on forest ecosystem resilience, provenance and kaitiakitanga (sensu stewardship of resources), water quality, and harvest of food and/or medicines from forests than non-Maori. These results demonstrate inherent cultural differences in valuing the range of forest ecosystem services that soils support. It is important that cultural views are understood and integrated into future soil health testing schemes to reflect the needs of all stakeholders. Ultimately, this work will help increase the sustainability of planted forest ecosystems in New Zealand, ensure the forestry sectors social licence to operate, and add value to forest products by demonstrating environmental and cultural stewardship of forest products.	[Coker, Graham; Bayne, Karen; Smaill, Simeon; Wakelin, Steven] Scion, Forest Syst, Riccarton, New Zealand; [Richard, Mathis] AroSup Dijon, Dijon, France; [Garrett, Loretta; Matson, Amanda] Forest Syst Scion, Rotorua, New Zealand; [Wakelin, Steven] Lincoln Univ, BioProtect Res Ctr, Lincoln, New Zealand	Lincoln University - New Zealand	Wakelin, S (corresponding author), Scion, Forest Syst, Riccarton, New Zealand.; Wakelin, S (corresponding author), Lincoln Univ, BioProtect Res Ctr, Lincoln, New Zealand.	Steve.A.Wakelin@scionresearch.com	; Wakelin, Steve/C-3170-2011	Bayne, Karen/0000-0001-8731-8449; Garrett, Loretta/0000-0001-7687-6795; Smaill, Simeon/0000-0001-6242-4931; Wakelin, Steve/0000-0002-1167-8699	Growing Confidence in Forestry Futures (GCFF) programme [C04X1306]; Forest Growers Levy Trust; New Zealand Ministry of Business Innovation and Employment (MBIE)	Growing Confidence in Forestry Futures (GCFF) programme; Forest Growers Levy Trust; New Zealand Ministry of Business Innovation and Employment (MBIE)(New Zealand Ministry of Business, Innovation and Employment (MBIE))	GC, KB, SS, LG, AM, and SW recieved funding from the Growing Confidence in Forestry Futures (GCFF) programme (Contract number C04X1306). GCFF was co-funded by the Forest Growers Levy Trust and the New Zealand Ministry of Business Innovation and Employment (MBIE). The funders had approved the study design, data collection and analysis, but had no role in the preparation of the manuscript. They support the decision to publish, and this support is and would be irrespective of the studies findings, outcomes, or implications real or inferred.; Funding was provided by the Growing Confidence in Forestry Futures (GCFF) programme (Contract number CO4X1306). GCFF was co-funded by the Forest Growers Levy Trust and the New Zealand Ministry of Business Innovation and Employment (MBIE). Marie McCarthy, Richard Yao, and Sandra Velarde, all from Scion, provided useful input into the development of this approach. S.A. Wakelin is also supported by the Bioprotection Research Excellence, a New Zealand government centre of research excellence. We thank the anonymous reviewers and journal editor for their time and efforts during assessment and improvement of this manuscript.	Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; [Anonymous], 2005, EC HUM WELL BEING SY; Bardgett RD, 2014, NATURE, V515, P505, DOI 10.1038/nature13855; Bastida F, 2008, GEODERMA, V147, P159, DOI 10.1016/j.geoderma.2008.08.007; Bloem J., 2005, MICROBIOLOGICAL METH; Blum Winfried E. H., 2005, Reviews in Environmental Science and Bio/Technology, V4, P75, DOI 10.1007/s11157-005-2236-x; Brockerhoff EG, 2017, BIODIVERS CONSERV, V26, P3005, DOI 10.1007/s10531-017-1453-2; Bunemann EK, 2018, SOIL BIOL BIOCHEM, V120, P105, DOI 10.1016/j.soilbio.2018.01.030; Clarke K.R., CHANGE MARINE COMMUN, V2nd; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Curtis TP, 2002, P NATL ACAD SCI USA, V99, P10494, DOI 10.1073/pnas.142680199; Lopes AAD, 2013, SOIL SCI SOC AM J, V77, P461, DOI 10.2136/sssaj2012.0191; Deal RL, 2012, FOREST POLICY ECON, V17, P69, DOI 10.1016/j.forpol.2011.12.007; Doran J. W., 1997, P1; Faber JH, 2013, INTEGR ENVIRON ASSES, V9, P276, DOI 10.1002/ieam.1398; Food and Agriculture Organization of the United Nations, 2015, STAT WORLDS SOIL RES; Forest Owners Association, 2016, FACTS FIG 015 2016; Hughes D, 2009, EUROCHOICES, V8, P6, DOI 10.1111/j.1746-692X.2009.00139.x; Julian JP, 2017, HYDROL EARTH SYST SC, V21, P1149, DOI 10.5194/hess-21-1149-2017; Kruger I, 2017, BIOTECHNOL AGRON SOC, V21, P219; Liu CLC, 2018, GLOB ECOL CONSERV, V15, DOI 10.1016/j.gecco.2018.e00419; Lyver POB, 2017, BIODIVERS CONSERV, V26, P3183, DOI 10.1007/s10531-016-1142-6; Lyver PO, 2017, ECOSYST SERV, V27, P92, DOI 10.1016/j.ecoser.2017.08.009; McCluskey J. J., 2009, Agricultural and Resource Economics Review, V38, P345; Miller R, 2005, MAORI CONNECTIONS FO; Ministry for the Environment, 2016, FREE TRAD ENV COOP A; Ministry for the Environment & Statistics New Zealand, 2015, NZ ENV REP SER ENV R; Nordstrom EM, 2011, SILVA FENN, V45, P253, DOI 10.14214/sf.116; Organisation for Economic Co-Operation and Development, 1996, ENV PERF REV; Orwin KH, 2015, GLOBAL CHANGE BIOL, V21, P2844, DOI 10.1111/gcb.12949; Pulleman M, 2012, CURR OPIN ENV SUST, V4, P529, DOI 10.1016/j.cosust.2012.10.009; R Core Team, 2013, R LANG ENV STAT COMP; Ritz K, 2009, ECOL INDIC, V9, P1212, DOI 10.1016/j.ecolind.2009.02.009; Smaill SJ, 2014, ENVIRON MANAGE, V53, P783, DOI 10.1007/s00267-014-0239-5; Sparling GP, 2002, J ENVIRON QUAL, V31, P1848, DOI 10.2134/jeq2002.1848; Stone D, 2016, APPL SOIL ECOL, V97, P12, DOI 10.1016/j.apsoil.2015.08.005; Tait P, 2016, INT FOOD RES J, V23, P1787; Torsvik V, 2002, SCIENCE, V296, P1064, DOI 10.1126/science.1071698; Turbe A., 2010, SOIL BIODIVERSITY FU; Wagg C, 2014, P NATL ACAD SCI USA, V111, P5266, DOI 10.1073/pnas.1320054111; Wakelin SA, 2013, NEW ZEAL J AGR RES, V56, P248, DOI 10.1080/00288233.2013.822003; Wakelin S. A., 2013, SOIL BIOL BIOCHEM, V83, P568; Yao RT, 2013, ECOSYSTEM SERVICES IN NEW ZEALAND: CONDITIONS AND TRENDS, P62; 1995, J FOREST, V93, P18	44	2	2	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2019	14	8							e0221291	10.1371/journal.pone.0221291	http://dx.doi.org/10.1371/journal.pone.0221291			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5RZ	31437193	gold, Green Published, Green Submitted			2022-12-26	WOS:000485036900048
J	Kong, L; Duan, YL; Ye, YF; Cai, ZZ; Wang, F; Qu, XJ; Qiu, RH; Wu, CY; Wu, WR				Kong, Lan; Duan, Yuanlin; Ye, Yanfang; Cai, Zhengzheng; Wang, Feng; Qu, Xiaojie; Qiu, Ronghua; Wu, Chunyan; Wu, Weiren			Screening and analysis of proteins interacting with OsMADS16 in rice (Oryza sativa L.)	PLOS ONE			English	Article							FLORAL ORGAN IDENTITY; MADS BOX GENES; ECTOPIC EXPRESSION; FLOWER DEVELOPMENT; CLASS-B; ARABIDOPSIS; IDENTIFICATION; CONSERVATION; HOMEOSTASIS; HOMOLOG	OsMADS16, a class B floral organ identity gene, plays a pivotal role in stamen formation in rice. To date, little is known about the interacting partners of OsMADS16 except for several MADS-box proteins. In this study, we constructed a high-quality cDNA library of young panicles (< 5 cm in length) and performed yeast two-hybrid (Y2H) screening using OsMADS16 as bait. Eleven candidate proteins interacting with OsMADS16 were identified by Y2H and validated by BiFC and Co-IP assays. Subcellular localization results further confirmed the possibility of the interactions of OsMADS16 with 10 of the candidate proteins in natural rice cells. Bioinformatics analysis indicated that these partners exerted various molecular, cellular and physiological functions. Some of them were known or likely to be related to reproductive events, such as stamen primordium initiation, differentiation and development (OsMADS2, OsMADS4 and OsCOP9) and pollen development (OsbHLH40 and Os6PGDH). Our results provide an important reference for further research on OsMADS16-mediated regulation mechanism on floral organ development and pollen formation.	[Kong, Lan; Duan, Yuanlin; Ye, Yanfang; Cai, Zhengzheng; Wu, Weiren] Fujian Agr & Forestry Univ, Fujian Key Lab Crop Breeding Design, Fuzhou, Fujian, Peoples R China; [Kong, Lan; Duan, Yuanlin; Ye, Yanfang; Cai, Zhengzheng; Qu, Xiaojie; Qiu, Ronghua; Wu, Chunyan; Wu, Weiren] Fujian Agr & Forestry Univ, Key Lab Genet Breeding & Multiple Utilizat Crops, Minist Educ, Fuzhou, Fujian, Peoples R China; [Wang, Feng] Fujian Acad Agr Sci, Biotechnol Res Inst Biotechnol, Fuzhou, Fujian, Peoples R China	Fujian Agriculture & Forestry University; Fujian Agriculture & Forestry University; Fujian Academy of Agricultural Sciences	Duan, YL; Wu, WR (corresponding author), Fujian Agr & Forestry Univ, Fujian Key Lab Crop Breeding Design, Fuzhou, Fujian, Peoples R China.; Duan, YL; Wu, WR (corresponding author), Fujian Agr & Forestry Univ, Key Lab Genet Breeding & Multiple Utilizat Crops, Minist Educ, Fuzhou, Fujian, Peoples R China.	ylduan863@fafu.edu.cn; wuwr@fafu.edu.cn			National Science Foundation of China [NSFC: 31671665, 31871600]; Natural Science Foundation of Fujian Provincial of China [2014J01093]; Sci-Tech Development Founds of Fujian Agriculture and Forestry University [KF2015081, KF2015082]; International Sci-Tech Cooperation and Exchange Program of Fujian Agriculture and Forestry University [KXGH17014]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Fujian Provincial of China; Sci-Tech Development Founds of Fujian Agriculture and Forestry University; International Sci-Tech Cooperation and Exchange Program of Fujian Agriculture and Forestry University	This work was funded by National Science Foundation of China (NSFC: 31671665 and 31871600), Natural Science Foundation of Fujian Provincial of China (2014J01093), Sci-Tech Development Founds of Fujian Agriculture and Forestry University (NO.: KF2015081 and KF2015082) and the International Sci-Tech Cooperation and Exchange Program of Fujian Agriculture and Forestry University (Grant number: KXGH17014).	Adamczyk BJ, 2009, PLANT PHYSIOL, V149, P1713, DOI 10.1104/pp.109.135806; Agrawal G, 2005, PLANT MOL BIOL, V59, P125, DOI 10.1007/s11103-005-2161-y; Chen ZQ, 2017, FUNCT PLANT BIOL, V44, P635, DOI [10.1071/FP16314, 10.1071/fp16314]; Ciaffi M, 2011, SEX PLANT REPROD, V24, P247, DOI 10.1007/s00497-011-0175-y; COEN ES, 1991, NATURE, V353, P31, DOI 10.1038/353031a0; Cutler SR, 2010, ANNU REV PLANT BIOL, V61, DOI [10.1146/annurevarplant-042809-112122, DOI 10.1146/ANNUREVARPLANT-042809-112122]; Ding LY, 2007, THESIS; Dreni L, 2013, MOL PLANT, V6, P650, DOI 10.1093/mp/sst019; Duan YL, 2012, PLANT MOL BIOL, V80, P429, DOI 10.1007/s11103-012-9958-2; He Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095246; Hu LF, 2011, PLANT CELL, V23, P515, DOI 10.1105/tpc.110.074369; Huang F, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-89; Huang J, 2003, MOL BIOL REP, V30, P223, DOI 10.1023/A:1026392422995; Immink RGH, 2010, SEMIN CELL DEV BIOL, V21, P87, DOI 10.1016/j.semcdb.2009.10.004; Ito T, 2004, NATURE, V430, P356, DOI 10.1038/nature02733; Ji XM, 2011, PLANT PHYSIOL, V156, P647, DOI 10.1104/pp.111.176164; Kang HG, 1998, PLANT MOL BIOL, V38, P1021, DOI 10.1023/A:1006051911291; Ko SS, 2014, PLANT CELL, V26, P2486, DOI 10.1105/tpc.114.126292; Kyozuka J, 2002, PLANT CELL PHYSIOL, V43, P130, DOI 10.1093/pcp/pcf010; Lee S, 2003, PLANTA, V217, P904, DOI 10.1007/s00425-003-1066-8; Liu Yongming, 2015, Yichuan, V37, P1194, DOI 10.16288/j.yczz.15-229; Liu Y, 2013, PLANT CELL, V25, P1288, DOI 10.1105/tpc.113.110049; Lopez-Dee ZP, 1999, DEV GENET, V25, P237, DOI 10.1002/(SICI)1520-6408(1999)25:3&lt;237::AID-DVG6&gt;3.0.CO;2-L; Moon YH, 1999, PLANT MOL BIOL, V40, P167, DOI 10.1023/A:1026429922616; Mundt KE, 1999, CURR BIOL, V9, P1427, DOI 10.1016/S0960-9822(00)80091-3; Pelaz S, 2000, NATURE, V405, P200, DOI 10.1038/35012103; [彭强 Peng Qiang], 2012, [华中农业大学学报, Journal of Huazhong Agricultural University], V31, P404; Peng ZH, 2001, DEVELOPMENT, V128, P4277; Robles P, 2005, INT J DEV BIOL, V49, P633, DOI 10.1387/ijdb.052020pr; Sato H, 2012, PLANT SCI, V183, P183, DOI 10.1016/j.plantsci.2011.08.010; Sentoku N, 2005, MOL GENET GENOMICS, V273, P1, DOI 10.1007/s00438-004-1093-6; Seok HY, 2010, BIOCHEM BIOPH RES CO, V401, P598, DOI 10.1016/j.bbrc.2010.09.108; Song JiangWei, 2014, Chinese Journal of Veterinary Science, V34, P865; Theissen G, 2001, CURR OPIN PLANT BIOL, V4, P75, DOI 10.1016/S1369-5266(00)00139-4; Theissen G, 2001, NATURE, V409, P469, DOI 10.1038/35054172; van Adrichem NLM, 2014, 2014 IEEE JOINT INTELLIGENCE AND SECURITY INFORMATICS CONFERENCE (JISIC), P9, DOI 10.1109/JISIC.2014.12; Xiao H, 2003, PLANT MOL BIOL, V52, P957, DOI 10.1023/A:1025401611354; Yamaguchi T, 2006, PLANT CELL, V18, P15, DOI 10.1105/tpc.105.037200; Yang JW, 2014, PLANT MOL BIOL REP, V32, P153, DOI 10.1007/s11105-013-0633-9; Yao SG, 2008, PLANT CELL PHYSIOL, V49, P853, DOI 10.1093/pcp/pcn050; Yin LL, 2012, PLANT CELL, V24, P1049, DOI 10.1105/tpc.111.094854; Yoshida H, 2011, J EXP BOT, V62, P4719, DOI 10.1093/jxb/err272; Yun DP, 2013, MOL PLANT, V6, P743, DOI 10.1093/mp/sst003; Zhang DS, 2008, MOL PLANT, V1, P599, DOI 10.1093/mp/ssn028; Zhang Ming-Yong, 1998, Acta Phytophysiologica Sinica, V24, P55; Zhang Y, 2011, PLANT METHODS, V7, DOI 10.1186/1746-4811-7-30	46	6	7	6	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2019	14	8							e0221473	10.1371/journal.pone.0221473	http://dx.doi.org/10.1371/journal.pone.0221473			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5RZ	31437207	Green Published, Green Submitted, gold			2022-12-26	WOS:000485036900078
J	Tambo, JA; Aliamo, C; Davis, T; Mugambi, I; Romney, D; Onyango, DO; Kansiime, M; Alokit, C; Byantwale, ST				Tambo, Justice A.; Aliamo, Caroline; Davis, Tamsin; Mugambi, Idah; Romney, Dannie; Onyango, David O.; Kansiime, Monica; Alokit, Christine; Byantwale, Stephen T.			The impact of ICT-enabled extension campaign on farmers' knowledge and management of fall armyworm in Uganda	PLOS ONE			English	Article							PROPENSITY SCORE; MOBILE PHONES; AGRICULTURAL EXTENSION; HOST PLANTS; INFORMATION; COMMUNICATION; INNOVATION; SERVICES; ADOPTION; MESSAGE	This study evaluates the unique and combined effects of three complementary ICT-based extension methods - interactive radio, mobile SMS messages and village-based video screenings - on farmers' knowledge and management of fall armyworm (FAW), an invasive pest of maize that is threatening food security in sub-Saharan Africa and Asia. Building on a survey of maize farmers in western Uganda and using various selection-on-observables estimators, we find consistent evidence that participation in the ICT-based extension campaigns significantly increases farmers' knowledge about FAW and stimulates the adoption of agricultural technologies and practices for the management of the pest. We also show that exposure to multiple campaign channels yields significantly higher outcomes than exposure to a single channel, with some evidence of additive effects. These results are robust to alternative estimators and also to hidden bias. Results further suggest that among the three ICT channels, radio has greater reach, video exerts a stronger impact on the outcome measures, and greater gains are achieved when video is complemented by radio. Our findings imply that complementary ICT-based extension campaigns (particularly those that allow both verbal and visual communication) hold great potential to improve farmers' knowledge and trigger behavioural changes in the identification, monitoring and sustainable management of a new invasive pest, such as FAW.	[Tambo, Justice A.] CABI, Delemont, Switzerland; [Aliamo, Caroline; Alokit, Christine] CABI, Entebbe, Uganda; [Davis, Tamsin] CABI, Wallingford, Oxon, England; [Mugambi, Idah; Romney, Dannie; Onyango, David O.; Kansiime, Monica] CABI, Nairobi, Kenya; [Byantwale, Stephen T.] MAAIF, Entebbe, Uganda		Tambo, JA (corresponding author), CABI, Delemont, Switzerland.	j.tambo@cabi.org		Tambo, Justice/0000-0001-8895-7066	International Fund for Agricultural Development (IFAD) through CABI's Plantwise programme; UK (Department for International Development); China (Chinese Ministry of Agriculture); Australia (Australian Centre for International Agricultural Research); Canada (Agriculture and Agri-Food Canada); Netherlands (Directorate-General for International Cooperation); Switzerland (Swiss Agency for Development and Cooperation)	International Fund for Agricultural Development (IFAD) through CABI's Plantwise programme; UK (Department for International Development); China (Chinese Ministry of Agriculture); Australia (Australian Centre for International Agricultural Research); Canada (Agriculture and Agri-Food Canada); Netherlands (Directorate-General for International Cooperation); Switzerland (Swiss Agency for Development and Cooperation)	This research was financially supported by the International Fund for Agricultural Development (IFAD) through CABI's Plantwise programme. CABI is an international intergovernmental organization and we gratefully acknowledge the core financial support from our member countries (and lead agencies) including the UK (Department for International Development), China (Chinese Ministry of Agriculture), Australia (Australian Centre for International Agricultural Research), Canada (Agriculture and Agri-Food Canada), The Netherlands (Directorate-General for International Cooperation) and Switzerland (Swiss Agency for Development and Cooperation). See https://www.cabi.org/about-cabi/who-we-work-with/keydonors/for details.	Aker JC, 2016, FOOD POLICY, V60, P44, DOI 10.1016/j.foodpol.2015.03.006; Aker JC, 2011, AGR ECON-BLACKWELL, V42, P631, DOI 10.1111/j.1574-0862.2011.00545.x; Anderson J. R., 2007, HDB AGR EC, V3, P2343, DOI [10.1016/S1574-0072(06)03044-1, DOI 10.1016/S1574-0072(06)03044-1]; Baumuller H, 2018, J INT DEV, V30, P134, DOI 10.1002/jid.3314; Bell M., 2015, ICT POWERING BEHAV C; Bentley J., 2015, 6 GFRAS; Bentley J, 2014, DEV PRACT, V24, P921, DOI 10.1080/09614524.2014.942216; Boa E, 2016, 24 GFRAS; CABI, 2019, CAMP REP PART COMM C; Caliendo M, 2008, J ECON SURV, V22, P31, DOI 10.1111/j.1467-6419.2007.00527.x; Casmuz Augusto, 2010, Rev. Soc. Entomol. Argent., V69, P209; Chowdhury A, 2015, INT J AGR SUSTAIN, V13, P326, DOI 10.1080/14735903.2014.997461; Davis K. E., 2008, Journal of International Agricultural and Extension Education, V15, P15; Day R., 2017, Outlooks on Pest Management, V28, P196, DOI 10.1564/v28_oct_02; Desiere S, 2015, EVAL PROGRAM PLANN, V49, P10, DOI 10.1016/j.evalprogplan.2014.11.002; Dohmen T, 2011, J EUR ECON ASSOC, V9, P522, DOI 10.1111/j.1542-4774.2011.01015.x; Fafchamps M, 2012, WORLD BANK ECON REV, V26, P383, DOI 10.1093/wber/lhr056; FAO, 2018, INTEGRATED MANAGEMEN; Fu XL, 2016, J DEV STUD, V52, P1561, DOI 10.1080/00220388.2016.1146700; Goergen G, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165632; Hudson HE, 2017, TELECOMMUN POLICY, V41, P670, DOI 10.1016/j.telpol.2017.05.010; Imbens GW, 2009, J ECON LIT, V47, P5, DOI 10.1257/jel.47.1.5; Kumela T, 2019, INT J PEST MANAGE, V65, P1, DOI 10.1080/09670874.2017.1423129; Larochelle C, 2019, J DEV STUD, V55, P548, DOI 10.1080/00220388.2017.1393522; Lechner M, 2002, REV ECON STAT, V84, P205, DOI 10.1162/003465302317411488; MAAIF, 2018, FALL ARM TECHN BRIEF; Matuschke I, 2009, AGR ECON-BLACKWELL, V40, P493, DOI 10.1111/j.1574-0862.2009.00393.x; Ministry of Agriculture Animal Industry and Fisheries (MAAIF), 2016, NAT AGR EXT STRAT; Montezano DG, 2018, AFR ENTOMOL, V26, P286, DOI 10.4001/003.026.0286; Nakasone E, 2016, AGR ECON-BLACKWELL, V47, P49, DOI 10.1111/agec.12314; Prasanna B.M., 2018, FALL ARMYWORM AFRICA, VFirst ed.; Rosenbaum P. R., 2002, OBSERVATIONAL STUDIE; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; Rwomushana I, 2018, FALL ARMYWORM IMPACT; Saravanan R, 2015, 17 GFRAS; Saravanan R., 2015, 11 GFRAS; Schreiner, 2015, SIMPLE POVERTY SCORE; Sekabira H., 2017, Food Policy, V73, P95, DOI 10.1016/j.foodpol.2017.10.004; Shiferaw B, 2011, FOOD SECUR, V3, P475, DOI 10.1007/s12571-011-0153-0; Shimamoto D, 2015, FOOD POLICY, V57, P135, DOI 10.1016/j.foodpol.2015.10.005; Sones K. R., 2015, CAB Reviews, V10, P1, DOI 10.1079/PAVSNNR201510030; StataCorp, 2013, STAT REL 13 STAT SOF; Toepfer S, 2019, J PLANT DIS PROTECT, V126, P103, DOI 10.1007/s41348-018-0202-4; Uganda Bureau of Statistics, 2010, UG CENS AGR 2008 200, V1; Van Campenhout B, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169557; Van Mele P, 2010, DEV PRACT, V20, P414, DOI 10.1080/09614521003710021; Wooldridge JM, 2010, ECONOMETRIC ANALYSIS OF CROSS SECTION AND PANEL DATA, 2ND EDITION, P1; Zossou E, 2009, INT J AGR SUSTAIN, V7, P119, DOI 10.3763/ijas.2009.0438; Zoundji GC, 2018, INT J AGR SUSTAIN, V16, P54, DOI 10.1080/14735903.2018.1428393	50	21	21	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2019	14	8							e0220844	10.1371/journal.pone.0220844	http://dx.doi.org/10.1371/journal.pone.0220844			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW5QN	31433814	Green Submitted, Green Published, gold			2022-12-26	WOS:000485033100016
J	King, MA; Ward, MD; Mayer, TA; Plamper, ML; Madsen, CM; Cheuvront, SN; Kenefick, RW; Leon, LR				King, Michelle A.; Ward, Matthew D.; Mayer, Thomas A.; Plamper, Mark L.; Madsen, Clifford M.; Cheuvront, Samuel N.; Kenefick, Robert W.; Leon, Lisa R.			Influence of prior illness on exertional heat stroke presentation and outcome	PLOS ONE			English	Article							RISK-FACTORS; HEATSTROKE; INJURY; SUSCEPTIBILITY; PERMEABILITY; HYPERTHERMIA; DYSFUNCTION; IMMERSION; MARATHON; EXERCISE	Introduction Precipitating factors that contribute to the severity of exertional heat stroke (EHS) are unclear. The purpose of this study was to determine the effect of prior illness (PI) on EHS severity. Methods We performed a retrospective clinical record review of 179 documented cases of EHS at the Marine Corps Base in Quantico, Virginia. Results Approximately 30% of EHS cases had a medically documented PI. Anthropometrics (height, weight, body mass index) and commonly associated risk factors for EHS (age, number of days in training, wet bulb globe temperature, sleep patterns) did not differ between PI and no illness (NI) groups. PI patients presented with higher maximal rectal core temperatures (40.6 +/- 1.0 degrees C vs. 40.3 +/- 1.2 degrees C; P = 0.0419), and elevated pulse rates (118.1 +/- 16.7 bpm vs. 110.5 +/- 24.2 bpm; P = 0.0397). At the point of care, biomarker values were similar between PI and NI groups, with the exception of a trend toward elevated monocytes in those with PI (7.9 +/- 2.9% vs 6.7 +/- 2.7%; P = 0.0521). Rate and duration of cooling were similar between PI and NI patients. Conclusion This study indicates that PI has a minimal effect on the patient presentation, severity and treatment outcome of EHS. The results of this study have important implications for military, civilian, and occupational populations who are at risk for EHS.	[King, Michelle A.; Ward, Matthew D.; Mayer, Thomas A.; Plamper, Mark L.; Cheuvront, Samuel N.; Kenefick, Robert W.; Leon, Lisa R.] US Army Res Inst Environm Med, Thermal & Mt Med Div, Natick, MA 01760 USA; [Madsen, Clifford M.] John H Bradley Branch Hlth Clin, Marine Corps Base, Quantico, VA USA	United States Department of Defense; United States Army	Leon, LR (corresponding author), US Army Res Inst Environm Med, Thermal & Mt Med Div, Natick, MA 01760 USA.	lisa.r.leon.civ@mail.mil		Mayer, Thomas/0000-0002-1581-9196	Department of the Army USAMRAA [W81XWH-13-MOMJPC5-IPPEHA]	Department of the Army USAMRAA	LRL received funding from the Department of the Army USAMRAA, grant #W81XWH-13-MOMJPC5-IPPEHA; https://www.usamraa.army.mil/. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2007, TECHN MAN NEHC TM OE; BISCHOF JC, 1995, BIOPHYS J, V68, P2608, DOI 10.1016/S0006-3495(95)80445-5; Bouchama A, 2002, NEW ENGL J MED, V346, P1978, DOI 10.1056/NEJMra011089; BURGER FJ, 1964, AM J PHYSIOL, V206, P1057, DOI 10.1152/ajplegacy.1964.206.5.1057; Carter R, 2007, J SPORT REHABIL, V16, P238, DOI 10.1123/jsr.16.3.238; Casa DJ, 2010, MED SCI SPORT EXER, V42, P1246, DOI 10.1249/MSS.0b013e3181e26cbb; CLOWES GHA, 1974, NEW ENGL J MED, V291, P564, DOI 10.1056/NEJM197409122911106; COSTRINI AM, 1979, AM J MED, V66, P296, DOI 10.1016/0002-9343(79)90548-5; Davies HD, 2017, PEDIATRICS, V140, DOI 10.1542/peds.2017-2477; Demartini JK, 2015, MED SCI SPORT EXER, V47, P240, DOI 10.1249/MSS.0000000000000409; Dematte JE, 1998, ANN INTERN MED, V129, P173, DOI 10.7326/0003-4819-129-3-199808010-00001; Department of the Army and Air Force, 2003, TECHN B MED, V507; Epstein Y, 1999, MED SCI SPORT EXER, V31, P224, DOI 10.1097/00005768-199902000-00004; FITZGERALD L, 1991, INT J SPORTS MED, V12, pS5, DOI 10.1055/s-2007-1024742; Gardner JW, 1996, MED SCI SPORT EXER, V28, P939, DOI 10.1097/00005768-199608000-00001; Gilchrist I., 2010, Morbidity and Mortality Weekly Report, V59, P1009; Kiyatkin EA, 2009, NEUROSCIENCE, V161, P926, DOI 10.1016/j.neuroscience.2009.04.004; Leon LR, 2015, COMPR PHYSIOL, V5, P611, DOI 10.1002/cphy.c140017; Lim CL, 2007, AM J PHYSIOL-REG I, V292, pR186, DOI 10.1152/ajpregu.00921.2005; Lim CL, 2006, SPORTS MED, V36, P39, DOI 10.2165/00007256-200636010-00004; Lin XJ, 2009, AM J MED SCI, V337, P265, DOI 10.1097/MAJ.0b013e31818b0fa2; MALAMUD N, 1946, Mil Surg, V99, P397; NIEMAN DC, 1994, INT J SPORTS MED, V15, pS131, DOI 10.1055/s-2007-1021128; NOAKES TD, 1983, EUR J APPL PHYSIOL, V52, P75, DOI 10.1007/BF00429029; Notley SR, 2018, MORPHOLOGICAL PHYSL; Novosad VL, 2013, AM J PHYSIOL-GASTR L, V305, pG418, DOI 10.1152/ajpgi.00166.2013; PETERS EM, 1983, S AFR MED J, V64, P582; Roberts WO, 2006, MED SCI SPORT EXER, V38, P1197, DOI 10.1249/01.mss.0000227302.80783.0f; Sarkar S, 2013, J PEDIATR-US, V162, P208, DOI 10.1016/j.jpeds.2012.08.039; SHAPIRO Y, 1990, MED SCI SPORT EXER, V22, P6; Shephard RJ, 1999, CRIT REV IMMUNOL, V19, P285; SHIBOLET S, 1967, Q J MED, V36, P525; SHIBOLET S, 1976, AVIAT SPACE ENVIR MD, V47, P280; Smith JE, 2005, BRIT J SPORT MED, V39, P503, DOI 10.1136/bjsm.2004.013466; Smith R, 2016, BMJ CASE REP, V2016; Sonna LA, 2004, J APPL PHYSIOL, V96, P1943, DOI 10.1152/japplphysiol.00886.2003; Varghese GM, 2005, EMERG MED J, V22, P185, DOI 10.1136/emj.2003.009365; Wallace RF, 2006, AVIAT SPACE ENVIR MD, V77, P415; Yaqub B, 1998, J NEUROL SCI, V156, P144, DOI 10.1016/S0022-510X(98)00037-9	40	11	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2019	14	8							e0221329	10.1371/journal.pone.0221329	http://dx.doi.org/10.1371/journal.pone.0221329			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5OC	31430332	Green Published, Green Submitted, gold			2022-12-26	WOS:000485026800044
J	Ali, NB; Tahsina, T; Hoque, DME; Hasan, MM; Iqbal, A; Huda, TM; El Arifeen, S				Ali, Nazia Binte; Tahsina, Tazeen; Hoque, Dewan Md. Emdadul; Hasan, Mohammad Mehedi; Iqbal, Afrin; Huda, Tanvir M.; El Arifeen, Shams			Association of food security and other socioeconomic factors with dietary diversity and nutritional statuses of children aged 6-59 months in rural Bangladesh	PLOS ONE			English	Article							COMPLEMENTARY FEEDING PRACTICES; YOUNG-CHILDREN; LOW-INCOME; INFANT; HEALTH; ADEQUACY; GROWTH; INTERVENTIONS; DETERMINANTS; EDUCATION	Introduction Dietary diversity score (DDS) is a proxy indicator for measuring nutrient adequacy. In this study, we aimed to identify the nutritional statuses and current patterns of DDS among children between 6-59 months old and their associations with different individual and household level factors in rural Bangladesh. Methods The Nobokoli programme of World Vision Bangladesh was implemented in Mymensingh, Sherpur, Rangpur, Dinajpur, Thakurgaon, Panchagar, and Nilphamari districts of Bangladesh between 2014 and 2017. A cross-sectional community household survey was administered between July and October 2014 to collect baseline data to evaluate the Nobokoli programme. A total of 6,468 children between 6-59 months old were included in the final analysis. Anthropometric data was collected following WHO guidelines on using wooden height and digital weight scales. We collected food intake information for the past 24 hours of the survey. The WHO's child growth standard medians were used to identify the nutritional indices of stunting, wasting, and underweight. Food items consumed were categorized into nine food groups and the DDS was constructed by counting the consumption of food items across these groups during the preceding 24 hour period. The association of DDS and nutritional status (stunting, wasting and underweight) with sociodemographic factors and household food security status were examined using multivariable models; linear regression and logistics regression respectively. Results The prevalence of stunting, wasting and underweight among children aged 6-59months were 36.8%, 18.2% and 37.7% respectively. Our findings revealed that almost all children ate any form of starch followed by consumption of milk or milk products (76%) and fleshy meat/fish (61%) respectively. The mean DDS among children was 3.93(sd 1.47). Forty percent of the children obtained a DDS score less than 4. Multivariable analysis suggested that children whose mothers had higher educational attainment and are skilled workers had higher DDS (15% and 48% respectively) compared to their counterparts. The DDS showed strong positive association with household wealth status. Children from food secure households had 26% higher DDS compared to children from food insecure households. Similarly, increasing maternal education and household wealth were found to be protective against childhood stunting and undernutrition. Discussion Our findings reiterate the need for improving household socioeconomic factors and household food security status for improving dietary diversity practices and nutritional status of children. Evidence-based solutions are needed to be implemented and expanded at scale to ensure appropriate dietary practices and improve nutritional status of the children in local context.	[Ali, Nazia Binte; Tahsina, Tazeen; Hoque, Dewan Md. Emdadul; Hasan, Mohammad Mehedi; Iqbal, Afrin; Huda, Tanvir M.; El Arifeen, Shams] Icddr B, MCHD, Dhaka, Bangladesh	International Centre for Diarrhoeal Disease Research (ICDDR)	Ali, NB (corresponding author), Icddr B, MCHD, Dhaka, Bangladesh.	nazia.ali@icddrb.org	Md. Emdadul Hoque, Dewan/O-3606-2015	Md. Emdadul Hoque, Dewan/0000-0001-8219-9196; Ali, Nazia Binte/0000-0001-5010-9563	World Vision Bangladesh [Gr01194]	World Vision Bangladesh	World Vision Bangladesh funded the evaluation of "Nobokoli" programme conducted by Maternal and Child health Division of icddr,b. Grant number was Gr01194. Ms Tazeen Tahsina is the principle investigator of the research protocol. The sponsors or funders play no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research protocol was funded by World Vision Bangladesh. We acknowledge with gratitude the commitment of World Vision Bangladesh to its research efforts. We are also grateful to the Governments of Bangladesh, Canada, Sweden and the UK for providing core/unrestricted support.	Agbadi P, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177377; Ahmadi D, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5541-3; Ahmed AS, 2012, INDIAN PEDIATR, V49, P821, DOI 10.1007/s13312-012-0187-2; Alam A., 2016, SEASONAL FOOD SECURI; Alderman H, 2017, WORLD DEV, V94, P448, DOI 10.1016/j.worlddev.2017.02.007; [Anonymous], 2006, MALAWI MED J, V18; [Anonymous], 2018, J INT AIDS SOC S6, V21; Arimond M, 2004, J NUTR, V134, P2579, DOI 10.1093/jn/134.10.2579; Arsenault JE, 2013, J NUTR, V143, P197, DOI 10.3945/jn.112.169524; Bashir MK, 2013, J SCI FOOD AGR, V93, P1251, DOI 10.1002/jsfa.6038; Bhutta ZA, 2008, LANCET, V371, P417, DOI 10.1016/S0140-6736(07)61693-6; Bhutta ZA, 2013, LANCET, V382, P452, DOI 10.1016/S0140-6736(13)60996-4; Birhane T, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-680; Black RE, 2003, LANCET, V361, P2226, DOI 10.1016/S0140-6736(03)13779-8; Chandrasekhar S, 2017, MATERN CHILD NUTR, V13, DOI 10.1111/mcn.12447; Darmon N, 2015, NUTR REV, V73, P643, DOI 10.1093/nutrit/nuv027; Endale Worku, 2014, BMC Res Notes, V7, P130, DOI 10.1186/1756-0500-7-130; FAO, 2013, STATE HUNGER BUILDIN; Gelli A, 2017, TRIALS, V18, DOI 10.1186/s13063-017-2156-4; Gulati JK, 2010, ANTHROPOLOGIST, V12, P131, DOI 10.1080/09720073.2010.11891143; Hanif HM, 2013, INT BREASTFEED J, V8, DOI 10.1186/1746-4358-8-10; Hillbruner C, 2008, FOOD NUTR BULL, V29, P221, DOI 10.1177/156482650802900308; Hoddinott J YY, 2002, 136 INT FOOD POL RES; Huda TM, 2018, MATERN CHILD NUTR, V14, DOI 10.1111/mcn.12440; Huda TM, 2018, JMIR MHEALTH UHEALTH, V6, DOI 10.2196/mhealth.8832; Human development report, 2014, HUMAN DEV REPORT 201; Iqbal S, 2017, NUTR J, V16, DOI 10.1186/s12937-017-0297-7; (JPGSPH) HKIHaJPGSoPH, 2014, STAT FOOD INS NUTR B; Kabir A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172119; Kabir I, 2012, MATERN CHILD NUTR, V8, P11, DOI 10.1111/j.1740-8709.2011.00379.x; Kennedy G., 2011, GUID MEAS HOUS IND D; Kimmons JE, 2005, J NUTR, V135, P444, DOI 10.1093/jn/135.3.444; Kirkpatrick SI, 2010, ARCH PEDIAT ADOL MED, V164, P754, DOI 10.1001/archpediatrics.2010.117; Kulwa KBM, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1077; Marriott BP, 2012, MATERN CHILD NUTR, V8, P354, DOI 10.1111/j.1740-8709.2011.00380.x; Miller LC, 2017, INT J EQUITY HEALTH, V16, DOI 10.1186/s12939-017-0681-0; Motbainor A, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3186-7; Muehlhoff E, 2017, MATERN CHILD NUTR, V13, DOI 10.1111/mcn.12411; Mulmi P, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186765; Muraya KW, 2017, HEALTH POLICY PLANN, V32, pV31, DOI 10.1093/heapol/czx032; Na MZ, 2016, J NUTR, V146, P2109, DOI 10.3945/jn.116.234229; Nair N, 2017, LANCET GLOB HEALTH, V5, pE1004, DOI 10.1016/S2214-109X(17)30339-X; Nair N, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1655-z; National Institute of Population Research and Training Mitra and Associates ICF International, 2015, BANGL DEM HLTH SURV; NIPORT Mitra and Associates and ICF International, 2013, BANGL DEM HLTH SURV; NIPORT Mitra and Associates ICF International and ICBBRB, 2012, BANGL MAT MORT HLTH; Ochieng J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189022; Ogle BM, 2001, ASIA PAC J CLIN NUTR, V10, P21, DOI 10.1046/j.1440-6047.2001.00206.x; Onyango A, 1998, INT J EPIDEMIOL, V27, P484, DOI 10.1093/ije/27.3.484; Osendarp SJM, 2016, WORLD REV NUTR DIET, V115, P184, DOI 10.1159/000442104; Owais A, 2016, PUBLIC HEALTH NUTR, V19, P1875, DOI 10.1017/S1368980015003195; Patel A, 2012, MATERN CHILD NUTR, V8, P28, DOI 10.1111/j.1740-8709.2011.00385.x; Prudhon C, 2018, MATERN CHILD NUTR, V14, DOI 10.1111/mcn.12457; Rasheed S, 2011, FOOD NUTR BULL, V32, P192, DOI 10.1177/156482651103200302; Reinbott A, 2015, PAEDIATR INT CHILD H, V35, P124, DOI 10.1179/2046905514Y.0000000155; Renzaho AMN, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14121502; Robert RC, 2017, MATERN CHILD NUTR, V13, DOI 10.1111/mcn.12264; Ruel Marie T., 2003, Food and Nutrition Bulletin, V24, P231; Saha KK, 2008, J NUTR, V138, P1383, DOI 10.1093/jn/138.7.1383; Saleh F, 2014, J HEALTH POPUL NUTR, V32, P89; Sanghvi T, 2017, MATERN CHILD NUTR, V13, DOI 10.1111/mcn.12406; Sanghvi T, 2016, MATERN CHILD NUTR, V12, P141, DOI 10.1111/mcn.12277; Stevens B, 2017, PUBLIC HEALTH NUTR, V20, P121, DOI [10.1017/S136898001600183X, 10.1017/s136898001600183x]; Steyn NP, 2014, NUTRITION, V30, P55, DOI 10.1016/j.nut.2013.06.002; Tahsina T, 2015, EVALUATION BANGLADES; Tahsina T, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196237; Tegegne M, 2017, ARCH PUBLIC HEALTH, V75, DOI 10.1186/s13690-017-0216-6; Thorne-Lyman AL, 2010, J NUTR, V140, p182S, DOI 10.3945/jn.109.110809; Torheim LE, 2004, EUR J CLIN NUTR, V58, P594, DOI 10.1038/sj.ejcn.1601853; Uraguchi Zenebe B, 2012, J Asian Afr Stud, V47, P33; Vazir S, 2013, MATERN CHILD NUTR, V9, P99, DOI 10.1111/j.1740-8709.2012.00413.x; Vir SC, 2016, MATERN CHILD NUTR, V12, P72, DOI 10.1111/mcn.12255	72	27	27	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2019	14	8							e0221929	10.1371/journal.pone.0221929	http://dx.doi.org/10.1371/journal.pone.0221929			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW6AB	31465509	Green Published, gold, Green Submitted			2022-12-26	WOS:000485058200071
J	Yoshimatsu, S; Sone, T; Nakajima, M; Sato, T; Okochi, R; Ishikawa, M; Nakamura, M; Sasaki, E; Shiozawa, S; Okano, H				Yoshimatsu, Sho; Sone, Takefumi; Nakajima, Mayutaka; Sato, Tsukika; Okochi, Ryotaro; Ishikawa, Mitsuru; Nakamura, Mari; Sasaki, Erika; Shiozawa, Seiji; Okano, Hideyuki			A versatile toolbox for knock-in gene targeting based on the Multisite Gateway technology	PLOS ONE			English	Article							STEM-CELLS; ADULT NEUROGENESIS; COMMON MARMOSET; SELF-RENEWAL; VITRO; CRISPR-CAS9; NUCLEASES; FATE; RECONSTITUTION; ESTABLISHMENT	Knock-in (KI) gene targeting can be employed for a wide range of applications in stem cell research. However, vectors for KI require multiple complicated processes for construction, including multiple times of digestion/ligation steps and extensive restriction mapping, which has imposed limitations for the robust applicability of KI gene targeting. To circumvent this issue, here we introduce versatile and systematic methods for generating KI vectors by molecular cloning. In this approach, we employed the Multisite Gateway technology, an efficient in vitro DNA recombination system using proprietary sequences and enzymes. KI vector construction exploiting these methods requires only efficient steps, such as PCR and recombination, enabling robust KI gene targeting. We show that combinatorial usage of the KI vectors generated using this method and site-specific nucleases enabled the precise integration of fluorescent protein genes in multiple loci of human and common marmoset (marmoset; Callithrix jacchus) pluripotent stem cells. The methods described here will facilitate the usage of KI technology and ultimately help to accelerate stem cell research.	[Yoshimatsu, Sho; Sone, Takefumi; Nakajima, Mayutaka; Sato, Tsukika; Okochi, Ryotaro; Ishikawa, Mitsuru; Nakamura, Mari; Shiozawa, Seiji; Okano, Hideyuki] Keio Univ, Sch Med, Dept Physiol, Shinjuku Ku, Tokyo, Japan; [Yoshimatsu, Sho] RIKEN, Ctr Brain Sci, Lab Proteolyt Neurosci, Wako, Saitama, Japan; [Sasaki, Erika] Cent Inst Expt Anim, Kawasaki, Kanagawa, Japan; [Sasaki, Erika; Okano, Hideyuki] RIKEN, Ctr Brain Sci, Lab Marmoset Neural Architecture, Wako, Saitama, Japan	Keio University; RIKEN; RIKEN	Shiozawa, S; Okano, H (corresponding author), Keio Univ, Sch Med, Dept Physiol, Shinjuku Ku, Tokyo, Japan.; Okano, H (corresponding author), RIKEN, Ctr Brain Sci, Lab Marmoset Neural Architecture, Wako, Saitama, Japan.	shiozawa@keio.jp; hidokano@keio.jp	Sone, Takefumi/AAB-9423-2020; Sone, Takefumi/L-1348-2013; Okano, Hideyuki/X-9131-2019; Shiozawa, Seiji/L-1248-2013	Sone, Takefumi/0000-0003-3467-679X; Sone, Takefumi/0000-0003-3467-679X; Okano, Hideyuki/0000-0001-7482-5935; Shiozawa, Seiji/0000-0002-3504-5415	Japan Society for the Promotion of Science (JSPS) [15K06924]; RIKEN Junior Research Associate Program	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); RIKEN Junior Research Associate Program	Data presented herein were generated during the "Construction of System for Spread of Primate Model Animals" project, performed under the Strategic Research Program for Brain Sciences and Brain Mapping by Integrated Neurotechnologies for Disease Studies (Brain/MINDS) of the MEXT and the AMED (to H.O. and S.S.); and Scientific Research in Innovative Areas, a MEXT Grant-in-Aid project FY2014-2018 "Brain Protein Aging and Dementia Control" (to H.O.). This work was financially supported by Grant Number 15K06924 from Japan Society for the Promotion of Science (JSPS) to T.S. Also, S.Y. was supported by RIKEN Junior Research Associate Program.	Chen YT, 2000, GENESIS, V28, P31, DOI 10.1002/1526-968X(200009)28:1<31::AID-GENE40>3.0.CO;2-K; Chorev M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04476-0; Fang F, 2018, NAT CELL BIOL, V20, DOI 10.1038/s41556-018-0094-3; Fong HL, 2008, STEM CELLS, V26, P1931, DOI 10.1634/stemcells.2007-1002; Goncalves JT, 2016, CELL, V167, P897, DOI 10.1016/j.cell.2016.10.021; Hartley JL, 2000, GENOME RES, V10, P1788, DOI 10.1101/gr.143000; Hayashi K, 2012, SCIENCE, V338, P971, DOI 10.1126/science.1226889; Hayashi K, 2011, CELL, V146, P519, DOI 10.1016/j.cell.2011.06.052; He XJ, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkw064; Heise K, 2013, ASSAY DRUG DEV TECHN, V11, P244, DOI 10.1089/adt.2013.509; Hikabe O, 2016, NATURE, V539, P299, DOI 10.1038/nature20104; Hockemeyer D, 2011, NAT BIOTECHNOL, V29, P731, DOI 10.1038/nbt.1927; Hockemeyer D, 2009, NAT BIOTECHNOL, V27, P851, DOI 10.1038/nbt.1562; Hong YK, 2002, DEV DYNAM, V225, P351, DOI 10.1002/dvdy.10163; Hosoya M, 2017, CELL REP, V18, P68, DOI 10.1016/j.celrep.2016.12.020; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Hube F, 2015, INT J MOL SCI, V16, P4429, DOI 10.3390/ijms16034429; Ichiyanagi N, 2016, STEM CELL REP, V6, P496, DOI 10.1016/j.stemcr.2016.02.011; Iiizumi S, 2006, BIOTECHNIQUES, V41, P311, DOI 10.2144/000112233; Irie N, 2015, CELL, V160, P253, DOI 10.1016/j.cell.2014.12.013; Iwano T, 2012, DEVELOPMENT, V139, P3051, DOI 10.1242/dev.080002; Karreman C, 1998, NUCLEIC ACIDS RES, V26, P2508, DOI 10.1093/nar/26.10.2508; Kleinstiver BP, 2016, NATURE, V529, P490, DOI 10.1038/nature16526; Li XH, 2013, P NATL ACAD SCI USA, V110, pE2279, DOI 10.1073/pnas.1305987110; Mano S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0204964; Ming GL, 2011, NEURON, V70, P687, DOI 10.1016/j.neuron.2011.05.001; Mu YL, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-85; Naito Y, 2015, BIOINFORMATICS, V31, P1120, DOI 10.1093/bioinformatics/btu743; Nakamoto FK, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-32573-1; Noce T, 2001, CELL STRUCT FUNCT, V26, P131, DOI 10.1247/csf.26.131; Nyabi O, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp112; Ohinata Y, 2005, NATURE, V436, P207, DOI 10.1038/nature03813; Okano H, 2012, SEMIN FETAL NEONAT M, V17, P336, DOI 10.1016/j.siny.2012.07.002; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Saitou M, 2016, CELL STEM CELL, V18, P721, DOI 10.1016/j.stem.2016.05.001; Sakaguchi H, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9896; Sasaki E, 2005, STEM CELLS, V23, P1304, DOI 10.1634/stemcells.2004-0366; Sasaki K, 2015, CELL STEM CELL, V17, P178, DOI 10.1016/j.stem.2015.06.014; SCHWARTZ F, 1991, P NATL ACAD SCI USA, V88, P10416, DOI 10.1073/pnas.88.23.10416; Seibler J, 1998, BIOCHEMISTRY-US, V37, P6229, DOI 10.1021/bi980288t; Shiozawa S, 2011, STEM CELLS DEV, V20, P1588, DOI 10.1089/scd.2010.0351; Slaymaker IM, 2016, SCIENCE, V351, P84, DOI 10.1126/science.aad5227; Sone T, 2012, METHODS MOL BIOL, V801, P227, DOI 10.1007/978-1-61779-352-3_15; Suda Y, 2018, MOL BRAIN, V11, DOI 10.1186/s13041-018-0349-8; Suh H, 2007, CELL STEM CELL, V1, P515, DOI 10.1016/j.stem.2007.09.002; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Tanaka Y, 2018, STEM CELL RES, V28, P100, DOI 10.1016/j.scr.2018.01.036; THOMAS KR, 1987, CELL, V51, P503, DOI 10.1016/0092-8674(87)90646-5; Tsai SQ, 2014, NAT BIOTECHNOL, V32, P569, DOI 10.1038/nbt.2908; Yamashiro C, 2018, SCIENCE, V362, P356, DOI 10.1126/science.aat1674; Yoshimatsu S, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-37990-w; Yusa K, 2011, P NATL ACAD SCI USA, V108, P1531, DOI 10.1073/pnas.1008322108; Zhang F, 2014, HUM MOL GENET, V23, pR40, DOI 10.1093/hmg/ddu125; Zhang Shuchen, 2014, World J Stem Cells, V6, P305, DOI 10.4252/wjsc.v6.i3.305; Zhao S, 2016, TRANSL LUNG CANCER R, V5, P120, DOI 10.3978/j.issn.2218-6751.2016.01.05; Zhou Q, 2016, CELL STEM CELL, V18, P330, DOI 10.1016/j.stem.2016.01.017; Zwaka TP, 2003, NAT BIOTECHNOL, V21, P319, DOI 10.1038/nbt788	57	7	7	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2019	14	8							e0221164	10.1371/journal.pone.0221164	http://dx.doi.org/10.1371/journal.pone.0221164			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5WO	31454364	Green Published, gold, Green Submitted			2022-12-26	WOS:000485049000012
J	Tani, T; Eitsuka, T; Katayama, M; Nagamine, T; Nakaya, Y; Suzuki, H; Kiyono, T; Nakagawa, K; Inoue-Murayama, M; Onuma, M; Fukuda, T				Tani, Tetsuya; Eitsuka, Takahiro; Katayama, Masafumi; Nagamine, Takashi; Nakaya, Yumiko; Suzuki, Hajime; Kiyono, Tohru; Nakagawa, Kiyotaka; Inoue-Murayama, Miho; Onuma, Manabu; Fukuda, Tomokazu			Establishment of immortalized primary cell from the critically endangered Bonin flying fox (Pteropus pselaphon)	PLOS ONE			English	Article							DEPENDENT KINASE 4; PRAIRIE VOLE; CYCLIN D; EXPRESSION; BOVINE; FIBROBLASTS; SENESCENCE; SYSTEM; LINES	The Bonin flying fox (Pteropus pselaphon) is one of the most critically endangered species of animals. The number of this species is estimated to be around 150; being classified at the top rank in the list by International Union of Animal Conservation. Our group previously showed that expression of CDK4, CYCLIN D1, and telomerase reverse transcriptase (TERT) efficiently induce immortalization of human, bovine, swine, monkey, and buffalo-derived cells. In this manuscript, we successfully established the primary cells from Bonin flying fox. We introduced CDK4, CYCLIN D1, and TERT into the primary cells. The established cells showed efficient expression of introduced genes at the protein level. Furthermore, the established cells were free from senescence, indicating it reached to immortalization. Moreover, we showed that interspecies somatic cell nuclear transfer of Bonin flying fox derived cell into bovine embryo allowed the development of the embryo to 8 cell stages. Our established cell has the potential to contribute to species conservation.	[Tani, Tetsuya] Kindai Univ, Dept Agr, Lab Anim Reprod, Nara, Japan; [Eitsuka, Takahiro; Nakagawa, Kiyotaka] Tohoku Univ, Grad Sch Agr Sci, Sendai, Miyagi, Japan; [Katayama, Masafumi; Inoue-Murayama, Miho; Onuma, Manabu; Fukuda, Tomokazu] Natl Inst Environm Studies, Wild Life Genome Collaborat Res Grp, Tsukuba, Ibaraki, Japan; [Katayama, Masafumi; Onuma, Manabu] Natl Inst Environm Studies, Ecol Risk Assessment & Control Sect, Ctr Environm Biol & Ecosyst, Tsukuba, Ibaraki, Japan; [Nagamine, Takashi; Nakaya, Yumiko] Conservat & Anim Welf Trust, Okinawa, Japan; [Suzuki, Hajime] Inst Boninol, Tokyo, Japan; [Kiyono, Tohru] Ctr Res Inst, Div Carcinogenesis & Canc Prevent, Tokyo, Japan; [Kiyono, Tohru] Ctr Res Inst, Dept Cell Culture Technol, Natl Canc, Tokyo, Japan; [Inoue-Murayama, Miho] Kyoto Univ, Wildlife Res Ctr, Kyoto, Japan; [Fukuda, Tomokazu] Iwate Univ, Grad Sch Sci & Engn, Morioka, Iwate, Japan; [Fukuda, Tomokazu] Iwate Univ, SPERC, Morioka, Iwate, Japan	Kindai University (Kinki University); Tohoku University; National Institute for Environmental Studies - Japan; National Institute for Environmental Studies - Japan; Kyoto University; Iwate University; Iwate University	Onuma, M; Fukuda, T (corresponding author), Natl Inst Environm Studies, Wild Life Genome Collaborat Res Grp, Tsukuba, Ibaraki, Japan.; Onuma, M (corresponding author), Natl Inst Environm Studies, Ecol Risk Assessment & Control Sect, Ctr Environm Biol & Ecosyst, Tsukuba, Ibaraki, Japan.; Kiyono, T (corresponding author), Ctr Res Inst, Div Carcinogenesis & Canc Prevent, Tokyo, Japan.; Kiyono, T (corresponding author), Ctr Res Inst, Dept Cell Culture Technol, Natl Canc, Tokyo, Japan.; Fukuda, T (corresponding author), Iwate Univ, Grad Sch Sci & Engn, Morioka, Iwate, Japan.; Fukuda, T (corresponding author), Iwate Univ, SPERC, Morioka, Iwate, Japan.	tkiyono@ncc.go.jp; monuma@nies.go.jp; tomofukuda009@gmail.com	tani, tetsuya/AAR-7581-2021; Fukuda, Tomokazu/O-1257-2018	tani, tetsuya/0000-0001-5276-8941; Fukuda, Tomokazu/0000-0001-8456-0483	Japan Society for the promotion of science (JSPS) KAKENHI [17H05810]; Ministry of Education, Culture, Sports, Science, and Technology; Waksman Foundation of Japan inc.	Japan Society for the promotion of science (JSPS) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Waksman Foundation of Japan inc.(Waksman Foundation of Japan Inc.)	This work was supported by Japan Society for the promotion of science (JSPS) KAKENHI (Grant number, 17H05810). This project is supported by Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology, and research grant from Waksman Foundation of Japan inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Crameri G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008266; Donai K, 2014, J BIOTECHNOL, V176, P50, DOI 10.1016/j.jbiotec.2014.02.017; Donai K, 2013, ANAL BIOCHEM, V443, P104, DOI 10.1016/j.ab.2013.08.014; Fukuda T, 2005, MOL CELL BIOL, V25, P5270, DOI 10.1128/MCB.25.12.5270-5281.2005; Fukuda T, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-27271-x; Fukuda T, 2016, CYTOTECHNOLOGY, V68, P1937, DOI 10.1007/s10616-016-0004-0; Fukuda T, 2016, IN VITRO CELL DEV-AN, V52, P20, DOI 10.1007/s11626-015-9943-6; Fukuda T, 2012, BIOSCI BIOTECH BIOCH, V76, P1372, DOI 10.1271/bbb.120155; Garbe JC, 2014, CELL CYCLE, V13, P3423, DOI 10.4161/15384101.2014.954456; Gouko R, 2018, CYTOTECHNOLOGY, V70, P1619, DOI 10.1007/s10616-018-0254-0; Haga K, 2007, CANCER SCI, V98, P147, DOI 10.1111/j.1349-7006.2006.00373.x; Katayama M, 2019, BIOCH BIOPHYS ACTA; Katayama M, 2019, J CELL PHYSIOL, V234, P6709, DOI 10.1002/jcp.27417; Katayama M, 2017, J REPROD DEVELOP, V63, P311, DOI 10.1262/jrd.2016-164; Katayama M, 2016, EXP ANIM TOKYO, V65, P87, DOI 10.1538/expanim.15-0061; Kuroda K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143473; Kuroda K, 2015, J CELL BIOCHEM, V116, P205, DOI 10.1002/jcb.24963; Laing ED, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11030260; Matsushita S, 2004, ANIM REPROD SCI, V84, P293, DOI 10.1016/j.anireprosci.2004.02.008; Qin XY, 2012, CANCER BIOL THER, V13, P296, DOI 10.4161/cbt.18942; Qin XJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043500; Shiomi K, 2011, GENE THER, V18, P857, DOI 10.1038/gt.2011.44; Stogbauer L, 2020, NEUROSURG REV, V43, P903, DOI 10.1007/s10143-019-01087-3; Sun YJ, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195128; Tani T, 2006, CLONING STEM CELLS, V8, P61, DOI 10.1089/clo.2006.8.61	25	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2019	14	8							e0221364	10.1371/journal.pone.0221364	http://dx.doi.org/10.1371/journal.pone.0221364			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5UR	31449544	Green Published, Green Submitted, gold			2022-12-26	WOS:000485044000012
J	Chetelat, J; Cott, PA; Rosabal, M; Houben, A; McClelland, C; Rose, EB; Amyot, M				Chetelat, John; Cott, Peter A.; Rosabal, Maikel; Houben, Adam; McClelland, Christine; Rose, Elise Belle; Amyot, Marc			Arsenic bioaccumulation in subarctic fishes of a mine-impacted bay on Great Slave Lake, Northwest Territories, Canada	PLOS ONE			English	Article							FRESH-WATER FISH; TROPHIC TRANSFER; GIANT MINE; MERCURY; BIOTRANSFORMATION; SPECIATION; METALS; ACCUMULATION; WHITEFISH; LEAD	A subarctic fish community in mine-impacted Yellowknife Bay (Great Slave Lake, Northwest Territories, Canada) was investigated for biological and ecological processes controlling arsenic bioaccumulation. Total concentrations of arsenic, antimony, and metals were measured in over 400 fishes representing 13 species, and primary producers and consumers were included to characterize food web transfer. Yellowknife Bay had slightly more arsenic in surface waters (similar to 3 mu g/L) relative to the main body of Great Slave Lake (<1 mu g/L), resulting in two-fold higher total arsenic concentrations in muscle of burbot (Lota lota), lake whitefish (Coregonus clupeaformis), and northern pike (Esox lucius). Other mining-associated contaminants, specifically antimony, lead, and silver, were typically below analytical detection in those fish species. No evidence was found for enhanced bioaccumulation of arsenic in long-lived, slow-growing subarctic fishes. Food web biodilution of total arsenic occurred between primary producers, aquatic invertebrates, and fish, although trophic position did not explain arsenic concentrations among fishes. Pelagic-feeding species had higher total arsenic concentrations compared to littoral fishes. Arsenic accumulated in subarctic fishes to comparable levels as fishes from lakes around the world with similar water arsenic concentrations. This first comprehensive study for a subarctic freshwater food web identified the importance of water exposure, biodilution, and habitat-specific feeding on arsenic bioaccumulation.	[Chetelat, John; McClelland, Christine] Environm & Climate Change Canada, Natl Wildlife Res Ctr, Ottawa, ON, Canada; [Cott, Peter A.] Govt Northwest Terr, Environm & Nat Resources Cumulat Impact Monitorin, Yellowknife, NT, Canada; [Rosabal, Maikel] Univ Quebec Montreal, Dept Sci Biol, Montreal, PQ, Canada; [Rose, Elise Belle] Carleton Univ, Geog & Environm Studies, Ottawa, ON, Canada; [Amyot, Marc] Univ Montreal, CEN, Dept Sci Biol, Montreal, PQ, Canada; [Cott, Peter A.] Joint Task Force North, Dept Natl Def, Yellowknife, NT, Canada; [Houben, Adam] Polar Knowledge Canada, Div Sci & Technol, Cambridge Bay, NU, Canada	Environment & Climate Change Canada; Canadian Wildlife Service; National Wildlife Research Centre - Canada; University of Quebec; University of Quebec Montreal; Carleton University; Universite de Montreal	Chetelat, J (corresponding author), Environm & Climate Change Canada, Natl Wildlife Res Ctr, Ottawa, ON, Canada.	john.chetelat@canada.ca	Amyot, Marc/A-7182-2008; Chételat, John/AAE-4711-2020	Amyot, Marc/0000-0002-0340-3249; Chételat, John/0000-0002-9380-7203; Houben, Adam/0000-0002-0336-7583; Rosabal, Maikel/0000-0002-5420-3490	Environment Canada [JC02]; NWT Cumulative Impact Monitoring Program (Government of the Northwest Territories) [161]; Fisheries and Oceans Canada	Environment Canada(CGIAR); NWT Cumulative Impact Monitoring Program (Government of the Northwest Territories); Fisheries and Oceans Canada	This study was supported with funding to JC from Environment Canada, 2013, (JC02); the NWT Cumulative Impact Monitoring Program (Government of the Northwest Territories, Project #161, 2014 to 2016) to JC; and Fisheries and Oceans Canada (Contaminated Sites, 2014 to 2016). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amlund H, 2006, ENVIRON TOXICOL CHEM, V25, P1787, DOI 10.1897/05-107R1.1; Amundsen PA, 2003, HYDROBIOLOGIA, V497, P109, DOI 10.1023/A:1025465705717; Andrade CF, 2010, APPL GEOCHEM, V25, P199, DOI 10.1016/j.apgeochem.2009.11.005; [Anonymous], R LANG ENV STAT COMP, DOI DOI 10.1080/02705060.2017.1422558; [Anonymous], 1981 2010 CLIM NORM; AZCUE JM, 1994, J GREAT LAKES RES, V20, P717, DOI 10.1016/S0380-1330(94)71189-8; Boyle D, 2008, ENVIRON SCI TECHNOL, V42, P5354, DOI 10.1021/es800230w; Burger J, 2005, ENVIRON MONIT ASSESS, V110, P171, DOI 10.1007/s10661-005-6689-8; Burger J, 2002, ENVIRON RES, V89, P85, DOI 10.1006/enrs.2002.4330; Canadian Hydrographic Service, 2005, CART CAN HYDR SERV C; Canadian North Environmental Services, 2017, GIANT MIN HUM HLTH E; Caumette G, 2014, ENVIRON CHEM, V11, P496, DOI 10.1071/EN14039; Caumette G, 2012, J ENVIRON MONITOR, V14, P2841, DOI 10.1039/c2em30572k; Caumette G, 2011, ENVIRON SCI TECHNOL, V45, P9917, DOI 10.1021/es2025092; Chen CY, 2008, WATER AIR SOIL POLL, V190, P115, DOI 10.1007/s11270-007-9585-8; Chen CY, 2000, ENVIRON SCI TECHNOL, V34, P3878, DOI 10.1021/es991070c; Chen LZ, 2018, ENVIRON POLLUT, V238, P17, DOI 10.1016/j.envpol.2018.03.011; Chen WY, 2012, ENVIRON SCI POLLUT R, V19, P3868, DOI 10.1007/s11356-012-1012-z; Chetelat J, 2018, 201705 NWT NW TERR G; Chetelat J, 2013, ECOTOXICOLOGY, V22, P1020, DOI 10.1007/s10646-013-1087-4; Cott PA, 2011, J APPL ICHTHYOL, V27, P49, DOI 10.1111/j.1439-0426.2011.01843.x; Cott PA, 2016, J GREAT LAKES RES, V42, P223, DOI 10.1016/j.jglr.2015.11.004; Cott PA, 2014, J GREAT LAKES RES, V40, P435, DOI 10.1016/j.jglr.2014.02.017; Culioli JL, 2009, AQUAT TOXICOL, V94, P286, DOI 10.1016/j.aquatox.2009.07.016; de Rosemond S, 2008, ENVIRON MONIT ASSESS, V147, P199, DOI 10.1007/s10661-007-0112-6; Dutton J, 2011, ENVIRON TOXICOL CHEM, V30, P2107, DOI 10.1002/etc.600; Dutton J, 2011, SCI TOTAL ENVIRON, V409, P3438, DOI 10.1016/j.scitotenv.2011.05.022; Erickson RJ, 2019, AQUAT TOXICOL, V210, P227, DOI 10.1016/j.aquatox.2019.03.001; Erickson RJ, 2011, AQUAT TOXICOL, V104, P108, DOI 10.1016/j.aquatox.2011.04.003; Erickson RJ, 2010, CAN J FISH AQUAT SCI, V67, P1816, DOI 10.1139/F10-098; Evans MS, 2005, SCI TOTAL ENVIRON, V351, P94, DOI 10.1016/j.scitotenv.2005.01.052; Evans MS, 2005, SCI TOTAL ENVIRON, V351, P479, DOI 10.1016/j.scitotenv.2004.12.086; Bubach DF, 2018, ENVIRON SCI POLLUT R, V25, P6340, DOI 10.1007/s11356-017-0898-x; Falk P, 2010, CHANDOS INF PROF SER, P73; Fox J., 2019, R COMPANION APPL REG, V.; Gawel JE, 2014, SCI TOTAL ENVIRON, V472, P530, DOI 10.1016/j.scitotenv.2013.11.004; Golder, 2017, PHAS 5 ENV EFF MON P; Griboff J, 2018, ECOTOX ENVIRON SAFE, V148, P275, DOI 10.1016/j.ecoenv.2017.10.028; Grosell M, 2012, FISH PHYSIOL, V31A, P53, DOI 10.1016/S1546-5098(11)31002-3; Has-Schon E, 2015, CHEMOSPHERE, V135, P289, DOI 10.1016/j.chemosphere.2015.04.015; HOCKING D, 1978, JAPCA J AIR WASTE MA, V28, P133, DOI 10.1080/00022470.1978.10470580; Indian and Northern Affairs Canada, 2010, BRUL MIN PROJ ASS RE; Jackson FJ, 1996, YELLOWKNIFE BACK BAY; Jamieson HE, 2014, REV MINERAL GEOCHEM, V79, P533, DOI 10.2138/rmg.2014.79.12; Jankong P, 2007, ENVIRON CHEM, V4, P11, DOI 10.1071/EN06084; Jia YY, 2018, SCI TOTAL ENVIRON, V625, P600, DOI 10.1016/j.scitotenv.2017.12.328; Jiang ZG, 2018, ECOTOX ENVIRON SAFE, V157, P1, DOI 10.1016/j.ecoenv.2018.03.078; Juncos R, 2016, CHEMOSPHERE, V144, P2277, DOI 10.1016/j.chemosphere.2015.10.092; Kalff J., 2002, INLAND WATER SYSTEM; Kelly JM, 2009, AQUAT TOXICOL, V92, P240, DOI 10.1016/j.aquatox.2009.02.007; Kirby J, 2005, ENVIRON SCI TECHNOL, V39, P5999, DOI 10.1021/es050546r; Kumari B, 2017, ENVIRON CHEM LETT, V15, P43, DOI 10.1007/s10311-016-0588-9; Li Y, 2017, FISH RES, V195, P169, DOI 10.1016/j.fishres.2017.07.014; McIntyre D. O., 2011, FISH PHYSIOL, V31, P297; Midwood JD, 2015, WETLANDS, V35, P69, DOI 10.1007/s13157-014-0593-3; Moore JW, 1978, EFFECTS METAL MINES; Muir AM, 2014, ECOL FRESHW FISH, V23, P453, DOI 10.1111/eff.12098; Muir D, 2005, SCI TOTAL ENVIRON, V351, P464, DOI 10.1016/j.scitotenv.2004.07.036; Oksanen J., 2018, R PACKAGE VERSION, V2, P4; Ouedraogo O, 2013, SCI TOTAL ENVIRON, V444, P243, DOI 10.1016/j.scitotenv.2012.11.095; Pedlar RM, 2002, AQUAT TOXICOL, V57, P167, DOI 10.1016/S0166-445X(01)00198-9; Power M, 2002, J APPL ECOL, V39, P819, DOI 10.1046/j.1365-2664.2002.00758.x; Rahman MA, 2012, ENVIRON RES, V116, P118, DOI 10.1016/j.envres.2012.03.014; RAWSON D. S., 1951, JOUR FISH RES BD CANADA, V8, P207; SCHINDLER DW, 1995, SCI TOTAL ENVIRON, V160-61, P1, DOI 10.1016/0048-9697(95)04340-7; Shah AQ, 2009, FOOD CHEM, V112, P520, DOI 10.1016/j.foodchem.2008.05.095; Silke R., 2009, OPERATIONAL HIST MIN; Soeroes C, 2005, J AGR FOOD CHEM, V53, P9238, DOI 10.1021/jf0516639; Stantec, 2014, AN CONT TISS FISH CA; Ward DM, 2012, SCI TOTAL ENVIRON, V421, P230, DOI 10.1016/j.scitotenv.2012.01.058; Wood CM, 2012, FISH PHYSIOL, V31A, P1, DOI 10.1016/S1546-5098(11)31001-1; WOODWARD DF, 1995, CAN J FISH AQUAT SCI, V52, P1994, DOI 10.1139/f95-791; Yang F, 2017, B ENVIRON CONTAM TOX, V98, P226, DOI 10.1007/s00128-016-2018-x; Zhang W, 2017, SCI TOTAL ENVIRON, V586, P296, DOI 10.1016/j.scitotenv.2017.01.222; Zhang W, 2016, AQUAT TOXICOL, V179, P65, DOI 10.1016/j.aquatox.2016.08.017; Zhang W, 2016, ENVIRON SCI TECHNOL, V50, P2413, DOI 10.1021/acs.est.5b06307; Zhang W, 2016, CHEMOSPHERE, V147, P297, DOI 10.1016/j.chemosphere.2015.12.121; Zhang W, 2011, AQUAT TOXICOL, V105, P582, DOI 10.1016/j.aquatox.2011.08.009	78	9	10	4	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2019	14	8							e0221361	10.1371/journal.pone.0221361	http://dx.doi.org/10.1371/journal.pone.0221361			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5TR	31442230	gold, Green Published, Green Submitted			2022-12-26	WOS:000485041400028
J	Tuomisto, S; Huhtala, H; Martiskainen, M; Goebeler, S; Lehtimaki, T; Karhunen, PJ				Tuomisto, Sari; Huhtala, Heini; Martiskainen, Mika; Goebeler, Sirkka; Lehtimaki, Terho; Karhunen, Pekka J.			Age-dependent association of gut bacteria with coronary atherosclerosis: Tampere Sudden Death Study	PLOS ONE			English	Article							REAL-TIME PCR; MICROBIOTA; TRANSLOCATION; METABOLISM; SIGNATURES; ASSAY; DIET	Background The gut microbiome is thought to remain stable into old age. Gut bacteria and their translocation may play a role in the development of coronary heart disease (CHD) by modulating cholesterol levels and immune responses, as well as by producing toxic metabolites and bacterial endotoxins. The association of changes in the gut microbiome with the severity of coronary atherosclerosis and the ability of gut bacteria themselves to translocate into coronary plaques has not been studied. Materials and methods As a part of the Tampere Sudden Death Study, we measured age-dependent changes in the relative ratios of major intestinal bacterial communities (Bacteroides species [spp.], the Clostridium leptum group, the Clostridium coccoides group, Bifidobacterium spp., Enterobactericeae, Lactobacillus spp.) and Streptococcus spp. in both feces and coronary plaques of the same male autopsy cases (n = 67, age range 44-95) using real-time quantitative PCR (qPCR). The area of coronary atherosclerotic lesions were measured by computer-assisted morphometry. Fecal bacterial DNA measurements from healthy volunteers served as a control for gut bacterial analyses of autopsy cases. The relative amount of bacterial DNA in a sample was determined with the comparative Cq method. Results The relative ratios of fecal Lactobacillus spp., Bifidobacterium spp., the Clostridium coccoides group, and Bacteroides spp. did not differ between controls and autopsy cases and showed no age-dependence. In contrast, the ratios of the Clostridium leptum group, Enterobactericeae, and Streptococcus spp. increased with age. Elevated relative ratios of fecal Enterobactericeae associated with a larger coronary plaque fibrotic area (p = 0.001), and the Clostridium leptum group with a larger calcification area (p = 0.015). Intestinal bacterial DNA could be amplified in 67.6% of the coronary plaques, the most common being Streptococcus spp. (41.0%), followed by Enterobactericeae (12.1%), Clostridium leptum (2.4%), and Lactobacillus spp. (2.4%). The percentages of Streptococcus spp. DNA decreased, and those of Enterobactericeae increased in coronary plaques along with age. Conclusions DNA of the Clostridium leptum group and pathogenic Enterobactericeae increase in the gut microbiome with age and can be detected in the same individual's coronary plaques along with pathogenic Streptococcus spp., associating with more severe coronary atherosclerosis.	[Tuomisto, Sari; Martiskainen, Mika; Lehtimaki, Terho; Karhunen, Pekka J.] Tampere Univ, Finnish Cardiovasc Res Ctr Tampere, Fac Med & Hlth Technol, Tampere, Finland; [Tuomisto, Sari; Lehtimaki, Terho; Karhunen, Pekka J.] Fimlab Labs Ltd, Pirkanmaa Hosp Dist, Tampere, Finland; [Huhtala, Heini] Tampere Univ, Fac Social Sci, Tampere, Finland; [Martiskainen, Mika; Goebeler, Sirkka] Natl Inst Hlth & Welf, Tampere, Finland	Tampere University; Pirkanmaa Hospital District; Tampere University; Finland National Institute for Health & Welfare	Tuomisto, S (corresponding author), Tampere Univ, Finnish Cardiovasc Res Ctr Tampere, Fac Med & Hlth Technol, Tampere, Finland.; Tuomisto, S (corresponding author), Fimlab Labs Ltd, Pirkanmaa Hosp Dist, Tampere, Finland.	Sari.Tuomisto@tuni.fi	Lehtimäki, Terho/AAD-1094-2022	Lehtimäki, Terho/0000-0002-2555-4427; Tuomisto, Sari/0000-0002-2376-6338	Pirkanmaa Regional Fund of the Finnish Cultural Foundation Pirkanmaan Rahasto; Foundation for Medical Research; Competitive Research Funding of the Pirkanmaa Hospital District; Academy of Finland [286284]; Sydantutkimussaatio; Tampereen Tuberkuloosisdatio; Diabetes Research Foundation of Finnish Diabetes Association; European Union [201668]	Pirkanmaa Regional Fund of the Finnish Cultural Foundation Pirkanmaan Rahasto; Foundation for Medical Research; Competitive Research Funding of the Pirkanmaa Hospital District; Academy of Finland(Academy of Finland); Sydantutkimussaatio; Tampereen Tuberkuloosisdatio; Diabetes Research Foundation of Finnish Diabetes Association; European Union(European Commission)	This study was financially supported by the Pirkanmaa Regional Fund of the Finnish Cultural Foundation Pirkanmaan Rahasto (FI) to PhD Sari Tuomisto and Juhani Aho; the Foundation for Medical Research to PhD Sari Tuomisto; the Competitive Research Funding of the Pirkanmaa Hospital District to Professor Terho Lehtimaki and Professor Pekka J Karhunen, the Academy of Finland (286284) to Professor Terho Lehtimaki; Sydantutkimussaatio to Professor Terho Lehtimaki and Professor Pekka J Karhunen; the Tampereen Tuberkuloosisdatio to Professor Terho Lehtimaki; the Diabetes Research Foundation of Finnish Diabetes Association to Professor Terho Lehtimaki; the European Union 7th Framework Program for the AtheroRemo Project [grant number 201668] to Professor Terho Lehtimaki and Professor Pekka J. Karhunen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944; Backhed F, 2004, P NATL ACAD SCI USA, V101, P15718, DOI 10.1073/pnas.0407076101; Bodin L, 2005, J BIOMED BIOTECHNOL, P248, DOI 10.1155/JBB.2005.248; Moreira APB, 2012, BRIT J NUTR, V108, P801, DOI 10.1017/S0007114512001213; Brunk Clifford F., 2002, Current Issues in Molecular Biology, V4, P13; Bubner B, 2004, BMC BIOTECHNOL, V4, DOI 10.1186/1472-6750-4-14; Canny GO, 2008, INFECT IMMUN, V76, P3360, DOI 10.1128/IAI.00187-08; Caplan MS, 1999, GASTROENTEROLOGY, V117, P577, DOI 10.1016/S0016-5085(99)70450-6; Claesson MJ, 2011, P NATL ACAD SCI USA, V108, P4586, DOI 10.1073/pnas.1000097107; Ducluzeau R., 1989, MICROBIAL ECOLOGY IN; Furet JP, 2009, FEMS MICROBIOL ECOL, V68, P351, DOI 10.1111/j.1574-6941.2009.00671.x; Heeney DD, 2018, CURR OPIN BIOTECH, V49, P140, DOI 10.1016/j.copbio.2017.08.004; Karlsson FH, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2266; Kashtanova DA, 2016, NUTRITION, V32, P620, DOI 10.1016/j.nut.2015.12.037; Koren O, 2011, P NATL ACAD SCI USA, V108, P4592, DOI 10.1073/pnas.1011383107; Laugerette F, 2011, BIOCHIMIE, V93, P39, DOI 10.1016/j.biochi.2010.04.016; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Rodriguez JM, 2015, MICROB ECOL HEALTH D, V26, DOI 10.3402/mehd.v26.26050; North BJ, 2012, CIRC RES, V110, P1097, DOI 10.1161/CIRCRESAHA.111.246876; O'Boyle CJ, 1998, GUT, V42, P29, DOI 10.1136/gut.42.1.29; Ott SJ, 2006, CIRCULATION, V113, P929, DOI 10.1161/CIRCULATIONAHA.105.579979; Martinez GP, 2014, BENEF MICROBES, V5, P235, DOI 10.3920/BM2013.0079; Pessi T, 2013, CIRCULATION, V127, P1219, DOI 10.1161/CIRCULATIONAHA.112.001254; Rehman Tayyab, 2012, Endocrine Metabolic & Immune Disorders-Drug Targets, V12, P361; Ren WY, 2014, AGING CLIN EXP RES, V26, P183, DOI 10.1007/s40520-013-0148-0; Rondanelli M, 2015, WORLD J CLIN CASES, V3, P156, DOI 10.12998/wjcc.v3.i2.156; Sandek A, 2007, J AM COLL CARDIOL, V50, P1561, DOI 10.1016/j.jacc.2007.07.016; Suzuki N, 2005, CLIN MED RES, V3, P176, DOI 10.3121/cmr.3.3.176; Tang WHW, 2013, NEW ENGL J MED, V368, P1575, DOI 10.1056/NEJMoa1109400; Tremaroli V, 2012, NATURE, V489, P242, DOI 10.1038/nature11552; Troseid M, 2015, J INTERN MED, V277, P717, DOI 10.1111/joim.12328; Tuomisto S, 2014, BMC GASTROENTEROL, V14, DOI 10.1186/1471-230X-14-40; Tuomisto S, 2013, GUT PATHOG, V5, DOI 10.1186/1757-4749-5-35; Tuomisto S, 2013, J FORENSIC SCI, V58, P910, DOI 10.1111/1556-4029.12124; Ussher JR, 2013, ATHEROSCLEROSIS, V231, P456, DOI 10.1016/j.atherosclerosis.2013.10.013; Vaiserman AM, 2017, AGEING RES REV, V35, P36, DOI 10.1016/j.arr.2017.01.001; Vakhitov D, 2017, J VASC SURG, V17, P31603; van der Meer JJ, 2008, EUR J CLIN INVEST, V38, P857, DOI 10.1111/j.1365-2362.2008.02031.x; Yang S, 2002, J CLIN MICROBIOL, V40, P3449, DOI 10.1128/JCM.40.9.3449-3454.2002; Yoshida A, 2003, J CLIN MICROBIOL, V41, P863, DOI 10.1128/JCM.41.2.863-866.2003; ZAMPARELLI MS, 2016, J MOL SCI, V17, DOI DOI 10.3390/IJMS17081225	41	11	12	5	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2019	14	8							e0221345	10.1371/journal.pone.0221345	http://dx.doi.org/10.1371/journal.pone.0221345			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5RZ	31437200	gold, Green Published, Green Submitted			2022-12-26	WOS:000485036900054
J	Giacomucci, S; Cros, CDN; Perron, X; Mathieu-Denoncourt, A; Duperthuy, M				Giacomucci, Sean; Cros, Candice Danabe-Nieto; Perron, Xavier; Mathieu-Denoncourt, Annabelle; Duperthuy, Marylise			Flagella-dependent inhibition of biofilm formation by sub-inhibitory concentration of polymyxin B in Vibrio cholerae	PLOS ONE			English	Article							VIRULENCE GENE-EXPRESSION; VPS BIOSYNTHESIS GENES; HOST-DEFENSE PEPTIDES; GROUP-A STREPTOCOCCUS; ANTIMICROBIAL PEPTIDES; EL-TOR; MOTILITY; IDENTIFICATION; ALTERNATIVES; ARCHITECTURE	Biofilm formation is a common strategy used by bacteria in order to survive and persist in he environment. In Vibrio cholerae (V. cholerae), a Gram-negative pathogen responsible for the cholera disease, biofilm-like aggregates are important for the pathogenesis and disease transmission. Biofilm formation is initiated by the attachment of the bacteria to a surface, followed by maturation stages involving the formation of a biofilm matrix. In V. cholerae, flagella are essential for the initial step of biofilm formation, allowing the bacteria to swim and to detect a surface. In this study, we explored the effect of polymyxin B (PmB), a cationic bacterial antimicrobial peptide, on biofilm formation in pathogenic V. cholerae strains belonging to the O1 and O139 serotypes. We found that sub-inhibitory concentration of PmB induces a reduction of the biofilm formation by V. cholerae O1 and O139. Experiment on preformed biofilm demonstrated that the biofilm formation inhibition occurs at the initial step of biofilm formation, where the flagella are essential. We further characterize the effect of PmB on V. cholerae flagellation. Our results demonstrate that the flagellin expression is not reduced in presence of sub-inhibitory concentration of PmB. However, a decrease of the abundance of flagellin associated with the bacterial cells together with an increase in the secretome was observed. Electron microscopy observations also suggest that the abundance of aflagellated bacteria increases upon PmB supplementation. Finally, in agreement with the effect on the flagellation, a reduction of the bacterial motility is observed. Altogether, our results suggest that the PmB affect V. cholerae flagella resulting in a decrease of the motility and a compromised ability to form biofilm.	[Giacomucci, Sean; Cros, Candice Danabe-Nieto; Perron, Xavier; Mathieu-Denoncourt, Annabelle; Duperthuy, Marylise] Univ Montreal, Dept Microbiol Infectiol & Immunol, Succ Ctr Ville, Montreal, PQ, Canada; [Perron, Xavier] INRS, Inst Armand Frappier, Laval, PQ, Canada	Universite de Montreal; University of Quebec; Institut national de la recherche scientifique (INRS)	Duperthuy, M (corresponding author), Univ Montreal, Dept Microbiol Infectiol & Immunol, Succ Ctr Ville, Montreal, PQ, Canada.	marylise.duperthuy@umontreal.ca	Duperthuy, Marylise/AFO-2793-2022	Duperthuy, Marylise/0000-0002-9226-9343; Giacomucci, Sean/0000-0001-5746-7742	Natural Sciences and Engineering Research Council of Canada (NSERC) [RGPIN-2017-05322]; Canadian Government through Genome Canada	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Government through Genome Canada	This research was supported by the Natural Sciences and Engineering Research Council of Canada (NSERC http://www.nserccrsng.gc.ca/index_ eng. asp) Discovery grant (RGPIN-2017-05322 -M. D). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank Dr. Sun Nyunt Wai for generously providing all the V. cholerae strains and the anti-flagellin and anti-CRP antibodies. Proteomic analyses were performed by the Center for Advanced Proteomics Analyses, a Node of the Canadian Genomic Innovation Network that is supported by the Canadian Government through Genome Canada. Electron microscopy acquisitions were performed by Arnaldo Nakamura from the Plateforme de Microscopie E ' lectronique de l'Institut Armand-Frappier, INRS.	Allue-Guardia A, 2018, GENOME ANNOUNCEMENTS, V6, DOI [10.1128/genomeA.00098-18, 10.1128/genomea.00098-18]; [Anonymous], 2007, FREE RADIC BIOL MED, V43, P995, DOI [10.1016/j.freeradbiomed.2007.06.026, DOI 10.1016/J.FREERADBIOMED.2007.06.026]; Antunes LCM, 2011, REV MED MICROBIOL, V22, P12, DOI 10.1097/MRM.0b013e3283410d22; Bahar AA, 2013, PHARMACEUTICALS-BASE, V6, P1543, DOI 10.3390/ph6121543; Baltzer SA, 2011, J MOL MICROB BIOTECH, V20, P228, DOI 10.1159/000331009; Berditsch M, 2015, ANTIMICROB AGENTS CH, V59, P5288, DOI 10.1128/AAC.00682-15; Berk V, 2012, SCIENCE, V337, P236, DOI 10.1126/science.1222981; Bilecen K, 2009, ENVIRON MICROBIOL, V11, P2015, DOI 10.1111/j.1462-2920.2009.01923.x; Brennan CA, 2014, ELIFE, V3, DOI 10.7554/eLife.01579; Casper-Lindley C, 2004, J BACTERIOL, V186, P1574, DOI 10.1128/JB.186.5.1574-1578.2004; Chattejee SN, 2003, BBA-MOL BASIS DIS, V1639, P65, DOI 10.1016/j.bbadis.2003.08.004; Choi KY, 2012, J INNATE IMMUN, V4, P361, DOI 10.1159/000336630; Clemens JD, 2017, LANCET, V390, P1539, DOI 10.1016/S0140-6736(17)30559-7; da Costa JP, 2015, APPL MICROBIOL BIOT, V99, P2023, DOI 10.1007/s00253-015-6375-x; Daugelavicius R, 2000, ANTIMICROB AGENTS CH, V44, P2969, DOI 10.1128/AAC.44.11.2969-2978.2000; Davies D, 2003, NAT REV DRUG DISCOV, V2, P114, DOI 10.1038/nrd1008; de la Fuente-Nunez C, 2012, ANTIMICROB AGENTS CH, V56, P2696, DOI 10.1128/AAC.00064-12; Destoumieux-Garzon D, 2014, ANTIBIOTICS-BASEL, V3, P540, DOI 10.3390/antibiotics3040540; Doiron K, 2018, COLLOID SURFACE B, V167, P524, DOI 10.1016/j.colsurfb.2018.04.051; Duperthuy M, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003620; Echazarreta MA, 2018, J BACTERIOL, V200, DOI 10.1128/JB.00029-18; Faruque SM, 2006, P NATL ACAD SCI USA, V103, P6350, DOI 10.1073/pnas.0601277103; Faruque SM, 2003, P NATL ACAD SCI USA, V100, P1304, DOI 10.1073/pnas.0337468100; FUERST JA, 1988, J BACTERIOL, V170, P1488, DOI 10.1128/jb.170.4.1488-1494.1988; Fux CA, 2005, TRENDS MICROBIOL, V13, P34, DOI 10.1016/j.tim.2004.11.010; GANGAROS.EJ, 1967, B WORLD HEALTH ORGAN, V36, P987; Gardel CL, 1996, INFECT IMMUN, V64, P2246, DOI 10.1128/IAI.64.6.2246-2255.1996; GEIS G, 1993, J MED MICROBIOL, V38, P371, DOI 10.1099/00222615-38-5-371; GOODMAN FD, 1957, AM J CLIN PATHOL, V28, P427; Gottschalk S, 2015, J MED MICROBIOL, V64, P1504, DOI 10.1099/jmm.0.000177; Gryllos I, 2008, P NATL ACAD SCI USA, V105, P16755, DOI 10.1073/pnas.0803815105; Gu HY, 2017, CURR MICROBIOL, V74, P863, DOI 10.1007/s00284-017-1256-4; GUENTZEL MN, 1975, INFECT IMMUN, V11, P890, DOI 10.1128/IAI.11.5.890-897.1975; Haiko Johanna, 2013, Biology (Basel), V2, P1242, DOI 10.3390/biology2041242; Hammer BK, 2009, J BACTERIOL, V191, P169, DOI 10.1128/JB.01307-08; Hancock REW, 2006, NAT BIOTECHNOL, V24, P1551, DOI 10.1038/nbt1267; Hase CC, 2001, MICROBIOL-UK, V147, P831, DOI 10.1099/00221287-147-4-831; HRANITZKY KW, 1980, INFECT IMMUN, V27, P597, DOI 10.1128/IAI.27.2.597-603.1980; Karched M, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-18; Klose KE, 1998, J BACTERIOL, V180, P303, DOI 10.1128/JB.180.2.303-316.1998; Kovacikova G, 2002, INFECT IMMUN, V70, P5355, DOI 10.1128/IAI.70.10.5355-5362.2002; Lauriano CM, 2004, J BACTERIOL, V186, P4864, DOI 10.1128/JB.186.15.4864-4874.2004; Lee Ya-Ling, 2007, Journal of Microbiology Immunology and Infection, V40, P474; Lin Q, 2018, INT J ANTIMICROB AG, V52, P667, DOI 10.1016/j.ijantimicag.2018.04.019; Loutet SA, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-472; Lutz C, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00375; Mahlapuu M, 2016, FRONT CELL INFECT MI, V6, DOI 10.3389/fcimb.2016.00194; Mathur J, 2007, MOL MICROBIOL, V63, P848, DOI 10.1111/j.1365-2958.2006.05544.x; Matsui H, 2005, ANTIMICROB AGENTS CH, V49, P3396, DOI 10.1128/AAC.49.8.3396-3403.2005; Millikan DS, 2004, J BACTERIOL, V186, P4315, DOI 10.1128/JB.186.13.4315-4325.2004; Moreno MG, 2017, CURR TOP MED CHEM; MORRISON DC, 1976, IMMUNOCHEMISTRY, V13, P813, DOI 10.1016/0019-2791(76)90181-6; Mukherjee S, 2015, IMMUNITY, V42, P28, DOI 10.1016/j.immuni.2014.12.028; Nakao R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051241; Narendrakumar L., 2018, BIOTECHNOLOGICAL APP, P63, DOI [10.1007/978-981-10-9026-4_4, DOI 10.1007/978-981-10-9026-4_4]; O'Shea YA, 2004, J CLIN MICROBIOL, V42, P4657, DOI 10.1128/JCM.42.10.4657-4671.2004; PAJNI S, 1995, J MED MICROBIOL, V42, P20, DOI 10.1099/00222615-42-1-20; Prouty MG, 2001, MOL MICROBIOL, V39, P1595, DOI 10.1046/j.1365-2958.2001.02348.x; Rasmussen L, 2011, ANTIMICROB AGENTS CH, V55, P4134, DOI 10.1128/AAC.00482-11; Rios AC, 2016, MICROBIOL RES, V191, P51, DOI 10.1016/j.micres.2016.04.008; Rompikuntal PK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134098; Sato Y, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194556; Sengupta C, 2016, J INFECT DIS, V214, P1571, DOI 10.1093/infdis/jiw435; Strempel N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082240; Syed KA, 2009, J BACTERIOL, V191, P6555, DOI 10.1128/JB.00949-09; Tamayo R, 2010, INFECT IMMUN, V78, P3560, DOI 10.1128/IAI.00048-10; Tischler AD, 2004, MOL MICROBIOL, V53, P857, DOI 10.1111/j.1365-2958.2004.04155.x; Utada AS, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5913; VAITUZIS Z, 1969, J BACTERIOL, V100, P512, DOI 10.1128/JB.100.1.512-521.1969; van Alphen LB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045343; Velarde JJ, 2014, J BIOL CHEM, V289, P36315, DOI 10.1074/jbc.M114.605394; WALDOR MK, 1994, INFECT IMMUN, V62, P72, DOI 10.1128/IAI.62.1.72-78.1994; Wang S, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17050603; Watnick PI, 1999, MOL MICROBIOL, V34, P586, DOI 10.1046/j.1365-2958.1999.01624.x; Watnick PI, 2001, MOL MICROBIOL, V39, P223, DOI 10.1046/j.1365-2958.2001.02195.x; Yan J, 2016, P NATL ACAD SCI USA, V113, pE5337, DOI 10.1073/pnas.1611494113; Yasir M, 2018, MATERIALS, V11, DOI 10.3390/ma11122468; Yildiz FH, 2001, J BACTERIOL, V183, P1716, DOI 10.1128/JB.183.5.1716-1726.2001; Zheng JS, 2015, ENVIRON MICROBIOL, V17, P2133, DOI 10.1111/1462-2920.12662	79	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2019	14	8							e0221431	10.1371/journal.pone.0221431	http://dx.doi.org/10.1371/journal.pone.0221431			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5OC	31430343	Green Published, gold, Green Submitted			2022-12-26	WOS:000485026800051
J	Liu, YH; He, B; Li, KR; Li, F; Zhang, LY; Li, XQ; Zhao, L				Liu, Yong-Hong; He, Bo; Li, Kai-Rui; Li, Fei; Zhang, Lu-Yao; Li, Xian-Qiang; Zhao, Li			First report of border disease virus in Melophagus ovinus (sheep ked) collected in Xinjiang, China	PLOS ONE			English	Article							GENETIC-CHARACTERIZATION; SMALL RUMINANTS; BDV; PESTIVIRUSES; IDENTIFICATION; PHYLOGENIES	Melophagus ovinus (sheep ked) is a blood-sucking ectoparasite that is parasitic primarily on sheep. It is widely distributed in different geographical regions worldwide. In China, it has been mainly found in Xinjiang, Gansu, and Tibet in recent years. In addition to causing direct damage to the animal hosts, M. ovinus also carries pathogens and serves as a vector for disease transmission. Border disease virus (BDV) is a positive-sense, single-stranded RNA pestivirus that mainly infects and causes border disease (BD) in sheep and goats worldwide. Since 2012, this disease has been reported in 4 provinces in China. In the present study, we investigated the presence of BDV in M. ovinus from Xinjiang and Gansu. Frozen M. ovinus collected during 2017 and 2018 from Xinjiang and Gansu and preserved in our laboratory were studied. First, total RNA of M. ovinus was extracted, followed by reverse transcription, PCR (RT-PCR) amplification of the 50-UTR of BDV, and sequencing of the amplified products. Finally, the sequencing results were analyzed using DNAStar, MEGA 5.0 molecular biology software, and the BLAST online platform. The results from RT-PCR and sequencing analyses showed that among the samples included in the study, only the M. ovinus collected from Qinghe County in Alta, Xinjiang in 2018 tested positive for BDV. BLAST analysis showed that the viral strain with the most similar nucleotide identity to the sequence of the China/BDV/2018 fragment was the goat-derived BDV strain AH12-02 collected in Anhui, China, in 2012. A phylogenetic-tree analysis showed the strain to exhibit a BDV-3 genotype. This is the first report globally on BDV detected in M. ovinus and is also the first report of BDV discovered in Xinjiang, China. This study reconfirms the presence of BDV in China.	[Liu, Yong-Hong; Zhao, Li] Inner Mongolia Agr Univ, Coll Vet Med, Hohhot, Peoples R China; [He, Bo; Li, Kai-Rui; Li, Fei; Zhang, Lu-Yao; Li, Xian-Qiang; Zhao, Li] Tarim Univ, Coll Anim Sci, Aral, Peoples R China; [Li, Fei] Anim Loimia Controlling & Diagnost Ctr Aksu Reg, Aksu, Peoples R China	Inner Mongolia Agricultural University; Tarim University	Zhao, L (corresponding author), Inner Mongolia Agr Univ, Coll Vet Med, Hohhot, Peoples R China.; Zhao, L (corresponding author), Tarim Univ, Coll Anim Sci, Aral, Peoples R China.	zhaolidky@126.com		Liu, Yonghong/0000-0003-4432-9433	National Natural Science Foundation of China [31460655, 31860698]; open project of the Key Laboratory of Tarim Animal Husbandry Science and Technology, Xinjiang Production & Construction Corps [HS201501, HS201801]; Inner Mongolia Agricultural University High-level Talents Research Start-up Fund Project	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); open project of the Key Laboratory of Tarim Animal Husbandry Science and Technology, Xinjiang Production & Construction Corps; Inner Mongolia Agricultural University High-level Talents Research Start-up Fund Project	This study was funded by the Inner Mongolia Agricultural University High-level Talents Research Start-up Fund Project, the National Natural Science Foundation of China (No. 31460655 and No. 31860698) and the open project of the Key Laboratory of Tarim Animal Husbandry Science and Technology, Xinjiang Production & Construction Corps (No. HS201501 and No. HS201801).	Albayrak H, 2012, TROP ANIM HEALTH PRO, V44, P677, DOI 10.1007/s11250-011-9955-5; Becher P, 2003, VIROLOGY, V311, P96, DOI 10.1016/S0042-6822(03)00192-2; Braun U, 2013, SCHWEIZ ARCH TIERH, V155, P123, DOI 10.1024/0036-7281/a000428; Cabezon O, 2010, J VET DIAGN INVEST, V22, P744, DOI 10.1177/104063871002200514; Chu CY, 2011, VET MICROBIOL, V149, P526, DOI 10.1016/j.vetmic.2010.11.031; Couvreur B, 2002, VIRUS RES, V85, P17, DOI 10.1016/S0168-1702(02)00014-X; Duan DY, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2323-1; Dubois E, 2008, VET MICROBIOL, V130, P69, DOI 10.1016/j.vetmic.2008.01.002; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Giammarioli M, 2015, VIRUS GENES, V50, P321, DOI 10.1007/s11262-014-1165-6; Giangaspero M, 2011, J VET MED SCI, V73, P1629, DOI 10.1292/jvms.11-0072; Hurtado A, 2003, VIRUS RES, V92, P67, DOI 10.1016/S0168-1702(02)00315-5; Krametter-Froetscher R, 2007, ZOONOSES PUBLIC HLTH, V54, P209, DOI 10.1111/j.1863-2378.2007.01049.x; Leskova V, 2013, ACTA VIROL, V57, P17, DOI 10.4149/av_2013_01_17; Li WL, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-80; Liu D, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1885-7; Liu X., 2013, GENOME ANNOUNC, V1, P1, DOI DOI 10.1128/GEN0MEA.00502-13; Liu YH, 2018, KOREAN J PARASITOL, V56, P365, DOI 10.3347/kjp.2018.56.4.365; Luzzago C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168232; Ma J.G., 2017, SEROLOGICAL INVESTIG; Mainar-Jaime RC, 1999, PREV VET MED, V40, P193, DOI 10.1016/S0167-5877(99)00027-6; Mao L, 2015, VIROL J, V12, DOI 10.1186/s12985-014-0217-9; Marco I, 2015, ANIM HEALTH RES REV, V16, P70, DOI 10.1017/S1466252315000055; McFadden AMJ, 2012, NEW ZEAL VET J, V60, P290, DOI 10.1080/00480169.2012.675568; Mishra N, 2016, COMP IMMUNOL MICROB, V44, P1, DOI 10.1016/j.cimid.2015.11.001; Nettleton PF, 1998, VET RES, V29, P327; Oguzoglu TC, 2009, VET MICROBIOL, V135, P374, DOI 10.1016/j.vetmic.2008.09.085; Peletto S, 2016, ARCH VIROL, V161, P471, DOI 10.1007/s00705-015-2696-4; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Small RW, 2005, VET PARASITOL, V130, P141, DOI 10.1016/j.vetpar.2005.03.005; Stalder H, 2017, GENOME ANNOUNCEMENTS, V5, DOI [10.1128/genomeA.01238-17, 10.1128/genomea.01238-17]; Stalder HP, 2005, PREV VET MED, V72, P37, DOI 10.1016/j.prevetmed.2005.01.020; Strong R, 2010, VET MICROBIOL, V141, P208, DOI 10.1016/j.vetmic.2009.09.010; Tamura K, 2004, P NATL ACAD SCI USA, V101, P11030, DOI 10.1073/pnas.0404206101; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thabti F, 2005, ARCH VIROL, V150, P215, DOI 10.1007/s00705-004-0427-3; Valdazo-Gonzalez B, 2006, VET MICROBIOL, V117, P141, DOI 10.1016/j.vetmic.2006.06.008; Vilcek S, 2000, VET RES, V31, P437, DOI 10.1051/vetres:2000130; Zhao L, 2018, PARASITE VECTOR, V11, DOI 10.1186/s13071-018-2788-6	39	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2019	14	8							e0221435	10.1371/journal.pone.0221435	http://dx.doi.org/10.1371/journal.pone.0221435			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5OC	31430353	Green Submitted, gold, Green Published			2022-12-26	WOS:000485026800053
J	Orban, G; Meszena, D; Tasnady, KR; Rozsa, B; Ulbert, I; Marton, G				Orban, Gabor; Meszena, Domokos; Tasnady, Kinga Reka; Rozsa, Balazs; Ulbert, Istvan; Marton, Gergely			Method for spike detection from microelectrode array recordings contaminated by artifacts of simultaneous two-photon imaging	PLOS ONE			English	Article							ELECTRODE ARRAY; BRAIN-TISSUE; RESPONSES; PROBE	The simultaneous utilization of electrophysiological recordings and two-photon imaging allows the observation of neural activity in a high temporal and spatial resolution at the same time. The three dimensional monitoring of morphological features near the microelectrode array makes the observation more precise and complex. In vitro experiments were performed on mice neocortical slices expressing the GCaMP6 genetically encoded calcium indicator for monitoring the neural activity with two-photon microscopy around the implanted microelectrodes. A special filtering algorithm was used for data analysis to eliminate the artefacts caused by the imaging laser. Utilization of a special filtering algorithm allowed us to detect and sort single unit activities from simultaneous two-photon imaging and electrophysiological measurement.	[Orban, Gabor; Marton, Gergely] Obuda Univ, Doctoral Sch Mat Sci & Technol, Budapest, Hungary; [Orban, Gabor; Meszena, Domokos; Tasnady, Kinga Reka; Marton, Gergely] Hungarian Acad Sci, Inst Cognit Neurosci & Psychol, Res Ctr Nat Sci, Budapest, Hungary; [Meszena, Domokos; Rozsa, Balazs; Ulbert, Istvan; Marton, Gergely] Pazmany Peter Catholic Univ, Fac Informat Technol & Bion, Budapest, Hungary; [Rozsa, Balazs] Hungarian Acad Sci, Inst Expt Med, Budapest, Hungary	Obuda University; Hungarian Academy of Sciences; Hungarian Research Centre for Natural Sciences; Hungarian Academy of Sciences; Hungarian Institute of Experimental Medicine	Orban, G (corresponding author), Obuda Univ, Doctoral Sch Mat Sci & Technol, Budapest, Hungary.; Orban, G (corresponding author), Hungarian Acad Sci, Inst Cognit Neurosci & Psychol, Res Ctr Nat Sci, Budapest, Hungary.	orban.gabor@ttk.mta.hu	Ulbert, Istvan/F-2213-2010; Meszéna, Domokos/U-3696-2017; Tasnády, Kinga Réka/AAF-7449-2021; Balazs, Rozsa/C-6306-2015	Meszéna, Domokos/0000-0003-4042-2542; Tasnády, Kinga Réka/0000-0002-8406-9106; Balazs, Rozsa/0000-0003-1427-7003	Hungarian Brain Research Program Grant [2017-1.2.1NKP-2017-00002]; European Union [VEKOP-2.3.2-16-2017-00013]; State of Hungary; European Regional Development Fund; Hungarian National Research, Development and Innovation Office [PD121015]; New National Excellence Program of the Ministry of Human Capacities [UNKP-18-3-I-OE-105]; New National Excellence Program at the Pazmany Peter Catholic University [UNKP-18-3-IIIPPKE-35]	Hungarian Brain Research Program Grant; European Union(European Commission); State of Hungary; European Regional Development Fund(European Commission); Hungarian National Research, Development and Innovation Office; New National Excellence Program of the Ministry of Human Capacities; New National Excellence Program at the Pazmany Peter Catholic University	The research leading to these results has received funding from the Hungarian Brain Research Program Grant (Grant No. 2017-1.2.1NKP-2017-00002) to Istvan Ulbert. The research within project No. VEKOP-2.3.2-16-2017-00013 by Istvan Ulbert was supported by the European Union and the State of Hungary, co-financed by the European Regional Development Fund. Gergely Marton is thankful to the Hungarian National Research, Development and Innovation Office (PD121015). Gabor Orban was Supported by the UNKP-18-3-I-OE-105 New National Excellence Program of the Ministry of Human Capacities. Domokos Meszena was supported by the New National Excellence Program (No. UNKP-18-3-IIIPPKE-35) at the Pazmany Peter Catholic University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrese JC, 2013, J NEURAL ENG, V10, DOI 10.1088/1741-2560/10/6/066014; Bass C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183309; Bertran MA, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196527; Chabuda A, 2018, IEEE T NEUR SYS REH, V26, P344, DOI 10.1109/TNSRE.2017.2734164; Dana H, 2014, PLOS ONE, V9, DOI [10.1126/science.aab1687, 10.1371/journal, DOI 10.1126/SCIENCE.AAB1687]; Edelman BJ, 2016, IEEE T BIO-MED ENG, V63, P4, DOI 10.1109/TBME.2015.2467312; Fiala A, 2010, CURR BIOL, V20, pR897, DOI 10.1016/j.cub.2010.08.053; Fiath R, 2018, BIOSENS BIOELECTRON, V106, P86, DOI 10.1016/j.bios.2018.01.060; Gilgunn PJ, 2013, I IEEE EMBS C NEUR E, P719, DOI 10.1109/NER.2013.6696035; Hajos N, 2009, EUR J NEUROSCI, V29, P319, DOI 10.1111/j.1460-9568.2008.06577.x; Hillman EMC, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2789693; Hochberg LR, 2012, NATURE, V485, P372, DOI 10.1038/nature11076; Hotson G, 2016, J NEURAL ENG, V13, DOI 10.1088/1741-2560/13/2/026017; Ito S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105324; Karumbaiah L, 2012, BIOMATERIALS, V33, P5983, DOI 10.1016/j.biomaterials.2012.05.021; Kerr JND, 2007, J NEUROSCI, V27, P13316, DOI 10.1523/JNEUROSCI.2210-07.2007; Kerr JND, 2005, P NATL ACAD SCI USA, V102, P14063, DOI 10.1073/pnas.0506029102; KOCKANAT S, 2018, CUMHUR SCI J, V39, P294, DOI DOI 10.17776/csj.407424; Konrad P, 2010, NEUROBIOL DIS, V38, P369, DOI 10.1016/j.nbd.2009.12.007; Kozai TDY, 2016, J NEUROSCI METH, V258, P46, DOI 10.1016/j.jneumeth.2015.10.007; Kozai TDY, 2015, J MATER CHEM B, V3, P4965, DOI 10.1039/c5tb00108k; Kozai TDY, 2015, ACS CHEM NEUROSCI, V6, P48, DOI 10.1021/cn500256e; Kozai TDY, 2015, BIOMATERIALS, V37, P25, DOI 10.1016/j.biomaterials.2014.10.040; Kuzum D, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6259; Laszlo G, 2011, SENSOR ACTUAT A-PHYS, V166, P14, DOI 10.1016/j.sna.2010.12.019; Malik WQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020490; Marton G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145307; Materka A, 2006, ADV MED SIGNAL INFOR; Neto JP, 2016, J NEUROPHYSIOL, V116, P892, DOI 10.1152/jn.00103.2016; Pacheco S, 2017, SCI REP, V7, P2045, DOI [10.1038/s41598-017-01960-5, DOI 10.1038/S41598-017-01960-5]; Park DW, 2016, NAT PROTOC, V11, P2201, DOI 10.1038/nprot.2016.127; Polikov VS, 2005, J NEUROSCI METH, V148, P1, DOI 10.1016/j.jneumeth.2005.08.015; Prance H, 2007, REV SCI INSTRUM, V78, DOI 10.1063/1.2751399; Prasad A, 2012, J NEURAL ENG, V9, DOI 10.1088/1741-2560/9/5/056015; Qiang Y, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aat0626; Quiroga RQ, 2004, NEURAL COMPUT, V16, P1661, DOI 10.1162/089976604774201631; Rousche PJ, 1998, J NEUROSCI METH, V82, P1, DOI 10.1016/S0165-0270(98)00031-4; Scholvinck ML, 2013, NEUROIMAGE, V80, P297, DOI 10.1016/j.neuroimage.2013.04.010; Schwartz AB, 2006, NEURON, V52, P205, DOI 10.1016/j.neuron.2006.09.019; Shew WL, 2010, J NEUROSCI METH, V192, P75, DOI 10.1016/j.jneumeth.2010.07.023; So PTC, 2000, ANNU REV BIOMED ENG, V2, P399, DOI 10.1146/annurev.bioeng.2.1.399; Stocking KC, 2019, IEEE T BIO-MED ENG, V66, P2402, DOI 10.1109/TBME.2018.2889832; Stosiek C, 2003, P NATL ACAD SCI USA, V100, P7319, DOI 10.1073/pnas.1232232100; Wertz A, 2015, SCIENCE, V349, P70, DOI 10.1126/science.aab1687; Wu V, 2011, J MAGN RESON IMAGING, V33, P1184, DOI 10.1002/jmri.22530; Zhang TS, 2006, J NEUROSCI METH, V155, P308, DOI 10.1016/j.jneumeth.2005.12.022	46	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2019	14	8							e0221510	10.1371/journal.pone.0221510	http://dx.doi.org/10.1371/journal.pone.0221510			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5OC	31430357	Green Published, gold, Green Accepted, Green Submitted			2022-12-26	WOS:000485026800063
J	Polonen, P; Deen, AJ; Leinonen, HM; Jyrkkanen, HK; Kuosmanen, S; Mononen, M; Jain, A; Tuomainen, T; Pasonen-Seppanen, S; Hartikainen, JM; Mannermaa, A; Nykter, M; Tavi, P; Johansen, T; Heinaniemi, M; Levonen, AL				Polonen, Petri; Deen, Ashik Jawahar; Leinonen, Hanna M.; Jyrkkanen, Henna-Kaisa; Kuosmanen, Suvi; Mononen, Mimmi; Jain, Ashish; Tuomainen, Tomi; Pasonen-Seppanen, Sanna; Hartikainen, Jaana M.; Mannermaa, Arto; Nykter, Matti; Tavi, Pasi; Johansen, Terje; Heinaniemi, Merja; Levonen, Anna-Liisa			Nrf2 and SQSTM1/p62 jointly contribute to mesenchymal transition and invasion in glioblastoma	ONCOGENE			English	Article							TRANSCRIPTION FACTOR NRF2; KEAP1-NRF2 PATHWAY; SIGNALING PATHWAYS; CELL LINE; ACTIVATION; MUTATIONS; GENE; EXPRESSION; P62; ABNORMALITIES	Accumulating evidence suggests that constitutively active Nrf2 has a pivotal role in cancer as it induces pro-survival genes that promote cancer cell proliferation and chemoresistance. The mechanisms of Nrf2 dysregulation and functions in cancer have not been fully characterized. Here, we jointly analyzed the Broad-Novartis Cancer Cell Line Encyclopedia (CCLE) and the Cancer Genome Atlas (TCGA) multi-omics data in order to identify cancer types where Nrf2 activation is present. We found that Nrf2 is hyperactivated in a subset of glioblastoma (GBM) patients, whose tumors display a mesenchymal subtype, and uncover several different mechanisms contributing to increased Nrf2 activity. Importantly, we identified a positive feedback loop between SQSTM1/p62 and Nrf2 as a mechanism for activation of the Nrf2 pathway. We also show that autophagy and serine/threonine signaling regulates p62 mediated Keap1 degradation. Our results in glioma cell lines indicate that both Nrf2 and p62 promote proliferation, invasion and mesenchymal transition. Finally, Nrf2 activity was associated with decreased progression free survival in TCGA GBM patient samples, suggesting that treatments have limited efficacy if this transcription factor is overactivated. Overall, our findings place Nrf2 and p62 as the key components of the mesenchymal subtype network, with implications to tumorigenesis and treatment resistance. Thus, Nrf2 activation could be used as a surrogate prognostic marker in mesenchymal subtype GBMs. Furthermore, strategies aiming at either inhibiting Nrf2 or exploiting Nrf2 hyperactivity for targeted gene therapy may provide novel treatment options for this subset of GBM.	[Polonen, Petri; Pasonen-Seppanen, Sanna; Tavi, Pasi; Heinaniemi, Merja] Univ Eastern Finland, Sch Med, Inst Biomed, POB 1627, FIN-70211 Kuopio, Finland; [Deen, Ashik Jawahar; Leinonen, Hanna M.; Jyrkkanen, Henna-Kaisa; Kuosmanen, Suvi; Mononen, Mimmi; Tuomainen, Tomi; Levonen, Anna-Liisa] Univ Eastern Finland, AI Virtanen Inst Mol Sci, Dept Biotechnol & Mol Med, POB 1627, FIN-70211 Kuopio, Finland; [Jain, Ashish; Johansen, Terje] Univ Tromso, Inst Med Biol, N-9037 Tromso, Norway; [Jain, Ashish] Oslo Univ Hosp, Inst Canc Res, Dept Mol Cell Biol, N-0379 Oslo, Norway; [Jain, Ashish] Univ Oslo, Fac Med, Ctr Canc Biomed, POB 1627, N-0379 Oslo, Norway; [Hartikainen, Jaana M.; Mannermaa, Arto] Univ Eastern Finland, Inst Clin Med, POB 1627, FIN-70211 Kuopio, Finland; [Nykter, Matti] Univ Tampere, Fac Med & Life Sci, POB 100, FIN-33014 Tampere, Finland; [Nykter, Matti] Univ Tampere, BioMediTech Inst, POB 100, FIN-33014 Tampere, Finland	University of Eastern Finland; University of Eastern Finland; UiT The Arctic University of Tromso; University of Oslo; University of Oslo; University of Eastern Finland; Tampere University; Tampere University	Levonen, AL (corresponding author), Univ Eastern Finland, AI Virtanen Inst Mol Sci, Dept Biotechnol & Mol Med, POB 1627, FIN-70211 Kuopio, Finland.	anna-liisa.levonen@uef.fi	Johansen, Terje/N-2971-2015; Jain, Ashish/H-7356-2017; Hartikainen, Jaana M/E-6256-2015; Heinaniemi, Merja/AAS-4530-2020; Linna-Kuosmanen, Suvi/P-4574-2018	Johansen, Terje/0000-0003-1451-9578; Jain, Ashish/0000-0001-6549-2788; Hartikainen, Jaana M/0000-0001-8267-1905; Heinaniemi, Merja/0000-0001-6190-3439; Linna-Kuosmanen, Suvi/0000-0002-3278-2727; Levonen, Anna-Liisa/0000-0002-6575-2137; Nykter, Matti/0000-0001-6956-2843; Tuomainen, Tomi/0000-0002-2387-6369	Finnish Cancer Organizations; Jane and Aatos Erkko Foundation; Sigrid Juselius Foundation; Academy of Finland; Finnish Cultural Foundation; Cancer Society of Finland; North-Savo Regional Cancer Society; Fund of Matti and Vappu Maukonen	Finnish Cancer Organizations; Jane and Aatos Erkko Foundation; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Academy of Finland(Academy of Finland); Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science); Cancer Society of Finland; North-Savo Regional Cancer Society; Fund of Matti and Vappu Maukonen	This study was supported by the Finnish Cancer Organizations, The Jane and Aatos Erkko Foundation, Sigrid Juselius Foundation, Academy of Finland, Finnish Cultural Foundation, Cancer Society of Finland, North-Savo Regional Cancer Society and Fund of Matti and Vappu Maukonen. Mrs. Arja Korhonen is thanked for her technical assistance. We thank SIBLabs for performing TEM and Dr. Eeva-Liisa Eskelinen, University of Helsinki, for helping with the analysis of TEM pictures.	Agnihotri S, 2016, NEURO-ONCOLOGY, V18, P160, DOI 10.1093/neuonc/nov125; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Bouvy-Liivrand M, 2017, NUCLEIC ACIDS RES, V45, P9837, DOI 10.1093/nar/gkx680; Bowman RL, 2017, NEURO-ONCOLOGY, V19, P139, DOI 10.1093/neuonc/now247; Brennan CW, 2013, CELL, V155, P462, DOI 10.1016/j.cell.2013.09.034; Carro MS, 2010, NATURE, V463, P318, DOI 10.1038/nature08712; Chang JT, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-443; Collisson EA, 2014, NATURE, V511, P543, DOI 10.1038/nature13385; Galavotti S, 2013, ONCOGENE, V32, P699, DOI 10.1038/onc.2012.111; Goldstein LD, 2016, CELL REP, V16, P2605, DOI 10.1016/j.celrep.2016.08.010; Hanzelmann S, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-7; Hayes JD, 2014, TRENDS BIOCHEM SCI, V39, P199, DOI 10.1016/j.tibs.2014.02.002; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Ichimura Y, 2013, MOL CELL, V51, P618, DOI 10.1016/j.molcel.2013.08.003; Inami Y, 2011, J CELL BIOL, V193, P275, DOI 10.1083/jcb.201102031; Jain A, 2010, J BIOL CHEM, V285, P22576, DOI 10.1074/jbc.M110.118976; Jin LT, 2015, CANCER CELL, V27, P257, DOI 10.1016/j.ccell.2014.12.006; Johansen T, 2011, AUTOPHAGY, V7, P279, DOI 10.4161/auto.7.3.14487; Johnson DR, 2012, J NEURO-ONCOL, V107, P359, DOI 10.1007/s11060-011-0749-4; Jyrkkanen HK, 2011, BIOCHEM J, V440, P167, DOI 10.1042/BJ20110526; Kanamori M, 2014, NEURO-ONCOLOGY, V1, P1; Kansanen E, 2012, FREE RADICAL BIO MED, V52, P973, DOI 10.1016/j.freeradbiomed.2011.11.038; Kansanen E, 2011, J BIOL CHEM, V286, P14019, DOI 10.1074/jbc.M110.190710; Kansanen E, 2009, J BIOL CHEM, V284, P33233, DOI 10.1074/jbc.M109.064873; Kim YR, 2010, J PATHOL, V220, P446, DOI 10.1002/path.2653; Komatsu M, 2010, NAT CELL BIOL, V12, P213, DOI 10.1038/ncb2021; Koponen JK, 2007, MOL THER, V15, P2172, DOI 10.1038/sj.mt.6300302; Lau A, 2010, MOL CELL BIOL, V30, P3275, DOI 10.1128/MCB.00248-10; Leinonen HM, 2014, ADV CANCER RES, V122, P281, DOI 10.1016/B978-0-12-420117-0.00008-6; Leinonen HM, 2012, CANCER RES, V72, P6227, DOI 10.1158/0008-5472.CAN-12-1166; Levine AJ, 2010, SCIENCE, V330, P1340, DOI 10.1126/science.1193494; Liberzon A, 2011, BIOINFORMATICS, V27, P1739, DOI 10.1093/bioinformatics/btr260; Lister A, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-37; Mitsuishi Y, 2012, FRONT ONCOL, V2, DOI 10.3389/fonc.2012.00200; Noushmehr H, 2010, CANCER CELL, V17, P510, DOI 10.1016/j.ccr.2010.03.017; Omuro A, 2013, JAMA-J AM MED ASSOC, V310, P1842, DOI 10.1001/jama.2013.280319; Ooi A, 2013, CANCER RES, V73, P2044, DOI 10.1158/0008-5472.CAN-12-3227; Padmanabhan B, 2006, MOL CELL, V21, P689, DOI 10.1016/j.molcel.2006.01.013; Pajares M, 2016, AUTOPHAGY, V12, P1902, DOI 10.1080/15548627.2016.1208889; Rinaldi M, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17060984; Rokavec M, 2017, SCI REP, V7, P1; Sanchez-Vega F, 2018, CELL, V173, P321, DOI 10.1016/j.cell.2018.03.035; Shibata T, 2008, P NATL ACAD SCI USA, V105, P13568, DOI 10.1073/pnas.0806268105; Shibata T, 2010, CANCER RES, V70, P9095, DOI 10.1158/0008-5472.CAN-10-0384; Singer E, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2014.566; Singh A, 2006, PLOS MED, V3, P1865, DOI 10.1371/journal.pmed.0030420; Solis LM, 2010, CLIN CANCER RES, V16, P3743, DOI 10.1158/1078-0432.CCR-09-3352; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tanida I, 2004, INT J BIOCHEM CELL B, V36, P2503, DOI 10.1016/j.biocel.2004.05.009; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Xie Y, 2015, EBIOMEDICINE, V2, P1351, DOI 10.1016/j.ebiom.2015.08.026; Yamamoto A, 1998, CELL STRUCT FUNCT, V23, P33, DOI 10.1247/csf.23.33; Yoo NJ, 2012, HISTOPATHOLOGY, V60, P943, DOI 10.1111/j.1365-2559.2012.04178.x	53	34	35	1	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	DEC 12	2019	38	50					7473	7490		10.1038/s41388-019-0956-6	http://dx.doi.org/10.1038/s41388-019-0956-6			18	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	JV7GY	31444413	Green Accepted			2022-12-26	WOS:000502530500003
J	Zhao, PP; Li, S; Wang, HA; Dang, YN; Wang, LF; Liu, T; Wang, SH; Li, XH; Zhang, K				Zhao, Panpan; Li, Shuang; Wang, Huanan; Dang, Yanna; Wang, Lefeng; Liu, Tong; Wang, Shaohua; Li, Xinhong; Zhang, Kun			Sin3a regulates the developmental progression through morula-to-blastocyst transition via Hdac1	FASEB JOURNAL			English	Article						preimplantation; Hdac2; trophectoderm; pluripotency; embryo	GENOME INTEGRITY; MOUSE; COMPLEX; P53; EXPRESSION; TRANSCRIPTION; INTERACTS; PROTEIN; ARREST; DOMAIN	Suppressor interacting 3a (Sin3a) is a scaffold component of the chromatin repressive complex Sin3/histone deacetylase (Hdac). Sin3a has been shown as a hub gene driving preimplantation development in both mice and humans. However, its precise functions during preimplantation development remain unclear. Here, we show that the embryos arrested at morula stage upon specific depletion of Sin3a in mouse early embryos. Given the reduced cell number in Sin3a-depleted embryos, blocked cell proliferation is observed, likely because of the increased level of Trp53 acetylation at lysine 379. Moreover, we found that Sin3a depletion reduces Cdx2 and Tir Na Nog (Nanog), suggesting a failure of the first cell fate decision. In addition, we noted a striking increase of genome-wide DNA methylation, likely attributed to the increased nuclear DNA methyltransferase 1 observed in Sin3a-depleted embryos. Notably, RNA sequencing analyses showed 717 genes are differentially expressed, and Gene Ontology analysis of down-regulated genes (e.g., Hdac1) revealed top enriched terms involving protein deacetylation. Consistently, we confirmed a significant decrease of Hdac1 mRNA and protein abundance. Importantly, the development and Trp53 acetylation in Sin3a-depleted embryos could be rescued by expression of Hdac1 but not Hdac2. In summary, our results indicate a vital role of Sin3a in safeguarding the developmental progression through the morula-to-blastocyst transition via Hdac1.	[Zhao, Panpan; Li, Shuang; Wang, Huanan; Dang, Yanna; Wang, Lefeng; Liu, Tong; Wang, Shaohua; Zhang, Kun] Zhejiang Univ, Sch Med, Sir Run Run Shaw Hosp, Lab Mammalian Mol Embryol,Coll Anim Sci, Hangzhou, Peoples R China; [Zhao, Panpan; Li, Shuang; Wang, Huanan; Dang, Yanna; Wang, Lefeng; Liu, Tong; Wang, Shaohua; Li, Xinhong; Zhang, Kun] Zhejiang Univ, Sch Med, Sir Run Run Shaw Hosp, Assisted Reprod Unit,Dept Obstet & Gynecol, Hangzhou, Peoples R China; [Li, Xinhong; Zhang, Kun] Shanghai Key Lab Vet Biotechnol, Shanghai, Peoples R China	Zhejiang University; Zhejiang University	Zhang, K (corresponding author), Zhejiang Univ, 301 E Bldg,866 Yuhangtang Rd, Hangzhou 310058, Zhejiang, Peoples R China.	kzhang@zju.edu.cn	shaohua, wang/AAB-7904-2022	Zhang, Kun/0000-0002-2324-9381	National Natural Science Foundation of China [31672416, 31872348]; Zhejiang Provincial Natural Science Foundation of China [LY19C180002]; Foundation of Shanghai Key Laboratory of Veterinary Biotechnology [klab201708]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province); Foundation of Shanghai Key Laboratory of Veterinary Biotechnology	The authors thank all members of the K.Z. laboratory for their helpful discussions and comments. This study was supported by National Natural Science Foundation of China (31672416 and 31872348 to K.Z.), the Zhejiang Provincial Natural Science Foundation of China (LY19C180002 to H.W.), and the Foundation of Shanghai Key Laboratory of Veterinary Biotechnology (klab201708). The authors declare no conflicts of interest.	Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Cao ZB, 2015, DEVELOPMENT, V142, P1606, DOI 10.1242/dev.120238; Chen ZY, 2015, P NATL ACAD SCI USA, V112, P4618, DOI 10.1073/pnas.1422088112; Cowley SM, 2005, MOL CELL BIOL, V25, P6990, DOI 10.1128/MCB.25.16.6990-7004.2005; David G, 2003, GENE DEV, V17, P2396, DOI 10.1101/gad.1109403; Ealy AD, 2019, J ANIM SCI, V97, P2555, DOI 10.1093/jas/skz116; Eckersley-Maslin MA, 2018, NAT REV MOL CELL BIO, V19, P436, DOI 10.1038/s41580-018-0008-z; Fleming TP, 2018, LANCET, V391, P1842, DOI [10.1016/S0140-6736(18)30312-X, 10.1016/s0140-6736(18)30312-x]; Harrington EA, 1998, P NATL ACAD SCI USA, V95, P11945, DOI 10.1073/pnas.95.20.11945; Hassig CA, 1997, CELL, V89, P341, DOI 10.1016/S0092-8674(00)80214-7; Icardi L, 2012, P NATL ACAD SCI USA, V109, P12058, DOI 10.1073/pnas.1206458109; Ito A, 2002, EMBO J, V21, P6236, DOI 10.1093/emboj/cdf616; Ji QH, 2014, J CELL SCI, V127, P4679, DOI 10.1242/jcs.154245; Jimenez R, 2015, BIOL REPROD, V93, DOI 10.1095/biolreprod.115.133504; Kimura H, 1999, MOL BIOL CELL, V10, p285A; Krisher RL, 2013, ANNU REV ANIM BIOSCI, V1, P393, DOI 10.1146/annurev-animal-031412-103647; Kruiswijk F, 2015, NAT REV MOL CELL BIO, V16, P393, DOI 10.1038/nrm4007; Lagger G, 2002, EMBO J, V21, P2672, DOI 10.1093/emboj/21.11.2672; Laugesen A, 2014, CELL STEM CELL, V14, P735, DOI 10.1016/j.stem.2014.05.006; Li E, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a019133; Liu WQ, 2016, CELL DISCOV, V2, DOI 10.1038/celldisc.2016.10; Liu Z, 2018, CELL, V174, P245, DOI 10.1016/j.cell.2018.01.036; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Ma PP, 2008, DEV BIOL, V319, P110, DOI 10.1016/j.ydbio.2008.04.011; Ma PP, 2015, CELL REP, V13, P1552, DOI 10.1016/j.celrep.2015.10.031; Ma PP, 2012, P NATL ACAD SCI USA, V109, pE481, DOI 10.1073/pnas.1118403109; Mann MRW, 2004, DEVELOPMENT, V131, P3727, DOI 10.1242/dev.01241; Market-Velker BA, 2010, HUM MOL GENET, V19, P36, DOI 10.1093/hmg/ddp465; Matoba S, 2014, CELL, V159, P884, DOI 10.1016/j.cell.2014.09.055; McDonel P, 2012, DEV BIOL, V363, P62, DOI 10.1016/j.ydbio.2011.12.019; Messerschmidt D, 2016, DEVELOPMENT, V143, P1993, DOI 10.1242/dev.133439; Patro R, 2017, NAT METHODS, V14, P417, DOI 10.1038/nmeth.4197; RIETHMACHER D, 1995, P NATL ACAD SCI USA, V92, P855, DOI 10.1073/pnas.92.3.855; Rivera RM, 2008, HUM MOL GENET, V17, P1, DOI 10.1093/hmg/ddm280; Rossant J, 2018, ANNU REV GENET, V52, P185, DOI 10.1146/annurev-genet-120116-024544; Rouault JP, 1996, NAT GENET, V14, P482, DOI 10.1038/ng1296-482; Sahraeian SME, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00050-4; Spencer T. E., 2013, Animal Frontiers, V3, P48, DOI 10.2527/af.2013-0033; Suzuki S, 2015, DEVELOPMENT, V142, P2375, DOI 10.1242/dev.120493; Tucci V, 2019, CELL, V176, P952, DOI 10.1016/j.cell.2019.01.043; Wang JL, 2006, NATURE, V444, P364, DOI 10.1038/nature05284; Wang Y, 2013, DEV CELL, V24, P345, DOI 10.1016/j.devcel.2013.01.012; Wen J, 2012, FERTIL STERIL, V97, P1331, DOI 10.1016/j.fertnstert.2012.02.053; Wiltbank MC, 2016, THERIOGENOLOGY, V86, P239, DOI 10.1016/j.theriogenology.2016.04.037; Xue ZG, 2013, NATURE, V500, P593, DOI 10.1038/nature12364; Yao CF, 2017, DEVELOPMENT, V144, P2618, DOI 10.1242/dev.149708; Zenker J, 2017, SCIENCE, V357, P925, DOI 10.1126/science.aam9335; Zhang K, 2013, DEV BIOL, V383, P15, DOI 10.1016/j.ydbio.2013.09.005; Zhang K, 2013, DEV BIOL, V373, P359, DOI 10.1016/j.ydbio.2012.10.026; Zilfou JT, 2001, MOL CELL BIOL, V21, P3974, DOI 10.1128/MCB.21.12.3974-3985.2001	50	8	10	0	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2019	33	11					12541	12553		10.1096/fj.201901213R	http://dx.doi.org/10.1096/fj.201901213R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC8ZX	31450981	Green Published			2022-12-26	WOS:000507461600073
J	Kim, YE; Park, WS; Sung, DK; Ahn, SY; Chang, YS				Kim, Young Eun; Park, Won Soon; Sung, Dong Kyung; Ahn, So Yoon; Chang, Yun Sil			Antenatal betamethasone enhanced the detrimental effects of postnatal dexamethasone on hyperoxic lung and brain injuries in newborn rats	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; ALVEOLAR COUNT METHOD; INTRATRACHEAL TRANSPLANTATION; BRONCHOPULMONARY DYSPLASIA; PRETERM INFANTS; GLUCOCORTICOIDS; INTRAUTERINE; REAPPRAISAL; DISEASE; IMPACT	Purpose To determine the effects of antenatal betamethasone and/or postnatal dexamethasone administration on hyperoxic lung and brain injuries in newborn rats. Methods Newborn Sprague-Dawley rats were divided into five experimental groups: normoxia-vehicle-vehicle group, hyperoxia-vehicle-vehicle group, hyperoxia-betamethasone-vehicle group, hyperoxia-vehicle-dexamethasone group, and hyperoxia-betamethasone-dexamethasone group according to (i) whether rats were exposed to normoxia or hyperoxia after birth to postnatal day (P) 14, (ii) whether antenatal betamethasone (0.2mg/kg) or vehicle was administered to pregnant rats at gestation days 19 and 20, and (iii) whether three tapering doses of dexamethasone (0.5, 0.3, 0.1mg/kg per day) or vehicle were administered on P5, 6 and 7, respectively. The lungs and brains were harvested for histological and biochemical analyses at P8 and P14. Results Postnatal dexamethasone but not antenatal betamethasone significantly enhanced hyperoxia-induced reduction in body weight gain and alveolarization and increased lung terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) positive cells both at P8 and P14, transiently increased hyperoxia-induced reductions in brain weight gain and angiogenesis, and increase in brain TUNEL-positive cells at P8 but not at P14. Co-administration of antenatal betamethasone significantly enhanced dexamethasone-induced impairments in alveolarization both at P8 and P14, transient increases in lung and brain oxidative stresses, and increases in brain TUNEL-positive cells at P8 but not at P14. Conclusion Although postnatal dexamethasone but not antenatal betamethasone alone significantly increased hyperoxic lung and brain injuries, co-administration of antenatal betamethasone significantly enhanced the detrimental effects of postnatal dexamethasone on hyperoxic lung and brain injuries in newborn rats.	[Kim, Young Eun; Park, Won Soon; Sung, Dong Kyung; Ahn, So Yoon; Chang, Yun Sil] Sungkyunkwan Univ, Samsung Med Ctr, Dept Pediat, Sch Med, Seoul, South Korea; [Kim, Young Eun; Park, Won Soon; Sung, Dong Kyung; Ahn, So Yoon; Chang, Yun Sil] Samsung Med Ctr, Stem Cell & Regenerat Med Inst, Seoul, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center	Chang, YS (corresponding author), Sungkyunkwan Univ, Samsung Med Ctr, Dept Pediat, Sch Med, Seoul, South Korea.; Chang, YS (corresponding author), Samsung Med Ctr, Stem Cell & Regenerat Med Inst, Seoul, South Korea.	yschang@skku.edu		Chang, Yun Sil/0000-0001-9201-2938	Samsung Medical Center [GFO3190091]	Samsung Medical Center(Samsung)	This research was supported by a grant for the 20 by 20 Project from Samsung Medical Center (GFO3190091) to YSC.	Anderson PJ, 2006, SEMIN PERINATOL, V30, P227, DOI 10.1053/j.semperi.2006.05.010; Baraldi E, 2007, NEW ENGL J MED, V357, P1946, DOI 10.1056/NEJMra067279; Barbazanges A, 1996, J NEUROSCI, V16, P3943; Bellavance MA, 2012, IMMUNOL REV, V248, P36, DOI 10.1111/j.1600-065X.2012.01129.x; Burri PH, 2006, BIOL NEONATE, V89, P313, DOI 10.1159/000092868; Chang YS, 2014, J PEDIATR-US, V164, P966, DOI 10.1016/j.jpeds.2013.12.011; Chang YS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052419; Chang YS, 2011, CELL TRANSPLANT, V20, P1843, DOI 10.3727/096368911X565038; Chang YS, 2009, CELL TRANSPLANT, V18, P869, DOI 10.3727/096368909X471189; Chao CM, 2015, FRONT MED-LAUSANNE, V2, DOI 10.3389/fmed.2015.00027; COONEY TP, 1982, THORAX, V37, P572, DOI 10.1136/thx.37.8.572; COONEY TP, 1982, THORAX, V37, P580, DOI 10.1136/thx.37.8.580; Dammann O, 2004, BIOL NEONATE, V85, P305, DOI 10.1159/000078175; Diack SL, 1930, J NUTR, V3, P289, DOI 10.1093/jn/3.3.289; Doyle LW, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001145.pub4; Doyle LW, 2005, PEDIATRICS, V115, P655, DOI 10.1542/peds.2004-1238; Herrera EA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009250; Pham H, 2014, EXP NEUROL, V252, P114, DOI 10.1016/j.expneurol.2013.11.025; Kim YE, 2016, PEDIATR RES, V80, P415, DOI 10.1038/pr.2016.88; Martinez Fernando D, 2009, Proc Am Thorac Soc, V6, P272, DOI 10.1513/pats.200808-092RM; Nadeau S, 2003, J NEUROSCI, V23, P5536, DOI 10.1523/jneurosci.23-13-05536.2003; O'Reilly M, 2014, AM J PHYSIOL-LUNG C, V307, pL948, DOI 10.1152/ajplung.00160.2014; Poon AWH, 2016, BIOL OPEN, V5, P475, DOI 10.1242/bio.017665; Ramsay PL, 1998, BIOCHEM PHARMACOL, V56, P259, DOI 10.1016/S0006-2952(98)00138-5; Ratner V, 2007, NEONATOLOGY, V92, P50, DOI 10.1159/000100086; Snyder JM, 2005, PEDIATR RES, V57, P384, DOI 10.1203/01.PDR.0000151315.81106.D3; Sorrells SF, 2007, BRAIN BEHAV IMMUN, V21, P259, DOI 10.1016/j.bbi.2006.11.006; Thebaud B, 2001, PEDIATRICS, V107, P413, DOI 10.1542/peds.107.2.413; Vackova Z, 2009, REPROD TOXICOL, V28, P46, DOI 10.1016/j.reprotox.2009.02.006; Yoo HS, 2013, PEDIATR RES, V73, P726, DOI 10.1038/pr.2013.51	30	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2019	14	8							e0221847	10.1371/journal.pone.0221847	http://dx.doi.org/10.1371/journal.pone.0221847			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW6BO	31469886	gold, Green Published, Green Submitted			2022-12-26	WOS:000485062200033
J	Kitano, T; Nabeshima, Y; Abe, Y; Otsuji, Y; Takeuchi, M				Kitano, Tetsuji; Nabeshima, Yosuke; Abe, Yasuhiko; Otsuji, Yutaka; Takeuchi, Masaaki			Accuracy and reliability of novel semi-automated two-dimensional layer specific speckle tracking software for quantifying left ventricular volumes and function	PLOS ONE			English	Article							GLOBAL LONGITUDINAL STRAIN; 3-DIMENSIONAL ECHOCARDIOGRAPHY; MYOCARDIAL DEFORMATION; AORTIC-STENOSIS; IMAGE QUALITY; QUANTIFICATION; FEASIBILITY; VALIDATION; REPRODUCIBILITY; QUANTITATION	Purpose To determine whether the semi-automated two-dimensional echocardiography (2DE) layer strain software, compared to cardiac magnetic resonance (CMR), is reliable for left ventricular (LV) volume quantification. Methods and results We retrospectively selected 84 patients who underwent CMR and 2DE on the same day. Novel 2DE layer strain software automatically provides LV contour in 3 myocardial layers and performs layer specific speckle tracking analysis, which calculates LV volumes, ejection fraction (LVEF), and global longitudinal strain (GLS) in each layer. These values were compared with reference values from CMR disk-area summation and feature tracking methods. Coverage probability (CP) was determined using predefined cut-off values and absolute differences in LV volumes of 30 mL, those in LVEF of 10%, and those in GLS of 4%. The software did not work in 3 patients (feasibility: 96%). Different layers resulted in different degrees of under-or over-estimation of LV volumes. Epicardial tracking significantly overestimated the LV volumes and significantly underestimated LVEF and GLS. Mid-myocardial tracking had less underestimation of LV volumes and equivalent CP values of LVEF (0.77 vs. 0.75 using the disk-area summation method and 0.90 vs. 0.94 using the feature tracking method) and GLS (0.95 vs. 0.92) compared with endocardial tracking. The new software showed excellent reproducibility, especially endocardial and mid-myocardial tracking. Conclusions Mid-myocardial tracking with the novel 2DE strain software provided less bias of LV volumes with high CP values of LVEF and GLS, which suggests that mid-myocardial layer speckle tracking analysis approximates CMR derived LV functional parameters.	[Kitano, Tetsuji; Nabeshima, Yosuke; Otsuji, Yutaka] Univ Occupat & Environm Hlth, Sch Med, Dept Internal Med 2, Kitakyushu, Fukuoka, Japan; [Abe, Yasuhiko] Canon Med Syst, Otawara, Japan; [Takeuchi, Masaaki] Univ Occupat & Environm Hlth Hosp, Dept Lab & Transfus Med, Kitakyushu, Fukuoka, Japan	University of Occupational & Environmental Health - Japan; University of Occupational & Environmental Health - Japan	Kitano, T (corresponding author), Univ Occupat & Environm Hlth, Sch Med, Dept Internal Med 2, Kitakyushu, Fukuoka, Japan.	syuukyuu1986@gmail.com	Kitano, Tetsuji/AAR-7390-2021	Kitano, Tetsuji/0000-0002-8539-5907	Canon Medical Systems	Canon Medical Systems	MT received an equipment grant from Canon Medical Systems. YA is an employee of Canon Medical Systems. The other authors declare that they have no conflict of interest. The funder provided support in the form of salary for Yasuhiko Abe, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Abe Y, 2014, JPN J MED ULTRASON S, V41, pS533; Alcidi GM, 2018, EUR HEART J-CARD IMG, V19, P1390, DOI 10.1093/ehjci/jex306; Aurich M, 2014, J AM SOC ECHOCARDIOG, V27, P1017, DOI 10.1016/j.echo.2014.07.006; Bech-Hanssen O, 2016, SCAND CARDIOVASC J, V50, P154, DOI 10.3109/14017431.2016.1148195; Chukwu EO, 2008, J AM SOC ECHOCARDIOG, V21, P990, DOI 10.1016/j.echo.2008.07.009; Greupner J, 2012, J AM COLL CARDIOL, V59, P1897, DOI 10.1016/j.jacc.2012.01.046; Jenkins C, 2009, EUR HEART J, V30, P98, DOI 10.1093/eurheartj/ehn484; Kawamura R, 2014, J CARDIOL, V63, P230, DOI 10.1016/j.jjcc.2013.08.010; Khouri MG, 2018, J AM SOC ECHOCARDIOG, V31, P361, DOI 10.1016/j.echo.2017.11.018; Kim SA, 2016, CAN J CARDIOL, V32, P211, DOI 10.1016/j.cjca.2015.04.025; Lancellotti P, 2010, HEART, V96, P1364, DOI 10.1136/hrt.2009.190942; Levy F, 2017, ARCH CARDIOVASC DIS, V110, P580, DOI 10.1016/j.acvd.2016.12.015; Marsan NA, 2011, ANN THORAC SURG, V91, P113, DOI 10.1016/j.athoracsur.2010.08.048; Mor-Avi V, 2011, J AM SOC ECHOCARDIOG, V24, P277, DOI 10.1016/j.echo.2011.01.015; Muraru D, 2010, EUR J ECHOCARDIOGR, V11, P359, DOI 10.1093/ejechocard/jep217; Nagata Y, 2018, ECHO RES PRACT, V5, P27, DOI 10.1530/ERP-17-0047; Nagata Y, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180584; Negishi T, 2018, J ECHOCARDIOGR, V16, P20, DOI 10.1007/s12574-017-0344-6; Nitta S, 2013, MAGN RESON MATER PHY, V26, P451, DOI 10.1007/s10334-012-0361-4; Plana JC, 2014, EUR HEART J-CARD IMG, V15, P1063, DOI 10.1093/ehjci/jeu192; Sarvari SI, 2013, JACC-CARDIOVASC IMAG, V6, P535, DOI 10.1016/j.jcmg.2013.01.009; Shibayama K, 2013, J CARDIOL, V61, P281, DOI 10.1016/j.jjcc.2012.11.005; Stoebe S, 2018, ECHO RES PRACT, V5, P51, DOI 10.1530/ERP-17-0083; Sugioka K, 2003, ECHOCARDIOGR-J CARD, V20, P313, DOI 10.1046/j.1540-8175.2003.03036.x; Tamborini G, 2017, J AM SOC ECHOCARDIOG, V30, P1049, DOI 10.1016/j.echo.2017.06.026; Tsang W, 2016, JACC-CARDIOVASC IMAG, V9, P769, DOI 10.1016/j.jcmg.2015.12.020; Unlu S, 2018, J AM SOC ECHOCARDIOG, V31, P374, DOI 10.1016/j.echo.2017.11.008; Vo HQ, 2018, JACC-CARDIOVASC IMAG, V11, P196, DOI 10.1016/j.jcmg.2016.12.025; Yingchoncharoen T, 2012, CIRC-CARDIOVASC IMAG, V5, P719, DOI 10.1161/CIRCIMAGING.112.977348	29	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2019	14	8							e0221204	10.1371/journal.pone.0221204	http://dx.doi.org/10.1371/journal.pone.0221204			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW6BO	31469858	Green Published, Green Submitted, gold			2022-12-26	WOS:000485062200013
J	Tonelli, AR; Aulak, KS; Ahmed, MK; Hausladen, A; Abuhalimeh, B; Casa, CJ; Rogers, SC; Timm, D; Doctor, A; Gaston, B; Dweik, RA				Tonelli, Adriano R.; Aulak, Kulwant S.; Ahmed, Mostafa K.; Hausladen, Alfred; Abuhalimeh, Batool; Casa, Charlie J.; Rogers, Stephen C.; Timm, David; Doctor, Allan; Gaston, Benjamin; Dweik, Raed A.			A pilot study on the kinetics of metabolites and microvascular cutaneous effects of nitric oxide inhalation in healthy volunteers	PLOS ONE			English	Article							PERSISTENT PULMONARY-HYPERTENSION; S-NITROSOTHIOLS SIGNAL; IN-VIVO EVALUATION; BRAIN-DAMAGE; BLOOD-FLOW; INHALED NO; NITRATE; NITROSOHEMOGLOBIN; HEMOGLOBIN; THERAPY	Rationale Inhaled nitric oxide (NO) exerts a variety of effects through metabolites and these play an important role in regulation of hemodynamics in the body. A detailed investigation into the generation of these metabolites has been overlooked. Objectives We investigated the kinetics of nitrite and S-nitrosothiol-hemoglobin (SNO-Hb) in plasma derived from inhaled NO subjects and how this modifies the cutaneous microvascular response. Findings We enrolled 15 healthy volunteers. Plasma nitrite levels at baseline and during NO inhalation (15 minutes at 40 ppm) were 102 (86-118) and 114 (87-129) nM, respectively. The nitrite peak occurred at 5 minutes of discontinuing NO (131 (104-170) nM). Plasma nitrate levels were not significantly different during the study. SNO-Hb molar ratio levels at baseline and during NO inhalation were 4.7E-3 (2.5E-3-5.8E-3) and 7.8E-3 (4.1E-3-13.0E-3), respectively. Levels of SNO-Hb continued to climb up to the last study time point (30 min: 10.6E-3 (5.3E-3-15.5E-3)). The response to acetylcholine iontophoresis both before and during NO inhalation was inversely associated with the SNO-Hb level (r: -0.57, p = 0.03, and r: -0.54, p = 0.04, respectively). Conclusions Both nitrite and SNO-Hb increase during NO inhalation. Nitrite increases first, followed by a more sustained increase in Hb-SNO. Nitrite and Hb-SNO could be a mobile reservoir of NO with potential implications on the systemic microvasculature.	[Tonelli, Adriano R.; Dweik, Raed A.] Cleveland Clin, Dept Pulm Allergy & Crit Care Med, Resp Inst, Cleveland, OH 44106 USA; [Tonelli, Adriano R.; Dweik, Raed A.] Cleveland Clin, Pathobiol Div, Lerner Res Inst, Cleveland, OH 44106 USA; [Aulak, Kulwant S.; Abuhalimeh, Batool; Casa, Charlie J.] Cleveland Clin, Inflammat & Immun, Lerner Res Inst, Cleveland, OH 44106 USA; [Ahmed, Mostafa K.] Assiut Univ, Fac Med, Dept Chest Dis, Assiut, Egypt; [Hausladen, Alfred] Case Western Reserve Univ, Sch Med, Inst Transformat Mol Med, Cleveland, OH USA; [Hausladen, Alfred] Case Western Reserve Univ, Sch Med, Dept Med, Cleveland, OH 44106 USA; [Hausladen, Alfred] Univ Hosp Cleveland, Med Ctr, Cleveland, OH 44106 USA; [Rogers, Stephen C.; Doctor, Allan] Univ Maryland, Sch Med, Dept Pediat, Baltimore, MD 21201 USA; [Timm, David] Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA; [Gaston, Benjamin] Indiana Univ Sch Med, Herman B Wells Ctr Pediat Res, Indianapolis, IN 46202 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Egyptian Knowledge Bank (EKB); Assiut University; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University Hospital; University Hospitals of Cleveland; University System of Maryland; University of Maryland Baltimore; Washington University (WUSTL); Indiana University System; Indiana University Bloomington	Tonelli, AR (corresponding author), Cleveland Clin, Dept Pulm Allergy & Crit Care Med, Resp Inst, Cleveland, OH 44106 USA.; Tonelli, AR (corresponding author), Cleveland Clin, Pathobiol Div, Lerner Res Inst, Cleveland, OH 44106 USA.	tonella@ccf.org	Timm, David Daniel/AAX-9362-2021	Timm, Dave/0000-0003-1246-2707; Rogers, Stephen/0000-0003-1139-4730; Tonelli, Adriano/0000-0002-2321-9545	NIH [R01GM113838, R01HL130307]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL130307] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM113838] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	ART is supported by NIH grant #R01HL130307 and AD is supported by NIH grant #R01GM113838. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adrie C, 1996, CIRCULATION, V94, P1919, DOI 10.1161/01.CIR.94.8.1919; AHN H, 1987, MED BIOL ENG COMPUT, V25, P207, DOI 10.1007/BF02442852; Alzawahra WF, 2008, AM J PHYSIOL-HEART C, V295, pH499, DOI 10.1152/ajpheart.00374.2008; Bhat T, 2015, REV CARDIOVASC MED, V16, P1, DOI 10.3909/ricm0718; BRAMAN RS, 1989, ANAL CHEM, V61, P2715, DOI 10.1021/ac00199a007; Brucken A, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-1128-x; Cannon RO, 2001, J CLIN INVEST, V108, P279, DOI 10.1172/JCI12761; Coggins MP, 2007, ARTERIOSCL THROM VAS, V27, P1877, DOI 10.1161/ATVBAHA.107.142943; COX RD, 1980, ANAL CHEM, V52, P332, DOI 10.1021/ac50052a028; CULOTTA E, 1992, SCIENCE, V258, P1862, DOI 10.1126/science.1361684; Daiber A, 2003, NITRIC OXIDE-BIOL CH, V9, P44, DOI 10.1016/j.niox.2003.08.002; Daiber A, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20010187; Dejam A, 2007, CIRCULATION, V116, P1821, DOI 10.1161/CIRCULATIONAHA.107.712133; Derwall M, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-1050-2; Dixon F, 2018, ACTA PAEDIATR, V107, P2092, DOI 10.1111/apa.14436; Doctor A, 2005, P NATL ACAD SCI USA, V102, P5709, DOI 10.1073/pnas.0407490102; Doctor A, 2006, BLOOD, V108, P3225, DOI 10.1182/blood-2006-05-026047; Drabkin DL, 1935, J BIOL CHEM, V112, P51; Droog EJ, 2004, MICROVASC RES, V67, P197, DOI 10.1016/j.mvr.2003.12.003; Fox-Robichaud A, 1998, J CLIN INVEST, V101, P2497, DOI 10.1172/JCI2736; Fredriksson I, 2009, MICROVASC RES, V78, P4, DOI 10.1016/j.mvr.2009.02.008; FROSTELL C, 1991, CIRCULATION, V83, P2038, DOI 10.1161/01.CIR.83.6.2038; FURCHGOTT RF, 1980, NATURE, V288, P373, DOI 10.1038/288373a0; GASTON B, 1993, P NATL ACAD SCI USA, V90, P10957, DOI 10.1073/pnas.90.23.10957; Gaston Benjamin, 2006, Proc Am Thorac Soc, V3, P170, DOI 10.1513/pats.200506-049BG; Gaston B, 2014, J APPL PHYSIOL, V116, P1290, DOI 10.1152/japplphysiol.01050.2013; Gonzalez A, 2010, J PERINATOL, V30, P420, DOI 10.1038/jp.2009.171; Gow A, 2007, J CHROMATOGR B, V851, P140, DOI 10.1016/j.jchromb.2007.01.052; Hajian B, 2016, INT J CHRONIC OBSTR, V11, P1533, DOI 10.2147/COPD.S106480; Hataishi R, 2006, AM J PHYSIOL-HEART C, V291, pH379, DOI 10.1152/ajpheart.01172.2005; Hausladen A, 2007, P NATL ACAD SCI USA, V104, P2157, DOI 10.1073/pnas.0611191104; HOGMAN M, 1993, LANCET, V341, P1664, DOI 10.1016/0140-6736(93)90802-N; Hon YY, 2010, DRUG METAB DISPOS, V38, P1707, DOI 10.1124/dmd.110.034355; Ibrahim YI, 2012, J PEDIATR-US, V160, P245, DOI 10.1016/j.jpeds.2011.07.040; IGNARRO LJ, 1987, P NATL ACAD SCI USA, V84, P9265, DOI 10.1073/pnas.84.24.9265; Jia L, 1996, NATURE, V380, P221, DOI 10.1038/380221a0; Kelm M, 1999, CARDIOVASC RES, V41, P765, DOI 10.1016/S0008-6363(98)00259-4; KELM M, 1990, CIRC RES, V66, P1561, DOI 10.1161/01.RES.66.6.1561; Kida K, 2014, CRIT CARE, V18, DOI 10.1186/cc13779; KINSELLA JP, 1992, LANCET, V340, P819, DOI 10.1016/0140-6736(92)92687-B; Kinsella JP, 1997, SEMIN PERINATOL, V21, P418, DOI 10.1016/S0146-0005(97)80007-9; Lang JD, 2007, J CLIN INVEST, V117, P2583, DOI 10.1172/JCI31892; Lauer T, 2001, P NATL ACAD SCI USA, V98, P12814, DOI 10.1073/pnas.221381098; Lee JS, 1996, CIRC RES, V78, P337, DOI 10.1161/01.RES.78.2.337; Lei C, 2018, AM J RESP CRIT CARE, V198, P1279, DOI [10.1164/rccm.201710-2150OC, 10.1164/rccm.201708-1713RR]; Lipton AJ, 2001, NATURE, V413, P171, DOI 10.1038/35093117; Liu XP, 1998, J BIOL CHEM, V273, P18709, DOI 10.1074/jbc.273.30.18709; Lundberg JO, 2008, AM J PHYSIOL-HEART C, V295, pH477, DOI 10.1152/ajpheart.00611.2008; Marozkina NV, 2015, ANNU REV PHYSIOL, V77, P431, DOI 10.1146/annurev-physiol-021113-170352; Mathru M, 2007, ANESTHESIOLOGY, V106, P275, DOI 10.1097/00000542-200702000-00015; McMahon Timothy J, 2006, Proc Am Thorac Soc, V3, P153, DOI 10.1513/pats.200507-066BG; McMahon TJ, 2002, NAT MED, V8, P711, DOI 10.1038/nm718; MONCADA S, 1993, NEW ENGL J MED, V329, P2002; Moya MP, 2001, P NATL ACAD SCI USA, V98, P5792, DOI 10.1073/pnas.091109498; Nagasaka Y, 2008, ANESTHESIOLOGY, V109, P675, DOI 10.1097/ALN.0b013e318186316e; NATHAN C, 1992, FASEB J, V6, P3051, DOI 10.1096/fasebj.6.12.1381691; Palmer LA, 2008, METHOD ENZYMOL, V440, P157, DOI 10.1016/S0076-6879(07)00809-9; Palmer LA, 2007, J CLIN INVEST, V117, P2592, DOI 10.1172/JCI29444; Palmer LA, 2013, RESP PHYSIOL NEUROBI, V185, P571, DOI 10.1016/j.resp.2012.11.009; PALMER RMJ, 1987, NATURE, V327, P524, DOI 10.1038/327524a0; PINDER A G, 2009, METHOD MOL BIOL, V476, P10; Rix PJ, 2015, CLIN PHARMACOKINET, V54, P261, DOI 10.1007/s40262-014-0201-y; ROBERTS JD, 1992, LANCET, V340, P818, DOI 10.1016/0140-6736(92)92686-A; Roberts JD, 1997, NEW ENGL J MED, V336, P605, DOI 10.1056/NEJM199702273360902; Rosselli M, 1998, HUM REPROD UPDATE, V4, P3, DOI 10.1093/humupd/4.1.3; Roustit M, 2012, MICROCIRCULATION, V19, P47, DOI 10.1111/j.1549-8719.2011.00129.x; Ruan SY, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1566-0; Samouilov A, 1998, ANAL BIOCHEM, V258, P322, DOI 10.1006/abio.1998.2609; SAVILLE B, 1958, ANALYST, V83, P670, DOI 10.1039/an9588300670; Saygin D, 2019, MICROCIRCULATION, V26, DOI 10.1111/micc.12440; Singel DJ, 2005, ANNU REV PHYSIOL, V67, P99, DOI 10.1146/annurev.physiol.67.060603.090918; Singel DJ, 2004, NATURE, V430, P297, DOI 10.1038/430297a; Sonveaux P, 2005, CIRC RES, V96, P1119, DOI 10.1161/01.RES.0000168740.04986.a7; STERN MD, 1975, NATURE, V254, P56, DOI 10.1038/254056a0; Stewart DL, 2018, MINERVA PEDIATR, V70, P51, DOI 10.23736/S0026-4946.17.04944-1; STUEHR DJ, 1985, P NATL ACAD SCI USA, V82, P7738, DOI 10.1073/pnas.82.22.7738; Terpolilli NA, 2016, J CEREBR BLOOD F MET, V36, P2096, DOI 10.1177/0271678X15605848; Terpolilli NA, 2013, J CEREBR BLOOD F MET, V33, P311, DOI 10.1038/jcbfm.2012.176; Terpolilli NA, 2012, CIRC RES, V110, P727, DOI 10.1161/CIRCRESAHA.111.253419; Tonelli AR, 2015, AM J RESP CRIT CARE, V192, P1014, DOI 10.1164/rccm.201506-1091LE; Tonelli AR, 2013, PULM CIRC, V3, P20, DOI 10.4103/2045-8932.109911; Tonelli AR, 2010, RESP MED, V104, P481, DOI 10.1016/j.rmed.2009.11.015; Troncy E, 1997, BRIT J ANAESTH, V79, P631, DOI 10.1093/bja/79.5.631; Turner J, 2008, TRENDS CARDIOVAS MED, V18, P109, DOI 10.1016/j.tcm.2008.02.001; Wagner HM., 1970, LUFT, V30, P380; WESTFELT UN, 1995, BRIT J PHARMACOL, V114, P1621, DOI 10.1111/j.1476-5381.1995.tb14948.x; WINK DA, 1991, SCIENCE, V254, P1001, DOI 10.1126/science.1948068; Yu BL, 2019, BRIT J PHARMACOL, V176, P246, DOI 10.1111/bph.14512	88	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2019	14	8							e0221777	10.1371/journal.pone.0221777	http://dx.doi.org/10.1371/journal.pone.0221777			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW6BO	31469867	Green Published, Green Submitted, gold			2022-12-26	WOS:000485062200028
J	Yu, TT; Lu, XF; Bai, Y; Mei, XP; Guo, ZF; Liu, CX; Cai, YL				Yu, Tingting; Lu, Xuefeng; Bai, Yang; Mei, Xiupeng; Guo, Zhifeng; Liu, Chaoxian; Cai, Yilin			Overexpression of the maize transcription factor ZmVQ52 accelerates leaf senescence in Arabidopsisy	PLOS ONE			English	Article							MOTIF-CONTAINING PROTEINS; JASMONIC ACID; CHLOROPHYLL DEGRADATION; PHYTOCHROME; AUXIN	Leaf senescence plays an important role in the improvement of maize kernel yields. However, the underlying regulatory mechanisms of leaf senescence in maize are largely unknown. We isolated ZmVQ52 and studied the function of ZmVQ52 which encoded, a VQ family transcription factor. ZmVQ52 is constitutively expressed in maize tissues, and mainly expressed in the leaf; it is located in the nucleus of maize protoplasts. Four WRKY family proteins-ZmWRKY20, ZmWRKY36, ZmWRKY50, and ZmWRKY71-were identified as interacting with ZmVQ52. The overexpression of ZmVQ52 in Arabidopsis accelerated premature leaf senescence. The leaf of the ZmVQ52-overexpression line showed a lower chlorophyll content and higher senescence rate than the WT. A number of leaf senescence regulating genes were up-regulated in the ZmVQ52-overexpression line. Additionally, hormone treatments revealed that the leaf of the ZmVQ52-overexpressed line was more sensitive to salicylic acid (SA) and jasmonic acid (JA), and had an enhanced tolerance to abscisic acid (ABA). Moreover, a transcriptome analysis of the ZmVQ52-overexpression line revealed that ZmVQ52 is mainly involved in the circadian pathway and photosynthetic pathways.	[Yu, Tingting; Lu, Xuefeng; Bai, Yang; Mei, Xiupeng; Guo, Zhifeng; Liu, Chaoxian; Cai, Yilin] Southwest Univ, Coll Agron & Biotechnol, Key Lab Biotechnol & Crop Qual Improvement, Maize Res Inst, Chongqing, Peoples R China	Southwest University - China	Cai, YL (corresponding author), Southwest Univ, Coll Agron & Biotechnol, Key Lab Biotechnol & Crop Qual Improvement, Maize Res Inst, Chongqing, Peoples R China.	caiyilin1789@163.com	yu, tingting/HGA-4783-2022		major projects of Chongqing [Cstc2016shms-ztzx80017, Cstc2016shms-ztz80016, Cstc2016shms-ztzx80013]	major projects of Chongqing	This work was funded by major projects of Chongqing (Cstc2016shms-ztzx80017, Cstc2016shms-ztz80016 and Cstc2016shms-ztzx80013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Besseau S, 2012, J EXP BOT, V63, P2667, DOI 10.1093/jxb/err450; Brouwer B, 2014, J EXP BOT, V65, P4037, DOI 10.1093/jxb/eru060; Chen GH, 2012, J EXP BOT, V63, P275, DOI 10.1093/jxb/err278; Chen LG, 2017, MOL PLANT, V10, P1174, DOI 10.1016/j.molp.2017.07.008; Cheng Y, 2012, PLANT PHYSIOL, V159, P810, DOI 10.1104/pp.112.196816; Erik A, 2014, EMBO J, V24, P2579; Gao QM, 2011, PLANT PHYSIOL, V155, P464, DOI 10.1104/pp.110.166876; Guo P, 2017, PLANT CELL; Han M, 2014, MOL CELLS, V37, P532, DOI 10.14348/molcells.2014.0128; He YH, 2002, PLANT PHYSIOL, V128, P876, DOI 10.1104/pp.010843; Jiang YJ, 2014, PLANT CELL, V26, P230, DOI 10.1105/tpc.113.117838; Jing SJ, 2009, PLANT GROWTH REGUL, V58, P181, DOI 10.1007/s10725-009-9366-z; Kim H, 2016, J EXPT BOT, V67; Kim H, 2018, P NATL ACAD SCI USA, V115, P8448, DOI 10.1073/pnas.1722407115; Kim J, 2018, J EXP BOT, V69, P787, DOI 10.1093/jxb/erx287; Lai ZB, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-68; Lei GJ, 2014, PLANT CELL ENVIRON, V37, P852, DOI 10.1111/pce.12203; Li S, 2016, PLANT CELL REP, V35, P1729, DOI 10.1007/s00299-016-1991-1; Li YL, 2014, PLANT PHYSIOL, V164, P2068, DOI 10.1104/pp.113.234492; LICHTENTHALER HK, 1987, METHOD ENZYMOL, V148, P350; Lim PO, 2007, ANNU REV PLANT BIOL, V58, P115, DOI 10.1146/annurev.arplant.57.032905.105316; Miao Y, 2004, PLANT MOL BIOL, V55, P853, DOI 10.1007/s11103-005-2142-1; Narusaka M, 2008, J GEN PLANT PATHOL, V74, P345, DOI 10.1007/s10327-008-0117-1; Oda-Yamamizo C, 2016, SCI REP-UK, V6, DOI 10.1038/srep23609; Qiu K, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005399; Rutherford S, 2002, CURR OPIN PLANT BIOL, V5, P518, DOI 10.1016/S1369-5266(02)00307-2; Sakuraba Y, 2016, PLANT CELL REP, V35, P155, DOI 10.1007/s00299-015-1876-8; Seo PJ, 2011, PLANTA, V233, P189, DOI 10.1007/s00425-010-1293-8; Song WB, 2016, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.01177; Song Y, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.00280; von Saint Paul V, 2011, PLANT CELL, V23, P4124, DOI 10.1105/tpc.111.088443; Weyhe M, 2014, PLANT SIGNAL BEHAV, V9, DOI 10.4161/psb.29519; Xie YD, 2010, PLANT CELL ENVIRON, V33, P828, DOI 10.1111/j.1365-3040.2009.02109.x; Xu F, 2011, PLANT PHYSIOL, V157, P2131, DOI 10.1104/pp.111.182899; Yang JD, 2014, PLANT CELL, V26, P4862, DOI 10.1105/tpc.114.133769; Yu J, 2016, J EXP BOT, V67, P751, DOI 10.1093/jxb/erv487; Zelazny E, 2007, P NATL ACAD SCI USA, V104, P12359, DOI 10.1073/pnas.0701180104; Zhou X, 2011, MOL CELLS, V31, P303, DOI 10.1007/s10059-011-0047-1	38	6	9	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2019	14	8							e0221949	10.1371/journal.pone.0221949	http://dx.doi.org/10.1371/journal.pone.0221949			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW6BO	31469881	Green Submitted, gold, Green Published			2022-12-26	WOS:000485062200041
J	Campiche, R; Daniltchenko, M; Imfeld, D; Peters, EMJ				Campiche, Remo; Daniltchenko, Maria; Imfeld, Dominik; Peters, Eva M. J.			Effects of the selective TrkA agonist gambogic amide on pigmentation and growth of human hair follicles in vitro	PLOS ONE			English	Article							RECEPTOR; NEUROTROPHINS; EXPRESSION; CYCLE; SKIN; CLASSIFICATION; INVOLVEMENT; MELANOCYTES; FAMILY; CELLS	The human hair follicle is a neuroendocrine mini-organ that can be used to study aging processes in vitro. Neurotrophins maintain homeostasis in hair biology via the Trk-family of receptors. TrkA, the high affinity receptor for nerve growth factor (NGF), is expressed in hair follicle melanocytes and keratinocytes, where it regulates proliferation, differentiation and apoptosis and may thereby play a role in hair pigmentation and growth. We investigated TrkA expression during the human hair cycle and the effects of a selective high affinity TrkA agonist, Gambogic Amide, on hair pigmentation and hair growth in human hair follicles in vitro. In human scalp skin, TrkA expression was strongest in proliferating melanocytes reestablishing the pigmentary unit in the hair bulb during the early hair growth phase, anagen. During high anagen and in the de-composing pigmentary-unit of the regression phase, catagen, bulb-melanocytes lost TrkA expression and only undifferentiated outer root sheath melanocytes maintained it. In cultured human anagen hair follicles, Gambogic Amide was able to prevent gradual pigment loss, while it stimulated hair shaft elongation. This was achieved by increased melanocyte activation, migration and dendricity, highlighted by distinct c-KIT-expression in melanocyte sub-populations. Our results suggest that Gambogic Amide can maintain hair follicle pigmentation by acting on undifferentiated melanocytes residing in the outer root sheath and making them migrate to establish the pigmentary-unit. This suggests that the selective TrkA agonist Gambogic Amide acts as an anti-hair greying and hair growth promoting molecule in vitro.	[Campiche, Remo; Imfeld, Dominik] DSM Nutr Prod Personal Care & Aroma, Kaiseraugst, Switzerland; [Daniltchenko, Maria; Peters, Eva M. J.] Univ Med Charite, Charite Ctr CC12 Internal Med & Dermat, Dept Psychosomat Med, Berlin, Germany; [Peters, Eva M. J.] Univ Hosp Giessen & Marburg, Dept Psychosomat Med & Psychotherapy, Psychoneuroimmunol Lab, Giessen, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University Hospital of Giessen & Marburg	Campiche, R (corresponding author), DSM Nutr Prod Personal Care & Aroma, Kaiseraugst, Switzerland.	remo.campiche@dsm.com	Campiche, Remo/AAW-2700-2020	Campiche, Remo/0000-0002-2216-7851	DSM Nutritional Products; National Institute of Mental Health [R01MH109466, F30MH10924]; National Institute of Aging [R01AG062249]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH109466] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG062249] Funding Source: NIH RePORTER	DSM Nutritional Products; National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute of Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was funded in part by DSM Nutritional Products with a project grant to EMJP. EMJP also received grants from National Institute of Mental Health (grants R01MH109466 and F30MH10924) and from National Institute of Aging (grant R01AG062249). RC and DI are employees of DSM Nutritional Products and received regular salaries from the company. The funder provided support in the form of salaries for authors [RC, DI], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Adema GJ, 1996, BRIT J CANCER, V73, P1044, DOI 10.1038/bjc.1996.202; Adly MA, 2006, J CUTAN PATHOL, V33, P559, DOI 10.1111/j.1600-0560.2006.00443.x; Alexeev V, 2006, J INVEST DERMATOL, V126, P1102, DOI 10.1038/sj.jid.5700125; Arck PC, 2003, EXP DERMATOL, V12, P580, DOI 10.1034/j.1600-0625.2003.00028.x; Arck PC, 2006, FASEB J, V20, P1567, DOI 10.1096/fj.05-4039fje; Boissy RE, 1997, PIGM CELL RES, V10, P12, DOI 10.1111/j.1600-0749.1997.tb00461.x; Botchkarev VA, 2004, PROG BRAIN RES, V146, P493; Botchkarev VA, 1998, J INVEST DERMATOL, V111, P279, DOI 10.1046/j.1523-1747.1998.00277.x; Botchkarev VA, 2006, J INVEST DERMATOL, V126, P1719, DOI 10.1038/sj.jid.5700270; Botchkareva NV, 2001, FASEB J, V15, P645, DOI 10.1096/fj.00-0368com; Caserta M, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00058; Choi HI, 2011, BRIT J DERMATOL, V165, P1183, DOI 10.1111/j.1365-2133.2011.10625.x; Commo S, 2004, BRIT J DERMATOL, V150, P435, DOI 10.1046/j.1365-2133.2004.05787.x; Commo S, 2000, PIGM CELL RES, V13, P253, DOI 10.1034/j.1600-0749.2000.130407.x; Costa RO, 2018, MOL NEUROBIOL, V55, P2934, DOI 10.1007/s12035-017-0505-7; Ioannou MS, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18030599; Jang SW, 2007, P NATL ACAD SCI USA, V104, P16329, DOI 10.1073/pnas.0706662104; Marconi A., 2006, International Journal of Cosmetic Science, V28, P255, DOI 10.1111/j.1467-2494.2006.00321.x; Matama T, 2015, TRENDS BIOTECHNOL, V33, P707, DOI 10.1016/j.tibtech.2015.10.001; Mondal AC, 2019, INT J NEUROSCI, V129, P283, DOI 10.1080/00207454.2018.1527328; Muller-Rover S, 2001, J INVEST DERMATOL, V117, P3, DOI 10.1046/j.0022-202x.2001.01377.x; Na YJ, 2007, BIOCHEM PHARMACOL, V74, P780, DOI 10.1016/j.bcp.2007.05.028; Obianyo O, 2013, BBA-PROTEINS PROTEOM, V1834, P2213, DOI 10.1016/j.bbapap.2012.08.021; Paus R, 2004, DIFFERENTIATION, V72, P489, DOI 10.1111/j.1432-0436.2004.07209004.x; Paus R, 2007, J INVEST DERM SYMP P, V12, P20, DOI 10.1038/sj.jidsymp.5650050; Paus R, 2011, PIGM CELL MELANOMA R, V24, P89, DOI 10.1111/j.1755-148X.2010.00808.x; PEACOCKE M, 1988, P NATL ACAD SCI USA, V85, P5282, DOI 10.1073/pnas.85.14.5282; Peters EMJ, 2006, AM J PATHOL, V168, P221, DOI 10.2353/ajpath.2006.050163; Peters EMJ, 2005, J INVEST DERMATOL, V124, P675, DOI 10.1111/j.0022-202X.2005.23648.x; Peters EMJ, 2002, J HISTOCHEM CYTOCHEM, V50, P751, DOI 10.1177/002215540205000602; Peters EMJ, 2007, AM J PATHOL, V171, P1872, DOI 10.2353/ajpath.2007.061206; Peters EMJ, 2013, J INVEST DERMATOL, V133, P1150, DOI 10.1038/jid.2012.462; Peters EMJ, 2011, J COSMET SCI, V62, P121; PHILPOTT MP, 1990, J CELL SCI, V97, P463; Seiberg M, 2013, INT J COSMETIC SCI, V35, P532, DOI 10.1111/ics.12090; Shen JY, 2015, PHARMACOL REP, V67, P217, DOI 10.1016/j.pharep.2014.09.002; Shi Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093589; SLOMINSKI A, 1993, J THEOR BIOL, V164, P103, DOI 10.1006/jtbi.1993.1142; Slominski A, 2000, ENDOCR REV, V21, P457, DOI 10.1210/er.21.5.457; Slominski A, 2004, PHYSIOL REV, V84, P1155, DOI 10.1152/physrev.00044.2003; Slominski A, 2005, J INVEST DERMATOL, V124, P13, DOI 10.1111/j.0022-202X.2004.23528.x; SLOMINSKI A, 1993, J INVEST DERMATOL, V101, pS90, DOI 10.1111/1523-1747.ep12362991; Slominski A, 2009, EXP DERMATOL, V18, P760, DOI 10.1111/j.1600-0625.2009.00892.x; Slominski AT, 2013, ENDOCR REV, V34, P827, DOI 10.1210/er.2012-1092; Syrris P, 2002, HUM MUTAT, V20, DOI 10.1002/humu.9057; Tjarks BJ, 2017, J CUTAN PATHOL, V44, P45, DOI 10.1111/cup.12851; Tobin DJ, 2001, EXP GERONTOL, V36, P29, DOI 10.1016/S0531-5565(00)00210-2; Tobin DJ, 2007, HOUSEHOLD PERSONAL C, P15; Wood JM, 2009, FASEB J, V23, P2065, DOI 10.1096/fj.08-125435; YAAR M, 1994, J CLIN INVEST, V94, P1550, DOI 10.1172/JCI117496; Yin LL, 2015, J INVEST DERMATOL, V135, P2455, DOI 10.1038/jid.2015.179	51	4	4	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2019	14	8							e0221757	10.1371/journal.pone.0221757	http://dx.doi.org/10.1371/journal.pone.0221757			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW6AB	31465471	Green Published, Green Submitted, gold			2022-12-26	WOS:000485058200044
J	Dudziak, K; Bulak, P; Zapalska, M; Borner, A; Szczerba, H; Lesniowska-Nowak, J; Nowak, M				Dudziak, Karolina; Bulak, Piotr; Zapalska, Magdalena; Boerner, Andreas; Szczerba, Hubert; Lesniowska-Nowak, Justyna; Nowak, Michal			Using intervarietal substitution lines for the identification of wheat chromosomes involved in early responses to water-deficit stress	PLOS ONE			English	Article							TRITICUM-AESTIVUM L.; ANTIOXIDANT ENZYME-ACTIVITIES; DROUGHT-STRESS; OXIDATIVE STRESS; LIPID-PEROXIDATION; GENE-EXPRESSION; ASCORBATE PEROXIDASE; HYDROGEN-PEROXIDE; ABIOTIC STRESSES; OSMOTIC-STRESS	Water deficit induces reactive oxygen species (ROS) overproduction, which in turn inhibits plant growth and development. High concentrations of ROS disrupt the osmotic balance in plant cells and alter membrane integrity. Chromosomes carrying structural or regulatory genes must be detected to better understand plant response mechanisms to stress. The aim of our study was to identify Triticum aestivum L. chromosomes involved in early responses to short-term water-deficit stress (1, 3 and 6 h). In the present study, intervarietal substitution lines of drought-tolerant 'Saratovskaya 29' and sensitive 'Janetzkis Probat' wheat cultivars were examined. We studied the biochemical plant response system and conducted an analysis of catalase, ascorbate peroxidase and guaiacol peroxidase activities, levels of lipid peroxidation and changes in relative water content. Our results determined that the first reaction was a significant increase in guaiacol peroxidase (GPX) activity. However, the strongest impact on plant responses was found for catalase (CAT), which caused a significant decrease in lipid peroxidation (LPO) levels. Our findings indicate that chromosomes 5A, 4B, 6B and 7D are associated with early responses to short-term osmotic stress in wheat.	[Dudziak, Karolina; Zapalska, Magdalena; Lesniowska-Nowak, Justyna; Nowak, Michal] Univ Life Sci Lublin, Inst Plant Genet Breeding & Biotechnol, Lublin, Poland; [Dudziak, Karolina] Med Univ Lublin, Chair & Dept Biochem & Mol Biol, Lublin, Poland; [Bulak, Piotr] Polish Acad Sci, Inst Agrophys, Dept Nat Environm Biogeochem, Lublin, Poland; [Boerner, Andreas] Leibniz Inst Plant Genet & Crop Plant Res IPK, Gatersleben, Germany; [Szczerba, Hubert] Univ Life Sci Lublin, Fac Food Sci & Biotechnol, Dept Biotechnol Microbiol & Human Nutr, Lublin, Poland	University of Life Sciences in Lublin; Medical University of Lublin; Polish Academy of Sciences; Bohdan Dobrzanski Institute of Agrophysics of the Polish Academy of Sciences; Leibniz Institut fur Pflanzengenetik und Kulturpflanzenforschung; University of Life Sciences in Lublin	Nowak, M (corresponding author), Univ Life Sci Lublin, Inst Plant Genet Breeding & Biotechnol, Lublin, Poland.	michal.nowak@up.lublin.pl	Bulak, Piotr/J-2187-2019; Sozoniuk, Magdalena/HIK-1262-2022; Nowak, Michal/V-3956-2018	Bulak, Piotr/0000-0002-0611-002X; Sozoniuk, Magdalena/0000-0001-7990-8000; Nowak, Michal/0000-0002-9166-2530; Dudziak, Karolina/0000-0001-9922-6760; Szczerba, Hubert/0000-0001-7429-1777; Lesniowska-Nowak, Justyna/0000-0003-4910-5690				AEBI H, 1984, METHOD ENZYMOL, V105, P121; Ahmad MQ, 2014, INT J AGRIC BIOL, V16, P862; Balakhnina TI, 2015, PLANT GROWTH REGUL, V75, P557, DOI 10.1007/s10725-014-0021-y; Baloglu MC, 2014, GENE, V550, P117, DOI 10.1016/j.gene.2014.08.025; Bandurska H, 1997, ACTA SOC BOT POL, V66, P177, DOI 10.5586/asbp.1997.022; BARRS HD, 1962, AUST J BIOL SCI, V15, P413, DOI 10.1071/BI9620413; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chakraborty Usha, 2012, Braz. J. Plant Physiol., V24, P117, DOI 10.1590/S1677-04202012000200005; Chugh V, 2011, INDIAN J BIOCHEM BIO, V48, P47; Claussen W, 2005, PLANT SCI, V168, P241, DOI 10.1016/j.plantsci.2004.07.039; Csiszar J, 2012, PLANT PHYSIOL BIOCH, V52, P119, DOI 10.1016/j.plaphy.2011.12.006; Dodig D, 2015, J AGR SCI-CAMBRIDGE, V153, P466, DOI 10.1017/S002185961400029X; DUBCOVSKY J, 1995, THEOR APPL GENET, V91, P795, DOI 10.1007/BF00220962; FAO, 2017, FAOSTAT DAT COLL; Fleury D, 2010, J EXP BOT, V61, P3211, DOI 10.1093/jxb/erq152; Gill SS, 2010, PLANT PHYSIOL BIOCH, V48, P909, DOI 10.1016/j.plaphy.2010.08.016; Harb A, 2015, J PLANT INTERACT, V10, P109, DOI 10.1080/17429145.2015.1033023; Harsh A., 2016, Annals of Agricultural Science (Cairo), V61, P57, DOI 10.1016/j.aoas.2016.02.001; Hernandez JA, 2002, PHYSIOL PLANTARUM, V115, P251, DOI 10.1034/j.1399-3054.2002.1150211.x; Hossain A, 2013, INT J PLANT PROD, V7, P615; Jiang YW, 2010, J AM SOC HORTIC SCI, V135, P303, DOI 10.21273/JASHS.135.4.303; Kader DZA, 2011, J TAIBAH UNIV SCI, V5, P14; Kaur P, 2009, AFR J BIOTECHNOL, V8, P619; Kirigwi FM, 2007, MOL BREEDING, V20, P401, DOI 10.1007/s11032-007-9100-3; Kolarovic L, 2009, PLANT GROWTH REGUL, V59, P21, DOI 10.1007/s10725-009-9384-x; LAGUDAH ES, 1991, GENOME, V34, P375, DOI 10.1139/g91-059; Lata C, 2011, PROTOPLASMA, V248, P817, DOI 10.1007/s00709-010-0257-y; Li HY, 2013, EXCLI J, V12, P89; Li XN, 2013, ECOTOX ENVIRON SAFE, V89, P150, DOI 10.1016/j.ecoenv.2012.11.025; Li Z, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00280; Lobell DB, 2011, SCIENCE, V333, P616, DOI [10.1126/science.1204531, 10.1126/science.1206376]; Manavalan LP, 2017, PLANT STRESS PHYSIOLOGY, 2ND EDITION, P1, DOI 10.1079/9781780647296.0001; Marcinska I, 2013, ACTA PHYSIOL PLANT, V35, P451, DOI 10.1007/s11738-012-1088-6; Mathews KL, 2008, THEOR APPL GENET, V117, P1077, DOI 10.1007/s00122-008-0846-8; Mickky B.M., 2017, EJBAS, V4, P47, DOI DOI 10.1016/J.EJBAS.2016.10.001; MITTLER R, 1994, PLANT J, V5, P397, DOI 10.1111/j.1365-313X.1994.00397.x; Mohammadkhani Nayer, 2007, Pak J Biol Sci, V10, P3835, DOI 10.3923/pjbs.2007.3835.3840; Mushtaq S., 2012, ASIAN J PHARM BIOL R, V2, P45; Mwadzingeni L, 2016, J INTEGR AGR, V15, P935, DOI 10.1016/S2095-3119(15)61102-9; Naderi Rana, 2014, Acta Biologica Szegediensis, V58, P95; NAKANO Y, 1981, PLANT CELL PHYSIOL, V22, P867; Nikolaeva MK, 2010, RUSS J PLANT PHYSL+, V57, P87, DOI 10.1134/S1021443710010127; Osipova SV, 2011, ACTA PHYSIOL PLANT, V33, P2169, DOI 10.1007/s11738-011-0756-2; Osipova SV, 2013, ACTA PHYSIOL PLANT, V35, P2455, DOI 10.1007/s11738-013-1280-3; Ozfidan C, 2013, ENVIRON EXP BOT, V86, P44, DOI 10.1016/j.envexpbot.2010.09.008; Pena-Bautista RJ, 2017, CEREAL FOOD WORLD, V62, P231, DOI 10.1094/CFW-62-5-0231; QUARRIE SA, 1994, THEOR APPL GENET, V89, P794, DOI 10.1007/BF00223721; Rampino P, 2006, PLANT CELL ENVIRON, V29, P2143, DOI 10.1111/j.1365-3040.2006.01588.x; Salem KFM, 2007, CEREAL RES COMMUN, V35, P1367, DOI 10.1556/CRC.35.2007.3.1; Sharma P, 2005, PLANT GROWTH REGUL, V46, P209, DOI 10.1007/s10725-005-0002-2; Sheoran S, 2015, APPL BIOCHEM BIOTECH, V177, P1282, DOI 10.1007/s12010-015-1813-x; Shiferaw B, 2013, FOOD SECUR, V5, P291, DOI 10.1007/s12571-013-0263-y; Sofo A, 2015, INT J MOL SCI, V16, P13561, DOI 10.3390/ijms160613561; Strauss J. A., 2000, South African Journal of Plant and Soil, V17, P20; Sultan MARF, 2012, CZECH J GENET PLANT, V48, P178, DOI 10.17221/21/2012-CJGPB; Turkan I, 2005, PLANT SCI, V168, P223, DOI 10.1016/j.plantsci.2004.07.032; UCHIYAMA M, 1978, ANAL BIOCHEM, V86, P271, DOI 10.1016/0003-2697(78)90342-1; Uzilday B, 2012, PLANT SCI, V182, P59, DOI 10.1016/j.plantsci.2011.03.015; Varga B, 2012, ACTA PHYSIOL PLANT, V34, P849, DOI 10.1007/s11738-011-0882-x; Weng MY, 2015, PAK J BOT, V47, P49; Xu LX, 2011, J AM SOC HORTIC SCI, V136, P247, DOI 10.21273/JASHS.136.4.247; Yoon HJ, 2013, NAT NANOTECHNOL, V8; Zalibekov ZG, 2011, ARID ECOSYST, V1, P1, DOI 10.1134/S2079096111010094; Zarei S., 2012, J CELL MOL RES, V4, P43, DOI DOI 10.22067/JCMR.V4I1.18249; ZHANG JX, 1994, PLANT CELL PHYSIOL, V35, P785, DOI 10.1093/oxfordjournals.pcp.a078658	65	0	0	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2019	14	8							e0221849	10.1371/journal.pone.0221849	http://dx.doi.org/10.1371/journal.pone.0221849			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW6AB	31465430	Green Published, Green Submitted, gold			2022-12-26	WOS:000485058200058
J	Munoz-Lozano, C; Martin-Vega, D; Martinez-Carrasco, C; Sanchez-Zapata, JA; Morales-Reyes, Z; Gonzalvez, M; Moleon, M				Munoz-Lozano, Carlos; Martin-Vega, Daniel; Martinez-Carrasco, Carlos; Sanchez-Zapata, Jose A.; Morales-Reyes, Zebensui; Gonzalvez, Moises; Moleon, Marcos			Avoidance of carnivore carcasses by vertebrate scavengers enables colonization by a diverse community of carrion insects	PLOS ONE			English	Article							BEETLES COLEOPTERA DERMESTIDAE; WILDLIFE CARCASSES; NATURAL HABITATS; DECOMPOSITION; SUCCESSION; ASSEMBLAGES; DYNAMICS; DIPTERA; IDENTIFICATION; TRICHINELLA	Carrion resources sustain a complex and diverse community of both vertebrate and invertebrate scavengers, either obligate or facultative. However, although carrion ecology has received increasing scientific attention in recent years, our understanding of carrion partitioning in natural conditions is severely limited as most studies are restricted either to the vertebrate or the insect scavenger communities. Moreover, carnivore carcasses have been traditionally neglected as study model. Here, we provide the first data on the partitioning between vertebrate and invertebrate scavengers of medium-sized carnivore carcasses, red fox (Vulpes vulpes (Linnaeus)), in two mountainous Mediterranean areas of south-eastern Spain. Carcasses were visited by several mammalian and avian scavengers, but only one carcass was partially consumed by golden eagle Aquila chrysaetos (Linnaeus). These results provide additional support to the carnivore carrion-avoidance hypothesis, which suggests that mammalian carnivores avoid the consumption of carnivore carcasses to prevent disease transmission risk. In turn, the absence of vertebrate scavengers at carnivore carcasses enabled a diverse and well-structured successional community of insects to colonise the carcasses. The observed richness and abundance of the most frequent families was more influenced by the decomposition time than by the study area. Overall, our study encourages further research on carrion resource partitioning in natural conditions.	[Munoz-Lozano, Carlos; Martinez-Carrasco, Carlos; Gonzalvez, Moises] Univ Murcia, Dept Anim Hlth, Reg Campus Int Excellence,Campus Mare Nostrum, Murcia, Spain; [Martin-Vega, Daniel] Nat Hist Museum, Dept Life Sci, London, England; [Martin-Vega, Daniel] Univ Alcala De Henares, Dept Life Sci, Madrid, Spain; [Sanchez-Zapata, Jose A.; Morales-Reyes, Zebensui] Univ Miguel Hernandez, Dept Appl Biol, Alicante, Spain; [Moleon, Marcos] CSIC, EBD, Dept Conservat Biol, Donana Biol Stn, Seville, Spain; [Moleon, Marcos] Univ Granada, Dept Zool, Granada, Spain	University of Murcia; Natural History Museum London; Universidad de Alcala; Universidad Miguel Hernandez de Elche; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD); University of Granada	Martin-Vega, D (corresponding author), Nat Hist Museum, Dept Life Sci, London, England.; Martin-Vega, D (corresponding author), Univ Alcala De Henares, Dept Life Sci, Madrid, Spain.	daniel.martinve@uah.es	Martín-Vega, Daniel/A-8365-2017; Juan, Moisés Gonzálvez/ABG-3146-2020; Morales-Reyes, Zebensui/A-4134-2018; REYES, ZEBENSUI MORALES/AAD-6525-2019; Gonzálvez, Moisés/AFU-0670-2022; Martínez-Carrasco Pleite, Carlos/G-5272-2016; Moleon, Marcos/K-2875-2014	Martín-Vega, Daniel/0000-0002-5626-5441; Juan, Moisés Gonzálvez/0000-0003-0423-3189; Morales-Reyes, Zebensui/0000-0002-4529-8651; Gonzálvez, Moisés/0000-0003-0423-3189; Martínez-Carrasco Pleite, Carlos/0000-0002-8742-0109; Moleon, Marcos/0000-0002-3126-619X	Spanish Ministry of Economy, Industry and Competitiveness; EU ERDF [CGL2015-66966-C2-1-2-R, CGL2017-89905-R]; EC [FP7-PEOPLE-2013-IEF-624575]; University of Alcala (Ayudas Postdoctorales UAH); MINECO [RYC-2015-19231];  [FPU12/00823]	Spanish Ministry of Economy, Industry and Competitiveness(Spanish Government); EU ERDF(European Commission); EC(European CommissionEuropean Commission Joint Research Centre); University of Alcala (Ayudas Postdoctorales UAH); MINECO(Spanish Government); 	This study was partly funded by the Spanish Ministry of Economy, Industry and Competitiveness and EU ERDF funds through the projects CGL2015-66966-C2-1-2-R and CGL2017-89905-R. D.M.-V. was supported by an EC funded Marie Curie Intra-European Fellowship (FP7-PEOPLE-2013-IEF-624575) and a research contract from the University of Alcala (Ayudas Postdoctorales UAH), Z.M.-R. by a pre-doctoral grant (FPU12/00823), and M.M. by a research contract Ramon y Cajal from the MINECO (RYC-2015-19231).	Amendt J, 2011, FORENSIC SCI MED PAT, V7, P379, DOI 10.1007/s12024-010-9209-2; Amendt J, 2007, INT J LEGAL MED, V121, P90, DOI 10.1007/s00414-006-0086-x; Arnaldos MI, 2005, FORENSIC SCI INT, V149, P57, DOI 10.1016/j.forsciint.2004.04.087; Arnaldos MI, 2004, INT J LEGAL MED, V118, P197, DOI 10.1007/s00414-004-0446-3; Barton PS, 2013, OECOLOGIA, V171, P761, DOI 10.1007/s00442-012-2460-3; Bates LN, 2016, FORENSIC SCI INT, V261, P93, DOI 10.1016/j.forsciint.2016.02.008; Baz A, 2010, B INSECTOL, V63, P21; Beasley JC, 2012, OIKOS, V121, P1021, DOI 10.1111/j.1600-0706.2012.20353.x; Bonacci T, 2011, ENTOMOL GEN, V33, P63; BRAACK LEO, 1987, OECOLOGIA, V72, P402, DOI 10.1007/BF00377571; Bugelli V, 2018, FOREN SCI RES, V3, P94, DOI 10.1080/20961790.2017.1418622; Burnham K.P, 2002, PRACTICAL INFORM THE; Charabidze D, 2014, INT J LEGAL MED, V128, P1021, DOI 10.1007/s00414-013-0945-1; DeVault TL, 2004, CAN J ZOOL, V82, P502, DOI 10.1139/Z04-022; DeVault TL, 2003, OIKOS, V102, P225, DOI 10.1034/j.1600-0706.2003.12378.x; Diaz-Aranda LM, 2018, INT J LEGAL MED, V132, P1795, DOI 10.1007/s00414-018-1909-2; Diaz-Aranda LM, 2018, J FORENSIC LEG MED, V56, P21, DOI 10.1016/j.jflm.2018.03.005; Farwig N, 2014, OECOLOGIA, V175, P1291, DOI 10.1007/s00442-014-2974-y; Gamble HR, 2000, VET PARASITOL, V93, P393, DOI 10.1016/S0304-4017(00)00354-X; Gavin MC, 2010, CONSERV BIOL, V24, P89, DOI 10.1111/j.1523-1739.2009.01387.x; HANSKI I, 1987, ECOL ENTOMOL, V12, P257, DOI 10.1111/j.1365-2311.1987.tb01004.x; Haskell Neal H., 1990, P82; Henrich M, 2017, J ORNITHOL, V158, P287, DOI 10.1007/s10336-016-1363-1; Hill JE, 2018, ECOL EVOL, V8, P2518, DOI 10.1002/ece3.3840; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; Houston D.C., 1985, Ornithological Monographs, P856; HOUSTON DC, 1986, CONDOR, V88, P318, DOI 10.2307/1368878; HOUSTON DC, 1988, IBIS, V130, P402, DOI 10.1111/j.1474-919X.1988.tb00998.x; Inger R, 2016, ECOL EVOL, V6, P7015, DOI 10.1002/ece3.2414; KAPEL CM, 1994, ACTA VET SCAND, V35, P125; Lin SW, 2013, FORENSIC SCI INT, V232, P46, DOI 10.1016/j.forsciint.2013.06.016; Martin-Piera F, 2000, MUSEO NACL CIENCIAS, V14; Martin-Vega D, 2013, MED VET ENTOMOL, V27, P64, DOI 10.1111/j.1365-2915.2012.01028.x; Martin-Vega D, 2017, FORENSIC SCI INT, V278, P87, DOI 10.1016/j.forsciint.2017.06.036; Martin-Vega D, 2015, ENVIRON ENTOMOL, V44, P966, DOI 10.1093/ee/nvv077; Martin-Vega D, 2012, ANN ENTOMOL SOC AM, V105, P44, DOI 10.1603/AN11062; Martin-Vega D, 2011, J INSECT CONSERV, V15, P747, DOI 10.1007/s10841-011-9429-0; Mateo-Tomas P, 2017, GLOBAL ECOL BIOGEOGR, V26, P1459, DOI 10.1111/geb.12673; Mateo-Tomas P, 2015, DIVERS DISTRIB, V21, P913, DOI 10.1111/ddi.12330; Matuszewski S, 2008, FORENSIC SCI INT, V180, P61, DOI 10.1016/j.forsciint.2008.06.015; Matuszewski S, 2014, INT J LEGAL MED, V128, P1039, DOI 10.1007/s00414-014-0965-5; Matuszewski S, 2010, FORENSIC SCI INT, V194, P85, DOI 10.1016/j.forsciint.2009.10.016; Mei M, 2013, ZOOKEYS, P7, DOI 10.3897/zookeys.310.4914; Michaud JP, 2012, J MED ENTOMOL, V49, P1, DOI 10.1603/ME10229; Moleon M, 2017, J ANIM ECOL, V86, P1179, DOI 10.1111/1365-2656.12714; Moleon M, 2015, BIOSCIENCE, V65, P1003, DOI 10.1093/biosci/biv101; Moleon M, 2015, OIKOS, V124, P1391, DOI 10.1111/oik.02222; Moleon M, 2014, BIOL REV, V89, P1042, DOI 10.1111/brv.12097; Morales-Reyes Z, 2017, ACTA OECOL, V79, P81, DOI 10.1016/j.actao.2016.12.012; Niederegger S, 2017, RECHTSMEDIZIN, V27, P8, DOI 10.1007/s00194-016-0137-7; Ogada DL, 2012, CONSERV BIOL, V26, P453, DOI 10.1111/j.1523-1739.2012.01827.x; Olea P.P., 2019, CARRION ECOLOGY MANA; Olson ZH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147798; Pereira LM, 2014, MAMMAL REV, V44, P44, DOI 10.1111/mam.12005; Perez AE, 2016, ANN ENTOMOL SOC AM, V109, P72, DOI 10.1093/aesa/sav102; Perez-Marcos M, 2016, ANN SOC ENTOMOL FR, V52, P264, DOI 10.1080/00379271.2016.1259014; Prieto Pilona F, 2000, B SEA, V30, P1; Rivas-Martinez S., 1987, MEMORIA MAPA SERIES; Ruzicka RE, 2012, ETHOLOGY, V118, P187, DOI 10.1111/j.1439-0310.2011.01997.x; Sanchez-Zapata JA, 2007, TECHNICAL REPORT; Sanchez-Zapata JA, 2010, BIRD STUDY, V57, P352, DOI 10.1080/00063651003674946; SCHOENLY K, 1987, OECOLOGIA, V73, P192, DOI 10.1007/BF00377507; Schoenly KG, 2007, J MED ENTOMOL, V44, P881, DOI 10.1603/0022-2585(2007)44[881:CPACOF]2.0.CO;2; Sebastian-Gonzalez E, 2016, ECOLOGY, V97, P95, DOI 10.1890/15-0212.1; Sebastian-Gonzalez E, 2013, IBIS, V155, P881, DOI 10.1111/ibi.12079; Selva N, 2005, CAN J ZOOL, V83, P1590, DOI 10.1139/Z05-158; Sugiura S, 2018, ECOGRAPHY, V41, P1173, DOI 10.1111/ecog.03226; Sugiura S, 2013, BIOL CONSERV, V159, P206, DOI 10.1016/j.biocon.2012.11.003; Szpila K, 2014, MED VET ENTOMOL, V28, P133, DOI 10.1111/mve.12021; Tomberlin JK, 2011, TRENDS ECOL EVOL, V26, P53, DOI 10.1016/j.tree.2010.12.001; Tomberlin JK, 2011, WILDLIFE FORENSICS M, P81; Tuccia F, 2019, MICROBIOLOGYOPEN, V8, DOI 10.1002/mbo3.828; Velasquez Y, 2010, MED VET ENTOMOL, V24, P293, DOI 10.1111/j.1365-2915.2010.00879.x; Wallace JR., 2015, CARRION ECOLOGY EVOL; Watson EJ, 2005, J MED ENTOMOL, V42, P193, DOI 10.1603/0022-2585(2005)042[0193:ISADOW]2.0.CO;2; Watson EJ, 2003, J MED ENTOMOL, V40, P338, DOI 10.1603/0022-2585-40.3.338; Whitman Douglas W., 2010, Journal of Orthoptera Research, V19, P377, DOI 10.1665/034.019.0228; Wilson EE, 2011, TRENDS ECOL EVOL, V26, P129, DOI 10.1016/j.tree.2010.12.011; Zuur Alain F., 2009, P1	79	20	24	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2019	14	8							e0221890	10.1371/journal.pone.0221890	http://dx.doi.org/10.1371/journal.pone.0221890			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW6AB	31465519	Green Published, gold, Green Submitted			2022-12-26	WOS:000485058200065
J	Helmer, RA; Kaur, G; Smith, LA; Chilton, BS				Helmer, Rebecca A.; Kaur, Gurvinder; Smith, Lisa A.; Chilton, Beverly S.			Helicase-like transcription factor (Hltf) gene-deletion promotes oxidative phosphorylation (OXPHOS) in colorectal tumors of AOM/DSS-treated mice	PLOS ONE			English	Article							COLON CARCINOGENESIS; MOUSE MODEL; CANCER; DNA; TUMORIGENESIS; METHYLATION; DEFICIENCY; SERUM	The helicase-like transcription factor (HLTF) gene-a tumor suppressor in human colorectal cancer (CRC)-is regulated by alternative splicing and promoter hypermethylation. In this study, we used the AOM/DSS-induced mouse model to show Hltf-deletion caused poor survival concomitant with increased tumor multiplicity, and dramatically shifted the topographic distribution of lesions into the rectum. Differential isoform expression analysis revealed both the truncated isoform that lacks a DNA-repair domain and the full length isoform capable of DNA damage repair are present during adenocarcinoma formation in controls. iPathway-Guide identified 51 dynamically regulated genes of 10,967 total genes with measured expression. Oxidative Phosphorylation (Kegg: 00190), the top biological pathway perturbed by Hltf-deletion, resulted from increased transcription of Atp5e, Cox7c, Uqcr11, Ndufa4 and Ndufb6 genes, concomitant with increased endogenous levels of ATP (p = 0.0062). Upregulation of gene expression, as validated with qRT-PCR, accompanied a stable mtDNA/nDNA ratio. This is the first study to show Hltf-deletion in an inflammation-associated CRC model elevates mitochondrial bioenergetics.	[Helmer, Rebecca A.; Kaur, Gurvinder; Chilton, Beverly S.] Texas Tech Univ, Hlth Sci Ctr, Dept Cell Biol & Biochem, Lubbock, TX 79430 USA; [Smith, Lisa A.] Texas Tech Univ, Hlth Sci Ctr, Dept Pathol, Lubbock, TX 79430 USA	Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center; Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center	Chilton, BS (corresponding author), Texas Tech Univ, Hlth Sci Ctr, Dept Cell Biol & Biochem, Lubbock, TX 79430 USA.	Beverly.chilton@ttuhsc.edu		Chilton, Beverly/0000-0002-8066-8697	CH Foundation	CH Foundation	BSC received funding from The CH Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barresi V, 2018, BCM CANC, V18, P1246; Bowcutt R, 2014, WORLD J GASTROENTERO, V20, P15216, DOI 10.3748/wjg.v20.i41.15216; Cherukuri DP, 2014, MOL ONCOL, V8, P169, DOI 10.1016/j.molonc.2013.10.009; De Robertis Mariangela, 2011, J Carcinog, V10, P9, DOI 10.4103/1477-3163.78279; Doan KN, 2019, CURR GENET; Giroux V, 2008, INT J CANCER, V123, P303, DOI 10.1002/ijc.23532; Habtezion A, 2016, GASTROENTEROLOGY, V150, P340, DOI 10.1053/j.gastro.2015.10.046; Helmer RA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080461; Helmer RA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066799; Herbst A, 2009, EUR J GASTROEN HEPAT, V21, P565, DOI 10.1097/MEG.0b013e328318ecf2; Jackstadt R, 2016, J PATHOL, V238, P141, DOI 10.1002/path.4645; Kaur G, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0200211; King AJF, 2012, BRIT J PHARMACOL, V166, P877, DOI 10.1111/j.1476-5381.2012.01911.x; Leiter EH, 2009, METHODS MOL BIOL, V560, P1, DOI 10.1007/978-1-59745-448-3_1; Letts JA, 2017, NAT STRUCT MOL BIOL, V24, P800, DOI 10.1038/nsmb.3460; Leung WK, 2007, AM J GASTROENTEROL, V102, P1070, DOI 10.1111/j.1572-0241.2007.01108.x; Li PA, 2017, J NEUROSCI RES, V95, P2025, DOI 10.1002/jnr.24042; Liang TJ, 2017, ONCOTARGET, V8, P46468, DOI 10.18632/oncotarget.17576; Liyanage SU, 2017, MITOCHONDRION, V32, P31, DOI 10.1016/j.mito.2016.11.001; Maran RRM, 2009, J PHARMACOL EXP THER, V328, P469, DOI 10.1124/jpet.108.145409; Moinova HR, 2002, P NATL ACAD SCI USA, V99, P4562, DOI 10.1073/pnas.062459899; MOOLENBEEK C, 1981, LAB ANIM, V15, P57, DOI 10.1258/002367781780958577; Neufert C, 2007, NAT PROTOC, V2, P1998, DOI 10.1038/nprot.2007.279; Philipp AB, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-245; Poole LA, 2017, CRIT REV BIOCHEM MOL, V52, P696, DOI 10.1080/10409238.2017.1380597; Quiros Pedro M, 2017, Curr Protoc Mouse Biol, V7, P47, DOI 10.1002/cpmo.21; Rao CV, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00130; Sandhu S, 2012, MOL CANCER, V11, DOI 10.1186/1476-4598-11-18; Shan MR, 2018, PLOS COMPUT BIOL, V14, DOI 10.1371/journal.pcbi.1006584; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Snider AJ, 2016, METHODS MOL BIOL, V1438, P245, DOI 10.1007/978-1-4939-3661-8_14; Stidham RW, 2018, CLIN COLON RECT SURG, V31, P168, DOI 10.1055/s-0037-1602237; Sun XC, 2018, SIGNAL TRANSDUCT TAR, V3, DOI 10.1038/s41392-018-0011-z; Suzuki R, 2006, CARCINOGENESIS, V27, P162, DOI 10.1093/carcin/bgi205; Tanaka T, 2012, INT J INFLAMM, V2012, DOI 10.1155/2012/658786; Thaker AI, 2012, JOVE, V67, P1; Wallner M, 2006, CLIN CANCER RES, V12, P7347, DOI 10.1158/1078-0432.CCR-06-1264; Wei FY, 2015, CELL METAB, V21, P428, DOI 10.1016/j.cmet.2015.01.019; Zarkavelis G, 2017, ANN GASTROENTEROL, V30, P613, DOI 10.20524/aog.2017.0191; Zeineldin M, 2013, BBA-REV CANCER, V1836, P80, DOI 10.1016/j.bbcan.2013.01.001; Zheng J, 2012, ONCOL LETT, V4, P1151, DOI 10.3892/ol.2012.928	41	3	3	3	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2019	14	8							e0221751	10.1371/journal.pone.0221751	http://dx.doi.org/10.1371/journal.pone.0221751			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5XV	31461471	Green Submitted, Green Published, gold			2022-12-26	WOS:000485052300050
J	Zekewos, A; Egeno, T; Loha, E				Zekewos, Alemayehu; Egeno, Tariku; Loha, Eskindir			The magnitude of hypertension and its risk factors in southern Ethiopia: A community based study	PLOS ONE			English	Article							BODY-MASS INDEX; TO-HEIGHT RATIO; BLOOD-PRESSURE; PREVALENCE; OBESITY; PREHYPERTENSION; POPULATIONS; PREVENTION; MANAGEMENT; CHILDREN	Background Prevention and control of hypertension has not been given due attention though previous studies indicated that hypertension is growing public health problem. Objective This study aimed to determine the prevalence of hypertension and associated factors in Bona district, southern Ethiopia. Methods A community based cross-sectional study was conducted on 1952 participants aged >= 25 years in Bona District, southern Ethiopia. Data were collected from consented participants recruited using multistage sampling technique. Data were entered, checked for quality and analyzed by SPSS for Windows version 20.0. Since the outcome variables were ordered categorical, we used multinomial logistic regression model to identify associated factors. Among the independent variables included in the model no multicolinearity was observed. The level of significance was set at P value <= 0.05. Results The observed prevalence of hypertension (21.8%) was remarkable in rural setting. Out of hypertensive participants, 195 (45.9%) were newly diagnosed. About one third of the participants (31.4%) had central obesity measured by waist-to-height ratio >= 0.50. Being male, age advancement, high BMI (>= 25.0 kg/m(2)) and central obesity (waist-to-height ratio >= 0.50) were positively associated with both systolic and diastolic hypertension. Systolic hypertension was negatively associated with high family income. The likely hood of developing diastolic hypertension increased in participants with family history of hypertension. Conclusion The overall prevalence of hypertension, 21.8%, is alarmingly high that it can be said that hypertension is becoming a silent epidemic in Ethiopia. Nationwide survey is needed to get the clear magnitude of hypertension so that early detection and management strategies can be enforced.	[Zekewos, Alemayehu] Hawassa Univ, Coll Med & Hlth Sci, Biochem Unit, Hawassa, Ethiopia; [Egeno, Tariku] Hawassa Univ, Coll Med & Hlth Sci, Dept Internal Med, Hawassa, Ethiopia; [Loha, Eskindir] Hawassa Univ, Coll Med & Hlth Sci, Sch Publ Hlth, Hawassa, Ethiopia	Hawassa University; Hawassa University; Hawassa University	Zekewos, A (corresponding author), Hawassa Univ, Coll Med & Hlth Sci, Biochem Unit, Hawassa, Ethiopia.	alemzeke@yahoo.com	Shumbullo, Eskindir Loha/ABB-6422-2021; loha, eskindir/AAN-4925-2020	Shumbullo, Eskindir Loha/0000-0003-0003-2734; 				Abdissa SG, 2015, ETHIOP J HEALTH DEV, V29, P22; Alwan A, 2011, GLOBAL STATUS REPORT ON NONCOMMUNICABLE DISEASES 2010, P1; Andy JJ, 2012, ETHNIC DIS, V22, P335; Awoke A, 2012, BMC CARDIOVASC DISOR, V12, DOI 10.1186/1471-2261-12-113; Bovet P, 2002, INT J EPIDEMIOL, V31, P240, DOI 10.1093/ije/31.1.240; Browning LM, 2010, NUTR RES REV, V23, P247, DOI 10.1017/S0954422410000144; Cappuccio FP, 2004, HYPERTENSION, V43, P1017, DOI 10.1161/01.HYP.0000126176.03319.d8; Chen TL, 2012, INDIAN PEDIATR, V49, P463, DOI 10.1007/s13312-012-0075-8; Chobanian AV., 2003, HYPERTENSION, V42, P1206, DOI [10.1161/01.HYP.0000107251, DOI 10.1161/01.HYP.9.2_PT_2.II36, DOI 10.1161/01.HYP.0000107251.49515.C2]; Choi JR, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5662-8; Esaiyas A., 2018, J VASC MED SURG, V06, P1, DOI [10.4172/2329-6925.1000354, DOI 10.4172/2329-6925.1000354]; Ezzati M, 2002, LANCET, V360, P1347, DOI 10.1016/S0140-6736(02)11403-6; Giday A, 2010, ETHIOP J HEALTH DEV, V24, P145; Gudina EK, 2013, INTEGR BLOOD PRESS C, V6, P111, DOI 10.2147/IBPC.S47298; Helelo TP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112790; Hendriks ME, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032638; Ibrahim MM, 2012, LANCET, V380, P611, DOI 10.1016/S0140-6736(12)60861-7; Isezuo SA, 2011, J HUM HYPERTENS, V25, P224, DOI 10.1038/jhh.2010.56; Ji H, 2010, HYPERTENSION, V55, P1275, DOI 10.1161/HYPERTENSIONAHA.109.144949; Joshi MD, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1177; Kearney PM, 2004, J HYPERTENS, V22, P11, DOI 10.1097/00004872-200401000-00003; Kearney PM, 2005, LANCET, V365, P217, DOI 10.1016/S0140-6736(05)70151-3; Lau DCW, 2007, CAN MED ASSOC J, V176, pS1, DOI 10.1503/cmaj.061409; Lawoyin T O, 2002, West Afr J Med, V21, P208; Mathers C, 2009, GLOB HLTH RISKS MORT; Nshisso LD, 2012, DIABETES METAB SYND, V6, P36, DOI 10.1016/j.dsx.2012.05.005; Pereira M, 2009, J HYPERTENS, V27, P963, DOI 10.1097/HJH.0b013e3283282f65; Price AJ, 2018, LANCET DIABETES ENDO, V6, P208, DOI 10.1016/S2213-8587(17)30432-1; Sandberg K, 2012, BIOL SEX DIFFER, V3, DOI 10.1186/2042-6410-3-7; Tesfaye F, 2007, J HUM HYPERTENS, V21, P28, DOI 10.1038/sj.jhh.1002104; Tesfaye F, 2009, BMC CARDIOVASC DISOR, V9, DOI 10.1186/1471-2261-9-39; WHO, 2008, RAIS BLOOD PRESS SIT; *WHO AFRO, 2005, CARD DIS AFR REG CUR; World Health Organization (WHO), 2013, WORLD HLTH REPORT 20; Yoo Eun-Gyong, 2016, Korean J Pediatr, V59, P425	35	12	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2019	14	8							e0221726	10.1371/journal.pone.0221726	http://dx.doi.org/10.1371/journal.pone.0221726			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5XV	31461475	Green Submitted, Green Published, gold			2022-12-26	WOS:000485052300048
J	Bert, F; Gualano, MR; Voglino, G; Rossello, P; Perret, JP; Siliquini, R				Bert, Fabrizio; Gualano, Maria Rosaria; Voglino, Gianluca; Rossello, Paola; Perret, Jean Paul; Siliquini, Roberta			Orthorexia Nervosa: A cross-sectional study among athletes competing in endurance sports in Northern Italy	PLOS ONE			English	Article							EATING-DISORDERS; PREVALENCE; SAMPLE; QUESTIONNAIRE; ADAPTATION; STUDENTS; BEHAVIOR	wOrthorexia Nervosa (ON) is an eating disorder marked by an excessive control over the quality of the food eaten. Some groups present a higher prevalence of ON and people practicing sports seems to be a population at risk. The aim of this study is to assess the prevalence of ON in endurance athletes and to compare their prevalence with the ones recorded in the sedentary population and in athletes playing other sports. A cross-sectional survey was carried in Piedmont and Valle d'Aosta, among 549 participants in local sports events aged between 18 and 40 years old. The questionnaire assessed socio-demographic characteristics, physical activity, nutrition and diet, the ORTO-15 questionnaire and Eating Habits Questionnaire (EHQ). The sample was stratified according to the minutes of sport practiced in a week and the type of sport played. Crosstab chi-square analyses to determine group differences on categorical variables (e.g. gender), and ANOVAs or t tests to determine group differences on continuous variables were performed. When required, post hoc analyses were performed. Linear and logistic regressions were performed in order to investigate potential predictors of orthorexia. The EHQ mean scores ware significantly higher in people who practice sports >150 minutes/week. EHQ score resulted to be positively correlated with endurance sport practice >150 minutes/week, with a coefficient of 2.407 (I.C. 95% [0.27; 4.54], p = 0.027). Analyses carried out suggested a correlation between endurance sport practice and ON. Further studies should be performed to identify diagnostic criteria and to compare different questionnaire used to assess them.	[Bert, Fabrizio; Gualano, Maria Rosaria; Voglino, Gianluca; Rossello, Paola; Siliquini, Roberta] Univ Turin, Dept Publ Hlth Sci, Turin, Italy; [Perret, Jean Paul] Univ Turin, Degree Course Dietet, Turin, Italy	University of Turin; University of Turin	Voglino, G (corresponding author), Univ Turin, Dept Publ Hlth Sci, Turin, Italy.	gianluca.voglino@unito.it	Voglino, Gianluca/AAX-6240-2020; Gualano, Maria Rosaria/AAJ-2525-2020	Voglino, Gianluca/0000-0002-5516-3419; Perret, Jean Paul/0000-0003-4840-3186				Alvarenga MS, 2012, EAT WEIGHT DISORD-ST, V17, pE29, DOI 10.1007/BF03325325; Arusoglu G, 2008, TURK PSIKIYATR DERG, V19, P283; Asil E, 2015, ECOL FOOD NUTR, V54, P303, DOI 10.1080/03670244.2014.987920; Bosi ATB, 2007, APPETITE, V49, P661, DOI 10.1016/j.appet.2007.04.007; Bratland-Sanda S, 2013, EUR J SPORT SCI, V13, P499, DOI 10.1080/17461391.2012.740504; Bratman S, 2000, HLTH FOOD JUNKIES; Brytek-Matera A, 2015, J EAT DISORD, V3, DOI [10.1186/s40337-016-0105-3, 10.1186/s40337-015-0038-2]; Brytek-Matera A, 2014, EAT WEIGHT DISORD-ST, V19, P69, DOI 10.1007/s40519-014-0100-0; Bundros J, 2016, APPETITE, V101, P86, DOI 10.1016/j.appet.2016.02.144; Dell'Osso L, 2018, COMPR PSYCHIAT, V81, P66, DOI 10.1016/j.comppsych.2017.11.007; Dell'Osso L, 2016, RIV PSICHIATR, V51, P190, DOI 10.1708/2476.25888; Donini L M, 2005, Eat Weight Disord, V10, pe28; Donini L M, 2004, Eat Weight Disord, V9, P151; Dunn TM, 2016, EAT BEHAV, V21, P11, DOI 10.1016/j.eatbeh.2015.12.006; Eriksson L, 2008, SCAND J MED SCI SPOR, V18, P389, DOI 10.1111/j.1600-0838.2007.00723.x; Gleaves DH., 2013, INT J PSYCHOL ASSESS, V12, P1, DOI DOI 10.1017/CBO9781107415324.004; Gramaglia C, 2017, BMC PSYCHIATRY, V17, DOI 10.1186/s12888-017-1241-2; Gubiec E., 2015, MED OG NAUK ZDR, V21, P95, DOI [10.5604/20834543.1142367, DOI 10.5604/20834543.1142367]; Valera JH, 2014, EAT WEIGHT DISORD-ST, V19, P469, DOI 10.1007/s40519-014-0131-6; Jerez T, 2015, REV CHIL NUTR, V42, P41, DOI 10.4067/S0717-75182015000100005; Joy E, 2016, BRIT J SPORT MED, V50, P154, DOI 10.1136/bjsports-2015-095735; Koven NS, 2015, NEUROPSYCH DIS TREAT, V11, P385, DOI 10.2147/NDT.S61665; Lubich D, 1990, MED DELLO SPORT, V43, P223; Missbach B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135772; Moroze RM, 2015, PSYCHOSOMATICS, V56, P397, DOI 10.1016/j.psym.2014.03.003; Oberle CD, 2018, EAT WEIGHT DISORD-ST, V23, P67, DOI 10.1007/s40519-017-0470-1; Oberle CD, 2017, APPETITE, V108, P303, DOI 10.1016/j.appet.2016.10.021; Pontes J. B., 2014, DEMETRA, V9, P533, DOI [10.12957/demetra.2014.8576, DOI 10.12957/DEMETRA.2014.8576]; Ramacciotti CE, 2011, EAT WEIGHT DISORD-ST, V16, pE127, DOI 10.1007/BF03325318; Segura-Garcia C, 2012, EAT WEIGHT DISORD-ST, V17, pE226, DOI 10.3275/8272; Stochel M, 2015, PSYCHIATR POL, V49, P119, DOI 10.12740/PP/25962; Sundgot-Borgen J, 2004, CLIN J SPORT MED, V14, P25, DOI 10.1097/00042752-200401000-00005; SUNDGOTBORGEN J, 1993, INT J SPORT NUTR, V3, P29, DOI 10.1123/ijsn.3.1.29; Varga M, 2014, BMC PSYCHIATRY, V14, DOI 10.1186/1471-244X-14-59; Varga M, 2013, EAT WEIGHT DISORD-ST, V18, P103, DOI 10.1007/s40519-013-0026-y; von Elm E, 2007, LANCET, V370, P1453, DOI 10.1016/S0140-6736(07)61602-X	36	26	26	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2019	14	8							e0221399	10.1371/journal.pone.0221399	http://dx.doi.org/10.1371/journal.pone.0221399			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5WO	31454390	Green Published, gold			2022-12-26	WOS:000485049000020
J	Cho, YJ; Osgood, RS; Bell, LN; Karoly, ED; Shore, SA				Cho, Youngji; Osgood, Ross S.; Bell, Lauren N.; Karoly, Edward D.; Shore, Stephanie A.			Ozone-induced changes in the serum metabolome: Role of the microbiome	PLOS ONE			English	Article							BILE-ACID METABOLISM; GUT MICROBIOTA; POLYAMINE METABOLISM; AIR-POLLUTION; INHALED OZONE; LUNG-FUNCTION; TIME-SERIES; EXPOSURE; PULMONARY; MORTALITY	Ozone is an asthma trigger. In mice, the gut microbiome contributes to ozone-induced air-way hyperresponsiveness, a defining feature of asthma, but the mechanistic basis for the role of the gut microbiome has not been established. Gut bacteria can affect the function of distal organs by generating metabolites that enter the blood and circulate systemically. We hypothesized that global metabolomic profiling of serum collected from ozone exposed mice could be used to identify metabolites contributing to the role of the microbiome in ozone-induced airway hyperresponsiveness. Mice were treated for two weeks with a cocktail of antibiotics (ampicillin, neomycin, metronidazole, and vancomycin) in the drinking water or with control water and then exposed to air or ozone (2 ppm for 3 hours). Twenty four hours later, blood was harvested and serum analyzed via liquid-chromatography or gas-chromatography coupled to mass spectrometry. Antibiotic treatment significantly affected 228 of the 562 biochemicals identified, including reductions in the known bacterially-derived metabolites, equol, indole propionate, 3-indoxyl sulfate, and 3-(4-hydroxyphenyl) propionate, confirming the efficacy of the antibiotic treatment. Ozone exposure caused significant changes in 334 metabolites. Importantly, ozone-induced changes in many of these metabolites were different in control and antibiotic-treated mice. For example, most medium and long chain fatty acids declined by 20-50% with ozone exposure in antibiotic-treated but not control mice. Most taurine-conjugated bile acids increased with ozone exposure in antibiotic-treated but not control mice. Ozone also caused marked (9-fold and 5-fold) increases in the polyamines, spermine and spermidine, respectively, in control but not antibiotic-treated mice. Each of these metabolites has the capacity to alter airway responsiveness and may account for the role of the microbiome in pulmonary responses to ozone.	[Cho, Youngji; Osgood, Ross S.; Shore, Stephanie A.] Harvard TH Chan Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02115 USA; [Bell, Lauren N.; Karoly, Edward D.] Metabolon Inc, Durham, NC USA	Harvard University; Harvard T.H. Chan School of Public Health; Metabolon	Shore, SA (corresponding author), Harvard TH Chan Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02115 USA.	sshsore@hsph.harvard.edu			US National Institute of Environmental Health and Safety [ES024032, ES000002, ES013307]; US National Heart Lung and Blood Institute [HL007118]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007118] Funding Source: NIH RePORTER	US National Institute of Environmental Health and Safety; US National Heart Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was funded by the US National Institute of Environmental Health and Safety grants: ES024032 (SAS), ES000002 (SAS), and ES013307 (SAS). Ross Osgood was supported by the US National Heart Lung and Blood Institute grant HL007118 (RSO). The funding agencies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. EDK and LNB were employees of Metabolon Inc. at the time of the study. Metabolon did not fund the study but performed the metabolomic analysis described in the manuscript on a fee for service basis. EDK provided advice on study design, data collection, and analysis, and LNB performed some of the analysis of the data. Both assisted in the interpretation of the data. Neither participated in the decision to publish.	Alexeeff SE, 2007, CHEST, V132, P1890, DOI 10.1378/chest.07-1126; Almstrand AC, 2015, ANAL BIOCHEM, V474, P50, DOI 10.1016/j.ab.2014.12.018; Atkinson C, 2005, EXP BIOL MED, V230, P155, DOI 10.1177/153537020523000302; Backhed F, 2004, P NATL ACAD SCI USA, V101, P15718, DOI 10.1073/pnas.0407076101; Backhed F, 2007, P NATL ACAD SCI USA, V104, P979, DOI 10.1073/pnas.0605374104; Barfod Kenneth Klingenberg, 2015, Open Microbiol J, V9, P167, DOI 10.2174/1874285801509010167; Bell ML, 2005, EPIDEMIOLOGY, V16, P436, DOI 10.1097/01.ede.0000165817.40152.85; Bennett WD, 2007, INHAL TOXICOL, V19, P1147, DOI 10.1080/08958370701665475; Birukova A, 2019, TOXICOL SCI; Bulusu S, 2016, ANN CLIN BIOCHEM, V53, P312, DOI 10.1177/0004563215597010; Chang S, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01984; Cho YJ, 2019, AM J RESP CELL MOL, V60, P198, DOI 10.1165/rcmb.2018-0099OC; Cho Y, 2018, AM J RESP CELL MOL, V59, P346, DOI 10.1165/rcmb.2017-0404OC; CLEMONS GK, 1980, J ENVIRON PATHOL TOX, V4, P359; ELSAYED NM, 1987, ARCH BIOCHEM BIOPHYS, V255, P392, DOI 10.1016/0003-9861(87)90407-3; Esther CR, 2015, CHEST, V148, P507, DOI 10.1378/chest.14-1800; Evans M., 2014, METABOLOMICS, V4, P1, DOI DOI 10.4172/2153-0769.1000132; Foster WM, 2000, J APPL PHYSIOL, V89, P1804, DOI 10.1152/jappl.2000.89.5.1804; Gent JF, 2003, JAMA-J AM MED ASSOC, V290, P1859, DOI 10.1001/jama.290.14.1859; Gleason JA, 2015, J ASTHMA, V52, P815, DOI 10.3109/02770903.2015.1033726; Gordon CJ, 2014, INHAL TOXICOL, V26, P380, DOI 10.3109/08958378.2014.905659; Grasemann H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046618; Hashmi H, 2016, AM J RESP CRIT CARE, V193; HATCH GE, 1994, AM J RESP CRIT CARE, V150, P676, DOI 10.1164/ajrccm.150.3.8087337; Holmes E, 2012, CELL METAB, V16, P559, DOI 10.1016/j.cmet.2012.10.007; Ito K, 2005, EPIDEMIOLOGY, V16, P446, DOI 10.1097/01.ede.0000165821.90114.7f; Ji M, 2011, ENVIRON RES LETT, V6, DOI 10.1088/1748-9326/6/2/024006; Jump RLP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101267; Koh A, 2018, CELL, V175, P947, DOI 10.1016/j.cell.2018.09.055; KUROSAWA M, 1992, ALLERGY, V47, P638, DOI 10.1111/j.1398-9995.1992.tb02388.x; Last JA, 2005, TOXICOL APPL PHARM, V208, P117, DOI 10.1016/j.taap.2005.02.001; Liang LR, 2019, LANCET PLANET HEALTH, V3, pE270, DOI 10.1016/S2542-5196(19)30085-3; Lin WQ, 2016, J FOOD SCI, V81, pH3026, DOI 10.1111/1750-3841.13544; Long SL, 2017, MOL ASPECTS MED; Louis P, 2017, ENVIRON MICROBIOL, V19, P29, DOI 10.1111/1462-2920.13589; Manosalva C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119715; Marathe S.A., 2015, J CLIMATOLOGY WEATHE, V03; Mardinoglu A, 2015, MOL SYST BIOL, V11, DOI 10.15252/msb.20156487; Mathews JA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181017; Matsumoto M, 2012, SCI REP-UK, V2, DOI 10.1038/srep00233; Miller DB, 2016, TOXICOL SCI, V150, P312, DOI 10.1093/toxsci/kfv331; Miller DB, 2015, TOXICOL APPL PHARM, V286, P65, DOI 10.1016/j.taap.2015.03.025; Mizuta K, 2015, AM J PHYSIOL-LUNG C, V309, pL970, DOI 10.1152/ajplung.00041.2015; Nicholson JK, 2012, SCIENCE, V336, P1262, DOI 10.1126/science.1223813; North ML, 2013, AM J RESP CELL MOL, V48, P694, DOI 10.1165/rcmb.2012-0323OC; Nukina K, 2001, J NEUROIMMUNOL, V115, P46, DOI 10.1016/S0165-5728(01)00260-0; Pegg AE, 2009, IUBMB LIFE, V61, P880, DOI 10.1002/iub.230; Penney NC, 2015, INT J OBESITY, V39, P1565, DOI 10.1038/ijo.2015.115; Postler TS, 2017, CELL METAB, V26, P110, DOI 10.1016/j.cmet.2017.05.008; Rajagopal S, 2013, AM J PHYSIOL-GASTR L, V304, pG527, DOI 10.1152/ajpgi.00388.2012; Reikvam DH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017996; Rice MB, 2013, AM J RESP CRIT CARE, V188, P1351, DOI 10.1164/rccm.201308-1414OC; Rothhammer V, 2016, NAT MED, V22, P586, DOI 10.1038/nm.4106; Sayin SI, 2013, CELL METAB, V17, P225, DOI 10.1016/j.cmet.2013.01.003; Sharon G, 2019, CELL, V177, P1600, DOI 10.1016/j.cell.2019.05.004; Shin SY, 2014, NAT GENET, V46, P543, DOI 10.1038/ng.2982; Shore SA, 2011, INHAL TOXICOL, V23, P878, DOI 10.3109/08958378.2011.622316; Sipka S, 2014, INT ARCH ALLERGY IMM, V165, P1, DOI 10.1159/000366100; Soga T, 2006, J BIOL CHEM, V281, P16768, DOI 10.1074/jbc.M601876200; Sridharan GV, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6492; Stanek LW, 2011, TOXICOL SCI, V120, pS8, DOI 10.1093/toxsci/kfq367; Sudo N, 2004, J PHYSIOL-LONDON, V558, P263, DOI 10.1113/jphysiol.2004.063388; Sun JC, 2013, J CHROMATOGR B, V932, P134, DOI 10.1016/j.jchromb.2013.05.030; Swann JR, 2011, P NATL ACAD SCI USA, V108, P4523, DOI 10.1073/pnas.1006734107; Tang WHW, 2013, NEW ENGL J MED, V368, P1575, DOI 10.1056/NEJMoa1109400; Tashiro H, 2019, AM J RESP CELL MOL B; Tremaroli V, 2012, NATURE, V489, P242, DOI 10.1038/nature11552; Turner MC, 2016, AM J RESP CRIT CARE, V193, P1134, DOI 10.1164/rccm.201508-1633OC; UMEZU T, 1993, ENVIRON RES, V61, P51, DOI 10.1006/enrs.1993.1049; Velagapudi VR, 2010, J LIPID RES, V51, P1101, DOI 10.1194/jlr.M002774; Virili C, 2017, MOL CELL ENDOCRINOL, V458, P39, DOI 10.1016/j.mce.2017.01.053; Wahlstrom A, 2016, CELL METAB, V24, P41, DOI 10.1016/j.cmet.2016.05.005; Wang YD, 2011, HEPATOLOGY, V54, P1421, DOI 10.1002/hep.24525; Wang ZN, 2011, NATURE, V472, P57, DOI 10.1038/nature09922; Wikoff WR, 2009, P NATL ACAD SCI USA, V106, P3698, DOI 10.1073/pnas.0812874106; Zarrinpar A, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05336-9	76	11	11	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2019	14	8							e0221633	10.1371/journal.pone.0221633	http://dx.doi.org/10.1371/journal.pone.0221633			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5WO	31454377	Green Published, gold, Green Submitted			2022-12-26	WOS:000485049000034
J	Peng, ED; Schmitt, MP				Peng, Eric D.; Schmitt, Michael P.			Identification of zinc and Zur-regulated genes in Corynebacterium diphtheriae	PLOS ONE			English	Article							SYSTEM; SIDEROPHORE; HOST; YERSINIABACTIN; ACQUISITION; METABOLISM; RESISTANCE; TOXICITY; SURFACE; HEMIN	Corynebacterium diphtheriae is a Gram-positive bacterial pathogen and the causative agent of diphtheria, a severe disease of the upper respiratory tract of humans. Factors required for C. diphtheriae to survive in the human host are not well defined, but likely include the acquisition of essential metals such as zinc. In C. diphtheriae, zinc-responsive global gene regulation is controlled by the Zinc Uptake Regulator (Zur), a member of the Fur-family of transcriptional regulators. In this study, we use transcriptomics to identify zinc-regulated genes in C. diphtheriae by comparing gene expression of a wild-type strain grown without and with zinc supplementation. Zur-regulated genes were identified by comparing wild-type gene expression with that of an isogenic zur mutant. We observed zinc repression of several putative surface proteins, the heme efflux system hrtBA, various ABC transporters, and the non-ribosomal peptide synthetase/polyketide synthase cluster sidAB. Furthermore, increased gene expression in response to zinc was observed for the alcohol dehydrogenase, adhA. Zinc and Zur regulation were confirmed for several genes by complementing the zur deletion and subsequent RT-qPCR analysis. We used MEME to predict Zur binding sites within the promoter regions of zinc-and Zur-regulated genes, and verified Zur binding by electrophoretic mobility shift assays. Additionally, we characterized cztA (dip1101), which encodes a putative cobalt/zinc/cadmium efflux family protein. Deletion of cztA results in increased sensitivity to zinc, but not to cobalt or cadmium. This study advances our knowledge of changes to Zur-dependent global gene expression in response to zinc in C. diphtheriae. The identification of zinc-regulated ABC transporters herein will facilitate future studies to characterize zinc transport in C. diphtheriae.	[Peng, Eric D.; Schmitt, Michael P.] US FDA, Lab Resp & Special Pathogens, Div Bacterial Parasit & Allergen Prod, Ctr Biol Evaluat & Res, Silver Spring, MD 20993 USA	US Food & Drug Administration (FDA)	Peng, ED; Schmitt, MP (corresponding author), US FDA, Lab Resp & Special Pathogens, Div Bacterial Parasit & Allergen Prod, Ctr Biol Evaluat & Res, Silver Spring, MD 20993 USA.	eric.peng@fda.hhs.gov; michael.schmitt@fda.hhs.gov			FDA	FDA(United States Department of Health & Human Services)	The project was funded by intramural funding from the FDA to MPS. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreini C, 2006, J PROTEOME RES, V5, P3173, DOI 10.1021/pr0603699; Bailey T L, 1994, Proc Int Conf Intell Syst Mol Biol, V2, P28; Becker KW, 2014, FEMS MICROBIOL REV, V38, P1235, DOI 10.1111/1574-6976.12087; Bibb LA, 2010, J BACTERIOL, V192, P4606, DOI 10.1128/JB.00525-10; Bobrov AG, 2014, MOL MICROBIOL, V93, P759, DOI 10.1111/mmi.12693; Botella H, 2011, CELL HOST MICROBE, V10, P248, DOI 10.1016/j.chom.2011.08.006; Cassat JE, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aan6361; Cerdeno-Tarraga AM, 2003, NUCLEIC ACIDS RES, V31, P6516, DOI 10.1093/nar/gkg874; Dow A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196300; Drazek ES, 2000, MOL MICROBIOL, V36, P68, DOI 10.1046/j.1365-2958.2000.01818.x; Gaspar AH, 2006, J BACTERIOL, V188, P1526, DOI 10.1128/JB.188.4.1526-1533.2006; Grim KP, 2017, MBIO, V8, DOI [10.1128/mbio.01281-17, 10.1128/mBio.01281-17]; Kehl-Fie TE, 2010, CURR OPIN CHEM BIOL, V14, P218, DOI 10.1016/j.cbpa.2009.11.008; Kozlyuk N, 2019, METHODS MOL BIOL, V1929, P275, DOI 10.1007/978-1-4939-9030-6_18; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Kunkle CA, 2003, J BACTERIOL, V185, P6826, DOI 10.1128/JB.185.23.6826-6840.2003; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; McDevitt CA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002357; Mikhaylina A, 2018, BIOCHEM SOC T, V46, P983, DOI 10.1042/BST20170228; Ong CLY, 2015, SCI REP-UK, V5, DOI 10.1038/srep10799; Ong CLY, 2014, J INFECT DIS, V209, P1500, DOI 10.1093/infdis/jiu053; Oram DM, 2006, J BACTERIOL, V188, P2959, DOI 10.1128/JB.188.8.2959-2973.2006; Ott L, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180105; Palmer LD, 2016, ANNU REV GENET, V50, P67, DOI 10.1146/annurev-genet-120215-035146; PAPPENHEIMER AM, 1977, ANNU REV BIOCHEM, V46, P69, DOI 10.1146/annurev.bi.46.070177.000441; Peixoto RS, 2017, MICROBIOL-SGM, V163, P692, DOI 10.1099/mic.0.000467; Peng ED, 2018, J BACTERIOL, V200, DOI 10.1128/JB.00051-18; Popovic T, 1996, J INFECT DIS, V174, P1064, DOI 10.1093/infdis/174.5.1064; Schroder J, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-12; Shafeeq S, 2013, MOL MICROBIOL, V88, P1047, DOI 10.1111/mmi.12256; SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784; Simonyan V, 2016, DATABASE-OXFORD, DOI 10.1093/database/baw022; Smith KF, 2009, J BACTERIOL, V191, P1595, DOI 10.1128/JB.01392-08; STUDIER FW, 1986, J MOL BIOL, V189, P113, DOI 10.1016/0022-2836(86)90385-2; Swaminathan A, 2007, MOL MICROBIOL, V66, P961, DOI 10.1111/j.1365-2958.2007.05968.x; TAI SPS, 1990, MICROB PATHOGENESIS, V9, P267, DOI 10.1016/0882-4010(90)90015-I; Ton-That H, 2003, MOL MICROBIOL, V50, P1429, DOI 10.1046/j.1365-2958.2003.03782.x; Wittchen M, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-018-4481-8; Zackular JP, 2015, J BIOL CHEM, V290, P18991, DOI 10.1074/jbc.R115.645085; Zajdowicz S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034591; Zalewski PD, 2005, PHARMACOL THERAPEUT, V105, P127, DOI 10.1016/j.pharmthera.2004.09.004	41	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2019	14	8							e0221711	10.1371/journal.pone.0221711	http://dx.doi.org/10.1371/journal.pone.0221711			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5WO	31454392	Green Submitted, Green Published, gold			2022-12-26	WOS:000485049000044
J	Khater, IM; Aroca-Ouellette, ST; Meng, FR; Nabi, IR; Hamarneh, G				Khater, Ismail M.; Aroca-Ouellette, Stephane T.; Meng, Fanrui; Nabi, Ivan Robert; Hamarneh, Ghassan			Caveolae and scaffold detection from single molecule localization microscopy data using deep learning	PLOS ONE			English	Article							PLASMA-MEMBRANE; PTRF	Caveolae are plasma membrane invaginations whose formation requires caveolin-1 (Cav1), the adaptor protein polymerase I, and the transcript release factor (PTRF or CAVIN1). Caveolae have an important role in cell functioning, signaling, and disease. In the absence of CAVIN1/PTRF, Cav1 forms non-caveolar membrane domains called scaffolds. In this work, we train machine learning models to automatically distinguish between caveolae and scaffolds from single molecule localization microscopy (SMLM) data. We apply machine learning algorithms to discriminate biological structures from SMLM data. Our work is the first that is leveraging machine learning approaches (including deep learning models) to automatically identifying biological structures from SMLM data. In particular, we develop and compare three binary classification methods to identify whether or not a given 3D cluster of Cav1 proteins is a caveolae. The first uses a random forest classifier applied to 28 hand-crafted/designed features, the second uses a convolutional neural net (CNN) applied to a projection of the point clouds onto three planes, and the third uses a PointNet model, a recent development that can directly take point clouds as its input. We validate our methods on a dataset of super-resolution microscopy images of PC3 prostate cancer cells labeled for Cav1. Specifically, we have images from two cell populations: 10 PC3 and 10 CAVIN1/PTRF-transfected PC3 cells (PC3-PTRF cells) that form caveolae. We obtained a balanced set of 1714 different cellular structures. Our results show that both the random forest on hand-designed features and the deep learning approach achieve high accuracy in distinguishing the intrinsic features of the caveolae and non-caveolae biological structures. More specifically, both random forest and deep CNN classifiers achieve classification accuracy reaching 94% on our test set, while the PointNet model only reached 83% accuracy. We also discuss the pros and cons of the different approaches.	[Khater, Ismail M.; Aroca-Ouellette, Stephane T.; Hamarneh, Ghassan] Simon Fraser Univ, Sch Comp Sci, Med Image Anal Lab, Burnaby, BC V5A 1S6, Canada; [Meng, Fanrui; Nabi, Ivan Robert] Univ British Columbia, Dept Cellular & Physiol Sci, LSI Imaging, Life Sci Inst, Vancouver, BC V6T 1Z3, Canada	Simon Fraser University; University of British Columbia	Khater, IM (corresponding author), Simon Fraser Univ, Sch Comp Sci, Med Image Anal Lab, Burnaby, BC V5A 1S6, Canada.	ikhater@sfu.ca	Hamarneh, Ghassan/AAE-6673-2021; Nabi, Ivan/GWZ-5144-2022	Nabi, Ivan/0000-0002-0670-0513; Khater, Ismail M/0000-0001-7827-7745; Hamarneh, Ghassan/0000-0001-5040-7448; Aroca-Ouellette, Stephane/0000-0001-5880-8430	CIHR [PJT-156424, PJT-159845]; NSERC; Prostate Cancer Canada; CFI/BCKDF; China Scholarship Council	CIHR(Canadian Institutes of Health Research (CIHR)); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Prostate Cancer Canada; CFI/BCKDF; China Scholarship Council(China Scholarship Council)	This work was supported by grants from the CIHR (PJT-156424, PJT-159845), NSERC, Prostate Cancer Canada and CFI/BCKDF (IRN, GH) and a China Scholarship Council doctoral fellowship (FM).	Baddeley D, 2015, NAT METHODS, V12, P1019, DOI 10.1038/nmeth.3641; Boyd N, 2018, 267096 BIORXIV, DOI [10.1101/267096, DOI 10.1101/267096]; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Caetano FA, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004634; Dai A, 2017, PROC CVPR IEEE, P6545, DOI 10.1109/CVPR.2017.693; Dempsey GT, 2011, NAT METHODS, V8, P1027, DOI [10.1038/NMETH.1768, 10.1038/nmeth.1768]; Folling J, 2008, NAT METHODS, V5, P943, DOI 10.1038/nmeth.1257; Gabor KA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117225; Gabor KA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068759; Hill MM, 2008, CELL, V132, P113, DOI 10.1016/j.cell.2007.11.042; Huang B, 2008, SCIENCE, V319, P810, DOI 10.1126/science.1153529; Khater IM, 2019, BIOINFORMATICS; Khater IM, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-46174-z; Khater IM, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-27216-4; Lajoie P, 2007, J CELL BIOL, V179, P341, DOI 10.1083/jcb.200611106; Lajoie P, 2009, J CELL BIOL, V185, P381, DOI 10.1083/jcb.200811059; Levet F, 2015, NAT METHODS, V12, P1065, DOI [10.1038/NMETH.3579, 10.1038/nmeth.3579]; Lillemeier BF, 2010, NAT IMMUNOL, V11, P90, DOI 10.1038/ni.1832; Meng FR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126056; Moon H, 2014, ONCOGENE, V33, P3561, DOI 10.1038/onc.2013.315; Nanni L, 2017, PATTERN RECOGN, V71, P158, DOI 10.1016/j.patcog.2017.05.025; Nassar ZD, 2013, NAT REV UROL, V10, P529, DOI 10.1038/nrurol.2013.168; Nehme E, 2018, OPTICA, V5, P458, DOI 10.1364/OPTICA.5.000458; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Ouyang W, 2018, NAT BIOTECHNOL, V36, P460, DOI 10.1038/nbt.4106; Owen DM, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2273; Owen DM, 2010, J BIOPHOTONICS, V3, P446, DOI 10.1002/jbio.200900089; Pageon SV, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003947; Parton RG, 2013, NAT REV MOL CELL BIO, V14, P98, DOI 10.1038/nrm3512; Ribeiro MT, 2016, KDD'16: PROCEEDINGS OF THE 22ND ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P1135, DOI 10.1145/2939672.2939778; Rossy J, 2013, NAT IMMUNOL, V14, P82, DOI 10.1038/ni.2488; Rubin-Delanchy P, 2015, NAT METHODS, V12, P1072, DOI [10.1038/nmeth.3612, 10.1038/NMETH.3612]; Rusk N, 2016, NAT METHODS, V13, P35, DOI 10.1038/nmeth.3707; Shen DG, 2017, ANNU REV BIOMED ENG, V19, P221, DOI 10.1146/annurev-bioeng-071516-044442; Sherman E, 2016, METHODS APPL FLUORES, V4, DOI 10.1088/2050-6120/4/2/022002; Stone MB, 2017, CHEM REV, V117, P7457, DOI 10.1021/acs.chemrev.6b00716; Su H, 2015, IEEE I CONF COMP VIS, P945, DOI 10.1109/ICCV.2015.114; Tachikawa M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08259-5; van der Maaten L, 2008, J MACH LEARN RES, V9, P2579; Westin CF, 1997, P ISMRM 97	40	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2019	14	8							e0211659	10.1371/journal.pone.0211659	http://dx.doi.org/10.1371/journal.pone.0211659			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5UR	31449531	gold, Green Submitted, Green Published			2022-12-26	WOS:000485044000003
J	Huang, SH; Chuang, YC; Lee, YC; Hung, CC; Sheng, WH; Su, JJ; Sun, HY; Chen, YC; Chang, SC				Huang, Sung-Hsi; Chuang, Yu-Chung; Lee, Yi-Chien; Hung, Chien-Ching; Sheng, Wang-Huei; Su, Jen Jen; Sun, Hsin-Yun; Chen, Yee-Chun; Chang, Shan-Chwen			Lumbar puncture for non-HIV-infected non-transplant patients with cryptococcosis: Should it be mandatory for all?	PLOS ONE			English	Article							NEOFORMANS MENINGITIS; PRACTICE GUIDELINES; CLINICAL-FEATURES; FUNGAL-INFECTIONS; ANTIGEN TITERS; DISEASE; MANAGEMENT; PULMONARY; SOCIETY	Background The indications for lumbar puncture in non-HIV-infected, non-transplant (NHNT) patients with cryptococcosis without meningeal signs need to be more fully defined. Objectives This study was designed to determine the optimal predictors of central nervous system (CNS) involvement in adult NHNT patients with cryptococcosis. Methods The study population consisted of adult NHNT patients with culture-confirmed cryptococcosis who sought care at a university hospital in Taiwan from 2002 to 2016. We used a case control method to identify the clinical characteristics and laboratory findings associated with CNS involvement in patients who underwent a diagnostic lumbar puncture. In the sensitivity analysis, we included additional control patients who did not undergo lumbar puncture, but were followed beyond 12 months without the development of CNS involvement in the absence of exposure to any fungicidal agents. Results We entered 270 NHNT adult patients into the study during the 15-year period. CNS involvement was confirmed in 66 (71.0%) of 93 patients who underwent lumbar puncture. A multi-variable analysis revealed that presence of neurological manifestations and elevated serum CRAG titers were independently associated with a 23.97-fold (95% confidence interval [CI], 4.37-182.23) and 1.53-fold (per 2-fold increment, 95% CI 1.26-1.92) increased odds ratio for CNS involvement, respectively. Headache and focal neurologic signs were independently associated with CNS involvement. A cut-off serum CRAG titer of >= 1:64 provided the highest diagnostic performance by Youden index (sensitivity 83% and specificity 65%). Similar findings were noted in the sensitivity analysis including 198 (73%) patients. Conclusion Lumbar puncture is indicated for NHNT patients with cryptococcosis who have neurologic manifestations or a serum CRAG titer of >= 1:64.	[Huang, Sung-Hsi] Natl Taiwan Univ Hosp, Dept Internal Med, Hsin Chu Branch, Hsinchu, Taiwan; [Huang, Sung-Hsi; Hung, Chien-Ching] Natl Taiwan Univ, Dept Trop Med & Parasitol, Coll Med, Taipei, Taiwan; [Chuang, Yu-Chung; Hung, Chien-Ching; Sheng, Wang-Huei; Sun, Hsin-Yun; Chen, Yee-Chun; Chang, Shan-Chwen] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei, Taiwan; [Lee, Yi-Chien] Fu Jen Catholic Univ Hosp, Dept Internal Med, New Taipei, Taiwan; [Su, Jen Jen] Natl Taiwan Univ Hosp, Dept Neurol, Taipei, Taiwan; [Chen, Yee-Chun] Natl Taiwan Univ, Sch Med, Coll Med, Taipei, Taiwan; [Chang, Shan-Chwen] Natl Taiwan Univ, Grad Inst Clin Pharm, Coll Med, Taipei, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University; National Taiwan University Hospital; Fu Jen Catholic University; Fu Jen Catholic University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University	Chen, YC (corresponding author), Natl Taiwan Univ Hosp, Dept Internal Med, Taipei, Taiwan.; Chen, YC (corresponding author), Natl Taiwan Univ, Sch Med, Coll Med, Taipei, Taiwan.	yeechunchen@gmail.com	Chen, Yee-Chun/AGW-7535-2022; CHUANG, YU-CHUNG/F-4627-2016	Chen, Yee-Chun/0000-0002-1816-9010; CHUANG, YU-CHUNG/0000-0003-3094-8276; Su, Jen-Jen/0000-0001-5132-3334; Huang, Sung-Hsi/0000-0002-1858-6367	Ministry of Health and Welfare, Taiwan [MOHW105-TDU-B-211-133015]	Ministry of Health and Welfare, Taiwan	This study was supported by grants to YCC from the Ministry of Health and Welfare, Taiwan (MOHW105-TDU-B-211-133015). The funding sources had no role in study design and conduct; data collection, analysis, or interpretation; or in the writing of the manuscript or the decision to submit it for publication.	Baddley JW, 2008, EUR J CLIN MICROBIOL, V27, P937, DOI 10.1007/s10096-008-0529-z; Bratton EW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043582; Brizendine KD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060431; Brouwer AE, 2005, J INFECT DIS, V192, P681, DOI 10.1086/432073; Chau TTH, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-199; Chen YC, 2000, DIAGN MICR INFEC DIS, V36, P175, DOI 10.1016/S0732-8893(99)00137-6; CURRIE BP, 1993, J CLIN MICROBIOL, V31, P2519, DOI 10.1128/JCM.31.9.2519-2522.1993; De Pauw B, 2008, CLIN INFECT DIS, V46, P1813, DOI 10.1086/588660; Ecevit IZ, 2006, CLIN INFECT DIS, V42, P1443, DOI 10.1086/503570; Hajian-Tilaki K, 2018, STAT METHODS MED RES, V27, P2374, DOI 10.1177/0962280216680383; Jean SS, 2002, QJM-INT J MED, V95, P511, DOI 10.1093/qjmed/95.8.511; Kung HC, 2018, J MICROBIOL IMMUNOL, V51, P1, DOI 10.1016/j.jmii.2017.07.006; Liao CH, 2012, J MICROBIOL IMMUNOL, V45, P296, DOI 10.1016/j.jmii.2011.12.005; Limper AH, 2011, AM J RESP CRIT CARE, V183, P96, DOI 10.1164/rccm.2008-740ST; Osawa R, 2010, TRANSPLANTATION, V89, P69, DOI 10.1097/TP.0b013e3181bcda41; Pasquier E, 2018, CLIN INFECT DIS, V66, P1122, DOI 10.1093/cid/cix870; Perfect JR, 2010, CLIN INFECT DIS, V50, P291, DOI 10.1086/649858; Rolfes MA, 2014, CLIN INFECT DIS, V59, P1607, DOI 10.1093/cid/ciu596; Rosen LB, 2013, J IMMUNOL, V190, P3959, DOI 10.4049/jimmunol.1202526; Sancesario G, 2011, NEUROL SCI, V32, P519, DOI 10.1007/s10072-011-0496-5; Shih CC, 2000, QJM-MON J ASSOC PHYS, V93, P245, DOI 10.1093/qjmed/93.4.245; Shoham S, 2005, CLIN INFECT DIS, V40, P477, DOI 10.1086/427213; Spec A, 2017, CLIN INFECT DIS, V64, P558, DOI 10.1093/cid/ciw786; Spec A, 2016, OPEN FORUM INFECT DI, V3, DOI 10.1093/ofid/ofv197; Sun HY, 2004, CLIN INFECT DIS, V38, P1790, DOI 10.1086/421272; To KKW, 2006, SCAND J INFECT DIS, V38, P1110, DOI 10.1080/00365540600664118; Tseng HC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057955; Wake RM, 2018, CLIN INFECT DIS, V66, P686, DOI 10.1093/cid/cix872	28	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2019	14	8							e0221657	10.1371/journal.pone.0221657	http://dx.doi.org/10.1371/journal.pone.0221657			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5RZ	31437259	Green Published, Green Submitted, gold			2022-12-26	WOS:000485036900093
J	Nuvunga, JJ; da Silva, CP; de Oliveira, LA; de Lima, RR; Balestre, M				Nuvunga, Joel Jorge; da Silva, Carlos Pereira; de Oliveira, Luciano Antonio; de Lima, Renato Ribeiro; Balestre, Marcio			Bayesian factor analytic model: An approach in multiple environment trials	PLOS ONE			English	Article								One of the main challenges in plant breeding programs is the efficient quantification of the genotype-by-environment interaction (GEI). The presence of significant GEI may create difficulties for breeders in the selection and recommendation of superior genotypes for a wide environmental network. Among the diverse statistical procedures developed for this purpose, we highlight those based on mixed models and factor analysis that are called factor analytic (FA) models. However, some inferential issues are related to the factor analytic model, such as Heywood cases that make the model non-identifiable. Moreover, the representation of the loads and factors in the conventional biplot does not involve any measurement of uncertainty. In this work, we propose dealing with the FA model using the Bayesian framework with direct sampling of factor loadings via spectral decomposition; this guarantees identifiability in the estimation process and eliminates the need for the rotationality of factor loadings or imposition of any ad hoc constraints. We used simulated and real data to illustrate the method's application in multi-environment trials (MET) and to compare it with traditional FA mixed models on controlled unbalancing. In general, the Bayesian FA model was robust under different simulated unbalanced levels, presenting the superior predictive ability of missing data when compared to competing models, such as those based on FA mixed models. In addition, for some scenarios, the classical FA mixed model failed in estimating the full FA model, illustrating the parametric problems of convergence in these models. Our results suggest that Bayesian factorial models might be successfully used in plant breeding for MET analysis.	[Nuvunga, Joel Jorge; da Silva, Carlos Pereira; de Oliveira, Luciano Antonio; de Lima, Renato Ribeiro; Balestre, Marcio] Univ Fed Lavras, Dept Stat DES, Lavras, MG, Brazil; [Nuvunga, Joel Jorge] Eduardo Mondlane Univ, Chibuto Coll Business & Entrepreneurship, Chibuto, Maputo, Mozambique; [de Oliveira, Luciano Antonio] Fed Univ Grande Dourados, Fac Exact Sci & Technol FACET, Grande Dourados, MS, Brazil	Universidade Federal de Lavras; Eduardo Mondlane University; Universidade Federal da Grande Dourados	Balestre, M (corresponding author), Univ Fed Lavras, Dept Stat DES, Lavras, MG, Brazil.	marciobalestre@dex.ufla.br	de Lima, Renato Ribeiro/AAL-5027-2020	de Lima, Renato Ribeiro/0000-0003-4607-4964	Escola Superior de Negocios e Emprededoriso de Chibuto, Chibuto; Universidade Eduardo Mondlane; Fundacao Calouste Gulbenkian; Fundo Nacional de Investigacao de Mocambique; CAPES (Coordenacao de Aperfeicoamento de Pessoal de Ensino Superior); CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico) [302674/2015-2]	Escola Superior de Negocios e Emprededoriso de Chibuto, Chibuto; Universidade Eduardo Mondlane; Fundacao Calouste Gulbenkian(European Commission); Fundo Nacional de Investigacao de Mocambique; CAPES (Coordenacao de Aperfeicoamento de Pessoal de Ensino Superior)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by Fundacao Calouste Gulbenkian, Fundo Nacional de Investigacao de Mocambique, Escola Superior de Negocios e Emprededoriso de Chibuto, Chibuto, Universidade Eduardo Mondlane, CAPES (Coordenacao de Aperfeicoamento de Pessoal de Ensino Superior) and CNPq (Conselho Nacional de Desenvolvimento Cientffico e Tecnologico Grant #302674/2015-2).; The authors would like to thank the Fundacao Calouste Gulbenkian, Fundo Nacional de Investigacao de Mocambique, Escola Superior de Negocios e Emprededoriso de Chibuto, Chibuto, Universidade Eduardo Mondlane, CAPES (Coordenacao de Aperfeicoamento de Pessoal de Ensino Superior) and CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico-Grant #302674/2015-2) for supporting this research.	Akaike H., 1973, INT S INF THEOR; Burgueno J, 2012, CROP SCI; Burgueno J, 2007, CROP SCI; Burgueno J, 2008, CROP SCI, V48, P1291, DOI 10.2135/cropsci2007.11.0632; Butler DG, 2009, QUEENSL DEP PRIM IND; Cornelius PL, 1997, J STAT COMPUT SIMUL; Melo WMC, 2014, SCI WORLD J, DOI 10.1155/2014/924348; Crossa, 2016, CROP SCI, DOI [10.2135/cropsci2015.07.0410, DOI 10.2135/CROPSCI2015.07.0410]; Crossa J, 2006, CROP SCI; Crossa J, 2011, CROP SCI; Crossa J., 1990, ADV AGRON; Crossa J., 2012, CURR GENOMICS; da Silva CP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131414; de los Campos G, 2007, GENET SEL EVOL; de Oliveira LA, 2016, GENET MOL RES, V15, DOI 10.4238/gmr.15028612; De Oliveira LA, 2015, CROP SCI; Edwards JW, 2006, CROP SCI; GABRIEL K.R., 2002, J SOC FRANCAISE STAT, V143, P5; Gelman A., 2006, BAYESIAN ANAL; Geweke J, 1996, REV FINANCIAL STUDIE; Green PJ, 1995, BIOMETRIKA; Heidelberger P, 1983, OPER RES; Hill WG, 1984, ANIM PROD; Hobert JP, 1996, J AM STAT ASS; Hogan JW, 2004, J AM STAT ASS; Huang E, 2003, LANCE; Kelly AM, 2007, CROP SCI; Krivitsky, 2007, BAYESIAN STAT; Lado B, 2016, CROP SCI, V56, P2165, DOI 10.2135/cropsci2015.04.0207; Liu G., 2001, BAYESIAN COMPUTATION; Mardia K., 1979, MULTIVARIATE ANAL, V15, P518; Meyer K, 2008, GENETICS; Meyer K, 2009, GENET SEL EVOL, V41, DOI 10.1186/1297-9686-41-21; Nuvunga JJ, 2015, GENET MOL RES; Ooms JCL, 2009, HIGHEST POSTERIOR DE; Perez-Elizalde S, 2012, J AGR BIOL ENV STAT; Piepho HP, 1998, THEOR APPL GENET; Piepho HP, 1997, BIOMETRICS; Raftery A. E., 1992, BAYESIAN STAT; Ronnegard L, 2010, GENET SEL EVOL, V42, DOI 10.1186/1297-9686-42-8; Runcie DE, 2013, GENETICS; Smith A, 2001, BIOMETRICS; SMITH AB, 2005, J AGR SCI; Smith AB, 2015, THEOR APPL GENET; Smith AB, 2002, QUANT GENET GENOMICS; Stefanova KT, 2010, CROP SCI; Team RC, 2016, R LANG ENV STAT COMP; Ter Braak CJF, 2005, GENETICS; Thompson R, 2003, NZ J STAT; Tyriseva A-M, 2011, GENET SEL EVOL; Viele K, 2000, J STAT PLAN INFER, V84, P201, DOI 10.1016/S0378-3758(99)00151-2; Wang SG, 2002, SCI CHINA SER A, V45, P1301; Wang YB, 2019, J COMPUT GRAPH STAT, V28, P334, DOI 10.1080/10618600.2018.1529600; Wolpert DH, 1997, IEEE T EVOL COMPUT, DOI 10.1109/4235.585893; Xue J., 2017, AVERAGE E BIC LIKE C; Yan W, 2000, CROP SCI; Yan W, 2010, CROP SCI; Yang RC, 2009, CROP SCI	58	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2019	14	8							e0220290	10.1371/journal.pone.0220290	http://dx.doi.org/10.1371/journal.pone.0220290			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5RZ	31437167	Green Submitted, gold, Green Published			2022-12-26	WOS:000485036900011
J	Silva, AL; Alves, FS; Kerr, MWA; Xabregas, LA; Gama, FM; Rodrigues, MGA; Torres, AS; Tarrago, AM; Sampaio, VS; Carvalho, MPSS; Fraiji, NA; Malheiro, A; Costa, AG				Silva-Junior, Alexander Leonardo; Alves, Fabiola Silva; Athaydes Kerr, Marlon Wendell; Xabregas, Lilyane Amorim; Gama, Fabio Magalhaes; Almeida Rodrigues, Maria Gabriela; Torres, Alexandre Santos; Tarrago, Andrea Monteiro; Sampaio, Vanderson Souza; Socorro Sampaio Carvalho, Maria Perpetuo; Fraiji, Nelson Abrahim; Malheiro, Adriana; Costa, Allyson Guimaraes			Acute lymphoid and myeloid leukemia in a Brazilian Amazon population: Epidemiology and predictors of comorbidity and deaths	PLOS ONE			English	Article							COMPARATIVE RISK-ASSESSMENT; CHILDHOOD LEUKEMIA; MORTALITY TRENDS; YOUNG-ADULTS; CHILDREN; CANCER; WORLD; ADOLESCENTS; COUNTRIES; SURVIVAL	Introduction Leukemia is the most common cancer in children and has the highest rates of incidence in industrialized countries, followed by developing countries. This epidemiologic profile can mainly be attributed to the availability of diagnostic resources. In Brazil, leukemia diagnosis is a challenge due to financial viability, lack of hemovigilance services in isolated regions and the vast size of the territory. Its incidence in the state of Amazonas has been increasing since 2010. Therefore, this study aims to describe the epidemiological pattern and spatial distribution of patients with acute lymphoid leukemia and acute myeloid leukemia in Amazonas and identify the predictors of comorbidity and death. Materials and methods A retrospective cross-sectional study was carried out based on patients' data which was obtained from the database of a referral center for the period of 2005 to 2015. Variables included age, gender, ethnicity, civil status, schooling, income, location of residence, subtype of leukemia, comorbidities, and date of death. The spatial distribution was performed using QGIS v.2.18. Stata software was used for univariable and multivariable logistic regression to evaluate the association between both comorbidities and death for all characteristic groups of ALL and AML. Results The group that was studied was composed of 577 ALL and 266 AML patients. For both, most patients were male, with a schooling period of 1-4 years, received<1 minimum wage, and lived mostly in Manaus, followed by the municipality of Tefe. There was no association between the development of comorbidities and analyzed variables in patients with ALL. AML patients that were >60 years old and with family history of the disease had the highest risk of developing comorbidities (OR = 5.06, p = 0.038; OR = 2.44, p = 0.041, respectively). Furthermore, patients with ALL and in the 41-50-year age group had a higher risk of death (OR = 31.12; p = 0.001). No association between death and explanatory variables were found in patients with AML. In addition, significant difference was observed in time to death (chi2 = 4,098.32, p = 0.000), with 50% of patients with AML dying within two years after diagnosis, whereas in ALL, this percentual of death only is reached in approximately 5 years. Conclusion Our study describes the data of patients with acute leukemia in Amazonas, a remote region in the north of Brazil. In addition, it highlights the importance of hemovigilance in an Amazon region state, while focusing on peripheral areas which don't have prevention, diagnosis and treatment tools for this disease.	[Silva-Junior, Alexander Leonardo; Alves, Fabiola Silva; Athaydes Kerr, Marlon Wendell; Xabregas, Lilyane Amorim; Gama, Fabio Magalhaes; Torres, Alexandre Santos; Tarrago, Andrea Monteiro; Socorro Sampaio Carvalho, Maria Perpetuo; Fraiji, Nelson Abrahim; Malheiro, Adriana; Costa, Allyson Guimaraes] Fundacao Hosp Hematol & Hemoterapia Amazonas HEMO, Diretoria Ensino & Pesquisa, Manaus, AM, Brazil; [Silva-Junior, Alexander Leonardo; Alves, Fabiola Silva; Athaydes Kerr, Marlon Wendell; Xabregas, Lilyane Amorim; Tarrago, Andrea Monteiro; Socorro Sampaio Carvalho, Maria Perpetuo; Fraiji, Nelson Abrahim; Malheiro, Adriana; Costa, Allyson Guimaraes] Univ Estado Amazonas, Programa Posgrad Ciencias Aplicadas & Hematol, Manaus, AM, Brazil; [Gama, Fabio Magalhaes; Tarrago, Andrea Monteiro; Malheiro, Adriana; Costa, Allyson Guimaraes] Univ Fed Amazonas UFAM, Inst Ciencias Biol, Programa Posgrad Imunol Basica & Aplicada, Manaus, AM, Brazil; [Almeida Rodrigues, Maria Gabriela; Sampaio, Vanderson Souza; Costa, Allyson Guimaraes] Univ Estado Amazonas, Programa Posgrad Med Trop, Manaus, AM, Brazil; [Almeida Rodrigues, Maria Gabriela; Sampaio, Vanderson Souza; Costa, Allyson Guimaraes] Fundacao Med Trop Dr Heitor Vieira Dourado FMT HV, Inst Pesquisa Clin Carlos Borborema, Manaus, Amazonas, Brazil; [Sampaio, Vanderson Souza] Fundacao Vigilancia Saude Amazonas, Manaus, Amazonas, Brazil	Universidade do Estado do Amazonas; Universidade Federal de Amazonas; Universidade do Estado do Amazonas	Costa, AG (corresponding author), Fundacao Hosp Hematol & Hemoterapia Amazonas HEMO, Diretoria Ensino & Pesquisa, Manaus, AM, Brazil.; Costa, AG (corresponding author), Univ Estado Amazonas, Programa Posgrad Ciencias Aplicadas & Hematol, Manaus, AM, Brazil.; Costa, AG (corresponding author), Univ Fed Amazonas UFAM, Inst Ciencias Biol, Programa Posgrad Imunol Basica & Aplicada, Manaus, AM, Brazil.; Costa, AG (corresponding author), Univ Estado Amazonas, Programa Posgrad Med Trop, Manaus, AM, Brazil.; Costa, AG (corresponding author), Fundacao Med Trop Dr Heitor Vieira Dourado FMT HV, Inst Pesquisa Clin Carlos Borborema, Manaus, Amazonas, Brazil.	allyson.gui.costa@gmail.com	Hanna, Fabíola Silva Alves/AAB-9819-2022; Magalhães-Gama, Fábio/AAC-7835-2022; Tarrago, Andrea/AAJ-3758-2021; Sampaio, Vanderson/AAQ-1418-2020; Silva-Junior, Alexander Leonardo/AAB-9945-2022; Sampaio, Vanderson/M-4337-2015; Costa, Allyson Guimarães/AAD-3923-2021	Hanna, Fabíola Silva Alves/0000-0002-1582-2969; Magalhães-Gama, Fábio/0000-0003-1373-0953; Tarrago, Andrea/0000-0003-3125-580X; Sampaio, Vanderson/0000-0001-7307-8851; Silva-Junior, Alexander Leonardo/0000-0002-5645-252X; Sampaio, Vanderson/0000-0001-7307-8851; Costa, Allyson Guimarães/0000-0002-7312-6822; Malheiro, Adriana/0000-0002-1107-8079	Fundacao de Amparo a Pesquisa do Estado do Amazonas (FAPEAM); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); FAPEAM; CAPES (PNPD/CAPES program)	Fundacao de Amparo a Pesquisa do Estado do Amazonas (FAPEAM)(Fundacao de Amparo a Pesquisa do Estado do Amazonas (FAPEAM)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); FAPEAM; CAPES (PNPD/CAPES program)	Financial support was provided by grants from Fundacao de Amparo a Pesquisa do Estado do Amazonas (FAPEAM), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES). MWAK, FSA and LAX have fellowship from FAPEAM (Master student). AGC fellowship from CAPES (PNPD/CAPES program). AM is level 2 research fellow from CNPq. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abboud MR, 2014, CURR OPIN ONCOL, V26, P650, DOI 10.1097/CCO.0000000000000125; [Anonymous], 2017, EST 2018 INC CANC BR, V1, P128; Arber DA, 2016, BLOOD, V127, P2391, DOI 10.1182/blood-2016-03-643544; Azevedo-Silva F, 2009, CANCER EPIDEMIOL, V33, P403, DOI 10.1016/j.canep.2009.09.004; Bain BJ, 2013, BRENNERS ENCY GENETI, DOI [10.1016/B978-0-12-374984-0.00515-5, DOI 10.1016/B978-0-12-374984-0.00515-5]; Balmant NV, 2017, J ADOLESC YOUNG ADUL, V6, P341, DOI 10.1089/jayao.2016.0042; Barbosa SF da C, 2015, REV PAN-AMAZ SAUDE, V6, P43, DOI [10.5123/S2176-62232015000300006, DOI 10.5123/S2176-62232015000300006]; Belson M, 2007, ENVIRON HEALTH PERSP, V115, P138, DOI 10.1289/ehp.9023; Bhatia S, 2002, BLOOD, V100, P1957, DOI 10.1182/blood-2002-02-0395; BLOOMFIELD CD, 1986, BLOOD, V67, P415; Curado MP, 2011, REV PANAM SALUD PUBL, V29, P96, DOI 10.1590/S1020-49892011000200004; Danaei G, 2005, LANCET, V366, P1784, DOI 10.1016/S0140-6736(05)67725-2; daSilva FF, 2017, REV BRAS PESQUI SAUD, V19, P43; de Camargo B, 2010, INT J CANCER, V126, P715, DOI 10.1002/ijc.24799; De Kouchkovsky I, 2016, BLOOD CANCER J, V6, DOI 10.1038/bcj.2016.50; Deschler B, 2006, CANCER-AM CANCER SOC, V107, P2099, DOI 10.1002/cncr.22233; Dores GM, 2012, BLOOD, V119, P34, DOI 10.1182/blood-2011-04-347872; FACINA T., 2014, REV BRAS CANCEROL, V60, P63, DOI DOI 10.32635/2176-9745.RBC.2014V60N1.964; Ferman S, 2013, CLINICS, V68, P219, DOI [10.6061/CLINICS/2013(02)OA16, 10.6061/clinics/2013(02)OA16]; Forouzanfar MH, 2016, LANCET, V388, P1659, DOI 10.1016/S0140-6736(16)31679-8; Gabe Cristina, 2009, Rev. Bras. Hematol. Hemoter., V31, P74; Greaves M, 2006, NAT REV CANCER, V6, P193, DOI 10.1038/nrc1816; Grimwade LF, 2017, METHODS, V112, P39, DOI 10.1016/j.ymeth.2016.06.023; Hoffbrand AV, 2013, FUNDAMENTOS HEMATOLO; IBGE, 2018, BRAS SINT AM MAN PAN; B. Junior Lacy C., 2015, J. Bras. Patol. Med. Lab., V51, P72, DOI 10.5935/1676-2444.20150013; Malta DC, 2014, EPIDEMIOL SERV SAUDE, V23, P599, DOI [10.5123/S1679-49742014000400002, 10.5123/S1679-49742014000400017, 10.5123/S1679-49742014000300002]; Mejia-Arangure JM, 2016, B MED HOSP INFANT M, V73, P55, DOI [10.1016/j.bmhimx.2015.12.005, 10.1016/S2444-3409(16)30019-X]; Miranda-Filho Adalberto, 2018, Lancet Haematol, V5, pe14, DOI 10.1016/S2352-3026(17)30232-6; Parkin DM, 2001, INT J CANCER, V94, P153, DOI 10.1002/ijc.1440; de Oliveira MSP, 2009, BLOOD CELL MOL DIS, V42, P121, DOI 10.1016/j.bcmd.2008.10.012; Pombo-de-Oliveira Maria S., 2005, Rev. Bras. Hematol. Hemoter., V27, P21, DOI 10.1590/S1516-84842005000100007; Reis RD, 2016, PEDIATR HEMAT ONCOL, V33, P83, DOI 10.3109/08880018.2015.1130763; Reis RD, 2011, PEDIATR BLOOD CANCER, V56, P58, DOI 10.1002/pbc.22736; Ribeiro KB, 2007, CANCER-AM CANCER SOC, V110, P1823, DOI 10.1002/cncr.22982; Ribeiro KB, 2008, INT J CANCER, V123, P1907, DOI 10.1002/ijc.23738; Santana LR, 2007, GAZ MED BAHIA, V77, P51; SASAKI K, 2016, BLOOD, V128; Scarfo L, 2016, CRIT REV ONCOL HEMAT, V104, P169, DOI 10.1016/j.critrevonc.2016.06.003; Shysh AC, 2017, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-017-4644-6; Silva DB, 2000, ARQ CATARINENSES MED, V29, P1; Terwilliger T, 2017, BLOOD CANCER J, V7, DOI 10.1038/bcj.2017.53; Vieira A.F., 2017, REV UNILUS ENS PESQ, V14, P130; Whitehead TP, 2016, CURR PROB PEDIATR AD, V46, P317, DOI 10.1016/j.cppeds.2016.08.004; WHO, 2012, IARC CANC BAS NO 11	45	9	9	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2019	14	8							e0221518	10.1371/journal.pone.0221518	http://dx.doi.org/10.1371/journal.pone.0221518			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5RZ	31437246	Green Published, gold, Green Submitted			2022-12-26	WOS:000485036900085
J	Hossain, MM; Tsuzuki, T; Sakakibara, K; Imaizumi, F; Ikegaya, A; Inagaki, M; Takahashi, I; Ito, T; Takamatsu, H; Kumanogoh, A; Negishi, T; Yukawa, K				Hossain, Md. Mosharaf; Tsuzuki, Takamasa; Sakakibara, Kazuki; Imaizumi, Fumitaka; Ikegaya, Akihiro; Inagaki, Mami; Takahashi, Ikuko; Ito, Takuji; Takamatsu, Hyota; Kumanogoh, Atsushi; Negishi, Takayuki; Yukawa, Kazunori			PlexinA1 is crucial for the midline crossing of callosal axons during corpus callosum development in BALB/cAJ mice	PLOS ONE			English	Article							PIONEERING AXONS; NORMAL MOUSE; GUIDANCE; SEMAPHORIN; RECEPTOR; MECHANISMS; FOREBRAIN; NEUROPILIN; PATHWAYS; AGENESIS	The corpus callosum (CC) is the biggest commissure that links cerebral hemispheres. Guidepost structures develop in the cortical midline during CC development and express axon guidance molecules that instruct neurons regarding the proper direction of axonal elongation toward and across the cortical midline. Neuropilin-1 (Npn1), a high affinity receptor for class 3 semaphorins (Sema3s) localized on cingulate pioneering axons, plays a crucial role in axon guidance to the midline through interactions with Sema3s. However, it remains unclear which type of Plexin is a component of Sema3 holoreceptors with Npn1 during the guidance of cingulate pioneering axons. To address the role of PlexinA1 in CC development, we examined with immunohistochemistry the localization of PlexinA1, Npn1, and Sema3s using embryonic brains from wild-type (WT) and PlexinA1-deficient (PlexinA1 knock-out (KO)) mice with a BALB/cAJ background. The immunohistochemistry confirmed the expression of PlexinA1 in callosal axons derived from the cingulate and neocortex of the WT mice on embryonic day 17.5 (E17.5) but not in the PlexinA1 KO mice. To examine the role of PlexinA1 in the navigation of callosal axons, the extension of callosal axons toward and across the midline was traced in brains of WT and PlexinA1 KO mice at E17.5. As a result, callosal axons in the PlexinA1 KO brains had a significantly lower incidence of midline crossing at E17.5 compared with the WT brains. To further examine the role of PlexinA1 in CC development, the CC phenotype was examined in PlexinA1 KO mice at postnatal day 0.5 (P0.5). Most of the PlexinA1 KO mice at P0.5 showed agenesis of the CC. These results indicate the crucial involvement of PlexinA1 in the midline crossing of callosal axons during CC development in BALB/cAJ mice.	[Hossain, Md. Mosharaf; Tsuzuki, Takamasa; Sakakibara, Kazuki; Imaizumi, Fumitaka; Ikegaya, Akihiro; Inagaki, Mami; Ito, Takuji; Negishi, Takayuki; Yukawa, Kazunori] Meijo Univ, Fac Pharm, Dept Physiol, Nagoya, Aichi, Japan; [Takahashi, Ikuko] Meijo Univ, Fac Pharm, Radioisotope Ctr, Nagoya, Aichi, Japan; [Takamatsu, Hyota; Kumanogoh, Atsushi] Osaka Univ, Immunol Frontier Res Ctr, Dept Immunopathol, Suita, Osaka, Japan; [Ito, Takuji] Aichi Med Univ, Dept Neurol, Sch Med, Nagakute, Aichi, Japan	Meijo University; Meijo University; Osaka University; Aichi Medical University	Yukawa, K (corresponding author), Meijo Univ, Fac Pharm, Dept Physiol, Nagoya, Aichi, Japan.	kyukawa@meijo-u.ac.jp	Hossain, Mosharaf/AAP-9079-2020	Hossain, Mosharaf/0000-0002-1554-3476; Ito, Takuji/0000-0002-5078-0119	Japanese Ministry of Education, Culture, Sports, Science, and Technology (KAKENHI) [16K08478]	Japanese Ministry of Education, Culture, Sports, Science, and Technology (KAKENHI)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	KY was supported by #16K08478 of the Japanese Ministry of Education, Culture, Sports, Science, and Technology (KAKENHI) (http://www.jsps.go.jp/j-grantsinaid/index.html).The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABOITIZ F, 1992, BRAIN RES, V598, P143, DOI 10.1016/0006-8993(92)90178-C; Andrews W, 2006, DEVELOPMENT, V133, P2243, DOI 10.1242/dev.02379; Bagnard D, 2000, J NEUROSCI, V20, P1030, DOI 10.1523/JNEUROSCI.20-03-01030.2000; Bagnard D, 1998, DEVELOPMENT, V125, P5043; Bagri A, 2002, NEURON, V33, P233, DOI 10.1016/S0896-6273(02)00561-5; Castellani V, 2000, NEURON, V27, P237, DOI 10.1016/S0896-6273(00)00033-7; Chedotal A, 2011, CURR OPIN NEUROBIOL, V21, P68, DOI 10.1016/j.conb.2010.07.008; Chen H, 1997, NEURON, V19, P547, DOI 10.1016/S0896-6273(00)80371-2; Dickson BJ, 2002, SCIENCE, V298, P1959, DOI 10.1126/science.1072165; Donahoo ALS, 2009, SEMIN PEDIATR NEUROL, V16, P127, DOI 10.1016/j.spen.2009.07.003; EGAAS B, 1995, ARCH NEUROL-CHICAGO, V52, P794, DOI 10.1001/archneur.1995.00540320070014; Fazeli A, 1997, NATURE, V386, P796, DOI 10.1038/386796a0; Fenlon LR, 2015, TRENDS NEUROSCI, V38, P264, DOI 10.1016/j.tins.2015.02.007; Fothergill T, 2014, CEREB CORTEX, V24, P1138, DOI 10.1093/cercor/bhs395; Gu CH, 2003, DEV CELL, V5, P45, DOI 10.1016/S1534-5807(03)00169-2; Guo HL, 2000, BIOCHEM BIOPH RES CO, V276, P649, DOI 10.1006/bbrc.2000.3533; He ZG, 1997, CELL, V90, P739, DOI 10.1016/S0092-8674(00)80534-6; Hu ZL, 2003, J NEUROSCI, V23, P10963; Islam SM, 2009, SCIENCE, V323, P388, DOI 10.1126/science.1165187; Ito T, 2014, INT J MOL MED, V33, P1122, DOI 10.3892/ijmm.2014.1690; JERET JS, 1987, BRAIN DEV-JPN, V9, P255, DOI 10.1016/S0387-7604(87)80042-6; Kamnasaran D, 2005, CLIN INVEST MED, V28, P267; Keeble TR, 2006, J NEUROSCI, V26, P5840, DOI 10.1523/JNEUROSCI.1175-06.2006; KOESTER SE, 1994, J NEUROSCI, V14, P6608; Kolodkin AL, 1997, CELL, V90, P753, DOI 10.1016/S0092-8674(00)80535-8; Lim JWC, 2015, DEVELOPMENT, V142, P3746, DOI 10.1242/dev.119909; Lindwall C, 2007, CURR OPIN NEUROBIOL, V17, P3, DOI 10.1016/j.conb.2007.01.008; Lungu Ovidiu, 2012, Front Psychiatry, V3, P1, DOI 10.3389/fpsyt.2012.00001; Lyoo IK, 1996, BIOL PSYCHIAT, V40, P1060; Magara F, 1999, P NATL ACAD SCI USA, V96, P4656, DOI 10.1073/pnas.96.8.4656; Mendes SW, 2006, J NEUROSCI, V26, P882, DOI 10.1523/JNEUROSCI.3162-05.2006; Mizuno S, 2010, MAMM GENOME, V21, P525, DOI 10.1007/s00335-010-9292-4; Moes P, 2009, CHILD CARE HLTH DEV, V35, P656, DOI 10.1111/j.1365-2214.2009.00942.x; Molyneaux BJ, 2009, J NEUROSCI, V29, P12343, DOI 10.1523/JNEUROSCI.6108-08.2009; Nakamura F, 2009, J COMP NEUROL, V516, P360, DOI 10.1002/cne.22125; Nawabi H, 2010, GENE DEV, V24, P396, DOI 10.1101/gad.542510; Niquille M, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000230; Nishikimi M, 2013, NEURAL PLAST, V2013, DOI 10.1155/2013/149060; OZAKI HS, 1992, J COMP NEUROL, V323, P81, DOI 10.1002/cne.903230107; Ozaki HS, 1998, J COMP NEUROL, V400, P197, DOI 10.1002/(SICI)1096-9861(19981019)400:2<197::AID-CNE3>3.0.CO;2-4; Pasterkamp RJ, 2003, CURR OPIN NEUROBIOL, V13, P79, DOI 10.1016/S0959-4388(03)00003-5; Piper M, 2009, CEREB CORTEX, V19, pI11, DOI 10.1093/cercor/bhp027; Plachez C, 2005, CURR TOP DEV BIOL, V69, P267, DOI 10.1016/S0070-2153(05)69010-2; Qiu MS, 1996, DEV BIOL, V178, P174, DOI 10.1006/dbio.1996.0207; Rash BG, 2001, J COMP NEUROL, V434, P147, DOI 10.1002/cne.1170; Richards LJ, 2002, BRAZ J MED BIOL RES, V35, P1431, DOI 10.1590/S0100-879X2002001200004; Rohm B, 2000, MECH DEVELOP, V93, P95, DOI 10.1016/S0925-4773(00)00269-0; Ruediger T, 2013, CEREB CORTEX, V23, P604, DOI 10.1093/cercor/bhs044; Serafini T, 1996, CELL, V87, P1001, DOI 10.1016/S0092-8674(00)81795-X; Shu TZ, 2003, DEVELOPMENT, V130, P2929, DOI 10.1242/dev.00514; Shu TZ, 2001, J NEUROSCI, V21, P2749, DOI 10.1523/JNEUROSCI.21-08-02749.2001; SILVER J, 1993, J COMP NEUROL, V328, P415, DOI 10.1002/cne.903280308; SILVER J, 1982, J COMP NEUROL, V210, P10, DOI 10.1002/cne.902100103; Son AI, 2017, SCI REP-UK, V7, DOI 10.1038/srep45359; Takahashi T, 2001, NEURON, V29, P429, DOI 10.1016/S0896-6273(01)00216-1; Takahashi T, 1999, CELL, V99, P59, DOI 10.1016/S0092-8674(00)80062-8; Takegahara N, 2006, NAT CELL BIOL, V8, P615, DOI 10.1038/ncb1416; Tamagnone L, 1999, CELL, V99, P71, DOI 10.1016/S0092-8674(00)80063-X; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Van Battum EY, 2015, LANCET NEUROL, V14, P532, DOI 10.1016/S1474-4422(14)70257-1; van der Knaap LJ, 2011, BEHAV BRAIN RES, V223, P211, DOI 10.1016/j.bbr.2011.04.018; WAHLSTEN D, 1989, J HERED, V80, P11; WAHLSTEN D, 1989, J NEUROGENET, V5, P61, DOI 10.3109/01677068909167265; WAHLSTEN D, 1989, EXPERIENTIA, V45, P828, DOI 10.1007/BF01954057; WAHLSTEN D, 1974, BRAIN RES, V68, P1, DOI 10.1016/0006-8993(74)90530-7; Wu KY, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005334; YORKE CH, 1975, J COMP NEUROL, V164, P233, DOI 10.1002/cne.901640206; Yoshida M, 1997, DEVELOPMENT, V124, P101; Zhao H, 2011, J COMP NEUROL, V519, P834, DOI 10.1002/cne.22536; Zhou J, 2013, P NATL ACAD SCI USA, V110, pE2714, DOI 10.1073/pnas.1310233110; Zylbersztejn K, 2012, J CELL BIOL, V196, P37, DOI 10.1083/jcb.201106113	71	10	10	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2019	14	8							e0221440	10.1371/journal.pone.0221440	http://dx.doi.org/10.1371/journal.pone.0221440			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5OC	31430342	Green Published, Green Submitted, gold			2022-12-26	WOS:000485026800055
J	Sun, BW; Mason, S; Wilson, RC; Hazard, SE; Wang, YB; Fang, R; Wang, QW; Yeh, ES; Yang, MX; Roberts, TM; Zhao, JJ; Wang, Q				Sun, Bowen; Mason, Seth; Wilson, Robert C.; Hazard, Starr E.; Wang, Yubao; Fang, Rong; Wang, Qiwei; Yeh, Elizabeth S.; Yang, Meixiang; Roberts, Thomas M.; Zhao, Jean J.; Wang, Qi			Inhibition of the transcriptional kinase CDK7 overcomes therapeutic resistance in HER2-positive breast cancers	ONCOGENE			English	Article							TRASTUZUMAB RESISTANCE; MEDIATES RESISTANCE; TERMINAL DOMAIN; RECEPTOR; ACTIVATION; LAPATINIB; TUMORS; EXPRESSION; MUTATIONS; PATHWAY	Resistance of breast cancer to human epidermal growth factor receptor 2 (HER2) inhibitors involves reprogramming of the kinome through HER2/HER3 signaling via the activation of multiple tyrosine kinases and transcriptional upregulation. The heterogeneity of induced kinases prevents kinase targeting by a single kinase inhibitor and presents a major challenge to the treatment of therapeutically recalcitrant HER2-positive breast cancers (HER2+ BCs). As a result, there is a critical need for effective treatment that attacks the aberrant kinome activation associated with resistance to HER2-targeted therapy. Here, we describe a novel treatment strategy that targets cyclin-dependent kinase 7 (CDK7) in HER2 inhibitor-resistant (HER2iR) breast cancer. We show that both HER2 inhibitor-sensitive (HER2iS) and HER2iR breast cancer cell lines exhibit high sensitivity to THZ1, a newly identified covalent inhibitor of the transcription regulatory kinase CDK7. CDK7 promotes cell cycle progression through inhibition of transcription, rather than via direct phosphorylation of classical CDK targets. The transcriptional kinase activity of CDK7 is regulated by HER2, and by the receptor tyrosine kinases activated in response to HER2 inhibition, as well as by the downstream SHP2 and PI3K/AKT pathways. A low dose of THZ1 displayed potent synergy with the HER2 inhibitor lapatinib in HER2iR BC cells in vitro. Dual HER2 and CDK7 inhibition induced tumor regression in two HER2iR BC xenograft models in vivo. Our data support the utilization of CDK7 inhibition as an additional therapeutic avenue that blocks the activation of genes engaged by multiple HER2iR kinases.	[Sun, Bowen; Yeh, Elizabeth S.; Yang, Meixiang] Jinan Univ, Biomed Translat Res Inst, Affiliated Hosp 1, Guangzhou 510632, Peoples R China; [Sun, Bowen; Yeh, Elizabeth S.; Yang, Meixiang] Jinan Univ, Sch Pharm, Guangzhou 510632, Peoples R China; [Sun, Bowen; Mason, Seth; Wilson, Robert C.; Wang, Qi] Med Univ South Carolina, Dept Pathol & Lab Med, Charleston, SC 29425 USA; [Hazard, Starr E.] Med Univ South Carolina, Computat Biol Resource Ctr, Charleston, SC 29425 USA; [Wang, Yubao; Fang, Rong; Wang, Qiwei; Roberts, Thomas M.; Zhao, Jean J.] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; [Wang, Yubao; Fang, Rong; Wang, Qiwei; Roberts, Thomas M.; Zhao, Jean J.] Harvard Med Sch, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Fang, Rong] Ningbo Univ, Sch Med, Zhejiang Prov Key Lab Pathophysiol, Dept Pathol, Ningbo 315211, Peoples R China; [Yeh, Elizabeth S.] Med Univ South Carolina, Dept Cell & Mol Pharmacol & Expt Therapeut, Charleston, SC 29425 USA	Jinan University; Jinan University; Medical University of South Carolina; Medical University of South Carolina; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Ningbo University; Medical University of South Carolina	Wang, Q (corresponding author), Med Univ South Carolina, Dept Pathol & Lab Med, Charleston, SC 29425 USA.	wangq@musc.edu	mason, seth/GYU-3141-2022	Hazard, E. Starr/0000-0002-4645-7642; Wang, Qiwei/0000-0003-3897-2529	American Cancer Society [ACS_IRG IRG-97-219-14]; Genomic Shared Resource, Hollings Cancer Center, Medical University of South Carolina [P30 CA138313]; NIH [R01 CA187305, R35 CA210057 CA187918, 1P50CA168504]; Breast Cancer Research Foundation; Rosanna's Rush for Research	American Cancer Society(American Cancer Society); Genomic Shared Resource, Hollings Cancer Center, Medical University of South Carolina; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Breast Cancer Research Foundation; Rosanna's Rush for Research	This work was supported by pilot research funding form an American Cancer Society Institutional Research Grant awarded to the Hollings Cancer Center, Medical University of South Carolina (ACS_IRG IRG-97-219-14, QW); Supported in part by the Genomic Shared Resource, Hollings Cancer Center, Medical University of South Carolina (P30 CA138313); NIH grants R01 CA187305 (ESY), R35 CA210057 CA187918 (TMR and JJZ), 1P50CA168504 (TMR and JJZ); the Breast Cancer Research Foundation (JJZ); Rosanna's Rush for Research (JJZ). We also like to thank Dr Stephen Ethier (Medical University of South Carolina, SC, USA) for providing cell line Sum149.	Akhtar MS, 2009, MOL CELL, V34, P387, DOI 10.1016/j.molcel.2009.04.016; Alexander PB, 2017, J BIOL CHEM, V292, P748, DOI 10.1074/jbc.M116.754960; Bentires-Alj M, 2006, NAT MED, V12, P114, DOI 10.1038/nm1341; Bentires-Alj M, 2004, CANCER RES, V64, P8816, DOI 10.1158/0008-5472.CAN-04-1923; Berns K, 2007, CANCER CELL, V12, P395, DOI 10.1016/j.ccr.2007.08.030; Blackwell KL, 2010, J CLIN ONCOL, V28, P1124, DOI 10.1200/JCO.2008.21.4437; Chen DS, 2002, ONCOGENE, V21, P4921, DOI 10.1038/sj.onc.1205420; Chen YNP, 2016, NATURE, V535, P148, DOI 10.1038/nature18621; Chipumuro E, 2014, CELL, V159, P1126, DOI 10.1016/j.cell.2014.10.024; Chou TC, 2006, PHARMACOL REV, V58, P621, DOI 10.1124/pr.58.3.10; Christensen CL, 2014, CANCER CELL, V26, P909, DOI 10.1016/j.ccell.2014.10.019; Diehl JA, 1998, GENE DEV, V12, P3499, DOI 10.1101/gad.12.22.3499; Dueck AC, 2013, CLIN CANCER RES, V19, P5798, DOI 10.1158/1078-0432.CCR-13-0558; Eichhorn PJA, 2008, CANCER RES, V68, P9221, DOI 10.1158/0008-5472.CAN-08-1740; Emery CM, 2009, P NATL ACAD SCI USA, V106, P20411, DOI 10.1073/pnas.0905833106; Ercan D, 2010, ONCOGENE, V29, P2346, DOI 10.1038/onc.2009.526; Glover-Cutter K, 2009, MOL CELL BIOL, V29, P5455, DOI 10.1128/MCB.00637-09; Goel S, 2016, CANCER CELL, V29, P255, DOI 10.1016/j.ccell.2016.02.006; Greulich H, 2005, PLOS MED, V2, P1167, DOI 10.1371/journal.pmed.0020313; Hanker AB, 2017, CLIN CANCER RES, V23, P4323, DOI 10.1158/1078-0432.CCR-16-2287; Hanker AB, 2013, P NATL ACAD SCI USA, V110, P14372, DOI 10.1073/pnas.1303204110; Harrod A, 2017, ONCOGENE, V36, P2286, DOI 10.1038/onc.2016.382; Hellmuth K, 2008, P NATL ACAD SCI USA, V105, P7275, DOI 10.1073/pnas.0710468105; Hynes NE, 2005, NAT REV CANCER, V5, P341, DOI 10.1038/nrc1609; Jeselsohn R, 2018, CANCER CELL, V33, P173, DOI 10.1016/j.ccell.2018.01.004; Julovi SM, 2018, FRONT ENDOCRINOL, V9, DOI 10.3389/fendo.2018.00120; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Kwiatkowski N, 2014, NATURE, V511, P616, DOI 10.1038/nature13393; Larochelle S, 2007, MOL CELL, V25, P839, DOI 10.1016/j.molcel.2007.02.003; Larochelle S, 2012, NAT STRUCT MOL BIOL, V19, P1108, DOI 10.1038/nsmb.2399; Liu PX, 2009, NAT REV DRUG DISCOV, V8, P627, DOI 10.1038/nrd2926; Loi S, 2014, ANN ONCOL, V25, P1544, DOI 10.1093/annonc/mdu112; Lu YH, 2001, JNCI-J NATL CANCER I, V93, P1852, DOI 10.1093/jnci/93.24.1852; Mayer IA, 2014, CLIN CANCER RES, V20, P782, DOI 10.1158/1078-0432.CCR-13-0583; Moasser MM, 2015, JAMA ONCOL, V1, P1154, DOI 10.1001/jamaoncol.2015.2286; Musolino A, 2008, J CLIN ONCOL, V26, P1789, DOI 10.1200/JCO.2007.14.8957; Nagata Y, 2004, CANCER CELL, V6, P117, DOI 10.1016/j.ccr.2004.06.022; Neel BG, 2003, TRENDS BIOCHEM SCI, V28, P284, DOI 10.1016/S0968-0004(03)00091-4; Oliveras-Ferraros C, 2012, CELL CYCLE, V11, P4020, DOI 10.4161/cc.22225; Palancade B, 2003, EUR J BIOCHEM, V270, P3859, DOI 10.1046/j.1432-1033.2003.03794.x; Prahallad A, 2015, CELL REP, V12, P1978, DOI 10.1016/j.celrep.2015.08.037; Rusan M, 2018, CANCER DISCOV, V8, P59, DOI 10.1158/2159-8290.CD-17-0461; Scaltriti M, 2007, J NATL CANCER I, V99, P628, DOI 10.1093/jnci/djk134; Scaltriti M, 2011, P NATL ACAD SCI USA, V108, P3761, DOI 10.1073/pnas.1014835108; Sherr CJ, 2004, GENE DEV, V18, P2699, DOI 10.1101/gad.1256504; Stoeck A, 2014, CANCER DISCOV, V4, P1154, DOI 10.1158/2159-8290.CD-13-0830; Stuhlmiller TJ, 2014, CLIN PHARMACOL THER, V95, P413, DOI 10.1038/clpt.2014.8; Stuhlmiller TJ, 2015, CELL REP, V11, P390, DOI 10.1016/j.celrep.2015.03.037; Wang Q, 2016, ONCOGENE, V35, P3607, DOI 10.1038/onc.2015.406; Wang YB, 2015, CELL, V163, P174, DOI 10.1016/j.cell.2015.08.063; Zhang SQ, 2002, MOL CELL BIOL, V22, P4062, DOI 10.1128/MCB.22.12.4062-4072.2002; Zhuang GL, 2010, CANCER RES, V70, P299, DOI 10.1158/0008-5472.CAN-09-1845	52	30	31	3	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN	2020	39	1					50	63		10.1038/s41388-019-0953-9	http://dx.doi.org/10.1038/s41388-019-0953-9			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	KG3NM	31462705	hybrid, Green Published			2022-12-26	WOS:000509849200005
J	Buxbaum, JN				Buxbaum, Joel N.			Unravelling Alzheimer's Disease: It's Not the Whole Story, but A beta Still Matters	FASEB JOURNAL			English	Review							AMYLOID-BETA; NEUROFIBRILLARY TANGLES; MICE; TRANSMISSION; HYPOTHESIS; SEVERITY; MODELS	In late 2016, we solicited a series of reviews covering the variety of processes that appeared to be involved in the pathogenesis of neurodegenerative disorders, particularly Alzheimer's disease (AD). These essays have appeared at regular intervals in The FASEB Journal. My instructions to the researchers were simply not to emphasize A beta per se because there had been many reviews both supporting and questioning the etiologic role of A beta in the late-onset, sporadic form of AD, and reciting either of those scientific positions would be redundant. My colleagues responded admirably, and I believe that their contributions have significantly informed readers' awareness of the current state of knowledge of AD. I have written my epilogue from the perspective of an investigator interested in the role of protein aggregation in human disease and as a physician who may be charged with making a diagnosis and prescribing treatment for a patient. We do not yet have etiology-based therapies of AD, but we continue to gain insight into the mechanisms responsible for synaptic loss and the consequent functional deterioration. A silver therapeutic bullet does not seem to be in the offing. It is more likely that an iterative approach will lead to the development of a group of treatments that are AD specific or applicable to various features of the entire class of neurodegenerative disorders. How and when those therapies succeed or fail will, in turn, provide additional insights into disease pathogenesis, which will inform the development of succeeding generations of therapeutics.-Buxbaum, J. N. Unravelling Alzheimer's disease: it's not the whole story, but A beta still matters.	[Buxbaum, Joel N.] Scripps Res Inst, 10550 North Torrey Pines Rd, La Jolla, CA 92037 USA; [Buxbaum, Joel N.] Protego Biopharma, San Diego, CA USA; [Buxbaum, Joel N.] Scintillon Inst, San Diego, CA USA	Scripps Research Institute	Buxbaum, JN (corresponding author), Scripps Res Inst, 10550 North Torrey Pines Rd, La Jolla, CA 92037 USA.	jbux@scripps.edu						ARRIAGADA PV, 1992, NEUROLOGY, V42, P631, DOI 10.1212/WNL.42.3.631; Bateman RJ, 2012, NEW ENGL J MED, V367, P795, DOI 10.1056/NEJMoa1202753; BIERER LM, 1995, ARCH NEUROL-CHICAGO, V52, P81, DOI 10.1001/archneur.1995.00540250089017; Borchelt DR, 1996, NEURON, V17, P1005, DOI 10.1016/S0896-6273(00)80230-5; BRICKER NS, 1969, AM J MED, V46, P1, DOI 10.1016/0002-9343(69)90053-9; Buxbaum JN, 2019, AMYLOID, V26, P55, DOI 10.1080/13506129.2019.1575201; Chavez-Gutierrez L, 2012, EMBO J, V31, P2261, DOI 10.1038/emboj.2012.79; Cummings DM, 2015, BRAIN, V138, P1992, DOI 10.1093/brain/awv127; Currais A, 2017, FASEB J, V31, P5, DOI 10.1096/fj.201601184; Fagoonee S, 2019, INFECT DIS-NOR, V51, P399, DOI 10.1080/23744235.2019.1588472; Fillit H., 2018, CLIN TRIALS REPORT A; Golde TE, 2016, NAT REV NEUROL, V12, P433, DOI 10.1038/nrneurol.2016.105; Guo QX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080706; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Huang YWA, 2017, CELL, V168, P427, DOI 10.1016/j.cell.2016.12.044; Itzhaki RF, 2017, FASEB J, V31, P3216, DOI 10.1096/fj.201700360; Jaunmuktane Z, 2015, NATURE, V525, P247, DOI 10.1038/nature15369; Jucker M, 2018, NAT NEUROSCI, V21, P1341, DOI 10.1038/s41593-018-0238-6; Kumar DKV, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf1059; Lahiri DK, 2005, NEUROBIOL AGING, V26, P1329, DOI 10.1016/j.neurobiolaging.2004.11.005; Lehrer RI, 2012, IMMUNOL REV, V245, P84, DOI 10.1111/j.1600-065X.2011.01082.x; Liddelow SA, 2019, FASEB J, V33, P1528, DOI 10.1096/fj.201802592; Maheshwari P, 2015, J ALZHEIMERS DIS, V43, P957, DOI 10.3233/JAD-140621; MARSHALL BJ, 1984, LANCET, V1, P1311; Matarin M, 2015, CELL REP, V10, P633, DOI 10.1016/j.celrep.2014.12.041; Moir RD, 2019, FRONT AGING NEUROSCI, V11, DOI 10.3389/fnagi.2019.00070; Moir RD, 2018, ALZHEIMERS DEMENT, V14, P1602, DOI 10.1016/j.jalz.2018.06.3040; Montacute R, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0826-5; Moulder KL, 2013, ALZHEIMERS RES THER, V5, DOI 10.1186/alzrt213; Onos KD, 2016, BRAIN RES BULL, V122, P1, DOI 10.1016/j.brainresbull.2015.12.003; Panza F, 2019, NAT REV NEUROL, V15, P73, DOI 10.1038/s41582-018-0116-6; Pimenova AA, 2018, BIOL PSYCHIAT, V83, P300, DOI 10.1016/j.biopsych.2017.05.014; Pir GJ, 2017, FASEB J, V31, P5137, DOI 10.1096/fj.201701007; Reiman EM, 2011, J ALZHEIMERS DIS, V26, P321, DOI 10.3233/JAD-2011-0059; Ridge PG, 2016, NEUROBIOL AGING, V41, DOI 10.1016/j.neurobiolaging.2016.02.024; Sassi C, 2014, NEUROBIOL AGING, V35, DOI 10.1016/j.neurobiolaging.2014.06.002; Sato C, 2018, NEURON, V98, P861, DOI 10.1016/j.neuron.2018.04.035; Selkoe DJ, 2016, EMBO MOL MED, V8, P595, DOI 10.15252/emmm.201606210; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Singh K, 2019, PHARMACEUTICALS-BASE, V12, DOI 10.3390/ph12020062; STEERE AC, 1983, NEW ENGL J MED, V308, P733, DOI 10.1056/NEJM198303313081301; STEERE AC, 1977, ARTHRITIS RHEUM, V20, P7, DOI 10.1002/art.1780200102; Venegas C., 2019, FASEB J; Zott B, 2018, ANNU REV NEUROSCI, V41, P277, DOI 10.1146/annurev-neuro-080317-061725	44	3	3	0	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2019	33	9					9701	9705		10.1096/fj.201901895	http://dx.doi.org/10.1096/fj.201901895			5	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IS5TA	31465249	Bronze			2022-12-26	WOS:000482214200002
J	Sarabon, N; Kozinc, Z; Podrekar, N				Sarabon, Nejc; Kozinc, Zige; Podrekar, Nastja			Using shear-wave elastography in skeletal muscle: A repeatability and reproducibility study on biceps femoris muscle	PLOS ONE			English	Article							STATIC STRETCHING PROGRAM; STIFFNESS; TISSUE; RELIABILITY; HAMSTRINGS; POSITION; HARDNESS; STRAIN; AGE	Shear-wave electrography (SWE) is a method used to assess tissue elasticity. Recently, it has been used to assess muscle stiffness, but the reliability of SWE for this purpose has not been thoroughly investigated. The purpose of this study was to evaluate the repeatability and reproducibility of SWE on porcine meat specimens and the human biceps femoris muscle. Measurements on meat specimens (n = 20) were performed by three raters and with a custom-built device that allowed constant application force. Measurements on human participants (n = 20) were performed by two raters in relaxed and stretched muscle positions on two visits. Most aspects of repeatability and reproducibility were good or high, with intraclass correlation coefficient (ICC) values above 0.70. Minimal detectable changes were lower in a relaxed (6-10%) than stretched (15-16%) muscle position. In conclusion, SWE is a reliable tool for assessing muscle stiffness if the muscle is examined in relaxed condition, while changing the force applied with the probe for as little as 1.5 N results in significantly lower repeatability.	[Sarabon, Nejc; Kozinc, Zige; Podrekar, Nastja] Univ Primorska, Fac Hlth Sci, Izola, Slovenia; [Sarabon, Nejc; Kozinc, Zige] Univ Primorska, Andrej Marusic Inst, Koper, Slovenia; [Podrekar, Nastja] InnoRennew Ctr Excellence, Izola, Slovenia	University of Primorska; University of Primorska	Sarabon, N (corresponding author), Univ Primorska, Fac Hlth Sci, Izola, Slovenia.; Sarabon, N (corresponding author), Univ Primorska, Andrej Marusic Inst, Koper, Slovenia.	nejc.sarabon@fvz.upr.si		Sarabon, Nejc/0000-0003-0747-3735; Kozinc, Ziga/0000-0003-3555-8680	Horizon 2020 Framework Programme of the European Union; H2020 WIDESPREAD-2-Teaming [739574]; Republic of Slovenia from the European Union of the European Regional Development Fund	Horizon 2020 Framework Programme of the European Union; H2020 WIDESPREAD-2-Teaming; Republic of Slovenia from the European Union of the European Regional Development Fund	The authors gratefully acknowledge the Horizon 2020 Framework Programme of the European Union; H2020 WIDESPREAD-2-Teaming: #739574 and the Republic of Slovenia for investment funding from the European Union of the European Regional Development Fund. The funding bodies were not involved in study conception, design, data collection or analysis, nor in preparation of the manuscript. The funders only provided resources for author salaries and will provide submission fees in case the article is accepted.	Akagi R, 2014, SCAND J MED SCI SPOR, V24, P950, DOI 10.1111/sms.12111; Akagi R, 2015, ULTRASOUND MED BIOL, V41, P2906, DOI 10.1016/j.ultrasmedbio.2015.07.011; Andonian P, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161855; Bercoff J, 2004, IEEE T ULTRASON FERR, V51, P396, DOI 10.1109/TUFFC.2004.1295425; Brandenburg JE, 2016, DEV MED CHILD NEUROL, V58, P1288, DOI 10.1111/dmcn.13179; Du LJ, 2016, CLIN IMAG, V40, P1075, DOI 10.1016/j.clinimag.2016.05.008; Dubois G, 2015, ULTRASOUND MED BIOL, V41, P2284, DOI 10.1016/j.ultrasmedbio.2015.04.020; Eby SF, 2015, CLIN BIOMECH, V30, P22, DOI 10.1016/j.clinbiomech.2014.11.011; Eby SF, 2013, J BIOMECH, V46, P2381, DOI 10.1016/j.jbiomech.2013.07.033; Enderlein G., 2007, BIOMETRICAL J, V30, P304, DOI [10.1002/bimj.4710300308, DOI 10.1002/BIMJ.4710300308]; Ewertsen C, 2016, ULTRASONICS, V71, P127, DOI 10.1016/j.ultras.2016.06.007; Ferraioli G, 2014, J ULTRAS MED, V33, P197, DOI 10.7863/ultra.33.2.197; Frulio N, 2013, Diagn Interv Imaging, V94, P515, DOI 10.1016/j.diii.2013.02.005; Hatta T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155102; Hirayama K, 2015, ACTA RADIOL OPEN, V4, DOI 10.1177/2058460115603420; Ichihashi N, 2016, J SPORT SCI, V34, P2155, DOI 10.1080/02640414.2016.1172725; Kawada N, 2016, WORLD J GASTROENTERO, V22, P3712, DOI 10.3748/wjg.v22.i14.3712; Kot BCW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044348; Le Sant G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139272; Lin PL, 2014, EUR RADIOL, V24, P2729, DOI 10.1007/s00330-014-3320-9; Liu BX, 2016, ULTRASOUND MED BIOL, V42, P835, DOI 10.1016/j.ultrasmedbio.2015.10.024; MacDonald D, 2016, ULTRASOUND MED BIOL, V42, P1018, DOI 10.1016/j.ultrasmedbio.2015.12.002; Mendes B, 2018, EUR J APPL PHYSIOL, V118, P2403, DOI 10.1007/s00421-018-3967-z; Morales-Artacho AJ, 2017, SCAND J MED SCI SPOR, V27, P1959, DOI 10.1111/sms.12832; Nakamura M, 2016, MANUAL THER, V24, P1, DOI 10.1016/j.math.2016.03.012; Nakamura M, 2014, ULTRASOUND MED BIOL, V40, P1991, DOI 10.1016/j.ultrasmedbio.2014.03.024; Point M, 2018, SCAND J MED SCI SPOR, V28, P260, DOI 10.1111/sms.12872; Sandrin L, 1999, ULTRASONIC IMAGING, V21, P259, DOI 10.1177/016173469902100402; Sarvazyan AP, 1998, ULTRASOUND MED BIOL, V24, P1419, DOI 10.1016/S0301-5629(98)00110-0; Sarvazyan A, 2011, CURR MED IMAGING, V7, P255, DOI 10.2174/157340511798038684; Suh CH, 2017, EUR RADIOL, V27, P222, DOI 10.1007/s00330-016-4378-3; Tas S, 2017, J ULTRAS MED, V36, P565, DOI 10.7863/ultra.16.03032; Umegaki H, 2015, MANUAL THER, V20, P610, DOI 10.1016/j.math.2015.02.006; Umehara J, 2015, CLIN BIOMECH, V30, P1056, DOI 10.1016/j.clinbiomech.2015.09.007; Wells PNT, 2011, J R SOC INTERFACE, V8, P1521, DOI 10.1098/rsif.2011.0054	35	22	23	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2019	14	8							e0222008	10.1371/journal.pone.0222008	http://dx.doi.org/10.1371/journal.pone.0222008			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW6BO	31469888	Green Published, gold, Green Submitted			2022-12-26	WOS:000485062200046
J	Wiczling, P; Daghir-Wojtkowiak, E; Kaliszan, R; Markuszewski, MJ; Limon, J; Koczkowska, M; Stukan, M; Kuzniacka, A; Ratajska, M				Wiczling, Pawel; Daghir-Wojtkowiak, Emilia; Kaliszan, Roman; Markuszewski, Michal Jan; Limon, Janusz; Koczkowska, Magdalena; Stukan, Maciej; Kuzniacka, Alina; Ratajska, Magdalena			Bayesian multilevel model of micro RNA levels in ovarian-cancer and healthy subjects	PLOS ONE			English	Article							EFFECT SIZE; BIOMARKERS; IDENTIFICATION; MICROARRAYS; TARGETS	In transcriptomics, micro RNAs (miRNAs) has gained much interest especially as potential disease indicators. However, apart from holding a great promise related to their clinical application, a lot of inconsistent results have been published. Our aim was to compare the miRNA expression levels in ovarian cancer and healthy subjects using the Bayesian multilevel model and to assess their potential usefulness in diagnosis. We have analyzed a case-control observational data on expression profiling of 49 preselected miRNA-based ovarian cancer indicators in 119 controls and 59 patients. A Bayesian multilevel model was used to characterize the effect of disease on miRNA levels controlling for differences in age and body weight. The difference between the miRNA level and health status of the patient on the scale of the data variability were discussed in the context of their potential usefulness in diagnosis. Additionally, the cross-validated area under the ROC curve (AUC) was used to assess the expected out-of-sample discrimination index of a different sets of miRNAs. The proposed model allowed us to describe the set of miRNA levels in patients and controls. Three highly correlated miRNAs: miR-101-3p, miR-142-5p, miR-148a-3p rank the highest with almost identical effect sizes that ranges from 0.45 to 1.0. For those miRNAs the credible interval for AUC ranged from 0.63 to 0.67 indicating their limited discrimination potential. A little benefit in adding information from other miRNAs was observed. There were several miRNAs in the dataset (miR-604, hsa-miR-221-5p) for which inferences were uncertain. For those miRNAs more experimental effort is needed to fully assess their effect in the context of new hits discovery and usefulness as disease indicators. The proposed multilevel Bayesian model can be used to characterize the panel of miRNA profile and to assess the difference in expression levels between healthy and cancer individuals.	[Wiczling, Pawel; Daghir-Wojtkowiak, Emilia; Kaliszan, Roman; Markuszewski, Michal Jan] Med Univ Gdansk, Dept Biopharmaceut & Pharmacodynam, Gdansk, Poland; [Limon, Janusz; Koczkowska, Magdalena; Kuzniacka, Alina; Ratajska, Magdalena] Med Univ Gdansk, Dept Biol & Genet, Gdansk, Poland; [Stukan, Maciej] Gdynia Oncol Ctr, Dept Gynecol Oncol, Powstania Styczniowego, Gdynia, Poland	Fahrenheit Universities; Medical University Gdansk; Fahrenheit Universities; Medical University Gdansk	Wiczling, P (corresponding author), Med Univ Gdansk, Dept Biopharmaceut & Pharmacodynam, Gdansk, Poland.	wiczling@gumed.edu.pl	Wiczling, Paweł/T-3987-2018; Stukan, Maciej/ABA-4741-2020; Ratajska, Magdalena/AAT-6333-2020; Markuszewski, Michal/X-7198-2019	Wiczling, Paweł/0000-0002-2878-3161; Ratajska, Magdalena/0000-0001-7015-1865; Markuszewski, Michal/0000-0003-1166-4817; Kuzniacka, Alina/0000-0002-9396-3273	Polish National Science Centre [2011/02/A/NZ2/00017, 2012/07/E/NZ7/04411]	Polish National Science Centre	This work was supported by the Polish National Science Centre project: 2011/02/A/NZ2/00017 and 2012/07/E/NZ7/04411. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r This work was supported by the Polish National Science Centre project: 2011/02/A/NZ2/00017 and 2012/07/E/NZ7/04411. The authors thank all the patients and their families who participated in this study for their invaluable contribution. Dr Koczkowska is also affiliated with the Medical Genomics Laboratory, Department of Genetics, University of Alabama at Birmingham.	Boos DD, 2011, AM STAT, V65, P213, DOI 10.1198/tas.2011.10129; Chen QX, 2016, STAT MED, V35, P4546, DOI 10.1002/sim.7021; Chen X, 2020, GENOMICS, V112, P809, DOI 10.1016/j.ygeno.2019.05.021; Chen X, 2019, BRIEF BIOINFORM, V20, P515, DOI 10.1093/bib/bbx130; Chen X, 2018, PLOS COMPUT BIOL, V14, DOI 10.1371/journal.pcbi.1006418; Chen X, 2017, RNA BIOL, V14, P952, DOI 10.1080/15476286.2017.1312226; Chen X, 2016, ONCOTARGET, V7, P65257, DOI 10.18632/oncotarget.11251; Chen X, 2016, SCI REP-UK, V6, DOI 10.1038/srep21106; Chen X, 2012, MOL BIOSYST, V8, P2792, DOI 10.1039/c2mb25180a; Das J, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1010; Debernardi S, 2015, AM J CANCER RES, V5, P3455; Deng T, 2016, CELL PHYSIOL BIOCHEM, V39, P1716, DOI 10.1159/000447872; Eftekharian MM, 2019, J MOL NEUROSCI, V68, P153, DOI 10.1007/s12031-019-01294-z; Erkanli A, 2006, CANCER RES, V66, P1792, DOI 10.1158/0008-5472.CAN-05-0669; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Estep M, 2010, ALIMENT PHARM THER, V32, P487, DOI 10.1111/j.1365-2036.2010.04366.x; Feckler A, 2018, ENVIRON TOXICOL CHEM, V37, P1949, DOI 10.1002/etc.4127; Fritz CO, 2012, J EXP PSYCHOL GEN, V141, P2, DOI 10.1037/a0024338; Gelman A., 2007, DATA ANAL USING REGR; Halsey LG, 2015, NAT METHODS, V12, P179, DOI 10.1038/nmeth.3288; Harrell FE, BIOSTATISTICS BIOMED; Harrell FE, 1985, BIOSTATISTICS STAT B; Iorio MV, 2012, EMBO MOL MED, V4, P143, DOI 10.1002/emmm.201100209; Jin XL, 2010, J HYDROL, V383, P147, DOI 10.1016/j.jhydrol.2009.12.028; Koech MK, 2014, POSTERIOR F VALUE BA; Kruschke JK, 2018, PSYCHON B REV, V25, P178, DOI 10.3758/s13423-016-1221-4; Lakens D, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00863; Lan W, 2015, IEEE INT C BIOINFORM, P183, DOI 10.1109/BIBM.2015.7359678; Lee I, 2009, GENOME RES, V19, P1175, DOI 10.1101/gr.089367.108; Li JQ, 2017, ONCOTARGET, V8, P21187, DOI 10.18632/oncotarget.15061; Liang C, 2019, PLOS COMPUT BIOL, V15, DOI 10.1371/journal.pcbi.1006931; Liu D, 2014, J BIOMET BIOSTAT, V5, P2; Lu MH, 2017, CANCER BIOMARK, V18, P143, DOI 10.3233/CBM-160024; Luo JW, 2017, IEEE ACCESS, V5, P2503, DOI 10.1109/ACCESS.2017.2672600; Ma XL, 2019, EXP THER MED, V17, P2129, DOI 10.3892/etm.2019.7195; MAO Q, 2019, J COMPUT BIOL, V26, DOI DOI 10.1089/CMB.2019.0012; Mork S, 2014, BIOINFORMATICS, V30, P392, DOI 10.1093/bioinformatics/btt677; Moustafa AA, 2017, EXP BIOL MED, V242, P536, DOI 10.1177/1535370216681554; Niu YW, 2019, BMC BIOINFORMATICS, V20, DOI 10.1186/s12859-019-2640-9; Okada K, 2017, BEHAV RES METHODS, V49, P979, DOI 10.3758/s13428-016-0760-y; Sayad A, 2019, METAB BRAIN DIS, V34, P1201, DOI 10.1007/s11011-019-00418-z; Shapira I, 2014, BRIT J CANCER, V110, P976, DOI 10.1038/bjc.2013.795; Swellam M, 2016, TUMOR BIOL, V37, P10571, DOI 10.1007/s13277-016-4948-7; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; van Aert RCM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175302; Voellenkle C, 2010, PHYSIOL GENOMICS, V42, P420, DOI 10.1152/physiolgenomics.00211.2009; Wang CC, 2019, RNA BIOL, V16, P257, DOI 10.1080/15476286.2019.1568820; Wang J, 2016, J CELL PHYSIOL, V231, P25, DOI 10.1002/jcp.25056; Wu D, 2013, RNA, V19, P876, DOI 10.1261/rna.035055.112; Xu LH, 2016, CELL PHYSIOL BIOCHEM, V38, P939, DOI 10.1159/000443046; Xuan P, 2015, BIOINFORMATICS, V31, P1805, DOI 10.1093/bioinformatics/btv039; Yang Y, 2016, BMC BIOINFORMATICS, V17, DOI 10.1186/s12859-015-0853-0; You ZH, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005455; Zekri ARN, 2016, TUMOR BIOL, V37, P12273, DOI 10.1007/s13277-016-5097-8; Zhao Y, 2019, BIOINFORMATICS, V35, P4730, DOI 10.1093/bioinformatics/btz297	55	5	5	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2019	14	8							e0221764	10.1371/journal.pone.0221764	http://dx.doi.org/10.1371/journal.pone.0221764			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW6AB	31465488	Green Published, Green Submitted, gold			2022-12-26	WOS:000485058200048
J	Anderson, A; Thornton, O; Coats, R; Capozio, A; Astill, S				Anderson, Anna; Thornton, Oliver; Coats, Rachel; Capozio, Antonio; Astill, Sarah			The effect of using a cycling workstation on mouse dexterity	PLOS ONE			English	Article							DUAL-TASK INTERFERENCE; PHYSICAL-ACTIVITY; SEDENTARY TIME; SITTING TIME; ACTIVE WORKSTATION; OFFICE WORKERS; METAANALYSIS; MORTALITY; ASSOCIATION; REDUCTIONS	This study investigated the effect of using a cycling workstation on mouse dexterity, including if and how this changed with practice. Thirty-four healthy adults were allocated to a sitting group (n = 17) or cycling group (n = 17). All participants completed standardised computer tasks on 6 occasions: baseline and final-all participants were seated; practice 1 to 4-sitting group participants were seated, cycling group participants pedalled on an under desk cycle. Three computer tasks were employed: (1) Tracking (continuous task)-participants used the mouse pointer to track a dot in a figure of 8 pattern at 3 different speeds without a guide then with a guide (2) Aiming (discrete task)-participants moved the mouse pointer to a dot which repeatedly disappeared then reappeared again in different locations, creating the outline of a pentagram (3) Steering (continuous task)-participants steered the mouse pointer around two different pathways. Accuracy was measured during the Tracking and Steering tasks as the root mean square error and penalised path accuracy respectively. Speed was measured during the Aiming task as the movement time. Data was analysed using frequentist and Bayes Factor analyses. During the continuous tasks (Tracking and Steering), accuracy was impaired among participants using the cycling workstation, both compared to their accuracy when seated and to the accuracy of participants in the sitting group. In contrast, no deficits in speed were noted among participants using the cycling work station during the discrete task (Aiming). No learning effects were observed among either group for any tasks. These findings suggest using a cycling workstation may impair the accuracy but not speed of mouse use, regardless of task practice. Overall this supports the implementation of cycling workstations in typical office settings, but suggests cycling workstations may impair productivity among workers performing high precision mouse tasks.	[Anderson, Anna; Thornton, Oliver; Capozio, Antonio; Astill, Sarah] Univ Leeds, Fac Biol Sci, Sch Biomed Sci, Leeds, W Yorkshire, England; [Anderson, Anna] Leeds Teaching Hosp NHS Trust, Physiotherapy Dept, Leeds, W Yorkshire, England; [Coats, Rachel] Univ Leeds, Fac Med & Hlth, Sch Psychol, Leeds, W Yorkshire, England	University of Leeds; University of Leeds; University of Leeds	Astill, S (corresponding author), Univ Leeds, Fac Biol Sci, Sch Biomed Sci, Leeds, W Yorkshire, England.	S.L.Astill@leeds.ac.uk	Coats, Rachel/AAH-6980-2019	Coats, Rachel/0000-0003-4415-408X; Astill, Sarah/0000-0002-9443-6934; Anderson, Anna/0000-0002-4048-6880; Capozio, Antonio/0000-0002-4809-2632	Wellcome Trust (Biomedical Vacation Scholarship) [202423/Z/16/Z]; Health Education England; Wellcome Trust	Wellcome Trust (Biomedical Vacation Scholarship)(Wellcome Trust); Health Education England; Wellcome Trust(Wellcome TrustEuropean Commission)	Funded by OT: Wellcome Trust (Biomedical Vacation Scholarship. https://wellcome.ac.uk/.202423/Z/16/Z. AA: Health Education England. https://www.hee.nhs.uk/our-work/clinical-academic-careers. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank Leeds Teaching Hospitals NHS Trust Physiotherapy Department and Health Education England for enabling preparatory work for this study to be undertaken as part of a Health Education England Integrated Clinical Academic Programme Internship Award 2015/2016 (cohort 2). Health Education England had no influence on the planning or conducting of the study, or on the writing of the manuscript. We also acknowledge the Wellcome Trust for awarding a Biomedical Vacation Scholarship to Oliver Thornton to undertake this study.	American College of Sports Medicine, 2010, ACSMS GUIDELINES EXE; Arem H, 2015, JAMA INTERN MED, V175, P959, DOI 10.1001/jamainternmed.2015.0533; Barchard KA, 2015, ANAL SOC ISS PUB POL, V15, P418, DOI 10.1111/asap.12095; Biswas A, 2015, ANN INTERN MED, V162, P123, DOI 10.7326/M14-1651; Britten L, 2016, GAIT POSTURE, V48, P42, DOI 10.1016/j.gaitpost.2016.04.027; Buckley JP, 2015, BRIT J SPORT MED, V49, P1357, DOI 10.1136/bjsports-2015-094618; Button KS, 2013, NAT REV NEUROSCI, V14, P365, DOI 10.1038/nrn3475; Carr LJ, 2014, INT J WORKPLACE HEAL, V7, P2, DOI 10.1108/IJWHM-03-2013-0008; Carr LJ, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003261; Carr LJ, 2012, BRIT J SPORT MED, V46, P430, DOI 10.1136/bjsm.2010.079574; Chastin SFM, 2015, OBESITY, V23, P1800, DOI 10.1002/oby.21180; Church TS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019657; Commissaris DACM, 2014, APPL ERGON, V45, P1570, DOI 10.1016/j.apergo.2014.05.003; Culmer PR, 2009, J NEUROSCI METH, V184, P184, DOI 10.1016/j.jneumeth.2009.07.025; Ding D, 2016, LANCET, V388, P1311, DOI 10.1016/S0140-6736(16)30383-X; Ekelund U, 2016, LANCET, V388, P1302, DOI 10.1016/S0140-6736(16)30370-1; Elmer SJ, 2014, APPL ERGON, V45, P1240, DOI 10.1016/j.apergo.2014.03.001; Flatters I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088692; Grooten WJA, 2017, APPL ERGON, V60, P1, DOI 10.1016/j.apergo.2016.10.006; Kazi A, 2014, OCCUP MED-OXFORD, V64, P497, DOI 10.1093/occmed/kqu099; Keadle SK, 2017, MED SCI SPORT EXER, V49, P1572, DOI 10.1249/MSS.0000000000001257; Koren K, 2016, APPL ERGON, V54, P83, DOI 10.1016/j.apergo.2015.11.013; Lee IM, 2012, LANCET, V380, P219, DOI 10.1016/S0140-6736(12)61031-9; Mulder J, 2016, J MATH PSYCHOL, V72, P1, DOI 10.1016/j.jmp.2016.01.002; Neuhaus M, 2014, OBES REV, V15, P822, DOI 10.1111/obr.12201; Ng SW, 2012, OBES REV, V13, P659, DOI 10.1111/j.1467-789X.2011.00982.x; Ojo SO, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15030417; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Patterson R, 2018, EUR J EPIDEMIOL; Pilcher JJ, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.00957; Straker LM, 2009, HUM FACTORS, V51, P831, DOI 10.1177/0018720810362079; Strobach T, 2017, ADV COGN PSYCHOL, V13, P28, DOI 10.5709/acp-0204-7; Torbeyns T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165510; van Emmerik REA, 2002, EXERC SPORT SCI REV, V30, P177, DOI 10.1097/00003677-200210000-00007; Wagenmakers EJ, 2018, PSYCHON B REV, V25, P58, DOI [10.3758/s13423-017-1323-7, 10.3758/s13423-017-1343-3]; Watanabe K, 2014, NAT NEUROSCI, V17, P601, DOI 10.1038/nn.3667	36	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2019	14	8							e0220896	10.1371/journal.pone.0220896	http://dx.doi.org/10.1371/journal.pone.0220896			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW5XV	31461444	Green Published, Green Submitted, gold			2022-12-26	WOS:000485052300018
J	Rhodes, KL; Baremore, I; Graham, RT				Rhodes, Kevin L.; Baremore, Ivy; Graham, Rachel T.			Grouper (Epinephelidae) spawning aggregations affect activity space of grey reef sharks, Carcharhinus amblyrhynchos, in Pohnpei, Micronesia	PLOS ONE			English	Article							BROWN-MARBLED GROUPER; NASSAU GROUPER; WHALE SHARKS; RED HIND; CAMOUFLAGE GROUPER; RHINCODON-TYPUS; MOVEMENT; DYNAMICS; PATTERNS; VULNERABILITY	Fish spawning aggregations (FSA) act as biological hotspots that concentrate food and nutrients across a broad trophic spectrum. In Pohnpei (Federated States of Micronesia), 20 female grey reef sharks (Carcharhinus amblyrhynchos) were acoustically tagged at two multi-species grouper (Epinephelidae) FSA to examine the likelihood that these mesopredators utilize FSA as a seasonal food source. Both FSA sites are within small-scale MPAs, thus providing a secondary opportunity to examine their conservation potential during these ephemeral events. Shark movement and residency was gauged against known spatial and temporal grouper reproductive patterns using an array of 15 and 50 acoustic receivers at Ant Atoll and Pohnpei (Island), respectively. Activity space was investigated using Kernel Density estimates of individual sharks, and residency indices (RI) were analyzed based on daily and monthly occurrence at the array. Three distinct residency patterns were identified: transient, semi-transient, or resident (Daily RI <0.40, >0.40 to 0.80, or >0.80, respectively). Generalized linear mixed models (GLMMs) were used to identify biological and environmental factors influencing shark activity space, including month, temperature, shark size, spawning month, and residency pattern. Findings revealed significant changes in average monthly residency indices and kernel densities during spawning months in support of an opportunistic foraging strategy around FSA. Monthly residency was higher during spawning months among semi-resident and transient sharks, while average monthly activity space was concentrated around FSA. Best-fit models for the GLMM indicated that activity spaces were most influenced by month and grouper spawning month. Seven of 20 sharks demonstrated inter-island movement and wide variations in individual movement and spatial requirements were shown. The concentration of sharks and groupers at unprotected FSA sites increases their vulnerability to fishing and supports the need for combined area and non-area management measures to effectively protect these species.	[Rhodes, Kevin L.; Baremore, Ivy; Graham, Rachel T.] MarAlliance, San Francisco, CA 94107 USA; [Rhodes, Kevin L.] Pacific Marine Sci & Conservat, Grass Valley, CA 95945 USA		Rhodes, KL (corresponding author), MarAlliance, San Francisco, CA 94107 USA.; Rhodes, KL (corresponding author), Pacific Marine Sci & Conservat, Grass Valley, CA 95945 USA.	klrhodes_grouper@yahoo.com		Baremore, Ivy/0000-0002-7088-2219; Rhodes, Kevin/0000-0003-2085-5527	Pohnpei State Department of Lands and Natural Resources; Pohnpei State Office of Fisheries and Aquaculture	Pohnpei State Department of Lands and Natural Resources; Pohnpei State Office of Fisheries and Aquaculture	The Pohnpei State Department of Lands and Natural Resources and Office of Fisheries and Aquaculture provided support throughout the study. Taylor Paul, Trace Loren, Scotty Malakai, and Quincy Malakai captured the animals. Rich Adams provided housing during tagging operations and Anthony Nolan provided goods and services throughout the project. This paper is dedicated to Zeddy Seymour.	Aguilar-Perera A, 2006, MAR ECOL PROG SER, V327, P289, DOI 10.3354/meps327289; Akaike H., 1973, P 2 INT S INF THEOR, P267, DOI 10.1007/978-1-4612-1694-0; Anderson RC, 1998, NEWSLETTER IUCN SSC; Archer SK, 2015, CORAL REEFS, V34, P19, DOI 10.1007/s00338-014-1208-4; Barnett A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036574; Barton K., 2013, MUMIN MULTI MODEL IN; Beerkircher L.R., 2002, MAR FISH REV, V64, P40, DOI DOI 10.1037/0003-066x.59.1.29; Beets J, 1999, ENVIRON BIOL FISH, V55, P91, DOI 10.1023/A:1007404421518; Bijoux J, 2013, ENDANGER SPECIES RES, V22, P145, DOI 10.3354/esr00534; Bond ME, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032983; Calenge C, 2006, ECOL MODEL, V197, P516, DOI 10.1016/j.ecolmodel.2006.03.017; Venegas RD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018994; DeMitcheson YS, 2012, FISH FISH SER, V35, P1, DOI 10.1007/978-94-007-1980-4; *DEV COR TEAM, 2008, R LANG ENV STAT COMP; Erisman B, 2017, FISH FISH, V18, P128, DOI 10.1111/faf.12132; Erisman B, 2012, SCI REP-UK, V2, DOI 10.1038/srep00284; Espinoza M, 2015, MAR BIOL, V162, P343, DOI 10.1007/s00227-014-2572-x; Espinoza M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106885; Etpison Mandy T., 2018, Aqua, V23, P121; Francis MP, 2006, ENVIRON BIOL FISH, V77, P407, DOI 10.1007/s10641-006-9109-1; Graham NAJ, 2010, AQUAT CONSERV, V20, P543, DOI 10.1002/aqc.1116; Graham RT, 2012, CORAL REEFS, V31, P1017, DOI 10.1007/s00338-012-0921-0; Graham RT, 2006, J ROY SOC INTERFACE, V3, P109, DOI 10.1098/rsif.2005.0082; Green AL, 2015, BIOL REV, V90, P1215, DOI 10.1111/brv.12155; Hamilton RJ, 2012, BIOL CONSERV, V145, P246, DOI 10.1016/j.biocon.2011.11.020; Hamilton RJ, 2011, BIOL CONSERV, V144, P1850, DOI 10.1016/j.biocon.2011.03.024; Hamilton R. J., 2006, SPC LIVE REEF FISH I, V16, P13; Hartup JA, 2013, CORAL REEFS, V32, P367, DOI 10.1007/s00338-013-1022-4; Heupel MR, 2014, MAR ECOL PROG SER, V496, P47, DOI 10.3354/meps10529; Heupel MR, 2009, FISH RES, V95, P350, DOI 10.1016/j.fishres.2008.10.005; Heupel MR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009650; Heyman WD, 2001, MAR ECOL PROG SER, V215, P275, DOI 10.3354/meps215275; Heyman WD, 2008, B MAR SCI, V83, P531; Hoffmayer Eric R., 2007, Gulf and Caribbean Research, V19, P69; Houk P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130823; Hueter R. E., 2005, Journal of Northwest Atlantic Fishery Science, V35, P239; Hutchinson N, 2010, CORAL REEFS, V29, P511, DOI 10.1007/s00338-010-0584-7; Jacoby DMP, 2010, BEHAV ECOL, V21, P808, DOI 10.1093/beheco/arq061; Johannes RE, 1999, MARINE CONSERVATION, P144; Laffoley D, 2014, AQUAT CONSERV, V24, P238, DOI 10.1002/aqc.2531; Lararidis E., 2014, LUNAR LUNAR PHASE DI; MCKIBBEN JN, 1986, B MAR SCI, V38, P89; de Mitcheson YS, 2013, FISH FISH, V14, P119, DOI 10.1111/j.1467-2979.2011.00455.x; Mourier J, 2016, CURR BIOL, V26, P2011, DOI 10.1016/j.cub.2016.05.058; Mucientes GR, 2009, BIOL LETTERS, V5, P156, DOI 10.1098/rsbl.2008.0761; Nemeth RS, 2007, ENVIRON BIOL FISH, V78, P365, DOI 10.1007/s10641-006-9161-x; Nemeth RS, 2012, FISH FISH SER, V35, P21, DOI 10.1007/978-94-007-1980-4_2; Nemeth RS, 2005, MAR ECOL PROG SER, V286, P81, DOI 10.3354/meps286081; Olsen D. A., 1978, P GULF CARIB FISH I, V131, P130; Pebesma E.J., 2005, R NEWS, V5, P9; Pickard AE, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151221; Rhodes KL, 2008, CORAL REEFS, V27, P443, DOI 10.1007/s00338-007-0331-x; Rhodes KL, 2014, CORAL REEFS, V33, P765, DOI 10.1007/s00338-014-1172-z; Rhodes KL, 2012, CORAL REEFS, V31, P443, DOI 10.1007/s00338-012-0875-2; Rhodes KL, 2008, FISH B-NOAA, V106, P194; Rhodes KL, 2011, MAR ECOL PROG SER, V421, P183, DOI 10.3354/meps08904; Rhodes KL, 2002, ENVIRON BIOL FISH, V63, P27, DOI 10.1023/A:1013840621820; Robbins WD, 2006, CURR BIOL, V16, P2314, DOI 10.1016/j.cub.2006.09.044; ROBERTSON DR, 1983, ENVIRON BIOL FISH, V9, P193, DOI 10.1007/BF00692372; Robinson DP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058255; Sadovy Y, 2005, CORAL REEFS, V24, P254, DOI 10.1007/s00338-005-0474-6; Sancho G, 2000, MAR ECOL PROG SER, V203, P275, DOI 10.3354/meps203275; Schlaff AM, 2017, MAR ECOL PROG SER, V571, P169, DOI 10.3354/meps12107; Simpfendorfer CA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016918; Sims David W., 2005, P127; Smale M. J., 2009, IUCN RED LIST THREAT, V2009, DOI [10.2305/IUCN.UK.2009-2.RLTS.T39365A10216946.en, DOI 10.2305/IUCN.UK.2009-2.RLTS.T39365A10216946.EN]; Smith SE, 1998, MAR FRESHWATER RES, V49, P663, DOI 10.1071/MF97135; Speed CW, 2010, MAR ECOL PROG SER, V408, P275, DOI 10.3354/meps08581; Starr RM, 2007, MAR ECOL PROG SER, V343, P239, DOI 10.3354/meps06897; Strasburg DW., 1958, FISHERY B, V138; Vianna GMS, 2012, PLOS ONE, V8, DOI [10.1371/journal.pone.0042437, DOI 10.1371/JOURNAL.PONE.0042437]; Waldie PA, 2016, ROY SOC OPEN SCI, V3, DOI 10.1098/rsos.150694; Warren-Rhodes K, 2003, AMBIO, V32, P481, DOI 10.1639/0044-7447(2003)032[0481:MEAITI]2.0.CO;2; Weideli OC, 2015, CORAL REEFS, V34, P835, DOI 10.1007/s00338-015-1290-2; Wetherbee BM, 1997, MAR ECOL PROG SER, V151, P181, DOI 10.3354/meps151181; Whaylen L, 2004, ENVIRON BIOL FISH, V70, P305, DOI 10.1023/B:EBFI.0000033341.57920.a8; White TD, 2017, BIOL CONSERV, V207, P64, DOI 10.1016/j.biocon.2017.01.009; WORTON BJ, 1989, ECOLOGY, V70, P164, DOI 10.2307/1938423; Zar JH, 1999, BIOSTATISTICAL ANAL; Zuur Alain F., 2009, P1	80	5	5	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2019	14	8							e0221589	10.1371/journal.pone.0221589	http://dx.doi.org/10.1371/journal.pone.0221589			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5XV	31461474	Green Published, gold, Green Submitted			2022-12-26	WOS:000485052300037
J	Rungruangsak-Torrissen, K; Manoonpong, P				Rungruangsak-Torrissen, Krisna; Manoonpong, Poramate			Neural computational model GrowthEstimate: A model for studying living resources through digestive efficiency	PLOS ONE			English	Article							SPECIES IDENTIFICATION; STOCK ASSESSMENTS; GROWTH; FISH; NETWORKS; SYSTEMS	The neural computational model GrowthEstimate is introduced with focusing on new perspectives for the practical estimation of weight specific growth rate (SGR, % day(-1)). It is developed using recurrent neural networks of reservoir computing type, for estimating SGR based on the known data of three key biological factors relating to growth. These factors are: (1) weight (g) for specifying the age of the growth stage; (2) digestive efficiency through the pyloric caecal activity ratio of trypsin to chymotrypsin (T/C ratio) for specifying genetic differences in food utilization and growth potential, basically resulting from food consumption under variations in food quality and environmental conditions; and (3) protein growth efficiency through the condition factor (CF, 100 x g cm(-3)), as higher dietary protein level affecting higher skeletal growth (length) and resulting in lower CF. The computational model was trained using four datasets of different salmonids with size variations. It was evaluated with 15% of each dataset, resulting in an acceptable range of SGR outputs. Additional tests with different species indicated similarity between the estimated SGR outputs and the real SGR values, and the same ranking of wild population growth. The developed model GrowthEstimate is exceptionally useful for the precise and comparable growth estimation of living resources at individual levels, especially in natural ecosystems where the studied individuals, environmental conditions, food availability and consumption rates cannot be controlled. It is a revelation and will help to minimize uncertainty in wild stock assessment process. This will improve our knowledge in nutritional ecology, through the biochemical effects of climate change and environmental impact on the growth performance quality of aquatic living resources in the wild, as well as in aquaculture. The original GrowthEstimate software is available at GitHub repository (https://github.com/RungruangsakTorrissenManoonpong/GrowthEstimate). All other relevant data are within the paper. It will be improved for generality for future use, and required co-operations of the biodata collections of different species from different climate zones. Therefore, a co-operation will be available.	[Rungruangsak-Torrissen, Krisna] Inst Marine Res, Ecosyst Proc Res Grp, Matredal, Norway; [Manoonpong, Poramate] Univ Southern Denmark, Maersk Mc Kinney Moller Inst, Ctr Biorobot, Embodied Artificial Intelligence & Neurorobot Lab, Odense M, Denmark; [Manoonpong, Poramate] Vidyasirimedhi Inst Sci & Technol, Sch Informat Sci & Technol, Bioinspired Robot & Neural Engn Lab, Rayong, Thailand	Institute of Marine Research - Norway; University of Southern Denmark; Vidyasirimedhi Institute of Science & Technology	Rungruangsak-Torrissen, K (corresponding author), Inst Marine Res, Ecosyst Proc Res Grp, Matredal, Norway.; Manoonpong, P (corresponding author), Univ Southern Denmark, Maersk Mc Kinney Moller Inst, Ctr Biorobot, Embodied Artificial Intelligence & Neurorobot Lab, Odense M, Denmark.; Manoonpong, P (corresponding author), Vidyasirimedhi Inst Sci & Technol, Sch Informat Sci & Technol, Bioinspired Robot & Neural Engn Lab, Rayong, Thailand.	Krisnart@outlook.com; poma@mmmi.sdu.dk		Rungruangsak-Torrissen, Krisnart/0000-0001-6545-1935				Abhishek K, 2012, PROC TECH, V4, P311, DOI 10.1016/j.protcy.2012.05.047; Agatonovic-Kustrin S, 2000, J PHARMACEUT BIOMED, V22, P717, DOI 10.1016/S0731-7085(99)00272-1; Allken V, 2019, ICES J MAR SCI, V76, P342, DOI 10.1093/icesjms/fsy147; Almeida JS, 2002, CURR OPIN BIOTECH, V13, P72, DOI 10.1016/S0958-1669(02)00288-4; Anderson SC, 2017, FISH FISH, V18, P732, DOI 10.1111/faf.12200; Benzer R., 2015, INT J FISH AQUA STUD, V2, P341; Cabreira AG, 2009, ICES J MAR SCI, V66, P1119, DOI 10.1093/icesjms/fsp009; Chamchuen Phanu, 2014, Journal of Marine Biology, P436789; Ching T, 2018, J R SOC INTERFACE, V15, DOI 10.1098/rsif.2017.0387; Dasgupta S, 2015, FRONT NEUROROBOTICS, V9, DOI 10.3389/fnbot.2015.00010; Dasgupta S, 2013, EVOL SYST-GER, V4, P235, DOI 10.1007/s12530-013-9080-y; Deng ZD, 2006, IEEE IJCNN, P3128; Egmont-Petersen M, 2002, PATTERN RECOGN, V35, P2279, DOI 10.1016/S0031-3203(01)00178-9; Falk T, 2019, NAT METHODS, V16, P67, DOI 10.1038/s41592-018-0261-2; Franceschini S, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22761-4; Goudarzi A, 2014, PREPRINT; He X, 2016, FISH RES, V180, P92, DOI 10.1016/j.fishres.2015.08.018; Hermans M, 2012, NEURAL COMPUT, V24, P104, DOI 10.1162/NECO_a_00200; HOUDE E D, 1981, Rapports et Proces-Verbaux des Reunions Conseil International pour l'Exploration de la Mer, V178, P441; Jaeger H, 2004, SCIENCE, V304, P78, DOI 10.1126/science.1091277; Jaeger H., 2002, P ADV NEURAL INFORM, V15, P609; Jones W, 2017, EMERG TOP LIFE SCI, V1, P257, DOI 10.1042/ETLS20160025; Koenigstein S, 2016, FISH FISH, V17, P972, DOI 10.1111/faf.12155; Kolody DS, 2016, FISH RES, V180, P177, DOI 10.1016/j.fishres.2015.06.016; Lawson GL, 2001, ICES J MAR SCI, V58, P275, DOI 10.1006/jmsc.2000.1009; Miller TH, 2019, SCI TOTAL ENVIRON, V648, P80, DOI 10.1016/j.scitotenv.2018.08.122; Pu LM, 2019, PLOS COMPUT BIOL, V15, DOI 10.1371/journal.pcbi.1006718; Punt AE, 2016, FISH RES, V180, P147, DOI 10.1016/j.fishres.2014.11.007; Ricker W.E., 1979, BIOENERGETICS GROWTH, VVIII, P677, DOI DOI 10.1016/S1546-5098(08)60034-5; Rungruangsak-Torrissen K, 2006, FISH PHYSIOL BIOCHEM, V32, P7, DOI 10.1007/s10695-005-0630-5; Rungruangsak-Torrissen K, 1998, FISH PHYSIOL BIOCHEM, V19, P247, DOI 10.1023/A:1007731717021; Rungruangsak-Torrissen K, 2001, LOW WAKE FI, V17, P415; Rungruangsak-Torrissen K., 2018, BIOCH TECHNIQUES DEV; Rungruangsak-Torrissen K, 2012, TRYPSIN STRUCTURE BI, P1; Rungruangsak-Torrissen K, 2009, SCH RES EXCH, V2009; Rungruangsak-Torrissen K, 2014, SALMON BIOL ECOLOGIC, P85; Rungruangsak-Torrissen K, 2007, J FOOD BIOCHEM, V31, P726, DOI 10.1111/j.1745-4514.2007.00139.x; Rungruangsak-Torrissen K, 2007, J FOOD BIOCHEM, V31, P509, DOI 10.1111/j.1745-4514.2007.00127.x; Rungruangsak-Torrissen K, 2009, FISH PHYSIOL BIOCHEM, V35, P255, DOI 10.1007/s10695-008-9206-5; RUNGRUANGSAKTORRISSEN K, 2012, OPEN FISH SCI J, V5, P44, DOI DOI 10.2174/1874401X01205010044; Siddiqui SA, 2018, ICES J MAR SCI, V75, P374, DOI 10.1093/icesjms/fsx109; Simmonds EJ, 1996, ICES J MAR SCI, V53, P189; Smart JJ, 2016, FISH FISH, V17, P955, DOI 10.1111/faf.12154; Sunde J, 2001, FISH PHYSIOL BIOCHEM, V25, P335, DOI 10.1023/A:1023233024001; Suryanarayana I, 2008, FISH RES, V92, P115, DOI 10.1016/j.fishres.2008.01.012; Tharwat A, 2018, FISH RES, V204, P324, DOI 10.1016/j.fishres.2018.03.008; Villon S, 2018, ECOL INFORM, V48, P238, DOI 10.1016/j.ecoinf.2018.09.007; Webb S, 2018, NATURE, V554, P555, DOI 10.1038/d41586-018-02174-z; Webber DN, 2016, FISH RES, V180, P67, DOI 10.1016/j.fishres.2015.08.016; Xu Y, 2016, FISH RES, V180, P138, DOI 10.1016/j.fishres.2015.08.017	50	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2019	14	8							e0216030	10.1371/journal.pone.0216030	http://dx.doi.org/10.1371/journal.pone.0216030			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5XV	31461459	Green Published, Green Submitted, gold			2022-12-26	WOS:000485052300004
J	Crum, TE; Schnabel, RD; Decker, JE; Regitano, LCA; Taylor, JF				Crum, Tamar E.; Schnabel, Robert D.; Decker, Jared E.; Regitano, Luciana C. A.; Taylor, Jeremy F.			CRUMBLER: A tool for the prediction of ancestry in cattle	PLOS ONE			English	Article							POPULATION-STRUCTURE; INFERENCE	In many beef and some dairy production systems, crossbreeding is used to take advantage of breed complementarity and heterosis. Admixed animals are frequently identified by their coat color and body conformation phenotypes, however, without pedigree information it is not possible to identify the expected breed composition of an admixed animal and in the presence of selection, the actual composition may differ from expectation. As the roles of DNA and genotype data become more pervasive in animal agriculture, a systematic method for estimating the breed composition (the proportions of an animal's genome originating from ancestral pure breeds) has utility for a variety of downstream analyses including the estimation of genomic breeding values for crossbred animals, the estimation of quantitative trait locus effects, and heterosis and heterosis retention in advanced generation composite animals. Currently, there is no automated or semi-automated ancestry estimation platform for cattle and the objective of this study was to evaluate the utility of extant public software for ancestry estimation and determine the effects of reference population size and composition and number of utilized single nucleotide polymorphism loci on ancestry estimation. We also sought to develop an analysis pipeline that would simplify this process for members of the livestock genomics research community. We developed and tested a tool, "CRUMBLER", to estimate the global ancestry of cattle using ADMIXTURE and SNPweights based on a defined reference panel. CRUMBLER, was developed and evaluated in cattle, but is a species agnostic pipeline that facilitates the streamlined estimation of breed composition for individuals with potentially complex ancestries using publicly available global ancestry software and a specified reference population SNP dataset. We developed the reference panel from a large cattle genotype data set and breed association pedigree information using iterative analyses to identify purebred individuals that were representative of each breed. We also evaluated the numbers of markers necessary for breed composition estimation and simulated genotypes for advanced generation composite animals to evaluate the precision of the developed tool. The developed CRUMBLER pipeline extracts a specified subset of genotypes that is common to all current commercially available genotyping platforms, processes these into the file formats required for the analysis software, and predicts admixture proportions using the specified reference population allele frequencies.	[Crum, Tamar E.; Schnabel, Robert D.; Decker, Jared E.; Taylor, Jeremy F.] Univ Missouri, Div Anim Sci, Columbia, MO 65211 USA; [Schnabel, Robert D.; Decker, Jared E.] Univ Missouri, Informat Inst, Columbia, MO USA; [Regitano, Luciana C. A.] Embrapa Pecuaria Sudeste, Sao Carlos, SP, Brazil	University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA)	Crum, TE; Taylor, JF (corresponding author), Univ Missouri, Div Anim Sci, Columbia, MO 65211 USA.	tamar.crum@mail.missouri.edu; taylorjerr@missouri.edu	Regitano, Luciana/C-7002-2012	Regitano, Luciana/0000-0001-9242-8351; Decker, Jared/0000-0001-5685-7343	NIHUSDA Dual Purpose with Dual Benefit Program [NIH 1R01HD084353]; USDA-NIFA [2013-6800420364, 2015-67015-23183, 2016-67015-24923, 2017-67015-26760]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD084353] Funding Source: NIH RePORTER	NIHUSDA Dual Purpose with Dual Benefit Program; USDA-NIFA(United States Department of Agriculture (USDA)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	JT and RS appreciate the support of NIHUSDA Dual Purpose with Dual Benefit Program grant number NIH 1R01HD084353. JT and RS are supported by USDA-NIFA grants 2013-6800420364, 2015-67015-23183, 2016-67015-24923 and 2017-67015-26760. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander DH, 2009, GENOME RES, V19, P1655, DOI 10.1101/gr.094052.109; Burnett MS, 2006, AM J EPIDEMIOL, V163, P486, DOI 10.1093/aje/kwj057; Chang CC, 2015, GIGASCIENCE, V4, DOI 10.1186/s13742-015-0047-8; Chen CY, 2013, BIOINFORMATICS, V29, P1399, DOI 10.1093/bioinformatics/btt144; Decker JE, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004254; Decker JE, 2009, P NATL ACAD SCI USA, V106, P18644, DOI 10.1073/pnas.0904691106; Kuehn LA, 2011, J ANIM SCI, V89, P1742, DOI 10.2527/jas.2010-3530; Lawson DJ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05257-7; Leesburg VLR, 2014, J ANIM SCI, V92, P2387, DOI 10.2527/jas.2013-6890; MCCANN LP, 1974, BATTLE BULL RUNTS; Neibergs HL, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1164; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Pritchard JK, 2000, GENETICS, V155, P945; Puechmaille SJ, 2016, MOL ECOL RESOUR, V16, P608, DOI 10.1111/1755-0998.12512; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Raj A, 2014, GENETICS, V197, P573, DOI 10.1534/genetics.114.164350; Saatchi M, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1004; SANDERS JO, 1980, J ANIM SCI, V50, P1188, DOI 10.2527/jas1980.5061188x; Seabury CM, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3754-y; Wang JL, 2017, MOL ECOL RESOUR, V17, P981, DOI 10.1111/1755-0998.12650; Whitacre L, 2014, STRUCTURAL VARIATION; Wiedemar N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093435	23	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2019	14	8							e0221471	10.1371/journal.pone.0221471	http://dx.doi.org/10.1371/journal.pone.0221471			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5UR	31449539	Green Published, Green Submitted, gold			2022-12-26	WOS:000485044000018
J	Amirfallah, A; Arason, A; Einarsson, H; Gudmundsdottir, ET; Freysteinsdottir, ES; Olafsdottir, KA; Johannsson, OT; Agnarsson, BA; Barkardottir, RB; Reynisdottir, I				Amirfallah, Arsalan; Arason, Adalgeir; Einarsson, Hjorleifur; Gudmundsdottir, Eydis Thorunn; Freysteinsdottir, Edda Sigridur; Olafsdottir, Kristrun Audur; Johannsson, Oskar Thor; Agnarsson, Bjarni Agnar; Barkardottir, Rosa Bjork; Reynisdottir, Inga			High expression of the vacuole membrane protein 1 (VMP1) is a potential marker of poor prognosis in HER2 positive breast cancer	PLOS ONE			English	Article							COMPREHENSIVE MOLECULAR PORTRAITS; FUSION TRANSCRIPTS; SOMATIC MUTATIONS; WORSE PROGNOSIS; GENE FUSION; AUTOPHAGY; MACROAUTOPHAGY; ABERRATIONS; METASTASIS; LANDSCAPE	Background Fusion genes result from genomic structural changes, which can lead to alterations in gene expression that supports tumor development. The aim of the study was to use fusion genes as a tool to identify new breast cancer (BC) genes with a role in BC progression. Methods Fusion genes from breast tumors and BC cell lines were collected from publications. RNA-Seq data from tumors and cell lines were retrieved from databanks and analyzed for fusions with SOAPfuse or the analysis was purchased. Fusion genes identified in both tumors (n = 1724) and cell lines (n = 45) were confirmed by qRT-PCR and sequencing. Their individual genes were ranked by selection criteria that included correlation of their mRNA level with copy number. The expression of the top ranked gene was measured by qRT-PCR in normal tissue and in breast tumors from an exploratory cohort (n = 141) and a validation cohort (n = 277). Expression levels were correlated with clinical and pathological factors as well as the patients' survival. The results were followed up in BC cohorts from TCGA (n = 818) and METABRIC (n = 2509). Results Vacuole membrane protein 1 (VMP1) was the most promising candidate based on specific selection criteria. Its expression was higher in breast tumor tissue than normal tissue (p = 1x10(-4)), and its expression was significantly higher in HER2 positive than HER2 negative breast tumors in all four cohorts analyzed. High expression of VMP1 associated with breast cancer specific survival (BCSS) in cohort 1 (hazard ratio (HR) = 2.31, CI 1.27-4.18) and METABRIC (HR = 1.26, CI 1.02-1.57), and also after adjusting for HER2 expression in cohort 1 (HR = 2.03, CI 1.10-3.72). BCSS was not significant in cohort 2 or TCGA cohort, which may be due to differences in treatment regimens. Conclusions The results suggest that high VMP1 expression is a potential marker of poor prognosis in HER2 positive BC. Further studies are needed to elucidate how VMP1 could affect pathways supportive of tumorigenesis.	[Amirfallah, Arsalan; Einarsson, Hjorleifur; Gudmundsdottir, Eydis Thorunn; Reynisdottir, Inga] Natl Univ Hosp Iceland, Cell Biol Unit Pathol Dept, Landspitali, Reykjavik, Iceland; [Amirfallah, Arsalan; Arason, Adalgeir; Barkardottir, Rosa Bjork; Reynisdottir, Inga] Univ Iceland, Biomed Ctr, Reykjavik, Iceland; [Arason, Adalgeir; Freysteinsdottir, Edda Sigridur; Barkardottir, Rosa Bjork] Natl Univ Hosp Iceland, Landspitali, Mol Pathol Unit, Pathol Dept, Reykjavik, Iceland; [Olafsdottir, Kristrun Audur; Agnarsson, Bjarni Agnar] Natl Univ Hosp Iceland, Landspitali, Pathol Dept, Reykjavik, Iceland; [Johannsson, Oskar Thor] Natl Univ Hosp Iceland, Landspitali, Dept Oncol, Reykjavik, Iceland; [Agnarsson, Bjarni Agnar] Univ Iceland, Fac Med, Reykjavik, Iceland; [Einarsson, Hjorleifur] Univ Copenhagen, Sect Computat & RNA Biol, Dept Biol, Copenhagen, Denmark	University of Iceland; Landspitali National University Hospital; Landspitali National University Hospital; Landspitali National University Hospital; University of Iceland; University of Copenhagen	Reynisdottir, I (corresponding author), Natl Univ Hosp Iceland, Cell Biol Unit Pathol Dept, Landspitali, Reykjavik, Iceland.; Reynisdottir, I (corresponding author), Univ Iceland, Biomed Ctr, Reykjavik, Iceland.	ingar@landspitali.is	Amirfallah, Arsalan/HHS-4478-2022	Reynisdottir, Inga/0000-0002-9730-7476	Icelandic Centre [152530-051]; Scientific Fund of Landspitali-The National University Hospital in Iceland [A-2015-039, A-2018-034]; Gongum saman	Icelandic Centre; Scientific Fund of Landspitali-The National University Hospital in Iceland; Gongum saman	This work was supported by a grant to IR, RBB, BAA, OTJ and Ad Ar from The Icelandic Centre for Research Fund (152530-051, www.rannis.is), to IR, RBB, BAA and OTJ from The Scientific Fund of Landspitali -The National University Hospital in Iceland (A-2015-039, A-2018-034, www.landspitali.is), and grants from Gongum saman (2013 and 2017 to IR and RBB, and 2018 to Ar Am, http://www.gongumsaman.is/).The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank Dr. Helga M. Ogmundsdottir for her thorough review of the manuscript and Dr. Katrin Halldorsdottir for her assistance with figures. The authors also thank the ladies in Gongum saman for their enthusiasm as well as their efforts to support scientists working on breast cancer in Iceland.	Andersen CL, 2002, AM J PATHOL, V161, P73, DOI 10.1016/S0002-9440(10)64158-2; Asmann YW, 2012, CANCER RES, V72, P1921, DOI 10.1158/0008-5472.CAN-11-3142; Asmann YW, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr362; Banerji S, 2012, NATURE, V486, P405, DOI 10.1038/nature11154; Bradburn MJ, 2003, BRIT J CANCER, V89, P605, DOI 10.1038/sj.bjc.6601120; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chen SN, 2016, TUMOR BIOL, V37, P2321, DOI 10.1007/s13277-015-3800-9; Ciriello G, 2015, CELL, V163, P506, DOI 10.1016/j.cell.2015.09.033; Curtis C, 2012, NATURE, V486, P346, DOI 10.1038/nature10983; Edgren H, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-1-r6; Fujita S, 2008, J MOL BIOL, V378, P492, DOI 10.1016/j.jmb.2008.03.015; Galluzzi L, 2015, EMBO J, V34, P856, DOI 10.15252/embj.201490784; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Gilabert M, 2013, J CELL PHYSIOL, V228, P1834, DOI 10.1002/jcp.24343; Gudmundsdottir ET, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-621; Guo L, 2012, CANCER SCI, V103, P2110, DOI 10.1111/cas.12025; Guo XZ, 2015, ONCOL REP, V34, P2557, DOI 10.3892/or.2015.4240; Hampton OA, 2009, GENOME RES, V19, P167, DOI 10.1101/gr.080259.108; Haverty PM, 2008, GENE CHROMOSOME CANC, V47, P530, DOI 10.1002/gcc.20558; Hu ZY, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-96; Inaki K, 2011, GENOME RES, V21, P676, DOI 10.1101/gr.113225.110; Jacot W, 2013, BBA-REV CANCER, V1836, P146, DOI 10.1016/j.bbcan.2013.04.004; Jarman EJ, 2019, BREAST CANCER RES, V21, DOI 10.1186/s13058-019-1097-0; Jasra S, 2018, CURR TREAT OPTION ON, V19, DOI 10.1007/s11864-018-0547-8; Jia WL, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-2-r12; Jonsson G, 2012, CANCER RES, V72, P4028, DOI 10.1158/0008-5472.CAN-12-0097; Jonsson G, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2596; Kalyana-Sundaram S, 2012, NEOPLASIA, V14, P702, DOI 10.1593/neo.12914; Kangaspeska S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048745; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Letessier A, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-245; Liu YH, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07264-0; Lo Re AE, 2012, J BIOL CHEM, V287, P25325, DOI 10.1074/jbc.M112.370809; Loncle C, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.202; Molejon MI, 2013, AUTOPHAGY, V9, P933, DOI 10.4161/auto.24390; Molejon MI, 2013, SCI REP-UK, V3, DOI 10.1038/srep01055; Natrajan R, 2009, CLIN CANCER RES, V15, P2711, DOI 10.1158/1078-0432.CCR-08-1878; Nik-Zainal S, 2016, NATURE, V534, P47, DOI 10.1038/nature17676; Parker BC, 2013, J CLIN INVEST, V123, P855, DOI 10.1172/JCI67144; Pereira B, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11479; Perez-Tenorio G, 2011, BREAST CANCER RES TR, V128, P713, DOI 10.1007/s10549-010-1058-x; Persson H, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01176-1; Qadir MA, 2008, BREAST CANCER RES TR, V112, P389, DOI 10.1007/s10549-007-9873-4; Ren L, 2018, J CANCER, V9, P2082, DOI 10.7150/jca.23681; Reynisdottir I, 2013, CANCER MED-US, V2, P437, DOI 10.1002/cam4.88; Ribas J, 2012, NUCLEIC ACIDS RES, V40, P6821, DOI 10.1093/nar/gks308; Rodriguez ME, 2017, PHOTOCH PHOTOBIO SCI, V16, P1631, DOI 10.1039/c7pp00161d; Rueda OM, 2019, NATURE, V567, P399, DOI 10.1038/s41586-019-1007-8; Sahlberg KK, 2013, MOL ONCOL, V7, P392, DOI 10.1016/j.molonc.2012.10.012; Samaddar JS, 2008, MOL CANCER THER, V7, P2977, DOI 10.1158/1535-7163.MCT-08-0447; Sauermann M, 2008, ONCOGENE, V27, P1320, DOI 10.1038/sj.onc.1210743; Schulte I, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-719; Siegel RL, 2018, CA-CANCER J CLIN, V68, P7, DOI 10.3322/caac.21442; Singh SS, 2017, ONCOGENE; Staaf J, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2568; Stephens PJ, 2009, NATURE, V462, P1005, DOI 10.1038/nature08645; Tabara LC, 2019, INT J DEV BIOL; Tabara LC, 2018, TRAFFIC, V19, P624, DOI 10.1111/tra.12581; Tognon C, 2002, CANCER CELL, V2, P367, DOI 10.1016/S1535-6108(02)00180-0; Tomlins SA, 2005, SCIENCE, V310, P644, DOI 10.1126/science.1117679; Vazquez-Martin A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006251; Vega-Rubin-de-Celis S, 2018, P NATL ACAD SCI USA, V115, P4176, DOI 10.1073/pnas.1717800115; Watson IR, 2013, NAT REV GENET, V14, P703, DOI 10.1038/nrg3539; Yoshihara K, 2015, ONCOGENE, V34, P4845, DOI 10.1038/onc.2014.406; Zhao YG, 2017, MOL CELL, V67, P974, DOI 10.1016/j.molcel.2017.08.005; Zheng LL, 2016, MOL CELL BIOCHEM, V416, P1, DOI 10.1007/s11010-016-2684-3; Zhou YT, 2016, ACTA BIOCH BIOPH SIN, V48, P60, DOI 10.1093/abbs/gmv119; Zimmerman MW, 2017, CANC DISCOV	68	4	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2019	14	8							e0221413	10.1371/journal.pone.0221413	http://dx.doi.org/10.1371/journal.pone.0221413			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5TR	31442252	Green Submitted, gold, Green Published			2022-12-26	WOS:000485041400032
J	Fraleigh, NL; Oliva, R; Lewicky, JD; Martel, AL; Acevedo, R; Dagmar, GR; Le, HT				Fraleigh, Nya L.; Oliva, Reynaldo; Lewicky, Jordan D.; Martel, Alexandrine L.; Acevedo, Reinaldo; Dagmar, Garcia-Rivera; Hoang-Thanh Le			Assessing the immunogenicity and toxicity of the AFPL1-conjugate nicotine vaccine using heterologous and homologous vaccination routes	PLOS ONE			English	Article							NEISSERIA-MENINGITIDIS; PROTEOLIPOSOME; MUCOSAL; ADJUVANTS; RESPONSES; EFFICACY; CELLS	Despite the increased risks of cancers and cardiovascular related diseases, tobacco smoking continues to be prevalent in the population due largely in part to the addictive nature of nicotine. Nicotine vaccines are an attractive alternative to the current smoking cessation options but have yet to be successful enough in clinical trials to reach the market due to a lack of neutralizing antibodies and inconsistent results. Using AFPL1 derived from the Cuban meningococcal vaccine as an adjuvant, we have previously published promising results with an intranasally administered nicotine vaccine. In order to examine the immunogenicity and safety of this vaccine in mice we set up a pilot trial administering the vaccine either intranasally, intramuscularly or utilizing both routes simultaneously and evaluated immune responses and clinical symptoms throughout the duration of the vaccination protocol and post-mortem. These data further demonstrate the ability of the AFPL1 nicotine conjugate vaccine to be a safe and potential candidate for clinical use.	[Fraleigh, Nya L.; Lewicky, Jordan D.; Martel, Alexandrine L.; Hoang-Thanh Le] Hlth Sci North Res Inst, Sudbury, ON, Canada; [Oliva, Reynaldo; Acevedo, Reinaldo; Dagmar, Garcia-Rivera] Finlay Inst Vaccines, Havana, Cuba; [Hoang-Thanh Le] Northern Ontario Sch Med, Med Sci Div, Sudbury, ON, Canada; [Hoang-Thanh Le] Laurentian Univ, Chem & Biochem Dept, Sudbury, ON, Canada; [Hoang-Thanh Le] Laurentian Univ, Biol Dept, Sudbury, ON, Canada	Health Sciences North; Northern Ontario School of Medicine; Northern Ontario School of Medicine; Laurentian University; Laurentian University	Le, HT (corresponding author), Hlth Sci North Res Inst, Sudbury, ON, Canada.; Le, HT (corresponding author), Northern Ontario Sch Med, Med Sci Div, Sudbury, ON, Canada.; Le, HT (corresponding author), Laurentian Univ, Chem & Biochem Dept, Sudbury, ON, Canada.; Le, HT (corresponding author), Laurentian Univ, Biol Dept, Sudbury, ON, Canada.	hle@hsnri.ca	Acevedo, Reinaldo/AAL-4180-2020	Oliva, Reynaldo/0000-0001-8198-9161	Canadian Institutes of Health Research [148531]; Northern Cancer Foundation	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Northern Cancer Foundation	This work was supported by the Canadian Institutes of Health Research (Project Grant 148531) and the Northern Cancer Foundation (2017-2019). The funders provided support in the form of salaries for authors [RO, NLF, JDL, ALM] but did not have any role in study design, data collection and interpretation, or the decision to submit the work for publication. There was no financial contribution from the Finlay Institute of Vaccines, and the authors RA and GRD provided support in the form of research materials developed there.	[Anonymous], 2010, GUIDE CARE USE LAB A; [Anonymous], 2003, WHO TECHN REP SER, V927; Baek YO, 2012, TOX RESEARCH, V28, P225, DOI 10.5487/TR.2012.28.4.225; Bracho G, 2006, VACCINE, V24, pS30, DOI 10.1016/j.vaccine.2005.01.108; Cerutti A, 2011, ANNU REV IMMUNOL, V29, P273, DOI 10.1146/annurev-immunol-031210-101317; Chakravarty S, 2005, J NEUROSCI, V25, P1788, DOI 10.1523/jneurosci.4268-04.2005; Del Campo J, 2010, VACCINE, V28, P1193, DOI 10.1016/j.vaccine.2009.11.035; del Campo J, 2009, METHODS, V49, P301, DOI 10.1016/j.ymeth.2009.03.025; Farinas M, 2014, RETEL; Ferreira T, 2010, IMAGJ USER GUIDE VER; Fraleigh NL, 2016, HELIYON, V2, DOI 10.1016/j.heliyon.2016.e00147; Fujihashi K, 2002, VACCINE, V20, P2431, DOI 10.1016/S0264-410X(02)00155-X; Aznar EG, 2015, CAN J MICROBIOL, V61, P531, DOI 10.1139/cjm-2015-0063; Hamilton JL, 2013, AM FAM PHYSICIAN, V87, P254; Hatsukami DK, 2005, CLIN PHARMACOL THER, V78, P456, DOI 10.1016/j.clpt.2005.08.007; Hoogsteder PHJ, 2014, ADDICTION, V109, P1252, DOI 10.1111/add.12573; Hu Y, 2016, BIOMATERIALS, V106, P228, DOI 10.1016/j.biomaterials.2016.08.028; Lopez Y, 2011, VACCINE, V29, P3596, DOI 10.1016/j.vaccine.2011.02.074; Lorenzen E, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00628; Matta SG, 2007, PSYCHOPHARMACOLOGY, V190, P269, DOI 10.1007/s00213-006-0441-0; McCluskie MJ, 2015, INT IMMUNOPHARMACOL, V29, P663, DOI 10.1016/j.intimp.2015.09.012; Moreno AY, 2009, PHARMACOL BIOCHEM BE, V92, P199, DOI 10.1016/j.pbb.2009.01.015; Oliva-Hernández Reynaldo, 2019, Vaccimonitor, V28, P9; Pentel PR, 2014, ADV PHARMACOL, V69, P553, DOI 10.1016/B978-0-12-420118-7.00014-7; Perez O, 2007, SCAND J IMMUNOL, V66, P271, DOI 10.1111/j.1365-3083.2007.01981.x; Perez O, 2004, IMMUNOL CELL BIOL, V82, P603, DOI 10.1111/j.1440-1711.2004.01293.x; Perez O, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00407; Quinn DI, 1997, CLIN PHARMACOKINET, V33, P344, DOI 10.2165/00003088-199733050-00003; Rodriguez T, 2006, VACCINE, V24, pS24, DOI 10.1016/j.vaccine.2005.01.106; Rodriguez T, 2005, VACCINE, V23, P1312, DOI 10.1016/j.vaccine.2004.07.049; Suckow MA, LAB MOUSE; Thorn JM, 2017, VACCINES-BASEL, V5, DOI 10.3390/vaccines5020011; van Schayck OCP, 2014, ADDICTION, V109, P1223, DOI 10.1111/add.12569; Wern JE, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00569; Zeigler DF, 2019, VACCINE, V37, P1584, DOI 10.1016/j.vaccine.2019.02.003; Zhao ZM, 2018, BIOMATERIALS, V155, P165, DOI 10.1016/j.biomaterials.2017.11.021	36	5	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2019	14	8							e0221708	10.1371/journal.pone.0221708	http://dx.doi.org/10.1371/journal.pone.0221708			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5TR	31442285	Green Submitted, Green Published, gold			2022-12-26	WOS:000485041400070
J	Frank, M; Dragano, N; Arendt, M; Forstner, AJ; Nothen, MM; Moebus, S; Erbel, R; Jockel, KH; Schmidt, B				Frank, Mirjam; Dragano, Nico; Arendt, Marina; Forstner, Andreas J.; Noethen, Markus M.; Moebus, Susanne; Erbel, Raimund; Joeckel, Karl-Heinz; Schmidt, Boerge			A genetic sum score of risk alleles associated with body mass index interacts with socioeconomic position in the Heinz Nixdorf Recall Study	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; ENVIRONMENT INTERACTIONS; EDUCATION; OBESITY; HEALTH; INCOME	Body mass index (BMI) is influenced by genetic, behavioral and environmental factors, while interactions between genetic and socioeconomic factors have been suggested. Aim of the study was to investigate whether socioeconomic position (SEP) interacts with a BMI-related genetic sum score (GRS(BMI)) to affect BMI in a population-based cohort. SEP-related health behaviors and a GRS associated with educational attainment (GRS(Edu)) were included in the analysis to explore potential interactions underlying the GRS(BMI)xSEP effect. Baseline information on SEP indicators (education, income), BMI, smoking, physical activity, alcohol consumption and genetic risk factors were available for 4,493 participants of the Heinz Nixdorf Recall Study. Interaction analysis was based on linear regression as well as on stratified analyses. In SEP-stratified analyses, the highest genetic effects were observed in the lowest educational group with a 0.24 kg/m(2) higher BMI (95% CI: 0.16; 0.31) and in the lowest income quartile with a 0.14 kg/m(2) higher BMI (95% CI: 0.09; 0.18) per additional risk allele. Indication for a GRS(BMI)xSEP interaction was observed for education (beta(GRSbmixeducation) = -0.02 [95% CI:-0.03; -0.01]) and income (beta(GRSbmixincome) = -0.05 [95% CI: -0.08; -0.02]). When adjusting for interactions with the GRS(Edu) and SEP-related health behaviors, effect size estimates of the GRS(BMI)xSEP interaction remained virtually unchanged. Results gave indication for an interaction of BMI-related genetic risk factors with SEP indicators, showing substantially stronger genetic effects in low SEP groups. This supports the hypothesis that expression of genetic risks is higher in socioeconomically disadvantaged environments. No indication was observed that the GRS(BMI)xSEP interaction was affected by other SEP-related factors included in the analysis.	[Frank, Mirjam; Arendt, Marina; Moebus, Susanne; Erbel, Raimund; Joeckel, Karl-Heinz; Schmidt, Boerge] Univ Duisburg Essen, Inst Med Informat Biometry & Epidemiol, Essen, Germany; [Dragano, Nico] Univ Hosp Dusseldorf, Inst Med Sociol, Ctr Hlth & Soc, Dusseldorf, Germany; [Forstner, Andreas J.; Noethen, Markus M.] Univ Bonn, Inst Human Genet, Sch Med, Bonn, Germany; [Forstner, Andreas J.; Noethen, Markus M.] Univ Hosp Bonn, Bonn, Germany; [Forstner, Andreas J.] Univ Marburg, Ctr Human Genet, Marburg, Germany; [Forstner, Andreas J.] Univ Basel, Dept Biomed, Basel, Switzerland; [Forstner, Andreas J.] Univ Basel, Dept Psychiat UPK, Basel, Switzerland	University of Duisburg Essen; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf Hospital; University of Bonn; University of Bonn; Philipps University Marburg; University of Basel; University of Basel	Frank, M (corresponding author), Univ Duisburg Essen, Inst Med Informat Biometry & Epidemiol, Essen, Germany.	Mirjam.frank@uk-essen.de		Moebus, Susanne/0000-0002-0072-5410	Heinz Nixdorf Foundation; German Ministry of Education and Science [01GS0820]; German Research Council [SI 236/8-1, SI 236/91]; Open Access Publication Fund of the University of Duisburg-Essen	Heinz Nixdorf Foundation; German Ministry of Education and Science; German Research Council(German Research Foundation (DFG)); Open Access Publication Fund of the University of Duisburg-Essen	This work was supported by the Heinz Nixdorf Foundation; the German Ministry of Education and Science [grants Nationales Genomforschungsnetz, 01GS0820], the German Research Council [projects SI 236/8-1, SI 236/91]. We also acknowledge support from the Open Access Publication Fund of the University of Duisburg-Essen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad S, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003607; Albuquerque D, 2017, BRIT MED BULL, V123, P159, DOI 10.1093/bmb/ldx022; Amin V, 2017, SOC SCI MED, V195, P12, DOI 10.1016/j.socscimed.2017.10.027; Ball K, 2002, INT J OBESITY, V26, P559, DOI 10.1038/sj.ijo.0801960; Borghol N, 2012, INT J EPIDEMIOL, V41, P62, DOI 10.1093/ije/dyr147; Cauchi S, 2009, J MOL MED, V87, P537, DOI 10.1007/s00109-009-0451-6; Corella D, 2012, NUTR METAB CARDIOVAS, V22, P651, DOI 10.1016/j.numecd.2010.10.006; Deloukas P, 2013, NAT GENET, V45, P25, DOI 10.1038/ng.2480; Everson SA, 2002, J PSYCHOSOM RES, V53, P891, DOI 10.1016/S0022-3999(02)00303-3; Foraita R, 2015, INT J OBESITY, V39, P1, DOI 10.1038/ijo.2014.156; Galobardes B, 2006, J EPIDEMIOL COMMUN H, V60, P95, DOI 10.1136/jech.2004.028092; Galobardes B, 2000, ANN EPIDEMIOL, V10, P532, DOI 10.1016/S1047-2797(00)00075-2; Geyer S, 2006, J EPIDEMIOL COMMUN H, V60, P804, DOI 10.1136/jech.2005.041319; Hagenaars A., 1994, POVERTY STAT LATE 19; HOUSE JS, 1994, J HEALTH SOC BEHAV, V35, P213, DOI 10.2307/2137277; Howie B, 2011, G3-GENES GENOM GENET, V1, P457, DOI 10.1534/g3.111.001198; Johnson W, 2005, BEHAV GENET, V35, P579, DOI 10.1007/s10519-005-3598-0; Johnson W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016290; Johnson W, 2010, INT J EPIDEMIOL, V39, P406, DOI 10.1093/ije/dyp314; Keller MC, 2014, BIOL PSYCHIAT, V75, P18, DOI 10.1016/j.biopsych.2013.09.006; Knol MJ, 2012, INT J EPIDEMIOL, V41, P514, DOI 10.1093/ije/dyr218; Komulainen K, 2018, INT J OBESITY, V42, P866, DOI 10.1038/ijo.2017.174; Li SX, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000332; Liu SY, 2015, SOC SCI MED, V127, P150, DOI 10.1016/j.socscimed.2014.09.009; Locke AE, 2015, NATURE, V518, P197, DOI 10.1038/nature14177; Mackenbach, 2006, HLTH INEQUALITIES EU; McGuinness D, 2012, INT J EPIDEMIOL, V41, P151, DOI 10.1093/ije/dyr215; McLaren L, 2007, EPIDEMIOL REV, V29, P29, DOI 10.1093/epirev/mxm001; Okbay A, 2016, NATURE, V533, P539, DOI 10.1038/nature17671; Pampel FC, 2010, ANNU REV SOCIOL, V36, P349, DOI 10.1146/annurev.soc.012809.102529; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Qi L, 2008, NUTR REV, V66, P684, DOI 10.1111/j.1753-4887.2008.00128.x; Rask-Andersen M, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006977; Schmermund A, 2002, AM HEART J, V144, P212, DOI 10.1067/mhj.2002.123579; Schmidt B, 2017, CIRC-CARDIOVASC GENE, V10, DOI 10.1161/CIRCGENETICS.116.001441; Stang A, 2005, EUR J EPIDEMIOL, V20, P489, DOI 10.1007/s10654-005-5529-z; Statistical Computing Software R, 2011, R LANG ENV STAT COMP; Tyrrell J, 2017, INT J EPIDEMIOL, V46, P559, DOI 10.1093/ije/dyw337; Winham SJ, 2013, J CHILD PSYCHOL PSYC, V54, P1120, DOI 10.1111/jcpp.12114; Wu SQ, 2015, SCI REP-UK, V5, DOI 10.1038/srep11354	40	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2019	14	8							e0221252	10.1371/journal.pone.0221252	http://dx.doi.org/10.1371/journal.pone.0221252			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW5TR	31442235	Green Submitted, Green Published, gold			2022-12-26	WOS:000485041400027
J	Jonsson, H; Aspelund, T; Eiriksdottir, G; Harris, TB; Launer, LJ; Gudnason, V				Jonsson, Helgi; Aspelund, Thor; Eiriksdottir, Gudny; Harris, Tamara B.; Launer, Lenore J.; Gudnason, Vilmundur			Hyperuricemia is associated with intermittent hand joint pain in a cross sectional study of elderly females: The AGES-Reykjavik Study	PLOS ONE			English	Article							ASYMPTOMATIC HYPERURICEMIA; RENAL-DISEASE; URIC-ACID; GOUT; OSTEOARTHRITIS; ALLOPURINOL	Background The debate whether "asymptomatic hyperuricemia" should be treated is still ongoing. The objective of this cross-sectional study was to analyze whether hyperuricema in the elderly is associated with joint pain. Methods and findings Participants in the population-based AGES-Reykjavik Study (males 2195, females 2975, mean age 76(6)) answered standardized questions about joint pain. In addition they recorded intermittent hand joint pain by marking a diagram of the hand. In males, no association was found between hyperuricemia and pain. Females however, showed a positive association between hyperuricemia and joint pain at many sites. After adjustment for age, BMI and hand osteoarthritis however, only intermittent hand joint pain (OR 1.30(1.07-1.58), p = 0.008) and intermittent pain in >= 10 hand joints (OR 1.75(1.32-2.31), p<0.001) remained significant. The best model for describing the relationship between serum uric acid levels (SUA) and intermittent hand joint pain in >= 10 joints was non-linear with a cut-off at 372 mu mol/L. The attributable surplus number of symptomatic females with SUA >= 372 mu mol/L was approximately 2.0% of the study population for those reporting pain in >= 10 hand joints. Next after having severe hand osteoarthritis, SUA >= 372 was an independent predictive factor of intermittent pain in >= 10 hand joints. Intermittent hand joint pain was also an independent risk factor for worse general health description. Conclusion Results from this population based study indicate that hyperuricemia in elderly females may be a rather frequent cause of intermittent hand joint pain, often in many joints. The most likely explanation relates to low-grade urate crystal induced inflammation. Our data do not allow for assessment of the severity of symptoms or whether they merit specific treatment, but intermittent hand joint pain was an independent predictor of worse general health. These findings may be an important contribution to the debate on whether hyperuricemia should be treated.	[Jonsson, Helgi] Landspitalinn Univ Hosp, Reykjavik, Iceland; [Jonsson, Helgi; Aspelund, Thor; Gudnason, Vilmundur] Univ Iceland, Reykjavik, Iceland; [Aspelund, Thor; Eiriksdottir, Gudny; Gudnason, Vilmundur] Iceland Heart Assoc, Kopavogur, Iceland; [Harris, Tamara B.; Launer, Lenore J.] NIA, Bethesda, MD 20892 USA	Landspitali National University Hospital; University of Iceland; Icelandic Heart Association; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Jonsson, H (corresponding author), Landspitalinn Univ Hosp, Reykjavik, Iceland.; Jonsson, H (corresponding author), Univ Iceland, Reykjavik, Iceland.	helgi@hi.is	Gudnason, Vilmundur/AAE-7126-2019; Aspelund, Thor/C-5983-2008	Gudnason, Vilmundur/0000-0001-5696-0084; Aspelund, Thor/0000-0002-7998-5433; Jonsson, Helgi/0000-0003-0187-8985; Eiriksdottir, Gudny/0000-0002-8197-0652	NIH [N01-AG-12100]; NIA Intramural Research Program; Althingi (the Icelandic Parliament); Icelandic Osteoarthritis Fund; University of Iceland Research Fund; Hjartavernd (the Icelandic Heart Association)	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIA Intramural Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Althingi (the Icelandic Parliament); Icelandic Osteoarthritis Fund; University of Iceland Research Fund; Hjartavernd (the Icelandic Heart Association)	Age, Gene/Environment Susceptibility Reykjavik Study (AGES-Reykjavik) has been funded by NIH contract N01-AG-12100 to TBH, the NIA Intramural Research Program, Hjartavernd (the Icelandic Heart Association), and the Althingi (the Icelandic Parliament), the Icelandic Osteoarthritis Fund and the University of Iceland Research Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeles AM, 2015, CURR RHEUMATOL REP, V17, DOI 10.1007/s11926-015-0495-2; [Anonymous], R LANG ENV STAT COMP, DOI DOI 10.1080/02705060.2017.1422558; Chhana A, 2015, BMC MUSCULOSKEL DIS, V16, DOI 10.1186/s12891-015-0762-4; Dalbeth N, 2015, ANN RHEUM DIS, V74, P908, DOI 10.1136/annrheumdis-2014-206397; Desideri G, 2015, Curr Med Res Opin, V31 Suppl 2, P27, DOI 10.1185/03007995.2015.1087982; Fong YY, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-017-1863-x; Grundy SM, 2004, CIRCULATION, V109, P433, DOI 10.1161/01.CIR.0000111245.75752.C6; Harris TB, 2007, AM J EPIDEMIOL, V165, P1076, DOI 10.1093/aje/kwk115; Helgadottir GP, OSTEOARTHRITIS CA SC, V15, pC186; Hooper L, 2011, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD011834, 10.1002/14651858.CD002137.pub2]; Hsu HJ, 2014, BMC NEPHROL, V15, DOI 10.1186/1471-2369-15-6; Jonsson H, 2012, BMC MUSCULOSKEL DIS, V13, DOI 10.1186/1471-2474-13-20; Jonsson H, 2011, ANN RHEUM DIS, V70, P1087, DOI 10.1136/ard.2010.144980; Kanbay M, 2011, CLIN J AM SOC NEPHRO, V6, P1887, DOI 10.2215/CJN.11451210; Kuo CF, 2015, NAT REV RHEUMATOL, V11, P649, DOI 10.1038/nrrheum.2015.91; Levy GD, 2014, J RHEUMATOL, V41, P955, DOI 10.3899/jrheum.131159; Li X, 2017, BMJ-BRIT MED J, V357, DOI 10.1136/bmj.j2376; Liu P, 2015, INTERNAL MED, V54, P2129, DOI 10.2169/internalmedicine.54.4310; Reuss-Borst MA, 2014, SPRINGERPLUS, V3, DOI 10.1186/2193-1801-3-592; Roddy E, 2008, RHEUMATOLOGY, V47, P732, DOI 10.1093/rheumatology/ken087; Roddy E, 2011, J FOOT ANKLE RES, V4, DOI 10.1186/1757-1146-4-13; Rustad P, 2004, SCAND J CLIN LAB INV, V64, P271, DOI 10.1080/00365510410006324; Stewart S, 2015, J FOOT ANKLE RES, V8, DOI 10.1186/s13047-015-0091-8; Vinik O, 2014, J RHEUMATOL, V41, P70, DOI 10.3899/jrheum.140465; Wang S, 2019, OSTEOARTHR CARTILAGE, V27, P1301, DOI 10.1016/j.joca.2019.05.013; Wood S.N., 2017, GEN ADDITIVE MODELS; Zalawadiya SK, 2015, EUR J PREV CARDIOL, V22, P513, DOI 10.1177/2047487313519346; Zhao G, 2013, ATHEROSCLEROSIS, V231, P61, DOI 10.1016/j.atherosclerosis.2013.08.023	28	2	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2019	14	8							e0221474	10.1371/journal.pone.0221474	http://dx.doi.org/10.1371/journal.pone.0221474			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5TR	31442261	Green Published, Green Submitted, gold			2022-12-26	WOS:000485041400037
J	Alsamhan, A; Ragab, AE; Dabwan, A; Nasr, MM; Hidri, L				Alsamhan, Ali; Ragab, Adham E.; Dabwan, Abdulmajeed; Nasr, Mustafa M.; Hidri, Lotfi			Prediction of formation force during single-point incremental sheet metal forming using artificial intelligence techniques	PLOS ONE			English	Article							SURFACE-ROUGHNESS; OPTIMIZATION; PARAMETERS; OPERATIONS; MODEL	Single-point incremental forming (SPIF) is a technology that allows incremental manufacturing of complex parts from a flat sheet using simple tools; further, this technology is flexible and economical. Measuring the forming force using this technology helps in preventing failures, determining the optimal processes, and implementing on-line control. In this paper, an experimental study using SPIF is described. This study focuses on the influence of four different process parameters, namely, step size, tool diameter, sheet thickness, and feed rate, on the maximum forming force. For an efficient force predictive model based on an adaptive neuro-fuzzy inference system (ANFIS), an artificial neural network (ANN) and a regressions model were applied. The predicted forces exhibited relatively good agreement with the experimental results. The results indicate that the performance of the ANFIS model realizes the full potential of the ANN model.	[Alsamhan, Ali; Ragab, Adham E.; Dabwan, Abdulmajeed; Nasr, Mustafa M.; Hidri, Lotfi] King Saud Univ, Ind Engn Dept, Riyadh, Saudi Arabia	King Saud University	Dabwan, A (corresponding author), King Saud Univ, Ind Engn Dept, Riyadh, Saudi Arabia.	abmj999@yahoo.com	Ragab, adham E./ABD-1135-2020; Hidri, Lotfi/ABD-1566-2020	Ragab, adham E./0000-0002-7339-6419; M. Nasr, Mustafa/0000-0003-4833-2322; Alsamhan, Ali/0000-0001-5208-4902; Dabwan, Abdulmajeed/0000-0003-4907-6615	Deanship of Scientific Research at King Saud University [RG-1439-56]	Deanship of Scientific Research at King Saud University(King Saud University)	Deanship of Scientific Research at King Saud University funding this work through research group No (RG-1439-56).; The authors extend their appreciation to the Deanship of Scientific Research at King Saud University for funding this work through research group no. (RG-1439-56).	Abraham A, 2005, STUD FUZZ SOFT COMP, P53; Ambrogio G, 2006, J MATER PROCESS TECH, V177, P413, DOI 10.1016/j.jmatprotec.2006.04.076; Ambrogio G, 2005, J MATER PROCESS TECH, V162, P156, DOI 10.1016/j.jmatprotec.2005.02.148; Amino H., 2002, INT C 7 TECHNOLOGY P, P1015; Anwar S., 2017, P INT C IND ENG OP M; Arfa H, 2013, INT J MATER FORM, V6, P483, DOI 10.1007/s12289-012-1101-z; Bagudanch I, 2013, PROCEDIA ENGINEER, V63, P354, DOI 10.1016/j.proeng.2013.08.207; Bambach, 2003, C COMP PLAST COMPLAS; Daoud A.K., 2016, INT C IND ENG OP MAN; Duflou J, 2007, J MATER PROCESS TECH, V189, P65, DOI 10.1016/j.jmatprotec.2007.01.005; Filice L, 2006, CIRP ANN-MANUF TECHN, V55, P245, DOI 10.1016/S0007-8506(07)60408-9; Fiorentino A, 2013, INT J ADV MANUF TECH, V68, P557, DOI 10.1007/s00170-013-4777-4; Henrard C, 2011, COMPUT MECH, V47, P573, DOI 10.1007/s00466-010-0563-4; Ingarao G, 2012, J CLEAN PROD, V29-30, P255, DOI 10.1016/j.jclepro.2012.01.012; Iseki H, 2001, J MATER PROCESS TECH, V111, P150, DOI 10.1016/S0924-0136(01)00500-3; Jang J.-S. R., 1991, AAAI-91. Proceedings Ninth National Conference on Artificial Intelligence, P762; Jeswiet J., 2005, CIRP ANN-MANUF TECHN, V54, P88, DOI [DOI 10.1016/S0007-8506(07)60021-3, 10.1016/S0007-8506(07)60021-3]; Jeswiet J, 2005, FORCES SINGLE POINT; Kant G, 2015, PROC CIRP, V31, P453, DOI 10.1016/j.procir.2015.03.043; Kar S, 2014, APPL SOFT COMPUT, V15, P243, DOI 10.1016/j.asoc.2013.10.014; Khan MS, 2015, INT J ADV MANUF TECH, V76, P2071, DOI 10.1007/s00170-014-6431-1; Kumar A, 2018, SADH AC P ENG SCI, V43; Kurra S, 2015, J MATER RES TECHNOL, V4, P304, DOI 10.1016/j.jmrt.2015.01.003; Li YL, 2014, ADV MATER RES-SWITZ, V939, P313, DOI 10.4028/www.scientific.net/AMR.939.313; Lievers WB, 2004, ACTA MATER, V52, P3001, DOI 10.1016/j.actamat.2004.03.002; Oleksik V, 2010, AIP CONF PROC, V1252, P1208, DOI 10.1063/1.3457520; Papelnjak T, 2004, STROJ VESTN-J MECH E, V50, P31; Pepelnjak T, 2001, STROJ VESTN-J MECH E, V47, P94; Petek A, 2009, CIRP ANN-MANUF TECHN, V58, P283, DOI 10.1016/j.cirp.2009.03.092; Petek A., 2009, ARCH MAT SCI ENG, V35, P107, DOI DOI 10.1016/J.BRAINRESBULL.2007.10.039; Syukor A, 2011, AUSTR J BASIC APPL S, V5, P1647; Tanaka S, 2007, AIP CONF PROC, V908, P775, DOI 10.1063/1.2740904; Do VC, 2017, PROCEDIA ENGINEER, V184, P35, DOI 10.1016/j.proeng.2017.04.068	33	18	18	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2019	14	8							e0221341	10.1371/journal.pone.0221341	http://dx.doi.org/10.1371/journal.pone.0221341			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5RZ	31437217	Green Submitted, Green Published, gold			2022-12-26	WOS:000485036900053
J	Jimenez-Jimenez, S; Santana, O; Lara-Rojas, F; Arthikala, MK; Armada, E; Hashimoto, K; Kuchitsu, K; Salgado, S; Aguirre, J; Quinto, C; Cardenas, L				Jimenez-Jimenez, Saul; Santana, Olivia; Lara-Rojas, Fernando; Arthikala, Manoj-Kumar; Armada, Elisabeth; Hashimoto, Kenji; Kuchitsu, Kazuyuki; Salgado, Sandra; Aguirre, Jesus; Quinto, Carmen; Cardenas, Luis			Differential tetraspanin genes expression and subcellular localization during mutualistic interactions in Phaseolus vulgaris	PLOS ONE			English	Article							ROOT HAIR-CELLS; MEMBRANE H+-ATPASE; NADPH OXIDASE GENE; MEDICAGO-TRUNCATULA; PLANT-GROWTH; MYCORRHIZAL FUNGI; NITROGEN-FIXATION; APICAL MERISTEM; RHIZOBIUM; PLASMODESMATA	Arbuscular mycorrhizal fungi and rhizobia association with plants are two of the most successful plant-microbe associations that allow the assimilation of P and N by plants, respectively. These mutualistic interactions require a molecular dialogue, i.e., legume roots exude flavonoids or strigolactones which induce the Nod factors or Myc factors synthesis and secretion from the rhizobia or fungi, respectively. These Nod or Myc factors trigger several responses in the plant root, including calcium oscillations, and reactive oxygen species (ROS). Furthermore, superoxide and H2O2 have emerged as key components that regulate the transitions from proliferation to differentiation in the plant meristems. Similar to the root meristem, the nodule meristem accumulates superoxide and H2O2. Tetraspanins are trans membrane proteins that organize into tetraspanin web regions, where they recruit specific proteins into platforms required for signal transduction, membrane fusion, cell trafficking and ROS generation. Plant tetraspanins are scaffolding proteins associated with root radial patterning, biotic and abiotic stress responses, cell fate determination, and hormonal regulation and recently have been reported as a specific marker of exosomes in animal and plant cells and key players at the site of plant fungal infection. In this study, we conducted transcriptional profiling of the tetraspanin family in common bean (Phaseolus vulgaris L. var. Negro Jamapa) to determine the specific expression patterns and subcellular localization of tetraspanins during nodulation or under mycorrhizal association. Our results demonstrate that the tetraspanins are transcriptionally modulated during the mycorrhizal association, but are also expressed in the infection thread and nodule meristem development. Subcellular localization indicates that tetraspanins have a key role in vesicular trafficking, cell division, and root hair polar growth.	[Jimenez-Jimenez, Saul; Santana, Olivia; Lara-Rojas, Fernando; Armada, Elisabeth; Salgado, Sandra; Quinto, Carmen; Cardenas, Luis] Univ Nacl Autonoma Mexico, Inst Biotecnol, Dept Biol Mol Plantas, Cuernavaca, Morelos, Mexico; [Arthikala, Manoj-Kumar] Univ Nacl Autonoma Mexico, Ciencias Agrogen, Escuela Nacl Estudios Super, Unidad Leon, Guanajuato, Mexico; [Hashimoto, Kenji; Kuchitsu, Kazuyuki] Tokyo Univ Sci, Dept Appl Biol Sci, Noda, Chiba, Japan; [Aguirre, Jesus] Univ Nacl Autonoma Mexico, Inst Fisiol Celular, Mexico City, DF, Mexico	Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico; Tokyo University of Science; Universidad Nacional Autonoma de Mexico	Cardenas, L (corresponding author), Univ Nacl Autonoma Mexico, Inst Biotecnol, Dept Biol Mol Plantas, Cuernavaca, Morelos, Mexico.	luisc@ibt.unam.mx	Kuchitsu, Kazuyuki/G-3024-2013; Armada, Elisabeth/H-9673-2015; Aguirre, Jesus/G-9976-2013; Arthikala, Manoj/ACX-5368-2022; Arthikala, Manoj-Kumar/H-1331-2016	Kuchitsu, Kazuyuki/0000-0001-8854-0375; Armada, Elisabeth/0000-0001-9948-2115; Aguirre, Jesus/0000-0002-7847-9379; Arthikala, Manoj-Kumar/0000-0002-4535-6524; Lara-Rojas, Fernando/0000-0002-3306-1139	Conacyt [240595, 132155, 253247, 314168]; Investigacion en Fronteras de la Ciencia [2015-1-319]; DGAPA-UNAM [PAPIIT IV200519, IN209118]	Conacyt(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Investigacion en Fronteras de la Ciencia; DGAPA-UNAM(Universidad Nacional Autonoma de Mexico)	We acknowledge the funding support from Conacyt for grants 240595,132155, and 253247 (to LC), Investigacion en Fronteras de la Ciencia 2015-1-319 (to JA), and DGAPA-UNAM for grants PAPIIT IV200519 (to JA) and IN209118 (to LC). SJ was supported by Conacyt PhD Scholarship number 314168. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blanco FA, 2009, PLANT CELL, V21, P2797, DOI 10.1105/tpc.108.063420; Arthikala MK, 2014, NEW PHYTOL, V202, P886, DOI 10.1111/nph.12714; Arthikala MK, 2013, PLANT CELL PHYSIOL, V54, P1391, DOI 10.1093/pcp/pct089; Bates TR, 1996, PLANT CELL ENVIRON, V19, P529, DOI 10.1111/j.1365-3040.1996.tb00386.x; Becker JD, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0197-3; Benitez-Alfonso Y, 2009, P NATL ACAD SCI USA, V106, P3615, DOI 10.1073/pnas.0808717106; Bhosale R, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03851-3; Boavida LC, 2013, PLANT PHYSIOL, V163, P696, DOI 10.1104/pp.113.216598; Borges A, 2012, PLANT CELL REP, V31, P827, DOI 10.1007/s00299-011-1204-x; Cai Q, 2018, SCIENCE, V360, P1126, DOI 10.1126/science.aar4142; Cardenas L, 2000, PLANT PHYSIOL, V123, P443, DOI 10.1104/pp.123.2.443; Cardenas L, 1999, PLANT J, V19, P347, DOI 10.1046/j.1365-313X.1999.00517.x; Cardenas L, 1995, PLANT MOL BIOL, V29, P453, DOI 10.1007/BF00020977; Cardenas L, 2008, PLANT J, V56, P802, DOI 10.1111/j.1365-313X.2008.03644.x; Cardenas L, 2008, PLANT SIGNAL BEHAV, V3, P1101, DOI 10.4161/psb.3.12.7004; Cardenas L, 2009, PLANT SIGNAL BEHAV, V4, P4, DOI 10.4161/psb.4.1.7341; Charrin S, 2014, J CELL SCI, V127, P3641, DOI 10.1242/jcs.154906; Chaubet N, 1996, PLANT J, V10, P425, DOI 10.1046/j.1365-313X.1996.10030425.x; Chen T, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00973; Clergeot PH, 2001, P NATL ACAD SCI USA, V98, P6963, DOI 10.1073/pnas.111132998; Cnops G, 2000, DEVELOPMENT, V127, P3385; Complainville A, 2003, PLANT CELL, V15, P2778, DOI 10.1105/tpc.017020; Couto N, 2018, BIOCHIMIE, V155, P2, DOI 10.1016/j.biochi.2018.03.006; Dalla Via V, 2017, PLANT MOL BIOL, V93, P549, DOI 10.1007/s11103-016-0581-5; Damiani I, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00454; DELGADO MJ, 1994, SOIL BIOL BIOCHEM, V26, P371, DOI 10.1016/0038-0717(94)90286-0; Denarie J, 1996, ANNU REV BIOCHEM, V65, P503, DOI 10.1146/annurev.bi.65.070196.002443; Dubrovsky JG, 2008, P NATL ACAD SCI USA, V105, P8790, DOI 10.1073/pnas.0712307105; Duffield A, 2003, P NATL ACAD SCI USA, V100, P15560, DOI 10.1073/pnas.2536699100; Edens WA, 2001, J CELL BIOL, V154, P879, DOI 10.1083/jcb.200103132; Ehlers K, 2001, PROTOPLASMA, V216, P1, DOI 10.1007/BF02680127; Estrada-Navarrete G, 2007, NAT PROTOC, V2, P1819, DOI 10.1038/nprot.2007.259; Faulkner C, 2013, P NATL ACAD SCI USA, V110, P9166, DOI 10.1073/pnas.1203458110; Ferguson BJ, 2019, PLANT CELL ENVIRON, V42, P41, DOI 10.1111/pce.13348; Fernandez-Calvino L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018880; Finet C, 2012, DEV BIOL, V369, P19, DOI 10.1016/j.ydbio.2012.05.039; FISHER RF, 1992, NATURE, V357, P655, DOI 10.1038/357655a0; FOEHSE D, 1983, PLANT SOIL, V74, P359, DOI 10.1007/BF02181353; Foreman J, 2003, NATURE, V422, P442, DOI 10.1038/nature01485; Garcia-Espana A, 2008, GENOMICS, V91, P326, DOI 10.1016/j.ygeno.2007.12.005; Garcia-Espana A, 2006, MOL PHYLOGENET EVOL, V41, P355, DOI 10.1016/j.ympev.2006.04.023; Garcia-Espana A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004680; Gaudioso-Pedraza R, 2018, CURR BIOL, V28, P3562, DOI 10.1016/j.cub.2018.09.031; Genre A, 2008, PLANT CELL, V20, P1407, DOI 10.1105/tpc.108.059014; Guimaraes PM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140937; Hager A, 2003, J PLANT RES, V116, P483, DOI 10.1007/s10265-003-0110-x; Heck C, 2016, CURR BIOL, V26, P2770, DOI 10.1016/j.cub.2016.07.059; Herrbach V, 2017, J EXP BOT, V68, P568, DOI 10.1093/jxb/erw474; Hervera A, 2018, NAT CELL BIOL, V20, P307, DOI 10.1038/s41556-018-0039-x; Huang C, 2018, CELL MOL LIFE SCI, V75, P3423, DOI 10.1007/s00018-018-2803-2; Imaichi R, 2007, AM J BOT, V94, P1911, DOI 10.3732/ajb.94.12.1911; Jin L, 2018, P NATL ACAD SCI USA, V115, P11760, DOI 10.1073/pnas.1812138115; JUNIPER BE, 1969, PLANTA, V89, P352, DOI 10.1007/BF00387235; Kankanala P, 2007, PLANT CELL, V19, P706, DOI 10.1105/tpc.106.046300; Karimi M, 2002, TRENDS PLANT SCI, V7, P193, DOI 10.1016/S1360-1385(02)02251-3; Kaymakanova M., 2008, General and Applied Plant Physiology, V34, P177; Krajinski F, 2014, PLANT CELL, V26, P1808, DOI 10.1105/tpc.113.120436; Krishnamoorthy Lakshmi, 2018, Biochemistry, V57, P3993, DOI 10.1021/acs.biochem.8b00429; Larrainzar E, 2015, PLANT PHYSIOL, V169, P233, DOI 10.1104/pp.15.00350; Lee Y, 2013, CELL, V153, P402, DOI 10.1016/j.cell.2013.02.045; Libault M, 2010, PLANT PHYSIOL, V152, P541, DOI 10.1104/pp.109.148379; Lieber D, 2011, CURR BIOL, V21, P1009, DOI 10.1016/j.cub.2011.05.015; Lopez-Bucio J, 2002, PLANT PHYSIOL, V129, P244, DOI 10.1104/pp.010934; Malamy JE, 1997, DEVELOPMENT, V124, P33; Mani B, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.01088; Mathesius U, 1998, PLANT J, V14, P23, DOI 10.1046/j.1365-313X.1998.00090.x; Maule A, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00030; Miller DD, 1999, PLANT J, V17, P141, DOI 10.1046/j.1365-313X.1999.00358.x; Montiel J, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17050680; Montiel J, 2012, PLANT CELL PHYSIOL, V53, P1751, DOI 10.1093/pcp/pcs120; Morelli AE, 2004, BLOOD, V104, P3257, DOI 10.1182/blood-2004-03-0824; Moribe H, 2004, J CELL SCI, V117, P5209, DOI 10.1242/jcs.01403; Moribe Hiroki, 2013, Worm, V2, pe23415, DOI 10.4161/worm.23415; Moribe H, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002957; Murakami E, 2018, ELIFE, V7, DOI [10.7554/eLife.33506, 10.7554/elife.33506]; O'Rourke JA, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-866; Oldroyd GED, 2013, NAT REV MICROBIOL, V11, P252, DOI 10.1038/nrmicro2990; Oldroyd GED, 2011, ANNU REV GENET, V45, P119, DOI 10.1146/annurev-genet-110410-132549; Osipova MA, 2012, PLANT PHYSIOL, V158, P1329, DOI 10.1104/pp.111.188078; Reimann R, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00545; Rezaie J, 2018, MOL NEUROBIOL, V55, P3372, DOI 10.1007/s12035-017-0582-7; Russo G, 2019, NEW PHYTOL, V221, P1036, DOI 10.1111/nph.15398; Rutter BD, 2017, PLANT PHYSIOL, V173, P728, DOI 10.1104/pp.16.01253; Salmon MS, 2013, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00307; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schmutz J, 2010, NATURE, V463, P178, DOI 10.1038/nature08670; Schoenfeld N, 2004, FASEB J, V18, P158, DOI 10.1096/fj.03-0420fje; Schurmann J, 2013, MOL PLANT MICROBE IN, V26, P1151, DOI 10.1094/MPMI-03-13-0064-R; Sevilem I, 2015, METHODS MOL BIOL, V1217, P3, DOI 10.1007/978-1-4939-1523-1_1; Shaw SL, 2003, PLANT PHYSIOL, V131, P976, DOI 10.1104/pp.005546; Siegmund U, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0055879, 10.1371/annotation/84c258cf-4f98-43d8-a4f0-7032cba36f22]; Smith SE, 2003, PLANT PHYSIOL, V133, P16, DOI 10.1104/pp.103.024380; Takeda S, 2008, SCIENCE, V319, P1241, DOI 10.1126/science.1152505; Thomas CL, 2008, PLOS BIOL, V6, P180, DOI 10.1371/journal.pbio.0060007; Tsukagoshi H, 2010, CELL, V143, P606, DOI 10.1016/j.cell.2010.10.020; vanBel AJE, 1996, J EXP BOT, V47, P1129, DOI 10.1093/jxb/47.Special_Issue.1129; Veneault-Fourrey C, 2005, FUNGAL GENET BIOL, V42, P306, DOI 10.1016/j.fgb.2005.01.009; Wang ET, 2014, PLANT CELL, V26, P1818, DOI 10.1105/tpc.113.120527; Wang F, 2015, PLANT PHYSIOL, V169, P2200, DOI 10.1104/pp.15.01310; Wang F, 2012, PLANT SCI, V190, P9, DOI 10.1016/j.plantsci.2012.03.005; Yamaguchi H, 2017, PHYS REV E, V96, DOI 10.1103/PhysRevE.96.012401; Yamaguchi N, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01252-6; Yokota K, 2009, PLANT CELL, V21, P267, DOI 10.1105/tpc.108.063693; Yuan W, 2017, J EXP BOT, V68, P1731, DOI 10.1093/jxb/erx040; Zeng J, 2017, EMBO J, V36, P2844, DOI 10.15252/embj.201695955; Zepeda I, 2014, PLANT CELL PHYSIOL, V55, P580, DOI 10.1093/pcp/pct202; Zhu T, 1998, PROTOPLASMA, V203, P35, DOI 10.1007/BF01280585; Zoller M, 2009, NAT REV CANCER, V9, P40, DOI 10.1038/nrc2543	108	7	7	3	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2019	14	8							e0219765	10.1371/journal.pone.0219765	http://dx.doi.org/10.1371/journal.pone.0219765			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5RZ	31437164	Green Submitted, Green Published, gold			2022-12-26	WOS:000485036900009
J	Jinno, N; Hori, Y; Naitoh, I; Miyabe, K; Yoshida, M; Natsume, M; Kato, A; Asano, G; Sano, H; Hayashi, K				Jinno, Naruomi; Hori, Yasuki; Naitoh, Itaru; Miyabe, Katsuyuki; Yoshida, Michihiro; Natsume, Makoto; Kato, Akihisa; Asano, Go; Sano, Hitoshi; Hayashi, Kazuki			Predictive factors for the mortality of acute pancreatitis on admission	PLOS ONE			English	Article							AMERICAN-COLLEGE; EARLY-STAGE; CT; CLASSIFICATION; NECROSIS; DEFINITIONS; SEVERITY; ATLANTA	Background and aims The revised Atlanta classification is widely used for the evaluation of acute pancreatitis (AP) severity. However, this classification cannot be used within 48 hours of AP onset. The aim of this study was to investigate the predictive factors of mortality in patients with AP on admission. Methods We evaluated the association between AP mortality and clinical parameters at the time of admission in patients with AP from April 2013 to December 2017 at one university hospital and one tertiary care referral center. Results A total of 203 consecutive patients were enrolled. Nine patients (4.4%) died despite multidisciplinary treatment. In a multivariable analysis, hematocrit >= 40% (odds ratio [OR], 1.07; 95% confidence interval [CI], 1.01-1.13; P = 0.021), blood urea nitrogen (BUN) >= 40 mg/dL (OR, 1.26; 95% CI, 1.11-1.42; P<0.001), base excess < -3.0 mmol/L (OR, 1.15; 95% CI, 1.04-1.26; P = 0.004), and inflammation extending to the rectovesical excavation (OR, 1.19; 95% CI, 1.10-1.30; P<0.001) on admission were significantly associated with mortality. Conclusion Among the imaging findings, inflammation extending to the rectovesical excavation was the only independent predictive factor for mortality in AP. This simple finding, obtained on computed tomography without contrast agent on admission, might be a promising prognostic factor for AP.	[Jinno, Naruomi; Hori, Yasuki; Naitoh, Itaru; Miyabe, Katsuyuki; Yoshida, Michihiro; Natsume, Makoto; Kato, Akihisa; Asano, Go; Hayashi, Kazuki] Nagoya City Univ, Grad Sch Med Sci, Dept Gastroenterol & Metab, Nagoya, Aichi, Japan; [Sano, Hitoshi] Toyokawa City Hosp, Dept Gastroenterol, Toyokawa, Japan	Nagoya City University	Hori, Y (corresponding author), Nagoya City Univ, Grad Sch Med Sci, Dept Gastroenterol & Metab, Nagoya, Aichi, Japan.	yhori@med.nagoya-cu.ac.jp	Naitoh, Itaru/AAB-7252-2020	Naitoh, Itaru/0000-0001-8342-886X; Miyabe, Katsuyuki/0000-0002-4915-9835				BALTHAZAR EJ, 1990, RADIOLOGY, V174, P331, DOI 10.1148/radiology.174.2.2296641; Banks PA, 2013, GUT, V62, P102, DOI 10.1136/gutjnl-2012-302779; Besselink M, 2013, PANCREATOLOGY, V13, pE1, DOI 10.1016/j.pan.2013.07.063; BONE RC, 1992, CRIT CARE MED, V20, P864, DOI 10.1097/00003246-199206000-00025; BRADLEY EL, 1993, ARCH SURG-CHICAGO, V128, P586; Casas JD, 2004, AM J ROENTGENOL, V182, P569, DOI 10.2214/ajr.182.3.1820569; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Dellinger EP, 2012, ANN SURG, V256, P875, DOI 10.1097/SLA.0b013e318256f778; Forsmark CE, 2016, NEW ENGL J MED, V375, P1972, DOI 10.1056/NEJMra1505202; Hori Y, 2019, PANCREATOLOGY, V19, P224, DOI 10.1016/j.pan.2019.02.004; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Pienkowska J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146965; Spanier BWM, 2010, PANCREATOLOGY, V10, P222, DOI 10.1159/000243731; Stimac D, 2007, AM J GASTROENTEROL, V102, P997, DOI 10.1111/j.1572-0241.2007.01164.x; Takeda K, 2010, J HEPATO-BIL-PAN SCI, V17, P37, DOI 10.1007/s00534-009-0213-4; Tenner S, 2013, AM J GASTROENTEROL, V108, P1400, DOI 10.1038/ajg.2013.218; Tsuji Y, 2007, CLIN GASTROENTEROL H, V5, P1484, DOI 10.1016/j.cgh.2007.07.014; Tsuji Y, 2014, AM J ROENTGENOL, V202, pW349, DOI 10.2214/AJR.13.10957; van Santvoort HC, 2010, NEW ENGL J MED, V362, P1491, DOI 10.1056/NEJMoa0908821; Yadav AK, 2015, ABDOM IMAGING, V40, P488, DOI 10.1007/s00261-014-0226-6	20	11	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2019	14	8							e0221468	10.1371/journal.pone.0221468	http://dx.doi.org/10.1371/journal.pone.0221468			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5RZ	31437218	gold, Green Published, Green Submitted			2022-12-26	WOS:000485036900077
J	Marshall, L; McCormick, WD; Cooke, GM				Marshall, Lucy; McCormick, Wanda D.; Cooke, Gavan M.			Perception of the ethical acceptability of live prey feeding to aquatic species kept in captivity	PLOS ONE			English	Article							FISH; ENRICHMENT; CUTTLEFISH; BEHAVIOR; ABILITY; WELFARE; MEMORY; PAIN	Previous research into public perceptions of live prey feeding has been focused on terrestrial animals. The reasons for this likely relate to the difficulty humans have in being compassionate to animals who are phylogenetically distantly related. In order to test these assumptions, the general public (two groups; one who had just visited an aquarium; and one group who had just visited a zoo), aquarium professionals in the UK/US and terrestrial zoo animal professionals (UK) were investigated to see how they would differ in their responses when asked about feeding various live aquatic animals to one another. Likert based surveys were used to obtain data face to face and via online social media. Demographics in previous research identified a lower acceptance of live prey feeding by females, however in aquatic animals this was not reflected. Instead, separations in perception were seen to exist between participants dependent on whether they had just visited a zoo or aquarium, or worked with animals.	[Marshall, Lucy] Univ Bristol, Fac Hlth Sci, Langford Vet Sch, Bristol, Avon, England; [Marshall, Lucy; McCormick, Wanda D.; Cooke, Gavan M.] Anglia Ruskin Univ, Fac Life Sci, Cambridge, England; [McCormick, Wanda D.] Univ Northampton, Fac Hlth & Soc, Northampton, England	University of Bristol; Anglia Ruskin University; University of Northampton	Marshall, L (corresponding author), Univ Bristol, Fac Hlth Sci, Langford Vet Sch, Bristol, Avon, England.; Marshall, L (corresponding author), Anglia Ruskin Univ, Fac Life Sci, Cambridge, England.	lucy.m.a.marshall@gmail.com		Cooke, Gavan/0000-0001-7997-0998; McCormick, Wanda/0000-0002-6287-7321				Arndt C, 2016, AQUAC RES, V47, P3156, DOI 10.1111/are.12766; ARONSON LR, 1971, ANN NY ACAD SCI, V188, P378, DOI 10.1111/j.1749-6632.1971.tb13110.x; Barney E., 2010, J ENVIRON EDUC, V36, P41; Bashaw MJ, 2003, ZOO BIOL, V22, P189, DOI 10.1002/zoo.10065; Beran MJ, 2006, J EXP PSYCHOL-ANIM B, V32, P111, DOI 10.1037/0097-7403.32.2.111; Bottery M, 2016, EDUCATIONAL LEADERSHIP FOR A MORE SUSTAINABLE WORLD, P1; Braithwaite VA, 2004, ANIM WELFARE, V13, pS87; Broom DM, 2007, DIS AQUAT ORGAN, V75, P99, DOI 10.3354/dao075099; Cooper JE, 2014, J EXOT PET MED, V23, P244, DOI 10.1053/j.jepm.2014.06.003; Cottle L., 2009, ZOO BIOL, V28, P1; Cox ES, 2000, AQUACULTURE, V183, P285, DOI 10.1016/S0044-8486(99)00302-6; Daly B, 2006, ANTHROZOOS, V19, P113, DOI 10.2752/089279306785593801; Department of Environment Food and Rural Affairs, 2007, WELF FARM AN ENGL RE, P7; Domingues P, 2004, AQUACULTURE, V229, P239, DOI 10.1016/S0044-8486(03)00351-X; Doubleday KF, 2017, GEOFORUM, V81, P32, DOI 10.1016/j.geoforum.2017.02.005; Doutrelant C, 2001, BEHAV ECOL, V12, P283, DOI 10.1093/beheco/12.3.283; Duncan J, 1996, COGNITIVE PSYCHOL, V30, P257, DOI 10.1006/cogp.1996.0008; Eovaldi B, 2016, WILD ENVIRON MED, V27, P184, DOI 10.1016/j.wem.2015.10.012; Feld M, 2005, BEHAV BRAIN RES, V158, P251, DOI 10.1016/j.bbr.2004.09.005; Gliem J., 2003, SCHOLARWORKS; Hartley J, 2014, INT J CLIN HLTH PSYC, V14, P83, DOI 10.1016/S1697-2600(14)70040-7; Ings R, 1997, ZOO BIOL, V16, P343; Jensen E., 2017, ZOO BIOL, V9999, P1; Kieffer J.D., 1992, Reviews in Fish Biology and Fisheries, V2, P125, DOI 10.1007/BF00042881; Kuba MJ, 2010, ANIM COGN, V13, P507, DOI 10.1007/s10071-009-0301-5; Magee B, 2013, J EXP BIOL, V216, P353, DOI 10.1242/jeb.072041; MARKOWITZ H, 1995, ZOO BIOL, V14, P371, DOI 10.1002/zoo.1430140408; Mather JA, 2017, CURR OPIN BEHAV SCI, V16, P131, DOI 10.1016/j.cobeha.2017.06.008; Mazurek J., 2016, THESIS; Nosal A., 2016, PLOS ONE, V11, P8; Ormandy Elisabeth H, 2014, Animals (Basel), V4, P391, DOI 10.3390/ani4030391; Palma J, 2014, FISH PHYSIOL BIOCHEM, V40, P739, DOI 10.1007/s10695-013-9881-8; Panagiotarakou E, 2016, J AGR ENVIRON ETHIC, V29, P1057, DOI 10.1007/s10806-016-9648-1; Panksepp J, 2017, NEUROSCI BIOBEHAV R, V76, P187, DOI 10.1016/j.neubiorev.2016.09.010; Quirke T, 2013, ZOO BIOL, V32, P490, DOI 10.1002/zoo.21082; Rose JD, 2002, REV FISH SCI, V10, P1, DOI 10.1080/20026491051668; Ruskell AD, 2015, ZOO BIOL, V34, P170, DOI 10.1002/zoo.21192; Secretary of State's Standard Modern Zoo Practice, 2012, SECR STAT MOD ZOO PR, V1; Skibiel AL, 2007, ZOO BIOL, V26, P371, DOI 10.1002/zoo.20147; Sneddon LU, 2003, APPL ANIM BEHAV SCI, V83, P153, DOI 10.1016/S0168-1591(03)00113-8; Sneddon LU, 2014, ANIM BEHAV, V97, P201, DOI 10.1016/j.anbehav.2014.09.007; Sullivan Gail M, 2013, J Grad Med Educ, V5, P541, DOI 10.4300/JGME-5-4-18; Sundstrom LF, 2001, ANIM BEHAV, V61, P249, DOI 10.1006/anbe.2000.1593; Sykes AV, 2014, CEPHALOPOD CULTURE, P175, DOI DOI 10.1007/978-94-017-8648-5_11; Thomas N, 2016, PALG MAC ANIM ETHICS, P97, DOI 10.1057/978-1-137-58685-8_5; Tonkins BM, 2015, APPL ANIM BEHAV SCI, V168, P77, DOI 10.1016/j.applanim.2015.04.004; Vindas M., 2014, P ROYAL SOC, V281, P1784; Vorster AP, 2015, NEUROSCI BIOBEHAV R, V50, P103, DOI 10.1016/j.neubiorev.2014.09.020; Wang N., 2015, PREC 2 INT WORKSH EN, P21; WHALEY JE, 2006, BEST PRACTICES MARIN	50	1	1	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2019	14	8							e0216777	10.1371/journal.pone.0216777	http://dx.doi.org/10.1371/journal.pone.0216777			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW5RZ	31437256	Green Submitted, Green Accepted, Green Published, gold			2022-12-26	WOS:000485036900004
J	Monjardino, T; Silva, P; Amaro, J; Carvalho, O; Guimaraes, JT; Santos, AC; Lucas, R				Monjardino, Teresa; Silva, Poliana; Amaro, Joana; Carvalho, Ofelia; Guimaraes, Joao Tiago; Santos, Ana Cristina; Lucas, Raquel			Bone formation and resorption markers at 7 years of age: Relations with growth and bone mineralization	PLOS ONE			English	Article							PEDIATRIC REFERENCE INTERVALS; SECONDARY SEXUAL CHARACTERISTICS; HEALTHY-CHILDREN; ALKALINE-PHOSPHATASE; BIOCHEMICAL PARAMETERS; METABOLISM MARKERS; REFERENCE CURVES; BETA-CROSSLAPS; PUBERTAL BOYS; OSTEOCALCIN	Purpose We aimed to describe bone formation and resorption markers in generally healthy prepubertal children using total alkaline phosphatase (tALP), osteocalcin (OC) and beta-isomerized C-terminal telopeptides of type I collagen (beta-CTx) serum concentrations and to estimate markers' correlations with anthropometric growth (height, weight, body mass index and trajectories of weight gain) as well as bone mineral content (BMC) and areal density (aBMD). Methods We assessed 395 7-year-old children from the Generation XXI cohort with tALP, OC and beta-CTx concentrations determined from a fasting venous blood sample and BMC/aBMD measured by dual-energy X-ray absorptiometry. Gender-specific reference intervals for tALP, OC and beta-CTx in 7-year-old children were established by calculating the 2.5th and 97.5th percentiles. Pearson and partial correlation coefficients (controlling for sex, age, body size and season) between bone markers and growth measures were computed. Results tALP increased with height (r(partial) controlled for sex = 0.26, 95%CI: 0.17, 0.35), was higher in overweight than in healthy weight children, and in children who gained weight above average during infancy. No correlations were found between OC or beta-CTx and growth. In girls, OC was slightly correlated with subtotal BMC (r(partial) = 0.22, 95%CI: 0.08, 0.35), subtotal aBMD (r(partial) = 0.20, 95%CI: 0.06, 0.33) and lumbar spine aBMD (r(partial) = 0.23, 95%CI: 0.09, 0.36). tALP and beta-CTx were not correlated with any of the DXA-derived bone measures. Conclusion This study contributed to the description of bone turnover at 7 years of age and suggested that bone metabolism markers measured in a single point in time have limited ability to describe anthropometric growth and overall bone status in generally healthy prepubertal children.	[Monjardino, Teresa; Silva, Poliana; Amaro, Joana; Carvalho, Ofelia; Guimaraes, Joao Tiago; Santos, Ana Cristina; Lucas, Raquel] Univ Porto, EPIUnit, Inst Saude Publ, Porto, Portugal; [Guimaraes, Joao Tiago] Ctr Hosp Univ Sao Joao, Serv Patol Clin, Porto, Portugal; [Guimaraes, Joao Tiago] Univ Porto, Fac Med, Dept Biomed, Porto, Portugal; [Santos, Ana Cristina; Lucas, Raquel] Univ Porto, Fac Med, Dept Ciencias Saude Publ & Forenses & Educ, Porto, Portugal; [Silva, Poliana] Univ Catolica Portuguesa, Ctr Biotecnol & Quim Fina, Lab Associado, Escola Super Biotecnol, Porto, Portugal	Universidade do Porto; Universidade do Porto; Universidade do Porto; Universidade Catolica Portuguesa	Monjardino, T (corresponding author), Univ Porto, EPIUnit, Inst Saude Publ, Porto, Portugal.	teresa.monjardino@ispup.up.pt	santos, ana/GWV-5678-2022; Guimarães, João Tiago/T-3079-2017; Santos, Ana/AAY-2314-2020; Vieira Pinto de Carvalho, Ofelia Maria/L-2780-2014	Guimarães, João Tiago/0000-0003-4836-6311; Monjardino, Teresa/0000-0003-4944-3366; Santos, Ana/0000-0002-2992-5299; Lucas, Raquel/0000-0002-4408-8134; Amaro, Joana/0000-0003-4499-5524; Vieira Pinto de Carvalho, Ofelia Maria/0000-0002-7450-9980	European Regional Development Fund (ERDF), through the Operational Programme Competitiveness and Internationalization; Foundation for Science and Technology (FCT) Portuguese Ministry of Science, Technology and Higher Education -under the project "STEPACHE - Raizes pediatricas da resposta ampliada a dor:das influencias contextuais a estratificagao do risco" [POCI-01-0145-FEDER-029087, PTDC/SAU-EPI/29087/2017]; Foundation for Science and Technology (FCT) Portuguese Ministry of Science, Technology and Higher Education -under the project "BioAdversity: Como a adversidade social na infancia condiciona a saude: A biologia da adversidade social" [POCI-01-0145-FEDER-016838, PTDC/DTP-EPI/1687/2014]; Foundation for Science and Technology (FCT) Portuguese Ministry of Science, Technology and Higher Education -under the project "PathMOB: Risco cardiometabolico na infancia: desde o inicio da vida ao fim da infancia" [POCI-01-0145-FEDER-016837, PTDC/DTP-EPI/3306/2014]; Foundation for Science and Technology (FCT) Portuguese Ministry of Science, Technology and Higher Education -under the project "Qualidade e dinamica osseas na infancia: as alteragOes antropometricas longitudinais fazem diferenca?" [EXPL/DTP-EPI/0280/2012]; Unidade de Investigacao em Epidemiologia -Instituto de SaUde Publica da Universidade do Porto (EPI Unit) [POCI-01-0145-FEDER-006862, UID/DTP/04750/2019]; Administragao Regional de SaUde Norte (Regional Department of Ministry of Health); Fundacao Calouste Gulbenkian; FCT [SFRH/BD/92370/2013, IF/01060/2015]; Norte Portugal Regional Operational Programme (NORTE 2020), under the PORTUGAL 2020 Partnership Agreement, through the ERDF [NORTE-01-0145-FEDER-000003]; Human Potential Operating Program of the European Social Fund (POPH/FSE Program); Fundação para a Ciência e a Tecnologia [EXPL/DTP-EPI/0280/2012] Funding Source: FCT	European Regional Development Fund (ERDF), through the Operational Programme Competitiveness and Internationalization; Foundation for Science and Technology (FCT) Portuguese Ministry of Science, Technology and Higher Education -under the project "STEPACHE - Raizes pediatricas da resposta ampliada a dor:das influencias contextuais a estratificagao do risco"; Foundation for Science and Technology (FCT) Portuguese Ministry of Science, Technology and Higher Education -under the project "BioAdversity: Como a adversidade social na infancia condiciona a saude: A biologia da adversidade social"; Foundation for Science and Technology (FCT) Portuguese Ministry of Science, Technology and Higher Education -under the project "PathMOB: Risco cardiometabolico na infancia: desde o inicio da vida ao fim da infancia"; Foundation for Science and Technology (FCT) Portuguese Ministry of Science, Technology and Higher Education -under the project "Qualidade e dinamica osseas na infancia: as alteragOes antropometricas longitudinais fazem diferenca?"; Unidade de Investigacao em Epidemiologia -Instituto de SaUde Publica da Universidade do Porto (EPI Unit); Administragao Regional de SaUde Norte (Regional Department of Ministry of Health); Fundacao Calouste Gulbenkian(European Commission); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); Norte Portugal Regional Operational Programme (NORTE 2020), under the PORTUGAL 2020 Partnership Agreement, through the ERDF; Human Potential Operating Program of the European Social Fund (POPH/FSE Program); Fundação para a Ciência e a Tecnologia	This study was funded by the European Regional Development Fund (ERDF), through the Operational Programme Competitiveness and Internationalization, and national funding from the Foundation for Science and Technology (FCT) Portuguese Ministry of Science, Technology and Higher Education -under the projects "STEPACHE - Raizes pediatricas da resposta ampliada a dor:das influencias contextuais a estratificagao do risco (POCI-01-0145-FEDER-029087; PTDC/SAU-EPI/29087/2017); "BioAdversity: Como a adversidade social na infancia condiciona a saude: A biologia da adversidade social" (POCI-01-0145-FEDER-016838; PTDC/DTP-EPI/1687/2014); "PathMOB: Risco cardiometabolico na infancia: desde o inicio da vida ao fim da infancia" (POCI-01-0145-FEDER-016837; PTDC/DTP-EPI/3306/2014) and "Qualidade e dinamica osseas na infancia: as alteragOes antropometricas longitudinais fazem diferenca?" (EXPL/DTP-EPI/0280/2012). This work was also supported by the Unidade de Investigacao em Epidemiologia -Instituto de SaUde Publica da Universidade do Porto (EPI Unit) (POCI-01-0145-FEDER-006862; UID/DTP/04750/2019), by Administragao Regional de SaUde Norte (Regional Department of Ministry of Health) and Fundacao Calouste Gulbenkian. This research was also supported by the PhD Grant SFRH/BD/92370/2013 (Teresa Monjardino) co - funded by the FCT and Human Potential Operating Program of the European Social Fund (POPH/FSE Program) and by the FCT Investigator contract IF/01060/2015 (Ana Cristina Santos). This study is also a result of the project "DOCnet: Diabetes & obesity at the crossroads between Oncological and Cardiovascular diseases a system analysis NETwork towards precision medicine" (NORTE-01-0145-FEDER-000003), supported by Norte Portugal Regional Operational Programme (NORTE 2020), under the PORTUGAL 2020 Partnership Agreement, through the ERDF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abou El Hassan M, 2015, CLIN BIOCHEM, V48, P1151, DOI 10.1016/j.clinbiochem.2015.05.002; Alves E, 2012, INT J PUBLIC HEALTH, V57, P837, DOI 10.1007/s00038-012-0340-6; Ambroszkiewicz J, 2018, CARTILAGE, V9, P255, DOI 10.1177/1947603516686145; Bayer M, 2014, OSTEOPOROSIS INT, V25, P729, DOI 10.1007/s00198-013-2485-4; Bhattoa Harjit Pal, 2018, EJIFCC, V29, P117; Bonnick SL, 2006, AM J MED, V119, p25S, DOI 10.1016/j.amjmed.2005.12.020; Clinical and Laboratory Standards Institute, 2008, DEF EST VER REF INT; Crabtree NJ, 2014, J CLIN DENSITOM, V17, P225, DOI 10.1016/j.jocd.2014.01.003; Csakvary V, 2013, BONE, V54, P106, DOI 10.1016/j.bone.2013.01.040; Csakvary V, 2012, HORM RES PAEDIAT, V78, P203, DOI 10.1159/000342335; de Onis M, 2007, B WORLD HEALTH ORGAN, V85, P660, DOI 10.2471/BLT.07.043497; Eapen E, 2008, EJIFCC, V19, P123; Fonseca MJ, 2017, NUTRITION, V33, P58, DOI 10.1016/j.nut.2016.08.008; Gennai I, 2016, CLIN BIOCHEM, V49, P802, DOI 10.1016/j.clinbiochem.2016.04.005; Gu WJ, 2017, LAB MED, V48, P166, DOI 10.1093/labmed/lmx017; Herman-Giddens ME, 2012, PEDIATRICS, V130, pE1058, DOI 10.1542/peds.2011-3291; HermanGiddens ME, 1997, PEDIATRICS, V99, P505, DOI 10.1542/peds.99.4.505; Hilsted L, 2013, SCAND J CLIN LAB INV, V73, P1, DOI 10.3109/00365513.2012.721519; Holick MF, 2011, J CLIN ENDOCR METAB, V96, P1911, DOI 10.1210/jc.2011-0385; Huang Y, 2011, CLIN BIOCHEM, V44, P771, DOI 10.1016/j.clinbiochem.2011.04.008; Jurimae J, 2010, CURR OPIN PEDIATR, V22, P494, DOI 10.1097/MOP.0b013e32833b0b9e; Larsen PS, 2013, PAEDIATR PERINAT EP, V27, P393, DOI 10.1111/ppe.12060; Lombardi G, 2012, CLIN CHEM LAB MED, V50, P771, DOI 10.1515/cclm-2011-0614; Lucas D, 2016, BROOKINGS PAP ECO AC, P1; MAGNUSSON P, 1995, PEDIATR RES, V38, P955, DOI 10.1203/00006450-199512000-00021; Matusik Pawel, 2015, Pediatr Endocrinol Diabetes Metab, V21, P154, DOI 10.18544/PEDM-21.04.0037; Monjardino T, 2017, J PEDIATR-US, V191, P117, DOI 10.1016/j.jpeds.2017.08.033; Mora S, 2009, J BONE MINER METAB, V27, P721, DOI 10.1007/s00774-009-0092-4; Nishizawa Y, 2013, J BONE MINER METAB, V31, P1, DOI 10.1007/s00774-012-0392-y; Okabe R, 2001, CLIN CHEM, V47, P1410; Rauchenzauner M, 2007, J CLIN ENDOCR METAB, V92, P443, DOI 10.1210/jc.2006-1706; Rochefort GY, 2011, CLIN ENDOCRINOL, V75, P265, DOI 10.1111/j.1365-2265.2011.04031.x; Schmidt-Gayk H, 2004, CLIN CHEM LAB MED, V42, P90, DOI 10.1515/CCLM.2004.017; Seibel Markus J, 2005, Clin Biochem Rev, V26, P97; Seydewitz HH, 2001, CLIN CHEM LAB MED, V39, P980, DOI 10.1515/CCLM.2001.159; Shaw JLV, 2014, CLIN BIOCHEM, V47, P166, DOI 10.1016/j.clinbiochem.2013.11.008; Sims Natalie A, 2014, Bonekey Rep, V3, P481, DOI 10.1038/bonekey.2013.215; Swolin-Eide D, 2007, ACTA PAEDIATR, V96, P720, DOI 10.1111/j.1651-2227.2007.00236.x; Tahmasebi Houman, 2017, EJIFCC, V28, P43; Tietz NW, 2001, FUNDAMENTALS CLIN CH; Tubic B, 2016, BONE, V84, P230, DOI 10.1016/j.bone.2016.01.008; Tuchman S, 2008, J PEDIATR-US, V153, P484, DOI 10.1016/j.jpeds.2008.04.028; Vaitkeviciute D, 2016, J PEDIATR ENDOCR MET, V29, P723, DOI 10.1515/jpem-2015-0282; van Coeverden SCCM, 2002, CLIN ENDOCRINOL, V57, P107, DOI 10.1046/j.1365-2265.2002.01573.x; van der Sluis IM, 2002, HORM RES, V57, P170, DOI 10.1159/000058378; Vasikaran S, 2011, OSTEOPOROSIS INT, V22, P391, DOI 10.1007/s00198-010-1501-1; Wagner D, 2009, CLIN BIOCHEM, V42, P1549, DOI 10.1016/j.clinbiochem.2009.07.013; Wheater G, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-201; Zierk J, 2017, CLIN CHEM LAB MED, V55, P102, DOI 10.1515/cclm-2016-0318	49	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2019	14	8							e0219423	10.1371/journal.pone.0219423	http://dx.doi.org/10.1371/journal.pone.0219423			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5RZ	31437153	Green Published, Green Submitted, gold			2022-12-26	WOS:000485036900006
J	Rinehart, S; Long, JD				Rinehart, S.; Long, J. D.			Conspecifics, not pollen, reduce omnivore prey consumption	PLOS ONE			English	Article							INTRAGUILD PREDATION; CANNIBALISM; DENSITY; PREFERENCE; PLANT; CONSEQUENCES; INTERFERENCE; SALAMANDERS; COMPLEXITY; RESPONSES	Pollen can decrease (via reduced consumption) or increase (via numerical response) an omnivores consumption of animal prey. Although pollen can increase predation pressure through numerical responses of omnivores, pollen may also suppress predation by increasing omnivore interactions with conspecifics. Despite this potential, studies of the impacts of pollen on predation by omnivores often overlook the effect of these tissues on intraspecific interactions between omnivores. We designed three studies to examine how Spartina foliose pollen and conspecific density impact scale insect prey consumption by ladybeetle (Naemia seriata) omnivores. First, we assessed how pollen impacts scale insect consumption by isolated ladybeetles. Second, we measured how pollen influences ladybeetle prey suppression when numerical responses were possible. Third, because initial experiments suggested the consumption rates of individual ladybeetles depended on conspecific density, we compared per capita consumption rates of ladybeetles across ladybeetle density. Pollen did not influence prey consumption by isolated ladybeetles. When numerical responses were possible, pollen did not influence total predation on prey despite increasing ladybeetle density, suggesting that pollen decreased per capita prey consumption by ladybeetles. The discrepancy between these studies is likely a consequence of differences in ladybeetle density-the presence of only two other conspecifics decreased per capita prey consumption by 76%. Our findings suggest that pollen may not alter the population level effects of omnivores on prey when omnivore numerical responses are offset by reductions in per capita predation rate.	[Rinehart, S.; Long, J. D.] San Diego State Univ, Dept Biol, San Diego, CA 92182 USA; [Rinehart, S.; Long, J. D.] San Diego State Univ, Coastal & Marine Inst Lab, San Diego, CA 92182 USA; [Rinehart, S.] Univ Calif Davis, Dept Ecol & Evolut, Davis, CA 95616 USA; [Rinehart, S.] Hebrew Univ Jerusalem, Dept Ecol Evolut & Behav, Jerusalem, Israel	California State University System; San Diego State University; California State University System; San Diego State University; University of California System; University of California Davis; Hebrew University of Jerusalem	Rinehart, S (corresponding author), San Diego State Univ, Dept Biol, San Diego, CA 92182 USA.; Rinehart, S (corresponding author), San Diego State Univ, Coastal & Marine Inst Lab, San Diego, CA 92182 USA.; Rinehart, S (corresponding author), Univ Calif Davis, Dept Ecol & Evolut, Davis, CA 95616 USA.; Rinehart, S (corresponding author), Hebrew Univ Jerusalem, Dept Ecol Evolut & Behav, Jerusalem, Israel.	srinehart@ucdavis.edu		Rinehart, Shelby/0000-0001-9820-1350	NSF [DGE-1321850]; CSU COAST Graduate Research Fellowship; Garden Club of America Restoration Fellowship; Zuckerman STEM Leadership Foundation Fellowship; Lady Davis Trust Fellowship; Minerva Center for Movement Ecology Postdoctoral Fellowship	NSF(National Science Foundation (NSF)); CSU COAST Graduate Research Fellowship; Garden Club of America Restoration Fellowship; Zuckerman STEM Leadership Foundation Fellowship; Lady Davis Trust Fellowship; Minerva Center for Movement Ecology Postdoctoral Fellowship	Funding for this work was provided by a NSF Graduate Research Fellowship (grant no. DGE-1321850; https://wm.nsfgrfp.org/), a CSU COAST Graduate Research Fellowship (https://www2.calstateedui), a Garden Club of America Restoration Fellowship (https://mw.gcamerica.Um/scholarships/details/id/13), Zuckerman STEM Leadership Foundation Fellowship (http://zuckerman-scholars.orgi), a Lady Davis Trust Fellowship (http://lcift.hultacti/), and a Minerva Center for Movement Ecology Postdoctoral Fellowship (http://move-ecol-minerva.huji.aciV) to S.R. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank B. Collins and S. Schroeter for access to Sweetwater Marsh and San Dieguito Lagoon. T. Grosholz, R. Karban, D. Deutschman, G. Vermeji, and J. Walker provided comments that improved the study design and final manuscript. F. Ventola, G. Cooper, and C. Knight provided field and laboratory assistance. Thank you to N. Fulner, K. Habersberger, Z. Kornfeld, and E.L. Yang for providing inspiration throughout this project. This is contribution No. 65 of San Diego State University's Coastal and Marine Institute.	ABRAMS PA, 1987, OECOLOGIA, V73, P272, DOI 10.1007/BF00377518; Abrams PA, 2000, TRENDS ECOL EVOL, V15, P337, DOI 10.1016/S0169-5347(00)01908-X; Badii MH, 2004, EXP APPL ACAROL, V34, P263, DOI 10.1007/s10493-004-1180-8; Buck TL, 2003, J EXP MAR BIOL ECOL, V292, P103, DOI 10.1016/S0022-0981(03)00146-1; Calabuig A, 2018, J ECON ENTOMOL, V111, P72, DOI 10.1093/jee/tox301; Coll M, 2002, ANNU REV ENTOMOL, V47, P267, DOI 10.1146/annurev.ento.47.091201.145209; Corkum LD, 2004, J ETHOL, V22, P23, DOI 10.1007/s10164-003-0095-x; Cottrell TE, 1998, ENVIRON ENTOMOL, V27, P1375, DOI 10.1093/ee/27.6.1375; CRAWLEY MJ, 1975, J ANIM ECOL, V44, P877, DOI 10.2307/3725; Eubanks MD, 1999, ECOLOGY, V80, P1253, DOI 10.1890/0012-9658(1999)080[1253:TECOVI]2.0.CO;2; Eubanks MD, 2000, ECOLOGY, V81, P936, DOI 10.2307/177168; GAGE MJG, 1995, P ROY SOC B-BIOL SCI, V261, P25, DOI 10.1098/rspb.1995.0112; Groenteman R, 2006, ECOL ENTOMOL, V31, P155, DOI 10.1111/j.0307-6946.2006.00772.x; Hassell MP., 1978, DYNAMICS ARTHROPOD P; Karban R, 2006, ECOLOGY, V87, P922, DOI 10.1890/0012-9658(2006)87[922:DRISVA]2.0.CO;2; Kratina P, 2009, OECOLOGIA, V159, P425, DOI 10.1007/s00442-008-1225-5; Leon-Beck M, 2007, J INSECT BEHAV, V20, P67, DOI 10.1007/s10905-006-9063-y; MANSOUR RA, 1991, MAR ECOL PROG SER, V72, P239, DOI 10.3354/meps072239; Maselou DA, 2014, BIOL CONTROL, V79, P92, DOI 10.1016/j.biocontrol.2014.09.002; Musser FR, 2003, ENVIRON ENTOMOL, V32, P1131, DOI 10.1603/0046-225X-32.5.1131; Nakashima Y, 2003, ENTOMOL EXP APPL, V106, P79, DOI 10.1046/j.1570-7458.2003.00002.x; PETERSON CH, 1989, OECOLOGIA, V80, P82, DOI 10.1007/BF00789935; PIMM SL, 1978, NATURE, V275, P542, DOI 10.1038/275542a0; PIMM SL, 1977, NATURE, V268, P329, DOI 10.1038/268329a0; POLIS GA, 1991, AM NAT, V138, P123, DOI 10.1086/285208; POLIS GA, 1989, ANNU REV ECOL SYST, V20, P297, DOI 10.1146/annurev.es.20.110189.001501; Polis GA, 1996, AM NAT, V147, P813, DOI 10.1086/285880; Rinehart SA, 2018, ECOSPHERE, V9, DOI 10.1002/ecs2.2273; Rinehart SA, 2017, ECOLOGY, V98, P2653, DOI 10.1002/ecy.1956; Shakya S, 2009, BIOL CONTROL, V50, P281, DOI 10.1016/j.biocontrol.2009.04.012; Skalski GT, 2001, ECOLOGY, V82, P3083; WALDE SJ, 1994, J ANIM ECOL, V63, P337, DOI 10.2307/5552; Wildy EL, 2001, OECOLOGIA, V128, P202, DOI 10.1007/s004420100641; Ziemba RE, 1999, OECOLOGIA, V120, P524, DOI 10.1007/s004420050886	34	0	0	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2019	14	8							e0215264	10.1371/journal.pone.0215264	http://dx.doi.org/10.1371/journal.pone.0215264			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5RZ	31437158	Green Submitted, Green Published, gold			2022-12-26	WOS:000485036900003
J	Wilson, JL; Wang, LZ; Zhang, ZY; Hill, NS; Polgar, P				Wilson, Jamie L.; Wang, Lizhen; Zhang, Zeyu; Hill, Nicholas S.; Polgar, Peter			Participation of PLK1 and FOXM1 in the hyperplastic proliferation of pulmonary artery smooth muscle cells in pulmonary arterial hypertension	PLOS ONE			English	Article							M1 TRANSCRIPTION FACTOR; SIGNAL-TRANSDUCTION; KINASE 1; EXPRESSION; CYCLE; FOXO1; PHOSPHORYLATION; SUPPRESSION; METABOLISM; INHIBITION	Vascular smooth muscle cells from the pulmonary arteries (HPASMC) of subjects with pulmonary arterial hypertension (PAH) exhibit hyperplastic growth. The PAH HPASMC display an increased sensitivity to fetal bovine serum (FBS) and undergo growth at a very low, 0.2%, FBS concentration. On the other hand, normal HPASMC (obtained from non-PAH donors) do not proliferate at low FBS (0.2%). A previous genomic study suggested that the nuclear factor, FOXM1 and the polo like kinase 1 (PLK1) are involved in promoting this hyperplastic growth of the PAH HPASMC. Here we find that limiting the action of FOXM1 or PLK1 not only restricts the hyperplastic proliferation of the PAH HPASMC but also modulates the FBS stimulated growth of normal HPASMC. The PAH HPASMC exhibit significantly elevated PLK1 and FOXM1 expression and decreased p27 (quiescence protein) levels compared to normal HPASMC. Regulation of the expression of FOXM1 and PLK1 is accompanied by the regulation of downstream expression of cell cycle components, Aurora B, cyclin B1 and cyclin D1. Expression of these cell cycle components is reversed by the knockdown of FOXM1 or PLK1 expression/activity. Furthermore, the knockdown of PLK1 expression lowers the protein level of FOXM1. On the other hand, inhibiting the action of FOXO1, a growth inhibitor, further increases the expression of FOXM1 in PAH HPASMC. Although PLK1 and FOXM1 clearly participate in PAH HPASMC hyperplasia, at this time it is not clear whether their increased activity is the primary driver of the hyperplastic behavior of the PAH HPASMC or merely a component of the pathway(s) leading to this response.	[Wilson, Jamie L.; Wang, Lizhen; Zhang, Zeyu; Hill, Nicholas S.; Polgar, Peter] Tufts Med Ctr, Tupper Res Inst, Boston, MA 02111 USA; [Wilson, Jamie L.; Wang, Lizhen; Zhang, Zeyu; Hill, Nicholas S.; Polgar, Peter] Tufts Med Ctr, Pulm Crit Care & Sleep Div, Boston, MA 02111 USA; [Wang, Lizhen] Guangdong Second Prov Gen Hosp, Dept Pulm & Crit Care Med, Guangzhou, Guangdong, Peoples R China; [Zhang, Zeyu] Cent South Univ, Xiangya Hosp 3, Postdoctoral Res Stn Clin Med, Changsha, Hunan, Peoples R China; [Zhang, Zeyu] Cent South Univ, Xiangya Hosp 3, Ctr Clin Pharmacol, Changsha, Hunan, Peoples R China	Tufts Medical Center; Tufts Medical Center; Central South University; Central South University	Wilson, JL (corresponding author), Tufts Med Ctr, Tupper Res Inst, Boston, MA 02111 USA.; Wilson, JL (corresponding author), Tufts Med Ctr, Pulm Crit Care & Sleep Div, Boston, MA 02111 USA.	jwilson8@tuftsmedicalcenter.org	Wilson, Jamie/J-5913-2019		National Heart, Lung, and Blood Institute of the National Institutes of Health [HL133796]	National Heart, Lung, and Blood Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by grant HL133796 (JW) from the National Heart, Lung, and Blood Institute of the National Institutes of Health (https://www.nhibi.gov/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Accili D, 2004, CELL, V117, P421, DOI 10.1016/S0092-8674(04)00452-0; Anders L, 2011, CANCER CELL, V20, P620, DOI 10.1016/j.ccr.2011.10.001; Boucherat O, 2017, PULM CIRC, V7, P285, DOI 10.1177/2045893217701438; Bourgeois A, 2018, J MOL MED, V96, P223, DOI 10.1007/s00109-017-1619-0; Chen X, 2013, MOL CELL BIOL, V33, P227, DOI 10.1128/MCB.00881-12; Cholewa BD, 2017, CANCER LETT, V385, P179, DOI 10.1016/j.canlet.2016.10.025; Cholewa BD, 2014, J PROTEOME RES, V13, P5041, DOI 10.1021/pr5002516; Comhair SAA, 2012, AM J RESP CELL MOL, V46, P723, DOI 10.1165/rcmb.2011-0416TE; Dai JB, 2018, CELL SIGNAL, V51, P119, DOI 10.1016/j.cellsig.2018.08.003; Dai ZY, 2018, AM J RESP CRIT CARE, V198, P788, DOI 10.1164/rccm.201709-1835OC; Fouty BW, 2001, AM J RESP CELL MOL, V25, P652, DOI 10.1165/ajrcmb.25.5.4592; Fu Z, 2008, NAT CELL BIOL, V10, P1076, DOI 10.1038/ncb1767; Fu Z, 2017, CANCERS, V9, DOI 10.3390/cancers9100131; Goncharov DA, 2014, CIRCULATION, V129, P864, DOI 10.1161/CIRCULATIONAHA.113.004581; Harbaum L, 2014, EUR RESPIR J, V43, P1513, DOI 10.1183/09031936.00185713; Humbert M, 2008, AM J RESP CRIT CARE, V178, P551, DOI 10.1164/rccm.200806-867ED; Jurasz P, 2010, PHARMACOL THERAPEUT, V126, P1, DOI 10.1016/j.pharmthera.2009.12.006; Kalinichenko VV, 2003, J BIOL CHEM, V278, P37888, DOI 10.1074/jbc.M305555200; Kim IM, 2005, J BIOL CHEM, V280, P22278, DOI 10.1074/jbc.M500936200; Krupczak-Hollis K, 2004, DEV BIOL, V276, P74, DOI 10.1016/j.ydbio.2004.08.022; Krymskaya VP, 2011, FASEB J, V25, P1922, DOI 10.1096/fj.10-175018; Kudryashova TV, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19102957; Kudryashova TV, 2016, AM J RESP CRIT CARE, V194, P866, DOI 10.1164/rccm.201510-2003OC; Laoukili J, 2005, NAT CELL BIOL, V7, P126, DOI 10.1038/ncb1217; LEE KS, 1995, MOL CELL BIOL, V15, P7143; Li H. H., 2017, PLANT CELL TISSUE OR, V2017, P1, DOI DOI 10.1016/J.EC0LM0DEL.2017.01.003; Lindqvist A, 2009, J CELL BIOL, V185, P193, DOI 10.1083/jcb.200812045; Liu ZX, 2017, TRANSL ONCOL, V10, P22, DOI 10.1016/j.tranon.2016.10.003; Luo Y, 2014, GENE THER, V21, P751, DOI 10.1038/gt.2014.49; Paulin R, 2014, EUR RESPIR J, V43, P531, DOI 10.1183/09031936.00181312; Perros F, 2008, AM J RESP CRIT CARE, V178, P81, DOI 10.1164/rccm.200707-1037OC; Raghavan A, 2012, AM J RESP CELL MOL, V46, P431, DOI 10.1165/rcmb.2011-0128OC; Rai PR, 2008, AM J RESP CRIT CARE, V178, P558, DOI 10.1164/rccm.200709-1369PP; Ramaswamy S, 2002, CANCER CELL, V2, P81, DOI 10.1016/S1535-6108(02)00086-7; Savai R, 2014, NAT MED, V20, P1289, DOI 10.1038/nm.3695; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sengupta A, 2013, CIRC RES, V112, P267, DOI 10.1161/CIRCRESAHA.112.277442; Sur S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147937; Tran Hien, 2003, Sci STKE, V2003, pRE5, DOI 10.1126/stke.2003.172.re5; Tuder RM, 2013, J AM COLL CARDIOL, V62, pD4, DOI 10.1016/j.jacc.2013.10.025; Ustiyan V, 2009, DEV BIOL, V336, P266, DOI 10.1016/j.ydbio.2009.10.007; Wang IC, 2010, DEV BIOL, V347, P301, DOI 10.1016/j.ydbio.2010.08.027; Wang IC, 2005, MOL CELL BIOL, V25, P10875, DOI 10.1128/MCB.25.24.10875-10894.2005; Wang XH, 2001, P NATL ACAD SCI USA, V98, P11468, DOI 10.1073/pnas.201360898; Wilson JL, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195780; Wilson Jamie L, 2015, Curr Top Pept Protein Res, V16, P1; Wilson JL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123662; Yang XD, 2005, CIRC RES, V96, P1053, DOI 10.1161/01.RES.0000166926.54293.68; Yu J, 2015, J CELL BIOCHEM, V116, P386, DOI 10.1002/jcb.24987; Yu J, 2013, J CELL PHYSIOL, V228, P322, DOI 10.1002/jcp.24132; Yuan CF, 2014, CELL CYCLE, V13, P807, DOI 10.4161/cc.27727; Yuan JXJ, 1998, CIRCULATION, V98, P1400, DOI 10.1161/01.CIR.98.14.1400	52	9	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2019	14	8							e0221728	10.1371/journal.pone.0221728	http://dx.doi.org/10.1371/journal.pone.0221728			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5RZ	31437238	Green Submitted, Green Published, gold			2022-12-26	WOS:000485036900104
J	Kweon, J; Jang, AH; Shin, HR; See, JE; Lee, W; Lee, JW; Chang, S; Kim, K; Kim, Y				Kweon, Jiyeon; Jang, An-Hee; Shin, Ha Rim; See, Ji-Eun; Lee, Woochang; Lee, Jong Won; Chang, Suhwan; Kim, Kyunggon; Kim, Yongsub			A CRISPR-based base-editing screen for the functional assessment of BRCA1 variants	ONCOGENE			English	Article							GENOMIC DNA; SITES	Genetic mutations in BRCA1, which is crucial for the process of DNA repair and maintenance of genomic integrity, are known to increase markedly the risk of breast and ovarian cancers. Clinical genetic testing has been used to identify new BRCA1 variants; however, functional assessment and determination of their pathogenicity still poses challenges for clinical management. Here, we describe that CRISPR-mediated cytosine base editor, known as BE3, can be used for the functional analysis of BRCA1 variants. We performed CRISPR-mediated base-editing screening using 745 gRNAs targeting all exons in BRCA1 to identify loss-of-function variants and identified variants whose function has heretofore remained unknown, such as c.-97C>T, c.154C>T, c.3847C>T, c.5056C>T, and c.4986+5G>A. Our results show that CRISPR-mediated base editor is a powerful tool for the reclassification of variants of uncertain significance (VUSs) in BRCA1.	[Kweon, Jiyeon; Jang, An-Hee; Shin, Ha Rim; See, Ji-Eun; Chang, Suhwan; Kim, Yongsub] Univ Ulsan, Coll Med, Asan Med Inst Convergence Sci & Technol, Dept Biomed Sci,Asan Med Ctr, Seoul, South Korea; [Kweon, Jiyeon; Jang, An-Hee; Shin, Ha Rim; See, Ji-Eun; Kim, Yongsub] Univ Ulsan, Coll Med, Stem Cell Immunomodulat Res Ctr, Seoul, South Korea; [Lee, Woochang] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Lab Med, Seoul, South Korea; [Lee, Jong Won] Univ Ulsan, Coll Med, Asan Med Ctr, Div Breast Surg,Dept Surg, Seoul, South Korea; [Kim, Kyunggon] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Convergence Med, Seoul, South Korea; [Kim, Kyunggon] Asan Inst Life Sci, Clin Prote Core Lab, Seoul, South Korea	University of Ulsan; University of Ulsan; University of Ulsan; Asan Medical Center; University of Ulsan; Asan Medical Center; University of Ulsan; Asan Medical Center	Kim, Y (corresponding author), Univ Ulsan, Coll Med, Asan Med Inst Convergence Sci & Technol, Dept Biomed Sci,Asan Med Ctr, Seoul, South Korea.; Kim, Y (corresponding author), Univ Ulsan, Coll Med, Stem Cell Immunomodulat Res Ctr, Seoul, South Korea.	yongsub1.kim@gmail.com		Kim, Yongsub/0000-0002-9334-4333; Chang, Suhwan/0000-0002-0282-0120	National Research Foundation of Korea [2017M3A9B4062419, 2019R1F1A1057637, 2018R1A5A2020732]; Korean Health Technology R&D Project, Ministry of Health and Welfare, Republic of Korea [HI17C0337]; Asan institute for Life Sciences, Republic of Korea [2018-784, 2018-725]	National Research Foundation of Korea(National Research Foundation of Korea); Korean Health Technology R&D Project, Ministry of Health and Welfare, Republic of Korea; Asan institute for Life Sciences, Republic of Korea	This work was supported by the National Research Foundation of Korea (grants 2017M3A9B4062419, 2019R1F1A1057637, and 2018R1A5A2020732 to Y.K.), the Korean Health Technology R&D Project, Ministry of Health and Welfare, Republic of Korea (grant HI17C0337 to Y.K.), and Asan institute for Life Sciences, Republic of Korea (grants 2018-784, and 2018-725 to Y.K.).	Bae S, 2014, BIOINFORMATICS, V30, P1473, DOI 10.1093/bioinformatics/btu048; Blomen VA, 2015, SCIENCE, V350, P1092, DOI 10.1126/science.aac7557; BRUNAK S, 1991, J MOL BIOL, V220, P49, DOI 10.1016/0022-2836(91)90380-O; Desmet FO, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp215; Farmer H, 2005, NATURE, V434, P917, DOI 10.1038/nature03445; Findlay GM, 2018, NATURE, V562, P217, DOI 10.1038/s41586-018-0461-z; Findlay GM, 2014, NATURE, V513, P120, DOI 10.1038/nature13695; Gaudelli NM, 2017, NATURE, V551, P464, DOI 10.1038/nature24644; Gibson TJ, 2013, NAT METHODS, V10, P715, DOI 10.1038/nmeth.2534; Hess GT, 2016, NAT METHODS, V13, P1036, DOI [10.1038/NMETH.4038, 10.1038/nmeth.4038]; Hu JH, 2018, NATURE, V556, P57, DOI 10.1038/nature26155; Joung J, 2017, NAT PROTOC, V12, P828, DOI 10.1038/nprot.2017.016; Kim K, 2017, NAT BIOTECHNOL, V35, P435, DOI 10.1038/nbt.3816; Kim Y, 2013, NAT BIOTECHNOL, V31, P251, DOI 10.1038/nbt.2517; Knott GJ, 2018, SCIENCE, V361, P866, DOI 10.1126/science.aat5011; Komor AC, 2016, NATURE, V533, P420, DOI 10.1038/nature17946; Kuchenbaecker KB, 2017, JAMA-J AM MED ASSOC, V317, P2402, DOI 10.1001/jama.2017.7112; Kweon J, 2018, ARCH PHARM RES, V41, P875, DOI 10.1007/s12272-018-1029-z; Kweon J, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0199473; Landrum MJ, 2016, NUCLEIC ACIDS RES, V44, pD862, DOI 10.1093/nar/gkv1222; Millot GA, 2012, HUM MUTAT, V33, P1526, DOI 10.1002/humu.22150; Nishimasu H, 2018, SCIENCE, V361, P1259, DOI 10.1126/science.aas9129; Park DS, 2017, MOL CELLS, V40, P823, DOI 10.14348/molcells.2017.0262; Roy R, 2012, NAT REV CANCER, V12, P68, DOI 10.1038/nrc3181; Sayers EW, 2019, NUCLEIC ACIDS RES, V47, pD94, DOI 10.1093/nar/gky989; Wang T, 2015, SCIENCE, V350, P1096, DOI 10.1126/science.aac7041	26	35	35	0	5	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN	2020	39	1					30	35		10.1038/s41388-019-0968-2	http://dx.doi.org/10.1038/s41388-019-0968-2			6	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	KG3NM	31467430	hybrid, Green Published			2022-12-26	WOS:000509849200003
J	Gmerek, L; Martyniak, K; Horbacka, K; Krokowicz, P; Scierski, W; Golusinski, P; Golusinski, W; Schneider, A; Masternak, MM				Gmerek, Lukasz; Martyniak, Kari; Horbacka, Karolina; Krokowicz, Piotr; Scierski, Wojciech; Golusinski, Pawel; Golusinski, Wojciech; Schneider, Augusto; Masternak, Michel M.			MicroRNA regulation in colorectal cancer tissue and serum	PLOS ONE			English	Article							GENE; KEGG; RNA	Colorectal cancer is recognized as the fourth leading cause of cancer-related deaths worldwide. Thus, there is ongoing search for potential new biomarkers allowing quicker and less invasive detection of the disease and prediction of the treatment outcome. Therefore, the aim of our study was to identify colorectal cancer specific miRNAs expressed in cancerous and healthy tissue from the same patient and to further correlate the presence of the same miRNAs in the circulation as potential biomarkers for diagnosis. In the current study we detected a set of 40 miRNAs differentially regulated in tumor tissue when comparing with healthy tissue. Additionally, we found 8 miRNAs differentially regulated in serum of colorectal cancer patients. Interestingly, there was no overlap in miRNAs regulated in tissue and serum, suggesting that serum regulated miRNAs may be not actively secreted from colorectal tumor cells. However, four of differentially expressed miRNAs, including miR-21, miR-17, miR-20a and miR-32 represent the miRNAs characteristic for different tumor types, including breast, colon, lung, pancreas, prostate and stomach cancer. This finding suggests important groups of miRNAs which can be further validated as markers for diagnosis of tumor tissue and regulation of carcinogenesis.	[Gmerek, Lukasz; Martyniak, Kari; Masternak, Michel M.] Univ Cent Florida, Coll Med, Burnett Sch Biomed Sci, Orlando, FL 32816 USA; [Gmerek, Lukasz; Horbacka, Karolina; Krokowicz, Piotr] Poznan Univ Med Sci, Dept Gen & Colorectal Surg, Poznan, Poland; [Scierski, Wojciech] Med Univ Silesia, Dept Otorhinolaryngol & Laryngol Oncol Zabrze, Katowice, Poland; [Golusinski, Pawel] Univ Zielona Gora, Dept Otolaryngol & Maxillofacial Surg, Zielona Gora, Poland; [Golusinski, Pawel; Golusinski, Wojciech; Masternak, Michel M.] Poznan Univ Med Sci, Greater Poland Canc Ctr, Dept Head & Neck Surg, Poznan, Poland; [Schneider, Augusto] Univ Fed Pelotas, Fac Nutr, Pelotas, RS, Brazil	State University System of Florida; University of Central Florida; Poznan University of Medical Sciences; Medical University Silesia; University of Zielona Gora; Poznan University of Medical Sciences; Wielkopolskie Centrum Onkologii; Universidade Federal de Pelotas	Masternak, MM (corresponding author), Univ Cent Florida, Coll Med, Burnett Sch Biomed Sci, Orlando, FL 32816 USA.; Masternak, MM (corresponding author), Poznan Univ Med Sci, Greater Poland Canc Ctr, Dept Head & Neck Surg, Poznan, Poland.; Schneider, A (corresponding author), Univ Fed Pelotas, Fac Nutr, Pelotas, RS, Brazil.	augustoschneider@gmail.com; michal.masternak@ucf.edu	Schneider, Augusto/B-5011-2014	Schneider, Augusto/0000-0002-3410-2860; Martyniak, Kari/0000-0001-5519-404X; GOLUSINSKI, WOJCIECH/0000-0002-6075-3464; Wojciech, Scierski/0000-0003-3242-8047	Florida Legislative Crohn's grant	Florida Legislative Crohn's grant	The study was funded by the Florida Legislative Crohn's grant (MMM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aherne ST, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1327-5; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bell DW, 2010, J PATHOL, V220, P231, DOI 10.1002/path.2645; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Calin GA, 2006, CANCER RES, V66, P7390, DOI 10.1158/0008-5472.CAN-06-0800; Chan JK, 2014, GYNECOL ONCOL, V132, P739, DOI 10.1016/j.ygyno.2014.01.034; Chen X, 2012, TRENDS CELL BIOL, V22, P125, DOI 10.1016/j.tcb.2011.12.001; Cirillo F, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20122922; Cortez MA, 2011, NAT REV CLIN ONCOL, V8, P467, DOI 10.1038/nrclinonc.2011.76; Cuellar TL, 2005, J ENDOCRINOL, V187, P327, DOI 10.1677/joe.1.06426; Danese E, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08784-3; Elghoroury EA, 2018, CLIN BREAST CANCER, V18, pE721, DOI 10.1016/j.clbc.2017.11.022; Falzone L, 2018, AGING-US, V10, P1000, DOI 10.18632/aging.101444; He ZY, 2016, MOL CANCER, V15, DOI 10.1186/s12943-016-0533-3; Johannessen C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186658; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kanehisa M, 2016, NUCLEIC ACIDS RES, V44, pD457, DOI 10.1093/nar/gkv1070; Kelley KA, 2018, DIS COLON RECTUM, V61, P1290, DOI 10.1097/DCR.0000000000001192; Kolenda T, 2017, REP PRACT ONCOL RADI, V22, P378, DOI 10.1016/j.rpor.2017.07.001; Liu CX, 2016, ONCOTARGETS THER, V9, P2865, DOI 10.2147/OTT.S103460; Lopez YON, 2018, REP PRACT ONCOL RADI, V23, P6, DOI [10.1016/j.rpot.2017.10.003, 10.1016/j.rpor.2017.10.003]; Masuda T, 2017, CANCERS, V9, DOI 10.3390/cancers9090124; Matkovich SJ, 2013, CIRC RES, V113, P62, DOI 10.1161/CIRCRESAHA.113.300975; McGuire S, 2016, ADV NUTR, V7, P418, DOI 10.3945/an.116.012211; Ohshima K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013247; Osako Y, 2016, INT J ONCOL, V49, P2255, DOI 10.3892/ijo.2016.3745; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rueda A, 2015, NUCLEIC ACIDS RES, V43, pW467, DOI 10.1093/nar/gkv555; Schneider A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-18945-z; Sun XR, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-18739-3; Takahashi M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046684; Tsai HL, 2013, TRANSL RES, V162, P258, DOI 10.1016/j.trsl.2013.07.009; Vlachos IS, 2015, NUCLEIC ACIDS RES, V43, pW460, DOI 10.1093/nar/gkv403; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Vychytilova-Faltejskova P, 2016, CARCINOGENESIS, V37, P941, DOI 10.1093/carcin/bgw078; Witold K, 2018, REP PRACT ONCOL RADI, V23, P75, DOI 10.1016/j.rpor.2017.12.003; Xie BB, 2018, ONCOL REP, V40, P3551, DOI 10.3892/or.2018.6726; Yan LX, 2016, INT J ONCOL, V48, P471, DOI 10.3892/ijo.2015.3287; Yan Y, 2017, ONCOTARGET, V8, P8206, DOI 10.18632/oncotarget.14143; Yang J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107202; Zheng H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077853	41	24	25	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2019	14	8							e0222013	10.1371/journal.pone.0222013	http://dx.doi.org/10.1371/journal.pone.0222013			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW6BO	31469874	Green Published, Green Submitted, gold			2022-12-26	WOS:000485062200047
J	Husain, R; Weeden, H; Bogush, D; Deguchi, M; Soliman, M; Potlakayala, S; Katam, R; Goldman, S; Rudrabhatla, S				Husain, Rabab; Weeden, Hannah; Bogush, Daniel; Deguchi, Michihito; Soliman, Mario; Potlakayala, Shobha; Katam, Ramesh; Goldman, Stephen; Rudrabhatla, Sairam			Enhanced tolerance of industrial hemp (Cannabis sativa L.) plants on abandoned mine land soil leads to overexpression of cannabinoids	PLOS ONE			English	Article							METAL CONTAMINATED SOIL; SHOOT CD TRANSLOCATION; HEAVY-METALS; PHYTOREMEDIATION; ACCUMULATION; GROWTH; DNA	Industrial activities have a detrimental impact on the environment and health when high concentrations of pollutants are released. Phytoremediation is a natural method of utilizing plants to remove contaminants from the soil. The goal of this study was to investigate the ability of Cannabis sativa L. to sustainably grow and remediate abandoned coal mine land soils in Pennsylvania. In this study, six different varieties of industrial hemp (Fedora 17, Felina 32, Ferimon, Futura 75, Santhica 27, and USO 31) were grown on two different contaminated soil types and two commercial soils (Miracle-Gro Potting Mix and PRO-MIX HP Mycorrhizae High Porosity Grower Mix). Plants growing in all soil types were exposed to two environmental conditions (outside and in the greenhouse). Seed germination response and plant height indicated no significant differences among all hemp varieties grown in different soils, however on an average, the height of the plants grown in the greenhouse exceeded that of the plants grown outdoors. In addition, heavy metal analysis of Arsenic, Lead, Nickel, Mercury, and Cadmium was performed. The concentration of Nickel was 2.54 times greater in the leaves of hemp grown in mine land soil outdoors when compared to greenhouse conditions. No differences were found between expression of heavy metal transporter genes. Secondary metabolite analysis of floral buds from hemp grown in mine land soil displayed a significant increase in the total Cannabidiol content (2.16%, 2.58%) when compared to Miracle-Gro control soil (1.08%, 1.6%) for outdoors and in the greenhouse, respectively. Molecular analysis using qRT-PCR indicated an 18-fold increase in the expression of the cannabidiolic acid synthase gene in plants grown on mine land soil. The data indicates a high tolerance to heavy metals as indicated from the physiological and metabolites analysis.	[Husain, Rabab; Weeden, Hannah; Bogush, Daniel; Deguchi, Michihito; Potlakayala, Shobha; Rudrabhatla, Sairam] Penn State Harrisburg, Middletown, PA 17057 USA; [Husain, Rabab; Katam, Ramesh] Florida A&M Univ, Dept Biol Sci, Tallahassee, FL 32307 USA; [Soliman, Mario] Burrell Coll Osteopath Med, Las Cruces, NM USA; [Goldman, Stephen] Univ Toledo, Dept Environm Sci, 2801 W Bancroft St, Toledo, OH 43606 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; State University System of Florida; Florida A&M University; University System of Ohio; University of Toledo	Rudrabhatla, S (corresponding author), Penn State Harrisburg, Middletown, PA 17057 USA.	svr11@psu.edu	Katam, Ramesh/ABD-4806-2021		National Science Foundation [1560049]	National Science Foundation(National Science Foundation (NSF))	This work received financial support by the National Science Foundation, grant number 1560049 (https://www.nsf.gov/) to RH. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aina R, 2004, PHYSIOL PLANTARUM, V121, P472, DOI 10.1111/j.1399-3054.2004.00343.x; Amaducci S., 2008, Journal of Industrial Hemp, V13, P5, DOI 10.1080/15377880801898691; [Anonymous], HEMP PROD; Asati A., 2016, INT J APPL INNOVATIO, V5, P56; Bauddh K, 2017, PHYTOREMEDIATION POT; Berni R, 2018, ENV EXPT BOT; Bouyer D, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1313-0; Chaney RL, 1997, CURR OPIN BIOTECH, V8, P279, DOI 10.1016/S0958-1669(97)80004-3; Chibuike G.U., 2014, APPL ENVIRON SOIL SC, DOI [10.1155/2014/752708, DOI 10.1155/2014/752708, 10.1155/ 2014/752708]; CUNNINGHAM SD, 1995, TRENDS BIOTECHNOL, V13, P393, DOI 10.1016/S0167-7799(00)88987-8; De Backer B, 2009, J CHROMATOGR B, V877, P4115, DOI 10.1016/j.jchromb.2009.11.004; Gagne SJ, 2012, P NATL ACAD SCI USA, V109, P12811, DOI 10.1073/pnas.1200330109; Hajar EWI, 2014, PROCEDIA ENVIRON SCI, V20, P386, DOI 10.1016/j.proenv.2014.03.049; Ismael MA, 2019, METALLOMICS, V11, P255, DOI [10.1039/c8mt00247a, 10.1039/C8MT00247A]; JONES CG, 1989, J CHEM ECOL, V15, P979, DOI 10.1007/BF01015193; Kinet JM, 2018, PHYSL FLOWERING, VIII; Konopko Cooperative, COOP SUST PROD PROC; Laghmouchi Y, 2017, BIOCATAL AGR BIOTECH, V10, P156, DOI 10.1016/j.bcab.2017.03.002; Li CF, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1773-0; Linger P, 2005, BIOL PLANTARUM, V49, P567, DOI 10.1007/s10535-005-0051-4; Linger P, 2002, IND CROP PROD, V16, P33, DOI 10.1016/S0926-6690(02)00005-5; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Marrugo-Negrete J, 2015, CHEMOSPHERE, V127, P58, DOI 10.1016/j.chemosphere.2014.12.073; Mishra RPN, 2006, CURR MICROBIOL, V52, P383, DOI 10.1007/s00284-005-0296-3; Mishra S, ADV SCI 0807, P103; Munz E, 2017, NEW PHYTOL, V216, P1181, DOI 10.1111/nph.14736; Nasim SA, 2010, REV ENVIRON CONTAM T, V203, P139, DOI 10.1007/978-1-4419-1352-4_5; Park W, 2017, PLANT BIOTECHNOL REP, V11, P209, DOI 10.1007/s11816-017-0447-6; Sahodaran NK, 2019, EXPT AGR, P1; Salentijn EMJ, 2015, IND CROP PROD, V68, P32, DOI 10.1016/j.indcrop.2014.08.011; Saxena G., 2019, PHYTOREMEDIATION HEA; Schachtsiek J, 2018, PLANTA MED, V84, P214, DOI 10.1055/s-0043-125087; Schluttenhofer C, 2017, TRENDS PLANT SCI, V22, P917, DOI 10.1016/j.tplants.2017.08.004; Shi GR, 2009, BIOTECHNOL ADV, V27, P555, DOI 10.1016/j.biotechadv.2009.04.006; Tangahu BV, 2011, INT J CHEM ENG, V2011, DOI 10.1155/2011/939161; Ullah R, 2019, WATER AIR SOIL POLL, V230, DOI 10.1007/s11270-019-4089-x; Uraguchi S, 2009, J EXP BOT, V60, P2677, DOI 10.1093/jxb/erp119; USEPA, 1996, SW846 USEPA OFF SOL; van Bakel H, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-10-r102; Vaverkove M.D., 2017, WASTE BIOMASS VALORI, P1; Vert G, 2002, PLANT CELL, V14, P1223, DOI 10.1105/tpc.001388; Wong CKE, 2009, NEW PHYTOL, V181, P71, DOI 10.1111/j.1469-8137.2008.02638.x; Yang SX, 2016, SCI TOTAL ENVIRON, V562, P427, DOI 10.1016/j.scitotenv.2016.03.208	43	26	28	3	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2019	14	8							e0221570	10.1371/journal.pone.0221570	http://dx.doi.org/10.1371/journal.pone.0221570			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW6AB	31465423	Green Published, Green Submitted, gold			2022-12-26	WOS:000485058200027
J	Chandel, I; Ten Hagen, KG; Panin, V				Chandel, Ishita; Ten Hagen, Kelly G.; Panin, Vlad			Sweet rescue or surrender of the failing heart?	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material							NATRIURETIC PEPTIDE	Natriuretic peptides (NPs) are hormones involved in maintaining heart health that undergo proteolytic cleavage to become activated. Previous work has shown that O-GalNAc glycans affect their processing and activation. Here, Goetze, Schjoldager, and colleagues now provide comprehensive characterization of O-glycosylation of NPs, revealing that all members of the NP family can be modified by O-GalNAc glycans. Intriguingly, the study discovers glycans in the receptor-binding region of the A-type natriuretic peptide (ANP), demonstrating that they affect both stability and activity of ANP. These results may inform future therapeutic approaches for heart failure using peptide glycoforms.	[Chandel, Ishita; Panin, Vlad] Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA; [Ten Hagen, Kelly G.] NIDCR, NIH, Bethesda, MD 20892 USA	Texas A&M University System; Texas A&M University College Station; National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR)	Panin, V (corresponding author), Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA.	panin@tamu.edu			National Institutes of Health [RO1 NS099409, NS075534, Z01-DE000713]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS099409] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health Grants RO1 NS099409 and NS075534 (to V. P.) and Z01-DE000713 (to K. G. T. H.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Brockhausen I., 2015, ESSENTIALS GLYCOBIOL, P113, DOI DOI 10.1101/GLYCOBIOLOGY.3E.010; Goth CK, 2018, TRENDS BIOCHEM SCI, V43, P269, DOI 10.1016/j.tibs.2018.02.005; Hansen LH, 2019, J BIOL CHEM, V294, P12567, DOI 10.1074/jbc.RA119.008102; Nakagawa Y, 2019, PEPTIDES, V111, P18, DOI 10.1016/j.peptides.2018.05.012; Nakagawa Y, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.116.003601; Potter LR, 2011, FEBS J, V278, P1808, DOI 10.1111/j.1742-4658.2011.08082.x; Schellenberger U, 2006, ARCH BIOCHEM BIOPHYS, V451, P160, DOI 10.1016/j.abb.2006.03.028; Semenov AG, 2009, CLIN CHEM, V55, P489, DOI 10.1373/clinchem.2008.113373; Topol EJ, 2011, NEW ENGL J MED, V365, P81, DOI 10.1056/NEJMe1103116; Varki A, 2017, GLYCOBIOLOGY, V27, P3, DOI 10.1093/glycob/cww086	10	0	0	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 23	2019	294	34					12579	12580		10.1074/jbc.H119.010228	http://dx.doi.org/10.1074/jbc.H119.010228			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IV6YV	31444307	Green Published, hybrid			2022-12-26	WOS:000484414600002
J	Kellie, DJ; Blake, KR; Brooks, RC				Kellie, Dax J.; Blake, Khandis R.; Brooks, Robert C.			What drives female objectification? An investigation of appearance-based interpersonal perceptions and the objectification of women	PLOS ONE			English	Article							SEXUAL OBJECTIFICATION; PHYSICAL ATTRACTIVENESS; QUESTIONNAIRE LENGTH; MIND PERCEPTION; DEHUMANIZATION; IMPLICIT; RECOGNITION; PREFERENCES; PSYCHOLOGY; RESOURCE	Previous research finds that both men and women perceive sexualized women as lacking in certain human qualities such as mental capacity and moral status. The mechanism underlying this effect, however, is unclear. The present two studies test how appearance-based judgements affect the degree to which a broad sample of women are objectified. In Study 1 (N = 279), full-body images of women wearing different clothing outfits were rated by male and female participants on perceived attractiveness, sexual intent and age. In Study 2, male and female participants (N = 1,695) viewed these same images from Study 1 and rated them on two dimensions of objectification (agency and patiency). We analyzed associations between these dimensions of objectification and the averaged appearance-based perceptions from Study 1. We find that women perceived as more open to casual sex are attributed less mental capacity and less moral status. We also find that participants tend to associate attractiveness with greater mental and moral status in women, but we find only limited evidence that perceived age influences objectification. Our findings suggest that although positive attractiveness biases may mitigate the amount a woman is objectified, greater female objectification may be prompted by observers' negative stereotypes of promiscuous women.	[Kellie, Dax J.; Blake, Khandis R.; Brooks, Robert C.] Univ New South Wales, Sch Biol Earth & Environm Sci, Evolut & Ecol Res Ctr, Sydney, NSW, Australia	University of New South Wales Sydney	Kellie, DJ (corresponding author), Univ New South Wales, Sch Biol Earth & Environm Sci, Evolut & Ecol Res Ctr, Sydney, NSW, Australia.	d.kellie@unsw.edu.au	Kellie, Dax/AAI-2554-2020	Kellie, Dax/0000-0001-7408-273X				Agthe M, 2016, EVOL PSYCHOL-US, V14, DOI 10.1177/1474704916653968; Agthe M, 2011, PERS SOC PSYCHOL B, V37, P1042, DOI 10.1177/0146167211410355; Aviezer H, 2012, SCIENCE, V338, P1225, DOI 10.1126/science.1224313; Aviezer H, 2012, J PERS SOC PSYCHOL, V103, P20, DOI 10.1037/a0027411; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Baumeister RF, 2004, PERS SOC PSYCHOL REV, V8, P339, DOI 10.1207/s15327957pspr0804_2; Bernard P, 2018, SOC PSYCHOL PERS SCI, V9, P550, DOI 10.1177/1948550617714582; Bernard P, 2012, PSYCHOL SCI, V23, P469, DOI 10.1177/0956797611434748; Blake KR, 2016, AGGRESSIVE BEHAV, V42, P483, DOI 10.1002/ab.21644; Boothroyd LG, 2008, EVOL HUM BEHAV, V29, P211, DOI 10.1016/j.evolhumbehav.2007.12.009; BUSS DM, 1989, BEHAV BRAIN SCI, V12, P1, DOI 10.1017/S0140525X00023992; BUSS DM, 1993, PSYCHOL REV, V100, P204, DOI 10.1037/0033-295X.100.2.204; Cikara M, 2011, J COGNITIVE NEUROSCI, V23, P540, DOI 10.1162/jocn.2010.21497; Civile C, 2016, PSYCHOL WOMEN QUART, V40, P199, DOI 10.1177/0361684315604820; Cogoni C, 2018, CORTEX, V99, P258, DOI 10.1016/j.cortex.2017.11.020; DION K, 1972, J PERS SOC PSYCHOL, V24, P285, DOI 10.1037/h0033731; Eagly A. H., 2016, SOCIAL ROLE THEORY S, P1, DOI 10.1002/9781118663219.wbegss183; Eagly AH, 1999, AM PSYCHOL, V54, P408, DOI 10.1037/0003-066X.54.6.408; Eastwick PW, 2013, SOC PERSONAL PSYCHOL, V7, P275, DOI 10.1111/spc3.12026; Edlund JE, 2014, PERS INDIV DIFFER, V64, P72, DOI 10.1016/j.paid.2014.02.005; FEINGOLD A, 1992, PSYCHOL BULL, V111, P304, DOI 10.1037/0033-2909.111.2.304; Festinger L, 1954, HUM RELAT, V7, P117, DOI 10.1177/001872675400700202; Fink B, 2014, PERS INDIV DIFFER, V58, P138, DOI 10.1016/j.paid.2013.10.015; Fisher CI, 2016, PERS INDIV DIFFER, V101, P396, DOI 10.1016/j.paid.2016.06.022; Fredrickson BL, 1998, J PERS SOC PSYCHOL, V75, P269, DOI 10.1037/0022-3514.75.1.269; Fredrickson BL, 1997, PSYCHOL WOMEN QUART, V21, P173, DOI 10.1111/j.1471-6402.1997.tb00108.x; Galesic M, 2009, PUBLIC OPIN QUART, V73, P349, DOI 10.1093/poq/nfp031; Gervais SJ, 2013, SEX ROLES, V69, P557, DOI 10.1007/s11199-013-0316-x; Gervais SJ, 2012, EUR J SOC PSYCHOL, V42, P743, DOI 10.1002/ejsp.1890; Goff PA, 2008, J PERS SOC PSYCHOL, V94, P292, DOI 10.1037/0022-3514.94.2.292; Graff K, 2012, SEX ROLES, V66, P764, DOI 10.1007/s11199-012-0145-3; Gray HM, 2007, SCIENCE, V315, P619, DOI 10.1126/science.1134475; Gray K, 2012, PSYCHOL INQ, V23, P101, DOI 10.1080/1047840X.2012.651387; Gray K, 2011, J PERS SOC PSYCHOL, V101, P1207, DOI 10.1037/a0025883; Gray K, 2009, J PERS SOC PSYCHOL, V96, P505, DOI 10.1037/a0013748; Gurung RAR, 2007, SEX ROLES, V57, P91, DOI 10.1007/s11199-007-9219-z; Gwinn JD, 2013, J EXP SOC PSYCHOL, V49, P464, DOI 10.1016/j.jesp.2013.01.005; Haque OS, 2012, PERSPECT PSYCHOL SCI, V7, P176, DOI 10.1177/1745691611429706; Haselton MG, 2003, J RES PERS, V37, P34, DOI 10.1016/S0092-6566(02)00529-9; Haslam N, 2013, NEBR SYM MOTIV, V60, P25, DOI 10.1007/978-1-4614-6959-9_2; Heflick NA, 2011, J EXP SOC PSYCHOL, V47, P572, DOI 10.1016/j.jesp.2010.12.020; Heflick NA, 2009, J EXP SOC PSYCHOL, V45, P598, DOI 10.1016/j.jesp.2009.02.008; Henrich J, 2010, NATURE, V466, P29, DOI 10.1038/466029a; HERZOG AR, 1981, PUBLIC OPIN QUART, V45, P549, DOI 10.1086/268687; Holland E, 2017, BRIT J SOC PSYCHOL, V56, P314, DOI 10.1111/bjso.12152; Holland E, 2016, PSYCHOL WOMEN QUART, V40, P108, DOI 10.1177/0361684315602887; Holland E, 2013, PSYCHOL WOMEN QUART, V37, P462, DOI 10.1177/0361684312474800; Hopstaken JF, 2015, PSYCHOPHYSIOLOGY, V52, P305, DOI 10.1111/psyp.12339; Hosoda M, 2003, PERS PSYCHOL, V56, P431, DOI 10.1111/j.1744-6570.2003.tb00157.x; JACKSON LA, 1995, SOC PSYCHOL QUART, V58, P108, DOI 10.2307/2787149; KENRICK DT, 1992, BEHAV BRAIN SCI, V15, P75, DOI 10.1017/S0140525X00067595; Kunstman JW, 2011, J PERS SOC PSYCHOL, V100, P282, DOI 10.1037/a0021135; Lammers J, 2011, GROUP PROCESS INTERG, V14, P113, DOI 10.1177/1368430210370042; Lavrakas PJ., 2008, ENCY SURVEY RES METH, DOI [DOI 10.4135/9781412963947, 10.4135/9781412963947]; Loughnan S, 2015, REV INT PSYCHOL SOC, V28, P125; Loughnan S, 2014, SOC PSYCHOL-GERMANY, V45, P54, DOI 10.1027/1864-9335/a000159; Loughnan S, 2013, PSYCHOL WOMEN QUART, V37, P455, DOI 10.1177/0361684313485718; Loughnan S, 2010, EUR J SOC PSYCHOL, V40, P709, DOI 10.1002/ejsp.755; Lyons H, 2011, J SEX RES, V48, P437, DOI 10.1080/00224499.2010.506679; Maestripieri D, 2017, BEHAV BRAIN SCI, V40, P1, DOI 10.1017/S0140525X16000340; Mitchell G, 2012, PERSPECT PSYCHOL SCI, V7, P109, DOI 10.1177/1745691611432343; Moradi B, 2008, PSYCHOL WOMEN QUART, V32, P377, DOI 10.1111/j.1471-6402.2008.00452.x; Morris KL, 2018, PERS SOC PSYCHOL B, V44, P1302, DOI 10.1177/0146167218765739; Nussbaum M. C., 1999, SEX SOCIAL JUSTICE; Parks-Stamm EJ, 2008, PERS SOC PSYCHOL B, V34, P237, DOI 10.1177/0146167207310027; Pazhoohi F, 2017, EVOL PSYCHOL SCI, V3, P118, DOI DOI 10.1007/S40806-016-0079-Z; Penke L, 2008, J PERS SOC PSYCHOL, V95, P1113, DOI 10.1037/0022-3514.95.5.1113; Pinsof D, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178534; Price ME, 2014, ARCH SEX BEHAV, V43, P1289, DOI 10.1007/s10508-014-0320-4; Puts DA, 2010, EVOL HUM BEHAV, V31, P157, DOI 10.1016/j.evolhumbehav.2010.02.005; Puvia E., 2014, HUMANNESS DEHUMANIZA, P186, DOI DOI 10.4324/9780203110539; Puvia E, 2015, REV INT PSYCHOL SOC, V28, P63; Puvia E, 2013, SEX ROLES, V68, P484, DOI 10.1007/s11199-012-0255-y; Reynolds T, 2018, J EXP SOC PSYCHOL, V78, P195, DOI 10.1016/j.jesp.2018.03.011; Rudman LA, 2012, PERS SOC PSYCHOL B, V38, P734, DOI 10.1177/0146167212436401; Rule NO, 2009, SEX ROLES, V61, P644, DOI 10.1007/s11199-009-9658-9; Saguy T, 2010, PSYCHOL SCI, V21, P178, DOI 10.1177/0956797609357751; Sanchez DT, 2007, PSYCHOL WOMEN QUART, V31, P401, DOI 10.1111/j.1471-6402.2007.00389.x; Schmitt DP, 2005, BEHAV BRAIN SCI, V28, P247, DOI 10.1017/S0140525X05000051; Stapel DA, 2004, J PERS SOC PSYCHOL, V87, P468, DOI 10.1037/0022-3514.87.4.468; Stillman TF, 2009, EVOL HUM BEHAV, V30, P124, DOI 10.1016/j.evolhumbehav.2008.09.005; Strelan P, 2005, SEX ROLES, V52, P707, DOI 10.1007/s11199-005-3737-3; Symons D, 1979, EVOLUTION HUMAN SEXU; Trivers R. L., 1972, SEXUAL SELECTION DES, P136, DOI DOI 10.1002/AJPA.1330400226; Tyler JM, 2017, BRIT J SOC PSYCHOL, V56, P334, DOI 10.1111/bjso.12157; Vaes J, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-42928-x; Vaes J, 2011, EUR J SOC PSYCHOL, V41, P774, DOI 10.1002/ejsp.824; Vaillancourt T, 2011, AGGRESSIVE BEHAV, V37, P568, DOI 10.1002/ab.20413; Van den Stock J, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00053; Waytz A, 2015, SOC PSYCHOL PERS SCI, V6, P352, DOI 10.1177/1948550614553642; Waytz A, 2010, TRENDS COGN SCI, V14, P383, DOI 10.1016/j.tics.2010.05.006; Weeden J., 2014, HIDDEN AGENDA POLITI, DOI 10.1515/9781400851966; Weeden J, 2008, EVOL HUM BEHAV, V29, P327, DOI 10.1016/j.evolhumbehav.2008.03.004; Weeden J, 2013, EVOL HUM BEHAV, V34, P440, DOI 10.1016/j.evolhumbehav.2013.08.006; Williams MJ, 2017, J PERS SOC PSYCHOL, V112, P201, DOI 10.1037/pspi0000068; Zell E, 2016, SEX ROLES, V75, P287, DOI 10.1007/s11199-016-0622-1	96	4	4	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2019	14	8							e0221388	10.1371/journal.pone.0221388	http://dx.doi.org/10.1371/journal.pone.0221388			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW5TR	31442260	gold, Green Published			2022-12-26	WOS:000485041400030
J	Sun, CH; Chiang, FS; Squires, D; Rogers, A; Jan, MS				Sun, Chin-Hwa; Chiang, Fu-Sung; Squires, Dale; Rogers, Anthony; Jan, Man-Ser			More landings for higher profit? Inverse demand analysis of the bluefin tuna auction price in Japan and economic incentives in global bluefin tuna fisheries management	PLOS ONE			English	Article							FLEXIBILITIES; MARKETS; SYSTEMS; FISH	This paper estimates the price changes in global bluefin tuna (BFT) markets in response to shifts in regional and global landings to evaluate the conservation and economic incentives from changes in the Total Allowable Catch (TAC) managed by all three Regional Fisheries Management Organizations. A fisherman's income, and thus the financial incentive to accept management measures controlling catch levels, depends in part on how responsive price is to overall catch. Individual fisherman, with their own best interest in mind, used to wish to increase their individual landings and create an incentive to ask to increase the TAC for the industry, without realizing the possible revenue loss due to the resulting falling prices. To protect the value of all stakeholders' property rights, a consensus to avoid abruptly raising the TAC, without first considering the potential loss due to market response, is needed. Alternatively, if revenue increases with lower TAC, a positive economic incentive for conservation is created if price increasing proportionately more than the lower supply, with harvest profits boosted by lower costs of production. To capture the complexity of substituting across various sources of supply and product form, a general synthetic inverse demand system is estimated to identify the impact of overall landings on BFT prices. This system estimates price flexibilities of both fresh and frozen longline-caught sashimi-grade tunas (Pacific, Atlantic and southern bluefins, and bigeye) at the Tokyo Center Market in Japan, including the Tsukiji Market, the world's largest fish auction market that served as the single global price leader for BFT. The resulting estimation shows that own-quantity price flexibilities of every type of fresh and frozen BFTs are less than unity and inflexible in their own consumption. This creates poor individual producer incentives for fishermen to reduce wild or farmed BFT supply, as there is a chance to increase their own revenue, under the unlikely condition that the total supply is fixed. However, by observing the rapid increases in the TAC of Eastern Atlantic bluefin tuna (EABFT) in the coming years, suppliers may not be better off as price will drop proportionally faster and total revenue if the estimated scale flexibility is greater than one. Based on the estimated scale flexibility of frozen BFT, which is slightly less than unity, the frozen subsector of EABFT suppliers is the only winner under the supply increases. Suppliers of frozen BFT in other regions, fresh BFT (in the Atlantic and elsewhere), and southern BFT and bigeye tuna will all be harmed through lower revenue by the supply increases. Additionally, while total revenue might stay the same for frozen BFT suppliers, fishermen will potentially receive lower profits due to higher operating costs associated with increased landings when the supply of EABFT increases. Given the number of sectors that ultimately lose financially in the short term and given the ecological (and production) risks accompanying an abrupt increase in fishing pressure in the long term, the global economic losses resulting from an increase in the allowable catch of Atlantic bluefin tuna will outweigh any potential increases to revenue.	[Sun, Chin-Hwa; Chiang, Fu-Sung; Jan, Man-Ser] Natl Taiwan Ocean Univ, Inst Appl Econ, Keelung, Taiwan; [Squires, Dale] Univ Calif San Diego, Dept Econ, La Jolla, CA 92093 USA; [Rogers, Anthony] Calif Ocean Sci Trust, Oakland, CA USA	National Taiwan Ocean University; University of California System; University of California San Diego	Sun, CH (corresponding author), Natl Taiwan Ocean Univ, Inst Appl Econ, Keelung, Taiwan.	jsun5678@gmail.com		Rogers, Anthony/0000-0001-7233-0496	Pew Charitable Trusts; Ocean Foundation; NOAA Fisheries; National Science Foundation; Coupled Natural and Human systems project called Fishscape under NSF [CNH-1010280]	Pew Charitable Trusts; Ocean Foundation; NOAA Fisheries(National Oceanic Atmospheric Admin (NOAA) - USA); National Science Foundation(National Science Foundation (NSF)); Coupled Natural and Human systems project called Fishscape under NSF	This study is partly sponsored by The Pew Charitable Trusts, Ocean Foundation, NOAA Fisheries, and the National Science Foundation and is funded through Coupled Natural and Human systems project called Fishscape under NSF Grant No. CNH-1010280 (DGW JS) (https://www.nsf.gov/news/news_summ.jsp?cntn_id=117917&org=ERE&from=news).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Any results in this study do not necessarily represent the views or positions of any of the funding bodies.	Allen R, 2010, 536 FAO FISH AQ; Amorim AF, 2011, IUCN RED LIST THREAT, V2011, DOI [10.2305/IUCN.UK.2011-2.RLTS.T21860A9331546.en, DOI 10.2305/IUCN.UK.2011-2.RLTS.T21860A9331546.EN]; [Anonymous], 2014, REP 2014 ATL BLUEF T; Asche F, 1997, AM J AGR ECON, V79, P1182, DOI 10.2307/1244275; Barclay K, 2008, CAPTURING WEALTH FROM TUNA: CASE STUDIES FROM THE PACIFIC, P1; Barten A.P., 1993, EMPIR ECON, V18, P129, DOI [10.1007/BF01238883, DOI 10.1007/BF01238883]; BARTEN AP, 1989, EUR ECON REV, V33, P1509, DOI 10.1016/0014-2921(89)90075-5; Bertignac Michel, 2000, MARINE RESOURCE EC, V15, P151; Birkenbach AM, 2017, NATURE, V544, P223, DOI 10.1038/nature21728; BOSE S, 1996, MARINE RESOURCE EC, V11, P143, DOI DOI 10.1086/MRE.11.3.42629157; Brown M.G., 1995, EMPIR ECON, V20, P519, DOI [10.1007/BF01180680, DOI 10.1007/BF01180680]; Brown M. G., 2001, J AGR APPL EC, V33, P403; Costello C, 2008, SCIENCE, V321, P1678, DOI 10.1126/science.1159478; Cournot A.A., 1838, RECHERCHES PRINCIPES; Cuaresma JC, 2017, GLOBAL ENVIRON CHANG, V42, P226, DOI 10.1016/j.gloenvcha.2015.02.012; Curtis R, 2017, FISHERIES BUYBACKS; Guillotreau P, 2017, REV FISH BIOL FISHER, V27, P909, DOI 10.1007/s11160-016-9456-8; Holt MT, 2002, EUR ECON REV, V46, P117, DOI 10.1016/S0014-2921(00)00088-X; HOUCK JP, 1965, J FARM ECON, V47, P789, DOI 10.2307/1236288; HUANG KS, 1994, AM J AGR ECON, V76, P313, DOI 10.2307/1243633; ICCAT, 2017, P 2 REG M COMM, V1; Jeon Y, 2008, OCEAN DEV INT LAW, V39, P32, DOI 10.1080/00908320701641594; Jimenez-Toribio R, 2010, PROG OCEANOGR, V86, P166, DOI 10.1016/j.pocean.2010.04.022; Just R, 2004, APPL WELFARE EC PUBL; KIMOTO M, 1994, NIPPON KAGAKU KAISHI, P18, DOI 10.1246/nikkashi.1994.18; King G, 1804, NATURAL POLITICAL OB; Kitson G, 1983, HIGH VALUE FINFISH M; LAITINEN K, 1979, ECON LETT, V3, P153, DOI 10.1016/0165-1765(79)90109-5; Majkowski J, 2007, 483 FAO; Marshall A., 1890, PRINCIPLES POLITICAL; Miyake M.P., 2010, 543 FAO, P125; Nielsen M., 2005, MAR RESOUR ECON, V20, P185, DOI [DOI 10.1086/MRE.20.2.42629468, https://doi.org/10.1086/mre.20.2.42629468]; Owen AD, 2001, RELATIONSHIP WORLD P, V1, P32; Owen AD, 1993, AUSTR CTR INT AGR RE, V28, P231; Pala C, 2009, SCIENCE, V324, P1133, DOI 10.1126/science.324_1133; Park H, 1999, AM J AGR ECON, V81, P950, DOI 10.2307/1244337; Park H., 2004, MAR RESOUR ECON, V19, P333, DOI DOI 10.1086/mre.19.3.42629438; Serdy Andrew, 2017, OTHER AUSTR JAPAN LI; Squires D, 2006, ENVIRON DEV ECON, V11, P747, DOI 10.1017/S1355770X06003251; Sun C. H., 1999, AGR EC, V22, P51; Sun C-H, 2009, PICES ANN M OCT 23 N; Sun CH, 2004, SELECTION DECISION R; Sun CH, 2005, CCSBTMP050508, P1; Sun CH, 1998, 9 INT C INT I FISH E; Sun CH, 2007, TAIWAN EC FORECAST P, V37, P55; Sun Chin-Hwa, 2000, Journal of the Fisheries Society of Taiwan, V27, P45; Sun CHJ, 2017, MAR POLICY, V79, P62, DOI 10.1016/j.marpol.2017.02.006; Sun CHJ, 2017, ENVIRON RESOUR ECON, V66, P749, DOI 10.1007/s10640-015-9971-4; Sun ChinHwa, 1999, Journal of Agricultural Economics (Nongye Jingyi), P49; Sun J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159626; Sun CH, 2019, DEEP-SEA RES PT II, V169, DOI 10.1016/j.dsr2.2019.07.009; Tokunaga K, 2018, MAR RESOUR ECON, V33, P27, DOI 10.1086/694898; WESSELLS CR, 1994, CAN J AGR ECON, V42, P87, DOI 10.1111/j.1744-7976.1994.tb00008.x; WOHLGENANT MK, 1989, AM J AGR ECON, V71, P241, DOI 10.2307/1241581; Wu I.F., 2007, THESIS	55	4	4	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2019	14	8							e0221147	10.1371/journal.pone.0221147	http://dx.doi.org/10.1371/journal.pone.0221147			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW5TR	31442249	Green Published, Green Submitted, gold			2022-12-26	WOS:000485041400023
J	Chen, C; Chen, YJ; Huang, WJ; Jiang, YJ; Zhang, HH; Wu, W				Chen, Chen; Chen, Youjun; Huang, Wenjuan; Jiang, Yijie; Zhang, Huihui; Wu, Wei			Mining of simple sequence repeats (SSRs) loci and development of novel transferability-across EST-SSR markers from de novo transcriptome assembly of Angelica dahurica	PLOS ONE			English	Article							CPG ISLANDS; ROOTS; COUMARINS; EXPRESSION	Angelica dahurica is a widely grown plant species with multiple uses, especially in the medical field. However, the frequent introduction of A. dahurica to new areas has made it difficult to distinguish between varieties. Simple sequence repeats (SSRs) detected based on transcriptome analyses are very useful for constructing genetic maps and analyzing genetic diversity. They are also relevant for the molecular marker-assisted breeding of A. dahurica. We identified 33,724 genic SSR loci based on transcriptome sequencing data. A total of 114 primer pairs were designed for the SSR loci and were tested for their specificity and diversity. Ten SSR loci in untranslated regions were ultimately selected. Subsequently, 56 A. dahurica ecotypes collected from different regions were analyzed. The SSR loci comprised 2-8 alleles, with a mean of 5.2 alleles per locus. The polymorphic information content value and Shannon's information index were 0.6274-0.2702 (average of 0.4091) and 1.3040-0.5618 (average of 0.8475), respectively. Thus, the 10 novel SSRs identified in this study were almost in accordance with Harvey-Weinberg equilibrium and will be useful for analyzing A. dahurica genetic relationships. The results of this study confirm the potential value of transcriptome databases for the development of new SSR markers.	[Chen, Chen; Huang, Wenjuan; Jiang, Yijie; Zhang, Huihui; Wu, Wei] Sichuan Agr Univ, Agron Coll, Chengdu, Sichuan, Peoples R China; [Chen, Youjun] Qinghai Univ, Key Laborary Super Forage Germplasm Qinghai Tibet, Xining, Qinghai, Peoples R China	Sichuan Agricultural University; Qinghai University	Wu, W (corresponding author), Sichuan Agr Univ, Agron Coll, Chengdu, Sichuan, Peoples R China.	ewuwei@sicau.edu.cn		Chen, Chen/0000-0003-1733-3496	project of 13th Five-year Plan for Breeding Cooperation in Sichuan Province [2016NYZ0036]	project of 13th Five-year Plan for Breeding Cooperation in Sichuan Province	The work is supported by the project of 13th Five-year Plan for Breeding Cooperation in Sichuan Province, grant number: 2016NYZ0036 (http://202.61.89.120/) to WW. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cao YJ, 2017, NEUROREPORT, V28, P426, DOI [10.1097/WNR.0000000000000778, 10.1097/wnr.0000000000000778]; Chatterji S, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-4-r29; Chen W, 2015, NOVO ASSEMBLY CHARAC; Chen XM, 2016, GENE, V576, P537, DOI 10.1016/j.gene.2015.11.001; Chinese Pharmacopoeia Commission, 2015, PHARMACOPOEIA PEOPLE, VI; Colburn BC, 2017, MOL BREEDING, V37, DOI 10.1007/s11032-016-0616-2; CROSS SH, 1995, CURR OPIN GENET DEV, V5, P309, DOI 10.1016/0959-437X(95)80044-1; Cui XY, 2018, EUPHYTICA, V214, DOI 10.1007/s10681-018-2114-6; Hernando CE, 2017, BBA-GENE REGUL MECH, V1860, P84, DOI 10.1016/j.bbagrm.2016.07.001; Han HS, 2018, HELIYON, V4, DOI 10.1016/j.heliyon.2018.e00577; Jabbari K, 2004, GENE, V333, P143, DOI 10.1016/j.gene.2004.02.043; Kang J, 2008, J PHARMACEUT BIOMED, V47, P778, DOI 10.1016/j.jpba.2008.03.010; Kim YK, 2007, PHYTOTHER RES, V21, P288, DOI 10.1002/ptr.2043; KIMURA Y, 1982, PLANTA MED, V45, P183, DOI 10.1055/s-2007-971370; LARSEN F, 1992, GENOMICS, V13, P1095, DOI 10.1016/0888-7543(92)90024-M; Lechner D, 2004, PHYTOCHEMISTRY, V65, P331, DOI 10.1016/j.phytochem.2003.11.010; Li B, 2014, PHYTOCHEM ANALYSIS, V25, P229, DOI 10.1002/pca.2496; Mardis ER, 2008, TRENDS GENET, V24, P133, DOI 10.1016/j.tig.2007.12.007; Mignone F, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-3-reviews0004; Pan L, 2018, EST SSR MARKER CHARA; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Petrillo E, 2014, RNA BIOL, V11, P1215, DOI 10.4161/15476286.2014.972852; Porebski S, 1997, MODIFICATION CTAB DN, P8; Rogozin I, 2005, ANAL EVOLUTION EXON, P118; Scarano E, 1967, HETEROGENEITY THYMIN, P1394; Sen S, 2018, MOL BIOL REP, V45, P453, DOI 10.1007/s11033-018-4181-0; Srivastava AK, 2018, TRENDS PLANT SCI, V23, P248, DOI 10.1016/j.tplants.2017.11.003; Thiel T, 2003, THEOR APPL GENET, V106, P411, DOI 10.1007/s00122-002-1031-0; Varshney RK, 2006, THEOR APPL GENET, V113, P239, DOI 10.1007/s00122-006-0289-z; Varshney RK, 2005, TRENDS BIOTECHNOL, V23, P48, DOI 10.1016/j.tibtech.2004.11.005; Vinogradov AE, 2005, TRENDS GENET, V21, P639, DOI 10.1016/j.tig.2005.09.002; Wang GH, 2017, J BIOSCI BIOENG, V123, P679, DOI 10.1016/j.jbiosc.2017.01.003; Wang N, 2001, CHINA J CHINESE MAT, V09, P8; Wei W, 2016, PHYTOCHEMISTRY, V123, P58, DOI 10.1016/j.phytochem.2016.01.006; Yakuji Nippo Ltd, 2010, JAP PHARM SOC JAP PH; Yeh FC, 1998, POPGENE VERSION 1 31, P11; Zhang J, 2017, DEV EST SSR MARKERS; Zhang XN, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177862	38	9	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2019	14	8							e0221040	10.1371/journal.pone.0221040	http://dx.doi.org/10.1371/journal.pone.0221040			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5RZ	31437239	Green Published, Green Submitted, gold			2022-12-26	WOS:000485036900029
J	Pendegraft, AH; Guo, BY; Yi, NJ				Pendegraft, Amanda H.; Guo, Boyi; Yi, Nengjun			Bayesian hierarchical negative binomial models for multivariable analyses with applications to human microbiome count data	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; DIFFERENTIAL EXPRESSION ANALYSIS; GUT MICROBIOME; GASTROINTESTINAL MICROBIOTA; FEATURES; HEALTH; STATE; AGE	The analyses of large volumes of metagenomic data extracted from aggregate populations of microscopic organisms residing on and in the human body are advancing contemporary understandings of the integrated participation of microbes in human health and disease. Next generation sequencing technology facilitates said analyses in terms of diversity, community composition, and differential abundance by filtering and binning microbial 16S rRNA genes extracted from human tissues into operational taxonomic units. However, current statistical tools restrict study designs to investigations of limited numbers of host characteristics mediated by limited numbers of samples potentially yielding a loss of relevant information. This paper presents a Bayesian hierarchical negative binomial model as an efficient technique capable of compensating for multivariable sets including tens or hundreds of host characteristics as covariates further expanding analyses of human microbiome count data. Simulation studies reveal that the Bayesian hierarchical negative binomial model provides a desirable strategy by often outperforming three competing negative binomial model in terms of type I error while simultaneously maintaining consistent power. An application of the Bayesian hierarchical negative binomial model using subsets of the open data published by the American Gut Project demonstrates an ability to identify operational taxonomic units significantly differentiable among persons diagnosed by a medical professional with either inflammatory bowel disease or irritable bowel syndrome that are consistent with contemporary gastrointestinal literature.	[Pendegraft, Amanda H.; Guo, Boyi; Yi, Nengjun] Univ Alabama Birmingham, Sch Publ Hlth, Dept Biostat, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham	Yi, NJ (corresponding author), Univ Alabama Birmingham, Sch Publ Hlth, Dept Biostat, Birmingham, AL 35294 USA.	nyi@uab.edu	Guo, Boyi/HHN-5962-2022	Guo, Boyi/0000-0003-2950-2349				Anders S, 2013, NAT PROTOC, V8, P1765, DOI 10.1038/nprot.2013.099; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; [Anonymous], 2013, TEXTS STAT SCI SERIE; Blaser MJ, 2016, SCIENCE, V352, P544, DOI 10.1126/science.aad9358; Bokulich NA, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad7121; Cho I, 2012, NATURE, V488, P621, DOI 10.1038/nature11400; Cho I, 2012, NAT REV GENET, V13, P260, DOI 10.1038/nrg3182; Costalonga M, 2014, IMMUNOL LETT, V162, P22, DOI 10.1016/j.imlet.2014.08.017; Dahlhamer JM, 2016, MMWR-MORBID MORTAL W, V65, P1166, DOI 10.15585/mmwr.mm6542a3; David LA, 2014, NATURE, V505, P559, DOI 10.1038/nature12820; Debelius JW, 2016, J MICROBIOL BIOL EDU, V17, P46, DOI 10.1128/jmbe.v17i1.1034; Ehrlich SD, 2011, METAGENOMICS OF THE HUMAN BODY, P307, DOI 10.1007/978-1-4419-7089-3_15; Ertz-Archambault N, 2017, WORLD J GASTROENTERO, V23, P1899, DOI 10.3748/wjg.v23.i10.1899; Fettweis JM, 2014, MICROBIOL-SGM, V160, P2272, DOI 10.1099/mic.0.081034-0; Forbes JD, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01081; Gelman A., 2007, DATA ANAL USING REGR; Giongo A, 2011, ISME J, V5, P82, DOI 10.1038/ismej.2010.92; Halfvarson J, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2017.4; Hartstra AV, 2015, DIABETES CARE, V38, P159, DOI 10.2337/dc14-0769; Hollister EB, 2014, GASTROENTEROLOGY, V146, P1449, DOI 10.1053/j.gastro.2014.01.052; Kassinen A, 2007, GASTROENTEROLOGY, V133, P24, DOI 10.1053/j.gastro.2007.04.005; Knights D, 2013, GUT, V62, P1505, DOI 10.1136/gutjnl-2012-303954; Kostic AD, 2015, CELL HOST MICROBE, V17, P260, DOI 10.1016/j.chom.2015.01.001; Kostic AD, 2014, GASTROENTEROLOGY, V146, P1489, DOI 10.1053/j.gastro.2014.02.009; Kuczynski J, 2012, NAT REV GENET, V13, P47, DOI 10.1038/nrg3129; Lambeth SM, 2016, J DIABETES OBESITY, V2, P1; Lederberg J, 2001, SCIENTIST, V15, P8; Leung MHY, 2015, SCI REP-UK, V5, DOI 10.1038/srep11845; Liu B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037919; Malinen E, 2010, WORLD J GASTROENTERO, V16, P4532, DOI 10.3748/wjg.v16.i36.4532; Marchesi JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020447; McDonald D, 2018, MSYSTEMS, V3, DOI 10.1128/mSystems.00031-18; McMurdie PJ, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003531; McMurdie PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061217; Methe BA, 2012, NATURE, V486, P215, DOI 10.1038/nature11209; Mondot S, 2016, GUT, V65, P954, DOI 10.1136/gutjnl-2015-309184; Neto AG, 2015, ANN TRANSL MED, V3, DOI 10.3978/j.issn.2305-5839.2015.08.07; O'Toole PW, 2015, SCIENCE, V350, P1214, DOI 10.1126/science.aac8469; Paulson JN, 2013, NAT METHODS, V10, P1200, DOI [10.1038/NMETH.2658, 10.1038/nmeth.2658]; Peterson J, 2009, GENOME RES, V19, P2317, DOI 10.1101/gr.096651.109; Pozhitkov AE, 2015, BMC ORAL HEALTH, V15, DOI 10.1186/s12903-015-0109-4; Ranjan R, 2016, BIOCHEM BIOPH RES CO, V469, P967, DOI 10.1016/j.bbrc.2015.12.083; Raymond F, 2016, ISME J, V10, P707, DOI 10.1038/ismej.2015.148; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Salonen A, 2010, MICROBIOL-SGM, V156, P3205, DOI 10.1099/mic.0.043257-0; Sanschagrin Sylvie, 2014, J Vis Exp, DOI 10.3791/51709; SAVAGE DC, 1977, ANNU REV MICROBIOL, V31, P107, DOI 10.1146/annurev.mi.31.100177.000543; Schwabe RF, 2013, NAT REV CANCER, V13, P800, DOI 10.1038/nrc3610; Sims D, 2014, NAT REV GENET, V15, P121, DOI 10.1038/nrg3642; Sohn MB, 2015, BIOINFORMATICS, V31, P2269, DOI 10.1093/bioinformatics/btv165; Walters WA, 2014, FEBS LETT, V588, P4223, DOI 10.1016/j.febslet.2014.09.039; Weiss S, 2017, MICROBIOME, V5, DOI 10.1186/s40168-017-0237-y; Whitehead WE, 2017, EXPERT REV GASTROENT, V11, P281, DOI 10.1080/17474124.2017.1292130; Wu GD, 2011, SCIENCE, V334, P105, DOI 10.1126/science.1208344; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053; Yi NJ, 2014, STAT APPL GENET MOL, V13, P35, DOI 10.1515/sagmb-2012-0040; Yi NJ, 2012, STAT APPL GENET MOL, V11, DOI 10.1515/1544-6115.1803; Zapata HJ, 2015, J AM GERIATR SOC, V63, P776, DOI 10.1111/jgs.13310	58	4	4	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2019	14	8							e0220961	10.1371/journal.pone.0220961	http://dx.doi.org/10.1371/journal.pone.0220961			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5RZ	31437194	Green Submitted, Green Published, gold			2022-12-26	WOS:000485036900024
J	Romero-Lastra, P; Sanchez, MPAC; Llama-Palacios, A; Figuero, E; Herrera, D; Sanz, M				Romero-Lastra, Patricia; Sanchez, Mari Prime A. C.; Llama-Palacios, Arancha; Figuero, Elena; Herrera, David; Sanz, Mariano			Gene expression of Porphyromonas gingivalis ATCC 33277 when growing in an in vitro multispecies biofilm	PLOS ONE			English	Article							FUSOBACTERIUM-NUCLEATUM; MOLECULAR CHAPERONES; PERIODONTAL-DISEASE; TREPONEMA-DENTICOLA; MICROARRAY ANALYSIS; DEFICIENT MUTANT; STRESS TOLERANCE; VIRULENCE; PROTEINS; MODEL	Background and objective Porphyromonas gingivalis, an oral microorganism residing in the subgingival biofilm, may exert diverse pathogenicity depending on the presence of specific virulence factors, but its gene expression has not been completely established. This investigation aims to compare the transcriptomic profile of this pathogen when growing within an in vitro multispecies biofilm or in a planktonic state. Materials and methods P. gingivalis ATCC 33277 was grown in anaerobiosis within multi-well culture plates at 37 degrees C under two conditions: (a) planktonic samples (no hydroxyapatite discs) or (b) within a multi-species-biofilm containing Streptococcus oralis, Actinomyces naeslundii, Veillonella parvula, Fusobacterium nucleatum and Aggregatibacter actinomycetemcomitans deposited on hydroxyapatite discs. Scanning Electron Microscopy (SEM) and Confocal Laser Scanning Microscopy (CLSM) combined with Fluorescence In Situ Hybridization (FISH) were used to verify the formation of the biofilm and the presence of P. gingivalis. Total RNA was extracted from both the multispecies biofilm and planktonic samples, then purified and, with the use of a microarray, its differential gene expression was analyzed. A linear model was used for determining the differentially expressed genes using a filtering criterion of two-fold change (up or down) and a significance p-value of <0.05. Differential expression was confirmed by Reverse Transcription-quantitative Polymerase Chain Reaction (RT-qPCR). Results SEM verified the development of the multispecies biofilm and FISH confirmed the incorporation of P. gingivalis. The microarray demonstrated that, when growing within the multispecies biofilm, 19.1% of P. gingivalis genes were significantly and differentially expressed (165 genes were up-regulated and 200 down-regulated), compared with planktonic growth. These genes were mainly involved in functions related to the oxidative stress, cell envelope, transposons and metabolism. The results of the microarray were confirmed by RT-qPCR. Conclusion Significant transcriptional changes occurred in P. gingivalis when growing in a multispecies biofilm compared to planktonic state.	[Romero-Lastra, Patricia; Sanchez, Mari Prime A. C.; Llama-Palacios, Arancha] Univ Complutense Madrid, Fac Odontol, Lab Dent Res, Madrid, Spain; [Sanchez, Mari Prime A. C.; Llama-Palacios, Arancha; Figuero, Elena; Herrera, David; Sanz, Mariano] Univ Complutense Madrid, Fac Odontol, ETEP Res Grp, Madrid, Spain	Complutense University of Madrid; Complutense University of Madrid	Figuero, E (corresponding author), Univ Complutense Madrid, Fac Odontol, ETEP Res Grp, Madrid, Spain.	elfiguer@ucm.es	Figuero, Elena/G-8364-2017; Llama-Palacios, Arancha/H-2245-2017; Sanz, Mariano/G-8244-2017	Figuero, Elena/0000-0002-3129-1416; Llama-Palacios, Arancha/0000-0001-6486-0120; Sanz, Mariano/0000-0002-6293-5755; Sanchez, Maria Carmen/0000-0003-3965-790X; Sanchez, Maria del Carmen/0000-0003-3269-533X	DENTAID - UCM Extraordinary Chair in Periodontal Research; Dentaid Extraordinary Chair for Periodontal Research (Catedra Extraordinaria Dentaid en InvestigaciOn Periodontal), Complutense University of Madrid, Spain	DENTAID - UCM Extraordinary Chair in Periodontal Research; Dentaid Extraordinary Chair for Periodontal Research (Catedra Extraordinaria Dentaid en InvestigaciOn Periodontal), Complutense University of Madrid, Spain	This study was partially supported by research funds from "The DENTAID - UCM Extraordinary Chair in Periodontal Research". This financial support had no influence in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This investigation was supported by Dentaid Extraordinary Chair for Periodontal Research (Catedra Extraordinaria Dentaid en InvestigaciOn Periodontal), Complutense University of Madrid, Spain. We thank I. Lopez and L. Almonacid from the Centro Nacional de Biotecnologia (AutOnoma University of Madrid, Spain) for hybridizations and statistical analysis of the microarrays and RT-qPCR performed by the Genomics Facility. We thank C. Perez from the Centre of Microscopy and Cytometry from Complutense University of Madrid, Spain.	Asai Y, 2005, INFECT IMMUN, V73, P2157, DOI 10.1128/IAI.73.4.2157-2163.2005; Bakthavatchalu V, 2011, MOL ORAL MICROBIOL, V26, P303, DOI 10.1111/j.2041-1014.2011.00619.x; Bao K, 2014, BMC MICROBIOL, V14, DOI 10.1186/s12866-014-0258-7; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Beenken KE, 2004, J BACTERIOL, V186, P4665, DOI 10.1128/JB.186.14.4665-4684.2004; Brogden KA, 2005, LANCET, V365, P253, DOI 10.1016/S0140-6736(05)70155-0; Butler SM, 2006, MOL MICROBIOL, V60, P553, DOI 10.1111/j.1365-2958.2006.05128.x; Capestany CA, 2008, J BACTERIOL, V190, P1436, DOI 10.1128/JB.01632-07; Carvalho PC, 2016, MEDIAT INFLAMM, V2016, DOI 10.1155/2016/7465852; Diaz P.I., 2009, REV 150 NICA PERIODO, V2, P187, DOI [10.1016/S0718-5391(09)70033-3, DOI 10.1016/S0718-5391(09)70033-3]; Donlan RM, 2002, EMERG INFECT DIS, V8, P881, DOI 10.3201/eid0809.020063; Frees D, 2004, MOL MICROBIOL, V54, P1445, DOI 10.1111/j.1365-2958.2004.04368.x; Frias-Lopez J, 2012, J BACTERIOL, V194, P2082, DOI 10.1128/JB.06328-11; Garneau JE, 2010, NATURE, V468, P67, DOI 10.1038/nature09523; Guggenheim B, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-280; Hajishengallis G, 2012, MOL ORAL MICROBIOL, V27, P409, DOI 10.1111/j.2041-1014.2012.00663.x; Hajishengallis G, 2014, EUR J IMMUNOL, V44, P328, DOI 10.1002/eji.201344202; Henderson B, 2006, INFECT IMMUN, V74, P3693, DOI 10.1128/IAI.01882-05; Hendrickson EL, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00261; Hennequin C, 2001, MICROBIOL-UK, V147, P87, DOI 10.1099/00221287-147-1-87; Henry LG, 2012, FUTURE MICROBIOL, V7, P497, DOI [10.2217/FMB.12.17, 10.2217/fmb.12.17]; Hosogi Y, 2005, INFECT IMMUN, V73, P2327, DOI 10.1128/IAI.73.4.2327-2335.2005; Hovik H, 2012, J BACTERIOL, V194, P100, DOI 10.1128/JB.06385-11; Ihaka R., 1996, J COMPUT GRAPH STAT, V5, P299, DOI [DOI 10.1080/10618600.1996.10474713, 10.2307/1390807]; Imlay JA, 2008, ANNU REV BIOCHEM, V77, P755, DOI 10.1146/annurev.biochem.77.061606.161055; Johnson SM, 2014, BIOORG MED CHEM LETT, V24, P786, DOI 10.1016/j.bmcl.2013.12.100; Kadowaki T, 2000, J BIOCHEM, V128, P153, DOI 10.1093/oxfordjournals.jbchem.a022735; Kajfasz JK, 2009, J BACTERIOL, V191, P2060, DOI 10.1128/JB.01609-08; Kesavalu L, 2007, INFECT IMMUN, V75, P1704, DOI 10.1128/IAI.00733-06; Kolenbrander PE, 2010, NAT REV MICROBIOL, V8, P471, DOI 10.1038/nrmicro2381; KROGFELT KA, 1988, MICROB PATHOGENESIS, V4, P231, DOI 10.1016/0882-4010(88)90073-3; Kuboniwa M, 2017, NAT MICROBIOL, V2, P1493, DOI 10.1038/s41564-017-0021-6; Kuboniwa M, 2010, PERIODONTOL 2000, V52, P38, DOI 10.1111/j.1600-0757.2009.00311.x; Lamont RJ, 1998, MICROBIOL MOL BIOL R, V62, P1244, DOI 10.1128/MMBR.62.4.1244-1263.1998; Lee JY, 2006, J PERIODONTAL RES, V41, P10, DOI 10.1111/j.1600-0765.2005.00832.x; Lemos JAC, 2002, J BACTERIOL, V184, P6357, DOI 10.1128/JB.184.22.6357-6366.2002; Lewis JP, 2006, MICROBIOL-SGM, V152, P3367, DOI 10.1099/mic.0.29011-0; Lewis JP, 2010, PERIODONTOL 2000, V52, P94, DOI 10.1111/j.1600-0757.2009.00329.x; Lewis JP, 2009, MICROBIOL-SGM, V155, P3758, DOI 10.1099/mic.0.027953-0; Lewthwaite J, 1998, TRENDS MICROBIOL, V6, P426, DOI 10.1016/S0966-842X(98)01362-6; Limoli DH, 2015, MICROBIOL SPECTR, V3, DOI 10.1128/microbiolspec.MB-0011-2014; Liu D, 2016, J BIOTECHNOL, V218, P1, DOI 10.1016/j.jbiotec.2015.11.017; Llama-Palacios A, 2017, J PROTEOME RES, V16, P3158, DOI 10.1021/acs.jproteome.7b00127; Lo AW, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-18; Lopatin DE, 1999, J PERIODONTOL, V70, P1185, DOI 10.1902/jop.1999.70.10.1185; Marraffini LA, 2008, SCIENCE, V322, P1843, DOI 10.1126/science.1165771; Marsh PD, 2004, CARIES RES, V38, P204, DOI 10.1159/000077756; Marsh Philip D, 2006, BMC Oral Health, V6 Suppl 1, pS14, DOI 10.1186/1472-6831-6-S1-S14; Miller MB, 2001, ANNU REV MICROBIOL, V55, P165, DOI 10.1146/annurev.micro.55.1.165; Mitchell HL, 2010, MICROBIOL-SGM, V156, P774, DOI 10.1099/mic.0.033654-0; Mohammed MMA, 2017, ANAEROBE, V44, P133, DOI 10.1016/j.anaerobe.2017.03.002; Moon JH, 2014, BMC MICROBIOL, V14, DOI 10.1186/s12866-014-0218-2; Nagano K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043722; NAKAYAMA K, 1994, J BACTERIOL, V176, P1939, DOI 10.1128/jb.176.7.1939-1943.1994; Orth RKH, 2011, MOL ORAL MICROBIOL, V26, P229, DOI 10.1111/j.2041-1014.2011.00612.x; Park JH, 2014, J PERIODONTAL IMPLAN, V44, P79, DOI 10.5051/jpis.2014.44.2.79; Parveen N, 2011, MOL MICROBIOL, V79, P7, DOI 10.1111/j.1365-2958.2010.07455.x; Paster BJ, 2001, J BACTERIOL, V183, P3770, DOI 10.1128/JB.183.12.3770-3783.2001; Rahman T, 2017, EUR BIOPHYS J BIOPHY, V46, P647, DOI 10.1007/s00249-017-1238-2; Redanz S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027827; Romero-Lastra P, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174669; Rouquette C, 1998, MOL MICROBIOL, V27, P1235, DOI 10.1046/j.1365-2958.1998.00775.x; Sampson TR, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00037; Sanchez MC, 2011, J PERIODONTAL RES, V46, P252, DOI 10.1111/j.1600-0765.2010.01341.x; Sanchez MC, 2019, BMC MICROBIOL, V19, DOI 10.1186/s12866-019-1423-9; Sanz M, 2017, J CLIN PERIODONTOL, V44, pS5, DOI 10.1111/jcpe.12682; Schembri MA, 2003, MOL MICROBIOL, V48, P253, DOI 10.1046/j.1365-2958.2003.03432.x; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Skar CK, 2003, ANAEROBE, V9, P305, DOI 10.1016/j.anaerobe.2003.08.004; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Smyth GK, 2003, METHODS, V31, P265, DOI 10.1016/S1046-2023(03)00155-5; Socransky SS, 2002, PERIODONTOL 2000, V28, P12, DOI 10.1034/j.1600-0757.2002.280102.x; SOCRANSKY SS, 1992, J PERIODONTOL, V63, P322, DOI 10.1902/jop.1992.63.4s.322; Stein LY, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00629; Tribble GD, 2007, J BACTERIOL, V189, P6382, DOI 10.1128/JB.00460-07; Trindade SC, 2013, J PERIODONTOL, V84, P650, DOI 10.1902/jop.2012.120230; Ueshima J, 2003, INFECT IMMUN, V71, P1170, DOI 10.1128/IAI.71.3.1170-1178.2003; Wan XY, 1997, FEBS LETT, V407, P32, DOI 10.1016/S0014-5793(97)00302-5; Wang Y, 2018, J CELL BIOL, V217, P1915, DOI 10.1083/jcb.201708007; Yamamoto R, 2011, APPL ENVIRON MICROB, V77, P6733, DOI 10.1128/AEM.00746-11; Yuan LH, 2005, INFECT IMMUN, V73, P4146, DOI 10.1128/IAI.73.7.4146-4154.2005; Yuan LH, 2007, FEMS IMMUNOL MED MIC, V51, P388, DOI 10.1111/j.1574-695X.2007.00326.x	82	12	12	3	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2019	14	8							e0221234	10.1371/journal.pone.0221234	http://dx.doi.org/10.1371/journal.pone.0221234			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5RZ	31437202	Green Published, gold, Green Submitted			2022-12-26	WOS:000485036900039
J	Giralt, AN; Nostlingerl, C; Lee, J; Salami, O; Lallemant, M; Onyango-Ouma, W; Nyamongo, I; Marchal, B				Giralt, Ariadna Nebot; Nostlingerl, Christiana; Lee, Janice; Salami, Olawale; Lallemant, Marc; Onyango-Ouma, Washington; Nyamongo, Isaac; Marchal, Bruno			Understanding acceptance of and adherence to a new formulation of paediatric antiretroviral treatment in the form of pellets (LPV/r)-A realist evaluation	PLOS ONE			English	Article							BEHAVIORAL SKILLS MODEL; THERAPY; ACCEPTABILITY; ADOLESCENTS; INFORMATION; MOTIVATION; COUNTRIES	Background Improving access to paediatric HIV treatment requires large-scale antiretroviral treatment programmes and medication adapted to infants and children's needs. The World Health Organisation recommends lopinavir/ritonavir plus two nucleoside reverse transcriptase inhibitors as first-line treatment for all HIV-infected children younger than three years, usually given as a syrup. A pellet formulation (i.e. tiny cylinders of compressed medication put in capsules) was developed to overcome the syrup formulation's disadvantages such as bitterness, toxicity and cold storage. This study assessed multi-level factors influencing caregivers' acceptance of and adherence to lopinavir/ritonavir pellets as well as their underlying mechanisms. Methods A realist evaluation (a theory-driven evaluation method considering the social context and mechanisms of change), embedded in a clinical trial was carried out in three hospital settings in Kenya. Data were collected through document review, observations (n = 34) in home and clinic settings and semi-structured interviews (n = 44) with caregivers and providers. Data analysis was based on realist principles. Results High levels of treatment initiation and adherence were observed. Taste masking, neutral packaging and easy storage made the new formulation highly acceptable. Caregivers developed individual strategies to deliver the treatment, particularly to overcome specific problems e.g. in case of just-weaned babies or food shortage. A refined program theory emerged from the triangulated findings showing that ease of administration combined with increased self-efficacy and competences of the caregivers, and effective provider support contributed to high levels of adherence. Conclusions Formulating combined antiretroviral treatment in the form of pellets is clearly a more acceptable solution for infants and children and their caregivers compared to the syrup. Further research in non-trial settings may shed light on factors related to providers, services and the health system that contribute to better adherence of such formulations.	[Giralt, Ariadna Nebot; Nostlingerl, Christiana; Marchal, Bruno] Inst Trop Med, Dept Publ Hlth, Antwerp, Belgium; [Lee, Janice; Lallemant, Marc] Drugs Neglected Dis Initiat, Geneva, Switzerland; [Salami, Olawale] Drugs Neglected Dis Initiat, Nairobi, Kenya; [Onyango-Ouma, Washington; Nyamongo, Isaac] Univ Nairobi, Inst Anthropol Gender & African Studies, Museum Hill, Nairobi, Kenya	Institute of Tropical Medicine (ITM); University of Nairobi	Marchal, B (corresponding author), Inst Trop Med, Dept Publ Hlth, Antwerp, Belgium.	bmarchal@itg.be	Salami, Olawale/AAR-7462-2020	Salami, Olawale/0000-0001-9186-8160; Nyamongo, Isaac K./0000-0003-1796-9590				Amico KR, 2005, AIDS CARE, V17, P661, DOI 10.1080/09540120500038058; Ammon N, 2018, PUBLIC HEALTH, V157, P20, DOI 10.1016/j.puhe.2017.12.010; Andrieux-Meyer I, 2018, CONFERENCE ON RETROV; [Anonymous], 2003, ADHERENCE LONG TERM; Biadgilign S, 2008, BMC PEDIATR, V8, DOI 10.1186/1471-2431-8-53; Bikaako-Kajura W, 2006, AIDS BEHAV, V10, pS85, DOI 10.1007/s10461-006-9141-3; Braun M, 2011, JAIDS-J ACQ IMM DEF, V56, pE122, DOI 10.1097/QAI.0b013e31820a7f2f; Byakika-Tusiime J, 2009, AIDS BEHAV, V13, pS82, DOI 10.1007/s10461-009-9546-x; Dachew BA, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-875; Desclaux A, 2009, SOC SCI MED, V69, P821, DOI 10.1016/j.socscimed.2009.06.007; DNDi, 2015, CONTRACT NO PROTOCOL; Emmett SD, 2010, JAIDS-J ACQ IMM DEF, V54, P368, DOI 10.1097/QAI.0b013e3181cf4882; FISHER JD, 1992, PSYCHOL BULL, V111, P455, DOI 10.1037/0033-2909.111.3.455; Fisher JD, 2006, HEALTH PSYCHOL, V25, P462, DOI 10.1037/0278-6133.25.4.462; Giralt AN, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-014528; Haberer Jessica, 2009, Curr HIV/AIDS Rep, V6, P194, DOI 10.1007/s11904-009-0026-8; Hejoaka F, 2009, SOC SCI MED, V69, P869, DOI 10.1016/j.socscimed.2009.05.041; Hudelson C, 2015, AIDS CARE, V27, P805, DOI 10.1080/09540121.2015.1011073; Katz IT, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.3.18640; Marchal B, 2018, DOING REALIST RES, DOI DOI 10.4135/9781526451729.N6; Marchal B, 2012, EVALUATION-US, V18, P192, DOI 10.1177/1356389012442444; May T, 2011, SOCIAL RES ISSUES ME; McHenry Megan Song, 2017, J Int Assoc Provid AIDS Care, V16, P215, DOI 10.1177/2325957416668995; Mellins CA, 2004, PEDIATR INFECT DIS J, V23, P1035, DOI 10.1097/01.inf.0000143646.15240.ac; Musante K., 2010, PARTICIPANT OBSERVAT; Musiime V, 2014, JAIDS-J ACQ IMM DEF, V66, P148, DOI 10.1097/QAI.0000000000000135; Patton M. Q., 2002, QUALITATIVE RES EVAL, V3, P344; Pawson R., 1997, REALISTIC EVALUATION; Phelps BR, 2011, PEDIATR DRUGS, V13, P175, DOI 10.2165/11587300-000000000-00000; Phillips LA, 2013, PSYCHOL HEALTH, V28, P1135, DOI 10.1080/08870446.2013.793798; Posse M, 2008, TROP MED INT HEALTH, V13, P904, DOI 10.1111/j.1365-3156.2008.02091.x; Salami O, 2017, INTERNATIONAL CONFER; Sekhon M, 2018, BRIT J HEALTH PSYCH, V23, P519, DOI 10.1111/bjhp.12295; Simoni JM, 2007, PEDIATRICS, V119, pE1371, DOI 10.1542/peds.2006-1232; UNAIDS, 2018, UNAIDS FACT SHEET WO; Vreeman Rachel C, 2015, AIDS, V29 Suppl 1, pS47, DOI 10.1097/QAD.0000000000000669; Weiser SD, 2014, AIDS, V28, P115, DOI 10.1097/01.aids.0000433238.93986.35; WHO, 2018, AIDS FREE FRAMEWORK; WHO, 2013, THE USE OF ANTIRETRO; WHO, 2013, CONSOLIDATED GUIDELI; Wong G, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0643-1; World Health Organization, 2010, ANT THER HIV INF INF; Yin R.K., 2003, CASE STUDY RES DESIG, V179	43	3	3	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2019	14	8							e0220408	10.1371/journal.pone.0220408	http://dx.doi.org/10.1371/journal.pone.0220408			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW5QN	31433803	Green Published, Green Submitted, gold			2022-12-26	WOS:000485033100010
J	Chu, KA; Hsu, CH; Lin, MC; Chu, YH; Hung, YM; Wei, JCC				Chu, Kuo-An; Hsu, Chun-Hsiang; Lin, Mei-Chen; Chu, Yi-Hsin; Hung, Yao-Min; Wei, James Cheng-Chung			Association of iron deficiency anemia with tuberculosis in Taiwan: A nationwide population-based study	PLOS ONE			English	Article							BONE-MINERAL DENSITY; PULMONARY TUBERCULOSIS; HIV-INFECTION; RISK; IMMUNITY	Background Iron deficiency is associated with decreased cellular immunity, which may predispose patients with iron deficiency anemia (IDA) to increased risk of developing tuberculosis (TB). This study investigated the relationship between newly diagnosed IDA and TB infection in Taiwan. Methods The study included data on 21,946 patients with incident IDA and 87,555 non-IDA controls from a national database covering the period 2000-2012. IDA and non-IDA subjects were matched 1: 4 on age, gender, and index year. The follow-up period was defined as the time from the initial IDA diagnosis to the date of developing TB or 31 December 2013. Cox proportional hazards models were used to estimate hazard ratios and 95% confidence intervals, with the control group as the reference. Results The adjusted hazard ratio of TB for the IDA group was 1.99 (95% confidence interval, 1.77-2.25) compared with the control group. The subgroup analysis showed that for both genders, all age groups, and patients with diabetes mellitus, hyperlipidemia, hypertension, cancer, chronic obstructive pulmonary disease, and hepatitis B virus infection, the IDA group had significantly higher TB incidence. The association was significantly stronger within the 5 years after new IDA diagnosis for both genders and all age groups. Conclusions Higher TB incidence was discovered in the IDA group, especially for patients with comorbidities.	[Chu, Kuo-An; Hsu, Chun-Hsiang] Kaohsiung Vet Gen Hosp, Dept Internal Med, Div Chest Med, Kaohsiung, Taiwan; [Chu, Kuo-An] Shu Zen Jr Coll Med & Management, Dept Nursing, Kaohsiung, Taiwan; [Chu, Kuo-An; Hung, Yao-Min] Natl Yang Ming Univ, Sch Med, Taipei, Taiwan; [Lin, Mei-Chen] China Med Univ Hosp, Management Off Hlth Data, Taichung, Taiwan; [Chu, Yi-Hsin] Natl Cheng Kung Univ Hosp, Dept Family Med, Tainan, Taiwan; [Hung, Yao-Min] Kaohsiung Municipal United Hosp, Kaohsiung, Taiwan; [Hung, Yao-Min] Kaohsiung Vet Gen Hosp, Dept Emergency Med, Kaohsiung, Taiwan; [Hung, Yao-Min] Yuhing Jr Coll Hlth Care & Management, Kaohsiung, Taiwan; [Wei, James Cheng-Chung] Nanjing Med Univ, Affiliated BenQ Hosp, BenQ Med Ctr, Dept Rheumatol, Nanjing, Jiangsu, Peoples R China; [Wei, James Cheng-Chung] Chung Shan Med Univ, Inst Med, Taichung, Taiwan; [Wei, James Cheng-Chung] Chung Shan Med Univ Hosp, Dept Med, Taichung, Taiwan; [Wei, James Cheng-Chung] China Med Univ, Grad Inst Integrated Med, Taichung, Taiwan	Kaohsiung Veterans General Hospital; National Yang Ming Chiao Tung University; China Medical University Taiwan; China Medical University Hospital - Taiwan; National Cheng Kung University; National Cheng Kung University Hospital; Kaohsiung Veterans General Hospital; Nanjing Medical University; Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University Hospital; China Medical University Taiwan	Hung, YM (corresponding author), Natl Yang Ming Univ, Sch Med, Taipei, Taiwan.; Hung, YM (corresponding author), Kaohsiung Municipal United Hosp, Kaohsiung, Taiwan.; Hung, YM (corresponding author), Kaohsiung Vet Gen Hosp, Dept Emergency Med, Kaohsiung, Taiwan.; Hung, YM (corresponding author), Yuhing Jr Coll Hlth Care & Management, Kaohsiung, Taiwan.; Wei, JCC (corresponding author), Nanjing Med Univ, Affiliated BenQ Hosp, BenQ Med Ctr, Dept Rheumatol, Nanjing, Jiangsu, Peoples R China.; Wei, JCC (corresponding author), Chung Shan Med Univ, Inst Med, Taichung, Taiwan.; Wei, JCC (corresponding author), Chung Shan Med Univ Hosp, Dept Med, Taichung, Taiwan.; Wei, JCC (corresponding author), China Med Univ, Grad Inst Integrated Med, Taichung, Taiwan.	ymhung1@gmail.com; jccwei@gmail.com	Wei, James Cheng-Chung/AAL-8947-2020	Wei, James Cheng-Chung/0000-0002-1235-0679	Ministry of Health and Welfare, Taiwan [MOHW108-TDU-B-212-133004]; Academia Sinica Stroke Biosignature Project [BM10701010021]; MOST Clinical Trial Consortium for Stroke [MOST 107-2321-B-039 -004]; Tseng-Lien Lin Foundation, Taichung, Taiwan; Katsuzo and Kiyo Aoshima Memorial Funds, Japan; China Medical University Hospital	Ministry of Health and Welfare, Taiwan; Academia Sinica Stroke Biosignature Project; MOST Clinical Trial Consortium for Stroke; Tseng-Lien Lin Foundation, Taichung, Taiwan; Katsuzo and Kiyo Aoshima Memorial Funds, Japan; China Medical University Hospital	This work was supported by grants from the Ministry of Health and Welfare, Taiwan (MOHW108-TDU-B-212-133004), China Medical University Hospital, Academia Sinica Stroke Biosignature Project (BM10701010021), MOST Clinical Trial Consortium for Stroke (MOST 107-2321-B-039 -004-), Tseng-Lien Lin Foundation, Taichung, Taiwan, and Katsuzo and Kiyo Aoshima Memorial Funds, Japan.	Barboza Carlos Eduardo Galvão, 2008, J. bras. pneumol., V34, P959, DOI 10.1590/S1806-37132008001100012; Camaschella C, 2015, NEW ENGL J MED, V372, P1832, DOI 10.1056/NEJMra1401038; Chang KH, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003056; Chang KH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103078; Cheng KC, 2018, MEDICINE, V97, DOI [10.1097/MD.0000000000011388, 10.1097/md.0000000000011388]; Cherayil BJ, 2010, ARCH IMMUNOL THER EX, V58, P407, DOI 10.1007/s00005-010-0095-9; Davies PDO, 2003, ANN MED, V35, P235, DOI 10.1080/07853890310005713; DeLoughery TG, 2014, NEW ENGL J MED, V371, P1324, DOI 10.1056/NEJMra1215361; Ganz T, 2018, INT J HEMATOL, V107, P7, DOI 10.1007/s12185-017-2366-2; Getahun H, 2010, CLIN INFECT DIS, V50, pS201, DOI 10.1086/651492; Jeon CY, 2008, PLOS MED, V5, P1091, DOI 10.1371/journal.pmed.0050152; Korkmaz U, 2012, EUR J INTERN MED, V23, P154, DOI 10.1016/j.ejim.2011.11.009; Kumar V, 2010, INDIAN J PEDIATR, V77, P789, DOI 10.1007/s12098-010-0120-3; Lai SW, 2014, CLIN MICROBIOL INFEC, V20, P764, DOI 10.1111/1469-0691.12516; Laudisio A, 2009, CLIN RHEUMATOL, V28, P145, DOI 10.1007/s10067-008-0998-6; Lin HH, 2007, PLOS MED, V4, P173, DOI 10.1371/journal.pmed.0040020; Lonnroth K, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-289; Lonnroth K, 2010, INT J EPIDEMIOL, V39, P149, DOI 10.1093/ije/dyp308; MACDOUGALL LG, 1975, J PEDIATR-US, V86, P833, DOI 10.1016/S0022-3476(75)80211-3; Maggini S, 2018, NUTRIENTS, V10, DOI 10.3390/nu10101531; Min J, 2018, J KOREAN MED SCI, V33, DOI 10.3346/jkms.2018.33.e341; Murray CJL, 2018, LANCET INFECT DIS, V18, P261, DOI 10.1016/S1473-3099(17)30703-X; Oppenheimer SJ, 2001, J NUTR, V131, p616S, DOI 10.1093/jn/131.2.616S; Pan ML, 2017, NUTRIENTS, V9, DOI 10.3390/nu9060616; Raaschou P, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i262; STEIGER Z, 1976, AM J SURG, V131, P668, DOI 10.1016/0002-9610(76)90174-4; Su VYF, 2017, CHEST, V152, P598, DOI 10.1016/j.chest.2017.04.170; Tansarli GS, 2013, EUR J CLIN MICROBIOL, V32, P1253, DOI 10.1007/s10096-013-1877-x; Wang SH, 2019, RESPIROLOGY, V24, P467, DOI 10.1111/resp.13482; WHO, TUBERCULOSIS; World Health Organization, 2021, 10 THREATS GLOB HLTH	31	5	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2019	14	8							e0221908	10.1371/journal.pone.0221908	http://dx.doi.org/10.1371/journal.pone.0221908			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW6BO	31469869	gold, Green Published, Green Submitted			2022-12-26	WOS:000485062200037
J	Calabrese, D; Roma, G; Bergling, S; Carbone, W; Mele, V; Nuciforo, S; Fofana, I; Campana, B; Szkolnicka, D; Hay, DC; Tchorz, J; Bouwmeester, T; Wieland, S; Heim, MH				Calabrese, Diego; Roma, Guglielmo; Bergling, Sebastian; Carbone, Walter; Mele, Valentina; Nuciforo, Sandro; Fofana, Isabel; Campana, Benedetta; Szkolnicka, Dagmara; Hay, David C.; Tchorz, Jan; Bouwmeester, Tewis; Wieland, Stefan; Heim, Markus H.			Liver biopsy derived induced pluripotent stem cells provide unlimited supply for the generation of hepatocyte-like cells	PLOS ONE			English	Article							EPIGENETIC MEMORY; TRANSCRIPTION FACTORS; IN-VITRO; DIFFERENTIATION; EXPRESSION; INDUCTION; PHENOTYPE; ENDODERM; DISEASE	Background & aims Hepatocyte-like cells (HLCs) differentiated from induced pluripotent stem cells (iPSCs) have emerged as a promising cell culture model to study metabolism, biotransformation, viral infections and inherited liver diseases. iPSCs provide an unlimited supply for the generation of HLCs, but incomplete HLC differentiation remains a major challenge. iPSC may carry-on a tissue of origin dependent expression memory influencing iPSC differentiation into different cell types. Whether liver derived iPSCs (Li-iPSCs) would allow the generation of more fully differentiated HLCs is not known. Methods In the current study, we used primary liver cells (PLCs) expanded from liver needle biopsies and reprogrammed them into Li-iPSCs using a non-integrative Sendai virus-based system. Li-iPSCs were differentiated into HLCs using established differentiation protocols. The HLC phenotype was characterized at the protein, functional and transcriptional level. RNA sequencing data were generated from the originating liver biopsies, the Li-iPSCs, fibroblast derived iPSCs, and differentiated HLCs, and used to characterize and compare their transcriptome profiles. Results Li-iPSCs indeed retain a liver specific transcriptional footprint. Li-iPSCs can be propagated to provide an unlimited supply of cells for differentiation into Li-HLCs. Similar to HLCs derived from fibroblasts, Li-HLCs could not be fully differentiated into hepatocytes. Relative to the originating liver, Li-HLCs showed lower expression of liver specific transcription factors and increased expression of genes involved in the differentiation of other tissues. Conclusions PLCs and Li-iPSCs obtained from small pieces of human needle liver biopsies constitute a novel unlimited source for the production of HLCs. Despite the preservation of a liver specific gene expression footprint in Li-iPSCs, the generation of fully differentiated hepatocytes cannot be achieved with the current differentiation protocols.	[Calabrese, Diego; Mele, Valentina; Nuciforo, Sandro; Fofana, Isabel; Campana, Benedetta; Wieland, Stefan; Heim, Markus H.] Univ Basel, Univ Hosp Basel, Dept Biomed, Basel, Switzerland; [Roma, Guglielmo; Bergling, Sebastian; Carbone, Walter; Tchorz, Jan; Bouwmeester, Tewis] Novartis Pharma AG, Novartis Inst BioMed Res, Forum 1 Novartis Campus, Basel, Switzerland; [Campana, Benedetta; Heim, Markus H.] Univ Hosp Basel, Div Gastroenterol & Hepatol, Basel, Switzerland; [Szkolnicka, Dagmara; Hay, David C.] MRC Ctr Regenerat Med, 5 Little France Dr, Edinburgh, Midlothian, Scotland	University of Basel; Novartis; University of Basel	Heim, MH (corresponding author), Univ Basel, Univ Hosp Basel, Dept Biomed, Basel, Switzerland.; Heim, MH (corresponding author), Univ Hosp Basel, Div Gastroenterol & Hepatol, Basel, Switzerland.	markus.heim@unibas.ch	Heim, Markus/A-7526-2008; Szkolnicka, Dagmara/AAN-3810-2020	Heim, Markus/0000-0002-7523-4894; Szkolnicka, Dagmara/0000-0003-1125-3575; Bergling, Sebastian/0000-0002-6840-3266; Calabrese, Diego/0000-0002-0259-8611; Nuciforo, Sandro/0000-0002-1863-1869; Carbone, Walter/0000-0001-6150-8295	European Research Council [609883]; SystemsX.ch grant MERiC; Swiss National Science Foundation [310030B_147089, 310030_166202]; University of Basel; MRC [MR/K017047/1] Funding Source: UKRI	European Research Council(European Research Council (ERC)European Commission); SystemsX.ch grant MERiC; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); University of Basel; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was funded by European Research Council Synergy grant 609883 (MERiC), by SystemsX.ch grant MERiC, by Swiss National Science Foundation grants 310030B_147089 and 310030_166202 to MHH. DC was supported by a University of Basel Funds for Junior Researchers grant. Novartis Pharma AG provided support in the form of salaries for authors G.R., S.B., W.C., J.T. and T.B., and research materials, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "author contributions" section.	Ala A, 2011, SEMIN LIVER DIS, V31, P208, DOI 10.1055/s-0031-1276648; Asahina K, 2012, J GASTROEN HEPATOL, V27, P80, DOI 10.1111/j.1440-1746.2011.07001.x; BALLET F, 1984, HEPATOLOGY, V4, P849, DOI 10.1002/hep.1840040509; Bar-Nur O, 2011, CELL STEM CELL, V9, P17, DOI 10.1016/j.stem.2011.06.007; Baxter M, 2015, J HEPATOL, V62, P581, DOI 10.1016/j.jhep.2014.10.016; BERRY MN, 1969, J CELL BIOL, V43, P506, DOI 10.1083/jcb.43.3.506; Buganim Y, 2013, NAT REV GENET, V14, P427, DOI 10.1038/nrg3473; Carpagnano GE, 2017, LUNG, V195, P679, DOI 10.1007/s00408-017-0033-2; Castell JV, 2006, EXPERT OPIN DRUG MET, V2, P183, DOI 10.1517/17425255.2.2.183; Cereghini S, 1996, FASEB J, V10, P267, DOI 10.1096/fasebj.10.2.8641560; Choi SS, 2009, HEPATOLOGY, V50, P2007, DOI 10.1002/hep.23196; Costa RH, 2003, HEPATOLOGY, V38, P1331, DOI 10.1016/j.hep.2003.09.034; Fusaki N, 2009, P JPN ACAD B-PHYS, V85, P348, DOI 10.2183/pjab.85.348; Gao XG, 2017, CELL BIOL TOXICOL, V33, P407, DOI 10.1007/s10565-017-9383-z; Gaspar-Maia A, 2011, NAT REV MOL CELL BIO, V12, P36, DOI 10.1038/nrm3036; Gordillo M, 2015, DEVELOPMENT, V142, P2094, DOI 10.1242/dev.114215; Hansel MC, 2014, CELL TRANSPLANT, V23, P27, DOI 10.3727/096368912X662453; Hay DC, 2007, CLONING STEM CELLS, V9, P51, DOI 10.1089/clo.2006.0045; HAYNES BF, 1984, J EXP MED, V159, P1149, DOI 10.1084/jem.159.4.1149; Heim MH, 2016, J HEPATOL, V65, pS22, DOI 10.1016/j.jhep.2016.07.037; Heslop JA, 2017, STEM CELL TRANSL MED, V6, P1321, DOI 10.1002/sctm.16-0029; Ijpenberg A, 2007, DEV BIOL, V312, P157, DOI 10.1016/j.ydbio.2007.09.014; Jiang JM, 2013, SCIENCE, V342, P111, DOI 10.1126/science.1236921; Kapp MB, 2006, J CLIN PATHOL, V59, P335, DOI 10.1136/jcp.2005.030957; Knofler M, 1998, GENE, V224, P77, DOI 10.1016/S0378-1119(98)00511-3; Kyttala A, 2016, STEM CELL REP, V6, P200, DOI 10.1016/j.stemcr.2015.12.009; Li JX, 2000, GENE DEV, V14, P464; Liberzon A, 2015, CELL SYST, V1, P417, DOI 10.1016/j.cels.2015.12.004; Liepelt A, 2016, AM J PHYSIOL-GASTR L, V311, pG203, DOI 10.1152/ajpgi.00193.2016; Liu H, 2010, HEPATOLOGY, V51, P1810, DOI 10.1002/hep.23626; Medine CN, 2011, JOVE-J VIS EXP, DOI 10.3791/2969; Nelakanti Raman V, 2015, Curr Protoc Stem Cell Biol, V32, DOI 10.1002/9780470151808.sc04a08s32; Nukaya D, 2015, GENES CELLS, V20, P367, DOI 10.1111/gtc.12227; PANDOLFI PP, 1995, NAT GENET, V11, P40, DOI 10.1038/ng0995-40; Pera MF, 2000, J CELL SCI, V113, P5; Pinzani M, 2011, J HEPATOL, V55, P459, DOI 10.1016/j.jhep.2011.02.001; Polo JM, 2010, NAT BIOTECHNOL, V28, P848, DOI 10.1038/nbt.1667; Powell LW, 2016, LANCET, V388, P706, DOI 10.1016/S0140-6736(15)01315-X; Puche JE, 2013, COMPR PHYSIOL, V3, P1473, DOI 10.1002/cphy.c120035; Roymans D, 2005, DRUG METAB DISPOS, V33, P1004, DOI 10.1124/dmd.104.003046; Santhosh S, 2008, WORLD J GASTROENTERO, V14, P4672, DOI 10.3748/wjg.14.4672; Schlaeger TM, 2015, NAT BIOTECHNOL, V33, P58, DOI 10.1038/nbt.3070; Shiihara T, 2004, AM J MED GENET A, V128A, P214, DOI 10.1002/ajmg.a.20552; Si-Tayeb K, 2010, HEPATOLOGY, V51, P297, DOI 10.1002/hep.23354; Sridharan R, 2009, CELL, V136, P364, DOI 10.1016/j.cell.2009.01.001; STRAIN AJ, 1995, AM J PATHOL, V146, P537; Sullivan GJ, 2010, HEPATOLOGY, V51, P329, DOI 10.1002/hep.23335; Sun YL, 2011, HEPATOB PANCREAT DIS, V10, P55, DOI 10.1016/S1499-3872(11)60008-8; Suzuki A, 2008, DEVELOPMENT, V135, P1589, DOI 10.1242/dev.016634; Szkolnicka D., 2014, CURR PROTOC STEM CEL, V30; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Vaskova EA, 2013, ACTA NATURAE, V5, P15, DOI 10.32607/20758251-2013-5-4-15-21; Wesselschmidt RL, 2011, METHODS MOL BIOL, V767, P231, DOI 10.1007/978-1-61779-201-4_17; Wilkening S, 2003, DRUG METAB DISPOS, V31, P1035, DOI 10.1124/dmd.31.8.1035; Xue ZF, 2013, WORLD J GASTROENTERO, V19, P1380, DOI 10.3748/wjg.v19.i9.1380; Yu Y, 2012, STEM CELL RES, V9, P196, DOI 10.1016/j.scr.2012.06.004	56	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2019	14	8							e0221762	10.1371/journal.pone.0221762	http://dx.doi.org/10.1371/journal.pone.0221762			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW6AB	31465481	Green Submitted, Green Published, gold			2022-12-26	WOS:000485058200047
J	Choi, JM; Lim, SH; Han, YM; Lee, H; Seo, JY; Park, HE; Kwak, MS; Chung, GE; Choi, SY; Kim, JS				Choi, Ji Min; Lim, Seon Hee; Han, Yoo Min; Lee, Heesun; Seo, Ji Yeon; Park, Hyo Eun; Kwak, Min-Sun; Chung, Goh Eun; Choi, Su-Yeon; Kim, Joo Sung			Association between Helicobacter pylori infection and arterial stiffness: Results from a large cross-sectional study	PLOS ONE			English	Article							ANKLE VASCULAR INDEX; CORONARY-HEART-DISEASE; CHLAMYDIA-PNEUMONIAE; CARDIOVASCULAR EVENTS; MYOCARDIAL-INFARCTION; RISK; INCREASE; ATHEROSCLEROSIS; CYTOMEGALOVIRUS; EPIDEMIOLOGY	Background Chronic systemic inflammation is an important causative factor in the pathogenesis of atherosclerosis. However, the effect of chronic Helicobacter pylori (Hp) infection on arterial stiffness, a predictor of cardiovascular events, remains unclear. We evaluated the association between Hp infection and arterial stiffness in asymptomatic healthy individuals. Methods Arterial stiffness was evaluated using the cardio-ankle vascular index (CAVI). We included subjects who underwent CAVI and anti-Hp IgG antibody evaluations, simultaneously, between March 2013 and July 2017. Demographic characteristics and metabolic and cardiovascular parameters were compared with respect to anti-Hp IgG antibody status. Multivariable logistic regression analyses were performed to determine the effect of Hpseropositivity and conventional cardiovascular risk factors on arterial stiffness. Results Of 2,251 subjects, 1,326 (58.9%) were included in the Hp-seropositive group. Median age (P < 0.001) and systolic blood pressure (P = 0.027) were significantly higher in the Hp-seropositive than in the Hp-seronegative group. Levels of LDL-cholesterol were significantly higher in the Hp-seropositive than in the Hp-seronegative group (P = 0.016). Other serum metabolic parameters were not significantly different between the two groups. The median CAVI value and the proportion of subjects with a CAVI >= 8 were significantly higher in the Hp-seropositive than in the Hp-seronegative group (both P < 0.001). On multivariable logistic regression analyses, Hp-seropositivity, age, body mass index, waist circumference, smoking, hypertension, diabetes mellitus, and dyslipidemia were significantly associated with high CAVI values. In the subgroup analysis conducted according to age group, a tendency towards an increased association between Hp-seropositivity and CAVI was observed with increasing age, even though the difference did not reach the statistical significance. Conclusions Hp-seropositivity was significantly associated with arterial stiffness. Hp infection may contribute to the development of cardiovascular diseases.	[Choi, Ji Min; Lim, Seon Hee; Han, Yoo Min; Lee, Heesun; Seo, Ji Yeon; Park, Hyo Eun; Kwak, Min-Sun; Chung, Goh Eun; Choi, Su-Yeon; Kim, Joo Sung] Seoul Natl Univ Hosp, Healthcare Syst Gangnam Ctr, Healthcare Res Inst, Dept Internal Med, Seoul, South Korea; [Kim, Joo Sung] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul, South Korea; [Kim, Joo Sung] Seoul Natl Univ, Coll Med, Liver Res Inst, Seoul, South Korea	Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University (SNU)	Lim, SH (corresponding author), Seoul Natl Univ Hosp, Healthcare Syst Gangnam Ctr, Healthcare Res Inst, Dept Internal Med, Seoul, South Korea.	limsh@snuh.org	Stefanadis, Christodoulos/ABH-2232-2020; Choi, Su-Yeon/C-4312-2013; Han, Yoo Min/AAC-5661-2022	Stefanadis, Christodoulos/0000-0001-5974-6454; Choi, Su-Yeon/0000-0001-9977-4740; 				Blum A, 2011, AM J MED, V124, P1171, DOI 10.1016/j.amjmed.2011.08.015; Choi SY, 2016, PULSE, V4, P17, DOI 10.1159/000448462; Choi SY, 2013, J ATHEROSCLER THROMB, V20, P911, DOI 10.5551/jat.18267; Choi SY, 2013, J ATHEROSCLER THROMB, V20, P178, DOI 10.5551/jat.14753; Danesh J, 1999, AM HEART J, V138, pS434, DOI 10.1016/S0002-8703(99)70270-X; Danesh J, 1999, HEART, V81, P245, DOI 10.1136/hrt.81.3.245; Eusebi LH, 2014, HELICOBACTER, V19, P1, DOI 10.1111/hel.12165; Everhart JE, 2000, GASTROENTEROL CLIN N, V29, P559, DOI 10.1016/S0889-8553(05)70130-8; Farsak B, 2000, J CLIN MICROBIOL, V38, P4408, DOI 10.1128/JCM.38.12.4408-4411.2000; Figura N, 2014, J CLIN PATHOL, V67, DOI 10.1136/jclinpath-2013-201743; Franceschi F, 2014, HELICOBACTER, V19, P52, DOI 10.1111/hel.12159; Glasser SP, 1997, AM J HYPERTENS, V10, P1175; Han YM, 2018, J DIGEST DIS, V19, P529, DOI 10.1111/1751-2980.12660; Hu HQ, 2013, HYPERTENS RES, V36, P334, DOI 10.1038/hr.2012.192; Jafarzadeh Abdollah, 2011, Acta Med Indones, V43, P105; Jang SY, 2014, J KOREAN MED SCI, V29, P798, DOI 10.3346/jkms.2014.29.6.798; Konturek SJ, 2006, J PHYSL PHARM; Kowalski M, 2002, DIGEST LIVER DIS, V34, P398, DOI 10.1016/S1590-8658(02)80036-6; Kubozono T, 2007, CIRC J, V71, P89, DOI 10.1253/circj.71.89; Laek B, 2013, ATHEROSCLEROSIS, V230, P268, DOI 10.1016/j.atherosclerosis.2013.07.053; Lavie CJ, 2013, JACC-HEART FAIL, V1, P93, DOI 10.1016/j.jchf.2013.01.006; Lee C, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-019327; Lee JH, 2008, HELICOBACTER, V13, P288, DOI 10.1111/j.1523-5378.2008.00616.x; Lee M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193646; Lim SH, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0204762; Liu J, 2015, HELICOBACTER, V20, P176, DOI 10.1111/hel.12188; Liuzzo G, 2001, Rays, V26, P221; Majka Jolanta, 2002, Med Sci Monit, V8, pCR675; Mayr M, 2003, STROKE, V34, P610, DOI 10.1161/01.STR.0000058481.82639.EF; Mendall MA, 1997, HEART, V78, P273, DOI 10.1136/hrt.78.3.273; MENDALL MA, 1994, BRIT HEART J, V71, P437; NAGAYAMA D, 2017, VASC HEALTH RISK MAN, V13, P1, DOI [DOI 10.2147/VHRM.S119646, 10.2147/VHRM.S119646]; Nakamura K, 2008, CIRC J, V72, P598; Niemela S, 1996, HEART, V75, P573, DOI 10.1136/hrt.75.6.573; Park HE, 2012, J ATHEROSCLER THROMB, V19, P570, DOI 10.5551/jat.12484; Park JB, 2013, J ATHEROSCLER THROMB, V20, P557, DOI 10.5551/jat.15149; Pietroiusti A, 2002, CIRCULATION, V106, P580, DOI 10.1161/01.CIR.0000023894.10871.2F; Saijo Y, 2005, HYPERTENS RES, V28, P283, DOI 10.1291/hypres.28.283; Sakane Kosuke, 2008, J Atheroscler Thromb, V15, P261; Schillaci G, 2005, HYPERTENSION, V45, P1078, DOI 10.1161/01.HYP.0000165313.84007.7d; Schottker B, 2012, ATHEROSCLEROSIS, V220, P569, DOI 10.1016/j.atherosclerosis.2011.11.029; Sealy-Jefferson S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065959; Shirai K, 2006, J ATHEROSCLER THROMB, V13, P101, DOI 10.5551/jat.13.101; Shirai K, 2011, J ATHEROSCLER THROMB, V18, P924; Sun CK, 2013, INTEGR BLOOD PRESS C, V6, P27, DOI 10.2147/IBPC.S34423; Tamura A, 2002, AM J GASTROENTEROL, V97, P861, DOI 10.1111/j.1572-0241.2002.05601.x; VAINIO H, 1994, ENVIRON HEALTH PERSP, V102, P590, DOI 10.1289/ehp.94102590; Vlachopoulos C, 2010, J AM COLL CARDIOL, V55, P1318, DOI 10.1016/j.jacc.2009.10.061; von Elm E, 2007, LANCET, V370, P1453, DOI 10.1016/S0140-6736(07)61602-X; Yoshikawa H, 2007, HELICOBACTER, V12, P559, DOI 10.1111/j.1523-5378.2007.00523.x	50	13	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2019	14	8							e0221643	10.1371/journal.pone.0221643	http://dx.doi.org/10.1371/journal.pone.0221643			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW6AB	31465466	Green Submitted, gold, Green Published			2022-12-26	WOS:000485058200035
J	Karmacharya, D; Manandhar, P; Manandhar, S; Sherchan, AM; Sharma, AN; Joshi, J; Bista, M; Bajracharya, S; Awasthi, NP; Sharma, N; Llewellyn, B; Waits, LP; Thapa, K; Kelly, MJ; Vuyisich, M; Starkenburg, SR; Hero, JM; Hughes, J; Wultsch, C; Bertola, L; Fountain-Jones, NM; Sinha, AK				Karmacharya, Dibesh; Manandhar, Prajwol; Manandhar, Sulochana; Sherchan, Adarsh M.; Sharma, Ajay N.; Joshi, Jyoti; Bista, Manisha; Bajracharya, Shailendra; Awasthi, Nagendra P.; Sharma, Netra; Llewellyn, Bronwyn; Waits, Lisette P.; Thapa, Kanchan; Kelly, Marcella J.; Vuyisich, Momchilo; Starkenburg, Shawn R.; Hero, Jean-Marc; Hughes, Jane; Wultsch, Claudia; Bertola, Laura; Fountain-Jones, Nicholas M.; Sinha, Amit K.			Gut microbiota and their putative metabolic functions in fragmented Bengal tiger population of Nepal	PLOS ONE			English	Article							COMMUNITIES; WILD; CONSERVATION; DIVERSITY; SEQUENCES; METAGENOMICS; DISTURBANCE; LANDSCAPE; BACTERIAL; PHYLOGENY	Bengal tigers (Panthera tigris tigris) serve a pivotal role as an apex predator in forest ecosystems. To increase our knowledge on factors impacting the viability and health of this endangered species, we studied the gut microbiota in 32 individual Bengal tigers from three geographically separated areas (Chitwan National Park (CNP), Bardia National Park (BNP) and Suklaphanta Wildlife Reserve (SWR)) in Nepal, using noninvasive genetic sampling methods. Gut microbiota influence the immune system, impact various physiological functions, and modulates metabolic reactions, that ultimately impact the host health, behavior and development. Across the tiger populations in Nepal, we found significant differences in the composition of microbial communities based on their geographic locations. Specifically, we detected significant differences between CNP and the other two protected areas (CNP vs BNP: pseudo t = 1.944, P = 0.006; CNP vs SWR: pseudo t = 1.9942, P = 0.0071), but no differences between BNP and SWR. This mirrors what has been found for tiger gene flow in the same populations, suggesting gut microbiota composition and host gene flow may be linked. Furthermore, predictive metagenome functional content analysis (PICRUSt) revealed a higher functional enrichment and diversity for significant gut microbiota in the Chitwan tiger population and the lowest enrichment and diversity in Suklaphanta. The CNP tiger population contained higher proportions of microbiota that are associated with predicted functions relevant for metabolism of amino acid, lipid, xenobiotics biodegradation, terpenoides and polyketides than the SWR population. We conclude the tiger population structure, gut microbiota profile and associated functional metabolic categories are correlated, with geographically most separated CNP and SWR tiger population having the most distinct and different host genotype and microbiota profiles. Our work dramatically expands the understanding of tiger microbiota in wild populations and provides a valuable case study on how to investigate genetic diversity at different hierarchical levels, including hosts as well as their microbial communities.	[Karmacharya, Dibesh; Manandhar, Prajwol; Manandhar, Sulochana; Sherchan, Adarsh M.; Sharma, Ajay N.; Joshi, Jyoti; Bista, Manisha; Bajracharya, Shailendra; Awasthi, Nagendra P.; Sinha, Amit K.] Ctr Mol Dynam Nepal, Kathmandu, Nepal; [Karmacharya, Dibesh; Hughes, Jane] Griffith Univ, Sch Environm, Brisbane, Qld, Australia; [Sharma, Netra; Llewellyn, Bronwyn] US Agcy Int Dev, Environm Team, Kathmandu, Nepal; [Waits, Lisette P.] Univ Idaho, Dept Fish & Wildlife Sci, Moscow, ID 83843 USA; [Thapa, Kanchan; Kelly, Marcella J.] Virginia Tech, Dept Fish & Wildlife Conservat, Blacksburg, VA USA; [Vuyisich, Momchilo; Starkenburg, Shawn R.] Los Alamos Natl Lab, Appl Genom, Los Alamos, NM USA; [Hero, Jean-Marc] Univ Sunshine Coast, Sch Sci & Educ, Sunshine Coast, Qld, Australia; [Wultsch, Claudia] Amer Museum Nat Hist, Sackler Inst Comparat Genom, New York, NY 10024 USA; [Wultsch, Claudia] CUNY Hunter Coll, Bioinformat & Computat Genom Lab, New York, NY 10021 USA; [Bertola, Laura] CUNY City Coll, Dept Biol, New York, NY USA; [Bertola, Laura] Leiden Univ, Inst Environm Sci, Leiden, Netherlands; [Fountain-Jones, Nicholas M.] Univ Minnesota, Dept Vet Populat Med, Minneapolis, MN USA	Griffith University; United States Agency for International Development (USAID); Idaho; University of Idaho; Virginia Polytechnic Institute & State University; United States Department of Energy (DOE); Los Alamos National Laboratory; University of the Sunshine Coast; American Museum of Natural History (AMNH); City University of New York (CUNY) System; Hunter College (CUNY); City University of New York (CUNY) System; City College of New York (CUNY); Leiden University; Leiden University - Excl LUMC; University of Minnesota System; University of Minnesota Twin Cities	Karmacharya, D (corresponding author), Ctr Mol Dynam Nepal, Kathmandu, Nepal.; Karmacharya, D (corresponding author), Griffith Univ, Sch Environm, Brisbane, Qld, Australia.	dibesh@cmdn.org	Thapa, Kanchan/AGU-3365-2022; Awasthi, Nagendra Prasad/AAE-6160-2022; Bertola, Laura/U-5299-2019; Karmacharya, Dibesh/GVU-4782-2022; Kelly, Marcella/B-4891-2011	Bertola, Laura/0000-0002-3445-0355; Kelly, Marcella/0000-0001-9044-3873; Karmacharya, Dibesh/0000-0001-5093-6737; Manandhar, Prajwol/0000-0002-5259-0706; Fountain-Jones, Nicholas/0000-0001-9248-8493	DBK USAID [FOG AID-367-G-11-00001]; United States Agency for International Development	DBK USAID; United States Agency for International Development(United States Agency for International Development (USAID))	Funded by DBK USAID FOG AID-367-G-11-00001 United States Agency for International Development.	Amato, 2013, MICROBIOME SCI MED, V1, DOI 10.2478/micsm; Amato KR, 2013, ISME J, V7, P1344, DOI 10.1038/ismej.2013.16; Anderson M.J., 2008, PERMANOVA PRIMER GUI; Anderson MJ, 2006, ECOL LETT, V9, P683, DOI 10.1111/j.1461-0248.2006.00926.x; Anderson MJ, 2003, ECOLOGY, V84, P511, DOI 10.1890/0012-9658(2003)084[0511:CAOPCA]2.0.CO;2; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Bahrndorff S, 2016, INT J GENOMICS, V2016, DOI 10.1155/2016/5304028; Baniya RK, 2017, PREY SELECTION BY TI; Barber-Meyer SM, 2013, J ZOOL, V289, P10, DOI 10.1111/j.1469-7998.2012.00956.x; Barelli C, 2015, SCI REP-UK, V5, DOI 10.1038/srep14862; Becker AAMJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123933; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bhagavatula J, 2006, BMC GENET, V7, DOI 10.1186/1471-2156-7-48; Brucker RM, 2012, EVOLUTION, V66, P349, DOI 10.1111/j.1558-5646.2011.01454.x; Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Caporaso JG, 2010, BIOINFORMATICS, V26, P266, DOI 10.1093/bioinformatics/btp636; CHAO A, 1984, SCAND J STAT, V11, P265; Chao A., 2005, ENCY STAT SCI; Chen L, 2016, J APPL GENET, V57, P275, DOI 10.1007/s13353-015-0319-0; Clayton JB, 2016, P NATL ACAD SCI USA; Clemente JC, 2012, CELL, V148, P1258, DOI 10.1016/j.cell.2012.01.035; da Costa PM, 2013, INT J ENV RES PUB HE, V10, P278, DOI 10.3390/ijerph10010278; David LA, 2014, NATURE, V505, P559, DOI 10.1038/nature12820; Degnan PH, 2012, P NATL ACAD SCI USA, V109, P13034, DOI 10.1073/pnas.1110994109; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Dhakal M., 2018, STATUS TIGERS PREY N, DOI 10.13140/2.1.3290.2407; Dinerstein E, 2007, BIOSCIENCE, V57, P508, DOI 10.1641/B570608; Duarte AM, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1908-4; Fisher RA, 1943, J ANIM ECOL, V12, P42, DOI 10.2307/1411; Fountain-Jones NM, 2017, FUNCT ECOL, V31, P1441, DOI 10.1111/1365-2435.12845; Gomez A, 2016, CELL REP, V14, P2142, DOI 10.1016/j.celrep.2016.02.013; Gomez A, 2015, MOL ECOL, V24, P2551, DOI 10.1111/mec.13181; GOWER JC, 1975, PSYCHOMETRIKA, V40, P33, DOI 10.1007/BF02291478; Handl S, 2011, FEMS MICROBIOL ECOL, V76, P301, DOI 10.1111/j.1574-6941.2011.01058.x; He Y, 2015, MICROBIOME, V3, DOI 10.1186/s40168-015-0081-x; Kanagaraj R, 2011, ECOGRAPHY, V34, P970, DOI 10.1111/j.1600-0587.2010.06482.x; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; KENNEY JS, 1995, CONSERV BIOL, V9, P1127, DOI 10.1046/j.1523-1739.1995.9051116.x-i1; Khadka BB, 2016, HIGH PREY DENSITY OB; Kohl KD, 2018, J ANIM ECOL, V87, P323, DOI 10.1111/1365-2656.12692; Langille MGI, 2013, NAT BIOTECHNOL, V31, P814, DOI 10.1038/nbt.2676; Ley RE, 2006, CELL, V124, P837, DOI 10.1016/j.cell.2006.02.017; Ley RE, 2008, SCIENCE, V320, P1647, DOI 10.1126/science.1155725; Markowitz VM, 2012, NUCLEIC ACIDS RES, V40, pD115, DOI 10.1093/nar/gkr1044; McMurdie PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061217; Menke S, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00526; Menotti-Raymond M, 1999, GENOMICS, V57, P9, DOI 10.1006/geno.1999.5743; Menotti-Raymond MA, 2005, J FORENSIC SCI, V50, P1061, DOI 10.1520/JFS2004317; Nelson TM, 2013, ENVIRON MICROBIOL, V15, P1132, DOI 10.1111/1462-2920.12022; Nicholson JK, 2012, SCIENCE, V336, P1262, DOI 10.1126/science.1223813; NTGP/ CMDN, 2014, NEP TIG GEN PROJ FIN; Parks DH, 2014, BIOINFORMATICS, V30, P3123, DOI 10.1093/bioinformatics/btu494; Phillips CD, 2012, MOL ECOL, V21, P2617, DOI 10.1111/j.1365-294X.2012.05568.x; Podolsky DK, 2002, BEST PRACT RES CL GA, V16, P933, DOI 10.1053/bega.2002.0354; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Quercia S, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00587; R Development Core Team RDCT, 2014, R LANG ENV STAT COMP; Redford KH, 2012, CONSERV BIOL, V26, P195, DOI 10.1111/j.1523-1739.2012.01829.x; Round JL, 2009, NAT REV IMMUNOL, V9, P313, DOI 10.1038/nri2515; Schwab C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027905; Seidensticker J, 2010, INTEGR ZOOL, V5, P285, DOI 10.1111/j.1749-4877.2010.00214.x; SEUTIN G, 1991, CAN J ZOOL, V69, P82, DOI 10.1139/z91-013; Shannon C. E., 1949, MATH THEORY COMMUNIC; Sharma R, 2008, MOL ECOL RESOUR, V8, P1480, DOI 10.1111/j.1755-0998.2008.02292.x; Shrestha M. K., 2004, RELATIVE UNGULATE AB; Simpson E.H., 1949, NATURE; Smith JLD, 1998, CONSERV BIOL, V12, P1338, DOI 10.1046/j.1523-1739.1998.97068.x; Sommer F, 2013, NAT REV MICROBIOL, V11, P227, DOI 10.1038/nrmicro2974; Stumpf RM, 2016, BIOL CONSERV, V199, P56, DOI 10.1016/j.biocon.2016.03.035; Suchodolski JS, 2011, VET CLIN N AM-SMALL, V41, P261, DOI 10.1016/j.cvsm.2010.12.006; Targan SR, 2005, IMMUNOL REV, V206, P296, DOI 10.1111/j.0105-2896.2005.00286.x; Thapa K, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193495; Treves A, 2003, CONSERV BIOL, V17, P1491, DOI 10.1111/j.1523-1739.2003.00059.x; Tun HM, 2012, J MICROBIOL METH, V88, P369, DOI 10.1016/j.mimet.2012.01.001; Tung J, 2015, ELIFE, V4, DOI 10.7554/eLife.05224; Wasimuddin, 2017, MOL ECOL, V26, P5515, DOI 10.1111/mec.14278; Wikramanayake E, 2004, CONSERV BIOL, V18, P839, DOI 10.1111/j.1523-1739.2004.00145.x; Wu XY, 2016, APPL MICROBIOL BIOT, V100, P3577, DOI 10.1007/s00253-015-7257-y; Wultsch C, 2015, WILDLIFE SOC B, V39, P403, DOI 10.1002/wsb.540; Xue ZS, 2015, MBIO, V6, DOI 10.1128/mBio.00022-15; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053; Zhang HH, 2015, ANN MICROBIOL, V65, P703, DOI 10.1007/s13213-014-0909-9; Zhang HH, 2010, MOL BIOL REP, V37, P4013, DOI 10.1007/s11033-010-0060-z; Zimmermann A, 2010, CONT VIEWS HUMAN CAR; Zoetendal Erwin G., 2001, Microbial Ecology in Health and Disease, V13, P129, DOI 10.1080/089106001750462669	86	8	8	4	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2019	14	8							e0221868	10.1371/journal.pone.0221868	http://dx.doi.org/10.1371/journal.pone.0221868			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW6AB	31465520	gold, Green Published, Green Submitted			2022-12-26	WOS:000485058200062
J	Lee, SH; Chu, KB; Kang, HJ; Quan, FS				Lee, Su-Hwa; Chu, Ki-Back; Kang, Hae-Ji; Quan, Fu-Shi			Virus-like particles containing multiple antigenic proteins of Toxoplasma gondii induce memory T cell and B cell responses	PLOS ONE			English	Article							INFLUENZA-VIRUS; MICRONEEDLE DELIVERY; VACCINE; GENERATION; IMMUNOGENICITY; PROTECTION; EPITOPES; ANTIBODY; IMMUNITY; SUBSETS	Although the efforts to develop vaccine against Toxoplasma gondii infection were made for decades, there is currently no licensed vaccine available for humans. Upon discovering a number of T or B cell epitope regions from T. gondii IMC, ROP18 and MIC8, multi-antigen VLPs or combination VLPs were generated. Mice immunized with multi-antigen VLPs or combination VLPs were challenge infected with T. gondii (ME49). T. gondii-specific IgG, IgG isotypes and IgA antibody responses, memory T and B cell responses and protection were evaluated. All the mice survived upon T. gondii challenge infection by multi-antigen VLPs vaccination. Vaccinated mice elicited higher levels of parasite-specific IgG and IgG2a antibody responses in sera, IgA antibody responses in feces, CD4(+) and CD8(+) T cell responses, and cytokines (IFN-gamma, IL-10) responses compared to combination VLPs. In particular, the multi-antigen VLPs vaccination showed significantly higher levels of antibody secreting cell (ASC) responses, CD4(+) and CD8(+) effector memory T cells, and memory B cells than combination VLPs. Multi-antigen VLPs vaccination showed significant reduction of brain cyst counts and size, and all mice survived. Prediction and analysis of epitopes have indicated that IMC, ROP18 and MIC8 showed partially overlapping epitopes for T and B cells. Our results indicated that antibody responses, memory T and B cells induced by multi-antigen VLPs vaccination might contribute to the complete protection upon T. gondii (ME49) challenge infection.	[Lee, Su-Hwa; Chu, Ki-Back; Kang, Hae-Ji] Kyung Hee Univ, Grad Sch, Dept Biomed Sci, Seoul, South Korea; [Quan, Fu-Shi] Kyung Hee Univ, Dept Med Zool, Sch Med, Seoul, South Korea; [Quan, Fu-Shi] Kyung Hee Univ, Grad Sch, Sch Med, Dept Med Res,Ctr Bioreact React Oxygen Species, Seoul, South Korea; [Quan, Fu-Shi] Kyung Hee Univ, Sch Med, Grad Sch, Biomed Sci Inst, Seoul, South Korea	Kyung Hee University; Kyung Hee University; Kyung Hee University; Kyung Hee University	Quan, FS (corresponding author), Kyung Hee Univ, Dept Med Zool, Sch Med, Seoul, South Korea.; Quan, FS (corresponding author), Kyung Hee Univ, Grad Sch, Sch Med, Dept Med Res,Ctr Bioreact React Oxygen Species, Seoul, South Korea.; Quan, FS (corresponding author), Kyung Hee Univ, Sch Med, Grad Sch, Biomed Sci Inst, Seoul, South Korea.	fsquan@khu.ac.kr			National Research Foundation of Korea (NRF) [2018R1A2B6003535, 2018R1A6A1A03025124]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea)	This work was supported by grants from the National Research Foundation of Korea (NRF) (2018R1A2B6003535, 2018R1A6A1A03025124).	Amanna IJ, 2011, VIROLOGY, V411, P206, DOI 10.1016/j.virol.2010.12.016; Campos M, 2003, INT J PARASITOL, V33, P655, DOI 10.1016/S0020-7519(03)00066-3; Chu HH, 2016, IMMUNITY, V45, P159, DOI 10.1016/j.immuni.2016.06.013; Dubey JP, 2009, VET PARASITOL, V163, P1, DOI 10.1016/j.vetpar.2009.02.026; Dunay IR, 2018, CLIN MICROBIOL REV, V31, DOI 10.1128/CMR.00057-17; Farber DL, 2014, NAT REV IMMUNOL, V14, P24, DOI 10.1038/nri3567; Foroutan M, 2018, INFECT GENET EVOL, V62, P193, DOI 10.1016/j.meegid.2018.04.033; Golubovskaya V, 2016, CANCERS, V8, DOI 10.3390/cancers8030036; Huang SY, 2016, INT J INFECT DIS, V48, P14, DOI 10.1016/j.ijid.2016.04.014; Huber VC, 2001, J IMMUNOL, V166, P7381, DOI 10.4049/jimmunol.166.12.7381; Jankovic D, 1999, J IMMUNOL, V162, P345; Jayasekera JP, 2007, J VIROL, V81, P3487, DOI 10.1128/JVI.02128-06; Jongert E, 2009, MEM I OSWALDO CRUZ, V104, P252, DOI 10.1590/S0074-02762009000200019; Kang HJ, 2018, KOREAN J PARASITOL, V56, P429, DOI 10.3347/kjp.2018.56.5.429; Kim AR, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191277; Kim YC, 2016, J DRUG TARGET, V24, P943, DOI 10.3109/1061186X.2016.1159213; Lau YL, 2008, EXP PARASITOL, V119, P373, DOI 10.1016/j.exppara.2008.03.016; Lee DH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161231; Lee S, 2018, FRONT IMMUNOL, V9, DOI [10.3389/fimmu.2018.00009, DOI 10.3389/FIMMU.2018.00009]; Lee SH, 2018, VACCINE, V36, P5692, DOI 10.1016/j.vaccine.2018.08.016; Lee SH, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175644; Mevelec MN, 2005, VACCINE, V23, P4489, DOI 10.1016/j.vaccine.2005.04.025; Montoya JG, 2004, LANCET, V363, P1965, DOI 10.1016/S0140-6736(04)16412-X; Mozdzanowska K, 2006, VIROLOGY, V352, P418, DOI 10.1016/j.virol.2006.05.008; Nutt SL, 2015, NAT REV IMMUNOL, V15, P160, DOI 10.1038/nri3795; Odendahl M, 2005, BLOOD, V105, P1614, DOI 10.1182/blood-2004-07-2507; Quan FS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009161; Rashid I, 2011, VACCINE, V29, P8838, DOI 10.1016/j.vaccine.2011.09.099; Robert-Gangneux F, 2012, CLIN MICROBIOL REV, V25, P264, DOI 10.1128/CMR.05013-11; Sallusto F, 2004, ANNU REV IMMUNOL, V22, P745, DOI 10.1146/annurev.immunol.22.012703.104702; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Sallusto F, 2016, ANNU REV IMMUNOL, V34, P317, DOI 10.1146/annurev-immunol-032414-112056; Sbierski-Kind J, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01069; Slifka MK, 1998, IMMUNITY, V8, P363, DOI 10.1016/S1074-7613(00)80541-5; Song JM, 2010, CLIN VACCINE IMMUNOL, V17, P1381, DOI 10.1128/CVI.00100-10; Svitek N, 2018, NPJ VACCINES, V3, DOI 10.1038/s41541-018-0073-5; Wang HF, 2007, PARASITOL INT, V56, P263, DOI 10.1016/j.parint.2007.04.003; Wang J, 2019, TRENDS PARASITOL, P204, DOI [10.1016/j.meegid.2018.04.033, DOI 10.1016/J.MEEGID.2018.04.033]; Wang YH, 2014, PARASITE VECTOR, V7, DOI 10.1186/s13071-014-0474-x; Wang YH, 2011, VACCINE, V29, P8619, DOI 10.1016/j.vaccine.2011.09.016; Yang W, 2000, VACCINE, V19, P103, DOI 10.1016/S0264-410X(00)00165-1; Zanetti M, 2006, TRENDS IMMUNOL, V27, P511, DOI 10.1016/j.it.2006.09.004; Zhou J, 2016, PARASITE, V23, DOI 10.1051/parasite/2016017; Zielinski CE, 2011, IMMUNOL REV, V240, P40, DOI 10.1111/j.1600-065X.2010.01000.x	44	12	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2019	14	8							e0220865	10.1371/journal.pone.0220865	http://dx.doi.org/10.1371/journal.pone.0220865			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW6AB	31465461	Green Published, Green Submitted, gold			2022-12-26	WOS:000485058200008
J	Tikhonenkov, DV; Jhin, SH; Eglit, Y; Miller, K; Plotnikov, A; Simpson, AGB; Park, JS				Tikhonenkov, Denis, V; Jhin, Soo Hwan; Eglit, Yana; Miller, Kai; Plotnikov, Andrey; Simpson, Alastair G. B.; Park, Jong Soo			Ecological and evolutionary patterns in the enigmatic protist genus Percolomonas (Heterolobosea; Discoba) from diverse habitats	PLOS ONE			English	Article							CRYPTIC DIVERSITY; N. SP.; AMOEBOZOA ARCELLINIDA; SALINITY PREFERENCE; MOLECULAR EVOLUTION; FRESH-WATER; FLAGELLATE; PHYLOGENY; AMEBA; ULTRASTRUCTURE	The heterotrophic flagellate Percolomonas cosmopolitus (Heterolobosea) is often observed in saline habitats worldwide, from coastal waters to saturated brines. However, only two cultures assigned to this morphospecies have been examined using molecular methods, and their 18S rRNA gene sequences are extremely different. Further the salinity tolerances of individual strains are unknown. Thus, our knowledge on the autecology and diversity in this morphospecies is deficient. Here, we report 18S rRNA gene data on seven strains similar to P. cosmopolitus from seven geographically remote locations (New Zealand, Kenya, Korea, Poland, Russia, Spain, and the USA) with sample salinities ranging from 4% to 280%, and compare morphology and salinity tolerance of the nine available strains. Percolomonas cosmopolitus-like strains show few-to-no consistent morphological differences, and form six clades separated by often extremely large 18S rRNA gene divergences (up to 42.4%). Some strains grow best at salinities from 75 to 125% and represent halophiles. All but one of these belong to two geographically heterogeneous clusters that form a robust monophyletic group in phylogenetic trees; this likely represents an ecologically specialized subclade of halophiles. Our results suggest that P. cosmopolitus is a cluster of several cryptic species (at least), which are unlikely to be distinguished by geography. Interestingly, the 9 Percolomonas strains formed a clade in 18S rRNA gene phylogenies, unlike most previous analyses based on two sequences.	[Tikhonenkov, Denis, V] Russian Acad Sci, Papanin Inst Biol Inland Waters, Borok, Russia; [Tikhonenkov, Denis, V] Russian Acad Sci, Zool Inst, St Petersburg, Russia; [Jhin, Soo Hwan; Park, Jong Soo] Kyungpook Natl Univ, Sch Earth Syst Sci, Res Inst Dok Do & Ulleung Do Isl, Dept Oceanog, Daegu, South Korea; [Jhin, Soo Hwan; Park, Jong Soo] Kyungpook Natl Univ, Sch Earth Syst Sci, Kyungpook Inst Oceanog, Daegu, South Korea; [Eglit, Yana; Miller, Kai; Simpson, Alastair G. B.] Dalhousie Univ, Dept Biol, Halifax, NS, Canada; [Plotnikov, Andrey] Inst Cellular & Intracellular Symbiosis UB RAS, Ctr Shared Sci Equipment Persistence Microorganis, Orenburg, Russia; [Simpson, Alastair G. B.] Canadian Inst Adv Res, Program Integrated Microbial Divers, Toronto, ON, Canada	Papanin Institute for Biology of Inland Waters; Russian Academy of Sciences; Russian Academy of Sciences; Zoological Institute of the Russian Academy of Sciences; Kyungpook National University; Kyungpook National University; Dalhousie University; Russian Academy of Sciences; Orenburg Federal Research Center of the Ural Branch of the Russian Academy of Sciences; Institute of Cellular & Intracellular Symbiosis; Canadian Institute for Advanced Research (CIFAR)	Park, JS (corresponding author), Kyungpook Natl Univ, Sch Earth Syst Sci, Res Inst Dok Do & Ulleung Do Isl, Dept Oceanog, Daegu, South Korea.	jongsoopark@knu.ac.kr	Tikhonenkov, Denis/ABA-4225-2020; Park, Jong Soo/AAJ-3576-2020; Tikhonenkov, Denis/E-9449-2014; Plotnikov, Andrey O./C-2198-2013	Tikhonenkov, Denis/0000-0002-4882-2148; Park, Jong Soo/0000-0001-6253-5199; Tikhonenkov, Denis/0000-0002-4882-2148; Plotnikov, Andrey O./0000-0001-6830-4068; Simpson, Alastair/0000-0002-4133-1709	National Institute of Biological Resources (NIBR) - Ministry of Education of the Republic of Korea [2016R1A6A1A05011910, 2017K2A9A1A06049946, 2019R1A2C200 2379, NIBR201801208]; National Institute of Biological Resources (NIBR) - Ministry of Environment (MOE) of the Republic of Korea [NIBR201801208]; Russian Foundation for Basic Research grant [18-504-51028]; Ministry of Education and Science of the Russian Federation grant [AAAA-A18-118012690098-5]; Natural Sciences and Engineering Research Council of Canada [298366-2014]; Basic Science Research Programs through the National Research Foundation of Korea (NRF)	National Institute of Biological Resources (NIBR) - Ministry of Education of the Republic of Korea; National Institute of Biological Resources (NIBR) - Ministry of Environment (MOE) of the Republic of Korea; Russian Foundation for Basic Research grant(Russian Foundation for Basic Research (RFBR)); Ministry of Education and Science of the Russian Federation grant; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Basic Science Research Programs through the National Research Foundation of Korea (NRF)	This research was supported by the Basic Science Research Programs through the National Research Foundation of Korea (NRF), a grant from the National Institute of Biological Resources (NIBR), funded by the Ministry of Education (2016R1A6A1A05011910, 2017K2A9A1A06049946, and 2019R1A2C200 2379) and the Ministry of Environment (MOE) of the Republic of Korea (NIBR201801208), respectively, all to J.S.P., a Russian Foundation for Basic Research grant (No 18-504-51028) and a Ministry of Education and Science of the Russian Federation grant (AAAA-A18-118012690098-5), both to D.V.T., and a Natural Sciences and Engineering Research Council of Canada Discovery Grant (298366-2014) to A.G.B.S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azovsky AI, 2016, PROTIST, V167, P411, DOI 10.1016/j.protis.2016.07.001; Bendif E, 2014, J PHYCOL, V50, P140, DOI 10.1111/jpy.12147; Beszteri B, 2005, PROTIST, V156, P317, DOI 10.1016/j.protis.2005.07.002; Bickford D, 2007, TRENDS ECOL EVOL, V22, P148, DOI 10.1016/j.tree.2006.11.004; Cavalier-Smith T, 2008, J EUKARYOT MICROBIOL, V55, P501, DOI 10.1111/j.1550-7408.2008.00356.x; Deane JA, 1998, EUR J PHYCOL, V33, P149, DOI 10.1017/S0967026298001553; Degerlund M, 2012, J PLANKTON RES, V34, P416, DOI 10.1093/plankt/fbs004; Fawley MW, 2015, PHYCOLOGIA, V54, P545, DOI 10.2216/15-60.1; Fenchel T, 2005, AQUAT MICROB ECOL, V41, P49, DOI 10.3354/ame041049; FENCHEL T, 1986, J MAR BIOL ASSOC UK, V66, P465, DOI 10.1017/S002531540004306X; Finlay BJ, 1999, PROTIST, V150, P229, DOI 10.1016/S1434-4610(99)70025-8; Finlay BJ, 2002, SCIENCE, V296, P1061, DOI 10.1126/science.1070710; Foissner W, 1999, PROTIST, V150, P363, DOI 10.1016/S1434-4610(99)70037-4; Fucikova K, 2014, J PHYCOL, V50, P14, DOI 10.1111/jpy.12118; Hanouskova P, 2019, J EUKARYOT MICROBIOL, V66, P120, DOI 10.1111/jeu.12637; Harding T, 2018, J EUKARYOT MICROBIOL, V65, P556, DOI 10.1111/jeu.12495; Harding T, 2013, PROTIST, V164, P272, DOI 10.1016/j.protis.2012.08.002; Heger TJ, 2013, MOL ECOL, V22, P5172, DOI 10.1111/mec.12449; Heger TJ, 2010, MOL PHYLOGENET EVOL, V55, P113, DOI 10.1016/j.ympev.2009.11.023; Jhin SH, 2019, J EUKARYOT MICROBIOL, V66, P221, DOI 10.1111/jeu.12664; John U, 2014, PROTIST, V165, P779, DOI 10.1016/j.protis.2014.10.001; Kaczmarska I, 2014, AM J BOT, V101, P267, DOI 10.3732/ajb.1300306; Karnkowska-Ishikawa A, 2010, J PHYCOL, V46, P172, DOI 10.1111/j.1529-8817.2009.00765.x; Katz LA, 2011, J MOL EVOL, V73, P266, DOI 10.1007/s00239-011-9468-x; Keelig PJ, 2002, EUR J PROTISTOL, V38, P279, DOI 10.1078/0932-4739-00874; Kim JI, 2013, J PHYCOL, V49, P82, DOI 10.1111/jpy.12018; Kim JI, 2010, J PHYCOL, V46, P1278, DOI 10.1111/j.1529-8817.2010.00910.x; Kirby WA, 2015, J EUKARYOT MICROBIOL, V62, P227, DOI 10.1111/jeu.12172; Koch TA, 2005, PROTIST, V156, P97, DOI 10.1016/j.protis.2004.12.001; Lahr DJG, 2014, BIOESSAYS, V36, P950, DOI 10.1002/bies.201400056; LARSEN J, 1990, J NAT HIST, V24, P801, DOI 10.1080/00222939000770571; Lee WJ, 2003, OPHELIA, V57, P63, DOI 10.1080/00785236.2003.10409506; MEDLIN L, 1988, GENE, V71, P491, DOI 10.1016/0378-1119(88)90066-2; Montresor M, 2003, PHYCOLOGIA, V42, P56, DOI 10.2216/i0031-8884-42-1-56.1; Mylnikov AP, 2016, BIOL BULL+, V43, P587, DOI 10.1134/S1062359016070128; Nikolaev SI, 2004, J EUKARYOT MICROBIOL, V51, P575, DOI 10.1111/j.1550-7408.2004.tb00294.x; Nylander JAA., 2004, MRMODELTEST 2 2; Oliverio AM, 2014, PROTIST, V165, P196, DOI 10.1016/j.protis.2014.02.001; Oren Aharon, 2008, Saline Syst, V4, P2, DOI 10.1186/1746-1448-4-2; PANEK T, 2012, DIVERSITY MICROORGAN, P3; Panek T, 2014, PROTIST, V165, P542, DOI 10.1016/j.protis.2014.05.005; Panek T, 2012, PROTIST, V163, P807, DOI 10.1016/j.protis.2011.11.002; Park JS, 2007, PROTIST, V158, P397, DOI 10.1016/j.protis.2007.03.004; Park JS, 2016, J EUKARYOT MICROBIOL, V63, P100, DOI 10.1111/jeu.12260; Park JS, 2015, PROTIST, V166, P422, DOI 10.1016/j.protis.2015.06.001; Park JS, 2012, J EUKARYOT MICROBIOL, V59, P601, DOI 10.1111/j.1550-7408.2012.00641.x; Park JS, 2012, EXTREMOPHILES, V16, P161, DOI 10.1007/s00792-011-0416-x; Park JS, 2011, PROTIST, V162, P691, DOI 10.1016/j.protis.2011.05.004; Park JS, 2010, ENVIRON MICROBIOL, V12, P1173, DOI 10.1111/j.1462-2920.2010.02158.x; Park JS, 2009, PROTIST, V160, P265, DOI 10.1016/j.protis.2008.10.002; POST FJ, 1983, HYDROBIOLOGIA, V105, P95, DOI 10.1007/BF00025180; Ristau K, 2013, MOL ECOL, V22, P4562, DOI 10.1111/mec.12414; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; RUINEN JAKOBA, 1938, ARCH PRO TISTENK, V90, P210; Saez AG, 2003, P NATL ACAD SCI USA, V100, P7163, DOI 10.1073/pnas.1132069100; Santoferrara LF, 2015, PROTIST, V166, P78, DOI 10.1016/j.protis.2014.11.005; Scheckenbach F, 2006, APPL ENVIRON MICROB, V72, P6638, DOI 10.1128/AEM.02547-05; Skaloud P, 2013, J EUKARYOT MICROBIOL, V60, P350, DOI 10.1111/jeu.12040; Sogin Mitchell L., 1996, V54, P167; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stoupin D, 2012, EUR J PROTISTOL, V48, P263, DOI 10.1016/j.ejop.2012.01.004; Tong SM, 1997, MAR BIOL, V128, P517, DOI 10.1007/s002270050118; Trewick SA, 1998, BIOL J LINN SOC, V63, P307, DOI 10.1006/bijl.1997.0197; von der Heyden S, 2004, J EUKARYOT MICROBIOL, V51, P402; Whittaker KA, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-209; Yubuki N, 2008, EUR J PROTISTOL, V44, P241, DOI 10.1016/j.ejop.2007.12.001	66	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2019	14	8							e0216188	10.1371/journal.pone.0216188	http://dx.doi.org/10.1371/journal.pone.0216188			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW6AB	31465455	Green Published, gold, Green Submitted			2022-12-26	WOS:000485058200002
J	Amosova, AV; Zoshchuk, SA; Volovik, VT; Shirokova, AV; Horuzhiy, NE; Mozgova, GV; Yurkevich, OY; Artyukhova, MA; Lemesh, VA; Samatadze, TE; Muravenko, OV				Amosova, Alexandra, V; Zoshchuk, Svyatoslav A.; Volovik, Valentina T.; Shirokova, Anna, V; Horuzhiy, Nickolai E.; Mozgova, Galina, V; Yurkevich, Olga Yu; Artyukhova, Margarita A.; Lemesh, Valentina A.; Samatadze, Tatiana E.; Muravenko, Olga, V			Phenotypic, biochemical and genomic variability in generations of the rapeseed (Brassica napus L.) mutant lines obtained via chemical mutagenesis	PLOS ONE			English	Article							ERUCIC-ACID CONTENT; OLEIC-ACID; DIETARY RECOMMENDATIONS; GENETIC DIVERSITY; MARKERS; IDENTIFICATION; CANOLA; HYBRIDIZATION; SUBSTITUTION; INHERITANCE	The phenotypic, biochemical and genetic variability was studied in M2-M5 generations of ethyl methansulfonat (EMS, 0.2%) mutagenized rapeseed lines generated from canola, '00', B. napus cv. Vikros. EMS mutagenesis induced extensive diversity in morphological and agronomic traits among mutant progeny resulted in selection of EMS populations of B. napus- and B. rapa-morphotypes. The seeds of the obtained mutant lines were high-protein, low in oil and stabilized in contents of main fatty acids which make them useful for feed production. Despite the increased level of various meiotic abnormalities revealed in EMS populations, comparative karyotype analysis and FISH-based visualization of 45S and 5S rDNA indicated a high level of karyotypic stability in M2-M5 plants, and therefore, the obtained mutant lines could be useful in further rapeseed improvement. The revealed structural chromosomal reorganizations in karyotypes of several plants of B. rapa-type indicate that rapeseed breeding by chemical mutagenesis can result in cytogenetic instability in the mutant progeny, and therefore, it should include the karyotype examination. Our findings demonstrate that EMS at low concentrations has great potential in rapeseed improvement.	[Amosova, Alexandra, V; Zoshchuk, Svyatoslav A.; Yurkevich, Olga Yu; Artyukhova, Margarita A.; Samatadze, Tatiana E.; Muravenko, Olga, V] Russian Acad Sci, Engelhardt Inst Mol Biol, Moscow, Russia; [Volovik, Valentina T.] Fed Williams Res Ctr Forage Prod & Agroecol, Lobnya, Moscow Region, Russia; [Shirokova, Anna, V] Russian Acad Sci, Koltzov Inst Dev Biol, Moscow, Russia; [Horuzhiy, Nickolai E.; Mozgova, Galina, V; Lemesh, Valentina A.] Natl Acad Sci Belarus, Inst Genet & Cytol, Minsk, BELARUS	Russian Academy of Sciences; Engelhardt Institute of Molecular Biology, RAS; Russian Academy of Sciences; Koltzov Institute of Developmental Biology of the Russian Academy of Sciences; National Academy of Sciences of Belarus (NASB); Institute of Genetics & Cytology of the National Academy of Sciences of Belarus	Amosova, AV (corresponding author), Russian Acad Sci, Engelhardt Inst Mol Biol, Moscow, Russia.	amomar@mail.ru	Yurkevich, Olga Yu./CAI-2654-2022; Yurkevich, Olga Yu./CAF-7659-2022; Tatiana, Samatadze/AAD-4816-2019	Yurkevich, Olga Yu./0000-0003-4124-2367; Yurkevich, Olga Yu./0000-0003-4124-2367; Tatiana, Samatadze/0000-0002-1012-3560; amosova, alexandra/0000-0002-5208-6702; Artyukhova, Margarita/0000-0001-7946-0744	Russian Foundation for Basic Research [17-29-08034ofi_m]; Program of Fundamental Research for State Academies [0120136 3824]	Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Program of Fundamental Research for State Academies	This work was supported by the Russian Foundation for Basic Research, No. 17-29-08034ofi_m, to OVM, and the Program of Fundamental Research for State Academies, No. 0120136 3824, to OVM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akif'ev A. P., 1996, Radiatsionnaya Biologiya Radioekologiya, V36, P789; Albertin W, 2006, GENETICS, V173, P1101, DOI 10.1534/genetics.106.057554; Amosova AV, 2017, EUPHYTICA, V213, DOI 10.1007/s10681-017-2009-y; Amosova AV, 2014, J GENET, V93, P133, DOI 10.1007/s12041-014-0351-6; AULD DL, 1992, CROP SCI, V32, P657, DOI 10.2135/cropsci1992.0011183X003200030016x; Barret P, 1998, THEOR APPL GENET, V96, P177, DOI 10.1007/s001220050725; Barthes L, 2001, GENOME, V44, P929, DOI 10.1139/gen-44-5-929; Bhat T.A., 2017, CHROMOSOME STRUCTURE, P219, DOI [10.1007/978-81-322-3673-3_11, DOI 10.1007/978-81-322-3673-3_11]; Bocianowski J, 2012, J APPL GENET, V53, P27, DOI 10.1007/s13353-011-0062-0; Browse J, 1998, PLANT LIPID BIOSYNTH, P131; Bus A, 2011, THEOR APPL GENET, V123, P1413, DOI 10.1007/s00122-011-1676-7; Cheung WY, 1997, THEOR APPL GENET, V94, P569, DOI 10.1007/s001220050453; Delourme R, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-120; DIERS BW, 1994, THEOR APPL GENET, V88, P662, DOI 10.1007/BF01253968; Fourmann M, 1998, THEOR APPL GENET, V96, P852, DOI 10.1007/s001220050812; Gaeta RT, 2007, PLANT CELL, V19, P3403, DOI 10.1105/tpc.107.054346; Gebauer SK, 2006, AM J CLIN NUTR, V83, p1526S, DOI 10.1093/ajcn/83.6.1526S; GERLACH WL, 1980, NUCLEIC ACIDS RES, V8, P4851, DOI 10.1093/nar/8.21.4851; GERLACH WL, 1979, NUCLEIC ACIDS RES, V7, P1869, DOI 10.1093/nar/7.7.1869; Gilchrist EJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084303; Girke A, 2012, GENET RESOUR CROP EV, V59, P1441, DOI 10.1007/s10722-011-9772-8; Golubovskaya I N, 1979, Int Rev Cytol, V58, P247, DOI 10.1016/S0074-7696(08)61477-1; HARVEY BL, 1964, CAN J PLANT SCI, V44, P104, DOI 10.4141/cjps64-019; Hasterok Robert, 2000, Journal of Applied Genetics, V41, P1; Howell EC, 2002, GENETICS, V161, P1225; Howell EC, 2008, GENETICS, V180, P1849, DOI 10.1534/genetics.108.095893; Howell PM, 1996, GENOME, V39, P348, DOI 10.1139/g96-045; Hu XY, 2006, THEOR APPL GENET, V113, P497, DOI 10.1007/s00122-006-0315-1; Iniguez-Luy F, 2011, GENETICS GENOMICS BR, P215; JAYABALAN N, 1987, CYTOLOGIA, V52, P1, DOI 10.1508/cytologia.52.1; Jesske T, 2013, THEOR APPL GENET, V126, P1053, DOI 10.1007/s00122-012-2036-y; Johnson GH, 2007, J AM DIET ASSOC, V107, P1726, DOI 10.1016/j.jada.2007.07.015; Jourdren C, 1996, EUPHYTICA, V90, P351, DOI 10.1007/BF00027487; Katavic V, 2002, EUR J BIOCHEM, V269, P5625, DOI 10.1046/j.1432-1033.2002.03270.x; Kharkwal MC, 2004, PLANT BREEDING: MENDELIAN TO MOLECULAR APPROACHES, P601; Korneichuk VA, 1983, MANUAL BRASSICA NAPU; Lauridsen C, 1999, J ANIM SCI, V77, P105; LEVAN A, 1964, HEREDITAS-GENETISK A, V52, P201, DOI 10.1111/j.1601-5223.1964.tb01953.x; Mason AS, 2016, PLANT BIOLOGY, V18, P883, DOI 10.1111/plb.12462; McDonald BE, 1995, BRASSICA OILSEEDS PR, P291; Mensah JK, 2007, AFR J BIOTECHNOL, V6, P668; Mikolajczyk K, 2010, PLANT BREEDING, V129, P502, DOI 10.1111/j.1439-0523.2009.01730.x; Mitra P. K., 1996, J CYTOLOGY GENETICS, V31, P205; Mizuno Y, 2014, PLANT BIOTECHNOL-NAR, V31, P185, DOI 10.5511/plantbiotechnology.14.0109b; Muravenko OV, 2009, GENETICA, V135, P245, DOI 10.1007/s10709-008-9273-7; Muravenko OV, 2003, CYTOM PART A, V51A, P52, DOI 10.1002/cyto.a.10002; Napier JA, 2014, CURR OPIN PLANT BIOL, V19, P68, DOI 10.1016/j.pbi.2014.04.001; OHLROGGE J, 1995, PLANT CELL, V7, P957, DOI 10.1105/tpc.7.7.957; Parkin IAP, 1995, GENOME, V38, P1122, DOI 10.1139/g95-149; Przybylski R, 2013, J AM OIL CHEM SOC, V90, P1271, DOI 10.1007/s11746-013-2278-0; Rajib Roychowdhury, 2011, Current Botany, V2, P19; Ramsey J, 1998, ANNU REV ECOL SYST, V29, P467, DOI 10.1146/annurev.ecolsys.29.1.467; Rapoport IA, 1966, SUPER MUTAGENS; Rapoport IA., 1993, DISCOVERY CHEM MUTAG; Samatadze TE, 2012, BIOL BULL+, V39, P515, DOI 10.1134/S1062359012060106; Samatadze TE, 2018, GENET RESOUR CROP EV, V65, P1637, DOI 10.1007/s10722-018-0640-7; SCARTH R, 1988, CAN J PLANT SCI, V68, P509, DOI 10.4141/cjps88-061; Scarth R., 1994, CAN J PLANT SCI, V75, P203, DOI DOI 10.4141/CJPS95-037; Scheffler JA, 1997, THEOR APPL GENET, V94, P583, DOI 10.1007/s001220050454; Schierholt A, 2001, CROP SCI, V41, P1444, DOI 10.2135/cropsci2001.4151444x; Schierholt A, 2000, THEOR APPL GENET, V101, P897, DOI 10.1007/s001220051559; Sharafi Y, 2015, INT J FOOD PROP, V18, P2145, DOI 10.1080/10942912.2014.968284; Shu QY, 2012, PLANT MUTATION BREEDING AND BIOTECHNOLOGY, P301, DOI 10.1079/9781780640853.0301; Snowdon R., 2007, Oilseeds, P55; Snowdon RJ, 2002, THEOR APPL GENET, V104, P533, DOI 10.1007/s00122-001-0787-y; Soltis PS, 2009, ANNU REV PLANT BIOL, V60, P561, DOI 10.1146/annurev.arplant.043008.092039; SOMERVILLE C, 1991, SCIENCE, V252, P80, DOI 10.1126/science.252.5002.80; SONG K, 1992, GENOME, V35, P992, DOI 10.1139/g92-152; SONG KM, 1995, P NATL ACAD SCI USA, V92, P7719, DOI 10.1073/pnas.92.17.7719; Spasibionek S, 2006, PLANT BREEDING, V125, P259, DOI 10.1111/j.1439-0523.2006.01213.x; STEFANSSON BR, 1975, CAN J PLANT SCI, V55, P343, DOI 10.4141/cjps75-053; Tah P. R., 2006, International Journal of Botany, V2, P219; Tanhuanpaa P, 1998, MOL BREEDING, V4, P543, DOI 10.1023/A:1009642317634; Tomlekova N, 2014, IMPROVEMENT CROPS ER, P217, DOI [10.1007/978-1-4614-8824-8-9, DOI 10.1007/978-1-4614-8824-8_9, DOI 10.1007/978-1-4614-8824-8-9]; U. N., 1935, Japanese Journal of Botany, V7, P389; Wang N, 2008, NEW PHYTOL, V180, P751, DOI 10.1111/j.1469-8137.2008.02619.x; Wu J, 2014, BREEDING SCI, V64, P321, DOI 10.1270/jsbbs.64.321; Xiong ZY, 2011, P NATL ACAD SCI USA, V108, P7908, DOI 10.1073/pnas.1014138108; Yang QY, 2012, THEOR APPL GENET, V125, P715, DOI 10.1007/s00122-012-1863-1; Zeerak N. A., 1992, Phytomorphology, V42, P81; Zheng JS, 2015, PLANT SYST EVOL, V301, P1781, DOI 10.1007/s00606-014-1177-7; Zhu B, 2016, GENETICS, V204, P1015, DOI 10.1534/genetics.116.190967; Zou Jun, 2011, Genetics, genomics and breeding of oilseed brassicas, P158	83	6	6	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2019	14	8							e0221699	10.1371/journal.pone.0221699	http://dx.doi.org/10.1371/journal.pone.0221699			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5XV	31461492	Green Submitted, gold, Green Published			2022-12-26	WOS:000485052300046
J	Bocheux, R; Pernot, P; Borderie, V; Plamann, K; Irsch, K				Bocheux, Romain; Pernot, Pascal; Borderie, Vincent; Plamann, Karsten; Irsch, Kristina			Quantitative measures of corneal transparency, derived from objective analysis of depth-resolved corneal images, demonstrated with full-field optical coherence tomographic microscopy	PLOS ONE			English	Article							IN-VIVO; KERATOMILEUSIS	Loss of corneal transparency, as occurs with various pathologies, infections, immune reactions, trauma, aging, and surgery, is a major cause of visual handicap worldwide. However, current means to assess corneal transparency are extremely limited and clinical and eye-bank practice usually involve a subjective and qualitative observation of opacities, sometimes with comparison against an arbitrary grading scale, by means of slit-lamp biomicroscopy. Here, we describe a novel objective optical data analysis-based method that enables quantifiable and standardized characterization of corneal transparency from depth-resolved corneal images, addressing the demand for such a means in both the laboratory and clinical ophthalmology setting. Our approach is based on a mathematical analysis of the acquired optical data with respect to the light attenuation from scattering processes in the corneal stroma. Applicable to any depth-resolved corneal imaging modality, it has been validated by means of full-field optical coherence tomographic microscopy (FF-OCT or FF-OCM). Specifically, our results on ex-vivo corneal specimens illustrate that 1) in homogeneous tissues, characterized by an exponential light attenuation with stromal depth (z), the computation of the scattering mean-free path (l(s)) from the rate of exponential decay allows quantification of the degree of transparency; 2) in heterogeneous tissues, identified by significant deviations from the normal exponential z -profile, a measure of exponential-decay model inadequacy (e.g., by computation of the Birge ratio) allows the estimation of severity of stromal heterogeneity, and the associated depth-dependent variations around the average l(s) enables precise localization of the pathology.	[Bocheux, Romain; Plamann, Karsten] Inst Polytech Paris, LOB, Ecole Polytech, CNRS UMR 7645,INSERM 1182, Palaiseau, France; [Bocheux, Romain; Plamann, Karsten] Inst Polytech Paris, Ecole Polytech, LOA ENSTA ParisTech, CNRS UMR 7639, Palaiseau, France; [Bocheux, Romain; Borderie, Vincent; Irsch, Kristina] Sorbonne Univ, Vis Inst, Quinze Vingts Natl Eye Hosp, GRC32,CIC1423,CNRS UMR 7210,INSERM U968, Paris, France; [Pernot, Pascal] Univ Paris Sud, Lab Chim Phys, CNRS UMR 8000, Orsay, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut Polytechnique de Paris; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); Institut Polytechnique de Paris; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); CHNO des Quinze-Vingts; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universite Paris Saclay	Irsch, K (corresponding author), Sorbonne Univ, Vis Inst, Quinze Vingts Natl Eye Hosp, GRC32,CIC1423,CNRS UMR 7210,INSERM U968, Paris, France.	kristina.irsch@inserm.fr	PERNOT, Pascal/M-3709-2019; Borderie, Vincent/AAT-1092-2021	PERNOT, Pascal/0000-0001-8586-6222; Borderie, Vincent/0000-0002-1395-8483; Irsch, Kristina/0000-0003-2525-4288	European Union [709104]; Fondation de l'Avenir pour la recherche medicale; LabEx PALM	European Union(European Commission); Fondation de l'Avenir pour la recherche medicale; LabEx PALM	This work has received funding from the European Union's Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie grant agreement No. 709104 (KI), from the Fondation de l'Avenir pour la recherche medicale (KP, KI), and from the LabEx PALM (KP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, TEXTS STAT SCI SERIE; Beaurepaire E, 1998, OPT LETT, V23, P244, DOI 10.1364/OL.23.000244; Braunstein RE, 1996, OPHTHALMOLOGY, V103, P439; Dubois A, 2002, APPL OPTICS, V41, P805, DOI 10.1364/AO.41.000805; FANTES FE, 1990, ARCH OPHTHALMOL-CHIC, V108, P665, DOI 10.1001/archopht.1990.01070070051034; Garg P, 2005, EYE, V19, P1106, DOI 10.1038/sj.eye.6701968; Gelman A, 2015, J EDUC BEHAV STAT, V40, P530, DOI 10.3102/1076998615606113; Ghouali W, 2015, CURR EYE RES, V40, P526, DOI 10.3109/02713683.2014.935444; HUANG D, 1991, SCIENCE, V254, P1178, DOI 10.1126/science.1957169; Irsch K, 2015, P FIO; Irsch K, 2019, J VIS EXP; IZATT JA, 1994, ARCH OPHTHALMOL-CHIC, V112, P1584, DOI 10.1001/archopht.1994.01090240090031; Lohmann C P, 1992, Refract Corneal Surg, V8, P114; MAURICE DM, 1957, J PHYSIOL-LONDON, V136, P263, DOI 10.1113/jphysiol.1957.sp005758; Mazlin V, 2018, BIOMED OPT EXPRESS, V9, P557, DOI 10.1364/BOE.9.000557; O'Donnell Clare, 2004, Cont Lens Anterior Eye, V27, P161, DOI 10.1016/j.clae.2004.08.001; Pisella PJ, 2001, OPHTHALMOLOGY, V108, P1744, DOI 10.1016/S0161-6420(01)00771-0; Plamann K, 2010, J OPTICS-UK, V12, DOI 10.1088/2040-8978/12/8/084002; Stave J, 2002, OPHTHALMOLOGE, V99, P276, DOI 10.1007/s003470100535; SWANSON EA, 1993, OPT LETT, V18, P1864, DOI 10.1364/OL.18.001864; van de Pol C, 2001, AM J OPHTHALMOL, V132, P204, DOI 10.1016/S0002-9394(01)01003-0; Wang JH, 2004, INVEST OPHTH VIS SCI, V45, P3493, DOI 10.1167/iovs.04-0096; Whitcher JP, 2001, B WORLD HEALTH ORGAN, V79, P214	23	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2019	14	8							e0221707	10.1371/journal.pone.0221707	http://dx.doi.org/10.1371/journal.pone.0221707			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5XV	31461476	Green Submitted, Green Published, gold			2022-12-26	WOS:000485052300047
J	Flemming, SA; Nol, E; Kennedy, LV; Bedard, A; Giroux, MA; Smith, PA				Flemming, Scott A.; Nol, Erica; Kennedy, Lisa, V; Bedard, Audrey; Giroux, Marie-Andree; Smith, Paul A.			Spatio-temporal responses of predators to hyperabundant geese affect risk of predation for sympatric-nesting species	PLOS ONE			English	Article							PEAK FOOD AVAILABILITY; MEDIATED INTERACTIONS; NUMERICAL RESPONSES; CAPE CHURCHILL; CLIMATE-CHANGE; CHICK GROWTH; SNOW GEESE; PREY; BIRDS; SURVIVAL	The Arctic is undergoing rapid changes, with anthropogenic shifts in climate having important and well-documented impacts on habitat. Populations of predators and their prey are affected by changing climate and other anthropogenic factors, and these changing trophic interactions could have profound effects on breeding populations of Arctic birds. Variable abundance of lemmings (a primary prey of generalist Arctic predators) and increasing abundance of light geese (Lesser Snow and Ross' Geese; a secondary prey) could have negative consequences for numerous sympatric shorebirds (an incidental prey). Using 16 years of predator-prey observations and 13-years of shorebird nest survival data at a site near a goose colony we identify relationships among geese, lemmings, and their shared predators and then relate predator indices to shorebird risk of nest predation. During two years, we also placed time-lapse cameras and artificial shorebird nests at increasing distances from a goose colony to document spatial trends in predators and their effect on risk of predation. In the long-term data, yearly indices of light geese positively influenced indices of gulls and jaegers, and shorebird nest predation rate was negatively correlated with jaeger and fox indices. All three predator indices were highest near the goose colony and artificial nest predation probability was negatively correlated with distance from goose colony, but these effects were less apparent during the second year. Combined, these results highlight the variation in predator-mediated interactions between geese and shorebirds and outline one mechanism by which hyperabundant geese may be contributing to local or regional declines in Arctic-nesting shorebird populations.	[Flemming, Scott A.; Kennedy, Lisa, V] Trent Univ, Environm & Life Sci, Peterborough, ON, Canada; [Nol, Erica] Trent Univ, Biol Dept, Peterborough, ON, Canada; [Bedard, Audrey; Giroux, Marie-Andree] Univ Moncton, Dept Chim & Biochim, New Brunswick, NJ USA; [Smith, Paul A.] Environm & Climate Change Canada, Natl Wildlife Res Ctr, Ottawa, ON, Canada; [Flemming, Scott A.] Environm & Climate Change Canada, Canadian Wildlife Serv, Gatineau, PQ, Canada	Trent University; Trent University; Environment & Climate Change Canada; Canadian Wildlife Service; National Wildlife Research Centre - Canada; Environment & Climate Change Canada; Canadian Wildlife Service	Flemming, SA (corresponding author), Trent Univ, Environm & Life Sci, Peterborough, ON, Canada.; Flemming, SA (corresponding author), Environm & Climate Change Canada, Canadian Wildlife Serv, Gatineau, PQ, Canada.	scott.flemming@canada.ca			Environment and Climate Change Canada; Natural Sciences and Engineering Research Council of Canada; Ontario Graduate Scholarship; W. Garfield Weston Award for Northern Research; Arctic Goose Joint Venture	Environment and Climate Change Canada; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Ontario Graduate Scholarship(Ontario Graduate Scholarship); W. Garfield Weston Award for Northern Research; Arctic Goose Joint Venture	This study was funded by Environment and Climate Change Canada, Natural Sciences and Engineering Research Council of Canada (SAF), Ontario Graduate Scholarship (SAF), and the W. Garfield Weston Award for Northern Research (SAF). Support for this research was also provided by the Arctic Goose Joint Venture. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham KF, 2005, GLOBAL CHANGE BIOL, V11, P841, DOI 10.1111/j.1365-2486.2005.00943.x; Abraham KF, 2005, ARCT ANTARCT ALP RES, V37, P269, DOI 10.1657/1523-0430(2005)037[0269:GCIVAL]2.0.CO;2; Abrams PA, 1996, ECOLOGY, V77, P610, DOI 10.2307/2265634; Alisauskas RT, 2011, WILDLIFE MONOGR, P1, DOI 10.1002/wmon.5; Andres BA, 2012, ARCTIC, V65, P411; Baldwin FB, 2011, AUK, V128, P404, DOI 10.1525/auk.2011.10266; Ballantyne K, 2011, WATERBIRDS, V34, P151, DOI 10.1675/063.034.0203; Bart J, 2007, J AVIAN BIOL, V38, P73, DOI 10.1111/j.2007.0908-8857.03698.x; Batt B., 1997, ARCTIC ECOSYSTEMS PE; Bentzen R, 2017, POLAR BIOL, V40, P1527, DOI 10.1007/s00300-017-2074-7; Bety J, 2002, J ANIM ECOL, V71, P88, DOI 10.1046/j.0021-8790.2001.00581.x; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Clinchy M, 2004, P ROY SOC B-BIOL SCI, V271, P2473, DOI 10.1098/rspb.2004.2913; Corkery CA, 2019, POLAR BIOL, V42, P593, DOI 10.1007/s00300-019-02456-w; Fauteux Dominique, 2018, ECOSPHERE, V9, pe02124; Flemming SA, 2019, ECOSPHERE, V10, DOI 10.1002/ecs2.2785; Flemming SA, 2019, J APPL ECOL, V56, P976, DOI 10.1111/1365-2664.13336; Flemming SA, 2016, ENVIRON REV, V24, P393, DOI 10.1139/er-2016-0007; Fraser JD, 2013, CAN J ZOOL, V91, P13, DOI 10.1139/cjz-2012-0233; Gaston AJ, 1997, ARCTIC, V50, P101; Gilg O, 2006, OIKOS, V113, P193, DOI 10.1111/j.2006.0030-1299.14125.x; Gilg O, 2009, GLOBAL CHANGE BIOL, V15, P2634, DOI 10.1111/j.1365-2486.2009.01927.x; Giroux MA, 2012, J ANIM ECOL, V81, P533, DOI 10.1111/j.1365-2656.2011.01944.x; Hochachka WM, 2000, CONFID INTERVALS, V78, P9; HOLT RD, 1977, THEOR POPUL BIOL, V12, P197, DOI 10.1016/0040-5809(77)90042-9; Kausrud KL, 2008, NATURE, V456, P93, DOI 10.1038/nature07442; Kerbes, 2014, SURVEYS NESTING LESS; Lamarre JF, 2017, ECOSPHERE, V8, DOI 10.1002/ecs2.1788; Latham ADM, 2013, ECOGRAPHY, V36, P1276, DOI 10.1111/j.1600-0587.2013.00035.x; Leafloor J. O., 2012, EVALUATION SPECIAL M; Legagneux P, 2012, ECOLOGY, V93, P1707, DOI 10.1890/11-1973.1; Liebezeit JR, 2009, ECOL APPL, V19, P1628, DOI 10.1890/08-1661.1; Liebezeit JR, 2007, CONDOR, V109, P32, DOI 10.1650/0010-5422(2007)109[32:ATDOSE]2.0.CO;2; Lima SL, 2009, BIOL REV, V84, P485, DOI 10.1111/j.1469-185X.2009.00085.x; McGowan CP, 2015, CONDOR, V117, P494, DOI 10.1650/CONDOR-15-9.1; McKinnon L, 2012, CAN J ZOOL, V90, P961, DOI 10.1139/Z2012-064; Mckinnon L, 2010, SCIENCE, V328, P46, DOI 10.1126/science.328.5974.46-b; McKinnon L, 2010, SCIENCE, V327, P326, DOI 10.1126/science.1183010; McKinnon L, 2014, AUK, V131, P619, DOI 10.1642/AUK-13-154.1; McKinnon L, 2013, OIKOS, V122, P1042, DOI 10.1111/j.1600-0706.2012.20708.x; McKinnon L, 2009, J FIELD ORNITHOL, V80, P280, DOI 10.1111/j.1557-9263.2009.00231.x; Meltofte H., 2007, MEDDELELSER GRONLAND; Pedersen AO, 2018, POLAR BIOL, V41, P619, DOI 10.1007/s00300-017-2223-z; Post E, 2009, SCIENCE, V325, P1355, DOI 10.1126/science.1173113; Reiteri ME, 2011, WILSON J ORNITHOL, V123, P266, DOI 10.1676/10-097.1; Reneerkens J, 2016, ECOL EVOL, V6, P7375, DOI 10.1002/ece3.2361; Roth JD, 2003, J ANIM ECOL, V72, P668, DOI 10.1046/j.1365-2656.2003.00739.x; Saalfeld ST, 2019, ECOL EVOL, V9, P6693, DOI 10.1002/ece3.5248; Samelius G, 1999, CAN J ZOOL, V77, P1327, DOI 10.1139/cjz-77-8-1327; Sammler JE, 2008, CONDOR, V110, P325, DOI 10.1525/cond.2008.8438; Schartel TE, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151483; Schmidt NM, 2012, P ROY SOC B-BIOL SCI, V279, P4417, DOI 10.1098/rspb.2012.1490; Senner NR, 2017, OIKOS, V126, P61, DOI 10.1111/oik.03325; Skinner WR, 1998, GLOB CHANGE BIOL, V4, P3, DOI 10.1046/j.1365-2486.1998.00097.x; Smith PA, 2012, ANIM BEHAV, V84, P835, DOI 10.1016/j.anbehav.2012.07.004; Smith PA, 2012, WATERBIRDS, V35, P106, DOI 10.1675/063.035.0111; Smith PA, 2010, OECOLOGIA, V163, P613, DOI 10.1007/s00442-010-1644-y; Smith PA, 2007, CONDOR, V109, P15; Travers M, 2010, ECOL LETT; Walpole B, 2008, CAN J ZOOL, V86, P1346, DOI 10.1139/Z08-119; Weiser EL, 2018, IBIS, V160, P608, DOI 10.1111/ibi.12571; Wilson DJ, 2001, CAN J ZOOL, V79, P525, DOI 10.1139/cjz-79-3-525; Zanette LY, 2011, SCIENCE, V334, P1398, DOI 10.1126/science.1210908	63	7	8	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2019	14	8							e0221727	10.1371/journal.pone.0221727	http://dx.doi.org/10.1371/journal.pone.0221727			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5XV	31461483	Green Published, Green Submitted, gold			2022-12-26	WOS:000485052300049
J	Kinyanyi, D; Amwayi, P; Wamalwa, M; Obiero, G				Kinyanyi, Dickson; Amwayi, Peris; Wamalwa, Mark; Obiero, George			Comparative in silico study of congocidine congeners as potential inhibitors of African swine fever virus	PLOS ONE			English	Article							MINOR-GROOVE; VACCINIA VIRUS; DISTAMYCIN-A; B-DNA; BINDING; NETROPSIN; PROTEIN; DRUGS; CONFORMATION; RECOGNITION	African swine fever virus (ASFV) infection is fatal in domesticated pigs, with a mortality rate approaching 100%. This may result in economic losses and threats to food security. Currently, there are no approved vaccines or antiviral therapies for ASFV. Therefore, in this study, we evaluated congocidine congeners and a tris-benzimidazole as potential inhibitors of ASFV transcription using an in silico approach. We applied redocking of congocidine and docking of its congeners and a tris-benzimidazole to a receptor containing B-DNA with AT-motifs as a target to mimic conserved ASFV late gene promoters. Subsequently, the binding scores of DNA-ligand docked complexes were evaluated and their binding affinity was estimated. Molecular dynamics (MD) simulation was then used to assess ligand behavior within the minor groove. From our results, it is evident the less toxic congocidine congeners and tris-benzimidazole could dock to AT-rich regions significantly. Additionally, the predicted binding affinities had suitable values comparable to other experimentally determined minor groove binders, MD simulation of the docked DNA-ligand complexes and subsequent molecular trajectory visualization further showed that the ligands remained embedded in the minor groove during the time course of simulation, indicating that these ligands may have potential applications in abrogating ASFV transcription.	[Kinyanyi, Dickson; Amwayi, Peris] Tech Univ Kenya, Dept Biochem & Biotechnol, Nairobi, Kenya; [Wamalwa, Mark] Kenyatta Univ, Dept Biochem & Biotechnol, Nairobi, Kenya; [Obiero, George] Univ Nairobi, Ctr Biotechnol & Bioinformat, Nairobi, Kenya	Technical University of Kenya; Kenyatta University; University of Nairobi	Kinyanyi, D (corresponding author), Tech Univ Kenya, Dept Biochem & Biotechnol, Nairobi, Kenya.	dkinyanyi@gmail.com		Wamalwa, Mark/0000-0001-7714-2697				ABAGYAN R, 1994, J MOL BIOL, V235, P983, DOI 10.1006/jmbi.1994.1052; ABAGYAN R, 1994, J COMPUT CHEM, V15, P488, DOI 10.1002/jcc.540150503; Abrescia NGA, 1999, NUCLEIC ACIDS RES, V27, P1593, DOI 10.1093/nar/27.7.1593; Aymami J, 1999, NUCLEIC ACIDS RES, V27, P2691, DOI 10.1093/nar/27.13.2691; Bavan S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092064; BECKER Y, 1972, ANTIMICROB AGENTS CH, V1, P483, DOI 10.1128/AAC.1.6.483; BEERMAN TA, 1991, BIOCHIM BIOPHYS ACTA, V1090, P52, DOI 10.1016/0167-4781(91)90036-L; BELLORINI M, 1995, NUCLEIC ACIDS RES, V23, P1657, DOI 10.1093/nar/23.10.1657; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; BIALER M, 1980, J MED CHEM, V23, P1144, DOI 10.1021/jm00184a018; Bowers K. J., 2006, P 2006 ACM IEEE C SU, P43, DOI DOI 10.1145/1188455.1188544; Broyles SS, 2004, J VIROL, V78, P2137, DOI 10.1128/JVI.78.4.2137-2141.2004; CARRONDO MAAFDT, 1989, BIOCHEMISTRY-US, V28, P7849, DOI 10.1021/bi00445a047; Chacon MR, 1995, VIROLOGY, V214, P670, DOI 10.1006/viro.1995.0083; CHIANG SY, 1994, BIOCHEMISTRY-US, V33, P7033, DOI 10.1021/bi00189a003; COLL M, 1989, BIOCHEMISTRY-US, V28, P310, DOI 10.1021/bi00427a042; Daina A, 2017, SCI REP-UK, V7, DOI 10.1038/srep42717; Fuchs JE, 2011, J CHEM INF MODEL, V51, P2223, DOI 10.1021/ci200237c; Galindo I, 2000, J GEN VIROL, V81, P59, DOI 10.1099/0022-1317-81-1-59; Galindo I, 2015, VIRUS RES, V200, P45, DOI 10.1016/j.virusres.2015.01.022; Garcia-Escudero R, 2000, J VIROL, V74, P8176, DOI 10.1128/JVI.74.17.8176-8182.2000; GEIERSTANGER BH, 1995, ANNU REV BIOPH BIOM, V24, P463, DOI 10.1146/annurev.bb.24.060195.002335; GRESH N, 1984, MOL PHARMACOL, V25, P452; HARSHMAN KD, 1985, NUCLEIC ACIDS RES, V13, P4825, DOI 10.1093/nar/13.13.4825; Hernaez B, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005595; Kelly C, 2011, J DRUG DELIV, V2011, DOI 10.1155/2011/727241; Kim S, 2016, NUCLEIC ACIDS RES, V44, pD1202, DOI 10.1093/nar/gkv951; Kinyanyi D, 2018, PEERJ, V6, DOI 10.7717/peerj.4396; Knutson BA, 2006, J VIROL, V80, P6784, DOI 10.1128/JVI.02705-05; Lam PCH, 2018, J COMPUT AID MOL DES, V32, P187, DOI 10.1007/s10822-017-0058-x; LOWN JW, 1989, J MED CHEM, V32, P2368, DOI 10.1021/jm00130a024; Murphy KJ, 2014, NUTRIENTS, V6, P682, DOI 10.3390/nu6020682; Nelson SM, 2007, MUTAT RES-FUND MOL M, V623, P24, DOI 10.1016/j.mrfmmm.2007.03.012; Nii T, 2005, INT J PHARMACEUT, V298, P198, DOI 10.1016/j.ijpharm.2005.04.029; O'Donnell V, 2015, J VIROL, V89, P8556, DOI 10.1128/JVI.00969-15; Oliveira GP, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.01041; Oliveira GP, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9010016; Oliveros M, 1999, J VIROL, V73, P8934, DOI 10.1128/JVI.73.11.8934-8943.1999; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Raush E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007394; Rodriguez JM, 2013, VIRUS RES, V173, P15, DOI 10.1016/j.virusres.2012.09.014; Savjani Ketan T, 2012, ISRN Pharm, V2012, P195727, DOI 10.5402/2012/195727; Schapira M, 1999, J MOL RECOGNIT, V12, P177, DOI 10.1002/(SICI)1099-1352(199905/06)12:3<177::AID-JMR451>3.0.CO;2-Z; Shaikh SA, 2004, ARCH BIOCHEM BIOPHYS, V429, P81, DOI 10.1016/j.abb.2004.05.019; Shaikh SA, 2007, J MED CHEM, V50, P2240, DOI 10.1021/jm060542c; Spitzer GM, 2009, J CHEM INF MODEL, V49, P1063, DOI 10.1021/ci800455f; Staroverov SA, 2006, DRUG DELIV, V13, P351, DOI 10.1080/10717540500459084; Tang J, 2014, J DRUG TARGET, V22, P313, DOI 10.3109/1061186X.2013.875029; Yakimovich A, 2017, J VIROL, V91, DOI 10.1128/JVI.00838-17; YOON C, 1988, P NATL ACAD SCI USA, V85, P6332, DOI 10.1073/pnas.85.17.6332; ZAKRZEWSKA K, 1983, NUCLEIC ACIDS RES, V11, P8825, DOI 10.1093/nar/11.24.8825	51	1	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2019	14	8							e0221175	10.1371/journal.pone.0221175	http://dx.doi.org/10.1371/journal.pone.0221175			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5XV	31461446	gold, Green Published, Green Submitted			2022-12-26	WOS:000485052300025
J	Narita, T; Qi, B; Murakami, M; Sugiya, H				Narita, Takanori; Qi, Bing; Murakami, Masataka; Sugiya, Hiroshi			Pilocarpine induces the residual secretion of salivary fluid in perfused submandibular glands of rats	PLOS ONE			English	Article							SJOGRENS-SYNDROME; CHOLINERGIC STIMULATION; INDUCED XEROSTOMIA; ORAL PILOCARPINE; 4-DAMP MUSTARD; DRY MOUTH; MECHANISM; SUBTYPES; MANAGEMENT; SYMPTOMS	Pilocarpine is an M3 muscarinic agonist that is widely used for the treatment of xerostomia caused by various diseases and medical conditions. Pilocarpine induced the secretion of salivary fluid in perfused submandibular glands of rats. The secretion of salivary fluid observed after removal of pilocarpine was referred to as residual fluid secretion. The volume of fluid and time of the residual secretion depended on the dose of pilocarpine. Such a residual effect of pilocarpine was observed on fluid secretion via the paracellular pathway and oxygen consumption. When a muscarinic antagonist was added to the perfusate immediately after cessation of pilocarpine, residual secretion of salivary fluid did not occur. These observations indicate that the residual secretion of salivary fluid is a characteristics of the interaction of pilocarpine with muscarinic receptors.	[Narita, Takanori; Qi, Bing; Sugiya, Hiroshi] Nihon Univ, Lab Vet Biochem, Coll Bioresource Sci, Fujisawa, Kanagawa, Japan; [Narita, Takanori; Qi, Bing; Sugiya, Hiroshi] Nihon Univ, Sch Dent Matsudo, Dept Physiol, Matsudo, Chiba, Japan; [Murakami, Masataka] Natl Inst Physiol Sci, Dept Nanostruct Physiol, Okazaki, Aichi, Japan; [Qi, Bing] Nanjing Med Univ, Affiliated Hosp Stomatol, Dept Oral Pathol, Nanjing, Jiangsu, Peoples R China	Nihon University; Nihon University; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS); Nanjing Medical University	Sugiya, H (corresponding author), Nihon Univ, Lab Vet Biochem, Coll Bioresource Sci, Fujisawa, Kanagawa, Japan.; Sugiya, H (corresponding author), Nihon Univ, Sch Dent Matsudo, Dept Physiol, Matsudo, Chiba, Japan.	sugiya.hiroshi@nihon-u.ac.jp	Narita, Takanori/F-1092-2011	Narita, Takanori/0000-0003-0295-5014				Al Hamad A, 2019, ORAL DIS, V25, P1027, DOI 10.1111/odi.12952; Borella TL, 2008, BRIT J PHARMACOL, V155, P1256, DOI 10.1038/bjp.2008.355; Chainani-Wu N, 2006, SPEC CARE DENT, V26, P164, DOI 10.1111/j.1754-4505.2006.tb01719.x; Cheng CQ, 2016, J AM DENT ASSOC, V147, P236, DOI 10.1016/j.adaj.2015.09.014; Derk CT, 2004, POSTGRAD MED, V116, P49, DOI 10.3810/pgm.2004.09.1587; Ehlert FJ, 1996, LIFE SCI, V58, P1971, DOI 10.1016/0024-3205(96)00187-7; Ehlert FJ, 1996, J PHARMACOL EXP THER, V276, P405; FOX PC, 1991, ARCH INTERN MED, V151, P1149, DOI 10.1001/archinte.151.6.1149; FOX PC, 1985, J AM DENT ASSOC, V110, P519, DOI 10.14219/jada.archive.1985.0384; Fox RI, 2001, CLIN IMMUNOL, V101, P249, DOI 10.1006/clim.2001.5128; Gautam D, 2004, MOL PHARMACOL, V66, P260, DOI 10.1124/mol.66.2.260; JOENSUU H, 1993, RADIOTHER ONCOL, V26, P33, DOI 10.1016/0167-8140(93)90023-2; JOHNSON JT, 1993, NEW ENGL J MED, V329, P390, DOI 10.1056/NEJM199308053290603; Kondo Y, 2011, J PHARMACOL EXP THER, V337, P267, DOI 10.1124/jpet.110.174946; Li JC, 2006, LIFE SCI, V79, P2441, DOI 10.1016/j.lfs.2006.08.006; de Almeida RL, 2006, BRAIN RES, V1085, P144, DOI 10.1016/j.brainres.2006.02.013; Margaix-Munoz M, 2009, MED ORAL PATOL ORAL, V14, pE325; Matsuzaki T, 1999, CELL TISSUE RES, V295, P513, DOI 10.1007/s004410051257; Melvin JE, 2005, ANNU REV PHYSIOL, V67, P445, DOI 10.1146/annurev.physiol.67.041703.084745; Mercadante V, 2017, ORAL ONCOL, V66, P64, DOI 10.1016/j.oraloncology.2016.12.031; MURAKAMI M, 1986, AM J PHYSIOL, V251, pG84, DOI 10.1152/ajpgi.1986.251.1.G84; Murakami M, 2001, J PHYSIOL-LONDON, V537, P899; MURAKAMI M, 1990, J PHYSIOL-LONDON, V426, P127, DOI 10.1113/jphysiol.1990.sp018130; Nezu A, 2015, EXP PHYSIOL, V100, P640, DOI 10.1113/EP085110; Nusair S, 1999, SEMIN ARTHRITIS RHEU, V28, P360, DOI 10.1016/S0049-0172(99)80002-X; Pedersen AML, 2018, J ORAL REHABIL, V45, P730, DOI 10.1111/joor.12664; Peppi M, 2004, J ANAT, V205, P257, DOI 10.1111/j.0021-8782.2004.00332.x; Proctor GB, 2014, MONOGR ORAL SCI, V24, P14, DOI 10.1159/000358781; Qi B, 2010, ARCH ORAL BIOL, V55, P737, DOI 10.1016/j.archoralbio.2010.06.012; RENZI A, 1993, J DENT RES, V72, P1481, DOI 10.1177/00220345930720110401; Renzi A, 2002, BRAIN RES BULL, V58, P455, DOI 10.1016/S0361-9230(02)00817-1; RHODUS NL, 1991, ORAL SURG ORAL MED O, V72, P545, DOI 10.1016/0030-4220(91)90491-T; STEWART DJ, 1983, AM J PHYSIOL, V245, pG364, DOI 10.1152/ajpgi.1983.245.3.G364; Sykes DA, 2009, MOL PHARMACOL, V76, P543, DOI 10.1124/mol.108.054452; Takakura ACT, 2003, J DENT RES, V82, P993, DOI 10.1177/154405910308201211; Tanasiewicz M, 2016, ADV CLIN EXP MED, V25, P199, DOI 10.17219/acem/29375; Tanzer JM, 1995, J DENT RES, V74, P1845, DOI 10.1177/00220345950740120701; Turner RJ, 2002, ORAL DIS, V8, P3, DOI 10.1034/j.1601-0825.2002.10815.x; Venables PJW, 2004, BEST PRACT RES CL RH, V18, P313, DOI 10.1016/j.berh.2004.02.010; Vivino FB, 1999, ARCH INTERN MED, V159, P174, DOI 10.1001/archinte.159.2.174; Vivino FB, 2001, SCAND J RHEUMATOL, V30, P1; Wei F, 2015, WORLD J GASTROENTERO, V21, P1444, DOI 10.3748/wjg.v21.i5.1444; Zhang GH, 2013, CHIN J DENT RES, V16, P13	43	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2019	14	8							e0221832	10.1371/journal.pone.0221832	http://dx.doi.org/10.1371/journal.pone.0221832			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5XV	31461497	Green Submitted, Green Published, gold			2022-12-26	WOS:000485052300059
J	Savonnet, L; Duprey, S; Jane, SV; Wang, XG				Savonnet, Leo; Duprey, Sonia; Jane, Serge Van Sint; Wang, Xuguang			Pelvis and femur shape prediction using principal component analysis for body model on seat comfort assessment. Impact on the prediction of the used palpable anatomical landmarks as predictors	PLOS ONE			English	Article								A personalized pelvis and femur shape is required to build a finite element buttock thigh model when experimentally investigating seating discomfort. The present study estimates the shape of pelvis and femur using a principal component analysis (PCA) based method with a limited number of palpable anatomical landmarks (ALs) as predictors. A leave-one-out experiment was designed using 38 pelvises and femurs from a same sample of adult specimens. As expected, prediction errors decrease with the number of ALs. Using the maximum number of easily palpable ALs (13 for pelvis and 4 for femur), average errors were 5.4 and 4.8 mm respectively for pelvis and femur. Better prediction was obtained when the shapes of pelvis and femur were predicted separately without merging the data of both bones. Results also show that the PCA based method is a good alternative to predict hip and lumbosacral joint centers with an average error of 5.0 and 9.2 mm respectively.	[Savonnet, Leo; Duprey, Sonia; Wang, Xuguang] Univ Claude Bernard Lyon 1, Univ Lyon, Lyon, France; [Jane, Serge Van Sint] Univ Libre Bruxelles, LABO, Brussels, Belgium	UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Universite Libre de Bruxelles	Wang, XG (corresponding author), Univ Claude Bernard Lyon 1, Univ Lyon, Lyon, France.	xuguang.wang@ifsttar.fr		Wang, Xuguang/0000-0001-9181-6045	Direction Generale de l'Aviation Civile [2014930818]; Zodiac Seat France	Direction Generale de l'Aviation Civile; Zodiac Seat France	The present work was partially supported by Direction Generale de l'Aviation Civile (project no 2014930818) in collaboration with Zodiac Seat France. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen B, 2003, ACM T GRAPHIC, V22, P587, DOI 10.1145/882262.882311; [Anonymous], [No title captured]; Beillas P., 2015, IRCOBI 2015 C; Blanc R, 2012, MED IMAGE ANAL, V16, P1156, DOI 10.1016/j.media.2012.04.004; Brodeur R. R., 1996, 960481 SAE; Chang Shu, 2012, International Journal of Human Factors Modelling and Simulation, V3, P133; Ehrig RM, 2007, J BIOMECH, V40, P2150, DOI 10.1016/j.jbiomech.2006.10.026; Lafage V., 2001, P INT SOC BIOM 18 C; McCann Kevin, 2005, P56; Nerot A, 2016, J BIOMECH, V49, P3415, DOI 10.1016/j.jbiomech.2016.09.006; Peng JF, 2015, J BIOMECH, V48, P396, DOI 10.1016/j.jbiomech.2014.11.040; Rajamani KT, 2007, MED IMAGE ANAL, V11, P99, DOI 10.1016/j.media.2006.05.001; Savonnet L, 2018, COMPUT METHOD BIOMEC, V21, P379, DOI 10.1080/10255842.2018.1466117; Schumann S, 2013, J BIOMECH, V46, P197, DOI 10.1016/j.jbiomech.2012.11.005; Sholukha V, 2017, MED ENG PHYS, V40, P117, DOI 10.1016/j.medengphy.2016.11.008; Sholukha V, 2011, J BIOMECH, V44, P712, DOI 10.1016/j.jbiomech.2010.10.039; TROCHU F, 1993, ENG COMPUT, V9, P160, DOI 10.1007/BF01206346; van Sint Jan S., 2007, COLOR ATLAS SKELETAL; Yates KM, 2018, J BIOMECH, V74, P50, DOI 10.1016/j.jbiomech.2018.04.016; Yates KM, 2016, J BIOMECH, V49, P1540, DOI 10.1016/j.jbiomech.2016.03.027; Zhu ZL, 2011, J BIOMECH, V44, P2362, DOI 10.1016/j.jbiomech.2011.07.006	21	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2019	14	8							e0221201	10.1371/journal.pone.0221201	http://dx.doi.org/10.1371/journal.pone.0221201			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5WO	31454359	Green Published, gold, Green Submitted			2022-12-26	WOS:000485049000013
J	Liang, SJ; Gao, Y; Liu, YL; Qiu, CC; Chen, YH; Zhu, SY				Liang, ShouJun; Gao, Yong; Liu, YaoLi; Qiu, ChengCheng; Chen, YanHao; Zhu, ShangYong			Contrast-enhanced Ultrasound in evaluating of angiogenesis and tumor staging of nasopharyngeal carcinoma in nude mice	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; INVASIVE BREAST-CANCER; MICROVESSEL DENSITY; ANTIANGIOGENIC THERAPY; BEVACIZUMAB; COMBINATION; EXPRESSION; RADIATION; VEGF	Objective To explore the use of Contrast-enhanced Ultrasound (CEUS) in evaluating angiogenesis in a xenograft nasopharyngeal carcinoma (NPC) model in nude mice and the evolution of CEUS parameters according to the growth of NPC. Methods Nude mice were divided into three groups according to experiments conducted at various times from tumor implantation (8 mice/group; group A:4 weeks from implantation; group B:6 weeks from implantation; group C:8 weeks from implantation). CNE-2 cells were transplanted in 24 nude mice and CEUS evaluations of the tumors were performed at 4, 6 or 8 weeks from implantation. CEUS parametric perfusion images and pathological findings were recorded. R version 3.4.4 software was used to analyze the CEUS parameters and pathological findings. Results One-way anova analysis indicated statistically significant differences among the three groups with the parameters of peak intensity (PI) (p<0.001), area wash in (AWI) (p<0.001), area wash out (AWO) (p<0.001) and tumor volumes (p<0.001). Pearson correlation coefficient analysis indicated that microvessel density (MVD) was correlated with tumor volume (r = 0.644, p = 0.001), PI (r = 0.904, p<0.0001), AWI (r = 0.547, p = 0.008) and AWO (r = 0.744, P<0.0001). Tumor volume was correlated with MVD (r = 0.644, p = 0.001), PI (r = 0.625, p = 0.002), AWI (r = 0.528, p = 0.012) and AWO (r = 0.784, p<0.001). The percentage of necrosis in histological sections was correlated with the percentage of CEUS unperfused area (r = 0.446, p = 0.038). Spearman rank correlation coefficient analysis indicated that vascular endothelial growth factor (VEGF) was correlated with PI (r = 0.462, P = 0.032). Welch t test indicated PI, AWI and AWO parameters were significantly lower than that of kidneys (p<0.001, p = 0.009, p = 0.005). Conclusions The CEUS parameters PI, AWI and AWO indirectly reflect the MVD and the tumor volume in our model of subcutaneous transplanted NPC in nude mice, providing precious information on angiogenesis and tumor growth. VEGF may play a role in promoting angiogenesis of NPC.	[Liang, ShouJun; Qiu, ChengCheng; Chen, YanHao] Guangxi Med Univ, Nanning, Guangxi, Peoples R China; [Liang, ShouJun; Gao, Yong; Liu, YaoLi; Qiu, ChengCheng; Chen, YanHao; Zhu, ShangYong] Guangxi Med Univ, Affiliated Hosp 1, Dept Diagnost Ultrasound, Nanning, Guangxi, Peoples R China	Guangxi Medical University; Guangxi Medical University	Zhu, SY (corresponding author), Guangxi Med Univ, Affiliated Hosp 1, Dept Diagnost Ultrasound, Nanning, Guangxi, Peoples R China.	zhushangyong2018@163.com		Qiu, Cheng-Cheng/0000-0003-0179-9734	National Natural Science Foundation of China [81560288]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China, grant number: 81560288, http://www.nsfc.gov.cn/, to SYZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Argiris A, 2013, ANN ONCOL, V24, P220, DOI 10.1093/annonc/mds245; Chen Z, 2015, SAUDI MED J, V36, P658, DOI 10.15537/smj.2015.6.11460; Cui YF, 2016, ONCOTARGET, V7, P27243, DOI 10.18632/oncotarget.8402; Dietrich CF, 2018, ULTRASOUND INT OPEN, V4, pE2, DOI 10.1055/s-0043-123931; Dizeux A, 2017, ULTRASOUND MED BIOL, V43, P2000, DOI 10.1016/j.ultrasmedbio.2017.03.021; Gao Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099679; Gao Y, 2014, J ULTRAS MED, V33, P827, DOI 10.7863/ultra.33.5.827; Guo SP, 2017, J ULTRAS MED, V36, P2287, DOI 10.1002/jum.14262; Hu Y, 2018, CLIN OTOLARYNGOL, V43, P425, DOI 10.1111/coa.12982; Huang GW, 2000, LARYNGOSCOPE, V110, P2066, DOI 10.1097/00005537-200012000-00017; Ji XM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056208; Jiang F, 2015, J CANCER RES THER, V11, pC179, DOI 10.4103/0973-1482.168181; Ko EY, 2008, KOREAN J RADIOL, V9, P243, DOI 10.3348/kjr.2008.9.3.243; Laugesen NG, 2017, ULTRASOUND INT OPEN, V3, pE2, DOI 10.1055/s-0042-124502; Lee NY, 2012, LANCET ONCOL, V13, P172, DOI 10.1016/S1470-2045(11)70303-5; Li Y, 2015, TUMOR BIOL, V36, P8755, DOI 10.1007/s13277-015-3610-0; Liu H, 2014, ULTRASOUND MED BIOL, V40, P293, DOI 10.1016/j.ultrasmedbio.2013.10.004; Mischi M, 2012, IEEE T ULTRASON FERR, V59, P621, DOI 10.1109/TUFFC.2012.2241; Qian CN, 2016, CHIN J CANCER, V35, P1, DOI 10.1186/s40880-015-0070-2; Qian CN, 1999, ONCOLOGY-BASEL, V57, P36, DOI 10.1159/000011998; Qian CN, 1998, J LARYNGOL OTOL, V112, P849, DOI 10.1017/S0022215100141878; Qian CN, 1997, J CANCER RES CLIN, V123, P645, DOI 10.1007/s004320050119; Russo G, 2012, BJU INT, V110, pE794, DOI 10.1111/j.1464-410X.2012.11444.x; Saracco A, 2017, ACTA RADIOL, V58, P394, DOI 10.1177/0284185116658322; SCOTT PAE, 1994, CANCER TREAT REV, V20, P393, DOI 10.1016/0305-7372(94)90020-5; Shi WX, 2016, BRIT J RADIOL, V89, DOI 10.1259/bjr.20150973; Soo RA, 2006, ANN ONCOL, V17, P1625, DOI 10.1093/annonc/mdl283; Turco Simona, 2016, IEEE Rev Biomed Eng, V9, P121, DOI 10.1109/RBME.2016.2583541; Vellayappan BA, 2014, RADIOL ONCOL, V48, P331, DOI 10.2478/raon-2014-0011; Wang DH, 2019, AM J CANCER RES, V9, P479; WEIDNER N, 1991, NEW ENGL J MED, V324, P1, DOI 10.1056/NEJM199101033240101; Weidner N, 2008, METHOD ENZYMOL, V444, P305, DOI 10.1016/S0076-6879(08)02814-0; Wu S, 2015, PLOS ONE, V10; Xie XH, 2010, EUR RADIOL, V20, P239, DOI 10.1007/s00330-009-1538-8; Xing J, 2018, MED ULTRASON, V20, P37, DOI 10.11152/mu-1234; Xu ZM, 2011, CANCER SCI, V102, P1789, DOI 10.1111/j.1349-7006.2011.02013.x; Xuan ZD, 2017, EXPERT REV ANTICANC, V17, P1169, DOI 10.1080/14737140.2017.1395284; Ye ZM, 2014, MOL CLIN ONCOL, V2, P666, DOI 10.3892/mco.2014.331; Zhou J, 2019, PLOS ONE, V14; Zhou JH, 2012, EUR J RADIOL, V81, P1360, DOI 10.1016/j.ejrad.2011.01.099; Zhou JH, 2017, ANGIOGENESIS, V20, P547, DOI 10.1007/s10456-017-9566-5	41	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2019	14	8							e0221638	10.1371/journal.pone.0221638	http://dx.doi.org/10.1371/journal.pone.0221638			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5TR	31442259	Green Submitted, Green Published, gold			2022-12-26	WOS:000485041400061
J	Sell, SL; Boone, DR; Weisz, HA; Cardenas, C; Willey, HE; Bolding, IJ; Micci, MA; Falduto, MT; Torres, KEO; DeWitt, DS; Prough, DS; Hellmich, HL				Sell, Stacy L.; Boone, Deborah R.; Weisz, Harris A.; Cardenas, Cesar; Willey, Hannah E.; Bolding, Ian J.; Micci, Maria-Adelaide; Falduto, Michael T.; Torres, Karen E. O.; DeWitt, Douglas S.; Prough, Donald S.; Hellmich, Helen L.			MicroRNA profiling identifies a novel compound with antidepressant properties	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; KYNURENINE PATHWAY; MAJOR DEPRESSION; GLUCOCORTICOID-RECEPTOR; SYNAPSE FORMATION; PROTEIN; INHIBITION; EXPRESSION; STRESS; CREB	Patients with traumatic brain injury (TBI) are frequently diagnosed with depression. Together, these two leading causes of death and disability significantly contribute to the global burden of healthcare costs. However, there are no drug treatments for TBI and antidepressants are considered off-label for depression in patients with TBI. In molecular profiling studies of rat hippocampus after experimental TBI, we found that TBI altered the expression of a subset of small, non-coding, microRNAs (miRNAs). One known neuroprotective compound (17 beta-estradiol, E2), and two experimental neuroprotective compounds (JM6 and PMI-006), reversed the effects of TBI on miRNAs. Subsequent in silico analyses revealed that the injury-altered miRNAs were predicted to regulate genes involved in depression. Thus, we hypothesized that drug-induced miRNA profiles can be used to identify compounds with antidepressant properties. To confirm this hypothesis, we examined miRNA expression in hippocampi of injured rats treated with one of three known antidepressants (imipramine, fluoxetine and sertraline). Bioinformatic analyses revealed that TBI, potentially via its effects on multiple regulatory miRNAs, dysregulated transcriptional networks involved in neuroplasticity, neurogenesis, and circadian rhythms-networks known to adversely affect mood, cognition and memory. As did E2, JM6, and PMI-006, all three antidepressants reversed the effects of TBI on multiple injury-altered miRNAs. Furthermore, JM6 reduced TBI-induced inflammation in the hippocampus and depression-like behavior in the forced swim test; these are both properties of classic antidepressant drugs. Our results support the hypothesis that miRNA expression signatures can identify neuroprotective and antidepressant properties of novel compounds and that there is substantial overlap between neuroprotection and antidepressant properties.	[Sell, Stacy L.; Boone, Deborah R.; Willey, Hannah E.; Bolding, Ian J.; Micci, Maria-Adelaide; DeWitt, Douglas S.; Prough, Donald S.; Hellmich, Helen L.] Univ Texas Med Branch, Dept Anesthesiol, Galveston, TX 77555 USA; [Weisz, Harris A.] Univ Texas Med Branch, Grad Sch Biomed Sci, Galveston, TX 77555 USA; [Cardenas, Cesar] Univ Mississippi, Med Ctr, Psychiat & Human Behav, Jackson, MS 39216 USA; [Falduto, Michael T.; Torres, Karen E. O.] GenUs BioSyst, Northbrook, IL USA; [Falduto, Michael T.] Paradise Genom Inc, Northbrook, IL USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Mississippi; University of Mississippi Medical Center	Hellmich, HL (corresponding author), Univ Texas Med Branch, Dept Anesthesiol, Galveston, TX 77555 USA.	hhellmic@utmb.edu		DeWitt, Douglas/0000-0001-9810-8156	Moody Foundation; National Institutes of Health [NS052532]	Moody Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the Moody Foundation and National Institutes of Health (NS052532). Paradise genomics provided support in the form of salary for MTF but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of MTF are articulated in the 'author contributions' section.	Albrecht JS, 2015, J NEUROTRAUM, V32, P1223, DOI 10.1089/neu.2014.3651; Baudry A, 2010, SCIENCE, V329, P1537, DOI 10.1126/science.1193692; Boone DK, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06341-6; Broderick JA, 2011, GENE THER, V18, P1104, DOI 10.1038/gt.2011.50; Bryant RA, 2010, AM J PSYCHIAT, V167, P312, DOI 10.1176/appi.ajp.2009.09050617; Cheng LC, 2009, NAT NEUROSCI, V12, P399, DOI 10.1038/nn.2294; Claes S, 2011, PSYCHIAT RES, V188, P355, DOI 10.1016/j.psychres.2011.03.012; delPeso L, 1997, SCIENCE, V278, P687; Duman RS, 2004, BIOL PSYCHIAT, V56, P140, DOI 10.1016/j.biopsych.2004.02.033; Dwivedi Y, 2011, J CHEM NEUROANAT, V42, P142, DOI 10.1016/j.jchemneu.2011.04.002; Engler-Chiurazzi EB, 2016, BRAIN RES, V1645, P79, DOI 10.1016/j.brainres.2016.06.016; Fann JR, 2000, J NEUROPSYCH CLIN N, V12, P226, DOI 10.1176/appi.neuropsych.12.2.226; Farley S, 2010, INT J NEUROPSYCHOPH, V13, P1207, DOI 10.1017/S1461145709991076; Forrest CM, 2013, BRAIN RES, V1504, P1, DOI 10.1016/j.brainres.2013.01.031; FUKUI S, 1991, J NEUROCHEM, V56, P2007, DOI 10.1111/j.1471-4159.1991.tb03460.x; Gao HM, 2008, TRENDS IMMUNOL, V29, P357, DOI 10.1016/j.it.2008.05.002; Gerhard Danielle M, 2018, Curr Behav Neurosci Rep, V5, P36; Guillamondegui O. D., 2011, COMP EFFECTIVENESS R; Hajszan T, 2005, EUR J NEUROSCI, V21, P1299, DOI 10.1111/j.1460-9568.2005.03968.x; HICKS RR, 1994, BRAIN RES, V655, P91, DOI 10.1016/0006-8993(94)91601-2; Jiang C, 2013, TRANSL NEUROSCI, V4, P46, DOI 10.2478/s13380-013-0103-8; Johnson R, 2008, NEUROBIOL DIS, V29, P438, DOI 10.1016/j.nbd.2007.11.001; Johnson R, 2009, NEUROMOL MED, V11, P183, DOI 10.1007/s12017-009-8063-4; Kawashima H, 2010, NEUROSCIENCE, V165, P1301, DOI 10.1016/j.neuroscience.2009.11.057; Kobeissy FH, 2015, MOL NEUROBIOL, V52, P696, DOI 10.1007/s12035-014-8898-z; Kumar A., 2015, NAT PROD CHEM RES, V3, P1; Launay JM, 2011, TRANSL PSYCHIAT, V1, DOI 10.1038/tp.2011.54; Li NX, 2010, SCIENCE, V329, P959, DOI 10.1126/science.1190287; Li Y, 2014, NEUROSCI LETT, V566, P292, DOI 10.1016/j.neulet.2014.03.008; Liu BB, 2015, PSYCHOPHARMACOLOGY, V232, P541, DOI 10.1007/s00213-014-3690-3; Lucki I, 1997, BEHAV PHARMACOL, V8, P523, DOI 10.1097/00008877-199711000-00010; Mainio A, 2007, BRAIN INJURY, V21, P851, DOI 10.1080/02699050701504265; Mellios N, 2011, NAT NEUROSCI, V14, P1240, DOI 10.1038/nn.2909; Myint AM, 2007, J AFFECT DISORDERS, V98, P143, DOI 10.1016/j.jad.2006.07.013; Nestler EJ, 2002, NEURON, V34, P13, DOI 10.1016/S0896-6273(02)00653-0; Nibuya M, 1996, J NEUROSCI, V16, P2365; Novaes LS, 2017, NEUROPHARMACOLOGY, V113, P457, DOI 10.1016/j.neuropharm.2016.10.026; Pike BR, 2000, J NEUROTRAUM, V17, P283, DOI 10.1089/neu.2000.17.283; Rao V, 2009, J NEUROPSYCH CLIN N, V21, P420, DOI 10.1176/appi.neuropsych.21.4.420; Rapoport MJ, 2012, CNS DRUGS, V26, P111, DOI 10.2165/11599560-000000000-00000; Ray SK, 2003, CNS NEUROL DISORD-DR, V2, P173, DOI 10.2174/1568007033482887; Redell JB, 2010, J NEUROTRAUM, V27, P2147, DOI 10.1089/neu.2010.1481; Rojo DR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023111; Sales AJ, 2019, MOL NEUROBIOL, V56, P1070, DOI 10.1007/s12035-018-1143-4; Santarelli L, 2003, SCIENCE, V301, P805, DOI 10.1126/science.1083328; Satz P, 1998, BRAIN INJURY, V12, P537, DOI 10.1080/026990598122313; Schratt GM, 2006, NATURE, V439, P283, DOI 10.1038/nature04367; Sell SL, 2008, PSYCHONEUROENDOCRINO, V33, P1051, DOI 10.1016/j.psyneuen.2008.05.006; Sell SL, 2008, ANESTHESIOLOGY, V108, P873, DOI 10.1097/ALN.0b013e31816c8a15; Shalgi R, 2009, AGING-US, V1, P762, DOI 10.18632/aging.100085; Smalheiser NR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033201; Stalnacke BM, 2007, BRAIN INJURY, V21, P933, DOI 10.1080/02699050701553189; Tsuchimine S, 2018, PSYCHIAT RES, V263, P296, DOI 10.1016/j.psychres.2017.12.077; Wang SS, 2017, PROG NEURO-PSYCHOPH, V79, P417, DOI 10.1016/j.pnpbp.2017.07.024; Warden DL, 2006, J NEUROTRAUM, V23, P1468, DOI 10.1089/neu.2006.23.1468; Wilson JTL, 2000, J NEUROL NEUROSUR PS, V69, P204, DOI 10.1136/jnnp.69.2.204; Wroblewski BA, 1996, J CLIN PSYCHIAT, V57, P582, DOI 10.4088/JCP.v57n1206; Zanos P, 2016, NATURE, V533, P481, DOI 10.1038/nature17998; Zhao C, 2009, NAT STRUCT MOL BIOL, V16, P365, DOI 10.1038/nsmb.1576; Zwilling D, 2011, CELL, V145, P863, DOI 10.1016/j.cell.2011.05.020	60	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2019	14	8							e0221163	10.1371/journal.pone.0221163	http://dx.doi.org/10.1371/journal.pone.0221163			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW5TR	31442236	Green Published, gold, Green Submitted			2022-12-26	WOS:000485041400024
J	Sutherland, T; Mpirimbanyi, C; Nziyomaze, E; Niyomugabo, JP; Niyonsenga, Z; Muvunyi, CM; Mueller, A; Bebell, LM; Nkubana, T; Musoni, E; Talmor, D; Rickard, J; Riviello, ED				Sutherland, Tori; Mpirimbanyi, Christophe; Nziyomaze, Elie; Niyomugabo, Jean-Paul; Niyonsenga, Zack; Muvunyi, Claude Mambo; Mueller, Ariel; Bebell, Lisa M.; Nkubana, Theoneste; Musoni, Emile; Talmor, Daniel; Rickard, Jennifer; Riviello, Elisabeth D.			Widespread antimicrobial resistance among bacterial infections in a Rwandan referral hospital	PLOS ONE			English	Article							PIPERACILLIN-TAZOBACTAM; BETA-LACTAMASES; INTENSIVE-CARE; ENTEROBACTERIACEAE; PREVALENCE	Background Resistance among bacterial infections is increasingly well-documented in high-income countries; however, relatively little is known about bacterial antimicrobial resistance in low-income countries, where the burden of infections is high. Methods We prospectively screened all adult inpatients at a referral hospital in Rwanda for suspected infection for seven months. Blood, urine, wound and sputum samples were cultured and tested for antibiotic susceptibility. We examined factors associated with resistance and compared hospital outcomes for participants with and without resistant isolates. Results We screened 19,178 patient-days, and enrolled 647 unique participants with suspected infection. We obtained 942 culture specimens, of which 357 were culture-positive specimens. Of these positive specimens, 155 (43.4%) were wound, 83 (23.2%) urine, 64 (17.9%) blood, and 55 (15.4%) sputum. Gram-negative bacteria comprised 323 (88.7%) of all isolates. Of 241 Gram-negative isolates tested for ceftriaxone, 183 (75.9%) were resistant. Of 92 Gram-negative isolates tested for the extended spectrum beta-lactamase (ESBL) positive phenotype, 66 (71.7%) were ESBL positive phenotype. Transfer from another facility, recent surgery or antibiotic exposure, and hospital-acquired infection were each associated with resistance. Mortality was 19.6% for all enrolled participants. Conclusions This is the first published prospective hospital-wide antibiogram of multiple specimen types from East Africa with ESBL testing. Our study suggests that low-resource settings with limited and inconsistent access to the full range of antibiotic classes may bear the highest burden of resistant infections. Hospital-acquired infections and recent antibiotic exposure are associated with a high proportion of resistant infections. Efforts to slow the development of resistance and supply effective antibiotics are urgently needed.	[Sutherland, Tori; Mueller, Ariel; Talmor, Daniel] Harvard Med Sch, BIDMC, Dept Anesthesia Crit Care & Pain Med, Boston, MA 02115 USA; [Mpirimbanyi, Christophe; Nziyomaze, Elie; Niyomugabo, Jean-Paul; Niyonsenga, Zack; Rickard, Jennifer] Univ Rwanda, Kigali Univ Teaching Hosp, Coll Med & Hlth Sci, Dept Surg,Sch Med & Pharm, Kigali, Rwanda; [Muvunyi, Claude Mambo; Musoni, Emile] Univ Rwanda, Kigali Univ Teaching Hosp, Coll Med & Hlth Sci, Dept Clin Biol,Sch Med & Pharm, Kigali, Rwanda; [Bebell, Lisa M.] Massachusetts Gen Hosp, MGH Global Hlth, Div Infect Dis, Boston, MA 02114 USA; [Bebell, Lisa M.] Harvard Med Sch, Boston, MA 02115 USA; [Nkubana, Theoneste] Kigali Univ Teaching Hosp, Dept Pathol, Kigali, Rwanda; [Rickard, Jennifer] Univ Minnesota, Dept Surg, Box 242 UMHC, Minneapolis, MN 55455 USA; [Riviello, Elisabeth D.] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Div Pulm Crit Care & Sleep Med, Boston, MA 02115 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; University of Rwanda; University of Rwanda; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; University of Minnesota System; University of Minnesota Twin Cities; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Sutherland, T (corresponding author), Harvard Med Sch, BIDMC, Dept Anesthesia Crit Care & Pain Med, Boston, MA 02115 USA.	sutherlant@email.chop.edu		Riviello, Elisabeth/0000-0002-9443-3928	Department of Surgery, University of Minnesota; Beth Israel Deaconess Anesthesiology Foundation	Department of Surgery, University of Minnesota(University of Minnesota System); Beth Israel Deaconess Anesthesiology Foundation	This work received internal funding from the Department of Surgery, University of Minnesota (https://www.surgery.umn.edu/) to JR. This work also received internal department funding from the Beth Israel Deaconess Anesthesiology Foundation (https://www.bidmc.org/centers-and-departments/anesthesia-criticalc-are-and-pain-medicine) to TS/EDR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ampaire L, 2016, AFR J LAB MED, V5, DOI 10.4102/ajlm.v5i1.432; Bebell LM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175456; Bebell LM, 2014, GLOB HEART, V9, P347, DOI 10.1016/j.gheart.2014.08.009; Bernabe KJ, 2017, INT J ANTIMICROB AG, V50, P629, DOI 10.1016/j.ijantimicag.2017.07.002; Castanheira M, 2014, ANTIMICROB AGENTS CH, V58, P833, DOI 10.1128/AAC.01896-13; (CDC) CfDCaP, HEALTHCARE ASSOCIATE; Centers for Disease Control and Prevention (CDC), LAB TEST MRSA 2017; Chemouni B, 2018, WORLD DEV, V106, P87, DOI 10.1016/j.worlddev.2018.01.023; CLSI, 2020, PERF STAND ANT SUSC, V40; Da Silva GJ, 2012, VIRULENCE, V3, P18, DOI 10.4161/viru.3.1.18382; Dheda K, 2017, LANCET RESP MED, V5, P291, DOI [10.1016/S2213-2600(17)30079-6, 10.1016/s2213-2600(17)30079-6]; Ducel G, 2002, PREVENTION HOSP ACQU, V2nd; Gales AC, 2012, DIAGN MICR INFEC DIS, V73, P354, DOI 10.1016/j.diagmicrobio.2012.04.007; JMI Laboratories, SENTRY ANT SURV PROG; Kurz MSE, 2017, TROP MED INT HEALTH, V22, P210, DOI 10.1111/tmi.12824; Lai PS, 2017, BMJ GLOB HEALTH, V2, DOI 10.1136/bmjgh-2017-000475; Mukagendaneza MJ, 2019, PATIENT SAF SURG, V13, DOI 10.1186/s13037-019-0190-8; Musicha P, 2017, LANCET INFECT DIS, V17, P1042, DOI 10.1016/S1473-3099(17)30394-8; Ntirenganya C, 2015, AM J TROP MED HYG, V92, P865, DOI 10.4269/ajtmh.14-0607; Paterson DL, 2001, J CLIN MICROBIOL, V39, P2206, DOI 10.1128/JCM.39.6.2206-2212.2001; Rosenblatt-Farrell N, 2009, ENVIRON HEALTH PERSP, V117, pA248; Tadesse BT, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2713-1; Tamma PD, 2015, CLIN INFECT DIS, V60, P1319, DOI 10.1093/cid/civ003; Versporten A, 2018, LANCET GLOB HEALTH, V6, pE619, DOI [10.1016/S2214-109X(18)30186-4, 10.1016/s2214-109x(18)30186-4]; Vincent JL, 2014, LANCET RESP MED, V2, P380, DOI 10.1016/S2213-2600(14)70061-X; Vincent JL, 2009, JAMA-J AM MED ASSOC, V302, P2323, DOI 10.1001/jama.2009.1754; Walker KJ, 2018, CAN J INFECT DIS MED, V2018, DOI 10.1155/2018/3747521; Wang Y, 2017, LANCET INFECT DIS, V17, P390, DOI 10.1016/S1473-3099(16)30527-8; Williams PCM, 2018, LANCET INFECT DIS, V18, pE33, DOI 10.1016/S1473-3099(17)30467-X; Wilson ML, 2004, CLIN INFECT DIS, V38, P1150, DOI 10.1086/383029; World Health Organization, GLOB TUB REP 2017; World Health Organization, 2017, ESSE MED LIST; World Health Organization, 2014, ANT RES GLOB REP SUR; World Health Organization, 2015, GLOBAL ACTION PLAN O; Zimhony O, 2006, ANTIMICROB AGENTS CH, V50, P3179, DOI 10.1128/AAC.00218-06	35	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2019	14	8							e0221121	10.1371/journal.pone.0221121	http://dx.doi.org/10.1371/journal.pone.0221121			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5TR	31443107	Green Submitted, Green Published, gold			2022-12-26	WOS:000485041400022
J	Balaban, M; Moshiri, N; Mai, U; Jia, XF; Mirarab, S				Balaban, Metin; Moshiri, Niema; Mai, Uyen; Jia, Xingfan; Mirarab, Siavash			TreeCluster: Clustering biological sequences using phylogenetic trees	PLOS ONE			English	Article							PROTEIN; HIV; NUCLEOTIDE; ALIGNMENT; RECONSTRUCTION; DATABASE	Clustering homologous sequences based on their similarity is a problem that appears in many bioinformatics applications. The fact that sequences cluster is ultimately the result of their phylogenetic relationships. Despite this observation and the natural ways in which a tree can define clusters, most applications of sequence clustering do not use a phylogenetic tree and instead operate on pairwise sequence distances. Due to advances in large-scale phylogenetic inference, we argue that tree-based clustering is under-utilized. We define a family of optimization problems that, given an arbitrary tree, return the minimum number of clusters such that all clusters adhere to constraints on their heterogeneity. We study three specific constraints, limiting (1) the diameter of each cluster, (2) the sum of its branch lengths, or (3) chains of pairwise distances. These three problems can be solved in time that increases linearly with the size of the tree, and for two of the three criteria, the algorithms have been known in the theoretical computer scientist literature. We implement these algorithms in a tool called TreeCluster, which we test on three applications: OTU clustering for microbiome data, HIV transmission clustering, and divide-and-conquer multiple sequence alignment. We show that, by using tree-based distances, TreeCluster generates more internally consistent clusters than alternatives and improves the effectiveness of downstream applications. TreeCluster is available at https://github.cominiernascifireeCluster.	[Balaban, Metin; Moshiri, Niema] Univ Calif San Diego, Bioinformat & Syst Biol Grad Program, La Jolla, CA 92093 USA; [Mai, Uyen] Univ Calif San Diego, Comp Sci & Engn, La Jolla, CA 92093 USA; [Jia, Xingfan] Univ Calif San Diego, Dept Math, La Jolla, CA 92093 USA; [Mirarab, Siavash] Univ Calif San Diego, Dept Elect & Comp Engn, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Mirarab, S (corresponding author), Univ Calif San Diego, Dept Elect & Comp Engn, La Jolla, CA 92093 USA.	smirarab@ucsd.edu	Moshiri, Niema/AAV-8750-2020	Moshiri, Niema/0000-0003-2209-8128; Balaban, Metin/0000-0002-6947-5915; Mirarab, Siavash/0000-0001-5410-1518	National Institutes of Health (NIH) [5P30A1027767-28]; NSF [NSF-1815485, NSF-1845967, AC1-1053575]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027767] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institutes of Health (NIH) subaward 5P30A1027767-28 to M.B., U.M, N.M, and S.M. and NSF grant NSF-1815485 and NSF-1845967 to M.B., U.M., and S.M. Computations were performed on the San Diego Supercomputer Center (SDSC) through XSEDE allocations, which is supported by the NSF grant AC1-1053575. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r This work was supported by the National Institutes of Health (NIH) subaward 5P30A1027767-28 to M.B., U.M, N.M, and S.M. and NSF grant NSF-1815485 and NSF-1845967 to M.B., U. M., and S.M. Computations were performed on the San Diego Supercomputer Center (SDSC) through XSEDE allocations, which is supported by the NSF grant ACI-1053575.	Aldous JL, 2012, CLIN INFECT DIS, V55, P1135, DOI 10.1093/cid/cis612; Amir A, 2017, MSYSTEMS, V2, DOI 10.1128/mSystems.00199-16; Bezemer D, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001898; Brown AJL, 2011, J INFECT DIS, V204, P1463, DOI 10.1093/infdis/jir550; Cai YP, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr349; Callahan BJ, 2016, NAT METHODS, V13, P581, DOI [10.1038/NMETH.3869, 10.1038/nmeth.3869]; Chen W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070837; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Eddy Sean R, 2009, Genome Inform, V23, P205; Edgar R.C., 2016, BIORXIV, V081257, DOI 10.1101/081257; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Enright AJ, 2002, NUCLEIC ACIDS RES, V30, P1575, DOI 10.1093/nar/30.7.1575; Eshleman SH, 2011, J INFECT DIS, V204, P1918, DOI 10.1093/infdis/jir651; FARLEY A, 1981, INT J COMPUT INF SCI, V10, P55, DOI 10.1007/BF00978378; FARRIS JS, 1972, AM NAT, V106, P645, DOI 10.1086/282802; Gonzalez A, 2018, NAT METHODS, V15, P796, DOI 10.1038/s41592-018-0141-9; Goodrich JK, 2014, CELL, V158, P250, DOI 10.1016/j.cell.2014.06.037; HILLIS DM, 1993, SYST BIOL, V42, P182, DOI 10.2307/2992540; Hue S, 2004, AIDS, V18, P719, DOI [10.1097/00002030-200403260-00002, 10.1097/01.aids.0000111455.61782.c3]; Hue S, 2014, AIDS, V28, P1967, DOI 10.1097/QAD.0000000000000383; Hughes GJ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000590; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; KLUGE AG, 1969, SYST ZOOL, V18, P1, DOI 10.2307/2412407; Kundu S., 1977, SIAM Journal on Computing, V6, DOI 10.1137/0206012; Leitner T, 1996, P NATL ACAD SCI USA, V93, P10864, DOI 10.1073/pnas.93.20.10864; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Liu K, 2009, SCIENCE, V324, P392, DOI 10.1126/science.1170540; Liu K, 2012, SYST BIOL, V61, P90, DOI 10.1093/sysbio/syr095; Mai U, 2017, LECT N BIOINFORMAT, V10562, P116, DOI 10.1007/978-3-319-67979-2_7; Mai U, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182238; Maidak BL, 2001, NUCLEIC ACIDS RES, V29, P173, DOI 10.1093/nar/29.1.173; Mehta SR, 2012, J INFECT DIS, V205, P1529, DOI 10.1093/infdis/jis231; Mirarab S, 2015, J COMPUT BIOL, V22, P377, DOI 10.1089/cmb.2014.0156; Mirarab S, 2011, BIOINFORMATICS, V27, P3250, DOI 10.1093/bioinformatics/btr553; Moshiri N., 2018, BIORXIV, DOI [10.1101/325522, DOI 10.1101/325522]; Moshiri N, 2019, BIOINFORMATICS, V35, P1852, DOI 10.1093/bioinformatics/bty921; Nguyen NP, 2016, NPJ BIOFILMS MICROBI, V2, DOI 10.1038/npjbiofilms.2016.4; Nguyen NPD, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0688-z; Pond SLK, 2018, MOL BIOL EVOL, V35, P1812, DOI 10.1093/molbev/msy016; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Quast Christian, 2013, Nucleic Acids Res, V41, pD590, DOI 10.1093/nar/gks1219; Ragonnet-Cronin M, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-317; Sagulenko P, 2018, VIRUS EVOL, V4, DOI 10.1093/ve/vex042; Schloss PD, 2011, APPL ENVIRON MICROB, V77, P3219, DOI 10.1128/AEM.02810-10; Schloss PD, 2005, APPL ENVIRON MICROB, V71, P1501, DOI 10.1128/AEM.71.3.1501-1506.2005; Sievers F, 2013, BIOINFORMATICS, V29, P989, DOI 10.1093/bioinformatics/btt093; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Steinegger M, 2017, NAT BIOTECHNOL, V35, P1026, DOI 10.1038/nbt.3988; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Tavare S., 1986, LECT MATH LIFE SCI, V17, P57; Warnow T., 2017, COMPUTATIONAL PHYLOG; Wertheim JO, 2018, J INFECT DIS, V218, P1943, DOI 10.1093/infdis/jiy431; Wheeler TJ, 2007, BIOINFORMATICS, V23, pI559, DOI 10.1093/bioinformatics/btm226; Zheng Q, 2018, GENOME BIOL, V19, DOI 10.1186/s13059-018-1450-0	55	37	37	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2019	14	8							e0221068	10.1371/journal.pone.0221068	http://dx.doi.org/10.1371/journal.pone.0221068			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5RZ	31437182	Green Published, Green Submitted, gold			2022-12-26	WOS:000485036900032
J	Holota, Y; Dovbynchuk, T; Kaji, I; Vareniuk, I; Dzyubenko, N; Chervinska, T; Zakordonets, L; Stetska, V; Ostapchenko, L; Serhiychuk, T; Tolstanova, G				Holota, Yuliia; Dovbynchuk, Taisa; Kaji, Izumi; Vareniuk, Igor; Dzyubenko, Natalia; Chervinska, Tetiana; Zakordonets, Liudmyla; Stetska, Viktoria; Ostapchenko, Liudmyla; Serhiychuk, Tetiana; Tolstanova, Ganna			The long-term consequences of antibiotic therapy: Role of colonic short-chain fatty acids (SCFA) system and intestinal barrier integrity	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; PROTEIN-COUPLED RECEPTOR; GUT MICROBIOTA; ULCERATIVE-COLITIS; MATRIX METALLOPROTEINASE-2; GPR43; EXPRESSION; RESPONSES; EXPOSURE; TRANSPORTERS	Epidemiological studies revealed that antibiotics exposure increases a risk of inflammatory bowel diseases (IBD) development. It remained largely unknown how antibiotic-induced dysbiosis confers the risk for enhanced inflammatory response. The aim of the present study was to test the hypothesis that SCFAs, their receptors and transporters mediate the antibiotic long-term effects on the functional state of colonic mucosa and susceptibility to the experimental colitis. Male Wistar rats were treated daily for 14 days with antibiotic ceftriaxone (300 mg/kg, i.m.) or vehicle; euthanized by CO2 inhalation followed by cervical dislocation in 1, 14 or 56 days after antibiotic withdrawal. We found increased cecum weight and sustained changes in microbiota composition after ceftriaxone treatment with increased number of conditionally pathogenic enterobacteria, E. coli, Clostridium, Staphylococcus spp. and hemolytic bacteria even at 56 days after antibiotic withdrawal. The concentration of SCFAs was decreased after ceftriaxone withdrawal. We found decreased immunoreactivity of the FFA2, FFA3 receptors, SMCT1 and increased MCT1 & MCT4 transporters of SCFAs in colon mucosa. These changes evoked a significant shift in colonic mucosal homeostasis: the disturbance of oxidant-antioxidant balance; activation of redox-sensitive transcription factor HIF1 alpha and ERK1/2 MAP kinase; increased colonic epithelial permeability and bacterial translocation to blood; morphological remodeling of the colonic tissue. Ceftriaxone pretreatment significantly reinforced inflammation during experimental colitis 56 days after ceftriaxone withdrawal, which was confirmed by increased histopathology of colitis, Goblet cell dysfunction, colonic dilatation and wall thickening, and increased serum levels of inflammatory cytokines (TNF-alpha and IL-10). Since the recognition of the importance of microbiota metabolic activity rather than their composition in the development of inflammatory disorders, e.g. IBD, the present study is the first report on the role of the SCFA system in the long lasting side effects of antibiotic treatment and its implication in IBD development.	[Holota, Yuliia; Dovbynchuk, Taisa; Vareniuk, Igor; Dzyubenko, Natalia; Chervinska, Tetiana; Stetska, Viktoria; Ostapchenko, Liudmyla; Serhiychuk, Tetiana; Tolstanova, Ganna] Taras Shevchenko Natl Univ Kyiv, Kiev, Ukraine; [Kaji, Izumi] Univ Calif Los Angeles, CURE West LA VA Med Ctr, Los Angeles, CA USA; [Zakordonets, Liudmyla] Bogomolets Natl Med Univ, Kiev, Ukraine; [Kaji, Izumi] Vanderbilt Univ, Med Ctr, Nashville, TN USA	Ministry of Education & Science of Ukraine; Taras Shevchenko National University Kiev; University of California System; University of California Los Angeles; Bogomolets National Medical University; Vanderbilt University	Tolstanova, G (corresponding author), Taras Shevchenko Natl Univ Kyiv, Kiev, Ukraine.	gtolstanova@gmail.com	Kaji, Izumi/AAI-4749-2021	Kaji, Izumi/0000-0001-5395-0497; Dovbynchuk, Taisa/0000-0001-7451-6315; Ostapchenko, Ludmila/0000-0001-7181-6048; Tolstanova, Ganna/0000-0002-5286-5044; Stetska, Viktoriia/0000-0002-0110-7737	Ministry of Education and Science of Ukraine [16BF036-01, 19BF036-01]	Ministry of Education and Science of Ukraine	The study was supported by the Ministry of Education and Science of Ukraine Grants: 16BF036-01, 19BF036-01 to Taras Shevchenko National University of Kyiv.; We thank Dr. Iwanaga in Hokkaido University for providing SCMT antibody, Prof. Szabo in University of Irvine for providing Erk1/2, p38 and HIF1a antibodies, Prof. Zholos in Taras Shevchenko National University of Kyiv for editing manuscript. The present study was supported by the Ministry of Education and Science of Ukraine Grants: 16BF036-01, 19BF036-01 to Taras Shevchenko National University of Kyiv.	Ang ZW, 2016, SCI REP-UK, V6, DOI 10.1038/srep34145; Aniwan S, 2018, J CROHNS COLITIS, V12, P137, DOI 10.1093/ecco-jcc/jjx135; Antonopoulos DA, 2009, INFECT IMMUN, V77, P2367, DOI 10.1128/IAI.01520-08; Arnal ME, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118092; Bender A, 2001, Z GASTROENTEROL, V39, P911, DOI 10.1055/s-2001-18537; Bertrand RL., 2014, ADV ENZYME RES, V2, P77, DOI [10.4236/aer.2014.22008, DOI 10.4236/AER.2014.22008]; Blaser MJ, 2016, SCIENCE, V352, P544, DOI 10.1126/science.aad9358; Brestoff JR, 2013, NAT IMMUNOL, V14, P676, DOI 10.1038/ni.2640; Brown AJ, 2003, J BIOL CHEM, V278, P11312, DOI 10.1074/jbc.M211609200; Campbell BJ, 2001, GLYCOCONJUGATE J, V18, P851, DOI 10.1023/A:1022240107040; Campbell EL, 2014, IMMUNITY, V40, P66, DOI 10.1016/j.immuni.2013.11.020; Castaneda FE, 2005, GASTROENTEROLOGY, V129, P1991, DOI 10.1053/j.gastro.2005.09.017; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; Chen CA, 2012, EXP BIOL MED, V237, P777, DOI 10.1258/ebm.2012.011157; Cresci GA, 2010, J GASTROINTEST SURG, V14, P449, DOI 10.1007/s11605-009-1045-x; Deng XM, 2009, J PHARMACOL EXP THER, V331, P1071, DOI 10.1124/jpet.109.158022; Dengler F, 2015, J ANIM PHYSIOL AN N, V99, P379, DOI 10.1111/jpn.12201; Dethlefsen L, 2011, P NATL ACAD SCI USA, V108, P4554, DOI 10.1073/pnas.1000087107; Donohoe DR, 2011, CELL METAB, V13, P517, DOI 10.1016/j.cmet.2011.02.018; Dovbynchuk T, 2015, Fiziol Zh, V61, P76; Perez-Cobas AE, 2013, GUT, V62, P1591, DOI 10.1136/gutjnl-2012-303184; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; Fu JX, 2011, J CLIN INVEST, V121, P1657, DOI 10.1172/JCI45538; Ganapathy V, 2009, PHARMACOL THERAPEUT, V121, P29, DOI 10.1016/j.pharmthera.2008.09.005; Garg P, 2006, J IMMUNOL, V177, P4103, DOI 10.4049/jimmunol.177.6.4103; Garg P, 2009, AM J PHYSIOL-GASTR L, V296, pG175, DOI 10.1152/ajpgi.90454.2008; Gupta J, 2014, CANCER CELL, V25, P484, DOI 10.1016/j.ccr.2014.02.019; Gustafsson A, 1998, SCAND J GASTROENTERO, V33, P721; Hartney T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027531; Harty RF, 2013, DIGEST DIS SCI, V58, P3386, DOI 10.1007/s10620-013-2840-5; Hashash JG, 2015, INFLAMM BOWEL DIS, V21, P2576, DOI 10.1097/MIB.0000000000000534; Holota Y, 2015, STUDIA BIOL, V9, P49; Holota Yu V, 2016, Ukr Biochem J, V88, P35, DOI 10.15407/ubj88.06.035; Horton DB, 2015, PEDIATRICS, V136, pE333, DOI 10.1542/peds.2015-0036; HOVERSTAD T, 1986, SCAND J GASTROENTERO, V21, P997, DOI 10.3109/00365528608996411; HOVERSTAD T, 1986, SCAND J GASTROENTERO, V21, P621, DOI 10.3109/00365528609003109; Hviid A, 2011, GUT, V60, P49, DOI 10.1136/gut.2010.219683; Iwanaga T, 2006, BIOMED RES-TOKYO, V27, P243, DOI 10.2220/biomedres.27.243; Jernberg C, 2010, MICROBIOL-SGM, V156, P3216, DOI 10.1099/mic.0.040618-0; Kamp ME, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163750; Karaki S, 2006, CELL TISSUE RES, V324, P353, DOI 10.1007/s00441-005-0140-x; Karczewski J, 2014, AUTOIMMUNITY, V47, P494, DOI 10.3109/08916934.2014.938322; Kendrick SFW, 2010, HEPATOLOGY, V51, P1988, DOI 10.1002/hep.23572; Kim Chang H, 2014, Immune Netw, V14, P277, DOI 10.4110/in.2014.14.6.277; Kim MH, 2013, GASTROENTEROLOGY, V145, P396, DOI 10.1053/j.gastro.2013.04.056; Knoop KA, 2016, GUT, V65, P1100, DOI 10.1136/gutjnl-2014-309059; Kronman MP, 2012, PEDIATRICS, V130, pE794, DOI 10.1542/peds.2011-3886; Kruidenier L, 2003, J PATHOL, V201, P28, DOI 10.1002/path.1409; Larauche M, 2009, AM J PHYSIOL-GASTR L, V297, pG215, DOI 10.1152/ajpgi.00072.2009; Le Poul E, 2003, J BIOL CHEM, V278, P25481, DOI 10.1074/jbc.M301403200; Li ZS, 2011, J NEUROSCI, V31, P8998, DOI 10.1523/JNEUROSCI.6684-10.2011; Liu HC, 2013, AM J PHYSIOL-GASTR L, V304, pG793, DOI 10.1152/ajpgi.00249.2012; Lopez CA, 2016, SCIENCE, V353, P1249, DOI 10.1126/science.aag3042; Macia L, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7734; Marild K, 2013, BMC GASTROENTEROL, V13, DOI 10.1186/1471-230X-13-109; Marinho HS, 2014, REDOX BIOL, V2, P535, DOI 10.1016/j.redox.2014.02.006; Maslowski KM, 2009, NATURE, V461, P1282, DOI 10.1038/nature08530; Masui R, 2013, INFLAMM BOWEL DIS, V19, P2848, DOI 10.1097/01.MIB.0000435444.14860.ea; Moura FA, 2015, REDOX BIOL, V6, P617, DOI 10.1016/j.redox.2015.10.006; Nair Anroop B, 2016, J Basic Clin Pharm, V7, P27, DOI 10.4103/0976-0105.177703; Nilsson NE, 2003, BIOCHEM BIOPH RES CO, V303, P1047, DOI 10.1016/S0006-291X(03)00488-1; Nohr MK, 2015, NEUROSCIENCE, V290, P126, DOI 10.1016/j.neuroscience.2015.01.040; Otsuka M, 2010, GASTROENTEROLOGY, V138, P1255, DOI 10.1053/j.gastro.2010.01.005; Rashid MU, 2015, CLIN INFECT DIS, V60, pS77, DOI 10.1093/cid/civ137; ROEDIGER WEW, 1990, LIPIDS, V25, P646, DOI 10.1007/BF02536016; ROEDIGER WEW, 1980, LANCET, V2, P712; Rooks MG, 2016, NAT REV IMMUNOL, V16, P341, DOI 10.1038/nri.2016.42; Satoh H, 1997, JPN J PHARMACOL, V73, P299, DOI 10.1254/jjp.73.299; SAVAGE DC, 1968, J EXP MED, V128, P97, DOI 10.1084/jem.128.1.97; Scott FI, 2016, GASTROENTEROLOGY, V151, P120, DOI 10.1053/j.gastro.2016.03.006; Scott NA, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aao4755; Shaw SY, 2011, AM J GASTROENTEROL, V106, P2133, DOI 10.1038/ajg.2011.304; Sivaprakasam S, 2018, COMPR PHYSIOL, V8, P299, DOI 10.1002/cphy.c170014; Smith PM, 2013, SCIENCE, V341, P569, DOI 10.1126/science.1241165; Tang Y, 2011, INT J CANCER, V128, P847, DOI 10.1002/ijc.25638; Tazoe H, 2009, BIOMED RES-TOKYO, V30, P149, DOI 10.2220/biomedres.30.149; Tedelind S, 2007, WORLD J GASTROENTERO, V13, P2826, DOI 10.3748/wjg.v13.i20.2826; Thangaraju M, 2008, J GASTROINTEST SURG, V12, P1773, DOI 10.1007/s11605-008-0573-0; Thibault R, 2010, INFLAMM BOWEL DIS, V16, P684, DOI 10.1002/ibd.21108; Tilg H, 2015, GASTROENTEROLOGY, V148, P1107, DOI 10.1053/j.gastro.2014.12.036; Tolstanova G, 2012, LAB INVEST, V92, P9, DOI 10.1038/labinvest.2011.122; Tulstrup MVL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144854; Vieira AT, 2015, ARTHRITIS RHEUMATOL, V67, P1646, DOI 10.1002/art.39107; Vinolo MAR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021205; Weydert CJ, 2010, NAT PROTOC, V5, P51, DOI 10.1038/nprot.2009.197; Wlodarska M, 2011, INFECT IMMUN, V79, P1536, DOI 10.1128/IAI.01104-10; Wu W, 2017, MUCOSAL IMMUNOL, V10, P946, DOI 10.1038/mi.2016.114; Yano JM, 2015, CELL, V161, P264, DOI 10.1016/j.cell.2015.02.047; Zhao XY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167032	89	49	52	4	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2019	14	8							e0220642	10.1371/journal.pone.0220642	http://dx.doi.org/10.1371/journal.pone.0220642			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5RZ	31437166	Green Submitted, gold, Green Published			2022-12-26	WOS:000485036900015
J	Wigger, L; Casals-Casas, C; Baruchet, M; Trang, KB; Pradervand, S; Naldi, A; Desvergne, B				Wigger, Leonore; Casals-Casas, Cristina; Baruchet, Michael; Trang, Khanh B.; Pradervand, Sylvain; Naldi, Aurelien; Desvergne, Beatrice			System analysis of cross-talk between nuclear receptors reveals an opposite regulation of the cell cycle by LXR and FXR in human HepaRG liver cells	PLOS ONE			English	Article							X-RECEPTOR; BILE-ACIDS; DOWN-REGULATION; MOUSE-LIVER; ALPHA GENE; PROLIFERATION; INHIBIT; ACTIVATION; BINDING; EXPRESSION	Transcriptional regulations exert a critical control of metabolic homeostasis. In particular, the nuclear receptors (NRs) are involved in regulating numerous pathways of the intermediate metabolism. The purpose of the present study was to explore in liver cells the interconnectedness between three of them, LXR, FXR, and PPAR alpha, all three known to act on lipid and glucose metabolism, and also on inflammation. The human cell line HepaRG was selected for its best proximity to human primary hepatocytes. Global gene expression of differentiated HepaRG cells was assessed after 4 hours and 24 hours of exposure to GW3965 (LXR agonist), GW7647 (PPAR alpha agonist), and GW4064 and CDCA (FXR synthetic and natural agonist, respectively). Our work revealed that, contrary to our expectations, NR specificity is largely present at the level of target genes, with a smaller than expected overlap of the set of genes targeted by the different NRs. It also highlighted the much broader activity of the synthetic FXR ligand compared to CDCA. More importantly, our results revealed that activation of FXR has a pro-proliferative effect and decreases the number of tetraploid (or binucleated) hepatocytes, while LXR inhibits the cell cycle progression, inducing hepatocyte differentiation and an increase in tetraploidism. Conclusion: these results highlight the importance of analyzing the different NR activities in a context allowing a direct confrontation of each receptor outcome, and reveals the opposite role of FXR and LXR in hepatocyte cells division and maturation.	[Wigger, Leonore; Pradervand, Sylvain] Univ Lausanne, Lausanne Genom Technol Facil, Ctr Integrat Genom, Lausanne, Switzerland; [Wigger, Leonore; Pradervand, Sylvain] Vital IT, Swiss Inst Bioinformat, Lausanne, Switzerland; [Casals-Casas, Cristina; Baruchet, Michael; Trang, Khanh B.; Naldi, Aurelien; Desvergne, Beatrice] Univ Lausanne, Ctr Integrat Genom, Lausanne, Switzerland; [Naldi, Aurelien] Ecole Normale Super, Computat Syst Biol Team, Inst Biol, Paris, France	University of Lausanne; Swiss Institute of Bioinformatics; University of Lausanne; UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS)	Naldi, A; Desvergne, B (corresponding author), Univ Lausanne, Ctr Integrat Genom, Lausanne, Switzerland.; Naldi, A (corresponding author), Ecole Normale Super, Computat Syst Biol Team, Inst Biol, Paris, France.	aurelien.naldi@gmail.com; Beatrice.Desvergne@unil.ch	Desvergne, Beatrice/C-8892-2016; Naldi, Aurélien/B-5401-2008; Sharma, Ashwani/AAK-3879-2020	Naldi, Aurélien/0000-0002-6495-2655; Sharma, Ashwani/0000-0001-9835-1973; Casals-Casas, Cristina/0000-0001-8769-177X; Trang, Khanh/0000-0002-9434-508X	Etat de vaud, FNRS [31003k135583/1, 310030_156771/1]; Novartis; FP7 NR -NET [606806]	Etat de vaud, FNRS; Novartis(Novartis); FP7 NR -NET	This study was supported by the Etat de vaud, FNRS (grant 31003k135583/1 and 310030_156771/1; BD) Novartis (Grant to CC), and FP7 NR -NET (606806; BD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blaschke F, 2004, CIRC RES, V95, pE110, DOI 10.1161/01.RES.0000150368.56660.4f; Boergesen M, 2012, MOL CELL BIOL, V32, P852, DOI 10.1128/MCB.06175-11; Borude P, 2012, HEPATOLOGY, V56, P2344, DOI 10.1002/hep.25918; Calkin AC, 2012, NAT REV MOL CELL BIO, V13, P213, DOI 10.1038/nrm3312; Celton-Morizur S, 2010, ADV EXP MED BIOL, V676, P123; Celton-Morizur S, 2010, CELL CYCLE, V9, P460, DOI 10.4161/cc.9.3.10542; Celton-Morizur S, 2009, J CLIN INVEST, V119, P1880, DOI 10.1172/JCI38677; Cerec V, 2007, HEPATOLOGY, V45, P957, DOI 10.1002/hep.21536; Chen WD, 2011, BBA-MOL BASIS DIS, V1812, P888, DOI 10.1016/j.bbadis.2010.12.006; Desvergne B, 2006, PHYSIOL REV, V86, P465, DOI 10.1152/physrev.00025.2005; Francis GA, 2003, ANNU REV PHYSIOL, V65, P261, DOI 10.1146/annurev.physiol.65.092101.142528; Fujiwara T, 2005, NATURE, V437, P1043, DOI 10.1038/nature04217; Goodwin B, 2000, MOL CELL, V6, P517, DOI 10.1016/S1097-2765(00)00051-4; Gripon P, 2002, P NATL ACAD SCI USA, V99, P15655, DOI 10.1073/pnas.232137699; Hart SN, 2010, DRUG METAB DISPOS, V38, P988, DOI 10.1124/dmd.109.031831; Huang WD, 2006, SCIENCE, V312, P233, DOI 10.1126/science.1121435; Kawamata Y, 2003, J BIOL CHEM, V278, P9435, DOI 10.1074/jbc.M209706200; Kim I, 2007, CARCINOGENESIS, V28, P940, DOI 10.1093/carcin/bgl249; Kim KH, 2010, J LIPID RES, V51, P3425, DOI 10.1194/jlr.M007989; Landry S, 2011, EMBO REP, V12, P444, DOI 10.1038/embor.2011.46; Li S, 2015, ONCOL REP, V34, P2674, DOI 10.3892/or.2015.4207; Li TG, 2006, HEPATOLOGY, V43, P1202, DOI 10.1002/hep.21183; Lin CY, 2016, EXPERT OPIN THER TAR, V20, P61, DOI 10.1517/14728222.2015.1081169; Lo Sasso G, 2010, HEPATOLOGY, V51, P1334, DOI 10.1002/hep.23436; Mendez J, 2000, MOL CELL BIOL, V20, P8602, DOI 10.1128/MCB.20.22.8602-8612.2000; Nibourg GAA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038778; Parks DJ, 1999, SCIENCE, V284, P1365, DOI 10.1126/science.284.5418.1365; Pascual-Garcia M, 2011, J IMMUNOL, V186, P4656, DOI 10.4049/jimmunol.1000585; Repa JJ, 2000, GENE DEV, V14, P2819, DOI 10.1101/gad.844900; Rogue A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018816; Samanez CH, 2012, ARCH PHYSIOL BIOCHEM, V118, P102, DOI 10.3109/13813455.2012.683442; Savic D, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0328-6; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Sporn MB, 2001, TRENDS MOL MED, V7, P395, DOI 10.1016/S1471-4914(01)02100-1; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Suzuki A, 2008, DEVELOPMENT, V135, P1589, DOI 10.1242/dev.016634; Talukdar S, 2007, J LIPID RES, V48, P2647, DOI 10.1194/jlr.M700189-JLR200; Thomas AM, 2010, HEPATOLOGY, V51, P1410, DOI 10.1002/hep.23450; Torra IP, 2003, MOL ENDOCRINOL, V17, P259, DOI 10.1210/me.2002-0120; van der Meer DLM, 2010, NUCLEIC ACIDS RES, V38, P2839, DOI 10.1093/nar/gkq012; Wang B, 2015, NATURE, V524, P180, DOI 10.1038/nature14863; Wang YD, 2008, HEPATOLOGY, V48, P1632, DOI 10.1002/hep.22519; Wang YD, 2008, CELL RES, V18, P1087, DOI 10.1038/cr.2008.289; Zelcer N, 2009, SCIENCE, V325, P100, DOI 10.1126/science.1168974; Zhou HN, 2018, ONCOL LETT, V15, P7617, DOI 10.3892/ol.2018.8342	45	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2019	14	8							e0220894	10.1371/journal.pone.0220894	http://dx.doi.org/10.1371/journal.pone.0220894			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5RZ	31437187	Green Published, gold, Green Submitted			2022-12-26	WOS:000485036900021
J	Yin, JY; Wei, YF; Liu, DZ; Hu, PL; Lu, Q; Ang, EL; Zhao, HM; Zhang, Y				Yin, Jinyu; Wei, Yifeng; Liu, Dazhi; Hu, Piling; Lu, Qiang; Ang, Ee Lui; Zhao, Huimin; Zhang, Yan			An extended bacterial reductive pyrimidine degradation pathway that enables nitrogen release from ?-alanine	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						pyrimidine; reductase; nitrogen metabolism; pyridoxal phosphate; enzyme kinetics; beta-alanine; 2-oxoglutarate; 3-hydroxypropionate; aminotransferase; enzyme phylogeny; reductive pathway; nitrogen assimilation; malonic semialdehyde reductase	SACCHAROMYCES-KLUYVERI; CATABOLISM; EXPRESSION; URACIL	The reductive pyrimidine catabolic pathway is the most widespread pathway for pyrimidine degradation in bacteria, enabling assimilation of nitrogen for growth. This pathway, which has been studied in several bacteria including Escherichia coli B, releases only one utilizable nitrogen atom from each molecule of uracil, whereas the other nitrogen atom remains trapped in the end product ?-alanine. Here, we report the biochemical characterization of a ?-alanine:2-oxoglutarate aminotransferase (PydD) and an NAD(P)H-dependent malonic semialdehyde reductase (PydE) from a pyrimidine degradation gene cluster in the bacterium Lysinibacillus massiliensis. Together, these two enzymes converted ?-alanine into 3-hydroxypropionate (3-HP) and generated glutamate, thereby making the second nitrogen from the pyrimidine ring available for assimilation. Using bioinformatics analyses, we found that PydDE homologs are associated with reductive pyrimidine pathway genes in many Gram-positive bacteria in the classes Bacilli and Clostridia. We demonstrate that Bacillus smithii grows in a defined medium with uracil or uridine as its sole nitrogen source and detected the accumulation of 3-HP as a waste product. Our findings extend the reductive pyrimidine catabolic pathway and expand the diversity of enzymes involved in bacterial pyrimidine degradation.	[Yin, Jinyu; Liu, Dazhi; Hu, Piling; Lu, Qiang; Zhang, Yan] Tianjin Univ, Tianjin Key Lab Modern Drug Delivery & High Effic, Collaborat Innovat Ctr Chem Sci & Engn, Sch Pharmaceut Sci & Technol, Tianjin 300072, Peoples R China; [Wei, Yifeng; Ang, Ee Lui; Zhao, Huimin] ASTAR, Inst Chem & Engn Sci, Metab Engn Res Lab, Singapore, Singapore; [Zhao, Huimin] Univ Illinois, Dept Chem & Biomol Engn, 600 S Mathews Ave, Urbana, IL 61801 USA	Tianjin University; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Sustainability for Chemicals, Energy & Environment (ISCE2); University of Illinois System; University of Illinois Urbana-Champaign	Zhang, Y (corresponding author), Tianjin Univ, Tianjin Key Lab Modern Drug Delivery & High Effic, Collaborat Innovat Ctr Chem Sci & Engn, Sch Pharmaceut Sci & Technol, Tianjin 300072, Peoples R China.; Zhao, HM (corresponding author), Univ Illinois, Dept Chem & Biomol Engn, 600 S Mathews Ave, Urbana, IL 61801 USA.	zhao5@illinois.edu; yan.zhang@tju.edu.cn	Zhang, Yan/K-1638-2015	Zhang, Yan/0000-0003-2031-0631; Zhao, Huimin/0000-0002-9069-6739	National Science Foundation of China [31870049, 31570060]; Agency for Science, Technology, and Research of Singapore [1535j00137]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Agency for Science, Technology, and Research of Singapore(Agency for Science Technology & Research (A*STAR))	This work was supported by National Science Foundation of China Grants 31870049 and 31570060 (to Y. Z.) and by the Agency for Science, Technology, and Research of Singapore Visiting Investigator Program Grant 1535j00137 (to H. Z.). The authors declare that they have no conflicts of interest with the contents of this article.	Eyre-Walker A, 2007, NAT REV GENET, V8, P610, DOI 10.1038/nrg2146; FELSENSTEIN J, 1978, SYST ZOOL, V27, P401, DOI 10.2307/2412923; GRIMSHAW CE, 1981, BIOCHEMISTRY-US, V20, P5650, DOI 10.1021/bi00523a002; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Kim KS, 2010, J BACTERIOL, V192, P4089, DOI 10.1128/JB.00201-10; Letunic I, 2016, NUCLEIC ACIDS RES, V44, pW242, DOI 10.1093/nar/gkw290; Li MY, 2019, BIOCHEM J, V476, P1605, DOI 10.1042/BCJ20190206; NAKAMURA K, 1961, BIOCHIM BIOPHYS ACTA, V50, P147, DOI 10.1016/0006-3002(61)91071-X; Nallamsetty S, 2007, NAT PROTOC, V2, P383, DOI 10.1038/nprot.2007.50; Otte J, 2015, APPL ENVIRON MICROB, V81, P1700, DOI 10.1128/AEM.03390-14; PATEL BN, 1987, FEMS MICROBIOL LETT, V40, P33; Poelarends GJ, 2003, J BIOL CHEM, V278, P48674, DOI 10.1074/jbc.M306706200; Rasmussen AA, 2014, EUKARYOT CELL, V13, P31, DOI 10.1128/EC.00202-13; Schnackerz KD, 2008, NUCLEOS NUCLEOT NUCL, V27, P794, DOI 10.1080/15257770802145983; Soong CL, 2002, J BIOL CHEM, V277, P7051, DOI 10.1074/jbc.M110784200; Suzek BE, 2015, BIOINFORMATICS, V31, P926, DOI 10.1093/bioinformatics/btu739; TRAUT TW, 1984, BIOCHEMISTRY-US, V23, P2533, DOI 10.1021/bi00306a033; VOGELS GD, 1976, BACTERIOL REV, V40, P403, DOI 10.1128/MMBR.40.2.403-468.1976; West TP, 1998, CAN J MICROBIOL, V44, P1106, DOI 10.1139/cjm-44-11-1106; Whelan S, 2001, MOL BIOL EVOL, V18, P691, DOI 10.1093/oxfordjournals.molbev.a003851; Wilding M, 2016, APPL ENVIRON MICROB, V82, P3846, DOI 10.1128/AEM.00665-16; Zhang Q, 2011, NAT CHEM BIOL, V7, P154, DOI [10.1038/nchembio.512, 10.1038/NCHEMBIO.512]; Zhao SW, 2014, ELIFE, V3, DOI 10.7554/eLife.03275; Zhou Y, 2019, BIOSCIENCE REP, V39, DOI 10.1042/BSR20190715; Zhou Y, 2019, BIOCHEM J, V476, P733, DOI 10.1042/BCJ20190005	25	7	8	2	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 25	2019	294	43					15662	15671		10.1074/jbc.RA119.010406	http://dx.doi.org/10.1074/jbc.RA119.010406			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JQ9JD	31455636	hybrid, Green Published			2022-12-26	WOS:000499253000010
J	Gering, C; Koivisto, JT; Parraga, J; Leppiniemi, J; Vuornos, K; Hytonen, VP; Miettinen, S; Kellomaki, M				Gering, Christine; Koivisto, Janne T.; Parraga, Jenny; Leppiniemi, Jenni; Vuornos, Kaisa; Hytonen, Vesa P.; Miettinen, Susanna; Kellomaki, Minna			Design of modular gellan gum hydrogel functionalized with avidin and biotinylated adhesive ligands for cell culture applications	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; OSTEOGENIC DIFFERENTIATION; EXTRACELLULAR-MATRIX; ALGINATE HYDROGELS; BINDING; GROWTH; ELASTICITY; GELATION	This article proposes the coupling of the recombinant protein avidin to the polysaccharide gellan gum to create a modular hydrogel substrate for 3D cell culture and tissue engineering. Avidin is capable of binding biotin, and thus biotinylated compounds can be tethered to the polymer network to improve cell response. The avidin is successfully conjugated to gellan gum and remains functional as shown with fluorescence titration and electrophoresis (SDS-PAGE). Self-standing hydrogels were formed using bioamines and calcium chloride, yielding long-term stability and adequate stiffness for 3D cell culture, as confirmed with compression testing. Human fibroblasts were successfully cultured within the hydrogel treated with biotinylated RGD or biotinylated fibronectin. Moreover, human bone marrow stromal cells were cultured with hydrogel treated with biotinylated RGD over 3 weeks. We demonstrate a modular and inexpensive hydrogel scaffold for cell encapsulation that can be equipped with any desired biotinylated cell ligand to accommodate a wide range of cell types.	[Gering, Christine; Koivisto, Janne T.; Parraga, Jenny; Leppiniemi, Jenni; Vuornos, Kaisa; Hytonen, Vesa P.; Miettinen, Susanna; Kellomaki, Minna] Tampere Univ, BioMediTech, Fac Med & Hlth Technol, Tampere, Finland; [Vuornos, Kaisa; Miettinen, Susanna] Tampere Univ Hosp, Res Dev & Innovat Ctr, Tampere, Finland; [Hytonen, Vesa P.] Fimlab Labs, Tampere, Finland	Tampere University; Tampere University; Tampere University Hospital	Gering, C (corresponding author), Tampere Univ, BioMediTech, Fac Med & Hlth Technol, Tampere, Finland.	christine.gering@tuni.fi	Hytonen, Vesa P./E-8855-2013; Gering, Christine/AAD-9217-2019; Koivisto, Janne Tapio/P-7057-2019; Kellomaki, Minna/G-6190-2010	Hytonen, Vesa P./0000-0002-9357-1480; Gering, Christine/0000-0002-0476-2622; Koivisto, Janne Tapio/0000-0002-7904-4780; Leppiniemi, Jenni/0000-0002-7225-1648; Kellomaki, Minna/0000-0003-4321-1820; Miettinen, Susanna/0000-0002-0647-9556; Vuornos, Kaisa/0000-0003-4731-3314	Innovation Funding Agency 'Business Finland'; Competitive State Research Financing of the Expert Responsibility area of Tampere University Hospital; Academy of Finland [290506]	Innovation Funding Agency 'Business Finland'; Competitive State Research Financing of the Expert Responsibility area of Tampere University Hospital; Academy of Finland(Academy of Finland)	The project was funded from several sources: the Innovation Funding Agency 'Business Finland' (formerly TEKES) as the Human Spare Parts program (MK, CG, JK, JP), by the Competitive State Research Financing of the Expert Responsibility area of Tampere University Hospital (KV, SM), by Academy of Finland project 290506	Agard NJ, 2004, J AM CHEM SOC, V126, P15046, DOI 10.1021/ja044996f; Anjum F, 2016, BIOMATERIALS, V87, P104, DOI 10.1016/j.biomaterials.2016.01.050; Berrier AL, 2007, J CELL PHYSIOL, V213, P565, DOI 10.1002/jcp.21237; Blache U, 2016, ADV HEALTHC MATER, V5, P489, DOI 10.1002/adhm.201500795; Bondalapati S, 2014, MACROMOL RAPID COMM, V35, P1754, DOI 10.1002/marc.201400354; Broguiere N, 2018, ADV MATER, V30, DOI 10.1002/adma.201801621; da Silva LP, 2018, ADV HEALTHC MATER, V7, DOI 10.1002/adhm.201700686; De France KJ, 2017, CHEM MATER, V29, P4609, DOI 10.1021/acs.chemmater.7b00531; De Silva DA, 2013, J APPL POLYM SCI, V130, P3374, DOI 10.1002/app.39583; Desai RM, 2015, BIOMATERIALS, V50, P30, DOI 10.1016/j.biomaterials.2015.01.048; Doner LW, 1997, CARBOHYD POLYM, V32, P245, DOI 10.1016/S0144-8617(96)00168-3; Doube M, 2010, BONE, V47, P1076, DOI 10.1016/j.bone.2010.08.023; Douglas TEL, 2014, J TISSUE ENG REGEN M, V8, P906, DOI 10.1002/term.1616; Drury JL, 2003, BIOMATERIALS, V24, P4337, DOI 10.1016/S0142-9612(03)00340-5; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Ferris CJ, 2015, J MATER CHEM B, V3, P1106, DOI 10.1039/c4tb01727g; Frantz C, 2010, J CELL SCI, V123, P4195, DOI 10.1242/jcs.023820; Gebraad A, 2018, FEBS J, V285, P2337, DOI 10.1111/febs.14485; Gering C, 2017, EMBEC NBC 2017, P811; He XZ, 2008, LANGMUIR, V24, P12508, DOI 10.1021/la802447v; Hermanson GT, 2013, BIOCONJUGATE TECHNIQUES, 3RD EDITION, P259, DOI 10.1016/B978-0-12-382239-0.00004-2; Hobzova R, 2011, E-POLYMERS, V11, P474, DOI [10.1515/epoly.2011.11.1.474, DOI 10.1515/EPOLY.2011.11.1.474]; Hughes CS, 2010, PROTEOMICS, V10, P1886, DOI 10.1002/pmic.200900758; Hytonen VP, 2005, J BIOL CHEM, V280, P10228, DOI 10.1074/jbc.M414196200; Justice BA, 2009, DRUG DISCOV TODAY, V14, P102, DOI 10.1016/j.drudis.2008.11.006; Kirchmajer DM, 2014, CARBOHYD RES, V388, P125, DOI 10.1016/j.carres.2014.02.018; Koivisto JT, 2017, BIOMED MATER, V12, DOI 10.1088/1748-605X/aa62b0; Kojima N, 2006, BIOMATERIALS, V27, P4904, DOI 10.1016/j.biomaterials.2006.05.026; Kraehenbuehl TP, 2009, BIOMATERIALS, V30, P4318, DOI 10.1016/j.biomaterials.2009.04.057; Laitinen OH, 2007, TRENDS BIOTECHNOL, V25, P269, DOI 10.1016/j.tibtech.2007.04.001; Langer R, 2004, NATURE, V428, P487, DOI 10.1038/nature02388; Lee JW, 2017, COLLOID SURFACE B, V155, P229, DOI 10.1016/j.colsurfb.2017.04.014; Leppiniemi J, 2017, ACS APPL MATER INTER, V9, P21959, DOI 10.1021/acsami.7b02756; Levental I, 2007, SOFT MATTER, V3, P299, DOI 10.1039/b610522j; Li S, 2005, ANNU REV BIOMED ENG, V7, P105, DOI 10.1146/annurev.bioeng.7.060804.100340; Li Z, 2009, TISSUE ENG PT A, V15, P1729, DOI 10.1089/ten.tea.2008.0247; Lin SJ, 2006, BIOMATERIALS, V27, P1462, DOI 10.1016/j.biomaterials.2005.08.031; Mackova H, 2016, MACROMOL BIOSCI, V16, P1621, DOI 10.1002/mabi.201600159; McKee C, 2017, COLLOID SURFACE B, V159, P62, DOI 10.1016/j.colsurfb.2017.07.051; Morris ER, 2012, FOOD HYDROCOLLOID, V28, P373, DOI 10.1016/j.foodhyd.2012.01.004; Oliveira MB, 2016, ACTA BIOMATER, V41, P119, DOI 10.1016/j.actbio.2016.05.033; Osmalek T, 2014, INT J PHARMACEUT, V466, P328, DOI 10.1016/j.ijpharm.2014.03.038; Oyen ML, 2014, INT MATER REV, V59, P44, DOI 10.1179/1743280413Y.0000000022; Pacelli S, 2016, EUR POLYM J, V77, P114, DOI 10.1016/j.eurpolymj.2016.02.007; Ray S, 2015, LANGMUIR, V31, P1921, DOI 10.1021/la503213f; Rosano C, 1999, BIOMOL ENG, V16, P5, DOI 10.1016/S1050-3862(99)00047-9; Silva NA, 2012, BIOMATERIALS, V33, P6345, DOI 10.1016/j.biomaterials.2012.05.050; Silva-Correia J, 2013, ADV HEALTHC MATER, V2, P568, DOI 10.1002/adhm.201200256; Storm C, 2005, NATURE, V435, P191, DOI 10.1038/nature03521; Tallawi M, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2015.0254; Tibbitt MW, 2009, BIOTECHNOL BIOENG, V103, P655, DOI 10.1002/bit.22361; Tsaryk R, 2017, J TISSUE ENG REGEN M, V11, P637, DOI 10.1002/term.1959; VROMAN L, 1980, BLOOD, V55, P156; Walters NJ, 2015, ACTA BIOMATER, V11, P3, DOI 10.1016/j.actbio.2014.09.038; Wylie RG, 2011, NAT MATER, V10, P799, DOI [10.1038/NMAT3101, 10.1038/nmat3101]; ZHANG SG, 1993, P NATL ACAD SCI USA, V90, P3334, DOI 10.1073/pnas.90.8.3334	56	5	5	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2019	14	8							e0221931	10.1371/journal.pone.0221931	http://dx.doi.org/10.1371/journal.pone.0221931			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW6BO	31469884	Green Published, Green Submitted, gold			2022-12-26	WOS:000485062200039
J	Ree, ZH; Yao, RJ; Liu, Q; Deng, YT; Shen, LH; Deng, HD; Zuo, ZC; Wang, Y; Deng, JL; Cui, HM; Hu, YC; Ma, XP; Fang, J				Ree, Zhihua; Yao, Renjie; Liu, Qi; Deng, Youtian; Shen, Liuhong; Deng, Huidan; Zuo, Zhicai; Wang, Ya; Deng, Junliang; Cui, Hengmin; Hu, Yanchun; Ma, Xiaoping; Fang, Jing			Effects of antibacterial peptides on rumen fermentation function and rumen microorganisms in goats	PLOS ONE			English	Article							GROWTH-PERFORMANCE; IN-VITRO; DIETARY SUPPLEMENTATION; INTESTINAL MORPHOLOGY; ANTIMICROBIAL PEPTIDE-A3; MONENSIN SUPPLEMENTATION; NUTRIENT DIGESTIBILITY; RUMINAL FERMENTATION; FECAL MICROFLORA; VALLEY PROTEIN	Although many studies have confirmed that antimicrobial peptides (AMPs: PBD-mI and LUC-n) can be used as feed additives, there are few reports of their use in ruminants. The present study aimed to investigate the impact of AMPs on ameliorating rumen fermentation function and rumen microorganisms in goats. Eighteen 4-month-old Chuanzhong black goats were used in a 60-day experiment (6 goats per group). Group I was used as the control and was fed a basal diet, the group II were fed the basal diet supplemented with 2 g of AMPs [per goat/day] and group III were fed the basal diet supplemented 3 g of AMPs [per goat/day], respectively. Rumen fluid samples were collected at 0, 20 and 60 days. Bacterial 16S rRNA genes and ciliate protozoal 18S rRNA genes were amplified by PCR from DNA extracted from rumen samples. The amplicons were sequenced by Illumina MiSeq. Rumen fermentation parameters and digestive enzyme activities were also examined. Our results showed that dietary supplementation with AMPs increased the levels of the bacterial genera Fibrobacter, Anaerovibrio and Succiniclasticum and also increased the ciliates genus Ophryoscolex, but reduced the levels of the bacterial genera Selenomonas, Succinivibrio and Treponema, and the ciliate genera Polyplastron, Entodinium, Enoploplastron and Isotricha. Supplementation with AMPs increased the activities of xylanase, pectinase and lipase in the rumen, and also increased the concentrations of acetic acid, propionic acid and total volatile fatty acids. These changes were associated with improved growth performance in the goats. The results revealed that the goats fed AMPs showed improved rumen microbiota structures, altered ruminal fermentation, and improved efficiency regarding the utilization of feed; thereby indicating that AMPs can improve growth performance. AMPs are therefore suitable as feed additives in juvenile goats.	[Ree, Zhihua; Yao, Renjie; Liu, Qi; Deng, Youtian; Shen, Liuhong; Deng, Huidan; Zuo, Zhicai; Wang, Ya; Deng, Junliang; Cui, Hengmin; Hu, Yanchun; Ma, Xiaoping; Fang, Jing] Sichuang Agr Univ, Key Lab Anim Dis & Human Hlth Sichuan Prov, Key Lab Environm Hazard & Anim Dis Sichuan Prov, Coll Vet Med, Chengdu, Sichuan, Peoples R China	Key Laboratory of Animal Disease & Human Health of Sichuan Province; Sichuan Agricultural University	Deng, JL (corresponding author), Sichuang Agr Univ, Key Lab Anim Dis & Human Hlth Sichuan Prov, Key Lab Environm Hazard & Anim Dis Sichuan Prov, Coll Vet Med, Chengdu, Sichuan, Peoples R China.	dengjl213@126.com			Changjiang Scholars & Innovative Research Team of Ministry of Education of China Funds [IRT0848]; Chang-jiang Scholars and Innovative Research Team for Universities [IRT0848]	Changjiang Scholars & Innovative Research Team of Ministry of Education of China Funds; Chang-jiang Scholars and Innovative Research Team for Universities	Financial support for this research was provided by the Changjiang Scholars & Innovative Research Team of Ministry of Education of China Funds (Grant no. IRT0848).; This research was financially supported by grants from the Chang-jiang Scholars and Innovative Research Team for Universities (Grant No. IRT0848). We thank Kate Fox, DPhil, from Liwen Bianji, Edanz Group China (www.liwenbianji.cn/ac), for editing the English text of a draft of this manuscript.	Andersen AS, 2010, J ANTIMICROB CHEMOTH, V65, P1646, DOI 10.1093/jac/dkq165; Aranha C, 2004, CONTRACEPTION, V69, P333, DOI 10.1016/j.contraception.2003.11.002; Bera-Maillet C, 2004, APPL ENVIRON MICROB, V70, P2172, DOI 10.1128/AEM.70.4.2172-2179.2004; BERGEN WG, 1984, J ANIM SCI, V58, P1465, DOI 10.2527/jas1984.5861465x; Booyse DG, 2014, ZOOTAXA, V3846, P138, DOI 10.11646/zootaxa.3846.1.8; Bradshaw JP, 2003, BIODRUGS, V17, P233, DOI 10.2165/00063030-200317040-00002; BRANINE ME, 1990, J ANIM SCI, V68, P1139, DOI 10.2527/1990.6841139x; BRODERICK GA, 1980, J DAIRY SCI, V63, P64, DOI 10.3168/jds.S0022-0302(80)82888-8; Candanosa E, 2008, J ANIM VET ADV, V7, P184; Choi SC, 2013, BRIT POULTRY SCI, V54, P738, DOI 10.1080/00071668.2013.838746; de la Fuente G, 2009, EUR J PROTISTOL, V45, P112, DOI 10.1016/j.ejop.2008.07.001; Dehority BA, 2008, J ANIM SCI, V86, P1395, DOI 10.2527/jas.2007-0238; Dehority BA, 2003, J EUKARYOT MICROBIOL, V50, P220, DOI 10.1111/j.1550-7408.2003.tb00121.x; Guo C., 2014, INHIBITORY ACTIVITY, DOI [10.3851/IMP2918, DOI 10.3851/IMP2918]; Guo W, 2015, ANAEROBE, V34, P74, DOI 10.1016/j.anaerobe.2015.04.010; Han XF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117811; HINO T, 1993, J DAIRY SCI, V76, P2213, DOI 10.3168/jds.S0022-0302(93)77558-X; Horwitz W., 1970, OFFICIAL METHODS ANA, V11, DOI DOI 10.1002/JPS.2600600253; Huang HW, 2000, BIOCHEMISTRY-US, V39, P8347, DOI 10.1021/bi000946l; Hwang B, 2011, BIOCHEM BIOPH RES CO, V405, P267, DOI 10.1016/j.bbrc.2011.01.026; Jami E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085423; Jiao LF, 2014, ANIM FEED SCI TECH, V195, P85, DOI 10.1016/j.anifeedsci.2014.05.014; Jin Z, 2008, J ANIM SCI, V86, P1562, DOI 10.2527/jas.2007-0414; Jin Z., 2008, ANIM FEED SCI TECH, V140, P139, DOI [10.1016/j.anifeedsci.2007.12.006, DOI 10.1016/J.ANIFEEDSCI.2007.12.006]; Keymanesh K, 2009, WORLD J MICROB BIOT, V25, P933, DOI 10.1007/s11274-009-9984-7; Kittelmann S, 2015, APPL ENVIRON MICROB, V81, P2433, DOI 10.1128/AEM.03697-14; Kittelmann S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0047879; Kittelmann S, 2011, FEMS MICROBIOL ECOL, V75, P468, DOI 10.1111/j.1574-6941.2010.01022.x; KOTARSKI SF, 1992, J NUTR, V122, P178, DOI 10.1093/jn/122.1.178; Le OT, 2017, ANIM PROD SCI, V57, P912, DOI 10.1071/AN15776; Lee SH, 2014, ANIM FEED SCI TECH, V188, P102, DOI 10.1016/j.anifeedsci.2013.12.001; Liu JH, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00167; Luo C., 2015, INT C INF ENG MECH M, DOI [10.2991/icimm-15.2015.73, DOI 10.2991/ICIMM-15.2015.73]; MADONI P, 1994, BIORESOURCE TECHNOL, V48, P245, DOI 10.1016/0960-8524(94)90153-8; Maletzki C, 2014, ONCOTARGET, V5, P4467, DOI 10.18632/oncotarget.2039; Martinele I., 2010, Arch. zootec., V59, P169, DOI 10.4321/s0004-05922010000200002; Matsuzaki K, 1999, BBA-BIOMEMBRANES, V1462, P1, DOI 10.1016/S0005-2736(99)00197-2; Ohh SH, 2010, ARCH GEFLUGELKD, V74, P30; Patra AK, 2012, APPL ENVIRON MICROB, V78, P4271, DOI 10.1128/AEM.00309-12; Peng ZX, 2016, SCI REP-UK, V6, DOI 10.1038/srep26790; Peng ZX, 2014, APPL MICROBIOL BIOT, V98, P5487, DOI 10.1007/s00253-014-5560-7; PRINS RA, 1975, A VAN LEEUW J MICROB, V41, P1, DOI 10.1007/BF02565031; Ren ZH, 2015, J ANIM SCI, V93, P127, DOI 10.2527/jas.2014-7933; Saido-Sakanaka H, 2004, PEPTIDES, V25, P19, DOI 10.1016/j.peptides.2003.12.009; Shai Y, 1999, BBA-BIOMEMBRANES, V1462, P55, DOI 10.1016/S0005-2736(99)00200-X; STACKEBRANDT E, 1988, INT J SYST BACTERIOL, V38, P321, DOI 10.1099/00207713-38-3-321; STANTON TB, 1980, ARCH MICROBIOL, V127, P145, DOI 10.1007/BF00428018; STEWART CS, 1989, APPL MICROBIOL BIOT, V30, P433; Sutton JD, 2003, J DAIRY SCI, V86, P3620, DOI 10.3168/jds.S0022-0302(03)73968-X; Tanaka T, 2012, PEPTIDES, V34, P242, DOI 10.1016/j.peptides.2011.07.027; Tang ZR, 2009, BRIT J NUTR, V101, P998, DOI 10.1017/S0007114508055633; Wang WJ, 2013, ASIAN AUSTRAL J ANIM, V26, P72, DOI 10.5713/ajas.2012.12277; Wang YZ, 2007, ANIM FEED SCI TECH, V135, P263, DOI 10.1016/j.anifeedsci.2006.07.013; Wang ZB, 2015, ANIM FEED SCI TECH, V201, P99, DOI 10.1016/j.anifeedsci.2015.01.001; WARNER RL, 1972, J ANIM SCI, V34, P161; Williams A, 1992, SPRINGER SERIES CONT; Wright ADG, 2011, ANIM FEED SCI TECH, V166-67, P248, DOI 10.1016/j.anifeedsci.2011.04.015; Wu SD, 2012, PEPTIDES, V35, P225, DOI 10.1016/j.peptides.2012.03.030; Yoon JH, 2014, LIVEST SCI, V159, P53, DOI 10.1016/j.livsci.2013.10.025; Yoon JH, 2012, ANIM FEED SCI TECH, V177, P98, DOI 10.1016/j.anifeedsci.2012.06.009; Yuan Wei, 2015, Chinese Journal of Animal Nutrition, V27, P885; Yue ZB, 2012, RENEW ENERG, V46, P255, DOI 10.1016/j.renene.2012.03.030; ZHU H, 1994, J BACTERIOL, V176, P3885, DOI 10.1128/JB.176.13.3885-3894.1994	63	11	14	3	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2019	14	8							e0221815	10.1371/journal.pone.0221815	http://dx.doi.org/10.1371/journal.pone.0221815			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW6BO	31469857	Green Submitted, Green Published, gold			2022-12-26	WOS:000485062200031
J	Lisci, C; Lewis, JE; Daniel, ZCTR; Stevenson, TJ; Monnier, C; Marshall, HJ; Fowler, M; Ebling, FJP; Ferri, GL; Cocco, C; Jethwa, PH				Lisci, Carlo; Lewis, Jo E.; Daniel, Zoe C. T. R.; Stevenson, Tyler J.; Monnier, Chloe; Marshall, Hayley J.; Fowler, Maxine; Ebling, Francis J. P.; Ferri, Gian-Luca; Cocco, Cristina; Jethwa, Preeti H.			Photoperiodic changes in adiposity increase sensitivity of female Siberian hamsters to systemic VGF derived peptide TLQP-21	PLOS ONE			English	Article							GENE-EXPRESSION; BODY-WEIGHT; FOOD-INTAKE; TISSUE; CELLS; WHITE; BROWN; RECEPTOR; HORMONES; ACID	TLQP-21, a peptide encoded by the highly conserved vgf gene, is expressed in neuroendocrine cells and has been the most prominent VGF-derived peptide studied in relation to control of energy balance. The recent discovery that TLQP-21 is the natural agonist for the complement 3a receptor 1 (C3aR1) has revived interest in this peptide as a potential drug target for obesity. We have investigated its function in Siberian hamsters (Phodopus sungorus), a rodent that displays natural seasonal changes in body weight and adiposity as an adaptation to survive winter. We have previously shown that intracerebroventricular administration of TLQP-21 reduced food intake and body weight in hamsters in their long-day fat state. The aim of our current study was to determine the systemic actions of TLQP-21 on food intake, energy expenditure and body weight, and to establish whether adiposity affected these responses. Peripheral infusion of TLQP-21 (1mg/kg/day for 7 days) in lean hamsters exposed to short photoperiods (SP) reduced cumulative food intake in the home cage (p<0.05), and intake when measured in metabolic cages (P<0.01). Energy expenditure was significantly increased (p<0.001) by TLQP-21 infusion, this was associated with a significant increase in uncoupling protein 1 mRNA in brown adipose tissue (BAT) (p<0.05), and body weight was significantly reduced (p<0.05). These effects of systemic TLQP-21 treatment were not observed in hamsters exposed to long photoperiod (LP) with a fat phenotype. C3aR1 mRNA and protein were abundantly expressed in the hypothalamus, brown and white adipose tissue in hamsters, but changes in expression cannot explain the differential response to TLQP-21 in lean and fat hamsters.	[Lisci, Carlo; Ferri, Gian-Luca; Cocco, Cristina] Univ Cagliari, Dept Biomed Sci, NEF Lab, Cagliari, Italy; [Lewis, Jo E.; Monnier, Chloe; Marshall, Hayley J.; Fowler, Maxine; Ebling, Francis J. P.] Univ Nottingham, Med Sch, Sch Life Sci, Nottingham, England; [Lewis, Jo E.] Univ Cambridge, Inst Metab Sci, Cambridge, England; [Lewis, Jo E.] Univ Cambridge, MRC, Metab Dis Unit, Cambridge, England; [Daniel, Zoe C. T. R.; Jethwa, Preeti H.] Univ Nottingham, Sch Biosci, Sutton Bonington Campus, Nottingham, England; [Stevenson, Tyler J.] Univ Glasgow, Inst Biodivers Anim Hlth & Comparat Med, Glasgow, Lanark, Scotland	University of Cagliari; University of Nottingham; University of Cambridge; University of Cambridge; University of Nottingham; University of Glasgow	Jethwa, PH (corresponding author), Univ Nottingham, Sch Biosci, Sutton Bonington Campus, Nottingham, England.	preeti.jethwa@nottingham.ac.uk	Ferri, Luca Angelo/AAC-5890-2022; Jethwa, Preeti/Y-3123-2019	Ferri, Luca Angelo/0000-0001-9031-6284; Jethwa, Preeti/0000-0003-4401-284X; FERRI, Gian-Luca/0000-0003-2768-349X; Stevenson, Tyler/0000-0003-2644-9685	British Society of Neuroendocrinology; Regione Sardegna (RAS) basic research funds [CRP-26206]	British Society of Neuroendocrinology; Regione Sardegna (RAS) basic research funds	This work was supported by the British Society of Neuroendocrinology (PHJ; https://www.neuroendo.org.uk/) and Regione Sardegna (RAS) basic research funds CRP-26206 (GLF; https://www.researchitaly.it/en/home/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bao RY, 2019, P NATL ACAD SCI USA, V116, P13116, DOI 10.1073/pnas.1902896116; Barrett P, 2005, ENDOCRINOLOGY, V146, P1930, DOI 10.1210/en.2004-1452; Barrett P, 2006, J ENDOCRINOL, V191, P687, DOI 10.1677/joe.1.06929; Bartolomucci A, 2006, P NATL ACAD SCI USA, V103, P14584, DOI 10.1073/pnas.0606102103; Bartolomucci A, 2008, Eat Weight Disord, V13, pe49; Bowers RR, 2005, AM J PHYSIOL-REG I, V288, pR1354, DOI 10.1152/ajpregu.00792.2004; Brancia C, 2010, J ENDOCRINOL, V207, P329, DOI 10.1677/JOE-10-0189; Cero C, 2017, MOL METAB, V6, P148, DOI 10.1016/j.molmet.2016.10.005; Chaudhri O, 2006, PHILOS T R SOC B, V361, P1187, DOI 10.1098/rstb.2006.1856; Cocco C, 2007, J HISTOCHEM CYTOCHEM, V55, P619, DOI 10.1369/jhc.6A7040.2007; D'Amato F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142333; D'Amato F, 2012, J CHEM NEUROANAT, V44, P57, DOI 10.1016/j.jchemneu.2012.05.001; De Silva A, 2012, GUT LIVER, V6, P10, DOI 10.5009/gnl.2012.6.1.10; Demas GE, 2002, AM J PHYSIOL-REG I, V282, pR114, DOI 10.1152/ajpregu.2002.282.1.R114; EBLING FJP, 1994, GEN COMP ENDOCR, V95, P475, DOI 10.1006/gcen.1994.1147; Guo ZK, 2018, NEUROPEPTIDES, V71, P97, DOI 10.1016/j.npep.2018.06.003; Hannedouche S, 2013, J BIOL CHEM, V288, P27434, DOI 10.1074/jbc.M113.497214; Jethwa PH, 2010, J NEUROENDOCRINOL, V22, P564, DOI 10.1111/j.1365-2826.2010.02001.x; Jethwa PH, 2007, ENDOCRINOLOGY, V148, P4044, DOI 10.1210/en.2007-0038; Lewis JE, 2017, ENDOCRINOLOGY, V158, P3090, DOI 10.1210/en.2017-00591; Lewis JE, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03607-x; Lewis JE, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00079; Lewis JE, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172724; Lewis JE, 2016, J MOL ENDOCRINOL, V56, P123, DOI 10.1530/JME-15-0224; Loczenski-Brown DM, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0218970; Molteni L, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.01386; Noli B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141193; Noli B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108456; Parker HE, 2014, EXP PHYSIOL, V99, P1116, DOI 10.1113/expphysiol.2014.079764; Possenti R, 2012, BIOCHEM J, V441, P511, DOI 10.1042/BJ20111165; Reddy AB, 1999, EUR J NEUROSCI, V11, P3255, DOI 10.1046/j.1460-9568.1999.00746.x; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Severini C, 2009, BRIT J PHARMACOL, V157, P984, DOI 10.1111/j.1476-5381.2009.00192.x; Sibilia V, 2010, NEUROENDOCRINOLOGY, V92, P189, DOI 10.1159/000319791; Turolla EA, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.01274; Villarroya F, 2018, CELL METAB, V27, P954, DOI 10.1016/j.cmet.2018.04.006; Warner A, 2010, AM J PHYSIOL-REG I, V298, pR1409, DOI 10.1152/ajpregu.00279.2009; YOUNGSTROM TG, 1995, AM J PHYSIOL-REG I, V268, pR744, DOI 10.1152/ajpregu.1995.268.3.R744	38	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2019	14	8							e0221517	10.1371/journal.pone.0221517	http://dx.doi.org/10.1371/journal.pone.0221517			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW6AB	31465472	Green Published, Green Submitted, gold, Green Accepted			2022-12-26	WOS:000485058200022
J	Justwan, F; Baumgaertner, B; Carlisle, JE; Carson, E; Kizer, J				Justwan, Florian; Baumgaertner, Bert; Carlisle, Juliet E.; Carson, Emma; Kizer, Jordan			The effect of trust and proximity on vaccine propensity	PLOS ONE			English	Article							RISK PERCEPTION; ATTITUDES; PARENTS; CHILDREN; FLU	The main goal of this paper is to study the effects of (1) trust in government medical experts and (2) proximity to a recent disease outbreak on vaccine propensity. More specifically, we explore how these variables affect attitudes with regards to measles. Using original survey data, collected in January/February 2017, we obtain three main empirical findings. First, contrary to our expectations, an individual's proximity to a recent measles outbreak has no independent effect on vaccination attitudes. Second, corroborating previous studies in the field, we find that trust in institutions such as the CDC has a positive effect on our dependent variable. Third, there is a significant interactive relationship between proximity and trust in governmental medical experts. While distance from a previous measles outbreak has no effect on vaccination attitudes for respondents with medium or high levels of trust, the variable exerts a negative effect for subjects with little confidence in government medical experts. In other words: low-trust individuals who live farther away from a recent measles outbreak harbor less favorable views about vaccination for this particular disease than low-trust respondents who live close to an affected area. This implies that citizens who are skeptical of the CDC and similar institutions base their vaccination decision-making to some degree on whether or not a given disease occurs in close vicinity to their community.	[Justwan, Florian; Baumgaertner, Bert] Univ Idaho, Dept Polit & Philosophy, Moscow, ID 83843 USA; [Carlisle, Juliet E.] Univ Utah, Dept Polit Sci, Salt Lake City, UT USA; [Kizer, Jordan] Univ Texas Austin, Lyndon B Johnson Sch Publ Affairs, Austin, TX 78712 USA	Idaho; University of Idaho; Utah System of Higher Education; University of Utah; University of Texas System; University of Texas Austin	Justwan, F (corresponding author), Univ Idaho, Dept Polit & Philosophy, Moscow, ID 83843 USA.	fjustwan@uidaho.edu			National Institutes of Health [P20GM104420]; University of Idaho, College of Letters, Arts, and Social Sciences Undergraduate Collaborative Key Grant; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM104420] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Idaho, College of Letters, Arts, and Social Sciences Undergraduate Collaborative Key Grant; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health, P20GM104420 to BB and the University of Idaho, College of Letters, Arts, and Social Sciences Undergraduate Collaborative Key Grant to FJ. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baumgaertner B, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191728; Bianco A, 2019, VACCINE, V37, P984, DOI 10.1016/j.vaccine.2018.12.062; Bolton P, 1998, PUBLIC HEALTH REP, V113, P521; Borse RH, 2013, EMERG INFECT DIS, V19, P439, DOI 10.3201/eid1903.120394; Byington CL, 2014, PEDIATRICS, V134, P377, DOI 10.1542/peds.2014-1494; Chandran S, 2004, J CONSUM RES, V31, P375, DOI 10.1086/422116; DALES LG, 1993, WESTERN J MED, V159, P455; Driedger SM, 2015, BMC PUBLIC HEALTH, V15, P1, DOI [10.1186/1471-2458-15-1, DOI 10.1186/1471-2458-15-1]; Fill MMA, 2016, MMWR-MORBID MORTAL W, V65, P1039, DOI 10.15585/mmwr.mm6538a3; Hamilton LC, 2015, SAGE OPEN, V5, DOI 10.1177/2158244015602752; Harclerode MA, 2016, J ENVIRON MANAGE, V184, P132, DOI 10.1016/j.jenvman.2016.07.045; Hulsey E, 2015, VACCINE, V33, P2546, DOI 10.1016/j.vaccine.2015.04.020; Jena Anupam B, 2017, HARVARD BUS REV, P1; Langford IH, 2000, RISK ANAL, V20, P691, DOI 10.1111/0272-4332.205062; Larson HJ, 2014, VACCINE, V32, P2150, DOI 10.1016/j.vaccine.2014.01.081; Liberman N, 2008, SCIENCE, V322, P1201, DOI 10.1126/science.1161958; Martin LR, 2017, ANN BEHAV MED, V51, P652, DOI 10.1007/s12160-017-9888-y; Napolitano F, 2018, HUM VACC IMMUNOTHER, V14, P1558, DOI 10.1080/21645515.2018.1463943; O'Connor RE, 1998, RISK ANAL, V18, P547, DOI 10.1023/B:RIAN.0000005929.21712.78; Olive Jacqueline K, 2018, PLoS Med, V15, pe1002616, DOI 10.1371/journal.pmed.1002616; Peters E, 1996, J APPL SOC PSYCHOL, V26, P1427, DOI 10.1111/j.1559-1816.1996.tb00079.x; Poland GA, 2010, VACCINE, V28, pD3, DOI 10.1016/j.vaccine.2010.08.024; Rosoff H, 2012, RISK ANAL, V32, P729, DOI 10.1111/j.1539-6924.2012.01769.x; Rudisill C, 2012, SOC SCI MED, V75, P1362, DOI 10.1016/j.socscimed.2012.06.005; Salmon DA, 2005, ARCH PEDIAT ADOL MED, V159, P470, DOI 10.1001/archpedi.159.5.470; SHAWN DH, 1987, CAN MED ASSOC J, V136, P1038; Smith PJ, 2004, PEDIATRICS, V114, P187, DOI 10.1542/peds.114.1.187; Spence A, 2012, RISK ANAL, V32, P957, DOI 10.1111/j.1539-6924.2011.01695.x; Survey Sampling International, 2017, GLOB PAN BOOK; Suryadevara M, 2013, PEDIATRICS, V132, P319, DOI 10.1542/peds.2012-3927; Timmermans DRM, 2005, VACCINE, V23, P3329, DOI 10.1016/j.vaccine.2005.01.075; Vannice KS, 2011, PEDIATRICS, V127, pS120, DOI 10.1542/peds.2010-1722R; Vaske JJ, 2018, HUM DIMENS WILDL, V23, P115, DOI 10.1080/10871209.2018.1399317; Venkat H, 2017, MMWR-MORBID MORTAL W, V66, pS43, DOI 10.15585/mmwr.mm6620a5; Wadman M, 2017, SCIENCE, V356, P364, DOI 10.1126/science.356.6336.364; Williams BL, 1999, RISK ANAL, V19, P1019, DOI 10.1023/A:1007095808381; Wooten KG, 2007, AM J HEALTH BEHAV, V31, P434, DOI 10.5993/AJHB.31.4.10; Wu SS, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-636; Zielinski-Gutierrez EC, 2006, ECOHEALTH, V3, P28, DOI 10.1007/s10393-005-0001-9	39	16	17	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2019	14	8							e0220658	10.1371/journal.pone.0220658	http://dx.doi.org/10.1371/journal.pone.0220658			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW5XV	31461443	gold, Green Submitted, Green Published			2022-12-26	WOS:000485052300013
J	della Valle, E; Marracino, P; Pakhomova, O; Liberti, M; Apollonio, F				della Valle, Elena; Marracino, Paolo; Pakhomova, Olga; Liberti, Micaela; Apollonio, Francesca			Nanosecond pulsed electric signals can affect electrostatic environment of proteins below the threshold of conformational effects: The case study of SOD1 with a molecular simulation study	PLOS ONE			English	Article							SUPEROXIDE-DISMUTASE MUTANTS; DNA DAMAGE; CU/ZN-SOD; FIELDS; ENZYME; ELECTROPORE; MECHANISMS; BINDING; CANCER; STRESS	Electric fields can be a powerful tool to interact with enzymes or proteins, with an intriguing perspective to allow protein manipulation. Recently, researchers have focused the interest on intracellular enzyme modifications triggered by the application of nanosecond pulsed electric fields. These findings were also supported by theoretical predictions from molecular dynamics simulations focussing on significant variations in protein secondary structures. In this work, a theoretical study utilizing molecular dynamics simulations is proposed to explore effects of electric fields of high intensity and very short nanosecond duration applied to the superoxide dismutase (Cu/Zn-SOD or SOD-1), an important enzyme involved in the cellular antioxidant defence mechanism. The effects of 100-nanosecond pulsed electric fields, with intensities ranging from 10(8) to 7x10(8) V/m, on a single SOD1 enzyme are presented. We demonstrated that the lowest intensity of 10(8) V/m, although not inducing structural changes, can produce electrostatic modifications on the reaction centre of the enzyme, as apparent from the dipolar response and the electric field distribution of the protein active site. Electric pulses above 5x10(8) V/m produced a fast transition between the folded and a partially denatured state, as inferred by the secondary structures analysis. Finally, for the highest field intensity used (7x10(8) V/m), a not reversible transition toward an unfolded state was observed.	[della Valle, Elena] Univ Michigan, BioElect Vis Lab, Ann Arbor, MI 48109 USA; [Marracino, Paolo] Rise Technol Srl, Rome, Italy; [Pakhomova, Olga] Old Dominion Univ, Frank Reidy Res Ctr Bioelect, Norfolk, VA USA; [Liberti, Micaela; Apollonio, Francesca] Sapienza Univ Rome, Dept Informat Engn Elect & Telecommun, Rome, Italy	University of Michigan System; University of Michigan; Old Dominion University; Sapienza University Rome	Apollonio, F (corresponding author), Sapienza Univ Rome, Dept Informat Engn Elect & Telecommun, Rome, Italy.	francesca.apollonio@uniroma1.it	Apollonio, Francesca/U-2533-2017; Liberti, Micaela/T-7522-2017	Apollonio, Francesca/0000-0001-6937-9731; Liberti, Micaela/0000-0002-7494-2696				Abdallah DM, 2009, EUR J PHARMACOL, V603, P93, DOI 10.1016/j.ejphar.2008.11.057; Ahmad M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1258; Amadei A, 2006, J PHYS CHEM B, V110, P7538, DOI 10.1021/jp057095h; Amadei A, 2015, RSC ADV, V5, P96551, DOI 10.1039/c5ra15605j; Amadei A, 2007, THEOR CHEM ACC, V117, P637, DOI 10.1007/s00214-006-0197-y; Apollonio F, 2008, IEEE T MICROW THEORY, V56, P2511, DOI 10.1109/TMTT.2008.2005890; Astrakas L, 2011, J APPL PHYS, V109, DOI 10.1063/1.3585867; Auclair JR, 2010, P NATL ACAD SCI USA, V107, P21394, DOI 10.1073/pnas.1015463107; Avena M, 2015, J CHEM PHYS, V142, DOI 10.1063/1.4917024; Ayers JI, 2016, ACTA NEUROPATHOL, V131, P103, DOI 10.1007/s00401-015-1514-0; Azan A, 2017, SCI REP-UK, V7, DOI 10.1038/srep40448; Beebe SJ, 2015, BIOELECTROCHEMISTRY, V103, P52, DOI 10.1016/j.bioelechem.2014.08.014; Bekard I, 2014, SOFT MATTER, V10, P431, DOI 10.1039/c3sm52653d; Beqollari D, 2016, SKELET MUSCLE, V6, DOI 10.1186/s13395-016-0094-6; Bernardi M, 2019, PHYS CHEM CHEM PHYS, V21, P3339, DOI 10.1039/c8cp06643d; Bernardi M, 2018, J CHEM PHYS, V149, DOI 10.1063/1.5044665; Bonifacino T, 2016, NEUROBIOL DIS, V95, P122, DOI 10.1016/j.nbd.2016.07.011; Breton M, 2012, BIOELECTROMAGNETICS, V33, P106, DOI 10.1002/bem.20692; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; CARLIOZ A, 1986, EMBO J, V5, P623, DOI 10.1002/j.1460-2075.1986.tb04256.x; Carr L, 2017, SCI REP-UK, V7, DOI 10.1038/srep41267; Childers MC, 2017, MOL SYST DES ENG, V2, P9, DOI [10.1039/c6me00083e, 10.1039/C6ME00083E]; Cleveland DW, 2001, NAT REV NEUROSCI, V2, P806, DOI 10.1038/35097565; D'Alessandro M, 2004, J PHYS CHEM B, V108, P16255, DOI 10.1021/jp0487861; Denzi A, 2013, J MEMBRANE BIOL, V246, P761, DOI 10.1007/s00232-013-9546-7; Ding F, 2012, J MOL BIOL, V421, P548, DOI 10.1016/j.jmb.2011.12.029; Dolashka P, 2011, SPECTROCHIM ACTA A, V83, P67, DOI 10.1016/j.saa.2011.07.048; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Fafarman AT, 2012, P NATL ACAD SCI USA, V109, pE299, DOI 10.1073/pnas.1111566109; Falconi M, 2001, BIOPHYS J, V80, P2556, DOI 10.1016/S0006-3495(01)76227-3; Freedman KJ, 2013, SCI REP-UK, V3, DOI 10.1038/srep01638; Fridovich I, 1998, PROTEIN SCI, V7, P2688, DOI 10.1002/pro.5560071225; FRIDOVICH I, 1986, ADV ENZYMOL RAMB, V58, P61; Fried SD, 2017, ANNU REV BIOCHEM, V86, P387, DOI 10.1146/annurev-biochem-061516-044432; GETZOFF ED, 1983, NATURE, V306, P287, DOI 10.1038/306287a0; GETZOFF ED, 1992, NATURE, V358, P347, DOI 10.1038/358347a0; HALLIWELL B, 1982, TRENDS BIOCHEM SCI, V7, P270, DOI 10.1016/0968-0004(82)90003-2; HALLIWELL B, 1992, J NEUROCHEM, V59, P1609, DOI 10.1111/j.1471-4159.1992.tb10990.x; Hamming R. W., 1989, DIGITAL FILTERS; Hekstra DR, 2016, NATURE, V540, P400, DOI 10.1038/nature20571; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hess B, 2004, J PHYS CHEM B, V108, P16255; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; IMLAY JA, 1988, SCIENCE, V240, P1302, DOI 10.1126/science.3287616; IMLAY JA, 1988, SCIENCE, V240, P640, DOI 10.1126/science.2834821; In S, 2016, MOL NEUROBIOL, V53, P777, DOI 10.1007/s12035-014-9087-9; Jensen MO, 2012, SCIENCE, V336, P229, DOI 10.1126/science.1216533; Kaur SJ, 2016, GENE, V577, P109, DOI 10.1016/j.gene.2015.11.049; Kawakami T, 2009, INT J IMPOT RES, V21, P348, DOI 10.1038/ijir.2009.28; Lee YEK, 2009, ANNU REV ANAL CHEM, V2, P57, DOI 10.1146/annurev.anchem.1.031207.112823; Lugli F, 2010, J CHEM THEORY COMPUT, V6, P3516, DOI 10.1021/ct1001335; Marracino P, 2017, J MEMBRANE BIOL, V250, P11, DOI 10.1007/s00232-016-9917-y; Marracino P, BIORXIV, DOI [10.1101/533984, DOI 10.1101/533984]; Marracino P, 2018, ACS OMEGA, V3, P15361, DOI 10.1021/acsomega.8b02230; Marracino P, 2015, BIOELECTROMAGNETICS, V36, P377, DOI 10.1002/bem.21916; Marracino P, 2013, J PHYS CHEM B, V117, P2273, DOI 10.1021/jp309857b; MCCORD JM, 1969, J BIOL CHEM, V244, P6049; Muratori C, 2017, J BIOL CHEM, V292, P19381, DOI 10.1074/jbc.M117.803049; Nowick JS, 2008, ACCOUNTS CHEM RES, V41, P1319, DOI 10.1021/ar800064f; Ojeda-May P, 2010, BIOPHYS J, V99, P595, DOI 10.1016/j.bpj.2010.04.040; Peixoto EBMI, 2009, AM J NEPHROL, V29, P309, DOI 10.1159/000163767; Perry JJP, 2007, NEUROSCIENCE, V145, P1280, DOI 10.1016/j.neuroscience.2006.10.045; Perry JJP, 2010, BBA-PROTEINS PROTEOM, V1804, P245, DOI 10.1016/j.bbapap.2009.11.004; Reale R, 2013, J CHEM PHYS, V139, DOI 10.1063/1.4832383; Schmidlin T, 2013, PROTEIN ENG DES SEL, V26, P503, DOI 10.1093/protein/gzt030; Schutz CN, 2001, PROTEINS, V44, P400, DOI 10.1002/prot.1106; Slocum JD, 2018, ANNU REV PHYS CHEM, V69, P253, DOI 10.1146/annurev-physchem-052516-045011; Sondergaard CR, 2011, J CHEM THEORY COMPUT, V7, P2284, DOI 10.1021/ct200133y; Suydam IT, 2006, SCIENCE, V313, P200, DOI 10.1126/science.1127159; Toschi F, 2009, J PHYS CHEM B, V113, P369, DOI 10.1021/jp807896g; Tyner KM, 2007, BIOPHYS J, V93, P1163, DOI 10.1529/biophysj.106.092452; van Gunsteren W, 1996, BIOMOLECULAR SIMULAT; Wang XW, 2014, J PHYS CHEM A, V118, P8942, DOI 10.1021/jp501051r; Wood JD, 2003, NEUROPATH APPL NEURO, V29, P529, DOI 10.1046/j.0305-1846.2003.00518.x; Yang PK, 2014, BIOPOLYMERS, V101, P861, DOI 10.1002/bip.22464; Yang PK, 2013, INT J MOL SCI, V14, P14408, DOI 10.3390/ijms140714408; Zanetti-Polzi L, 2013, THEOR CHEM ACC, V132, DOI 10.1007/s00214-013-1393-1; Zhao W, 2007, J AGR FOOD CHEM, V55, P9850, DOI 10.1021/jf072186s	78	18	18	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2019	14	8							e0221685	10.1371/journal.pone.0221685	http://dx.doi.org/10.1371/journal.pone.0221685			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5WO	31454403	Green Submitted, Green Published, gold			2022-12-26	WOS:000485049000041
J	Attarilar, S; Salehi, MT; Al-Fadhalah, KJ; Djavanroodi, F; Mozafari, M				Attarilar, Shokouh; Salehi, Mohamad Taghi; Al-Fadhalah, Khaled J.; Djavanroodi, Faramarz; Mozafari, Masoud			Functionally graded titanium implants: Characteristic enhancement induced by combined severe plastic deformation	PLOS ONE			English	Article							ULTRAFINE-GRAINED TITANIUM; SURFACE NANOCRYSTALLIZATION; DYNAMIC RECRYSTALLIZATION; NANOSTRUCTURED MATERIALS; MECHANICAL-PROPERTIES; STAINLESS-STEEL; ELASTIC-MODULUS; CELL RESPONSE; PURE TITANIUM; MICROSTRUCTURE	Commercially pure titanium was processed by equal channel angular pressing (ECAP) and surface mechanical attrition treatment (SMAT) for the purpose of developing functionally graded titanium used for implants and a gradient structure including nanostructured, deformed and undeformed zones were produced on the samples. In particular, it was aimed to design the gradient-structure in the titanium with enhanced properties by applying 4 ECAP passes to form bulk structure of ultrafine-grains and subsequently subjecting SMAT to the surface of ECAPed samples to produce nanostructured surface region. Microstructural examination was made by electron back scatter diffraction (EBSD). Also, microhardness, nanoindentation, topography, roughness and wettability were evaluated. To examine the biological response, human osteosarcoma cells were cultured in contact with the samples in various time periods and morphology change, cell viability and alkaline phosphate activity were conducted also cell morphology was monitored. EBSD showed development of ultrafine-grained structure after 4 passes of ECAP with an average grain size of 500 nm. Applying SMAT resulted in additional refinement in the ECAP samples, particularly in the subsurface regions to a depth of 112 mu m. Furthermore, the SMATed samples showed an enhancement in roughness, wettability and hardness magnitudes. Viability enhanced up to 7% in SMATed (+) ECAPed sample, although the acceptable cell adhesion, improved cell differentiation and mineralization were seen. The combined use of ECAP and SMAT has shown a good potential for optimizing the design of modern functionally graded medical devices and implants.	[Attarilar, Shokouh; Salehi, Mohamad Taghi] Iran Univ Sci & Technol, Mat Sci & Engn Dept, Tehran, Iran; [Al-Fadhalah, Khaled J.] Kuwait Univ, Coll Engn & Petr, Dept Mech Engn, Kuwait, Kuwait; [Djavanroodi, Faramarz] Prince Mohammad Bin Fahd Univ, Coll Engn, Dept Mech Engn, Al Khobar, Saudi Arabia; [Djavanroodi, Faramarz] Imperial Coll London, Dept Mech Engn, London, England; [Mozafari, Masoud] Univ Toronto, Mt Sinai Hosp, Lunenfeld Tanenbaum Res Inst, Toronto, ON, Canada	Iran University Science & Technology; Kuwait University; Prince Mohammad Bin Fahd University; Imperial College London; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute	Salehi, MT (corresponding author), Iran Univ Sci & Technol, Mat Sci & Engn Dept, Tehran, Iran.; Mozafari, M (corresponding author), Univ Toronto, Mt Sinai Hosp, Lunenfeld Tanenbaum Res Inst, Toronto, ON, Canada.	salehi@iust.ac.ir; mozafari.masoud@gmail.com	Attarilar, shokooh/AFJ-9343-2022; Attarilar, shokooh/AAF-6381-2022; Mozafari, Masoud/I-3061-2013; Djavanroodi, faramarz/ABD-6078-2021	Attarilar, shokooh/0000-0003-3354-9692; Attarilar, shokooh/0000-0003-3354-9692; Mozafari, Masoud/0000-0002-0232-352X; 	Kuwait University [GE 01/07]	Kuwait University	The authors gratefully acknowledge the technical support provided by Kuwait University General Facility project (GE 01/07) for sample preparation, scanning electron microscopy, and EBSD measurements.; The authors gratefully acknowledge the technical support provided by Kuwait University General Facility project (GE 01/07) for sample preparation, scanning electron microscopy, and EBSD measurements.	Abbasi M, 2015, ACS NANO, V9, P10991, DOI 10.1021/acsnano.5b04296; Al-Samman T, 2008, MAT SCI ENG A-STRUCT, V490, P411, DOI 10.1016/j.msea.2008.02.004; Astaraee AH, 2017, MATER DESIGN, V116, P365, DOI 10.1016/j.matdes.2016.12.045; Bagherifard S, 2009, SURF ENG, V25, P3, DOI 10.1179/026708408X334087; Bagherifard S., 2017, ACTA BIOMATER; Bagherifard S, 2014, ACS APPL MATER INTER, V6, P7963, DOI 10.1021/am501119k; Bahl S, 2018, MATER DESIGN, V144, P169, DOI 10.1016/j.matdes.2018.02.022; Basu S., 2016, P R SOC A, V472, P1; Beausir B.., 2017, ANAL TOOLS ELECT XRA; Beygelzimer Y, 2002, ULTRAFINE GRAINED MATERIALS II, P297; Bornstein MM, 2008, CLIN ORAL IMPLAN RES, V19, P233, DOI 10.1111/j.1600-0501.2007.01473.x; Chen YJ, 2010, METALL MATER TRANS A, V41A, P787, DOI 10.1007/s11661-009-0040-x; Chen YJ, 2010, MAT SCI ENG A-STRUCT, V527, P789, DOI 10.1016/j.msea.2009.09.005; Cho KT, 2012, MAT SCI ENG A-STRUCT, V543, P44, DOI 10.1016/j.msea.2012.02.043; Dai K, 2007, MAT SCI ENG A-STRUCT, V463, P46, DOI 10.1016/j.msea.2006.07.159; Dds Y. S., 2014, J PROSTHODONT RES, V59, P20; Ebrahimi M, 2016, MAT SCI ENG A-STRUCT, V650, P1, DOI 10.1016/j.msea.2015.10.014; Ebrahimi M, 2014, MATER DESIGN, V63, P531, DOI 10.1016/j.matdes.2014.06.043; Estrin Y, 2018, WOODH PUBL SER BIOM, P419, DOI 10.1016/B978-0-12-812456-7.00019-6; Estrin Y, 2013, ACTA MATER, V61, P782, DOI 10.1016/j.actamat.2012.10.038; Faraji G, 2011, MATER LETT, V65, P3009, DOI 10.1016/j.matlet.2011.06.039; Ferreira M. R. W, 2016, INT J BIOMATER, V2016, P1; Figueiredo RB, 2007, ACTA MATER, V55, P4769, DOI 10.1016/j.actamat.2007.04.043; Gadelmawla ES, 2002, J MATER PROCESS TECH, V123, P133, DOI 10.1016/S0924-0136(02)00060-2; Geetha M, 2009, PROG MATER SCI, V54, P397, DOI 10.1016/j.pmatsci.2008.06.004; Gomes CC, 2011, GENET MOL BIOL, V34, P116, DOI 10.1590/S1415-47572010005000118; Hahn BD, 2009, ACTA BIOMATER, V5, P3205, DOI 10.1016/j.actbio.2009.05.005; Hashmi S, 2014, COMPREHENSIVE MATERIALS PROCESSING, VOL 1: ASSESSING PROPERTIES OF CONVENTIONAL AND SPECIALIZED MATERIALS, pXXVII; Huang L., 2006, NANOMECHANICAL PROPE, Vl, P208; Humphreys F.J., 2004, RECRYSTALLIZATION RE, DOI 10.1016/B978-0-08-044164-1.X5000-2; Jin Xiao, 2019, MAT BASEL, V12, P140; Jin Z., 2009, SURFACE NANOCRYSTALL, P515; Kawalko J, 2018, MATER CHARACT, V141, P19, DOI 10.1016/j.matchar.2018.04.037; Kim T. N., 2016, BIOMED MATER, V2, pS117; Kubacka D, 2019, APPL SURF SCI, V472, P54, DOI 10.1016/j.apsusc.2018.04.120; Liu XL, 2018, SCRIPTA MATER, V150, P57, DOI 10.1016/j.scriptamat.2018.03.007; Lu K, 2004, MAT SCI ENG A-STRUCT, V375, P38, DOI 10.1016/j.msea.2003.10.261; Meyers MA, 2006, PROG MATER SCI, V51, P427, DOI 10.1016/j.pmatsci.2005.08.003; Misra RDK, 2013, ACTA BIOMATER, V9, P6245, DOI 10.1016/j.actbio.2012.12.003; Moskalenko VA, 2017, MAT SCI ENG A-STRUCT, V700, P707, DOI 10.1016/j.msea.2017.06.057; Muley SV, 2016, ACTA BIOMATER, V30, P408, DOI 10.1016/j.actbio.2015.10.043; Nie F. L., 2012, IN VITRO VIVO STUDIE, P1694, DOI [10.1002/jbm.a.34472, DOI 10.1002/JBM.A.34472]; Niinomi M, 1998, MAT SCI ENG A-STRUCT, V243, P231, DOI 10.1016/S0921-5093(97)00806-X; OLIVER WC, 1992, J MATER RES, V7, P1564, DOI 10.1557/JMR.1992.1564; Ponsonnet L, 2003, MAT SCI ENG C-BIO S, V23, P551, DOI 10.1016/S0928-4931(03)00033-X; Pougis A, 2014, SCRIPTA MATER, V72-73, P59, DOI 10.1016/j.scriptamat.2013.10.020; Qarni MJ, 2017, MAT SCI ENG A-STRUCT, V699, P31, DOI 10.1016/j.msea.2017.05.040; Saito Y, 1998, SCRIPTA MATER, V39, P1221, DOI 10.1016/S1359-6462(98)00302-9; Sakai T, 2014, PROG MATER SCI, V60, P130, DOI 10.1016/j.pmatsci.2013.09.002; Shahab F, 2006, BIOMATERIALS, V27, P3532, DOI 10.1016/j.biomaterials.2006.02.027; Shuman DJ, 2007, MATER CHARACT, V58, P380, DOI 10.1016/j.matchar.2006.06.005; Sorensen C, 2014, METALL MATER TRANS A, V45A, P4165, DOI 10.1007/s11661-014-2345-7; Stolyarov VV, 2001, MAT SCI ENG A-STRUCT, V299, P59, DOI 10.1016/S0921-5093(00)01411-8; Sun ZL, 1997, J BIOMED MATER RES, V34, P29, DOI 10.1002/(SICI)1097-4636(199701)34:1<29::AID-JBM5>3.0.CO;2-P; Sunil BR, 2013, MAT SCI ENG C-MATER, V33, P1607, DOI 10.1016/j.msec.2012.12.095; Unal O, 2014, VACUUM, V110, P202, DOI 10.1016/j.vacuum.2014.08.004; Valiev B. R. Z., 2008, ADV ENG MATER, V10, P15; Valiev RZ, 2008, MATER SCI FORUM, V584-586, P49, DOI 10.4028/www.scientific.net/MSF.584-586.49; Valiev RZ, 2018, WOODH PUBL SER BIOM, P393, DOI 10.1016/B978-0-12-812456-7.00018-4; Valiev RZ, 2006, PROG MATER SCI, V51, P881, DOI 10.1016/j.pmatsci.2006.02.003; Valiev RZ, 2000, PROG MATER SCI, V45, P103, DOI 10.1016/S0079-6425(99)00007-9; Wang Y, 2014, FUNDAMENTALS RECRYST; Wassmann T, 2017, INT J IMPLANT DENT, V3, P1, DOI 10.1186/s40729-017-0093-3; Wennerberg A, 2009, CLIN ORAL IMPLAN RES, V20, P172, DOI 10.1111/j.1600-0501.2009.01775.x; Wu XL, 2014, MATER RES LETT, V2, P185, DOI 10.1080/21663831.2014.935821; Wurschum R, 2003, ADV ENG MATER, V5, P365, DOI 10.1002/adem.200310079; Yan HT, 2009, J MATER PROCESS TECH, V209, P2627, DOI 10.1016/j.jmatprotec.2008.06.012; Yang DK, 2013, ACTA MATER, V61, P2840, DOI 10.1016/j.actamat.2013.01.018; Yao C, 2005, CERAM TRANS, V159, P239; Yin F, 2015, METALL MATER TRANS A, V46A, P1253, DOI 10.1007/s11661-014-2689-z; Zheng CY, 2011, APPL SURF SCI, V257, P9086, DOI 10.1016/j.apsusc.2011.05.105; Zheng CY, 2011, APPL SURF SCI, V257, P5634, DOI 10.1016/j.apsusc.2011.01.062; Zhu KY, 2004, ACTA MATER, V52, P4101, DOI 10.1016/j.actamat.2004.05.023; Zhu YT, 2004, SCRIPTA MATER, V51, P825, DOI 10.1016/j.scriptamat.2004.05.006; Zhu YT, 2004, NAT MATER, V3, P351, DOI 10.1038/nmat1141	75	35	36	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2019	14	8							e0221491	10.1371/journal.pone.0221491	http://dx.doi.org/10.1371/journal.pone.0221491			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5TR	31442256	gold, Green Published, Green Submitted			2022-12-26	WOS:000485041400038
J	Chen, MH; Zhang, XJ; Hao, W				Chen, Minghui; Zhang, Xiaojie; Hao, Wei			H3K4 dimethylation at FosB promoter in the striatum of chronic stressed rats promotes morphine-induced conditioned place preference	PLOS ONE			English	Article							GYRUS GRANULE NEURONS; EARLY GENE-EXPRESSION; DELTA-FOSB; GLUCOCORTICOID-RECEPTOR; NUCLEUS-ACCUMBENS; BEHAVIORAL SENSITIZATION; DOPAMINOCEPTIVE NEURONS; CORTICOSTERONE LEVELS; SWIM STRESS; HISTONE H3	Expression of FosB gene in striatum is essential in addiction establishment. Activated glucocorticoid receptors (GRs) induce FosB gene expression in response to stressor. Therefore, elevation of FosB expression in striatum serves as one mechanism by which stress increases risk for addiction. In this study, adult male Sprague-Dawley rats were used to investigate whether chronic stress result in histone modifications at FosB gene promoter in striatum and how these histone modifications affect FosB expression and the establishment of addiction behavior after administration of drugs of abuse. Animals were randomly assigned to three groups: Electric foot shock (EFS) group received 7-day EFS to induce chronic stress; electric foot shock plus mifepristone (EFS + Mif) group were injected with mifepristone, a nonspecific GRs antagonist, before EFS; control group did not receive any EFS. All groups then received 2-day conditioned place preference (CPP) training with morphine (5 mg/kg body weight) to test vulnerability to drug addiction. Before and after morphine administration, FosB mRNA in striatum was quantified by real-time RT-PCR. Levels of histone H3/H4 acetylation and histone H3K4 dimethylation at FosB promoter in striatum after morphine administration were measured by using chromatin immunoprecipitation (ChIP) plus real-time PCR. EFS group had stronger place preference to morphine and had significantly higher level of FosB mRNA in striatum than the other two groups. H3K4 dimethylation was 2.6-fold higher in EFS group than control group, while no statistical difference in H3/H4 acetylation. Mifepristone administration before EFS decreased histone H3K4 dimethylation and FosB mRNA in striatum, and also diminished morphine-induced conditioned place preference. Altogether, increased level of H3K4 dimethylation at FosB promoter in striatum is partially dependent on the activation of GR and responsible for the elevated level of morphine-induced FosB mRNA in chronic stressed animals.	[Chen, Minghui; Zhang, Xiaojie; Hao, Wei] Cent S Univ, Xiangya Hosp 2, Dept Psychiat, Changsha, Hunan, Peoples R China; [Chen, Minghui; Zhang, Xiaojie; Hao, Wei] Cent S Univ, Mental Hlth Inst, Changsha, Hunan, Peoples R China; [Chen, Minghui; Zhang, Xiaojie; Hao, Wei] Natl Clin Res Ctr Mental Disorders, Changsha, Hunan, Peoples R China; [Chen, Minghui; Zhang, Xiaojie; Hao, Wei] Natl Technol Inst Mental Disorders, Changsha, Hunan, Peoples R China; [Chen, Minghui; Zhang, Xiaojie; Hao, Wei] Hunan Key Lab Psychiat & Mental Hlth, Changsha, Hunan, Peoples R China	Central South University; Central South University	Hao, W (corresponding author), Cent S Univ, Xiangya Hosp 2, Dept Psychiat, Changsha, Hunan, Peoples R China.; Hao, W (corresponding author), Cent S Univ, Mental Hlth Inst, Changsha, Hunan, Peoples R China.; Hao, W (corresponding author), Natl Clin Res Ctr Mental Disorders, Changsha, Hunan, Peoples R China.; Hao, W (corresponding author), Natl Technol Inst Mental Disorders, Changsha, Hunan, Peoples R China.; Hao, W (corresponding author), Hunan Key Lab Psychiat & Mental Hlth, Changsha, Hunan, Peoples R China.	weihao57@163.com		Chen, Minghui/0000-0002-0316-2289	National Key R&D Program of China [2017YFC1310400]; Key Program of the National Natural Science of China [81130020]; National 973 Program [2015CB553500]	National Key R&D Program of China; Key Program of the National Natural Science of China; National 973 Program(National Basic Research Program of China)	This work was funded by National Key R&D Program of China"(No. 2017YFC1310400), the Key Program of the National Natural Science of China (81130020), and National 973 Program (2015CB553500) to WH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alibhai IN, 2007, BRAIN RES, V1143, P22, DOI 10.1016/j.brainres.2007.01.069; Ambroggi F, 2009, NAT NEUROSCI, V12, P247, DOI 10.1038/nn.2282; Anier K, 2010, NEUROPSYCHOPHARMACOL, V35, P2450, DOI 10.1038/npp.2010.128; Attarzadeh-Yazdi G, 2013, BEHAV BRAIN RES, V252, P339, DOI 10.1016/j.bbr.2013.06.018; Bali A, 2015, EUR J PHARMACOL, V746, P282, DOI 10.1016/j.ejphar.2014.10.017; Barik J, 2010, BIOL PSYCHIAT, V68, P231, DOI 10.1016/j.biopsych.2010.03.037; Bilang-Bleuel A, 2005, EUR J NEUROSCI, V22, P1691, DOI 10.1111/j.1460-9568.2005.04358.x; Boyce-Rustay JM, 2008, BEHAV BRAIN RES, V186, P133, DOI 10.1016/j.bbr.2007.07.031; Bremner JD, 1996, AM J PSYCHIAT, V153, P369; Campos AC, 2013, REV BRAS PSIQUIATR, V35, pS101, DOI 10.1590/1516-4446-2013-1139; Chandramohan Y, 2007, J NEUROCHEM, V101, P815, DOI 10.1111/j.1471-4159.2006.04396.x; Chinenov Y, 2008, P NATL ACAD SCI USA, V105, P20185, DOI 10.1073/pnas.0810863105; Conrad KL, 2011, ALCOHOL, V45, P585, DOI 10.1016/j.alcohol.2010.11.002; Covington HE, 2001, PSYCHOPHARMACOLOGY, V158, P388, DOI 10.1007/s002130100858; Der-Avakian A, 2006, PSYCHONEUROENDOCRINO, V31, P653, DOI 10.1016/j.psyneuen.2006.02.004; Deroche-Gamonet V, 2003, J NEUROSCI, V23, P4785; Dong ZF, 2006, HIPPOCAMPUS, V16, P809, DOI 10.1002/hipo.20216; Druley K A, 1988, Recent Dev Alcohol, V6, P89; Grakalic I, 2006, PSYCHOPHARMACOLOGY, V189, P277, DOI 10.1007/s00213-006-0562-5; Hansson AC, 2008, BRAIN RES, V1215, P1, DOI 10.1016/j.brainres.2008.03.080; Herrmann L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042603; Kaur A, 2015, N-S ARCH PHARMACOL, V388, P497, DOI 10.1007/s00210-015-1084-7; Koob GF, 2005, NAT NEUROSCI, V8, P1442, DOI 10.1038/nn1105-1442; Kosten TA, 2002, PSYCHONEUROENDOCRINO, V27, P35, DOI 10.1016/S0306-4530(01)00035-X; LaPlant Q, 2010, NAT NEUROSCI, V13, P1137, DOI 10.1038/nn.2619; Larson EB, 2010, J NEUROCHEM, V115, P112, DOI 10.1111/j.1471-4159.2010.06907.x; Levine AA, 2005, P NATL ACAD SCI USA, V102, P19186, DOI 10.1073/pnas.0509735102; LINSKY AS, 1985, J STUD ALCOHOL, V46, P72, DOI 10.15288/jsa.1985.46.72; Liu XB, 2005, MOL BRAIN RES, V137, P47, DOI 10.1016/j.molbrainres.2005.02.021; Lutfy K, 2006, J NEUROCHEM, V99, P1321, DOI 10.1111/j.1471-4159.2006.04217.x; Majewska MD, 2002, PSYCHONEUROENDOCRINO, V27, P5, DOI 10.1016/S0306-4530(01)00033-6; Mantsch JR, 2007, NEUROPSYCHOPHARMACOL, V32, P367, DOI 10.1038/sj.npp.1301077; Marinelli M, 1998, P NATL ACAD SCI USA, V95, P7742, DOI 10.1073/pnas.95.13.7742; Marinelli M, 2002, EUR J NEUROSCI, V16, P387, DOI 10.1046/j.1460-9568.2002.02089.x; Matuszewich L, 2004, NEUROSCIENCE, V124, P637, DOI 10.1016/j.neuroscience.2003.12.007; McClung CA, 2004, MOL BRAIN RES, V132, P146, DOI 10.1016/j.molbrainres.2004.05.014; Meng SS, 2014, PSYCHOPHARMACOLOGY, V231, P27, DOI 10.1007/s00213-013-3204-8; Nestler EJ, 2008, PHILOS T R SOC B, V363, P3245, DOI 10.1098/rstb.2008.0067; Nestler Eric J, 2012, Clin Psychopharmacol Neurosci, V10, P136, DOI 10.9758/cpn.2012.10.3.136; Nunez C, 2010, J NEUROCHEM, V114, P475, DOI 10.1111/j.1471-4159.2010.06765.x; Perrotti LI, 2005, EUR J NEUROSCI, V21, P2817, DOI 10.1111/j.1460-9568.2005.04110.x; Piazza PV, 1998, TRENDS PHARMACOL SCI, V19, P67, DOI 10.1016/S0165-6147(97)01115-2; Prasad BM, 1995, ANN NY ACAD SCI, V771, P617, DOI 10.1111/j.1749-6632.1995.tb44714.x; Renthal W, 2007, NEURON, V56, P517, DOI 10.1016/j.neuron.2007.09.032; Renthal William, 2009, Dialogues Clin Neurosci, V11, P257; Renthal W, 2009, SEMIN CELL DEV BIOL, V20, P387, DOI 10.1016/j.semcdb.2009.01.005; Retana-Marquez S, 2003, HORM BEHAV, V44, P327, DOI 10.1016/j.yhbeh.2003.04.001; Robinson TE, 2000, ADDICTION, V95, pS91; Robison AJ, 2011, NAT REV NEUROSCI, V12, P623, DOI 10.1038/nrn3111; Sinha R, 2003, PSYCHOPHARMACOLOGY, V170, P62, DOI 10.1007/s00213-003-1525-8; Sinha R, 2009, BIOL PSYCHIAT, V66, P100, DOI 10.1016/j.biopsych.2009.05.003; Stamp J, 2001, NEUROSCIENCE, V107, P465, DOI 10.1016/S0306-4522(01)00364-5; Stamp JA, 2008, BRAIN RES, V1204, P94, DOI 10.1016/j.brainres.2008.02.019; Stohr T, 1999, BEHAV BRAIN RES, V103, P85, DOI 10.1016/S0166-4328(99)00027-3; Tata DA, 2008, SYNAPSE, V62, P325, DOI 10.1002/syn.20497; Ulery PG, 2007, EUR J NEUROSCI, V25, P224, DOI 10.1111/j.1460-9568.2006.05262.x; Vialou V, 2010, J NEUROSCI, V30, P14585, DOI 10.1523/JNEUROSCI.2496-10.2010; Vialou V, 2010, NAT NEUROSCI, V13, P745, DOI 10.1038/nn.2551; Yang Y, 2004, J NEUROSCI, V24, P2412, DOI 10.1523/JNEUROSCI.5544-03.2004; Zachariou V, 2006, NAT NEUROSCI, V9, P205, DOI 10.1038/nn1636; Zentner GE, 2013, NAT STRUCT MOL BIOL, V20, P259, DOI 10.1038/nsmb.2470; Zhang XJ, 2011, NEUROPSYCHOBIOLOGY, V64, P211, DOI 10.1159/000327603	62	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2019	14	8							e0221506	10.1371/journal.pone.0221506	http://dx.doi.org/10.1371/journal.pone.0221506			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5TR	31442272	Green Published, gold, Green Submitted			2022-12-26	WOS:000485041400040
J	Lin, C; Mendoza-Espinosa, P; Rouzina, I; Guzman, O; Moreno-Razo, JA; Francisco, JS; Bruinsma, R				Lin, Chen; Mendoza-Espinosa, Paola; Rouzina, Ioulia; Guzman, Orlando; Antonio Moreno-Razo, Jose; Francisco, Joseph S.; Bruinsma, Robijn			Specific inter-domain interactions stabilize a compact HIV-1 Gag conformation	PLOS ONE			English	Article							PARTICLE MESH EWALD; TYPE-1 GAG; IN-VITRO; HELICAL CONFORMATION; TERMINAL DOMAIN; CAPSID PROTEIN; GENOMIC RNA; FORCE-FIELD; MEMBRANE; BINDING	HIV-1 Gag is a large multidomain poly-protein with flexible unstructured linkers connecting its globular subdomains. It is compact when in solution but assumes an extended conformation when assembled within the immature HIV-1 virion. Here, we use molecular dynamics (MD) simulations to quantitatively characterize the intra-domain interactions of HIV-1 Gag. We find that the matrix (MA) domain and the C-terminal subdomain CA(ctd) of the CA capsid domain can form a bound state. The bound state, which is held together primarily by interactions between complementary charged and polar residues, stabilizes the compact state of HIV-1 Gag. We calculate the depth of the attractive free energy potential between the MA/CA(ctd) sites and find it to be about three times larger than the dimerization interaction between the CA(ctd) domains. Sequence analysis shows high conservation within the newly-found intra-Gag MA/CA(ctd) binding site, as well as its spatial proximity to other well known elements of Gag-such as CA(ctd)'s SP1 helix region, its inositol hexaphosphate (IP6) binding site and major homology region (MHR), as well as the MA trimerization site. Our results point to a high, but yet undetermined, functional significance of the intra-Gag binding site. Recent biophysical experiments that address the binding specificity of Gag are interpreted in the context of the MA/CA(ctd) bound state, suggesting an important role in selective packaging of genomic RNA by Gag.	[Lin, Chen] Univ Calif Los Angeles, Dept Chem & Biochem, 405 Hilgard Ave, Los Angeles, CA 90024 USA; [Mendoza-Espinosa, Paola; Guzman, Orlando; Antonio Moreno-Razo, Jose] Univ Autonoma Metropolitana, Dept Fis, Mexico City, DF, Mexico; [Rouzina, Ioulia] Ohio State Univ, Dept Chem & Biochem, Columbus, OH 43210 USA; [Francisco, Joseph S.] Univ Penn, Dept Chem, Philadelphia, PA 19104 USA; [Bruinsma, Robijn] Univ Calif Los Angeles, Dept Phys & Astron, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; Universidad Autonoma Metropolitana - Mexico; University System of Ohio; Ohio State University; University of Pennsylvania; University of California System; University of California Los Angeles	Guzman, O (corresponding author), Univ Autonoma Metropolitana, Dept Fis, Mexico City, DF, Mexico.; Bruinsma, R (corresponding author), Univ Calif Los Angeles, Dept Phys & Astron, Los Angeles, CA 90095 USA.	ogl@xanum.uam.mx; bruinsma@ucla.edu	Guzman, Orlando/GXV-9375-2022	Guzman, Orlando/0000-0002-4485-517X	National Science Foundation-Division of Materials Research [1610384]; National Science Foundation-XSEDE computing resources [TGMCB180123]; University of Nebraska-Holland Computing Centre computing resources; Consejo Nacional de Ciencia y Tecnologia (Mexico), Project "Fronteras de la Ciencia" [2015-02-1450]; NSF-DMR [1610384]; Consejo Nacional de Ciencia y Tecnologia (Mexico) [2015-02-1450]	National Science Foundation-Division of Materials Research(National Science Foundation (NSF)); National Science Foundation-XSEDE computing resources; University of Nebraska-Holland Computing Centre computing resources; Consejo Nacional de Ciencia y Tecnologia (Mexico), Project "Fronteras de la Ciencia"; NSF-DMR(National Science Foundation (NSF)); Consejo Nacional de Ciencia y Tecnologia (Mexico)(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This work was supported by National Science Foundation-Division of Materials Research, Grant 1610384, https://www.nsf.gov/div/index.jsp?div-DMR (RB); National Science Foundation-XSEDE computing resources, Charge #TGMCB180123, https://www.xsede.orgi; The University of Nebraska-Holland Computing Centre computing resources, https://hcc.unl.edu/ (JSF and CL); and Consejo Nacional de Ciencia y Tecnologia (Mexico), Project "Fronteras de la Ciencia" 2015-02-1450, https://www.conacyt.gob.mx/(JAMR, OG, PME).; We are grateful to Professor Mauricio Comas-Garcia, Professor Karin Musier-Forsyth and Dr. William Cantara for reading and commenting on drafts of the manuscript. We also thank the reviewer of this paper for valuable comments regarding improvement of the analysis and interpretation of results. We thank the NSF-DMR for support under Grant 1610384 (RB). Computational resources were provided by the NSF through XSEDE computing resources. JSF and CL thank the University of Nebraska and the Holland Computing Centre for providing computational resources. JAMR, PME and OG acknowledge support from Consejo Nacional de Ciencia y Tecnologia (Mexico) Project "Fronteras de la Ciencia" 2015-02-1450.	Alfadhli A, 2016, J VIROL, V90, P5657, DOI 10.1128/JVI.00509-16; Bayro MJ, 2016, J AM CHEM SOC, V138, P12029, DOI 10.1021/jacs.6b07259; Belfetmi A, 2016, RNA, V22, P506, DOI 10.1261/rna.054445.115; BERENDSEN HJC, 1987, J PHYS CHEM-US, V91, P6269, DOI 10.1021/j100308a038; Best RB, 2012, J CHEM THEORY COMPUT, V8, P3257, DOI 10.1021/ct300400x; Campbell S, 1999, J VIROL, V73, P2270, DOI 10.1128/JVI.73.3.2270-2279.1999; Campbell S, 2001, P NATL ACAD SCI USA, V98, P10875, DOI 10.1073/pnas.191224698; Carlson LA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001173; Cheng TMK, 2007, PROTEINS, V68, P503, DOI 10.1002/prot.21419; Chukkapalli V, 2008, J VIROL, V82, P2405, DOI 10.1128/JVI.01614-07; Coffin J, 1997, RETROVIRUSES; Comas-Garcia M, 2017, ELIFE, V6, DOI 10.7554/eLife.27055; Comas-Garcia M, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8090246; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Datta SAK, 2016, J VIROL, V90, P1773, DOI 10.1128/JVI.02061-15; Datta SAK, 2011, J VIROL, V85, P4111, DOI 10.1128/JVI.00006-11; Datta SAK, 2011, J MOL BIOL, V406, P205, DOI 10.1016/j.jmb.2010.11.051; Dick RA, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10110640; Dick RA, 2018, NATURE, V560, P509, DOI 10.1038/s41586-018-0396-4; Dilley KA, 2017, J VIROL, V91, DOI 10.1128/JVI.02319-16; Dubois N, 2018, RNA BIOL, V15, P923, DOI 10.1080/15476286.2018.1481696; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Frenkel D., 2002, UNDERSTANDING MOLECU; Fuentes-Azcatl R, 2014, J PHYS CHEM B, V118, P1263, DOI 10.1021/jp410865y; Guarnera E, 2016, CURR OPIN STRUC BIOL, V37, P1, DOI 10.1016/j.sbi.2015.10.004; Hendrix J, 2015, J CELL BIOL, V210, P629, DOI 10.1083/jcb.201504006; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jones CP, 2016, J VIROL, V5, P17063; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Jouvenet N, 2011, J MOL BIOL, V410, P501, DOI 10.1016/j.jmb.2011.04.062; Keane SC, 2015, SCIENCE, V348, P917, DOI 10.1126/science.aaa9266; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; KUMAR S, 1992, J COMPUT CHEM, V13, P1011, DOI 10.1002/jcc.540130812; Kutluay SB, 2014, CELL, V159, P1096, DOI 10.1016/j.cell.2014.09.057; Lampel A, 2013, ACTA CRYSTALLOGR F, V69, P602, DOI 10.1107/S1744309113011871; Li GD, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-126; Liu Y, 2017, J MOL BIOL, V429, P2542, DOI 10.1016/j.jmb.2017.06.018; Mercredi PY, 2016, J MOL BIOL, V428, P1637, DOI 10.1016/j.jmb.2016.03.005; Mitra M, 2013, BIOCHEMISTRY-US, V52, P8226, DOI 10.1021/bi401250a; Munro JB, 2014, J VIROL, V88, P3577, DOI 10.1128/JVI.03353-13; Negi SS, 2007, BIOINFORMATICS, V23, P3397, DOI 10.1093/bioinformatics/btm474; O'Carroll IP, 2013, VIRUS RES, V171, P341, DOI 10.1016/j.virusres.2012.10.016; O'Carroll IP, 2012, J VIROL, V86, P12991, DOI 10.1128/JVI.06287-11; Olson ED, 2019, SEMIN CELL DEV BIOL, V86, P129, DOI 10.1016/j.semcdb.2018.03.015; Oostenbrink C, 2004, J COMPUT CHEM, V25, P1656, DOI 10.1002/jcc.20090; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Porollo A, 2007, PROTEINS, V66, P630, DOI 10.1002/prot.21248; Purdy MD, 2018, P NATL ACAD SCI USA, V115, P13258, DOI 10.1073/pnas.1806806115; Saad JS, 2006, P NATL ACAD SCI USA, V103, P11364, DOI 10.1073/pnas.0602818103; Schur FKM, 2016, SCIENCE, V353, P506, DOI 10.1126/science.aaf9620; Schur FKM, 2015, NATURE, V517, P505, DOI 10.1038/nature13838; Su CT., 2017, J BIOMOL STRUCT DYN, DOI DOI 10.1080/07391102.2017.1417160; Tanaka M, 2016, J VIROL, V90, P1944, DOI 10.1128/JVI.02698-15; Ternois F, 2005, NAT STRUCT MOL BIOL, V12, P678, DOI 10.1038/nsmb967; Tina KG, 2007, NUCLEIC ACIDS RES, V35, pW473, DOI 10.1093/nar/gkm423; Todd GC, 2017, RNA, V23, P395, DOI 10.1261/rna.058453.116; Vangone A, 2011, BIOINFORMATICS, V27, P2915, DOI 10.1093/bioinformatics/btr484; von Schwedler UK, 2003, J VIROL, V77, P5439, DOI 10.1128/JVI.77.9.5439-5450.2003; Wagner JM, 2011, ELIFE, V85, P1549; Waheed AA, 2012, AIDS RES HUM RETROV, V28, P54, DOI [10.1089/aid.2011.0230, 10.1089/AID.2011.0230]; Webb JA, 2013, RNA, V19, P1078, DOI 10.1261/rna.038869.113; Wu H, 2013, VIRUS RES, V42, P2525; Wu H, 2013, VIRUS RES, V171, P263, DOI 10.1016/j.virusres.2012.07.008; Xiong P, 2017, J MOL BIOL, V429, P426, DOI 10.1016/j.jmb.2016.11.022; Zhu XL, 2011, PROTEINS, V79, P2671, DOI 10.1002/prot.23094	66	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2019	14	8							e0221256	10.1371/journal.pone.0221256	http://dx.doi.org/10.1371/journal.pone.0221256			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5RZ	31437199	gold, Green Published, Green Submitted			2022-12-26	WOS:000485036900043
J	Berhe, A; Bayray, A; Berhe, Y; Teklu, A; Desta, A; Araya, T; Zielinski, R; Roosevelt, L				Berhe, Almaz; Bayray, Alemayehu; Berhe, Yibrah; Teklu, Alula; Desta, Amanuel; Araya, Tsige; Zielinski, Ruth; Roosevelt, Lee			Determinants of postnatal care utilization in Tigray, Northern Ethiopia: A community based cross-sectional study	PLOS ONE			English	Article							DISTRICT; MOTHERS	Introduction Globally, 289,000 women die from complications related to pregnancy, childbirth, or the postnatal period every year. Two-thirds of all maternal deaths occur during the first six weeks following birth and more than two thirds of newborn deaths occur during the first week of life, These statistics underscore the importance of postnatal care, an often neglected service according to the World Health Organization (WHO). The purpose of this study was to assess the factors associated with postnatal service utilization in the Tigray region of Ethiopia. Methods The study was a community-based, cross-sectional study. A multi-stage sampling method was used to select study districts randomly from the entire region. A total of 1,690 participants were selected using systematic random sampling. Participants were 18-49 years old, had given birth within the last six months, and were residents of the district for at least six months. Using SPSS version 20 means, frequencies, and percentages were calculated for the sub-group of participants who did attend postnatal care. Barriers to non-attendance of postatal care were analyzed using descriptive statistics. Bivariate analysis was undertaken to assess the association between demographic, obstetric, and knowledge regarding PNC and attendance at antenatal care. Variables with a P value, <0.05 were included in the multi-variate logistic regression analysis to identify the determinant factors of postnatal care utilization. Result Of the women surveyed, 132 (8%) obtained postnatal care. Women who did not receive postnatal care reported lack of awareness of the services (n = 1110, 73.3%). Most mothers who received postnatal care reported that they were aware of the service prior to the birth of their child (n = 101, 76.5%). Women were more likely to receive postnatal services if they lived in an urban area (odds ratio 1.96, 95% confidence interval 1.07, 3.59), had greater than a secondary education (OR 3.60, 95% CI 1.32,9.83), delivered by cesarean section (OR 2.88 95% CI 1.32,6.29), had four or more antenatal visits (OR 4.84, 95% CI 1.57,14.9), or had a planned pregnancy (OR 6.47, 95% CI 2.04,20.5). Conclusion Postnatal care service utilization is very low in Tigray region. Interventions targeted at increasing women's awareness of the importance of postnatal services and improving accessibility, particularly in rural areas, is needed.	[Berhe, Almaz; Bayray, Alemayehu; Berhe, Yibrah; Araya, Tsige] Mekelle Univ, Sch Med & Hlth Sci, Addis Adaba, Ethiopia; [Teklu, Alula] St Pauls Hosp, Millennium Med Coll, Addis Adaba, Ethiopia; [Desta, Amanuel] Ctr Int Reprod Hlth Training, Ann Arbor, MI USA; [Zielinski, Ruth; Roosevelt, Lee] Univ Michigan, Sch Nursing, Ann Arbor, MI 48109 USA	Mekelle University; University of Michigan System; University of Michigan	Roosevelt, L (corresponding author), Univ Michigan, Sch Nursing, Ann Arbor, MI 48109 USA.	morgaine@umich.edu			Center for International Reproductive Health Training (CIRHT) at the University of Michigan [N018416]	Center for International Reproductive Health Training (CIRHT) at the University of Michigan	This work was financially supported by an anonymous donor through the Center for International Reproductive Health Training (CIRHT) at the University of Michigan [Project Grant number N018416]. The funding source did not have any involvement in the study design, data collection, analysis and interpretation of data, writing of the manuscript and the decision to submit the article for publication.	Afework MF, 2010, ETHIOP J HEALTH DEV, V24, P87; [Anonymous], POP HOUS CENS 2007; [Anonymous], 2014, SCI J PUBLIC HLTH, DOI [DOI 10.11648/j.sjph.20140203.15, DOI 10.11648/J.SJPH.20140203.15]; Darega B, 2016, BMC PREGNANCY CHILDB, V16, DOI 10.1186/s12884-016-0940-x; Expanded Programme on Immunization, WHOIVB0423; Gabriel SA, 2009, BE J ECON ANAL POLI, V9, DOI 10.1186/1471-2393-9-34; Khanal V, 2014, BMC WOMENS HEALTH, V14, DOI 10.1186/1472-6874-14-19; Lawn JE, 2014, LANCET, V384, P189, DOI 10.1016/S0140-6736(14)60496-7; Li C, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-31; Limenih Miteku Andualem, 2016, Int J Reprod Med, V2016, P7095352, DOI 10.1155/2016/7095352; Matijasevich A, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-335; Miller S, 2016, LANCET, V388, P2176, DOI 10.1016/S0140-6736(16)31472-6; Rahman M, 2011, HEALTH SOC CARE COMM, V19, P138, DOI 10.1111/j.1365-2524.2010.00953.x; Regassa N, 2011, AFR HEALTH SCI, V11, P390; Ronsmans C, 2006, LANCET, V368, P1189, DOI 10.1016/S0140-6736(06)69380-X; Say L, 2007, B WORLD HEALTH ORGAN, V85, P812, DOI 10.2471/BLT.06.035659; Sines E., 2015, POSTNATAL CARE CRITI; Tesfahun F, 2014, MATERN CHILD HLTH J, V18, P2341, DOI 10.1007/s10995-014-1474-3; Tigray regional health bureau annual profile 2007 Ethiopian fiscal year, 1997, REFUGEE HLTH APPROAC; WHO UNICEF UNFPA Bank W & UNDP, 2014, TRENDS MAT MORT 1990; Winch PJ, 2005, LANCET, V366, P478, DOI 10.1016/S0140-6736(05)66836-5; World Health Organization, 2014, WHO REC POSTN CAR MO; World Health Organization (WHO), 2012, TRENDS MAT MORT 1990	23	20	20	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2019	14	8							e0221161	10.1371/journal.pone.0221161	http://dx.doi.org/10.1371/journal.pone.0221161			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5OC	31430356	gold, Green Published, Green Submitted			2022-12-26	WOS:000485026800031
J	Caldo, KMP; Xu, Y; Falarz, L; Jayawardhane, K; Acedo, JZ; Chen, GQ				Caldo, Kristian Mark P.; Xu, Yang; Falarz, Lucas; Jayawardhane, Kethmi; Acedo, Jeella Z.; Chen, Guanqun			Arabidopsis CTP:phosphocholine cytidylyltransferase 1 is phosphorylated and inhibited by sucrose nonfermenting 1?related protein kinase 1 (SnRK1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						protein phosphorylation; serine; threonine protein kinase; metabolic regulation; enzyme kinetics; plant biochemistry; energy signaling; KIN10; membrane lipid; phosphatidylcholine biosynthesis; sucrose nonfermenting 1?related protein kinase 1	CTP-PHOSPHOCHOLINE CYTIDYLYLTRANSFERASE; PHOSPHATIDYLCHOLINE BIOSYNTHESIS; TERMINAL DOMAIN; ENZYME-ACTIVITY; IDENTIFICATION; ACTIVATION; EXPRESSION; THALIANA; SITE; LOCALIZATION	De novo phosphatidylcholine (PC) biosynthesis via the Kennedy pathway involves highly endergonic biochemical reactions that must be fine-tuned with energy homeostasis. Previous studies have shown that CTP:phosphocholine cytidylyltransferase (CCT) is an important regulatory enzyme in this pathway and that its activity can be controlled at both transcriptional and posttranslational levels. Here we identified an important additional mechanism regulating plant CCT1 activity. Comparative analysis revealed that Arabidopsis CCT1 (AtCCT1) contains catalytic and membrane-binding domains that are homologous to those of rat CCT1. In contrast, the C-terminal phosphorylation domain important for stringent regulation of rat CCT1 was apparently missing in AtCCT1. Instead, we found that AtCCT1 contains a putative consensus site (Ser-187) for modification by sucrose nonfermenting 1?related protein kinase 1 (SnRK1 or KIN10/SnRK1.1), involved in energy homeostasis. Phos-tag SDS-PAGE coupled with MS analysis disclosed that SnRK1 indeed phosphorylates AtCCT1 at Ser-187, and we found that AtCCT1 phosphorylation substantially reduces its activity by as much as 70%. An S187A variant exhibited decreased activity, indicating the importance of Ser-187 in catalysis, and this variant was less susceptible to SnRK1-mediated inhibition. Protein truncation and liposome binding studies indicated that SnRK1-mediated AtCCT1 phosphorylation directly affects the catalytic domain rather than interfering with phosphatidate-mediated AtCCT1 activation. Overexpression of the AtCCT1 catalytic domain in Nicotiana benthamiana leaves increased PC content, and SnRK1 co-expression reduced this effect. Taken together, our results suggest that SnRK1 mediates the phosphorylation and concomitant inhibition of AtCCT1, revealing an additional mode of regulation for this key enzyme in plant PC biosynthesis.	[Caldo, Kristian Mark P.; Xu, Yang; Falarz, Lucas; Jayawardhane, Kethmi; Chen, Guanqun] Univ Alberta, Dept Agr Food & Nutr Sci, Edmonton, AB T6G 2G2, Canada; [Acedo, Jeella Z.] Univ Alberta, Dept Chem, Edmonton, AB T6G 2G2, Canada	University of Alberta; University of Alberta	Chen, GQ (corresponding author), Univ Alberta, Dept Agr Food & Nutr Sci, Edmonton, AB T6G 2G2, Canada.	gc24@ualberta.ca	Chen, Guanqun/K-7009-2012; Acedo, Jeella/ABE-5296-2021; Caldo, Kristian/AAM-8663-2020; Acedo, Jeella/U-2365-2019	Chen, Guanqun/0000-0001-5790-3903; Acedo, Jeella/0000-0002-6648-770X; Xu, Yang/0000-0001-7587-2194	University of Alberta [RES0036786]; Alberta Innovates grant [AgFC2019F111R]; Alberta Agriculture and Forestry grant [AgFC2019F135R]; Natural Sciences and Engineering Research Council of Canada [RGPIN-2016-05926]; Canada Research Chairs program [RES0037649]	University of Alberta(University of Alberta); Alberta Innovates grant; Alberta Agriculture and Forestry grant; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canada Research Chairs program(Canada Research Chairs)	This work was supported by University of Alberta start-up research grant RES0036786, Alberta Innovates grant AgFC2019F111R, Alberta Agriculture and Forestry grant AgFC2019F135R, Natural Sciences and Engineering Research Council of Canada discovery grant RGPIN-2016-05926, and Canada Research Chairs program grant RES0037649. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Arnold RS, 1996, BIOCHEMISTRY-US, V35, P9917, DOI 10.1021/bi960397c; Bachmann M, 1996, PLANT CELL, V8, P505, DOI 10.1105/tpc.8.3.505; Brault JP, 2016, ANAL BIOCHEM, V510, P26, DOI 10.1016/j.ab.2016.07.018; Brown CJ, 2002, J MOL EVOL, V55, P104, DOI 10.1007/s00239-001-2309-6; Buchan DWA, 2013, NUCLEIC ACIDS RES, V41, pW349, DOI 10.1093/nar/gkt381; Caldo KMP, 2018, PLANT J, V96, P287, DOI 10.1111/tpj.14029; Caldo KMP, 2017, PLANT PHYSIOL, V175, P667, DOI 10.1104/pp.17.00934; Choi SB, 1997, MOL CELLS, V7, P58; CORNELL R, 1989, J BIOL CHEM, V264, P9077; CORNELL RB, 1995, BIOCHEM J, V310, P699, DOI 10.1042/bj3100699; Cornell RB, 2000, TRENDS BIOCHEM SCI, V25, P441, DOI 10.1016/S0968-0004(00)01625-X; Cornell RB, 2016, BBA-MOL CELL BIOL L, V1861, P847, DOI 10.1016/j.bbalip.2015.12.022; Craddock CP, 2015, PLANT CELL, V27, P1251, DOI 10.1105/tpc.15.00037; DALE S, 1995, EUR J BIOCHEM, V233, P506, DOI 10.1111/j.1432-1033.1995.506_2.x; Ding ZW, 2012, J BIOL CHEM, V287, P38980, DOI 10.1074/jbc.M112.402081; Durek P, 2010, NUCLEIC ACIDS RES, V38, pD828, DOI 10.1093/nar/gkp810; Gibellini F, 2010, IUBMB LIFE, V62, P414, DOI 10.1002/iub.337; Halford NG, 2003, J EXP BOT, V54, P467, DOI 10.1093/jxb/erg038; HATCH GM, 1992, J BIOL CHEM, V267, P15751; Helmink BA, 2003, BIOCHEMISTRY-US, V42, P5043, DOI 10.1021/bi027431+; Hornbeck PV, 2015, NUCLEIC ACIDS RES, V43, pD512, DOI 10.1093/nar/gku1267; Huang AHC, 2018, PLANT PHYSIOL, V176, P1894, DOI 10.1104/pp.17.01677; KENNEDY EP, 1958, AM J CLIN NUTR, V6, P216, DOI 10.1093/ajcn/6.3.216; Laurie S, 2003, J EXP BOT, V54, P739, DOI 10.1093/jxb/erg085; Lee J, 2014, J BIOL CHEM, V289, P1742, DOI 10.1074/jbc.M113.526970; Mietkiewska E, 2014, PLANTA, V240, P575, DOI 10.1007/s00425-014-2109-z; MOORE TS, 1982, ANNU REV PLANT PHYS, V33, P235, DOI 10.1146/annurev.pp.33.060182.001315; Nunes C, 2013, PLANT PHYSIOL BIOCH, V63, P89, DOI 10.1016/j.plaphy.2012.11.011; OHLROGGE J, 1995, PLANT CELL, V7, P957, DOI 10.1105/tpc.7.7.957; PELECH SL, 1989, TRENDS BIOCHEM SCI, V14, P28, DOI 10.1016/0968-0004(89)90086-8; Purcell PC, 1998, PLANT J, V14, P195, DOI 10.1046/j.1365-313X.1998.00108.x; Ramezanpour M, 2018, J BIOL CHEM, V293, P7070, DOI 10.1074/jbc.RA118.002053; RAO ST, 1973, J MOL BIOL, V76, P241, DOI 10.1016/0022-2836(73)90388-4; Roitinger E, 2015, MOL CELL PROTEOMICS, V14, P556, DOI 10.1074/mcp.M114.040352; Shen W, 2009, PLANT PHYSIOL, V150, P996, DOI 10.1104/pp.108.132787; SPARACE SA, 1981, PLANT PHYSIOL, V67, P261, DOI 10.1104/pp.67.2.261; Sugden C, 1999, PLANT PHYSIOL, V120, P257, DOI 10.1104/pp.120.1.257; Tasseva G, 2004, FEBS LETT, V566, P115, DOI 10.1016/j.febslet.2004.04.015; Tiessen A, 2003, PLANT J, V35, P490, DOI 10.1046/j.1365-313X.2003.01823.x; Toroser D, 2000, PLANT PHYSIOL, V123, P403, DOI 10.1104/pp.123.1.403; TRONCHERE H, 1994, BBA-LIPID LIPID MET, V1212, P137, DOI 10.1016/0005-2760(94)90248-8; Veitch DP, 1998, EUR J BIOCHEM, V255, P227, DOI 10.1046/j.1432-1327.1998.2550227.x; Wang X, 2013, J PROTEOMICS, V78, P486, DOI 10.1016/j.jprot.2012.10.018; WANG YL, 1995, J BIOL CHEM, V270, P354, DOI 10.1074/jbc.270.1.354; Wang Z, 2011, JOVE-J VIS EXP, DOI 10.3791/2518; Ward JJ, 2004, J MOL BIOL, V337, P635, DOI 10.1016/j.jmb.2004.02.002; Wright PE, 2015, NAT REV MOL CELL BIO, V16, P18, DOI 10.1038/nrm3920; Wurzinger B, 2018, PLANT PHYSIOL, V176, P1085, DOI 10.1104/pp.17.01404; Xu Y, 2018, LIPIDS, V53, P663, DOI 10.1002/lipd.12081; Zhai ZY, 2018, PLANT CELL, V30, P2616, DOI 10.1105/tpc.18.00521; Zhai ZY, 2017, PLANT CELL, V29, P871, DOI 10.1105/tpc.17.00019; Zhang YH, 2009, PLANT PHYSIOL, V149, P1860, DOI 10.1104/pp.108.133934	52	12	12	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 25	2019	294	43					15862	15874		10.1074/jbc.RA119.008047	http://dx.doi.org/10.1074/jbc.RA119.008047			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JQ9JD	31439667	hybrid, Green Published			2022-12-26	WOS:000499253000026
J	Deng, QW; Zhang, JZ; Li, T; He, WM; Fang, L; Lee, HC; Zhao, YJ				Deng, Qi Wen; Zhang, Jingzi; Li, Ting; He, Wei Ming; Fang, Lei; Lee, Hon Cheung; Zhao, Yong Juan			The transferrin receptor CD71 regulates type II CD38, revealing tight topological compartmentalization of intracellular cyclic ADP-ribose production	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						calcium intracellular release; CD38; cell compartmentalization; cell surface enzyme; cyclic ADP Ribose (cADPR); membrane topology	DEPENDENT SIGNALING COMPLEX; CYCLASE; CELLS; IDENTIFICATION; ACTIVATION; ASSAY	The CD38 molecule (CD38) catalyzes biogenesis of the calcium-mobilizing messenger cyclic ADP-ribose (cADPR). CD38 has dual membrane orientations, and type III CD38, with its catalytic domain facing the cytosol, has low abundance but is efficient in cyclizing cytosolic NAD to produce cADPR. The role of cell surface type II CD38 in cellular cADPR production is unknown. Here we modulated type II CD38 expression and assessed the effects of this modulation on cADPR levels. We developed a photoactivatable cross-linking probe based on a CD38 nanobody, and, combining it with MS analysis, we discovered that cell surface CD38 interacts with CD71. CD71 knockdown increased CD38 levels, and CD38 knockout reciprocally increased CD71, and both could be cocapped and coimmunoprecipitated. We constructed a chimera comprising the N-terminal segment of CD71 and a CD38 nanobody to mimic CD71's ligand property. Overexpression of this chimera induced a dramatically large decrease in CD38 via lysosomes. Remarkably, cellular cADPR levels did not decrease correspondingly. Bafilomycin-mediated blockade of lysosomal degradation greatly elevated active type II CD38 by trapping it in the lysosomes but also did not increase cADPR levels. Retention of type II CD38 in the endoplasmic reticulum (ER) by expressing an ER construct that prevented its transport to the cell surface likewise did not change cADPR levels. These results provide first and direct evidence that cADPR biogenesis occurs in the cytosol and is catalyzed mainly by type III CD38 and that type II CD38, compartmentalized in the ER or lysosomes or on the cell surface, contributes only minimally to cADPR biogenesis.	[Deng, Qi Wen; Li, Ting; He, Wei Ming; Lee, Hon Cheung; Zhao, Yong Juan] Peking Univ, Shenzhen Grad Sch, Key Lab Chem Genom, State Key Lab Chem Oncogen, Shenzhen 518055, Guangdong, Peoples R China; [Zhang, Jingzi; Fang, Lei] Nanjing Univ, Med Sch, Jiangsu Key Lab Mol Med, Nanjing 210093, Jiangsu, Peoples R China	Peking University; University Town of Shenzhen; Nanjing University	Lee, HC; Zhao, YJ (corresponding author), Peking Univ, Shenzhen Grad Sch, Key Lab Chem Genom, State Key Lab Chem Oncogen, Shenzhen 518055, Guangdong, Peoples R China.	leehoncheung@gmail.com; zhaoyongjuan@pku.edu.cn	Zhao, Yongjuan/AAS-9919-2021; Lee, Hon Cheung/C-4329-2009	Fang, Lei/0000-0002-2582-4845; Zhao, Yong Juan/0000-0003-4564-1912; Deng, Qiwen/0000-0002-4153-1778	National Science Foundation of China [31571438, 31871403, 31671463]	National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by National Science Foundation of China grants (31571438, 31871403, and 31671463). The authors declare that they have no conflicts of interest with the contents of this article.	An N, 2018, MOL PHARMACEUT, V15, P4577, DOI 10.1021/acs.molpharmaceut.8b00584; Bryksin AV, 2010, BIOTECHNIQUES, V48, P463, DOI 10.2144/000113418; Deaglio S, 1998, J IMMUNOL, V160, P395; Deaglio S, 2007, BLOOD, V109, P5390, DOI 10.1182/blood-2006-12-061812; Durig J, 2002, LEUKEMIA, V16, P30, DOI 10.1038/sj.leu.2402339; Fang C, 2018, J BIOL CHEM, V293, P8151, DOI 10.1074/jbc.RA118.002113; GIORGI JV, 1994, J INFECT DIS, V170, P775, DOI 10.1093/infdis/170.4.775; Graeff R, 2002, BIOCHEM J, V361, P379, DOI 10.1042/bj3610379; Graeff R, 2001, J BIOL CHEM, V276, P12169, DOI 10.1074/jbc.M011299200; GRAEFF RM, 1994, J BIOL CHEM, V269, P30260; Heukers R, 2014, NANOMED-NANOTECHNOL, V10, P1441, DOI 10.1016/j.nano.2013.12.007; Higy M, 2004, BIOCHEMISTRY-US, V43, P12716, DOI 10.1021/bi048368m; Kato I, 1999, J BIOL CHEM, V274, P1869, DOI 10.1074/jbc.274.4.1869; KENDALL JM, 1994, ANAL BIOCHEM, V221, P173, DOI 10.1006/abio.1994.1394; Kubala MH, 2010, PROTEIN SCI, V19, P2389, DOI 10.1002/pro.519; LEE HC, 1989, J BIOL CHEM, V264, P1608; Li T, 2018, ANAL CHIM ACTA, V1029, P65, DOI 10.1016/j.aca.2018.04.061; Li T, 2016, SCI REP-UK, V6, DOI 10.1038/srep27055; Liu J, 2017, P NATL ACAD SCI USA, V114, P8283, DOI 10.1073/pnas.1703718114; Martin DN, 2013, P NATL ACAD SCI USA, V110, P10777, DOI 10.1073/pnas.1301764110; Philip M, 2017, NATURE, V545, P452, DOI 10.1038/nature22367; Radoshitzky SR, 2007, NATURE, V446, P92, DOI 10.1038/nature05539; RUIZARGUELLES GJ, 1994, MAYO CLIN PROC, V69, P684, DOI 10.1016/S0025-6196(12)61350-0; STATES DJ, 1992, TRENDS BIOCHEM SCI, V17, P495, DOI 10.1016/0968-0004(92)90337-9; SUTHERLAND R, 1981, P NATL ACAD SCI-BIOL, V78, P4515, DOI 10.1073/pnas.78.7.4515; Wu Y, 2019, J BIOL CHEM, V294, P4247, DOI 10.1074/jbc.RA118.005844; Zhao YJ, 2015, BBA-MOL CELL RES, V1853, P2095, DOI 10.1016/j.bbamcr.2014.10.028; Zhao YJ, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002700; Zhao YJ, 2011, J BIOL CHEM, V286, P22170, DOI 10.1074/jbc.M111.228379; Zilber MT, 2005, BLOOD, V106, P3074, DOI 10.1182/blood-2004-10-4094; Zubiaur M, 2002, J BIOL CHEM, V277, P13, DOI 10.1074/jbc.M107474200	31	10	10	3	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 18	2019	294	42					15293	15303		10.1074/jbc.RA119.010010	http://dx.doi.org/10.1074/jbc.RA119.010010			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JQ9HM	31434741	hybrid, Green Published			2022-12-26	WOS:000499248700009
J	Han, HT; Chen, N; Huang, XG; Liu, B; Tian, JK; Lei, HT				Han, Haote; Chen, Na; Huang, Xionggao; Liu, Bing; Tian, Jingkui; Lei, Hetian			Phosphoinositide 3-kinase ? inactivation prevents vitreous-induced activation of AKT/MDM2/p53 and migration of retinal pigment epithelial cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						phosphatidylinositide 3-kinase (PI 3-kinase); Akt PKB; mouse double minute 2 homolog (MDM2); p53; migration	CHRONIC LYMPHOCYTIC-LEUKEMIA; PENETRATING EYE INJURY; MDM2 T309G MUTATION; PROLIFERATIVE VITREORETINOPATHY; GROWTH-FACTORS; SILICONE-OIL; PI3K; EXPRESSION; INHIBITOR; SURVIVAL	Phosphoinositide 3-kinases (PI3Ks) are a family of lipid kinases that play a critical role in transmitting signals from cell-surface molecules to intracellular protein effectors. Key PI3Ks include PI3K?, PI3K?, and PI3K?, which are regulated by receptors. The signaling pathway comprising the PI3Ks, along with a Ser/Thr kinase (AKT), a proto-oncogene product (mouse double minute (MDM)2), and a tumor suppressor protein (p53), plays an essential role in experimental proliferative vitreoretinopathy (PVR), which is a fibrotic blinding eye disorder. However, which PI3K isoforms are involved in PVR is unknown. A major characteristic of PVR is the formation of epi (or sub)-retinal membranes that consist of extracellular matrix and cells, including retinal pigment epithelium (RPE) cells, glial cells, and macrophages. RPE cells are considered key players in PVR pathogenesis. Using immunoblotting and immunofluorescence analyses, we herein provide the evidence that PI3K? is highly expressed in human RPEs when it is primarily expressed in leukocytes. We also found that PI3K? inactivation through two approaches, CRISPR/Cas9-mediated depletion and a PI3K?-specific inhibitor (idelalisib), not only blocks vitreous-induced activation of AKT and MDM2 but also abrogates a vitreous-stimulated decrease in p53. Furthermore, we demonstrate that PI3K? inactivation prevents vitreous-induced proliferation, migration, and contraction of human RPEs. These results suggest that PI3K? may represent a potential therapeutic target for RPE-related eye diseases, including PVR.	[Han, Haote; Chen, Na; Huang, Xionggao; Liu, Bing; Lei, Hetian] Schepens Eye Res Inst Massachusetts Eye & Ear, Boston, MA 02114 USA; [Han, Haote; Chen, Na; Huang, Xionggao; Liu, Bing; Lei, Hetian] Harvard Med Sch, Dept Ophthalmol, Boston, MA 02115 USA; [Han, Haote; Tian, Jingkui] Zhejiang Univ, Coll Biomed Engn & Instrument Sci, Hangzhou 310027, Zhejiang, Peoples R China; [Han, Haote; Tian, Jingkui] Zhejiang Univ, Zhejiang Malaysia Joint Res Ctr Tradit Med, Hangzhou 310027, Zhejiang, Peoples R China; [Chen, Na] Shanghai Jiao Tong Univ, Renji Hosp, Sch Med, Dept Ophthalmol, Shanghai 200127, Peoples R China; [Huang, Xionggao] Hannan Med Univ, Dept Ophthalmol, Affiliated Hosp 1, Haikou 57000, Hainan, Peoples R China	Harvard University; Harvard Medical School; Zhejiang University; Zhejiang University; Shanghai Jiao Tong University	Lei, HT (corresponding author), Harvard Med Sch, Dept Ophthalmol, Schepens Eye Res Inst Massachusetts Eye & Ear, Boston, MA 02114 USA.	Hetian_lei@meei.harvard.edu			National Institutes of Health [R01EY012509]; Research to Prevent Blindness; China Scholarship Council [01806320148]; Department of Ophthalmology, Harvard Medical School; NATIONAL EYE INSTITUTE [R01EY012509] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); China Scholarship Council(China Scholarship Council); Department of Ophthalmology, Harvard Medical School; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by National Institutes of Health Grant R01EY012509, Research to Prevent Blindness (to H. L.), Department of Ophthalmology, Harvard Medical School (to H. L.), and China Scholarship Council Grant 01806320148 (to H. H.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abrams GW, 1997, ARCH OPHTHALMOL-CHIC, V115, P335, DOI 10.1001/archopht.1997.01100150337005; Agrawal RN, 2007, NAT PROTOC, V2, P67, DOI 10.1038/nprot.2007.4; Ali K, 2004, NATURE, V431, P1007, DOI 10.1038/nature02991; Andrews A, 1999, INVEST OPHTH VIS SCI, V40, P2683; Bilanges B, 2019, NAT REV MOL CELL BIO, V20, P515, DOI 10.1038/s41580-019-0129-z; BURGERING BMT, 1995, NATURE, V376, P599, DOI 10.1038/376599a0; Pastor JC, 2016, PROG RETIN EYE RES, V51, P125, DOI 10.1016/j.preteyeres.2015.07.005; Casaroli-Marano RP, 1999, INVEST OPHTH VIS SCI, V40, P2062; Clayton E, 2002, J EXP MED, V196, P753, DOI 10.1084/jem.20020805; CLEARY PE, 1979, BRIT J OPHTHALMOL, V63, P306, DOI 10.1136/bjo.63.5.306; CLEARY PE, 1979, BRIT J OPHTHALMOL, V63, P312, DOI 10.1136/bjo.63.5.312; Colyer MH, 2008, OPHTHALMOLOGY, V115, P2087, DOI 10.1016/j.ophtha.2008.05.013; CONNOR TB, 1989, J CLIN INVEST, V83, P1661, DOI 10.1172/JCI114065; Cui J, 2009, EXP EYE RES, V88, P438, DOI 10.1016/j.exer.2008.10.020; Duan YJ, 2016, J BIOL CHEM, V291, P16339, DOI 10.1074/jbc.M116.729467; Erdurman FC, 2011, EYE, V25, P1491, DOI 10.1038/eye.2011.212; Ferrari S, 2011, CURR GENOMICS, V12, P238, DOI 10.2174/138920211795860107; Fisher CR, 2018, INVEST OPHTH VIS SCI, V59, pAMD41, DOI 10.1167/iovs.18-24289; Foukas LC, 2010, P NATL ACAD SCI USA, V107, P11381, DOI 10.1073/pnas.0906461107; FRANKE TF, 1995, CELL, V81, P727, DOI 10.1016/0092-8674(95)90534-0; Fritsch C, 2014, MOL CANCER THER, V13, P1117, DOI 10.1158/1535-7163.MCT-13-0865; Gnanasundram SV, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-02282-w; Gopal AK, 2014, NEW ENGL J MED, V370, P1008, DOI 10.1056/NEJMoa1314583; Guo XQ, 2007, INVEST OPHTH VIS SCI, V48, P4050, DOI 10.1167/iovs.06-1216; Herman SEM, 2010, BLOOD, V116, P2078, DOI 10.1182/blood-2010-02-271171; Hou HY, 2018, OPHTHALMIC RES, V60, P195, DOI 10.1159/000488492; Huang XG, 2017, INVEST OPHTH VIS SCI, V58, DOI 10.1167/iovs.16-20537; Ikuno Y, 2002, INVEST OPHTH VIS SCI, V43, P483; Ikuno Y, 2002, INVEST OPHTH VIS SCI, V43, P2406; Lannutti BJ, 2011, BLOOD, V117, P591, DOI 10.1182/blood-2010-03-275305; LEAVER PK, 1989, GRAEF ARCH CLIN EXP, V227, P323, DOI 10.1007/BF02169405; Lei HT, 2006, PLANT CELL REP, V25, P1205, DOI 10.1007/s00299-006-0187-5; Lei HT, 2015, MOL CELL BIOL, V35, P1673, DOI 10.1128/MCB.01248-14; Lei HT, 2014, MOL CELL BIOL, V34, P110, DOI 10.1128/MCB.00839-13; Lei HT, 2012, AM J PATHOL, V181, P866, DOI 10.1016/j.ajpath.2012.05.036; Lei HT, 2011, INVEST OPHTH VIS SCI, V52, P5016, DOI 10.1167/iovs.11-7442; Lei HT, 2011, MOL CELL BIOL, V31, P1788, DOI 10.1128/MCB.01321-10; Lei H, 2010, AM J PATHOL, V177, P132, DOI 10.2353/ajpath.2010.090604; Lei HT, 2009, INVEST OPHTH VIS SCI, V50, P3394, DOI 10.1167/iovs.08-3042; Lei H, 2009, J BIOL CHEM, V284, P6329, DOI 10.1074/jbc.M808426200; Lei HT, 2004, CIRC RES, V94, P902, DOI 10.1161/01.RES.0000124979.46214.E3; Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30; Luo J, 2003, CANCER CELL, V4, P257, DOI 10.1016/S1535-6108(03)00248-4; Ma GE, 2016, INVEST OPHTH VIS SCI, V57, P3935, DOI 10.1167/iovs.16-19405; Maeder ML, 2019, NAT MED, V25, P229, DOI 10.1038/s41591-018-0327-9; Manning BD, 2017, CELL, V169, P381, DOI 10.1016/j.cell.2017.04.001; Morescalchi F, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/269787; Murugeswari P, 2017, CYTOKINE, V95, P126, DOI 10.1016/j.cyto.2017.02.013; Negrel A D, 1998, Ophthalmic Epidemiol, V5, P143, DOI 10.1076/opep.5.3.143.8364; Pastor-Idoate S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082283; Pennock S, 2014, PROG RETIN EYE RES, V40, P16, DOI 10.1016/j.preteyeres.2013.12.006; Puri KD, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00256; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Schiff L, 2019, COMMUN BIOL, V2, DOI 10.1038/s42003-019-0406-6; Schmidt GW, 2008, OPHTHALMOLOGY, V115, P202, DOI 10.1016/j.ophtha.2007.04.008; Simo R, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/190724; Somoza JR, 2015, J BIOL CHEM, V290, P8439, DOI 10.1074/jbc.M114.634683; Stockert JC, 2018, ACTA HISTOCHEM, V120, P159, DOI 10.1016/j.acthis.2018.02.005; Strauss O, 2005, PHYSIOL REV, V85, P845, DOI 10.1152/physrev.00021.2004; Swiech L, 2015, NAT BIOTECHNOL, V33, P102, DOI 10.1038/nbt.3055; Tan E, 2004, INVEST OPHTH VIS SCI, V45, P764, DOI 10.1167/iovs.03-1114; Vanhaesebroeck B, 2001, ANNU REV BIOCHEM, V70, P535, DOI 10.1146/annurev.biochem.70.1.535; Vanhaesebroeck B, 1997, P NATL ACAD SCI USA, V94, P4330, DOI 10.1073/pnas.94.9.4330; Vanhaesebroeck B, 2012, NAT REV MOL CELL BIO, V13, P195, DOI 10.1038/nrm3290; Vanhaesebroeck B, 2010, NAT REV MOL CELL BIO, V11, P329, DOI 10.1038/nrm2882; VERGARA O, 1989, EXP EYE RES, V49, P1115, DOI 10.1016/S0014-4835(89)80030-2; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Weichel ED, 2008, OPHTHALMOLOGY, V115, P2235, DOI 10.1016/j.ophtha.2008.08.033; Wong CA, 2002, CAN J OPHTHALMOL, V37, P211, DOI 10.1016/S0008-4182(02)80112-0; Wu WY, 2019, MED RES REV, V39, P665, DOI 10.1002/med.21537; Wu WY, 2017, EXP EYE RES, V161, P116, DOI 10.1016/j.exer.2017.06.007; Yang QS, 2015, CLIN CANCER RES, V21, P1537, DOI 10.1158/1078-0432.CCR-14-2034; Yao HP, 2019, FASEB J, V33, P3212, DOI 10.1096/fj.201800858RR; Zhang F, 2015, HUM GENE THER, V26, P409, DOI 10.1089/hum.2015.29002.fzh; Zhou GH, 2017, INVEST OPHTH VIS SCI, V58, P5361, DOI 10.1167/iovs.17-22045; Zhou QY, 2012, CURR EYE RES, V37, P318, DOI 10.3109/02713683.2011.635397; ZHOU SY, 1993, CELL, V72, P767, DOI 10.1016/0092-8674(93)90404-E	78	11	11	2	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 18	2019	294	42					15408	15417		10.1074/jbc.RA119.010130	http://dx.doi.org/10.1074/jbc.RA119.010130			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JQ9HM	31467081	hybrid, Green Published			2022-12-26	WOS:000499248700018
J	Bitsouni, V; Lycett, S; Opriessnig, T; Doeschl-Wilson, A				Bitsouni, Vasiliki; Lycett, Samantha; Opriessnig, Tanja; Doeschl-Wilson, Andrea			Predicting vaccine effectiveness in livestock populations: A theoretical framework applied to PRRS virus infections in pigs	PLOS ONE			English	Article							RESPIRATORY SYNDROME VIRUS; MODIFIED-LIVE VACCINE; FADE-OUT; EFFICACY; TRANSMISSION; DISEASE; STRATEGIES; CHALLENGE; MODEL; HERD	Vaccines remain one of the main tools to control infectious diseases in domestic livestock. Although a plethora of veterinary vaccines are on the market and routinely applied to protect animals against infection with particular pathogens, the disease in question often continues to persist, sometimes at high prevalence. The limited effectiveness of certain vaccines in the field leaves open questions regarding the required properties that an effective vaccine should have, as well as the most efficient vaccination strategy for achieving the intended goal of vaccination programmes. To date a systematic approach for studying the combined effects of different types of vaccines and vaccination strategies is lacking. In this paper, we develop a theoretical framework for modelling the epidemiological consequences of vaccination with imperfect vaccines of various types, administered using different strategies to herds with different replacement rates and heterogeneity in vaccine responsiveness. Applying the model to the Porcine Reproductive and Respiratory Syndrome (PRRS), which despite routine vaccination remains one of the most significant endemic swine diseases worldwide, we then examine the influence of these diverse factors alone and in combination, on within-herd virus transmission. We derive threshold conditions for preventing infection invasion in the case of imperfect vaccines inducing limited sterilizing immunity. The model developed in this study has practical implications for the development of vaccines and vaccination programmes in livestock populations not only for PRRS, but also for other viral infections primarily transmitted by direct contact.	[Bitsouni, Vasiliki; Lycett, Samantha; Opriessnig, Tanja; Doeschl-Wilson, Andrea] Univ Edinburgh, Roslin Inst, Easter Bush Campus, Edinburgh, Midlothian, Scotland; [Bitsouni, Vasiliki; Lycett, Samantha; Opriessnig, Tanja; Doeschl-Wilson, Andrea] Univ Edinburgh, R D SVS, Easter Bush Campus, Edinburgh, Midlothian, Scotland; [Opriessnig, Tanja] Iowa State Univ, Coll Vet Med, Dept Vet Diagnost & Prod Anim Med, Ames, IA USA	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; University of Edinburgh; Iowa State University	Bitsouni, V (corresponding author), Univ Edinburgh, Roslin Inst, Easter Bush Campus, Edinburgh, Midlothian, Scotland.; Bitsouni, V (corresponding author), Univ Edinburgh, R D SVS, Easter Bush Campus, Edinburgh, Midlothian, Scotland.	vbitsouni@gmail.com	Opriessnig, Tanja/F-2984-2012; Lycett, Samantha/F-9598-2013	Opriessnig, Tanja/0000-0001-9642-0904; Lycett, Samantha/0000-0003-3159-596X; Bitsouni, Vasiliki/0000-0002-0684-0583	EU Horizon 2020 project SAPHIR [633184]; BBSRC Institute Strategic Programme Grants [BBS/E/D/20002173]; University of Edinburgh Chancellor's Fellowship; BBSRC [BBS/E/D/20002174, BBS/E/D/20241866, BBS/E/D/20002173, BBS/E/D/20241864] Funding Source: UKRI	EU Horizon 2020 project SAPHIR; BBSRC Institute Strategic Programme Grants(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); University of Edinburgh Chancellor's Fellowship; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Financial support for this research was provided by the EU Horizon 2020 project SAPHIR (https://www.h2020-saphir.eu), Project No. 633184 (VB, SL and ADW), by the BBSRC (https://bbsrc.ukri.org/research/institutes/strategically-funded-institutes/) Institute Strategic Programme Grants ISPG 2, Theme 2 (no. BBS/E/D/20002173) (SL, TO and ADW) and by the University of Edinburgh Chancellor's Fellowship (https://www.ed.ac.uk/human-resources/jobs/chancellors-fellowships) (SL).	ANDERSON R M, 1991; Arruda AG, 2016, PREV VET MED, V128, P41, DOI 10.1016/j.prevetmed.2016.03.010; Arruda AG, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172638; Arruda AG, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166596; Azman AS, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.1341; Azman AS, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001901; Bassaganya-Riera J, 2004, VIRAL IMMUNOL, V17, P25, DOI 10.1089/088282404322875430; Bishop S, PROC 7TH WORLD CONGR, P13; Butler JE, 2014, IMMUNOL RES, V59, P81, DOI 10.1007/s12026-014-8549-5; Cano JP, 2007, AM J VET RES, V68, P565, DOI 10.2460/ajvr.68.5.565; Charerntantanakul Wasin, 2012, World J Virol, V1, P23, DOI 10.5501/wjv.v1.i1.23; Charpin C, 2012, VET RES, V43, DOI 10.1186/1297-9716-43-69; Corzo CA, 2010, VIRUS RES, V154, P185, DOI 10.1016/j.virusres.2010.08.016; Elbasha EH, 2007, EMERG INFECT DIS, V13, P28, DOI 10.3201/eid1301.060438; Evans CM, 2010, PREV VET MED, V93, P248, DOI 10.1016/j.prevetmed.2009.11.001; Feng ZL, 2011, AAPS J, V13, P427, DOI 10.1208/s12248-011-9284-7; Gandon S, 2003, P ROY SOC B-BIOL SCI, V270, P1129, DOI 10.1098/rspb.2003.2370; Gandon S, 2007, J R SOC INTERFACE, V4, P803, DOI 10.1098/rsif.2006.0207; Glass Elizabeth J., 2004, Animal Health Research Reviews, V5, P197, DOI 10.1079/AHR200469; Goldberg TL, 2003, VIROLOGY, V317, P197, DOI 10.1016/j.virol.2003.07.009; Grais RF, 2008, J R SOC INTERFACE, V5, P67, DOI 10.1098/rsif.2007.1038; Hill H., 1990, PROC MYSTERY SWINE D, P29; Holtkamp DJ, 2013, J SWINE HEALTH PROD, V21, P72; Hu J, 2014, TRANSBOUND EMERG DIS, V61, P109, DOI 10.1111/tbed.12016; Martinez-Lobo FJ, 2013, VET RES, V44, DOI 10.1186/1297-9716-44-115; Jeong J, 2014, AM J VET RES, V75, P260, DOI 10.2460/ajvr.75.3.260; Jorge S., 2017, BIOTECHNOL RES INNOV, V1, P6, DOI [10.1016/j.biori.2017.10.001, DOI 10.1016/J.BIORI.2017.10.001]; Keeling MJ, 2003, NATURE, V421, P136, DOI 10.1038/nature01343; Keeling MJ., 2008, MODELING INFECT DIS, DOI DOI 10.1515/9781400841035; Kim H, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-323; Kimman TG, 2009, VACCINE, V27, P3704, DOI 10.1016/j.vaccine.2009.04.022; Lee NH, 2012, CLIN EXP VACCINE RES, V1, P18, DOI 10.7774/cevr.2012.1.1.18; Linhares DCL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144265; Linhares DCL, 2012, VACCINE, V30, P407, DOI 10.1016/j.vaccine.2011.10.075; Lipschutz-Powell D, 2014, GENET SEL EVOL, V46, DOI 10.1186/1297-9686-46-15; Lunney JK, 2016, ANNU REV ANIM BIOSCI, V4, P129, DOI 10.1146/annurev-animal-022114-111025; Madson DM, 2009, VET RES, V40, DOI 10.1051/vetres:2008048; Mateu E, 2008, VET J, V177, P345, DOI 10.1016/j.tvjl.2007.05.022; McShane H, 2014, TUBERCULOSIS, V94, P105, DOI 10.1016/j.tube.2013.11.003; Meeusen ENT, 2007, CLIN MICROBIOL REV, V20, P489, DOI 10.1128/CMR.00005-07; MENANTEAUHORTA AM, 1985, CAN J COMP MED, V49, P10; Meng XJ, 2000, VET MICROBIOL, V74, P309, DOI 10.1016/S0378-1135(00)00196-6; Mortensen S, 2002, PREV VET MED, V53, P83, DOI 10.1016/S0167-5877(01)00260-4; Murtaugh MP, 2011, VACCINE, V29, P8192, DOI 10.1016/j.vaccine.2011.09.013; Nan YC, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01635; Nathues H, 2018, PREV VET MED, V152, P89, DOI 10.1016/j.prevetmed.2018.02.005; Nielsen HS, 2001, J GEN VIROL, V82, P1263, DOI 10.1099/0022-1317-82-6-1263; Nodelijk G, 2000, EPIDEMIOL INFECT, V124, P173, DOI 10.1017/S0950268899003246; Olsen SC, 2013, REV SCI TECH OIE, V32, P207; Papatsiros VG, 2006, J VET MED B, V53, P266, DOI 10.1111/j.1439-0450.2006.00965.x; Pileri E, 2016, VET RES, V47, DOI 10.1186/s13567-016-0391-4; Pileri E, 2015, VET MICROBIOL, V175, P7, DOI 10.1016/j.vetmic.2014.11.007; Radford AD, 2006, VET MICROBIOL, V117, P14, DOI 10.1016/j.vetmic.2006.04.004; Read AF, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002198; Rose N, 2015, VACCINE, V33, P2493, DOI 10.1016/j.vaccine.2015.03.040; Roth JA, 2001, VET CLIN N AM-FOOD A, V17, P585, DOI 10.1016/S0749-0720(15)30008-6; Rowland Raymond R. R., 2012, Frontiers in Genetics, V3, P260, DOI 10.3389/fgene.2012.00260; Savard C, 2016, CAN J VET RES, V80, P1; Scortti M, 2007, VET REC, V161, P809; Scortti M, 2006, VET J, V172, P506, DOI 10.1016/j.tvjl.2005.07.015; Shim E, 2012, VACCINE, V30, P6700, DOI 10.1016/j.vaccine.2012.08.045; Shoemaker CA, 2009, J WORLD AQUACULT SOC, V40, P573, DOI 10.1111/j.1749-7345.2009.00279.x; Sutmoller P, 2002, REV SCI TECH OIE, V21, P519, DOI 10.20506/rst.21.3.1366; Thanawongnuwech R, 2010, VIRUS RES, V154, P133, DOI 10.1016/j.virusres.2010.09.003; Tibbetts SA, 2003, J VIROL, V77, P2522, DOI 10.1128/JVI.77.4.2522-2529.2003; Tsairidou S, 2018, FRONT VET SCI, V5, DOI 10.3389/fvets.2018.00310; van den Berg TP, 2000, AVIAN PATHOL, V29, P175, DOI 10.1080/03079450050045431; Wang R, 2013, VACCINE, V31, P5537, DOI 10.1016/j.vaccine.2013.09.023; Wills RW, 2003, J CLIN MICROBIOL, V41, P58, DOI 10.1128/JCM.41.1.58-62.2003; Zhou L, 2010, VIRUS RES, V154, P31, DOI 10.1016/j.virusres.2010.07.016; Zuckermann FA, 2007, VET MICROBIOL, V123, P69, DOI 10.1016/j.vetmic.2007.02.009	71	22	22	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2019	14	8							e0220738	10.1371/journal.pone.0220738	http://dx.doi.org/10.1371/journal.pone.0220738			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW6BO	31469850	Green Submitted, Green Published, gold			2022-12-26	WOS:000485062200009
J	Ye, SL; Han, JC; Liu, TC				Ye, Shenglan; Han, Jichang; Liu, Tiancheng			Determination of optimum irrigation strategies and effect of drip irrigation system on growth and water use efficiency of pear jujube in Loess Hilly region of northern Shaanxi	PLOS ONE			English	Article							DEFICIT IRRIGATION; FRUIT-QUALITY; YIELD; PROGRAMS	The aim of this study is to explore suitable drip irrigation system on the water saving and high yield of pear-jujube from 2009 to 2012 years in the mountain of northern Shaanxi. The treatments consisted of combinations of 5 drip irrigation systems (DP). The irrigation quota of DP-1, DP-2 and DP-3 treatment was 100 m(3) hm(-2), 135 m(3) hm(-2) and 180 m(3) hm(-2), respectively, irrigated 4 times. The irrigation quota of DP-4 and DP-5 treatment was 135 m(3) hm(-2) and irrigated 3 and 2times, respectively; and with no irrigation as the control (C). Results indicated that bearing branch length of jujube, fruit set and yield of different drip irrigation system are significantly better than C (P< 0.05). Bearing branch length and yield of DP-3 treatment are reached maximum in 2012, which are 22.0 cm and 16772.8 m(3) hm(-2). And they are increased by 47.7% and 13.2% compared with C, respectively. In addition, the water consumption of different irrigation treatment increases along with the increasing of irrigation amount. And the DP-3 treatment is the highest in different years. The water use efficiency of pear-jujube of low irrigation quota is better than the high irrigation quota. Water use efficiency of 135 m(3) hm(-2) and irrigated 2 times treatment is the best, which is 1.92 m(3) hm(-2). Considering the lack of high annual precipitation, we conclude that DP-5 treatment was the best drip irrigation system in the mountain of northern Shaanxi.	[Ye, Shenglan; Han, Jichang; Liu, Tiancheng] Shaanxi Prov Land Engn Construct Grp Co Ltd, Xian, Shaanxi, Peoples R China; [Ye, Shenglan; Han, Jichang] Shaanxi Prov Land Engn Construct Grp Co Ltd, Inst Land Engn & Technol, Xian, Shaanxi, Peoples R China		Ye, SL (corresponding author), Shaanxi Prov Land Engn Construct Grp Co Ltd, Xian, Shaanxi, Peoples R China.; Ye, SL (corresponding author), Shaanxi Prov Land Engn Construct Grp Co Ltd, Inst Land Engn & Technol, Xian, Shaanxi, Peoples R China.	shenglan_ye@126.com		ye, shenglan/0000-0002-0659-2647	Shaanxi Provincial Land Engineering Construction Group Co., Ltd. [DJNY2019-23]	Shaanxi Provincial Land Engineering Construction Group Co., Ltd.	This research was supported by Shaanxi Provincial Land Engineering Construction Group Co., Ltd. internal project (DJNY2019-23). The funding organizations had no role in the design, management, analysis, or interpretation of the data, nor in the preparation, review or approval of the manuscript. The funder, Jichang Han, provided support in the supervision and funding acquisition of this study, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The company, Shaanxi Provincial Land Engineering Construction Group Co., Ltd., provided support in the form of salaries for authors [Shenglan Ye, Jichang Han, Tiancheng Liu], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the author contributions' section.	Abrisqueta JM, 2008, AGR WATER MANAGE, V95, P959, DOI 10.1016/j.agwat.2008.03.003; [艾鹏睿 Ai Pengrui], 2018, [灌溉排水学报, Journal of Irrigation and Drainage], V37, P9; Black DM, 1960, PLANT SOIL, V11, P102; Cetin O, 2019, AGR WATER MANAGE, V223, DOI 10.1016/j.agwat.2019.105693; Che YinWei, 2012, Journal of Northwest A & F University - Natural Science Edition, V40, P177; [崔红艳 Cui Hongyan], 2015, [核农学报, Journal of Nuclear Agricultural Sciences], V29, P812; Farquhar G., 2014, Zhongguo Shengtai Nongye Xuebao / Chinese Journal of Eco-Agriculture, V22, P886; [高继平 Gao Jiping], 2016, [核农学报, Journal of Nuclear Agricultural Sciences], V30, P596; Han Zhan-jiang, 2009, Yingyong Shengtai Xuebao, V20, P2671; Hou JA, 2013, EFFECTS DIFFERENT CO; Hou JA, 2019, NONWOOD FOREST RES, V37, P58, DOI [10.14067/j.cnki.1003-8981.2019.02.009, DOI 10.14067/J.CNKI.1003-8981.2019.02.009]; Intrigliolo DS, 2009, AGR WATER MANAGE, V96, P282, DOI 10.1016/j.agwat.2008.08.001; Jasechko S, 2013, NATURE, V496, P347, DOI 10.1038/nature11983; Li ShiHua, 2010, Agricultural Science & Technology - Hunan, V11, P164; Liu EK, 2016, AGR WATER MANAGE, V167, P75, DOI 10.1016/j.agwat.2015.12.026; Liu M., 2012, T CSAE, V28, P98; Ma WenJun, 2010, Transactions of the Chinese Society of Agricultural Engineering, V26, P73; Nie ZiJin, 2013, Acta Agronomica Sinica, V39, P1687, DOI 10.3724/SP.J.1006.2013.01687; Patane C, 2011, SCI HORTIC-AMSTERDAM, V129, P590, DOI 10.1016/j.scienta.2011.04.030; Qi JX, 2017, WATER SAVING IRRIGAT, V4, P50; Ren YuZhong, 2012, Transactions of the Chinese Society of Agricultural Engineering, V28, P95; Sumner DM, 2005, J HYDROL, V308, P81, DOI 10.1016/j.jhydrol.2004.10.023; [孙三民 Sun Sanmin], 2013, [灌溉排水学报, Journal of Irrigation and Drainage], V32, P122; Ucan K, 2010, AGR WATER MANAGE, V98, P227, DOI 10.1016/j.agwat.2010.08.005; Wang JianDong, 2008, Transactions of the Chinese Society of Agricultural Engineering, V24, P39; [王娟 Wang Juan], 2014, [灌溉排水学报, Journal of Irrigation and Drainage], V33, P126; Wang LiXia, 2013, Acta Agronomica Sinica, V39, P1864, DOI 10.3724/SP.J.1006.2013.01864; Wang ZN, 2013, IRRIGATION DRAINAGE; Xu DQ., 2002, PHOTOSYNTHESIS EFFIC; [闫亚丹 YAN Ya-dan], 2009, [干旱地区农业研究, Agricultural Research in the Arid Areas], V27, P174; Yan ZhongXin, 2010, Journal of Northwest A & F University - Natural Science Edition, V38, P102; [杨晓婷 Yang Xiaoting], 2016, [华北农学报, Acta Agriculturae Boreali-Sinica], V31, P192; Yildirim O, 2009, TURK J AGRIC FOR, V33, P243, DOI 10.3906/tar-0806-19; Yonts CD, 2018, AGR WATER MANAGE, V199, P138, DOI 10.1016/j.agwat.2017.12.024; ZHANG L, 2019, J IRRIGATION DRAINAG, V38, P1, DOI DOI 10.1016/J.TELE.2019.01.009; [张乐 Zhang Le], 2018, [灌溉排水学报, Journal of Irrigation and Drainage], V37, P24; Zhang XiaoXing, 2018, Transactions of the Chinese Society of Agricultural Engineering, V34, P143; Zhang YingHua, 2016, Transactions of the Chinese Society of Agricultural Engineering, V32, P88; [张源沛 Zhang Yuanpei], 2011, [中国农学通报, Chinese Agricultural Science Bulletin], V27, P64; [郑国保 Zheng Guobao], 2018, [新疆农业科学, Xinjiang Agricultural Sciences], V55, P2212; [周丽丽 Zhou Lili], 2018, [农业机械学报, Transactions of the Chinese Society for Agricultural Machinery], V49, P235	41	4	4	4	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2019	14	8							e0221925	10.1371/journal.pone.0221925	http://dx.doi.org/10.1371/journal.pone.0221925			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW6AB	31465512	Green Published, Green Submitted, gold			2022-12-26	WOS:000485058200070
J	Culbert, NJ; Gilles, JRL; Bouyer, J				Culbert, Nicole J.; Gilles, Jeremie R. L.; Bouyer, Jeremy			Investigating the impact of chilling temperature on male Aedes aegypti and Aedes albopictus survival	PLOS ONE			English	Article							DIPTERA-CULICIDAE; DENGUE	In genetic control programmes, including the sterile insect technique (SIT), it is crucial to release insects of the highest quality with maximum survival. It is likely that male mosquitoes will follow the trend of other insects in SIT programmes and be stored, transported and eventually released under chilled conditions. The aim of our study was to investigate the impact of different chilling temperatures on male Aedes aegypti and Ae. albopictus survival by exposing them to a range of temperatures for different durations. Ae. aegypti were found to be less sensitive to the impact of chilling, with only 6 degrees C causing a marginal decrease in survival in comparison to non-chilled controls. Conversely, Ae. albopictus displayed a significantly reduced survival at all chilling temperatures even when exposed for a short time. In both species, longer exposure to low temperatures reduced survival. Our results uncovered that Ae. albopictus are more sensitive to chilling, regardless of the temperature, when compared to Ae. aegypti. Such results indicate differences in thermal tolerances between species and the necessity of conducting experiments on a species by species basis when determining temperature limits for any insect destined for release as part of a genetic control programme.	[Culbert, Nicole J.; Gilles, Jeremie R. L.; Bouyer, Jeremy] Joint Food & Agr Org United Nat Int Atom Energy A, Insect Pest Control Lab, Vienna, Austria; [Culbert, Nicole J.] Univ Liverpool, Inst Integrat Biol, Liverpool, Merseyside, England; [Culbert, Nicole J.] Univ Liverpool, Ctr Genom Res, Liverpool, Merseyside, England; [Bouyer, Jeremy] CIRAD, UMR ASTRE CIRAD INRA Anim Hlth Terr Risks & Ecosy, Campus Int Baillarguet, Montpellier, France	International Atomic Energy Agency; University of Liverpool; University of Liverpool; CIRAD; INRAE	Culbert, NJ (corresponding author), Joint Food & Agr Org United Nat Int Atom Energy A, Insect Pest Control Lab, Vienna, Austria.; Culbert, NJ (corresponding author), Univ Liverpool, Inst Integrat Biol, Liverpool, Merseyside, England.; Culbert, NJ (corresponding author), Univ Liverpool, Ctr Genom Res, Liverpool, Merseyside, England.	nicole.j.culbert@gmail.com	Bouyer, Jérémy/AAK-7370-2020	Bouyer, Jérémy/0000-0002-1913-416X	joint FAO/IAEA; European Research Council under the European Union's Horizon 2020 research and innovation programme [682387-REVOLINC]; University of Liverpool	joint FAO/IAEA; European Research Council under the European Union's Horizon 2020 research and innovation programme(European Research Council (ERC)); University of Liverpool	This work has been funded by the joint FAO/IAEA and by the European Research Council under the European Union's Horizon 2020 research and innovation programme (grant agreement no. 682387-REVOLINC) and the University of Liverpool cover the tuition fees of NJC under a bursary scheme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alto BW, 2013, AM J TROP MED HYG, V88, P497, DOI 10.4269/ajtmh.12-0421; [Anonymous], 2017, GUIDELINES ROUTINE C; Balestrino F, 2014, J MED ENTOMOL, V51, P155, DOI 10.1603/ME13130; Balestrino F, 2012, J MED ENTOMOL, V49, P595, DOI 10.1603/ME11188; Balestrino F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091914; Bjelis M, 2013, J APPL ENTOMOL, V137, P154, DOI 10.1111/j.1439-0418.2011.01660.x; Brady OJ, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-351; Burnham K P, 2003, MODEL SELECT MULTIMO; Chang LH, 2007, J MED ENTOMOL, V44, P205, DOI 10.1603/0022-2585(2007)44[205:DSOAAA]2.0.CO;2; Christophers, 1960, AEDES AEGYPTI L YELL; Coetzee M, 2013, ANNU REV ENTOMOL, V58, P393, DOI 10.1146/annurev-ento-120811-153628; Colinet H, 2010, ANN APPL BIOL, V156, P147, DOI 10.1111/j.1744-7348.2009.00374.x; Culbert NJ, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-34469-6; Culbert NJ, 2017, ENTOMOL EXP APPL, V164, P276, DOI 10.1111/eea.12610; Enkerlin W., 2007, GUIDANCE PACKING SHI; FAY R. W., 1959, MOSQUITO NEWS, V19, P144; Fischer S, 2011, J VECTOR ECOL, V36, P94, DOI 10.1111/j.1948-7134.2011.00145.x; FOCKS DA, 1980, J MED ENTOMOL, V17, P567, DOI 10.1093/jmedent/17.6.567; HANSON SM, 1995, J AM MOSQUITO CONTR, V11, P35; Hendrichs J., 2009, STERILE INSECT TECHN, P953; HURVICH CM, 1995, BIOMETRICS, V51, P1077, DOI 10.2307/2533006; Khosa S. S., 2000, Journal of Biological Control, V14, P71; Kress A, 2017, J INSECT PHYSIOL, V99, P113, DOI 10.1016/j.jinsphys.2017.04.003; Kumar Parminder, 2005, Journal of Biological Control, V19, P17; McGraw EA, 2013, NAT REV MICROBIOL, V11, P181, DOI 10.1038/nrmicro2968; Mubarqui RL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103077; Neven LG, 2010, ANN ENTOMOL SOC AM, V103, P418, DOI 10.1603/AN09133; Pagabeleguem S, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0869-3; Reinhold JM, 2018, INSECTS, V9, DOI 10.3390/insects9040158; Schmidt CA, 2018, PARASITE VECTOR, V11, DOI 10.1186/s13071-018-2808-6; Semper C, 1883, NATURAL CONDITIONS E; World Health Organization, 2017, GLOB VECT CONTR RESP; Zheng ML, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-014-0631-2	33	16	16	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2019	14	8							e0221822	10.1371/journal.pone.0221822	http://dx.doi.org/10.1371/journal.pone.0221822			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5WO	31454400	gold, Green Published			2022-12-26	WOS:000485049000048
J	Postnikova, EN; Pettitt, J; Van Ryn, CJ; Holbrook, MR; Bollinger, L; Yu, SQ; Cai, YY; Liang, JN; Sneller, MC; Jahrling, PB; Hensley, LE; Kuhn, JH; Fallah, MP; Bennett, RS; Reilly, C				Postnikova, Elena N.; Pettitt, James; Van Ryn, Collin J.; Holbrook, Michael R.; Bollinger, Laura; Yu, Shuiqing; Cai, Yingyun; Liang, Janie; Sneller, Michael C.; Jahrling, Peter B.; Hensley, Lisa E.; Kuhn, Jens H.; Fallah, Mosoka P.; Bennett, Richard S.; Reilly, Cavan			Scalable, semi-automated fluorescence reduction neutralization assay for qualitative assessment of Ebola virus-neutralizing antibodies in human clinical samples	PLOS ONE			English	Article								Antibody titers against a viral pathogen are typically measured using an antigen binding assay, such as an enzyme-linked immunosorbent assay (ELISA), which only measures the ability of antibodies to identify a viral antigen of interest. Neutralization assays measure the presence of virus-neutralizing antibodies in a sample. Traditional neutralization assays, such as the plaque reduction neutralization test (PRNT), are often difficult to use on a large scale due to being both labor and resource intensive. Here we describe an Ebola virus fluorescence reduction neutralization assay (FRNA), which tests for neutralizing antibodies, that requires only a small volume of sample in a 96-well format and is easy to automate. The readout of the FRNA is the percentage of Ebola virus-infected cells measured with an optical reader or overall chemiluminescence that can be generated by multiple reading platforms. Using blinded human clinical samples (EVD survivors or contacts) obtained in Liberia during the 2013-2016 Ebola virus disease outbreak, we demonstrate there was a high degree of agreement between the FRNA-measured antibody titers and the Filovirus Animal Non-clinical Group (FANG) ELISA titers with the FRNA providing information on the neutralizing capabilities of the antibodies.	[Postnikova, Elena N.; Pettitt, James; Holbrook, Michael R.; Bollinger, Laura; Yu, Shuiqing; Cai, Yingyun; Liang, Janie; Jahrling, Peter B.; Hensley, Lisa E.; Kuhn, Jens H.; Bennett, Richard S.] NIAID, Integrated Res Facil Ft Detrick, NIH, Res Plaza, Frederick, MD 21702 USA; [Van Ryn, Collin J.; Reilly, Cavan] Univ Minnesota, Div Biostat, Coordinating Ctr Biometr Res, Minneapolis, MN USA; [Sneller, Michael C.] NIAID, Lab Immunoregulat, NIH, 10 Ctr Dr, Bethesda, MD USA; [Jahrling, Peter B.] NIAID, Emerging Viral Pathogens Sect, Lab Immunoregulat, Div Intramural Res,NIH, Res Plaza, Frederick, MD USA; [Fallah, Mosoka P.] Natl Publ Hlth Inst Liberia, Monrovia, Liberia	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Minnesota System; University of Minnesota Twin Cities; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Bennett, RS (corresponding author), NIAID, Integrated Res Facil Ft Detrick, NIH, Res Plaza, Frederick, MD 21702 USA.	richard.bennett@nih.gov	Holbrook, Michael/AAT-6865-2020; Kuhn, Jens H./B-7615-2011	Holbrook, Michael/0000-0002-0824-2667; Kuhn, Jens H./0000-0002-7800-6045; Hensley, Lisa/0000-0003-1188-4342; Cai, Yingyun/0000-0002-1101-0920; Bennett, Richard/0000-0002-7227-4831	US National Institute of Allergy and Infectious Diseases (NIAID) Division of Intramural Research; Battelle Memorial Institute; National Institutes of Allergy and Infectious Diseases; US National Institute of Allergy and Infectious Diseases (NIAID) Division of Clinical Research; NIAID [HHSN272200700016I]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZICAI009006] Funding Source: NIH RePORTER	US National Institute of Allergy and Infectious Diseases (NIAID) Division of Intramural Research; Battelle Memorial Institute; National Institutes of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); US National Institute of Allergy and Infectious Diseases (NIAID) Division of Clinical Research; NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by US National Institute of Allergy and Infectious Diseases (NIAID) Divisions of Intramural Research and Clinical Research. This work was funded in part through Battelle Memorial Institute's prime contract with NIAID under Contract No. HHSN272200700016I (E.N.P., M.R.H., L.B., S.Y., Y.C., J.L., J.H.K., R.S. B.). The authors acknowledge funding by the National Institutes of Allergy and Infectious Diseases; ClinicalTrials.gov number, NCT02431923.	Ahuka-Mundeke S, 2018, LANCET, V392, P213, DOI 10.1016/S0140-6736(18)31387-4; Baize S, 2014, NEW ENGL J MED, V371, P1418, DOI 10.1056/NEJMoa1404505; Bramble MS, 2018, J INFECT DIS, V218, P1929, DOI 10.1093/infdis/jiy453; Bukreyev AA, 2014, ARCH VIROL, V159, P821, DOI 10.1007/s00705-013-1846-9; Dyer O, 2018, BMJ-BRIT MED J, V362, DOI 10.1136/bmj.k3421; Kennedy SB, 2017, NEW ENGL J MED, V377, P1438, DOI 10.1056/NEJMoa1614067; Kilgore N, 2012, VIRUSES-BASEL, V4, P2312, DOI 10.3390/v4102312; Konduru K, 2018, J VIROL METHODS, V254, P1, DOI 10.1016/j.jviromet.2018.01.003; Kuhn JH, 2018, HARRISONS PRINCIPLES, P1509; Logue J, 2018, J VIROL METHODS, V255, P84, DOI 10.1016/j.jviromet.2018.02.018; Meyer M, 2019, TRENDS MICROBIOL, V27, P8, DOI 10.1016/j.tim.2018.08.008; Postnikova E, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194880; Rimoin AW, 2018, J INFECT DIS, V217, P223, DOI 10.1093/infdis/jix584; Shurtleff AC, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8040113; World Health Organization, 2016, BERLIN HAYOM	15	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2019	14	8							e0221407	10.1371/journal.pone.0221407	http://dx.doi.org/10.1371/journal.pone.0221407			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5WO	31454374	Green Published, Green Submitted, gold			2022-12-26	WOS:000485049000021
J	Xu, RR; Wu, YX; Wang, GX; Zhang, X; Wu, W; Xu, Z				Xu, Rongrong; Wu, Yongxiang; Wang, Gaoxu; Zhang, Xuan; Wu, Wei; Xu, Zan			Evaluation of industrial water use efficiency considering pollutant discharge in China	PLOS ONE			English	Article							SYSTEMS; IMPACT	China is facing severe pressure on its water resources and water environments. Calculating the industrial water efficiency of each province is an important index for the central government to evaluate local governments. In the traditional water resources evaluation index, the industrial water use efficiency and pollutant discharge are evaluated separately. In this paper, we collected industrial input data, output data and pollutant discharge data with a four-stage data envelopment analysis to calculate China's industrial water use efficiency with and without considering pollutant discharge, and then analyzed the factors influencing the industrial water use efficiency. The results show that the eastern coastal provinces of China have the highest water use efficiency and are less affected by pollutant discharge than other provinces. The industrial water use efficiency of the central and western provinces is lower than that of the other provinces, and the industrial water use efficiency in the central provinces is greatly affected by pollutant discharge. Factor endowment, economic development level, scientific and technological progress, industrial structure, proportion of foreign investment, water consumption per 10000 yuan of value-added by industry, industrial sewage treatment capacity and educational investment have a significant influence on the industrial water use efficiency of China. We suggest that the government strengthen the construction of sewage plants and other related infrastructure in central provinces when conducting the industrial transfer of heavy polluting enterprises.	[Xu, Rongrong; Wu, Yongxiang; Wang, Gaoxu; Wu, Wei; Xu, Zan] Nanjing Hydraul Res Inst, Hydrol & Water Resources Dept, Nanjing, Jiangsu, Peoples R China; [Wu, Yongxiang] State Key Lab Hydrol Water Resources & Hydraul En, Nanjing, Jiangsu, Peoples R China; [Zhang, Xuan] Hohai Univ, Hydrol & Water Resources Coll, Nanjing, Jiangsu, Peoples R China	Nanjing Hydraulic Research Institute; Hohai University	Wu, YX (corresponding author), Nanjing Hydraul Res Inst, Hydrol & Water Resources Dept, Nanjing, Jiangsu, Peoples R China.; Wu, YX (corresponding author), State Key Lab Hydrol Water Resources & Hydraul En, Nanjing, Jiangsu, Peoples R China.	xurongrong2017@gmail.com; yxwu@nhri.cn			National Key Research and Development Program of China [2017YFC0405805, 2017YFC0405803]; Basic Research Projects of the Central Research Institute in Nanjing Hydraulic Research Institute [Y516031, Y517013, Y517015, Y519001]	National Key Research and Development Program of China; Basic Research Projects of the Central Research Institute in Nanjing Hydraulic Research Institute	This work was supported by the National Key Research and Development Program of China (No. 2017YFC0405805, 2017YFC0405803) and Basic Research Projects of the Central Research Institute in Nanjing Hydraulic Research Institute (Y516031, Y517013, Y517015, Y519001).	ANDERSEN P, 1993, MANAGE SCI, V39, P1261, DOI 10.1287/mnsc.39.10.1261; Asghari M., 2013, INT J SCI RES SOC SC, V1, P92, DOI [10.12983/ijsres-2013-p092-100, DOI 10.12983/IJSRES-2013-P092-100]; Bekchanov M, 2010, WATER-SUI, V2, P200, DOI 10.3390/w2020200; Bian YW, 2014, RESOUR CONSERV RECY, V83, P15, DOI 10.1016/j.resconrec.2013.11.010; CHARNES A, 1978, EUR J OPER RES, V2, P429, DOI 10.1016/0377-2217(78)90138-8; Deng GY, 2016, ECOL INDIC, V69, P12, DOI 10.1016/j.ecolind.2016.03.052; Deng GY, 2015, WATER RESOUR MANAG, V29, P2947, DOI 10.1007/s11269-015-0980-4; Dong HJ, 2013, SCI TOTAL ENVIRON, V442, P215, DOI 10.1016/j.scitotenv.2012.10.049; Florke M, 2013, GLOBAL ENVIRON CHANG, V23, P144, DOI 10.1016/j.gloenvcha.2012.10.018; Fujii Hidemichi, 2013, J CLEAN PROD, V59, P22; Geng Y, 2014, J CLEAN PROD, V76, P116, DOI 10.1016/j.jclepro.2014.04.047; Geng Y, 2014, J CLEAN PROD, V75, P130, DOI 10.1016/j.jclepro.2014.03.082; Gidion DK, 2019, UTIL POLICY, V57, P48, DOI 10.1016/j.jup.2019.02.001; Guerrini A, 2013, WATER RESOUR MANAG, V27, P4559, DOI 10.1007/s11269-013-0426-9; Hu Z, 2018, J HYDROLOGY, V562; Kouchak-iPenchah H, 2017, ENV PROGR SUSTAINABL, V36; Lee J, 2018, J WATER RESOURCES PL, V144; Lorenzo-Toja Y, 2015, WATER RES, V68, P651, DOI 10.1016/j.watres.2014.10.040; Manjunatha AV, 2011, J ENVIRON MANAGE, V92, P2924, DOI 10.1016/j.jenvman.2011.07.001; Meng FY, 2016, APPL ENERG, V183, P1, DOI 10.1016/j.apenergy.2016.08.158; Millimet DL, 2016, J APPL ECONOMET, V31, P652, DOI 10.1002/jae.2451; Moore AD, 2011, AGR SYST, V104, P162, DOI 10.1016/j.agsy.2010.05.007; Ren CF, 2017, SUSTAINABILITY-BASEL, V9, DOI 10.3390/su9010052; Renzetti S, 2009, LAND ECON, V85, P627, DOI 10.3368/le.85.4.627; Shi QL, 2015, SUSTAINABILITY-BASEL, V7, P56, DOI 10.3390/su7010056; Tian G, 2018, ENVIRON SCI POLLUT R, V25, P1; Veettil P, 2013, WATER RESOUR MANAG, V27, P55, DOI 10.1007/s11269-012-0155-5; Wang Q, 2016, ENVIRON POLLUT, V218, P358, DOI 10.1016/j.envpol.2016.07.011; WANG SQ, 2018, WATER-SUI, V10, DOI DOI 10.3390/W10070832; Wang YS, 2015, J CLEAN PROD, V101, P301, DOI 10.1016/j.jclepro.2015.03.092; Wang Y, 2016, IEEE INT SYMP CIRC S, P1, DOI 10.1109/ISCAS.2016.7527155; Wei W, 2016, RESOURCES CONSERVATI, V128; Willis RM, 2013, J CLEAN PROD, V60, P107, DOI 10.1016/j.jclepro.2011.08.006; Xiong YJ, 2016, ENVIRON EARTH SCI, V75, DOI 10.1007/s12665-015-4873-x; Xue B, 2014, ECOL INDIC, V38, P272, DOI 10.1016/j.ecolind.2013.11.020; Yang N, 2018, SUSTAINABILITY-BASEL, V10, DOI 10.3390/su10072569; ZHANG ZL, 2016, SUSTAINABILITY-BASEL, V8, DOI DOI 10.3390/SU8030222; Zhao H., 2015, J CLEANER PRODUCTION; Zhao HX, 2018, J ENVIRON MANAGE, V213, P247, DOI 10.1016/j.jenvman.2017.08.007; Zhao X, 2017, J CLEAN PROD, V168, DOI [10.1016/j.jclepro.2017.05.198, DOI 10.1016/J.JCLEPRO.2017.05.198]; Zhou H, 2016, URBAN WATER J, V13, P156, DOI 10.1080/1573062X.2014.949798; Zhou Y, 2014, ENVIRON EARTH SCI, V72, P1243, DOI 10.1007/s12665-013-3042-3	42	9	9	4	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2019	14	8							e0221363	10.1371/journal.pone.0221363	http://dx.doi.org/10.1371/journal.pone.0221363			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5WO	31454367	gold, Green Submitted, Green Published			2022-12-26	WOS:000485049000017
J	Fleck, D; Curry, C; Donnan, K; Logue, O; Graham, K; Jackson, K; Keown, K; Winder, J; Shields, MD; Hughes, CM				Fleck, Deborah; Curry, Chistopher; Donnan, Kate; Logue, Orla; Graham, Kathryn; Jackson, Kate; Keown, Karen; Winder, John; Shields, Michael D.; Hughes, Ciara M.			Investigating the clinical use of structured light plethysmography to assess lung function in children with neuromuscular disorders	PLOS ONE			English	Article							DISEASE	Background Children and young people with neuromuscular disorders (NMD), such as Duchenne Muscular Dystrophy (DMD), develop progressive respiratory muscles weakness and pulmonary restriction. Pulmonary function monitoring of the decline in lung function allows for timely intervention with cough assist techniques and nocturnal non-invasive ventilation (NIV). NMD may find the measurement of lung function difficult using current techniques. Structured Light Plethysmography (SLP) has been proposed as a novel, non-contact, self-calibrating, non-invasive method of assessing lung function. The overarching aim of this study was to investigate the use of SLP as a novel method for monitoring respiratory function in children with neuromuscular disease. Methods SLP thoraco-abdominal (TA) displacement was correlated with forced vital capacity measurements recorded by spirometry and the repeatability of the measurements with both methods examined. SLP tidal breathing parameters were investigated to assess the range and repeatability of regional right and left side TA displacement and rib cage and abdominal wall displacement. Results The comparison of the FVC measured with SLP and with spirometry, while having good correlation (R = 0.78) had poor measurement agreement (95% limits of agreement: - 1.2 to 1.2L) The mean relative contribution of right and left TA displacement in healthy controls was 50:50 with a narrow range. Repeatability of this measure with SLP was found to be good in healthy controls and moderate in NMD children with/without scoliosis but with a wider range. The majority of the control group displayed a predominant rib cage displacement during tidal breathing and those who displayed predominant abdominal wall displacement showed displacement of both regions close to 50:50 with similar results for the rib cage and abdomen. In comparison, children with NMD have a more variable contribution for all of these parameters. In addition, SLP was able to detect a reduction in abdominal contribution to TA displacement with age in the DMD group and detect paradoxical breathing in children with NMD. Using SLP tracings during tidal breathing we were able to identify three specific patterns of breathing amongst healthy individuals and in children with NMD. Conclusions SLP is a novel method for measuring lung function that requires limited patient cooperation and may be especially useful in children with neuromuscular disorders. Measuring the relative contributions of the right and left chest wall and chest versus abdominal movements allows a more detailed assessment.	[Fleck, Deborah; Winder, John; Hughes, Ciara M.] Ulster Univ, Sch Hlth Sci, Nursing & Hlth Res Inst, Belfast, Antrim, North Ireland; [Curry, Chistopher; Donnan, Kate; Logue, Orla; Graham, Kathryn; Jackson, Kate; Shields, Michael D.] Queens Univ Belfast, Ctr Expt Med, Belfast, Antrim, North Ireland; [Jackson, Kate; Keown, Karen; Shields, Michael D.] Belfast Hlth & Social Care Trust, Royal Belfast Hosp Sick Children, Belfast, Antrim, North Ireland	Ulster University; Queens University Belfast	Shields, MD (corresponding author), Queens Univ Belfast, Ctr Expt Med, Belfast, Antrim, North Ireland.; Shields, MD (corresponding author), Belfast Hlth & Social Care Trust, Royal Belfast Hosp Sick Children, Belfast, Antrim, North Ireland.	m.shields@qub.ac.uk		Fleck, Deborah/0000-0001-5427-0098; Shields, Michael/0000-0002-3793-3571	Queen's University Belfast's bequieth fund (Carroll Trust)	Queen's University Belfast's bequieth fund (Carroll Trust)	The funding to rent the SLP equipment (from Pneumacare) was from the Queen's University Belfast's bequieth fund (The Carroll Trust). No researchers salaries were provided related to this piece of research. Pneumacare allowed a short rent free extensive (4 months) to allow completion of the study. None of the funders had any role in the study design, topic of study (respiratory function in neuromuscular disease), data collection, data analysis, decision to publish or preparation of the manuscript.	Alimohamed S, 2011, THORAX, V66, pA121, DOI 10.1136/thoraxjnl-2011-201054c.134; Allen J, 2010, PAEDIATR RESPIR REV, V11, P18, DOI 10.1016/j.prrv.2009.10.002; Bach JR, 1997, CHEST, V112, P1024, DOI 10.1378/chest.112.4.1024; Bland J. M., 1987, BIOCH CLIN, V11, P399, DOI DOI 10.1016/J.IJNURSTU.2009.10.001; de Boer W, 2010, BRIT MACH VIS C P; Fauroux B, 2015, CHEST, V147, P552, DOI 10.1378/chest.14-0819; Fauroux B, 2014, RESPIROLOGY, V19, P782, DOI 10.1111/resp.12330; Gauld LM, 2003, AM J RESP CRIT CARE, V168, P804, DOI 10.1164/rccm.200303-451OC; Gozal D, 2000, PEDIATR PULM, V29, P141, DOI 10.1002/(SICI)1099-0496(200002)29:2<141::AID-PPUL9>3.0.CO;2-Y; HOWARD RS, 1993, Q J MED, V86, P175; Hull J, 2012, THORAX, V67, P1, DOI 10.1136/thoraxjnl-2012-201964; Lanini B, 2003, AM J RESP CRIT CARE, V168, P109, DOI 10.1164/rccm.200207-745OC; Lau E, 2009, BRIT THOR SOC WINT M; Lo Mauro A, 2010, EUROPEAN RESP J, V35, P5; Lo Mauro A, 2016, BREATHE, V12, P319, DOI 10.1183/20734735.012716; LoMauro A, 2018, EUR RESPIR J, V51, DOI 10.1183/13993003.01418-2017; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Motamedi-Fakhr S, 2017, PHYSIOL REP, V5, DOI 10.14814/phy2.13124; Perez A, 1996, CHEST, V110, P454, DOI 10.1378/chest.110.2.454; Perez T, 2006, REV NEUROL-FRANCE, V162, P437; Phillips MF, 2001, AM J RESP CRIT CARE, V164, P2191, DOI 10.1164/ajrccm.164.12.2103052; Ricotti V, 2016, DEV MED CHILD NEUROL, V58, P77, DOI 10.1111/dmcn.12922; Schroth MK, 2009, PEDIATRICS, V123, pS245, DOI 10.1542/peds.2008-2952K	23	5	5	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2019	14	8							e0221207	10.1371/journal.pone.0221207	http://dx.doi.org/10.1371/journal.pone.0221207			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5UR	31449525	Green Published, Green Submitted, gold			2022-12-26	WOS:000485044000009
J	Tumino, BJ; Duff, TJ; Goodger, JQD; Cawson, JG				Tumino, Bianca J.; Duff, Thomas J.; Goodger, Jason Q. D.; Cawson, Jane G.			Plant traits linked to field-scale flammability metrics in prescribed burns in Eucalyptus forest	PLOS ONE			English	Article							FIRE BEHAVIOR; FUEL MOISTURE; IGNITION BEHAVIOR; SPECIES TRAITS; NATURAL FUELS; LEAF; LITTER; GRASS; ACCUMULATION; IGNITABILITY	Vegetation is a key determinant of wildfire behaviour at field scales as it functions as fuel. Past studies in the laboratory show that plant flammability, the ability of plants to ignite and maintain combustion, is a function of their traits. However, the way the traits of individual plants combine in a vegetation community to affect field flammability has received little attention. This study aims to bridge the gap between the laboratory and field by linking plant traits to metrics of field-scale flammability. Across three prescribed burns, in Eucalyptus-dominated damp and dry forest, we measured pre-burn plant species abundance and postburn field flammability metrics (percentage area burnt, char and scorch height). For understory species with dominant cover-abundance, we measured nine traits that had been demonstrated to influence flammability in the laboratory. We used fourth-corner ordination to evaluate covariation between the plant traits, species abundance and flammability. We found that several traits covaried at the species level. In some instances, these traits (e.g. specific leaf area and bulk density) could have cumulative effects on the flammability of a species while in other instances (e.g. moisture and specific leaf area) they may have counteractive effects, assuming trait effects on flammability are akin to previous research. At field scales, species with similar traits tended to co-occur, suggesting that the effects of individual traits accumulate within a plant community. Fourth-corner analyses found the trait-field flammability relationship to be statistically significant. Traits significantly associated with increasing field flammability metrics were: bulk density (negatively associated) and hydrocarbon quantity, specific leaf area and surface area to volume ratio (all positively associated). Our study demonstrates that some traits known to influence flammability in the laboratory can be associated with field-scale flammability metrics. Further research is needed to isolate the contributions of individual traits to understand how species composition drives forest flammability.	[Tumino, Bianca J.; Duff, Thomas J.; Cawson, Jane G.] Univ Melbourne, Sch Ecosyst & Forest Sci, Burnley, Vic, Australia; [Goodger, Jason Q. D.] Univ Melbourne, Sch BioSci, Parkville, Vic, Australia	University of Melbourne; University of Melbourne	Tumino, BJ (corresponding author), Univ Melbourne, Sch Ecosyst & Forest Sci, Burnley, Vic, Australia.	bee.tumino@unimelb.edu.au	Duff, Thomas/AAE-8591-2019	Duff, Thomas/0000-0003-2116-3901; Cawson, Jane/0000-0003-3702-9504; Pickering, Bianca/0000-0001-8824-5376; Goodger, Jason/0000-0001-7392-3891	project titled "Managing bushfire in Tall Mist Forests - fuel hazard and moisture relationships" within the integrated Forest Ecosystem Research program - Victorian Government's Department of Environment, Water, Land and Planning (DEWLP)	project titled "Managing bushfire in Tall Mist Forests - fuel hazard and moisture relationships" within the integrated Forest Ecosystem Research program - Victorian Government's Department of Environment, Water, Land and Planning (DEWLP)	This research was conducted as part of an Honours project. Funding was received through a project titled "Managing bushfire in Tall Mist Forests - fuel hazard and moisture relationships" within the integrated Forest Ecosystem Research program, a forest research program funded by the Victorian Government's Department of Environment, Water, Land and Planning (DEWLP). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen SE, 1986, METHODS PLANT ECOLOG, P300; Anderson H. E., 1970, Fire Technology, V6, P312, DOI 10.1007/BF02588932; Anderson WR, 2015, INT J WILDLAND FIRE, V24, P443, DOI 10.1071/WF14130; Behm AL, 2004, INT J WILDLAND FIRE, V13, P355, DOI 10.1071/WF03075; Bradstock RA, 2010, LANDSCAPE ECOL, V25, P607, DOI 10.1007/s10980-009-9443-8; Brown AM, 2014, METHODS ECOL EVOL, V5, P344, DOI 10.1111/2041-210X.12163; BUNTING SC, 1983, J RANGE MANAGE, V36, P169, DOI 10.2307/3898155; Bureau of Meteorology, 2017, CLIM STAT AUSTR LOC; Cardoso AW, 2018, GRASS SPECIES FLAM M, V1, P1; Cawson J., 2018, ADV FOREST FIRE RES, P484; Cawson JG, 2019, INT J WILDLAND FIRE, V28, P198, DOI 10.1071/WF18070; Cawson JG, 2018, ECOSPHERE, V9, DOI 10.1002/ecs2.2211; Cawson JG, 2017, FOREST ECOL MANAG, V400, P568, DOI 10.1016/j.foreco.2017.06.046; Cheal DC, 2010, 84 VICT GOV DEP SUST; Cheney NP, 2012, FOREST ECOL MANAG, V280, P120, DOI 10.1016/j.foreco.2012.06.012; Chuvieco E, 2010, ECOL MODEL, V221, P46, DOI 10.1016/j.ecolmodel.2008.11.017; Costermans L., 2009, NATIVE TREES SHRUBS, P58; Cubino JP, 2018, J ECOL, V106, P1582, DOI 10.1111/1365-2745.12933; Dahale A, 2013, INT J WILDLAND FIRE, V22, P625, DOI 10.1071/WF12040; Rivera JD, 2012, COMBUST SCI TECHNOL, V184, P224, DOI 10.1080/00102202.2011.630332; DICKINSON KJM, 1985, J BIOGEOGR, V12, P121, DOI 10.2307/2844836; Dimitrakopoulos AP, 2001, FIRE TECHNOL, V37, P143, DOI 10.1023/A:1011641601076; Dimitrakopoulos AP, 2001, INT J WILDLAND FIRE, V10, P23, DOI 10.1071/WF01003; Doledec S, 1996, ENVIRON ECOL STAT, V3, P143, DOI 10.1007/BF02427859; Dray S, 2014, ECOLOGY, V95, P14, DOI 10.1890/13-0196.1; Dray S, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i04; Duff TJ, 2019, FOREST ECOL MANAG, V433, P431, DOI 10.1016/j.foreco.2018.11.009; Duff TJ, 2014, J VEG SCI, V25, P323, DOI 10.1111/jvs.12092; Duff TJ, 2013, INT J WILDLAND FIRE, V22, P318, DOI 10.1071/WF11087; Engber EA, 2012, CAN J FOREST RES, V42, P1965, DOI 10.1139/x2012-138; Engstrom JD, 2004, COMBUST SCI TECHNOL, V176, P1577, DOI 10.1080/00102200490474278; Etlinger MG, 2004, INT J WILDLAND FIRE, V13, P479, DOI 10.1071/WF04039; Fahn A, 2002, ISRAEL J PLANT SCI, V50, pS59; Fernandes PM, 2012, NEW PHYTOL, V194, P606, DOI 10.1111/j.1469-8137.2012.04065.x; Finney MA, 2013, INT J WILDLAND FIRE, V22, P25, DOI 10.1071/WF11117; Fletcher TH, 2007, COMBUST SCI TECHNOL, V179, P1183, DOI 10.1080/00102200601015574; Ganteaume A, 2018, INT J WILDLAND FIRE, V27, P342, DOI 10.1071/WF17001; Ganteaume A, 2013, ENVIRON MANAGE, V52, P467, DOI 10.1007/s00267-013-0067-z; Gill A. M., 2005, Australian Forestry, V68, P87; Gill A.M., 1996, IGNITABILITY LEAVES; GILL AM, 1978, AUST FOREST RES, V8, P199; Givnish T., 1979, Topics in plant population biology., P375; Grigulis K, 2005, GLOBAL CHANGE BIOL, V11, P1042, DOI 10.1111/j.1365-2486.2005.00980.x; Grootemaat S, 2017, OIKOS, V126, P1428, DOI 10.1111/oik.03886; Grootemaat S, 2015, FUNCT ECOL, V29, P1486, DOI 10.1111/1365-2435.12449; Hines F., 2010, OVERALL FUEL HAZARD; Hoffmann WA, 2012, ECOL LETT, V15, P759, DOI 10.1111/j.1461-0248.2012.01789.x; HOGENBIRK JC, 1995, WATER AIR SOIL POLL, V82, P161, DOI 10.1007/BF01182830; Judd T., 1990, ECOLOGY WATER RELATI; Kauf Z., 2016, TESTING VEGETATION F; Keane R.E., 2015, WILDLAND FUEL FUNDAM, DOI DOI 10.1007/978-3-319-09015-3; Keetch J., 1968, DROUGHT INDEX FOREST; King DJ, 2006, NEW PHYTOL, V172, P440, DOI 10.1111/j.1469-8137.2006.01842.x; Lusk CH, 2002, OECOLOGIA, V132, P188, DOI 10.1007/s00442-002-0974-9; MarsdenSmedley JB, 1995, INT J WILDLAND FIRE, V5, P215, DOI 10.1071/WF9950215; Matthews S, 2014, INT J WILDLAND FIRE, V23, P78, DOI 10.1071/WF13005; Matthews S, 2010, INT J WILDLAND FIRE, V19, P800, DOI 10.1071/WF08188; McArthur AG, 1967, FIRE BEHAV EUCALYPT; McCaw LW, 1991, P C BUSHF MOD FIR DA, P147; MONTGOMERY KR, 1971, FOREST SCI, V17, P475; Moon K, 2016, FIRE SAF J, DOI [10.1016/j.firesaf.2016.01.004, DOI 10.1016/J.FIRESAF.2016.01.004]; MOONEY HA, 1970, EVOLUTION, V24, P292, DOI 10.1111/j.1558-5646.1970.tb01762.x; Murray BR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079205; MUTCH RW, 1970, FOREST SCI, V16, P64; Nobel PS, 2009, PHYSICOCHEMICAL AND ENVIRONMENTAL PLANT PHYSIOLOGY, 4TH EDITION, P1; Nowacki GJ, 2008, BIOSCIENCE, V58, P123, DOI 10.1641/B580207; Nyman P, 2018, AGR FOREST METEOROL, V252, P49, DOI 10.1016/j.agrformet.2017.12.255; Ormeno E, 2009, FOREST ECOL MANAG, V257, P471, DOI 10.1016/j.foreco.2008.09.019; Owens MK, 1998, J CHEM ECOL, V24, P2115, DOI 10.1023/A:1020793811615; PAPIO C, 1990, FOREST ECOL MANAG, V35, P249, DOI 10.1016/0378-1127(90)90006-W; Pausas JG, 2017, J ECOL, V105, P289, DOI 10.1111/1365-2745.12691; Pausas JG, 2012, NEW PHYTOL, V194, P610, DOI 10.1111/j.1469-8137.2012.04132.x; Peel MC, 2007, HYDROL EARTH SYST SC, V11, P1633, DOI 10.5194/hess-11-1633-2007; Perez-Harguindeguy N, 2013, AUST J BOT, V61, P167, DOI 10.1071/BT12225; PHILPOT CW, 1970, FOREST SCI, V16, P461; Philpot CW, 1969, EFFECT REDUCED EXTRA; Pickett BM, 2010, INT J WILDLAND FIRE, V19, P153, DOI 10.1071/WF07121; Plucinski MP, 2008, INT J WILDLAND FIRE, V17, P628, DOI 10.1071/WF07046; Reich P. B., 2003, International Journal of Plant Sciences, V164, pS143, DOI 10.1086/374368; Rossiter NA, 2003, DIVERS DISTRIB, V9, P169, DOI 10.1046/j.1472-4642.2003.00020.x; Rothermel R., 1966, FIRE SPREAD CHARACTE; Rothermel R., 1972, MATH MODEL PREDICTIN; Saharjo BH, 1999, J FOREST RES, V4, P57; Scarff FR, 2006, FUNCT ECOL, V20, P745, DOI 10.1111/j.1365-2435.2006.01174.x; Schunk C, 2017, AGR FOREST METEOROL, V234, P31, DOI 10.1016/j.agrformet.2016.12.007; Schwilk DW, 2015, NEW PHYTOL, V206, P486, DOI 10.1111/nph.13372; Schwilk DW, 2011, J ECOL, V99, P970, DOI 10.1111/j.1365-2745.2011.01828.x; Simpson KJ, 2016, J ECOL, V104, P138, DOI 10.1111/1365-2745.12503; Singer RJ, 1999, AUST J ECOL, V24, P18, DOI 10.1046/j.1442-9993.1999.00942.x; Smis A, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00496; State Government of Victoria, 2018, BIOR EVC BENCHM; Tachajapong W, 2008, COMBUST SCI TECHNOL, V180, P593, DOI 10.1080/00102200701838800; Tepley AJ, 2018, J ECOL, V106, P1925, DOI 10.1111/1365-2745.12950; Tolhurst K.G., 1999, SYNOPSIS KNOWLEDGE U; van Wagtendonk JW, 2006, FIRE IN CALIFORNIA'S ECOSYSTEMS, P38; VANWILGEN BW, 1990, J ECOL, V78, P210, DOI 10.2307/2261046; Varner JM, 2015, CURR FOR REP, V1, P91, DOI 10.1007/s40725-015-0012-x; Walsh SF, 2017, INT J WILDLAND FIRE, V26, P191, DOI [10.1071/WF16106, 10.1071/wf16106]; White RH, 2010, INT J WILDLAND FIRE, V19, P213, DOI 10.1071/WF07128; Zylstra P, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160715	100	14	14	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2019	14	8							e0221403	10.1371/journal.pone.0221403	http://dx.doi.org/10.1371/journal.pone.0221403			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5UR	31449564	gold, Green Published			2022-12-26	WOS:000485044000015
J	Xue, D; Li, JM; Wu, WF; Tian, Q; Wang, JX				Xue, Di; Li, Jingmei; Wu, Weifei; Tian, Qiao; Wang, JiaXiang			Homology analysis of malware based on ensemble learning and multifeatures	PLOS ONE			English	Article							CLASSIFICATION	With the exponential increase in malware, homology analysis has become a hot research topic in the malware detection field. This paper proposes MHAS, a malware homology analysis system based on ensemble learning and multifeatures. MHAS generates grayscale images from malware binary files and then uses the opcode tool IDA Pro to extract opcode sequences and system call graphs. Thus, RGB images and M-images are generated on the image matrix. Then, MHAS uses convolutional neural networks (CNNs) as base learners to perform bagging ensemble learning to learn features from the grayscale images, RGB images and M-images. Next, MHAS integrates the nine base learners using voting, learning and selective ensemble (in that order) and maps the integration results to the result matrix. Finally, the result matrix is again integrated using the learning method to obtain the final malware classification result. To verify the accuracy of MHAS, we performed a malware family classification experiment, that included samples of 10 malware families. The results showed that MHAS can reach an accuracy rate of 99.17%, meaning that it can effectively analyze and identify malware families.	[Xue, Di; Li, Jingmei; Wu, Weifei; Tian, Qiao; Wang, JiaXiang] Harbin Engn Univ, Coll Comp Sci & Technol, Harbin, Heilongjiang, Peoples R China	Harbin Engineering University	Xue, D (corresponding author), Harbin Engn Univ, Coll Comp Sci & Technol, Harbin, Heilongjiang, Peoples R China.	dixue@hrbeu.edu.cn		Xue, Di/0000-0002-6430-5466	National Key Research and Development Plan of China [2016YFB0801004]	National Key Research and Development Plan of China	This work was supported by the National Key Research and Development Plan of China under Grant No. 2016YFB0801004 to JW. The funder provides the funds for Xue Di to conduct the research and for student helpers who assisted in the writing review and editing.	Andrew Zisserman, 2015, Arxiv, DOI arXiv:1409.1556; AO Kaspersky Lab, 2018, KASP SEC B; Arasu A., 2001, TOIT, V1, P2, DOI DOI 10.1145/383034.383035; Bilar D., 2007, OPCODES PREDICTOR MA; Breiman L, 1996, MACH LEARN, V24, P49; Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324; Charikar M. S., 2002, P 34 ANN ACM S THEOR, P380, DOI DOI 10.1145/509907.509965; Christiaan B, 2018, MCAFEE LABS THREATS; Ding YX, 2013, COMPUT SECUR, V39, P315, DOI 10.1016/j.cose.2013.08.008; Eagle C., 2011, IDA PRO BOOK UNOFFIC; Gandotra E., 2014, J INFORM SECURITY, V5, P56, DOI [DOI 10.4236/JIS.2014.52006, 10.4236/jis.2014.52006]; Han KS, 2015, INT J INF SECUR, V14, P1, DOI 10.1007/s10207-014-0242-0; Han K, 2014, SCI WORLD J, DOI 10.1155/2014/132713; Han Xiao-guang, 2014, Journal on Communications, V35, P125, DOI 10.3969/j.issn.1000-436x.2014.08.016; He KM, 2014, LECT NOTES COMPUT SC, V8691, P346, DOI 10.1007/978-3-319-10578-9_23; Huang F, 2016, ACTA POLYM SIN, P399; Imran M, 2016, J INTELL FUZZY SYST, V31, P837, DOI 10.3233/JIFS-169015; Ioffe S., 2015, INT C ONMACHINE LEAR, V37, P448, DOI DOI 10.1007/S13398-014-0173-7.2; Kancherla K, 2013, IEEE SYM COMPUT INTE, P40, DOI 10.1109/CICYBS.2013.6597204; Kolosnjaji Bojan, 2016, AI 2016: Advances in Artificial Intelligence. 29th Australasian Joint Conference. Proceedings: LNAI 9992, P137, DOI 10.1007/978-3-319-50127-7_11; Kosmidis K., 2017, PAN HELL C INF; Lee T, 2018, J SUPERCOMPUT, V74, P3489, DOI 10.1007/s11227-015-1594-6; Liu L, 2017, FRONT INFORM TECH EL, V18, P1336, DOI 10.1631/FITEE.1601325; Maas A.L., 2013, INT C MACHINE LEARNI, V30, P3, DOI DOI 10.1016/0010-0277(84)90022-2; Makandar A, 2017, 2017 1ST IEEE INTERNATIONAL CONFERENCE ON DATA MANAGEMENT, ANALYTICS AND INNOVATION (ICDMAI), P76, DOI 10.1109/ICDMAI.2017.8073489; Merler S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059468; Nataraj L., 2011, P 4 ACM WORKSHOP SEC, P21, DOI DOI 10.1145/2046684.2046689; Nataraj Lakshmanan, 2011, PROC 8 INT S VIS CYB, P1; Rass S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0168675; Santos I, 2010, LECT NOTES COMPUT SC, V5965, P35, DOI 10.1007/978-3-642-11747-3_3; Shin ECR, 2015, PROCEEDINGS OF THE 24TH USENIX SECURITY SYMPOSIUM, P611; Siddiqui MS, 2008, INMIC: 2008 INTERNATIONAL MULTITOPIC CONFERENCE, P357, DOI 10.1109/INMIC.2008.4777763; Tobiyama S, 2016, P INT COMP SOFTW APP, P577, DOI 10.1109/COMPSAC.2016.151; Wang TT, 2017, 2017 2ND IEEE INTERNATIONAL CONFERENCE ON CLOUD COMPUTING AND BIG DATA ANALYSIS (ICCCBDA 2017), P328, DOI 10.1109/ICCCBDA.2017.7951933; WILCOXON F, 1946, J ECON ENTOMOL, V39, P269, DOI 10.1093/jee/39.2.269; Yang Yi, 2011, Journal of Software, V22, P2438, DOI 10.3724/SP.J.1001.2011.03888; Zhao BL, 2017, J COMMUN, P86; Zhou ZH, 2002, ARTIF INTELL, V137, P239, DOI 10.1016/S0004-3702(02)00190-X	38	8	8	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2019	14	8							e0211373	10.1371/journal.pone.0211373	http://dx.doi.org/10.1371/journal.pone.0211373			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5UR	31449533	Green Published, Green Submitted, gold			2022-12-26	WOS:000485044000002
J	Inurria, A; Arencibia, A; Calabuig, P; Gomez, M; Deniz, S; Oros, J				Inurria, Alicia; Arencibia, Alberto; Calabuig, Pascual; Gomez, May; Deniz, Soraya; Oros, Jorge			Mortality associated with ingestion of sea urchins in loggerhead sea turtles (Caretta caretta): A case series	PLOS ONE			English	Article							CANARY-ISLANDS; ECHINODERMATA; CONSERVATION	Aims The aims of this study were: a) to describe the pathological and laboratory findings in a case series of stranding and mortality associated with ingestion of large amounts of sea urchins in loggerhead turtles (Caretta caretta), and b) to alert veterinarians and biologists involved in sea turtle conservation of this cause of stranding and/or death. Methods The six loggerheads studied were stranded on the coasts of Gran Canaria, Canary Islands, Spain, between 2008 and 2015. Post mortem studies included pathological, microbiological, and sea urchin species identification procedures. Results All turtles showed severe intestinal impaction caused by large amounts of sea urchins, mainly affecting the colon and the caudal half of the small intestine. Histologically, severe focal fibrinonecrotic enteritis was diagnosed in two turtles. In the remaining turtles, lesions ranged from mild desquamation of the intestinal epithelium to severe congestion of the blood vessels of lamina propria, submucosa, muscular and serosa, and edema. Vibrio sp. was isolated from the spleen and intestinal mucosa of a loggerhead in which focal fibrinonecrotic enteritis had been diagnosed. In five turtles, all the remains were fragments from long-spined sea urchins (Diadema africanum); the last turtle contained a mixture of long-spined sea urchin (90%) and purple sea urchin (Sphaerechinus granularis) (10%) remains. Conclusions Although the prevalence of this cause of stranding was low (< 1.6%) compared to other mortality causes, continued overfishing and anthropogenic climate change could increase its incidence. Intestinal impaction with large amounts of sea urchins should be included in the differential diagnosis of gastrointestinal diseases in sea turtles, and the possible toxic effect of some sea urchin species on sea turtles should also be investigated.	[Inurria, Alicia; Arencibia, Alberto; Oros, Jorge] ULPGC, Dept Morphol, Vet Fac, Arucas, Las Palmas, Spain; [Calabuig, Pascual] Tafira Wildlife Rehabil Ctr, Tafira Baja Palmas Gran, Spain; [Gomez, May] ULPGC, Univ Inst Sustainable Aquaculture & Marine Ecosys, Marine Ecophysiol Grp EOMAR, Telde, Las Palmas, Spain; [Deniz, Soraya] ULPGC, Vet Fac, Unit Infect Dis, Arucas, Las Palmas, Spain	Universidad de Las Palmas de Gran Canaria; Universidad de Las Palmas de Gran Canaria; Universidad de Las Palmas de Gran Canaria	Oros, J (corresponding author), ULPGC, Dept Morphol, Vet Fac, Arucas, Las Palmas, Spain.	jorge.oros@ulpgc.es	Calabuig, Pascual/AAB-1723-2019; Orós, Jorge/G-8824-2015; Gómez, May/L-9561-2014	Orós, Jorge/0000-0002-8346-5393; Gómez, May/0000-0002-7396-6493; Inurria, Alicia/0000-0002-2686-7468				Aguirre AA, 2009, REV SCI TECH OIE, V28, P597, DOI 10.20506/rst.28.2.1902; Alender CB, 1967, ANIMAL TOXINS, P145, DOI DOI 10.1016/B978-0-08-012209-0.50023-7; Boylan SM, 2017, SEA TURTLE HLTH REHA, P337; casaLe p., 2015, IUCN RED LIST THREAT, DOI [10.2305/IUCN.UK.2015, DOI 10.2305/IUCN.UK.2015]; Clemente S, 2014, MAR ECOL PROG SER, V506, P1, DOI 10.3354/meps10829; Flint M, 2010, ECOHEALTH, V7, P135, DOI 10.1007/s10393-010-0300-7; Flint M, 2009, J VET DIAGN INVEST, V21, P733, DOI 10.1177/104063870902100601; GHYOOT M, 1994, ZOOMORPHOLOGY, V114, P73, DOI 10.1007/BF00396641; Hernandez Jose Carlos, 2013, P471; Madeira Di Beneditto Ana Paula, 2015, Marine Biodiversity Records, V8, pe122, DOI 10.1017/S1755267215001001; Nakagawa H, 2003, J TOXICOL-TOXIN REV, V22, P633, DOI 10.1081/TXR-120026918; Oros J, 2005, DIS AQUAT ORGAN, V63, P13, DOI 10.3354/dao063013; Oros J, 2004, VET REC, V155, P169, DOI 10.1136/vr.155.6.169; Oros J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149398; Parsons ECM, 2014, CONSERV BIOL, V28, P1206, DOI 10.1111/cobi.12303; REIDARSON TH, 1994, J ZOO WILDLIFE MED, V25, P158; Rodriguez-Barreras R, 2015, MAR BIOL RES, V11, P1100, DOI 10.1080/17451000.2015.1064140; Schumacher J, 1996, J ZOO WILDLIFE MED, V27, P386; Sheppard-Brennand H, 2017, ECOGRAPHY, V40, P1029, DOI 10.1111/ecog.02380; Stamper MA, 2009, J ZOO WILDLIFE MED, V40, P196, DOI 10.1638/2007-0101.1; Tomas J, 2001, J ZOOL, V255, P525, DOI 10.1017/S0952836901001613; Torrent, 2001, MANUAL NECROPSIA TOR; Tuya F, 2006, J MAR BIOL ASSOC UK, V86, P791, DOI 10.1017/S0025315406013713; Wallace BP, 2009, J EXP MAR BIOL ECOL, V373, P50, DOI 10.1016/j.jembe.2009.03.006; Williams SR, 2013, J ZOO WILDLIFE MED, V44, P457, DOI 10.1638/2011-0179R1.1; Zavala-Norzagaray AA, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00635	26	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2019	14	8							e0221730	10.1371/journal.pone.0221730	http://dx.doi.org/10.1371/journal.pone.0221730			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5TR	31442294	Green Published, Green Submitted, gold			2022-12-26	WOS:000485041400072
J	Koyama, N; Iwai, Y; Nagai, Y; Aoshiba, K; Nakamura, H				Koyama, Nobuyuki; Iwai, Yuki; Nagai, Yoshiaki; Aoshiba, Kazutetsu; Nakamura, Hiroyuki			Idiopathic pulmonary fibrosis in small cell lung cancer as a predictive factor for poor clinical outcome and risk of its exacerbation	PLOS ONE			English	Article							PROGNOSTIC-SIGNIFICANCE; INTERSTITIAL PNEUMONIA; HISTOLOGIC PATTERN; CIGARETTE-SMOKING; DISEASE; CHEMOTHERAPY; ALVEOLITIS; IMPACT	Objective Lung cancer frequently co-exists with idiopathic interstitial pneumonia (IIP), which can be subdivided into idiopathic pulmonary fibrosis (IPF) and IIP other than IPF (other IIP). Although chemotherapy in small cell lung cancer (SCLC) patients with IIP may result in the exacerbation of IIP, these patients commonly receive chemotherapy. This study aimed to assess the risks and benefits of chemotherapy in SCLC patients with IIP. Methods We retrospectively analyzed the medical records of 122 patients with SCLC who received chemotherapy. Patients with secondary interstitial lung disease (ILD) of known etiology were excluded. Eligible patients were divided into two groups: SCLC with and without IIP. The former group was subdivided into those with IPF and other IIP. Results Of the 47 (39.2%) SCLC patients with IIP, 20 had IPF and 27 had other IIP. The frequency of chemotherapy-induced ILD development or IIP exacerbation was higher in patients with IPF (40.0%) than in those with other IIP (3.7%) and non-IIP (1.4%). Logistic regression analysis demonstrated that ILD development or IIP exacerbation was independently associated with IPF (P = 0.007). Time to treatment failure (P < 0.001) and overall survival (P = 0.001) were different among the groups., Cox proportional hazard model revealed that IPF was independently associated with time to treatment failure (P = 0,017) and overall survival (P = 0.006). Other IIP had no impact on time to treatment failure or overall survival. Development of ILD or exacerbation of IIP independently reduced time to treatment failure and overall survival. Conclusions Comorbid IPF can be an independent, negative prognostic indicator and at high risk of ILD development or IIP exacerbation in SCLC patients. Early diagnosis and intervention for chemotherapy-induced IIP exacerbation will be beneficial for SCLC patients with IPF, who need close monitoring for its onset.	[Koyama, Nobuyuki] Tokyo Med Univ, Ibaraki Med Ctr, Dept Clin Oncol, Ibaraki, Japan; [Iwai, Yuki; Aoshiba, Kazutetsu; Nakamura, Hiroyuki] Tokyo Med Univ, Ibaraki Med Ctr, Dept Resp Med, Ibaraki, Japan; [Nagai, Yoshiaki] Jichi Med Univ, Dept Resp Med, Shimotsuke, Tochigi, Japan	Tokyo Medical University; Tokyo Medical University; Jichi Medical University	Koyama, N (corresponding author), Tokyo Med Univ, Ibaraki Med Ctr, Dept Clin Oncol, Ibaraki, Japan.	nkoyama@tokyo-med.ac.jp		Koyama, Nobuyuki/0000-0002-3989-2275	JSPS KAKENHI [JP17K09671]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work received a research grant from JSPS KAKENHI Grant Number JP17K09671 to NK. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atsumi K, 2018, INTERNAL MED, V57, P655, DOI 10.2169/internalmedicine.9331-17; Baumgartner KB, 1997, AM J RESP CRIT CARE, V155, P242, DOI 10.1164/ajrccm.155.1.9001319; Bunn PA, 2016, J THORAC ONCOL, V11, P453, DOI 10.1016/j.jtho.2016.01.012; Daniil ZD, 1999, AM J RESP CRIT CARE, V160, P899, DOI 10.1164/ajrccm.160.3.9903021; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Hubbard R, 2000, AM J RESP CRIT CARE, V161, P5, DOI 10.1164/ajrccm.161.1.9906062; Kalemkerian GP, 2013, J NATL COMPR CANC NE, V11, P78, DOI 10.6004/jnccn.2013.0011; Kato E, 2018, ERJ OPEN RES, V4, DOI 10.1183/23120541.00111-2016; Kawasaki H, 2001, J SURG ONCOL, V76, P53, DOI 10.1002/1096-9098(200101)76:1<53::AID-JSO1009>3.0.CO;2-T; Kenmotsu H, 2011, J THORAC ONCOL, V6, P1242, DOI 10.1097/JTO.0b013e318216ee6b; Khuder SA, 2001, LUNG CANCER, V31, P139, DOI 10.1016/S0169-5002(00)00181-1; Le Jeune I, 2007, RESP MED, V101, P2534, DOI 10.1016/j.rmed.2007.07.012; Lee T, 2014, RESP MED, V108, P1549, DOI 10.1016/j.rmed.2014.07.020; Liu Y, 2018, CLIN RESPIR J, V12, P1700, DOI 10.1111/crj.12732; Matsushita H, 1995, PATHOL INT, V45, P925, DOI 10.1111/j.1440-1827.1995.tb03417.x; Minegishi Y, 2011, J THORAC ONCOL, V6, P801, DOI 10.1097/JTO.0b013e3182103d3c; Minna JD, 2003, CANCER CELL, V4, P163, DOI 10.1016/S1535-6108(03)00221-6; Miyazaki K, 2010, MED ONCOL, V27, P763, DOI 10.1007/s12032-009-9283-z; Nicholson AC, 2000, AM J RESP CRIT CARE, V162, P2213, DOI 10.1164/ajrccm.162.6.2003049; Pezzi TA, 2018, JAMA ONCOL, V4, DOI 10.1001/jamaoncol.2017.4504; Pietanza MC, 2015, CLIN CANCER RES, V21, P2244, DOI 10.1158/1078-0432.CCR-14-2958; Simon-Blancal V, 2012, RESPIRATION, V83, P28, DOI 10.1159/000329891; Togashi Y, 2012, CLIN LUNG CANCER, V13, P304, DOI 10.1016/j.cllc.2011.11.001; Tomassetti S, 2015, CHEST, V147, P157, DOI 10.1378/chest.14-0359; Travis W.D., 2002, AM J RESP CRIT CARE, V165, P277, DOI [DOI 10.1164/AJRCCM.165.2.ATS01, 10.1164/ajrccm.165.2.ats01]; TURNERWARWICK M, 1980, THORAX, V35, P496, DOI 10.1136/thx.35.7.496; Vancheri C, 2010, EUR RESPIR J, V35, P496, DOI 10.1183/09031936.00077309; Vancheri C, 2013, EUR RESPIR REV, V22, P265, DOI 10.1183/09059180.00003613; Vancheri C, 2013, EUR RESPIR J, V41, P262, DOI 10.1183/09031936.00115112; Watanabe N, 2014, INT J CLIN ONCOL, V19, P260, DOI 10.1007/s10147-013-0554-5	30	8	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2019	14	8							e0221718	10.1371/journal.pone.0221718	http://dx.doi.org/10.1371/journal.pone.0221718			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5TR	31442290	gold, Green Published, Green Submitted			2022-12-26	WOS:000485041400071
J	Picard, C; Poirier, A; Belanger, S; Labonte, A; Auld, D; Poirier, J; Breitner, JCS; Poirier, J; Etienne, P; Villeneuve, S; Tremblay-Mercier, J				Picard, Cynthia; Poirier, Alexandre; Belanger, Stephanie; Labonte, Anne; Auld, Daniel; Poirier, Judes; Breitner, John C. S.; Poirier, Judes; Etienne, Pierre; Villeneuve, Sylvia; Tremblay-Mercier, Jennifer		PREVENT-AD Res Grp	Proprotein convertase subtilisin/kexin type 9 (PCSK9) in Alzheimer's disease: A genetic and proteomic multi-cohort study	PLOS ONE			English	Article							STEROL-REGULATORY ELEMENT; APOLIPOPROTEIN-E; CEREBROSPINAL-FLUID; COGNITIVE FUNCTION; CIRCULATING PCSK9; RANDOMIZED-TRIAL; LDL CHOLESTEROL; RISK-FACTORS; LIPID-LEVELS; BERBERINE	Background Proprotein convertase subtilisin/kexin type 9 (PCSK9) is a hepatic enzyme that regulates circulating low-density lipoprotein (LDL) cholesterol levels by binding to LDL receptors (LDLR) and promoting their degradation. Although PCSK9 inhibitors were shown to reduce the risk of cardiovascular disease, a warning was issued concerning their possible impact on cognitive functions. In Alzheimer's disease (AD), it is believed that cognitive impairment is associated with cholesterol metabolism alterations, which could involve PCSK9. The main objective of this study is to determine if PCSK9 plays a significant role in the pre-symptomatic phase of the disease when the pathophysiological markers of AD unfolds and, later, when cognitive symptoms emerge. Methods and findings To test if PCSK9 is associated with AD pathology, we measured its expression levels in 65 autopsy confirmed AD brains and 45 age and gender matched controls. Messenger ribonucleic acid (mRNA) were quantified using real-time polymerase chain reaction (RT-PCR) and protein levels were quantified using enzyme-linked immunosorbent assay (ELISA). PCSK9 was elevated in frontal cortices of AD subjects compared to controls, both at the mRNA and protein levels. LDLR protein levels were unchanged in AD frontal cortices, despite and upregulation at the mRNA level. To verify if PCSK9 dysregulation was observable before the onset of AD, we measured its expression in the cerebrospinal fluid (CSF) of 104 "at-risk" subjects and contrasted it with known apolipoproteins levels and specific AD biomarkers using ELISAs. Positive correlations were found between CSF PCSK9 and apolipoprotein E (APOE), apolipoprotein J (APOJ or CLU), apolipoprotein B (APOB), phospho Tau (pTau) and total Tau. To investigate if PCSK9 levels were driven by genetic variants, we conducted an expression quantitative trait loci (eQTL) study using bioinformatic tools and found two polymorphisms in strong association. Further investigation of these variants in two independent cohorts showed a female specific association with AD risk and with CSF Tau levels in cognitively impaired individuals. Conclusions PCSK9 levels differ between control and AD brains and its protein levels correlate with those of other lipoproteins and AD biomarkers even before the onset of the disease. PCSK9 regulation seems to be under tight genetic control in females only, with specific variants that could predispose to increased AD risk.	[Picard, Cynthia; Poirier, Alexandre; Belanger, Stephanie; Labonte, Anne; Poirier, Judes; Breitner, John C. S.] Douglas Mental Hlth Univ Inst, Montreal, PQ, Canada; [Picard, Cynthia; Labonte, Anne; Poirier, Judes; Breitner, John C. S.] Ctr Studies Prevent Alzheimers Dis, Montreal, PQ, Canada; [Picard, Cynthia; Poirier, Judes; Breitner, John C. S.] McGill Univ, Dept Psychiat, Montreal, PQ, Canada; [Auld, Daniel] Genome Quebec Innovat Ctr, Montreal, PQ, Canada	McGill University	Poirier, J (corresponding author), Douglas Mental Hlth Univ Inst, Montreal, PQ, Canada.; Poirier, J (corresponding author), Ctr Studies Prevent Alzheimers Dis, Montreal, PQ, Canada.; Poirier, J (corresponding author), McGill Univ, Dept Psychiat, Montreal, PQ, Canada.	judes.poirier@mcgill.ca		Poirier, Alexandre/0000-0002-6754-6003; Auld, Daniel/0000-0002-9486-1105; Picard, Cynthia/0000-0003-1107-6839; Anne, Labonte/0000-0001-8076-7540	Canadian Institutes of Health Research [MOP 119321]; Natural Sciences and Engineering Research Council of Canada [RGPIN-2015-03790]; J.-Louis Levesque Foundation; Lemaire Family Foundation; McGill University and Genome Quebec Innovation Centre; ICAO Charity Drive	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); J.-Louis Levesque Foundation; Lemaire Family Foundation; McGill University and Genome Quebec Innovation Centre; ICAO Charity Drive	This study was supported by the Canadian Institutes of Health Research (MOP 119321) to JP, the Natural Sciences and Engineering Research Council of Canada (RGPIN-2015-03790) to JP, the J.-Louis Levesque Foundation, the Lemaire Family Foundation, the McGill University and Genome Quebec Innovation Centre, and the ICAO Charity Drive. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asai M, 2007, BIOCHEM BIOPH RES CO, V352, P498, DOI 10.1016/j.bbrc.2006.11.043; Baigent C, 2010, LANCET, V376, P1670, DOI 10.1016/S0140-6736(10)61350-5; Beecham GW, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004606; Beffert U, 1998, J NEUROCHEM, V70, P1458; Buxbaum JD, 2001, J ALZHEIMERS DIS, V3, P221; Cameron J, 2008, ATHEROSCLEROSIS, V201, P266, DOI 10.1016/j.atherosclerosis.2008.02.004; Canuel M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064145; CARLSSON J, 1991, CLIN CHIM ACTA, V196, P167, DOI 10.1016/0009-8981(91)90070-S; Chen YQ, 2014, LIPIDS, V49, P445, DOI 10.1007/s11745-014-3895-6; Chiang LW, 2001, P NATL ACAD SCI USA, V98, P2814, DOI 10.1073/pnas.051630598; Cohen JC, 2006, NEW ENGL J MED, V354, P1264, DOI 10.1056/NEJMoa054013; Costet P, 2008, TRENDS BIOCHEM SCI, V33, P426, DOI 10.1016/j.tibs.2008.06.005; Courtemanche H, 2018, J ALZHEIMERS DIS, V62, P1519, DOI 10.3233/JAD-170993; Danik M, 2000, CRIT REV NEUROBIOL; DeKosky ST, 2008, JAMA-J AM MED ASSOC, V300, P2253, DOI 10.1001/jama.2008.683; Delaneau O, 2012, NAT METHODS, V9, P179, DOI [10.1038/NMETH.1785, 10.1038/nmeth.1785]; Durbin R, 2014, BIOINFORMATICS, V30, P1266, DOI 10.1093/bioinformatics/btu014; Elliott DA, 2010, CLIN LIPIDOL, V5, P555, DOI 10.2217/CLP.10.37; Farrer LA, 1997, JAMA-J AM MED ASSOC, V278, P1349, DOI 10.1001/jama.1997.03550160069041; Fassbender K, 2001, P NATL ACAD SCI USA, V98, P5856, DOI 10.1073/pnas.081620098; Feldman HH, 2010, NEUROLOGY, V74, P956, DOI 10.1212/WNL.0b013e3181d6476a; Ferri N, 2016, ENDOCRINE, V54, P588, DOI 10.1007/s12020-016-0939-0; Geifman N, 2017, ALZHEIMERS RES THER, V9, DOI 10.1186/s13195-017-0237-y; Ghosh M, 2015, J LIPID RES, V56, P463, DOI 10.1194/jlr.M055780; Giugliano RP, 2017, NEW ENGL J MED, V377, P633, DOI 10.1056/NEJMoa1701131; Hu XL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016616; Jeong HJ, 2008, J LIPID RES, V49, P399, DOI 10.1194/jlr.M700443-JLR200; Ji HF, 2011, MOLECULES, V16, P6732, DOI 10.3390/molecules16086732; Jick H, 2000, LANCET, V356, P1627, DOI 10.1016/S0140-6736(00)03155-X; Jonas MC, 2008, EMBO REP, V9, P916, DOI 10.1038/embor.2008.132; KHACHATURIAN ZS, 1985, ARCH NEUROL-CHICAGO, V42, P1097, DOI 10.1001/archneur.1985.04060100083029; Kivipelto M, 2002, ANN INTERN MED, V137, P149, DOI 10.7326/0003-4819-137-3-200208060-00006; Koch S, 2001, J LIPID RES, V42, P1143; Kong WJ, 2004, NAT MED, V10, P1344, DOI 10.1038/nm1135; Lambert JC, 2013, NAT GENET, V45, P1452, DOI 10.1038/ng.2802; Leduc V, 2015, MOL PSYCHIATR, V20, P867, DOI 10.1038/mp.2014.81; Leduc V, 2016, PHARMACOGENET GENOM, V26, P1, DOI 10.1097/FPC.0000000000000178; Leduc V, 2010, TRENDS MOL MED, V16, P469, DOI 10.1016/j.molmed.2010.07.008; Lelental N, 2016, J ALZHEIMERS DIS, V52, P51, DOI 10.3233/JAD-150883; Lipinski MJ, 2016, EUR HEART J, V37, P536, DOI 10.1093/eurheartj/ehv563; Liu ML, 2010, J LIPID RES, V51, P2611, DOI 10.1194/jlr.M006635; Mannarino MR, 2018, J CLIN LIPIDOL, V12, P1123, DOI 10.1016/j.jacl.2018.05.012; Mastrocola R, 2011, NEUROBIOL DIS, V44, P116, DOI 10.1016/j.nbd.2011.06.010; McCarthy S, 2016, NAT GENET, V48, P1279, DOI 10.1038/ng.3643; Miron J, 2018, ALZHEIMERS DEMENT, V14, P787, DOI 10.1016/j.jalz.2017.12.004; Muldoon MF, 2000, AM J MED, V108, P538, DOI 10.1016/S0002-9343(00)00353-3; Muldoon MF, 2004, AM J MED, V117, P823, DOI 10.1016/j.amjmed.2004.07.041; Nguyen D, 2010, BIOCHEMISTRY-US, V49, P10881, DOI 10.1021/bi1017655; Ooi TC, 2015, CLIN CHIM ACTA, V446, P97, DOI 10.1016/j.cca.2015.03.036; OSBORNE TF, 1988, J BIOL CHEM, V263, P3380; Paquette M, 2018, J GERIATR PSYCH NEUR, V31, P90, DOI 10.1177/0891988718764330; Phillips MC, 2014, IUBMB LIFE, V66, P616, DOI 10.1002/iub.1314; Picard C, 2018, NEUROBIOL AGING, V66, DOI 10.1016/j.neurobiolaging.2018.01.018; PITAS RE, 1987, J BIOL CHEM, V262, P14352; POIRIER J, 1993, NEUROSCIENCE, V55, P81, DOI 10.1016/0306-4522(93)90456-P; Poirier J, 2015, ALZHEIMERS DEMENT, V11, P118, DOI [10.1016/j.jalz.2015.07.016, DOI 10.1016/J.JALZ.2015.07.016]; Poirier S, 2008, J BIOL CHEM, V283, P2363, DOI 10.1074/jbc.M708098200; Postmus I, 2013, J LIPID RES, V54, P561, DOI 10.1194/jlr.P033969; Puglielli L, 2001, NAT CELL BIOL, V3, P905, DOI 10.1038/ncb1001-905; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rashid S, 2005, P NATL ACAD SCI USA, V102, P5374, DOI 10.1073/pnas.0501652102; Refolo LM, 2001, NEUROBIOL DIS, V8, P890, DOI 10.1006/nbdi.2001.0422; Robinson JG, 2015, NEW ENGL J MED, V372, P1489, DOI 10.1056/NEJMoa1501031; Rockwood K, 2002, ARCH NEUROL-CHICAGO, V59, P223, DOI 10.1001/archneur.59.2.223; Rousselet E, 2011, J LIPID RES, V52, P1383, DOI 10.1194/jlr.M014118; Sabatine MS, 2017, NEW ENGL J MED, V377, P787; Sano M, 2011, NEUROLOGY, V77, P556, DOI 10.1212/WNL.0b013e318228bf11; Seidah NG, 2014, CIRC RES, V114, P1022, DOI 10.1161/CIRCRESAHA.114.301621; Seidah NG, 2003, P NATL ACAD SCI USA, V100, P928, DOI 10.1073/pnas.0335507100; SMITH JR, 1990, J BIOL CHEM, V265, P2306; Solomon A, 2009, DEMENT GERIATR COGN, V28, P75, DOI 10.1159/000231980; Sundar PD, 2007, NEUROBIOL AGING, V28, P856, DOI 10.1016/j.neurobiolaging.2006.04.005; Tibolla G, 2011, NUTR METAB CARDIOVAS, V21, P835, DOI 10.1016/j.numecd.2011.06.002; Wang XL, 2005, LIFE SCI, V77, P3058, DOI 10.1016/j.lfs.2005.02.033; Whitmer RA, 2005, NEUROLOGY, V64, P277, DOI 10.1212/01.WNL.0000149519.47454.F2; Wolozin B, 2007, BMC MED, V5, DOI 10.1186/1741-7015-5-20; Zhao XS, 2017, MOL MED REP, V15, P712, DOI 10.3892/mmr.2016.6055	77	20	20	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2019	14	8							e0220254	10.1371/journal.pone.0220254	http://dx.doi.org/10.1371/journal.pone.0220254			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5RZ	31437157	Green Submitted, gold, Green Published			2022-12-26	WOS:000485036900010
J	Ganguly, SS; Hostetter, G; Tang, L; Frank, SB; Saboda, K; Mehra, R; Wang, LS; Li, XH; Keller, ET; Miranti, CK				Ganguly, Sourik S.; Hostetter, Galen; Tang, Lin; Frank, Sander B.; Saboda, Kathylynn; Mehra, Rohit; Wang, Lisha; Li, Xiaohong; Keller, Evan T.; Miranti, Cindy K.			Notch3 promotes prostate cancer-induced bone lesion development via MMP-3	ONCOGENE			English	Article							MATRIX METALLOPROTEINASES; CELLS; PROGRESSION; INHIBITION; ASSOCIATION; EXPRESSION; CASTRATION; METASTASES; OSTEOBLAST; INDUCTION	Prostate cancer metastases primarily localize in the bone where they induce a unique osteoblastic response. Elevated Notch activity is associated with high-grade disease and metastasis. To address how Notch affects prostate cancer bone lesions, we manipulated Notch expression in mouse tibia xenografts and monitored tumor growth, lesion phenotype, and the bone microenvironment. Prostate cancer cell lines that induce mixed osteoblastic lesions in bone expressed 5-6 times more Notch3, than tumor cells that produce osteolytic lesions. Expression of active Notch3 (NICD3) in osteolytic tumors reduced osteolytic lesion area and enhanced osteoblastogenesis, while loss of Notch3 in osteoblastic tumors enhanced osteolytic lesion area and decreased osteoblastogensis. This was accompanied by a respective decrease and increase in the number of active osteoclasts and osteoblasts at the tumor-bone interface, without any effect on tumor proliferation. Conditioned medium from NICD3-expressing cells enhanced osteoblast differentiation and proliferation in vitro, while simultaneously inhibiting osteoclastogenesis. MMP-3 was specifically elevated and secreted by NICD3-expressing tumors, and inhibition of MMP-3 rescued the NICD3-induced osteoblastic phenotypes. Clinical osteoblastic bone metastasis samples had higher levels of Notch3 and MMP-3 compared with patient matched visceral metastases or osteolytic metastasis samples. We identified a Notch3-MMP-3 axis in human prostate cancer bone metastases that contributes to osteoblastic lesion formation by blocking osteoclast differentiation, while also contributing to osteoblastogenesis. These studies define a new role for Notch3 in manipulating the tumor microenvironment in bone metastases.	[Ganguly, Sourik S.; Li, Xiaohong; Miranti, Cindy K.] Ctr Canc & Cell Biol, Program Skeletal Dis & Tumor Microenvironm, Grand Rapids, MI 49503 USA; [Ganguly, Sourik S.; Tang, Lin; Frank, Sander B.; Miranti, Cindy K.] Univ Arizona, Canc Ctr, Dept Cellular & Mol Med, Tucson, AZ 85719 USA; [Hostetter, Galen] Van Andel Res Inst, Tissue Repository & Pathol Core, Grand Rapids, MI USA; [Saboda, Kathylynn; Miranti, Cindy K.] Univ Arizona, Canc Ctr, Tucson, AZ 85719 USA; [Mehra, Rohit; Wang, Lisha; Keller, Evan T.] Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA	University of Arizona; Van Andel Institute; University of Arizona; University of Michigan System; University of Michigan	Miranti, CK (corresponding author), Ctr Canc & Cell Biol, Program Skeletal Dis & Tumor Microenvironm, Grand Rapids, MI 49503 USA.; Miranti, CK (corresponding author), Univ Arizona, Canc Ctr, Dept Cellular & Mol Med, Tucson, AZ 85719 USA.; Miranti, CK (corresponding author), Univ Arizona, Canc Ctr, Tucson, AZ 85719 USA.	cmiranti@email.arizona.edu	Miranti, Cindy/AAJ-3783-2020	, Xiaohong/0000-0001-5074-193X; Frank, Sander/0000-0001-7591-944X	DOD [W81XWH-14-1-0479, W81XWH-16-1-0136]; University of Arizona Cancer Center (UACC) [NIH/NCI P30CA023074]; Van Andel Research Institute (VARI); University of Arizona; DOD Prostate Cancer Research Program [W81XWH-14-2-0182, W81XWH-14-2-0183, W81XWH-14-2-0185, W81XWH-14-2-0186, W81XWH-15-2-0062]	DOD(United States Department of Defense); University of Arizona Cancer Center (UACC); Van Andel Research Institute (VARI); University of Arizona; DOD Prostate Cancer Research Program	Funding for this project was provided by a DOD Postdoctoral Fellowship W81XWH-16-1-0136 (SSG), DOD W81XWH-14-1-0479 (SBF, LT, CKM), University of Arizona Cancer Center (UACC) NIH/NCI P30CA023074 (KS, CKM), the Van Andel Research Institute (VARI) (GH, XL), and the University of Arizona (CKM). The TMA obtained from the Prostate Cancer Biorepository Network (PCBN) was supported by funds from the DOD Prostate Cancer Research Program: W81XWH-14-2-0182, W81XWH-14-2-0183, W81XWH-14-2-0185, W81XWH-14-2-0186, and W81XWH-15-2-0062. We wish to thank the following: Dr Denise Roe, Director of Biostatistics Shared Resource at UACC for biostatistics support; Dr Chunyan Liu at Ventana Medical Services, Oro Valley, AZ for her pathology services; Dr Colm Morrissey in the Department of Urology, University of Washington, Seattle WA, for his assistance with providing pathological assessment of bone metastasis lesions in the PCBN TMA. Alexandra VanderArk, Veronique Schulz, and Ghada Y.T Mohsen at Van Andel Research Institute for their technical expertise; Zachary Madaj for statistical analysis expertise; Lisa Turner, Kristin Feenstra, and Bree Berghuis of the VARI Pathology and Biorepository Core for their pathology and Aperio expertise; Su Yanli and Staff of the VARI Vivarium and Transgenics core for technical assistance with animal experiments; David Nadziejka for technical editing of the paper; Jeanie Wedberg and Michelle Minard at the Van Andel Institute and David Alvarado at University of Arizona for their administrative support.	Ally MMTM, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/183653; Bin Hafeez B, 2009, CLIN CANCER RES, V15, P452, DOI 10.1158/1078-0432.CCR-08-1631; Boyce BF, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2165; Campeau E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006529; Cui D, 2015, CLIN CANCER RES, V21, P4619, DOI 10.1158/1078-0432.CCR-15-0242; Cui J, 2018, INT J CANCER, V143, P645, DOI 10.1002/ijc.31346; Dang L, 2006, DEV NEUROSCI-BASEL, V28, P58, DOI 10.1159/000090753; Danza G, 2013, INT J CANCER, V133, P2577, DOI 10.1002/ijc.28293; Edick MJ, 2007, MOL BIOL CELL, V18, P2481, DOI 10.1091/mbc.E06-04-0261; Evans KE, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-4; Frank SB, 2017, J CELL SCI, V130, P1952, DOI 10.1242/jcs.197152; Frank SB, 2017, BMC BIOTECHNOL, V17, DOI 10.1186/s12896-017-0341-x; Frank SB, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00273; Frieling JS, 2017, ONCOGENE, V36, P4498, DOI 10.1038/onc.2017.70; Furic L, 2010, P NATL ACAD SCI USA, V107, P14134, DOI 10.1073/pnas.1005320107; Ganguly SS, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00364; Garcia AJ, 2013, J BONE MINER RES, V28, P283, DOI 10.1002/jbmr.1747; Gilkes DM, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17101669; Gong YX, 2014, CANCERS, V6, P1298, DOI 10.3390/cancers6031298; Hong MH, 2000, J BONE MINER RES, V15, P911, DOI 10.1359/jbmr.2000.15.5.911; Huang JF, 2016, J BUON, V21, P235; Hudson RS, 2012, NUCLEIC ACIDS RES, V40, P3689, DOI 10.1093/nar/gkr1222; Ibrahim T, 2010, CANCER-AM CANCER SOC, V116, P1406, DOI 10.1002/cncr.24896; Imamura Y, 2016, INT J UROL, V23, P654, DOI 10.1111/iju.13137; Jin JK, 2011, INT J CANCER, V128, P2545, DOI 10.1002/ijc.26024; Jung K, 1997, INT J CANCER, V74, P220, DOI 10.1002/(SICI)1097-0215(19970422)74:2<220::AID-IJC14>3.0.CO;2-H; Karayi MK, 2004, PROSTATE CANCER P D, V7, P6, DOI 10.1038/sj.pcan.4500697; Keller ET, 2004, J CELL BIOCHEM, V91, P718, DOI 10.1002/jcb.10662; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; Kusano K, 1998, ENDOCRINOLOGY, V139, P1338, DOI 10.1210/en.139.3.1338; Kwon OJ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5416; Li XH, 2012, MOL CANCER RES, V10, P494, DOI 10.1158/1541-7786.MCR-11-0506; Long Q, 2011, AM J PATHOL, V179, P46, DOI 10.1016/j.ajpath.2011.03.008; Lynch CC, 2005, CANCER CELL, V7, P485, DOI 10.1016/j.ccr.2005.04.013; Mehner Christine, 2015, Genes Cancer, V6, P480; Ross AE, 2011, PROSTATE, V71, P1568, DOI 10.1002/pros.21373; Roudier MP, 2008, J UROLOGY, V180, P1154, DOI 10.1016/j.juro.2008.04.140; Sasaki K, 2007, J BIOMED MATER RES B, V80B, P491, DOI 10.1002/jbm.b.30622; Sethi N, 2011, CANCER CELL, V19, P192, DOI 10.1016/j.ccr.2010.12.022; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; Sottnik JL, 2013, CURR MOL MED, V13, P626; Srivastava P, 2013, GENE, V530, P273, DOI 10.1016/j.gene.2013.06.087; Su QT, 2016, HISTOL HISTOPATHOL, V31, P149, DOI 10.14670/HH-11-685; Thalmann GN, 2000, PROSTATE, V44, P91; Wang XD, 2004, J BIOL CHEM, V279, P24733, DOI 10.1074/jbc.M401602200; Ye QF, 2012, ONCOL LETT, V3, P879, DOI 10.3892/ol.2012.572; Yu XB, 2006, STEM CELLS, V24, P876, DOI 10.1634/stemcells.2005-0598; Zanotti S, 2010, MOL CELL BIOL, V30, P886, DOI 10.1128/MCB.01285-09; Zhang SB, 2014, NEOPLASIA, V16, P158, DOI 10.1593/neo.131870; Zhang ZY, 2010, AM J PATHOL, V177, P1459, DOI 10.2353/ajpath.2010.090476	50	18	21	0	5	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN	2020	39	1					204	218		10.1038/s41388-019-0977-1	http://dx.doi.org/10.1038/s41388-019-0977-1			15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	KG3NM	31467432	Green Accepted			2022-12-26	WOS:000509849200014
J	Xu, BS; Chen, HY; Que, Y; Xiao, W; Zeng, MS; Zhang, X				Xu, Bu-Shu; Chen, Huo-Ying; Que, Yi; Xiao, Wei; Zeng, Mu-Sheng; Zhang, Xing			ALK(ATI) interacts with c-Myc and promotes cancer stem cell-like properties in sarcoma	ONCOGENE			English	Article							CASSETTE TRANSPORTER GENES; SOFT-TISSUE SARCOMAS; LUNG-CANCER; ALK; EXPRESSION; PHENOTYPE; MUTATIONS; RECEPTOR; PATHWAY; TUMORS	Soft tissue sarcoma (STS) is a highly malignant tumor with limited targeted therapies. A novel anaplastic lymphoma kinase (ALK) transcript, ALK(ATI), was identified recently and could be targeted by ALK inhibitors in melanoma. However, the clinical and functional role of aberrant ALK(ATI) expression in STS remains unknown. Here we demonstrate that as a new ALK transcript, ALK(ATI) is frequently found in STS. ALK(ATI) expression correlates with a lower probability of progression-free survival in STS patients. Compared with the other ALK isoforms, ALK(ATI) expresses not only in the cytoplasm, but also in the nucleus of sarcoma cells. Functionally, overexpression of ALK(ATI) promoted cancer stem cell (CSC)-like properties in sarcoma cells by promoting sphere formation and upregulating the expression of stem cell markers. Moreover, the ALK inhibitors not only suppressed the oncogenic functions of ALK(ATI) but also attenuated ALK(ATI)-induced CSC-like properties by reducing the expression of stem cell markers such as c-Myc, ABCG2, BMI1, and OCT4 both in vitro and in vivo. Furthermore, ALK(ATI) interacted with c-Myc and increased the binding of c-Myc to the ABCG2 promoter, resulting in the induction of stem cell-like properties. Together, these findings indicate that ALK(ATI) may be a potential prognostic marker and therapeutic target for STS patients harboring such ALK aberrations.	[Xu, Bu-Shu; Chen, Huo-Ying; Que, Yi; Xiao, Wei; Zhang, Xing] Sun Yat Sen Univ, Melanoma & Sarcoma Med Oncol Unit, State Key Lab Oncol South China, Collaborat Innovat Ctr Canc Med,Canc Ctr, 651 Dongfeng Rd East, Guangzhou 510060, Peoples R China; [Chen, Huo-Ying] Guilin Med Univ, Affiliated Hosp 2, Dept Lab Med, Guilin 541100, Peoples R China; [Zeng, Mu-Sheng] Sun Yat Sen Univ, State Key Lab Oncol South China, Collaborat Innovat Ctr Canc Med, Canc Ctr, 651 Dongfeng Rd East, Guangzhou 510060, Peoples R China	State Key Lab Oncology South China; Sun Yat Sen University; Guilin Medical University; State Key Lab Oncology South China; Sun Yat Sen University	Zhang, X (corresponding author), Sun Yat Sen Univ, Melanoma & Sarcoma Med Oncol Unit, State Key Lab Oncol South China, Collaborat Innovat Ctr Canc Med,Canc Ctr, 651 Dongfeng Rd East, Guangzhou 510060, Peoples R China.	zhangxing@sysucc.org.cn		zeng, musheng/0000-0003-3509-5591	National Key Research and Development Program [2017YFA0505600]; National Natural Science Foundation of China Programs [81772863, 81572403]	National Key Research and Development Program; National Natural Science Foundation of China Programs(National Natural Science Foundation of China (NSFC))	This work was supported by the National Key Research and Development Program (2017YFA0505600) and the National Natural Science Foundation of China Programs (Grant Nos 81772863 and 81572403). We thank Dr Deng Xianming (Principal Investigator for Chemical Biology and Medicinal Chemistry School of Life Sciences, Xiamen University, China) for generously providing the plasmids.	[Anonymous], 2013, FDA APPR PAZ HYDR; [Anonymous], 2016, FDA APPR 1 DRUG SHOW; Armstrong F, 2007, EUR J CANCER, V43, P640, DOI 10.1016/j.ejca.2006.12.005; Beck B, 2013, NAT REV CANCER, V13, P727, DOI 10.1038/nrc3597; Bonvini P, 2013, BRIT J CANCER, V109, P3084, DOI 10.1038/bjc.2013.653; Brown HK, 2017, CANCER LETT, V386, P189, DOI 10.1016/j.canlet.2016.11.019; Busam KJ, 2016, AM J SURG PATHOL, V40, P786, DOI 10.1097/PAS.0000000000000611; Clevers H, 2011, NAT MED, V17, P313, DOI 10.1038/nm.2304; Dandawate PR, 2016, SEMIN CANCER BIOL, V40-41, P192, DOI 10.1016/j.semcancer.2016.09.001; Deshmukh A, 2016, MOL CANCER, V15, DOI 10.1186/s12943-016-0555-x; FDA, 2015, LAB CHANG REQ SOFT T; FDA, 2016, FDA GRANTS ACC APPR; Feng BH, 2013, ONCOL REP, V30, P815, DOI 10.3892/or.2013.2486; Fujiwara T, 2016, STEM CELLS INT, V2016, DOI 10.1155/2016/2603092; Grande E, 2011, MOL CANCER THER, V10, P569, DOI 10.1158/1535-7163.MCT-10-0615; Gravina GL, 2016, RADIAT RES, V185, P411, DOI 10.1667/RR14237.1; Haldar M, 2007, CANCER CELL, V11, P375, DOI 10.1016/j.ccr.2007.01.016; Huang FF, 2013, CANCER LETT, V336, P96, DOI 10.1016/j.canlet.2013.04.006; Ishibashi Y, 2015, ONCOL REP, V33, P1667, DOI 10.3892/or.2015.3806; Janoueix-Lerosey I, 2008, NATURE, V455, P967, DOI 10.1038/nature07398; Jiang Q, 2017, ORPHANET J RARE DIS, V12, DOI 10.1186/s13023-017-0647-8; Kim J, 2010, CELL, V143, P313, DOI 10.1016/j.cell.2010.09.010; Kimbara S, 2014, JPN J CLIN ONCOL, V44, P868, DOI 10.1093/jjco/hyu069; Kuo CY, 2018, CANCER COMMUN, V38, DOI 10.1186/s40880-018-0317-9; Lee JC, 2017, J PATHOL, V241, P316, DOI 10.1002/path.4836; Lewis JJ, 1997, J CLIN ONCOL, V15, P646, DOI 10.1200/JCO.1997.15.2.646; Lin CY, 2012, CELL, V151, P56, DOI 10.1016/j.cell.2012.08.026; Mansfield AS, 2016, ANN ONCOL, V27, P2111, DOI 10.1093/annonc/mdw405; Pisters PWT, 1996, J CLIN ONCOL, V14, P1679, DOI 10.1200/JCO.1996.14.5.1679; Porro A, 2011, MOL CANCER RES, V9, P1054, DOI 10.1158/1541-7786.MCR-10-0510; Porro A, 2010, J BIOL CHEM, V285, P19532, DOI 10.1074/jbc.M109.078584; Riggi N, 2005, CANCER RES, V65, P11459, DOI 10.1158/0008-5472.CAN-05-1696; Schulte JH, 2011, CLIN CANCER RES, V17, P5082, DOI 10.1158/1078-0432.CCR-10-2809; Shaw AT, 2009, J CLIN ONCOL, V27, P4247, DOI 10.1200/JCO.2009.22.6993; Sheng JY, 2016, SURG CLIN N AM, V96, P1141, DOI 10.1016/j.suc.2016.06.006; Subbiah V, 2015, J HEMATOL ONCOL, V8, DOI 10.1186/s13045-015-0160-2; Todaro M, 2010, GASTROENTEROLOGY, V138, P2151, DOI 10.1053/j.gastro.2009.12.063; Toro JR, 2006, INT J CANCER, V119, P2922, DOI 10.1002/ijc.22239; Van Roosbroeck K, 2010, HAEMATOL-HEMATOL J, V95, P509, DOI 10.3324/haematol.2009.014761; Wang YW, 2018, CANCER COMMUN, V38, DOI 10.1186/s40880-018-0307-y; Wiesner T, 2015, NATURE, V526, P453, DOI 10.1038/nature15258; Xia P, 2015, AM J CANCER RES, V5, P1602; Xie XK, 2013, MOL MED REP, V8, P168, DOI 10.3892/mmr.2013.1484; Zhou JX, 2013, ANN ONCOL, V24, P1319, DOI 10.1093/annonc/mds626	44	9	9	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN	2020	39	1					151	163		10.1038/s41388-019-0973-5	http://dx.doi.org/10.1038/s41388-019-0973-5			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	KG3NM	31462708				2022-12-26	WOS:000509849200010
J	Jenner, LP; Kurth, JM; van Helmont, S; Sokol, KP; Reisner, E; Dahl, C; Bradley, JM; Butt, JN; Cheesman, MR				Jenner, Leon P.; Kurth, Julia M.; van Helmont, Sebastian; Sokol, Katarzyna P.; Reisner, Erwin; Dahl, Christiane; Bradley, Justin M.; Butt, Julea N.; Cheesman, Myles R.			Heme ligation and redox chemistry in two bacterial thiosulfate dehydrogenase (TsdA) enzymes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cytochrome; electron transfer; electrochemistry; ultraviolet-visible spectroscopy (UV-Vis spectroscopy); oxidation-reduction (redox); Campylobacter; biogeochemical sulfur cycle; magnetic circular dichroism (MCD); protein film electrochemistry (PFE); sulfur metabolism; tetrathionate reductase; thiosulfate oxidase; thiosulfate dehydrogenase	MAGNETIC CIRCULAR-DICHROISM; CYTOCHROME-C; AXIAL LIGATION; ACTIVE-SITE; ALLOCHROMATIUM-VINOSUM; SULFUR-OXIDATION; PROTEIN; LIGANDS; ELECTRON; IDENTIFICATION	Thiosulfate dehydrogenases (TsdAs) are bidirectional bacterial di-heme enzymes that catalyze the interconversion of tetrathionate and thiosulfate at measurable rates in both directions. In contrast to our knowledge of TsdA activities, information on the redox properties in the absence of substrates is rather scant. To address this deficit, we combined magnetic CD (MCD) spectroscopy and protein film electrochemistry (PFE) in a study to resolve heme ligation and redox chemistry in two representative TsdAs. We examined the TsdAs from Campylobacter jejuni, a microaerobic human pathogen, and from the purple sulfur bacterium Allochromatium vinosum. In these organisms, the enzyme functions as a tetrathionate reductase and a thiosulfate oxidase, respectively. The active site Heme 1 in both enzymes has His/Cys ligation in the ferric and ferrous states and the midpoint potentials (E-m) of the corresponding redox transformations are similar, ?185 mV versus standard hydrogen electrode (SHE). However, fundamental differences are observed in the properties of the second, electron transferring, Heme 2. In C. jejuni, TsdA Heme 2 has His/Met ligation and an E-m of +172 mV. In A. vinosum TsdA, Heme 2 reduction triggers a switch from His/Lys ligation (E-m, ?129 mV) to His/Met (E-m, +266 mV), but the rates of interconversion are such that His/Lys ligation would be retained during turnover. In summary, our findings have unambiguously assigned E-m values to defined axial ligand sets in TsdAs, specified the rates of Heme 2 ligand exchange in the A. vinosum enzyme, and provided information relevant to describing their catalytic mechanism(s).	[Jenner, Leon P.; Bradley, Justin M.; Butt, Julea N.; Cheesman, Myles R.] Univ East Anglia, Ctr Mol & Struct Biochem, Sch Chem, Norwich Res Pk, Norwich NR4 7TJ, Norfolk, England; [Kurth, Julia M.; van Helmont, Sebastian; Dahl, Christiane] Rheinische Friedrich Wilhelms Univ Bonn, Inst Mikrobiol & Biotechnol, D-53115 Bonn, Germany; [Sokol, Katarzyna P.; Reisner, Erwin] Univ Cambridge, Dept Chem, Lensfield Rd, Cambridge CB2 1EW, England	University of East Anglia; University of Bonn; University of Cambridge	Bradley, JM; Butt, JN; Cheesman, MR (corresponding author), Univ East Anglia, Ctr Mol & Struct Biochem, Sch Chem, Norwich Res Pk, Norwich NR4 7TJ, Norfolk, England.	justin.bradley@uea.ac.uk; j.butt@uea.ac.uk; m.cheesman@uea.ac.uk	Dahl, Christiane/H-4786-2019; Sokol, Katarzyna P./AAN-5619-2020; Kurth, Julia/AAE-7008-2021; Butt, Julea/E-2133-2011	Dahl, Christiane/0000-0001-8288-7546; Butt, Julea/0000-0002-9624-5226; Bradley, Justin/0000-0003-1635-4455; Jenner, Leon/0000-0002-9657-4783; Kurth, Julia/0000-0002-1221-1230	United Kingdom Biotechnology and Biological Sciences Research Council [BB/L022176/1, BB/K009885/1]; Engineering and Physical Sciences Research Council DTA Ph.D. studentship; ERC Consolidator Grant "MatEnSAP" [682833]; Deutsche Forschungsgemeinschaft [Da 351/7-2]; Aventis Foundation Scholarship - Stiftung Stipendien-Fonds des Verbandes der Chemischen Industrie [700051]; BBSRC [BB/K009885/1, BB/L022176/1] Funding Source: UKRI	United Kingdom Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council DTA Ph.D. studentship(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); ERC Consolidator Grant "MatEnSAP"; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Aventis Foundation Scholarship - Stiftung Stipendien-Fonds des Verbandes der Chemischen Industrie; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by United Kingdom Biotechnology and Biological Sciences Research Council Grants BB/L022176/1 and BB/K009885/1 (to J. N. B. and M. R. C.) and an Engineering and Physical Sciences Research Council DTA Ph.D. studentship (to K. P. S.) and ERC Consolidator Grant "MatEnSAP" 682833 (to E. R.). This work was also supported by Deutsche Forschungsgemeinschaft Grant Da 351/7-2 (to C. D.) and by Aventis Foundation Scholarship 700051 awarded by Stiftung Stipendien-Fonds des Verbandes der Chemischen Industrie (to J. M. K.). The authors declare that they have no conflicts of interest with the contents of this article.	Alric J, 2004, J BIOL CHEM, V279, P26090, DOI 10.1074/jbc.M400361200; Bamford VA, 2002, EMBO J, V21, P5599, DOI 10.1093/emboj/cdf566; Bard A.J., 2000, ELECTROCHEMICAL METH; Barker PD, 1996, BIOCHEMISTRY-US, V35, P13618, DOI 10.1021/bi961127x; Battistuzzi G, 2002, J AM CHEM SOC, V124, P5315, DOI 10.1021/ja017479v; Battistuzzi G, 2001, EUR J INORG CHEM, P2989; Berka V, 1998, BIOCHEMISTRY-US, V37, P6136, DOI 10.1021/bi980133l; Bradley JM, 2012, J BIOL CHEM, V287, P40350, DOI 10.1074/jbc.M112.396192; Bradley JM, 2011, J AM CHEM SOC, V133, P19676, DOI 10.1021/ja209144h; Brito JA, 2015, J BIOL CHEM, V290, P9222, DOI 10.1074/jbc.M114.623397; CHEESMAN MR, 1991, ADV INORG CHEM, V36, P201, DOI 10.1016/S0898-8838(08)60040-9; Cheesman MR, 2001, BIOCHEMISTRY-US, V40, P10562, DOI 10.1021/bi0100081; COASSIN M, 1991, ARCH BIOCHEM BIOPHYS, V290, P458, DOI 10.1016/0003-9861(91)90566-2; DAWSON JH, 1983, INORG CHIM A-BIOINOR, V79, P184, DOI 10.1016/S0020-1693(00)95217-4; DAWSON JH, 1978, BIOCHEMISTRY-US, V17, P33, DOI 10.1021/bi00594a006; DAWSON JH, 1982, J BIOL CHEM, V257, P3606; de Rosny E, 2006, BIOCHEMISTRY-US, V45, P9727, DOI 10.1021/bi060537a; Denkmann K, 2012, ENVIRON MICROBIOL, V14, P2673, DOI 10.1111/j.1462-2920.2012.02820.x; Dhawan IK, 1999, BIOCHEMISTRY-US, V38, P12805, DOI 10.1021/bi991303c; FUKUMORI Y, 1979, CURR MICROBIOL, V3, P117, DOI 10.1007/BF02602443; GADSBY PMA, 1987, BIOCHEM J, V246, P43, DOI 10.1042/bj2460043; GADSBY PMA, 1990, J AM CHEM SOC, V112, P5003, DOI 10.1021/ja00169a002; Go YM, 2015, FREE RADICAL BIO MED, V84, P227, DOI 10.1016/j.freeradbiomed.2015.03.022; Grabarczyk DB, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173395; Grabarczyk DB, 2015, J BIOL CHEM, V290, P9209, DOI 10.1074/jbc.M114.618025; Grein F, 2010, BIOCHEMISTRY-US, V49, P8290, DOI 10.1021/bi1007673; Ilcu L, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05268-2; Joshi M, 2013, BIOCHIMIE, V95, P1980, DOI 10.1016/j.biochi.2013.07.030; Kappler U, 2008, J BIOL CHEM, V283, P22206, DOI 10.1074/jbc.M800315200; Kilmartin JR, 2016, J INORG BIOCHEM, V162, P309, DOI 10.1016/j.jinorgbio.2016.04.015; Kilmartin JR, 2011, J BIOL CHEM, V286, P24872, DOI 10.1074/jbc.M110.212183; KOLAND JG, 1984, BIOCHEMISTRY-US, V23, P1051, DOI 10.1021/bi00301a003; Kurth JM, 2017, FEMS MICROBIOL LETT, V364, DOI 10.1093/femsle/fnx003; Kurth JM, 2016, BIOSCIENCE REP, V36, DOI 10.1042/BSR20160457; Kurth JM, 2016, J BIOL CHEM, V291, P24804, DOI 10.1074/jbc.M116.753863; Kurth JM, 2015, J AM CHEM SOC, V137, P13232, DOI 10.1021/jacs.5b08291; LEVER ABP, 1990, INORG CHEM, V29, P1271, DOI 10.1021/ic00331a030; Liu YW, 2013, MOL MICROBIOL, V88, P173, DOI 10.1111/mmi.12176; Ludwig R, 2013, ANAL BIOANAL CHEM, V405, P3637, DOI 10.1007/s00216-012-6627-x; Marritt SJ, 2008, J AM CHEM SOC, V130, P8588, DOI 10.1021/ja802641a; Marvin KA, 2009, BIOCHEMISTRY-US, V48, P7056, DOI 10.1021/bi900697c; MAYHEW SG, 1978, EUR J BIOCHEM, V85, P535, DOI 10.1111/j.1432-1033.1978.tb12269.x; MCKNIGHT J, 1993, EUR J BIOCHEM, V213, P683, DOI 10.1111/j.1432-1033.1993.tb17808.x; Mersch D, 2015, J AM CHEM SOC, V137, P8541, DOI 10.1021/jacs.5b03737; Motomura T, 2017, J BIOL CHEM, V292, P9599, DOI 10.1074/jbc.M116.746263; Mowat CG, 2000, J BIOL INORG CHEM, V5, P584, DOI 10.1007/s007750000141; Nakajima H, 2001, J BIOL CHEM, V276, P7055, DOI 10.1074/jbc.M003972200; NJUS D, 1993, BIOCHIM BIOPHYS ACTA, V1144, P235, DOI 10.1016/0005-2728(93)90108-R; Nye DB, 2018, BIOCHEMISTRY-US, V57, P631, DOI 10.1021/acs.biochem.7b01155; Page CC, 1999, NATURE, V402, P47, DOI 10.1038/46972; Preimesberger MR, 2017, BIOCHEMISTRY-US, V56, P551, DOI 10.1021/acs.biochem.6b00926; RAPHAEL AL, 1991, J AM CHEM SOC, V113, P1038, DOI 10.1021/ja00003a045; Reedy CJ, 2008, NUCLEIC ACIDS RES, V36, pD307, DOI 10.1093/nar/gkm814; Reijerse EJ, 2007, BIOCHEMISTRY-US, V46, P7804, DOI 10.1021/bi7003526; RIGBY SEJ, 1988, BIOCHEM J, V256, P571, DOI 10.1042/bj2560571; RUX JJ, 1991, FEBS LETT, V290, P49, DOI 10.1016/0014-5793(91)81222-T; Saha R, 2013, BIOCHEMISTRY-US, V52, P8878, DOI 10.1021/bi401343t; Sasakura Y, 2002, J BIOL CHEM, V277, P23821, DOI 10.1074/jbc.M202738200; SHIMIZU T, 1975, BIOCHEMISTRY-US, V14, P4172, DOI 10.1021/bi00690a004; SHIMIZU T, 1981, BIOCHIM BIOPHYS ACTA, V669, P46, DOI 10.1016/0005-2795(81)90222-1; Sigman JA, 1999, BIOCHEMISTRY-US, V38, P11122, DOI 10.1021/bi990815o; SIMPKIN D, 1989, BIOCHEMISTRY-US, V28, P8033, DOI 10.1021/bi00446a010; Singh S, 2009, J INORG BIOCHEM, V103, P689, DOI 10.1016/j.jinorgbio.2009.01.009; Springs SL, 2002, BIOCHEMISTRY-US, V41, P4321, DOI 10.1021/bi012066s; SVASTITS EW, 1989, BIOCHEM BIOPH RES CO, V165, P1170, DOI 10.1016/0006-291X(89)92725-3; Teh AH, 2015, SCI REP-UK, V5, DOI 10.1038/srep11407; UBBINK M, 1994, BIOCHEMISTRY-US, V33, P10051, DOI 10.1021/bi00199a032; VICKERY L, 1975, BIOCHIM BIOPHYS ACTA, V386, P87, DOI 10.1016/0005-2795(75)90249-4; Zheng Z, 2009, PROTEINS, V75, P719, DOI 10.1002/prot.22282	69	12	12	2	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 22	2019	294	47					18002	18014		10.1074/jbc.RA119.010084	http://dx.doi.org/10.1074/jbc.RA119.010084			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JY1UF	31467084	hybrid, Green Published, Green Accepted			2022-12-26	WOS:000504206800025
J	Perez-Alos, L; Bayarri-Olmos, R; Skjoedt, MO; Garred, P				Perez-Alos, Laura; Bayarri-Olmos, Rafael; Skjoedt, Mikkel-Ole; Garred, Peter			Combining MAP-1:CD35 or MAP-1:CD55 fusion proteins with pattern-recognition molecules as novel targeted modulators of the complement cascade	FASEB JOURNAL			English	Article						MASPs; RCA family; complement regulation; lectin pathway; chimeric proteins	MANNOSE-BINDING LECTIN; INDUCED ARTHRITIS; CRYSTAL-STRUCTURE; SERINE PROTEASES; PATHWAY; INHIBITOR; SYSTEM; IMMUNE; DEFICIENCY; ACTIVATION	Dysregulation of the complement system is involved in the pathogenesis of several diseases, and its inhibition has been shown to be a feasible therapeutic option. Therefore, there is an interest in the development of complement modulators to treat complement activation-related inflammatory pathologies. Mannose-binding lectin (MBL)/ficolin/collectin-associated protein-1 (MAP-1) is a regulatory molecule of the lectin pathway (LP), whereas complement receptor 1 (CD35) and decay-accelerating factor (CD55) are membrane-anchored regulators with effects on the central effector molecule C3. In this study, we developed 2 novel soluble chimeric inhibitors by fusing MAP-1 to the 3 first domains of CD35 (CD35(1-3)) or the 4 domains of CD55 (CD55(1-4)) to modulate the complement cascade at 2 different stages. The constructs showed biologic properties similar to those of the parent molecules. In functional complement activation assays, the constructs were very efficient in inhibiting LP activation at the level of C3 and in the formation of terminal complement complex. This activity was enhanced when coincubated with recombinant LP recognition molecules MBL and ficolin-3. Recombinant MAP-1 fusion proteins, combined with recombinant LP recognition molecules to target sites of inflammation, represent a novel and effective therapeutic approach involving the initiation and the central and terminal effector functions of the complement cascade.	[Perez-Alos, Laura; Bayarri-Olmos, Rafael; Skjoedt, Mikkel-Ole; Garred, Peter] Rigshosp, Sect 7631, Dept Clin Immunol, Lab Mol Med, Ole Maaloeesvej 26, DK-2200 Copenhagen, Denmark	Rigshospitalet; University of Copenhagen	Garred, P (corresponding author), Rigshosp, Sect 7631, Dept Clin Immunol, Lab Mol Med, Ole Maaloeesvej 26, DK-2200 Copenhagen, Denmark.	peter.garred@regionh.dk		Skjodt, Mikkel-Ole/0000-0003-1306-6482; Perez-Alos, Laura/0000-0002-0368-4976	Danish Research Foundation of Independent Research [DFF-6110-00489]; Lundbeck Research Foundation; Novo Nordisk Research Foundation; Svend Andersen Research Foundation	Danish Research Foundation of Independent Research; Lundbeck Research Foundation(Lundbeckfonden); Novo Nordisk Research Foundation(Novo Nordisk Foundation); Svend Andersen Research Foundation	The authors thank Jytte Bryde Clausen and Jesper Andresen for excellent technical assistance, and R. P. Taylor (University of Virginia, Charlottesville, VA, USA) for kindly providing the 3D9 anti-complement receptor 1 mAb. This work was supported by the Danish Research Foundation of Independent Research (DFF-6110-00489), the Lundbeck Research Foundation, the Novo Nordisk Research Foundation, and the Svend Andersen Research Foundation. L.P.-A. and R.B.-O. are joint first authors. R.B.-O., M.-O.S., and P.G. are listed as inventors on patent applications and patents using mannose-binding lectin/ficolin/collectin-associated protein-1 as a vehicle for therapeutic inhibition. L.P.-A. declares no conflicts of interest.	Banda NK, 2014, J IMMUNOL, V193, P2455, DOI 10.4049/jimmunol.1400752; Bayarri-Olmos R, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02238; Bohlson SS, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01308; Brodbeck WG, 1996, J IMMUNOL, V156, P2528; Degn SE, 2009, J IMMUNOL, V183, P7371, DOI 10.4049/jimmunol.0902388; Dobo J, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01851; Forneris F, 2012, CURR OPIN STRUC BIOL, V22, P333, DOI 10.1016/j.sbi.2012.04.001; Fridkis-Hareli M, 2019, MOL IMMUNOL, V105, P150, DOI 10.1016/j.molimm.2018.09.013; Garred P, 2003, MOL IMMUNOL, V40, P73, DOI 10.1016/S0161-5890(03)00104-4; GARRED P, 1988, SCAND J IMMUNOL, V27, P319, DOI 10.1111/j.1365-3083.1988.tb02353.x; Garred P, 2016, IMMUNOL REV, V274, P74, DOI 10.1111/imr.12468; Harboe M, 2008, J CELL MOL MED, V12, P1074, DOI 10.1111/j.1582-4934.2008.00350.x; Harboe M, 2009, MOL IMMUNOL, V47, P373, DOI 10.1016/j.molimm.2009.09.005; Harris CL, 2018, MOL IMMUNOL, V102, P89, DOI 10.1016/j.molimm.2018.06.008; Hein E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015443; Hertz CE, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01945; Holers VM, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01057; Hourcade D, 2000, IMMUNOPHARMACOLOGY, V49, P103, DOI 10.1016/S0162-3109(00)80296-9; Kouser L, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00093; Larsen F, 2004, J BIOL CHEM, V279, P21302, DOI 10.1074/jbc.M400520200; Linton SM, 2000, ARTHRITIS RHEUM-US, V43, P2590, DOI 10.1002/1529-0131(200011)43:11<2590::AID-ANR29>3.0.CO;2-R; Merle NS, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00262; Miwa T, 2001, INT IMMUNOPHARMACOL, V1, P445, DOI 10.1016/S1567-5769(00)00043-6; MOLLNES TE, 1985, SCAND J IMMUNOL, V22, P183, DOI 10.1111/j.1365-3083.1985.tb01870.x; Mulligan MS, 1999, J IMMUNOL, V162, P4952; Munthe-Fog L, 2008, MOL IMMUNOL, V45, P2660, DOI 10.1016/j.molimm.2007.12.012; Nordmaj MA, 2015, FASEB J, V29, P4945, DOI 10.1096/fj.15-277103; Ozen A, 2017, NEW ENGL J MED, V377, P52, DOI 10.1056/NEJMoa1615887; Parej K, 2014, MOL IMMUNOL, V59, P1, DOI 10.1016/j.molimm.2013.12.003; Pavlov VI, 2012, CIRCULATION, V126, P2227, DOI 10.1161/CIRCULATIONAHA.112.123968; Ricklin D, 2016, SEMIN IMMUNOL, V28, P208, DOI 10.1016/j.smim.2016.06.001; Ricklin D, 2016, NAT REV NEPHROL, V12, P383, DOI 10.1038/nrneph.2016.70; Ricklin D, 2013, J IMMUNOL, V190, P3831, DOI 10.4049/jimmunol.1203487; Ricklin D, 2010, NAT IMMUNOL, V11, P785, DOI 10.1038/ni.1923; Rosbjerg A, 2014, J IMMUNOL, V192, P4352, DOI 10.4049/jimmunol.1303263; Schatz-Jakobsen JA, 2016, IMMUNOL REV, V274, P59, DOI 10.1111/imr.12465; Schmidt CQ, 2013, J IMMUNOL, V190, P5712, DOI 10.4049/jimmunol.1203548; Seelen MA, 2005, J IMMUNOL METHODS, V296, P187, DOI 10.1016/j.jim.2004.11.016; SEYA T, 1995, MICROBIOL IMMUNOL, V39, P295, DOI 10.1111/j.1348-0421.1995.tb02205.x; Skerra A, 2000, METHOD ENZYMOL, V326, P271; Skjoedt MO, 2012, J BIOL CHEM, V287, P32913, DOI 10.1074/jbc.M112.386680; Skjoedt MO, 2010, J BIOL CHEM, V285, P8234, DOI 10.1074/jbc.M109.065805; Smith BO, 2002, CELL, V108, P769, DOI 10.1016/S0092-8674(02)00672-4; Teillet F, 2008, J BIOL CHEM, V283, P25715, DOI 10.1074/jbc.M803551200; Tomlinson S, 2018, MOL IMMUNOL, V102, P120, DOI 10.1016/j.molimm.2018.06.005; Wallis R, 2007, IMMUNOBIOLOGY, V212, P289, DOI 10.1016/j.imbio.2006.11.004; Zipfel PF, 2009, NAT REV IMMUNOL, V9, P729, DOI 10.1038/nri2620	47	3	3	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2019	33	11					12723	12734		10.1096/fj.201901643R	http://dx.doi.org/10.1096/fj.201901643R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC8ZX	31469600	Green Published			2022-12-26	WOS:000507461600087
J	Xu, XM; Kobayashi, S; Timm, D; Huang, Y; Zhao, FY; Shou, WNA; Liang, QR				Xu, Xianmin; Kobayashi, Satoru; Timm, Derek; Huang, Yuan; Zhao, Fengyi; Shou, Weinian; Liang, Qiangrong			Enhanced mTOR complex 1 signaling attenuates diabetic cardiac injury in OVE26 mice	FASEB JOURNAL			English	Article						rapamycin; diabetes; cardiomyopathy; autophagy; oxidative stress	RAPAMYCIN TREATMENT; MAMMALIAN TARGET; MECHANISTIC TARGET; INHIBITION; HEART; REPERFUSION; PROTECTS; OVEREXPRESSION; CARDIOMYOCYTES; HYPERGLYCEMIA	The protein kinase mechanistic target of rapamycin (mTOR) performs diverse cellular functions through 2 distinct multiprotein complexes, mTOR complex (mTORC)1 and 2. Numerous studies using rapamycin, an mTORC1 inhibitor, have implicated a role for mTORC1 in several types of heart disease. People with diabetes are more susceptible to heart failure. mTORC1 activity is increased in the diabetic heart, but its functional significance remains controversial. To investigate the role of mTORC1 in the diabetic heart, we crossed OVE26 type 1 diabetic mice with transgenic mice expressing a constitutively active mTOR (mTORca) or kinase-dead mTOR (mTORkd) in the heart. The expression of mTORca or mTORkd affected only mTORC1 but not mTORC2 activities, with corresponding changes in the activities of autophagy, a cellular degradation pathway negatively regulated by mTORC1. Diabetic cardiac damage in OVE26 mice was dramatically reduced by mTORca but exacerbated by mTORkd expression as assessed by changes in cardiac function, oxidative stress, and myocyte apoptosis. These findings demonstrated that the enhanced mTORC1 signaling in the OVE26 diabetic heart was an adaptive response that limited cardiac dysfunction, suggesting that manipulations that enhance mTORC1 activity may reduce diabetic cardiac injury, in sharp contrast to the results previously obtained with rapamycin.	[Xu, Xianmin; Timm, Derek] Sanford Res, Sioux Falls, SD USA; [Kobayashi, Satoru; Huang, Yuan; Liang, Qiangrong] New York Inst Technol, Coll Osteopath Med, Dept Biomed Sci, Old Westbury, NY 11568 USA; [Zhao, Fengyi] Xi An Jiao Tong Univ, Hlth Sci Ctr, Affiliated Hosp 1, Dept Endocrinol, Xian, Peoples R China; [Shou, Weinian] Indiana Univ Sch Med, Herman B Wells Ctr Pediat Res, Riley Heart Ctr, Dept Pediat, Indianapolis, IN 46202 USA	Sanford Health; New York Institute Technology; Xi'an Jiaotong University; Indiana University System; Indiana University Bloomington	Liang, QR (corresponding author), New York Inst Technol, Coll Osteopath Med, Northern Blvd,POB 8000, Old Westbury, NY 11568 USA.	qliang03@nyit.edu			American Diabetes Association [1-09-CD-09]	American Diabetes Association(American Diabetes Association)	The authors are grateful to the Physiology Core Facility at the Sanford Research/University of South Dakota (USD) for performing echocardiographic and hemodynamic measurements. The authors also thank the Imaging Core Facility for assistance with confocal microscopy. This work was supported by a Career Development Grant (1-09-CD-09) from the American Diabetes Association. Parts of this study were presented at the 74th Scientific Sessions of the American Diabetes Association (June 13-17, 2014, San Francisco, CA, USA). Most of the work was conducted at Sanford Research/USD at the time that corresponding author Q.L. was employed. The authors declare no conflicts of interest.	Alessi DR, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.267pe27; Aoyagi T, 2015, AM J PHYSIOL-HEART C, V308, pH1530, DOI 10.1152/ajpheart.00008.2015; Aoyagi T, 2012, AM J PHYSIOL-HEART C, V303, pH75, DOI 10.1152/ajpheart.00241.2012; Baba Y, 2018, AM J PHYSIOL-HEART C, V314, pH659, DOI 10.1152/ajpheart.00452.2017; Belenchia AM, 2018, OXID MED CELL LONGEV, V2018, DOI 10.1155/2018/8364608; Buss SJ, 2009, J AM COLL CARDIOL, V54, P2435, DOI 10.1016/j.jacc.2009.08.031; Cunningham JT, 2007, NATURE, V450, P736, DOI 10.1038/nature06322; Curtis MJ, 2018, BRIT J PHARMACOL, V175, P987, DOI 10.1111/bph.14153; Das A, 2015, BASIC RES CARDIOL, V110, DOI 10.1007/s00395-015-0486-5; EPSTEIN PN, 1989, CELL, V58, P1067, DOI 10.1016/0092-8674(89)90505-9; Filippone SM, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/4619720; Fonarow GC, 2006, ENDOCRIN METAB CLIN, V35, P575, DOI 10.1016/j.ecl.2006.05.003; Fraenkel M, 2008, DIABETES, V57, P945, DOI 10.2337/db07-0922; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; Guertin DA, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.267pe24; Harston RK, 2011, AM J PHYSIOL-HEART C, V300, pH1696, DOI 10.1152/ajpheart.00545.2010; Hausenloy DJ, 2004, CARDIOVASC RES, V63, P305, DOI 10.1016/j.cardiores.2004.04.011; Houde VP, 2010, DIABETES, V59, P1338, DOI 10.2337/db09-1324; Huynh K, 2014, PHARMACOL THERAPEUT, V142, P375, DOI 10.1016/j.pharmthera.2014.01.003; Jennings DL, 2018, INT J CARDIOL, V265, P71, DOI 10.1016/j.ijcard.2018.03.111; Kobayashi S, 2007, J BIOL CHEM, V282, P21945, DOI 10.1074/jbc.M703048200; Lamming DW, 2012, SCIENCE, V335, P1638, DOI 10.1126/science.1215135; Lassaletta AD, 2014, ANN THORAC SURG, V97, P901, DOI 10.1016/j.athoracsur.2013.09.059; Liang QR, 2002, DIABETES, V51, P174, DOI 10.2337/diabetes.51.1.174; Luck C, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/5724046; Maisch B, 2011, HERZ, V36, P102, DOI 10.1007/s00059-011-3429-4; Maloyan A, 2009, CIRC RES, V104, P1021, DOI 10.1161/CIRCRESAHA.108.193516; Morita M, 2017, MOL CELL, V67, P922, DOI 10.1016/j.molcel.2017.08.013; Morviducci L, 2018, DIABETES RES CLIN PR, V143, P428, DOI 10.1016/j.diabres.2018.04.001; Reifsnyder PC, 2018, ANN NY ACAD SCI, V1418, P106, DOI 10.1111/nyas.13557; Samidurai A, 2017, BRIT J PHARMACOL, V174, P4771, DOI 10.1111/bph.14059; Sciarretta S, 2018, CIRC RES, V122, P489, DOI 10.1161/CIRCRESAHA.117.311147; Shen WH, 2008, J BIOL CHEM, V283, P13842, DOI 10.1074/jbc.M801510200; Shen X, 2004, AM J PHYSIOL-ENDOC M, V287, pE896, DOI 10.1152/ajpendo.00047.2004; Shende P, 2011, CIRCULATION, V123, P1073, DOI 10.1161/CIRCULATIONAHA.110.977066; Song XX, 2010, AM J PHYSIOL-CELL PH, V299, pC1256, DOI 10.1152/ajpcell.00338.2010; Suhara T, 2017, CURR DIABETES REP, V17, DOI 10.1007/s11892-017-0865-4; Voelkers M, 2013, CIRCULATION, V128, P2132, DOI 10.1161/CIRCULATIONAHA.113.003638; Wang J, 2017, ARCH MED SCI, V13, P947, DOI 10.5114/aoms.2016.59712; Xu LF, 2016, BBA-MOL CELL RES, V1863, P1894, DOI 10.1016/j.bbamcr.2016.01.003; Xu XM, 2013, J BIOL CHEM, V288, P18077, DOI 10.1074/jbc.M113.474650; Zhang DH, 2010, J CLIN INVEST, V120, P2805, DOI 10.1172/JCI43008; Zhu WQ, 2009, CIRCULATION, V119, P99, DOI 10.1161/CIRCULATIONAHA.108.799700; Zhu Y, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0054221, 10.1371/journal.pone.0071727]	44	5	5	0	1	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2019	33	11					12800	12811		10.1096/fj.201901206R	http://dx.doi.org/10.1096/fj.201901206R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC8ZX	31469601				2022-12-26	WOS:000507461600093
J	Parsons, PJ; Grinsted, L; Field, J				Parsons, Paul John; Grinsted, Lena; Field, Jeremy			Partner choice correlates with fine scale kin structuring in the paper wasp Polistes dominula	PLOS ONE			English	Article							POPULATION-STRUCTURE; SOCIAL WASP; CUTICULAR HYDROCARBONS; MICROSATELLITE LOCI; GENETIC DIVERSITY; RECOGNITION CUES; DISPERSAL; EVOLUTION; HYMENOPTERA; RELATEDNESS	Cooperation among kin is common in animal societies. Kin groups may form by individuals directly discriminating relatives based on kin recognition cues, or form passively through natal philopatry and limited dispersal. We describe the genetic landscape for a primitively eusocial wasp, Polistes dominula, and ask whether individuals choose cooperative partners that are nearby and/or that are genetic relatives. Firstly, we genotyped an entire sub-population of 1361 wasps and found genetic structuring on an extremely fine scale: the probability of finding genetic relatives decreases exponentially within just a few meters of an individual's nest. At the same time, however, we found a lack of genetic structuring between natural nest aggregations within the population. Secondly, in a separate dataset where similar to 2000 wasps were genotyped, we show that wasps forced experimentally to make a new nest choice tended to choose new nests near to their original nests, and that these nests tended to contain some full sisters. However, a significant fraction of wasps chose nests that did not contain sisters, despite sisters being present in nearby nests. Although we cannot rule out a role for direct kin recognition or natal nest-mate recognition, our data suggest that kin groups may form via a philopatric rule-of-thumb, whereby wasps simply select groups and nesting sites that are nearby. The result is that most subordinate helpers obtain indirect fitness benefits by breeding cooperatively.	[Parsons, Paul John] Univ Exeter, Coll Life & Environm Sci Biosci, Exeter, Devon, England; [Grinsted, Lena] Royal Holloway Univ London, Sch Biol Sci, Egham, Surrey, England; [Field, Jeremy] Univ Exeter, Coll Life & Environm Sci, Penryn, Cornwall, England; [Parsons, Paul John] Univ Sheffield, Dept Anim & Plant Sci, Western Bank, Sheffield, S Yorkshire, England	University of Exeter; University of London; Royal Holloway University London; University of Exeter; University of Sheffield	Parsons, PJ (corresponding author), Univ Exeter, Coll Life & Environm Sci Biosci, Exeter, Devon, England.; Parsons, PJ (corresponding author), Univ Sheffield, Dept Anim & Plant Sci, Western Bank, Sheffield, S Yorkshire, England.	p.parsons@exeter.ac.uk		Parsons, Paul J./0000-0002-1995-9110; Grinsted, Lena/0000-0003-3904-3721	Natural Environment Research Council [NE/K00655X/1, NE/M003191/1]; European Research Council (ERC) under the European Horizon's 2020 research and innovation programme [695744]; Leverhulme Trust, Early Career Fellowship [ECF-2016-080]; NERC [NE/K00655X/1, NE/M003191/2, NBAF010001, NE/M003191/1] Funding Source: UKRI	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); European Research Council (ERC) under the European Horizon's 2020 research and innovation programme(European Research Council (ERC)); Leverhulme Trust, Early Career Fellowship(Leverhulme Trust); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was funded by Natural Environment Research Council grants NE/K00655X/1 and NE/M003191/1 awarded to J. F., and is also part of a project that has received funding from the European Research Council (ERC) under the European Horizon's 2020 research and innovation programme (grant agreement No. 695744). L. G. was additionally supported by The Leverhulme Trust, Early Career Fellowship ECF-2016-080. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank C. Accleton, R. Bonifacii, M. Tiradon, E. Jax and M. R. Minano for help with field work; C. Smith for assisting with genotyping; D. Dawson, T. Burke and the NERC Biomolecular Analysis Facility at Sheffield University for running the autosequencer plates and the referees for their comments which improved the manuscript. This work was funded by Natural Environment Research Council grants NE/K00655X/1 and NE/M003191/1 awarded to J.F., and is also part of a project that has received funding from the European Research Council (ERC) under the European Horizon's 2020 research and innovation programme (grant agreement No. 695744). L.G. was additionally supported by The Leverhulme Trust, Early Career Fellowship ECF-2016-080.	Baracchi D, 2016, SCI NAT-HEIDELBERG, V103, DOI 10.1007/s00114-016-1406-8; Bebbington K, 2017, P NATL ACAD SCI USA, V114, pE9036, DOI 10.1073/pnas.1704350114; Bos N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019435; Bretman A, 2011, MOL ECOL, V20, P3045, DOI 10.1111/j.1365-294X.2011.05140.x; Cant MA, 2001, P ROY SOC B-BIOL SCI, V268, P1959, DOI 10.1098/rspb.2001.1754; Chust G, 2016, SCI REP-UK, V6, DOI 10.1038/srep28730; Clobert J, 2009, ECOL LETT, V12, P197, DOI 10.1111/j.1461-0248.2008.01267.x; Cote J, 2010, ECOLOGY, V91, P1485, DOI 10.1890/09-0387.1; Dapporto L, 2004, BEHAV ECOL SOCIOBIOL, V56, P315, DOI 10.1007/s00265-004-0800-y; DAVIS SK, 1990, EVOLUTION, V44, P1242, DOI 10.1111/j.1558-5646.1990.tb05228.x; FIELD J, 1992, BIOL REV, V67, P79, DOI 10.1111/j.1469-185X.1992.tb01659.x; Field J, 2018, CURR BIOL, V28, P3267, DOI 10.1016/j.cub.2018.08.014; Field J, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2015.0093; Friedel A, 2017, INSECT SOC, V64, P465, DOI 10.1007/s00040-017-0559-6; Gamboa AJ, 2004, ANN ZOOL FENN, V41, P1095; Gamboa GJ, 2004, INSECT SOC, V51, P153, DOI 10.1007/s00040-003-0721-1; Gandon S, 1999, J THEOR BIOL, V200, P345, DOI 10.1006/jtbi.1999.0994; Grabowska-Zhang AM, 2016, BEHAV ECOL, V27, P1263, DOI 10.1093/beheco/arw042; Grinsted L, 2017, P ROY SOC B-BIOL SCI, V284, DOI 10.1098/rspb.2017.0904; Grinsted L, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms13750; Grinsted L, 2011, BEHAV ECOL, V22, P1187, DOI 10.1093/beheco/arr105; Groenewoud F, 2016, P NATL ACAD SCI USA, V113, P4104, DOI 10.1073/pnas.1524178113; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI 10.1016/0022-5193(64)90039-6; Hatchwell BJ, 2010, ETHOLOGY, V116, P203, DOI 10.1111/j.1439-0310.2009.01732.x; Hatchwell BJ, 2009, PHILOS T R SOC B, V364, P3217, DOI 10.1098/rstb.2009.0109; Henshaw MT, 2000, MOL ECOL, V9, P2155, DOI 10.1046/j.1365-294X.2000.01053.x; Henter HJ, 2003, EVOLUTION, V57, P1793, DOI 10.1111/j.0014-3820.2003.tb00587.x; Hocherl N, 2015, ECOSPHERE, V6, DOI 10.1890/ES15-00254.1; Innocent TM, 2010, J EVOLUTION BIOL, V23, P1374, DOI 10.1111/j.1420-9101.2010.02015.x; Jetz W, 2011, CURR BIOL, V21, P72, DOI 10.1016/j.cub.2010.11.075; Johnson RN, 2004, ANN ENTOMOL SOC AM, V97, P732, DOI 10.1603/0013-8746(2004)097[0732:ASLOGD]2.0.CO;2; Johnstone RA, 1997, P ROY SOC B-BIOL SCI, V264, P1547, DOI 10.1098/rspb.1997.0215; Johnstone RA, 2012, P ROY SOC B-BIOL SCI, V279, P787, DOI 10.1098/rspb.2011.1257; Kallimanis AS, 2006, EVOL ECOL RES, V8, P529; Kather R, 2015, J CHEM ECOL, V41, P871, DOI 10.1007/s10886-015-0631-5; Keller L, 1997, TRENDS ECOL EVOL, V12, P99, DOI 10.1016/S0169-5347(96)10065-3; Keller LF, 2002, TRENDS ECOL EVOL, V17, P230, DOI 10.1016/S0169-5347(02)02489-8; KLAHN JE, 1979, BEHAV ECOL SOCIOBIOL, V5, P417, DOI 10.1007/BF00292528; Konovalov DA, 2004, MOL ECOL NOTES, V4, P779, DOI 10.1111/j.1471-8286.2004.00796.x; Kozyra KB, 2015, INSECT SOC, V62, P423, DOI 10.1007/s00040-015-0421-7; Leadbeater E, 2014, BEHAV ECOL, V25, P344, DOI 10.1093/beheco/art113; Leadbeater E, 2011, SCIENCE, V333, P874, DOI 10.1126/science.1205140; Leadbeater E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011997; Lehtonen TK, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19266-5; Lengronne T, 2012, ECOL EVOL, V2, P2610, DOI 10.1002/ece3.366; Li XY, 2019, BIOL REV, V94, P721, DOI 10.1111/brv.12475; Liebert AE, 2006, ANN ZOOL FENN, V43, P595; Lopez-Uribe MM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125719; Matthiopoulos J, 2005, J ANIM ECOL, V74, P716, DOI 10.1111/j.1365-2656.2005.00970.x; Mullon C, 2018, NAT ECOL EVOL, V2, P132, DOI 10.1038/s41559-017-0397-y; NONACS P, 1995, ECOLOGY, V76, P953, DOI 10.2307/1939359; Nonacs P, 2011, P NATL ACAD SCI USA, V108, P10808, DOI 10.1073/pnas.1100297108; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; QUELLER DC, 1992, TRENDS ECOL EVOL, V7, P322, DOI 10.1016/0169-5347(92)90120-Z; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Riehl C, 2010, CURR BIOL, V20, P1830, DOI 10.1016/j.cub.2010.09.005; Schmid-Egger C, 2017, ZOOKEYS, P53, DOI 10.3897/zookeys.713.11335; Schuttler SG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088074; Seppa P, 2011, INSECT SOC, V58, P345, DOI 10.1007/s00040-011-0149-y; Starks PT, 2003, ANN ZOOL FENN, V40, P53; STRASSMANN JE, 1983, J KANSAS ENTOMOL SOC, V56, P621; Strassmann JE, 1997, MOL ECOL, V6, P97, DOI 10.1046/j.1365-294X.1997.00158.x; Sumana A, 2005, ETHOLOGY, V111, P469, DOI 10.1111/j.1439-0310.2005.01072.x; TAYLOR PD, 1992, EVOL ECOL, V6, P352, DOI 10.1007/BF02270971; Team,R.C, 2018, R LANG ENV STAT COMP; Tibbetts EA, 2009, BEHAV ECOL SOCIOBIOL, V63, P1377, DOI 10.1007/s00265-009-0764-z; Valtonen M, 2014, BMC ECOL, V14, DOI 10.1186/1472-6785-14-22; van Zweden JS, 2010, INSECT HYDROCARBONS: BIOLOGY, BIOCHEMISTRY, AND CHEMICAL ECOLOGY, P222, DOI 10.1017/CBO9780511711909.012; Wang JL, 2011, MOL ECOL RESOUR, V11, P141, DOI 10.1111/j.1755-0998.2010.02885.x; Webb JK, 2010, BEHAV ECOL, V21, P72, DOI 10.1093/beheco/arp152; Wickham H, 2017, FLEXIBLY RESHAPE DAT; Wolf JBW, 2008, P ROY SOC B-BIOL SCI, V275, P2063, DOI 10.1098/rspb.2008.0356; Woxvold IA, 2006, MOL ECOL, V15, P3139, DOI 10.1111/j.1365-294X.2006.03009.x; Zanette L, 2009, BEHAV ECOL, V20, P773, DOI 10.1093/beheco/arp060; Zanette LRS, 2008, MOL ECOL, V17, P2590, DOI 10.1111/j.1365-294X.2008.03785.x	75	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2019	14	8							e0221701	10.1371/journal.pone.0221701	http://dx.doi.org/10.1371/journal.pone.0221701			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW6AB	31465487	Green Published, gold, Green Submitted			2022-12-26	WOS:000485058200038
J	Fukuda, Y; Webb, G; Manolis, C; Lindner, G; Banks, S				Fukuda, Yusuke; Webb, Grahame; Manolis, Charlie; Lindner, Garry; Banks, Sam			Translocation, genetic structure and homing ability confirm geographic barriers disrupt saltwater crocodile movement and dispersal	PLOS ONE			English	Article							NORTHERN-TERRITORY; CROCODYLUS-POROSUS; ESTUARINE CROCODILES; OUTWARD JOURNEY; R PACKAGE; MANAGEMENT; ATTACKS; NAVIGATION; AUSTRALIA; COASTAL	Translocated saltwater crocodiles (Crocodylus porosus) in the Northern Territory (NT) of Australia often return to their original capture sites, which complicates management interventions aimed at reducing human-crocodile conflict. We examined the spatial events implicated in this homing ability, using ARGOS satellite tracking devices. Five large male C. porosus (3.03 m to 4.02 m TL) were shifted and released 100-320 km from their capture sites, and 3 additional ones (3.67 m to 4.23 m TL) were released at their site of capture as controls. Translocated crocodiles were more mobile than the controls, and moved at sea in the direction of their original capture site. However, they were unable or unwilling to swim around a geographic structure, Cobourg Peninsula, which prevented homing being achieved in all five cases. Two control crocodiles remained near their capture sites, but one, after the first year, made a 900km journey for six months, before returning to its original capture and release site. Genetic analysis of tissue samples from nests across the NT coast demonstrated significant genetic structure across the coast, and confirmed that Cobourg Peninsula contributes to genetic differentiation among populations along the NT coast. These results provide new insights into C. porosus movements, which have management significance for the maintenance of public safety.	[Fukuda, Yusuke] Northern Terr Govt, Dept Environm & Nat Resources, Palmerston, NT, Australia; [Fukuda, Yusuke] Australian Natl Univ, Res Sch Biol, Acton, ACT, Australia; [Webb, Grahame; Manolis, Charlie] Wildlife Management Int Pty Ltd, Karama, NT, Australia; [Webb, Grahame; Banks, Sam] Charles Darwin Univ, Res Inst Environm & Livelihoods, Coll Engn IT & Environm, Darwin, NT, Australia; [Lindner, Garry] Australian Govt, Pk Australia, Jabiru, NT, Australia	Northern Territory Government; Australian National University; Charles Darwin University	Fukuda, Y (corresponding author), Northern Terr Govt, Dept Environm & Nat Resources, Palmerston, NT, Australia.; Fukuda, Y (corresponding author), Australian Natl Univ, Res Sch Biol, Acton, ACT, Australia.	yusuke.fukuda@nt.gov.au	Fukuda, Yusuke/AAN-4676-2020	Fukuda, Yusuke/0000-0002-8675-318X	Parks Australia; Wildlife Management International Pty. Limited; Australian National University; Northern Territory Government; National Geographic Society [51-16]; Holsworth Wildlife Research Endowment [HWRE2016R2027NEW]; IUCN-SSC Crocodile Specialist Group Student Research Assistance Scheme [15/5]; ACT Herpetological Association	Parks Australia; Wildlife Management International Pty. Limited; Australian National University(Australian National University); Northern Territory Government; National Geographic Society(National Geographic Society); Holsworth Wildlife Research Endowment; IUCN-SSC Crocodile Specialist Group Student Research Assistance Scheme; ACT Herpetological Association	The satellite tracking of crocodiles was financially supported by Parks Australia (https://parksaustralia.gov.au/) and Wildlife Management International Pty. Limited (http://www.wmi.com.au/). The genetic analyses presented in this study were financially supported by the Australian National University (http://www.anu.edu.au/), Northern Territory Government (https://nt.gov.au/), National Geographic Society (grant number 51-16, https://www.nationalgeographic.org/grants/global-impact/asia/), Holsworth Wildlife Research Endowment (grant number HWRE2016R2027NEW, https://www.ecolsoc.org.au/awards-and-prizes/holsworth-wildlife-researchen-dowment), IUCN-SSC Crocodile Specialist Group Student Research Assistance Scheme (grant number 15/5, http://www.iucncsg.org/pages/General-Information.html), and ACT Herpetological Association (http://www.actha.org.au/).	Australian Hydrographic Office AG, 2018, DIG CHARTS; Brackhane S, 2018, J WILDLIFE MANAGE, V82, P1332, DOI 10.1002/jwmg.21497; Brien Matthew, 2010, Herpetological Review, V41, P305; Brien ML, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080872; Brien ML, 2013, BEHAVIOUR, V150, P737, DOI 10.1163/1568539X-00003078; Bureau of Meteorology, 2018, CLIM DAT ONL; Caldicott DGE, 2005, WILD ENVIRON MED, V16, P143, DOI 10.1580/1080-6032(2005)16[143:CAIAAA]2.0.CO;2; Campbell HA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062127; Campbell HA, 2010, J ANIM ECOL, V79, P955, DOI 10.1111/j.1365-2656.2010.01709.x; Chen KY, 2018, METHODS ECOL EVOL, V9, P439, DOI 10.1111/2041-210X.12897; Combrink X, 2015, THESIS; Dominguez-Laso J, 2008, CROCODILE SPEC GROUP, V27, P5; Freitas C, 2008, MAR MAMMAL SCI, V24, P315, DOI 10.1111/j.1748-7692.2007.00180.x; Fukuda Y, 2007, WILDLIFE RES, V34, P167, DOI 10.1071/WR06110; Fukuda Y, 2014, J WILDLIFE MANAGE, V78, P1239, DOI 10.1002/jwmg.767; Fukuda Y, 2013, HERPETOL CONSERV BIO, V8, P641; Fukuda Y, 2011, J WILDLIFE MANAGE, V75, P1253, DOI 10.1002/jwmg.191; HOCUTT CH, 1992, J ZOOL, V226, P231, DOI 10.1111/j.1469-7998.1992.tb03836.x; KAR SK, 1983, BIOL CONSERV, V25, P377, DOI 10.1016/0006-3207(83)90071-X; KIEPENHEUER J, 1978, NATURWISSENSCHAFTEN, V65, P113, DOI 10.1007/BF00440558; Kilian Andrzej, 2012, Methods Mol Biol, V888, P67, DOI 10.1007/978-1-61779-870-2_5; Landguth EL, 2010, MOL ECOL RESOUR, V10, P854, DOI 10.1111/j.1755-0998.2010.02867.x; Leach GJ, 2009, MANAGEMENT PROGRAM S; LOHMANN KJ, 1993, BIOL BULL, V185, P149, DOI 10.2307/1542138; Lohmann KJ, 2004, NATURE, V428, P909, DOI 10.1038/428909a; Manel S, 2005, TRENDS ECOL EVOL, V20, P136, DOI 10.1016/j.tree.2004.12.004; MESSEL H., 1981, MONOGRAPH, V1; Morgan C, 2009, ORLAND SENTINEL 0310; Nichols T., 2008, URBAN HERPETOLOGY HE, V3, P503; NRMMC, 2009, CODE PRACTICE HUMANE; Palmer C, 2017, MAR FRESHWATER RES, V68, P1726, DOI 10.1071/MF16296; Pembleton LW, 2013, MOL ECOL RESOUR, V13, P946, DOI 10.1111/1755-0998.12129; Pinheiro J, 2020, R PACKAGE VERSION 31; Read MA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000949; RODDA GH, 1984, BEHAV ECOL SOCIOBIOL, V14, P241, DOI 10.1007/BF00299494; Saalfeld K., 2015, WILDLIFE TRADE MANAG; Saalfeld K., 2016, MANAGEMENT PROGRAM S; SCHMIDT I, 1992, J COMP PHYSIOL A, V171, P285, DOI 10.1007/BF00223958; Stevenson, 2010, CROCODILES STATUS SU, P99; TOGEL A, 1992, BEHAV ECOL SOCIOBIOL, V31, P73, DOI 10.1007/BF00166339; Walker MM, 2002, CURR OPIN NEUROBIOL, V12, P735, DOI 10.1016/S0959-4388(02)00389-6; WALSH B, 1993, WILDLIFE RES, V20, P127, DOI 10.1071/WR9930127; Webb G., 1989, CROCODILES AUSTR; Webb G., 2000, CROCODILES, P195; Webb G.J.W., 1991, P125; WEBB GJW, 1977, J WILDLIFE MANAGE, V41, P572, DOI 10.2307/3800531; WEBB GJW, 1977, COPEIA, P238; Wiltschko W, 2005, J COMP PHYSIOL A, V191, P675, DOI 10.1007/s00359-005-0627-7; Woolard John W., 2004, Herpetological Review, V35, P164; Zheng XW, 2012, BIOINFORMATICS, V28, P3326, DOI 10.1093/bioinformatics/bts606	50	12	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2019	14	8							e0205862	10.1371/journal.pone.0205862	http://dx.doi.org/10.1371/journal.pone.0205862			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5XV	31461452	gold, Green Published, Green Submitted			2022-12-26	WOS:000485052300001
J	Georges, A; Galbiati, L; Clair, C				Georges, Aurelien; Galbiati, Laura; Clair, Carole			Smoking in men and women with type 2 diabetes: A qualitative gender-sensitive exploration of barriers to smoking cessation among people with type 2 diabetes	PLOS ONE			English	Article							CIGARETTE-SMOKING; GLYCEMIC CONTROL; SEX-DIFFERENCES; RISK-FACTORS; MELLITUS; MORTALITY	Objectives Despite growing evidence of the impact of smoking on diabetes complications, people with type 2 diabetes still smoke at high rates and little is known about the specific barriers to quit smoking in this group. The purpose of this article is to explore the perception of smoking, and motivation and barriers to quit among smokers with type 2 diabetes. This exploratory study will help designing a smoking cessation intervention tailored to the needs of people with type 2 diabetes. We hypothesize both that living with diabetes and gender may raise additional difficulties to quit smoking. Setting The qualitative exploratory research included ten in-depth semi-structured individual interviews and five focus groups conducted in an Ambulatory Care University Hospital in Switzerland. The thematic analysis was conducted with a gender-sensitive focus. Participants Both current and former smokers recruited from the ambulatory clinic and the community took part in the qualitative interviews. We restricted the analysis to 21 current smokers only. Results The sample included 12 men and 9 women with type 2 diabetes, having a mean age of 59.4 years, who had diabetes for an average of 9 years with a mean HbA1c of 7.4%. We found that harmful effects of tobacco were superficially understood, and participants used several patterns of thinking to minimize the risks. The relation between tobacco and diabetes was poorly known. Readiness to change was related to personal self-image and meaningful engagement in life and social relationships. Barriers could be organized into three groups: dependence, psychological habits and social barriers. Barriers were markedly shaped by gender and living with diabetes. Conclusions Results suggest that "one-fits-all" smoking cessation interventions do not satisfy the needs of type 2 diabetic smokers. Personalized smoking cessation interventions should be preferred and should pursue positive psychological outcomes addressing contextual factors.	[Georges, Aurelien] Univ Lausanne, Dept Ambulatory Care & Community Med, PcD, Lausanne, Switzerland; [Galbiati, Laura] Univ Lausanne, Inst Psychol, Lausanne, Switzerland; [Clair, Carole] Univ Lausanne, Dept Ambulatory Care & Community Med, Lausanne, Switzerland; [Georges, Aurelien] Univ Lausanne, Ctr Primary Care & Publ Hlth, Dept Prevent & Hlth Promot, Lausanne, Switzerland; [Galbiati, Laura] Univ Fribourg, Inst Psychol, Fribourg, Switzerland; [Clair, Carole] Univ Lausanne, Ctr Primary Care & Publ Hlth, Dept Training Res & Innovat, Lausanne, Switzerland	University of Lausanne; University of Lausanne; University of Lausanne; University of Lausanne; University of Fribourg; University of Lausanne	Clair, C (corresponding author), Univ Lausanne, Dept Ambulatory Care & Community Med, Lausanne, Switzerland.; Clair, C (corresponding author), Univ Lausanne, Ctr Primary Care & Publ Hlth, Dept Training Res & Innovat, Lausanne, Switzerland.	carole.clair@unisante.ch	Clair, Carole/D-9786-2014; Clair, Carole/AAF-6675-2021	Clair, Carole/0000-0001-5281-0943; Clair, Carole/0000-0001-5281-0943	Swiss National Science Foundation [PZ00P3_154732]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	Carole Clair received a fund from the Swiss National Science Foundation (Ambizione grant PZ00P3_154732). http://www.snf.ch/en/Pages/default.aspx. The funder had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Andrews T, 2012, GROUNDED THEORY REV, V11, P39; Berlin I, 2003, ADDICTION, V98, P1575, DOI 10.1046/j.1360-0443.2003.00523.x; BIBEAU G, 1988, MED ANTHROP Q, V2, P402; BOTT U, 1994, DIABETIC MED, V11, P362, DOI 10.1111/j.1464-5491.1994.tb00287.x; Bottorff JL, 2014, INT J EQUITY HEALTH, V13, DOI 10.1186/s12939-014-0114-2; Brooks J, 2015, QUAL RES PSYCHOL, V12, P202, DOI 10.1080/14780887.2014.955224; Chaturvedi V, 2015, 2015 IEEE INTERNATIONAL CONFERENCE ON DIGITAL SIGNAL PROCESSING (DSP), P1266, DOI 10.1109/ICDSP.2015.7252084; Chau TK, 2015, J CLIN NURS, V24, P2545, DOI 10.1111/jocn.12854; Clair C, 2015, J GEN INTERN MED, V30, P1193, DOI 10.1007/s11606-015-3354-y; Csordas T. J., 1994, EMBODIMENT EXPERIENC, P1; Dressler WW, 2001, MED ANTHROPOL Q, V15, P455, DOI 10.1525/maq.2001.15.4.455; ELDERVASS D, 2012, SOCIOLOGIA PROBLEMA, V70, P5, DOI DOI 10.3390/IJERPH120201449; Eliasson B, 2003, PROG CARDIOVASC DIS, V45, P405, DOI 10.1053/pcad.2003.00103; Fisher W, 2003, SOCIAL PSYCHOL FDN H; Fulkerson JA, 2003, J ADOLESCENT HEALTH, V32, P306, DOI 10.1016/S1054-139X(02)00566-9; Garey L, 2018, PSYCHOL ADDICT BEHAV, V32, P660, DOI 10.1037/adb0000391; Good B, 1994, MED RATIONALITY EXPE; Greaves L., 1996, SMOKE SCREEN WOMENS; Greaves L, 2015, INT J ENV RES PUB HE, V12, P1449, DOI 10.3390/ijerph120201449; Gunton JE, 2002, DIABETES CARE, V25, P796, DOI 10.2337/diacare.25.4.796-a; HAIREJOSHU D, 1994, DIABETES EDUCATOR, V20, P410, DOI 10.1177/014572179402000508; Herman WH, 2016, DIABETES CARE, V39, pS3, DOI 10.2337/dc16-S002; Iino K, 2004, DIABETES OBES METAB, V6, P181, DOI 10.1111/j.1462-8902.2004.00329.x; King Nigel, 2004, ESSENTIAL GUIDE QUAL, P256, DOI DOI 10.4135/9781446280119.N21; Le Boudec J, 2016, J DIABETES COMPLICAT, V30, P43, DOI 10.1016/j.jdiacomp.2015.10.005; MALARCHER AM, 1995, DIABETES CARE, V18, P694, DOI 10.2337/diacare.18.5.694; Meyer KA, 2001, DIABETES CARE, V24, P1528, DOI 10.2337/diacare.24.9.1528; Nentwich JC, 2014, GENDER WORK ORGAN, V21, P121, DOI 10.1111/gwao.12025; Nilsson PM, 2004, DIABETES METAB, V30, P261, DOI 10.1016/S1262-3636(07)70117-9; O'Brien BC, 2014, ACAD MED, V89, P1245, DOI 10.1097/ACM.0000000000000388; Peng K, 2018, J DIABETES, V10, P408, DOI 10.1111/1753-0407.12625; Perkins KA, 2008, NICOTINE TOB RES, V10, P1245, DOI 10.1080/14622200802097506; Peytremann-Bridevaux I, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-232; Qin R, 2013, INT J CARDIOL, V167, P342, DOI 10.1016/j.ijcard.2011.12.100; Ryden L, 2014, DIABETES VASC DIS RE, V11, P133, DOI 10.1177/1479164114525548; Sattar N, 2013, BEST PRACT RES CL EN, V27, P501, DOI 10.1016/j.beem.2013.05.006; Seligman M.E.P., 2011, FLOURISH VISIONARY N; Smith PH, 2015, NICOTINE TOB RES, V17, P463, DOI 10.1093/ntr/ntu212; Solberg LI, 2004, ANN FAM MED, V2, P26, DOI 10.1370/afm.36; SORENSEN G, 1987, J BEHAV MED, V10, P129, DOI 10.1007/BF00846421; STAMLER J, 1993, DIABETES CARE, V16, P434, DOI 10.2337/diacare.16.2.434; SUAREZ L, 1984, AM J EPIDEMIOL, V120, P670, DOI 10.1093/oxfordjournals.aje.a113933; Substance Abuse and Mental Health Services Administration (US) and Office of the Surgeon General (US), 2020, SMOK CESS REP SURG G; Targher G, 1997, J CLIN ENDOCR METAB, V82, P3619, DOI 10.1210/jc.82.11.3619; Tschope D, 2012, BMC ENDOCR DISORD, V12, DOI 10.1186/1472-6823-12-23; Turner RC, 1998, BMJ-BRIT MED J, V316, P823, DOI 10.1136/bmj.316.7134.823; Wilkinson Richard, 2003, SOCIAL DETERMINANTS; Wood W, 2015, SEX ROLES, V73, P461, DOI 10.1007/s11199-015-0480-2; Yu MK, 2013, J DIABETES RES, V2013, DOI 10.1155/2013/575814	49	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2019	14	8							e0221783	10.1371/journal.pone.0221783	http://dx.doi.org/10.1371/journal.pone.0221783			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW5XV	31461485	Green Published, gold, Green Submitted			2022-12-26	WOS:000485052300053
J	Schmidt, AF; Heerspink, HJL; Denig, P; Finan, C; Groenwold, RHH				Schmidt, Amand F.; Heerspink, Hiddo J. L.; Denig, Petra; Finan, Chris; Groenwold, Rolf H. H.			When drug treatments bias genetic studies: Mediation and interaction	PLOS ONE			English	Article							ASSOCIATION	Background Increasingly, genetic analyses are conducted using information from subjects with established disease, who often receive concomitant treatment. We determined when treatment may bias genetic associations with a quantitative trait. Methods Graph theory and simulated data were used to explore the impact of drug prescriptions on (longitudinal) genetic effect estimates. Analytic derivations of longitudinal genetic effects are presented, accounting for the following scenarios: 1) treatment allocated independently of a genetic variant, 2) treatment that mediates the genetic effect, 3) treatment that modifies the genetic effect. We additionally evaluate treatment modelling strategies on bias, the root mean squared error (RMSE), coverage, and rejection rate. Results We show that in the absence of treatment by gene effect modification or mediation, genetic effect estimates will be unbiased. In simulated data we found that conditional models accounting for treatment, confounding, and effect modification were generally unbiased with appropriate levels of confidence interval coverage. Ignoring the longitudinal nature of treatment prescription, however (e.g. because of incomplete records in longitudinal data), biased these conditional models to a similar degree (or worse) as simply ignoring treatment. Conclusion The mere presence of (drug) treatment affecting a GWAS phenotype is insufficient to bias genetic associations with quantitative traits. While treatment may bias associations through effect modification and mediation, this might not occur frequently enough to warrant general concern at the presence of treated subjects in GWAS. Should treatment by gene effect modification or mediation be present however, current GWAS approaches attempting to adjust for treatment insufficiently account for the multivariable and longitudinal nature of treatment trajectories and hence genetic estimates may still be biased.	[Schmidt, Amand F.; Finan, Chris] UCL, Fac Populat Hlth, Inst Cardiovasc Sci, London, England; [Schmidt, Amand F.] Univ Med Ctr Utrecht, Div Heart & Lungs, Dept Cardiol, Utrecht, Netherlands; [Heerspink, Hiddo J. L.; Denig, Petra] Univ Groningen, Univ Med Ctr Groningen, Dept Clin Pharm & Pharmacol, Groningen, Netherlands; [Groenwold, Rolf H. H.] Leiden Univ, Med Ctr, Dept Clin Epidemiol, Leiden, Netherlands	University of London; University College London; Utrecht University; Utrecht University Medical Center; University of Groningen; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Schmidt, AF (corresponding author), UCL, Fac Populat Hlth, Inst Cardiovasc Sci, London, England.; Schmidt, AF (corresponding author), Univ Med Ctr Utrecht, Div Heart & Lungs, Dept Cardiol, Utrecht, Netherlands.	amand.schmidt@ucl.ac.uk	Heerspink, Hiddo J Lambers/K-3358-2014; Denig, Petra/L-9865-2014; Schmidt, Amand Floriaan/G-6602-2017	Heerspink, Hiddo J Lambers/0000-0002-3126-3730; Denig, Petra/0000-0002-7929-4739; Schmidt, Amand Floriaan/0000-0003-1327-0424; Finan, Chris/0000-0002-3319-1937	British Heart Foundation [PG/18/50/33837] Funding Source: Medline	British Heart Foundation(British Heart Foundation)		[Anonymous], R LANG ENV STAT COMP, DOI DOI 10.1080/02705060.2017.1422558; Ehret GB, 2016, NAT GENET, V48, P1171, DOI 10.1038/ng.3667; Hirschhorn JN, 2005, NAT REV GENET, V6, P95, DOI 10.1038/nrg1521; Hirst JA, 2012, DIABETES CARE, V35, P446, DOI 10.2337/dc11-1465; Martono DP, 2016, CURR MED RES OPIN, V32, P2021, DOI 10.1080/03007995.2016.1227774; Messner JW, 2016, R J, V8, P173; Messner JW, 2014, WIND ENERGY, V17, P1753, DOI 10.1002/we.1666; Patel RS, 2019, CIRC-GENOM PRECIS ME, V12, DOI 10.1161/CIRCGEN.119.002471; Patel RS, 2019, CIRC-GENOM PRECIS ME, V12, DOI 10.1161/CIRCGEN.119.002470; Patel RS, 2015, EUR HEART J, V36, P2674; Schmidt AF, 2016, PHARMACOEPIDEM DR S, V25, P355, DOI 10.1002/pds.3965; Tobin MD, 2005, STAT MED, V24, P2911, DOI 10.1002/sim.2165; van Buuren S, 2011, J STAT SOFTW, V45, P1; Venables W.N., 2002, MODERN APPL STAT S, P183, DOI [10.1007/978-0-387-21706-2_7, DOI 10.1007/978-0-387-21706-2_7, DOI 10.1198/TECH.2003.S33]; Voorham J, 2007, J AM MED INFORM ASSN, V14, P349, DOI 10.1197/jamia.M2128	15	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2019	14	8							e0221209	10.1371/journal.pone.0221209	http://dx.doi.org/10.1371/journal.pone.0221209			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5XV	31461463	Green Published, Green Submitted, gold			2022-12-26	WOS:000485052300026
J	van Keulen, D; Pouwer, MG; Emilsson, V; Matic, LP; Pieterman, EJ; Hedin, U; Gudnason, V; Jennings, LL; Holmstrom, K; Nielsen, BS; Pasterkamp, G; Lindeman, JHN; van Gool, AJ; Gelpke, MDS; Princen, HMG; Tempel, D				van Keulen, Danielle; Pouwer, Marianne G.; Emilsson, Valur; Matic, Ljubica Perisic; Pieterman, Elsbet J.; Hedin, Ulf; Gudnason, Vilmundur; Jennings, Lori L.; Holmstrom, Kim; Nielsen, Boye Schnack; Pasterkamp, Gerard; Lindeman, Jan H. N.; van Gool, Alain J.; Gelpke, Maarten D. Sollewijn; Princen, Hans M. G.; Tempel, Dennie			Oncostatin M reduces atherosclerosis development in APOE*3Leiden.CETP mice and is associated with increased survival probability in humans	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; NECROSIS-FACTOR-ALPHA; INHIBITS ATHEROSCLEROSIS; NATURAL-HISTORY; EXPRESSION; INFLAMMATION; CYTOKINES; CHOLESTEROL; MACROPHAGES; NEUTROPHILS	Objective Previous studies indicate a role for Oncostatin M (OSM) in atherosclerosis and other chronic inflammatory diseases for which inhibitory antibodies are in development. However, to date no intervention studies with OSM have been performed, and its relation to coronary heart disease (CHD) has not been studied. Approach and results Gene expression analysis on human normal arteries (n = 10) and late stage/advanced carotid atherosclerotic arteries (n = 127) and in situ hybridization on early human plaques (n = 9) showed that OSM, and its receptors, OSM receptor (OSMR) and Leukemia Inhibitory Factor Receptor (LIFR) are expressed in normal arteries and atherosclerotic plaques. Chronic OSM administration in APOE*3Leiden.CETP mice (n = 15/group) increased plasma E-selectin levels and monocyte adhesion to the activated endothelium independently of cholesterol but reduced the amount of inflammatory Ly-6C High monocytes and atherosclerotic lesion size and severity. Using aptamer-based proteomics profiling assays high circulating OSM levels were shown to correlate with post incident CHD survival probability in the AGES-Reykjavik study (n = 5457). Conclusions Chronic OSM administration in APOE*3Leiden.CETP mice reduced atherosclerosis development. In line, higher serum OSM levels were correlated with improved post incident CHD survival probability in patients, suggesting a protective cardiovascular effect.	[van Keulen, Danielle; Tempel, Dennie] Univ Med Ctr Utrecht, Lab Expt Cardiol, Utrecht, Netherlands; [van Keulen, Danielle; Pasterkamp, Gerard; Tempel, Dennie] Univ Med Ctr Utrecht, Lab Clin Chem & Haematol, Utrecht, Netherlands; [van Keulen, Danielle; Tempel, Dennie] Quorics BV, Rotterdam, Netherlands; [van Keulen, Danielle; Pouwer, Marianne G.; Pieterman, Elsbet J.; Princen, Hans M. G.] Gaubius Lab, TNO Metab Hlth Res, Leiden, Netherlands; [Pouwer, Marianne G.] Leiden Univ, Dept Cardiol, Med Ctr, Leiden, Netherlands; [Emilsson, Valur; Gudnason, Vilmundur] Iceland Heart Assoc, Kopavogur, Iceland; [Emilsson, Valur] Univ Iceland, Fac Pharmaceut Sci, Reykjavik, Iceland; [Matic, Ljubica Perisic; Hedin, Ulf] Karolinska Inst, Dept Mol Med & Surg, Solna, Sweden; [Gudnason, Vilmundur] Univ Iceland, Fac Med, Reykjavik, Iceland; [Jennings, Lori L.] Novartis Inst Biomed Res, Cambridge, MA USA; [Holmstrom, Kim; Nielsen, Boye Schnack] Bioneer AS, Horsholm, Denmark; [Lindeman, Jan H. N.] Leiden Univ, Dept Vasc Surg, Med Ctr, Leiden, Netherlands; [van Gool, Alain J.] TNO Microbiol & Syst Biol, Zeist, Netherlands; [Gelpke, Maarten D. Sollewijn] Mol Profiling Consulting, London, England; [Tempel, Dennie] SkylineDx BV, Rotterdam, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Netherlands Organization Applied Science Research; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Icelandic Heart Association; University of Iceland; Karolinska Institutet; University of Iceland; Novartis; Bioneer A/S; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Netherlands Organization Applied Science Research	Tempel, D (corresponding author), Univ Med Ctr Utrecht, Lab Expt Cardiol, Utrecht, Netherlands.; Tempel, D (corresponding author), Univ Med Ctr Utrecht, Lab Clin Chem & Haematol, Utrecht, Netherlands.; Tempel, D (corresponding author), Quorics BV, Rotterdam, Netherlands.; Tempel, D (corresponding author), SkylineDx BV, Rotterdam, Netherlands.	d.tempel@umcutrecht.nl	Gudnason, Vilmundur/AAE-7126-2019; Holmstrøm, Kim/AAU-2568-2020; Princen, Hans MG/AID-9392-2022	Gudnason, Vilmundur/0000-0001-5696-0084; Holmstrøm, Kim/0000-0003-0374-5270; Princen, Hans MG/0000-0002-7206-1596; Emilsson, Valur/0000-0001-9982-0524; van Gool, Alain/0000-0003-0010-5286	European Union Seventh Framework Programme (FP7/2007-2013) [602936]; TNO research program "Preventive Health Technologies"; Swedish Heart and Lung Foundation; Swedish Research Council [K2009-65X-2233-01-3, K2011-3579, K2013-65X-06816-30-4, 349-2007-8703]; Uppdrag Besegra Stroke [P581/2011-123]; Strategic Cardiovascular Program of Karolinska Institutet; Strategic Cardiovascular Program of Stockholm County Council; Stockholm County Council [ALF2011-0260, ALF-2011-0279, ALF-2013-0301]; Foundation for Strategic Research; European Commission; Swedish Society for Medical Research (SSMF); Swedish Heart and Lung Foundation (HLF); Tore Nilsson's Foundation, Sweden; Magnus Bergvall's Foundation, Sweden; Karolinska Institutet Foundation, Sweden; NIH [N01-AG-1-2100, HSS271201200022C]; NIA Intramural Research Program (US); Hjartavernd (the Icelandic Heart Association); Althingi (the Icelandic Parliament); Novartis	European Union Seventh Framework Programme (FP7/2007-2013); TNO research program "Preventive Health Technologies"; Swedish Heart and Lung Foundation(Swedish Heart-Lung Foundation); Swedish Research Council(Swedish Research CouncilEuropean Commission); Uppdrag Besegra Stroke; Strategic Cardiovascular Program of Karolinska Institutet; Strategic Cardiovascular Program of Stockholm County Council; Stockholm County Council(Stockholm County Council); Foundation for Strategic Research; European Commission(European CommissionEuropean Commission Joint Research Centre); Swedish Society for Medical Research (SSMF); Swedish Heart and Lung Foundation (HLF); Tore Nilsson's Foundation, Sweden; Magnus Bergvall's Foundation, Sweden; Karolinska Institutet Foundation, Sweden; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIA Intramural Research Program (US); Hjartavernd (the Icelandic Heart Association); Althingi (the Icelandic Parliament); Novartis(Novartis)	This work was supported by the European Union Seventh Framework Programme (FP7/2007-2013) [grant number 602936] (CarTarDis project, https://ec.europa.eu/research/health) and the TNO research program "Preventive Health Technologies". The BiKE study was conducted with support from the Swedish Heart and Lung Foundation, the Swedish Research Council (K2009-65X-2233-01-3, K2011-3579, K2013-65X-06816-30-4 and 349-2007-8703), Uppdrag Besegra Stroke (P581/2011-123), the Strategic Cardiovascular Programs of Karolinska Institutet and Stockholm County Council, the Stockholm County Council (ALF2011-0260, ALF-2011-0279 and ALF-2013-0301), the Foundation for Strategic Research and the European Commission (CarTarDis, AtheroRemo, VIA and AtheroFlux projects). Ljubica Perisic Matic is the recipient of fellowships from the Swedish Society for Medical Research (SSMF) and the Swedish Heart and Lung Foundation (HLF), and acknowledges research funding from Tore Nilsson's, Magnus Bergvall's and Karolinska Institutet Foundations, Sweden. The AGES-Reykjavik study was funded by NIH contracts N01-AG-1-2100 and HSS271201200022C, the NIA Intramural Research Program (US), Hjartavernd (the Icelandic Heart Association) and the Althingi (the Icelandic Parliament). The protein measurements in the AGES-Reykjavik study were sponsored by Novartis. The funders provided support in the form of salaries for authors [DvK, MGP, VE, LPM, EJP, UH, VG, LLJ and AJG], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Albasanz-Puig A, 2011, ATHEROSCLEROSIS, V216, P292, DOI 10.1016/j.atherosclerosis.2011.02.003; Aldi S, 2018, MOL THER-METH CLIN D, V10, P17, DOI 10.1016/j.omtm.2018.05.003; Anderson CM, 2016, J CELL BIOCHEM, V117, P2201, DOI 10.1002/jcb.25606; Awad F, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175336; Boesten LSM, 2005, CARDIOVASC RES, V66, P179, DOI 10.1016/j.cardiores.2005.01.001; BROWN TJ, 1991, J IMMUNOL, V147, P2175; Chistiakov DA, 2015, ACTA PHYSIOL, V214, P33, DOI 10.1111/apha.12466; Choy EH, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4312; Demyanets S, 2007, AM J PHYSIOL-HEART C, V293, pH1962, DOI 10.1152/ajpheart.01366.2006; Dewey FE, 2017, NEW ENGL J MED, V377, P211, DOI 10.1056/NEJMoa1612790; Du FY, 2012, FRONT BIOSCI-LANDMRK, V17, P2327, DOI 10.2741/4055; Dumas A, 2012, J CELL MOL MED, V16, P1274, DOI 10.1111/j.1582-4934.2011.01412.x; Emilsson V, 2018, SCIENCE, V361, P769, DOI 10.1126/science.aaq1327; Finn AV, 2010, ARTERIOSCL THROM VAS, V30, P1282, DOI 10.1161/ATVBAHA.108.179739; Guihard P, 2015, AM J PATHOL, V185, P765, DOI 10.1016/j.ajpath.2014.11.008; Hanna RN, 2012, CIRC RES, V110, P416, DOI 10.1161/CIRCRESAHA.111.253377; Harris TB, 2007, AM J EPIDEMIOL, V165, P1076, DOI 10.1093/aje/kwk115; Hurst SM, 2002, J IMMUNOL, V169, P5244, DOI 10.4049/jimmunol.169.9.5244; Kakutani Y, 2015, J CELL BIOCHEM, V116, P1325, DOI 10.1002/jcb.25088; Kim WM, 2017, NAT MED, V23, P535, DOI 10.1038/nm.4338; Kirii H, 2003, ARTERIOSCL THROM VAS, V23, P656, DOI 10.1161/01.ATV.0000064374.15232.C3; Komori T, 2013, J BIOL CHEM, V288, DOI 10.1074/jbc.M113.461905; Kubin T, 2011, CELL STEM CELL, V9, P420, DOI 10.1016/j.stem.2011.08.013; Kuhnast S, 2014, J LIPID RES, V55, P2103, DOI 10.1194/jlr.M051326; Kuhnast S, 2012, J HYPERTENS, V30, P107, DOI 10.1097/HJH.0b013e32834ddd8e; Landlinger C, 2017, EUR HEART J, V38, P2499, DOI 10.1093/eurheartj/ehx260; Libby P, 2012, ARTERIOSCL THROM VAS, V32, P2045, DOI 10.1161/ATVBAHA.108.179705; Low ASL, 2017, ANN RHEUM DIS, V76, DOI 10.1136/annrheumdis-2016-209784; McLaren JE, 2011, PROG LIPID RES, V50, P331, DOI 10.1016/j.plipres.2011.04.002; Modur V, 1997, J CLIN INVEST, V100, P158, DOI 10.1172/JCI119508; Modur V, 1997, J CLIN INVEST, V100, P2752, DOI 10.1172/JCI119821; Nakamura K, 2004, HEPATOLOGY, V39, P635, DOI 10.1002/hep.20086; Perisic L, 2016, J INTERN MED, V279, P293, DOI 10.1111/joim.12448; Ramji DP, 2015, CYTOKINE GROWTH F R, V26, P673, DOI 10.1016/j.cytogfr.2015.04.003; Ridker PM, 2017, NEW ENGL J MED, V377, P1119, DOI 10.1056/NEJMoa1707914; Schnittker D, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/317503; Seljeflot I, 2002, ATHEROSCLEROSIS, V162, P179, DOI 10.1016/S0021-9150(01)00696-7; Shioi A, 2002, CIRC RES, V91, P9, DOI 10.1161/01.RES.0000026421.61398.F2; Stary HC, 2000, ARTERIOSCL THROM VAS, V20, P1177, DOI 10.1161/01.ATV.20.5.1177; Takata F, 2008, NEUROSCI LETT, V441, P163, DOI 10.1016/j.neulet.2008.06.030; THOMA B, 1994, J BIOL CHEM, V269, P6215; Thomas G, 2015, ARTERIOSCL THROM VAS, V35, P1306, DOI 10.1161/ATVBAHA.114.304650; van Dijk RA, 2010, ATHEROSCLEROSIS, V210, P100, DOI 10.1016/j.atherosclerosis.2009.11.016; van Keulen D, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0204911; vanVlijmen BJM, 1996, J CLIN INVEST, V97, P1184, DOI 10.1172/JCI118532; Vasse M, 1999, ARTERIOSCLER THROMB, V19; Wahl AF, 2001, ANN RHEUM DIS, V60, pIII75; West NR, 2012, ENDOCR-RELAT CANCER, V19, P181, DOI 10.1530/ERC-11-0326; West NR, 2017, NAT MED, V23, P579, DOI 10.1038/nm.4307; Zampetaki A, 2008, CARDIOVASC RES, V78, P413, DOI 10.1093/cvr/cvn081; Zhang Q, 2008, CYTOKINE GROWTH F R, V19, P347, DOI 10.1016/j.cytogfr.2008.08.003; Zhang XT, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/317905; Zhang X, 2017, J LIPID RES, V58, P895, DOI 10.1194/jlr.M074112; Zhao F, 2017, EBIOMEDICINE, V25, P136, DOI 10.1016/j.ebiom.2017.08.019	54	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2019	14	8							e0221477	10.1371/journal.pone.0221477	http://dx.doi.org/10.1371/journal.pone.0221477			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5XV	31461490	Green Published, gold, Green Submitted			2022-12-26	WOS:000485052300035
J	Jeon, GS; You, SJ; Kim, MG; Kim, YM; Cho, SI				Jeon, Gyeong-Suk; You, Sun-Ju; Kim, Myo-Gyeong; Kim, Yoo-Mi; Cho, Sung-Il			Psychometric properties of the Korean version of the Copenhagen Burnout Inventory in Korean homecare workers for older adults	PLOS ONE			English	Article							VALIDATION; EMPLOYEES; STRESS	Background Despite the increasing number of homecare workers, a reliable and valid tool with which to measure burnout among Korean homecare workers is still lacking. The aim of this study was to examine the reliability and construct validity of the Korean version of the Copenhagen Burnout Inventory (CBI-K). Methods The study population consisted of 465 homecare workers. Data were collected in 2016 through a self-administered questionnaire including the three subscales of the CBI-K, the Center for Epidemiologic Studies Depression Scale (CESD-10), a measure of work-life conflict, and questions about respondents' sociodemographic characteristics. Results The confirmatory factor analyses results showed that the model fit indices of the refined three-factor model, in which the PB, WRB, and CRB subscales each contained six items, were acceptable (CFI = 0.924, SRMR = 0.049, RMSEA = 0.091). Furthermore, based on the results for construct reliability, discriminant validity of the refined three-factor model and job characteristics of homecare workers, we proposed that an abbreviated two-factor scale using the PB and CRB subscales could be used, with appropriate model fit indices (CFI = 0.950, SRMR = 0.047, RMSEA = 0.084). Each of the PB, WRB, and CRB subscales of CBI-K were associated with depressive symptoms even after controlling for covariates. Conclusions The CBI-K has adequate reliability and validity for use with homecare workers. To increase its practicality, we suggest a refined form comprising only PB and CRB subscales can be used rather than a three-factor model.	[Jeon, Gyeong-Suk; You, Sun-Ju] Mokpo Natl Univ, Dept Nursing, Muan Gun, Jeollanam Do, South Korea; [Jeon, Gyeong-Suk; Cho, Sung-Il] Seoul Natl Univ, Inst Hlth & Environm, Seoul, South Korea; [Kim, Myo-Gyeong] Seoul Womens Coll Nursing, Dept Nursing, Seoul, South Korea; [Kim, Yoo-Mi] Sangji Univ, Dept Hlth Policy & Management, Wonju, Kangwon Do, South Korea; [Cho, Sung-Il] Seoul Natl Univ, Grad Sch Publ Hlth, Dept Publ Hlth Sci, Seoul, South Korea	Mokpo National University; Seoul National University (SNU); Sangji University; Seoul National University (SNU)	You, SJ (corresponding author), Mokpo Natl Univ, Dept Nursing, Muan Gun, Jeollanam Do, South Korea.	sunju@mokpo.ac.kr	Kim, Myogyeong/AAM-4203-2020	Kim, Myo-Gyeong/0000-0002-1780-1125; Jeon, Gyeong-Suk/0000-0001-8574-7936; Kim, Yoomi/0000-0003-1471-1965	Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea [HI16C1365]	Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea	This research was supported by a grant from the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (grant number: HI16C1365). https://www.khidi.or.kr/kps.	[Anonymous], 2010, JEJU HESISTANT UNDER; Ben Natan M, 2010, INT NURS REV, V57, P113, DOI 10.1111/j.1466-7657.2009.00771.x; Borritz M, 2006, SCAND J PUBLIC HEALT, V34, P49, DOI 10.1080/14034940510032275; Choi H.K., 2011, KOREAN J SOCIAL WELF, V29, P113; Chon Kang Nan, 2010, [The Korean Society of Community Living Science, 한국지역사회생활과학회지], V21, P19; Demerouti E, 2001, J APPL PSYCHOL, V86, P499, DOI 10.1037//0021-9010.86.3.499; Campos JADB, 2013, PSICOL-REFLEX CRIT, V26, P87, DOI 10.1590/S0102-79722013000100010; Fong TCT, 2014, J PSYCHOL, V148, P255, DOI 10.1080/00223980.2013.781498; FORNELL C, 1981, J MARKETING RES, V18, P39, DOI 10.2307/3151312; FREUDENBERGER HJ, 1974, J SOC ISSUES, V30, P159, DOI 10.1111/j.1540-4560.1974.tb00706.x; Hermida R., 2015, COMPUT METHODS SOC S, V3, P5; Hurrell J, 1992, PSYCHOL JOB STRESS E, P675; Irwin M, 1999, ARCH INTERN MED, V159, P1701, DOI 10.1001/archinte.159.15.1701; 전경숙, 2017, [Korean Journal of Occupational Health Nursing, 한국직업건강간호학회지], V26, P10; Kennedy BR, 2005, J NURS SCHOLARSHIP, V37, P381, DOI 10.1111/j.1547-5069.2005.00065.x; Korczak Dieter, 2010, GMS Health Technol Assess, V6, pDoc09, DOI 10.3205/hta000087; Kristensen TS, 2005, WORK STRESS, V19, P192, DOI 10.1080/02678370500297720; Maslach C, 2016, MASLACH BURNOUT INVE; Maslach C., 1996, MASLACH BURNOUT INVE; Maslach C., 1976, HUM BEHAV, V5, P16, DOI DOI 10.12691/EDUCATION-1-11-7; Maslach C., 2009, OXFORD HDB ORG WELL, P86; Maslach C, 2016, WORLD PSYCHIATRY, V15, P103, DOI 10.1002/wps.20311; McDonald RP, 2002, PSYCHOL METHODS, V7, P64, DOI 10.1037//1082-989X.7.1.64; Milfont TL, 2008, SOC INDIC RES, V89, P169, DOI 10.1007/s11205-007-9229-9; Ruiz EM, 2013, REV ESP SALUD PUBLIC, V87, P165, DOI [10.4321/S1135-57272013000200006, 10.4321/s1135-57272013000200006]; National Institute for Occupational Safety and Health, NOISH HAZ REV OCC HA; Poghosyan L, 2010, RES NURS HEALTH, V33, P288, DOI 10.1002/nur.20383; REICHHERZER T, 2006, CONFIRMATORY FACTOR, P86; Schaufeli W.B., 2003, HDB WORK HLTH PSYCHO, V2, P282, DOI DOI 10.1002/0470013400.CH19; Shadfar S, 2013, INT J ACAD RES BUSIN, V3, P579; Ungerson C., 2005, SOCIOL REV, P188, DOI DOI 10.1111/j.1467-954X.2005.00580.x; Winwood PC, 2003, AUST DENT J, V48, P102, DOI 10.1111/j.1834-7819.2003.tb00017.x; World Health Organization, WORLD REP AG HLTH 20; World Health Organization, HOME CARE EUROPE CUR; Yeh WY, 2007, INT J BEHAV MED, V14, P126, DOI 10.1007/BF03000183; yongho Chon，, 2017, [Studies on Life and Culture, 생명연구], V43, P129; Yoon JY., 2012, STATUS TASKS WORKING, P71	37	10	10	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2019	14	8							e0221323	10.1371/journal.pone.0221323	http://dx.doi.org/10.1371/journal.pone.0221323			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW5WO	31454378	Green Published, Green Submitted, gold			2022-12-26	WOS:000485049000016
J	Zhou, H; Zhuang, ZX; Sun, YQ; Chen, Q; Zheng, XY; Liang, YT; Mahboob, S; Wang, Q; Zhang, R; Al-Ghanim, KA; Shao, CW; Li, YJ				Zhou, He; Zhuang, Zi-Xin; Sun, Yu-Qing; Chen, Qi; Zheng, Xin-Yi; Liang, Yu-Ting; Mahboob, Shahid; Wang, Qian; Zhang, Rui; Al-Ghanim, Khalid A.; Shao, Chang-Wei; Li, Ya-Juan			Changes in DNA methylation during epigenetic-associated sex reversal under low temperature in Takifugu rubripes	PLOS ONE			English	Article							METHYLOME; EXPRESSION; PATTERNS; FISH	DNA methylation has frequently been implicated in sex determination and differentiation in teleost species. In order to detect the DNA methylation patterns established during sexual differentiation in tiger pufferfish T. rubripes, we performed comprehensive whole genome methylation sequencing and analyses of the gonads of male, female, and pseudo male. We obtained a total of 33.12, 32.44, and 31.60 Gb clean data for male, female, and pseudo male, with a sequencing depth of 66.44x, 60.47x and 54.86x, respectively. The methylation level of cytosine (C) residues in the genomic DNA from gonads was 11.016%, 10.428%, and 11.083% in male, female, and pseudo male, respectively. More than 65% of C methylation was at CpG sites, and less than 1% was at CHG and CHH sites. In each regulatory element, there were low methylation levels on both sides of the transcription start site, and higher methylation levels in exons, introns, and downstream of genes. The highest mCpG was on chromosome 8 and the lowest mCpG was on chromosome 5. Comparisons of whole-genome DNA methylation between pairs of samples revealed that there were 3,173 differentially methylated regions (DMRs) between female and male, and 3,037 DMRs between male and pseudo male, corresponding to 0.232% and 0.223% of the length of the genome, respectively. There were only 1,635 DMRs between female and pseudo male, representing 0.127% of the length of the genome. A number of differentially methylated genes (DMGs) related to sex determination and differentiation were selected, such as amhr2 and pfcyp19a. After Bisulfite Sequencing PCR (BSP) verification, amhr2 was exhibited low methylation level in normal males and pseudo male, and high methylation level in normal females but pfcyp19a showed low methylation level in normal females and high methylation level in normal males and pseudo males. These results provide information about the molecular epigenetic mechanisms of DNA methylation during lowtemperature induced masculinization of tiger pufferfish, and increase our understanding of the mechanisms of sex determination and differentiation in this important aquaculture fish species.	[Zhou, He; Zhuang, Zi-Xin; Sun, Yu-Qing; Chen, Qi; Zheng, Xin-Yi; Liang, Yu-Ting; Zhang, Rui; Li, Ya-Juan] Dalian Ocean Univ, Key Lab Marine Bioresources Sustainable Utilizat, Dalian, Peoples R China; [Zhou, He; Zhuang, Zi-Xin; Sun, Yu-Qing; Chen, Qi; Zheng, Xin-Yi; Liang, Yu-Ting; Zhang, Rui; Li, Ya-Juan] Dalian Ocean Univ, Key Lab Mariculture, PRC, Agriculatu Re Minist, Dalian, Peoples R China; [Mahboob, Shahid; Al-Ghanim, Khalid A.] King Saud Univ, Coll Sci, Dept Zool, Riyadh, Saudi Arabia; [Wang, Qian; Shao, Chang-Wei] Minist Agr, Key Lab Sustainable Dev Marine Fisheries, Yellow Sea Fisheries Res Inst, CAFS, Qingdao, Peoples R China	Dalian Ocean University; Dalian Ocean University; King Saud University; Chinese Academy of Fishery Sciences; Yellow Sea Fisheries Research Institute, CAFS; Ministry of Agriculture & Rural Affairs	Li, YJ (corresponding author), Dalian Ocean Univ, Key Lab Marine Bioresources Sustainable Utilizat, Dalian, Peoples R China.; Li, YJ (corresponding author), Dalian Ocean Univ, Key Lab Mariculture, PRC, Agriculatu Re Minist, Dalian, Peoples R China.; Shao, CW (corresponding author), Minist Agr, Key Lab Sustainable Dev Marine Fisheries, Yellow Sea Fisheries Res Inst, CAFS, Qingdao, Peoples R China.	shaocw@ysfri.ac.cn; liyajuan@dlou.edu.cn	Shao, Changwei/I-2054-2016; Rana, Shahid Mahboob/P-1131-2014	Shao, Changwei/0000-0002-6953-2203; Rana, Shahid Mahboob/0000-0003-4969-5387	National Natural Science Foundation of China [41606178]; Liaoning Doctor Scientific Research Foundation Project [201501185]; Liaoning Department of Education Key Laboratory of Basic Research Project [LZ2015010]; International Scientific Partnership Program ISPP at King Saud University [0050]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Liaoning Doctor Scientific Research Foundation Project; Liaoning Department of Education Key Laboratory of Basic Research Project; International Scientific Partnership Program ISPP at King Saud University	Funded by He Zhou, National Natural Science Foundation of China (NO. 41606178), Liaoning Doctor Scientific Research Foundation Project (NO. 201501185); Ya-Juan Li, Liaoning Department of Education Key Laboratory of Basic Research Project (No. LZ2015010); Shahid Mahboob, International Scientific Partnership Program ISPP at King Saud University for funding this research work through ISPP No. 0050.	Aberg KA, 2012, EPIGENOMICS-UK, V4, P605, DOI [10.2217/EPI.12.59, 10.2217/epi.12.59]; Anastasiadi D, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10861-6; Anonymous, 2011, Marine Sciences (Beijing), V35, P128; Ball MP, 2009, NAT BIOTECHNOL, V27, P361, DOI 10.1038/nbt.1533; Bang IC, 1996, J AQUACULTURE, V9, P125; Baroiller JF, 2001, COMP BIOCHEM PHYS C, V130, P399, DOI 10.1016/S1532-0456(01)00267-8; Beardmore JA, 2001, AQUACULTURE, V197, P283, DOI 10.1016/S0044-8486(01)00590-7; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Bird A, 2007, NATURE, V447, P396, DOI 10.1038/nature05913; DEVLIN RH, 1994, AQUACULTURE, V128, P211, DOI 10.1016/0044-8486(94)90310-7; Devlin RH, 2002, AQUACULTURE, V208, P191, DOI 10.1016/S0044-8486(02)00057-1; Dowen RH, 2012, P NATL ACAD SCI USA, V109, pE2183, DOI 10.1073/pnas.1209329109; Feng SH, 2010, P NATL ACAD SCI USA, V107, P8689, DOI 10.1073/pnas.1002720107; Flores KB, 2013, INTEGR COMP BIOL, V53, P359, DOI 10.1093/icb/ict019; Hattori G, 2012, J FISHERIES SOC JAPA, V78, P87, DOI [10.2331/suisan.78.87, DOI 10.2331/SUISAN.78.87]; Huang W, 2009, MOL CELL ENDOCRINOL, V307, P224, DOI 10.1016/j.mce.2009.04.003; Jiang L, 2013, CELL, V153, P773, DOI 10.1016/j.cell.2013.04.041; Jiang N, 2014, GENOME BIOL EVOL, V6, P2998, DOI 10.1093/gbe/evu238; Jones PA, 2001, SCIENCE, V293, P1068, DOI 10.1126/science.1063852; Kamiya T, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002798; Kikuchi K, 2007, GENETICS, V175, P2039, DOI 10.1534/genetics.106.069278; Klose RJ, 2006, TRENDS BIOCHEM SCI, V31, P89, DOI 10.1016/j.tibs.2005.12.008; Kobayashi Y, 2010, COMP BIOCHEM PHYS A, V155, P237, DOI 10.1016/j.cbpa.2009.11.004; Lei J. L., 2005, MARINE FISH CULTURE, P683; Li QH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019428; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Nagarajan A, 2014, METHODS MOL BIOL, V1176, P23, DOI 10.1007/978-1-4939-0992-6_3; Navarro-Martin L, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002447; Penman DJ, 2008, REV FISH SCI, V16, P16, DOI 10.1080/10641260802324610; Reue K, 2008, FEBS LETT, V582, P90, DOI 10.1016/j.febslet.2007.11.014; Saxonov S, 2006, P NATL ACAD SCI USA, V103, P1412, DOI 10.1073/pnas.0510310103; Shao CW, 2014, GENOME RES, V24, P604, DOI 10.1101/gr.162172.113; Sun LX, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158483; Taiwo O, 2012, NAT PROTOC, V7, P617, DOI 10.1038/nprot.2012.012; Wan ZY, 2016, SCI REP-UK, V6, DOI 10.1038/srep35903; Wang D, 2009, ANIM GENET, V40, P978, DOI 10.1111/j.1365-2052.2009.01941.x; Wu GC, 2010, BIOL REPROD, V83, P443, DOI 10.1095/biolreprod.110.084681; Xi YP, 2009, BMC BIOINFORMATICS, V10, DOI [10.1186/1471-2105-10-S1-S58, 10.1186/1471-2105-10-232]; Zemach A, 2010, SCIENCE, V328, P916, DOI 10.1126/science.1186366; Zhou H, 2019, J OCEANOL LIMNOL, V37, P1125, DOI 10.1007/s00343-019-7382-z; Zhou He, 2015, Journal of Dalian Ocean University, V30, P41	41	19	20	3	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2019	14	8							e0221641	10.1371/journal.pone.0221641	http://dx.doi.org/10.1371/journal.pone.0221641			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5WO	31454376	gold, Green Published, Green Submitted			2022-12-26	WOS:000485049000035
J	Guha, D; Jakubovic, R; Leung, MK; Ginsberg, HJ; Fehlings, MG; Mainprize, TG; Yee, A; Yang, VXD				Guha, Daipayan; Jakubovic, Raphael; Leung, Michael K.; Ginsberg, Howard J.; Fehlings, Michael G.; Mainprize, Todd G.; Yee, Albert; Yang, Victor X. D.			Quantification of computational geometric congruence in surface-based registration for spinal intra-operative three-dimensional navigation	PLOS ONE			English	Article							PEDICLE SCREW PLACEMENT; ACCURACY	Background Context Computer-assisted navigation (CAN) may guide spinal instrumentation, and requires alignment of patient anatomy to imaging. Iterative closest-point (ICP) algorithms register anatomical and imaging surface datasets, which may fail in the presence of geometric symmetry (congruence), leading to failed registration or inaccurate navigation. Here we computationally quantify geometric congruence in posterior spinal exposures, and identify predictors of potential navigation inaccuracy. Methods Midline posterior exposures were performed from C1-S1 in four human cadavers. An optically-based CAN generated surface maps of the posterior elements at each level. Maps were reconstructed to include bilateral hemilamina, or unilateral hemilamina with/without the base of the spinous process. Maps were fitted to symmetrical geometries (cylindrical/spherical/planar) using computational modelling, and the degree of model fit quantified based on the ratio of model inliers to total points. Geometric congruence was subsequently assessed clinically in 11 patients undergoing midline exposures in the cervical/thoracic/lumbar spine for posterior instrumented fusion. Results In cadaveric testing, increased cylindrical/spherical/planar symmetry was seen in the highcervical and subaxial cervical spine relative to the thoracolumbar spine (p<0.001). Extension of unilateral exposures to include the ipsilateral base of the spinous process decreased symmetry independent of spinal level (p<0.001). In clinical testing, increased cylindrical/spherical/planar symmetry was seen in the subaxial cervical relative to the thoracolumbar spine (p<0.001), and in the thoracic relative to the lumbar spine (p<0.001). Symmetry in unilateral exposures was decreased by 20% with inclusion of the ipsilateral base of the spinous process. Conclusions Geometric congruence is most evident at C1 and the subaxial cervical spine, warranting greater vigilance in navigation accuracy verification. At all levels, inclusion of the base of the spinous process in unilateral registration decreases the likelihood of geometric symmetry and navigation error. This work is important to allow the extension of line-of-sight based registration techniques to minimally-invasive unilateral approaches.	[Guha, Daipayan; Ginsberg, Howard J.; Fehlings, Michael G.; Mainprize, Todd G.; Yang, Victor X. D.] Univ Toronto, Dept Surg, Div Neurosurg, Toronto, ON, Canada; [Guha, Daipayan; Fehlings, Michael G.; Yang, Victor X. D.] Univ Toronto, Inst Med Sci, Toronto, ON, Canada; [Guha, Daipayan; Jakubovic, Raphael; Leung, Michael K.; Yang, Victor X. D.] Sunnybrook Hlth Sci Ctr, Biophoton & Bioengn Lab, Toronto, ON, Canada; [Jakubovic, Raphael] Ryerson Univ, Dept Biomed Phys, Toronto, ON, Canada; [Ginsberg, Howard J.] Univ Toronto, Inst Biomat & Biomed Engn, Toronto, ON, Canada; [Yee, Albert] Univ Toronto, Div Orthoped Surg, Dept Surg, Toronto, ON, Canada; [Yang, Victor X. D.] Ryerson Univ, Dept Elect & Comp Engn, Toronto, ON, Canada	University of Toronto; University of Toronto; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; Toronto Metropolitan University; University of Toronto; University of Toronto; Toronto Metropolitan University	Guha, D (corresponding author), Univ Toronto, Dept Surg, Div Neurosurg, Toronto, ON, Canada.; Guha, D (corresponding author), Univ Toronto, Inst Med Sci, Toronto, ON, Canada.; Guha, D (corresponding author), Sunnybrook Hlth Sci Ctr, Biophoton & Bioengn Lab, Toronto, ON, Canada.	deep.guha@mail.utoronto.ca	Guha, Daipayan/AAV-1008-2021	Guha, Daipayan/0000-0002-2052-4819; Yang, Victor/0000-0002-1166-8271	Natural Sciences and Engineering Research Council of Canada (NSERC); Canada Foundation for Innovation (CFI); Canadian Institutes of Health Research (CIHR) [FRN 142931]	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Foundation for Innovation (CFI)(Canada Foundation for Innovation); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	This research is supported by the Natural Sciences and Engineering Research Council of Canada (NSERC) and the Canada Foundation for Innovation (CFI) to DG. Salary support for DG is provided in part by a Canadian Institutes of Health Research (CIHR) Postdoctoral Fellowship (FRN 142931). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research is supported by the Natural Sciences and Engineering Research Council of Canada (NSERC) and the Canada Foundation for Innovation (CFI). Salary support for DG is provided in part by a Canadian Institutes of Health Research (CIHR) Postdoctoral Fellowship (FRN 142931).	Armesto L, 2010, IEEE INT CONF ROBOT, P1367, DOI 10.1109/ROBOT.2010.5509371; Barsa P, 2016, EUR SPINE J, V25, P1643, DOI 10.1007/s00586-016-4476-6; Berner A., 2008, S VOL POINT BAS GRAP, P1; BESL PJ, 1992, IEEE T PATTERN ANAL, V14, P239, DOI 10.1109/34.121791; Bourgeois AC, 2015, J SPINAL DISORD TECH, V28, P324, DOI 10.1097/BSD.0000000000000152; CHEN Y, 1991, 1991 IEEE INTERNATIONAL CONFERENCE ON ROBOTICS AND AUTOMATION, VOLS 1-3, P2724, DOI 10.1109/ROBOT.1991.132043; Choo Alexander D, 2008, SAS J, V2, P189, DOI 10.1016/SASJ-2008-0007-RR; Clements LW, 2008, ROBUST SURFACE REGIS, P2528; Fichtner J, 2017, WORLD NEUROSURG; Gelfand N, 2003, P 4 INT C 3 D DIG IM; Guha D, 2017, CAN J SURG CANADIAN, V60, pS104; Hartl R, 2013, WORLD NEUROSURG, V79, P162, DOI 10.1016/j.wneu.2012.03.011; Hecht N, 2010, J NEUROSURG-SPINE, V36, pE1, DOI [10.3171/SPI.2008.9.11.450, DOI 10.3171/SPI.2008.9.11.450]; Jakubovic R, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-32424-z; Jakubovic R, 2016, J NEUROSURG, V124, pA1184; Lehmann B, 2017, EPIJOURNAL GEOM ALGE, V1; Luther N, 2015, J SPINAL DISORD TECH, V28, pE298, DOI 10.1097/BSD.0b013e31828af33e; Mason A, 2014, J NEUROSURG-SPINE, V20, P196, DOI 10.3171/2013.11.SPINE13413; Maurer CR, 1996, IEEE T MED IMAGING, V15, P836, DOI 10.1109/42.544501; Nelson EM, 2014, SPINE J, V14, P2985, DOI 10.1016/j.spinee.2014.06.003; Pomerleau F, 2013, AUTON ROBOT, V34, P133, DOI 10.1007/s10514-013-9327-2; Pottmann H, 2003, VISUALIZATION AND MATHEMATICS III, P221; Robertson PA, 1998, SPINE, V23, P60, DOI 10.1097/00007632-199801010-00013; Tian NF, 2011, EUR SPINE J, V20, P846, DOI 10.1007/s00586-010-1577-5; Villard J, 2014, SPINE, P39; Wagner SC, 2018, J CLIN NEUROSCI, V47, P198, DOI 10.1016/j.jocn.2017.09.024; Wei Xin, 2010, Proceedings 2010 International Conference on Computational and Information Sciences (ICCIS 2010), P565, DOI 10.1109/ICCIS.2010.144; Ying SH, 2009, IEEE T AUTOM SCI ENG, V6, P559, DOI 10.1109/TASE.2009.2021337	28	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2019	14	8							e0207137	10.1371/journal.pone.0207137	http://dx.doi.org/10.1371/journal.pone.0207137			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5UR	31450234	Green Published, gold			2022-12-26	WOS:000485044000001
J	Pratt, EPS; Harvey, KE; Salyer, AE; Hockerman, GH				Pratt, Evan P. S.; Harvey, Kyle E.; Salyer, Amy E.; Hockerman, Gregory H.			Regulation of cAMP accumulation and activity by distinct phosphodiesterase subtypes in INS-1 cells and human pancreatic beta-cells	PLOS ONE			English	Article							STIMULATED INSULIN-SECRETION; CA2+-INDUCED CA2+ RELEASE; ELEMENT-BINDING PROTEIN; GLUCAGON-LIKE PEPTIDE-1; ADENYLYL-CYCLASE; CYCLIC-AMP; GLUCOSE-INTOLERANCE; RAT ISLETS; ACTIVATION; KINASE	Pancreatic beta-cells express multiple phosphodiesterase (PDE) subtypes, but the specific roles for each in beta-cell function, particularly in humans, is not clear. We evaluated the cellular role of PDE1, PDE3, and PDE4 activity in the rat insulinoma cell line INS-1 and in primary human beta-cells using subtype-selective PDE inhibitors. Using a genetically encoded, FRET-based cAMP sensor, we found that the PDE1 inhibitor 8MM-IBMX, elevated cAMP levels in the absence of glucose to a greater extent than either the PDE3 inhibitor cilostamide or the PDE4 inhibitor rolipram. In 18 mM glucose, PDE1 inhibition elevated cAMP levels to a greater extent than PDE3 inhibition in INS-1 cells, while PDE4 inhibition was without effect. Inhibition of PDE1 or PDE4, but not PDE3, potentiated glucose-stimulated insulin secretion in INS-1 cells. PDE1 inhibition, but not PDE3 or PDE4 inhibition, reduced palmitate-induced caspase-3/7 activation, and enhanced CREB phosphorylation in INS-1 cells. In human beta-cells, only PDE3 or PDE4 inhibition increased cAMP levels in 1.7 mM glucose, but PDE1, PDE3, or PDE4 inhibition potentiated cAMP levels in 16.7 mM glucose. Inhibition of PDE1 or PDE4 increased cAMP levels to a greater extent in 16.7 mM glucose than in 1.7 mM glucose in human beta-cells. In contrast, elevation of cAMP levels by PDE3 inhibition was not different at these glucose concentrations. PDE1 inhibition also potentiated insulin secretion from human islets, suggesting that the role of PDE1 may be conserved between INS-1 cells and human pancreatic beta-cells. Our results suggest that inhibition of PDE1 may be a useful strategy to potentiate glucose-stimulated insulin secretion, and to protect beta-cells from the toxic effects of excess fatty acids.	[Pratt, Evan P. S.; Harvey, Kyle E.; Salyer, Amy E.; Hockerman, Gregory H.] Purdue Univ, Dept Med Chem & Mol Pharmacol, W Lafayette, IN 47907 USA; [Pratt, Evan P. S.] Purdue Univ, Interdisciplinary Life Sci Program, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Hockerman, GH (corresponding author), Purdue Univ, Dept Med Chem & Mol Pharmacol, W Lafayette, IN 47907 USA.	gregh@purdue.edu			Integrated Islet Distribution Program [BS374]; Richard and Anne Borch Award; Purdue Research Foundation; Purdue Executive Vice President for Research and Partnerships	Integrated Islet Distribution Program; Richard and Anne Borch Award; Purdue Research Foundation; Purdue Executive Vice President for Research and Partnerships	This work was supported by a pilot grant from the Integrated Islet Distribution Program (#BS374 to G. H. H.), a Richard and Anne Borch Award (to G. H. H.), a grant from the Purdue Executive Vice President for Research and Partnerships (to G. H. H.), and a Purdue Research Foundation Grant (to E.P. S.P.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal SR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095835; Ahn HS, 1997, J MED CHEM, V40, P2196, DOI 10.1021/jm9608467; ASFARI M, 1992, ENDOCRINOLOGY, V130, P167, DOI 10.1210/en.130.1.167; Baillie GS, 2009, FEBS J, V276, P1790, DOI 10.1111/j.1742-4658.2009.06926.x; Biden TJ, 2014, TRENDS ENDOCRIN MET, V25, P389, DOI 10.1016/j.tem.2014.02.003; Borner S, 2011, NAT PROTOC, V6, P427, DOI 10.1038/nprot.2010.198; Brentnall M, 2013, BMC CELL BIOL, V14, DOI 10.1186/1471-2121-14-32; Brissova M, 2005, J HISTOCHEM CYTOCHEM, V53, P1087, DOI 10.1369/jhc.5C6684.2005; Butler AE, 2003, DIABETES, V52, P102, DOI 10.2337/diabetes.52.1.102; Choi YH, 2006, J CLIN INVEST, V116, P3240, DOI 10.1172/JCI24867; Costes S, 2006, DIABETES, V55, P2220, DOI 10.2337/db05-1618; Cunha DA, 2009, DIABETES, V58, P2851, DOI 10.2337/db09-0685; Delmeire D, 2003, DIABETOLOGIA, V46, P1383, DOI 10.1007/s00125-003-1203-8; DeNinno MP, 2012, BIOORG MED CHEM LETT, V22, P5721, DOI 10.1016/j.bmcl.2012.06.079; Dodge KL, 2001, EMBO J, V20, P1921, DOI 10.1093/emboj/20.8.1921; Dodge-Kafka KL, 2005, NATURE, V437, P574, DOI 10.1038/nature03966; Dou HQ, 2015, DIABETOLOGIA, V58, P324, DOI 10.1007/s00125-014-3437-z; Dov A, 2008, ENDOCRINOLOGY, V149, P741, DOI 10.1210/en.2007-0968; Dyachok O, 2004, CELL CALCIUM, V36, P1, DOI 10.1016/j.ceca.2003.11.004; Dyachok O, 2006, NATURE, V439, P349, DOI 10.1038/nature04410; Dyachok O, 2008, CELL METAB, V8, P26, DOI 10.1016/j.cmet.2008.06.003; Dzhura I, 2011, ISLETS, V3, P121, DOI 10.4161/isl.3.3.15507; Dzhura I, 2010, J PHYSIOL-LONDON, V588, P4871, DOI 10.1113/jphysiol.2010.198424; Garber AJ, 2011, DIABETES CARE, V34, pS258, DOI 10.2337/dc11-s230; Goraya TA, 2005, CELL SIGNAL, V17, P789, DOI 10.1016/j.cellsig.2004.12.017; Goraya TA, 2004, J BIOL CHEM, V279, P40494, DOI 10.1074/jbc.M313441200; Gromada J, 2004, BASIC CLIN PHARMACOL, V95, P252, DOI 10.1111/j.1742-7843.2004.t01-1-pto950502.x; Han P, 1999, J BIOL CHEM, V274, P22337, DOI 10.1074/jbc.274.32.22337; Harndahl L, 2004, J BIOL CHEM, V279, P15214, DOI 10.1074/jbc.M308952200; Harndahl L, 2002, J BIOL CHEM, V277, P37446, DOI 10.1074/jbc.M205401200; Heimann E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014191; HIDAKA H, 1979, J PHARMACOL EXP THER, V211, P26; Hinke SA, 2012, EMBO J, V31, P3991, DOI 10.1038/emboj.2012.244; Hodson DJ, 2014, DIABETES, V63, P3009, DOI 10.2337/db13-1607; Holz GG, 2014, BBA-MOL BASIS DIS, V1842, P2593, DOI 10.1016/j.bbadis.2014.06.023; Holz GG, 1999, J BIOL CHEM, V274, P14147, DOI 10.1074/jbc.274.20.14147; Hoppa MB, 2009, CELL METAB, V10, P455, DOI 10.1016/j.cmet.2009.09.011; Idevall-Hagren O, 2010, J BIOL CHEM, V285, P23005, DOI 10.1074/jbc.M109.095992; Jhala US, 2003, GENE DEV, V17, P1575, DOI 10.1101/gad.1097103; Johnson JD, 2004, FASEB J, V18, P878, DOI 10.1096/fj.03-1280fje; Kang GX, 2006, J PHYSIOL-LONDON, V573, P595, DOI 10.1113/jphysiol.2006.107391; Kang GX, 2003, J BIOL CHEM, V278, P8279, DOI 10.1074/jbc.M211682200; Kitaguchi T, 2013, BIOCHEM J, V450, P365, DOI 10.1042/BJ20121022; Klarenbeek J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122513; Kong H, 2008, BIOCHEM J, V414, P441, DOI 10.1042/BJ20080489; Koschinski A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13021-y; Kwon G, 2004, J BIOL CHEM, V279, P8938, DOI 10.1074/jbc.M310330200; Landa LR, 2005, J BIOL CHEM, V280, P31294, DOI 10.1074/jbc.M505657200; Leech CA, 2010, VITAM HORM, V84, P279, DOI [10.1016/B978-0-12-381517-0.00010-2, 10.1016/S0083-6729(10)84008-7]; Lefkimmiatis K, 2013, J CELL BIOL, V202, P453, DOI 10.1083/jcb.201303159; Lester LB, 1997, P NATL ACAD SCI USA, V94, P14942, DOI 10.1073/pnas.94.26.14942; Liu GH, 2006, J PHARMACOL EXP THER, V318, P152, DOI 10.1124/jpet.105.097477; Liu HG, 2006, J BIOL CHEM, V281, P21096, DOI 10.1074/jbc.M601307200; Malmgren S, 2013, J BIOL CHEM, V288, P11973, DOI 10.1074/jbc.M112.422527; Michel JJC, 2004, BIOCHEM J, V381, P587, DOI 10.1042/BJ20040846; Mika D, 2015, P NATL ACAD SCI USA, V112, P2023, DOI 10.1073/pnas.1419992112; Murthy KS, 2002, AM J PHYSIOL-CELL PH, V282, pC508, DOI 10.1152/ajpcell.00373.2001; Nijholt IM, 2008, CELL SIGNAL, V20, P1715, DOI 10.1016/j.cellsig.2008.05.001; OHTA M, 1993, J PHARMACOL EXP THER, V264, P35; Omori K, 2007, CIRC RES, V100, P309, DOI 10.1161/01.RES.0000256354.95791.f1; Parker JC, 1995, BIOCHEM BIOPH RES CO, V217, P916, DOI 10.1006/bbrc.1995.2858; Penmatsa H, 2010, MOL BIOL CELL, V21, P1097, DOI 10.1091/mbc.E09-08-0655; RABINOVITCH A, 1980, J CLIN INVEST, V66, P1065, DOI 10.1172/JCI109935; Ramos LS, 2008, J GEN PHYSIOL, V132, P329, DOI 10.1085/jgp.200810044; Ramos-Espiritu L, 2016, NAT CHEM BIOL, V12, P838, DOI [10.1038/NCHEMBIO.2151, 10.1038/nchembio.2151]; Richter W, 2008, EMBO J, V27, P384, DOI 10.1038/sj.emboj.7601968; Rorsman P, 2000, NEWS PHYSIOL SCI, V15, P72; SCHWABE U, 1976, MOL PHARMACOL, V12, P900; SHAFIEENICK R, 1995, BRIT J PHARMACOL, V115, P1486, DOI 10.1111/j.1476-5381.1995.tb16641.x; Shakur Y, 2000, J BIOL CHEM, V275, P38749, DOI 10.1074/jbc.M001734200; Shibasaki T, 2004, J BIOL CHEM, V279, P7956, DOI 10.1074/jbc.M309068200; Skelin M, 2011, CELL CALCIUM, V49, P89, DOI 10.1016/j.ceca.2010.12.005; Soderling SH, 2000, CURR OPIN CELL BIOL, V12, P174, DOI 10.1016/S0955-0674(99)00073-3; Song WJ, 2011, CELL METAB, V13, P308, DOI 10.1016/j.cmet.2011.02.002; Soulsby MD, 2005, BIOCHEM J, V392, P493, DOI 10.1042/BJ20051325; Tengholm A, 2012, UPSALA J MED SCI, V117, P355, DOI 10.3109/03009734.2012.724732; Tian G, 2015, DIABETES, V64, P904, DOI 10.2337/db14-1036; Tian G, 2012, J CELL SCI, V125, P5084, DOI 10.1242/jcs.107201; Tian G, 2011, DIABETES, V60, P1535, DOI 10.2337/db10-1087; Truchan NA, 2015, ISLETS, V7, DOI 10.1080/19382014.2015.1076607; Vang AG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012011; Vikman J, 2009, AM J PHYSIOL-ENDOC M, V297, pE452, DOI 10.1152/ajpendo.90585.2008; Waddleton D, 2008, BIOCHEM PHARMACOL, V76, P884, DOI 10.1016/j.bcp.2008.07.025; Walz HA, 2007, CELL SIGNAL, V19, P1505, DOI 10.1016/j.cellsig.2007.01.030; Walz HA, 2006, J ENDOCRINOL, V189, P629, DOI 10.1677/joe.1.06522; Weir GC, 2004, DIABETES, V53, pS16, DOI 10.2337/diabetes.53.suppl_3.S16; Willoughby D, 2010, J BIOL CHEM, V285, P20328, DOI 10.1074/jbc.M110.120725; Zhao AZ, 1998, J CLIN INVEST, V102, P869, DOI 10.1172/JCI3920; Zhao AZ, 1997, P NATL ACAD SCI USA, V94, P3223, DOI 10.1073/pnas.94.7.3223; Zhao Z, 2014, MOL ENDOCRINOL, V28, P1682, DOI 10.1210/me.2014-1120; Zippin JH, 2002, FASEB J, V16, P82, DOI 10.1096/fj.02-0598fje; Zippin JH, 2013, J BIOL CHEM, V288, P33283, DOI 10.1074/jbc.M113.510073	92	11	11	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2019	14	8							e0215188	10.1371/journal.pone.0215188	http://dx.doi.org/10.1371/journal.pone.0215188			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5TR	31442224	Green Submitted, gold, Green Published			2022-12-26	WOS:000485041400002
J	Cavrois, M; Hilton, JF; Roan, NR; Takeda, M; Seidman, D; Averbach, S; Chang, E; Raman, N; Greenblatt, R; Shacklett, BL; Smith-Mccune, K				Cavrois, Marielle; Hilton, Joan F.; Roan, Nadia R.; Takeda, Margaret; Seidman, Dominika; Averbach, Sarah; Chang, Eric; Raman, Nandhini; Greenblatt, Ruth; Shacklett, Barbara L.; Smith-Mccune, Karen			Effects of the levonorgestrel-containing intrauterine device, copper intrauterine device, and levonorgestrel-containing oral contraceptive on susceptibility of immune cells from cervix, endometrium and blood to HIV-1 fusion measured ex vivo	PLOS ONE			English	Article							DENDRITIC CELLS; FEMALE; TRANSMISSION; INFECTION; RESPONSES; WOMEN	Globally, HIV/AIDS is a leading cause of morbidity worldwide among reproductive-aged cis-gender women, highlighting the importance of understanding effects of contraceptives on HIV-1 risk. Some observational studies suggest there may be an increased risk of HIV-1 acquisition among women using the long-acting injectable progestin contraceptive, depomedroxyprogesterone acetate. The potential mechanism of this susceptibility is unclear. There are few data on the role of the upper female reproductive tract in HIV-1 transmission, and the mechanisms of HIV-1 infection are likely to differ in the upper compared to the lower reproductive tract due to differences in tissue composition and variable effects of sex steroids on mucosal immune cell distribution and activity. In this study, we measured the susceptibility of mucosal immune cells from the upper female reproductive tract to HIV-1 entry using the virion-based HIV-1 fusion assay in samples from healthy female volunteers. We studied 37 infectious molecular clones for their ability to fuse to cells from endometrial biopsies in three participants and found that subtype (B or C) and origin of the virus (transmitted founder or chronic control) had little influence on HIV-1 fusion susceptibility. We studied the effect of contraceptives on HIV-1 susceptibility of immune cells from the cervix, endometrium and peripheral blood by comparing fusion susceptibility in four groups: users of the copper intrauterine device (IUD), levonorgestrel-containing oral contraceptive, levonorgestrel-containing IUD and unexposed controls (n = 58 participants). None of the contraceptives was associated with higher rates of HIV-1 entry into female reproductive tract cells compared to control samples from the mid-luteal phase.	[Cavrois, Marielle; Roan, Nadia R.; Chang, Eric; Raman, Nandhini] Gladstone Inst Virol & Immunol, San Francisco, CA USA; [Hilton, Joan F.] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA USA; [Roan, Nadia R.] Univ Calif San Francisco, Dept Urol, San Francisco, CA USA; [Takeda, Margaret; Seidman, Dominika; Smith-Mccune, Karen] Univ Calif San Francisco, Dept Obstet Gynecol & Reprod Sci, San Francisco, CA 92103 USA; [Averbach, Sarah] Univ Calif San Diego, Dept Obstet Gynecol & Reprod Sci, San Diego, CA 92103 USA; [Greenblatt, Ruth] Univ Calif San Francisco, Dept Clin Pharm, San Francisco, CA 94143 USA; [Greenblatt, Ruth] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Shacklett, Barbara L.] Univ Calif Davis, Sch Med, Dept Med Microbiol & Immunol, Davis, CA 95616 USA; [Cavrois, Marielle] Gilead Sci Inc, 353 Lakeside Dr, Foster City, CA 94404 USA	University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Diego; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California Davis; Gilead Sciences	Smith-Mccune, K (corresponding author), Univ Calif San Francisco, Dept Obstet Gynecol & Reprod Sci, San Francisco, CA 92103 USA.	Karen.mccune@ucsf.edu	Shacklett, Barbara/A-7288-2009	Shacklett, Barbara/0000-0002-7067-732X; Averbach, Sarah/0000-0002-1924-7770; Raman, Nandhini/0000-0003-1657-4351	National Institute of Allergy and infectious Diseases, National Institutes of Health [R01A1111925]; National Center for Advancing Translational Sciences, National Institutes of Health, through UCSF-CTSI [UL1 TR991872]; NATIONAL CANCER INSTITUTE [P30CA093373] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI111925] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK108350] Funding Source: NIH RePORTER	National Institute of Allergy and infectious Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Center for Advancing Translational Sciences, National Institutes of Health, through UCSF-CTSI; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was funded by the National Institute of Allergy and infectious Diseases, National Institutes of Health, through R01A1111925 (PI Smith-McCune) and by the National Center for Advancing Translational Sciences, National Institutes of Health, through UCSF-CTSI Grant Number UL1 TR991872 to support the collection of clinical samples. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2019, LANCET; Buhling KJ, 2014, CONTRACEPTION, V89, P162, DOI 10.1016/j.contraception.2013.11.011; Cavrois M, 2006, J VIROL, V80, P1992, DOI 10.1128/JVI.80.4.1992-1999.2006; Cavrois M, 2002, NAT BIOTECHNOL, V20, P1151, DOI 10.1038/nbt745; Chen JC, 2015, BIO PROTOC, V5; DEVINCENZI I, 1992, BRIT MED J, V304, P809; Eastment MC, 2018, AIDS, V32, P687, DOI 10.1097/QAD.0000000000001768; Gesner M, 2014, BIO PROTOC, V4; Hladik F, 2008, NAT REV IMMUNOL, V8, P447, DOI 10.1038/nri2302; Kapiga SH, 1998, AIDS, V12, P75, DOI 10.1097/00002030-199801000-00009; Li M, 2006, J VIROL, V80, P11776, DOI 10.1128/JVI.01730-06; Martin HL, 1998, J INFECT DIS, V178, P1053, DOI 10.1086/515654; Merbah M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050839; Parrish NF, 2013, P NATL ACAD SCI USA, V110, P6626, DOI 10.1073/pnas.1304288110; Polis CB, 2016, AIDS, V30, P2665, DOI 10.1097/QAD.0000000000001228; Pudney J, 2005, BIOL REPROD, V73, P1253, DOI 10.1095/biolreprod.105.043133; Quillay H, 2015, J VIROL, V89, P1329, DOI 10.1128/JVI.01730-14; Roan NR, 2009, J VIROL, V83, P73, DOI 10.1128/JVI.01366-08; Rodriguez-Garcia M, 2013, J REPROD IMMUNOL, V97, P74, DOI 10.1016/j.jri.2012.10.010; Salazar-Gonzalez JF, 2009, J EXP MED, V206, P1273, DOI 10.1084/jem.20090378; Shacklett BL, 2011, AM J REPROD IMMUNOL, V65, P230, DOI 10.1111/j.1600-0897.2010.00948.x; Shanmugasundaram U, 2016, AM J REPROD IMMUNOL, V76, P137, DOI 10.1111/aji.12535; Sharkey DJ, 2012, J IMMUNOL, V188, P2445, DOI 10.4049/jimmunol.1102736; Stieh DJ, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004440; Wira CR, 2008, AIDS, V22, P1909, DOI 10.1097/QAD.0b013e3283060ea4; World health Organization, 2007, REPORT OF A TECHNICA; World Health Organization, 2012, PROGRAMMATIC AND RES; World Health Organization, 2012, HORMONAL CONTRACEPTI; Ziegler-Heitbrock L, 2010, BLOOD, V116, pE74, DOI 10.1182/blood-2010-02-258558	29	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2019	14	8							e0221181	10.1371/journal.pone.0221181	http://dx.doi.org/10.1371/journal.pone.0221181			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5RZ	31437197	Green Published, gold			2022-12-26	WOS:000485036900034
J	Cesaro, A; Defrene, J; Lachhab, A; Page, N; Tardif, MR; Al-Shami, A; Oravecz, T; Fortin, PR; Daudelin, JF; Labrecque, N; Aoudjit, F; Pelletier, M; Tessier, PA				Cesaro, Annabelle; Defrene, Joan; Lachhab, Asmaa; Page, Nathalie; Tardif, Melanie R.; Al-Shami, Amin; Oravecz, Tamas; Fortin, Paul R.; Daudelin, Jean-Francois; Labrecque, Nathalie; Aoudjit, Fawzi; Pelletier, Martin; Tessier, Philippe A.			Enhanced myelopoiesis and aggravated arthritis in S100a8-deficient mice	PLOS ONE			English	Article							URATE MONOHYDRATE CRYSTALS; S100 PROTEIN CP-10; OXIDATIVE MODIFICATIONS; CARTILAGE DESTRUCTION; HEMATOPOIETIC STEM; RECEPTOR 4; CELLS; ACTIVATION; EXPRESSION; INFLAMMATION	Expressed strongly by myeloid cells, damage-associated molecular pattern (DAMP) proteins S100A8 and S100A9 are found in the serum of patients with infectious and autoimmune diseases. Compared to S100A9, the role of S100A8 is controversial. We investigated its biological activity in collagen-induced arthritis using the first known viable and fertile S100a8-deficient (S100a8(-/-)) mouse. Although comparable to the wild type (WT) in terms of lymphocyte distribution in blood and in the primary and secondary lymphoid organs, S100a8(-/-) mice had increased numbers of neutrophils, monocytes and dendritic cells in the blood and bone marrow, and these all expressed myeloid markers such as CD11b, Ly6G and CD86 more strongly. Granulocyte-macrophage common precursors were increased in S100a8(-/-) bone marrow and yielded greater numbers of macrophages and dendritic cells in culture. The animals also developed more severe arthritic disease leading to aggravated osteoclast activity and bone destruction. These findings were correlated with increased inflammatory cell infiltration and cytokine secretion in the paws. This study suggests that S100A8 is an anti-inflammatory DAMP that regulates myeloid cell differentiation, thereby mitigating the development of experimental arthritis.	[Cesaro, Annabelle; Defrene, Joan; Lachhab, Asmaa; Page, Nathalie; Tardif, Melanie R.; Fortin, Paul R.; Aoudjit, Fawzi; Pelletier, Martin; Tessier, Philippe A.] Univ Laval, Ctr Rech CHU Quebec, Axe Rech Malad Infect & Immunitaires, Quebec City, PQ, Canada; [Al-Shami, Amin; Oravecz, Tamas] Lexicon Pharmaceut Inc, The Woodlands, TX USA; [Fortin, Paul R.] Univ Laval, Fac Med, Dept Med, Quebec City, PQ, Canada; [Daudelin, Jean-Francois; Labrecque, Nathalie] Maisonneuve Rosemont Hosp, Res Ctr, Montreal, PQ, Canada; [Labrecque, Nathalie] Univ Montreal, Dept Med, Montreal, PQ, Canada; [Labrecque, Nathalie] Univ Montreal, Dept Microbiol Infectiol & Immunol, Montreal, PQ, Canada; [Aoudjit, Fawzi; Pelletier, Martin; Tessier, Philippe A.] Univ Laval, Fac Med, Dept Microbiol Infectiol & Immunol, Quebec City, PQ, Canada; [Cesaro, Annabelle] Univ Orleans, Dept Sci, Orleans, France; [Al-Shami, Amin] Univ Texas MD Anderson Canc Ctr, ORBIT, Houston, TX 77030 USA; [Oravecz, Tamas] Janssen Res & Dev, Janssen Biotherapeut, Spring House, PA USA	Laval University; Lexicon Pharmaceuticals; Laval University; Universite de Montreal; Universite de Montreal; Universite de Montreal; Laval University; Universite de Orleans; University of Texas System; UTMD Anderson Cancer Center; Johnson & Johnson; Janssen Pharmaceuticals	Tessier, PA (corresponding author), Univ Laval, Ctr Rech CHU Quebec, Axe Rech Malad Infect & Immunitaires, Quebec City, PQ, Canada.; Tessier, PA (corresponding author), Univ Laval, Fac Med, Dept Microbiol Infectiol & Immunol, Quebec City, PQ, Canada.	Philippe.tessier@crchudequebec.ulaval.ca	Cesaro, Annabelle/AAX-3177-2020	Defrene, Joan/0000-0002-8484-5857; Fortin, Paul R./0000-0002-7278-2596; Aoudjit, Fawzi/0000-0001-9579-2941	Pfizer; Amgen; BMS; Abbvie; Roche; Sanofi-Genzyme; Merck Co.; Canadian Institutes of Health Research [143057, 136975]	Pfizer(Pfizer); Amgen(Amgen); BMS(Bristol-Myers Squibb); Abbvie(AbbVie); Roche(Roche Holding); Sanofi-Genzyme(Sanofi-AventisGenzyme Corporation); Merck Co.(Merck & Company); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	Unrestricted funds to support the CHU de Quebec-Universite Laval Biobank Repository Database were granted by Pfizer, Amgen, BMS, Abbvie, Roche, Sanofi-Genzyme and Merck & Co. This work was supported by grants to MP (143057), PAT and FA (136975) from the Canadian Institutes of Health Research. MP is a Junior 2 scholar from the Fonds de recherche du Quebec-Sante (FRQS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anceriz N, 2007, BIOCHEM BIOPH RES CO, V354, P84, DOI 10.1016/j.bbrc.2006.12.203; Averill MM, 2011, CIRCULATION, V123, P1216, DOI 10.1161/CIRCULATIONAHA.110.985523; Baker JR, 2011, DEV DYNAM, V240, P2194, DOI 10.1002/dvdy.22709; Bianchi ME, 2007, J LEUKOCYTE BIOL, V81, P1, DOI 10.1189/jlb.0306164; BOYUM A, 1968, SCAND J CLIN LAB INV, VS 21, P77; Cesaro A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045478; Cheng PY, 2008, J EXP MED, V205, P2235, DOI 10.1084/jem.20080132; Cornish CJ, 1996, J CELL PHYSIOL, V166, P427, DOI 10.1002/(SICI)1097-4652(199602)166:2<427::AID-JCP21>3.0.CO;2-6; Davies John Q, 2005, Methods Mol Biol, V290, P91; DEVERY JM, 1994, J IMMUNOL, V152, P1888; Doussiere J, 2002, EUR J BIOCHEM, V269, P3246, DOI 10.1046/j.1432-1033.2002.03002.x; EDGEWORTH J, 1991, J BIOL CHEM, V266, P7706; Endoh Y, 2009, J IMMUNOL, V182, P2258, DOI 10.4049/jimmunol.0802683; Foell D, 2004, ARTHRITIS RHEUM-US, V50, P3762, DOI 10.1002/art.20631; Foell D, 2007, NAT CLIN PRACT RHEUM, V3, P382, DOI 10.1038/ncprheum0531; Gomes LH, 2013, FREE RADICAL BIO MED, V58, P170, DOI 10.1016/j.freeradbiomed.2012.12.012; Grevers LC, 2011, ARTHRITIS RHEUM-US, V63, P1365, DOI 10.1002/art.30290; Grimbaldeston MA, 2003, J INVEST DERMATOL, V121, P1168, DOI 10.1046/j.1523-1747.2003.12561.x; Harrison CA, 1999, J BIOL CHEM, V274, P8561, DOI 10.1074/jbc.274.13.8561; Henke MO, 2006, EXP LUNG RES, V32, P331, DOI 10.1080/01902140600959580; Hiroshima Y, 2014, J IMMUNOL, V192, P2800, DOI 10.4049/jimmunol.1302556; Hobbs JAR, 2003, MOL CELL BIOL, V23, P2564, DOI 10.1128/MCB.23.7.2564-2576.2003; INABA K, 1992, J EXP MED, V176, P1693, DOI 10.1084/jem.176.6.1693; Kondo M, 2003, ANNU REV IMMUNOL, V21, P759, DOI 10.1146/annurev.immunol.21.120601.141007; Korndorfer IP, 2007, J MOL BIOL, V370, P887, DOI 10.1016/j.jmb.2007.04.065; Kotake S, 1996, J BONE MINER RES, V11, P88; LACKMANN M, 1992, J BIOL CHEM, V267, P7499; LACKMANN M, 1993, J IMMUNOL, V150, P2981; Laouedj M, 2017, BLOOD, V129, P1980, DOI 10.1182/blood-2016-09-738005; Lim SY, 2008, J IMMUNOL, V181, P5627, DOI 10.4049/jimmunol.181.8.5627; Lim SY, 2011, ANTIOXID REDOX SIGN, V15, P2235, DOI 10.1089/ars.2010.3641; Lim SY, 2010, J BIOL CHEM, V285, P14377, DOI 10.1074/jbc.M109.075242; Lim SY, 2009, J LEUKOCYTE BIOL, V86, P577, DOI 10.1189/jlb.1008608; Loser K, 2010, NAT MED, V16, P713, DOI 10.1038/nm.2150; Manitz MP, 2003, MOL CELL BIOL, V23, P1034, DOI 10.1128/MCB.23.3.1034-1043.2003; McInnes IB, 2011, NEW ENGL J MED, V365, P2205, DOI 10.1056/NEJMra1004965; Mueller C, 2012, DIGEST DIS, V30, P40, DOI 10.1159/000342600; Oduro KA, 2012, BLOOD, V120, P2203, DOI 10.1182/blood-2011-11-391342; Passey RJ, 1999, J IMMUNOL, V163, P2209; Pelletier M, 2014, METHOD ENZYMOL, V542, P125, DOI 10.1016/B978-0-12-416618-9.00007-8; Perera C, 2010, IMMUNOL CELL BIOL, V88, P41, DOI 10.1038/icb.2009.88; Popovic K, 2005, ARTHRITIS RHEUM, V52, P3639, DOI 10.1002/art.21398; Raftery MJ, 2001, J BIOL CHEM, V276, P33393, DOI 10.1074/jbc.M101566200; Rammes A, 1997, J BIOL CHEM, V272, P9496; Raquil MA, 2008, J IMMUNOL, V180, P3366, DOI 10.4049/jimmunol.180.5.3366; Ryckman C, 2003, J IMMUNOL, V170, P3233, DOI 10.4049/jimmunol.170.6.3233; Ryckman C, 2004, J LEUKOCYTE BIOL, V76, P433, DOI 10.1189/jlb.0603294; Ryckman C, 2003, ARTHRITIS RHEUM-US, V48, P2310, DOI 10.1002/art.11079; Simard JC, 2011, J IMMUNOL, V186, P3622, DOI 10.4049/jimmunol.1002956; Simard JC, 2010, J LEUKOCYTE BIOL, V87, P905, DOI 10.1189/jlb.1009676; Sun Y, 2013, MOL IMMUNOL, V53, P443, DOI 10.1016/j.molimm.2012.10.002; Sunahori K, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1939; Tardif MR, 2015, J IMMUNOL RES, V2015, DOI 10.1155/2015/296149; van Lent PLEM, 2008, ANN RHEUM DIS, V67, P1750, DOI 10.1136/ard.2007.077800; van Lent PLEM, 2008, ARTHRITIS RHEUM-US, V58, P3776, DOI 10.1002/art.24074; van Lent PL, 2010, ARTHRITIS RHEUM-US, V62, P3353, DOI 10.1002/art.27654; Vandal K, 2003, J IMMUNOL, V171, P2602, DOI 10.4049/jimmunol.171.5.2602; Wattler S, 1999, BIOTECHNIQUES, V26, P1150, DOI 10.2144/99266rr02; Xu K, 2001, J IMMUNOL, V166, P6358, DOI 10.4049/jimmunol.166.10.6358; Zhao J, 2011, ANTIOXID REDOX SIGN, V14, P1589, DOI 10.1089/ars.2010.3583; Zreiqat H, 2007, J MOL HISTOL, V38, P381, DOI 10.1007/s10735-007-9117-2	61	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2019	14	8							e0221528	10.1371/journal.pone.0221528	http://dx.doi.org/10.1371/journal.pone.0221528			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5RZ	31437241	Green Published, Green Submitted, gold			2022-12-26	WOS:000485036900087
J	Fernandez-Alvarez, I; Zapata-Cachafeiro, M; Vazquez-Lago, J; Lopez-Vazquez, P; Pineiro-Lamas, M; Rodriguez, RG; Figueiras, A; Gestal, AE; Caamano, F; Gestal-Otero, JJ; Taracido, M; Lopez-Duran, A; Salgado, A; Gonzalez, EL; Sastre, I				Fernandez-Alvarez, Iria; Zapata-Cachafeiro, Maruxa; Vazquez-Lago, Juan; Lopez-Vazquez, Paula; Pineiro-Lamas, Maria; Garcia Rodriguez, Raquel; Figueiras, Adolfo; Estany Gestal, Ana; Caamano, Francisco; Gestal-Otero, Juan J.; Taracido, Margarita; Lopez-Duran, Ana; Salgado, Angel; Lopez Gonzalez, Elena; Sastre, Isabel		GREPHEPI Grp	Pharmaceutical companies information and antibiotic prescription patterns: A follow-up study in Spanish primary care	PLOS ONE			English	Article							RESPIRATORY-TRACT INFECTIONS; ANTIMICROBIAL RESISTANCE; PRESCRIBING BEHAVIOR; DRUG INFORMATION; PHYSICIAN; INDUSTRY; GUIDELINES; DETERMINANTS; ATTITUDES; QUALITY	Objectives To assess the impact of sources of drug information on antibiotic prescribing patterns (quantity and quality) among primary care physicians. Methods We conducted a cohort study on primary care physicians who were actively engaged in medical practice in 2010 in a region in north-west Spain (Galicia), fulfilling inclusion criteria (n = 2100). As the independent variable, we took the perceived utility of 6 sources of information on antibiotics, as measured by the validated KAAR-11 questionnaire. As dependent variables, we used: (1) a quality indicator (appropriate quality, defined as any case where 6 of the 12 indicators proposed by the European Surveillance of Antimicrobial Consumption Network [ESAC-Net] were better than the mean values for Spain); and, (2) a quantity indicator (high prescribing), defined as any case where defined daily doses (DDD) per 1 000 inhabitants per day of antibacterials for systemic use were higher than the mean values for Spain. The adjusted odds ratio for a change in the interquartile range (IqOR) for each sources of information on antibiotics was calculated using Generalized Linear Mixed Models. Results The questionnaire response rate was 68%. Greater perceived utility of pharmaceutical sales representatives increases the risk of having high prescribing (1/IqOR = 2.50 [95%CI: 1.63-3.66]) and reduces the probability of having appropriate quality (1/IqOR = 2.28 [95%CI: 1.77-3.01]). Greater perceived utility of clinical guidelines increases the probability of having appropriate quality (1/IqOR = 1.25 [95%CI: 1.02-1.54]) and reduces the probability of high prescribing (1/IqOR = 1.25 [95%CI: 1.02-1.54]). Conclusions Sources of information on antibiotics are an important determinant of the quantity and quality of antibiotic prescribing in primary care. Commercial sources of information influence prescribing negatively, and clinical guidelines are associated with better indicators.	[Fernandez-Alvarez, Iria] Santiago De Compostela Univ, Teaching Hosp, Prevent Med Serv, Santiago De Compostela, Spain; [Zapata-Cachafeiro, Maruxa; Vazquez-Lago, Juan; Lopez-Vazquez, Paula; Figueiras, Adolfo; Caamano, Francisco; Gestal-Otero, Juan J.; Taracido, Margarita; Lopez Gonzalez, Elena] Univ Santiago de Compostela, Dept Prevent Med & Publ Hlth, Santiago De Compostela, Spain; [Zapata-Cachafeiro, Maruxa; Pineiro-Lamas, Maria; Figueiras, Adolfo] CIBER Epidemiol & Salud Publ CIBERESP, Consortium Biomed Res Epidemiol & Publ Hlth, Santiago De Compostela, Spain; [Pineiro-Lamas, Maria; Figueiras, Adolfo] Hlth Res Inst Santiago De Compostela IDIS, Santiago De Compostela, Spain; [Garcia Rodriguez, Raquel] Univ A Coruna, Teaching Hosp, Prevent Med Serv, Coruna, Spain; [Estany Gestal, Ana] Hlth Res Inst Santiago De Compostela FIDIS, Unit Methodol Res, Santiago De Compostela, Spain; [Lopez-Duran, Ana] Univ Santiago de Compostela, Dept Clin Psychol & Psychobiol, Santiago De Compostela, Spain; [Salgado, Angel] Univ Hosp Alvaro Cunqueiro, Unit Supporting Res, Vigo, Spain; [Sastre, Isabel] Hlth Care Ctr San Jose A, Primary Care Pharm Unit, La Coruna, Spain	Universidade de Santiago de Compostela; Universidade de Santiago de Compostela; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Complexo Hospitalario Universitario de Santiago de Compostela; Universidade da Coruna; Universidade de Santiago de Compostela; Complejo Hospitalario Universitario A Coruna	Figueiras, A (corresponding author), Univ Santiago de Compostela, Dept Prevent Med & Publ Hlth, Santiago De Compostela, Spain.; Figueiras, A (corresponding author), CIBER Epidemiol & Salud Publ CIBERESP, Consortium Biomed Res Epidemiol & Publ Hlth, Santiago De Compostela, Spain.; Figueiras, A (corresponding author), Hlth Res Inst Santiago De Compostela IDIS, Santiago De Compostela, Spain.	adolfo.figueiras@usc.es	lopez-duran, ana/ABE-1205-2021; /AAD-1740-2020; Caamano-Isorna, Francisco/AAL-3770-2020; lopez-duran, ana/N-1645-2014; Vazquez-Lago, Juan/M-2632-2016; Figueiras Guzman, Adolfo/K-8563-2015	lopez-duran, ana/0000-0001-7661-8972; lopez-duran, ana/0000-0001-7661-8972; Vazquez-Lago, Juan/0000-0003-3457-9957; Pineiro-Lamas, Maria/0000-0003-3655-100X; Zapata Cachafeiro, Maruxa/0000-0002-0648-7716; Figueiras Guzman, Adolfo/0000-0002-5766-8672; Lopez-Vazquez, Paula M/0000-0002-6836-2863	Institute de Salud Carlos III [PI081239, PI09/90609]; Spanish State Plan for Scientific and Technical Research and Innovation 2012-2016; European Regional Development Fund (ERDF); Mutua Madrilena insurance company	Institute de Salud Carlos III(Instituto de Salud Carlos III); Spanish State Plan for Scientific and Technical Research and Innovation 2012-2016; European Regional Development Fund (ERDF)(European Commission); Mutua Madrilena insurance company	This work was supported in part by the Institute de Salud Carlos III (PI081239, PI09/90609) Spanish State Plan for Scientific and Technical Research and Innovation 2012-2016, The European Regional Development Fund (ERDF) and the Mutua Madrilena insurance company. The funders had no role in study design, data-collection and -analysis, decision to publish, or preparation of the manuscript.	Abdelhamid A, 2014, BRIT J GEN PRACT, V64, pE719, DOI 10.3399/bjgp14X682309; Agencia Espanola de Medicamentos y Productos Sanitarios (AEMPS), 2015, PLAN ESTR ACCION RED; Aiello AE, 2006, AM J PUBLIC HEALTH, V96, P1910, DOI 10.2105/AJPH.2005.077214; [Anonymous], 2008, PERIODICO ARAGON; [Anonymous], 1941, NOTICIAS CATOLICAS, V25; Arnold SR, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003539.pub2; Bell BG, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-13; Bharathiraja R., 2005, Indian Journal of Pediatrics, V72, P877, DOI 10.1007/BF02731121; Brax H, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175493; Brenner PS, 2016, SOC PSYCHOL QUART, V79, P333, DOI 10.1177/0190272516628298; Caamano F, 2002, EUR J PUBLIC HEALTH, V12, P187, DOI 10.1093/eurpub/12.3.187; Carlsen B, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-218; Chimonas S, 2007, J GEN INTERN MED, V22, P184, DOI 10.1007/s11606-006-0041-z; CLEARY J D, 1992, Journal of Pharmacy Technology, V8, P27; Coenen S, 2007, QUAL SAF HEALTH CARE, V16, P440, DOI 10.1136/qshc.2006.021121; Costelloe Ceire, 2010, BMJ, V340, pc2096, DOI 10.1136/bmj.c2096; DeJong C, 2016, JAMA INTERN MED, V176, P1114, DOI 10.1001/jamainternmed.2016.2765; Dyar OJ, 2016, EXPERT REV ANTI-INFE, V14, P403, DOI 10.1586/14787210.2016.1151353; ECDC, 2017, PROP EU GUID PRUD US; European Centre for Disease Prevention and Control, 2016, QUAL IND ANT CONS CO; Fadlallah R, 2018, EUR J PUBLIC HEALTH, V28, P224, DOI 10.1093/eurpub/ckx204; Farmaindustria, 2016, COD BUEN PRACT; Fickweiler F, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-016408; Figueiras A, 2001, MED CARE, V39, P158, DOI 10.1097/00005650-200102000-00006; Figueiras A, 2000, EUR J CLIN PHARMACOL, V56, P747, DOI 10.1007/s002280000217; Gagnon MA, 2008, PLOS MED, V5, P29, DOI 10.1371/journal.pmed.0050001; Galan Herrera S, 2004, Aten Primaria, V34, P231, DOI 10.1157/13066401; Garcés Redondo Guillermo, 2010, Rev Clin Med Fam, V3, P5, DOI 10.4321/s1699-695x2010000100003; Gonzalez-Gonzalez C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141820; Hagen TL, 2017, DAN MED J, V64; Ioannidis JPA, 2018, CIRC-CARDIOVASC QUAL, V11, DOI 10.1161/CIRCOUTCOMES.118.004889; Klein EY, 2018, P NATL ACAD SCI USA, V115, pE3463, DOI 10.1073/pnas.1717295115; Livermore DM, 2005, LANCET INFECT DIS, V5, P450, DOI 10.1016/S1473-3099(05)70166-3; Lobo E, 2012, GAC SANIT, V26, P336, DOI 10.1016/j.gaceta.2011.11.003; Lopez-Vazquez P, 2016, J ANTIMICROB CHEMOTH, V71, P2972, DOI 10.1093/jac/dkw238; Lopez-Vazquez P, 2012, J EVAL CLIN PRACT, V18, P473, DOI 10.1111/j.1365-2753.2010.01610.x; Mackinnon A, 1992, INT J METH PSYCH RES, V2, P233; Malo S, 2016, FAM PRACT, V33, P471, DOI 10.1093/fampra/cmw037; Malo S, 2015, BASIC CLIN PHARMACOL, V116, P337, DOI 10.1111/bcpt.12316; Mather C, 2005, SOC SCI MED, V60, P1323, DOI 10.1016/j.socscimed.2004.07.011; Moliner Javier, 2009, Rev Calid Asist, V24, P72, DOI 10.1016/S1134-282X(09)70656-6; Muijrers PEM, 2005, FAM PRACT, V22, P624, DOI 10.1093/fampra/cmi074; Napti P. R., 2016, J BUSINESS SOCIAL SC, V1, P201; Petersen I, 2007, BMJ-BRIT MED J, V335, P982, DOI 10.1136/bmj.39345.405243.BE; Pokorny AMJ, 2015, INTERN MED J, V45, P1085, DOI 10.1111/imj.12855; Rodrigues AT, 2016, CURR MED RES OPIN, V32, P949, DOI 10.1185/03007995.2016.1154520; Rodrigues AT, 2013, INT J ANTIMICROB AG, V41, P203, DOI 10.1016/j.ijantimicag.2012.09.003; Rothman KJ., 2008, MODERN EPIDEMIOLOGY, V3rd ed; Scheipl F., 2020, LINEAR MIXED EFFECTS, DOI 10.18637/jss.v067.i01; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Sintchenko V, 2004, J AM MED INFORM ASSN, V11, P71, DOI 10.1197/jamia.M1166; Spurling GK, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000352; Strama, 2000, GUID TREATM RHIN PHA; van der Velden AW, 2012, BRIT J GEN PRACT, V62, DOI 10.3399/bjgp12X659268; Vazquez-Lago JM, 2012, FAM PRACT, V29, P352, DOI 10.1093/fampra/cmr084; Wood S, 2017, PLOS ONE, V12, DOI [10.1371/journal.pone.0183168, 10.1371/journal.pone.0186060]; Zapata-Cachafeiro M, 2019, J ANTIMICROB CHEMOTH, V74, P511, DOI 10.1093/jac/dky440; Zapata-Cachafeiro M, 2014, J ANTIMICROB CHEMOTH, V69, P3156, DOI 10.1093/jac/dku229; ZIEGLER MG, 1995, JAMA-J AM MED ASSOC, V273, P1296, DOI 10.1001/jama.273.16.1296	59	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2019	14	8							e0221326	10.1371/journal.pone.0221326	http://dx.doi.org/10.1371/journal.pone.0221326			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW5RZ	31437201	gold, Green Published, Green Submitted			2022-12-26	WOS:000485036900050
J	Fuchsjager, N; Winterleitner, H; Krause, R; Feierl, G; Koch, H				Fuchsjaeger, Nina; Winterleitner, Herwig; Krause, Robert; Feierl, Gebhard; Koch, Horst			Susceptibility of microorganisms causing acute hand infections	PLOS ONE			English	Article							BACTERIAL SKIN; EPIDEMIOLOGY; MANAGEMENT	Hand infections are a common presentation at the emergency departments. Without knowing the source of infection clinicians are dependent on systematic reports on the bacterial spectrum and susceptibility tests of the specific infection in their patient community. This study was based on a retrospective chart review of patients presenting to our outpatient clinic with acute hand infections. We documented patient demographics, the etiology, location, culture tests of the infection and analyzed if certain bacteria could be cultured significantly more often in certain etiologies or in specific sites of the hand infection. Susceptibility tests were added. Bacterial swabs of 204 patients were analyzed. Overall S. aureus was found in 53% of all cases, in only one case revealed methicillin-resistant S. aureus (MRSA). There was no significant difference in the bacterial spectrum according to the etiology of the hand infections, except for animal bites where Pasteurella multocida was the dominating bacteria in 63% of all cases. Amoxicillin-clavulanic acid, fluoroquinolones, and piperacillin were effective against the main bacteria. Our study confirms the previously published antibiotic resistance reports and reinforces the current antibiotic treatment guidelines also in this western European population.	[Fuchsjaeger, Nina; Winterleitner, Herwig; Koch, Horst] Med Univ Graz, Dept Surg, Div Plast Aesthet & Reconstruct Surg, Graz, Austria; [Krause, Robert] Med Univ Graz, Sect Infect Dis & Trop Med, Dept Internal Med, Graz, Austria; [Feierl, Gebhard] Med Univ Graz, Inst Hyg Microbiol & Environm Med, Graz, Austria	Medical University of Graz; Medical University of Graz; Medical University of Graz	Fuchsjager, N (corresponding author), Med Univ Graz, Dept Surg, Div Plast Aesthet & Reconstruct Surg, Graz, Austria.	nina.fuchsjaeger@gmail.com		Fuchsjager, Nina/0000-0001-6329-9140				Anwar MU, 2008, SURG INFECT, V9, P357, DOI 10.1089/sur.2007.031; Citron DM, 2007, J CLIN MICROBIOL, V45, P2819, DOI 10.1128/JCM.00551-07; Federal Office of Consumer Protection and Food Safety Paul-Ehrlich-Gesellschaft fur Chemotherapie e. V, 2016, GERMAP 2015 REP CONS, P186; Fowler JR, 2013, J HAND SURG-AM, V38A, P1189, DOI 10.1016/j.jhsa.2013.03.013; Garau J, 2013, CLIN MICROBIOL INFEC, V19, pE377, DOI 10.1111/1469-0691.12235; GLASS KD, 1982, J HAND SURG-AM, V7, P388, DOI 10.1016/S0363-5023(82)80150-0; Houshian S, 2006, INT J INFECT DIS, V10, P315, DOI 10.1016/j.ijid.2005.06.009; Kock R, 2010, EUROSURVEILLANCE, V15, P12, DOI 10.2807/ese.15.41.19688-en; McDonald LS, 2011, J HAND SURG-AM, V36A, P1403, DOI 10.1016/j.jhsa.2011.05.035; Pastila S, 2012, VOX SANG, V103, P93, DOI 10.1111/j.1423-0410.2012.01591.x; Pulido-Cejudo A, 2017, THER ADV INFECT DIS, V4, P143, DOI 10.1177/2049936117723228	11	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2019	14	8							e0220555	10.1371/journal.pone.0220555	http://dx.doi.org/10.1371/journal.pone.0220555			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5RZ	31437151	Green Published, gold, Green Submitted			2022-12-26	WOS:000485036900014
J	Guaman-Guevara, F; Austin, H; Hicks, N; Streeter, R; Austin, WEN				Guaman-Guevara, Fabricio; Austin, Heather; Hicks, Natalie; Streeter, Richard; Austin, William E. N.			Impacts of ocean acidification on intertidal benthic foraminiferal growth and calcification	PLOS ONE			English	Article							CO2; CARBON; CALCITE; SYSTEM; RATES	Foraminifera are expected to be particularly susceptible to future changes in ocean carbonate chemistry as a function of increased atmospheric CO2. Studies in an experimental recirculating seawater system were performed with a dominant benthic foraminiferal species collected from intertidal mudflats. We investigated the experimental impacts of ocean acidification on survival, growth/calcification, morphology and the biometric features of a calcareous species Elphidium williamsoni. Foraminifera were exposed for 6 weeks to four different pH treatments that replicated future scenarios of a high CO2 atmosphere resulting in lower seawater pH. Results revealed that declining seawater pH caused a decline in foraminiferal survival rate and growth/calcification (mainly through test weight reduction). Scanning electron microscopy image analysis of live specimens at the end of the experimental period show changes in foraminiferal morphology with clear signs of corrosion and cracking on the test surface, septal bridges, sutures and feeding structures of specimens exposed to the lowest pH conditions. These findings suggest that the morphological changes observed in shell feeding structures may serve to alter: (1) foraminiferal feeding efficiency and their long-term ecological competitiveness, (2) the energy transferred within the benthic food web with a subsequent shift in benthic community structures and (3) carbon cycling and total CaCO3 production, both highly significant processes in coastal waters. These experimental results open-up the possibility of modelling future impacts of ocean acidification on both calcification and dissolution in benthic foraminifera within mid-latitude intertidal environments, with potential implications for understanding the changing marine carbon cycle.	[Guaman-Guevara, Fabricio; Austin, Heather; Streeter, Richard; Austin, William E. N.] Univ St Andrews, Sch Geog & Sustainable Dev, St Andrews, Fife, Scotland; [Hicks, Natalie] Univ Essex, Sch Biol Sci, Colchester, Essex, England; [Austin, William E. N.] SAMS, Oban, Argyll, Scotland	University of St Andrews; University of Essex	Austin, WEN (corresponding author), Univ St Andrews, Sch Geog & Sustainable Dev, St Andrews, Fife, Scotland.; Austin, WEN (corresponding author), SAMS, Oban, Argyll, Scotland.	wena@st-andrews.ac.uk		GUAMAN, FABRICIO/0000-0002-1008-1452; Streeter, Richard/0000-0003-2261-4540; Hicks, Natalie/0000-0003-0843-9731	Secretaria de Educacion Superior, Ciencia, Tecnologia e Innovacion de la Republica del Ecuador (SENESCYT)	Secretaria de Educacion Superior, Ciencia, Tecnologia e Innovacion de la Republica del Ecuador (SENESCYT)	This work is a contribution to FGG's PhD study programme at the University of St Andrews, UK, and is funded by Secretaria de Educacion Superior, Ciencia, Tecnologia e Innovacion de la Republica del Ecuador (SENESCYT). The funder had no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER SP, 1984, J FORAMIN RES, V14, P159, DOI 10.2113/gsjfr.14.3.159; Allison N, 2011, CHEM GEOL, V289, P171, DOI 10.1016/j.chemgeo.2011.08.001; ALLISON N, CULTURE STUDIES, pCO32, DOI DOI 10.1666/13051; Allison N, 2008, CHEM GEOL, V253, P83, DOI 10.1016/j.chemgeo.2008.04.010; Andersson AJ, 2008, MAR ECOL PROG SER, V373, P265, DOI 10.3354/meps07639; Austin HA, 2005, MAR MICROPALEONTOL, V57, P68, DOI 10.1016/j.marmicro.2005.07.002; Beaufort L, 2011, NATURE, V476, P80, DOI 10.1038/nature10295; Bentov S, 2006, GEOCHEM GEOPHY GEOSY, V7, DOI 10.1029/2005GC001015; Bernhard JM, 2004, J FORAMIN RES, V34, P96, DOI 10.2113/0340096; Blackford JC, 2010, J MARINE SYST, V81, P12, DOI 10.1016/j.jmarsys.2009.12.016; BOUTROUMAZEILLE.V, SEDIMENT; Briguglio A, 2014, PALEOBIOLOGY, V40, P494, DOI 10.1666/13051; Briguglio A, 2011, TURK J EARTH SCI, V20, P683, DOI 10.3906/yer-0910-44; Caldeira K, 2003, NATURE, V425, P365, DOI 10.1038/425365a; Cornwall CE, 2016, ICES J MAR SCI, V73, P572, DOI 10.1093/icesjms/fsv118; CORTES CL, 2017, NAT COMMUN, V8, DOI DOI 10.1007/S00227-012-1921-X; Currie AR, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01599; DEVELOPMENT C, 2014, R A LANGUAGE AND ENV, DOI DOI 10.4319/LO.2011.56.4.1200; Dias BB, 2010, J GEOL SOC LONDON, V167, P843, DOI 10.1144/0016-76492010-050; Dickson AG, 2003, MAR CHEM, V80, P185, DOI 10.1016/S0304-4203(02)00133-0; DICKSON AG, 2007, PICES SPECIAL PUBLIC, pCO2, DOI DOI 10.1144/0016-76492010-050; Dissard D, 2009, GEOCHEM GEOPHY GEOSY, V10, DOI 10.1029/2009GC002417; Doo SS, 2014, BIOL BULL-US, V226, P169, DOI 10.1086/BBLv226n3p169; Duarte CM, 2008, ESTUAR COAST, V31, P233, DOI 10.1007/s12237-008-9038-7; Dupont S, 2013, MAR BIOL, V160, P1835, DOI 10.1007/s00227-012-1921-x; Edmunds PJ, 2016, BIOSCIENCE, V66, P350, DOI 10.1093/biosci/biw023; Engel BE, 2015, J FORAMIN RES, V45, P190, DOI 10.2113/gsjfr.45.2.190; Fabricius KE, 2011, NAT CLIM CHANGE, V1, P165, DOI 10.1038/NCLIMATE1122; Fabry VJ, 2008, ICES J MAR SCI, V65, P414, DOI 10.1093/icesjms/fsn048; Feely RA, 2004, SCIENCE, V305, P362, DOI 10.1126/science.1097329; Field C.B., 2014, SPEC REP GLOB WARM 1, DOI 10.1017/cbo9780511976988.002; FOX J, 2011, COMPANION; Fujita K, 2011, BIOGEOSCIENCES, V8, P2089, DOI 10.5194/bg-8-2089-2011; Gaylord B, 2011, J EXP BIOL, V214, P2586, DOI 10.1242/jeb.055939; GLAS MS, GLAS, pO2, DOI DOI 10.1371/JOURNAL.PONE.0050010; GOODAY AJ, 1992, NATO ADV SCI I C-MAT, V360, P63; Haynert K, 2014, BIOGEOSCIENCES, V11, P1581, DOI 10.5194/bg-11-1581-2014; Haynert K, 2011, MAR ECOL PROG SER, V432, P53, DOI 10.3354/meps09138; Heinz P, 2002, DEEP-SEA RES PT I, V49, P517, DOI 10.1016/S0967-0637(01)00070-X; Henehan MJ, 2017, BIOGEOSCIENCES, V14, P3287, DOI 10.5194/bg-14-3287-2017; Hikami M, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL048501; Hintz CJ, 2004, LIMNOL OCEANOGR-METH, V2, P160, DOI 10.4319/lom.2004.2.160; Ingels J, 2018, J EXP MAR BIOL ECOL, V502, P211, DOI 10.1016/j.jembe.2017.07.012; Keul N, 2013, BIOGEOSCIENCES, V10, P6185, DOI 10.5194/bg-10-6185-2013; Khanna N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083118; Kroeker KJ, 2013, GLOBAL CHANGE BIOL, V19, P1884, DOI 10.1111/gcb.12179; Kuroyanagi A, 2009, MAR MICROPALEONTOL, V73, P190, DOI 10.1016/j.marmicro.2009.09.003; LABELLING E, MAR ECOL PROG SER, DOI DOI 10.1038/NATURE10295; LABELLING E, 2012, MAR ECOL PROG SER, V7; LABELLING E, MAR ECOL PROG SER, DOI DOI 10.1007/978-4-431-54388-6_6; LABELLING E, 2010, MAR ECOL PROG SER, V274, P87; LABELLING E, MAR ECOL PROG SER, DOI DOI 10.1016/J.MARMICRO.2014.09.003; LABELLING E, MAR ECOL PROG SER, DOI DOI 10.1038/NCOMMS14144; LABELLING E, MAR ECOL PROG SER, DOI DOI 10.1093/BIOSCI/BIW023; LABELLING E, 2014, MAR ECOL PROG SER, DOI DOI 10.1016/J.MARMICRO.2008.09.004; LABELLING E, 2009, MAR ECOL PROG SER, V52, P75; LABELLING E, 2000, MAR ECOL PROG SER, V202, P289; LABELLING E, MAR ECOL PROG SER, DOI DOI 10.1371/JOURNAL.PONE.0050010; LABELLING E, MAR ECOL PROG SER, DOI DOI 10.5194/BG-11-1581-2014; LABELLING E, MAR ECOL PROG SER; Langer MR, 2008, J EUKARYOT MICROBIOL, V55, P163, DOI 10.1111/j.1550-7408.2008.00321.x; Lecroq B, 2014, ENVIRON SCI ENG, P91, DOI 10.1007/978-4-431-54388-6_6; Lemasson AJ, 2017, J EXP MAR BIOL ECOL, V492, P49, DOI 10.1016/j.jembe.2017.01.019; LINKE P, 1993, MAR MICROPALEONTOL, V20, P215, DOI 10.1016/0377-8398(93)90034-U; Lombard F, 2009, MAR MICROPALEONTOL, V70, P1, DOI 10.1016/j.marmicro.2008.09.004; Maier C, 2012, P ROY SOC B-BIOL SCI, V279, P1716, DOI 10.1098/rspb.2011.1763; Marshall BJ, 2013, PALEOCEANOGRAPHY, V28, P363, DOI 10.1002/palo.20034; McIntyre-Wressnig A, 2013, MAR ECOL PROG SER, V472, P45, DOI 10.3354/meps09918; MEWES A, MICROPALEONTOLOGY, DOI DOI 10.1016/J.CHEMGEO.2008.04.010; MITHTHAPALA S, 2013, TIDAL FLATS COASTAL, DOI DOI 10.1016/J.JEMBE.2017.07.012; MOODLEY L, PM J; MURRAY JW, 2006, PRESS, DOI DOI 10.1111/J.1550-7408.2008.00321.X; MUSPACING D, 2016, J FORAMIN RES, V46, P61; Orr JC, 2005, NATURE, V437, P681, DOI 10.1038/nature04095; Pettit LR, 2015, ECOL EVOL, V5, P1784, DOI 10.1002/ece3.1475; Pierrot D, 2006, ORNL CDIAC 105A, DOI [10.3334/CDIAClag.0O2SYS XIS CDIAC105a, DOI 10.3354/MEPS09918]; Prazeres M, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.2782; RAVEN, 2005, R SOC, P1, DOI DOI 10.1098/RSPB.2011.1763; Ries J, 2011, NAT CLIM CHANGE, V1, P294, DOI 10.1038/nclimate1204; ROGGATZ C, 2016, OCEAN ACIDIFICATION, P3914, DOI DOI 10.1002/PALO.20034; Sabine CL, 2004, SCIENCE, V305, P367, DOI 10.1126/science.1097403; Saraswat R, 2015, ESTUAR COAST SHELF S, V153, P96, DOI 10.1016/j.ecss.2014.12.005; Sinutok S, 2011, LIMNOL OCEANOGR, V56, P1200, DOI 10.4319/lo.2011.56.4.1200; UTHICKE S, 2013, SCI REP-UK, V3, DOI DOI 10.1098/RSPB.2014.2782; Venables W. N., 2002, SPRINGER; Vogel N, 2012, J EXP MAR BIOL ECOL, V424, P15, DOI 10.1016/j.jembe.2012.05.008; Waldbusser GG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128376; Widdicombe S, 2008, J EXP MAR BIOL ECOL, V366, P187, DOI 10.1016/j.jembe.2008.07.024; Wyness AJ, 2019, SCI TOTAL ENVIRON, V661, P155, DOI 10.1016/j.scitotenv.2019.01.061; Zeebe RE, 2008, SCIENCE, V321, P51, DOI 10.1126/science.1159124	90	4	4	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2019	14	8							e0220046	10.1371/journal.pone.0220046	http://dx.doi.org/10.1371/journal.pone.0220046			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5QN	31433797	Green Submitted, Green Accepted, Green Published, gold			2022-12-26	WOS:000485033100008
